<SEC-DOCUMENT>0000950170-23-009492.txt : 20230323
<SEC-HEADER>0000950170-23-009492.hdr.sgml : 20230323
<ACCEPTANCE-DATETIME>20230323161342
ACCESSION NUMBER:		0000950170-23-009492
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		101
CONFORMED PERIOD OF REPORT:	20221231
FILED AS OF DATE:		20230323
DATE AS OF CHANGE:		20230323

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Equillium, Inc.
		CENTRAL INDEX KEY:			0001746466
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				821554746
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38692
		FILM NUMBER:		23756358

	BUSINESS ADDRESS:	
		STREET 1:		2223 AVENIDA DE LA PLAYA
		STREET 2:		SUITE 105
		CITY:			LA JOLLA
		STATE:			CA
		ZIP:			92037
		BUSINESS PHONE:		(858) 412-5302

	MAIL ADDRESS:	
		STREET 1:		2223 AVENIDA DE LA PLAYA
		STREET 2:		SUITE 105
		CITY:			LA JOLLA
		STATE:			CA
		ZIP:			92037
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>eq-20221231.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="ASCII"?><!-- DFIN New ActiveDisclosure (SM) Inline XBRL Document - http://www.dfinsolutions.com/ --><!-- Creation Date :2023-03-23T11:19:41.4399+00:00 --><!-- Copyright (c) 2023 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:nonNumeric="http://www.xbrl.org/dtr/type/non-numeric" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:stpr="http://xbrl.sec.gov/stpr/2022" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:eq="http://equilliumbio.com/20221231" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:srt="http://fasb.org/srt/2022" xmlns:utr="http://www.xbrl.org/2009/utr">
 <head>
  <title>10-K</title>
  <meta http-equiv="Content-Type" content="text/html" />
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <div style="display:none;"><ix:header><ix:hidden><ix:nonFraction id="F_7b20e3c0-5f9d-4152-8056-9265a122f74d" name="us-gaap:CommitmentsAndContingencies" contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="F_e9cd9fc4-b2d3-4e1c-814b-17b62754d416" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="C_1a97b4e1-6653-4a2c-a233-548bf388b221" unitRef="U_shares" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="F_67670f1b-d32e-411d-94c3-bb52f2db6f60" name="us-gaap:CommitmentsAndContingencies" contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonNumeric id="F_25b946aa-ecb7-4d36-9827-13132f6bd5be" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" contextRef="C_6658e49b-c37e-401c-873e-60a833ca00d9" format="ixt-sec:durwordsen">three year</ix:nonNumeric><ix:nonNumeric id="F_2e4945d0-b4a5-4e03-8b7c-8e13fa8a2580" name="dei:AmendmentFlag" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5">false</ix:nonNumeric><ix:nonNumeric id="F_fe087972-da05-45cf-9bbf-511a325aec83" name="dei:EntityCentralIndexKey" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5">0001746466</ix:nonNumeric><ix:nonFraction id="F_0fa15c8b-e902-4287-b1e7-c4c493e1c465" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" contextRef="C_1a97b4e1-6653-4a2c-a233-548bf388b221" unitRef="U_USDollarShare" xsi:nil="true"></ix:nonFraction><ix:nonNumeric id="F_ce0f5a29-0bcc-4dd4-b7f6-18f9deaf9632" name="dei:DocumentFiscalPeriodFocus" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5">FY</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="eq-20221231.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="C_53fe6a42-e9c0-41f9-a76d-589ed71e0cd6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">eq:BionizTherapeuticsIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-02-14</xbrli:startDate><xbrli:endDate>2022-02-14</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_4ba266ad-8527-41b5-81de-63143638b62c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">eq:TwoThousandEighteenEquityIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_c004a059-d1b3-45bc-90d2-29b2939452f6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_c0403c73-e303-4bd7-ae36-cf044f363dc1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">eq:EighteenMonthsAfterClosingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">eq:BionizTherapeuticsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-02-14</xbrli:startDate><xbrli:endDate>2022-02-14</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_1adba1d3-86e2-48ca-8036-09ebd512337c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">eq:USTreasurySecuritiesMaturingBetweenOneAndFiveYearsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_0dabeff1-f05f-4737-8f45-b0cb38473eb4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">eq:LoanAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_0b4db976-5656-4c9e-a811-53098826741a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_cba59bb2-f211-4a75-beff-6ddac7dfa0b7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_257b0705-b56f-4bd5-86f9-1add29602d4d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eq:AssetPurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">eq:OnoPharmaceuticalCoLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_e4e76746-9176-4a76-9703-056a9ff95868"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_07d00b46-0b94-46d4-a9c0-90bd6e6336f4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_d3ce0459-c113-4153-9f4d-e1ca48da2c0b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EquityUnitPurchaseAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-03</xbrli:startDate><xbrli:endDate>2021-02-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_ef6b21dc-276b-4e2a-a0f4-7de1ea76111b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">eq:TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_b41b6a74-0d46-45fe-8820-d94fa8d877f1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_944e0e4f-c4c3-48bc-98c4-915a5ff4bfa0"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_72940a8c-6662-4785-be1e-cde22f293e80"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">eq:PurchaseRightMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">eq:EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-10-01</xbrli:startDate><xbrli:endDate>2018-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_149d869a-5e0a-4913-9abe-a27afa766de4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_2c8bb5f0-73a3-432f-b12e-cb35048d1783"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EquityUnitPurchaseAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-02-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_7e0f633d-433f-45b3-b81e-21ab345a28bd"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">eq:EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-03-16</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_9c160bc4-2896-4f45-abda-cba01dca2910"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">eq:TwoThousandEighteenEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_63b408ff-0cee-4c70-85c3-c4f148eb4da9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_b6af3c69-cf78-4826-98db-46603272fd07"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eq:AssetPurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">eq:OnoPharmaceuticalCoLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-16</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_a14519ee-c0f5-4735-a3a2-5d78ee96686f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">eq:TwoThousandEighteenEquityIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_68cc81fd-50c1-4591-b9ee-381a6c7b9fe5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">eq:USTreasurySecuritiesMaturingBetweenOneAndFiveYearsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_6d2cc007-04de-46ef-a689-02aac4462b5a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_2aa60dea-0a24-4f41-b6e1-70e203413f85"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_4640a459-b05e-473c-894a-3d5c68449919"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">eq:TwoThousandEighteenEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_6658e49b-c37e-401c-873e-60a833ca00d9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_25c4ee43-e391-45e8-bf6c-c2ae9bfee741"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">eq:BioconMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-05-01</xbrli:startDate><xbrli:endDate>2019-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_842e44ed-200a-4457-8510-53e0331535d8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">eq:OfficeSpaceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_be912e1f-de6a-4c8b-a190-56fa543de795"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">eq:CertificatesOfDepositMaturingInOneYearOrLessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_83d4ef1f-863c-4921-aa0e-cb290fba239d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_ad7f8586-d120-48a1-a08d-4f84857dfb6d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eq:AssetPurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">eq:OnoPharmaceuticalCoLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_0a2a2736-708e-4c3e-8299-f827f8de0192"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_dd41c6fa-2d24-44bd-8378-e697929d4bb8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">eq:LaboratorySpaceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_4c0fe461-a7c8-4a97-8e27-000bcb673943"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eq:AssetPurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">eq:OnoPharmaceuticalCoLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_251e65bb-85a5-4df7-a709-d3e4c8e42ad6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eq:PurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">eq:LincolnParkCapitalFundLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_9cad8da7-5192-43d1-ae8d-b306505ebc15"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_e6610ebe-288f-4417-8098-af8696e03c7e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_dc409b2a-6dec-4757-a385-691c05150979"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_ea3c06e5-f9a7-4f24-ba11-8679304c0196"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eq:PurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">eq:LincolnParkCapitalFundLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_977951f9-d851-4284-8eb0-cbc7afea37a5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f789eb1e-5a5d-41b1-8bb7-3d3ed1258e7d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_677e006f-7dec-4e8f-81db-464e67389b27"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_e0e5cffb-5c83-464c-b236-5ae5c1b3c851"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_9f870e6c-ab80-49c3-9591-da8f10d045b8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">eq:BionizTherapeuticsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-02-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c886a389-5f87-408e-8648-17d8507a401b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_900c0b60-4130-48e3-ad64-738fc1374bc7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_90508498-eb7a-4af4-a10b-9b578a529f24"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">eq:TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_5678bab9-8bd4-4b16-94e3-655278d75cd5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eq:EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_8d880863-715e-4b80-9a73-33be4ffa0166"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">eq:EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_cf62e2c5-8574-4b02-a168-a9fa58f93586"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eq:AssetPurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">eq:UpfrontPaymentAmortizationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">eq:OnoPharmaceuticalCoLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_71653c3b-caef-4b07-8b00-6e7024629fb3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">eq:BionizTherapeuticsIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_3170d519-6bfe-4d96-886d-1344675502df"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">eq:LoanAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_1f42c1eb-d268-41b0-9bcf-d37f47a8c53a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_b46e12c4-af83-4e15-baf8-0903ab9bd6b5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_70c8e717-7ae0-400b-a2e5-1384948ea4b2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">eq:BionizTherapeuticsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_be335ae5-27dc-40a0-a672-67f87605ecfa"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_2573431b-071f-404a-987e-c3e834333417"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_b15585d5-5e76-4fec-adb1-0f3694e76b0d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_8a38518a-9c62-4c14-a61d-b505eb2f5458"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">eq:BionizTherapeuticsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_9520a266-f74a-45cf-96ed-ba178f032640"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eq:StockOptionsIssuedAndOutstandingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c23792dc-2be3-45bf-8cdc-a38a13c8ab6a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eq:AssetPurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">eq:OnoPharmaceuticalCoLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-12-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_c2f2d003-05db-4149-bb1f-60dc7a7a84c7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:PrimeRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_f14aee5f-c103-44b8-acee-a339e014b6d3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-03-16</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_28f69ea9-8c53-458e-9ebe-8b9949dd4224"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_b6ed3cd2-aa70-4e39-9223-49223b495228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_b4ad71ba-3e8b-4d50-87b0-1a81a509c6eb"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">eq:USTreasurySecuritiesMaturingInOneYearOrLessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_da6b0f69-4d60-4727-93e2-76b6699fc7cd"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">eq:EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_8a5bef62-cef2-4949-81e3-78ec03bd91d4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eq:FollowOnOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_69239b5b-2176-4437-a3e8-98a7b914e359"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201613Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_ffafa14c-b663-42ee-861b-6f858b3f4acf"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">eq:BionizTherapeuticsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-02-14</xbrli:startDate><xbrli:endDate>2022-02-14</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_157bf7c1-6ef7-43ab-b719-f85e3a11f1d5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_292ee269-376c-4392-9f5a-40817da138a6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">eq:BionizTherapeuticsIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">eq:ContingentConsiderationForAchievementOfCommercializationEventsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-02-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_73660a62-57e2-407a-a1a0-1c6619629881"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_677cb0dd-b0f9-4917-b6b9-3a7ad67b6397"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">eq:LoanAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_565ac908-720e-4507-8d96-ab25dfe4fc94"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_de394fb6-0ca8-4cc8-866d-6ad6f457d88c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">eq:ResearchAndDevelopmentServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eq:AssetPurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">eq:OnoPharmaceuticalCoLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_abcb788b-9185-48aa-bc09-238334507b89"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eq:AssetPurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">eq:OnoPharmaceuticalCoLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-16</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_3c1013be-6aec-4534-8322-81766349f268"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_1398193c-be70-4924-b7ab-8d837ee248c4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">eq:SiliconValleyBankMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-10</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_0d524201-b596-46e6-95bc-8b3b552ccc88"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">eq:TwoThousandSeventeenEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_6c924f5d-0e36-4f69-96ed-b71e41b42d0f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">eq:BioconMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-05-01</xbrli:startDate><xbrli:endDate>2017-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_4eb35088-1593-4e17-8c6a-8c9e0bdad77b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EquityUnitPurchaseAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-03</xbrli:startDate><xbrli:endDate>2021-02-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_f31a63db-28e5-4d6c-8641-5e09fcfbb9ac"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_acb33667-c8a3-4249-a4a8-738294c5d493"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_07b42072-8725-4287-82d7-ff7786912150"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_6c6eb418-4e31-405d-80e2-4eeaa0ed0949"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_1498053c-86a8-4e41-8116-8cb7e9c5b74c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_5c7a06ba-06bd-4791-bb56-70c464bf5ade"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_b03e82a1-d7f8-42dc-a88d-a8edb9f55f3c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_4facbb57-718b-4710-bf34-290be7c869f0"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">eq:TwoThousandSeventeenEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_9b5e1bd0-1a40-47d8-9914-690c782ec9e9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">eq:USTreasurySecuritiesMaturingInOneYearOrLessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_ea16d6a3-2485-40dc-a25d-8c4cc56dd7fd"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">eq:BionizTherapeuticsIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">eq:ContingentConsiderationForAchievementOfRegulatoryEventsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-02-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_266429a4-9ee0-4360-bdef-2bb916cfaeee"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_16cc5d93-7f4c-4d9b-a05e-409bae73f77d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_211f9a22-9355-4cd5-ae5c-f45e20a3dcdc"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_1b636714-e678-4bb2-be3e-3c64ae434607"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eq:PurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">eq:LincolnParkCapitalFundLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-27</xbrli:startDate><xbrli:endDate>2020-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_f45561af-aa60-4d08-8038-0001fb9d29dc"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_09b9a242-1fa2-404a-b6a9-1fc05149e6a4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">eq:USTreasurySecuritiesMaturingInOneYearOrLessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_1074585e-0f9e-4a71-aac7-7580a74d418f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:AU</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_e6cf51a2-311a-4401-b240-c4af424355e4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_2ad7083d-d4d8-4d36-9fad-554b54c6601f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_8f6e6b13-aff0-4ec5-80eb-ec47346f2d4d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">eq:CertificatesOfDepositMaturingInOneYearOrLessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_af77d479-58a1-4eb8-be05-a05f0b6de156"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_593cac69-ae06-423d-93b0-db39a502796a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_22c07448-b3c4-4d7d-8903-20b3a5bbb42d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">eq:USTreasurySecuritiesMaturingBetweenOneAndFiveYearsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_0a414f75-a619-4136-9add-c3356d8e1816"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_58ee8b88-7fcf-463a-aada-7b6967a5d010"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">eq:TwoThousandEighteenEquityIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_ff05e412-5d32-4d51-9c1b-fcbe95cea7f7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_c10ac679-9a2b-4cbc-b11a-d6a2b12c4221"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EquityUnitPurchaseAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-02-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_503c038a-2434-4c52-8c73-7bfdbfb92be8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_32d659e3-aa51-4be5-b51f-bb1491642234"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eq:EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_916e47cd-8d5b-46a6-ada5-c452d339e627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_118d4267-0758-4b9a-ac2a-e75bcfe13d76"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:AustralianTaxationOfficeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">eq:AustralianResearchAndDevelopmentTaxIncentiveProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_b6dbee35-e2f1-45ca-95ca-0d1198cb8c23"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_b79b178e-6c81-4a59-9acf-58713aad69ee"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eq:AwardsAvailableUnder2018PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_7b79d852-2622-42ae-b02e-a2784258be60"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">eq:TwoThousandEighteenEquityIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_6b91f489-4f82-44f0-b32f-1000032af149"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">eq:EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-10-01</xbrli:startDate><xbrli:endDate>2018-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_88bc9f46-dcc0-4d03-aa1a-d56bf1d35be2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_bff86cb7-8d58-45e7-9e93-1982cad8799f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EquityUnitPurchaseAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-03</xbrli:startDate><xbrli:endDate>2021-02-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_c28101d2-ae40-418c-83d4-9715bbaa72e3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">eq:LoanAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_ce9aa43c-a54c-413f-ab08-401b60dd98cf"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_6f4556dd-c18e-4dc1-9c4a-842fa90452f5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">eq:USTreasurySecuritiesMaturingInOneYearOrLessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_74785e69-c479-4de9-938d-9e775d1f539a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">eq:LoanAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_d6cbfdc9-1278-4b59-8f64-1c4df657d268"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_9d1df5ec-262f-43c2-9feb-7e49b25fe95f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_1a97b4e1-6653-4a2c-a233-548bf388b221"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">eq:TwoThousandEighteenEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_0b2819ec-57f5-46d8-b912-9734d9b101d1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c197641e-f183-4f80-9bfd-23288c4df7df"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eq:StockOptionsIssuedAndOutstandingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_fae7480f-6d94-4ea1-b4e4-5cde09bbcd56"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_24991024-50f4-435b-ba4f-adcad994e80c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f54cdfd1-dd2b-4d74-aa9b-16e8ecf08b91"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_48927eeb-5e48-4e18-bce6-146239c106d3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eq:AwardsAvailableUnder2018PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="U_Investor"><xbrli:measure>eq:Investor</xbrli:measure></xbrli:unit><xbrli:unit id="U_JPY"><xbrli:measure>iso4217:JPY</xbrli:measure></xbrli:unit><xbrli:unit id="U_pure"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:unit id="U_shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="U_Installment"><xbrli:measure>eq:Installment</xbrli:measure></xbrli:unit><xbrli:unit id="U_USDollarShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:unit id="U_USD"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit></ix:resources></ix:header></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;padding-bottom:1.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:2.25pt double;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:2.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:17.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">UNITED STATES</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:17.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">SECURITIES AND EXCHANGE COMMISSION</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:17.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Washington, D.C. 20549</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="margin-left:40.0%;text-indent:0.0%;padding-bottom:1.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:0.25pt solid;margin-right:40.0%;text-align:center;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:3.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:18.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">FORM </span><span style="font-size:18.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_03e456fe-3401-4774-a22e-5089a2a9ad3b" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="dei:DocumentType"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:18.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10-K</span></ix:nonNumeric></span></p>
  <p style="margin-left:40.0%;text-indent:0.0%;padding-bottom:1.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:0.25pt solid;margin-right:40.0%;text-align:center;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(Mark One)</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:-4.749%;padding-left:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_17e83137-4a3d-4168-b627-3698fa5e6ffd" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="dei:DocumentAnnualReport" format="ixt-sec:boolballotbox"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#9746;</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For the fiscal year ended </span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_d15a0136-d0d7-4a1f-82cd-216837a0e7b3" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="dei:DocumentPeriodEndDate" format="ixt:datemonthdayyearen"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_2ff2cb16-b670-4a58-8dd5-fdab43040bd0" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="dei:CurrentFiscalYearEndDate" format="ixt:datemonthdayen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">,</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_eaeff4e0-63ec-4f23-b178-78262c781a24" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="dei:DocumentFiscalYearFocus"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></ix:nonNumeric></span></ix:nonNumeric></span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:3.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OR</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:-4.749%;padding-left:4.533%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_5292321d-0a65-434f-879e-7ace341cf9d2" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="dei:DocumentTransitionReport" format="ixt-sec:boolballotbox"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Commission File Number </span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_32059148-bff3-40f1-9bf8-ee57a7c56c96" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="dei:EntityFileNumber"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">001-38692</span></ix:nonNumeric></span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="margin-left:40.0%;text-indent:0.0%;padding-bottom:1.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:0.25pt solid;margin-right:40.0%;text-align:center;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:23.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_5b25706d-ebae-4272-9014-d1dad26e1a59" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="dei:EntityRegistrantName"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:23.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">EQUILLIUM, INC.</span></ix:nonNumeric></span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(Exact name of registrant as specified in its Charter)</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="margin-left:40.0%;text-indent:0.0%;padding-bottom:1.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:0.25pt solid;margin-right:40.0%;text-align:center;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:49.5%;"></td>
    <td style="width:1.019%;"></td>
    <td style="width:49.481%;"></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_45e508fb-dadd-4413-b2a0-57870abbe521" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Delaware</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_15e625fa-c8ed-48d7-9f7d-3b0abf0755b9" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="dei:EntityTaxIdentificationNumber"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">82-1554746</span></ix:nonNumeric></span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(State or other jurisdiction of</span></p><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">incorporation or organization)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(I.R.S. Employer</span></p><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Identification No.)</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_f67bb410-2231-4a9b-b011-ff575394ae5f" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="dei:EntityAddressAddressLine1"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2223 Avenida de la Playa</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_cc095359-7efe-44b7-92ce-3ea99aaf5468" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="dei:EntityAddressAddressLine2"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Suite 105</span></ix:nonNumeric></span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_fe89a2f0-336d-4fb1-a69b-9e7d2324f4a0" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="dei:EntityAddressCityOrTown"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">La Jolla</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_8243b7aa-826a-4d11-9043-2c02a53a7d76" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="dei:EntityAddressStateOrProvince"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">CA</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_d0d504c6-f9b3-439d-935b-aa70fc4cad86" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="dei:EntityAddressPostalZipCode"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">92037</span></ix:nonNumeric></span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(Address of principal executive offices)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(Zip Code)</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Registrant&#x2019;s telephone number, including area code: (</span><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_3691326a-eae1-4795-8087-f4cebb67ec78" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="dei:CityAreaCode"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">858</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">) </span><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_16424abd-545e-4579-9cd7-0d873089a8eb" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="dei:LocalPhoneNumber"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">412-5302</span></ix:nonNumeric></span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Securities registered pursuant to Section 12(b) of the Act:</span></p>
  <p style="margin-left:40.0%;text-indent:0.0%;padding-bottom:1.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:0.25pt solid;margin-right:40.0%;text-align:center;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:40.0%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:18.0%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:40.0%;"></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Title of each class</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Trading</span></p><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Symbol</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of each exchange on which registered</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_2f53b1ba-7f72-42cc-a4d1-4e03ae81dee6" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="dei:Security12bTitle"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Common Stock, par value $0.0001 per share</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_2e0bb9f6-9113-448e-a7d4-84d7d71055d8" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="dei:TradingSymbol"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">EQ</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_5d0a1e64-b97b-4244-beec-d7f559801578" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Nasdaq Global Market</span></ix:nonNumeric></span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Securities registered pursuant to 12(g) of the Act: None</span></p>
  <p style="margin-left:40.0%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:0.75pt solid;margin-right:40.0%;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes &#9744; </span><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_1417e780-2b06-483d-841f-9be63557ca3f" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="dei:EntityWellKnownSeasonedIssuer"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">No</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#9746;</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act. Yes &#9744; </span><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_d8b76456-eec9-46b6-a319-b2c2f72b7242" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="dei:EntityVoluntaryFilers"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">No</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#9746;</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. </span><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_08a3515e-b4e5-43d6-b298-2f7f41bb7530" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="dei:EntityCurrentReportingStatus"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Yes</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#9746; No &#9744;</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). </span><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_84af4de9-4157-4124-a403-183a9d1d843d" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="dei:EntityInteractiveDataCurrent"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Yes</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#9746; No &#9744;</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of &#x201c;large accelerated filer,&#x201d; &#x201c;accelerated filer,&#x201d; &#x201c;smaller reporting company,&#x201d; and &#x201c;emerging growth company&#x201d; in Rule 12b-2 of the Exchange Act.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:19.481%;"></td>
    <td style="width:1.296%;"></td>
    <td style="width:58.444%;"></td>
    <td style="width:19.481%;"></td>
    <td style="width:1.296%;"></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Large accelerated filer</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#9744;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accelerated filer</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#9744;</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_c554df0e-e502-411e-9812-b4237e9d01d9" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Non-accelerated filer</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#9746;</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Smaller reporting company</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_329bc41f-2e36-4d5b-b988-fb7111e2b311" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="dei:EntitySmallBusiness" format="ixt-sec:boolballotbox"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#9746;</span></ix:nonNumeric></span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;Emerging growth company</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_15a82305-49a7-4d11-aa1f-e2df659fca2a" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#9746;</span></ix:nonNumeric></span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_e8ae4fa9-fe90-4085-9c31-9918bbb67004" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="dei:EntityExTransitionPeriod" format="ixt-sec:boolballotbox"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Indicate by check mark whether the registrant has filed a report on and attestation to its management&#x2019;s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. </span><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_c00c52d1-f0ff-446b-8268-4ea890d69355" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="dei:IcfrAuditorAttestationFlag" format="ixt-sec:boolballotbox"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. &#9744;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant&#x2019;s executive officers during the relevant recovery period pursuant to &#167; 240.10D-1(b). &#9744;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes &#9744; No </span><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_c0c0fa40-46e7-40c9-9332-9998007e47db" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="dei:EntityShellCompany" format="ixt:booleanfalse"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#9746;</span></ix:nonNumeric></span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The aggregate market value of the voting and non-voting common equity held by non-affiliates of the registrant as of June 30, 2022 (the last business day of the registrant&#x2019;s most recently completed second fiscal quarter) was approximately $</span><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b0ec1890-fa02-4bf1-aae4-d766c69c30e8" contextRef="C_63b408ff-0cee-4c70-85c3-c4f148eb4da9" name="dei:EntityPublicFloat" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">43.1</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million based on the closing price of the registrant&#x2019;s common stock on June 30, 2022 of $2.04 per share, as reported by the Nasdaq Global Market.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of March 16, 2023, there were </span><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_0c75fa15-dcaf-4140-89da-0af69e1138b7" contextRef="C_f14aee5f-c103-44b8-acee-a339e014b6d3" name="dei:EntityCommonStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">34,414,149</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of the registrant&#x2019;s common stock outstanding.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:2.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <div style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_fe72cea6-d31d-47e1-a90e-901041ab32dc" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="dei:DocumentsIncorporatedByReferenceTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">DOCUMENTS INCORPORATED BY REFERENCE</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Part III of this Annual Report on Form 10-K incorporates by reference certain information from the registrant&#x2019;s definitive Proxy Statement for its 2023 annual meeting of stockholders, which the registrant intends to file pursuant to Regulation 14A with the Securities and Exchange Commission not later than 120 days after the registrant&#x2019;s fiscal year end of December 31, 2022. Except with respect to information specifically incorporated by reference in this Form 10-K, the Proxy Statement is not deemed to be filed as part of this Form 10-K.</span></p></ix:nonNumeric></div>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:12.741%;"></td>
    <td style="width:9.537%;"></td>
    <td style="width:11.481%;"></td>
    <td style="width:22.824%;"></td>
    <td style="width:13.5%;"></td>
    <td style="width:29.917%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Auditor Firm Id:</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_0713d429-af3b-4b29-b79e-6af5ef937b47" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="dei:AuditorFirmId"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">185</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Auditor Name:</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_cf44e8a5-ed65-46b3-a1b3-0475238336d9" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="dei:AuditorName"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">KPMG LLP</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Auditor Location:</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_31b3e65f-1316-4ec0-aabe-ba8355e3e460" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="dei:AuditorLocation"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">San Diego, California, United States</span></ix:nonNumeric></span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;padding-bottom:1.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:2.25pt double;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:9.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Table of Contents</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:14.008%;"></td>
    <td style="width:80.377%;"></td>
    <td style="width:5.615%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(0,0,0,1);padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Page</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#part_i"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">PART I</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 1.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_1_business"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Business</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 1A.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_1a_risk_factors"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Risk Factors</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">40</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 1B.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_1b_unresolved_staff_comments"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unresolved Staff Comments</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">92</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 2.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_2_properties"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Properties</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">92</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 3.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_3_legal_proceedings"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Legal Proceedings</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">92</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 4.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_4_mine_safety_disclosures"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Mine Safety Disclosures</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">92</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#part_ii"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">PART II</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">93</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 5.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_5_market_for_registrants_common_equ"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Market for Registrant&#x2019;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">93</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 6.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item6_reserved"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[Reserved]</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">93</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 7.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_7_managements_discussion_analysis_f"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Management&#x2019;s Discussion and Analysis of Financial Condition and Results of Operations</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">94</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 7A.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_7a_quantitative_qualitative_disclos"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Quantitative and Qualitative Disclosures About Market Risk</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">105</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 8.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_8_financial_statements_supplementar"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Financial Statements and Supplementary Data</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">106</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 9.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_9_changes_in_disagreements_with_acc"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Changes in and Disagreements With Accountants on Accounting and Financial Disclosure</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">106</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 9A.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_9a_controls_procedures"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Controls and Procedures</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">106</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 9B.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_9b_or_information"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other Information</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">106</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;&#160;Item 9C.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_9c_disclosure_regarding_foreign"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Disclosure Regarding Foreign Jurisdictions that Prevent Inspections.</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">106</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#partiii"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">PART III</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">107</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 10.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_10_directors_executive_ficers_corpo"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Directors, Executive Officers and Corporate Governance</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">107</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 11.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_11_executive_compensation"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Executive Compensation</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">107</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 12.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_12_security_ownership_certain_benef"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">107</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 13.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_13_certain_relationships_related_tr"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Certain Relationships and Related Transactions, and Director Independence</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">107</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 14.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_14_principal_accounting_fees_servic"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Principal Accountant Fees and Services</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">107</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#part_iv"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">PART IV</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">108</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 15.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_15_exhibits_financial_statement_sch"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibits and Financial Statement Schedules</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">108</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 16.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_16_form_10k_summary"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Form 10-K Summary</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">111</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#signatures"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">SIGNATURES</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">112</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">This Annual Report on Form 10-K contains forward-looking statements. The forward-looking statements are contained principally in the sections entitled &#x201c;Risk Factors,&#x201d; &#x201c;Management&#x2019;s Discussion and Analysis of Financial Condition and Results of Operations&#x201d; and &#x201c;Business.&#x201d; These statements relate to future events or to our future financial performance and involve known and unknown risks, uncertainties and other factors which may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Forward-looking statements include, but are not limited to, statements about:</span></p>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our plans to research, develop and commercialize our product candidates and any future product candidates;</span></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our ability to obtain and maintain regulatory approval for our product candidates in any of the indications for which we plan to develop them;</span></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the potential benefits and risks of the transactions contemplated by the Asset Purchase Agreement dated December 5, 2022, or the Asset Purchase Agreement, entered into by us and Ono Pharmaceutical Co., Ltd., or Ono;</span></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our estimated timeline for announcing data from our clinical studies, for interacting with regulatory authorities, and for initiating clinical studies;</span></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our ability to obtain funding for our operations, including funding necessary to commence and complete the clinical studies of our product candidates;</span></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the success, cost, and timing of our product development activities, including our ongoing and planned clinical studies;</span></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the beneficial characteristics, safety, efficacy, and therapeutic effects of our product candidates;</span></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the size of the markets for our product candidates, and our ability to serve those markets;</span></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the rate and degree of market acceptance of any of our product candidates;</span></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our ability to develop and maintain sales and marketing capabilities, whether alone or with potential future collaborators;</span></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">regulatory developments in the United States and in other territories where we may conduct business, including the clinical development and potential commercialization of our product candidates;</span></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the performance of our contract service providers, including Biocon Limited and other suppliers and manufacturers;</span></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the safety, efficacy and market success of competing therapies that are or become available;</span></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our ability to attract and retain key scientific or management personnel;</span></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our expectations regarding the period during which we qualify as an emerging growth company under the Jumpstart Our Business Startups Act, as amended, or JOBS Act;</span></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our ability to attract and retain collaborators with development, regulatory and commercialization expertise;</span></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the accuracy of our estimates regarding expenses, future revenues, capital requirements and needs for additional financing; and</span></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our expectations regarding our ability to obtain and maintain intellectual property protection for our product candidates and our ability to operate our business without infringing on the intellectual property rights of others.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In some cases, you can identify these statements by terms such as &#x201c;anticipate,&#x201d; &#x201c;believe,&#x201d; &#x201c;could,&#x201d; &#x201c;estimate,&#x201d; &#x201c;expects,&#x201d; &#x201c;intend,&#x201d; &#x201c;may,&#x201d; &#x201c;plan,&#x201d; &#x201c;potential,&#x201d; &#x201c;predict,&#x201d; &#x201c;project,&#x201d; &#x201c;should,&#x201d; &#x201c;will,&#x201d; &#x201c;would&#x201d; or the negative of those terms, and similar expressions that convey uncertainty of future events or outcomes. These forward-looking statements reflect our management&#x2019;s beliefs, opinions and views with respect to future events and are based on estimates, assumptions and information available to us as of the date of this Annual Report on Form 10-K, and while we believe such information forms a reasonable basis for such statements, such information may be limited or incomplete and our statements should not be read</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">to indicate that we have conducted an exhaustive inquiry into, or review of, all potentially available relevant information. These statements are inherently uncertain and are subject to risks and uncertainties. We discuss many of these risks in greater detail under the heading &#x201c;Risk Factors.&#x201d; Moreover, we operate in a very competitive and rapidly changing environment. New risks emerge from time to time. It is not possible for our management to predict all risks, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements we may make. Given these uncertainties, you should not place undue reliance on these forward-looking statements.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">You should carefully read this Annual Report on Form 10-K and the documents that we reference herein and have filed as exhibits to the Annual Report on Form 10-K completely and with the understanding that our actual future results may be materially different from what we expect. We qualify all of the forward-looking statements in this Annual Report on Form 10-K by these cautionary statements.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Except as required by law, we assume no obligation to update these forward-looking statements publicly, or to update the reasons actual results could differ materially from those anticipated in any forward-looking statements, whether as a result of new information, future events or otherwise.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">RISK FACTORS SUMMARY</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We face many risks and uncertainties, as more fully described in this section under the heading &#x201c;Risk Factors.&#x201d; Some of these risks and uncertainties are summarized below. The summary below does not contain all of the information that may be important to you, and you should read this summary together with the more detailed discussion of these risks and uncertainties contained in &#x201c;Risk Factors.&#x201d;</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We have incurred significant losses since our inception, expect to incur significant losses for the foreseeable future and may never achieve or maintain profitability;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We will require substantial additional funding to continue and complete the development and any commercialization of EQ101 and EQ102, and if Ono does not exercise its option, itolizumab (EQ001), and any future product candidates. If we are unable to raise this capital when needed, we may be forced to delay, reduce or eliminate our research and development programs or other operations;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Raising additional capital may cause dilution to our stockholders, restrict our operations or require us to relinquish rights to our technologies or product candidates;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are highly dependent on the successful development of our current product candidates, EQ101, EQ102 and itolizumab (EQ001), and we may not be able to obtain regulatory or marketing approval for, or successfully commercialize, these product candidates in any of the indications for which we plan to develop them;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Any delays in the commencement or completion, or termination or suspension, of our ongoing, planned or future clinical studies could result in increased costs to us, delay or limit our ability to raise capital or generate revenue and adversely affect our commercial prospects;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Interim, topline or preliminary data from our clinical studies that we announce or publish from time to time may change as more patient data become available and are subject to audit and verification procedures that could result in material changes in the final data;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are and may become further dependent on Ono for funding the clinical development and commercialization of itolizumab (EQ001). If Ono terminates our Asset Purchase Agreement, does not exercise its option, or does not achieve the milestones specified in the Asset Purchase Agreement, our business and financial condition would be adversely impacted;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We have licensed itolizumab from Biocon pursuant to an exclusive license agreement, which license is conditioned upon us meeting certain diligence obligations with respect to the development, regulatory approval and commercialization of itolizumab, and making significant milestone payments in connection with regulatory approval and commercial milestones as well as royalty payments;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We have licensed the rights to itolizumab in the United States, Canada, Australia, and New Zealand. Any adverse developments that occur during any research, clinical, or commercial use of itolizumab by Biocon or third parties in other jurisdictions may affect our ability to obtain regulatory approval of or successfully commercialize itolizumab (EQ001) or otherwise adversely impact our business;</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If we are unable to obtain or protect intellectual property rights covering our product candidates, or if the scope of the intellectual property protection is not sufficiently broad, our competitors could develop and commercialize products similar or identical to ours, and we may not be able to compete effectively in our market;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The manufacture of pharmaceutical products, especially biologics, is complex and we may encounter difficulties in production, distribution and delivery of our product candidates. If CMOs, including Biocon, our exclusive CMO for itolizumab (EQ001), encounter such difficulties, our ability to provide supply of our product candidates for clinical studies, our ability to obtain marketing approval, or our ability to obtain commercial supply of our products, if approved, could be delayed or stopped;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We rely, and intend to continue to rely, on CROs to conduct our clinical studies and perform some of our research and preclinical studies. If these third parties do not satisfactorily carry out their contractual duties, fail to comply with applicable regulatory requirements or meet expected deadlines, our development programs may be delayed or subject to increased costs or we may be unable to obtain regulatory approval, each of which may have an adverse effect on our business, financial condition, results of operations and prospects;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We currently have no marketing and sales organization and have no experience as a company in commercializing products, and we may have to invest significant resources to develop these capabilities. If we are unable to establish marketing and sales capabilities or enter into agreements with parties to market and sell our products, if approved, we may not be able to generate product revenue; and</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Even if our product candidates receive marketing approval in any indication, they may fail to achieve the degree of market acceptance by physicians, patients, hospitals, healthcare payors and others in the medical community necessary for commercial success.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="part_i"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">PART</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> I</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_1_business"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 1. Bus</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">iness.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Overview</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are a clinical-stage biotechnology company leveraging a deep understanding of immunobiology to develop novel therapeutics to treat severe autoimmune and inflammatory, or immuno-inflammatory, disorders with high unmet medical need. Our strategy is focused on advancing the clinical development of our product candidates, including potentially pursuing additional indications and acquiring new product candidates and platforms to expand our pipeline. We intend to commercialize our product candidates either independently or through partnerships or otherwise monetize our pipeline through strategic transactions.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our current clinical-stage product candidates consist of EQ101, EQ102 and itolizumab (EQ001). EQ101 and EQ102 are synthetic peptides engineered to specifically inhibit key disease-driving, clinically validated cytokine targets aimed at addressing unmet needs across a range of immuno-inflammatory indications. EQ101 is a first-in-class, selective, tri-specific inhibitor of IL-2, IL-9 and IL-15, and EQ102 is a first-in-class, selective, bi-specific inhibitor of IL-15 and IL-21. Itolizumab (EQ001) is a first-in-class monoclonal antibody that selectively targets the immune checkpoint receptor CD6, which plays a central role in the modulation of effector T cell, or T</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:sub;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">eff</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> cell, activity and trafficking that drives a number of immuno-inflammatory diseases across multiple therapeutic areas. Our novel and differentiated pipeline of first-in-class immunology assets has the potential to address unmet medical needs in numerous areas, including dermatology, gastroenterology, rheumatology, hematology, transplant science, oncology and pulmonology.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img268224062_0.jpg" alt="img268224062_0.jpg" style="width:672px;height:302px;" />&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are focused on developing EQ101, EQ102 and itolizumab (EQ001) as potential best-in-class, disease modifying treatments for multiple severe immuno-inflammatory disorders and currently have active clinical development programs with all three assets. The following chart summarizes the status of our current clinical development programs.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Details for each program are outlined in &#x2018;Our Initial Clinical Indications&#x2019; section below.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img268224062_1.jpg" alt="img268224062_1.jpg" style="width:672px;height:241px;" />&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Strategy</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our goal is to become a leading, fully-integrated biotechnology company focused on therapies for severe immuno-inflammatory disorders. To achieve our goal, we intend to:</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Develop EQ101 for the treatment of Alopecia Areata. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are conducting a Phase 2 proof-of-concept clinical study in subjects with alopecia areata, or AA. The primary objective of the study is to evaluate the safety and tolerability of EQ101 administered intravenously, or IV, with secondary objectives including the evaluation of drug efficacy, pharmacokinetic/pharmacodynamic, or PK/PD, properties, and changes in patient biomarkers. In addition, we are developing a subcutaneous, or SC, formulation of EQ101 expected to be ready for subsequent clinical studies.</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Develop EQ102 for the treatment of Celiac Disease. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are conducting a Phase 1 first-in-human, randomized, double-blind, placebo-controlled clinical study of EQ102 administered SC as single or multiple doses in up to 64 healthy volunteers. The primary objective of the study is to assess the safety and tolerability of EQ102, with secondary objectives including the assessment of PK/PD changes. Following the multiple ascending dose, or MAD, part of this study, we are planning an additional part which will evaluate the biological activity of EQ102 in subjects with celiac disease.</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Develop itolizumab (EQ001) for the treatment of GVHD.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> We are conducting  EQUATOR, a pivotal Phase 3 clinical study of itolizumab (EQ001) in acute graft-versus-host disease, or aGVHD. The randomized, double-blind, placebo-controlled study will assess the efficacy and safety of itolizumab (EQ001) versus placebo as a first-line therapy for aGVHD in combination with corticosteroids. </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Develop itolizumab (EQ001) for the treatment of lupus and lupus nephritis. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are conducting the Type B portion of EQUALISE, a Phase 1b proof-of-concept clinical study of itolizumab (EQ001) in patients with lupus nephritis, or LN. We completed the Type A portion, which was a MAD study involving 35 systemic lupus erythematosus, or SLE, patients to evaluate the safety, tolerability, PK/PD and clinical activity of itolizumab (EQ001) dosed SC every two weeks, or Q2W. </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Opportunistically expand our pipeline.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> We will</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">continue to conduct preclinical and translational studies and assimilate learnings from clinical studies to help inform the selection of additional indications for future development of our product candidates. We will also leverage the collective talent within our organization to opportunistically discover, acquire or in-license other high-value therapeutic programs that may complement our core strategy or have the potential for synergistic therapeutic benefit in combination with EQ101, EQ102 or itolizumab (EQ001).</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Build a commercial infrastructure.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> If any of our product candidates are approved, we may commercialize them ourselves in indications that can be effectively targeted using a specialty sales force. For other indications that require a larger sales force, we may commercialize approved products through collaborations with other parties. </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Acquisition</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We acquired the exclusive worldwide rights to EQ101 and EQ102 through the acquisition of Bioniz Therapeutics, Inc., or Bioniz, in February 2022. Through the acquisition, we expanded our immunology pipeline with first-in-class immuno-inflammatory product candidates across a range of development stages and obtained a proprietary platform for discovering additional, novel multi-cytokine targeting product candidates. See Note 6 of the Notes to Financial Statements included in this Annual Report on Form 10-K, for further details of this acquisition.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Partnerships</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Option Agreement with Ono</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On December 5, 2022, we entered into the Asset Purchase Agreement with Ono, pursuant to which we granted Ono the exclusive right, but not the obligation, to acquire our rights to itolizumab (EQ001), or the Option. These rights include all therapeutic indications and the rights to commercialize itolizumab (EQ001) in the United States, Canada, Australia, and New Zealand. In exchange for the Option, Ono paid us a one-time, upfront payment of an amount equal to JPY 3.5 billion, or $26.4 million.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If Ono exercises the Option, Ono will pay us a one-time, payment of an amount equal to JPY 5.0 billion, or approximately $37.2 million based on the currency exchange rate quoted by MUFG Bank, Ltd. on March 16, 2023. We are also eligible to receive up to $101.4 million upon the achievement of certain development and commercialization milestones.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are responsible for conducting all research and development of itolizumab (EQ001), which will be funded by Ono on a quarterly basis from July 1, 2022 through the option period. Unless terminated early, the option period will expire three months following the delivery of topline data from the EQUALISE clinical study in LN and interim data from the EQUATOR Phase 3 clinical study in aGVHD.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Asset Purchase Agreement can be terminated at any time by Ono upon written notice, provided that in limited circumstances Ono will be obligated to continue to reimburse us for research and development costs and expenses of itolizumab (EQ001) for a certain period of time following such termination. If Ono does not timely exercise its Option, the Asset Purchase Agreement and the Option will automatically terminate. The Asset Purchase Agreement also contains customary termination rights for both parties for material breach and an outside date (subject to limited adjustments) that permits either party to terminate the Asset Purchase Agreement if the closing has not occurred by December 31, 2025.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Asset Purchase Agreement contains customary representations and warranties with respect to both Equillium and Ono. Additionally, we are subject to customary obligations and covenants, including affirmative and negative operating covenants with respect to our business as it applies to the development and exploitation of itolizumab (EQ001), exclusivity obligations that prohibit us, except in limited circumstances, including in connection with the sale of our company, from pursuing a direct or indirect sale, license or other disposition of all or any portion of our itolizumab (EQ001) program or any of the assets to be purchased pursuant to the Asset Purchase Agreement, and indemnification obligations, which, except in limited circumstances, are subject to customary caps and deductibles. See Note 9 of the Notes to Consolidated Financial Statements included in this Annual Report on Form 10-K, for further details of the Asset Purchase Agreement.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Collaboration and License Agreement with Biocon</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We acquired the rights to itolizumab (EQ001) in May 2017, pursuant to a collaboration and license agreement with Biocon SA (subsequently assigned to Biocon Limited, or together, Biocon). Pursuant to that agreement and subsequent amendments, or Biocon License, Biocon granted us an exclusive license to develop, make, have made, use, sell, have sold, offer for sale, import and otherwise exploit itolizumab (EQ001) and any pharmaceutical composition or preparation containing or comprising itolizumab (EQ001) that uses Biocon technology or Biocon know-how, or collectively, a Biocon Product, in the United States, Canada, Australia and New Zealand, or the Equillium Territory. Our collaboration with Biocon includes an exclusive supply agreement for clinical and commercial drug product of itolizumab (EQ001), or the Clinical Supply Agreement. Biocon currently manufactures itolizumab (EQ001) at commercial scale in a facility in India regulated by the U.S. Food and Drug Administration, or FDA. In addition, we have agreed to co-fund an ongoing Phase 2 clinical study of itolizumab in subjects with ulcerative colitis being conducted by Biocon in India.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In consideration for the rights granted to us by Biocon, we issued to Biocon 2,316,134 shares of common stock. In addition, we are obligated to pay Biocon up to an aggregate of $30 million in regulatory milestone payments upon the achievement of certain regulatory approvals and up to an aggregate of $565 million in sales milestone payments upon the achievement of first commercial sale of product and specified levels of product sales. We are also required to pay royalties on tiers of aggregate annual net sales of Biocon Products by us, our affiliates and our sublicensees in the United States and Canada at percentages from the mid-single digits to sub-teen double digits and on tiers of aggregate annual net sales of Biocon Products by us and our affiliates (but not our sublicensees) in Australia and New Zealand, in each case, subject to adjustments in certain circumstances.  Biocon is also required to pay us royalties at comparable percentages for sales of itolizumab outside of the Equillium Territory if the approvals in such geographies included or referenced our data, including data from certain of our clinical studies, subject to adjustments in certain circumstances. Should Ono exercise its Option to acquire our rights to</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">itolizumab (EQ001), the aforementioned milestone payments and royalties potentially owed to Biocon would become Ono&#x2019;s responsibility, and the potential royalties on sales of itolizumab (EQ001) outside of the Equillium Territory would become Ono&#x2019;s right. See Note 9 of the Notes to Consolidated Financial Statements included in this Annual Report on Form 10-K for further details of the Biocon License and Clinical Supply Agreement.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Understanding the Basis of Our Approach: Multi-Cytokine Inhibition</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(255,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Targeted Inhibition of Disease-Associated &#x3b3;C Cytokines with Novel Compounds Generated from a Proprietary Discovery Platform</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our proprietary multi-cytokine platform generates rationally designed composite peptides that selectively block key cytokines at the shared receptor level targeting pathogenic cytokine redundancies and synergies while preserving non-pathogenic signaling.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">This approach provides multi-cytokine inhibition at the receptor level and is expected to avoid the broad immuno-suppression and off-target safety liabilities of Janus kinase, or JAK, inhibitors. Many immune-mediated diseases are driven by the same combination of dysregulated cytokines, and we believe identifying the key cytokines for these diseases will allow us to target and develop customized treatment strategies for multiple autoimmune diseases.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Many monoclonal antibody, or mAb, therapies are targeted to a single cytokine or cytokine receptor and may not completely address the disease pathology if more than one cytokine is implicated in the disease process. Another therapeutic approach, inhibition of the Janus kinase/signal transducer and activator of transcription, or JAK/STAT, signaling pathway, lacks specificity as it inhibits a signaling pathway that is utilized by many cytokines regardless of their involvement in the disease. As a result, this class of compounds is often associated with serious side effects. Our proprietary peptides selectively block multiple disease driving cytokines while maintaining the healthy immune balance through the normal function of other family members. See </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Figure 1.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><img src="img268224062_2.jpg" alt="img268224062_2.jpg" style="width:672px;height:329px;" />&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Figure 1: </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Rationally-designed, selective inhibition of multiple cytokines is believed to represent an optimized therapeutic modality compared to mAb and JAK inhibitors.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Equillium&#x2019;s Multi-Cytokine Inhibitors Selectively Block Activity of Certain Cytokines by Binding Pockets in the </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Symbol&quot;, serif;font-style:italic;min-width:fit-content;">g</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">C  Common Receptor</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">EQ101 is a first-in-class, tri-specific inhibitor of IL-2, IL-9 and IL-15, three inflammatory cytokines implicated in multiple diseases. It selectively blocks those three key pathogenic cytokines while preserving non-pathogenic signaling related to the other </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Symbol&quot;, serif;font-style:italic;min-width:fit-content;">g</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">C</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">cytokine family members, IL-4, IL-7 and IL-21 (</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Figure 2). </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">EQ101 has demonstrated clinical proof-of-concept as a novel tri-specific cytokine inhibitor through a completed Phase 1/2 clinical study in cutaneous T cell lymphoma, or CTCL, a</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">dermato-oncology indication. The study achieved its primary objective of safety and tolerability and showed clinically meaningful improvements in the modified severity-weighted assessment tool, or SWAT, scores. In that study, the compound was shown to be well tolerated with a favorable safety profile with no drug-related serious adverse events, or SAEs, no dose-limiting toxicities, and no clinically significant laboratory abnormalities.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img268224062_3.jpg" alt="img268224062_3.jpg" style="width:342px;height:427px;" />&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Figure 2: </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">EQ101 inhibits IL-2, IL-9 and IL-15, but not IL-4-, IL-7 and IL-21</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">EQ102 is a first-in-class, selective inhibitor of IL-15 and IL-21 (</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Figure 3</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">). It has undergone substantial translational work supporting its potential use as a treatment for various gastrointestinal diseases including celiac disease, an immune disorder related to gluten exposure. The high degree of selectivity for IL-15 and IL-21 inhibition aligns well with the demonstrated key involvement of these two cytokines that work synergistically in driving the pathology in celiac disease and other inflammatory gut and hepatic disorders.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img268224062_4.jpg" alt="img268224062_4.jpg" style="width:344px;height:405px;" />&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Figure 3: </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">EQ102 inhibits IL-15 and IL-21, but not IL-2, IL-4, IL-7, and IL-9</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">EQ101 &amp; EQ102 Product Development</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">EQ101</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">EQ101 is a synthetic peptide covalently conjugated to a polyethylene glycol, or PEG, molecule in a site-specific manner. The drug substance is currently manufactured under good manufacturing practices, or GMP, by a contract manufacturing organization, or CMO, located in the United States. EQ101 drug product is currently formulated as a lyophilized powder for IV injection following reconstitution with Sterile Water for Injection, or SWFI. EQ101 SC formulation development is ongoing and expected to be ready for subsequent clinical studies.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Preclinical proof-of-concept studies of EQ101 have been conducted utilizing an animal model of immune-mediated hair loss. Non-Obese-Diabetic, or NOD, severe immune-deficient, or SCID, &#x3b3;c (CD132)-/- (NSG) mice are deficient in lymphoid cells and were used for generating a humanized mouse model of immune-mediated hair loss, which has been used by other labs (Sonntag 2015). Humanized mice that are transplanted with human peripheral blood mononuclear cells manifest symptoms including severe systemic hair loss or alopecia. Following the development of significant alopecia, approximately 4&#x2212;5 weeks post-transplant, the animals initiated study treatment. Response to treatment was evaluated using survival, body weight, serum cytokine levels (i.e., IL-2, IL-6, IL-15, TNF</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Symbol&quot;, serif;min-width:fit-content;">a</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, IFN&#x3b3;), and hair regrowth.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The efficacy results from the intervention studies found that EQ101 blockade of IL-2, IL-9 and IL-15 signaling resulted in significant regrowth of hair in this immune-mediated hair loss mouse model of AA. In addition, EQ101 also reduced circulating levels of the inflammatory cytokines IL-6 and interferon gamma, or IFN&#x3b3;, which are part of the immuno-inflammatory process observed in patients with AA. In this mouse model, EQ101 appeared to be more efficacious than an anti-IL-2 mAb, an anti-IL-15 mAb, and the JAK 1/2 inhibitor ruxolitinib. These results suggest that EQ101 has promise as a novel potential treatment for patients with AA.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">EQ101 has been evaluated by Bioniz in three completed human clinical studies. One was a single ascending dose, or SAD, clinical study in healthy volunteers and another was a MAD clinical study in healthy volunteers. In the SAD study, subjects received EQ101 administered IV, at a single dose of 0.2, 0.4, 0.8, 1.6, 3.2, or 6.4 mg/kg. In the MAD study, subjects received four weekly IV doses of EQ101 at 0.5, 1, or 1.5 mg/kg or three doses every other week at 2 or 3 mg/kg. A total of 43 healthy</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">subjects received at least 1 dose of EQ101 in each of the two studies. EQ101 was considered well-tolerated with no deaths, serious or severe treatment-emergent adverse events, infusion reactions or dose-limiting toxicities, or DLTs.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Bioniz also evaluated EQ101 in an open-label Phase 1/2 dose-ranging clinical study of patients with large granular lymphocyte leukemia, or LGLL, or refractory cutaneous T cell lymphoma, or rCTCL, to characterize the safety, tolerability, clinical efficacy, and PK/PD of EQ101. The study enrolled 50 subjects, 30 with refractory CTCL and 20 with LGLL. Four escalating dose levels of 0.5 mg/kg, 1.0 mg/kg, 2.0 mg/kg and 4.0 mg/kg were administered weekly by IV infusion for up to 74 weeks. The study found that EQ101 was well-tolerated, with no DLTs, no infusion reactions, and no deaths, and only one subject discontinued participation due to an adverse event. Subjects treated with EQ101 exhibited a reduction in IL-2 and IL-15 dependent cells and inflammation, with improvements in skin lesions and a favorable overall response rate observed. Both the FDA and the European Medicines Agency, or EMA, granted EQ101 Orphan Drug designations for the treatment of CTCL in July 2019 and April 2021, respectively.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">EQ102</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(255,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">EQ102 is also a synthetic peptide that is conjugated to a PEG molecule in a site-specific manner. The drug substance is currently manufactured under GMP by a CMO located in China. EQ102 drug product is supplied as a lyophilized powder for reconstitution using SWFI prior to SC administration.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our Phase 1 clinical study is the first human clinical study of EQ102. Safety, toxicity, and PK/PD of EQ102 have been previously evaluated during the nonclinical development program that included 4-week toxicology studies in both rodents and Cynomolgus nonhuman primates, or NHP, using SC administration. In addition, an evaluation of toxicokinetic and anti-drug antibody, or ADA, potential and immunophenotype analyses were also performed in those studies. Dose-ranging studies were conducted in both mice and NHP to characterize the maximum tolerated doses and to inform dose selection for clinical development.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Understanding the Basis of Our Approach: CD6-ALCAM Pathway Inhibition</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">The Role of CD6 in Autoimmunity</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The role of the immune system is to defend the body against foreign organisms and cells, including cancerous cells, and in doing so must distinguish accurately between self- and non-self entities, a process called tolerance. Autoimmunity is an immune response directed against the body&#x2019;s own healthy cells and tissues, and is the underlying process in many inflammatory diseases. Autoimmunity results from a loss of tolerance caused in part by an imbalance in the relationship between T effector cells, or T</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:sub;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">eff</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> cells, and regulatory T cells, or T</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:sub;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">reg</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> cells. See </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Figure 4</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><img src="img268224062_5.jpg" alt="img268224062_5.jpg" style="width:672px;height:232px;" />&#160;</p>
  <p style="margin-left:3.4%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Figure 4: Autoimmunity is a balancing act. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">T</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:sub;font-size:5.36pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">reg</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> cells play an important role in preventing T</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:sub;font-size:5.36pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">eff</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> cells targeting of self-antigens that can lead to autoimmunity and tissue destruction.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Immune checkpoints are critical regulators of immune activation pathways, can be either co-stimulatory (activating) or co-inhibitory (inhibiting), and are crucial for maintaining immune balance and preventing autoimmunity. We believe co-stimulatory checkpoints are attractive drug targets for the treatment of immuno-inflammatory diseases, and more recently they have become a focus of development in immuno-inflammation.&#x202f;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">CD6 is a co-stimulatory receptor that plays an integral role in modulating T cell activation, proliferation, differentiation and trafficking. CD6 serves as a key checkpoint in regulating T</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:sub;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">eff</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> cells that are central to autoimmune responses. Preclinical and clinical studies have shown that blockade of CD6 co-stimulation leads to selective inhibition of pathogenic T</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:sub;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">eff</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> cell activity and trafficking, while preserving the important regulatory function of T</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:sub;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">reg</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> cells. Such studies and new insights into the underlying biology highlight CD6 as a resurgent target for the treatment of multiple immuno-inflammatory diseases.&#x202f;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Activated leukocyte cell adhesion molecule, or ALCAM, is a ligand of CD6 that is expressed on hematopoietic tissues such as antigen-presenting cells, where it is important for immune synapse formation and optimal co-stimulation. Binding of ALCAM to domain-3 of CD6 leads to the downstream activation of several mitogen activated protein kinase pathways related to T cell activation, proliferation, differentiation and survival. See </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Figure 5.&#x202f;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ALCAM is also expressed on non-hematopoietic tissues such as the vascular endothelium, blood-brain barrier, skin, lung, kidney and gut, where it selectively facilitates the trafficking of T cells expressing CD6.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img268224062_6.jpg" alt="img268224062_6.jpg" style="width:615px;height:284px;" />&#160;</p>
  <p style="margin-left:3.4%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Figure 5: CD6 co-stimulation drives pathogenic T cell development and activity</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Co-stimulation occurs through the binding of ALCAM to domain-3 of CD6, leading to synergistic activation resulting in a five-fold increase in IL-2 receptor mediated T</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:5.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">eff</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> cell proliferation. Co-stimulation through CD6 promotes a pro-inflammatory response including the activation of pSTAT3 and ROR&#x3b3;t resulting in increased expression of IL-23R and pathogenic secretion of several T</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:5.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">eff</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> pro-inflammatory cytokines. ALCAM expressed on tissues such as the skin, lung, gut, blood-brain-barrier and kidney, selectively facilitates the trafficking of T</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:5.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">eff</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> cells expressing CD6. Notably, T</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:5.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">h</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">17 cells (that are steroid insensitive) and associated cytokines suppress T</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:5.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">reg</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> cell activity leading to a high T</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:5.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">h</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">17:T</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:5.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">reg</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> ratio characteristic of chronic autoimmunity.&#x202f;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Modulation of T</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;vertical-align:sub;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">eff </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cell Activity with Itolizumab (EQ001)</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Itolizumab (EQ001) is a humanized antibody that selectively binds to human CD6 and inhibits the interaction of CD6 with its ligand ALCAM, preventing co-stimulation, and thereby reducing T</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:sub;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">eff</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> cell activity and trafficking. Preclinical studies of itolizumab (EQ001) have shown that blockade of CD6 leads to a reduction in T</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:sub;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">eff</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> cell proliferation and downregulation of several important pathways that contribute to T</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:sub;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">eff</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> cell development such as Th1, Th2 and Th17 cells. Critically, CD6 blockade leads to the downregulation of important cellular pathways that control inflammation, including STAT3 and ROR&#x3b3;t. The downregulation of these pathways is accompanied by decreased secretion of the pro-inflammatory T</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:sub;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">eff</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> cytokines IFN-&#x3b3;, TNF-&#x3b1;, IL-6 and IL-17.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Additionally, by inhibiting the binding of ALCAM to CD6, itolizumab modulates lymphocyte trafficking and results in reduced T</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:sub;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">eff</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> cell infiltration into inflamed tissues. Based on its broad multi-modal mechanism, we believe itolizumab (EQ001) has the potential to treat multiple immuno-inflammatory diseases, including those that are resistant or refractory to existing therapies. See </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Figure 6</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img268224062_7.jpg" alt="img268224062_7.jpg" style="width:610px;height:276px;" />&#160;</p>
  <p style="margin-left:3.4%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Figure 6: Blockade of CD6 by itolizumab (EQ001) inhibits T</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:5.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">eff</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> cell activation, proliferation</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">,</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> differentiation and trafficking.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> Itolizumab (EQ001) selectively binds to domain-1 of CD6 and inhibits the interaction of ALCAM, preventing co-stimulation and thereby reducing T</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:5.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">eff</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> cell proliferation. Blockade of CD6 downregulates pSTAT and ROR&#x3b3;t resulting in reduced expression of IL-23R and secretion of pro-inflammatory T</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:5.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">eff</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> cytokines IFN-&#x3b3;, TNF-&#x3b1;, IL-6 and IL-17. Additionally, inhibiting the binding of ALCAM to CD6, reduces lymphocyte trafficking into inflamed tissues such as the skin, lung, gut, blood-brain-barrier and kidney. Reduction in the number and activity of T</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:5.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">h</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">17 cells inhibiting the T</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:5.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">reg</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> cells restores immune balance and promotes immune tolerance.&#x202f;</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Itolizumab (EQ001) Product Development</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Itolizumab has shown activity in completed clinical studies conducted by Biocon in patients with rheumatoid arthritis, psoriasis, and acute respiratory distress syndrome, or ARDS, related to COVID-19. Itolizumab has been approved for the treatment of moderate to severe plaque psoriasis in India where it was originally launched by Biocon under the brand name ALZUMAb. ALZUMAb is produced in an NS0 cell line and is currently available only in an IV formulation. Itolizumab (EQ001) contains the identical monoclonal antibody sequence produced in a Chinese hamster ovary, or CHO, cell line and may be administered by IV or SC. CHO cell lines are the industry-standard antibody therapeutic production system. In September 2020, the Drugs Controller General of India granted approval to Biocon of itolizumab produced in a CHO cell line, marketed by Biocon in India under the brand name ALZUMAb-L, or ALZUMAb Lyophilized, for the treatment of plaque psoriasis, as well as emergency use authorization of ALZUMAb-L for the treatment of cytokine release syndrome in COVID-19 patients with moderate to severe ARDS. Moving forward, Biocon is planning on transitioning their marketing and commercialization efforts from ALZUMAb to ALZUMAb-L. Itolizumab (EQ001) and ALZUMAb-L are different drug product names for the same formulation.&#x202f;</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Itolizumab (EQ001) is manufactured by Biocon at commercial scale in an FDA regulated manufacturing facility in India. Biocon has generated data demonstrating the analytical biocomparability of itolizumab (EQ001)/ALZUMAb-L and ALZUMAb using industry-standard physicochemical and biofunctional characterization methods.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Itolizumab (EQ001) Phase 1 Clinical Study in Healthy Subjects</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Biocon conducted a Phase 1 clinical study of itolizumab (EQ001) in 37 healthy subjects that was completed in Australia in the fourth quarter of 2017. The study was conducted in two stages, with the first stage designed to assess the safety, tolerability, PK, PD, and immunogenicity of ascending single doses of itolizumab (EQ001) SC, and the second stage designed to compare the PK of itolizumab (EQ001) IV to ALZUMAb and determine the absolute bioavailability of itolizumab (EQ001) SC.&#x202f;</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x202f;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The administration of single doses of itolizumab (EQ001) SC in Stage 1 was found to be well tolerated, with a low incidence (2/24) of low titer anti-drug antibodies. There were no SAEs, DLTs, or drug discontinuations reported. No clinically meaningful changes in physical examinations or vital signs were observed, whereas transient decreases in lymphocyte counts without clinical consequences were seen in 11/24 (46%) subjects. In general, observed AEs were transient, mild to moderate</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">14</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">in severity, were not dose dependent, and most were consistent with those observed in prior clinical experience with ALZUMAb.&#x202f;</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x202f;</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In Stage 2, the infusion of single doses of both itolizumab (EQ001) IV and ALZUMAb was associated with the development&#x202f;of transient, reversible, grade 2 to 3 decreases in lymphocyte counts in the healthy subjects. As a result, Stage 2 of the study was terminated early following the enrollment of seven subjects, yielding limited overall safety data and insufficient PK data for evaluation. There were no SAEs reported. No other clinically meaningful abnormalities or trends were noted in clinical chemistry, hematology, and urinalysis parameters. Similar to Stage 1, a transient decrease in T cells expressing CD4, and to a lesser extent CD8, a two- to three-times increase in the proportion of T</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">reg</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> cells, and saturation of CD6 receptors were observed across itolizumab (EQ001) and ALZUMAb cohorts.&#x202f;</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x202f;</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">While similar decreases in lymphocyte counts have not been reported with ALZUMAb previously, the timing of hematologic assessments in prior clinical studies may not have occurred at sufficiently early time-points to detect this transient response. Additionally, ALZUMAb had previously only been dosed in patients with active autoimmune disease and not healthy subjects. Importantly, the magnitude and kinetics of lymphocyte decreases were similar for itolizumab (EQ001) IV and ALZUMAb in Stage 2, while administration of itolizumab (EQ001) SC demonstrated milder decreases in lymphocyte counts, which would be expected based on the different PK properties of SC versus IV formulations. Furthermore, ALZUMAb had been well tolerated with demonstrated safety and clinical activity in three clinical studies in India in patients with rheumatoid arthritis and chronic plaque psoriasis, with a total of 333 patients exposed to ALZUMAb to date in clinical studies at doses ranging from 0.2 mg/kg to 1.6 mg/kg over a period of four years. Therefore, we believe the transient decreases in lymphocyte counts seen in the Phase 1 clinical study in healthy subjects represent a PD property of both itolizumab (EQ001) and ALZUMAb that will be monitored going forward, and the results of the Phase 1 clinical study support the advancement of itolizumab (EQ001) SC and IV into further clinical development in patients with immuno-inflammatory disease.&#x202f;</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our Initial Clinical Indications</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Alopecia Areata Market Overview</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">AA is an inflammatory, non-scarring autoimmune-mediated condition resulting in hair loss that has limited treatment options for those with severe disease. The condition occurs when the immune system attacks hair follicles on any hair-bearing area of the body, most frequently on the head and face. The lifetime incidence of AA is estimated at about two percent globally, while the prevalence is estimated to be 0.1% to 0.2%. AA affects men and women of all racial and ethnic groups. It has a higher prevalence in children and adolescents with 40% of cases occurring prior to age 20, and 80% before age 40. The causes of AA are not fully understood, but it is believed to result from a loss of immune privilege in the hair follicle following a triggering event (e.g., stress, infection, trauma) facilitated by IFN&#x3b3;, that leads to an upregulation of inflammatory cytokine signaling resulting in autoimmune-mediated hair loss. AA is associated with other immune-mediated or autoimmune disorders such as thyroiditis, vitiligo, and atopic diseases. Approximately 50% of patients have chronic relapsing, remitting disease persisting more than 12 months and approximately 10% to 35% ultimately experience complete loss of scalp hair (alopecia totalis) or complete loss of scalp and body hair (alopecia universalis). AA has a psychosocial burden that can have a significant negative impact on health-related quality of life and has been associated with depression and anxiety.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Rationale for EQ101 for the Treatment of Alopecia Areata</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">IL-2, IL-9, and IL-15 have been identified as being upregulated in animal models of AA and in human biopsies of AA lesions. Studies have demonstrated cytotoxic CD8+ NKG2D+ T cells were both necessary and sufficient for the disease induction in mouse models of AA, with IL-2 increasing the number of CD8+ cells and IL-15 increasing the expression of NKG2D and the production of IFN&#x3b3; by follicular epithelial cells that aberrantly transforms these T cells into cytotoxic T cells that attack the hair follicle. IL-15 released by dendritic cells and/or the follicular epithelial cells is believed to be the initiating event that promotes production of IFN&#x3b3;, which leads to the initial loss of immune privilege of the hair follicle, and production of IL-2 that leads to T cell proliferation. Global transcriptional profiling of mouse and human AA skin revealed gene expression signatures indicative of cytotoxic T cell infiltration and upregulation of IL-2 and IL-15 that have been shown to promote the activation and survival of IFN&#x3b3;-producing CD8+ NKG2D+ effector T cells. In addition, the pathologic activation by IL-9 of mast cells that produce and secrete Th2 cytokines (IL-5, IL-6 and IL-13) and TGF</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Symbol&quot;, serif;min-width:fit-content;">&#xf062;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and facilitate antigen presentation of the hair follicle to these cytotoxic T cells has been implicated in AA.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Several clinical studies have been conducted with JAK inhibitors for the treatment of AA. Initially, investigator-initiated studies using tofacitinib and ruxolitinib produced moderate response rates in small numbers of subjects that had been otherwise refractory to standard of care treatments. More recently, several industry-sponsored studies observed efficacy of</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">JAK inhibitors in the treatment of AA using baricitinib, ritlecitinib and deuruxolitinib. Baricitinib was granted FDA approval for the treatment of AA in June 2022.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Despite the results of those clinical studies and the approval of baricitinib, the efficacy of JAK inhibitors may be limited by their PK properties which can result in inadequate blockade of JAK signaling between doses and by the additional signaling pathways (PI3K, AKT, mTOR and MAPK/ERK) associated with the </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Symbol&quot;, serif;min-width:fit-content;">&#xf067;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">c cytokines that are not inhibited by the JAK inhibitors, which can lead to an incomplete blockade of pathologic cytokine signaling. Furthermore, safety issues have been associated with JAK inhibitors, due to their wide-ranging inhibitory effects on non-disease-related cytokine signaling, which may limit their utility and acceptance by physicians and patients. We believe EQ101 is a more selective and effective inhibitor of IL-2, IL-9, and IL-15 (i.e., disease-driving cytokines) and may provide a novel therapeutic approach for the treatment of AA.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Development Plan in Alopecia Areata</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We have two open Investigational New Drug applications, or INDs, for EQ101 for AA and CTCL. In November 2022, we initiated a Phase 2 clinical study </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(Figure 7)</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> of EQ101 in subjects with AA in Australia.  This is a multicenter, open-label, proof-of-concept clinical study in approximately 30 adult subjects between 18 and 60 years of age, with at least 35% scalp hair loss due to AA. Subjects will be dosed IV once weekly for 24 weeks with EQ101 at a dose level of 2 mg/kg, and subsequently followed for an additional four weeks. The primary objective of the study is to evaluate the safety and tolerability of EQ101 in subjects with moderate to severe AA over a 24-week treatment period. Secondary objectives will be to evaluate drug efficacy, PK/PD properties, and to assess changes in patient biomarkers. We expect to announce initial data from the Phase 2 clinical study of EQ101 in AA in the second half of 2023 and topline data in mid-2024. We are developing an SC formulation of EQ101 for planned use in subsequent clinical studies.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img268224062_8.jpg" alt="img268224062_8.jpg" style="width:672px;height:277px;" />&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Figure 7: </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Phase 2 open label clinical study of EQ101 in alopecia areata</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Celiac Disease Market Overview</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Celiac disease is a chronic inflammatory intestinal disorder caused by inappropriate cellular and humoral immune responses to the dietary intake of gluten in the genetically susceptible individual. Celiac disease is one of the most common autoimmune disorders, with a reported prevalence of 0.5% to 1% of the global population and affecting approximately 2.3 million people in the United States. The prevalence of celiac disease has increased over the past 50 years and the rate of diagnosis has risen over the past two decades. Although celiac disease can occur at any age, onset most commonly occurs either in the first two&#x2009;years of life or in the second or third decades of life. Celiac disease occurs selectively in individuals expressing the gene human leukocyte antigen (HLA)-DQ2 or HLA-DQ8. In celiac disease, a mucosal inflammatory response in the intestinal epithelia leads to villous atrophy, and crypt cell hyperplasia. The loss of mucosal integrity in celiac disease is associated with a high burden of illness resulting from a plethora of intestinal and extraintestinal disease manifestations. Currently, there are no approved products to treat celiac disease, and strict adherence to a gluten-free diet is currently the only approach for celiac disease patients to manage the disease. A full recovery is often observed in pediatric celiac disease patients, but over 40% of adult celiac disease patients maintain histological abnormalities &#x2013; such as villous structural damage &#x2013; following complete removal of dietary gluten. Further complicating the gluten-free treatment strategy, 5% of adult patients</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">16</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">can develop a refractory form of celiac disease, characterized by severe villous atrophy and the presence of abnormal intraepithelial lymphocytes, or IELs, which is considered the early stages of enteropathy associated T cell lymphoma, a potentially lethal condition not confined to intestinal epithelia.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Rationale for EQ102 for the Treatment of Celiac Disease</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">IL-15 has been identified as a key driver of celiac disease pathogenesis. IL-15 is chronically upregulated in the lamina propria and epithelium of the intestine and directly correlates with the severity of mucosal damage. This proinflammatory cytokine acts on distinct cell types resulting in malfunction of multiple immune mechanisms. Elevated IL-15 in the intestinal lamina propria has been shown to promote phenotypic changes to tolerogenic dendritic cells leading to a block in the generation of regulatory T cells, or T</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:sub;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">regs</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, a lymphocyte subset critical for maintaining tolerance to self-antigens and promoting tolerance to innocuous dietary antigens. The reduction of inducible T</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:sub;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">regs</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> to dietary antigens elevates the potential for an intestinal inflammatory immune response to gluten intake. IL&#x2011;15 expression is also correlated with the upregulation of the activating NKG2D receptor on cytotoxic lymphocytes and its associated cytotoxic pathway, and with the complementary major histocompatibility complex class I chain-related (MIC) ligands (i.e., MICA and MICB) at the epithelial cell surface that triggers their subsequent killing by cytotoxic lymphocytes.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Another &#x3b3;c cytokine that has been implicated in celiac disease is IL-21. IL-21 has a robust genetic association with celiac disease. IL-21 is produced by the gluten-specific CD4 T cells in celiac disease and has the capacity to promote cytolysis in intestinal intraepithelial cytotoxic T lymphocytes (IE&#x2011;CTL). IL-21 is only over-expressed in active celiac disease (patients who have gut tissue destruction) and not in potential celiac disease (those who only have antibody response and no gut tissue damage). This suggests that IL&#x2011;21 may be a co-factor along with IL-15 in causing tissue damage in active celiac disease. Furthermore, IL-21 is known to be a key cytokine in the development of B cell differentiation and plasma cell generation, and therefore antibody response. A key characteristic of celiac disease is the presence of autoantibodies to transglutaminase 2 (TG2) that are produced by TG2-specific B cells. In addition to the infiltration of IE-CTLs in the lamina propria of the small bowel, there is evidence of plasmacytosis in the lamina propria which may highlight the potential pathogenic effect of autoantibody production in celiac disease. Recent studies highlighted the importance of crosstalk between CD4 T cells and B cells in activating the cytotoxic immune attack against gut tissue in celiac disease. IL&#x2011;21, as a major B-cell cytokine, may play a key role in orchestrating both antibody and cytotoxic responses in celiac disease. IL-21 inhibition may control the production of autoantibodies in these patients.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Further support that these two &#x3b3;c cytokines work in concert is bolstered by evidence that IL-15 drives IL&#x2011;21 secretion in IELs derived from patients with active celiac disease. EQ102 specifically inhibits the activity of IL-15 and IL-21, but not the remaining &#x3b3;c cytokines in the family (IL-2, -4, -7, or -9), thus targeting the key pathogenic cytokines in celiac disease while preserving the functional immune system through other uninterrupted &#x3b3;c cytokines. EQ102 has been thoroughly characterized, and we believe it is uniquely positioned to provide a specific two-pronged approach to downregulate the cytotoxic activity of IELs in celiac disease by inhibiting the synergistic effect of IL-15 and IL-21. We believe EQ102 may control the gliadin mediated inflammatory effect in celiac disease by acting on both B and T cell arms in a highly selective manner.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Development Plan in Celiac Disease</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In September 2022, we initiated a Phase 1 first-in-human clinical study of EQ102 in healthy volunteers in Australia. It is a randomized, double-blind, placebo-controlled study of EQ102 administered SC as single or multiple doses in up to 64 healthy volunteers. In Part A, healthy volunteers will be enrolled and randomized to five cohorts (n=8 per cohort) to receive single doses of EQ102 or placebo. The starting dose in Part A will be 50 mg, with five ascending dose levels planned up to 1,000 mg. In Part B, healthy volunteers will be enrolled and randomized to three cohorts (n=8 per cohort) to receive multiple doses of EQ102 or placebo. In Part B, up to three dose levels will be evaluated, where the starting dose will be based on safety and pharmacokinetic data from Part A. The primary objective of the study is to assess the safety and tolerability of EQ102, with secondary objectives including PK/PD changes after SAD and MAD. Following the MAD portion of this study, we plan to conduct a proof-of-concept Part C of the study, which is expected to evaluate the biological activity of EQ102 in subjects with celiac disease. See </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Figure 8 </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">for an overview of the Phase 1 clinical study of EQ102. We expect to announce data from the SAD and MAD parts of the study in the second half of 2023 and celiac disease patient data in 2024.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">17</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img268224062_9.jpg" alt="img268224062_9.jpg" style="width:672px;height:233px;" />&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Figure 8: </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">EQ102 Phase 1 clinical study design</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Graft-Versus-Host Disease Market Overview</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Graft-versus-host disease, or GVHD, is a multisystem disorder that is a common complication of allogeneic hematopoietic stem cell transplants, or allo-HSCT, caused by the transplanted immune system, more specifically T</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">eff  </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">cells, recognizing and attacking the recipient&#x2019;s body. GVHD is the leading cause of non-relapse mortality in patients receiving an allo-HSCT. The risk of GVHD limits the number and type of patients receiving allo-HSCT and we believe that a therapy that can attenuate GVHD risk could significantly expand the patient population eligible for allo-HSCT.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">According to the Center for International Blood &amp; Marrow Transplant Research and other published reports, there were approximately 10,000 allo-HSCT&#x2019;s expected to have been performed in the United States in 2020 and the number of procedures has grown at an average annual growth rate of approximately 4% since 2007. Approximately 30-70% of allo-HSCT recipients develop aGVHD. Five-year survival for patients that respond to first-line treatment with corticosteroids has been reported to be as low as 53% while in steroid refractory aGVHD, the overall 5-year survival has been reported to be as low as 5%. We estimate that the incidence of aGVHD in 2020 was approximately 5,800 patients and the total prevalence of GVHD was approximately 16,000 patients. We estimate that by the year 2030, the annual incidence of aGVHD could be up to 7,000 patients and the total prevalence of GVHD could be up to 20,000 patients.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Rationale for Itolizumab (EQ001) for the Treatment of GVHD</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Itolizumab (EQ001) Selectively Targets GVHD Pathogenesis</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">There is a high unmet medical need for a safe, effective and targeted treatment of GVHD. We believe itolizumab (EQ001) has the potential to be a best-in-class treatment for aGVHD based on its ability to target the underlying biology of GVHD in a highly selective way. Further, this approach is also promising as we consider future development in the prevention of GVHD and the treatment of chronic GVHD, or cGVHD.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">It is well established that T</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">h</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">17 cells, driven by pSTAT3 signaling, play a role in the pathogenesis of aGVHD, and studies have shown that pSTAT3 was significantly increased in T cells of GVHD patients. In aGVHD, additional studies have reported that T</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">h</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">17 cells and IL-17 serum levels were significantly elevated in patients at onset compared with HSCT patients without aGVHD. As the disease progresses, T</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">h</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">17 cells traffic from the peripheral blood into GVHD target tissues where they trigger damage. Furthermore, the expansion of T</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">h</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">17 cells in the early phase of aGVHD plays a role in the transition to cGVHD. In GVHD patients, studies have shown a high T</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">h</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">17:T</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">reg</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> ratio suggesting a loss of tolerance. Notably the increased number of circulating T</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">h</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">17 cells was accompanied by a decrease in T</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">reg</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> cells, suggesting a loss of T</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">eff</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> cell regulation. Such regulatory mechanisms are crucial for eliminating alloreactive T cell activity, thus preventing sustained autoimmune responses and tissue destruction in GVHD.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We believe itolizumab (EQ001) can selectively target elements of the underlying pathogenesis of aGVHD by: a) inhibiting T</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">eff</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> cells proliferation; b) downregulating the STAT3 pathway associated with development of pathogenic T</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">h</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">17 cells driving GVHD pathogenesis; c) inhibiting trafficking of T</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">eff </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">cells into GVHD target tissues preventing further inflammation and organ damage; and d) reducing the T</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">h</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">17:T</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">reg</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> ratio associated with the development of GVHD and thereby promoting tolerance.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Third-party Clinical Experience with Targeting CD6 in GVHD</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Clinical evidence to support the rationale of treating GVHD with itolizumab (EQ001) comes from previously-reported third-party clinical experience with CD6-expressing T cell depletion in patients receiving bone marrow transplants for hematologic malignancies where it has been demonstrated that using an anti-CD6 monoclonal antibody to deplete T cells from donor bone marrow or lymphocyte infusions has the potential to prevent aGVHD. In a study evaluating the clinical effects of selective in vitro CD6 expressing T cell depletion of donor allogeneic bone marrow using a monoclonal antibody to CD6 and rabbit complement, Soiffer et al. reported that in vitro T cell depletion with an anti-CD6 monoclonal antibody effectively reduced the incidence of both acute and chronic GVHD after allogeneic bone marrow transplant without compromising engraftment.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Subsequent studies further confirmed the feasibility of CD6-expressing T cell depletion in patients undergoing allogeneic bone marrow transplantation from human leukocyte antigen identical related and unrelated donors. In these studies, CD6 expressing depletion of the donor stem cell product was the sole method for GVHD prophylaxis. The low incidence of aGVHD reported in patients receiving allogeneic bone marrow treated with anti-CD6 monoclonal antibodies was attributed to the early appearance of a population of peripheral CD3 expressing T lymphocytes with a CD6-negative phenotype, which showed diminished reactivity to allogeneic stimulation in mixed lymphocyte reaction assays. Although the above described approach is one of ex vivo CD6-expressing T cell depletion, we believe that it further supports the role of CD6-expressing T cells in aGVHD pathogenesis and validates CD6 as a potentially important target for modulation for the treatment of GVHD.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Development Plan in GVHD</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our Investigational New Drug application, or IND, with the FDA for aGVHD was accepted in July 2018. The FDA granted itolizumab (EQ001) Fast Track designation for the treatment of aGVHD in December 2018 and Orphan Drug designations for both the prevention and treatment of aGVHD in February 2019.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In March 2019, we initiated EQUATE</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">an open-label Phase 1b clinical study of itolizumab (EQ001) as a first-line therapy concomitant with steroids for the treatment of aGVHD. In the EQUATE clinical study, we are assessing safety, PK, PD, and a number of clinical outcomes including complete response, or CR, rate, overall response rate, or ORR, survival and steroid taper. An overview of the design of the EQUATE study is depicted in </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Figure 9</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img268224062_10.jpg" alt="img268224062_10.jpg" style="width:672px;height:223px;" />&#160;</p>
  <p style="margin-left:1.667%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Figure 9: </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Overview of the EQUATE clinical study design</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In February 2023, we presented final safety and efficacy results from the EQUATE clinical study at the Tandem Meetings of the American Society of Transplantation and Cellular Therapy and the Center for International Blood &amp; Marrow Transplant Research. Data was presented from a total of 30 subjects treated with itolizumab (EQ001) at doses of 0.4, 0.8, or 1.6 mg/kg. Itolizumab (EQ001) treatment in combination with systemic corticosteroids was associated with rapid and durable high rates of overall clinical response, where response at Day 29 was associated with improved progression-free survival through 1 year. Further, responders were able to taper steroids by 70% at Day 29 and 99% at Day 169. Itolizumab (EQ001) was well-tolerated in severe aGVHD patients. Based on these findings and feedback from both the FDA and leading physicians in the field of hematopoietic stem cell transplantation, in March 2022 we initiated EQUATOR, a Phase 3 pivotal clinical study in first-line aGVHD.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">EQUATOR is a randomized, double-blind clinical study that will assess the efficacy and safety of itolizumab (EQ001) versus placebo as a first-line therapy for aGVHD in combination with corticosteroids. The primary objective of the study is to achieve early disease response, with key secondary objectives to evaluate durability of response, corticosteroid use, survival</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">19</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">outcomes, and cGVHD incidence. The primary endpoint assessment is CR rate at Day 29, with key secondary endpoints of overall response rate, or ORR, at Day 29 and durability of CR rate from Day 29 through Day 99.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The EQUATOR study will compare the efficacy and safety of IV administered itolizumab (EQ001) versus placebo (randomized 1:1) as a first-line therapy in up to 200 adult and adolescent patients with Grade III-IV aGVHD or Grade II aGVHD with lower GI involvement, in combination with high doses of corticosteroids, the current standard of care. Per the study protocol, patients must receive itolizumab (EQ001) within 3 days of the first administration of high-dose corticosteroids with a treatment period from Days 1-99 and a follow-up period from Days 100-365. Eligible subjects who receive 2 mg/kg methylprednisolone or equivalent on Day 1 will be randomized in a 1:1 ratio to the following two treatment groups: Group A: itolizumab (EQ001), 1.6 mg/kg initial dose followed by 6 doses of 0.8 mg/kg once every two weeks (Q2W), plus systemic corticosteroids (100 subjects), or Group B: placebo, 7 doses Q2W, plus systemic corticosteroids (100 subjects). An independent data monitoring committee will regularly review safety data, and an interim analysis is planned after approximately 100 subjects have completed Day 29 assessments to evaluate the safety and efficacy of treatment. We anticipate that interim review occurring in 2024. An overview of the design of the EQUATOR study is depicted in </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Figure 10</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img268224062_11.jpg" alt="img268224062_11.jpg" style="width:672px;height:293px;" />&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Figure 10: </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Overview of the EQUATOR clinical study design</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Lupus Market Overview</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">SLE is a heterogeneous, multisystem, autoimmune disease characterized by the presence of multiple autoantibodies and deposition of immune complexes in various tissues. Based on publicly available sources, we estimate that SLE impacts between 250,000 and 322,000 people in the United States.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">LN is the most frequent, serious manifestation of SLE occurring in up to 30-60% of SLE patients. It is estimated there are over 100,000 patients living with LN in the United States; despite the significant number of people affected, there are currently only two FDA-approved drugs for this condition.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Current Therapies for Lupus Nephritis and their Limitations</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Current standard-of-care therapy for the most aggressive type of LN, called proliferative LN or Class III or IV LN, consists of broad-based immunosuppressive drugs, such as prednisolone, mycophenolate mofetil, or MMF, and cyclophosphamide, which come with significant toxicities. LN is predominantly a disease of young women, and these drugs carry with them a number of toxicities that are particularly problematic for this population including weight gain, edema, moon face, infection risk, diabetes, and infertility.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">While these therapies have improved 5-year survival for LN patients, as many as 50-75% of patients are refractory to treatment and those that respond will likely relapse within five years. In those patients who are refractory or relapse after initial treatment with induction therapy, there is no consensus or strong evidence to support what treatments may be effective. The prognosis for patients with proliferative LN remains poor and up to 40% of patients will progress to end-stage renal disease, or ESRD, requiring dialysis or kidney transplant. Overall, the available options are quite limited for LN patients, particularly those that are refractory to, or relapse from standard induction therapy. Recently, two new therapies have been</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">20</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">approved for LN. GlaxoSmithKline&#x2019;s Benlysta, which was approved for LN in December 2020, targets BLyS and inhibits the stimulation of autoreactive B-cells. Aurinia Pharmaceuticals, Inc.&#x2019;s Lupkynis, which was approved in January 2021, is a calcineurin inhibitor that blocks IL-2 expression and inhibits autoreactive T cells. Despite those recent approvals, there remains a significant need for new therapies that are more effective, can maintain a durable response, and carry a better safety profile.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Rationale for Itolizumab (EQ001) for the Treatment of LN</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Itolizumab (EQ001) Selectively Targets T</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">eff</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> Cells that Play a Central Role in the Pathogenesis of LN</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Despite the presence of autoantibody formation and inflammatory cytokines in SLE and LN, B cell-directed and single-cytokine targeted therapies have largely failed in clinical development. More recent evidence has demonstrated that T</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">eff </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">cells play a central role in the pathogenesis of both SLE and LN in that they mediate tissue damage and also enhance the production of autoantibodies by promoting B cell differentiation, proliferation and maturation. Multiple T</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">eff</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> cells/cytokines, such T</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">h</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1/IFN-&#x3b3;, T</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">h</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2/IL-4 and T</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">h</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">17/IL-17, have all been implicated in the immunopathogenesis of both SLE and LN, highlighting the complex nature of the disease. However, T</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">h</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">17 cells are emerging as key targets as it has been demonstrated that high levels of IL-17 predict poor histopathological outcome after immunosuppressive therapy in patients with LN. Elevated levels of T</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">h</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">17 cells are accompanied by a decrease of T</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">reg </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">cells, suggesting that loss of this functional immune balance may be involved in the pathogenesis of renal damage in SLE patients. Therefore, targeting T</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">eff</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> cells, or molecules that modulate T</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">eff</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> cell activity, while preserving T</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">reg </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">activity could prove to be a successful therapeutic strategy for patients with SLE and LN.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We believe the unique mechanism of action of itolizumab (EQ001) can selectively target elements of the underlying pathogenesis of LN by: a) inhibiting multiple pathogenic T</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">eff</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> cells and cytokine secretion; b) inhibiting trafficking of T</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">eff</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> cells  into kidney tissues; and c) reducing the T</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">h</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">17:T</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">reg</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> ratio associated with LN.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Translational Research Supporting Itolizumab (EQ001) in LN</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Given the central role that T</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">eff</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> cells play in the immunopathogenesis of SLE and LN, we believe itolizumab (EQ001), which has been shown to block the CD6-ALCAM pathway and inhibit both the activity as well as trafficking of T</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">eff</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> cells into tissues, represents a promising therapeutic approach in this disease. To support this hypothesis, data from preclinical experiments in animal models of SLE and glomerulonephritis demonstrated that treatment with an anti-CD6 mAb lowers pro-inflammatory cytokines and improves disease activity, proteinuria, and renal function. In addition, validation for targeting the CD6-ALCAM pathway with itolizumab (EQ001) in LN is bolstered by translational research findings in human tissue and was published in the </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Journal of Clinical Investigation </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">in January 2022. The manuscript highlights data confirming the role of T cells activated by the CD6-ALCAM pathway in the development of LN and supports our research of itolizumab (EQ001) as a potentially novel therapeutic for treating LN.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Research conducted at the University of Houston, supported by a Target Identification in Lupus Grant from the Lupus Research Alliance, has shown that patients with active LN have substantial elevations in urinary ALCAM and that ALCAM levels in the urine track with disease activity. See </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Figure 11</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. These data further highlight the potentially important pathogenic role of the CD6-ALCAM pathway in patients with LN.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">21</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img268224062_12.jpg" alt="img268224062_12.jpg" style="width:672px;height:340px;" />&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img268224062_13.jpg" alt="img268224062_13.jpg" style="width:672px;height:217px;" />&#160;</p>
  <table style="margin-left:3.398%;border-spacing:0;table-layout:fixed;width:95.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:100.0%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Figure 11: ALCAM is a predictive biomarker in patients with active LN</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. The graph depicts levels of ALCAM in the urine of active LN, active (non-renal) SLE, inactive SLE and healthy controls by ELISA. ALCAM was highest in active LN patients while SLE patients were higher than healthy controls. The table compares the performance of urinary protein markers in differentiating active LN (N=89) from inactive LN (N=60) in African-American and Hispanic systemic lupus erythematosus patients.</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition to target validation, this research on urinary biomarkers may also have important implications in how we develop itolizumab (EQ001) in LN. The ease and scalability of using urine as a non-invasive liquid biopsy of the kidney provides us an opportunity to potentially change the way we identify and treat patients with LN. A biomarker-guided treatment approach using real-time urinary testing of the CD6-ALCAM pathway to determine the right patients for therapy, guide treatment, and monitor the disease has the potential to increase the chance of advancing a targeted therapeutic to drug approval and significantly improve patient care. Specifically, elevations in urinary biomarkers, such as soluble ALCAM or CD6, could be used to identify patients most likely to respond to itolizumab (EQ001). An evaluation of these biomarkers will be an important part of the development program and forms the initial basis for exploring a personalized medicine biomarker strategy with itolizumab (EQ001).</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Development Plan in LN</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In July 2019, our IND for lupus/LN was accepted by the FDA, and in December 2019 the FDA granted itolizumab (EQ001) Fast Track designation for the treatment of LN. In September 2019, we initiated EQUALISE, a Phase 1b proof-of-concept clinical study of itolizumab (EQ001) in patients with SLE and in patients with LN. The completed Type A portion was a MAD study involving 35 SLE patients to evaluate the safety, tolerability, PK, PD, and clinical activity of SC doses of itolizumab (EQ001) ranging from 0.4 mg/kg to 3.2 mg/kg Q2W. The ongoing Type B portion of the study is open label and</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">22</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">is evaluating up to 20 newly diagnosed or refractory LN patients who will be treated with itolizumab (EQ001) dosed at 1.6 mg/kg SC Q2W for up to 24 weeks. The selection of the 1.6 mg/kg dose was based on the totality of the safety, tolerability, and PK/PD data in the Type A part of the study that demonstrated a plateau in the reduction of CD6 cell surface expression above the 1.6 mg/kg dose. In addition to the same objectives as were in the Type A portion of the study, the Type B portion will also assess potential clinical activity of itolizumab (EQ001) in LN patients based on proteinuria levels and SLEDAI-2K scores. An overview of the design of the EQUALISE study is depicted in </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Figure 12</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img268224062_14.jpg" alt="img268224062_14.jpg" style="width:672px;height:276px;" />&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Figure 12: </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Overview of the EQUALISE clinical study design</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In March 2021, we reported favorable topline data from the Type A group of the EQUALISE study in patients with SLE where the data showed itolizumab (EQ001) was well tolerated. In addition, itolizumab (EQ001) demonstrated a dose-dependent reduction of cell surface CD6 expression on effector T cells, an indicator of drug activity, consistent with its mechanism of action.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In September 2022, we announced interim results from the Type B LN portion of the study where itolizumab (EQ001) demonstrated clinically meaningful responses in highly proteinuric subjects. The interim data reported on 13 patients, with 11 patients reaching at least 12 weeks of treatment and 6 patients reaching 28 weeks or the end of study, or EOS. Based on published guidelines for the management of LN from the European League Against Rheumatism, or EULAR, and European Renal Association-European Dialysis and Transplant Association, or ERA-EDTA, clinical activity assessments in this study are focused on the change in UPCR from baseline; proportion of patients with a CR, defined as 50% or greater reduction in UPCR and less than 0.5-0.7 g/g; and proportion of patients achieving a partial response, or PR, defined as 50% or greater reduction in UPCR. Subjects in the interim analysis were highly proteinuric with a baseline mean UPCR of 5.8 g/g. Clinically meaningful responses were observed by week 28 (EOS) including 3 of 6 (50%) subjects achieving a CR (UPCR &lt; 0.7 g/g), 2 of 6 (33%) subjects achieving a PR (UPCR &gt; 50% reduction) and 4 of 6 (67%) subjects achieving greater than 80% reduction in UPCR. In all subjects receiving more than one dose, 8 of 12 (67%) subjects achieved greater than 50% reduction in UPCR, we observed an average reduction of 60% in UPCR (over 3g of proteinuria) and subjects titrated steroid dose to &lt; 7.5 mg/day consistent with EULAR/ERA-EDTA recommendations. Itolizumab (EQ001) treatment was generally well tolerated with no drug related serious adverse events or treatment discontinuations. We expect to announce topline data from the Type B portion of the EQUALISE study of patients with active proliferative LN in the first half of 2024.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Intellectual Property</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our intellectual property is critical to our business and we strive to protect it, including by obtaining and maintaining patent protection in the United States and internationally for our product candidates, discovery platforms, novel biological discoveries, epitopes, new therapeutic approaches and potential indications, and other inventions that are important to our business. For our product candidates, generally we intend to initially pursue patent protection covering compositions of matter and methods of use. Throughout the development of our product candidates, we intend to identify additional means of obtaining patent protection that would potentially enhance commercial success, including claims targeting newly identified compositional improvements, methods of design, methods of treating and additional therapeutic targets.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of March 3, 2023, our patent portfolio related to itolizumab included issued patents and pending patent applications exclusively licensed from Biocon in the United States, Australia, Canada, and New Zealand, pending international and</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">23</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">national stage patent applications filed under the Patent Cooperation Treaty, or PCT, that we own. The terms of the Biocon License are discussed above in &#x201c;Business&#x2014;Partnerships&#x2014;Collaboration and License Agreement with Biocon&#x201d;.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Specifically, as of March 3, 2023, our licensed rights from Biocon related to itolizumab included nine issued patents in the United States, six issued patents in Australia, four issued patents in Canada, six issued patents in New Zealand, and pending patent applications in the United States, Australia, Canada, and New Zealand. Five of our issued U.S. patents are expected to expire in 2028 (absent any patent term extension for regulatory delays) and include claims directed to the antibody sequence of itolizumab and methods of formulating and using itolizumab alone or in combination with other agents to treat various T cell mediated diseases and disorders including GVHD and transplant rejection. Two of our issued U.S. patents are expected to expire in 2034 (absent any patent term extension for regulatory delays), and include claims directed to treating multiple sclerosis or inflammatory bowel disease with itolizumab in certain patients exhibiting increased numbers of T</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:sub;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">h</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">17 cells, wherein certain of the methods include monitoring IL-23R expression. Our issued Australia, Canadian, and New Zealand patents are expected to expire between 2027 and 2034. Our licensed rights from Biocon include a pending patent application family related to methods of using itolizumab to treat lupus, which includes one issued U.S. patent and pending applications in the United States, Australia, Canada, and New Zealand. Patents that may issue from our pending in-licensed patent applications are expected to expire between 2028 and 2041, absent any patent term adjustments or extensions.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Additionally, we own one patent application family related to methods of using itolizumab to treat severe asthma, which is pending in the United States, Australia, Canada, and New Zealand. If granted, any patents that issue from this patent family are expected to expire in 2039, absent any patent term adjustments or extensions. We also own one pending PCT application related to itolizumab dosing regimens, companion biomarkers, in vitro test lot assays, and ex vivo transplant therapies. If granted, any patents that issue from this PCT application are expected to expire in 2041, absent any patent term adjustments or extensions.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We also co-own one pending patent application family with the University of Houston System, which relates to diagnostic methods for using itolizumab to treat LN and is pending in the United States, Australia, Canada, and New Zealand. If granted, any patents that issue from this patent family are expected to expire in 2040, absent any patent term adjustments or extensions.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of March 3, 2023, through our acquisition of Bioniz, we wholly own a patent portfolio directed to composite peptide antagonists. This wing of our portfolio includes six additional patent families, including those related to the IL-2, IL-9, IL-15 peptide antagonist EQ101 (formerly known as BNZ-1), the IL-15 and IL-21 peptide antagonist EQ102 (formerly known as BNZ-2), other peptide sequences, and other related technologies for peptide modulation of multi-cytokine signaling largely in the &#x3b3;c-cytokine family space.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Of these six composite peptide families, the first family includes claims currently directed to composite peptides covering EQ101, methods of designing such peptides, and methods of using such peptides to treat various T cell mediated diseases and disorders (including but not limited to RA, immune-mediated hair loss, and myositis). This family currently includes seven issued U.S patents, three issued Australian patents, one issued Canadian patent, one issued Brazilian patent, one issued Chinese patent, 38 patents in European states, and two issued Japanese patents. Also pending are applications in the United States, Brazil, Canada, China, Europe, Hong Kong, and Japan. If granted, any patents in this patent family are expected to expire in 2032, absent any patent term adjustments or extensions.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The second patent family in our composite peptide portfolio includes claims currently directed to other multi-cytokine family peptide antagonists, as well as their methods of production. This family includes two issued U.S. patents and a pending U.S. application. If granted, any patents in this patent family are expected to expire in 2034, absent any patent term adjustments or extensions.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The third patent application family includes claims currently directed to composite peptides covering EQ102 and its methods of use to treat various T cell mediated diseases and disorders (including but not limited to celiac disease and inflammatory bowel disease). This family includes three issued U.S. patents, two issued Australian patents, 24 patents in European states, one issued Hong Kong patent, one issued Japanese patent, and one issued Korean patent. Also pending are applications in the United States, Australia, Canada, China, Europe, Hong Kong, India Japan, and Korea. If granted, any patents in this patent family are expected to expire in 2036, absent any patent term adjustments or extensions.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The fourth and fifth patent families include claims currently directed towards compositions and methods of treating various therapeutic targets (including, but not limited to, alopecia areata and related disorders). The fourth patent family includes one issued Australian patent. Collectively, these families include pending applications in the United States, Australia, Brazil, Canada, China, Europe, Hong Kong, India, Japan, and Korea.  If granted, any patents in this patent family are expected to expire in either 2038 or 2040, absent any patent term adjustments or extensions.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">24</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The sixth patent family includes claims currently directed to EQ101 for use in methods of treating cytokine-release syndrome and related disorders.  This family includes pending applications in the United States, Australia, Canada, China, Europe, Japan and Korea. If granted, any patents in this patent family are expected to expire in 2041, absent any patent term adjustments or extensions.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We file U.S. provisional patent applications as well as U.S. non-provisional applications and PCT applications that claim the benefit of the priority date of earlier filed provisional applications, when applicable. Provisional applications for patents were designed to provide a lower-cost first patent filing in the United States. Corresponding non-provisional patent applications must be filed not later than 12 months after the provisional application filing date. The corresponding non-provisional application benefits in that the priority date(s) of the patent application is/are the earlier provisional application filing date(s), and the patent term of the finally issued patent is calculated from the later non-provisional application filing date. This system allows us to obtain an early priority date, add material to the patent application(s) during the priority year, obtain a later start to the patent term and to delay prosecution costs, which may be useful in the event that we decide not to pursue examination in an application. The PCT system allows a single application to be filed within 12 months of the original priority date of the patent application, and to designate all of the 153 PCT member states in which national patent applications can later be pursued based on the international patent application filed under the PCT. The PCT searching authority performs a patentability search and issues a non-binding patentability opinion which can be used to evaluate the chances of success for the national applications in foreign countries prior to having to incur the filing fees. Although a PCT application does not issue as a patent, it allows the applicant to seek protection in any of the member states through national-phase applications. At the end of the period of 2 1/2 years from the first priority date of the patent application, separate patent applications can be pursued in any of the PCT member states either by direct national filing or, in some cases by filing through a regional patent organization, such as the European Patent Organization. The PCT system delays expenses, allows a limited evaluation of the chances of success for national/regional patent applications and enables substantial savings where applications are abandoned within the first 2 1/2 years of filing.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We intend to prosecute the pending applications that we own and in-license and to pursue patent issuance and protection in key commercial markets where we expect significant product sales may occur.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">With the enactment of the Biologics Price Competition and Innovation Act of 2009, or BPCIA, an abbreviated pathway for the approval of biosimilar and interchangeable biological products was created. The abbreviated regulatory pathway establishes legal authority for the FDA to review and approve biosimilar biologics, including the possible designation of a biosimilar as interchangeable based on its similarity to an existing reference product. Under the BPCIA, an application for a biosimilar product cannot be approved by the FDA until 12 years after the original branded product is approved under a Biologics License Application, or BLA.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The patent positions of biotechnology companies like ours are generally uncertain and involve complex legal, scientific and factual questions. We recognize that the ability to obtain patent protection and the degree of such protection depends on a number of factors, including the extent of the prior art, the novelty and non-obviousness of the invention, and the ability to satisfy the enablement requirement of the patent laws. In addition, the coverage claimed in a patent application can be significantly reduced before the patent is issued, and its scope can be reinterpreted after issuance. Consequently, we may not obtain or maintain adequate patent protection for any of our product candidates. We cannot predict whether the patent applications we are currently pursuing will issue as patents in any particular jurisdiction or whether the claims of any issued patents will provide sufficient proprietary protection from competitors. Any patents that we hold may be challenged, circumvented or invalidated by third parties.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our commercial success will also depend in part on not infringing the proprietary rights of third parties. In addition, we have licensed rights under proprietary technologies of third parties to develop, manufacture and commercialize specific aspects of our products and services. It is uncertain whether the issuance of any third-party patent would require us to alter our development or commercial strategies, alter our processes, obtain licenses or cease certain activities. The expiration of patents or patent applications licensed from third parties or our breach of any license agreements or failure to obtain a license to proprietary rights that we may require to develop or commercialize our future technology may have a material adverse impact on us. If third parties prepare and file patent applications in the United States that also claim technology to which we have rights, we may have to participate in interference proceedings in the United States Patent and Trademark Office, or USPTO, to determine priority of invention. For a more comprehensive discussion of the risks related to our intellectual property, please see &#x201c;Risk Factors&#x2014;Risks Related to Intellectual Property.&#x201d;</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The term of individual patents depends upon the legal term of the patents in the countries in which they are obtained. In most countries in which we file, the patent term is 20 years from the earliest date of filing a non-provisional patent application related to the patent. A U.S. patent also may be afforded a patent term adjustment, or PTA, under certain circumstances to compensate for delays in obtaining the patent from the USPTO. In some instances, such a PTA may result in a U.S. patent</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">25</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">term extending beyond 20 years from the earliest date of filing a non-provisional patent application related to the U.S. patent. In addition, in the United States, the term of a U.S. patent that covers an FDA-approved drug may also be eligible for patent term extension, which permits patent term restoration as compensation for the patent term lost during the FDA regulatory review process. The Hatch-Waxman Act permits a patent term extension of up to five years beyond the expiration of the patent. The length of the patent term extension is related to the length of time the drug is under regulatory review. Patent term extension cannot extend the remaining term of a patent beyond a total of 14 years from the date of product approval and only one patent applicable to an approved drug may be extended. Similar provisions are available in Europe and other foreign jurisdictions to extend the term of a patent that covers an approved drug. In the future, if and when our products receive FDA approval, we expect to apply for patent term extensions on patents covering those products. We plan to seek patent term extensions to any of our issued patents in any jurisdiction where these are available, however there is no guarantee that the applicable authorities, including the FDA in the United States, will agree with our assessment of whether such extensions should be granted, and if granted, the length of such extensions.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We also rely on trade secrets relating to product candidates and seek to protect and maintain the confidentiality of proprietary information to protect aspects of our business that are not amenable to, or that we do not consider appropriate for, patent protection. Although we take steps to protect our proprietary information and trade secrets, including through contractual means with our employees and consultants, third parties may independently develop substantially equivalent proprietary information and techniques or otherwise gain access to our trade secrets, including through breaches of such agreements with our employees and consultants. Thus, we may not be able to meaningfully protect our trade secrets. It is our policy to require our employees, consultants, outside scientific partners, sponsored researchers and other advisors to execute confidentiality agreements upon the commencement of employment or consulting relationships with us. These agreements provide that all confidential information concerning our business or financial affairs developed or made known to the individual during the course of the individual&#x2019;s relationship with us is to be kept confidential and not disclosed to third parties except in specific circumstances. Our agreements with employees also provide that all inventions conceived by the employee in the course of employment with us or from the employee&#x2019;s use of our confidential information are our exclusive property.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Competition</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The biotechnology and pharmaceutical industries are characterized by continuing technological advancement and significant competition. While we believe that our product candidates, technology, knowledge, experience and scientific resources provide us with competitive advantages, we face competition from major pharmaceutical and biotechnology companies, academic institutions, governmental agencies and public and private research institutions, among others. Any product candidates that we successfully develop and commercialize will compete with existing therapies and new therapies that may become available in the future. Key product features that would affect our ability to effectively compete with other therapeutics include the efficacy, safety and convenience of our products. The level of generic competition and the availability of reimbursement from government and other third-party payors will also significantly affect the pricing and competitiveness of our products. Our competitors also may obtain FDA or other regulatory approval for their products more rapidly than we may obtain approval for ours, which could result in our competitors establishing a strong market position before we are able to enter the market.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Many of the companies against which we may compete have significantly greater financial resources and expertise in research and development, manufacturing, preclinical testing, conducting clinical studies, obtaining regulatory approvals and marketing approved products than we do. Smaller or early-stage companies may also prove to be significant competitors, particularly through collaborative arrangements with large and established companies. These competitors also compete with us in recruiting and retaining qualified scientific and management personnel and establishing clinical study sites and patient registration for clinical studies, as well as in acquiring technologies complementary to, or necessary for, our programs.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Moreover, there are several companies marketing or developing treatments that may be approved for the same indications and/or diseases as our product candidates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Alopecia Areata</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The management of AA currently involves the use of a variety of topical, intralesional, and systemic agents, as well as devices, but the response to treatment varies widely. First-line therapies typically rely on topical or intralesional corticosteroids and in more severe patients, systemic corticosteroids. For refractory disease, immunosuppressive agents such as methotrexate, azathioprine and cyclosporine may be used. There is currently only one product, baricitinib, a JAK inhibitor with a brand name of Olumiant, approved by the FDA for the treatment of AA. Clinical studies have studied JAK inhibitors and S1P modulators, among others. Companies involved in alopecia areata drug development include Arcutis Biotherapeutics, Inc., ASLAN Pharmaceuticals Limited, Concert Pharmaceuticals, Inc. (acquired by Sun Pharmaceutical Industries Ltd.), Forte Biosciences, Inc., Horizon Therapeutics plc, Legacy Healthcare, Pfizer Inc., Reistone Biopharma, Zelgen Biopharmaceuticals Co., Ltd., and Zura Bio Limited.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">26</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Celiac Disease</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The only available treatment for celiac disease is lifelong adherence to a strict gluten-free diet. Most patients have difficulty maintaining such a diet and many patients do not fully respond, with symptoms persisting despite avoidance of gluten. There are currently no FDA-approved therapies for treatment of celiac disease. We are aware of a number of companies with development programs targeting the condition including Anokion SA, Calypso Biotech BV, Chugai Pharmaceutical Co., Ltd., IGY Immune Technologies &amp; Life Sciences Inc., Immunic, Inc., ImmunogenX, Inc., Protagonist Therapeutics, Inc., Provention Bio, Selecta Biosciences, Theriva Biologics, Inc., Takeda Pharmaceuticals, and Zedira GmbH.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">aGVHD</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Corticosteroids, or steroids, remain the standard of care for the first-line treatment of aGVHD. There are currently no FDA-approved therapies indicated as a first-line treatment of aGVHD. Second-line therapy consists of off-label immunosuppressives for which the therapeutic benefit has not been established, and Incyte Corporation&#x2019;s ruxolitinib which was approved for the treatment of steroid refractory aGVHD in 2019.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, we are aware of a number of companies with development programs in first-line and steroid refractory aGVHD, including AltruBio, Inc., ASC Therapeutics, CSL Behring LLC, Cynata Therapeutics Limited, ElsaLys Biotech, Humanigen, Inc., Maat Pharma SA, Medac GmbH, Mesoblast Limited, Shenzhen Xbiome Biotech, Co., Ltd., VectivBio Holding AG, and Zelgen Biopharmaceuticals Co., Ltd.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Lupus Nephritis</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Standard of care induction treatment in patients with the most severe forms of LN, called proliferative LN or Class III or IV LN, is typically IV methylprednisolone followed by oral prednisone with the addition of MMF or cyclophosphamide. Standard of care for maintenance therapy is typically a combination of corticosteroids and MMF or calcineurin inhibitors. There are currently two approved therapies for the treatment of LN. One is GlaxoSmithKline&#x2019;s Benlysta, approved in 2020, and the other is Lupkynis (voclosporin), which was approved in January 2021 and is marketed by Aurinia Pharmaceuticals Inc.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are aware of a number of companies with development programs targeting LN including Amgen Inc., AstraZeneca plc, Boehringer Ingelheim GmbH, Bristol-Myers Squibb Company, Corestem Co., Ltd., CSL Behring LLC, Genentech Inc., Jansen Pharmaceutical Companies of Johnson &amp; Johnson, Kezar Life Sciences, Inc., Novartis AG,  Omeros Corporation and Vera Therapeutics, Inc.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sales and Marketing</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Given our stage of development, we have not yet established a commercial organization or distribution capabilities.  We expect to manage sales, marketing, patient access and distribution either through internal resources or through third-party relationships. While we may commit significant financial and management resources to commercial activities, we will also consider collaborating with one or more pharmaceutical companies to enhance our commercial capabilities. Should Ono exercise its option to acquire our rights to itolizumab (EQ001), the commercialization of itolizumab (EQ001) would be Ono&#x2019;s responsibility.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Manufacturing</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We do not own or operate manufacturing facilities for the production of our product candidates, nor do we have plans to develop our own manufacturing operations in the foreseeable future. We rely on CMOs to manufacture EQ101 and EQ102. We rely on Biocon, our contract manufacturer, pursuant to the Biocon License and Biocon Supply Agreement, for all our required raw materials, drug substance and drug product needs for preclinical research, clinical studies and commercial supply of itolizumab (EQ001). Biocon manufactures itolizumab (EQ001) at commercial scale at its FDA-regulated facility in Bangalore, India.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">With respect to any future product candidates, we expect to rely on contract manufacturers for all our required raw materials, drug substance and drug product needs for preclinical research, clinical studies and commercial supply.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Government Regulation and Product Approval</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The FDA and other regulatory authorities at federal, state, and local levels, as well as in foreign countries, extensively regulate, among other things, the research, development, testing, manufacture, quality control, import, export, safety, effectiveness, labeling, packaging, storage, distribution, record keeping, approval, advertising, promotion, marketing, post-approval monitoring, and post-approval reporting of biologics such as those we are developing. We, along with third-party contractors, will be required to navigate the various preclinical, clinical and commercial approval requirements of the</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">27</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">governing regulatory agencies of the countries in which we wish to conduct studies or seek approval or licensure of our product candidates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In the United States, the FDA regulates biologics under both the Federal Food, Drug and Cosmetic Act, or FDCA, and the Public Health Services Act, or PHSA, and their implementing regulations. The process required by the FDA before biologic product candidates may be marketed in the United States generally involves the following:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x25aa;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">completion of preclinical laboratory tests and animal studies performed in accordance with the FDA&#x2019;s current Good Laboratory Practices, or GLP, regulations; </span></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x25aa;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">submission to the FDA of an IND, which must become effective before clinical studies may begin and must be updated annually or when significant changes are made; </span></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x25aa;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">approval by an independent Institutional Review Board, or IRB, or ethics committee at each clinical site before the study is commenced; </span></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x25aa;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">performance of adequate and well-controlled human clinical studies to establish the safety, purity and potency of the proposed biologic product candidate for its intended purpose; </span></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x25aa;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">preparation of and submission to the FDA of a biologics license application, or BLA, for product candidates that are manufactured in biological systems like itolizumab (EQ001), or a New Drug Application, or NDA, for product candidates like EQ101 or EQ102 that are manufactured through chemical synthesis, after completion of all pivotal clinical studies that includes substantial evidence of safety, purity and potency from results of nonclinical testing and clinical studies; </span></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x25aa;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">a determination by the FDA within 60 days of its receipt of a BLA or NDA to file the application for review; </span></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x25aa;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">satisfactory completion of an FDA Advisory Committee review, if applicable;</span></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x25aa;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">satisfactory completion of an FDA pre-approval inspection of the manufacturing facility or facilities at which the proposed product is produced to assess compliance with current good manufacturing practice, or cGMP and to assure that the facilities, methods and controls are adequate to preserve the biological product&#x2019;s continued safety, purity and potency, and of selected clinical investigation sites to assess compliance with Good Clinical Practices, or GCP; and </span></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x25aa;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">FDA review and approval, or licensure, of the BLA or NDA to permit commercial marketing of the product for particular indications for use in the United States. </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Preclinical and Clinical Development</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Prior to beginning the first clinical study with a product candidate in the United States, we must submit an IND to the FDA. An IND is a request for authorization from the FDA to administer an investigational new drug product to humans. The central focus of an IND submission is on the general investigational plan and the protocol(s) for clinical studies. The IND also includes results of animal and </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">in vitro</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> studies assessing the toxicology, PK, pharmacology, and PD characteristics of the product candidate; chemistry, manufacturing, and controls information; and any available human data or literature to support the use of the investigational product. An IND must become effective before human clinical studies may begin. The IND automatically becomes effective 30 days after receipt by the FDA, unless the FDA, within the 30-day time period, raises safety concerns or questions about the proposed clinical study. In such a case, the IND may be placed on clinical hold and the IND sponsor and the FDA must resolve any outstanding concerns or questions before the clinical study can begin. Submission of an IND therefore may or may not result in FDA authorization to begin a clinical study.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Clinical studies involve the administration of the investigational product to human subjects under the supervision of qualified investigators in accordance with GCPs, which include the requirement that all research subjects provide their informed consent for their participation in any clinical study. Clinical studies are conducted under protocols detailing, among other things, the objectives of the study, the parameters to be used in monitoring safety and the effectiveness criteria to be evaluated. A separate submission to the existing IND must be made for each successive clinical study conducted during product development and for any subsequent protocol amendments. Furthermore, an independent IRB for each site proposing to conduct the clinical study must review and approve the plan for any clinical study and its informed consent form before the clinical study begins at that site, and must monitor the study until completed. Regulatory authorities, the IRB or the sponsor may suspend a clinical study at any time on various grounds, including a finding that the subjects are being exposed to an unacceptable health risk or that the study is unlikely to meet its stated objectives. Some studies also include oversight by an independent group of qualified experts organized by the clinical study sponsor, known as a data safety monitoring board,</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">28</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">which provides authorization for whether or not a study may move forward at designated check points based on access to certain data from the study and may halt the clinical study if it determines that there is an unacceptable safety risk for subjects or other grounds, such as no demonstration of efficacy. There are also requirements governing the reporting of ongoing clinical study results to public registries.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For purposes of BLA or NDA approval, human clinical studies are typically conducted in three sequential phases that may overlap.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x25aa;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Phase 1&#x2014;The investigational product is initially introduced into healthy human subjects or patients with the target disease or condition. These studies are designed to test the safety, dosage tolerance, absorption, metabolism, distribution and elimination of the investigational product in humans, the side effects associated with increasing doses, and, if possible, to gain early evidence on effectiveness. </span></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x25aa;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Phase 2&#x2014;The investigational product is administered to a limited patient population with a specified disease or condition to evaluate the preliminary efficacy, optimal dosages and dosing schedule and to identify possible adverse side effects and safety risks. Multiple Phase 2 clinical studies may be conducted to obtain information prior to beginning larger and more expensive Phase 3 clinical studies. </span></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x25aa;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Phase 3&#x2014;The investigational product is administered to an expanded patient population to further evaluate dosage, to provide statistically significant evidence of clinical efficacy and to further test for safety, generally at multiple geographically dispersed clinical study sites. These clinical studies are intended to establish the overall risk/benefit ratio of the investigational product and to provide an adequate basis for product approval. </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In some cases, the FDA may require, or companies may voluntarily pursue, additional clinical studies after a product is approved to gain more information about the product. These so-called Phase 4 clinical study may be made a condition to approval of the BLA or NDA. Concurrent with clinical studies, companies may complete additional animal studies and develop additional information about the biological characteristics of the product candidate, and must finalize a process for manufacturing the product in commercial quantities in accordance with cGMP requirements. The manufacturing process must be capable of consistently producing quality batches of the product candidate and, among other things, must develop methods for testing the identity, strength, quality and purity of the final product, or for biologics, the safety, purity and potency. Additionally, appropriate packaging must be selected and tested and stability studies must be conducted to demonstrate that the product candidate does not undergo unacceptable deterioration over its shelf life.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Submission, Review and Approval of a BLA or NDA</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Assuming successful completion of all required testing in accordance with all applicable regulatory requirements, the results of product development, nonclinical studies and clinical studies are submitted to the FDA as part of a BLA or NDA requesting approval to market the product for one or more indications. The BLA or NDA must include all relevant data available from pertinent preclinical and clinical studies, including negative or ambiguous results as well as positive findings, together with detailed information relating to the product&#x2019;s chemistry, manufacturing, controls, and proposed labeling, among other things. The submission of a BLA or NDA requires payment of a substantial application user fee to FDA, unless a waiver or exemption applies.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Once a BLA or NDA has been submitted, the FDA&#x2019;s goal is to review standard applications within ten months after it accepts the application for filing, or, if the application qualifies for priority review, six months after the FDA accepts the application for filing. In both standard and priority reviews, the review process is often significantly extended by FDA requests for additional information or clarification. The FDA reviews a BLA or NDA to determine, among other things, whether a product is safe, pure and potent and the facility in which it is manufactured, processed, packed, or held meets standards designed to assure the product&#x2019;s continued safety, purity and potency. The FDA may convene an advisory committee to provide clinical insight on application review questions. Before approving a BLA or an NDA, the FDA will typically inspect the facility or facilities where the product is manufactured. The FDA will not approve an application unless it determines that the manufacturing processes and facilities are in compliance with cGMP requirements and adequate to assure consistent production of the product within required specifications. Additionally, before approving a BLA or an NDA, the FDA will typically inspect one or more clinical sites to assure compliance with GCP. If the FDA determines that the application, manufacturing process or manufacturing facilities are not acceptable, it will outline the deficiencies in the submission and often will request additional testing or information. Notwithstanding the submission of any requested additional information, the FDA ultimately may decide that the application does not satisfy the regulatory criteria for approval.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">After the FDA evaluates a BLA or an NDA and conducts inspections of manufacturing facilities where the investigational product and/or its drug substance will be produced, the FDA may issue an approval letter or a Complete Response letter. An approval letter authorizes commercial marketing of the product with specific prescribing information for specific indications.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">29</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">A Complete Response letter will describe all of the deficiencies that the FDA has identified in the BLA or NDA, except that where the FDA determines that the data supporting the application are inadequate to support approval, the FDA may issue the Complete Response letter without first conducting required inspections, testing submitted product lots, and/or reviewing proposed labeling. In issuing the Complete Response letter, the FDA may recommend actions that the applicant might take to place the BLA or NDA in condition for approval, including requests for additional information or clarification. The FDA may delay or refuse approval of a BLA or NDA if applicable regulatory criteria are not satisfied, require additional testing or information and/or require post-marketing testing and surveillance to monitor safety or efficacy of a product.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If regulatory approval of a product is granted, such approval will be granted for particular indications and may entail limitations on the indicated uses for which such product may be marketed. For example, the FDA may approve the BLA or NDA with a Risk Evaluation and Mitigation Strategy, or REMS, to ensure the benefits of the product outweigh its risks. A REMS is a safety strategy to manage a known or potential serious risk associated with a product and to enable patients to have continued access to such medicines by managing their safe use, and could include medication guides, physician communication plans, or elements to assure safe use, such as restricted distribution methods, patient registries and other risk minimization tools. The FDA also may condition approval on, among other things, changes to proposed labeling or the development of adequate controls and specifications. Once approved, the FDA may withdraw the product approval if compliance with pre- and post-marketing requirements is not maintained or if problems occur after the product reaches the marketplace. The FDA may require one or more Phase 4 post-market studies and surveillance to further assess and monitor the product&#x2019;s safety and effectiveness after commercialization, and may limit further marketing of the product based on the results of these post-marketing studies.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Expedited Development and Review Programs</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Any marketing application for a new therapeutic product submitted to the FDA for approval may be eligible for FDA programs intended to expedite the FDA review and approval process, such as priority review, fast track designation, breakthrough therapy and accelerated approval.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">A product is eligible for priority review if it has the potential to provide safe and effective therapy where no satisfactory alternative therapy exists or to provide a significant improvement in the treatment, diagnosis or prevention of a serious disease or condition compared to marketed products. For products containing new molecular entities, priority review designation means the FDA&#x2019;s goal is to take action on the marketing application within six months of the 60-day filing date (compared with ten months under standard review).</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">To be eligible for a fast track designation, the FDA must determine, based on the request of a sponsor, that a product is intended to treat a serious or life-threatening disease or condition and demonstrates the potential to address an unmet medical need by providing a therapy where none exists or a therapy that may be potentially superior to existing therapy based on efficacy or safety factors. Fast track designation provides opportunities for frequent interactions with the FDA review team to expedite development and review of the product. The FDA may also review sections of the BLA or NDA for a fast track product on a rolling basis before the complete application is submitted, if the sponsor and FDA agree on a schedule for the submission of the application sections, and the sponsor pays any required user fees upon submission of the first section of the BLA or NDA.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, a sponsor can request designation of a product candidate as a &#x201c;breakthrough therapy.&#x201d; A breakthrough therapy is defined as a drug or biologic that is intended, alone or in combination with one or more other drugs or biologics, to treat a serious or life-threatening disease or condition, and preliminary clinical evidence indicates that the drug or biologic may demonstrate substantial improvement over existing therapies on one or more clinically significant endpoints, such as substantial treatment effects observed early in clinical development. Drugs or biologics designated as breakthrough therapies are also eligible for accelerated approval. The FDA must take certain actions, such as holding timely meetings and providing advice, intended to expedite the development and review of an application for approval of a breakthrough therapy.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Additionally, products studied for their safety and effectiveness in treating serious or life-threatening diseases or conditions may receive accelerated approval upon a determination that the product has an effect on a surrogate endpoint that is reasonably likely to predict clinical benefit, or on a clinical endpoint that can be measured earlier than irreversible morbidity or mortality, that is reasonably likely to predict an effect on irreversible morbidity or mortality or other clinical benefit, taking into account the severity, rarity, or prevalence of the condition and the availability or lack of alternative treatments. As a condition of accelerated approval, the FDA will generally require the sponsor to perform adequate and well-controlled post-marketing clinical studies to verify and describe the anticipated effect on irreversible morbidity or mortality or other clinical benefit. In addition, the FDA currently requires as a condition for accelerated approval pre-approval of promotional materials, which could adversely impact the timing of the commercial launch of the product.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">30</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Even if a product qualifies for one or more of these programs, the FDA may later decide that the product no longer meets the conditions for qualification or decide that the time period for FDA review and approval will not be shortened. Furthermore, priority review, fast track designation, breakthrough therapy designation, and accelerated approval do not change the standards for approval but may expedite the development or approval process.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Orphan Drug Designation</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Under the Orphan Drug Act, the FDA may grant orphan designation to a drug or biologic intended to treat a rare disease or condition, which is a disease or condition that affects fewer than 200,000 individuals in the United States, or more than 200,000 individuals in the United States for which there is no reasonable expectation that the cost of developing and making available in the United States a drug or biologic for this type of disease or condition will be recovered from sales in the United States for that drug or biologic. Orphan designation must be requested before submitting a BLA or NDA. After the FDA grants orphan designation, the generic identity of the therapeutic agent and its potential orphan use are disclosed publicly by the FDA. The orphan drug designation does not convey any advantage in, or shorten the duration of, the regulatory review or approval process.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If a product that has orphan designation subsequently receives the first FDA approval for the disease for which it has such designation, the product is entitled to orphan exclusivity, which means that the FDA may not approve any other applications, including a full BLA or NDA, to market the same product for the same indication for seven years, except in limited circumstances, such as a showing of clinical superiority to the product with orphan drug exclusivity. Orphan exclusivity does not prevent FDA from approving a different drug or biologic for the same disease or condition, or the same drug or biologic for a different disease or condition. Among the other benefits of orphan drug designation are tax credits for certain research and a waiver of the BLA or NDA application fee.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">A designated orphan product may not receive orphan exclusivity if it is approved for a use that is broader than the indication for which it received orphan designation. In addition, exclusive marketing rights in the United States may be lost if the FDA later determines that the request for designation was materially defective or if the manufacturer is unable to assure sufficient quantities of the product to meet the needs of patients with the rare disease or condition.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Post-Approval Requirements</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Any products manufactured or distributed by us pursuant to FDA approvals are subject to pervasive and continuing regulation by the FDA, including, among other things, requirements relating to quality control and quality assurance, record-keeping, reporting of adverse experiences, periodic reporting, product sampling and distribution, and advertising and promotion of the product. After approval, most changes to the approved product, such as adding new indications or other labeling claims, are subject to prior FDA review and approval. There also are continuing user fee requirements, under which FDA assesses an annual program fee for each product identified in an approved BLA or NDA. Biologic manufacturers and their subcontractors are required to register their establishments with the FDA and certain state agencies, and are subject to periodic unannounced inspections by the FDA and certain state agencies for compliance with cGMP, which impose certain procedural and documentation requirements upon us and our third-party manufacturers. Changes to the manufacturing process are strictly regulated, and, depending on the significance of the change, may require prior FDA approval before being implemented. FDA regulations also require investigation and correction of any deviations from cGMP and impose reporting requirements upon us and any third-party manufacturers that we may decide to use. Accordingly, manufacturers must continue to expend time, money and effort in the area of production and quality control to maintain compliance with cGMP and other aspects of regulatory compliance.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The FDA may withdraw approval if compliance with regulatory requirements and standards is not maintained or if problems occur after the product reaches the market. Later discovery of previously unknown problems with a product, including AEs of unanticipated severity or frequency, or with manufacturing processes, or failure to comply with regulatory requirements, may result in revisions to the approved labeling to add new safety information; imposition of post-market studies or clinical studies to assess new safety risks; or imposition of distribution restrictions or other restrictions under a REMS program. Other potential consequences include, among other things:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x25aa;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">restrictions on the marketing or manufacturing of a product, mandated modification of promotional materials or issuance of corrective information, issuance by FDA or other regulatory authorities of safety alerts, Dear Healthcare Provider letters, press releases or other communications containing warnings or other safety information about the product, or complete withdrawal of the product from the market or product recalls; </span></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x25aa;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">fines, warning or untitled letters or holds on post-approval clinical studies; </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">31</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x25aa;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">refusal of the FDA to approve pending applications or supplements to approved applications, or suspension or revocation of existing product approvals; </span></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x25aa;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">product seizure or detention, or refusal of the FDA to permit the import or export of products; or </span></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x25aa;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">injunctions, consent decrees or the imposition of civil or criminal penalties. </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The FDA closely regulates the marketing, labeling, advertising and promotion of biologics. A company can make only those claims relating to safety and efficacy, purity and potency that are approved by the FDA and in accordance with the provisions of the approved label. However, companies may share truthful and not misleading information that is otherwise consistent with the product&#x2019;s FDA approved labeling. The FDA and other agencies actively enforce the laws and regulations prohibiting the promotion of off-label uses. Failure to comply with these requirements can result in, among other things, adverse publicity, warning letters, corrective advertising and potential civil and criminal penalties. Physicians may prescribe legally available products for uses that are not described in the product&#x2019;s labeling and that differ from those tested by us and approved by the FDA. Such off-label uses are common across medical specialties. Physicians may believe that such off-label uses are the best treatment for many patients in varied circumstances. The FDA does not regulate the behavior of physicians in their choice of treatments. The FDA does, however, restrict manufacturer&#x2019;s communications on the subject of off-label use of their products.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Regulation of Diagnostic Tests</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The co-development and validation of a diagnostic marker related to the CD6-ALCAM pathway and other urinary biomarkers for a companion diagnostic to identify LN patients most likely to respond to itolizumab (EQ001) will subject us and any diagnostic collaborator to device regulations of the FDA. </span><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unless an exemption applies, diagnostic tests require marketing clearance or approval from the FDA prior to commercial distribution. The two primary types of FDA marketing authorization applicable to a medical device are premarket notification, also called 510(k) clearance, and premarket approval, or PMA approval. We expect that any companion diagnostic developed for itolizumab (EQ001) will utilize the PMA pathway.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">PMA applications must be supported by valid scientific evidence, which typically requires extensive data, including technical, preclinical, clinical and manufacturing data, to demonstrate to the FDA&#x2019;s satisfaction the safety and effectiveness of the device. For diagnostic tests, a PMA application typically includes data regarding analytical and clinical validation studies. As part of its review of the PMA, the FDA will conduct a pre-approval inspection of the manufacturing facility or facilities to ensure compliance with the Quality System Regulation, which requires manufacturers to follow design, testing, control, documentation and other quality assurance procedures. On August 6, 2014, the FDA issued a final guidance document addressing the development and approval process for &#x201c;In Vitro Companion Diagnostic Devices.&#x201d; According to the guidance, a companion diagnostic device and its corresponding drug should be approved or cleared contemporaneously by the FDA for the use indicated in the therapeutic product labeling.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Biosimilars and Reference Product Exclusivity</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Patient Protection and Affordable Care Act, as amended by the Health Care and Education Reconciliation Act, or collectively, the Affordable Care Act, signed into law in 2010, includes the BPCIA, which created an abbreviated approval pathway for biological products that are biosimilar to or interchangeable with an FDA-approved reference biological product. To date, a number of biosimilars have been licensed under the BPCIA, and numerous biosimilars have been approved in Europe. The FDA has issued several guidance documents outlining its approach to the review and approval of biosimilars.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Biosimilarity, which requires that there be no clinically meaningful differences between the biological product and the reference product in terms of safety, purity, and potency, can be shown through analytical studies, animal studies, and clinical studies. Interchangeability requires that a product is biosimilar to the reference product and the product must demonstrate that it can be expected to produce the same clinical results as the reference product in any given patient and, for products that are administered multiple times to an individual, the biologic and the reference biologic may be alternated or switched after one has been previously administered without increasing safety risks or risks of diminished efficacy relative to exclusive use of the reference biologic. Complexities associated with the larger, and often more complex, structures of biological products, as well as the processes by which such products are manufactured, pose significant hurdles to implementation of the abbreviated approval pathway that are still being worked out by the FDA.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Under the BPCIA, an application for a biosimilar product may not be submitted to the FDA until four years following the date that the reference product was first licensed by the FDA. In addition, the approval of a biosimilar product may not be made effective by the FDA until 12 years from the date on which the reference product was first licensed. During this 12-year period of exclusivity, another company may still market a competing version of the reference product if the FDA approves a full BLA for the competing product containing that applicant&#x2019;s own preclinical data and data from adequate and well-controlled clinical studies to demonstrate the safety, purity and potency of its product. The BPCIA also created certain</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">32</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">exclusivity periods for biosimilars approved as interchangeable products. At this juncture, it is unclear whether products deemed &#x201c;interchangeable&#x201d; by the FDA will, in fact, be readily substituted by pharmacies, which are governed by state pharmacy law.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The BPCIA is complex and continues to be interpreted and implemented by the FDA. In addition, recent government proposals have sought to reduce the 12-year reference product exclusivity period. Other aspects of the BPCIA, some of which may impact the BPCIA exclusivity provisions, have also been the subject of recent litigation. As a result, the ultimate impact, implementation, and impact of the BPCIA is subject to significant uncertainty.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Other U.S. Healthcare Laws and Compliance Requirements</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In the United States, our current and future operations are subject to regulation by various federal, state and local authorities in addition to the FDA, including but not limited to, the Centers for Medicare &amp; Medicaid Services, or CMS, other divisions of the U.S. Department of Health and Human Services, or HHS (such as the Office of Inspector General, Office for Civil Rights and the Health Resources and Service Administration), the U.S. Department of Justice, or DOJ, and individual U.S. Attorney offices within the DOJ, and state and local governments. For example, our clinical research, sales, marketing and scientific/educational grant programs may have to comply with the anti-fraud and abuse provisions of the Social Security Act, the false claims laws, the privacy and security provisions of the Health Insurance Portability and Accountability Act, or HIPAA, and similar state laws, each as amended, as applicable.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The federal Anti-Kickback Statute prohibits, among other things, any person or entity, from knowingly and willfully offering, paying, soliciting or receiving any remuneration, directly or indirectly, overtly or covertly, in cash or in kind, to induce or in return for purchasing, leasing, ordering or arranging for the purchase, lease or order of any item or service reimbursable, in whole or in part, under Medicare, Medicaid or other federal healthcare programs. The term remuneration has been interpreted broadly to include anything of value. The federal Anti-Kickback Statute has been interpreted to apply to arrangements between therapeutic product manufacturers on one hand and prescribers, purchasers, and formulary managers on the other. There are a number of statutory exceptions and regulatory safe harbors protecting some common activities from prosecution. The exceptions and safe harbors are drawn narrowly and practices that involve remuneration that may be alleged to be intended to induce prescribing, purchasing or recommending may be subject to scrutiny if they do not qualify for an exception or safe harbor. Failure to meet all of the requirements of a particular applicable statutory exception or regulatory safe harbor does not make the conduct per se illegal under the federal Anti-Kickback Statute. Instead, the legality of the arrangement will be evaluated on a case-by-case basis based on a cumulative review of all of its facts and circumstances. Our practices may not in all cases meet all of the criteria for protection under a statutory exception or regulatory safe harbor.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Additionally, the intent standard under the federal Anti-Kickback Statute was amended by the Affordable Care Act, to a stricter standard such that a person or entity no longer needs to have actual knowledge of the statute or specific intent to violate it in order to have committed a violation. In addition, the Affordable Care Act codified case law that a claim including items or services resulting from a violation of the federal Anti-Kickback Statute constitutes a false or fraudulent claim for purposes of the federal False Claims Act, or FCA (discussed below).</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The federal false claims, including the FCA, and civil monetary penalty laws, which can be enforced by private citizens, on behalf of the government, through civil qui tam actions, prohibit any person or entity from, among other things, knowingly presenting, or causing to be presented, a false or fraudulent claim for payment to, or approval by, the federal government, including federal healthcare programs, such as Medicare and Medicaid, knowingly making, using, or causing to be made or used a false record or statement material to a false or fraudulent claim to the federal government, or knowingly making a false statement to improperly avoid, decrease or conceal an obligation to pay money to the federal government. A claim includes &#x201c;any request or demand&#x201d; for money or property presented to the U.S. government. For instance, historically, pharmaceutical and other healthcare companies have been prosecuted under these laws for allegedly providing free product to customers with the expectation that the customers would bill federal programs for the product. Other companies have been prosecuted for causing false claims to be submitted because of the companies&#x2019; marketing of the product for unapproved, off-label, and thus generally non-reimbursable, uses.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">HIPAA created additional federal civil and criminal statutes that prohibit, among other things, knowingly and willfully executing, or attempting to execute, a scheme to defraud or to obtain, by means of false or fraudulent pretenses, representations or promises, any money or property owned by, or under the control or custody of, any healthcare benefit program, including private third-party payors, willfully obstructing a criminal investigation of a healthcare offense, and knowingly and willfully falsifying, concealing or covering up by trick, scheme or device, a material fact or making any materially false, fictitious or fraudulent statement in connection with the delivery of or payment for healthcare benefits, items or services. Like the federal Anti-Kickback Statute, the Affordable Care Act amended the intent standard for certain</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">33</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">healthcare fraud statutes under HIPAA such that a person or entity no longer needs to have actual knowledge of the statute or specific intent to violate it in order to have committed a violation.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Also, many states have similar, and typically more prohibitive, fraud and abuse statutes or regulations that apply to items and services reimbursed under Medicaid and other state programs, or, in several states, apply regardless of the payor.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We may be subject to data privacy and security regulations by both the federal government and the states in which we conduct our business. HIPAA, as amended by the Health Information Technology for Economic and Clinical Health Act, or HITECH, and their implementing regulations, impose requirements on covered entities, business associates and their covered subcontractors relating to the privacy, security and transmission of individually identifiable health information. Among other things, HITECH makes HIPAA&#x2019;s privacy and security standards directly applicable to business associates, independent contractors, or agents of covered entities, which include certain healthcare providers, health plans and healthcare clearinghouses, that receive or obtain protected health information in connection with providing a service on behalf of a covered entity. HITECH also created four new tiers of civil monetary penalties, amended HIPAA to make civil and criminal penalties directly applicable to business associates, and gave state attorneys general new authority to file civil actions for damages or injunctions in federal courts to enforce HIPAA and seek attorneys&#x2019; fees and costs associated with pursuing federal civil actions. In addition, many state laws govern the privacy and security of health information in specified circumstances, many of which differ from each other in significant ways, are often not pre-empted by HIPAA, and may have a more prohibitive effect than HIPAA, thus complicating compliance efforts.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We may develop products that, once approved, may be administered by a physician. Under currently applicable U.S. law, certain products not usually self-administered (including injectable drugs) may be eligible for coverage under Medicare through Medicare Part B. Medicare Part B is part of original Medicare, the federal health care program that provides health care benefits to the aged and disabled, and covers outpatient services and supplies, including certain biopharmaceutical products, that are medically necessary to treat a beneficiary&#x2019;s health condition. As a condition of receiving Medicare Part B reimbursement for a manufacturer&#x2019;s eligible drugs, the manufacturer is required to participate in other government healthcare programs, including the Medicaid Drug Rebate Program and the 340B Drug Pricing Program. The Medicaid Drug Rebate Program requires pharmaceutical manufacturers to enter into and have in effect a national rebate agreement with the Secretary of HHS as a condition for states to receive federal matching funds for the manufacturer&#x2019;s outpatient drugs furnished to Medicaid patients. Under the 340B Drug Pricing Program, the manufacturer must extend discounts to entities that participate in the program.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, many pharmaceutical manufacturers must calculate and report certain price reporting metrics to the government, such as average sales price, or ASP, and best price. Penalties may apply in some cases when such metrics are not submitted accurately and timely. Further, these prices for drugs may be reduced by mandatory discounts or rebates required by government healthcare programs or private payors and by any future relaxation of laws that presently restrict imports of drugs from countries where they may be sold at lower prices than in the United States.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Additionally, the federal Physician Payments Sunshine Act, or the Sunshine Act, within the Affordable Care Act, and its implementing regulations, require that certain manufacturers of drugs, devices, biological and medical supplies for which payment is available under Medicare, Medicaid or the Children&#x2019;s Health Insurance Program (with certain exceptions) report annually to CMS information related to certain payments or other transfers of value made or distributed to physicians, as defined by such law, other healthcare professionals (such as physician assistants and nurse practitioners), and teaching hospitals, or to entities or individuals at the request of, or designated on behalf of, the physicians and teaching hospitals and to report annually certain ownership and investment interests held by physicians and their immediate family members.  Failure to report accurately could result in penalties. In addition, many states also govern the reporting of payments or other transfers of value, many of which differ from each other in significant ways, are often not pre-empted, and may have a more prohibitive effect than the Sunshine Act, thus further complicating compliance efforts.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In order to distribute products commercially, we must comply with state laws that require the registration of manufacturers and wholesale distributors of drug and biological products in a state, including, in certain states, manufacturers and distributors who ship products into the state even if such manufacturers or distributors have no place of business within the state. Some states also impose requirements on manufacturers and distributors to establish the pedigree of product in the chain of distribution, including some states that require manufacturers and others to adopt new technology capable of tracking and tracing product as it moves through the distribution chain. Several states have enacted legislation requiring pharmaceutical and biotechnology companies to establish marketing compliance programs, file periodic reports with the state, make periodic public disclosures on sales, marketing, pricing, clinical studies and other activities, and/or register their sales and medical representatives, as well as to prohibit pharmacies and other healthcare entities from providing certain physician prescribing data to pharmaceutical and biotechnology companies for use in sales and marketing, and to prohibit</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">34</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">certain other sales and marketing practices. All of our activities are potentially subject to federal and state consumer protection and unfair competition laws.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Ensuring business arrangements with third parties comply with applicable healthcare laws and regulations is a costly endeavor. If our operations are found to be in violation of any of the federal and state healthcare laws described above or any other current or future governmental regulations that apply to us, we may be subject to significant penalties, including without limitation, civil, criminal and/or administrative penalties, damages, fines, disgorgement, imprisonment, exclusion from participation in government programs, such as Medicare and Medicaid, injunctions, private &#x201c;qui tam&#x201d; actions brought by individual whistleblowers in the name of the government, or refusal to allow us to enter into government contracts, contractual damages, reputational harm, administrative burdens, diminished profits and future earnings, additional reporting obligations and oversight if we become subject to a corporate integrity agreement or other agreement to resolve allegations of non-compliance with these laws, and the curtailment or restructuring of our operations, any of which could adversely affect our ability to operate our business and our results of operations.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Coverage, Pricing and Reimbursement</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Significant uncertainty exists as to the coverage and reimbursement status of any product candidates for which we may obtain regulatory approval. In the United States and in foreign markets, sales of any products for which we receive regulatory approval for commercial sale will depend, in part, on the extent to which third-party payors provide coverage and establish adequate reimbursement levels for such products. In the United States, third-party payors include federal and state healthcare programs, private managed care providers, health insurers and other organizations. Coverage and adequate reimbursement from governmental healthcare programs, such as Medicare &amp; Medicaid in the United States, and commercial payors are critical to new product acceptance.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our ability to commercialize any products successfully also will depend in part on the extent to which coverage and reimbursement for these products and related treatments will be available from government health administration authorities, private health insurers and other organizations. Government authorities and other third-party payors, such as private health insurers and health maintenance organizations, decide which therapeutics they will pay for and establish reimbursement levels. Coverage and reimbursement by a third-party payor may depend upon a number of factors, including the third-party payor&#x2019;s determination that use of a therapeutic is:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x25aa;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">a covered benefit under its health plan; </span></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x25aa;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">safe, effective and medically necessary; </span></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x25aa;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">appropriate for the specific patient; </span></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x25aa;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">cost-effective; and </span></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x25aa;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">neither experimental nor investigational. </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We cannot be sure that reimbursement will be available for any product that we commercialize and, if coverage and reimbursement are available, what the level of reimbursement will be. Coverage may also be more limited than the purposes for which the product is approved by the FDA or comparable foreign regulatory authorities. Reimbursement may impact the demand for, or the price of, any product for which we obtain regulatory approval.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Third-party payors are increasingly challenging the price, examining the medical necessity, and reviewing the cost-effectiveness of medical products, therapies and services, in addition to questioning their safety and efficacy. Obtaining reimbursement for our products may be particularly difficult because of the higher prices often associated with branded drugs and drugs administered under the supervision of a physician. We may need to conduct expensive pharmacoeconomic studies in order to demonstrate the medical necessity and cost-effectiveness of our products, in addition to the costs required to obtain FDA approvals. Our product candidates may not be considered medically necessary or cost-effective. Obtaining coverage and reimbursement approval of a product from a government or other third-party payor is a time-consuming and costly process that could require us to provide to each payor supporting scientific, clinical and cost-effectiveness data for the use of our product on a payor-by-payor basis, with no assurance that coverage and adequate reimbursement will be obtained. A third-party payor&#x2019;s decision to provide coverage for a product does not imply that an adequate reimbursement rate will be approved. Further, one third-party payor&#x2019;s determination to provide coverage for a product does not assure that other payors will also provide coverage for the product. Adequate third-party reimbursement may not be available to enable us to maintain price levels sufficient to realize an appropriate return on our investment in product development. If reimbursement is not available or is available only at limited levels, we may not be able to successfully commercialize any product candidate that we successfully develop. Additionally, we or our collaborators may develop companion diagnostic tests for use with our</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">35</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">product candidates. Companion diagnostic tests require coverage and reimbursement separate and apart from the coverage and reimbursement for their companion pharmaceutical or biological products. Similar challenges to obtaining coverage and reimbursement, applicable to pharmaceutical products, will apply to companion diagnostics.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Different pricing and reimbursement schemes exist in other countries. In the European Union, governments influence the price of biopharmaceutical products through their pricing and reimbursement rules and control of national health care systems that fund a large part of the cost of those products to consumers. Some jurisdictions operate positive and negative list systems under which products may only be marketed once a reimbursement price has been agreed. To obtain reimbursement or pricing approval, some of these countries may require the completion of clinical studies that compare the cost effectiveness of a particular product candidate to currently available therapies. Other member states allow companies to fix their own prices for medicines but monitor and control company profits. The downward pressure on health care costs has become intense. As a result, increasingly high barriers are being erected to the entry of new products. In addition, in some countries, cross-border imports from low-priced markets exert a commercial pressure on pricing within a country.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The marketability of any product candidates for which we receive regulatory approval for commercial sale may suffer if government and third-party payors fail to provide coverage and adequate reimbursement. In addition, emphasis on managed care, the increasing influence of health maintenance organizations, and additional legislative changes in the United States has increased, and we expect will continue to increase, the pressure on healthcare pricing. The Inflation Reduction Act of 2022, or IRA, which was passed into law in August 2022, included drug pricing reforms that have the potential to adversely impact our ability to successfully commercialize our product candidates and could lessen the real or perceived value of our product candidates, which would negatively impact our business. The downward pressure on the rise in healthcare costs in general, particularly prescription medicines, medical devices and surgical procedures and other treatments, has become very intense. Coverage policies and third-party payor reimbursement rates may change at any time. Even if favorable coverage and reimbursement status is attained for one or more products for which we receive regulatory approval, less favorable coverage policies and reimbursement rates may be implemented in the future.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Healthcare Reform</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In the United States and some foreign jurisdictions, there have been, and continue to be, several legislative and regulatory changes and proposed changes regarding the healthcare system that could prevent or delay marketing approval of product candidates, restrict or regulate post-approval activities, and affect the ability to profitably sell product candidates for which marketing approval is obtained. Among policy makers and payors in the United States and elsewhere, there is significant interest in promoting changes in healthcare systems with the stated goals of containing healthcare costs, improving quality and/or expanding access. In the United States, the pharmaceutical industry has been a particular focus of these efforts and has been significantly affected by major legislative initiatives.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For example, the Affordable Care Act has substantially changed healthcare financing and delivery by both governmental and private insurers. Among the Affordable Care Act provisions of importance to the pharmaceutical and biotechnology industries, in addition to those otherwise described above, are the following:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x25aa;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">an annual, nondeductible fee on any entity that manufactures or imports certain specified branded prescription drugs and biologic agents apportioned among these entities according to their market share in some government healthcare programs; </span></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x25aa;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">an increase in the statutory minimum rebates a manufacturer must pay under the Medicaid Drug Rebate Program to 23.1% and 13% of the average manufacturer price for most branded and generic drugs, respectively, and capped the total rebate amount for innovator drugs at 100% of the Average Manufacturer Price, or AMP; </span></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x25aa;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">a Medicare Part D coverage gap discount program, in which manufacturers must now agree to offer 70% point-of-sale discounts off negotiated prices of applicable brand drugs to eligible beneficiaries during their coverage gap period, as a condition for the manufacturers&#x2019; outpatient drugs to be covered under Medicare Part D; </span></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x25aa;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">extension of manufacturers&#x2019; Medicaid rebate liability to covered drugs dispensed to individuals who are enrolled in Medicaid managed care organizations; </span></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x25aa;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">expansion of eligibility criteria for Medicaid programs by, among other things, allowing states to offer Medicaid coverage to additional individuals and by adding new mandatory eligibility categories for individuals with income at or below 133% of the federal poverty level, thereby potentially increasing manufacturers&#x2019; Medicaid rebate liability; </span></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x25aa;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">expansion of the entities eligible for discounts under the 340B Drug Discount Program; </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">36</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x25aa;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">a Patient-Centered Outcomes Research Institute to oversee, identify priorities in, and conduct comparative clinical effectiveness research, along with funding for such research; </span></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x25aa;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">expansion of healthcare fraud and abuse laws, including the FCA and the federal Anti-Kickback Statute, new government investigative powers, and enhanced penalties for noncompliance; </span></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x25aa;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">a new methodology by which rebates owed by manufacturers under the Medicaid Drug Rebate Program are calculated for drugs that are inhaled, infused, instilled, implanted, or injected; </span></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x25aa;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">requirements to report certain financial arrangements with physicians and teaching hospitals; </span></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x25aa;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">a requirement to annually report certain information regarding drug samples that manufacturers and distributors provide to physicians; </span></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x25aa;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">establishment of a Center for Medicare &amp; Medicaid Innovation at CMS to test innovative payment and service delivery models to lower Medicare &amp; Medicaid spending; and </span></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x25aa;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">a licensure framework for follow on biologic products. </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">There have been legal and political challenges to certain aspects of the Affordable Care Act. Since January 2017, the Trump administration signed several executive orders and other directives designed to delay, circumvent, or loosen certain requirements mandated by the Affordable Care Act. On June 17, 2021 the U.S. Supreme Court dismissed a challenge on procedural grounds that argued the Affordable Care Act is unconstitutional in its entirety because the &#x201c;individual mandate&#x201d; was repealed by Congress. Prior to the U.S. Supreme Court ruling,  on January 28, 2021, President Biden issued an executive order that initiated a special enrollment period for purposes of obtaining health insurance coverage through the Affordable Care Act marketplace. The executive order also instructed certain governmental agencies to review and reconsider their existing policies and rules that limit access to healthcare, including among others, reexamining Medicaid demonstration projects and waiver programs that include work requirements, and policies that create unnecessary barriers to obtaining access to health insurance coverage through Medicaid or the Affordable Care Act. In addition, on August 16, 2022, President Biden signed the IRA into law which among other things, extends enhanced subsidies for individuals purchasing health insurance coverage in Affordable Care Act marketplaces through plan year 2025. The IRA also eliminates the &#x201c;donut hole&#x201d; under the Medicare Part D program beginning in 2025 by significantly lowering the beneficiary maximum out-of-pocket cost and creating a new manufacturer discount program. It is possible that the Affordable Care Act will be subject to judicial or Congressional challenges in the future. It is unclear such challenges and the healthcare reform measures of the Biden administration will impact the Affordable Care Act and our business.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We anticipate that the Affordable Care Act, will continue to result in additional downward pressure on coverage and the price that we receive for any approved product, and could seriously harm our business. Any reduction in reimbursement from Medicare and other government programs may result in a similar reduction in payments from private payors. The implementation of cost containment measures or other healthcare reforms may prevent us from being able to generate revenue, attain profitability, or commercialize our products. Such reforms could have an adverse effect on anticipated revenue from product candidates that we may successfully develop and for which we may obtain regulatory approval and may affect our overall financial condition and ability to develop product candidates.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Further legislation or regulation could be passed that could harm our business, financial condition and results of operations. Other legislative changes have been proposed and adopted since the Affordable Care Act was enacted. For example, in August 2011, President Obama signed into law the Budget Control Act of 2011, which, among other things, created the Joint Select Committee on Deficit Reduction to recommend to Congress proposals in spending reductions. The Joint Select Committee on Deficit Reduction did not achieve a targeted deficit reduction of at least $1.2 trillion for fiscal years 2012 through 2021, triggering the legislation&#x2019;s automatic reduction to several government programs. This includes aggregate reductions to Medicare payments to providers of up to 2% per fiscal year, which went into effect beginning on April 1, 2013 and will stay in effect through 2031 unless additional Congressional action is taken. Under current legislation the actual reduction in Medicare payments will vary from 1% in 2022 to up to 4% in the final fiscal year of this sequester. Additionally, on March 11, 2021, President Biden signed the American Rescue Plan Act of 2021 into law, which eliminates the statutory Medicaid drug rebate cap, currently set at 100% of a drug&#x2019;s average manufacturer price, for single source and innovator multiple source drugs, beginning January 1, 2024. In January 2013, the American Taxpayer Relief Act of 2012 was signed into law, which, among other things, further reduced Medicare payments to several types of providers, including hospitals, imaging centers and cancer treatment centers, and increased the statute of limitations period for the government to recover overpayments to providers from three to five years.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">37</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Additionally, there has been increasing legislative and enforcement interest in the United States with respect to specialty drug pricing practices. Specifically, there have been several recent U.S. Congressional inquiries and proposed federal legislation designed to, among other things, bring more transparency to drug pricing, reduce the cost of prescription drugs under Medicare, review the relationship between pricing and manufacturer patient programs, and reform government program reimbursement methodologies for drugs. At the federal level, in July 2021, the Biden administration released an executive order, &#x201c;Promoting Competition in the American Economy,&#x201d; with multiple provisions aimed at prescription drugs. In response to Biden&#x2019;s executive order, on September 9, 2021, HHS released a Comprehensive Plan for Addressing High Drug Prices that outlines principles for drug pricing reform and sets out a variety of potential legislative policies that Congress could pursue as well as potential administrative actions HHS can take to advance these principles. In addition, the IRA, among other things, (1) directs HHS to negotiate the price of certain single-source drugs and biologics covered under Medicare and (2) imposes rebates under Medicare Part B and Medicare Part D to penalize price increases that outpace inflation. These provisions will take effect progressively starting in fiscal year 2023, although they may be subject to legal challenges. It is currently unclear how the IRA will be implemented but is likely to have a significant impact on the pharmaceutical industry. Further, the Biden administration released an additional executive order on October 14, 2022, directing HHS to submit a report on how the Center for Medicare and Medicaid Innovation can be further leveraged to test new models for lowering drug costs for Medicare and Medicaid beneficiaries. It is unclear whether this executive order or similar policy initiatives will be implemented in the future. Individual states in the United States have also become increasingly active in passing legislation and implementing regulations designed to control biopharmaceutical product pricing, including price or patient reimbursement constraints, discounts, restrictions on certain product access and marketing cost disclosure and transparency measures, and, in some cases, designed to encourage importation from other countries and bulk purchasing.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">The Foreign Corrupt Practices Act</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Foreign Corrupt Practices Act, or FCPA, prohibits any U.S. individual or business from paying, offering, or authorizing payment or offering of anything of value, directly or indirectly, to any foreign official, political party or candidate for the purpose of influencing any act or decision of the foreign entity in order to assist the individual or business in obtaining or retaining business. The FCPA also obligates companies whose securities are listed in the United States to comply with accounting provisions requiring us to maintain books and records that accurately and fairly reflect all transactions of the corporation, including international subsidiaries, and to devise and maintain an adequate system of internal accounting controls for international operations.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Additional Regulation</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition to the foregoing, state and federal laws regarding environmental protection and hazardous substances, including the Occupational Safety and Health Act, the Resource Conservancy and Recovery Act and the Toxic Substances Control Act, affect our business. These and other laws govern our use, handling and disposal of various biological, chemical and radioactive substances used in, and wastes generated by, our operations. If our operations result in contamination of the environment or expose individuals to hazardous substances, we could be liable for damages and governmental fines. We believe that we are in material compliance with applicable environmental laws and that continued compliance therewith will not have a material adverse effect on our business. We cannot predict, however, how changes in these laws may affect our future operations.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Government Regulations Related to Economic Sanctions</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pursuant to various laws, regulations, and executive orders, the U.S. Treasury Department&#x2019;s Office of Foreign Assets Control, or OFAC, administers and enforces economic and trade sanctions that prohibit or restrict certain activities with embargoed countries, sanctioned entities, and sanctioned individuals for particular foreign policy and national security reasons. The scope of the sanctions varies significantly, but may include comprehensive restrictions on imports, exports, investment, and facilitation of foreign transactions involving a sanctioned jurisdiction, entity or person, as well as non-sanctioned persons and entities acting on behalf of sanctioned jurisdictions, entities or people.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">One such set of regulations is the Cuban Assets Control Regulations, or CACR. The CACR prohibits U.S. persons from engaging in virtually all transactions involving property of the government of Cuba or Cuban nationals, or property in which the government of Cuba or any Cuban national has at any time on or since July 8, 1963 had any interest of any nature whatsoever, direct or indirect. Where activity is prohibited by the CACR, engagement in such activity must be authorized by a general or specific license granted by OFAC. The antibody sequence for both itolizumab (EQ001) and ALZUMAb was developed exclusively by Cuban nationals. We currently rely on a general license in the CACR, relating to Cuban-origin pharmaceuticals, to import and conduct clinical studies relating to itolizumab (EQ001).</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In November 2019, OFAC notified us that after careful consideration, which included consultation with the FDA, OFAC determined that itolizumab falls within the definition of &#x201c;Cuban-origin pharmaceutical&#x201d; and, as such, the general licenses at section 515.547(b) and (c) of the CACR authorize the conduct of clinical studies for itolizumab for the purpose of seeking</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">38</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">approval for the drug from the FDA. Thus, no further authorization is required from OFAC at this time for our ongoing and planned clinical studies of itolizumab.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Other Regulations</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are also subject to numerous federal, state and local laws relating to such matters as safe working conditions, manufacturing practices, environmental protection, fire hazard control, and disposal of hazardous or potentially hazardous substances. We may incur significant costs to comply with such laws and regulations now or in the future.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Employees</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31, 2022, we employed 36 employees, all of whom were full-time and engaged in research and development activities, operations, finance, business development or administration. We also engage temporary employees and consultants as needed.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Corporate Information</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We were originally incorporated as Attenuate Biopharmaceuticals, Inc. in Delaware in March 2017 and subsequently changed our name to Equillium, Inc. in May 2017. Our principal executive offices are located at 2223 Avenida de la Playa, Suite 105, La Jolla, CA 92037. We have five wholly-owned subsidiaries, Bioniz Therapeutics, Inc., a Delaware corporation, Equillium Australia Pty LTD, an Australian proprietary limited corporation, Equillium Acquisition Sub, Inc., a Delaware corporation, Triumph Acquisition Sub, Inc., a Delaware corporation, and Triumph Merger Sub, Inc., a Delaware corporation. Our telephone number is (858) 412-5302. Our website address is </span><span><span style="background-color:rgba(0,0,0,0);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">www.equilliumbio.com</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Our website and the information contained on, or that can be accessed through, the website will not be deemed to be incorporated by reference in, and are not considered part of, this Annual Report on Form 10-K. Our Annual Reports on Form 10&#x2011;K, Quarterly Reports on Form 10&#x2011;Q, Current Reports on Form 8&#x2011;K and amendments to such reports filed or furnished pursuant to Section 13(a) and 15(d) of the Securities Exchange Act of 1934, as amended, or the Exchange Act, are available free of charge on our website as soon as reasonably practical after we electronically file such material with, or furnish it to, the SEC.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">All brand names or trademarks appearing in this Annual Report on Form 10-K are the property of their respective holders. Use or display by us of other parties&#x2019; trademarks, trade dress, or products in this Annual Report on Form 10-K is not intended to, and does not, imply a relationship with, or endorsements or sponsorship of, us by the trademark or trade dress owners.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are an &#x201c;emerging growth company&#x201d; as defined in the JOBS Act. We will remain an emerging growth company until the earlier of (1) the last day of the fiscal year (a) following the fifth anniversary of our initial public offering (i.e. December 31, 2023), (b) in which we have total annual gross revenue of at least $1.235 billion or (c) in which we are deemed to be a large accelerated filer, which means the market value of our common stock that is held by non-affiliates exceeds $700 million as of the prior June 30th and (2) the date on which we have issued more than $1.0 billion in non-convertible debt during the prior three-year period.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">39</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_1a_risk_factors"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 1A. Ri</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">sk Factors.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">RISK FACTORS</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">You should carefully consider the following risk factors, as well as the other information in this report, before deciding whether to purchase, hold or sell shares of our common stock. The occurrence of any of the following risks could harm our business, financial condition, results of operations and/or growth prospects or cause our actual results to differ materially from those contained in forward-looking statements we have made in this report and those we may make from time to time. You should consider all of the factors described as well as the other information in our financial statements and the related notes and &#x201c;Management&#x2019;s Discussion and Analysis of Financial Condition and Results of Operations&#x201d; when evaluating our business. If any of the following risks actually occurs, our business, financial condition, results of operations and future growth prospects would likely be materially and adversely affected. In these circumstances, the market price of our common stock would likely decline and you may lose all or part of your investments. Additional risks and uncertainties not presently known to us or that we currently deem immaterial also may impair our business operations.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Risks Related to Our Financial Position and Need for Additional Capital</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We have incurred significant losses since our inception, expect to incur significant losses for the foreseeable future and may never achieve or maintain profitability.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are a clinical-stage biotechnology company incorporated in March 2017 and our operations, to date, have consisted of organizing and staffing our company, business planning, raising capital, in-licensing rights to itolizumab (EQ001), conducting non-clinical research, filing three INDs, conducting clinical development of itolizumab (EQ001), conducting business development activities such as the acquisition of Bioniz in February 2022 and the Asset Purchase Agreement with Ono in December 2022, initiating clinical studies of EQ101 and EQ102, and the general and administrative activities associated with being a public company. We have never completed the development of any product candidate through to marketing approval, and we have never generated any revenue from sales of an approved product. Consequently, we have no meaningful operations upon which to evaluate our business, and predictions about our future success or viability may not be as accurate as they could be if we had a history of successfully developing and commercializing biopharmaceutical products.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Investment in biopharmaceutical product development is highly speculative because it entails substantial upfront capital expenditures and significant risk that a product candidate will fail to gain regulatory approval or become commercially viable. We have never generated any revenues from sales of an approved product, and we cannot estimate with precision the extent of our future losses. For the years ended December 31, 2022 and 2021, our net losses were $62.4 million and $39.1 million, respectively. As of December 31, 2022, we had an accumulated deficit of $172.4 million. We expect to incur operating losses for the foreseeable future as we execute our plan to advance our research and development activities into later stages of clinical development, ramp up clinical development of EQ101 and EQ102, perform discovery research and conduct formulation and device development of our product candidates, potentially expand the indications for which we conduct clinical development of our product candidates, potentially acquire or develop new products and/or product candidates, seek regulatory approvals of and potentially commercialize any approved products, hire additional personnel and protect our intellectual property. Furthermore, in connection with the acquisition of Bioniz, we expanded our pipeline from one product candidate to three product candidates, all at various stages of development. This expansion of our pipeline may accelerate the rate at which our operating losses increase as we incur costs to further the development and seek regulatory approval for these product candidates. In addition, if we obtain regulatory approval for any of our product candidates, we expect to incur increased sales and marketing expenses, with certain of such investments potentially being made in advance of an approval. As a result, we expect to continue to incur significant operating losses and negative cash flows for the foreseeable future. These losses have had and will continue to have an adverse effect on our financial position and working capital.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">40</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">To become and remain profitable, we must develop or acquire and eventually commercialize a product with significant market potential. This will require us to be successful in a range of challenging activities, including completing preclinical studies and clinical studies of our product candidates, obtaining marketing approvals for our product candidates, manufacturing, marketing and selling our product candidates if we obtain marketing approval, and satisfying post-marketing requirements, if any. We may never succeed in these activities and, even if we succeed in obtaining approval for and commercializing our product candidates, we may never generate revenues that are significant enough to achieve profitability. In addition, we may encounter unforeseen expenses, difficulties, complications, delays and other known and unknown challenges. Furthermore, because of the numerous risks and uncertainties associated with biopharmaceutical product development, we are unable to accurately predict the timing or amount of increased expenses or when, or if, we will be able to achieve profitability. If we do achieve profitability, we may not be able to sustain or increase profitability on a quarterly or annual basis and we may continue to incur substantial research and development and other expenditures to develop and market additional product candidates. Our failure to become and remain profitable would decrease the value of the company and could impair our ability to raise capital, maintain our research and development efforts, expand our business or continue our operations. A decline in the value of our company could also cause you to lose all or part of your investment.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We will require substantial additional funding to continue and complete the development and any commercialization of EQ101 and EQ102, and if Ono does not exercise its option, itolizumab (EQ001), and any future product candidates. If we are unable to raise this capital when needed, we may be forced to delay, reduce or eliminate our research and development programs or other operations.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We expect our expenses to increase substantially during the next few years. The development of biotechnology product candidates is capital intensive. As we conduct non-clinical research and clinical development of our product candidates, we will need substantial additional funds to maintain and expand our capabilities in a variety of areas including discovery and non-clinical research, clinical development, regulatory affairs, product development, product quality assurance, and pharmacovigilance. In addition, if we obtain marketing approval for any of our product candidates, we expect to incur significant commercialization expenses for marketing, sales, manufacturing and distribution. Some of those commercialization investments may be made at-risk in advance of receiving an approval.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31, 2022, we had $71.0 million in cash, cash equivalents and short-term investments. We expect that our existing cash, cash equivalents and short-term investments as of December 31, 2022, will enable us to fund our operations into 2025. However, changing circumstances or inaccurate estimates by us may cause us to use capital significantly faster than we currently anticipate, and we may need to spend more money than currently expected because of circumstances beyond our control. For example, our ongoing and future clinical studies of our product candidates may encounter technical, enrollment or other issues that could cause our development costs to increase more than we expect. We do not have sufficient funds to complete the clinical development of EQ101 or EQ102, and if Ono does not exercise its option, itolizumab (EQ001), through regulatory approval for our current indications. We will need to raise substantial additional capital to complete the development and commercialization of each of those product candidates, which additional capital may be raised through the sale of our common stock or other securities or through the entering into of alternative strategic transactions, the terms of which may require us to divest one or more of our product candidates, such as our Asset Purchase Agreement with Ono, or cause our stockholders to incur substantial dilution.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Future capital requirements will depend on many factors, including:</span></p>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the initiation, progress, timing, costs and results of our ongoing and future clinical studies of our product candidates, including as such activities may be adversely impacted by the COVID-19 pandemic or other public health epidemics or outbreaks;</span></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the number and scope of indications we decide to pursue for our product development;</span></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">non-clinical research and toxicology studies necessary to support the successful clinical development and potential approvals of our product candidates;</span></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">formulation and device development work related to our product candidates;</span></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the cost, timing and outcome of regulatory review of any BLA or NDA we may submit for our product candidates;</span></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the costs and timing of manufacturing our product candidates and products;</span></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the costs of preparing, filing and prosecuting patent applications, maintaining and enforcing our intellectual property rights and defending intellectual property-related claims;</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">41</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our efforts to enhance operational systems and our ability to attract, hire and retain qualified personnel, including personnel to support the development of our product candidates;</span></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the costs associated with being a public company;</span></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our ability to enter into partnerships or otherwise monetize our pipeline through strategic transactions on a timely basis, on terms that are favorable to us, or at all;</span></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the terms and timing of establishing and maintaining collaborations, licenses and other similar arrangements, including our Asset Purchase Agreement with Ono;</span></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the extent to which we acquire or in-license other product candidates and technologies; </span></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the legal and other transactional costs associated with our business development activities; and</span></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the cost associated with commercializing our product candidates if any are approved for commercial sale.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In March 2020, we entered into a purchase agreement, or the Purchase Agreement, with Lincoln Park Capital Fund, LLC or Lincoln Park, which provides that, upon the terms and subject to the conditions and limitations set forth therein, we may sell to Lincoln Park up to $15.0 million of shares of our common stock from time to time over the 36&#x2011;month term of the Purchase Agreement. Upon execution of the Purchase Agreement, we issued 65,374 shares of our common stock to Lincoln Park as commitment shares in accordance with the closing conditions contained within the Purchase Agreement. As of December 31, 2022 and as of the date of the filing of this Annual Report on Form 10-K, we have not sold any shares of our common stock to Lincoln Park under the Purchase Agreement. The Purchase Agreement will expire on May 1, 2023.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our commercial revenues, if any, are expected to be primarily derived from sales of products, which is unlikely to happen within the next 12 months, if ever. Under the Asset Purchase Agreement with Ono, we received a one-time, upfront payment of JPY 3.5 billion, or approximately $26.4 million, and are (i) entitled to receive a one-time, payment of JPY 5.0 billion, or approximately $37.2 million (based on the currency exchange rate quoted by MUFG Bank, Ltd. on March 16, 2023) if Ono exercises its exclusive option to acquire our rights to itolizumab and (ii) eligible to receive up to $101.4 million upon the achievement of certain milestones. However, there is no assurance that Ono will exercise its option or that we will ever receive any milestone payments. Additionally, due to the risks associated with foreign exchange rates, if Ono exercises the Option, the one-time upfront payment of JPY 5.0 billion may result in a USD value that is significantly less than expected. Accordingly, we will need to obtain substantial additional funding in connection with our continuing operations. Adequate additional financing may not be available to us on acceptable terms, or at all. Our ability to raise additional capital may be adversely impacted by potential worsening global economic conditions and disruptions to, and volatility in, the credit and financial markets in the United States and worldwide resulting from the COVID-19 pandemic or other public health epidemics or outbreaks, bank failures, the conflict between Russia and Ukraine, and monetary policy changes of federal agencies that have increased interest rates to address increasing inflationary pressures on the economy. If such disruptions persist and deepen, we could experience an inability to access additional capital. Subject to limited exceptions, we are prohibited from incurring indebtedness without the prior written consent of the lenders pursuant to the loan agreement we entered into with Oxford Finance LLC and Silicon Valley Bank, or SVB, in September 2019, as amended in December 2020, April 2021 and February 2022, or the Loan Agreement. In addition, we may seek additional capital due to favorable market conditions or strategic considerations even if we believe we have sufficient funds for our current or future operating plans. If we are unable to raise capital when needed or on attractive terms, we would be forced to delay, reduce or eliminate our research and development programs or other operations, or enter into partnerships or otherwise monetize our pipeline through strategic transactions on terms that may not be as favorable to us as if we developed or commercialized the product candidates ourselves. In addition, we may not be able to access a portion of our existing cash, cash equivalents and investments due to market conditions. For example, on March 10, 2023, the Federal Deposit Insurance Corporation, or FDIC, took control and was appointed receiver of SVB. At the time the FDIC took control, we held assets valued at approximately $8.2 million in a sweep account with SVB. We received full access to those funds on March 13, 2023. As of the date of the filing of this Annual Report on Form 10-K, we have full access to and control over all of our cash, cash equivalents and short-term investments. In addition, because a substantial majority of our cash, cash equivalents and short-term investments is held at financial institution unaffiliated with SVB, we do not expect any material impact to our operations directly related to the closure of SVB. If other banks and financial institutions enter receivership or become insolvent in the future in response to financial conditions affecting the banking system and financial markets, our ability to access our existing cash, cash equivalents and investments may be threatened and could have a material adverse effect on our business and financial condition.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">42</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">The terms of our Loan Agreement place restrictions on our operating and financial flexibility.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In September 2019, we entered into the Loan Agreement providing for up to $20.0 million in term loans, which is secured by a first priority perfected security interest in substantially all of our current and future assets, other than our intellectual property (except rights to payment from the sale, licensing or disposition of such intellectual property). We borrowed $10.0 million upon execution of the Loan Agreement. The availability of any further credit from this Loan Agreement beyond that initial $10.0 million advancement has lapsed.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Loan Agreement includes affirmative and restrictive covenants, including covenants regarding delivery of financial statements, maintenance of inventory, payment of taxes, maintenance of insurance, protection of intellectual property rights, dispositions of property, business combinations or acquisitions, incurrence of additional indebtedness or liens, investments and transactions with affiliates, among other customary covenants. We are also restricted from paying dividends or making other distributions or payments on our capital stock, subject to limited exceptions.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Loan Agreement also includes events of default, the occurrence and continuation of which provide Oxford Finance LLC, as collateral agent, with the right to exercise remedies against us and the collateral securing the loans under the Loan Agreement, including foreclosure against our properties securing the Loan Agreement, including our cash, potentially requiring us to renegotiate our agreement on terms less favorable to us or to immediately cease operations. These events of default include, among other things, our failure to satisfy our payment obligations under the Loan Agreement, the breach of certain of our other covenants under the Loan Agreement, or the occurrence of a material adverse change, cross defaults to other indebtedness or material agreements, judgment defaults and defaults related to failure to maintain governmental approvals failure of which to maintain could result in a material adverse effect. Further, if we are liquidated, the lenders&#x2019; right to repayment would be senior to the rights of the holders of our common stock to receive any proceeds from the liquidation. The lenders could declare a default upon the occurrence of any event that they interpret as a material adverse change as defined under the Loan Agreement, thereby requiring us to repay the loan immediately or to attempt to reverse the declaration of default through negotiation or litigation. Any declaration by the lenders of an event of default could significantly harm our business and prospects and could cause the price of our common stock to decline.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Additionally, while we have not been materially and adversely affected as an immediate result of the FDIC taking control and being appointed receiver of SVB on March 10, 2023, we may in the future be adversely impacted, including having to repay all outstanding amounts owed under the Loan Agreement or in receiving timely consent to incur additional indebtedness.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Risks Related to our Business and to the Development and Regulatory Approval of our Product Candidates</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We are highly dependent on the successful development of our current product candidates, EQ101, EQ102 and itolizumab (EQ001), and we may not be able to obtain regulatory or marketing approval for, or successfully commercialize, these product candidates in any of the indications for which we plan to develop them.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our future success will depend almost entirely on our ability to successfully develop, obtain regulatory approval for and then successfully commercialize EQ101, EQ102 and itolizumab (EQ001), in any of the indications for which we are currently planning to develop them, including treatment of AA with EQ101, treatment of celiac disease with EQ102, or treatment of aGVHD and LN with itolizumab (EQ001), which may never occur. We currently generate no revenues from sales of any biopharmaceutical products, and we may never be able to develop or commercialize a marketable biopharmaceutical product.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Before we can market and sell any of our product candidates in the United States, we will need to manage research and development activities, commence and complete clinical studies, obtain necessary regulatory approvals from the FDA and build a commercial organization or enter into a marketing collaboration with a third party, among other things. We cannot assure you that we will be able to successfully complete the necessary clinical studies and/or obtain regulatory approval and develop sufficient commercial capabilities for any of our product candidates. We have not submitted a BLA or an NDA to the FDA or filed for approval with any other regulatory authority outside the United States for any product candidate. Further, our product candidates may not receive regulatory approval even if they are successful in clinical studies. If we do not receive regulatory approvals, our business, prospects, financial condition and results of operations will be adversely affected. Even if we obtain regulatory approval, we may never generate significant revenues from any commercial sales of any of our products. If any of our product candidates are approved and we fail to successfully commercialize them, we may be unable to generate sufficient revenues to sustain and grow our business, and our business, prospects, financial condition and results of operations will be adversely affected.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">43</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We have and may in the future enter into partnerships or similar arrangements or otherwise monetize our pipeline through strategic transactions, which may harm our ability to realize a return, if any, on our investments and may increase our need for external funding.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We may enter into partnerships or similar arrangements or otherwise monetize our pipeline through strategic transactions for purposes of raising additional capital and allocating our available capital and other resources to developing and commercializing our other or future product candidates. For example, in December 2022 we entered into the Asset Purchase Agreement with Ono pursuant to which we granted Ono the exclusive option to acquire our rights to itolizumab (EQ001). Despite our efforts, we may be unable to enter into future partnerships or otherwise monetize our pipeline through strategic transactions with third parties on favorable terms or at all. Supporting diligence activities conducted by third parties and negotiating the financial and other terms of a strategic arrangement are long, costly and complex processes with uncertain results, and we may fail to derive any financial benefit from these activities. Any efforts toward finding a strategic partner for one or more of our product candidates may divert the time and attention of our management away from their day-to-day activities, which may adversely affect our focus on the discovery and development of our current product candidates that we intend to continue to develop and commercialize. Further, potential strategic partners may develop alternative products or pursue alternative technologies either on their own or in collaboration with others, potentially resulting in us receiving no future milestone or royalty payments under any such arrangement. We may enter into a strategic transaction for one or more of our product candidates that prove to be more successful than the product candidates we decide to continue to develop and commercialize. As a result, our financial position and the return we realize on our research and development activities could be negatively affected, and we could be required to seek additional funding to support our operations through equity offerings, debt financings or other capital sources, which could result in substantial dilution to our existing stockholders and could cause the price of our common stock to decline. Any of the foregoing could have a material adverse effect on our competitive position, business prospects, financial condition and results of operations.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We may wish to acquire rights to future assets through in-licensing or may attempt to form collaborations with respect to our current or future product candidates, but may not be able to do so, which may cause us to alter or delay our development and commercialization plans.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The development and potential commercialization of our product candidates will require substantial additional capital to fund expenses. We may, in the future, decide to collaborate with biotechnology or pharmaceutical companies for the development and potential commercialization of product candidates, such as our Asset Purchase Agreement with Ono. We will face significant competition in seeking appropriate collaborators. We may not be successful in our efforts to establish other strategic partnerships or alternative arrangements for any product candidates because they may be deemed to be at too early of a stage of development for collaborative effort and potential parties may not view such product candidates as having the requisite potential to demonstrate safety and efficacy. If and when we collaborate on the development and commercialization of product candidates other than itolizumab (EQ001), we can expect to relinquish some or all of the control over the future success of that product candidate to the partner. Our ability to reach a definitive agreement for a collaboration will depend, among other things, upon our assessment of the collaborator&#x2019;s resources and expertise, the terms and conditions of the proposed collaboration and the proposed collaborator&#x2019;s evaluation of a number of factors. Those factors may include the following:</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the design or results of clinical studies;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the likelihood of approval by the FDA or comparable foreign regulatory authorities;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the potential market for the product candidate;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the costs and complexities of manufacturing and delivering such product candidate to patients;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the potential of competing products;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the existence of uncertainty with respect to our ownership of technology or other rights, which can exist if there is a challenge to such ownership without regard to the merits of the challenge; and</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">industry and market conditions generally.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The collaborator may also consider alternative product candidates or technologies for similar indications that may be available to collaborate on and whether such a collaboration could be more attractive than the one with us for our product candidate. We may also be restricted under any license agreements from entering into agreements on certain terms or at all with potential collaborators. Collaborations are complex and time-consuming to negotiate and document. In addition, there have been a significant number of recent business combinations among large pharmaceutical companies that have resulted in a reduced number of potential future collaborators and changes to the strategies of the combined company. As a result, we</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">44</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">may not be able to negotiate collaborations on a timely basis, on acceptable terms, or at all. If we are unable to do so, we may have to curtail the development of such product candidate, reduce or delay one or more of our other development programs, delay the potential commercialization or reduce the scope of any planned sales or marketing activities for such product candidate, or increase our expenditures and undertake development, manufacturing or commercialization activities at our own expense. If we elect to increase our expenditures to fund development, manufacturing or commercialization activities on our own, we may need to obtain additional capital, which may not be available to us on acceptable terms or at all. If we do not have sufficient funds, we may not be able to further develop our future product candidates or bring them to market and generate product revenue. Even if we are successful in our efforts to establish such collaborations, the terms that we agree upon may not be favorable to us, and we may not be able to maintain such collaborations if, for example, development approval of a product candidate is delayed, the safety of a product candidate is questioned or sales of an approved product candidate are unsatisfactory.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We have limited experience in clinical development and have not successfully completed late-stage clinical studies or obtained regulatory approval for any product candidate.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We initiated our first clinical study in the first quarter of 2019, which was a Phase 1 clinical study of itolizumab (EQ001) for the treatment of aGVHD. Since then, we have initiated three additional clinical studies of itolizumab (EQ001), two of which were Phase 1 clinical studies in uncontrolled asthma and lupus/LN and one was a Phase 3 clinical study in aGVHD. The Phase 1 study in uncontrolled asthma has been completed, but the Phase 1 study in lupus/LN and the Phase 3 study in aGVHD are currently ongoing.  In September 2022, we initiated a Phase 1 first-in-human clinical study of EQ102 in healthy volunteers in Australia, and in November 2022 we initiated a Phase 2 clinical study of EQ101 in subjects with AA in Australia. We have three active INDs with the FDA for the use of itolizumab (EQ001) in the treatment of aGVHD, LN, and COVID-19 patients, and we have not filed an IND with the FDA for the use of itolizumab (EQ001) for the treatment of uncontrolled moderate to severe asthma. Through the acquisition of Bioniz, we have INDs with the FDA for the use of EQ101 in the treatment of HTLV-I-associated myelopathy/tropical spastic paraparesis, CTCL, and AA. Because of our limited interaction with the FDA, we may not learn of certain information or data that the FDA may request until future interactions. In part because of our limited infrastructure, experience conducting clinical studies as a company and regulatory interactions, we also cannot be certain that our ongoing and future clinical studies will be completed on time, if at all, that our planned clinical studies will be initiated on time, if at all, or that our planned development programs would be acceptable to the FDA.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Adverse safety and toxicology findings may emerge as we conduct non-clinical research or clinical studies. In addition, success in early clinical studies does not mean that later clinical studies will be successful, because later-stage clinical studies may be conducted in broader patient populations and involve different study designs. For example, although itolizumab (EQ001) and ALZUMAb share the same primary monoclonal antibody sequence, they are manufactured in different cell lines and thus could be considered different biopharmaceutical products. Therefore, results seen in clinical studies of ALZUMAb conducted by Biocon may not be predictive of the results of our clinical studies of itolizumab (EQ001). Furthermore, our future clinical studies will need to demonstrate sufficient safety and efficacy in larger patient populations for approval by the FDA. Companies frequently suffer significant setbacks in advanced clinical studies, even after earlier clinical studies have shown promising results, and we cannot be certain that we will not face similar setbacks. Moreover, preclinical and clinical data are often susceptible to varying interpretations and analyses, and many companies that have believed their product candidates performed satisfactorily in preclinical studies and clinical studies have nonetheless failed to obtain marketing approval of their products. In addition, only a small percentage of product candidates under development result in the submission of a BLA or NDA to the FDA and even fewer are approved for commercialization.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our ability to generate product revenues, which we do not expect will occur for at least the next several years, if ever, will depend heavily on our ability to successfully complete the above activities and any other activities required for the successful development and eventual commercialization of our product candidates. The success of our product candidates will further depend on factors such as:</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">completion of our ongoing and future clinical studies and preclinical studies with favorable results, including activities that may be adversely impacted by the COVID-19 pandemic or other public health epidemics or outbreaks;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">acceptance of INDs by the FDA for our future clinical studies, as applicable;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">timely and successful enrollment in, and completion of, clinical studies with favorable results;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">demonstrating safety, efficacy and acceptable risk-benefit profile of our product candidates to the satisfaction of the FDA;</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">45</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">receipt of marketing approvals from the FDA;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">maintaining arrangements with our contract manufacturing organizations, or CMOs, for clinical and, if and when approved, commercial supply of EQ101 and EQ102 and with Biocon, our manufacturer of itolizumab (EQ001), for cell lines and drug product clinical supply and, if and when approved, for commercial supply of itolizumab (EQ001); </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">establishing sales, marketing and distribution capabilities and launching commercial sale of our product candidates, if and when approved in one or more indications;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">acceptance of our product candidates, if and when approved, by patients, the medical community and third-party payors;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">effectively competing with other therapies;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">obtaining and maintaining patent, trade secret and other intellectual property protection and regulatory exclusivity for our product candidates; and</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">maintaining a continued acceptable safety profile of our products, following approval.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If we do not achieve one or more of these factors in a timely manner, we could experience significant delays or an inability to successfully obtain marketing approval and commercialize our product candidates, which would materially harm our business.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Itolizumab (EQ001) is a monoclonal antibody that selectively targets CD6, a target for which there are no FDA-approved therapies. This makes it difficult to predict the timing and costs of clinical development for itolizumab (EQ001). We do not know whether our approach in targeting CD6 will allow us to develop any products of commercial value.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Targeting CD6 is a therapeutic approach that represents a significant component of our current research and development, and the successful development of this therapeutic approach to the diseases we are targeting for treatment plays a major factor in our future success. To date, there are no FDA-approved drugs that target CD6, and while there are a number of independent studies clinically validating CD6 as a target, other than our partner Biocon, CD6 has not traditionally been a pathway targeted by other biopharmaceutical companies. The regulatory approval process for novel product candidates such as itolizumab (EQ001) can be more expensive and take longer than for other, better known or extensively studied therapeutic approaches. Delay or failure to obtain, or unexpected costs in obtaining, the regulatory approval necessary to bring itolizumab (EQ001) to market could decrease our ability to generate sufficient revenue to maintain our business.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Additionally, companion diagnostic tests may be developed for use with itolizumab (EQ001). We, or our collaborators, will be required to obtain FDA clearance or approval for these tests, as well as coverage and reimbursement separate and apart from the approval and coverage and reimbursement we seek for our itolizumab (EQ001). Our inability to collaborate with a companion diagnostics developer could have a material and adverse effect on our business, financial condition, results of operations and prospects.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We have licensed the rights to itolizumab in the United States, Canada, Australia, and New Zealand. Any adverse developments that occur during any research, clinical, or commercial use of itolizumab by Biocon or third parties in other jurisdictions may affect our ability to obtain regulatory approval of or successfully commercialize itolizumab (EQ001) or otherwise adversely impact our business.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Biocon, its Cuban partner, CIMAB, S.A., and their licensees, over which we have no control, have the rights to develop itolizumab worldwide and commercialize itolizumab in geographies outside of the Equillium Territory (as defined below). Itolizumab is approved in India for the treatment of moderate to severe plaque psoriasis, and is marketed by Biocon as ALZUMAb. Biocon was also granted restricted emergency use approval of itolizumab by the Drugs Controller General of India, or DCGI, for the treatment of cytokine release syndrome, or CRS, in COVID-19 patients with moderate to severe ARDS in India. In September 2020, the DCGI granted approval of itolizumab produced in a Chinese hamster ovary (CHO) cell line, marketed in India under the brand name ALZUMAb-L, or ALZUMAb Lyophilized, for the treatment of chronic plaque psoriasis, as well as restricted emergency use authorization for the treatment of CRS in COVID-19 patients with moderate to severe ARDS. We are also aware that ALZUMAb and ALZUMAb-L have been and may continue to be used in India on a compassionate use basis, off label, and/or in investigator-initiated studies.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are unaware of any currently active and ongoing clinical studies of itolizumab in Cuba. Centro de Immunologia Molecular was granted emergency use authorization of itolizumab for patients with severe COVID-19 in Cuba.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">46</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The results of clinical studies with itolizumab conducted by Biocon or third parties as well as the ongoing adverse event reporting related to the clinical or commercial use of itolizumab supported by Biocon or third parties could impact our development plans and the potential commercial prospects for itolizumab (EQ001). Further, we do not control and are unable to validate study results reported by Biocon or third parties. Any errors or omissions in the data and public disclosures reported by Biocon or third parties could have a material adverse effect on our stock price and business plans.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If serious adverse events occur with patients using itolizumab as an approved therapy or during any clinical studies, exploratory studies, or other clinical uses of itolizumab conducted or supported by Biocon or third parties, regulatory authorities, including the FDA, may delay, limit or deny approval of itolizumab (EQ001), suspend our clinical development of itolizumab (EQ001), or require us to conduct additional clinical studies as a condition of marketing approval, which would increase our costs and adversely impact our business. If we receive regulatory approval for itolizumab (EQ001) and a new and serious safety issue is identified in connection with the commercial use of ALZUMAb or ALZUMAb-L or in clinical studies, exploratory studies, or other clinical uses of itolizumab conducted or supported by Biocon or third parties, regulatory authorities may withdraw their approval of the product or otherwise restrict our ability to market and sell itolizumab. In addition, treating physicians may be less willing to administer our product due to concerns over such adverse events, which would limit our ability to commercialize itolizumab (EQ001) and could potentially adversely impact our ability to conduct clinical development of itolizumab (EQ001).</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">If we fail to develop or acquire other product candidates or products, our business and prospects would be limited.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">One element of our strategy is to expand our pipeline by acquiring a portfolio of other product candidates through business or product candidate acquisitions such as our acquisition of Bioniz. The success of this strategy depends in large part upon the combination of our regulatory, development and commercial capabilities and expertise and our ability to identify, select and acquire product candidates for therapeutic indications that complement or augment our current pipeline, or that otherwise fit into our development or strategic plans on terms that are acceptable to us. Identifying, selecting and acquiring promising product candidates requires substantial technical, financial and human resources expertise. Efforts to do so may not result in the actual acquisition or license of a particular product candidate, potentially resulting in a diversion of our management&#x2019;s time and the expenditure of our resources with no resulting benefit. If we are unable to identify, select and acquire suitable product candidates from third parties or acquire businesses at valuations and on other terms acceptable to us, or if we are unable to raise capital required to acquire businesses or new product candidates, our business and prospects will be limited and may require us to divest one or more of our product candidates to enable us to acquire businesses or new product candidates or progress the development of our other product candidates.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Moreover, any product candidate we acquire may require additional, time-consuming development or regulatory efforts prior to commercial sale or prior to expansion into other indications, including pre-clinical studies if applicable, and extensive clinical testing and approval by the FDA and applicable foreign regulatory authorities. All product candidates are prone to the risk of failure that is inherent in pharmaceutical drug development, including the possibility that the product candidate will not be shown to be sufficiently safe and/or effective for approval by regulatory authorities. In addition, we cannot assure that any such products that are approved will be manufactured or produced economically, successfully commercialized or widely accepted in the marketplace or be more effective or desired than other commercially available alternatives.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, if we fail to successfully commercialize and further develop our product candidates, there is a greater likelihood that we will fail to successfully develop a pipeline of other product candidates to follow our existing product candidates or be able to acquire other product candidates to expand our existing portfolio, and our business and prospects would be harmed.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Potential natural disasters, some possibly related to the increasing effects of climate change, could damage or destroy clinical study sites, our office spaces, laboratories, and/or warehouses, which could have a significant negative impact on our operations.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are vulnerable to the increasing impact of climate change and other natural disasters. Volatile changes in weather conditions, including extreme heat or cold, could increase the risk of wildfires, floods, blizzards, hurricanes and other weather-related disasters. Such extreme weather events, or other natural disasters such as earthquakes, can cause power outages and network disruptions that may result in disruption to operations and may impact our ability to continue or complete our clinical studies, which will negatively impact our operations and delay our plans to commercialize our product candidates. They could also cause significant damage to or destruction of our clinical study sites resulting in temporary or long-term closures of these facilities. Such disasters could also result in loss or damage to office buildings, laboratories, employee and/or patient homes, employees and/or patients relocating to other parts of the country or being unwilling to travel to the clinical study site locations, and the inability to recruit key employees and/or enroll patients. This could result in</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">47</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">adverse impacts to the available workforce and/or patient samples, damage to or destruction of materials and/or data, or the inability to conduct clinical studies and deliver new data.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We have licensed itolizumab from Biocon pursuant to an exclusive license agreement, which license is conditioned upon us meeting certain diligence obligations with respect to the development, regulatory approval and commercialization of itolizumab, and making significant milestone payments in connection with regulatory approval and commercial milestones as well as royalty payments.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">  </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are party to an exclusive license agreement with Biocon, pursuant to which we initially acquired an exclusive license to develop, make, have made, use, sell, have sold, offer for sale, import and otherwise exploit itolizumab and any pharmaceutical composition or preparation containing or comprising itolizumab in the United States and Canada and which was later amended to grant us the same exclusive license in Australia and New Zealand as well, or, collectively, the Equillium Territory. We are obligated, under this agreement, to achieve certain development milestones within specified timeframes in order to retain all of the licensed rights. Certain of such milestones are largely outside of our control. We are also obligated to use commercially reasonable efforts to develop and seek regulatory approval for, and if regulatory approval is obtained, to commercialize, itolizumab in the Equillium Territory and to secure funding for the development of itolizumab in two or more indications. Further, we are obligated to make certain cash milestone payments to Biocon upon completion of certain regulatory approval and commercial milestones and are required to pay royalties to Biocon on net sales of itolizumab, if approved. Though we believe that the royalty rates and milestone payments are reasonable in light of our business plan, we will require large amounts of capital to satisfy these obligations. We may become obligated to make a milestone payment when we do not have the cash on hand to make such payment, which could require us to delay our clinical studies, curtail our operations, scale back our commercialization and marketing efforts or seek funds to meet these obligations on terms unfavorable to us. In addition, if we are unable to make any payment when due or, if we fail to achieve the development milestones within the timeframes required by the license agreement, or to satisfy our general diligence obligation to use commercially reasonable efforts to develop, register and commercialize itolizumab and to secure funding for the development of itolizumab in two or more indications, Biocon may have the right to limit the scope of our license or terminate the agreement and all of our rights to develop and commercialize itolizumab.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We are and may become further dependent on Ono for funding the clinical development and commercialization of itolizumab (EQ001). If Ono terminates our Asset Purchase Agreement, does not exercise its option, or does not achieve the milestones specified in the Asset Purchase Agreement, our business and financial condition would be adversely impacted.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In December 2022, we entered into the Asset Purchase Agreement with Ono pursuant to which we granted Ono the exclusive option to acquire our rights to itolizumab (EQ001), which option expires three months following the delivery of topline data from the EQUALISE clinical study in LN and interim data from the EQUATOR Phase 3 clinical study in aGVHD. During the option period, we will be responsible for conducting all research and development of itolizumab (EQ001), which will be funded by Ono on a quarterly basis commencing July 1, 2022. If Ono fails to provide such funding, our financial condition and ability to conduct continued research and development of itolizumab (EQ001) would be adversely affected.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In the event that Ono exercises its option to acquire our rights to itolizumab (EQ001), we would no longer control the clinical development and potential commercialization of itolizumab (EQ001). Per the Asset Purchase Agreement and depending on Ono&#x2019;s election, we may conduct and be compensated for certain activities on Ono&#x2019;s behalf, but we would not control any itolizumab (EQ001) activities. Ono would be responsible for filing future applications with the FDA or other regulatory authorities for approval of itolizumab (EQ001) and will be the owner of any marketing approvals issued by the FDA or other regulatory authorities for itolizumab (EQ001). If the FDA or other regulatory authorities approve itolizumab (EQ001), Ono would also be responsible for the launch, marketing and sale of the resulting product. However, we cannot control whether Ono will devote sufficient attention and resources to the clinical development of itolizumab (EQ001) or will proceed in an expeditious manner. Even if the FDA or other regulatory agencies approve itolizumab (EQ001), Ono may elect not to proceed with the commercialization of the resulting product in one or more countries. If the development of itolizumab (EQ001) does not progress for these or any other reasons, we would be prevented from obtaining further revenues, including certain development and commercialization milestones, from itolizumab (EQ001) and from otherwise realizing the benefit of such transaction, which could harm our business.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">48</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">The development and commercialization of biopharmaceutical products are subject to extensive regulation, and we may not obtain regulatory approvals for our product candidates in any of the indications for which we plan to develop them, or any future product candidates, on a timely basis or at all.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The clinical development, manufacturing, labeling, packaging, storage, recordkeeping, advertising, promotion, export, import, marketing, distribution, adverse event reporting, including the submission of safety and other post-marketing information and reports, and other possible activities relating to our current product candidates, as well as any other product candidate that we may develop in the future, are subject to extensive regulation. Marketing approval of a new therapeutic product in the United States requires the submission of an NDA or a BLA to the FDA, and we are not permitted to market any product candidate in the United States until we obtain approval from the FDA for that product. An NDA or BLA must be supported by extensive clinical and preclinical data, as well as extensive information regarding pharmacology, chemistry, manufacturing and controls. Similar submissions are required for approval by the relevant regulatory authority in other territories outside the United States before a therapeutic product can be marketed.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">FDA and other applicable regulatory approval is not guaranteed, and the review and approval process is an expensive and uncertain process that may take several years. Regulatory authorities, like the FDA, also have substantial discretion in the approval process. The number and types of preclinical studies and clinical studies that will be required for approval varies depending on the product candidate, the disease or the condition that the product candidate is designed to treat and the regulations applicable to any particular product candidate. Despite the time and expense associated with preclinical studies and clinical studies, failure can occur at any stage. The results of preclinical and early clinical studies of our product candidates may not be predictive of the results of our later-stage clinical studies.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Clinical study failure may result from a multitude of factors including flaws in study design, dose selection, placebo effect, patient enrollment criteria and failure to demonstrate favorable safety or efficacy traits, and failure in clinical studies can occur at any stage. Companies in the biopharmaceutical industry frequently suffer setbacks in the advancement of clinical studies due to lack of efficacy or adverse safety profiles, notwithstanding promising results in earlier studies. Based upon negative or inconclusive results, we may decide, or regulators may require us, to conduct additional clinical studies or preclinical studies. In addition, data obtained from clinical studies are susceptible to varying interpretations, and regulators may not interpret our data as favorably as we do, which may further delay, limit or prevent marketing approval.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The FDA and other applicable regulatory authorities could delay, limit or deny approval of a product candidate for many reasons, including because they:</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">may not deem our product candidate to be adequately safe and effective;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">may not agree that the data collected from clinical studies are acceptable or sufficient to support the submission of a BLA, NDA or other submission or to obtain regulatory approval, and may impose requirements for additional preclinical studies or clinical studies;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">may determine that adverse events experienced by participants in our clinical studies represents an unacceptable level of risk;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">may determine that population studied in the clinical study may not be sufficiently broad or representative to assure safety in the full population for which we seek approval;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">may not accept clinical data from studies, which are conducted at clinical facilities or in countries where the standard of care is potentially different from that of the United States;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">may disagree regarding the formulation, labeling and/or the specifications;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">may not approve the manufacturing processes or facilities associated with our product candidate;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">may change approval policies or adopt new regulations; or</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">may not accept a submission due to, among other reasons, the content or formatting of the submission.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Generally, public concern regarding the safety of biopharmaceutical products could delay or limit our ability to obtain regulatory approval, result in the inclusion of unfavorable information in our labeling, or require us to undertake other activities that may entail additional costs. We have not obtained approval from the FDA or any other applicable regulatory authority for any product. This lack of experience may impede our ability to obtain FDA or any other applicable regulatory approval in a timely manner, if at all, of our product candidates.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">49</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If we experience delays in obtaining approval or if we fail to obtain approval of any of our product candidates, our commercial prospects will be harmed and our ability to generate revenues will be materially impaired which would adversely affect our business, prospects, financial condition and results of operations.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Any delays in the commencement or completion, or termination or suspension, of our ongoing, planned or future clinical studies could result in increased costs to us, delay or limit our ability to raise capital or generate revenue and adversely affect our commercial prospects.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Any delays in the commencement or completion, or termination or suspension, of our ongoing, planned or future clinical studies could result in increased costs to us, delay or limit our ability to generate revenue and adversely affect our commercial prospects. Before we can initiate clinical studies of our product candidates in any distinct indication in the United States, we must submit the results of preclinical studies to the FDA along with other information, including information about their chemistry, manufacturing and controls and our proposed clinical study protocol, as part of an IND or similar regulatory filing. To date, we have only submitted INDs for clinical studies of itolizumab (EQ001) for the treatment of aGVHD, LN, and COVID-19. In addition, there are open INDs for EQ101 in HTLV-I-associated myelopathy/tropical spastic paraparesis, CTCL and AA, which were originally filed by Bioniz prior to our acquisition of the EQ101 asset.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Before obtaining marketing approval from the FDA or from any other applicable regulatory authority outside of the United States for the sale of any of our product candidates in any indication, we must conduct extensive clinical studies to demonstrate the safety and efficacy of those product candidates. Clinical testing is expensive, time consuming and uncertain as to outcome. In addition, we expect to rely in part on preclinical, clinical and quality data generated by our partner, Biocon, as well as contract research organizations, or CROs, and other contracted parties for regulatory submissions for our product candidates. While we have or will have agreements governing these contracted parties&#x2019; services, we have limited influence over their actual performance. If these parties do not make data available to us, or, if applicable, make regulatory submissions in a timely manner, in each case pursuant to our agreements with them, our development programs may be significantly delayed and we may need to conduct additional studies or collect additional data independently. In either case, our development costs would increase.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The FDA and other applicable regulatory authorities may require us to conduct additional preclinical studies of our existing or any future product candidates before they allow us to initiate clinical studies, which may lead to additional delays and increase the costs of our preclinical development programs. Any such delays in the commencement or completion of our ongoing, planned or future clinical studies could significantly affect our product development costs. We do not know whether our ongoing and future studies will be completed on schedule, if at all, or whether our studies will begin on time, if at all. The commencement and completion of clinical studies can be delayed for a number of reasons, including delays related to:</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">impacts and risks associated with global health epidemics or outbreaks such as those related to COVID-19;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the FDA or other applicable regulatory authorities disagreeing as to the design or implementation of our clinical studies;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">obtaining FDA or other applicable regulatory authorizations to commence a study or reaching a consensus with the applicable FDA regulators on study design;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">any failure or delay in reaching an agreement with CROs and clinical study sites, the terms of which can be subject to extensive negotiation and may vary significantly among different CROs and study sites;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">obtaining approval from one or more IRBs;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">additional nonclinical pharmacology and toxicology studies to support Phase 2 and 3 clinical studies;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">IRBs refusing to approve, suspending or terminating the study at an investigational site, precluding enrollment of additional subjects, or withdrawing their approval of the study;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">changes to clinical study protocol;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">clinical sites deviating from study protocol or dropping out of a study;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">manufacturing sufficient quantities of product candidate or obtaining sufficient quantities of combination therapies for use in clinical studies; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">subjects failing to enroll or remain in our study at the rate we expect, or failing to return for post-treatment follow-up;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">subjects choosing an alternative treatment, or participating in competing clinical studies;</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">50</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">lack of adequate funding to continue the clinical study;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">subjects experiencing severe or unexpected drug-related adverse effects;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">occurrence of serious adverse events in studies of the same class of agents conducted by other companies;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">selection of clinical end points that require prolonged periods of clinical observation or analysis of the resulting data;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">a facility manufacturing our product candidates or any of their components being ordered by the FDA (or its own regulatory authorities if such facility is located outside the United States) to temporarily or permanently shut down or cease export of such materials due to violations of cGMP regulations or other applicable requirements, changes in export restrictions and controls, or infections or cross-contaminations during the manufacturing process;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">any changes to our manufacturing process that may be necessary or desired;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">third-party clinical investigators losing the licenses or permits necessary to perform our clinical studies, not performing our clinical studies on our anticipated schedule or consistent with the clinical study protocol, GCP, or other regulatory requirements;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">us, or our  contractors not performing data collection or analysis in a timely or accurate manner or improperly disclosing data prematurely or otherwise in violation of a clinical study protocol; or</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our contractors becoming debarred or suspended or otherwise penalized by the FDA or other government or regulatory authorities for violations of regulatory requirements, in which case we may need to find a substitute contractor, and we may not be able to use some or all of the data produced by such contractors in support of our marketing applications.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We could also encounter delays if a clinical study is suspended or terminated by us, by the IRBs of the institutions in which such studies are being conducted, by a Data Safety Monitoring Board for such study or by the FDA or by other regulatory agencies or health authorities that have jurisdiction in countries in which the study is being conducted. Such authorities may impose such a suspension or termination due to a number of factors, including failure to conduct the clinical study in accordance with regulatory requirements or our clinical protocols, inspection of the clinical study operations or study site by the FDA or other regulatory agencies resulting in the imposition of a clinical hold, unforeseen safety issues or adverse side effects, failure to demonstrate a benefit from using a pharmaceutical, changes in governmental regulations or administrative actions or lack of adequate funding to continue the clinical study. In addition, changes in regulatory requirements and policies may occur, and we may need to amend clinical study protocols to comply with these changes. Amendments may require us to resubmit our clinical study protocols to IRBs for reexamination, which may impact the costs, timing or successful completion of a clinical study.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Certain of our scientific advisors or consultants who receive compensation from us are likely to be investigators for our future clinical studies. Under certain circumstances, we may be required to report some of these relationships to the FDA or other regulatory agencies. The FDA or other regulatory agencies may conclude that a financial relationship between us and a principal investigator has created a conflict of interest or otherwise affected interpretation of the clinical study. The FDA or other applicable regulatory agency may therefore question the integrity of the data generated at the applicable clinical study site and the utility of the clinical study itself may be jeopardized. This could result in a delay in approval, or rejection, of our marketing applications by the FDA or other regulatory agencies and may ultimately lead to the denial of marketing approval of our product candidates in one or more indications. If we experience delays in the completion of, or termination of, any clinical study of our product candidates, the commercial prospects of such product candidate will be harmed, and our ability to generate product revenues will be delayed. Moreover, any delays in completing our clinical studies will increase our costs, slow down our development and approval process and jeopardize our ability to commence product sales and generate revenues from product sales which may harm our business, financial condition, results of operations and prospects significantly.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">51</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">If we experience delays or difficulties in enrolling patients in our ongoing or planned clinical studies, our receipt of necessary regulatory approval could be delayed or prevented.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We may not be able to continue our ongoing or initiate our future clinical studies of our product candidates if we are unable to identify and enroll a sufficient number of eligible patients to participate in these studies as required by the FDA or other applicable regulatory authorities. Multiple factors could contribute to such challenges of enrolling our clinical studies, including impacts related to the COVID-19 pandemic or other public health epidemics or outbreaks, which have already adversely impacted enrollment in our clinical studies. In addition, some of our competitors may have ongoing clinical studies for product candidates that would treat the same indications as our product candidates, and patients who would otherwise be eligible for our clinical studies may instead enroll in clinical studies of our competitors&#x2019; product candidates. Patient enrollment is also affected by other factors, including:</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">impacts and risks associated with global health epidemics or outbreaks such as those related to COVID-19;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">severity of the disease under investigation;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our ability to recruit clinical study investigators of appropriate competencies and experience;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">invasive procedures required to obtain evidence of the product candidate&#x2019;s performance during the clinical study;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">availability and efficacy of approved medications for the disease under investigation;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">eligibility criteria defined in the protocol for the study in question;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the size of the patient population required for analysis of the study&#x2019;s primary endpoints;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">perceived risks and benefits;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">efforts to facilitate timely enrollment in clinical studies;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">reluctance of physicians to encourage patient participation in clinical studies;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the ability to monitor patients adequately during and after treatment;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our ability to obtain and maintain patient consents; and</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">proximity and availability of clinical study sites for prospective patients.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our inability to enroll and retain a sufficient number of patients for our clinical studies would result in significant delays or may require us to abandon one or more clinical studies altogether. Enrollment delays in our clinical studies may result in increased development costs, which would cause the value of our company to decline and limit our ability to obtain additional financing.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">The COVID-19 global pandemic, or other actual or threatened public health epidemics or outbreaks, may continue to adversely impact our business, including our clinical studies, and could further impact other aspects of our business including our supply chain, personnel, and our business development activities, the magnitude and extent of which are uncertain.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our clinical studies have been and may continue to be affected by the coronavirus and remains a significant risk that enrollment of all of our active clinical studies and the timing of data from those studies may be adversely impacted by the COVID-19 pandemic. Clinical site initiation and patient enrollment in our current and future clinical studies may be delayed due to prioritization of hospital resources toward the coronavirus. Patients in our ongoing or planned clinical studies may also choose to not enroll, not participate in follow-up clinical visits or drop out of the study as a precaution against contracting the coronavirus. Further, some patients may not be able or willing to comply with clinical study protocols if quarantines impede patient movement or interrupt healthcare services. Similarly, our ability to recruit and retain principal investigators and site staff who, as healthcare providers, may have heightened exposure to the coronavirus, may be adversely impacted. These events could delay our clinical studies, increase the cost of completing our clinical studies and negatively impact the integrity, reliability or robustness of the data from our clinical studies.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Quarantines, shelter-in-place and similar government orders, or the perception that such orders, shutdowns or other restrictions on the conduct of business operations could occur, related to the coronavirus or other infectious diseases could impact personnel at third-party manufacturing facilities upon which we rely, or the availability or cost of materials, which could disrupt the supply chain for our clinical studies. In particular, certain of our service providers involved in clinical studies are located in regions that have been subject to coronavirus-related actions and policies that limit the conduct of</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">52</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">normal business operations. To the extent our suppliers and service providers are unable to comply with their obligations under our agreements with them or they are otherwise unable to deliver or are delayed in delivering goods and services to us due to the coronavirus, our ability to continue advancing development of our product candidates may become impaired.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The spread of the coronavirus, or other infectious diseases and actions taken to reduce their spread may also materially affect us economically. While the potential economic impact brought by, and the duration of, the coronavirus or other infectious diseases may be difficult to assess or predict, there could be a significant disruption of global financial markets, reducing our ability to access capital, which could in the future negatively affect our liquidity and financial position.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Despite progress in the administration of vaccines, the extent to which the outbreak of coronavirus variants and any related containment and mitigation measures that have been or may in the future be put into place across the globe, may impact our clinical studies, our supply chain, our access to capital and our business development activities, will depend on future developments, which are highly uncertain and cannot be predicted with confidence, such as the duration of the pandemic, the scope and magnitude of any resurgence in the outbreak due to variants of the virus, the efforts by governments and businesses to contain the pandemic and any resurgences, business closures or business disruptions and the impact on the economy and capital markets.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Adverse side effects or other safety risks associated with our product candidates could delay or preclude approval, cause us to suspend or discontinue clinical studies, abandon further development, limit the commercial profile of an approved label, or result in significant negative consequences following marketing approval, if any.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As is the case with pharmaceuticals generally, it is likely that there may be side effects and adverse events associated with our product candidates in our ongoing and future clinical studies as well as in clinical studies, investigator-initiated studies, or off-label usage in jurisdictions where itolizumab is available commercially.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">EQ101 has been well-tolerated with no dose limiting toxicities or infusion reactions reported in subjects that have been dosed in prior studies completed by Bioniz, including healthy volunteers, subjects with large granular lymphocyte leukemia and CTCL. Our Phase 2 clinical study of EQ101 in subjects with AA is currently ongoing as is our Phase 1 first-in-human clinical study of EQ102 in healthy volunteers.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Based on our current limited clinical experience with itolizumab (EQ001), expected adverse events include lymphopenia, injection site reactions, infusion-/injection-related reactions (including fever and headache), and other systemic hypersensitivity reactions including rash, urticaria, erythema, and pruritus.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The most common adverse drug reactions that have been identified from the itolizumab (EQ001) clinical programs were injection site reactions (designated an identified risk) with SC administration and lymphopenia (designated an important identified risk).  Additionally, infection has been designated as an important potential risk. Lymphopenia events were common treatment emergent adverse events reported across itolizumab (EQ001) studies. A decrease in lymphocyte count is a known pharmacodynamic marker of itolizumab (EQ001). These events were generally transient following the first dose, did not decline with continued dosing, and resolved when itolizumab (EQ001) treatment was withdrawn. Further, the declines in lymphocyte count were not associated with infection or other clinical sequelae.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Biocon may also continue to support the use of ALZUMAb or ALZUMAb-L in their own sponsored clinical studies, off-label use, investigator-initiated studies, or third party-sponsored studies over which we have no control. For example, Biocon is studying itolizumab in ulcerative colitis as part of a Phase 2 clinical study being conducted in India, which Equillium is collaborating and co-funding. Given such ongoing usage of itolizumab by Biocon or third parties, there is a risk that adverse events may impact our ability to conduct clinical development and successfully commercialize itolizumab (EQ001). Further, there is a risk that any such adverse events are not properly reported, which may also adversely impact our business.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Although itolizumab (EQ001) and ALZUMAb share the same primary monoclonal antibody sequence, they are manufactured in different cell lines and thus could be considered different biopharmaceutical products. Therefore, clinical results seen with ALZUMAb may have no bearing on results, including adverse events, that may be seen with itolizumab (EQ001). Through the date of the filing of this Annual Report on Form 10-K, we are not aware of any meaningful change in the benefit-to-risk profile of itolizumab.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Results of our clinical studies could reveal a high and unacceptable severity and prevalence of side effects or unexpected characteristics. Undesirable side effects caused by our product candidates could result in the delay, suspension or termination of clinical studies by us, the FDA or other applicable regulatory authorities for a number of reasons. Additionally, a material percentage of patients in our aGVHD clinical studies may die from this disease, possibly as a result of itolizumab (EQ001),</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">53</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">which could impact development of itolizumab (EQ001). If we elect or are required to delay, suspend or terminate any clinical study, the commercial prospects of our product candidates will be harmed and our ability to generate product revenues from this product candidate will be delayed or eliminated. Serious adverse events observed in clinical studies could hinder or prevent market acceptance of our product candidates. Any of these occurrences may harm our business, prospects, financial condition and results of operations significantly.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Moreover, if any of our product candidates are associated with undesirable side effects in clinical studies or have characteristics that are unexpected, we may elect to abandon or limit their development to more narrow uses or subpopulations in which the undesirable side effects or other characteristics are less prevalent, less severe or more acceptable from a risk-benefit perspective, which may limit the commercial expectations for our product candidates, if approved. We may also be required to modify our study plans based on findings in our clinical studies. Many product candidates that initially showed promise in early stage testing have later been found to cause side effects that prevented further development. In addition, regulatory authorities may draw different conclusions or require additional testing to confirm these determinations.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">It is possible that as we test our product candidates in larger, longer and more extensive clinical studies, including with different dosing regimens, or as the use of our product candidates becomes more widespread following any regulatory approval, illnesses, injuries, discomforts and other adverse events that were observed in earlier studies, as well as conditions that did not occur or went undetected in previous studies, will be reported by patients. If such side effects become known later in development or upon approval, if any, such findings may harm our business, financial condition, results of operations and prospects significantly.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, if any of our product candidates receives marketing approval, and we or others later identify undesirable side effects caused by that approved product or any related products, a number of potentially significant negative consequences could result, including:</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">regulatory authorities may withdraw approval of the approved product;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">we may be required to recall a product or change the way the approved product is administered to patients;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">regulatory authorities may require additional warnings on the label, such as a &#x201c;black box&#x201d; warning or a contraindication, or issue safety alerts, &#x201c;Dear Healthcare Provider&#x201d; letters, press releases or other communications containing warnings or other safety information about the product;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">we may be required to implement a Risk Evaluation and Mitigation Strategy, or REMS, or create a medication guide outlining the risks of such side effects for distribution to patients;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">additional restrictions may be imposed on the marketing or promotion of the particular product or the manufacturing processes for the product or any component thereof;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">we could be sued and held liable for harm caused to patients;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the approved product could become less competitive; and</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our reputation may suffer.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Any of these events could prevent us from achieving or maintaining market acceptance of any of our product candidates, if approved, and could significantly harm our business, financial condition, results of operations and prospects.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Interim, topline or preliminary data from our clinical studies that we announce or publish from time to time may change as more patient data become available and are subject to audit and verification procedures that could result in material changes in the final data.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">From time to time, we may publicly disclose preliminary or topline data from our clinical studies, which is based on a preliminary analysis of then-available data, and the results and related findings and conclusions are subject to change following a more comprehensive review of the data related to the particular study. We also make assumptions, estimations, calculations and conclusions as part of our analyses of data, and we may not have received or had the opportunity to fully and carefully evaluate all data. As a result, the topline results that we report may differ from future results of the same clinical studies, or different conclusions or considerations may qualify such results, once additional data have been received and fully evaluated. Topline data also remain subject to audit and verification procedures that may result in the final data being materially different from the preliminary data we previously published. As a result, topline data should be viewed with caution until the final data are available. From time to time, we may also disclose interim data from our clinical studies.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">54</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Interim data from clinical studies that we may complete are subject to the risk that one or more of the clinical outcomes may materially change as patient enrollment continues and more patient data become available. Adverse differences between preliminary or interim data and final data could significantly harm our business prospects. Further, disclosure of interim data by us or by our competitors could result in volatility in the price of our common stock.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Further, others, including regulatory agencies, may not accept or agree with our assumptions, estimates, calculations, conclusions or analyses, or may interpret or weigh the importance of data differently, which could impact the value of the particular program, the approvability or commercialization of the particular product candidate or product and our company in general. In addition, the information we choose to publicly disclose regarding a particular study or clinical study is based on what is typically extensive information, and you or others may not agree with what we determine is the material or otherwise appropriate information to include in our disclosure, and any information we determine not to disclose may ultimately be deemed significant with respect to future decisions, conclusions, views, activities or otherwise regarding a particular biopharmaceutical product, biopharmaceutical product candidate or our business. If the topline data that we report differ from actual results, or if others, including regulatory authorities, disagree with the conclusions reached, our ability to obtain approval for, and commercialize, our product candidates may be harmed, which could harm our business, operating results, prospects or financial condition.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">In the past, we have conducted clinical studies of itolizumab (EQ001) outside of the United States, and we are and may in the future continue to use sites outside of the United States for clinical studies of EQ101, EQ102 and itolizumab (EQ001), including our Phase 3 pivotal clinical study of itolizumab (EQ001) in aGVHD, as well as possibly for clinical studies of any other product candidates. The FDA may not accept data from such studies, in which case our development plans will be delayed, which could materially harm our business.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In the fourth quarter of 2017, Biocon completed a Phase 1 clinical study of itolizumab (EQ001) in healthy subjects in Australia to assess the safety and tolerability of the SC version of itolizumab (EQ001). The study also included a separate stage to compare the pharmacokinetics of the IV administration of itolizumab (EQ001) to ALZUMAb and determine the absolute bioavailability of SC itolizumab (EQ001), but this stage was terminated early due to the occurrence of an initial decrease in lymphocyte counts and transient lymphopenia. We submitted this data to the FDA as part of our IND submissions for the conduct of clinical studies for the treatment of aGVHD, LN and COVID-19. However, it is possible that the FDA will not authorize us to proceed with clinical studies in connection with any future IND submissions in other indications that have different patient populations and we may be required to conduct additional Phase 1 clinical studies, which would be costly and time consuming, and delay aspects of our development plan, which could harm our business.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We have utilized sites in Australia and New Zealand for a Phase 1b clinical study of itolizumab (EQ001) in uncontrolled moderate to severe asthma, and we have utilized sites in India for a Phase 1b clinical study of itolizumab (EQ001) in lupus and LN. Also, we are utilizing sites from a variety of countries outside of the United States in our pivotal Phase 3 clinical study of itolizumab (EQ001) in aGVHD, including sites in Europe, Asia and elsewhere. Our Phase 2 clinical study of EQ101 in subjects with AA and our Phase 1 first-in-human clinical study of EQ102 in healthy volunteers and subjects with celiac disease are both being conducted in Australia. Although the FDA may accept data from clinical studies conducted entirely outside the United States and not under an IND, acceptance of such clinical study data is generally subject to certain conditions. For example, the FDA requires the clinical study to have been conducted in accordance with GCPs, and the FDA must be able to validate the data from the clinical studies through an onsite inspection if it deems such inspection necessary. In addition, when clinical studies are conducted only at sites outside of the United States, the FDA generally does not provide advance comment on the clinical protocols for the studies, and therefore there is an additional potential risk that the FDA could determine that the study design or protocol for a non-U.S. clinical study was inadequate, which would likely require us to conduct additional clinical studies. Conducting clinical studies outside the United States also exposes us to additional risks, including risks associated with:</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">additional foreign regulatory requirements;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">foreign exchange fluctuations;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">compliance with foreign manufacturing, customs, shipment and storage requirements;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">cultural differences in medical practice and clinical research; and</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">diminished protection of intellectual property in some countries.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">55</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We may not be successful in our efforts to expand our pipeline by identifying additional indications for which to test our product candidates in the future. We may expend our limited resources to pursue a particular indication for a product candidate and fail to capitalize on other product candidates or indications that may be more profitable or for which there is a greater likelihood of success.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our translational biology program may initially show promise in identifying additional indications for which our product candidates may have therapeutic benefit, yet this may fail to yield additional clinical development opportunities for our product candidates for a number of reasons, including, our product candidates may, on further study, be shown to have harmful side effects, limited to no efficacy or other characteristics that indicate that it is unlikely to receive marketing approval and achieve market acceptance in such additional indications. Research programs to identify additional indications for our product candidates require substantial technical, financial and human resources.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Because we have limited financial and managerial resources, we must prioritize our research programs and will need to focus our development efforts on the potential treatment of certain, limited indications. As a result, we may forego or delay pursuit of opportunities with other indications or for any future product candidates, or divest product candidates that later prove to have greater commercial potential. Our resource allocation decisions may cause us to fail to capitalize on viable commercial products or profitable market opportunities. Our spending toward developing our product candidates for specific indications may not yield any approved or commercially viable products. If we do not accurately evaluate the commercial potential or target market for our product candidates, we may pursue indications that are less attractive and may also relinquish valuable rights to that product candidate through collaboration, licensing or other royalty arrangements in cases in which it would have been more advantageous for us to retain sole development and commercialization rights to such product candidate.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Even if we receive regulatory approval for any of our product candidates, we will be subject to ongoing regulatory obligations and continued regulatory review, which may result in significant additional expense. Additionally, any of our product candidates, if approved, could be subject to labeling and other restrictions and market withdrawal and we may be subject to penalties if we fail to comply with regulatory requirements or experience unanticipated problems with our products.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Any regulatory approvals that we receive for any of our product candidates may be subject to limitations on the approved indicated uses for which the product may be marketed or to the conditions of approval, or contain requirements for potentially costly post-marketing testing, including Phase 4 clinical studies, and surveillance to monitor the safety and efficacy of the product candidate. In addition, if the FDA approves any product candidate, the manufacturing processes, labeling, packaging, distribution, adverse event reporting, storage, advertising, promotion, import, export and record keeping for the product will be subject to extensive and ongoing regulatory requirements, which can be costly and time consuming. These requirements include submissions of safety and other post-marketing information and reports, registration, as well as continued compliance with cGMPs and GCPs, for any clinical studies that we conduct post-approval. We must incur significant expenses and spend time and effort to ensure compliance with these complex regulations. Later discovery of previously unknown problems with a product, including adverse events of unanticipated severity or frequency, undesirable side effects caused by the product, problems encountered by our contracted manufacturers or manufacturing processes, or failure to comply with regulatory requirements, either before or after product approval, may result in, among other things:</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">restrictions on the marketing or manufacturing of the product;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">requirements to include additional warnings on the label;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">requirements to create a medication guide outlining the risks to patients;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">withdrawal of the product from the market;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">voluntary or mandatory product recalls;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">requirements to change the way the product is administered or for us to conduct additional clinical studies;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">fines, warning letters or holds on clinical studies;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">refusal by the FDA to approve pending applications or supplements to approved applications filed by us or our strategic partners, or suspension or revocation of product license approvals;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">product seizure or detention, or refusal to permit the import or export of products;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">injunctions or the imposition of civil or criminal penalties; and</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">harm to our reputation.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">56</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Additionally, if any product candidate receives marketing approval, the FDA could require us to adopt a REMS to ensure that the benefits of the therapy outweigh its risks, which may include, among other things, a medication guide outlining the risks for distribution to patients and a communication plan to health care practitioners. Any of these events could prevent us from achieving or maintaining market acceptance of the product or the particular product candidate at issue and could significantly harm our business, prospects, financial condition and results of operations.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, if we have any product candidate approved, our product labeling, advertising and promotion will be subject to regulatory requirements and continuing regulatory review. The FDA strictly regulates the promotional claims that may be made about biopharmaceutical products. In particular, a product may not be promoted for uses that are not approved by the FDA as reflected in the product&#x2019;s approved labeling. If we receive marketing approval for a product candidate, physicians may nevertheless prescribe it to their patients in a manner that is inconsistent with the approved label. If we are found to have promoted such off-label uses, we may become subject to significant liability. The FDA and other agencies actively enforce the laws and regulations prohibiting the promotion of off-label uses, and a company that is found to have improperly promoted off-label uses may be subject to significant sanctions. The federal government has levied large civil and criminal fines against companies for alleged improper promotion and has enjoined several companies from engaging in off-label promotion. The FDA has also requested that companies enter into consent decrees or permanent injunctions under which specified promotional conduct is changed or curtailed.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The FDA&#x2019;s policies may change and additional government regulations may be enacted that could prevent, limit or delay regulatory approval of our product candidates. We cannot predict the likelihood, nature or extent of government regulation that may arise from future legislation or administrative action, either in the United States or abroad. If we are slow or unable to adapt to changes in existing requirements or the adoption of new requirements or policies, or if we are not able to maintain regulatory compliance, we may lose any marketing approval that we may have obtained and we may not achieve or sustain profitability, which would adversely affect our business, prospects, financial condition and results of operations.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Even if our product candidates receive marketing approval in any indication, they may fail to achieve the degree of market acceptance by physicians, patients, hospitals, healthcare payors and others in the medical community necessary for commercial success.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If any of our product candidates receive marketing approval in any one or more indication, it may nonetheless fail to gain sufficient market acceptance by physicians, patients, third-party payors and others in the medical community. If they do not achieve an adequate level of acceptance, we may not generate significant product revenues and we may not become profitable. The degree of market acceptance, if approved for commercial sale in any indication, will depend on a number of factors, including:</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">efficacy and potential advantages compared to alternative treatments;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our ability to offer the approved product for sale at competitive prices;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">convenience and ease of administration compared to alternative treatments;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the willingness of the target patient population to try new therapies and of physicians to prescribe these therapies;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the strength of marketing and distribution support;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">potential product liability claims;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the timing of market introduction as well as competitive biopharmaceutical products;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the effectiveness of our or any of our potential future sales and marketing strategies;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">unfavorable publicity;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">sufficient third-party payor coverage and adequate reimbursement;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the willingness of patients to pay all, or a portion of, out-of-pocket costs associated with our products in the absence of sufficient third-party coverage and adequate reimbursement; and</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the prevalence and severity of any side effects.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">57</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We currently have no marketing and sales organization and have no experience as a company in commercializing products, and we may have to invest significant resources to develop these capabilities. If we are unable to establish marketing and sales capabilities or enter into agreements with contracted third parties to market and sell any of our approved products, we may not be able to generate product revenue.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We have no internal sales, marketing or distribution capabilities, nor have we commercialized a product. If any of our product candidates ultimately receives regulatory approval, we may not be able to effectively market and distribute it. We may have to seek collaborators or invest significant amounts of financial and management resources to develop internal sales, distribution and marketing capabilities, some of which will be committed prior to any confirmation that any of our product candidates will be approved, if at all. We may not be able to enter into collaborations or hire consultants or external service providers to assist us in sales, marketing and distribution functions on acceptable financial terms, or at all. In addition, our product revenues and our profitability, if any, may be lower if we rely on contracted parties for these functions than if we were to market, sell and distribute our products ourselves. We likely will have limited control over such contracted parties, and any of them may fail to devote the necessary resources and attention to sell and market our products effectively. Even if we determine to perform sales, marketing and distribution functions ourselves, we could face a number of additional related risks, including:</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">we may not be able to attract and build an effective marketing department or sales force;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the cost of establishing a marketing department or sales force may exceed our available financial resources and the revenue generated by any approved product candidates; and</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our direct sales and marketing efforts may not be successful.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We face substantial competition, which may result in others discovering, developing or commercializing products more quickly or marketing them more successfully than us. If their product candidates are shown to be safer or more effective than ours, then our commercial opportunity will be reduced or eliminated.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The development and commercialization of new products is highly competitive. We compete in the segments of the pharmaceutical, biotechnology and other related markets that develop drugs and biologics for the treatment of immuno-inflammatory diseases. Our commercial opportunity could be reduced or eliminated if our competitors develop and commercialize products that are safer, more effective, have fewer or less severe side effects, are more convenient or are less expensive than any products that we may develop, or that would render any products that we may develop obsolete or non-competitive. Our competitors also may obtain marketing approval for their products more rapidly than we may obtain approval for ours, which could result in our competitors establishing a strong market position before we are able to enter the market.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are aware that other products addressing the same indications as EQ101, EQ102 and itolizumab (EQ001) are in development, and some have been approved. For the treatment of AA, Eli Lilly and Company recently received FDA approval of Olumiant. Other private and public companies involved in AA drug development include Arcutis Biotherapeutics, Inc., ASLAN Pharmaceuticals Limited, Concert Pharmaceuticals, Inc. (acquired by Sun Pharmaceutical Industries Ltd.), Forte Biosciences, Inc., Horizon Therapeutics plc, Legacy Healthcare, Pfizer Inc., Reistone Biopharma, Zelgen Biopharmaceuticals Co., Ltd., and Zura Bio Limited. There are no approved products for celiac disease. Private and public companies with development programs targeting celiac disease include Anokion SA, Calypso Biotech BV, Chugai Pharmaceutical Co., Ltd., IGY Immune Technologies &amp; Life Sciences Inc., Immunic, Inc., ImmunogenX, Inc., Protagonist Therapeutics, Inc., Provention Bio, Selecta Biosciences, Theriva Biologics, Inc., Takeda Pharmaceuticals, and Zedira GmbH. There are no FDA-approved therapies indicated as a first-line treatment of aGVHD. Second-line therapy consists of off-label immunosuppressives for which the therapeutic benefit has not been established, and Incyte Corporation&#x2019;s ruxolitinib which was approved for the treatment of steroid refractory aGVHD in 2019. Other private and public companies with development programs in first-line and steroid refractory aGVHD, including AltruBio, Inc., ASC Therapeutics, CSL Behring LLC, Cynata Therapeutics Limited, ElsaLys Biotech, Humanigen, Inc., Maat Pharma SA, Medac GmbH, Mesoblast Limited, Shenzhen Xbiome Biotech, Co., Ltd., VectivBio Holding AG, and Zelgen Biopharmaceuticals Co., Ltd. There are currently two approved therapies for the treatment of LN: GlaxoSmithKline&#x2019;s Benlysta, approved in 2020, and Aurinia Pharmaceuticals&#x2019; Lupkynis, approved in January 2021.  Other private and public companies involved in LN drug development include Amgen Inc., AstraZeneca plc, Boehringer Ingelheim GmbH, Bristol-Myers Squibb Company, Corestem Co., Ltd., CSL Behring LLC, Genentech Inc., Jansen Pharmaceutical Companies of Johnson &amp; Johnson, Kezar Life Sciences, Inc., Novartis AG, Omeros Corporation and Vera Therapeutics, Inc.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Many of our competitors, such as large pharmaceutical and biotechnology companies like Pfizer Inc. and Eli Lilly and Company, have significantly greater financial resources and expertise in research and development, manufacturing,</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">58</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">preclinical studies, conducting clinical studies, obtaining regulatory approvals and marketing approved products than we have. These competitors also compete with us in recruiting and retaining qualified scientific and management personnel and establishing clinical study sites and patient registration for clinical studies, as well as in acquiring technologies complementary to, or necessary for, our programs. In addition, these larger companies may be able to use their greater market power to obtain more favorable distribution and sales-related agreements with third parties, which could give them a competitive advantage over us.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Further, as more product candidates within a particular class of biopharmaceutical products proceed through clinical development to regulatory review and approval, the amount and type of clinical data that may be required by regulatory authorities may increase or change. Consequently, the results of our clinical studies for product candidates in those classes will likely need to show a risk benefit profile that is competitive with or more favorable than those products and product candidates in order to obtain marketing approval or, if approved, a product label that is favorable for commercialization. If the risk benefit profile is not competitive with those products or product candidates, we may have developed a product that is not commercially viable, that we are not able to sell profitably or that is unable to achieve favorable pricing or reimbursement. In such circumstances, our future product revenues and financial condition would be materially and adversely affected.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Mergers and acquisitions in the pharmaceutical and biotechnology industries may result in even more resources being concentrated among a smaller number of our competitors. Smaller and other early stage companies may also prove to be significant competitors, particularly through collaborative arrangements with large and established companies. These third parties compete with us in recruiting and retaining qualified scientific and management personnel, establishing clinical study sites and subject enrollment for clinical studies, as well as in acquiring technologies complementary to, or necessary for, EQ101, EQ102, itolizumab (EQ001) or any future programs.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The key competitive factors affecting the success of any of our product candidates are likely to be their efficacy, safety, convenience and availability of reimbursement. If we are not successful in developing, commercializing and achieving higher levels of reimbursement than our competitors, we will not be able to compete against them and our business would be materially harmed.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Our current product candidates and any future product candidates for which we intend to seek approval as biologic products may face competition sooner than anticipated.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Affordable Care Act, includes a subtitle called the BPCIA, which created an abbreviated approval pathway for biological products that are biosimilar to or interchangeable with an FDA-licensed reference biological product. Under the BPCIA, an application for a biosimilar product may not be submitted to the FDA until four years following the date that the reference product was first licensed by the FDA. In addition, the approval of a biosimilar product may not be made effective by the FDA until 12 years from the date on which the reference product was first licensed. During this 12-year period of exclusivity, another company may still market a competing version of the reference product if the FDA approves a full BLA for the competing product containing the sponsor&#x2019;s own preclinical data and data from adequate and well-controlled clinical studies to demonstrate the safety, purity and potency of their product. The law is complex and is still being interpreted and implemented by the FDA. As a result, its ultimate impact, implementation and meaning are subject to uncertainty. While it is uncertain when such processes intended to implement BPCIA may be fully adopted by the FDA, any such processes could have a material adverse effect on the future commercial prospects for our biological products.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We believe that any of our product candidates approved as a biological product under a BLA should qualify for the 12-year period of exclusivity. However, there is a risk that this exclusivity could be shortened due to congressional action or otherwise, or that the FDA will not consider our product candidates to be reference products for competing products, potentially creating the opportunity for biosimilar competition sooner than anticipated. Other aspects of the BPCIA, some of which may impact the BPCIA exclusivity provisions, have also been the subject of recent litigation. Moreover, the extent to which a biosimilar, once approved, will be substituted for any one of our reference products in a way that is similar to traditional generic substitution for non-biological products is not yet clear, and will depend on a number of marketplace and regulatory factors that are still developing.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">If market opportunities for our product candidates are smaller than we believe they are, our potential revenue may be adversely affected and our business may suffer.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We only have the rights to itolizumab (EQ001) for the Equillium Territory, and we are focused on the development of itolizumab (EQ001) for immuno-inflammatory diseases, with current plans to develop it for the treatment of patients with aGVHD and LN. We have global rights to EQ101 and EQ102 and currently have plans to develop those product candidates</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">59</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">for alopecia areata and celiac disease, respectively. Our projections of addressable patient populations that have the potential to benefit from treatment with our product candidates are based on estimates and may prove to be incorrect. If any of our estimates are inaccurate, the market opportunities for our product candidates could be significantly diminished and have an adverse material impact on our business.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We may not ultimately realize the potential benefits of orphan drug designation for EQ101 or itolizumab (EQ001).</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">EQ101 has been granted orphan drug designation by the FDA and EMA for CTCL, and itolizumab (EQ001) has been granted orphan drug designations by the FDA for both the prevention and treatment of aGVHD. The FDA grants orphan designation to drugs that are intended to treat rare diseases with fewer than 200,000 patients in the United States or that affect more than 200,000 persons but are not expected to recover the costs of developing and marketing a treatment drug. Orphan drugs do not require prescription drug user fees with a marketing application, may qualify the drug development sponsor for certain tax credits, and may be eligible for a market exclusivity period of seven years (with certain exceptions). However, orphan drug designation neither shortens the development time nor regulatory review time of a product candidate nor gives the candidate any advantage in the regulatory review or approval process. Even if we are awarded marketing exclusivity, the FDA can still approve another drug containing the same active ingredient and used for the same orphan indication if it determines that a subsequent drug is safer, more effective or makes a major contribution to patient care, and orphan exclusivity can be lost if the orphan drug manufacturer is unable to assure that a sufficient quantity of the orphan drug is available to meet the needs of patients with the rare disease or condition. Orphan drug exclusivity may also be lost if the FDA later determines that the initial request for designation was materially defective. In addition, orphan drug exclusivity does not prevent the FDA from approving competing drugs for the same or similar indication containing a different active ingredient. If orphan drug exclusivity is lost and we were unable to successfully enforce any remaining patents covering our eligible product candidates, we could be subject to biosimilar competition earlier than we anticipate. In addition, if a subsequent drug is approved for marketing for the same or a similar indication as EQ101 or itolizumab (EQ001), we may face increased competition and lose market share regardless of orphan drug exclusivity.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Fast track designation by the FDA may not actually lead to a faster development or regulatory review or approval process.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We have received fast track designation for itolizumab (EQ001) for the treatment of aGVHD and LN. If a product is intended for the treatment of a serious or life-threatening condition and the product demonstrates the potential to address unmet medical needs for this condition, the product sponsor may apply for FDA fast track designation. Even with fast track designation, we may not experience a faster development process, review or approval compared to conventional FDA procedures. The FDA may withdraw fast track designation if it believes that the designation is no longer supported by data from our clinical development program.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Even if we receive marketing approval, we may not be able to successfully commercialize any of our approved products due to unfavorable pricing regulations or third-party coverage and reimbursement policies, which could make it difficult for us to sell any of our approved products profitably.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Obtaining coverage and adequate reimbursement approval for a product from a government or other third-party payor is a time-consuming and costly process that could require us to provide supporting scientific, clinical and cost effectiveness data for the use of our approved products to the payor. There may be significant delays in obtaining such coverage and reimbursement for newly approved products, and coverage may be more limited than the purposes for which the product is approved by the FDA. Moreover, eligibility for coverage and reimbursement does not imply that a product will be paid for in all cases or at a rate that covers our costs, including research, development, intellectual property, manufacture, sale and distribution expenses. Interim reimbursement levels for new products, if applicable, may also not be sufficient to cover our costs and may not be made permanent. Reimbursement rates may vary according to the use of the product and the clinical setting in which it is used, may be based on reimbursement levels already set for lower cost products and may be incorporated into existing payments for other services. Net prices for products may be reduced by mandatory discounts or rebates required by government healthcare programs or private payors, by any future laws limiting pharmaceutical prices and by any future relaxation of laws that presently restrict imports of product from countries where they may be sold at lower prices than in the United States.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">There is significant uncertainty related to the insurance coverage and reimbursement of newly approved products. Third-party payors often rely upon Medicare coverage policy and payment limitations in setting reimbursement policies, but also have their own methods and approval process apart from Medicare coverage and reimbursement determinations. Decisions regarding the extent of coverage and amount of reimbursement to be provided for any product candidates that we develop will be made on a payor-by-payor basis. One third-party payor&#x2019;s determination to provide coverage for a drug does not assure that other payors will also provide coverage and adequate reimbursement for the drug. Additionally, a third-party payor&#x2019;s</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">60</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">decision to provide coverage for a therapy does not imply that an adequate reimbursement rate will be approved. Third-party payors are increasingly challenging the price, examining the medical necessity and reviewing the cost-effectiveness of medical products, therapies and services, in addition to questioning their safety and efficacy.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Coverage and reimbursement by a third-party payor may depend upon a number of factors, including the third-party payor&#x2019;s determination that use of a product is:</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">a covered benefit under its health plan;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">safe, effective and medically necessary;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">appropriate for the specific patient;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">cost-effective; and</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">neither experimental nor investigational.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We cannot be sure that coverage or reimbursement will be available for any product that we commercialize and, if coverage and reimbursement are available, what the level of reimbursement will be. Obtaining adequate reimbursement for our products may be particularly difficult because of the higher prices often associated with branded therapeutics and therapeutics administered under the supervision of a physician. Similarly, because our product candidates are physician-administered injectables, separate reimbursement for the product itself may or may not be available. Instead, the administering physician may be reimbursed for providing the treatment or procedure in which our product is used. Our inability to promptly obtain coverage and adequate reimbursement rates from both government-funded and private payors for any approved products that we develop could have a material adverse effect on our operating results, our ability to raise capital needed to commercialize products and our overall financial condition.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Reimbursement may impact the demand for, and the price of, any product for which we obtain marketing approval. Assuming we obtain coverage for a given product by a third-party payor, the resulting reimbursement payment rates may not be adequate or may require co-payments that patients find unacceptably high. Each third-party payor determines whether or not it will provide coverage for a therapy, what amount it will pay the manufacturer for the therapy and on what tier of its list of covered drugs, or formulary, it will be placed. The position on a third-party payor&#x2019;s formulary, generally determines the co-payment that a patient will need to make to obtain the therapy and can strongly influence the adoption of such therapy by patients and physicians. Patients who are prescribed medications for the treatment of their conditions, and their prescribing physicians, generally rely on third-party payors to reimburse all or part of the costs associated with those medications. Patients are unlikely to use our products unless coverage is provided and reimbursement is adequate to cover all or a significant portion of the cost of our products. Therefore, coverage and adequate reimbursement is critical to new product acceptance. Coverage decisions may depend upon clinical and economic standards that disfavor new products when more established or lower cost therapeutic alternatives are already available or subsequently become available. Additionally, if we or our collaborators develop companion diagnostic tests for use with our product candidates, such tests will be subject to the coverage and reimbursement process separate and apart from the coverage and reimbursement we seek for our product candidates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We expect to experience pricing pressures in connection with the sale of our product candidates due to the trend toward managed healthcare, the increasing influence of health maintenance organizations and additional legislative changes. The downward pressure on healthcare costs in general, particularly prescription medicines, medical devices and surgical procedures and other treatments, has become very intense. As a result, increasingly high barriers are being erected to the successful commercialization of new products. Further, the adoption and implementation of any future governmental cost containment or other health reform initiative may result in additional downward pressure on the price that we may receive for any approved product.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Risks Related to Manufacturing and Our Reliance on Third Parties</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">The manufacture of pharmaceutical products, especially biologics, is complex and we may encounter difficulties in production, distribution and delivery of our product candidates. If CMOs, including Biocon, our exclusive CMO for itolizumab (EQ001), encounter such difficulties, our ability to provide supply of our product candidates for clinical studies, our ability to obtain marketing approval, or our ability to obtain commercial supply of our products, if approved, could be delayed or stopped.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We have no experience in biologic manufacturing and do not own or operate, and we do not expect to own or operate, facilities for product manufacturing, storage and distribution, or testing. We are completely dependent on third-party CMOs</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">61</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">to fulfill our clinical and commercial supply of our product candidates. However, the process of manufacturing pharmaceutical products, especially biologics, is complex, highly-regulated and subject to multiple risks. Such manufacturing is highly susceptible to product loss due to contamination, equipment failure, improper installation or operation of equipment, vendor or operator error, inconsistency in yields, variability in product characteristics and difficulties in scaling the production process. Even minor deviations from normal manufacturing processes could result in reduced production yields, product defects and other supply disruptions and higher costs. If microbial, viral or other contaminations are discovered at the facilities of our manufacturer, such facilities may need to be closed for an extended period of time to investigate and remedy the contamination, which could delay clinical studies, result in higher costs of drug product and adversely harm our business. In addition, if the facilities of our manufacturer are located outside of the United States, as is the case currently for itolizumab (EQ001) and EQ102, the production, distribution and delivery of pharmaceutical products are also subject to the laws and regulations of the country. Any changes in the laws and regulations of another country, or disruptions in production or the supply chain related to geopolitical issues or health pandemics, could delay clinical studies, result in higher costs of drug product and adversely harm our business. Moreover, if the FDA determines that our manufacturer is not in compliance with FDA laws and regulations, including those governing cGMPs, the FDA may deny BLA approval until the deficiencies are corrected or we replace the manufacturer in our BLA with a manufacturer that is in compliance.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, there are risks associated with large scale manufacturing for clinical studies or commercial scale including, among others, cost overruns, potential problems with process scale-up, process reproducibility, stability issues, compliance with cGMPs, lot consistency and timely availability and delivery of raw materials. Even if we obtain regulatory approval for our product candidates or any future product candidates, there is no assurance that our CMOs will be able to manufacture the approved product to specifications acceptable to the FDA or other regulatory authorities, to produce it in sufficient quantities to meet the requirements for the potential launch of the product or to meet potential future demand. Further, our contracted manufacturers may experience manufacturing or shipping difficulties due to resource constraints or as a result of natural disasters, labor disputes, unstable political environments, or public health epidemics such as the COVID-19 outbreak. If our manufacturers are unable to produce sufficient quantities for clinical studies or for commercialization, commercialization efforts would be impaired, which would have an adverse effect on our business, financial condition, results of operations and growth prospects.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Scaling up pharmaceutical manufacturing processes, especially biological processes and peptide synthesis, is a difficult and uncertain task, and our CMOs may not have the necessary capabilities to complete the implementation and development process of further scaling up production, transferring production to other sites, or managing its production capacity to timely deliver our supplies of EQ101, EQ102, itolizumab (EQ001) or other future product candidates (including other biologics) or meet product demand.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In May 2017, we entered into an exclusive clinical supply agreement with Biocon and have agreed to enter into an exclusive commercial supply agreement with Biocon in the future. Biocon manufactures itolizumab (EQ001) at its FDA regulated facility in Bangalore, India. Our dependence on Biocon subjects us to further risks and uncertainties related to our ability to fulfill our clinical and commercial supply of itolizumab (EQ001). For example, in March 2020, due to the spread of the coronavirus, the Indian government restricted the export of 26 active pharmaceutical ingredients and the medicines made from them. These export restrictions are indefinite and may be expanded. If the export restrictions are expanded to include itolizumab (EQ001), our supply of itolizumab (EQ001) may be disrupted, delayed or stopped indefinitely and our ability to continue development of itolizumab (EQ001), including our ongoing clinical studies, may be significantly impacted and may result in higher costs of drug product and adversely harm our business. If Biocon is unable to meet our manufacturing requirements (due to export restrictions or otherwise), it has the discretion to outsource manufacturing to a third party and the joint steering committee may determine to shift manufacturing to a third party. However, transfer of the manufacturing of biologic products to a new contract manufacturer, whether related to itolizumab (EQ001) or any of our current or future product candidates, can be lengthy and involve significant additional costs. Even if we are able to adequately validate and scale-up the manufacturing process with a contract manufacturer, we will still need to negotiate with such contract manufacturer an agreement for commercial supply and it is not certain we will be able to come to agreement on terms acceptable to us, if at all. In addition, Biocon has certain rights to reacquire exclusive manufacturing rights for itolizumab (EQ001), even after a third party has been engaged following shortfalls by Biocon, which may make it difficult and expensive to engage any third-party manufacturer for itolizumab (EQ001) other than Biocon.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">62</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We rely, and intend to continue to rely, on CROs to conduct our clinical studies and perform some of our research and preclinical studies. If these third parties do not satisfactorily carry out their contractual duties, fail to comply with applicable regulatory requirements or meet expected deadlines, our development programs may be delayed or subject to increased costs or we may be unable to obtain regulatory approval, each of which may have an adverse effect on our business, financial condition, results of operations and prospects.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We do not have the ability to independently conduct all aspects of our preclinical testing or clinical studies ourselves. As a result, we are and will be dependent on third parties to conduct our ongoing and future preclinical studies and clinical studies of EQ101, EQ102 and itolizumab (EQ001) and any future preclinical studies and clinical studies of any other product candidates. The timing of the initiation and completion of these studies will therefore be partially controlled by such third parties and may result in delays to our development programs.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Specifically, we expect CROs, clinical investigators and consultants to play a significant role in the conduct of these studies and the subsequent collection and analysis of data. However, we will not be able to control all aspects of their activities. Nevertheless, we are responsible for ensuring that each clinical study is conducted in accordance with the applicable protocol and legal, regulatory and scientific standards, and our reliance on the CROs and other third parties does not relieve us of our regulatory responsibilities. Should our CROs engage in unethical, illegal, or non-compliant activities, such behavior could adversely impact our business. Further, should we terminate our contractual relationship with a CRO for such improprieties, transitioning to a different CRO may delay, disrupt or otherwise adversely impact the progress of the clinical study. We and our CROs are required to comply with GCP requirements, which are regulations and guidelines enforced by the FDA, for product candidates in clinical development. Regulatory authorities enforce these GCP requirements through periodic inspections of study sponsors, clinical study investigators and clinical study sites. If we or any of our CROs or clinical study sites fail to comply with applicable GCP requirements, the data generated in our clinical studies may be deemed unreliable, and the FDA may require us to perform additional clinical studies before approving our marketing applications. In addition, our clinical studies must be conducted with product produced under cGMP regulations. Our failure to comply with these regulations may require us to stop and/or repeat clinical studies, which would delay the marketing approval process.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">There is no guarantee that any such CROs, clinical study investigators or other third parties on which we rely on will devote adequate time and resources to our development activities or perform as contractually required. If any of these third parties fail to meet expected deadlines, adhere to our clinical protocols or meet regulatory requirements, otherwise performs in a substandard manner, or terminates its engagement with us, the timelines for our development programs may be extended or delayed or our development activities may be suspended or terminated. If our clinical study site terminates for any reason, we may experience the loss of follow-up information on subjects enrolled in such clinical study unless we are able to transfer those subjects to another qualified clinical study site, which may be difficult or impossible. In addition, clinical study investigators for our clinical study may serve as scientific advisors or consultants to us from time to time and may receive cash or equity compensation in connection with such services. If these relationships and any related compensation result in perceived or actual conflicts of interest, or the FDA concludes that the financial relationship may have affected the interpretation of the study, the integrity of the data generated at the applicable clinical study site may be questioned and the utility of the clinical study itself may be jeopardized, which could result in the delay or rejection of any marketing application we submit by the FDA. Any such delay or rejection could prevent us from commercializing EQ101, EQ102, itolizumab (EQ001) or any future product candidates.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Furthermore, these third parties may also have relationships with other entities, some of which may be our competitors for whom they may also be conducting clinical studies or other biopharmaceutical product development activities that could harm our competitive position. If these third parties do not successfully carry out their contractual duties, meet expected deadlines or conduct our clinical studies in accordance with regulatory requirements or our stated protocols, we will not be able to obtain, or may be delayed in obtaining, marketing approvals for EQ101, EQ102, itolizumab (EQ001) or any future product candidates and will not be able to, or may be delayed in our efforts to, successfully commercialize our products.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Our reliance on contracted parties requires us to share our trade secrets, which increases the possibility that a competitor will discover them or that our trade secrets will be misappropriated or disclosed.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Because we rely on contracted parties to research, develop, and manufacture our product candidates, we must share trade secrets with them. The need to share trade secrets and other confidential information increases the risk that such trade secrets become known by our competitors, are inadvertently incorporated into the technology of others, or are disclosed or used in violation of confidentiality agreements. Given that our proprietary position is based, in part, on our know-how and trade secrets, a competitor&#x2019;s independent discovery of our trade secrets or other unauthorized use or disclosure would impair our competitive position and may have a material adverse effect on our business.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">63</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Agreements with our advisors, employees, contractors and consultants may contain certain limited publication rights. For example, any academic institution that we may collaborate with will likely expect to be granted rights to publish data arising out of such collaboration and any joint research and development programs may require us to share trade secrets under the terms of our research and development or similar agreements. Despite our efforts to protect our trade secrets, our competitors may discover our trade secrets, either through breach of our agreements, independent development or publication of information by any of our collaborators. A competitor&#x2019;s discovery of our trade secrets would impair our competitive position and have an adverse impact on our business.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Risks Related to Intellectual Property</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">If we are unable to obtain or protect intellectual property rights covering our product candidates, or if the scope of the intellectual property protection is not sufficiently broad, our competitors could develop and commercialize products similar or identical to ours, and we may not be able to compete effectively in our market.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our success depends in significant part on our, and with respect to itolizumab (EQ001), Biocon&#x2019;s, ability to establish, maintain and protect patents and other intellectual property rights with respect to our proprietary technologies, research programs, and product candidates, including EQ101, EQ102 and itolizumab (EQ001), and operate without infringing the intellectual property rights of others. The patent prosecution process is expensive and time-consuming, and we and our current or future licensors, licensees or partners may not be able to prepare, file and prosecute all necessary or desirable patent applications at a reasonable cost or in a timely manner. It is also possible that we or our current and future licensors, licensees or partners will fail to identify patentable aspects of our research or inventions made in the course of development and commercialization activities before it is too late to obtain patent protection on them. Although we enter into confidentiality agreements with parties who have access to patentable aspects of our research and development programs, such as our employees, corporate collaborators, outside scientific collaborators, CROs, contract manufacturers, consultants, independent contractors, advisors and other third parties, any of these parties may breach these agreements and disclose such results before a patent application is filed, thereby jeopardizing our ability to seek patent protection on technology relating to our research programs. Moreover, in some circumstances, we may not have the right to control the preparation, filing and prosecution of patent applications, or to maintain the patents, covering technology that we license from or license to third parties and are reliant on our licensors, licensees or partners. Therefore, these patents and applications may not be prosecuted and enforced in a manner consistent with the best interests of our business. If our current or future licensors, licensees or partners fail to establish, maintain or protect such patents and other intellectual property rights, such rights may be reduced or eliminated. If our licensors, licensees or partners are not fully cooperative or disagree with us as to the prosecution, maintenance or enforcement of any patent rights, such patent rights could be compromised. There may be significant pressure on the U.S. government and international governmental bodies to limit the scope of patent protection both inside and outside the United States for disease treatments that prove successful, as a matter of public policy regarding worldwide health concerns.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The patent position of biotechnology companies generally is highly uncertain, involves complex legal and factual questions and has in recent years been the subject of much litigation, resulting in court decisions, including Supreme Court decisions, which have increased uncertainties as to the ability to enforce patent rights in the future. In addition, the laws of foreign countries may not protect our rights to the same extent as the laws of the United States, allowing foreign competitors a better opportunity to create, develop and market competing product candidates, or vice versa. We cannot be certain that the claims in our pending patent applications directed to our product candidates such as EQ101, EQ102 and itolizumab (EQ001), as well as technologies relating to our research programs, will be considered patentable by the United States Patent and Trademark Office, or USPTO, or by patent offices in foreign countries. Furthermore, even if they are unchallenged, patents in our portfolio may not adequately exclude third parties from practicing relevant technology or prevent others from designing around our claims. As a result, the issuance, scope, validity, enforceability and commercial value of our and our current or future licensors&#x2019;, licensees&#x2019; or partners&#x2019; patent rights are highly uncertain. Our and our licensors&#x2019;, licensees&#x2019; or partners&#x2019; pending and future patent applications may not result in patents being issued, which protect our technology or products, in whole or in part, or their intended uses, methods of manufacture or formulations, or which effectively prevent others from commercializing competitive technologies and products. The patent examination process may require us or our licensors, licensees or partners to narrow the scope of the claims of our or our licensors&#x2019;, licensees&#x2019; or partners&#x2019; pending and future patent applications, which may limit the scope of patent protection that may be obtained. In the past, we have not always been able to obtain the full scope of patent protection we have initially sought in our patent applications, and as described above and as is typical for most biotechnology patent prosecution, we have been required to narrow or eliminate patent claims as part of the patent prosecution process. In addition, some patent applications that we or our licensors have filed have not resulted in issued patents because we or our licensors have abandoned those patent applications as changes in business and/or legal strategies dictated.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">64</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We cannot assure you that all of the potentially relevant prior art&#x2014;information that was or is deemed available to a person of skill in the relevant art prior to the priority date of the claimed invention&#x2014;relating to our patents and patent applications has been found. If such prior art exists, it can invalidate a patent or prevent a patent from issuing from a pending patent application, and we may be subject to a third party pre-issuance submission of prior art to the USPTO. Even if patents do successfully issue and even if such patents cover our product candidates, third parties may initiate litigation or opposition, interference, re-examination, post-grant review, inter partes review, nullification or derivation action in court or before patent offices, or similar proceedings challenging the validity, enforceability or scope of such patents, which may result in the patent claims being narrowed or invalidated, may allow third parties to commercialize our product candidates and compete directly with us, without payment to us, or limit the duration of the patent protection of our technology and products. The legal threshold for initiating such proceedings may be low, so that even proceedings with a low probability of success might be initiated. In addition, if the breadth or strength of protection provided by our patents and patent applications is threatened, regardless of the outcome, it could dissuade companies from collaborating with us to license, develop or commercialize current or future product candidates. Our and our licensors&#x2019;, licensees&#x2019; or partners&#x2019; patent applications cannot be enforced against third parties practicing the technology claimed in such applications unless and until a patent issues from such applications, and then only to the extent the issued claims cover the technology.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Because patent applications in the United States and most other countries are confidential for a period of time after filing, and some remain so until issued, we cannot be certain that we or our licensors were the first to file any patent application related to our research programs and product candidates such as EQ101, EQ102 and itolizumab (EQ001). Even where we have a valid and enforceable patent, we may not be able to exclude others from practicing our invention where the other party can show that they used the invention in commerce before our filing date or the other party benefits from a compulsory license. In addition, patents have a limited lifespan. In the United States, if all maintenance fees are timely paid, the natural expiration of a patent is generally 20 years from its earliest U.S. filing date. Various extensions may be available, but the life of a patent, and the protection it affords, is limited. Even if patents covering our product candidates are obtained, once the patent life has expired for a product, we may be open to competition from competitive medications, including biosimilar or generic medications.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">If we are not able to obtain patent term extension in the United States under the Hatch-Waxman Act and in foreign countries under similar legislation, thereby potentially extending the term of our marketing exclusivity for EQ101, EQ102, itolizumab (EQ001) or any other product candidates that we may identify, our business may be materially harmed.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Given the amount of time required for the development, testing and regulatory review of new product candidates, patents protecting such candidates might expire before or shortly after such candidates are commercialized. As a result, our owned and licensed patent portfolio may not provide us with sufficient rights to exclude others from commercializing products similar or identical to ours. We expect to seek extensions of patent terms where these are available in any countries where we are prosecuting patents. This includes in the United States under the Drug Price Competition and Patent Term Restoration Act of 1984, or Hatch-Waxman Act, which permits a patent term extension of up to five years beyond the expiration of the patent. The Hatch-Waxman Act allows a maximum of one patent to be extended per FDA-approved product as compensation for the patent term lost during the FDA regulatory review process. A patent term extension cannot extend the remaining term of a patent beyond a total of 14 years from the date of product approval and only those claims covering such approved drug product, a method for using it or a method for manufacturing it may be extended. Patent term extension may also be available in certain foreign countries upon regulatory approval of our product candidates. However, the applicable authorities, including the FDA and USPTO, in the United States, and any equivalent foreign regulatory authority, may not agree with our assessment of whether such extensions are available, and may refuse to grant extensions to our patents, or may grant more limited extensions than we request. If this occurs, our competitors may take advantage of our investment in development and clinical studies by referencing our clinical and preclinical data and launch their product earlier than might otherwise be the case.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The degree of future protection for our proprietary rights is uncertain, and we cannot predict:</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">if and when patents may issue based on our patent applications;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the scope of protection of any patent issuing based on our patent applications;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">whether the claims of any patent issuing based on our patent applications will provide protection against competitors;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">whether any of the patents we own or license will be found to ultimately be valid and enforceable;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">whether or not third parties will find ways to invalidate or circumvent our patent rights;</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">65</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">whether or not others will obtain patents claiming aspects similar to those covered by our patents and patent applications;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">whether the patents of others will not have an adverse effect on our business;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">whether we will develop additional proprietary technologies or products that are separately patentable;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">whether we will need to initiate litigation or administrative proceedings to enforce and/or defend our patent rights which will be costly whether we win or lose; and/or</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">whether the patent applications that we own or in-license will result in issued patents with claims that cover our product candidates or uses thereof in the United States or in other foreign countries.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We depend on intellectual property licensed from Biocon and termination of our license could result in the loss of significant rights, which would harm our business.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We currently in-license certain intellectual property that is important to our business from Biocon and, in the future, we may enter into additional agreements that provide us with licenses to valuable intellectual property or technology. We rely to some extent on Biocon to file patent applications and to otherwise protect the intellectual property we license from them. We have limited control over these activities or any other intellectual property that may be related to our in-licensed intellectual property. For example, we cannot be certain that such activities by Biocon have been or will be conducted in compliance with applicable laws and regulations or will result in valid and enforceable patents and other intellectual property rights. We have limited control over the manner in which Biocon initiates an infringement proceeding against a third-party infringer of the intellectual property rights, or defend certain of the intellectual property that is licensed to us. It is possible that our licensor&#x2019;s infringement proceeding or defense activities may be less vigorous than had we conducted them ourselves.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Furthermore, in-licensed patents may be subject to a reservation of rights by one or more third parties. Further, our existing license with Biocon imposes, and future agreements may also impose, various diligence, milestone payment, royalty, insurance and other obligations on us. If we fail to comply with these obligations, we may be required to pay damages and our licensor may have the right to terminate the license, in which event we would not be able to develop or market the products covered by such licensed intellectual property and our competitors or other third parties might be able to gain access to technologies and products that are identical to ours. Our business would suffer if any current or future licenses terminate, if the licensors fail to abide by the terms of the license, if the licensors fail to enforce licensed patents against infringing third parties, if the licensed patents or other rights are found to be invalid or unenforceable, or if we are unable to enter into necessary licenses on acceptable terms. Furthermore, if any current or future licenses terminate, or if the underlying patents fail to provide the intended exclusivity, competitors or other third parties may gain the freedom to seek regulatory approval of, and to market, products identical to ours. Moreover, our licensors may own or control intellectual property that has not been licensed to us and, as a result, we may be subject to claims, regardless of their merit, that we are infringing or otherwise violating the licensor&#x2019;s rights. Disputes may also arise between us and our licensor regarding intellectual property subject to a license agreement, including those relating to:</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the scope of rights granted under the license agreement and other interpretation-related issues;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">whether and the extent to which our technology and processes infringe on intellectual property of the licensor that is not subject to the license agreement;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our right to sublicense patent and other rights to third parties under collaborative development relationships;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">whether we are complying with our diligence obligations with respect to the use of the licensed technology in relation to our development and commercialization of our product candidates; and</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the allocation of ownership of inventions and know-how resulting from the joint creation or use of intellectual property by our licensors and by us and our partners.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, intellectual property or technology license agreements, including our existing agreements, are complex, and certain provisions in such agreements may be susceptible to multiple interpretations. The resolution of any contract interpretation disagreement that may arise could narrow what we believe to be the scope of our rights to the relevant intellectual property or technology, or increase what we believe to be our financial or other obligations under the relevant agreement, either of which could have a material adverse effect on our business, financial condition, results of operations, and prospects. If disputes over intellectual property that we have licensed prevent or impair our ability to maintain our current licensing arrangements on acceptable terms, we may be unable to successfully develop and commercialize the affected product candidates. We are generally also subject to all of the same risks with respect to protection of intellectual property</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">66</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">that we license as we are for intellectual property that we own, which are described below. If we or our licensor fail to adequately protect this intellectual property, our ability to commercialize products could suffer.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Because our programs may require the use of proprietary rights held by third parties, the growth of our business may depend in part on our ability to acquire, in-license or use these proprietary rights. We may be unable to acquire or in-license any compositions, methods of use, processes or other third-party intellectual property rights from third parties that we identify as necessary for our product candidates. The licensing and acquisition of third-party intellectual property rights is a competitive area, and a number of more established companies are also pursuing strategies to license or acquire third-party intellectual property rights that we may consider attractive. These established companies may have a competitive advantage over us due to their size, cash resources and greater clinical development and commercialization capabilities.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, companies that perceive us to be a competitor may be unwilling to assign or license rights to us. We also may be unable to license or acquire third-party intellectual property rights on terms that would allow us to make an appropriate return on our investment. In addition, while we cannot currently determine the amount of the royalty obligations we would be required to pay on sales of future products, if any, the amounts may be significant. The amount of our future royalty obligations will depend on the technology and intellectual property we use in products that we successfully develop and commercialize, if any. Therefore, even if we successfully develop and commercialize products, we may be unable to achieve or maintain profitability.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">In the future, we may need to obtain additional licenses of third-party technology that may not be available to us or are available only on commercially unreasonable terms, and which may cause us to operate our business in a more costly or otherwise adverse manner that was not anticipated.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">From time to time we may be required to license technologies relating to our therapeutic research programs from additional third parties to further develop or commercialize our product candidates such as EQ101, EQ102, itolizumab (EQ001) and/or others. Should we be required to obtain licenses to any third-party technology, including any such patents required to manufacture, use or sell our product candidates, such licenses may not be available to us on commercially reasonable terms, or at all. The inability to obtain any third-party license required to develop or commercialize any of our product candidates could cause us to abandon any related efforts, which could seriously harm our business and operations.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Any collaboration arrangements that we may enter into in the future may not be successful, which could adversely affect our ability to develop and commercialize our products.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Any future collaborations that we enter into may not be successful. The success of our collaboration arrangements will depend heavily on the efforts and activities of our collaborators. Collaborations are subject to numerous risks, which may include that:</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">collaborators have significant discretion in determining the efforts and resources that they will apply to collaborations;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">collaborators may not pursue development and commercialization of our products or may elect not to continue or renew development or commercialization programs based on study or test results, changes in their strategic focus due to the acquisition of competitive products, availability of funding or other external factors, such as a business combination that diverts resources or creates competing priorities;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">collaborators could independently develop, or develop with third parties, products that compete directly or indirectly with our products or product candidates;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">a collaborator with marketing, manufacturing and distribution rights to one or more products may not commit sufficient resources to or otherwise not perform satisfactorily in carrying out these activities;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">we could grant exclusive rights to our collaborators that would prevent us from collaborating with others;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">collaborators may not properly maintain or defend our intellectual property rights or may use our intellectual property or proprietary information in a way that gives rise to actual or threatened litigation that could jeopardize or invalidate our intellectual property or proprietary information or expose us to potential liability;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">disputes may arise between us and a collaborator that causes the delay or termination of the research, development or commercialization of our current or future products or that results in costly litigation or arbitration that diverts management attention and resources;</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">67</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">collaborations may be terminated, and, if terminated, may result in a need for additional capital to pursue further development or commercialization of the applicable current or future products;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">collaborators may own or co-own intellectual property covering our products that results from our collaborating with them, and in such cases, we would not have the exclusive right to develop or commercialize such intellectual property; and</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">a collaborator&#x2019;s sales and marketing activities or other operations may not be in compliance with applicable laws resulting in civil or criminal proceedings.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We may not identify relevant third-party patents or may incorrectly interpret the relevance, scope or expiration of a third-party patent, which might adversely affect our ability to develop and market our products.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We cannot assure you that our operations do not, or will not in the future, infringe existing or future patents. We cannot guarantee that any of our patent searches or analyses, including the identification of relevant patents, the scope of patent claims or the expiration of relevant patents, are complete or thorough, nor can we be certain that we have identified each and every third party patent and pending application in the United States and abroad that is relevant to our therapeutic research programs or necessary for the commercialization of our product candidates such as EQ101, EQ102, itolizumab (EQ001) and/or others in any jurisdiction.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Numerous U.S. and foreign patents and pending patent applications exist in our market that are owned by third parties, and there may be third-party patents or patent applications with claims to materials, formulations, methods of manufacture or methods for treatment related to the use or manufacture of our products and/or product candidates that we may identify. Our competitors in both the United States and abroad, many of which have substantially greater resources and have made substantial investments in patent portfolios and competing technologies, may have applied for or obtained or may in the future apply for and obtain, patents that will prevent, limit or otherwise interfere with our ability to make, use and sell our products. We do not always conduct independent reviews of pending patent applications of and patents issued to third parties. Patent applications in the United States and elsewhere are typically published approximately 18 months after the earliest filing for which priority is claimed, with such earliest filing date being commonly referred to as the priority date. Certain U.S. applications that will not be filed outside the United States can remain confidential until patents issue. In addition, patent applications in the United States and elsewhere can be pending for many years before issuance, or unintentionally abandoned patents or applications can be revived. Furthermore, pending patent applications that have been published can, subject to certain limitations, be later amended in a manner that could cover our technologies, our products or the use of our products. As such, there may be applications of others now pending or recently revived patents of which we are unaware, potentially relating to our research programs and product candidates such as EQ101, EQ102, itolizumab (EQ001) and others, or their intended uses. These applications may later result in issued patents, or the revival of previously abandoned patents, that will prevent, limit or otherwise interfere with our ability to make, use or sell our products.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The scope of a patent claim is determined by an interpretation of the law, the written disclosure in a patent and the patent&#x2019;s prosecution history. Our interpretation of the relevance or the scope of a patent or a pending application may be incorrect, which may negatively impact our ability to market our products. We may incorrectly determine that our products are not covered by a third party patent or may incorrectly predict whether a third party&#x2019;s pending application will issue with claims of relevant scope. Our determination of the expiration date of any patent in the United States or abroad that we consider relevant may be incorrect, which may negatively impact our ability to develop and market our product candidates. Our failure to identify and correctly interpret relevant patents may negatively impact our ability to develop and market our products.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We cannot provide any assurances that third party patents do not exist which might be enforced against our current technology, including our research programs, product candidates, which include EQ101, EQ102, itolizumab (EQ001) and others, their respective methods of use, manufacture and formulations thereof, and could result in either an injunction prohibiting our manufacture or future sales, or, with respect to our future sales, an obligation on our part to pay royalties and/or other forms of compensation to third parties, which could be significant.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">If we are sued for infringing intellectual property rights of third parties, such litigation could be costly and time consuming and could prevent or delay us from developing or commercializing our product candidates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our commercial success depends, in part, on our ability to develop, manufacture, market and sell EQ101, EQ102, and itolizumab (EQ001), and other potential future product candidates without infringing the intellectual property and other proprietary rights of third parties. Third parties may allege that we have infringed or misappropriated their intellectual property. Litigation or other legal proceedings relating to intellectual property claims, with or without merit, is unpredictable and generally expensive and time consuming and, even if resolved in our favor, is likely to divert significant resources from</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">68</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our core business, including distracting our technical and management personnel from their normal responsibilities. In addition, there could be public announcements of the results of hearings, motions or other interim proceedings or developments and if securities analysts or investors perceive these results to be negative, it could have a substantial adverse effect on the market price of our common stock. Such litigation or proceedings could substantially increase our operating losses and reduce the resources available for development activities or any future sales, marketing or distribution activities. We may not have sufficient financial or other resources to adequately conduct such litigation or proceedings. Some of our competitors may be able to sustain the costs of such litigation or proceedings more effectively than we can because of their greater financial resources and more mature and developed intellectual property portfolios. Uncertainties resulting from the initiation and continuation of patent litigation or other proceedings could have a material adverse effect on our ability to compete in the marketplace. We cannot assure you that our operations do not, or will not in the future, infringe existing or future patents.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">There is a substantial amount of intellectual property litigation in the biotechnology and pharmaceutical industries, and we may become party to, or threatened with, litigation or other adversarial proceedings regarding intellectual property rights with respect to our product candidates. Our competitors in both the United States and abroad, many of which have substantially greater resources and have made substantial investments in patent portfolios and competing technologies, may have applied for or obtained or may in the future apply for and obtain, patents that will prevent, limit or otherwise interfere with our ability to make, use and sell our product candidates. Third parties may assert infringement claims against us based on existing or future intellectual property rights. The pharmaceutical and biotechnology industries have produced a significant number of patents, and it may not always be clear to industry participants, including us, which patents cover various types of products or methods of use. The coverage of patents is subject to interpretation by the courts, and the interpretation is not always uniform. If we were sued for patent infringement, we would need to demonstrate that our product candidates, products or methods either do not infringe the patent claims of the relevant patent or that the patent claims are invalid or unenforceable, and we may not be able to do this. Proving invalidity may be difficult. For example, in the United States, proving invalidity in court requires a showing of clear and convincing evidence to overcome the presumption of validity enjoyed by issued patents. Even if we are successful in these proceedings, we may incur substantial costs and the time and attention of our management and scientific personnel could be diverted in pursuing these proceedings, which could have a material adverse effect on our business and operations. In addition, we may not have sufficient resources to bring these actions to a successful conclusion. Furthermore, because of the substantial amount of discovery required in connection with intellectual property litigation or administrative proceedings, there is a risk that some of our confidential information could be compromised by disclosure.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If we are found to infringe a third party&#x2019;s intellectual property rights, we could be forced, including by court order, to cease developing, manufacturing or commercializing the infringing product candidate or product. Alternatively, we may be required to obtain a license from such third party in order to use the infringing technology and continue developing, manufacturing or marketing the infringing product candidate. However, we may not be able to obtain any required license on commercially reasonable terms or at all. Even if we were able to obtain a license, it could be non-exclusive, thereby giving our competitors access to the same technologies licensed to us. In addition, we could be found liable for monetary damages, including treble damages and attorneys&#x2019; fees if we are found to have willfully infringed a patent. A finding of infringement could prevent us from commercializing our product candidates or force us to cease some of our business operations, and could divert the time and attention of our technical personnel and management, cause development delays, and/or require us to develop non-infringing technology, which may not be possible on a cost-effective basis, which could materially harm our business. Claims that we have misappropriated the confidential information or trade secrets of third parties could have a similar negative impact on our business.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We may become involved in lawsuits to protect or enforce our patents or other intellectual property, which could be expensive, time consuming and unsuccessful.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Competitors may infringe our patents, trademarks, copyrights or other intellectual property that relate to our current and future product candidates, including EQ101, EQ102, itolizumab (EQ001) and others, their respective methods of use, manufacture and formulations thereof. To counter infringement or unauthorized use, we or our licensor may be required to file infringement claims, which can be expensive and time consuming and divert the time and attention of our management and scientific personnel. Any claims we or our licensor assert against perceived infringers could provoke these parties to assert counterclaims against us alleging that we infringe their patents, in addition to counterclaims asserting that our patents are invalid or unenforceable, or both. In patent litigation in the United States, defendant counterclaims alleging invalidity and/or unenforceability are commonplace, and the outcome following legal assertions of invalidity and unenforceability is unpredictable. In any patent infringement proceeding, there is a risk that a court will decide that a patent that we own or have licensed is invalid or unenforceable, in whole or in part, and that we do not have the right to stop the other party from using the invention at issue. There is also a risk that, even if the validity of such patents is upheld, the court will construe the</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">69</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">patent&#x2019;s claims narrowly or decide that we do not have the right to stop the other party from using the invention at issue on the grounds that our patent claims do not cover the invention. An adverse outcome in a litigation or proceeding involving our patents could limit our ability to assert our patents against those parties or other competitors and may curtail or preclude our ability to exclude third parties from making and selling similar or competitive products.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Interference or derivation proceedings provoked by third parties or brought by us or declared by the USPTO may be necessary to determine the priority of inventions with respect to our patents or patent applications. An unfavorable outcome could require us to cease using the related technology or to attempt to license rights to it from the prevailing party. For example, an unfavorable outcome could require us to cease using the related technology or to attempt to license rights to it from the prevailing party. Our business could be harmed if the prevailing party does not offer us a license on commercially reasonable terms or at all, or if a non-exclusive license is offered and our competitors gain access to the same technology. Our defense of litigation or interference or derivation proceedings may fail and, even if successful, may result in substantial costs and distract our management and other employees. In addition, the uncertainties associated with litigation could have a material adverse effect on our ability to raise the funds necessary to continue our clinical studies, continue our research programs, license necessary technology from third parties, or enter into development partnerships that would help us bring EQ101, EQ102, itolizumab (EQ001) or other product candidates that we may identify to market. Any of these occurrences could adversely affect our competitive business position, results of operations business prospects and financial condition. Similarly, if we assert trademark infringement claims, a court may determine that the marks we have asserted are invalid or unenforceable, or that the party against whom we have asserted trademark infringement has superior rights to the marks in question. In this case, we could ultimately be forced to cease use of such trademarks.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Even if we establish infringement, the court may decide not to grant an injunction against further infringing activity and instead award only monetary damages, which may or may not be an adequate remedy. Furthermore, because of the substantial amount of discovery required in connection with intellectual property litigation, there is a risk that some of our confidential information could be compromised by disclosure during litigation. There could also be public announcements of the results of hearings, motions or other interim proceedings or developments. If securities analysts or investors perceive these results to be negative, it could have a material adverse effect on the price of shares of our common stock. Moreover, we cannot assure you that we will have sufficient financial or other resources to file and pursue such infringement claims, which typically last for years before they are concluded. Even if we ultimately prevail in such claims, the monetary cost of such litigation and the diversion of the attention of our management and scientific personnel could outweigh any benefit we receive as a result of the proceedings.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Because of the expense and uncertainty of litigation, we may not be in a position to enforce our intellectual property rights against third parties.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Because of the expense and uncertainty of litigation, we may conclude that even if a third party is infringing our issued patent relating to our research programs and product candidates, any patents that may be issued as a result of our pending or future patent applications or other intellectual property rights, the risk-adjusted cost of bringing and enforcing such a claim or action may be too high or not in the best interest of our company or our stockholders. In such cases, we may decide that the more prudent course of action is to simply monitor the situation or initiate or seek some other non-litigious action or solution.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We may be subject to claims that our employees, consultants or independent contractors have wrongfully used or disclosed confidential information of third parties.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We employ individuals who previously worked with other companies, including our competitors or potential competitors. We could in the future be subject to claims that we or our employees, consultants, or independent contractors have inadvertently or otherwise used or disclosed alleged trade secrets or other confidential information of current or former employers or competitors. Although we try to ensure that our employees, consultants and independent contractors do not use the intellectual property, proprietary information, know-how or trade secrets of others in their work for us, we may become subject to claims that we caused an individual to breach the terms of his or her non-competition or non-solicitation agreement, or that we or these individuals have, inadvertently or otherwise, used or disclosed the alleged trade secrets or other proprietary information of a current or former employer or competitor.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">While we may litigate to defend ourselves against these claims, even if we are successful, litigation could result in substantial costs and could be a distraction to management and other employees. If our defenses to these claims fail, in addition to requiring us to pay monetary damages, a court could prohibit us from using technologies or features that are essential to our product candidates, including EQ101, EQ102 or itolizumab (EQ001), if such technologies or features are found to incorporate or be derived from the trade secrets or other proprietary information of the current or former employers. Moreover, any such litigation or the threat thereof may adversely affect our reputation, our ability to form strategic alliances</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">70</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">or sublicense our rights to collaborators, engage with scientific advisors or hire employees or consultants, each of which would have an adverse effect on our business, results of operations and financial condition.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We may not be able to protect our intellectual property rights throughout the world.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Filing, prosecuting and defending all current and future patents in all countries throughout the world would be prohibitively expensive, and our intellectual property rights in some countries outside the United States can be less extensive than those in the United States. In addition, the laws of some foreign countries do not protect intellectual property rights to the same extent as federal and state laws in the United States. Consequently, we may not be able to prevent third parties from practicing our inventions in all countries outside the United States, or from selling or importing products made using our inventions in and into the United States or other jurisdictions. Competitors may use our technologies in jurisdictions where we have not obtained patent protection to develop their own products and, further, may export otherwise infringing products to territories where we have patent protection but enforcement is not as strong as that in the United States. These products may compete with our product candidates, and our patents or other intellectual property rights may not be effective or sufficient to prevent them from competing.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The legal systems of many foreign countries do not favor the enforcement of patents and other intellectual property protection, which could make it difficult for us to stop the infringement of our patents or marketing of competing products in violation of our proprietary rights. For example, some foreign countries have compulsory licensing laws under which a patent owner must grant licenses to third parties. In addition, some countries limit the enforceability of patents against third parties, including government agencies or government contractors. In these countries, patents may provide limited or no benefit. In Europe, expected by the end of 2023, European applications will soon have the option, upon grant of a patent, of becoming a Unitary Patent which will be subject to the jurisdiction of the Unitary Patent Court, or UPC.  This will be a significant change in European patent practice. As the UPC is a new court system, there is no precedent for the court, increasing the uncertainty of any litigation. It is our initial belief that the UPC, while offering a cheaper streamlined process, has potential disadvantages to patent holders, such as making a single European patent vulnerable in all jurisdictions when challenged in a single jurisdiction. Given the present uncertainty, we plan to opt out of the UPC where we are able. Proceedings to enforce our patent rights in foreign jurisdictions could result in substantial costs and divert our efforts and attention from other aspects of our business, could put our patents at risk of being invalidated or interpreted narrowly and our patent applications at risk of not issuing and could provoke third parties to assert claims against us. We may not prevail in any lawsuits that we initiate, and the damages or other remedies awarded, if any, may not be commercially meaningful. Accordingly, our efforts to enforce our intellectual property rights around the world may be inadequate to obtain a significant commercial advantage from the intellectual property that we develop or license.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Obtaining and maintaining patent protection depends on compliance with various procedural, document submissions, fee payment and other requirements imposed by governmental patent agencies, and our patent protection could be reduced or eliminated for non-compliance with these requirements.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Periodic maintenance fees, renewal fees, annuities fees and various other governmental fees on patents and/or patent applications are due to be paid to the USPTO and foreign patent agencies in several stages over the lifetime of the patent and/or patent application. The USPTO and various foreign governmental patent agencies also require compliance with a number of procedural, documentary, fee payment and other similar provisions during the patent application process. While an inadvertent lapse can in many cases be cured by payment of a late fee or by other means in accordance with the applicable rules, there are situations in which noncompliance can result in abandonment or lapse of the patent or patent application, resulting in partial or complete loss of patent rights in the relevant jurisdiction. Non-compliance events that could result in abandonment or lapse of a patent or patent application include, but are not limited to, failure to respond to official actions within prescribed time limits, non-payment of fees and failure to properly legalize and submit formal documents. If we fail to maintain the patents and patent applications covering our research programs and product candidates such as EQ101, EQ102, itolizumab (EQ001) and others as well as their respective methods of use, manufacture and formulations thereof, our competitive position would be adversely affected, as, for example, competitors might be able to enter the market earlier than would otherwise have been the case.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We may rely on trade secret and proprietary know-how which can be difficult to trace and enforce and, if we are unable to protect the confidentiality of our trade secrets, our business and competitive position would be harmed.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition to seeking patents for some of our technology and product candidates, we may also rely on trade secrets, including unpatented know-how, technology and other proprietary information, to maintain our competitive position with respect to our research programs and product candidates. Elements of our product candidates, including processes for their preparation and manufacture, may involve proprietary know-how, information, or technology that is not covered by patents,</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">71</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">and thus for these aspects we may consider trade secrets and know-how to be our primary intellectual property. Any disclosure, either intentional or unintentional, by our employees, the employees of third parties with whom we share our facilities or third party consultants and vendors that we engage to perform research, clinical studies or manufacturing activities, or misappropriation by third parties (such as through a cybersecurity breach) of our trade secrets or proprietary information could enable competitors to duplicate or surpass our technological achievements, thus eroding our competitive position in our market.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Trade secrets and know-how can be difficult to protect. We require our employees to enter into written employment agreements containing provisions of confidentiality and obligations to assign to us any inventions generated in the course of their employment. We and any third parties with whom we share facilities enter into written agreements that include confidentiality and intellectual property obligations to protect each party&#x2019;s property, potential trade secrets, proprietary know-how, and information. We further seek to protect our potential trade secrets, proprietary know-how, and information in part, by entering into non-disclosure and confidentiality agreements with parties who are given access to them, such as our corporate collaborators, outside scientific collaborators, CROs, contract manufacturers, consultants, advisors and other third parties. With our consultants, contractors, and outside scientific collaborators, these agreements typically include invention assignment obligations. However, we cannot be certain that such agreements have been entered into with all relevant parties, and we cannot be certain that our trade secrets and other confidential proprietary information will not be disclosed or that competitors will not otherwise gain access to our trade secrets or independently develop substantially equivalent information and techniques. Moreover, despite these efforts, any of these parties may breach the agreements and disclose our proprietary information, including our trade secrets, and we may not be able to obtain adequate remedies for such breaches. Monitoring unauthorized uses and disclosures is difficult, and we do not know whether the steps we have taken to protect our proprietary technologies will be effective. Unauthorized parties may also attempt to copy or reverse engineer certain aspects of our products that we consider proprietary. Enforcing a claim that a party illegally disclosed or misappropriated a trade secret is difficult, expensive and time-consuming, and the outcome is unpredictable. In addition, some courts inside and outside the United States are less willing or unwilling to protect trade secrets.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Trade secrets may be independently developed by others in a manner that could prevent legal recourse by us. Trade secrets will over time be disseminated within the industry through independent development, the publication of journal articles and the movement of personnel skilled in the art from company to company or academic to industry scientific positions. Though our agreements with third parties typically restrict the ability of our advisors, employees, collaborators, licensors, suppliers, third-party contractors and consultants to publish data potentially relating to our trade secrets, our agreements may contain certain limited publication rights. Because from time to time we expect to rely on third parties in the development, manufacture, and distribution of our products and provision of our services, we must, at times, share trade secrets with them. Despite employing the contractual and other security precautions described above, the need to share trade secrets increases the risk that such trade secrets become known by our competitors, are inadvertently incorporated into the technology of others, or are disclosed or used in violation of these agreements. If any of our trade secrets were to be lawfully obtained or independently developed by a competitor or other third party, we would have no right to prevent them from using that technology or information to compete with us. If any of our trade secrets were to be disclosed to or independently developed by a competitor or other third party, our competitive position would be harmed.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We may become subject to claims challenging the inventorship or ownership of our patents and other intellectual property.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We or our licensor may be subject to claims that former employees, consultants, independent contractors, collaborators or other third parties have an interest in our patents or other intellectual property as an owner, co-owner, inventor or co-inventor. The failure to name the proper inventors on a patent application can result in the patents issuing thereon being unenforceable. Inventorship disputes may arise from conflicting views regarding the contributions of different individuals named as inventors, the effects of foreign laws where foreign nationals are involved in the development of the subject matter of the patent, conflicting obligations of third parties involved in developing our product candidates or as a result of questions regarding co-ownership of potential joint inventions. In addition, while it is our policy to require our employees, consultants, advisors, contractors and other third parties who may be involved in the conception or development of intellectual property rights to execute agreements assigning such intellectual property rights to us, we or our licensors may be unsuccessful in executing such agreements with each party who, in fact, conceives or develops intellectual property rights that we regard as our own. The assignment of intellectual property rights may not be self-executing or sufficient in scope, or the assignment agreements may be breached. Furthermore, individuals executing agreements with us may have preexisting or competing obligations to a third party, such as an academic institution, and thus an agreement with us or our licensors may be ineffective in perfecting ownership of inventions developed by that individual. Litigation may be necessary to resolve these and other claims challenging inventorship and/or ownership. Alternatively, or additionally, we may enter into agreements to clarify the scope of our rights in such intellectual property. If we fail in defending any such claims, in addition to paying monetary</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">72</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">damages, we may lose valuable intellectual property rights, such as exclusive ownership of, or right to use, valuable intellectual property. Such an outcome could have a material adverse effect on our business. Even if we are successful in defending against such claims, litigation could result in substantial costs and be a distraction to management and other employees.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Patent terms may be inadequate to protect our competitive position on our product candidates for an adequate amount of time.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Patent rights are of limited duration. In the United States, the natural expiration of a patent is generally 20 years after its first effective non-provisional filing date. Given the amount of time required for the development, testing and regulatory review of new product candidates, patents protecting such candidates might expire before or shortly after such product candidates are commercialized. Even if patents covering our product candidates are obtained, once the patent life has expired for a product, we may be open to competition from biosimilar or generic products. A patent term extension based on regulatory delay may be available in the United States. However, only a single patent can be extended for each marketing approval, and any patent can be extended only once, for a single product. Moreover, the scope of protection during the period of the patent term extension does not extend to the full scope of the claim, but instead only to the scope of the product as approved. Laws governing analogous patent term extensions in foreign jurisdictions vary widely, as do laws governing the ability to obtain multiple patents from a single patent family. Additionally, we may not receive an extension if we fail to apply within applicable deadlines, fail to apply prior to expiration of relevant patents or otherwise fail to satisfy applicable requirements. If we are unable to obtain patent term extension or restoration, or the term of any such extension is less than we request, the period during which we will have the right to exclusively market our product will be shortened and our competitors may obtain approval of competing products following our patent expiration, and our revenue could be reduced, possibly materially.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">If our trademarks and trade names are not adequately protected, then we may not be able to build name recognition in our markets of interest and our business may be adversely affected.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We currently have two U.S. trademark registrations for EQUILLIUM respectively covering Classes 5 and 42, and one Canadian trademark registration for EQUILLIUM covering both Classes 5 and 42. Our current or future trademarks or trade names may be challenged, infringed, circumvented or declared generic or descriptive determined to be infringing on other marks. We may not be able to protect our rights to these trademarks and trade names or may be forced to stop using these names, which we need for name recognition by potential partners or customers in our markets of interest. During trademark registration proceedings, we may receive rejections. Although we would be given an opportunity to respond to those rejections, we may be unable to overcome such rejections. In addition, in the USPTO and in comparable agencies in many foreign jurisdictions, third parties are given an opportunity to oppose pending trademark applications and to seek to cancel registered trademarks. Opposition or cancellation proceedings may be filed against our trademarks, and our trademarks may not survive such proceedings. If we are unable to establish name recognition based on our trademarks and trade names, we may not be able to compete effectively, and our business may be adversely affected. We may license our trademarks and trade names to third parties, such as distributors. Though these license agreements may provide guidelines for how our trademarks and trade names may be used, a breach of these agreements or misuse of our trademarks and tradenames by our licensees may jeopardize our rights in or diminish the goodwill associated with our trademarks and trade names.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Intellectual property rights do not necessarily address all potential threats to our competitive advantage.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The degree of future protection afforded by our intellectual property rights is uncertain because intellectual property rights have limitations and may not adequately protect our business or permit us to maintain our competitive advantage. For example:</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">others may be able to make product candidates that are similar to ours but that are not covered by the claims of the patents that we own or have exclusively licensed;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">we or our licensors or future collaborators might not have been the first to make the inventions covered by the issued patent or pending patent application that we own or have exclusively licensed;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">we or our licensors or future collaborators might not have been the first to file patent applications covering certain of our inventions;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">others may independently develop similar or alternative technologies or duplicate any of our technologies without infringing our intellectual property rights;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">it is possible that our pending patent applications will not lead to issued patents;</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">73</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">issued patents that we own or have exclusively licensed may be held invalid or unenforceable, as a result of legal challenges by our competitors;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our competitors might conduct research and development activities in countries where we do not have patent rights and then use the information learned from such activities to develop competitive products for sale in our major commercial markets;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">we may not develop additional proprietary technologies that are patentable; and</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the patents of others may have an adverse effect on our business.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Should any of these events occur, they could significantly harm our business, financial condition, results of operations and prospects.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Risks Related to Employees, Managing Our Growth and Other Legal Matters</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We are highly dependent on the services of our key personnel.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are highly dependent on the services of our key personnel, Bruce D. Steel, who serves as our President and Chief Executive Officer and Stephen Connelly, Ph.D., who serves as our Chief Scientific Officer. Although we have entered into agreements with them regarding their employment, they are not for a specific term and each of them may terminate their employment with us at any time, though we are not aware of any present intention of any of these individuals to leave us.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We expect to expand our development, regulatory and operational capabilities and, as a result, we may encounter difficulties in managing our growth, which could disrupt our operations.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31, 2022, we had 36 full-time employees. As we advance the clinical development of EQ101, EQ102 and itolizumab (EQ001), and potentially other product candidates, we expect to experience significant growth in the number of our employees and the scope of our operations across a variety of areas including non-clinical research, clinical development, quality, regulatory affairs, pharmacovigilance, manufacturing and supply chain, as well as general and administrative functions. If EQ101, EQ102, itolizumab (EQ001), or any future product candidates receive marketing approval, we would expect to add employees in sales, marketing and distribution. To manage our anticipated future growth, we must:</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">identify, recruit, integrate, maintain and motivate additional qualified personnel;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">identify and lease additional facilities;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">manage our development efforts effectively, including the initiation and conduct of clinical studies for EQ101, EQ102, itolizumab (EQ001) and any future product candidates; and</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">improve our operational, financial and management controls, reporting systems and procedures.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our future financial performance and our ability to develop, manufacture and commercialize our product candidates will depend, in part, on our ability to effectively manage any future growth, and our management may also have to divert financial and other resources, and a disproportionate amount of its attention away from day-to-day activities in order to devote a substantial amount of time, to managing these growth activities.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We currently rely, and for the foreseeable future will continue to rely, in substantial part on certain CROs, CMOs, other contract service providers, advisors and consultants to provide certain services, including assuming substantial responsibilities for the conduct of our ongoing and future clinical studies and the manufacture of EQ101, EQ102, itolizumab (EQ001) and any future product candidates. We cannot assure you that the services of such contract service providers, advisors and consultants will continue to be available to us on a timely basis when needed, or that we can find qualified replacements. In addition, if we are unable to effectively manage our outsourced activities or if the quality or accuracy of the services provided by our vendors or consultants is compromised for any reason, our clinical studies may be extended, delayed or terminated, and we may not be able to obtain marketing approval of our product candidates or otherwise advance our business. We cannot assure you that we will be able to properly manage our existing vendors or consultants or find other competent outside vendors and consultants on economically reasonable terms, or at all.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If we are not able to effectively expand our organization by leasing additional facilities, hiring new employees and expanding our groups of consultants and contractors, we may not be able to successfully implement the tasks necessary to further develop and commercialize our product candidates and, accordingly, may not achieve our research, development and commercialization goals.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">74</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Our future success depends on our ability to retain key employees, consultants and advisors and to attract, retain and motivate qualified personnel.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our industry has experienced a high rate of turnover in recent years. Our ability to compete in the highly competitive biopharmaceuticals industry depends upon our ability to attract, retain and motivate highly skilled and experienced personnel with scientific, medical, regulatory, manufacturing and management skills and experience. We conduct our operations primarily in the Greater San Diego Area region that is home to many other biopharmaceutical companies as well as many academic and research institutions, resulting in fierce competition for qualified personnel. We may not be able to attract or retain qualified personnel in the future due to the intense competition for a limited number of qualified personnel among biopharmaceutical companies. Many of the other biopharmaceutical companies against which we compete have greater financial and other resources, different risk profiles and a longer history in the industry than we do. Our competitors may provide higher compensation, more diverse opportunities and/or better opportunities for career advancement. Any or all of these competing factors may limit our ability to continue to attract and retain high quality personnel, which could negatively affect our ability to successfully develop and commercialize our product candidates and to grow our business and operations as currently contemplated.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Third-party expectations relating to environmental, social and governance factors may impose additional costs and expose us to new risks.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In recent years, there has been an increased focus from certain investors, employees and other stakeholders concerning corporate responsibility, specifically related to environmental, social and governance, or ESG, factors. Third-party providers of ESG ratings and reports on companies have increased in number, resulting in varied and, in some cases, inconsistent standards. Topics taken into account in such assessments include, among others, the company&#x2019;s efforts and impacts with respect to climate change and human rights, ethics and compliance with the law, and the role of the company&#x2019;s board of directors in supervising various sustainability issues.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Some investors may use third-party ESG ratings and reports to guide their investment strategies and, in some cases, may choose not to invest in us if they believe our ESG practices are inadequate. The criteria by which companies&#x2019; ESG practices are assessed are evolving, which could result in greater expectations of us and cause us to undertake costly initiatives to satisfy such new criteria. Alternatively, if we elect not to or are unable to satisfy new criteria or do not meet the criteria of a specific third-party provider, some investors may conclude that our policies with respect to ESG are inadequate and choose not to invest in us.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If our ESG practices do not meet evolving investor or other stakeholder expectations and standards, then our reputation, our ability to attract or retain employees and our desirability as an investment or business partner could be negatively impacted. Similarly, our failure or perceived failure to adequately pursue or fulfill our goals and objectives or to satisfy various reporting standards within the timelines we announce, or at all, could expose us to additional regulatory, social or other scrutiny of us, the imposition of unexpected costs, or damage to our reputation, which in turn could have a material adverse effect on our business, financial condition, cash flows and results of operations and could cause the market value of our common stock to decline.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Our employees, clinical study investigators, CROs, consultants, vendors and any potential commercial partners may engage in misconduct or other improper activities, including non-compliance with regulatory standards and requirements and insider trading.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are exposed to the risk of fraud or other misconduct by our employees, clinical study investigators, CROs, consultants, vendors and any potential commercial partners. Misconduct by these parties could include intentional, reckless and/or negligent conduct or disclosure of unauthorized activities to us that violates: (i) FDA laws and regulations or those of comparable foreign regulatory authorities, including those laws that require the reporting of true, complete and accurate information, (ii) manufacturing standards, (iii) federal and state health and data privacy, security, fraud and abuse, government price reporting, transparency reporting requirements, and other healthcare laws and regulations in the United States and abroad, (iv) sexual harassment and other workplace misconduct, or (v) laws that require the true, complete and accurate reporting of financial information or data. Such misconduct could also involve the improper use of information obtained in the course of clinical studies, which could result in regulatory sanctions and cause serious harm to our reputation. We have adopted a code of conduct applicable to all of our employees, as well as a disclosure program and other applicable policies and procedures, but it is not always possible to identify and deter employee misconduct, and the precautions we take to detect and prevent this activity may not be effective in controlling unknown or unmanaged risks or losses or in protecting us from governmental investigations or other actions or lawsuits stemming from a failure to comply with these laws or</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">75</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">regulations. If any such actions are instituted against us, and we are not successful in defending ourselves or asserting our rights, those actions could have a significant impact on our business, including the imposition of significant civil, criminal and administrative penalties, damages, fines, disgorgement, imprisonment, exclusion from government funded healthcare programs, such as Medicare, Medicaid and other federal healthcare programs, contractual damages, reputational harm, diminished profits and future earnings, additional integrity reporting and oversight obligations, and the curtailment or restructuring of our operations, any of which could adversely affect our ability to operate our business and our results of operations.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Our internal information technology systems, or those of our CROs or other contractors or consultants, may fail or suffer security breaches, loss or leakage of data and other disruptions, which could result in a material disruption of our development programs, compromise sensitive information related to our business or prevent us from accessing critical information, potentially exposing us to liability or otherwise adversely affecting our business.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In the ordinary course of our business, we may collect, receive, store, process, generate, use, transfer, disclose, make accessible, protect, secure, dispose of, transmit, and share (collectively, processing) proprietary, confidential, and sensitive data, including personal data (such as health-related and biometric personal information), intellectual property, and trade secrets (collectively, sensitive information).</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We may rely upon third-party service providers and technologies to operate critical business systems to process sensitive information in a variety of contexts, including, without limitation, third-party providers of cloud-based infrastructure, encryption and authentication technology, employee email, and other functions. Our ability to monitor these third parties&#x2019; information security practices is limited, and these third parties may not have adequate information security measures in place. We may share or receive sensitive information with or from third parties.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cyberattacks, malicious internet-based activity, and online and offline fraud are prevalent and continue to increase. These threats are becoming increasingly difficult to detect. These threats come from a variety of sources, including traditional computer &#x201c;hackers,&#x201d; threat actors, and persons with authorized access to our systems (such as through mistakes, theft, or misuse). Threat actors, personnel, sophisticated nation-states, and nation-state-supported actors now engage and are expected to continue to engage in cyberattacks, including for geopolitical and/or military reasons. Specifically, we and the third parties we rely on may be vulnerable to a heightened risk of cyberattacks that could materially disrupt our systems and operations, supply chain, and ability to produce, sell and distribute our goods and services.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We and the third parties we rely on may be subject to a variety of evolving threats, including but not limited to social-engineering attacks (including through phishing attacks), malicious code (such as viruses and worms), malware (including as a result of advanced persistent threat intrusions), denial-of-service attacks, credential stuffing, personnel misconduct or error, software bugs, server malfunctions, software or hardware failures, loss of data or other information technology assets, adware, telecommunications failures, earthquakes, fires, floods, and other similar threats.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Ransomware attacks, including by organized criminal threat actors, nation-states, and nation-state-supported actors, are becoming increasingly prevalent and severe and can lead to significant interruptions in our operations, loss of data and income, reputational harm, and diversion of funds. Extortion payments may alleviate the negative impact of a ransomware attack, but we may be unwilling or unable to make such payments due to, for example, applicable laws or regulations prohibiting such payments.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Similarly, supply-chain attacks have increased in frequency and severity, and we cannot guarantee that third parties and infrastructure in our supply chain or our third-party partners&#x2019; supply chains have not been compromised or that they do not contain exploitable defects or bugs that could result in a breach of or disruption to our information technology systems (including our products and services) or the third-party information technology systems that support us and our services. Furthermore, the COVID-19 pandemic and our remote workforce poses increased risks to our information technology systems and data, as more of our employees work from home, utilizing network connections outside our premises.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Any of the previously identified or similar threats could cause a security incident or other interruption, which could result in unauthorized, unlawful, or accidental acquisition, modification, destruction, loss, alteration, encryption, disclosure of, or access to our sensitive information. A security incident or other interruption could disrupt our ability (and that of third parties upon whom we rely) to provide our products and services.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We may expend significant resources or modify our business activities (including our clinical study activities) to try to protect against security incidents. Certain data privacy and security obligations may require us to implement and maintain specific security measures, industry-standard or reasonable security measures to protect our information technology systems</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">76</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">and sensitive information. There can be no assurance that the security measures we and our third-party suppliers have implemented will be effective. We are not always able to detect vulnerabilities in our security controls, systems, or software (including third-party software we have installed on our systems). Further, we may experience delays in deploying remedial measures designed to address any such identified vulnerabilities. Efforts to identify and remediate vulnerabilities, if any, in our information technology systems or software (including third-party software we have installed on our systems) may not be successful.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Applicable data privacy and security obligations may require us to notify relevant stakeholders of security incidents. Such disclosures are costly, and the disclosures or the failure to comply with such requirements could lead to adverse consequences. If we (or a third party upon whom we rely) experience a security incident or are perceived to have experienced a security incident, we may experience adverse consequences. These consequences may include: government enforcement actions (for example, investigations, fines, penalties, audits, and inspections); additional reporting requirements and/or oversight; restrictions on processing sensitive information (including personal data); litigation (including class claims); indemnification obligations; negative publicity; reputational harm; monetary fund diversions; interruptions in our operations (including the delay of development and commercialization of our product candidates); financial loss; and other similar harms.  Security incidents and attendant consequences that we or our third party providers could experience may cause customers to stop using our products and services, deter new customers from using our products and services, and negatively impact our ability to grow and operate our business.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our contracts may not contain limitations of liability, and even where they do, there can be no assurance that limitations of liability in our contracts are sufficient to protect us from liabilities, damages, or claims related to our data privacy and security obligations. We cannot be sure that our insurance coverage will be adequate or sufficient to protect us from or to mitigate liabilities arising out of our privacy and security practices, that such coverage will continue to be available on commercially reasonable terms or at all, or that such coverage will pay future claims.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We are subject to stringent and changing obligations related to data privacy and security. Our actual or perceived failure to comply with such obligations could lead to regulatory investigations or actions; litigation; fines and penalties; disruptions of our business operations; reputational harm; loss of revenue or profits; loss of customers or sales; and other adverse business consequences.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our data processing activities, including information from study participants, may subject us to numerous data privacy and security obligations, such as various laws, regulations, guidance, industry standards, external and internal privacy and security policies, contractual provisions, and other obligations that govern the processing of personal data by us and on our behalf. In the United States, numerous federal and state laws and regulations, including federal health information privacy laws, state data breach notification laws, state health information privacy laws, and federal and state consumer protection laws, that govern the collection, use, disclosure, and protection of health-related and other personal information could apply to our operations or the operations of our collaborators. In addition, we may obtain health information from third parties (including research institutions from which we obtain clinical study data) that are subject to privacy and security requirements under the federal Health Insurance Portability and Accountability Act of 1996, or HIPAA, as amended by the Health Information Technology for Economic and Clinical Health Act of 2009, or HITECH. Depending on the facts and circumstances, we could be subject to criminal penalties if we knowingly obtain, use, or disclose individually identifiable health information maintained by a HIPAA-covered entity in a manner that is not authorized or permitted by HIPAA.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Additionally, the California Consumer Privacy Act of 2018, or CCPA, imposes obligations on covered businesses and could impact our operations. These obligations include, but are not limited to, providing specific disclosures in privacy notices and affording California residents certain rights related to their personal data. The CCPA allows for statutory fines for noncompliance (up to $7,500 per violation) and a private right of action for certain breaches. In addition, the California Privacy Rights Act of 2020, or CPRA, effective January 1, 2023, will expand the CCPA. Additionally, the CPRA establishes a new California Privacy Protection Agency to implement and enforce the CPRA, which could increase the risk of enforcement. Other states have enacted data privacy laws. For example, Virginia, Colorado, Utah, and Connecticut, all have passed privacy laws that became effective in 2023. Additionally, several states and localities, as well as foreign jurisdictions, have enacted statutes banning or restricting the collection of biometric information. We collect biometric data that may subject us to biometric privacy laws. For example, the Illinois Biometric Information Privacy Act, or BIPA, regulates the collection, use, safeguarding, and storage of biometric information. BIPA provides for substantial penalties and statutory damages and have generated significant class action activity, and the cost of litigating and settling any claims that we have violated BIPA or similar laws could be significant.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Outside the United States, an increasing number of laws, regulations, and industry standards apply to data privacy and security, and could apply to our operations. For example, the European Union&#x2019;s General Data Protection Regulation, or EU</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">77</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">GDPR, and the United Kingdom&#x2019;s GDPR, or UK GDPR, impose strict requirements for processing personal data. For example, under the EU GDPR, government regulators may impose temporary or definitive bans on data processing, as well as fines of up to 20 million euros or 4% of annual global revenue, whichever is greater. Further, individuals may initiate litigation related to processing of their personal data.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Certain jurisdictions have enacted data localization laws and cross-border personal data transfer laws, which could make it more difficult to transfer information across jurisdictions (such as transferring or receiving personal data that originates in the EU or in other foreign jurisdictions). Existing mechanisms that facilitate cross-border personal data transfers may change or be invalidated. The European Commission released a set of &#x201c;Standard Contractual Clauses,&#x201d; or SCCs, that are a valid mechanism to transfer personal data outside of the EEA, but there exists some uncertainty regarding whether the SCCs will remain a valid mechanism. Additionally, the SCCs impose additional compliance burdens, such as conducting transfer impact assessments to determine whether additional security measures are necessary to protect the at-issue personal data.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, the UK similarly restricts personal data transfers outside of those jurisdictions to countries, such as the United States, that do not provide an adequate level of personal data protection, and certain countries outside Europe (e.g. China) have also passed or are considering laws requiring local data residency or otherwise impeding the transfer of personal data across borders, any of which could increase the cost and complexity of doing business. The inability to import personal data to the United States could significantly and negatively impact our business operations, including by limiting our ability to conduct clinical study activities in Europe and elsewhere; limiting our ability to collaborate with parties that are subject to such cross-border data transfer or localization laws; or requiring us to increase our personal data processing capabilities and infrastructure in foreign jurisdictions at significant expense.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Although we endeavor to comply with all applicable data privacy and security obligations, we may at times fail to do so (or be perceived to have failed to have done so). Moreover, despite our efforts, our personnel or third parties upon whom we rely on may fail to comply with such obligations, which could negatively impact our business operations and compliance posture. For example, any failure by a third-party processor to comply with applicable law, regulations, or contractual obligations could result in adverse effects, including inability to or interruption in our ability to operate our business and proceedings against us by governmental entities or others. Consequences for our failure to comply may include, but are not limited to, government enforcement actions (e.g., investigations, fines, penalties, audits, inspections, and similar); litigation (including class-related claims); additional reporting requirements and/or oversight; bans on processing personal data; orders to destroy or not use personal data; and imprisonment of company officials.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Any of these events could have a material adverse effect on our reputation, business, or financial condition, including but not limited to: loss of customers; interruptions or stoppages in our business operations (including, as relevant, clinical studies); inability to process personal data or to operate in certain jurisdictions; limited ability to develop or commercialize our products; expenditure of time and resources to defend any claim or inquiry; adverse publicity; or revision or restructuring of our operations.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Our ability to use our net operating loss carryforwards and certain other tax attributes may be limited.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31, 2022, we had aggregate U.S. federal net operating loss, or NOL, carryforwards of approximately $116.4 million. Our U.S. federal NOLs generated in taxable years beginning before January 1, 2018 could expire unused. Under current U.S. federal income tax law, U.S. federal NOLs generated in taxable years beginning after December 31, 2017, may be carried forward indefinitely, but the deductibility of such U.S. federal NOLs is generally limited to 80% of taxable income. It is uncertain if and to what extent various states will conform to the current U.S. federal income tax law.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, under Sections 382 and 383 of the Internal Revenue Code of 1986, as amended, or IRC, and corresponding provisions of state law, if a corporation undergoes an &#x201c;ownership change,&#x201d; which is generally defined as a greater than 50 percentage-point cumulative change (by value) in its equity ownership over a three-year period, the corporation&#x2019;s ability to use its pre-change NOL carryforwards and other pre-change tax attributes (such as research tax credits) to offset its post-change income or taxes may be limited. It is possible that we have experienced one or more ownership changes in the past. In addition, we may also experience ownership changes in the future as a result of subsequent shifts in our stock ownership some of which may be outside of our control. As a result, our ability to use our pre-ownership change NOL carryforwards to offset U.S. federal taxable income (if we earned net taxable income) and any other pre-ownership change tax attributes may be subject to limitations, which could potentially result in increased future tax liability to us. In addition, at the state level, there may be periods during which the use of NOLs is suspended or otherwise limited, which could accelerate or permanently increase state taxes owed.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">78</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Tax Cuts and Jobs Act provides for amendments to IRC Section 174 which beginning in 2022, require taxpayers to capitalize their U.S. based and non-U.S. based research and experimental, or R&amp;E expenditures and amortize them over a period of five or fifteen years, respectively. Additionally, software development costs are specifically included as R&amp;E expenditures under Section 174(c)(3) and, therefore, will be subject to the same mandatory amortization period of five or fifteen years. Prior to the Tax Cuts and Jobs Act amendment, Section 174 allowed taxpayers to either immediately deduct R&amp;E expenditures in the year paid or incurred or elect to capitalize and amortize over a period of at least 60 months. Section 174, as amended, may have a significant impact to our tax position in future years.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We conduct significant operations through our Australian wholly-owned subsidiary. If we lose our ability to operate in Australia, or if our subsidiary is unable to receive the research and development tax credit allowed by Australian regulations, our business and results of operations will suffer.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In January 2019, we formed a wholly-owned Australian subsidiary, Equillium Australia Pty Ltd, to initially conduct the clinical development of itolizumab (EQ001) for the treatment of uncontrolled asthma in Australia and New Zealand. That subsidiary is also conducting our current clinical studies of EQ101 and EQ102 and may conduct further clinical studies in the future. Due to the geographical distance and lack of employees currently in Australia, as well as our lack of experience operating in Australia, we may not be able to efficiently or successfully monitor, develop or commercialize our product candidates in Australia and New Zealand, including conducting clinical studies. Furthermore, we have no assurance that the results of any clinical studies that we conduct for our product candidates in Australia and New Zealand will be accepted by the FDA or other foreign regulatory authorities for development and commercialization approvals.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, current Australian tax regulations provide for a refundable research and development tax credit. If we lose our ability to operate Equillium Australia Pty Ltd in Australia, are ineligible or unable to receive the research and development tax credit, or receive a refund that is materially less than our expectations, or if the Australian government significantly reduces or eliminates the tax credit, our financial forecasts could be incorrect and our business and results of operations would be adversely affected.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">If we fail to comply with U.S. export control and economic sanctions, our business, financial condition and prospects may be materially and adversely affected.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our business and our products are subject to U.S. export control laws and regulations, including the U.S. Export Administration Regulations and economic and trade sanctions regulations administered by the U.S. Treasury Department&#x2019;s Office of Foreign Assets Control, or OFAC. Our company must comply with these laws and regulations. The antibody sequence for itolizumab (EQ001) is derived from Cuban-origin intellectual property and thus we believe this to be a pharmaceutical of Cuban origin, which would make the import, development and commercialization of itolizumab (EQ001) subject to these laws, sanctions and regulations. We currently rely on a general license issued by OFAC under the Cuban Assets Control Regulations, or CACR, relating to Cuban-origin pharmaceuticals to import and conduct clinical studies relating to itolizumab (EQ001). In the absence of the OFAC general license, all of our development and potential commercialization activities for itolizumab (EQ001) would be prohibited under the CACR, and we would be required to request a specific license from OFAC authorizing such activities, which OFAC could deny.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We submitted to OFAC, and subsequently amended and supplemented, a request for interpretive guidance confirming the applicability of the general license to itolizumab (EQ001), or in its absence, a specific license authorization from OFAC authorizing activities relating to the commercialization of itolizumab (EQ001), or the Submission. We simultaneously requested that OFAC treat the Submission as a voluntary disclosure if OFAC concluded that our determination that the general license applies to itolizumab (EQ001) was in error.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In November 2019, OFAC notified us that after careful consideration, which included consultation with the FDA, OFAC determined that itolizumab (EQ001) falls within the definition of &#x201c;Cuban-origin pharmaceutical&#x201d; and, as such, the general licenses at section 515.547(b) and (c) of the CACR authorize the conduct of clinical studies for itolizumab (EQ001) for the purpose of seeking approval for the drug from the FDA. Thus, no further authorization is required from OFAC at this time for our ongoing and future clinical studies of itolizumab (EQ001).</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Even though OFAC has concluded that the general license for Cuban-origin pharmaceuticals applies to itolizumab (EQ001), there can be no assurance that the general license will not be revoked or modified by OFAC in the future, or that we will remain in compliance with the general license or other export laws and regulations. If OFAC revokes or modifies the general license, or otherwise determines that the general license does not apply to itolizumab (EQ001), and OFAC then denies our request for a specific license or delays issuance of a specific license, we will be unable to deal in, or otherwise commercialize, itolizumab (EQ001). In that case, we would be required to cease operations related to itolizumab (EQ001),</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">79</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">which would materially and adversely affect our financial condition and business prospects. In addition, in the absence of the general or specific license, the transfer, sale and/or purchase of our securities could be prohibited, and the ownership or possession of our securities could be subject to an affirmative OFAC reporting requirement relating to blocked property. Any violations of the CACR or other applicable export control and sanctions laws could subject us and certain of our employees to substantial civil or criminal penalties.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Changes in healthcare law and implementing regulations, as well as changes in healthcare policy, may impact our business in ways that we cannot currently predict and may have a significant adverse effect on our business and results of operations.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">There have been, and continue to be, numerous legislative and regulatory changes and proposed changes regarding the healthcare system that could prevent or delay marketing approval of product candidates, restrict or regulate post-approval activities and affect our ability to profitably sell any product candidates for which we obtain marketing approval. Among policy makers and payors in the United States there is significant interest in promoting changes in healthcare systems with the stated goals of containing healthcare costs, improving quality and/or expanding access and the pharmaceutical industry has been a particular focus of these efforts and has been significantly affected by major legislative initiatives.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Patient Protection and Affordable Care Act of 2010, as amended by the Health Care and Education Reconciliation Act of 2010, or collectively the Affordable Care Act, substantially changed the way healthcare is financed by both the government and private insurers, and significantly impacts the U.S. pharmaceutical industry. The Affordable Care Act, among other things: (i) introduced a &#x201c;average manufacturer price&#x201d; calculation for drugs and biologics that are inhaled, infused, instilled, implanted or injected and that are not generally dispensed through retail community pharmacies; (ii) increased the minimum Medicaid rebates owed by manufacturers under the Medicaid Drug Rebate Program and expanded rebate liability from fee-for-service Medicaid utilization to include the utilization of Medicaid managed care organizations as well; (iii) established a branded prescription drug fee that pharmaceutical manufacturers of branded prescription drugs must pay to the federal government; (iv) expanded the list of covered entities eligible to participate in the 340B drug pricing program by adding new entities to the program; (v) established Medicare Part D coverage gap discount program, in which manufacturers currently must agree to offer 70% point-of-sale discounts off negotiated prices of applicable branded drugs to eligible beneficiaries during their coverage gap period, as a condition for the manufacturer&#x2019;s outpatient drugs to be covered under Medicare Part D; (vi) expanded eligibility criteria for Medicaid programs by, among other things, allowing states to offer Medicaid coverage to additional individuals, including individuals with income at or below 133% of the federal poverty level, thereby potentially increasing manufacturers&#x2019; Medicaid rebate liability; (vii) created a licensure framework for follow-on biologic products; and (viii) established a Center for Medicare &amp; Medicaid Innovation at the Centers for Medicare &amp; Medicaid Services to test innovative payment and service delivery models to lower Medicare and Medicaid spending.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">There have been judicial, Congressional and executive challenges to certain aspects of the Affordable Care Act. For example, on June 17, 2021, the U.S. Supreme Court held in a 7-2 opinion that the states and individuals challenging the constitutionality of Affordable Care Act do not have standing to challenge the law. The U.S. Supreme Court did not reach the merits of the challenge regarding Affordable Care Act&#x2019;s constitutionality, but the decision ended the case. Further, prior to the U.S. Supreme Court ruling, on January 28, 2021, President Biden issued an executive order that initiated a special enrollment period for purposes of obtaining health insurance coverage through the Affordable Care Act marketplace. The executive order also instructed certain governmental agencies to review and reconsider their existing policies and rules that limit access to healthcare, including among others, reexamining Medicaid demonstration projects and waiver programs that include work requirements, and policies that create unnecessary barriers to obtaining access to health insurance coverage through Medicaid or the Affordable Care Act. In addition, on August 16, 2022, President Biden signed the IRA into law, which among other things, extends enhanced subsidies for individuals purchasing health insurance coverage in Affordable Care Act marketplaces through plan year 2025. The IRA also eliminates the &#x201c;donut hole&#x201d; under the Medicare Part D program beginning in 2025 by significantly lowering the beneficiary maximum out-of-pocket cost and creating a new manufacturer discount program. It is possible that the Affordable Care Act will be subject to judicial or Congressional challenges in the future. It is unclear how any such challenges and the healthcare reform measures of the Biden administration will impact the Affordable Care Act. We are continuing to monitor any changes to the Affordable Care Act that, in turn, may potentially impact our business in the future.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other legislative changes have been proposed and adopted since the Affordable Care Act was enacted. These changes include aggregate reductions to Medicare payments to providers of 2% per fiscal year pursuant to the Budget Control Act of 2011 and subsequent laws, which began in 2013 and will remain in effect until 2031 unless additional Congressional action is taken. Under current legislation the actual reduction in Medicare payments will vary from 1% in 2022 to up to 4% in the final fiscal year of this sequester. Additionally, on March 11, 2021, President Biden signed the American Rescue Plan Act of 2021 into law, which eliminates the statutory Medicaid drug rebate cap, currently set at 100% of a drug&#x2019;s average manufacturer</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">80</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">price, for single source and innovator multiple source drugs, beginning January 1, 2024. In January 2013, the American Taxpayer Relief Act of 2012 was signed into law, which, among other things, further reduced Medicare payments to several types of providers, including hospitals, imaging centers and cancer treatment centers, and increased the statute of limitations period for the government to recover overpayments to providers from three to five years. New laws may result in additional reductions in Medicare and other healthcare funding, which may materially adversely affect customer demand and affordability for our products and, accordingly, the results of our financial operations.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Also, there has been heightened governmental scrutiny recently over the manner in which pharmaceutical companies set prices for their marketed products, which have resulted in several Congressional inquiries and proposed federal legislation, as well as state efforts, designed to, among other things, bring more transparency to product pricing, reduce the cost of prescription drugs under Medicare, review the relationship between pricing and manufacturer patient programs, and reform government program reimbursement methodologies for drug products. At the federal level, in July 2021, the Biden administration released an executive order, &#x201c;Promoting Competition in the American Economy,&#x201d; with multiple provisions aimed at prescription drugs. In response to Biden&#x2019;s executive order, on September 9, 2021, the Department of Health and Human Services, or HHS, released a Comprehensive Plan for Addressing High Drug Prices that outlines principles for drug pricing reform and sets out a variety of potential legislative policies that Congress could pursue as well as potential administrative actions HHS can take to advance these principles. In addition, the IRA, among other things, (1) directs HHS to negotiate the price of certain single-source drugs and biologics covered under Medicare and (2) imposes rebates under Medicare Part B and Medicare Part D to penalize price increases that outpace inflation. These provisions will take effect progressively starting in fiscal year 2023, although they may be subject to legal challenges. It is currently unclear how the IRA will be implemented but is likely to have a significant impact on the pharmaceutical industry. Further, the Biden administration released an additional executive order on October 14, 2022, directing HHS to submit a report on how the Center for Medicare and Medicaid Innovation can be further leveraged to test new models for lowering drug costs for Medicare and Medicaid beneficiaries. It is unclear whether this executive order or similar policy initiatives will be implemented in the future. At the state level, individual states in the United States are increasingly active in passing legislation and implementing regulations designed to control pharmaceutical and biological product pricing, including price or patient reimbursement constraints, discounts, restrictions on certain product access and marketing cost disclosure and transparency measures, and, in some cases, designed to encourage importation from other countries and bulk purchasing. The IRA also included drug pricing reforms, which have the potential to adversely impact our ability to successfully commercialize our product candidates and could lessen the real or perceived value of our product candidates, which would negatively impact our business.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We expect that these and other healthcare reform measures that may be adopted in the future, may result in more rigorous coverage criteria and lower reimbursement, and in additional downward pressure on the price that we receive for any approved product. Any reduction in reimbursement from Medicare or other government-funded programs may result in a similar reduction in payments from private payors. The implementation of cost containment measures or other healthcare reforms may prevent us from being able to generate revenue, attain profitability or commercialize our drugs, once marketing approval is obtained.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">If any of our services providers are characterized as employees, we would be subject to employment and tax withholding liabilities and other additional costs.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We rely on independent contractors to provide certain services to us. We structure our relationships with these outside services providers in a manner that we believe results in an independent contractor relationship, not an employee relationship. An independent contractor is generally distinguished from an employee by his or her degree of autonomy and independence in providing services. A high degree of autonomy and independence is generally indicative of an independent contractor relationship, while a high degree of control is generally indicative of an employment relationship. Tax or other regulatory authorities may challenge our characterization of services providers as independent contractors both under existing laws and regulations and under laws and regulations adopted in the future. We are aware of a number of judicial decisions and legislative proposals that could bring about major changes in the way workers are classified, including the California legislature&#x2019;s recent passage of California Assembly Bill 5, which California Governor Gavin Newsom signed into law in September 2019, or AB 5, and Assembly Bill 2257, or AB 2257, which went into effect in September 2020 and amended certain portions of AB 5. AB 5 and AB 2257 are often referred to collectively simply as AB 5. AB 5 purports to codify the holding of the California Supreme Court&#x2019;s unanimous decision in Dynamex Operations West, Inc. v. Superior Court of Los Angeles, which introduced a new test for determining worker classification that is widely viewed as expanding the scope of employee relationships and narrowing the scope of independent contractor relationships. While AB 5 exempts certain licensed health care professionals, including physicians and psychologists, not all of our independent contractors work in exempt occupations. Given AB 5&#x2019;s recent passage, there is little guidance from the regulatory authorities charged with its enforcement and there is a significant degree of uncertainty regarding its application. In addition, AB 5 has been the subject</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">81</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">of widespread national discussion and it is possible that other jurisdictions might enact similar laws. As a result, there is significant uncertainty regarding what the state, federal and foreign worker classification regulatory landscape will look like in future years. The current economic climate indicates that the debate over worker classification will continue for the foreseeable future. If such regulatory authorities or state, federal or foreign courts were to determine that our services providers are employees and not independent contractors, we would, among other things, be required to withhold income taxes, to withhold and pay Social Security, Medicare and similar taxes, to pay unemployment and other related payroll taxes, and to provide certain employee benefits. We could also be liable for unpaid past taxes and other costs and subject to penalties. As a result, any determination that the service providers we characterize as independent contractors should be classified as employees could adversely impact our business, financial condition and results of operations.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We may be subject to applicable foreign, federal and state fraud and abuse, transparency, government price reporting, and other healthcare laws and regulations. If we are unable to comply, or have not fully complied, with such laws, we could face substantial penalties.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Healthcare providers and third-party payors will play a primary role in the recommendation and prescription of any future product candidates for which we obtain marketing approval. Our arrangements with third-party payors and customers may expose us to broadly applicable fraud and abuse and other healthcare laws and regulations that may affect the business or financial arrangements and relationships through which we conduct research and would market, sell and distribute our products. Even though we do not and will not control referrals of healthcare services or bill directly to Medicare, Medicaid or other third-party payors, federal and state healthcare laws and regulations pertaining to fraud and abuse and patients&#x2019; rights are and will be applicable to our business. The laws that may affect our ability to operate include, but are not limited to:</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the federal Anti-Kickback Statute, which prohibits, among other things, any person or entity from knowingly and willfully soliciting, receiving, offering or paying any remuneration, directly or indirectly, overtly or covertly, in cash or in kind, to induce or reward either the referral of an individual for, or the purchase, order or recommendation of an item or service reimbursable, in whole or in part, under a federal healthcare program, such as the Medicare and Medicaid programs. The term &#x201c;remuneration&#x201d; has been broadly interpreted to include anything of value. The federal Anti-Kickback Statute has also been interpreted to apply to arrangements between pharmaceutical manufacturers on the one hand and prescribers, purchasers, and formulary managers on the other the other hand. There are a number of statutory exceptions and regulatory safe harbors protecting some common activities from prosecution. Additionally, the intent standard under the federal Anti-Kickback Statute was amended by the Affordable Care Act such that a person or entity no longer needs to have actual knowledge of the statute or specific intent to violate it in order to have committed a violation. In addition, the Affordable Care Act codified case law that a claim including items or services resulting from a violation of the federal Anti-Kickback Statute constitutes a false or fraudulent claim for purposes of the federal False Claims Act, or FCA;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">federal civil and criminal false claims laws, such as the FCA which can be enforced by private citizens, on behalf of the government, through civil qui tam actions, and civil monetary penalty laws prohibits individuals or entities from, among other things, knowingly presenting, or causing to be presented, false, fictitious or fraudulent claims for payment or approval by the federal government, including federal health care programs, such as Medicare and Medicaid, and knowingly making, using or causing to be made or used a false record or statement material to a false or fraudulent claim, or knowingly making a false statement to improperly avoid, decrease or conceal an obligation to pay money to the federal government. In addition, a claim including items or services resulting from a violation of the federal Anti-Kickback Statute constitutes a false or fraudulent claim for purposes of the FCA. As a result of a modification made by the Fraud Enforcement and Recovery Act of 2009, a claim includes &#x201c;any request or demand&#x201d; for money or property presented to the U.S. government. In addition, manufacturers can be held liable under the FCA even when they do not submit claims directly to government payors if they are deemed to &#x201c;cause&#x201d; the submission of false or fraudulent claims. Criminal prosecution is also possible for making or presenting a false, fictitious or fraudulent claim to the federal government. Government enforcement agencies and private whistleblowers have investigated pharmaceutical companies for or asserted liability under the FCA for a variety of alleged promotional and marketing activities, such as providing free product to customers with the expectation that the customers would bill federal programs for the product, providing consulting fees and other benefits to physicians to induce them to prescribe products, engaging in promotion for &#x201c;off-label&#x201d; uses, and submitting inflated best price information to the Medicaid Rebate Program;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">HIPAA, among other things, imposes criminal and civil liability for executing or attempting to execute a scheme to defraud any healthcare benefit program, including private third-party payors, knowingly and willfully embezzling or stealing from a healthcare benefit program, willfully obstructing a criminal investigation of a healthcare offense, and knowingly and willfully falsifying, concealing or covering up a material fact or making any materially false, fictitious or fraudulent statement or representation, in connection with the delivery of or </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">82</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <div style="margin-left:4.528%;text-indent:0;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;visibility:hidden;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;"></span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">payment for healthcare benefits, items or services. Like the federal Anti-Kickback Statute, the Affordable Care Act amended the intent standard for certain healthcare fraud statutes under HIPAA such that a person or entity no longer needs to have actual knowledge of the statute or specific intent to violate it in order to have committed a violation;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">HIPAA, as amended by HITECH and their implementing regulations, which imposes privacy, security and breach reporting obligations with respect to individually identifiable health information upon entities subject to the law, such as health plans, healthcare clearinghouses and certain healthcare providers, known as covered entities, and their respective business associates and their subcontractors that perform services for them that involve individually identifiable health information. HITECH also created new tiers of civil monetary penalties, amended HIPAA to make civil and criminal penalties directly applicable to business associates, and gave state attorneys general new authority to file civil actions for damages or injunctions in U.S. federal courts to enforce the federal HIPAA laws and seek attorneys&#x2019; fees and costs associated with pursuing federal civil actions;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the U.S. federal Food, Drug and Cosmetic Act, which prohibits, among other things, the adulteration or misbranding of drugs, biologics and medical devices;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the Public Health Service Act, which prohibits, among other things, the introduction of a biological product into interstate commerce without an approved BLA;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">federal and state consumer protection and unfair competition laws, which broadly regulate marketplace activities and activities that potentially harm consumers;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the federal transparency requirements under the Physician Payments Sunshine Act, created under the Affordable Care Act, which requires, among other things, certain manufacturers of drugs, devices, biologics and medical supplies reimbursed under Medicare, Medicaid, or the Children&#x2019;s Health Insurance Program to annually report to the Centers for Medicare &amp; Medicaid Services information related to payments and other transfers of value provided to physicians, as defined by such law, other healthcare professionals (such as physician assistants and nurse practitioners), and teaching hospitals and physician ownership and investment interests, including such ownership and investment interests held by a physician&#x2019;s immediate family members;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">state and foreign law equivalents of each of the above federal laws, such as anti-kickback and false claims laws, that may impose similar or more prohibitive restrictions, and may apply to items or services reimbursed by any non-governmental third-party payors, including private insurers; and</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">state and foreign laws that require pharmaceutical companies to implement compliance programs and comply with the pharmaceutical industry&#x2019;s voluntary compliance guidelines and the relevant compliance guidance promulgated by the federal government; track and report gifts, compensation and other remuneration provided to physicians, other health care providers, and certain health care entities; report information related to drug pricing; and/or ensure the registration and compliance of sales personnel. In addition, we may be subject to federal, state and foreign laws that govern the privacy and security of health information or personally identifiable information in certain circumstances, including state health information privacy and data breach notification laws which govern the collection, use, disclosure, and protection of health-related and other personal information, many of which differ from each other in significant ways and often are not pre-empted by HIPAA, thus complicating compliance efforts.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We have entered into consulting and scientific advisory board arrangements with physicians and other healthcare providers, including some who could influence the use of EQ101, EQ102, itolizumab (EQ001) and any future product candidates, if approved. Because of the complex and far-reaching nature of these laws, regulatory agencies may view these transactions as prohibited arrangements that must be restructured, or discontinued, or for which we could be subject to other significant penalties. We could be adversely affected if regulatory agencies interpret our financial relationships with providers who may influence the ordering of and use of EQ101, EQ102, itolizumab (EQ001) or any future product candidates, if approved, to be in violation of applicable laws.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The scope and enforcement of each of these laws is uncertain and subject to rapid change in the current environment of healthcare reform. Federal and state enforcement bodies have recently increased their scrutiny of interactions between healthcare companies, healthcare providers and other third parties, including charitable foundations, which has led to a number of investigations, prosecutions, convictions and settlements in the healthcare industry. It is possible that governmental authorities may conclude that our business practices, including our consulting arrangements with physicians, some of whom receive stock options as compensation for services provided, do not comply with current or future statutes, regulations, agency guidance or case law involving applicable healthcare laws. Responding to investigations can be time and</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">83</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">resource-consuming and can divert management&#x2019;s attention from the business. Any such investigation or settlement could increase our costs or otherwise have an adverse effect on our business.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Ensuring that our business arrangements with third parties comply with applicable healthcare laws and regulations will likely be costly. If our operations are found to be in violation of any of these laws or any other current or future governmental laws and regulations that may apply to us, we may be subject to significant civil, criminal and administrative penalties, damages, fines, disgorgement, imprisonment, exclusion from government funded healthcare programs, such as Medicare and Medicaid, contractual damages, reputational harm, diminished profits and future earnings, additional reporting obligations and oversight if we become subject to a corporate integrity agreement or other agreement to resolve allegations of non-compliance with these laws, and the curtailment or restructuring of our operations, any of which could substantially disrupt our operations. If any of the physicians or other healthcare providers or entities with whom we expect to do business is found to be not in compliance with applicable laws, they may be subject to significant criminal, civil or administrative sanctions, including exclusions from government funded healthcare programs.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We are subject to certain U.S. and certain foreign anti-corruption, anti-money laundering, export control, sanctions, and other trade laws and regulations. We can face serious consequences for violations.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S. and foreign anti-corruption, anti-money laundering, export control, sanctions, and other trade laws and regulations, or collectively Trade Laws, prohibit, among other things, companies and their employees, agents, CROs, legal counsel, accountants, consultants, contractors, and other partners from authorizing, promising, offering, providing, soliciting, or receiving, directly or indirectly, corrupt or improper payments or anything else of value to or from recipients in the public or private sector. Violations of Trade Laws can result in substantial criminal fines and civil penalties, imprisonment, the loss of trade privileges, debarment, tax reassessments, breach of contract and fraud litigation, reputational harm, and other consequences. We have direct or indirect interactions with officials and employees of government agencies or government-affiliated hospitals, universities, and other organizations. We also expect our non-U.S. activities to increase over time. We expect to rely on contract service providers for research, preclinical studies, and clinical studies and/or to obtain necessary permits, licenses, patent registrations, and other marketing approvals. We can be held liable for the corrupt or other illegal activities of our personnel, agents, or partners, even if we do not explicitly authorize or have prior knowledge of such activities. Any violations of the laws and regulations described above may result in substantial civil and criminal fines and penalties, imprisonment, the loss of export or import privileges, debarment, tax reassessments, breach of contract and fraud litigation, reputational harm and other consequences.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Risks Related to Ownership of our Common Stock</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">The stock price of our common stock may be volatile or may decline regardless of our operating performance, and you could lose all or part of your investment.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The market price of our common stock may fluctuate significantly in response to numerous factors, many of which are beyond our control, including:</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our operating performance and the performance of other similar companies;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">delays or other adverse impacts to our clinical studies from global health epidemics or outbreaks, such as those related to COVID-19;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our ability to enroll and retain subjects in our ongoing and future clinical studies;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">results from our ongoing and future clinical studies with our current and future product candidates, and the results of the clinical studies of our competitors or of Biocon;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">adverse events observed in our clinical studies or in the clinical studies, exploratory studies, or other clinical uses of itolizumab supported by Biocon or third parties or during post-approval use of itolizumab;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the timing of data from our ongoing and planned clinical studies of EQ101, EQ102 and itolizumab (EQ001);</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">changes in our projected operating results that we provide to the public, our failure to meet these projections or changes in recommendations by securities analysts that elect to follow our common stock;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">regulatory or legal developments of ours, our competitors&#x2019; or Biocon&#x2019;s; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the level of expenses related to future product candidates or clinical development programs;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">changes in the structure of healthcare payment systems;</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">84</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our ability to achieve product development goals in the timeframe we announce;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">announcements of clinical study results, regulatory developments, acquisitions or mergers, strategic alliances or significant agreements by us, by our competitors, or by Biocon;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the success or failure of our efforts to acquire, license or develop additional product candidates;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">recruitment or departure of key personnel;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the economy as a whole and market conditions in our industry;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">trading activity by a limited number of stockholders who together beneficially own a substantial proportion of our outstanding common stock;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the size of our market float; and</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">any other factors discussed in this report.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, the stock markets have experienced extreme price and volume fluctuations, including as a result of the COVID-19 pandemic, bank failures and the conflict between Russia and Ukraine, that have affected and continue to affect the market prices of equity securities of many life sciences companies. Stock prices of many biopharmaceutical companies have fluctuated in a manner unrelated or disproportionate to the operating performance of those companies. In the past, stockholders have filed securities class action litigation following periods of market volatility. If we were to become involved in securities litigation, it could subject us to substantial costs, divert resources and the attention of management from our business and adversely affect our business.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Raising additional capital may cause dilution to our stockholders, restrict our operations or require us to relinquish rights to our technologies or product candidates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Until such time, if ever, as we can generate substantial product revenues, we expect to finance our cash needs through a combination of equity offerings, debt financings, collaboration and license agreements, such as our Asset Purchase Agreement with Ono. To the extent that we raise additional capital through the sale of equity or convertible debt securities, your ownership interest will be diluted and the terms of these securities may include liquidation or other preferences that adversely affect your rights as a common stockholder.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In March 2020, we entered into the Purchase Agreement with Lincoln Park which provides that, upon the terms and subject to the conditions and limitations set forth therein, we may sell to Lincoln Park up to $15.0 million of shares of our common stock, from time to time over the 36-month term of the Purchase Agreement, and we issued an additional 65,374 shares of our common stock to Lincoln Park as commitment shares under the Purchase Agreement. As of December 31, 2022 and as of the date of the filing of this Annual Report on Form 10-K, we have not sold any shares of our common stock to Lincoln Park under the Purchase Agreement. The Purchase Agreement will expire on May 1, 2023.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Debt financing, if available, may involve agreements that include covenants limiting or restricting our ability to take specific actions, such as incurring additional debt, making capital expenditures or declaring dividends. Subject to limited exceptions, our Loan Agreement also prohibits us from incurring indebtedness without the prior written consent of the lenders.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If we raise funds through collaboration and license agreements with third parties, such as our Asset Purchase Agreement with Ono, we may have to relinquish valuable rights to our technologies, future revenue streams, research programs or product candidates or grant licenses on terms that may not be favorable to us. If we are unable to raise additional funds through equity or debt financings when needed, we may be required to delay, limit, reduce or terminate our product development or future commercialization efforts or grant rights to develop and market product candidates that we would otherwise prefer to develop and market ourselves.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">If there are substantial sales of shares of our common stock, the price of our common stock could decline.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The price of our common stock could decline if there are substantial sales of our common stock, particularly sales by our directors, executive officers and significant stockholders, or if there is a large number of shares of our common stock available for sale and the market perceives that sales will occur. As of March 16, 2023, we had 34,414,149 shares of our common stock outstanding. Shares held by directors, executive officers and other affiliates will be subject to volume limitations under Rule 144 under the Securities Act. We have registered shares of common stock that we have issued and may issue under our employee equity incentive plans, which shares may be sold freely in the public market upon issuance. Sales of our common stock by current stockholders may make it more difficult for us to sell equity or equity-related securities</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">85</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">in the future at a time and price that we deem reasonable or appropriate, and make it more difficult for other stockholders to sell shares of our common stock.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The market price of the shares of our common stock could decline as a result of the sale of a substantial number of our shares of common stock in the public market or the perception in the market that the holders of a large number of shares intend to sell their shares. We are unable to predict the effect that sales may have on the prevailing market price of our common stock.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">The concentration of our stock ownership will likely limit your ability to influence corporate matters, including the ability to influence the outcome of director elections and other matters requiring stockholder approval.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our executive officers, directors and the holders of more than 5% of our outstanding common stock, in the aggregate, beneficially own a significant percentage of our common stock. As a result, these stockholders, acting together, will have significant influence over all matters that require approval by our stockholders, including the election of directors and approval of significant corporate transactions. Corporate actions might be taken even if other stockholders oppose them. This concentration of ownership might also have the effect of delaying or preventing a change of control of our company that other stockholders may view as beneficial.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Delaware law and provisions in our amended and restated certificate of incorporation and amended and restated bylaws could make a merger, tender offer or proxy contest difficult, thereby depressing the trading price of our common stock.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Provisions of our amended and restated certificate of incorporation and amended and restated bylaws may delay or discourage transactions involving an actual or potential change in our control or change in our management, including transactions in which stockholders might otherwise receive a premium for their shares or transactions that our stockholders might otherwise deem to be in their best interests. Therefore, these provisions could adversely affect the price of our common stock. Among other things, our amended and restated certificate of incorporation and amended and restated bylaws:</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">permit our board of directors to issue up to 10,000,000 shares of preferred stock, with any rights, preferences and privileges as they may designate (including the right to approve an acquisition or other change in our control);</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">provide that the authorized number of directors may be changed only by resolution of the board of directors;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">provide that the board of directors or any individual director may only be removed with cause and the affirmative vote of the holders of at least 66-2/3% of the voting power of all of our then outstanding common stock;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">provide that all vacancies, including newly created directorships, may, except as otherwise required by law, be filled by the affirmative vote of a majority of directors then in office, even if less than a quorum;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">divide our board of directors into three classes;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">require that any action to be taken by our stockholders must be effected at a duly called annual or special meeting of stockholders and not be taken by written consent;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">provide that stockholders seeking to present proposals before a meeting of stockholders or to nominate candidates for election as directors at a meeting of stockholders must provide notice in writing in a timely manner and also specify requirements as to the form and content of a stockholder&#x2019;s notice;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">do not provide for cumulative voting rights (therefore allowing the holders of a majority of the shares of common stock entitled to vote in any election of directors to elect all of the directors standing for election, if they should so choose);</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">provide that special meetings of our stockholders may be called only by the chairman of the board, our Chief Executive Officer or by the board of directors pursuant to a resolution adopted by a majority of the total number of authorized directors; and</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">provide that the Court of Chancery of the State of Delaware will be the sole and exclusive forum for the following types of actions or proceedings under Delaware statutory or common law; (i) any derivative action or proceeding brought on our behalf, (ii) any action asserting a claim of breach of a fiduciary duty owed by any of our directors or officers to us or our stockholders, (iii) any action asserting a claim against us arising pursuant to any provision of the Delaware General Corporation Law or our certificate of incorporation or bylaws, or (iv) any action asserting a claim against us governed by the internal affairs doctrine. These provisions would not apply to suits brought to enforce a duty or liability created by the Exchange Act. Furthermore, Section 22 of the Securities Act creates concurrent jurisdiction for federal and state courts over all such Securities Act actions. Accordingly, both state and federal courts have jurisdiction to entertain such claims.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">86</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The amendment of any of these provisions, with the exception of the ability of our board of directors to issue shares of preferred stock and designate any rights, preferences and privileges thereto, would require approval by the holders of at least 66-2/3% of our then-outstanding common stock. In addition, as a Delaware corporation, we are subject to Section 203 of the Delaware General Corporation Law. These provisions may prohibit large stockholders, in particular those owning 15% or more of our outstanding voting stock, from merging or combining with us for a certain period of time. A Delaware corporation may opt out of this provision by express provision in its original certificate of incorporation or by amendment to its certificate of incorporation or bylaws approved by its stockholders. However, we have not opted out of this provision.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">These and other provisions in our amended and restated certificate of incorporation, amended and restated bylaws and Delaware law could make it more difficult for stockholders or potential acquirors to obtain control of our board of directors or initiate actions that are opposed by our then-current board of directors, including delay or impede a merger, tender offer or proxy contest involving our company. The existence of these provisions could negatively affect the price of our common stock and limit opportunities for you to realize value in a corporate transaction.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Our amended and restated certificate of incorporation provides that the Court of Chancery of the State of Delaware and the federal district courts of the United States of America will be the exclusive forums for substantially all disputes between us and our stockholders, which could limit our stockholders&#x2019; ability to obtain a favorable judicial forum for disputes with us or our directors, officers, or employees.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our amended and restated certificate of incorporation provides that the Court of Chancery of the State of Delaware is the exclusive forum for the following types of actions or proceedings under Delaware statutory or common law:</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">any derivative action or proceeding brought on our behalf;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">any action asserting a breach of fiduciary duty;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">any action asserting a claim against us arising under the Delaware General Corporation Law, our amended and restated certificate of incorporation, or our amended and restated bylaws; and </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">any action asserting a claim against us that is governed by the internal-affairs doctrine.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">This provision would not apply to suits brought to enforce a duty or liability created by the Exchange Act. Furthermore, Section 22 of the Securities Act creates concurrent jurisdiction for federal and state courts over all such Securities Act actions. Accordingly, both state and federal courts have jurisdiction to entertain such claims. To prevent having to litigate claims in multiple jurisdictions and the threat of inconsistent or contrary rulings by different courts, among other considerations, our amended and restated certificate of incorporation further provides that the federal district courts of the United States of America will be the exclusive forum for resolving any complaint asserting a cause of action arising under the Securities Act. While the Delaware courts have determined that such choice of forum provisions are facially valid and several state study courts have enforced such provisions and required that suits asserting Securities Act claims be filed in federal court, there is no guarantee that courts of appeal will affirm the enforceability of such provisions and a stockholder may nevertheless seek to bring a claim in a venue other than those designated in the exclusive forum provisions. In such instance, we would expect to vigorously assert the validity and enforceability of the exclusive forum provisions of our amended and restated certificate of incorporation. This may require significant additional costs associated with resolving such action in other jurisdictions and there can be no assurance that the provisions will be enforced by a court in those other jurisdictions. If a court were to find either exclusive forum provision in our amended and restated certificate of incorporation to be inapplicable or unenforceable in an action, we may incur further significant additional costs associated with litigating Securities Act claims in state court, or both state and federal court, which could seriously harm our business, financial condition, results of operations, and prospects.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">These exclusive forum provisions may limit a stockholder&#x2019;s ability to bring a claim in a judicial forum that it finds favorable for disputes with us or our directors, officers, or other employees, which may discourage lawsuits against us and our directors, officers and other employees. If a court were to find either exclusive-forum provision in our amended and restated certificate of incorporation to be inapplicable or unenforceable in an action, we may incur further significant additional costs associated with resolving the dispute in other jurisdictions, all of which could seriously harm our business.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">87</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">General Risk Factors</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">As a public company in the United States, we incur significant legal and financial compliance costs and we are subject to the Sarbanes-Oxley Act. We can provide no assurance that we will, at all times, in the future be able to report that our internal controls over financial reporting are effective.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Companies that file reports with the SEC, including us, are subject to the requirements of Section 404 of the Sarbanes-Oxley Act of 2002. Section 404 requires management to establish and maintain a system of internal control over financial reporting, and annual reports on Form 10-K filed under the Securities Exchange Act of 1934, as amended, or the Exchange Act, must contain a report from management assessing the effectiveness of a company&#x2019;s internal control over financial reporting. Ensuring that we have adequate internal financial and accounting controls and procedures in place to produce accurate financial statements on a timely basis remains a costly and time-consuming effort that needs to be re-evaluated frequently. Failure on our part to have effective internal financial and accounting controls would cause our financial reporting to be unreliable, could have a material adverse effect on our business, operating results, and financial condition, and could cause our stock price to decline as a result.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If we cannot conclude that we have effective internal control over our financial reporting, or if our independent registered public accounting firm is unable to provide an unqualified opinion regarding the effectiveness of our internal control over financial reporting, investors could lose confidence in the reliability of our financial statements. Failure to comply with reporting requirements could also subject us to sanctions and/or investigations by the SEC, The Nasdaq Global Market or other regulatory authorities.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Furthermore, stockholder activism, the current political environment and the current high level of government intervention and regulatory reform may lead to substantial new regulations and disclosure obligations, which may lead to additional compliance costs and impact the manner in which we operate our business in ways we cannot currently anticipate. Our management and other personnel will need to devote a substantial amount of time to these compliance initiatives. Moreover, any new regulations or disclosure obligations may increase our legal and financial compliance costs and will make some activities more time-consuming and costly.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We or the parties upon whom we depend on may be adversely affected by earthquakes, fires, other natural disasters, or other sudden, unforeseen and severe adverse events, including public health events, and our business continuity and disaster recovery plans may not adequately protect us from a serious disaster.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our headquarters and main research facility are located in the Greater San Diego Area, which in the past has experienced severe earthquakes and fires. If these earthquakes, fires, other natural disasters, terrorism and similar unforeseen events beyond our control prevented us from using all or a significant portion of our headquarters or research facility, it may be difficult or, in certain cases, impossible for us to continue our business for a substantial period of time. We do not have a disaster recovery or business continuity plan in place and may incur substantial expenses as a result of the absence or limited nature of our internal or third party service provider disaster recovery and business continuity plans, which, particularly when taken together with our lack of earthquake insurance, could have a material adverse effect on our business. Furthermore, integral parties in our supply chain are operating from single sites, increasing their vulnerability to natural disasters or other sudden, unforeseen and severe adverse events, including public health events such as the COVID-19 pandemic that could impact our business. If such an event were to affect our supply chain, it could have a material adverse effect on our ability to conduct our clinical studies, our development plans and business. For example, in March 2020, due to the spread of the coronavirus, the Indian government restricted the export of 26 active pharmaceutical ingredients and the medicines made from them. These export restrictions are indefinite and may be expanded. If the export restrictions are expanded to include itolizumab (EQ001), our supply of itolizumab (EQ001) may be disrupted, delayed or stopped indefinitely and our ability to continue development of itolizumab (EQ001), including our ongoing clinical studies, may be significantly impacted and may result in higher costs of drug product and adversely harm our business.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Changes in patent law in the United States and other jurisdictions could diminish the value of patents in general, thereby impairing our ability to protect our product candidates.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As is the case with other biopharmaceutical companies, our success is heavily dependent on intellectual property, particularly patents relating to our research programs and product candidates. Obtaining and enforcing patents in the biopharmaceutical industry involves both technological and legal complexity and is therefore costly, time consuming and inherently uncertain. Changes in either the patent laws or interpretation of the patent laws in the United States or USPTO rules and regulations could increase the uncertainties and costs. Recent patent reform legislation in the United States and other countries, including the Leahy-Smith America Invents Act, or the Leahy-Smith Act, signed into law on September 16, 2011, could increase those</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">88</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">uncertainties and costs surrounding the prosecution of our patent applications and the enforcement or defense of our issued patents. The Leahy-Smith Act includes a number of significant changes to U.S. patent law. These include provisions that affect the way patent applications are prosecuted, redefine prior art and provide more efficient and cost-effective avenues for competitors to challenge the validity of patents. These include allowing third-party submission of prior art to the USPTO during patent prosecution and additional procedures to attack the validity of a patent by USPTO administered post-grant proceedings, including post-grant review, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">inter partes </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">review, and derivation proceedings. After March 2013, under the Leahy-Smith Act, the United States transitioned to a first inventor to file system in which, assuming that the other statutory requirements are met, the first inventor to file a patent application will be entitled to the patent on an invention regardless of whether a third party was the first to invent the claimed invention. However, the Leahy-Smith Act and its implementation could increase the uncertainties and costs surrounding the prosecution of our patent applications, our ability to obtain future patents, and the enforcement or defense of our issued patents, all of which could have a material adverse effect on our business, financial condition, results of operations and prospects.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The U.S. Supreme Court has ruled on several patent cases in recent years, either narrowing the scope of patent protection available in certain circumstances or weakening the rights of patent owners in certain situations. Depending on future actions by the U.S. Congress, the U.S. courts, the USPTO and the relevant law-making bodies in other countries, the laws and regulations governing patents could change in unpredictable ways that would weaken our ability to obtain new patents or to enforce our existing patents and patents that we might obtain in the future.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Product liability lawsuits against us could cause us to incur substantial liabilities and could limit our commercialization of any product candidates that we may develop.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We face an inherent risk of product liability exposure related to the testing of EQ101, EQ102, itolizumab (EQ001) and any future product candidates in human clinical studies and will face an even greater risk if we commercially sell any products that we may develop. If we cannot successfully defend ourselves against claims that EQ101, EQ102, itolizumab (EQ001) or any future product candidates or products caused injuries, we could incur substantial liabilities. Regardless of merit or eventual outcome, product liability claims may result in:</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">delay or termination of clinical studies;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">decreased demand for any product candidates or products that we may develop;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">injury to our reputation and significant negative media attention;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">withdrawal of clinical study subjects;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">initiation of investigations by regulators;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">significant costs to defend the related litigation and diversion of management&#x2019;s time and our resources;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">substantial monetary awards to clinical study subjects or patients;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">product recalls, withdrawals or labeling, or marketing or promotional restrictions;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">loss of revenue; and</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the inability to commercialize any products that we may develop.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We currently have product liability insurance. However, the amount of insurance may not be adequate to cover all liabilities that we may incur. We anticipate that we will need to increase our insurance coverage as EQ101, EQ102, itolizumab (EQ001) and any future product candidates advance through clinical studies and if we successfully commercialize any products. Insurance coverage is increasingly expensive. We may not be able to maintain insurance coverage at a reasonable cost or in an amount adequate to satisfy any liability that may arise.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Changes in tax laws or regulations that are applied adversely to us or our customers may have a material adverse effect on our business, cash flow, financial condition or results of operations.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">New income, sales, use or other tax laws, statutes, rules, regulations or ordinances could be enacted at any time, which could affect the tax treatment of our domestic and foreign earnings. Any new taxes could adversely affect our domestic and international business operations, and our business and financial performance. Further, existing tax laws, statutes, rules, regulations or ordinances could be interpreted, changed, modified or applied adversely to us. For example, on December 22, 2017, U.S. federal income tax legislation was signed into law (H.R. 1, &#x201c;An Act to provide for reconciliation pursuant to titles II and V of the concurrent resolution on the budget for fiscal year 2018&#x201d;), informally titled the Tax Cuts and Jobs Act, that</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">89</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">significantly revised the IRC. Future guidance from the Internal Revenue Service and other tax authorities with respect to the Tax Cuts and Jobs Act may affect us, and certain aspects of the Tax Cuts and Jobs Act could be repealed or modified in future legislation.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Effective January 1, 2022, the Tax Cuts and Jobs Act modified Internal Revenue Code Section 174 to require taxpayers&#x2019; U.S. based and non-U.S. based R&amp;E expenditures to be capitalized and amortized over a period of five or fifteen years, respectively. Prior to the Tax Cuts and Job Act amendment, Section 174 allowed taxpayers to either immediately deduct R&amp;E expenditures in the year paid or incurred, or elect to capitalize and amortize over a period of at least 60 months. Unless the United States Department of the Treasury issues regulations that narrow the application of this provision to a smaller subset of our research and development expenses or the provision is deferred, modified, or repealed by Congress, it could harm our future operating results by effectively increasing our future tax obligations. The actual impact of this provision will depend on multiple factors, including the amount of research and development expenses we will incur, whether we achieve sufficient income to fully utilize such deductions and whether we conduct our research and development activities inside or outside the United States.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Legislation enacted on March 27, 2020, entitled the Coronavirus Aid, Relief, and Economic Security Act, or the CARES Act, modified certain provisions of the Tax Cuts and Jobs Act. In addition, the recently enacted IRA includes provisions that will impact the U.S. federal income taxation of corporations, including imposing a minimum tax on the book income of certain large corporations and an excise tax on certain corporate stock repurchases that would be imposed on the corporation repurchasing such stock. It is uncertain if and to what extent various states will conform to the Tax Cuts and Jobs Act, the CARES Act or the IRA. We do not expect the Tax Cuts and Jobs Act or the CARES Act to have a material impact on our current projection of minimal cash taxes for the near future. However, we continue to examine the impact that the Tax Cuts and Jobs Act, the CARES Act and the IRA may have on our business in the longer term. We urge prospective investors to consult with their legal and tax advisors with respect to this legislation and the potential tax consequences of investing in or holding our common stock.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">If we fail to comply with environmental, health and safety laws and regulations, we could become subject to fines or penalties or incur costs that could have a material adverse effect on the success of our business.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We, and the third parties with whom we share our facilities, are subject to numerous environmental, health and safety laws and regulations, including those governing laboratory procedures and the handling, use, storage, treatment and disposal of hazardous materials and wastes. Each of our operations involve the use of hazardous and flammable materials, including chemicals and biological and radioactive materials. Each of our operations also produce hazardous waste products. We generally contract with third parties for the disposal of these materials and wastes. We cannot eliminate the risk of contamination or injury from these materials. We could be held liable for any resulting damages in the event of contamination or injury resulting from the use of hazardous materials by us or the third parties with whom we share our facilities, and any liability could exceed our resources. We also could incur significant costs associated with civil or criminal fines and penalties.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Although we maintain workers&#x2019; compensation insurance to cover us for costs and expenses we may incur due to injuries to our employees resulting from the use of hazardous materials, this insurance may not provide adequate coverage against potential liabilities. We do not maintain insurance for environmental liability or toxic tort claims that may be asserted against us in connection with our storage or disposal of biological, hazardous or radioactive materials.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, we may incur substantial costs in order to comply with current or future environmental, health and safety laws and regulations. These current or future laws and regulations may impair our research and development. Failure to comply with these laws and regulations also may result in substantial fines, penalties or other sanctions.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">If securities or industry analysts do not publish research or publish inaccurate or unfavorable research about our business, our stock price and trading volume could decline.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The trading market for our common stock will depend in part on the research and reports that securities or industry analysts publish about us or our business. If one or more of the analysts who cover us downgrade our common stock or publish inaccurate or unfavorable research about our business, our common stock price would likely decline. If one or more of these analysts cease coverage of us or fail to publish reports on us regularly, demand for our common stock could decrease, which might cause our common stock price and trading volume to decline.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">90</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Our disclosure controls and procedures may not prevent or detect all errors or acts of fraud.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are subject to the periodic reporting requirements of the Exchange Act. We designed our disclosure controls and procedures to reasonably assure that information we must disclose in reports we file or submit under the Exchange Act is accumulated and communicated to management, and recorded, processed, summarized and reported within the time periods specified in the rules and forms of the SEC.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We believe that any disclosure controls and procedures or internal controls and procedures, no matter how well-conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">These inherent limitations include the realities that judgments in decision-making can be faulty, and that breakdowns can occur because of simple error or mistake. For example, our directors or executive officers could inadvertently fail to disclose a new relationship or arrangement causing us to fail to make any related party transaction disclosures. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people or by an unauthorized override of the controls. Accordingly, because of the inherent limitations in our control system, misstatements due to error or fraud may occur and not be detected. In addition, we do not have a risk management program or processes or procedures for identifying and addressing risks to our business in other areas.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We are an &#x201c;emerging growth company,&#x201d; and we cannot be certain if the reduced reporting requirements applicable to emerging growth companies will make our common stock less attractive to investors.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are an &#x201c;emerging growth company&#x201d; as defined in the Jumpstart Our Business Startups Act of 2012, as amended, or JOBS Act, and we intend to take advantage of some of the exemptions from reporting requirements that are applicable to other public companies that are not emerging growth companies, including:</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">being permitted to provide only two years of audited financial statements, in addition to any required unaudited interim financial statements, with correspondingly reduced &#x201c;Management&#x2019;s Discussion and Analysis of Financial Condition and Results of Operations&#x201d; disclosure;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">not being required to comply with the auditor attestation requirements in the assessment of our internal control over financial reporting;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">not being required to comply with any requirement that may be adopted by the Public Company Accounting Oversight Board regarding mandatory audit firm rotation or a supplement to the auditor&#x2019;s report providing additional information about the audit and the financial statements;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">reduced disclosure obligations regarding executive compensation; and</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">not being required to hold a non-binding advisory vote on executive compensation or obtain stockholder approval of any golden parachute payments not previously approved.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, as an &#x201c;emerging growth company&#x201d; the JOBS Act allows us to delay adoption of new or revised accounting pronouncements applicable to public companies until such pronouncements are made applicable to private companies. We have elected to use this extended transition period under the JOBS Act.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We cannot predict if investors will find our common stock less attractive because we will rely on these exemptions. If some investors find our common stock less attractive as a result, there may be a less active trading market for our common stock and our stock price may be more volatile. We may take advantage of these reporting exemptions until we are no longer an emerging growth company. We will remain an emerging growth company until the earlier of (1) the last day of the fiscal year (a) following the fifth anniversary of our initial public offering (i.e. December 31, 2023), (b) in which we have total annual gross revenue of at least $1.235 billion or (c) in which we are deemed to be a large accelerated filer, which means the market value of our common stock that is held by non-affiliates exceeds $700 million as of the prior June 30th and (2) the date on which we have issued more than $1.0 billion in non-convertible debt during the prior three-year period.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We do not intend to pay dividends for the foreseeable future.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We have never declared nor paid cash dividends on our capital stock. We currently intend to retain any future earnings to finance the operation and expansion of our business, and we do not expect to declare or pay any dividends in the foreseeable future, including due to limitations that are currently imposed by our Loan Agreement. In addition, the terms of any future debt agreements may preclude us from paying dividends. Consequently, stockholders must rely on sales of their common stock after price appreciation, which may never occur, as the only way to realize any future gains on their investment.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">91</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We could be subject to securities class action litigation.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In the past, securities class action litigation has often been brought against a company following a decline in the market price of its securities. This risk is especially relevant for us because biopharmaceutical companies have experienced significant stock price volatility in recent years. If we face such litigation, it could result in substantial costs and a diversion of management&#x2019;s attention and resources, which could harm our business.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_1b_unresolved_staff_comments"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 1B. Unresolved</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> Staff Comments.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">None.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_2_properties"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 2. Properties.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We lease approximately 1,750 square feet of space for our current headquarters in La Jolla, California under a lease that expires in February 2027. We also lease additional office and laboratory spaces in La Jolla, California, under leases with various expiration dates, with the latest extending through February 2027. We had been leasing office space in South San Francisco, California which expired at the end of February 2023 and was not renewed.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We believe that our existing facilities are adequate to meet our current needs, and that suitable additional alternative spaces will be available in the future on commercially reasonable terms.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_3_legal_proceedings"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 3. Legal </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Proceedings.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">None.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_4_mine_safety_disclosures"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 4. Mine Saf</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ety Disclosures.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Not applicable.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">92</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;" id="part_ii"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">PART</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> II</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_5_market_for_registrants_common_equ"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 5. Market for Registrant&#x2019;s Common Equity, Related Stock</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">holder Matters and Issuer Purchases of Equity Securities.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Market Information</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our common stock began trading on the Nasdaq Global Market under the symbol &#x201c;EQ&#x201d; on October 12, 2018. Prior to that date, there was no public trading market for our common stock.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Holders of Record</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of March 16, 2023, there were approximately 46 stockholders of record of our common stock. The actual number of stockholders is greater than this number of record holders and includes stockholders who are beneficial owners but whose shares are held in street name by brokers and other nominees. This number of holders of record also does not include stockholders whose shares may be held in trust or by other entities.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Dividend Policy</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We have never declared or paid cash dividends on our capital stock. We currently intend to retain all available funds and any future earnings for use in the operation of our business and do not anticipate paying any dividends on our common stock in the foreseeable future, including due to limitations that are currently imposed by our Loan Agreement. Any future determination to declare dividends will be made at the discretion of our board of directors and will depend on, among other factors, our financial condition, operating results, capital requirements, contractual restrictions, general business conditions and other factors that our board of directors may deem relevant.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Securities Authorized for Issuance Under Our Equity Compensation Plans</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Information about our equity compensation plans will be included in our definitive proxy statement to be filed with the SEC with respect to our 2023 Annual Meeting of Stockholders and is incorporated herein by reference.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Recent Sales of Unregistered Securities</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">None.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Purchases of Equity Securities by the Issuer and Affiliated Purchasers</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">None.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item6_reserved"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 6. [</span><span id="item_6_selected_financial_data"></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">R</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">eserved]</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">93</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_7_managements_discussion_analysis_f"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 7. Management&#x2019;s Discussion and Analysis of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Financial Condition and Results of Operations.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">You should read the following discussion and analysis of our financial condition and results of operations together with the section entitled &#x201c;Selected Financial Data&#x201d; and our consolidated financial statements and related notes appearing elsewhere in this Annual Report on Form 10-K. This discussion and analysis contain forward-looking statements based upon current expectations that involve risks and uncertainties. Our actual results may differ materially from those anticipated in these forward-looking statements as a result of various factors, including those discussed in the section entitled &#x201c;Risk Factors&#x201d; and in other parts of this Annual Report on Form 10-K. Please also see the section entitled &#x201c;Special Note Regarding Forward-Looking Statements.&#x201d;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Overview</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are a clinical-stage biotechnology company leveraging a deep understanding of immunobiology to develop novel therapeutics to treat severe autoimmune and inflammatory, or immuno-inflammatory, disorders with high unmet medical need. Our strategy is focused on advancing the clinical development of our product candidates, including potentially pursuing additional indications and acquiring new product candidates and platforms to expand our pipeline. We intend to commercialize our product candidates either independently or through partnerships or otherwise monetize our pipeline through strategic transactions.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our current clinical-stage product candidates consist of EQ101, EQ102 and itolizumab (EQ001). EQ101 and EQ102 are synthetic peptides engineered to specifically inhibit key disease-driving, clinically validated cytokine targets aimed at addressing unmet needs across a range of immuno-inflammatory indications. EQ101 is a first-in class, selective, tri-specific inhibitor of IL-2, IL-9 and IL-15, and EQ102 is a first-in class, selective, bi-specific inhibitor of IL-15 and IL-21. Itolizumab (EQ001) is a first-in-class monoclonal antibody that selectively targets the immune checkpoint receptor CD6, which plays a central role in the modulation of effector T cell, or T</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:sub;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">eff</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> cell, activity and trafficking that drives a number of immuno-inflammatory diseases across multiple therapeutic areas. Our novel and differentiated pipeline of first-in-class immunology assets has the potential to address unmet medical needs in numerous areas, including dermatology, gastroenterology, transplant science, hematology, rheumatology, oncology and pulmonology.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We acquired the exclusive worldwide rights to EQ101 and EQ102 through the acquisition of Bioniz in February 2022. Through the acquisition we expanded our immunology pipeline with first-in-class immuno-inflammatory product candidates across a range of development stages and obtained a proprietary platform for discovering additional, novel multi-cytokine targeting product candidates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On December 5, 2022, we entered into the Asset Purchase Agreement with Ono pursuant to which we granted Ono an exclusive option to acquire our rights to itolizumab (EQ001) or the Option. These rights include all therapeutic indications and the rights to commercialize itolizumab (EQ001) in the United States, Canada, Australia, and New Zealand. In exchange for the Option, Ono paid us a one-time, upfront payment of an amount equal to JPY 3.5 billion, or $26.4 million.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If Ono exercises the Option, Ono will pay us a one-time, payment of an amount equal to JPY 5.0 billion, or approximately $37.2 million based on the currency exchange rate quoted by MUFG Bank, Ltd on March 16, 2023. We are also eligible to receive up to $101.4 million upon the achievement of certain development and commercialization milestones.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pursuant to the Asset Purchase Agreement, we are responsible for conducting all research and development of itolizumab (EQ001), which will be funded by Ono on a quarterly basis from July 1, 2022 through the option period. Unless terminated early, the option period will expire three months following the delivery of topline data from the EQUALISE clinical study in LN and interim data from the EQUATOR Phase 3 clinical study in aGVHD.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Asset Purchase Agreement can be terminated at any time by Ono upon written notice, provided that in limited circumstances Ono will be obligated to continue to reimburse us for research and development costs and expenses of itolizumab (EQ001) for a certain period of time following such termination. If Ono does not timely exercise its Option, the Asset Purchase Agreement and the Option will automatically terminate. The Asset Purchase Agreement also contains customary termination rights for both parties for material breach and an outside date (subject to limited adjustments) that permits either party to terminate the Asset Purchase Agreement if the closing has not occurred by December 31, 2025.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are focused on developing EQ101, EQ102 and itolizumab (EQ001) as potential best-in-class, disease modifying treatments for multiple severe immuno-inflammatory disorders and currently have active clinical development programs with all three assets.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">94</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In March 2022, we initiated EQUATOR, a global Phase 3 pivotal clinical study of itolizumab (EQ001) in 200 patients with aGVHD. The decision to initiate the EQUATOR study was based on findings from our completed Phase 1b clinical study in aGVHD, called EQUATE, and feedback from both the FDA and leading physicians in the field of hematopoietic stem cell transplantation.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In September 2022, we initiated a Phase 1 first-in-human clinical study of EQ102 administered SC in up to 64 healthy volunteers in Australia. We are planning an additional part to the study which will evaluate the biological activity of EQ102 in subjects with celiac disease.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In November 2022, we initiated a Phase 2 proof-of-concept clinical study of EQ101 that is expected to enroll approximately 30 subjects with alopecia areata in Australia.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are conducting the Type B portion of EQUALISE, a Phase 1b proof-of-concept clinical study of itolizumab (EQ001) in patients with lupus/LN. The ongoing Type B portion of the study will evaluate up to 20 newly diagnosed or refractory LN patients who will be treated with itolizumab (EQ001) for up to 24 weeks. The Type A portion of the study has been completed, and was a MAD study involving 35 SLE patients to evaluate the safety, tolerability, PK/PD and clinical activity of itolizumab (EQ001) administered SC.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are also collaborating with Biocon and co-funding a Phase 2 clinical study of itolizumab in subjects with ulcerative colitis. The study, which is being conducted by Biocon in India and commenced in November 2022, is a randomized, double-blinded, placebo-controlled clinical study in up to 30 subjects to evaluate the safety and efficacy of itolizumab in patients with moderate to severe ulcerative colitis.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We have a proprietary product discovery platform that we can leverage to design novel peptides to target and inhibit multiple cytokines that are involved in validated biological and disease pathways. We also have ongoing translational biology programs to assess the therapeutic utility of our product candidates in additional indications where the mechanism of action is believed to play an important role in the pathogenesis of a particular disease. Our selection of current and future indications is driven by our analysis of the scientific, translational, clinical and commercial rationale for advancing our product candidates into further development.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Since our inception, substantially all of our efforts have been focused on organizing and staffing our company, business planning, raising capital, in-licensing rights to itolizumab (EQ001), conducting non-clinical research, filing three INDs, conducting clinical development of our product candidates, conducting business development activities such as the acquisition of Bioniz, the Asset Purchase Agreement with Ono and other transactions not completed, and the general and administrative activities associated with operating a public company. Furthermore, in connection with the acquisition of Bioniz, we expanded our pipeline from one product candidate to three product candidates, all at various stages of development. This expansion may accelerate the rate at which our operating losses increase as we incur costs to further the development and seek regulatory approval for these product candidates. In 2022, we generated revenue from the Asset Purchase Agreement related to the one-time, upfront payment from Ono in exchange for the Option as well as from the itolizumab (EQ001) development funding from Ono. We have not generated any revenue from product sales, milestone payments or royalties. Since inception, we have primarily financed our operations through our initial public offering, or IPO, a follow-on public offering, a registered direct offering, private placements of convertible promissory notes, term loans and sales of our common stock through &#x201c;at-the-market&#x201d; sales agreements, or ATM offerings, with Jefferies LLC, or Jefferies, and revenue generated from the Asset Purchase Agreement.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We have incurred losses since our inception. For the years ended December 31, 2022 and 2021, our net losses were $62.4 million and $39.1 million, respectively. As of December 31, 2022, we had an accumulated deficit of $172.4 million. Substantially all of our operating losses resulted from expenses incurred in connection with our research and development activities, non-clinical and clinical activities and general and administrative costs associated with our operations.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We expect to continue to incur significant expenses and increasing losses into the foreseeable future. We anticipate our expenses will increase substantially as we advance our research and development activities, including the ongoing and future clinical development of EQ101, EQ102 and itolizumab (EQ001), potentially expand the indications in which we conduct clinical development of our product candidates, potentially acquire additional products and/or product candidates, seek regulatory approval for and potentially commercialize any approved product candidates, hire additional personnel, protect our intellectual property, incur increasing expenses associated with our outstanding debt, and incur general corporate costs. We expect that our existing cash, cash equivalents and short-term investments as of December 31, 2022 will enable us to fund our operations into 2025.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">95</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We do not expect to generate any revenues from product sales unless and until we successfully complete development and obtain regulatory approval for EQ101, EQ102, or any future product candidate, which is unlikely to happen within the next 12 months, if ever. Further, under the Asset Purchase Agreement with Ono, our revenues related to itolizumab (EQ001) are limited to the upfront option fee already received, reimbursement of our development costs of itolizumab (EQ001) during the option period, and the potential option exercise fee and potential milestone payments. If Ono does not exercise its Option, we would not expect to generate any revenues from product sales of itolizumab (EQ001) unless and until we successfully complete development and obtain regulatory approval for itolizumab (EQ001), which is unlikely to happen within the next 12 months, if ever. Accordingly, until such time as we can generate significant revenue from sales of our product candidates, if ever, we expect to finance our cash needs through a combination of equity offerings, debt financings, and collaboration and license agreements, such as our Asset Purchase Agreement with Ono. However, we may not be able to secure additional financing or enter into such other arrangements in a timely manner or on favorable terms, if at all. As a result of the conflict between Russia and Ukraine, bank failures, inflationary pressures on the economy and monetary policy responses by government agencies and other macroeconomic factors, the global credit and financial markets have experienced extreme volatility, including diminished liquidity and credit availability, declines in consumer confidence, declines in economic growth and uncertainty about economic stability. There can be no assurance that further deterioration in credit and financial markets and confidence in economic conditions will not occur. If equity and credit markets deteriorate, it may make any necessary debt or equity financing more difficult to obtain, more costly and/or more dilutive. In addition, subject to limited exceptions, our loan and security agreement with Oxford Finance LLC and SVB also prohibits us from incurring indebtedness without the prior written consent of the lenders, which consent may be withheld at their sole and absolute discretion. On March 10, 2023, </span><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the FDIC took control and was appointed receiver of SVB. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">At the time the FDIC took control, we held assets valued at approximately $8.2 million in a sweep account with SVB. We received full access to those funds on March 13, 2023. As of the date of the filing of this Annual Report on Form 10-K, we have full access to and control over all of our cash, cash equivalents and short-term investments. In addition, because a substantial majority of our cash, cash equivalents and short-term investments are held at a financial institution unaffiliated with SVB, we do not expect any material impact to our operations directly related to the closure of SVB, but we may in the future be adversely impacted, including having to repay all outstanding amounts owed under the Loan Agreement or in receiving timely consent to incur additional indebtedness. Our failure to raise capital or enter into such other arrangements when needed would have a negative impact on our financial condition and could force us to delay, reduce or terminate our research and development programs or other operations, or grant rights to develop and market product candidates that we would otherwise prefer to develop and market ourselves.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Financial Overview</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Revenue</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">To date, we have not generated any revenues from therapeutic product sales, developmental milestones or royalties. In 2022, our revenues were derived from an upfront payment under the Asset Purchase Agreement as well as from development funding from Ono. In the future, we may generate revenue from collaboration or license agreements we may enter into with respect to our product candidates, including further revenue such as development funding and potential option exercise and milestone payments from the Asset Purchase Agreement, as well as product sales from any approved product, which approval is unlikely to happen within the next 12 months, if ever. Our ability to generate product revenues will depend on the successful development and eventual commercialization of EQ101, EQ102, itolizumab (EQ001) if Ono does not exercise its option, and any future product candidates. If we fail to complete the development of EQ101, EQ102, itolizumab (EQ001) or any future product candidates in a timely manner, or to obtain regulatory approval for our product candidates, our ability to generate future revenue and our results of operations and financial position would be materially adversely affected.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Asset Purchase Agreement with Ono Pharmaceutical Co., Ltd.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On December 5, 2022, we entered into the Asset Purchase Agreement pursuant to which we granted Ono the Option in exchange for a one-time,  upfront payment of an amount equal to JPY 3.5 billion, or $26.4 million. These rights include all therapeutic indications and the rights to commercialize itolizumab in the United States, Canada, Australia, and New Zealand.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If Ono exercises the Option, we will receive JPY 5.0 billion, or approximately $37.2 million based on the currency exchange rate quoted by MUFG Bank, Ltd. on March 16, 2023. We are also eligible to receive up to $101.4 million upon achievement of certain development and commercialization milestones.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are responsible for conducting all research and development of itolizumab, which will be funded by Ono on a quarterly basis from July 1, 2022, through the option period. Unless terminated early, the option period will expire three months following the delivery of topline data from the EQUALISE clinical study in LN and interim data from the EQUATOR Phase 3 clinical study in aGVHD.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">During the year ended December 31, 2022, we recognized $15.8 million of revenue under the Asset Purchase Agreement. As of December 31, 2022, aggregate deferred revenue related to the Asset Purchase Agreement was $25.1 million.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">96</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Research and Development Expenses</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Research and development expenses primarily consist of costs associated with our non-clinical research and clinical development of our product candidates. Our research and development expenses include:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">salaries and other related costs, including stock-based compensation and benefits, for personnel in research and development functions;</span></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> per patient clinical study costs; </span></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">external research and development expenses incurred under arrangements with third parties, such as consultants and advisors for research and development;</span></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">costs of services performed by third parties, such as contract research organizations, or CROs, that conduct research and development activities on our behalf; </span></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">costs related to preparing and filing three INDs with the FDA and other regulatory interactions and submissions;</span></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">pharmacovigilance costs related to global drug safety monitoring and reporting;</span></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">external expenses related to chemistry, manufacturing, and controls, or CMC and supply of drug product; and</span></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">costs related to general overhead expenses such as travel, insurance, rent expenses, lab supplies and equipment associated with our research and development activities.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We expense research and development costs as incurred. We account for nonrefundable advance payments for goods and services that will be used in future research and development activities as expenses when the service has been performed or when the goods have been received.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our direct research and development expenses consist principally of external costs, such as fees paid to CROs and consultants in connection with our non-clinical research and clinical development.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We recognize the Australian Research and Development Tax Incentive, or the Tax Incentive, as a reduction of research and development expense. The amounts are determined based on our eligible research and development expenditures and are non-refundable, provided that in order to qualify for the Tax Incentive the filing entity must have revenue of less than AUD $20.0 million during the tax year for which a reimbursement claim is made and cannot be controlled by an income tax exempt entity. The Tax Incentive is recognized when there is reasonable assurance that the Tax Incentive will be received, the relevant expenditure has been incurred, and the amount can be reliably measured or reliably estimated.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We plan to substantially increase our research and development expenses for the foreseeable future as we advance the development of EQ101, EQ102, and itolizumab (EQ001) if Ono does not exercise its option, potentially expand the number of indications for which we are developing those product candidates, and potentially acquire or develop new product candidates. The successful development of EQ101, EQ102 and itolizumab (EQ001) is highly uncertain. At this time, due to the inherently unpredictable nature of pre-clinical and clinical development, we cannot reasonably estimate the nature, timing or costs of the efforts that will be necessary to complete the remainder of the development of our product candidates or the period, if any, in which material net cash inflows from the sales from our product candidates may commence. Clinical development timelines, the probability of success, and development costs can differ materially from expectations.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Completion of clinical studies may take several years or more, and the length of time generally varies according to the type, complexity, novelty, and intended use of a product candidate. The cost of clinical studies may vary significantly over the life of a project as a result of differences arising during clinical development, including, among others:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">per patient clinical study costs; </span></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the number of clinical studies required for approval; </span></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the number of sites and the number of countries included in our clinical studies; </span></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the length of time required to enroll suitable patients; </span></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the inefficiencies and additional costs related to any delays and potential restarts of clinical studies;</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">97</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the number of doses that patients receive; </span></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the number of patients that participate in our clinical studies; </span></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the drop-out or discontinuation rates of patients in our clinical studies; </span></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the duration of patient follow-up; </span></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">potential additional safety monitoring or other studies requested by regulatory agencies; </span></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the number and complexity of procedures, analyses and tests performed during our clinical studies; </span></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the costs of procuring drug product for our clinical studies; </span></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the phase of development of the product candidate; and </span></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the efficacy and safety profile of the product candidate. </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Acquired In-Process Research and Development Expenses</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Acquired in-process research and development expense consist of the cost to acquire the rights to develop new product candidates associated with the Bioniz acquisition as those product candidates acquired were deemed to have no alternative future use.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">General and Administrative Expenses</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">General and administrative expenses consist primarily of salaries and other related costs, including stock-based compensation and benefits, and consulting fees for executive, human resources, investor relations, finance, and accounting functions. Other significant costs include legal fees relating to patent and corporate matters, insurance, travel, board expenses, facility costs and taxes.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We anticipate that our general and administrative expenses will increase in future periods, reflecting an expanding infrastructure, increased legal, audit, tax and other professional fees associated with being a public company and maintaining compliance with stock exchange listing and SEC requirements, director and officer insurance premiums associated with being a public company, and accounting and investor relations costs. In addition, if we obtain regulatory approval for any product candidate, we expect to incur expenses associated with building the infrastructure and capabilities to commercialize such product. However, the timing of any such approval is highly uncertain, and it may be several years, if ever, that we receive any such regulatory approval.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Interest Expense</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Interest expense consists of interest and amortization of discounts on our outstanding term loans payable.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Interest Income</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Interest income consists primarily of interest income earned on cash, cash equivalents and short-term investments, and is recognized when earned.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Other Income (Expense), Net</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other income (expense), net consists primarily of a foreign currency transaction gain related to the Ono upfront payment  which was denominated in JPY and net foreign currency gains and losses related to our Australian subsidiary.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">98</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Results of Operations</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Comparison of the Years Ended December 31, 2022 and 2021</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following table sets forth our results of operations for the years ended December 31, 2022 and 2021 (in thousands):</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:50.439%;"></td>
    <td style="width:1.667%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:12.613%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.667%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:14.883%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.667%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:11.064%;"></td>
    <td style="width:1.0%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year Ended<br />December</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">31,</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Change</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Revenue</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15,759</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15,759</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Research and development</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">37,547</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">26,379</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11,168</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Acquired in-process research and development</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">23,049</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">23,049</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">General and administrative</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">17,239</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11,407</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5,832</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Interest expense</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(1,053</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(1,073</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">20</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Interest income</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">420</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">57</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">363</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other income (expense), net</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">281</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(250</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">531</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Revenue</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">During the year ended December 31, 2022, we recognized revenue of $15.8 million under our Asset Purchase Agreement with Ono. Amortization of the upfront payment represented $4.0 million, and development funding from July 1, 2022 through December 31, 2022 represented $11.8 million. There was no revenue recognized in the year ended December 31, 2021.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Research and Development Expenses</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Research and development expenses were $37.5 million for the year ended December 31, 2022, compared to $26.4 million for the year ended December 31, 2021. The increase in research and development expense primarily includes the following changes:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$7.3 million increase in clinical development expenses, primarily driven by start-up expenses related to our EQUATOR clinical study and to a lesser extent start-up expenses for our EQ102 and EQ101 clinical studies including costs associated with the purchase of drug substance and drug product for these studies, partially offset by lower costs for our other itolizumab (EQ001) clinical studies;</span></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$2.7 million increase in non-clinical research expenses;</span></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$1.3 million increase in employee compensation and benefits;</span></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$0.4 million of transaction costs associated with the Bioniz asset acquisition, primarily legal expenses;</span></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$0.4 million increase in consulting expenses to support our research and development activities; and</span></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$0.9 million decrease in research and development expenses associated with the recording of a Tax Incentive benefit from the Australian Tax Office, or ATO, as a reduction to research and development expenses associated with our EQ101 and EQ102 clinical studies being conducted in Australia.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Acquired In-Process Research and Development Expenses</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">There were $23.0 million of acquired in-process research and development expenses for the year ended December 31, 2022 resulting from accounting for the Bioniz acquisition as an asset acquisition where the product candidates acquired were determined to have no alternative future use. The consideration in excess of the tangible net liabilities acquired was expensed.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">General and Administrative Expenses</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">General and administrative expenses were $17.2 million for the year ended December 31, 2022, compared to $11.4 million for the year ended December 31, 2021. The increase in general and administrative expense primarily includes the following changes:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$2.4 million increase in legal fees related to business development activities;</span></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$1.4 million increase in employee compensation and benefits;</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">99</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$0.8 million increase in consulting expenses related to our increased business development activities in 2022;</span></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$0.7 million increase in costs related to the write-off of the capitalized issuance costs associated with our Open Market Sale Agreement with Jefferies as well as with our Purchase Agreement with Lincoln Park that we believe is unlikely to be used prior to its expiration in May 2023; and</span></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$0.5 million increase in overhead.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Interest Expense</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Interest expense was $1.1 million for the years ended December 31, 2022 and 2021. Interest expense consists of interest on our term notes payable.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Interest Income</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Interest income was $0.4 million for the year ended December 31, 2022, compared to $0.1 million for the year ended December 31, 2021. The increase in interest income was primarily due to higher interest rates on our short-term investments during 2022 compared to 2021.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Other Income (Expense), Net</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other income, net was $0.3 million for the year ended December 31, 2022, compared to other expense, net of $0.3 million for the year ended December 31, 2021. The change during 2022 compared to 2021 was primarily driven by a realized foreign currency gain of $0.6 million on the Ono upfront payment of JPY 3.5 billion due to the strengthening of the Japanese Yen between the time of invoicing and cash receipt, partially offset by increases in net unrealized foreign currency transaction losses related to our Australian subsidiary.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Liquidity and Capital Resources</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We have incurred losses and negative cash flows from operations since inception. As of December 31, 2022, we had an accumulated deficit of $172.4 million and anticipate that we will continue to incur net losses for the foreseeable future. As of December 31, 2022, we had $59.1 million in cash and cash equivalents and $11.9 million in short-term investments.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Sources of Liquidity</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Asset Purchase Agreement with Ono</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On December 5, 2022, we entered into the Asset Purchase Agreement with Ono, pursuant to which the Company granted Ono the exclusive right, but not the obligation, to acquire our rights to itolizumab. These rights include all therapeutic indications and the rights to commercialize itolizumab in the United States, Canada, Australia, and New Zealand. In exchange for the Option, Ono paid us a one-time upfront payment of an amount equal to JPY 3.5 billion, or $26.4 million.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If Ono exercises the Option, Ono will pay us a one-time, payment of an amount equal to JPY 5.0 billion, or approximately $37.2 million based on the currency exchange rate quoted by MUFG Bank Ltd. on March 16, 2023. We are also eligible to receive up to $101.4 million upon the achievement of certain development and commercialization milestones. As of December 31, 2022, we have not received the option exercise payment or any milestone payments.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are responsible for conducting all research and development of itolizumab, which will be funded by Ono on a quarterly basis from July 1, 2022, through the option period. The option period will expire three months following the delivery of topline data from the EQUALISE study in LN and interim data from the EQUATOR Phase 3 clinical study in aGVHD.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31, 2022, we have received $12.2 million in development funding from Ono.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">2020 Purchase Agreement</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In March 2020, we entered into the Purchase Agreement with Lincoln Park, which provides that, upon the terms and subject to the conditions and limitations set forth therein, we may sell to Lincoln Park up to $15.0 million of shares of our common stock from time to time over the 36-month term of the Purchase Agreement. Upon execution of the Purchase Agreement, we issued 65,374 shares of our common stock to Lincoln Park as commitment shares in accordance with the closing conditions contained within the Purchase Agreement. We have not sold any shares of our common stock to Lincoln Park under the Purchase Agreement through the date of the filing of this Annual Report on Form 10-K. The Purchase Agreement will expire on May 1, 2023.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">100</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">September 2019 Loan Agreement</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In September 2019, we entered into the Loan Agreement, with Oxford Finance LLC and Silicon Valley Bank, or together, the Lenders, pursuant to which we borrowed $10.0 million, or the Term Loan, which represents the maximum amount we are permitted to borrow under the terms of the Loan Agreement.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Term Loan matures on June 1, 2024, or the Maturity Date, and is repaid through interest-only payments, which originally  extended through June 30, 2021, followed by 36 equal monthly payments of principal and interest. The Term Loan bears interest at a floating per annum rate equal to the greater of (i) 8.25% and (ii) the sum of (a) the prime rate reported in The Wall Street Journal on the last business day of the month that immediately precedes the month in which the interest will accrue, plus (b) 3.00%.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On April 23, 2021, the Loan Agreement was amended to (i) change the final payment percentage from 4.5% to 5.0% and (ii) extend the interest-only payment period based on achieving the following milestones: (a) we achieve positive data in our Phase 1b aGVHD study of itolizumab (EQ001) supporting a formal decision to advance into Phase 2 or Phase 3 development, and as confirmed by our Board of Directors in written board minutes, or the Interest-Only Extension Milestone, and (b) we initiate a pivotal Phase 3 aGVHD study, or the Interest-Only Extension II Milestone. In May 2021, we achieved the Interest-Only Extension Milestone, and in March 2022, we obtained confirmation from Lenders that the Interest-Only Extension II Milestone had been achieved, which extended the interest-only payments through September 30, 2022, followed by 24 equal monthly principal payments and interest.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In February 2022, we entered into the Third Amendment to the Loan Agreement which added Bioniz Therapeutics, Inc. as a secured party to the loan.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On March 10, 2023, </span><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the FDIC took control and was appointed receiver of SVB. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">At the time the FDIC took control, we held assets valued at approximately $8.2 million in a sweep account with SVB. We received full access to those funds on March 13, 2023. As of the date of the filing of this Annual Report on Form 10-K, we have full access to and control over all of our cash, cash equivalents and short-term investments. In addition, because a substantial majority of our cash, cash equivalents and short-term investments are held at a financial institution unaffiliated with SVB, we do not expect any material impact to our operations directly related to the closure of SVB, but we may in the future be adversely impacted, including having to repay all outstanding amounts owed under the Loan Agreement or in receiving timely consent to incur additional indebtedness.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Funding Requirements</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We expect our expenses to increase substantially in connection with our ongoing and future activities, particularly as we advance and expand our clinical development of EQ101, EQ102, and itolizumab (EQ001) if Ono does not exercise its option, including potential new indications. We expect that our primary uses of capital will be for clinical development services, non-clinical research, manufacturing, legal and other regulatory compliance expenses, compensation and related expenses, risk management, and general overhead costs.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We expect that our existing cash, cash equivalents and short-term investments as of December 31, 2022 will enable us to fund our currently planned operations into 2025. We have based this estimate on assumptions that may prove to be wrong, and we could use our capital resources sooner than we expect. Furthermore, our operating plans may change, and we may need additional funds sooner than planned. Additionally, the process of testing product candidates in clinical studies is costly, and the timing of progress in these studies is uncertain. Because the outcome of these efforts is uncertain, we cannot estimate the actual amounts necessary to successfully complete the development and commercialization of EQ101, EQ102 and itolizumab (EQ001) or any of our other product candidates or whether, or when, we may achieve profitability.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our future capital requirements will depend on many factors, including:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">whether Ono exercises its option and the extent to which milestones payments, if any, are received:</span></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the initiation, progress, timing, costs and results of our ongoing and future clinical studies of EQ101, EQ102, itolizumab (EQ001) and other product candidates, including as such activities may be adversely impacted by the COVID-19 pandemic and the evolving conflict between Russia and Ukraine and recent bank failures; </span></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the number and scope of indications we decide to pursue for the development of our product candidates; </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">101</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the cost, timing and outcome of regulatory review of any BLA we may submit for our product candidates; </span></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the costs and timing of manufacturing EQ101, EQ102, itolizumab (EQ001) and other product candidates; </span></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the costs of preparing, filing and prosecuting patent applications, maintaining and enforcing our intellectual property rights and defending intellectual property-related claims; </span></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our efforts to enhance operational systems and our ability to attract, hire and retain qualified personnel, including personnel to support the development of our product candidates; </span></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the costs associated with being a public company; </span></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our ability to enter into partnerships or otherwise monetize our pipeline through strategic transactions on a timely basis, on terms that are favorable to us, or at all;</span></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the terms and timing of establishing and maintaining collaborations, licenses and other similar arrangements; </span></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the extent to which we acquire or in-license other product candidates and technologies;</span></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the legal and other transactional costs associated with our business development activities; and </span></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the cost associated with commercializing EQ101, EQ102 and itolizumab (EQ001) or any of our other product candidates, if approved for commercial sale. </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Until such time as we can generate substantial product revenues, if ever, we expect to finance our cash needs through a combination of equity offerings, debt financings, and collaboration and license agreements, such as our Asset Purchase Agreement with Ono. The sale of additional equity or convertible debt could result in additional dilution to our stockholders and the terms of these securities may include liquidation or other preferences that adversely affect the rights of our existing common stockholders. The incurrence of debt financing would result in debt service obligations and the governing documents would likely include operating and financing covenants that would restrict our operations. As a result of the conflict between Russia and Ukraine, bank failures, inflationary pressures on the economy and monetary policy responses taken by government agencies and other macroeconomic factors, the global credit and financial markets have experienced extreme volatility, including diminished liquidity and credit availability, declines in consumer confidence, declines in economic growth and uncertainty about economic stability. There can be no assurance that further deterioration in credit and financial markets and confidence in economic conditions will not occur. If equity and credit markets deteriorate, it may make any necessary debt or equity financing more difficult to obtain, more costly and/or more dilutive. If we raise additional funds through collaboration or license agreements, we may have to relinquish valuable rights to our technologies, future revenue streams, research programs or product candidates or grant licenses on terms that may not be favorable to us and/or that may reduce the value of our common stock. If we are unable to raise capital when needed or on attractive terms, we would be forced to delay, reduce or eliminate our research and development programs or other operations. Any of these actions could have a material effect on our business, financial condition and results of operations. We have experienced net losses and negative cash flows from operating activities since our inception and expect to continue to incur net losses into the foreseeable future. We had an accumulated deficit of $172.4 million as of December 31, 2022. We expect operating losses and negative cash flows to continue for at least the next several years as we incur costs related to the development of EQ101, EQ102, and itolizumab (EQ001) if Ono does not exercise its option, and any our other product candidates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Material Cash Requirements</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our expected material cash requirements are comprised of contractually obligated expenditures consisting of term loan payments, including principal, interest and the final payment fee on maturity, and amounts due under our operating leases. For additional information relating to our term loans or leases, see Notes 7, 10 and 12 of the Notes to Consolidated Financial Statements included in this Annual Report on Form 10-K. We have no material non-cancelable purchase commitments with service providers, as we have generally contracted on a cancelable, purchase order basis. Our expected material cash requirements do not include potential contingent payments upon the achievement by us of regulatory and commercial milestones that we may be required to make under the terms of the merger agreement pursuant to which we acquired Bioniz, nor do they include potential contingent payments upon the achievement by us of regulatory and commercial milestones or royalty payments that we may be required to make under license agreements we have entered into or may enter into with various entities pursuant to which we have in-licensed certain intellectual property, including the Biocon License. For further details on the potential contingent payments related to our acquisition of Bioniz and related to the Biocon License, see Notes 6 and 9 of the Notes to Consolidated Financial Statements included in this Annual Report on Form 10-K.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">102</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Cash Flows</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following table sets forth the primary sources and uses of cash for each of the periods set forth below (in thousands):</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:80.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:66.478%;"></td>
    <td style="width:1.486%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:13.275%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.486%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:13.275%;"></td>
    <td style="width:1.0%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year Ended<br />December</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">31,</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net cash provided by (used in):</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Operating activities</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(8,733</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(32,081</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Investing activities</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18,684</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">27,406</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Financing activities</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(1,215</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">31,061</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Effect of exchange rate changes on cash</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(2</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net increase in cash and cash equivalents</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8,741</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">26,384</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Operating Activities</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net cash used in operating activities was $8.7 million during the year ended December 31, 2022. Net cash used in operating activities during 2022 primarily related to our net loss of $62.4 million, adjusted for non-cash expense of $23.0 million related to the acquired in-process research and development charge attributed to the Bioniz acquisition, non-cash stock-based compensation expense of $4.8 million and net cash inflows from a change in deferred revenue of $25.1 million associated with the one-time receipt of our upfront payment from Ono received in connection with entering into the Asset Purchase Agreement in December 2022.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net cash used in operating activities was $32.1 million during the year ended December 31, 2021 primarily related to our net loss of $39.1 million, adjusted for non-cash stock-based compensation expense of $4.4 million and net cash inflows from a change in our operating assets and liabilities of $1.7 million.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Investing Activities</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net cash provided by investing activities was $18.7 million during the year ended December 31, 2022. We purchased $14.9 million of short-term investments and $33.2 million of our short-term investments matured during the period. Purchases of property and equipment for the year ended December 31, 2022 totaled $0.3 million. As a result of the Bioniz acquisition, we acquired cash totaling $0.7 million.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net cash provided by investing activities was $27.4 million during the year ended December 31, 2021. We purchased $33.0 million of short-term investments and $60.5 million of our short-term investments matured during the period. Purchases of property and equipment for the year ended December 31, 2021 totaled $0.1 million.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Financing Activities</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net cash used in financing activities totaled $1.2 million during the year ended December 31, 2022. We began making principal payments on our outstanding notes payable starting in October 2022 which totaled $1.4 million. These payments were offset by proceeds from issuance of shares under our employee stock purchase plan totaling $0.2 million.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net cash provided by financing activities totaled $31.1 million during the year ended December 31, 2021. We received net proceeds from the sale of shares related to our registered direct offering totaling $29.9 million and proceeds from both the issuance of shares under our employee stock purchase plan and proceeds from the exercise of stock options totaling $1.2 million.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Off-Balance Sheet Arrangements</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We did not have during the periods presented, and we do not currently have, any off-balance sheet arrangements, as defined under SEC rules, and similarly did not and do not have any holdings in variable interest entities. We do have certain contingent consideration liabilities in the form of potential milestone payments that are included in our Biocon License and in our merger agreement with Bioniz which are not reflected in our balance sheet. However, based on our current operating plans and our assessment of the probability and potential timing of such payments, we believe those payments, if any, are remote and highly unlikely to come due within the next 12 months.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">103</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Critical Accounting Policies and Estimates</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our management&#x2019;s discussion and analysis of our financial condition and results of operations is based on our consolidated financial statements, which have been prepared in accordance with generally accepted accounting principles in the United States. The preparation of our consolidated financial statements requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities and expenses and the disclosure of contingent assets and liabilities in our consolidated financial statements and accompanying notes. We evaluate these estimates on an ongoing basis. We base our estimates on historical experience, known trends and events, financial models and various other factors that we believe are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">While our significant accounting policies are more fully described in Note 2 to our consolidated financial statements appearing elsewhere in this Annual Report on Form 10-K, we believe that the following accounting policies are the most critical for fully understanding and evaluating our financial condition and results of operations.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Revenue Recognition</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We recognize revenue in a manner that depicts the transfer of control of a product or a service to a customer and reflects the amount of the consideration we are entitled to receive in exchange for such product or service. In doing so, we follow a five-step approach: (1) identify the contract with a customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, (iv) allocate the transaction price to the performance obligations, and (v) recognize revenue when (or as) the customer obtains control of the product or service. We consider the terms of a contract and all relevant facts and circumstances when applying the revenue recognition standard. We apply the revenue recognition standard, including the use of any practical expedients, consistently to contracts with similar characteristics and in similar circumstances.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">A customer is a party that has entered into a contract with us, where the purpose of the contract is to obtain a product or a service that is an output of our ordinary activities in exchange for consideration. To be considered a contract, (i) the contract must be approved (in writing, orally, or in accordance with other customary business practices), (ii) each party&#x2019;s rights regarding the product or the service to be transferred can be identified, (iii) the payment terms for the product or the service to be transferred can be identified, (iv) the contract must have commercial substance (that is, the risk, timing or amount of future cash flows is expected to change as a result of the contract), and (v) it is probable that we will collect substantially all of the consideration to which we are entitled to receive in exchange for the transfer of the product or the service.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">A performance obligation is defined as a promise to transfer a product or a service to a customer. We identify each promise to transfer a product or a service (or a bundle of products or services, or a series of products and services that are substantially the same and have the same pattern of transfer) that is distinct. A product or a service is distinct if both (i) the customer can benefit from the product or the service either on its own or together with other resources that are readily available to the customer and (ii) our promise to transfer the product or the service to the customer is separately identifiable from other promises in the contract. Each distinct promise to transfer a product or a service is a unit of accounting for revenue recognition. If a promise to transfer a product or a service is not separately identifiable form other promises in the contract, such promises should be combined into a single performance obligation.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The transaction price is the amount of consideration we are entitled to receive in exchange for the transfer of control of a product or a service to a customer. To determine the transaction price, we consider the existence of any significant financing component, the effects of any variable elements, noncash considerations and consideration payable to the customer. If a significant financing component exists, the transaction price is adjusted for the time value of money. If an element of variability exists, we must estimate the consideration we expect to receive and use that amount as the basis for recognizing revenue as the product or the service is transferred to the customer. There are two methods for determining the amount of variable consideration: (i) the expected value method, which is the sum of probability-weighted amounts in a range of possible consideration amounts, and (ii) the most likely amount method, which identifies the single most likely amount in a range of possible consideration amounts.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If a contract has multiple performance obligations, we allocate the transaction price to each distinct performance obligation in an amount that reflects the consideration we are entitled to receive in exchange for satisfying each distinct performance</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">104</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">obligation. For each distinct performance obligation, revenue is recognized when (or as) we transfer control of the product or the service applicable to such performance obligation.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In those instances where we first receive consideration in advance of satisfying its performance obligation, we classify such consideration as deferred revenue until (or as) we satisfy such performance obligation. In those instances where we first satisfy our performance obligation prior to our receipt of consideration, the consideration is recorded as accounts receivable.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We expense incremental costs of obtaining and fulfilling a contract as and when incurred if the expected amortization period of the asset that would be recognized is one year or less, or if the amount of the asset is immaterial. Otherwise, such costs are capitalized as contract assets if they are incremental to the contract and amortized to expense proportionate to revenue recognition of the underlying contract.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Accrued Research and Development Expense</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are required to estimate our expenses resulting from our obligations under contracts with vendors, consultants and contract research organizations, in connection with conducting research and development activities. The financial terms of these contracts are subject to negotiations, which vary from contract to contract and may result in payment flows that do not match the periods over which materials or services are provided under such contracts. We reflect research and development expenses in our consolidated financial statements by matching those expenses with the period in which services and efforts are expended. We account for these expenses according to the progress of the preclinical study or clinical study as measured by the timing of various aspects of the study or related activities. We determine accrual estimates through review of the underlying contracts along with preparation of financial models taking into account discussions with research and other key personnel as to the progress of studies, or other services being conducted. During the course of a study or clinical study, we adjust our rate of expense recognition if actual results differ from our estimates.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Although we do not expect our estimates to be materially different from amounts actually incurred, if our estimates of the status and timing of services performed differ from the actual status and timing of services performed, it could result in us reporting amounts that are too high or too low in any particular period. To date, there have been no material differences between our estimates of such expenses and the amounts actually incurred.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Stock-based Compensation Expense</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We measure employee and non-employee stock-based awards, including stock options and stock purchase rights, at grant-date fair value and record compensation expense on a straight-line basis over the vesting period of the award. We use the Black-Scholes option pricing model to value our stock option awards. Estimating the fair value of stock option awards requires management to apply judgment and make estimates of certain assumptions, including the volatility of our common stock, the expected term of our stock options and the expected dividend yield on the measurement date. As a result, if factors change and management uses different assumptions, stock-based compensation expense could be materially different for future awards.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Income Taxes</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We account for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences that have been included in the consolidated financial statements. Under this method, deferred tax assets and liabilities are determined on the basis of the differences between the consolidated financial statements and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. We record a full valuation allowance against net deferred tax assets unless, based upon the available evidence, it is more likely than not that the deferred tax assets will be realized.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We record uncertain tax positions on the basis of a two-step process whereby (i) management determines whether it is more likely than not that the tax positions will be sustained on the basis of the technical merits of the position and (ii) for those tax positions that meet the more likely-than-not recognition threshold, management recognizes the largest amount of tax benefit that is more than 50 percent likely to be realized upon ultimate settlement with the related tax authority. We will recognize interest and penalties in income tax expense if and when incurred.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Recent Accounting Pronouncements</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">See Note 1 to our consolidated financial statements included elsewhere in this Annual Report on Form 10-K for information concerning recent accounting pronouncements.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_7a_quantitative_qualitative_disclos"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 7A. Quantitative and Qualitat</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ive Disclosures About Market Risk.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Not required for smaller reporting companies.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">105</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_8_financial_statements_supplementar"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 8. Financial Statement</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">s and Supplementary Data.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The financial statements and supplementary data required by this item are included after the signature page of this Annual Report on Form 10-K beginning on page F-1.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_9_changes_in_disagreements_with_acc"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 9. Changes in and Disagreements With Accou</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ntants on Accounting and Financial Disclosure.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">None.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_9a_controls_procedures"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 9A. Controls </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">and Procedures.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Evaluation of Disclosure Controls and Procedures</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in our periodic and current reports that we file with the SEC is recorded, processed, summarized and reported within the time periods specified in the SEC&#x2019;s rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. In designing and evaluating the disclosure controls and procedures, management recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable and not absolute assurance of achieving the desired control objectives. In reaching a reasonable level of assurance, management necessarily was required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures. In addition, the design of any system of controls also is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Over time, controls may become inadequate because of changes in conditions, or the degree of compliance with policies or procedures may deteriorate. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31, 2022, we carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended, or Exchange Act. Based on this evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective at the reasonable assurance level as of December 31, 2022.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Management&#x2019;s Report on Internal Control over Financial Reporting</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our management is responsible for establishing and maintaining adequate internal control over financial reporting as such term is defined in Exchange Act Rule 13a-15(f) and 15d-15(f). Internal control over financial reporting is a process designed under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with accounting principles generally accepted in the United States of America.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31, 2022, our management assessed the effectiveness of our internal control over financial reporting using the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission in </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Internal Control-Integrated Framework (2013 Framework). </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Based on this assessment, our management concluded that, as of December 31, 2022, our internal control over financial reporting was effective based on those criteria.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Changes in Internal Control over Financial Reporting</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">There were no changes in our internal control over financial reporting that occurred during the quarter ended December 31, 2022 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_9b_or_information"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 9B. Other</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> Information.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">None.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_9c_disclosure_regarding_foreign"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 9C.    </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Disclosure Regarding Foreign</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> Jurisdictions that Prevent Inspection</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Not applicable.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">106</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;" id="partiii"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">PART III</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_10_directors_executive_ficers_corpo"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 10. Directors, Executive Off</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">icers and Corporate Governance.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Except as set forth below, the information required by this item will be contained in our definitive proxy statement, or the Proxy Statement, to be filed with the SEC in connection with the Annual Meeting of Stockholders within 120 days after the conclusion of our fiscal year ended December 31, 2022 under the sections entitled &#x201c;Election of Directors,&#x201d; &#x201c;Information Regarding the Board of Directors and Corporate Governance,&#x201d; &#x201c;Information Regarding Committees of the Board,&#x201d; &#x201c;Executive Officers&#x201d; and &#34;Delinquent Section 16(a) Reports&#34; and is incorporated in this Annual Report on Form10-K by reference.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We have adopted a Code of Business Conduct and Ethics that applies to all officers, directors and employees, including our principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions. The Code of Business Conduct and Ethics is available on our website at </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">www.equilliumbio.com</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. The information on our website is not incorporated by reference into this Annual Report on Form 10-K. If we make any substantive amendments to the Code of Business Conduct and Ethics or grants any waiver from a provision of the code to any executive officer or director, we will promptly disclose the nature of the amendment or waiver on our website or in a current report on Form 8-K.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_11_executive_compensation"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 11. Executiv</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">e Compensation.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The information required by this item will be contained in the Proxy Statement under the section entitled &#x201c;Executive and Director Compensation&#x201d; and is incorporated in this Annual Report on Form 10-K by reference.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_12_security_ownership_certain_benef"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 12. Security Ownership of Certain Beneficial Ow</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ners and Management and Related Stockholder Matters.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The information required by this item will be contained in the Proxy Statement under the sections entitled &#x201c;Security Ownership of Certain Beneficial Owners and Management&#x201d; and &#34;Securities Authorized for Issuance under Equity Compensation Plans&#34; and is incorporated in this Annual Report on Form 10-K by reference.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_13_certain_relationships_related_tr"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 13. Certain Relationships and Related </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Transactions, and Director Independence.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The information required by this item will be contained in the Proxy Statement under the sections entitled &#x201c;Transactions with Related Persons and Indemnification&#x201d; and &#34;Information Regarding the Board of Directors and Corporate Governance&#34; and is incorporated in this Annual Report on Form 10-K by reference.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_14_principal_accounting_fees_servic"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 14. Principal Accoun</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">tant Fees and Services.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The information required by this item will be contained in the Proxy Statement under the section entitled &#x201c;Principal Accountant Fees and Services&#x201d; and is incorporated in this Annual Report on Form 10-K by reference.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">107</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;" id="part_iv"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">PART</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> IV</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_15_exhibits_financial_statement_sch"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 15. Exhibits and Financ</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ial Statement Schedules.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a)(1) </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Consolidated Financial statements:</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Consolidated Financial Statements of Equillium, Inc. and Report of Independent Registered Public Accounting Firm are included after the Signatures page of this Annual Report on Form 10-K beginning on page F-1.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a)(2) </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Financial Statement Schedules:</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">These schedules have been omitted because the required information is included in the financial statements or notes thereto or because they are not applicable or not required.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a)(3) </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibits</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:9.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit Index</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:9.98%;"></td>
    <td style="width:1.002%;"></td>
    <td style="width:89.018%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit</span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Number</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.75pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.75pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Description</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;2.1&#134;&#134;*</span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1746466/000119312522043939/d320942dex21.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Agreement and Plan of Merger, dated February 14, 2022, by and among Registrant, Bioniz Therapeutics, Inc., Project JetFuel Merger Sub, Inc. and Kevin Green, solely in his capacity as Securityholders&#x2019; Representative, incorporated by reference by Exhibit 2.1 of the Registrant&#x2019;s Current Report on Form 8-K, filed with the Securities and Exchange Commission on February 16, 2022.</span></a></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;2.2*</span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1746466/000119312522238883/d336866dex21.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Agreement and Plan of Merger, dated September 6, 2022, by and among the Registrant, Metacrine, Inc. Equillium Acquisition Sub, Inc., Triumph Acquisition Sub, Inc., and Triumph Merger Sub, Inc., as amended by Amendment No. 1 to Agreement and Plan of Merger, dated October 26, 2022, incorporated by reference to Exhibit 2.1 of the Registrant&#x2019;s Registration Statement on Form S-4 (File No. 333-268024), originally filed with the Securities and Exchange Commission on October 27, 2022.</span></a></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;3.1</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1746466/000119312518300246/d634419dex31.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Amended and Restated Certificate of Incorporation of the Registrant, incorporated by reference to Exhibit 3.1 of the Registrant&#x2019;s Current Report on Form 8-K filed on October 16, 2018.</span></a></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;3.2</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1746466/000119312518300246/d634419dex32.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Amended and Restated Bylaws of the Registrant, incorporated by reference to Exhibit 3.2 of the Registrant&#x2019;s Current Report on Form 8-K filed October 16, 2018.</span></a><span style="color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;4.1</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1746466/000119312518290169/d582934dex41.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Form of Common Stock Certificate of the Registrant, incorporated by reference to Exhibit 4.1 of the Registrant&#x2019;s Registration Statement on Form S-1 (File No. 333-227387), as amended, originally filed with the Securities and Exchange Commission on September 17, 2018.</span></a></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;4.2</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1746466/000156459019042933/eq-ex42_45.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Warrant to Purchase Common Stock, dated September 30, 2019, issued to Oxford Valley Finance LLC, incorporated by reference to Exhibit 4.2 of the Registrant&#x2019;s Quarterly Report on Form 10-Q, filed with the Securities and Exchange Commission on November 12, 2019.</span></a></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;4.3</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1746466/000156459019042933/eq-ex43_43.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Warrant to Purchase Common Stock, dated September 30, 2019, issued to Silicon Valley Bank, incorporated by reference to Exhibit 4.3 of the Registrant&#x2019;s Quarterly Report on Form 10-Q, filed with the Securities and Exchange Commission on November 12, 2019.</span></a></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;4.4</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1746466/000156459020013207/eq-ex44_352.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Description of Common Stock, incorporated by reference to Exhibit 4.4 of the Registrant&#x2019;s Annual Report on Form 10-K, filed with the Securities and Exchange Commission on March 26, 2020.</span></a></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;4.5</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/0001746466/000156459021004194/eq-ex41_7.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Form of Warrant, issued February 5, 2021, incorporated by reference to Exhibit 4.1 of the Registrant&#x2019;s Current Report on Form 8-K, filed with the Securities and Exchange Commission on February 4, 2021.</span></a></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;4.6</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1746466/000156459020014185/eq-ex41_27.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Registration Rights Agreement, dated as of March 27, 2020, by and between the Registrant and Lincoln Park Capital Fund, LLC, incorporated by reference to Exhibit 4.1 of the Registrant&#x2019;s Current Report on Form 8-K filed on March 30, 2020.</span></a></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.1+</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1746466/000119312518275420/d582934dex101.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Form of Indemnity Agreement by and between the Registrant and its directors and officers, incorporated by reference to Exhibit 10.1 of the Registrant&#x2019;s Registration Statement on Form S-1 (File No. 333-227387), as amended, originally filed with the Securities and Exchange Commission on September 17, 2018.</span></a></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.2+</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1746466/000119312518275420/d582934dex102.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Equillium, Inc. 2017 Equity Incentive Plan and Forms of Option Grant Notice, Option Agreement and Notice of Exercise thereunder, incorporated by reference to Exhibit 10.2 of the Registrant&#x2019;s Registration Statement on Form S-1 (File No. 333-227387), as amended, originally filed with the Securities and Exchange Commission on September 17, 2018.</span></a></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">108</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:9.98%;"></td>
    <td style="width:1.002%;"></td>
    <td style="width:89.018%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.3+</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1746466/000119312518300276/d632051dex992.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Equillium 2018 Equity Incentive Plan and Forms of Stock Option Grant Notice, Option Agreement and Notice of Exercise thereunder, incorporated by reference to Exhibit 99.2 of the Registrant&#x2019;s Registration Statement on Form S-8 (File No. 333-227859) filed with the Securities and Exchange Commission on October 16, 2018.</span></a></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.4+</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1746466/000119312518300276/d632051dex993.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Equillium, Inc. 2018 Employee Stock Purchase Plan, incorporated by reference to Exhibit 99.3 of the Registrant&#x2019;s Registration Statement on Form S-8 (File No. 333-227859) filed with the Securities and Exchange Commission on October 16, 2018.</span></a><span style="color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.5&#134;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1746466/000119312518275420/d582934dex106.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Collaboration and License Agreement, dated May 22, 2017, by and between the Registrant and Biocon SA (which was subsequently assigned to Biocon Limited effective March 2018), incorporated by reference to Exhibit 10.6 of the Registrant&#x2019;s Registration Statement on Form S-1 (File No. 333-227387), as amended, originally filed with the Securities and Exchange Commission on September 17, 2018.</span></a></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.6&#134;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1746466/000119312518275420/d582934dex107.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Clinical Supply Agreement, dated May 22, 2017, by and between the Registrant and Biocon SA (which was subsequently assigned to Biocon Limited effective March 2018), incorporated by reference to Exhibit 10.7 of the Registrant&#x2019;s Registration Statement on Form S-1 (File No. 333-227387), as amended, originally filed with the Securities and Exchange Commission on September 17, 2018.</span></a></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.7</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1746466/000119312518275420/d582934dex108.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Standard Office Lease, effective as of February 1, 2018, by and between the Registrant and La Jolla Shores Plaza, LLC, incorporated by reference to Exhibit 10.8 of the Registrant&#x2019;s Registration Statement on Form S-1 (File No. 333-227387), as amended, originally filed with the Securities and Exchange Commission on September 17, 2018.</span></a></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.8+</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1746466/000119312518275420/d582934dex109.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Offer Letter, dated June 1, 2018, by and between the Registrant and Daniel M. Bradbury, incorporated by reference to Exhibit 10.9 of the Registrant&#x2019;s Registration Statement on Form S-1 (File No. 333-227387), as amended, originally filed with the Securities and Exchange Commission on September 17, 2018.</span></a></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.9+</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1746466/000119312518275420/d582934dex1010.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Offer Letter, dated March 19, 2018, by and between the Registrant and Jason A. Keyes, incorporated by reference to Exhibit 10.10 of the Registrant&#x2019;s Registration Statement on Form S-1 (File No. 333-227387), as amended, originally filed with the Securities and Exchange Commission on September 17, 2018.</span></a></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.10+</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1746466/000119312518275420/d582934dex1011.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Offer Letter, dated June 1, 2018, by and between the Registrant and Bruce D. Steel, incorporated by reference to Exhibit 10.11 of the Registrant&#x2019;s Registration Statement on Form S-1 (File No. 333-227387), as amended, originally filed with the Securities and Exchange Commission on September 17, 2018.</span></a></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.11+</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1746466/000119312518275420/d582934dex1012.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Amended and Restated Offer Letter, dated June 7, 2018, by and between the Registrant and Stephen Connelly, Ph.D., incorporated by reference to Exhibit 10.12 of the Registrant&#x2019;s Registration Statement on Form S-1 (File No. 333-227387), as amended, originally filed with the Securities and Exchange Commission on September 17, 2018.</span></a></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.12</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/0001746466/000119312518290169/d582934dex1014.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">First Amendment to Collaboration and License Agreement, effective as of September 28, 2018, by and between the Registrant and Biocon Limited, incorporated by reference to Exhibit 10.14 of the Registrant&#x2019;s Registration Statement on Form S-1 (File No. 333-227387), as amended, originally filed with the Securities and Exchange Commission on October 2, 2018.</span></a></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.13</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/0001746466/000156459020013207/eq-ex1015_170.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Second Amendment to Collaboration and License Agreement dated April 22, 2019, by and between the Registrant and Biocon Limited, incorporated by reference to Exhibit 10.15 of the Registrant&#x2019;s Annual Report on Form 10-K, filed with the Securities and Exchange Commission on March 26, 2020.</span></a></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.14</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/0001746466/000156459019042933/eq-ex101_44.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Loan and Security Agreement, effective as of September 30, 2019, by and among the Registrant, Oxford Finance LLC and Silicon Valley Bank, incorporated by reference to Exhibit 10.1 of the Registrant&#x2019;s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 12, 2019.</span></a><span style="color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.15&#134;&#134;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/0001746466/000156459020013207/eq-ex1018_169.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Third Amendment to Collaboration and License Agreement, dated December 10, 2019, by and between the Registrant and Biocon Limited, incorporated by reference to Exhibit 10.18 of the Registrant&#x2019;s Annual Report on Form 10-K, filed with the Securities and Exchange Commission on March 26, 2020.</span></a></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.16+</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/0001746466/000156459020013207/eq-ex1019_351.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Offer Letter, dated January 19, 2018, by and between the Registrant and Christine Zedelmayer, incorporated by reference to Exhibit 10.19 of the Registrant&#x2019;s Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 26, 2020.</span></a></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.17+</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/0001746466/000156459020013207/eq-ex1020_349.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">First Amendment to Offer Letter, effective as of January 1, 2020, by and between the Registrant and Daniel M. Bradbury, incorporated by reference to Exhibit 10.20 of the Registrant&#x2019;s Annual Report on Form 10-K, filed with the Securities and Exchange Commission on March 26, 2020.</span></a></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.18+</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/0001746466/000156459020013207/eq-ex1022_348.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">First Amendment to Offer Letter, effective as of January 1, 2020, by and between the Registrant and Bruce D. Steel, incorporated by reference to Exhibit 10.22 of the Registrant&#x2019;s Annual Report on Form 10-K, filed with the Securities and Exchange Commission on March 26, 2020.</span></a></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">109</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:9.98%;"></td>
    <td style="width:1.002%;"></td>
    <td style="width:89.018%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.19+</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/0001746466/000156459020013207/eq-ex1023_350.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">First Amendment to Offer Letter, effective as of January 1, 2020, by and between the Registrant and Christine Zedelmayer, incorporated by reference to Exhibit 10.23 of the Registrant&#x2019;s Annual Report on Form 10-K, filed with the Securities and Exchange Commission on March 26, 2020.</span></a></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.20</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/0001746466/000156459020014185/eq-ex101_26.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Purchase Agreement, dated March 27, 2020, by and between the Registrant and Lincoln Park Capital Fund, LLC, incorporated by reference to Exhibit 10.1 of the Registrant&#x2019;s Current Report on Form 8-K filed with the Securities and Exchange Commission on March 30, 2020.</span></a></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.21</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/0001746466/000119312520192229/d61529dex11.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Open Market Sale Agreement, dated as of July 14, 2020, by and between the Registrant and Jefferies LLC, incorporated by reference to Exhibit 1.1 of the Registrant&#x2019;s Current Report on Form 8-K, filed with the Securities and Exchange Commission on July 14, 2020.</span></a></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.22+</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1746466/000119312520322379/d848298dex101.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Offer Letter, dated December 15, 2020, by and between the Registrant and Dolca Thomas, M.D., incorporated by reference to Exhibit 10.1 of the Registrant&#x2019;s Current Report on Form 8-K, filed with the Securities and Exchange Commission on December 21, 2020.</span></a></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.23</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1746466/000095017022004407/eq-ex10_23.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">First Amendment to Loan and Security Agreement by and between Registrant and Oxford Finance LLC, dated December 18, 2020, incorporated by reference to Exhibit 10.23 of the Registrant&#x2019;s Annual Report on Form 10-K, filed with the Securities and Exchange Commission on March 23, 2022.</span></a></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.24+</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1746466/000156459021015103/eq-ex1028_993.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Amended and Restated Offer Letter, effective January 26, 2021, by and between the Registrant and Joel Rothman, incorporated by reference to Exhibit 10.28 of the Registrant&#x2019;s Annual Report on Form 10-K, filed with the Securities and Exchange Commission on March 24, 2021.</span></a></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.25+</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1746466/000095017022004407/eq-ex10_25.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Equillium, Inc. Non-Employee Director Compensation Policy, as amended, incorporated by reference to Exhibit 10.25 of the Registrant&#x2019;s Annual Report on Form 10-K, filed with the Securities and Exchange Commission on March 23, 2022.</span></a></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.26</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1746466/000095017021000224/eq-20210331-ex10_3.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Fourth Amendment to Collaboration and License Agreement by and between Registrant and Biocon Limited, dated April 14, 2021, incorporated by referenced to Exhibit 10.3 of the Registrant&#x2019;s Quarterly Report on Form 10-Q, filed with the Securities and Exchange Commission on May 13, 2021.</span></a></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.27</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1746466/000095017021000224/eq-20210331-ex10_4.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Second Amendment to Loan and Security Agreement by and between Registrant and Oxford Finance LLC, dated April 23, 2021, incorporated by reference to Exhibit 10.4 of the Registrant's Quarterly Report on Form 10-Q, filed with the Securities and Exchange Commission on May 13, 2021.</span></a></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.28</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1746466/000095017022004407/eq-ex10_28.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Third Amendment to Loan and Security Agreement by and between Registrant and Oxford Finance LLC, dated February 14, 2022, incorporated by reference to Exhibit 10.28 of the Registrant's Annual Report on Form 10-K, filed with the Securities and Exchange Commission on March 23, 2022.</span></a></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.29</span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="eq-ex10_29.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Fifth Amendment to Collaboration and License Agreement by and between Registrant and Biocon Limited, dated November 18, 2022.</span></a></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.30</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1746466/000095017022004407/eq-ex10_29.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Confidential Separation Agreement and General Release of All Claims dated February 13, 2022, by and between Registrant and Dolca Thomas, M.D., incorporated by reference to Exhibit 10.29 of the Registrant's Annual Report on Form 10-K, filed with the Securities and Exchange Commission on March 23, 2022.</span></a></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.31&#134;&#134;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="eq-ex10_31.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Asset Purchase Agreement, dated December 5, 2022, by and between the Registrant and Ono Pharmaceutical Co., Ltd.</span></a></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">21.1</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="eq-ex21_1.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Subsidiaries of Equillium, Inc.</span></a></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">23.1</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="eq-ex23_1.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Consent of Independent Registered Public Accounting Firm.</span></a></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">24.1</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#power_attorney"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Power of Attorney. Reference is made to the signature page hereto.</span></a></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">31.1</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="eq-ex31_1.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Certification of Principal Executive Officer pursuant to Rules 13a-14(a) and 15d-14(a) of the Securities Exchange Act, as amended.</span></a></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">31.2</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="eq-ex31_2.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Certification of Principal Financial Officer pursuant to Rules 13a-14(a) and 15d-14(a) of the Securities Exchange Act, as amended.</span></a></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">32.1**</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="eq-ex32_1.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Certification of Principal Executive Officer and Principal Financial Officer pursuant to Rules 13a-14(b) or 15d-14(b) of the Securities Exchange Act, as amended, and 18 U.S.C. Section 1350.</span></a></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">101.INS</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Inline XBRL Instance Document &#x2013; the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">101.SCH</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Inline XBRL Taxonomy Extension Schema Document</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">101.CAL</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Inline XBRL Taxonomy Extension Calculation Linkbase Document</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">101.DEF</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Inline XBRL Taxonomy Extension Definition Linkbase Document</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">110</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:9.98%;"></td>
    <td style="width:1.002%;"></td>
    <td style="width:89.018%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">101.LAB</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Inline XBRL Taxonomy Extension Label Linkbase Document</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">101.PRE</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Inline XBRL Taxonomy Extension Presentation Linkbase Document</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">104</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:85.185%;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;padding-bottom:1.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:0.75pt solid;margin-right:85.185%;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">* Schedules and exhibits to the agreement have been omitted pursuant to Item 601(a)(5) of Regulation S-K. A copy of any omitted schedule and/or exhibit will be furnished to the Securities and Exchange Commission upon request..</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">** This certification will not be deemed &#x201c;filed&#x201d; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#x201c;Exchange Act&#x201d;), or otherwise subject to the liability of that section. Such certification will not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except to the extent specifically incorporated by reference into such filing.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">+ Indicates management contract or compensatory plan.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#134; Confidential treatment has been granted with respect to certain portions of this exhibit. Omitted portions have been filed separately with the Securities and Exchange Commission.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#134;&#134; Certain information in this exhibit has been omitted pursuant to Item 601 of Regulation S-K.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_16_form_10k_summary"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 16. Form </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10-K Summary.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">None.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">111</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;" id="signatures"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">SIGNA</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">TURES</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this annual report on Form 10-K to be signed on its behalf by the undersigned, thereunto duly authorized</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:57.996%;"></td>
    <td style="width:1.002%;"></td>
    <td style="width:4.861%;"></td>
    <td style="width:36.141%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(254,254,254,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;padding-left:0.028in;vertical-align:top;padding-right:0.014in;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;padding-left:0.028in;vertical-align:bottom;padding-right:0.014in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(254,254,254,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;padding-left:0.028in;vertical-align:bottom;padding-right:0.014in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">EQUILLIUM, INC.</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(254,254,254,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;padding-left:0.028in;vertical-align:middle;padding-right:0.014in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;padding-left:0.028in;vertical-align:bottom;padding-right:0.014in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;padding-left:0.028in;vertical-align:bottom;padding-right:0.014in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;padding-left:0.028in;vertical-align:bottom;padding-right:0.014in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(254,254,254,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;padding-left:0.028in;vertical-align:bottom;padding-right:0.014in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Date: </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">March 23, 2023</span></p></td>
    <td style="background-color:rgba(254,254,254,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;padding-left:0.028in;vertical-align:bottom;padding-right:0.014in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;padding-left:0.028in;vertical-align:top;padding-right:0.014in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">By:</span></p></td>
    <td style="background-color:rgba(254,254,254,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;padding-left:0.028in;vertical-align:bottom;border-bottom:0.5pt solid;padding-right:0.014in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Bruce D. Steel</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(254,254,254,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;padding-left:0.028in;vertical-align:bottom;padding-right:0.014in;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;padding-left:0.028in;vertical-align:bottom;padding-right:0.014in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;padding-left:0.028in;vertical-align:middle;padding-right:0.014in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;padding-left:0.028in;vertical-align:bottom;padding-right:0.014in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Bruce D. Steel</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(254,254,254,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;padding-left:0.028in;vertical-align:bottom;padding-right:0.014in;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;padding-left:0.028in;vertical-align:bottom;padding-right:0.014in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;padding-left:0.028in;vertical-align:bottom;padding-right:0.014in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(254,254,254,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;padding-left:0.028in;vertical-align:bottom;padding-right:0.014in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">President and Chief Executive Officer</span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(Principal Executive Officer)</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:3.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;" id="power_attorney"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">POWER OF </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ATTORNEY</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Bruce D. Steel and Jason A. Keyes, and each of them, as his or her true and lawful attorneys-in-fact and agents, each with the full power of substitution, for him or her and in his or her name, place or stead, in any and all capacities, to sign any and all amendments to this Annual Report on Form 10-K and to file the same, with exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or their substitute or substitutes, may lawfully do or cause to be done by virtue hereof.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this report has been signed by the following persons in the capacities and on the dates indicated.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:40.0%;"></td>
    <td style="width:1.2%;"></td>
    <td style="width:37.996%;"></td>
    <td style="width:1.002%;"></td>
    <td style="width:19.802%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">SIGNATURE</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">TITLE</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">DATE</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Bruce D. Steel</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">President and</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">March 23, 2023</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Bruce D. Steel</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Chief Executive Officer</span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">(Principal Executive Officer)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Jason A. Keyes</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Chief Financial Officer</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">March 23, 2023</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Jason A. Keyes</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">(Principal Financial and Accounting Officer)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Daniel M. Bradbury</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Chairman of the Board of Directors</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">March 23, 2023</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Daniel M. Bradbury</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Stephen Connelly, Ph.D.</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Member of the Board of Directors</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">March 23, 2023</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Stephen Connelly, Ph.D.</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Martha J. Demski</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Member of the Board of Directors</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">March 23, 2023</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Martha J. Demski</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Bala S. Manian, Ph.D.</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Member of the Board of Directors</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">March 23, 2023</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Bala S. Manian, Ph.D.</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Charles McDermott</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Member of the Board of Directors</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">March 23, 2023</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Charles McDermott</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Mark Pruzanski, M.D.</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Member of the Board of Directors</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">March 23, 2023</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Mark Pruzanski, M.D.</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Barbara Troupin, M.D.</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Member of the Board of Directors</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">March 23, 2023</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Barbara Troupin, M.D.</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/Y. Katherine Xu, M.D</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Member of the Board of Directors</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">March 23, 2023</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;Y. Katherine Xu, M.D</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">112</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">INDEX TO CONSOLIDATED FINANCIAL STATEMENTS</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">EQUILLIUM, INC.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:94.643%;"></td>
    <td style="width:5.357%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:right;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><a href="#report_independent_auditors_registered_p"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Report of Independent Registered Public Accounting Firm (PCAOB ID: 185)</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:right;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><a href="#balance_sheets"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Consolidated Balance Sheets</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:right;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><a href="#statements_operations_comprehensive_loss"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Consolidated Statements of Operations and Comprehensive Loss</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:right;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><a href="#statements_stockholders_equity_deficit"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Consolidated Statements of Stockholders&#x2019; Equity</span><span style="color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:right;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><a href="#statements_cash_flows"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Consolidated Statements of Cash Flows</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:right;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><a href="#notestoconsolidatedfinancialstatements"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Notes to Consolidated Financial Statements</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;" id="report_independent_auditors_registered_p"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">REPORT OF INDEPENDENT </span><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">R</span><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">EGISTERED PUBLIC ACCOUNTING FIRM</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">To the Stockholders and Board of Directors</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Equillium, Inc.:</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Opinion on the Consolidated Financial Statements</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We have audited the accompanying consolidated balance sheets of Equillium, Inc. and subsidiaries (the Company) as of December 31, 2022 and 2021, the related consolidated statements of operations and comprehensive loss, stockholders&#x2019; equity, and cash flows for the years then ended, and the related notes (collectively, the consolidated financial statements). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2022 and 2021, and the results of its operations and its cash flows for the years then ended, in conformity with U.S. generally accepted accounting principles.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Basis for Opinion</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">These consolidated financial statements are the responsibility of the Company&#x2019;s management. Our responsibility is to express an opinion on these consolidated financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company&#x2019;s internal control over financial reporting. Accordingly, we express no such opinion.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ KPMG LLP</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We have served as the Company&#x2019;s auditor since 2018.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">San Diego, California</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">March 23, 2023</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Equillium, Inc.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;" id="balance_sheets"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Consolidated Balance </span><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sheets</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(In thousands, except share and par value data)</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:67.108%;"></td>
    <td style="width:1.493%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:12.883000000000001%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.493%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:13.022%;"></td>
    <td style="width:1.0%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31,</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Assets</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Current assets:</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cash and cash equivalents</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_dd35efc4-0c70-4a7c-a5f2-99d10b490841" contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">59,107</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_1fa15f81-5ec3-4368-93f6-6590a5b1df63" contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">50,366</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Short-term investments</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_709712c6-ad0e-447b-b4ec-fc2fac73daf0" contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">11,916</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a1347111-a90c-4f5b-a17f-7130e6005a0d" contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">30,345</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accounts receivable</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_0d17d78f-5713-427f-9897-846dc6824beb" contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192" name="us-gaap:AccountsReceivableNetCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,838</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Prepaid expenses and other current assets</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_02a66d84-779d-44a5-9555-95f2ac97a742" contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,874</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_45391533-b016-4df2-a2a0-91fa8c50a985" contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,659</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total current assets</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f6694e79-dc3b-4f92-bc6d-7f80e57bcd99" contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192" name="us-gaap:AssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">76,735</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_267fff64-e7a1-48bd-a665-b5fdb533f9de" contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94" name="us-gaap:AssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">83,370</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Operating lease right-of-use assets</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_32e18531-472a-43ac-b94a-69e7cdc03470" contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192" name="us-gaap:OperatingLeaseRightOfUseAsset" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,191</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_01e553b1-defa-4672-bd60-bd66d3f8c30e" contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94" name="us-gaap:OperatingLeaseRightOfUseAsset" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,645</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Property and equipment, net</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_01b81547-5f05-4656-89ed-ecb551e761f1" contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192" name="us-gaap:PropertyPlantAndEquipmentNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">391</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a1a0b9ba-d58d-45e4-8f04-21115e76a3fd" contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94" name="us-gaap:PropertyPlantAndEquipmentNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">237</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other assets</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c3c2e3ed-5dd9-4163-916d-b77692f90bcf" contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192" name="us-gaap:OtherAssetsNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">104</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d9268628-6abc-4dad-af0f-c2555d3b965a" contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94" name="us-gaap:OtherAssetsNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">153</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total assets</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_bb9c6b87-b72b-4402-8eee-be08e7c9b8fe" contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192" name="us-gaap:Assets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">78,421</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_63dd0cf8-e128-40f2-8746-54d2e8ca4c88" contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94" name="us-gaap:Assets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">85,405</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Liabilities and stockholders' equity</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Current liabilities:</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accounts payable</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e582869d-4836-476f-9020-4cb742e1d2e9" contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192" name="us-gaap:AccountsPayableCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,977</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f78c35bc-e686-4a88-9694-d9667d522309" contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94" name="us-gaap:AccountsPayableCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,225</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accrued expenses</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f8be418b-b2c8-4c49-bee8-c3b425442d17" contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192" name="us-gaap:AccruedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">7,239</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b15a449e-92da-4a00-9bf2-82ce51e16e06" contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94" name="us-gaap:AccruedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">5,886</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Current portion of deferred revenue</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_474d206b-1127-4e1d-a5e1-6ef6bd83aeaa" contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192" name="us-gaap:DeferredRevenueCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">14,700</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Current portion of long-term notes payable</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_2f22fc30-18ed-4c6a-9d6c-d7ac8ef490de" contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192" name="us-gaap:NotesPayableCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">5,714</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_205e3a0f-87b5-44e4-9980-b032b1ab2b63" contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94" name="us-gaap:NotesPayableCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,428</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Current portion of operating lease liabilities</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_986f3e83-82d9-47c1-a58d-06de9dae6934" contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192" name="us-gaap:OperatingLeaseLiabilityCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">408</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_134fe571-5c58-4686-acac-fc892a6d67cd" contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94" name="us-gaap:OperatingLeaseLiabilityCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">376</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total current liabilities</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_fc7f5aa2-da8c-418b-99a7-9f1586d65986" contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192" name="us-gaap:LiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">32,038</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_9e9118c1-e0ba-42cc-b37a-baa5d5be638c" contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94" name="us-gaap:LiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">8,915</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Long-term notes payable</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_1b8048d7-f88c-4e33-bf32-78c74d683f54" contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192" name="us-gaap:LongTermNotesPayable" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,239</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d5792190-5d3a-49d3-8526-d01a87dfc37d" contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94" name="us-gaap:LongTermNotesPayable" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">8,750</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Long-term deferred revenue</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ed361848-56b2-46aa-a0ba-b5fd925a507f" contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192" name="us-gaap:DeferredRevenueNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">10,378</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Long-term operating lease liabilities</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_30bdfc3e-ff85-47d1-abc9-d7d5ce3b3297" contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192" name="us-gaap:OperatingLeaseLiabilityNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">824</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b568173b-2293-49d9-83d7-69d83e63d3f3" contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94" name="us-gaap:OperatingLeaseLiabilityNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,235</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total liabilities</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_234077c4-f2ff-4f3b-962e-cdba03d35917" contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192" name="us-gaap:Liabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">46,479</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_283d59c5-ec33-4e33-adb2-4bfef6b3a105" contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94" name="us-gaap:Liabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">18,900</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="-sec-ix-hidden:F_67670f1b-d32e-411d-94c3-bb52f2db6f60;"><span style="-sec-ix-hidden:F_7b20e3c0-5f9d-4152-8056-9265a122f74d;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Commitments and contingencies</span></span></span></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Stockholders' equity:</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Common stock, $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_98407b4f-d688-4878-adc1-d36aa1ce1490" contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192" name="us-gaap:CommonStockParOrStatedValuePerShare" unitRef="U_USDollarShare" decimals="INF"><ix:nonFraction id="F_6e72d5fb-49cd-4bfa-8350-5e6e9771e879" contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94" name="us-gaap:CommonStockParOrStatedValuePerShare" unitRef="U_USDollarShare" decimals="INF">0.0001</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;par value; </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_7b5606f6-f6c5-4f7e-9c74-e4d77b3cb78a" contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192" name="us-gaap:CommonStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_51e4ea55-a656-4d22-a0dd-321bd9ae51ce" contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94" name="us-gaap:CommonStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">200,000,000</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;shares<br />&#160;&#160;&#160;authorized as of December 31, 2022 and 2021;<br />&#160;&#160;&#160;</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c428bbfd-f44f-4f03-95e2-45f729bedf22" contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192" name="us-gaap:CommonStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_2c6eb3c4-52c6-44a7-b97c-d71170e3940c" contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192" name="us-gaap:CommonStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">34,414,149</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;and </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_48b03629-52c4-4ad8-b95f-87047f729279" contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94" name="us-gaap:CommonStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_37b0c05e-e687-401a-95fd-51d02bbda00e" contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94" name="us-gaap:CommonStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">29,455,668</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;shares issued and outstanding as of<br />&#160;&#160;&#160;December 31, 2022 and 2021, respectively</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_111485df-b612-432d-b6a9-071b27cb8c08" contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192" name="us-gaap:CommonStockValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">3</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_bff68d4a-f2dd-4f34-9800-2faaba100db2" contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94" name="us-gaap:CommonStockValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Additional paid-in capital</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_73a1fe88-633d-466b-8fbc-4ccfab64c6f0" contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192" name="us-gaap:AdditionalPaidInCapitalCommonStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">204,268</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_9c5a0a64-8a81-480f-8e8b-cd655370c593" contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94" name="us-gaap:AdditionalPaidInCapitalCommonStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">176,618</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accumulated other comprehensive income (loss)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_5b3e77ac-64ca-4158-9146-0120d03f436f" contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">76</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_9d21dc03-fe23-4280-a74c-cb48b083749f" contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">138</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accumulated deficit</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_66ca9752-9e99-4ff1-b337-c05ea499cf9b" contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192" name="us-gaap:RetainedEarningsAccumulatedDeficit" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">172,405</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_0f1bd330-47fc-4106-9cc7-e5006ac5498a" contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94" name="us-gaap:RetainedEarningsAccumulatedDeficit" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">109,977</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total stockholders' equity</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_65d1fa98-dea6-4c26-8175-42cf63ecda13" contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">31,942</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_964bd1c7-3935-477b-9161-3b0de93fab40" contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">66,505</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total liabilities and stockholders' equity</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_1fb8a7d4-09e8-419b-af49-269ae644a788" contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192" name="us-gaap:LiabilitiesAndStockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">78,421</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_27c7db4e-48d8-4ce1-95d0-452d911d1d7f" contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94" name="us-gaap:LiabilitiesAndStockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">85,405</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">See accompanying notes.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Equillium, Inc.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;" id="statements_operations_comprehensive_loss"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Consolidated Statements of Operations</span><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and Comprehensive Loss</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(In thousands, except share and per share data)</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:66.018%;"></td>
    <td style="width:1.471%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:12.783000000000001%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.471%;"></td>
    <td style="width:1.471%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:12.783000000000001%;"></td>
    <td style="width:1.0%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year Ended<br />December 31,</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year Ended<br />December 31,</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Revenue</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_7322651d-adfc-4d03-9a46-a5acea347189" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">15,759</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Operating expenses:</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Research and development</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_21d56114-b74b-4731-bd5c-a76cccff49ea" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:ResearchAndDevelopmentExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">37,547</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a29aed43-e15e-4f58-8740-d12c9ac9d4ca" contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2" name="us-gaap:ResearchAndDevelopmentExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">26,379</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Acquired in-process research and development</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a0acf332-c4eb-46ff-85f4-93d854a51f09" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="eq:AcquiredInProcessResearchAndDevelopment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">23,049</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">General and administrative</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_4e01ac6d-ecf0-4be1-b1be-5a96758a3a9f" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:GeneralAndAdministrativeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">17,239</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a9c2676d-d634-4616-940f-f966419d7890" contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2" name="us-gaap:GeneralAndAdministrativeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">11,407</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total operating expenses</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_83639d62-6e2e-4cf3-90b7-5ee83340a1b7" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:OperatingExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">77,835</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b4b305be-ecf6-4b4e-b3fb-5b1d1623b932" contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2" name="us-gaap:OperatingExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">37,786</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Loss from operations</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_154c5251-f010-4b1e-abdd-d6ca5312ab84" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:OperatingIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">62,076</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_24aa24d5-f5eb-4155-a510-f6d6ee2062e1" contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2" name="us-gaap:OperatingIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">37,786</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other expense, net:</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Interest expense</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a3650ee6-e791-416d-a574-8b0a04500c91" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:InterestExpenseDebt" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,053</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_2a721fa4-4a77-43e3-a415-8acaa3af10c8" contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2" name="us-gaap:InterestExpenseDebt" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,073</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Interest income</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_70fb4225-108f-4e9f-9619-564aa7396744" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:InvestmentIncomeInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">420</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_bb26c8cd-2fdb-4ae6-831f-d4984a94eefb" contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2" name="us-gaap:InvestmentIncomeInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">57</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other income (expense), net</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6d4e7c07-92a9-4309-bd75-d0546b96d9af" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:OtherNonoperatingIncomeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">281</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_5ac3f4d4-9cc0-4021-9d6c-65dcf9fb090d" contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2" name="us-gaap:OtherNonoperatingIncomeExpense" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">250</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total other expense, net</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c4e5372d-d1a7-48b7-946f-9a569de89202" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:NonoperatingIncomeExpense" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">352</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a2d6dd10-09cb-47d8-8554-08a8a7d3a8be" contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2" name="us-gaap:NonoperatingIncomeExpense" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">1,266</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net loss</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d5bb3589-d5b6-4e59-b6be-61d2f1d0daa5" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">62,428</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_0150caa4-f4bc-4f4a-8caf-605041b942be" contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">39,052</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other comprehensive income, net:</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unrealized loss on available-for-sale securities, net</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_759a5db3-1156-48ef-9619-7aa2873547e2" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">38</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c8d3ca62-a793-44f0-8c2a-564ec5df607d" contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">59</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Foreign currency translation gain</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_de2f9eb2-935c-4ad3-8ffc-82ebdbc02f60" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">252</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_4f28fbd6-c384-4af1-8a63-3e8f5f756790" contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">218</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total other comprehensive income, net</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a9f9bbd8-57d3-4d65-aa49-4cd745c2d629" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">214</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d56827c4-3430-4265-ab8b-a02c2af10fb0" contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">159</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Comprehensive loss</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d4f7bb47-4052-4737-9a63-8e932872890c" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:ComprehensiveIncomeNetOfTax" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">62,214</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_7da57cc7-c30a-418e-b3cd-0cd6e005d044" contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2" name="us-gaap:ComprehensiveIncomeNetOfTax" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">38,893</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net loss per share, basic and diluted</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a063aa55-2caf-4ffd-9368-a3c14394e549" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:EarningsPerShareBasic" unitRef="U_USDollarShare" scale="0" decimals="2" sign="-" format="ixt:numdotdecimal"><ix:nonFraction id="F_1a7794f0-1eda-4eeb-91ff-5d157881f846" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:EarningsPerShareDiluted" unitRef="U_USDollarShare" scale="0" decimals="2" sign="-" format="ixt:numdotdecimal">1.85</ix:nonFraction></ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8329824e-967e-4647-a3b3-c121a77e14b4" contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2" name="us-gaap:EarningsPerShareBasic" unitRef="U_USDollarShare" scale="0" decimals="2" sign="-" format="ixt:numdotdecimal"><ix:nonFraction id="F_c6927dae-5421-4090-b899-5744de435bf9" contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2" name="us-gaap:EarningsPerShareDiluted" unitRef="U_USDollarShare" scale="0" decimals="2" sign="-" format="ixt:numdotdecimal">1.36</ix:nonFraction></ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Weighted-average number of common shares outstanding, <br />&#160;&#160;&#160;basic and diluted</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_fe17d8ff-0607-4d8c-8153-b7b2d649c071" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal"><ix:nonFraction id="F_5237cd37-20dd-4d62-a385-691529193387" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">33,727,945</ix:nonFraction></ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_1b43da46-876a-4180-af52-f3e359e98765" contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal"><ix:nonFraction id="F_f13f63ad-eb7c-40c7-8839-255bcc39a3ca" contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">28,806,310</ix:nonFraction></ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">See accompanying notes.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Equillium, Inc.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;" id="statements_stockholders_equity_deficit"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Consolidated Statements of Stockhold</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ers&#x2019; Equity</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(In thousands, except share data)</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:37.514%;"></td>
    <td style="width:0.074%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:10.033999999999999%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:0.074%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:5.212%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:0.074%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:7.740999999999999%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:0.074%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:9.575000000000001%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:0.074%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:9.376000000000001%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:0.074%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:8.1%;"></td>
    <td style="width:1.0%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Additional</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accumulated<br />Other</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Common Stock</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Paid-in</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Comprehensive</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accumulated</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Stockholders'</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Shares</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Amount</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Capital</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Income (Loss)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Deficit</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Equity</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Balance at December 31, 2020</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_33cb0246-a70f-4185-9d12-5e07dbf399d3" contextRef="C_af77d479-58a1-4eb8-be05-a05f0b6de156" name="us-gaap:SharesIssued" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">24,753,102</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_369dacca-dfbc-4da6-b55f-5a1f7a60c9af" contextRef="C_af77d479-58a1-4eb8-be05-a05f0b6de156" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_61d6d966-e4a9-498b-bf21-56c62697fdfe" contextRef="C_b15585d5-5e76-4fec-adb1-0f3694e76b0d" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">141,074</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d57c7043-af59-47fc-8ec2-cbfbbf7afc3c" contextRef="C_83d4ef1f-863c-4921-aa0e-cb290fba239d" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">297</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d7b4325f-7a2f-4a9e-9179-f721c137acc2" contextRef="C_be335ae5-27dc-40a0-a672-67f87605ecfa" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">70,925</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_4d0cb6ff-514b-4144-bd02-e2377e399707" contextRef="C_593cac69-ae06-423d-93b0-db39a502796a" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">69,854</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Issuance of common stock from follow-on offering, net of issuance costs</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_af49da5f-4427-460c-9afe-99526e58f617" contextRef="C_dc409b2a-6dec-4757-a385-691c05150979" name="us-gaap:StockIssuedDuringPeriodSharesOther" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">4,285,710</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_580eccd3-e293-4479-87a4-f465c61a8223" contextRef="C_07b42072-8725-4287-82d7-ff7786912150" name="us-gaap:StockIssuedDuringPeriodValueOther" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">29,909</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a9796e1e-eb32-4302-aee1-fa42af52bc7a" contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2" name="us-gaap:StockIssuedDuringPeriodValueOther" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">29,909</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exercise of stock options</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_29855bcc-2ed8-4a5b-9b93-de554011db99" contextRef="C_dc409b2a-6dec-4757-a385-691c05150979" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">326,454</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c222dbfc-088a-4271-a6d0-3f043f111ef8" contextRef="C_07b42072-8725-4287-82d7-ff7786912150" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">891</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6e9cfb12-49c6-4adc-981a-8a455f47bc47" contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">891</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Issuance of common stock under employee stock purchase plan</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_5388a31e-5b0e-4aeb-9121-e66ccde27f29" contextRef="C_dc409b2a-6dec-4757-a385-691c05150979" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">90,402</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_48d99cdc-b411-41c2-9b1c-e06a3c3eeb49" contextRef="C_07b42072-8725-4287-82d7-ff7786912150" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">261</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b8b5463f-6429-4a68-aab5-f416fa1969ea" contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">261</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Vesting of restricted stock liability</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c75fc0e2-2ba5-4f3c-9591-d12a4b2e19a5" contextRef="C_07b42072-8725-4287-82d7-ff7786912150" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">73</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_7adfa302-e66c-43e7-a042-93d3b6854178" contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">73</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Stock-based compensation expense</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8ce11e09-dc70-4156-a26c-2d68b199a99b" contextRef="C_07b42072-8725-4287-82d7-ff7786912150" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,410</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_2c26d2ae-aad9-4a72-b111-cfc1a3280821" contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,410</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Comprehensive income</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_69159db1-16b3-497f-bda3-b8c35f96a15f" contextRef="C_211f9a22-9355-4cd5-ae5c-f45e20a3dcdc" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">159</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_90a52a14-d202-427a-888e-6195d4af629c" contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">159</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net loss</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_1974160d-18c5-4c73-9986-2cfca0caf1af" contextRef="C_157bf7c1-6ef7-43ab-b719-f85e3a11f1d5" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">39,052</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b4bc43f1-d899-46d9-b8c9-e11ce9a02c9e" contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">39,052</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Balance at December 31, 2021</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_4606e253-ff57-4147-8b00-22d0d1952750" contextRef="C_b46e12c4-af83-4e15-baf8-0903ab9bd6b5" name="us-gaap:SharesIssued" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">29,455,668</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ce7f66e9-a793-4b13-a857-02a0cdaf7f0f" contextRef="C_b46e12c4-af83-4e15-baf8-0903ab9bd6b5" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8fdac0d5-89a5-4a40-94e2-d0da243990e7" contextRef="C_2ad7083d-d4d8-4d36-9fad-554b54c6601f" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">176,618</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e605d158-a883-45e4-89c5-a383bbdd7cb7" contextRef="C_f31a63db-28e5-4d6c-8641-5e09fcfbb9ac" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">138</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e6dd910f-85e4-4475-a947-40a4d66ff950" contextRef="C_677e006f-7dec-4e8f-81db-464e67389b27" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">109,977</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_35b4403f-f481-431c-8b62-70877d2bf127" contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">66,505</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Issuance of common stock for Bioniz acquisition</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_45ae8d45-860d-43d2-a962-4710ecba9ac5" contextRef="C_71653c3b-caef-4b07-8b00-6e7024629fb3" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">4,820,230</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_3258674e-8c2b-4474-b39d-4f0f335f2a6c" contextRef="C_71653c3b-caef-4b07-8b00-6e7024629fb3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c353ef65-4cff-4b97-bcf9-6884dc630fca" contextRef="C_70c8e717-7ae0-400b-a2e5-1384948ea4b2" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">22,541</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_dfe35c6a-294b-477b-91ea-2aa6c7be6042" contextRef="C_8a38518a-9c62-4c14-a61d-b505eb2f5458" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">22,542</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Issuance of common stock under employee stock purchase plan</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_def5a5c3-0fa4-4eb4-b253-cce1a764252f" contextRef="C_900c0b60-4130-48e3-ad64-738fc1374bc7" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">138,251</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c9f82c36-8cde-4e3d-84a5-0f2aefce1695" contextRef="C_149d869a-5e0a-4913-9abe-a27afa766de4" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">215</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ed70cf89-d3db-4558-a1bb-c3f160907b41" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">215</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Vesting of restricted stock liability</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_2ad28802-e194-4d44-962c-7957ae50a5d3" contextRef="C_149d869a-5e0a-4913-9abe-a27afa766de4" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">53</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_14863160-4aaf-4f92-8bdf-e6506e8533e2" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">53</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Stock-based compensation expense</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_65f447d7-54ff-4d9c-8de4-a860f092c06f" contextRef="C_149d869a-5e0a-4913-9abe-a27afa766de4" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,841</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_cb00919f-3c13-4faf-81bc-2047a7df6edf" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,841</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Comprehensive income</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_75788ea5-c177-45c2-81cf-a9f4fcd17616" contextRef="C_e6cf51a2-311a-4401-b240-c4af424355e4" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">214</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_cf154857-9609-43d6-adea-9198847b12af" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">214</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net loss</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_fb594f71-bfe5-49c1-9740-91c1828a2e5e" contextRef="C_1498053c-86a8-4e41-8116-8cb7e9c5b74c" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">62,428</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8a553b4e-b256-4778-a892-96388b340096" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">62,428</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Balance at December 31, 2022</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6f616c1d-c6ad-4fa2-8c2e-53e2d7834c87" contextRef="C_6d2cc007-04de-46ef-a689-02aac4462b5a" name="us-gaap:SharesIssued" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">34,414,149</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_22cbc31d-430d-4e71-860b-026a185ad2b2" contextRef="C_6d2cc007-04de-46ef-a689-02aac4462b5a" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">3</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_90fc1954-3653-40be-8987-bafba62e3999" contextRef="C_f789eb1e-5a5d-41b1-8bb7-3d3ed1258e7d" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">204,268</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_958a9df7-3560-4164-9fe2-044d2dae5628" contextRef="C_1f42c1eb-d268-41b0-9bcf-d37f47a8c53a" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">76</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_83a50443-8085-4b99-a122-f5f45bb203e2" contextRef="C_3c1013be-6aec-4534-8322-81766349f268" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">172,405</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_885083bd-c245-44be-95f5-4a574920eea2" contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">31,942</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">See accompanying notes.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Equillium, Inc.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;" id="statements_cash_flows"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Consolidated Statements o</span><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">f Cash Flows</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(In thousands)</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:63.084%;"></td>
    <td style="width:1.128%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:15.643%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:0.503%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:15.643%;"></td>
    <td style="width:1.0%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year Ended<br />December 31,</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year Ended<br />December 31,</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Operating activities:</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net loss</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_2eda0e87-357a-4546-8e8e-e1d54fa02638" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:ProfitLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">62,428</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6dbdb6c3-e248-4013-abcb-ca50b0f964c6" contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2" name="us-gaap:ProfitLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">39,052</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Adjustments to reconcile net loss to cash used in operating activities:</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Acquired in-process research and development</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_bf24e39f-333e-4a8d-8d14-17d02d692dc5" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:ResearchAndDevelopmentInProcess" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">23,049</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Depreciation and amortization</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d4f20108-ae84-42dd-89d9-fea4e0c79ce8" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:DepreciationAndAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">118</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_93cad7c9-dabb-4770-bea6-c129c4cbed59" contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2" name="us-gaap:DepreciationAndAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">72</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Stock-based compensation</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e8ae27fd-1d0b-4d6c-b669-dbbe2facf72b" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:ShareBasedCompensation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,841</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_21ee58ec-dae7-4fb6-96d6-e62692f8a938" contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2" name="us-gaap:ShareBasedCompensation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,410</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net unrealized loss on foreign currency transactions</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_4d342a2b-2d86-47df-8d11-ed974f390627" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:ForeignCurrencyTransactionGainLossUnrealized" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">260</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d52612af-d4e8-4566-a863-c25093d5b75f" contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2" name="us-gaap:ForeignCurrencyTransactionGainLossUnrealized" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">240</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Amortization of term loan discount and issuance costs</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8b91f358-6e4a-4992-a295-7f3e9ea21069" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">203</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a708a469-fabd-4503-a005-3d1a43a8e65e" contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">237</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Amortization of investments, net</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f8027d26-16c4-4461-a6e3-36e5c57f3a9a" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">127</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a926d384-3d94-4f79-8311-bd9e5be3fbc4" contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2" name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">314</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Deferred revenue</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_03e22572-5612-4363-a3b6-074800ad8ebb" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:IncreaseDecreaseInDeferredRevenue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">25,078</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Changes in operating assets and liabilities:</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accounts receivable</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_04be2b9f-8040-4655-8c10-d936824a8735" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:IncreaseDecreaseInAccountsReceivable" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,838</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Prepaid expenses and other current assets</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_0699e069-ca1c-450a-865c-e8d07c10184b" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">158</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_9844029d-1ee7-4114-94cd-e063b1cc961b" contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">214</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accounts payable</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_bb14faa4-288c-4824-a635-fcc100164e45" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:IncreaseDecreaseInAccountsPayable" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,508</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f4f0df6c-3395-42fa-b442-5b07209f9610" contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2" name="us-gaap:IncreaseDecreaseInAccountsPayable" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">1,578</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accrued expenses</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_648627c5-2b77-4f13-9ed0-ac247ac33fb9" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">432</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d8396eee-2fdd-496b-b9dc-cc9ff86b477c" contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,099</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Right-of-use assets and lease liabilities, net</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d0c488fe-b500-492f-8d89-32f829adaf55" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="eq:IncreaseDecreaseInRightOfUseAssetsAndLeaseLiabilitiesNet" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">75</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_9d357bc9-24b9-423b-9212-b708083d9921" contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2" name="eq:IncreaseDecreaseInRightOfUseAssetsAndLeaseLiabilitiesNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">37</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net cash used in operating activities</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_64a5a7fa-85af-44c3-bec1-671b71c6efe6" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">8,733</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_08bf0511-1bee-44bc-a0d9-39e408f5738a" contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">32,081</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Investing activities:</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Purchases of property and equipment</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e6ebd948-7205-4f97-ae22-482456c95488" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">279</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8922767a-a1a5-4a75-81c7-9627b2deb091" contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">57</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Purchases of short-term investments</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_afe05314-618b-412e-a2b6-2ca3e4567f7b" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:PaymentsToAcquireShortTermInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">14,962</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c7cbcdc4-2454-4000-985a-4a38fcfd4048" contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2" name="us-gaap:PaymentsToAcquireShortTermInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">32,992</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Maturities of short-term investments</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a5f78ab1-1922-4aaa-838e-d7a575ac8491" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">33,225</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_2b9d0d3e-a3cf-4a2b-8ddf-70bf51f57b36" contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">60,455</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cash acquired in Bioniz acquisition</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e5b0d7b1-7c00-48c4-8997-459d6354662d" contextRef="C_8a38518a-9c62-4c14-a61d-b505eb2f5458" name="us-gaap:CashAcquiredFromAcquisition" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">700</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net cash provided by investing activities</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b32e9bb6-216b-4b28-a566-021ed2674d03" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">18,684</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d3eb389a-0439-4d8a-ac3b-f40135dc0582" contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">27,406</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Financing activities:</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Proceeds from issuance of common stock from follow-on offering, net of issuance costs</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_dc49c0d0-f6a2-481e-9b1f-1a95b6582926" contextRef="C_8a5bef62-cef2-4949-81e3-78ec03bd91d4" name="us-gaap:ProceedsFromIssuanceOfCommonStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">29,909</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Principal repayments on notes payable</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_7dc9d47b-d879-4bee-962a-865de294ff0c" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:RepaymentsOfNotesPayable" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,429</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Proceeds from exercise of stock options</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ffcb1bcc-2771-43bf-928b-8f842ea18d0d" contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2" name="us-gaap:ProceedsFromStockOptionsExercised" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">891</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Proceeds from ESPP purchases</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_28aa36e9-c858-4b6f-aefa-9cd5b8476dd7" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:ProceedsFromStockPlans" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">214</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_4e313dda-b820-48c4-81e3-d1024cbc4f88" contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2" name="us-gaap:ProceedsFromStockPlans" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">261</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net cash (used in) provided by financing activities</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_139d0111-2efa-4bab-9467-5f61e8aedd4e" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">1,215</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_08afe9a0-b009-4841-84bb-aab3eeca2d08" contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">31,061</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Effect of exchange rate changes on cash and cash equivalents</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e9eebe71-c48a-43e4-802d-b8660fd917cc" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">5</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_fe9b79ab-c3f7-47cb-afcd-66f0e3314ba9" contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">2</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net increase in cash and cash equivalents</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a535ab97-3272-48e3-bf67-660c428ae0a7" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">8,741</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_30b010b4-b686-4b45-a38c-cc26be61bfa6" contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">26,384</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cash and cash equivalents at beginning of period</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_3a9b6414-9d1a-49c1-93f6-e861c085fb07" contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">50,366</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a8b40bc6-9cfc-458e-8b23-071f094621d7" contextRef="C_593cac69-ae06-423d-93b0-db39a502796a" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">23,982</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cash and cash equivalents at end of period</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_2a12ef6c-8876-40a7-8278-bf3fc985d342" contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">59,107</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_2181bfa3-18f0-49b4-bbef-666b4c6e2eec" contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">50,366</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Supplemental cash flow information:</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cash paid for interest</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_fe3061c6-8852-432f-8b97-2f46c6861fef" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:InterestPaidNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">847</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_04952975-b5ec-4415-b667-5054c7868728" contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2" name="us-gaap:InterestPaidNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">836</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Fair value of Bioniz assets acquired</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_210ed8a6-5424-486f-8091-3c0084e4058a" contextRef="C_8a38518a-9c62-4c14-a61d-b505eb2f5458" name="us-gaap:FairValueOfAssetsAcquired" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">23,049</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Issuance of common stock for Bioniz acquisition</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_7b5f0979-e64b-46fc-8ba8-71768c95285a" contextRef="C_8a38518a-9c62-4c14-a61d-b505eb2f5458" name="us-gaap:StockIssued1" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">22,542</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Bioniz net liabilities assumed</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_1082750d-9640-40bf-9b55-8dd7f508b09c" contextRef="C_8a38518a-9c62-4c14-a61d-b505eb2f5458" name="us-gaap:LiabilitiesAssumed1" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">507</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Right-of-use assets obtained in exchange for lease obligations</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_78a3d9dd-3043-44b1-9f5c-f1b2cba4ae01" contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,759</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Amounts included in accounts payable for purchases of property and equipment</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b8aa8552-c1a6-4eb4-a282-8dfef4890e28" contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">14</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">See accompanying notes.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="notestoconsolidatedfinancialstatements"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></p>
  <div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_c62a4021-9d93-4730-8f35-d576ff9884f1" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" escape="true" continuedAt="F_c62a4021-9d93-4730-8f35-d576ff9884f1_1"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1. Organization and Accounting Pronouncements</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Description of Business</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Equillium, Inc. (the Company) was incorporated in the state of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_332f8cac-3c2c-4c14-8327-37ae50600e02" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Delaware</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> on </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_e4e606cb-1e4f-434d-8c55-44e62f468bc7" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="dei:EntityIncorporationDateOfIncorporation" format="ixt:datemonthdayyearen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">March 16, 2017</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. The Company is a clinical-stage biotechnology company </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">leveraging a deep understanding of immunobiology to develop novel therapeutics to treat severe autoimmune and inflammatory (immuno-inflammatory), disorders with high unmet medical need. The Company&#x2019;s strategy is focused on advancing the clinical development of its product candidates, including potentially pursuing additional indications and acquiring new product candidates and platforms to expand its pipeline. The Company intends to commercialize its product candidates either independently or through partnerships or otherwise monetize its pipeline through strategic transactions.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company's current clinical-stage product candidates consist of EQ101, EQ102 and itolizumab (EQ001). EQ101 and EQ102 are synthetic peptides engineered to specifically inhibit key disease-driving, clinically validated cytokine targets aimed at addressing unmet needs across a range of immuno-inflammatory indications. EQ101 is a first-in class, selective, tri-specific inhibitor of IL-2, IL-9 and IL-15, and EQ102 is a first-in class, selective, bi-specific inhibitor of IL-15 and IL-21. Itolizumab (EQ001) is a first-in-class monoclonal antibody that selectively targets the immune checkpoint receptor CD6, which plays a central role in the modulation of effector T cell, or T</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:sub;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">eff</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> cell, activity and trafficking that drives a number of immuno-inflammatory diseases across multiple therapeutic areas. The Company's novel and differentiated pipeline of first-in-class immunology assets has the potential to address unmet medical needs in numerous areas, including dermatology, gastroenterology, transplant science, hematology, rheumatology, oncology and pulmonology.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">From inception through December 31, 2022, the Company has devoted substantially all of its efforts to organizing and staffing the Company, business planning, raising capital, in-licensing rights to itolizumab (EQ001), conducting non-clinical research, filing three Investigational New Drug applications (INDs), conducting clinical development of the Company's product candidates, conducting business development activities such as the acquisition of Bioniz Therapeutics, Inc. (Bioniz),  the Asset Purchase Agreement with Ono Pharmaceutical Co., Ltd. (Ono) and other transactions not completed, and the general and administrative activities associated with operating a public company.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Liquidity and Business Risks</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31, 2022, the Company had $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e2567229-95dc-4fd6-8b06-a2b2f23a46aa" contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192" name="us-gaap:CashCashEquivalentsAndShortTermInvestments" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">71.0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million in cash, cash equivalents and short-term investments. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company has incurred significant operating losses and negative cash flows from operations. The Company expects to use its cash, cash equivalents, and short-term investments to fund research and development of its product candidates, for potentially acquiring and conducting research and development of new products, and for working capital and other general corporate purposes. The Company does not expect to generate any revenues from product sales unless and until the Company successfully completes development and obtains regulatory approval of any of its product candidates, which is unlikely to happen within the next 12 months, if ever. Accordingly, until such time as the Company can generate significant revenue from sales of its product candidates, if ever, the Company expects to finance its cash needs through a combination of equity offerings, debt financings, and collaboration and license agreements, such as its Asset Purchase Agreement with Ono. However, the Company may not be able to secure additional financing or enter into such other arrangements in a timely manner or on favorable terms, if at all. As a result of the conflict between Russia and Ukraine, bank failures, inflationary pressures on the economy and monetary policy responses taken by government agencies and other macroeconomic factors, the global credit and financial markets have experienced extreme volatility, including diminished liquidity and credit availability, declines in consumer confidence, declines in economic growth and uncertainty about economic stability. There can be no assurance that further deterioration in credit and financial markets and confidence in economic conditions will not occur. If equity and credit markets deteriorate, it may make any necessary debt or equity financing more difficult to obtain, more costly and/or more dilutive. The Company&#x2019;s failure to raise capital or enter into such other arrangements when needed would have a negative impact on the Company&#x2019;s financial condition and could force the Company to delay, reduce or terminate its research and development programs or other operations, or grant rights to develop and market product candidates that the Company would otherwise prefer to develop and market itself. Management believes that the Company&#x2019;s cash, cash equivalents and short-term investments as of December 31, 2022 will be sufficient to fund operations for at least the next 12 months from the date this Annual Report on Form 10-K is filed with the Securities and Exchange Commission (SEC).</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Basis of Presentation</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The accompanying consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (GAAP) and the rules and regulations of the SEC. Any reference in these notes to applicable guidance</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">is meant to refer to GAAP as found in the Accounting Standards Codification (ASC) and Accounting Standards Updates (ASU) promulgated by the Financial Accounting Standards Board (FASB).</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Principles of Consolidation</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The accompanying consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Foreign Currency Translation</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company&#x2019;s wholly-owned subsidiary in Australia uses its local currency as its functional currency. Assets and liabilities are translated into U.S. dollars at quarter-end exchange rates and revenues and expenses are translated at average exchange rates during the year-to-date periods. Foreign currency translation adjustments for the reported periods are included in accumulated other comprehensive income in the Company&#x2019;s consolidated statements of comprehensive loss, and the cumulative effect is included in the stockholders&#x2019; equity section of the Company&#x2019;s consolidated balance sheets.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_27991cad-17a8-4131-82ae-da6a0be2f5ee" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" escape="true" continuedAt="F_27991cad-17a8-4131-82ae-da6a0be2f5ee_1"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Recently Issued and Recently Adopted Accounting Pronouncements</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In June 2016, the FASB issued ASU No. 2016-13, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Measurement of Credit Losses on Financial Instruments</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, which will require a reporting entity to use a new forward-looking impairment model for most financial assets that generally will result in the earlier recognition of allowances for losses. The ASU, along with related amendments, revised the measurement of credit losses for financial assets measured at amortized cost from an incurred loss to an expected loss methodology. The ASU affected receivables, debt securities, net investment in leases, and most other financial assets that represent a right to receive cash. The Company </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_dfe66253-788d-4b4d-8dff-866c6c26a95b" contextRef="C_69239b5b-2176-4437-a3e8-98a7b914e359" name="us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted" format="ixt:booleantrue"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">adopted</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> this standard effective </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_ed27e405-9b75-4173-b6cc-509b674091f8" contextRef="C_69239b5b-2176-4437-a3e8-98a7b914e359" name="us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate" format="ixt:datemonthdayyearen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">January 1, 2022</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> using the modified retrospective approach. Due to the nature of the Company's investment portfolio, the adoption of the guidance did</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_4ea35248-bbd4-4533-8fc5-a586e33df2bb" contextRef="C_69239b5b-2176-4437-a3e8-98a7b914e359" name="us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect" format="ixt:booleantrue"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> no</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">t have a material effect on the Company's consolidated financial statements and no allowance was recorded for expected credit losses.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></ix:nonNumeric></div></ix:nonNumeric></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span><ix:continuation id="F_c62a4021-9d93-4730-8f35-d576ff9884f1_1"><span><ix:continuation id="F_27991cad-17a8-4131-82ae-da6a0be2f5ee_1"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">From time to time, new accounting pronouncements are issued by the FASB or other standard setting bodies that are adopted by the Company as of the specified effective date. The Company has evaluated recently issued pronouncements and does not believe any will have a material impact on the Company's consolidated financial statements or related financial statement disclosures. Other accounting standard updates effective for interim and annual periods beginning after December 31, 2022 are not expected to have a material impact on the Company&#x2019;s financial position, results of operations or cash flows.</span></ix:continuation></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></ix:continuation></span><span style=""></span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">   </span></p>
  <div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_968158cc-8932-4a7a-be1e-60718a4912a4" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:SignificantAccountingPoliciesTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2. Summary of Significant Accounting Policies</span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_c3898495-bf04-47b4-95bb-0fd4cec04c09" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:UseOfEstimates" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Use of Estimates</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The preparation of the Company&#x2019;s consolidated financial statements requires the Company to make estimates and assumptions that impact the reported amounts of assets, liabilities and expenses and the disclosure of contingent assets and liabilities in the consolidated financial statements and accompanying notes. Significant estimates in the Company&#x2019;s consolidated financial statements relate to accrued research and development expense, revenue recognition and the valuation of equity awards. Management evaluates its estimates on an ongoing basis. Although estimates are based on the Company&#x2019;s historical experience, knowledge of current events, and actions it may undertake in the future, actual results may ultimately materially differ from these estimates and assumptions.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></ix:nonNumeric></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_bf558d1e-1f50-4570-b17e-82ef512803a6" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:ConcentrationRiskCreditRisk" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Concentration of Credit Risk and Off-Balance Sheet Risk</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Financial instruments which potentially subject the Company to significant concentration of credit risk consist of cash and cash equivalents and short-term investments. The Company maintains deposits in federally insured financial institutions in excess of federally insured limits. The Company has not experienced any losses in such accounts, and management believes that the Company is not exposed to significant credit risk due to the financial position of the depository institutions in which those deposits are held. The Company&#x2019;s investment policy includes guidelines for the quality of the related institutions and financial instruments and defines allowable investments that the Company may invest in, which the Company believes minimizes the exposure to concentration of credit risk.</span></p></ix:nonNumeric></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_3425b429-fdaf-4705-b173-33b2a4c8c83c" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:ComprehensiveIncomePolicyPolicyTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Comprehensive Loss</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company is required to report all components of comprehensive loss, including net loss, in the consolidated financial statements in the period in which they are recognized. Comprehensive loss is defined as the change in equity during a period from transactions and other events and circumstances from non-owner sources, including unrealized gains and losses on investments and foreign currency gains and losses. Other comprehensive income, net includes unrealized losses and gains on short-term investments as well as foreign currency translation gains and losses.</span></p></ix:nonNumeric></div><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></ix:exclude><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_5bb4a8ef-2802-482d-a6b5-56ef92d67fd3" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Cash and Cash Equivalents</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cash and cash equivalents include cash in readily available checking and savings accounts, and money market funds. The Company considers all highly liquid investments with an original maturity of three months or less from the date of purchase to be cash equivalents. At December 31, 2022 and 2021, the Company's cash and cash equivalents were primarily comprised of money market funds.</span></p></ix:nonNumeric></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_16578163-1bc5-422a-a219-dfffda919932" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="eq:ShortTermInvestmentsPolicyTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Short-Term Investments</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Available-for-sale securities are carried at fair value, with the unrealized gains and losses reported in comprehensive loss. The amortized cost of available-for-sale debt securities is adjusted for amortization of premiums and accretion of discounts to maturity. Such amortization and accretion are included in interest income. Realized gains and losses and declines in value judged to be other-than-temporary, if any, on available-for-sale securities are included in other income or expense. The cost of securities sold is based on the specific identification method. Interest and dividends on securities classified as available-for-sale are included in interest income.</span></p></ix:nonNumeric></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_9c666fef-73e4-40da-8b94-bd92e9125dcd" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:ReceivablesPolicyTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Accounts Receivable</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accounts receivable includes trade accounts receivables from the Ono Asset Purchase Agreement (see Note 9). Reimbursable costs that have not been invoiced as of the balance sheet date are recorded as unbilled accounts receivable. As of December 31, 2022, the Company had unbilled accounts receivable totaling $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_32866f53-af49-43ee-a3f8-8d2bb29b9ae3" contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192" name="us-gaap:AccountsReceivableNetCurrent" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">2.8</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million classified as accounts receivable on its consolidated balance sheet. As of December 31, 2021, the Company did </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a39562c3-06eb-449a-b7fc-a1555d8eb2bb" contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94" name="us-gaap:AccountsReceivableNetCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt-sec:numwordsen">no</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">t have any amount recorded within accounts receivable on its consolidated balance sheet. The Company makes judgments as to its ability to collect outstanding receivables and provide an allowance for receivables when collection becomes doubtful. Allowance for credit risk for accounts receivables  are established based on various factors including credit profiles of the Company&#x2019;s customers, historical payments and current economic trends. The Company reviews its allowance for accounts receivables by assessing individual accounts receivable over a specific aging and amount.  The estimate of expected credit losses is based on information about past events, current economic conditions, and forecasts of future economic conditions that affect the collectability. Accounts receivable are written-off on a case by case basis, net of any amounts that may be collected. As of each of December 31, 2022 and 2021, </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_73a697ad-7281-4309-998f-cc0efd111058" contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" unitRef="U_USD" scale="3" decimals="-3" format="ixt-sec:numwordsen"><ix:nonFraction id="F_7c1a2b48-42cb-4445-93fe-e47c9d9e1d4d" contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" unitRef="U_USD" scale="3" decimals="-3" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> credit losses have been recorded by the Company.</span></p></ix:nonNumeric></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_91540477-194f-45f3-8ea6-214bdbac9b1a" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="eq:PrepaidExpensesAndOtherCurrentAssetsPolicyPolicyTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Prepaid Expenses and Other Current Assets</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Prepaid expenses and other current assets primarily represent amounts related to director and officer insurance, preclinical research and clinical study agreements, equity issuance costs and an estimated tax refund from the Australian Tax Office for eligible research and development expenditures.</span></p></ix:nonNumeric></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_dd6acc5b-3250-42d7-98f8-1c25dcc17255" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" escape="true" continuedAt="F_dd6acc5b-3250-42d7-98f8-1c25dcc17255_1"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Property and Equipment</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p></ix:nonNumeric></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span><ix:continuation id="F_dd6acc5b-3250-42d7-98f8-1c25dcc17255_1"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Property and equipment is stated at cost and depreciated using the straight-line method over the estimated useful lives of the assets (generally </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="-sec-ix-hidden:F_25b946aa-ecb7-4d36-9827-13132f6bd5be;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">three</span></span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> to </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_5ce4fd9d-f20e-4140-ae71-f4e8c899ad6c" contextRef="C_6c6eb418-4e31-405d-80e2-4eeaa0ed0949" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:durwordsen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">five years</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">).</span></ix:continuation></span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_dd35255a-2855-4b8e-905f-c89a39c1c2ab" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:LesseeLeasesPolicyTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Leases</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company determines if an arrangement is a lease at inception. Lease right-of-use assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. For operating leases with an initial term greater than 12 months, the Company recognizes operating lease right-of-use assets and operating lease liabilities based on the present value of lease payments over the lease term at the commencement date. Operating lease right-of-use assets are comprised of the lease liability plus any lease payments made and excludes lease incentives. Lease terms include options to renew or terminate the lease when we are reasonably certain that the renewal option will be exercised or when it is reasonably certain that the termination option will not be exercised. For our operating leases, if the interest rate used to determine the present value of future lease payments is not readily determinable, the Company estimates its incremental borrowing rate as the discount rate for the lease. Our incremental borrowing rate is estimated to approximate the interest rate on a collateralized basis with similar terms and payments, and in similar economic environments. Lease expense for lease payments is recognized on a straight-line basis over the lease term. The Company has elected the practical expedient to not separate lease and non-lease components.</span></p></ix:nonNumeric></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_09f8d620-7aa6-4861-a075-763eb14fbb99" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Impairment of Long-Lived Assets</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Long-lived </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">assets consist primarily of property and equipment. An impairment loss is recorded if and when events and circumstances indicate that assets might be impaired and the undiscounted cash flows estimated to be generated by those</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9</span></p>
       <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">assets </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">are less than the carrying amount of those assets. While the Company&#x2019;s current and historical operating losses and negative cash flows are indicators of impairment, management believes that future cash flows to be received support the carrying value of its long-lived assets and, accordingly, has not recognized any impairment losses since inception.</span></p></ix:nonNumeric></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_a3e08e78-3e74-4931-8390-304ed7e97085" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="eq:AccruedResearchAndDevelopmentExpensePolicyTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Accrued Research and Development Expense</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company is required to estimate its expenses resulting from its obligations under contracts with vendors, consultants and contract research organizations, in connection with conducting research and development activities. The financial terms of these contracts are subject to negotiations, which vary from contract to contract and may result in payment flows that do not match the periods over which materials or services are provided under such contracts. The Company reflects research and development expenses in its consolidated financial statements by matching those expenses with the period in which services and efforts are expended. The Company accounts for these expenses according to the progress of the nonclinical or clinical study as measured by the timing of various aspects of the study or related activities. The Company determines accrual estimates through review of the underlying contracts along with preparation of financial models taking into account discussions with research and other key personnel as to the progress of studies, or other services being conducted. During the course of a non-clinical study or clinical study, the Company adjusts its rate of expense recognition if actual results differ from its estimates. The Company classifies its estimates for accrued research and development expenses as accrued expenses on the accompanying consolidated balance sheet.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></ix:nonNumeric></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_77a7033d-f9f3-4987-9bec-88711ee8d928" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="eq:AustralianResearchAndDevelopmentTaxIncentivePolicyTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Australian Research and Development Tax Incentive</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company is eligible under the Australian Research and Development Tax Incentive Program, or the Tax Incentive, to obtain a cash refund from the Australian Taxation Office for eligible research and development expenditures. To be eligible, the Company must have revenue of less than AUD $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_3ac57557-7965-40de-bb87-995b9ba193a2" contextRef="C_118d4267-0758-4b9a-ac2a-e75bcfe13d76" name="eq:ResearchAndDevelopmentTaxIncentiveRevenueCriteria" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">20.0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million during the reimbursable period and cannot be controlled by income tax exempt entities. The Tax Incentive is recognized as a reduction to research and development expense when there is reasonable assurance that the Tax Incentive will be received, the relevant expenditure has been incurred, and the amount can be reliably measured. The Company classifies its estimate for the Tax Incentive as prepaid expenses and other current assets on the accompanying consolidated balance sheet. As of December 31, 2022 and 2021, the Company recorded $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_08e197e0-eda9-4710-b8b6-6ade26096993" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="eq:PrepaidAndOtherCurrentAssetsTaxIncentive" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">1.0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_bf14a918-3a7c-4188-8aa9-792c8d934760" contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2" name="eq:PrepaidAndOtherCurrentAssetsTaxIncentive" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">0.3</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> within  prepaid and other current assets attributed to the Tax Incentive, respectively.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></ix:nonNumeric></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_9855419a-9e00-432a-9dc7-533b815e7cd2" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:RevenueRecognitionPolicyTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Revenue Recognition</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company recognizes revenue in a manner that depicts the transfer of control of a product or a service to a customer and reflects the amount of the consideration the Company is entitled to receive in exchange for such product or service. In doing so, the Company follows a five-step approach: (i) identify the contract with a customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, (iv) allocate the transaction price to the performance obligations, and (v) recognize revenue when (or as) the customer obtains control of the product or service. The Company considers the terms of a contract and all relevant facts and circumstances when applying the revenue recognition standard. The Company applies the revenue recognition standard, including the use of any practical expedients, consistently to contracts with similar characteristics and in similar circumstances.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">A customer is a party that has entered into a contract with the Company, where the purpose of the contract is to obtain a product or a service that is an output of the Company&#x2019;s ordinary activities in exchange for consideration. To be considered a contract, (i) the contract must be approved (in writing, orally, or in accordance with other customary business practices), (ii) each party&#x2019;s rights regarding the product or the service to be transferred can be identified, (iii) the payment terms for the product or the service to be transferred can be identified, (iv) the contract must have commercial substance (that is, the risk, timing or amount of future cash flows is expected to change as a result of the contract), and (v) it is probable that the Company will collect substantially all of the consideration to which it is entitled to receive in exchange for the transfer of the product or the service.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">A performance obligation is defined as a promise to transfer a product or a service to a customer. The Company identifies each promise to transfer a product or a service (or a bundle of products or services, or a series of products and services that are substantially the same and have the same pattern of transfer) that is distinct. A product or a service is distinct if both (i) the customer can benefit from the product or the service either on its own or together with other resources that are readily available to the customer and (ii) the Company&#x2019;s promise to transfer the product or the service to the customer is separately identifiable from other promises in the contract. Each distinct promise to transfer a product or a service is a unit of accounting for revenue recognition. If a promise to transfer a product or a service is not separately identifiable from other promises in the contract, such promises should be combined into a single performance obligation.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10</span></p>
       <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The transaction price is the amount of consideration the Company is entitled to receive in exchange for the transfer of control of a product or a service to a customer. To determine the transaction price, the Company considers the existence of any significant financing component, the effects of any variable elements, noncash considerations and consideration payable to the customer. If a significant financing component exists, the transaction price is adjusted for the time value of money. If an element of variability exists, the Company must estimate the consideration it expects to receive and uses that amount as the basis for recognizing revenue as the product or the service is transferred to the customer. There are two methods for determining the amount of variable consideration: (i) the expected value method, which is the sum of probability-weighted amounts in a range of possible consideration amounts, and (ii) the mostly likely amount method, which identifies the single most likely amount in a range of possible consideration amounts.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If a contract has multiple performance obligations, the Company allocates the transaction price to each distinct performance obligation in an amount that reflects the consideration the Company is entitled to receive in exchange for satisfying each distinct performance obligation. For each distinct performance obligation, revenue is recognized when (or as) the Company transfers control of the product or the service applicable to such performance obligation.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In those instances where the Company first receives consideration in advance of satisfying its performance obligation, the Company classifies such consideration as deferred revenue until (or as) the Company satisfies such performance obligation. In those instances where the Company first satisfies its performance obligation prior to its receipt of consideration, the consideration is recorded as accounts receivable.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company expenses incremental costs of obtaining and fulfilling a contract as and when incurred if the expected amortization period of the asset that would be recognized is one year or less, or if the amount of the asset is immaterial. Otherwise, such costs are capitalized as contract assets if they are incremental to the contract and amortized to expense proportionate to revenue recognition of the underlying contract.</span></p></ix:nonNumeric></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_65ab6737-a827-449c-b3c0-b9e4f74fcaeb" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="eq:ContractAssetsPolicyPolicyTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Contract Assets</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company does not have material amounts of contract assets since revenue is recognized as control of goods is transferred or as services are performed. There are a small number of research and development services that may occur over a period of time, but that period of time is generally very short in duration. Any contract assets that may arise are recorded in accounts receivable in the Company&#x2019;s consolidated balance sheet net of an allowance for credit losses.</span></p></ix:nonNumeric></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_8383f712-9b44-41c2-8b7c-e0649ac3dfd6" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="eq:ContractLiabilitiesPolicyPolicyTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Contract Liabilities</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company&#x2019;s contract liabilities consist of advance payments and deferred revenue. The Company classifies advance payments and deferred revenue as current or noncurrent based on the timing of when it expects to recognize revenue. Generally, all contract liabilities are expected to be recognized within one year and are included in deferred revenue in the Company&#x2019;s consolidated balance sheet. The noncurrent portion of deferred revenue is included and separately disclosed in the Company&#x2019;s consolidated balance sheet.</span></p></ix:nonNumeric></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_e3faeb9b-d61e-41be-9e26-a832ba32f1eb" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:InProcessResearchAndDevelopmentPolicy" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Acquired In-Process Research and Development Expense</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company has acquired, and may continue to acquire, the rights to develop new product candidates. Payments to acquire a new product candidate, as well as future milestone payments associated with asset acquisitions in which contingent payments are resolved are immediately expensed as acquired in-process research and development provided that the product candidate has not achieved regulatory approval for marketing and, absent obtaining such approval, has no alternative future use.</span></p></ix:nonNumeric></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_565bfba3-1b5c-416d-b808-95e9507f0e7f" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:ResearchAndDevelopmentExpensePolicy" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Research and Development</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Research and development expenses include salaries and related overhead expenses, non-cash stock-based compensation expense, external research and development expenses incurred under arrangements with third parties, costs of services performed by consultants and contract research organizations, and regulatory costs including those related to preparing and filing INDs with the FDA. Research and development costs are expensed as incurred.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></ix:nonNumeric></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_ec7d2825-a96c-45e6-8cf1-d4340362dddb" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="eq:PatentCostsPolicyTextBlock" escape="true" continuedAt="F_ec7d2825-a96c-45e6-8cf1-d4340362dddb_1"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Patent Costs</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p></ix:nonNumeric></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span><ix:continuation id="F_ec7d2825-a96c-45e6-8cf1-d4340362dddb_1"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company expenses all costs as incurred in connection with patent applications (including direct application fees, and the legal and consulting expenses related to making such applications) and such costs are included in general and administrative expenses in the consolidated statement of operations.</span></ix:continuation></span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></ix:exclude><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_0529d847-d62e-4e2b-9611-710a5cc35720" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Stock-based Compensation</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company measures employee and nonemployee stock-based awards, including stock options and purchase rights, at grant-date fair value and records compensation expense on a straight-line basis over the vesting period of the award. The Company uses the Black-Scholes option pricing model to value its stock option awards. Estimating the fair value of stock option awards requires management to apply judgment and make estimates of certain assumptions, including the volatility of the Company&#x2019;s common stock, the expected term of the Company&#x2019;s stock options, the expected dividend yield and the fair value of the Company&#x2019;s common stock on the measurement date. As a result, if factors change and management uses different assumptions, stock-based compensation expense could be materially different for future awards.</span></p></ix:nonNumeric></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_4bd2f5f8-3da6-4912-b49f-77d108006ab0" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:IncomeTaxPolicyTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Income Taxes</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company accounts for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the consolidated financial statements. Under this method, deferred tax assets and liabilities are determined on the basis of the differences between the consolidated financial statements and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in income in the period that includes the enactment date.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company recognizes deferred tax assets to the extent that the Company believes these assets are more likely than not to be realized. In making such a determination, management considers all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax-planning strategies, and results of recent operations. If management determines that the Company would be able to realize its deferred tax assets in the future in excess of their net recorded amount, management would make an adjustment to the deferred tax asset valuation allowance, which would reduce the provision for income taxes.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company records uncertain tax positions on the basis of a two-step process whereby (1) management determines whether it is more likely than not that the tax positions will be sustained on the basis of the technical merits of the position and (2) for those tax positions that meet the more- likely-than-not recognition threshold, management recognizes the largest amount of tax benefit that is more than </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_917eb0f7-0a59-4eee-a200-c1a8eee51986" contextRef="C_6658e49b-c37e-401c-873e-60a833ca00d9" name="eq:PercentageOfTaxBenefitToBeRealizedUponUltimateSettlementWithTaxAuthority" unitRef="U_pure" scale="-2" decimals="2" format="ixt:numdotdecimal">50</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> percent likely to be realized upon ultimate settlement with the related tax authority. The Company recognizes interest and penalties related to unrecognized tax benefits within income tax expense. Any accrued interest and penalties are included within the related tax liability.</span></p></ix:nonNumeric></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_e65bf5e3-3640-4bdc-ac2d-2c5324a6121a" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:EarningsPerSharePolicyTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Net Loss per Share</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Basic net loss per share is calculated by dividing the net loss by the weighted-average number of common shares outstanding for the period. Diluted net loss per share is computed by dividing the net loss by the weighted average number of common shares and common share equivalents outstanding for the period. Common stock equivalents are only included when their effect is dilutive. The Company&#x2019;s potentially dilutive securities include outstanding options under the Company&#x2019;s equity incentive plan and outstanding warrants to purchase common stock, each of which have been excluded from the computation of diluted net loss per share as they would be anti-dilutive to the net loss per share. For all periods presented, there is no difference in the number of shares used to calculate basic and diluted shares outstanding due to the Company&#x2019;s net loss position.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_4b2c1c2c-8c56-4b37-91af-e59394302e1b" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Potentially dilutive securities not included in the calculation of diluted net loss per share attributable to common stockholders because to do so would be anti-dilutive are as follows (in common stock equivalent shares):</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
        <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;">
         <tr style="visibility:collapse;">
          <td style="width:61.855%;"></td>
          <td style="width:0.994%;"></td>
          <td style="width:1.0%;"></td>
          <td style="width:15.388%;"></td>
          <td style="width:1.0%;"></td>
          <td style="width:1.279%;"></td>
          <td style="width:1.009%;"></td>
          <td style="width:1.0%;"></td>
          <td style="width:15.474%;"></td>
          <td style="width:1.0%;"></td>
         </tr>
         <tr style="height:8.0pt;">
          <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="7" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year Ended<br />December 31,</span></p></td>
          <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:8.0pt;">
          <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
          <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
          <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Common stock options</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e953f4ed-5047-4451-ace2-4777fe850c61" contextRef="C_b6dbee35-e2f1-45ca-95ca-0d1198cb8c23" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">5,102,501</ix:nonFraction></span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_1c391dda-3401-4d27-a4de-d8ed5dd2618f" contextRef="C_d6cbfdc9-1278-4b59-8f64-1c4df657d268" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">3,947,025</ix:nonFraction></span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Common stock warrants</span></p></td>
          <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e463fbf9-7a12-4d3c-b48e-60f68d034d2a" contextRef="C_266429a4-9ee0-4360-bdef-2bb916cfaeee" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">1,366,141</ix:nonFraction></span></p></td>
          <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_be65e261-768b-4c68-b80c-5137d2eab6ad" contextRef="C_b6ed3cd2-aa70-4e39-9223-49223b495228" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">1,366,141</ix:nonFraction></span></p></td>
          <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_995710ea-64cf-4136-a27f-28548fa1d929" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">6,468,642</ix:nonFraction></span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_cbbd40df-433f-4b28-ade8-72f65fbed1c7" contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">5,313,166</ix:nonFraction></span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
         </tr>
        </table></ix:nonNumeric></div></ix:nonNumeric></div></ix:nonNumeric></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_cbd3d599-5b1d-41bb-9056-88dc58cf5e96" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:FairValueDisclosuresTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3. Fair Value of Financial Instruments</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The accounting guidance defines fair value, establishes a consistent framework for measuring fair value and expands disclosure for each major asset and liability category measured at fair value on either a recurring or nonrecurring basis. Fair value is defined as an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. As a basis for considering such assumptions, the accounting guidance establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value as follows:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="margin-left:3.333%;text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Level 1</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="margin-left:3.333%;text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Level 2</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;Quoted prices for similar assets and liabilities in active markets, quoted prices in markets that are not active, or inputs which are observable, either directly or indirectly, for substantially the full term of the asset or liability.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="margin-left:3.333%;text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Level 3</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (i.e., supported by little or no market activity).</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Financial assets measured at fair value on a recurring basis consist of the Company&#x2019;s cash equivalents and short-term investments. Cash equivalents consisted of money market funds and short-term investments consisted of U.S. treasury securities and certificates of deposit. The Company obtains pricing information from its investment manager and generally determines the fair value of investment securities using standard observable inputs, including reported trades, broker/dealer quotes, and bid and/or offers.</span></p><div style="font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;"><ix:nonNumeric id="F_47852e37-f8c5-47ea-8fed-9a7b5a5356bd" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following tables summarize the Company&#x2019;s assets that require fair value measurements on a recurring basis and their respective input levels based on the fair value hierarchy (in thousands):</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:43.102%;"></td>
        <td style="width:1.145%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:10.312%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.156%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:12.783%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.156%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:11.65%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.156%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:9.541%;"></td>
        <td style="width:1.0%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="10" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Fair Value Measurements Using</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Quoted Prices in</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Significant</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Significant</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Active Markets</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unobservable</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">for Identical</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Observable</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Inputs</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Assets (Level 1)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Inputs (Level 2)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(Level 3)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Short-term investments:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S. treasury securities</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_853742af-ff87-471b-bd32-30284f24e671" contextRef="C_2573431b-071f-404a-987e-c3e834333417" name="us-gaap:InvestmentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">11,916</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c8fcfd49-c2be-40e2-8e6f-8ff50fa55c8e" contextRef="C_07d00b46-0b94-46d4-a9c0-90bd6e6336f4" name="us-gaap:InvestmentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">11,916</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_23bcbd9b-25bb-4d49-9fc3-21ad66c774a5" contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192" name="us-gaap:InvestmentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">11,916</ix:nonFraction></span></p></td>
        <td style="border-top:0.5pt solid rgba(255,255,255,0.01);background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_235424ff-5427-4230-b84c-59f9ece4270d" contextRef="C_5c7a06ba-06bd-4791-bb56-70c464bf5ade" name="us-gaap:InvestmentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">11,916</ix:nonFraction></span></p></td>
        <td style="border-top:0.5pt solid rgba(255,255,255,0.01);background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
        <td style="border-top:0.5pt solid rgba(255,255,255,0.01);background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
        <td style="border-top:0.5pt solid rgba(255,255,255,0.01);background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="10" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Fair Value Measurements Using</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Quoted Prices in</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Significant</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Significant</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Active Markets</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unobservable</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">for Identical</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Observable</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Inputs</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Assets (Level 1)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Inputs (Level 2)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(Level 3)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Short-term investments:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S. treasury securities</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f37bc87c-92b8-47ab-90ed-23c3e8c24106" contextRef="C_f45561af-aa60-4d08-8038-0001fb9d29dc" name="us-gaap:InvestmentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">29,121</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_fb5b3630-606c-4095-bbf6-278fc001f044" contextRef="C_24991024-50f4-435b-ba4f-adcad994e80c" name="us-gaap:InvestmentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">29,121</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Certificates of deposit</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_06139c31-89d8-4a8b-894c-2e527d12b0f4" contextRef="C_977951f9-d851-4284-8eb0-cbc7afea37a5" name="us-gaap:InvestmentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,224</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ab796921-f1be-4cc0-971b-0c0e1dd06c67" contextRef="C_88bc9f46-dcc0-4d03-aa1a-d56bf1d35be2" name="us-gaap:InvestmentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,224</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_033a2aae-ae78-4227-aa23-50be391b8c4f" contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94" name="us-gaap:InvestmentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">30,345</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_7c681590-0e67-44c4-92b0-ec4ad02c1754" contextRef="C_e0e5cffb-5c83-464c-b236-5ae5c1b3c851" name="us-gaap:InvestmentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">30,345</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S. treasury securities and certificates of deposit are valued using Level 1 inputs. Level 1 securities are valued at unadjusted quoted prices in active markets that are observable at the measurement date for identical, unrestricted assets or liabilities. Fair values determined by Level 2 inputs, which utilize data points that are observable such as quoted prices, interest rates and yield curves, require the exercise of judgment and use of estimates, that if changed, could significantly affect the Company&#x2019;s financial position and results of operations. Investments in agency securities are valued using Level 2 inputs. Level 2 securities are initially valued at the transaction price and subsequently valued and reported utilizing inputs other than quoted prices that are observable either directly or indirectly, such as quotes from third-party pricing vendors.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The carrying amounts of the Company&#x2019;s financial instruments, including cash and cash equivalents, prepaid and other current assets, accounts payable, and accrued liabilities, approximate fair value due to their short maturities. At December 31, 2022 and 2021, the carrying amount of the Company&#x2019;s notes payable of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e9515f87-d2af-486c-a022-31a6b0a63e54" contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192" name="us-gaap:NotesPayable" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">9.0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_1c36fd9b-7566-41b1-b63f-def8ed5ae4b7" contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94" name="us-gaap:NotesPayable" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">10.2</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million, respectively, approximated their fair value as the terms of the notes are consistent with the market terms of transactions with similar profiles (Level 2 inputs). None of the Company&#x2019;s non-financial assets or liabilities are recorded at fair value on a non-recurring basis.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company did </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_983cc593-b2f1-43c4-a2ca-d6aef0f25b86" contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_dd094ad1-023d-49d3-8d73-de1c8665857b" contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">t hold any Level 1, 2 or 3 financial liabilities that are recorded at fair value on a recurring basis as of December 31, 2022 or 2021.</span></p></ix:nonNumeric></div>
  <div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_40e8f37b-751a-4719-b3fc-fc1e66c7f22b" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="eq:ShortTermInvestmentsTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4. Short-term Investments</span></p><div style="font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;"><ix:nonNumeric id="F_9e4cabae-5fc0-42dd-980d-ad0460c52199" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following table summarizes the Company&#x2019;s short-term investments (in thousands):</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:47.169%;"></td>
        <td style="width:0.543%;"></td>
        <td style="width:9.997%;"></td>
        <td style="width:0.543%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:8.01%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:0.543%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:8.01%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:0.556%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:8.326%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:0.265%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:8.035%;"></td>
        <td style="width:1.0%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Maturity</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Amortized</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unrealized</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unrealized</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Estimated</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(in years)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cost</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Gains</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Losses</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Fair Value</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S. treasury securities</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_7a6d51d4-c8d3-4f86-924c-ebf9517cacca" contextRef="C_09b9a242-1fa2-404a-b6a9-1fc05149e6a4" name="us-gaap:DebtSecuritiesAvailableForSaleTerm" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1 </span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">or less</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e77249b0-504a-4b18-91ea-6b15ec7b405f" contextRef="C_b4ad71ba-3e8b-4d50-87b0-1a81a509c6eb" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">12,006</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_1241a878-c69f-46c7-ae09-027aa7c3aeda" contextRef="C_b4ad71ba-3e8b-4d50-87b0-1a81a509c6eb" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">90</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_2967f45f-645b-479d-9934-4e837abfbcbb" contextRef="C_b4ad71ba-3e8b-4d50-87b0-1a81a509c6eb" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">11,916</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_cb19f79e-a724-4898-ac26-7f54e6bfc4ca" contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">12,006</ix:nonFraction></span></p></td>
        <td style="border-top:0.5pt solid rgba(255,255,255,0.01);background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
        <td style="border-top:0.5pt solid rgba(255,255,255,0.01);background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_cb6147bd-f1be-4e7f-8733-c92ff9970e38" contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">90</ix:nonFraction></span></p></td>
        <td style="border-top:0.5pt solid rgba(255,255,255,0.01);background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_23bf9dc7-5efb-43b3-9061-f56b7d5c63af" contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">11,916</ix:nonFraction></span></p></td>
        <td style="border-top:0.5pt solid rgba(255,255,255,0.01);background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S. treasury securities</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_d40c88f1-3a66-40c2-8a07-1eab0c2f6c78" contextRef="C_6f4556dd-c18e-4dc1-9c4a-842fa90452f5" name="us-gaap:DebtSecuritiesAvailableForSaleTerm" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;or less</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_dd6d8828-e7a4-4011-8bad-c25a0a1f4a62" contextRef="C_9b5e1bd0-1a40-47d8-9914-690c782ec9e9" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">17,122</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_133c8259-78e3-4dcc-be5b-7d0fd0cc62ab" contextRef="C_9b5e1bd0-1a40-47d8-9914-690c782ec9e9" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">7</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_61231e3b-d38d-4609-ae88-bbfd2f97807d" contextRef="C_9b5e1bd0-1a40-47d8-9914-690c782ec9e9" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">17,115</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S. treasury securities</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&gt;</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_ea6f4312-2f6e-4dad-9dd7-b6f85be9ac92" contextRef="C_22c07448-b3c4-4d7d-8903-20b3a5bbb42d" name="us-gaap:DebtSecuritiesAvailableForSaleTerm" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;and &lt;</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_6f8d5f79-5479-4dd5-a2f2-1b12bba7c52e" contextRef="C_1adba1d3-86e2-48ca-8036-09ebd512337c" name="us-gaap:DebtSecuritiesAvailableForSaleTerm" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5</span></ix:nonNumeric></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_92e36803-75be-4f27-a8ce-ca80a169a276" contextRef="C_68cc81fd-50c1-4591-b9ee-381a6c7b9fe5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">12,049</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6c0131b7-5d21-4229-9dd2-72e61c1c8889" contextRef="C_68cc81fd-50c1-4591-b9ee-381a6c7b9fe5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">43</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d5e8b142-2f8b-4d09-ac2e-910cec7ca76e" contextRef="C_68cc81fd-50c1-4591-b9ee-381a6c7b9fe5" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">12,006</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Certificates of deposit</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_b49b78cc-bb14-422f-876e-4b55607fa9a2" contextRef="C_8f6e6b13-aff0-4ec5-80eb-ec47346f2d4d" name="us-gaap:DebtSecuritiesAvailableForSaleTerm" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;or less</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_955aa26e-c998-4331-b6ac-e4e27b4bd87c" contextRef="C_be912e1f-de6a-4c8b-a190-56fa543de795" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,226</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_72994be7-725d-4d7e-b5f3-1caaf96d48ce" contextRef="C_be912e1f-de6a-4c8b-a190-56fa543de795" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a27f9a1a-c45a-49d2-a7d5-d7520bf92e5c" contextRef="C_be912e1f-de6a-4c8b-a190-56fa543de795" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,224</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_dc3a273c-e07a-402e-8bce-234f7de93dff" contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">30,397</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_1d01875d-1e1c-40ce-a4be-426a3e85cc40" contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">52</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_62cac7ca-1e20-4169-830e-993e1f9ec454" contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">30,345</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">All of the Company&#x2019;s available-for-sale securities are available to the Company for use in its current operations. As a result, the Company categorizes all of these securities as current assets even though the stated maturity of some individual securities may be </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_48376537-e2d7-4947-864f-e8ba73107203" contextRef="C_6658e49b-c37e-401c-873e-60a833ca00d9" name="eq:AvailableForSaleSecuritiesDebtMaturitiesPeriod" format="ixt-sec:durwordsen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">one year</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> or more beyond the balance sheet date. All of the Company&#x2019;s securities have a maturity within </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_1eebb87a-b551-4b13-b1fd-dc7cd2a987f4" contextRef="C_6c6eb418-4e31-405d-80e2-4eeaa0ed0949" name="eq:AvailableForSaleSecuritiesDebtMaturitiesPeriod" format="ixt-sec:durwordsen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">two years</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> of the balance sheet date.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">There were </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_68dbb7be-c2c1-461b-95ee-fbb248be5042" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_f6322cc5-f5ea-40cf-9d01-05b148ed57fa" contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2" name="us-gaap:OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> impairments considered other-than-temporary during the periods presented, as it is management&#x2019;s intention and ability to hold the securities until a recovery of the cost basis or recovery of fair value. Unrealized gains and losses are included in accumulated other comprehensive income (loss).</span></p></ix:nonNumeric></div>
  <div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_583c2745-6a36-428e-a5bd-a6ba386800ff" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5. Property and Equipment</span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_5fad6cdc-57ef-4ce3-9b05-afa4dbafe9fb" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:PropertyPlantAndEquipmentTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Property and equipment consisted of the following (in thousands):</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:65.971%;"></td>
        <td style="width:1.472%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:13.571%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.458%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:13.529%;"></td>
        <td style="width:1.0%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Furniture &amp; fixtures</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c4d56e8c-49a2-487d-8f69-05ce62bd3b63" contextRef="C_0b2819ec-57f5-46d8-b912-9734d9b101d1" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">60</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c9221b33-aee1-405b-9dde-23eedf3444fb" contextRef="C_e4e76746-9176-4a76-9703-056a9ff95868" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">60</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Machinery &amp; lab equipment</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_3bddea93-ddd0-4fd7-95fe-1d3dcc99d72d" contextRef="C_ce9aa43c-a54c-413f-ab08-401b60dd98cf" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">534</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_4ab93f50-32a9-4576-b5ce-e77c9d96d2eb" contextRef="C_28f69ea9-8c53-458e-9ebe-8b9949dd4224" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">282</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Computer equipment</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_2363fc1d-c2ef-45db-b034-a927f9f68ac5" contextRef="C_503c038a-2434-4c52-8c73-7bfdbfb92be8" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">26</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_30a2b7b0-133c-46b3-b922-79cb58d4ce1d" contextRef="C_16cc5d93-7f4c-4d9b-a05e-409bae73f77d" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">42</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Leasehold improvements</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8ffe6b74-4709-4f30-8b7d-11922a351f1a" contextRef="C_b03e82a1-d7f8-42dc-a88d-a8edb9f55f3c" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">20</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Less accumulated depreciation and amortization</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_7a571f22-6b9f-47d4-ba84-f03cec040e74" contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">249</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_58acf986-6d08-4dfe-84af-b128262c1c66" contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">147</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Property and equipment, net</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_300b6e6a-4843-432e-bca9-8fd511864cc3" contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192" name="us-gaap:PropertyPlantAndEquipmentNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">391</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_cfffe51d-2a42-418c-9497-f5d05bcca309" contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94" name="us-gaap:PropertyPlantAndEquipmentNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">237</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Depreciation expense related to property and equipment was approximately $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f04de0b9-4911-4c25-8eaf-1cc0c9927106" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:Depreciation" unitRef="U_USD" decimals="0" format="ixt:numdotdecimal">118,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8c114296-ed55-492f-8ae1-30478d4bc864" contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2" name="us-gaap:Depreciation" unitRef="U_USD" decimals="0" format="ixt:numdotdecimal">72,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> for the years ended December 31, 2022 and 2021, respectively. During the year ended December 31, 2022, the Company disposed of fully depreciated property and equipment totaling approximately $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c63fcdc2-65db-4383-92c0-2979c9baacc9" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:PropertyPlantAndEquipmentDisposals" unitRef="U_USD" decimals="0" format="ixt:numdotdecimal">16,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. There were </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_fac0e2ad-69d5-4322-913c-9bbcd48b5703" contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2" name="us-gaap:PropertyPlantAndEquipmentDisposals" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> dispositions of property and equipment for the year ended December 31, 2021. </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_26c74843-d8b7-498f-9389-96cdb952c663" contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2" name="us-gaap:GainLossOnDispositionOfAssets1" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_e7642e92-088c-46ea-aa26-84b1fce74ca9" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:GainLossOnDispositionOfAssets1" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen">No</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> material gains or losses on the disposal of property and equipment have been recorded for the years ended December 31, 2022 or 2021.</span></p></ix:nonNumeric></div>
  <div style="font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;"><ix:nonNumeric id="F_938af2db-5d75-47a4-8097-b4f119adb9d6" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:BusinessCombinationDisclosureTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6. Acquisition</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On February 14, 2022, the Company entered into an Agreement and Plan of Merger with Project JetFuel Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of the Company (Merger Sub), Bioniz and Kevin Green, solely in his capacity as representative of the securityholders of Bioniz (the Securityholders&#x2019; Representative).</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As consideration for the acquisition of Bioniz, the Company agreed to (a) issue up to an aggregate of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6b87d4ba-5bcc-4581-b158-cbdac1b9ffaa" contextRef="C_53fe6a42-e9c0-41f9-a76d-589ed71e0cd6" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">5,699,492</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of the Company&#x2019;s common stock (Merger Shares), and (b) make contingent payments up to an aggregate of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_7636d535-ef39-411e-9775-0621353d8be4" contextRef="C_ea16d6a3-2485-40dc-a25d-8c4cc56dd7fd" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">57.5</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million based on the achievement of certain regulatory events for the Bioniz product candidates commencing on first U.S. approval, and up to an aggregate of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_45685a56-0e41-4629-9b83-6cf2e3e4f8e1" contextRef="C_292ee269-376c-4392-9f5a-40817da138a6" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" unitRef="U_USD" scale="6" decimals="-6" format="ixt:numdotdecimal">250</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million based on the achievement of certain commercialization events for product candidate BNZ-1 (now referred to as EQ101) as set forth in the Merger Agreement. The Merger Shares may be adjusted downward after the closing, pursuant to procedures set forth in the Merger Agreement, including with respect to indemnification claims and in connection with the finalization of transaction expenses, debt, net exercise taxes and working capital amounts at closing.</span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">14</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">At the closing, the Company delivered to the transfer agent </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_12b72eca-40e9-4156-8703-de394bebf8ae" contextRef="C_ffafa14c-b663-42ee-861b-6f858b3f4acf" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">4,820,230</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of its common stock for issuance to former stockholders of Bioniz per the terms of the Merger Agreement. Up to an additional </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_cf77248f-51a8-43d8-b443-d862dd31f42b" contextRef="C_c0403c73-e303-4bd7-ae36-cf044f363dc1" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">879,252</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of the Company's common stock, pending any adjustments per the terms of the Merger Agreement, will be issued to former stockholders of Bioniz </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_2a09163a-bfc6-4bca-b396-ced889640a33" contextRef="C_ffafa14c-b663-42ee-861b-6f858b3f4acf" name="eq:TermsOfMergerAgreement" format="ixt-sec:durmonth"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> months after closing. The acquisition of Bioniz expanded the Company's pipeline of novel immunomodulatory drug candidates, adding two first-in-class clinical stage assets, BNZ-1 and BNZ-2, now referred to as EQ101 and EQ102, respectively, and a proprietary product discovery platform.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company determined the acquisition</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">constituted an acquisition of assets instead of a business combination as substantially all of the fair value of the gross assets acquired was concentrated in a group of similar identifiable assets, and therefore, the acquisition was not considered a business. As the Company is recording the transaction as an asset acquisition under ASC 805, the contingent payments will be recognized upon achievement and at that time will be expensed to in-process research and development. Transaction costs of approximately $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_3931002b-9308-4e93-b5bc-14e6cb758eeb" contextRef="C_8a38518a-9c62-4c14-a61d-b505eb2f5458" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">0.4</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million associated with the acquisition were included in the Company&#x2019;s research and development expense during the year ended December 31, 2022.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_891f7c56-7e46-4c49-930e-d7f91eaae3ae" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">A summary of the purchase price allocation is as follows (in thousands):</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:80.253%;"></td>
        <td style="width:1.792%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:15.956%;"></td>
        <td style="width:1.0%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Amount</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Assets acquired:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cash</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_dfba0af3-19cb-4dba-9ce9-56b83d8d94a5" contextRef="C_9f870e6c-ab80-49c3-9591-da8f10d045b8" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">700</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Prepaid expenses and other current assets</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_2250d456-37ba-407c-8d28-b5b40ef039ac" contextRef="C_9f870e6c-ab80-49c3-9591-da8f10d045b8" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">28</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Fixed assets</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_168bcb51-a8a2-4427-9a02-7e38198cfc6a" contextRef="C_9f870e6c-ab80-49c3-9591-da8f10d045b8" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">6</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total assets acquired</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_080d68c4-912d-47a0-80c7-cfd547c46f52" contextRef="C_9f870e6c-ab80-49c3-9591-da8f10d045b8" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">734</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Liabilities assumed:</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accounts payable</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_11f74e99-fe7b-424a-9b81-80b2148ee4e1" contextRef="C_9f870e6c-ab80-49c3-9591-da8f10d045b8" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">265</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accrued expenses</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_21e075d5-6b71-4838-b81e-b4cc31ef0ab4" contextRef="C_9f870e6c-ab80-49c3-9591-da8f10d045b8" name="eq:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">976</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total liabilities assumed</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_14ef4e12-9ad0-4649-b375-c1757fd69d74" contextRef="C_9f870e6c-ab80-49c3-9591-da8f10d045b8" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,241</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net liabilities acquired</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_850620c0-5803-442b-a091-d055adc9602d" contextRef="C_9f870e6c-ab80-49c3-9591-da8f10d045b8" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">507</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Issuance of common stock for Bioniz acquisition</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_40970b13-5427-495d-b58d-15d6553025b8" contextRef="C_9f870e6c-ab80-49c3-9591-da8f10d045b8" name="us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">22,542</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Acquired in-process research and development</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_08a2597e-2322-4716-b380-ccba8e993e91" contextRef="C_9f870e6c-ab80-49c3-9591-da8f10d045b8" name="eq:BusinessCombinationAcquiredInProcessResearchAndDevelopment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">23,049</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div></ix:nonNumeric></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_44240d68-712d-43dc-99c9-a29579956752" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:LesseeOperatingLeasesTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7.  Leases</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company&#x2019;s leases relate primarily to office and laboratory facilities located in La Jolla and South San Francisco, California. The Company&#x2019;s lease of office space in South San Francisco expired in </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_2366b5a0-802d-44ce-82ff-3b242c6a8567" contextRef="C_842e44ed-200a-4457-8510-53e0331535d8" name="eq:LesseeOperatingLeaseExpiredDate" format="ixt:datemonthyearen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">February 2023</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and the Company did not renew that lease. The Company&#x2019;s lease of laboratory space in La Jolla expires in </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_b85cbaf4-3799-4ef2-8267-b55cc30d1e36" contextRef="C_dd41c6fa-2d24-44bd-8378-e697929d4bb8" name="eq:LesseeOperatingLeaseExpirationYear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2025</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, and the Company's leases of office space in La Jolla expire in </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_8a4614d7-df69-4ac4-8ef6-4ac7d0b47588" contextRef="C_842e44ed-200a-4457-8510-53e0331535d8" name="eq:LesseeOperatingLeaseExpirationYear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2027</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. The terms of the Company&#x2019;s non-cancelable operating lease arrangements typically contain fixed lease payment which increases over the term of the lease at fixed rates, and include rent holidays and provide for additional renewal periods. Lease expense is recognized over the term of the lease on a straight-line basis. All of the Company&#x2019;s leases are classified as operating leases. The Company has determined that periods covered by options to extend the Company&#x2019;s leases are excluded from the lease term as the Company is not reasonably certain the Company will exercise such options. Operating lease expense, including expenses related to short-term leases, were $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_dcd906b7-eeb0-43c7-9b29-bfacffca7e98" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:OperatingLeaseExpense" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">0.6</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d71d200b-361e-4373-a0b7-74bb8303d4a8" contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2" name="us-gaap:OperatingLeaseExpense" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">0.3</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million for the years ended December 31, 2022 and 2021, respectively.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company records its right-of-use-assets within other assets (long term) and its operating lease liabilities within other current and long-term liabilities.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></ix:exclude><div style="font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;"><ix:nonNumeric id="F_d378cb23-764a-4559-9566-3f936b2e4a45" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="eq:SummaryOfAdditionalInformationRelatedToLeasesTableTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Additional information related to the Company&#x2019;s leases as of and for the year ended December 31, 2022, is as follows (in thousands, except lease term and discount rate):</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:69.578%;"></td>
        <td style="width:3.036%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:25.386000000000003%;"></td>
        <td style="width:1.0%;"></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Balance sheet information</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Right-of-use assets</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_4b1af21d-67b8-469c-913a-537ea4659b31" contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192" name="us-gaap:OperatingLeaseRightOfUseAsset" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,191</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Lease liabilities, current</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_baec1d69-75b6-44c5-ab81-4a1252b0af1d" contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192" name="us-gaap:OperatingLeaseLiabilityCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">408</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Lease liabilities, non-current</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_044e1325-5e3e-4f1a-81a1-0c08a6422dbb" contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192" name="us-gaap:OperatingLeaseLiabilityNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">824</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total lease liabilities</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_3a11deea-7da5-4c04-b88d-35d27ae2aeae" contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192" name="us-gaap:OperatingLeaseLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,232</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other information</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Weighted average remaining lease term</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_e05a1b2e-2aa7-4a0c-a7bd-8cad84a93f93" contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3.07</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;years</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Weighted average discount rate</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_743bb37c-d04e-47ba-afff-7564879d01e4" contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" unitRef="U_pure" scale="-2" decimals="4" format="ixt:numdotdecimal">8.25</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Supplemental cash flow information</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Operating cash flows from operating leases</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_2ed686af-6ce9-48b3-ba1d-7b7c379ba65c" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:OperatingLeasePayments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">465</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Right-of-use assets obtained in exchange for lease obligations</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_840e3255-2739-4999-aa74-14a1f5fe46ba" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">&#x2014;</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_33c06049-c2b2-4735-84be-8f04eef0151b" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Maturities of lease liabilities as of December 31, 2022 were as follows (in thousands):</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:77.265%;"></td>
        <td style="width:3.669%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:17.066%;"></td>
        <td style="width:1.0%;"></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year ending December 31,</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2023</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_747a8e8a-3121-4da0-ac0e-2d5c5ebda2d4" contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">494</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2024</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_5eb30439-8d1f-414e-9ca2-829e06358b67" contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">492</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2025</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b8e5a1cb-116b-4bc0-9d47-de1849b0fdc4" contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">219</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2026</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ba2be63a-8615-4b7c-a3ee-f4bab5e0df63" contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">169</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2027</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_fd3db80f-e506-429a-a746-9878f53fbb04" contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">28</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total undiscounted lease payments</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_3b76ab63-40e3-4130-87b8-0e236a8a0159" contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,402</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Less: imputed interest</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_da6b7e80-f500-4fb8-ac6d-eda533720d89" contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">170</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total lease liabilities</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c98ea04a-bf15-45e2-b20f-4b2ce82b55a7" contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192" name="us-gaap:OperatingLeaseLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,232</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31, 2022, the Company does not have any leases that have not yet commenced that create significant rights and obligations.</span></p></ix:nonNumeric></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_e4155c92-a89d-4627-83a9-c4c58e328641" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8. Accrued Expenses</span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_88e34ee2-e9d9-44c4-b2c4-173ade74175f" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accrued expenses consisted of the following (in thousands):</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.327%;"></td>
        <td style="width:1.466%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:13.322000000000001%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.48%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:13.406%;"></td>
        <td style="width:1.0%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accrued payroll and other employee benefits</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8481044a-a625-4367-8bfe-743055edb943" contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,975</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_78a53c1c-801a-4f16-86f0-246559f7c4a7" contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,511</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Clinical development</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_7f95c2e3-f5a5-4591-b4cb-e8c14c82a23a" contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192" name="eq:AccruedClinicalDevelopment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,253</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_9f74bbc5-c7fd-428f-a33a-86dc32119840" contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94" name="eq:AccruedClinicalDevelopment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,627</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other accruals</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_3e467e88-aadb-4c5b-b4f6-bebc157316e3" contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192" name="us-gaap:OtherAccruedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">472</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b0b94126-ccce-4709-8a4b-5b7bb222dff9" contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94" name="us-gaap:OtherAccruedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">245</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Non-clinical research</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_37d035a3-de32-4952-8810-3643563c3b61" contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192" name="eq:AccruedNonClinicalResearch" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">465</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d46bf4ab-388f-4915-831a-59679a1a2670" contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94" name="eq:AccruedNonClinicalResearch" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">432</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accrued interest</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8f967b73-baf0-404e-bfb2-81adef3ff05e" contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192" name="us-gaap:InterestPayableCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">74</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_28a6ce80-d413-4d99-a137-8b00e79da363" contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94" name="us-gaap:InterestPayableCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">71</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total accrued expenses</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a1817a2d-446d-4905-98f7-f41c9959a082" contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192" name="us-gaap:AccruedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">7,239</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b9c236b2-674b-462f-852d-3fd14e94ed6f" contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94" name="us-gaap:AccruedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">5,886</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div></ix:nonNumeric></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_b683cd4d-7e25-41b6-9b47-40e460f3d5e8" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:CollaborativeArrangementDisclosureTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9. Partnerships</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Asset Purchase Agreement with Ono Pharmaceutical Co., Ltd.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On December 5, 2022, the Company and Ono, a Japan kabushiki kaisha, entered into an Asset Purchase Agreement pursuant to which the Company granted Ono the exclusive right, but not the obligation, to acquire the Company&#x2019;s rights to itolizumab (the Option). These rights include all therapeutic indications and the rights to commercialize itolizumab in the United States, Canada, Australia, and New Zealand. In exchange for the Option, Ono paid the Company a one-time, upfront payment of an amount</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> equal to JPY </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a973658a-69f1-4aa4-947d-24d04f44e7ce" contextRef="C_257b0705-b56f-4bd5-86f9-1add29602d4d" name="eq:UpfrontNonRefundableAndNonCreditablePaymentReceivableUponExchangeOfOption" unitRef="U_JPY" scale="9" decimals="-8" format="ixt:numdotdecimal">3.5</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> billion, or $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ca0be8fd-1988-4633-9e82-4a0e027b8a7b" contextRef="C_257b0705-b56f-4bd5-86f9-1add29602d4d" name="eq:UpfrontNonRefundableAndNonCreditablePaymentReceivableUponExchangeOfOption" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">26.4</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If Ono exercises the Option, Ono will pay the Company a one-time payment of an amount equal to JPY </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_fdb9108a-1a8f-46cd-a8e0-62042680a924" contextRef="C_b6af3c69-cf78-4826-98db-46603272fd07" name="eq:OneTimePaymentReceivableUponExercisesTheOption" unitRef="U_JPY" scale="9" decimals="-8" format="ixt:numdotdecimal">5.0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> billion, or approximately $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_dd5e77e8-d0b2-4573-ad96-f4973b6015af" contextRef="C_b6af3c69-cf78-4826-98db-46603272fd07" name="eq:OneTimePaymentReceivableUponExercisesTheOption" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">37.2</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million based on the currency exchange rate quoted by MUFG Bank, Ltd. on March 16, 2023. The Company is also eligible to receive up to $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8f9cdbb4-95f0-4d88-8d6d-1547552075b2" contextRef="C_abcb788b-9185-48aa-bc09-238334507b89" name="eq:EligibleToReceivePaymentOnAchievementOfCertainDevelopmentMilestones" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">101.4</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million upon the achievement of certain development and commercialization milestones.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">16</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company is responsible for conducting all research and development of itolizumab, which will be funded by Ono on a quarterly basis from July 1, 2022, through the option period. Unless terminated early, t</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_0cc2d36c-5b07-4934-863f-5150d654eca5" contextRef="C_ad7f8586-d120-48a1-a08d-4f84857dfb6d" name="eq:OptionPeriodExpiryCondition"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">he option period will expire three months following the delivery of topline data from the EQUALISE clinical study in lupus nephritis and interim data from the EQUATOR Phase 3 clinical study in acute graft-versus-host disease. </span></ix:nonNumeric></span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"></span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Asset Purchase Agreement can be terminated at any time by Ono upon written notice, provided that in limited circumstances Ono will be obligated to continue to reimburse the Company for research and development costs and expenses of itolizumab for a certain period of time following such termination. If Ono does not timely exercise its Option, the Asset Purchase Agreement and the Option will automatically terminate. The Asset Purchase Agreement also contains customary termination rights for both parties for material breach and an outside date (subject to limited adjustments) that permits either party to terminate the Asset Purchase Agreement if the closing has not occurred by December 31, 2025.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Asset Purchase Agreement contains customary representations and warranties with respect to both the Company and Ono. Additionally, the Company is subject to customary obligations and covenants, including affirmative and negative operating covenants on the Company with respect to its business as it applies to the development and exploitation of itolizumab, exclusivity obligations that prohibit the Company, except in limited circumstances, including in connection with the sale of the Company, from pursuing a direct or indirect sale, license or other disposition of all or any portion of the Company's itolizumab program or any of the assets to be purchased pursuant to the Asset Purchase Agreement and indemnification obligations, which, except in limited circumstances, are subject to customary caps and deductibles.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company applied ASC 808, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Collaborative Arrangements,</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> to the Asset Purchase Agreement and determined that the agreement is applicable to such guidance. The Company concluded that Ono represented a customer and applied relevant guidance from ASC 606, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Revenue Recognition</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, (ASC 606) to evaluate the appropriate accounting for the Asset Purchase Agreement. In accordance with this guidance, the Company identified its performance obligations, including its grant of a license to Ono to certain of its intellectual property subject to certain conditions and the conduct of research and development services. The Company determined that its grant of a license to Ono to certain of its intellectual property subject to certain conditions was not distinct from other performance obligations because such grant is dependent on the conduct and results of the research and development services. Accordingly, the Company determined that all performance obligations should be accounted for as one combined performance obligation, and that the combined performance obligation is transferred over the expected term of the conduct of the research and development services.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company also assessed, in connection with the upfront and non-creditable payment of JPY </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_be00b6d5-537f-42af-b476-a6e228f3145b" contextRef="C_257b0705-b56f-4bd5-86f9-1add29602d4d" name="eq:UpfrontNonRefundableAndNonCreditablePaymentInvoiced" unitRef="U_JPY" scale="9" decimals="-8" format="ixt:numdotdecimal">3.5</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> billion or $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_5310e859-e8d8-41de-9c82-1aa45bfea536" contextRef="C_257b0705-b56f-4bd5-86f9-1add29602d4d" name="eq:UpfrontNonRefundableAndNonCreditablePaymentInvoiced" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">25.8</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million, invoiced on December 5, 2022, that there was not a significant financing component in the Asset Purchase Agreement. The Company received payment of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_dc899d99-2091-471d-b737-fa0b076ca82d" contextRef="C_c23792dc-2be3-45bf-8cdc-a38a13c8ab6a" name="eq:UpfrontPaymentReceived" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">26.4</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million related to this upfront payment in December 2022 which included a foreign currency realized gain of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b7c43985-0962-4865-85c3-f02ee5c5ca01" contextRef="C_c23792dc-2be3-45bf-8cdc-a38a13c8ab6a" name="us-gaap:ForeignCurrencyTransactionGainLossRealized" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">0.6</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million as the initial invoice for the upfront payment was denominated in JPY.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company also assessed the effects of any variable elements under the Asset Purchase Agreement. Such assessment evaluated, among other things, the likelihood of receiving (i) option fees and (ii) various clinical, regulatory and commercial milestone payments. Based on its assessment, the Company concluded that, based on the likelihood of these variable components occurring, there was not a significant variable element included in the transaction price. Accordingly, the Company has not assigned a transaction price to any option fees or milestone payments under the Asset Purchase Agreement given the substantial uncertainty related to their achievement.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In accordance with ASC 606, the Company determined that the initial transaction price under the Asset Purchase Agreement equals $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_57f7d57a-d729-426e-a57e-2c11cb65f2ff" contextRef="C_257b0705-b56f-4bd5-86f9-1add29602d4d" name="eq:InitialTransactionPrice" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">102.6</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million, consisting of the upfront and non-creditable payment of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d9233618-9e87-4cb7-b9cd-de20fc608079" contextRef="C_257b0705-b56f-4bd5-86f9-1add29602d4d" name="eq:UpfrontAndNonCreditablePaymentInvoiced" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">25.8</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million and the aggregate estimated research and development funding of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_5ab75151-4f8b-4cac-8d45-4de00c829bad" contextRef="C_257b0705-b56f-4bd5-86f9-1add29602d4d" name="eq:EstimatedResearchAndDevelopmentFunding" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">76.8</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million over the estimated option period. The upfront payment of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_cfe7fb65-7d71-42d4-82f1-aad4dbdaeeff" contextRef="C_257b0705-b56f-4bd5-86f9-1add29602d4d" name="us-gaap:DeferredRevenue" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">25.8</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million was recorded as deferred revenue and is being recognized as revenue over time in conjunction with the Company&#x2019;s conduct of research and development services as the research and development services are the primary component of the combined performance obligations. Revenue associated with the upfront payment will be recognized based on actual costs incurred as a percentage of the estimated total costs expected to be incurred over the expected term of the research and development services. Reimbursable research and development costs will be recognized as revenue as incurred.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company recognized revenue of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_369d0116-9a90-4a9c-9cf7-420cfb780758" contextRef="C_ad7f8586-d120-48a1-a08d-4f84857dfb6d" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">15.8</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million under the Asset Purchase Agreement during the year ended December 31, 2022. Such revenue was comprised of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8c53d6e4-46d0-4541-b359-968613d99bcc" contextRef="C_de394fb6-0ca8-4cc8-866d-6ad6f457d88c" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">11.8</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million associated with development funding and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6b9932f4-16f6-464a-835e-608e7749e47a" contextRef="C_cf62e2c5-8574-4b02-a168-a9fa58f93586" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">4.0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million associated with the amortization of the upfront payment during the year ended December 31, 2022. As of December 31, 2022, aggregate deferred revenue related to the Asset Purchase Agreement was $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f23f3b85-8f7b-431e-b65d-57d581ae69a0" contextRef="C_4c0fe461-a7c8-4a97-8e27-000bcb673943" name="us-gaap:DeferredRevenue" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">25.1</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million, which consisted of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e2e19053-b2ed-4ca2-bcf3-ecdd7f5296fd" contextRef="C_4c0fe461-a7c8-4a97-8e27-000bcb673943" name="us-gaap:DeferredRevenueCurrent" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">14.7</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million classified as current and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_af3dbb31-040d-4842-bcc3-950d82d97e6b" contextRef="C_4c0fe461-a7c8-4a97-8e27-000bcb673943" name="us-gaap:DeferredRevenueNoncurrent" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">10.4</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million as long-term.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">17</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31, 2022, the Company has received $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6c687b9b-1d9b-487e-879a-3dc8dbbc56e5" contextRef="C_c23792dc-2be3-45bf-8cdc-a38a13c8ab6a" name="eq:ProceedsFromResearchAndDevelopmentFees" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">12.2</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million in cash of aggregate development funding from Ono.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Biocon Collaboration and License Agreement</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In May 2017, the Company entered into a collaboration and license agreement (which was amended in September 2018, April 2019, December 2019, April 2021 and November 2022), clinical supply agreement, investor rights agreement, and common stock purchase agreement (collectively License Agreements) with Biocon SA (subsequently assigned to Biocon Limited, or together, Biocon). Pursuant to the License Agreements, Biocon granted the Company an exclusive license to develop, make, have made, use, sell, have sold, offer for sale, import and otherwise exploit itolizumab and any pharmaceutical composition or preparation containing or comprising itolizumab that uses Biocon technology or Biocon know-how (collectively a Biocon Product) in the United States, Canada, Australia and New Zealand (collectively Equillium Territory). The Company also has the right to sublicense through multiple tiers to third parties, provided such sublicenses comply with the terms of the License Agreements and the Company provides Biocon a copy of each sublicense agreement within 30 days of execution. If the Company grants a third party a sublicense of its rights to develop and commercialize Biocon Products in Australia or New Zealand, the Company will be required to pay Biocon a high double-digit percentage of any upfront payment the Company receives from such sublicensee for such sublicense, as well as a high double-digit percentage of any additional payments the Company receives from such sublicensee for such sublicense, including but not limited to royalty payments on net sales of Biocon Products by such sublicensee. Under the License Agreements, the Company granted back to Biocon a license to use its technology and know-how related to itolizumab and Biocon Products in certain countries outside of the Equillium Territory. Pursuant to the License Agreements, Biocon agreed to be the Company&#x2019;s exclusive supplier of itolizumab clinical drug product. Biocon will provide clinical drug product at no cost for up to three concurrent orphan indications until the Company&#x2019;s first U.S. regulatory approval and all other clinical drug product at Biocon&#x2019;s cost. In addition, we have agreed to co-fund an ongoing Phase 2 clinical study of itolizumab in subjects with ulcerative colitis being conducted by Biocon in India.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In consideration of the rights granted to the Company by Biocon, the Company issued Biocon a total of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_42a7171d-52e4-481f-8414-e2c79f8bd7da" contextRef="C_25c4ee43-e391-45e8-bf6c-c2ae9bfee741" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">2,316,134</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of its common stock.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, the Company is obligated to pay Biocon up to an aggregate of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_90f3999b-461c-4a1c-a781-2050bf5df1eb" contextRef="C_6c924f5d-0e36-4f69-96ed-b71e41b42d0f" name="eq:RegulatoryMilestonePaymentsUponAchievementOfCertainRegulatoryApprovals" unitRef="U_USD" scale="6" decimals="INF" format="ixt:numdotdecimal">30</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million in regulatory milestone payments upon the achievement of certain regulatory approvals and up to an aggregate of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_9b52abd2-dd96-4ba0-9101-e635fe1d8979" contextRef="C_6c924f5d-0e36-4f69-96ed-b71e41b42d0f" name="eq:SalesMilestonePaymentsUponTheAchievementOfFirstCommercialSaleOfProductAndSpecifiedLevelsOfProductSales" unitRef="U_USD" scale="6" decimals="INF" format="ixt:numdotdecimal">565</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million in sales milestone payments upon the achievement of first commercial sale of product and specified levels of product sales. The Company is also required to pay royalties on tiers of aggregate annual net sales of Biocon Products by the Company, the Company's affiliates and the Company's sublicensees in the United States and Canada at percentages from the mid-single digits to sub-teen double-digits and on tiers of aggregate annual net sales of Biocon Products by the Company and the Company's affiliates (but not the Company's sublicensees) in Australia and New Zealand, in each case, subject to adjustments in certain circumstances. Biocon is also required to pay the Company royalties at comparable percentages for sales of itolizumab (EQ001) outside of the Equillium Territory if the approvals in such geographies included or referenced the Company&#x2019;s data including data from certain of the Company&#x2019;s clinical studies, subject to adjustments in certain circumstances. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Should Ono exercise its option to acquire our rights to itolizumab (EQ001), as described below, the aforementioned milestone payments and royalties potentially owed to Biocon would become Ono&#x2019;s responsibility, and the potential royalties on sales of itolizumab outside of the Equillium Territory would be become Ono&#x2019;s right.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  Under the License Agreements, net sales are calculated on a country-by-country basis and are subject to adjustments, including whether the Biocon Product is sold in the form of a combination product. As of December 31, 2022, the Company has not made or received payments in connection with the milestones or royalties within the agreement.</span></p></ix:nonNumeric></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_404d88df-8a54-4f83-ab85-ee429ab62f75" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:MortgageNotesPayableDisclosureTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10. Notes Payable</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span>&#160;</p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On September 30, 2019 (the Effective Date), the Company entered into a Loan and Security Agreement (the Loan Agreement) with two lenders (the Lenders) pursuant to which the Company borrowed $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ed42fe4c-717a-443c-9b03-f294ccd1d324" contextRef="C_90508498-eb7a-4af4-a10b-9b578a529f24" name="us-gaap:LineOfCredit" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">10.0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million from the Lenders (the Term Loan), which represents the maximum amount the Company is permitted to borrow under the terms of the Loan Agreement.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Term Loan matures on </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_3fd64f09-6016-4320-bb97-f2e16d6950c3" contextRef="C_0b4db976-5656-4c9e-a811-53098826741a" name="us-gaap:LineOfCreditFacilityExpirationDate1" format="ixt:datemonthdayyearen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">June 1, 2024</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> (the Maturity Date) and is repaid through interest-only payments, which originally extended through June 30, 2021, followed by </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_958e07ed-ab03-41b0-ad62-efd9dfa1c6dc" contextRef="C_ef6b21dc-276b-4e2a-a0f4-7de1ea76111b" name="eq:LineOfCreditFacilityFrequencyOfPaymentsPrincipalAndInterest" unitRef="U_Installment" decimals="INF" format="ixt:numdotdecimal">36</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> equal </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_3ee14ee6-42d9-4926-adee-1075235432f0" contextRef="C_9cad8da7-5192-43d1-ae8d-b306505ebc15" name="us-gaap:DebtInstrumentFrequencyOfPeriodicPayment"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">monthly</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> payments of principal and interest. The Term Loan bears interest at a floating per annum rate equal to the greater of (i) </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_2e1afc3d-60c2-4ac5-babf-1449de273f9f" contextRef="C_944e0e4f-c4c3-48bc-98c4-915a5ff4bfa0" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" unitRef="U_pure" scale="-2" decimals="4" format="ixt:numdotdecimal">8.25</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% and (ii) the sum of (a) the </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_9b84ca8d-16e4-45d6-869b-4c7ef610d860" contextRef="C_9cad8da7-5192-43d1-ae8d-b306505ebc15" name="us-gaap:DebtInstrumentInterestRateBasisForEffectiveRate"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">prime rate</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> reported in The Wall Street Journal on the last business day of the month that immediately precedes the month in which the interest will accrue, plus (b) </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_5e7806ab-7e47-4f11-ac53-a738312672ca" contextRef="C_c2f2d003-05db-4149-bb1f-60dc7a7a84c7" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" unitRef="U_pure" scale="-2" decimals="4" format="ixt:numdotdecimal">3.00</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On April 23, 2021, the Loan Agreement was amended to (i) change the final payment percentage from </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_7e8728e7-3e93-4f4d-91a2-5fbf2cc1640e" contextRef="C_677cb0dd-b0f9-4917-b6b9-3a7ad67b6397" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" unitRef="U_pure" scale="-2" decimals="3" format="ixt:numdotdecimal">4.5</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% to </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ac684ede-4a59-42e0-98fb-2e3365fcfe1f" contextRef="C_c28101d2-ae40-418c-83d4-9715bbaa72e3" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" unitRef="U_pure" scale="-2" decimals="3" format="ixt:numdotdecimal">5.0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% and (ii) extend the interest-only payment period based on achieving the following milestones: (a) the Company achieving positive data in the Company's Phase 1b aGVHD study of itolizumab (EQ001) supporting a formal decision to advance into Phase 2 or Phase 3 development, and as confirmed by the Company's Board of Directors in written board minutes (the Interest-Only Extension Milestone) and (b) the Company initiating a pivotal Phase 3 aGVHD study (the Interest-Only Extension II Milestone). In May 2021, the Company achieved the Interest-Only Extension Milestone, and in March 2022, the Company obtained confirmation from the Lenders that the Interest-Only Extension II Milestone had been achieved, which extended the interest-only payments through September 30, 2022, followed by </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6425c307-7190-47c3-8d42-62bf4f279145" contextRef="C_0dabeff1-f05f-4737-8f45-b0cb38473eb4" name="eq:LineOfCreditFacilityFrequencyOfPaymentsPrincipalAndInterest" unitRef="U_Installment" decimals="INF" format="ixt:numdotdecimal">24</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> equal </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_0b7a9d27-5686-4452-8d08-9e1aa52116d0" contextRef="C_3170d519-6bfe-4d96-886d-1344675502df" name="us-gaap:DebtInstrumentFrequencyOfPeriodicPayment"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">monthly</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> principal payments and interest.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In February 2022, the Company entered into the Third Amendment to the Loan Agreement (the Third Amendment) which added Bioniz as a secured party to the loan.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Under authoritative guidance, the April 2021 amendment did not meet the criteria to be accounted for as a troubled debt restructuring. In addition, the Company performed a quantitative analysis and determined that the terms of the new debt and original debt instrument are not substantially different. Accordingly, the April 2021 amendment was accounted for as a debt modification. A new effective interest rate that equates the revised cash flows to the carrying amount of the original debt was computed and applied prospectively. The effective interest rate as of December 31, 2022 is </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_9d26e4bc-6211-460f-b6dd-aa07598d7a85" contextRef="C_74785e69-c479-4de9-938d-9e775d1f539a" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" unitRef="U_pure" scale="-2" decimals="4" format="ixt:numdotdecimal">11.86</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company will be required to make a final payment of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_7840b061-73d5-4db2-9a0f-99d931d2e5b0" contextRef="C_9cad8da7-5192-43d1-ae8d-b306505ebc15" name="eq:DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaidAsPercent" unitRef="U_pure" scale="-2" decimals="4" format="ixt:numdotdecimal">5.00</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of the original principal amount of the Term Loan drawn payable on the earlier of (i) the Maturity Date, (ii) the acceleration of the Term Loan in the event of a default, or (iii) the prepayment of the Term Loan (the Final Payment). The Company may prepay all, but not less than all, of the Term Loan upon </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_e6be88e9-ae5f-4a56-a841-18d629664750" contextRef="C_9cad8da7-5192-43d1-ae8d-b306505ebc15" name="eq:RequiredNoticePeriodForDebtPrepayment" format="ixt-sec:durday"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">30</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> days&#x2019; advance written notice </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">to the lender, provided that the Company will be obligated to pay a prepayment fee equal to (i) </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d81f1d22-559e-4655-8855-3edc33d75df7" contextRef="C_9cad8da7-5192-43d1-ae8d-b306505ebc15" name="eq:DebtPrepaymentFeeAsPercentOnYearOne" unitRef="U_pure" scale="-2" decimals="4" format="ixt:numdotdecimal">3.00</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of the principal amount of the Term Loan prepaid on or before the first anniversary of the applicable funding date, (ii) </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ee6563e5-9c9d-40e6-979b-5be6907deedc" contextRef="C_9cad8da7-5192-43d1-ae8d-b306505ebc15" name="eq:DebtPrepaymentFeeAsPercentOnYearTwo" unitRef="U_pure" scale="-2" decimals="4" format="ixt:numdotdecimal">2.00</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of the principal amount of the Term Loan prepaid between the first and second anniversary of the funding date, and (iii) </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_90bdd24c-b6c1-42ea-b020-4e7e47e83d31" contextRef="C_9cad8da7-5192-43d1-ae8d-b306505ebc15" name="eq:DebtPrepaymentFeeAsPercentFromYearThree" unitRef="U_pure" scale="-2" decimals="4" format="ixt:numdotdecimal">1.00</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of the principal amount of the Term Loan prepaid thereafter, and prior to the Maturity Date (each, a Prepayment Fee).</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In connection with entering into the Loan Agreement, the Company issued to the Lenders warrants exercisable for </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d17551ed-31e1-4a8b-8207-8abe21461e1e" contextRef="C_90508498-eb7a-4af4-a10b-9b578a529f24" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">80,428</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of the Company&#x2019;s common stock (the Warrants). The Warrants are exercisable in whole or in part, immediately, and have a per share </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">exercise price of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_5da95eb8-fb0f-4271-8f22-416531ac46bb" contextRef="C_90508498-eb7a-4af4-a10b-9b578a529f24" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_USDollarShare" scale="0" decimals="2" format="ixt:numdotdecimal">3.73</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, which was the closing price of the Company&#x2019;s common stock reported on the Nasdaq Global Market on the day prior to the Effective Date. The Warrants will terminate on the earlier of September 30, 2029 or the closing of certain merger or consolidation transactions.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_575e1962-a19d-48c9-bd75-558116cedacf" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The aggregate carrying amounts of the Term Loan is comprised of the following (in thousands):</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:67.108%;"></td>
        <td style="width:1.493%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:12.883000000000001%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.493%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:13.022%;"></td>
        <td style="width:1.0%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Principal</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_382c1a7c-c988-467f-8884-a7b8acebec2b" contextRef="C_b41b6a74-0d46-45fe-8820-d94fa8d877f1" name="us-gaap:DebtInstrumentCarryingAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">8,571</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_4c463f3c-a224-4f6b-94b7-8ab8ced8aef0" contextRef="C_916e47cd-8d5b-46a6-ada5-c452d339e627" name="us-gaap:DebtInstrumentCarryingAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">10,000</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Add: accreted liability for final payment fee</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_79696f80-5429-4b5f-a3aa-ae1e7d2f0777" contextRef="C_b41b6a74-0d46-45fe-8820-d94fa8d877f1" name="eq:AccretedLiabilityForFinalPaymentFee" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">430</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f4cd1eb3-d0df-476b-bdc7-1ae496980767" contextRef="C_916e47cd-8d5b-46a6-ada5-c452d339e627" name="eq:AccretedLiabilityForFinalPaymentFee" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">310</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Less: unamortized discount</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_5db261b9-afc3-430f-9f60-d4b6963dda01" contextRef="C_b41b6a74-0d46-45fe-8820-d94fa8d877f1" name="us-gaap:DebtInstrumentUnamortizedDiscount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">48</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_abfb099e-6efe-454f-becc-3c5c706cf820" contextRef="C_916e47cd-8d5b-46a6-ada5-c452d339e627" name="us-gaap:DebtInstrumentUnamortizedDiscount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">132</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_745d74ea-760b-4ab3-aa99-52d9a46c1747" contextRef="C_b41b6a74-0d46-45fe-8820-d94fa8d877f1" name="us-gaap:LongTermDebt" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">8,953</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_60b24ef1-0b94-4d94-b7f8-e08a24106099" contextRef="C_916e47cd-8d5b-46a6-ada5-c452d339e627" name="us-gaap:LongTermDebt" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">10,178</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Upon the occurrence of certain events, including but not limited to the Company&#x2019;s failure to satisfy its payment obligations under the Loan Agreement, the breach of certain of its other covenants under the Loan Agreement, or the occurrence of a material adverse change, cross defaults to other indebtedness or material agreements, judgment defaults and defaults related to failure to maintain governmental approvals failure of which to maintain could result in a material adverse effect, the Lenders will have the right, among other remedies, to declare all principal and interest immediately due and payable, to exercise secured party remedies, to receive the Final Payment and, if the payment of principal and interest is due prior to the Maturity Date, to receive the applicable Prepayment Fee. At December 31, 2022, the Company was in compliance with the covenants contained in the Loan Agreement.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">19</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></ix:exclude><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_43b47ea4-ea26-4544-91f1-34c76829c987" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Future maturities of the Term Loan, including the Final Payment fee, as of December 31, 2022 were as follows (in thousands):</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:80.253%;"></td>
        <td style="width:1.792%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:15.956%;"></td>
        <td style="width:1.0%;"></td>
       </tr>
       <tr>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year ending December 31, 2023</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_eedd0bad-b2bc-493b-8a32-077e6cb08bef" contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192" name="eq:DebtInstrumentCarryingAmountIncludingUnaccretedLiabilityForFinalPaymentFeeMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">5,714</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year ending December 31, 2024</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_3dff44ea-19ae-494c-a9e0-af5fbad8c727" contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192" name="eq:DebtInstrumentCarryingAmountIncludingUnaccretedLiabilityForFinalPaymentFeeMaturitiesRepaymentsOfPrincipalInYearTwo" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,357</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_93041eeb-88f9-43c6-abb2-1c768b9e9f7f" contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192" name="us-gaap:LongTermDebt" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">9,071</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unaccreted balance for Final Payment fee on Term Loans</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6421d3d5-8b1e-4296-926e-33169a37a22e" contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192" name="eq:UnaccretedLiabilityForFinalPaymentFee" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">70</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unamortized discounts</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f4f35d3f-98aa-4fbe-b48d-2b77f2918f7b" contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192" name="us-gaap:DebtInstrumentUnamortizedDiscount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">48</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ec04bc3e-7d83-4bc6-aac0-e9ddcdc4e71a" contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192" name="eq:DebtInstrumentCarryingAmountIncludingUnaccretedLiabilityForFinalPaymentFee" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">8,953</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Less current portion</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8ab5cfa0-4b7a-4b38-8a13-67d1c2297e6b" contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192" name="us-gaap:LongTermDebtCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">5,714</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Noncurrent portion</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8abbfc16-67d4-4e0a-aa82-61b1bd7ad879" contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192" name="us-gaap:LongTermDebtNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,239</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div></ix:nonNumeric></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_1cfba161-5069-4df3-9693-8ee728544074" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11. Stockholders&#x2019; Equity</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31, 2022, the Company&#x2019;s authorized capital stock consisted of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_3d6611ca-3676-4cdc-83ba-05809425a242" contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192" name="us-gaap:CommonStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">200,000,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of common stock, par value $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_3e24f5fb-d7df-485a-ab0d-53cb4773c801" contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192" name="us-gaap:CommonStockParOrStatedValuePerShare" unitRef="U_USDollarShare" decimals="INF">0.0001</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> per share, and </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_7feb4b63-ca55-4750-b2da-1ce64d3d1ab8" contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192" name="us-gaap:PreferredStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">10,000,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of preferred stock, par value $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d20b2e43-c342-4479-a71b-0a217d88b467" contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192" name="us-gaap:PreferredStockParOrStatedValuePerShare" unitRef="U_USDollarShare" decimals="INF">0.0001</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> per share.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company had </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_5ae533a4-c513-401b-b329-65df43865f6c" contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192" name="us-gaap:CommonStockSharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">34,414,149</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_907f8c70-8a23-4816-9d70-f218587e4ba4" contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94" name="us-gaap:CommonStockSharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">29,455,668</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of common stock outstanding as of December 31, 2022 and 2021, respectively.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Registered Direct Offering and related warrants</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On February 3, 2021, the Company entered into a securities purchase agreement (the Securities Purchase Agreement) with </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_3ae290c9-b07c-4d44-9c15-67963c6e305f" contextRef="C_bff86cb7-8d58-45e7-9e93-1982cad8799f" name="eq:NumberOfInstitutionalInvestors" unitRef="U_Investor" decimals="INF" format="ixt-sec:numwordsen">two</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> institutional investors (the Purchasers), relating to the issuance and sale (the Offering) of an aggregate of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_52230e53-1f7a-43b2-8810-26e96243e293" contextRef="C_4eb35088-1593-4e17-8c6a-8c9e0bdad77b" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">4,285,710</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of common stock and warrants to purchase </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d836840e-2cce-4d4f-a6fe-ee7e2a6d43f6" contextRef="C_c10ac679-9a2b-4cbc-b11a-d6a2b12c4221" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">1,285,713</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of common stock (the Warrants) for aggregate gross proceeds to the Company from this Offering of approximately $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_9eec71dc-a171-4dd5-9a8f-cd94e988b321" contextRef="C_bff86cb7-8d58-45e7-9e93-1982cad8799f" name="eq:GrossProceedsFromIssuanceOfCommonStock" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">30.0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million, excluding any proceeds the Company may receive upon exercise of the Warrants. No underwriter or placement agent participated in the Offering. The proceeds, net of related issuance costs, were $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_2ba7faf4-67ff-43d7-8b10-29579a938d3c" contextRef="C_bff86cb7-8d58-45e7-9e93-1982cad8799f" name="us-gaap:ProceedsFromIssuanceOfCommonStock" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">29.9</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Warrants are exercisable immediately upon issuance at an initial exercise price of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f8fc048f-c649-4917-91d9-8858c5810c90" contextRef="C_2c8bb5f0-73a3-432f-b12e-cb35048d1783" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_USDollarShare" decimals="INF">14.00</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> per share and are exercisable on a cashless basis. The Warrants expire on the earlier of (i) the fifth anniversary of issuance or (ii) the 15th calendar date following the date on which the Company closes upon an equity financing that results in not less than $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_beab5094-53f2-421d-8e02-5347ceb0fc2a" contextRef="C_d3ce0459-c113-4153-9f4d-e1ca48da2c0b" name="eq:GrossProceedsFromIssuanceOfCommonStock" unitRef="U_USD" scale="6" decimals="-6" format="ixt:numdotdecimal">25</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million of gross proceeds to the Company at a price per share of common stock equal to or greater than $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_81a45000-435c-4145-9783-8c34f54005e3" contextRef="C_2c8bb5f0-73a3-432f-b12e-cb35048d1783" name="us-gaap:SharesIssuedPricePerShare" unitRef="U_USDollarShare" decimals="INF">25.00</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, at which time, all remaining Warrants will automatically be exercised on a cashless basis. The exercise price and the number of shares of common stock purchasable upon the exercise of the Warrants are subject to adjustment upon the occurrence of specific events, including stock dividends, stock splits, reclassifications and combinations of the Company&#x2019;s common stock. All of the warrants are recorded within equity in accordance with authoritative accounting guidance.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pursuant to the terms of the Securities Purchase Agreement, the Company appointed Dr. Yu (Katherine) Xu, Ph. D. to the Board as a nominee of the Purchasers.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Purchase Agreement</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On March 27, 2020, the Company entered into a purchase agreement (Purchase Agreement), with Lincoln Park, which provides that, upon the terms and subject to the conditions and limitations set forth therein, the Company may sell to Lincoln Park up to $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_003c4199-e516-4237-a0b0-37316a58121b" contextRef="C_1b636714-e678-4bb2-be3e-3c64ae434607" name="eq:EstimatedMaximumAmountOfCommonStockIssuable" unitRef="U_USD" scale="3" decimals="-2" format="ixt:numdotdecimal">15.0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million of shares of its common stock from time to time over the </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_1255aa3e-5c80-435c-9ba2-f17af017833b" contextRef="C_1b636714-e678-4bb2-be3e-3c64ae434607" name="eq:TermOfPurchaseAgreement" format="ixt-sec:durwordsen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">36-month</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> term of the Purchase Agreement. Upon execution of the Purchase Agreement, the Company issued </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_abf6734c-2293-41fa-894c-055a93f80c6f" contextRef="C_1b636714-e678-4bb2-be3e-3c64ae434607" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">65,374</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of its common stock to Lincoln Park as commitment shares in accordance with the closing conditions contained within the Purchase Agreement. The commitment shares were valued using the closing price of the Company&#x2019;s common stock on the effective date of the Purchase Agreement resulting in a fair market value of approximately $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_2bf46546-14d2-4722-bf4a-c597a34f1c78" contextRef="C_1b636714-e678-4bb2-be3e-3c64ae434607" name="eq:FairMarketValueOfCommitmentShares" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">0.2</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million. The fair market value of the commitment shares as well as other issuance costs associated with the Purchase Agreement totaled $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_472789f9-f469-4061-9a02-fa30ef8b68cd" contextRef="C_1b636714-e678-4bb2-be3e-3c64ae434607" name="us-gaap:PaymentsOfStockIssuanceCosts" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">0.4</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million. These issuance costs were classified as prepaid expenses and other current assets in the accompanying consolidated balance sheet as of December 31, 2021.  There have been </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_11c588a5-a866-4a3e-8d13-6129e1d94155" contextRef="C_251e65bb-85a5-4df7-a709-d3e4c8e42ad6" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" unitRef="U_shares" decimals="0" format="ixt-sec:numwordsen">no</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> sales of the Company&#x2019;s stock under this Purchase Agreement as of December 31, 2022 and through the date of the filing of this Annual Report on Form 10-K. The Purchase Agreement expires on </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_88a8e2a1-7709-4503-9a9c-949f3a89ac80" contextRef="C_ea3c06e5-f9a7-4f24-ba11-8679304c0196" name="eq:PurchaseAgreementExpirationDate" format="ixt:datemonthdayyearen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">May 1, 2023</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Since the Company believes it is unlikely to sell any shares to Lincoln Park prior to the Purchase Agreement expiring, the capitalized issuance costs were written off as of December 31, 2022 to general and administrative expense.</span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">20</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">2018 Equity Incentive Plan</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In October 2018, the Company adopted the 2018 Equity Incentive Plan (the 2018 Plan) which replaced the Company&#x2019;s legacy 2017 Equity Incentive Plan (the 2017 Plan). The 2018 Plan provides for the grant of incentive stock options, non-statutory stock options, stock appreciation rights, restricted stock awards, restricted stock unit awards, performance stock awards, performance cash awards and other forms of stock awards. As of December 31, 2022, the 2018 Plan had a maximum of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_551a4fe7-22a7-4954-907b-f5ddd69caf47" contextRef="C_a14519ee-c0f5-4735-a3a2-5d78ee96686f" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">784,331</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> total shares available for issuance. </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_aa39f005-ec5d-4e9e-b98f-fd69e5292316" contextRef="C_1a97b4e1-6653-4a2c-a233-548bf388b221" name="eq:EquityIncentivePlanDescription"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The number of shares of common stock reserved for issuance under the 2018 Plan will automatically increase on January 1 of each calendar year through January 1, 2028, in an amount equal to 5.0% of the total number of shares of the Company&#x2019;s capital stock outstanding on the last day of the calendar month before the date of each automatic increase, or a lesser number of shares determined by the Board.</span></ix:nonNumeric></span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Options granted under the 2018 Plan are exercisable at various dates as determined upon grant and will expire no more than </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_c4e31daa-eabd-4a52-addf-7e89e56472e7" contextRef="C_58ee8b88-7fcf-463a-aada-7b6967a5d010" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:durwordsen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ten years</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> from their date of grant. The exercise price of each option shall be determined by the Board based on the estimated fair value of the Company&#x2019;s stock on the date of the option grant. The exercise price shall not be less than </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e2b83408-a906-465a-a50f-5c14dd36726b" contextRef="C_4ba266ad-8527-41b5-81de-63143638b62c" name="eq:MinimumOptionsExercisePriceAsPercentageOfFairMarketValueOfCommonStock" unitRef="U_pure" scale="-2" decimals="INF" format="ixt:numdotdecimal">100</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of the fair market value of the Company&#x2019;s common stock at the time the option is granted. Most option grants generally vest </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_fd633a79-31a8-478b-beb5-a541337be5a1" contextRef="C_7b79d852-2622-42ae-b02e-a2784258be60" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" unitRef="U_pure" scale="-2" decimals="2" format="ixt:numdotdecimal">25</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% on the first anniversary of the original vesting commencement date, with the balance vesting monthly over the remaining </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_1acf3ae7-a798-4bec-9630-28850b7c47d1" contextRef="C_4ba266ad-8527-41b5-81de-63143638b62c" name="eq:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRemainingVestingPeriod" format="ixt-sec:durwordsen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">three years</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Stock Options</span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_e6540ba4-1c33-4622-a084-34c8188f8b02" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following summarizes stock option activity for the year ended December 31, 2022:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:50.131%;"></td>
        <td style="width:0.713%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:12.533999999999999%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:0.844%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:6.307%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:0.713%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:10.41%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:0.844%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:9.507%;"></td>
        <td style="width:1.0%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Outstanding Options</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Weighted-<br />Average <br />Exercise Price<br />Per Share</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Weighted<br />Average<br />Remaining<br />Contractual<br />Term<br />(in years)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Aggregate<br />Intrinsic Value<br />(in thousands) </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Balances as of December 31, 2021</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_415cebe3-b500-4c21-803c-8d39739c84b1" contextRef="C_9c160bc4-2896-4f45-abda-cba01dca2910" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">3,947,025</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_2948110b-6c36-447e-bc0a-a6d1261421db" contextRef="C_9c160bc4-2896-4f45-abda-cba01dca2910" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" unitRef="U_USDollarShare" scale="0" decimals="2">4.58</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Granted</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_83f3ff46-668b-4ffb-9bb7-7c00ef203b03" contextRef="C_1a97b4e1-6653-4a2c-a233-548bf388b221" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">2,169,800</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_831bf75a-c3f1-4ab9-a0a8-848d2ca6657f" contextRef="C_1a97b4e1-6653-4a2c-a233-548bf388b221" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" unitRef="U_USDollarShare" scale="0" decimals="2">3.63</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exercised</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="-sec-ix-hidden:F_e9cd9fc4-b2d3-4e1c-814b-17b62754d416;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></span></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="-sec-ix-hidden:F_0fa15c8b-e902-4287-b1e7-c4c493e1c465;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></span></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Forfeitures and cancellations</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_0125e25b-21e5-47a4-9db5-ffe833aee1dd" contextRef="C_1a97b4e1-6653-4a2c-a233-548bf388b221" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">1,014,324</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_90fe45e0-cb09-4a27-93a1-9a6acbe28e11" contextRef="C_1a97b4e1-6653-4a2c-a233-548bf388b221" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" unitRef="U_USDollarShare" scale="0" decimals="2">4.90</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Balances as of December 31, 2022</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_056d53e9-0364-4776-bcf5-df3211d69903" contextRef="C_4640a459-b05e-473c-894a-3d5c68449919" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">5,102,501</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c51d9d10-b078-4f36-9c26-45c3b2f7af28" contextRef="C_4640a459-b05e-473c-894a-3d5c68449919" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" unitRef="U_USDollarShare" scale="0" decimals="2">4.11</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_51eafb38-6b4e-45bc-970e-daa3ff169030" contextRef="C_1a97b4e1-6653-4a2c-a233-548bf388b221" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7.71</span></ix:nonNumeric></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_bd8784fc-0055-4304-85a2-61493abaaf00" contextRef="C_4640a459-b05e-473c-894a-3d5c68449919" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Options exercisable as of December 31, 2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_9a4a27bf-0cd7-412f-b4e1-ca0927616d98" contextRef="C_4640a459-b05e-473c-894a-3d5c68449919" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">2,483,222</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_0bbe39c3-c328-48f3-bde7-4cbb69fc9371" contextRef="C_4640a459-b05e-473c-894a-3d5c68449919" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" unitRef="U_USDollarShare" scale="0" decimals="2">4.23</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_f583764a-67aa-471f-af22-2dcd792339a1" contextRef="C_1a97b4e1-6653-4a2c-a233-548bf388b221" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6.75</span></ix:nonNumeric></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_4bccb99b-951a-4290-9052-fd9ccab54601" contextRef="C_4640a459-b05e-473c-894a-3d5c68449919" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><div style="text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.333%;">(a)</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Aggregate intrinsic value in this table was calculated as the positive difference, if any, between the closing price per share of the Company&#x2019;s common stock on December 31, 2022 of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_89f71c25-12ae-45dc-8607-0e435fd49c2a" contextRef="C_cba59bb2-f211-4a75-beff-6ddac7dfa0b7" name="us-gaap:SharePrice" unitRef="U_USDollarShare" scale="0" decimals="2" format="ixt:numdotdecimal">1.06</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and the price of the underlying options.</span></div></div></ix:nonNumeric></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The aggregate intrinsic value of stock options exercised was </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_de3d9dcd-3deb-4600-92bf-1f265bad7d75" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" unitRef="U_USD" scale="6" decimals="-6" format="ixt-sec:numwordsen">none</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_af68308e-522d-4e2b-bceb-c2664f192ea7" contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">0.4</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million for the years ended December 31, 2022 and 2021, respectively. Cash received from stock options exercised was </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_88c5fffa-f216-4158-a4e0-8c1d9b01076c" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:ProceedsFromStockOptionsExercised" unitRef="U_USD" scale="6" decimals="-6" format="ixt-sec:numwordsen">none</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_17418a12-b280-492f-bf01-bc31b3701d17" contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2" name="us-gaap:ProceedsFromStockOptionsExercised" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">0.9</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million for the years ended December 31, 2022 and 2021, respectively.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The fair value of stock options that vested in the years ended December 31, 2022 and 2021 was $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_84e5a6ff-942b-48b7-9493-c486ab7ebca2" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">4.5</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_7e4256c2-acb5-4c8e-8940-fa96d4ea9635" contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">3.0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million, respectively. The weighted-average grant-date fair value of options granted was $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_755ea9b7-cdb9-42ed-88e7-37f686782c8b" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" unitRef="U_USDollarShare" scale="0" decimals="2">2.49</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_0314ef5c-b691-425c-9099-e1735585597f" contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" unitRef="U_USDollarShare" scale="0" decimals="2">3.94</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> for the years ended December 31, 2022 and 2021, respectively.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31, 2022, unrecognized compensation expense related to unvested stock options was $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b5cd9542-e62a-46ea-9945-9454e5771ee4" contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">6.7</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million and is expected to be recognized over a weighted-average period of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_fff2d060-6cfb-4704-b217-da0a3e47a556" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.6</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> years.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">21</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">2018 Employee Stock Purchase Plan</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In October 2018, the Company adopted the 2018 </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_cd0986cb-7b85-44d0-b503-771339301bc1" contextRef="C_8d880863-715e-4b80-9a73-33be4ffa0166" name="eq:EmployeeStockPurchasePlanDescription"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Equity Stock Purchase Plan (ESPP) whereby eligible employees may elect to withhold up to </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_66609d91-e569-4ee4-8d35-4970d1142543" contextRef="C_6b91f489-4f82-44f0-b32f-1000032af149" name="eq:WithholdPercentageOfEmployeesEarningsToPurchaseSharesOfCommonStock" unitRef="U_pure" scale="-2" decimals="2" format="ixt:numdotdecimal">15</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of their earnings to purchase shares of the Company&#x2019;s common stock at a price per share equal to the lower of (i) </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d2e15c19-3534-45ad-ba5e-78ed07a91af7" contextRef="C_6b91f489-4f82-44f0-b32f-1000032af149" name="eq:MinimumStockPricePerShareAsPercentageOfFairMarketValueOfCommonStock" unitRef="U_pure" scale="-2" decimals="INF" format="ixt:numdotdecimal">85</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of the fair market value of a share of the Company&#x2019;s common stock on the first date of an offering or (ii) </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_deddec0f-8d39-475e-8254-b91551739f9a" contextRef="C_72940a8c-6662-4785-be1e-cde22f293e80" name="eq:MinimumStockPricePerShareAsPercentageOfFairMarketValueOfCommonStock" unitRef="U_pure" scale="-2" decimals="INF" format="ixt:numdotdecimal">85</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of the fair market value of a share of the Company&#x2019;s common stock on the date of the purchase right (purchase right). Initially, </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_28b5cd0a-e42f-4809-ba9d-06d219d48d25" contextRef="C_da6b0f69-4d60-4727-93e2-76b6699fc7cd" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">343,275</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of the Company&#x2019;s common stock were approved for issuance under the ESPP pursuant to purchase rights granted to the Company&#x2019;s employees or to employees of any of the Company&#x2019;s designated affiliates. The number of shares of the Company&#x2019;s common stock reserved for issuance will automatically increase on January 1 of each calendar year through January 1, 2028, by the lesser of (1) 1.0% of the total number of shares of the Company&#x2019;s common stock outstanding on the last day of the calendar month before the date of the automatic increase, and (2) </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f5d60629-d3ed-4e58-84e1-f8c65f0c876d" contextRef="C_da6b0f69-4d60-4727-93e2-76b6699fc7cd" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">343,275</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares; provided that before the date of any such increase, the Board may determine that such increase will be less than the amount set forth in clauses (1) and (2)</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31, 2022, the Company had issued </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_73259d40-179a-4882-8a3f-64aa67240992" contextRef="C_7e0f633d-433f-45b3-b81e-21ab345a28bd" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">307,417</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of common stock under the ESPP, </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_aadc27ba-ac63-4a4f-a61d-1ce635c5fc23" contextRef="C_8d880863-715e-4b80-9a73-33be4ffa0166" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">138,251</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> of which were issued during the year ended December 31, 2022. The Company had </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_807593c4-9069-4103-a2f7-980fce4c0022" contextRef="C_8d880863-715e-4b80-9a73-33be4ffa0166" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">925,963</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares available for future issuance under the ESPP as of December 31, 2022.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Liability for Early Exercise of Restricted Stock Options</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">All stock option grants under the 2017 Plan provide for exercise of the stock option prior to vesting. Shares of common stock issued upon exercise of unvested options are subject to repurchase by the Company at the respective original exercise price until vested. Consideration received for the exercise of unvested stock options is recorded as a liability and reclassified into equity as the related award vests.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31, 2022</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, there were no unvested shares issued under early exercise provisions subject to repurchase by the Company. As of December 31, 2021, there were </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e1cc44e2-f82f-4959-a474-70b58b9ad859" contextRef="C_4facbb57-718b-4710-bf34-290be7c869f0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">43,135</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> unvested shares issued under early exercise provisions that were subject to repurchase by the Company. The balance sheet reflects an unvested stock liability of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_cf511860-e03d-4376-bb0f-ced636e083af" contextRef="C_0d524201-b596-46e6-95bc-8b3b552ccc88" name="eq:UnvestedStockLiability" unitRef="U_USD" decimals="0" format="ixt-sec:numwordsen">none</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_5dec1a5f-d16a-4a20-86f1-c82af24d438d" contextRef="C_4facbb57-718b-4710-bf34-290be7c869f0" name="eq:UnvestedStockLiability" unitRef="U_USD" decimals="0" format="ixt:numdotdecimal">53,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> as of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022 and 2021, respectively. As of December 31, 2021, the unvested stock liability was considered short-term and was classified as accrued expenses on the accompanying consolidated balance sheet.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Stock-based Compensation Expense</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_016868ba-fa7b-4e25-86a7-1cf74d2d87fe" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total non-cash stock-based compensation expense for all stock awards and purchase rights, net of forfeitures recognized as they occur, that was recognized in the consolidated statement of operations is as follows (in thousands):</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.327%;"></td>
        <td style="width:1.466%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:13.322000000000001%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.48%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:13.406%;"></td>
        <td style="width:1.0%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year Ended <br />December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Research and development</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_2c09e938-6778-48c1-b977-13e31ff95963" contextRef="C_ff05e412-5d32-4d51-9c1b-fcbe95cea7f7" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,799</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_3de6a73a-8959-42e9-9d83-8c3b9ccd64b8" contextRef="C_c004a059-d1b3-45bc-90d2-29b2939452f6" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,976</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">General and administrative</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_9193a7b0-8aca-4e6b-b0ef-da41f81df776" contextRef="C_c886a389-5f87-408e-8648-17d8507a401b" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,042</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_0225a541-4b2c-4147-9b8a-bf9184441cc7" contextRef="C_fae7480f-6d94-4ea1-b4e4-5cde09bbcd56" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,434</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ddc72299-75a8-415e-b24f-a2423054db71" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,841</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_be3b2d68-7e9b-4b4e-9fcb-e160db7dc1d4" contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,410</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_14f1b332-adb3-4223-a017-e867f2ca1c4e" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The weighted-average assumptions used in the Black-Scholes option pricing model to determine the fair value of the employee and nonemployee stock option grants were as follows:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:67.29%;"></td>
        <td style="width:1.502%;"></td>
        <td style="width:14.867%;"></td>
        <td style="width:1.502%;"></td>
        <td style="width:14.838%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="3" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year Ended <br />December 31,</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Risk-free interest rate</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e2b52f8e-c84b-41e1-902b-b4081f32b07c" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" unitRef="U_pure" scale="-2" decimals="4" format="ixt:numdotdecimal">1.93</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f5204ec4-ce7e-4be0-8356-71f55d1bd212" contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" unitRef="U_pure" scale="-2" decimals="4" format="ixt:numdotdecimal">0.68</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Expected volatility</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ee322998-3661-45e2-9e17-844dbe59fd4f" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" unitRef="U_pure" scale="-2" decimals="4" format="ixt:numdotdecimal">81.60</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_fd629560-1de1-4d5a-aad5-9a08f38fbc17" contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" unitRef="U_pure" scale="-2" decimals="4" format="ixt:numdotdecimal">88.55</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Expected term (in years)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_dc1a667b-8989-4fec-b305-7817bcf938de" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.84</span></ix:nonNumeric></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_aee9ddf3-80e6-4667-a4d2-4dfe10fbc260" contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6.01</span></ix:nonNumeric></span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Expected dividend yield</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ceb62c59-25c0-48f8-a596-7c1443ef97b2" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" unitRef="U_pure" scale="-2" decimals="2" format="ixt:numdotdecimal">0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6896c53b-6da1-4e3d-8c72-928f384ee301" contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" unitRef="U_pure" scale="-2" decimals="2" format="ixt:numdotdecimal">0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Risk-free interest rate. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The risk-free rate assumption is based on the U.S. Treasury instruments, the terms of which were consistent with the expected term of the Company&#x2019;s stock options.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Expected volatility. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Due to the Company&#x2019;s limited operating history and lack of company-specific historical or implied volatility as a private company, the expected volatility assumption was determined by examining the historical volatilities of a group of industry peers whose share prices are publicly available.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">22</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Expected term. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The expected term of stock options represents the weighted-average period the stock options are expected to be outstanding. The Company uses the simplified method for estimating the expected term as provided by the SEC. The simplified method calculates the expected term as the average of the time-to-vesting and the contractual life of the options.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Expected dividend yield. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The expected dividend assumption is based on the Company&#x2019;s history and expectation of dividend payouts. The Company has not paid and does </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_85fc9285-7301-49ac-8222-9077ca62c6c6" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="eq:DividendsPaidOnCommonStock" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">t intend to pay dividends.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Forfeitures</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. The Company reduces stock-based compensation expense for actual forfeitures during the period.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Common Stock Reserved for Future Issuance</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_f58d385d-aa49-4329-8494-a6f68ea81dc5" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="eq:CommonStockReservedForFutureIssuanceTableTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Common stock reserved for future issuance consists of the following as of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022 and 2021:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:67.477%;"></td>
        <td style="width:1.009%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:13.204%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.023%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:13.289%;"></td>
        <td style="width:1.0%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Stock options issued and outstanding</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a7bc8091-a447-4d73-b50d-b8bcd2458b85" contextRef="C_c197641e-f183-4f80-9bfd-23288c4df7df" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">5,102,501</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a4be6de3-bbec-450d-9121-3dde4a7902d6" contextRef="C_9520a266-f74a-45cf-96ed-ba178f032640" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">3,947,025</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Warrants for common stock</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_1e101c49-f627-462f-bb21-bbe3a60d57cd" contextRef="C_f54cdfd1-dd2b-4d74-aa9b-16e8ecf08b91" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">1,366,141</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_cbf388ce-f568-4ce4-90f9-f7eca82681d5" contextRef="C_0a414f75-a619-4136-9add-c3356d8e1816" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">1,366,141</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Awards available under the 2018 Equity Incentive Plan</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ed582681-b275-49b5-8436-88460d4a585a" contextRef="C_b79b178e-6c81-4a59-9acf-58713aad69ee" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">784,331</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d851cb98-84c4-4179-81b4-cc7f2ea42af7" contextRef="C_48927eeb-5e48-4e18-bce6-146239c106d3" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">467,024</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Employee stock purchase plan</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_3d1cf996-9764-4919-a763-1069d79a272c" contextRef="C_32d659e3-aa51-4be5-b51f-bb1491642234" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">925,963</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_da38eb7a-cfb5-43aa-8aae-1ef97cf1353b" contextRef="C_5678bab9-8bd4-4b16-94e3-655278d75cd5" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">769,658</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_40257d3e-3405-4545-b2e0-be667740723a" contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">8,178,936</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_322d4835-8367-41a6-b838-62332d2dd673" contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">6,549,848</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div></ix:nonNumeric></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_d136fd30-51c7-4d5d-a388-00ef960f496b" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12. Commitments and Contingencies</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Leases and Other Commitments</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31, 2022, the Company leased certain office and laboratory space in La Jolla and South San Francisco, California under non-cancelable operating leases. The lease for office space in South San Francisco expired in February 2023 and was not renewed, the lease for laboratory space in La Jolla expires in February 2025 and the leases for office spaces in La Jolla expire in February 2027.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company enters into service agreements with indemnification clauses in the ordinary course of business. Pursuant to such clauses, the Company indemnifies, defends, holds harmless, and agrees to reimburse the indemnified party for losses suffered or incurred by third party claims arising out of the indemnified party&#x2019;s</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">performance of service. The Company has not incurred costs to defend lawsuits pursuant to these indemnification clauses.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Litigation</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31, 2022, there was </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_7d1ba932-cd08-4f3f-8fad-fe8695bc72aa" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:LitigationSettlementExpense" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> litigation against the Company.</span></p></ix:nonNumeric></div>
  <div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_5b08dff1-1968-4407-8209-bbe4ac6ca4e2" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:IncomeTaxDisclosureTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13. Income Taxes</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_59845dca-b725-45f2-a292-80f692aac484" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The components of loss before income tax provision (benefit) for the years ended December 31, 2022 and 2021 consisted of the following (in thousands):</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">		&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:65.971%;"></td>
        <td style="width:1.472%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:13.571%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.458%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:13.529%;"></td>
        <td style="width:1.0%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year Ended <br />December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S.</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c5bf9db3-a817-4506-bb93-3d0e1aa4710a" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">60,403</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_773c8299-e8a0-4ad0-8d20-aaab52a3bb1c" contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">37,705</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Foreign</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_9d85a3c2-3145-4d74-a0c3-f5a3666c9764" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">2,025</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_48aa031c-d397-4281-8d63-e6d7a6beb46e" contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">1,347</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_eae49744-6943-4af0-b42d-a95596c37243" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">62,428</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e4ff6293-1b99-4b3a-9c89-17fb54611bf7" contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">39,052</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company has </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_5d188271-f553-4035-af1c-780f69a1bb93" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:CurrentIncomeTaxExpenseBenefit" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_ebd817df-f16d-4587-813a-613fa3f675e2" contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2" name="us-gaap:CurrentIncomeTaxExpenseBenefit" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_ae435fe3-91da-49ca-9d37-e00ccb10447b" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:DeferredIncomeTaxExpenseBenefit" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_ad72b777-9802-4fcf-821d-f8f1603f2888" contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2" name="us-gaap:DeferredIncomeTaxExpenseBenefit" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">t recorded a current or deferred tax expense or benefit for the years ended </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022 and 2021.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">23</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></ix:exclude><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_877fa89d-2faf-4556-b6a1-0b5c68ac6663" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="eq:SummaryOfReconciliationOfExpectedStatutoryFederalIncomeTaxProvisionToActualIncomeTaxProvisionTableTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following is a reconciliation of the expected statutory federal income tax provision to our actual income tax provision for the years ended </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022 and 2021 (in thousands):</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:65.971%;"></td>
        <td style="width:1.472%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:13.571%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.458%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:13.529%;"></td>
        <td style="width:1.0%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year Ended<br />December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Income taxes at statutory rates</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_38e9022c-aecb-4bd6-841f-3fdb79f39fa9" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">13,110</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_4fa41e32-3b58-442a-b40a-62e4c8e1fef1" contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">8,201</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">State income tax, net of federal benefit</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Stock-based compensation</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_79776f0a-4230-45fe-bb26-54b19b91b52f" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">533</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_dd6dae07-0aeb-4f61-94ea-09caed272ee0" contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">451</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Permanent items</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_4ecca56d-b050-49cf-be20-fcc8995d82c0" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="eq:IncomeTaxReconciliationPermanentItems" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">128</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_66128e8f-df76-4060-b6cf-6188b9ee6004" contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2" name="eq:IncomeTaxReconciliationPermanentItems" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">31</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Federal research and orphan drug credits</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b546acb8-c49a-4386-8c3b-c5fbfdc3bca8" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="eq:IncomeTaxReconciliationFederalResearchAndOrphanDrugCredits" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,152</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d5173624-a1f8-421b-b9a6-3f6837480750" contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2" name="eq:IncomeTaxReconciliationFederalResearchAndOrphanDrugCredits" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,713</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Foreign rate differential</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_339a8659-0bb8-4fbc-8e87-5549deed7cd1" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">425</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_fb654f0b-c8b0-4535-9896-3403e6c78e30" contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">72</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Transaction costs</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b8162cf8-818b-455a-afdf-ceb52d44113a" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="eq:EffectiveIncomeTaxRateReconciliationTransactionCostsAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">89</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Acquired in-process research and development</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c5706dc0-8f7b-48de-bb4d-5243b66bac85" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,840</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Change in federal valuation allowance</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_874153ff-8cac-4b26-b713-90b8a26ef207" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">8,247</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ee9679b1-82e4-428b-9196-8e3e92101898" contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">9,360</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c962d1bd-9ceb-4702-b9ab-804fe495cb6f" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:IncomeTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_94da8225-5332-439d-a4d5-1661d7695345" contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2" name="us-gaap:IncomeTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_97b8386b-a204-4abe-a196-828496f746f4" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The tax effects of temporary differences that give rise to significant portions of the deferred tax assets and deferred tax liabilities as of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022 and 2021 are as follows (in thousands):</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:65.971%;"></td>
        <td style="width:1.472%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:13.571%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.458%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:13.529%;"></td>
        <td style="width:1.0%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Deferred tax assets:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net operating loss carryforward</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_4590dab1-a11c-44f5-b30a-ed70f4fe9349" contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">28,222</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c8400e7d-6a76-47b5-a299-271cc3b1ca40" contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">19,344</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Credits</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e1bf5fe0-73b8-4891-868a-ca942d0221c5" contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwards" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">9,289</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d1d339da-1c06-439a-b568-41178483ceb7" contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwards" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,940</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Capitalized research expenditures</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_046bbc79-5e9d-4aab-9115-9f69c0ac00ba" contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192" name="eq:DeferredTaxAssetsCapitalizedResearchExpenditures" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">7,086</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Equity compensation</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_7423c846-a534-4f33-ae04-a52bb120807a" contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,829</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_dda97600-2359-4af6-bbd2-e90373ea80a1" contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,134</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a8e06f82-3133-435e-8db7-4d4152f426c0" contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192" name="us-gaap:DeferredTaxAssetsOther" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,196</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d12688b5-7f2f-43c4-8f1c-46caec1be897" contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94" name="us-gaap:DeferredTaxAssetsOther" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,184</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total deferred tax assets</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_3779fa89-140d-423e-8661-b9ac000fe12e" contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192" name="us-gaap:DeferredTaxAssetsGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">47,622</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_97a7adcc-8569-4639-8d54-0e10f2e15d5b" contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94" name="us-gaap:DeferredTaxAssetsGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">25,602</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Valuation allowance</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_4a02ecc4-46b3-486a-8b1a-7e2167ed53c8" contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192" name="us-gaap:DeferredTaxAssetsValuationAllowance" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">46,317</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_5189b5b3-174d-4458-af22-3ed979b2e65f" contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94" name="us-gaap:DeferredTaxAssetsValuationAllowance" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">25,215</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total deferred tax assets, net of allowance</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_253ef32f-6dfa-4972-85ca-10ab4d4b9bea" contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192" name="us-gaap:DeferredTaxAssetsNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,305</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_5d506720-0a1d-48bd-96d6-54b22dbb5831" contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94" name="us-gaap:DeferredTaxAssetsNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">387</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Deferred tax liabilities:</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Operating lease right-of-use asset</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_08a576dd-bed0-41b1-abaf-19ed4977e004" contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192" name="us-gaap:DeferredTaxLiabilitiesLeasingArrangements" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">284</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_550e17cf-ebee-4f3c-821a-96898d20e652" contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94" name="us-gaap:DeferredTaxLiabilitiesLeasingArrangements" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">346</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Deferred revenue</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f12e5571-9e9a-4aae-940a-741fe6ae68fe" contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192" name="us-gaap:DeferredTaxLiabilitiesTaxDeferredIncome" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">945</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_9e8e7d11-b914-43f0-b9e6-0582a8016f69" contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192" name="us-gaap:DeferredTaxLiabilitiesOther" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">76</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_daee637d-4bd2-451b-82f2-15c4342a6965" contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94" name="us-gaap:DeferredTaxLiabilitiesOther" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">41</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total deferred tax liabilities</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6e8c003f-bca5-45c5-ae1b-7812e8e07220" contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192" name="us-gaap:DeferredIncomeTaxLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,305</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d64c8433-3b04-49ab-907d-d0eeee71540a" contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94" name="us-gaap:DeferredIncomeTaxLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">387</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net deferred taxes</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_cb513720-6774-47a7-987c-9a0464bb55c6" contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_2e5a2f31-dc6a-46ee-bae9-0f4ef3ae1684" contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company has established a valuation allowance against its net deferred tax assets due to the uncertainty surrounding the realization of such assets. The Company periodically evaluates the recoverability of the deferred tax assets. At such time as it is determined that it is more likely than not that deferred assets are realizable, the valuation allowance will be reduced. The Company has recorded a full valuation allowance of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_74374b06-2f14-4317-bca8-545fc2b7394f" contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192" name="us-gaap:DeferredTaxAssetsValuationAllowance" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">46.3</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million as of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> as it does not believe it is more likely than not that certain deferred tax assets will be realized primarily due to the generation of pre-tax book losses in the current year, the lack of feasible tax-planning strategies, the limited existing taxable temporary differences, and the subjective nature of forecasting future taxable income into the future. The Company increased its valuation allowance by approximately $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_33914755-b009-41a4-b7d7-8ee894cbe536" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">21.1</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million during the year ended </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">At December 31, 2022</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, the Company had federal and California tax loss carryforwards of approximately $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_4cb00f7b-1574-46c2-b51e-2f3513becef6" contextRef="C_e6610ebe-288f-4417-8098-af8696e03c7e" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">116.4</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_9fac22f5-913a-49d1-bf39-585e170958f2" contextRef="C_73660a62-57e2-407a-a1a0-1c6619629881" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">90.6</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million, respectively. The federal net operating loss carryover includes $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_766aa7bc-5ef5-4346-902d-8b93d66a18e0" contextRef="C_acb33667-c8a3-4249-a4a8-738294c5d493" name="us-gaap:OperatingLossCarryforwards" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">112.7</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million of net operating losses generated subsequent to 2017. </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_6040f3f9-f458-4aa4-8982-4ab5aa6e6a1b" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:OperatingLossCarryforwardsLimitationsOnUse"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Federal net operating losses generated after December 31, 2017 carryover indefinitely </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">but the deductibility of such federal net operating losses is limited</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> to </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_9e1e3f7a-298b-4ab6-b48d-3f1e43da5cb6" contextRef="C_6c6eb418-4e31-405d-80e2-4eeaa0ed0949" name="eq:OperatingLossCarryforwardsLimitationRateOnTaxableIncome" unitRef="U_pure" scale="-2" decimals="2" format="ixt:numdotdecimal">80</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of taxable income.</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> The federal net operating losses generated prior to 2018 as well as the state net operating loss carryforwards, begin to expire in </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_38413c41-a3a4-4e24-9e42-442718c20952" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="eq:OperatingLossCarryforwardsExpirationYear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2037 </span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">unless previously utilized. The Company has $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d5017a25-0fb3-4674-830e-7287b4a877c3" contextRef="C_1074585e-0f9e-4a71-aac7-7580a74d418f" name="us-gaap:OperatingLossCarryforwards" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">2.5</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million of Australian net operating loss carryforwards as of December 31, 2022 that are carried forward indefinitely.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">At December 31, 2022</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, the Company had federal and state tax credit carryforwards of approximately $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_40d38f84-f179-4e1c-a078-782d919f3f6c" contextRef="C_e6610ebe-288f-4417-8098-af8696e03c7e" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwards" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">7.2</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_55504a32-a6ed-43e9-971a-088aaba8ca5b" contextRef="C_2aa60dea-0a24-4f41-b6e1-70e203413f85" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwards" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">2.6</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million, respectively, after reduction for uncertain tax positions. The Company has not performed a formal research and development credit study with respect to these credits. The federal credits will begin to expire in </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_5df710b5-6cf2-4769-a224-65c1055a8947" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="eq:TaxCreditCarryforwardExpirationYear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2037</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, if unused, and the state credits carryforward indefinitely.</span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">24</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pursuant to the Internal Revenue Code of 1986, as amended (IRC), specifically Section 382 and 383, the Company&#x2019;s </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ability to use net operating loss and research and development tax credit carryforwards (tax attribute carryforwards) to offset future taxable income is limited if the Company experiences a cumulative change in ownership of more than </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_67fe6309-f2f8-4cfe-b737-5c964c6e8e76" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="eq:CumulativeChangeInOwnershipPercentage" unitRef="U_pure" scale="-2" decimals="2" format="ixt:numdotdecimal">50</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% within a </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_ae793328-0071-4a5a-85e7-c1bebb9f7e8d" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="eq:CumulativeChangeInOwnershipPeriod" format="ixt-sec:durwordsen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">three-year</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> testing period. The Company has not completed an ownership change analysis pursuant to IRC Section 382. If ownership changes within the meaning of IRC Section 382 are identified as having occurred, the amount of remaining tax attribute carryforwards available to offset future taxable income and income tax expense in future years may be significantly restricted or eliminated, including those acquired through Bioniz. Further, our deferred tax assets associated with such tax attributes could be significantly reduced or eliminated upon realization of an ownership change within the meaning of IRC Section 382. If eliminated, the related asset would be removed from the deferred tax asset schedule, with a corresponding reduction in the valuation allowance. Due to the existence of the valuation allowance, limitations created by ownership changes, if any, will not impact our effective tax rate.</span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_3a1fd49c-cc54-4551-8747-2792d9bbbc65" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following table summarizes the reconciliation of the unrecognized tax benefits activity during the years ended December 31, 2022 and 2021 (in thousands):</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.327%;"></td>
        <td style="width:1.466%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:13.322000000000001%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.48%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:13.406%;"></td>
        <td style="width:1.0%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year Ended<br />December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unrecognized tax benefits &#x2013; beginning</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6bdddbe7-4df9-4e15-b147-4ddb20f7dd26" contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94" name="us-gaap:UnrecognizedTaxBenefits" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">5,487</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_2ac8a6bb-fe35-4196-8792-54a38b90af8b" contextRef="C_593cac69-ae06-423d-93b0-db39a502796a" name="us-gaap:UnrecognizedTaxBenefits" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,667</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Gross increases &#x2013; tax positions in prior period</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_3468a98a-f2b9-4f6a-a0d0-455137ff1292" contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,266</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Gross decreases &#x2013; tax positions in prior period</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Gross increase &#x2013; current-period tax positions</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_09ec7db9-fb67-45ff-8a77-9013def69069" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">392</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_be3d2078-55ad-4251-be01-d04eaaa7a84a" contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">554</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Gross decrease &#x2013; current-period tax positions</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Settlements</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Lapse of statute of limitations</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unrecognized tax benefits &#x2013; ending</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_1a6bdbbe-2166-4bd8-b6d2-eee178c4b52d" contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192" name="us-gaap:UnrecognizedTaxBenefits" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">5,879</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b4c6d273-c955-4306-9b3e-63eaadbe267c" contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94" name="us-gaap:UnrecognizedTaxBenefits" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">5,487</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The unrecognized tax benefit amounts are reflected in the determination of the Company&#x2019;s deferred tax assets. If recognized, none of these amounts would affect the Company&#x2019;s effective tax rate, since it would be offset by an equal corresponding adjustment in the deferred tax asset valuation allowance. The Company does not foresee material changes to its liability for uncertain tax benefits within the next twelve months.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company&#x2019;s policy is to recognize interest and/or penalties related to income tax matters in income tax expense. The Company had no accrual for interest or penalties on the Company's consolidated balance sheet as of December 31, 2022 and has not recognized interest and/or penalties in the consolidated statement of operations for the year ended December 31, 2022.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">All tax years for both federal and state purposes remain open and subject to examination by tax jurisdictions.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The 2017 tax reform act amended the IRC, effective for amounts paid or incurred in tax years beginning after December 31, 2021, to eliminate the immediate expensing of research and experimental (R&amp;E) expenditures and require taxpayers to charge their R&amp;E expenditures and software development costs (collectively, R&amp;E expenditures) to a capital account. Capitalized costs are required to be amortized over </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_d7a467f0-32a0-44c5-ad78-756ed729f71e" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="eq:ResearchAndExperimentalExpendituresCapitalizedCostAmortizationPeriod" format="ixt-sec:durwordsen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">five years</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> (</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_fa8566cc-accb-4d90-876d-b210f5cd66d1" contextRef="C_9d1df5ec-262f-43c2-9feb-7e49b25fe95f" name="eq:ResearchAndExperimentalExpendituresCapitalizedCostAmortizationPeriod" format="ixt-sec:durwordsen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15 years</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> for expenditures attributable to foreign research).</span></p></ix:nonNumeric></div>
  <div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_c3388e02-8511-4333-b912-036f4ef5d0f6" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:CompensationAndEmployeeBenefitPlansTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">14. Retirement Plan</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company sponsors an employee savings plan that qualifies as a deferred salary arrangement under Section 401(k) of the IRC. Participating employees may defer up to the Internal Revenue Service annual contribution limit. The Company did </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_078fde81-44ee-4b64-950b-82cd50a9cf32" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_0186d00f-d59b-484a-8c73-1215673394cb" contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2" name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">t make any contributions for the years ended December 31, 2022 or 2021.</span></p></ix:nonNumeric></div>
  <div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_a9e3ade7-2790-430b-a318-2d0c0e8a6f8f" contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5" name="us-gaap:SubsequentEventsTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15. Subsequent Events</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On March 10, 2023, Silicon Valley Bank (SVB) was closed by the California Department of Financial Protection and Innovation, which appointed the Federal Deposit Insurance Corporation as receiver. At the time of the closure, the Company held assets valued at approximately $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_4c28e568-3dcf-41fa-bcd6-e4b00c76bfc8" contextRef="C_1398193c-be70-4924-b7ab-8d837ee248c4" name="us-gaap:AssetsHeldInTrust" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">8.2</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million in a sweep account with SVB. The Company received full access to those funds on March 13, 2023. As of the date of the filing of this Annual Report on Form 10-K, the Company has full access to and control over all of its cash, cash equivalents and short-term investments. In addition, because a substantial majority of the Company's cash, cash equivalents and short-term investments is held at a financial institution unaffiliated with SVB, the Company does not expect any material impact to the Company's operations directly related to the closure of SVB.</span></p></ix:nonNumeric></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">25</span></p>
  <hr style="page-break-after:always;" />
 </body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10
<SEQUENCE>2
<FILENAME>eq-ex10_29.htm
<DESCRIPTION>EX-10.29
<TEXT>
<html>
 <head>
  <title>EX-10</title>
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">CERTAIN INFORMATION CONTAINED IN THIS EXHIBIT, MARKED BY [***], HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE THE REGISTRANT HAS DETERMINED THAT IT IS BOTH NOT MATERIAL AND IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Confidential		</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">EXHIBIT 10.29</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">FIFTH AMENDMENT TO<br>COLLABORATION AND LICENSE AGREEMENT</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);font-variant:small-caps;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">This Fifth Amendment to Collaboration and License Agreement </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">(</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;font-style:italic;min-width:fit-content;">&#x201c;Amendment&#x201d;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">) is made and entered into effective as of November 18, 2022 (the </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;font-style:italic;min-width:fit-content;">&#x201c;Amendment Date&#x201d;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">), by and between </font><font style="background-color:rgba(0,0,0,0);font-variant:small-caps;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Equillium, Inc.</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">, a corporation organized under the laws of the State of Delaware, USA, with its principal office at 2223 Avenida de la Playa, Suite 108, La Jolla, California 92037, USA (</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;font-style:italic;min-width:fit-content;">&#x201c;Equillium&#x201d;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">), and </font><font style="background-color:rgba(0,0,0,0);font-variant:small-caps;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Biocon Limited</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">, a company incorporated and existing under the laws of India and having its registered office at 20th KM, Hosur Road, Electronics City P.O. Bangalore 560 100, India (</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;font-style:italic;min-width:fit-content;">&#x201c;Biocon&#x201d;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">).</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">  </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);font-variant:small-caps;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Recitals</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);font-variant:small-caps;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Whereas,</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> Equillium and Biocon (as successor-in-interest to Biocon&#x2019;s Affiliate, Biocon SA) are parties to that certain Collaboration and License Agreement dated May 22, 2017 (the </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;font-style:italic;min-width:fit-content;">&#x201c;Original Agreement&#x201d;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">), as amended by that certain First Amendment to Collaboration and License Agreement dated September 28, 2018, that certain Second Amendment to Collaboration and License Agreement dated April 22, 2019, that certain Third Amendment to Collaboration and License Agreement dated December 10, 2019, and that certain Fourth Amendment to Collaboration and License Agreement dated April 14, 2021 (collectively with the Original Agreement, the </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;font-style:italic;min-width:fit-content;">&#x201c;Agreement&#x201d;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">);</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);font-variant:small-caps;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Whereas</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">,</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> Equillium and Biocon would like to extend the term for entering into the Commercial Supply Agreement;</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);font-variant:small-caps;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Whereas</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">,</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> the parties now wish to amend the Agreement as expressly set forth herein.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">  </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);font-variant:small-caps;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Agreement</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);font-variant:small-caps;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Now, Therefore,</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> in consideration of the foregoing premises and the mutual covenants contained herein and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, Equillium and Biocon hereby agree as follows:</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">The first paragraph of Section 4.3 of the Original Agreement is hereby amended and restated to read in its entirety as follows:</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#x201c;4.3 Commercial Supply for the Equillium Territory.</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> Subject to the terms and conditions of this Agreement, during the Term, Biocon agrees to Manufacture and supply to Equillium such quantities of Product for commercial use and distribution in the Equillium Territory as may be set forth on purchase orders placed by Equillium in accordance with</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">the provisions of the Commercial Supply Agreement, and Equillium agrees that Biocon shall be Equillium&#x2019;s exclusive supplier for the Product for the Equillium Territory on the terms set forth in the Commercial Supply Agreement. No later than [***] prior to the first anticipated NDA submission, the parties shall negotiate in good faith and enter into a separate written manufacturing and supply agreement containing commercially reasonable terms (the </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;font-style:italic;min-width:fit-content;">&#x201c;Commercial Supply Agreement&#x201d;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">) pursuant to which the purchase price for the commercial supply of Product shall be equal to [***]% of Biocon&#x2019;s Fully-Burdened Manufacturing Cost, as well as a commercially reasonable and customary quality assurance agreement (the </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;font-style:italic;min-width:fit-content;">&#x201c;Commercial Quality Agreement&#x201d;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">), pursuant to which Biocon shall manufacture and supply to Equillium, or have manufactured and supplied to Equillium, and Equillium shall accept such manufacture and supply from Biocon as Equillium&#x2019;s exclusive supplier, Product for commercialization in the Field in the Equillium Territory. Without limiting the generality of the foregoing, the Commercial Supply Agreement shall provide as follows:&#x201d;</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);font-variant:small-caps;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">In Witness Whereof,</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> the parties have duly executed this Fifth Amendment to Collaboration and License Agreement as of the Amendment Date.</font></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:50.075%;"></td>
    <td style="width:49.925%;"></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);font-variant:small-caps;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Equillium, Inc.</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:36.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);font-variant:small-caps;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Biocon Limited</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">By: </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">/s/ Bruce Steel</font></p><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Name: Bruce D. Steel</font></p><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Title: Chief Executive Officer</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">1. By: </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">/s/ Siddharth Mittal</font></p><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Name: </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Siddharth Mittal</font></p><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Title: </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">CEO and MD</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">2. By:</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">/s/ Indranil Sen</font></p><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Name: </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Indranil Sen</font></p><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Title: </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">CFO</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10
<SEQUENCE>3
<FILENAME>eq-ex10_31.htm
<DESCRIPTION>EX-10.31
<TEXT>
<html>
 <head>
  <title>EX-10</title>
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">CERTAIN INFORMATION CONTAINED IN THIS EXHIBIT, MARKED BY [***], HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE THE REGISTRANT HAS DETERMINED THAT IT IS BOTH NOT MATERIAL AND IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">EXECUTION VERSION</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;padding-bottom:1.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:24.0pt;border-bottom:0.5pt solid;text-align:right;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">EXhibit 10.31</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:24.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ASSET PURCHASE AGREEMENT</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:24.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">between</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:24.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Ono Pharmaceutical Co., Ltd.,</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:24.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">and</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:24.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Equillium, Inc.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:24.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Dated as of December 5, 2022</font></p>
  <p style="text-indent:0.0%;padding-bottom:1.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:24.0pt;border-bottom:0.5pt solid;text-align:center;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:24.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">281923888 v10</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="margin-left:1.067%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:1.065%;text-align:center;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Table of Contents</font></p>
  <p style="margin-left:1.067%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:1.065%;text-align:center;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:1.067%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:10.0pt;margin-right:1.065%;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Page</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <table style="border-spacing:0;table-layout:fixed;width:99.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:96.663%;"></td>
    <td style="width:3.337%;"></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;" id="mptableofcontents"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.	DEFINITIONS</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.	PURCHASE OPTION</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">20</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:36.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:36.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.1	Grant of Purchase Option</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">20</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:36.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:36.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.2	Upfront Payment</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">20</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:36.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:36.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.3	Exercise of Purchase Option</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">20</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:36.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:36.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.4	Updated Disclosure Schedules.</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">21</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:36.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:36.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.5	Effect of No Exercise</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">21</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3.	PURCHASE AND SALE</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">22</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:36.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:36.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3.1	Purchase and Sale of Assets</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">22</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:36.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:36.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3.2	Excluded Assets</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">23</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:36.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:36.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3.3	Assumed Liabilities</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">24</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:36.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:36.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3.4	Excluded Liabilities</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">24</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:36.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:36.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3.5	Consents and Waivers; Further Assurances.</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">25</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:36.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:36.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3.6	Closing.</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">26</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:36.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:36.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3.7	Contingent Consideration.</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">27</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.	REPRESENTATIONS AND WARRANTIES OF EQUILLIUM</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">30</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:36.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:36.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.1	Organization and Qualification</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">30</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:36.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:36.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.2	Authority</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">31</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:36.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:36.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.3	No Conflict; Required Filings and Consents.</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">31</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:36.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:36.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.4	Purchased Assets</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">32</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:36.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:36.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.5	Compliance with Law; Permits.</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">32</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:36.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:36.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.6	Litigation.</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">33</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:36.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:36.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.7	Intellectual Property.</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">34</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:36.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:36.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.8	Regulatory Compliance</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">38</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:36.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:36.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.9	Clinical Studies.</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">39</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:36.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:36.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.10	Acquired Contracts.</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">40</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:36.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:36.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.11	CIM Contracts</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">40</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:36.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:36.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.12	Books and Records</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">41</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:36.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:36.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.13	Insurance</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">41</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:36.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:36.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.14	Affiliate Interests and Transactions</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">41</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:36.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:36.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.15	Brokers</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">41</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:99.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:44.582%;"></td>
    <td style="width:10.835%;"></td>
    <td style="width:44.582%;"></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">i</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="margin-left:1.067%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:1.065%;text-align:center;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Table of Contents</font></p>
  <p style="margin-left:1.067%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:1.065%;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(continued)</font></p>
  <p style="margin-left:1.067%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:10.0pt;margin-right:1.065%;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Page</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <table style="border-spacing:0;table-layout:fixed;width:99.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:96.663%;"></td>
    <td style="width:3.337%;"></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:36.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:36.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.16	Not Insolvent</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">41</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:36.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:36.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.17	Taxes.</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">41</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.	LIMITATIONS ON REPRESENTATIONS AND WARRANTIES OF EQUILLIUM</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">42</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:36.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:36.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.1	Independent Investigation</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">42</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:36.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:36.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.2	No Other Representations and Warranties</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">42</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:36.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:36.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.3	Projections</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">43</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:36.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:36.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.4	As-Is</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">43</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:36.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:36.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.5	Disclosure Schedules</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">43</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6.	REPRESENTATIONS AND WARRANTIES OF ONO</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">43</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:36.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:36.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6.1	Organization</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">44</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:36.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:36.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6.2	Authority</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">44</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:36.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:36.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6.3	No Conflict; Required Filings and Consents.</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">44</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:36.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:36.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6.4	Litigation</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">45</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:36.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:36.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6.5	Financing</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">45</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:36.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:36.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6.6	Brokers</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">45</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:36.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:36.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6.7	Not Insolvent</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">45</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7.	COVENANTS</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">45</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:36.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:36.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7.1	Conduct of Business Prior to the Closing</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">45</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:36.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:36.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7.2	Restricted Actions</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">45</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:36.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:36.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7.3	No Transfer of Control</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">47</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:36.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:36.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7.4	Covenants Regarding Information.</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">47</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:36.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:36.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7.5	Notification of Certain Matters.</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">48</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:36.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:36.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7.6	Exclusivity.</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">49</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:36.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:36.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7.7	Confidentiality.</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">50</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:36.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:36.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7.8	Consents and Filings.</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">52</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:36.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:36.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7.9	Public Announcements</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">53</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:36.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:36.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7.10	Books and Records</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">53</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:36.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:36.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7.11	Transfer of Regulatory Materials.</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">53</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:36.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:36.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7.12	Communication with Agencies</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">54</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:36.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:36.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7.13	Adverse Experience Reporting</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">54</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:36.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:36.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7.14	Delivery of Assets</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">54</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:99.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:44.582%;"></td>
    <td style="width:10.835%;"></td>
    <td style="width:44.582%;"></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ii</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="margin-left:1.067%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:1.065%;text-align:center;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Table of Contents</font></p>
  <p style="margin-left:1.067%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:1.065%;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(continued)</font></p>
  <p style="margin-left:1.067%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:10.0pt;margin-right:1.065%;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Page</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <table style="border-spacing:0;table-layout:fixed;width:99.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:96.663%;"></td>
    <td style="width:3.337%;"></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:36.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:36.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7.15	Regulatory Compliance</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">54</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:36.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:36.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7.16	Clinical Studies</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">55</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8.	PROGRAM ACTIVITIES</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">56</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:36.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:36.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8.1	Development Plan and Development Budget</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">56</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:36.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:36.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8.2	Deviations from the Development Plan</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">56</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:36.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:36.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8.3	Equillium Program Responsibilities.</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">56</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:36.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:36.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8.4	Records, Reports and Information.</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">57</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:36.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:36.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8.5	Regulatory</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">57</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:36.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:36.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8.6	Delivery and Review of Development Program Data Package.</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">58</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:36.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:36.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8.7	Due Diligence Investigation.</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">59</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:36.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:36.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8.8	Liaison</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">60</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:36.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:36.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8.9	No Development by Ono</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">60</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:36.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:36.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8.10	Development Funding</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">60</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:36.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:36.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8.11	Financial Records and Audit</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">61</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:36.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:36.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8.12	Insurance</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">63</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:36.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:36.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8.13	Patent Prosecution and Maintenance</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">63</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:36.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:36.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8.14	Intellectual Property Rights.</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">63</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9.	TAX MATTERS</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">64</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:36.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:36.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9.1	Transaction Taxes</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">64</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:36.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:36.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9.2	Transaction Taxes on Article 8</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">64</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:36.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:36.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9.3	Purchase Price Allocation</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">64</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:36.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:36.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9.4	Foreign Derived Intangible Income</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">64</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:36.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:36.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9.5	Withholding Rights.</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">65</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.	CONDITIONS TO CLOSING</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">65</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:36.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:36.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.1	General Conditions</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">65</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:36.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:36.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.2	Conditions to Obligations of Equillium</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">66</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:36.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:36.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.3	Conditions to Obligations of Ono</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">66</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11.	INDEMNIFICATION</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">67</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:36.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:36.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11.1	Survival.</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">67</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:36.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:36.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11.2	Indemnification.</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">68</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:36.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:36.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11.3	Materiality Scrape</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">68</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:99.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:44.582%;"></td>
    <td style="width:10.835%;"></td>
    <td style="width:44.582%;"></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">iii</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="margin-left:1.067%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:1.065%;text-align:center;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Table of Contents</font></p>
  <p style="margin-left:1.067%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:1.065%;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(continued)</font></p>
  <p style="margin-left:1.067%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:10.0pt;margin-right:1.065%;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Page</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <table style="border-spacing:0;table-layout:fixed;width:99.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:96.663%;"></td>
    <td style="width:3.337%;"></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:36.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:36.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11.4	Claim Notices</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">69</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:36.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:36.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11.5	Third Party Claim Procedures.</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">69</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:36.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:36.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11.6	Direct Claim Procedures.</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">70</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:36.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:36.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11.7	Subrogation</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">71</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:36.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:36.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11.8	Limits on Indemnification.</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">71</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:36.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:36.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11.9	No Anti-Sandbagging</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">73</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:36.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:36.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11.10	Effect of Waiver</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">73</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:36.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:36.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11.11	Tax Matters</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">73</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:36.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:36.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11.12	Right of Set Off</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">73</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:36.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:36.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11.13	Exclusive Remedy</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">73</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:36.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:36.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11.14	Fraud</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">74</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12.	TERMINATION</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">74</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:36.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:36.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12.1	Termination</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">74</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:36.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:36.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12.2	Automatic Termination</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">75</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:36.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:36.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12.3	Effect of Termination</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">75</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:36.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:36.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12.4	Reimbursement After Termination</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">75</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13.	GENERAL PROVISIONS</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">76</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:36.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:36.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13.1	Payments</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">76</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:36.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:36.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13.2	Fees and Expenses</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">76</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:36.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:36.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13.3	Amendment and Modification</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">76</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:36.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:36.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13.4	Waiver</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">76</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:36.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:36.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13.5	Notices</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">76</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:36.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:36.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13.6	Interpretation</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">77</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:36.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:36.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13.7	Entire Agreement</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">78</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:36.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:36.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13.8	No Third-Party Beneficiaries</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">78</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:36.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:36.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13.9	Governing Law</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">78</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:36.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:36.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13.10	Arbitration.</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">78</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:36.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:36.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13.11	Enforcement</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">79</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:36.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:36.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13.12	Waiver of Jury Trial</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">80</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:36.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:36.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13.13	Assignment; Successors.</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">80</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:36.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:36.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13.14	Severability</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">80</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:99.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:44.582%;"></td>
    <td style="width:10.835%;"></td>
    <td style="width:44.582%;"></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">iv</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="margin-left:1.067%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:1.065%;text-align:center;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Table of Contents</font></p>
  <p style="margin-left:1.067%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:1.065%;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(continued)</font></p>
  <p style="margin-left:1.067%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:10.0pt;margin-right:1.065%;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Page</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <table style="border-spacing:0;table-layout:fixed;width:99.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:96.663%;"></td>
    <td style="width:3.337%;"></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:36.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:36.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13.15	Counterparts</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">80</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:36.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:36.0pt;text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13.16	No Presumption Against Drafting Party</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">81</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">EXHIBIT A</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">EXHIBIT B</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">EXHIBIT C</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:99.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:44.582%;"></td>
    <td style="width:10.835%;"></td>
    <td style="width:44.582%;"></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">v</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ASSET PURCHASE AGREEMENT</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);font-variant:small-caps;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">This Asset Purchase Agreement</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> (this &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Agreement</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) is being entered into as of December 5, 2022, by and between Ono Pharmaceutical Co., Ltd., a Japan </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">kabushiki kaisha</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> (&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Ono</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;), and Equillium, Inc., a Delaware corporation (&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Equillium</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;). Ono and Equillium are referred to herein individually as a &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Party</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; and together as the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Parties</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);font-variant:small-caps;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">RECITALS</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">A.	Equillium owns or has certain rights and obligations related to the humanized anti-CD6 monoclonal antibody known by the INN itolizumab, a clinical stage, first-in-class immune modifying monoclonal antibody.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">B.	Equillium hereby wishes to grant Ono, and Ono wishes to receive, an exclusive option to purchase and assume from Equillium the Business.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">C.	As consideration for the option, Ono has agreed to (a) make an Upfront Payment and (b) reimburse certain Development Costs incurred by Equillium in the performance of the Program.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">D.	On the date of this Agreement, the Parties entered into that certain Development Agreement (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Development Agreement</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) in connection with the performance of certain activities for Products from and after the Closing.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">E.	The board of directors of Equillium has, upon the terms and subject to the conditions set forth herein, (a) determined that this Agreement is advisable, (b) determined that this Agreement and the transactions contemplated hereby are fair to and in the best interests of Equillium and its stockholders and (c) approved this Agreement and the transactions contemplated hereby.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);font-variant:small-caps;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">AGREEMENT</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In consideration of the foregoing and the mutual covenants and agreements herein contained, and intending to be legally bound hereby, the Parties agree as follows:</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.	DEFINITIONS</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For purposes of this Agreement:</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Acceptance for Filing</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means, with respect to a BLA filed for a Product in the U.S., that the FDA has accepted such BLA for substantive review as evidenced by receipt of notice from the FDA of such acceptance or other evidence that the FDA has commenced its substantive review of such BLA.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Acquired Contracts</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means each Contract to which any Equillium Person is a party or has any right, title or interest and that primarily relates to, or is otherwise necessary for the Exploitation of, the Program, the Compound, any Product or the Purchased Assets, including (a) the Biocon Agreements, (b) the Service Contracts, (c) all licenses, and (d) all materials transfer</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">281923888 v10</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">agreements, but excluding invention assignment agreements with employees, consultants and contractors that assign or grant to any Equillium Person ownership of inventions and intellectual property developed in the course of providing services to any Equillium Person by such employees, consultants and contractors.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Action</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means any claim, complaint, demand, action, suit, litigation, charge, inquiry, proceeding, audit or investigation by or before any Governmental Authority, or any other arbitration, mediation or similar proceeding.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Affiliate</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means, with respect to any Person, any other Person that directly, or indirectly through one or more intermediaries, controls, is controlled by or is under common control with, such first Person (but excluding, with respect to Equillium, any portfolio companies of venture capital or investment funds that are stockholders of Equillium, which portfolio company may otherwise be deemed to be &#x201c;under common control with&#x201d; Equillium). For purposes of this definition, &#x201c;control&#x201d;, including the terms &#x201c;controlled&#x201d;, &#x201c;controlled by&#x201d; and &#x201c;under common control with&#x201d;, means the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies of a Person, whether through the ownership of voting securities, as trustee or executor, as general partner or managing member, by Contract or otherwise, including the ownership, directly or indirectly, of securities having the power to elect a majority of the board of directors or similar body governing the affairs of such Person.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Aggregate Payments</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means the aggregate amount paid or payable (subject to the Offset Right, and without taking into account any deduction or withholding required under applicable Law) by Ono to Equillium in respect of [***].</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">aGVHD</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means acute graft-versus-host disease (aGVHD).</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Ancillary Agreements</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means the Assignment of Intellectual Property, and the Bill of Sale and Assignment and Assumption Agreement.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Assignment of Intellectual Property</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means an instrument of assignment of Transferred Intellectual Property in form and substance agreed between the Parties.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Assumed Liabilities</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning provided in Section 3.3.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Authorizations</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means Governmental Authorizations and Non-Governmental Authorizations.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Bill of Sale and Assignment and Assumption Agreement</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means a bill of sale and assignment and assumption agreement for the Business in form and substance agreed between the Parties.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Biocon</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means Biocon Limited, or its successor-in-interest under any of the Biocon Agreements, as applicable.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Biocon Agreements</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means the Biocon License, [***] and each other Contract entered into by Biocon or its Affiliates on the one hand, and any Equillium Person on the other</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">281923888 v10</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">hand, in connection with the Compound or any Product. For the avoidance of doubt, Biocon Agreements expressly exclude any agreement of Biocon or its Affiliates to which no Equillium Person is a party.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Biocon Data</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means data resulting from any pre-clinical study or clinical trial of the Compound or any Product conducted by or on behalf of Biocon, any of its Affiliates, or any of its or their respective Third Party licensees and sublicensees, together with the applicable protocol for each such study or trial, as well as all associated site-related documentation, investigator brochures, investigational review board correspondence and data monitoring committee minutes and documentation, in each case except to the extent that any such study or trial was conducted by any Equillium Person.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Biocon Know-How</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning provided in the Biocon License.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Biocon License</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means the Collaboration and License Agreement, dated May 22, 2017, by and between Equillium and Biocon (as the successor-in-interest to Biocon SA), as amended on September 28, 2018, April 22, 2019, December 10, 2019, April 14, 2021 and November 18, 2022, and as it may have been amended after the date of this Agreement in compliance with the terms of this Agreement.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Biocon License Termination</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning provided in Section 3.7(c)(i)(3).</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Biocon Patents</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning provided in the Biocon License.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Biocon Technology</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning provided in the Biocon License.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">BLA</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means, as applicable, a Biologics License Application (as more fully described in 21 CFR Part 601, et seq., or its successor regulation), or a New Drug Application (as more fully described in 21 CFR Part 314.50, et seq., or its successor regulation), or any successor application to either of the foregoing.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Books and Records</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means all books, ledgers, files, reports, plans, records, manuals and other materials, including books of account, records, files, invoices, correspondence and memoranda, scientific records and files (including laboratory notebooks and invention disclosures), supplier lists, data, specifications, operating history information and inventory records (in any form or medium), in each case, of, primarily maintained for, primarily relating to or otherwise necessary for, the Business, but excluding: (a) any such items to the extent (i) they are included in or primarily related to any Excluded Assets or Excluded Liabilities or (ii) any Law</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">281923888 v10</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">prohibits their transfer; and (b) all minute books, stock books and similar corporate records of any Equillium Person.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Business</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means the Purchased Assets and the Assumed Liabilities.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Business Day</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means any day that is not a Saturday, a Sunday or other day on which banks are required or authorized by Law to be closed in The City of New York, United States or Tokyo, Japan.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">CDC</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means the Centers for Disease Control and Prevention.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">CIM Contract</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means each Contract entered into by Biocon or its Affiliates on the one hand, and any CIM Entity on the other hand, in each case in connection with the Compound or any Product.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">CIM Entities</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means CIMAB S.A., Centro de Inmunologia Molecular and their respective Affiliates.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Claim Notice</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning provided in Section 11.1(c).</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Clinical Data</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means data resulting from any clinical trial of the Compound or any Product conducted by or on behalf of any Equillium Person, together with the applicable protocol for each such trial, as well as all associated site-related documentation, investigator brochures, investigational review board correspondence and data monitoring committee minutes and documentation; but, in each case, excluding Biocon Data.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Closing</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning provided in Section 3.6(a). &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Closing Date</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning provided in Section 3.6(a).</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Closing Payment</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means an amount equal to JPY 5.0 billion plus Milestone Payments with respect to any Milestone Events achieved prior to the Closing Date.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Code</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means the Internal Revenue Code of 1986, as amended.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Commercialization Discontinuation</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning provided in Section 3.7(c)(i)(2).</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Commercially Reasonable Efforts</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means [***].</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Completion Date</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means the later of (a) the date of the database lock for the EQUALISE Trial and (b) the date of first availability of the results of the interim analysis of the EQUATOR Trial.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Compound</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means the humanized anti-CD6 monoclonal antibody known by the INN itolizumab, as further described in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit A</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> hereto.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Confidential Information</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning provided in Section 7.7(a).</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">281923888 v10</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Constituent Documents</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means, with respect to any Person (other than an individual), all charter, organizational and other documents by which such Person establishes its legal existence or which govern its internal affairs, including (a) the certificate of registration, memorandum and articles of association, charter and bylaws or other similar organizing documents of a company or corporation, (b) the certificate of formation and limited liability company agreement of a limited liability company, (c) the certificate of registration of partnership (if applicable) and agreement of partnership of a partnership and (d) the comparable documents of any other entities.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Contract</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means any contract, agreement, or legally binding arrangement or understanding, whether written or oral and whether express or implied.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Control</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; or &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Controlled</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means, with respect to any Intellectual Property, possession by a Person of the ability (whether by ownership, license or otherwise) to transfer ownership of, to grant access to, to grant use of or to grant a license or a sublicense of or under, such Intellectual Property without violating the terms of any agreement or other arrangement with any Third Party.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Core Contracts</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means the Acquired Contracts other than the Standard Contracts.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">COVID-19</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means SARS-CoV-2 or COVID-19, and any evolutions thereof or related or associated epidemics, pandemic or disease outbreaks.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">COVID-19 Measures</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means any quarantine, &#x201c;shelter in place&#x201d;, &#x201c;stay at home&#x201d;, workforce reduction, social distancing, shut down, closure, sequester or any other Law, order, directive, guideline or recommendation by any Governmental Authority or public health agency in connection with or in response to COVID-19, including the CARES Act, the Consolidated Appropriations Act, 2021 (and applicable rules and regulations promulgated thereunder) and all OSHA and CDC guidelines and requirements, such as social distancing, cleaning, and other similar or related measures.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Data</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means Pre-Clinical Data and Clinical Data.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Data Package Delivery Date</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning provided in Section 8.6(a).</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Data Package Review Period</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning provided in Section 8.6(b).</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Develop</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;, &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Developing</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; or &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Development</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means [***].</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Development Agreement</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning provided in Recital D.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Development Budget</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means the budget of Development Costs for Development Plan activities included in the Development Plan.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Development Costs</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means FTE Costs and Out-of-Pocket Expenses incurred between July 1, 2022 and the Closing Date (in each case inclusive) by an Equillium Person in connection with the performance of the Program, including for:</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">281923888 v10</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a)	[***];</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(b)	[***];</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(c)	[***]; and</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(d)	[***].</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***].</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Development Discontinuation</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning provided in Section 3.7(c)(i)(1).</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Development Funding</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning provided in Section 8.10.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Development Plan</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning provided in Section 8.1.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Development Program Data Package</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means a data package with respect to the Development Plan activities conducted by or on behalf of Equillium consisting of the following: (a) the top-line results of, and full tables, figures and listings, and EDC (Electronic Data Capture) data, clinical trial-related documents and any other related documentation for,[***] the EQUALISE Trial, wherein such results shall be based, at a minimum, on [***]patients who have completed at least [***] of drug administration; (b) the results of the interim analysis of the EQUATOR Trial as made available to Equillium; (c) with respect to any clinical trial other than the EQUALISE Trial and the EQUATOR Trial and any non-clinical study conducted as part of the Program, and to the extent not previously provided in writing or electronically to Ono pursuant to this Agreement, final (to the extent available) or interim reports of the results of any such other clinical trials and non-clinical studies, to the extent in the possession or control of Equillium as of the Completion Date; and (d) any SDV (Source Data Verification) report with respect to any of the foregoing (a), (b) and (c).</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Development Records</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning provided in Section 8.4(b).</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Diligence Limitations</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning provided in Section 8.6(c).</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Diligence Period</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning provided in Section 3.7(b).</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Direct Claim</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning provided in Section 11.6(a).</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Disclosing Party</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning provided in Section 7.7(a)(ii).</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Disclosure Schedules</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means the Disclosure Schedules attached to this Agreement.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Discontinuation Notice</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning provided in Section 3.7(c)(i).</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Discontinuation Notice Period</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning provided in Section 3.7(c)(ii).</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Due Diligence Investigation</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning provided in Section 8.7(a).</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">281923888 v10</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Encumbrance</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means any charge, claim, mortgage, lien, exclusive license, pledge, security interest, easement, encroachment, right of first refusal or similar restriction or encumbrance of any kind, as security or otherwise, including (a) any restriction on transfer or other assignment, (b) any restriction of or relating to use, receipt of income or exercise of any other attribute of ownership and (c) any agreement to create any of the foregoing. However, Encumbrance excludes any non-exclusive license under Intellectual Property Rights.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">EQUALISE Trial</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means the Equillium-sponsored clinical trial titled &#x201c;Study of EQ001 (Itolizumab) in Systemic Lupus Erythematosus With or Without Active Proliferative Nephritis (EQUALISE)&#x201d; (NCT04128579).</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">EQUATOR Trial</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means the Equillium-sponsored clinical trial titled &#x201c;A Study of Itolizumab in Combination With Corticosteroids for the First-Line Treatment of Acute Graft Versus Host Disease (EQUATOR)&#x201d; (NCT05263999).</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Equillium Change of Control</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning provided in Section 7.6(a).</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Equillium Indemnified Parties</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning provided in Section 11.2(b).</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Equillium Person</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means each of Equillium and each of its Subsidiaries.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Equillium Territory</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means the U.S. (including its territories and possessions), Canada, Australia and New Zealand.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Equillium&#x2019;s Actual Knowledge</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means, for any particular matter, the actual knowledge of Equillium&#x2019;s Chief Executive Officer, Chief Financial Officer, Chief Operating Officer and Chief Scientific Officer, without any duty of inquiry.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Equillium&#x2019;s Knowledge</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means, for any particular matter, the (a) actual knowledge of Equillium&#x2019;s Chief Executive Officer, Chief Financial Officer, Chief Operating Officer and Chief Scientific Officer and (b) the knowledge that each such individual would have had after Reasonable Inquiry.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Excepted Circumstance</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning provided in Section 7.1.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Excluded Assets</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning provided in Section 3.2.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Excluded Liabilities</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning provided in Section 3.4.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Excluded Programs</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means (a) Equillium&#x2019;s specific multi-cytokine inhibitor programs (including EQ101 and EQ102) or with its proprietary discovery platform for generating rationally designed composite peptides that selectively block key cytokines and (b) any other program (excluding the Program) developed, licensed or otherwise acquired by Equillium following the date of this Agreement.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">281923888 v10</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exploit</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; or &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exploitation</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means develop, make, manufacture, use, sell, offer for sale, import, export, market, promote, distribute and commercialize, or have any of the foregoing done.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">FDA</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means the U.S. Food and Drug Administration, or any successor agency thereto in the U.S.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">FDCA</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means the U.S. Federal Food, Drug, and Cosmetic Act.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">First U.S. Commercial Sale</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means [***].</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Fraud</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means intentional common law fraud under Delaware law (and not constructive fraud, negligent misrepresentation or omission, or any form of fraud premised on recklessness or negligence).</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">FTE</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means the equivalent of a full-time employee&#x2019;s work time over a 12-month period (including normal vacations, sick days and holidays), expressed as a total number of labor hours per year.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">FTE Costs</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means, for a given calendar quarter, the sum of the FTE Costs Per FTE for all FTEs who have performed Program activities during such calendar quarter.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">FTE Costs Per FTE</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means, for a given calendar quarter, with respect to each FTE who has performed Program activities during such calendar quarter, the amount calculated by multiplying the applicable FTE Rate for such FTE by the percentage of such FTE&#x2019;s time expended in the performance of Program activities during such calendar quarter.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">FTE Rate</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means the applicable FTE rate per calendar quarter for each FTE involved in performing the Program, calculated on [***]. The Parties acknowledge that the FTE Rate for a particular FTE covers [***], but excludes [***].</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Fundamental R&amp;Ws</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means the representations and warranties of Equillium set forth in Sections 4.1, 4.2, 4.3(a)(i), 4.4(a), 4.10(c) (solely with respect to the Biocon License) and 4.15.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">GAAP</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means United States generally accepted accounting principles and practices as in effect on the date hereof.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Good Clinical Practices</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; or &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">GCP</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means all applicable Good Clinical Practice standards for the design, conduct, performance, monitoring, auditing, recording, analyses and reporting of clinical trials (a) as set forth in the ICH Harmonised Tripartite Guideline for Good Clinical Practice (CPMP/ICH/135/95) and any other applicable guidelines for good clinical practice for trials on medicinal Product, (b) the Declaration of Helsinki (2004) as last amended at the 52nd World Medical Association in October 2000 and any further amendments or clarifications thereto, (c) the U.S. C.F.R. Title 21, Parts 50 (Protection of Human Subjects), 56 (Institutional Review Boards) and 312 (Investigational New Drug Application), as may be amended from time to time and (d) the equivalent applicable Laws in any relevant jurisdiction, each as may be</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">281923888 v10</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">amended and applicable from time to time and in each case, that provide for, among other things, assurance that the clinical data and reported results are credible and accurate and protect the rights, integrity, and confidentiality of trial subjects.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Good Laboratory Practices</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; or &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">GLP</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means all applicable Good Laboratory Practice standards, including, as applicable, (a) as set forth in the then-current good laboratory practice standards promulgated or endorsed by the FDA as defined in 21 C.F.R. Part 58 and (b) the equivalent applicable Laws in any relevant jurisdiction, each as may be amended and applicable from time to time.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Government Official</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means (a) any official, employee or representative of, or any other person acting in an official capacity for or on behalf of (i) any Governmental Authority, including any entity owned or controlled by any Governmental Authority, (ii) any political party or political candidate or (iii) any public international organization and (b) any candidate for political office or any person acting on his or her behalf.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Governmental Authority</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means any United States or non-United States federal, national, supranational, state, provincial, local or similar government, governmental, quasi-governmental, taxing, regulatory or administrative authority, branch, office, agency or commission or other similar body or any court, tribunal or arbitral or judicial body (including any grand jury).</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Governmental Authorizations</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means all licenses, permits, certificates and other authorizations, consents, waivers, exemptions and approvals issued by or obtained from a Governmental Authority.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">HSR Act</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ICH</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Immediate Family</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means, with respect to any specified Person, such Person&#x2019;s spouse, children, parents, grandparents, grandchildren and siblings, including adoptive relationships and relationships through marriage, or any other relative of such Person that shares such Person&#x2019;s home.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Inbound Licenses</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning provided in Section 4.7(i).</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">IND</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means an Investigational New Drug Application.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Indication</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means the treatment, prevention, palliation or diagnosis of a particular disease, disorder or condition in humans. For the avoidance of doubt, treatment (with treatment on the first line and second line being treated collectively as treatment), prevention, palliation and/or diagnosis of the same disease, disorder or condition shall be treated as the same Indication.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Indemnified Party</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning provided in Section 11.5(a).</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">281923888 v10</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Indemnifying Party</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning provided in Section 11.5(a).</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Information</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means any and all tangible and intangible (a) techniques, technology, practices, trade secrets, inventions (whether patentable or not), methods, knowledge, know-how, skill, experience, test data and results (including pharmacological, toxicological and clinical test data and results), analytical and quality control data, results or descriptions, software and algorithms and (b) compositions of matter, cells, cell lines, assays, animal models and physical, biological or chemical material; that, in each case, are not in the public domain.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">INN</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means International Nonproprietary Name.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Intellectual Property</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means: (a) inventions (whether patentable or unpatentable and whether or not reduced to practice), improvements thereto, and patents, patent applications and patent disclosures, together with any reissuances, provisionals, divisionals, substitutions, continuations, continuations-in-part, revisions, extensions and reexaminations thereof; (b) trademarks, service marks, trade dress, logos, trade names, company names, &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">doing business as</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; names and fictitious names, together with translations, adaptations, derivations and combinations thereof and including goodwill associated therewith, and applications, registrations and renewals in connection therewith; (c) copyrightable works, copyrights, and applications, registrations and renewals in connection therewith; (d) mask works and applications, registrations and renewals in connection therewith; (e) Trade Secrets; (f) copies and tangible embodiments and expressions (in whatever form or medium), all improvements and modifications and derivative works of any of the foregoing; and (g) all rights to sue at law or in equity for any past or future infringement or other impairment of any of the foregoing, including the right to receive all proceeds and damages therefrom.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Inventory</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means all inventory related to the Compound or any Product, wherever located, including all quantities of the Compound active pharmaceutical ingredient, any Product drug substance or drug product, finished goods, work in process, raw materials, packaging, pre-clinical and clinical supplies and all other materials and supplies and parts to be used or consumed by any Equillium Person or any of their respective agents in the production of finished goods whether held at any location or facility of any such Person or in transit to any such Person, in each case as of the Closing Date, except to the extent included in Excluded Assets.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">IP R&amp;Ws</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means the representations and warranties of Equillium set forth in Sections 4.7(a), (b) and (c).</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Itolizumab Business</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning provided in Section 3.7(c)(i)(4).</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Joint Invention</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning provided in the Biocon License.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Joint Patent</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning provided in the Biocon License.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Law</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means any statute, law, ordinance, regulation, rule, code, executive order, injunction, judgment, decree or Order of any Governmental Authority, all as amended from time to time, together with any rules, regulations and compliance guidances promulgated thereunder.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">281923888 v10</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Liabilities</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means all debts, liabilities, commitments and obligations, whether accrued or fixed, absolute or contingent, matured or unmatured, determined or determinable, liquidated or unliquidated, asserted or unasserted, known or unknown, whenever or however arising, including those arising under applicable Law or any Action or Order of a Governmental Authority and those arising under any Contract, regardless of whether such debt, liability, commitment or obligation would be required to be reflected on a balance sheet prepared in accordance with GAAP or disclosed in the notes thereto.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Listed Licensed Patents</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning provided in Section 4.7(d).</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Listed Owned Patents</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning provided in Section 4.7(d).</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Listed Patents</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning provided in Section 4.7(d).</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Lookback Date</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means [***].</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Losses</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning provided in Section 11.2(a).</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Manufacture</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; or &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Manufacturing</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means all activities related to the manufacturing of the Compound or any Product, as the case may be, or any ingredient thereof, including manufacturing for clinical use or commercial sale, in-process and product testing and analysis, quality assurance and quality control, handling and storage of the Compound or any Product and ongoing stability tests and regulatory activities related to any of the foregoing.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Manufacturing Cost</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means, with respect to the Compound or any Product manufactured on behalf of Equillium by Biocon or its Affiliate under the [***] , in each case, determined in accordance with [***] standard cost accounting policies that are in accordance with GAAP and consistently applied [***].</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Material Adverse Effect</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means any event, change, circumstance, occurrence, effect, result or state of facts that, individually or in the aggregate, has a material adverse effect on the Purchased Assets taken as a whole; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided, however,</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> that, Material Adverse Effect shall not include any event, change, circumstance, occurrence, effect or state of facts to the extent resulting directly or indirectly from (1) changes generally affecting the industry in which any Equillium Person operates generally, or the economy or the financial or securities markets, in the United States or any jurisdiction in which any Equillium Person has substantial business operations, or any general shutdown of the government of the United States or any jurisdiction in which any Equillium Person has substantial business operations, (2) the outbreak of war or acts of terrorism, (3) changes in Law, GAAP or other applicable accounting standards or the interpretations thereof, (4) acts of God or other calamities (including wild fires), epidemic or pandemic, national or international political or social conditions, including the engagement by any country in hostilities, whether commenced before or after the date hereof, and whether or not pursuant to the declaration of a national emergency or war, or the occurrence or threatened occurrence of any military or terrorist attack, (5) any action taken by any Equillium Person at Ono&#x2019;s express written direction, (6) the failure of any Equillium Person to meet internal expectations or projections (other than any event, occurrence, fact, condition, change or effect underlying such failure, except to the extent not otherwise excluded in this definition of Material Adverse Effect), (7) any changes in financial,</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">281923888 v10</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">banking or securities markets in general, including any disruption thereof and any decline in the price of any security or any market index or any change in prevailing interest rates, (8) any breach by Ono of any provision of this Agreement or the taking of any other action by Ono or (9) the announcement, execution or delivery of this Agreement, including any disruption in (or loss of) supplier, service provider, partner or similar relationships or any loss of employees; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided, however,</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> that the exception in this clause (9) shall not apply to that portion of any representation or warranty contained in this Agreement to the extent that the purpose of such portion of such representation or warranty is to address the consequences resulting from the execution, delivery or announcement of this Agreement; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided, further</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, that with respect to clauses (1), (2), (3), (4) and (7), if the impact of such event, change, circumstance, occurrence, effect or state of facts is disproportionately adverse to the Equillium Persons, taken as a whole, as compared to other similarly situated companies, then such impact shall be taken into account in determining whether there has been a Material Adverse Effect.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Milestone Event</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning provided in Section 3.7(a).</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Milestone Obligor</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means each of Ono, any of its Affiliates and any Ono Licensee.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Milestone Payment</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning provided in Section 3.7(a).</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Mouse Assets</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means [***]</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Negotiation Period</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning provided in Section 3.7(c)(ii).</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Non-Governmental Authorizations</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means all licenses, permits, certificates and other authorizations, consents, waivers, exemptions and approvals other than Governmental Authorizations.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Offset Right</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning provided in Section 11.12.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Ono Indemnified Parties</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning provided in Section 11.2(a).</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Ono Licensee</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means any Third Party to whom Ono or an Affiliate of Ono directly or indirectly grants a license, sublicense or other right to Exploit any Product, beyond the mere right to purchase Products from Ono or its Affiliate.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Option Exercise Effective Date</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means the date on which Ono exercises the Purchase Option in accordance with Section 2.3.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Option Period</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means the period commencing on the date on which the full amount of the Upfront Payment (less any deduction or withholding made in accordance with Section 9.5) is paid to Equillium in accordance with Section 2.2 and ending on the earlier of (a) the end of the Data Package Review Period and (b) the effective date of termination of this Agreement in accordance with Article 12.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">281923888 v10</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Order</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means any decree, order, judgment, writ, award, injunction, stipulation, determination or consent of or by a Governmental Authority.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Ordinary Course of Business</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means, with respect to any Person, the ordinary course of business consistent with the applicable Person&#x2019;s past custom and practice; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided, however,</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> that actions taken (or omitted) reasonably and in good faith to respond to COVID-19 shall be deemed Ordinary Course of Business, so long as such actions (or omissions) are reasonably consistent with such Person&#x2019;s actions (or omissions) taken prior to the date of this Agreement in response to COVID-19 or in response to any new COVID-19 Measures implemented following the date of this Agreement but prior to Closing.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Out-of-Pocket Expenses</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means [***]</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Outbound Licenses</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning provided in Section 4.7(h).</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Patent Rights</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means (a) all national, regional and international patents and patent applications filed in any country of the world, including provisional patent applications, (b) all patent applications filed either from such patents and patent applications or from a patent application claiming priority from either of these, including any continuation, continuation-in-part, division, provisional, converted provisional and continued prosecution applications, or any substitute applications, (c) any patent issued with respect to or in the future issued from any such patent applications including utility models, petty patents and design patents and certificates of invention and (d) any and all extensions or restorations by existing or future extension or restoration mechanisms, including revalidations, reissues, reexaminations and extensions (including any supplementary protection certificates and the like) of the foregoing patents or patent applications.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Permitted Encumbrances</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means: (a) statutory or common law liens for Taxes that are not yet delinquent or liens for Taxes being contested in good faith through appropriate proceedings and for which adequate reserves have been established in accordance with GAAP; (b) statutory or common law liens in favor of carriers, warehousemen, mechanics and materialmen, to secure claims for labor, materials or supplies and other like liens; (c) liens in favor of customs and revenue authorities arising as a matter of Law to secure payments of customs duties in connection with the importation of goods; (d) Encumbrances that do not, individually or in the aggregate, materially impair or interfere with the continued ownership, use, operation or value of the assets to which they are related; and (e) the Development Agreement.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Permits</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means all permits, licenses, franchises, approvals, certificates, consents, waivers, exemptions, registrations or other authorizations issued to, or required to be obtained or maintained by, Equillium by a Governmental Authority with respect to the conduct or operation of the Program as currently conducted or the ownership or use of the Purchased Assets.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Person</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means an individual, corporation, partnership, limited liability company, limited liability partnership, syndicate, person, trust, association, organization or other entity, including any Governmental Authority, and including any successor, by merger or otherwise, of any of the foregoing.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">281923888 v10</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Phase 2 Trial</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means a human clinical trial that would satisfy the requirements for a Phase 2 study as defined in 21 CFR &#167; 312.21(b) (or any amended or successor regulations), regardless of where such clinical trial is conducted.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Phase 3 Trial</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means a human clinical trial that would satisfy the requirements for a Phase 3 study as defined in 21 CFR &#167; 312.21(c) (or any amended or successor regulations), regardless of where such clinical trial is conducted.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pivotal Trial</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means: (a) a Phase 3 Trial; or (b) any other human clinical trial that the applicable Regulatory Authority in a country of the Equillium Territory has agreed, whether before first dosing of the first patient in such trial (e.g., pursuant to a special protocol assessment agreement with the FDA) or after first dosing of the first patient in such trial (e.g., based on an interim data analysis), is sufficient to form the primary basis of an efficacy claim in a BLA submission, regardless of whether the sponsor of such trial characterizes or refers to such trial as a &#x201c;Phase 3&#x201d;, &#x201c;Phase 2b&#x201d; or &#x201c;Phase 2b/3&#x201d; trial (or otherwise) in the applicable protocol, on clinicaltrials.gov or in any other context. If a human clinical trial does not constitute a Pivotal Trial at the time of first dosing of the first patient in such trial, but is later determined by the applicable Regulatory Authority to be sufficient to form the primary basis of an efficacy claim in a BLA submission, then, for purposes of Section 3.7(a) hereof, &#x201c;first dosing of the first patient&#x201d; in such Pivotal Trial shall be deemed to have occurred on the date of such determination by the applicable Regulatory Authority.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pre-Clinical Data</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means data resulting from any pre-clinical study of the Compound or any Product conducted by or on behalf of any Equillium Person, together with the applicable protocol for each such study; but, in each case, excluding Biocon Data.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Product</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means any pharmaceutical product containing or comprising the Compound, whether or not as the sole active ingredient and in any dosage, form or formulation.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Program</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means all activities of any Equillium Person (including activities performed by any Third Party on behalf of any Equillium Person, but excluding activities performed by Biocon, any of its Affiliates or any of its or their respective Third Party licensees and sublicensees) directed primarily to the Development or Exploitation of the Compound or any Product up to the Closing Date (including any activities performed under this Agreement up to the Closing Date).</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Program Confidential Information</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means information pertaining to the Purchased Assets, the Compound, any Product or the Program, including, and solely to the extent pertaining to the Purchased Assets, the Compound, any Product or the Program, information relating to licensors, suppliers, vendors, subscribers, distributors, financial statements and information, budgets and projections, business plans, production costs, market research, marketing, sales and distribution strategies, manufacturing techniques, processes and business methods, technical information, pending projects and proposals, new business plans and initiatives, research and development projects, inventions, discoveries, ideas, technologies, trade secrets, know-how, formulae, designs, patterns, marks, names, improvements, industrial designs, mask works, works of authorship and other Intellectual Property, devices, samples, plans, drawings and</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">14</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">281923888 v10</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">specifications, photographs and digital images, computer software and programming, all other confidential information and materials relating to the business or affairs of any Equillium Person, and all notes, analyses, compilations, studies, summaries, reports, manuals, documents and other materials prepared by or for any Equillium Person containing or based in whole or in part on any of the foregoing, whether in verbal, written, graphic, electronic or any other form and whether or not conceived, developed or prepared in whole or in part by any Equillium Person. For clarity, and notwithstanding anything to the contrary contained in the foregoing definition, Program Confidential Information excludes information to the extent pertaining to any Excluded Asset or Excluded Liability.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Program Invention</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means any invention, whether or not patentable, that is made, conceived, discovered or generated in the performance of the Program.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Program IP</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning provided in Section 8.14(a).</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Program Know-How</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means Information not included in the Program Patents which is: (a) Controlled by any Equillium Person immediately prior to the Closing; and (b) directed to the Development or Exploitation of the Compound or any Product, or otherwise primarily used or held for use in, or necessary for the Exploitation of, the Program, but excluding, in any event, (i) any Information that is an Excluded Asset and (ii) Biocon Know-How.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Program Patents</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means: (a) the patents and patent applications listed on </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit B</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">; (b) any and all divisionals, continuations and continuations-in-part of the patents and patent applications referenced in the preceding clause (a); (c) the foreign patent applications associated with the patent applications referenced in the preceding clauses (a) and (b); (d) the patents issued or issuing from the patent applications referenced in the preceding clauses (a) through (c); and (e) reissues, reexaminations, restorations (including supplemental protection certificates) and extensions of any patent or patent application referenced in the preceding clauses (a) through (d); but excluding, in any event (i) Biocon&#x2019;s joint ownership interest in and to Joint Patents, and (ii) Biocon Patents.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Purchase Option</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning provided in Section 2.1.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Purchase Option Exercise Notice</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning provided in Section 2.3.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Purchase Price</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means the aggregate of the Upfront Payment, the Closing Payment and the value of the Milestone Payments with respect to any Milestone Events achieved after the Closing Date (if any) paid to Equillium.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Purchased Assets</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning provided in Section 3.1.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Quarterly Advance</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning provided in Section 8.10(b).</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Quarterly Estimate</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning provided in Section 8.10(a).</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Reasonable Inquiry</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means, with respect to the individuals set forth in the definition of &#x201c;Equillium&#x2019;s Knowledge&#x201d;, a review by each such individual of one&#x2019;s files and inquiry</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">281923888 v10</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">of direct reports. With respect to matters involving Intellectual Property, Reasonable Inquiry does not require that the individuals set forth in the definition of &#x201c;Equillium&#x2019;s Knowledge&#x201d; have conducted, obtain or have obtained any freedom-to-operate opinions or similar opinions of counsel or any Intellectual Property clearance searches, and no knowledge of any Third Party Intellectual Property that would have been revealed by such inquiries, opinions or searches will be imputed to such individuals or the direct reports of any of the foregoing; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided, further</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, that any such opinions or searches that have been conducted or obtained prior to the date of this Agreement will not be excluded from the definition &#x201c;Equillium&#x2019;s Knowledge&#x201d; as a result of this sentence.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Receiving Party</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning provided in Section 7.7(a)(ii).</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Record Retention Period</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means, with respect to Development Records relating to a Product, the period commencing on the date upon which such Development Records were created and ending on the later of (a) the [***] anniversary of the date on which Regulatory Approval for such Product is obtained and (b) the [***] anniversary of the date on which Development or Manufacture efforts for such Product are terminated (or such later date as required under applicable Law).</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Regulatory Approval</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means any and all approvals, licenses, registrations, permits, certificates and other authorizations, consents, waivers and exemptions of any Regulatory Authority that are necessary to market and sell a particular Product in a particular jurisdiction.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Regulatory Authority</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means the FDA and any health regulatory authority in any jurisdiction that is a counterpart to the FDA and holds responsibility for granting regulatory marketing approval for a Product in such jurisdiction, and any successor(s) thereto.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Regulatory Filings</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning provided in Section 4.8(d).</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Regulatory Materials</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means all regulatory applications, submissions and Permits (including all &#x201c;Investigational New Drug Applications&#x201d; and &#x201c;New Drug Applications&#x201d; for FDA purposes, foreign counterparts thereof and all Regulatory Approvals) for the Compound or any Product in the Equillium Territory, and all correspondence with the FDA and other Regulatory Authorities in the Equillium Territory relating to the Compound or any Product or any of the foregoing regulatory applications, submissions and Permits; that, in each case, are in the possession of or controlled by, or held by or for, any Equillium Person at the Closing Date, whether generated, filed or held by or for any Equillium Person.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Regulatory Materials Transfer Date</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning provided in Section 7.11(b).</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Related Party</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means, with respect to any specified Person: (a) any Affiliate of such specified Person; (b) any officer, director, principal or employee of such specified Person; (c) any Immediate Family member of a Person described in clause (b); or (d) any other Person who holds, individually or together with any Affiliate, officer, director, principal or employee of such other Person and any member(s) of such Person&#x2019;s Immediate Family more than 10% of the outstanding voting equity or ownership interests of such specified Person.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">16</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">281923888 v10</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Representatives</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means, with respect to any Person, the officers, directors, principals, employees, agents, auditors, advisors, bankers and other representatives of such Person.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Results</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means all data (including preclinical, clinical, technical, chemical, safety and scientific data and information), know-how and other results and information generated by or resulting from the performance of the Development Plan, including relevant laboratory notebook information, screening data, regulatory data and synthesis schemes.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sale of the Business</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning provided in Section 3.7(c)(i)(4).</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Service Contracts</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning provided in Section 4.7(j).</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Standard Contracts</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means (a) &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">shrink wrap</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; or other licenses for generally commercially available software (including open source software) or hosted services, (b) non-exclusive licenses to customers, vendors or suppliers of Equillium entered into in the Ordinary Course of Business, (c) non-disclosure agreements entered into (i) in the Ordinary Course of Business or (ii) in connection with discussions, negotiations and transactions related to this Agreement or other potential strategic transactions, (d) clinical trial Contracts and material transfer Contracts entered into in the Ordinary Course of Business, and (e) any Contract that (i) does not require a payment to or from any Equillium Person in excess of $[***] in any calendar year and (ii) could not otherwise reasonably be expected to be material to the Exploitation of the Program, the Compound, any Product or the Purchased Assets.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Subsidiary</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means, with respect to any Person, any other Person in respect of which the first Person (directly or indirectly, and whether alone or with any other Subsidiary) (a) owns 50% or more of the stock or other equity interests or (b) possesses the power to direct or cause the direction of the management and policies, whether through the ownership of voting securities, as trustee or executor, as general partner or managing member, by Contract or otherwise, including the ownership of securities having the power to elect a majority of the board of directors or similar body governing the affairs of such other Person. The term &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Subsidiary</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; shall include all Subsidiaries of such Subsidiary.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Tax Documents</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning provided in Section 2.2.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Tax Return</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means any return, declaration, report, statement, information statement, claim for refund and other document filed or required to be filed (or provided to a payee) with a Governmental Authority with respect to Taxes, including any schedule or attachment thereto, and including any amendment thereof.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Taxes</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means (a) all federal, state, local, foreign and other net income, gross income, gross receipts, sales, use, ad valorem, transfer, franchise, profits, registration, license, lease, service, service use, withholding, payroll, employment, excise, severance, stamp, occupation, premium, property, windfall profits, customs duties or other taxes imposed by a Governmental Authority, together with any interest and any penalties, additions to tax or additional amounts with respect thereto (including any amounts attributable to the nonpayment thereof or a failure to file any tax return), (b) all liability for payment of amounts described in clause (a) whether as a result of transferee liability, being a member of an affiliated, consolidated, combined</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">17</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">281923888 v10</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">or similar group or otherwise through operation of Law and (c) all liability for the payment of amounts described in clauses (a) or (b) as a result of any tax sharing, tax indemnity, tax allocation or similar agreement or arrangement or any other Contract to indemnify any Person.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Third Party</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means any Person other than Ono, Ono&#x2019;s Affiliates, Equillium and Equillium&#x2019;s Subsidiaries.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Third Party Claim</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning provided in Section 11.5(a).</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Trade Secrets</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means trade secrets and confidential business information, including source code, inventions (whether patentable or not), invention disclosures, discoveries, improvements, ideas, research and development, know-how, formulas, compositions, processes and techniques, technical data, designs, drawings, specifications, customer and supplier lists, pricing and cost information, business and marketing plans and proposals and all other documentation relating to any of the foregoing and all corresponding rights in Confidential Information and other non-public information.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Transaction Documents</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means this Agreement, the Development Agreement and the Ancillary Agreements.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Transaction Taxes</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning provided in Section 9.1.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Transactions</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means the transactions and arrangements contemplated by this Agreement and the other Transaction Documents, including (a) the sale of the Purchased Assets and the other transactions and arrangements described in the Recitals and (b) the execution, delivery and performance of the other Transaction Documents.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Transferred Information</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning provided in Section 7.4(c).</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Transferred Intellectual Property</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means (a) the Program Patents, Program Know-How and Data, (b) any Intellectual Property arising from the Program and (c) other than any Excluded Assets, any and all other Intellectual Property in or to the Compound or any Product or that is primarily used or held for use in or necessary for the Exploitation for the Program and that is Controlled by any Equillium Person at the Closing Date, and with respect to each of (a), (b) and (c), all rights to use, enforce, disclose, protect, apply for, file, register, maintain, extend or renew the same, and seek Patent Rights and other protection therefor, all rights to transfer and grant licenses and other rights with respect thereto subject to the licenses and rights granted to Biocon under, and the terms and conditions of, the Biocon License, and all rights to bring Actions for all past, present and future infringements or misappropriations thereof or relating thereto, seek damages, injunctive relief, costs and other remedies on account thereof and to settle, and collect and retain the proceeds from, any such Actions; but, in any event, excluding (i) Biocon&#x2019;s joint ownership interest in and to Joint Inventions and Joint Patents and (ii) Biocon Technology.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Update Notice</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning provided in Section 7.5(b).</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Updated Disclosure Schedules</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning provided in Section 2.4(a).</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">281923888 v10</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Upfront Payment</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; has the meaning provided in Section 2.2.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S.</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means the United States of America.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.	PURCHASE OPTION</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.1	Grant of Purchase Option</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Subject to the payment by Ono to Equillium of the Upfront Payment in accordance with Section 2.2, Equillium hereby grants to Ono, and Ono hereby accepts, an irrevocable (only during the Option Period and subject to the earlier termination of this Agreement in accordance with its terms) and exclusive (as set forth in Section 7.6) option to acquire all of the Purchased Assets on the terms and subject to the conditions of this Agreement (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Purchase Option</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;), which shall be exercisable only during the Option Period and on the terms and subject to the conditions set forth in this Agreement.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.2	Upfront Payment</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Within [***] following receipt by Ono of (a) (i) an invoice issued by Equillium and (ii) taxation documents (Form 3 and Form 17 of the Japan National Tax Agency, and certification of residence issued by the US Internal Revenue Service) ((i) and (ii) collectively, the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Tax Documents</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) from Equillium or (b)[***], Ono shall pay to Equillium a one-time payment of an amount equal to JPY 3.5 billion (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Upfront Payment</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;). If Equillium delivers the notice referred to in clause (b), Equillium shall[***]. For the avoidance of doubt, Ono&#x2019;s obligation to pay the Upfront Payment under this Section 2.2 is subject to Section 9.5.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.3	Exercise of Purchase Option</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Ono may, in its sole discretion, at any time during the Option Period, exercise the Purchase Option by delivering to Equillium a written notice of Ono&#x2019;s election to exercise the Purchase Option (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Purchase Option Exercise Notice</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;), which such notice shall contain Ono&#x2019;s selection of one of the following plans:</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">a plan to have Equillium continue to perform Development activities on behalf of Ono following the Closing in accordance with the Development Plan following the Closing (&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Outsourced Development Plan</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;);</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(b)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">a plan to have Equillium continue to perform Development activities on behalf of Ono following the Closing in accordance with the Development Plan subject to the transition of control and responsibility of other aspects of the Program to Ono as soon as reasonably practicable following the Closing, (&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Partial Development Plan</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;); or</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">a plan to have Equillium transition full control and responsibility for the Program to Ono as soon as reasonably practicable after the Closing while continuing to perform Development activities in accordance with the Development Plan only until such transition is complete (&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Transition Development Plan</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;).Ono may only deliver one Purchase Option Exercise Notice during the Option Period, and such Purchase Option Exercise Notice shall be deemed delivered on the date determined in accordance with Section 13.5. If Ono selects the Partial Development Plan, at least [***] prior to the Closing, Ono shall notify Equillium in writing of those aspects of the Program that Ono wishes to transition from Equillium to Ono.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">19</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">281923888 v10</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.4	Updated Disclosure Schedules</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If Ono delivers the Purchase Option Exercise Notice to Equillium during the Option Period, Equillium shall, within [***] following receipt of the Purchase Option Exercise Notice, deliver to Ono a revised set of disclosure schedules (as updated in accordance with this Section 2.4(b), the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Updated Disclosure Schedules</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) reflecting the Update Notices and any other changes to the Disclosure Schedules required to make such Disclosure Schedules and Equillium&#x2019;s representations and warranties contained in Article 4 true, complete and correct in all respects on and as of the date of the Purchase Option Exercise Notice in light of any change, condition or event that occurred or arose after the date of this Agreement.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(b)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Equillium may from time to time deliver to Ono a further revised set of the Updated Disclosure Schedules no later than [***] prior to the Closing reflecting any other changes to the Updated Disclosure Schedules required to make such Updated Disclosure Schedules and Equillium&#x2019;s representations and warranties contained in Article 4 true, complete and correct in all respects on and as of the date of the delivery of such Updated Disclosure Schedules in light of any change, condition or event that occurred or arose after the last date on which Equillium delivered the Updated Disclosures Schedules to Ono.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(c)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In connection with the delivery of the Updated Disclosure Schedules (including any further revision in accordance with Section 2.4(b)), Equillium shall make available to Ono copies of all Acquired Contracts or other documents referenced in such Updated Disclosure Schedules, and shall provide to Ono any information reasonably requested by Ono in order to evaluate the information disclosed in the Updated Disclosure Schedules.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(d)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(e)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.5	Effect of No Exercise</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. If Ono does not deliver a Purchase Option Exercise Notice by 5:00 p.m. Pacific Time on the last day of the Option Period, then at such time (a) the Purchase Option shall no longer be exercisable and shall terminate and be of no further force or effect, (b) this Agreement will terminate subject to the terms of Section 12.3 and (c) the Development Agreement shall terminate pursuant to its terms.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3.	PURCHASE AND SALE</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3.1	Purchase and Sale of Assets</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Upon the terms and subject to the conditions of this Agreement, at the Closing, Equillium shall sell, assign, transfer, convey and deliver, or cause to be sold, assigned, transferred, conveyed and delivered, to Ono, and Ono shall purchase from Equillium, all of each Equillium Person&#x2019;s right, title and interest, in and to all of the following assets to the extent related primarily to, or otherwise necessary for the Exploitation of, the Program, the Compound or any Product, in each case free and clear of any Encumbrances (other than Permitted Encumbrances) (collectively, the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Purchased Assets</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;):</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">20</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">281923888 v10</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">all Transferred Intellectual Property, wherever held or registered, and the right to sue and collect damages related thereto for past, present and future infringement of any of the foregoing;</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(b)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the right to claim priority to the provisional applications listed on </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Schedule 3.1(b)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> with respect solely to any subject matter disclosed therein that is disclosed in the Program Patents, including subject matter that covers the Compound or any Product (including the composition or formulation of, or any method of making or using, the Compound or any Product);</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(c)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">all Regulatory Materials;</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(d)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the Acquired Contracts;</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(e)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">all Inventory;</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(f)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(i) all research and development reports and disclosure memoranda in the possession of or controlled by any Equillium Person primarily relating to, or otherwise necessary for the Exploitation of, the Program, the Compound or any Product, including study reports, clinical trial related documents (including consent forms, study contracts, site agreements and manuscripts) and in process publications and (ii) all worldwide safety reports in the possession of or controlled by any Equillium Person with respect to the Program, the Compound or any Product;</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(g)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">all prepaid expenses and deposits related primarily to the Program, the Compound, any Product or any other part of the Business, provided that the inclusion of these assets does not absolve Ono of its obligations to reimburse Equillium pursuant to Article 8;</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(h)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">all causes of action, lawsuits, judgments, claims, complaints and demands of any nature available to or being pursued by any Equillium Person to the extent related to the Program, the Compound, any Product or any other part of the Business, whether arising by way of counterclaim or otherwise, choate or inchoate, known or unknown or contingent or non-contingent, except to the extent included in the Excluded Assets;</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(i)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">all guaranties, warranties, indemnities and similar rights in favor of any Equillium Person to the extent primarily related to the Program, the Compound, any Product or any other part of the Business;</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(j)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">all Books and Records;</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(k)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the Mouse Assets;</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(l)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">all drug samples used, or held for use, in connection with obtaining Regulatory Approval of a Product;</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(m)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">all Data and Program Know-How and tangible embodiments of Biocon Data and Biocon Know-How (including to the extent any of the foregoing is stored on any electronic medium) in the possession of or controlled by any Equillium Person; and</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">21</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">281923888 v10</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(n)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">all other assets of any Equillium Person that are primarily used or held for use in connection with, or otherwise necessary for the Exploitation of, the Program, the Compound or any Product, but excluding any Excluded Assets.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3.2	Excluded Assets</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. For the purposes of this Agreement, the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Excluded Assets</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; shall mean any asset of any Equillium Person other than the Purchased Assets, including:</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">any asset or class of assets excluded from the definition of Purchased Assets set forth in Section 3.1 by virtue of the limitations set forth therein;</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(b)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">all assets (including Intellectual Property) of any Equillium Person that are both (i) not primarily used or held for use in the Program and (ii) not necessary for the Program; including all assets (including Intellectual Property) of any Equillium Person primarily used or held for use in the Excluded Programs;</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(c)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">all Contracts other than the Acquired Contracts;</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(d)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">all rights of Equillium under this Agreement and the other Transaction Documents;</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(e)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">any cash or cash equivalents;</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(f)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">any prepaid expenses and deposits that are not Purchased Assets pursuant to Section 3.1(g);</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(g)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">any Tax records of any Equillium Person (including all Tax Returns) except those solely relating to the Business or the Program;</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(h)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">all rights of any Equillium Person to any refunds, or rights or claims to refunds, of Taxes, Tax deposits, Tax credits or other Tax assets for any taxable period (or portions thereof) ending on or before the Closing Date;</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(i)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">insurance policies or the right to make claims under any insurance policy, other than the rights under &#x201c;claims made&#x201d; insurance policies with respect to events occurring after the Closing Date;</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(j)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">all leasehold interests and, other than the Inventory, all biological or chemical materials, machinery, equipment, furniture, furnishings, fixtures and other tangible property; and</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(k)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">any asset identified on </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Schedule 3.2(k)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Excluded Assets shall be excluded from the sale, assignment, transfer, conveyance and delivery to Ono hereunder, and the Equillium Persons shall retain all right, title and interest in, to and under, the Excluded Assets. To the extent this Section 3.2 conflicts with any other provision of this Agreement, the provisions of this Section 3.2 will control.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">22</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">281923888 v10</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3.3	Assumed Liabilities</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Subject to the terms and conditions set forth herein, effective at the Closing, Ono hereby assumes and agrees to pay, perform and discharge (a) all Liabilities of each Equillium Person, to the extent arising out of, relating to (including relating to any fact, circumstance, occurrence, condition, act or omission) or in connection with the Purchased Assets in respect of the period after the Closing, including (i) all Liabilities of each Equillium Person under the Acquired Contracts in respect of the period after the Closing and (ii) those Liabilities set forth on </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Schedule 3.3</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, (b) Ono&#x2019;s share of Transaction Taxes pursuant to Section 9.1 and (c) any Taxes imposed with respect to, arising out of or relating to the Program or the Purchased Assets for any taxable period (or portions thereof) beginning after the Closing Date, in each case, other than the Excluded Liabilities (collectively, the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Assumed Liabilities</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;).</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3.4	Excluded Liabilities</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Notwithstanding any other provision of this Agreement to the contrary, Ono shall not assume or have any Liability in respect of any Excluded Liabilities, each of which shall be retained and shall be paid, performed and discharged when due by the Equillium Persons. For the purposes of this Agreement, &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Excluded Liabilities</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; shall mean the following Liabilities of any Equillium Person:</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">all Liabilities arising out of or relating to the Excluded Assets;</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(b)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">all Liabilities of any Equillium Person to the extent arising out of, relating to or in connection with the Purchased Assets in respect of the period before the Closing, including for the avoidance of doubt any Liability that arises after the Closing but that arises out of, relates to or is in connection with any breach under or failure to comply with any Acquired Contract, applicable Law, Permit or Order that occurred at or before the Closing;</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(c)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">any trade accounts payable, other accrued expenses or other current liabilities of any Equillium Person;</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(d)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">any notes payable or long-term debt of any Equillium Person;</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(e)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">all Taxes arising out of, relating to or in connection with the Program or the Purchased Assets attributable to any taxable period (or portions thereof) ending on or before the Closing Date;</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(f)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Equillium&#x2019;s share of Transaction Taxes pursuant to Section 9.1;</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(g)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">all Liabilities in respect of the Representatives of any Equillium Person;</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(h)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">all Liabilities and obligations of Equillium under, or arising or incurred in connection with the negotiation, preparation, execution or performance of, this Agreement and the other Transaction Documents;</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(i)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">except for Liabilities arising or incurred with respect to the Development Agreement, which shall be handled in accordance with the terms of the Development Agreement, all Liabilities arising or incurred in connection with the acts or omissions of any Equillium Person after the Closing, provided that this clause (i) shall not limit Ono&#x2019;s obligations under Section 11.2(b)(ii); and</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">23</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">281923888 v10</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(j)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">all Liabilities arising out of or relating to the Contracts set forth on </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Schedule 4.15</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> of the Disclosure Schedules.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Excluded Liabilities shall be excluded from the assignment, transfer, conveyance and delivery to, and assumption by, Ono hereunder, and the Equillium Persons shall retain and pay, perform and discharge when due all the Excluded Liabilities. To the extent this Section 3.4 conflicts with any other provision of this Agreement, the provisions of this Section 3.4 will control.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3.5	Consents and Waivers; Further Assurances</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Nothing in this Agreement or the Ancillary Agreements shall be construed as an agreement to assign any Purchased Asset or Assumed Liability that by its terms or pursuant to applicable Law is not capable of being sold, assigned, transferred or delivered without the consent or waiver of a Third Party or Governmental Authority unless and until such consent or waiver shall be given. The Parties shall use commercially reasonable efforts to obtain such consents and waivers and to resolve the impediments to the sale, assignment, transfer or delivery contemplated by this Agreement or the Ancillary Agreements and to obtain any other consents and waivers necessary to convey to Ono all of the Business. In the event any such consents or waivers are not obtained prior to the Closing Date, Equillium shall continue for a period of [***] following the Closing to use its commercially reasonable efforts to obtain the relevant consents or waivers. Equillium shall reasonably cooperate with Ono in any lawful and economically feasible arrangement to provide Ono with the benefit of the interest Equillium had in each Purchased Asset not sold, assigned, transferred or delivered to Ono, including performance by Equillium, if economically feasible, as agent; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided, however,</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> that Ono shall undertake to pay or satisfy the corresponding liabilities for the enjoyment of such benefit to the extent Ono would have been responsible therefor hereunder if such consents or waivers had been obtained. After the expiry of such [***]period, any unassigned Purchased Asset shall be deemed an Excluded Asset and Equillium shall have no further obligation to Ono with respect to such Excluded Assets.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(b)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">From time to time at or following the Closing, each Party shall execute, acknowledge and deliver all such further conveyances, notices, assumptions and releases and such other instruments as reasonably necessary to convey the Purchased Assets to Ono pursuant to the terms of this Agreement, and shall take such further actions, as may be reasonably necessary or appropriate to transfer fully to Ono all the Purchased Assets and to assure fully to Equillium the assumption of the Assumed Liabilities. Without limiting the generality of the foregoing, from time to time at or following the Closing, upon Ono&#x2019;s reasonable request and at Equillium&#x2019;s expense, Equillium shall: (i) execute, acknowledge and deliver all such further conveyances, notices, assumptions and releases and such other instruments as may be reasonably necessary to perfect, record, evidence, establish or confirm Ono&#x2019;s sole ownership (or, in the case of Joint Patents, Ono&#x2019;s joint ownership with Biocon) of all right, title and interest in and to the Transferred Intellectual Property and as may be necessary for Ono to have standing to prosecute, maintain, enforce and defend the Program Patents; (ii) provide copies of any documentation in Equillium&#x2019;s or its patent counsel&#x2019;s possession relating to inventorship of inventions claimed in the Program Patents and of any inventor assignments related thereto; and (iii) to the extent required under applicable Law, adequately compensate any inventors of Transferred Intellectual Property.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">24</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">281923888 v10</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(c)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition to Section 3.5(b), Equillium shall also, at any time upon Ono&#x2019;s reasonable request and at Ono&#x2019;s expense, reasonably cooperate with Ono in the prosecution, maintenance, enforcement, or defense of the Transferred Intellectual Property, including by reasonably providing information, and executing and delivering documents and other instruments as may be reasonably requested by Ono.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3.6	Closing</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In the event that the Option Exercise Effective Date occurs, the sale and purchase of the Purchased Assets and the assumption of the Assumed Liabilities contemplated by this Agreement (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Closing</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) shall take place via electronic exchange of the documentation required to be delivered at the Closing in accordance with Sections 3.6(b) and (c), on the [***] following the satisfaction or, to the extent permitted by applicable Law, waiver of all conditions to the obligations of the Parties set forth in Article 10 (other than such conditions as may, by their terms, only be satisfied at the Closing or on the Closing Date), or at such other place or at such other time or on such other date as Equillium and Ono mutually may agree in writing. The day on which the Closing takes place is referred to as the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Closing Date</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(b)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">At the Closing, Ono shall:</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(i)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">pay or cause to be paid to Equillium an amount equal to the Closing Payment;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(ii)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">deliver or cause to be delivered to Equillium:</font></p>
  <p style="text-indent:26.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(1)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">a counterpart to the Bill of Sale and Assignment and Assumption Agreement, duly executed by Ono;</font></p>
  <p style="text-indent:26.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(2)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">a counterpart to the Assignment of Intellectual Property, duly executed by Ono; and</font></p>
  <p style="text-indent:26.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(3)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">a certificate certifying the fulfillment of the conditions set forth in Section 10.2(a), duly executed by an authorized representative of Ono.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(c)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">At the Closing, Equillium shall deliver or cause to be delivered to Ono:</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(i)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the following documents:</font></p>
  <p style="text-indent:26.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(1)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">a counterpart to the Bill of Sale and Assignment and Assumption Agreement, duly executed by Equillium;</font></p>
  <p style="text-indent:26.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(2)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">a counterpart to the Assignment of Intellectual Property, duly executed by Equillium; and</font></p>
  <p style="text-indent:26.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(3)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">a certificate certifying the fulfillment of the conditions set forth in Sections 10.3(a) and (b), duly executed by an authorized representative of Equillium;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">25</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">281923888 v10</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(ii)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">all Transferred Information in accordance with Section 7.4(c);</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(iii)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">all tangible Purchased Assets; and</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(iv)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">all means of access to the Purchased Assets, including, if applicable, all keys, combinations, access codes, account numbers and passwords associated with the Purchased Assets.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(d)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">All of the actions to be taken and documents to be executed and delivered at the Closing (as provided in Sections 3.6(b) and (c)) shall be deemed to be taken, executed and delivered simultaneously, and no such action, execution or delivery will be effective until all are complete.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3.7	Contingent Consideration</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a)	Milestone Payments</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Within [***] following the first occurrence of each of the events set forth in the table below (each, a &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Milestone Event</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; and collectively, the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Milestone Events</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;), whether any such Milestone Event is achieved by Ono (including by Equillium on Ono&#x2019;s behalf pursuant to this Agreement or the Development Agreement), any Affiliate of Ono or any Ono Licensee, Ono shall deliver written notice to Equillium of the achievement of such Milestone Event. Within [***] following delivery by Equillium to Ono of the Tax Documents in respect of the amount corresponding to such Milestone Event in the table below (each, a &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Milestone Payment</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;), Ono shall pay such Milestone Payment to Equillium in cash; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided, however,</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> that the Milestone Payment with respect to any Milestone Event that occurs prior to the Closing shall be included in the Closing Payment and shall not be payable prior to the Closing or if the Closing does not occur for any reason. Notwithstanding the foregoing, Ono shall have no obligation to pay the relevant Milestone Payment to Equillium with respect to any Milestone Event (i) [***] or (ii) [***].</font></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="background-color:#ffffff;font-weight:bold;visibility:collapse;">
    <td style="width:72.139%;"></td>
    <td style="width:27.861%;"></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="border-top:0.5pt solid;background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Milestone Event</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p></td>
    <td style="border-top:0.5pt solid;background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Milestone Payment</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;margin-right:0.10902777777777778in;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.	[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***] USD</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;margin-right:0.10902777777777778in;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.	[***]*</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***] USD</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;margin-right:0.10902777777777778in;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3.	[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***] USD</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;margin-right:0.10902777777777778in;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.	[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***] USD</font></p></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;margin-right:0.10902777777777778in;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.	[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;[***]USD</font></p></td>
   </tr>
  </table>
  <p style="margin-left:3.333%;text-indent:-3.448%;padding-left:3.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">*	If Milestone Event 2 is achieved without Milestone Event 1 having first been achieved, then the Milestone Payments corresponding to both Milestone Event 1 and Milestone Event 2 shall be payable upon the achievement of Milestone Event 2.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Each of the Milestone Payments set forth above shall be payable only one time, for the first achievement of the applicable Milestone Event.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">26</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">281923888 v10</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(b)	Diligence Obligation</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. In respect of each Milestone Event, commencing upon the Closing and continuing until the earliest of (i) such time as the relevant Milestone Payment under Section 3.7(a) has been paid, (ii) [***] after the Closing and (iii) the expiry of any Discontinuation Notice Period relating to a Development Discontinuation, a Commercialization Discontinuation or a Biocon License Termination or, if Equillium delivers to Ono a notice of interest in accordance with Section 3.7(c)(ii), the relevant Negotiation Period (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Diligence Period</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;), Ono shall use Commercially Reasonable Efforts to [***]. In addition, and without limiting Ono&#x2019;s obligations with respect to the Assumed Liabilities, Ono shall comply with the diligence obligations under the Biocon License. For the avoidance of doubt, after the expiry of the Diligence Period in respect of any Milestone Event, Ono shall not be required to perform its diligence obligations in respect of such Milestone Event pursuant to this Section 3.7(b). Equillium&#x2019;s sole and exclusive remedy in respect of any breach by Ono of this Section 3.7(b) shall be indemnification under Section 11.2(b)(ii).</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(c)	Notice of Certain Events</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(i)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Without limiting the generality of Ono&#x2019;s obligations under Sections 3.7(d) and 3.7(e), if, at any time during the Diligence Period:</font></p>
  <p style="text-indent:26.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(1)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">before Regulatory Approval of any Product for at least one Indication in the Equillium Territory is obtained, Ono (or the applicable Milestone Obligor(s)) considers discontinuing, or makes a determination to discontinue, Development of all Products or efforts to seek Regulatory Approval of all Products for all indications in all of the Equillium Territory (a &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Development Discontinuation</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;);</font></p>
  <p style="text-indent:26.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(2)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">after Regulatory Approval of any Product for at least one Indication in the Equillium Territory is obtained, Ono (or the applicable Milestone Obligor(s)) considers discontinuing (or not pursuing), or makes a determination to discontinue or not to pursue), commercialization of all Products in all of the Equillium Territory (a &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Commercialization Discontinuation</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;);</font></p>
  <p style="text-indent:26.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(3)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Ono proposes to terminate the Biocon License for any reason (a &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Biocon License Termination</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;); or</font></p>
  <p style="text-indent:26.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(4)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Ono makes a determination to sell, transfer or otherwise dispose of substantially all the assets of the Program as operated by Ono or Ono&#x2019;s business related thereto (in each case, the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Itolizumab Business</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;), following the Closing Date (a &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sale of the Business</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;),</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">then, in each case, Ono shall promptly notify Equillium of the proposed or planned Development Discontinuation, Commercialization Discontinuation, Biocon License Termination or Sale of the Business in writing (such notice, a &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Discontinuation Notice</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;).</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(ii)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">During the [***] period beginning on delivery of the Discontinuation Notice (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Discontinuation Notice Period</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;), Ono shall not, as applicable, (A) take steps to initiate the Development Discontinuation, or, except to the extent a Regulatory Authority requires the withdrawal of Products from the market in a country of the Equillium</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">27</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">281923888 v10</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Territory, the Commercialization Discontinuation or (B) deliver notice of termination of the Biocon License to Biocon. If Equillium delivers to Ono written notice of its interest in taking over the Itolizumab Business prior to the end of the Discontinuation Notice Period, the Parties shall negotiate in good faith for up to [***] from the delivery of such notice of interest (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Negotiation Period</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) regarding the commercially reasonable terms and conditions upon which Ono would sell, license or otherwise transfer the Itolizumab Business to Equillium. Notwithstanding the foregoing, Ono shall not be prohibited from conducting discussions and negotiations or entering into any binding agreement with any Third Party regarding a Sale of the Business during the Discontinuation Notice Period and, if applicable, the Negotiation Period.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(d)	Update Reports</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Until the expiration of the Diligence Period, Ono shall send to Equillium a status report regarding the Development, registration and commercialization of Products in the Equillium Territory and the status of efforts to achieve the Milestone Events (each such report, an &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Update Report</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;), with the first such Update Report due [***].Within [***] after receipt of an Update Report, if Equillium requests a meeting with representatives of Ono to discuss such report, Ono shall make available for such a meeting (i) those of its employees and representatives who are responsible for the applicable activities set forth in the Update Report, (ii) at least one of its senior officers with operating responsibility for the activities of Ono related to the Milestone Events and (iii) a qualified, designated employee(s) with appropriate expertise and knowledge of Ono&#x2019;s Development, registration and commercialization activities with respect to Products (whether undertaken by Ono or any other Milestone Obligor), in each case who can respond to the reasonable questions posed by Equillium.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(e)	Restrictions on Disposition of Program</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Ono shall not consolidate with or merge into any other Person, assign, convey, transfer, license or lease its properties and assets substantially as an entirety to any Person, or assign, convey, transfer, license or lease substantially all of the Purchased Assets or substantially all of the assets of the Program as operated by Ono following the Closing Date, to any Person (and, without limiting the generality of the foregoing, shall not consummate a Sale of the Business to any Third Party), unless such Person has expressly assumed (or will by operation of Law assume) the obligation to pay each previously unpaid Milestone Payment when due, all of Ono&#x2019;s obligations under the Biocon Agreements and the obligation to perform every other duty and covenant of Ono under this Agreement.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(f)	Late Payments</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. In the event that any Milestone Payment due under Section 3.7(a) or any Development Funding due under Section 8.10(b) or (d) is not made when due, the amount of such overdue payment shall accrue interest at a rate [***]% over the [***], for the period from the due date for payment until the date of actual payment; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided, however,</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> that in no event shall such rate exceed the maximum legal annual interest rate. The payment of such interest shall not limit Equillium from exercising any other rights it may have as a consequence of the lateness of any payment under Section 3.7(a) or 8.10(b) or (d).</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(g)	Milestone Disputes</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. If Equillium believes in good faith that a Milestone Event has been achieved, it shall notify Ono in writing of such belief and provide Ono with evidence of justification that such Milestone Event has been achieved. To the extent that Ono agrees, Ono shall make (or cause to be made) to Equillium the applicable Milestone Payment within [***] after receipt of such notice in accordance with Section 3.7(a), together with any late</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">28</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">281923888 v10</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">payment interest payable in accordance with Section 3.7(f) accruing from [***] after the earlier of (a) the date of such notice and (b) the date on which Ono had actual knowledge of the achievement of such Milestone Event, through the date the Milestone Payment is actually paid to Equillium. To the extent that Ono disagrees and disputes such achievement, the Parties shall discuss and attempt to resolve such dispute. If the Parties are unable to resolve such dispute within [***] of notification by Equillium of its belief, the Parties shall submit the dispute for arbitration in accordance with Section 13.10.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.	REPRESENTATIONS AND WARRANTIES OF EQUILLIUM</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Equillium makes the following representations and warranties to Ono (a) on the date of this Agreement, as of such date, qualified by the disclosures set forth in the Disclosure Schedules and (b) on the Closing Date, as of such date, qualified by the disclosures set forth in the Updated Disclosure Schedules (subject to Section 2.4(d)):</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.1	Organization and Qualification</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Equillium is a corporation duly organized, validly existing and in good standing under the laws of the State of Delaware and has all requisite corporate power and authority to carry on its business as now conducted and as presently proposed to be conducted. Equillium is duly qualified to transact business and is in good standing in each jurisdiction in which the failure to be so qualified or in good standing could reasonably be expected to (a) have a Material Adverse Effect or (b) materially impair the ability of Equillium to consummate, or prevent or materially delay, any of the Transactions.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.2	Authority</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Equillium has full corporate power and authority to execute and deliver this Agreement and each of the other Transaction Documents to which it will be a party, to perform its obligations hereunder and thereunder and to consummate the Transactions. The execution, delivery and performance by Equillium of this Agreement and each of the other Transaction Documents to which it will be a party and the consummation by Equillium of the Transactions have been duly and validly authorized by all necessary corporate action. This Agreement has been, and upon their execution each of the other Transaction Documents to which Equillium will be a party will have been, duly executed and delivered by Equillium and, assuming due execution and delivery by each of the other parties hereto and thereto, this Agreement constitutes, and upon their execution each of the other Transaction Documents to which Equillium will be a party will constitute, the legal, valid and binding obligations of Equillium, enforceable against Equillium in accordance with their respective terms subject to bankruptcy, insolvency, reorganization, moratorium and similar Laws relating to or affecting (a) creditors&#x2019; rights, (b) general principles of equity or (c) the availability of specific performance, injunctive relief and other equitable remedies.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.3	No Conflict; Required Filings and Consents</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The execution, delivery and performance by Equillium of this Agreement and each of the other Transaction Documents to which Equillium will be a party, and the consummation of the Transactions, do not and will not (with or without notice or lapse of time or both):</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(i)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">conflict with or violate any Equillium Person&#x2019;s Constituent Documents;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">29</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">281923888 v10</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(ii)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">conflict with or violate any Law or Permit applicable to any Equillium Person, the Program or any of the Business or by which any Equillium Person, the Program or any of the Business may be bound or affected;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(iii)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(A) result in any breach of, (B) constitute a default under, (C) require any consent or approval of or notice to any Person pursuant to, (D) give to any other Person any express right of termination, amendment, modification, acceleration or cancellation of, (E) allow the imposition of any fees or penalties, require the offering or making of any payment to or give rise to any increased, guaranteed, accelerated or additional rights or entitlements of any Person in respect of or (F) result in the creation of any Encumbrance (other than Permitted Encumbrances) on any of the Purchased Assets pursuant to, in each case any Core Contract; or</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(iv)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(A) allow the imposition of any fees or penalties, require the offering or making of any payment to or give rise to any increased, guaranteed, accelerated or additional rights or entitlements of any Person in respect of or (B) result in the creation of any Encumbrance (other than Permitted Encumbrances) on any of the Purchased Assets pursuant to, in each case any Standard Contract.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(b)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">No Equillium Person is required to file, seek or obtain any notice, authorization, approval, order, permit, consent or other Permit of or with any Governmental Authority in connection with the execution, delivery and performance by Equillium of this Agreement or any of the other Transaction Documents to which it will be a party or the consummation of the Transactions.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.4	Purchased Assets</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. For purposes of this Section 4.4, the representations and warranties made as of the date of this Agreement are in respect of the Purchased Assets as of the date of this Agreement.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Equillium Persons have good and valid title to or a valid leasehold interest in all of the tangible Purchased Assets, free and clear of any Encumbrance (other than Permitted Encumbrances).</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(b)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">At the Closing, Ono will receive good, valid and marketable title to (or a valid leasehold interest in, as the case may be) the tangible Purchased Assets.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(c)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The tangible Purchased Assets comprise all of the tangible assets used in connection with the Program and that are necessary for the continuation of the Program.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(d)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">All tangible Purchased Assets owned or leased by any Equillium Person are structurally sound, in good operating condition (normal wear and tear excepted) and adequate for the uses to which such tangible Purchased Assets are used.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(e)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Except for used, obsolete, damaged or defective Inventory that has been written off or reserved for in Equillium&#x2019;s most recent financial statements filed with its quarterly report on Form 10-Q with the United States Securities and Exchange Commission on November 14, 2022, all Inventory (i) was acquired and has been maintained in the Ordinary Course of Business, and (ii) is of good and merchantable quality.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">30</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">281923888 v10</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(f)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Purchased Assets do not comprise any real property, fixed assets or rights under any Contracts of employment or any interest in any of the foregoing.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.5	Compliance with Law; Permits</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Each Equillium Person is, and at all times since the Lookback Date has been, in compliance in all material respects with all Laws applicable in respect of the conduct of the Program, the ownership and conduct of the Business and the use of the Purchased Assets.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(b)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">No Equillium Person nor, to Equillium&#x2019;s Knowledge, any of their respective Representatives, has received since the Lookback Date any written notice, order or Action from any Governmental Authority alleging that any Equillium Person is not in compliance with any such Laws.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(c)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">No Equillium Person nor any of their respective officers, directors, principals or employees has:</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(i)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">offered, authorized, made or paid, directly or indirectly, any bribes, kickbacks or other similar payments or offers or transfers of value to any Government Official (or to another Person at the request or with the assent or acquiescence of such Government Official) in connection with obtaining or retaining business or to secure an improper advantage in connection with the Program or the Business; or</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(ii)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">directly or indirectly committed any violation of any applicable Law that relates to bribery, corruption or money laundering, such as the U.S. Foreign Corrupt Practices Act 1977, in connection with the Program or the Business.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(d)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Schedule 4.5</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> of the Disclosure Schedules sets forth a true and complete list of all material Permits necessary for each Equillium Person to own, lease and use the Purchased Assets and to carry on the Program as currently conducted. The Equillium Persons hold all such Permits and each Equillium Person is, and at all times since the Lookback Date has been, in compliance in all material respects with all such Permits. All such Permits are in full force and effect and no suspension, cancellation, modification, revocation or nonrenewal of any Permit is pending or threatened in writing. True and complete copies of such Permits in connection with the EQUATOR trial (and all amendments thereto) have been made available to Ono prior to the date of this Agreement.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(e)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">No Equillium Person has received any written notice, order or Action since the Lookback Date from any Governmental Authority alleging that any Equillium Person is not in compliance with any Permits referred to in Section 4.5(d).</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(f)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">No Equillium Person engages in (i) the design, fabrication, development, testing, production or manufacture of one or more &#x201c;critical technologies&#x201d; within the meaning of the U.S. Defense Production Act 1950, as amended, including all implementing regulations thereof (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">DPA</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;), (ii) the ownership, operation, maintenance, supply, manufacture or servicing of &#x201c;covered investment critical infrastructure&#x201d; within the meaning of the DPA (where such activities are covered by column 2 of Appendix A to 31 C.F.R. Part 800) or (iii) the maintenance or</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">31</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">281923888 v10</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">collection, directly or indirectly, of &#x201c;sensitive personal data&#x201d; of U.S. citizens within the meaning of the DPA.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.6	Litigation</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Except as set forth on </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Schedule 4.6</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> of the Disclosure Schedules, (i) there is no Action pending or threatened in writing in connection with the Program or the Business or any Equillium Person&#x2019;s conduct or ownership thereof and (ii) to Equillium&#x2019;s Knowledge, no such Action has been initiated since the Lookback Date.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(b)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">There is no Action pending or threatened in writing against any Equillium Person that would, or would be reasonably likely to, delay, restrain, prevent, enjoin or otherwise prohibit the execution, delivery or performance by Equillium of this Agreement or any of the other Transaction Documents to which it will be a party or consummation of the Transactions.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(c)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">There is no Order of, or investigation pending or threatened in writing by, any Governmental Authority relating to (i) the Program or the Business or any Equillium Person&#x2019;s conduct or ownership thereof or (ii) the Transactions.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(d)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">There is no Action by any Equillium Person pending, or which any Equillium Person intends to initiate, against any other Person in connection with the Program or the Business.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.7	Intellectual Property</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Except for Biocon&#x2019;s joint ownership interest in and to any Joint Inventions and Joint Patents or as set forth on </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Schedule 4.7(a)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> of the Disclosure Schedules, the Equillium Persons are the exclusive owners of all right, title and interest in and to the Transferred Intellectual Property, free and clear of all Encumbrances other than Permitted Encumbrances. No Equillium Person has transferred ownership of, or granted any exclusive license of, or exclusive right to use, or authorized the retention of any exclusive rights to use or joint ownership of, any Transferred Intellectual Property to any other Person.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(b)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">At the Closing, Ono will receive good, valid and marketable title to (i) the Transferred Intellectual Property, (ii) all Regulatory Materials, (iii) all Data and Program Know-How (including to the extent any of the foregoing is stored on any electronic medium) in the possession of or controlled by any Equillium Person and (iv) the assets set forth in Sections 3.1(b) and (h).</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(c)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Transferred Intellectual Property and the Biocon Technology constitute all the Intellectual Property used in connection with the Program.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(d)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Schedule 4.7(d)(i)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> of the Disclosure Schedules sets forth a complete and accurate list of all patent applications and patents owned by any Equillium Person that claim inventions that are primarily used or held for use in or necessary for the Program (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Listed Owned Patents</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) and identifies any Listed Owned Patents that are Joint Patents. To Equillium&#x2019;s Knowledge, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Schedule 4.7(d)(ii)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> of the Disclosure Schedules sets forth a complete and accurate list of all patents Controlled but not owned by any Equillium Person that claim inventions that are</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">32</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">281923888 v10</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">primarily used or held for use in or necessary for the Program (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Listed Licensed Patents</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; and, collectively with the Listed Owned Patents, the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Listed Patents</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;). Other than the Listed Patents, no Equillium Person owns or controls any patents that are primarily used or held for use in or necessary for the Program.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(e)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">All Listed Owned Patents and, to Equillium&#x2019;s Knowledge, all Listed Licensed Patents, have been duly filed and maintained, including the timely submission of all necessary filings and fees in accordance with the legal and administrative requirements of the appropriate Governmental Authority, and have not lapsed (other than lapsed provisional applications that have been converted to non-provisional applications), expired or been abandoned. No Equillium Person has received any written notice of any inventorship challenge, interference, invalidity or unenforceability with respect to any Listed Owned Patent or, to Equillium&#x2019;s Knowledge, the Listed Licensed Patents. All assignments of the Listed Owned Patents to each Equillium Person and proper documentation of chain of title thereto have been executed in writing and properly recorded with the applicable Governmental Entity, including the United States Patent and Trademark Office, in the name of the relevant Equillium Person. To Equillium&#x2019;s Knowledge, all assignments of the Listed Licensed Patents and proper documentation of chain of title thereto have been executed in writing and properly recorded with the applicable Governmental Authority, including the United States Patent and Trademark Office.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(f)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">There are no actions that are required to be taken (i) in the case of the representation and warranty made as of the date of this Agreement, within 90 days of the date of this Agreement or (ii) in the case of the representation and warranty made on the Closing Date, within 90 days of the Closing Date, with respect to the Listed Owned Patents or, to Equillium&#x2019;s Knowledge, the Listed Licensed Patents, including the payment of any registration, maintenance or renewal fees or the filing of any response to the United States Patent and Trademark Office actions or foreign equivalents.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(g)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">No Equillium Person is a party to any pending and served proceeding or, to Equillium&#x2019;s Knowledge, pending but not served proceeding or threatened proceeding, in which any Person is (i) contesting the right of any Equillium Person to use, exercise, sell, license, transfer or dispose of any Transferred Intellectual Property, Biocon Technology, the Compound, any Product or any right or interest in any of the foregoing or (ii) challenging the validity or enforceability of any Listed Owned Patent or the ownership of any Transferred Intellectual Property, and no Equillium Person has received any written communication threatening any such proceeding. To Equillium&#x2019;s Knowledge, there is no pending proceeding or proceeding that has been threatened in writing where any Person is (A) contesting the right of Biocon or any sublicensee of Biocon to use, exercise, sell, license, transfer or dispose of any Biocon Technology or any right or interest therein or (B) challenging the validity or enforceability of any Listed Licensed Patent, and, to Equillium&#x2019;s Knowledge, since the Lookback Date, no such proceeding has been threatened in writing. No Equillium Person is subject to any outstanding Order restricting in any manner the licensing, assignment, transfer, use or conveyance of the Transferred Intellectual Property or Biocon Technology or any right or interest therein by such Equillium Person.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(h)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Schedule 4.7(h)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> of the Disclosure Schedules lists all licenses, sublicenses and other agreements to which any Equillium Person is a party and pursuant to which any Person is</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">33</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">281923888 v10</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">granted (i) any right to Exploit the Compound or any Product, or to otherwise Exploit any Transferred Intellectual Property or Biocon Technology, (ii) any covenant not to assert/sue or other immunity from suit under or any other rights to, any Transferred Intellectual Property or Biocon Technology, (iii) any ownership right or title, whether actual or contingent, to any Transferred Intellectual Property or (iv) any option or right of first refusal relating to any Transferred Intellectual Property or Biocon Technology (collectively, &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Outbound Licenses</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;); provided that without prejudice to their status as &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Outbound Licenses</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Schedule 4.7(h)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> of the Disclosure Schedules need not list (1) non-disclosure agreements, (2) materials transfer agreements on customary terms, (3) Service Contracts or (4) the Development Agreement. Equillium has delivered or otherwise made available to Ono accurate and complete copies of all Outbound Licenses, and each Equillium Person is in compliance with all Outbound Licenses in all material respects.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(i)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Schedule 4.7(i)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> of the Disclosure Schedules lists all licenses, sublicenses and other agreements to which any Equillium Person is a party and pursuant to which any Third Party grants to any Equillium Person (i) any right to Exploit the Compound or any Product, or to otherwise Exploit any Transferred Intellectual Property or Biocon Technology, (ii) any covenant not to assert/sue or other immunity from suit under or any other rights to, any Intellectual Property claiming or covering the Exploitation of the Compound or any Product or Biocon Technology, (iii) any ownership right or title, whether actual or contingent, to any Intellectual Property claiming or covering the Exploitation of the Compound or any Product, or any other Transferred Intellectual Property or Biocon Technology or (iv) an option or right of first refusal relating to any Intellectual Property claiming or covering the Exploitation of the Compound or any Product, or any other Transferred Intellectual Property or Biocon Technology (collectively, &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Inbound Licenses</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;); provided that (x) without prejudice to their status as &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Inbound Licenses</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Schedule 4.7(i)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> of the Disclosure Schedules need not list (1) licenses for off-the-shelf software or generally available software, (2) non-disclosure agreements, (3) material transfer agreements on customary terms and (4) Service Contracts and (y) </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Schedule 4.7(i)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> of the Disclosure Schedules need not list, and Inbound Licenses do not include, invention assignment agreements with employees, consultants and contractors that assign or grant to any Equillium Person ownership of inventions and intellectual property developed in the course of providing services to any Equillium Person by such employees, consultants and contractors. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Schedule 4.7(i)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> of the Disclosure Schedules also identifies all Inbound Licenses requiring any Equillium Person to license, assign or otherwise grant rights to any other Person for any additions, modifications or improvements to any Transferred Intellectual Property made by or for any Equillium Person. Equillium has delivered or otherwise made available to Ono copies of all Inbound Licenses, and each Equillium Person is in compliance with all Inbound Licenses in all material respects.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(j)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Schedule 4.7(j)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> of the Disclosure Schedules lists all agreements for Development (including pre-clinical and clinical) or other services being provided by any Third Party related to the Program, the Compound or any Product (&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Service Contracts</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;), provided that, without prejudice to their status as &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Service Contracts</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Schedule 4.7(j)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> of the Disclosure Schedules need not list Standard Contracts. Equillium has delivered or otherwise made available to Ono copies of all Service Contracts (other than Standard Contracts), and each applicable Equillium Person is in compliance with all Service Contracts in all material respects. Equillium has provided Ono with access to (i) all material Data, (ii) to the extent existing in recorded form,</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">34</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">281923888 v10</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">all material Program Know-How and (iii) all material Biocon Data in any Equillium Person&#x2019;s possession in recorded form. Equillium has provided to Ono or made available current, true and complete copies of all Regulatory Materials.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(k)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Each Equillium Person&#x2019;s conduct of the Program and each Equillium Person&#x2019;s practice of any Transferred Intellectual Property or Biocon Technology has not infringed or misappropriated any Intellectual Property rights of any Person. No Equillium Person has received any written communication (i) alleging that the conduct of the Program or the practice of any Transferred Intellectual Property or Biocon Technology infringes or misappropriates the Intellectual Property rights of any Person or (ii) notifying such Equillium Person that the conduct of the Program or the practice of any Transferred Intellectual Property or Biocon Technology requires a license to any Person&#x2019;s Intellectual Property.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(l)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">No Equillium Person has brought any Action alleging: (i) infringement of any Transferred Intellectual Property or Biocon Technology; or (ii) breach of any Outbound License, and, to Equillium&#x2019;s Knowledge, there does not exist any fact which could reasonably form the basis of any such allegation of breach. No Equillium Person has entered into any agreement granting any third Person the right to bring infringement actions with respect to, or otherwise to enforce rights with respect to, any Transferred Intellectual Property or Biocon Technology.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(m)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Each Equillium Person has taken all commercially reasonable and customary measures and precautions necessary to protect and maintain the confidentiality of the Program Know-How and Biocon Know-How. Each Equillium Person has complied in all material respects with all applicable Laws pertaining to privacy and security of protected health information within the Clinical Data or the Regulatory Materials. No Equillium Person has received any written communication alleging any violation of such Laws.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(n)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Neither the execution, delivery or performance of this Agreement or the other Transaction Documents, nor the consummation of the Transactions, will (i) result in or give any other Person the right to cause a loss of, or Encumbrance, or restriction on any Transferred Intellectual Property, including any non-compete or similar restrictions related to the operation of the Program anywhere in the world, (ii) constitute a breach by any Equillium Person of any Inbound Licenses or Outbound Licenses, (iii) result in the grant, assignment or transfer to any other Person of any license or other rights or interests under any Transferred Intellectual Property or (iv) cause any modification, cancellation, termination, suspension of, or acceleration of any payment with respect to any Inbound License or Outbound License.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(o)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Each current or former employee, consultant and independent contractor employed by any Equillium Person or providing services related to the Program or the Transferred Intellectual Property has executed a valid and binding written agreement (i) expressly assigning to such Equillium Person all right, title and interest in any Transferred Intellectual Property invented, created, developed, conceived or reduced to practice during the term of such employee&#x2019;s employment or such consultant&#x2019;s or independent contractor&#x2019;s work related to the Transferred Intellectual Property and (ii) requiring each such employee, consultant or independent contractor to protect and preserve all confidential Transferred Intellectual Property and Third Party</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">35</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">281923888 v10</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">confidential information. Such assignments have either been directly assigned to Equillium or indirectly assigned to Equillium through intercompany agreements.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(p)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Except as set forth on </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Schedule 4.7(p)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> of the Disclosure Schedules, no Equillium Person has, and to Equillium&#x2019;s Knowledge, neither Biocon nor any of its sublicensees has (i) sought, applied for or received any support, funding, resources, materials or assistance from any Governmental Authority, university, college or other educational or non-profit institution or research center in connection with the Program or the creation or development of the Transferred Intellectual Property or (ii) used any facilities of any Governmental Authority, university, college or other educational institution or research center in connection with the Program or the creation or development of the Transferred Intellectual Property. To Equillium&#x2019;s Knowledge, no current or former employee who was in any way involved in (or has in any way contributed to) the Program or the creation or development of the Transferred Intellectual Property has performed services for any Governmental Authority, university, college or other educational or non-profit institution or research center during a period of time during which such employee was also performing services for any Equillium Person that could result in any adverse claim or right relating to the Transferred Intellectual Property. No Governmental Authority, university, college or other educational or non-profit institution or research center has (a) any claim of right to ownership of or other Encumbrances with respect to the Transferred Intellectual Property or (b) to Equillium&#x2019;s Knowledge, asserted in writing any such claim with respect to the Biocon Technology, in each case (a) and (b) other than Permitted Encumbrances.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.8	Regulatory Compliance</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The use of the Purchased Assets and the operation of the Program are in compliance in all material respects with all applicable Laws and there are no material violations of any such Laws.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(b)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Since the Lookback Date, Equillium has not received any written or, to Equillium&#x2019;s Knowledge, oral notice from any Regulatory Authority alleging any material non-compliance with any Laws applicable to the conduct of the Program.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(c)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">There are no Actions pending or threatened in writing or, to Equillium&#x2019;s Knowledge, orally by any Regulatory Authority which could reasonably be expected to prohibit or impede the conduct of the Program as currently conducted or contemplated to be conducted.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(d)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Equillium Persons have filed all forms, applications, notices, statements, reports, data and other information and documents required to be filed with any Regulatory Authority in connection with the conduct of the Program (collectively, the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Regulatory Filings</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;), and all such filings have been made in a timely manner, except where a failure to file timely could not reasonably be expected to have a Material Adverse Effect. No Equillium Person has made any materially false or misleading statements in, or, to Equillium&#x2019;s Knowledge, material omissions from, any Regulatory Filing. Equillium has delivered or made available to Ono true and complete copies of (i) the Regulatory Filings, including all supplements and amendments thereto and (ii) all material written communications to and from the FDA and each other Regulatory Authority.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">36</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">281923888 v10</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(e)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">To Equillium&#x2019;s Knowledge, the Regulatory Filings do not contain any materially false or misleading statements based on information provided by or on behalf of Biocon or its Affiliates.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(f)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">No officer, director, principal, employee or, to Equillium&#x2019;s Knowledge, any other Representative, in each case of any Equillium Person, has been excluded from participating in the Medicare program or any other program of a Governmental Authority. None of the officers, directors, agents or managing employees (as that term is defined in 42 U.S.C. &#167; 1320a 5(b)) of any Equillium Person have been excluded from participating in the Medicare program or any other program of any Governmental Authority or been subject to sanction pursuant to 42 U.S.C. &#167; 1320a 7a or 1320a 8 or been convicted of a criminal offense under the Anti-Kickback Statute (42 U.S.C. &#167; 1320a 7b). No employee or contractor of Equillium has been debarred by the FDA pursuant to section 306 of the FDCA (21 U.S.C. &#167; 335a) or has been convicted of a crime that could lead to debarment.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(g)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Each Equillium Person:</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(i)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">is and at all times has been in compliance with all Laws applicable to the Development, manufacture, packaging, processing, use, distribution, marketing, labeling, promotion, sale, offer for sale, storage, import, export, disposal or other Exploitation of the Compound or any Product;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(ii)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">has not received any FDA Form 483, notice of adverse finding, warning letter, untitled letter or other correspondence or notice from any Regulatory Authority alleging or asserting non-compliance with any Laws or Authorizations in connection with the Program;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(iii)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">possesses all Authorizations necessary for its conduct of the Program and no Equillium Person is in material violation of any such Authorization;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(iv)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">has not received notice of any Action from any Regulatory Authority or Third Party alleging that the Compound or any Product, the conduct of the Program or any other operation or activity related to the Compound or any Product is in violation of any Laws or Authorizations and, to Equillium&#x2019;s Knowledge, no Regulatory Authority or Third Party is considering any such Action;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(v)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">has not received notice that any Regulatory Authority has taken, is taking or intends to take any action to limit, suspend, modify or revoke any Authorization related to the Program; and</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(vi)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">has filed, obtained, maintained or submitted all material reports, documents, forms, notices, applications, records, claims, submissions and supplements or amendments with respect to the Program as required by any Laws or Authorizations, and all such reports, documents, forms, notices, applications, records, claims, submissions and supplements or amendments were materially complete and correct on the date filed (or were corrected or supplemented by a subsequent submission where required by applicable Law).</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">37</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">281923888 v10</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.9	Clinical Studies</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The preclinical studies and clinical trials of the Compound and the Products conducted by or on behalf of (i) any Equillium Person and (ii) to Equillium&#x2019;s Actual Knowledge, Biocon, in each case were and, if still ongoing, are being conducted in all material respects in accordance with experimental protocols, informed consents, procedures and controls pursuant to accepted professional scientific standards and all Laws and Authorizations applicable to such studies and trials, including the FDCA and the rules and regulations promulgated thereunder. All materials used in such trials complied with applicable Laws and Authorizations, and there have not been any material deficiencies or defects in such materials.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(b)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">No Equillium Person has received any notices or correspondence from any Regulatory Authority requiring the termination, suspension or material modification of any preclinical study or clinical trial of the Compound or any Product conducted by or on behalf of any Equillium Person. No Equillium Person has received any written or, to Equillium&#x2019;s Knowledge, oral communication from any Person threatening any Action against such Equillium Person arising from the administration of the Compound or any Product to any Person in the course of any clinical trial conducted by or on behalf of such Equillium Person.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.10	Acquired Contracts</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Contracts listed on </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Schedule 4.10</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> of the Disclosure Schedules represent all Core Contracts in effect as of the date of this Agreement. Equillium has delivered or made available to Ono true and complete copies of all Core Contracts, including any amendments or supplements thereto.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(b)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Acquired Contracts comprise all of the Contracts used in connection with the Program.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(c)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Each Acquired Contract is a legal, valid, binding and enforceable agreement of each relevant Equillium Person and, to Equillium&#x2019;s Knowledge, each other party thereto, subject to bankruptcy, insolvency, reorganization, moratorium and similar Laws relating to or affecting (i) creditors&#x2019; rights, (ii) general principles of equity or (iii) the availability of specific performance, injunctive relief and other equitable remedies, and is in full force and effect with respect to each relevant Equillium Person and, to Equillium&#x2019;s Knowledge, each other party thereto.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(d)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">No Equillium Person nor, to Equillium&#x2019;s Knowledge, any other party is in breach or violation of, or default under, any Acquired Contract (in each case with or without notice or lapse of time or both), nor has any Equillium Person given or received any written notice of any such breach, violation or default.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(e)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">No party to any Acquired Contract has initiated any Action in respect of any such Contract.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(f)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Immediately following the Closing, Ono will be permitted to exercise all of the rights of each Equillium Person under the Core Contracts to the same extent that each Equillium Person is permitted to exercise such rights immediately prior to the Closing without any payment</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">38</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">281923888 v10</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">of any additional amounts or consideration, other than as expressly set forth in the Core Contracts disclosed by Equillium to Ono before the date of this Agreement.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(g)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Equillium is not a party to any Contract, and is not in privity of contract, with any CIM Entity.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.11	CIM Contracts</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. To Equillium&#x2019;s Knowledge:</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other than as may be expressly set forth in the CIM Contracts disclosed by Equillium to Ono before the date of this Agreement, the consummation of the Transactions does not and will not (with or without notice or lapse of time or both) (A) result in any breach of, (B) constitute a default under, (C) require any consent or approval of or notice to any CIM Entity pursuant to, (D) give to any CIM Entity any express right of termination, amendment, modification, acceleration or cancellation of, (E) allow the imposition of any fees or penalties, require the offering or making of any payment to or give rise to any increased, guaranteed, accelerated or additional rights or entitlements of any CIM Entity in respect of or (F) result in the creation of any Encumbrance (other than Permitted Encumbrances) on any of the rights under, in each case any CIM Contract;</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(b)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">no party to any CIM Contract is in breach or violation of, or default under, any CIM Contract (in each case with or without notice or lapse of time or both), nor has any party to any CIM Contract given or received any written notice of any such breach, violation or default; and</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(c)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">no party to any CIM Contract has initiated any Action in respect of any such Contract.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.12	Books and Records</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. The Books and Records have been kept accurately in the Ordinary Course of Business, the transactions entered therein represent </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">bona fide</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> transactions and the Business and the revenues and expenses of each Equillium Person related thereto have been properly recorded in such Books and Records. The Books and Records are in good order and complete, and have been maintained in accordance with sound business practices.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.13	Insurance</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Each Equillium Person maintains, and has at all times maintained, in full force and effect insurance coverage for the Business that is customary for comparably situated companies.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.14	Affiliate Interests and Transactions</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Except as set forth on </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Schedule 4.14</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> of the Disclosure Schedules, and to Equillium&#x2019;s Knowledge, no Related Party of any Equillium Person: (i) owns or has owned, directly or indirectly, or has or has had any financial interest in, any of the Purchased Assets; or (ii) has or has had any business dealings or a financial interest in any transaction with any Equillium Person involving the Program, the Compound, any Product or any other part of the Business; except in any such Person&#x2019;s capacity as a holder of equity interests in Equillium.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.15	Brokers</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Except as set forth on </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Schedule 4.15</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> of the Disclosure Schedules, no broker, finder or investment banker is entitled to any brokerage, finder&#x2019;s or other fee or</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">39</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">281923888 v10</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">commission in connection with the Transactions based upon arrangements made by or on behalf of Equillium. No Contract set forth on </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Schedule 4.15</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> of the Disclosure Schedules provides for any brokerage, finder&#x2019;s or other fee or commission in connection with the Transactions in each case for which Ono or any of its Affiliates may become liable.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.16	Not Insolvent</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. No Equillium Person is insolvent or unable to make payments as and when they come due, nor has any Equillium Person suspended payments to its creditors, and no petition has been filed with respect to any Equillium Person for commencement of bankruptcy, civil rehabilitation, special liquidation or other insolvency proceedings (or other equivalent procedures), nor does any cause for such proceedings exist. The execution, delivery and performance by Equillium of this Agreement and each of the other Transaction Documents to which Equillium will be a party, and the consummation of the Transactions, will not cause any Equillium Person to become insolvent or to not make or suspend such payments.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.17	Taxes</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Each Equillium Person has paid all (i) Taxes required to be paid by it with respect to the Business or the Program and (ii) Taxes payable in connection with the entry into the Biocon Agreements. Each Equillium Person has withheld, collected and deposited all amounts with respect to the Business or the Program in accordance with applicable Tax Law.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(b)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Each Equillium Person has filed all Tax Returns that are required to be filed by it (taking into account any extensions of time to file) with respect to the Business and the Program. Insofar as such Tax Returns related to the Business or the Program, such Tax Returns were true, correct and complete in all material respects and were prepared in material compliance with all applicable Laws. No proposed adjustment, audit or administrative or judicial proceeding or other Action is pending or threatened in writing with respect to any Tax or Tax Return related to the Business or the Program. No written claim, deficiency or assessment of Tax has been asserted by any Governmental Authority with respect to the Business or the Program which claim, deficiency or assessment has not been fully satisfied, settled and resolved. No Equillium Person has waived or agreed to an extension of any statute of limitation in respect of Taxes with respect to the Business or the Program.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(c)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">There are no Encumbrances for Taxes (other than Encumbrances described in clause (a) of the definition of &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Permitted Encumbrances</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) upon any of the Purchased Assets.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(d)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">No written claim has been made by any Governmental Authority in a jurisdiction in which an Equillium Person does not file Tax Returns that such Equillium Person may be required to file Tax Returns in, or may be subject to taxation by, such jurisdiction with respect to the Business or the Program.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(e)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">No Equillium Person is a party to or bound by, or has any obligation under, any Tax allocation, Tax indemnity or Tax sharing agreement with respect to the Business or the Program.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">40</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">281923888 v10</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.	LIMITATIONS ON REPRESENTATIONS AND WARRANTIES OF EQUILLIUM</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.1	Independent Investigation</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Ono acknowledges that it has conducted, to its satisfaction, an independent investigation, review and analysis of the Program and the Purchased Assets and acknowledges that it has been provided adequate access to the personnel, properties, assets, premises, books and records, and other documents and data of the Equillium Persons for such purpose. Ono, together with its advisors, have such knowledge and expertise in financial and business matters as to be capable of evaluating the merits and risks of the transactions contemplated by this Agreement and the Ancillary Agreements. Ono is knowledgeable about the Program and Purchased Assets and about the usual and customary practices of companies engaged in businesses similar to such business and is able to independently evaluate its investment decision.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.2	No Other Representations and Warranties</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. The Parties acknowledge that no current or former stockholder, director, officer, employee, Affiliate, advisor or Representative of Equillium has made or is making any representations or warranties whatsoever regarding Equillium or the subject matter of this Agreement, express or implied. Except as expressly provided in (a) Article 4, (b) the Disclosure Schedules, (c) any other Transaction Document or (d) any certificate delivered in accordance with this Agreement or any other Transaction Document, Equillium has not made and is not making, and Ono is not relying upon, any representations or warranties whatsoever regarding the Purchased Assets, the Program, any Equillium Person or the subject matter of this Agreement, express or implied. No current or former stockholder, director, officer, employee, Affiliate, advisor or Representative of Equillium or any of its Affiliates shall have any liability of any nature to any Ono Indemnified Party with respect to the breach by Equillium of any representation, warranty, covenant or agreement contained in this Agreement.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.3	Projections</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. In connection with the due diligence investigation by Ono, its Affiliates and their respective Representatives, Ono, its Affiliates and their respective Representatives have received and may continue to receive after the date of this Agreement from the Equillium Persons and their respective Representatives certain estimates, projections, forecasts and other forward-looking information, as well as certain business plan information, regarding the Purchased Assets, the Program and their operations. Ono hereby acknowledges that there are uncertainties inherent in attempting to make such estimates, projections, forecasts and other forward-looking statements, as well as in such business plans. Accordingly, Ono hereby acknowledges and agrees that, except for or in respect of the representations and warranties expressly set forth in Article 4, the Disclosure Schedules or any other Transaction Document, no Equillium Person nor any of their respective Representatives or stockholders (a) has made or is making any express or implied representation or warranty with respect to or (b) shall have any liability with respect to, in each case such estimates, projections, forecasts, forward-looking statements or business plans.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.4	As-Is</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Except as otherwise set forth in this Agreement or in any other Transaction Document, the Business is being sold and transferred to Ono on an &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">as is</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; basis and except as set forth in this Agreement or in any other Transaction Document, all warranties, express or implied, including warranties of merchantability and fitness for use, are excluded from the sale and transfer of the Business.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">41</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">281923888 v10</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.5	Disclosure Schedules</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. The Disclosure Schedules have been arranged, for purposes of convenience only, as separate parts corresponding to the subsections of Article 4. The representations and warranties contained in Article 4 are subject to (a) the exceptions and disclosures set forth in the part of the Disclosure Schedules corresponding to the particular subsection of Article 4 in which such representation and warranty appears, (b) any exceptions or disclosures explicitly cross-referenced in such part of the Disclosure Schedules by reference to another part of the Disclosure Schedules and (c) any exception or disclosure set forth in any other part of the Disclosure Schedules to the extent it is reasonably apparent on the face of such disclosure that such exception or disclosure is intended to qualify another part of the Disclosure Schedules. No reference to or disclosure of any item or other matter in the Disclosure Schedules shall be construed as an admission or indication that such item or other matter is material (nor shall it establish a standard of materiality for any purpose whatsoever) or that such item or other matter is required to be referred to or disclosed in the Disclosure Schedules. The information set forth in the Disclosure Schedules is disclosed solely for the purposes of this Agreement, and no information set forth therein shall be deemed to be an admission by either Party to any Third Party of any matter whatsoever, including of any violation of law or breach of any agreement.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6.	REPRESENTATIONS AND WARRANTIES OF ONO</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Ono makes the following representations and warranties to Equillium (a) on the date of this Agreement, as of such date and (b) on the Closing Date, as of such date:</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6.1	Organization</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Ono is a corporation duly organized, validly existing and in good standing under the laws of Japan and has all requisite corporate power and authority to carry on its business as now conducted. Ono is duly qualified to transact business and is in good standing in each jurisdiction in which the failure to be so qualified or in good standing could reasonably be expected to materially impair the ability of Ono to consummate, or prevent or materially delay, any of the Transactions.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6.2	Authority</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Ono has full corporate power and authority to execute and deliver this Agreement and each of the other Transaction Documents to which it will be a party, to perform its obligations hereunder and thereunder and to consummate the Transactions. The execution, delivery and performance by Ono of this Agreement and each of the other Transaction Documents to which it will be a party and the consummation by Ono of the Transactions have been duly and validly authorized by all necessary corporate action. This Agreement has been, and upon their execution each of the other Transaction Documents to which Ono will be a party will have been, duly executed and delivered by Ono and, assuming due execution and delivery by each of the other parties hereto and thereto, this Agreement constitutes, and upon their execution each of the other Transaction Documents to which Ono will be a party will constitute, the legal, valid and binding obligations of Ono, enforceable against Ono in accordance with their respective terms subject to bankruptcy, insolvency, reorganization, moratorium and similar Laws relating to or affecting (a) creditors&#x2019; rights, (b) general principles of equity or (c) the availability of specific performance, injunctive relief and other equitable remedies.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6.3	No Conflict; Required Filings and Consents</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">42</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">281923888 v10</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The execution, delivery and performance by Ono of this Agreement and each of the other Transaction Documents to which Ono will be a party, and the consummation of the Transactions, do not and will not (with or without notice or lapse of time or both):</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(i)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">conflict with or violate Ono&#x2019;s Constituent Documents;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(ii)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">conflict with or violate any Law or Permit applicable to Ono; or</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(iii)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(A) result in any breach of, (B) constitute a default under or (C) require any consent of any Person pursuant to, any Contract to which Ono is a party;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">except for any such conflicts, violations, breaches, defaults or other occurrences that could not reasonably be expected to, individually or in the aggregate, materially impair the ability of Ono to consummate, or prevent or materially delay, any of the Transactions.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(b)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Subject to the satisfaction of the condition set forth in Section 10.3(c), Ono is not required to file, seek or obtain any notice, authorization, approval, order, permit, consent or other Permit of or with any Governmental Authority in connection with the execution, delivery and performance by Ono of this Agreement or any of the other Transaction Documents to which it will be party or the consummation of the Transactions, except for (i) the filing of post-fact foreign exchange reports required under Japanese law and (ii) such Permits the failure of which to file, seek or obtain would not reasonably be expected to, individually or in the aggregate, materially impair the ability of Ono to consummate, or prevent or materially delay, any of the Transactions.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6.4	Litigation</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. There is no Action pending or threatened in writing against Ono that would, or would be reasonably likely to, delay, restrain, prevent, enjoin or otherwise prohibit the execution, delivery or performance by Ono of this Agreement or any of the other Transaction Documents to which it will be a party or consummation of the Transactions.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6.5	Financing</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Ono has, or will have at the Closing, sufficient funds on hand and available through existing liquidity facilities (without restrictions on drawdown that would cause late payment of the Closing Payment or any Milestone Payment) to permit Ono to consummate the Transactions.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6.6	Brokers</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. No broker, finder or investment banker is entitled to any brokerage, finder&#x2019;s or other fee or commission in connection with the Transactions based upon arrangements made by or on behalf of Ono.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6.7	Not Insolvent</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Ono is not insolvent or unable to make payments as and when they come due, nor has Ono suspended payments to its creditors, and no petition has been filed with respect to Ono for commencement of bankruptcy, civil rehabilitation, special liquidation or other insolvency proceedings (or other equivalent procedures), nor does any cause for such proceedings exist. The execution, delivery and performance by Ono of this Agreement and each of the other Transaction Documents to which Ono will be a party, and the consummation of the Transactions, will not cause Ono to become insolvent or to not make or suspend such payments.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">43</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">281923888 v10</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7.	COVENANTS</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7.1	Conduct of Business Prior to the Closing</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Between the date of this Agreement and the Closing Date, except (x) as set forth on </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Schedule 7.1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> of the Disclosure Schedules as of the date of this Agreement, (y) as otherwise required or expressly permitted by this Agreement (including Article 8), any other Transaction Document, any Acquired Contract disclosed to Ono before the date of this Agreement or applicable Law (including COVID-19 Measures) or (z) with the prior written consent of Ono (which consent shall not be unreasonably conditioned, withheld or delayed) (each of (x) to (z), an &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Excepted Circumstance</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;), Equillium shall use commercially reasonable efforts to (a) cause the Program and the Business to be conducted in the ordinary course consistent with past practice and in compliance in all material respects with applicable Law and in accordance with Article 8, (b) preserve substantially intact the Program and the Purchased Assets and (c) maintain satisfactory relationships of the Program with its material suppliers and other Persons with which the Program has material business relations. It is acknowledged and agreed that any reasonable COVID-19 Measure adopted in good faith by any Equillium Person in response to the effects of COVID-19 will not be deemed to violate or breach the foregoing obligations.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7.2	Restricted Actions</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. By way of amplification of Section 7.1 and not limitation, between the date of this Agreement and the Closing Date, Equillium shall not, and shall cause that none of its Subsidiaries shall, do or propose to do, directly or indirectly, any of the following in connection with the Program or the Business except in an Excepted Circumstance:</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">issue, sell, pledge, dispose of or otherwise subject to any Encumbrance (other than Permitted Encumbrances) any Purchased Assets;</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(b)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">amend, waive, modify, grant any material consent under or terminate any Core Contract, or amend, waive, modify, consent to the termination of or terminate Equillium&#x2019;s rights thereunder, in each case other than in the ordinary course of business consistent with past practice;</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(c)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">cancel, compromise, settle, waive or release any material right, claim or Action relating to the Program or the Business, other than in the ordinary course of business;</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(d)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">terminate any Biocon Agreement;</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(e)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">commence any Action relating to the Program or the Business, other than in good faith and in the Ordinary Course of Business, provided that if any Action is proposed to be commenced in respect of any Biocon Agreement or otherwise against Biocon, Equillium shall (i) provide Ono with reasonable prior written notice, which notice shall not be less than 30 days prior to commencing such Action, (ii) provide Ono with a reasonable opportunity to discuss the matter with Equillium and (iii) consider in good faith Ono&#x2019;s views in respect thereof;</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(f)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">permit the lapse of any existing policy of insurance relating to the Program or the Business without the purchase of a substantially similar policy;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">44</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">281923888 v10</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(g)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">permit the lapse of, abandon or cease prosecution or maintenance of any material right relating to Transferred Intellectual Property, provided that the foregoing shall not be construed to prohibit ordinary course prosecution actions with respect to Program Patents, including amending, or agreeing to amend, the scope of a claim of a pending patent application within such Program Patents, or filing a terminal disclaimer with respect to or abandoning a claim of a pending patent application within such Program Patents in favor of a related claim contained in another patent application filed by or on behalf of Equillium that would constitute a Program Patent;</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(h)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">permit the lapse of, abandon or cease prosecution or maintenance of any Biocon Patent in the Equillium Territory or any Joint Patent, provided that the foregoing shall not be construed to prohibit ordinary course prosecution actions with respect to any Biocon Patent in the Equillium Territory or any Joint Patent, including amending, or agreeing to amend, the scope of a claim of a pending patent application within any Biocon Patent in the Equillium Territory or any Joint Patent, or filing a terminal disclaimer with respect to or abandoning a claim of a pending patent application within any Biocon Patent in the Equillium Territory or any Joint Patent in favor of a related claim contained in another patent application filed by or on behalf of Equillium in the Equillium Territory that would constitute a Biocon Patent or another patent application filed by or on behalf of Equillium that would constitute a Joint Patent;</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(i)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">except as expressly permitted by Section 7.2(g) or Section 7.2(h), cancel, compromise, settle, waive or release any material right, claim or Action relating to the Transferred Intellectual Property, any Biocon Patent in the Equillium Territory or any Joint Patent; or</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(j)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">announce an intention, enter into any formal or informal agreement, authorize or otherwise make a commitment to do any of the foregoing;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> that Equillium may [***].</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7.3	No Transfer of Control</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Notwithstanding Sections 7.1 and 7.2, nothing contained herein shall give to Ono, directly or indirectly, rights to control or direct the operations of Equillium prior to the Closing. Until the Closing, each Party shall exercise, consistent with and subject to the terms and conditions hereof, complete control and supervision of its operations.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7.4	Covenants Regarding Information</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Subject to </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 7.4(b)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, from the date hereof through the earlier of the Closing Date and the termination of this Agreement pursuant to Article 12, Equillium shall afford Ono and its Representatives, at Ono&#x2019;s sole cost and expense, reasonable access (including for inspection and copying) at reasonable times to the Business and each Equillium Person&#x2019;s Representatives, properties, offices, plants and other facilities and books and records relating to the Program and the Business, and shall disclose to Ono such operating and other data and information in connection with the Program and the Business as Ono may reasonably request.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(b)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Equillium&#x2019;s obligations under Section 7.4(a) shall be subject to the following limitations:</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">45</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">281923888 v10</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(i)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Equillium may limit access or refuse to disclose any data or information to the extent that doing so could reasonably be expected to cause (A) a loss of any applicable privileges (including attorney-client privilege) or trade secrets or (B) a breach of any confidentiality obligations under any Contract disclosed to Ono before the date of this Agreement or applicable Law; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided, however,</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> that Equillium shall cooperate with Ono to develop substitute arrangements, to the extent reasonably possible, to allow for such access or disclosure in a manner that does not result in such loss or breach.</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(ii)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The auditors and independent accountants of Equillium shall not be obligated to make any work papers available to any Person unless and until such Person has signed a customary confidentiality and hold harmless agreement relating to access to such work papers in form and substance reasonable acceptable to such auditors or independent accountants.</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(iii)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For so long as any applicable COVID-19 Measures are in effect, each Equillium Person shall be permitted to provide access through virtual or other remote means.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(c)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On the Closing Date, Equillium shall deliver or cause to be delivered to Ono all agreements, documents, books and records and files primarily related to, or otherwise necessary for the Exploitation of, the Program, the Compound, any Product or the Business, and all computer disks, records, tapes and any other storage medium on which any such agreements, documents, books and records or files are stored, that are in the possession of or under the control of any Equillium Person (such information, the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Transferred Information</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;).</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(d)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Following the Closing Date, Equillium shall not, and shall cause that none of its Subsidiaries shall, retain in its possession or under its control, in any form, any Transferred Information; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided, however,</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> that (i) Equillium shall be entitled to retain in its possession or under its control (A) such copies of Transferred Information as are required to be maintained for insurance purposes or by Law and (B) in any event a single copy of all Transferred Information in its secure files as necessary for Equillium to monitor its compliance with, and to monitor and enforce Ono&#x2019;s compliance with, the Parties&#x2019; respective obligations under the Transaction Documents and the Biocon Agreements, and (ii) no Equillium Person shall be required to destroy any computer files stored securely by it that are created pursuant to such Person&#x2019;s standard and automatic backup or archival procedures. If Equillium discovers following the Closing Date that it or any of its Subsidiaries is in possession of or has under its control any such Transferred Information (other than copies thereof that Equillium is permitted to retain as set forth above), Equillium shall (a) deliver to Ono any such information and (b) thereafter delete and erase, or cause the deletion or erasure, of all such information as soon as reasonably practicable, except as otherwise required by Law or to the extent that such information is included in computer files stored securely by Equillium or any of its Subsidiaries that are created pursuant to such Person&#x2019;s standard and automatic backup or archival procedures. For the avoidance of doubt, any information retained by any Equillium Person in accordance with any exception set forth in this Section 7.4(d) shall be subject to the restrictions set forth in Section 7.7.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7.5	Notification of Certain Matters</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Each Party shall give prompt written notice to the other Party of:</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">46</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">281923888 v10</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(i)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the occurrence or non-occurrence of any change, condition or event, the occurrence or non-occurrence of which would cause a breach of a representation or warranty or covenant of such notifying Party contained in this Agreement, which breach would cause, in the case Equillium is such notified Party, any of the conditions to the obligations of Equillium to consummate the Closing set forth in Section 10.1 or Section 10.2, or in the case Ono is such notified Party, any of the conditions to the obligations of Ono to consummate the Closing set forth in Section 10.1 or Section 10.3, not to be satisfied;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(ii)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the receipt of any written notice or other communication from any Person alleging that the consent of such Person is or may be required in connection with the consummation of the Transactions; and</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(iii)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">any Action pending or threatened in writing against such notifying Party or the Parties relating to the Transactions.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(b)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Until the Closing Date, if any change, condition or event occurs or arises after the date of this Agreement that could reasonably be expected to (i) cause any of the conditions to the obligations of Ono to consummate the Closing set forth in (A) Section 10.3(a) not to be satisfied as a result of a breach or inaccuracy of any Fundamental R&amp;W or any representation and warranty set forth in Section 4.5(b), (c) or (e), 4.6, 4.7(g) or (k), 4.8(b), (c), (f) or (g)(ii), (iv) or (v), 4.9(b), 4.10(e) (solely with respect to Core Contracts) or 4.16 or (B) Section 10.3(b) not to be satisfied, then Equillium shall promptly (and in any case [***] of the date that Equillium becomes aware, to Equillium&#x2019;s Knowledge, of a relevant change, condition or event) or (ii) otherwise cause any of the conditions to the obligations of Ono to consummate the Closing set forth in Section 10.3(a) not to be satisfied, then Equillium shall within [***] of [***] in which the relevant change, condition or event occurs or arises, in each case provide Ono with written notice (email being sufficient) of such change, condition or event (each such notice, an &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Update Notice</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;). Except as provided in Section 2.4, no Update Notice nor any information Ono may otherwise obtain from Equillium or any other Person shall be deemed to cure any breach of any representation or warranty made in this Agreement or any other Transaction Document or have any effect for purposes of determining Equillium&#x2019;s satisfaction of the conditions set forth in Section 10.1 and Section 10.3 or liability under Section 11.2(a).</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7.6	Exclusivity</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Except as otherwise consented to by Ono in writing (not to be unreasonably withheld, conditioned or delayed) or, subject to Section 13.13(b), in circumstances that will involve (x) a merger or consolidation of all of Equillium&#x2019;s business into the business of another Person or (y) a sale of all of the Program and the Purchased Assets together with all or substantially all of Equillium&#x2019;s other business ((x) and (y) each an &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Equillium Change of Control</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;), Equillium agrees that prior to Closing, Equillium shall not, and shall take all action necessary to ensure that none of its Subsidiaries or any of its or their respective Representatives shall, and shall not authorize its Subsidiaries or any of its or their respective Representatives to, directly or indirectly:</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(i)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">solicit, initiate, consider, knowingly encourage, knowingly facilitate the making of or accept any other proposals or offers from any Person relating to any direct or indirect</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">47</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">281923888 v10</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">sale, purchase, transfer, lease, license or other disposition of all or any portion of the Program or the Purchased Assets, other than (A) as expressly permitted by Section 7.1, (B) disposal of inventory of the Compound and Products in the ordinary course of business consistent with past practice or (C) non-exclusive licenses granted to Third Party service providers of any Equillium Person in connection with provision of services to any Equillium Person in the ordinary course of business; or</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(ii)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">participate in any discussions, conversations, negotiations or other communications regarding, or furnish to any other Person any information with respect to, or otherwise cooperate in any way with, assist or participate in, knowingly facilitate or encourage any effort or attempt by any other Person to seek to do, any of the foregoing.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(b)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Equillium shall, and shall cause its Subsidiaries and its and their respective Representatives to, immediately cease and cause to be terminated all existing discussions, conversations, negotiations and other communications with any Persons conducted heretofore with respect to any of the foregoing promptly after the date hereof (and in any case no later than [***]after the date hereof).</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(c)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Without limiting Section 7.6(a), if any Equillium Person or any of their respective Representatives receives any proposal or offer referred to in Section 7.6(a)(i), Equillium shall promptly (and in any case no later than [***] following such receipt) notify Ono in writing of such proposal or offer and the material terms and conditions thereof; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">that</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> no such notice shall be required with respect to an Equillium Change of Control.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7.7	Confidentiality</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a)	Confidential Information</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. For the purposes of this Agreement, subject to Section 7.7(c), &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Confidential Information</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means:</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(i)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the Program Confidential Information;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(ii)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">any information and materials other than the Program Confidential Information disclosed or furnished to one Party (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Receiving Party</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) by or on behalf of the other Party (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Disclosing Party</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) pursuant to or in connection with this Agreement; and</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(iii)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the terms of this Agreement and each other Transaction Document.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(b)	Ownership of Confidential Information</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. In respect of the Confidential Information:</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(i)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">that constitutes Program Confidential Information (A) Equillium shall be deemed to be the &#x201c;Disclosing Party&#x201d; until the Closing and the &#x201c;Receiving Party&#x201d; from the Closing and (B) Ono shall be deemed to be the &#x201c;Receiving Party&#x201d; until the Closing and the &#x201c;Disclosing Party&#x201d; from the Closing; and</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(ii)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">referred to in Section 7.7(a)(iii), each Party shall be deemed both a &#x201c;Disclosing Party&#x201d; and a &#x201c;Receiving Party&#x201d;.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">48</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">281923888 v10</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(c)	Exceptions</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Except in respect of Program Confidential Information from the Closing (which shall in all cases constitute Confidential Information of Ono from the Closing), Confidential Information shall not include any information which the Receiving Party can prove by competent written evidence:</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(i)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">is now, or hereafter becomes, through no breach of this Section 7.7 on the part of the Receiving Party or any of its Affiliates or its or their respective Representatives, generally known or available;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(ii)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">is known by the Receiving Party at the time of receiving such information from the Disclosing Party;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(iii)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">is hereafter furnished to the Receiving Party or any of its Affiliates by a Third Party, as a matter of right and without restriction on disclosure; or</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(iv)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">is independently discovered or developed by the Receiving Party or any of its Affiliates without the use or knowledge of, or reference to, Confidential Information of the Disclosing Party.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(d)	Treatment of Confidential Information</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Subject to Section 7.7(e), the Receiving Party shall, and shall cause its Affiliates and its and their respective Representatives to, disclose or use Confidential Information of the Disclosing Party only to the extent required to accomplish the purposes of the Transaction Documents. The Receiving Party shall use at least the same standard of care as it uses to protect proprietary or confidential information of its own (but in no event less than reasonable care) to ensure that its Affiliates and its and their respective Representatives do not make any unauthorized disclosure or unauthorized use of such Confidential Information. The Receiving Party shall promptly notify the Disclosing Party upon discovery of any unauthorized disclosure or unauthorized use of the Disclosing Party&#x2019;s Confidential Information.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(e)	Authorized Disclosure</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. The Receiving Party may disclose or use Confidential Information of the Disclosing Party if and to the extent such disclosure or use is reasonably necessary in the following instances:</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(i)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">disclosure to its Affiliates and its and their respective Representatives in relation to the negotiation, entry into or performance of the Transaction Documents or any matter arising out of the same, provided that such Persons are informed of the confidential nature of such information and of the Receiving Party&#x2019;s obligations under this Section 7.7;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(ii)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">prosecuting or defending litigation as permitted by any Transaction Document;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(iii)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">complying with applicable Law or the rules of any applicable stock exchange;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">49</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">281923888 v10</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(iv)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">in the case of Equillium as the Receiving Party, disclosure to Biocon to the extent required to comply with Equillium&#x2019;s obligations under the Biocon Agreements; or</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(v)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">issuing any press release or making any public statement in accordance with Section 7.9,</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided, however,</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> that if the Receiving Party is required to disclose or use the Disclosing Party&#x2019;s Confidential Information pursuant to clause (ii) or (iii), it will, except where prohibited by applicable Law, (A) give reasonable advance notice to the Disclosing Party of such disclosure or use, (B) use efforts to secure confidential treatment of such information at least as diligent as the Receiving Party would use to protect its own confidential information, but in no event less than commercially reasonable efforts and (C) cooperate with any efforts by the Disclosing Party, at the Disclosing Party&#x2019;s request and expense, to secure confidential treatment of such Confidential Information. Disclosure or use by the Receiving Party of Confidential Information in accordance with this Section 7.7(e) shall not, in and of itself, cause the information so disclosed or used to cease to be treated as Confidential Information under this Agreement, except to the extent that, by virtue of disclosure by the Receiving Party in full compliance with this Section 7.7(e), such information becomes generally known or available. The Parties shall consult with each other on the provisions of the Transaction Documents to be redacted in any filings made by the Parties with any Governmental Authority or as otherwise required by Law or the rules of any applicable stock exchange.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(f)	Term</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. This Section 7.7 shall apply until the date [***] from the date of this Agreement.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(g)	Return or Destruction</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. In the event that this Agreement is terminated prior to the Closing, each Party shall, and shall use its commercially reasonable efforts to cause its Affiliates and its and their respective Representatives to, promptly return to the applicable Party or destroy all documents (including all copies thereof) containing any such information or data; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided, however,</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> that neither Party shall be required to destroy any computer files stored securely by it that are created pursuant to such Party&#x2019;s standard and automatic backup or archival procedures; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided, further</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">however</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, that such information shall continue to be deemed Confidential Information.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(h)	Prior Non-Disclosure Agreements</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. As of the date of this Agreement, the terms of this Section 7.7 shall supersede the Mutual Non-Disclosure Agreement between the Parties dated [***](the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Confidentiality Agreement</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;). All &#x201c;Confidential Information&#x201d; (as defined in the Confidentiality Agreement) of a Party under the Confidentiality Agreement shall be deemed to have been disclosed under this Agreement and shall, subject to Section 7.7(b), constitute Confidential Information of such Party for the purposes of this Section 7.7.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7.8	Consents and Filings</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a)	Efforts to Close</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Subject to Ono having exercised the Purchase Option in accordance with Section 2.3, the Parties shall use all commercially reasonable efforts to take, or cause to be taken, all appropriate action to do, or cause to be done, all things necessary, proper or</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">50</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">281923888 v10</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">advisable under applicable Law or otherwise to satisfy the conditions set forth in Article 10 and consummate and make effective the Transactions as promptly as practicable.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(b)	Competition Clearance</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. In furtherance and not in limitation of Section 7.8(a), to the extent necessary to cause the satisfaction of the condition set out in Section 10.3(c), the Parties shall cooperate fully with each other, including by (i) making all filings, draft filings and notifications, to the extent applicable, to each relevant Governmental Authority as soon as reasonably practicable after the date of Ono&#x2019;s delivery of the Purchase Option Exercise Notice (and in any case, no later than  [***]after the delivery of such Notice, unless applicable Law requires an earlier filing), (ii) promptly providing the other with copies of all material written communications and the details of all material non-written communications from or with any such Governmental Authority, (iii) promptly notifying the other of any material communication from or with any such Governmental Authority, (iv) sharing in advance and considering in good faith the views of the other regarding all submissions to any such Governmental Authority and (v) promptly complying, to the extent necessary and reasonable, with any request for information from any such Governmental Authority, including any request for additional information and documentary material under the HSR Act and in any event in accordance with any relevant time limit. Nothing in this Section 7.8(b) shall require either Party to share information, documents or communications with the other if it is prohibited from doing so by the relevant Governmental Authority or otherwise by applicable Law.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(c)	Defense of Actions</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. In furtherance and not in limitation of Sections 7.8(a) and (b), in the event of any Action by a Governmental Authority to investigate or any Action by a Governmental Authority or other Third Party to challenge the Transactions under applicable Law, the Parties shall cooperate fully with each other, including by promptly providing the other with copies of all communications received and sharing in advance and considering in good faith the views of the other regarding all submissions, and shall use their respective commercially reasonable efforts in the defense of any such Action, and Equillium shall not settle or compromise any such Action without Ono&#x2019;s written consent.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(d)	No Adverse Action</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Notwithstanding anything herein to the contrary, Ono shall not be required by this Section 7.8 to take any action or agree to enter into any consent decree, hold separate order or other arrangement, that would (i) require the divestiture of any assets of Ono or any of its Affiliates or any portion of the Program or the Purchased Assets, (ii) require the termination of or adverse amendment of any Contract or (iii) limit Ono&#x2019;s freedom of action with respect to, or its ability to consolidate and control, any assets of Ono or any of its Affiliates or the Compound, any Product or any portion of the Program or the Purchased Assets.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7.9	Public Announcements</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. The Parties shall consult with each other before issuing any press release or otherwise making any public statements with respect to this Agreement or the Transactions. Neither Party shall issue any press release or make any public statement with respect to this Agreement or the Transactions prior to obtaining the other Party&#x2019;s written approval (which approval shall not be unreasonably withheld, conditioned or delayed), except that no such approval shall be required to the extent disclosure may be required by or advisable under applicable Law, including applicable securities Laws, or the listing requirements of any exchange on which securities of such Party are listed or traded.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">51</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">281923888 v10</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7.10	Books and Records</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. From and after the Closing Date, Ono shall preserve and retain all books and records relating to the Program or Purchased Assets for the longer of (a) [***] or (b) the period for which such books and records must be retained under applicable Law. In connection therewith, from and after the Closing Date, Ono shall make available to Equillium during normal business hours and upon reasonable prior written notice, but without unreasonably disrupting Ono&#x2019;s business, access to such books and records to the extent necessary to permit Equillium or its Affiliates to respond to any Third Party subpoena, examination or audit.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7.11	Transfer of Regulatory Materials</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Prior to the Closing, the Parties shall agree upon procedures to (i) transfer the Regulatory Materials from Equillium to Ono from the perspective of the applicable Regulatory Authorities and (ii) ensure a smooth transition from Equillium to Ono of all of the activities required to be undertaken by the holder of the Regulatory Materials, including adverse event reporting, annual reports to the FDA, handling and tracking of complaints and communications with investigators.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(b)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Following good faith consultations with Equillium, Ono shall deliver notice in writing to Equillium specifying the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Regulatory Materials Transfer Date</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;, which date shall be (i) no earlier than (A) the [***] or (B) [***] after the date of delivery of such notice and (ii) no later than [***] after the Closing Date. Subject to Section 7.11(d), on the Regulatory Materials Transfer Date, Equillium shall (x) send letters (in form and substance reasonably satisfactory to Ono) to the applicable Regulatory Authorities, including for the purposes of the matters set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Schedule 4.3(a)(ii)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> of the Disclosure Schedules, indicating that the Regulatory Materials have been transferred to Ono and that Ono is the new owner of the Regulatory Materials as of the Closing Date and (y) provide to Ono a copy of said letters.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(c)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Until the Regulatory Materials Transfer Date, Equillium shall be responsible for maintaining the Regulatory Materials, at Equillium&#x2019;s sole cost and expense. After such date, Ono will assume all responsibility for the Regulatory Materials, at Ono&#x2019;s sole cost and expense.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(d)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7.12	Communication with Agencies</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Until the Regulatory Materials Transfer Date, Equillium shall have responsibility for all communications with the applicable Regulatory Authorities relating to the Compound and each Product, and Equillium shall promptly provide Ono with copies of all communications to or from the applicable Regulatory Authorities with respect to the Compound or any Product and/or the manufacture thereof. After such date, Ono shall have responsibility for all such communications.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7.13	Adverse Experience Reporting</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Until the Regulatory Materials Transfer Date, Equillium shall be responsible for the adverse experience and safety reporting to the applicable Regulatory Authorities for each Product in compliance with the requirements of applicable Law. After such date, Ono shall assume such responsibility.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">52</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">281923888 v10</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7.14	Delivery of Assets</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Equillium shall deliver, or shall cause to be delivered, all non-physical Purchased Assets to Ono at the Closing in a format and manner as reasonably requested by Ono prior to the Closing Date.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7.15	Regulatory Compliance</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Until the Closing, Equillium shall ensure that:</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the use of the Purchased Assets and the operation of the Program comply in all material respects with all applicable Laws;</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(b)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(i) the Equillium Persons file all Regulatory Filings in a timely manner, except where a failure to file timely could not reasonably be expected to have a Material Adverse Effect and (ii) no Equillium Person makes any materially false or misleading statements in, or knowingly causes any material omissions from, any Regulatory Filing;</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(c)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(i) no officer, director, principal, employee or any other Representative, in each case of any Equillium Person, is excluded from participating in the Medicare program or any other program of a Governmental Authority, (ii) none of the officers, directors, agents or managing employees (as that term is defined in 42 U.S.C. &#167; 1320a 5(b)) of any Equillium Person are excluded from participating in the Medicare program or any other program of any Governmental Authority or become subject to sanction pursuant to 42 U.S.C. &#167; 1320a 7a or 1320a 8 or become convicted of a criminal offense under the Anti-Kickback Statute (42 U.S.C. &#167; 1320a 7b) and (iii) no employee or contractor of Equillium is debarred by the FDA pursuant to section 306 of the FDCA (21 U.S.C. &#167; 335a) or is convicted of a crime that could lead to debarment;</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(d)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the Regulatory Filings do not contain, to Equillium&#x2019;s Knowledge, any materially false or misleading statements based on information provided by or on behalf of Biocon or its Affiliates; and</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(e)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">each Equillium Person:</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(i)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">complies at all times with all Laws applicable to the Development, manufacture, packaging, processing, use, distribution, marketing, labeling, promotion, sale, offer for sale, storage, import, export, disposal or other Exploitation of the Compound or any Product;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(ii)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> (A) possesses at all times all Authorizations necessary for its conduct of the Program and (B) does not materially violate any such Authorizations;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(iii)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ensures that the Compound and each Product, the conduct of the Program and each other operation and activity related to the Compound or any Product is not in material violation of any Laws or Authorizations;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(iv)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">does not carry out any act or omission that may cause a Regulatory Authority to take any action to limit, suspend, modify or revoke any Authorization related to the Program; and</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(v)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">files, obtains, maintains or submits all material reports, documents, forms, notices, applications, records, claims, submissions and supplements or amendments with</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">53</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">281923888 v10</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">respect to the Program as required by any Laws or Authorizations, and all such reports, documents, forms, notices, applications, records, claims, submissions and supplements or amendments are materially complete and correct on the date filed (or are corrected or supplemented by a subsequent submission where required by applicable Law).</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7.16	Clinical Studies</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Until the Closing, Equillium shall ensure that:</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the preclinical studies and clinical trials of the Compound and the Products conducted by or on behalf an Equillium Person are being conducted in all material respects in accordance with experimental protocols, informed consents, procedures and controls pursuant to accepted professional scientific standards and all Laws and Authorizations applicable to such studies and trials, including the FDCA and the rules and regulations promulgated thereunder;</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(b)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">all materials used in such trials comply with applicable Laws and Authorizations, and there are no material deficiencies or defects in such materials; and</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(c)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">no Equillium Person carries out an act or omission that causes a Regulatory Authority to require the termination, suspension or material modification of any preclinical study or clinical trial of the Compound or any Product conducted by or on behalf of any Equillium Person.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8.	PROGRAM ACTIVITIES</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8.1	Development Plan and Development Budget</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Until the Closing, Equillium shall use Commercially Reasonable Efforts to Develop, or have Developed, Product in accordance with its written development plan attached hereto as </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit C</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Development Plan</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;). The Parties acknowledge that the Development Plan (including the Development Budget contained therein) has necessarily been prepared by Equillium based on assumptions made in good faith by Equillium at the time of preparation but that may later prove to have been inaccurate.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8.2	Deviations from the Development Plan</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Equillium may (i) use its sole discretion to Develop, or have Developed, each Product, taking into account the availability of new information relevant to the Development Program and new requirements, recommendations or guidelines of Regulatory Authorities and (ii) deviate from the Development Plan; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided, however,</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> that, in each case of (i) and (ii): (A) at least [***] prior to materially deviating from the Development Plan, Equillium shall notify Ono in writing of the nature of such deviation and the reason behind such deviation in reasonable detail; (B) Equillium may not, without Ono&#x2019;s prior written consent (a) [***], (b) [***] or (c) [***]; and (C) Equillium may not, without prior consultation with Ono and without considering in good faith Ono&#x2019;s comments related thereto (y) [***] or (z) [***]. For the avoidance of doubt, any deviation by Equillium in accordance with this Section 8.2 shall not constitute a breach of this Agreement.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8.3	Equillium Program Responsibilities</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Until the Closing, as between the Parties, the conduct of the Program shall be the sole responsibility of Equillium. Until the Closing, Equillium shall conduct, or have conducted,</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">54</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">281923888 v10</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the Program in accordance with applicable Laws and the Development Plan and shall use Commercially Reasonable Efforts to deliver the Development Program Data Package.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(b)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Subject to Section 8.2, prior to the Closing, Equillium may perform any or all Program activities through its Subsidiaries or one or more third-party subcontractors, provided that Equillium shall remain responsible for the performance of such activities by its Subsidiaries and subcontractors and the compliance of its Subsidiaries and subcontractors with the applicable provisions of this Agreement. Any breach of the terms of this Agreement by a Subsidiary or a third-party subcontractor of Equillium shall constitute a breach of this Agreement by Equillium. Without limiting the foregoing, the use of a Subsidiary or a third-party subcontractor by Equillium shall not otherwise relieve Equillium of its obligations under this Agreement.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(c)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Until the Closing, Equillium shall conduct the Program in a professional manner and in accordance with sound and ethical business and scientific practices, and in compliance with all applicable Laws, GCPs and GLPs. In addition, prior to the Closing, Equillium shall not use in any capacity, in connection with its Development of any Product hereunder, any Person who has been debarred pursuant to section 306 of the FDCA (or similar applicable Laws outside of the U.S.), or who is the subject of a conviction described in such section, and Equillium shall inform Ono in writing immediately if it or any Person who is performing services for Equillium hereunder is debarred or is the subject of a conviction described in section 306 (or similar applicable Laws outside of the U.S.), or if any action, suit, claim, investigation or legal administrative proceeding is pending or, to Equillium&#x2019;s Knowledge, is threatened, relating to the debarment of Equillium or any Person used in any capacity by Equillium in connection with its Development (or Manufacture) of any Product hereunder.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8.4	Records, Reports and Information</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Until the Closing, Equillium shall keep Ono reasonably informed on a regular basis of ongoing material Development Plan activities. Without limiting the generality of the foregoing, prior to the Closing, within [***] of each [***], Equillium shall deliver to Ono a written report summarizing (i) the progress and Results of the performance of the Program during such [***], (ii) any material safety issues arising from clinical trials under the Development Plan, (iii) information disclosed to Equillium by Biocon regarding the progress and results of non-clinical and clinical trials of any Product conducted by Biocon, including material safety issues reported to Equillium by Biocon, (iv) any clinical trials of any Product that are being, or are proposed to be, conducted jointly by Equillium and Biocon (to the extent not included in the Development Plan) and (v) any proposed deviation from the Development Plan by Equillium. If Ono desires a meeting relating to the reported summary, Equillium shall hold such a meeting with Ono to explain and discuss the issues raised by Ono.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(b)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Until the Closing, Equillium shall, and shall cause its Subsidiaries and third party sub-contractors to, maintain current and accurate records of all work conducted by such Persons in respect of the Development Plan and all data and other information resulting from such work (which records shall include, as applicable, books, records, reports, research notes, charts, graphs, comments, computations, analyses, recordings, photographs, computer programs and documentation thereof (e.g., samples of materials and other graphic or written data generated in</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">55</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">281923888 v10</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the Program)) (collectively, &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Development Records</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) for a period covering, at a minimum, the Record Retention Period. Such Development Records shall properly reflect all work done and results achieved in the performance of the Program in sufficient detail and in good scientific manner appropriate for regulatory and patent purposes. Until the Closing, Equillium shall document all preclinical studies and clinical trials to be conducted pursuant to the Development Plan in formal written study reports according to applicable national and international (e.g., ICH, GCP and GLP) guidelines, which reports shall be deemed and maintained as Development Records.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8.5	Regulatory</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Until the Closing, without limiting Sections 7.11 to 7.13:</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Equillium shall be responsible for the preparation of all Regulatory Materials necessary or desirable for the performance of the Program, including to the extent contemplated by the Development Plan, and obtaining and maintaining Regulatory Approvals for each Product. Equillium shall use Commercially Reasonable Efforts to submit such Regulatory Materials, as applicable, to the applicable Governmental Authorities in accordance with the time frames set forth in the Development Plan. For clarity, to the extent allowed by applicable Laws, all Regulatory Materials shall be held and owned by Equillium in its name. Equillium shall keep Ono reasonably informed regarding meetings and material communications with Regulatory Authorities regarding any Product.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(b)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Equillium shall, and shall cause each of its Subsidiaries to, maintain, or cause to be maintained, current and accurate records of all Regulatory Materials and regulatory data that such parties may acquire for a period covering, at a minimum, the Record Retention Period. In addition, Equillium shall keep Ono reasonably and regularly informed in connection with the preparation of all Regulatory Materials, Regulatory Authority review of Regulatory Materials, and Regulatory Approvals, in each case with respect to any Product.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(c)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Equillium shall be responsible for complying with pharmacovigilance obligations under applicable Laws in connection with the Program and each Product.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(d)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Equillium shall promptly inform Ono of notification of any action by, or notification or other information which it receives (directly or indirectly) from, any Regulatory Authority which (i) raises any material concerns regarding the safety or efficacy of any Product, (ii) is reasonably likely to lead to a recall, market withdrawal or market notification with respect to any Product or (iii) relates to expedited and periodic reports of adverse events with respect to any Product which may have an adverse impact on any Regulatory Approval.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(e)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If Equillium believes or determines in good faith that conducting or continuing a clinical trial under the Development Plan poses an unacceptable risk to patient / subject safety or is futile, or that the suspension or termination of any such clinical trial, or a deviation from or amendment to the protocol of any such clinical trial, is in the best interest of patients / subjects, or if any Regulatory Authority imposes a hold on, or requires or recommends the suspension or termination of, any such clinical trial, then, in each case, Equillium shall promptly inform Ono thereof. Notwithstanding anything in this Agreement to the contrary, with respect to any of the events described in the preceding sentence or under similar circumstances</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">56</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">281923888 v10</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">affecting patient / subject safety or compliance with applicable Laws or Regulatory Authority actions, until the Closing, Equillium shall have final decision-making authority on (and notify Ono with respect to such decision) whether to take such actions (including termination or suspension of a clinical trial or deviation from, or amendment to, the protocol for a clinical trial) as it determines in good faith are necessary, appropriate or advisable and consistent with the best interest of patients / subjects or required by applicable Law, including GCP.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8.6	Delivery and Review of Development Program Data Package</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Within [***] after the Completion Date, Equillium shall prepare and deliver to Ono, in writing or by access to a virtual data room, in a manner reasonably satisfactory to Ono, the Development Program Data Package (such date of delivery being the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Data Package Delivery Date</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;).</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(b)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Ono shall have the opportunity to review the Development Program Data Package during the [***] period following the Data Package Delivery Date (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Data Package Review Period</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;). During the Data Package Review Period, Ono may:</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(i)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">request from Equillium, and Equillium shall provide to Ono, (A) reasonable access under the supervision of appropriate personnel of Equillium during normal business hours (and subject to receipt of reasonable notice) to, and support from, its employees and consultants who were involved in the Program, including the preparation of the Development Program Data Package (including the Results, Clinical Data and Pre-Clinical Data) and (B) any additional information or data in Equillium&#x2019;s Control related to the Program, in each case (A) and (B), that is reasonably useful in evaluating the Development Program Data Package (including such information or data that may be reasonably useful in conducting (ii) below); and</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(ii)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">to the extent permitted by applicable Laws and Equillium&#x2019;s clinical trial agreements with the participating sites and Equillium&#x2019;s contracts with Third Party contractors used in the Development of the Product, either itself or through an independent and accredited auditor, verify the accuracy of the Development Program Data Package by conducting source data verification on the Development Program Data Package. Ono agrees that such investigation shall be conducted in such a manner as to not interfere unreasonably with the operations of Equillium.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(c)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Nothing in this Section 8.6 or in Section 8.7 shall obligate Equillium:</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(i)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">to disclose any information to Ono or any of its, or its Affiliates&#x2019;, Representatives if such disclosure would (A) based upon the advice of counsel, cause to be waived any attorney-client or other legal privilege or (B) contravene any applicable Law, fiduciary duty or binding agreement of confidentiality in effect as of the date of this Agreement to which Equillium is a party; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided, however,</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> that Ono and Equillium shall cooperate in good faith to make commercially reasonable substitute arrangements, to the extent reasonably possible, to provide Ono with access to such information to an extent and in a manner that does not result in the loss of any such privilege or the contravention of any such Law, duty or agreement; or</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">57</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">281923888 v10</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(ii)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">to disclose to Ono or its, or its Affiliates&#x2019;, Representatives, or otherwise provide Ono or its, or its Affiliates&#x2019;, Representatives with access to, any information related to any Excluded Program,</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the foregoing conditions and limitations, collectively, the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Diligence Limitations</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;. For so long as any applicable COVID-19 Measures are in effect, each Equillium Person may provide access under this Section 8.6 and Section 8.7 through virtual or other remote means.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8.7	Due Diligence Investigation</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Ono may perform a due diligence investigation regarding the Program for the purpose of assisting Ono in evaluating whether to exercise the Purchase Option (such investigation, as further described in this Section 8.7, a &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Due Diligence Investigation</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) (i) once prior to the Data Package Delivery Date and (ii) once during the [***] period following the Data Package Delivery Date, in each case, upon reasonable written notice to Equillium.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(b)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">During the [***] period following the Data Package Delivery Date or the date the notice regarding the Due Diligence Investigation has been received by Equillium pursuant to Section 13.5, as applicable, Ono may request from Equillium, and Equillium shall provide (subject to the Diligence Limitations) to Ono, (i) reasonable access under the supervision of appropriate personnel of Equillium during normal business hours (and subject to receipt of reasonable notice) to its officers, and to those of its employees and consultants of Equillium who were involved in the Program, including the preparation of the Development Program Data Package (including the Results, Clinical Data and Pre-Clinical Data), (ii) reasonable access to the Books and Records and (iii) any additional information or data concerning the Program as Ono may reasonably request, in each case for the purpose of assisting Ono in evaluating whether to exercise the Purchase Option.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(c)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Ono agrees that each Due Diligence Investigation shall be conducted in such a manner as to not interfere unreasonably with the operations of Equillium. In no event shall Ono&#x2019;s right to conduct Due Diligence Investigation(s) under this Section 8.7 extend beyond the expiration of the Data Package Review Period, provided that if Ono has reasonable cause to extend the Data Package Review Period, Ono shall notify Equillium of the same in writing and the Data Package Review Period shall be extended once only by an additional [***].</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8.8	Liaison</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Each Party shall appoint a single individual to act as the primary point of contact between the Parties regarding the Program until the Closing (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Liaison</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;). As soon as reasonably practicable following the date of this Agreement, each Party shall notify the other of the identity of its Liaison. Each Party may change its designated Liaison at any time upon notice to the other Party. The Liaison shall be the first point of referral for all matters of conflict resolution regarding the Program.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8.9	No Development by Ono</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Notwithstanding any provision of this Agreement to the contrary, in no event shall Ono or any of its Affiliates have the right to Develop the Compound or any Product prior to the Closing Date, and Ono hereby covenants, on behalf of itself and its Affiliates, that none of them will conduct, or have conducted, any Development of the Compound or any Product prior to the Closing Date.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">58</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">281923888 v10</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8.10	Development Funding</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Ono shall provide funding to Equillium for the Development Costs incurred prior to the Closing in the performance of the Program (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Development Funding</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) in accordance with the Development Plan, as set forth below.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">At least [***] before the end of each calendar quarter, Equillium shall notify Ono in writing of Equillium&#x2019;s good faith, reasonable estimates, by calendar quarter, of the FTE Costs of performing the Program in accordance with the Development Plan and the corresponding Out-of-Pocket Expenses, in each case for the four full calendar quarters immediately following such quarter (the estimate for each calendar quarter of such four-calendar quarter period, a &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Quarterly Estimate</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;).</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(b)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Each calendar quarter, Ono shall make a Development Funding payment to Equillium for [***]% of the Quarterly Estimate for the immediately following calendar quarter notified by Equillium in accordance with Section 8.10(a) (each, a &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Quarterly Advance</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;). Payment of the Quarterly Advance for the period commencing on October 1, 2022 and ending on December 31, 2022 shall be paid [***] following receipt by Ono of Equillium&#x2019;s invoice for such payment, and each subsequent Quarterly Advance shall be paid [***] of Ono&#x2019;s receipt of the relevant Quarterly Estimate in accordance with Section 8.10(a) and Equillium&#x2019;s invoice for such payment.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(c)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Subject to Section 8.10(d), within [***] (or as soon as reasonably practicable following the date of this Agreement with respect to the calendar quarter commencing on July 1, 2022 and ending September 30, 2022), Equillium shall provide a written report to Ono setting forth in reasonable detail the Development Costs actually incurred by Equillium during such calendar quarter, including (i) the Development Plan activities to which such Development Costs are attributable, (ii) the FTEs devoted to such Development Plan activities and (iii) upon Ono&#x2019;s written request (A) copies of invoices from Third Party vendors or contractors, (B) acknowledgement of receipt of fees from Regulatory Authorities and (C) such other reasonable documentation from the Company&#x2019;s accounting system to support the Out-of-Pocket Expenses, and shall issue to Ono a written invoice for the difference between (x) the actual Development Costs incurred in such calendar quarter and (y) the Quarterly Advance paid by Ono for such calendar quarter. If the Quarterly Advance paid by Ono for a particular calendar quarter exceeds the actual Development Costs for such calendar quarter, then Ono shall be entitled to a credit in the amount of the excess that will be applied to each amount payable in respect of Development Funding after delivery of such quarterly Development Cost report until exhausted; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided, however,</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> that if any credit remains unused after the final quarterly Development Cost report is delivered, then Equillium shall refund to Ono the amount of such remaining credit. For clarity, Ono&#x2019;s Development Funding obligation shall, in addition to the foregoing, include Development Costs actually incurred by Equillium from July 1, 2022 through the date of this Agreement.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(d)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Ono shall pay each invoice issued by Equillium pursuant to Section 8.10(c) within [***] of receipt. For clarity, Ono shall be obligated to reimburse all documented Development Costs actually incurred by Equillium in accordance with the Development Plan, regardless of whether such Development Costs exceed Development Cost estimates or are incurred before or after the calendar quarter in which they were expected to be incurred; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided, however,</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> that Ono shall not be required to pay any actual Development Costs incurred in any particular calendar year that exceeds [***]% of the Development Budget (as set forth in the Development</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">59</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">281923888 v10</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Plan) for such calendar year, unless the overage is the result of a change in scope of the Development Plan approved in writing by Ono or the overage is approved in writing for payment by Ono. For clarity, subject only to the preceding sentence, Ono shall be obligated to reimburse all documented Development Costs actually incurred by Equillium in accordance with the Development Plan, regardless of whether any such Development Costs exceed Development Cost estimates or are incurred before or after the accounting period in which they were expected to be incurred. Equillium agrees to promptly provide Ono with additional information reasonably requested by Ono related to the Development Costs during such calendar quarter to confirm that such Development Costs were incurred in accordance with the Development Plan and this Agreement.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8.11	Financial Records and Audit</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Equillium shall keep, and shall cause its Subsidiaries to keep, full, true and accurate records and books of account pertaining to Development Costs incurred by it in sufficient detail to permit Ono to confirm the accuracy of the Development Cost reports and invoices delivered by Equillium pursuant to Section 8.10, for at least [***] full calendar years following the end of the calendar year to which they pertain. Ono shall have the right, once annually, to cause an independent, internationally recognized accounting firm selected and engaged by Ono to audit such records and books in order to confirm the accuracy of such Development Cost reports and invoices for a period covering not more than the preceding two full calendar years (a &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Financial Audit</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;). The records and books of Equillium and its Subsidiaries for a particular calendar year shall be subject to audit by Ono under this Section 8.11 only once. Audits pursuant to this Section 8.11 may be exercised during normal business hours upon reasonable prior written notice to Equillium. The auditor will execute a reasonable written confidentiality agreement with Equillium, use reasonable efforts to minimize any disruption to Equillium&#x2019;s business, and disclose to Ono only such information as is reasonably necessary to provide Ono with information regarding any discrepancies between amounts reported and invoiced and Development Costs that Ono is obligated to reimburse under this Agreement. Equillium shall make personnel reasonably available during regular business hours to answer queries on all such books and records required for the purpose of the Financial Audit. The auditor shall deliver a copy of its findings to each of the Parties within [***] of the completion of the review, and in the absence of fraud or manifest error, the findings of such auditor shall be final and binding on each of the Parties. If such Financial Audit reveals that actual Development Costs in any calendar year (except to the extent such Development Costs exceeded [***]% of the Development Budget for such calendar year) exceeded the Development Costs invoiced by Equillium in such calendar year, then Ono shall pay the difference to Equillium. If such Financial Audit reveals that the Development Costs invoiced by Equillium in any calendar year exceeded actual Development Costs in such calendar year, then:</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Ono shall be entitled to credit such excess (i) against Development Costs invoiced pursuant to Section 8.10 in subsequent calendar quarter(s), if any or (ii) if there will be no subsequent invoices of Development Costs or if Ono is otherwise unable to apply the full amount of such credit against subsequently-invoiced Development Costs, and Ono has exercised the Purchase Option, against other amounts payable to Equillium pursuant to this Agreement; or</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(b)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">if the Purchase Option expires unexercised, or the Purchase Option is exercised but the Closing does not occur prior to the termination of this Agreement, and, in either</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">60</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">281923888 v10</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">case, Ono was not able to recover the full amount of such excess pursuant to clause (i) of Section 8.11(a) prior to such expiration or termination, then, within [***] after such expiration or termination, Equillium shall pay to Ono the amount of any such excess that Ono was not able to so recover;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">in each case (clauses (a) and (b)), </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided, however,</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> that if such Financial Audit reveals that the amount of such excess in any calendar year is greater than [***]% of actual Development Costs in such calendar year, then the amount of such excess that Ono is entitled to recover under Section 8.11(a) or (b), as applicable, shall bear interest at the rate set forth in Section 3.7(f) from the end of such calendar year until the date Ono recovers such excess pursuant to Section 8.11(a) or (b), as applicable. The cost of the accountants shall be the responsibility of Ono unless such Financial Audit reveals that the amount of such excess in any calendar year is greater than [***]% of actual Development Costs in such calendar year, in which case [***] for such costs.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8.12	Insurance</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Equillium shall procure and maintain insurance that is available on commercially reasonable terms, including general liability, clinical trial, product liability and other insurance as necessary, adequate to cover its obligations hereunder and which is consistent with normal business practices of prudent companies similarly situated at all times during which any Product is being clinically tested in human subjects or commercially distributed or sold by or on behalf of Equillium pursuant to this Agreement. Such insurance coverage shall be in amounts per loss occurrence and in the aggregate as are customary in the industry in the Equillium Territory, but shall not be less than [***] per loss occurrence and [***] in the aggregate each calendar year. Such insurance coverage shall not be construed to limit Equillium&#x2019;s liability under Article 11. Equillium shall provide Ono with written evidence of such insurance upon Ono&#x2019;s request.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8.13	Patent Prosecution and Maintenance</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Subject to Sections 7.2(g) and 8.14, until the Closing, as between the Parties, Equillium shall be solely responsible and have the sole authority for preparing, filing, prosecuting, maintaining, enforcing and defending all Patent Rights Controlled by Equillium, at Equillium&#x2019;s sole expense and using counsel selected by Equillium.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8.14	Intellectual Property Rights</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Until the Closing, inventorship of Program Inventions shall be determined in accordance with United States patent laws. Until the Closing, as between the Parties, Equillium shall solely own all right, title and interest in and to (i) all Results, (ii) all Program Know-How, including all Program Inventions, and all Patent Rights claiming such Program Inventions and (iii) any other Intellectual Property rights in and to the foregoing in clause (ii) throughout the world ((i) to (iii) collectively, the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Program IP</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;). To the extent any Representative of Ono is an inventor of any Program Invention as determined in accordance with United States patent laws or otherwise creates any Program IP, Ono hereby assigns and shall assign to Equillium (or if assignment is not permitted, waives enforcement of or grants to Equillium an exclusive, irrevocable, perpetual, worldwide, royalty-free, fully-paid license, with the right to sublicense through multiple tiers of sublicense under) all right, title and interest in and to such Program Invention and all Program IP, and shall cooperate fully, including by executing all papers and instruments and taking all actions, and requiring its Representatives to execute all papers and instruments and take all actions, to effectuate and perfect Equillium&#x2019;s sole ownership thereof and to enable Equillium to file,</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">61</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">281923888 v10</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">prosecute, defend and enforce patent rights claiming Program Inventions in any country in accordance with Section 8.13. For the avoidance of doubt, all Program IP shall constitute Transferred Intellectual Property and, following the Closing, Ono shall solely own all right, title and interest in and to the Program IP.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(b)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Without limiting Section 7.1 or 7.2, until the Closing, Equillium shall keep Ono reasonably informed of (i) the progress of the prosecution of any Program IP, (ii) the lapse or abandonment of any Program IP and (iii) the progress with regard to the enforcement and defense of any Program IP.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(c)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If Equillium plans to permit the lapse of, abandon or cease prosecution or maintenance of, any Patent Right included in the Program IP, Equillium shall notify Ono in writing promptly upon making such decision, but in no event fewer than 90 days (or as promptly as reasonably practicable) in advance of the due date of any payment or other action that is required to prosecute and maintain such Patent Right.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(d)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For the avoidance of doubt, except as expressly granted hereunder: (i) no right, title, interest or license under any information, know-how or Intellectual Property is granted or shall be granted under this Agreement by implication or estoppel; and (ii) any such right, title, interest or license is or shall be granted only as expressly provided in this Agreement.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9.	TAX MATTERS</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9.1	Transaction Taxes</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. [***] shall [***] bear [***] of all sales, use, value added, services, goods and services, consumption, transfer, stamp, registration, documentary, real property, personal property and similar Taxes (&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Transaction Taxes</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) incurred as a result of the Transactions (except to the extent in connection with a payment under Article 8). For the avoidance of doubt, &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Transaction Taxes</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; shall not include any Taxes based on income or gains. The Party customarily responsible under applicable Law shall file all related Tax Returns, and the non-preparing Party shall cooperate in duly and properly preparing, executing, and filing any certificates or other documents required to be filed in connection with such Transaction Taxes and Tax Returns.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9.2	Transaction Taxes on Article 8</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Notwithstanding anything to the contrary in this Agreement, all payments under Article 8 are exclusive of Transaction Taxes. If any Transaction Taxes are chargeable in respect of any payments under Article 8, Ono shall pay such Transaction Taxes at the applicable rate in respect of any such payments following the receipt of a valid invoice issued by Equillium setting forth the amount of such Transaction Taxes. Such Transaction Taxes shall be due on the due date of the payment to which such Transaction Taxes relate. Equillium shall reasonably cooperate with Ono in obtaining any reduction, exemption, credit and refund with respect to any such Transaction Taxes.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9.3	Purchase Price Allocation</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Within [***] following the Closing Date, Equillium shall prepare and deliver to Ono a draft schedule allocating the Purchase Price, the Assumed Liabilities and any other relevant items or adjustments (and all other capitalized costs) among the Purchased Assets in a manner consistent with Section 1060 of the Code, the applicable Treasury Regulations and other applicable Tax Law (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Proposed Allocation Schedule</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;). The Parties shall</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">62</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">281923888 v10</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">negotiate in good faith to resolve any disputes over the Proposed Allocation Schedule, and the allocation as agreed to by the Parties shall be the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Final Allocation Schedule</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;. Unless otherwise required by (i) applicable Law or (ii) the resolution of an audit by a tax authority, all Tax Returns filed, and Tax positions taken, by each Party shall be consistent with such Final Allocation Schedule.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9.4	Foreign Derived Intangible Income</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Ono shall use commercially reasonable efforts to provide, at Equillium&#x2019;s cost and expense, any information and documentation in its possession reasonably requested by Equillium to obtain the benefits of Section 250 of the Code, and the applicable Treasury Regulations, including information required to demonstrate the extent to which the Purchased Assets will be sold, consumed, used and/or manufactured outside of the United States.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9.5	Withholding Rights</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Ono shall be entitled to deduct and withhold (or cause to be deducted and withheld) from any amount otherwise payable to any Person pursuant to this Agreement such amounts as it is required to deduct and withhold with respect to the making of such payment under the Code or any provision of applicable Tax Law. At Equillium&#x2019;s written request, Ono shall use commercially reasonable efforts to assist Equillium in obtaining any reduction or exemption of any such withholding and to provide Equillium with a copy of the applicable tax payment receipt or such other reasonable evidence with respect to the payment of the applicable withheld amounts to the appropriate Governmental Authority. To the extent that such amounts are so withheld and remitted to the appropriate Governmental Authority in accordance with applicable Law, such withheld and remitted amounts shall be treated for all purposes of this Agreement as having been paid to the applicable Person in respect of whom such deduction and withholding was made.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(b)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If, after the date of this Agreement, (i) Ono unilaterally assigns, licenses or sublicenses its rights or obligations under this Agreement or changes its residency for applicable Tax purposes (each, an &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Ono Tax Action</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;), (ii) such Ono Tax Action was not pursuant to a request by Equillium or contemplated by or otherwise required to comply with this Agreement, (iii) as a result of such Ono Tax Action, Ono is required to withhold Taxes from or in respect of any amount payable under this Agreement and such Taxes exceed the amount of Taxes that would have been required to be withheld absent such Ono Tax Action (such excess, an &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Increased Withholding</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) and (iv) to the extent Equillium cannot reasonably be expected to obtain or utilize any credit or other Tax benefits in respect of such Increased Withholding in the taxable year Equillium receives such payment, then the applicable amount payable under this Agreement shall be increased as necessary so that after the making of all required withholdings (including withholdings on additional amounts payable) and the utilization of all credits and other Tax benefits that could be utilized in that taxable year (&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Used Credits</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;), Equillium is in the same net after-tax position had no such Ono Tax Action occurred; provided that to the extent Equillium obtains or utilizes a credit or other Tax benefits in respect of such Increased Withholding (other than Used Credits) in the immediately three succeeding taxable years, Equillium shall promptly pay to Ono an amount equal to the value of such credit or Tax benefits.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">63</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">281923888 v10</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.	CONDITIONS TO CLOSING</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.1	General Conditions</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. The respective obligations of Ono and Equillium to consummate the Closing shall be subject to the fulfillment, at or prior to the Closing, of each of the following conditions, any of which may, to the extent permitted by applicable Law, be waived in writing by either Party in its sole discretion (provided, that such waiver shall only be effective as to the obligations of such Party):</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a)	Purchase Option Exercise</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. The Option Exercise Effective Date shall have occurred.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(b)	No Injunction or Prohibition</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. No Governmental Authority shall have enacted, issued, promulgated, enforced or entered any Law (whether temporary, preliminary or permanent) that is then in effect and that enjoins, restrains, conditions, makes illegal or otherwise prohibits the consummation of the transactions contemplated by this Agreement.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(c)	No Action</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. No Action shall be pending before or by any Governmental Authority (i) challenging the transactions contemplated by this Agreement under applicable Law or (ii) seeking to restrain or prevent the carrying out of the transactions contemplated by this Agreement.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.2	Conditions to Obligations of Equillium</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. The obligations of Equillium to consummate the Closing shall be subject to the fulfillment, at or prior to the Closing, of each of the following conditions, any of which may be waived in writing by Equillium in its sole discretion:</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a)	Representations, Warranties and Covenants</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. The representations and warranties of Ono contained in this Agreement shall be true and correct both in all material respects (other than representations and warranties that are qualified as to materiality, which representations and warranties shall be true and correct in all respects) as of the Closing Date, or in the case of representations and warranties that are made as of a specified date, such representations and warranties shall be true and correct, to the extent set forth above, as of such specified date. Ono shall have materially performed all obligations and agreements and complied in all material respects with all covenants and conditions required to be performed or complied with by Ono prior to the Closing. Equillium shall have received from Ono the certificate referred to in Section 3.6(b)(ii)(3).</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(b)	Deliveries</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Equillium shall have received an executed copy of each of the documents listed in Section 3.6(b)(ii).</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.3	Conditions to Obligations of Ono</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. The obligations of Ono to consummate the Closing shall be subject to the fulfillment, at or prior to the Closing, of each of the following conditions, any of which may be waived in writing by Ono in its sole discretion:</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a)	Representations, Warranties and Covenants</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. The representations and warranties of Equillium contained in this Agreement (as qualified by the Updated Disclosure Schedules) shall be true and correct in all material respects (other than representations and</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">64</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">281923888 v10</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">warranties that are qualified as to materiality or Material Adverse Effect, which representations and warranties shall be true and correct in all respects) as of the Closing Date, or in the case of representations and warranties that are made as of a specified date, such representations and warranties shall be true and correct, to the extent set forth above, as of such specified date. Equillium shall have materially performed all obligations and agreements and complied in all material respects with all covenants and conditions required to be performed or complied with by Equillium prior to the Closing. Ono shall have received from Equillium the certificate referred to in Section 3.6(c)(i)(3).</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(b)	No Material Adverse Effect</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. No Material Adverse Effect, nor any event, change, circumstance, occurrence, effect, result or state of facts that could reasonably be expected to cause a Material Adverse Effect, shall have occurred since the delivery of the first set of Updated Disclosure Schedules in accordance with Section 2.4(a) and be uncured.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(c)	Competition Clearance</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. (i) The competent competition law Governmental Authorities of each jurisdiction in respect of which consent, approval, clearance or waiver under the applicable merger-control, antitrust, competition or trade regulation Laws of such jurisdiction is necessary or advisable in relation to the Closing shall have granted (or be deemed to have granted) such consent, approval, clearance or waiver, (ii) each applicable waiting period under all such Laws shall have expired or been terminated by the relevant Governmental Authority and (iii) there shall be no pending agreement between either Party and any Governmental Authority not to consummate the Closing.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(d)	Deliveries</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Ono shall have received an executed copy of each of the documents listed in Section 3.6(c)(i).</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(e)	Release of Encumbrances</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Ono shall have received evidence reasonably acceptable to Ono of the termination and release of any Encumbrances in respect of the Purchased Assets under or in connection with (i) the Loan and Security Agreement dated September 30, 2019, among Equillium, Oxford Finance LLC and Silicon Valley Bank, (ii) any debt facility entered into in accordance with the exception set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Schedule 7.1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and (iii) any loan or other agreement between Equillium and any of its Affiliates.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11.	INDEMNIFICATION</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11.1	Survival</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The representations and warranties of each Party contained in this Agreement (in the case of Equillium, as qualified by the Disclosure Schedules and the Updated Disclosure Schedules in accordance with Article 4) and any schedule or certificate or other document delivered pursuant hereto in connection with the transactions contemplated hereby shall survive the Closing until (i) in the case of the representations and warranties other than the Fundamental R&amp;Ws and IP R&amp;Ws, 5:00 p.m. (Pacific time) on the date [***] after the Closing Date, (ii) in the case of the IP R&amp;Ws, 5:00 p.m. (Pacific time) on the date [***] after the Closing Date, or (iii) in the case of the Fundamental R&amp;Ws, 5:00 p.m. (Pacific time) on the [***] of the Closing Date.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">65</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">281923888 v10</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(b)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The respective pre-Closing covenants and agreements of each Party contained in this Agreement shall survive the Closing until 5:00 p.m. (Pacific time) on the date [***] after the Closing Date, and the post-Closing covenants and agreements of each Party contained in this Agreement shall survive the Closing until the [***] following the expiration of the statute of limitations following the date all performance thereunder was due to be performed.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(c)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Neither Party shall have any liability for Losses in respect of a breach of representation, warranty, covenant or agreement or other indemnity matter contained in this Agreement unless a good faith written notice of a </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">bona fide</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> claim for indemnification pursuant to this Article 11 (a &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Claim Notice</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) is given by an Ono Indemnified Party to Equillium or an Equillium Indemnified Party to Ono (as the case may be) in accordance with Section 11.4 prior to the expiration of the survival period for the relevant representation, warranty, covenant or agreement, in which case such representation, warranty, covenant or agreement shall survive as to such claim until such claim has been finally resolved, without the requirement of commencing any Action in order to extend such survival period or preserve such claim.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(d)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">It is the express intent of the Parties that, if the applicable survival period for an item as contemplated by this Section 11.1 is shorter than the statute of limitations that would otherwise have been applicable to such item, then, by contract, the applicable statute of limitations with respect to such item shall be reduced to the shortened survival period contemplated by this Agreement. The Parties further acknowledge that the time periods set forth in this Section 11.1 for the assertion of claims under this Agreement are the result of arms-length negotiation between the Parties and that they intend for the time periods to be enforced as agreed by the Parties.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11.2	Indemnification</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Equillium shall save, defend, indemnify and hold harmless Ono and its Affiliates and the respective Representatives, successors and assigns of each of the foregoing (collectively, the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Ono Indemnified Parties</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; and each, an &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Ono Indemnified Party</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) from and against, and shall compensate and reimburse each of the foregoing for, any and all losses, damages, liabilities, deficiencies, interest, awards, judgments, penalties, costs and expenses (including reasonable documented out-of-pocket attorneys&#x2019; fees and expenses and other reasonable out-of-pocket expenses incurred in defending, asserting or settling the foregoing), but expressly excluding any unforeseeable, speculative, special or indirect damages (except to the extent paid by an Ono Indemnified Party to a Third Party in connection with a Third Party Claim) (collectively, &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Losses</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;), actually incurred by any of the foregoing as a result of or arising out of:</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(i)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">any breach of any representation or warranty made by Equillium contained in Article 4 (as qualified by the Disclosure Schedules and the Updated Disclosure Schedules in accordance with Article 4) or any certificate delivered pursuant to Section 3.6(c)(i);</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(ii)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">any breach by Equillium of any covenant or agreement contained in this Agreement (as qualified by the Disclosure Schedules or applicable Schedule); and</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(iii)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">any Excluded Liabilities.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">66</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">281923888 v10</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(b)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Ono shall save, defend, indemnify and hold harmless Equillium and its Affiliates and the respective Representatives, successors and assigns of each of the foregoing (collectively, the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Equillium Indemnified Parties</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; and each, an &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Equillium Indemnified Party</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) from and against, and shall compensate and reimburse each of the foregoing for, any and all Losses actually incurred by any of the foregoing as a result of or arising out of:</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(i)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">any breach of any representation or warranty made by Ono contained in Article 6 or any certificate delivered pursuant to Section 3.6(b)(ii);</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(ii)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">any breach by Ono of any covenant or agreement contained in this Agreement; and</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(iii)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">any Assumed Liabilities.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11.3	Materiality Scrape</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. For the purposes of determining (a) whether any breach of any representation or warranty contained in this Agreement has occurred and (b) the amount of Losses resulting from any such breach, the determination shall, other than in the case of Fundamental R&amp;Ws, in each case, be made without references to the terms &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">material</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;, &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">materiality</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;, &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Material Adverse Effect</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;, &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">material adverse effect</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; or other similar qualifications as to materiality contained in any such representation or warranty.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11.4	Claim Notices</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Each Claim Notice shall (a) state in good faith that the Indemnified Party has or may have a claim for Losses, (b) state in good faith the amount (estimated if necessary) of such Losses that have been or may be incurred, paid, reserved or accrued, (c) specify in reasonable detail the nature of the claim to which such Losses are related and the provision of the Agreement which gives rise to the claim and (d) with respect to Third Party Claims, include copies of any summons, written complaints or other pleadings which may have been served on such Indemnified Party.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11.5	Third Party Claim Procedures.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In respect of a claim arising out of or involving a Loss by any person against an Ono Indemnified Party or an Equillium Indemnified Party (such person, an &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Indemnified Party</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; and such claim, a &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Third Party Claim</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;), such Indemnified Party shall deliver a Claim Notice in respect thereof to Equillium or Ono, as applicable (such person, the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Indemnifying Party</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) with reasonable promptness after receipt by the Indemnified Party of notice of the Third Party Claim (and in any event within [***] after becoming aware of the Third Party Claim), and shall provide the Indemnifying Party with such information with respect thereto as the Indemnifying Party may reasonably request. The failure to timely deliver a Claim Notice, however, shall not release the Indemnifying Party from any of its obligations under this Article 11 except to the extent that the Indemnifying Party is materially prejudiced by such failure. The existence of any Third Party Claim shall not create a presumption of any indemnification obligation of either Party. A Party&#x2019;s consent to any settlement of a Third Party Claim shall not be used as evidence of the truth of the allegations in such Third Party Claim or the merits of such Third Party Claim. Furthermore, the existence of any Third Party Claim shall not create a presumption of any breach of any representations, warranties or covenants set forth in this Agreement or any Ancillary Agreement.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">67</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">281923888 v10</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(b)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Indemnifying Party shall have the right, upon written notice to the Indemnified Party within [***] of receipt of a Claim Notice from the Indemnified Party in respect of such Third Party Claim, to assume the defense thereof at the expense of the Indemnifying Party with counsel selected by the Indemnifying Party and reasonably satisfactory to the Indemnified Party; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided, however,</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> that the Indemnifying Party shall not be entitled to assume, and the Indemnified Party shall be entitled to have control over, the defense of any Third Party Claim (with counsel selected by the Indemnified Party and reasonably satisfactory to the Indemnifying Party) to the extent that such Third Party Claim seeks an order, injunction or other equitable relief against the Indemnified Party which, if successful, could reasonably be expected to interfere with the business, operations, assets or financial condition of the Indemnified Party. If the Indemnifying Party does not expressly elect to assume the defense of such Third Party Claim within the time period and otherwise in accordance with the first sentence of this Section 11.5(b), the Indemnified Party shall have the sole right to assume the defense of such Third Party Claim. The Party not controlling the defense of the Third Party Claim shall have the right to employ separate counsel and to participate in the defense thereof, but the fees and expenses of such counsel shall be at the expense of such Party unless, in the written opinion of outside counsel to the Indemnified Party, it is advisable for the Indemnified Party to be represented by separate counsel due to actual or potential conflicts of interest, in which case the Indemnified Party shall have the right to employ counsel to represent it and in that event the reasonable documented out-of-pocket fees and expenses of such separate counsel shall be paid by the Indemnifying Party.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(c)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Party not controlling the Third Party Claim (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Non-Controlling Party</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) shall reasonably cooperate with the Party controlling the Third Party Claim (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Controlling Party</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) in such defense and make available to the Controlling Party all witnesses, pertinent records, materials and information in the Non-Controlling Party&#x2019;s possession or under the Non-Controlling Party&#x2019;s control relating thereto as is reasonably required by the Controlling Party; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided, however,</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> that such actions and cooperation by the Non-Controlling Party will not unduly disrupt the operations of the Non-Controlling Party&#x2019;s business or cause the Non-Controlling Party to waive any statutory or common law privileges, breach any confidentiality obligations owed to third parties or otherwise cause any confidential information of the Non-Controlling Party to become public. The Controlling Party shall not, without the prior written consent of the Non-Controlling Party (which shall not be unreasonably withheld, conditioned or delayed), enter into any settlement or compromise or consent to the entry of any judgment with respect to such Third Party Claim; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided, however,</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> that if the Indemnifying Party (as the Controlling Party) is proposing to enter into any settlement or compromise or consent to the entry of any monetary judgment with respect to such Third Party Claim, such consent of the Indemnified Party (as the Non-Controlling Party) shall not be required if (i) the Indemnifying Party agrees to pay or cause to be paid any amounts payable pursuant to such settlement, compromise or judgment and such settlement, compromise or judgment includes no admission of liability by or other obligation on the part of the Indemnified Party, (ii) such settlement, compromise or judgment includes an unconditional written release by the claimant or plaintiff of the Indemnified Party from all liability in respect of such Third Party Claim and (iii) such settlement, compromise or judgment does not provide for injunctive or other non-monetary relief, including any restrictions or sanctions, that could reasonably be expected to affect the Indemnified Party.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">68</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">281923888 v10</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11.6	Direct Claim Procedures</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">An Indemnified Party seeking indemnification in respect of, arising out of or involving a Loss that does not involve a Third Party Claim being asserted against or sought to be collected from such Indemnified Party (a &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Direct Claim</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) shall deliver a Claim Notice in respect thereof to the Indemnifying Party with reasonable promptness (but in any event no later than 10 Business Days after becoming aware of facts supporting such Direct Claim), and shall provide the Indemnifying Party with such information with respect thereto as the Indemnifying Party may reasonably request. The failure to timely deliver a Claim Notice, however, shall not release the Indemnifying Party from any of its obligations under this Article 11 except to the extent that the Indemnifying Party is materially prejudiced by such failure.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(b)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Indemnified Party shall reasonably cooperate and assist the Indemnifying Party in determining the validity of any Direct Claim, including by providing reasonable access to and copies of information, records and documents relating to such Direct Claim; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided, however,</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> that such actions and cooperation by the Indemnified Party will not unduly disrupt the operations of the Indemnified Party&#x2019;s business or cause the Indemnified Party to waive any statutory or common law privileges, breach any confidentiality obligations owed to third parties or otherwise cause any confidential information of the Indemnified Party to become public.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(c)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If the Indemnifying Party does not notify the Indemnified Party within [***] following its receipt of a Claim Notice in respect of a Direct Claim that the Indemnifying Party disputes its liability to the Indemnified Party hereunder, such Direct Claim specified by the Indemnified Party in such Claim Notice shall be conclusively deemed a liability of the Indemnifying Party hereunder and the Indemnifying Party shall indemnify the Indemnified Party for such Losses (or, in the case of any notice in which the Losses (or any portion thereof) are estimated, the amount of such Losses (or such portion thereof) as finally determined) subject to the limitations of this Article 11. If the Indemnifying Party agrees that it has an indemnification obligation but asserts that it is obligated to pay a lesser amount than that claimed by the Indemnified Party, the Indemnifying Party shall indemnify the Indemnified Party for such lesser amount, without prejudice to or waiver of the Indemnified Party&#x2019;s claim for the difference. If the Indemnifying Party contests the payment of all or part of the claimed amount, the Indemnifying Party and the Indemnified Party shall use good faith efforts to resolve such dispute. If such dispute is not resolved within [***] following the delivery by the Indemnifying Party of such response, the Indemnifying Party and the Indemnified Party shall each have the right to submit such dispute to arbitration in accordance with the provisions of Section 13.10.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11.7	Subrogation</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. To the extent that an Indemnifying Party makes any indemnification payment to an Indemnified Party, the Indemnifying Party will, to the extent of such payment, be entitled to exercise, and will be subrogated to, any rights and remedies (including rights of indemnity, rights of contribution and other rights of recovery) that the Indemnified Party or any of its Affiliates may have against any Third Party with respect to the Losses to which such indemnification payment relates. The Indemnified Party shall take such actions as the Indemnifying Party may reasonably request (at the Indemnifying Party&#x2019;s cost and expense) for the purpose of enabling the Indemnifying Party to perfect or exercise the Indemnifying Party&#x2019;s right of subrogation under this Section 11.7.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">69</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">281923888 v10</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11.8	Limits on Indemnification</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Notwithstanding anything to the contrary contained in this Agreement:</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(i)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">no indemnification shall be available under Section 11.2(a)(i), Section 11.2(a)(ii) (solely with respect to any claim arising from or relating to the matters set forth in Section 7.15 or 7.16) or Section 11.2(b)(i) (A) in respect of any individual claim or series of related claims based on a similar set of operative facts unless the amount claimed is greater than an amount equal to $[***] (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">De Minimis Amount</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;), in which case the Indemnified Party shall be entitled to recover all Losses in connection with such claim or series of related claims (including the De Minimis Amount) and (B) unless and until the aggregate amount of indemnifiable Losses which may be recovered from the Indemnifying Party equals or exceeds an amount equal to $[***], in which case the Indemnifying Party shall be liable for the full amount of such Losses;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(ii)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">after the Closing, the maximum aggregate amount of indemnifiable Losses which may be recovered from Equillium under Section 11.2(a)(i) in respect of any of (A) the representations and warranties of Equillium other than the Fundamental R&amp;Ws and IP R&amp;Ws shall be an amount equal to 10% of the Aggregate Payments, (B) the IP R&amp;Ws shall be an amount equal to 50% of the Aggregate Payments, provided that any payments actually made by Equillium under Section 11.2(a)(i) that would reduce the maximum amount recoverable under clause (A) shall also reduce the maximum amount recoverable under this clause (B) or (C) the Fundamental R&amp;Ws shall be an amount equal to 100% of the Aggregate Payments;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(iii)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">prior to the Closing, other than in respect of Fraud, the maximum aggregate amount of indemnifiable Losses which may be recovered from Equillium under Section 11.2(a)(i) and (ii) shall be an amount equal to the Development Funding actually paid to Equillium;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(iv)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">in no event shall, other than (A) pursuant to Section 11.2(a)(iii) or 11.8(a)(iii) or (B) in respect of Fraud, Equillium be liable in the aggregate in excess of an amount equal to the sum of 100% of the Aggregate Payments;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(v)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">other than (A) pursuant to Section 11.2(a)(iii) or 11.8(a)(iii) or (B) in respect of Fraud, if the amount of indemnifiable Losses which may be recovered from Equillium at any given time exceeds (x) the amount of Aggregate Payments actually paid by Ono to Equillium, less (y) the amount of any payments actually made by Equillium under Section 11.2(a)(i) or (ii), the Ono Indemnified Parties&#x2019; recourse in respect of such excess shall be limited to the Offset Right;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(vi)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">notwithstanding anything in Sections 11.8(a)(iii), 11.8(a)(iv) and 11.8(a)(v) to the contrary, other than in respect of Fraud, the maximum aggregate amount of indemnifiable Losses for which Equillium shall be liable with respect to a breach of Section 7.6 shall be an amount equal to the sum of the Upfront Payment and the Development Funding actually paid to Equillium;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(vii)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the maximum aggregate amount of indemnifiable Losses which may be recovered from Ono under Section 11.2(b)(ii) in respect of any breach of Section 3.7(b)</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">70</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">281923888 v10</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">shall be an amount equal to the Milestone Payment with respect to the Milestone Event that was not achieved as a result of such breach; and</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(viii)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">in no event shall, other than pursuant to Section 11.2(b)(iii), Ono be liable in the aggregate in excess of an amount equal to 100% of the Aggregate Payments.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(b)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If an Indemnifying Party has indemnified any Indemnified Party under this Article 11 for any Losses that are actually recovered by the Indemnified Party under any policies of insurance, then the Indemnified Party shall promptly reimburse the amount of such indemnification to the Indemnifying Party to the extent of such recovery under any policies of insurance (net of documented associated expenses and costs of recovery and any premium increases or retroactive premium adjustments, in each case to the extent arising out of, related to or resulting from the relevant Losses). For purposes of calculating the amount of Loss incurred by an Indemnified Party for purposes of this Agreement there shall be deducted an amount equal to the amount of any other indemnification payments, contribution payments, reimbursements or refunds that are received by such Indemnified Party or any of such Indemnified Party&#x2019;s Affiliates in connection with such Losses or the circumstances giving rise thereto (net of documented associated expenses and costs of recovery and any premium increases or retroactive premium adjustments, in each case to the extent arising out of, related to or resulting from the relevant Losses). Each Indemnified Party shall use commercially reasonable efforts to mitigate any Losses, which in the absence of mitigation might give rise to or increase Losses in respect of any claim under this Article 11. In no event will multiple recovery for any Losses be allowed.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11.9	No Anti-Sandbagging</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. The right to indemnification or other remedy under or in respect of this Agreement shall not be affected by any investigation conducted, or any knowledge acquired (or capable of being acquired) (other than pursuant to the Disclosure Schedules), in each case whether before or after the date of this Agreement or the Closing Date, with respect to the accuracy or inaccuracy of or compliance with any representation, warranty, covenant or agreement contained in this Agreement.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11.10	Effect of Waiver</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. The waiver of any condition to Closing based upon the accuracy of any representation or warranty, or on the performance of or compliance with any covenant or agreement, shall not affect any right to indemnification or other remedy of the waiving Party based on such representations, warranties, covenants and agreements.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11.11	Tax Matters</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. All indemnification and other payments under this Article 11 shall, to the extent permitted by applicable Law, be treated for all applicable Tax purposes as adjustments to the Purchase Price.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11.12	Right of Set Off</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Subject to the limitations in this Article 11, Ono is expressly authorized to secure payment for any Losses as a result of, arising out of or relating to Section 11.2, through set off of amounts owed to Equillium in respect of the Closing Payment or other Milestone Payments (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Offset Right</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) against such Losses. If at the time the Closing Payment or any other Milestone Payment is due and payable pursuant to Section 8.10, 3.6(b)(i) or 3.7(a) (as the case may be) there is any outstanding Claim Notice, then Ono shall be entitled, but shall not be required, to withhold from any such payment, only the amount of unresolved Losses claimed</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">71</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">281923888 v10</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">in the Claim Notice in accordance with Section 11.4 (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Offset Amount</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;). If the final amount of Losses for such Claim Notice is finally determined in accordance with this Article 11 to be less than the Offset Amount withheld from such payment, then Ono shall promptly, and in any event within [***] following the final determination of the actual amount of such Losses, pay to Equillium the balance of the applicable payment. To the extent any Losses claimed in a Claim Notice have been resolved between the Parties, and a Milestone Payment is due and payable or is reasonably expected to be due and payable within [***] of such Losses having been resolved, Ono shall first recover such Losses against such Milestone Payment pursuant to its Offset Right before seeking to recover directly from Equillium.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11.13	Exclusive Remedy</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. The Parties acknowledge and agree that, after the Closing, this Article 11 will provide the exclusive remedy of the Ono Indemnified Parties against the Equillium Indemnified Parties and the Equillium Indemnified Parties against the Ono Indemnified Parties for any breach of any representation, warranty, covenant or other claim arising out of or relating to this Agreement, the certificates to be delivered under Section 3.6(c)(i) and Section 3.6(b)(ii) and/or the transactions contemplated hereby. No Ono Indemnified Party or Equillium Indemnified Party may avoid the limitations on liability, recovery and recourse set forth in this Article 11 by seeking damages for breach of contract, tort or pursuant to any other theory or liability. Nothing in this Section 11.13 shall limit any Person&#x2019;s right to seek and obtain any equitable relief to which any Person shall be entitled to pursuant to Section 13.11.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11.14	Fraud</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Notwithstanding anything to the contrary contained in this Agreement, the limitations set forth in this Article 11 that would otherwise apply for the benefit of an Indemnifying Party shall not apply in respect of any Losses that arise out of or result from Fraud by or on behalf of such Indemnifying Party.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12.	TERMINATION</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12.1	Termination</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. This Agreement may be terminated at any time prior to the Closing:</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">by mutual written consent of the Parties;</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(b)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">by Equillium, if Equillium is not then in material breach of its obligations under this Agreement and Ono breaches or fails to perform in any respect any of its representations, warranties or covenants contained in this Agreement and such breach or failure to perform (i) would give rise to the failure of a condition set forth in Section 10.2, (ii) cannot be or has not been cured within [***] following delivery by Equillium to Ono of written notice of such breach or failure to perform and (iii) has not been waived by Equillium;</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(c)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">by Ono, if Ono is not then in material breach of its obligations under this Agreement and:</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(i)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Equillium breaches or fails to perform in any respect any of its representations, warranties or covenants contained in this Agreement and such breach or failure to perform (A) would give rise to the failure of a condition set forth in Section 10.3, (B) cannot be or has not been cured within [***] following delivery by Ono to Equillium of written notice of such breach or failure to perform and (C) has not been waived by Ono; or</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">72</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">281923888 v10</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(ii)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">subject to Section 2.4(e), Equillium discloses to Ono (including in accordance with Section 2.4 or 7.5), or Ono otherwise becomes aware of, any change, condition or event that (A) would give rise to the failure of the condition set forth in Section 10.3(a) or (b) (assuming that the representations and warranties of Equillium are not qualified by the Updated Disclosure Schedules except with respect to (I) any item added to any list set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Schedule 4.5</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.7(d)(i)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> or </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(ii)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.7(i)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.7(j)</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> or </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.14</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> of the Disclosure Schedules in light of any change, condition or event that occurred or arose after the date of this Agreement or (II) any change, condition or event resulting from any action (x) required or expressly permitted under this Agreement or the Development Plan (as set forth in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit C</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> to this Agreement taking into account any amendment thereto signed on behalf of each Party) or (y) consented to by Ono in writing (email being sufficient)) and (B) cannot be or has not been cured within following delivery by Ono to Equillium of written notice of such expected failure;</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(d)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">by either Party if the Closing shall not have occurred by (as extended or shortened in accordance with this Section 12.1(d), the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Long-Stop Date</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;); </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided, however,</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> that:</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(i)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the right to terminate this Agreement under this Section 12.1(d) shall not be available if the failure of the Party so requesting termination to fulfill any obligation under this Agreement shall have been the cause of, or shall have resulted in, the failure of the Closing to occur on or prior to the Long-Stop Date;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(ii)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">if the Data Package Review Period has commenced and would end after the Long-Stop Date, the Long-Stop Date shall be extended automatically to the end of the Data Package Review Period;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(iii)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">if the Option Exercise Effective Date occurs (A) less than [***] before the Long-Stop Date, the Long-Stop Date shall be extended automatically or (B) more than [***] before the Long-Stop Date, the Long-Stop Date shall be shortened automatically, in each case to the [***] from the Option Exercise Effective Date; and</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(iv)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]before either Party exercises its right to terminate this Agreement under this Section 12.1(d), it shall notify the other Party of its intention to so terminate this Agreement and discuss with the other Party in good faith whether it would be reasonable to extend the Long-Stop Date; or</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(e)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">by Ono in its sole discretion by delivery to Equillium of written notice of such termination.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Party seeking to terminate this Agreement pursuant to this Section 12.1 (other than Section 12.1(a)) shall give prompt written notice of such termination to the other Party.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12.2	Automatic Termination</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. This Agreement shall terminate automatically in accordance with Section 2.5.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12.3	Effect of Termination</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. In the event of termination of this Agreement as provided in Section 12.1 or 12.2, this Agreement shall forthwith become void and there shall be no liability on the part of either Party except (a) for the provisions of Section 7.7 (Confidentiality), Section</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">73</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">281923888 v10</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7.9 (Public Announcements), Section 8.11(b) (Financial Records and Audit), Article 13 (General Provisions), this Section 12.3 and Section 12.4 and (b) that no such termination shall relieve either Party from any liability or damages arising out of any breach of any of its representations, warranties, covenants or agreements set forth in this Agreement, in which case the non-breaching Party shall be entitled to all rights and remedies available under this Agreement or applicable Law.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12.4	Reimbursement After Termination</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Without limiting Section 12.3, in the event of termination of this Agreement by Ono pursuant to Section 12.1(e), Ono shall be obligated to reimburse Development Costs incurred by Equillium during the period of [***] beginning upon the effective date of such termination in the performance of the Program in accordance with the Development Plan and the provisions of Sections 3.7(f), 8.10 and Article 9, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">mutatis mutandis</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13.	GENERAL PROVISIONS</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13.1	Payments</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. All payments hereunder shall be made by wire transfer of immediately available funds in United States dollars to such account as may be designated to the payor by the payee at least [***] prior to the applicable payment date. In respect of any payment to be made by Ono to Equillium where the relevant amount is denominated in JPY, the rate of exchange shall be that applied by [***] for the purchase by Ono of United States dollars with Japanese Yen at the time of the payment.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13.2	Fees and Expenses</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Except as otherwise provided herein, all fees and expenses incurred in connection with or related to this Agreement, the other Transaction Documents and the Transactions shall be paid by the Party incurring such fees or expenses, whether or not such transactions are consummated; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided, however,</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> that no such fees and expenses payable by Equillium shall be paid from any assets otherwise transferable to Ono pursuant hereto. In the event of termination of this Agreement, the obligation of each Party to pay its own expenses will be subject to any rights of such Party arising from a breach of this Agreement by the other.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13.3	Amendment and Modification</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. This Agreement may not be amended, modified or supplemented in any manner, whether by course of conduct or otherwise, except by an instrument in writing specifically designated as an amendment hereto, signed on behalf of each Party.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13.4	Waiver</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. No failure or delay of either Party in exercising any right or remedy hereunder shall operate as a waiver thereof, nor shall any single or partial exercise of any such right or power, or any abandonment or discontinuance of steps to enforce such right or power, or any course of conduct, preclude any other or further exercise thereof or the exercise of any other right or power. The rights and remedies of the Parties hereunder are cumulative and are not exclusive of any rights or remedies which they would otherwise have hereunder. Any agreement on the part of either Party to any such waiver shall be valid only if set forth in a written instrument executed and delivered by a duly authorized officer on behalf of such Party.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13.5	Notices</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. All notices, requests, consents and other communications hereunder must be in writing to be effective and shall be deemed duly given (a) on the date of delivery if delivered personally, (b) on the date of delivery if sent by e-mail, provided that any e-mail sent after 5:00 p.m. on a Business Day or at any time on any day which is not a Business Day, in each case for</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">74</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">281923888 v10</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the recipient, shall be deemed to have been sent on the next Business Day for such recipient, (c) on the first Business Day following the date of dispatch if delivered utilizing a next-day service by a recognized next-day courier or (d) on the earlier of confirmed receipt or the fifth Business Day following the date of mailing if delivered by registered or certified mail, return receipt requested, postage prepaid. All notices hereunder shall be delivered to the addresses set forth below, or pursuant to such other instructions as may be designated in writing by the Party to receive such notice:</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If to Ono, to:	Ono Pharmaceutical Co., Ltd.</font></p>
  <p style="margin-left:26.667%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8-2, Kyutaromachi 1-chome, Chuo-ku</font></p>
  <p style="margin-left:26.667%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Osaka 541-8564, Japan</font></p>
  <p style="margin-left:26.667%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Attention: Executive Director, Corporate Development and</font></p>
  <p style="margin-left:26.667%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Strategy; Senior Director, Legal Department</font></p>
  <p style="margin-left:26.667%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Email: [***]</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">With a copy (which shall not be required to constitute valid notice) to:</font></p>
  <p style="margin-left:26.667%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Morrison &amp; Foerster LLP</font></p>
  <p style="margin-left:26.667%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Shin-Marunouchi Building, 29th Floor</font></p>
  <p style="margin-left:26.667%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5-1, Marunouchi 1-Chome, Chiyoda-ku, Tokyo 100-6529</font></p>
  <p style="margin-left:26.667%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Japan</font></p>
  <p style="margin-left:26.667%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Attention: [***]</font></p>
  <p style="margin-left:26.667%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Email: [***]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If to Equillium, to:	Equillium, Inc.</font></p>
  <p style="margin-left:26.667%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2223 Avenida de la Playa, Suite 105</font></p>
  <p style="margin-left:26.667%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">La Jolla, CA 92037</font></p>
  <p style="margin-left:26.667%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">USA</font></p>
  <p style="margin-left:26.667%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Attention: Bruce Steel</font></p>
  <p style="margin-left:26.667%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Email: [***]</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">With a copy (which shall not be required to constitute valid notice) to:</font></p>
  <p style="margin-left:26.667%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cooley LLP</font></p>
  <p style="margin-left:26.667%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10265 Science Center Drive</font></p>
  <p style="margin-left:26.667%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">San Diego, CA 92121</font></p>
  <p style="margin-left:26.667%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">USA</font></p>
  <p style="margin-left:26.667%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Attention: [***]</font></p>
  <p style="margin-left:26.667%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Email: [***]</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13.6	Interpretation</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. When a reference is made in this Agreement to a Section, Article, Exhibit, Appendix or Schedule such reference shall be to a Section, Article, Exhibit, Appendix or Schedule of this Agreement unless otherwise indicated. The table of contents and headings contained in this Agreement or in any Exhibit, Appendix or Schedule are for convenience of reference purposes only and shall not affect in any way the meaning or interpretation of this Agreement. References to this Agreement or to any other document is a reference to such document as varied, amended, modified, novated or supplemented from time to time. All words</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">75</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">281923888 v10</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">used in this Agreement will be construed to be of such gender or number as the circumstances require. Any capitalized terms used in any Exhibit, Appendix or Schedule but not otherwise defined therein shall have the meaning as defined in this Agreement. All Exhibits, Appendices and Schedules annexed hereto or referred to herein are hereby incorporated in and made a part of this Agreement as if set forth herein. The word &#x201c;including&#x201d; and words of similar import when used in this Agreement will mean &#x201c;including, without limitation,&#x201d; unless otherwise specified. The words &#x201c;hereof,&#x201d; &#x201c;herein&#x201d; and &#x201c;hereunder&#x201d; and words of similar import when used in this Agreement shall refer to this Agreement as a whole and not to any particular provision in this Agreement. The term &#x201c;or&#x201d; is not exclusive. The word &#x201c;will&#x201d; shall be construed to have the same meaning and effect as the word &#x201c;shall.&#x201d; References to days mean calendar days unless otherwise specified. References to &#x201c;dollars&#x201d;, &#x201c;$&#x201d; or &#x201c;US$&#x201d; refer to United States dollars. References to &#x201c;JPY&#x201d; or &#x201c;&#165;&#x201d; refer to Japanese Yen.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13.7	Entire Agreement</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. This Agreement (including the Exhibits, Appendices and Schedules hereto, including the Disclosure Schedules and the Updated Disclosure Schedules) and the other Transaction Documents constitute the entire agreement, and supersede all prior written agreements, arrangements, communications and understandings and all prior and contemporaneous oral agreements, arrangements, communications and understandings between the Parties, with respect to the subject matter hereof and thereof. Notwithstanding any oral agreement or course of conduct of the Parties or their Representatives to the contrary, neither Party shall be under any legal obligation to enter into or complete the transactions contemplated hereby unless and until this Agreement shall have been executed and delivered by each Party.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13.8	No Third-Party Beneficiaries</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Except as provided in Article 11, nothing in this Agreement, express or implied, is intended to or shall confer upon any Person other than the Parties and their respective successors and permitted assigns any legal or equitable right, benefit or remedy of any nature under or by reason of this Agreement.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13.9	Governing Law</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. This Agreement and all disputes or controversies arising out of or relating to this Agreement or the transactions contemplated hereby shall be governed by, and construed in accordance with, the internal laws of the State of Delaware, without regard to its conflicts of laws principles or the laws of any other jurisdiction that might be applied because of the conflicts of laws principles of the State of Delaware.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13.10	Arbitration</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Any and all disputes and controversies arising out of, relating to or in connection with this Agreement, the other Transaction Documents (unless the relevant Transaction Document in dispute or controversy stipulates otherwise) or the Transaction (each, a &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Dispute</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) shall be finally settled by arbitration by a tribunal of three arbitrators under the ICC Rules of Arbitration in effect at the time of the arbitration (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ICC Rules</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) in accordance with the following terms and conditions:</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(i)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In the event of any conflict between the ICC Rules and the provisions of this Agreement, the provisions of this Agreement shall prevail.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">76</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">281923888 v10</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(ii)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In the event that any Party asserts that there exists a Dispute, such Party shall deliver a written notice to the other Party specifying the nature of the asserted Dispute and requesting a meeting to attempt to resolve the same. If no such resolution is reached within 30 days after the delivery of such notice, either Party may commence arbitration hereunder by delivering to the other Party a request for arbitration, which shall specify (A) the matters as to which arbitration is sought, (B) the nature of any Dispute, (C) the claims of the disputing Party, (D) the amount and nature of any Losses, if any, sought to be recovered as a result of an alleged claim and (E) any other matters required by the ICC Rules then in force.</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(iii)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Any dispute concerning the scope or applicability of this agreement to arbitrate or the propriety of commencing arbitration shall be determined by the arbitral tribunal.</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(iv)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The arbitration seat, or legal place of arbitration, shall be New York, New York, and the language of the arbitration shall be English.</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(v)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Parties agree to keep confidential the existence and contents of the arbitration, the arbitral proceedings, the submissions made by the Parties and the decisions made by the arbitral tribunal, except as may be necessary to prepare for or conduct the arbitration, as may be necessary in connection with a court application for a preliminary remedy or a judicial challenge to an arbitral award or its enforcement, or as required by applicable Law.</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(vi)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Ono and Equillium shall each have the right to nominate one arbitrator, and the two party-nominated arbitrators shall nominate the third arbitrator, who shall serve as President of the tribunal, [***] of the second arbitrator&#x2019;s appointment.</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(vii)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The arbitrators shall apply the substantive Law set forth in Section 13.9 without reference to conflicts of law principles.</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(viii)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The arbitrators shall have the power to grant any remedy or relief that they deem just and equitable and that is in accordance with the terms of this Agreement, including specific performance, and including injunctive relief, whether interim or final, and any such relief and any interim, provisional or conservatory measure ordered by the arbitrators may be specifically enforced by any court of competent jurisdiction. Each Party retains the right to seek interim, provisional or conservatory measures from judicial authorities, and any such request shall not be deemed incompatible with the agreement to arbitrate or a waiver of the right to arbitrate.</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(ix)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The award of the arbitrators shall be final and binding on the Parties and there shall be no appeal from or reexamination of the arbitrators&#x2019; award, except to correct manifest clerical errors.</font></p>
  <p style="text-indent:20.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(x)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The award of the arbitrators may be enforced by any court of competent jurisdiction and may be executed against the losing Party and its assets in any competent jurisdiction.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(b)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Except for arbitration proceedings pursuant to this Section 13.10, no action, suit or other proceeding (other than the enforcement of an arbitration decision, an action to compel arbitration or an application for interim, provisional or conservatory measures in connection with</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">77</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">281923888 v10</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the arbitration) shall be brought by or between the Parties in connection with any matter arising out of or in connection with this Agreement, the other Transaction Documents or the Transaction.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(c)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Each Party hereby irrevocably submits to the non-exclusive jurisdiction of any state or federal court sitting in the Borough of Manhattan, the City of New York, in connection with any such action, suit or proceeding permitted by Section 13.10(b), and agrees that any such action, suit or proceeding may be brought in such court; provided, that such consent to jurisdiction is solely for the purpose referred to in this Section 13.10(c) and shall not be deemed to be a general submission to jurisdiction other than for such purpose. Each Party hereby irrevocably waives defense of an inconvenient forum to the maintenance of any such action or proceeding.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13.11	Enforcement</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. The Parties agree that irreparable damage would occur in the event that any of the provisions of this Agreement were not performed in accordance with their specific terms or were otherwise breached. Accordingly, except in respect of Section 3.7(b), each Party shall be entitled to specific performance of the terms hereof, including an injunction or injunctions to prevent breaches of this Agreement and to enforce specifically the terms and provisions of this Agreement, this being in addition to any other remedy to which such Party is entitled at law or in equity. Except in respect of Section 3.7(b), each Party hereby further waives (a) any defense in any action for specific performance that a remedy at law would be adequate and (b) any requirement under any law to post security as a prerequisite to obtaining equitable relief.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13.12	Waiver of Jury Trial</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. EACH PARTY HEREBY IRREVOCABLY WAIVES ALL RIGHT TO A TRIAL BY JURY IN ANY ACTION, PROCEEDING OR COUNTERCLAIM ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13.13	Assignment; Successors</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Subject to Sections 13.13(b) and (c), neither this Agreement nor any of the rights, interests or obligations under this Agreement may be assigned, in whole or in part, by either Party without the prior written consent of the other Party, and any such assignment without such prior written consent shall be null and void. This Agreement will be binding upon, inure to the benefit of, and be enforceable by, the Parties and their respective successors and permitted assigns.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(b)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As a condition to and effective simultaneously with an Equillium Change of Control, Equillium shall assign this Agreement and its rights and obligations under this Agreement to the counterparty of such Equillium Change of Control, provided that (i) such assignment shall not enlarge, alter or change any obligation of Ono due to the assignee, and (ii) promptly following such Equillium Change of Control, such assignee confirms in writing to Ono that upon such Equillium Change of Control, it has assumed and is bound as Equillium under this Agreement and any other applicable Transaction Document.</font></p>
  <p style="text-indent:13.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(c)	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Ono may assign (i) this Agreement or its rights to purchase any of the Purchased Assets under this Agreement to any one or more of its Affiliates or (ii) this Agreement to the buyer upon the closing of a Sale of the Business, in each case without the prior consent of Equillium, provided that (A) such assignment does not enlarge, alter or change any obligation of Equillium due to the assignee, (B) Ono complies with Section 3.7(e) to the extent applicable and</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">78</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">281923888 v10</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(C) promptly following such assignment, such assignee confirms in writing to Equillium that upon such assignment, it has assumed and is bound as Ono under this Agreement and any other applicable Transaction Document (in the case of an assignment of any rights under this Agreement, to the extent applicable in respect of such rights).</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13.14	Severability</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Whenever possible, each provision or portion of any provision of this Agreement shall be interpreted in such manner as to be effective and valid under applicable Law, but if any provision or portion of any provision of this Agreement is held to be invalid, illegal or unenforceable in any respect under any applicable Law or rule in any jurisdiction, such invalidity, illegality or unenforceability shall not affect any other provision or portion of any provision in such jurisdiction, and this Agreement shall be reformed, construed and enforced in such jurisdiction as if such invalid, illegal or unenforceable provision or portion of any provision had never been contained herein.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13.15	Counterparts</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. This Agreement may be executed in several counterparts, each of which will constitute an original and all of which, when taken together, will constitute one agreement. This Agreement may be executed by .PDF or by other means of electronic signature (including DocuSign), and the exchange of a fully executed Agreement (in counterparts or otherwise) by electronic means in .PDF format shall in each case create a valid and binding obligation of the Party executing the same.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13.16	No Presumption Against Drafting Party</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Each Party acknowledges that it has been represented by legal counsel in connection with this Agreement and the transactions contemplated by this Agreement. Accordingly, any rule of law or any legal decision that would require interpretation of any claimed ambiguities in this Agreement against the drafting Party has no application and is expressly waived.</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">79</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">281923888 v10</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">IN WITNESS WHEREOF, Ono and Equillium have caused this Agreement to be executed as of the date first written above by their respective officers thereunto duly authorized.</font></p>
  <p style="margin-left:40.0%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);font-variant:small-caps;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ONO PHARMACEUTICAL CO., LTD.</font></p>
  <p style="margin-left:40.0%;text-indent:0.0%;font-size:10.0pt;margin-top:24.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">By: </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Gyo Sagara</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">	</font></p>
  <p style="margin-left:43.333%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name:  Gyo Sagara</font></p>
  <p style="margin-left:43.333%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Title:  President, Representative Director and CEO</font></p>
  <p style="margin-left:43.333%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:40.0%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);font-variant:small-caps;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">EQUILLIUM, INC.</font></p>
  <p style="margin-left:40.0%;text-indent:0.0%;font-size:10.0pt;margin-top:24.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">By: </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Bruce Steel</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">	</font></p>
  <p style="margin-left:43.333%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name:  Bruce Steel</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="margin-left:43.333%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Title:  Chief Executive Officer</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="margin-left:40.0%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.56%;text-indent:0.0%;font-size:10.0pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">82</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:38.32%;text-indent:0.0%;font-size:10.0pt;margin-top:3.95pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:37.574%;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">EXHIBIT A</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:38.32%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:37.537%;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Compound [***]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.56%;text-indent:0.0%;font-size:10.0pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">83</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:38.32%;text-indent:0.0%;font-size:10.0pt;margin-top:3.95pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:37.546%;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">EXHIBIT B</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:35.52%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:34.806%;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Program Patents</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.92%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.56%;text-indent:0.0%;font-size:10.0pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">84</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:38.32%;text-indent:0.0%;font-size:10.0pt;margin-top:3.95pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:37.565%;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">EXHIBIT C</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:35.52%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:34.806%;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Development Plan</font></p>
  <p style="margin-left:35.52%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:34.806%;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[***]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.56%;text-indent:0.0%;font-size:10.0pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</font></p>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21
<SEQUENCE>4
<FILENAME>eq-ex21_1.htm
<DESCRIPTION>EX-21.1
<TEXT>
<html>
 <head>
  <title>EX-21</title>
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit 21.1</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">SUBSIDIARIES OF EQUILLIUM, INC.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p>
  <table style="border-spacing:0;table-layout:fixed;width:92.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:47.962%;"></td>
    <td style="width:1.022%;"></td>
    <td style="width:51.016%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;padding-bottom:1.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:0.75pt solid;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of Subsidiary</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;padding-bottom:1.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:0.75pt solid;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Jurisdiction of Incorporation</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Equillium AUS Pty Ltd.</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Australia</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Bioniz Therapeutics, Inc.</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Delaware</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Triumph Acquisition Sub, Inc.</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Delaware</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Equillium Acquisition Sub, Inc.</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Delaware</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Triumph Merger Sub, Inc.</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Delaware</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:8.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23
<SEQUENCE>5
<FILENAME>eq-ex23_1.htm
<DESCRIPTION>EX-23.1
<TEXT>
<html>
 <head>
  <title>EX-23</title>
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Exhibit 23.1</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Consent of Independent Registered Public Accounting Firm</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">The Board of Directors<br>Equillium, Inc.:</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">We consent to the incorporation by reference in the registration statements (Nos. 333-254656, 333-230536, 333-227859, 333-263790, 333-237407, and 333-269154) on Form S-8, and (No. 333-269153) on Form S-3 of our report dated March 23, 2023, with respect to the consolidated financial statements of Equillium, Inc.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">/s/ KPMG LLP</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">San Diego, California<br>March 23, 2023</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31
<SEQUENCE>6
<FILENAME>eq-ex31_1.htm
<DESCRIPTION>EX-31.1
<TEXT>
<html>
 <head>
  <title>EX-31</title>
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit 31.1</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:13.2pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">CERTIFICATION PURSUANT TO</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">SECTION 302 OF THE SARBANES OXLEY ACT OF 2002</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:13.2pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">I, Bruce D. Steel, certify that:</font></p>
  <div style="text-indent:0.0%;display:flex;margin-top:6.6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.537%;">1.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">I have reviewed this annual report on Form 10-K of Equillium, Inc., a Delaware corporation (the &#34;registrant&#34;);</font></div></div>
  <div style="text-indent:0.0%;display:flex;margin-top:6.6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.537%;">2.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</font></div></div>
  <div style="text-indent:0.0%;display:flex;margin-top:6.6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.537%;">3.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</font></div></div>
  <div style="text-indent:0.0%;display:flex;margin-top:6.6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.537%;">4.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The registrant&#x2019;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">(a)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">(b)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">(c)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Evaluated the effectiveness of the registrant&#x2019;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">(d)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Disclosed in this report any change in the registrant&#x2019;s internal control over financial reporting that occurred during the registrant&#x2019;s most recent fiscal quarter (the registrant&#x2019;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#x2019;s internal control over financial reporting; and</font></div></div>
  <div style="text-indent:0.0%;display:flex;margin-top:6.6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.537%;">5.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The registrant&#x2019;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#x2019;s auditors and the audit committee of the registrant&#x2019;s board of directors (or persons performing the equivalent functions):</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">(a)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#x2019;s ability to record, process, summarize and report financial information; and</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">(b)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#x2019;s internal control over financial reporting.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <table style="border-spacing:0;table-layout:fixed;width:50.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:100.0%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Date: March 23, 2023</font></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Bruce D. Steel</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Bruce D. Steel</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Chief Executive Officer</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(Principal Executive Officer)</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31
<SEQUENCE>7
<FILENAME>eq-ex31_2.htm
<DESCRIPTION>EX-31.2
<TEXT>
<html>
 <head>
  <title>EX-31</title>
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit 31.2</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:13.2pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">CERTIFICATION PURSUANT TO</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">SECTION 302 OF THE SARBANES OXLEY ACT OF 2002</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:13.2pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">I, Jason A. Keyes, certify that:</font></p>
  <div style="text-indent:0.0%;display:flex;margin-top:6.6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.537%;">1.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">I have reviewed this annual report on Form 10-K of Equillium, Inc., a Delaware corporation (the &#34;registrant&#34;);</font></div></div>
  <div style="text-indent:0.0%;display:flex;margin-top:6.6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.537%;">2.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</font></div></div>
  <div style="text-indent:0.0%;display:flex;margin-top:6.6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.537%;">3.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</font></div></div>
  <div style="text-indent:0.0%;display:flex;margin-top:6.6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.537%;">4.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The registrant&#x2019;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">(a)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">(b)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Designed such control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">(c)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Evaluated the effectiveness of the registrant&#x2019;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">(d)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Disclosed in this report any change in the registrant&#x2019;s internal control over financial reporting that occurred during the registrant&#x2019;s most recent fiscal quarter (the registrant&#x2019;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#x2019;s internal control over financial reporting; and</font></div></div>
  <div style="text-indent:0.0%;display:flex;margin-top:6.6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.537%;">5.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The registrant&#x2019;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#x2019;s auditors and the audit committee of the registrant&#x2019;s board of directors (or persons performing the equivalent functions):</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">(a)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#x2019;s ability to record, process, summarize and report financial information; and</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">(b)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#x2019;s internal control over financial reporting.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <table style="border-spacing:0;table-layout:fixed;width:50.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:100.0%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Date: March 23, 2023</font></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Jason A. Keyes</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Jason A. Keyes</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Chief Financial Officer</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(Principal Financial and Accounting Officer)</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32
<SEQUENCE>8
<FILENAME>eq-ex32_1.htm
<DESCRIPTION>EX-32.1
<TEXT>
<html>
 <head>
  <title>EX-32</title>
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit 32.1</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Certification Pursuant to 18 U.S.C. Section 1350, as Adopted</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pursuant to the requirement set forth in Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended (the &#x201c;Exchange Act&#x201d;), and Section 1350 of Chapter 63 of Title 18 of the United States Code, each of the undersigned hereby certifies in his capacity as an officer of Equillium, Inc. (the &#x201c;Company&#x201d;), that, to the best of his knowledge:</font></p>
  <div style="text-indent:0.0%;font-size:0;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.984988947906702%;">(1)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the Company&#x2019;s Annual Report on Form 10-K for the annual period ended December 31, 2022, to which this Certification is attached as Exhibit 32.1 (the &#x201c;Report&#x201d;) fully complies with the requirements of Section 13(a) or Section 15(d) of the Exchange Act; and</font></div></div>
  <div style="text-indent:0.0%;font-size:0;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.984988947906702%;">(2)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <table style="border-spacing:0;table-layout:fixed;width:50.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:100.0%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Bruce D. Steel</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Bruce D. Steel</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Chief Executive Officer</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(Principal Executive Officer)</font></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Date: March 23, 2023</font></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.75pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Jason A. Keyes</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Jason A. Keyes</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Chief Financial Officer</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(Principal Financial and Accounting Officer)</font></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Date: March 23, 2023</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">This certification accompanies the Annual Report on Form 10-K to which it relates, is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of Equillium, Inc. under the Securities Act of 1933, as amended, or the Exchange Act (whether made before or after the date of the Form 10-K), in such filing.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </font></p>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>img268224062_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img268224062_0.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" <!#Y,# 2(  A$! Q$!_\0
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MUG_"P=6_Y][+_OA__BJ/^%@ZM_S[V7_?#_\ Q5<G11]1PW\B#^T<5_.SK/\
MA8.K?\^]E_WP_P#\51_PL'5O^?>R_P"^'_\ BJY.BCZCAOY$']HXK^=G6?\
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MKDZ*/J.&_D0?VCBOYV=9_P +!U;_ )][+_OA_P#XJC_A8.K?\^]E_P!\/_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_P# V3_XJC_A+?$O_0PZM_X&R?\ Q5'U9]P^N1['U917RG_PEOB7_H8=6_\
M V3_ .*H_P"$M\2_]##JW_@;)_\ %4?5GW#ZY'L?5E%?*?\ PEOB7_H8=6_\
M#9/_ (JC_A+?$O\ T,.K?^!LG_Q5'U9]P^N1['U917RG_P );XE_Z&'5O_ V
M3_XJC_A+?$O_ $,.K?\ @;)_\51]6?</KD>Q]645\I_\);XE_P"AAU;_ ,#9
M/_BJ/^$M\2_]##JW_@;)_P#%4?5GW#ZY'L?5E%?*?_"6^)?^AAU;_P #9/\
MXJC_ (2WQ+_T,.K?^!LG_P 51]6?</KD>Q]645\I_P#"6^)?^AAU;_P-D_\
MBJ/^$M\2_P#0PZM_X&R?_%4?5GW#ZY'L?5E%?*?_  EOB7_H8=6_\#9/_BJ/
M^$M\2_\ 0PZM_P"!LG_Q5'U9]P^N1['U917RG_PEOB7_ *&'5O\ P-D_^*H_
MX2WQ+_T,.K?^!LG_ ,51]6?</KD>Q]645\I_\);XE_Z&'5O_  -D_P#BJ/\
MA+?$O_0PZM_X&R?_ !5'U9]P^N1['U917RG_ ,);XE_Z&'5O_ V3_P"*H_X2
MWQ+_ -##JW_@;)_\51]6?</KD>Q]645\I_\ "6^)?^AAU;_P-D_^*H_X2WQ+
M_P!##JW_ (&R?_%4?5GW#ZY'L?5E%?*?_"6^)?\ H8=6_P# V3_XJC_A+?$O
M_0PZM_X&R?\ Q5'U9]P^N1['U917RG_PEOB7_H8=6_\  V3_ .*H_P"$M\2_
M]##JW_@;)_\ %4?5GW#ZY'L?5E%?*?\ PEOB7_H8=6_\#9/_ (JC_A+?$O\
MT,.K?^!LG_Q5'U9]P^N1['U917RG_P );XE_Z&'5O_ V3_XJC_A+?$O_ $,.
MK?\ @;)_\51]6?</KD>Q]645\I_\);XE_P"AAU;_ ,#9/_BJ/^$M\2_]##JW
M_@;)_P#%4?5GW#ZY'L?5E%?*?_"6^)?^AAU;_P #9/\ XJC_ (2WQ+_T,.K?
M^!LG_P 51]6?</KD>Q]645\I_P#"6^)?^AAU;_P-D_\ BJ/^$M\2_P#0PZM_
MX&R?_%4?5GW#ZY'L?5E%?*?_  EOB7_H8=6_\#9/_BJ/^$M\2_\ 0PZM_P"!
MLG_Q5'U9]P^N1['U917RG_PEOB7_ *&'5O\ P-D_^*H_X2WQ+_T,.K?^!LG_
M ,51]6?</KD>Q]645\I_\);XE_Z&'5O_  -D_P#BJ/\ A+?$O_0PZM_X&R?_
M !5'U9]P^N1['U917RG_ ,);XE_Z&'5O_ V3_P"*H_X2WQ+_ -##JW_@;)_\
M51]6?</KD>Q]645\I_\ "6^)?^AAU;_P-D_^*H_X2WQ+_P!##JW_ (&R?_%4
M?5GW#ZY'L?5E%?*?_"6^)?\ H8=6_P# V3_XJC_A+?$O_0PZM_X&R?\ Q5'U
M9]P^N1['U917RG_PEOB7_H8=6_\  V3_ .*H_P"$M\2_]##JW_@;)_\ %4?5
MGW#ZY'L?5E%?*?\ PEOB7_H8=6_\#9/_ (JC_A+?$O\ T,.K?^!LG_Q5'U9]
MP^N1['U917RG_P );XE_Z&'5O_ V3_XJC_A+?$O_ $,.K?\ @;)_\51]6?</
MKD>Q]645\I_\);XE_P"AAU;_ ,#9/_BJ/^$M\2_]##JW_@;)_P#%4?5GW#ZY
M'L?5E%?*?_"6^)?^AAU;_P #9/\ XJC_ (2WQ+_T,.K?^!LG_P 51]6?</KD
M>Q]645\I_P#"6^)?^AAU;_P-D_\ BJ/^$M\2_P#0PZM_X&R?_%4?5GW#ZY'L
M?5E%?*?_  EOB7_H8=6_\#9/_BJ/^$M\2_\ 0PZM_P"!LG_Q5'U9]P^N1['U
M917RG_PEOB7_ *&'5O\ P-D_^*H_X2WQ+_T,.K?^!LG_ ,51]6?</KD>Q]64
M5\I_\);XE_Z&'5O_  -D_P#BJ/\ A+?$O_0PZM_X&R?_ !5'U9]P^N1['U91
M7RG_ ,);XE_Z&'5O_ V3_P"*H_X2WQ+_ -##JW_@;)_\51]6?</KD>Q]645\
MI_\ "6^)?^AAU;_P-D_^*H_X2WQ+_P!##JW_ (&R?_%4?5GW#ZY'L?5E%?*?
M_"6^)?\ H8=6_P# V3_XJC_A+?$O_0PZM_X&R?\ Q5'U9]P^N1['U917RG_P
MEOB7_H8=6_\  V3_ .*H_P"$M\2_]##JW_@;)_\ %4?5GW#ZY'L?5E%?*?\
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M-D_^*H_X2WQ+_P!##JW_ (&R?_%4?5GW#ZY'L?5E%?*?_"6^)?\ H8=6_P#
MV3_XJE'B_P 2JP(\0ZKD'/-Y(?ZT?5GW#ZY'L?5=%?-%C\3/%U@^5U=YEQ@I
M<(L@/XD9_(UWWA_XUVMQ*L.OV7V7./\ 2+;+H/7*_> ^F?IWJ)4)HN&*IRT>
MAZS14-I=V]_:175K,DT$JADD0Y#"IJQ.D**** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "LGQ%K*:+I3S]9GRD(_P!K'4^PK6KR_P <
M:@;S7C;AB8K5=@&.-QY8_P A^%=N PZKUE%[+5G!F.)>'H.4=WHCGIII;F9Y
MIG9Y'.69CR34=%%?6I6T1\6VV[L****8@HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH VO#6NOHNHJS-_HLI"S+UX_O#W%>M*P
M90RD%2,@CH:\+KU'P3J)O= 6)VS);-Y1R>=O5?TX_"O#S?#*RK1]&?0Y)BG=
MT);;K]3I****\ ^C"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MW<])HHHKY ^V"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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ME"4=U891115""BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#ZH\'ZN
M==\):;J#MNEDA"RG(YD7Y6/'J03^-;E>>?!B=IO [H22(;R1!GL-JMQ_WU7H
M=>;-6DT>S2ES03"BBBI+"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH *\*KW6O"J]W)/^7GR_4^=S_\ Y=_/] HHHKWCYT**** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KK/A]_R'Y_^O5O_
M $)*Y.NL^'W_ "'Y_P#KU;_T)*Y,=_NT_0[<N_WJ'J>DT445\>?;A1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 5QWQ4_Y)OJW_;'_P!')78UQWQ4_P"2
M;ZM_VQ_]')50^)&=7X)>C/FRBBBO2/'"BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ KIO"'@C4_&%TPMAY-G&=LUTXRJG&< ?Q'V'3(SC-96@://X@UZS
MTJW.)+F0*6QG8O5FQD9PH)QWQ7U+I&DVFAZ5;Z=8Q^7;P+M4=R>I)]R<FL:M
M3D5EN=&'H>T=WL9?ASP1H7AB-?L-HK7 ZW4P#2GUY[#CH,"NBKG/%WC33?"%
MCYMT?-NI 3!:H<-(?4G^%??\L]*\5U;XK^*=2N6>WO%L(#D+#;H.![L023^0
M]A7-&G.IJ=DZU.E[I]&TC*&4JP!4C!!Z&OEF#QKXHMI/,37]2+>DEPSC\F)%
M=IX>^-&IVCI%KMNE]!GYIHE"2C\!A3],#ZU3P\EL3'%P;L]#L?%WPHTK74>Z
MTL)I^H8)^48BD/7Y@.G/<?D:\*U;2;W1-2FT_4(&AN(C@J>A'8@]P?6OJ:QU
M[2]2T?\ M:UO8GL0I9IB=H0#KNSTQ[UX#\1_&</BW5XULX$6RM,I%,R8DESU
M)/4+Z#\3R<"Z$IWLS+$PII<RW*?PW_Y*%H__ %U;_P! :OINOF3X;_\ )0M'
M_P"NK?\ H#5]-U.(^)&F#^!^H45X=X[^('BC1O&FHZ?8:GY-K"R"./[/$V,H
MI/)4GJ36?8_&7Q/;%!<K9W: C?OBVLP[\J0 ?P_#M4JA)JZ*>*@G9GM&L>%-
M"U\-_:6F6\[D >;MVR  Y^^,-^M>'>//AS<^$R+VS>2ZTICCS&'SPG/ ?'&#
MV;@9XP.,^N>#_B#I7BY?(CW6NH*N6MI#R1@9*G^(?KQTKJKBWAN[:6WN(UEA
ME4HZ.,AE/!!I1G*F[,<Z<*T;K[SX_HKH/&GAQO"_B>YT[DP?ZRW8]XVZ=^W(
M_"N?KN3NKH\R2<79A7:?##PU_P )#XLBDF3=9V.)YL]"<_(OXGGZ UQ=?37P
M^\-'PQX4@MYDVWD_[^YSU#D?=ZGH,#CTS65:?+$VP]/GGKLCI+JUM[VW>WNH
M(YX7&&CD4,K#W!KY?\9#24\5WT6B0"&QBD\M0&+!F'WB,]LYQ["O=?B5XH/A
MGPM)]GD"W]X?)M^F5_O/C/8=^<$K7S96>'B]S;&35U$****ZCB"BBB@ HHHH
M *='&\LB1QHSR.0JJHR6)Z #UIM=M\*]!76_&D$LRL;>P'VIL X+ C8">WS8
M/N%-3)\JN5"+E)11[QX:T6/P[X<LM*C.[R(\.W]YR<L>IZDFM.6))X7BD4-&
MZE64]P>"*?2*P90RD%2,@CH:\YN[N>RDDK(^4/$6C2>'_$-]I4C;C;R%58_Q
M*>5/X@@UEUZW\;="\J\L=>C^[,/LTPQ_$,E3^(W#_@(KR2O0IRYHIGD58<DW
M$*['X5_\E(TG_MM_Z)>N.KL?A7_R4C2?^VW_ *)>B?PL5+XX^J/I.OF3XD?\
ME"UC_KJO_H"U]-U\R?$C_DH6L?\ 75?_ $!:YL/\3.[&? O4Y:BBBNP\X559
MW5$4LS'  &237L'@GX0[ECU#Q,K+SNCL0W;_ *:$?^@C\3U%0_![P?'<R'Q+
M>KN6)REHAZ;AU?KVY S]>PKVDD $DX KEK56GRQ.[#X=-<\BO96%IIMJEK8V
MT5M GW8XD"J/P%6*\G\7_&**SFDLO#B17#KE6O),E <X^4?Q?7./K7FMWX]\
M5WIS+KUZO.?W,GE?^@8]:SC0E+5FL\5"&BU/J*J&K:)INNVAM=3LXKF(]-Z\
MJ<$9!Z@\GD5\[:9\2?%FELFS5I;F-3DQW8\T-[$GYOR(KU3P;\5[#7Y8K#5(
MUL-1<A$(),4S>@)^Z2<\'VY).*)49QU00Q%.>C.&\<_"RX\/PS:II+O=::GS
M21L,R0#N3_>4>O4=QP37G%?3GC7QI8^$=,+R[9KV8$06V?O>[>BC]>E?,\\Q
MN+B68I&AD<N5C4*JY.< #H/:NBC*4EJ<F)A"$O=(Z**U?#6CMX@\26&E*647
M$H5V7JJ#EB/<*":U;LKG.E=V1[O\*="_L;P7!/)_K]0/VEN.BD80?ES_ ,"-
M=Q3(HD@A2*-0L:*%51V X IP8$D @D'!QVKSI/F=SVH148J*/G'XI:#_ &)X
MTN)(T(M[\?:4.#@,2=XSZ[LG'8,*XJOH#XPZ"-3\*KJ<:L9].;?\JDDQL0&'
MX<'/8 ^]?/\ 7;2ES1/+Q$.2HPHHHK4Q/6/@99H^J:Q>D'S(88X0<]G8D_\
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M:?X\UF 9P;DR\_[8#_E\U3AGJT7C%HF<Y11176< 4444 ?7MC_R#[;_KDO\
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M?A_6M/MS<7ND:A;0*0#)-;.BC/3DC%%T%GN9U%%.CC>61(XT9Y'(5549+$]
M!ZTP&T5L?\(EXE_Z%[5O_ *3_P")K/O;"\TV?R+ZTGM9L!O+GC*-CUP1G%*Z
M8W%K=%>BBM/2?#VL:[($TS3KBYY*ET3Y%.,X+'@?B:&[;B2;T1F45U[?"[QF
MJ;SHK8QGBXB)_+=FN;U#2[_2I_(U"SGM9><+-&5S],]124D]F4X2CNBI16K#
MX7\07$,<T.A:G)%(H='2TD*LI&000.0:@OM&U32T1]0TV\M%<X0W$#1AC[9
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MSH4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !76?#[_D/S_]>K?^A)7)UUGP^_Y#\_\ UZM_Z$E<F._W:?H=N7?[U#U/
M2:***^//MPHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M"QT<5=6LT;8[+Y82SO=,AHHHKN/."BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MJZA.8WVAL'&.A!'>NF-W#Y'%)J-6_9GUU17S9_PM3QI_T&?_ "5A_P#B*/\
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M5PWQS_Y!.D?]=W_]!%>GV%G#IVGVUE;KMAMXEB0>BJ,#^5>8?'/_ )!.D?\
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M;>;(LQ4'S&7 V@]B/6NC$5XT(<\MCEPV&GB*GLX;^9Q56M,_Y"MG_P!=T_\
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MD9;'!"DC]\_I_O5Y76F6?5[2]BGYW_X!GFWUF\?;M=;6O^H4445ZIXX4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M^FV,6EZ9:V$ Q%;1+$GT48KRKXW:ZHAL-!B?YR?M,X'8<J@/U^8X]A[5B?\
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MGH/UKH[;P9HEL!FV:9O[TKD_H,#]*ZG3P-'24G-^6W]?,Y%4S"MK"*@O/?\
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MA_9_AVV0C$DH\Y^,<MT_3 _"N4U[0C+XXA@5<17K+(<+@ ?Q_CP3^->B
M  #H!77F>*52E!+KK_7XG%E.$=*M4E+[.B_K[C'U[5?[.;3XE(WW-TB'_<!&
M[^8_.MFO,/&^H&Y\0F)&(6U4("/[W4G^0_"O2[>9;BVBF4@K(@<$="",UQXG
M#^RHTY=7?_@?@=V%Q7MJ]6'2-K?K^)Y;XS@,'B>Y)^[*%=>?]D#^8-96F?\
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M'^)P/QK;+\4GAKS^S^70QS+!R6+2@OCV]>O^9W_A#2?[,T1&D3%Q<?O),C!
M_A7UX'ZDTSQGJ8T_0GA4_OKK,2C_ &?XC^7'XBNBQ@8%>3^+-5.J:Y+M/[B#
M]U&/7!Y/XG/X8KR\'"6*Q7M)]-7^B/6QU2.#PBIPW>B_5E;1=>NM"DF>UCA<
MR@!O-!/3TP1ZUZ;X>U*;5M%AO)U19'+ B,$#AB.Y/I7CU>K>"_\ D5K7ZO\
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MU&\DNKER\CG)]![#VJO7N8+!QPT/[SW/GL?C98J=]HK9'5> /^1@D_Z]V_\
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MU/)P.&C/'236D6W^.AL22)#$TDCJD: LS,< #U-<3J'Q"1)'33[3S%' EF.
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MUY1I'_(:L/\ KXC_ /0A3RJ3>'FOZV#.(I8JF^]OS/:*\Q\>_P#(Q#_K@O\
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M?Q5\6?\ A)O#=WI']B?9OM&S][]JW[=KJW38,_=QU[U[%_PB7AK_ *%[2?\
MP"C_ /B:Y3XD^'=$L/ &IW-GHVGV\Z>5MEAM41ES*@."!D<$BJC*GS*R)G"M
MRN\CY^HHHKL/."BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MWEQ92]E?]['^N#^IH_=/R"U>/9GI<4L<\2RQ2+)&PRKH<@CV-/KYZGTSQO\
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M&G_5CZ;$5%0I2J?U?H>;SS/<W$L\AR\CEV/N3DUZUX7N!<^&K%P"-L?EG/\
MLG;_ $KR&O2_ ,[2Z#)$V/W4Q ^A /\ ,FO>S>%\.FNC/G,EJ-8EI]41?$*
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MR?Y&N'TS_D*V?_7=/_0A71ED''"MOK<Y\VJ*>,272R_&Y[77FGC_ /Y&"/\
MZ]U_]":O2Z\T\?\ _(P1_P#7NO\ Z$U>;E/^\?)GJ9S_ +K\T4/"'_(TV/U;
M_P! ->M5Y+X0_P"1IL?JW_H!KUJM,Y_CQ]/U9GD?^[R]?T1X_P")?^1DO_\
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M-JXB<^3$/6/IU] HHHKK.(*]UKPJO=:\'._^7?S_ $/HL@_Y>?+]3SSXB?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBJ6KZI;:+I-SJ5VVV"W0NWJ?0#W)P/QH!NVK,+QUXSM_"&CF12DFH
M3@K;0GN?[S?[(_7I7E?A;P=K'Q$U5];URXE%BS_/,W#2X_AC'0 =,]!VJ#0=
M+U#XI>-9[_469;-"&G*GA$S\L2_7G]3UKZ M;:"RM8K:VB6*")0B1H,!0.@%
M=#?LE9;G)%.O+FE\)#INF66CV,=EI]M';V\?W408_$^I]S5NBBN<ZTK!1110
M 5QWQ4_Y)OJW_;'_ -')78UQWQ4_Y)OJW_;'_P!')50^)&=7X)>C/FRBBBO2
M/'"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M4<0OE#ZCY:\VHKSEE5%3YXMI^7_#'IO.*\H<DTFO-/7\3H?">H6>DZY+-=W
M6'RF02*K$,<C&!C/;N*[?_A,M _Y_P#_ ,@R?_$UY/16F(RZE7GSS;O\O\C/
M#9G6PT/9P2MYW_S+%](DVH7,L9RCRLRG'4$G%=MX6\2:3IN@Q6UW=^7,K,2O
MEN>I]0*X&BML1A85Z:IR;LC##8N>'J.K!*[[GH'B?Q+I&HZ!<6UK=^9,Y7:O
MEN,X8$\D8KS^BBGAL-##PY(;;ZBQ6*GBI\\TKVMH:&AW,-GK=G<3OLBCD#,V
M"<#\*](_X3+0/^?_ /\ (,G_ ,37D]%98G T\3)2FWIV_P"&-<)F-7"Q<8):
M]_\ AS4\1WD%_K]U<VS^9#(5VM@C.% Z'GM6711753@H14%TT..I-U)N;W;N
M=GH?CI[:)+;4T>9%&%G3E_\ @0/7Z]?K76V_B71KE R:C N>TC;"/SQ7C]%>
M?6RJA4?,M'Y'IT,XQ%*/*_>7F>RMKVD(,G4[/\)E/\C7/ZIX]LX8RFFHUQ*1
MP[@JB_GR?IQ]:\ZHJ*>448N\FV75SNO-6BDB>\O+B_N7N+J5I96ZL?\ /%04
M45ZJ22LCQVW)W>X4444Q!7K'_"9:!_S_ /\ Y!D_^)KR>BN3%8.GB;<[>G8[
M<)CJF%YN1)W[^7S.F\9ZK9:M>VTEE-YJ)&58[&7!S[@5G^&KVWT_Q!:W5U)Y
M<*;]S8)QE"!P.>IK)HJXX>,:/L5M:WWF<\5.5?V[2O=/RT/6/^$RT#_G_P#_
M "#)_P#$UYOKES#>:W>7$#[XI)"RM@C(_&L^BLL-@:>&DY0;U[_\,;8O,:N*
MBHS2T[?\.%>@>&/$ND:=H%O;75WY<R%MR^6YQEB1R!BO/Z*UQ.&AB(<D]M]#
M+"XJ>%GSP2O:VIWGBSQ%I6IZ(;>SNO,E\Q6V^6PX'U%<78R)#J%M+(<(DJLQ
MQT (S5>BE0PT*%-TXMV#$8N>(JJK-*_D>L?\)EH'_/\ _P#D&3_XFN&\7ZE:
M:IK"3V<OFQ"%5+;2O.3Z@>M8%%8X?+J6'GSP;O\ UY'1BLSK8FG[.:5O*_\
MF%=CX,US3M)M;I+ZX\II'4J-C-D8]@:XZBNG$4(UZ;IRV9R8;$2P]15(;KN>
MEZOXKT6ZT>\@AO=TLD+JB^4XR2..HKSW3I4@U2TFE;;'',C,<9P P)JM166'
MP<*$'"+=F;8G'5,1.,YI778]8_X3+0/^?_\ \@R?_$UPOBW4;74]:%Q9R^;%
MY2KNVE>1GU K!HK/#Y?2P\^>#=_/_AC3%9G6Q-/V<TK>5_\ ,Z'P=J=GI6KR
MSWLWE1M 4#;2W.Y3C@'T-=O_ ,)EH'_/_P#^09/_ (FO)Z*,1EU*O/GDW?\
MKR'ALSK8:G[."5O._P#F>@:5X\@WM!J08 ,0EPBY!'/WAU';IFNE77M(<9&I
MV?XS*/YFO&J*QJY31F[Q=C:CG5>$>624CUB^\7Z/91EA<BX?LD'S$_CT'YUY
MYKFO76N7(DF_=Q)_JX5.0OO[GWK*HK?#8"EAWS+5]V<^+S*MB5RRT79!7H^@
M^*-&LM#M+:XO-DL:89?*<X.?4"O.**UQ.%AB8J,V].QEA,7/"R<X):Z:G;^,
M=?TS5=(B@LKGS9%G#E?+9>-K#/('J*XBBBJP^'C0AR1V(Q.)GB:GM)[^1ZLG
MC'00B@W_ "!_SQD_^)KC_&>JV6K7MM)93>:B1E6.QEP<^X%<S17-0RZE0J>T
MBW?Y?Y'5B,TK8BFZ<TK>5_\ ,*N:;JEWI-T+BTEV-T8$95AZ$53HKNE%27+)
M71Y\92@U*+LT>F:;XZTV[55N]UI,>#N&Y#]"/Z@5M#7-)(S_ &G9?C.O^->,
MT5Y53)Z,G>+:/8IYW7BK229ZO?>,-&LHR5N1</V2$;L_CT_6N#UWQ->:X1&X
M$-LIRL2'/YGO6)171ALOHT'S+5]V<V*S.OB%RO1=D%>A>&O$ND:?X?M;6ZN_
M+F3?N7RW.,N2.0,=#7GM%;8G#0Q$%";TWT,,)BYX6;G!*]K:G>>+/$6E:GHA
MM[.Z\R7S%;;Y;#@?45P=%%/#8>.'AR0V\Q8K%3Q,_:32OY&AH^LW6BWGVBV(
M((P\;?=<>_\ C7HFF^,M)OXQYLOV2;'S),<#MT;H1S['VKRNBLL3@:6(UEH^
MZ-L)F-;#>['5=F>RG7=("[O[3L\>TZY_G6!K/CJT@B:+3/\ 2)CD>800J>_/
M7^5><T5S4LHHPE>3;.JKG5><>6*2'22/-*\LC%G=BS,>Y/4TVBBO5/'W"BBB
MF(**** "BBB@ HHHH *ZSX??\A^?_KU;_P!"2N3KK/A]_P A^?\ Z]6_]"2N
M3'?[M/T.W+O]ZAZGI-%%%?'GVX4444 %%%% !1110!Y]X\TPVM[!JL'R^80K
MD<8<<@_D/TKLM%U :IH]M=\;G3YP.S#@_J*K>*+,7OAR\3&61/-7V*\_R!'X
MUA_#RZ+V5Y:$_P"KD$@_X$,'_P!!_6O4D_;8)2>\';Y,\F"]ACW%;35_FOZ_
M$[2BBBO+/6"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MKQ[XV:^P%EH$+\,/M,X'?J$'_H1Q]*]AKP%E_P"$K^.!1QOA2^((/0I"/Y'9
M^M;45[UWT.?$M\JBNIZSX$\.+X9\*VMHR 74@\ZY..2[=OP&!^%=+1163=W=
MF\8J*L@HHHI#"BBB@ KCOBI_R3?5O^V/_HY*[&N.^*G_ "3?5O\ MC_Z.2JA
M\2,ZOP2]&?-E%%%>D>.%%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MBBB@ HHHH **** "BBB@ HHHH ZGX;_\E"T?_KJW_H#5]-U\R?#?_DH6C_\
M75O_ $!J^FZX\1\2/1P?P/U/FCXG?\E%U?\ WH__ $6E6OA;H&F>(_$US9ZM
M;?:($LVE5/,9,,'0 Y4@]":J_$[_ )*+J_\ O1_^BTK=^"7_ ".=Y_V#W_\
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M5F(].J"O._AC_P E%TC_ 'I/_1;UTJ;E3N<,J:A64>ET>S?\*K\%_P#0&_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@#WOX)?\B9>?]A!__1<=>DUYM\$O^1,O/^P@_P#Z+CKTFO/J_&SUZ'\-
M!11169J%%%% !1110 5YA\;X0WA?3Y\?,EZ$!]BC'_V45Z?7F_QL_P"1+M/^
MP@G_ *+DK2E\:,:_\-FW\,YO.^'>D,S9(1UY_P!F1A_2BJOPO_Y)UI7_ &V_
M]'/12G\3*I/W%Z&;J_\ R4J/_KZM_P"25Z37FVK_ /)2H_\ KZM_Y)7I-=^/
M_AT?\*/.RW^)7_Q,****\T]4**** "BBB@ KPJO=:\*KW<D_Y>?+]3YW/_\
MEW\_T"BBBO>/G0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "NL^'W_(?G_Z]6_]"2N3KK/A]_R'Y_\ KU;_ -"2N3'?
M[M/T.W+O]ZAZGI-%%%?'GVX4444 %%%% !1110 5YM\/O^0_/_UZM_Z$E>DU
MYM\/O^0_/_UZM_Z$E>E@_P#=JWHOU/*QW^]4/5_H>DT445YIZH4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M5X+\$O\ D<[S_L'O_P"C(Z]ZKP7X)?\ (YWG_8/?_P!&1UM3^"1S5OXD#WJB
MBBL3I"BBB@ HHHH *X[XJ?\ )-]6_P"V/_HY*[&N.^*G_)-]6_[8_P#HY*J'
MQ(SJ_!+T9\V4445Z1XX4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_7S'_6O)_AC_ ,E%TC_>D_\ 1;UZQ\8O^1#?_KYC_K7D_P ,?^2BZ1_O2?\
MHMZ5+^$RZ_\ 'C\CZ7KYD^)'_)0M8_ZZK_Z M?3=?,GQ(_Y*%K'_ %U7_P!
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MLM+*QR,@)BDS@'']^@#W&BO,=,^*K#P3<:SJT$'VTW3V]M;VZLHD(1&R<DX
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M5\Z7\B3:A<RQG*/*S*<=02<5&'BU>Z-L7.,DK.Y7KZH\&?\ (DZ'_P!>,/\
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MU&;S)Y. !PJ+V51V _\ K]233ITI2=Y"K5XPCRP,ZOK;1?\ D!:?_P!>T?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@!54LP502Q. !WKV+0-,_LG1H+0\R
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M?^N[_P#H(KQ6O:OC?_R"=)_Z[O\ ^@BO%: /K+1_^0)8?]>T?_H(J[5+1_\
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M:P6-I>QW4$^\23HJ@(5(8##'DG;V[5Y]:7,EG>0743%9(9%D1E.""#D$'\*
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M^)>@>&?"UKIEQ::@]PA=I7BC0JQ+$C&7!Z8'3M6__P +K\-_\^6J_P#?J/\
M^.4 >):EIUWI&HSV%]"8;F!MKH>W<?4$8(/H:]G^#OB274-+N-%NI-SV05K?
M(Y\H\$?@<?\ ?7M7F_C[Q#IOB?Q&NI:;;SPHT"I+YZ@,S@GG@D8V[1^%6OA7
M>-:?$"Q4.52X62)\'J-A(!_X$JT >Y>++^\TSPO?W.GP337@CVPK#&78,>-V
M!Z9S^%?,=Q9WT3L]S;7",22S21L"3WSFOK:LO5O$FC:&A;4]2M[<XSL9LN?H
MHY/X"@#S'PW\&X+O2X+K6KVXBFF7?Y%N5&Q2. 20>?7CV]ZB\5_"&WTO1KO4
MM)OYW^RQF5X;D*2549;# #D#)QBMW4/C3H=ON6QLKR[8 X+ 1H3VY.3^E<=K
MGQ?UC5;2XL[:RM;2WG1HVSF1]I&",G Z'TH \[KZ3^&E\]_X!TUY6=I(PT19
MSDG:Q _3%?-E?0?P@!'@.,D$9N)"/?D4 <+\9M5N+GQ/!IA)%M:0AU7/5WY+
M?D /P/K7+^#/"Y\7:[_9WVQ;55B:9G*[B0"!A1D9/([],FNQ^,^A3Q:O;ZY&
MC&VFC6&1NRR#./S'\C7F5M<SV=PEQ:SR03H<I)$Y5E/L1R* /;T^">@B$!]1
MU(RX^\K1A<_3:?YUYYXV\ 77A&>!XY_MEG<$K'($VLK#G:1D]N_L>E6=+^+7
MBC3PB3S07T:GD7$?S8]-RX/XG-=?IGQMLI-B:II4T))PTENX<?7!P?YT <+X
M"DUK2/%=E=6MA?/!(ZQW"QP,0T3'G/';K^%?2%9FC>(-*U^W\[3+V*X& 653
M\R9_O+U%:= !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %>"_!+_D<[S_L'O_Z,CKWJO!?@E_R.=Y_V#W_]&1UM3^"1
MS5OXD#WJBBBL3I"BBB@ HHHH *I:QIZZMHU[I[D 7,#Q9.>,@C/%7:*-@:OH
M?'TT4EO-)#*A22-BCJW52#@@TRO1OB[X6.D>(?[7MT L]18LV/X)OXO^^OO?
M7=Z5YS7I1ES*Z/%G!PDXL****HD**** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBNN^'?A5_%'B6(21;M/M666Z)Z$<E4_P"!
M$8^F:F325V.,7)V1[GX"TDZ+X)TNT=0)3%YLF,'YG.[DCKC./P[UT=%%><W=
MW/:BN5)(****0PHHHH **** "O-_C9_R)=I_V$$_]%R5Z17F_P ;/^1+M/\
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M_%_+^D>)/(JJ?N23]=/\SR6BO6/^$-T#_GP_\C2?_%4?\(;H'_/A_P"1I/\
MXJK_ +9H=G^'^9']AXC^:/X_Y'D]%>L?\(;H'_/A_P"1I/\ XJC_ (0W0/\
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M_GP_\C2?_%4?VS0[/\/\P_L/$?S1_'_(\GHKUC_A#= _Y\/_ "-)_P#%4?\
M"&Z!_P ^'_D:3_XJC^V:'9_A_F']AXC^:/X_Y'D]%>L?\(;H'_/A_P"1I/\
MXJC_ (0W0/\ GP_\C2?_ !5']LT.S_#_ ##^P\1_-'\?\CR>BO6/^$-T#_GP
M_P#(TG_Q5'_"&Z!_SX?^1I/_ (JC^V:'9_A_F']AXC^:/X_Y'D]%>L?\(;H'
M_/A_Y&D_^*H_X0W0/^?#_P C2?\ Q5']LT.S_#_,/[#Q'\T?Q_R/)Z*]8_X0
MW0/^?#_R-)_\51_PAN@?\^'_ )&D_P#BJ/[9H=G^'^8?V'B/YH_C_D>3T5ZQ
M_P (;H'_ #X?^1I/_BJ/^$-T#_GP_P#(TG_Q5']LT.S_  _S#^P\1_-'\?\
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M3_XJC^V:'9_A_F']AXC^:/X_Y'D]%>L?\(;H'_/A_P"1I/\ XJC_ (0W0/\
MGP_\C2?_ !5']LT.S_#_ ##^P\1_-'\?\CR>BO6/^$-T#_GP_P#(TG_Q5'_"
M&Z!_SX?^1I/_ (JC^V:'9_A_F']AXC^:/X_Y'D]%>L?\(;H'_/A_Y&D_^*H_
MX0W0/^?#_P C2?\ Q5']LT.S_#_,/[#Q'\T?Q_R/)Z*]8_X0W0/^?#_R-)_\
M51_PAN@?\^'_ )&D_P#BJ/[9H=G^'^8?V'B/YH_C_D>3T5ZQ_P (;H'_ #X?
M^1I/_BJ/^$-T#_GP_P#(TG_Q5']LT.S_  _S#^P\1_-'\?\ (\GHKUC_ (0W
M0/\ GP_\C2?_ !5'_"&Z!_SX?^1I/_BJ/[9H=G^'^8?V'B/YH_C_ )'D]%>L
M?\(;H'_/A_Y&D_\ BJ/^$-T#_GP_\C2?_%4?VS0[/\/\P_L/$?S1_'_(\GHK
MUC_A#= _Y\/_ "-)_P#%4?\ "&Z!_P ^'_D:3_XJC^V:'9_A_F']AXC^:/X_
MY'D]%>L?\(;H'_/A_P"1I/\ XJC_ (0W0/\ GP_\C2?_ !5']LT.S_#_ ##^
MP\1_-'\?\CR>BO6/^$-T#_GP_P#(TG_Q5'_"&Z!_SX?^1I/_ (JC^V:'9_A_
MF']AXC^:/X_Y'D]%>L?\(;H'_/A_Y&D_^*H_X0W0/^?#_P C2?\ Q5']LT.S
M_#_,/[#Q'\T?Q_R/)Z*]8_X0W0/^?#_R-)_\51_PAN@?\^'_ )&D_P#BJ/[9
MH=G^'^8?V'B/YH_C_D>3T5ZQ_P (;H'_ #X?^1I/_BJ/^$-T#_GP_P#(TG_Q
M5']LT.S_  _S#^P\1_-'\?\ (\GHKUC_ (0W0/\ GP_\C2?_ !5'_"&Z!_SX
M?^1I/_BJ/[9H=G^'^8?V'B/YH_C_ )'D]%>L?\(;H'_/A_Y&D_\ BJ/^$-T#
M_GP_\C2?_%4?VS0[/\/\P_L/$?S1_'_(\GHKUC_A#= _Y\/_ "-)_P#%4?\
M"&Z!_P ^'_D:3_XJC^V:'9_A_F']AXC^:/X_Y'D]%>L?\(;H'_/A_P"1I/\
MXJC_ (0W0/\ GP_\C2?_ !5']LT.S_#_ ##^P\1_-'\?\CR>BO6/^$-T#_GP
M_P#(TG_Q5'_"&Z!_SX?^1I/_ (JC^V:'9_A_F']AXC^:/X_Y'D]%>L?\(;H'
M_/A_Y&D_^*H_X0W0/^?#_P C2?\ Q5']LT.S_#_,/[#Q'\T?Q_R/)Z*]8_X0
MW0/^?#_R-)_\51_PAN@?\^'_ )&D_P#BJ/[9H=G^'^8?V'B/YH_C_D>3T5ZQ
M_P (;H'_ #X?^1I/_BJ/^$-T#_GP_P#(TG_Q5']LT.S_  _S#^P\1_-'\?\
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M@#Y8KUOX*ZZ$N+[0I7.)!]H@';(X<?EM/X&N;^*/AV'0/%6ZTA6*SO(Q+&B
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M#R[1M9OM!U.+4-/F,4\9_!AW5AW!KZGT^\CU'3;6^BSY=S"DR9]& (_G7R4
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MV"99%*1J/4L>/P'/' KWKP3X*M/"&FE01-?S ?:+C'7_ &5]%'Z]3V ZFB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH *\%^"7_ ".=Y_V#W_\ 1D=>
M]5X+\$O^1SO/^P>__HR.MJ?P2.:M_$@>]4445B=(4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !7F_QL_P"1+M/^P@G_ *+DKTBO-_C9
M_P B7:?]A!/_ $7)6E+XT95_X;-'X7_\DZTK_MM_Z.>BCX7_ /).M*_[;?\
MHYZ*4_B8Z7P1]#-U?_DI4?\ U]6_\DKTFO-M7_Y*5'_U]6_\DKTFN_'_ ,.C
M_A1YV6_Q*_\ B84445YIZH4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !7FWP^_Y#\__ %ZM_P"A)7I->;?#[_D/S_\ 7JW_ *$E>E@_
M]VK>B_4\K'?[U0]7^AZ31117FGJA1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110!S7Q!_Y$+6/^N']17S+7U_10!Q'PE_Y)
M_:?]=9?_ $,UV]%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5X+\$
MO^1SO/\ L'O_ .C(Z]ZKP7X)?\CG>?\ 8/?_ -&1UM3^"1S5OXD#WJBBBL3I
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **R_$NI3:-X5U?5+=8VGLK*
M:XC60$J61"P!P0<9'J*^=/\ AH[QA_T#=#_[\3?_ !V@#Z?HKY@_X:.\8?\
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MO2:\V^'W_(?G_P"O5O\ T)*]+!_[M6]%^IY6._WJAZO]#TFBBBO-/5"BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% '/^._\ DGGB7_L%77_HIJ^(*^W_ !W_ ,D\\2_]
M@JZ_]%-7Q!0![)X/^ W_  E?A33]<_X23[+]K0MY/V'?LPQ7[WF#/3TK;_X9
ME_ZF[_RF_P#VVO2?A!_R2C0/^N+_ /HQJ[>@#Y__ .&9?^IN_P#*;_\ ;:Z7
MP)\$?^$)\5V^N?\ "0_;?)1U\G[%Y>=RE?O>8?7TKUNB@ KY+^+_ ,2+CQAK
MTNFV4Y&AV4I2)48%;AP2#*2.H/\ #[<]2:^BOB3KK^'/AWK6I1,5G6#RHB,9
M#R$(I&?0MG\*^*J .@\(^#-9\;:J;#1X%8H-TL\I*Q0KV+'!Z]@ 2>>.#7N>
MG?LVZ%';J-3UO49Y\?,ULJ1+GV#!S^OY5UWP<\,VWAWX=:;*D:?:M2B6\N)0
M.7WC*#Z!2!CUR>YKOJ /GOQ-^SB\-L\_AG57GD4\6MZ "P]I%P,^Q 'N*\*N
M[2XL+R:TNX)(+B%RDD4BX9&'4$5]\U\Y_M&^&8;74M-\26\85KS-O=$#[SJ!
ML)]]N1_P$4 ;OP%^(<VK02>%-6G:2YMH_,LI9&&7B& 8_4E>HZ\9Z!:]OKX?
M\$:P^@>-]&U-&*B"[3?MZF,G:X_%2P_&ON"@#F_%'CWPWX/@9M7U*))@/EMH
MSOF;Z(.1]3@>]?+WQ#^*.K>/KD0NOV/28GW0V:-GG&-SGC<>N.PS^)B^)UO-
M=?%G78+>&2::2[VI'&I9F.T< #DUTUO\&;G2?A]J_B7Q&6BN8K1I+:Q7@H3C
M#2'U&3\OTR>U 'DE?='A3_D3]$_Z\(/_ $6M?"]?='A3_D3]$_Z\(/\ T6M
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M7^TU_P RM_V]_P#M&O*?AM_R4KPY_P!?\7_H5 'JW_#,O_4W?^4W_P"VT?\
M#,O_ %-W_E-_^VU] 44 ?/\ _P ,R_\ 4W?^4W_[;7JOP\\%_P#"!^&FT?\
MM#[=FX>;S?)\K[P QC<WIZUU=% &-XK\26GA+PU>:U>#=';IE8PP4R.>%4$]
MR?ZU\7>(_$>I^*M:GU;5K@S7,IZ#A8U[*H[*/3\>22:]P_:2UQTM-&T"-B%E
M9KN8<<[?E3W[O^0_#Q/PGHO_  D7BW2M(+;4N[E(W;T3/S'ZXS0!U_P_^#FL
M^-H$U&:9=-TAB0L\B%GEQ_<3C(SQDD#KUQBO4U_9O\+>0 VK:P9L<N'B"_\
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MY>XNYVW.[?H .P'0 =*O>%O!^M^,=26RT>S>4Y^>9@1%$/5VZ#^9[5TOQ1\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "O-OA]_R'Y_^O5O_0DKTFO-OA]_R'Y_^O5O_0DK
MTL'_ +M6]%^IY6._WJAZO]#TFBBBO-/5"BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_P C0!K_ +-O_(X:O_UX?^U%KZ#\2Z;-K/A75]+MVC6>]LIK>-I"0H9T*@G
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M>BE/XF.E\$?0S=7_ .2E1_\ 7U;_ ,DKTFO-M7_Y*5'_ -?5O_)*])KOQ_\
M#H_X4>=EO\2O_B84445YIZH4444 %%%% !1110 4444 %%%% !1110 4444
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MBGMY;V-9(I4#*ZEN00>"* .;HK[?_P"$$\'_ /0J:'_X+H?_ (FC_A!/!_\
MT*FA_P#@NA_^)H ^(*^W_ G_ "3SPU_V"K7_ -%+1_P@G@__ *%30_\ P70_
M_$UN000VMO%;V\4<,$2!(XXU"JB@8  '  '&* /F7]H]F/Q T]<G:-*C(&>
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "O!?@E_P CG>?]@]__ $9'7O5>"_!+_D<[
MS_L'O_Z,CK:G\$CFK?Q('O5%%%8G2%%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M5S_CO_DGGB7_ +!5U_Z*:N@KG_'?_)//$O\ V"KK_P!%-0!\05LV?B[Q+I]I
M':67B+5K:VC&$AAO9$11UX4-@5C5]+?#CX5>"M>^'VD:IJ>B^?>W$;-+)]JF
M7<0[#HK@#@#H* /"?^$[\8?]#7KG_@QF_P#BJ/\ A._&'_0UZY_X,9O_ (JO
MI_\ X4E\//\ H7O_ "=N/_CE'_"DOAY_T+W_ ).W'_QR@#C_ -GC7=8UO_A)
M/[6U6^O_ "?LWE_:[AY=F?-SC<3C.!T]!79?&F1H_A'KK(<$B%?P,\8/Z&M[
MPQX)\.^#OM7]@:?]C^U;/._?22;MN=OWV.,;FZ>M9?Q;LOM_PK\00Y(VVXFX
M_P"F;J__ ++0!\:5]Q>";9+3P)X?MT"@)IUN/E7&3Y:Y./<Y/XU\.U]I_#'4
M8=4^&?AZ:%@PCLH[=L#&&C'ED?FM '644UW2*-I)&5$4%F9C@ #J2:2*6.>)
M98I%DC895T.0?H: /-_CS"DOPJO789,5Q"Z^QWA?Y,:^2Z^I/VAM3CM/A]#8
ME\37MX@">JH"Q/X';^8KY>AADN)XX8D+R2,$11U))P!0!]HZ[+(GPDU.8,?,
M&A2N&/)SY!.:^*Z^W?$]@R_#C6=.A)=AI$\"$CJ?)*CI7Q%0!]H?"W_DF'A[
M_KT7^9I/BHJM\+_$(8 C[(3R.X((I/A5(LGPN\/,AR!:A?Q!(/ZBF_%F7R?A
M9X@;;G-MMQGU91_6@#XSK[A\$2-+X!\.2.<N^EVS,?4F):^'J^YO"$'V7P5H
M-OAAY6G6Z8;KQ&HY]Z /AN21I97D<Y=R68^I-?5_P#_Y)=;_ /7U-_Z%7RE<
M0/:W,MO(,21.48>X.#7U5\ )%?X7Q*IR4NYE;V.0?Y$4 >@ZZJOX>U-6 93:
M2@@C((V&OA"ONSQ'+Y'AC5IMN[R[*9L9QG"$U\)T ?8/P6D:3X1Z$SG) F7\
M!/(!^@K6UCX?>'/$'B>'7]8LOMMS!;K;QPS',*A69LE/XC\Y^]D=.*SO@Y!]
MG^$V@)AAF.1_F_VI7;\N:[F@!J(D4:QQJJ(H"JJC  '0 5\!5]_U\ 4 ?7'P
M*_Y)/IO_ %UG_P#1C5Z/7G'P*_Y)/IO_ %UG_P#1C5Z/0 4444 9^OZ@=)\.
M:GJ0QFTM)9QGI\B%OZ5\(LS.Q9B68G)).237VE\3I#%\,O$3*!DV3KS[\?UK
MXLH ^XO!5@NE^!]"LE&#%8PAN>K; 6/4]R:W:KZ>H73;55 "B%  .@X%6* /
MA'Q!_P C)JG_ %]R_P#H9KZ7_9Z_Y)J__7_+_P"@I7S1X@_Y&35/^ON7_P!#
M-?2_[/7_ "35_P#K_E_]!2@##^-G@'PSI7A/4/$5EIGE:K/>J\MQY\C;FD<E
MSM+%1DD]!]*^>K.-9;ZWC<91Y%5AZ@FOJKX^?\DNN/\ KZA_]"KY7T__ )"=
MK_UV3^8H ^P--^$?@;2-3MM1L=#\J[MI!+%)]KG;:PZ'!<@_C63\;_%\GACP
M0;2TE,=_JC&WC96PR1@9D8=^A"^VX5Z97SI^TM,[:OX?A)^1()G ]RR@_P#H
M(H \8T?2KK7-9L]*LE#7-W,L,><X!8XR<= .I/8 U]:^&/A!X0\/:9%!/I-M
MJ=U@&:XOHUE+-WPI&%'/  ],Y/->!? V&.7XL:674-LCF=<]CY;#/ZU]=4 >
M)?%CX.Z3)H%UKOANRCLKVS1IIK: 8CFC'+87HK 9(QUQC'3'SOINHW6D:G;:
MC8S-%=6T@DC=3T(_I7WFZ)+&T<BJZ,"K*PR"#U!%? LR+%/)&KAU5BH<=& /
M6@#[G\,ZU'XC\,:;K$6W%W;I*P7HK$?,OX-D?A7S-\?_ /DI\O\ UZ0_R->Q
M? 65Y/A79J[$K'<3*@/8;R<?F2?QKQWX_P#_ "4^7_KTA_D: -?]FW_D<-7_
M .O#_P!J+7N_CO\ Y)YXE_[!5U_Z*:O"/V;?^1PU?_KP_P#:BU[OX[_Y)YXE
M_P"P5=?^BFH ^(*^V/AQ_P DV\.?]@^'_P!!%?$]?;'PX_Y)MX<_[!\/_H(H
M S+OX.> KZ]GO+G0=\\\C2R/]LG&YF.2<!\#DUFZK\)OAAHFE76IZAHJPVEM
M&9)9&O;C@#T_><D] .I) KTMF"J68@*!DD]!7RM\9_B4?%NK?V-I4X;1+)\[
MUY%S*,@OG^Z,X'KR>XP >>:_=Z9>ZW=3Z-IW]GZ<7Q!;F1G95' +%B3D]3SC
MGBNX^$/PU?QOK!O[]671+&0>=Q_Q\.,'R@?3&"Q[ CU!'->!O!>H>.?$<.F6
M:E(00]U<$<0QYY;W/H.Y]LD?96B:+8>'M'MM*TRW6"TMTVHHZGU)/<D\D]S0
M!?50JA5 "@8 '05\)>(/^1DU3_K[E_\ 0S7W=7PCX@_Y&35/^ON7_P!#- 'T
MO^SU_P DU?\ Z_Y?_04KU>O*/V>O^2:O_P!?\O\ Z"E>KT ?$'CO_DH?B7_L
M*W7_ *-:O>/V;O\ D3-5_P"P@?\ T6E>#^._^2A^)?\ L*W7_HUJ]X_9N_Y$
MS5?^P@?_ $6E $'[2G_(MZ)_U]O_ .@5\ZV5G/J-_;65LA>XN)5BB4?Q,Q
M_,U]%?M*?\BWHG_7V_\ Z!7BWPX56^)/AP, 1_:$)P1W# B@#Z@\-_";P?X>
MTJ.T?1K+49\ S75] LK2-W(#9"CV'ZGFO ?C;X0T_P )^-(O[)@^SV5];B<0
MC.V-]Q#!?0< X[9(&!@5]:U\X_M*_P#(?T+_ *]9/_0A0!Y+X6T&;Q1XHT[1
M8"5>[F"%@,[%ZLWX*"?PKZYT_P"%O@G3M*33U\.V$Z 8::YA$DK'N2Y&1^&
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MR3#Q#_UZ-_,4 ?%]?='A3_D3]$_Z\(/_ $6M?"]?='A3_D3]$_Z\(/\ T6M
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M(LI;JX<@81>$!/5CT4>YXH ]"^ &BOJ/Q&6_,6Z'3;=Y2YZ!V&Q1]?F8_P#
M3Z5]1:A?VVEZ=<W]Y(([:VB:65SV51DUROPS\"1> _"ZV;,LFH7!$MY*IR"^
M,!5.!\H[?4GO7)?M$:Z;#P3:Z1&P#ZG<C>#WCCPQQ_P(QT >$^/O&U[XZ\2S
M:C<%X[1"4M+8GB&/_P"*.,D^OL !K_"Y? MIJC:KXRU-4-LX^S6+6TLBR-UW
MN54@@=E[GKQP?/Z* /K_ /X7;\//^AA_\DKC_P"-U-:?&/P%?7L%G;:]OGGD
M6*-/L<XW,QP!DI@<FOCJMCPE_P CGH7_ &$+?_T8M 'W/1110 4444 %%%%
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MTU;_ ,"U_P#BJ/8K^9!]8?\ *SWNBO!/L?Q8M_GW:L<\?Z]7_3)H_P"+L?\
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MO;N[]<U0U3P7XAL_"D?BW5898[>\NA&OGY\V0L&;S"#SM.#@GKG/0@D ZKX
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M>BE/XF.E\$?0S=7_ .2E1_\ 7U;_ ,DKTFO-M7_Y*5'_ -?5O_)*])KOQ_\
M#H_X4>=EO\2O_B84445YIZH4444 %%%% !1110 4444 %%%% !1110 4444
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M ':MZ+]3RL=_O5#U?Z'I-%%%>:>J%%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M$$'@@CC%244 <_\ \()X/_Z%30__  70_P#Q-;,5E:V]DME#;0QVB)Y:P)&
M@3&-H4<8QVJ>B@#G_P#A!/!__0J:'_X+H?\ XFC_ (03P?\ ]"IH?_@NA_\
MB:Z"B@#G_P#A!/!__0J:'_X+H?\ XFC_ (03P?\ ]"IH?_@NA_\ B:Z"B@"*
MVMH+.VCMK6"."")0D<42!511T  X HN+:"[MWM[F&.:%QAXY%#*P]P>#4M%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "O-OA]_R'Y_^O5O_ $)*])KS
M;X??\A^?_KU;_P!"2O2P?^[5O1?J>5CO]ZH>K_0])HHHKS3U0HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **HZCJ]AI,6^\N
M%C)&53JS?0=:X[4/'US/((M*M=@/ :4;G/T X'ZUU4,'6KZP6G?H<F(QU##Z
M3>O9;G>NZ1(7D9411DLQP!6%?>,M&LB56X-PX_A@&X?GT_6N2B\/>(]>99;U
MY%0Y*M<N1CZ+U'Y"MZP\ 6$&&O9Y+EO[H^1?TY_6NGZMA:/\6I=]E_7^1R?6
ML97_ (-/E7>7^7_#F;>?$*YD;;8V2(,X#2DL3^ QC]:IA_%^MA2OVL1GD$?N
M5/X\9KT&TTNQL /LMI#$0,;E49_/K5NCZ[1I_P &DO5Z_P!?>'U"O5_CU7Z+
M3^ON/.[;X?W\S!KR\ACSUVY=OZ"MFU\ :7$ ;B6>=NXW!5_(<_K75T5E4S'$
MS^U;T-J>5X6'V;^NIF6WAW1[4?NM.@^KKO/YMFM)5"C"@ >@I:*Y)5)3UD[G
M;"G""M!)>@4445!84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !2$!E*L 01
M@@]Z6B@#&O/"?AZ_R;K1+"1CCY_(4-Q_M 9KF[_X/^%;S<8(KJS8]/(F) /T
M;-=[15*<ELR)4X2W1XW?_ R0'.GZVI&/N7$./U!_I6-_P@WQ$\-8;3)IGC0X
M_P!!N_EZ_P!PD$C)]/6O?:*T5>774R>&ATT/!(OB9XX\/2+!JUL) GRE;VV,
M;'IW&.<=SGKGFNETSXX:=+M75-*N+=N 7@<2+VYP=I Z^OXUZI)&DT;1RHKH
MPP589!_"N8U3X=>%=6!,ND0PR$YWVW[H_DO!_$4<]-[H7LZL?AE?U)]*\=>&
M=9"BTU>W$C#/E3-Y;^XPV,_AFNBKR#5O@=&5+:-JSJ?^>=XH.>/[R@=_]GO[
M<\\-+^)/@EB;7[:UM&,_N&^T0X Z[.<#'J!TH]G"7PL/;5(_''[CZ HKQC1O
MC;<1'RM=TL2;< RVIVM[Y1C@G\1_AZ7H?B_0?$6U=-U&*28KN\ACMD'K\IYX
M]OZU$J<H[HTA6A/9FY1114&H4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 5X+\$O\ D<[S_L'O_P"C(Z]ZKP7X
M)?\ (YWG_8/?_P!&1UM3^"1S5OXD#WJBBBL3I"BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH *\W^-G_(EVG_ &$$_P#1<E>D5YO\;/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH "0 23@#O7#Z_P"-\,UIHYRV=K7!&?\ OD=_K_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 5YO\;/\ D2[3_L()_P"BY*](KS?XV?\
M(EVG_803_P!%R5I2^-&5?^&S1^%__).M*_[;?^CGHH^%_P#R3K2O^VW_ *.>
MBE/XF.E\$?0S=7_Y*5'_ -?5O_)*])KS;5_^2E1_]?5O_)*])KOQ_P##H_X4
M>=EO\2O_ (F%%%%>:>J%%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MO2:\V^'W_(?G_P"O5O\ T)*]+!_[M6]%^IY6._WJAZO]#TFBBBO-/5"BBB@
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M/4Y!4?3'&>IK@M!TF37-=LM,C<(US*$W'^$=S^6:^I-)T;3]#L4L].M8X(5
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MURJ7YAN=I_>1SVXC8@]OE QQTX_.OH*N)^*'A^RU;P?>7DD2"\LH_-AFQ\P
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MZ]ZKP7X)?\CG>?\ 8/?_ -&1UM3^"1S5OXD#WJBBBL3I"BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ KS;X??\ (?G_ .O5O_0DKTFO-OA]
M_P A^?\ Z]6_]"2O2P?^[5O1?J>5CO\ >J'J_P!#TFBBBO-/5"BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /-O%G_(Z1?]LOYUZ37F
MWBS_ )'2+_ME_.O2:]+'?P:/I_D>5E_\>O\ XO\ ,****\T]4**** "BBB@
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M .1'D_Z_9/\ T%*\]^,4COX]=68D);1JH/8<G'YD_G7H7P7_ .1'D_Z_9/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHKYT\2_'WQ5HWBK5]+M]/T9H+*]
MFMXVDAE+%4<J"<2 9P/04 ?1=%?,'_#1WC#_ *!NA_\ ?B;_ ..T?\-'>,/^
M@;H?_?B;_P".T ?3]%?,'_#1WC#_ *!NA_\ ?B;_ ..T?\-'>,/^@;H?_?B;
M_P".T ?3]%<=\,?%E_XT\&1:QJ,5M%</-)&5MU94PIP.&)/ZUV- !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%9>O>(M)\,::^H:Q?16ENO
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M/U_=R @;7P,^O7!.#0!]7T5\=?#FZ^W?&/2+S9L\_4&EV9SMW;CC/?K7V+0
M5GZCKND:.0-3U6QLLC</M-PD>1G&?F([UXK\8OB_>Z;J4OAKPS<&":$XO+Q/
MO!O^>:>F.[=<\#&#GC_"_P $?$_BZR75]0NTT^&Y DC>Z#22R@_Q;>HXY&3S
MD4 ?3&G>(=%UABNF:QI]ZR]1;7*2D?\ ?)-:5?+'B3X#^*?#D#:CI=S%J<<
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MZ7^&_C'_ (3CP;;ZK(BI=(Q@NE0842J 3CD\$$'\: .MHHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ KS;X??\ (?G_ .O5O_0DKTFO-OA]_P A^?\ Z]6_]"2O2P?^[5O1
M?J>5CO\ >J'J_P!#TFBBBO-/5"BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** /-O%G_(Z1?]LOYUZ37FWBS_ )'2+_ME_.O2:]+'?P:/
MI_D>5E_\>O\ XO\ ,****\T]4**** "BBB@ HHHH **** "BBB@ HHHH ***
M* /'?CM_S /^WC_VE7->"/B5_P (;HLVG?V3]L\RX:?S/M/EXRJKC&T_W>OO
M7M^O>%=%\3?9_P"U[+[3]GW>5^]=-N[&?ND9^Z.OI6-_PJOP7_T!O_)J;_XN
MNB-2')RR1R3HU/:.<&<=_P +V_ZEO_R>_P#M=4+[XX:K+$ZV6E6MNQR \CM(
M5'Z<_P"<5Z!_PJOP7_T!O_)J;_XNK-I\.?"-FX:+0[=B#G]\S2C\G)HYJ78/
M9XA[R_K[CPBRT[Q'\0M>\PM+=3R'$ES*,1Q*/4@8 &>@_ 5]"^%_#-EX5T:/
M3[,%C]Z69AAI7[D_T'85J6UI;64"P6MO%!"OW8XD"J/H!4U14JN6BV-*5!4]
M7JQKHDD;(ZAD8$,K#((/8U\W>,O"FH>!O$*W-H9$LS+YEE<J<E2#D*3V8?K^
M=?2=0W=G;7]I):W<$<]O(,/'(H96'N*5.IR,=:DJB\SS+0/C1ILUFB:[;RV]
MTH :2!-\;^^.H^G-)XA^-&FPVDD6@P37%TRX6:5-L:'UP>21Z8 K6O?@]X4N
MY&>)+RTW<[8)^!]-P;_)HL/@_P"%;*822I=WF#D+<3#;^2!<_C5WI7N96Q%K
M71Y9X"\)W?C#Q&+FY5VL(I?-NYV_C;KMYZDGKZ D^F?I&H;2SMK"TCM;2"."
MWC&$CC4*JCV%35%2ISLUHTE35NI\OZ-_R4K3_P#L,1_^CA7U!7+P_#KPK;ZG
M'J,6E;;N.83K)]HE.'!W XW8Z]NE=13JS4[6%0I.FG<*^7]9_P"2E:A_V&)/
M_1QKZ@KEYOAUX5N-3DU&72MUW),9VD^T2C+D[B<;L=>W2BE-0O<*])U$K'45
M2UG_ ) >H?\ 7M)_Z":NTR:&.X@DAE7='(I1AG&01@UDC9['S?\ "O\ Y*1I
M/_;;_P!$O7TG7-:5X \,:)J4.HZ=IGDW4.=DGGRMC(*GAF(Z$UTM:U9J<KHQ
MH4W3C9G'?%3_ ))OJW_;'_T<E<-\#/\ D(ZS_P!<HOYM7KVJZ59:WILVG:C#
MYUK-C?'N9<X(8<J0>H%4="\):'X:DFDTBQ^S-, LA\UWR!T^\Q]:%-*FXA*D
MW54^B.;^+F@SZQX2%Q:HSS6$GG%1WCP0WY<'\#7F?PX\>1^$+FXMKZ)Y-/N2
M&8QC+1..-P'<'N/88]#]%5QNL_##PQK5Q)<R6LEM/)RSVK[,DDDG!!&>?2G"
MI'EY9;$U:,G/VD'J13?%KP?%;^8FH2S/_P \DMG#?^/ #]:\U\2^)=<^)EV;
M/2=/E73[13,8@<] ?FD;H#P0![]Z[^V^#/A:!PTC7]R <[99P ?;Y5!KM].T
MRQTBS6TTZTBMH%Z)$N 3C&3ZG@<GDTU*$-8ZL'"K4TF[+R/ /A%=);^/[='8
M+Y\,D:Y[G&['_CM?15<O:?#KPK8:C%?VNE>3<Q2"6-TN)1M8'/3=C'MC%=14
M59J;NBZ%.5./*SY72XD\,^-_/E@+/I]^6:(G!.Q^1G\.M>X>&?B=IGBC6X=+
MMK.YAD>%G+3%<;A@E1@G(QDYXZ=*T/$OP_T'Q3<?:KZ&2.ZV[3/;OM9@.F<@
M@X]2*J^'/AGH7AG5(]2M);V6YCW!&GE! R"#PJC/!/6M)SA-:[F5.E4IRLMC
M-^*?@F;Q'81:GIL6_4;12K1CK-%UP/4@Y('?)[XKSWP%\1YO"*MIU_!)<::6
M+!4P)(6[[<]0?0D>N>N?H:N9U[P#X<\17!N;VP"W)^]/ QC9O]['#?4C-3"H
MN7EEL54HRYN>F[,QYOC%X4CBWI)>2MC.Q(,'Z<D#]:\E\2^(]7^(7B"%(;9R
MH/EVMG$2VW)ZGMD\9/'0>E>HQ_!7PRC[FN=3D']UIDQ^B"NRT;PUHWAZ-ETK
M3X;;=PSJ"78>A8Y)'MFJ4Z<-8[DRIU:FDW9&?X'\+)X3\.Q69*O=R?O;F0 <
MN1T![@=!^?&:XWXY?\@C2?\ KN__ *"*]7K)UWPUI'B6&&+5[3[2D+%D'F.F
M">/X2*SC.T^9FTZ=Z?)$Y'X+_P#(CR?]?LG_ *"E:OQ$\('Q;H 2V"C4+5C)
M;%C@-G[R$]LX'X@=LUO:+H6F^'K$V6EVWV>W+F0IO9_F. 3EB3V%:-)S]_F0
M1I_N^21\W>#O&>H> ]4N+6YM7>U=]MS:O\KHPXW#/1AZ=#^1'J8^,7A3[.LG
MF7@<C)B\CYA['G'ZUT'B#P;H7B;#:G8J\RC"SH2D@'IN'4>QR*Y;_A2OAGS2
M_P!IU/:23L\Y,#V^YG]:U<Z<]9;F,:=:GI%W1YQXX\=7GC>]BL[."6*PC<^3
M;C)>5NS,!P3Z =,GDUZM\,_!K^%M%:>]0#4KS#2K@'RE'1,_J??Z9K;T+P=H
M'APA]-TZ*.;;M,[Y>0^OS'D9[XP*W:F=1-<L=BZ=%J7/-W9SOC3PM'XM\/26
M!=8KA6$EO*PR%<>OL1D'ZY[5X3H'B'7/AUKTT4MJRYP+FRF^4..H(/8X/##/
M7O7N_B?QGI?A*2S74Q<8N]^QHD# ;-N<\Y_B%+&GAKQYHZ79MH-0M6RJO+$0
MZ$'D D!E_"B$G&-I+1BJTU.=XNTD</)\<K#[*3'HUS]HVG"M(NP'MSUQ^%><
M^(]1U[Q<9_$5[ PLH6$*, 1%'D\(N>I[G]>U>Y1?#/P=#-YJ:)&6]'ED=?\
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M\_[![_\ HR.O>J\%^"7_ ".=Y_V#W_\ 1D=;4_@D<U;^) ]ZHHHK$Z0HHHH
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M.QB4DDE<DD\YK<_X03P?_P!"IH?_ (+H?_B:/ G_ "3SPU_V"K7_ -%+704
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M .2=:5_VV_\ 1ST4?"__ ))UI7_;;_T<]%*?Q,=+X(^AFZO_ ,E*C_Z^K?\
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M%;12"5O-&"F0N=I#8.3CI7D4'P-^(>LL'U%K:W?GF]O?,(_[XW]:U=2^ /\
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M)_*OKW6_^0!J/_7K+_Z":^=+7]G;Q=!>03-J.B%8Y%8@3RYP#G_GE7T7K?\
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MP3_FO?\ W$?_ &6O>Z\$_P":]_\ <1_]EKWNMJW3T.;#_:]0HHHK$Z0HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\%^"7_(
MYWG_ &#W_P#1D=>]5X+\$O\ D<[S_L'O_P"C(ZVI_!(YJW\2![U1116)TA11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MO_)7M=_[=_\ TGCKZXL?^0?;?]<E_D* /C749W\,_%NXN]2@$[6.LF>:,?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !7F_QL_Y$NT_[""?^BY*](KS?XV?\B7:?]A!/_1<
ME:4OC1E7_ALT?A?_ ,DZTK_MM_Z.>BCX7_\ ).M*_P"VW_HYZ*4_B8Z7P1]#
M-U?_ )*5'_U]6_\ )*])KS;5_P#DI4?_ %]6_P#)*])KOQ_\.C_A1YV6_P 2
MO_B84445YIZH4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !7FWP^_Y#\__7JW_H25Z37FWP^_Y#\__7JW_H25Z6#_ -VK>B_4
M\K'?[U0]7^AZ31117FGJA1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% 'FWBS_D=(O\ ME_.O2:\V\6?\CI%_P!LOYUZ37I8[^#1]/\
M(\K+_P"/7_Q?YA1117FGJA1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M>"?\U[_[B/\ [+7O=>"?\U[_ .XC_P"RU[W6U;IZ'-A_M>H4445B=(4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>"_!+_D<
M[S_L'O\ ^C(Z]ZKP7X)?\CG>?]@]_P#T9'6U/X)'-6_B0/>J***Q.D**** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH *^2?CM_P E7U#_ *XP?^BUKZVKY)^.W_)5]0_ZXP?^
MBUH ^EO G_)//#7_ &"K7_T4M=!7/^!/^2>>&O\ L%6O_HI:Z"@#F?B'?3Z;
M\.]?NK9@LR64@5C_  Y&W/U&:^:_@GH>G:]\1H(=3A2>&"![A(I.5=U(QD=\
M9SCVKZNU738-8TB\TRZ7=!=P/!(/]E@0?YU\?:SX?\3_  J\717($L$MM*6M
M+Y%_=S+R >X^90<H><$YH ^S:J:GJ-MI&EW6HWD@CMK:)I9&) P ,]^]>!VO
M[2]XEHJW?AB"6YQ\TD5X8T)]0I1B!_P*LJ?4OB'\<)UL[:V6RT-7R[*&2W!&
M/ON>9&''RC..#@=: //="O'U#XBZ9>R##W&K12L,YP6E!/\ .OMZOBKQ+H<W
MP\^(+6+.]Q_9\\4\4A'E^:O#@CKCTR,\@U]G65W!J%C;WMLXD@N(EEC<'(96
M&0?R- 'QQ\5O^2H^(?\ KZ/_ *"*^SJ^,?BM_P E1\0_]?1_]!%?9U !7QE?
MPW'PW^*Y+Q.1IFHK,BKA#+#NW#'8;D./;-?9M>9?%KX6KXYLX]1TTQQ:W;)M
M4N<+<1C)$9]#D\'W(/J #T33[^UU33[>_L9TGM;A!)%*G1E/0U89@JEF("@9
M)/05\AZ7XE^(?PK>2P,-U:6V[<;:]M]\).<94^A/=3@^]:<_C#XG?%&(:390
M2FTGRDHLH#%$P[B20]!QT)YR1SG% '._%7Q/#XL^(.HW]HY>RC*V]NW]Y$&"
MP]BVYA[$5]6>!/\ DGGAK_L%6O\ Z*6OD7QQX0F\$:]'H]S<I<7 MXY97C!"
M!FSD+GD@>IQGT'2OKOP,K)\/_#:L"K#2K4$$8(/E+0!\J?$&QN?"?Q8U1T'S
MQW_VZW+ @$,WF+WY SC.>H-?7.@ZU9^(M"L]7L) ]M=Q"1"#G'JI]P<@^X-<
M1\6?ADGCO38[RQ*1:W9H1"6P!.G7RV/;G)4] 2?7(\'\/>-/&/PHU67398)(
MXPY:;3KU#L/;<OIG'# X/O0!]@5YY\0_BSI_@#4K"PDL6OY[A&DF2.;8T*=%
M/((.3NXR/N_2O+[_ /:2UN:T\NQT.QMIR,&621I0/<+Q^I-<KX9\#^*_BGXB
M;4KXW MYG5KK5+A,+C&,)TW'   7@<9P* /IWP7XKA\:>'(M:M[*XM()79$6
M?&6VG!(QU&<C\#7E'[2__(,\._\ 7:?^25[5I&E6>AZ1::781"*UM8A%&H]!
MW/J3U)[DDUYG\?O#5]KG@VVO-/MVG?3IS+*B+EA$5(9AWX(7(';GM0 []GK_
M ))J_P#U_P O_H*5ZO7QOX,^*OB/P-ILVGZ8+.6UE<R^7=1%MCD $J0P/\(X
MY'M7U+X!UZ;Q-X$TC6+DJUQ<0?OF4  NI*L<#@<J>* .CHHHH ^<?VDM'>/7
M='UI8G\J>W:U=P/E#(Q8 \<$ASU/(7V->B_ [7X-8^&]G:"13=::6MYD P5&
MXE#^*D<^H-=5XR\)V'C7PW<:-?Y17(>*95!:&0='&?J0?4$CO7S T/C?X+^)
M)9(U>!'/E^=L+VUVHY'/0GOCAAD],T ?7U>6_&OQ]?\ @O2=-AT6\2#4[JX+
MG,:R?N5!W9# @98KS['%< _[2FM&Q5$T"P%YMYE,CF,GUV=<>VZN4T;P[XN^
M,7BM]0NVD:)B//OI5*PPH#]Q.,9&>%'?D]S0![E\,M=UOXA> M3N-?:!1<O+
M:1&&+;E-F"Q&>>6([?=KYZ\#ZJW@;XG6-SJ"F,65T]M=J<_(#NC?(]LD_A7V
M!HND6>@:+9Z38(4M;2(11@]2!W/J2<DGU->/_&/X17.N7,GB7PY#YE\0/M=F
MN 9@!]]/5L=1W[<\$ ]M1TEC62-E=& 964Y!!Z$&G5\E^$_C!XJ\"P'1[F 7
MEM!\BVUZ&62#'\(/4 ?W3G';%:VO_M#^(M2LVM]*L+72RZE7F#&60?[I. OY
M'\* /1O%OQUTOPKXJN=%_LR6^6V 66>&8#;)SE-I';CG/<^E>F:5?C5=(L]0
M$$MN+J!)A%, '0, <,!T/-?,_P ,OA'JWB;68M9\16TUMI,<HE=;E2)+Q@<[
M<'G:>['KT'.2/J-5"J%4 *!@ =!0!\@_&W_DKVN_]N__ *3QU]<6/_(/MO\
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MF+*UD'SIN'+N/X3@X /(R<@<4 >ZT444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5YO\;/\
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ML_XC^!?^%@>'K?2?[1^P>3=K<^;Y'FYPCKMQN7^_G.>U>7_\,R_]3=_Y3?\
M[;0![!_PG?@__H:]#_\ !C#_ /%4?\)WX/\ ^AKT/_P8P_\ Q5>/_P##,O\
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M_P#!C#_\51_PG?@__H:]#_\ !C#_ /%5X_\ \,R_]3=_Y3?_ +;1_P ,R_\
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M /%5X_\ \,R_]3=_Y3?_ +;1_P ,R_\ 4W?^4W_[;0![!_PG?@__ *&O0_\
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M_P &,/\ \57C_P#PS+_U-W_E-_\ MM'_  S+_P!3=_Y3?_MM 'L'_"=^#_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% 'FWBS_ )'2+_ME_.O2:\V\6?\ (Z1?]LOYUZ37I8[^#1]/\CRL
MO_CU_P#%_F%%%%>:>J%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!X)_
MS7O_ +B/_LM>]UX)_P U[_[B/_LM>]UM6Z>AS8?[7J%%%%8G2%%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7@OP2_P"1SO/^
MP>__ *,CKWJO!?@E_P CG>?]@]__ $9'6U/X)'-6_B0/>J***Q.D**** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HK+\2Z;-K/A75]+MVC6>]LIK>-I"0H9T*@G )QD^AKYT_X9Q\
M8?\ 02T/_O\ S?\ QJ@#Z?HKY@_X9Q\8?]!+0_\ O_-_\:H_X9Q\8?\ 02T/
M_O\ S?\ QJ@#Z?HKY@_X9Q\8?]!+0_\ O_-_\:H_X9Q\8?\ 02T/_O\ S?\
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M5K#POX?TJ?S].T+3+.;_ )Z6]I'&WYJ!7SM_PSCXP_Z"6A_]_P";_P"-4?\
M#./C#_H):'_W_F_^-4 ?3]%?,'_#./C#_H):'_W_ )O_ (U1_P ,X^,/^@EH
M?_?^;_XU0!]/T5\P?\,X^,/^@EH?_?\ F_\ C5'_  SCXP_Z"6A_]_YO_C5
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MR5Z17F_QL_Y$NT_[""?^BY*TI?&C*O\ PV:/PO\ ^2=:5_VV_P#1ST4?"_\
MY)UI7_;;_P!'/12G\3'2^"/H9NK_ /)2H_\ KZM_Y)7I->;:O_R4J/\ Z^K?
M^25Z37?C_P"'1_PH\[+?XE?_ !,****\T]4**** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ KS;X??\A^?_KU;_P!"2O2:\V^'W_(?G_Z]
M6_\ 0DKTL'_NU;T7ZGE8[_>J'J_T/2:***\T]4**** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH \V\6?\CI%_VR_G7I->;>+/^1TB_P"V
M7\Z])KTL=_!H^G^1Y67_ ,>O_B_S"BBBO-/5"BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !7FWP^_Y#\__7JW_H25Z37F
MWP^_Y#\__7JW_H25Z6#_ -VK>B_4\K'?[U0]7^AZ31117FGJA1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% 'FWBS_D=(O\ ME_.O2:\
MV\6?\CI%_P!LOYUZ37I8[^#1]/\ (\K+_P"/7_Q?YA1117FGJA1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 >"?\U[_[B/\ [+7O=>"?\U[_ .XC_P"R
MU[W6U;IZ'-A_M>H4445B=(4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %>"_!+_D<[S_L'O\ ^C(Z]ZKP7X)?\CG>?]@]_P#T
M9'6U/X)'-6_B0/>J***Q.D**** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ KS?XV?\B7:?]A!/_1<E>D5YO\;/^1+M/^P@G_HN2M*7QHRK
M_P -FC\+_P#DG6E?]MO_ $<]%'PO_P"2=:5_VV_]'/12G\3'2^"/H9NK_P#)
M2H_^OJW_ ))7I->;:O\ \E*C_P"OJW_DE>DUWX_^'1_PH\[+?XE?_$PHHHKS
M3U0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /!/^:]_]Q'_ -EKWNO!
M/^:]_P#<1_\ 9:][K:MT]#FP_P!KU"BBBL3I"BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ KP7X)?\CG>?]@]_P#T9'7O5>"_
M!+_D<[S_ +![_P#HR.MJ?P2.:M_$@>]4445B=(4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !7F_QL_Y$NT_[""?^BY*](KS?XV?\B7:
M?]A!/_1<E:4OC1E7_ALT?A?_ ,DZTK_MM_Z.>BCX7_\ ).M*_P"VW_HYZ*4_
MB8Z7P1]#-U?_ )*5'_U]6_\ )*])KS;5_P#DI4?_ %]6_P#)*])KOQ_\.C_A
M1YV6_P 2O_B84445YIZH4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !7FWP^_P"0_/\ ]>K?^A)7I->;?#[_ )#\_P#UZM_Z$E>E@_\
M=JWHOU/*QW^]4/5_H>DT445YIZH4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110!YMXL_Y'2+_ME_.O2:\V\6?\CI%_VR_G7I->ECOX-'
MT_R/*R_^/7_Q?YA1117FGJA1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M >"?\U[_ .XC_P"RU[W7@G_->_\ N(_^RU[W6U;IZ'-A_M>H4445B=(4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>"_!+_D
M<[S_ +![_P#HR.O>J\%^"7_(YWG_ &#W_P#1D=;4_@D<U;^) ]ZHHHK$Z0HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHK)\2:Y#X<T"ZU29=_E+A(\X\QR<*OXDBFE?1";25V:U%>?\
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M.RW^)7_Q,****\T]4**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M\JDE64.C/:J***R.@**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%0W5U;V-K+=74R0P1*6>1SA5 [DT 345Y5K'QEA2<Q:)IWVB-3S/<L
M45O]U1S^)Q]*U-%^+FBWVV/5(Y-,F/&Y_GB/_ QT_$"M70J*/-;0P6*HN7(I
M*YZ#7(^,O'EKX/GM(9+.2[DG5I&6-PI1!@9YZY)Z>QKJ;:Y@O(%GMIXYH7&5
MDC8,I^A%>*?&-7C\7V;M]Q[$!?P=L_S%%""G449"Q565*DYQW/:K6YBO+2&Z
M@8-%,BR(P[@C(KR7XP:UYVI6.B1O\D"_:9@#U8Y5 ?H-Q_$51^'OQ$70TCT?
M5W/]FYQ!<=?L^?X6_P!CW[?3IQ/BS69-7\5:CJ4;*UO/=%(6)SOC7Y5(]L+F
MNBC1<*WO+8Y,3B55PWN/5Z$(<HRNDC)(C!D=3@JPY!!]12FXUBZMYK^]NKF[
M6*4++,9F8H3]TL,_*#V/3(Q6>9CZUH:+KKZ+?M.85N;>:)H+FV<_+-$W4?7N
M#ZBNVM)/WDM4>9AHR7N2;2?X&SH7C?7-!G5[6_EGA!^:UN9"Z,/0$Y*GW'ZU
MU'B#XM:AJ*+#H436$14;YY5#2DXY"CD #IDYS[5Y$ETP4'RGV]CUJY:7/VFZ
MAMDE6.2:18U,GR@%CC)SV&:RY:$GS21T<^*A%TXN_F=GH>G^*?&&H.MIJ5^P
M0_OKN:[D$<1].#RWL/TKU>.6+X>>''GUO7KW4N0J";!9G[*@Z_F361I_B[2/
M"NNV'@VSM,VJ%(I+T2#!E=002!UR2,G/>O/OBIKDNN>,);6&8BUTT^0BY(!?
M^,\>_'_ :Y9)UII6LOT.V+CAJ3ES7EMJ^I[#X+\7KXOL+JX^Q26C6\WELK-N
M4@C(PWK@C([5TH8,,@@_2OF'1="UW4]+NY]-M9YK>WDQ,D5USG:#G:2,\?RJ
M;PSXMO\ PO?K=6,C/;N09[5F^25?Z-Z&G+"WOR/;H$<?R\JJ1:OUZ'TS1573
M=0M]6TRVU"T?=!<1B1">N#Z^]9GB3Q=I'A:%&U"<F:0$Q6\0W22?0=A[G KD
M2;=D>@Y)*[>ANT50T75[77M'MM3LRQ@N%W*&&"IZ$'W!!%7Z0T[A1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5YO\;/^
M1+M/^P@G_HN2O2*\W^-G_(EVG_803_T7)6E+XT95_P"&S1^%_P#R3K2O^VW_
M *.>BCX7_P#).M*_[;?^CGHI3^)CI?!'T,W5_P#DI4?_ %]6_P#)*])KS;5_
M^2E1_P#7U;_R2O2:[\?_  Z/^%'G9;_$K_XF%%%%>:>J%%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 445A^(_$D?A^* "#[1<3D[(M^P8'5
MB<'CD#IWH W**SM$UFVUS3UNK?*L#MEB;[T;=P?\>XK1H **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "O-OA]_R'Y_\ KU;_ -"2
MO2:\V^'W_(?G_P"O5O\ T)*]+!_[M6]%^IY6._WJAZO]#TFBBBO-/5"BBB@
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M?"%@)[PM)/)D0VT9&^0_T7U/\SQ7DU]\8/$^I7&S2K6"U7DJD<1F?'N3P?P
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MAA7+7?Q@N8?!]I.(K4ZW=,_R(C".&,$J&P2<G(X&?7\;'QR_Y!&D_P#7=_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MK_XF%%%%>:>J%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M,@Y%%26%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M"9...W0\5]5111PQK'%&L<:\!4& /PKYW^+=Y'=>/[E(V#?9XHXF(]<9(_\
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M0P(P<\=*Z'X'L1XEU%,_*;/)'N'7_$U[+JVL:?H5B;W4K@6]N&"%RI;D\#@
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M7O=>"?\ ->_^XC_[+7O=;5NGH<V'^UZA1116)TA1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 5X+\$O\ D<[S_L'O_P"C(Z]Z
MKP7X)?\ (YWG_8/?_P!&1UM3^"1S5OXD#WJBBBL3I"BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0<[3CKCBK8\J6PBC'W0!T.""*(1YKBJU.5+09')BMWPYXTU+PR]__9J6PEN
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M ))7I->;:O\ \E*C_P"OJW_DE>DUWX_^'1_PH\[+?XE?_$PHHHKS3U0HHHH
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M3Z**U%544*BA5 P !@"N:IBX0TAJ_P #AJXN3TAH8\VC7>INTVM:S?7DS_>
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M>K?^A)7I8/\ W:MZ+]3RL=_O5#U?Z'I-%%%>:>J%%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 >;>+/^1TB_P"V7\Z])KS;Q9_R.D7_
M &R_G7I->ECOX-'T_P CRLO_ (]?_%_F%%%%>:>J%%%% !1110 50UG1[+7M
M)GTV_C+V\PP<'!4]00>Q!YJ_10G835U9GS3XB\):]X#U<7<1F^SQR9M]0A!
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MO_Z"*O?!+_D3+S_L(/\ ^BXZ[/7?#6D>)888M7M/M*0L60>8Z8)X_A(J31-
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>"_!+_D<[S_L'O\
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MIH;<Y7=&F.[MC/Z4X$$9'2BF(GBM)!()?.B;'0;20#Z]:;+E'Q,5'<..A_\
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MLGIQG-<9Z-S2HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MBJ-PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O-OA]_P A^?\
MZ]6_]"2O2:\V^'W_ "'Y_P#KU;_T)*]+!_[M6]%^IY6._P!ZH>K_ $/2:***
M\T]4**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \V\6
M?\CI%_VR_G7I->;>+/\ D=(O^V7\Z])KTL=_!H^G^1Y67_QZ_P#B_P PHHHK
MS3U0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "L;Q7H
M0\2>&;W2MRH\R QNW17!!4GVR.?;-;-%-.SNA-)JS/F;1M8USX;^)9DDMMDH
M'EW%M+]V5>Q!_4,/U%>AI\<M,,"E]'NQ-CE1(I4'Z_\ UJ]'U/1=,UF+R]2L
M+>Z4=/-C!*_0]1^%<]_PJWP9OW?V*,YS_P ?,N/RWUNZD):R6IRJC5AI"6AY
M#XM\<ZMX]NH-.MK-HK;S 8;2+,CR/C&2<<GK@ #&>_6O6_AOX.D\):)+]K(_
MM"[8/. 00@&0JY'7&2<^]=%I6@:3H<>S3-.M[48P6C0;F'NW4_B:T:B=1-<L
M59%TZ+4N>;NS/UV_ETK0;_488EE>U@>;RV. P49(S] :\;U?XU:E?::]M8Z;
M'8RR(4:?SR[+D8RG VGKZU[C-#'<0203('BD4HZGHP(P17,0_#;P?!="X31(
M2X;=AY'=,_[I8KCVQ2IR@OB156%27P.QP7P:\)RFZ?Q+>1%8T4QV>X$;F/#.
M/8#*^AW'TKV>FQQQPQ)%$BI&BA511@*!T '84ZE.;F[E4J:IQY4%%%%0:!11
M10 4444 %%%% '@G_->_^XC_ .RU[W7@G_->_P#N(_\ LM>]UM6Z>AS8?[7J
M%%%%8G2%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MN'@N$>!W6X0AD,1(93Z@CI]:] MO&GB*YTR.WGNXHY ,-+%&/,8=LD\ _04
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M,P[\G@?0<TRT\(7FLWPU;Q==M>W1Y6W!_=Q^W_UNE=C%%'#$L<2+'&HPJJ,
M"NR*HT-O>E^'_!-J>$J5=:GNKMU_X!Q^G_#NQ$@NM9N9]4NSRS2N=N?Y_F:Z
MJVT^RLT"VUI!"!_<C JS16<ZU2I\3/0I8>E25H1%W-ZG\Z,GU-)161L4[_2K
M#4T*WMG#/GNZC</H>HKGSX-N;&?S]!U^_P!/8<B-I#)&#]#U_&NLHK6%:<%9
M/0PJX:E5UE'4S=/\:ZSH;K!XJM%EM<@#4[1?E'O(O;]*[^VN8+RVCN+:5)H9
M!N1T.0P]JY$@,I5@"#P0>]8,5S=>#-1^T6"-)I4S;I[)>@/=D]#WQWI2C"KL
MK2_!_P"7Y''5PLJ:O%W7X_\ !/4:*K:?J%KJMC%>V4RRP2C*L/Y'T/M5FN1I
MIV9@G?8**** "BBB@"M=64=SA^4F7[LB\$?XTRUNV9_LUS\MRH_!QZBKE07-
MK'=( ^0PY5UX*GVII]&*W8I:]H5MKUCY$V4E0[H9EX:-O44GA7QE=:=<IX>\
M4L([I>+>\8X2=>V3ZU9MII4F-K<D&3&4<<;Q_C2:II%EK-H;:^@$B=0>ZGU!
M[5Z."Q\L/[D]8_EZ')B,,JOOPTE^?J=YUZ45YEX>UR]\(ZO#H6L7#SZ7<';9
M7;GF,]D8^E>F]:^AC*,XJ47=,\W5-IJS04444QA1110 4444 %%%% !1110
M5Q7C#QP='N!I&CQ)=ZQ(N2"?DMQ_>?W]O\F+QIXVDL9SH>A;9=6<?O)>J6J^
MI_VO05Q^G:;'I\;DNTUS*=TT\ARTC>I-9U:L:2N]^B_S./$8CE]V.XW3=/:T
M\VXN93<7]PV^XN&ZL3V^E6FF/F&*-=S@9;/1?K_A4=U,P>.VA;$TO?KL7NW]
M![FI884@3:@/7)).23ZD]Z\R<G-\TMV>=>X]00H!.3ZTM%%9@%%%% !1110
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M%%%>:>J%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!X)_P U[_[B/_LM
M>]UX)_S7O_N(_P#LM>]UM6Z>AS8?[7J%%%%8G2%%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !7@OP2_Y'.\_[![_^C(Z]ZKP7
MX)?\CG>?]@]__1D=;4_@D<U;^) ]ZHHHK$Z0HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH *1W6-&=V"JHR6)P /6EKR;XO>)9$>'P[;R%8V037A!QN!/RI]#@D_A5
MTX.I)11E6JQI0<Y="A\3O%^BZ_;6EGIDDMS+:W.\SHF(BNTJ0&)YZCH"..M>
M:)K-[IM\DVFW,EM<A64RQG!",,$?C_3/:H;B[58]_/EYP& XSZ9Z52BY7>3E
MGY->E:,(>RB[GC<TZM3VTU:VPK<%#R?G!)/UJ=[C8K,>PS4*Q>8@D?D'[H[
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M%_\ R3K2O^VW_HYZ*4_B8Z7P1]#-U?\ Y*5'_P!?5O\ R2O2:\VU?_DI4?\
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M8R,<[&[Q$^G<?4U<X^UC=?$OQ7_ _(\W%4?9OGCL]_)_\$],HHHKD.<****
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M -VK>B_4\K'?[U0]7^AZ31117FGJA1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% 'FWBS_D=(O\ ME_.O2:\V\6?\CI%_P!LOYUZ37I8
M[^#1]/\ (\K+_P"/7_Q?YA1117FGJA1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 >"?\U[_[B/\ [+7O=>"?\U[_ .XC_P"RU[W6U;IZ'-A_M>H4445B
M=(4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M#_.A0!\T;%<]U/!JI3YGY$4Z7(K]1ZQF*0-<KNC'W3CY2?>KLMTHM9#@9VX
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ KS?XV?\B7:?\ 803_ -%R5Z17F_QL_P"1+M/^P@G_ *+D
MK2E\:,J_\-FC\+_^2=:5_P!MO_1ST4?"_P#Y)UI7_;;_ -'/12G\3'2^"/H9
MNK_\E*C_ .OJW_DE>DUYMJ__ "4J/_KZM_Y)7I-=^/\ X='_  H\[+?XE?\
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M0=%92KXQWR<4T$*X195E&,Y!Y'L:18(EQ\BDCN1DTY@=A"8![4 #2(IP3SZ
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M,/MSG:>X/N*^JP6(]O14GNM'_7F>-6I^RJ.*VW1?HHHKJ,PHHHH ***.@R:
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M_(Z1?]LOYUZ37I8[^#1]/\CRLO\ X]?_ !?YA1117FGJA1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 >"?\ ->_^XC_[+7O=>"?\U[_[B/\ [+7O=;5N
MGH<V'^UZA1116)TA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 5X+\$O^1SO/^P>__HR.O>J\%^"7_(YWG_8/?_T9'6U/X)'-
M6_B0/>J***Q.D**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MM$HV%"?-NK#A#^ZC=&4,RY<GOGFF%G0X9=V>A7O3#)Y:GRY"0/X<9J0RKM+
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MG=\ >@P,FDZ4SRL<JS ^N<TW=+NV87(&<GO0Y/J-12O;J2UZQ\+_ !G ;?\
MX1/6BK6LP,=J\AXPW6)O8YX_+TKR17!.TC:WH:G3GBIE!5%8J-25*7,CV/XQ
M/%;6^@:7" L2"1P@_A5555_]"-=K\/+[[?X#TIRV7BB\AO7*$K_2OG1KF>ZG
M\VXFGN9VPH:1VD=O0#.3^%?17P_T*Y\/^$K>UO#BYD9IY(_^>9;G;^'?WS65
M>FJ=*,6]3?"U76KRFE[MD=11117&>D%%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M7F_QL_Y$NT_[""?^BY*](KS?XV?\B7:?]A!/_1<E:4OC1E7_ (;-'X7_ /).
MM*_[;?\ HYZ*/A?_ ,DZTK_MM_Z.>BE/XF.E\$?0S=7_ .2E1_\ 7U;_ ,DK
MTFO-M7_Y*5'_ -?5O_)*])KOQ_\ #H_X4>=EO\2O_B84445YIZH4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5GZQI
M=IK&GM9W? 8YC<<,C]BOO_\ 7K0KF/&?AR;7;.&6U(:YM262)VPL@.,^P;C@
M_4=Z /-M>T^[T:[-I>IANJ2*/EE7U7^H[?K7,7#[FQ6IJ<#B4V]]%-%<)T$V
M0Z>XS_3BL"1YQ*8A&'E! !W84D\#WH DHI8X9GNOLQ>-9067YL@,P/3/;(YI
MT\$]KS/"R+_>'S+^8H 9358.,C/XC%))\T+;><CMWJS<-:7;^:N"VT#AB" /
M:@"&I[&[:Q?[GF0DYV]U^G^%4_*DR5\X[.V!\WXFE\EARDK@_P"T=PH U8=6
M2,/$89!;Y_=G@E1Z$#MZ5GW5S$TFY0Y'0L4( _.F(Y8'(PRG##T-.H D.FS3
M@M&1DK@J>-W?@]JA3!0,N?FYYZGZT^&22U8M;D+N4H02<#/<#U%-6-RK+"H/
MEQESG^Z/ZT !4,,, 1Z&@*%&%  ]!4D<)DA>=Y!%;H<%\9+'T45$BX+, P#'
MA6;)'_UZ %9=R,OJ,5H1WRW-HHD4%67:RGH<<'\*S7!?$2_>?C([#N:?C;P!
M@#@#TH 0#:\D8)(1L GTQD?SJ6"YDM VS:\1Y:)_NGW]C4:6TC%GB.XDY*-W
M^A[5'(0T+=NQ!XQZYH ?*T3*)[5"JMR8L?R]/Y4GF #+*Z#U92!^=3WS)',5
M1A(_]U3G\_2E@OKB%-J1Q#(QEB6_3B@!D,,UPS+!$TFT L00 ,].I]J;,DEN
MP6>-H\\ D@C\P:GTZ[33[AFE.(I>&;'W6SP<#MR1Q1?2K*Y/S>6>[(0#^8H
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MW!FT!82<FWD:+Z+U4?D0/PKH*]A.ZNCVH2YHJ04444R@HHHH **** "BBB@
MHHHH **** "O-OA]_P A^?\ Z]6_]"2O2:\V^'W_ "'Y_P#KU;_T)*]+!_[M
M6]%^IY6._P!ZH>K_ $/2:***\T]4**** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH \V\6?\CI%_VR_G7I->;>+/\ D=(O^V7\Z])KTL=_
M!H^G^1Y67_QZ_P#B_P PHHHKS3U0HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** /!/^:]_P#<1_\ 9:][KP3_ )KW_P!Q'_V6O>ZVK=/0YL/]KU"BBBL3
MI"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MZ0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH *\W^-G_(EVG_803_T7)7I%>;_ !L_
MY$NT_P"P@G_HN2M*7QHRK_PV:/PO_P"2=:5_VV_]'/11\+_^2=:5_P!MO_1S
MT4I_$QTO@CZ&;J__ "4J/_KZM_Y)7I->;:O_ ,E*C_Z^K?\ DE>DUWX_^'1_
MPH\[+?XE?_$PHHHKS3U0HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ KS6[\9WFG>+[R9S)-91R-;FU5@  O&X9XSN!
M/T/L*]*KA/$?@";4M2EO=.NHH_/.Z2*8' ;N01GKZ8ZT 11^/M!UF466MZ8L
M4#G DGVRQJ?]KCY?KT]Z\NU6:P/B*>?345;%KL&$*2054X!&>QVY_&FZW!<:
M;=7-C<*$N8G,1 Y&>Q'L00?I5>ULO.220'"PX5<]!QR?RH DU%HYKI95&!*,
M-C^\.A_+^5-^W7#GRY&+,HR'_O#W]ZCE&WR5(8-NW ,,94@\_2D5C',DH7=M
MX*_WAW_&@!QMVRGV=07?EH^@ _O>U-ELIE97\R/>OHA_+.:TH[B&.PN+J,%@
M9".>">0 /;J*IB[:639*BHQY4J<@^WUH HLSF4)+F,8X*GAC]:D"R)RDI/LX
M!_E4DBALJP!!Z@U#Y+_=\UO+]._TS0 ]=[2N[*%R , YR1GG^5/I\,,D\T<$
M*%Y)&"(HZDG@"O:?"'@.TT.&.[OHTGU(C.3RL7LH]??\J /-=,\#>(-5C$L-
MB8HF&0\[! ?P//Z5T.G_  QUVVF:5Y]/PR;=ID?(Y_W*];JF^K:;'((WU"T5
MR<!3,H)YQTSZT >07WP[UVQT]H5M5N(06;_1I-S*,Y'!P2?H#TKCKBTDMYFA
ME:XCD4X9' 4CZC%?388, 5((/0BL3Q+X6L?$MBT4ZB.Y4?NKA1\R'W]1[?R/
M- 'STB/&Y=)6R5VG< >/:GP6$M[=0V]ON>ZF=4BRW5B< <\#DU;U33;G2-2G
ML+M0L\+;6P<@\9!'L00?QJSX:_Y&G2/^OV'_ -#% '16G@+Q$J*TFF[&(Y7S
MXS@_]]5!??#SQ(]ZTD&F;D=06_?QCYNA_B],5[?10!X0/AUXI4872@!Z">+_
M .*J&?P+XFMD9WTF4A1D^6RN?R4DFO?:* /F,V\UM?NEU#)#+$=OERH593W)
M!J;^T94F=!&CQ+\K*>K CGV[U]!:WX>T[Q!:&"^@5F (CE48>,^H/].GK7A7
MB?0)_#&MSVMQN,+G?!,1Q(F ,^Q'0_\ UQ0!D#RU9HXFW1CE/7;V!]QT_"GQ
M&(7*&9PB*"P)Z%NP_7/X4T ?>&.>X[UZ-\.O!UOJ4?\ ;&I1B6!7*P0N,JY'
M5CZC/&/44 <A8^'=8U=M]AIMS-$>1+LVH<^C-@'\*UI?AOKZ0&2+3]DH_@$J
M$/\ D>#[U[B J+@ *H'T %58=5TZXN3;07]K+.!DQ),K,!] <]Q0!\[7VF7V
MF2^5?6<ULY) $J$9QUP>A^HJK7TK?6%KJ=G):7L"302##(W^>#[BO"_%?A5]
M%\1KIZLQM;C,D$@SG9SP3Z@@9_ ]Z .95Y9#F-%VYP-QP30/-@A9I89%^8G(
M7(Y/J.*DB8D*3U[_ %K=L#TH Y^.99#MY5NN#W^GK4<L,:2JS#]VV01V!ZYK
M6UB+3C-'&J8G\U3(8CM"C(R3[X_&D-O-97J[^4BR1)_>XP./7DYH S!YD8^7
M,J?7YA_C6A9)+,@>.&9E)P"(FY([=*IS/&D^Y5V1/U Z*W],UL:3XMUK04%I
MI]T(H'D,V"@;+8 (.>Q [8H [3PEX-O+ZYCN]3MW@L8R&$<HPTQ'0;3R%]<]
M>G2O5*YKPGXRL_$]OLP(-0C7,MN3_P"/*>Z_J.]=+0 4444 %%%% !1110 U
MSB-CZ UYSX7._1VESGS;F:3..NZ0G^M>AW+!+65B< (3S]*\]\*H4\,6!88,
MD0DQ_O<_UKS<U?[A+S_1G3@U^]OY?Y&Q1117SIZAQ?Q5NF@\!7<"'#W3QP*?
MJXS^F:AL85MM/MH4&%2)5 _"H/BTP_LG0XCG$NK0H?U-7\;>/3BNS:A%=VW^
M1T8)7J3EZ(****S/2"BBB@"Q96-SJ$_D6L?F28+8W <?C6A_PBVM?\^?_D5/
M\:L^#?\ D.G_ *XM_,5Z!7I83!TZU/FDV>1C<?5H5>2*5K?UU/)+JUFL[E[>
MX39*GWER#CC/:H:[WQ=I N[/[=$O[Z!?FQ_$G?\ +K^=<%7)B:#HU.7IT.["
M8E8BFI=>H5IV_A[5;NW2>"UWQ.,JWF*,_F:S*].\/?\ ( L_]S^IK3!T(UIN
M,C+'XF>'@I02U?4X"^T;4--B66[M_+1FV@[U//X'VJA7=^-_^03!_P!=Q_Z"
M:X2HQ5&-&IR1-,%7E7I<\MS5A\-ZM/#'-':;HY%#*?,09!&1WJ&^T74-.A$U
MW;^7&S;0=ZGG!/8^QKT;2?\ D#6/_7O'_P"@BL?QM_R!H?\ KX7_ -!:NRI@
M:<:+J)N]OZZ'GT<QJSKJFTK7MU_S//+IML!]3Q6/(*TKMMS;?2ETG1KC6]12
MTMQ@'F20C(1?4UYL(N3LMSVI24(N4GHBAI^@ZEK;2IIUJ9S$ 7^95 STY)'H
M:35OASXMGTZ2.WTG?+N1E'VB(='4]V]J]NTG2;31K!+2T3:@Y9C]YV[DGUJK
MXE\26/A?2'O[TD_,$BB7[TCD@ #\2,GM7LTL#""4IO5?<?/U\UJ5.:$(KE?W
M_F90L[FUM8/M481R@!&X'G'/0TVI)KF6[<2S##D#Y1_#[5'7S]7DYWR;&D.;
ME7-N%1^1#OW^3'OZ[MHS5.42WUZ]NDC)%&!NVG!8T36TNF!9TE9HL@2(QR,>
MHIJE)QNA.:O8T/<U2.J6P8A?,< X+(A(_.GZB6&GRE>N!GZ9Y_2K-E! +1-B
MJ05ZTZ5+G"<^4C#I<VY:)P5<$!A4&DW,,5MY$K+'+'PRMQ1:JL=_>)%_J@PZ
M= V.:GEMH)CF6)'/J13C+V4F#7.B RI=:J)(<-'$A5G'0D]JH^*X]WAZXE /
MF0%9HV'565@<C\JV$18U"HH51T IES +JTFMVZ2HR'\1BG"M:LJG9H4J=Z;A
MW.MLI?.L;>7=NWQJV[UR*GKGO ]RUQX1L@Y)DB#1/GU5B/Y8KH:^N>YXJU04
M444AB,P52S'  R37C%G<MJ=S?:Q)]^_G:11Z(/E0?]\@5ZGXENUL?"^J7+D@
M1VLA&/7:<?KBO+M.A-OIEK"1@I$H(]\5S8N5J=N[.'&RVB32@F-E7JW&?2G*
MH50H& !@4M%><<!2E=KF]^RKQ'$%DE;N><JH_+)J[5#2LR027;??N9"^/[H'
M 'Y"K].782"BBBI&%%%% !1110 4444 2VUO+=W"00)OE<X5<@9_.F:[X-\1
M7D$$-O8;T\W=+^^C' &1U;UQ6EX=_P"0_:?[Q_D:])KLP]&,US,ZJ&'C5BW(
M\0_X0#Q/_P! S_R/%_\ %4?\(!XG_P"@9_Y'B_\ BJ]OHKI]C$V^HT^[_KY'
MAS> O$R#)TMOPFC/\FK)O]'U'2VQ?64\ SM#.A"D^QZ'\*^AZCGMX;J%H;B)
M)8F&&1U!!_ T.BNC%+ QM[K/F^BNH\:^%QX=U%6M]QL;C)BSR4(ZJ3_+V^E<
MO7.TT[,\V<'"3BPHHHI$A1110 4444 %:?AL'^T+T@\".,$>IRU9E:WAK'GW
M_KF/\L'_ .O4S^%C6YT-%%%<IH%%%% '4^!Y2+R_ASPR1OCWRP)_E^E=I7GG
MA.;RO$,2YP)8WC^IX;_V6O0Z]7#N]-'JX5WI(****V.@**** "BBB@ HHHH
M**** "BBB@ KS;X??\A^?_KU;_T)*])KS;X??\A^?_KU;_T)*]+!_P"[5O1?
MJ>5CO]ZH>K_0])HHHKS3U0HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@#S;Q9_R.D7_ &R_G7I->;>+/^1TB_[9?SKTFO2QW\&CZ?Y'
ME9?_ !Z_^+_,****\T]4**** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#P
M3_FO?_<1_P#9:][KP3_FO?\ W$?_ &6O>ZVK=/0YL/\ :]0HHHK$Z0HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\%^"7_(Y
MWG_8/?\ ]&1U[U7@OP2_Y'.\_P"P>_\ Z,CK:G\$CFK?Q('O5%%%8G2%%%%
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M0#&/S'M38P0O/!)R179JMNIYUE)Z]#ZM\*ZR/$'A?3]3W*9)H1YNT$ 2#AP
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MPUW4+R5I+BXA#R,3QG=V'8 < =@ *X;.2<V>IS*FXTXGLU?'3'&,G:N>6QG
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %>;_&S_D2[3_L()_Z+DKTBO-_C9_R)=I_V$$_]%R5I2^-
M&5?^&S1^%_\ R3K2O^VW_HYZ*/A?_P DZTK_ +;?^CGHI3^)CI?!'T,W5_\
MDI4?_7U;_P DKTFO-M7_ .2E1_\ 7U;_ ,DKTFN_'_PZ/^%'G9;_ !*_^)A1
M117FGJA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /-O%G_ ".D7_;+^=>D
MUYMXL_Y'2+_ME_.O2:]+'?P:/I_D>5E_\>O_ (O\PHHHKS3U0HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** /!/\ FO?_ '$?_9:][KP3_FO?_<1_]EKW
MNMJW3T.;#_:]0HHHK$Z0HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH *\%^"7_ ".=Y_V#W_\ 1D=>]5X+\$O^1SO/^P>__HR.
MMJ?P2.:M_$@>]4445B=(4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5F^(;\:7X<U*_P X
M-O;22#ZA3C]:TJ@O+.VU"SEM+R%)K>5=LD;C(84"9\ZZ/X;2[\*:OK5X5$-O
M;O%9JQ_UTP&68#OM4'\<^E<;7J?Q29-)U/2])TZ$165A9,\<"'@^861OJ=H/
M7UKRN/S)8ED6%RK="O->C%RG[SZGD34*:]FGMOZO44)YLB1=G.#].IJ4O%#=
MONR $&55<Y/:HF290&$,H93E3M[TLTBO<!QQYD8./S!K5/E7F<\ESR2OI8:I
M#J7& &8G'I[4M,*D'<APW?T/UI5<,<=&[@U%S5(4@,,&I5NYD38^9%['^(?X
MU&2 ,DX%(K*PRI!^E-2<=A2@I+WD(TR,PP<D]N]/CB1[=V7Y9@YY]?8TF!G.
M.::A(DD ^[QGZT)ZZA*.EHNQ]AQR++$DB_==0PSZ&O,?C?#N\-:=/C[EYLSG
M^\C'_P!EKJ/AYK$>M>"-.E60M+!&+:;)R0Z #GZC!_&K'C706\1^$[[3HP//
M90\))Q\ZG(_/&/QKSX^[/4]>?[RGIU/EO'S!@2K#NIP: ,9ZDGDDG)-/G22W
MDDCEC=)8V*NC##*P.""#T.:8V]7\LQL)/[I']?2N\\G1"U)<V=]:32P36LL$
MA7#I,I1O8X/I71> _#5SXB\66=N51K6%Q-=93*B-3D@Y/.[[OXYQ@&OI2^TZ
MRU. P7UI!<Q'^":,,/UK*=7DE9F]*@ZL'),^4TL;8KR'8^I<UWOPBLT@\;ET
M=L?9)!M8Y[K53XHV.C^'M?M['1;0Q2F+S9P9"44L?E !)(/!..F"*D^#LTTO
MCIO,D)'V23Y0,#JM;U*E*5%M(Y:-&O#$)2EHF>_U\R_$C_DH6L?]=5_] 6OI
MJOF/XDQ@_$+6#E@3*O0_["UPX?XF>IB_@7J<D^YF8K_!T&.IJ52&4$=#0BA1
M@?7FA(IMVV./S,GY57[W/8#O779GGMH^A_@^C+X"B)& UQ(1[C(']*ZS7YUM
M?#FJ7#ABL5I*Y"]2 A/%5?".CG0/">FZ:PQ)%"#*.OSM\S?J36/\4M772O M
MX@<+->8MHP1G.[[W_CH;]*X?BJ:=SU%[M+7L>(^&M(NO%NOP:79Q^4K?//,W
M/EQ@_,V/7G ]R*^E[&RM-(TV&SM4$-K;Q[4!/W5'J3_,UY!\#/\ C_UG_KE%
M_-J]IK7$U)3G9F."HPIPO%;GS=\1O&+>*==,=NY_LVT)2!>,.>[_ (XX]OJ:
MZ+X'?\AW5/\ KV7_ -"KV^BH=5<O*D6J#4^=L*^/*^PZHZU_R M0_P"O:3_T
M$TJ53DZ%5Z/M+:['R2L*-\I7\>_YU(]K/'$NUS+ IR%Q\R_XBHEN$3DALCJH
M'(J=KN:1 J$1)Z@Y8_CVKT8\EM3QY^UYE;;S(001D<BD9]I  RQZ"E "@ =!
M2XYSWK,U&H=\R1N&0,>3_@:D?RH;DX^1-HP2V<^OXU%]^3_90Y/UI7#LRL!N
M"YX[U2=D1*-Y;Z#Y)?. 1<^6#DGUIK%@ORC)H!# $'(-+2;;U8XQ459#45U.
M5D.[WZ'\*WO#UG:ZKJ2VNH:G#I,1'^OE0NK'T&, ?5B*Q4ZU=@&:TIQ;5D[&
M%:<8R3E&Y]#>"O!%IX4:ZN8+^2\:[5!O("KM&2, '!Z]:ZZOG+PYXMUCPO*!
M83>9:9RUG,28S_N]T/N./4&O>?#NMQ>(M!M=5@B>)+@']V^,J0Q4CCKR#7!B
M*-2G*\];]3U\'B:56-J>ENAJ4445SG8%%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>;_&
MS_D2[3_L()_Z+DKTBO-_C9_R)=I_V$$_]%R5I2^-&5?^&S1^%_\ R3K2O^VW
M_HYZ*/A?_P DZTK_ +;?^CGHI3^)CI?!'T,W5_\ DI4?_7U;_P DKTFO-M7_
M .2E1_\ 7U;_ ,DKTFN_'_PZ/^%'G9;_ !*_^)A1117FGJA1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7F_CHS:CX
MHM--M1OF$(2->V]V))/L @)]LUZ17-^([*UTZTU+7H(RNHFV\E9=Q.W.%! Z
M ].?:@#Q77=/32M>OK&-F=892NYNK' Y_&LYB0ORC+'@#U)Z5<U!II]5FC$4
MLDD:1[SU+ *%#>ISMY]ZK-;SE"#;7 ]_+/% %I;:"RN4C>6- T9,K.<9QW^N
M3T]*J$(2[P_ZEG)3W'K^>:EO)OM M)W&V0HT;@C!# C_ /754JT9+1=_O(>C
M?X&@!?)C#[PBAO4"I8I9+>=9XB!(N0-PR"#U%1I(KYQP1U4]12LRH,LP4>I.
M* -"?5([E KJ8I.FUNA^AK/4I),D9<@&15<J>0":"%=<'#*?Q!J.15CMV" *
M ,C []OUH ^C/"T8B\+:9&&+!;=0&/?BLWXB@_\ "#7^.F8L_P#?Q:/AY?&^
M\&VF]MTL)>)QG[I!R!_WR5K3\36+:EX9U&T2,22/ Q13W8<K^H% 'SPC/'*L
ML3E)%Z,/Y>XI\]Q-=2!YW#%1A0!@"HZ0[PL;&*0>8 8_E^_GTH 6G1-(\4UO
M&K&.1D)8#(1P1_3K]!398;F-<D1!O[I).*]-L_A@[:%9RP7QBNVA#RQ3+E2Y
M&<9'(]^#0!Q"Z&C+G[7(3ZA5Q^53Z+I]Q9^*='9L21&^A&]1C'SCJ/ZU?US1
M]<\-1E[BQ5H=P47 D!CR1Z#YOS K.T"^O)_%&D"2X(4WL.510H/SCCU_6@#Z
M#KQGXNL%\20$C(^PKQZ_.]>S5XS\6X]_BNT)8X%DAV]B?,>@#@HF<NZRG,@Q
MR23D=NM3([Q2I+&VV1#E3C-,:)V='C +#(()QD&@,YD,0B;S1U3T'KGTH ]7
M^$\L\L-ZT[%]R1L'/U;(_ C\C7I-><_"*&0:+>3N, RB)5/;&6/_ *$*]%9@
MBEF.% R30!\XZ^'7Q'J<L@.)+R4*_P#"<.1C/;'I71>!_"%[K=Q_: NI;*UA
M; GB;;(S8Y"'MUY/\^<<Y)J N-9N1LWQ:A.Q\I^3EFX/Z@&OH72]/BTK2[6P
M@SY=O&L8).2<#J?<]: +*+Y<2JSL^T<NV,GW.*K0ZKIUQ<FV@O[66<#)B296
M8#Z Y[BN'^).HW4TL&AVUQY$;Q>?<L!DLI)"+],JQ/T%>57$$UA<*KMSG,<J
M<9/]#0!]%:QIIU;2I[$7<]IYJ[3+ 0& [CZ&O#=4\+:MX6U<QJ5F4\IOR%G3
MV/8CT/3Z8KUGP%KDVN^&DENF9[F"0PR.1]_&"#^1'X@T[QU:B;PM<W*Q+)/:
MCS8]S8Q@_-S],T >"*&3*.I21?O(>HI68(I9C@#J:DGGENIO.F8%L;0%& !Z
M5&5#8R,X.: (Q,&9$ *.[!5WC R35Z:%;>Y2$R-*I3<Q=1M)SV'M_452D!<B
M)>_+$=A3[CS+CRP4\P*Q8KWZ=J +%U=B:,6\1!7(,C#IQVJK([+@*NYCT]!]
M:<A4H"N-O;%+0!)922095U\Q"Q)*#!&?;N*[7P]X:O=>@%Y8W%K%Y9^4O,1*
MA]<*"5_$@UQUL/FK?L'D@D6>"5X9D^[)&VUA^/\ 3I0![C9Q2P64$4\QGF2-
M5>4C&]@.3CWJ:N+\,>,9[V]ATS48P\\N1%<1C 8A2Q#+V.%/(X]A7:4 %%%%
M !1110!R/B-O-\4:=$R_+#;R2*?4L0#^6W]:2I_$O_(=T?\ ZYW'\DJ"OG<U
M_C_)'I8/^&_4****\TZRKJ5DNI:7=V+XVW$+Q<]L@BO*_ -RZZ3<:1/D7&FS
MM"RG^[G@_P Z]>KR;Q= ?"7Q!@UM1C3M67RKCL%D'<_AT_&NS#/GC*EWU7JO
M^ $)^SJQGTV?S_X)T]%,BE2:,/&P933ZS/:"BBB@#H?!O_(=/_7%OYBO0*\_
M\&_\AT_]<6_F*] KW<N_@_,^:S7_ 'CY(\]L]5.E>*+J1B?(DG=)1STW'G'J
M/\:]"!! (.0>]>4:G_R%KS_KN_\ Z$:['PAJWVFT-A*W[V$?)_M)_P#6_EBL
M,#B+3=*7R.G,<->G&M'HE<H>,=($4@U*!/E<[9@.S=F_'I^7K71>'O\ D 6?
M^Y_4U>N+>.ZMY()EW1R+M8>U0Z9:-8Z=#:LP8Q KN'?D\UV0H<E=S6S7XG!4
MQ/M,,J<MT_P,3QO_ ,@F#_KN/_037"5W?C?_ )!,'_7<?^@FN :3TKRLP_CL
M]K*_]W7JSUG2?^0-8_\ 7O'_ .@BKE4M'_Y =A_U[1_^@BI+Z^M]-M'NKJ0)
M$@_$GT'J:]N#2@F^Q\]-.51I=R2XN8+6,27$J1H6"@L<#). *EKQWQ%X@N-<
MN][Y2!#^ZB!X4>I]37H/A#75UK2 LC?Z5;X24'JW'#?C_,&N>CC(U:C@OEYG
M7B,OG0I*H_GY'&?$G0DTZ5M;BPEM*3]HP/N/U+?0_P _K5#X::>T/AV35)E*
MS:G*9\'LG\ _G7J^JZ9:ZSI-WIEZA>VNHFAE4'!VL,'![&N=:R&G!;1%"I$H
M5 !@8[5P9E2]E%N*TD]?Z\S6AB958QA+[/\ 7X"51OR\LL-JK%1)DN1W'I5Z
MJUY;-.$>)PDT9RI/3Z&O'BTGJ;O8BET9(X2\+;)$&0035BTE:>TCD;[Q'/UJ
M!FU.:,PN(XU/#2 Y./:GRS1V%O'&JECC:B#J<5M5<'90(A=;D20W=E(_V78\
M3'(1C@K4L,5Q)<"YNBH=051$Y"@]?QJ#^T98\-/;%8^[*V=OUJ\\JI TN<J%
MW U#E.W*RDHWN.) ZD#ZFH9K*WN&W2PJS>O2JEIIS7L(N)W8NXS]X\>PJ6V6
M6UO'M'<NFW>A)R1ZC--TY17,)23=BU%%'"@2- JCL*?145Q.MO;RSM]V-"Y^
M@&:RU;+V+/@A1*FKWH_Y;7I53ZJJ@#]2U=76%X-MVMO"EBLB[9'4R/[EF)_E
MBMVOLXQY8J*Z'A7OKW"BBBF!QOQ'!.EZ4>PU.//_ 'Q)_7%<I77_ !$5CH=E
M)_!'J$3.?0'<!^I%<A7#C-XGF8O^(5()O,O[@#HF$_$<G^=6ZRK)A_:5X!T\
MXC]!G]:U:XWN<4'>X4444BPHHHH **** "BBB@ HHHH U/#O_(?M/]X_R->D
MUYMX=_Y#]I_O'^1KTFO1PGP/U/1P?P/U"BN!\8?\AL?]<E_K7':KI$.HQ%P
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M4**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \V\6?\
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M:0;E%-A1114E!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%>;?&>_N[+PQ9QVMS+"L]SLE\MMN]=I.#CM[548\SL1.?)%
MR.]L=6L-3>X6QNXKC[._ERF)MP5L9QGH>O;I5RO+O@?_ ,BYJ7_7V/\ T 5Z
MC1./+*P4Y\\%)A1114EA1110 5PME\5M"OM>BT>*TU$7$MQ]G5FC39NSC)._
M./PKNJ^9/#O_ "4^Q_["@_\ 1E:TH*2=SGKU)0<;=3Z;HHHK(Z HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M\$_YKW_W$?\ V6O>Z\$_YKW_ -Q'_P!EKWNMJW3T.;#_ &O4****Q.D****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O!?@E_R
M.=Y_V#W_ /1D=>]5X+\$O^1SO/\ L'O_ .C(ZVI_!(YJW\2![U1116)TA111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M'7IH2)]ZK*7$</WCEO[JC)JDB2;@-X*@\@CK6C9V+S2"*"/=<7#B- H^\S'
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MQ.B2*MU=@PQ+WP?O$?0'KV)%:6O>)=+\.6AGU"Y5#@[(EY=SZ ?ER>.:\/\
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M>4'Y$95(QU+9_P#K?G3GA=7WQH75_O*O4'UJXEJXT>57_=R22*_/.WY@!^E
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MG5BNTHY[$<_**R?@]K\FJ^%I+"XD9YM.<1J3S^Z8?(/PPP^@%1?&W_D3+/\
M[""?^BY*B,+5.5FLJEZ7/$UOASXMO_%^DW=UJ$-M%)#/Y:BW5E!&T'G+'UKL
MZ\N^!_\ R+FI?]?8_P#0!7J-3424FD51;E339ROQ!\37OA3PXFHV,5O),;A8
MMLZDK@ACV(YXJG\./&&H>,+"^GU"&UB:WE5%%NK*"",\Y8U1^-'_ "(\?_7[
M'_Z"]9GP-_Y!&K?]=T_]!-6HKV5^IFYR]NHWT.P\>^([SPMX9;4K&."283(F
MV=25P<^A!_6N/TGXP;?#-SJ.LV]NUX)S%;6UJ&3S,*"22Q; &>OZ&MGXQ?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MZNK26Y0LRPO!\ZI'G@!1R.,9XY/?I7F4\\9N JDDL>!C'XT ! (P1D5"D@@
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M)_2N^K@?@[_R(4?_ %\R?TKOJFI\;*H_PT?._P 7_P#D?Y_^N$7\J]U\.?\
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MH \$_P":]_\ <1_]EKWNO!/^:]_]Q'_V6O>ZVK=/0YL/]KU"BBBL3I"BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KP7X)?\
M(YWG_8/?_P!&1U[U7@OP2_Y'.\_[![_^C(ZVI_!(YJW\2![U1116)TA1110
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MM+2*(ERBM'W'3Z&NN\+3^%DDCA\2VU^4''G03?NR/]I  P'T)^E<HX 9)#P
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M%;MM;Q6EK#;0+LAA01HN2<*!@#)]JN<U**2Z&=.DXSE)]3YG\::/=^%O&ER
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MY* #^(KMH88K>%(8(DBB085$4*JCV H=2,5: U1G.2E4?R'U\R>'?^2GV/\
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MR<DPEHLGU.PC-:<^G+41E[-N3G1D><:_\8[S4[4V.@V$MK+/^[\YFW2<G V
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MS8'Z?RJ$&7:4,N%/4(,9^II?,DDAA1\!(EPJ@Y&3U/N310 P[590[F./'WE
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MK7K4:?LX)=3V<)2Y*=WNPHHHK4Z@HHHH **** "BBB@ HHHH **** "BBB@
MKS;X??\ (?G_ .O5O_0DKTFO-OA]_P A^?\ Z]6_]"2O2P?^[5O1?J>5CO\
M>J'J_P!#TFBBBO-/5"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** /-O%G_(Z1?]LOYUZ37FWBS_ )'2+_ME_.O2:]+'?P:/I_D>5E_\
M>O\ XO\ ,****\T]4**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M$='L=4^)?CCSKO)1W$EU(H.R&,?PCGC., 9[Y]37T?%$D,*11J%C10JJ.P'
M%5=,TC3M&MC;Z;906L1.2L2!=Q]3ZGZU=IU)\STV)HTO9IWU;"BBBLS8****
M "BBB@ HHHH **** "BBB@ HHHH \$_YKW_W$?\ V6O>Z\$_YKW_ -Q'_P!E
MKWNMJW3T.;#_ &O4****Q.D**** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "O!?@E_R.=Y_V#W_ /1D=>]5X+\$O^1SO/\ L'O_
M .C(ZVI_!(YJW\2![U1116)TA1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MX;-'X7_\DZTK_MM_Z.>BCX7_ /).M*_[;?\ HYZ*4_B8Z7P1]#-U?_DI4?\
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M9H^P]F/>NXKZC 8&.&CS2^)_AY'B8G$NL[+X0HHHKT3F"BBB@ HHHH ****
M"LKQ%HXUS1Y;,.(Y<B2)R,A74Y&?;L?8UJT4-7%)*2LSP]A)%++!/&8YXG,<
MD9YVL/\ .0?0BC=7?^,O"TFH?\333D!O47$L0X\]1TQ_M#MZ]/3'G2R!UR,]
M<$$8(/<$=C7EUJ+IOR/GL31E1G;IT)MU&ZHMU&ZL3GYB7=1NQ46ZC=0',6EN
MG7K\P]ZD%X.Z'\ZH[J-U!2JR1?\ MB?W6I?MB?W6K/W4;J!^VD:(NHCUS^(I
ML(MXS^Z?8O\ <SQ^1Z?A5#=1NH!5F:X(/0@TM8^['2G>:X_C;\Z"_;KL:U-+
MJO5@/QK+,C'JQ/XTW=0)U^R-(W,0_BS]!3?MD?HU9^ZC=03[9FA]KC]&I?M<
M7^U^59VZC=0'MI&@;Q!T4FH)+AWXZ#T%5MU&Z@3JMDNZC=46ZC=03S$NZC=4
M6ZC=0',2[JN:)I)\1:VFG%BMK&OFW;+UV9X3V+'] :J:;87VO:@;#3$^=<>?
M<,/D@![GU;T6O7-"T&R\/Z>+2S0Y)W2RMR\K=V8^O\J[</0UYY?([\'AG4:G
M+;\S1CC2*-8XU"(@"JJC  '0"G445VGMA1110 4444 %%%% !1110 4444 %
M%%% !1110 5YM\/O^0_/_P!>K?\ H25Z37FWP^_Y#\__ %ZM_P"A)7I8/_=J
MWHOU/*QW^]4/5_H>DT445YIZH4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110!YMXL_Y'2+_ME_.O2:\V\6?\CI%_VR_G7I->ECOX-'T_
MR/*R_P#CU_\ %_F%%%%>:>J%%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0!X)_P U[_[B/_LM>]UX)_S7O_N(_P#LM>]UM6Z>AS8?[7J%%%%8G2%%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7@OP2_Y'
M.\_[![_^C(Z]ZKP7X)?\CG>?]@]__1D=;4_@D<U;^) ]ZHHHK$Z0HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MBE2U^S,7V!-O)-:TJ*J+F;(G4<'9&!O&,YXI]GI\M]'YS.RJ?NJIQBJ<)_<
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M17:>^DDK(****!A1110 4444 %%%% !1110 4444 %%%% !1110 5YM\/O\
MD/S_ /7JW_H25Z37FWP^_P"0_/\ ]>K?^A)7I8/_ ':MZ+]3RL=_O5#U?Z'I
M-%%%>:>J%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M>;>+/^1TB_[9?SKTFO-O%G_(Z1?]LOYUZ37I8[^#1]/\CRLO_CU_\7^84445
MYIZH4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '@G_->_P#N(_\ LM>]
MUX)_S7O_ +B/_LM>]UM6Z>AS8?[7J%%%%8G2%%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !7@OP2_Y'.\_P"P>_\ Z,CKWJO!
M?@E_R.=Y_P!@]_\ T9'6U/X)'-6_B0/>J***Q.D**** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 5YO\;/\ D2[3_L()_P"BY*](KS?X
MV?\ (EVG_803_P!%R5I2^-&5?^&S1^%__).M*_[;?^CGHH^%_P#R3K2O^VW_
M *.>BE/XF.E\$?0S=7_Y*5'_ -?5O_)*])KS;5_^2E1_]?5O_)*])KOQ_P##
MH_X4>=EO\2O_ (F%%%%>:>J%%%% !1110 4444 %%%% !1110 4444 %%%%
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M#'PE*H4Z6BX[HQ!J+_A57A'_ *!S?]_6K#^Q*?\ S\?W?\$U_M*I_(OO_P"
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MG]F6?'\?VH8;Z#K4_5ZJV_,YI9=B8O8YW[#&/N/,GT<G^=2):0H/N!R>K/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M\#17I'QF:6?QG##*N88K-#$"./F9MQ_0?E7*^%/!D_B[6#86K0PI&GF32O\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !7FWP^_Y#\__ %ZM_P"A)7I->;?#[_D/
MS_\ 7JW_ *$E>E@_]VK>B_4\K'?[U0]7^AZ31117FGJA1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% 'FWBS_D=(O^V7\Z])KS7Q01-X
MXB2,[FW1)@>O''ZUZ57I8[^#1]/\CRLO_CU_\7^84445YIZH4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M(RCA8QJNJVVPHHHK ZA&17&&4,/<9IB6\,;[TAC5NF54 U)10 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %>;_&S_D2[3_L()_Z+DKTBO-_C9_R)=I_V$$_]%R5I2^-&5?^&S1^
M%_\ R3K2O^VW_HYZ*/A?_P DZTK_ +;?^CGHI3^)CI?!'T,W5_\ DI4?_7U;
M_P DKTFO-M7_ .2E1_\ 7U;_ ,DKTFN_'_PZ/^%'G9;_ !*_^)A1117FGJA1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>;?#[_ )#\
M_P#UZM_Z$E>DUYM\/O\ D/S_ /7JW_H25Z6#_P!VK>B_4\K'?[U0]7^AZ311
M17FGJA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 445G:EKNG:4A-
MU<J''2-3N<_A_C50A*;Y8J[(G.,%S3=D:-87B#Q/:Z)&T0Q->$?+$.B^[>@_
M7^=<OJ/C:_U)OLNEV[0[S@%?FE;Z8Z?K]:LZ+X)FGE%YK3$Y^;R=V68_[1_I
M_*O2A@H45[3%.WEU9Y=3'SKOV>#5W_-T1!X/TBXU/4SK-XSLD;[E9_\ EJ_/
M/T%>ATR**.")(HD5(T&U548 %/KDQ6(>(J<ST71>1VX/"K#4^1:O=ONPHHHK
MF.H**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_D<[S_L'O_Z,CKWJO!?@E_R.=Y_V#W_]&1UM3^"1S5OXD#WJBBBL3I"BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M\VKUWX>_\B!HW_7#^IK:<$H*2.>G5E*K*+V1TU%%%8G0%%%% !1110 4444
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M5%%%8G2%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5Y
MO\;/^1+M/^P@G_HN2O2*\W^-G_(EVG_803_T7)6E+XT95_X;-'X7_P#).M*_
M[;?^CGHH^%__ "3K2O\ MM_Z.>BE/XF.E\$?0S=7_P"2E1_]?5O_ "2O2:\V
MU?\ Y*5'_P!?5O\ R2O2:[\?_#H_X4>=EO\ $K_XF%%%%>:>J%%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M9TS3M:\FSMY]D4?V6%MHP.,LA)_$U]-T %%%% !1110 4444 %%%% !1110
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MCO1I2 YN(<]WCSC_ +Y)K&6 Q,=X/\_R-X9CA9;37Y?F=-163#XFT6X(V:C
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M *.>M)_P48T_]XE_78[&OFSXJ?\ )2-6_P"V/_HE*^DZ^;/BI_R4C5O^V/\
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M[M@"9&.N2"?QKZ3TRT-AI-G9L06@@2(D'@E5 _I716^"*./#ZU)M'S=\./\
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M  [\27GB[P)INN7\<$=U=>;O2!2$&V5T& 23T4=ZZB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M445YIZH4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M1--AT[3H?)M8<[(]S-C)+'EB3U)JI33@HD1I-57/HRY7S9\5/^2D:M_VQ_\
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M]G?L,^">BK<ZW>ZQ*@*V<8CB)[.^<D?101_P*O<JY/X;Z$=!\%6<4F//N?\
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MK%_Z"*^0/BM_R5'Q#_U]'_T$5]<Z==V]CX5L[N[FC@MX;.-Y)9&VJBA 22:
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MCM()&X8C[S$#DJO&<8Y(&1G- ':T5\E6=G\3?BR9;A;F[N;+<4=I)A#;*>N
MHP">0. 3R,U9N?@E\0M"MWN[(13,H+,EA=D28 [ A<]^!DT ?5E%?,OPY^,>
MO:/X@@T3Q3<S75B\OD/)= ^?;/G&2Q^8@'@AN1^&#]-4 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5YO\;/\ D2[3
M_L()_P"BY*](KS?XV?\ (EVG_803_P!%R5I2^-&5?^&S1^%__).M*_[;?^CG
MHH^%_P#R3K2O^VW_ *.>BE/XF.E\$?0S=7_Y*5'_ -?5O_)*])KS;5_^2E1_
M]?5O_)*])KOQ_P##H_X4>=EO\2O_ (F%%%%>:>J%%%% !1110 4444 %%%%
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M@'U(XSD?7.C:-I_A_2;?2]+MDM[2!=J(OZDGN3U)/)->&?'WX>[6_P"$QTN
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M=VL-S;N)(9D$D;CHRD9!_*OG[]I#PXR7FE>(X8CLD0VEPRKP"#N0D^I!8?\
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MJ%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M6%QE6'^>*FKS6FG9GJIIJZ"BBBD,**** "BBB@ HHHH **** "BBB@ HHHH
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MTAUN*(BVU*%=[@''G(-I'H,J$/OS7M?PGT'4_#7P]L=+U>V^S7L4DI>/S%?
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M5= F9F2T=;B DYPKY#+[<@'_ ($:[OXPJK?"?7PP!'E(<$=Q(A%>/?LW;_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M+L^209!P"05=20#W!Q7T#\#_ !/XA\3:5J\WB"6XN'$Z20SRQ;%967!"8 7
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M5O\ T)*]+!_[M6]%^IY6._WJAZO]#TFBBBO-/5"BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M(I@-X4_=)QQR,'Z&M)E#*58 J1@@]#38HHX(4AAC2.*-0J(B@*JC@  =!3Z
M/CWGX8_&CLD&FZA[G_1G_7/E/[\^M6?B+>7/C[XQ3V-@3+_I":;:X.X *=I/
M^[N+MGI@_C7:_M(>'$CFTKQ)#& 92;.X;)Y(&Z/VZ!_R%9'[/&@MJ7C.]UV8
M,R:="0KD_P#+67(_'Y0_YC\0#Z2T^Q@TS3;6PME*V]K"D,0/95  _059HHH
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MX)Z<Y3D$#G((K[2KQWXQ_">3Q06\0Z%&#J\:!9[<8'VE1P"#_? XYZ@ =AD
M]>@GBN;>.X@D62&5 Z.IR&4C((_"I*^3?"_Q=\7> E71+ZV%S;6IV?8[Y&CE
MA']T-U7MPP.!P,5=\2_'SQ+K]C)IVFV<&EI.-C20LSS'/&%;C&?89]"* -;Q
M;\:?%%G\0]2L/#UU;SZ?'.MM;P20*P+KA6PPP3E]W?&,8]:U?VD+V[AT3PSI
MLKHRS22S3%1C=)&J*"/;]X]0?!CX37MMJ-OXJ\0V[6XB^:RM) 1)OZ;W4C@#
MJ!USSZ9]"^+G@6;QQX36*P"G4[*3S[920/,X(:/)( SP<GNHH Y/]G30].3P
MO>ZZ(8WU*2Z>W,QY:.,*AV#TR3D^O'H*]KKXX\(^-_$GPMUBZMQ:D+(=MS87
MB,H+#@,.X8<C/?WXQZ!>?M+WCP,++PQ!#-@[7FO#*H/8E0BY'XT =K\?-=@T
MSX<RZ<9 +G5)DBC0-AMJ,'=L>GRA3_OCUKSK]FW_ )'#5_\ KP_]J+4*_#OQ
M]\2$OO$GB22:V:.WD:T@GC(DD8 E8TCXV)GN>3D$!LYK/^ &KQ:;\2EMIFP-
M0M)+9,M@!P5<9_[X('UH ^K:^,O _P#R5W1O^PJO_H=?9M?&/BW2]8\ ?$:>
M7RVMYH+PW=E-L&V1-Y9& Z$>H[<@T ?9U?./[2O_ "']"_Z]9/\ T(5L?##X
MQ:_XM\<VFC:NEBD$MM(J_9XBA>11NW$ECSA6X&!STXXQ_P!I7_D/Z%_UZR?^
MA"@#T[X)?\DAT+_MX_\ 2B2O#?CSHTNF?$VYNR#Y.HPQW$9P< A0C#/<Y3/_
M  (5[E\$O^20Z%_V\?\ I1)5_P"(_@"T\?\ A\6;NL%_;DR6=P5SL8CE6[[6
MP,X] ><8H M?#WQ%#XH\#:5J,<BO+Y"Q7 7/RRJ ''//7GZ$5T]?'>GZKXV^
M#GB"6)H'M'D_UEO<IOM[D#H00<-C/52".F>HKM;C]I35V@Q;>'K&.;'WY9G=
M<_[HP?UH Z_]H7Q'%8>"XM"CE0W6I3(7CR,B%#NW8ZCYU4#Z'TK!_9KT>15U
MS6I(F"/Y=M"Y'#8RS]NWR=ZX'2?"GC7XM^(3J5WYYBD(\W4+E"L4:9Z1C@'&
M>%7UYQG-?4WAKP]8>%= M-'TV/;;VZ8W'[TC?Q.WJ2>?_K4 >3_M*?\ (MZ)
M_P!?;_\ H%7OV<?^2>:A_P!A63_T5%5']I3_ )%O1/\ K[?_ - J]^SC_P D
M\U#_ +"LG_HJ*@#V"O'_ -H[_DGFG_\ 85C_ /14M>P5X_\ M'?\D\T__L*Q
M_P#HJ6@"#]F[_D3-5_["!_\ 1:5>^*'Q<U'P#K\.EVVC6]P)K99TGEF;'+,I
M!4 ="OKT/O5']F[_ )$S5?\ L('_ -%I73?%KX>MX\\/1_8C&FJV):2V+\"0
M$?-&3VS@$'U'N30!T?@SQ"OBKP?I>M Q^9<P*9EC&%64<. ,D@!@<9.<8K:G
M@AN8'@N(DEA<;7CD4,K#T(/6OD/PUXZ\7_"N_N-*>W9$W[I=/OHV #8X9>A&
M>#D<' ZUV-U^TIJTEHR6OA^SAN","5YV=0?7;@?SH YKXX^&]'\-^.HXM'B2
MWCNK5;B6VC&$C<LP^4=@=N=O;Z$"O?OA#)<R_"G0&NP1((649_N"1@G_ (Z%
MKY]\/>$?%?Q=\4-J^H^;]DED7[5J+H$0*.-L8QAB ,8'3C.,U]7Z?86VEZ=;
M6%G&([:VB6*)!V51@4 6:*** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ KS?XV?\B7:?\ 803_ -%R5Z17F_QL_P"1+M/^
MP@G_ *+DK2E\:,J_\-FC\+_^2=:5_P!MO_1ST4?"_P#Y)UI7_;;_ -'/12G\
M3'2^"/H9NK_\E*C_ .OJW_DE>DUYMJ__ "4J/_KZM_Y)7I-=^/\ X='_  H\
M[+?XE?\ Q,****\T]4**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** ,>^\6>&],O)+._P#$&E6EU'C?#/>QQNN0",J3D9!!_&J_
M_"=^#_\ H:]#_P#!C#_\57G_ (V^!?\ PF/B^^U__A(_L?VKR_W'V'S-NV-4
M^]Y@SG;GIWKG_P#AF7_J;O\ RF__ &V@#V#_ (3OP?\ ]#7H?_@QA_\ BJ/^
M$[\'_P#0UZ'_ .#&'_XJO'_^&9?^IN_\IO\ ]MH_X9E_ZF[_ ,IO_P!MH ]@
M_P"$[\'_ /0UZ'_X,8?_ (JC_A._!_\ T->A_P#@QA_^*KQ__AF7_J;O_*;_
M /;:/^&9?^IN_P#*;_\ ;: /8/\ A._!_P#T->A_^#&'_P"*H_X3OP?_ -#7
MH?\ X,8?_BJ\?_X9E_ZF[_RF_P#VVC_AF7_J;O\ RF__ &V@#V#_ (3OP?\
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MN_\ *;_]MH_X9E_ZF[_RF_\ VV@#V#_A._!__0UZ'_X,8?\ XJC_ (3OP?\
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M\IO_ -MH ]@_X3OP?_T->A_^#&'_ .*H_P"$[\'_ /0UZ'_X,8?_ (JO'_\
MAF7_ *F[_P IO_VVC_AF7_J;O_*;_P#;: /8/^$[\'_]#7H?_@QA_P#BJ/\
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M9E_ZF[_RF_\ VV@#V#_A._!__0UZ'_X,8?\ XJC_ (3OP?\ ]#7H?_@QA_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH *\V^'W_(?G_Z]6_]"2O2:\V^'W_(?G_Z]6_]"2O2P?\
MNU;T7ZGE8[_>J'J_T/2:***\T]4**** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH \V\6?\CI%_P!LOYUZ37FWBS_D=(O^V7\Z])KTL=_!
MH^G^1Y67_P >O_B_S"BBBO-/5"BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M#_[_ ,W_ ,:H_P"&<?&'_02T/_O_ #?_ !J@#Z?HKY@_X9Q\8?\ 02T/_O\
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M *"6A_\ ?^;_ .-4 ?3]%?,'_#./C#_H):'_ -_YO_C5'_#./C#_ *"6A_\
M?^;_ .-4 ?3]%?,'_#./C#_H):'_ -_YO_C5'_#./C#_ *"6A_\ ?^;_ .-4
M ?3]9VI:!HVLLC:II-A?%.%-U;)+M^FX'%?./_#./C#_ *"6A_\ ?^;_ .-4
M?\,X^,/^@EH?_?\ F_\ C5 'TII^EZ?I-O\ 9]-L;6S@SGR[:%8U_)0!5NOF
M#_AG'QA_T$M#_P"_\W_QJC_AG'QA_P!!+0_^_P#-_P#&J /I^BOF#_AG'QA_
MT$M#_P"_\W_QJC_AG'QA_P!!+0_^_P#-_P#&J /I^BOF#_AG'QA_T$M#_P"_
M\W_QJC_AG'QA_P!!+0_^_P#-_P#&J /I'4=&TO6$":GIMG>H.BW,"R ?]] U
M#I_AO0M)E$NFZ+IUG(,X>VM4C//!Y4"OG3_AG'QA_P!!+0_^_P#-_P#&J/\
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M 'T_17S!_P ,X^,/^@EH?_?^;_XU1_PSCXP_Z"6A_P#?^;_XU0!]/T5\P?\
M#./C#_H):'_W_F_^-4?\,X^,/^@EH?\ W_F_^-4 ?3]%?,'_  SCXP_Z"6A_
M]_YO_C5'_#./C#_H):'_ -_YO_C5 'T_17S!_P ,X^,/^@EH?_?^;_XU1_PS
MCXP_Z"6A_P#?^;_XU0!]+7FGV6HQ"*^M+>YC!R$GC#C\B*SK?P=X7LY?-M?#
M>CP28QOBL8E./J%KYZ_X9Q\8?]!+0_\ O_-_\:H_X9Q\8?\ 02T/_O\ S?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %>;?#[_ )#\_P#UZM_Z$E>DUYM\/O\ D/S_ /7JW_H2
M5Z6#_P!VK>B_4\K'?[U0]7^AZ31117FGJA1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% 'FWBS_D=(O^V7\Z])KS;Q9_R.D7_;+^=>DU
MZ6._@T?3_(\K+_X]?_%_F%%%%>:>J%%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110!X)_S7O\ [B/_ ++7O=>"?\U[_P"XC_[+7O=;5NGH<V'^UZA1116)
MTA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5
MX+\$O^1SO/\ L'O_ .C(Z]ZKP7X)?\CG>?\ 8/?_ -&1UM3^"1S5OXD#WJBB
MBL3I"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M ,E*C_Z^K?\ DE>DUWX_^'1_PH\[+?XE?_$PHHHKS3U0HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "O-OA]_P A^?\ Z]6_]"2O2:\V
M^'W_ "'Y_P#KU;_T)*]+!_[M6]%^IY6._P!ZH>K_ $/2:***\T]4**** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \V\6?\CI%_VR_G7I
M->;>+/\ D=(O^V7\Z])KTL=_!H^G^1Y67_QZ_P#B_P PHHHKS3U0HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MP>__ *,CK:G\$CFK?Q('O5%%%8G2%%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 5YO\ &S_D2[3_ +""?^BY*](KS?XV?\B7:?\ 803_
M -%R5I2^-&5?^&S1^%__ "3K2O\ MM_Z.>BCX7_\DZTK_MM_Z.>BE/XF.E\$
M?0S=7_Y*5'_U]6_\DKTFO-M7_P"2E1_]?5O_ "2O2:[\?_#H_P"%'G9;_$K_
M .)A1117FGJA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %>;?#[_D/S_P#7JW_H25Z37FWP^_Y#\_\ UZM_Z$E>E@_]VK>B_4\K'?[U
M0]7^AZ31117FGJA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% 'FWBS_ )'2+_ME_.O2:\V\6?\ (Z1?]LOYUZ37I8[^#1]/\CRLO_CU
M_P#%_F%%%%>:>J%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!X)_S7O_
M +B/_LM>]UX)_P U[_[B/_LM>]UM6Z>AS8?[7J%%%%8G2%%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7@OP2_P"1SO/^P>__
M *,CKWJO!?@E_P CG>?]@]__ $9'6U/X)'-6_B0/>J***Q.D**** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M** "BBB@ HHHH **** "BBB@ KS;X??\A^?_ *]6_P#0DKTFO-OA]_R'Y_\
MKU;_ -"2O2P?^[5O1?J>5CO]ZH>K_0])HHHKS3U0HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M5YO\;/\ D2[3_L()_P"BY*](KS?XV?\ (EVG_803_P!%R5I2^-&5?^&S1^%_
M_).M*_[;?^CGHH^%_P#R3K2O^VW_ *.>BE/XF.E\$?0S=7_Y*5'_ -?5O_)*
M])KS;5_^2E1_]?5O_)*])KOQ_P##H_X4>=EO\2O_ (F%%%%>:>J%%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5YM\/O^0_/_P!>K?\
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M?^25Z37?C_X='_"CSLM_B5_\3"BBBO-/5"BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH *\V^'W_(?G_Z]6_]"2O2:\V^'W_(?G_Z]6_]
M"2O2P?\ NU;T7ZGE8[_>J'J_T/2:***\T]4**** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH \V\6?\CI%_P!LOYUZ37FWBS_D=(O^V7\Z
M])KTL=_!H^G^1Y67_P >O_B_S"BBBO-/5"BBB@"O?_\ (.N?^N3_ ,C7S/X
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %>"_!+_D<[S_ +![_P#HR.O>J\%^"7_(YWG_ &#W_P#1
MD=;4_@D<U;^) ]ZHHHK$Z0HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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ME>&_LT?\@SQ%_P!=H/Y/5[]H#Q1=VVGV'A73]XFU0[IMIY9 V%0<]VZ_3ZT
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M#AFV[@#$,U[;7@7QU_Y*'X._WA_Z-6@#WVBBB@ HHHH **** "BBB@ HHHH
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M?5O^V/\ Z.2N!^!O_(<U7_KV7_T*NB'\%G'4_P!XC_7<]OI&944LQ 4#))/
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MBBB@ HHHH ***\4^-_\ PFO]KZ3_ ,(K_P )!Y/D/YW]E^=MW;N-WE\9QZT
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MU '6>&_%&C^+=*74M%O%N+<G:W!5HV[JRGD'_P#6,BJ_C;Q/_P (=X0OM?\
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MCO [_P#?)0#]:]1\'_$#P_XXMW?1[IO.B ,MK,NR5!QR5SR.<9!(SWJ2_P#
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MBB@ KBO&7Q3\,^"I/L]]</<WV,_9+0!W'^]D@+^)S[&K_P 0?$Y\'^"-2UA
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M_> X4#IP<CI7KWB3X:^&->\/W&GIHFGVTQB(MYX+=8FA?'RD%1G&<9'0XZ4
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M%?\ R)^M_P#7A/\ ^BVKR_\ 9N_Y$S5?^P@?_1:4 >SUX%\=?^2A^#O]X?\
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MWOGD="1N?# >(7\#VEUXFO);F_NB9P)4"M%&0 BG '8;N>?FH \P_P";O/\
M/_/A7T!7S_\ \W>?Y_Y\*^@* "O"/V:/^09XB_Z[0?R>O=Z\(_9H_P"09XB_
MZ[0?R>@#W>O"/VE_^09X=_Z[3_R2O=Z\(_:7_P"09X=_Z[3_ ,DH ]PL?^0?
M;?\ 7)?Y"IZ@L?\ D'VW_7)?Y"IZ / O@5_R4/QC_O'_ -&M7OM>!? K_DH?
MC'_>/_HUJ]]H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_P".5/\ #/X9>.?#GQ&TS5]3T@PVD;2>?*;N%^&C9>0KDGDC\:]W\4^)M/\
M"6@7.K:C(H2%"4BW -*W9%SU)/\ C7G/PM^*^O\ CW7I-/N](LX;>" S3W,
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MA'OR-VW\W[4 >[?"OP__ ,(W\.=(M&0+<31?:I_7?)\V#[@%5_X#7!_M*?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH Y_QW_R3SQ+_ -@JZ_\ 135\F_#SP-)X_P!?GTJ*_2R:&U:Y\QHMX.'1
M<8R/[_Z5]9>._P#DGGB7_L%77_HIJ\ _9Q_Y*'J'_8*D_P#1L5 &Q_PS1=_]
M#1!_X!G_ .+J:W_9G;?FY\4C9Z167)_$OQ7T#10!Q'@KX5>&_ \WVNRCEN=1
M*;3=W+!F4'J%  "Y^F<<9-=O15>^N39:?<W2PR3M#$T@BCQNDP"=HS@9.,<T
M ?-7CSX->(M!\03:KX3MY[JP9S/$+5@)K8]=H48)'7;M!XX//7+L?C7\0?#U
MS+;:A-'=2+@-!J5KAHSC_9VMZ=37LO@7XS:9XW\2-HT>GRV,AA:2%YIE/FE<
M94 =\9/?A37?:EHVF:Q"8=3TZUO(R,%;B%7&,Y[CUYH \D\-?M%:-J$T=MKV
MG3:8[MM^T1-YL0XZMP&7TX#?X>H^(;E7\&ZK=6TJ.IT^:2.1"&5AY9((/0BO
M /CE\/\ PYX3M-/U+18FLY;N=HY+4.61AC)9<DE<' P..1C&*]*^#:3:M\&K
M:SO2YBD%Q;HSC.8RS#OU R1^&.U 'E'[.UO%-\1[F21 SP:;+)&3_"V^-<_D
MS#\:^I*^1OA?K47@#XJ-#K#K#%F73KJ7<0L3;AR?;>@SGH.>U?7- ",H92K
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M-="> G:ZD;7B;NK+V(_(]1D<UX5^TK_R']"_Z]9/_0A5?]FVXNE\7ZO;)O\
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MH?C'_>/_ *-:O?:\J^%7PWU_P7KFKZCK=YI]PU^@YM7<G?N+$D%% Z]J]5H
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M* ,[0]#T[PWH\&E:5;BWLX =B!BW4Y))/)))->8?'3P3XB\8_P!@_P!@:?\
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MY_\ KU;_ -"2O2P?^[5O1?J>5CO]ZH>K_0])HHHKS3U0HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "O!?@E_P CG>?]@]__ $9'7O5>"_!+_D<[S_L'O_Z,CK:G\$CF
MK?Q('O5%%%8G2%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M+6/@WPW;:-899(ANDE88,LA^\Y^OIV&!VK<HHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ K@/B5\+X?B)]@D;59+":S#JK"$2JP8KG(R#_  ^M=_10!YKX$^"^
MB>"M0CU22ZFU+4XP1'+(H1(\C!*H,\X)Y)/MBO2J** "BBB@ HHHH **** "
MBBB@#SZZ^#WAZ[\<+XLDO-3%^MY'>"-98_*WH00,;,X^4=_QKT&BB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "O-OA]_R'Y_^O5O_0DKTFO-OA]_R'Y_
M^O5O_0DKTL'_ +M6]%^IY6._WJAZO]#TFBBBO-/5"BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** /-O%G_(Z1?\ ;+^=>DUYMXL_Y'2+
M_ME_.O2:]+'?P:/I_D>5E_\ 'K_XO\PHHHKS3U0HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** /!/^:]_]Q'_ -EKWNO!/^:]_P#<1_\ 9:][K:MT]#FP
M_P!KU"BBBL3I"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ KP7X)?\CG>?]@]_P#T9'7O5>"_!+_D<[S_ +![_P#HR.MJ?P2.
M:M_$@>]4445B=(4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !7F_QL_Y$NT_[""?^BY*](KS?XV?\B7:?]A!/_1<E:4OC1E7_ALT?A?_
M ,DZTK_MM_Z.>BCX7_\ ).M*_P"VW_HYZ*4_B8Z7P1]#-U?_ )*5'_U]6_\
M)*])KS;5_P#DI4?_ %]6_P#)*])KOQ_\.C_A1YV6_P 2O_B84445YIZH4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_P!?3?\ H*5UE88JG&G6E".R.C"595:$9RW:"BBBN<Z0HHHH **** "BBB@
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M-#M[AVW2@;)/]X<?KP?QK5KP:D'"3A+='T=.HJD%..S"BBBH+"BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M]!@ ^L:Y/P_\2O"/BG5!INC:M]JNRA<1_9I4^4=3EE _6NLKY1^ '_)3XO\
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M +;?^CGHH^%__).M*_[;?^CGHI3^)CI?!'T,W5_^2E1_]?5O_)*])KS;5_\
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M_P ]@*]AKRLUHPIUDX*UT>QD]>=6@U-WLPKR;5/^1TF_Z_!_Z$*]9KR;5/\
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M5S]GK6Y=1\!W&G3R%VTZZ*1# ^6)P& ]3\V_KVP.W !ZY1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !7FWP^_Y#\__ %ZM_P"A)7I->;?#[_D/S_\ 7JW_ *$E>E@_]VK>B_4\
MK'?[U0]7^AZ31117FGJA1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% 'FWBS_D=(O^V7\Z])KS;Q9_R.D7_;+^=>DUZ6._@T?3_(\K+_
M ./7_P 7^84445YIZH4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M(I%*NCW<95E/!!!/(H YCX;_ !6TWQ^KVC6[66K0Q^9);EMRNN<%D;N.1D$
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M*^EL<;\3:2HC"]<DJ@8#WS6I^SKX2M;MM0\3WD"2O;RBUM-X!$;X#.V.S89
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M &"KK_T4U 'S1\)_'6G^ CKNHWL;SS26\<=M;(<&5]Q.,X.T#J3^A.!71/\
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MCS19'=-5@1F 79.!VQT;^GX"M*%54\PFI==#+$495,M@X_9U^1H^ 9%;P^Z
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M9_\ T6U?0_Q2_P"28>(?^O1OYB@#R?\ 9H_Y"'B/_KE!_-ZZ?]H[_DGFG_\
M85C_ /14M<Q^S1_R$/$?_7*#^;UT_P"T=_R3S3_^PK'_ .BI: +/[/7_ "35
M_P#K_E_]!2O(+TR:1^T4TERV /$*R,TG:-Y00?P5N*]?_9Z_Y)J__7_+_P"@
MI7(?M!>!KG[<GB^Q@+P.BPWVQ>48<+(?8C"Y[8'K0!]#45XSX'^/>AWFDPVW
MBF9K#48E"-/Y3/%/V#?*"5/KD8]^P7QU\=M%MM*EL?"LKZAJ=PNQ)DC98X<\
M9R<%FYX XSU/&" >;^#KF*]_:/\ M4#;H9M6O)$;U4^:1^AKTK]H^%W\"Z;,
MHRL>HJ&]LQO@_I^HKQWX11O#\7-#CD1DD2:165A@J1&^01ZU]2>.?#"^,/!V
MH:(72.2= 89'&0DBD,I]1R,''8F@#C?V?ITE^&*HART-[,C^Q^5OY,*]3KY)
M^'WC?4OA3XHO--UBRF%I(XCO;4\/$PZ2+V)P3[,".>AKW<?&OX?_ &1+@Z[C
M<,^7]FE+@^A 7_ZWO0!6^.UW';?"C48G=%:YF@B0,>6(D5\#WPA/T!KEOV:K
M=ET#7;DGY9+J.,?55)/_ *$*X#XD?$&^^*.MVFD:'87#6$4A-M;B/=-/)CER
M!G&!G '09)]OH7X<^$/^$)\&6FDR&-KHDS73Q]&E;K@XYP %SZ+0!U=%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %>;?#[_D/S_P#7JW_H25Z37FWP^_Y#\_\ UZM_Z$E>E@_]
MVK>B_4\K'?[U0]7^AZ31117FGJA1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% 'FWBS_ )'2+_ME_.O2:\V\6?\ (Z1?]LOYUZ37I8[^
M#1]/\CRLO_CU_P#%_F%%%%>:>J%%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110!X)_S7O_ +B/_LM>]UX)_P U[_[B/_LM>]UM6Z>AS8?[7J%%%%8G2%%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7@OP2
M_P"1SO/^P>__ *,CKWJO!?@E_P CG>?]@]__ $9'6U/X)'-6_B0/>J***Q.D
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "OF#]H[_DH>G_\ 8*C_ /1LM?3]?,'[1W_)
M0]/_ .P5'_Z-EH ]_P# G_)//#7_ &"K7_T4M:FJ:58:WITVGZG:175I,,/%
M*N0??V(Z@CD'D5E^!/\ DGGAK_L%6O\ Z*6N@H ^0O&7AW5_A%X]AN-*NW2)
MB9["X'4IG!C?L2.A'0@@]\#Z2^'OC>V\=^%XM2B41749\J[@'_+.0 $X_P!D
MYR#^'4&CXB^#8O''A"YTP[5NT_?6DC<!90#C)]#D@^QKYE^'/B^[^'7C<B]5
MX;1Y/LNI0.IW( V"<==R'/ZCO0!]BU\H_ #_ )*?%_UZ3?R%?5B.DL:R1LKH
MP#*RG((/0@U\I_ #_DI\7_7I-_(4 ?5U>4?M"_\ )-4_Z_XO_07KU>O*/VA?
M^2:I_P!?\7_H+T 5OV<?^2>:A_V%9/\ T5%7DWQT29?BSJAD^X\<!CX_A\I1
M_,-7K/[./_)/-0_["LG_ **BK"_:(\'7$[6?BRSCDDCBC%K>*.?+4$E'QC@9
M9@3G^[ZF@"*+]FI)X4EB\8AHW4,K#3>"#R#_ *VG?\,R_P#4W?\ E-_^VUJ_
M"CXQ:5<:';Z)XDO8[*^M$$45S</B.=!T)<\*P'!R>>"/0>B:K\1/"&CV!O+G
MQ#I[QXRBV\ZRO)QGY54DG^7(H \F_P"&9?\ J;O_ "F__;:]GN+-M.\%2V33
M&9K?3C"92,%RL>-V,GKC/6OG6U\=^-OB!\3'@\.ZG?V-K=RA4@1CLMX%XWL.
M0#CDGN3CT%?3TL"36KV[Y,;H4.3DD$8[]: /EW]GG_DI,O\ V#Y?_0DKZGKX
M[\ :Z?AO\2A)K$+HD#26=XJYS&"<%L=P" <=QT[5]2+X[\)/8QWG_"2Z2L$B
M[E9[M%)XSC!.<^W6@#SC]I'_ )$S2O\ L(#_ -%O6S\ _P#DEUO_ -?4W_H5
M>2?&/Q_!X\O8(-$6:32-,4N\[(5$CN0N[!&0.@&<'D\5ZW\ _P#DEUO_ -?4
MW_H5 'EW[1W_ "4/3_\ L%1_^C9:^C]"54\/:8J@*HM(@ !@ ;!7SA^T=_R4
M/3_^P5'_ .C9:^D-$_Y &G?]>L7_ *"* ,?XC_\ )-O$?_8/F_\ 037C_P"S
M1_R$/$?_ %R@_F]>P?$?_DFWB/\ [!\W_H)KQ_\ 9H_Y"'B/_KE!_-Z /H>O
MDGX[?\E7U#_KC!_Z+6OK:ODGX[?\E7U#_KC!_P"BUH ^KKZ^MM,L+B^O)EAM
M;>-I99&Z*H&2:^;M7^,WC7QEKG]F>#[>2SBD)$,,$:R3R*!U9B"%Z9^7&/4]
M:]G^*]E<ZA\+M?@M,F7[.),!<DJCJ[#'^ZIKPWX">*M$\.>(M1@UB:&T-]"B
MPW<Q"HA4DE2QX4-D'GC*CVH O#X9_&#7R%U75IX4.>+S569!QCI&6ZX[#O\
M6L7QW\(+CP/X5&M7^MQ75S+=)"(8XB =RLQ.XG)/RGM_];Z9NO%7AZRM#=W.
MN:=';@9\QKE,'Z<\_0=:^<?C+\2+?QM/#I6B++)I6GN9I;@@@2O]T,!V4;L
MGJ6[=P#T[]GK_DFK_P#7_+_Z"E9_[2/_ ")FE?\ 80'_ *+>K/[.<Q?X>7L9
M8$QZG( .X!CC/\\U%^T?"[^!=-F496/45#>V8WP?T_44 ;GP*_Y)/IO_ %UG
M_P#1C5P/[3",+SPW(1\K1W !]P8\_P Q6Q\%?'OAK3/ $.E:IK%I97=M-+\E
MP^S*LVX$$\'J?RKI/C9X0N/%7@<R6$'FW^G2?:41?O.FTAU4=SC!QU.W ]"
M;'PJD63X7>'F0Y M0OX@D']178U\V_!;XK67AZR/AKQ!,8;+>TEI=,,K#GED
M;T4GD''5CGCI[E=>._"5E;?:)_$NDB/;N&V[1BP_V0"2WX9H \Z_:0D0>"-+
MB(7>VI*P.>0!&^?YC]*TOV?H7B^&*NPXEO9G7Z?*O\U->._$WQI+\4/&%C8:
M+:N]M YM[%3P\[N0"V#]T'"X!Z 9/H/I;P3X<7PGX-TS11M+V\7[UEZ-(QW.
M?^^B?PH ^:+'_DXUO^QEE_\ 1[5ZU^T7#))\.K1T0LL6IQ.Y'\(\N09_,@?C
M7DMC_P G&M_V,LO_ */:OI'Q]X7'C#P7J.C!@L\J;[=B< 2J=R9.#P2,'V)H
M XG]G:=)/AU<QJ?FBU&0,/JB$']?T->MU\I?"?QW_P *W\1W^E:_!/!97+B.
MX#*=UK*F1N*=3UP<<\#KC%?1;>/O""V!O3XFTGR N[(NT)Z9QMSG=C^'&?:@
M#S+]I1E'AW0UR-QNW(&>2-G_ -<5W'P@_P"24:!_UQ?_ -&-7SO\6_B!'X\\
M21/9*ZZ98HT5MOX,A)^:3'\.<+QUPHSZ#Z(^$'_)*- _ZXO_ .C&H [>BBB@
M#S[XH_$Z'X?V$$5O EUJUT"887)"(HXWOCDC/&,C//(Q7CUAJ7QE^(-LUYIM
MU?\ V)Y#B6WECM$&#R%;*E@.G!/0]3FC]HFRN8?B!:W<@)M[BQ01-CC*LP9?
M<C(/_ A7LWP[\<>&=5\&Z5%;:A96D]O;1P2V<DJQO&ZJ 0%)R5X)![CWR  >
M51? CQSK;!M?\06ZH#D>;<27#@\#.",=/?M7#2>'T\*_%^RT2.Z^UBTU.U3S
MMFW>=R$\9..21C)KZ5\6?%/PMX4LY7EU*"\O5'R6=K*'=F(R V,[1[GU[U\K
MQZM>:E\0;;6[W,=Q=:C'=$OT&9 1C/\ ".@[8% 'V[7RC\ /^2GQ?]>DW\A7
MU=7RC\ /^2GQ?]>DW\A0!]75Q'Q?_P"24:__ -<4_P#1BUV]<9\687G^%GB!
M$&2+8/\ @K*Q_0&@#SO]FC_D&>(O^NT'\GKU?QW_ ,D\\2_]@JZ_]%-7A7P
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MN8L>6))Y)/)K0H \&_:.D6*^\'R.<(DERS'T ,->R:1XET/Q TRZ1JUG?-"
M9!;RARF<XSCZ&JGB?P3X=\8_9?[?T_[9]EW^3^^DCV[L;ON,,YVKU]*;X9\"
M^&_!\ES)H.G?9&N0HE/GR2;@N<??8XZGI0!T59]EH6CZ=>37ECI5C:W4^?.G
M@MT1Y,G)W,!DY//-:%% !7SW\??$^A:_H&D1Z1J]E?2173,ZV\RN5!3J0.U?
M0E>?_P#"DOAY_P!"]_Y.W'_QR@#L=$_Y &G?]>L7_H(J_4<$,=M;QP1+MCC4
M(BYS@ 8 J2@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MDKTL'_NU;T7ZGE8[_>J'J_T/2:***\T]4**** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MV=V;BU20Y]?F!I^G:%I&CDG3-*L;+(VG[-;I'D9SCY0.]:%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !7FWP^_Y#\__7JW_H25Z37FWP^_Y#\__7JW
M_H25Z6#_ -VK>B_4\K'?[U0]7^AZ31117FGJA1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% 'FWBS_D=(O\ ME_.O2:\V\6?\CI%_P!L
MOYUZ37I8[^#1]/\ (\K+_P"/7_Q?YA1117FGJA1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 445PGQ)\=?\(KIZV=BP_M:Z7=&< B
M%,X+D'KGD#MD'TP7&+D[(F<U!<S-[7_&.A>&0!J5\B3'E8$^>0^^T=![G K@
M[OXYV2.19Z'<3+GK-.(SCZ -7GWAKPGK7CS4YYEF.P-NN+VX)8;CV]6;V_E7
MK.F_!WPO:1@7:W-])U+22E!^ 3'\S6[C3AI+5G*JE:KK#1&-:_'2S>0"\T*>
M),\F&X$AQ]"%_G7>^'_&&A^)H_\ B6WBM,!EH)!MD7\#U_#(KG=1^#WA:[B8
M6D=Q8R;<*T4Q< ^I#YS],CIVKR/Q/X2UCP)JL4ID8Q;]UK?0Y7)'(_W6]OR)
MH4:<](Z,'4K4M9ZH^FZ*X7X;^._^$KL'M+XJ-6MEW28  E3/# =L9 /U'K@=
MU6$HN+LSJA-37,@HHHI%!1110 4444 %%%% !1110 4444 %%%% $5S.EK:S
M7#@E(D9V"]2 ,\5Q_AWXGZ+XFUF+2[*UU".>4,5::- OR@DYPY/;TKJ-9_Y
M>H?]>TG_ *":^?\ X2_\E$L?^N<O_HMJUA!.+;Z'/5J2C.,5U/HVBBBLCH"B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** /!/^:]_P#<1_\ 9:][KP3_ )KW
M_P!Q'_V6O>ZVK=/0YL/]KU"BBBL3I"BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ KP7X)?\CG>?\ 8/?_ -&1U[U7@OP2_P"1
MSO/^P>__ *,CK:G\$CFK?Q('O5%%%8G2%%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M>OU7J/Q%;% !12,P52S$!0,DGH*X[4OBQX%TFX:"Z\1VID4X(MU>< _6-6%
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M% !1110 4444 %%%% !1110 4444 %%%% 'FWBS_ )'2+_ME_.O2:\V\6?\
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M'8QA8R1QYC\9_!0WYBO=ZUK**=D889RE'FD]PHHHK$Z HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH \$_YKW_ -Q'_P!EKWNO!/\
MFO?_ '$?_9:][K:MT]#FP_VO4****Q.D**** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "O!?@E_R.=Y_P!@]_\ T9'7O5>"_!+_
M )'.\_[![_\ HR.MJ?P2.:M_$@>]4445B=(4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O
MG']I7_D/Z%_UZR?^A"OHZOG']I7_ )#^A?\ 7K)_Z$* -#QSX>_M;]GCPUJ<
M4>Z?2K6"7(7)\IU"N/89V,?9?RZ?]G_Q#_:W@%M,EDW3Z5.8L%LGRGRR'V&=
MZCV7\ND\':;!K'P?TC3+I=T%WI"02#_9:/!_G7A_P4U*?PK\5;GP_>MM^U>;
M92J/NB:,D@^O\+*/][\@#ZA=TBC:21E1%!9F8X  ZDFOFGP#')\2_CE=^(KL
ML;6SD-Y&.FT(P6!.G;Y3VSM)ZUZY\8O$!\/?#34GC<K<7H%E"1ZR9W?^.!S^
M%<_^SWX?.F>!I]6D0K-JDY92>\4>57_Q[S#^(H \=US_ )+[-_V,"?\ HX5]
M2^+="3Q-X2U31G"YN[=D0L,A7ZHWX,%/X5\M:Y_R7V;_ +&!/_1PKZ^H ^7_
M -G[7&T?QY=:)<YB74H2FQP01-%E@#Z?+Y@Y[XKZ@KY1^+VER^#/BT-6L(UC
M6=XM1ML)A1(&^8<=?G4L?]X?6OJ#3=5M=3T2UU:&11:7-NMPKL< (R[N<],#
MK0!X-^TCXA\R]TGP[$_RQ*;R=0V1N;*ID=B '_!A^/K?@31XO!GPXTZTNL0F
MWM3<7;,N-KL"[Y[\9(^@%?/OA2 _$WXYO?W,9DLVN7O9%8%L0Q\1J?;_ %:_
MC^%>^?%>XDMOA;X@DB8JQMO+)!(^5F"D?D30!\]Z_KWB+XR^.TTNPD86;2L+
M.V8LL4,8S^\DQGG'5L$\X'85ZAIG[./AR&QV:GJ>HW-TPYD@*Q*O'92&_4GZ
M5SO[-%C!)J7B*_93]H@A@A0^BN7+?K&M?1% 'RO\0?A9J?PUDM_$&AZE/-8Q
MR#%P/DFMGZ#)'4'U&/0CIGVGX3_$ ^._#;->>6NJV9$=TJX ?/W9 O8'GVR#
MBND\8V"ZIX*URR;;^^L9E4L. VPX/X'!_"OGO]G.\EA\>WUJ#^ZGT]RPX^\K
MI@_JP_&@#H_VB_%EY;-8>%[65XH9X?M5WM./,7<513[95B1WX]*L>%/V>]&G
MT6UO-=U&\FN;B%)#%;%8TC+#.,D$MC.,\?2KWQT^'.H>)DMO$&C0M<WEI#Y$
MUJ@)>2($L"@SR02W &3GVQ7F>@_&3QKX-BCTB[2.YBMB%\C4(F$L:8'R9R".
M.F<X^G% '0_$;X%V_AW0;G6_#][<S0VH,D]M<E68)QEE8 =.3@C.*[KX$^)=
M8UCPU=:;K*732:>RB"XG1OWD39PNX_>*E2/H1Z5F:%^T=HEY((M:TFZTXDX\
MV%Q.@XZGA6'T /:O6M&US3/$.FQZCI%[%=VDG22,]#C.".JGD9!P10!X?^TU
M_P RM_V]_P#M&N_^&6GP:M\%-+TZZ#&WN[.:"4*<$H[.IP>W!-<!^TU_S*W_
M &]_^T:])^$'_)*- _ZXO_Z,:@#Y_P#C+X+TCP5XCL+/1DF2&>T\UQ+)O^;>
MPX/T KVCP1\)O"MA!H?B*W@N5U 017()G)4.R GCTY->;_M)?\CAI'_7A_[4
M:OH#PI_R)^B?]>$'_HM: /%OVFO^96_[>_\ VC7I/P@_Y)1H'_7%_P#T8U>;
M?M-?\RM_V]_^T:])^$'_ "2C0/\ KB__ *,:@#P_X@ZCJ/Q'^,0\-1W1AM(+
MPV%NK9*QE3B20CC)R&/T %>CVG[.GA2*S$=W?ZI/<$'=,DB(,^R[3C\2:X7X
MJ_#KQ!X?\9S^*/#\-W/;75P;L2VBLTEM,26;.,D#.2&Z<XXXS%H?[1'B:P\N
M/5;*RU.%$"EAF&5B.Y897_QV@#.^(/PVU+X9ZM8:EHM_<S6\LA%O.GRS0R 9
MP=O7(R<@= :^C_ VN7?B+P9INIW]O);WLL96>-XS&=ZDJ2 >Q(R/K7%>'?C]
MX3UAHX=26XTBX<JO[\;XLG_;7H,]V"C]<>IQ2QSPI-#(DD4BAD=&!5E/(((Z
MB@!]%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5YM\/O
M^0_/_P!>K?\ H25Z37FWP^_Y#\__ %ZM_P"A)7I8/_=JWHOU/*QW^]4/5_H>
MDT445YIZH4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M!YMXL_Y'2+_ME_.O2:\V\6?\CI%_VR_G7I->ECOX-'T_R/*R_P#CU_\ %_F%
M%%%>:>J%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M  [FOEQI&\3>/?,B&W^T-2R@/\(>3C/'8'T[5IA]VS'%[11],:S_ ,@/4/\
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M$[N[%S5:DE961U/B/_D6-6_Z\IO_ $ UXQ\$O^1SO/\ L'O_ .C(Z]G\1_\
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M_7.+_P!%K3P_Q"QG\/YGT;1116!U!1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5Y
MO\;/^1+M/^P@G_HN2O2*\W^-G_(EVG_803_T7)6E+XT95_X;-'X7_P#).M*_
M[;?^CGHH^%__ "3K2O\ MM_Z.>BE/XF.E\$?0S=7_P"2E1_]?5O_ "2O2:\V
MU?\ Y*5'_P!?5O\ R2O2:[\?_#H_X4>=EO\ $K_XF%%%%>:>J%%%% !1110
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M?_"3*_@W0V4AE.GVY!!R"/+6O)_V@_!VIZO#INNZ9:O<K:(T-RD2[G52058
M<D9W9],CMDCD/AY\7_$EGJOA_P +WAMGTX7$5D6>+$J(6" 9R!\O Y&<"@#?
M_::_YE;_ +>__:->D_"#_DE&@?\ 7%__ $8U>;?M-?\ ,K?]O?\ [1KTGX0?
M\DHT#_KB_P#Z,:@"/1?BYX6U_P 3P^'[*2\^VREU4RVYC7<H)*G/(.%/4>W6
MMS6_!'ACQ&[2:MH=E<RLI4S&/;)@_P"VN&[GOQ7B?Q.^$NN6'BB7Q3X2AEG2
M6?[4T-MGSK>;.XLHZL"PR,<@G&,8K.M_CYXVT6,6.K:99S7$:@%KJ!XI3[L
M0/T% %OXL_![1?"GAV7Q!HMU/$D<J(]I.^]<,<?(W7KS@Y[\\5V'[.VJW5[X
M)O;&XD:2.RN]L&XYV(R@[1[9R?\ @1KS74=0^)7QBO(+$V#I9(P;RXH6AM8S
MTWNS$DGKP23P=HZU]!_#[P;#X&\)6^D)()9RQFN91T>5@ 2/8  #V H ZBBB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\V^'W_(?G_Z
M]6_]"2O2:\V^'W_(?G_Z]6_]"2O2P?\ NU;T7ZGE8[_>J'J_T/2:***\T]4*
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \V\6?\CI%
M_P!LOYUZ37FWBS_D=(O^V7\Z])KTL=_!H^G^1Y67_P >O_B_S"BBBO-/5"BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KEO''@JU\
M8Z6(V80W\ )MI^P)ZJWJIP/<=?8]3133:=T*45)69\P6EYXC^'GB!L(]K<J<
M20R#,<R^_9A[@_0BO1].^.-@T2C4])N8Y OS-;,K@M[!BN!U[G'OUKTK4]'T
M[6K8V^I64-U%S@2+DK]#U'X5QEY\&_"MS*7A%]:*<?)!."!_WV&/ZUO[2$_C
M6IR*C5I_PWH8^I?'&R6,C2](N))#T:Z=4 ]\+G/YBO.+J\\2?$/78U827ER?
MECCC7;'$O\E'J3^=>OVGP;\*V[@R_;KH9SMFG 'T^0+7::9I&G:-;&WTVR@M
M8B<E8D"[CZGU/UH]I"'P+4'1JU/XCT.?\ >"X_"&CE9=DFHW&&N)5S@8Z(/8
M9//?\JZVBBL&W)W9U1BHJR/E_P ?_P#(^ZU_U\M_2OJ"N7U#X=>%=4OYKZ\T
MKS;F=M\C_:)5W'Z!@*ZBM*DU))+H94:3A*3?4*^;/BI_R4C5O^V/_HE*^DZY
MK5? 'AC6]2FU'4=,\ZZFQOD\^5<X 4<*P'0"BE-0E=A7INI&R-VP_P"0=;?]
M<D_D*\?^+G@F<7;^)-/AWP,H^V(@Y0CC?@=B.I]>:]FC18HUC0850% ] *5E
M5U*L 5(P01P14PFXNZ+J4U4CRL\6\%_%V#3-*@TO7+>9UMT"174/S$J.@921
MT'<'TX[UOZS\9]#MK1O[*BGO+IE.S?'LC4]MV>3] /Q%:^K_  L\+:O,9OLD
MEG*Q)9K1]@.?]D@J/P JC:?!GPM;S!Y6O[I?[DTX _\ '%4_K6EZ3=V8*.(2
MY4T>8^$O#FH>/O%;WE\'>U,QFO;@@JK<Y* C@$YX Z#Z5] :QH]KK>B76DW*
MXMYX_+^4?<_ND>X(!'TJ>PT^STNS2TL;:*WMT^['$H4#W^OO5FHG4<G==#6E
M14(M/6^Y\R%-=^&GBY6*JES#]TD9CN(SZ>H/Y@^A%>K6'QF\-W%F)+Q+JTG
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MC0CX=\(V.GR >>%,DW^^QR?RSC\*ZIS?LU?=G!2IKVSMLCH:***Y3O"BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\V^'W_
M "'Y_P#KU;_T)*])KS;X??\ (?G_ .O5O_0DKTL'_NU;T7ZGE8[_ 'JAZO\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BL>#Q9X<N;];"W\0:5+>,Y06\=Y&TA8=1M!SGVK8H **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BLBP\5>'=5NUM-.U_2
M[RY8$K#;WD<CD#DX5236O0 4444 %%9%OXJ\.W=^+"VU_2YKTL4%O'>1M(6'
M4;0<Y&#^5:] !1110 4444 %%9%YXJ\.Z??-8WNOZ7;7B$!K>:\C20$@$94G
M/((/XUKT %%%% !163J'BCP]I-T;74M=TRSN  QBN;N.-\'H<,0<5J(Z2QK)
M&RNC ,K*<@@]"#0 ZBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HJ.>>&UMY;BXECA@B0O))(P544#)))X  YS5#3?$>AZS,\.EZS
MIU]*B[F2UNDE95Z9(4G H TZ*JZAJ5AI-J;K4;VVL[<$*9;B58T!/098@4S3
M=8TS687FTO4;2^B1MC/:SK*JMC."5)P>10!=HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "O-OA]_P A^?\ Z]6_]"2O2:\V^'W_ "'Y_P#KU;_T)*]+!_[M
M6]%^IY6._P!ZH>K_ $/2:***\T]4**** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH \V\6?\CI%_VR_G7I->;>+/\ D=(O^V7\Z])KTL=_
M!H^G^1Y67_QZ_P#B_P PHHHKS3U0HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** /!/^:]_P#<1_\ 9:][KP3_ )KW_P!Q'_V6O>ZVK=/0YL/]KU"BBBL3
MI"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K
MP7X)?\CG>?\ 8/?_ -&1U[U7@OP2_P"1SO/^P>__ *,CK:G\$CFK?Q('O5%%
M%8G2%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !117AMC^T#JFJ*[:?\
M#^\NU0@.;>[:0*??$)Q0![E17E/BKXOZKX<\1W.E0^"+R^CA6,BX2=E#;HU<
MC B/0L1U[5SUU^T5>V.S[9X%N+??G;YU\4W8ZXS#SU% 'N]%>(+\?-8=0R_#
MN^92,@BZ<@C_ +\ULW'Q<UJ/PYI>JP> K^XEO9)TDMHYG)@\LI@DB(_>W''
M^[WH ]6HKSGX;_%1OB#J6H6;:(=.:SC5R3=>:6).,8V+BO1J "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O-_C9_R)=I_P!A!/\
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M'PGX>.G:'H=O>6;3-+YLEI-(=Q !&48#L* /K2BJUC<//IEM<W 6-WA620=
MI*@GKTKR/QC^T#I.CW36?A^V75I4(WW!?;#WR%(Y8].>GN: /9:*^:(_VBO%
MB$3SZ)I36K'"E8Y5SSTW%R,\'M7J?@+XPZ%XWN%L&C?3=5896UF?<LN.NQ\#
M)'H0#Z X- 'HE%%>'VWQNU&#XGW^A:Q%IEOH=G=7D4EPD4GFA(1(5YWD%B44
M<+SG@4 >X45\XZE^T=KDM[))H^A62:?&V/\ 2@\CE<\$E6 4GTY^IKV3P7XO
M?Q'X%A\2ZI:QZ9$RR2/F7*"-"07R<8'RD\^E '545X'XD_:02*YE@\-Z.LT:
MY"W5ZQ <^HC7!QZ98'V%9$'[1/BJTG0ZIH&G-"3]V-)868=\%F;V[4 ?2=17
M,AAM9I5 +(A89Z<"N/\  /Q-T7Q_%+'9B2UU"%-\MG*06"YQN4_Q#I],C/45
M@_%KQYXF\)7-G:Z'I4%Y;W-N[3O+;R2;.<=48 <>M '&_"+QSXA\9?%2:?6-
M0>2,:?+LMHSLAC^=.B#C/N<GISQ7T+7Q/X#\2ZUX4\0/J.@V$=[=FW:,QR0O
M( A*Y.$(/4#G/>OJ/X8>*M;\7>&KG4-?L(K*ZCO&A2..%XP4"(0<.2>K-STX
MH X+X:_!GQ%X.\;6NM:C>Z7+;11R*RV\LC.2RD# 9 ._K7MMS(8;6:50"R(6
M&>G KQ+X:_&;Q%XQ\;6NBZC9:7%;2QR,S6\4BN"JDC!9R.WI6_\ %KQYXF\)
M7-G:Z'I4%Y;W-N[3O+;R2;.<=48 <>M '&_"+QSXA\9?%2:?6-0>2,:?+LMH
MSLAC^=.B#C/N<GISQ7T+7Q/X#\2ZUX4\0/J.@V$=[=FW:,QR0O( A*Y.$(/4
M#G/>OJ/X8>*M;\7>&KG4-?L(K*ZCO&A2..%XP4"(0<.2>K-STXH X+PM\&O$
M6B?$V#Q+<WNEO91W4TQ2.60R;7# <% ,_,.]>Y5X;X6^,OB+6_B;!X:N;+2T
MLI+J:$O'%()-J!B.2Y&?E':O<J "BO&O%?[0FC:3=2V>@V3:M)&=IN#)Y<.>
M^TX);GZ ]02.O%_\-#^,]OG_ -BZ3]FS][[/-C&<8W>9C/;- 'TS17B/A#]H
M:QU._CLO$>GKIWFL%2[A?=$I/]\'E1GOD]>< $U[=0!\D_%W_DN.I?\ 7:U_
M]$Q5];5\D_%W_DN.I?\ 7:U_]$Q5];4 %%%% 'RC\?\ _DI\O_7I#_(U]/Z)
M_P @#3O^O6+_ -!%?,'Q_P#^2GR_]>D/\C7T_HG_ " -._Z]8O\ T$4 7Z**
M* "BN.^)WBR_\%^#)=8TZ*VEN$FCC"W"LR88X/"D']:H?"3QUJ?CWP_>W^J0
M6D,L%UY*BU1E4KL4\[F;GDT >@445XO\5/B[K_@?Q<FDZ99Z9+ UJDQ:YBD9
MMQ+ \JX&.!VH ]HHJMIUP]WIEI<R!0\T*2,%Z E03BO']*^,FK3_ !9N_#6I
M1:5;:-;7=Y$]SL=76.%9"&+%]O\  ,\>O2@#VFBO O$'[1<IU![7PMHJ7$2D
MA+B[W$R\=1&N"!WY.2.PJAI'[2&K0W@37M#M)(=V'-GOC=!WX=F!/MD4 ?1E
M%9VAZYI_B/1K;5=+G$UI<+N1AP1V(([$'@BK=W=V]C:37=W-'!;PH7DED;:J
M*.22: )J*\#\2?M()%<RP>&]'6:-<A;J]8@.?41K@X],L#["J>D_M&:M;7JQ
M^)- @,#$9:S#Q.BYZA7)#=^,K]: /HBBO"?%GQVO['Q/:6OAQ=*O=*N8H9%F
MECD+Y8X8'#C!'3!&0>M>[4 %%%% !17,>-?'FB^!--6ZU25FFER+>UBYDE('
M8=ATR3P,_A7BEU^T7XENKMETC0=/6($D),LDS[<\9VLOMVH ]R\=_P#)//$O
M_8*NO_135X1^S;_R.&K_ /7A_P"U%K:B^.=AXH\':_I&LV@T[49],N4@D1MT
M,K&)L+D\JQ/0<@^N< XO[-O_ ".&K_\ 7A_[46@#V;XG>$[_ ,:>#)='TZ6V
MBN'FCD#7#,J84Y/*@G]*H?"3P+J?@+P_>V&J3VDTL]UYRFU=F4+L4<[E7G@U
M?^)WBR_\%^#)=8TZ*VEN$FCC"W"LR88X/"D']:H?"3QUJ?CWP_>W^J06D,L%
MUY*BU1E4KL4\[F;GDT >@45S_C'QEI/@C1#J>JN^TMLBAB ,DK>B@_F2>!^5
M>(7O[1GB&[NF71?#]DD8Y"S^9.^/4[2OM]/>@#Z/HKYXT?\ :1OHIQ%K^@0.
MH)#O9.T;)_P!R<_]]"O=- U_3?$VC0:KI5P)[28':V,%2."I'8@T :=%5K_4
M+32[":^O[F.VM85W22RMM51]:\.\2?M'107C0^&]*6YA4D?:+PE0_3D(.0.O
M4^G% 'O5%?-MK^T9XEM+D#5M T^2,C/EQ"2!L?5B_P#*O9O!'Q$T+QY:.^F2
MO'=Q*&GLYAB2,9QGT9?<>HS@G% '6445Y9XW^.6A^%+^?2[&VDU748"4E5'\
MN*)P<%2^#DCN #Z9!S@ ]3HKYG?]H?QC,9)K71-)%NI/+03/M'NP<#]!6YX=
M_:026]2'Q%HZP6[D W-FQ;R^>I0\D?0YXZ'.* /?**BMKF"\M8;JVE26"9%D
MCD0Y5U(R"#W!!KE?'OQ%TCP!812WPDN+NXSY%I"1N?'5B3]U>@S^0/- '7T5
M\V3_ +1/BJ[G<Z7H&G+"#]V1)9F4=LE67W[5J^'OVD0\T</B+15C1L!KFR<X
M7GKY;9.._P![/'0T >_456T^_M=4T^WO[&=)[6X0212IT93T-5M=U[3/#6E2
MZGJ]W':VL?5GZL>RJ.I)]!0!I45\^:W^T?=->M#X>T.%H<[8Y+PLS.<G!V*1
MCMQFJNG?M'ZU;77EZYX?LY$W#<+8O"ZCZ.6R>_:@#Z-HK \)^,M%\:Z5]OT:
MY,BJ0LL,@VR0L1G#+_49!P<$UOT %%%% !1110 4444 %%%% !1110 4444
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MN69XL>=;RKMEB)Z;A_4$CKSQ4GCO_DGGB7_L%77_ **:@#PC]FW_ )'#5_\
MKP_]J+7TO7S1^S;_ ,CAJ_\ UX?^U%KZ7H *\V^,/@75_'6DZ;::0ULLEO.T
MCFXD*C!7'& >:])HH ^6/^&>?&G_ #VTG_P(;_XBN.\:> ]7\"75K;ZN]JTE
MRC.GV>0L  <<Y K[8KYQ_:5_Y#^A?]>LG_H0H Y/P_\ !7Q3XET&TUBPETX6
MMTI:,2S,K8!(Y&T]P:T_^&>?&G_/;2?_  (;_P"(KW#X0?\ )*- _P"N+_\
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M^5NV[]B%MN<'&<8S@T :%%>8^"?C+I_B?2];U/5+*/1;/2A"9)7N3-O\S?P
M$!S\G &2<US>I?M*:9#<,NF>';JZB!P'N+A82?7@*_\ GTH ]RHKRKPC\>/#
MOB2^AL+ZWETF[F(6,RN'B9CVWC&/Q %>JT %%<WXO\=:#X'L4N=9N65Y<^3;
MQ+NEE(Z[1_4D#ISS7E5U^TQ;).1:>%II8>SS7HC8_P# 0C#]: />:*\G\.?'
M_P +:S<);:C%<:1,[8#S$/#[9<<C\1CWKU=6#*&4@J1D$=#0 M%>8^,/B_\
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M %CO8=N.@%=77S;X ^-_]A:-HOA?_A'O/\MQ!]I^V[<[W/.WRSTW=,]J^DJ
M"O"/V:/^09XB_P"NT'\GKW>O"/V:/^09XB_Z[0?R>@#W>O"/VE_^09X=_P"N
MT_\ )*]WKPC]I?\ Y!GAW_KM/_)* /<+'_D'VW_7)?Y"IZ@L?^0?;?\ 7)?Y
M"IZ / O@5_R4/QC_ +Q_]&M7OM>!? K_ )*'XQ_WC_Z-:O?: "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O-_C9_R)=I_P!A!/\
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ML+'&&,EL"/4?-'V[]0/2@#U3PG\$M6\*_$"/7;36+5+"WN7,,.&>1X&!&U^
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M)O\ B/PMH_BO3);#5[*.>-UPLA4>9$>S(W52/_UY!(KP#_A0/CW_ *#VE_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#S;Q9_R.D7_;+^=>DU
MYMXL_P"1TB_[9?SKTFO2QW\&CZ?Y'E9?_'K_ .+_ #"BBBO-/5"BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH \$_YKW_ -Q'_P!EKWNO!/\ FO?_ '$?
M_9:][K:MT]#FP_VO4****Q.D**** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MZR?^A"OHZOG']I7_ )#^A?\ 7K)_Z$* /5_A!_R2C0/^N+_^C&KMZXCX0?\
M)*- _P"N+_\ HQJ[>@#S_P"-O_)(==_[=_\ THCKQ/X'^"K+Q?XAO)]6A%SI
MVG1AC Q^5I9,A<C/3",?P%>V?&W_ ))#KO\ V[_^E$=<?^S5&HT#79 /F:ZC
M4GV"''\S0!ZHG@SPQ%?6E[%X?TV*YM&W0216R(4."!T Z9XST/(YKQOX[:-X
MP\1^(K6#3M%O[G2+2)0A@3>KRL3N; YX&%Y'&#ZU] 5QGCSXF:'X!AC2],EQ
MJ$R;X;*'[S+DC<Q/"KD$9ZGG .#@ B\)?"OPOX:T>W@ETBRO;\(IN+NYA$K/
M)CYBNX':O7 &..N3S2^*?A3X4\2Z;/"-(M+*\93Y5U:Q")D;'!.W 8>QSQ^!
M'DMS^T3XFOYS%HWA^QC+?=1_,N'';^$KZCM21Z[\</%:K':VM[9PR8PZVJ6H
M((SD.X!QCG(/?Z4 8_P!OKBQ^)HLQN5+NUEBE0G'*C>#CU!7'XFOHKQW_P D
M\\2_]@JZ_P#135\V? ]9%^+UFLV?-$=P'R<G.QL\U])^._\ DGGB7_L%77_H
MIJ /E/X9>$7\<>+(]%DN9(M.5?M=X$;!*)\HP.F[+[0>P8GV/U58^ ?".G68
MM+?PUI8B"[#YEJDC,/\ :9@6;KW)KQ#]FR)3XEUN7)W+9JH],%\_T%?2- 'R
MQ\<O >F>$=9L+_1XOL]GJ0DW6R@E8I$*DE3V!#C"]L''& />_AEJ\VN_#?0]
M0N)#),\'ENYZL48H2??Y:\T_:7_Y!GAW_KM/_)*[?X)?\DAT+_MX_P#2B2@#
MPWXE7::]\<9;76+GR=/BO(+)G+8$, *[CGM]YV_$U]':7X%\'Z?91QV'A_2S
M"5!5S LI<8X)=LEOJ2:X7XJ_!M_&%^=<T2:&#5&4+/'.Q"3A5P#D9PV HZ8.
M.U>0M9?%+X=S*$&LV<,9^4PL9K8XYZ#<AX['W]Z /3?BE\%(=1BMK_P9I<,-
MZ9=EQ:Q,L4;(<G>,D!2#Q@=0?;GT/X;Z5KFA>"++2?$!B:[M-T4;1R;\Q _(
M"?8':!Z 5X?X?_:)\1V!6/6[*UU2('F11Y$OYJ-O_CH^M?07A;Q3I?C'0XM7
MTB5G@<E&1QAXG&,HPYP1D?F",@T ?-OQ[D>'XJ-)&[)(EK"RLIP5(S@@^M>I
M_"_X2:9HNCP:MK]G%?:S=!9BMR@D6VSR  <@MW+>O3ISYK\:X8KGXS6\%P<0
MRQVR2'./E)P>>W%?4= '#^-OA=X?\7:1-"MC;66HA<P7D$01E8= V!\R^H/X
M8->*_!7Q#?>%/B+)X8OI&CMKR5[::%R<1W"Y ('8DKMZ=QGIQ]15\D^(O]&_
M:'9HOE*Z[ X[\^8AS^= 'NWQM_Y)#KO_ &[_ /I1'7$?LT?\@SQ%_P!=H/Y/
M7;_&W_DD.N_]N_\ Z41UQ'[-'_(,\1?]=H/Y/0!H_'O3_%.MV>G:;HFE7MWI
MZ!KBZ:V7?O?("+M')QR>AZCTK6^&OPGT+1/#%E=:QH]O=ZS<1++.;R(/Y)/S
M! C<*5& 3C.<\XP!U?C/QSHO@73$O-7F??*2MO;Q+NDF(QG Z #(R20!D=R
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MVI7<-I:Q#+RS.%4>G)[GL.]?'?Q,\4IXQ\;WNK6^\V/$%JS*5RB#KSZDD_\
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MA_2_$VDRZ9J]HES:2$$JV05(Z,I'(/N* ,'X?_$+2O'.C0RPSI%J2(!<V;L
MZL!R0.ZGL1^AXK>UWQ%I/AK3GO\ 5[Z*U@0$C>?F?'95ZL>1P*\+US]FR[6=
MWT#78'B)^2*_0JRCW= =W_?(JO9?LY^(;NZ5M:\0621C@M!YD[X]!N"^_P!/
M>@"SX-^*WC;QE\1(].LWA73+BY,K1&!"UM; \C=QDXXR<\G\*^AJYCP5X#T7
MP)IK6NEQ,TTN#<74O,DI [GL.N .!G\:Z>@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ KS;X??\ (?G_ .O5O_0DKTFO-OA]_P A^?\ Z]6_]"2O2P?^
M[5O1?J>5CO\ >J'J_P!#TFBBBO-/5"BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** /-O%G_(Z1?]LOYUZ37FWBS_ )'2+_ME_.O2:]+'
M?P:/I_D>5E_\>O\ XO\ ,****\T]4**** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@#P3_FO?\ W$?_ &6O>Z\$_P":]_\ <1_]EKWNMJW3T.;#_:]0HHHK
M$Z0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MV[]_=/%EC<:GX-URPLX_,NKK3[B&%-P&YVC8*,G@9)'6@#P#]FW_ )'#5_\
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M $<]%'PO_P"2=:5_VV_]'/12G\3'2^"/H9NK_P#)2H_^OJW_ ))7I->;:O\
M\E*C_P"OJW_DE>DUWX_^'1_PH\[+?XE?_$PHHHKS3U0HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %>"_!+_ )'.\_[![_\ HR.O>J\%^"7_ ".=Y_V#
MW_\ 1D=;4_@D<U;^) ]ZHHHK$Z0HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MBBO-/5"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M*WK7P+J<"W :>S/F1%!AVZDC_9]JNK@*--N,JNOI_P $BCF->JE*-%V?6_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110!YMXL_Y'2+_ +9?SKTFO-O%
MG_(Z1?\ ;+^=>DUZ6._@T?3_ "/*R_\ CU_\7^84445YIZH4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% '@G_->_^XC_ .RU[W7@G_->_P#N(_\ LM>]
MUM6Z>AS8?[7J%%%%8G2%%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MN;RXEN)W\W=+,Y=FQ*X&2>3P *4Z?*KWN53K<\N6UCJZ***R-PHHHH ****
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MA_7]4>JUA>,O^14O?^V?_H:UNUA>,O\ D5+W_MG_ .AK7#A?X\/5?F>CC/\
M=ZG^%_D87PX_YB?_ &R_]GKNJX7X<?\ ,3_[9?\ L]=U71F?^]2^7Y(YLI_W
M.'S_ #9YQ\0O^0S;?]>X_P#0FKN-$_Y &G?]>L7_ *"*X?XA?\AFV_Z]Q_Z$
MU=QHG_( T[_KUB_]!%;8K_<J1SX/_?JQ?HHHKRCV0HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\V^'W_(?G_P"O5O\ T)*]
M)KS;X??\A^?_ *]6_P#0DKTL'_NU;T7ZGE8[_>J'J_T/2:***\T]4**** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \V\6?\ (Z1?]LOY
MUZ37FWBS_D=(O^V7\Z])KTL=_!H^G^1Y67_QZ_\ B_S"BBBO-/5"BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@#SJX^,_ARVN98'LM5+1N4)$4>,@X_OU'
M_P +M\-?\^.K?]^H_P#XY7BUQ"MSXFE@<D+)>%"1UP7Q7M/_  I+PU_S_:M_
MW]C_ /C==4H4X[G#"K6J7Y0_X7;X:_Y\=6_[]1__ !RKME\7O"EY(B2375KN
MXS/#P/J5)JE_PI+PU_S_ &K?]_8__C=87B#X*?9[&6XT._FGFC!86UPJYD]@
MPP,X]N?:IM1>A;>(6MD>OV=[:ZC:I<V5Q%<0/]V2)@P/XBIZ^:/ /BRY\*>(
M8@\C"PG<1W43$X )QOQT##U],BOI>LZE/D9K1JJHKA11169L%%%% !7"V7Q6
MT*^UZ+1XK341<2W'V=6:--F[.,D[\X_"NZKYD\._\E/L?^PH/_1E:TH*2=SG
MKU)0<;=3Z;HHHK(Z HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** .%T3XKZ%KVLVVEVMIJ*3W#%4:6- H."><.3V]*[JOF3X<
M?\E"T?\ ZZG_ - :OINM:T%!V1SX>I*I%N04445D= 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '@G_
M #7O_N(_^RU[W7@G_->_^XC_ .RU[W6U;IZ'-A_M>H4445B=(4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>"_!+_D<[S_L'
MO_Z,CKWJO!?@E_R.=Y_V#W_]&1UM3^"1S5OXD#WJBBBL3I"BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** /D#_FX7_N:_P#V[KZ_KY _YN%_
M[FO_ -NZ^OZ "BBB@ HKP_\ :'UW6-$_X1S^R=5OK#SOM/F?9+AXM^/*QG:1
MG&3U]37H'PLO;K4/AGHEW>W,US<R1,7FFD+NQWL.6/)H ["BBOE^\\5>(E^/
M:Z<NOZH+'_A((X?LPO)/*\LS*"NW.-N.,8Q0!]0452UAWBT2_DC9D=;:1E93
M@@A3@@U\M^"OB]K'AJUUBYU#4KW5KR2%$LH+ZYDEC5]QRQR> !V!!/3/< 'U
MC17S3;Z3\:O&4']L)J-_9P2CS(46]^RAU;D;44@XZ8+>HY-5M+^*7CSX>^)!
MIGB];B[MP09K>ZVM*%/\<<@^]TXY*GD<=0 ?3]%4M)U6RUS2;;5-.F$UI<H)
M(G QD?0]#VQ7@/Q]\2Z]HWCJQM]+UO4K&!M,C=H[6Z>)2WFRC)"D#. !GV%
M'T7167X:EDG\*Z/--(\DLEE"SN[$LS% 223U-:E !17R_P#"[Q5XBU#XQZ?8
MWNOZI<V;RW(:WFO)'C($4A&5)QP0#^%?1OB'7+/PUX?OM9OV(MK2(R,!U8]%
M4>Y) 'N10!IT5\NMX\^*7Q*U"XB\.)<V]JO'E:?B)8@>FZ8X.XC_ &AG!( J
M6ZT?XV^%X?[1:^U>>./YFVWPN]N.<E"S9'7L1ZT ?3M>8_'S_DEUQ_U]0_\
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MHH_[Q+T_R.QHHHK Z@HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"O-_C9_R)=I_V$$_]%R5Z17F_P ;/^1+M/\ L()_Z+DK2E\:,J_\-FC\+_\
MDG6E?]MO_1ST4?"__DG6E?\ ;;_T<]%*?Q,=+X(^AFZO_P E*C_Z^K?^25Z3
M7FVK_P#)2H_^OJW_ ))7I-=^/_AT?\*/.RW^)7_Q,****\T]4**** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MC@A4 ?*.6]V/4GW-.:A3>UQ4Y5*RWM8\+L/B[XLTZZ(U!H;U0<-%/ (V'T*
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M.B1K@?4^I]SR:UGR4WM<QI>UJQ^*R/!+'XN^++"Z_P!-EAO%5L/%- J'W&4
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M_!+_ )'.\_[![_\ HR.MJ?P2.:M_$@>]4445B=(4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110!\@?\ -PO_ '-?_MW7U_7R!_S<+_W-?_MW
M7U_0 4444 ?/_P"TU_S*W_;W_P"T:])^$'_)*- _ZXO_ .C&KS;]IK_F5O\
MM[_]HUZ3\(/^24:!_P!<7_\ 1C4 =O7R3??\G&K_ -C+%_Z/6OK:ODB\96_:
M,4J01_PDL8R#W$Z@T ?5&M_\@#4?^O67_P!!-?*WP1\,V?B7X@(+^(2VUC U
MV8V7*.P954-D<C+9QWVU]4ZW_P @#4?^O67_ -!-?//[-MRJ^+-8M3]^2Q$@
M^BR*#_Z&* /I6O,/CKX;MM8^'UQJ1B7[;I96:*3;SL+ .N?3!S_P$5Z?7%?%
MNZBM/A9K[S-@/ (E]V9E4?J: .&_9NUJ2Y\/:OHTA!%G.D\9)YQ(""/H"F?^
M!5QW[1W_ "4/3_\ L%1_^C9:W?V9[>7S?$=R5(BVV\88@X+?.2 ?;C/U%87[
M1W_)0]/_ .P5'_Z-EH ^B/"G_(GZ)_UX0?\ HM:UZR/"G_(GZ)_UX0?^BUK7
MH ^2?A%_R7'3?^NUU_Z)EKW3XV:;>:G\+]12RC>5X7CF>- 2616&[ '7'WOH
M#7A7P@97^-VELI#*9;H@@Y!'DRU];,H92K %2,$'H: /F/X-?%+1O!>FW>CZ
MU!+'#/<&X2[B7?@E57:RCG'RY!&>IXKWS1?'?A7Q#Y8TO7K&>20X2$RA)2?^
MN;8;OZ5R/B;X$^$M>FFN;19]*NY"7+6S9C+$Y)*-P/HI45Y?K?[.WB>P1I-*
MO+/5%!.(\^1(1V.&^7_Q[\Z /8=/^#_A73/%3>(K=+L7GVHW4:"8+'$Q).U5
M4#Y>>ASZ=*S_ (^?\DNN/^OJ'_T*O'?!7Q%\3_#_ ,4QZ1KDUTVGK,L-W97C
M$F $_>3/W< YP.&'X$>Q?'S_ ))=<?\ 7U#_ .A4 =/\./\ DFWAS_L'P_\
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MNZ>"*=S'&5B9R2!G^$&O%?@W?V^J?'/Q7J%HY>VNH;N>)B""4:YC8'!Z<$4
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MA*2>)LSV22..:)XI45XW4JR,,A@>H([BOF'Q[H</A[QE?V%JI6URLD()SA6
M./H"2.>>*^H*^=?B[(C_ !!NE5@2D,2L/0[<_P B*RP[?-8VQB7(F>A_!?4'
MNO!TUH[9^R73*@]$8!O_ $(M7GWQ?_Y'^?\ ZX1?RKM?@="Z^']3G('EO=!
M<]U0$_\ H0KBOB__ ,C_ #_]<(OY5I#^,S.H[X>)N?!/0[:ZO=0U>XB#RVNR
M.W)P0I;)8X]<  'W->OZQI\6JZ->6$\2RQSPLA0]R1Q]#G!![&O-?@;_ ,@C
M5O\ KNG_ *":]7K&LWSLWP\5[)'QW7UGX?8OX:TIV.6:SA)/OL%?)E?6/AS_
M )%C2?\ KRA_] %;8G9'/@MV?,WBW_D<]=_["%Q_Z,:O2OA)X+TR_P!)EUO5
M+2*[=Y6B@BG0.BJ ,M@\$DDCGIBO-?%O_(YZ[_V$+C_T8U>]_"O_ ))OI/\
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M)2<9P<?E13LY2Y0K74(<Q].5C^+?^1,UW_L'W'_HMJS/ WC3_A-+.[N/[/\
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M&5?^&S1^%_\ R3K2O^VW_HYZ*/A?_P DZTK_ +;?^CGHI3^)CI?!'T,W5_\
MDI4?_7U;_P DKTFO-M7_ .2E1_\ 7U;_ ,DKTFN_'_PZ/^%'G9;_ !*_^)A1
M117FGJA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M%R\9/\2$\'/>M31/&=SI%FMI);+<0IG9\VQE]LX.1U_.O0=3TFRU>W$-Y"'
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %>;?#[_ )#\_P#UZM_Z$E>DUYM\/O\ D/S_ /7JW_H25Z6#_P!VK>B_
M4\K'?[U0]7^AZ31117FGJA1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% 'FWBS_D=(O^V7\Z])KS;Q9_R.D7_;+^=>DUZ6._@T?3_(\K
M+_X]?_%_F%%%%>:>J%%%% !1110 4444 %%%% !1110 4444 %%%% 'R9=0?
M:?$<]ONV^;=LF[&<9?&:]1_X43_U,G_DC_\ ;*\S_P"9O_[?_P#VI7U=776G
M*-K'GX>E"=^9'CO_  HG_J9/_)'_ .V5H6/P0TF&;=?:I=W*#^"-5CS]3S[^
ME>I45A[:?<Z5AZ2Z%'2=&T[0[);33+2.V@7^%!R?<D\D^Y-7J**SW-DDM$?,
MGPX_Y*%H_P#UU/\ Z U?3=?,/P]E$7C_ $9CCFXV\G'4$?UKZ>KHQ'Q(Y<'\
M#]0KYD\%_P#)2=,_Z_?ZFOI6[N8K*SGNIVVPP1M([>BJ,D_D*^9O ;%_B!H[
ML<LUT"3[\T4?AD+$_% ^GZ^9/#O_ "4^Q_["@_\ 1E?3=?,GAW_DI]C_ -A0
M?^C**&TAXK>/J?3=?+NMJ'^)&HHPRK:O*"/;SC7U%7R_K/\ R4K4/^PQ)_Z.
M-&'W8L7M$^H*I:S_ ,@/4/\ KVD_]!-7:I:S_P @/4/^O:3_ -!-8+<ZWL?/
M/PK_ .2D:3_VV_\ 1+U])U\V?"O_ )*1I/\ VV_]$O7TG6V(^(Y<'\#]3COB
MI_R3?5O^V/\ Z.2N&^!G_(1UG_KE%_-J[GXJ?\DWU;_MC_Z.2N&^!G_(1UG_
M *Y1?S:G'^"PG_O$?3_,M?':1Q'H,88[&,[$>I'EX_F?SK=^#,$<7@=I57#R
MW<C.?7 4#^59?QRLGDTG2;T*2D,SQ,WIO (_] JS\$M02?PQ?6&3YMM=;R.P
M5U&/U5J'_!$M,2[GIU%%0W=S%96<]U.VV&"-I';T51DG\A7.=A\P0G[%\08S
M"#^XU4; !D_++QQ^%>__ !"_Y$#6?^N']17@7AQ'UOX@:>V-IN-069AGH-^Y
MNWIGM7OOQ"_Y$#6?^N']1755^*)P8?\ AS9Y5\$U4^-+LD E=/<C(Z'S(Z][
MKP7X)?\ (YWG_8/?_P!&1U[U6=?XS;"?PS&\7JK>"]=# $?V?.>1W$;8KQ7X
M-?\ (]'_ *])/YK7M?BW_D3-=_[!]Q_Z+:O%/@U_R/1_Z])/YK54_P"'(FM_
M&@>C_%^1T\ 3JK$!YXE8#N,YQ^8'Y5RGP*MXVN];N2/WL:0QJ?9BY/\ Z"*[
M3XJ63WOP^U QJ6> I, /0,,_D"3^%>?_  1U!(/$.H6#,0;FW#J.Q*'^>&/Z
MT1_@L4],1&Y[G1117.=A\W_%:)(OB+J)08WK$Q'OY:U[[X<D,WA?296!#/90
ML01@Y*"OG7X@ZDNL>/-4G@^:,2B!-ISNV )D8ZY()_&OI/3+0V&DV=FQ!:"!
M(B0>"54#^E=%;X(HX\/K4FT?-WPX_P"2A:/_ -=3_P"@-7MGQ0D>/X<:NR,5
M)$2Y'H94!_0UXG\./^2A:/\ ]=3_ .@-7NOQ"LGO_ .L01J680^;@?[#!_\
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MOP2_Y'.\_P"P>_\ Z,CK:G\$CFK?Q('O5%%%8G2%%%% !1110 4444 %%%%
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M*^T];_Y &H_]>LO_ *":^:OV>;:"\\=:I;74$<\$ND2I)%*@974RQ9!!X(H
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M<@2QXR3G^Y6U&:A>YS8FE*HERGG.A_%77- T:VTNUM-.>"W!"-+&Y8Y)/.'
M[^E:/_"[?$O_ #XZ3_WZD_\ CE=C_P *2\-?\_VK?]_8_P#XW1_PI+PU_P _
MVK?]_8__ (W6CG2?0Q5/$)63.._X7;XE_P"?'2?^_4G_ ,<KV(I+XA\&%'\M
M)=1T_#8R%#21_GCFN._X4EX:_P"?[5O^_L?_ ,;KT*RM(["PM[.(L8X(EB4L
M>2%  S[\5G4E#3D-Z,:BO[1GR++%)!,\,J%)$8JRGJ"."*]DT;XUV4.CPPZI
MI]X][$BH7B9664@8+$D@@GKWKJ?%?PST;Q1=/>EY;.^8 -+" 5<^K*>IQW!'
M:N9L_@9:1SAKS7)IX@1E(K<1D_B6;^5:NI3FO>.>-&M3E[AYYXO\2ZEXRNSJ
MT]KY-E;E8(T0EEC+;F )[L=IYP.E;7P:_P"1Z/\ UZ2?S6O6=2^'VA:CX;M]
M!5)K2R@F$Z_9F4,SA2N6+ YR&^O J#PS\-M'\*ZM_:-C<W\DWEM'MGD0K@X]
M%![>M2ZL7!Q12P\U44GJ4OC%_P B%)_U\Q_UKYZ7=N!3.X<C'48[U]"_&+_D
M0I/^OF/^M>.> E5_'>C*P!4W !!'!&#5T7:G<C$J]5(]$T7XVVR::J:UI]RU
MZBX\RU"E93ZD$C;^&?PZ5P'C?QI<^,M3BF>$06MNK+!"#DC)Y8GU.![<"O4]
M>^#6CZG<FXTVZDTQF^]&L8DC_!<@C\\>PJ/1O@MI%C<I-J5]+J&PY$0C\I#]
M1DD_G4QG2C[RW+G3KR7(]C.^"WAN6%+KQ!<Q%5E3R+;</O+G+,/Q 'X&NC^+
MNFRZAX$EDB&XV<Z7!'.=HRIQ] V?H#7<QQQPQ)%$BI&BA511@*!T '84K*KJ
M58 J1@@C@BL74;GS'0J*5/D/DS0M7GT'7+/5+<9DMI ^W.-PZ%<^X)'XUZ[<
M_''3A8;K72;IKTK]R5E$:M_O DD?@/ZU;UOX+Z/J%P\^FWLVG,[%FCV"2,9_
MNC((_.DT;X+:18W*3:E?2ZAL.1$(_*0_49)/YUM*=*6K.:%*O#W8['C&LW%_
MJ&H/J>HJ1-?YN%8C 92Q7*^P*D#Z5['\#_\ D7-2_P"OL?\ H KH?$OPVT7Q
M1?075U+>6Y@MUMXX[5D1 BDD<%3_ 'C^E:/A7PE8>$+*>UT^:YECFD\QC<,K
M$' '&%'I2G5C*%D72H2A4YGL>/\ Q7L]7TCQ5+.;V\:PO1YD.9F*J< ,GH,'
MMZ$4[P%\3QX7TW^RM1LY;BS5R\4D+?/'DY(VG@C.3U')/7/'N6I:78ZQ9/9Z
MA;1W%N_5''?U'H?<5YMJ/P/TR>7=I^K7-JI'W)8Q, ?;E>/SHC4@X\LQ3HU(
MSYZ9G^*/C%8:EH=YIVEZ;<EKN%H&DNMJA P() 4G)P>.1_0^:>'-$N/$6O6N
MFVZ,?-<>8RC[B9^9CZ8%>IV_P+MU?-SK\LB^D=J$/YEC7H/ASPGI'A:U,.F6
M^UW $DSG=))CU/\ 08'M3]I""M 7L:M22=0VZ***Y3N"OE/Q;_R.>N_]A"X_
M]&-7U97G^H_!_P /ZGJ=W?S7FIK+=3/,X26,*&9B3C*=.:VHS4&[G-B:4JB2
MB7_A7_R3?2?^VW_HYZM_$+_D0-9_ZX?U%:F@:);>'-$M])LWE>"#=M:8@L=S
M%CD@ =2>U2:SI4&N:/<Z9<O(D-PFQVB(# >V01^E0Y+GOYFJB_9\O6Q\LZ!_
MR,>F?]?<7_H8KZDUS28=<T.\TN<[4N8BF[&=I[-CO@X/X5QEI\&_#ME>P74=
MYJAD@D610TL>"0<C/R>U>AUI5J*33B98>BX)J74^2;FWO_#^M-#*&M[^RF!X
M/*.IR"#^1!KUS2OC?9?8%75M-N1=JH!:VVLDA]>2"OZUW'B;P3HOBM%_M"!E
MG3A;B A9 /3.""/J#7!2? J,OF+Q"RKZ-9[C^>\5;J4YKWS%4:U)OV>J/.?$
M_BN]\2>(9M59GMPV$AC1S^[1>@S^)/U)KW#X8:5JFG^%EGU>XNWN+IMZ0W$K
M-Y,8^Z I/RD\DX]1GI5?PY\)]"T*ZCO)WEU"ZC(9#-@(A'<*._U)KO:BK4BU
MRQ-:%&49<\]SP7XV_P#(YV?_ &#T_P#1DE<;X9\07GAC6H=5LU5S'\CHWW74
M]5)[=/TKLOC;_P CG9_]@]/_ $9)5KX0:/8:[IWB.PU&W6>W?[.<-U4_O<$'
ML?<5LFE2NSFE%RKM+<VKCXXZ:-/W6VDW9O2/N2LHC4X_O Y/;L*\=O;R[UK5
MIKN;,UW=REB$7EF8] !^0%>O77P,M)+HM::Y-# 3Q');B1A_P(,/Y5U'A3X;
M:+X6E6Z&^\OQTN)@/D_W%'3]3[U"G3@KQ-)4JU1VGL:'@;P^WAGPG9Z?*JBY
MP9;C!S^\;DC\!@<>E>,_%_\ Y'^?_KA%_*OHBN,\2?#/1O%&L-J=[<W\<S(J
M%8)$"X'3JA/ZUG3J)3YI&]:DY4U")S?P-_Y!&K?]=T_]!->KUSWA3P?I_@^V
MN(-/FNI5N'#L;AE8@@8XPHKH:BI)2DVC2C%Q@HL^.Z^L?#G_ "+&D_\ 7E#_
M .@"N)_X4EX:_P"?[5O^_L?_ ,;KT*RM(["PM[.(L8X(EB4L>2%  S[\5I6J
M1FE8PPU&5-OF/EKQ;_R.>N_]A"X_]&-7O?PK_P"2;Z3_ -MO_1SU0U'X/^']
M3U.[OYKS4UENIGF<)+&%#,Q)QE.G-==H&B6WAS1+?2;-Y7@@W;6F(+'<Q8Y(
M '4GM3J5(RBD@HT90J.3-*OG?XO_ /(_S_\ 7"+^5?1%<9XD^&>C>*-8;4[V
MYOXYF14*P2(%P.G5"?UJ*4U&5V:8BFYPM$YOX&_\@C5O^NZ?^@FM?XR1-)X$
M++C$=U&S?3D?S(K?\*>#]/\ !]M<0:?-=2K<.'8W#*Q! QQA16S?6-MJ5C/9
M7D0EMIT*2(>X/TY'U'(H<U[3F01IOV7(]SY=\):XGAOQ18ZM)"TJ6[-N13R0
MRE3CW^:O?_"/CRQ\8W=]%96T\*6JHP,^ S[LYX&0,$>O.:Y"\^!EI).6L]<F
M@B).$EMQ(1^(9?Y5U7@OX?6G@V6XGBO9[J>==C%E"J%!R,#DY_&M*LJ<E=;F
M-"%6#L]CP_Q__P C[K7_ %\M_2O8O@[_ ,B%'_U\R?TIVL?"70=:U>ZU*YN]
M22:Y<NZQR(%!]LH3^M=+X:\.6?A;2!IMC)/)"'9]T[ MD_0 ?I2J5(R@HHJE
M1E&HY/8\*^)=IJ^C>+;I9[V[DM;HF:W9YV8;"?N\_P!T\8[#'K6MX'^*R>'=
M'BTG5+*:X@@)\F6%@7"DYVD$C.,G'/H*]GU?1=/UZP>RU*U2>%A_$.5/JIZ@
M^XKSB_\ @=I\TQ;3]8N+9"<[)H1+CV!!6G&I"4>69,J-2$^:F9/C+XMV6MZ#
M<Z5IFGW %R@1Y;G:NT9R<*I.>G7/X5Q'@G0[C7_%EA:PHYC2599W4?<C4Y)S
MV]![D5Z1;? NT1P;K79I4SR(K<1DCZEF]^U>BZ!X;TKPS8_9-+MA$K8,CDY>
M0CNQ[]_89X INI"$;0$J-2I-2J&M1117*=QEW'AK0;NX>XN=$TV::0Y>22T1
MF8^I)&35BPTC3=*\S^SM/M+/S,;_ +/"L>[&<9V@9QD_G5RBG=BY5O8****0
MPJI?:7I^J(B:A86MVJ'*K<0K(%/J,@XJW10#5S*A\+^'[>:.:'0M,CEC8.CI
M:1AE8'((('!%:M%%-ML226P5E3>%_#]Q-)--H6F22R,7=WM(RS,3DDDCDFM6
MBA-H&D]RI8Z7I^EHZ:?86MHKG++;PK&&/J< 9JW112&E8*:Z))&R.H9&!#*P
MR"#V-.HH Q_^$2\-?]"]I/\ X!1__$UI6MI;6%LEM9V\5O F=L4*!%7)R< <
M#DDU-13;;$HI;!1112&%%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 5YO\;/^1+M/^P@G_HN2O2*\W^-G_(EVG_803_T7)6E+XT95_X;-'X7_P#)
M.M*_[;?^CGHH^%__ "3K2O\ MM_Z.>BE/XF.E\$?0S=7_P"2E1_]?5O_ "2O
M2:\VU?\ Y*5'_P!?5O\ R2O2:[\?_#H_X4>=EO\ $K_XF%%%%>:>J%%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M?@E_R.=Y_P!@]_\ T9'6U/X)'-6_B0/>J***Q.D**** "BBB@ HHHH ****
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MP._X2S[#K/\ PE7]M>9YD7D?VKYN<8;=M\SMTSCVH ]9HHHH **** "BBB@
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M26SLZVMR\08[AR0I&:]@\%SS77@7P]<7$LDT\NF6SR22,69V,2DDD\DD\YH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \V\8_N?%\,K\*5C?\ ?\
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M****S-0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M&-S=/6NW^'&KWVO?#[2-4U.?S[VXC9I9-BKN(=AT4 #@#H* .IHHHH ****
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M%_\ R3K2O^VW_HYZ*4_B8Z7P1]#-U?\ Y*5'_P!?5O\ R2O2:\VU?_DI4?\
MU]6_\DKTFN_'_P .C_A1YV6_Q*_^)A1117FGJA1110 4444 %%%% !1110 4
M444 %?/_ .TU_P RM_V]_P#M&OH"OG_]IK_F5O\ M[_]HT >@?!+_DD.A?\
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M0VPS)\V62TMP0,*.FX\>F2<F@#UVY_:(\%P/MC@U>X']Z*W0#_QYP:ZGPO\
M%#PEXNN%M=-U,+>L,BUN5,4C>RYX8\'A2>E9MC\$? -G9BW?1FNGV[6GGN9"
M[^_RL #_ +H%>5?%GX/VOA+3?^$C\.RRK8Q.HN+>5]S0DD!61NN,D#!Y!/7T
M /I>N*\<?$_1/ -Y:6VJVNH3/=1F1#:QHP !QSN=:SO@UXXF\9>$2E_('U+3
MF6"=\Y:1<?(YYSDX()[E2:\W_:5_Y#^A?]>LG_H0H ]4\3_%OPKX42!;Z>XE
MNYH4F%I;1AY%5@"-V2%4X.<$YQ^%3^#/BAX<\<W<MII374=W%'YK0W$.UMO
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M6@ESN@E')CZ< \\'H1[UW_Q\_P"277'_ %]0_P#H5 &-^S=_R)FJ_P#80/\
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MY?V1$;&S;G.YE_OCIGO5?P=X%\+VVD:'J\&AVD>H"UAF%PJ8;>4!)_4UYO\
MM-?\RM_V]_\ M&@#VOPWK]KXH\/V>M64<T=M=*619@ X )'(!([>M-\0>*-$
M\+6:W>MZC#9Q,2$WDEG(Z[5&6;J.@-<_\(/^24:!_P!<7_\ 1C5X/XLEE^(/
MQV?2+ZZ>&U&H?V='@_ZN-&*G;GNQ#'ZM^% 'JD_[17@V*0HEIK$R_P!^.WC
M/_?4@/Z5U/AGXI^$/%=PEKI^J!+QSA;:Y0QNQ]!GACP> 35&T^"G@&ULQ;MH
MGV@X(:6:XD+M^(88_ "O*?B9\%I]#O+2]\'6=]=V\[E7MHPTKP,!D$$#.TX/
M)/!QZT ?2U%<]X&N-:N?!FFOXAMI;?55C,=PLI!9BI*ACC^\ #^-=#0!X_\
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MX?#M[::C)>2^7M>&-#'\YP,DN#]>*[NOE3X\S26_Q6,T3E)([:!T8=01D@T
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MDTA[MBN&FN+B3>WO\I !^@% &MX7^)?A3Q=(L&EZFHNV&?LLZF.3\ >&_P"
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MQF\.S>-3X56RU07POFL?,,4?E>8'*$YWYVY'IGVKI/ EU)>^ /#UQ*29'TZ
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M&'@_3];5522=,31J>$D4[6'KC()&>Q% '04444 %%%% !1110 4444 %%%%
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MH%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MBD7!P<'KT((]#TQ0!]>5\[?'7QUX;\2:%::7I.H_:;VTOR9H_(D3: K*>64
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M$:DZ/J]G>,!DI%*-Z_5>H_$5L5\G_$'X;:E\,]6L-2T6_N9K>60BWG3Y9H9
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MQ>+?K%_Z')7OU> _L\?\C%XM^L7_ *')7OU 'S_^TU_S*W_;W_[1KZ KY_\
MVFO^96_[>_\ VC7T!0 4444 %%%% !1110 4444 %%%% !7F_P ;/^1+M/\
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M+&?L\]K]G9\\;T9CC';AA^5>N_"OQ5:^*? 6FR1S*UY:0);7<9;+JZ#;N/\
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M_(?T+_KUD_\ 0A73_LW?\B9JO_80/_HM*YC]I7_D/Z%_UZR?^A"@#V?X<?\
M)-O#G_8/A_\ 017A_P"TE_R.&D?]>'_M1J]P^''_ "3;PY_V#X?_ $$5X?\
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M!)>;_-$+1KN!!V+(RIU[; N/:NVH *^<?VE?^0_H7_7K)_Z$*^CJ^<?VE?\
MD/Z%_P!>LG_H0H ]?^%O_),/#W_7HO\ ,UU]<A\+?^28>'O^O1?YFNOH *^5
M_P!H6[CN?B5'$CHS6UA%$X4\J2SO@^^'!^A%?2?B+Q%IGA;19]6U:X$-M$/J
MSMV51W8^G] 37R;HUG>_%3XK;Y8OEOKLW%RNXXBMP1E<@#HN%!XR<=,T ?4_
M@2UDLO 'AZWE!$B:= '4C!4[ 2/PZ5\TV/\ R<:W_8RR_P#H]J^M54*H50 H
M& !T%?)5C_R<:W_8RR_^CVH ^HO$6A6GB;P]>Z+?;OL]W'L8KC*G.0PSQD$
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M)WBG%^3/-!XF\3:2=EW&[!3_ ,O,)_F,9_.M*V^(J]+K3R/]J*3/Z$?UKN2
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M_3Z5;HHK,V2L%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M"Q@U/3;JPN5+6]U"\,H'=6!!_0T >6?L]^(#J?@:?29'+3:7.54'M%)EE_\
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M:D=,YR1[(>V10!Z7\?/^277'_7U#_P"A5D?LWVZKX(U2Y'WI-2:,_18T(_\
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M\2%#?#7Q&& (_L^4\_[IKQG]FK_D/Z[_ ->L?_H1KV?XC_\ )-O$?_8/F_\
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M%>0?LU?\A_7?^O6/_P!"- 'T=1110!YW\<IA%\)=60XS*\"#)Q_RV1OQ^[7
M?LSPN;CQ)/C]V%MTSZDF0_T_455_:&\96NHW=EX8L9EE%E(9[QEY"RXVJF?4
M MG_ '@.H(KT3X'^&I/#WP\@FN8FCNM2D-VZMC(0@!!^*@-Z_-^% '$?M-?\
MRM_V]_\ M&O2?A!_R2C0/^N+_P#HQJ\V_::_YE;_ +>__:->D_"#_DE&@?\
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MS38Y%^[(UNKN.,<,V2./>OFOXYZG;ZA\3;J*V(*6,$=J2HXW %B!]"V.W(-
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MX<6\N[2%]]O=V7,R+QPZ+SQWP""!GCH%B^.GQ TB);.^6UDG49WWEF5D([9
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MI+\7/"$>=M[/+SCY+=_SY JG+\:?#$>=L.I2<X^2%?SY84Z/X,^%D*[GU"3
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !7FWP^_Y#\__7JW_H25Z37FWP^_Y#\__7JW_H25Z6#_ -VK>B_4
M\K'?[U0]7^AZ31117FGJA1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !7FWP^_Y#\__7JW_H25Z37FWP^_Y#\__7JW_H25
MZ6#_ -VK>B_4\K'?[U0]7^AZ31117FGJA1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 5X+\$O^1SO/^P>_P#Z,CKWJO!?@E_R.=Y_V#W_
M /1D=;4_@D<U;^) ]ZHHHK$Z0HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHKCOB/X_M/
M 'A\7CHL]_<$QV=N6QO8#EF[[5R,X]0.,YH Z?4-2L=)LGO=1O(+2UCQNFGD
M"*,\#DUR%U\8_ %G.89?$<+,.IA@EE7_ +Z5"#^=?/VDZ!XT^-&NSWT]V7AB
M;$ES<,1!!G^"-1WQSM'L21G->EV?[->C)"!>^(+^:7NT,21+U]#N]N] 'INC
M^//"FOS"#3->L9YVP%B\S8[=N%;!/X#T]:Z*OF'QK\!]5\-6$VK:)?G4K:W!
MEDC*>7-$H!)8<X;&.V#[5TGP4^*UYJ%]%X5\07!GD=3]ANY#EV(&?+8]^ 2"
M>>,<Y% 'O5%%>;?%GXGIX%T]+&P"R:W=QEH0PRL"9(\QAWY! '<@YZ8(!W6J
MZUI>AVWVG5=0M;*'!PUQ*$SCL,]3["N2E^-'P^A8*WB)"2,_):S,/S"&O!/#
M'@#Q?\5]0DUF^O9%M7?$FHWI+;N>5B7^+'/ PHQC(Z5Z5#^S9H:P$3Z]J+S<
MX9$15]N"#_.@#U+1?&/ASQ')Y6D:U97<VS?Y4<H\P+Z[3S^G>MNOE_Q?\"->
M\-0MJ>@W;:I#"3(5C0QW$0!R" "=Q'M@\=/3H_A#\9+F[O;?PUXHN/->3"6E
M_*WS%NR2$]2>@;J3P<YS0![GJ&I6&DVINM1O;:SMP0IEN)5C0$]!EB!5?3/$
M.B:U))'I6L:??O&-SK:W*2E1ZD*3BF>)M%C\1^&-2T>7;B[MWB4MT5B/E;\&
MP?PKY>^#^JW'A/XKP6%ZK0&Y=]-N8FQE9"<*#[B15'XF@#ZVHHHH *QF\7>&
MEOS8-XATD7@E\DVYO8_,$F<;-N[.[/&.N:7Q5KT7ACPMJ6M3*K"T@:149MH=
M^BKGMEB!^-?-OP1T-_%/Q*DUC4%,Z6 :]D=L8:=F^3(]<EF&.Z4 ?4EU=VUC
M:R75W<16]O$-TDLSA$0>I)X JGIGB'1-:DDCTK6-/OWC&YUM;E)2H]2%)Q6%
M\4O^28>(?^O1OYBO(/V:O^0_KO\ UZQ_^A&@#Z,=TBC:21E1%!9F8X  ZDFL
M'_A._!__ $->A_\ @QA_^*K1UO\ Y &H_P#7K+_Z":^-O ?@]_'/B5=&CO5L
MV:%Y1*T>\?+CC&1ZT ?7'_"=^#_^AKT/_P &,/\ \55BW\6^&[PXM?$.DSG.
M/W5[&W/7L:\0_P"&:+O_ *&B#_P#/_Q=4K_]F[7(8'>QUNPN9%&521&BW>V?
MFP?\Y% 'TI17R+X=\;>+OA3XA.E:@D_V:"0"YTRX8%2,=4;G'&""IP>.HKZK
MT75[/7]%L]6L'+VMW$)8R>H!['T(.01ZB@"_1110 4444 %4!K>DMJ[:2-4L
MCJ2C)LQ<)YP&-WW,[NASTZ<UROQ%^)FE^ ].=-T=SK$B9M[('GG.'?'1>#[G
MH/4>%?!B^N=3^,UO?WLS375PMQ++(W5F*,2: /JZBBN?\:>*K7P9X6O-:NE\
MPQ#;##G!EE/"K^?4]@">U &U<W5O90-/=7$4$*]9)7"J/Q-9MGXL\.:C.L%C
MX@TJZF8A1'!>1NQ)Z# -?+.G:?XQ^-7B>5I;HRK =TDDI(@M$8]%7MG' ')V
M\G@FNZN_V:IDTQVL_$BRWZKE4DM=D;GTR&)'UP?I0!]"45\W_#SXCZYX(\5'
MP?XPDEDM!*+<-,^][1^ N&)YBQCCL"".X/TA0!\_>'OBU\4?%<4\FA^&]&O$
M@(64K&Z[2<X^],/0U[O<7\.G:6]]J4T=M##%YD\CMA4P.>:\2_9H_P"09XB_
MZ[0?R>G_ +06N7EQ<:-X.L6^:^99I5#<N2^R-2,=-P)^H]J +6H?'#4]8U&:
MR\!^&9]6\H$M<2Q.P]FV+@@=>I&>.E5I?BW\0O#F+GQ5X)2/3]R[YK>*2,("
M<'+%G7)R, X_6O6_#'ANP\)^'[71].C58H$ =]N&E?'S.WN3S^G0"M*[M+>^
MM)K2[ACGMYD*212+N5U/!!% &3X4\5Z7XRT.+5=*FW1M\LD;</"_=&'8C]>H
MXKR7Q7\3_B?X3$EWJ'AO2;?36N3!;S21N2_WBN0)LY*J3T%=3\//AA?> _%>
MKWD&J1/H]X&6.S"L6 #9C+,>Z@L/?/OQF?M'?\D\T_\ ["L?_HJ6@#TSPUJ4
MVL^%=(U2X6-9[VRAN)%C!"AG0,0,DG&3ZFM2N?\  G_)//#7_8*M?_12UT%
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M_&A[KGCU'&>H)ZR>#3?$&CRP2B"^T^[C*-M8,DBG@X(_F*\]\ _!NW\":_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M[%200?8B@#C_ -H":./X82([A6EO(40'^(\G'Y G\*S/V;T8>"-4D(^5M28
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7@OP2_P"1SO/^
MP>__ *,CKWJO!?@E_P CG>?]@]__ $9'6U/X)'-6_B0/>J***Q.D**** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M5H[*JS00 S[3D>:WS/SW^8G\*Z&@#D/BE_R3#Q#_ ->C?S%>0?LU?\A_7?\
MKUC_ /0C7K_Q2_Y)AXA_Z]&_F*\@_9J_Y#^N_P#7K'_Z$: /?];_ .0!J/\
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M/T0O);96SM6[%02SR[3C ^\?7"BOJBRM(-/L;>RMD$<%O$L4: 8"JHP!^0H
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M4 %>;_&S_D2[3_L()_Z+DKTBO-_C9_R)=I_V$$_]%R5I2^-&5?\ ALT?A?\
M\DZTK_MM_P"CGHH^%_\ R3K2O^VW_HYZ*4_B8Z7P1]#-U?\ Y*5'_P!?5O\
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M6'(/;Z$BO(;G]FBR>Y#6OB>XB@[I+:"1CS_>#J.F.U>[T4 >?^!_A#X>\$W
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MHHKS3U0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\%^
M"7_(YWG_ &#W_P#1D=>]5X+\$O\ D<[S_L'O_P"C(ZVI_!(YJW\2![U1116)
MTA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M(QGF88_!1Z9R?IZ^\^%?!^B^#---CHMKY2.0TLC-NDE;&,LQ_ET&3@<UNT4
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ KS;X??\A^?_KU;_P!"2O2:\V^'W_(?G_Z]6_\ 0DKTL'_NU;T7ZGE8
M[_>J'J_T/2:***\T]4**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "O!?@E_R.=Y_V#W_]&1U[U7@OP2_Y'.\_[![_ /HR.MJ?P2.:M_$@
M>]4445B=(4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M7F_QL_Y$NT_[""?^BY*](KS?XV?\B7:?]A!/_1<E:4OC1E7_ (;-'X7_ /).
MM*_[;?\ HYZ*/A?_ ,DZTK_MM_Z.>BE/XF.E\$?0S=7_ .2E1_\ 7U;_ ,DK
MTFO-M7_Y*5'_ -?5O_)*])KOQ_\ #H_X4>=EO\2O_B84445YIZH4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'C?Q9^+
M.O> _%5KI>EVFFS02V27#-=1NS!B[K@;748P@[>M<)_PT=XP_P"@;H?_ 'XF
M_P#CM?34EM!,VZ6&-V QEE!--^PVG_/K!_W[% 'S/_PT=XP_Z!NA_P#?B;_X
M[1_PT=XP_P"@;H?_ 'XF_P#CM<[\:D2/XMZXD:*BCR,!1@#]Q'7UG9V=JUC;
MLUM"6,:DDH,GB@#Y]T/]H'Q7J?B#3;";3]%6*ZNHH7*0RA@K. <9DZ\U](5
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M% !1110 4444 %%%% !1110 5YM\/O\ D/S_ /7JW_H25Z37FWP^_P"0_/\
M]>K?^A)7I8/_ ':MZ+]3RL=_O5#U?Z'I-%%%>:>J%%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !7@OP2_Y'.\_P"P>_\ Z,CKWJO!?@E_
MR.=Y_P!@]_\ T9'6U/X)'-6_B0/>J***Q.D**** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MQ1'JUV\RQQW0@9%VY9,XSU[UQW[27_(X:1_UX?\ M1J^@/"G_(GZ)_UX0?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH *\V^'W_(?G_Z]6_]"2O2:\V^'W_(?G_Z]6_]"2O2P?\ NU;T7ZGE8[_>
MJ'J_T/2:***\T]4**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "O!?@E_R.=Y_V#W_ /1D=>]5X+\$O^1SO/\ L'O_ .C(ZVI_!(YJW\2!
M[U1116)TA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M>;_&S_D2[3_L()_Z+DKTBO-_C9_R)=I_V$$_]%R5I2^-&5?^&S1^%_\ R3K2
MO^VW_HYZ*/A?_P DZTK_ +;?^CGHI3^)CI?!'T,W5_\ DI4?_7U;_P DKTFO
M-M7_ .2E1_\ 7U;_ ,DKTFN_'_PZ/^%'G9;_ !*_^)A1117FGJA1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M;>[=<"6>Y\Q8SZA0HW?B10!C?M%:K%>>.;/3XBK&QLP)2#R'<EL'_@.T_P#
MJ]DO?#TT/P/ET*4?Z5#H?EL.3^]6+./7&X5Y)\,/AMK7BOQ0GBWQ/#*MEYYN
M29\I)=2Y# A<?<R<YX!Q@>WTM0!\I? B/1+[QK<:7K6G6-X+NU8VRW=NLO[Q
M"&(4,"!\N\Y_V:^C?^$$\'_]"IH?_@NA_P#B:\!^)?POUOPCXBD\2>&HIWTX
MR_:%>USYEF^<\@<[<\ANW0XXSJZ+^TE=P6,<.LZ"EU<*,-<6\_E;_<H5.#ZD
M''H!0!Z_J7A7P)I&FW.HW_AO08+2VC,LLC:=$=J@9/ 7)^@Y-5_"%Y\/M0OI
M)?"5OHXNTC/F/96:Q.J$@8)"@@$@<=\5X'XN^)?B?XIM'H.F:4T-K(RL;.VS
M*\C \%FP/E!([ 9Y/M[9\)?AV? >@2M>LCZM?%7N2ARL8 .V,'H<9))'4GN
M* /0J*** "BBB@#YX_:7_P"0AX<_ZY3_ ,TKV#X<?\DV\.?]@^'_ -!%>/\
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MC'<5!\./C;=^9X=\)WFE0%-T-@EVDA!"\(F4QUZ G/O0!ROQ\L/LGQ2N9_\
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M;?#[_D/S_P#7JW_H25Z6#_W:MZ+]3RL=_O5#U?Z'I-%%%>:>J%%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !7@OP2_P"1SO/^P>__ *,C
MKWJO!?@E_P CG>?]@]__ $9'6U/X)'-6_B0/>J***Q.D**** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "O-OA]_R'Y_^O5O_ $)*])KS;X??\A^?_KU;_P!"2O2P?^[5O1?J>5CO
M]ZH>K_0])HHHKS3U0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH *\%^"7_(YWG_8/?_T9'7O5>"_!+_D<[S_L'O\ ^C(ZVI_!(YJW\2![
MU1116)TA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>
M;_&S_D2[3_L()_Z+DKTBO-_C9_R)=I_V$$_]%R5I2^-&5?\ ALT?A?\ \DZT
MK_MM_P"CGHH^%_\ R3K2O^VW_HYZ*4_B8Z7P1]#-U?\ Y*5'_P!?5O\ R2O2
M:\U\0_Z/X_CF;@>; ^?8;?\ "O2J[\?_  Z+_NGG9=_%KK^\_P!0HHHKS3U0
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O-OA]_P A
M^?\ Z]6_]"2O19Y!%;R2$X"(6/X"O/?AXA.L74F.%M]N?JP_PKTL)IAJS]/U
M/*QNN+H+S?Z'HU%%%>:>J%%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !7E'Q\\27^@>$+&+3+^>RNKJ\ ,MO*T<GEJI) *X/4K7J]
M>'?%/_B??&CP5X?4$K R7$G)'RM)E@/?;%^HH T_ O@/XA:)XHM=4\2^+GO-
M-A1S);?VE/*&)0@;E<!<#.>O4"L+Q+\7?$GBCQ(_ASX<VI<J64W:JKM* 1EE
MW?*B=1N;KD=*['XY^()-#^&]Q! [I/J4BV89>R$%GS[%5*_\"JU\'_!]MX7\
M"V4QMPNI:A$MS=2,N'^;E4/<!5(&/7)[T >>M\//C/$IOU\7L]QG?]F&J3$D
MD]-I7R_PSBNC^&OQ*UZ\\43>#/&EMY6M("8I=@0N0NXJRK\N=OS C@BO7ZP;
M[P7X>U'Q-:^([K3PVK6H417*S.A&TDC*JP5NIZ@\<=* .6^*?AOQEKOV*?PS
MX@72;:SBE:Y_TV6 R$X(_P!6IS@*>I[FN>_9]N]<UC3]9U75]7U&_B\U+:!;
MJY>4*P!9R Q//S)7:?%G5ET?X8:[,2-T]N;51ZF4[#^C$_A5/X*Z0-)^%VEY
M5%EO-]VY48W;S\I/J=@4?A0!Z!117A^N_P#"]O\ A(=3_LC_ )!GVN7['_QX
M_P"IWG9][YONXZ\^M 'N%%?/_P#QD/\ Y_L^N]^&?_"Q_M&H_P#">?ZK9']D
M_P"/?KEMW^J_X#UH ]#I&8*I9B H&23T%+7FOQS\0W.@_#F5+20QS:A.MGO4
MX94(9FQ]0I7_ (%0!Q?B7XN^)/%GB!O#GPXMF9<D?:U0&24#@L-_RQIS]X\]
M.1TIJ_#KXS*!>CQE^^ W>0=4F//IMV[/Z5Z!\'_!MMX5\#V<^Q&U#4HDNKF;
M SAAE4!]%!'XECWKT"@#R#X:_$K6;CQ%+X+\:P&'7(_]3*RJIDPN[:P'&[;\
MP(X(_7<^-?B"[\/?#BXEL+F6UN[FXBMXYX9"CID[CM(.<[4(X]:Z:]\':!J/
MB:T\1W5@'U:T4)#<"5UV@$D?*&"G[QZ@UY7\>VEUG7?"/A6W+EKNX+NJXSEF
M5$(Y[9?KQ^M '?:5I^NW'PAMK*#4)/[<NM+ %W=S/O261,DEP2P*[C@CN!]*
MN^ M#UKP_P"%HK+Q!JKZEJ7F.\L[3R3#!/R@,_)& .PY)^IXWX[:_>^'O!VF
MVFC75Q8W5U>*B-:.8V$:J<JI4@CDIP*T/B5JM_X3^#;!+ZX35!#;VBW2RGS#
M)E0[;\[LD*_.2<T >D45X5X0@^(WQ \(6*KK\FA:5$FQ;W+S7=XPSN<L6!VY
MXZC\<4[PKJOB?P3\8(O!>L:_/KME?Q[TFN'9G0["P8;B2O*D%<XP<T >O^([
M74;[PUJ5GI%PEOJ$]N\4$SNR"-F&-VY>01G((Z'%9O@+0]:\/^%HK+Q!JKZE
MJ7F.\L[3R3#!/R@,_)& .PY)^IX_X]>(]0T/PEI]OI-[<VE[>7H426TA1RBJ
M20"I!Y)3I74>(/$B?#[X>17^IR&YNK:WB@59)26N9]H&-QR22023R< F@#KJ
M*\1TCPY\2/B)IT6OZCXRF\/VUVHFM;33T<80C@D*ZD CD99CS4W@?Q1XJ\.?
M$M_ 7BR_74A.A>TNV;+?=+CGK@@$8;D$#''4 ]HHKRWXC^.-;B\1V'@KP:$.
MN7@W3SLH86R'IUR <98DC@ 8!)XR+KX;?$73[!]4MOB3?7&HPQF3[*Y?R6('
M*@LY4^V4Z^E 'M->._%76M7D^(_@[PSI.I7ED+F19+G[+.T9='D"_,%() ".
M?Q-=%\'_ !M?^-_![W6J*AOK2<V\DJ *)L*K!L#@'G! XXR,9P.,L WB7]J*
M\N-IDMM&@(&0"%VQA.?^VDC$=^/8T >YT45SOC;Q=9^"?"]SK%V-[+^[MX<X
M,TI!VKGMT))[ $\T =%7G/QOU^[\/_#F62QNIK6ZNKJ*WCF@=D=.2YPRD$9"
M$?0D=ZY/1_#7Q+^(.G_V]J7C"Y\/17(WVMG:(Z?)SC*JRD*<\$EB1@GM7!_$
MG6/%6I7.E^!M?CCEU2PNBJW:=+L2!1$W3T+9/OR,@T ?0GPU6^_X5QH4FI7=
MQ=W<]L)WFN)3(["0EURQ))P& 'L!755Q_C;Q1;?#?P(+R.(3/"L=I9PN<!WQ
MA<X[ *2<8Z8XKA-/\$?$GQ?I\>LZMX]N]'FN4$D5G9AE5%/(#!'4#C']X\\\
MYH ]KKF?B!XH?P=X)U'6X8XI;B!56&.4_*SLP49 () SD@'. :X'P%XH\5:-
M\2;KP#XHO5U,B,R6]WU884.,G@D%<\')![XKG/V@-,U:#5;.5=>NY[75I1'#
MI +")#&J#=C?AB68'[HZ_F >O?#F\U'4O .E:CJUP;B^O$:XDD(QP[L5 '0
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M[<K)+_SSSCW"XR./,]*S?VD=1+67A_18V7=//)<-N<*%V@(I.>!]]N21C!H
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 8_BB\%EX<O'SAG3RE]RW'\B3^%8?P\M2EE>79'^LD$8_P" C)_]"_2J
M7CS4C=7L&E0?-Y9#.!SESP!^1_6NRT73QI>CVUIQN1/G([L>3^IKU)+V."47
MO-W^2/)@_;X]R6T%;YO^OP+]%%%>6>L%%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !7AWAW_BHOVF];U#)DATF!XXVP<(RJL)7COE
MI.OO^'ML\R6]O)/(<)&I=C[ 9->*_L]P/?MXH\2SH!)?7@08'"GYI' /_;1>
MW84 2_M(VTLGA'2;E5S%%?%7/H61L?\ H)_2O4O"M];ZEX3TB\M9%DAEM(BK
M Y_A&0?<'(([$&F>+?#-GXO\,WFB7I*1W"C;(HR8W!RK#Z$#ZC([UX5IUC\6
M_A29+'3=/_M?2]Q9$CB:YBR<\JJD.G7)' SZT ?1S,%4LQ 4#))Z"N"\&_$Q
M?&WBS5]+T[23_9FG _\ $R^T;A*=VU<)MXW88CGHM>;7;_&/XE1#3+G3AH>F
M396X+0M;*5_VMY,A'; X.>>.GLW@OP=IW@?P_'I6G;GY\R>=_O32$ %CZ=
M.P'XD \Y_:'OI9=$T+P]:AFNM1OMZQJV-^T;0I[<M(O7N/:O7=-L8M+TNTT^
M 8AM84@C&/X54*/T%>,>*<>*/VDM"TG DM](B265"N C &;)/?.8AZ?K7N-
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M=7\1KX:T/3K"]N8)[TO<R6\#.D/1%9FZ+P[]?0UZTB)%&L<:JB* JJHP !T
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MX8<_C6O\>[/6=6\+Z9I6CZ5>7S37GF2FV@:38%4@;L X!+]3Z5W&H^%+>_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MZ"EE_P"!"?XURG_"N/\ J*_^2_\ ]E1_PKC_ *BO_DO_ /94>PP/_/U_<_\
M(/K&8?\ /E?>O\SJ_P"V])_Z"EE_X$)_C1_;>D_]!2R_\"$_QKE/^%<?]17_
M ,E__LJ/^%<?]17_ ,E__LJ/88'_ )^O[G_D'UC,/^?*^]?YG5_VWI/_ $%+
M+_P(3_&C^V])_P"@I9?^!"?XURG_  KC_J*_^2__ -E1_P *X_ZBO_DO_P#9
M4>PP/_/U_<_\@^L9A_SY7WK_ #.K_MO2?^@I9?\ @0G^-']MZ3_T%++_ ,"$
M_P :Y3_A7'_45_\ )?\ ^RH_X5Q_U%?_ "7_ /LJ/88'_GZ_N?\ D'UC,/\
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M2R_\"$_QH_MO2?\ H*67_@0G^-<I_P *X_ZBO_DO_P#94?\ "N/^HK_Y+_\
MV5'L,#_S]?W/_(/K&8?\^5]Z_P SJ_[;TG_H*67_ ($)_C1_;>D_]!2R_P#
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M%?\ R7_^RH_X5Q_U%?\ R7_^RH]A@?\ GZ_N?^0?6,P_Y\K[U_F=7_;>D_\
M04LO_ A/\:/[;TG_ *"EE_X$)_C7*?\ "N/^HK_Y+_\ V5'_  KC_J*_^2__
M -E1[# _\_7]S_R#ZQF'_/E?>O\ ,ZO^V])_Z"EE_P"!"?XT?VWI/_04LO\
MP(3_ !KE/^%<?]17_P E_P#[*C_A7'_45_\ )?\ ^RH]A@?^?K^Y_P"0?6,P
M_P"?*^]?YG5_VWI/_04LO_ A/\:/[;TG_H*67_@0G^-<I_PKC_J*_P#DO_\
M94?\*X_ZBO\ Y+__ &5'L,#_ ,_7]S_R#ZQF'_/E?>O\SJ_[;TG_ *"EE_X$
M)_C1_;>D_P#04LO_  (3_&N4_P"%<?\ 45_\E_\ [*C_ (5Q_P!17_R7_P#L
MJ/88'_GZ_N?^0?6,P_Y\K[U_F=7_ &WI/_04LO\ P(3_ !H_MO2?^@I9?^!"
M?XURG_"N/^HK_P"2_P#]E1_PKC_J*_\ DO\ _94>PP/_ #]?W/\ R#ZQF'_/
ME?>O\SJ_[;TG_H*67_@0G^-']MZ3_P!!2R_\"$_QKE/^%<?]17_R7_\ LJ/^
M%<?]17_R7_\ LJ/88'_GZ_N?^0?6,P_Y\K[U_F=7_;>D_P#04LO_  (3_&C^
MV])_Z"EE_P"!"?XURG_"N/\ J*_^2_\ ]E1_PKC_ *BO_DO_ /94>PP/_/U_
M<_\ (/K&8?\ /E?>O\SJ_P"V])_Z"EE_X$)_C1_;>D_]!2R_\"$_QKE/^%<?
M]17_ ,E__LJ/^%<?]17_ ,E__LJ/88'_ )^O[G_D'UC,/^?*^]?YG5_VWI/_
M $%++_P(3_&C^V])_P"@I9?^!"?XURG_  KC_J*_^2__ -E1_P *X_ZBO_DO
M_P#94>PP/_/U_<_\@^L9A_SY7WK_ #.K_MO2?^@I9?\ @0G^-']MZ3_T%++_
M ,"$_P :Y3_A7'_45_\ )?\ ^RH_X5Q_U%?_ "7_ /LJ/88'_GZ_N?\ D'UC
M,/\ GROO7^9U?]MZ3_T%++_P(3_&C^V])_Z"EE_X$)_C7*?\*X_ZBO\ Y+__
M &5'_"N/^HK_ .2__P!E1[# _P#/U_<_\@^L9A_SY7WK_,ZO^V])_P"@I9?^
M!"?XT?VWI/\ T%++_P "$_QKE/\ A7'_ %%?_)?_ .RH_P"%<?\ 45_\E_\
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MF'_/E?>O\SJ_[;TG_H*67_@0G^-']MZ3_P!!2R_\"$_QKE/^%<?]17_R7_\
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M%++_ ,"$_P :Y3_A7'_45_\ )?\ ^RH_X5Q_U%?_ "7_ /LJ/88'_GZ_N?\
MD'UC,/\ GROO7^9U?]MZ3_T%++_P(3_&C^V])_Z"EE_X$)_C7*?\*X_ZBO\
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M .2__P!E1_PKC_J*_P#DO_\ 94>PP/\ S]?W/_(/K&8?\^5]Z_S.K_MO2?\
MH*67_@0G^-']MZ3_ -!2R_\  A/\:Y3_ (5Q_P!17_R7_P#LJ/\ A7'_ %%?
M_)?_ .RH]A@?^?K^Y_Y!]8S#_GROO7^9U?\ ;>D_]!2R_P# A/\ &C^V])_Z
M"EE_X$)_C7*?\*X_ZBO_ )+_ /V5'_"N/^HK_P"2_P#]E1[# _\ /U_<_P#(
M/K&8?\^5]Z_S.K_MO2?^@I9?^!"?XT?VWI/_ $%++_P(3_&N4_X5Q_U%?_)?
M_P"RH_X5Q_U%?_)?_P"RH]A@?^?K^Y_Y!]8S#_GROO7^9U?]MZ3_ -!2R_\
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M^@I9?^!"?XURG_"N/^HK_P"2_P#]E1_PKC_J*_\ DO\ _94>PP/_ #]?W/\
MR#ZQF'_/E?>O\SJ_[;TG_H*67_@0G^--?7](09.IVA_W90?Y5RW_  KC_J*_
M^2__ -E3D^'* _/J;'Z08_\ 9J/8X'_GZ_N?^0>WS#_GTOO7^9JW?C?1;8'R
MY9+AO2)#_,XKG+[QIJFIR?9M,MS!OX C&^0_IQ^ K>MO 6D0D-,T]P?1WP/T
MP?UK?L]/L["/9:6T<*]]BX)^I[TU5P5'6$7)^>W]?(3HX^OI4FH+RW_KYG%:
M-X'GN)1=:RY4$[C"&R[?[Q[?S^E=W%#'!$D4**D:#"JHP *?17)B,54KN\W\
MNAVX;"4L-&T%\^H4445SG2%%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %8'BGPAI?BVQ\B^CVS(#Y-PGWXS_4>QK?HIIM.
MZ$XJ2LSY]O/#/C/X<WKWNF2RRV@^]/;#<C#_ *:(<X_'CT-=)HGQOB*K'KFF
MNK=#-:'(/_ &/'YFO7JYS6/ ?AK7&:2\TJ$3'K+#F-B?4E<9_'-:^TC+XT<_
ML9P_AOY,KV7Q)\(WR@IK,43'JLZM&1^)&/UK17Q?X:89'B'2OQO(Q_6N(N_@
M?H\A)L]4O8,]I L@'Y 5GM\"5S\OB,@>]EG_ -J4<M+N'/77V4>D_P#"6^&O
M^AATG_P-C_\ BJ/^$M\-?]##I/\ X&Q__%5YK_PHG_J9/_)'_P"V4?\ "B?^
MID_\D?\ [91RTOY@YZ_\OXGI7_"6^&O^AATG_P #8_\ XJC_ (2WPU_T,.D_
M^!L?_P 57FO_  HG_J9/_)'_ .V4?\*)_P"ID_\ )'_[91RTOY@YZ_\ +^)Z
M5_PEOAK_ *&'2?\ P-C_ /BJ/^$M\-?]##I/_@;'_P#%5YK_ ,*)_P"ID_\
M)'_[91_PHG_J9/\ R1_^V4<M+^8.>O\ R_B>E?\ "6^&O^AATG_P-C_^*H_X
M2WPU_P!##I/_ (&Q_P#Q5>:_\*)_ZF3_ ,D?_ME'_"B?^ID_\D?_ +91RTOY
M@YZ_\OXGI7_"6^&O^AATG_P-C_\ BJ/^$M\-?]##I/\ X&Q__%5YK_PHG_J9
M/_)'_P"V4?\ "B?^ID_\D?\ [91RTOY@YZ_\OXGI7_"6^&O^AATG_P #8_\
MXJC_ (2WPU_T,.D_^!L?_P 57FO_  HG_J9/_)'_ .V4?\*)_P"ID_\ )'_[
M91RTOY@YZ_\ +^)Z5_PEOAK_ *&'2?\ P-C_ /BJ/^$M\-?]##I/_@;'_P#%
M5YK_ ,*)_P"ID_\ )'_[91_PHG_J9/\ R1_^V4<M+^8.>O\ R_B>E?\ "6^&
MO^AATG_P-C_^*H_X2WPU_P!##I/_ (&Q_P#Q5>:_\*)_ZF3_ ,D?_ME'_"B?
M^ID_\D?_ +91RTOY@YZ_\OXGI7_"6^&O^AATG_P-C_\ BJ/^$M\-?]##I/\
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MZF3_ ,D?_ME'_"B?^ID_\D?_ +91RTOY@YZ_\OXGI7_"6^&O^AATG_P-C_\
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M6^&O^AATG_P-C_\ BJ/^$M\-?]##I/\ X&Q__%5YK_PHG_J9/_)'_P"V4?\
M"B?^ID_\D?\ [91RTOY@YZ_\OXGI7_"6^&O^AATG_P #8_\ XJC_ (2WPU_T
M,.D_^!L?_P 57FO_  HG_J9/_)'_ .V4?\*)_P"ID_\ )'_[91RTOY@YZ_\
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M8_\ XJC_ (2WPU_T,.D_^!L?_P 57FO_  HG_J9/_)'_ .V4?\*)_P"ID_\
M)'_[91RTOY@YZ_\ +^)Z5_PEOAK_ *&'2?\ P-C_ /BJ/^$M\-?]##I/_@;'
M_P#%5YK_ ,*)_P"ID_\ )'_[91_PHG_J9/\ R1_^V4<M+^8.>O\ R_B>E?\
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MC_\ BJ/^$M\-?]##I/\ X&Q__%5YK_PHG_J9/_)'_P"V4?\ "B?^ID_\D?\
M[91RTOY@YZ_\OXGI7_"6^&O^AATG_P #8_\ XJC_ (2WPU_T,.D_^!L?_P 5
M7FO_  HG_J9/_)'_ .V4?\*)_P"ID_\ )'_[91RTOY@YZ_\ +^)Z5_PEOAK_
M *&'2?\ P-C_ /BJ/^$M\-?]##I/_@;'_P#%5YK_ ,*)_P"ID_\ )'_[91_P
MHG_J9/\ R1_^V4<M+^8.>O\ R_B>E?\ "6^&O^AATG_P-C_^*H_X2WPU_P!#
M#I/_ (&Q_P#Q5>:_\*)_ZF3_ ,D?_ME'_"B?^ID_\D?_ +91RTOY@YZ_\OXG
MI7_"6^&O^AATG_P-C_\ BJ/^$M\-?]##I/\ X&Q__%5YK_PHG_J9/_)'_P"V
M4?\ "B?^ID_\D?\ [91RTOY@YZ_\OXGI7_"6^&O^AATG_P #8_\ XJC_ (2W
MPU_T,.D_^!L?_P 57FO_  HG_J9/_)'_ .V4?\*)_P"ID_\ )'_[91RTOY@Y
MZ_\ +^)Z5_PEOAK_ *&'2?\ P-C_ /BJ/^$M\-?]##I/_@;'_P#%5YK_ ,*)
M_P"ID_\ )'_[91_PHG_J9/\ R1_^V4<M+^8.>O\ R_B>E?\ "6^&O^AATG_P
M-C_^*H_X2WPU_P!##I/_ (&Q_P#Q5>:_\*)_ZF3_ ,D?_ME'_"B?^ID_\D?_
M +91RTOY@YZ_\OXGI7_"6^&O^AATG_P-C_\ BJ/^$M\-?]##I/\ X&Q__%5Y
MK_PHG_J9/_)'_P"V4?\ "B?^ID_\D?\ [91RTOY@YZ_\OXGI7_"6^&O^AATG
M_P #8_\ XJC_ (2WPU_T,.D_^!L?_P 57FO_  HG_J9/_)'_ .V4?\*)_P"I
MD_\ )'_[91RTOY@YZ_\ +^)Z5_PEOAK_ *&'2?\ P-C_ /BJ/^$M\-?]##I/
M_@;'_P#%5YK_ ,*)_P"ID_\ )'_[91_PHG_J9/\ R1_^V4<M+^8.>O\ R_B>
ME?\ "6^&O^AATG_P-C_^*H_X2WPU_P!##I/_ (&Q_P#Q5>:_\*)_ZF3_ ,D?
M_ME'_"B?^ID_\D?_ +91RTOY@YZ_\OXGI7_"6^&O^AATG_P-C_\ BJ/^$M\-
M?]##I/\ X&Q__%5YK_PHG_J9/_)'_P"V4?\ "B?^ID_\D?\ [91RTOY@YZ_\
MOXGI7_"6^&O^AATG_P #8_\ XJC_ (2WPU_T,.D_^!L?_P 57FO_  HG_J9/
M_)'_ .V4?\*)_P"ID_\ )'_[91RTOY@YZ_\ +^)Z5_PEOAK_ *&'2?\ P-C_
M /BJ/^$M\-?]##I/_@;'_P#%5YK_ ,*)_P"ID_\ )'_[91_PHG_J9/\ R1_^
MV4<M+^8.>O\ R_B>E?\ "6^&O^AATG_P-C_^*H_X2WPU_P!##I/_ (&Q_P#Q
M5>:_\*)_ZF3_ ,D?_ME'_"B?^ID_\D?_ +91RTOY@YZ_\OXGI7_"6^&O^AAT
MG_P-C_\ BJ/^$M\-?]##I/\ X&Q__%5YK_PHG_J9/_)'_P"V4?\ "B?^ID_\
MD?\ [91RTOY@YZ_\OXGI7_"6^&O^AATG_P #8_\ XJC_ (2WPU_T,.D_^!L?
M_P 57FO_  HG_J9/_)'_ .V4?\*)_P"ID_\ )'_[91RTOY@YZ_\ +^)Z5_PE
MOAK_ *&'2?\ P-C_ /BJ/^$M\-?]##I/_@;'_P#%5YK_ ,*)_P"ID_\ )'_[
M91_PHG_J9/\ R1_^V4<M+^8.>O\ R_B>E?\ "6^&O^AATG_P-C_^*H_X2WPU
M_P!##I/_ (&Q_P#Q5>:_\*)_ZF3_ ,D?_ME'_"B?^ID_\D?_ +91RTOY@YZ_
M\OXGI7_"6^&O^AATG_P-C_\ BJ/^$M\-?]##I/\ X&Q__%5YK_PHG_J9/_)'
M_P"V4?\ "B?^ID_\D?\ [91RTOY@YZ_\OXGI7_"6^&O^AATG_P #8_\ XJC_
M (2WPU_T,.D_^!L?_P 57FO_  HG_J9/_)'_ .V4?\*)_P"ID_\ )'_[91RT
MOY@YZ_\ +^)Z5_PEOAK_ *&'2?\ P-C_ /BJ/^$M\-?]##I/_@;'_P#%5YK_
M ,*)_P"ID_\ )'_[91_PHG_J9/\ R1_^V4<M+^8.>O\ R_B>E?\ "6^&O^AA
MTG_P-C_^*H_X2WPU_P!##I/_ (&Q_P#Q5>:_\*)_ZF3_ ,D?_ME'_"B?^ID_
M\D?_ +91RTOY@YZ_\OXGI7_"6^&O^AATG_P-C_\ BJ/^$M\-?]##I/\ X&Q_
M_%5YK_PHG_J9/_)'_P"V4?\ "B?^ID_\D?\ [91RTOY@YZ_\OXGI7_"6^&O^
MAATG_P #8_\ XJC_ (2WPU_T,.D_^!L?_P 57FO_  HG_J9/_)'_ .V4?\*)
M_P"ID_\ )'_[91RTOY@YZ_\ +^)Z5_PEOAK_ *&'2?\ P-C_ /BJ/^$M\-?]
M##I/_@;'_P#%5YK_ ,*)_P"ID_\ )'_[91_PHG_J9/\ R1_^V4<M+^8.>O\
MR_B>E?\ "6^&O^AATG_P-C_^*H_X2WPU_P!##I/_ (&Q_P#Q5>:_\*)_ZF3_
M ,D?_ME'_"B?^ID_\D?_ +91RTOY@YZ_\OXGI7_"6^&O^AATG_P-C_\ BJ/^
M$M\-?]##I/\ X&Q__%5YK_PHG_J9/_)'_P"V4?\ "B?^ID_\D?\ [91RTOY@
MYZ_\OXGI7_"6^&O^AATG_P #8_\ XJC_ (2WPU_T,.D_^!L?_P 57FO_  HG
M_J9/_)'_ .V4?\*)_P"ID_\ )'_[91RTOY@YZ_\ +^)Z5_PEOAK_ *&'2?\
MP-C_ /BJ/^$M\-?]##I/_@;'_P#%5YK_ ,*)_P"ID_\ )'_[91_PHG_J9/\
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M5_PEOAK_ *&'2?\ P-C_ /BJ/^$M\-?]##I/_@;'_P#%5YK_ ,*)_P"ID_\
M)'_[91_PHG_J9/\ R1_^V4<M+^8.>O\ R_B>E?\ "6^&O^AATG_P-C_^*H_X
M2WPU_P!##I/_ (&Q_P#Q5>:_\*)_ZF3_ ,D?_ME'_"B?^ID_\D?_ +91RTOY
M@YZ_\OXGI7_"6^&O^AATG_P-C_\ BJ/^$M\-?]##I/\ X&Q__%5YK_PHG_J9
M/_)'_P"V4?\ "B?^ID_\D?\ [91RTOY@YZ_\OXGI7_"6^&O^AATG_P #8_\
MXJC_ (2WPU_T,.D_^!L?_P 57FO_  HG_J9/_)'_ .V4?\*)_P"ID_\ )'_[
M91RTOY@YZ_\ +^)Z5_PEOAK_ *&'2?\ P-C_ /BJ/^$M\-?]##I/_@;'_P#%
M5YK_ ,*)_P"ID_\ )'_[91_PHG_J9/\ R1_^V4<M+^8.>O\ R_B>E?\ "6^&
MO^AATG_P-C_^*H_X2WPU_P!##I/_ (&Q_P#Q5>:_\*)_ZF3_ ,D?_ME'_"B?
M^ID_\D?_ +91RTOY@YZ_\OXGI7_"6^&O^AATG_P-C_\ BJ/^$M\-?]##I/\
MX&Q__%5YK_PHG_J9/_)'_P"V4?\ "B?^ID_\D?\ [91RTOY@YZ_\OXGI7_"6
M^&O^AATG_P #8_\ XJC_ (2WPU_T,.D_^!L?_P 57FO_  HG_J9/_)'_ .V4
M?\*)_P"ID_\ )'_[91RTOY@YZ_\ +^)Z5_PEOAK_ *&'2?\ P-C_ /BJ/^$M
M\-?]##I/_@;'_P#%5YK_ ,*)_P"ID_\ )'_[91_PHG_J9/\ R1_^V4<M+^8.
M>O\ R_B>E?\ "6^&O^AATG_P-C_^*H_X2WPU_P!##I/_ (&Q_P#Q5>:_\*)_
MZF3_ ,D?_ME'_"B?^ID_\D?_ +91RTOY@YZ_\OXGI7_"6^&O^AATG_P-C_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
:HHHH **** "BBB@ HHHH **** "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>img268224062_1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img268224062_1.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 8"$,,# 2(  A$! Q$!_\0
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M_@;)_P#%4?\ "6^)?^AAU;_P-D_^*K'HHY5V#FEW-C_A+?$O_0PZM_X&R?\
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M_@;)_P#%4?\ "6^)?^AAU;_P-D_^*K'HHY5V#FEW-C_A+?$O_0PZM_X&R?\
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M_@;)_P#%4?\ "6^)?^AAU;_P-D_^*K'HHY5V#FEW-C_A+?$O_0PZM_X&R?\
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M_@;)_P#%4?\ "6^)?^AAU;_P-D_^*K'HHY5V#FEW-C_A+?$O_0PZM_X&R?\
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M_@;)_P#%4?\ "6^)?^AAU;_P-D_^*K'HHY5V#FEW-C_A+?$O_0PZM_X&R?\
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M_@;)_P#%4?\ "6^)?^AAU;_P-D_^*K'HHY5V#FEW-C_A+?$O_0PZM_X&R?\
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M_@;)_P#%4?\ "6^)?^AAU;_P-D_^*K'HHY5V#FEW-C_A+?$O_0PZM_X&R?\
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M_@;)_P#%4?\ "6^)?^AAU;_P-D_^*K'HHY5V#FEW-C_A+?$O_0PZM_X&R?\
MQ5'_  EOB7_H8=6_\#9/_BJQZ*.5=@YI=S8_X2WQ+_T,.K?^!LG_ ,51_P )
M;XE_Z&'5O_ V3_XJL>BCE78.:7<V/^$M\2_]##JW_@;)_P#%4?\ "6^)?^AA
MU;_P-D_^*K'HHY5V#FEW-C_A+?$O_0PZM_X&R?\ Q5'_  EOB7_H8=6_\#9/
M_BJQZ*.5=@YI=S8_X2WQ+_T,.K?^!LG_ ,51_P );XE_Z&'5O_ V3_XJL>BC
ME78.:7<V/^$M\2_]##JW_@;)_P#%4?\ "6^)?^AAU;_P-D_^*K'HHY5V#FEW
M-C_A+?$O_0PZM_X&R?\ Q5'_  EOB7_H8=6_\#9/_BJQZ*.5=@YI=S8_X2WQ
M+_T,.K?^!LG_ ,51_P );XE_Z&'5O_ V3_XJL>BCE78.:7<V/^$M\2_]##JW
M_@;)_P#%4?\ "6^)?^AAU;_P-D_^*K'HHY5V#FEW-C_A+?$O_0PZM_X&R?\
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M_@;)_P#%4?\ "6^)?^AAU;_P-D_^*K'HHY5V#FEW-C_A+?$O_0PZM_X&R?\
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M_@;)_P#%4?\ "6^)?^AAU;_P-D_^*K'HHY5V#FEW-C_A+?$O_0PZM_X&R?\
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M_@;)_P#%4?\ "6^)?^AAU;_P-D_^*K'HHY5V#FEW-C_A+?$O_0PZM_X&R?\
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M_@;)_P#%4?\ "6^)?^AAU;_P-D_^*K'HHY5V#FEW-C_A+?$O_0PZM_X&R?\
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M_@;)_P#%4?\ "6^)?^AAU;_P-D_^*K'HHY5V#FEW-C_A+?$O_0PZM_X&R?\
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M_@;)_P#%4?\ "6^)?^AAU;_P-D_^*K'HHY5V#FEW-C_A+?$O_0PZM_X&R?\
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M_@;)_P#%4?\ "6^)?^AAU;_P-D_^*K'HHY5V#FEW-C_A+?$O_0PZM_X&R?\
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M_@;)_P#%4?\ "6^)?^AAU;_P-D_^*K'HHY5V#FEW-C_A+?$O_0PZM_X&R?\
MQ5'_  EOB7_H8=6_\#9/_BJQZ*.5=@YI=S8_X2WQ+_T,.K?^!LG_ ,51_P )
M;XE_Z&'5O_ V3_XJL>BCE78.:7<V/^$M\2_]##JW_@;)_P#%4?\ "6^)?^AA
MU;_P-D_^*K'HHY5V#FEW-C_A+?$O_0PZM_X&R?\ Q5'_  EOB7_H8=6_\#9/
M_BJQZ*.5=@YI=S8_X2WQ+_T,.K?^!LG_ ,51_P );XE_Z&'5O_ V3_XJL>BC
ME78.:7<V/^$M\2_]##JW_@;)_P#%4?\ "6^)?^AAU;_P-D_^*K'HHY5V#FEW
M-C_A+?$O_0PZM_X&R?\ Q5'_  EOB7_H8=6_\#9/_BJQZ*.5=@YI=S8_X2WQ
M+_T,.K?^!LG_ ,51_P );XE_Z&'5O_ V3_XJL>BCE78.:7<V/^$M\2_]##JW
M_@;)_P#%4?\ "6^)?^AAU;_P-D_^*K'HHY5V#FEW-C_A+?$O_0PZM_X&R?\
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M_@;)_P#%4?\ "6^)?^AAU;_P-D_^*K'HHY5V#FEW-C_A+?$O_0PZM_X&R?\
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M_@;)_P#%4?\ "6^)?^AAU;_P-D_^*K'HHY5V#FEW-C_A+?$O_0PZM_X&R?\
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M_@;)_P#%4?\ "6^)?^AAU;_P-D_^*K'HHY5V#FEW-C_A+?$O_0PZM_X&R?\
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M_@;)_P#%4?\ "6^)?^AAU;_P-D_^*K'HHY5V#FEW-C_A+?$O_0PZM_X&R?\
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M_@;)_P#%4?\ "6^)?^AAU;_P-D_^*K'HHY5V#FEW-C_A+?$O_0PZM_X&R?\
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M_@;)_P#%4?\ "6^)?^AAU;_P-D_^*K'HHY5V#FEW-C_A+?$O_0PZM_X&R?\
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M_@;)_P#%4?\ "6^)?^AAU;_P-D_^*K'HHY5V#FEW-C_A+?$O_0PZM_X&R?\
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M_@;)_P#%4?\ "6^)?^AAU;_P-D_^*K'HHY5V#FEW-C_A+?$O_0PZM_X&R?\
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M_@;)_P#%4?\ "6^)?^AAU;_P-D_^*K'HHY5V#FEW-C_A+?$O_0PZM_X&R?\
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M_@;)_P#%4?\ "6^)?^AAU;_P-D_^*K'HHY5V#FEW-C_A+?$O_0PZM_X&R?\
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M_@;)_P#%4?\ "6^)?^AAU;_P-D_^*K'HHY5V#FEW-C_A+?$O_0PZM_X&R?\
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M_@;)_P#%4?\ "6^)?^AAU;_P-D_^*K'HHY5V#FEW-C_A+?$O_0PZM_X&R?\
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MM:*\Z6[/9C\*/E.BBBO3/%"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** /JSPE_R)FA?]@^W_\ 1:T4>$O^1,T+_L'V_P#Z+6BO,ENSVH_"CY3H
MHHKTSQ0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MYD[HXBBBBMCG"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MOILJSI9(ZO.F"CLQ'"GN!CK[T*<N?E:T"5.FJ2DGJ>=4445L<X4444 %%%%
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M !1110 4444 %%%% !6C:>']:U"W%Q9:1J%S Q($D-L[J<=>0,5G5]&?"/\
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MH(!.6('4BK>N>#M>\-VT=QJUA]GBE?8C>=&^6QG'RL?2NM^"7_(YWG_8/?\
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M5\5/^2;ZM_VQ_P#1R54ZCC-174BG1C*FY/H?-E%%%;'.%%%% !1110 4444
M%%%% !1110 4444 %%%% !6CI&A:KKUP8-+L9KIU^]Y:_*F<XW,>%Z'J:30]
M)FUW6[/2X"%DN90FX]%'=O? R<>U?3MO;:1X.\.,L:K:Z?9QEW;&2?5CW+&L
M:E3DT6YO1H^TNWHD?/MS\-?&%K;F>31)F0#.(I$D;_OE6)_2N5961V1U*LIP
M01@@U],>'?B)H'B;4GT^REFCN1N\M9TV^<!U*\G/'.#@XSQP:Y'XR>%;9].7
MQ';1+'<QNL=T5&/,4\*Q]P<#Z'V%3"J^;EDC2IAX\G/3=SQ2BBBN@Y HHHH
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MCHTHRG)O9%&#P5X7M[=8$T#3BBC:#);J[?BS DGW)K U#X3>'+O6+:]BMQ!
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MKZ5W,_P@\-2ZQ!<1PO!8QQX>U25SYKYZEF8D#'88^HQSSWP)_P"8_P#]N_\
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M *)2N;TG5KW1-2AU#3YVAN(CD,.A'<$=P?2ND^*G_)2-6_[8_P#HE*XZM(?
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M\:\]^"?A]9KN\U^9 P@_T>W)[.0"Y^NT@?\  C5PJ_N[O=$5*'[Y);,Z77_
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MM<+\*_!V@^)-$O;C5K#[1+%<[$;SI$PNT''RL/6NZ^*__).M1_WH?_1BUA?
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"2WGDM;F*XA;;+$X=&
MP#A@<@\U]5Z5J-CXI\.Q7<:K+:7D)62-\'J,,C#\P:^4*ZKP5XYOO!UZVP&X
ML)CF>V+8!/\ >7T;^??MC&K3YUIN=&'JJF[/9FEX\^'EUX1G&HV#R3:6S\2#
M[]NV> WMTPWKQP<9X:662>9Y99&DD=BSNYR6)Y))[FOJ_2-9TSQ+I8NK&:.Y
MMI!M=3@E21RK#L<'I7B'Q-\!+X:N5U/34;^S+ARK)_SP?J!_NGG'IC'IF:56
M[Y9;EUZ%ESPV.Z^%/AK2(_#&FZ^MIC5)%F5I_,?D>8R_=SMZ #I7;ZSHFG>(
M+ V.IV_GVQ8/LWLO(Z<J0:\1^$6J:@WBZVTYK^Z-BL,I6V,S>6#C/"YQU)->
MC_%:_O-.\%-/8W<]K-]HC'F02%&P<\9'-95(OVEKF]*<?8WML>,^*- 6+Q_>
M:'HEHQ'G+'! K%CRH/5C[DY)XKV#PO\ "K0]%M5;4H(M3OF!WO,N8QGLJ'CC
M'4\]>G2N.^#=J=5\3ZEK-]*]S=V\*A9)F+MN?(W9/.=JD?0FNJ^+/BV[\/:1
M;66G2M#=WQ;,R_>CC7&=ISPQ)&#]>AP:N;DY*FC.E&"BZLD='?>!/"U_;M#+
MH5C&"/O00B)A]"N#VKG]*^$/ANSCN8[^W:_S,6@D>9T98]JX5MA )!W<X[UX
M-;:E?6=]]NM[N>*ZW;C,KD,3G))/?FOH[X=>))O$_A.*ZNV5KR&1H)V"XW,,
M$''NI&<<9STZ5,XSIK1E4ITZLK..IYQJWA'0[;XNZ9H<-CMTV>)6DA\USN)#
M_P 1;=V'>O9M)TFQT/3H]/TZ#R+6,DI'O9L9))Y8D]2:\/\ B[=7%G\0HKBU
MGE@G2TC*21.59>6Z$<BO3_AG>75_X"L+F\N9KF=FEW2S.78XD8#)//2BHFX*
M5QT7%5)12,/XI>%-$7PUJWB 67_$TS$?/\U_[Z)]W.W[O'2J?@#P!X8UOP3I
MVHZCIGG74WF;Y//E7.)&4<*P'0"N+^)^KZF?&FKZ:=1NS8[H_P#1O/;RON(W
MW<XZ\].M>L_"O_DF^D_]MO\ T<].7-&FM28<DZSTZ?J>#>+K"VTOQ;J=C9Q>
M5;03E(TW%MH^IR:ZWX3^%]&\32ZJNKV?VD0+$8_WKIMSNS]TC/05S?C[_D?-
M:_Z^6KO/@5_K]<_W8/YO6LVU3N84HIUK-::F/\6/"^C>&9=*72+/[,)UE,G[
MUWW8VX^\3CJ:L_#7X<6GB"R.LZR)'LRY2"W5]HEQP68CD 'C P<CTZWOCJP^
MTZ&N>0DQ_5/\*W?@[K]E=>&%T42!;VS9V,9X+HS$[AZX)P?3CU%9N4O9)HU4
M(/$-/8ZQO!?AAX#"?#^F[2,9%L@;_OH#/ZUX[\3? 5EX6,&HZ9-MM+B3R_LL
MCY9&P3E2>2N!WY!QR<\=;XK^'FNCQ%/XF\,ZH_VYWWF%WV-T PK="./NM@8X
MR:\J\6ZOK>KZ],^O*\5W%\GV=E*"(=<!3T'?WSFBDG>ZD&(DN5IQL^AA4445
MU'$=S\)=2M].\=P+<L%%U$UNC'& Y(*_F5Q]2*]9^)F@ZKXB\,1V6DG,GVI&
MEB+[0Z<CGU )#8/IGJ!7B'@OPK?^*M;6WLIFME@ EENL$^3SP1C'S9Z#(Z'T
MKZ>B0QQ(C.TC*H!=NK'U.*Y*SY9IK<[\-%RIN+V,VT*^'O"\']IWF_[%:J)[
MAV^\54 G)]3TS7RSJ-R+W4[N[ P)YGD /;<Q/]:]>^-<FN+;VD:<:&W,AC!R
M9<\!SZ8QCWSZ"O&=K%"X4[00"<< GI_(_E5T(V7-W,L5.\E#L)11170<H5]>
MV/\ R#[;_KDO\A7R%7U[8_\ (/MO^N2_R%<N)Z';@MY'R%77?#WQ7<^&O$<"
M>8YL+J18[B(<@YX# >HS^5<C170TFK,XXR<7='U/XST9-=\(ZC8LJF0PEXBW
M:1?F7GMR,?0FOEN**2>9(HHVDD=@J(@R6)X  [FOKM\K9-O."(SN)/M7@GP<
MTF*_\8M=S!66Q@,J*>?G)V@_@"3]<5S49<L6SNQ,.:<4NIVOA+X1:;IT$=SK
MRK?7K#/DY_=1<=/]H^YX]NY[+_A#_#.P)_PC^EX Q_QZ)G\\9IGBNU\0WNE"
MV\.75I:7#MB2>=F!5?\ 8PIY/J>@]^1Y6/A'XS%XMX-:LA=+]V;[5-O'7HVS
M/<_G4)N>LI6-&E3]V,+F]XQ^$-C=6LU[X<0VUXHW?9-W[N7J2%S]T\\<[> ,
M#K7B+0RK.8&B<3!MAC*G<&SC&.N<]J^H_"5GK^GZ,MIXAN[:[N8FVQSPLS%D
MQQO+ 9;KSW&,\Y->,_%;3TT3Q^+VUBVBY1+O!7"&3<0W3U*@GOECZUK1F[\K
MU,,127*II6/0_"7PKT;2;"&;5[5+_464-()OFCC/]T+T..F3G..V<5M:I\/?
M"VJVK0/H]M;G!VRVD8A=3C&<J,'KT((]JO6M[8^,?"S2VES(MO?0-&S1L!)$
M6&".^&&:\KF\->-_AQ'=S:'<_;].D1MYC3)C) &\Q$G##U&[A>>.*R7-)ZNS
M-Y*,(JT;HX/Q9X?/ACQ%<:7]JCN%CPRNAYVGD!AV;';_ !KW"'X8>#FTZ.4Z
M/ES"&)^TS=<9_OU\[RRR3S/++(TDCL6=W.2Q/))/<U];0?\ ((B_ZX#_ -!K
M6LY12U,,-&,G+0^2K>WEN[F*V@C:2:5Q'&B]68G  _&O=_"?PDTK3K..XUV(
M7U^P#-&S'RHCZ #[Q]2<CT%<'\';&*\\="60 FTM9)TS_>RJ?R<UZ?\ $_Q1
M=>&?#*FP;9=W<GDI)GF-<$LP]^@]LYHJRDY*$0H0@H.I,V;CP5X7N86BDT#3
M@K J3';K&W/H5 (/N*YRP^$'AJVNKQKJ!KR"1PUNKRNC0CNN58;AGH3S_,^"
MOJ>H2WRWTE]<O=J<B=I6,@_X%G->[_";Q7>>(=&N;/49&FNK!D G;K)&P.W)
M[L"IR?3'4Y-3.$X1NF73J4ZLK.)Y[\5?#>D^&]6L(-)M/LT<L!=U\QWR=V/X
MB:ZKX=> _#6N^#K:_P!2TWS[IY) S^?(N0&('"L!65\<?^0[I?\ U[-_Z%7<
M?"/_ ))[9_\ 767_ -#-.4G[).XH0BZ[5M""R^$7ARWUJXOIH6FMBP-O9EV\
MN+ ')).7)()Y..<8-=!<^"/"]W;-!)H.GJK#&Z*!8V'T90#^M>4?&'Q/>7'B
M!_#\4LD=E:HAE0' E=@'R>>0 5QGOGVK1^"6MW,MYJ&D3W$DD0A6:%'8D1[3
MM.WT'S+^52XSY.=LN,Z:J>S43COB#X-/@_6TCA9I+"Z4O;NW48/*'U(R.?0C
MWK/\)>%+WQ=K L;4^7$J[IK@KE8E[9]23P!_0&O4/CE"K:+I4Y W)<,@XYPR
MY//_  $5J?!S3(;3P4+Y5!FO9G9VQSA255?H,$_\"-:>U:I\W4Q]@G6Y>AM:
M3\//"^DVBP+I-O=,.6ENXQ*S'&,_,,#Z# J#7/AGX9UJV9$T^*PGQ\DUFHCV
MGCJH^4CCN/7!&:\[^+?C&_FUR;P_9W$D-E;J!.(SM\YV7)!(/*@$#'KG.>*X
M30?$NK>&[Q;G3+MX\'+Q$YCD''#+WZ?7T-1&G-KFOJ7.M2B^3ET/=;#X4>%(
MM/MH[W3%GNDB59I5N)@'< ;F W<9.37"^ /".AZWXF\16>HV/G06<NV!/-==
M@WL.JL"> .M>U:=>Q:EIEK?P_P"JN84E3Z, 1_.OF#4=5U'2_$VKMI]_=6C2
M7<H<V\S1EL.<9P1FBFY2NKCK*$.5VT/J;8OE[,?+C&/:O$_B#X.T'0];\,V^
MG6'D17MRR7"^=(V]0T8Q\S''WCTQUKVC<?L6[)W>7G/X5\O:=J^I:KXDT?\
MM'4+N\\N[CV?:)FDVY=<XW$XS@?E4T$[MIEXF4;)-;GL/B;X;^$]/\+:K>6N
MD^7<06DDD;_:)3M8*2#@M@UX/:VL]]=16MK$\T\K!4C09+$]J^HO&?\ R).N
M?]>,W_H!KR;X)Z3'=^(;[4I K?8H0J KG#.3\P/; 5A_P*KI3:@Y,RKTDZD8
MQ5KG5>%?A#I5C:13Z]']MOCAVBWD11GKC QN]\\''3UZ^3P;X8EB,3>'],"D
M8RMJBG\P,URWQ9\77OA[2[:QTZ1H;F^W[IU/S1HN,[3V)SU[<XYY'A5MJ5]9
MWWVZWNYXKK=N,RN0Q.<DD]^:483J+F;*G4ITGR*-SUOQE\'X$M9+[PWN1HU+
M-9.Q;?\ [C$YSCL<YKQJOIKX>>)9/%'A2&[N3F[A<P3MTW, #N_$$'COFO%/
MB;H\&C>.;R*V0)!.%N%0=%+?>Q[;@?ITJZ4Y7<)&6(IQY54ALSUVW^%W@^6P
MB<Z/^\>('/VF;J1_OT>'/A9X>T2!3=VZ:G=D?/+<IE.W"IT X[Y/7GM78V/_
M "#[;_KDO\A7S!XJ\57WB;7I+^6>41)(?LL62!"F>,#/!X!)'>LJ:G.ZN=%5
MTZ23Y=3WO6OASX9UBS:$:9;V<NT[)K2,1E3V.%P&^AKYVUS2+G0=:N]+NP/.
MMI-I(Z,.H8>Q!!_&O?\ X5ZQ/K'@B%KJ9YI[:9[=I')+'&&&2>O# ?A7EOQA
MA6+Q]*Z@9EMXG; QS@KSZ\**NBY*3BS+$1C*FJD4=[X+^%6E6.G07NMVPO-0
MD4.893F.'(^[M'#'GDG(XXQ73ZAX"\+:C;-!)HEG$".'MHA"P/KE<?KQ4_A_
M6;+Q7X9CN;.=@LL7E2A&P\+XP1[$=1^!KS.3P=XR^'UQ-?>&KK^T+)E/F0A?
MFZ=6BS\Q'8KD\=,9%9WE)N[LS9J,(JT;HX7QKX9'A/Q'+IJ72W$102Q-GYE4
MDX#CLW'XC!XSBN=J:ZNI[ZZENKJ5YIY6+/(YR6)[U#7:KVU/-DTW=!1113$%
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 ?5GA+_D3-"_[!]O\ ^BUHH\)?
M\B9H7_8/M_\ T6M%>9+=GM1^%'RG1117IGBA1110 4444 %%%% !1110 444
M4 %%%% !1110!]>V/_(/MO\ KDO\A7R&JL[JB*69C@ #))KZDL_%GAQ;&W5O
M$&E!A&H(-Y'D<?6IF\7^&E&3XATK\+R,_P!:X:<W"^AZ=:G&K;WK6/&OAY\/
M-3U#7+;4M3M9[.PM)%E'FIL:9U((4 \[?4XQU YZ>J?$37!H7@J_F5]MQ.GV
M>##;3N?@D'U RWX5#J_Q.\*Z3 7&HK>R_P ,5H/,+<XZ_='XGZ9KPWQAXPOO
M&&IK=72+##$"L$"G(C!Z\]R<=:M1E4E>2T,I2A1@XQ=VST#X$_\ ,?\ ^W?_
M -JU5^.:D:KI#[B08) %],,.?U_2F_!?5]-TK^V_[1U"TL_,\C9]HF6/=CS,
MXW$9QD?G4'QEU73M4OM);3[^UNUCCD#FWF60+DKC."<55G[:_P#6Q-U]6M_6
MYYWI5PEGJ]E<R?<AG21OH&!-?4_B*RDU'PUJEE"H::XM)8XP3C+%"!^N*^3:
M]\^'WQ(T_4M*M].UB\BM]2A78'E(1)E'"D,>-W3CN>E.O%NTET%A9Q5XOJ>"
M,K([(ZE64X((P0:^IO!=G)8>"]'MID>.5;5"Z.,,I(R01V(STJ\VF:3+=KJ3
M6-D]R!\MT84+CMP^,]_6N0\<_$?3M#TNXM=+O8KC5G!C00D.(#T+,>@(YX]>
MHQFLYS=6T4C:G35"\I,\6UJ^^S>/M1OT4-Y>J23*I/7$I.*^F)H[7Q!H#QAM
MUI?VQ 8=T=>OY&ODJO3/AY\31X?MQI.L^9)IZY,,RC<T/^R1W7]1[CII5IMI
M-=###U5&34MF<7X@\,ZIX:OY+;4+:1%#$1S;?DD&3@@].<9QUKL_A5X.U&Z\
M0VNN7-L\.GVN71I5QYS%?EVY[<@YZ<5ZY%XT\,31>8OB#30OH]RBG\B0:H)\
M0=%O/$]CH6F2B^GN&822Q']W$ A;.['S'CMQUYXQ4.K-QM8UC0IQDI<Q7^*_
M_).M1_WH?_1BU\^:5INH:KJ,5IID$DUVQRBQ\$8YSGMCUKZ ^+3%?AY? ?Q2
M1 _]]@_TK@_A'XHT'1#=6>I;+6[N'W)>28"% !\A;^'G)]#]<4Z3<:;:1->*
ME62;L0>'OBOKOA^==/UZ"2\@B(1A*-EQ$..Y^]@9.&Y/J*]:\7Z+;^)?"5Y;
M21H7,)EMWD&/+D RI]1Z'V)K4FL-,OI8KN>TM+B2+)CF>-7*9ZX8]*X?XC^/
MM.TO1;K2K&Y2XU&ZC:$B%P?(!&"6(Z'!X'6L[\\ERJS-K>S@^=W1\_T445W'
MF!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %>]_!+_D3+S_ +"#_P#HN.O!*]K^#^N:1IGA*ZAO]5L;
M25KYW"3W"1L5\N,9P3TX/Y5C75X'1A6E4U.6^,W_ "/2_P#7I'_-J]1^%?\
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M[-XR^(GA[1]/GM UOJMU(&C-HF)$!Z'S#T SP1U]NX^=Y7\V9Y-BIN8MM08
MSV ]*VA)SB[JQSU(QI27*[GT[X\T.?Q%X.OM/M.;DA9(E)QO92&V_C@CZD5\
MQ2Q203/%+&T<B,5='&"I'!!'8U[MX!^)]GJEG%INN7"6VHQ@(L\C82X'0')Z
M-Z@]>HZX'=W>EZ/?NEY>6%A<,G*S30HY7W#$<5A&;I>ZT=-2G&O:<6>3_!30
M+L7]WKTJ-':^2;>$L/\ 6L6!8CV&W'U/L:U_CA_R+>F_]??_ +(U=1'\0?#+
MZX=+CU2T"QPF1[EIE6$$%0$#$X8D,3P>,'\.)^,6MZ5J>@:?'I^IV5W(MUN9
M;>X60@;3R0">*$Y2J)M!)1A1<4[D/P*_U^N?[L'\WH^.O^OT/_=G_FE4_@SJ
MVFZ7-K)U#4+2T$BP[/M$RQ[L%\XR1GJ*/C-JVFZI-HQT_4+2[$:S;_L\RR;<
ME,9P3CH:NS]M?^MC.Z^K6_K<Z#X'_P#(MZE_U]_^R+7)?&K_ )':#_KQC_\
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ME3=D(V,D9/8'-95U:7,C?"2YHN+Z'G/QF\0FPT&#1H&(FOVW2D=HE/3\6Q^
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MM9ZQI]S.S1;8H;E'8XD4G !STK&^#NMZ5IF@:A'J&IV5I(UUN5;BX6,D;1R
M2.*Q2?LGZG0Y+ZPG?H8'QJ_Y':#_ *\8_P#T-Z]>\#?\B+HG_7I'_*O&/B[J
M%EJ7B^&>PO+>ZA%FBF2"574'<_&0>O(KU/P;XFT"U\&Z1!<:YIL,T=JBO')=
MQJRG'0@G(-543]G$FDU[:3/!/$__ "-FL_\ 7]/_ .C#7IOP)_YC_P#V[_\
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MO#>IVC7']K65LOF,BI<W"1NP!QNVDY /49[5%2HYK1:&E&C&E*[>IXC\5/\
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MM?TV21U2-+J)F9C@* PR2?2OH?Q1XH\/W'A+688==TR262QG1$2[C+,QC8
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M,_$.B6'@*PMKS6-/MIU:7=%-<HC#,C$9!.>E5-/V2(I->WDSR[XG?\E%U?\
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MGH&GQZ?J=E=R+=;F6WN%D(&T\D GBN"\#>,9_!VLFX"&:RG 2YA!Y(!X9?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 =O\+/#O\ ;OB^*>9-UII^+B3/0L/N+_WU
MS]%->H?%CQ&-%\)O91L/M.HAH%'I'CYSU]#C\:\4T/QAKOAN"6'2+X6T<K;W
M'DQODXQU92:KZYXBU7Q)=1W.K79N98T\M#L5 %R3T4 =^M8RIN4^9['1&M&%
M)Q6[,NBBBMCG"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** /JSPE_R)FA?]@^W_\ 1:T4>$O^1,T+_L'V_P#Z+6BO,ENSVH_"
MCY3HHHKTSQ0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#ZL\)?
M\B9H7_8/M_\ T6M%'A+_ )$S0O\ L'V__HM:*\R6[/:C\*/E.BBBO3/%"BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_P ;KTFBCVL^X>PI]CS;_A27AK_G^U;_ +^Q_P#QNC_A27AK_G^U;_O['_\
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M  I+PU_S_:M_W]C_ /C='_"DO#7_ #_:M_W]C_\ C=>DT4>UGW'["GV/-O\
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M_P"?[5O^_L?_ ,;KTFBCVL^X>PI]CS;_ (4EX:_Y_M6_[^Q__&Z/^%)>&O\
MG^U;_O['_P#&Z])HH]K/N'L*?8\V_P"%)>&O^?[5O^_L?_QNC_A27AK_ )_M
M6_[^Q_\ QNO2:*/:S[A["GV/-O\ A27AK_G^U;_O['_\;H_X4EX:_P"?[5O^
M_L?_ ,;KTFBCVL^X>PI]CS;_ (4EX:_Y_M6_[^Q__&Z/^%)>&O\ G^U;_O['
M_P#&Z])HH]K/N'L*?8\V_P"%)>&O^?[5O^_L?_QNC_A27AK_ )_M6_[^Q_\
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M_P"%)>&O^?[5O^_L?_QNC_A27AK_ )_M6_[^Q_\ QNO2:*/:S[A["GV/-O\
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M9S*$Q)(A&"">R#TKBW\*6*NRB6YP#C[R_P"%>X>-_P#D!Q_]=U_]!:O+9?\
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M_P"^E_PK<HH]C3[!]9K?S&'_ ,(K8_\ /6X_[Z7_  H_X16Q_P">MQ_WTO\
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M\(K8_P#/6X_[Z7_"MRBCV-/L'UFM_,8?_"*V/_/6X_[Z7_"C_A%;'_GK<?\
M?2_X5N44>QI]@^LUOYC#_P"$5L?^>MQ_WTO^%'_"*V/_ #UN/^^E_P *W**/
M8T^P?6:W\QA_\(K8_P#/6X_[Z7_"C_A%;'_GK<?]]+_A6Y11[&GV#ZS6_F,/
M_A%;'_GK<?\ ?2_X4?\ "*V/_/6X_P"^E_PK<HH]C3[!]9K?S&'_ ,(K8_\
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M_P (K8_\];C_ +Z7_"C_ (16Q_YZW'_?2_X5N44>QI]@^LUOYC#_ .$5L?\
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M_P"?[5O^_L?_ ,;H_P"%)>&O^?[5O^_L?_QNO2:*/:S[A["GV/-O^%)>&O\
MG^U;_O['_P#&Z/\ A27AK_G^U;_O['_\;KTFBCVL^X>PI]CS;_A27AK_ )_M
M6_[^Q_\ QNC_ (4EX:_Y_M6_[^Q__&Z])HH]K/N'L*?8\V_X4EX:_P"?[5O^
M_L?_ ,;H_P"%)>&O^?[5O^_L?_QNO2:*/:S[A["GV/-O^%)>&O\ G^U;_O['
M_P#&Z/\ A27AK_G^U;_O['_\;KTFBCVL^X>PI]CS;_A27AK_ )_M6_[^Q_\
MQNC_ (4EX:_Y_M6_[^Q__&Z])HH]K/N'L*?8\V_X4EX:_P"?[5O^_L?_ ,;H
M_P"%)>&O^?[5O^_L?_QNO2:*/:S[A["GV/-O^%)>&O\ G^U;_O['_P#&Z/\
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MBCVL^X>PI]BMIUC%IFF6EA"SM%:PI"A<@L550!G'?BBK-%9FNP4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<+)_R40?]=1_
MZ *[JN%D_P"2B#_KJ/\ T 4T)G=4444AA1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M HHHH **** "BBB@ HHHH **** "BBB@ KA;W_DHB?\ 76/_ - %=U7"WO\
MR41/^NL?_H IH3.ZHHHI#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M $;[I^E</X$_X_;O_KF/YUW#?=/TKA_ G_'[=_\ 7,?SIB>YW-%%%(84444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 5PLG_ "40?]=1_P"@"NZKA9/^2B#_ *ZC
M_P! %-"9W5%%%(84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 (WW3]*X?P)_Q^W?_ %S'\Z[AONGZ5P_@3_C]N_\
MKF/YTQ/<[FBBBD,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M'8W"*H()QQAC5NG)*[1FJL&[)G54445!H%%%% !1110 4444 %%%% !1110
M5PLG_)1!_P!=1_Z *[JN%D_Y*(/^NH_] %-"9W5%%%(84444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% '-^-_^0''_ -=U_P#06KRV7_6O_O&O4O&__(#C_P"NZ_\ H+5Y
M;+_K7_WC7J97\4CP<\^"'J,HHHKV3YL**** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MW;L_[(QTKKJ)1<79BC)25T%%%%(H**** "BBB@ HHHH **** "BBB@ HHHH
M***P?%'B_2O"=HLVH2DR29\J",9=R!Z=A[GUII-NR$VHJ[-ZBO,5^*^I31&Z
MM_!.I2V.,BX#-C&/:,C]:Z?PIX[T?Q:A2T=X;M1E[:; ?'&2,'!'/U]A5.G)
M*[1$:L).R9T]%%%0:!1110 445S7C?Q9_P (;HL.H_8OMGF7"P>7YOEXRK-G
M.#_=Z>]-)MV0I245=G2T56TZ[_M#2[2]V>7]HA279G.W<H.,]^M6:0PHHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M.X(R*\0^-FGPV_B2ROHT"R75N1+C^(H< GWP0/P%=Q\'[^2]\")%(2?LES)
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M!CKVK11BDG)[F+J2<FH+8] KR;XP:YI&I^$K6&PU6QNY5OD<I!<)(P7RY!G
M/3D?G7H7AC3;_2/#]K8ZE?M?740(>8_7@ GD@# R>?Y5Y=\4O!?A_P .>&;:
M\TG3_L\[WBQ,_G2/E2CDC#,1U ITDN<FNY.GHCT/PSXAT671-(LX]8T][HVL
M2>0MRA?<$'&W.<^U;,^JZ=:WL5E<:A:Q7<N#'!),JR/DX&%)R<D$?A7*^%?
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M-/!8^+K&2ZL=P1;U3N8CGH_1S['!XKT2_P#%VAZ7KMOH]Y?)#>3KN4-]U>>
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MY!&D_P#7=_\ T$5<6W55S.:2H.QZ9I4*6^CV4,:A8X[>-% &, * *MU7L/\
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M'-^T9)YBA@@#@$9&1;#!_#K^%:_P2_Y$R\_["#_^BXZS(?\ DXRX_P"N8_\
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M7%QI]Q>2O.@1A<.K  '/&%%=515<SM83A%RYK:A1114E!1110 4444 %%%%
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M&>1G-9?PG\)SZOXABUB:(BPL'WAV'#RC[H'K@X)]./6N_L_@UX6M9Q)(U_=
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M10 4444 %%%% '-^-_\ D!Q_]=U_]!:O+9?]:_\ O&O4O&__ " X_P#KNO\
MZ"U>6R_ZU_\ >->IE?Q2/!SSX(>HRBBBO9/FPHHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ H!(((.".]%% 'H_A+Q:+X)I^H/BY'$4K?\
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M:T"[N)+BXU+699I6+O(\\9+$]23Y=>BT549..Q$H1G\2/-O^%)>&O^?[5O\
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M[C3)[BX@AG 5V@8!B,YQD@\'OQ4/AOPW8>%=(73=/\PQ;VD9Y2"[L>Y( '0
M=.@%:]%%W:P<JOS=0HHHI#,?Q+X:L/%6DG3M0\T1>8LBO$P#HP[C((Z$CD'@
MUGWW@:RU#PI:>'9]0U'[';$882)YC@9VJQV8P,C& .@KJ**I2:)<(O5HHZ/I
M-KH6D6NF62D6]NFU=QR3W)/N223[FKU%%3N-*RL@KGO%?@W2_&%O;1:BUQ&U
MNY:.2!PK $<CD$8.!V["NAHIIM.Z"45)69%;0FWM88#+),8T"&24@N^!C+$
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MN_&7Q"T2-[[6/"EH;! 2_P!GD^91ZDAWP/?%=KX8\4Z;XKTS[;I[D%3MEA?
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !0"000<$=Z** /1_"7BT7P33]0
M?%R.(I6_Y:>Q_P!K^?UZ]E7@P)!!!P1WKT?PEXM%\$T_4'Q<CB*5O^6GL?\
M:_G]>OCXW!<O[RGMU1])EF9\UJ-9Z]'^C.RHHHKRCW@HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH ANHVFLYXD^\\;*,^I%<SX*T"^T+[=]M6,>=Y>S8V
M[INS_,5UE% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5PM[_R4
M1/\ KK'_ .@"NZKA;W_DHB?]=8__ $ 4T)G=4444AA1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% "-]T_2N'\"?\?MW_P!<Q_.NX;[I^E</X$_X_;O_
M *YC^=,3W.YHHHI#"BBB@ HHHH **** "BBB@ HHHH **\OU_P",/]AZ]>Z7
M_87G_9I#'YGVO;N]\;#C\ZS?^%[?]2W_ .3W_P!KK149O6QB\133LV>Q45Q7
M@7X@?\)I<7D7]F?8_LR*V?M'F;LDC^Z,=*H>,/BE_P (IK[Z7_8WVK;&K^;]
MJV9R,XQL/\Z7LY7Y;:E>VAR\]]#T2BO'A\=AD9\.$#N1>Y_]IUJZ9\:]"NI
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M!>6I7<(B=KJV<$ DD<@]SVHY)<O-T#VL>?DZG;4445!H%%%% !1110 4444
M%%%% !1110 445'<3Q6MO+<3R+'#$A>1V. J@9)/X4 245YA'\0?%/B2>9_!
M_AR.>RA;89[QL;C_ -]J >1QDGH>]:OA'XAMK6L2:#K&GMIVL)G$>3MD(&2
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH YOQO_P @./\ Z[K_ .@M7ELO^M?_ 'C7J7C?_D!Q_P#7
M=?\ T%J\ME_UK_[QKU,K^*1X.>?!#U&4445[)\V%%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4 D$$'!'>BB@#T?PEXM%\$
MT_4'Q<CB*5O^6GL?]K^?UZ]E7@P)!!!P1WKU/P9K-[JNG.MW$[&$A5N#TD]C
M[CU_R?&QV$4/WD-CZ;*\P=3]S4U?1_YG34445Y9[@4444 %%%% !1110 444
M4 %%%% !1110!%<RM#:32J 61&89Z9 KGO"/B2Y\0_;/M$,4?D;-OEYYW;NN
M3[5O7_\ R#KK_KD_\C7#_#+_ )BG_;+_ -GH ] HHHH **** "BBB@ HHHH
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M.V?4?ACUOXJ?\DWU;_MC_P"CDJ/9N$TBU552E)^1Y9\'&5/'#,Q 46<A))X
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MVEK=7VI1K;W6?(EB5I5DQC."@/K5C0_$>D^)+:6XTFZ^T11/L=O+9,-C./F
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M\?#O@^^O8VVW#+Y,')!WMQD?09;\*P_@_HPT[P8+UU FOY3*3WV#Y5'Z,?\
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M.?DW8&/09!I22<>9:%0;C+D;N=O11169L%%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110!S?C?_D!Q_P#7=?\ T%J\ME_UK_[QKU+QO_R
MX_\ KNO_ *"U>6R_ZU_]XUZF5_%(\'//@AZC****]D^;"BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MB@ HHHH **** "BBB@ HHHH **** "N%O?\ DHB?]=8__0!7=5PM[_R41/\
MKK'_ .@"FA,[JBBBD,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 1O
MNGZ5P_@3_C]N_P#KF/YUW#?=/TKA_ G_ !^W?_7,?SIB>YW-%%%(85E^(=&3
M7M$N-/9_++@%'_NL#D&M2BFG9W0FDU9GBG_"M_$GVLP_9X?+W8\_SEV8]<?>
MQ^%>J^'-#B\/:+%81OYC EY),8WN>I_D/PK6HK2=64U9F<*,8.Z"BBBLC4**
M** "BBB@#Y?\?_\ (^ZU_P!?+?TKWS2?"OAV31[%WT#2V=K>,LS6<9))4<GB
MO _'_P#R/NM?]?+?TKZ3T;_D!Z?_ ->T?_H(KIK-J,3APZ3G*X6.C:7I;.VG
MZ;9VC. '-O L98#IG &:\$^+_P#R/\__ %PB_E7T17SO\7_^1_G_ .N$7\JF
MA\9IBU:GIW/7?AI_R3O1_P#KF_\ Z,:NJ9E12S$!0,DD\ 5X1X:^+G_".^';
M/2?[#^T?9E*^;]KV;LL3TV''7UK.\3_%76?$5A)I\<,%E:2C;*L>6=QW!8]!
M] #[T.C)R8HXFG&"[G-ZY>/X@\5WMU;J6-Y=,85'!(+84?EBOJ33K7[#IEI:
M9!\B%(LCI\J@?TKQGX6> ;FXU&#Q!JD#16L!$EK&XP97YPV.H"G!'J<=J]'^
M(>N#0/!=]<+)LN)U^SP=<[WR.,="%W-^%.LU)J$18=.$74EU/"/'NO-XA\87
MUT'#01.8(",X\M20",^O)_&NG\-?%BW\-:!:Z5;^'=XA7YY/MF#(YY9B/+[G
MMS@8':L#X=>&HO$_BN*VNX6DL(4:6X 8KD8P!D<\L1TYQFO9O^%5^"_^@-_Y
M-3?_ !=:5)0C:$D94H59-U(NUSQ/QOXMB\8ZG!?KIGV*6.+RG_?^9O )(_A&
M,9/^17I/P4UTW.CWFBS29>T?S85/_/-CR!]&Y_X'6OJWPG\,3:3=1Z;IH@O3
M$WD2&XE8*^.,@MBO'/!.MGPSXRL[N;*1!S#<*W&$;@YSZ'!_"CW:D&H] M.E
M54I]3Z@KPSXE7,OBCXD6/AZVD_=PM';\-E0[D%F_ $ _[I^E>SZKJ,6DZ1=Z
MC-CR[:%I2"<9P,X^IZ?C7COPBTV76O%6H>)+UV>6W)(8G[TLF[)_ 9_,5C2T
M3GV.BO[S5-=3V>RM(K"PM[. $0V\2Q(#UVJ !^@KE?BI_P DWU;_ +8_^CDK
ML:X[XJ?\DWU;_MC_ .CDJ(?&C6K_  WZ'DOPGL+/4O&9@OK2"ZA^RR-Y<\8=
M<Y7G!&*]S_X1+PU_T+VD_P#@%'_\37SIX,\4?\(CKO\ :?V/[7^Y:+R_-\OK
MCG.#Z>E>@_\ "]O^I;_\GO\ [7715A-RO$Y,/4IQA:6YZS8Z=8Z9"T-A9V]I
M$S;RD$2QJ6P!G '7@?E7S#XSO/M_C36;CC!NY%4CNJG:/T KWWPEXT'BCPU>
M:RUC]D6VE>,Q^=YF=J*V<[1_>].U?/OAV&35?&&F1N2SW%[&7('JX+'C\32H
MIIML>)DI**CU/8/B7X;!^&EGY: 2Z.D6.3G9M",/_03_ ,!KS'0?%LFD>#M?
MT4%LWZKY/)PI/RR<>Z?R[U]':KIT6K:1=Z=-CR[F%HB2,XR,9^HZ_A7R9=6T
MMG=S6LZ%)H7:-U/4,#@C\Q3H/FBTR<2G"2E$]!^#6C?;_%DNHNH,6GQ%AG_G
MH^57]-Y_"LKXHV0L_B#J.W.V;9,,^K*,_KFO5_A'HW]F>"8[EUQ-?R&<Y_N_
M=4?D,_\  JXOXXVC)KVEWI'RRVS1 YZE&)/_ *&*(SO583IVPZ^\]5\'7HU#
MP;H]R"26M(U;/]Y1M;]0:\L^->O-/JEIH<3@Q6Z">4#/^L;( /T7G_@5=;\*
M]7B7X:^==2*D&G/,LC\G:@_>$GKT#?E7BEQ)>>+?%CNBEKK4;KY5_N[FX'T
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M['.7.!D#Z =Z?\)?^2B6/_7.7_T6U.,'&F[DSJ*I6BT>J?%S_DGMW_UUB_\
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MNU!_2N5^.7_(<TK_ *]F_P#0JZOX+_\ (CR?]?LG_H*4I?P4.'^\LD^,:AO
M;$CE;J,CZ\C^M<A\#?\ D.:K_P!>R_\ H5=C\8O^1"D_Z^8_ZUQWP-_Y#FJ_
M]>R_^A41_@L)_P"\(ZWXA?#=?%#?VEISI#JBKAPY^68 < ^C=@?SKR$CQ5X
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MA0N06*JH SCOQ5FBB[M8+*]S"LO"EC8^*[[Q&DUR][>1^5(LC@HJ_+]T8S_
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MMXUCBC&%5>@%2U\]B<3*O+R/L,%@H86%EK)[L****YCN"BBB@ HHHH ****
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MY[V[TD27$[EY'%Q*NYCU. P%=3123:V'**ENB*VMX;.UAMK>,1PPH(XT'15
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MYM%/1)$$H4^W(..G4GZUM3E"UGHSFJPJ<UXZKLRA_P )7\-O"R&Y\/:8+N^
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MAYU#XYZ[<MREI:B-.<X.(U_^*KTVJE'E(A/FNPHHHJ2PHHHH **** "BBB@
MHHHH **\S^$V;J^\5:H23]JO_P"1=O\ V>O3*J4>5V(ISYX\P4445)84444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !116)XRN1:>"]:F)(Q92J"!
MGYF4J/U(II7=A-V5S;HKD/AA;"V^'FEC'S2!Y#[Y=B/TQ6?\8K-+GP(\Y4EK
M6XCD4@=,G9^7S?RJE'WN4ASM3Y[=#OZ*R/"MVU_X2TBZ<DO)9Q%R>[;1G]<U
MKU+5G8M.ZN%%%%(84444 %%%% !1110!S?C?_D!Q_P#7=?\ T%J\ME_UK_[Q
MKU+QO_R X_\ KNO_ *"U>6R_ZU_]XUZF5_%(\'//@AZC****]D^;"BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBM_P ,^&9M<N/,DW1V
M49^>3NQ_NK[_ ,JBI4C3BY2>AI2I3JS4(*[8>&?#,VN7'F2;H[*,_/)W8_W5
M]_Y5ZK;V\-I;QV]O&L<48PJKT HM[>&TMX[>WC6.*,855Z 5+7SV)Q,J\O(^
MPP6"AA866LGNPHHHKF.X**** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@"&ZC::SGB3[SQLHSZD5R_@?0M0T3[?]NB6/SO+V8<-G&[/3ZBNNHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MH"8S"C!C\^.<L:[^B47%V80FIJZ"BBBI*"BBB@ HHHH **** "BBB@ HHHH
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MJ.EVE\B[5N84F"YS@,H.,]^M1**LI(TISDVXRW1Y7\/V5/BSXN9B H>Y))/
M'GUTFJ_%KPMI=T]NLUQ>.A*L;6,,H(.,98@'ZC(]Z\SL])O]?^*&OZ1:74EM
M;W5Y<"\>,<^2)22/Q.!Z<C->Z:1H6F:%:);:;9Q0(B[=RK\S?[S=3^-:5.5.
M[,:+FXM1TU,?PY\0O#WB:?[/:7+0W1^[!<@([>R\D$^P-=37E7Q:\.6MGIMO
MXDTR&.TOK6X3S)(1L+ GY6X_B#8YZX^@KT+P]J9UGP[IVHD8:XMT=QZ-CG]<
MU$HJW-$VA.7,X2W,_P +>--.\6R7T=A#=1FR*B3ST49W;L8PQ_NGTKAO&_\
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M%%% !1110 5PLG_)1!_UU'_H KNJX63_ )*(/^NH_P#0!30F=U1112&%%%%
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M9-KTN)8>-M?\.ZU!I7C:UB2&X.V'4(5^0MQUQQCGG@$9Z8KT'4;@VFEW=RI
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MA/&>=G]X9^]_A5KX29ENO%%T /+EOOEP<]W/7_@0J7XSS,?"]C91_P"LN;Y
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MZ>9F=MK2*A;^Z'( 'L.GX8[5RNJZ=XX^(TL-M>V"Z)HZRY99#EOJ5)#,0.G
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MHWC33M<\1:CHEM#=)<V!<2O*BA#M?8=I#$]?4"NCKR/X>_\ )6_%O_72X_\
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MWF&8XOLX XY 8OCZ9->RUK+W8)+J<\%S5)2?30****R.@Y#4?AUH]_XLM_$
M,MO-&WF2QP-L$K@Y#$CD'UQU_//7T44W)O<E14;V/&_B[_R.?AW_ '1_Z,%>
MR5XW\7?^1S\._P"Z/_1@KV2M)_!$RI?Q)_(YKQWXD/A?PK<7T1 NG(AM\C(\
MQLX/X $_A7+_  P\'A;9?%6L!KC4[PF6$RG<40_Q\_Q-USZ$>IK.^.LQ6VT.
M'^%WF<_4!!_[,:]8M+:.SLX+6+/EPQK&N>N ,#^5'PTU;J)+GJN_0FHHHK(Z
M#E?%O@'2?%TMO/=;X+F)@&FB W21YY0_T/;]*Z6VMTM+2&VC+E(D6-2[%F(
MP,D\D^]2T4W)M6)44FVCQOX1?\CGXB_W3_Z,->R5XW\(O^1S\1?[I_\ 1AKV
M2M*WQF6&_AA11161N%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 <-\7/\
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M /H(K9^#O_(A1_\ 7S)_2L;XY?\ ((TG_KN__H(IK^,3+_=OD>GV'_(.MO\
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MF3Z(/9RY&KZLX/P7XVM]!TZ#PYXH!TV[M44022*=DT1Y4Y P...?YY%=9?\
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MQ/.LMU=QC*J@ZX..@SDGUP.<UVNH_#[PKJMT]S=Z/$TSG+-&[QY/T4BM/2=
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M,O$Y^W?&KPQ8Y4K! 9^O0CS&Q_XX/SKTVLP^']+;7UUUK7.I+'Y:S&1N%QC
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M5TZ!I9-;LY=HR$MY!*S>P"YKD-!M]3\?^,K;Q/J%H]IH]A\UA&ZC,ISP<_4
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MI=K*R. ^#$'E^"YICR\]Y(Y8]3A5']#^=5_B8$O?%G@W3"_RR7A>50<';NC
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M>@]E"+B^:6EBJLU-<D-6S?\ %EM./@B8)!^_CL;7S![J8RW\C7,>"_AAX?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KA9/\ DH@_ZZC_ - %
M=U7"R?\ )1!_UU'_ * *:$SNJ***0PHHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@!&^Z?I7#^!/^/V[_ZYC^==PWW3]*X?
MP)_Q^W?_ %S'\Z8GN=S1112&%%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<+)
M_P E$'_74?\ H KNJX63_DH@_P"NH_\ 0!30F=U1112&%%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M &>@#T"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KA;W_DHB?]=8
M_P#T 5W5<+>_\E$3_KK'_P"@"FA,[JBBBD,**** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH 1ONGZ5P_@3_C]N_\ KF/YUW#?=/TKA_ G_'[=_P#7,?SI
MB>YW-%%%(84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &+_PEFB_\_9_[]/_
M (4?\)9HO_/V?^_3_P"%0_\ "&Z1_<F_[^4?\(;I']R;_OY3T%J3?\)9HO\
MS]G_ +]/_A1_PEFB_P#/V?\ OT_^%0_\(;I']R;_ +^4?\(;I']R;_OY1H&I
M-_PEFB_\_9_[]/\ X4?\)9HO_/V?^_3_ .%0_P#"&Z1_<F_[^4?\(;I']R;_
M +^4:!J3?\)9HO\ S]G_ +]/_A1_PEFB_P#/V?\ OT_^%0_\(;I']R;_ +^4
M?\(;I']R;_OY1H&I-_PEFB_\_9_[]/\ X4?\)9HO_/V?^_3_ .%0_P#"&Z1_
M<F_[^4?\(;I']R;_ +^4:!J3?\)9HO\ S]G_ +]/_A1_PEFB_P#/V?\ OT_^
M%0_\(;I']R;_ +^4?\(;I']R;_OY1H&I-_PEFB_\_9_[]/\ X4?\)9HO_/V?
M^_3_ .%0_P#"&Z1_<F_[^4?\(;I']R;_ +^4:!J3?\)9HO\ S]G_ +]/_A1_
MPEFB_P#/V?\ OT_^%0_\(;I']R;_ +^4?\(;I']R;_OY1H&I-_PEFB_\_9_[
M]/\ X4?\)9HO_/V?^_3_ .%0_P#"&Z1_<F_[^4?\(;I']R;_ +^4:!J3?\)9
MHO\ S]G_ +]/_A1_PEFB_P#/V?\ OT_^%0_\(;I']R;_ +^4?\(;I']R;_OY
M1H&I-_PEFB_\_9_[]/\ X4?\)9HO_/V?^_3_ .%0_P#"&Z1_<F_[^4?\(;I'
M]R;_ +^4:!J3?\)9HO\ S]G_ +]/_A1_PEFB_P#/V?\ OT_^%0_\(;I']R;_
M +^4?\(;I']R;_OY1H&I-_PEFB_\_9_[]/\ X4?\)9HO_/V?^_3_ .%0_P#"
M&Z1_<F_[^4?\(;I']R;_ +^4:!J3?\)9HO\ S]G_ +]/_A1_PEFB_P#/V?\
MOT_^%0_\(;I']R;_ +^4?\(;I']R;_OY1H&I-_PEFB_\_9_[]/\ X4?\)9HO
M_/V?^_3_ .%0_P#"&Z1_<F_[^4?\(;I']R;_ +^4:!J3?\)9HO\ S]G_ +]/
M_A1_PEFB_P#/V?\ OT_^%0_\(;I']R;_ +^4?\(;I']R;_OY1H&I-_PEFB_\
M_9_[]/\ X4?\)9HO_/V?^_3_ .%0_P#"&Z1_<F_[^4?\(;I']R;_ +^4:!J3
M?\)9HO\ S]G_ +]/_A1_PEFB_P#/V?\ OT_^%0_\(;I']R;_ +^4?\(;I']R
M;_OY1H&I-_PEFB_\_9_[]/\ X4?\)9HO_/V?^_3_ .%0_P#"&Z1_<F_[^4?\
M(;I']R;_ +^4:!J3?\)9HO\ S]G_ +]/_A1_PEFB_P#/V?\ OT_^%0_\(;I'
M]R;_ +^4?\(;I']R;_OY1H&I-_PEFB_\_9_[]/\ X4?\)9HO_/V?^_3_ .%0
M_P#"&Z1_<F_[^4?\(;I']R;_ +^4:!J3?\)9HO\ S]G_ +]/_A1_PEFB_P#/
MV?\ OT_^%0_\(;I']R;_ +^4?\(;I']R;_OY1H&I-_PEFB_\_9_[]/\ X5RC
MZG:'QD-0$O\ HOF!M^T]-N.F,UTO_"&Z1_<F_P"_E<P^E6H\7_V: WV?>%QN
MYQMSUH0G<ZW_ (2S1?\ G[/_ 'Z?_"C_ (2S1?\ G[/_ 'Z?_"H?^$-TC^Y-
M_P!_*/\ A#=(_N3?]_*-!ZDW_"6:+_S]G_OT_P#A1_PEFB_\_9_[]/\ X5#_
M ,(;I']R;_OY1_PAND?W)O\ OY1H&I-_PEFB_P#/V?\ OT_^%'_"6:+_ ,_9
M_P"_3_X5#_PAND?W)O\ OY1_PAND?W)O^_E&@:DW_"6:+_S]G_OT_P#A1_PE
MFB_\_9_[]/\ X5#_ ,(;I']R;_OY1_PAND?W)O\ OY1H&I-_PEFB_P#/V?\
MOT_^%'_"6:+_ ,_9_P"_3_X5#_PAND?W)O\ OY1_PAND?W)O^_E&@:DW_"6:
M+_S]G_OT_P#A1_PEFB_\_9_[]/\ X5#_ ,(;I']R;_OY1_PAND?W)O\ OY1H
M&I-_PEFB_P#/V?\ OT_^%'_"6:+_ ,_9_P"_3_X5#_PAND?W)O\ OY1_PAND
M?W)O^_E&@:DW_"6:+_S]G_OT_P#A1_PEFB_\_9_[]/\ X5#_ ,(;I']R;_OY
M1_PAND?W)O\ OY1H&I-_PEFB_P#/V?\ OT_^%'_"6:+_ ,_9_P"_3_X5#_PA
MND?W)O\ OY1_PAND?W)O^_E&@:DW_"6:+_S]G_OT_P#A1_PEFB_\_9_[]/\
MX5#_ ,(;I']R;_OY1_PAND?W)O\ OY1H&I-_PEFB_P#/V?\ OT_^%'_"6:+_
M ,_9_P"_3_X5#_PAND?W)O\ OY1_PAND?W)O^_E&@:DW_"6:+_S]G_OT_P#A
M1_PEFB_\_9_[]/\ X5#_ ,(;I']R;_OY1_PAND?W)O\ OY1H&I-_PEFB_P#/
MV?\ OT_^%'_"6:+_ ,_9_P"_3_X5#_PAND?W)O\ OY1_PAND?W)O^_E&@:DW
M_"6:+_S]G_OT_P#A1_PEFB_\_9_[]/\ X5#_ ,(;I']R;_OY1_PAND?W)O\
MOY1H&I-_PEFB_P#/V?\ OT_^%'_"6:+_ ,_9_P"_3_X5#_PAND?W)O\ OY1_
MPAND?W)O^_E&@:DW_"6:+_S]G_OT_P#A1_PEFB_\_9_[]/\ X5#_ ,(;I']R
M;_OY1_PAND?W)O\ OY1H&I-_PEFB_P#/V?\ OT_^%'_"6:+_ ,_9_P"_3_X5
M#_PAND?W)O\ OY1_PAND?W)O^_E&@:DW_"6:+_S]G_OT_P#A1_PEFB_\_9_[
M]/\ X5#_ ,(;I']R;_OY1_PAND?W)O\ OY1H&I-_PEFB_P#/V?\ OT_^%'_"
M6:+_ ,_9_P"_3_X5#_PAND?W)O\ OY1_PAND?W)O^_E&@:DW_"6:+_S]G_OT
M_P#A1_PEFB_\_9_[]/\ X5#_ ,(;I']R;_OY1_PAND?W)O\ OY1H&I-_PEFB
M_P#/V?\ OT_^%'_"6:+_ ,_9_P"_3_X5#_PAND?W)O\ OY1_PAND?W)O^_E&
M@:DW_"6:+_S]G_OT_P#A1_PEFB_\_9_[]/\ X5#_ ,(;I']R;_OY1_PAND?W
M)O\ OY1H&I-_PEFB_P#/V?\ OT_^%'_"6:+_ ,_9_P"_3_X5#_PAND?W)O\
MOY1_PAND?W)O^_E&@:DW_"6:+_S]G_OT_P#A1_PEFB_\_9_[]/\ X5#_ ,(;
MI']R;_OY1_PAND?W)O\ OY1H&I-_PEFB_P#/V?\ OT_^%'_"6:+_ ,_9_P"_
M3_X5#_PAND?W)O\ OY1_PAND?W)O^_E&@:DW_"6:+_S]G_OT_P#A1_PEFB_\
M_9_[]/\ X5#_ ,(;I']R;_OY1_PAND?W)O\ OY1H&I-_PEFB_P#/V?\ OT_^
M%'_"6:+_ ,_9_P"_3_X5#_PAND?W)O\ OY1_PAND?W)O^_E&@:DW_"6:+_S]
MG_OT_P#A1_PEFB_\_9_[]/\ X5#_ ,(;I']R;_OY1_PAND?W)O\ OY1H&I-_
MPEFB_P#/V?\ OT_^%'_"6:+_ ,_9_P"_3_X5#_PAND?W)O\ OY1_PAND?W)O
M^_E&@:DW_"6:+_S]G_OT_P#A1_PEFB_\_9_[]/\ X5#_ ,(;I']R;_OY1_PA
MND?W)O\ OY1H&I-_PEFB_P#/V?\ OT_^%'_"6:+_ ,_9_P"_3_X5#_PAND?W
M)O\ OY1_PAND?W)O^_E&@:DW_"6:+_S]G_OT_P#A1_PEFB_\_9_[]/\ X5#_
M ,(;I']R;_OY1_PAND?W)O\ OY1H&I-_PEFB_P#/V?\ OT_^%'_"6:+_ ,_9
M_P"_3_X5#_PAND?W)O\ OY1_PAND?W)O^_E&@:DW_"6:+_S]G_OT_P#A1_PE
MFB_\_9_[]/\ X5#_ ,(;I']R;_OY1_PAND?W)O\ OY1H&I-_PEFB_P#/V?\
MOT_^%'_"6:+_ ,_9_P"_3_X5#_PAND?W)O\ OY1_PAND?W)O^_E&@:DW_"6:
M+_S]G_OT_P#A1_PEFB_\_9_[]/\ X5#_ ,(;I']R;_OY1_PAND?W)O\ OY1H
M&I-_PEFB_P#/V?\ OT_^%'_"6:+_ ,_9_P"_3_X5#_PAND?W)O\ OY1_PAND
M?W)O^_E&@:DW_"6:+_S]G_OT_P#A1_PEFB_\_9_[]/\ X5#_ ,(;I']R;_OY
M1_PAND?W)O\ OY1H&I-_PEFB_P#/V?\ OT_^%'_"6:+_ ,_9_P"_3_X5#_PA
MND?W)O\ OY1_PAND?W)O^_E&@:DW_"6:+_S]G_OT_P#A1_PEFB_\_9_[]/\
MX5#_ ,(;I']R;_OY1_PAND?W)O\ OY1H&I-_PEFB_P#/V?\ OT_^%'_"6:+_
M ,_9_P"_3_X5#_PAND?W)O\ OY1_PAND?W)O^_E&@:DW_"6:+_S]G_OT_P#A
M1_PEFB_\_9_[]/\ X5#_ ,(;I']R;_OY1_PAND?W)O\ OY1H&I-_PEFB_P#/
MV?\ OT_^%'_"6:+_ ,_9_P"_3_X5#_PAND?W)O\ OY1_PAND?W)O^_E&@:DW
M_"6:+_S]G_OT_P#A1_PEFB_\_9_[]/\ X5#_ ,(;I']R;_OY1_PAND?W)O\
MOY1H&I-_PEFB_P#/V?\ OT_^%'_"6:+_ ,_9_P"_3_X5#_PAND?W)O\ OY1_
MPAND?W)O^_E&@:DW_"6:+_S]G_OT_P#A1_PEFB_\_9_[]/\ X5#_ ,(;I']R
M;_OY1_PAND?W)O\ OY1H&I-_PEFB_P#/V?\ OT_^%'_"6:+_ ,_9_P"_3_X5
M#_PAND?W)O\ OY1_PAND?W)O^_E&@:DW_"6:+_S]G_OT_P#A1_PEFB_\_9_[
M]/\ X5#_ ,(;I']R;_OY1_PAND?W)O\ OY1H&I-_PEFB_P#/V?\ OT_^%'_"
M6:+_ ,_9_P"_3_X5#_PAND?W)O\ OY1_PAND?W)O^_E&@:DW_"6:+_S]G_OT
M_P#A1_PEFB_\_9_[]/\ X5#_ ,(;I']R;_OY1_PAND?W)O\ OY1H&I-_PEFB
M_P#/V?\ OT_^%'_"6:+_ ,_9_P"_3_X5#_PAND?W)O\ OY1_PAND?W)O^_E&
M@:F5XIUS3M2TI(+2<R2"4,1L8<8/J/>O/I?]:_\ O&N]\3>'[#2],2>V60.9
M0AW-GC!_PKDZZL+B/8-NU[G!CL']:BH\UK>5S+HK4HKM_M/^Y^/_  #S/[#_
M .GGX?\ !,NBM2BC^T_[GX_\ /[#_P"GGX?\$RZ*U**/[3_N?C_P _L/_IY^
M'_!,NBM2BC^T_P"Y^/\ P _L/_IY^'_!,NBM2BC^T_[GX_\  #^P_P#IY^'_
M  3+HK4HH_M/^Y^/_ #^P_\ IY^'_!,NBM2BC^T_[GX_\ /[#_Z>?A_P3+HK
M4HH_M/\ N?C_ , /[#_Z>?A_P3+HK4HH_M/^Y^/_   _L/\ Z>?A_P $RZ*U
M**/[3_N?C_P _L/_ *>?A_P3+HK4HH_M/^Y^/_ #^P_^GGX?\$RZ*U**/[3_
M +GX_P# #^P_^GGX?\$RZ*U**/[3_N?C_P  /[#_ .GGX?\ !,NBM2BC^T_[
MGX_\ /[#_P"GGX?\$RZ*U**/[3_N?C_P _L/_IY^'_!,NBM2BC^T_P"Y^/\
MP _L/_IY^'_!,NBM2BC^T_[GX_\  #^P_P#IY^'_  3+HK4HH_M/^Y^/_ #^
MP_\ IY^'_!,NBM2BC^T_[GX_\ /[#_Z>?A_P3+HK4HH_M/\ N?C_ , /[#_Z
M>?A_P3+HK4HH_M/^Y^/_   _L/\ Z>?A_P $RZ*U**/[3_N?C_P _L/_ *>?
MA_P3+HK4HH_M/^Y^/_ #^P_^GGX?\$RZ*U**/[3_ +GX_P# #^P_^GGX?\$R
MZ*U**/[3_N?C_P  /[#_ .GGX?\ !,NBM2BC^T_[GX_\ /[#_P"GGX?\$RZ*
MU**/[3_N?C_P _L/_IY^'_!,NBM2BC^T_P"Y^/\ P _L/_IY^'_!,NBM2BC^
MT_[GX_\  #^P_P#IY^'_  3+HK4HH_M/^Y^/_ #^P_\ IY^'_!,NBM2BC^T_
M[GX_\ /[#_Z>?A_P3+HKK-!CTJYN/LVHJZ,Y_=RA\#/H?\:ZW_A#=(_N3?\
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M2/I7*^!M0M=&^W_;Y/*\WR]GRELXW9Z9]175?\(;I']R;_OY1_PAND?W)O\
MOY1H&I-_PEFB_P#/V?\ OT_^%'_"6:+_ ,_9_P"_3_X5#_PAND?W)O\ OY1_
MPAND?W)O^_E&@:DW_"6:+_S]G_OT_P#A1_PEFB_\_9_[]/\ X5#_ ,(;I']R
M;_OY1_PAND?W)O\ OY1H&I-_PEFB_P#/V?\ OT_^%'_"6:+_ ,_9_P"_3_X5
M#_PAND?W)O\ OY1_PAND?W)O^_E&@:DW_"6:+_S]G_OT_P#A1_PEFB_\_9_[
M]/\ X5#_ ,(;I']R;_OY1_PAND?W)O\ OY1H&I-_PEFB_P#/V?\ OT_^%'_"
M6:+_ ,_9_P"_3_X5#_PAND?W)O\ OY1_PAND?W)O^_E&@:DW_"6:+_S]G_OT
M_P#A1_PEFB_\_9_[]/\ X5#_ ,(;I']R;_OY1_PAND?W)O\ OY1H&I-_PEFB
M_P#/V?\ OT_^%'_"6:+_ ,_9_P"_3_X5#_PAND?W)O\ OY1_PAND?W)O^_E&
M@:DW_"6:+_S]G_OT_P#A1_PEFB_\_9_[]/\ X5#_ ,(;I']R;_OY1_PAND?W
M)O\ OY1H&I-_PEFB_P#/V?\ OT_^%'_"6:+_ ,_9_P"_3_X5#_PAND?W)O\
MOY1_PAND?W)O^_E&@:DW_"6:+_S]G_OT_P#A1_PEFB_\_9_[]/\ X5#_ ,(;
MI']R;_OY1_PAND?W)O\ OY1H&I-_PEFB_P#/V?\ OT_^%'_"6:+_ ,_9_P"_
M3_X5#_PAND?W)O\ OY1_PAND?W)O^_E&@:DW_"6:+_S]G_OT_P#A1_PEFB_\
M_9_[]/\ X5#_ ,(;I']R;_OY1_PAND?W)O\ OY1H&I-_PEFB_P#/V?\ OT_^
M%'_"6:+_ ,_9_P"_3_X5#_PAND?W)O\ OY1_PAND?W)O^_E&@:DW_"6:+_S]
MG_OT_P#A1_PEFB_\_9_[]/\ X5#_ ,(;I']R;_OY1_PAND?W)O\ OY1H&I-_
MPEFB_P#/V?\ OT_^%'_"6:+_ ,_9_P"_3_X5#_PAND?W)O\ OY1_PAND?W)O
M^_E&@:DW_"6:+_S]G_OT_P#A1_PEFB_\_9_[]/\ X5#_ ,(;I']R;_OY1_PA
MND?W)O\ OY1H&I-_PEFB_P#/V?\ OT_^%'_"6:+_ ,_9_P"_3_X5#_PAND?W
M)O\ OY1_PAND?W)O^_E&@:DW_"6:+_S]G_OT_P#A1_PEFB_\_9_[]/\ X5#_
M ,(;I']R;_OY1_PAND?W)O\ OY1H&I-_PEFB_P#/V?\ OT_^%'_"6:+_ ,_9
M_P"_3_X5#_PAND?W)O\ OY1_PAND?W)O^_E&@:DW_"6:+_S]G_OT_P#A7*7.
MIVDGC)=067-J)$._:>@4 \=>U=+_ ,(;I']R;_OY7,7.E6L7BY=-4-]G+HN-
MW."H)Y_&A"=SK?\ A+-%_P"?L_\ ?I_\*/\ A+-%_P"?L_\ ?I_\*A_X0W2/
M[DW_ '\H_P"$-TC^Y-_W\HT'J3?\)9HO_/V?^_3_ .%'_"6:+_S]G_OT_P#A
M4/\ PAND?W)O^_E'_"&Z1_<F_P"_E&@:DW_"6:+_ ,_9_P"_3_X4?\)9HO\
MS]G_ +]/_A4/_"&Z1_<F_P"_E'_"&Z1_<F_[^4:!J3?\)9HO_/V?^_3_ .%'
M_"6:+_S]G_OT_P#A4/\ PAND?W)O^_E'_"&Z1_<F_P"_E&@:DW_"6:+_ ,_9
M_P"_3_X4?\)9HO\ S]G_ +]/_A4/_"&Z1_<F_P"_E'_"&Z1_<F_[^4:!J3?\
M)9HO_/V?^_3_ .%'_"6:+_S]G_OT_P#A4/\ PAND?W)O^_E'_"&Z1_<F_P"_
ME&@:DW_"6:+_ ,_9_P"_3_X4?\)9HO\ S]G_ +]/_A4/_"&Z1_<F_P"_E'_"
M&Z1_<F_[^4:!J3?\)9HO_/V?^_3_ .%'_"6:+_S]G_OT_P#A4/\ PAND?W)O
M^_E'_"&Z1_<F_P"_E&@:DW_"6:+_ ,_9_P"_3_X4?\)9HO\ S]G_ +]/_A4/
M_"&Z1_<F_P"_E'_"&Z1_<F_[^4:!J3?\)9HO_/V?^_3_ .%'_"6:+_S]G_OT
M_P#A4/\ PAND?W)O^_E'_"&Z1_<F_P"_E&@:DW_"6:+_ ,_9_P"_3_X4?\)9
MHO\ S]G_ +]/_A4/_"&Z1_<F_P"_E'_"&Z1_<F_[^4:!J3?\)9HO_/V?^_3_
M .%'_"6:+_S]G_OT_P#A4/\ PAND?W)O^_E'_"&Z1_<F_P"_E&@:DW_"6:+_
M ,_9_P"_3_X4?\)9HO\ S]G_ +]/_A4/_"&Z1_<F_P"_E'_"&Z1_<F_[^4:!
MJ3?\)9HO_/V?^_3_ .%'_"6:+_S]G_OT_P#A4/\ PAND?W)O^_E'_"&Z1_<F
M_P"_E&@:DW_"6:+_ ,_9_P"_3_X4?\)9HO\ S]G_ +]/_A4/_"&Z1_<F_P"_
ME'_"&Z1_<F_[^4:!J3?\)9HO_/V?^_3_ .%'_"6:+_S]G_OT_P#A4/\ PAND
M?W)O^_E'_"&Z1_<F_P"_E&@:DW_"6:+_ ,_9_P"_3_X4?\)9HO\ S]G_ +]/
M_A4/_"&Z1_<F_P"_E'_"&Z1_<F_[^4:!J3?\)9HO_/V?^_3_ .%'_"6:+_S]
MG_OT_P#A4/\ PAND?W)O^_E'_"&Z1_<F_P"_E&@:DW_"6:+_ ,_9_P"_3_X4
M?\)9HO\ S]G_ +]/_A4/_"&Z1_<F_P"_E'_"&Z1_<F_[^4:!J3?\)9HO_/V?
M^_3_ .%'_"6:+_S]G_OT_P#A4/\ PAND?W)O^_E'_"&Z1_<F_P"_E&@:DW_"
M6:+_ ,_9_P"_3_X4?\)9HO\ S]G_ +]/_A4/_"&Z1_<F_P"_E'_"&Z1_<F_[
M^4:!J3?\)9HO_/V?^_3_ .%'_"6:+_S]G_OT_P#A4/\ PAND?W)O^_E'_"&Z
M1_<F_P"_E&@:DW_"6:+_ ,_9_P"_3_X4?\)9HO\ S]G_ +]/_A4/_"&Z1_<F
M_P"_E'_"&Z1_<F_[^4:!J3?\)9HO_/V?^_3_ .%'_"6:+_S]G_OT_P#A4/\
MPAND?W)O^_E'_"&Z1_<F_P"_E&@:DW_"6:+_ ,_9_P"_3_X4?\)9HO\ S]G_
M +]/_A4/_"&Z1_<F_P"_E'_"&Z1_<F_[^4:!J3?\)9HO_/V?^_3_ .%'_"6:
M+_S]G_OT_P#A4/\ PAND?W)O^_E'_"&Z1_<F_P"_E&@:DW_"6:+_ ,_9_P"_
M3_X4?\)9HO\ S]G_ +]/_A4/_"&Z1_<F_P"_E'_"&Z1_<F_[^4:!J3?\)9HO
M_/V?^_3_ .%'_"6:+_S]G_OT_P#A4/\ PAND?W)O^_E'_"&Z1_<F_P"_E&@:
MDW_"6:+_ ,_9_P"_3_X4?\)9HO\ S]G_ +]/_A4/_"&Z1_<F_P"_E'_"&Z1_
M<F_[^4:!J3?\)9HO_/V?^_3_ .%'_"6:+_S]G_OT_P#A4/\ PAND?W)O^_E'
M_"&Z1_<F_P"_E&@:DW_"6:+_ ,_9_P"_3_X4?\)9HO\ S]G_ +]/_A4/_"&Z
M1_<F_P"_E'_"&Z1_<F_[^4:!J2GQ9HI4C[6?^_3_ .%<MX4U.TTRZN'NY?+5
MT 4[2<G/L*Z0^#M( )V3?]_*YCPOI-KJUS<1W08JB C:V.<T"U.M_P"$LT7_
M )^S_P!^G_PH_P"$LT7_ )^S_P!^G_PJ'_A#=(_N3?\ ?RC_ (0W2/[DW_?R
MC0>I-_PEFB_\_9_[]/\ X4?\)9HO_/V?^_3_ .%0_P#"&Z1_<F_[^4?\(;I'
M]R;_ +^4:!J3?\)9HO\ S]G_ +]/_A1_PEFB_P#/V?\ OT_^%0_\(;I']R;_
M +^4?\(;I']R;_OY1H&I-_PEFB_\_9_[]/\ X4?\)9HO_/V?^_3_ .%0_P#"
M&Z1_<F_[^4?\(;I']R;_ +^4:!J3?\)9HO\ S]G_ +]/_A1_PEFB_P#/V?\
MOT_^%0_\(;I']R;_ +^4?\(;I']R;_OY1H&I-_PEFB_\_9_[]/\ X4?\)9HO
M_/V?^_3_ .%0_P#"&Z1_<F_[^4?\(;I']R;_ +^4:!J3?\)9HO\ S]G_ +]/
M_A1_PEFB_P#/V?\ OT_^%0_\(;I']R;_ +^4?\(;I']R;_OY1H&I-_PEFB_\
M_9_[]/\ X4?\)9HO_/V?^_3_ .%0_P#"&Z1_<F_[^4?\(;I']R;_ +^4:!J3
M?\)9HO\ S]G_ +]/_A1_PEFB_P#/V?\ OT_^%0_\(;I']R;_ +^4?\(;I']R
M;_OY1H&I-_PEFB_\_9_[]/\ X4?\)9HO_/V?^_3_ .%0_P#"&Z1_<F_[^4?\
M(;I']R;_ +^4:!J3?\)9HO\ S]G_ +]/_A1_PEFB_P#/V?\ OT_^%0_\(;I'
M]R;_ +^4?\(;I']R;_OY1H&I-_PEFB_\_9_[]/\ X4?\)9HO_/V?^_3_ .%0
M_P#"&Z1_<F_[^4?\(;I']R;_ +^4:!J3?\)9HO\ S]G_ +]/_A1_PEFB_P#/
MV?\ OT_^%0_\(;I']R;_ +^4?\(;I']R;_OY1H&I-_PEFB_\_9_[]/\ X4?\
M)9HO_/V?^_3_ .%0_P#"&Z1_<F_[^4?\(;I']R;_ +^4:!J3?\)9HO\ S]G_
M +]/_A1_PEFB_P#/V?\ OT_^%0_\(;I']R;_ +^4?\(;I']R;_OY1H&I-_PE
MFB_\_9_[]/\ X4?\)9HO_/V?^_3_ .%0_P#"&Z1_<F_[^4?\(;I']R;_ +^4
M:!J3?\)9HO\ S]G_ +]/_A1_PEFB_P#/V?\ OT_^%0_\(;I']R;_ +^4?\(;
MI']R;_OY1H&I-_PEFB_\_9_[]/\ X4?\)9HO_/V?^_3_ .%0_P#"&Z1_<F_[
M^4?\(;I']R;_ +^4:!J3?\)9HO\ S]G_ +]/_A1_PEFB_P#/V?\ OT_^%0_\
M(;I']R;_ +^4?\(;I']R;_OY1H&I-_PEFB_\_9_[]/\ X4?\)9HO_/V?^_3_
M .%0_P#"&Z1_<F_[^4?\(;I']R;_ +^4:!J3?\)9HO\ S]G_ +]/_A1_PEFB
M_P#/V?\ OT_^%0_\(;I']R;_ +^4?\(;I']R;_OY1H&I-_PEFB_\_9_[]/\
MX4?\)9HO_/V?^_3_ .%0_P#"&Z1_<F_[^4?\(;I']R;_ +^4:!J3?\)9HO\
MS]G_ +]/_A1_PEFB_P#/V?\ OT_^%0_\(;I']R;_ +^4?\(;I']R;_OY1H&I
M-_PEFB_\_9_[]/\ X4?\)9HO_/V?^_3_ .%0_P#"&Z1_<F_[^4?\(;I']R;_
M +^4:!J3?\)9HO\ S]G_ +]/_A1_PEFB_P#/V?\ OT_^%0_\(;I']R;_ +^4
M?\(;I']R;_OY1H&I-_PEFB_\_9_[]/\ X4?\)9HO_/V?^_3_ .%0_P#"&Z1_
M<F_[^4?\(;I']R;_ +^4:!J3?\)9HO\ S]G_ +]/_A1_PEFB_P#/V?\ OT_^
M%0_\(;I']R;_ +^4?\(;I']R;_OY1H&I-_PEFB_\_9_[]/\ X4?\)9HO_/V?
M^_3_ .%0_P#"&Z1_<F_[^4?\(;I']R;_ +^4:!J3?\)9HO\ S]G_ +]/_A1_
MPEFB_P#/V?\ OT_^%0_\(;I']R;_ +^4?\(;I']R;_OY1H&I-_PEFB_\_9_[
M]/\ X4?\)9HO_/V?^_3_ .%0_P#"&Z1_<F_[^4?\(;I']R;_ +^4:!J3?\)9
MHO\ S]G_ +]/_A1_PEFB_P#/V?\ OT_^%0_\(;I']R;_ +^4?\(;I']R;_OY
M1H&I-_PEFB_\_9_[]/\ X4?\)9HO_/V?^_3_ .%0_P#"&Z1_<F_[^4?\(;I'
M]R;_ +^4:!J3?\)9HO\ S]G_ +]/_A1_PEFB_P#/V?\ OT_^%0_\(;I']R;_
M +^4?\(;I']R;_OY1H&I-_PEFB_\_9_[]/\ X4?\)9HO_/V?^_3_ .%0_P#"
M&Z1_<F_[^4?\(;I']R;_ +^4:!J3?\)9HO\ S]G_ +]/_A1_PEFB_P#/V?\
MOT_^%0_\(;I']R;_ +^4?\(;I']R;_OY1H&I-_PEFB_\_9_[]/\ X4?\)9HO
M_/V?^_3_ .%0_P#"&Z1_<F_[^4?\(;I']R;_ +^4:!J3?\)9HO\ S]G_ +]/
M_A1_PEFB_P#/V?\ OT_^%0_\(;I']R;_ +^4?\(;I']R;_OY1H&I-_PEFB_\
M_9_[]/\ X4?\)9HO_/V?^_3_ .%0_P#"&Z1_<F_[^4?\(;I']R;_ +^4:!J3
M?\)9HO\ S]G_ +]/_A1_PEFB_P#/V?\ OT_^%0_\(;I']R;_ +^4?\(;I']R
M;_OY1H&I-_PEFB_\_9_[]/\ X4?\)9HO_/V?^_3_ .%0_P#"&Z1_<F_[^4?\
M(;I']R;_ +^4:!J3?\)9HO\ S]G_ +]/_A1_PEFB_P#/V?\ OT_^%0_\(;I'
M]R;_ +^4?\(;I']R;_OY1H&I-_PEFB_\_9_[]/\ X4?\)9HO_/V?^_3_ .%0
M_P#"&Z1_<F_[^4?\(;I']R;_ +^4:!J3?\)9HO\ S]G_ +]/_A1_PEFB_P#/
MV?\ OT_^%0_\(;I']R;_ +^4?\(;I']R;_OY1H&I-_PEFB_\_9_[]/\ X4?\
M)9HO_/V?^_3_ .%0_P#"&Z1_<F_[^4?\(;I']R;_ +^4:!J3?\)9HO\ S]G_
M +]/_A1_PEFB_P#/V?\ OT_^%0_\(;I']R;_ +^4?\(;I']R;_OY1H&I-_PE
MFB_\_9_[]/\ X4?\)9HO_/V?^_3_ .%0_P#"&Z1_<F_[^4?\(;I']R;_ +^4
M:!J3?\)9HO\ S]G_ +]/_A1_PEFB_P#/V?\ OT_^%0_\(;I']R;_ +^4?\(;
MI']R;_OY1H&I-_PEFB_\_9_[]/\ X4?\)9HO_/V?^_3_ .%0_P#"&Z1_<F_[
M^4?\(;I']R;_ +^4:!J3?\)9HO\ S]G_ +]/_A1_PEFB_P#/V?\ OT_^%0_\
M(;I']R;_ +^4?\(;I']R;_OY1H&I-_PEFB_\_9_[]/\ X4?\)9HO_/V?^_3_
M .%0_P#"&Z1_<F_[^4?\(;I']R;_ +^4:!J3?\)9HO\ S]G_ +]/_A1_PEFB
M_P#/V?\ OT_^%0_\(;I']R;_ +^4?\(;I']R;_OY1H&I-_PEFB_\_9_[]/\
MX4?\)9HO_/V?^_3_ .%0_P#"&Z1_<F_[^4?\(;I']R;_ +^4:!J3?\)9HO\
MS]G_ +]/_A1_PEFB_P#/V?\ OT_^%0_\(;I']R;_ +^4?\(;I']R;_OY1H&I
M-_PEFB_\_9_[]/\ X4?\)9HO_/V?^_3_ .%0_P#"&Z1_<F_[^4?\(;I']R;_
M +^4:!J3?\)9HO\ S]G_ +]/_A1_PEFB_P#/V?\ OT_^%0_\(;I']R;_ +^4
M?\(;I']R;_OY1H&I-_PEFB_\_9_[]/\ X4?\)9HO_/V?^_3_ .%0_P#"&Z1_
M<F_[^4?\(;I']R;_ +^4:!J3?\)9HO\ S]G_ +]/_A1_PEFB_P#/V?\ OT_^
M%0_\(;I']R;_ +^4?\(;I']R;_OY1H&I-_PEFB_\_9_[]/\ X4?\)9HO_/V?
M^_3_ .%0_P#"&Z1_<F_[^4?\(;I']R;_ +^4:!J3?\)9HO\ S]G_ +]/_A1_
MPEFB_P#/V?\ OT_^%0_\(;I']R;_ +^4?\(;I']R;_OY1H&I-_PEFB_\_9_[
M]/\ X4?\)9HO_/V?^_3_ .%0_P#"&Z1_<F_[^4?\(;I']R;_ +^4:!J3?\)9
MHO\ S]G_ +]/_A1_PEFB_P#/V?\ OT_^%0_\(;I']R;_ +^4?\(;I']R;_OY
M1H&I-_PEFB_\_9_[]/\ X4?\)9HO_/V?^_3_ .%0_P#"&Z1_<F_[^4?\(;I'
M]R;_ +^4:!J3?\)9HO\ S]G_ +]/_A1_PEFB_P#/V?\ OT_^%0_\(;I']R;_
M +^4?\(;I']R;_OY1H&I-_PEFB_\_9_[]/\ X4?\)9HO_/V?^_3_ .%0_P#"
M&Z1_<F_[^4?\(;I']R;_ +^4:!J3?\)9HO\ S]G_ +]/_A1_PEFB_P#/V?\
MOT_^%0_\(;I']R;_ +^4?\(;I']R;_OY1H&I-_PEFB_\_9_[]/\ X4?\)9HO
M_/V?^_3_ .%0_P#"&Z1_<F_[^4?\(;I']R;_ +^4:!J3?\)9HO\ S]G_ +]/
M_A1_PEFB_P#/V?\ OT_^%0_\(;I']R;_ +^4?\(;I']R;_OY1H&I-_PEFB_\
M_9_[]/\ X4?\)9HO_/V?^_3_ .%0_P#"&Z1_<F_[^4?\(;I']R;_ +^4:!J3
M?\)9HO\ S]G_ +]/_A1_PEFB_P#/V?\ OT_^%0_\(;I']R;_ +^4?\(;I']R
M;_OY1H&I-_PEFB_\_9_[]/\ X4?\)9HO_/V?^_3_ .%0_P#"&Z1_<F_[^4?\
M(;I']R;_ +^4:!J3?\)9HO\ S]G_ +]/_A1_PEFB_P#/V?\ OT_^%0_\(;I'
M]R;_ +^4?\(;I']R;_OY1H&I-_PEFB_\_9_[]/\ X4?\)9HO_/V?^_3_ .%0
M_P#"&Z1_<F_[^4?\(;I']R;_ +^4:!J3?\)9HO\ S]G_ +]/_A1_PEFB_P#/
MV?\ OT_^%0_\(;I']R;_ +^4?\(;I']R;_OY1H&I-_PEFB_\_9_[]/\ X4?\
M)9HO_/V?^_3_ .%0_P#"&Z1_<F_[^4?\(;I']R;_ +^4:!J;R.LD:NARK $'
MU%%$:+'&L:#"J  /844ACJ*** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "N%D_Y*(/^NH_] %=U7"R?\E$'_74?^@"FA,[JBBBD
M,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@#F_&__(#C_P"NZ_\ H+5Y]7H/C?\ Y <?
M_7=?_06KSZJ1+W"BBBF2%%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%=EX9\3?<L+]_:*5C^A_QKC:*0TSV6BN,\,^)ON6%^_M%*Q_0_XUV=26F%%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!!>3F
MUL;BX"[C%&S@'O@9K&\+^)'\11W+O;+!Y)4 !]V<Y]O:M35O^0-??]>\G_H)
MKC_AG_Q[ZC_OQ_R:@#O**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH BN)3!:RR@9*(6 /? S6%X6\3/XB^U[[58/(V8P^[.[=[>U;5_
M_P @ZZ_ZY/\ R-</\,O^8I_VR_\ 9Z /0**** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "N%O?^2B)_UUC_ /0!7=5PM[_R41/^NL?_ * *:$SNJ***
M0PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!&^Z?I7#^!/^/V[_P"N
M8_G7<-]T_2N'\"?\?MW_ -<Q_.F)[G<T444AA1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !7"R?\E$'_74?^@"NZKA9/\ DH@_ZZC_ - %-"9W5%%%(84444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% '-^-_P#D!Q_]=U_]!:O/J]!\;_\ (#C_ .NZ_P#H
M+5Y]5(E[A1113)"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MKLO#/B;[EA?O[12L?T/^-<;12&F>RT5QGAGQ-]RPOW]HI6/Z'_&NSJ2TPHHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH K:C$\^F7<,
M:[I)(751G&25(%<WX&T74-'AO5O[?R3(R%/G5LXSGH3ZUUM% !1110 4444
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MO_KF/YUW#?=/TKA_ G_'[=_]<Q_.F)[G<T444AA1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !7"R?\E$'_ %U'_H KNJX63_DH@_ZZC_T 4T)G=4444AA1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 <WXW_Y <?\ UW7_ -!:O/J]!\;_ /(#C_Z[K_Z"
MU>?52)>X4444R0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110!%<2F"UEE R40L >^!FL+PMXF?Q%]KWVJP>1LQA]V=V[V]JVK__ )!U
MU_UR?^1KA_AE_P Q3_ME_P"ST >@4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %<+>_\ )1$_ZZQ_^@"NZKA;W_DHB?\ 76/_ - %-"9W5%%%(844
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 C?=/TKA_ G_'[=_P#7,?SK
MN&^Z?I7#^!/^/V[_ .N8_G3$]SN:***0PHHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "O!_%_P 1?%6E^+M3L;/5
M?*MH)RD:?9XFVCZE2:]XKY?\?_\ (^ZU_P!?+?TK>@DY.YRXN3C%69=_X6IX
MT_Z#/_DK#_\ $5M^$/B+XJU3Q=IEC>:KYMM/.$D3[/$NX?4*#7LOAS_D6-)_
MZ\H?_0!6G1*K';E"-">CYW_7S"O,?&WQ9@T>XETW0T2YO$)66=^8XSZ#'WF!
M_ 8[\XU_BCXFD\/>%6CM7*7M\WDQL.J+U=NGIQ_P('M7E/PT\'1^*M<>2]0M
MIMF TP#8WL?NIZX.#G'8=LBBG!6YY;!6JRYE3AN51XG\=^(KB1[2^U>X<<LE
M@'4*.G2,#'6I;?QMXX\-W"K=7E\"<_NM11GW>OW^?R-?1EK:V]C:QVMK"D,$
M2[4CC7"J/856U;1M/URQ>SU&UCGA8$?,.5]U/4'W%/VT=N707U:>ZEJ<QX&^
M(MEXM7[).BVNJ*NXPY^60>J'V'4'GZUVU?+_ (FT2\\#>+C;PSN&A9;BTN.,
MLN?E;Z@@@^X/:OH?PGK8\1>&+#4_E\R6/$H'9P<-^H-35II>]'9E4*KE>$]T
M</\ $[XB76@W<6D:'<"*^3$ES+L5M@(RJ88$9.<GT&/7CSW_ (6IXT_Z#/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '-^-_^0''_ -=U_P#0
M6KSZO0?&_P#R X_^NZ_^@M7GU4B7N%%%%,D**** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH *[+PSXF^Y87[^T4K']#_C7&T4AIGL
MM%<9X9\3?<L+]_:*5C^A_P :[.I+3"BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH JZE&\VEW<4:[G>%U4#N2IQ7->!-(O]*AOEOK=H3(R%<D'.,Y
MZ&NOHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH A
MNT:6RGC099HV4#U)%<GX#T?4-)_M#[=;-#YOE[,D'.-V>A]Q7944 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !7"WO_ "41/^NL?_H KNJX6]_Y
M*(G_ %UC_P#0!30F=U1112&%%%% !1110 4444 %%%% !1110 4444 %%%%
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M)=74%C:2W5U*L4$*EY'8\*!U-?-?CWQ>_B_7?M$8DCL8 8[:)ST'=B.Q/'Y
M=JT/B#\09_%5R;*R9XM(B;Y5Z&<C^)O;T'XGGIT/PM^'@N3;^(]63]R#OM+=
MA]\@\.WMZ#OUZ8S4(JFN:6Y%2;K2]G#8[7X9>&)/#?A93=1&._O&\V=3U4?P
MJ?<#GZDCM7:445S2;D[L[8148J*"BBBD4%%%% !1110 4444 %%%% !7"R?\
ME$'_ %U'_H KNJX63_DH@_ZZC_T 4T)G=4444AA1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 <WXW_Y <?\ UW7_ -!:O/J]!\;_ /(#C_Z[K_Z"U>?52)>X4444R0HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH 1ONGZ5P_@3_C]N_^N8_G7<-]
MT_2N'\"?\?MW_P!<Q_.F)[G<T444AA7-^.]1N--\)74ML2LDA6+>#@H&."1^
M''XY[5TE5K^QM]3L9K*Z3?!,NUESBJBTFFR9)N+2/G DDDDY)[U[A\/]1N-2
M\*0M<NSR0R-%O;JP&"/T./PK"_X5-:?:RQU6;[-NXC\H;\>F[.,^^VN\T^PM
MM+L(;*TC\N")<*OZD_4G)KHK58RC9'/0I3A*[+-%%%<IU!1110 4444 >$?:
M=>M?C#K4GAVR@O+[=(/*G8!=GRY/++[=Z[!-7^*['!\-Z.@]6D'])JQ_#/\
MR7?6_P#=F_\ 9:]?K>I*UM.ARTH73=VM6>66_P /-?\ $VLV^J>-K^)XHA\M
ME >P/W3@8 /<C)([CMZBB)'&J(H5% "JHP !V%.HK*4G+<WA34-CYY^%GA>/
MQ+J\YOBSZ;9;)9+?=\LLAR$!&>F W\N]?0B(D<:HBA44 *JC  '85Y+\"_\
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M?4H-9L?.OK:12%::2-@A&.BD="#^=5!64FR:KYI04=CUI/%7AB.-437](5%
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M?_&W_D3+/_L()_Z+DKIO WB7_A*O#$&H.%6Y5C#<*HP!(,=/J"#^-<S\;?\
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M@'\ZU?!'_):_$_\ USN/_1T='C?_ )+7X8_ZYV__ *.DKH7\2_D<;5Z5O/\
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M9XF_Y+OHG^[#_P"S5UWQ4_Y)OJW_ &Q_]')7(^)O^2[Z)_NP_P#LU==\5/\
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M\Y2>XR:&*XA>&>))8G&&1U#*P]P:^>_BEX4A\,ZU#)8_N]/OPTB0@\1R+C<
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MXQYDD#X^IE-'QL_X_/#/_72?^<5='_+[^NQQ_P#,-_7<]<KR#PS_ ,EWUO\
MW9O_ &6O7Z\@\,_\EWUO_=F_]EK.GM+T-ZV\?4]?KYZ\$^&U\3^.;^VNW?\
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MJ5&=1U&FM#L:***R-PHHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH YOQO_ ,@./_KNO_H+5Y]7H/C?_D!Q_P#7=?\ T%J\
M^JD2]PHHHIDA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %=EX9\3?<L+]_:*5C^A_QKC:*0TSV6BN,\,^)ON6%^
M_M%*Q_0_XUV=26F%%%% !1110 4444 %%%% !1110 4444 5=2C>;2[N*-=S
MO"ZJ!W)4XKFO FD7^E0WRWUNT)D9"N2#G&<]#77T4 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 0W:-+93QH,LT;*!ZDBN3\!Z/J&
MD_VA]NMFA\WR]F2#G&[/0^XKLJ* "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ KA;W_DHB?]=8__ $ 5W5<+>_\ )1$_ZZQ_^@"FA,[JBBBD,***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH 1ONGZ5P_@3_ (_;O_KF/YUW
M#?=/TKA_ G_'[=_]<Q_.F)[G<T444AA1110 4444 %%%% !1110 4444 >0>
M&?\ DN^M_P"[-_[+7K]%%5.7,R*<.1-!1114EGD?P+_X\];_ .ND/\GKURBB
MJG+FE<BG#DBHGEWQP_Y%S3?^OL_^@&O1-&_Y >G_ /7M'_Z"*NT4.5XJ(*%I
MN7<\FU;PEK_@KQ!-K_@Z(7%E+S-IZ@G [C:/O+GICD9QC%7(_C/I\*"+4=%U
M*"]"C,2HI&[T^8@XS[5Z;15<Z?Q*Y'LG%^X['D5[J'BOXF;-.M-,DTG0I/FE
MN)P?WB@YZD<\CHO?J<4WX')Y4WB*/.=K0+GUQYM>OT4W4]UQ2$J/OJ;=V<%X
MJ\6>)/#/B/S1HK7GA_RAEX5)8-W)8?=.<#!X([Y/'/Z[\2)?%VEW&B>%]%OY
MIKM#%))(H&Q3UX4D<C(R2!7KM%)3BN@Y4Y._O:,Y_P %>'V\,^%K3396#3J"
M\Q4Y&]CDX.!P.E<CXK\(ZOHOB3_A+O",8DN78FZL]N0^?O$#C(;N!SGD>WIU
M%)3:=RG2BXJ/8\Q@^,]A @CUG1-1M+K',<:JP/;/S%3V]*S-1\1^*_B+%_96
MBZ-+8:9,?+N+F;)!&1G+$  >JC)->PT4^>*U2)=.;TE+0QO"_ANS\*Z)%IMF
M2P!+RRMP9'.,L?3H!CT K9HHJ&VW=FJ22L@HHHI#/(_&_P#R6OPQ_P!<[?\
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M>')#U"BBBLC<**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MUUE_]#->??&W_D<[/_L'I_Z,DKT'X1_\D]M/^NLO_H9J)_PD:T_]XD>"VO\
MR,</_7VO_H=?3OB37[7PSH5QJEW\RQ#"1AL&1ST4?YX )[5\Q6O_ ",</_7V
MO_H=>L?'2Y9+#1K4%MDDLLA&>"5"@?\ H9JZL>:449T)\D)R1YWJ_BCQ)XSU
M+R'FN)?.;$5C;;MGT"#KQGDY/6K2^%/'/AF#^TX+*^LT"[V>VE!(4<_,J$D#
MGG(]<]Z[CX'Z9:FTU+5&C5KH2"!'(Y5< G'UR/RKUVIG5Y'RI:%4\/[2//)Z
MGR3K&KWFNZI+J5^ZO=2A!(ZJ%W;5"@X''11TKZ6\"_\ (BZ)_P!>B?RKP?XE
M:=;Z9X]U*"U0)$Q24(!@*64,<?B37LVBW<EA\(8;R(XE@TAI4.>ZQDC^5%;6
M,;!AKQJ2N<?\0/BG=6]]/H_A^18_)8I->#YF+="J@C QS\W/MCJ>&M/"GC+Q
M3$+V.SO;R.3YA-<3 !_<%V&:K^"--@UOQKIEE>;7AEE+2!SPX52V#]<8_&OJ
M)55%"J % P !P!1.2I644%.#Q%Y3>A\QR?\ "8> [R+>U]IK<^7\VZ)_4=T;
MKG'/7->\>!]?U'Q'X>2\U/3GLYPVW<1A9AC[Z@\@?IZ'TZ">VM[I%2X@CF56
M#J)$# ,.A&>]2UE.HIK;4Z*5%TWH] HHJ"]G^RV%Q< 9,43/CUP":R-SQWXC
M_$R]74I]%T&X,$,/R3W43?.[=PI_A Z9'.<_CQ.E^$?%GB)?[1LK"ZN _(N)
M) F_MD,Y&[TXJAX=LX]8\5:;9W99X[F[1)3DY8%ANY]3SS7U9'''#$D42*D:
M*%5%& H'0 =A77.2I)**//IP>(;E)Z'S%J^M>)[/2Y/#6MM<>5N258[L$NF.
MFUCSM]N1QQCFNJ^"'_(SZA_UY'_T-:[+XR:?;W/@L7CH//M)U,;XY 8X8?0\
M'\!7&_!#_D9]0_Z\C_Z&M',I4F["4'"NDW</C?\ \C/I_P#UY#_T-JZWX7WL
M>F_"ZXOY06CMGGF8#J0HR?Y5R7QO_P"1GT__ *\A_P"AM78_"BVBO?AL]K.N
MZ&>6:-U]588(_(U,OX2+A_O$K'DM[K'B7Q]KJP!YKB:9CY-I$^V-!CD $X Q
MU)].34ELGC'P7K=O:PQWMI=R,!' /G28Y'  RK\^E/\ $/A?7? .MBXADG6)
M&+6U_!D @\<D?=/."#USW%=7X;^,+FXMXO$UI%,(\[+V*,>8A(QDKTZ$@[<<
M=JU;T]U71A%+F]]M2/8K*:Y_LJ"?4DBM[GR0]PJOE(VQEN?0<_XUX9XS^*6J
M:OJ#VFAW$UG8(VU'A.V68],[AR >P'_ZO3_B'J 3X:ZI=VLFY)H$574X#)(Z
MKGZ$-7SUH6L2Z!K$&IP6UM<30$F-;E2R!L8S@$<CMZ'FLJ,$TY-'1B:C34$S
M:B\ >,[V'[;_ &1=G!ZS.J29_P!UB&[^E7-#\>>)O!NJ-9WSSSPQ/MFLKLDE
M?]TGE3CIVYS@UI_\+M\2_P#/CI/_ 'ZD_P#CE<QXK\97OC"2WEU"SLHIH 56
M2W1U8J>QRQXS6J4I:36ASMPCK3D[GTKI6IVFLZ7;ZC8R>9;3KN1OT(/N#D'W
M%>7?$SXDW5C?2Z%H<WE21<7-TARP;^XI[8[GKGCC%7O@EJ$D_AR^L7;*VMP&
M3V#CI^8)_&O'(3_;/B6,SLQ^VW@WL3S\[\GZ\UE3II3=^AT5:TG3C;J:&G>%
M_%/BPO>VME=7NXDFXFD #G//SN1DY]ZEU34_%FC:=<^'=8>[2VN54F&[RV K
M!@48]LKC@XZ]Z^E[6U@L;2*UM8EB@A4)&BCA0.@KC_BOIUO>^ KV>5 9;0I+
M"^.5.X*?S!/Z>E.-;FDDUH*6&Y8-IZGF7P:_Y'H_]>DG\UKL/BWXTU#19+;1
M=,F>VEGB\Z:=#API) "GMRIR1STKC_@U_P CT?\ KTD_FM=[\4O USXDMX=3
MTU0]]:H4:'',L><X!]02>.^3WZD^7VJYA4U)T'R[GD5MX6\4WVF+KUO8W<UM
MDE9T?+G!Y(&=Q'7D"O3_ (0:UXEU2.XBOR]SI4*XCN9B=ZOQ\@/\0QU]..>Q
M\[\/>.?$7@V3[&CLUM&?FLKI3A<\G'=>I/'&3D@U[5X&\:Z5XILV@M(!9W<*
M[YK4* HR>64CJ"3]<FG6YN5W0L.H<RL[/L5?B)X]7PC9QVMHJR:I<J6C#<K$
MO3>P[\Y 'L?3!\9B@\7^.9V9/[0U+!P69CY2'TR<*OKCBI?B3=27?Q!U9G_@
MD$2C.0 J@?TS^-:&C?%;6=!TFWTVQT[2E@@7:"8I-S'NS8?DD\FJA!QBG%:D
MU*BG-J;LD9MQIGC+P,RW3I>Z<N0HDCE!C)/.TE25/3H:];^''Q"_X2J)[#4O
M*CU2%0P*\"=>[ =F'<>^1W \^O/C%KM_9S6EUIND2V\R%)$:*7#*1@C_ %E<
MWX(U&32_&VD7*-M!N4B<]?D<[6_1C1*#E%\RU%"HJ<UR/0^I:***XCTPHHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH YOQO_R X_\ KNO_ *"U>?5Z#XW_ .0''_UW7_T%J\^JD2]PHHHI
MDA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !79>&?$WW+"_?VBE8_H?\:XVBD-,]EHKC/#/B;[EA?O[12L
M?T/^-=G4EIA1110 4444 %%%% !1110 4444 0W<_P!ELI[C;N\J-GVYQG S
MBL?PSXD_X2*.Y?[)]G\DJ,>9OSG/L/2M+5O^0-??]>\G_H)KC_AG_P >^H_[
M\?\ )J .\HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M".XE\BVEFQNV(6QG&<#-8?ACQ/\ \)']J_T/[/Y&S_EKOW;L^PQTK8O_ /D'
M77_7)_Y&N'^&7_,4_P"V7_L] 'H%%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !7"WO_)1$_ZZQ_\ H KNJX6]_P"2B)_UUC_] %-"9W5%%%(84444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 C?=/TKA_ G_'[=_]<Q_.NX;[
MI^E</X$_X_;O_KF/YTQ/<[FBBBD,**** "BBB@ HHHH **** "BBB@ HHHH
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M-<D:QO47$A$3/'(?5=H)'T/ZURGQ)^)-MX@LO['T<.UD6#3SN"ID(/  _N\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** .;\;_\@./_ *[K_P"@M7GU>@^-_P#D!Q_]=U_]!:O/JI$O<***
M*9(4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %=EX9\3?<L+]_:*5C^A_QKC:*0TSV6BN,\,^)ON6
M%^_M%*Q_0_XUV=26F%%%% !1110 4444 %%%% %74HWFTN[BC7<[PNJ@=R5.
M*YKP)I%_I4-\M];M"9&0KD@YQG/0UU]% !1110 4444 %%%% !1110 4444
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M>AZA16?HVM6&OZ9'J&G3B:!^/0J>ZL.Q%:%9M6-4TU=!1110,**** "BBB@
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MB9KO_8/N/_1;5R?P7_Y$>3_K]D_]!2K7\-F<OXR]#T2BBBLC<**** "BBB@
MHHHH **** "N%D_Y*(/^NH_] %=U7"R?\E$'_74?^@"FA,[JBBBD,**** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@#F_&__(#C_P"NZ_\ H+5Y]7H/C?\ Y <?_7=?_06K
MSZJ1+W"BBBF2%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MMM'U:$!+V*?RUE'7&-P_(C/XUZA93_:K"WN",&6)7QZ9 ->:_'#_ )%S3?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MP&1DVA^^ <_SKL:* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** (+Q&DL;A$&6:-@ .YQ7)> -*OM,_M'[;:R0>9Y>S>.N-V?YBNTH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N%O?^2B)_P!=8_\
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M.<_WL8Z@5ZO15>T2V1'LF])2;1Y9\'=&U#2)M?6^L+NU5VA$1N(63>!YF<9
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** .;\;_P#(#C_Z[K_Z"U>?5Z#XW_Y <?\ UW7_ -!:O/JI
M$O<****9(4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !115W3-,N-5NUM[=?=G/1!ZF@8:9IEQJMVMO;K[LYZ(/4
MUZ7IFF6^E6BV]NON[GJY]31IFF6^E6BV]NON[GJY]35VI;*2"BBBD,**** "
MBBB@ HHHH **** "BBB@"&ZG%K9SW!7<(HV<@=\#-9/AOQ(GB*.X=+9H/)*@
M@ONSG/M[5H:M_P @:^_Z]Y/_ $$UQ_PS_P"/?4?]^/\ DU '>4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110!'<2^1;2S8W;$+8SC.!F
ML7PWXF3Q%]JV6K0>1LSE]V=V?;VK6O\ _D'77_7)_P"1KA_AE_S%/^V7_L]
M'H%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7"WO_)1$_P"NL?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MY]B20!Z\UW7A6RETWPGI-G.")HK6-74C!5MHR/P/%3/6"D]RJ?NU'%;&O17
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M*1E#*58 J1@@]#3B[-,F2YDT?-%>V?#B.YC\'P"X4JK2.T(/]PG_ !W&KO\
MPA/AL79N?[)A\PMNQEMF?]S.W'MBMY5"J%4 *!@ =!6]6LIJR1A1HN$KMBT4
M45SG2%%%% !1110!X1_8]YKGQAUJSL=7GTJ;=(_VB#.[ V_+PRGG/KVKL$^&
M_B$']Y\0]88>BF0?^U36/X9_Y+OK?^[-_P"RUZ_6]2;5DNQRTJ<9)M]V<3X=
M^&&BZ%?1ZC/)/J-^AW"6Y(*JW9@OJ.Q).#SZ5T/B;5&T7PSJ6HH"9(+=FCP
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ML;2*UM=,U2*"%0D:+#'A0.@_UE5/BI#/I'B[P]XI$+26MNR1R[>H*.7P>PW
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M7G_80?\ ]%QUT*ZG)K7PREU&9-DMQIDCNOOY9R1['K7/?!+_ )$R\_["#_\
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M_P!=U_\ 06KSZO0?&_\ R X_^NZ_^@M7GU4B7N%%%%,D**** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M *YC^==PWW3]*X?P)_Q^W?\ US'\Z8GN=S1112&%%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7"R?\ )1!_UU'_ * *
M[JN%D_Y*(/\ KJ/_ $ 4T)G=4444AA1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M:NU+9204444AA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 5PLG_ "40?]=1_P"@"NZKA9/^2B#_ *ZC_P! %-"9W5%%
M%(84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% '-^-_\ D!Q_]=U_]!:O/J]!\;_\@./_
M *[K_P"@M7GU4B7N%%%%,D**** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH ***NZ9IEQJMVMO;K[LYZ(/4T##3-,N-5NUM[=?=G/1!ZFO2],TRWTJT6WM
MU]W<]7/J:-,TRWTJT6WMU]W<]7/J:NU+9204444AA1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110!5U.-Y=*O(XU+.\#JJCJ25/%<M\
M/].O-/@OQ>6TL!=DVB1<9P#79T4 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH 1ONGZ5P_@3_ (_;O_KF/YUW#?=/TKA_ G_'
M[=_]<Q_.F)[G<T444AA1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MM_\ &C_A,M6_Y\H/^_;_ .-%@N=U17"_\)EJW_/E!_W[?_&C_A,M6_Y\H/\
MOV_^-%@N=U17"_\ "9:M_P ^4'_?M_\ &C_A,M6_Y\H/^_;_ .-%@N=U17"_
M\)EJW_/E!_W[?_&C_A,M6_Y\H/\ OV_^-%@N=U17"_\ "9:M_P ^4'_?M_\
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M6K?\^4'_ '[?_&C_ (3+5O\ GR@_[]O_ (T6"YW5%<+_ ,)EJW_/E!_W[?\
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M^$RU;_GR@_[]O_C18+G=45PO_"9:M_SY0?\ ?M_\:/\ A,M6_P"?*#_OV_\
MC18+G=45PO\ PF6K?\^4'_?M_P#&C_A,M6_Y\H/^_;_XT6"YW5%<+_PF6K?\
M^4'_ '[?_&C_ (3+5O\ GR@_[]O_ (T6"YW5%<+_ ,)EJW_/E!_W[?\ QH_X
M3+5O^?*#_OV_^-%@N=U17"_\)EJW_/E!_P!^W_QH_P"$RU;_ )\H/^_;_P"-
M%@N=U17"_P#"9:M_SY0?]^W_ ,:/^$RU;_GR@_[]O_C18+G=45PO_"9:M_SY
M0?\ ?M_\:/\ A,M6_P"?*#_OV_\ C18+G=45PO\ PF6K?\^4'_?M_P#&C_A,
MM6_Y\H/^_;_XT6"YW5%<+_PF6K?\^4'_ '[?_&C_ (3+5O\ GR@_[]O_ (T6
M"YW5%<+_ ,)EJW_/E!_W[?\ QH_X3+5O^?*#_OV_^-%@N=U17"_\)EJW_/E!
M_P!^W_QH_P"$RU;_ )\H/^_;_P"-%@N=U17"_P#"9:M_SY0?]^W_ ,:/^$RU
M;_GR@_[]O_C18+G=45PO_"9:M_SY0?\ ?M_\:/\ A,M6_P"?*#_OV_\ C18+
MG=45PO\ PF6K?\^4'_?M_P#&C_A,M6_Y\H/^_;_XT6"YW5%<+_PF6K?\^4'_
M '[?_&C_ (3+5O\ GR@_[]O_ (T6"YW5%<+_ ,)EJW_/E!_W[?\ QH_X3+5O
M^?*#_OV_^-%@N=U17"_\)EJW_/E!_P!^W_QH_P"$RU;_ )\H/^_;_P"-%@N=
MU17"_P#"9:M_SY0?]^W_ ,:/^$RU;_GR@_[]O_C18+G=45PO_"9:M_SY0?\
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M7,BY15/^T#_SZO\ ]]?_ %J/[0/_ #ZO_P!]?_6HY6',BY15/^T#_P ^K_\
M?7_UJ/[0/_/J_P#WU_\ 6HY6',BY15/^T#_SZO\ ]]?_ %J/[0/_ #ZO_P!]
M?_6HY6',BY15/^T#_P ^K_\ ?7_UJ/[0/_/J_P#WU_\ 6HY6',BY15/^T#_S
MZO\ ]]?_ %J/[0/_ #ZO_P!]?_6HY6',BY15/^T#_P ^K_\ ?7_UJ/[0/_/J
M_P#WU_\ 6HY6',BY15/^T#_SZO\ ]]?_ %J/[0/_ #ZO_P!]?_6HY6',BY15
M/^T#_P ^K_\ ?7_UJ/[0/_/J_P#WU_\ 6HY6',BY15/^T#_SZO\ ]]?_ %J/
M[0/_ #ZO_P!]?_6HY6',BY15/^T#_P ^K_\ ?7_UJ/[0/_/J_P#WU_\ 6HY6
M',BY15/^T#_SZO\ ]]?_ %J/[0/_ #ZO_P!]?_6HY6',BY15/^T#_P ^K_\
M?7_UJ/[0/_/J_P#WU_\ 6HY6',BY15/^T#_SZO\ ]]?_ %J/[0/_ #ZO_P!]
M?_6HY6',BY15/^T#_P ^K_\ ?7_UJ/[0/_/J_P#WU_\ 6HY6',BY15/^T#_S
MZO\ ]]?_ %J/[0/_ #ZO_P!]?_6HY6',BY15/^T#_P ^K_\ ?7_UJ/[0/_/J
M_P#WU_\ 6HY6',BY15/^T#_SZO\ ]]?_ %J/[0/_ #ZO_P!]?_6HY6',BY15
M/^T#_P ^K_\ ?7_UJ/[0/_/J_P#WU_\ 6HY6',BY15/^T#_SZO\ ]]?_ %J/
M[0/_ #ZO_P!]?_6HY6',BY15/^T#_P ^K_\ ?7_UJ/[0/_/J_P#WU_\ 6HY6
M',BY15/^T#_SZO\ ]]?_ %J/[0/_ #ZO_P!]?_6HY6',BY15/^T#_P ^K_\
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M1R,/:1/2Z*\T_P"%D:I_T#K?\F_QH_X61JG_ $#K?\F_QHY&'M(GI=%>:?\
M"R-4_P"@=;_DW^-'_"R-4_Z!UO\ DW^-'(P]I$]+HKS3_A9&J?\ 0.M_R;_&
MC_A9&J?] ZW_ ";_ !HY&'M(GI=%>:?\+(U3_H'6_P"3?XT?\+(U3_H'6_Y-
M_C1R,/:1/2Z*\T_X61JG_0.M_P F_P :/^%D:I_T#K?\F_QHY&'M(GI=%>:?
M\+(U3_H'6_Y-_C1_PLC5/^@=;_DW^-'(P]I$]+HKS3_A9&J?] ZW_)O\:/\
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M4_Z!UO\ DW^-'(P]I$]+HKS3_A9&J?\ 0.M_R;_&KT7C?4YHP\=G 0?]AO\
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M1_PF6K?\^4'_ '[?_&BP7.ZHKA?^$RU;_GR@_P"_;_XT?\)EJW_/E!_W[?\
MQHL%SNJ*X7_A,M6_Y\H/^_;_ .-'_"9:M_SY0?\ ?M_\:+!<[JBN%_X3+5O^
M?*#_ +]O_C1_PF6K?\^4'_?M_P#&BP7.ZHKA?^$RU;_GR@_[]O\ XT?\)EJW
M_/E!_P!^W_QHL%SNJ*X7_A,M6_Y\H/\ OV_^-'_"9:M_SY0?]^W_ ,:+!<[J
MBN%_X3+5O^?*#_OV_P#C1_PF6K?\^4'_ '[?_&BP7.ZHKA?^$RU;_GR@_P"_
M;_XT?\)EJW_/E!_W[?\ QHL%SNJ*X7_A,M6_Y\H/^_;_ .-'_"9:M_SY0?\
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M1_PF6K?\^4'_ '[?_&BP7.ZHKA?^$RU;_GR@_P"_;_XT?\)EJW_/E!_W[?\
MQHL%SNJ*X7_A,M6_Y\H/^_;_ .-'_"9:M_SY0?\ ?M_\:+!<[JBN%_X3+5O^
M?*#_ +]O_C1_PF6K?\^4'_?M_P#&BP7.ZHKA?^$RU;_GR@_[]O\ XT?\)EJW
M_/E!_P!^W_QHL%SNJ*X7_A,M6_Y\H/\ OV_^-'_"9:M_SY0?]^W_ ,:+!<[J
MBN%_X3+5O^?*#_OV_P#C1_PF6K?\^4'_ '[?_&BP7.ZHKA?^$RU;_GR@_P"_
M;_XT?\)EJW_/E!_W[?\ QHL%SNJ*X7_A,M6_Y\H/^_;_ .-'_"9:M_SY0?\
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M^W_QHL%SNJ*X7_A,M6_Y\H/^_;_XT?\ "9:M_P ^4'_?M_\ &BP7.ZHKA?\
MA,M6_P"?*#_OV_\ C1_PF6K?\^4'_?M_\:+!<[JBN%_X3+5O^?*#_OV_^-'_
M  F6K?\ /E!_W[?_ !HL%SNJ*X7_ (3+5O\ GR@_[]O_ (T?\)EJW_/E!_W[
M?_&BP7.ZHKA?^$RU;_GR@_[]O_C1_P )EJW_ #Y0?]^W_P :+!<[JBN%_P"$
MRU;_ )\H/^_;_P"-'_"9:M_SY0?]^W_QHL%SNJ*X7_A,M6_Y\H/^_;_XT?\
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M<[JBN%_X3+5O^?*#_OV_^-'_  F6K?\ /E!_W[?_ !HL%SNJ*X7_ (3+5O\
MGR@_[]O_ (T?\)EJW_/E!_W[?_&BP7.ZHKA?^$RU;_GR@_[]O_C1_P )EJW_
M #Y0?]^W_P :+!<[JBN%_P"$RU;_ )\H/^_;_P"-'_"9:M_SY0?]^W_QHL%S
MNJ*X7_A,M6_Y\H/^_;_XT?\ "9:M_P ^4'_?M_\ &BP7.ZHKA?\ A,M6_P"?
M*#_OV_\ C1_PF6K?\^4'_?M_\:+!<[JBN%_X3+5O^?*#_OV_^-'_  F6K?\
M/E!_W[?_ !HL%SNJ*X7_ (3+5O\ GR@_[]O_ (T?\)EJW_/E!_W[?_&BP7.Z
MHKA?^$RU;_GR@_[]O_C1_P )EJW_ #Y0?]^W_P :+!<[JBN%_P"$RU;_ )\H
M/^_;_P"-'_"9:M_SY0?]^W_QHL%SNJ*X7_A,M6_Y\H/^_;_XT?\ "9:M_P ^
M4'_?M_\ &BP7.ZHKA?\ A,M6_P"?*#_OV_\ C1_PF6K?\^4'_?M_\:+!<[JB
MN%_X3+5O^?*#_OV_^-'_  F6K?\ /E!_W[?_ !HL%SNJ*X7_ (3+5O\ GR@_
M[]O_ (T?\)EJW_/E!_W[?_&BP7.ZHKA?^$RU;_GR@_[]O_C1_P )EJW_ #Y0
M?]^W_P :+!<[JBN%_P"$RU;_ )\H/^_;_P"-'_"9:M_SY0?]^W_QHL%SNJ*X
M7_A,M6_Y\H/^_;_XT?\ "9:M_P ^4'_?M_\ &BP7.ZHKA?\ A,M6_P"?*#_O
MV_\ C1_PF6K?\^4'_?M_\:+!<[JBN%_X3+5O^?*#_OV_^-'_  F6K?\ /E!_
MW[?_ !HL%SNJ*X7_ (3+5O\ GR@_[]O_ (T?\)EJW_/E!_W[?_&BP7.ZHKA?
M^$RU;_GR@_[]O_C1_P )EJW_ #Y0?]^W_P :+!<[JBN%_P"$RU;_ )\H/^_;
M_P"-'_"9:M_SY0?]^W_QHL%SNJ*X7_A,M6_Y\H/^_;_XT?\ "9:M_P ^4'_?
MM_\ &BP7.ZHKA?\ A,M6_P"?*#_OV_\ C1_PF6K?\^4'_?M_\:+!<[JBN%_X
M3+5O^?*#_OV_^-'_  F6K?\ /E!_W[?_ !HL%SNJ*X7_ (3+5O\ GR@_[]O_
M (T?\)EJW_/E!_W[?_&BP7.ZHKA?^$RU;_GR@_[]O_C1_P )EJW_ #Y0?]^W
M_P :+!<[JBHX':2WBD889D!(]"112&24444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %<+)_P E$'_74?\ H KNJX63_DH@_P"N
MH_\ 0!30F=U1112&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110!S?C?_ ) <?_7=?_06
MKE=._P"/%/JW_H1KJO&__(#C_P"NZ_\ H+5RNG?\>*?5O_0C6D#*9:HHHJR
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M** "BBB@ HHHH **** "BBB@!&^Z?I7#^!/^/V[_ .N8_G7<-]T_2N'\"?\
M'[=_]<Q_.F)[G<T444AA1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7"R?\E$'
M_74?^@"NZKA9/^2B#_KJ/_0!30F=U1112&%%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M!S?C?_D!Q_\ 7=?_ $%JY73O^/%/JW_H1KJO&_\ R X_^NZ_^@M7*Z=_QXI]
M6_\ 0C6D#*9:HHHJR HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!&^Z?I7#^!/^/V[_ZY
MC^==PWW3]*X?P)_Q^W?_ %S'\Z8GN=S1112&%%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %<+)_P E$'_74?\ H KNJX63_DH@_P"NH_\ 0!30F=U1112&%%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110!S?C?_ ) <?_7=?_06KE=._P"/%/JW_H1KJO&_
M_(#C_P"NZ_\ H+5RNG?\>*?5O_0C6D#*9:HHHJR HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M1110 4444 %%%% !1110 4444 %%%% !1139)(X8GEE=4C12S.QP% ZDGL*
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M96<]U.VV&"-I';T51DG\A7E]EKWC[QQ)/>>'I+32=+C?9"UR@)E_$JV3ZX
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MXDL[?2-(CBGU3YGNK^X152)=V!P !P,=B3G@<5W_ (3L_%MJ;K_A)]3M+P9
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M'PGIL!MK;[3J-XYCM83R"1C)(')'(X'4D=*YAA\6;6T75&N;"Y&WS&TX1KO
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M?3')'->IZ/8G3-#T_3V8.UK;1PEAT)50N?TI5-8IO<=+2<HQV/*OCM_S /\
MMX_]I5[%7COQV_Y@'_;Q_P"TJ]BHG\$?F.G_ !9_(****R-R&[N8K*SGNIVV
MPP1M([>BJ,D_D*\6\">/9;GXD7CWKE;;67$:J>B..(AW[97 [L/2NB^,7B![
M;2;?P_9EFN]08&1$&6\H'@8Z_,V /7:PK"\8^ #H7@'2[ZT0#4--PUXZ');<
M<DCUVM@#CISVK>G%<OO=3DK3DY>[]G4]JHK"\':^GB7PQ9ZB&!F*[)QZ2+PW
M^/T(K=K%JSLSJ335T%%%%(84444 %%%% !1110 4444 %%%% !1110 4444
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M)_&#QC<61C\/6$S1-(GF74B,5;:> F1V/.?;'O7+^!OAA<>*+/\ M&^N&L[
MDB+:N7EQU(SP!U&?45,::Y>:;+J5I<_)36IWT'QH\+S2;7AU& ?WY(5(_P#'
M6)_2NWTK6=-URS%UIEY%=0GJ8VY4]<,.JGV.#7G&H_ _2VM6_LS4[R.Y )7[
M3M=">P.U01]>?I3?A[\.-=\/ZPNIW]^+1%RK6L#;_.';<>F._<_0TI1IM7BQ
MPE64K26AZ!XE\1V?A;2#J5]'/)"'5-L"@MD_4@?K65X5^(.D^+[^:ST^WO8I
M(HO-8W"(H(R!QACSS6;\8O\ D0I/^OF/^M<1\$/^1GU#_KR/_H:T1@G3<@E5
MDJRAT/;-1OHM,TR[OYE=HK6%YG" %BJJ2<9[\5QVB?%?0M>UFVTNUM-12>X8
MJC2QH%!P3SAR>WI71>+?^1,UW_L'W'_HMJ^?/AQ_R4+1_P#KJ?\ T!J*<%*+
M;"M5E&<8KJ>@?%GQEITEC?\ A80W7VZ-XF,A5?*QA7Z[L]#Z=:X?X<^++#PA
MK-U>:A#<RQRV_E*+=58@[@><D<<5W'Q9\&Z='8W_ (I$UU]ND>)3&67RL85.
MFW/0>O6N'^'/A.P\7ZS=6>H37,4<5OYJFW95).X#G(/'-;0Y/9^1SU/:>V\^
MA]%:=?1:GIEI?PJZQ74*3(' #!64$9QWYK UWXA>&_#TSV]W?>9=(<-! I=E
M/H>P_$UA?$+7W\#^#=/TC2Y95N98A;03,1N2.-5#-D#&[!4=NI(Z5YEX'\ 7
M?C22>X>Y-K8PMM><KO9WX)4#(YP<D]LCK64*<6N:6QO4K24E""NSTZV^,_A>
M>94DCU&W4D O+"I ]_E8G]*[C3-5L-9LEO-.NHKFW8XWQG.#Z'T/L:\VOO@?
MIALS_9^J7B704X-QM9&;''100,_6O.]$U75/AUXR>.=64PR>5=P9.V5/7\CN
M4_3L2*?LX37N/47MJE-KVBT/IFBFHZ21JZ,&1@"K*<@@]Q3JYSK"N4\0?$7P
MYX<F>WNKMI[M#AK>V3>R_4\*/H3FJWQ.\3R^&_"K?9'9+V\?R877J@ZLV?7'
M [Y(/:O%?!O@Z]\9ZH\4<AAMHOFN+EEW;<] /5C_ (UM3IIKFEL<U:M*,N2"
MU/7]/^,/A6]G\J5KRR!P ]S"-I_%"V/QJ;6OBMX?T34FLI([RY(17$UJL;QN
M& ((;>,\&L2[^!VEM9XL]6O([H+]^95=">/X0 0.O<]>^.?&M3TVYTC5+G3[
MM0MQ;R&-P.F1W'L>HK2%.G)Z&52M6IKWD?4D7B"TE\+'Q"L<PM!:M=["H\S8
M%+$8SC.!ZUS>C_%?P[K%Q-$J7EHD,+3R372(J!1CT8G/(P,<T67_ "1)O^P)
M)_Z*:O ='TZ;5]7M--@;;)=2K%N/09(Y/L.OX5,*<97N55K3BXVZGT+H'Q+T
M3Q)KBZ580WWFLK,LDD2A" ,G^(G]*Z35M9T[0[)KO4[N.V@7^)SR?8 <D^P%
M8'A'X?Z9X/NI[FTFGN)IHEC+S8RN#EMN , G;P<_=ZUX9XP\27?B_P 327 \
MQX=_E6D"Y.U>@P/5NI]S["E&G&<O=V*E6G3A>>[/6Y?C3X8CG,:P:E(H./,2
M%-I]^7!_2M2;XG>&8]%?4X+J2Z1&57@B0"9<]RK$<9XR.*Y/0_@E;-8QR:YJ
M%RMRZY:&U*@1GT+$'=^&/ZGC?'7P\NO!PBNH[C[7I\S;!+MVM&V,X8=.><$>
MAZ<9I0I2=DR'4KQCS-'L?A7X@Z3XOOYK/3[>]BDBB\UC<(B@C('&&//->,_$
MSQ'9^)?%*7%G'/&EO +9Q,H!+*[DD8)X^85N_!#_ )&?4/\ KR/_ *&M87Q,
M\.6?AKQ2EO9R3R)<0"Y<S,"0S.X(& ./E%5",8U&D14G.=%-G7?#'QQH^GZ7
M8>&Y;2Z:]GNB/,2-#'N9OE).[/'';M7+_$CQEIWC"ZT^73X;J);='5_M"JI)
M)&,88^E=5\,? 6EZAI>G>));B\6\BN"ZHCJ(R4;C(VY[>M<K\2/!NG>#[K3X
MM/FNI5N$=G^T,K$$$8QA1ZTX\GM--Q3]I[%7V.A^%OCK3-'T^W\/W$%XUW=W
MP$;QHIC&_:HR2P/7KQ7M=>*?"WP+IFL:?;^(+B>\6[M+X&-(W41G9M89!4GK
MUYKVNL*W+S:'3AN;D]X*K:A>+IVG7-Z\4LJ6\32M'$ 78*,D $C)JS161T'"
MZ+\6/#^N:Q;:9!!?PRW#;$>>- F<$@$AR>>@XZD5W5?,7C31I?"?C6Y@M\QQ
MK(+FT?&/E)R,?0Y'_ :^A?#VOV^M^&+762\<:20[YOFPL; ?."3T (/7M6U6
MFDE*.QS4*LI-QGNC+\5?$+2/"%_#9W\-Y+-+%YH%NBL N2.<L.X/Y5K>&_$%
MMXGT=-3M+>YAMW=E07"A2V#@D8)&,Y'X&OG+5[RZ\;>-Y)84)EO[A8X4Z[5X
M5?3H ,GZFOH&^N;7P+X%:5(P\6G6RHBJNWS'X49QTW,1D^Y-.=-1275BI5G.
M4F_A1:UWQ3HOAN-6U6^C@9AE(\%G8>RCFN1/QJ\,"8H+?4RH_P"6@A3!_P#'
M\_I7DFF:?K'Q"\6%'G,MU.3)//)TC08!./09  'L*]/B^!^CBTVRZK?-<X_U
MB!%3/^[@G_QZFZ=.&DGJ2JM6IK!:'<:#XLT3Q*A.EWR32*NYXB"LB#W4\^V1
MQ[UJW,Z6MK-<."4B1G8+U( SQ7S5XE\.:M\/O$,#1W+#DRVEW%D;@#CG_:'&
M1R.>X->Y:7KX\3?#V35-J))+:2B5$.0K@$$>W3/T(J9TTK-;&E*LY7C)6:,W
M1OBQX>UG4!:1Q7MM\CR-+<HBQJJJ6))#GL/2I=(^*&@ZYKT.D6,-\\TQ(20Q
M (<#)/WLC@'MVKYWLK::]O8+.WYEN)%B0>I8@ ?GBOHGPC\-]-\):@;^&YFN
M;EH3$6E484D@DJ!TZ8[_ %YJZE.$#*C5JU'Y%[Q'X]T#PO,+>_N6>Z.";>!=
M[J#W/8?B<\UDZ;\7O"VH7"PR275D6. UU$ OYJ3C\:\)<F\\2-_;=P\!ENB+
MR;;N:/+?.<#KCGI7H=_\)+74;:WO?".L)>VTCJC^=(IV ]6W*!T[KC/X\4W2
MA%6DQ*O5FVXH]M1TDC5T8,C %64Y!![BO/I/C)X>CO6M39ZIYBR&,D11XR#C
M^_77^'-#A\.:#:Z5!-),D"D>9(>6).2<=ADGCM7S!=?\C'-_U]M_Z'44J<9-
MW-*]6<$K=3ZSKB-?^*6B>'-;N-)O+74'G@V[FAC0J=RAA@EP>A':NWKYL^*G
M_)2-6_[8_P#HE*FC!2E9EXBI*G&\3Z'TG4H=8TFUU&W618;F,2(L@ 8 ^N"1
M^M<OK?Q2\,Z)=/:O//=SQG:ZVJ!MIS@C)('ZU7M9+N'X*1R6)(N%TK*E>H&W
MDCWQFO#_  Q9:/J&N16^N7[V-DP.94'.[L,D$#ZD54*2=V^AG5KRCRI;L]\T
M+XF^&M?NA:Q7,EK<-]Q+M F[V!!(S[9^F:["O$Y?@PTVLVK:;JB3Z)-EWG)!
MD11V&.&)[$8'7(Z9]HMX%MK:*!"Q2) BECDD 8Y/<U%107PLUI2J._.B2BBB
MLS8X'XQ?\B%)_P!?,?\ 6N ^#M_::;KFJ75[<1V\$=B2TDC8 ^=:[_XQ?\B%
M)_U\Q_UKP_PUX?NO$^N0:7:%5>3)>1AQ&@ZL?\]<5UTDG3:9P5VXUTT>UW'Q
MG\+0SF.--0G4-CS(X%"D>OS,#C\*Z[0?$>E>);(W6E72S(N ZX*O&3V93R/Y
M''%>8>)O@[8Z;X;N;[3+Z[DN[6(RNDY4K(%&6Q@ @XR1U[#WKC_ACJ4^G^/-
M/6)R([EC!*O9E(XS]" ?PJ/9PE%N/0M5JD)J-1;GTI7,Z_X_\.^')C;WM]ON
MEZP0+O=?KCA3[$BLGXH^+Y?#.AQVUBY34+[<B.#S$@^\P]^0!]2>U>3^"/ M
MYXVNYY7N3;V<+?OKAEWLS'G:!GD^I[>]3"FFN:6Q=6M)2Y(*[/4+;XS^%YYE
M22/4;=20"\L*D#W^5B?TKN=.U.QU>S6[TZ[BN8&Z/$V0#C.#Z'D<'D5YCJ?P
M/L39?\2K5+A;L+TNMK(Y_P" @%1^=>=^&-?U'P/XI!E$B)%*8;RU)X89PW'J
M.H/J/2J]G":]QD>VJ4VE46A]-R21PQ/+*ZI&BEF=C@*!U)/85P5_\8O"UG<-
M%&;V\"G&^WA&T_3<RYIOQ?N+C_A 0UF^Z"6YC$S(<@Q$$CGTW!*\H\#Z'X<U
MZ[N;;7=7DL)<*+90502$YSEF!''''!.>*5.G%QYI%5JTE-0B>Z^'?'&@^*',
M6GW9%P!DV\R['QZ@=_P)KE/BGXTTZVTS4?##PW1O9HD*R!%\L98-R=V>@]*S
M_#OPANM,\7K=W=Z&T^S=9H)(CM>9@<@$?PX(Y]>,=3C0^*?@O3KG3-1\3O-=
M"]AB0+&'7RSA@O(VYZ'UH2@IJS"4JKI.ZLSS+P!XEL_"OB0ZC?13R0^0\>V!
M06R2/4@=O6OHW1M5@US1[;4[9)$AN$WHLH 8#WP2/UKYR\ >&K/Q5XD.G7TL
M\</D/)N@8!L@CU!'?TKZ-T;2H-#T>VTRV>1X;=-B-*06(]\ #]*>(Y;^9.$Y
MK>1>HHHKG.P**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@#F_&_\ R X_^NZ_^@M7*Z=_QXI]6_\ 0C75>-_^0''_ -=U_P#0
M6KE=._X\4^K?^A&M(&4RU1115D!1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M200SO.\;#(;:!@'VW$<=^E>Y5Y!X9_Y+OK?^[-_[+7K]%5ZKT%ATK-^;./\
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MC9>:C$28I1,(R3G**H53^0%.G>TO05:W-#O<]MHHHK$Z#COBI_R3?5O^V/\
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M&E1^,>(M[-GJ-G<K>V-O=(,+-&L@&<\$9_K4]5["U%CIUM9JVY8(DB!QC(4
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_P#(YV?_ &#T_P#1DE2_!#_D9]0_Z\C_ .AK47QM_P"1SL_^P>G_ *,DJ_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ JYIVHRZ?/O3YD/WT[$?XU3HH [ZVN8KN!9H6W*?S
M!]#4U</IVHRZ?/O3YD/WT[$?XUV5M<Q7<"S0MN4_F#Z&LI1L;1E<FHHHJ2@H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N%O?\ DHB?]=8__0!7
M=5PM[_R41/\ KK'_ .@"FA,[JBBBD,**** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH 1ONGZ5P_@3_C]N_P#KF/YUW#?=/TKA_ G_ !^W?_7,?SIB>YW-
M%%%(84444 %%%% !1110 4444 %%%% 'G&A>%M9L_BSJFMW%GLTZ=9!'-YJ'
M=G;CY0<CH>U>CT454I.6Y$(*"L@JCK5O+=Z#J-M N^::VDC1<@98J0!D^]7J
M*E%-7T.(^%N@:GX<\,W-GJUM]GG>\:54\Q7RI1 #E21U!KMZ**<I<SNQ0BHQ
M44>?^*?AZNO>/-)U<(IL_P#E_5L8;9R@P>N[[I] *] HHIN3:2?0(P46VNH5
MYYXB^&T\FM?V[X6U :7J+'+KRL;$]3P#C/<8(->AT41DX[!."FK,\S_M#XM1
M1+;_ -CZ7,PX-SO0$\]2/, _\=I-.^'>L:WK$6K>-M02[\HDQ6,9R@YS@] !
MGL,YXR>U>FT57M'T5C/V*^TVQ%544*H 4#  ' %<3\4M U/Q'X9MK/2;;[1.
MEXLK)YBIA0C@G+$#J17;T5$9<KNC2<5*+BRCHMO+::#IUM.NR:&VCC=<@X8*
M 1D>]-UK1K'7]*FT[4(O,@E'8X93V93V(K0HHOK<=E:QY3!X1\<^#)9$\,ZC
M#J&GG)2VN&P5R<_=)"@^X(SZ"K$P^*^MC[-)%I^C1L,-+$XR!]0SD'Z8_"O3
MJ*OVCZI&7L4M$W8\1\1_"34+?2M/72(GU+46=WO9VE5 2<8P&(XZ^I[\9KV3
M4X9+C2KR&)=TDD#HHSC)*D"K5%*4W*URH4HPO;J<%\*_#FK>&]%OK?5K7[/+
M+<;T7S%?*[0,_*37>T44I2<G=E0BH1Y49VO:=-J^A7NGV]X]I+<1%%G09*__
M %CT/?!XKSZVB^*GAZW_ +/MX+#5X4&([B64%E'U9D)Z]P>GI7J5%$9V5K$R
MIJ3O>QY]X3\$:I%XBD\3>*+R.ZU-EQ%&@!6/C&>F,@= .F37H-%%$I.3NRH0
M4%9'G7PH\,:QX:MM435[/[,T[QF,>:C[@ V?NDXZBO1:**)2<G=BA!0CRH\P
MU3X>ZQHFOMKG@F]2"25CYMI+@+@\G!.05)['IV/3!+??%R[A$"Z3IUDW'^D(
M\9;\C(P]^E>GT57M'U5R/8KHVCB/!7@#_A';N;5M4NQ?ZS.#OE(RL9)Y*D\D
MGN>*[>BBHE)R=V:1BHJR/-O$'PTNH]7?7/".HG3;]R6>$DK&V>3@CIG^Z00?
M:F?;_BTJM;_V1IC'H+C>F?P'F?S6O3**OVCZJY'L5>\6UZ'E?_"M]:UA;O5/
M%>H#4+_[-(MK:1-A$<J=O/ &#V'&><FMWX6Z!J?ASPS<V>K6WV>=[QI53S%?
M*E$ .5)'4&NWHH=1M681HQC+F6X5XGX^TJW\2_%NQTFR1A</'&MZPQ@ 98GZ
MB/'?G@5Z]K&IP:+H]WJ5P1Y5M$9",XW$=!^)P/QKSKX1Z7/>RZGXNU!2;F^E
M=(F*X!!.78<=-W'!_A(IT_=3D367.U3/3X((K6WBMX4"11($11V4# %2445D
M;A45S;07EM+;7,22P2J5>-QD,#V(J6B@#RN3P)XJ\)W\UQX+U-&LYF):RN"/
ME_[ZR#TQNX/;U-2W%W\6]13[.NFZ=IH;K/&Z$C\W?]!7I]%:>T?5)F/L4MFT
M<)X.^'8T.^?6=9NQJ6LR'/FG)6(GJ03RQ_VB!Z8]>[HHJ)2<G=FD(*"LCSKX
M4>&-8\-6VJ)J]G]F:=XS&/-1]P ;/W2<=17HM%%.4G)W8H04(\J."^*GAS5O
M$FBV-OI-K]HEBN-[KYBIA=I&?F(K7U_2;Z]^'<^E6\&^]:S2(1;U&6 &1DG'
M;UKIJ*.=V2["]FKM]SE/AUH]_H/@ZWL-2@\BY221F3>K8!8D<J2*ZNBBDW=W
M*C%122.!\5_#DZEJJZYX?O1IFK [G8$JDC>IQR#ZGG/IZTEOOBS:I]F.EZ7>
M$<?:BR GWP'7Z_=KTNBJ51VL]2'25[IV]#R^U\ >(/$NJ0:AXVU%)((CN6PA
M;CZ'& H.!G&2?45Z='''#$D42*D:*%5%& H'0 =A3J*4I.6Y4*:AL>=1^&-8
M7XTS>(#9_P#$K9,"?S4Z^0$^[G=]X8Z4?%'PQK'B.YT-]*L_M"VKRF8^:B;0
M3'C[Q&?NGIZ5Z+1351W3[$NC%Q<>^ISWCC3+O6/!FI6%A#YUU,BB--P7)#J>
MI('0&H_ &E7NB>"=.T[48?)NH?,WQ[E;&9&8<J2.A%=+12YGR\I7(N;G^1YQ
MH7A;6;/XLZIK=Q9[-.G601S>:AW9VX^4'(Z'M7H]%%$I.6X0@H*R.>\<:9=Z
MQX,U*PL(?.NID41IN"Y(=3U) Z U'X TJ]T3P3IVG:C#Y-U#YF^/<K8S(S#E
M21T(KI:*.9\O*'(N;G^1R?C/P)9>+4CG\Y[34H%Q!=)V&<@,.XSDC&""?J#S
MT9^*^C?Z.D.G:S&@"K+(R@D>N2R$GUSG\>M0Z]X3USPMXED\3>#XQ,DV?M-B
M%!ZD$@*.JD\\<CZ58C^,=G:Q[-9T'5+.Y7Y618P1GO\ >*D=/2M4I6TU1A)Q
MYGS7B_S$;PUXX\72"+Q/J$&GZ62K26=GC,@SG;D9_5C]#6/X(TNUMOC'JT&G
MQ!;.P@>-<'."-B8SZYW=?>M&Y^)NL>((_LO@_P /WCSR' N9U!6,9ZX^Z/JS
M8'O73> _!O\ PBFG2R74WVC5+PA[J4G///R@]3U.3W--MQB[_<)1C.2<=;=3
MK:***YSK.:\?Z5>ZWX)U'3M.A\ZZF\O9'N5<XD5CRQ Z U)X'TR[T?P9IMA?
MP^3=0HPD3<&P2['J"1T(KH:*KF?+RD<BYN?Y%>^L;74K*:RO8$GMIEVR1N."
M/\]^U>9IX&\6^$+R:;PAJL4]E(V?L=T><?B-I/N"IKU2BB,W$)TU+5[GF4UQ
M\6=43[-_9^FZ8'^4SHZY /?[[D8]AFMKP;X!B\.W$VJ:C<_VAK4Y)>Y8$A,]
M=N><GNW7MQSGLZ*;F[66A*I).[=_4****@U.,\:^'/$6IW]CJGA[5_LT]FIQ
M;NQ5'.<YX'). "&XX'3FL"Z3XJZY;'3+BUT_3H)%V2W4;KEUZ'HS$9]@/PKU
M*BK51I6L92I)N]V8/A#PO;^$]"CT^%_-D)WS3;0"[GK^'855\:^"K/QCIR1R
M/Y%Y!DP7 &=N>JD=P<?A_/J**7,[\W4KDCR\MM#RZS_X6MH,(LHK.PU:&/Y(
MYII%R%' YWH3GWR:@/@GQ?XSO8)?&-]';6,+;A:6Y7/N!MR/Q))YXKUBBJ]H
M^B1'L5LVVB*VMH+.VBMK:)(H(E"I&@P% [ 5X]XELK;4?CG9V=Y"LUO-&B21
ML."/+:O9J\@UC_DX#3?]U/\ T6U.EN_05=:17FC27PMXW\)2,GA?4X;_ $S?
MF.RO#S&,YP,\8]<$9SG%1W(^+&N#[*\%EHT3?*\L,B@X^H9V'X8KU&BE[1]4
MA^Q6R;L<GX+\!V/A"*282M=:C.NV:Y<8XSG:H[#('J21] )OB%_R(&L_]</Z
MBNFKF?B%_P B!K/_ %P_J*2;<TV5**C3:78\]\(>"3K?@C3]6TF];3-;@EE"
MW,9($B[C\K8_GZ<$$=-TWGQ9LD:W_LW2]0() N=RJ3QC(&]/K]VM+X1_\D]M
M/^NLO_H9KN:N<VI-/4RITDX)IVTZ'E<'P]\1>*=1CO?&^J$P1'*65NP_+CY5
M]R,D@=>]>H6\$5K;Q6\$:QPQ($C11@*H& !^%245G*;EN;0IJ&QSOB[P=IWB
M_3U@N\Q7$?,-R@RT?J/<'TKD+2P^)_AB,6MF]AK5LJXC\Y^4'IEBA[>I%>HT
M4U-I6%*DF^;9GE=UH?Q(\7)]DU>YM-'L'R)HX6!+*3TPI.[Z%A[UWWASPYI_
MAC28]/T^/"CF21OO2MW9CZ_RK6HHE-M6"--1=]V><>/O"VLZWXOT&^T^S\ZV
MM64S/YJ+MQ(">"03QZ5Z/112<FTEV'&"BVUU"O.OA1X8UCPU;:HFKV?V9IWC
M,8\U'W !L_=)QU%>BT4*32:[@X)R4NP4445)9R'Q)T34-?\ "+V.F6_GW)G1
MPF]5X&<\L0*YC2;CXI:/I-KIUOX:TUH;:,1HTDJEB!ZXF _2O5J*M3LK6,I4
MDY<UVCR:[T#XC>,7%IKD]MI6FL<RQPLIR,],*26]<%L5Z+X?T&S\-Z-!IEBI
M$4?+.WWI&/5F]S_+ [5J442FVK#A347?=GFWQ9\*ZUXF_LC^R++[3]G\[S?W
MJ)MW;,?>(S]T]/2C^VOBQ_T+&D_]_5_^/5Z313531)H3I)R<DVKG Z7JWQ+E
MU6UCU+P]IL-BTJB>2.0%D3/)'[T\X]C6<WA+7/$'Q4&M:U8^3I-H<VP:5&W!
M/N#"L3RQ+G/N*]/HH]I;9![)/1ML****S-2KJ6GV^K:9=:?=*3!<Q-$^,9 (
MQD9[CJ/>N'^&6A^(O#!U'2=5LP+ R&6WN4E1@S?=/ .[#  C(&,'/)KT*BJ4
MFDT0X)R4NJ"BBBI+"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH *X63_ )*(/^NH_P#0!7=5PLG_ "40?]=1_P"@"FA,[JBBBD,****
M"LMO#.@O,9GT336E/5S:1EO3KBM2BFFT)I/<J7>EZ??VJ6MY86MQ;QD%(IH5
M=%(& 0",#@D4VQT;2]+9VT_3;.T9P YMX%C+ =,X S5VBB["RW"J]W86>H1>
M5>VD%S'_ ')HPX_(U8HI#,RV\.Z'9S++:Z-IT$JD$/%:HI!'0Y K3HHHO<22
M6P5!=6-I?1^7>6L%Q'R-LT8<<]>#4]% S,MO#NAV<RRVNC:=!*I!#Q6J*01T
M.0*TZ**+W$DEL07EE::A;FWO;6&Y@8@F.:,.I(Z<'BJ]CHFDZ9*TNGZ796DC
M+M9[>W2,D>A( XJ_13NPLKW"H;FTMKR+RKJWBGCSG9*@89^A^M344AF5%X8T
M"WDWPZ'ID;]-R6D8/Z"M155%"J % P !P!2T4VVQ));!1112&<KX^D\1VWA_
M[9X:N&2Y@?=+&L22&2/'. P/(Z\>]>3:3\5]5$[Q>)(8=9T^0!6ADAC4K[C"
MX/&>#U]17T'7(ZS\-/"^M7+7,UB;>=\EWMG\O<?4CIGWQSWK6G.*5I(YZM.;
M?-!G%I\4O!VF(+C1_"GE7O3Y;>& =.?G7)_2O/5CU7Q]XP=DC#7E]+N<C.R)
M>!D]2%48_+%>NQ_!7PRC[FN=3D']UIDQ^B"NST;P[I'AZ%HM*L(K96^\5R6;
MZL<D_G6GM(1^'<R]C4G93>A;AL+:'2X].,8EM4A$&R4!@R!=N&'0Y'6JMMX;
MT*SN$N+71=.@G0Y22*U164^Q R*TZ*Y[L[+(****0S+E\-Z%<3>=-HNG22]=
M[VJ%OS(JU<:9I]U9BSN+&VFM001#)$K("/\ 9(Q5JBG=BY44+'1-)TR5I=/T
MNRM)&7:SV]ND9(]"0!Q1?:'I&IS":_TJQNY578'GMTD8+DG&2.G)_.K]%%V'
M*K6(+.RM-/MQ;V5K#;0*21'#&$4$]>!Q4-]HVEZHR-J&FV=VR A#<0+(5!ZX
MR#BKM%%V%E:Q7LM/LM-@,%C:6]K"6W>7!&$7/K@#K5BBBD,**** "L^?0M(N
MKT7MQI5C-= @B>2W1GR.GS$9XQ6A11<32>X4444#&NB21LCJ&1@0RL,@@]C6
M6WA?P^\IE?0M,:0G)<VD9.?7.*UJ*:;0FD]R."WAMH_+MX8XDSG;&H49^@IS
MHDD;(ZAD8$,K#((/8TZBD,RH/#.@6TZ3V^AZ;%-&P9)([2-64CH00.#6K113
M;;$DEL5[NPL]0B\J]M(+F/\ N31AQ^1J&RT72M-<O8Z996K'JT$"H?T%7J*+
ML++<*1E5U*L 5(P01P12T4AF4_AC0)9O.DT/3'EX.]K2,GCISBM&""&UA6&W
MBCBB3A4C4*H^@%244[L226P52O=(TS4B#?Z=:71 P#/ KX'7'(J[12&U?<K6
M6FV.FQF.QLK>U0]5@B5 ?P ]S^=6:** V"BBB@"O>6-GJ-O]GOK6"ZAR#Y<\
M8=<CO@\5!8Z)I.F2M+I^EV5I(R[6>WMTC)'H2 .*OT4[L5E>XUT22-D=0R,"
M&5AD$'L:S;?PUH-I<)<6VB:;#-&<I)':(K*?4$#(K4HHNP:3W"H;JSM;Z'RK
MNVAN(LYV2H'&?7!J:BD,RX/#>A6LGF6^BZ=#)TW1VJ*?S K4HHH;N))+8*SK
MOP_HM_,9;S2+"XE/\<ULCG\R*T:*+V!I/<BM[:WM(1%;01PQ#HD:!0/P%%S:
MV][;O;W4$4\#\/%*@96[\@\&I:*!V,^RT'1]-G\^QTFPM9L%?,@MD1L>F0,U
MH4447N))+8****!A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 <WXW_Y <?_ %W7_P!!:N5T[_CQ3ZM_Z$:ZKQO_ ,@./_KN
MO_H+5RNG?\>*?5O_ $(UI RF6J***L@**** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH *N:=J,NGS[T^9#]].Q'^-4Z* .^MKF*[@6:%MRG\P?0U-7#Z=
MJ,NGS[T^9#]].Q'^-=E;7,5W LT+;E/Y@^AK*4;&T97)J***DH**** "BBB@
M HHHH **** "BBB@ HHHH **** "N%O?^2B)_P!=8_\ T 5W5<+>_P#)1$_Z
MZQ_^@"FA,[JBN0^(WBJ^\(>'K?4-/BMY99+I82+A69=I1V[$<Y45YC_PO#Q+
M_P ^.D_]^I/_ (Y6D*,IJZ)E4C%V9[[17@7_  O#Q+_SXZ3_ -^I/_CE'_"\
M/$O_ #XZ3_WZD_\ CE5]6F3[:)[[17@7_"\/$O\ SXZ3_P!^I/\ XY1_PO#Q
M+_SXZ3_WZD_^.4?5IA[:)[[17@7_  O#Q+_SXZ3_ -^I/_CE'_"\/$O_ #XZ
M3_WZD_\ CE'U:8>VB>^T5X%_PO#Q+_SXZ3_WZD_^.4?\+P\2_P#/CI/_ 'ZD
M_P#CE'U:8>VB>^T5X%_PO#Q+_P ^.D_]^I/_ (Y1_P +P\2_\^.D_P#?J3_X
MY1]6F'MHGOM%>!?\+P\2_P#/CI/_ 'ZD_P#CE'_"\/$O_/CI/_?J3_XY1]6F
M'MHGOM%>):%\8O$.I^(=-T^:STQ8KJZBA<I%(&"LX4XRYYP:]MK.=-PW+C)2
MV"BBBH*"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@!&^Z?I7#^!/^/V[_ .N8_G7<-]T_2N'\"?\ '[=_]<Q_.F)[G<T444AA
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !7"R?\E$'_74?^@"NZKA9/^2B#_KJ
M/_0!30F=U1112&%%%% !1110 45Y_P#&#4;[3/"5K-87EQ:2M?(A>"5HV*^7
M(<9!Z<#\JPO@UK.J:I?ZLNH:E>7:I%&4%Q.T@4DG.,DXK14WR<QBZR53V=CU
MVBO"_BGXNUZV\7S:9:7US8VMJB>7]FD:,R;E#%B0>>21Z<>N:]%^&NNWOB#P
M=#=:@YDN(Y'A:4C!D Q@_D<9]J)4VHJ01K*4W#L=?11169L%%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 <WXW_ .0''_UW
M7_T%JY73O^/%/JW_ *$:ZKQO_P @./\ Z[K_ .@M7*Z=_P >*?5O_0C6D#*9
M:HHHJR HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M7)7@5>^_'#_D2[/_ +"*?^BY*\"KOPWP'-6^(****W,@HHHH **** "BBB@
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MH **** "BLSQ#J_]@Z!>ZIY'G_9H]_E;]N[G&,X./RKB_"7Q5_X2GQ%!I/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KA9/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110!S?C?_ ) <?_7=?_06KE=._P"/%/JW_H1K
MJO&__(#C_P"NZ_\ H+5RNG?\>*?5O_0C6D#*9:HHHJR HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "KFG:C+I\^]/F0_?3L1_C5.N@T
M71=^VZNE^7JD9[^Y]J3:MJ.*;>AT,,JS0I*H(5P" PP:?116)N%%%% !1110
M 4444 %%%% !1110 4444 %<+>_\E$3_ *ZQ_P#H KNJX6]_Y*(G_76/_P!
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M$@FOEK6DUJP>/1M8-PALBWE03-D1[L9VG^Z=HZ<>G6O7O@?_ ,BYJ7_7V/\
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M\1ZS'<F(,L7G70*ER>@4'MUZ#'7O51H\LKMDSQ//!I+4ZWX(?\C/J'_7D?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MQ\#K: :5JMT$7[09UC+=PH7('TR3^5>L5\Q^#_%]_P""-7F=8#)#)\EU:O\
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MC\(75PJCS9;Q@[=R%5<#\,G\S7,_'+_D.:5_U[-_Z%75_!?_ )$>3_K]D_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !7"R?\E$'_ %U'_H KNJX63_DH@_ZZ
MC_T 4T)G=4444AA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0*!Y>'"@#VP:]1KP[X/_ /)0=9_Z]I?_ $:E132<)%3;YD>XUX9J]O'_ ,-
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MV%,T77M+\0V1N]*NTN80Q4D J5/H00"/Q%%G:X<RO;J:-%%%(84444 %%%%
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M*\._##1?#.LQ:I976H23Q!@JS2(5^8$'.$![^M=K110Y.6K%&$8JT3Y,NO\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH YOQO_P @./\ Z[K_ .@M
M7*Z=_P >*?5O_0C75>-_^0''_P!=U_\ 06KE=._X\4^K?^A&M(&4RU1115D!
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%=!HNB[]MU=+\O5(SW]S[4F[
M#2N&BZ+OVW5TOR]4C/?W/M72445DW<V2L%%%%(84444 %%%% !1110 4444
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M *%52HVBY7)CB>::C8]OHKSGXE_$*;PP8]+THQG494WO(PW>0IX&!T+'KST
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M#I$AQEKH$X]\UWGQV_Y@'_;Q_P"TJ<:?)42)G5]I1D['4_"/_DGMI_UUE_\
M0S7<UPWPC_Y)[:?]=9?_ $,UW-8U/C9TT?X<?01ONGZ5P_@3_C]N_P#KF/YU
MW#?=/TKA_ G_ !^W?_7,?SJ2WN=S1112&%%%% !1110 4444 %%%% !1110
M45Y3J_QH_LK6K[3O[ \W[+<20>9]LV[MK%<XV'&<=*J+\=E+#?X=(7N1>Y/_
M *!6OL9]C!XBDM+GL-%>?:/\8/#FI3"&Z%QI[DX#3J"G_?0Z?B!7H"LKJ&4@
MJ1D$'@BHE%QW-8SC/X6+1114E!1110 4444 %%%% !1110 4444 %%%>._\
M"]O^I;_\GO\ [751A*6QG.K&'Q,]BHKR"/XZQE\2^'F5?5;S<?RV"NHT#XJ>
M'-=N$M6DELKF1MJ)<J &/8!@2/SQ5.E-;H4:].3LF=O11169J%%%% !1110
M4444 %%>??$7XBS^$;FVT_3[6*:]EC$S-."8U0D@  $$DE3WXQWSQI_#_P 9
M-XQT>::>!(+NV<)*L9.ULC(89Y'?CGIUJ^27+S=#-58N?)U.NHHHJ#0****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MM%>7BEY)5/*1<CCN"3W] ?P\P\(>!-5\9232P.D%I$VV2YFR06Z[0.YY!/\
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MMGRQ!(&%!/0&J6D^-?#NMI=/8:G&\=J@>=Y$>)8U/<EP!VKE?C;_ ,B99_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M/S->I44U-6M)7)E3?-S1=CRF^\6>)O'43:9X:T:XL;*9C'-J%SQA._/13CJ
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '-^-_\
MD!Q_]=U_]!:N5T[_ (\4^K?^A&NJ\;_\@./_ *[K_P"@M7*Z=_QXI]6_]"-:
M0,IEJBBBK("BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBN@T71=^VZNE^7JD9[^Y]J3=
MAI7#1=%W[;JZ7Y>J1GO[GVKI***R;N;)6"BBBD,**** "BBB@ HHHH ****
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MXC@CGWRRMDXX/)_$UUO_  H_Q+_S_:3_ -_9/_C='_"C_$O_ #_:3_W]D_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MKL?7E<I\2-432O >IN6 >XC^S(,?>+_*1_WSN/X5PLOQUD,;"+P\JR=F>\W
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% '-^-_^0''_ -=U_P#06KE=._X\
M4^K?^A&NJ\;_ /(#C_Z[K_Z"U<KIW_'BGU;_ -"-:0,IEJBBBK("BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH ***Z#1=%W[;JZ7Y>J1GO[GVI-V&E<-%T7?MNKI?EZI&>_N?:ND
MHHK)NYLE8****0PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "N%O?\ DHB?]=8__0!7=5PM[_R41/\ KK'_ .@"FA,[JBBB
MD,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 1ONGZ5P_@3_C]N_P#K
MF/YUW#?=/TKA_ G_ !^W?_7,?SIB>YW-%%%(84444 %%%% !1110 4444 %%
M%% '*7?PV\)7][/>7.D[YYY&ED?[3*-S,<DX#8')[5$/A9X,4@C1AD<\W,Q_
M]GKL**KGEW(]E#LC&TKPGH&ARB73M*MH)AG$H7<XSUPQR1U]:V:**3;>Y226
MB,?7O"NB^)OL_P#:]E]I^S[O*_>NFW=C/W2,_='7TJ30_#FD^&[:6WTFU^SQ
M2OO=?,9\MC&?F)K4HHYG:PN6-^:VH5F:OX>TC7D5=4T^"YV_=9U^8=>C#GN:
MTZ*2=MAM)Z,Y*#X9>#K>42)HD98=I)I''Y,Q%=5##%;PI#!$D42#"HBA54>P
M%/HIN3>[%&,8[(Y;QYK>M>'=!&I:/:V]QY3_ .D+,C-M3'WAM(Z'K]:\O@^)
M6F^(;KR?&F@V,]L5V1SVL3"2+)YY+9V\Y^4@\=#7O#*KJ58 J1@@C@BO.=9^
M#6@ZA<M/8SSZ>7R3''AXP?8'D?3./3%:TY02M(QK0J-W@_D8L>K_  CT@+>6
MEB;J8=(3#+(1QZ2G;^M>=ZM>WWCCQE+/! QN;Z8)#"#G:, *,\#@#D_4UZ-'
M\"HP^9?$+,OHMGM/Y[S7=^&? VA^%"TFGP.]RPVFXG8-)CC@$  #CL*T]I".
MJ=V8^QJ3TDDEY&WIUFNG:7:6*-N6VA2$-C&0J@9QVZ59HHKE.[8*X[_A5?@O
M_H#?^34W_P 778T4U)K9DRC&6ZN<>OPM\&(P8:*,CUN92/R+UN:3X<T;0@?[
M,TVVMF(VET3YR/0L>2./6M2BFY2>[!0BMD%%%%248NK^$?#^NRF74M*MYYB,
M&7!5R..K+@GIZ\5G6_PT\'VS[H]$B)_Z:2R2#\F8UU=%4I26ER'3BW=HC@MX
M;6!(+>*.&&,;4CC4*JCT ' ITD<<T3Q2HKQNI5D89# ]01W%.HJ2SE+GX:>#
M[J9I9-$B5F))$4DD8_)6 %;NEZ-INB6Y@TRQ@M8V.6$28+'U)ZG\:O44W)O1
MLE0BG=(Q==\):'XEDADU>Q^TM""L9\UTP#U^ZP]*L:)H&F>'+)[/2;;[/ \A
ME9/,9\L0 3EB3T K2HHYG:P<L;WMJ>+^)OB?XJT+6KS2;O3-**HQ5?,@D(EC
M/0_?Y!']:CL]7^%6L1+<:KI']G797$D:+*(\_P"R(CC')Z@'CZ5ZAXE\):1X
MKM5AU. EX\^5/&VV2//7!_H01[5Y_<? NW9\VVORQKZ26H<_F&%;QG3MV9RS
MIU5+3WEYF!XO\9>&AX=F\/\ A*P\B&=U^T7 B""15.0,GYFY[MC X[UL?!'1
M)TDU#7)4*0NGV:$D??Y#.1[#"CT//I6MI/P5T:SF$NHWUQ?E2"(PHB0^N0"2
M?S%>D6UM!9VT5M;1)%!$H5(T& H'8"B=2*CRQ'3HS<^>?0SM=\-:1XEAABU>
MT^TI"Q9!YCI@GC^$BDT+PQH_AI)TTBS^S+.09!YKON(SC[Q..IK7HK#F=K'3
MRQOS6U*VHZ?:ZKI\UC>Q>;;3+MD3<5W#Z@@UC:/X%\-Z!J"WVF:=Y%RJE0_G
MR-P>O#,17144*32L#C%N[05@ZOX+\.:[,9M1TF"68]9%)C8_4J036]10FUL-
MQ3T9@:3X*\-Z'.L^GZ1!%,O*RMF1U^C,21^%47^&7A![EKAM(S*S[RWVF7[V
M<Y^_76T4^>7<GV<-K$5S;Q7=K-;3KOAF0QNN2,J1@C(]JYW3?A[X6TC4(;^Q
MTORKF$[HW^T2M@XQT+$=ZZ>BDI-;#<8MW:*FIZ9::QITUA?P^=:S "1-Q7(!
M!Z@@]0*R-'\"^&] U!;[3-.\BY52H?SY&X/7AF(KHJ*%)I6!QBW=H*P=7\%^
M'-=F,VHZ3!+,>LBDQL?J5()K>HH3:V&XIZ,YK3_A]X4TR=9K71H!(IR#*S2X
M.,?QDUTM%%#;>X**CLC-UO0-,\1V26>K6WVB!)!*J>8R88 @'*D'H35?0O"6
MA^&I)I-(L?LS3 +(?-=\@=/O,?6MJBCF=K"Y8WO;4AN[6&_LI[.Y3?!/&T4B
M9(W*PP1D<C@]JP-*\ >&-$U*'4=.TSR;J'.R3SY6QD%3PS$=":Z6BA-K1 XQ
M;NT5[VPM-2M7M;ZVBN8'^]'*@93^!KFO^%9>#O/\[^Q(]V<X\Z3;_P!\[L?I
M76T4*36S!PC+=$%G96NG6J6UE;Q6\"?=CB4*!^ J>BBD4%%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 5PLG_)1!_P!=1_Z *[JN%D_Y*(/^NH_] %-"9W5%%%(8
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% '-^-_^0''_ -=U_P#06KE=._X\4^K?^A&N
MJ\;_ /(#C_Z[K_Z"U<KIW_'BGU;_ -"-:0,IEJBBBK("BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHK
MH-%T7?MNKI?EZI&>_N?:DW8:5PT71=^VZNE^7JD9[^Y]JZ2BBLF[FR5@HHHI
M#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "N%O?\ DHB?]=8__0!7=5PM[_R41/\ KK'_ .@"FA,[JBBBD,**** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH 1ONGZ5P_@3_C]N_P#KF/YUW#?=
M/TKA_ G_ !^W?_7,?SIB>YW-%%%(84444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% 'G_Q@U&^TSPE:S6%Y<6DK7R(7@E:-BOER'&0>G _*
ML+X-:SJFJ7^K+J&I7EVJ11E!<3M(%))SC).*U/C;_P B99_]A!/_ $7)7/?
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MCJQ0K0GHF<E\;?\ D3+/_L()_P"BY*Y[X&?\A'6?^N47\VKH?C;_ ,B99_\
M803_ -%R5SWP,_Y".L_]<HOYM6J_@LYY?[RCC_B#>ZK+X[U'^T))5DMYV6V!
MXV1 YCV^G&#GWS7OO@RZO;WP;I5QJ/F?:G@!<R?>;L&/U&#^->7^-_B#=V'C
M"[LFT30[L63A(9KNU,DB@@'KNXY/;%=UKOBV_P!+^&UIXC@AMFO)H+>1D=6,
M8,@4G # ]^.:*EW&*L.DXQG*5SLZ*\%_X7;XE_Y\=)_[]2?_ !RC_A=OB7_G
MQTG_ +]2?_'*CV$R_K=,]ZHKD-*U_7)?AY=>(M2ALX[K[)+=6\,4;!=H0LF[
M+$G.,\$<$=ZXWPG\5]=U[Q38:7=6FG)!<.5=HHW# ;2>,N1V]*E4Y.]NAHZT
M59/J>PT45X?-\9/$,>K26HL]+\M9S&"8I,X#8_OTH0<]AU*L:=N8]PHK'\4Z
MK/H?AC4-3MDC>:WBWHLH)4G(ZX(/ZUY;HOQKOGU)1K=M9QV(1BYM87\PD [0
M,N1R<=?THC3E)70IUHP:4CVJBO#KWXX:L\S&PTJRAB["<O(WY@K72>$?B]9Z
MO-]CUN**PGVEEG5OW+8!)SDY4\<=<].N,TZ,TKV)CB*;=DSTVBO'-=^-TBW+
M1:%IT31*<">[R=_N$4C'?J?P'2C0?C9+)>)%KMA"D+G'G6F1L.>"58GCUYH]
MC.U[!]9IWM<]CHIJ.DD:NC!D8 JRG((/<5Q'C+XFZ;X6F:R@B-]J(QNB5]JQ
MY_O-SS[8_*LXQ<G9&LIQBKR9W-%>$#XWZ_YV3IVF&+/W0DF['IG?_2M/4OC=
M(^FP2:7I\4-YO(FBN@TB[<<%64KW]16GL)F*Q5/N>R5X+\;?^1SL_P#L'I_Z
M,DKT#X;>--1\8P:C)J$-K$;9HPGV=&7.X-G.6/I7G_QM_P"1SL_^P>G_ *,D
MJZ47&I9D8B2G1YD>@_"/_DGMI_UUE_\ 0S7<UX3X:^)EKX4\$6NG6]JUWJ >
M1F#$JD8+$C)[G'I^=$?QOUX2DRZ=IK1_W5613^>X_P J4J4Y2;00Q%.,$FSW
M:BN9\(>-],\86SFUW07<7,MM(1N _O ]U[9_/'%=-6+33LSJC)25T%%%%(84
M444 %<+)_P E$'_74?\ H KNJX63_DH@_P"NH_\ 0!30F=U1112&%%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110!S?C?_ ) <?_7=?_06KE=._P"/%/JW_H1KJO&__(#C
M_P"NZ_\ H+5RNG?\>*?5O_0C6D#*9:HHHJR HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHKH-%T7?MNKI?EZ
MI&>_N?:DW8:5PT71=^VZNE^7JD9[^Y]JZ2BBLF[FR5@HHHI#"BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KA
M;W_DHB?]=8__ $ 5W5<+>_\ )1$_ZZQ_^@"FA,[JBBBD,**** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHKE?%WC_2?"!CAN1)<7D@W+;PXR!ZL2>!^OM32;=D3*2BKLZJBO)+3XYVLE
MPJWFA2PQ$X9XKD2$#UP57/YUZG8WUKJ5E#>V4Z3VTR[HY$/!'^>W:G*$H[HF
M%6$_A98HHHJ30**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** $;[I^E</X$_P"/V[_ZYC^==PWW3]*X?P)_Q^W?
M_7,?SIB>YW-%%%(84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M =R?2OENW@F\2>)TBBC(EO[O[J\[=[9/X#)Y]J*+;34M@Q*491<=SV?XV_\
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M6<853[G)/MQZUG1E)S-L1""I[%OX%_\ 'GK?_72'^3U@_&W_ )'.S_[!Z?\
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M&.)22J*%&>N *O$=#+!_:70?1117,=H4444 %><ZO:RWGC">VB<+))( K,2
M/E%>C5PLG_)1!_UU'_H IH3#_A#M7_Y_H/\ OX_^%'_"':O_ ,_T'_?Q_P#"
MNZHHN%CA?^$.U?\ Y_H/^_C_ .%'_"':O_S_ $'_ '\?_"NZHHN%CA?^$.U?
M_G^@_P"_C_X4?\(=J_\ S_0?]_'_ ,*[JBBX6.%_X0[5_P#G^@_[^/\ X4?\
M(=J__/\ 0?\ ?Q_\*[JBBX6.%_X0[5_^?Z#_ +^/_A1_PAVK_P#/]!_W\?\
MPKNJ*+A8X7_A#M7_ .?Z#_OX_P#A1_PAVK_\_P!!_P!_'_PKNJ*+A8X7_A#M
M7_Y_H/\ OX_^%'_"':O_ ,_T'_?Q_P#"NZHHN%CA?^$.U?\ Y_H/^_C_ .%'
M_"':O_S_ $'_ '\?_"NZHHN%CA?^$.U?_G^@_P"_C_X4?\(=J_\ S_0?]_'_
M ,*[JBBX6.%_X0[5_P#G^@_[^/\ X4?\(=J__/\ 0?\ ?Q_\*[JBBX6.%_X0
M[5_^?Z#_ +^/_A1_PAVK_P#/]!_W\?\ PKNJ*+A8X7_A#M7_ .?Z#_OX_P#A
M1_PAVK_\_P!!_P!_'_PKNJ*+A8X7_A#M7_Y_H/\ OX_^%'_"':O_ ,_T'_?Q
M_P#"NZHHN%CA?^$.U?\ Y_H/^_C_ .%'_"':O_S_ $'_ '\?_"NZHHN%CA?^
M$.U?_G^@_P"_C_X4?\(=J_\ S_0?]_'_ ,*[JBBX6.%_X0[5_P#G^@_[^/\
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M^_C_ .%'_"':O_S_ $'_ '\?_"NZHHN%CA?^$.U?_G^@_P"_C_X4?\(=J_\
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MNJ*+A8X7_A#M7_Y_H/\ OX_^%'_"':O_ ,_T'_?Q_P#"NZHHN%CA?^$.U?\
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M61RW_",77_/2#\S_ (4?\(Q=?\](/S/^%=311<+(Y;_A&+K_ )Z0?F?\*/\
MA&+K_GI!^9_PKJ:*+A9'+?\ ",77_/2#\S_A1_PC%U_ST@_,_P"%=311<+(Y
M;_A&+K_GI!^9_P */^$8NO\ GI!^9_PKJ:*+A9'+?\(Q=?\ /2#\S_A1_P (
MQ=?\](/S/^%=311<+(Y;_A&+K_GI!^9_PH_X1BZ_YZ0?F?\ "NIHHN%D<M_P
MC%U_ST@_,_X4?\(Q=?\ /2#\S_A74T47"R.6_P"$8NO^>D'YG_"C_A&+K_GI
M!^9_PKJ:*+A9'+?\(Q=?\](/S/\ A1_PC%U_ST@_,_X5U-%%PLCEO^$8NO\
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MO^>D'YG_  KJ:*+A9'+?\(Q=?\](/S/^%'_",77_ #T@_,_X5U-%%PLCEO\
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M4T47"R.6_P"$8NO^>D'YG_"C_A&+K_GI!^9_PKJ:*+A9'+?\(Q=?\](/S/\
MA1_PC%U_ST@_,_X5U-%%PLCEU\-7:,&66 $>Y_PK9L/"ES?(=DUHKK]Y26S]
M>E7ZDAFDMY5EB8JZ]"*F2N*4$R#_ (0._P#^>UI^;?\ Q-'_  @=_P#\]K3\
MV_\ B:[+3M1COXNRRK]Y/ZCVJ[6#;1ERHX#_ (0._P#^>UI^;?\ Q-'_  @=
M_P#\]K3\V_\ B:[^BE=BY4<!_P ('?\ _/:T_-O_ (FC_A [_P#Y[6GYM_\
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M_/\ 0?\ ?Q_\*/\ A#M7_P"?Z#_OX_\ A7=447"QPO\ PAVK_P#/]!_W\?\
MPH_X0[5_^?Z#_OX_^%=U11<+'"_\(=J__/\ 0?\ ?Q_\*/\ A#M7_P"?Z#_O
MX_\ A7=447"QPO\ PAVK_P#/]!_W\?\ PH_X0[5_^?Z#_OX_^%=U11<+'"_\
M(=J__/\ 0?\ ?Q_\*/\ A#M7_P"?Z#_OX_\ A7=447"QPO\ PAVK_P#/]!_W
M\?\ PH_X0[5_^?Z#_OX_^%=U11<+'"_\(=J__/\ 0?\ ?Q_\*/\ A#M7_P"?
MZ#_OX_\ A7=447"QPO\ PAVK_P#/]!_W\?\ PH_X0[5_^?Z#_OX_^%=U11<+
M'"_\(=J__/\ 0?\ ?Q_\*/\ A#M7_P"?Z#_OX_\ A7=447"QPO\ PAVK_P#/
M]!_W\?\ PH_X0[5_^?Z#_OX_^%=U11<+'"_\(=J__/\ 0?\ ?Q_\*/\ A#M7
M_P"?Z#_OX_\ A7=447"QPO\ PAVK_P#/]!_W\?\ PH_X0[5_^?Z#_OX_^%=U
M11<+'"_\(=J__/\ 0?\ ?Q_\*/\ A#M7_P"?Z#_OX_\ A7=447"QPO\ PAVK
M_P#/]!_W\?\ PH_X0[5_^?Z#_OX_^%=U11<+'"_\(=J__/\ 0?\ ?Q_\*/\
MA#M7_P"?Z#_OX_\ A7=447"QPO\ PAVK_P#/]!_W\?\ PH_X0[5_^?Z#_OX_
M^%=U11<+'"_\(=J__/\ 0?\ ?Q_\*/\ A#M7_P"?Z#_OX_\ A7=447"QPO\
MPAVK_P#/]!_W\?\ PH_X0[5_^?Z#_OX_^%=U11<+'"_\(=J__/\ 0?\ ?Q_\
M*/\ A#M7_P"?Z#_OX_\ A7=447"QPO\ PAVK_P#/]!_W\?\ PH_X0[5_^?Z#
M_OX_^%=U11<+'"_\(=J__/\ 0?\ ?Q_\*/\ A#M7_P"?Z#_OX_\ A7=447"Q
MPO\ PAVK_P#/]!_W\?\ PH_X0[5_^?Z#_OX_^%=U11<+'"_\(=J__/\ 0?\
M?Q_\*/\ A#M7_P"?Z#_OX_\ A7=447"QPO\ PAVK_P#/]!_W\?\ PH_X0[5_
M^?Z#_OX_^%=U11<+'"_\(=J__/\ 0?\ ?Q_\*/\ A#M7_P"?Z#_OX_\ A7=4
M47"QPO\ PAVK_P#/]!_W\?\ PH_X0[5_^?Z#_OX_^%=U11<+'"_\(=J__/\
M0?\ ?Q_\*/\ A#M7_P"?Z#_OX_\ A7=447"QPO\ PAVK_P#/]!_W\?\ PH_X
M0[5_^?Z#_OX_^%=U11<+'"_\(=J__/\ 0?\ ?Q_\*/\ A#M7_P"?Z#_OX_\
MA7=447"QPO\ PAVK_P#/]!_W\?\ PH_X0[5_^?Z#_OX_^%=U11<+'"_\(=J_
M_/\ 0?\ ?Q_\*/\ A#M7_P"?Z#_OX_\ A7=447"QPO\ PAVK_P#/]!_W\?\
MPH_X0[5_^?Z#_OX_^%=U11<+'"_\(=J__/\ 0?\ ?Q_\*/\ A#M7_P"?Z#_O
MX_\ A7=447"QPO\ PAVK_P#/]!_W\?\ PH_X0[5_^?Z#_OX_^%=U11<+'"_\
M(=J__/\ 0?\ ?Q_\*/\ A#M7_P"?Z#_OX_\ A7=447"QPO\ PAVK_P#/]!_W
M\?\ PH_X0[5_^?Z#_OX_^%=U11<+'"_\(=J__/\ 0?\ ?Q_\*/\ A#M7_P"?
MZ#_OX_\ A7=447"QPO\ PAVK_P#/]!_W\?\ PH_X0[5_^?Z#_OX_^%=U11<+
M'"_\(=J__/\ 0?\ ?Q_\*/\ A#M7_P"?Z#_OX_\ A7=447"QPO\ PAVK_P#/
M]!_W\?\ PH_X0[5_^?Z#_OX_^%=U11<+'"_\(=J__/\ 0?\ ?Q_\*/\ A#M7
M_P"?Z#_OX_\ A7=447"QPO\ PAVK_P#/]!_W\?\ PH_X0[5_^?Z#_OX_^%=U
M11<+'"_\(=J__/\ 0?\ ?Q_\*/\ A#M7_P"?Z#_OX_\ A7=447"QPO\ PAVK
M_P#/]!_W\?\ PH_X0[5_^?Z#_OX_^%=U11<+'"_\(=J__/\ 0?\ ?Q_\*/\
MA#M7_P"?Z#_OX_\ A7=447"QPO\ PAVK_P#/]!_W\?\ PH_X0[5_^?Z#_OX_
M^%=U11<+'"_\(=J__/\ 0?\ ?Q_\*/\ A#M7_P"?Z#_OX_\ A7=447"QPO\
MPAVK_P#/]!_W\?\ PH_X0[5_^?Z#_OX_^%=U11<+'"_\(=J__/\ 0?\ ?Q_\
M*/\ A#M7_P"?Z#_OX_\ A7=447"QPO\ PAVK_P#/]!_W\?\ PH_X0[5_^?Z#
M_OX_^%=U11<+'"_\(=J__/\ 0?\ ?Q_\*/\ A#M7_P"?Z#_OX_\ A7=447"Q
MPO\ PAVK_P#/]!_W\?\ PH_X0[5_^?Z#_OX_^%=U11<+'"_\(=J__/\ 0?\
M?Q_\*/\ A#M7_P"?Z#_OX_\ A7=447"QPO\ PAVK_P#/]!_W\?\ PH_X0[5_
M^?Z#_OX_^%=U11<+'"_\(=J__/\ 0?\ ?Q_\*/\ A#M7_P"?Z#_OX_\ A7=4
M47"QPO\ PAVK_P#/]!_W\?\ PH_X0[5_^?Z#_OX_^%=U11<+'"_\(=J__/\
M0?\ ?Q_\*/\ A#M7_P"?Z#_OX_\ A7=447"QPO\ PAVK_P#/]!_W\?\ PH_X
M0[5_^?Z#_OX_^%=U11<+'"_\(=J__/\ 0?\ ?Q_\*/\ A#M7_P"?Z#_OX_\
MA7=447"QPO\ PAVK_P#/]!_W\?\ PH_X0[5_^?Z#_OX_^%=U11<+'"_\(=J_
M_/\ 0?\ ?Q_\*/\ A#M7_P"?Z#_OX_\ A7=447"QPO\ PAVK_P#/]!_W\?\
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M *ZQ_P#H KNJX6]_Y*(G_76/_P! %-"9W5%%%(84444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 <WXW_P"0''_UW7_T%JYS3/\ D'Q_
M5O\ T(UT?C?_ ) <?_7=?_06KG-,_P"0?']6_P#0C6M,J&Y;HHHK4T"BBB@
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MG7<-]T_2N'\"?\?MW_US'\Z8GN=S1112&%%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M/E6RW-VBBBL3H"BBB@ HHHH **** "N%D_Y*(/\ KJ/_ $ 5W5<+)_R40?\
M74?^@"FA,[JBBBD,**** "BBB@ HHHH **** "BBB@ HHJ"\O;33[<W%[=0V
MT"D R32!%!/3D\4 3T50L=;TG4Y6BT_5+*[D5=S);W"2$#U(!/%7Z+"33V"B
MBB@84444 %%%% !1110 4444 %%4;;6=+O;I[6UU*SGN$R'BBG5G7'7(!R*O
M4"3OL%%%% PHHHH ***IW^KZ;I7E_P!HZA:6?F9V?:)ECW8QG&XC.,C\Z ;M
MN7**JV.IV&IQM)I]];7<:':S6\JR 'T)!-6J O<**** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BJ%]K>DZ9*L
M6H:I96DC+N5+BX2,D>H!(XJQ9WMIJ%N+BRNH;F!B0)(9 ZDCKR.*=F*ZO8GH
MK.O-?T;3K@V][J]A;3  F.>Y1& /0X)S5RVNK>]MTN+6>*>!^4EB<,K=N".#
M19A=;$M%%%(84444 %%%% !1110 4444 %%%% !1110 4444 %%%9+^*/#Z3
M-"^NZ8LJMM*&[C# ],8SUII-B;2W-:BBBD,**** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@#F_&_\ R X_^NZ_^@M7.:9_R#X_JW_H1KH_&_\ R X_
M^NZ_^@M7.:9_R#X_JW_H1K6F5#<MT445J:!1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% $D,TEO*LL3%77H
M175Z=J,=_%V65?O)_4>U<A4D,TEO*LL3%77H14RC<35SN**I:=J,=_%V65?O
M)_4>U7:P:L9!1112 **** "BBB@ HHHH **** (YX4N;>6"3.R1"C8ZX(Q6=
MHOA^ST%)ELS*1*06\QL],^WO6K10 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 R6-9HGC?[KJ5./0UF:)X=LM \_[&93YVW=YC ],
MXQQ[FM:B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *X6]_Y*(G
M_76/_P! %=U7"WO_ "41/^NL?_H IH3.ZHHHI#"BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** $;[I^E</X$_P"/V[_ZYC^==PWW3]*X?P)_Q^W?_7,?
MSIB>YW-%%%(84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 5X[\.;=?%WCG6?$]_P#OC;R VZN 0I8G;Q_LJH _/K7L5>-_#FX_
MX1'QWJ_AB_VPBX<"!FX#,I.T G&=RMQZX%:T_AE;<PJ_'"^W]6/9*9-#'<02
M03('BD4HZGHP(P13Z9--';P23S.$BC4N['HH R361N>)^"]'&@?&F[TQ01'
MLOE@G)V,H9,GUVD5V/QB_P"1"D_Z^8_ZUQ_@W5TU[XUW>I1$F&99?+)SDH%"
MJ>>G '':NP^,7_(A2?\ 7S'_ %KIE?VD;^1Q0M[&=MM2U\+M&M]*\$6<T:#S
M[T>?-)CELD[1] N./J>YKM*Y_P "_P#(BZ)_UZ)_*N@K";O)G5324$D>20D6
M'[0\D5N/+2[B(E5. <P;SD#KEE!^O->MUY'-_P G&6__ %S/_I,U>N5=7IZ&
M=#[7JSR#X0?\C1XF_P!X?^AM7?\ CK_D1=;_ .O1_P"5<!\(/^1H\3?[P_\
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MX@\6&RU34?M%O]G=]GD1I\P(P<JH/>ND^(?Q#_X1+RK&QBCFU&9-^9.4B7D
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MV_Y@'_;Q_P"TJNC\:,\3_"9H_ __ )%S4O\ K['_ * *\]^*G_)2-6_[8_\
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MNN^+VLV=IX,N-,>5#>7C1B.(,-P4.&+$>GR8SZFLYI^V-:<E]7?HSSWX-?\
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MJSY8J"'ATYR=5GA7QO\ ^1GT_P#Z\A_Z&U=Y\(_^2>VG_767_P!#-<'\;_\
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M'XW_ .0''_UW7_T%JYS3/^0?']6_]"-:TRH;ENBBBM30**** "BBB@ HHHH
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M(4;'7!&*SM%\/V>@I,MF92)2"WF-GIGV]ZU:* "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** &2QK-$\;_==2IQZ&LS1/#MEH'G_8S*
M?.V[O,8'IG&./<UK44 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MWXQG&3SU'YU<H"X445E/XGT".3RWUS3%DZ;6NXP?RS32;$VEN:M<CX)\<?\
M"8S:G'_9WV3["R+GS_,W[MW^R,?=]^M=7%+'-&LD4BR1MR&0Y!_&O)O@G_Q^
M>)O^ND'\Y:J,4XMF<Y-3BEL[GKE%4X-5TZZO9;*WU"UENXLF2".96D3!P<J#
MD8) _&KE0:WN%%-=TCC9W8*B@EF8X  [FJUCJFGZHCOI]_:W:H<,UO,L@4^A
MP3B@+ENBBB@ HJ.>>&UA::XECBB3EGD8*H^I-9\7B30KB;R8=:TZ27IL2Z0M
M^0-.S$VEN:E%(K*ZAE(*D9!!X(I:0PHJG9ZMINH2RQ66H6ES)%_K$AF5RGU
M/%17>OZ-82>7>:M86SY(VS7*(<CKP33LQ76YHT5#:WEK?0^;:7,-Q%G&^)PX
MSZ9%/FFBMX9)II$CBC4N[NP"JH&223T I#'T54M]5TZ[M&N[:_M9K93AIHIE
M9 ?0L#CN*;8ZQI>ILRZ?J5G=LHRPMYUD('O@FG9BNB[1167/XFT&VE,5QK>F
MQ2#JDEW&I'X$T)-@VEN:E%0VUW;7D7FVMQ%/'G&^)PPS]1]:FI#.0O/'/V3X
M@6WA7^SM_G!3]I\_&,J6^[M]O6K7C?Q9_P (;HL.H_8OMGF7"P>7YOEXRK-G
M.#_=Z>]<+K'_ "<!IO\ NI_Z+:M;XV_\B99_]A!/_1<E;<BYHKN<SJ2Y)N^S
M.EUKQ?#HG@V'Q#-:N_G11LENK_Q. 0"V.GOC\*;X*\90>,]-FN8[1[62!PDD
M;/O'(R"#@9_(5-:6VG7?@&Q@U=838-80F;SFVH $4Y)[8(!S4_AG3] T_2_+
M\."U-DSDE[>7S0S=\MDDGZGBH?+RO34T7/S)WTL;-%4QJNG'4CIPU"U-\.3;
M><OFCC/W<YZ<].E%[JVFZ;C[=J%I:Y&?W\RIQ^)J;,TNBY152RU73M2!-A?V
MMT!U,$ROC\C5ND-.X4452OM8TO3&5=0U*SM&8947$ZQDCVR10#=MR[152RU7
M3M2!-A?VMT!U,$ROC\C2'5=.&I#3CJ%J+X\BV\Y?-/&?NYSTYZ=*=F*Z+E%%
M%(84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MQH.BJ!@#\JEHHK$Z0HHHH YOQO\ \@./_KNO_H+5SFF?\@^/ZM_Z$:Z/QO\
M\@./_KNO_H+5SFF?\@^/ZM_Z$:UIE0W+=%%%:F@4444 %%%% !1110 4444
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M7&\M3Q;Q%HES\*]5L=<T*ZG;2YI1%/;2R9!."=IZ9! ;!QP1UZ5Z9XFGBNO
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MZ+:M;XV_\B99_P#803_T7)5KXH&;^"IZFMJ__)'9/^P.G_HL54^#O_(A1_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<+)
M_P E$'_74?\ H KNJX63_DH@_P"NH_\ 0!30F=U1112&%%%% !15/5-5L=%T
M^6_U&X6WMH\;G8$]>!@#DGV%8-E\1_"FHWL5G9ZF\UQ,VV.-+28EC_WQ346]
M4B7.*=FSJJ**YB_^(?A/3;AH+C6H/,0X81*\H!],H"*$F]AN2CNSIZ*S=)\0
M:1KJ,^EZA!=;.65&^9?JIY'XBM*DU;<$T]4%%9)\4^'ED,9U[2Q(#M*F\CR#
MZ8S6M3::!-/8**:[I'&SNP5%!+,QP !W-9/_  EOAK_H8=)_\#8__BJ$FP;2
MW-BBL?\ X2WPU_T,.D_^!L?_ ,55JQUK2M4D=-/U.SNW099;>=9"H]3@G%%F
M',GU+U%<I=_$KPE8W<UI<ZJT4\+F.1&M9LJP."/N5T.FZE9ZOI\-_83K/:S#
M,<B@C/.#P>1R",&AQ:U:$IQ;LF6J***104444 %%8NN^+=#\-20IJ]^+=YP3
M&OENY(&,GY0<=>_]*UH)X[FWBN(F+12H'0D$9!&1P>13L[7$I)NQ)116'KGC
M#0O#<\4.K7WV:252Z#R7?(SC^%30DWH@;25V;E%9VBZ[IOB&Q-[I=S]HMPYC
M+[&3YA@D88 ]Q6C2:MN"::N@HHHH&%%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !16;K>OZ9X<LDO-6N?L\#R
M")7\MGRQ!(&%!/0&J^A>+=#\2R31Z1??:6A :0>4Z8!Z?>4>E/E=KD\T;VOJ
M;5%%%(H**** "BL[6M>TOP]9"[U6[2VA+!02"Q8^@ !)_ 4:/KNF>(+,W>E7
MB7,(;:2H(*GT(."/QIV=KBYE>U]31HKGM9\<>'?#]_\ 8M4U'[/<; ^SR)'^
M4]#E5([5K:9J=IK&G0W]A-YUK,"8WVE<@$CH0#U!H<6E<2E%NR9;HKGM1\<^
M&M*U0Z;?:M%#=C&Y"K$+G^\P&!^)KH%974,I!4C((/!%#36XU)/9BT444AA1
M110 445S>J^/O#&BZA)8:AJJQ7,>-Z+#(^W//)52,^U-)O83DHZMG245G:+K
MNG>(+(WFF3/-;ABOF&%T!(ZXW 9_"HYO%'A^WFDAFUW3(Y8V*.CW<896!P00
M3P119[!S*U[FK12*RNH92"I&00>"*6D,**R8_%7AV618X]>TMY'(556\C)8G
MH ,UK4VFA)I[!137=(XV=V"HH)9F.  .YK,@\3:!<SI!;ZYILLTC!4CCNXV9
MB>@ !Y-%F#:6YJT5DZ[XETGPU##-JUT;>.9BJ-Y3N"1SCY0<?C571?&WAWQ#
M>FSTO4EGN A?RS$Z$@=<;E&?PHY7:]A<\;VOJ=!1112*"BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH YOQO_ ,@./_KNO_H+5SFF?\@^/ZM_Z$:Z
M/QO_ ,@./_KNO_H+5SFF?\@^/ZM_Z$:UIE0W+=%%%:F@4444 %%%% !1110
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MP5ING^+;KQ)%/=M>7(8.CNIC&[&<#;GMZUTE7.2DU8RI0<4T^X4445!J>1_
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MY%N[W'(2ZE!4?@JKG\<U,>1694_:.\;+4L_"VVN8OA]9)> E9"[1J^#^[8G
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MT445J:!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 20S26\JRQ,5=>A%
M=7IVHQW\7995^\G]1[5R%:>C64\URLZ,8XXSRX[^PJ)I-$R2L=31116!F5-5
M9DTB]920P@<@@\@[37)_#JZN+J#4#<3RS%63!D<MC@^M=7JW_(&OO^O>3_T$
MUQ_PS_X]]1_WX_Y-0!WE%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 5[XD:?<D'!$38(^AKC?AS=W-U_:7VBXEFV^5M\QRV/O\ 3-=E
M?_\ (.NO^N3_ ,C7#_#+_F*?]LO_ &>@#T"BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MH%%%%24%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M5\H^)+@:CXMU6>$[UGO93&>F07.W],5IAMV98SX4?4]DS/86[,26,2DDGDG
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M^#.CVVH>);F]N$60V,0:)6&0'8X#?A@_C79?&W_D3+/_ +""?^BY*Y[X&?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH ***OZ9ICWTFYLK"I^9O7V%)NP-V#3-,
M>^DW-E85/S-Z^PKJXXTBC6.-0J*, "B.-(HUCC4*BC  IU82E<R;N%%%%2(B
MN(%N;66W<D)*A1BO7!&.*S=#\.VGA])UM))W$Q!;S6!QC/3 'K6O10 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 R:)9H9(F)"NI4
MXZX(K*T+PW9^'_M'V22=_/V[O-8'&W.,8 ]36Q10 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %<+>_\E$3_ *ZQ_P#H KNJX6]_Y*(G_76/_P!
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MIP6'I/F3%-XFJN5HPM/L9=1O8[:$'+'D_P!T=S7=>(-*\[P^(+=<FV 9%'<
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M*#T-YPC52N>"_P#"DO$O_/\ :3_W]D_^-UZA\/O#-[X4\./IU]+;R3&X:7=
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MU=<S33LSLC)25T>5_%7QAKOAO5;"'2;[[-'+ SN/)1\G=C^)37 ?\+4\:?\
M09_\E8?_ (BOI.OG+XM?\E$OO^N<7_HM:Z*+C+W6CDQ,9Q]]29#_ ,+4\:?]
M!G_R5A_^(KZ%T6XEN]!TZYG;?--;1R.V ,L5!)P/>L+X:?\ ).]'_P"N;_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 5PLG_)1!_UU'_H KNJX63_ )*(/^NH_P#0
M!30F=U1112&%%%% !1110 4444 %%%1SS);V\DS_ '(U+M] ,T 245RGP^\2
MZAXJ\.R:CJ,-O%)]H:-! K*I4!>?F)YR3WKJZ;5G9DQDI*Z"BBBD4%%%% !1
M110 4444 %%%<AXA\4W^E^--!T2TAMWBOR3,TBL650?X2",< ]0::3>Q,I**
MNSKZ***104444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110!S?C?_D!Q_\ 7=?_ $%JYS3/
M^0?']6_]"-='XW_Y <?_ %W7_P!!:N<TS_D'Q_5O_0C6M,J&Y;HHHK4T"BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%  *6D%+0 4444
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MOXCZG;:MX[U&XM'#PJ5B5U((8JH4D$=L@U[1HUK+??!^*S@&9I](:)!ZLT9
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ME]I.D:;J^PR:??0HZRCG8Y'*MZ<YQZCZ&NM*+C&YYTI2C*?+_6ITGPT\ ?\
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MO-OF[1P,?W1VR>3CJ0*TFHQTL8TY3E:5U8A\0>*[+PY=Z;:W4%S--J,ODP+
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M8+YLL*[1[_*Q./PKO;:Y@O+:*YMI4E@E4,DB'(8'N#535=$TW6M/:QO[2*:
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M9O7V%=7'&D4:QQJ%11@ 41QI%&L<:A448 %.K"4KF3=PHHHJ1!1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M<WXW_P"0''_UW7_T%JYS3/\ D'Q_5O\ T(UT?C?_ ) <?_7=?_06KG-,_P"0
M?']6_P#0C6M,J&Y;HHHK4T"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@!DT2S0R1,2%=2IQUP161H'ANV\/?:/L\TLGG[=WF8XVYZ8'O6U
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<+>_P#)1$_ZZQ_^
M@"NZKA;W_DHB?]=8_P#T 4T)G=4444AA1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% "-]T_2N'\"?\ '[=_]<Q_.NX;[I^E</X$_P"/V[_ZYC^=,3W.
MYHHHI#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH *BN+:"\MWM[F&.>%QAXY5#*P]"#P:EHH Y2X^&G@^Y?=)HD
M0/\ TSEDC'Y*PJ]I7@SPYHD@EL-(MHY001(P,CJ1TPS9(_"MVBJYY;7(5."=
MT@HHHJ2PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH *X63_DH@_ZZC_T 5W5<+)_R40?]=1_Z *:$SNJ***0P
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** .;\;_\@./_ *[K_P"@M7.:9_R#X_JW_H1K
MH_&__(#C_P"NZ_\ H+5SFF?\@^/ZM_Z$:UIE0W+=%%%:F@4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !115_3-,
M>^DW-E85/S-Z^PI-V!NP:9ICWTFYLK"I^9O7V%=7'&D4:QQJ%11@ 41QI%&L
M<:A448 %.K"4KF3=PHHHJ1!1110 4444 %%%% !1110 4444 5-4=H])O'1B
MKK Y5E."#M/(KE?A[?7=[!?F[NIYRK)M,LA;'!Z9KJ=6_P"0-??]>\G_ *":
MX_X9_P#'OJ/^_'_)J .\HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@""]9DL+AE)#")B"#R#@UQWP[O[R]_M+[7=SW&SRMOFR%]N=^<
M9Z=!787_ /R#KK_KD_\ (UP_PR_YBG_;+_V>@#T"BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ KA;W_DHB?\ 76/_ - %=U7"WO\ R41/^NL?_H I
MH3.ZHHHI#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** $;[I^E</X$_
MX_;O_KF/YUW#?=/TKA_ G_'[=_\ 7,?SIB>YW-%%%(84444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 5PLG_ "40?]=1_P"@"NZKA9/^2B#_ *ZC_P! %-"9W5%%
M%(84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% '-^-_\ D!Q_]=U_]!:N<TS_ )!\?U;_
M -"-='XW_P"0''_UW7_T%JYS3/\ D'Q_5O\ T(UK3*AN6Z***U- HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ KA9/^2B#_KJ/_0!7=5PLG_)1!_UU'_H IH3.ZHHHI#"BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH YOQO_R X_\ KNO_ *"U<YIG_(/C^K?^A&NC\;_\@./_
M *[K_P"@M7.:9_R#X_JW_H1K6F5#<MT445J:!1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M* (+UF2PN&4D,(F((/(.#7'?#N_O+W^TOM=W/<;/*V^;(7VYWYQGIT%=A?\
M_(.NO^N3_P C7#_#+_F*?]LO_9Z /0**** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "N%O?^2B)_P!=8_\ T 5W5<+>_P#)1$_ZZQ_^@"FA,[JBBBD,
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 1ONGZ5P_@3_C]N_^N8_G
M7<-]T_2N'\"?\?MW_P!<Q_.F)[G<T444AA1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 8'_"8Z1_?E_[]FC_ (3+2/[\O_?LU+_PB>B_\^A_[^O_ (T?\(GH
MO_/H?^_K_P"-/06I%_PF6D?WY?\ OV:/^$RTC^_+_P!^S4O_  B>B_\ /H?^
M_K_XT?\ ")Z+_P ^A_[^O_C1H&I%_P )EI']^7_OV:/^$RTC^_+_ -^S4O\
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M ,^A_P"_K_XT:!J1?\)EI']^7_OV:/\ A,M(_OR_]^S4O_")Z+_SZ'_OZ_\
MC1_PB>B_\^A_[^O_ (T:!J1?\)EI']^7_OV:/^$RTC^_+_W[-2_\(GHO_/H?
M^_K_ .-'_")Z+_SZ'_OZ_P#C1H&I%_PF6D?WY?\ OV:/^$RTC^_+_P!^S4O_
M  B>B_\ /H?^_K_XT?\ ")Z+_P ^A_[^O_C1H&I%_P )EI']^7_OV:/^$RTC
M^_+_ -^S4O\ PB>B_P#/H?\ OZ_^-'_")Z+_ ,^A_P"_K_XT:!J1?\)EI']^
M7_OV:/\ A,M(_OR_]^S4O_")Z+_SZ'_OZ_\ C1_PB>B_\^A_[^O_ (T:!J1?
M\)EI']^7_OV:/^$RTC^_+_W[-2_\(GHO_/H?^_K_ .-'_")Z+_SZ'_OZ_P#C
M1H&I%_PF6D?WY?\ OV:/^$RTC^_+_P!^S4O_  B>B_\ /H?^_K_XT?\ ")Z+
M_P ^A_[^O_C1H&I%_P )EI']^7_OV:/^$RTC^_+_ -^S4O\ PB>B_P#/H?\
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MO^$RTC^_+_W[-'_"9:1_?E_[]FI?^$3T7_GT/_?U_P#&C_A$]%_Y]#_W]?\
MQHT'J1?\)EI']^7_ +]FC_A,M(_OR_\ ?LU+_P (GHO_ #Z'_OZ_^-'_  B>
MB_\ /H?^_K_XT:!J1?\ "9:1_?E_[]FC_A,M(_OR_P#?LU+_ ,(GHO\ SZ'_
M +^O_C1_PB>B_P#/H?\ OZ_^-&@:D7_"9:1_?E_[]FC_ (3+2/[\O_?LU+_P
MB>B_\^A_[^O_ (T?\(GHO_/H?^_K_P"-&@:D7_"9:1_?E_[]FC_A,M(_OR_]
M^S4O_")Z+_SZ'_OZ_P#C1_PB>B_\^A_[^O\ XT:!J1?\)EI']^7_ +]FC_A,
MM(_OR_\ ?LU+_P (GHO_ #Z'_OZ_^-'_  B>B_\ /H?^_K_XT:!J1?\ "9:1
M_?E_[]FC_A,M(_OR_P#?LU+_ ,(GHO\ SZ'_ +^O_C1_PB>B_P#/H?\ OZ_^
M-&@:D7_"9:1_?E_[]FC_ (3+2/[\O_?LU+_PB>B_\^A_[^O_ (T?\(GHO_/H
M?^_K_P"-&@:D7_"9:1_?E_[]FC_A,M(_OR_]^S4O_")Z+_SZ'_OZ_P#C1_PB
M>B_\^A_[^O\ XT:!J1?\)EI']^7_ +]FC_A,M(_OR_\ ?LU+_P (GHO_ #Z'
M_OZ_^-'_  B>B_\ /H?^_K_XT:!J1?\ "9:1_?E_[]FC_A,M(_OR_P#?LU+_
M ,(GHO\ SZ'_ +^O_C1_PB>B_P#/H?\ OZ_^-&@:D7_"9:1_?E_[]FC_ (3+
M2/[\O_?LU+_PB>B_\^A_[^O_ (T?\(GHO_/H?^_K_P"-&@:D7_"9:1_?E_[]
MFC_A,M(_OR_]^S4O_")Z+_SZ'_OZ_P#C1_PB>B_\^A_[^O\ XT:!J1?\)EI'
M]^7_ +]FC_A,M(_OR_\ ?LU+_P (GHO_ #Z'_OZ_^-'_  B>B_\ /H?^_K_X
MT:!J1?\ "9:1_?E_[]FC_A,M(_OR_P#?LU+_ ,(GHO\ SZ'_ +^O_C1_PB>B
M_P#/H?\ OZ_^-&@:D7_"9:1_?E_[]FC_ (3+2/[\O_?LU+_PB>B_\^A_[^O_
M (T?\(GHO_/H?^_K_P"-&@:D7_"9:1_?E_[]FC_A,M(_OR_]^S4O_")Z+_SZ
M'_OZ_P#C1_PB>B_\^A_[^O\ XT:!J1?\)EI']^7_ +]FC_A,M(_OR_\ ?LU+
M_P (GHO_ #Z'_OZ_^-'_  B>B_\ /H?^_K_XT:!J1?\ "9:1_?E_[]FC_A,M
M(_OR_P#?LU+_ ,(GHO\ SZ'_ +^O_C1_PB>B_P#/H?\ OZ_^-&@:D7_"9:1_
M?E_[]FC_ (3+2/[\O_?LU+_PB>B_\^A_[^O_ (T?\(GHO_/H?^_K_P"-&@:D
M7_"9:1_?E_[]FC_A,M(_OR_]^S4O_")Z+_SZ'_OZ_P#C1_PB>B_\^A_[^O\
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M7_"9:1_?E_[]FC_A,M(_OR_]^S4O_")Z+_SZ'_OZ_P#C1_PB>B_\^A_[^O\
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MK_XT>T8<TCE/[0L_^>X_[Y;_  H_M"S_ .>X_P"^6_PKJ_\ A$]%_P"?0_\
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M?_&CVC#FD<I_:%G_ ,]Q_P!\M_A1_:%G_P ]Q_WRW^%=7_PB>B_\^A_[^O\
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M_P#C1H&I%_PF6D?WY?\ OV:/^$RTC^_+_P!^S4O_  B>B_\ /H?^_K_XT?\
M")Z+_P ^A_[^O_C1H&I%_P )EI']^7_OV:/^$RTC^_+_ -^S4O\ PB>B_P#/
MH?\ OZ_^-'_")Z+_ ,^A_P"_K_XT:!J1?\)EI']^7_OV:/\ A,M(_OR_]^S4
MO_")Z+_SZ'_OZ_\ C1_PB>B_\^A_[^O_ (T:!J1?\)EI']^7_OV:/^$RTC^_
M+_W[-2_\(GHO_/H?^_K_ .-'_")Z+_SZ'_OZ_P#C1H&I%_PF6D?WY?\ OV:/
M^$RTC^_+_P!^S4O_  B>B_\ /H?^_K_XT?\ ")Z+_P ^A_[^O_C1H&I%_P )
MEI']^7_OV:/^$RTC^_+_ -^S4O\ PB>B_P#/H?\ OZ_^-'_")Z+_ ,^A_P"_
MK_XT:!J1?\)EI']^7_OV:/\ A,M(_OR_]^S4O_")Z+_SZ'_OZ_\ C1_PB>B_
M\^A_[^O_ (T:!J1?\)EI']^7_OV:/^$RTC^_+_W[-2_\(GHO_/H?^_K_ .-'
M_")Z+_SZ'_OZ_P#C1H&I%_PF6D?WY?\ OV:/^$RTC^_+_P!^S4O_  B>B_\
M/H?^_K_XT?\ ")Z+_P ^A_[^O_C1H&I%_P )EI']^7_OV:/^$RTC^_+_ -^S
M4O\ PB>B_P#/H?\ OZ_^-'_")Z+_ ,^A_P"_K_XT:!J1?\)EI']^7_OV:/\
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MB_X3+2/[\O\ W[-'_"9:1_?E_P"_9J7_ (1/1?\ GT/_ ']?_&C_ (1/1?\
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MJ1?\)EI']^7_ +]FC_A,M(_OR_\ ?LU+_P (GHO_ #Z'_OZ_^-'_  B>B_\
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M  B>B_\ /H?^_K_XT:!J1?\ "9:1_?E_[]FC_A,M(_OR_P#?LU+_ ,(GHO\
MSZ'_ +^O_C1_PB>B_P#/H?\ OZ_^-&@:D7_"9:1_?E_[]FC_ (3+2/[\O_?L
MU+_PB>B_\^A_[^O_ (T?\(GHO_/H?^_K_P"-&@:D7_"9:1_?E_[]FC_A,M(_
MOR_]^S4O_")Z+_SZ'_OZ_P#C1_PB>B_\^A_[^O\ XT:!J1?\)EI']^7_ +]F
MC_A,M(_OR_\ ?LU+_P (GHO_ #Z'_OZ_^-'_  B>B_\ /H?^_K_XT:!J1?\
M"9:1_?E_[]FC_A,M(_OR_P#?LU+_ ,(GHO\ SZ'_ +^O_C1_PB>B_P#/H?\
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M+_SZ'_OZ_P#C1_PB>B_\^A_[^O\ XT:!J1?\)EI']^7_ +]FC_A,M(_OR_\
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M  B>B_\ /H?^_K_XT:!J1?\ "9:1_?E_[]FC_A,M(_OR_P#?LU+_ ,(GHO\
MSZ'_ +^O_C1_PB>B_P#/H?\ OZ_^-&@:D7_"9:1_?E_[]FC_ (3+2/[\O_?L
MU+_PB>B_\^A_[^O_ (T?\(GHO_/H?^_K_P"-&@:D7_"9:1_?E_[]FC_A,M(_
MOR_]^S4O_")Z+_SZ'_OZ_P#C1_PB>B_\^A_[^O\ XT:!J1?\)EI']^7_ +]F
MC_A,M(_OR_\ ?LU+_P (GHO_ #Z'_OZ_^-'_  B>B_\ /H?^_K_XT:!J1?\
M"9:1_?E_[]FC_A,M(_OR_P#?LU+_ ,(GHO\ SZ'_ +^O_C1_PB>B_P#/H?\
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M+_SZ'_OZ_P#C1_PB>B_\^A_[^O\ XT:!J1?\)EI']^7_ +]FC_A,M(_OR_\
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M  B>B_\ /H?^_K_XT:!J1?\ "9:1_?E_[]FC_A,M(_OR_P#?LU+_ ,(GHO\
MSZ'_ +^O_C1_PB>B_P#/H?\ OZ_^-&@:D7_"9:1_?E_[]FC_ (3+2/[\O_?L
MU+_PB>B_\^A_[^O_ (T?\(GHO_/H?^_K_P"-&@:D7_"9:1_?E_[]FC_A,M(_
MOR_]^S4O_")Z+_SZ'_OZ_P#C1_PB>B_\^A_[^O\ XT:!J1?\)EI']^7_ +]F
MC_A,M(_OR_\ ?LU+_P (GHO_ #Z'_OZ_^-'_  B>B_\ /H?^_K_XT:!J1?\
M"9:1_?E_[]FC_A,M(_OR_P#?LU+_ ,(GHO\ SZ'_ +^O_C1_PB>B_P#/H?\
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M+_SZ'_OZ_P#C1_PB>B_\^A_[^O\ XT:!J1?\)EI']^7_ +]FC_A,M(_OR_\
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M  B>B_\ /H?^_K_XT:!J1?\ "9:1_?E_[]FC_A,M(_OR_P#?LU+_ ,(GHO\
MSZ'_ +^O_C1_PB>B_P#/H?\ OZ_^-&@:D7_"9:1_?E_[]FC_ (3+2/[\O_?L
MU+_PB>B_\^A_[^O_ (T?\(GHO_/H?^_K_P"-&@:D7_"9:1_?E_[]FC_A,M(_
MOR_]^S4O_")Z+_SZ'_OZ_P#C1_PB>B_\^A_[^O\ XT:!J1?\)EI']^7_ +]F
MC_A,M(_OR_\ ?LU+_P (GHO_ #Z'_OZ_^-'_  B>B_\ /H?^_K_XT:!J1?\
M"9:1_?E_[]FC_A,M(_OR_P#?LU+_ ,(GHO\ SZ'_ +^O_C1_PB>B_P#/H?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MO7K8+&VM3J/T9U4:WV9'9T445[!UA1110 4444 %%%% !1110 4444 %%%%
M!1110!Q/Q(C=].L=B,V)6S@9[5T7AP$>&].!&"+=,C\*U** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@"IJCM'I-XZ,5=8'*LIP0=IY%<K\/;Z[
MO8+\W=U/.59-IED+8X/3-=3JW_(&OO\ KWD_]!-<?\,_^/?4?]^/^34 =Y11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% $%ZS)87#*2&
M$3$$'D'!KCOAW?WE[_:7VN[GN-GE;?-D+[<[\XSTZ"NPO_\ D'77_7)_Y&N'
M^&7_ #%/^V7_ +/0!Z!1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** (;J 75G/;EMHEC9"1VR,5E^'O#D/AZ.=(I
MY)O.()+@#&,_XUM44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 1SQ">"2(G =2I([9&*Q_#OAJ'P[]I\JXDF\_;G> ,;<_XUN44
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7"WO\ R41/^NL?_H K
MNJX6]_Y*(G_76/\ ] %-"9W5%%%(84444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 C?=/TKA_ G_ !^W?_7,?SKN&^Z?I7#^!/\ C]N_^N8_G3$]SN:*
M**0PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ KA9/^2B#_KJ/_0!7=5PLG_)1
M!_UU'_H IH3.ZHHHI#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH YOQO_R X_\ KNO_
M *"U<$.@KO?&_P#R X_^NZ_^@M7!#H*\O-/@CZG+B=D+1117BG(%%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% '6^&_$GE[+&^?Y.D4K'[OL?;WKLZ\?KK?#?B3R]EC?/\
MG2*5C]WV/M[UZV"QMK4ZC]&=5&M]F1V=%%%>P=84444 %%%% !1110 4444
M%%%% '#_ !*_Y!]C_P!=6_E72>&_^1:TW_KW3^5:E% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110!5U.1XM*O)(V*ND#LK#J"%/-<M\/]1O-0@OS
M>7,LY1DVF1LXR#73ZM_R!K[_ *]Y/_037'_#/_CWU'_?C_DU '>4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110!!>LR6%PRDAA$Q!!Y!
MP:Y#X?:E>ZA_:/VRZEGV>5M\QB=N=^<?D*ZZ_P#^0==?]<G_ )&N'^&7_,4_
M[9?^ST >@4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<+>_\E$3_
M *ZQ_P#H KNJX6]_Y*(G_76/_P! %-"9W5%%%(84444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 C?=/TKA_ G_'[=_\ 7,?SKN&^Z?I7#^!/^/V[_P"N
M8_G3$]SN:***0PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M?F^9T .<X'KZ4<DDN;H"J1<N2^IX)<^*?$*Z_-&->U01BZ90HO), ;NF,U]
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ME![^M>G5A5^+:QTX?^&M;A11169L%%%% !1110 4444 %%%% !1110 4444
M%<+)_P E$'_74?\ H KNJX63_DH@_P"NH_\ 0!30F=U1112&%%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@"KJ<CQ:5>21L5=('96'4$*>:Y;X?ZC>:A!?F\N99RC)M,
MC9QD&NGU;_D#7W_7O)_Z":X_X9_\>^H_[\?\FH [RBBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** (+UF2PN&4D,(F((/(.#7(?#[4KW4
M/[1^V74L^SRMOF,3MSOSC\A777__ "#KK_KD_P#(UP_PR_YBG_;+_P!GH ]
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *X6]_Y*(G_76/\ ] %=
MU7"WO_)1$_ZZQ_\ H IH3.ZHHHI#"BBB@ HHHH **** "BBB@ HHHH ****
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M8_ZYV_\ Z.DKURG4;Y8H*45[24O,Q_%.CVNN>&[VRNXPRF)G0]T< D,#V/\
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M *.DKURE4VB52^*7J%>1_$+_ )*WX2_ZZ6__ */KURO(_B%_R5OPE_UTM_\
MT?12^(,1\'S1VWQ"_P"1 UG_ *X?U%<!\'_"-I>6\GB'4(UG:.0PVD;\JF.6
M?'KDX'I@GN"._P#B%_R(&L_]</ZBLSX1_P#)/;3_ *ZR_P#H9IQ;5-V[BE%2
MKJ_8[FO(-:@A\+?&S1[C3T6*/4@@FC'"EI&,;8 _X"WUYKU^O(_B%_R5OPE_
MUTM__1]*ENT.O\*?FCN?''B)O"_A6ZU"( W!Q% ",C>W0GZ#)_"N=^&GA&&#
M3H_$NJ+]JU:_'GK+-\QC5N01G^(@Y)]\#OEWQFM9;CP/')&C,+>\25]HSA=K
MKD^@RPKI?!>H0:GX,TFX@/RBV2-AG[K(-K#\P:-J>G4/BK6?1&]7+^+O FE^
M+K=?/'V:\1@5NHD&['&0W]X8'?I^8/445FFT[HVE%25F5["T%AI]O9B:6801
MK&))F!=@!C+$ 9/O7E'P@_Y&CQ-_O#_T-J]?KR#X0?\ (T>)O]X?^AM6D/@D
M8U/XD/F&L?\ )P&F_P"ZG_HMJ]?KR+Q&%L_CSHLTIVK,D6"2.2=Z#]17KM%3
M:/H%'>7J4M9_Y >H?]>TG_H)KSOX'_\ (N:E_P!?8_\ 0!7H6ML$T#478X5;
M64D^VTUP7P2@*>$[V<GB2]( ]@B\_K^E$?X;"7\6/S,WQO/=>,_B%9^#H)6C
ML;=E>Y*-U.W<S?4*< >I->H:3I%AH>GQV.G6R00)_"HY8XZD]R<=37EMF4T3
MX^W*W8VK? ^2Y(QEU!'Z@K]:]@HJ:));!15W*3WN5K_3[35+*2SOK>.>WD!#
M(XR#_@?<<UX+J&@R>&?BMHFE+*\EFE];RVF_JL;2@X_!MP]\9[U]!UXYX\NX
M)_C'X:@B<-);S6JR@?PL9MP'Y$'\13HMW:)Q,59/K<]#\=?\B+K?_7H_\JP?
M@[_R(4?_ %\R?TK>\=?\B+K?_7H_\JP?@[_R(4?_ %\R?TI+^&_4I_QEZ'G=
MYH'_  DWQEO]+:1HX)+IFG93SY:C) ]S@ >A.>U>\V&GVFEV4=G8V\<%O& %
M1!@#_$^YYKRGPS_R7?6_]V;_ -EKU^G5;T7D+#Q7O/S9P?Q:T:TO_!5Q?R1C
M[78E7AD'!P6"LI/H0<X]0*VO >I2ZMX'TF\F.Z4P^6S<_,4)3)]SMS5;XE_\
MD[UC_KFG_HQ:A^%?_)-])_[;?^CGI?\ +OYCVK?+]3C(XV^)?Q.NH;R1GT/2
M2P6)3A7PVT=_XCDD^BXXXKUZUM;>QM8[6UA2&")=J1QKA5'L*\K^$)_L_7_$
MVD7*A+U)%8C(Y",RM^ +#\Z]:HJ[\O0*"O'F>[,S7- TWQ%I[V6I6R2QD':^
M!OC/]Y3V/^3D5XU\.].GTCXLR:=<RB66UCEB+@Y! &!CVQBO>*\=T*^CU'X^
MZC<1,&0+)$".AV($/_H-.FWRR7D36BN:+ZW/8J***Q.D\E^)%W=^)/&.F>"K
M*0QQ.5DN&!/S$@MR!V51N^I]J](T/0=.\.Z:ECIMNL42CYFQ\TA_O,>Y_P ]
M*\QU&9=%^/\ !>78*P7BHJ.1@?-%Y8Y/4;A7L%:U-(I+8PI*\I2>]R&ZM;>^
MM9+6ZA2:"5=KQR+E6'N*^?/&?AE?"_CRSMK8G[!<2I<6Z9.(\N R\^FT?ABO
MHFO'?B[?1R^+?#E@K R0-YK =M[J!_Z!3HM\UB<3%.%^IZAX@U9="\/WVJ.@
M?[-$75"<;FZ*,^Y(%><?#+PPNNR3^,=>07=U<3L;<2@%00<%\=.",#L,<=L=
ME\1+*74/ &L00J6<1"7 /9&#G]%-9_PGO[>\\ V<,.!):N\4J\<-N+9_$,/U
MI1TIMHJ2YJJ3VL=O7$_$'PE!JNERZQ9J(-9L4,\5P@^:0("=A]>G&>AQVS7;
M51UJ[AL=#O[JX<)#% [,Q],']:B+:=T:SBI1:9YM\#?^01JW_7=/_033/B1?
M7OB/Q=IO@BQ<I$[+)<,#U)R>?95!;W)]A3_@;_R"-6_Z[I_Z":@U1DT3X_6E
M[>+MAO43RW)& 6B\H'V^88_&MW_$;.1?P8KHV>F:'H.G>'=-2QTVW6*)1\S8
M^:0_WF/<_P">E7+JUM[ZUDM;J%)H)5VO'(N58>XJ:BN>[O<[$DE8^>/&7AS_
M (1;QK86%O(S:;+,MS:QDD^5N<!ER>3C:/PQWS7NGB/_ )%C5O\ KRF_] ->
M6_%N[AE\9^'[5'#30X:11_"&<8S[_*?T]:]2\1_\BQJW_7E-_P"@&MIMM1;.
M:DDI32.)^"7_ ")EY_V$'_\ 1<='QM_Y$RS_ .P@G_HN2CX)?\B9>?\ 80?_
M -%QT?&W_D3+/_L()_Z+DH_Y?"_YA_D=MX<_Y%C2?^O*'_T 5YM\0O\ DK?A
M+_KI;_\ H^O2?#G_ "+&D_\ 7E#_ .@"O-OB%_R5OPE_UTM__1]*G\;^9=;^
M&OD=9\2O$DGAOPE+);/LO+IOL\+!L,F026'T _ D54^&W@NUT+1X-4N$$NJW
MD8E>5N3$K#(5<]#@\^I]JR?C?;22>'=.N54E(KHJY Z;E.,_E7H>BW<-]H=A
M=6[AX98$96'I@?K2>E-6ZC2YJSOTV+U>2?$GP^?#%W;>,?#^+2>.<"X2,85B
MV3O(ST/W2.^?K7K=<+\7+ZWM? %W;2N!+=R1QQ+D9)#JY_#"G\Q2I-J2*KI.
M#;Z'5Z+J<>LZ)9:E'PMS"LF/[I(Y'X'(KP?P5X7A\4^/+V&\R;"VDDGF0''F
M$.0J_F?R!'&:]C\ 6TUIX#T:*<$/]G#X/4!B6'Z$5PGP@_Y&CQ-_O#_T-JN+
MY5*QE-<[AS'KD,,5O"D,$211(,*B*%51[ 5YA\9]+@CTNQUZ!?*U""Y6+S5X
M)4@D9]2"HQZ9->I5YW\:/^1'C_Z_8_\ T%ZBD_?1I72]FSLK'54G\-6VL3X5
M)+-;I]O0 H&.,UY7X'T;_A8'B2_\5:[&)K:*79#;.=R;NH4@CE5!''<GGW[R
MSM9+WX36]I$"9)]#6-0!DY:# X_&N;^"E_$_AR^TWE;FWNC(RG^ZP !_-2/R
MJEI&31$O>G%2V/35544*H 4#  ' %<[XO\(6'BS2I(9HHUO50BWN2/FC;KU'
M4>HKHZ1F5%+,0% R23P!62;3NCHE%25F>*?!02KXCUD3;O-$ #[CD[M_.:T/
MC9_Q^>&?^ND_\XJB^%-XNH^._$U\ARER7F7C'#2D]/QJ7XV?\?GAG_KI/_.*
MNG_E]_78XE_N[_KJ>N4445RG<%%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M ?)UZ[:YXHN'B8%KZ]8JQ&.7?@]O6OJ^-%BC6-!A5 4#T IU%:5*G/;0QHT?
M9W=[W/EWQUHPT+QGJ5DBA8?-\V(#H$?Y@/PSC\*]>^#FC?V?X1>_D3$NH2EP
M2,'RU^5?UW'\:]$HJIUG*/*33PZA/GN>7_&^R\WPWI]Z#S!=>61[.I.?S4?G
M5/X&7FZSUBQ,GW)(YE0G^\""0/\ @*Y_"O7**GVGN<EBO8_O?:7/.?BEX%N?
M$D$.J:8-]_:QF-H>\L><X'N"3QWS],^2:?XB\4^#C):6MS<V +'=#+$"-W0G
M:X(SQU%?4-%5"M9<K5R:F'YI<T79GS%IGA[Q-XZU<SE+B=YF!EO;C(11_O>G
MH!^ KZ.T72;;0M&M-+M ?)MHP@)ZL>I8^Y))/UJ_14U*CGIT*I453UW9\F77
M_(QS?]?;?^AU])^.O^1%UO\ Z]'_ )5T%%.=7F:=MB:=#D35]SYR^$O_ "42
MQ_ZYR_\ HMJ])^-'_(CQ_P#7['_Z"]>B442JWFI6"%#EIN%]SQ#X&_\ (<U7
M_KV7_P!"KV^BBIG/GE<TI4_9QY0HHHJ#0**** "BBB@ HHHH **** "BBB@
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M.]NA=HKP[3OC7K#ZE;KJ-KIR61D'G-%#)O"=]OSGFIM5^.%\UR1I&EV\< )
M:[+.S#UPI 7MQD_6K]A.YG]:IVO<]KHKRWPA\7X]7U"'3M:M([6:9@D=Q"3Y
M98] 0<E<GOD]>W6O4JSE!Q=F:PJ1FKQ"BN#\7_%'2_#,[V-M$=0U!>'1'"I$
M?1FYY]@/KBN$/QOU_P XD:=I@B[*4D)_/?\ TJHT9R5R)XBG%V;/=ZI:S_R
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M 4444 %%%% !1110 4444 %<+>_\E$3_ *ZQ_P#H KNJX6]_Y*(G_76/_P!
M%-"9W5%%%(84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 C?=/TKA_
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MN3_R-6*KW_\ R#KG_KD_\C0A/8^6_"7_ ".>A?\ 80M__1BU['\;?^1,L_\
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MF:_IHT;Q!J&FJS,EM</&K-U*@\$_ABOH3Q5XBN-$^'#:G"W^F26\:1N3]UW
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MD_Z_9/\ T%*J;;I*Y-)16(:CL>?_ !=T :5XM-]"C"WU!/-)QP)!PX!_)O\
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M_9?_ $(U] :K_P DPO?^P-)_Z)-?/_C;_D>-;_Z_9?\ T(U] :K_ ,DPO?\
ML#2?^B3755VB<%#>9\Y:#I,FN:[9:9&X1KF4)N/\([G\LU]&?\*\\*_V2VG#
M1K81LNWSMN9A[B0_-G\?TKPOX<?\E"T?_KJ?_0&KZ;I8B3320\)"+BVT?(]Y
M!)I.LW%N"?,M+ADR>#E&Q_2O<OC'8VC>$&OFM8#=K-'&LYC'F!<D[0W7')XK
MQGQ;_P CGKO_ &$+C_T8U>W?&+_D0I/^OF/^M7-^]%F=)>Y47]=3S[X.Z;8:
MGXCOHM0LK:[C6TW*EQ$L@!WKR 0>:V?C?;PVL'AR"WBCAAC%PJ1QJ%51^ZX
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MO_HMJ[;XY?\ ((TG_KN__H(KB?A+_P E$L?^N<O_ *+:NV^.7_((TG_KN_\
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M3P]%XG\66NGW#$6V&EFV]2JC.!Z9.!GWKW+6?AWX=OM FL;72+6WF$9\B:)
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M3X(^IRXG9"T445XIR!1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MG'Y"NNO_ /D'77_7)_Y&N'^&7_,4_P"V7_L] 'H%%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !7"WO_)1$_ZZQ_\ H KNJX6]_P"2B)_UUC_] %-"
M9W5%%%(84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 C?=/TKA_ G_'
M[=_]<Q_.NX;[I^E</X$_X_;O_KF/YTQ/<[FBBBD,**** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M*Q]'\+:-H-U=7.F6?D371S,WFNV[DGHQ..2>E;%%.[$TGJ%%%%(84444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M+RYC,K6Z'<8ES@9/0DG=TXXZFO9O@Y"8_ :N>DMU(X_0?TKR&ST_Q)\0]?\
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MJ.45'L$**A-RON>+>-_A)<K=RZAX:B62W?+/9!L,A[[,\$>V<CMGMR-MI/Q
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M&E6NGVRXAMXQ&OX=ZMUG.7-*YM2AR040HHHJ#0**** "BBB@ HHHH YOQO\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ KA;W_DHB?]=8__ $ 5W5<+>_\
M)1$_ZZQ_^@"FA,[JBBBD,**** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M 1ONGZ5P_@3_ (_;O_KF/YUW#?=/TKA_ G_'[=_]<Q_.F)[G<T444AA1110
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MW!O 7A1[(6AT&R\H#&X1XD_[['S?K7D_P;U^UTO7KO3[N41+?HOENQ 7>F2
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MU##T(S2@   # '0"@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH J
MZE(\.EW<L;;72%V4CL0IQ7,> =3O=3AOFO;F2<HR!=YZ9S72ZM_R!K[_ *]Y
M/_037'_#/_CWU'_?C_DU '>4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110!!>.T=C<.APRQL01V.*Y+P!JM]J?\ :/VVZDG\OR]F\],[
ML_R%=9?_ /(.NO\ KD_\C7#_  R_YBG_ &R_]GH ] HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH *X6]_Y*(G_76/_P! %=U7"WO_ "41/^NL?_H
MIH3.ZHHHI#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** $;[I^E</X$
M_P"/V[_ZYC^==PWW3]*X?P)_Q^W?_7,?SIB>YW-%%%(84444 %%%% !1110
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M21_9ZW<N!C/[O>>!^->/>!/$?AZ/7]2\2>*;Y5U.63,"F"1PF?O,-H..RCT
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M"7O4]/T(?A7_ ,DWTG_MM_Z.>N4^'O\ R5OQ;_UTN/\ T?75_"O_ ))OI/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M^/V[_P"N8_G7<-]T_2N'\"?\?MW_ -<Q_.F)[G<T444AA1110 4444 %%%%
M!1110 4444 <!XS^'TVIZFGB#P]<BRUJ(ACSM64COGLV..>#T/K6;;>-O'NE
M#[/J_@VXOY5X$MJK#/N2@=3^&*]1HK13TLU<R=+6\78\KO-5^(WBZ"2RL=$&
MAVLGRO-.Q60*>V3@_4JN>.U=?X*\'6W@[27MHYFGN)F#SRG(#$= %[ ?F?R
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MNY4X\T7$RO"\,MOX2T:&:-XY8[&!'1U(96$:@@@]"*XWQ5X%U2'7?^$F\'W
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MY3U9'DT>^1%+.UO(%51DDE3P*X3X.Z9?Z9H.H1ZA8W-I(]T&5;B)HR1M'(!
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M1@Y'/%>HT5*E9-=RY0YFGV/+O'6E:C=_$_PO=VVGW4UM"\!EFBA9DCQ-D[F
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MP:_Y'H_]>DG\UK:^.&K3?;].T=9"L B-RZ#HS%BJD^N-K?F:Q?@U_P CT?\
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MGO*C;9Q/JVBH+*9[FPMYW78\L2NR^A(!Q4]<9Z(4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110!5U*1X=+NY8VVND+LI'8A3BN8\ ZG>ZG#?->W,DY1D"[STSFNEU;_D#
M7W_7O)_Z":X_X9_\>^H_[\?\FH [RBBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** (+QVCL;AT.&6-B".QQ7)> -5OM3_ +1^VW4D_E^7
MLWGIG=G^0KK+_P#Y!UU_UR?^1KA_AE_S%/\ ME_[/0!Z!1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 5PM[_R41/^NL?_ * *[JN%O?\ DHB?]=8_
M_0!30F=U1112&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_H+5P0Z"O+S3X(^IRXG9"T445XIR!1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %<+>_P#)1$_ZZQ_^@"NZKA;W_DHB
M?]=8_P#T 4T)G=4444AA1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% "
M-]T_2N'\"?\ '[=_]<Q_.NX;[I^E</X$_P"/V[_ZYC^=,3W.YHHHI#"BBB@
MHHHH **** "BBB@ HHHH **\@MOB==Z3XK\2QZS>&>RM))H[.U6-%+.)=JKN
M S]W.2<_B:T+>\^*/B2-;JU2PT2V9<QB=!N;GN&#L#]0!BM'2:W,57B]DV>G
MT5Y7=:Y\2/"*?:]7MK36+!,F:2%0"J@]<J!M^I4^]=YX:\2Z?XJTI;_3W;:#
MLDC<8:-L9P?SZCBE*#2N5&HI.VS-BBHKFY@L[:6YN94B@B4L\CG 4#N37F3>
M._%'BS4);;P;IL<=E$Y1KZY7.3C.>>%^F">G3.*48.0YU%'<]2HKS)K/XM64
M(G&I:9?MQ_HX5 ?S**/_ !ZM3PC\0TUK4'T;6+,Z9K,?'DOD+(>N #R#C!P>
MO44W3=KK4E55>S5O4[FBJNIS26^E7DT3;9(X'=3C."%)%>0>'_BOJ<>@RB]W
M:MK4UT([2W2(+\N!R0@&>3QW)HC!R5T.=6,'9GM-%>9QP?%G5%^T?;=,TD'D
M0,JD_P#H+_SJN_C3QEX/N8E\6Z;%=:>[@&\M@ 5S[CY3T)P0"?6G[-]&B?;)
M:M-(]4K'\6_\B9KO_8/N/_1;5>TW4;75]-@U"RD\RVG3>C8QQ]/7M7!^/-/\
M;R1:U<V6L6,>@BU<M:N@\PQB+]X,^6>3AL?-WZBE!7E8JI*T;K4=\%_^1'D_
MZ_9/_04J7XC^ ;WQA)97%A=PQ36ZLC)<$A""0<@@'!Z]N>/2N*^'VG>.KKPX
M\GAS6;&SL?M# QSH"V_"Y/,;<8QWKLOB7XAUSPSX;TN:QO1#>/*(YY%C1PYV
M$G 9<=1Z"M6FJGNO4PC*+HVDG9'7^'M*;0_#]CIC3><UM$(S)C&X_3TK3JKI
MDTEQI5G-*VZ22!'8XQDE037&>+?B0-(U+^Q-#LFU/62=NP E(VZX('+'U QC
MUXQ6*BY,Z'*,(W9WM%>8PV/Q;NHOM#ZIIMHP_P"7=UC)/?JJ,/;[U6+#QWK6
MA:G;Z7XVTU+;[0^V&_@_U;?7&1U(Y&,9Y'>J]F^CN3[9=4T9/P3_ ./SQ-_U
MT@_G+7KE>1_!/_C\\3?]=(/YRUZ9K>MV'A_2Y=1U&81P1_BSMV51W)_SQ3JJ
M\V3AVE23?G^9H45Y5:^)/B%XQ_TC0;*UTK3R3Y<\X#;ATSE@=V,'[J_G4T[_
M !5T)/M$KV&M1*=SQP(-P Z@ *A/X GFE[-[70_;+=)V/3Z*Y?P;XVL?%]FW
MEK]GOX1^_M7/*_[2^JY_+OVS;\7^)H/"?A^74I8S*^X1PQ XWN<X&?3@D^PJ
M>5WY>I?/'EYKZ&[17EMLWQ7U*R35H;K3[9)!O33WC56P3Q]Y3CCU?-=3X(\2
M:GXBL;D:MI,EA=VD@BDRI5';KA0>1@8SG/4<TW!I7N*-52=K-'4T445!H%%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110!\V?%3_DI&K?]L?\ T2E7M'^$>N:SI=IJ,5[IT=O<QB10[ON
M/3(V8_6J/Q4_Y*1JW_;'_P!$I7N?@7_D1=$_Z]$_E77*;A"+1YU.G&I5DI?U
MJ<YX1^%&G^';V+4;VY-_>Q8:+Y=B1-Z@9^8^A/UQGIN_$+_D0-9_ZX?U%=-7
M,_$+_D0-9_ZX?U%8*3E)-G8X1A3:BCQCX2_\E$L?^N<O_HMJU_C7J<L_B:TT
MX.?(M[8.4SQO8G)_(+^M9'PE_P"2B6/_ %SE_P#1;5L?&O29+?Q'::HJMY-U
M!Y9;MO0\CVX*_D:Z7;VJ]#A5_J[MW.E^$W@W3HO#\6O7EO%<7ET6,7F*&$*
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MAA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MV3_T%*I?'#_D7--_Z^S_ .@&KOP7_P"1'D_Z_9/_ $%*I?'#_D7--_Z^S_Z
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MS-#MC3<%W'([D@5N45*=G<T:NK'BOP\\!^)="\9VE_J6F^1:QI(&?SXVP2A
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MONR*YMH+RVEMKF))8)5*O&XR&![$5YA)X$\5>$[^:X\%ZFC6<S$M97!'R_\
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MX%\&+X1T^;SIQ<ZA=-ON)P/R )YQ]>I-=713<VU;84:23NW<****@T"BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KA9/^2B#_KJ/_0!7=5PL
MG_)1!_UU'_H IH3.ZHHHI#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH YOQO_R X_\
MKNO_ *"U<$.@KO?&_P#R X_^NZ_^@M7!#H*\O-/@CZG+B=D+1117BG(%%%%
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M_.F)[G<T444AA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7"R?\E$'_74?^@"
MNZKA9/\ DH@_ZZC_ - %-"9W5%%%(84444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '-^-
M_P#D!Q_]=U_]!:N"'05WOC?_ ) <?_7=?_06K@AT%>7FGP1]3EQ.R%HHHKQ3
MD"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_P ^7_DNU'_"2>(O^?+_ ,EVHL%SNJ*X7_A)/$7_ #Y?^2[4?\))XB_Y\O\
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M6&2RQ'(A1B(&'!&#6;H=QJFB),MC:.PE(+[XF;IG'\Z+!<]0HKA?^$D\1?\
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K 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>img268224062_2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img268224062_2.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 9;#/L# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH *B?[YJ6HG^^:3*CN-HHHI%!1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 5/4%3TT3(****9(4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !43_ 'S4M1/]\TF5'<;1112*"BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ J>H*GIHF04444R0HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "HG^^:EJ)
M_OFDRH[C:***104444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %3U!4
M]-$R"BBBF2%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 5$_WS4M1/\ ?-)E1W&T444B
M@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **KW[,FG73*Q5EB<@@
MX(.#7D?]M:K_ -!.]_[_ +?XUUX;"2KIM.UCS\=F,<(TI1O<]DHKQO\ MK5?
M^@G>_P#?]O\ &C^VM5_Z"=[_ -_V_P :ZO[*G_,CA_M^G_(SV2BO./"&IW]S
MXABBN+ZYEC*.2DDK,.GH37H]<6(H.A/E;N>I@\7'%4_:15M;!1574-0MM,LW
MNKI]L:_FQ[ #N:\ZU7QGJ5\[+;.;6#/ C.&(]V_PIX?"U*_P[=R,7F%'"Z3U
M?9'I]%>(232S',LCN?5F)I89YK=P\,LD; Y#(Q!'Y5W?V4[?'^'_  3RO]8%
M?^'^/_ /;J*\TTGQMJ%DPCO#]K@_VOOCZ'O^->A6%_;:E:+<VDHDC;CW!]".
MQKAKX6I0^+;N>MA,?1Q2]QZ]GN6:***YCL"BBB@ HKS3Q7JFH6_B6[B@OKJ*
M-=F$29E ^13T!K&_MK5?^@G>_P#?]O\ &O2IY;.<%+FW/%JYW3IU)0<'HVON
M/9**\<&MZJ#G^T[S_O\ M_C6MI7C74;*15NV-W;]"&^^/<-W_&B>654KQ:8J
M>>T)2M)-'IM%06=W#?VD=U;OOBD&5-3UYS33LSVDU)76P4444AA1110 4444
M %%%% !1145Q=6]I&)+F>*%"=H:1PH)],FFDWH@;25V2T5276=+=@JZE9EB<
M "=<D_G5VFXM;HF,XR^%W"BO*?%.J7-]K5S"\C>1!(T:1@_*,'&<>M7_  3J
MMU'K$>GF1GMYE;Y&.0I"DY'ITQ7=++Y*E[2_2]CR89Q3EB/8\NE[7_X!Z/11
M17GGL!116'XQ_P"15O?^ ?\ H:U=.'/-1[LSK5/94Y5+7LF_N-RBO#:]IT[_
M )!=I_UQ3_T$5U8K!_5TGS7N<&7YC]<<ERVMYW_1%FBBBN(],**** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J>H*GIHF
M04444R0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M[\'_ /0UZ'_X,8?_ (JOD3QSXROO''B6;5;SY(QF.V@'2&($E5]SSDGN3V&
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MXJ47=,****DH**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *GJ"IZ:)D%%%
M%,D**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MQL/,8E4RPX5>BCIP/2OL.@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M)[+[=X>NXP!O1?-7/JO/\LC\:X)8F-7$QJ6LM#UH8&=# U*-[MW?X'DE>O\
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MFK+T'6X=<L?.12DJ?+*G]T^WM6I7@U(RC)J>Y]92G"<%*GMT"BBBH- HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ J>H*GIHF04444R0HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M9K6XNYXI8VZ,I1017B/Q*\"7/@3Q-):[7?3;@M)8SM_&G&5)_O+D _@<#(H
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MBB.=N%(P20=V3GJ,5R'QV^'NE^&OL&NZ):K:6US(;>X@CX19,90J.V0&R.G
MXY->[^!/^2>>&O\ L%6O_HI:\_\ VCO^2>:?_P!A6/\ ]%2T ?//A*\EL/&.
MBW4#LLD5]"P*G&?G&1]"./QK[FKX1\/_ /(R:7_U]Q?^ABONZ@#Y ^-O_)7M
M=_[=_P#TGCJ#X2^#[7QKXXCL+_+6-O"UU<1@D&15*KMR"",EAR.<9J?XV_\
M)7M=_P"W?_TGCKL/V:U4^(=<; W"T0 XY W_ /UA0!ZGXI^$OA77]!FLK31K
M#3KP(?LUU;0"(H^."VW&X>H.?SKX^DC:*5XW&'0E6'H17W[7PCX@_P"1DU3_
M *^Y?_0S0!],?L]WCW/PT:%W=EM;^6) W1051\#VRY/U)I/VA?\ DFJ?]?\
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MZ;\=?^23ZE_UU@_]&+7B/P(B>3XK6#*3B."=FQCIY9'\R.E>W?'7_DD^I?\
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MA),4BAE)&.*FKYEIIV9]TFFKH****0'E7C'_ )&J]_X!_P"@+3O!G_(T6O\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M1=N-S?W,YSWJ7XA^"_\ A//#2Z/_ &A]AQ<)-YOD^;]T$8QN7U]: /C33_\
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MBQ_Y!]M_UR7^0KP;_AF7_J;O_*;_ /;:]\@B\FWCBSG8@7..N!0!\R?M'?\
M)0]/_P"P5'_Z-EJO^SS_ ,E)E_[!\O\ Z$E>K_$?X/\ _"P/$-OJW]N_8/)M
M%MO*^R>;G#NV[.]?[^,8[4SX>?!K_A O$KZQ_;WV[=;M!Y7V/ROO%3G.]O[O
M3'>@#U.OC;XI^"YO!GC*YA6+;IUV[3V3C&"A.2O'3:3C'I@]Z^R:R/$7AG2/
M%>EMIVLV:7,!.Y<\-&V,;E/4'F@#XZ\(^.=>\$7DD^C781)0!-!*N^.3'3(]
M1ZC!]\9K:\7_ !?\4^,M,.FWKVMI9,09(;*-D$N.FXLS$CVSC@5W6M?LV7JR
MLVA:[;R1D_+'?(4*CW9 <_\ ?(JE9?LV^()) +_6],@3/)@$DIQQV(7W[T >
M0Z3I=YK>K6NF:?"TUW<R".)!W)]?0#J3T !-?;/A#P_'X5\):9HD;A_LD(5W
M P&<DL[#V+$G\:RO!'PV\/\ @2!CIT+37L@Q)>W&&E(_N@@?*OL/;.<5U] '
MS!^T=_R4/3_^P5'_ .C9:H? #_DI\7_7I-_(5Z]\1_@__P + \0V^K?V[]@\
MFT6V\K[)YN<.[;L[U_OXQCM4'@#X+?\ "#>*%UK_ (2#[;MA>+R?L?E?>QSN
MWGT]* /5Z*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "HG^^:EJ)_OFDRH[C:***104444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 CHLB,CJ&1AAE89!'H:YZP\&Z997;W#JTYW[HTD^Z@^G?\:Z*BM(59P34
M7:YE4H4ZC4IQNUL%%%%9FH4444 %%%% !1110 4444 %%%% !1110!XWK7_(
M>U'_ *^I/_0C76_#O_5:A_O1_P#LU0:AX'U.[U.ZN8Y[0)-,\BAG;(!)(S\M
M;GA30;K0TNA=20N92I7RB3C&>N0/6O:Q.(I2PW)&6NA\S@<'7AC54E%I7>OW
MG14445XI],%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %3U!4]-$R"
MBBBF2%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 5$_WS4M1/]\TF5'<;1112*"BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ J>H*GIHF04444R0HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "HG^^:EJ)_OFDRH[C:***104444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MM-.\N33M49=RV\[!EDP.0CC[Q'/! .!G'6O1* "BBB@ HHHH **** "BBB@
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MP6KE ^&)W,<$$?=5NOM7=5\[_M)ZV7U#1M"CE&V*-KN6,>K':A/T"O\ G]*
M&Z9J7Q\UC3+;4;"4RVER@DBD*6*[E/0X8 C\17H?PU_X67]OOO\ A._^/;RE
M^S?\>WW\\_ZKGIZUQGA;]H/1K:*QTJ^T&;3["WA2!)XKCS]BJNT978IQP.F:
M]RL;ZUU*QAO;*>.>VG0/'+&<JRGN* ,'QYXTL_ OAF75KF,S2%A%;P X,LA!
MP,]AP23Z"O&--T[XP?$BV76XM>.DV4F3;J+I[5'7./E6(%B.."WX$YJ7XXLV
MO_%'PQX98NL++$F5(R&GEVL1GCHJU]!VUM!9VL-K;1)%!"BQQQH,*B@8  [
M 4 >">%?B9XH\&>,/^$6^(+2S0NRQQW+@%HLGY7# ?O$/<G)&/8BOH"O&?VC
M-$ANO"%CK*QC[5970B+YQ^Z<'(]_F"8],GUKNOAQK!U7X::'J-S*N1:!)9"<
M#,>4))S_ +))_I0!UE<!XE\<ZGHWQ1\.>&+>"T:RU--TTDB,9%.6'RD, /NC
MJ#6__P )WX/_ .AKT/\ \&,/_P 57DWC3Q'H5U\<?!^H6^M:=-96\6)KF.Z1
MHXSN?[S X'4=?6@#WFBN?_X3OP?_ -#7H?\ X,8?_BJU[#4++5+1;O3[RWN[
M9R0LUO*LB'!P<,"1UH LT44C,%4LQ 4#))Z"@!:*\?\ $W[0OA_2+R2UT>QF
MUAXVVM,L@AA/^ZV"6[\[<>A(YK4\ ?&?2_'&J)I+:;<6&HNK.B%Q+&P4$G#X
M!S@9Y H ],HKA=3^*^A:)XSC\,:K::C97,CJJ7,R1^00W"ON#DA2>,D<=\8.
M.ZH *IZEJVFZ-;K<:IJ%I8P,X19+J98E+8)P"Q S@$X]C7*V7Q1T/4O'C^$+
M*VOY[V-W1[B-$,"[5RQ+;\X&-O3KQ7EGQY\?:5K%H_A.WM[Q;_3]162621%$
M3 1N#M(8G/SCJ!WH ^A+:Y@O+:.YM9XYX)5#QRQ.&5U/0@C@BI:\E^$?Q+T;
M6-/T?PC;VU^NH6MBJO))&@B.Q0#@AB?IQ76>.?B+HG@*TC?4'>:[F&8;.'!D
M<9P6.>%7W/X9H ZZBO"K/]I6PDO%2\\-SP6Y< RQW0D8+Z[2J_EFO8]"U[3/
M$NE1:GI%W'=6LG1DZJ>ZL.H(]#0!XKJGB'6X_P!IJ/24UC4%TTW,"_8UN7$.
M#;H2-F=O))/3K7OE?..K_P#)V$?_ %]6_P#Z3)7MOB_QIHW@C21J&KS. [;8
MH(@&EE/<*"1TZDD@#\10!T->)>%?CK<^(_B)!HO]E01Z5=RM%!(I;SEX)5FR
M<'.!D8&,]3CGTSPAXMM_&>DG5+/3=1M+0MMB>]C1/.]2H5FR!TR<>V<&N,\/
M:A\/YOB]J-EIGAZXM_$L3S>;>,@\K<O#E!O.TG)Y"@G)SUH ]4HKC/$GQ+T;
MPMXLT[PY?6U_)>7ZQM$\$:&,;Y"@W$L#U4YP#Q7(^+/V@='T'6)=/TK36U?R
M3MDG6Y$4>[N%.UMV/7@>F: /8:*Y?P1X\T?QYI3WFF-)'+"0MQ;2X$D1.<9Q
MP0<'![X/0@@6?%GC+1?!6E?;]9N3&K$K%#&-TDS 9PJ_U. ,C)% &_17A7_#
M1Z>9YG_"(W7V'/\ K_M?..F<;,=?]JO5O"/C/1O&VD_VAH\[,JG;+#(-LD+>
MC#)_,$@]CQ0!OT5PGQ!^*>C^ !%;S0R7NI3(72UB8+A><,['.T$C'0GKQ6%X
M+^.VE>*M9MM(N=(O+"]NGV0^6?M$9//4@!A]=N!R20!F@#UBBBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ J)_OFI:B?[YI,J.XVBBBD4%%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %4=:_
MY .H_P#7K)_Z":O51UK_ ) .H_\ 7K)_Z":NG\:]3.M_#EZ,YSX>_P#(.O/^
MNH_E6#!9SZAXSO[2&=H1+/,LCKUV;CD?CT_&M[X>_P#(.O/^NH_E5'0/^2@W
M_P#UTG_]"KUG)QJUI+L?/*"GA\-%[-ECQ)X4TVQT26[M%>.6$+G+DA^0#G/?
MGM5OPU-)-X(G$C%O+65%SV&,X_6M+Q;_ ,BO>_[J_P#H0K*\+?\ (DW?_;7_
M -!K!3E4PUYN_O'7*E"ECN6FK)P>WJ<_X4T4ZU--'/+(ME$5>1%.-[<A?Z_Y
M-6O&&@66D1VUQ8HT0D8JR;R1TR",\^O>KWP[_P!5J'^]'_[-4WQ"_P"0=9_]
M=3_*NB5:?UWDOI_P#CCAJ7]F.HU[W?YFCJ$KS^!&FD;=))9*S'U)4$U4^'__
M " 9_P#KZ;_T%:L77_)/E_Z\$_\ 015?X?\ _(!G_P"OIO\ T%:Y7_NT_P#$
M=Z=\;2;_ )#"UFUN;WQ_-;6C[)9"H#_W1Y8R?RS72)X'T9;7RF25I.\WF$-^
M73]*P-1U!-+^(LMW*I:-2H?'4 Q 9_#.:[R.^M)K8W,=S$T ZR!QM'U/:KQ%
M2K"%/DT5EL98*CAZE2M[1)OF>_;^NIYY;+/X1\6);F7=;R%59BO#1L>N/4'/
MY5T_C?\ Y%J3_KHG\ZYC6;D>)/%L$-G\\:E8E8=" 26;Z<G\!73^-_\ D6I/
M^NB?SK2I=U:,I?$[7,J-EA\1"'P*]ONU(]!T^+5/ MO93LZQR;LE" >)2>X/
MI7)VFAVT_BZ326>86ZNZA@1NX!(YQCMZ5V_@[_D5;+_@?_H;5S>G?\E*F_ZZ
MR_\ H)I4JDHSK)/:[^85Z-.5/#.2WY5\K;%[Q3ISZ9X1@LK)I&M8I?WI8Y;!
M)(SC QN/\JK:-HWAK6=/@C21TO0H\U?-PY;J< \$?0=/>NRO+NSM(2;R:&.-
M@<B1@-P[C!Z_2N,\3:#I5IIYU.PN%@?(:-$?*R<@?+SVSGBHP]9SBJ;;3;T:
MZOS-L9AHTYNK%*44K.+Z)=CN+>WBM;>."",1Q1C:JCL*DK+\.7DU_P"'[2YN
M"6E92&)[X8C/Z5J5Y]2+C-Q>Z/8I3C.G&4=FD<'X_647MB\@<V>TCY3_ !9Y
M_'&*OV'A[PQJ7D7%DQ<( S1"7.?]]3R/TK>U&YTO;]DU":VQ(=OERL,G/MV^
MM<1XBTZW\-7]M=Z5=-%,6/[K=N*?_6YQ@UZ-";J0C23<7K;LSQ<52C1JSQ$D
MIQ=KI[KT_P CH/&NK2:=I200,4EN6*[AU"CKCWY _$U@Z7'X/@L8_MUP9[EE
M!DRD@"GT&!5WQU%+=Z5IU^$*HN=Z]=N\*1_+%;&BQ:'J^G13Q6%B9 H$J^0F
M5;'.>*(.-/#)Z[N]@J1E6QTE[KLE923>G6R.*OKBPTO5HKWP_>,5[QE6&WVR
MPY!KT'49UNO"UW<*,++9.X'L4)JC=R>&++48K&>SL5FD_P"G=<+GIN..,UHZ
MNB1>';^.-51%M)%55&  $. !6=:JINGH_5]4;8:@Z2J^\K=ELG;\#GOA[_R#
MKS_KJ/Y5BZEJ-MK7B5UU*\,.G0,RIM4G(!QP #R>N?3\*VOA[_R#KS_KJ/Y5
MCZ8EGI?BVYL]5AADB=F17G0%1DY5N0<9'\ZZE95ZLNJ73?SL<,N9X2A#[+>M
M]O*_D7+E?!$UL\<4Q@D(^614E)4_0CFG>!=5D%W+I4DWF0[2\).>"#R![$<_
MA74RZ9HD-NT\EA8+$J[BYA3&/7I5?1)]#O\ =<:9;6\<D9VMM@".N<^W0XKF
ME7C*C)6DUW>MF=D<+.&(A*\8OLE:Z^\Y2Y6X\8>*)+99MMI;DX(Z*@."0/4_
MYZ5T3^"-%> 1K%,C#_EHLIW'\\C]*YW2;E?#7BZZ@O?EBDRGF=@"=RM],?S]
MJ[^:\MH(/.EGC2(KN#%A@CU'K58JI4IN,:3M&VENI.!HT*T9SKI.=W>_3_(Y
MG5_"UK_88DEGF:6PM'"%<*&P"1D8/\ZP_"7AVTUB"6XN))U>&4!1&P /&><@
MUVNI7$5UX:OIX'#Q/:R%6'<;36#\/?\ D'7G_74?RHA6JK#3;>J8JN%H/&TX
MJ*LT_P -BC\0_P#C]LO^N;?SKI_$VE?VKHLL:+F>/]Y%ZY';\1D?E7,?$/\
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MAC:0J.IP,X_2OGOX*^&[;QMXBUCQAXA5;RXAN 8HI#N3S6RQ8@]0HVA1DX_
M5]#3PQW-O)!*NZ.12CKG&01@BOFKPSK%U\#?'^I:-K4,TNCWA7;,B<N@)V2K
MSCH2& [\=J /HG5=!TG7++['JFG6MW;[2H2:,-M!&/E_NGW&",5'K>@6&O\
MA^YT6]A5[2>+R\$9*<<,,]P<$'U%<+JGQZ\#V-H\EE>7&HS #;##;NF[GU<*
M!7I4$OG6\<N,;T#8STR* /GCX>Z_=_"GQY>^#/$<Y32IY,PW$OR1HW\,HST1
M@,'G@CV-,T!&^+7QUFUB4L^C:45DC##CRXS^Z3N/F?+D'J-U;O[2%KHXT/2;
MN9<:RTYCMRN<M" 2^>V 2GOEN.IKK?@SX1'A?P);RS1E;[4@MU/N&"H(^12,
M]E/MR30!K?$;1=*U#P3KMY>Z99W-U;:7<M!/- KO$1&Q!5B,J<@'BO-?V?-
MT;5/"^H7>H:187=S#J&(IKBV21TPB$88@D<\\5ZQX[_Y)YXE_P"P5=?^BFKS
MC]F[_D3-5_["!_\ 1:4 8/QEEN_%/Q5T'P;]J>"P/D@C&0))&(9\=R%P #[]
M,FO<=&\-Z/H&F)IVF:=;V]LJA2JH,OCH6/5C[GFO(?CCX3U.WUC3O'NBQ&63
M3PANE R8_+;<DF!R1R0WH #ZD;^C_'WP;>Z2MQJ5Q/I]Z$_>6K0/)EL<[&4$
M$9Z9Q[XH \]^*6EP?"_XC:/XB\-*+1;@-*UK%\J J0'4=@K*P&,<<X[ =/\
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M1NR@E2.Q!)&*\V_X79::EX\T_0/#6F2ZQ:S'9/<1Y1@21\R!@/E49))P#V(
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M-[(T\\,"H\I*Y)9@,MSSSWJI\'O^2[>+/^N5Y_Z4QUL_M*?\BWHG_7V__H%
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M+A93LGAMR!&">4=/O#'8@$XZC(R0#TGQ]X&T;QAH%XEW:0K?+"QM[T(/,B8
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MU7^_(H(V]0.0S 9XR10!F_!_P1I?AWP;IVJ) DNIZC;QW4MRPRRAURJ*<?*
M&YQU.>O%=L^@:0^L0ZN=.MAJ4.0ETL863!!!!8<D8)X.1WZUXI\,/C%I>A:
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MQ(S&2I0X7;@C'3'O61>?#^UFF+VEX]NA.=C)O ^G(X^N:["BM88JM#X9&%3
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M!5;4]$TG6EC75=+LK]8B3&+JW24(3UQN!QTJ_10 U$2*-8XU5$4!551@ #H
M*H:9H&C:*TC:5I%A8-* )#:VR1%\=,[0,]36C10!GZSH6E>(;!K'5[&&\MB<
M[)5S@^H/4'W%9'A[X>>$_"MT;K1M%AM[DC F9WE=1C!VLY)7\,5T]% !1110
M!'/!#<P/!<1)+"XVO'(H96'H0>M<8_P?\ R7QNV\.6XE)SM6618_^^ VW\,5
MV]% $%G96NGVD=I96T-M;1C"0PQA$4=>%' JK>:!HVHW\-_?:1875Y" (KB>
MV1Y$P<C:Q&1@DD8[FM&B@ K.T[0-&TB:6;3-)L+*67B1[:V2-G[\E0,UHT4
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M?56<DK^&*ZBBB@ KDM:^&'@OQ!?27NI:#!)<R'=))&[Q%SZG8PR>>IZUUM%
M&;HN@:3X<L?L6CZ?!96^=Q6)<;CZL>K'W-:5%% !1110 4444 %%%% ',^(?
MA]X4\57 N=9T6"XN.,S*S12-@8 +(02,>IJUX?\ !_A[PLA71-(MK-F&UI%7
M=(PXX+MEB.!P36Y10!B>+O$=OX2\*ZAK=P PMHLI&21YDAX1>,XRQ SVZ]J\
MD^ 'AR>\GU/QOJ9>6ZNI7BAD<<L2=TK]><L<=.QKU[Q'X7T?Q9IZ6&MVC75J
MD@E$8FDC&X @$[&&>IZU;TG2;#0M*M],TRV2VLK==L429(49R>3R22223R2<
MT 7:IZEI.FZS;K;ZII]I?0*X=8[J%95#8(R P(S@D9]S5RB@"*VMH+.VCMK6
M"."")0D<42!511T  X J#4]*T_6K%[+4[*"\M7^]%.@9<^O/0^_45<HH XJS
M^$7@*PN_M4/ANV:3GB=Y)D_[X=BOZ5VBJ%4*H 4#  Z"EHH S7\/:))JPU9]
M'T]M2!#?;&MD,V0, [\;N  .O2KMS;07EM);74$<\$JE)(I4#*ZGJ"#P14M%
M %#3-$TG15D72M+LK!92#(+6W2(.1TSM SUIL&@:-;:G)J=OI-A%J$F2]U';
M(LK9ZY<#)S]:T:* ,Z\T#1M1OX;^^TBPNKR$ 17$]LCR)@Y&UB,C!)(QW-:-
M%% &=IV@:-I$TLVF:3864LO$CVULD;/WY*@9JW=6EM?6LEK=V\5Q;RC;)%,@
M=''H0>"*FHH X;_A3G@#[7]I_P"$<A\S.<>?+L_[XW;?PQ786&GV>EV<=G86
ML-K;1C"10H$4?@*LT4 8_B#PIH7BJU6WUO38;Q$.4+Y5E^C*0P_ U!X<\%>'
M/"0D_L/28;1I!AY 6>1AUQO8EL>V<5OT4 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M43_?-2U$_P!\TF5'<;1112*"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ J>H*GIHF04444R0HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBDW*.I'Y
MT +12;@>A'YTM !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M5$_WS4M1/]\TF5'<;1112*"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HH) ZFDW+_>'YT#%HHSFB@04444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %3U!4]-$R"BBBF2%%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *#P**:YPC'VH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !3)5W1.,XR*?2$9!%)ZH$>:W0VW4H_VC4-:FNVIM[]N/E;G-9=?%
M5X.%246?5TIJ<%)!11161H%%%% !5BQ7?>1+ZFJ]:V@6IN+]6QPG-;8>#G5C
M%=S.M)1IML[B(;84'H!7!?%*$G2HI1TW 5Z .E8'C#3?[1T*9 ,LBE@/>OM+
M:6/E;ZG@-%/EC:*5HW&&4X(IE2,**** "BBB@"6U&Z[A'JX_G7T1HD?E:/;(
M>RUX=X4TQM3UR"(+E0=Q/TKWZ)/+A1/[H JD)F5XA4M9@^E<E7=:C!]HLW3&
M3BN'=2CE3U!H!#:***!A1110 5) ";B+']\?SJ.M#1[8W%ZIQ\J\T =HOW1]
M*6@=**9(4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !43_?-
M2U$_WS294=QM%%%(H**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KD/%"%;Q
M#UR*Z^L#Q+:F2W$JC)6N+,8.>'=CLP,U&LKG(T445\H?1!1110 4444 %=9X
M73$#/Z\5R@!) '>NZT2V-M8*",$\UZF50<JW-V//S&:5*W<TJ***^D/!"BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH *GJ"IZ:)D%%%%,D**** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH *AN9A;V[R$_=&:FK&\23&+3N/XCBLJ]3V=.4^QI1AS
MU%'N<A?737=T\C'@GBJU%%?%RDY-R9]5&*BK(*ZGPO;(5:8@$]*Y:MG0M4%E
M+LD^X:Z\!.$*Z<]CFQD92HM1W.XQ7,^*+5/+$P #5M?VG:^7O\Y.F<9KE=>U
M5;V01Q?<'6O<S&M2]@TW=L\G TJGMD[&*C%&#*<$5WNB7OVRR4D_,.#7 UT?
MA68K</&3P1Q7D976<*ZCT9Z684E.ES=4==1117U)\\%%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% &3K>FB^MB5'SKR*X:2-HI"C#!%>G]:Q-5T*.[!DB&V2O(S' .K^\I[GI8
M+&*G[D]CB:*MW.FW-LY5HR0.X%52"IP017STH2@[25CVXRC)73$HI0I8X )J
MW;:;<W+@+&0/4BB,)3=HJX2G&*O)E:.-I9 B#)-=UHNG"QM06^^W)J'2M#CL
MP'D&Z2MKI7T67X!T?WE3<\3&XQ5?<AL%(RAU*L,@]:6BO6/-/'O'GA22RNVO
MK:,F)SEL#H:X/I7TQ<6T5U"T4R!T/8BO.O$/PW$SM/IS!2>2IZ4FAW/+**V;
MSPMJUG(5:U=P.ZBJBZ-J3'"V<I/^[2&4:D@@DN9EBB4L['  KHM,\#ZMJ#@&
M(Q#OO&*]+\-^";/15$DBB2?N6YQ181%X'\,#1[$7$R_OY!DY'(KL:  !@=**
MH0$9&*Y?7-,*2&>)?E/7%=13719%*L 0?6@#SRBNEO\ 0 Y+P'!]*Q9=-NHC
M@QD^X%(94HJ86EP3@1-^56[;1KF<C*[1[T#*,43S2!$&2:[#2=/%G!R/G;DT
M:?I,5F <9?U-:5,5PHHHH$%%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 5$_WS4M1/\ ?-)E1W&T444B@HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "HYX5GA:-AP14E%#2:LQIV=T<!J=@]C<%2/D)X-4:]#O+&*]B*2+^
M-<E?Z'/;,3&NY.V*^;QF7SIR<H*Z/=PN-C-<L]&9-%.:-T^\A'U%-KS&FMSO
MO<**D2"60X1&/T%;6F^'Y)6#S\+Z5M1P]2J[11G5KPIJ\F0Z'IC74XE<?NU_
M6NT50JA1T%1P6\=O&$C4 "I:^GPF%6'AR]>I\_B<0ZT[] HHHKJ.8**** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ J>H*GIHF04444R0HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH *CFGBMT+RN% ]3575-3ATNT::5AP.!ZUY3KGB:[U69@'*0YX4&M(0<CA
MQF/IX96>K['?WWC73;0E5;>X_*LL_$2'/$*_K7FY)/4YI0I8X4$GT%;*E$\&
M><8B3TT/4+7Q]8RMB9=GTKI+/4[6^C#PRJ<]L\UXN-(OFB\P0-MZ]*2TO[O3
M9P\3LC \@TG2B]CHI9O7IM>VCH>ZTA (P17->&?$\6JPB*4A9QV]:Z:N=IIV
M9]!1K0K04X/0K2:?:RG+Q*:B_LBQ_P"?=?RJ]163I4WJXHZ%4FMF0165O#]R
M-14^,45S_B/Q)#I%N55@TQZ"M:=*[Y8(RJ5%%<TV:]U?6]FA::55QV)KG+SQ
MWI\#%8OG(]:\YU'5[S4IB\\K$9X&>E4*]6G@(I>^SRJF82;]Q'I ^(D.1F%<
M?C6E:>-],N6"LQ5C7D\<;RMM12Q] *L2:==P('>%P/7%7+!4=MB(XVMON>XP
M74-R@:*16!]#4U>)Z3KUYI,ZF.1BF>5/>O5M#UR#6+8.C /CE:X*^%E2UW1W
MX?%1JZ;,UJ***Y3J"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "IZ@J>FB9!1113)"BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "FR()(V1AP1BG44/4#@-8T][.[8[?D8Y%
M9M>C7]C'?0%''/8UQ>H:/<63G"ED]17S&/P$J4G."O$]_!XR-2*C)ZF;11T.
M**\L] ***LVMC/=R!8T.#WJHQE)VBA2DHJ[&6UN]S.L:#))KT#3K1;.T2,#W
M-4](T:.P3>V#(>]:]?39=@O81YY_$SP<=BO:OECL@HHHKTSSPHHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH Y_Q9K(
MTG3&VG$D@PM>.S3/<2M+(268Y.:ZSQ_?--JWV8-E$Y%<?772C:)\=FV(=6NX
M]$%.C3S)43^\0*;3HW\N5'_ND&M#S%N>S>'-$M]/TV/,2EV&22*TKS3K:\MV
MBDB4@CTK-\-ZY;:CI\8$@$BC!4GFM2]U"WLH&DFD50!W-<3O<^[H^R]BN6W+
M8\5URQ&GZI+"OW<\5J^#M=?3M06&1SY+G&#ZUE:[?C4-4EF'W<\5GQ.8Y4<=
M5(-==KQLSX_VRHXESI;)GT$C!T##H13JRO#ET;S1+>8G)*UJUQM6=C[:G-3@
MI+J%<7XZUUK*U^R0/B1^OTKLV(523P *\3\4WK7FMS9.0C%177@J2G4N^AS8
MVJX4[+=F,26)).2>])117N'A&AHMC_:6J0VW]XU[38:7:V5JD,<*X [BO%M$
MOAIVJPW)Z*<5[98W]O>VZR0RJ^1DX->5F'/==CULNY;/N9'B?0[6\TN:01JL
MB+D$"O'74Q2E<\J>M>R^)]9MK'2ID,BF1UPJYKQJ5S)*SGJ3FM<OYN1WV,LP
MY>=6W/3? FO->0?8IFS(GW?I7;UXAX9O&L]:A921O(4U[<IR@/J*X\;24*EU
MU.O U7.G9]!:9+*L,32,< "GUA>*[LVND,%.#)D5QG:<1XBUF34KQE#$1*<
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MW@:]:ZTC:QSY9P*ZFO#JPY)N)[M*?/!2"BBBLRPHHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "IZ
M@J>FB9!1113)"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M$%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M!X4EGD6>[7:@Y"GO3L(T?!NCM#$;N5>6Y7/:NQIL<:Q1A$  '84ZK)"BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ JG=:G:V<@CFDVL1G&
M*N5Q_B?_ )":?[HI,:.O!! (Z&EIL?\ JU^E.IB"BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "D(#
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 5SNN:3=WUZLL"J5"@<MBNBK UK6+FPO%BB"[2 >128T;J A%
M!Z@4ZD0[D4GN*6F(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "HG^^:EJ)_O
MFDRH[C:***104444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1U&#12$A5+,0
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBN*^*^IWFD?#^^O+"=H+A"NUUZCF@#M:*\
ML^!6N:EKWA2]N-3NY+F5+HJK.<D#:.*]3H **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MK3PYIZP0*&E(S)*1RQHBC7-<32A2=.2NWT_4VZ***L^3"BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>?\ QH_Y
M)EJ/U7^=>@5Y_P#&C_DF6H_5?YT <W^SE_R)>H?]?A_]!%>R5XW^SE_R)>H?
M]?A_]!%>R4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5$_P!\U+43_?-)
ME1W&T444B@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"K?Z?:ZG;&W
MO(5EB)SM85-'!'! (8D"(J[54#@5)2,<*3[4%<SM:^ABV&C36FIM<LZE3G@5
MMD C!Z5S>EZC=3ZPT,DI:,9XKI*$)E.STJQT^6:6UMDB>9MSE1U-7***!RDY
M.[84444$A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %>?\ QH_Y)EJ/U7^=>@5Y_P#&C_DF6H_5?YT
M<W^SE_R)>H?]?A_]!%>R5XW^SE_R)>H?]?A_]!%>R4 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 5$_P!\U+43_?-)E1W&T444B@HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O/
M_C1_R3+4?JO\Z] KS_XT?\DRU'ZK_.@#F_V<O^1+U#_K\/\ Z"*]DKQO]G+_
M )$O4/\ K\/_ *"*]DH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J)_OF
MI:B?[YI,J.XVBBBD4%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %(_
MW&^E+2,,J1[4#.2T;_D/O_P*NNKG-,TRZM]8:>2/$9SSFNCI(&%%%%,04444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M 3T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MC"YH8'Q?XJ\*:GX0U=]/U&(J1S'(!\LB^HK"K[:\9>#-,\;:(UE>Q@2 9AG
M^:-J\&\,? K5[CQ=-:ZROE:9:/\ -,O_ "W'4!: *WP5\$ZUJOB"'7(9I;*P
MMFYE''F_[(]17U/573]/M-*L(;*RA6&WB4*B*, "K5 !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %>?_&C_DF6H_5?YUZ!7G_QH_Y)EJ/U7^=
M'-_LY?\ (EZA_P!?A_\ 017LE>-_LY?\B7J'_7X?_017LE !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %1/]\U+43_ 'S294=QM%%%(H**** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH *1CA2?04M(_P!QOI0,Q+#69[K4VMG1 HSR
M.M;E<CHW_(??_@5==0@84444""BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M\+ZM/<--9SB*.)G)VY/4'TYS7VH2 "3T%?+VD./&'[1C7*D20QWSR ]0T<?
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M\)=!CT'X=:7&$VS7,8N)CCG<W.#]* /'?$_P<\0>";%M=T35GN?LHWR!,HZ
M=2/6G_ 47NM?$74=9N[B262.!GE9C]YI#_\ 6KV'XL:LNC_#76)2VUYH3;I_
MO/Q7#?LWZ9Y7A[5=39<-/<")3ZJH']2: /;J*** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "N/\3_\ (33_ '1785A:QHL^
MH7:RQNH  '-)C1MQ_P"K7Z4ZD0;4 ]!2TQ!1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !7G_QH_P"29:C]5_G7H%>?_&C_ ))EJ/U7^= '
M-_LY?\B7J'_7X?\ T$5[)7C?[.7_ ")>H?\ 7X?_ $$5[)0 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !43_?-2U$_WS294=QM%%%(H**** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH *0C((-+2-]QOI0!G6NF6=O>&>)P93GC=6E7
M):,Q.ON"3CYJZVA#84444""BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M;OM5D^;R(YIPQ]6;:/T8U]&ZWI[ZKH5_I\<IA:Z@>$2#^'<"/ZUQ/PN^&9\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !7G_P :/^29:C]5_G7H%>?_ !H_Y)EJ/U7^= '-_LY?\B7J'_7X
M?_017LE>-_LY?\B7J'_7X?\ T$5[)0 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !43_?-2U$_WS294=QM%%%(H**** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH *1ON'Z4M(3@$^E '+:1!*FNNS1N%^;DCBNJK*M-:CN[XVRQD$9Y^
ME:M"&PHHHH$%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !4]0
M5/31,@HHHIDA1110 4444 %%%% !1110 4444 %%%% !1110 4444 <Q\0?#
MU]XH\&7NE:=<_9[F7:5;. <,#@_7%>%6FF_&#PJOV*U-X\"\* ^]?PKZ<HH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 5G7R:8TX-X(S)CC=6C7'^)_\ D)I_NBDQ
MHZ]<;1CIVI:;'_JU^E.IB"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "O/_C1_R3+4?JO\Z] KS_XT?\DRU'ZK_.@#F_V<O^1+U#_K\/\
MZ"*]DKQO]G+_ )$O4/\ K\/_ *"*]DH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ J)_OFI:B?[YI,J.XVBBBD4%%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %(_W&^E+2$9!'K0,Y+1O^0^_P#P*NNK(LM$^R:@;KS=V<\8K7H0
M,****!!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5/4%3TT3
M(****9(4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4449 H **3(]11D>HH 6BBB@ HHHH **** "N
M:U_3KJ[OUDAB+*% S2:W?:A87F(Y<1.,KQ69_;^H_P#/;]*38TCMT!"*#U I
MU<.FN:E(ZHLN68X Q79VRR+;H)FW28^8^]"86):***8@HHHH ***0D#J0/K0
M M%-\Q/[Z_G1YB?WU_.@!U%("",@@TM !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !129'J*,CU% "T444 %%%% !1110
M 5Y_\:/^29:C]5_G5GXI77B#3?"4FI^'KGRI[4[Y5V;MR=_RKYGUSXG^*O$.
MER:;J5^)+:0@LH0#.* /:_V<O^1+U#_K\/\ Z"*]DKXH\-_$'Q%X3LI+/2+P
M0PR/YC*4!R>E?0OP:UKQ1XETVYU?7KSS+9FV6Z; N<=30!ZE1110 4444 %%
M%(2!U.* %HIOF)_?7\Z/,3^^OYT .HI 0>A!^E+0 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5$_WS4M1/\
M?-)E1W&T444B@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BC(]:3(]10 M%&1ZT4 %%%% !111
M0 4C?=/TI:1_N-]*!G,:3=W$NMM&\SLG/RD\5U%<CHP/]OOQ_>KKJ2!A1113
M$%%%% !1110 44A=1U8#ZFD\Q/[Z_G0 ZBF^8A_C7\Z=0 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 5/4%3TT3(****9(4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 5B:[=2V\L(C;&0<UMUS
MWB3_ %T'^Z:!HSO[2NO^>AH&I7.?]952BD,Z[3+Y;J 9/SCJ*OUQ=C=-:W 8
M'CO7803+-$KJ>"*8F24444""BBB@#-UNQ^VZ>X4?O$^9:X4C!P:],KB=;TYK
M;4L1K\DQRH'KZ4F-$WAJQ\^[-RX^2+I[FNPJIIMFMC8QPCJ!ECZFK="!A111
M3$%%%% "$@ D]!7FWC+Q5*+O[)928"'YF'>ND\7Z^NE6#1QL/.<8%>02R-+(
MTCDEF.3FDV-&A_PD&H_\_#4?\)!J/_/PU9E%(9[1X/NI;K1@\S;FSU_"N@KF
M? W_ " A]1_(5TU42%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 50UB5X=/+H<-N%7ZS-=_Y!C?[PH P/[2NO\ GH:/[2NO^>AJ
MI12*.DTC4O.'E2M\WK6S7"PRM#*KJ<$&NOL+M;J ,#SWIB9;HHHH$%%%% $5
MQ;QW5M+;S*&CD4HRGN#7Q?\ $/PM)X2\87FGE2("WF0-V*'I7VK7DOQW\'_V
MWX776+:/-WI_+8'+1GK^5 'S9H&CW&OZ[9Z7;*3)<2!..P[G\J^V] T>WT#0
M[33+90L=O&%X[GN:\1_9[\'_ /'QXGNH_P#IC;9'_?1KZ H **** "BBB@ K
M@?&WB=[9A9VCX?JS"ND\2:S'I&G.Y8"1AA17B]W<R7=R\TA)9CFDV-%W_A(-
M1_Y^&H_X2#4?^?AJS**0SUWP/>3WFG,TSEB,5U=<;\/?^06_X5V542%%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %1/]\U+43_ 'S294=QM%%%(H**** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#F]5O9X=0=$?"@"J
M?]HW/_/0U+K7_(3D^@K/H*+T6IW"2*6?(SS73VUPMQ"'4]N:XJM/2;XP2^6Q
M^4T SJ**12& (I:"0HHHH 9*YCB9PNXJ,X]:PCXIB!*FU?(X/-=!7&:_8_9;
MXR*/W<G(^M)C1>7Q':(^];(AO4$5:M?$2W=RD,=L^6/7/2N1KJ/#-CMC:[<<
MMPOTH0VCH:***9(4444 %5[V[CLK5YI& "C-3D@ D]!7FOC?Q 9Y38P/\B_>
MQ0,Q]5\47MU?R/%*5CS\HS5+^W]1_P">[5F44AF]IFN7[ZA$K3D@FO88"6MX
MR>I45X;I/_(2A^M>XVW_ !ZQ?[HIH3):***!!1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %3U!4
M]-$R"BBBF2%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %<]XD_UT'^Z:Z&N>\2?ZZ#_=- T8=%%%(8
M5M:-?^6_DN>#TK%I58HP8'D4 =X.1169I5^+F$(Q^=>*TZ9(4444 %12V\4S
MQO(H)C.5]C4M% !1110 4444 %5-1OHM.LI+B5@H4<9]:M,P52S' '4UY7XW
M\1&^NC9P,?*3AO<TF!SNM:I)JNHR3NQP3P*SJ**DH**** /8O W_ " A]1_(
M5TU<SX&_Y 0^H_D*Z:K)"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH *B?[YJ6HG^^:3*CN-HHHI%!1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 <IK7_(3D^@K/K0UK_D)R?05GT%!2@D'(ZTE%(#IM(OO.B$3
M'YA6K7$V\[6\P=3TKKK.Y6YA# \XIB98HHHH$%4-7LA>V#J!\Z_,M7Z*!GGM
MK:O<W:0 <DX/M7?0Q+!"D2# 48JG:Z7';7\UR/X^@]*T*20-A1113$%%%5=0
MOHM/LY)Y" %&<>M &)XNUY=+L&BC<><XQCOBO(Y)&ED9W)+$YR:T-;U235=0
M>9B=N?E'M6;2*"BBBD!=TG_D)0_6O<;;_CUB_P!T5X=I/_(2A^M>XVW_ !ZQ
M?[HIH3):***8@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "IZ@J>FB9!1113)"BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MH**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@#E-:_Y"<GT%9]:&M?\A.3Z"L^@H****0!6CI5Z;>8
M(Q^4UG4 X.: .Z5@R@CH:6L?1[\2)Y3GYATK8IB"BBC(]:!!11D>M&:!A111
M0(1F"J23@"O+_&GB-KVX-G <1(<'ZUTWC+7_ .SK)K>)AYL@P?45Y2[M(Y=C
MECR328T-HHHI#"BBB@"[I/\ R$H?K7N-M_QZQ?[HKP[2?^0E#]:]QMO^/6+_
M '130F2T444Q!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %3U!4]-$R"BBBF2%%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %<]XD_UT'^Z:Z&N>\2?ZZ#_=- T8=%%%(84444 %*"00125:L;1KN<*.G<
MT =!HUVUQ!M<'*]ZTZAMK=+>((@Q4U,D**** "BBB@ )P":\F\<:S+>:@;4;
MEBC['CFO6:Y/QAX:CU*T:YA3$Z#.0.HI,#R.BGR1M%(T;C#*<$4RI*"BBB@
MHHHH ]B\#?\ ("'U'\A735S/@;_D!#ZC^0KIJLD**** "BBB@ HHHH ****
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M44 %%%% !1110 4444 %%%% !1110 4444 %%%% '*:U_P A.3Z"L^M#6O\
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M '130F2T444Q!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %3U!4]-$R"BBBF2%%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %<]XD_UT'^Z:Z&N>\2?ZZ#_=- T8=%%%(84444  &3@5U6CVHAM@Y'S-UK
MF[5/,N$7WKM(U"QJ!Z4Q,?1110(**** "BBB@ H(!&#THHH \F\=:.+'4OM$
M:_))R3[UR%>O^/+;S]")"C<K9S7D!X-2QH****0PHHHH ]B\#?\ ("'U'\A7
M35SG@J%XM!C+C ?!'N,5T=62%%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !69KO_(,;_>%:=9FN_\ (,;_ 'A0!RM%%%(H**** 'P_ZU?K7:6O
M_'NGTKB5.U@?2NSL)!)9QD'M0)EFBBBF(**** "BBB@ HHHH H:S_P @J?\
MW:\+N?\ CYE_WC7M7BB?[/H%R^>=O%>).V]V;U.:3&AM%%%2,**** /9?!'_
M "+-O^-='7.>"/\ D6;?\:Z.K)"BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "HG^^:EJ)_OFDRH[C:***10444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% '*:U_R$Y/H*SZT-:_Y"<GT%9]!04444@"M?0_]>:R*TM&
ME"7@4]#3 Y#XJJ?[2M6QQLZUYY7LGQ&TEKW2?M$2[G3^5>-D8.*SEN?9Y144
M\+%+H%%%%(],**** "BB@ DX'4T >E?"R$BXGF[%,?K5_P"(G_+.M/X?Z2=.
MT0/(/GD^;/M6!\0KG=J20@Y 4&M%L?#YE553%2:.*HHHI'"%%%% &QX7_P"1
MAM/]^O:Z\4\+_P#(PVG^_7M?:J0F%%%% @HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "IZ@J>FB
M9!1113)"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "N>\2?ZZ#_=-=#7/>)/\ 70?[IH&C#HHHI#"B
MBB@ !P<BNLTBZ$UJ%)^9>M<G5NPO&M)PV?E[B@1V5%16]PEQ&'0YJ6F(****
M "BBB@ HHKF/%7B6+2[1X8G!G<8&#TH Y#Q[K O-0^RQ,=D?##WKC:DGF>XF
M>60Y=CDFHZDH****0!1110![EX8_Y%VR_P"N8K6K)\,?\B[9?]<Q6M5DA111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %9FN_\@QO
M]X5IUF:[_P @QO\ >% '*T444B@HHHH *Z'0KH%#"QY[5SU2V\S03*ZG&* .
MXHJI97J740(/S=Q5NF2%%%% !1110 445B>(=>@TBS<EAYI' H Y7XAZR"RV
M$3$,O^L%>>59OKR2^O)+B5BS,>IJM4LH****0!1110![+X(_Y%FW_&NCKG/!
M'_(LV_XUT=62%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %1/]\U+43_?-)E1W&T444B@HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M .4UK_D)R?05GUH:U_R$Y/H*SZ"@HHHI %202&*96'8U'10!V&V/4+ HV"KK
M@UXGXM\.3:+J#E4/D.<J:]1TG4/(?RW/RGI6OJ&FVFKVABG175AP?2AJYWY?
MCI82I?[+W/G.BNZ\0?#V\LY&EL1YD/6N.EL+J%RLD$@(_P!FL['V%#%4JT>:
M$BM13_*DSC8WY5/!IUW<.%B@D)/^S0;.26K95KJ_!WAB;5M0CFD0BW0Y.1UK
M4\/_  ZN;ETFU#]W'UP.]>H6=E;:5:"*%51%')JE$\/,<VA"+IT7=]Q9I(M,
MTYGQB.)>@]*\6UF_;4-2FF+$J6.W/I76>,_$WGYLK5_EZ,0>M<)5,^6\V%%%
M%( HHHH V/"__(PVG^_7M?:O%/"__(PVG^_7M?:J0F%%%% @HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "IZ@J>FB9!1113)"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %5+VR2[B((^;L:M
MT4 <1<V[VTI1QCTJ&NQO[%+N(@CYNQKE+FV>VD*.*0R&BBB@84444 %;OA[[
M[_2L*MWP]]]_I0)G(_$;_D(1_P"[7"UW7Q&_Y"$?^[7"TF""BBBD,**** "K
MVF:7<:I=+#"A.3R?2H["PGU"Y6&%"237K_AKP]%HUF-P!E;DG'2FD(?X>\/0
M:-:J H,I'S-6Y115""BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ J)_OFI:B?[YI,J.XVBBBD4%%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4A (P:6B@#!U73.LT0^HK"((.#UKNB PP1Q6#JFEX)EB'U%
MT8=%*00<'K24AA1110 4Y/OCZTVG)]\?6@#J7_Y K_\ 7,UXI>_\?LO^\:]K
M?_D"O_US->*7O_'[+_O&A@BO1112 **** "@#)P**ZGPOX8EU*=9YE*PJ<\C
MK3 F\*^%)+^5;FY4B$<@'O7I]O;QVT2QQJ%4#M1!!';PK'&H"J,<5+3$%%%%
M @HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ J>H*GIHF04444R0HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "N>UZ%%(<#!KH:PO$'W5H!'/T444B@HHHH *Z?0O^/9OK7,5T^A?\
M>S?6@3/,O&__ ",$_P#O5S5=+XW_ .1@G_WJYJDQA1112 ***.] 'L/@FQ@B
MT*&=4'F..373U@^#O^1:M?I6]5DA1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !65K4*-;%B.1WK5K.
MUG_CS- ')T444B@HHHH *W?#WWW^E85;OA[[[_2@3.1^(W_(0C_W:X6NZ^(W
M_(0C_P!VN%I,$%%%%(84444 >H_#RQ@.E&Y* R[R,FNWKD?AY_R+Y_ZZ&NNJ
MT2%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 5$_WS4M1/\ ?-)E1W&T444B@HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ I" PP:6B@#DM5C6.[.T8S5&M'6?^/LUG4%!1112 *<GWQ]:;3D^
M^/K0!U+_ /(%?_KF:\4O?^/V7_>->UO_ ,@5_P#KF:\4O?\ C]E_WC0P17HH
MHI %%%% %K38UEU*WC<95G ->Y6EM%:VZ1Q*%4#M7B&D?\A:U_ZZ"O=4^XOT
MIH3%HHHIB"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J>H*GIHF04444R0HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "L+Q!]U:W:PO$'W5H!'/T444B@HHHH *Z?0O^/9O
MK7,5T^A?\>S?6@3/,O&__(P3_P"]7-5TOC?_ )&"?_>KFJ3&%%%%( H[T4=Z
M /:O!W_(M6OTK>K!\'?\BU:_2MZK)"BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "L[6?\ CS-:-9VL
M_P#'F: .3HHHI%!1110 5N^'OOO]*PJW?#WWW^E F<C\1O\ D(1_[M<+7=?$
M;_D(1_[M<+28(****0PHHHH ]:^'G_(OG_KH:ZZN1^'G_(OG_KH:ZZK1(444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !43_?-2U$_P!\TF5'<;1112*"BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@#E=9_P"/LUG5HZS_ ,?9K.H*"BBBD 4Y/OCZTVG)]\?6@#J7_P"0
M*_\ US->*7O_ !^R_P"\:]K?_D"O_P!<S7BE[_Q^R_[QH8(KT444@"BBB@"[
MI'_(6M?^N@KW5/N+]*\*TC_D+6O_ %T%>ZI]Q?I30F+1113$%%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !4]05/31,@HHHIDA1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M87B#[JUNUA>(/NK0".?HHHI%!1110 5T^A?\>S?6N8KI]"_X]F^M F>9>-_^
M1@G_ -ZN:KI?&_\ R,$_^]7-4F,****0!1WHH[T >U>#O^1:M?I6]6#X._Y%
MJU^E;U62%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_>KFJ3&%%%%( H[T4=Z /:O!W_(M6OTK>K!\'?\ (M6OTK>JR0HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ K.UG_CS-:-9VL_\>9H Y.BBBD4%%%% !6[X>^^_P!*PJW?#WWW^E F
M<C\1O^0A'_NUPM=U\1O^0A'_ +M<+28(****0PHHHH ]:^'G_(OG_KH:ZZN1
M^'G_ "+Y_P"NAKKJM$A1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %1/]\U+43_?-)E1W&T444B@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH Y76?^/LUG5HZS_Q]FLZ@H****0!3D^^
M/K3:<GWQ]: .I?\ Y K_ /7,UXI>_P#'[+_O&O:W_P"0*_\ US->*7O_ !^R
M_P"\:&"*]%%%( HHHH NZ1_R%K7_ *Z"O=4^XOTKPK2/^0M:_P#705[JGW%^
ME-"8M%%%,04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %3U!4]-$R"BBBF2%%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 5A>(/NK6[6%X@^ZM (Y^BBBD4%%%% !73Z%_P >
MS?6N8KI]"_X]F^M F>9>-_\ D8)_]ZN:KI?&_P#R,$_^]7-4F,****0!1WHH
M[T >U>#O^1:M?I6]6#X._P"1:M?I6]5DA1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6=K/_'F:T:S
MM9_X\S0!R=%%%(H**** "MWP]]]_I6%6[X>^^_TH$SD?B-_R$(_]VN%KNOB-
M_P A"/\ W:X6DP04444AA1110!ZU\//^1?/_ %T-==7(_#S_ )%\_P#70UUU
M6B0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "HG^^:EJ)_OFDRH[C:***104444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 <KK/_'V:SJT=9_X^S6=04%%%%( IR??'UIM.3[X^M '4O\
M\@5_^N9KQ2]_X_9?]XU[6_\ R!7_ .N9KQ2]_P"/V7_>-#!%>BBBD 4444 7
M=(_Y"UK_ -=!7NJ?<7Z5X5I'_(6M?^N@KW5/N+]*:$Q:***8@HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH *GJ"IZ:)D%%%%,D**** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M** /6OAY_P B^?\ KH:ZZN1^'G_(OG_KH:ZZK1(4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !43
M_?-2U$_WS294=QM%%%(H**** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** .5UG_C[-9U:
M.L_\?9K.H*"BBBD 4Y/OCZTVG)]\?6@#J7_Y K_]<S7BE[_Q^R_[QKVM_P#D
M"O\ ]<S7BE[_ ,?LO^\:&"*]%%%( HHHH NZ1_R%K7_KH*]U3[B_2O"M(_Y"
MUK_UT%>ZI]Q?I30F+1113$%%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !4]05/31,
M@HHHIDA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %87B#[JUNUA>(/NK0".?HHHI%!1
M110 5T^A?\>S?6N8KI]"_P"/9OK0)GF7C?\ Y&"?_>KFJZ7QO_R,$_\ O5S5
M)C"BBBD 4=Z*.] 'M7@[_D6K7Z5O5@^#O^1:M?I6]5DA1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M6=K/_'F:T:SM9_X\S0!R=%%%(H**** "MWP]]]_I6%6[X>^^_P!*!,Y'XC?\
MA"/_ ':X6NZ^(W_(0C_W:X6DP04444AA1110!ZU\//\ D7S_ -=#775R/P\_
MY%\_]=#775:)"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH *B?[YJ6HG^^:3*CN-HHHI%!1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110!RNL_\?9K.K1UG_C[-9U!04444@"G)]\?6FTY/
MOCZT =2__(%?_KF:\4O?^/V7_>->UO\ \@5_^N9KQ2]_X_9?]XT,$5Z***0!
M1110!=TC_D+6O_705[JGW%^E>%:1_P A:U_ZZ"O=4^XOTIH3%HHHIB"BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ J>H*GIHF04444R0HHHH **** "BBB@ HHHH
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MM(B?><+]30 ZBFK(C_=8'Z&D::)#AI%!]S0 ^BD5U895@1[4PSQ X,BY],T
M244FX8SD8]:8)XB<"1<^F: )**0LJC)( IJS1.<+(I/L: 'T4UI$099@OU-"
MR(_W7#?0T .HIC2QH<,ZCZFE5U<95@1[&@!U%1F>)3@R*#]:>&!&01CUH 6B
MH_/BSCS%SZ9IY95&20!ZT +6%X@^ZM;2S1,<+(I/L:Q?$!&U>: .?HHR#1D"
MD4%%%)D>M "UT^A?\>S?6N8KI-#EC6W(9U!ST)H$SS7QO_R,$_\ O5S5=+XW
M(_M^8_[5<SD>M)C%HHS29'K2 6CO1D"@'- 'M7@[_D6K7Z5O5SOA":-/#=J&
M=0<=S70JZL,JP(]JLD6BHS/$#@R+GZT_<,9R,>M "T5&)XB<"12?3-/9E499
M@![T +13%FB<X612?8TK2(GWF ^IH =135D1_NN&^AI&FC3[SJ/J: 'T4U75
MQE6!'L::9XE.#(H/UH DHI P(R",>M,\^+./,7/IF@"2BD+*!DD >M,6:)CA
M9%)]C0!)136=4&68 >YI%EC?[KJ?H: 'T4QY8T^^ZK]32K(CC*L#]#0 ZBF-
M-$IPTB@^YIP96&001ZT +14?GQ X\Q<^F:?N &<C'K0 M%1B>)C@2*3Z9I[.
MJC+, />@!:*8LT;G"NI^AI6D1/O.J_4T .HIJR(_W6#?0TC31H<,Z@^YH ?1
M2*RL,J01[4PSQ X,B@^F: )**3<N,Y&/6F">(G D7/IF@"2BD+*HR2 />FK-
M$YPLBD^QH ?137D1!EV"_4TBRQO]QU;Z&@!]%,:6-/O.H^II5=7&58$>QH =
M149GB4X,B@^YIX8$9!&/6@!:*C\^+./,7/UIY90,DC'K0 M%,6:)CA9%)] :
M5G5!EF 'N: '44Q98W^ZZGZ&AI43[SJ/J: 'T4U9$<95@?H:1IHE.&D4'W-
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M.YH$SD_B-_R$(_\ =KA:[CXB.KW\95@PV]JX;(]:3!"T44F1ZTABT44F1ZT
M>M_#S_D7S_UT-==7'_#UE7P\2Q 'F'K76K-&YPKJ3[&J1(^BFO(B??8+]30L
MB/\ =<'Z&F ZBF--&APSJ#[FE5U<95@1[&@!U%1F>)3@R*#]:?N&,Y&/6@!:
M*C$\1.!(N?3-/+*HR2 * %HIBS1,<+(I/L:5G1!EF ^IH =13%EC?[KJWT-#
MRQI]]U7ZF@!]%-5T<95@1[&FM-$IPTB@^YH DHI RD9!!'K3//BSCS%SZ9H
MDHI"R@9) 'K3%GB8X612?8T 244UG5!EF 'N:198W.%=3]#0 ^BF/+&GWW5?
MJ:571QE6!^AH =13&FC0X:10?<TY75AE6!'M0 M%1F>('!D4'ZT_<,9R,>M
M"T5&)XB<"1<^F:>751EF 'J: %HIBS1.<+(I/L:5I$3[S ?4T .HIJ2(_P!Q
MU;Z&D:6-#\SJOU- #Z*:KJXRK CV--,T2G!D4'ZT 244@92,@C'K3//BSCS%
MSZ9H DHI"R@9) 'K3%GB8X612?8T 244UG5!EF 'N:198W^ZZGZ&@!]%,>6-
M/ONJ_4TJNCC*L"/8T .HIC31*<-(H/N:<&5AD$$>U "T5'Y\0./,7/IFG[E
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M4?4T /HIJNKC*L#]#36FB4X:10?<T#)**0,I&001ZTSSXLX\Q<^F:!$E%(6
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M#5;2KV32W=+F-O+D.[<!TJ?5-56^MC:VJ,S/U..!0,=8Z>^J1"[NY&^?HH/
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MX7'>LJQN[BQO'N)XR8Y>3@=* -"[T86L#7%M*ZO&,]>M5]/MY]97[1=2L$'
M535B^UN*:V:*W1G=QCITJII-^^EIY%TC;"<A@* )KZQDTI!<VDC87[RD\4^S
MTPZA$+F[D<LW(7/ J+5-4^WQ_9K5&.[JQ'%2:;JZVD M[I&5EZ''!H#4@OX[
MG1W46TC-'+\H#=JNP:$LD(>XE=I&&2<UGZG=RZI(GV9#LB.[)'6M&WU^!80L
MZNDBC!&* ,Z7[9;WHTR.5BK\ANX%:)\/Q>5D2R>9C[V:R)[FXGU,:A'$=B<
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MY<0)SU-/@N1&@20$$4 ,E#VS (20W'-3I:@KEF)8U!/(T[@H.%YYJ=+I=OS
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M@!A154;5 H=%8+E013O^69H'W#FD,:RJK8  %#1HT@W*#Q2MRH)ZT'.U3WH
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M[IZTR _.R_P]Z (_)BCA4QQJ,]2!3I(T>W0,@(SWIZ\Q.#T!XI(\F%P>@Z4
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MF!4=.E2-D2(1U(YII^6Y^7UH C2WB".XB7=GKBG*BF!LJ#4B\3,!T(YID/\
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M\4N2;?)Z@\4 ,9$24*JA1[4KP1/<Y:-3QQD4LOW%)ZTKD[4/\5 #8T7SB-H
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M8Y/WL<4 -C^61EZGIFE4':Z#MSFD@SN8]\4JY\AR.N>: $B^9&0<>]!^:#T
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M_8=J2?("@?=Q3G^]&/X: &R\2ACSGG%/R5E#'G<.GI3).;C#=,T\<W!SV'%
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M,;(.W>DC^:,J./>E&1 <=<\TB\0''7O0 -\T(/0"E)S$#V':DDSY* =*5O\
M5H!]WO0 DO.UOTIS'YE?\A39OOJ.U/;_ %J@].U #&^28$\TX967U+#\J;UN
M/FIZY\U\]<<4 ,3Y92.I/>G+G#H/Q--A^^Q[TJY\ISW[T )$<JR?K0?FA..
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MT%./0>E "'KFG=P::?O4[^*@ [TO>D[THZF@ '6B@44 ***!THH *<.E-IU
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M>#Z]*E>>.15D1U/')!I++1+5+93,@DD899FYK(U#3VM=0BM[=RL4YR1GIZT
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M.S:WV)$%8#AAUK'TS3VNKV2*Z8LD)V@9ZT"-2"^MY6D195([#-+]JB@1Q+(
M,=":;J.CVPM7EA01R1KD%>*I:'IZWL/VF[_>'. #TH&7HKN&>W(616(/ S2/
M>P10%9)5##H,U4UO3H[.#[5:CRV4\@=*L:7I$#VRSW"B21QDEN: )OM$4\"L
MCAC[&HY=0MT6,-*N\'UK/UC3C92HUHVQ93M*BM6VT2T6V DC#LPY9N30 2S1
ML1(C@C')!J,ZC;?:543+GOS61<6#Q:REC'*1#)SC/2MXZ)9>1Y?E+G'WL<T
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M!WVJ*%&$D@ QQFB*ZAGMR%D4G/ S5+1M/2\C,]U^\.> >E&MZ<EG!]JM?W;
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M3DB@#!ECOKNZ74 NUD^ZA]*T/[>D\G;]ED\[IC'%7Z:57K@4 84,=[9W!O\
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M]1FEZ47"Q3&O.(=K6TGFXQTXK.1+Z"[;4BN7;J@]*W-JYS@9I:+A8I3:W)-
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MLGG8QTXS5ZDVC.<#-%P,***]LYA?;=[L?G3VJ_/K<LT7EP6T@D/!)'2K](%
M.0*+@8MF;O1Y"S(9(Y#DX[5/?:A/J41MH(&57^\S#I6H1D<T@ '08HN!E6-W
M/I*_9YHFDC'W2HIM[-=:P1''&T<2\Y;N:UR >HS2@ #BBX&;::M-9Q""YMW9
MEX#*.M5+E;S4KA;L*4\HY13WK<*@]1FE Q1<"BFNR)#M>VD\X<<#BL]8[Y+H
MZCL^<G[GM6[M4G.!2T7 HRZY))"4BMI/-(QR.!5&V%YIDYG*&19.7 [&ML*
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M1P*T:0*!T% &)9&[T=R60RQR'+8ZBIKZ^GU2(VT$#(K=68=*UB,]:0*!T&*
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M6"(HXFCB')+5-::I/8Q>1<0.VW@,HZUI@ =*0@'J,T7 Q+L7FJR"95,:QG*
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M!H 2BBB@84444 %!HH- "4444 %%%% @H-%!I )1110,**** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH ****8!1110 4444 %%%% !2TE+0(
M****0!1110 4444 %%%% !61K'05KUD:QT%- 8]%%%,84444 %;VD?ZAOK6#
M6]I'^H;ZTF(\X\9?\AV;_>KG:Z+QE_R'9O\ >KG:0!1110 4=Z*.] 'K_A+_
M )%VV^E;=8GA+_D7;;Z5MT %%%% PHHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****8!1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !2TE+0(****0!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %**2E% !1110 51U3_ (]35ZJ.J?\
M'J: .=HHHIC"BBB@ K6T7[[?2LFM;1?OM]*!')?$#_C_ $_W:XJNU^('_'^G
M^[7%4@"BBB@ HHHH ]2\ _\ (!/^^:ZJN5\ _P#(!/\ OFNJH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBBF 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%%( HHHH 45$_P!\U**B?[YH''<;1112+"BBB@ HHHH **** "BBB@!:***
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M1110 4444 %%%% A:***!A2TE+0 4444"%HHHI@%+24M !0.M% ZT .HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%, HHHH
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M !1113 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBBD 4444 **B?[YJ45$_WS0..X
MVBBBD6%%%% !1110 4444 %%%% "T444 %%%% !1110 4444 %%%% !1110
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M%% !1110 4444 %%%% !2BDI10 4444 %%%% !1110 4444 %5-5_P"0-?\
M_7M+_P"@&K=4M8.-$U _].TO_H!H ^?/@'SXWU _],&_]"KZ0KYP^ (_XK/4
M3_TQ/_H5?1]-B04444AA1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1113 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBBD 4444 **B?[YJ45$_
MWS0..XVBBBD6%%%% !1110 4444 %%%% "T444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ***!10 4444 8
MOB+_ (]H_P#>JWHW_(+A^E0:]!+/!&(D+$'G%6M*C>+3HD=2K <@T 7****
M"BBB@ HHHH **** "BBB@ HHHH ****!!2TE+3&%%%% "T444 %%%% !1110
M(6BBB@84M)2T %%%% A:***8!2TE+0 4#K10.M #J*** %'6G4T=:=0(****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M*GJ"IZ:)D%%%%,D**** "BBB@ HHHH **** "@T4&@!*6DI: "BBB@!****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****8!1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444@"BBB@!143_?-2BHG^^:!QW&T444BPHHHH **** "BBB@
MHHHH 6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@!110** "BBB@"CJ6H?8(T;9OW''6I[.X^U6J3;=N[M
M67XC_P!1#_O&KVD?\@R'Z4 7:*** "BBB@ HHHH **** "BBB@ HHHH ****
M!!2TE+3&%%%% "T444 %%%% !1110(6BBB@84M)2T %%%% A:***8!2TE+0
M4#K10.M #J*** %'6G4T=:=0(**** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH *GJ"IZ:)D%%%%,D**** "BBB@ HHHH
M**** "@T4&@!*6DI: "BBB@!**** "BBB@ HHHH 2BBB@ I*6DH *2EI* "D
MI:2D 4E+24#"D-+2&@!*#10: $I*6DH *0TM(: "BBBD,#TIM./2FT %%%%
M!1110 &DI324 %!HH- "4444#"BBB@ H-%!H 2BBB@ HHHH$%!HH-(!****!
MA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1113 **** "
MBBB@ HHHH *6DI:!!1112 **** "BBB@ HHHH **** "BBB@ HHHH *R]<FD
MAM$:-RI+XR*U*R/$/_'E'_O_ -* +.D2/+IT;R,68D\FKU9^C?\ (,C_ !K0
MH **** "BBB@ HHHH ****!A1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444P"BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "E
MI*6@04444@"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH *44E** "BBB@ HHHH **** "BBB@ K-\0G'
MAS4S_P!.TG_H)K2K+\2''AG4S_T[2?RH \*_9]'_ !5.JG_ID/YFOHFOG?\
M9\'_ !4NK'_ID/YFOHBFQ(****0PHHHH **** "BBB@ HHHH **** "BBB@
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M!H 2BBB@84444 %!HH- "4444 %%%% @H-%!I )1110,**** "BBB@ HHHH
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M;7+=_16KW6D,****0!1110 4444#"BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHI@%%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %+24M @HHHI %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4HI*44 %%%% !1110 4444 %%%% !6
M5XF./"VJ'_IV?^5:M9'BDX\*:J?^G9_Y4 >(?L]#_BH=8/\ TR7^9KZ&KY[_
M &>1_P 3W63_ -,U_F:^A*;$@HHHI#"BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBBF 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%( HHHH
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M$%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %3U!4]-$R"BBBF2%%%% !1110 4444 %%%% !0:*#0 E+24M !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!2TE+0(****0!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M2&!Z4VG'I3: "BBB@ HHHH #24II* "@T4&@!****!A1110 4&B@T )1110
M4444""@T4&D E%%% PHHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHI@%%%% !1110 4444 %+24M @HHHI %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MC_FU>^5X)^SF/W^NGVC_ *U[W0Q(****0PHHHH **** "BBB@ HHHH ****
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M=M'Y$>['7FM.T1H[6-&&&"X(JCJVI26#((U5MP[UH6\AEMTD(P6&: )****
M"BBB@ HHHH **** "BBB@ HHHH ****!!2TE+3&%%%% "T444 %%%% !1110
M(6BBB@84M)2T %%%% A:***8!2TE+0 4#K10.M #J*** %'6G4T=:=0 4444
M""BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBBF 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4M)2T""BBBD 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !2BDI10
M4444 %%%% !1110 4444 %<S\1#CX>:X?^G8_P Q735R_P 1SCX<ZZ?^G;_V
M84P/,OV=!^ZUH^Z?UKW6O#/V=!_HVLG_ &D_K7N=#$%%%%(84444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444P"BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHI %%%% "BHG^^:E%1/]\T#CN-HHHI%A1110 4444 %%%% !111
M0 M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% "BB@44 %%%% '.^)/]9%]#6W9_P#'G#_NBH;ZPM[QE,S$
M$=.<5;C18XU1?N@8% #J*** "BBB@ HHHH **** "BBB@ HHHH ****!!2TE
M+3&%%%% "T444 %%%% !1110(6BBB@84M)2T %%%% A:***8!2TE+0 4#K10
M.M #J*** %'6G4T=:=0 4444""BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH *GJ"IZ:)D%%%%,D**** "BBB@ HHHH ****
M"D-+2&@!*<.E-IPZ4 %%%% #:*** "DI:2@ HHHI -HHHH&%-IU-H **** $
MHHHH *2EI* "BBB@!****!A24M)0(****0!1110,#TIM./2FT %%%% !1110
M &DI324 %!HH- "4444#"BBB@ H-%!H 2BBB@ HHHH$%!HH-(!****!A1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1113 **** "BBB@
MHHHH *6DI:!!1112 **** "BBB@ HHHH **** "BBB@ HHHH *PO$0)$. 3U
MZ5NU4O;Z*RV>8I;=TP,T .TX8TZWS_<%6:9#(LT*2*,*PR!3Z "BBB@ HHHH
M **** "BBB@84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% "BB@44 %%%% %"^U(64BH86?<,Y%78W\R-7QC(SBN?UC4)XKXQ
MPR;0HY&!6Y:2^=:1R9R2O- $U%%% !1110 4444 %%%% !1110 4444 %%%%
M @I:2EIC"BBB@!:*** "BBB@ HHHH$+1110,*6DI: "BBB@0M%%%, I:2EH
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M4# ]*;3CTIM !1110 4444 !I*4TE !0:*#0 E%%% PHHHH *#10: $HHHH
M****!!0:*#2 2BBB@84444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M&1CM67+J.I+,X56V@G'R4 =+17,KJ6IEU!5L9&?DK6U*>>&R1X 3(2,X&>U
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M0?E1@>@_*EHH 3 ]!^5&!Z#\J6B@!,#T'Y48'H/RI:* $P/0?E1@>@_*EHH
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M_P ?$W^Z* .BHHHH **** "BBB@ HHHH **** "BBB@ HHHH ****8!1110
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M "BBB@ HHHH **** %HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *P=7U"9+V.&W<@KUQ
MW-;QX&:Y:W_TK7LGD;R?RH Z:'>84,F-^.<4^BB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH 444"B@ HHHH YC5B1K*X)ZKW]ZZ8?=%<YJD,KZNK+&
MQ7(Y ]ZZ,=!0 M%%% !1110 4444 %%%% !1110 4444 %%%% @I:2EIC"BB
MB@!:R-7U*>Q=$B1=K?Q&M>LGQ!$'T_?W5LT :-M,+BW25>C#-2UE>'YO,T_9
MGE#BM6@ HHHH$+1110,*6DI: "BBB@0M%%%, I:2EH *!UHH'6@!U%%% "CK
M3J:.M.H ****!!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %3U!4]-$R"BBBF2%! /4444 )M'H*6BB@ HHHH 0@'J ?K0%
M5>@ ^@I:* "D-+2&@!, = *<.E-IPZ4 ( !T%+110 T@9Z"BBB@ P#U I*6D
MH 0JIZJ#]12@ #  'THHI -I"H/50?J*6B@8=J;@#H!3J;0 4444 -*J>JJ?
MPI0 .@Q110 4TJ#U /U%.I* # QC'%& !P,444 )@>@HHHH&! ]!24M)0(,
M]0****0!1110,#TIM./2FT %%%% !1110 &DI324 %!HH- "4444#"BBB@ H
M-%!H 2BBB@ HHHH$%!HH-(!****!A1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1113 **** ,""RN%UL3-$PCWD[L<=#6_63%JSR:G]E,
M8 W$9_"M:@ HHHH *6DI:!!1112 **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "OF2/_DX5_\ L(-7TW7S)'_R<*__ &$&IH1]-T444#"BBB@
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M- "4444#"DI:2@04444@"BBB@8'I3:<>E-H **** "BBB@ -)2FDH *#10:
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MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /GS]HG_ )#VB?\
M7L?_ $,U[7X4_P"13TG_ *]8_P#T$5XI^T3_ ,A[1/\ KV/_ *&:]K\*?\BG
MI/\ UZQ_^@BGT$;%%%%(84444 %%%% !1110 4HI*44 %%%% !1110 4444
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M%% !1110 4444 %%%% !1110!\^?M$_\A[1/^O8_^AFO:_"G_(IZ3_UZQ_\
MH(KQ3]HG_D/:)_U['_T,U[7X4_Y%/2?^O6/_ -!%/H(V****0PHHHH ****
M"BBB@ I124HH **** "BBB@ HHHH *JZCJ-II-A->WTR0V\2DNS'BC4=1M-)
ML)KZ]F6&WB7<[L>E?+/Q*^)5WXSOVMK9FATF)OW<>>9/]IJ:0C"\=:UINO\
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M:E%1/]\T#CN-HHHI%A1110 4444 %%%% !1110 M%%% !1110 4444 %%%%
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M_%.K)J^KQO&MP#]F0@A50'&%SU&>]?57P_TW^R? .BVFW:PM4=QZ,PW']2:
M.EHHHI# ]*;3CTIM !1110 4444 !I*4TE !0:*#0 E%%% PHHHH *#10: $
MHHHH ****!!0:*#2 2BBB@84444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444P"BBCO0!GQZK!)??91$P?)&[ Q6A7,6W_ ",(_P!]OY&N
MGH **** "EI*6@04444@"BBB@ HHHH **** "BBB@ HHHH **** "L35].N;
MN[62% 5 QG(%;=8^J:I-9W*QQA2",\T :Z#" 'TI:13E0?44M !1110 4444
M %%%% !1110,**** "BBB@ HHHH **** "BBB@!LCB.-G(R%&:IV.I0WSNL<
M;*5&3D"K-S_QZR_[IK"\._\ 'Q-_NB@#HJ*** "BBB@ HHHH **** "BBB@
MHHHH **** "BBBF 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4M)2T""BBBD 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110!\^?M$_\ (>T3_KV/_H9KVOPI
M_P BGI/_ %ZQ_P#H(KQ3]HG_ )#VB?\ 7L?_ $,U[7X4_P"13TG_ *]8_P#T
M$4^@C8HHHI#"BBB@ HHHH **** "E%)2B@ HHHH **** "BBB@"AK.CV6O:5
M/INH1>9;S+AAZ>XKY1^(/P^O_!&J%6#2Z=*28+@#@CT/H:^O:S]:T6P\0:7-
MIVHP++;RC!!'*GU'O33$?$"(TCJB*6=C@*!DDU[Y\.OA#)9Z<FM:O"&OWPT%
MLW2-?4^]=#X*^#&G^&==GU*]F6]*/_HB$<(/4^]>BZG=/9V9EC +;@.:;8)'
MB/Q&^$,\EC)KFD08N$RUQ:I_$/[R_P"%>%,K(Q5@0P."#VK[CTN[>]M/,D S
MG'%>;^+O@IIOB'Q'!J=G,MG%(^;R)1]X>J^A-"8-'CGPY^'-[XVU(.X:'2XF
M_?3X^]_LK[U]6:7I=IHVFP:?8Q"*WA4*BCTI-)TFRT338;"P@6&WB7"JH_4U
M=I-@%%%%(84444 %%%% !1110 4444 %%%% !1110 4444 %?,D?_)PK_P#8
M0:OINOF2/_DX5_\ L(-30CZ;HHHH&%%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1112
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M44 %%%% !1110(*6DI:8PHHHH 6J>J(SZ;,J*68C@"KE0W=P+6V>8KNVC.*
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M0:FA'TW1110,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBBD 4444 **B?[YJ45$_W
MS0..XVBBBD6%%%% !1110 4444 %%%% "T444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 (>
MA^E<SIG_ "'#]6KISR*S+;2!;WWVGS23SQCUH TZ*** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@!110** "BBB@##U#4[FWU)88V4(2."*VQT%<QJW
M_(97ZK_.NG'W1]* %HHHH **** "BBB@ HHHH **** "BBB@ HHHH$%+24M,
M84444 +5+5_^07/]*NU#=V_VJV>$MMW#&: ,GPW_ *B;ZUN52T[3QIZ.HDW[
MCGI5V@&%%%% A:***!A2TE+0 4444"%HHHI@%+24M !0.M% ZT .HHHH 4=:
M=31UIU !1110(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ J>H*GIHF04444R0HHHH **** "BBB@ HHHH *0TM(: $IPZ4
MVG#I0 4444 -HHHH *2EI* "BBBD VBBB@84VG4V@ HHHH 2BBB@ I*6DH *
M*** $HHHH&%)2TE @HHHI %%%% P/2FTX]*;0 4444 %%%%  :2E-)0 4&B@
MT )1110,**** "@T4&@!**** "BBB@04&B@T@$HHHH&%%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%%, H[T44 <Q;?\C"/]]OY&NGJB
MDVGF\V((_/R>B\YJ]0 4444 %+24M @HHHI %%%% !1110 4444 %%%% !11
M10 4444 %<UX@_X_T_W172USVN02R7JE(V8;1R!0!OI_JU^E.IJ?<7Z4Z@ H
MHHH **** "BBB@ HHHH&%%%% !1110 4444 %%%% !1110!%<_\ 'K+_ +IK
M"\._\?$WT%= Y41L7QMQSFJMG+8R.PM1'N ^;:,4 7**** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBBF 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4M)2T""BBBD 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!\^?M$_\A[1/^O8_
M^AFO:_"G_(IZ3_UZQ_\ H(KQ3]HG_D/:)_U['_T,U[7X4_Y%/2?^O6/_ -!%
M/H(V****0PHHHH **** "BBB@ I124HH **** "BBB@ HHHH **** "LO7_^
M08?]\5J5FZY&\FG%44L=PX% #- _Y!__  *M6LS0XWCL-KJ5.[H:TZ "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OF2/_DX5_P#L(-7T
MW7S)'_R<*_\ V$&IH1]-T444#"BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHI %%%%
M "BHG^^:E%1/]\T#CN-HHHI%A1110 4444 %%%% !1110 M%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% "'H?I7.Z=<3OK)1II&3)^4L<5T1Z'Z5S.F _VX>.[4 =/1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 ***!10 4444 4+BWT][D//
MM\WC&6Q5\=*Y?5O^0ROU7^==./NCZ4 +1110 4444 %%%% !1110 4444 %%
M%% !1110(*6DI:8PHHHH 6J>J.T>FS,C%6 X(.#5RJ6K?\@N?Z4 4_#\TLT,
MIED=R#QN.:V:P_#?$$WUK<I PHHHIB%HHHH&%+24M !1110(6BBBF 4M)2T
M% ZT4#K0 ZBBB@!1UIU-'6G4 %%%% @HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "IZ@J>FB9!1113)"BBB@ HHHH ****
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M@ HHHH **** (KG_ (]9?]TUA>'?^/B;_=%;TZEX)%7J5(%9>CZ?<6<TC3*
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH ****0!1110 HJ)_OFI143_?- X[C:***184444
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MIHF04444R0HHHH **** "BBB@ HHHH *0TM(: $IPZ4VG#I0 4444 -HHHH
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M M%4I]5LX.#*&/HO-49/$48_U<#'_>.* -B9S' [CJH)%9FDZE/>RR+*$ 4
MC:,51FU^66-D$*J&&.N:I6%^]A(SJ@;<,$$T =C16$GB,9_>6Y _V6S5R'6[
M.4X+E#_M"@#1HIJ2)(NY&##U!S3J "BBB@ HHHH **** "BBB@ HHHH ****
M8!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !2TE+0(****0!1110 4444 %%%% !1110 4444
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MUHH'6@!U%%% "CK3J:.M.H ****!!1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1112 ****
M%%1/]\U**B?[YH''<;1112+"BBB@ HHHH **** "BBB@!:*** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M*0!1110,#TIM./2FT %%%% !1110 &DI324 %!HH- "4444#"BBB@ H-%!H
M2BBB@ HHHH$%!HH-(!****!A1110 4444 %%%% !1110 4444 %%%% !1169
MK%_]E@\M#^]?]!0!4UC5#EK:!N.CL/Y5A4=3DT4 %%%% !1110 4444 %%%%
M !1110 4Z.1X9!)&Q5AR"*;10!UVF:@M]#S@2K]X?UJ]7$6UP]K.LJ'D=?<5
MV5M<)<P)*AX8?E0(EHHHH **** "BBFR.L<;.YPJC)- #9YX[>)I)&PHKE=0
MU.6]?'W8AT7_ !I-2U!KV<X)$2_=']:I4 %%%*JLYPH)/M0,2BG,C)]Y2,^H
MIM !13E1W^ZI/T%#(R?>4CZB@!M%%.6-W&50GZ"@!M%*RE3A@0?0T*I8X4$G
MT% " D'(.#6]I>L$E8+D^RN?ZUB&&0#)C8#Z4R@#O.M%8NC7[L@@G#?[#GO[
M5M4""BBB@84444 %-DD6*-G<X51DFG5SFN7_ )DGV:,_(OWB.YH J:EJ+WLI
M .(E/RKZ^]4:** "BBB@ HHHH **** "BBB@ HHHH *FMKF2TF$D1P1U'K4-
M% ':6=W'>0"1#SW'H:L5Q^FWK65R&S^[;AA77JP=0RG((R#0 M%%% !1110
M4444 %%%%, HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ I:2EH$%%%%( HHHH **** "BBB@ H
MHHH ****  G R>E<IKFM&=FM;=L1CAF'\57?$.J&&/[)"V)&'SD=A7*5X.:8
MYI^QIOU_R/8R_!JWM9_+_,****\$]D**** "BBB@ HHHH **** "BBB@"[IV
MHRZ?.'4DH?O+ZUVUM<QW<"S1-E6%>>5JZ)J9L;D([?N7."/0^M>KEN.=&7LY
MOW7^!YV.PBJQYX_$OQ.THI 0P!!R#2U].?/A2BDI10 4444 (S!%+,0 .237
M,:KJS73&*$D0CJ?[U2ZWJ1=S:Q'Y1]\CO6)0 4444#"BC%% !111B@ HHHH
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M_?(.?<>M:U?7T:L:T%.&S/F:M.5.3A+=!1116A 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444@"BBB@!143_?-
M2BHG^^:!QW&T444BPHHHH **** "BBB@ HHHH 6BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H)P,FD)"@DG
M'>N;U75VF8PP-B,<%AWH N:AKB0YBML,_0MV%<_-/+<.7E<LWO4=% PHHHH
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M=W156POH[Z 2)P?XE]#5JF2+1113 *6DI: "@=:*!UH =1110 HZTZFCK3J
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M %HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MWKBK']BZC_SZO0!0HJ__ &+J/_/J]07%A<VBAIXB@/3- %>BK5OIUW=1^9#
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M** "@T4&@!**** "BBB@04&B@T@$HHHH&%%%% !1110 4444 %%%% !1110
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M[HIT444#-SPU)BYEC[%<UT]<CX?;&I@>HKKJ:$PI:2EIB"@=:*!UH =1110
MHZTZFCK3J "BBB@04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !4]05/31,@HHHIDA1110 4444 %%%% !1110 4AI:0T )3
MATIM.'2@ HHHH ;1110 4E+24 %%%%(!M%%% PIM.IM !1110 E%%% !24M)
M0 4444 )1110,*2EI*!!1112 ****!@>E-IQZ4V@ HHHH ****  TE*:2@ H
M-%!H 2BBB@84444 %!HH- "4444 %%%% @H-%!I )1110,**** "BBB@ HHH
MH **** "BBB@ HHHH Y'5HO*U*4=B<BJ5;GB&##Q3@=1M-8= !6A::S>64 A
M@9 @.>4S6?13$/FF>>9Y9#EW.2:9112& ."#Z5IOKU_) 86>/81MX3'%9E%
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M !1110 VBBB@ I*6DH ****0#:***!A3:=3: "BBB@!**** "DI:2@ HHHH
M2BBB@84E+24""BBBD 4444# ]*;3CTIM !1110 4444 !I*4TE !0:*#0 E%
M%% PHHHH *#10: $HHHH ****!!0:*#2 2BBB@84444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MCPW#YNJ!L<(N:QZZCPI#A)IB.IP*<=Q2V#Q7-A((0>N6-<O6QXDF\W5"H/"
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M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 4-8A,VG2
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MZ T37,AEN9)#_$Q-:_ARTCDN3<S,H6/[H8]36'1@>E"T!ZG1^(]4)D6VMY"
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MMH.]]3<\+_\ '])_N5G:G_R$KC_?-:/A?_C^D_W*SM3_ .0E<?[YIOH)=2J
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MVA6T)#2DRM[\"M145%"HH51V H H6&DPV8#M\\O]X]OI6A110 4444 %%%%
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M;#2XB3WY- &6JL[!54LQZ 5T&FZ'M(FN@">H3_&M*TTZWLE_=IEN['K5N@0
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M&@!*<.E-IPZ4 %%%% #:*** "DI:2@ HHHI -HHHH&%-IU-H **** $HHHH
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M-)T]3D6<0_"ITM;>/[D*+]%J6BE&E3CM%+Y#=2;W;#ITHHHJR HHHH ****
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M "T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% #)(DF0I(H93V-8=YX?ZO:M_P!OZ&M^B@#AY[::V;;-&R
M'W%15WC(KC#*&'H15";1;*8Y\K8?]@XH&<E170OX;C)^2X8>Q6HCX;?/%POY
M4 8=%;R^&S_%<_DM6(O#UJG^L=W_ $H YGOBK]KI%W<X.SRT_O/Q^E=-!8VU
MO_JH5!]<<U8H H66DV]GAL;Y/[S5?HHH$%%%% !1110 4444 %%%% !1110
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M, I:2EH *!UHH'6@!U%%% "CK3J:.M.H ****!!1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %3U!4]-$R"BBBF2%%%% !11
M10 4444 %%%% !2&EI#0 E.'2FTX=* "BBB@!M%%% !24M)0 4444@&T444#
M"FTZFT %%%% "4444 %)2TE !1110 E%%% PI*6DH$%%%%( HHHH&!Z4VG'I
M3: "BBB@ HHHH #24II* "@T4&@!****!A1110 4&B@T )1110 4444""@T4
M&D E%%% PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MI@%%%% !1110 4444 %+24M @HHHI %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444#"BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHI@%%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %+24M @HHHI %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4HI*44 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1113 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBBD 4444 **B?[YJ45$
M_P!\T#CN-HHHI%A1110 4444 %%%% !1110 M%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% "BB@44 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444""EI*6F,**** %HHH
MH **** "BBB@0M%%% PI:2EH ****!"T444P"EI*6@ H'6B@=: '4444 *.M
M.IHZTZ@ HHHH$%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 5/4%3TT3(****9(4444 %%%% !1110 4444 %(:6D- "4X=*
M;3ATH **** &T444 %)2TE !1112 ;1110,*;3J;0 4444 )1110 4E+24 %
M%%% "4444#"DI:2@04444@"BBB@8'I3:<>E-H **** "BBB@ -)2FDH *#10
M: $HHHH&%%%% !0:*#0 E%%% !1110(*#10:0"4444#"BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBBF 4444 %%%% !1110 4M)2T""
MBBBD 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBBF 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4M)2T""BBBD 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !2BDI10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%, HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH ****0!1110 HJ)_OFI143_ 'S0..XVBBBD6%%%% !1110
M4444 %%%% "T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 ***!10 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110(*6DI:8PHHHH 6BBB@ HHHH ****!"T444#"EI*6@
MHHHH$+1113 *6DI: "@=:*!UH =1110 HZTZFCK3J "BBB@04444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !4]05/31,@HHHI
MDA1110 4444 %%%% !1110 4AI:0T )3ATIM.'2@ HHHH ;1110 4E+24 %%
M%%(!M%%% PIM.IM !1110 E%%% !24M)0 4444 )1110,*2EI*!!1112 ***
M*!@>E-IQZ4V@ HHHH ****  TE*:2@ H-%!H 2BBB@84444 %!HH- "4444
M%%%% @H-%!I )1110,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH ****8!1110 4444 %%%% !2TE+0(****0!1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% PHHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****8!1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !2TE+0(****0!1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %**2E% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444P"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHI %%%% "
MBHG^^:E%1/\ ?- X[C:***184444 %%%% !1110 4444 +1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 H
MHH%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% @I:2EIC
M"BBB@!:*** "BBB@ HHHH$+1110,*6DI: "BBB@0M%%%, I:2EH *!UHH'6@
M!U%%% "CK3J:.M.H ****!!1110 4444 %%%% !1110 4444 %%%% !1110
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M HHHH *B?[YJ6HG^^:3*CN-HHHI%!1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 5/4%3TT3(****9(4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 445\^:7\2O%US\;Y/#LNK;M*&KSVPM_LT0_=J[A
M5W;=W0#G.: /H.BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 9++'
M!$TLLBQQJ,L[G 'U-95GXL\.:C.L%CX@TJZF8A1'!>1NQ)Z# -?/_P >M5U#
M6OB#9>&8)&,$"1+' "0&FD_B/J<$ >G/J:N3_LU:FNGJ]OXCM)+W W0R6[)&
M#[."2?\ OF@#Z,JM?:A9:9;&YO[RWM+<<&6XE6-1^).*LU\E^)(=6^*'QIO-
M(CN5&+N6UMS(6\N&&+=SCMD*3CNQ]Z /J+3O$.BZPQ73-8T^]9>HMKE)2/\
MODFI]1U33](MOM.IW]K96^X+YMS,L:[CT&6(&>#7C7AOX#7OA;QAI&LV^O6]
M[#:S^9,DEN86VX(^7!8$].N*J_'[PAXEUS6--U+2[&ZU"QAM?*:&V0R-')O)
M+;1R=P*]!_#S0![K;7,%Y;1W-K/'/!*H>.6)PRNIZ$$<$5+7F/P.\.:YX<\&
M7$.MQS6[371D@M9>L:;0,XSQDYXXZ9[UZ=0 4444 %%%% !6?J.NZ/I$D,>I
MZK8V4DV?*6YN$C,F.NT,1GJ.GK6A7R]\6O /B^_^(U_?6VDWNH6MXZ?9YK>,
MR*J[0 K8^Y@@CG []Z /J&BN9^'FE:EHGP_T;3=7=VOH(-L@<Y*#)*IG)^ZI
M"_\  :Z:@ HHHH **** "BBB@ HHHH **** "BBOFC]I+_D<-(_Z\/\ VHU
M'TO14%C_ ,@^V_ZY+_(5/0 4444 %%%% !169XAUNU\-^'K_ %F\(\BSA:0C
M<!O/\*@GNQPH]R*X+X,_$6[\;Z;?VVKS1MJMI+O^553?"W3"C^Z<J3_NYY-
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MPQ^-XUV\BT3Q/Y4%]*=MO>KA8YF/1&'16]#T/3@XR >UT444 %%%% !1110
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MVO4:UKX:=!I2ZF&%QE/$IN">G<****YSJ"BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BO-_B#_P AZ#_KU7_T)J=\/?\ D-7/_7N?_0EKN^I_N/;<WRL>
M9_:/^T_5^7K:]_\ @'HU%%%<)Z8454U2:2VTB]GB;;)' [HV,X(4D&O,_P#A
M,M?_ .?_ /\ (,?_ ,3750PLZZ;BUH<6*Q]/#-*:>O;_ (<]7HKRC_A,M?\
M^?\ _P#(,?\ \31_PF6O_P#/_P#^08__ (FM_P"S*O=?C_D<O]M8?L_P_P S
MU>BN4\%:S?ZM]N^W3^;Y7E[/D5<9W9Z >@KF/&__ ",\W^XG\JRIX-RK.E)V
M:_KR-ZN81CAUB(QNF[=N_KV/4J*\_P#AW_Q_7O\ US7^=>@5CB*/L:CA>YT8
M3$?6*2J6M<****Q.@**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M.2S')JUH9(U_3B"1_I,8X_WA6SRU*%W+4YXYTY5%%0T?F>RT445Y)[P4444
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M9CP-V#R#DC(^A SS[Q\,/&?_  F_@NWU"; OX6-O> # ,B@'</9@0WH"2.U
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MW5Q9_"?7)+<E6=8HG8$<(\J*WY@D?C7#_LUV=C_8^MWH1#J'VA(F<\LL6W(
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M6\#&UN89]OWO*D#8^N*\O\9?\C7>_P# /_0%K,M]1NK6SGM8)3''.1YFTX+
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M:!^J^8A4_49KT'EM+92=SR(YS7OS."M\_P SI?B#_P AZ#_KU7_T)J=\/?\
MD-7/_7N?_0EKF[[4;K4I(I+N7S)(XQ&'(Y(!)&?4\]:Z3X>_\AJY_P"O<_\
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M;ID'%>-UVUK_ ,DQNO\ ?/\ Z&M5C,.G-5$]6TB<OQ;5*5%QNDF_^ 1P^%]
M2Y#S>(K:2 '/EB1%)_X%N/\ *N_A2.."-(0!$J@(%Z8QQBO#J]NL_P#CQM_^
MN:_RK#,*<HJ+E*YU935A-R4(*.W?]2:J]U?6MC'YEU<10K@D%V SCT]:Y[Q7
MXH.DXL[,J;Q@&9C@B,?3UKSB>XFNIFFN)7ED;J[L23^)J,-@)55S2=D:8S-(
M4)<D%=_@CU0^,=!!Q]O'X1/_ /$U<L]<TR_?9;7L+OV7."?H#S7DL>F7\T1E
MBL;EXQU=8F(_/%5V5X9,,&1U/0C!!KI>74GI&3O\CA6<5XN\X*WS1[E17!>#
M_$MY+=QZ;=;YXV&(Y,99,#//J/?M]*[VO,KT949\LCV\-B88BGSP"BBBL3H.
M9\>?\BY_VV7^M>:P1>?<119V[W"YQG&3BO2O'G_(N?\ ;9?ZUYM;2+#=0RL"
M51U8XZX!KW<OO[#3NSY?-K?6E?LCM?\ A7/_ %%?_)?_ .RH_P"%<_\ 45_\
ME_\ [*K_ /PL'2?^?>]_[X3_ .*H_P"%@Z3_ ,^][_WPG_Q5<W/CO/[D=OLL
MK\OO?^9K:381>'='\B>[0QHQ8S.!&!D^Y_K7FGB*6.?Q#>RPR))&TF59#D'@
M="*[;7-4@UCP->7=NLBQEE7$@ /$B^A->:UO@*<KRJ3WO8Y<UJQ484::]VR:
M_%':^ [NPLXKU[JXMX)&*A3*ZJ2.>F:WM?OM-7PW=0PW5J/,A)C1)%^;GJ .
MO(/3WKRRM'4_^/32O^O3_P!JR5=7"*595+[O\C.AF$H8=TE%:+\W_P $SJ];
MTN]T@Z=8VJW5D75$VQ"120^.PSUS^->25HZ#_P C!I__ %\)_P"A"M,7056&
MKM8QP&*="I9*_-9'L=,EFC@B:6:1(XUY9W8 #ZDU6U34H-)T^2\GSM3HHZL3
MT KRC5]:O-9N3+<R'8#E(@?E0>W^->1AL)*OKLCZ#&X^&&5K7D^AZ3)XNT*-
ML-J"D_[*,W\A4UKXDT>\D"0W\6X] ^4S_P!]8KR:WLKN[S]FM9IL=?+C+8_*
MF3036\ACFB>-QU5U(/ZUW_V=2V4G?Y'E+.,0O><5;YGN%%>:^%_%<FG2K9WS
ML]FQPK'DQ'U^GM^7OZ57F8C#RH2M(]K"8N&)AS1WZH*:\B1(7D=40=68X JC
MK&KV^BV#7,_S'I'&#R[>G_UZ\KU36;W6)S)=3$KG*Q X1/H/Z]:UPV$E7UV1
MEC<PAAO=WEV/2YO%FAP2%'U!"1_<5G'Y@$4Z#Q3HERX2/4(@3TW@H/S8"O*(
M+.YNCBWMYICTQ&A;^5$]K<6K[+B"6%O21"I_6N[^SJ.W,[_(\K^V,1\7*K?/
M_,]M5E=0RL&5AD$'((ILLT<$32S2)'&O+.[  ?4FO)M#\0WVCW"")FE@)^:!
MCPWT]#7H'B.9;CPA=3*&"R0JX##! )!Y'K7#5PDJ52,6]&>I0S"->E*<59Q5
M['(^.KNVO-1M6MKB*=5AP3$X8 Y/I5/P?<0VOB**6XFCBC"."\C!1T]36#17
MM*@E1]E<^;EBG+$>WMK>Y[=;WEM>*S6UQ#.JG!,3A@#^%35QOP\_Y!UY_P!=
M1_*NRKY^O35.HX+H?6X6LZU&-1JUPHHHK$W"IZ@J>FB9!1113)"BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M=VC2QWV+*=9%5LD21G:>,X/'H]=C_P ,R_\ 4W?^4W_[;1_PS+_U-W_E-_\
MMM 'OD$T=S;QSQ-NCD4.C8QD$9!KY5^/_P#R4^7_ *](?Y&OJ#1K!M*T+3].
M>?SWM+:.!IMFSS"BA=VW)QG&<9KYH^-W_)8H?^N-M_.@#Z$\#>&H?"7@[3=(
MCB5)8X@UP1@EYF&7)/?G('L .U=#110!@>.+!-3\":]9NN[S+&;:-N[Y@I*G
M'U KQK]FB[<7/B*R+DHR02JA)P""X)';N,_0>E>ZZW_R -1_Z]9?_037@'[-
M7_(?UW_KUC_]"- 'T=7S1^TE_P CAI'_ %X?^U&KZ7KYH_:2_P"1PTC_ *\/
M_:C4 ?2%C_R#[;_KDO\ (5/4%C_R#[;_ *Y+_(5/0 4444 %>%_M%>+A;Z=9
M^%+:0^;=$75W@](U/R*>.<L"W7(V#UKVR^O;?3;"XO;N58K>WC:21V. J@9)
MKY$CT[7/C'\1-2FL3&LLQ:;?<L52&%<*BDJ&QQM'&>?Q- 'OOP6\('PMX$AG
MN(@NH:F1=3Y7#*A'[M#WX7G!Z%VKT&YMXKNUFMKA!)#,ACD0]&4C!'Y5\R_\
M,X^,/^@EH?\ W_F_^-4?\,X^,/\ H):'_P!_YO\ XU0!4\,SS?"3XV/IMU*Q
ML6E^R3.<?/!)@QN?<91CCT85]55\B>+/@QXF\'Z#+K%[/I]S;1,JR"T>1V0'
MC<04 QG SGN*]Z^#GBX>*O =LLTNZ_T_%K< XR<#Y&_%<?B#0!Z#7RYXH$OQ
M.^/?]CAW-E#<?8QM/W(HLF4@^Y#D'W'6OJ.OEKX:3QZ7^T!/;W2@.]U>6P)_
MA?+>OKMQ^- 'T]9V=OI]E!9VD*0VT"".*-!@*H& !4]%% !69/X>T>YUN'6I
M],M9=2@3RXKEXP709SP?7T/49..IK3HH *XCXO\ _)*-?_ZXI_Z,6NWKB/B_
M_P DHU__ *XI_P"C%H X_P#9N_Y$S5?^P@?_ $6E>SUXQ^S=_P B9JO_ &$#
M_P"BTKV>@#YAUC_DZ*/_ +"EM_Z E?3U?,.L?\G11_\ 84MO_0$KZ>H ^=/V
MA_##:?K&G^+;/=&;EA!.Z'!651F-ACG)52,Y_@%>T> _$Z^+_!FG:Q\HGECV
MW"J,!95X? ],@D>Q%3>,?#</BWPEJ.B3,$^TQ8C<_P $@.Y&^@8#/J,BO"_@
M%XCET+Q9J'A#4?W7VMF,:-U2XCR&7CCE0><]4 '6@#VSQ]XH3P?X,U#5R5\]
M$\NW4G[TK<+]<=?H#7C?[//A9[W5[_Q=?!I/(S!;/(,EI6YD?/J%./?>?2J_
MQZ\13^(/%NG>#]+W3"V==\<;Y\VYDX5<=,J" /=V%>[^$O#L'A3PKI^BP8(M
MH@'<?QN>6;H.I)H VJ^8='_Y.BD_["ES_P"@/7T]7S#H_P#R=%)_V%+G_P!
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M *+6OG'XW?\ )8H?^N-M_.OH[PI_R)^B?]>$'_HM:^<?C=_R6*'_ *XVW\Z
M/J6OF'6/^3HH_P#L*6W_ * E?3U?,.L?\G11_P#84MO_ $!* /IZO*/VA?\
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M<;7,^//^1<_[;+_6NFKF?'G_ "+G_;9?ZUOA?XT?4Y\=_NT_0\YL/^0C;?\
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MG_']9?\ 7-OYUE>"_P#D:;7_ '7_ /0#7;!N6#U[,\NHE',4E_,OT/1];_Y
M.H_]>LO_ *":\9KV;6_^0#J/_7K+_P"@FO&:SRSX)>IMG?\ $AZ'J'A/0(-.
MTZ&[D16O)EW[^Z*1PH_#K]37255TR5)M*M)(R"C0H1CZ"K5>76G*<VY;GNX>
MG"G2C&&QYUXWT.&PFBOK5 D<S%9$484-U!'UY_*L?PO=M9^([)EZ22")AZAN
M/ZBNS\?2(N@QH2-[SKM&>> <G_/K7!:0C2:U8HK%6:X0!AV^8<U[.&DZF&?/
MYGSF-@J6-3I]TSO/B#_R 8/^OI?_ $%J\[MH3<7<, !)D=4&.O)Q7HGQ!_Y
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MCX>_\AJY_P"O<_\ H2UVRDY8*[['F1BHYE9=SHO&]]]D\/M"I^>Y<1_AU/\
M+'XUYG B23HDLHBC+ ,Y!.T>N!S7>_$1&-C9. =HD8$^A(X_D:X2TM9KVZCM
MK=0TLAPJE@N3]3Q58!*-"_J3FLI2Q7+:]K6/1M.\0>%M+M%M[6Z"(!R?)?<Q
M]2=O)JS)XM\.S1M'+>*Z-P5:!R#^&VN'_P"$-U__ )\/_(T?_P 51_PANO\
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MO8Z[X>?\@Z\_ZZC^5:OC+_D5+W_@'_H:UE?#S_D'7G_74?RK5\9?\BI>_P#
M/_0UK&K_ +[\U^AT4/\ D6O_  O]3RE5+,%49). *]=T'0K?1;)$5$:Y9?WL
MHZL>N![?X5Y-;.L5U#(_W5=6/T!KVY6#*&4@@C(([UTYG.248K9G'DE.#E*;
MW5@95=2K*&5A@@C((KRWQ?HL6D:HK6ZE;>X4LJ]E(/('MT/XUZG7#_$61-EA
M%D;\NV,\@<?Y_"N7+YRC645LSOS:G&6&<GNMOO,GP+=M!XA6 ?=N(V4CW W
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MX_\ LQJAX(_Y&>'_ ''_ )5[</\ <ODSYJK_ ,C+_MY?H>I4445X1]0%%%%
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M +4]-O3J?@JX::-'\Q+1Y=D\+ @CRW. V.3R01@?>-9":[\<='5;00Z](%4
M,VG"YX]W*-D_CGUH ^FKZ^M-,LI;R^N8K:UB&Z2:9PJJ/<FODGXM?$,>._$*
M"RWKI-D&2V##!D)^](1VS@8'H!W)KH8?AS\4/B#=QGQ+=7-M9JV[??R\(<<E
M(5/7!]!Z9KK?'7P?EM?A]INA>#].-Y<I>B>ZF>6-))?D8;F+$# )P .F?J:
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MKH6KNV!IEYGWA8?S%=CPN%F^9/\ $\Z..QU-<CCKYIW.D'Q"N/M[.;-/LA
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MU[GSF:4*L\1S0BWHMD;O_"QO^H5_Y,?_ &-'_"QO^H5_Y,?_ &-87_"&Z_\
M\^'_ )&C_P#BJ/\ A#=?_P"?#_R-'_\ %57L,%W7W_\ !(^LYEV?_@/_  #T
M70]5_MK3%O/)\G+%=F_=T]\"O-/$_P#R,M__ -=/Z"O0O"MA<Z;H:6UW%Y<H
M=B5W \$^H-<IKWA?6;W7+NYM[/?%(^5;S4&1CT)KGPDJ=.O/5)=-?,Z\?"M5
MPM/W6Y==/(T?AW_QZW_^^G\C70>)?^1;O_\ KD:S/!FD7VDV]VM]!Y32.I4;
MU;. ?0FMC7+::\T2[MX$WRR1E57(&3^-85Y1>*YD]+HZL-"4<#R-:V>GWGC=
M>UZ;_P @NT_ZXI_Z"*\Q_P"$-U__ )\/_(T?_P 57J%E&\-A;Q.,.D2JP]"
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH ^?/VBO%'GW&G^$[4[F1A=7 4Y.X@JBX^A
M)Q[BO6?ASX7'A#P-INELI%R4\ZZSU\Y^6'X?=^BBN37X,&Z^(_\ PEVL:^+_
M #=&X:T-EM!P,1IN+GA<*.G(7\:]6H **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "HG^^:EJ)_OFDRH[C:***104444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !4]05/31,@HHHIDA1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %1/\ ?-2U
M$X)8\&DRH[C:*7:?0T;3Z&D4)12[3Z&C:?0T )12[3Z&C:?0T )12[3Z&C:?
M0T )12[3Z&C:?0T )12[3Z&C:?0T )12[3Z&C:?0T )12[3Z&C:?0T )12[3
MZ&C:?0T )12[3Z&C:?0T )12[3Z&C:?0T )12[3Z&C:?0T )12[3Z&C:?0T
M)12[3Z&C:?0T )12[3Z&C:?0T )12[3Z&C:?0T )12[3Z&C:?0T )12[3Z&C
M:?0T )12[3Z&C:?0T )12[3Z&C:?0T )12[3Z&C:?0T )12[3Z&C:?0T )12
M[3Z&C:?0T )12[3Z&C:?0T )12[3Z&C:?0T )12[3Z&C:?0T )12[3Z&C:?0
MT )12[3Z&C:?0T )12[3Z&C:?0T )12[3Z&C:?0T )12[3Z&C:?0T )12[3Z
M&C:?0T )12[3Z&C:?0T )12[3Z&C:?0T )12[3Z&C:?0T )12[3Z&C:?0T )
M12[3Z&C:?0T )12[3Z&C:?0T )12[3Z&C:?0T )12[3Z&C:?0T )12[3Z&C:
M?0T )12[3Z&C:?0T )12[3Z&C:?0T )12[3Z&C:?0T )12[3Z&C:?0T )12[
M3Z&C:?0T )12[3Z&C:?0T )12[3Z&C:?0T )12[3Z&C:?0T )12[3Z&C:?0T
M )12[3Z&C:?0T )12[3Z&C:?0T )12[3Z&C:?0T )12[3Z&C:?0T )12[3Z&
MC:?0T )12[3Z&C:?0T )12[3Z&C:?0T )12[3Z&C:?0T )12[3Z&C:?0T )1
M2[3Z&C:?0T )12[3Z&C:?0T )12[3Z&C:?0T )12[3Z&C:?0T )12[3Z&C:?
M0T )12[3Z&C:?0T )4]0[3Z&IJ:)D%%%%,D**** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
<@ HHHH **** "BBB@ HHHH **** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>img268224062_3.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img268224062_3.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 6\!)8# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M$+268*+>]R3C[B?_ !5<U=^!=4M+2>ZEN+1DAC:1@KL20!DX^7K7-1?ZY/\
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M]._X33P__P!!#_R#)_\ $UY1;V\MU<1V\*[I9&"HN0,D].M;7_"%^(/^@?\
M^1H__BJ]K%4:-22=25OFCYC XG$T8M48<R]&_P CT&#Q;H=S<1P0WVZ65PB+
MY3C))P!RM.\4:B=,\/W,R/MF<>7&1G.YN,C'<#)_"N(TKPEKEMK%E/-8[8HK
MB-W;S4. &!)X:NC^(9/_  C\..GVE<_]\M7GNA1C7A&#NGZ,]>.*Q$L+4G5C
MRM;:-?F>=6-J]]?V]JA ::14!/;)ZU[186-OIME':6R;8XQ@>I/J?<UY=X*Q
M_P )99Y'.),?]\-7K5:9G-\ZATM<RR.E'V<JG6]@IKHLB,CJ&1AAE89!'H:=
M17EGNGD/BK2%T;6GAB!$$@\R(>@/;\"*ZKX>:BTUA<6#L3Y#!X_96ZC\^?QJ
MG\2#']HT\ _O=K[OID8_K5?X=$_VQ=#M]GY_[Z%>U4?M<%S2W_R9\S22H9GR
M0VO^:N>D50US_D7]2_Z]9?\ T U?JAKG_(OZE_UZR_\ H!KR*?QKU/HJW\.7
MHSQB+_7)_O"O=J\)B_UR?[PKW:O3S3['S_0\/(=JGR_4PO&%P;?PM>%6*LX6
M,8[Y8 C\LUYCHMNMUK=C!(NY'G0,/49Y'Y5Z)X]S_P (T<9QYR9_6N$\+@-X
MFT\'_GJ#^E:8'W<-*2\_R,LS][&PB]M/S/8JXKXC6P:PL[O W)*8R>YW#/\
M[+7:URGQ!_Y%V/\ Z^%_DU>=@VU7C8]C,8J6%FGV.9\ SF+Q'Y>>)H64CZ8/
M]*]1KR?P3_R-5K_NO_Z :]8K?,E:M\CER5MX9^K_ $*&N?\ (OZE_P!>LO\
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M&(;KD'FNAT;QAJ.F2JL\K75MP&21B2!_LGM_*NT?Q7X8DA$+W4;1 8"-;N5
MZ=-M<)XD31#=)-HL^Y'SYD.QE"'U&1T/I_D:PJ>W]RK3:.>I1^J+VE"LF_)_
MI=W/5[*\@U"SBNK9]\,@RIJ/4]1@TK3Y;NX;"(.!W8]@/<UQGPZOV\R[T]B2
MNT3(,].<'^8IOQ&O6,]G8C(55,S<\$DX''M@_G7G+"?[3[+I^A[3S#_8OK"W
M_7;_ ()@:QXGU'5YGW3/#;MPL$;$*![_ -[\:QTDDC?>CLK_ -X'!KHO!V@Q
MZSJ$CW*EK:W ++_>8]!^A/X5Z@EK;QP^2D$2Q?W%0!?RKOK8NGAG[.,3RL/@
M*V-7MJD[7^9Y0?%NJOI1LGN9-P8,EPKE9 /0D=1^M7?"6JZC<^)[.&>_NI8F
MWY229F!^1CT)J]XY\/6UI"FI6<0B!?9,B],GD,!V]/Q%8O@O_D;;'_MI_P"B
MVJKTJF'E."MH_P B&J]+&0IU)7LU]USJ_'GVZUM[>_L[ZX@4-Y4B1RLH.<D'
M _$?E63X*\073:R;2^O)YDN$PGFR%L..1U/&1D<=3BN\U*QCU+3;BSD.%F0K
MG^Z>Q_ X->+ SV-YQNCG@D^A5@?\:Y\&HUZ$J3W1UYBYX7%1KQ>C_I_@>YUR
M7CK6Y=/LH;2UE>*XG.XNA(94'H1TR?Y&NBT^_BU#3(;Y#MCD3><G[OJ#]#G\
MJ\CU[4SJ^LW%V.(V.V,>BC@?X_C7/@</SU?>7P_F=>:8M4\.E!ZRV]#=\'S:
MIJNN)YVI7CV\ \R16G?#>@Z^OZ U3\<_\C1/_N)_Z#7;>#M*_LS0HV=<3W&)
M7SU /0?E_.N)\<_\C1/_ +B?^@UUT:BGBWR[)6//Q-&5++X\[U;3_!G1?#G_
M )!M[_UV'\JW]?UR'0M/\^0;Y7.V*//WC_@._P#]>L#X<_\ (-O?^NP_E7/>
M.+\WGB*2($&.V41KCUZG]3C\*Q=!5L9)/8ZHXIX?+HRCN]%^)FZEKVI:K*SW
M-R^QFW")&(1?H*I07,]K()()7B<$$%&QR*[+P/X=MKR%]2O8EE4/MA1NF1U)
M'?V_&N]DM;>: 02P1/"!@1L@*X^E;U<;3HR]G&-TCDP^65L3#VTYV;VZGE%Y
MXLU2\L[6(W4T4L.X-+#(4\P'&-P'<8/YUN> ]1OKS5[A+J\N)T$!(665F .X
M<\FLKQCH,6C:A');#%M< E5_N$8R/IR*N?#K_D-7/_7N?_0EJJJI2PKE!:&=
M!UX8Z,*LM4_T(O&]_>)K]Q:I=SK;F-,Q"0A#QZ=*Y4$J002".017K7BFPLWT
M._NGM(&N!$<2F,%Q^/6O*+<!KF($ @N 0?K5X&I&=+1;:&>:4)4\1J[\VOIJ
M=OX"U"]O-2NDNKRXG58<@2RLP!R/4UL^*/%4>BQ_9K;;)?.,X/(C'J??T'^3
MM166GZ<LD\-K;VX"DN\<07@<\X%>-:A>R:CJ$]W*27E<MUZ#L/H!@?A7)1IP
MQ59SM:*Z'HXFK4P&&C24KR=]?(??:K?ZC(7N[J67DD*6^49ZX'057AGFMY!)
M!*\3CHR,5/YBNX\/7OA32+.-I;I);TX=Y'MW)0^B_+QCVZUJWGB/PGJ$1CNY
MXYE(Q\UN^1]#MR*ZI8EQ?+&D[>GZ6.&."C./M)UXJ7K^MS$\.>-YHYDM-6DW
MPL<+<'[RG_:]17H=>(ZE%9PZA*EA<&>USF-RI4X]""!TZ5Z=X,OVOO#D)D)9
MX6,+$G.<<C]"*Y,?AXQBJL%:YZ&58R<INA4=[;/_ (/4F\1^(8=!L]V!)<R9
M$4?]3["O+K_6=0U.1FNKJ1P22$W$*/H.E7_%]\U]XDNN3LA;R5&>FW@_KFNB
M\$^&[:6R&J7L2RL['R4<950.,D>N<_EFMZ4:>%HJI):LY:]2MC\2Z--VBOTZ
MG#6UW<V<HDMIY(G'(*,15W5]:N-:-O)=!?.B0H648W<YSCM7L$]G;75OY$\$
M<D738R@@=N/2O*O%NBQZ+J^R#BWF7S(U/.WU'Y_H:K#XJG7J:QM(RQF K86E
MI.\7N;'PX_X_K[_KFO\ .O0Z\\^''_']??\ 7-?YUZ'7GX_^._D>SE/^Z1^?
MYA63XFFEM_#E[+#(\<BH"KHQ!'(Z$5K5C>+/^17O_P#<'_H0KFH_Q(^J.S$N
MU&;79_D>8PZ_JL<\<C:C>NJL"5-PV& /3K3]5\1:EJ\K-/<.D7\,,9VH!]._
MU-9T$+W%Q'!&,R2,$4>I)P*]?T30++1;9%BB5KC:/,F(RS'O@]A7N8FK2H6D
MXW?0^7P5#$8N\%-J/4\@BFE@</#*\;@Y#(Q!'Y5W?A7QC+<7,>G:FP9GPL4_
M0D]E;USZUTNL>'['6;>1)HD2=ONSJHWJ1TY[CVKQ^2.2WG>-P4EC8J1T((-1
M"=+&P::LT74IU\LJ*497B_Q]4>ZUS7BCQ5'HL?V:VVR7SC.#R(QZGW]!_DZF
MDZBMYH-M?RMC=#ND8CN/O'CW!KR#4+V34=0GNY22\KENO0=A] ,#\*X<'A54
MJ/GVB>KF6.=*C'V>\OR'WVJW^HR%[NZEEY)"EOE&>N!T%5X9YK>0202O$XZ,
MC%3^8KN/#U[X4TBSC:6Z26].'>1[=R4/HOR\8]NM:MYXC\)ZA$8[N>.92,?-
M;OD?0[<BO0EB7%\L:3MZ?I8\F."C./M)UXJ7K^MS$\.>-YHYDM-6DWPL<+<'
M[RG_ &O45Z'7B.I16<.H2I87!GM<YC<J5./0@@=.E>G>#+]K[PY"9"6>%C"Q
M)SG'(_0BN3'X>,8JK!6N>AE6,G*;H5'>VS_X/4Y#Q;JNHVWB>\A@O[J*)=F$
MCF90/D4] :I)XMU:/2S9I<R;V<LUPSEI,8^Z">@I?&G_ "-M]_VS_P#1:UK>
M"/#EO?J^I7B"2.-]D41Z%AR21W'(_6NO]U##QG-=$>=^_JXR=.E)J[?W7..E
MFEGD,DTCR.3DL[$DG\:UM(\3:CH\V8Y6EA/WH9&)4_3T->MR6MO- ()8(GA
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M ?R/Y52^'7_(:N?^O<_^A+7+WM[<ZA=/=74ADE<\L1^@KJ/AU_R&KG_KW/\
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M[5IW?Q%NY(]MI8Q0,006=S)^7 _K6TOKJE96:.:']FN%Y73[:E?_ (5WJ_\
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M?7_,[,RH2J82G./V4ONL4['P1J.H6,-W!<V?ERJ&7<[9'L?EZU/_ ,*[U?\
MY^++_OM__B:S=#\47^AJ8HMLMNQR8I,X!]0>U;DWQ'N&A ATZ))>[/(67\@!
M_.NFI]<4K0LT<='^SG33J73^95_X5WJ__/Q9?]]O_P#$UT?A/PW?:#/<M=30
M.DJJ (F8\@GKD#UKD+7QCKB7_G?:#.7(!A9?E/3@ =/PKU*TDFELX9+B(13.
M@9XP<[21TKEQD\1"/+4:LSNRZEA*E3GHIIQ[DU%%%>6>Z%%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 54U/3H=6TZ6RG9UBEQDQD \$'N#Z
M5;HIIN+NB914HN,MF<E_PKO2/^?B]_[[3_XFC_A7>D?\_%[_ -]I_P#$UUM%
M='UNO_,SE_L_"_R(Y>U\":79WD%S'/>%X9%D4,ZX)!R,_+[5U%%%95*LZCO-
MW-Z5"G135-6"N;U/P3I6H.TL:O:RMR3%]TGW4_TQ7244J=6=-W@[!5H4ZRY:
MBN<&WPV&X[=5('8&WS_[-5^Q^'^FV[![J::Z()^7[B$>X'/ZUUM%;RQM>2LY
M'-'+,+%W4/S?YGFVN>![U-19M)M_-M7^8*9%!0^GS$<>E:_A&RU_1Y6M;RR/
MV*0YW><A\MO4#=T/>NRHJI8VI.G[.23_ #(IY92IUO:P;3[:6_(*ANK=+RSG
MMI"P2:-HV*]0",''YU-17(G9W1Z#2:LSDU^'NDJP87%[D'/WT_\ B:ZRBBKJ
M59U/C=S*CAZ5&_LXVN%9NKZ%8:W"$NXSN7[DB'#+]#_C6E14QDXN\79FDX1G
M'EFKHX5_ANA<F/5&5>P:#)_/<*T-,\!Z=92K-<2/=R*V0& 5/;*]_P \>U=5
M16\L97DK.1QPRW"PES*'YA1117,=Q#=6Z7EG/;2%@DT;1L5Z@$8./SKF5^'N
MDJP87%[D'/WT_P#B:ZRBM:=:I35H.QA5PU*LTZD;V"BBBLC<**** "BBB@ H
MHHH *CGA6XMY(7)"R(4)'7!&*DHH6@FKZ,Y+_A7>D?\ /Q>_]]I_\375Q1B*
M)(UR0BA1GVIU%:5*U2I\;N8T<-2HW]G&UPHHHK,W"N8U3P/IE_(98-UI(3EO
M*&5/_ >WX8KIZ*TIU9TW>#L95J%.LN6HKG!CX;#=SJIQZ?9__LJV])\&Z7I;
MB5E:YG'1Y>@^B]/SS70T5K/%UIJSD<]/+\-3ES1AK]_YA6+K7B:TT&>*.ZM[
MIO-7<KQJI4X/(Y(YZ?F*VJR]?T2'7=.-NYV2*=T4F,[3_AZUE1Y.=>TV-\1[
M7V;]E\70YN;6?"GB6X$=[#);RX^6>4!/PW G_P >XJRG@/0C'YXNKEH<%MWF
MIMQ]=M<5J?AW4]*E*SVKM'GY98QN4_B.GT/-9>#G&#GIBO:CA[K]S4:7WGS,
ML9:3^LT4Y?=_PYV'BR\T>UTV/1](2+ E$DK1'(X!X+?Q'GUXQ5;P%;--XC$H
MX6")G/OGY<?K^E9.GZ#J>J.%MK20KG!D8;4'XFO4/#N@Q:#8>2&\R>0[I9/4
M]@/85GB*D*%%TT[MFV$I5<5B56E'EBONTV2->L'Q?JO]EZ%)L;$T_P"Z3GD9
M')_ ?S%;U>;>,8]5U;6BL.G7KVUN/+C(@<AC_$PX[GCW %>?@Z:G57-LCV,Q
MK2I4'R;O1'/Z)IK:MJ\%F,[6;+GT4<FO:%540(BA548  P *Y+P+HDNGVDUY
M=0O%<3'8J2+@J@]NHR?Y"NNK3'UO:5.5;(PRG#>QH\TEK+\N@5S^J^#]/UB_
M:\N)KI9& !$;*!P,=U-=!17)"I*F[Q=F>C5HPJQY:BNC,T70K70H)8K629UD
M;<?-()SC'8"M)E#*58 @C!![TM%*4Y2?-)ZCA3C3BH15D<KJG@33[Z9IK:1K
M1V)+*B[ES[#C%4K?X<6ZR W&HR2)W6.((3^))KMZ*W6,KI<JD<LLNPLI<SAK
M\SG[SP;I5W:6MJ!-!%;[BHB8 L6QDL2#D\"I=%\+6.A74EQ:RW#NZ;")64C&
M0>P'I6W14.O5<>5RT-5A*"FIJ*NBO?6<>H6,UI*S+'*NUBAP0/:N<C^'VDQR
M*XN+W*D$9=/_ (FNKHI0K5*:M%V'5PU&JU*I&[05'/;PW4#P3QK)$XPR,,@U
M)162=M4;-)JS..O?AY8S2L]I=2VRG^ C>!],D']:K)\-XPW[S5&8>BP8_P#9
MC7=45U+&UTK<QPO+,(W=P_,R])\/:=HR_P"BPYE/660[G/X]OPQ6I117/*<I
MN\G=G9"G&G'E@K(1E5T*.H96&"",@BN3U'P!I]W*9+29[0GJH7>OX#(Q^==;
M154ZTZ3O!V(K8>E75JD;G$VWPYMDD!N=0EE3^['&$S^.36I?>"])O5@0>=;I
M"FQ4A8 =<Y.0237145I+%UI.[D8QR_#1BXJ"LS&T3PU9:#++):RSN95"MYK
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MC*?4&N2F^'$32$PZDZ)DX5X=Q ^N17<T5=/$5:2M!D5L'0KN]2-W_78YC2?
M^FZ=,L\S/=3*<KO&%!]=O^)-1R?#[29)&<W%[EB2<.G_ ,375T4_K5:]^8GZ
MAAN51Y%9%>QLX]/L8;2)F:.)=JESDD>]3.BR(R.H9&&&5AD$>AIU%8-MN[.I
M127*MCD]0\ :;=2F2UEDM,]44;E_ 'D?G5!?ALH/S:J2/:WQ_P"S5W=%=,<;
M7BK*1Q2RW"R=W#\T8FD>%M,T<B2*,RW _P"6TO)'T'0?S]ZVZ**PG.4W>3NS
MJITH4H\L%9!1114&@4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4453U'4
M[;3;9IKB15 '?N:!QBY.RW+9.*HW6LV%F,S7*+[9KROQ'\1+FZD:&R^6/ID<
M5Q4^I7ERQ,L['/;-2Y'O8;(JDUS578]V?QOH2,5-ZF1['_"D'CG02<?;4_(_
MX5X"22<DG/UI.?4_G2YF=_\ 8%#^9GT=:^(-,O,>5=QG/OBM-6# $'(/>OF:
M*\N8"#'*RX]ZZK0O'M_82JD[;XNG)IJ1Q8C(9Q5Z3N>X45CZ)XBL]:@#P. ^
M.5)YK8JCP9TY4Y<LE9A11100%%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M-%;;NA0R ^F>.*^AM0T^VU2RDM+N)9(7^\K#(JAH/A;1O#=OY6EV,,&?O.B
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M.7'!_"M:OK:5158*:ZGS=2#IR<7T"BBBM" HHHH *CN)XK6!YYW5(D!9F8X
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@!#T-?*7A'_DMH_ZZR_UKZM/0U\I>$?^2VC_ *ZR
M_P!: /JT=!7R?;?\G%K_ -AH_P#H5?6 Z"OD^V_Y.+7_ +#1_P#0J /K&BBD
M8$HP!P2.#0!!)?6L3E'G16'4$TW^T;/_ )^(_P Z\/\ $OPI\7ZIXDO[VVU6
M8032[D'F <?3-98^#7C4,#_:TW!'_+7_ .O0!]' Y'%%4-&M9K+2H+>XD,DJ
M+AF/4UD^,_&>G>#M'EN[N13-M_=Q \L>U '.?&/QA!X=\(7%FK W=ZAB10>5
M!!^;]*XS]G[PM,HNM?O(SMEQY#GKD$@UR6A:)K?QA\9-J>H%TT]7RS8X5<]%
M'?K7T[ING6VE6$5G:1+'%&N JC]: +=%%% !1110!'<';;R'T4UYW?R&6^E8
M_P!XBO0KLD6LF,?=/7Z5YO+GSGSUS7A9S)^ZCV,K7Q,91117@GKA5_2[]K&Y
M5OX>]4**N$Y0DI1W1,X*<7%GH5MJMM/&&\P*?>H;_6K>WB8*P9B/PKA-S#HQ
M'XT$D]23]37J/-ZCC:VIYZRRFI7OH27,[7$[2,<DFHJ**\EMMW9Z*22LCH?"
MTVRXD4],<?F*["N'\.@F[./;^8KN*^GRJ3="QX&8I*M<3<,XS2YJA<6<LDNY
M'(XYYJ'[-=ITD_\ 'JZW5DGK$Y53BU\1JT5!$9%@)<Y; _E55K^2.5@\9V@D
M#'%7*K&*39*IN3LC@?C9;>([GPJJZ(S"W&3=A#ABO&.<U\H,K(Q5@0PZ@U]W
M_;H)U\J1<J_!#<@UXK\5/A EPDNM:#'B3EI(AW]351G&6S%*$H[GSS6AHVM7
MV@:E%?Z?.\4R'JIQD>AJE+$\,C1R*5=3@@CD4RK)/7?%'QSU/6O#D.GV49M;
MATQ<2KQ_WSSZ5Y&S,[%F8LQ.22<DTE% !6OX:MM6N==M5T;S!>AP49#C'/K2
M>'O#NH>)=3CLK"%G9CRV.%%?5_P^^'&G^#;!&*+)?,,O(1T_^O0!U.A+J"Z'
M9C5"IOA$/.*CC=WK1HHH **** "BBB@ HHHH \4^(^FFTU59]O$A//XFN(KW
MSQGH*ZQI$I5=TR+E/:O";FWDM9VBD!#*<5G):GVV48I5J"CU1#1112/6"BBB
M@ HHHH *Z#P;8O>^(+?Y28U8;CZ<U@*C.P51DGM7L?P[\.FPL1>3+\\W(!'3
MI32NSS\RQ*H4&^KT1W<,8BA2,=% %/HHK0^#"BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M%,1[M\"?%>@Z>C:5=QQPWTC96=N-W7O7T0"&4,#D'D$5\"12O#*LD;%74Y#
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MDE%%%24%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M)Q7SCHUEXK^+FLS3&\DBM(V^8AB%7V SUKTG]H.2=?#%NB9\IB=^.G48JY\
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M@J?X_<>U?)]:GAV+59=;MET996O=XV>6,]^_M0!]UT5F>'DU&/0;-=6;=?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%0RW,4*[F88SBJ#WT]P2MM&2 ?OXX_*@#1DGCB7<[ #U/2J$FJ%CMMXRY[G
MM38],:1MUPY;Z'']*T(K>.)0%0 CN!UI 9PMKNZ.9I"JGG"5:ATZ&+!QEA_%
MR":N44P$"@=!^-+110 4444 (0",'I6/?Z)'/EXAASV'2MFB@#A+C3Y[=L,A
M_*JQ4CJ#7H+QHX^90?J,U5DTNVDZHOX 4#N</1@GM78G0[7/"'_OK_ZU2II%
MJAR$'X@&D%SCXK6:5@JH3GVK=L- *D23YSV'^-;L=O'$,*BCZ"I:87&QQK&H
M50 !V%.HHH$%%%% !1110!!=VD%]:O;7"!XG^\IJGHOA_3?#\,D6FP>2DC;F
M&2<FM.B@".:&.XA>&5 \;C#*>A%<V_P]\,N[.VG#<QR?F-=110!RW_"N_#'_
M $#A_P!]&M72/#VF:$CKI]L(@YR><UJ44 %%%% !1110!D:QX9TK7GB;4+;S
M3$=RG)&#6I%$D,:QH,*HP!3Z* "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@!&4,"& (/8U@:MX3L=2#.$"28Z@=:Z"BJA.4'
M>+(G",U:2/*[WP!>0L3%\P[<UDR>$=75L"W)%>U8![4FU?0?E79''U%N<<LO
MIO;0\6C\(ZNS8-N0*UK+P!=S$-,=@SSS7J>U?0?E2X HECZCVT".7TUOJ<_I
M'A.QTW#[!))CJ16^JA0 HP!2T5QSG*;O)G9"$8*T4%%%%26%%%% !1110 $
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M -J@8]!3Z*8@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M 4]4&=,G_P!VO.O@\?W.K?\ 7Q7HVI\Z=/\ [IKSCX/?ZO5?^N]2]T>IAO\
M<:WR/4J***H\L**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHIKR+&I+$ #U.* '54NKZ.!<*0TA^Z/6JLM]-=-Y=JIP#R_
MI4MMIJ)\\OS.>N>0?\*0RNL%S?ONFW(G.!T8?6M*"VCMUPB@'')'>I0 !@#
MI:8@HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***,B@ HI-P]12YS0 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MZL4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 54U"[6RM6E8C
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MR7^0KYN^/W_([Z;_ -<S_P"A5](V/_(/MO\ KDO\A7S=\?O^1WTW_KF?_0J
M/H#PI_R*6D?]>D?_ *"*V*Q_"G_(I:1_UZ1_^@BMB@"M/J%I:N$GN(XV/9FQ
M47]LZ;_S^P?]]UYC\1_AWK_B77$N]-U.>&( _(C$ =/?VKC?^%,>,/\ H-77
M_?9_^*H ^BH+B*YC\R&19$_O*<BI*Y+X=^'K_P ->%XK#4;J2XG5V)9SDC)S
MZFNMH ^;/VC_ /D9],_Z]/\ V8U[OX-_Y$[2?^O6/_T$5X1^T?\ \C/IG_7I
M_P"S&O=_!O\ R)VD_P#7K'_Z"* -ROF7QW\/_%-U\2M2U?3;20K)<^;!(H]
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MA"O/?V;_ /CSU?\ Z[+_ "KT+XN?\DTU;_=7_P!"%>>_LW_\>>K_ /79?Y4
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MJN:/+9[G9A83]E5DMK*YZW1114G&%%%% !1110 4444 %%%% !1110 4444
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MG' KYFT#PIX_\,3SOIUD\3RJ$?C/ KZUIIC0G)1<_2@#YH\SXJ?\\7_[Y_\
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MUJTAA1113$%%%% !1110 4444 %%%% !1139)%B1G8X &30 ZJUW?062%I7
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M*DH2Y)_>;-%%%2=(4444 1W'_'M+_N'^5>4?#3CQ+>#_ 'OY5ZO/_P >\O\
MN'^5>4?#;CQ3>#_>_E4O='J8+_=:_HCUNBBBJ/+"BBB@ HHHH **** "BBB@
M JO>7*VT!8]3POUJ=F"*68X Y-8Y!U"_92?W2'!]^N"* )]-MSS<2?>?I[>U
M:5(!M&*6@ HHHH **** "BBB@ HHHH *@NKR*TB+RL !ZU6U+58=/BR2&D/
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "HG58$DDCC&[J<#K4M% FC'M-8W73PW"[,
M$@$\?GZ5L @C(Z5C:MIGF*9X0 RC)^E2:->23PF.7.Y3@$]ZIKJCGISE&?LY
M_(U:***DZ2.?_CWE_P!P_P J\H^'''BV\'^]_(5ZO/\ \>\G^Z?Y5Y1\.N/&
M%V/9OY"I>Z/4P7^[5_1'K=%%%4>6%%%% !1110 4444 %%%,ED$4;.2  .IH
M I:E<,BK#%S(_  []C4]E;K;VZJ#GOG%4;&/[7</<NORD\#/0C%:]( HHHI@
M%%%% !1110 4444 %8^K:U':*8H2'G/0#G_]50ZMK.U_L=F \K<%L\"G:3HP
MC;[5=?O)FY!;K2&0:=HLEQ+]KU#+.>B-V'H<UT2JJ*%4  = *7I13$%%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4456O[I+2TDED. %//X4 <M
MXV\5#1[9[:%\3NN..U>-7-S)=SM+*Q9B<\U=U[4I=3U2:61MWSG%9E2QA111
M2&=KX+\(#5YC<7'$2=CT->HQ>&-'B0*MC#CW4&L;X?S1/HVQ"-XP2*["J0F<
M%XH\"6<]I+<VB+"R MA1UKR?,VGWAP2DB&OHS4&5=/N&;H$.:^?=?D276[AX
M\;2QQBDQH]/\#>+CJ4:65TV9EX#,>H]*[P'(S7S?I=[)87\4T;%<,,XKZ T>
M^74-/CF7H5'\J:$S0HHHIB"@G R>E%07A(LIB/[AH H6GB?0[^^>QM-5M)[I
M&*-%'*&8$=1C\*U20H))P!R37RM\+R1\:R <9NIL_P#CU?45\<:?<D?\\F_E
M0!3M_$FB7>HRZ?;ZI:2WD1P\*2@LOX5J5\M> 2?^%T7!R<F<Y/\ P(5]2T %
M%%% !117->/QJ[>#+]="#?VDP58=O!!+#//;C- %O4_%V@:.YCOM6M(91_RS
M>4!ORJM8>/?"^I3B&WUJS,C'"J90":\7T'X%:MK2"^\17[I,3\T<I+,?QS57
MQQ\%)_#6DRZUI-V76V&]T7(*@=6S0!]**P=0RD$$9!%+7C7P(\:WNO6%UI.H
M2&22S5665VRSY)X_ "O8+F=;:UFG?[L2%S] ,T 2$A1DG %8Z^+/#[ZF--76
M+(WA)40B8;B1VQ7@_B+XG^)?'E\=)\+6\D-LYV>8IP[$\=<\5PGA.SN[#XFV
M5O?;OM4<Y#ECD[L'O0!]F44R+_4I_NBGT %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 55N9%L[9Y54G:,GUZ__
M %ZM4UT61"K $'L:"9*ZTW*>G:@M[%S@.#@C-7JYB>*32+X2(#Y3'CW'>NB@
MF6>%74]0*;1E1J-^[+="S_ZB3_=/\J\H^'G'C2['LW\A7K$W^HD_W3_*O)OA
M_P >-[L>S?R%0]T>W@?]WK^AZY1115'EA1110 4444 %%%% !65J4IFE2U0D
M;CA_IQS6C/*(86D(R%&36=ID1EE>Y?DG@9':D!H6\(AA5,#( SBI:**8!111
M0 4444 %%%!.!DT '2N>U;5WDD^Q67S2'AF':C5]6>5A967S._WF'85;TC2$
MLH_,?YI6ZM2&-TG1TM$\V7YI6ZDUL444Q!1110 4444 %%%% !1110 4444
M%%%% !1110 44$@#).!5:>_M[=-SR+CV(H LT5C+K\,MVD,(+*3RP7I6P#D
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** (9[:*Y4+*H89S41NK>WDC@!&6XX(XQ_P#J
MJW6'KEF?EN(P<C@X].2331C5;@N:*-B;F!S_ +)_E7D_@'_D>[H?[+?^@BO2
MM/O/M=A)G&Y5.0.W7%>:^ ^/'UT/]EO_ $$5,MSV,NDI86LUV/7****9YH44
M44 %%%% !114<\GE0N_4@9H S=2D,TR6R<D\D@]N]:<,:PQ*B]%&!6;IT7FW
M,ERP."24/;'-:M( HHHI@%%%% !1110 5@:UJQ5OLEM\TC<$"IM:U<6D?D08
M:=_E './\YIFAZ28!]KN?FG?D9YQ_P#7I#)M)T@6BF6?YIVY8GFM:BBF(***
M* "BBB@ HHHH **** "BBB@ HHHH **@N+N"UC\R9PJYQGTK#N/$,LS^78Q9
M;. Y^Z:+@;\L\<"%Y7"J.YK)N_$5O"2D67?L5 8']:IQ:-J%\^^\F,2-U5#G
M/ZUKVFCV=H 4B&\?Q$FEJ,QO.UC4CF)?)3')!QD?G5F#PXI;S+J9I6/49Q6\
M !T%+18+E:WL+:U'[J)5_"K-%%,05B>*;'^T-%EAVYX)_0UMTV10\;*>XQ0!
M\T3Q^3.\1_A8BHZ[+QWX<?3-0>>%"87)8D=LUQM24%%%%( HHHH **** '(A
MD=4'5CBO=O!-@;#0(HW7#]<_4"O+_!OAZ76-21F7;$C [CTKW&"(0PJ@ & !
MQ5(3)****8@J"]_X\IO]PU/45RC26TJ+]YE(% 'RU\,/^2V?]O4W_LU?45__
M ,@^Y_ZY-_(U\]_#OP9K]A\69-0NK$QVJ7,K,^X'@[L&OH>ZC,MI-&OWG1E'
MXB@#Y>\ _P#):+C_ *[_ /LPKZFKY1U3P1XSTGQK>7]A9$.LY:-PXP16L;_X
MK$Y\G]1_C0!]+.BR(R,,JPP1[5S,WP\\,SRM+)I5N7;DGRU_PKSOX<W7Q"F\
M6PIK<6W3MC&1LCKCBO;* .57X<^%T<,-*M\CI^[7_"NF_=VUN!PD<:X]@!4E
M<-\5K77+WP;<V^AJ3*X&_:VUL9'0T >9?$WXGW6O:A_PC7AAF<.WEO+&?OD]
M@1]<5VGPK^%\/A>S34=102:E* QW#.SH<>Q!KP_2?!?C71=06^M=-_?KG#,P
M/XUU?]H_%?'^H_4?XT ?2]%>$^"KWXDS>*[./4H0+(DF4DCI@U[=>M.NGW#6
MXS<")C&/5L<?K0!8KY0D_P"2Y#_K[?\ FU=/<:[\6ENG+6D88'D#;BN'/@_Q
MNVN-J_V!OM32&3=O'4T ?7L7^I3_ '13Z^?=&UGXK'4K:-K1#'D*V=OW>_Z5
M] KG:,]<4 +1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4R66.%"\KJB#JS' %/KRKXDWMSJ'C'0_"_VE[:RNR'G93C>-V,4M7)16
M['I9M[([9O&OAU)O*;5K4'.,[QC/UK;@N(;J%9H)4DB895T.0:YL?#SPJ++[
M/_8UH?EV^88AN^OUK3T/1;;PYI*V-L[M!'DKOQP"<XIZ69.NEA+?Q)IEUKT^
MBPSAKV%=SH!T''^-:U<MX9E\/ZQJ-]JVF6L8NA)Y<LX'+' [U?UWQ1I?AY4^
MW7"J[_=0$%C^%&R5]QVNW8VJ*X^T^)&@SRM%-,UNX&0) !G]:WM$UJUU[2XM
M0LV+029VDCT)']*+"N:5%<U)XZT.*YO89+M5:S<I)N('.,X%4X/B3H,M_':M
M*T7FG$;R !6_'-"UM;J-Z;G8T4T.I3?GY<9S[5RNI?$+1+"Z>V28SS1_?6+#
M;?UI7UL.W4ZRD=@B,Q. !FN2C^)'AZ6.W*7?[R:3RQ'@;@V/3-:GB;4AI_A2
M]O\ . D.X?C_ /KI5&XP<NP07-)1[E'P=XN_X2Q;^1+7R8K:;RE?=G?QUKJ*
MX/X1:?\ 8_ =I.RXDN<R-[_,:[RM9QY7R]K??;7\2(RYKOI=_=?0****@H**
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ IDL:S1-&W1A@T^HYIHX(R\K!5'4DX%
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MFJ=N51[?G>Y*OS.7]:$5O!':V\<$2A8XUVJ!V%47T'3Y-<76&@0WJH$$FT9
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MQ!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MDAZL(V*_RKM-+^('AS5E40ZA$LA_@9@"* .GHID<L<HS'(KCU4YI] !1110
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M]+.&'_KF@%6Z** "BBB@ HHI,CU% "T444 %%%% !1110 4444 4;S1M-O\
M/VNR@F)[N@-<9JGP@\.7S//;QO:W!^ZT1"@?D*]!HH \7D\)^._!Y#:-J3:C
M;YW>5(68_2K^F_&!K.;[+XDTR:Q=/E,FWY6/U)KUFLS5/#VEZQ"8KRTC=?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%4[_5;'2XQ)>W"0J>A8]:+@7**P;;QCH=U,(8
M[Y/,)P%((S6U-/'!;O-(VU$4LQ/8"AZ*[!:NQ)169H>NV?B"R:[L9-\0<IG!
M'(^M:=-JP!1112 **** "BBB@ HHK%\5:_'X:\/W&IR(7$> %!QDDXI-I*[&
MDV[(VJ*S]#U!M5T2SOWB,37$2R%"<XR*T*J2<79DIIJZ"BBBD,**** "BBB@
M HJ-)XY)&1&!9>N.U24 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%<-\1?'L/A+3A;VX$VIW(V00@\Y/ /
MYT 9WQ)\?/I*+H>B#[1K-W\B)'SLSGDX^E2_#OX=QZ#'_:^JG[3K%Q\[ROSM
MSV'YU4^&_@&>U=O$OB$F?6+O]YB09\L'D=>]>H4 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !6?K.FPZMI<]I,%(=<#/8U)>:C%:*=S#=V&:P+G7I9,
MK&2H]J+CBVG='B&MZ%<:9JLUML)56(4XZBJ7]FW6W=Y9Q]*]>NK>*\E,DR!F
M]<5%]@MMNWRQCZ5K[4]E9JTE='C[V\J?>0_E49!'48KUV71[.12#"OY5@ZCX
M1CE!:+@^@IJHF;T\SIR=I*QP%%:&H:1<6#D.AV^M9]:7N>C&2DKQ"BBBF4'3
MI72>'?&%_H,ZE)"T?=3S7-T4FKD3A&:Y9(^C?#GC&PUZ!=KA)L<JQKI001D=
M*^5K*_N-/G$MO(R,#G@UZ]X-^(\5[LL]3?;*>%D/>L94[:H\+%Y<X>]3U1Z7
M12*P=0RD%2,@CO2UF>6%%%% !1110 =>M>6_$7X>O/)_PDGAT_9M7M_G.SI)
MCGGUKU*CK0!P?PY\>Q>)[$V5Z/(U:U^2:%^#D<9YZUWE>0_$3P/>:9?#Q?X6
MS'>V_P TT,8QO7OTZ]:[+P'XWM/&>CB>/$=U'\LT.>5/^10!UE%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 A. 37CVA01^./B1K0UB0O;Z=(T<-JQX.&ZU[%7F_
MB?P%?1:U)XB\-71MM0;F1,X60]>U)/EFI/:S^3[CW@XK?0W[_P"'WAZ\2,)8
MQV[QL&61!SQ]:T]=U"RT;0Y;B_YM5 1QZYXKF/!GCR75=3ET+6;<VNKP_P !
M& P'<<^U4?C%<E])TW25^]>WD0P/0,,_SHFG916O,U^.@0LY7?3_ (<[7P[;
MZ=;Z);R:9 L%M,@E"CW'6LO5/'NE:?=O:1E[BX0X98EW ?E6=XXUB3PE\/DB
MM3MN71;6' Z$J0*M^!_"5II/AZ![F%)KRY42S22 ,22,X_6J?O2DULM"(NT8
MWW8U?B5H)M5D:<I*9%C,3+A@6..E=1=W\-EILM],VV&*,R,?8#->1^/M T^Y
M^)/AVULX52:1FEF1  "$P175_%N^.G^ +I(N)+@B! /]H$5$I?NN=;MM?DOS
M-(Q_>J#VM?[R^?B%HOV.&:.5I6F&42-<GIZ58T#QKIFO7DEE$S1W:<F)UP<5
M@_#;P):Z+X:M)KZ)9[R6)6)D ;:" 0!Z5CS6\0^/5JME&L8BM\S!!@'*<9K5
MQ2J\G>_X*YDI-TW-=/QU2_4]2O+VWL+9[BYE6.)1DLQQ7(R?$S25DW)'.]MG
M'G",XK \:W<WB?QWI_A*WD9;9!YUWM;&X*1P?SKT)- TF"P^RBQ@\E4VX*#I
MC%9IOEY^G3Y&CLI<G7K\RAIOC/2=7U7[!8SB:0*K' Z @G^E<K\8KDR:;I>D
MH<M>W<8*^P=<UD_"C2K9?&?B:]ME_P!'2411^Q#,*N^*/^)U\8-#TWJMG&\K
M=\'Y2*?*I2I)];-_^E?D+F</:/\ ENOGM^9Z9I]L+/3[>V7I&@459HI&(523
MT%.4KMR8HQLE%'/77C/2+/5;K3Y[A5EME5G!XZC-9I^)>C)<1+*)HX)"%65X
MR!GZUY[X-\._\)G\0];UN\):QAE$83/#D9 ^N,5U_P 6+'3K3P%*L=K"CF5%
MC*H 0Q]*B[C",I;NVGJ7:]24%TZ^AZ)%*DT*2QL"CJ&4CN#7.ZMXXTG2[DVH
MD:XN?^><(W8^N*Y[6/$$WA;X2V4P)-X]HD4>3SOVU?\  OA"VL-%BN[^);B_
MNOWLLLHW')Y[_6K<??DND=/F0I>Y%O=EO3/'^DW]Z+*5GM[EONI*NW/YUK>(
M-<BT#3C>2QNZA@N$7/7_ /57GWQ@T^TLK'2[^UB2"\CO8A&T:@$Y<9%=;XAO
M%@^'EW=W2*TBV3-\XS\VVLYR_=2FNCM^!<8_O(Q?57_&QYIX!\;S'7=:U*>W
MN)H[F8J@5"0H#'_&O;;*Z%Y:K,%90V>&&#7$?"K1+:W\#V\DUM&9)W:8[EY^
M;D5WJ(L:A44*HZ 5O-*/N=K(RB^9N7>XZBBBLRPHHHH **** "BBB@ HHHH
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MM64X7U1Y6-P"G[]/<]\HJM8W]OJ-JEQ;2*\;C((-6:Q/"::=F%%%% @HHHH
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MP-"VHR@QHRX*JN1R.U=O=:!I=[JMOJEQ:(][;KMBF.<H,YXK2W+[--?#9O\
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MMAB&4YRG.>/RK6;4JBET37W(SA>,&NK3^]G _&/3Y4\&6#P1EXK*X5Y%7KL
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M)VBL0W8 GM]#0!Z%X \)P^$?"]O9+M>=ANEEQRY)SS^==5110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MH **** "BBB@ HHHH **** "BBB@ HHHH *\@&I6L_QGO;Z]F5(-.M=@;/\
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M'- LX_CAJ LE_P!&M(""O96.TTXI>UC%]-?NU$V_9RDNUOOT/9T01HJ*, #
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M:\B0M=V++)" .<[AG^5;WP]UT^(O!6G7[N&F>/\ >#.2#D]:Z"]MTN[*:"1
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M1110 4444 %%%% !1110 4444 %%%% !1110 4444 4KW3H;Q?G4;NQK N-
MG0DQ@L/:NLI"H/49H X22PN8OO0OCUVU7F@E\B3Y#]T]J]!,,9_@7\JAN+:-
MK>50BY9"/NCTH'<\9P1UHJ[J]O\ 8KUHCQCUK&FOXXN,\U!1<HK%EU=LX45
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M6CM45OJ!6_0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110!YQ\:TSX NG/\( _,@5S_ , ;F2WLM7T>
MY8"2VE38IZX*D_UKJOC'%O\ AKJ38^Z8R?IYBUPOAR;_ (1SXX2Q2GRK'4;<
M/&?5@@ _6@#W>BBB@ HHHH **** "BBB@ KSGXA^*&M(S86S[9<\D>E=UJEV
MME82RLP&U21FOG;5;Z34+^6:5LG<<5,F>WDN#5:I[26R*CNTCEW))--HHJ#[
M *MZ;8R:C?);1@EF]*J5T_@ J/%MON].,^N:#+$3=.E*:Z(](T+P'I]K:(US
M&'D89/M6A>>"](NH&00 ,1P:Z(8P,=.U+5\J/@Y8RO*?/S.Y\_>*O#LFA7^S
M!V/RM<^&*G*D@UZQ\4#%Y4.[&_G'Z5Y-6?6Q]GEU>5?#J4]SUKX?^*_/B2PN
MI!N VIGO7I%?-.EWK:?J,-RO5&S7T-H]^M_I<5R6'SC/7I6D6?/9U@U1J*I#
M9_F:%1S3Q6\9DF=44=R:P]>\7:;H<+&6=6EQ\JJ0<UXYXG\>ZAKLCQQ,8;8G
M[BGK6L8-GGX;!5*SOLCL_&'Q*C@5[/3#NDZ&3/'TKR.ZNIKR=IIW+NQSDU$2
M2<DY-)6T8I;'T%##PH1M$ 2.E3)<%>M0T4.*>Y56C"JK21>6X4]33_.0]ZSJ
M.E0Z2.&65TWLS1,Z#O4;7('3FJ5%"I(<,KIK=W)7G9^G%1=>M%%:));'?3I0
MIJT4%%%%,T"BBB@ HHHH **** "K>EVOVW5K2U(R)9 N*J5UOPYTXW_BVW<#
MBV(EZ>])NR,ZL^2#EV/?;"+R-/MHCGY(E7GV%6***Y3Y!N[N%%%% @KQ7XN2
M/J?C_P *Z/"=\?FB6=1V"NI_K7M)(523T R:\3T//B7X_:A> >;86,;(C>C$
M*: /:XXTAB6-!A%& *=110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M2?2!1110 4444 %%%% !5*4Y>K,K;5-4R<G-;T(ZW.3%2TY0HHHKI.(****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 R49B<?[)KS_X:G;JOB2'_ )YSQ#_QTUZ$PRI'M7GG
MP\^7QAXTBQ_J[J =?^F9H ]$HHHH *J:GIMMJMC):742R1NI'(Z<=:MT4 G8
M^;O%WA2Y\+ZFT1#/:.<Q28Z#L#7/5]/:]H5IX@TV2SND!##Y6QRI]17SYXF\
M,7WAB_:&X0F G]W* <'VSZUO"=]&?0X'&JJN2?Q?F8E%%%:'IA1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M%+:SN;MMMO \A] *Z?2_ASKFI;2R"!3_ 'L&O<[+1-/L /L]ND>/[M: 55Z
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %>;_$G]WK>B3>DBK^<BUZ17F_Q7_=Q:3-Z7<2_G(M 'I%%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4$@#)Z5EZOXATS1(
MB][<HA'.P$;C]!7%2ZUXD\82&#2(&L;/K]HD!5F7VXQ0!T^O^,M-T)&1W,MU
M_#"BEF)_"N7%GXH\<-ON)6TK2'Y"*0SN/0]"*W] \":;HTBW4P-U?=3/+RP-
M=6!@8% &-H7A?2_#UMY-C;@$G+,Q+$GZFMFBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBDW#U% "T444 %%%% !1110 4444 %%%% !7G
M7Q@4C0--E'&-2M@3CI^\6O1:X#XP*6\'6V,9&IVO/_;04 =\#D CH:6H+)_,
MLH7]4!J>@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BD9E1<L
MP4>I.*XC6_B'!%='3=!MGU+4<[6C3(">^2,4 =??7]KIMJ]S>3I#"G5V/ KA
M+SQMJ6O7+V'A:S\U3\INGY3Z@@T67@G5==NDU#Q9>^:3@BTB)5%'8'!YKN[+
M3[73K=(+6%8XU&  * .0T?P"GFK>Z]<O?W8.0)&W(OL :[6**.% D4:H@Z*H
MP*?10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M,5WM0]SEQ$4FK!1112.<**** "BBB@ HHK*UGQ%I>@6QGU"[CB7H%+#<?H*
M-6N:\1^.-)\/*(W=[J[?(2WME\QRW;('(KFY-8\5>-)#!HT#:5II.?M<X*R.
MO^P1D>M=!X=\":3H+BY9#>:@3EKRX :0GZT <U'I'BKQXWG:U,VD:2P^6U@8
M,91VW C*UW6B>'M+\/6@M]-M$@3&&(ZM[FM2B@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_'Y'_O#^8KO:X*P_X_(_]X?S%=[42W./$[H****1S!113)9HX$+RNJ*.['%
M#ZK7E_:Z? TUU.D4:C)9C7'ZOX_4W#V&AVLE[=_=RH(5#ZDXQBJMEX)U#7+A
M+[Q1=&3G/V5>$Q]10 EYXVU+7IFL_"UFTN/E>X;&U?<#@FKFB_#V&.X&H:]<
M-J-Z>1O)V+[;3D5U]E86NGP+!:PK&BC  %6: &QQI#&L<:*B*,!5& *=110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MO3S89R?7-='TZ4 9>C^'M.T.!8[*W1"!@N%P3]:U*** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M%O$L<2 *JKV J);G'B?B1R&@?#RSL;G^TM7D_M'56.YIFR$!]DS@5V:J%&%
M ]!2T4CF"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 17$OE1[N?PI\;;D#>H!I)(UE7:W2G*H5
M0!T% "T444 %17*L]NZK]XKQ4M% $-JI6V0-]X#FIJA-PBRB,GYB<8Q4W6@
MHHHH **** "BBB@ K%\1RA+-0",DXQ]16R2 ,GI7':[>"YO2J_=3@\]2"::W
M-J$;S,JBBBK.\**** +5A_Q^1_[P_F*[VN"L/^/R/_>'\Q7>U$MSCQ.Z"BBB
MD<P4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% $-U*T46Y<9SW^E/B8M&K'N ?THE
MC$JA6Z496)!D@ #^5 #Z*:KJX!4Y!IU !1110!6N;;S<,O# \$=14T>X(-W4
M 4^F2*60@''!ZT /HJC:_:48K("1N^\?\:ND@4 +12 Y]:"0* %HJO/>06Z[
MI9 H]ZP-1\0EU,=J"N>K46-(4Y2V+>MZL((S!"V9&&"1V%<IDDY/6E9B[%F.
M2>])5I6.ZG34%9!1113+"BBE +' &2: +.G_ /'Y'_O#^8KO:YW1=&V@7%P.
M3T7T_P#KUT50]SAQ$U*6@4444C **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M"P'XTZO*O%NC>(4TA]:GU2:.9&_U$;%0HS[&NM\ ZO-K/AB*>X<O*C>66/?
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MH **** "BBB@ HHHH **** "BBB@"M<2%)5 &02!U/O5A3E0?:D95)R>M.H
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M6XG)P@_PJ=M%T]H4B-M%L0AE&P<&K]%!;K5']IAVJK;Z?;6UQ+/%$JR2DEV
M )S5JB@A2:5D5KVPMM014N8ED56W , <&K(&!BBB@')M6*U[8V^H0B*YB61
MP8!@#S5A5"*% P , 4M% <S:L%%%% @HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M >:V;A?W*D4I8&W Q0!DF\U&4&-E(!&-U0C1Y=IE#YDZYK;5?W.,<TL/)VT
M9'VO4T^3:2.F:8FFR7&]KAB7;[OL:VD<<@BFM@2)CCF@#,1[^Q01@%P.!44U
MM=7C!K@D)_=K:;B4D\C-).#YN>V!0!CPP7E@A,+$IUVT^66_O(MD@*H3FM7<
M G2EG3=$A'I0!B1:?/;RB:%L =1ZU-)<ZG,"@4A>]:D/^I8=Z6$?(W6@#"72
MI.9 W[S.35K[5J*H(T!)'>M& _,^:?!CS#0!@?V;+<NS3-\Q[5*&O[!EBBRR
MXK3V$71)J81_O QH QYX+O4,><2H[@TV"WNM.+-;DE3VK7G?Y\ 4IC_<QD>I
MS0!E2/J%^"C9C4]J9'ILMMM>W/S*.?<UM28"8 IEN,Q/SSF@#-%WJ<A,>T@#
MJ:K#2GY8L?-)SFM[_EC(.^*C@7YOFYH H+>:C&BP!"Q QNJO-ITUZV^=OGK<
M3'VDKCJM0NI6<#/>@#-B%Y8C:I+"F30W5\P^TY6+/2MN=0&7TJ.ZCR%P30!B
M36,UHZO;9V=<5-+-J5[&$8%(QUXQ6I-*D<:(QP34KJ#;+B@##&F2P$3PMAQ4
MIO-2D7R]I'^U6HK?NMM.4!8O>@#&_LAI%,KL3-V-.^U:E"OE@%@.]:J<@T!<
M9![T <^()[Z;=<$G P!6)JT5W9W( )9<<5V<=L87+$YR:YW72?MHSZ54=S?#
M_&<W(L]P!YO"^E(EO+"=T1X]*OR#Y<TJC]U6AVE%Y+J8;<$"F+9,J[D.'!R:
MT4_U=$9^4T 58)[MI%C .<]:ZJ'2&EMU=V)D/-8=H,3 ^]=M8M^[7//%9RW.
M7$]"G%=7]I'Y6PR8X'M4$ME/?9:Z;D]!Z5M)@SGBHY$Q+GM4G*95NE[IL?EP
MDLOI2R1WM_Q,2J]Q6QLPR-V(I)V ( '% &/#9SZ>Q>U/!'2I&N-3N@8\%%/6
MM,)F!<>M/?\ U8V\&@#"&DRIAX6(D'4U.+W4S^YVG<.K5I0 _,,\FI(Q\TB]
M\4 8)TMY"9)&/FGH:F6?4;9%A4%L=ZTE!$N#4V1]H QU% &%-8SW_-RW/I3H
M(KS3!B,EE],UJ3(4G'7!-3S8"KQ0!B3"^O@!< JM*EA-8L)H"<UL7)S$N*&8
M&W Q0!E/<:C=+L92J'O42Z5)$?/1OG'>MS9_HW'6F0OD&/'44 98OM2!V%21
MZU$=):Z+2RMF0\CVK;B4>6=W6F0\2CZT 94<VHV8" %E%126T^H3^9<$@?W:
MVV7=*V<XICQ8;(H R8H;[3V/E9,?85).M[?(!,"J>E;,B[XQUZ4V<;44>U &
M)'IL]LWFVS$ =14LL^I3KL"$+TS6K%S P'6GQ+^Y(R>* .<31I(_WB-\^<FK
MOVO4]OEH"3W/K6K!CY@12PKB1J ,$Z3)/EY2=YJS%/?6<8B52^.G-:*MB<@T
M8WW'M0!CS6UQJ',Y*CT-+#!=:>N("2O85K3C:V*4I^[C- &3(U_?Q&.3*#O2
M1:?+:D/;GD#GWK9? 7@5&H/DG'7- &?]LU&4&+85'<XJJVE.^'#$2YSFM\#_
M $9\=>*B@7Y^: ,];O4H\1A2<#K5>73);QS)*WSGI6\,><R^U5@I6<#/&: ,
M^*6_L(Q$,OBDEBN[Y@UV<)G@5LS[0Z\5'=(6V<T 9,5K<V#F2!LKZ47#ZA>C
M:P*1UKN,1BGRKF 8H PTTV:WQ-;MAQU]ZE>[U&5?+"E?5JU _P"ZV <TX(/*
M]Z ,,:/)(IEW_O>N:G^TZE"OE@%L<9K4B.Q"OK2*-IYR: ,*2QGN9?-N6W$C
M@>E3PC4+%,)ED["M:0 XXIRG:.>: ,J:*[O5!N,A/2H+>SN-.E::W8[3_#6U
M-DK[4J@&WH R9+C4;L;<%%[U$FE2Q_O8&VN.36Z@ A--A;]VPH RTO-2D0P
M'/K58Z.\A+NQ\WKFMZV4+N.*;$W[QLT 9L=SJ%M&(E!8C@&H6T^:ZRURWS'M
M6U'S.:CD4B7.: ,N%+W3X]L1+*.@I)([R_\ ]>2J>E;)7:RGL1FED(Q@"@#$
MBL9[)C);'CTIYFU*\!C(*#N:U%4^2N#WJ1^(_EX- &&NE2IAX&(D7DFIUO\
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M:!B1',NSM3G;;)M'2DC'/O2OU]Z &/Q, .E/EP&7 J-3\X!ZU(YV$9YH ;<
M#;BI&.(EIDZYP:60_NU% "3<0YI4YMQFDD^:$"E'$ H ?$V%HI(B-M% $<7S
M/FG@;IC["FH0DI%2  3_ %% $!8M-BI)^&C4?C22 )-FGD!R'H AN6VE5[4]
M_DA '4TDX# -3O\ 61 =Q0 V0;+<GN:1"1%N[BGG#KL]*;%@ED]: %B(V%_4
M5'&A>4&I478Q0^E,W>7*%H >SB4].14<IY%2,NR4>E,N.&!]30 IY442G:-O
MI3V $0:DD :,-WH 1CM@)%)]RW!]1FI  \)'H*8N'CV^@H +;H7/04(<@DT1
ML "GK4@0*,>M %> ;Y23V-2?>E([5&I\N8CWJ=@$._UH @F8F? Z5*2 H3N1
M39%&W=3F 9%<=0* &R A5%"G;&"/XJ<YW1 ^E$ #Q'VH  1%$6/>HH 2[-4N
M!)$5]*;"0K$4"')R['TJ.-MUQ4RC;*5]:B.(Y<T#'/\ \?(%1SG]^HJ=@ ZO
MZC-1S ;U>@!T_"HHZU',?+52.]2G$I!]*)U#*/:@"I<PM(4<=JLE<1 ]\57:
MX"LJ$=:MJ03M]J (T(')I&RS;ATI<CS=M/(P^V@",@,0>XIS'(^E))A)%7UI
M[@*![T 4HKAI7*GL:Y_Q%_Q]CZ5U!MTBPR]37,>(<&['TJH[FV'^,R&_U0H7
M_59I6^YBE3&S%:'<,'W#1%R":<1A<4V,XXH$36_,R_6NTLCYD* ]A7&0 "9?
M<UVMOB*WC;U%9RW.;$]"4']YM[4QV._;VJ4#C?2.HV[JDY13A$ [L*:X(C I
MW$D2G^Z*4X,7N*!$:G";O6G [4+BB !T(]*<@#(Z>] $</+DTY>9F]N:;&0L
MA%28"S'W% R$-NN *DD&V<"D<!)=U2-ABLGK0!%=-AU'K3G^2( =323@-M?W
MI21(![4 -F^2-2.].3B(MZBG2 /%_NTV!@V4/X4 *HVQECUQ440+R>]3'@[#
M34PDX^E A0^YP:C(WR<^M.QME [42D(X]S0,;(26VU+.H50!2.G :EG<,H-
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MH"Y9&IW3P[HX-R"I(M4CFC"2#RV7M6W'!'$NQ5 7'2N;\26Z0RPO& I8\XH
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M(W4#<Z@F@+E!-4,".L\.W<13&U94EQ%'O:M'5;2.:S=F R!D&L_P]:QNK2.
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MTWF8;9D >E=,\4;H8RJX(QC% 7,1]4@F'F@X*]14<NI74P#16_RCO5 V"_\
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MPQ(S0%QRZG(T/EP1%\]Z6'5&@4QW$.TMWK4TVVBBL82JC)7K46MP0_V;-(P
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M *;)#'(NUE!'6@=SEK[6GU-?LME&VYNIZ57M7O= FQ<H3&W<'-=C'!'$"$7
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M+:*/[J8HH'<EHHHH$%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 ,:,,<G&?IFG@8&*K7$I210!
MD$@=3[U84Y4'VH 6BBB@ I&^Z?I2T4 5+82;R7!QVS]!7.^)/^/V/_=_J:ZM
M2F?EQ7*>)/\ C]C_ -W^IIK<WP_QF+1115G<%%%% $MM_P ?,?\ O"N]MO\
MCVC^E<%;?\?,?^\*[VV_X]H_I4RW.7$]"6BBBI.0**** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH :54G)Q^-.' JM.7\U=@SR,\9]:L+
M]Q?I0 M%%% !2-]T_2EHH JVJR!COSCMD^PKG/$G_'['_N_U-=6KANE<IXD_
MX_8_]W^IIK<WP_QF+1115G<%%%% $MM_Q\Q_[PKO;;_CVC^E<%;?\?,?^\*[
MVV_X]H_I4RW.7$]"6BBBI.0**** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH 8ZH2"P!^M.# \ BFO&'ZEA]#BD6((<AF/U- $A.*0,#T(
MH8;AC)'TIBPA#D,Q^IS0!(3BFE@00".E*PW*1DC/I3%A"-D,WXF@"&VA,;$G
MO[>PKG/$@)O8^/X?ZFNMJ&6UBF(+@G'2A:&E.?)*[//\'T-&#Z&N\_L^W_NG
M\Z/[/M_[I_.JYCH^LKL<'@^AHP?0UWG]GV_]T_G1_9]O_=/YT<P?65V.(ME/
MVF/@_>%=Y;?\>T?TJ-;"!6#!3D>]6 ,#%)NYC5JJ>PM%%%(Q"BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
5HH **** "BBB@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>img268224062_4.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img268224062_4.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 5O!)T# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MDU.,CAU%>RW+RV>,E.7UA.WGW\BY1117GGKA7&ZEX]_L_4KBS_LWS/)<IO\
M/QG'MMKLJ\:\2?\ (R:A_P!=VKNP%&%6;4U?0\K-<35H4XRI.S;/4]"U;^V]
M+6]\CR=S%=F_=T]\"M*N:\"?\BQ'_P!='_G72US5XJ-648[)G;A9RJ4(3ENT
M@HHHK(Z HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH *H:Y_R+^I?]>LO_ * :OU0US_D7]2_Z]9?_ $ U=/XUZF=;^'+T9XO&
M0LBD] 0:]9_X33P__P!!#_R#)_\ $UY* 6( ZGBMW_A"_$'_ $#_ /R-'_\
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M7MGJ5JEK>7$"M#DB*5E!.3Z&L"Q\5ZM8QS@74LTDB@*\TA?R_< \9K7^(O\
MR%;3_KA_[,:S/".A)K6IMYX)M8 &D .-Q/0?C@_E7115-852FM#CQ,J\L=*%
M*3NW^ABW-Y<WDADN;B69SWD8FK.G:SJ&E3"2TN77U0G*M]1TKV2&TMX+;[/%
M!&D.-NP*,$=.E</XX\.VUM:C4[*$188)-'&N%P>C<=.<#WS^<4L;3JR]G*-D
MS3$996P\/;1G=K5]&=-X=UZ+7K RA1'/'A98\]#V(]C7)^/K^\M]8B@ANYXX
M7M1NC20A6RS Y X/%97@R_:R\26ZY/EW&87 [YZ?KBO1==L+.XTR\GFM())D
MMGVR/&"RX4D8)Y'-<\H1PN)6ETSLA4GCL$U>TEO\CQJNW\":C?7FN31W-[<3
MH+9F"RRLP!W+S@GWKB*]PM].L;.0R6UE;P.1M+11*I(],@>U=>858PARM;GG
MY10G4J\\791M?SW/'O[<U?\ Z"E[_P"!#_XUZ_I;M)I%D[L6=H$+,QR2=HY-
M>(U[/97"VGAFWN&&5BLU<CV"9K',H)1CRHZ,EJ2<IN3Z&#XL\6G3F;3]/(-U
MC]Y+U$?L/]K^7\O/+F\N;R0R7-Q+,Y[R,339YI+JXDFD):21BS'U)->L>'O#
M5IH]G$SPH]Z0#)*PR0?1?0#VZUJW2P5-:7;,(JOF=9ZVBOP_X)YEIVM:AI4H
M>TN74=T)RK?4?C46HWAU#49[LIL,SERH/0FO8=2T>QU:$QW=NKG&!(!AU^A_
M&O'=0LWT_4)[20AFA<H2._O5X7$4Z\G)*TC+'82MA8J+E>/ZGI?@3_D6(_\
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M8J>)A"TVK,[L!2P56K>DFG'74O4445Y)[X4444 %%%% !1110 4444 %%%%
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M**** "BBB@ HHHH Y>Z\":7>7D]S)/>!YI&D8*ZX!)R<?+[UO:;81:7I\5E
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MG\,1,_4.1^@KI:V1^=XB'LZLH=F%%%%!B%%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !7BWQ1A=?$WF$?(T8P?PKVFN#^)>BM
M>:4MY"F9(C\_TI2V/3RBLJ6*3?70\9HHHK,^Y"BBB@ HHHH *=&,R*/<4VM7
MP[I;ZOK,%J@/+ DT$3FH1<I;(]P\(6_V;P[ A7;GYOS K=J*VA%O:Q0C^! O
MY"I:U/SJM/VE24^["BBB@S"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5E:]XALO#
MED+N^\WRBP7]VN3D_C6K7G_Q<_Y%=/\ KJO\Q2>B.G!THUJ\:<MFSN+&\BU"
MRBNH=WER#*[A@U8K'\+?\BU8_P"Y_4UL4S*K%1G**Z,****#,**** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ KS_XN?\ (KI_UU7^8KT"N"^+"!O"@)[2K_.E+8[<N_WJ'J=+X6_Y
M%JQ_W/ZFMBL/P>Y?PGIS,>3'S^9K<IHPQ'\67JPHHHH,0HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH *"0.M4K[4H;)/G;+=E'6N:N]9N+@D;]J]@
M* .M>YAC^](H_&HAJ-H6V^<N?QKAS*YZL3^-)O([G\Z!V._2>*3[DBG\:DZU
MY\DTB,&#,/QK7LM>FC;;*2Z>O>@+'545!;745U$'C;(J>@04444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M2:.WU"! ;F)SM _VAGMP?I0!W)( ))P!U->(?$WXV?V3>?V5X;</<12 SW&
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M.S+W;%0]39\&?\BAIO\ UR_J:W:YWP+_ ,B9IO\ US/\S714+8RQ*M6GZO\
M,****9@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M;?##1/&]S;7-VGDW$3?/+$,-(G<''7MSVH ^=?AM\,[SQSJ&^;S+?2XC^]F
MY;V6OJ[0="L/#FD0:;I\*QP0J%&!RQ]3[U8TW3+/2+"*RL8$@MXE"JB* .![
M5;H \Y^)?PLLO&]M]KMR+;58Q\LO9P.Q'>OE/5=)O=%U"6QU"W>&>(X96'\O
M6OO*N+\=_#?2?'$$)N%$%U$X(G1?F*YY!_#- 'SG\-/AI>>.=1\V7=!I41_>
MS8^]_LK[]>:^EK?PG!HEG%;:2GEP1 !5X_,FMO1M&LM!TJ#3M/@2&WA4* H
MR?4^YJ_50FXNZ(G!25F58I/LUBCW+X(4;B?7%30SQSQAXV#*>XIEW;+=P-$Y
M(!KGY;6[TJ4R1EFC!ZC/ZU<8J?74F4G#IH=/15'3=0^WHQV%2N,U>K-IIV9I
M&2DKH****0PHHHH **** "N)^*7_ ")\G_71?YUVU<3\4O\ D3Y/^NB_SI/8
MZ\!_O,/4U/ O_(F:;_US/\S715SO@7_D3--_ZYG^9KHJ%L9XK^//U?YA1113
M, HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HI"0!DG JA<ZFD;;(1YC].* +SNJ EC@#FLZ;4VD)2UC9ST)VFHTLK
MB\8/=.0O4)SQ6C#;10*%11QWQS2 SX]-FG.^ZD8'^Z,5I101PIM10!W]ZDHI
M@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M4K/S.LHIL<B2H'C8,IZ$'-.K,]#<**** "BBB@ HHHH **** "BBB@ HHHH
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MDCYEC&#]*\NKIO!=T8-5\O/$F%J4-GI-%%%62%%%% 'RGX]_Y+O!_P!?\/\
MZ-KZH7_CW'^Y_2OE?Q[_ ,EW@_Z_X?\ T;7U0O\ Q[C_ '/Z4 ?+OPW_ .2\
MI_UTE_\ 0#7U-7RS\-_^2\I_UTE_] -?4U !1110 51N='TV\F,US8V\LAZL
M\8)J]10!F?\ ".:+_P! NT_[]"O$OC]=Z?86EAH6G6=O%//)YLC1* V!P%..
MQW _A7O5U<QV=I-<RG$<2%V/L!FOE[0K>]^*7QE>^G >SBF,DA/R@1)A1CWQ
MB@#V[X3^%6\*>![:"=2MW<'SYU/.UCQC/T KN:10%4 = ,4M !1110 4444
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M]]J-SJ,YEN)68DYQGI2ZE?RZE?27$S%F8G&:J5V0@HH^+QV.GB9_W>B"@9)
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M6.80H%RP\I6^9\?3^5?4ME:1V-C!:Q*JI"@0!1@<#% $]%%% !1110 4444
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M 89P54]SUKZUT71;'0-+AT_3X%A@B& %&,^] &A1110 4444 %%%% !1110
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M&'6N)U#P?>VK,\>V2/L1FO2J*30[GC+V%TC$-!(,>U-%I.>D3_E7LS(KJ58
M@]0:8EM!&VY(D!]0HI<H7/*+/0KZ\<*L+#/][BNLTCP6D!62]978<A1G'XUV
M%%.P7&1QI#&$C4*HZ 4^BBF(**** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "FNBR(589!&"*=10!Y+XP\-2:9=M=0(6MG/8=#7)U] W%O%=0M#
M,@=&Z@UYUK_@*2%GN-/PT?783R*Z:=7HSYC,<JE&3J45==C@Z*L36-U;L5E@
M=2/45!M.<8.:V/"::W$HIRQNYPJ$GV%:NF>&]1U.8)' R@_Q,,"DVEN5"G.H
M[05S+BB>>58XU+,QP *];\'>'?[(LA/*!]HD'/'04OA[P?;:/MFFVRW _B[
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MN)A^[7[@/UI)7.HW@BC.85P3GO6K%&L4:HO0#%(8\# P****8@HHHH ****
M"BBB@ HHHH ***:[K&A=V"J!DDT .JK=ZA;629FE53V7O61>^(&D<V^GH7D)
MV[L<?A3;309KAUGU&9G_ .F9)X_PI7'8BEU2^U:;R;%&CC/\>#Q[Y%6['PY%
M$WFW3>=(>2"./_KUM10I"@2-=JCM3Z+!<:B+&H5%"J.@ P*=113$%%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110!6N+"VNO\ 70H_U4&J3^&=(<Y:RB)_
MW16M13NT9RHTY_%%,S(?#^EP',=G$#_NBM%$6- J*%4= !3J*&V]QPIPA\*L
M%%%%(L**** "BBB@ HHHH *RM9\-Z/X@\C^U;""Z\EPZ>8N<&M6B@!J(L:!$
M4*JC  [4ZBB@ K)U_P -:7XFLTMM4M4GC1U==P!P0<UK44 1PPQV\"0PHJ1Q
MJ%55'  Z"I*** &21),A210RGL16#>:-+ WFVA9L'.!U'^?2NAHIIV,JE*-3
M<SM)N+F>)_M"D;3@$C!K1!!Z'-1NF(V$8 )]*YU+N[TN[*W&YP3D\]?<46N0
MY^R24M?,Z:BH+6[CNXA)&?P[BIZ1NFFKH****!A1110 5S7C[_D3[[_</\C7
M2US7C[_D3[[_ '#_ "-)['1A/X\/5%'X7_\ (F6WU/\ ,UV=<9\+_P#D3+;Z
MG^9KLZ%L7CO]YGZL****9R!1110 4444 %%%% !1110 5FZC<L3]FAY<]1CM
MBK=W.MO SD\XXJEIMNSL;J7DMTS0!;LK46T(&/F/4]ZLT44 %%%% !1110 4
M444 %%%% !12,P52S$ #J37/ZCKY,AM;!#)*3MW#D?AB@#2U#5K;3T^=P9.R
M#J:PUBU#7Y0\I,5L#Q@8JWI^@%I!=7[F64_-M//YUOJJJH50 !V I;C*EAIL
M&GQ!8URQ'S-W-7***8@HHHH **** "BBB@ HHHH **** "BBB@ HI&94&6(
M]2:YC5_'.E:6S1K*)I5ZJK=* .HHKRJZ^*DLC$0V85>Q+G-48?B3>QR,S1[@
M>Q<\4KCL>QT5YMI_Q2C=@EU:[!_>5Z[;3->T_5HPUK<(Q[KD9IB-.BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M2A5'I4U%@"BBBF(**** "BBB@ HHHH **** "BBB@ HHHH *9-,D$+RR,%1
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M7<#QC.:^5/'O_)=X/^O^'_T;7U0O_'N/]S^E &'8>-_#6IZP=(LM6AFOP2#
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MTV[T*6UB=2QE\MAMQCKDUYIXV\2?\++^)-KI7VJ*VTBWE\M9'.%P.6)]^H%
M'0_!?PG/XCU^Y\:ZTGF_O2T/F#(=SG)Y].,5QX 'QYCQ_P!! _UKZ.TG6_"V
MC:5:Z;9ZG;);V\:QQC=V P*^:?M]I_PNM+WST^S"_P!QESQCGF@#Z\7[H^E+
M5#3M9T[5-RV-Y%.4 +!#G%7Z "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M5&+G@ '-=Q0!@ 44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M<5[E;6Z6MO'#& %10!@5%IVFVNEVJV]K&$0>@ZU;II$A1113 **** "BBB@
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MB2&,)&H51P .U(9B67AN)")+QC-)WYX_QK<2-(U 10 !BG44Q!1110 4444
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M[3" \5@-[K[$ \_B:]L P,"O$/!9&N_'C7M3Y,5M"8E/^TI4?XU[?0 4444
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MUI1.K.:E.E2Y4ES2-.BBBM#Y4**** *U^NZT88SR/YUS==3.N^%E%9^GZ<$
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MXEN-3NPN+9W0B.)O79N.>/>NN\$^$#X,\*)HT-V)I%+-Y_E[1N/?&?ZUU%%
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MO)YU>TW*P/#\X'XUW%FDZ6Z+<.&DQS@4^&"*!-D2!5]JDII";"BBBF(****
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M*^S?"GB"W\2:!;7\# [T&_'9N]?#=>^?L]^(Y#-<:$YR@4R+GMS0!]!T444
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M^-]M%=K8>*M*N-(NMVUG*YB4_7->MUFZOX?TG7K<P:I8072%=H\Q Q'TSTH
ML6&HV>IVL=U97,<\,@RKH>HJU7C=_P#![5/#]T]_X&URXLV'S"UD;*L?3/
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MY/Y"O+->_:"TRWFDM]!L)K^5>%=E^1C^!S6;I'[/]S?3_:O%.L2S,PYCC/S
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M'\:\WKTKX(6PN?'L (SL&[\J /K4<@44#I10 4444 ?*?CW_ )+O!_U_P_\
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MPEX?N-4OI50(I$2GG>^.%_.OGOX<^&+_ .)'CN;Q+JVYK&*;S7+'[QS\J#V
M_E3K"P\0_''Q:;V]+6VBV[8XR%5<G@>K$<$CVKZ.T71;'0-+AT[3H$AMXE
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M)%1!T51@4 <7X.^%^A>$H_.\H7NH/_K+J<;F)]@<X_"NWHHH **** "BBB@
MHHHH ;)(D4;2.P55&22<8%>9ZY\68+6ZDMM/MS)L./-+<$_3%>@:S;/>:-=V
M\>=\D3*N/4BOF*\MGM+R6WESOC8@YK2G%/<]3+L-2JW<];'HJ?%^^&-UNK?D
M/Z5?M_C*@ $^FD^I5_\ ZU>245IR1/4> P[^R?0&F_$S0+X*))OL\C<!7/\
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MJ/PY\=&W9-(U&3]UTBD/;VK*<.J/'Q^"YOWM-:]3V&BCK16)X84444 %%%%
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MH^@I] !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !116/XJUN/P[X8O]4D./(B)4^C'@?KB@#RGQ?*_P 0_BM8
M>%8\MI.G'SKO:3ASD9![<8->UPQ)!"D,2A8T4*H'8"O+_@GH\O\ 8E[XFO@#
M?:Q.TS'T&X]/3.:]3H **** "BBB@ HHHH **** "BBB@ HHHH **** "N7\
M0H1=[NQQ_*NHK&\06YDMUD7^ \T CDZ*#12*"BBB@ HHJG?70A3:#\QH 2ZO
MEA!"\M63)=22,26./3-1.Y9B2>33:FXQ<G.<T%CZTE;GAK0SJUT6DR(X^?K0
M!C*)''R@FH)K:-R5EB!/N*]FATBQAC"K;1\=R*IZIX>LKVW;$2QN!D%13L"D
MT]#PG4="&TR0<GT%<ZRE&*L,$5Z3>VKV5T\$@P02*YW6=*62,SQ###L*UIU.
MC/7P>/=^2I]YR]%*002#U%)70>R%*K%6#*<$'((I**!GM?PX\:C4K==+OYA]
MI08C=SRX':O1Z^4[2[FL;N.YMW*2QL&4@XKZ%\$^)X_$FCJ[,/M,0 E'OZUA
M4C;5'@9CA/9OVD-F=/11169Y04444 %>3_&G0KA;&R\6:6K+J&DR!V=."(^<
MUZQ4%Y:Q7MG-:SQB2*5"K(>A% &=X7UV'Q)X;LM5A*XN(@S*#]TXY%;%>,_!
MV\FT#Q#KO@F[?'V6<R6X/4YZX]@!7LU !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%9VNZ2NN:+=:
M<UQ+;^>A42Q'#(2,9'O7GEKX/^(^B V>E>*+:>Q7B-KM<R >_P A_G0!@_%S
M3[/P[XO\,:MH<:V^K7%WLDC@^4S#<N 0/7)'O4OQLGFUA?#7AP?N[R_=960_
MPD#G/XFNIT'X9;-;77_$VH/JNJH<Q;N(XL="H '/X5)K'@;4=9^)VF^(IY[<
MZ=I^##%D[]W&<C&.H/>@#E/CB[16'A;3-I6V:]C#XZ'MBO7K<VVFZ-&=RQVM
MO #NSPJJ/\*YWXA>"[;QMHD=D]P+>YAD$MO+W#"N.O?!?BR70IHO%?BE$T2R
M@+,MH &D11T8E1V'K0!D_#N\C\6?&WQ!KR?ZI(]L9ZYV[5S^E6/&%O%XL^/&
MBZ,7W6]I")I,'@.NYL?^.BG?L]Z4L-CK6HI&PB>Y,=NY_CC_ ,BNKT'P%?6'
MQ*U7Q3?3P2)<D_9T1B60'.0>!ZT =1XKO?[+\(ZK>CY1;VKOP.F!7E7PR@N]
M'^$>MZSY;&2]D>>+Y<94X7CUZ&O1_'^@ZEXF\)7.DZ9-#%-<$*[3,0NS!!Z
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MW3CL>#]:O>$-'\56,\]SXFUB*]ED "1PJ B ?\!!YH ZZBBB@ HHHH ****
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M\<8)()/X-7LD,J3P1S1G<DBAE/J#7#_%WP^_B#X?WT<"!KFWQ/&<<KM(+8_
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 4=9OX],T:[O93A(8BQ->9_ :Q9O#
M-]K5Q\UU?73$N>I48Q6]\8=0^P?#C4L-AIU\I?<FK_PST[^S/AYHT#*5D-NK
M.#_>[T =;1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%!( R:
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MTI;IY5M%'_=0+^0H DHHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#R/X\S>?HNC:3&3YMQ?
MHV!W4!LUZO;Q)!;1Q1J$15 "CH!7COQ._P!,^+G@VQ)S'\S,ON,_XU[,. *
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MBQ/$7C9E$5N0;734(*1G'?DY[GKUK2^*O@>_\5V5A=:0ZC4-.F\Z)6Z.1T%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@#Q3X_:>U]#I01=SEBJCU/)KJ_@QJ?\ :7PVT\9R;;_1
MSSTV@?XTWXFPJU]X79@"KZFL1S[H]<[\')'T#Q)XD\'3MC[+/YL6?XL^GX"@
M#V2BBB@ HHHH **** "FNP1&8G  SS3JQ_%%R;/PY>3 X*I_44%TX.<U%=3Q
MGQIK<FL:[-G_ %<3%4'M7-U)-(9IGD/5B34=9'Z)1IJE34(] H/2BB@U/7OA
M-;1_V#+<%09#(1GN, ?XUZ)7BWP]\4Q:+,;.Z;;!(>OH:]?BU*SEA$J7,90C
M.=U7%K8^(S>A4CBI2:T>Q4\1P1W&@W:2 %?+)KYUG01W$B+T!XKV'QQXRM+7
M3Y;&UD$DLHVDJ>!7C>2Q+'K42=WH>UD5&I3I2<U9/84$KT)%)110>Z%.BBDG
MD$<2%W/0"FUZ=\+] MKJ!M3F0,RMM7-!RXS$QPU)U9'(P^"]9FB\S[.R\9P:
MR+W3[O3I3'=0M&>Q(ZU],8'H*YCQKH=MJ>B3R,@\Z)"4.*;BUJ>%AL]G*JHU
M(Z,\$90PP15.1#&V*O.ABD:,]5.*CE0.E73GROR/H*U)3C=;E*HYH(YXRDB@
M@U(1@T5UGFM7T9RNH^'&4F2WYS_#6)+97$)(DC(KT6HW@BD^^@/UJ'33V/-K
M993F[P=CS;!]*559C@ FO0O[.M"?]0GY4JZ?:J<B!!^%3[)G+_9,_P"8XBWT
MJZN&&V(X]:Z33= CM\/-\S>];2(J#"J *=5Q@D=M#+Z5)W>K$ "@ # %+115
MG>%%%% PHHHH *ZWX<V(OO%MOG_EE^\S[CFN2KUKX0:6-ESJ#KAONI4R=D<N
M,J>SH29ZQ1117,?*A1110 A(4$DX Y->,_#Z237?C-XGUI^1;*;13G.,'_!:
M]3\1ZE#I/AW4+V=PB10.03ZX.!^=<!\"M,DB\)W6LS@B?5+EI6!]F.#^.: /
M4Z*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M/A1M6O5/V_57^T.QZ[" 5!_6O2ZC@@CMH$AA0)&@VJJ] *DH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@#C/BJF_X>:G[(#^M=+HTOGZ-9R?WHE-87Q*3?\/M8]H2?
MUK0\'R^=X0TN3^] IH T[^R@U*PGLKI-\$Z&.1?52,&O'?AMJ$W@GQMJ/@34
MF(@D<S6+GH<@':/8#->U5YM\6_!TNLZ/'K>E(5UG33YL4B [F49RO'U_2@#T
MFBN1^'/C&+QEX4M[PNOVV,>7=1]U<=3CL#774 %%%1S3Q6Z%YI%C4=2QP* )
M*"<#)Z5QFN?$C1M*W1Q2BXF X$?(S]:\VUKXF:SJ9*6[_98^F$ZD5:@V=M'
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** .;\?KO\
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MH'_T*S8XW8Y!(_+F@"UX,\-:IX_\0IXV\4QE;($G3[&3D!<X!(/T].:]I
M & .U-CC2&-8XU"HHPJCH!3J "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M5 2T$A'>3FM^&VAMTV11JB^@J6BI;;..=2<_B=PHHHI$!1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %<#X,.SQWXMA];G?^8%=
M]7GGA9MGQ7\5P^L<;_F: /0Z*** "BBB@ HHHH **** "BBB@".:"*XC,<T2
M2(>JNH(/X&O./$7P:T;4IY+W2I)--O&.XE"61C_NG@#Z"O2Z*"HR<7>+L?-L
MFD>(_AYK<=YK&A)JMA&P)FMR2,?3 YKUKPQ\4O">OP)'!>)93\#[-<81@?8
MUVY4,,, ?K7&>)?A9X6\3.TUQ8^1=-R;BW.UR?K3;;W*J5IU'>;N=DCI(NY&
M##U!IU>,-\-?&GA%6F\(^(Y)H%.?L5P<E_QX%)'\4/&^@N$\2>#Y71?O/9C<
M3^I%(S/:**\\TGXT>$-015N[Q]-N3U@N8V!'X@8KK[+Q)HVH('M=2MG!&?\
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MD8_BN&Y_F:]DHH \:.J_&6T_UNG:=/C^X":;_P )?\6H_O>&H&^B-_A7L]%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M;PM;A[^XS,YVQV\0+R.W8!1S^=<E)9^+_'LZ/<M)X?T%N?)!!N)E]^H'T(H
MUM<^(UC::BVBZ)"VJZV0=MO%]U2/[Y["J%EX(U;Q+/\ ;_&]\94.#'I=NQ6%
M,="Q&"Q]CD5UVA>&-)\.6WDZ;:)$3]^3'S.?4GUK7H @L[*VT^V6WM+>."%>
MB1J%'Y"IZ** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "HTGC>5HU;++U'I4E58;9H[J68L"'[>E %JBBB@"&Y@\
M^/;G![&G0*Z1@2'+#J?6I*BGWB)C'][MQ0!+145O(9859A@D<BI: "BBB@ H
MHHH *X+XF#:FAS?W+Y/U917>UPOQ3&-!L9?[FH6XS]94% '=4UW6-"S$!1U)
MIU<WXAU3'^AQ'D\L1_*@N$'-V1EZKJ#7]T2"?*7A5S^M4***T1Z*22L@H'WA
M10/O"@9Z#:_\>R?2IJAM?^/9/I4U9GERW"BBB@044$@=:X35OB1;OJ$NC>&;
M636-67(98A^[BQP2S''3VS0!V&HZG8Z3:-=:A=0VT"]9)7"C\S7 7'B[7_&,
MK6/A&S>VLFR&U:X4A<9Q\@Z-^=3Z;\/KS5[I=1\;7YU*93F*T0E88O3@ 9(]
M\UW]O;PVL"0V\211(,*B#  H Y7P[\/]/TB07VH.=5U9@-]Y=#<?^ @YVCZ&
MNNHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ J&.Y62=X@#N3KFIJKQ6PCN9)<D[^U %BBBB@ HH
MHH :2J#G@4ZHKB$31,G0GH:;:QR11!9&#$=/I0!/1110 4444 %</\51_P 4
ME$Y_@OK9ORF2NXKB/BS@> ;MS_!+"WY2+0!TFH:FMMIJRY_>2("H^M<8[M([
M.YRS')-(E^^H65I,Y)'D)M_*BK2L>A1I\D0HHHIFH4#[PHH'WA0!Z#:_\>R?
M2IJAM?\ CV3Z57U76=/T2S>[U&[BMX5&=TC 9]A[UF>7+<O5S/BCQSH_A6)1
M<R-<74AVQVMN-\C'Z#./J:YG_A)?$OCV&6#PQ;OI.G[L'4KE?FD7H1&N"/QS
M72^'O NDZ#F=@]]?L=SW=VQD<GVSG:/84".8_L3Q;X[N4N-9N6TC0G 9;"%O
MWLJGLY_IBN\T;0-+\/V8M=+LXK:(==B@%CZGU-:5% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 57BN?,N9(L?<]O\ Z]6*ACMTCF>51\S]: )J*** "BBB@".:7RHV
M?!.!GBH[2265"\@QDG QVJ;*2 CAA^=*%"C   H 6BBB@ HHHH *R/$_A^W\
M3Z!<:3<R211S8R\>,C!![_2M>B@#SR32FT9(K'+,D2!$=NK <9J.NSUNQ%W9
M,P'[R,9!KC/K5IW/1I3YXA1113- H'WA10/O"@!]]\0YIY1I7A+3GU345.)&
M=2L47KN)(S^&:DTCX<-<:HNM>*[]]4U#JL.<0Q>R@8SC/?-=IIMI;6EM_H\$
M<6\[FV+C)]35RLSRY;C418U"HH51T &*=110(**** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ JI!<227DT3$;4Z<5;IBQ(KEE4!CU(')H ?1110 4C9QQUI:0G R:
M *EE;O%N9SR3TJY3(I4F3<AR/6GT %%%% !1110 4444 (RAE*GH1@UP6HPB
M#4)D' SD5WU<3KN/[4?'H/Y"G'<Z<,_>:,ZBBBK.P*!]X44#[PH ]!M?^/9/
MI4U0VO\ Q[)]*FK,\N6X4444""BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 50M0W]H7!.<<_SJ_2
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MP3FYN["BBB@@**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@""
M[E:& NF,CU^E20L7A1CU90:<P5AA@"/>@  8'2@!:*** "@T4UP2A ZT "E6
M7*XQ7#:K_P A2X_WS78V,3Q0,KC!W$]<UQVJ_P#(4N/]\TX[G3AOB93HHHJS
ML"BBB@#>\-V<4LCSN,LA&T'M[UU/2N>\+_ZJ;ZC^M=#6;W."N_?84444&(44
M44 %%%% !1110 444R:58(7E;[J*6/X4!N/HK@O OB+5->U?43=.#;0LR*%S
MC((Q^E=[23N;XBA*A/V<MPHHHIF 4444 %%<OXA\;6N@:M;Z<UK-/--M/R'
M4$XR:Z:-_,B5]I7< <'J*+FLZ,X14Y+1[#J***#(**** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M;Z'8,?MEZZJ0IY"YZ_3BIOH>E6P4)5J<:6BDD]>G<V/#_C/3_$E]+;6*3$1
MDR,A"_G725A>%?#EOX;T>*VB4><R@ROCEF_^MFMVFO,X<1[+VC5'X0K-U77M
M,T55-_=QPEONJS $_05)J^HQ:3I5Q>RL%6)"1GN<<"O/O ^D_P#"4W=QXBUD
M&XW.1!&_11GKQWXQ0WT-</AXRA*M5=HK[V^QU-OX^\.W,RQ+?HI8X!<@#^=6
M_$]]'!X4OKE&#(UNVPCH<J<58U#P[I.J0B*[L870= !M_E7'_$J2'1_!L.FV
MO[M&955223M'!'ZT.]C2A3HU:T(TTT[ZW*7P[U72]"\,R7-_>0PO<R&0*S ,
M>W3\*[+3?&6AZK<K;VMZAE;A58@$_3FN2^'?@FW33H]5U.'S)I.8HY.D8SZ>
MO'ZU2^(4,%MXST62UC5+@RQ@A1@$;O:I5TCMJT:&)Q4X)OFUUZ:'K%9&J^)]
M(T5Q'>WD<<AYV;AN_*H?$VMMH7AJ6^; FV[4';>0?\*YGP!X:2YM1XAU5?M%
MY<DM&9#D(OT_.JOT/.HX>'LG6JOW5HK=6=':^-M O(I'CU"(>6I8JS ,0!DX
M&:T=)UFSUJV-Q92;X@<;JXKXFZ#IL>AR:K'%Y%W&0H:,8W D#!K9^'EK]D\%
M68( +!F/&/XC2N[V-:M"A]6]O3OJ[69=EU#0+SQ"MA-%!+J48^4NBEE YX/6
MK^JZQ9:+:?:;Z41Q9 R?6O-_!)_M?XCZKJ.<^4 P(/8@BI_C!>8MK"R4DF0L
MQ4#T*XHOI<U>!B\5##W>ROY:79VE]XNT738XVN;V-#(-P3<-V/7&:DTGQ1I&
MM2F*QNT>0#.S(S^6:P_!7@RVTS3H;R_3S]0D7<6D.[RP?X1[5RNK0BS^+EJN
MF@0LX!D"< Y8[OTHNQ0PN'J2G3@W>*;OTT/7J***H\H**** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BLVWUNRN)-@D"L>FX$9_2K
M=Q=P6T0DED55/0GO0!/167'K]C(^WS-ON0<?RJ^]Q$D/FM(!'_>[4 2T5E?V
M_8[]OF=^N#C^5:"7$3P^:K@Q_P!X=* ):*RY-?L4?;YF>>H!Q_*KT%U#<Q^9
M%(K+[4 345FSZ[90R;#(&/?:"<?I5FUOK>\7,,@;'4#M0!9HK/N=9L[5]CR
MMW R<4^TU2UO3MBD!;^[SF@"[152[U*VLSB60!O[O.:BM=8M+IPB288G !!!
M- &A15>ZOH+--TT@7/3WJI!KME,X02;2>FX$?TH TZ*AFN8;>/S)9%5?4U17
M7[%I OF8SW(./Y4 :E%1&XB$/FEU"8SNSQ6>WB"Q5]OF9]P#C^5 &K1445S#
M-#YJ2*4_O#I5"77K&*39YF[W )'\J -2BJ]M>P7<>^*0,!U]JKW&M6=LY1I
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M9)!N'51G-)::M:7C;8Y &[*<@T 7J*JW>H6UFN9I%![#N:@M];L[APBR88]
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M%K5M+CDMFF@41S1_,&4<_2JFA60O(S>WG[UWY7=SBGZIK<<L#6UF2\K_ "G
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M(_!(Z"@-;CM"TX7$0OKO$CR?=W<XK1O]*M[BV<! K@95@,8-9&C:F=.3['>
MJ%^ZV*O:CKUO';LD!\R5AA0M&@:W,_1;$WEU*]XQD\H[%!Z<'%;T^FVDT11H
ME ]0!D5S6E7TNEW3_:T;9,<[O0DUMW.OV<,)96WL1PJ\YH0.YBZ99276IRVU
MQ(7@MVP%/0_YQ73-I]JT7EF%-N.F*Y.PO+BPU![V>-O)G;) [5T;:]8K%O,N
M1Z#K0@9S_P!@E.KG3%E;R"0Y'MUKJ8].M8XA&(4QCTKD_M5U_:7]J+$0@(&/
M45T4>O6+P[S)C Y!ZT(;,;5K22ROHX;5S'%<D J/UK?M=,MH(%41*3CDD=:Y
MC4;R?4KP7%NA,4!RN1UK>M->M98 9&\MP,,K<<T(3,SQ#:'3VBN+-O+:0[2H
MZ5KZ=I,%O;J7422MRS,,UA:W>MK#I#9J2D1W%\=:U=.UV%H1'<YCF7@Y[T!T
M(M>LDM[?[9;?NI8^=R\9Z5-HVFQFV6ZN ))Y.26YQ5'6]46_C^QV@+ECAF[5
M+I&LK;PBTO,HZ<*3T(HZAT+NJZ7#);-+$H29/F5@,=*S] L1>JU[=GS7)PN[
MM4^J:W&T)M[4EY7XXZ"J6C:B=*+6MXI5"<JU'4.ANWFDVUU R^6JOCY6 Q@U
M@:%:OJ%Q+]K<R1P'"J?\^U:U[X@MH83Y)\R0C"A?6L/2+N72;AVN4/E3G.?2
M@#J9M-M9HC&T2X([#I7,V5C+<:FUC)(6MX3NVD]<]*W9M?LHHMX?<>RKR37/
M6MU<VM^=1DC/ER'!&.@H8(ZO^S[7RO+\E-N,8P*YF^L9(=42RBD*V\K;MN>E
M;O\ ;MB8/,\P=.G>N<N;VYNM0_M".,^5&V%&.HH8(ZN+3;6&(1K"F,<\=:YS
M6K5]/O(C9R&-;@[64<?YZULPZ_92P"1GVG'*G@@U@:K>3:M=H]K&WE0'()[T
M,$=-::5;6T(7RU9OXF(ZUCZ_:"R"75K^Z?.T[>]7K+7[::$"8^7*!\P/%9>M
M7_\ :K+;6BEE4Y9L=Z 5S5TG28H;59)E#S/\S,PSUIFL:9$+8W%NHCFCY!7B
MH=*UR-(%M[O*2IQST-,U;6DGB-I9@R2/P6'04:!J/T&Q6XM_M=U^\E?D%N<"
MKNI:7;S6CLJ!'0%@RC!Z5DZ)J?V",V=Z"I4_*QZ8J[J.NV_V=H8#YDKC: .>
MM =2AX?LVU#-S>-YFP[54]*WKG3K6:!E:%>G''2N<T:]DT<F&\5O+DY##M6U
M=:]:1V[%'WL1\H7GFA S&TVSDO-2-O<2&2&VR I-=*^G6KQE#"F,8^Z*Y.QO
M+C3[W[7/&?*F.6P.E=$^O6*P>8),C' '7\J$#,0V4@UO^S1*WV7[^S/;K72K
MI]JL>P0IM],5R9OKHZH-5\H^7G&WVKHUUZQ:'S/,P/0\&A [F#J-E);ZNEG;
M2%(K@\J#P.:Z2VTRUMX1&(E/')(Y-<Q>W5Q?:DM];1GRX.F1UK>M=?M)H07?
M8X'S*WK0ALS-<M_[.F66S/E>9\A"]\UK:=I4$%JN^-6D(^9B,YK"U>];5KA4
MM%)CC^;<1U(K4TW7H&@6*XS',O!ST- :D>NV*6MJ;VU_=RQ\_+QFGZ)8)/;"
M\N@)9Y.26YQ536=4&I1FQLP6W?>;L*71=5%C#]BO 49/NL>AHZAT-'5=+@FM
M'=%"2("RL!@\5G:#9'4 ;R[/F;3L4'VJUJ>N0&W>"W_>2N-H Y'-9^CWS:03
M!=J1&_S!@.AH%T.@N=,M;B%D,2@D<$#H:Y[3;22]U)X;J0R0V_"J>E:]WK]I
M# 3&^^0CY .>:PK"]GTZ^-S<1DQ3\M@=* 5SJ7TVT>(QF%-N,#CI7,0V4KZR
M^G><QM5^;;FMZ37K%(3()-W' '7\JYR*\NH]4;4S$1$W&SVH8T=:NGVJQ^6(
M$"^F*YJ^M)(-56QMI"D-R<E >!S6XNNV+0^9YG&.AZUSEY<W%[?_ &^"-A'#
M]W/<4,2.JM],M8(1&L2GCDD=:PM<M'T^1)[)C$)3L8+Q6G;:_:30AG;8X'S*
M>,5B:QJ$FK.([-&,<7S;B.IH8*YOZ?I=O#;(6C5G899B,YK-\0V*VEN+VU/E
M2*0OR\9JSIVNP-;*EP?+E088'BJ&MZD-4A^Q6:ECG<6QP* ZFAHVF1BU6XG
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M!14\AX28?C23C=B4=Z (+NSMYO+5XQGU%!M(+4!8HP/4U8;$D ?^)>*23$D
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MS2386-0?O&@!6Q';A.[<TDF(X @ZMR:,8MLMR>U##%M\W4]* %C BA+]2>E
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M:;;@9:0_PTL0_=LS?='2DMP2Y_N]Z '1'!>8]NE,A422ECTZU)%AIF/\ J)
M6GPO3- $BXDG+'HE,)\V?VS3\;KC"=!UJ.3F;"4 2/B2=4'1:9,V^0*.@XI\
MH_>(J_>[TVXP' '4=: '2@#9$/QIMP0-L8[4Z7Y8T!^^:2<!40?Q=Z !_P!U
M %'5NM++B*%4'?FDZ6^7ZGI0XVVXW_>/2@!4Q%;EN[<4#]U;YZEJ2(?NF9N1
MCC-*@_<EG_"@!( %1I#VXI8L*C3'KT%-MP3DG[O>G0C)9S]P=J &0+N<L>@I
M\9#RM(?X:CA!:7 Z=ZD0;ISM^[WH 8@\V?GIFG\2W'H%J/&Z?"<<U(PS.%7\
M: &.?-GV]!G%/E&Z18AT'6F2_P"N 3J*?,,%%'WSUH ;.V7"#H.*=+A(UC'4
M]:2XP"H'W@.:'&(1G[QZ4 $Y"(L8[=:5<16^>[4DP"PKN^\:(QB!F?D=J %_
MU5OZEJ2 !$:0_A2J,6[,W?IFDMQD,3]T4 +$0D;2GJW%-MURY<]N:=",AV/W
M.U,@!:4XZ=Z 'QD-(\IID8\V?)IZ#=.V/N5&,M/\E $G$MQG^%:8Y\Z?TI[C
M-P%3\:9+_K\)^E #Y,/*L0Z"FSG=($'0<4Z489%7[]-N,!@!UH =+@(D0[TD
MY"*L8_&E<;8%_OGI23 +$H/WCS0 IQ'; #JU(^(K<+W;DTJC%L2WX4F-ML2W
M)/2@ CQ'"7/4]*<J^7 7_B:FPC]V6;[HI8\^2Q;[O84 -MP 6D/:G18P\I_"
MFVPRY/\ ".M.B^9W/\ H 9"HDE+'MS3TQ+.6/1>E,B!:;Y>F?TIX&ZXPO '6
M@!@_?3Y[9I[8EG"#HM,;F<A/7'%/D&)55/O#K0 R9O,EP.G2GR@92%>U,GP)
M %ZT^7*H@_CH ;<,,J@Z"G2?NX50=339P%55_BZFE88MP6^\>E !*1'"L8[\
MT+^ZMRW<T.-ML-WWC2Q#$+._3H,T )Q%;^[4081&E/44(/\ 1RS_ (46PSN)
M^Y0 L7R1M*>IZ4VW +EST'-.A_B9ON"F0C=*<?=[T /B(:1I3_#TIB#S9\GI
MFGQ\W!Q]P=:C W3D)QS0!)Q+<^R5&Y\V;';.*D?FX"I]#4<O^MPO4<4 22X:
M1(QT7K39Y/G"@<+Q3IA@HH^_WHG*@J#U YH 0 O:X7J#S1;\HZCKBJ]IJ%M+
M-(J3+],T[S4AEWLX5<]2: )X1F)T_BIML0)2#UQ5=-2M'O"$G3\ZED=5FWA@
M%SUH EA!65E/4TR,>7< -4$FIV8N@HG3.,9S5BYD1W5E8$=S0 X#9=?-WZ&H
MV!2?+>M07.I6BE%,Z;A[U/++'*BNCAACJ* )7^6X1S]WUIER/WN[L>]5Y]0M
M8K<)),N_/3-3">*>V4QR*_T- $DPRL;C[H'-)< E58=*@:]MX+=A+,H.?ND\
MTZ"ZAGM3LE5CV - $S?/:KM_AZT2 M;(5[=:@2ZAM@QFD51Z$TEG?6TPD"2J
M?09H GC^:!E'44JC=:E1U'6H4GC@DW22!%]S3+;4+66Y94F7\^M %BV/#KW(
MI8 <.G\50F18YM[.%7/4U%_:5HUX%2= <\G/6@"Q;G;,0>.U/B&RX8-U.<5%
M,Z^:7##;ZU#/J=IYL:B==W<YH G V3X;UJ1QMNE9NA[U'.Z.0R,&&.HJ"XU*
MU2-$>==X]Z )Y@5FR>14D_WT?^&HVFCG@1HW5_<&HI;^V@M]LLRAL],\T 3W
M(.5;L13I/F@4CH.M0Q7,-Q:#9(KG/0&F_;(+>-A+*J^@)H GF!:)&'0#F@#?
M:D+VJ&TO()X&"2J?;-+'<Q6[$RRJBX[F@"8C=:C;_#UI(?FA=1]XU!9W]K+(
MZK,F/3/6G)*D,NYW"+ZDT 31 F%T'WA3;;AV4]2,5#;ZE:27A5)T_/KS3Y75
M9B^X!?6@"6$8>1#P2*BC^28!NQJ%]3M#=*JSIGOS4T[*S;E8$>HH E^Y=$MT
M/2HY 5GR?6H+G4K1%1&G0O\ 7I5B26.:)&1P_')% #KC =7;&P^M)<#YPX^Z
M>F*HZC>6Z6/EM,N_/ STJ>VGBFTZ,+(K$#H#TH L3#=$K#H*+CYD5QTZ5!]M
MM[>%Q-*HXX!-+;7<$]LPCE5O;- $V"]KA>QYI)5,EF0M1I<Q6^\RRJ@QT)IE
MIJ%M)YFV92,=,T &GQ,EI)&<!B<UR%]S=3@==QKK8+N($R%PBCN:XV]O()-6
MFV2#!8XYIQW.G#?$R*+J1WI8^-R]ZC9E5MV0!ZTTW<!G $BY^M:'621_+)S3
MAQ*0>],D8;MP/'K4<MW &4>8N?K0!TOASY96)]:Z23Y;A6/W37-:"ZNK,I!&
M.HK:N-1M8X0CS+O],UD]S@K?&3S@K-D]#R*?,,K&_P##49FBFMT*2*_'8U$]
M_;06[)+,H/89H,BQ<@G:X^Z12N-]LA7H.M0PW4-Q:$)*K'L :074%O&_G2JH
M]": )I1NMU(Z#K2Q_-;%1U'6J]G>V\\<@253Z#-.2XBMV+2R*B^YH E WVN!
MU!Y%%ORK*.N*KVNH6TL[A)EY[9I_F)%+N9PJYZF@":$'8Z?Q4RW.V7!X.*@7
M4K1[[:DZ=>N:EE=1*7# +GKVH EB!25E/4U&@V3C=ZU#-J5F;E5^T)N[G-3W
M+HSAD8$8ZT 2'Y+L%NA[U%("D^6]:@N-2M%1$:="X]ZGDECFA5D=7]Q0!)-Q
M(C_PTVX!WANQ%037]M#;;99EW9Z9J1+F*>T'ER*YST!H EE^:)&'0=:2<%HT
M8=*@-Y;V\+":51_LD\TMM=P3V[A)5;V!H G^]:X';J*"-UJN.W45%%<PV[$S
M2J@_VC4=G?VLSNJ3+],]: +$/S0NHZXI8\F!E'4=:A65(90[N$7/4TR#4;22
M[94G3\^M $]L<.PZ$C%.A!#.AX:H7=4EWE@JYZFHFU.T:Z55G3(ZG- %B'Y)
ML-UZ4]!LNCN[U',R&3>K @\YJ"YU*T5XU\]=W?F@"<@I/\WK4L@VW*L?NFHI
MI4E561PPQU!J&?4;6.%4DF7=Z9Z4 3W"D29/0T^?D(XY6HS-'/;(8Y%?Z&HW
MOK:" K+,H/H3S0!/<@G:PZ8I7&ZV4KR!UJ&"Z@N+3"2JQST!I%NX+='$LJKQ
MT)H FE&Z%&'0"A?GMB!U':H+.]MYX7595/MFG)/';L6ED5%QW- $WWK; [=1
M26_*2*.I'%065_:S3LJ3*?;/6G"1(I=S.%7U- $L8)B=!]ZDM^)"#P35>+4K
M1[W"3I^?6I9'59=P8 =<T 2PC;,ZGJ>E1I\D^&]:@FU.T^U(HG3/<YJ>=U<A
MD8$8ZB@"3&RZ);H>AJ.0%9N?6H;C4K1!&K3H7^O2IY98Y8T:-PXQR10 ^;_6
MJ_\ ":;<@B0-V-03:A:Q0!9)UW>F>E2+<13VJ[)%<CT- $DPW1JPZ"BX&Y58
M=,5";VWMX'$TJKQP":+6[@GMF"2JWH,T 3$;[7Y>QYI7&^W!7MUJ!+F&W#>=
M(JC'0FDLKZVF+A)E(],T 3P_- ZCK3H^;5U ^;TJ!)8X'W2.$'O4<&HVLEV0
MDZ?G0!8MS]Y>YIT (\Q.C&H6D5)=VX*N>IJ-M2LVO0%G3/KF@">#Y9\&GH"E
MPP;J>E13.N_>K#;ZU%/J5IYJ)YZ;NYSTH F_U=P-WK4DGRW*L>AIEPZ.$=&!
MXYQ4%SJ-K'$J/,N_Z]* )YP5G+'H3FGSC.Q_X:C,\<]NC)(K\=C44E];PV[+
M+,H/89H GN020PZ$<4Y@7M5V]NM0Q7,-Q:?NY%8^@-(MU#;JQFE51Z$T 32#
M?;J5[=:6+YK=E'6J]G>V\PD"3*<]LTY)HX'+22!%]S0!+&"UJ5'4')HMOXE[
MD56MM1M9+EU2=?SZU(9%CEWEPJYZF@":$':Z?Q4R#Y9^:@&I6CWN%G3.>3FI
M9G7S2X8;?6@"6,%)RK=3WJ-1LG^;UJ"?4K3SD47";O7-3SR)(0Z,&&.HH D8
M;;I6/3UIDP*S9/0\U7N=1M8XT1IEW@^M3M-'- A1U?Z4 22_>C?^'%-N =P;
ML14$E_;0VQ669<YZ9YJ6.>*>R!217.>QH DD&ZW0CD#K1.-T2,.@'-0?:X+>
M)A-*J^Q-%I>6\\+A)5/MF@"8?/;$+U%*?FM0!U7K4,=S%;L3+(J+CG)IEG?V
MLTCJDR_3/6@"Q!\T<BCJ12Q F%D'WA4*RI#+O=PBYZFHXM2M)+PA)T'KSUH
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M(.YB!_GTK<T[4X+V %6PX'S*>U :F'K.F_V4OVRR)1<_,@Z58TG1H[J);N]
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MY;DEE)[YH#6Q=O- M)(";>-89%&5916-IUK/JMV\%TQ$<'##^\<UTM]J,%G
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M<=*L44Q&7'H%DC[MA/H"<U>DM()8/):-2F,8P*FHH RO^$?L=V=AQZ9J^EI
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH AN93#"7 SCWQ3XFWQ(_]X T21K*NUNE.50JA1T Q0 M%%%
M!0>:*:^=AQUH %4*#C^=<-JO_(4N/]\UV%CO\AO,!!W'J,<5Q^JG_B:7'^^:
M<=SIPWQ,IT49HS6AV!11FC- '3>%_P#53?4?UKH:Y[PO_JIOJ/ZUT-9'GUOC
M84444&04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
=HH **** "BBB@ HHHH **** "BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>img268224062_5.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img268224062_5.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" +4"#0# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BJEO>B>ZEAV8V=\]>:MT %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'B?BWXJ^(
M]$\6:EIMHMB;>WEV)YD+%L8!Y.[WK&_X73XL_N:;_P" [?\ Q5>GZM\*_#>M
M:M<ZE=B\^T7#[WV3X&<8X&/:O!?%NF6VB^+-2TVTW_9[:79'O;<<8!Y/XUT0
MY):6..I[2&MSJ_\ A=/BS^YIO_@.W_Q5>O\ @'7KSQ+X0M=4OQ$+B5Y%;RE*
MKA7('!)["O/O ?PT\/>(_"5KJ=^+O[1*SAO+FVCAB!QBO5- T*R\-Z1%IFG^
M9]FC9F7S&W-EB2>?J:BHX[(THJ>\GH:=%0W5U;V5L]Q=3QP0H,M)(P50/<FN
M(OOC#X3LYC''/=7>#@M;PY7\V(K-1;V-I2C'=G>T5R.C?$SPMK<J0Q:A]GG?
M[L=TOEDGTSTS^-==UH::W&I)[')_$?5K_1/!5U?:;<&WND>,+(%#8!8 \$$=
M*\U\ ^/?$^L>-=/L-0U9Y[64OOC,48SA21R%!ZBN]^+G_).[[_KI%_Z&*\?^
M%W_)1=*^K_\ H#5M!+D9S59-54DSZ9HHK.UC7M*T"V%QJM]#:QGA=YY;Z*.3
M^ K ZF[;FC17G<WQI\*Q2E%74)0/XT@&#^; UT&A^/?#?B&806.I)]H/2&4&
M-C],]?PJG&2Z$*I%NR9TE%%8NN>+=#\-20QZO?"V>8%HP8G;('7[H-2E?8IM
M+5FU17.KXY\-OH<NLKJ:&PCD\HR%&4E\9VA2 2?H*K>&?B'H?BO4)+'3Q=+.
MB%\31;05!QD$$^HZXI\K%SQO:YU=%,EFC@B>6:1(XT&6=V "CU)-</J/Q>\)
MV$QB2XN+L@X+6T65'XDC/X4*+>P2DH[L[NBN5T#XB>&_$4ZV]I?>5<M]V"X7
MRV;V'8GV!IU_\1?"FF7\UE>:L(KF!MDB>1(=I],A<4<KVL'/&U[G4455TW4K
M35].AO[&;SK6==T<FTKN&<=" :Q=5\?>&-$U&2PU'5!!=1X+Q^3(V,C(Y"D4
M6;T&Y)*[9TE%8D?B_0)-"_MH:G$NG%BHF<,F6!P0 0"3[ 5S#?&;PF+GR@;Y
MDSCS1!\OUZY_2FHM]!.<5NST*BJ&D:WINO60N]+O([F$G!*'E3Z$'D'V-7ZD
MI.X44V22.&-I)75(U&69C@ >I-<7J?Q8\):;(T8O9+MUX(M8]X_!C@'\#32;
MV)<E'=G;45P-E\8O"5W+LDFNK7D#=/!Q_P".DUVUE?VFI6JW-E<Q7$#_ '9(
MG# _B*'%K<(SC+9EBBBJ]]?VFFVCW5]<Q6\"#+22L% _.D46**X"\^,?A.UF
MV1RW=T/[\$''_CQ!J[I/Q1\*:O*D2WYM97Z)=)Y?/IG[OZU7)+L1[2&USLJ*
M0$, 000>012U)84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!DZ=_R%
M+K\?YUK5DZ=_R%+K\?YUK4 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M;7K);R.&"T@<;HVNW*%QZ@ $_F!6?X!TR#5_&^EVERH:$R;W4]&VC./TKZE
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M<_Y*)>_]<HO_ $&O1_@E_P B;<?]?;_R%><?%S_DHE[_ -<HO_0:<?XC%/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_3)KC3+V&)2^YY+=U4?(W4D8I0?N,=5?O4=Y\;M*DN_#MEJ4:[A93$28[*X
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M@]2QXI^K^$=8TS5KFQ33[VY6!]GG16KE7XZCCI3A%1ZZDU)RJ*]M#Z"^&O\
MR3K1?^N!_P#0C7BGQ7_Y*+J/^['_ .@"O;OAW!+;> -'AGBDBE6$ADD4JR_,
M>H/(KQWXGZ1J=UX_U":WTV]FB98\/%;NRGY!W Q6=/XV:U5^[1Z;\'O^2>6W
M_7>7_P!"-=+XJ_Y%+5_^O.7_ -!-<_\ ":VN+3P%;PW,$L$HFE)25"C#YCV-
M=%XGC>7PKJL<:,[M:2A549).T\ 5$OC-H_PUZ'RSH7_(?TS_ *^XO_0Q7U%X
MLTIM;\*:GIT8S)- PC![N.5_4"OFW1-"UA-<TUWTC4%5;J(EFM9  -XY/%?5
M=:57JFC'#K1IGR)I=_<:'K=K?1J1/:3A]C<<J>5/ZBOJ/P_XGTKQ+81W6GW2
M.6'S0EAOC/<$5Y]\1?A;+JEY+K.@JGVF3YI[4G&\_P!Y3Z^HKQR[T_4]'G9;
MNUNK.13@ET9/U[U32J(A.5%V:T/K#4M6T_2+9KG4+R&VB49)D8#\AWK*\-^-
M=$\5*XTVZS,A.Z"0;7QZX[BOF"&&^U.0)#'<W;@@ (&D(/ZUZE\/OA;J:ZG;
MZQK7F64<#!XH%?$CGMG'W1[=34.G&*U9I&M*<M%H>A_$?29-8\"ZC;PKNEC4
M3(H[E#G^6:^>O"FLQ:!XEL]1G@6:W1MLT;*#E#P< ]QU_"OK"O$?'_PHNH[R
M;5/#D/G02$O)9KPT9[E/4>W:BG)?"PKP;:G$]6TM_#^LV:76G1V%Q"PR"D:G
M'U&.#6?XAUSPIX8M_,U%+,/G"PQQ*TC?\!%?,\T5]IDICF2YM).ZN&C)_E4]
MAI&K:W.JV-E=7<C\!E0L/Q;H/SJO9+N1]8>R6I]-Z+?>&?$-L+C2Q8W"]2JQ
M*&7ZKC(K>  & , 5YU\-OAR?"^[5-397U.1-JHARL*GJ,]R?6O1:QE:^ATPN
MU=H****DL**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#)T[_ )"EU^/\ZUJR
M=._Y"EU^/\ZUJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ K%\6ZVGA[PM?ZDQ >*(B,>KGA1^9%;5>8_%W3_$&MP6&F:1I
MEQ<VRDSS/&1C=T4<D=.3^(JHJ[U(J-J+:/#]/LKG6=6@LX/GN;J4("W=F/4_
MSKT3_A1OB#_H):9_WU)_\36E\*O >J:=XDEU36M/DM1;18@$N/F=N,C!/09_
M,5[16LZC3LCGI4$U>1X+_P *-\0?]!+3/^^I/_B:X7Q'H%YX9UJ;2[THTT85
MM\>=K@C((S^7X5]:5Y9\7?!M_KK6&HZ19O<W4>89DCQDIU!Y/8Y_.B%5MV8Z
ME!*-XG0_##7O[<\$VGF-NN+3_1I.>?E^Z?RQ^5<[\<K%YO#^FWJ@E;>X*-CM
MO'_V-4OA-HWB7P[K=U;ZCI%S!8W463(Y7:KKTZ'N"17JFKZ5::WI-SIM['OM
MYTVL.X]"/<'!J&U&=T:).=.SW/GWX5>)K/PWXFD_M"016MW%Y1E/1&!!!/MU
M'XU[CJ_C+0='TV2]FU.V<*I*)'*&9SV  KPKQ'\+_$6B7;BVM)-0L\DI- ,G
M'^TO4&N=M_"^NW$HCAT34"YZ VSK^I K648R=[F$:DZ:Y;%*XDEU"_ED529;
MB4D*.I+'@?K7UOI=K]BTBSM?^>,"1_DH%>5?#OX67-AJ$6LZ^BH\)W06F0Q#
M=F;MQV%>P5G5DGHC6A!Q3;ZGS%\3/^2C:S_UT3_T6M>T?"?_ ))WI_UD_P#0
MC7FOC[P5XEU/QSJE[9:-<3VTKJ4D7;A@$4=SZ@UZI\.--O=)\$65GJ%N]O<H
M7W1OC(RQ(Z54VN1$TDU4;/)?C%H<NG^+SJ00_9K] P?'&]1@C^1K7^%/Q L=
M*L3H6L3""(.7MIW^Z,]58]N>0:]:\0:!8>)=(ETW4(]T3\JP^]&W9@?45X#X
MA^%?B/1;A_LUJVH6N?EEMQDX]UZ@_G1&491Y6*<90GSQ/>[OQ3H-C:FYN-7L
MUB SD3!B?H!R:^>/B!XM'B_Q$;J%62S@3RK=6ZE<Y+'W)_3%9$'A?7;B810Z
M'J!<] ;9U_4C%>B^#O@[>3W,=YXD @MD.X6BMEY/9B.@_6FHQAK<F4IU?=2.
MH^#6A2:9X6EU"="LFH2!T!'/EKPI_')/TQ7G/Q@_Y*%<?]<(OY5]&1HD4:QQ
MJ%10%50,  =J\.^)O@_Q#K'C6>\T[2;BYMFAC42)MP2!SU-3"5YW9I5A:FHH
MZGX)?\B;<?\ 7V_\A7G'Q<_Y*)>_]<HO_0:]5^$^C:EH?A::VU.SDM9FN6<)
M)C)&!SP:X7XE>#O$6K^-[J\T_2+BXMGCC"R)MP2%YZFG%KVC%.+]DE8[;X-?
M\D_B_P"OF7^==AKO_(O:E_UZR_\ H!KF_A;I-_HO@R.TU*U>VN!/(QC?&<$\
M'BNGU>*2?1;^&)2\DEO(J*.I)4@"LY?$;07N(^2],_Y"5E_UWC_]"%?8"_='
MTKYDT_X?>+8K^T=]!NE5)49B=O !&>]?3:\*/I5UFG:QEADU>YY+\=_^03HW
M_7Q)_P"@UA_ W_D9-2_Z]1_Z%76_&#0-5U[3=+CTJQENWBG=G$>/E!7 /)K)
M^$7A?7-"UZ_GU33)K6*2W"JTF,$[NG!IIKV=A.+]M<A^._W]$^DO_LM0_ C_
M (_]:_ZY1?S:MGXP^'=8UYM).E:?-=^5YGF>7CY<[<=3[5'\'_#>LZ#>:J^J
MZ=-:++'&(S)CYB"V>A]Z+KV=@Y7[:YZO7RAXP_Y'36_^OZ;_ -"-?5]?./B?
MP)XIO/%6K7-MHES)!+=RO&Z[<,I8D'K2HM)NY6(3:5CVOP!_R(.B?]>JU3^*
M/_)-]8_W(_\ T8E:7@RSN-/\&Z3:7<+0W$5NJR1MU4^E5OB%I]WJG@75+*Q@
M>>YE5 D28RV)%)Z^P-0OC-&OW=O(\#^'?_)0-%_Z^/Z&OH[Q)9-J7AC5+).6
MGM9(Q]2IKQ#P1X(\3:=XTTJ\O-%N8;>*;=)(VW"C!]Z^@ZNJ_>31GAXOE:9\
M@:;>/INJVMYL)>WF60J?8\BOJ/3O%^@:EIJ7T.JVJQ,N2))0K)Z@@\Y%>8^/
M_A1>/J$^K>'HA-',2\MH#AE8]2G8@^E>9S>&=<AE,<FB:@''7_17/Z@5;4:B
MO<RBYTFU8Z'XG^)+3Q+XM,U@_F6EM"($D[.0221[9./PKTOX*6+V_@^>Z=2/
MM-TQ7/=5 &?SS^5>>>&?A5KVM7D9O[9].L0<R22C#D>BKZ_6OH33["VTO3X+
M&TC$=O @2-1V J:DDH\J+HQDY.<CQ'XY_P#(RZ9_UZ'_ -"K<^!/_(*UC_KX
M3_T&HOB[X7US7=>L)]+TR:[BCMBKM'C .[..36M\'] U70=.U2/5;&6T>69&
M028^8!?8T-KV=@47[:YZ2WW3]*^/M1_Y"%Y_UVD_]"-?8+<J?I7S'??#[Q=)
M>W3IH-TRO*Y4@KR"3CO2HM*]QXE-VL?1.G_\BM;?]>2_^@5\F3?ZV3_>/\Z^
MM[*"6/P];P.A$JVJH4/4-MQBOFZ7X>>+S(Y&@7>"QQRO^-.DTKBQ$6TK(^EM
M*_Y ]C_U[Q_^@BOE3Q)_R-&L?]?L_P#Z&U?5NG1O%I=I'(I5TA164]B%&:^=
M-=\!>*[GQ!J<\.A73Q2W<KHPVX92Y(/7TI4FDW<>(3:5CWCP;_R)FC_]>D?\
MJOZQIL.L:/=Z=.,QW,31GVR.M5?"]M/9>%M+MKF-HIXK9$=&ZJ0.16O63W-T
MO=LSY#ECO-"UEX][0WEG,5##@JRGJ*N^%]%E\3^*+33OF(GDW3-Z(.6/^?6M
MSXKM8O\ $"]^Q<L%03XZ>9CG'X8S[YKN_@IX<^S:;<Z_.G[RZ/E09'1 >3^)
M_E74Y6C<X8T[U.4]5AACMX(X8E"1QJ%51T ' %/HHKD/0"BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** ,G3O\ D*77X_SK
M6K)T[_D*77X_SK6H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#)T[_ )"E
MU^/\ZUJR=._Y"EU^/\ZUJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_P!\T?VQ:_[?_?- &A16?_;%K_M_]\T?VQ:_[?\ WS0!H45G_P!L6O\ M_\
M?-']L6O^W_WS0!H45G_VQ:_[?_?-']L6O^W_ -\T :%%9_\ ;%K_ +?_ 'S1
M_;%K_M_]\T :%%9_]L6O^W_WS1_;%K_M_P#?- &A16?_ &Q:_P"W_P!\T?VQ
M:_[?_?- &A16?_;%K_M_]\T?VQ:_[?\ WS0!H57OX_-L95[[<C\.:K_VQ:_[
M?_?-!U>T((^?G_9H P*FM[=IW(R%11EF/0"HCC)QTSQ5H';I3%?XY<-] .*
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M>*?E4U% $/V2W_YXI^5'V2W_ .>*?E4U% $/V2W_ .>*?E1]DM_^>*?E4U%
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MHYYA;P-*P)"C) J2JNI?\@^;Z?UH EMYEN(%E4$!NQJ6JFF?\@Z'Z'^9JW0
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MMOO+YJCOC/\ *@#7HK*365!Q/"R'VJY%?VLOW9E!]&XH LT4 Y&110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !659?\ (9NOH?YB
MM6J5O9R0W\T[,I63. .O6@"[1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 55U+_D'S?3^M6JANX6GM9(E(#,,#/2@"+3/
M^0=#]#_,U;J"SA:WM8XG(++G..G6IZ "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** ,G3O^0I=?C_.M:LG3O^0I=?C_ #K6H **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHKFIO&^E6GBB;0KTO:R(JE;B7 B=F&0N<\'ZXII-[ =+6-=^)=
M-BEU&SANXGU"R@:9[?/S8 S^/;..F:\J'C'6]/U_4+VWOS<1&[F7[-.VZ)D5
MRH Q]W@=1^M<5J&J'5M1DN-17RI);AY9PI(V[@0.?[O05M'#R>XM2>'4[;6M
M7CFU[4&S<9:XN1#YS)P2%5><#.!QTK;B\575COTO1M8U"YLIHV5UU&%=H7!!
M"\E@#GOC&*XY&*RR)%$[0+@JW&<?3O2!Q<.6CF"1*I#2#W'0?A7:Z4)*_P"
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 ,>*.48=%;ZBJDNDVLGW5*'_9-7J* ,@Z7<P<VUR?H>*/M6I6W
M^MAWJ.^/ZBM>B@#,CUF$G$L;H?SJ[%=V\WW)5)],X-+);PS?ZR-6^HJG+H]N
M_*%D/L<B@#1HK(^P7UOS!<;AZ$X_G1]OOK?B>WW#UQB@#7HK/BUBV?APT9]Q
MD5<CN(91^[D5OH: )**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I ZEBH8$
MCJ :6LJR_P"0S=_0_P Q0!JT444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %(2%&20!ZFEJKJ7_ "#IOI_6@"R"&&001ZBE
MJIIG_(.A^A_F:MT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 9.G?\A2Z_'^=:U9.G?\ (4NOQ_G6M0 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%<UXV\4?\
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M#5.3182<Q2.A_.M.B@#(^S:E;?ZJ;S%';/\ C0-4N83BYMC]1Q6O00",$9H
MHQ:M:R=6*'_:%6TECD&4=6'L:AEL+67[T*@^J\53?1@#N@F9#Z&@#5HK(V:I
M;?=;S5'X_P#UZ5=7>,[;BW93ZCC^= &M15.+4[67_EIM/HPQ5M65QE6##U!H
M 6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ K.M+>6/5+B5D(1LX/KR*T:* "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ JO?1O+92HB[F(X'XU8H
MH K6$;Q6422+M8 Y'XU9HHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH *1E5AAE!'H12T4 5)=,M9?^
M6>T^JG%5&T>2,[K>X*GWX_E6M10!D;]5MOO*)5_/_P"O3DUD [9X60]\5JTU
MXTD&'16'N,T 01:A:R_=E4'T;BK(((R#D51ETFUDY52A_P!DU6.EW,)S;7)'
ML3B@#7HK(^TZG;?ZV'S%'?'^%21ZU$>)8V0^W- &G14$5Y;S?<E4GT)P:GH
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M]L]_I5<H1<+(3(03C> =S9[XYSCKSVI\VZ>:1!.4<%=H)R.F>E3LK;U=7VL
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MB@!EI,9[6.4CDCFIJ9#$D$2QIG:O3)I] !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %(2%!)( '))[4M>43_$B86.O:9KMMY4RK<0Q36R$A2 5"N,D@Y_B''/:
MJC%RV$W8]0M[VUN[<W%O<Q2PC.9$<,HQUY%>3>+?B38:WX-O;.)9;.ZFD14A
M<Y:>$MDLI'J!@CMFN+2[N+&QFCTV\DLVN(?*E\L_*X(P<KT_'K6,MX1*4DMU
MD9D$(3@X/;\*ZHX9IW8-,TM*U:VM7G:]T2.^5XPD(FG,8B/.3A<YSQZ=*@DN
MX[B*[C"_886VJMO9L^W)Y^ZQ.2367&[PHX+B38[+L53V..#_ (T@=-HF:,RS
M2MB),XQV%=,HP:YEN&CU'@BVM9_/'[^8>6I)SC\>U2LSM TH=&0<,8V)9/S'
M-1L[ +YJD&$[=A.69_?^E.8M#:2D_-+(/FQZG@ 5<4]XC7D*S1Q1A "V%X0#
M)Q3#&L?ERA#&#]UXFR!^72D@FDAD$4+20LPRY/+<>_I2MF-VQ<3%F.X@ ,2?
MKBJ;;UZ!N2+<W)P@NS($+,D<HX3=C) XQG K5O?$EYJ.F:7HQ@(@T^$JH$N5
M:0D_.W Q@' './QK&2)A=!WD+/LRP)SC/0$^O%2K$TDQ2*01NREP2?O$=!4.
M$7'F:V%;2YW^C>*->DO]"LUU!88(YK>V6WMXPJ%<JIW9R6XR>M>WU\I_VE-;
MW4*K-);3POYFY7VD8!P01]:ZWPIXHM-"O[C6+AY[J58C!#;K*2TTC88EB3PJ
M@#D]VXSBN2M0ZQ#1;'O]%>:Z1\7(;J[2/5-*-E Y"B>*?S0A/]X;5('N,UZ2
M"& (.0>017+.$H.TD,6BBBI **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J"UO;6]1GM;F*=48J
MQC<, 1V.*\WD^*,FE>(]9TG7K4Q103.EM-;H=RK_  ;QG)RI4Y'KTKR/3]7O
M-(3SM+O9;.9XMK-"< @CN.A_I713PTII]#BK8V%-I;]'Y'J7BKXH:9?^%M?L
M+>22TO03!;DG/VA-^UF0CIQN_2O)]#U:ST^YDDOM$CU&(Q;(XY9C&J-D?-QU
MX&,5FI<&-@KH'VIL Z_0BH_FC9P64E3]T _H:Z%345:+W.25:4Y)S6JV-:75
M1.URL,2Z=;O'@P6;N%;=D'(8G)( 'X5DJ1 DC2 EF78">HIFY2/,92Q)PJU(
MVY1ME4J8_O G))_PJE9+0B2;DTWN.^8QE@R,!U"GD4GRJH49/' ')- )1'<_
M>(_+VID3O$RA"R,>IZG\*=T"4K,78%4.%*!NZ-W]P*E^UW1@2W^U.T*,9$B?
M[H8@ L!ZX J-B0Y8RN6;D]R:-IWHS.2V"2#S@=J7H.[ZF[>>*[V[\,Z9X=$1
M6VLRTCE9,B9R<J2,< 9X'//-;VF>-/$26^DZ;9WJVT%N\4216Z#Y_F ^8G).
M<_2N&$>^3:KA"P/)]J>EY/:S1F.1X9XW#JZ-@@CG(/UH48J+YE_PXI3FYKE=
MMK^A]@T5\V^#_%$&DZT^N:I=W-P;:-MD(E+O/(XP!R>@&XD]N*[O2_C;;7%X
MJ:EH[VEJW!GBG\W9[LNT<?3-<<J,D[+4]*&*@TG+2_<]7HIL<B2QK)&P9' 9
M6'0@]Z=6)TA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &3IW_(4NOQ_G6M
M63IW_(4NOQ_G6M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 >??%3Q#I5OX;N]#F(FO[M%"1!<^7EN'8_P]
M#CO7B2B**8F;/DNC*?121@'\N*ZKXCI<CQ5>W6H1R6RS702T5A_K@BJ"W^Z!
MCZEO:N3G4.-CDA"K$X[D*2!7HX>$?9-B5FFR,.S_ .C2* 60@D-^&<4\QY@8
M22#?DL7]&SG-1H$D<^?$%9PNW/.<#G!_I4WDJH78 "K;AN&03[CO77&[5RE=
MZC8KCS H96#'C.T[2?8TZ7S,J$^[GYL$9_#/%+=W4TJ,6BV$*?F0\?A2!PDI
MB9]W/R/C&\?XTU*ZY6._1B)O%NT\)D!5P[$\L,<$?ADU['\&5 TG5#DL6N%)
M8G))VUX_M(W[)&02##A3PU>P_!IE.DZH%(XG4$#M\M<V)A:FV_(5K'GWC\$_
M$#5/+#@"4;R>A^4=!7-7&YRJ>467J6X./PR*[#QY:P#QEJLD]ZT),H( QC[H
M]LFN121SYF%:1$./,1>OOCJ*NE*/(HO0/(CW HSL9F1&VF-MJY/8<=N:DC"P
MQ_,57))/. ">PJ!VS,)@"(D(#9R,^_X5*Q9+J&>$HS<_(V"' !./T_E5WY4Y
M;V%>VHU8P\\DFPF)UPQ8<$CIC]:<AM=A_>SNQ'R[#G9[^XJ6^O+B[M\K%&B'
M!8!B2R_7'%)&P(VXVD8^7V[$>U"7-H]&/K86,EHU+#!(YJ'?@;V:0SQY?R^B
MG'IZBIED1R0K D=J;]F\R3S!<F)EY#,1M'L15SUC=:CEMH,A298U4383 Y48
M;'IFF*&MR@+%"IRDR_U_SS4L)(@ Z[/ER.C8[BHV:5]\;%8SY;,,'.?8Y%2^
M51N)VM<5)':5A<1).K,0,';@C\_6M?0/#^IZL\ITZV5DA<*"UVB,A(SU)!(P
M>H]Q67&?,2/9&(X5^95[L3W-+%#-YQD'ENY&-C<#';FHE"3C=;_H*SW/?/AU
M8:UI>F7UEJZ2H([G]QODWC:5&=K=USG%=G7FWPLO;*&VFLFUF>6ZEPRV-PFS
MRL9SY>6;<#GL>W05Z37DSOS.XEL%%%%2,**** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J.>9;>%I
M6!*J,D#K4E5=2_Y!\WT_K0!-!,MQ LJ@A6Z ]:DJIIG_ "#H?H?YFK= !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MO;1]=R$C+M^!X'Y]J]9JEI&G6NDZ3:V%G_Q[PQA4).2P]2>Y/6KM>3.3D[L
MHHHJ0"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH *BN8?M%N\6[;N&,XJ6FR2)%&7<[5'4T ,MH/
MLUND6[=M[XQ4M-CD2:,21MN4]#3J "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBD()4@'!Q
MU]* ,WQ!K4/A_0[G4YU+B$#:@."[D@*OXDBOGOQ)XCN->U&2:>:W:ZG41NL
MPL:+D^N2><9K6\1V.HV>J36.OSSW=PI+QO-(S),F>'5<[1[@#@UREU!#)E%1
M4 .1L4#!KOP]#3FW!)O4;;LZ,TJ#:C+M4D]<$\U';MA#&_WUY8YSG/>I'0S;
M!+L*(,*BKA1^%-:%"%"84*<X"C!^HKMBI+6Q23(YCYZX1UV!U!8<G)ST].E3
M006OES*5*S*^5=3R 1^O>HV(\N1+A]N"&!'R[E!YQ[CTI\T 5D:.XCD1\ 2
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !574O\ D'S?3^M6J@NX6GM)
M(DQN88&: (],_P"0=#]#_,U;J"SA:WM(XGQN7.<=.M3T %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MAA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MHH **** "BBB@#)T[_D*77X_SK6K)T[_ )"EU^/\ZUJ "BBB@ HHHH ****
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M,;,]NO-+;H,&09&X8VYX7!/3\2:9NW&4@8F8[%5AT7U^G4TN5))]Q;:A;H)
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M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%-D#&-@A 8@XSZT
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M10 4444 9.G?\A2Z_'^=:U9.G?\ (4NOQ_G6M0 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% %/5K:XO
M-(O+6TG$%Q-"\<<I'W&((!KQ3Q'X,U/PWHT<]U=Z>-TBPQ11!W))^H'0 FO=
MZYSQ'X,L/%%[:7%]<W:+;*RB*&0*KY(SGC(Z8R,&M*=1P8O0^<'^TP7GF1LS
M2 E8Y ,)_M C\L_A4L]Q.S"25(]H^\5SD>]>I?$GPF]JNG7&D6+?88(&MO+M
MXRWE'.X,0,D@\Y///6O*KJ*VBNBL:SS%4#R+./GC.<$>A'IC'7I7H4JT9:]6
M%[ @567RY5DBD4NI'4<_Y_(TYP'(C+[4()=L]%'7_#\:=+ ;"8QW,$EK*_S;
M)T,;$>N&QQ4$L/F3QR#! '(!P3].U=%WR::E?9T)&8W,(B-NB1 @@E1NP.P]
M*9-*\3!8XMV!N(!QQ[4DBQ,<>6T&""'+%L^V1DBB5E:-6B@,"[@))"Y9B,^O
MI47MHD*X]I4\MBX8#;G#+C(J:REBCMI!=?(T2EER<[E]/K56:$07#22+(RHH
M(8Y(/OGI2F.W:VBFD5';[[^9GGT4>GT[TI2DUYA=D,;K%#'*R 2R9P6.0">]
M2)''PC$F.,-*Y=<<#\.F2*>R^8?-N BC& F>%_\ KU&TJM=0MYSSH.-F_.!D
M=_3('Z4232$U8G'^E"/]TL<:@E0HP3GN<5H:)H&J:[J,FF:=&&F53(9)3A(T
MQP6/UXJC;O,M[(L4 $);*+)\IYSP#Z\'BNZ\->![WQ+/#<W,=S9:=-:^8LR.
MK*YR"H([XY^E9SJJ$?=T87TTW,+PE!+8^+].MQ$LA>Z:UN(B0ZRJ25<'LPX)
M_"O?](T+3=!AEATRU6WCED\QU4DC/X]![5@>&/A[8>'+\WQN)+NY52D+.@58
ME/7 '<^M=A7#6J*<KH HHHK$84444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 445GZUK-GH&
MDS:E?NRV\(&[:NXG)P !W.30#=M6:%5[]&DLI412S$< ?6N?\4^*8M.\#2ZS
M8RAC<1*+1QW9^%/X9S^%>5Z-\5-:\/6;6MTAU57?*37,S;X_4$X)8=QZ<UK"
MC.<7)=#GJ8FG3FH2>K/<]/C>*QB1U*L <@_6K->76'QGLI+&5K_3)DNUQY45
MN^]9?^!'&W'O6AX?^(>I:M%-J-WH<5EH< )EOVNN%QUP"HW?AWI2I3CJT5'$
M4INT7<]!HK%T3Q5H_B"TAN+&\3]\6"12D)(<'GY3S6U6;5C5-/5!1110,***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@#P'XH_8Y_%5Y-9NT@BV&<C@)*O!"GO\N"?0BN/EF>0QQW+++'
MG*NXZ'MG_&NY\0:';:#/>)K6V]U"]DFDM+6.1DCCC9V/FR-P2><!1Z5P@588
M?+FD5@ORDM@9KU,,DXBB,VHUPD'RV\<ZY_>'Y1[CZYZ=C5VXL(+= BC?TRSG
M)-9TS[$2WDC\Y/X,'D"E$:ED".P@D7"A'XR,D@CZ5I%-/74:W)+EBB*P!)SC
MCL2, T^.".+&T<@8R3DX_&G,5CC)/"J.U0R1K&KN8U=&.6S]Y?4@_P!*UDK/
MF*>CN6%:2.42Q, X&#D9!'H:BEGN.K2>:KG:0O&,^E1(Z+<%5CVG&U57^+OG
MTJ2.T:*<YAR2V]4248S[\5#DGJMR6[["VK[9K6V9"9&=$V^Q..?PKU'QMX?\
M%>&(IR]C.U[<6Q^S11O)MC(_B9MW<^IQQTKS'3XG.IPS%RCM*JNH'W?F'&>W
M05Z#\9(TFUZQ("LPL\*3S@[FK&:G*<5T#5ES2/ &AZ/HMM?:]8:A?7-TFXVM
MG'(RH"/X@G?GJ34?B?P3I=_X=N=7T2WO[(VJ[I+6XA=#M'=0W/'7J:Z6SUF3
MQGH-@V@^(UTG4(5"W%NR(Q) P05//'4$5@>,KS5="T:2"X\9B]O)%*2V0AC
M9&&#G RHP3UK"$I.6]G\_P K C.\(^%-'/AI/%'B=V6US^Z@!(#=LG').<@
M5O:!X<^'OBC4)9;&UE+1QX:UE=TXX^88;)_,U1\*7&A^+? D7A2]N5M;FV8/
M$KOC.22O?G[Q&/I6_P"!/!UGX5U65)=7BO=2,&WRXQC8F1DD9/4XZT3G=2YF
M[] W/&]?8?VU<Q1HZB&:0(%/W5#D '/L*HB.1XE;*F53N4CH?:K^LQ!_$.I1
MKL.^ZF?Y\_.=YXS6<(YXY"8D1!@DH3D$^WI7;#;4>O4&E,G[Q"VV+!<#W(&#
M^&:</)@EAG2//SC.Q<E@>M.%Y-(5+IA(SEHU!# ]B<]:BWK&R/O5H_,W94\J
M#U!';UJ7+>Y-^H]V>W$HPI/#JH_AW$X7^530SW6UC'$(@JY9WY_ #O186MO>
M7L<$]]':1R.[_:)$+(,?=W8Y"].>U=EX<TK^R/'6EV>KVT<A,HPH;?&^X$QR
MH1]X9 _/VJ)U5&/+?H%]+7/6/"?A:Q\/Z?%*EN?[0EB7[3/(=SEL E<]ESV'
M%=%117EMWU8PHHHI %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !7@7QD.GS^*";23S+E(%%TH'",O*\^I4\CMQ7OM>&>+M"L
M]!UG4=3\0C[=+?SR-I]E$[*KCO)*W8#(&T?_ *MZ#2D<N+3=/3[^QY<\KNJI
M(V^/L6[>F:9\ID51B,/D9;[OUIY CW!B, _@!43':H0J'4GY0.U=C?<\Y17V
M2U-:QPJ%'S<?>;G-02':H;&=ISBF!1\NTL$(Q\I[U+PB^@ H;3=TK"C%I6;N
M-2-5 [G'4G-/5F1PZ'##U'!J,@ ,VT,#R01R/I2 JL@ 7'&!C^+-).VQ35]Q
M[R2!M^X-SR!QBFF5E0*Q8M_"#S3O(*2'<GWCG"L/UI K^:S$[7Y!&.G^?ZT-
M/=BC*.R.P^'_ ((3Q;J4[W<DJ:=:(&F:/[[,>BC'K@FNYC\'>"-8;^S;70->
MTV=LHEX]M.BDCN2V1^8%<[\*/$ECHUQJ&E7MS]C2_4>7=9'[N0 @9)X'7J>,
MBN\N-/UVSM6NKWXB)!9A-R3""++<<=1@_AU[5SSOS.[L=M*W(K*_?;_,QOAA
MI5OX<\7ZUHEZ&EU2  0S $*8, ^N.<J>E;7@.\\+7.LZ\V@V<T# (9_,##=R
MV>K'OFN2^&.JW.I_$;4;J]O?M;M:LHN'4(74, #M' X[5)\'F1-;\3G<%5HE
M.TGI\\E3-/5OR+IR2Y4EU9YOXC?2KK7+J30X##ISX\E7W!EXYZD]_>LZ21Y$
MB#Y+ =5]N*;'S&,<#M["DV;=J#&#W;O[5U*Z5D<$K-\S *SIDD;LY4T$EP2N
M1L&Y@/Y4@5U?Y5"^HSD&GB>1@ RX Y*CJ:%;J$K]!N$4K(HS\P/ Y/K3W^5W
M(P V6"^GUIC-CYP05+9XZ@_2K6GV]M=Z@D-Q>K:P2.0URT9=4 Z$@<XSC\Z+
MV0DKR1#$\N?E0+@9+,>!7TEX!\):=HNBV=^+;=J=S;J\L\O+C<,[1_='L/QK
MQ[2M".@^--'M]8MX+NUFGC9"C;X;B-SM5U/< D''M7TE6&(F[**>AUX2FN:4
MFM5H%%%%<AZ 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 9.G?\A2Z_'^=:U9.G?\A2Z_
M'^=:U !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MHFF7*>$=$-G/,/FFN$"@9[XW$GZ9%><.#/<NV%&/D,G<^N/3ZT"%)9?DR'C
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M30-,@M+=%+QQJCS[ 'DQW)'N37G8F4;Z$6UT-2BBBN0H**** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KB/B7/J T2.TT
M[03J<ESN4R_9_.^S=.0N#R<G![8KMZ*:=G<F2YE:]CY&N=+DL;R>&ZA:WD@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110!DZ=_R%+K\?YUK5DZ=_P A2Z_'^=:U !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MIY&\F)0@'4*,]!3Y XB9L[<#.XCI3Y6NH6(Y"88MR!0B#D8[4DP*[9(R4EW
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% 'E'C_P"%]WJVI2ZKH8B>2X.ZXMI&VY?^\I/'/<&O*=?\,:GX:N8;2_\
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M>O:0 H    Z 54TS2;#1K,6FG6L=O "6VH.I/<GJ3[FKE<=6I[23D,****S
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MVK"JHI-LZJ#FY)):=_(]-HHHKD/0"BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M ,,!Z4B*2"RN>2:D0*KCS%9XP.0#SGU]ZI:D.RU $'H0::SX;&0/=NE+E&E
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** ,G3O^0I=?C_ #K6K)T[_D*77X_SK6H **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110!DZ=_R%+K\?YUK5DZ=_R%+K\?YUK4 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% &3IW_(4NOQ_G6M63IW_(4NOQ_G6M0 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH R=._Y"EU^/\ZUJR=._P"0I=?C_.M:@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** ,G3O\ D*77X_SK6K)T[_D*77X_SK6H **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M 9.G?\A2Z_'^=:U9.G?\A2Z_'^=:U !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 9.G?\A2Z_'^=:U9.G?\A2Z_'^=:U !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** ,G3O^0I=?C_ #K6K)T[_D*77X_SK6H **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** ,G3O^0I=?C_.M:LG3O\ D*77X_SK
M6H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** /*_BAI.K:YXCTRSMTV6$5L\K
MW4N1#"<_,SMTR% P.O/UKQO5;:TM=4GAL+M[VU!^6X:/R]Y[X7)X]#WKZ?\
M%D6E3>%[\:V7&G+'OF*$A@ <C&.>N*^7M2\F?4G^P&58'D(BCE8,ZIV+$=Z[
M*#<HV['FXJ,83YN_Z?H42 H97!,; >^,4X32K%\LQ= <889Q2D+',D3!F7=\
MW<_2H\;  28VVX8$$9'TK?5'-[LNA*N[DL02?3M3< 8QG;W"XS2A),#/R#TQ
MDTG$8[DD_B:0]]AN?21B2>!@#\Z5B3(I5N!P>,C\:;*!@@$9/.TT_,@5$#D
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MVHR4E=!1112&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 9.G?\A2Z_'^=:U9.G?\ (4NOQ_G6M0 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M1"V,=NLA7+.<*O?VKZ^N'CBMI9)0#&J%G!'8#FODB\0O=RW\2QQQ23MY8C4
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MGO[5 Q)^\,+D#:>]-IQ)4HSNAVYY$!8X !VJ.WO4>XE8@GH<>Q_SFGN#Y>U
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 9.G?\A2Z_'^=:U9=A
M&ZZE<LR,%.<$CKS6I0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MI&@P%%3UQ3ES2;/4IPY(J(4445)84444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
<B@ HHHH **** "BBB@ HHHH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>img268224062_6.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img268224062_6.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" **!8(# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***0,I8J",CJ/2@!:***
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBD5E;.T@X.#CUH 6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH ***0D $DX ZF@!:*0$,H(((/
M((I: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH ***3<N[;D;L9Q0 M%%% !1110 4444 %%%% !1110 4444 %%%%
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M4X;':O-_"FH0I!J.FS0.Z7,3.S*^,!5)(KHO [V$6FWL\*RQ*K#S&F<-P![
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M^B'5K"3S;<(S$=""!DJ1V-<O9?$A]:MT.A>'[O4+@+NFC$@1(?0%R,9..F*
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M&,@'.* .]HJ*UG%U:0W 4J)4#@'MD9J6@ HHHH **** "BBB@ HHHH ****
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M3<8E0+GG(/2MFT\,6L&@/I$KM-$[%MQ&"#[?3%8:_#F$2C=J$ABS]T(,UO\
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M_P#WZ@K6\.1>+$UF,ZI:PQVFUMS+'$#G''W>:[:B@ HHHH **** "N$\.?\
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MSC4OM!M[T\Y6%.Y/N*Z'XBVT-GHVA6Q7;IL5]$DP[!!TS72VWABQM?%-UKZ
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M<Y\3;R.XTVS\/0$27^H7,82,<E5# ECZ=*2'X?:I!;QV\7C/5XX8U"JB-M
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MIX-9=[\,SK$3OK.O7E[>9'ERL %B&<D*G3F@"3QE_P AWP=_U^?^RBI?B/\
MZG0/^PK%_6MO5_#D>K7NDW+W#QG3I?-4  [^,8-.\0>'X]?2Q62=X?LETER-
MH!W%<\?K0!C_ !#_ .0=HO\ V%[;^9JE;^6WQFO?MF/,%BGV/=TQ_%M_7]:Z
MC7]"37;>SB>=HA;7<=R"HSN*=OUJ#Q)X5L_$<<+R22VUY;G=!=0-M>,_7N*
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MK0!Z]I/_ "![+_K@G_H(JY4-G";:R@@)R8XU3/T&*FH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH I:AI&G:M&(]0L;>Z1>5$T8;!]L]*ATWP
M]H^CLSZ=IMM;.PP7CC 8CZ]:TZ* "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M+V_\/PSWYW3;G7?Q\X#$ \5MUQ_AA+V)=+FC#R64T,L<JYXC8.2&Q[]*["@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M8RI<S8D89"*,G'K7E;7$07EJCAO_ +2OF33%Y,X+,<G Z?IBLUFU1TW)PU_
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M1"CJ&4C!!'!H 2-UEC61#E6 8'U!IU9NDZE]N>\MWB$,UI,8F0'M_"?Q%:5
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MM:QO3FY736J"BBBH- HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MT445B=(4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M2M6]TX>([Z99F*06#[8<=?.P#N/L,CCO5A=8GCT.2>6)6O(G\@JIPK29P#[
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MZ>9'>2%[4KU:4X!0_H0:L-I$_P#8"6X93=I(+D?W3('WX^F>*.PEU/(/B/\
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M8\[O3;GGUJY/I<MII-D+;][/8D2!3_RT_O#]3BAB74TM.^T?8(?M18SX^8N
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M$\<W^G^.K/3].NY(K>T,9N%0\.Q()!]MN/S-=%\6?$-WHOABT;3;EX+BYN5
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M-<WEN"DP_P"6;_Q?D017C^@KXKU2XU?7=/T5+R+5?,A=Y<$!2>0.?P_"NO\
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M0 4444 %%%% !1110 4444 ':N?\&_\ (#D_Z_+G_P!&M70=JY_P;_R Y/\
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MGXT[2_%&E:;9&WFN&7,C-&@4MY2$\ _S_&N'GL4FB*)&6<\*H&<GM3DM(U0
MKSCFI><2]DGRZW^12RBE[9KF=K?/_ACI[75]*6"T<3*+V*Z:2>?.3LR<DGN"
M, "KVH>*=%OKBRW3YMXIMTJ2*0",<$^H!YKAEL%%PTFPB,C ;'!;TI\UE%)$
MR!"21@ <Y-:2SA\\5R:.WX]B(913]G.\]5>W;3O^IW&G>)M)TU;E7G*Q23L\
M,:@MM0XY]@3DXK/&JZ7*DK"96OOMGG+<9Y$?][/8 9&*Y>*R6.-5D0AP,,#V
M/>F&P'V@2B,^5C:S@?Q=@:(YN_:23CHK_AW%+*:?LX-3U=K]M>WZ'=:MXJT>
M_M5A2=F42JTB%2N] >119>(]'TZZO91.JVD[JT"1C.<#YF [ G^5<4]I$R$;
M>U,AL#"FR>/;(/O+C&/\BH6<2]BY<NM_E_6AI+**7MTE)VM\_P"M3JI]8TF[
M;4RTBS7,S*ULYX90.@']W:>36];>,-&D>.W-YE^%WLI"D_6O-I+!7F218R47
M[[ ?=!Z?K4IM8L8(_&BIG#48M1W_ .&T%2RBES33GZ?GJ>E:;LFU^^N;3'V4
MHJ.5/RR2@\D?0<9K9D_U;?0UE>%XFA\.6<;)LPG QCC/%:LG^K;Z&O;4N9)G
MB<O*VC&\(_\ (LVGU?\ ]#-;=8GA'_D6;3ZO_P"AFMN@ J.>%+FWD@D&4D4J
MP]014E% %#2+7^S]/BT\W(F>W7;GN%[9'TJ_68U@\7B :C&Z+%)#Y4RGJQ!^
M4_SK3H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH ***KW][#IMA<7MRVV&",R.?8"@"!M%TUM775C9Q&_5=@N,?,!
MC&*MW$$5U;2V\Z"2&5"CHW1E(P0?PKRFU\0^//&SS7F@)#8:8C%8VDQE\>YZ
MUN^%=5\8W%Y?:+KMD(Y8HB8]011M!(^7CHWK^%:.#6[,(U8MZ)ZG3GPSHAT<
M:2=-@-@&WB K\H.<Y_.KBZ;9IIRZ>+:/[&J>6(2,KM],&O---^)5WI>FZ[:^
M(BAU;3V(A"KM$I/ &/8\_0U'/JWQ!3P9!KZW-L%*//,K1@%(^-N!W)Y/XT_9
MRZL7MH=$=Q:^!O#%E=K=6^C6J3*=RG;G:?8&M;4=+L=7LS::A;1W%N2&,;C(
MR.E<#X*\2^(I]%N?$7B*> Z.+=GC** VY6P>!]#6=::[\0/&?F:CHB06&FAB
M(1)C+X]SUH<)7U>P*I#ETCOTL>D7/A_2;P60N+"&06./LVX?ZK&,8_(?E4NI
MZ1I^LVHMM2M(KF$,&"2#(!]:XWP=XUU*YUR7PUXDME@U:($HZC E YZ?3GCK
M6$/BA=:7J7B6/494E^RRF*P@5,%FW,.?8 #-'LYWL/VM.UWU/2KCP_I-VUDU
MQ80R&QQ]FW#_ %6,8Q^0_*K=[96VHV<MI>0I-;RC#QN.&%>?-K/BO3?AK>Z[
MJ=Q&M^X1X(_* \I"P'(]2#^%4O$WC?6],\ >'=6MIXUN[T S,8P0?EST[4*G
M)O<'5@E=KI<[:V\$^&K.4RV^C6L<A1DW*ISM92K#\02/QK3TW2K#1[3[+IUK
M';0;BVR,8&3U-<;J7CE[OX67'B/2I$CO(Q&KJ1N\MS(JL"/H3CZBLKQ-XSUV
MP\&>&+^RGC6\U%1YS,@()*@_AR:.2<MP]I3CJETN=_>^&]&U&^^VW>G037)C
M,?FL/FVD$8^F":?#H6E0:0^DQ6,*6#@AK<+\I!ZUS'A3_A.#K .OW%D]CY3<
M0LI;=QCI^-:?CSQ#<^&?"EQJ-I&KW 98T+#(4L<9(]JFSNHIE*4>5S:L:JZ'
MI::.=(6QA&GD%3;A?EP3GI]>:A@\,Z);75I<PZ; DUHGEV[@<QKSP/S/YUQW
M@G4O&UUJ%I+J+6U[I%W"93<1D?NSV''?/&*R)?$OC?5?&.M:7HMU:+%8S, )
M@JX7=@<GK5<DKM7(]K"R?+^!Z>VB:8^KIJS64)U!%VK<%?F QC^M07GAC1+^
M\FN[K38);B9/+DD8<LO'!_(5S.H^+M1\'^"X+G71#<ZS-(T<441&UCG@\=@,
M9^M8:'XJW-J-31[=,C>MH54''ICU]LT*$M[CE4CMRWZ['J%C8VNFV<=G90)!
M;QC"1H,!><U730],CUA]72RB74'7:UP!\Q& ,'\ /RKAM8\9>(+;X:#6I;+^
MSM2$ZQ%77(89P6 /3-9VD^-_%6E:WI%OXB2VFL]5"^4T6 R[L8/'U'%"IRU8
M.M!-)H]+L]%TW3[ZYO;2SBAN;H[IY%',ASGG\33=5T+2]<B6/4[&&Y53E?,7
MD?0UY[XD\2^+&^(,V@:%<6R*(A(HF4 ?=R>33]4O/B)IOA8W\EQ8F:W>:2Y9
M-I'E!4VX]\[_ -*.1Z.X.K'5<NB.[TCPWH^A;SIFGP6S/PS(OS'\:FNM%TV]
MU&WU"YLXI;NV_P!3*P^9._%>8:=XH\:MX*O_ !)=W%L;7[/FV8(-V\2!3D?@
MU=!/X];1_ASINM7JBXU&\C CC48#OSS[ 4.$K[A&K"VUEN=;'H.EQ:P^K1V,
M*Z@XPUP!AB,8YIUWHNFWU_;7UU9Q2W5J<PRL.4.<\5YJDOQ5FL_[63[.H*[U
MLRJ[L>FWU]LUOZ/X\.O^!]7U"%!;ZII]M(TL1&=CA25.#V)!_(T.$EK<%4@]
M&K=3NJ*\X^&?C^?Q,+C3]5=/[0CS)&RC;YB=QCU']:N_#[Q+J>OWVNQ:A*CI
M:7/EP[4Q@98?T%2Z;5[]"HUHRM;J=U1114&H4444 %%%% !1110 4444 %%%
M% !1110!FZ_J3Z3HES>Q('DC7Y5/3)XKF-!\<SW5[%::A!&/-(598^.3ZBNF
M\0QPR>'[X3JQC$1)"]>*\@TR\^Q7T%W=I^ZA82-LY/'.*RG)QDK'J8+#TJU"
MHY1;DMFO0]RHKC-,^(5M=R(EW:/;!SP^[< #TS76K=V[B4I-&_E9WA6!*X]:
MTC)2U1P5:-2C+EJ*S)20H))  ZDU#;7MK>!C;7$4P4X/EN&P?PKR7XB?$&UU
M'PTEMI-VT<SW!2:+HY0=_H:X[2?%>DZ+I<3VVGWG]K*#OF%R50G/!P.M="HN
MUWN<$L2E*RV[GN4?BRQ?Q1=:!,OERQ1AU9R,2<9(%>,WOB:WN_$5_,S(D#R$
M1A5P !P*Y75M:O=4U1;^>X=YL -(ORDX]Q6<3YC,RLO/.W/-;O"P<7&7]>AC
M1S.K2J1JT]+7^[LSTS0OB,^@F^LXK-)II6'E'?P#[XZUV[^,KWPYHL>H>(I8
M)9KEPD-I;@93UW'V%?/465=6CSO!W CJ#ZU9EOKUI%$D[R%6+C<=PR3DFA4(
M\J26A,\94G.4YRNV?3^B>+-'\02O#870>5!ED88./;UK:W+NV[ANZXSS7S)X
M>\8RZ9XL77+Y/,(5@RP@+D[<#BM;1?B-J5I=:C>[%EO;PC$DK$B,>@6L_JSD
M[0-/KL8QO4/H:JTNH6<$GES7<$;_ -UY #5'3]1GG\,V]Y/M-W);>857C+8S
MP*\@N'-U*YFQ)<2-R&ZECVKBJ3Y-+'M8+"+%7;E9)'L5WXBTBQE\NXOX4<#)
M&<X_*M"">*Y@2:"19(G&593D$5XG%I=\I6V:UG,W0J4/7TKU[0; Z9H=K:,,
M.B?-]3R:4)N3=U8K%8:E1A%QGS-FE1116APA1110 4444 %%%% !1110 44A
MX!KQ2+QKXYN3JU[9RVDEGILI$JNB@[<]O6KA!RV,ZE50M<]LHK%\,^((_$'A
MJWU=D$(="9%)X4CKSZ<5YYH'Q.OM1^('V.=T&DW$K10 I@C^Z<_YZT*G)W\A
M2K15O,].BT338-5EU2*SB2^E&'G ^9A2KHVG+J[ZLMI&+]TV-/CYBO Q^@KD
M?B-J?BG1;==2T66!+"&+_2-X!;<6P, _45DV/B#QC#X"U/Q!J,]OM-LDMDRJ
M,C+#.1]#5*#:O<EU(J7+;;4[9O!OAUH[B,Z1;;+AP\R[3AV&2"?S-;$$$5M!
M'!!&L<4:A411@*!VKC%\2WY^%7]N>?'_ &C]E\S=@8W9]*KV_CQ]-^&MIK^I
M@3WDP*HBC;O?)Q]!Q2<9,:J07EI<ZJ+PUHT+7C1Z= AO05N<+_K0>N:MZ?IU
MGI5FEG86Z6]NF=L:#@9.37F$%Q\4M1LQJ\)MHHW7S([4J 2O;@UU'@[QU%X@
MTF[DOXQ:7E@#]JC/0 ?Q#\C1*$K;W"%2#=K6.CM=&TZRU"YO[:SBBNKDYFE4
M<O\ 6DO-%TV_OK>]NK.*6YMN89&'*?2O-(O$_C7QO>7$GAF..RTR%MJRR8RQ
M^I[^PK=\):GXTCUZ32/$5BLL*Q^8+Q, #TY'!S^=-PDM;ZBC5C+1+3TT.PU/
M2-/UFV^SZC9Q7,6<A9%S@U0TOP=X?T:Y^TV&E6\4_:3&2/IGI7 ZAXE\9WWC
MG5-&T2YM5CM6)43*HPO'<]:M>)?$7BSPSX%M;N\N+;^U'O"CM&H9=F"1[=J?
M)+17W$ZL'>3CL>@RZ)ILVK1ZI)9Q-?1C:DY'S*/\FHW\/:1)JPU5["$W^,>?
MCYNF/Y5RT'CE]6^&=YKEDR1ZA;18D3&0D@([>AZUB:OXWURT^'6B:O#/&+RZ
MF*RL8Q@CGM^%)0EM\ANK32O;S/08?#.B6^F7&FPZ; EE<-OFA ^5SQR?R'Y5
M=@T^TM=/6PAMT2T5/+$0'RA?2N.\;>-[G0WLM*TFV%SK-ZH,:D9" \ X[G.:
MP9YOBEH\(U*8V]Y&N&DMD 8@=Q@<_E0H2:NV#J1B[);=CTK2]'T[1;=H--M(
MK6)FWLD8P"?6L_4?!7AS5KHW-YI-O).WWGQ@GZXK3TNYN+S3+:YNK5K6>1 S
MP,<E#Z5Y/KOB+X@:9XJ@T<7%H'O7)M1M4C;N(&3VZ4H*3>C'4E",5=71ZSI^
MFV6E6BVMA:Q6\"]$C7 JU5#11J"Z/:C52AO_ "QYY3IN[XK@]?\ &NN:KXFE
M\.>#X$>:W)%Q=.,A2.#UX !XSZTE%R94IJ$4SL-3\(>']9N?M-_I5O-.>LA7
M!/UQUK1T_3;+2K1;6PM8K>!>B1K@5YU::A\1=!U>TBU.UCU2SN9!&3$!E">^
M1T[]?2H->\2^+YOB#>:#H5Q;(L4:NJS*HP-H)Y/N:KDD]+F?M8+WN77T/1[/
M1=-T^]N;RTLXH;FY.9I$'+G.>?SJ_7E^N:_XO\-^ GOM1N;7^TC?K&C1 ,OE
M%>G'?(-=M=:C<1>#)=11A]I6Q,P;'&[9GI]:EQ>Y<:D=4E;J;5%<I\/-;OO$
M'A&'4-0=7N&D=257' /'%<%IWC#QSXBO+K4-&-L\4%P(SIYQO"$\$@\X]3]:
M:IMMKL)UHI)VW/:**C@:1H(VF0)*5!=0<@'N,U)69L%%%% !1110 4444 %%
M%% !1110 4444 %%%% !VKG_  ;_ ,@.3_K\N?\ T:U=!VKG_!O_ " Y/^OR
MY_\ 1K4 =!65?^'=-U&;SIH2LAZM&VTM]:U:*F48R5I*XXR<7>+L4XM*L8;(
MV:6R>0WWD(SGZU3MO#&E6UQYZ0%F!RH=BP4^PK8HH<(NUUL-3DKV>YF:EH%A
MJCB2>-EE''F1MM)'O4EEHMA86SV\, *2#$A?DO\ 4U?HHY(\W-;4.>7+RWT,
M)/".DI<>=Y4C#.1&SY3\JMZCH=AJ:KY\1#(,*\9VD#T^E:5!.!DU*I4TG%15
MGY#=2;:;;NC.T_1+#38G2"')<8=G.XL/0UD7.B^&[:Z,DTFW!R81)\OY5'J^
MO27+M;V3E(!PTJ]7^GH*PP .E>+C<TH47[*$%)K[D=V'PM6?ON35_O9LZ_XV
MM-"L8OL-J]TQX5$4JJ >M5M)T+4M>UBW\0ZX]OY8BQ;VT7S+M8=S^-4#R,'D
M>]:.C:JVF3)$[?Z&QP5/2/W'M6F"SV-22IU(\K>E_P"MC+$98X^^I72Z&RGA
M'24N/-\J0C.1&7.S\JN:CHEAJ:(L\6"@PKH=I ]*T:*]94J:32BK/R.9U)MI
MMNZ,[3M$L=+1A;Q$LPPSR'<Q'IFJ<GA'29+GSO*D4$Y,:OA/RK=HH=*FTHN*
MLO(%4FFVF[LH7FBV%]:I;2P 1QC";."GT-1:=X?T_2W,D$;-(1C?(VX@>U:E
M%/V<.;FMJ+GER\M]##G\)Z5<7)F,<B9.2B/A3^%7;C1K"YL5LWMU$*?<"\%?
MH:OT4*G!7LEKN-U)NUV]#)T[PYIVF3>=#&[R]GD;<5^E1WGA;3+RX,[1R1L3
MEA&^T-]16U12]E3Y>7E5O0/:SYN;F=RBVCV#V LC;)Y Y"CL?7/K56P\,Z;I
M]P)XT>20?=,K;MOTK8HING!M-K5"4Y)-)Z,Q[_PSINH3F:2-TD/WC$VW=]:M
M1Z/81V!LEMD\AOO*>Y]<^M7J*%3@FY):L'.323>B,2U\*Z7:7(G6.21@<J)'
MW 'Z5/J7A_3]4D$D\;++_?C;:3]:U**7LJ?+R\JMZ#]K/FYKNY0M-&L+*T>V
MB@4QN,/OY+?4U2C\):3%<>=Y4C '(C9\J/PK<HINE!VNEIL"J35[-ZB    #
M '0"DD_U;?0TZFR?ZMOH:L@QO"/_ "+-I]7_ /0S6W6)X1_Y%FT^K_\ H9K;
MH **** *.L63ZAI5Q;1-LE9<QMG&&'(_6K-MYOV:+SP!-L&\ Y&<<U+63I\%
M[:ZWJ*2%WLYBLT+L<[6/#*/YT :U%%% !1110!R4?C2,>-9M#G1$B'R1RYZO
MZ&NMKP+QB'B\8:D<E6$Y8$=1Z&N\\&?$"*^2/3M6D6.Z&%CF/ D^OH:RC53D
MXL[JV#<:4:L-4TKGH-%%%:G"%%%% !7+>)/'.FZ!F!3]IO/^>2'[O^\>U87C
MOQ]]@+Z5I,H-P1B:=3GR_8>]>4&4NQ9F+,3DDG)-85:RCHMSTL'@'67//2/Y
MG6:G\0=?U%SY=U]DB[) ,?F>]=7\--7U?4;B\2\GEN+95!#R<[6] :\[T'1[
MC7]6BL;?@MR[]D7N:]\TG2K71M.BLK1 L:#D]V/<GWJ://)\TGH:8_V%*/LH
M15_R+U%%%=)Y(4444 %%%% !1110 4444 %8'C:PFU/P7JMI;@F9X"5"]200
M<?CBM^BFG9W%)731YY\,O%&D/X1MM/DN(;6ZLP4EBD8+GDG<,]<_SKJ-/\6Z
M)JNLSZ597J374*;V"\J1WP>^._UK*UGX9^&=:O'NYK1H9G.7,#[ Q]2.E:GA
M[PEHWAB)ETVU"._WY7.YV_&KDX.[ZF,%4C:+M9'F_P 2]#LI_B-X?+)@:@Z1
MW '\0#@9^N#C\*]!\;QK%X"U>-%"HMHP4#L*MZIX8TS6-4L-1O(W:XL6#0E7
MP <YY'?D5>U'3[?5=.N+"Z4M!.A1P#@D'WH<[\OD-4[.7F>9Z383ZG\ ?LUL
MK-*8I&55ZMMF)(_2M?X;^*='D\'65F]W#;W-HGERQ2,%/'?GUKL-&TBTT'2H
M=-L59;:'.P,V3R23S]2:YW5_ACX8UB]>[FM'AE<Y?R'V!C]*?/%W3[DJG.-G
M'>UCEEOH?%/QML;K23YEMIT!6>X3HW#]_JP7\#7#:AI5]<^*?$>K6,:RMI5[
MY[Q,,Y7>><=\8Y]J]^T+PYI?ART-MIEJL*DY9NK.?<]ZBTSPMI6DZAJ%[:PM
MYU^<W&]MP;DGI^)JE52V(EAW):][G(^)_$5KXG^#][J-L<%D198^\;AQD5RG
MBX _"_P6",C*_P#H->DP?#W0+:PO[&&*=;6^(,T0E.,@Y&/2K%]X)T74-(T_
M2[B*4VM@08%$A!&!CD]Z(SC';N.5*<D[[VM^)Y#X\TF[\%S:E96@)T76E5D7
MM&ZNK8^HQ^1]JN^,T63X=>!T=]BLJ@MZ#8O->P:[H&G>(]--AJ4)DAW!A@X*
MD=P:SM2\#:)JNCV&EW44K6MBNV +(00,8Y/?I355:7%+#OWN79_YF%X-\+Z)
MI.N"ZL/$<E_/Y3+Y+2AA@XR<"NE\6:AHEAH,QU\K]AF_=LA4DL3V '?O^%5-
M!\ :#X<U+[?IT,RS["F7E+#!Z\?A6SJ^CV.NZ=)8:A LUO)U!Z@]B#V-9RDG
M*]S6$&H-))'DOA^X;P7X_LM(TO4UU'1=4(*QJ^XQ[B<$^A'ZBLR/1=-UKXC>
M)X]2U=]-2.X=D97"[SO/'->H^'_AYX?\-W_VZRMY&N0"$>5]VS/I5?4/AAX9
MU/4;B_N8)S/<2&20K,0"3R>*T]K&YC["?*EIOL<-XRT>#0M(\+ZC97#ZIING
M7;F64L&SN=6_]E(_*O4(/%^@7&F+J"ZK;+;LF[+N 1[$=<U+IWAO2]-T+^Q8
M;</8?-F*7YLY.3G-<T_PA\*/<>:(+A5SGRQ,=M0Y1DK2-%"<'>-M3*^(NO:?
MXB^&$E]ILWFP&Z1"2,$$'H1_GK7)^"=*@L/B#I]KX@>65VMTGTYV<["2H91S
M[9&/45[!>>$-%O?#ZZ&UH(K!6#".([>1WS4>H>"]&U)M->>*02:<JK;NDA5E
M QC)[]*J-2*CRDRHRE-3?D>8^*=,LM6^,-Q:W^H-80&W5C,K!2"%&!DUU;Z3
M8:-\+?$%OIVIMJ,+1S.9F<-AB@&WCV /XULZW\//#_B#4WU"_AF:X<!25E*C
M &!Q5O3_  =H^F>'KO0[:*065V6,JER22RA3S] *'432\@C1DI2=M[G!V_\
MR;J?^N3_ /I0:Q_$%M-'\/\ P5K A:6VL2#,H&0 6!&?^^<?B*]87PII2>%O
M^$<$<G]G;2NW?\V"V[K]:N6FC6-GHL>D) 'LHX_+$<GS97T-+VJ6OF#H-JS[
M)%"+QGX>ETD:D-4MQ;E-YW. P]B.N?:O,O"Z2ZAI?C[7XX7AL;NWG$((P&.'
M)_$#'YUV+?"/PFUUYWV:<+G/EB8[:ZPZ/8?V+)I$=NL5D\+0F*/Y0%(P<4N:
M,5[I3A4F[RZ'AUCH%U!X!TGQ?HP*ZAI\LAFV=7C#GGWQW]C73_!:X-W)X@N2
MNTS3K(0.V=QKT;1]"L-#TA=+LXR+1=WR.=V=QR<_G5?P_P"%-*\,_:?[,A>,
M7+!G#/D<9QCTZU4JJ::)A0<91?WFU1116!U!1110 4444 %%%% !1110 55G
MU*RM9/+FN8T<=5)Y%66SM..N.*YSPQ]F_LN?[9Y?V[SI/M?FXW9W'&<]MN,=
ML4 ;4FHV<*QM)<Q*)!N0[OO#U%30S17$8DAD61#T93D5SG_$O_X2/2_L_D?9
M#:7&S&-OWDSC\<U1NKXZ?>:Q)I!3R76&/=_RRCG9MN[TX!!./04 =7.D&I6=
MQ;B0,C!HG*G.#W%>?7'P^U(W B2:%X'.#+G!4?2NM\.%[03:3)Y+O;!7,T1X
MD+9))_VLY_.N5\?^,]3TFV,FEJDMA.K0?:4ZQ2@\\T*DJC2-(8VIA8R<7H]S
MG?%&FW/A14DNE\Z!VVI)%TR.Q]*X:[\2W(O[VYT^YGMA=,V=K8.T]C5*^UJ[
ME6:)+VXFAE4"03,2"?\ ]?>LD%57J<>E=U"C&@FEU/,QV.K8YQE4?P[$JS%U
M='/!ZM43=%49YZYJ8NDD:H3\P'8<5$,D$=.><5O(X(;NRL2JK"V,H4!<X^@]
M:B7(!/MQ3TD?R]GH.<TQ<[>G2AN]K!%6O<1&=2-I*YZD&G#=G(+ =SFE=3&V
MUQAAV%#R$PX?EL\4EIHQO6S2W$(4[L9VGIFG,VQ0T1)..1W!I@ZXST'/UHP2
M>#C-%[#M>USKO"WB,V&HI>:E=SN8%Q;QEC\[D8'L .M;K;+D@DH\DKX#9ZL?
M>O.3*'MS"PR0<AO2O0-"\6Z+_P (7%H]U8R)=V\RR)-&!\Y#9R2>E<N*P_M7
M&S/6RK,_J4)WBKOJV>[Z?;M::=;6[N7:.-5+$Y)(%6:Y73/'>GZSKRZ7IL,U
MS\FZ2=<;$_Q]*ZJN9Q<=S2,U/5.X4444B@HHHH **** "BBB@ HHHH 1ONGZ
M5X-X0\%1^+=2UHS:C<6T,5T0\4720$GK7O1Y%8^B>&=-\/27;Z?&ZM=/YDNY
M]V3[5I"?*G8QJ4N>2OLCFO'%Q:^#?ATVG:>/+\Q1:P+GYCG[Q]^,_G7DUV=1
MA\)V%JN@7-M)82FX^VE3WYYX^E>^ZUX7TSQ!=6=QJ"22-:-OB4/A<YSR._05
MIW5K#>6<UK.@:&5#&Z^H(P:J-511%2@YMZV70X+Q1JR:Y\&YM14Y,T$9;V;<
M ?UJ"]_Y($O_ &#X_P#T):ZF'P7H\'AN;0$2;^SY6W,AD)(.<\'MR*MR>'-.
MD\-#P^R/]@$0BV[_ )MH.1S^%+GBM%W'[.3;;[6/&U\!(?AK_P )!_:UYN^S
M>;]FS\G7&.M2:O9S2?"+PY?QQF6*RF+RKVVD]_;C]:]@'AO3AX;_ + V/]@\
MORMN[YMOUJ73M$L-,T9-)@AW6:*5$<GS9!]<]:KVWYD?5NB[?B9^G^,M N=$
MBOQJ5O'"(P65G *8'((KSCPO:S^([GQQJ=C&Z6U[&Z0<8W,23C\OYUU\WPE\
M*371G^RS("<F-)2%_*NPL-/M-+LX[2QMT@@C&%1!@"IYHQ3Y2^2<VN?H>8?#
MKQ#;)X)N-#CNX+'6+<R!!.0N6))!Y]#Q6=8^)/&+>-K#0_[9MKW=(K3FW4,J
MH#E@3CT'ZUWNN_#GPYK]XUW<VK17#?>>!MFX^I'K5[P[X-T7PN'.FVNV5QAI
M7.YR/3/I5.<-7W)5*II&^B/)[S1]/UGXIZ]#J.JMIT:L6617"[CQQS5WQWIE
MEI/PVL;6PU!K^ :AN\YF#9)!XXKNM4^&GAO6-3GU"[@G:XG;<Y64@$_2IG^'
MV@/H$6BM#-]BCF,ZKYISN/O^-/VJT\B?82M)66IY?XWTJ[\&3W,^G(1I&M6_
MER1C[J/P<>WJ/J:/$'_)'_#/_7P?ZU[3JVB6.MZ2^F7T7F6S #&<$8Z$'UK+
MN? NAW>A6FC30RFSM&WQ*)""#[G\:%56EQRP[N^79HX?Q'<1^&?BOI6NZ@C&
MPN+=4$N,B-MNT_EP?H:] U#QCH&FZ>;V?4[<Q 9 C<,S?0#K5S5=$T[6M/-C
MJ%LD\&. W53Z@]C7*V_PD\*6]T)S;3R@'(CDE)7\:CFC)+FZ%\M2#?);4[*Q
MO;?4K&&\M)!);S*'1QW!KS7QM_R5SPK_ +@_]#:O3XHHX(EBB14C4855& ![
M"LK4/#&F:GKEEK%S&YO+,8A8/@#DGD=^M3"2B[EU(.44O0V*\A\%ZC:^$_'?
MB#2=8;[--=3;X9I. XR2.?<'(KUZL/Q#X0T7Q.J?VG:!Y$X65#M<#TSZ40DE
M=/9A4@W:4=T-OO&GA_3[JVMIM2A,MQ((T6,[L$]SCH*\L\0:78ZO\8-1MM0U
M)M/@\E6\Y6"\A5XR:]"T7X:>&M#O5O(+5YIT.4:=]X4^H'K3]9^'/A[7M4EU
M&^@F:XEQN*RE1P,#C\*N,H1>AG.%2<=4MS@_&6D:?HWPN>WT[5&U&)M31VE9
MPV&V$8X]@/SKN9M4L+OP!<P6UY!+,FEDLB."1A,'(J5?AWX>70'T003?8GN/
MM)7S3G?C;G/TINE?#KP]H[736<$RFYMVMY-TI.4;&1^@H<XM:A&G-/1+5&'\
M*=7TZT\#00W%]!'*))6,;. V,D]/I7*^*)-(M9F\9^#]72&X2?9/; XWG/)"
M^A[C\:] T[X8>&=,U""^MK>830OO3=*2,^XJ.7X4^%9M2-XUG(,MO,*R$1D_
M3T]J:G!2;)=*HX*-EH=1HM^VJ:)97[)Y;7$"2%?0D9J]38XTBC6.-0J* %4#
M@"G5@SJ6VH4444#"BBB@ HHHH **** "BBB@ HHHH **** #M7/^#?\ D!R?
M]?ES_P"C6KH.U<_X-_Y <G_7Y<_^C6H Z"BBB@ HHHH **** "L'Q-?F"V2T
MC8B2?.['9._Y]*WJXC7)?-UJX_V-J#\!G^M>?F>(=##2E'=Z?>=.$IJI52>Q
MG@8&!TI0I() ) ZTE:>DL?*O$_A,+''O7QE&FJDU%O<]VI+DC<S*0@$$'H:6
MBLBSN-%F,^CVSL<L$VD_3C^E9VO^)XM#O["V:(R"X?\ ?,/^6,?3>?;) JYH
M>+?08'<X4*SDGL,DUR,%AK7B)M2U6%+$VFI(8(1<%MRPJ2!C [GYORK]%I-N
M$6][(^8E;F=CKO$.J2:/HD]]$BR-'C"L>#D@5?NKF&SM9;F=PD,2EW8]@*X.
M]OIY_AW>V=_@7^GLMO<<]<$;6^A&#72>)X?[8\,:E964L<D\D#;45@<GTJR2
MC#?^*-9C%YIT-C96;C="+O<TDB]B0/NYK9T>[U&XCECU.Q%M<1-C=&VZ.0>J
MGK^=1Z'K%EJ.D6\T,J)A KQ,0&C8#!4CMBFW?B33H+#4+F*X2;[$/G"'(W'H
MN>YH KMXI@3Q>NA&,X,?^O\ X1+U"?7:":M>(M=B\.Z6+Z9"T8E1& ZX)P37
M&KX=\3MH3.?L'VJ2?[>9"6\T2=0.F.!\M;%YJ$'B*#PV1&"EU<[Y(F_A**2R
MD>Q&* .K-Q$+7[3O!AV>9O[;<9S6=X<UR+Q%I(U"%=J-(Z ?0X_ES7*AKIF_
MX0G+JXESYV./L?7KZ_P_E6WX51;2^UW3T4)'#>!T4=E9%Q_*@#I:*** "BBB
M@ HHHH **** "FR?ZMOH:=39/]6WT- &-X1_Y%FT^K_^AFMNL3PC_P BS:?5
M_P#T,UMT %%%% !65KS7\5I#<:>'>2&=&>)1GS$SAA_6M6B@! <@'UI:S-&N
MKJ9+J"\YGMYV3?MP&7JI'X5IT 5Y+ZUANHK62XC2>7)2,MAF^@JQ7E'Q/>6Q
M\1Z=?0,5D6/<I]"&KT30-8AUW1K>_A(^=<.O]UNXJ5)-M=C:=%QIQJ=&>7_%
M+2GM-<3457]S=( 3Z..O]*\_:3'0U]&^(]"@\1:/+8S?*Q&8WQ]QNQKYVUC3
M;K1M3FL+M=LT1P?0CL1[5RUZ=GS(]K+,0IP]E+=?D=CX8^)U[I 2UU%6N[0<
M!L_O$'U[UZ)9_$7PS=H"=16$]Q,"N*^>2<]:80>S$41KR6CU-*V5TIN\=#Z,
MNOB#X8M4+'5(Y,=H@6-<!XG^*\]ZCVNC(UM"1AIG^^WT':O,=I[NQI0 *<J\
MGL*EE5*#O+4L^:7)9B22<DGO3A)5;-+NKG/3LD>[?##0TL- &HR+_I%YSD]D
M'0?UKNJSM!6-- T]8L;! F,?2M&O2BK*R/C*LW4FYOJ%%%%,@**** "BBB@
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ML$(9UW>QK:-DDGN<TKN3:V["$X7) YZ8ZTH8A=JG@C%)M)8G@9.?I4DD@(V
M #J2!WII=26^EKG1>![^>R\01Q)JHTZVE_UTS'&%'.*]Y\&^*1XHAOY5C"QV
M\_EQ-_>3'!/O7S$_E[-@^:3(.X'BO>/AA<S:5!+HU]:I"3&+J.<=)%/?/0US
MUX*S?4Z\+4?,ET_JWH>ET4@(8 @Y!Y!%+7$>F%%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 =JY_
MP;_R Y/^ORY_]&M70=JY_P &_P#(#D_Z_+G_ -&M0!T%%%% !1110 4444 %
M<#K#"+7+M7XRX8?0@5WU<?XSTR3*:G""55=DP'8=FKS<UH.MAFH[K4[,#.,:
MRYNNAD @C(I\<TD.[RV*[EVMCN*QDN)$Z-4HO9.^*^.Y))W1] Z3-&G10/=3
MQV\?WY6V@^GJ?PK/6[=V"@$LQP !R37<>'M'>S3[5=+BY<8"_P!Q?3ZUW9=@
M)8BJFU[JW_R./&5O8PMU9KBVB%H+4H&A">7M/<8Q3XHHX(DBB14C0!551@ #
MM3Z*^U/GRI/IEC<B<36L3BX 6;<OWP.F:CLM$TS3IC+9V<4,A&TL@YQ5^B@#
M(O?"^B:A<&>YT^)Y3U925)^N",_C5M=)T]+-+1;.$6Z,&6,+\N1R#BKE% !5
M6/3K.&19([:-75F=2!T9NI_&K5% $?DQ>?Y_EKYNW;OQSCTS2);0Q3R3)&JR
M2XWL!RV.F:EHH **** "BBB@ HHHH **** "FR?ZMOH:=39/]6WT- &-X1_Y
M%FT^K_\ H9K;K$\(_P#(LVGU?_T,UMT %%%% !1110!FZA?RV.HV"[%-M<.8
MG;'*MCY:TJBN0WV>0QQK)(JED5NA8#BJNBZD-6TJ&\V;'<$.F<[&!P1^= '
M?%Z'$&G7&.C,F?UKDO!/C)_#.H-'/E["<CS%'5#_ 'A7H_Q0L#>>$))E!+6T
M@DX].AKP9FKDJMPJ<R/>P%.%?#.G+N?2Z>*-#DM1<KJEKY6,Y,@'Z5X9X^UZ
MU\0^)I+FS'[A$$:OC&_'>N7)S0!2G6YE:QT87+HT*G/S7#&:4+3@*;+((QTR
MQZ"L#T]$KL7;Q33N_N@CV-5F+.<LQ/MVH7*'*DBJL9N3+(PW3\J0BB-Q+UX<
M=:D(I%K57/8_AKXVM)M,BT74)EAN8!MA9S@2+V&?45Z6"",@Y!KY/(P<BMFR
M\7^(+",1V^JW*H.BEMP'YUTPKJUI'B8G*7*;E2>_1GTO17@5G\3O$UNP+W4<
MX])(Q_2O1?"/Q%L]?=+.\06M\>%&?DD^A]?:M8U8R=D>=6P->BN:2T\CN***
M*T.,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHSFB@ JIJ=Y!8:;/<W-P+>)$.9?[OO5NJ.L:5;ZWI4^GW6[R9EP2
MIP1Z$4U:^HG>VAX!X[T751+)J\U]:ZC;95#<PLN3GIN4<YKBMNTL&<;AT'K7
M3>.O#1\*^(3IZW#26DB"6,YYQTY'KG-<S)&4D*D@D8(KT8:QONCQJFD^79_?
M^(PD=P0?7TI <_Q?I4C2\# &T#G%,VC.0>/2F_(F+;6H$9&1G/:NP\4>*[;7
M_#.BZ;!;RQ2:>H21GQAOEQQ6+H?A[5/$=T]OI=L96C7<[$X5![DU<?P)KXU=
M](6R=K[R_-";@ 4]0>E2^5O7H:+G2]U;^1H:SX#NH8A=:88FA6QCN6BDG!E.
M5RS!>N!5'P)X@@\.>)8M1GAEFC2-EV1XSR,=ZZ;6EO\ PYJXU;5=-N(+673!
M8(2RD^8(\=CTKC(=#U6VT1=>:S?^SB=GF\=>G3ZU%-J6DWH:5DX^]36J*FJ7
M4=_K5Y>")A'/<-)L8\@$YQ]:Z/Q9XQAUZRTS3+"T:VT^SA \ER/O],_Y]:S-
M%\)ZWXC@EN-+LC.D;[7.X#!Z]ZD_X0?Q#_;/]D"P;[:8_-*;AA5]2>@%5>*?
MH1RSE%JVYSY "D8.1WSQ2\[NG;D#M6IK?AO5?#EU'!J=H8VE&493N5_H16='
M TLZPJG[QF"@=\FK3NKK8S<7%V>Y'MR22<TF5P0,9'>NU\?>%(O#ATHP?ZN>
MV42D'/[P=:X^*2%5/F*'&.F*(6EJ.I>#M:]B,R'/SCG&.*[;0?&UU;^&[G07
MMS<M*ABM9!]^(,>5'M7%_NQ'Z'/ ]/I71>%/%%SX5OXI_L5M/ 7RV^(%O^ M
MU!I3C=7M<*<TG:_+T/I+1!.-#L1<H4F$"!U/8XJ_7-^%_&VE^*VF2Q$J21 ,
MRRK@D'N*Z2O/DFG9GL0E&44XNZ"BBBI*"BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ [5S_@W_D!R?]?E
MS_Z-:N@[5S_@W_D!R?\ 7Y<_^C6H Z"BBB@ HHHH **** "L?4M=M+5GMPGV
MB3&&0?='L3_2HO$.JO:QBTMVQ-*,LX_@7_$UR@  P*\;,LT^K/V=/67Y'=A<
M)[7WI;%2]L_/N?-M$CMHSUBR6'X>E-L]-,UP([RY2VC)P) I8?CTQ5Z@C(P:
M^;CBVZG/4BGY;?D>OR24.2$FOQ_,['2O#UAIFV2)/-FQ_K7Y/X>E:U<UX9U!
MMS:?*Q.!NA)/;N*Z6OM<+4IU*,9TE9,^?K1G&;4W=A111709!1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %-D_U;?0TZFR?ZMOH: ,;PC_R+-I]
M7_\ 0S6W6)X1_P"19M/J_P#Z&:VZ "BBB@ HHHH *RXKVWM-;_LE+?RC+$;A
M&'"N<_-^-:E9VK/:6<']JW%N9&M%+*R#+*#P<4 6;^SBU"PGLYAF.9"C?C7S
M3X@T:YT'6)["Y4AD;Y6[,O8BOIN*5)H4EC.4=0RGU!KG_%_A*T\4Z:T;JJ7:
M#,,^.5/H?:LZE/G1VX'%_5YZ[/<^<0,U(!4ES:2V-Y+:SJ5EB<HP/J*8*X'I
MH?60:DKH"0JECT%42Q=BQZG]*L7+<*@[\FJ]4B9.[L%%%%,D 2K!AU%75(90
MPZ&J53VS=4].12:'%V9,149%2FF,*E&C0U35B&1HW5T8JZG(8'D&JU2H:#-J
M^C/H'P#XF_X2'1 D[YO;;"2^K#LU=97SOX0\0/X=UR*[Y,#?),H[J?\ "OH.
MVN(KNWCN('#Q2*&5@>"*[Z4^>/F?*XW#^PJV6SV):***T.,**** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BHY9XH5W2RH@'=F K&N_&/A^S.V34X6?^Y$=[?D* -VBN3/
MC5[DXTO0-5O,]',/EJ?Q;%2I?>+[L?)H]E9 ][BYWD?@HH Z>BN8?3/%EUQ+
MKMI;+W%M:Y/YL?Z5%_PA=S.<WWBC6)L]1'(L0_04 =4TB+]YU'U-02:C8Q?Z
MR\@3ZR 5AQ^!=$'^O6[NCZSW3MG]15E/!WAV/IH]JW^^F[^= $LOBK0(/];K
M%DOUF%4W\>>&4Z:M _\ USRW\JTXM!TB'_5Z79I](%_PJRME:)]RUA7Z1@4
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M$>QXJWKFFZEX?\9:0PU6:[M;@Q_9;D2DEXMPXK(\+^)[?0HKNUOM(M]0LKL
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MEHK ZCF?MWC'_H"Z;_X&'_XFC[=XQ_Z NF_^!A_^)KIJ* .9^W>,?^@+IO\
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M9ZI80@?^/-D_I73T4 <O#X!T02"6\6ZU"7.=UW<._/TSBMZUTRPLE"VME;P
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M0S6Q99(VV30R##Q,.JL* -.BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MVT"X1!^)/<GWJQ7VV$PZP]%4UT_,^:K575FYL****Z3(**** "BBB@ HHHH
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M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ [5S_@W_ ) <G_7Y<_\
MHUJZ#M7/^#?^0')_U^7/_HUJ .@HHHH **** "BBH+VY6SLIKAND:EOK0W;5
M@9^L:VFG#R8E$ERPR%/11ZFN-OD_M.X\^[.^7& R_+@?A_6GO))-(\TK;I9#
MN8^])7QF/S.IB)N,':'Y^I[N&PD::3E\1473K=75\,2IR QW#\0>#79Z)KBS
M;;.X2.*0<1E!A6]L=C[5R](1GH2"#D$=C6>"S&KAI[WCU1>(PT:R\STBBJ&C
M7QU#38Y6_P!:OR2?[P[_ (]?QJ_7VL9*45*.S/ ::=F%%%%4(**** "BBB@
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M?9#>PL_]W=@_D:.97/1NMB]1113&%%%% !1110 4444 %%%% !1110 4444
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M3/#-NODQB6[(_>7#CYC]/05+?_\ (X:1_P!<)_\ V6MVL*__ .1PTC_KA/\
M^RU[J5MCY^4G)\TG=E;X@?\ (FWO_ ?YBO#Q&)EMHV) <[21[M7N'Q _Y$V]
M_P" _P Q7B4/^LLO]_\ ]FKU\#_"?K^AY.._BKT_4U/$?@N]\-.)2/.L9,;)
MU'3V8=C53PY<O8^(M/N$."LZC\"<'^=?03VT-Y8_9[B)989$"LC#((Q7C6L^
M%9=!\7V=O$&>TN)U:!O;<,J?<5\_.ERR4HGUN'QOM:<J57>SU^1[1<017=K)
M!,NZ*5"K#U!KP+6-,N?"OB,P$G,,@E@?^\N<@U] @84#T%8/BKPM;>)M/$3D
M174?,,V.5/H?4&M:D.9:;G#A,1[&?O?"]&:6D:A'JNE6U[$<K*@;Z'N*NUR/
M@31-8T&UNK34FC,&_, 1MWU/L#Z5UU6M5J<\TE)J+N@HHHIDA1110 4444 %
M%%% !1110 4444 %%%<O?^([K4+V32O#4:3W*<3WCC,%O^/\3>P_&@#2UKQ%
M9:(L:3%YKN8X@M81NDE/L/3W/%8\6@:CXBE%SXF8):@[HM+A;Y!Z>:?XS[=*
MU-$\-6VD,US([W>I2_ZZ\FY=O8?W1["MJ@!L<<<,2Q1(J1H,*JC  ]!3J**
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M%26%%%% !1110 4444 %%%% !1110 4444 %%%% !VKG_!O_ " Y/^ORY_\
M1K5T':N?\&_\@.3_ *_+G_T:U '04444 %%%% !110>!F@#&UW5VL(U@M\?:
M9!G)Z(/7_"N1Y+%V9G=N69CDGZFIKRX:[O[BX?\ B<A?91P/\?QJ&OB\TQLJ
M]9P3]U:?\$]W!T%3@I/=A4UG=SZ?/YULVT_Q(?NN/<?UI@BD,1E",8P<%L<
MTRN"E5J49*<'9G3.$:BY9:G>V%]%J-HMQ%D \,IZJ>X-6JX_PY>&WU/[.?\
M5W _)AT_3-=A7W.#Q*Q-%5/O]3YZO2=*HX!63KVO6^A6?FR?/,_$40ZL?Z"M
M2218HGD<X5023[5XUJ^IRZOJ<MY(3ACB-?[J=A_6MJM3D5SIP&#^LU+/9;D>
MHZC=:K>-=7<F]ST'91Z 55HJY%IES-I\MZBJ88OO'<,C\.M<+;D[GUT53HQ4
M5HBG7K7A&]^W>&[1VD#R(#&Y!S@@X&?PQ7DIZ5L^%=6?1=4B&[_1IB$E4^_\
M7U%:T)J+L^IY^:X:5:ES1WCJ>N4445VGR84444 %%%% !1110 4444 %%%%
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M?(A_[Y7D_B:V],T+2M&CV:=86]L.YC0 GZGJ: ,0^*]3OOET?PU?3 ]);LK
MGUY)/Z4Y;7QI>\SZCING(?X;>$S,/Q; _2NIHH Y,^"#='=J?B#6+OU5;CRD
M/X)BK5MX%\-6W(TF"9O[UQF4G_OHFNBHH IP:5IUL,6]A:Q ?\\X57^0JVJ*
MOW5 ^@I:* *NHPW4^GSQ6-R+:Y9<1S% P0^N#UKEK;X=6,LZW6NW]YK-P#G%
MS(1&#[(.*[.B@""UL[6QA$-I;Q01C@)$@4#\!4]%% 'C_P 64G.J6YD=RC "
M&,<C !W$^ASC\C7FTBJN =P;J?:O6?BE#<W[A8K=5BLXO,>X<[023PH/<\<
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MG$0ASZ/R6YZ3134=9$5T8,K#(([BG5J>8%%%% !1110 4444 %%%% !39/\
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M#- &E15!-;TYX9)?M(58R ^]64KDX&01D#WJS#=P7$DL<,JNT1"R!>=IQG%
M$U%%% !1110 5CZ[X@@T6.*-8VNK^X.VVM(OOR-_0>I/%1:_XA_LQXK"QA^U
MZM<?ZBV'0#^^Y[**-"\/?V?+)J.H2B\U>X'[ZY(X4?W4'\*B@"#1O#TYOO[9
MUV1;G5&_U<8_U=JO]U!Z^I[UTE8NM>)].T5EAD9[B]?_ %=G;KOE?\.P]S65
M_9GB'Q* VK7)TK3V_P"7&T;]ZX]'D[?1: +VJ>,-.L+K[#;++J.HGI:VB[V'
M^\>B_B:IG3_$^OG.HWJZ-9G_ )=K)MTQ'HTAX'X"M_2]&T[1K80:?:1P)WVC
MEO<GJ3]:O4 9&D^&=(T4E[.S03'[T\GSR-]6/-:]%% !1110 4444 %%%% !
M1110 4444 %%%% '/>,=&GUS1Q:VUO!)*6^_*Y7RQW(QWKP&>S%I<21.P+0L
M5E5NH/(P/6OIY@2I ."1P:^?_$WA/6],N9KBXM-T"'!N%(Q(2>O7.3651=3R
M\QI7M-(YGRCY6\L0@Z$#K30A\MG ^0'!)]:0DD;=Q&.V>E  R>XZ#;61Y&XH
M8E2,L-QSQP*TM+U5["2\)$1-W;/;-NR-H88S6=++O$>%P%&VHUR%#-GGH*"E
M-Q=T:E]JKW^GZ78O&J1V*-&KJ3EP6SD_G6<!M<D$L >?<9I65D"%A@,,BF]B
M"HSQ0*4Y2=Y ,!@IRO/)ZTZ6-48;9=X/.5'2D5EP2RDJ1@#.,&DS\HR 0.X]
MZ!#D#%OD!+8S\M:WABYGL-9AN[:))W5@%B=B-V3TX(K/%G+A!N :3^$'D+7I
MWPYT">U:WNY["UN;>4MB?C? P]1[_P!:<=7H;X:FYU$DST+1+)+/3_D@>#SG
M,S0MC]V6ZKQVK2HHKI/HTK*R"BBB@84444 %%%% !1110 4444 %%%% !111
M0 5RWC#_ (_?#G_84C_K74URWC#_ (_?#G_84C_K0!U-%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>$?&/Q ][K\>
MD1/^XLURX'>0_P" Q7NSL$1G8X51DU\G:]?/J6OW]Y(<M+.S?K6^'C>5SEQ<
MK1MW,ZI8+6XNGV6]O+,WI&A8_I45>\^!-/\ $4_A;3S!=Z?869CR'A@WS,,]
M]W _6NF<^57..E3YW8\HM? ?BF\7=%HET >\BA/YXJU-\-/%L%M)<2:25CC4
MNW[Z,D #)XW5[D?"MU-<"2Z\2ZM+'WB618@?^^0#63XR\.6>G^$=3O(KS4DE
MCA)5C>R$9Z8()P0<UBJS;L=#PR2N>8W_ (>U+5-"\,:;IMJUQ/\ 8Y+AE! P
M&D//-8MSX&\46@)ET2[P.Z)N_E7H%Y!;6NI^'8[O4[NQC&D*@>S8^8&R2,@#
M)'TS6CH]IKEW?3VEKXRU*&91OABOK,#>GKSUZCIBJYVB723?_#'BT]C>6I(N
M+2>$CM)&5_F*KU]'KIGCF*("74=&U YY6XMBG'U7_"O,_BI8W%G>Z<USI^G6
MLDD1+&RSACGOD"JA5YG8BI0Y8\QP%O/):W,5Q"Q66)PZ,.Q!R*^JO#>KIKOA
MVQU%"#YT0+ =F[C\Z^4:]U^"E\TWAN\LV;/V>?*CT##/\\U->-XW*PDK3Y>Y
MZ=7(?$G7VT#PA</"VVXN?W$9],]3^6:Z^O%/CAJ#OJ>FZ>#^[CB,Q'NQQ_(5
MSTH\TDCLKRY8-GD_7K7M7P?N()?"6JVLMGYRK+\Z@9,H8?=KQ6O2_@W?7-OK
M.HPQ,7B^S>:T ZN0P&1[X)KJJJ\#@P[M41UVH:/=ZQX>O_"<T"QW\0^TVC32
M;MT>?E&[NPY4GZ5X1+&\,KQ2*5="58'L17TOK,;:V([[2KZ&VFT]6D$[J<@D
M<HP/(7'7(]*PKJ#PGXHTLVVL6::7JFPM^]4129Q]Y6X#@UE3J<IO5I<ST9X'
M6CH>A7_B+4DL-.A\R9AN.3@*/4GL*]6?X5^%(=*6XDUF;<JAV?S4PPZD8^E=
M!!=^']#2.S\(6D5WJ/"E+9=^Y?\ II)V'?.<\=*T=96]TRCAW?WF58;2/P3I
M>GZ+81)#JMR%+WG#J#P'>0==HSQVK)^('@K2=+\'W.H23&34%D5EN7 #RLQY
M!QP1^'&*[JRT;[/9W]]K,\3WMW&1<2C[D28^XN?X1^O6N2^*SRWO@A+F&%OL
MBS1X9^&Q@X8#T.0*QC)N2.F<4H.Z/"Z]I^"NOF:TN]"F?+0_OH0?[I/S#\\?
MG7BU=;\-;]K#QYIS!B%F8PM[AA_CBNBI'FBSBHRY9IGTM1117 >L%%%% !11
M10 4444 %%%% !1110 4444 ':N?\&_\@.3_ *_+G_T:U=!VKG_!O_(#D_Z_
M+G_T:U '04444 %%%% !1110!S?BC2Y9HQ?VJEI$&)$ Y9?4>XKBQ>MC(.0:
M]8KG=7\*6-ZSW$3_ &64Y9F'W#[D?_JKQLPRM8B7M*?Q=?,]'!XU4ER5%I^1
MQ7VY_04QKMR,D\436$ZW#1P2PRQC_EK@@'Z#O5S2H18W(GNX(KLJ<JN2H7^>
M3]:^?C0@JG)4DH_C^5SUY5X\G-"+?X?F=3X3TR2&!K^Y0K)*,1J>JIZ_C72U
MF:=KEIJ#>4"8IO\ GF_&?H>]:=?98:-.-*,:3O$^;K2G*;E/<*Y#X@:1;WFD
M)?F$&XM74AQUVDX.?;O77U'<01W5O)!,H:.12K ]P:V:NK!1J.E-370\-+*.
MI J-KB)!RXK6\1^"-8TVX=[*%[RT)RAC&74>A'7\16%!X7UVZ621K":"*-2S
MR3J450/KU_"O/=.:=K'V]+%86=/VCJ)+UU^X479GD\N ?5SVJPD8C'')/4GJ
M:CM(!;VZI_$>6/J:GJ?(TT;Y@HK0BT74)K$WD=LQAP3G(R0.I ZD5GGI19H4
M9QE?E=['J?@O48K[P[ BRAI8 4=>Z\G'Z5T5>.>'M3?1M6@G0_NB0DJ^JG_.
M:]-UO7$TF&!8H6NKRZ?R[:!#@NW7)/8 <DUWTY\T3X_'X5X>K;H]36HKF#-X
MT@7[1)!I%P@Y:UBWJ^/0.3@G\*-4U369-4TRQTP6]J]W \LGVN,N4*X^7"L/
M6M#A.GHKEQK&M:+=P)KZ6<MG/((EN[567RW/0.I)X)[@U>\1:O+I\$%K9 -J
M5X_E6ZD9 ]6/L!0!M44R(.L2+(V]PH#-C&3W-/H **** "FR?ZMOH:=39/\
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MD?\ 6NIKEO&'_'[X<_["D?\ 6@#J:*** "BBB@ HHHH **** "BBB@ HHHH
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M_P#CSG_ZYM_*N=\/ZS8V?AZPBEE^<1_-M&=O/>M'7]0DM-+?[,BR33*RQY;
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MF:].,$EHCP)U92E>3$+@E]_S*%P&[@=L4D<BM&=REF Y . /ZYI 1\RA.&;
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MZ?8>E(\(-LDS!R9<J!G''M_C418[O+)4*,$-(1V[4 /CN4MVEVJX0NQ*@Y"
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M!'+G^@]JZ*C-'X5RMMN[.^,5%6044<T4AA1110 4444 %%%% !1110 4444
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M=9D\O0-+,=N?^7Z^!1/JJ=3^.*=_PAKZ@XDU_5KO4&_YXHQBA'_ 5Z_C75
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M* "BBB@ HHHH **** "BBB@ HHHH **BGGBMH))YY%CAC4L[L< #UKQ+QO\
M%NYO))+#P\Y@MA\K771W_P!WT%5&+EL1.:BM3U/7/&>@>'0PU"_C$H_Y8Q_.
MY_ ?UK@+_P".=LK%=/TB21>SSR;<_@/\:\7=WE<O([.[')9CDFFUNJ26YS2K
MR>QZ<_QNUTSADLK18_[F"?UK6L?CH-P%_HQQW:&3^AKQNBG[./8GVL^Y]/:%
M\0_#?B#:EO?"&=O^6-Q\C?X'\ZZGZ5\<=#D<'UKT+P9\4]2T"2*TU-WO-.^[
M\QR\0]CW'M6<J78VA7Z2/H:BJ>F:G9ZQ817UA.LUO(,JR_R/O5RL3H"BBB@
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M .NE;1;Q]12R2YB:/R1.)USM$?KZYJQ:Z,+?4HQ.4N+2>&5XW7<!E1TP>0:
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MJ(BQHJ(H55&  , "@""PL+73+..ULX$AA0855&*LT44 %%%% !1110 4444
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M2JRAD1@N<\8XS35L[EK=+AK9A;^9M9N@)'45ZCH7AZSM].(DB2:.5A+'O3!
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M Y'2C)!XZ4?6@@CK3 "<MFDP2:<2N!@<]Z3]*0 JDDXH_*E5MN2!0N,_-TH
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M.R X)[>U>E7OANRNKQ;GRU!3YO+' =NHS5"^TK4]3)\ZWAC"Y(57^7/]3[T
M<+'-F-HXQ&N[EB!D_AZ4Q88UWQ[<AL'@\J?\*U'T6>VO9%DB94DY5B,<^E/M
M]%,VI6XD5O+9PJX.-^#\P_ 4 9 +0PHQ<%IF)VMS@ XI]I9RM,0D3F1CM5<<
MFNCT30K>XUQ@R%H(F9O;@\#Z5T$WAZ9-2-W8W"P[B3R.5SUQ[4 <:=!NFN#'
M%<'S67#QP $D^A/TK5TG0U,B6\MM+YH)_P!(*YP/1@?YBNSLK3[+"%8HTO\
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M:<JKMY.*& F[#;AP:UXKY&M]P.V<D!L=ZR& V@]ZO:;-;1R@3I@]F)XJ9*Z
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M;HK*4G+<VC",=@HHHJ2PHHHH **** "BBB@ HHHH .U<_P"#?^0')_U^7/\
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MUY[B9$MID@*Q-M(#,?FS]2*B$%!<J-:]>5>?/+?R-'4;&\6_N+E+9Y4^W03
M)U95CP2/QJQJ]_J,]O#!:6%Y&LV?.E51NC7T ]3^E;X& !G/O2U9B<=?>'9+
M^>!K2*:U2"R"PAF*_,&)V-CJ".OUKJ-/&W3X%^S?9L(!Y/\ <]JLT4 %%%%
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M.QB P%@3^0J_5;3F#:7:,.AA0_\ CHJS0 4444 %%%% !1110 4444 %%%%
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M:L4R)/+B5,YP,4^N<04444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MW8J>AS7IM?28.FH4DM;^9X69U)2K:VMT:ZKU"BBBNH\X**** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4'D<C-%% '.W\,SN\S1$+GTK/5@ 58<=JZJZMC=*J&0J@.2 .M9-_9
M*DZC&R+& P&<5K&71C,G!/2CI3S&X9MN6V]QTIE: .4A00?RIN:4X)Z_C0P&
M0%.: $I77:![TA'S<TK8P,9HN G<8ZTYB"OO302,8 -/"Y;@$CO0 B1N^=JD
MD#)P*TM-M$N8SCY9$/7UJ>QM+GRFV,(PPZD=:T+.T6TC(SEFZFLY3$6<4445
MD 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M6W10!B?\(GI'_/.Y_P# R7_XJC_A$](_YYW/_@9+_P#%5MT4 8G_  B>D?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 445%<_P#'K-_N'^5
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MD >]<MX^T-_$'A686KNMW //MV1B"2!R./45YI:Z_J?Q#NM"\.DRQ+;C=?2
MD%]O&>/;]32C3YE>Y4ZW)+EMZ'N;.J@%F !]33NO2O$/B#;*/'=M::[<7EMH
M1A5+:2'E8R!C//H>O>O3_!ND/HWAZ&W;5I-35OG29CD!3T"]\?C1*%HIW"%5
MRDXVV.@HHHK,V"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
+ %%%% !1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>img268224062_7.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img268224062_7.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" )X!7<# 2(  A$! Q$!_\0
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M2<D_**VZ$[HB4>6378****9(4444 %%%(&5LX(.#@X/2@!:*:LB,S*KJ67J
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M;W5S%>M.5A92"A&>3R<]ZCM[2'3_ (F+!;*(XLY"CH,IDC\Z7P?_ ,A#7?\
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M7Q1H=N9+A6L;WS+D+&V"I4=/[WTK7F?P[K/BSP]J;3WBW\L,C64>"J,H!)W
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M%S/>H?MI2S"J4WR CA@1TSCGBG?$G_D6M/\ ^O\ M_YT>//^0[X0_P"PFO\
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MV/\ L_[3G[8=V_?MZXZ8KK)_$V@>#U31KN^N#+;P!U\T&220$D#G^(YJD?\
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MSN;>I QV[UT-% &/XHT&+Q)X>NM,D(5I%S&Y_@<<J?S_ $JSHFE0Z)HEGIL
M'EV\83([GJ3^))/XU?HH X_5?"FI6^N2ZWX9U"*TNK@ 75O.FZ&;'0\<@_X]
MN^1K7@GQ/XKT^1=;U>T61,&VM[9&6)7R,LY/)^7<!]:]'HH Y_Q7X?GU_2;:
MT@FCC>*YBF+/G!"GD<4>(] GUG4=#N89HT73[L7$@?.6 QP,=ZZ"B@#F?$OA
M:75+RWU;2[S[!K%J-L<^W*NIZJX[BLJX\-^+O$"K9:]J]G%II/[Z.Q1@\P'8
MD] ?\BN[HH YW5_#1O+KP^;-HH+?2K@2>60>4"X 7%;.H6[7FG7-LC!6FB9
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M?/*H>1QW-=/(N^)T'\2D4ZB@#"\':%/X<\,VVF7$L<LL18EX\[3DD]ZW:**
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBLI_$NB([(VJV892009AP: -6BLG_ (2C
M0O\ H+V?_?Y:/^$HT+_H+V?_ '^6@#6HK)_X2C0O^@O9_P#?Y:/^$HT+_H+V
M?_?Y: -:BLG_ (2C0O\ H+V?_?Y:/^$HT+_H+V?_ '^6@#6HK)_X2C0O^@O9
M_P#?Y:/^$HT+_H+V?_?Y: -:BLG_ (2C0O\ H+V?_?Y:/^$HT+_H+V?_ '^6
M@#6HK)_X2C0O^@O9_P#?Y:/^$HT+_H+V?_?Y: -:BLG_ (2C0O\ H+V?_?Y:
M/^$HT+_H+V?_ '^6@#6HK)_X2C0O^@O9_P#?Y:/^$HT+_H+V?_?Y: -:BLG_
M (2C0O\ H+V?_?Y:/^$HT+_H+V?_ '^6@#6HK)_X2C0O^@O9_P#?Y:/^$HT+
M_H+V?_?Y: -:BLG_ (2C0O\ H+V?_?Y:/^$HT+_H+V?_ '^6@#6HK)_X2C0O
M^@O9_P#?Y:/^$HT+_H+V?_?Y: -:BLG_ (2C0O\ H+V?_?Y:/^$HT+_H+V?_
M '^6@#6HK)_X2C0O^@O9_P#?Y:/^$HT+_H+V?_?Y: -:BLG_ (2C0O\ H+V?
M_?Y:/^$HT+_H+V?_ '^6@#6HK)_X2C0O^@O9_P#?Y:MV6JV&I%Q97D%P4QO$
M3AMN>F<?2@"W1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 ':N?\ "=O _ANW9H8V8R39)4'_ ):O
M70=JP_"/_(LVW_72;_T:] &M]DMO^?>+_O@4?9+;_GWB_P"^!4U!('4T 0_9
M+;_GWB_[X%'V2V_Y]XO^^!4W2D!!Z$&@"+[);?\ /O%_WP*/LEM_S[Q?]\"I
M2P498@#U-"LKC*L&'J#0!%]DMO\ GWB_[X%'V2V_Y]XO^^!4U% $/V2V_P"?
M>+_O@4?9+;_GWB_[X%34R5#)"Z!V0LI&Y>H]Q0 S[);?\^\7_? H^R6W_/O%
M_P!\"N+L-8U'PKK$>CZ_,;BSN&Q:7[>O]UO\_I7=54X.)$)J:\R'[);?\^\7
M_? H^R6W_/O%_P!\"IJ*DLA^R6W_ #[Q?]\"C[);?\^\7_? J:B@"'[);?\
M/O%_WP*/LEM_S[Q?]\"IJ* (?LEM_P ^\7_? H^R6W_/O%_WP*FHH A^R6W_
M #[Q?]\"C[);?\^\7_? J:B@"'[);?\ /O%_WP*/LEM_S[Q?]\"IJ* (?LEM
M_P ^\7_? H^R6W_/O%_WP*FHH A^R6W_ #[Q?]\"C[);?\^\7_? J:B@"'[)
M;?\ /O%_WP*/LEM_S[Q?]\"IJ* (?LEM_P ^\7_? KG-]GIOC6\NY6,*FUMH
M %&%)>1P,@>X S[^]=37-7.G0ZKX@UFQN"PCEL;<%D.&4[I,$'U!YH Z6BH+
M6>*>(^3-YHC8QLW?<O!S[U/0 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 ':L/PC_P BS;?]=)O_ $:]
M;G:L/PC_ ,BS;?\ 72;_ -&O0!N5X]\1+[5-;\33V>BSNB:':FYG*,1E\@XX
MZG&/UKURYE:"UEE6-I&1"P1!DL0.@]Z\IT+X<:KJL%WJNJ:K>Z7>7\KM+;Q#
MJN3@-S]>/3% '2ZOK@UKX27>K6[E'ELMQVG!1QPPS['-><>%[YHM;\._V#JF
MHW5[.P&H6\FXQJO&[KVQGZ5T^G>'];TOPAXJ\,-:3SQ ,UA,%XF#=0/?H<?6
MNV\&:6-,\+:;'+9I;W:VZK-\@5L^YH XZ2VO?B+XOU:SGOY[70]*D\CR8&VF
M63D$G\CU]JW-%\ OX=UR&[TO6KM;'!$]I,=XD],>GUZUEW^G^(/!GBN_UK1=
M/;4],U)@]Q:QGYT?U Z]23^-:>AZ_P"+-<UR%GT'^S-)C!$WVO(D<GIMZ?RQ
M0!VU%%% !39)$BC:21@J("S,3P .].JCK-BVIZ)?6*OL:X@>,-Z$C%"$]C@O
M$OB$>,K*71]#TB>^7>/]+*[40@]1_P#7QUKT'3()[72K2WN9/,GBA1)'_O,
M 37(?#O7;5]-_L&58X-0L69'C&!YF"<L/4^OYUW-:U=/<2T1C0][]XW=L***
M*R-PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "L6U_Y'+4O^O.W
M_P#0I*VJQ;7_ )'+4O\ KSM__0I* +-M:P:=J=TPN,&_?S5@;^^J@,5^H )^
ME:-9NL:8VH+:213_ &>XM+A9TDQG@<,I]BI(_&M%'61 Z,&5AD$'((H 6BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M6HLO4H:K7_+J=)8>,KJT<G4&\^$@_-M 93VZ=B<#\:KR>*M7>;S%G6,9XC5
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M.JQ%B54_3./H!6I63=:=<?\ "1V6J6TBJBQ/!=(Q^^AY4CW##\B: -:BBB@
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M5A^!9/AZ+C11$)!KVU.2LN/-V\_[/K[5GM-XD\5?$6^\0>';."Y73G\B'SV
M10 0",D9)Y/XTK>_=]!\S5.R>K[:GH_P\\0R>(?!EO=32>;=PYAF)ZLR]"?J
M"#7G.DZCXM\3Z]?2VGB,6FJ6]QM73I250Q@X.!T.._&:M^ +C4?"?CC4-&UF
MV6W>_B-RL$)#+N&6 3!/;<,>PK(\8>(/#>M(==TI[C3/$5O< "+RR#,,_>..
M <?RP>M"C:3LMPE.\$V]5\CK/B7J^LV&L^'K&UUG[!]J4I/,#MC!RHW'T R:
M=83:K8>&/$=T_B^WU::.SW1&VD#&!AGG\?Z5@^/[J*\N_!%WX@C*12VZR7RA
M2" =A?@<COQUK7MW\%MX/\4?\(H'$GV$^?N$@XP=OWOQZ4K6@M/ZN.]ZDG?\
M?+L9FD_\+$N/"T?B.PUT7,95G:UD4,Y"D@]5P>G8YKTCP1XG7Q9X;BU J$G5
MC%.@Z*X]/8@@_C7GGA?XD:+X?^'T&G[Y9=3CCD"P+$<;B21ENF.174_"71+G
M1_!V^[0QRWDQN AX*H0 ,C\,_B*51:.ZZZ%T9>\E%WTU.\HHHKG.L**** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** /+_'E]KTGCW2=%TC5I+$7</4?=W9/)X]JBM/$7BOP;XHL=,\57,=]I
M]\WEQ7**/E)('7 Z$C(/8U%X\U.UT?XK:!?WLACMH8=SL%+8&6[#FJGB'6X/
MB1XKT+3-"CEDMK68S3W#H5 7()Z], 'ZDBNE*Z5UI8X92M)M/6^B'>*-6UJ;
MXF:CI-OXF72+2.)'1IW"H#L0D#W))/YUL7/BF[\(> !<R:M!KFH3W)B@GC;<
MF2.AQZ#M[BN8\3MX=7XQ:J?$P8V'V>/&T,?G\N/'W>>F:O\ B;2M)U+X=VU[
MX.A>6RT^],S)M?)X 8X;DX^7\,T[*T4_(7-).;3UUZ_H7(?"/Q U&U75)_%#
MVU\XWI:AB$7T! X!_ U8US5?%VF?"ZXNM6E6UU6.X1%EA(W,FX#)QP">>E:=
ME\6_#$VE+<W5S);W 7]Y;F)BP;T&!@_6L;QEXFA\5?"B\U""UGMT%RB!9EQG
M##D'H14KF;7,NI;Y%%N$M;=S)T?Q3XCT;7]"BNM>@U:VU/9O@4AFBW8Z\9!&
M?YU8\4ZOK4OQ(O-)M_$RZ3:I$KJTSA4!VCCZG-97@_3[3PEXZTHZE DUOJ5J
MDEG</_RR=@/PSG*_B#4WBAO#Z_%V^/B4,;#R%^Z&/S[1C[O/K5V7-HNAE>7)
MJ^O<]+\%M/;^'IY+_7X-7*3,QNHGW*BA5^7/MR?QKSC1/B'JT_CZ&\NIYET&
M^NGMX4<811P%_$94GZFM+6=?\.:3\,;N'PEO\N_N3;(,.#O*KO/S<_=P/J17
M,ZEX3\:V_@Q+&YTFU33[$M=^8DBF4<$L>&YX[8[4HQ6KEU+J3EHH]-=-3T+X
MKZ[JFBZ+9#3IVM8[F?RY[E1DQKCMZ9Y]^*L> K37[=9Y+O7HM6TAT!M)LEG8
M]SD\C'3!SS67/X]T6X\#:0VN6DMU!J"^3<E4RL;*<,3[]QCGO61\-;M+3QSJ
M>D:)>37F@&)I59U(V'C'7OR1GO4\KY&K%\Z=5.^YB^']5\0ZY:SSS>.X-.,<
MIC$=U*%9A@'(]N<?A72>*KWQ#/XVT;0]*UQK?[39(3*IRCL Q+=.^*XOP<_@
M5=/NO^$I$AN_M!\K:)#\F!_=XZYKJO$VJZ;HOQ0\.ZC+(8].AL5*L%+$(0P7
MCKW%:27O:+\#"#]R[?;J7['Q%XJ\(^*[+2/%5Q%>V5\VR&Z0#Y2>!S@=R,@^
MM>J5XWK6M0_$;QKH5EH<4LEK92^=/.Z%0!D$]>G _$FO9*PJ+:ZU.NB[W2=U
MT"BBBLC<**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M #M6'X1_Y%FV_P"NDW_HUZW.U8?A'_D6;;_KI-_Z->@"UJEK<.\%]9A6NK4-
MMC<X$BMC<N>Q.!@U:LKV*_M%N(B0IR&5N"C#@@CL0:DGE$$$DK*[!%+$(I9C
MCT ZUBVUC<W5OK$WEFT_M#_51MPP^0+O8=B?Y =Z>Z)>CT,S3)&^WVEF7/\
M8\,I-E<;?]<XS\A/H,G!_BQ[<ZOB*22 V<]G^\U)'86T&,B7(PP/H,<[NV*K
M7$LVHZ?'I$6FW%K.IC!8IB. *0=RMT.,<8J]?M)8ZNFHFWEG@,'DGR5WM&=V
M<[1R0>,X]!5=2%M87P\5?3FD,C/<22L]P&7:4D[KCMC@?K6';R,^I06,CXT>
M.ZWV]QMQYLH;<(\^@;^+OC'UV;*">[;4[K9):"\54B###C"D;R.QY'_?(J@6
MGGT9-"73)DN%C2,L4Q%'C'SA^AQC(QSFA;@]D7O$+/"MG<6H#ZA'*1;0GI*2
M,,I]!CG/;%2>'BK:>\S/FXEE9[E2,;). 5QVQ@#]>]1WZR66L0ZFUO)<P+;M
M"WEKN>(E@<A>X.,''H*2RMI[J75+P1/:)>(J1HPPV0I'F,.Q.0/7"BCH/[1D
MV<C#4(+ 2$Z-'<DP7.W_ %DH;/EY] <_-WQBNDU._%C H2-IKF4[((5ZNW]
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MFY7= V3AN">A[<'FK>G>.I4\7ZIH.N00VC6R-+!*K'$B ;L\_P"SS^!I.G)
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M"??/3:A907]HT4Q("G>LBG#1L.C ]B*'HPBKH^:M=_Y#M\=Q8><W+1[#C/\
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MPSZXS4#Q-H^J0-;%?LE],4D@_NR$%MZ_7!R/?/K4OL4M+,VJQ;7_ )'+4O\
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MC '%6ZJUMY&:H-M<WG^)MT445@=04444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 =JP_"/\ R+-M_P!=)O\ T:];G:L/PC_R+-M_UTF_]&O0
M!;UJW6739)?,:*6V!GBE49*,HST[CJ".X->8W5_JVH7!N)[R17/(5'*JOL *
M]>=5=&1@"K#!![BN(NO!=VEP1:2Q- 3\N\D%1Z&O.S&GB)PBJ/S/1RVK0I3D
MZJWVNKG(1WNI"YDC%W)D#<#TV;NI!]6P<GV]S223:A!"SB]F&SYPVXL4(_B&
M>_\ GI7=R>"8_P"SD6.9?MP)+2$85L_P_08X_P#KU7T_P9.;E6OWC\A3DHAR
M7]O85RRHX_VL'?:W7[[_ -:G5'$8)49QY5K?I]UNWZ''^=?S1Q_Z3)&BCY4C
M<J!Z]^23R2>233$N]3CN6C%W)C!D7_88\,P/8D<9^O<DUV-YX+N5N&^Q21M
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MIC*\I2#+D&;!P"HQSFN@U7Q_#H7AFQO]2LY(]2O%S'8 _/G/?T'3\ZPO'O\
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M$WC[5++P;=ZYJ&A/:S0W"Q+;R,1N!Q\V<>]:VF^,[?5/ MSXCMHP7M[>226
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M>$I\CG!6>YW-%%%?6'CA11D9QGGTHH **8LT3MM61"WH&&:?0 4444 %%%%
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MU\'SV[;)=6N95NYW!P&F#JW!]!M 'L*ZP=!GK0 4444 %%%% !1110 4444
M%8MK_P CEJ7_ %YV_P#Z%)6U6+:_\CEJ7_7G;_\ H4E &U1110 4444 !&1@
M]*S[&XMX[RXTJ&#R!:(C(HZ,C \CV!!'X5H5G:A)::=*FIS1MO.VV,B_PJS#
M&?;.* -&N&^).K:EH]KIT]A<M"#*V_'\1 ! /MUKN:X7XK0>9X6AF _U-TI/
MT*L/ZBIG?E=C;#J+JQ4MFSJ="U>'7-&MM0AX$J_,N?N-W'X&J7B_P\GB30I;
M48%PG[R!SV<=OH1Q7E_P^\8)H.H-8WLFW3[DYW'I$_K]#WKVU75T#HP92,@@
MY!I0DIQN77I3PU6W;8^6[N&>SN9+>XC:*:-BKHPP0:K,Q['%>@?%\V7_  DM
MO]G*FY\C_2-OKGY<^^/Z5YW7%./+)I'TV%JNM1C-JUR[:ZSJE@-MK>SQ*.R2
MD#\JDN/$.M7:;)]0N74]FF.*S\&C;1SON7]7IMWY5]R$RQ^\WX"G!L4TD#J<
M?6EQ4FB2Z#P]?3VA6JV6@6%L@XCMT'XX&:^7:^C? VOP:]X9M720&X@C6*=,
M\JP&,_CUKHP]M3QLXC*T'TU_0Z6BBBNH\(**** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BJ4M_F5H;2(SRKPV#A5/N:18=1D&
M9+J*(_W8X\X_$FL_:*]DKD\W8O450:/4HN8YX9O]ETVY_$5)!?K),()D:&?&
M0C?Q?0]Z:J*]GH'-W+=%%9VN7DMAI,UQ 0)%QC(SWISDH1<GT&W97-&HIYTM
MH3+(2%'H,U!I-S)=Z5;7$I!DD3+8%3W()MI (Q(2/N$XS3A)22EW"]U='-ZI
MJ+7<F$++$!P#W/O69CC/Z5+< K,P\MD&>%;J*C[9K?T.?5ZL3I1U[49I0Q'2
M@99L)I%O(55R 7&0#UJUKDLGV]X]YV;0=N>*HVC*EY"[D!0X)/I5^[6/4=9"
M1R#8X W#GM4O>Y2^&QEUM6;L^A79=F.#W.?2LJ:WFMR"\;*">"1UJ_:7$4>C
M743. ['Y5]:'L$=&9JNR-^[9USZ'&:V;R1K'28[9G+33<N2>@_SQ6;IOD"]1
MKAPJ+\WL31J%U]KNGE!^7.%'H*;U8D[(J[OEQBC'&>_M1WH]QUID@!DFE[\=
M*3G'6DSB@"S!(3(D<DC&%&!P.WK79JP90RG((R#7&6=P+:8%E#QM\KJ>XKH;
M*[C:[6VAD+PK",?7/^%1+4T@[&G1114&H4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !VK#\(_\
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MUD_P/#Q>*]L[1^%!1117J'$%%%% !1110 4444 %%%% !1110 4444 %%%%
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M/&826'EW3+U%%%:'&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M!6L?^ 3T =+17-?\)I;?] K6/_ )Z/\ A-+7^+3-77ZV3T =+17,MX[T>/\
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ME6'4(1;LQ $JMF,GT/<?C2C6A)V3''$TY.USJJ***U-PHHHH **** "BBB@
MHHHH *Q;7_D<M2_Z\[?_ -"DK:K%M?\ D<M2_P"O.W_]"DH VJ*** "BBB@
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MO#'#&.BQJ%'Y"I:** "BBB@ HHHH **** "@@$8(R*** ,_[)/9ONL64Q'K
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M@UKUWGR333LPHHHH$%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%4=3UC3]'M_.O[J.!.P8\M[ =30!>JK?ZE9:7;F>^NHH(QSEVQ_\
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M DBMY'0D9Y"DBE4S&K)6CH51R:A!WE>1+:6D%C;);V\8CB08514U>6^%M?\
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M'RGYI6_NIW_/H*JG2J5ZJCU;)G:E!R>R.YT6$P:+:1M][R@Q^IY/\ZOT@ 4
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M9763_P M!_*NEE_U+_[IKF?!/_'E=?\ 70?RKGJ_[Q3^9<OXD?F=.ZH1EPI
M]:PM4O8WN%$:*6B/#$9YK8NU#VSJ5W9Z '!)KEIPRRE64J1ZUU,*LFMAKR,Q
M(8\DY;W--^O2@^]"MCC .:DYP.,\<BBDZ49&>V: % R<#O2$4IY.<<&@8S@G
M%  ,8)/7M1R #CCM1CI24 +@A<]JOZ=<O&ZQ*6W,PZGC;FJ&3W/3M4MO(BS9
M<$J>/<>XH0XNS.OHJM97'VA'(.55MJGU&*LU9UIW"BBB@84444 %%%% !4-R
M)#;L(OO^U344 9]K9[@6F4@= O\ 6ENK5$BW("!G!&>QJ_5#4)BI6/HIY)]?
M:LY1BHB=DBU;.9+=&/7&#^%2U#:J5MD!')&?SJ:K6VHT%0W5NEU 8GR >X[5
M-6!XLTC5M9TV&#2-4.G3I,':49^9<$8X]R#^%,-S8CM((UB 0?NON^Q]:2*R
M@AG:9$_>-U8G-><?\()XX_Z',_DU4+?PQXUN-;O=,'B]P]K'%(7.[#;]V/RV
MT[BLCUZBO,/^$$\<?]#F?R:N_P!#L[O3]%M;6_NOM=U&N))_[YR>:0S0HHHH
M *H7X*RQR 9_Q'-7Z9+$LT91^A_2IDKJPF-@G6=,KP1U![5+4-O;I;J0I)).
M234U-7MJ-!1113 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ JC<6LL<YNK,@2-_K(V/RR?X'WJ]14RBI+435RBNJ6Y/E7(
M,$G=)1@'\>AJ*WMM&L&,MO'9PL<DLNT'FM%T208=58>A&:S8+2W_ +9NQY$>
M!'$1\HX^]4.52.E]R&G=7)#J7GY2PC,[=-Y&$'X]_P *FM+3[.6EE?S+B3[\
MA'Z#T%60 !@# ]!2U2@[WD[LI+JPHHHJR@HHHH **** "BBB@ HHHH ****
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M"BBB@ HHHH **** "BBB@ K%M?\ D<M2_P"O.W_]"DK:K%M?^1RU+_KSM_\
MT*2@#:HHHH **** "BBB@ HHHH *Q_$NO0^'='>]D7<Y.R)/[SD' _0G\*V*
MS=;T2SU_3C97BMLW!U93@JP[C]?SI.]M"H\O,N;8^=C<27DMQ<S$&26:1V(]
M2Q)_G7H^DRKJ&FVR6A5Y70($!Y#8QS2:;X)TB+P]>WLBRS3)=30)O;Y1B4H#
M@=3WJ]H=M%I>JVLEJNSYUC8 ?>5CC!_//X5X&8PIRK4Z55[OI]Q[4<0IT6Z:
MMRHZCPOX4LO#-IMB DNI /-G(Y;V'H*WZ**^@2ML>(VY.[,#5/\ D<O#_P#U
MSNO_ $%*I_$C_D1[W_?B_P#1BU<U3_D<O#__ %SNO_04KSSQ]XBN]:UQ]#LV
M(M86V%0>)''))]A_2M\.O?YV[*.K?DCGQ#]SE2NY:)>;.3M/^/O3/^NJ_P#H
M=?0][96^H6DEK=1++#(NUE85X%<:+=PVT<B2(S0@G"\'KGBO4/AWXHEU[3)+
M:\8M=VV/G/5T/0GW[?E6E;$4<7#VE"7,H[_-F=&A5PD_9UXV<MOD<:OAB?0O
MB+IUD,O \ZRP28ZH#G!]QT->S4QH8WD21HU9TSM8CE<]<4^N*,5&]CT:U:56
MSENE8Y;QAX.A\2VZRQ,(;^(8CD/1A_=:K/@S3=2TGP^EGJ;*9(W81A6SM3L,
M_7-=!13LKW(=23AR-Z!1113("BBB@ HHHH **** "BBB@ HHHH *I:KJUEHM
MBUW?3"*)>!W+'T [FJ.N>(XM+D2SMH6O=3F_U5I%U_WF/\*^YJMI?AN5[T:M
MKTRWFI=8T _=6P]$'K[]: *@L=4\7-YFIB33]&/*6:MB6<>LA[#_ &1756UK
M!96R6]M"D4,8PJ(, "I:* "BBJ5]J^G:8FZ]O8(!_P!-' /Y4 7:*Y67QQ;S
M-Y>D:9?ZF_9H8BJ?]]-BE$_C*_7Y+73],0]#*YF<?@.* -K[VO8/2.VR/Q8Y
M_D*MSPQW$#PRKNC=2K#U!K!TZQU'3-22?4]4-ZUR#%GRPBQGJ  /7FNBK.'5
M>9*ZGG6H^"Y+>266[OXDTR,%_,;[X] ?QP*JN!XJO(%6[LX[R.%1"J@[6ZY4
M^X%;_P 19&&AP1 D+),-WX D5YSI$[P:K9J"?.6=,$=\M7J87!J6'>MMSP,7
M6A0K^RC&Z=K]_P"ET/7/#V@C1;9C)();J3'F.!@8]![5<U?C39' R4*N,>H8
M&KU4-3;>L%H.6GE48]%!W$_I^M>5-*--I'N\JA#E0DE_(8G'V&Y^Z?X16-X(
M_P"/*Z_ZZ#^5=-+_ *E_]TUS/@G_ (\KK_KH/Y5A--8B%WW)?\2/S.CN8%N(
M2CL5&<Y!Z5RLN2[[I-Q4XSGJ*ZB^4O9R '  R<>@KE,8Y(X[5U,57<3/RXQ2
M#% P*4G))Q2,26WF2"3S'B$@ (VFM/4W@@B6-;9,RIG</X:QSG:0/K6KK&W=
M;;L_ZOC%-;&D7[K,LL?+V@=ZU1<V=MY,$$*3[L!W[YK)8,K%2"&!Z'K6Q96+
M6D/VN6)I)<?)&!TH04[E/4K=+>]9(AA2 V,]*IU+=><9V>X4B1N<$5$1@X/Z
M4B);@"H!RN?2@8R,8_&@^U';I0(Z#3+W>D<)@*'^\HX-:E<YIMT\<B!VD91P
M%%='5(ZJ<KH****984444 %%%% !1110 4A4-U /U%+10 4444 %%%% !7.:
M;_R/NO?]>UK_ .U*Z.N<TW_D?=>_Z]K7_P!J4 ='1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !116%XJ\56'A32VN[
MQMTC<0PJ?FD;_#WII-NR$VDKLU[J[M[&V>XNIXX84&6=VP!7G6N?&72+(O%I
M=O)?2#@.?D3_ !->3>)O%^J^*;QI;V8B$']W;H<(@^G<^]8%=4*"7Q'#4Q3>
MD#T.[^,?B2=B8%M;=>P6/=^IJHOQ9\6*V?M<)]C$*X>IH8/,@N)22!$H/XE@
M/\:U]G!=##VM1]3TK3?C7JT+J-0L;>XCS\QCRC8]NU>B^'OB1X?\0NL*7!M;
MEND,_P N3['H:^:J4$@@@X([BHE1BRX8F<=]3ZOUG3I]2MXX[>Y\@JVXMD\C
M'M6+_P (MJ7_ $%3^;?XUYGX%^*-UI$L>GZU(]Q8$A5E8Y>'_$5[K!/%<P)/
M!(LD4BAD=3D$>M>;7P4'+FG^;.N'LZWO=3EO^$6U+_H*G\V_QI!X3U$,6&J?
M,>"<MS^M==16/U*CY_>R_8P.2_X1;4O^@J?S;_&C_A%M2_Z"I_-O\:ZVL[7-
M<L?#VERZA?RA(D' [N>P [FA8&D^C^]B=*"5V3VZBPTZ-;F=<1)AY6.!]<FN
M'UWXNZ%IC/%9![^8<9CX3/U/7\*\I\7^/=4\57+*SM;V /R6R'C'JWJ:Y2O4
MIX=)*YS5,4]H'H][\9O$,['[-#:VR^@7<?S-9_\ PMGQ9NS]KA^GE"N(HK?V
M<.Q@ZU1]3TNP^-.N0./MEK:W*=\ H?TKO] ^*GA_6I$@F=K&X;@+/]TG_>Z5
M\ZT5,J,&7'$U(];GV$K*ZAE(*GD$'@TM?.G@OXD:AX:F2VNW>[TTG!C8Y:/W
M4_TKZ!T[4;35K"*]LIEFMY5RK*?\\URSIN!W4JT:BTW+5%%%9FH4444 %%%%
M !1110 4444 %%%% !1110 4444 ':L/PC_R+-M_UTF_]&O6YVK#\(_\BS;?
M]=)O_1KT ;E%%% !1110 56U&X-KIMS.#@I&2/KCBK-9GB $Z%=X&<*"?H""
M:F;<8MH<5=I'%*-J@>E+15FP:W2\1[HGREYP!G)[5^>17/-)O?JSZ9OECHAD
M]K-;",S)M\Q=RCVJ&M76)8YH[219S*Q1LDC'>LJM,33C3JN,'II^1-*3E"[W
M.I\+7!>REMF.?)?Y<]E/./SS6]7*>%6/V^Z7^$Q(3]<FNKK[3+JCJ86$I;V_
M+0\'$Q4:TD@HHHKM,#S[X@:F[W<.F(Q$:*)9 .['IGZ#^=<770^-XV3Q3.6Z
M.B,OTQC^8-<]7!6;<V?8Y9",<-'EZZDUEIT>HWT5N6BB9S@.XXSV'%)=6QL[
MN:U8J6A=D)4<$@XXJ7394@U.UED;:B2JS'T -+JDL=QJUY-$VZ.2=V5O4$G%
M1]DZ4FJNBTM^)40M%*)48K(""K#J".E>Q>']2.K:+;W;X\TC;)CIN'!_QKQV
MO2? ;"/P[(TC!4^T-@L<#H*WP[=VCRL[I1]E&?6]CK**:DL<HS&ZN/53FG5U
MGS04444 %%%% !1110 4444 %8MK_P CEJ7_ %YV_P#Z%)6U6+:_\CEJ7_7G
M;_\ H4E &U1110 4444 %%%% !1110 4444 <II"V[>%-3^U2>5 +R[9I/[F
M)G.?PQ7%:?XF>+5(KB2V62VB?< "06]#_6NLME+>#K_C*C4;@O\ [OVALUP-
MSHDUM=,L:N\;YV;,D_0T8>."JXM4\2ES6O%OUU^>QQYA4QE*A[3#/W;^];7T
M^1[+I>JVNL6@N+5\KG#*>JGT-6_,3=MWKN],\UY?X0BOM/FE6'S-]RK0I$>&
M!QD2<]E_K6*][>VTC)()4N0WSM*3G-=-;#355PHKF.:.9<M&,ZL;7_K\3TW5
M/^1R\/\ _7.Z_P#04KPO4I)8=:NR[%9TN')/<-N->EVNKWN_2+VZC9I;:"^9
M"W\85$(_PKF[VST'7=1BO]1:\M[DX^U+;Q@I,1_$/[I/>G1Q%+#3E#$:71VR
MPU7&4HU:";M;\3,U?4]^E0!"5,X!?Z8SBMWX3%V\1717[@MCN_[Z&/ZUI:YX
M=\''1XV6[NQYPS;^4V\ICC.#V[<TG@NYL-&U.TTS2XYI%N7(N9YU =SM.T =
M@,?J:Y,%4H87"/#W7-)_GM^!VXRA6Q6)6(BGR177R6OXGJ-84EYJ,7B(VK7$
M M%@-P?W9W;0V,9K=K/DTXR:T;QF4Q&U-N4[G+9IF12MI];U*S%_;O;6\<H#
MV\$BEBR'H7/8D<\=*J:AKMY;ZJUHUQ9V9CLH[@K-EMSL7!48Z@;>WK5VUM-8
MTZS6Q@>VFBB&R&67(94'W0P'7 X]\57O?#+W]\]Y/.AN1;0I#,$Y29&=MV/0
M[L8],T ;=A</=Z=;7,D1B>6)7:,]5)&<58ID7F>2GG;?,VC?MZ9[XI] !111
M0 4444 %%%% !1102 "2< =Z "N9U37[J[OGT;PZJ2WR\3W3#,5J/?U;_9JO
M=ZG>^*+J73-"E:"QC.RZU(#KZI%ZGU/:NATO2K/1K)+2QA$<2\GN6/<D]S[T
M 5=#\/VNB)(ZLT]Y.=UQ=2\O*WU[#V%:]4]1U6QTFW,]_=1P1]BYY/T'4USR
MZ[KNO[ET+3_LEJ>!?7RXS[K'U/XT =/<W=O90--=3QPQ*,EY&"@?G7.-XS6^
M9H] TZYU-QQYJC9"/^!GK^%/M/!=H91<ZS<3:M=]=UR?D4_[*=!721QI#&(X
MT5$7@*HP!0!RR:3XHU4%M5U=+")O^7?3U^;'H7/]*N:=X,T+3I?/6S$]QWFN
M6,KG\36_10 BJJ*%4  = !2T44 0W=LEW;M"^1GD$=5(Y!'XU!:7C;Q:W>$N
M5'X2#U'^%7:BN+:&Z3;,@8#D'N/H:B47?FCN)KJC-\2:+_;ND/:K((YE(>)S
MT##U]JY7P]X"N[75X;_4Y8=L/S+''R2PZ9/IWKLA9WD)Q!>ED[+,N['X]:##
MJ3\&ZAC'JD>3^M;0QE6%-TTG9^AR5,)2J555G'5%FYNHK2+S)6P.@'<GT [U
M7LX99)WO;E=LCC;''_SS3T^I[T^#3XHI!*[--,/^6DAR1]/2K=8).3O(ZK-Z
ML9+_ *E_]TUS/@G_ (\KK_KH/Y5T[KN1E]1BLO0M';1X)8VE$GF-NR!C%9U(
M2=:$ELKDR3<TS1N?,^S/Y0RY& *Y.9/+E90P;'<=*[&N<U.U\B4.[!C)Z#&*
MW9-5:7,\.<$8'/>DI<9.,].])CYL#CZU)@'7BI7EFF>,RR%L$ 9["HAGKU H
M&?6@:=C5NEADFO&$962(JP?/4U2_M&\_Y^7J)I&8L=['?][/>F''%.Y3G=Z$
MDLLDSAY9"[8QD]JB)I<\=J#MVY&<TB &,=\TX*SE4&,DX&?6FCDXIT8/FC'4
M>G- (V=&M?+ED:3AT&-I[9K9JM9I)Y0DF4"5@,D=QVJS5HZXJRL%%%%!0444
M4 %%%% !1110 4444 %%%% !1110 5SFF_\ (^Z]_P!>UK_[4KHZYS3?^1]U
M[_KVM?\ VI0!T=%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 5=1U"WTK3KB^NWV00(7<^PKY@\4^)+KQ1K<VH7)(0G;
M#%GB-.PKT_XUZ\\-I9Z'"V///G3X[J.%'YY/X"O%JZZ$++F//Q52\N1= HJU
M9Z9?ZBVVRLY[@YQ^[0FNAM/AKXMO "NDO$#WF<)6SDENSF4)/9'*5L16_E>$
M+B[(_P!??1PK]$1F/_H2UT7_  J/Q0%);[ I_NFY&:(_#M]JOA#P[I=BB&ZN
M;J\F*NX4?+L7K^%2YQ>S+5.2W1PM%==<_#'Q=;9SI1EQ_P \9 U8UUX:UVRS
M]ITB\CQZQ$_RJE*+V9+A);HRJ]6^$?C-[:\7P[?29MYC_HK,?N/_ '?H?YUY
M6Z/&VUT9&'9A@TL4LD$R31,4D1@RL.H(Z&B<5)684YN$KH^P**R/"^L#7O#-
MAJ0(W31#?CLPX;]0:UZ\]JSL>NG=70R65(8GED8*B*69CT '4U\U>/?%\OBO
M7'=&9;" E+>/V[L?<UZO\7=??2O"HL8&VS7[^62.HC'+?GP/QKY]KIH0TYF<
M6*J:\B.A\,^$Y_$,H:2?[%9;Q%]JDC)0N>BY]:B\5>%[SPIJOV*Z=959=T4R
M#Y7'^([BO6_AI<'4?AF]B;)9_+GDM@F<!\X;<Q[8W=?:J_B/1+[7/!]SH4_E
M?VKHA69&')N(MK8([\C@_P"TM5[1\UF3[%.FFMSQ"BE961MKJRMZ,,&DK<Y
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M6,45U(LDJ#:748W =#]<8JS0 444UW6-&=V"HHRS$X % "NZQHSNP55&22<
M"N/EN+GQM.]M92/!X?4E9KI3M>Z/=4]%]336>X\<W)CB,D'AV%\.XX:^([#T
MC]^]:.I>(K/1FBTG3+4WE_@+%96P&$'JQZ** -=%L=%TT*/*M;.W3 R0JJ!7
M./XBU/7V\GPS:@6Y.&U*Z4B,?[B]6_E3[;PO<ZI<B^\3W NG!S'8Q\00_A_$
M?<UU*(L:!$4*JC 51@ 4 <_IWA"RMKO^T+^234M1/_+Q<G.W_=7HM=%THHH
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ML1ZU@:7J=WH-_%H>NRF1'XLM0;@3#^X_HX_6@#JZ*** "BBB@ HHHH ****
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M$970.A#*PR".XK*\2DC0+DCT'\Q4UF#9WLEEG]RP\V'_ &1GE?P/\Z@\3?\
M(OW7T'\Q7+5E>C*_9G5)W@PT%!-X<MD;.&0@_F:<=*<N!Y@V=SCFCPY_R +3
M_=/\S6C-.D(&[.3T [U=!7I1]$73FXP5F8LUG<12XC96V8=CTXJ*5V<#=G!Y
M&>]27$\DTISQGK4!))R?UKLA#E.:M6=1Z@&P>G&*,<D"@8!R1D4#M6AB*22
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MP%49)K3E1ESOH$DCS2-)([.['+,QR2:]1^%'@=[Z\3Q!J$1%K"<VR,/]8_\
M>^@_G3O!'PGN+R2+4/$"&&V'S+:_Q/Z;O0>U>UPPQV\*0PHJ1H JJHP !VK"
MK55N6)U4*#OS2'T445RG<%%%% !1110 4444 %%%% !1110 4444 %%%% !V
MK#\(_P#(LVW_ %TF_P#1KUN=JP_"/_(LVW_72;_T:] &Y1110 4444 %%%%
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M))Y2Q1QQK%'&O(51T%3=<IMRS]O?I;OI]Q3Q70^&/ .E:S8?;)Y[CB1E:)2
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MU;V]M].LIKRZD$<$*%W<]@*XC0-/E\4ZS_PE^LIY=I&#_9EK+TC3_GHWN>M
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MJ=WX?OXM#UR5I8I#ML=0?I*.R.>SC]: .LHHHH **** "BBB@ HHHH ****
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MF,8W 8SS3KR-I(QC.T'+ =354$XPBGT2%;W+&&1Z'- S@$ CW%(<9(':C<Q
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M<TW_ )'W7O\ KVM?_:E='6/9:;/!XIU74'V^1<PP)'@\Y3?G/_?0H V****
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M4#S2;F?@XY].*52S95%-1.AKS3XO^%4U/0O[:MHA]LLAF0J.7B[Y^G7\Z]*
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M]32?;RJM$LF(7(\Q2?O$?=_K^E=I8^&=&U*6\"1%K6&;9!)&Q48P,J".H4Y
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M_6AA#-J2JS;B[.UN^G<X5;^24A9Y0R(,0#.2J9/7_@6[\,4XWTD)W6DNR;!
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MQIDIOXA'=V\IADP,9(]NU>=4HR@KLFQT%%%%8B"BBB@ HHHH **** "BBB@
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M,D]O821,V0ES?R%V'T0=_P :CS-/(;>Z&@T^6&]OIX+!3C*L/-N96/WF/U/
MJ.X:#2+&58-2EU"\=%M]^-Y@AS\QPO' Y]\5,VG66IW41OS)?2(=P,V#@_[*
M#A?J:OW,1MHO+M46&#&&*?*!ZY/%%PY3QSXJ>)M)UJ33-.TEA/#81D&<=#D
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M$$>IV\<;2C*LCC@@C!^E>@6GQ(MK0WTL5@@N[N19%C5CMZ8)/Y=J\K59)FW
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M:X8[92YR21Z_E67O/DB+"X!SG')K<\1P:(+FWETO4)YTE)\Q)4P\>.F3WK#
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M  V\+ZS(TLVFI#,W)D@/ED_7'%;1K=SGE0_E/F2BO<[WX':5)S9:G<PG_IH
MX_I3[+X(:-$ ;R_NIV[[,(#5>UB9^QF>$]\=S7:>%/AIK7B61998VL;#O-*N
M&8?[*]Z]NT;P#X:T)Q)9Z9$9ATEE^=OS-=*!@8 P/:HE5[&D:'\QD^'O#>F^
M&--6RTZ$*/XY#RTA]6-:]%%8MW.A*VB"BBB@84444 %%%% !1110 4444 ':
ML/PC_P BS;?]=)O_ $:];G:L/PC_ ,BS;?\ 72;_ -&O0!H:M;R7>D7EM"<2
M2PNB_4@BO*C"J;E:/:5X8,,%?K7K\DL<*%Y75$'5F. *HE-(O;E6Q9SS]L%6
M:N'&X+ZTE[UK'=@\:\-?2]SS-])GALXKZ2(_9I"50D?=QCGZ'_V6HUL)+V06
MULF9Y/E3'8^OT%>O-&CQF-D5D(QM(XK.M[C1+6[-M;3V$5R3@Q(Z!R?3'6N>
M651=2,E+16_ WCFLU"4>75W_ !/,3:_9V:&2+9)'\K*PY!IQTN<0#4#$PM"?
M+!QQNZY^G;->I7L.FEEDODM=W\+3;?TS4BW%E) X6:W:)!\V'4JH]ZF.413D
M^;?;^NI4LVFU'W=CRA;-KMUMX(]TTORH!ZGO]*#9M:.;>:/;+'\K@^HKU:WM
MK"V0SV\5O&A&XR(  1ZYHDM;&_"RO#!<#^%RH;]:G^QU[/EY];_UH/\ M>7M
M.;ETMW/+AI$[V+:@(R;5'"'COC[WT'3\:A%N)66../<[\*JCDFO7Q&@CV!%"
M8QMQQ4,-A9V\ADAM88W/5E0 U<\IC)Q][9$PS:<5+W=W<\JN-,ETVY>VND_?
M DEL??R<[A]<TZ'2KB[@FN+>)FA@ ,H4?>Y_7'7\*]5N+.VNP!<01R@= Z@T
M^.*.&,1QQJB#HJC JO[+C[651RT=]/7S)_M2?LE32U5OP\CR#RXR!\HP>F*?
M)ILU@XBNX2DCC>H;^Z>1^73VQ7JRZ?9)/YRVL(E_OA!G\ZDGM;>Z39<0QRKZ
M.H-9+)TH.+GJS1YO)S3Y=/4\IM]*N+Y9GM8V*PIODVC[P_N_7OCVJ#RX]OW1
MBO7H8(K>,1PQI&@_A48%0M8V*2&Y:V@#J,F0H,C\:<\H4H1BI["AFTE.4G'?
MS/*-6\)7-GHL.HE6*2$LZ 8:+)^7],?B:@M+.>*RAEN8I-D@_=O(N P]O3UQ
M[UVUUK&I>)(;BTTFP4V;YC-Q,< _3T_6NBT_2X[;1[>PN DXC3:VY<@GZ&NJ
MKA(UJ?LT[+N6\=4I1BZEN:^W6WZ'F,.F3ZC*8+.,F4#<2O8#DY^O3\:C\I%!
M!4#'7(QCZUZ[!:V]JFRWACB7T10*CDT^SEF$TEK"THZ.4!-<KRA.FHJ>J)6;
MR4W)QT?F>5/I5Q;0QW<Z,+>X_P!4&_AQP?IGK3K;3IM0N4MK/*7#'Y77^#_:
MKUF2*.6,QR1JZ'^%AD5';V=M: BW@CB!Z[% K3^RX^UC-2T5OP,_[4G[*4&M
M7?\ $\E-N(2T;Q;&3AE(Y6G'2IXH1?O$?LLAV(QZ CJ?QXY_V:]7FL+.XD$D
MUK#(XZ,R FI6BC>/RV12F,;2.*B.417->>^W]=2Y9O-\ON['DUK9M<WD,,$9
M,K.-NT=.>OT%>N#@"H+>RM;0DV]O%%GKL0#-3UV8+"?5H.-[W./&8MXF2E:U
M@HHHKL.0**** "L6U_Y'+4O^O.W_ /0I*VJQ;7_D<M2_Z\[?_P!"DH VJ***
M "BBL[7;>[O-'GM;)MLL^(R^[!1"0&(]PN: &:=ICVVJ:EJ%PRO-=2*J8_@B
M485?S+'\:U*9#$D$,<,8PD:A5'H ,"GT %%%% !1110 4A /4 TM% %!=%TY
M<@6D>#U!'%8^H>&(HB;NV,CLHP8B <K['&21_C73T4 <S8>'-LUK>/\ NV#;
MY$/7 (*#ZCG/UJ_INBFROYKN256=]P 5<=3FM>B@"*2V@ED#R0H[CH64$BI
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MH+,^W:H//?FK'@.U\7Z1'9Z1J>G6L6F01L/.60%\\D=#ZF@#OZ*** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 =JP_"/\ R+-M
M_P!=)O\ T:];G:L/PC_R+-M_UTF_]&O0!N4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% '(:[J>I7OB)-!TV<6QV;I)>A/&>/P]*U-#\-PZ-))<-/
M)<W<HP\K_P!*I^*-"N+F6/5]-8K?VP& /XP/3WY/UZ5:\.^(XM:A,<BB*]B_
MUD1XS[C/\NU0OBU.R3;H+V>W7O?S\OP-VBBBK.,**** "BBB@ HHHH ****
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MGD>]>KUY>*J\SLB&%%%%<@@HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** #M6'X1_Y%FV_P"NDW_H
MUZW.U8?A'_D6;;_KI-_Z->@#<HHHH **** "BBB@ HHHH **** "BBC% !11
MBC% !11BC% !7!^*);+3];M-0TV>/^T?-Q-#&<[Q[@=#V]\UO^,)KFW\-7+V
MI97RH9E/(4D U'X<T31X;"WO+6-9I'4-YS\MGO\ 2HEJ['50M3C[67I;OZG0
MCI1115G*%%%% !1110 4444 %%%% !1110 5BVO_ ".6I?\ 7G;_ /H4E;58
MMK_R.6I?]>=O_P"A24 ;59VIZDMG<6-FL(FFO9?+"9QA "78^P'\Q6C69I]Y
M:ZK>7-Q%;@FSE>U2X8#YNF_;[9&/JM &D %4*H  & !VI:** "BBB@ HHHH
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M@99+G4;76[682*$9) 2!SGE3T/:L>\\+07]OIUOHFD7XE('F74Z[5ESSG'(
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M*&5AW%25C^%[&XT[0+>WNB?-&6*G^')SBMBJ3NC&I%1FXQ=T@HHHID!1110
M4444 %%%% !1110 5BVO_(Y:E_UYV_\ Z%)6U6+:_P#(Y:E_UYV__H4E %[4
M]2M])LC=7.[9O2-5099F9@J@#UR14EE96^GVJ6UK&(XER0H]222?Q))JK,-/
MU/5$MGD,EQISK<&,9PI8,%)[$]2!VX-:5 !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MHP !T%/HHK 04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 ':L/PC_ ,BS;?\ 72;_
M -&O6YVK#\(_\BS;?]=)O_1KT ;E%%% !1110 4444 %%%% !1110 49'K11
M0 9'K1D>M%% !D>M&1ZT44 (<$8KD=&:+PSJ\VDW*+'#.^^UG(^\.FTG\O\
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M6\965EX,;Q+9+]LML*54':3E@,'T(S61X9^(5[XAU>UM'\.75K;W"LPNF)*
M!2PYQCG&/QH4)6N#JQ32ON=Y1114&@4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %8,7A=+=#';ZMJ<,6
MYF$:3#"Y))QQZDUO44 8G_"/2?\ 0<U;_O\ C_"C_A'I/^@YJW_?\?X5MT4
M8G_"/2?]!S5O^_X_PH_X1Z3_ *#FK?\ ?\?X5MT4 8G_  CTG_0<U;_O^/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M25^B+E%%%8G2%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M:AC[,VTG?G&.W'45M5XEXK_Y$KX?_6/_ -!2O8]1OX=+TRYO[AML-O$TCGV
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!7'?$OP_J/B3PNMCID2R3BX23:SA> #GD_6NQHIQ?*[HF45*+BSSB+PAK&A>
M.['6M'@0VEQ"L>HQ>8JX. &(!Z\@-QW!]:S]0\/>-].\>ZKKF@6EJ\=UA5::
M1>5P.Q(QR*]7HJ_:,S="/1^9PNH>%=5\9>"4M/$?DVVLQRM)%)%@JAY S@]"
M.O\ ]:N=-I\35LDTN?3].OA&-D=W.$D*CIG)/7W(S7KE%"J-= =%/6[.$\.?
M#Q=)\'ZCI=S<![W4XR+B91\JDC@#U S^-<?_ ,(G\09- 7PBT-F-,$G-SO&-
MN[/7KC//3->UT4*K).X.A%I):'FWC?P7JMWH/AZPT.-)WTLC)D<+T4 'D^HJ
MKK&G_$3Q!X7N],U"RLUDFFCVF&55'EC<6S\Q[A/UKU.BA5&@=%-MW>IYL_P9
M\/?V:45KK[9Y6!)YOR[\=<8Z9JSH?A_7X?A=J'A^_MT6\\F6&V E4AE8<<YX
MY)%>@44>TD]QJC!.ZT./\->%)$^&D/AO6H@KM'*DJJP;;F1F!!'<9!KE['2?
MB/X0A;2M)%IJ.GJQ^SR2$90'V)!'TY%>L44E4>H.BK*SM8X7P1X+O]+U*Z\0
M:_<K<:S=@A@O(B4]L]SP.G Q7,1?#/4[K0/$5O=V\:7<UV+JP;S%.2-W&1TR
M#CGV]*]AHI^UE>XG0@TE_6ID>&!JJ>';2+6HA'?Q)Y<F'#[L<!LCU&*YWX;^
M&M3\.1:NNI0K&;FZ\R+:X;*\^G2NYHJ>9ZKN7R*Z?89*I:)U'4J0*XSX:^'-
M2\-Z7?P:G"L<DUT9$"N&RN!Z5VU%)2:30W%.2EV. \<^%=5\7^(](M#&$T*W
M.^XE$@#%CU '7H  ?]HUE>(?@[IJZ/*_A];@:DA5HA+/\IYY'/3BO5**M59*
MUC.5"$FV^IY]XS\/^(/$W@'3[/[,AU5'C:X0RJ!D @G.<<GG\:7X@^%M6\0>
M'-'L].A22:VE5I0T@7 "8ZGKS7H%%)5&K>0W1B[WZG$_$OPYJ7B31[*VTR%9
M98KH2.&<+A<$=_K47Q)\)7OB;PU90:?$CWMM*K!6<+\I4AAD^^W\J[NBA3:M
M;H.5*,KWZGF6O_#^\N_AEI6C6<4;:C9E)"I< %B#O&3QU/Z5K)X?U;2OA2FA
MZ; K:F;?RV7S  &=LN=QXXRWZ5V]%'M'L+V,4[KM8\QT?X-:(-'M?[6%R=0,
M8,_ES84,>PX[=*U?AUX>UCPNFIZ;?1K]@\\R6D@D#$@\'@<C@ UW-%#J2::8
M1HPBTX]#AM)\-:G:_%35]=FA4:?<P;(W#@DG"=NH^Z:=XQM?&D>L6FI>&[A9
M[:-"DEBY 4D]SG&[MWXQ[UV]%'.[W'[)6:3\S@_AQX5U30Y-6U/6!%%=ZE*'
M-O#C:@!8]N.K'CL!7>444I2<G=E0@H1Y4%%%%24%%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
&%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>img268224062_8.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img268224062_8.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" :G$"4# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "@44"@!:
M2EI* '=J!1VH%(!12FD%*: "@44"@!12T@I: "BBB@8#K3J:.M.H$':EI.U+
M2&%+24M,!:***0!2TE+3 6EI*6D,*.]%'>@!U**2E% !1110,6E%)2B@!110
M**0!2TE+0 HHH%%, I:2EI **!0*!0 4M)2T **!0*!0P%I:2EH& I12"E%
M"T444@%H%% H&+2TE+0(*4=:2E'6@8M%%% A:***!@*6D%+2 6BBBF "EI!2
MT@'=J*.U%  *6D%+3&+1112 *6DI:8Q:6DI:0!2TE+0 4HZ4E*.E "T444 %
M*.E)2CI0 M%%%(!:*** %%% HH 6BBB@8HZ4X4T=*<* $[TM)WI: %%**04H
MH *6DI:0!2BDI13&+1112 6BBB@04ZFTZ@ HHHH&**6D%+0 4"B@4 **6D%+
M0 M%%%(8"EI!2T +2TE+0 "EI!2T +2TE+0 =Z!1WH% Q:6DI:!!1110,6EI
M*6@!:.]%'>@ I:2EH 6BBB@ I:2EH&+1112 6EI*6F HHH%%(!:***!BBE%(
M*44@"@T4&F HI12"E%( I:2EH *44E** "EI*6@8M HH% "BB@44 +2BDI10
M HHH%% Q:4TE*:0 **!10 M+24M !WHH[T4 +2TE+0 4"B@4 +2TE+0,!2]Z
M04O>@ I:2EI +0**!0 M+24M "T444 +WHH[T4 +1110!WGA[_D!6W_ O_0C
M11X>_P"0%;?\"_\ 0C16#W.N.R/DZBBBO3/$"BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M2E'6@8M%%% A:***!@*6D%+2 6BBBF "EI!2T@'=J*.U%  *6D%+3&+1112
M*6DI:8Q:6DI:0!2TE+0 4HZ4E*.E "T444 %*.E)2CI0 M%%%(!:*** %%%
MHH 6BBB@8HZ4X4T=*<* $[TM)WI: %%**04HH *6DI:0!2BDI13&+1112 6B
MBB@04ZFTZ@ HHHH&**6D%+0 4"B@4 **6D%+0 M%%%(8"EI!2T +2TE+0 "E
MI!2T +2TE+0 =Z!1WH% Q:6DI:!!1110,6EI*6@!:.]%'>@ I:2EH 6BBB@
MI:2EH&+1112 6EI*6F HHH%%(!:***!BBE%(*44@"@T4&F HI12"E%( I:2E
MH *44E** "EI*6@8M HH% "BB@44 +2BDI10 HHH%% Q:4TE*:0 **!10 M+
M24M !WHH[T4 +2TE+0 4"B@4 +2TE+0,!2]Z04O>@ I:2EI +0**!0 M+24M
M "T444 +WHH[T4 +1110!WGA[_D!6W_ O_0C11X>_P"0%;?\"_\ 0C16#W.N
M.R/DZBBBO3/$"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M)WI: %%**04HH *6DI:0!2BDI13&+1112 6BBB@04ZFTZ@ HHHH&**6D%+0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M2T +2TE+0 "EI!2T +2TE+0 =Z!1WH% Q:6DI:!!1110,6EI*6@!:.]%'>@
MI:2EH 6BBB@ I:2EH&+1112 6EI*6F HHH%%(!:***!BBE%(*44@"@T4&F H
MI12"E%( I:2EH *44E** "EI*6@8M HH% "BB@44 +2BDI10 HHH%% Q:4TE
M*:0 **!10 M+24M !WHH[T4 +2TE+0 4"B@4 +2TE+0,!2]Z04O>@ I:2EI
M+0**!0 M+24M "T444 +WHH[T4 +1110!WGA[_D!6W_ O_0C11X>_P"0%;?\
M"_\ 0C16#W.N.R/DZBBBO3/$"BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MHHH&**6D%+0 4"B@4 **6D%+0 M%%%(8"EI!2T +2TE+0 "EI!2T +2TE+0
M=Z!1WH% Q:6DI:!!1110,6EI*6@!:.]%'>@ I:2EH 6BBB@ I:2EH&+1112
M6EI*6F HHH%%(!:***!BBE%(*44@"@T4&F HI12"E%( I:2EH *44E** "EI
M*6@8M HH% "BB@44 +2BDI10 HHH%% Q:4TE*:0 **!10 M+24M !WHH[T4
M+2TE+0 4"B@4 +2TE+0,!2]Z04O>@ I:2EI +0**!0 M+24M "T444 +WHH[
MT4 +1110!WGA[_D!6W_ O_0C11X>_P"0%;?\"_\ 0C16#W.N.R/DZBBBO3/$
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "@44"@!:
M2EI* '=J!1VH%(!12FD%*: "@44"@!12T@I: "BBB@8#K3J:.M.H$':EI.U+
M2&%+24M,!:***0!2TE+3 6EI*6D,*.]%'>@!U**2E% !1110,6E%)2B@!110
M**0!2TE+0 HHH%%, I:2EI **!0*!0 4M)2T **!0*!0P%I:2EH& I12"E%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M2E'6@8M%%% A:***!@*6D%+2 6BBBF "EI!2T@'=J*.U%  *6D%+3&+1112
M*6DI:8Q:6DI:0!2TE+0 4HZ4E*.E "T444 %*.E)2CI0 M%%%(!:*** %%%
MHH 6BBB@8HZ4X4T=*<* $[TM)WI: %%**04HH *6DI:0!2BDI13&+1112 6B
MBB@04ZFTZ@ HHHH&**6D%+0 4"B@4 **6D%+0 M%%%(8"EI!2T +2TE+0 "E
MI!2T +2TE+0 =Z!1WH% Q:6DI:!!1110,6EI*6@!:.]%'>@ I:2EH 6BBB@
MI:2EH&+1112 6EI*6F HHH%%(!:***!BBE%(*44@"@T4&F HI12"E%( I:2E
MH *44E** "EI*6@8M HH% "BB@44 +2BDI10 HHH%% Q:4TE*:0 **!10 M+
M24M !WHH[T4 +2TE+0 4"B@4 +2TE+0,!2]Z04O>@ I:2EI +0**!0 M+24M
M "T444 +WHH[T4 +1110!WGA[_D!6W_ O_0C11X>_P"0%;?\"_\ 0C16#W.N
M.R/DZBBBO3/$"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MI.]+0 HI12"E% !2TE+2 *44E**8Q:***0"T444""G4VG4 %%%% Q12T@I:
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M]^%/ASX4U+PII=[=Z5YEQ/;(\C_:)1N8CDX#8%>"5]2>!O\ D1=$_P"O2/\
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M %%%% !1110 4444 %?4FO\ _)/-4_[!4O\ Z*-?+=?4FO\ _)/-4_[!4O\
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MO_7I'_-J\]IT_@1%;^(PHHHK0S"BBB@ HHHH **** "BBB@ HHHH ]B^!/\
MS'_^W?\ ]JUS'Q?_ .1_N/\ KA%_Z#73_ G_ )C_ /V[_P#M6N8^+_\ R/\
M<?\ 7"+_ -!KGC_&9UR_W9>O^9PE%%%=!R!1110 4444 %%%% !1110![W\$
MO^1,O/\ L(/_ .BXZ\M^)'_)0M8_ZZK_ .@+7J7P2_Y$R\_["#_^BXZ\M^)'
M_)0M8_ZZK_Z M<T/XLCKJ_P(G+4445TG(%%%% !1110 4444 %%%% !1110
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MW,Z1EL_=!/)_ 9-?35Q<:)X'\-AF5;/3K8!55%)+$]!ZEB>Y^I/>OG_X;_\
M)0M'_P"NK?\ H#5Z?\;F(\(6*]C?J?\ R&_^-<U7WIJ)V8=\E.4UN7+/XO>%
M=0\R*22[LB1A3<P\,3[H6Q^..M?/=%%:PIJ&QSU*LJEN;H%%%%:&84444 %%
M%% !7H7P9_Y'IO\ KTD_FM>>UZ%\&?\ D>F_Z])/YK6=3X&:4?XB.@^.W_,
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MMK_UTD_]"->!U[Y\+O\ D1;7_KI)_P"A&G7^$G"_&>->)_\ D;=:_P"O^?\
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M[I./QKRJD%+6D8J.QC.HY[BT444R0%>E?#?_ )!-W_UW_P#917FHKTKX;_\
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M**!0 M+24M "T444 +WHH[T4 +1110!WGA[_ ) 5M_P+_P!"-%'A[_D!6W_
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M%85IIQY4=.&I24N=Z)'C?QG=&\<H%QE;.,-]=S'^1%3_  2_Y'.\_P"P>_\
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MX)MJ>7X4>#9$*KI;Q$C[R7,N1^;$5X)J7B76]7EDDO\ 5+J<R?>4R$)] HX
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M6'!/L0*\TL-6U'2Y!)87US:L#G,,A7G\.M>L^!OBU)<W,.E^(MN^1ECAO$7
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MAX\\.)<6;Q-=B,265T.C \[2?[I_0\^Q2G*#M/8;ITZL>:GH^Q\V5[%\"?\
MF/\ _;O_ .U:\?DC>*1XY$9)$)5E88*D=01ZU[!\"?\ F/\ _;O_ .U:TK?
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MVRWA <*?1!T)]SD>W>L95)2?+ WA2A"//4^XZ.#X4>#X4VOITDQ_O27,@/\
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M ''4FO<OAQ>7-]X,MI[NXFN)C)(#),Y=CACCD\U-:,DKMZ%X>4&[):V*5_\
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MT5&UCT?_ (0#2O\ GXO?^^U_^)KHY[5+BQDM'+".2(Q$CK@C'YUY'_;6J_\
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M%/J9RE%[(8**!15$"TM)2T '>BCO10 M+24M !0**!0 M+24M P%+WI!2]Z
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M2"S,<DF[A))_[[KW3QAXC;PKX?DU46?VL)(J&/S?+X8XSG!]NU>=_P#"]O\
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M+?\ Y/?_ &NIFJLU9HTIRH4W=2_K[CSOQKI2:+XSU6PBVB))B\:JNT*K@.%
M]@P'X5Z)\"?^8_\ ]N__ +5KSGQ=XB7Q3XAFU9;(6AE1%:,2;\E1C).!G@#M
M7HWP)_YC_P#V[_\ M6KJ7]EJ94;>WTVU(?CAK#M>:;HJ,PC1#=2#C#$DJOOD
M /\ ]]5Y'7H/QDD#^.]H;.RTC4CTY8_UKSZKI*T$9UW>HPJ6VG>UNH;B/_61
M.'7/J#D5%15F1].?$*!;SX?:PIP5\CS!DD?=(8?RKYCKZC\7J'\ :N#_ ,^$
MA_),U\N5AA_A9UXSXDPHHHKH.0*^I-?_ .2>:I_V"I?_ $4:^6Z^I-?_ .2>
M:I_V"I?_ $4:YJ^\3KPNTCY;KZDQ;>"? S>5$#%IMH6"$@;V SR0.K,>3CJ:
M^:=&94UW3V==R+<QEAC.1N%?1'Q0C>7X<ZNJ#)"QMU["5"?T!HK:N*##:1E)
M;GSA>WEQJ%[->7<K2W$[EY';JQ/6H***Z#D"BBBF![U\&M>?4?#D^ESREY=/
M<"//7RFY ]\$-]!@5Q?QJ_Y':#_KQC_]#>M/X&+(=4UA@?W8AC##WW''\C69
M\:O^1V@_Z\8__0WKFBK5F=DFWAU<XK0/^1DTO_K[B_\ 0Q7TMXRUMO#WA+4-
M2C!\V./;%@9P[$*I^@)!_"OFG0/^1DTO_K[B_P#0Q7O'Q>#GX?W&T@ 3Q;O<
M;O\ '%%97G%!AVU3FT?/$DCRR/)([/(Y+,S')8GJ2?6FT45TG&%%%% 'T?\
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M_HN.O+?B1_R4+6/^NJ_^@+7J7P2_Y$R\_P"P@_\ Z+CKRWXD?\E"UC_KJO\
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M/!,=X(RMQ?R-)(S* 2JDJH]<8!(_WCZUQ'C+P3XU\2>*K[41I#-"S[( ;N+
MC7A< OQGKCU)KU/P,V? >C%,-BT3@'N!TKS_ /X7M_U+?_D]_P#:ZYXN?.W%
M'9-4U3C&;L<=_P *K\:?] ;_ ,FH?_BZ/^%5^-/^@-_Y-0__ !==C_PO;_J6
M_P#R>_\ M='_  O;_J6__)[_ .UUIS5NW]?>8<F'_F?]?(X[_A5?C3_H#?\
MDU#_ /%UZ?\ "O1?$GAVUOM/UJR,%JS++;GSD?#=&'RL>ORG\#ZU@_\ "]O^
MI;_\GO\ [71_PO;_ *EO_P GO_M=3+VLE9HNFZ$)<RD_Z^1@_&325L?&"7L8
M 6^@#M_OK\I_0+7G==?XZ\<#QK+8O_9OV(VJN/\ 7>9OW8_V1C&/UKD*WIIJ
M*3.:JXN;<=@HHHJS,]O^"_B*WFTB;0)G5+J"1I85/'F(W)QZD'.?8CT-8GQ
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MOVO9NW(&Z;#C[WK6/_PO;_J6_P#R>_\ M=90=5122-JBH2DW*3O_ %Y''?\
M"J_&G_0&_P#)J'_XNC_A5?C3_H#?^34/_P 778_\+V_ZEO\ \GO_ +71_P +
MV_ZEO_R>_P#M=5S5NW]?>1R8?^9_U\B#X>^$/&/ACQ7!=7.EF.QE5HKD_:8C
M\I'!P&SPP!Z>M;?QKTE;GPY9ZHH'FVD^PG_8<<_J%_,UE_\ "]O^I;_\GO\
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MYTO=1T553;]YG-_\(!XG_P"@9_Y'B_\ BJ/^$ \3_P#0,_\ (\7_ ,572_\
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MY.WW3QC./PKR7Q/8)IGB6_M(\"-9=R +@!6&X#'L#BNQ_P"%K?\ 4%_\FO\
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M1??B;./4=Q^(R*JTM(-CV>ZD2;29Y8V#(\#,I'0@KQ7C->MVBLOA&%7&&%B
M0>WR5Y)6=+J;U^@5Z_J7_(LW?_7F_P#Z :\@KU_4O^19N_\ KS?_ - -%3=!
M1V9Y%1116AB>T7UP+2PN+DC/E1L^/7 S7C<DCRRO)(Q9W)9B>Y->L>(GV>'K
MX_\ 3(C\^*\EK*EL;UWJD***!16I@>OZ1(9=%L78Y9H$)/OM%>7:M=&]U>[N
M"^\/*VUO]D<#] *]-T8D>'K(CJ+9/_0:\EK*FM6=%5Z(44HI!2BM# ],\'L3
MX;MP>S.!_P!]&O/M43R]6O$ P%G<8_X$:] \'?\ (N0_[[_SK@=9_P"0W?\
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ML]#6?_PJOQI_T!O_ ":A_P#BZT4XVW,94IW>C..HKL?^%5^-/^@-_P"34/\
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M]*^"7_(YWG_8/?\ ]&1UYK7I7P2_Y'.\_P"P>_\ Z,CK.K\#-:'\1%KXX_\
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MF\C4.&7^ZV#\R^G/';N#FG[*;3V9JU[>FFMT?-=%=9JOPU\5Z4[;M*DNHU(
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M[C1IV)DL6#Q$GK&V>/P.?^^AZ5T?Q%UX>'?!EW+&S)<7 ^RP%&*E68'D$=,
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M0Q/2_!W_ "+D/^^_\ZX'6?\ D-W_ /U\R?\ H1KOO!W_ "+D/^^_\ZX'6?\
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M@H_$<#?_ /(1N?\ KJ_\S4!J>_\ ^0C<_P#75_YFH#5HR>X"B@44 +2TE+0
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M112C2A'6PYXBI)6;.Q\">._^$)_M#_B6_;?M?E_\M_+V;-W^R<YW?I69XO\
M$G_"5^()-5^R?9=\:IY7F;\8&,YP/Y5@T5?*K\W4S=23CR= HHJ>RM);^_M[
M.  S7$JQ1@G&68X'ZFF2>Q?!3P\8K6[\03*0TV;>WR/X 06/7N0!T_A/K7,_
M%_Q"FK^*5TZ!E:#30T98=Y&QO[]L ?4&O7;N6R\!> V:-?W.GVX6-?\ GI(>
M!G ZLYR3CN37S'//+=7$MQ.Y>65R[N>K,3DG\ZYZ7OS<SLK_ +NFJ:^9'111
M72<84444 %%%% '>^"/B5_PANBS:=_9/VSS+AI_,^T^7C*JN,;3_ '>OO7+^
M)-9_X2'Q#>:K]G^S_:7#>5OW[< #K@9Z>E95%2H).Z+=23BHMZ(****H@Z;P
MUX\U[PLGE6-PLEKDG[-<+OC!/<<@C\"*])L?CCICQDW^CW<,F< 0.LH(]<G;
MS[?K7B%%9RI1ENC6%><-$SW>7XW^'Q&3#I^IN_8.D:@_B'/\JY#Q'\8=7U6%
M[;2X1ID+ J9%?=*1[-@;?PYYZUYO125&"Z#EB:DE:XK,SNSNQ9F.22<DFDHH
MK4Q"BBB@ HHHH UM \2ZKX9O3<Z7=&%GP)$(#)( >C _CSU&3@BO4-,^.4)C
M"ZMH\BN%&9+20,&/?Y6Q@?B:\9HK.5.,MT:0K3A\+/>O^%W>'-O_ !XZKNQT
M\J/_ .+K"UGXWS21M'HVEB)BO^NNFW$'V4<?F3]*\BHJ50@BWBJCZES5-5O]
M:OGO=1NI+FX88+N>@] .@'L*IT45J8-WU84444P-#0M7GT#7+/5+;F2VD#[<
MXW+T9?Q!(_&I_$VOW'B?7[G5;E=AE.$B#%A&@X50?IUZ9))QS6112LKW'S.W
M+T"BBBF(*569'5T8JRG((."#244 >B>'OC!KFD0K;ZA%'JD"#"F1MDHP  -X
M!R.#U!.3UKM(_C=X?(_>:?J:GT5(V_\ 9Q7@]%9.C!]#:.(J15KGM>H_'&R6
M(C3-(N))">#<N$ ]\+G/TR/K7F7B3QCK7BJ8-J5UF%6W1V\8VQH?8=SR>3D^
M]8-%.-.,=D3.M.>C9Z?X=^+_ /8/A^STK^PO/^S1[/-^U[=W).<;#CKZUYK=
M3?:;N:?;M\R1GVYSC)SBHJ*<8*+NA2J2DDF]CO?!'Q*_X0W19M._LG[9YEPT
M_F?:?+QE57&-I_N]?>N7\2:S_P )#XAO-5^S_9_M+AO*W[]N !UP,]/2LJBF
MH).Z!U).*BWH@KIO"GCK6/"4I6TD$UFQ!>UF)*=>2O\ =/N/Q!P*YFBFTFK,
MF,G%W1[A9?''2GB!OM)O89.X@99!^9*U/+\;] "$PZ=J;OC@.D:C\PYKPBBL
MO80-_K53N=]XE^+.N:[ ]K:(FFVK@JZQ-ND<'L7/;Z 5P-%%:1BHJR,93E-W
MDPHHHJB3J/"_C[7/"F(K299K+=DVLXW)SUQW4_0X]0:]'L?CCI;Q+]OTF\BD
M_B\AED'X9*UXA16<J49:M&L*\X*R9[K<?'#0UB8VVF:C))@[5D"("?0D,<?E
M7!^)?BIK^OQO;0,NG6;C#1VY.]QQPS]>QZ8X.#FN&HI1I0CK8<L14DK-G7^!
M/'/_  A4E\W]G?;/M008\_R]NW=_LG/WOTJGXU\5?\)AK<>I?8OLFR!8?+\W
MS,X+'.<#^]Z=JYRBKY%S<W4CVDN7DOH%=;X%\;_\(7<7LO\ 9_VS[2BKCSO+
MV[2?]DYZUR5%#2DK,F,G%W1TOC?Q9_PF6M0ZC]B^Q^7;K!Y?F^9G#,V<X'][
MI[5S5%%-))602DY.["MSPYXMUCPM<-)IESM1R#)"XW1R8]1_48-8=%#2>C!-
MIW1[3I_QRM&C U+1YT<=6MI X/X-C'YFM%OC=X<Q\MCJI/O%&/\ V>O!:*R]
MA W6*J=SUC6_C;>3QR0Z)IR6V1@7%PV]QQU"C@$'IDL..G->87^H7FJ7DEW?
M7,EQ<2'+/(V3_P#6'MTJM15QA&.QE.K.?Q,****L@**** .N\)?$36/"<?V:
M$I=6&2?LTQ.%)Z[3_#S^'M7HUK\<-$>$&[TS4(I<<K%LD4?B67^5>%T5G*E&
M6K1K"O4@K)GL6N?&Y7MC'H6G2)*V1YUWCY.G(52<GKU/IUKR2]O;G4;V:\O)
MGFN)FW22.<EC4%%.,(QV)G5E/XF%203S6LZ3V\LD4J'*R1L593[$=*CHJB#U
M#0?C3JMFB0ZS:1Z@@(!F0B*3&><@#:W'3@=.3WKJ4^-WATK\]AJBMZ+'&1_Z
M&*\&HK-T8/H;QQ-1*USV35/CC'Y>W2-(8R'/[R[? 'I\J]?S%>8:[XCU7Q)>
M"YU6[>=UR$7@)&#V51P.@^N.:RJ*J-.,=D1.M.?Q,]4_X7-_Q(O[,_L#_EV^
MS^9]L_V=N<;/TS7E=%%$8*.PIU)3^)FKX;UG_A'O$-GJOV?[1]F<MY6_9NR"
M.N#CKZ5TWC?XD?\ "9:3!8_V3]C\J<3;_M'F9^4C&-H]:X2BFX)N[$JDE%Q6
MS"BBBJ)+>F:I?:-?QWNGW+V]S']UT_D1T(]C7J.C_&^>*)8]8TM9F YFMGVD
M_53Q^HKR.BHE",MT7"K.'PL]Z7XW>',?-8ZJ#[11G_V>LS5/CC;B+;I.D2M(
M0?GNW"A3V^5<Y_,?X>,45"H0-7BJCZFQX@\4:OXFN_/U.[:0 G9$ORQQCT5?
MQQDY/J36/116J26B.=MMW85T/@SQ1_PB.NG4_L?VO,+1>7YOE]2.<X/IZ5SU
M%#2:LQQDXNZ.Q\=^._\ A-O[/_XEOV+[)YG_ "W\S?OV_P"R,8V_K7'444HQ
M459!*3D[L***ZGX>>'U\1^,;2VF0/:P9N)U/1D4C@^H+%0?8FFW9781BY-)'
MMO@/18O"7@>+[6PAD9#>7;OQL)4$YYXVJ /P)KY_\3:TWB'Q)?:JR[1<291<
M8(0 *H/)YV@9KVSXO>(?[)\*C3HF(N=2)CX[1#!<_CD+C_:/I7S[6%!-WF^I
MTXF25J:Z!11170<H4444 %%%% '<^%/BCK'AJV6REC74+).$CE<AXQQPK<X'
MM@UWT7QO\/F,&;3]31^X1(V _$N/Y5X1164J4).]C:&(J15DSV^\^..EI$QL
MM(O)9.PG=8Q^8W5P'B;XDZ_XEC:W>9;.S)(,%L2N]3D8=LY;@\C@'TKCZ*<:
M4([(4Z]22LV%=/X+\;7O@V_DDAC%S:3#$ULS[0Q'1@<'!'T/'X8YBBK:35F9
MQDXNZ/4->^+5EXCT>;3+_P ,L891PRW^&1AT8'R^HKR^BBE&"CHASJ2F[R"B
MBBJ)"K%C?76FWL5Y93O!<PMN21#@@_Y[=ZKT4@/5]$^-M[;Q1PZUIR79'!N(
M&\MB,=2N,$_3:/:NB7XW>'"/FL-5!]HXS_[/7@U%9.C!]#=8FHM+GM>H_'&R
M6(C3-(N))">#<N$ ]\+G/TR/K7F/B/Q?K/BJ</J5SF)6W1V\8VQQ_0?U.3[U
MA454:<8[(B=:<]&PHHHK0S.Y\#_$7_A#--N;/^ROMGG3>;O^T>7MX QC:?2N
M=\3ZW_PD?B.\U;[/]G^T%3Y6_?MPH7K@9Z>E9%%2H)/FZE.I)Q47L%;'A77O
M^$9\26FK_9OM/V??^ZW[-VY&7K@X^]GIVK'HIM75F2FT[H[;QS\0O^$TM+2#
M^R_L?V>1GW?:/,W9&,?=&*XFBBE&*BK(J4W-WD=+X(\6?\(;K4VH_8OMGF6[
M0>7YOEXRRMG.#_=Z>]6/'7C?_A-+BRE_L_[']F1EQYWF;MQ'^R,=*Y*BCD7-
MS=1^TER\E] I\4LD$R2Q2-'(C!D=#@J1R"#V-,HID'I6B?&?6M/A\K4[6+4@
M!\LA;RI.O<@$'TZ5UT?QN\/D?O-/U-3Z*D9_]G%>#T"LW1@^AO'$U(Z7/<[K
MXX:.B$VFE7TK]A*4C'Y@M7 >)_B;KWB2*2U#K8V+C:T%OU<>C-U/T& ?2N,I
M*(TH1U2%*O4EHV.[4"CM0*T,117<>&OBEKOA^)+:8KJ%FO"QSG#J.?NOU[]\
M\# Q7#BE-3**DK,J,Y1=XL]RM_C;HC1*;G3-0CD(&Y8PC@'T!+#/Y5%>_&[2
MUB;[!I5Y+)_#Y[+&/QP6KQ*@5'L(&WUJIW.I\3>/=<\4[H;J=8;(G(M8!M3C
MIN[MVZG&>@%;7@_XG?\ "*:$-,_LC[5B1I/,^T[.O;&P_P Z\]%+5.$6K6,U
M5FI<U]31U[5/[;UV]U/R?)^TRF3R]V[;GMG S^59U%%7:R(;OJRWINI7ND7R
M7EA<O;W"9 =#S@]1[UZ9H_QJO(56/5]-CN.>9K=MC8_W3D$_B*\H'6G5$H1E
MN7"I.'PL]T7XT^'B@+V.J!NX$<9'_H=4[[XVV*QC[!I%Q*YZ_:)%C _+=G]*
M\7[4M0J,#7ZU4[G0^(_&NM^*&VW]R%MP<K;0C9&#QVZGIW)QDXQ7/TE+6J22
MLC"4G)W8M%%7=(TR;6=7M=.M_P#6W$@0$]O4_@,G\*!)7=CV+X/: UEHMQK$
MRD27K!8@1TC7//XG/_?(]:X7XG:^-;\6RPQ,&M;$&WC([L#\Y_[ZX^BBO8/$
M6H6_@WP1,]JNP6T M[5>OS$;5SZXZGZ&OFQF9W+NQ9F.22<DFL*7O2<V=E=\
MD%304M)2UN<@4=Z*.] #J44E** +-AJ%WIEY'=V5Q)!/&<JZ'!_'U'L>*]'T
M;XR7<,:1:Q8+<X&#/ =C'CJ5/!)/H0.>E>7T5,H1EN:0J2A\+/;Q\9- V\V.
MI[O3RX\?^AUC:M\999(VCTC31$2/]=<MN(/LHX_7\*\JI14*C!&CQ%1K<T;K
M6[[4=734M1N)+J=75LN<< YP.P'L!CFNWU[XJ_VWH=WIO]B^3]H39YGVK=MY
MSTV#/YUYP**IPB[7,XU)*]GN%=%X.\4?\(GJ\M_]C^U>9 8=GF[,993G.#_=
M_6N=I:II-69*DXNZ.F\9>+?^$NO;:Y^P_9/)C,>WS?,W<YSG:*YJ@44))*R!
MR<G=A7?^%_B5_P (UH46F?V3]I\MF;S/M.S.3GIM/\ZX"EI2BI*S'"<H.\2W
MJ=[_ &EJU[?^7Y?VF=YMF[.W<Q.,]^M510*!3Z$MW85UGASX@:QX=C2V5ENK
M)>!!-_#_ +K=1^H]JY.EI-)JS*C)Q=T>R6WQBTIT!NM-O(F[B(JX_,E:E?XO
MZ&!^[L=18_[2(/\ V8UXN*!6;HP-OK-0[O7?BEK&J0M;V4::="PPQC;=(>N1
MNP,#IT /'6N'9F=BS,68G)).233:6KC%1V,I3E)WDP%>CV/Q4^QZ%;Z9_8V_
MR;9;?S/M6,X4+G&SVZ9KS@4HHE%2W",Y0^$6BBBF2+0**!0,6N]\/_$.R\.:
M:MG9^'^>LDIN_FD;U/R?IVK@J6E**EHQPFXNZ/4O^%Q?]0'_ ,G/_L*!\8L_
M\P'_ ,G/_L*\MI1UJ/90[&OMZG<]2_X7#_U O_)O_P"PH_X7#_U O_)O_P"P
MKRZBCV4.POK%3N=UXE^(O_"1:)+IW]E?9][*WF?:-^,'/3:/YUPU%%7&*CHB
M)3<G>0"EI!2T$BUZ-+\5?,TU[/\ L7&Z$Q;_ +5TR,9QLKSFBDXJ6Y49RCL
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ME[.(W6FR>\O;F_N&N+J9I93P6;^7M4%%%69BT^.1X9%DB=D=3D,IP1^-,I:
M.OTWQ]>0*J7\*W*Y_P!8OR/C^1_2ME?B#I9'S6UX#[*I_P#9J\XH[U#IQ9HJ
MLT=W>?$)=F+*Q.[^],W _ =?SKD=1U2]U6<2WD[2,/NCH%^@[52I::BEL*4Y
M2W.Q_P"$[_XEWV3^S?\ EEY6[S_;&<;:X^BBA12V%*3EN%=A<^.?M&F36?\
M9VWS(6BW^?G&5QG&VN/I:'%/<(R<=A:***8CK=2\:_VCIT]G_9_E^:NW?YV<
M?AMKE*2EI**6Q4I.6XHHH%%,DZZS\;?9-.AM/[/W^5&(]WG8S@8SC;7)444D
MDMBG)O<44HI!2B@1TNC>+?[)TU+3[#YNTD[_ #=N<G/3!K!O;C[7?7%SMV>=
M(TFW.<9.<9J"@T)).XW)M68HJ_IFL7NDR%K67"L?F1AE6^HJ@*44,2=MCM[?
MQY"5 N;)U;N8F!!_ XJR?'.FXXM[O/\ NK_\57G]+4<D33VLCKK[QS-(K)8V
MPBSP))#N(X[#IG\ZY:>XFNIFFGE:21CRS'-14HJE%+8ER<MPJ]I5_P#V9J4-
MYY7F^7N^3=MSD$=<'UJC2T"3MJ;FN^(?[:BAC^R^3Y;$Y\S=G/X"L044"A*R
MT&VV[L444"BF(Z32?%?]EZ=':?8O-V$G=YNW.23TP?6L*YF^TW<T^W;YCL^W
M.<9.<5#2BDDEJ4Y-JS%%=)I?BO\ LW38K3[%YGEY^?S<9R2>F/>N;%%#2>X*
M36Q+/+Y]Q++C;O<MC.<9.:8:2E- @%% HH 6EI*6@ [T4=Z* %I:2EH *!10
M* %I:2EH& I>](*7O0 4M)2T@%H%% H 6EI*6@!:*** %[T4=Z* %HHHH [S
MP]_R K;_ (%_Z$:*/#W_ " K;_@7_H1HK![G7'9'R=1117IGB!1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110!V/PSUS3O#WBLWNJ7'V>W^S.F_8S_,2,#"@GM6M\6/%&C>)I=*
M;2+S[2(%E$G[ITVYVX^\!GH:\XHJ.1<W,:*JU#DZ!1115F84444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MHHHH$%.IM.H ****!BBEI!2T % HH% "BEI!2T +1112& I:04M "TM)2T
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M12 6BBB@8HI12"E%( H-%!I@**44@I12 *6DI: "E%)2B@ I:2EH&+0**!0
MHHH%% "THI*44 ***!10,6E-)2FD "B@44 +2TE+0 =Z*.]% "TM)2T % HH
M% "TM)2T# 4O>D%+WH *6DI:0"T"B@4 +2TE+0 M%%% "]Z*.]% "T444 =Y
MX>_Y 5M_P+_T(T4>'O\ D!6W_ O_ $(T5@]SKCLCY.HHHKTSQ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M*!BTM)2T""E'6DI1UH&+1110(6BBB@8"EI!2T@%HHHI@ I:04M(!W:BCM10
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ H%% H 6DI:2@!W:@4=J!2 44II!2F@ H%% H 44M(*
M6@ HHHH& ZTZFCK3J!!VI:3M2TAA2TE+3 6BBBD 4M)2TP%I:2EI#"CO11WH
M =2BDI10 4444#%I124HH 444"BD 4M)2T ***!13 *6DI:0"B@4"@4 %+24
MM "B@4"@4,!:6DI:!@*44@I10 M%%%(!:!10*!BTM)2T""E'6DI1UH&+1110
M(6BBB@8"EI!2T@%HHHI@ I:04M(!W:BCM10 "EI!2TQBT444@"EI*6F,6EI*
M6D 4M)2T %*.E)2CI0 M%%% !2CI24HZ4 +1112 6BBB@!110** %HHHH&*.
ME.%-'2G"@!.]+2=Z6@!12BD%** "EI*6D 4HI*44QBT444@%HHHH$%.IM.H
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MQ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H%% H
M6DI:2@!W:@4=J!2 44II!2F@ H%% H 44M(*6@ HHHH& ZTZFCK3J!!VI:3M
M2TAA2TE+3 6BBBD 4M)2TP%I:2EI#"CO11WH =2BDI10 4444#%I124HH 44
M4"BD 4M)2T ***!13 *6DI:0"B@4"@4 %+24M "B@4"@4,!:6DI:!@*44@I1
M0 M%%%(!:!10*!BTM)2T""E'6DI1UH&+1110(6BBB@8"EI!2T@%HHHI@ I:0
M4M(!W:BCM10 "EI!2TQBT444@"EI*6F,6EI*6D 4M)2T %*.E)2CI0 M%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MHHHH$%.IM.H ****!BBEI!2T % HH% "BEI!2T +1112& I:04M "TM)2T
MI:04M "TM)2T '>@4=Z!0,6EI*6@04444#%I:2EH 6CO11WH *6DI: %HHHH
M *6DI:!BT444@%I:2EI@***!12 6BBB@8HI12"E%( H-%!I@**44@I12 *6D
MI: "E%)2B@ I:2EH&+0**!0 HHH%% "THI*44 ***!10,6E-)2FD "B@44 +
M2TE+0 =Z*.]% "TM)2T % HH% "TM)2T# 4O>D%+WH *6DI:0"T"B@4 +2TE
M+0 M%%% "]Z*.]% "T444 =YX>_Y 5M_P+_T(T4>'O\ D!6W_ O_ $(T5@]S
MKCLCY.HHHKTSQ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M12 6BBB@8HI12"E%( H-%!I@**44@I12 *6DI: "E%)2B@ I:2EH&+0**!0
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M7X+_ .@-_P"34W_Q='_"J_!?_0&_\FIO_BZ[&BCGEW#V4/Y5]QQW_"J_!?\
MT!O_ ":F_P#BZ/\ A5?@O_H#?^34W_Q==C11SR[A[*'\J^XX[_A5?@O_ * W
M_DU-_P#%T?\ "J_!?_0&_P#)J;_XNNQHHYY=P]E#^5?<<=_PJOP7_P! ;_R:
MF_\ BZ/^%5^"_P#H#?\ DU-_\778T4<\NX>RA_*ON.._X57X+_Z W_DU-_\
M%T?\*K\%_P#0&_\ )J;_ .+KL:*.>7</90_E7W''?\*K\%_] ;_R:F_^+H_X
M57X+_P"@-_Y-3?\ Q==C11SR[A[*'\J^XX[_ (57X+_Z W_DU-_\71_PJOP7
M_P! ;_R:F_\ BZ[&BCGEW#V4/Y5]QQW_  JOP7_T!O\ R:F_^+H_X57X+_Z
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M"_\ H#?^34W_ ,778T4<\NX>RA_*ON.._P"%5^"_^@-_Y-3?_%T?\*K\%_\
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MCO\ A5?@O_H#?^34W_Q='_"J_!?_ $!O_)J;_P"+KL:*.>7</90_E7W''?\
M"J_!?_0&_P#)J;_XNC_A5?@O_H#?^34W_P 778T4<\NX>RA_*ON.._X57X+_
M .@-_P"34W_Q='_"J_!?_0&_\FIO_BZ[&BCGEW#V4/Y5]QQW_"J_!?\ T!O_
M ":F_P#BZ/\ A5?@O_H#?^34W_Q==C11SR[A[*'\J^XX[_A5?@O_ * W_DU-
M_P#%T?\ "J_!?_0&_P#)J;_XNNQHHYY=P]E#^5?<<=_PJOP7_P! ;_R:F_\
MBZ/^%5^"_P#H#?\ DU-_\778T4<\NX>RA_*ON.._X57X+_Z W_DU-_\ %T?\
M*K\%_P#0&_\ )J;_ .+KL:*.>7</90_E7W''?\*K\%_] ;_R:F_^+H_X57X+
M_P"@-_Y-3?\ Q==C11SR[A[*'\J^XX[_ (57X+_Z W_DU-_\71_PJOP7_P!
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MK\%_] ;_ ,FIO_BZ/^%5^"_^@-_Y-3?_ !==C11SR[A[*'\J^XX[_A5?@O\
MZ W_ )-3?_%T?\*K\%_] ;_R:F_^+KL:*.>7</90_E7W''?\*K\%_P#0&_\
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MIO\ XNC_ (57X+_Z W_DU-_\778T4<\NX>RA_*ON.._X57X+_P"@-_Y-3?\
MQ='_  JOP7_T!O\ R:F_^+KL:*.>7</90_E7W''?\*K\%_\ 0&_\FIO_ (NC
M_A5?@O\ Z W_ )-3?_%UV-%'/+N'LH?RK[CCO^%5^"_^@-_Y-3?_ !='_"J_
M!?\ T!O_ ":F_P#BZ[&BCGEW#V4/Y5]QQW_"J_!?_0&_\FIO_BZ/^%5^"_\
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M<<=_PJOP7_T!O_)J;_XNC_A5?@O_ * W_DU-_P#%UV-%'/+N'LH?RK[CCO\
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MF_\ BZ[&BCGEW#V4/Y5]QQW_  JOP7_T!O\ R:F_^+H_X57X+_Z W_DU-_\
M%UV-%'/+N'LH?RK[CCO^%5^"_P#H#?\ DU-_\71_PJOP7_T!O_)J;_XNNQHH
MYY=P]E#^5?<<=_PJOP7_ - ;_P FIO\ XNC_ (57X+_Z W_DU-_\778T4<\N
MX>RA_*ON.._X57X+_P"@-_Y-3?\ Q='_  JOP7_T!O\ R:F_^+KL:*.>7</9
M0_E7W''?\*K\%_\ 0&_\FIO_ (NC_A5?@O\ Z W_ )-3?_%UV-%'/+N'LH?R
MK[CCO^%5^"_^@-_Y-3?_ !='_"J_!?\ T!O_ ":F_P#BZ[&BCGEW#V4/Y5]Q
MQW_"J_!?_0&_\FIO_BZ/^%5^"_\ H#?^34W_ ,778T4<\NX>RA_*ON.._P"%
M5^"_^@-_Y-3?_%T?\*K\%_\ 0&_\FIO_ (NNQHHYY=P]E#^5?<<=_P *K\%_
M] ;_ ,FIO_BZ/^%5^"_^@-_Y-3?_ !==C11SR[A[*'\J^XX[_A5?@O\ Z W_
M )-3?_%T?\*K\%_] ;_R:F_^+KL:*.>7</90_E7W''?\*K\%_P#0&_\ )J;_
M .+H_P"%5^"_^@-_Y-3?_%UV-%'/+N'LH?RK[CCO^%5^"_\ H#?^34W_ ,71
M_P *K\%_] ;_ ,FIO_BZ[&BCGEW#V4/Y5]QQW_"J_!?_ $!O_)J;_P"+H_X5
M7X+_ .@-_P"34W_Q==C11SR[A[*'\J^XX[_A5?@O_H#?^34W_P 71_PJOP7_
M - ;_P FIO\ XNNQHHYY=P]E#^5?<<=_PJOP7_T!O_)J;_XNC_A5?@O_ * W
M_DU-_P#%UV-%'/+N'LH?RK[CCO\ A5?@O_H#?^34W_Q='_"J_!?_ $!O_)J;
M_P"+KL:*.>7</90_E7W''?\ "J_!?_0&_P#)J;_XNC_A5?@O_H#?^34W_P 7
M78T4<\NX>RA_*ON.._X57X+_ .@-_P"34W_Q='_"J_!?_0&_\FIO_BZ[&BCG
MEW#V4/Y5]QQW_"J_!?\ T!O_ ":F_P#BZ/\ A5?@O_H#?^34W_Q==C11SR[A
M[*'\J^XX[_A5?@O_ * W_DU-_P#%T?\ "J_!?_0&_P#)J;_XNNQHHYY=P]E#
M^5?<<=_PJOP7_P! ;_R:F_\ BZ/^%5^"_P#H#?\ DU-_\778T4<\NX>RA_*O
MN.._X57X+_Z W_DU-_\ %T?\*K\%_P#0&_\ )J;_ .+KL:*.>7</90_E7W''
M?\*K\%_] ;_R:F_^+H_X57X+_P"@-_Y-3?\ Q==C11SR[A[*'\J^XX[_ (57
MX+_Z W_DU-_\71_PJOP7_P! ;_R:F_\ BZ[&BCGEW#V4/Y5]QQW_  JOP7_T
M!O\ R:F_^+H_X57X+_Z W_DU-_\ %UV-%'/+N'LH?RK[CCO^%5^"_P#H#?\
MDU-_\71_PJOP7_T!O_)J;_XNNQHHYY=P]E#^5?<<=_PJOP7_ - ;_P FIO\
MXNC_ (57X+_Z W_DU-_\778T4<\NX>RA_*ON.._X57X+_P"@-_Y-3?\ Q='_
M  JOP7_T!O\ R:F_^+KL:*.>7</90_E7W''?\*K\%_\ 0&_\FIO_ (NC_A5?
M@O\ Z W_ )-3?_%UV-%'/+N'LH?RK[CCO^%5^"_^@-_Y-3?_ !='_"J_!?\
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MZ/\ A5?@O_H#?^34W_Q==C11SR[A[*'\J^XX[_A5?@O_ * W_DU-_P#%T?\
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MF)?_ (JNGHHYY=P]G#LCF/\ A7GA7_H%_P#DQ+_\51_PKSPM_P! O_R8E_\
MBJZ>BCGEW#V<.R.8_P"%>^%O^@7_ .3$O_Q5'_"O?"W_ $"__)B7_P"*KIZ*
M.>7</9P[(YC_ (5[X6_Z!?\ Y,2__%4O_"O?"W_0+_\ )B7_ .*KIJ*.>7</
M9P[(YG_A7WA?_H%_^3$O_P 51_PK[PO_ - O_P F)?\ XJNFHHYY=P]G#L<S
M_P *^\+_ /0+_P#)B7_XJC_A7WA?_H%_^3$O_P 57344<\NX>SAV.9_X5_X7
M_P"@9_Y'E_\ BJ7_ (5_X7_Z!G_D>7_XJNEHHYY=P]G#L<U_PK_PQ_T#/_(\
MO_Q5'_"O_#'_ $#/_(\O_P 572T4<\NX>SAV.:_X0#PQ_P! S_R/)_\ %4?\
M(!X8_P"@9_Y'D_\ BJZ6BCGEW#V<.QS7_" >&/\ H&?^1Y/_ (JC_A /#'_0
M,_\ (\G_ ,572T4<\NX>SAV.;_X0'PQ_T#/_ "/)_P#%4?\ " ^&?^@9_P"1
MY/\ XJNDHHYY=P]G#L<W_P (#X9_Z!G_ )'D_P#BJ/\ A ?#/_0,_P#(\G_Q
M5=)11S2[A[.'8YO_ (0'PS_T#/\ R/)_\51_P@7AG_H&?^1Y/_BJZ2BCFEW#
MV<.QS?\ P@7AG_H&_P#D>3_XJC_A O#/_0-_\CR?_%5TE%'-+N'LX=CG/^$"
M\-?] W_R/)_\51_P@?AK_H&_^1Y/_BJZ.BCFEW#V<.QSG_"!^&O^@;_Y'D_^
M*H_X03PU_P! W_R/)_\ %5T=%'-+N'LX=CG/^$$\-?\ 0-_\CR?_ !5'_"">
M&O\ H&_^1Y/_ (JNCHHYI=Q\D>QSO_"">&_^@;_Y'D_^*H_X03PW_P! W_R/
M)_\ %5T5%'-+N')'L<[_ ,(+X;_Z!O\ Y'D_^*H_X07PW_T#O_(\G_Q5=%11
MS2[AR1['._\ ""^&_P#H&_\ D>3_ .*H_P"$&\-_] [_ ,CR?_%5T5%'-+N'
M)'L<]_P@WAS_ *!W_D>3_P"*H_X0;PY_T#O_ "/)_P#%5T-%'-+N')'L<]_P
M@WAS_H'?^1Y/_BJ/^$&\.?\ 0._\CR?_ !5=#11S2[AR1['/?\(/X<_Z!W_D
M:3_XJC_A!_#G_0._\C2?_%5T-%'-+N')'L<]_P (/X<_Z!W_ )'D_P#BJ/\
MA!_#G_0._P#(\G_Q5=#11S2[AR1['/\ _"$>'?\ H'?^1I/_ (JC_A"/#O\
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M1T/_ )\?_(K_ /Q5'_"(Z'_SX_\ D5_\:VZ*.9]PY(]C%_X1+0_^?'_R*_\
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MS_\ (K_XT?\ "+:-_P ^?_D5_P#&MBBCF?<.6/8R/^$7T;_GS_\ (K_XT?\
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M5_SZ_P#D1O\ &M2BB[#E78BM[>*T@6"!-D:YP,DXR<]Z*EHI#"BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MX2^;_GTC_P"^C1_PE\W_ #Z1_P#?1KJMB?W5_*C8G]U?RHN@L^YRO_"7S?\
M/I'_ -]&C_A+YO\ GTC_ .^C75;$_NK^5&Q/[J_E1=!9]SE?^$OF_P"?2/\
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M?2/_ +Z-'_"7S?\ /I'_ -]&NJV)_=7\J-B?W5_*BZ"S[G*_\)?-_P ^D?\
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M!9]SE?\ A+YO^?2/_OHT?\)?-_SZ1_\ ?1KJMB?W5_*C8G]U?RHN@L^YRO\
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M-_SZ1_\ ?1H_X2^;_GTC_P"^C75;$_NK^5&Q/[J_E1=!9]SE?^$OF_Y](_\
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M -##JW_@;)_\51_PEOB7_H8=6_\  V3_ .*H^K/N'UR/8^K**^4_^$M\2_\
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M7F__  E.L_\ /Y_Y"3_"C_A*=9_Y_/\ R$G^%']IT>S_  _S#ZS ](HKS?\
MX2G6?^?S_P A)_A1_P )3K/_ #^?^0D_PH_M.CV?X?YA]9@>D45YO_PE.L_\
M_G_D)/\ "C_A*=9_Y_/_ "$G^%']IT>S_#_,/K,#TBBO-_\ A*=9_P"?S_R$
MG^%'_"4ZS_S^?^0D_P */[3H]G^'^8?68'I%%>;_ /"4ZS_S^?\ D)/\*/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MAX._Z __ ),S?_%T?\*P\'?] ?\ \F9O_BZZZBCGEW#V4/Y4<C_PK#P=_P!
M?_R9F_\ BZ/^%8>#O^@/_P"3,W_Q===11SR[A[*'\J.1_P"%8>#O^@/_ .3,
MW_Q='_"L/!W_ $!__)F;_P"+KKJ*.>7</90_E1R/_"L/!W_0'_\ )F;_ .+H
M_P"%8>#O^@/_ .3,W_Q===11SR[A[*'\J.1_X5AX._Z _P#Y,S?_ !='_"L/
M!W_0'_\ )F;_ .+KKJ*.>7</90_E1R/_  K#P=_T!_\ R9F_^+H_X5AX._Z
M_P#Y,S?_ !===11SR[A[*'\J.1_X5AX._P"@/_Y,S?\ Q='_  K#P=_T!_\
MR9F_^+KKJ*.>7</90_E1R/\ PK#P=_T!_P#R9F_^+H_X5AX._P"@/_Y,S?\
MQ===11SR[A[*'\J.1_X5AX._Z __ ),S?_%T?\*P\'?] ?\ \F9O_BZZZBCG
MEW#V4/Y4<C_PK#P=_P! ?_R9F_\ BZ/^%8>#O^@/_P"3,W_Q===11SR[A[*'
M\J.1_P"%8>#O^@/_ .3,W_Q='_"L/!W_ $!__)F;_P"+KKJ*.>7</90_E1R/
M_"L/!W_0'_\ )F;_ .+H_P"%8>#O^@/_ .3,W_Q===11SR[A[*'\J.1_X5AX
M._Z _P#Y,S?_ !='_"L/!W_0'_\ )F;_ .+KKJ*.>7</90_E1R/_  K#P=_T
M!_\ R9F_^+H_X5AX._Z _P#Y,S?_ !===11SR[A[*'\J.1_X5AX._P"@/_Y,
MS?\ Q='_  K#P=_T!_\ R9F_^+KKJ*.>7</90_E1R/\ PK#P=_T!_P#R9F_^
M+H_X5AX._P"@/_Y,S?\ Q===11SR[A[*'\J.1_X5AX._Z __ ),S?_%T?\*P
M\'?] ?\ \F9O_BZZZBCGEW#V4/Y4<C_PK#P=_P! ?_R9F_\ BZ/^%8>#O^@/
M_P"3,W_Q===11SR[A[*'\J.1_P"%8>#O^@/_ .3,W_Q='_"L/!W_ $!__)F;
M_P"+KKJ*.>7</90_E1R/_"L/!W_0'_\ )F;_ .+H_P"%8>#O^@/_ .3,W_Q=
M==11SR[A[*'\J.1_X5AX._Z _P#Y,S?_ !='_"L/!W_0'_\ )F;_ .+KKJ*.
M>7</90_E1R/_  K#P?\ ] C_ ,F9O_BZI7?PC\,3HPA2ZMF/1HYB<?\ ?6:[
MNBG[27<3I4WT1X7XA^$>K:9&T^ERC481R8PNR4?09(;\.?:N#MKF[TN_2>WD
MEMKN!\JPRK(P_P ]*^L*X3Q_X M_$-G+?V$*QZM&-P*\"<#^%O?T/X'VVA7Z
M2.:KA;>] M?#SXAIXKC-A?A(=4B3/R\+.HZLH['U'XCV[VOD.VN;O2]0CN('
MDM[NWDRK#AD8?YZ5]0>$?$,7B?PW:ZDF!(PV3(/X)!]X?U'L145J?+JMC3#5
MG-<LMS<HHHK Z@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH *X;Q?JYN+G^SX6_=1',F/XF]/P_G77:I>#3]-GN3C*+\
MH/=N@_6O+27FE).6D=OQ)->9F5=QBJ<>IS8B=ERHT=$TEM4N\-D6Z<R,/Y"N
M]BBCAB6.) B*,!0.!572K!=.T^.  ;\9<^K=ZNUTX/#*C#7=[ETJ?(O,****
MZS4**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !A9>,=,DNK6-X987"30R$$J2,@@CJ#SSQT-=%2::=F.,E)704444AA1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5X[\=O^8!_P!O
M'_M*O8J\=^.W_, _[>/_ &E6M'XT88G^$S"^#'_(X7?_ %X/_P"C(Z]SKPSX
M,?\ (X7?_7@__HR.O<ZJO\9&%_AA1116)TA1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!R/Q/_P"2=ZK_
M -L?_1J5X=X2_P"1ST+_ +"%O_Z,6O<?B?\ \D[U7_MC_P"C4KPWPE_R.>A?
M]A"W_P#1BUU4?@9P8G^*OZZGU91117(>@%%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M?$>T\7!K.YC2TU1!GR@V5E7N4SZ=Q^//..YK"47%V9U0FIJ\0HHHI%!1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M);G4]"U"\V_O9[FZC<,?9"Q 'X9I/$?A[X<:W92+:ZIH>G7F/W4UM=1(H/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O'?CM_S /\
MMX_]I5[%7COQV_Y@'_;Q_P"TJUH_&C#$_P )F%\&/^1PN_\ KP?_ -&1U[G7
MAGP8_P"1PN_^O!__ $9'7N=57^,C"_PPHHHK$Z0HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH Y'XG_P#)
M.]5_[8_^C4KPWPE_R.>A?]A"W_\ 1BU[E\3_ /DG>J_]L?\ T:E>&^$O^1ST
M+_L(6_\ Z,6NJC\#.#$_Q5_74^K****Y#T HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MH_\ 7D?_ $-:]%\>> _^$V_L_P#XF7V+[)YG_+#S-^_;_M#&-OZU6\#?#?\
MX0S5+B]_M;[9YT/E;/L_EX^8'.=Q]*Z%4C[+EZG$Z4_;\]M/^ =W1117.=IY
MI\;_ /D2[/\ ["*?^BY*\Z^$G_)1;#_KG+_Z+:O:_''A+_A,M%AT[[=]C\NX
M6?S/*\S.%9<8R/[W7VKG/"7PH_X1;Q%!JW]M?:O*5U\K[+LSN4CKO/KZ5T0J
M15-Q>YQ5*4W64DM-#TBOG7XP_P#)0)_^O>+^5?15>=>,/A9_PEGB!]5_MG[+
MNC5/*^R[\8&,YWC^511DHRNS7$PE.%HE'X&_\BYJ7_7V/_0!7+?&_P#Y'2S_
M .P<G_HR2O4_ W@W_A"]-N;3[?\ ;//F\W?Y/E[> ,8W'TK*\<?#3_A,M:AU
M'^U_L?EVZP>7]F\S.&9LYW#^]T]JM3BJKET,Y4IN@H6U,7X%_P#('U?_ *^$
M_P#037K%<GX%\%?\(59W=O\ VA]L^T2*^[R?+VX&,?>.:ZRLJC4I-HWHQ<::
M3/DG7_\ D8]4_P"ON7_T,U](?#S_ ))_HO\ U[_U-<5J'P1^W:E=7?\ PD.S
MSYGEV?8L[=Q)QGS.>M>D>'=(_L'P_9:5Y_G_ &:/9YNS;NYSG&3C\ZVK5(RB
MDCGP]*<)MR11\=_\B)K?_7H_\J^:M _Y&/2_^ON+_P!#%?4VNZ7_ &WH5]IG
MG>3]JA:+S-N[;GOC(S^=>::?\$?L.I6MW_PD._R)DEV?8L;MI!QGS..E*C4C
M&+3'B*4YS3BCTG7]'AU_0;W2Y^$N(RN?[K=5/X$ _A7RMJ%C=Z+JL]E<J8KN
MUDVMM/0CH0?U!KZ[KE_%G@/1_%T8>Z0P7B@!+J+[X ['L1]:FC5Y-'L7B*'M
M%>.YP7AWXV1P:?%;Z_97$T\8VFXMMI,@]2I(P>G0_E6;XR^+TVM:?+INC6LE
MI;3*5EGE8>8RGL .%R.O)Z]J)O@=KJS 0:GISQ=V<NK?D%/\ZZ?PM\&[+2KN
M&^UFZ6_FC.Y;=$Q$&[9SRWKT'OFM6Z*?,C!+$R7(SPBOJ:T_Y)W!_P!@E?\
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MXO*> @'./F8$'C(/I]"-XU8*"3.2="JZKE$@B^.6CFTW2Z5?K<X_U:%&3/\
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MH_VO]C\NW6#R_LWF9PS-G.X?WNGM5_P)X&_X0F&^C_M'[;]J9&SY'E[=N?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0!P?C;_D,P_]>Z_^A-4W@S_E]_[9_P#LU0^-O^0S#_U[K_Z$U3>#/^7W_MG_
M .S5XM/_ '_YO\CC7\<ZJBBBO;.L**** "BBB@ HHHH **** "BBB@ HHHH
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M110 4444 %%%% !1110 4444 %%%% !1110!5U'4K/2;-KN^N$@A4XW-W/H
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M!XJS7F?@W_DI_B#_ +>/_1RU<8W3?8B4^5I=STRBBBH+"BBB@ HHHH ****
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MTKG+:?X@ZW_I,#6NF6[C=&LJ+TZ="&;WYQ6?X9A_X3#QS>ZQ>*)+>T(,:$Y
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M./>J_C!IO$7CJQ\.*Q6"(@N 1U*[F/U"_P">:](MK>&TMH[>WC6.&-0J(O0
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MV"/H5I#=71E 9)B  F#D_>7G.._>M6BLT[.YHU=6/%_M7B+_ (6-]H^P6_\
M;G_/MN'E_P"IQUW?W.?O=?RKTSP[=>(KG[3_ &_86]IMV^3Y+ [NN[/S-T^7
MTZUQ_P#S7#_/_/M7IE;5I:)6Z&%&.K=^K/*+/4K72/B;K%[>2;(8Q*2>Y/&
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MV18W149%&\X*X('0\CMTHY').ZLQ<Z@U:5T>B^(;G7[:& Z#8V]U(6/FB9@
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M]K$NHPZ5-)I-O'<7PV^7'(<*WS#.>1VR>M>16MSXA7X@23Q6-NVLEFW6Y8;
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MU_CXNZ>4)+%X-W'3_(K:EK>/D8UM&I>9ZC4%]_R#[G_KDW\C4]07W_(/N?\
MKDW\C62W-7L<#\)O^/#4O^NJ?R->BUYU\)O^/#4O^NJ?R->BUI6_B,SH?PT>
M::XIU/XMZ=:/\\< 0[#TX!D/^?\ ]5>EUYLF/^%W29QG;QG_ *]Q7I-%7:*\
MA4MY/S&30QW$$D$J[HY%*.OJ",$5YS\,9&L]4UG29 V8V#88]"K%3Q^(_*O2
M:\W\&?\ )2/$7^]/_P"CA1#X)(*GQQ9Z17F_Q;_X]]*_WI?Y+7I%>;_%O_CW
MTK_>E_DM%#^(@K_PV>D4445D;!1110 4444 %%%% !7COQV_Y@'_ &\?^TJ]
MBKQWX[?\P#_MX_\ :5:T?C1AB?X3,+X,?\CA=_\ 7@__ *,CKW.O#/@Q_P C
MA=_]>#_^C(Z]SJJ_QD87^&%%%%8G2%%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '(_$__ ))WJO\ VQ_]
M&I7AOA+_ )'/0O\ L(6__HQ:]R^)_P#R3O5?^V/_ *-2O#?"7_(YZ%_V$+?_
M -&+751^!G!B?XJ_KJ?5E%%%<AZ 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M?PQ6DXN?OQ,Z<E3]R1VU>77T\<_QDM_+96$;HA*G/(3D?@>/PK8OO'W]H/\
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MP!INLEKBTQ97O7?&/D<]MR]OJ/UJ]XL\077AVQ@NK>P:ZC,@$S<XC3WQT)Z
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M5=<L1(I&>,XR/QKT'_A'-#_Z NG?^ J?X5SOCCPM=:A)#K.D';J-M@E4X:0
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M3('4^Q&:KZUI-OK>E3V%SPD@X8#)1NS"O/\ 2=;U/P%(=*URTEET_<?(GBY
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M/AZ/Q)H[VI98YT.^&1AG:WH?8]#_ /6KD-#\87?A@+HOB:TN$\H8AG R=HX
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M_1J5T7P^_P"1'T[_ +:_^C'KG?"?_)4]?_W9O_1J4=9ATA_70[S5O^0/??\
M7O)_Z":X;X3?\>&I?]=4_D:[G5O^0/??]>\G_H)KAOA-_P >&I?]=4_D:F/\
M.14OXL?F>BUYGXXA?P[XLT[Q':J-LC8E4#&6 P?^^E./P->F5B>+=,CU;PQ?
M6[L%*QF5&)P%9>1GVXP?8U-.7++4JK'FCIN<M\1=8:\MM/T;3V\TW^V;Y,G>
MA/R8]03S^ KM](TV+1])M=/AY2! N[&-QZEL>YR?QKR_X;:8^I:ZVHW.Z2*Q
MC"QEB" Y&%&#V R?KBO7:JK[MH(BC>5YOJ%%%%8FYYCXJ TWXG:7?W!VV\AB
M;?V&#M/Y<&O3JY[QAX:7Q)I'E)M6\A)>W<],]U/L?Y@5S6C^.9]"1=(\3V=Q
M%- -BSA<EE'3=Z_[PSG]3LU[2*MNC!/V<G?9GHU<!\5KJ(:-8V6<SR7/FJH_
MNJK _JP_6K]]\2O#]M"6MI9KR0@X2.)EY[9+ 8'TS6/HFB:IXJ\0KX@UV PV
MD>&M[=Q]X#[H /\ #WR>OXTZ<7%\TM+!4FIKDCK<[S2+9[+1;"UD&)(;>.-A
MG."% /\ *O.]/_Y+//\ [\G_ *+KU"O+]/\ ^2SS_P"_)_Z+I4G?F] JJW*O
M,]0HHHK$W"O,_!O_ "4_Q!_V\?\ HY:],KQ[3?$%IX;^(.N7EY',\;RW$0$*
M@G)E![D<?*:VI)M22,*K2<6SV&BN&_X6KH?_ #Z:C_W[3_XNGQ?%'1)IDB6U
MU ,[!1F-,<_\#J?93[%^VAW-KQ=I+:SX9O+2)=TX421#N64YP/KR/QK!^&>M
M)=:,VE2L?M-HQ*J>\9/]"2/RKNJX/Q+X/O8M4_M_PX_E7RL9)(0<;SW*]N><
M@\']"X-./(R9IJ7.CO*X/QWX5>8?V]I(:._MR'D6($-(!_$,?Q#]1].5L/B5
M!%_H^O6%Q8W:CYML9VG\#\P^G/UJ]<_$CPW FZ.YFN3_ '8H6!_\>P*<8U(2
MND$ITYQLV3>$?%L&OZ4\ER\4-W;+FX7.!M_O\]!_*N:\,J?%/Q"O->\O_0[;
M_5[EZG&U./7 +>Q'TKD-5CN;^:]UO3M,N+/392 ^W.P9QGGT)YQT&1[5ZUX)
M?3&\+VPTK/E+D2[OO>9U;=ZGD?ABM)Q4$VNOX&<).HTGT_$Z&H+[_D'W/_7)
MOY&IZ@OO^0?<_P#7)OY&N9;G2]C@?A-_QX:E_P!=4_D:]%KSKX3?\>&I?]=4
M_D:]%K2M_$9G0_AH\TUQCI'Q:T^^E*B*X" ,3PH*F,Y],=:]+KE_''AJ3Q#I
M4;6O_'[:L7A7(&_.,KDGCH#GVK*T7XBVT48L?$$<MI>0#9)(8V(8CU Y!_"F
MTYQ36Z)34)-2V9W<DB0Q/+(VU$4LQ/8#K7FWPPB>YU35]4*X1R$!/JS%B/T'
MYTOB+Q;+XG7^PO#<$L_G_++,4V@KZ#/0>I.*[3PWH<?A[1(;!"'<9>60#&]S
MU/\ (#V HMR0:>["_/--;(UJ\W^+?_'OI7^]+_):](KS?XM_\>^E?[TO\EI4
M/XB'7_AL](HHHK(V"BBB@ HHHH **** "O'?CM_S /\ MX_]I5[%7COQV_Y@
M'_;Q_P"TJUH_&C#$_P )F%\&/^1PN_\ KP?_ -&1U[G7AGP8_P"1PN_^O!__
M $9'7N=57^,C"_PPHHHK$Z0HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH Y'XG_P#).]5_[8_^C4KPWPE_
MR.>A?]A"W_\ 1BU[E\3_ /DG>J_]L?\ T:E>&^$O^1ST+_L(6_\ Z,6NJC\#
M.#$_Q5_74^K****Y#T HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MR.%W_P!>#_\ HR.O<ZJO\9&%_AA1116)TA1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!R/Q/_ .2=ZK_V
MQ_\ 1J5X;X2_Y'/0O^PA;_\ HQ:]R^)__).]5_[8_P#HU*\-\)?\CGH7_80M
M_P#T8M=5'X&<&)_BK^NI]64445R'H!1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 <'XV_P"0S#_U[K_Z$U3>#/\ E]_[9_\ LU0^-O\ D,P_
M]>Z_^A-4W@S_ )??^V?_ +-7BT_]_P#F_P CC7\<ZJBBBO;.L**** "BBB@
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M?\P#_MX_]I5K1^-&&)_A,PO@Q_R.%W_UX/\ ^C(Z]SKPSX,?\CA=_P#7@_\
MZ,CKW.JK_&1A?X84445B=(4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 <C\3_ /DG>J_]L?\ T:E>&^$O
M^1ST+_L(6_\ Z,6O<OB?_P D[U7_ +8_^C4KPWPE_P CGH7_ &$+?_T8M=5'
MX&<&)_BK^NI]64445R'H!1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 <'XV_Y#,/_7NO_H35-X,_Y??^V?\ [-4/C;_D,P_]>Z_^A-4W@S_E
M]_[9_P#LU>+3_P!_^;_(XU_'.JHHHKVSK"BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K+\1_\@"Z_P"
M_P#H0K4K+\1_\@"Z_P" _P#H0K'$?P9^C_(F?PLXK2O^0Q9?]?$?_H0KU6O*
MM*_Y#%E_U\1_^A"O5:X,K^"7J8X;9A1117J'2%%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 9>O:]:^'=/6]NXYGC,@
MCQ" 3D@GN1Z5=LKN._L+>\B#".>)95##D!@",^_-<C\4?^14C_Z^D_\ 06KH
MO#G_ "*^D_\ 7E#_ .@"M'%<B9FI/G<2CI7C+2]5DOE030+9+NFDG"JH&2."
M"?2LJ;XB">=TT31+W4T0X,B*5'X *3Z=0.M<1X9T9]>\3W5@\DBV6]I;D(<;
M@K' _,_U[5[3;V\-K;QP01K'%&H5$48 %7.,(/N9TY3FM['+:)X^LM4O5L+N
MUFT^\<X1)>58\8 . <_45UM<1\3=+BN/#XU)8U%Q:2+^]'#;"<8]^2#_ )-=
M'X;OWU/PWI]Y(<R20C>2<Y8<$_F#42BN52B7"3YG&1J4445F:E>]OK73K5[J
M\G2&%!EG<X'T]S[5QC_$I;BZ:'1]$N]0V]U)4GWP%8UEZT\WC;QVNB([)I]B
MS>;MX/RX#GZY^4?GW->CV5C:Z=:I:V<"0PH,*B# ^ON?>M>6,%[VK,>:4V^5
MV2.4L_B):_;1::QI]SI4IQ@S E1]> 1VYQCZ5KW_ (JL-/UVRTB2.=Y[M4:-
MXPI3#,5&3G/;TK1U+3+35K)[2]A66%NQ'*GU!['WKR!+&ZTKXAZ9IMS,TRVM
MQ%' S?\ /+=N7_T(U4(PGY"G*<+7U/:JR]:\0:=H%MYU_/M)X2->7?Z#^O2K
M]U<1V=I-<S'$4*-(Y] !DUYIX4TUO&FOWGB#5XQ);QOMCA/*%NR^X48X[D\]
M\Q"*:<GLBYS::C'=FG#\1;V])>P\+7MU #CS$8G^2$?K6IH7CS3-9NDLY$EL
MKQN!%-C#'T#>OU KJ%4*H50 H& !T%87B?PQ:^(K%@56.]1?W%QT*GL"?[N:
M=X/2UA6J+6]SD?!O_)3_ !!_V\?^CEKLO$/B:R\-0P2WD5Q(LS%5\E02,>N2
M*\^^&3RR>,;Y[AF:9K60R,QR2WF)DGWS6M\6?^/#3?\ KJ_\A6DXIU5%F4)M
M4G)'H44@FA2500KJ&&>O-/J"Q_Y!]M_UR7^0J>N9G4C$/BBQ7Q2OAXQ7'VMA
MD/M7R_N;^N<]!Z54^(/_ "(^H_\ ;+_T8E<[)_R6V+_=_P#:!KHOB#_R(^H_
M]LO_ $8E;<JC.-O(PYG*$K^8?#[_ )$?3O\ MK_Z,>N(\:^-=-\2:-#9V<%V
MDB7"RDS(H& K#LQY^85V_P /O^1'T[_MK_Z,>LSXJ_\ (KVW_7ZO_H#U46O:
MN_<F:?L59]"+PY\0-*^RZ3H_V>]^T;(;7=L79NP%SG=G&?:N^K,\.?\ (KZ3
M_P!>4/\ Z *TZRFTWHC:FFEJPK#\1^*;'PW!&9PTMQ+_ *N"/[S>_L*W*\RU
MJYM].^+-O=ZF-MJ$78[KE1\A ;\&[]J=.*D]15).*T-)?B/);/$VK>'KVQMY
M?NRDDY^@*KGMT-=G97MMJ-G'=VDJRP2#*.O0\X_F*6YMK;4;)[>XC2>WF7#*
M>0P_SWI]O;PVMO'!!&L<4:A411@ 4I.+6BL.*DGJ[F-H?BJQ\07EU;6D5PCV
MWWS*J@'DCC!/I6[7F?PT_P"0_K?X?^A&O3*=2*C*R%2DY1NREJVIPZ-I<^H7
M"R-%" 6$8!8Y('&2/6DT?58-;TJ'4;9)$AFW;5D ###%3G!/<5E^._\ D2M2
M_P!U/_0UJ/X??\B/IW_;7_T8]'*N3F\PYG[3E\CF=4_Y+'9_\ _] -;NK?$+
M3;*Y^RV$,NIW .&$'W1_P+G)^@(]ZX[QM;W%W\0Q:VC%9YECB4@X^\N#^A->
MEZ%X?L/#]BMO:1+OQ^\F(^>0]R3_ $Z5K/E48M]C*',Y24>YR[_$B:RE4:KX
M;O;*-NC,QR?H&5<_G77:1K-AKEF+JPG$D><,,89#Z$=JN2Q1SQ-%-&DD;##(
MZY!'N#7ENK6DGP_\5VU]8.XTN[/[R,G( !^9/P!!!Z_D:A*,]$K,MN4-6[H]
M.O;N.PL+B\E#&.")I6"CDA02<>_%4M!UZU\1:>U[:1S)&)#'B8 '( /8GUH\
M0L&\*ZJRD%393$$=#\AKGOA=_P BI)_U]/\ ^@K4J*Y&RG)\ZB=E--%;PO-/
M(D42#+.[!54>I)KC+CXD6LEU]FT?2[S4I 3_ *M=H..XP"3^0K/\:WMQKWB6
MS\*6C,D6]6N6"YZC=GZ*O/;G\*[G2M)LM&LDM+&!8XU')_B8^I/<T^6,4G+5
ML7-*4FHZ)'(K\2#:S!=7T"^L5)QN.3C\&"UV.GZE9ZK:+=6-PD\+<;E['T(Z
M@^QJ2YM;>]@:"YA2:)A@HZY!KS. /X#\?1V<3R'2[[;\IYX8D _56_''UIJ,
M9KW59B<I0?O.Z/4JQ=<\5:5X?4"\GW3'D0189\>N,\#ZXJ?Q!JZZ'H=UJ!56
M:)?D5C]YB< ?F:X[P)X:74$/B36/]*N9W+0K*,@8.-Y![Y!QV &?3$PBK<TM
MBIR=^6.Y93X@:C<KYMCX3O[B _=D4M@_DA'ZU8T[XD:5<SB"_@GT^4]#*,I^
M?4?EBNSK(\0>'+'Q%8M!<H%EQ^[G5?GC/;ZCGI_^NFI0>C0G&HM4[FLCK(BN
MC!E89# Y!'K7E?C7QKINMZ1)IMM!=I,DX):1%"_+D'HQ/Z5Z)H>D1Z%I,.GQ
M32S)'D[I#SDG)QZ#/:N>^)O_ "*)_P"OA/ZT4N53%5YG R/#/Q TK3M&L-+F
MM[UIXP(RR(I7)/NV>_I7:Z]K]EX>L#=7CGD[8XU^](WH/\:J>"O^1-TS_KE_
M[,:Y7X@O';>+M"N;V,M8)M+Y7<#A\L,=#QCBJM&52UB>:4*=[]BY_P +(N(D
M2YNO#5[#8,V!<;B01[94 GVS77Z3J]EK=BMY83>9$3M/&"K8!((]>15B.2WO
M[,.C1SVTR<'AE=3_ #%,L;"UTRT2ULH$A@3HB_YYK.3BUHK,UBI)ZNZ+-4=8
MU2+1=,EOYH9I8HL;Q" 6 )QGDBKU1W$$5U;2V\Z;XI4*.N>JD8(_*I5KZE.]
MM"IHVKVNNZ9%?VF\12$C:^ RD'&" 3C_ .N*OUYQX"N)=$\0ZEX8O&.X,7AZ
MX) YQQ_$N#^'O7H5S<1VEK-<RG$<2-(Y] !DU4X\LK(FG/FC=E/^V['^W_[%
M\P_;/)\[!X&/3/<XYQZ5HUX2=5U,ZXWBU8W,8O-H<CCI]PX_V,#Z5[C:W$=Y
M:0W,)S%,BR(?4$9%54I\EB:53GN5M8U:VT33)=0N]YBCQD( 68DX  )'K56'
MQ':S>&FUWR+E+549]CJH<@'&0,X[>M<?\0+E]9U[3/#-LV&+AY6ZA6;@9'LN
M3^-=3XFMX[3P/?VT0Q'%:>6@]   *.1)*^[#G;<K;(N:%KEMX@T[[=:),D6\
MIB4 -D?0FO/?&OC73=;TB33;:"[29)P2TB*%^7(/1B?TKH_AE_R*(_Z^'_I1
M\3?^11/_ %\)_6JBHQJVL1-RE2O?H9'AGX@:5IVC6&ES6]ZT\8$99$4KDGW;
M/?TK0^*O_(KVW_7ZO_H#UM>"O^1-TS_KE_[,:Q?BK_R*]M_U^K_Z ]-->UT7
M4&G[)W?0NOXKTWP]X;TL7#F6Y>TCV6\7+'Y!U]!T_P#KUG2?$:\MU2:Z\+WL
M-JPW><S$9'J,H >H[U/X \/K!I\6MWH:6_N$'EO)R8X@,*!GU4#GTP/7/:LH
M92K %2,$'H:F3A%VM<J*G)7O8SM%URQU^P%W8R$KG:Z,,,A]"*TJ\RTB-?#W
MQ6GTVW.RTNE.$Z 93>!^!R!7IM14BHO39E4Y.2UW054U348=)TR>_G5VBA7<
MPC +'G'&2*MU@>-?^1-U/_KE_P"S"E%7DD5)VBV1KXVT?^P%UB1Y8879D2)P
M/,<@X.%!.?SK%F^(MW#']H?PO>K99XG=BH(_[XQ^M9GPUT./4$?4[Y1-';,8
M;:-QE5;[S-C_ (%_G%>GLH92K %2,$'H:TDH0E:US*#G.-[V,S0O$%AXALC<
MV+M\IVO&X =#VR,GK6'J'C^VCO'L]'T^YU:>,X;[.#L_ @$GH>V/>N'UBSGT
MOQQ>Z/HSM!'?;(-B]E?:2/89S^%>M:5I%EHMBEI8PB.-1RW\3GU8]S3E&$-=
M[A&4YZ;6.9TWXBVD^H"QU6PGTR=FVCS3E5/^T2 5[=ORKM*Y#XC:9;7?A:>\
M>,?:;7:T<G< L 1],'\\5H^"[N2]\'Z;-*Q9_+*$GJ=K%1_*IDHN/-$J,I*7
M)+4V+N[M[&TENKJ58H(EW.[= *XN3XDI<7!BT?1+W4,=U!7)]@ QQCZ5EZU-
M/XT\<IH*22)IUFY,P4=UX=OKSM&>F?<UZ-96-KIMJMM9V\<$*]$08_$^I]SS
M1RQ@O>U8N:4V^5V2..M_B3;QW"PZQI-WIQ8XW,"P'U& ?R!KM;>XANK>.>"1
M9(I%#(ZG((JOJ6EV6KVC6U];I-&P(&X<K[@]C7G_ (5N[CPMXQN/#%U*TEI*
MY\EB. Q&5/XC@^]'+&:;CHT'-*#2EJF>F5@>(?&&E^'1Y=P[2W1&5MXN6]B3
MT _7V-6/$VLC0M N;X &11MB![N>!_C^%<K\/_#B3PGQ%J8^T7=PY>$R<[>?
MO_[Q/Y?C2C%6YI;#G)WY8[DJ?$/4'B%P/"E\;4\^<&8C'UV8Z^]:5KXNTOQ%
MHU\EL[1W(MI"T$HPV-O4=B*ZJN(\>>&HIK"76K!?(O[92\CQ\>8F/FSCJ0._
MID&JBX2=K6%)3BKWN4?A-_QX:E_UU3^1KT1F"J68@*!DD]!7G?PF_P"/#4O^
MNJ?R-6/B+K%S_HOAZQ#&XOL&3 ZJ3@*/J0<_2G4CS56B:<N6DF6]0^(NG07A
ML]-M;C4[@/M'D?<;_=/)//H,'UJJWQ&N;1P=4\,WUG%QER23^3*O\ZZ;0/#M
MCX>L%M[6,&0C][.1\TA[GV'MVK4DCCFC,<J*Z-U5AD'\*GFIK1(OEJ/5LHZ1
MK>GZ[:_:-/N%E48WKT9#Z$=O\XIVL:K!HFE3:C<I(\,.W<L8!8Y8*,9([FO.
M=>M3X"\5VFJ:<&6PN2?,A'3&1N0?@01[_2NL\>NLG@._D0Y5A$0?4&1*'!<R
MMLQ*H^65]T%UXZTV#2;2]BAN)IKP$P6B@>80"020"<#@_P"<XM>'-?O-;-R+
MK1KC3C 5'[XGYB><<@'I@].]<[\+])C33)=6E4//*YBB8\E$7KCTR<_D*[V6
M5((7FD;;'&I9CC. .31-1BW%(=-RDE)LI:OK>GZ%:_:-0N%B4YV+U9SZ =_\
MYKDH_B-=7K.=,\,WMY"IQO5CG';(56Q^=9.A6C>/?%=UJNH@M86Q CA)X(R=
MJ?3J3Z_C7J,<:11K'&BHB *JJ,  = !3:C#1J[%%RGJG9'+Z)X[T[5KP6-Q%
M+87K':L4W1CZ ^OL<5=M/%5C>^(Y]#CBN!<P[MSLJ[#CK@YSW]*E\1>';3Q#
MI[PS(JW"J3!.!\T;=N?3/4?UP:\Y\!&Z/C^<7K,UTL<JRENNX$ Y]^*:C"2<
MD)RG&2B^IZ%XB\56/AG[-]MBN)/M&[9Y*J<;<9SDC^\*\ST#Q58Z5XRU36)X
MKAK>[\W8J*I<;I PR"0.@]:]HKS/P;_R4_Q!_P!O'_HY:*3CRO0552YHZG;^
M'_$%IXDL'O+..9(TE,1$R@'( /8GCYA4FLZYI^@VGVB_G"*3A$'+.?8=^M7Y
M)$AB>61MJ(I9B>P'6O,=!M?^$\\4W6K:DC/I]M\L4+=.^U3CTZGU/M41BG=O
M9%RDXVBMV:J_$2ZO"7TOPQ?WD ./,!/_ +*K#]:LZ;\1M,NKD6NH6\VFSEL#
MSN4'IEN,?B,>]=BB+&BHBA548"@8 'I61XB\.67B'3Y()XU$X7]U.!\R'MSZ
M<\BFI0>C0.-1:IW-=6#*&4@J1D$=#2UP/PWUBY9;K0+T-YMEDQY'*J&PRGZ$
M\?\ UA7?5$X\KL7"7-&X4445)04444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !7COQV_Y@'_;Q_[2KV*O'?CM_P P#_MX
M_P#:5:T?C1AB?X3,+X,?\CA=_P#7@_\ Z,CKW.O#/@Q_R.%W_P!>#_\ HR.O
M<ZJO\9&%_AA1116)TA1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110!R/Q/_ .2=ZK_VQ_\ 1J5X;X2_Y'/0
MO^PA;_\ HQ:]R^)__).]5_[8_P#HU*\-\)?\CGH7_80M_P#T8M=5'X&<&)_B
MK^NI]64445R'H!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M<'XV_P"0S#_U[K_Z$U3>#/\ E]_[9_\ LU0^-O\ D,P_]>Z_^A-4W@S_ )??
M^V?_ +-7BT_]_P#F_P CC7\<ZJBBBO;.L**** "BBB@ HHHH **** "BBB@
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MD^N3S54XM1DWV)J23G%+N>NUYGX-_P"2G^(/^WC_ -'+7IE>9^#?^2G^(/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KQWX[?\ , _[>/\
MVE7L5>._';_F ?\ ;Q_[2K6C\:,,3_"9A?!C_D<+O_KP?_T9'7N=>&?!C_D<
M+O\ Z\'_ /1D=>YU5?XR,+_#"BBBL3I"BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#D?B?_R3O5?^V/\
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M;FD?]!2R_P# A/\ &CV<^S#VU/\ F7WE^BJ']N:1_P!!2R_\"$_QH_MS2/\
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MS2/^@I9?^!"?XT>SGV8>VI_S+[R_15#^W-(_Z"EE_P"!"?XT?VYI'_04LO\
MP(3_ !H]G/LP]M3_ )E]Y?HJA_;FD?\ 04LO_ A/\:/[<TC_ *"EE_X$)_C1
M[.?9A[:G_,OO+]%4/[<TC_H*67_@0G^-']N:1_T%++_P(3_&CV<^S#VU/^9?
M>7Z*H?VYI'_04LO_  (3_&C^W-(_Z"EE_P"!"?XT>SGV8>VI_P R^\OT50_M
MS2/^@I9?^!"?XT?VYI'_ $%++_P(3_&CV<^S#VU/^9?>7Z*H?VYI'_04LO\
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M:/[<TC_H*67_ ($)_C1[.?9A[:G_ #+[R_15#^W-(_Z"EE_X$)_C1_;FD?\
M04LO_ A/\:/9S[,/;4_YE]Y?HJA_;FD?]!2R_P# A/\ &C^W-(_Z"EE_X$)_
MC1[.?9A[:G_,OO+]%4/[<TC_ *"EE_X$)_C1_;FD?]!2R_\  A/\:/9S[,/;
M4_YE]Y?HJA_;FD?]!2R_\"$_QH_MS2/^@I9?^!"?XT>SGV8>VI_S+[R_15#^
MW-(_Z"EE_P"!"?XT?VYI'_04LO\ P(3_ !H]G/LP]M3_ )E]Y?HJA_;FD?\
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MVYI'_04LO_ A/\:/[<TC_H*67_@0G^-'LY]F'MJ?\R^\OT50_MS2/^@I9?\
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MHHKVSK"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MV9I**ENCCK3X9^'[:59)!=7.#G;-*,'_ +Y KKH88K>%(8(TBB085$4*JCT
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M2:MT47=K!97N-DC26-HY$5T<%65AD$'J"*Y*]^&WA^\E:1$N+4L<E8) !^3
MXKKZ*<9..S%*$9;HY/3_ (<^'["996BFNF7D"Y<,N?<  '\:ZM5"J%4 *!@
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MX7?_ %X/_P"C(Z]SKPSX,?\ (X7?_7@__HR.O<ZJO\9&%_AA1116)TA1110
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MC_P _L+_ *>?A_P3Q*BO;:*/[4_N?C_P _L+_IY^'_!/$J*]MHH_M3^Y^/\
MP _L+_IY^'_!/$J*]MHH_M3^Y^/_   _L+_IY^'_  3Q*BO;:*/[4_N?C_P
M_L+_ *>?A_P3Q*BO;:*/[4_N?C_P _L+_IY^'_!/$J*]MHH_M3^Y^/\ P _L
M+_IY^'_!/$J*]MHH_M3^Y^/_   _L+_IY^'_  3Q*BO;:*/[4_N?C_P _L+_
M *>?A_P3Q*BO;:*/[4_N?C_P _L+_IY^'_!/$J*]MHH_M3^Y^/\ P _L+_IY
M^'_!/$J*]MHH_M3^Y^/_   _L+_IY^'_  3Q*BO;:*/[4_N?C_P _L+_ *>?
MA_P3Q*BO;:*/[4_N?C_P _L+_IY^'_!/$J*]MHH_M3^Y^/\ P _L+_IY^'_!
M/$J*]MHH_M3^Y^/_   _L+_IY^'_  3Q*BO;:*/[4_N?C_P _L+_ *>?A_P3
MQ*BO;:*/[4_N?C_P _L+_IY^'_!/$J*]MHH_M3^Y^/\ P _L+_IY^'_!/$J*
M]MHH_M3^Y^/_   _L+_IY^'_  3Q*BO;:*/[4_N?C_P _L+_ *>?A_P3Q*BO
M;:*/[4_N?C_P _L+_IY^'_!/$J*]MHH_M3^Y^/\ P _L+_IY^'_!/$J*]MHH
M_M3^Y^/_   _L+_IY^'_  3Q*BO;:*/[4_N?C_P _L+_ *>?A_P3Q*BO;:*/
M[4_N?C_P _L+_IY^'_!/$J*]MHH_M3^Y^/\ P _L+_IY^'_!/$J*]MHH_M3^
MY^/_   _L+_IY^'_  3Q*BO;:*/[4_N?C_P _L+_ *>?A_P3Q*BO;:*/[4_N
M?C_P _L+_IY^'_!/$J*]MHH_M3^Y^/\ P _L+_IY^'_!/$J*]MHH_M3^Y^/_
M   _L+_IY^'_  3Q*BO;:*/[4_N?C_P _L+_ *>?A_P3Q*BO;:*/[4_N?C_P
M _L+_IY^'_!/$J*]MHH_M3^Y^/\ P _L+_IY^'_!/$J*]MHH_M3^Y^/_   _
ML+_IY^'_  3Q*BO;:*/[4_N?C_P _L+_ *>?A_P3Q*BO;:*/[4_N?C_P _L+
M_IY^'_!/$J*]MHH_M3^Y^/\ P _L+_IY^'_!/$J*]MHH_M3^Y^/_   _L+_I
MY^'_  3Q*BO;:*/[4_N?C_P _L+_ *>?A_P3Q*BO;:*/[4_N?C_P _L+_IY^
M'_!/$J*]MHH_M3^Y^/\ P _L+_IY^'_!/$J*]MHH_M3^Y^/_   _L+_IY^'_
M  3Q*BO;:*/[4_N?C_P _L+_ *>?A_P3Q*BO;:*/[4_N?C_P _L+_IY^'_!/
M$J*]MHH_M3^Y^/\ P _L+_IY^'_!/$J*]MHH_M3^Y^/_   _L+_IY^'_  3Q
M*BO;:*/[4_N?C_P _L+_ *>?A_P3Q*BO;:*/[4_N?C_P _L+_IY^'_!/$J*]
MMHH_M3^Y^/\ P _L+_IY^'_!/$J*]MHH_M3^Y^/_   _L+_IY^'_  3Q*BO;
M:*/[4_N?C_P _L+_ *>?A_P3Q*BO;:*/[4_N?C_P _L+_IY^'_!/$J*]MHH_
MM3^Y^/\ P _L+_IY^'_!/$J*]MHH_M3^Y^/_   _L+_IY^'_  3Q*BO;:*/[
M4_N?C_P _L+_ *>?A_P3Q*BO;:*/[4_N?C_P _L+_IY^'_!/$J*]MHH_M3^Y
M^/\ P _L+_IY^'_!/$J*]MHH_M3^Y^/_   _L+_IY^'_  3Q*BO;:*/[4_N?
MC_P _L+_ *>?A_P3Q*BO;:*/[4_N?C_P _L+_IY^'_!/$J*]MHH_M3^Y^/\
MP _L+_IY^'_!/$J*]MHH_M3^Y^/_   _L+_IY^'_  3Q*BO;:*/[4_N?C_P
M_L+_ *>?A_P3Q*BO;:*/[4_N?C_P _L+_IY^'_!/$J*]MHH_M3^Y^/\ P _L
M+_IY^'_!/$J*]MHH_M3^Y^/_   _L+_IY^'_  3Q*BO;:*/[4_N?C_P _L+_
M *>?A_P3Q*BO;:*/[4_N?C_P _L+_IY^'_!/$J*]MHH_M3^Y^/\ P _L+_IY
M^'_!/$J*]MHH_M3^Y^/_   _L+_IY^'_  3Q*BO;:*/[4_N?C_P _L+_ *>?
MA_P3Q*BO;:*/[4_N?C_P _L+_IY^'_!/$J*]MHH_M3^Y^/\ P _L+_IY^'_!
M/$J*]MHH_M3^Y^/_   _L+_IY^'_  3Q*BO;:*/[4_N?C_P _L+_ *>?A_P3
MQ*BO;:*/[4_N?C_P _L+_IY^'_!/$J*]MHH_M3^Y^/\ P _L+_IY^'_!/$J*
M]MHH_M3^Y^/_   _L+_IY^'_  3Q*BO;:*/[4_N?C_P _L+_ *>?A_P3Q*BO
M;:*/[4_N?C_P _L+_IY^'_!/$J*]MHH_M3^Y^/\ P _L+_IY^'_!/%$D>)P\
M;LCCHRG!%=9H7CB[LW2#46-S;=/,/,B?C_%^/-=??Z+IVHQE;BUC)/1U&UA^
M(KSC7M"FT2["DF2W?F.3'7V/O6T*]'%^Y-:_UL<U7"XG+W[2G*Z_K='K\$\5
MU D\#AXI!N5EZ$5)7G7@+6F@O#I4SDQ39:+/\+#DC\1^H]Z]%KR<10=&HXL^
M@P>)6)I*HOGZA1116!U!1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 <'XV_Y#,/_ %[K_P"A-4W@S_E]_P"V?_LU0^-O^0S#
M_P!>Z_\ H35-X,_Y??\ MG_[-7BT_P#?_F_R.-?QSJJ***]LZPHHHH ****
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M*"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MYJ"*\X\)6NI>(K(Z#%*]MIB2--=31CER0 J_IT_'L*]+L_"'A^RA$2:5:R8
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M)VB)RG%7EL=_:7]G?HSV=W!<JIPS0R!P#Z'%6*\_^$__ "![_P#Z^!_Z"*]
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M';_F ?\ ;Q_[2KV*O'?CM_S /^WC_P!I5K1^-&&)_A,PO@Q_R.%W_P!>#_\
MHR.O<Z\,^#'_ ".%W_UX/_Z,CKW.JK_&1A?X84445B=(4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 <C\
M3_\ DG>J_P#;'_T:E>&^$O\ D<]"_P"PA;_^C%KW+XG_ /).]5_[8_\ HU*\
M-\)?\CGH7_80M_\ T8M=5'X&<&)_BK^NI]64445R'H!1110 4444 %%%% !1
M110 4444 %%%% !1110!0US_ )%_4O\ KUE_] ->*U[5KG_(OZE_UZR_^@&O
M%:]K*_@EZGS6>_Q(>A[;1117C'T@4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 51UG_D!:A_U[2?\ H)J]5'6?^0%J'_7M)_Z":NG\:]3.M_#E
MZ,\@KWFO!J]YKT\U^Q\_T/#R'_EY\OU"BBBO(/H0HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** .#\;?\AF'_ *]U_P#0FJ;P
M9_R^_P#;/_V:H?&W_(9A_P"O=?\ T)JF\&?\OO\ VS_]FKQ:?^__ #?Y'&OX
MYU5%%%>V=84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %9?B/_D 77_ ?_0A6I67XC_Y %U_P'_T(5CB/
MX,_1_D3/X6<5I7_(8LO^OB/_ -"%>JUY5I7_ "&++_KXC_\ 0A7JM<&5_!+U
M,<-LPHHHKU#I"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "O,_!O\ R4_Q!_V\?^CEKTRO,_!O_)3_ !!_V\?^CEK6
MG\,C&I\4?4[W6Y&AT#494&62UE8 >H4UR'PHMXUT&]N0/WDESY;'V55(_P#0
MC7=S0QW$$D$J[HY%*.OJ",$5YGX-OV\*>(KWP[J;^7'+)F)V/R[^QY[,,<^P
MIPUA)()Z5(MGI]%%4=8U:UT33)KZ[<*D8^5<\NW91[FLDKZ(U;LKL\_\,XLO
MBKJEO!&!%)YRE1T49#<?B,?C7IU>>?#JPN;V_P!0\2WB?-<LRQ$CKELL1[#
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M!N!_H!^-<[X:TOQH?#]J^E:M86]FZEHXW0;ADG.?W9YS[FNY\2:5_;7A^\L
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MKBH^S>I$G+VBT/9**9%&(84B4DJBA1GKQ3ZYCI"BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K+\1_\@"Z_P" _P#H
M0K4K+\1_\@"Z_P" _P#H0K'$?P9^C_(F?PLXK2O^0Q9?]?$?_H0KU6O*M*_Y
M#%E_U\1_^A"O5:X,K^"7J8X;9A1117J'2%%%% !1110 4444 %%%% !1110
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MH]P[^'-=,$3'=Y4Y.,^^ 0>.^*)_"'BS62(M:\0Q_9CPZ6X.&'7E0J@\^O\
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MU4?@9P8G^*OZZGU91117(>@%%%% !1110 4444 %%%% !1110 4444 %%%%
M%#7/^1?U+_KUE_\ 0#7BM>U:Y_R+^I?]>LO_ * :\5KVLK^"7J?-9[_$AZ'M
MM%%%>,?2!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% &7+XET&"9X9M;TV.6-BKH]V@96'!
M!!/!IG_"5^'?^@_I?_@9'_C7A/B7PUKT_BK6)H=$U*2*2]F9'2T<JRER000.
M17+RQ203/#-&\<L;%71U(96'!!!Z&NE4(M;G#+%2B]CZ>_X2OP[_ -!_2_\
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MROX)>ICAMF%%%%>H=(4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MC4KPWPE_R.>A?]A"W_\ 1BU[E\3_ /DG>J_]L?\ T:E>&^$O^1ST+_L(6_\
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MZ=(^P[_OQ,<X!QU!QU_#TS2=*>EB)1KTUS7N>\VUS#=VT=Q;RI+#*H9'0Y#
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MQ/(=/OHD@U%5W)LSLF ')'H>IQZ5S_C_ .&^DZ9H$VK:/');M;8,D.]G5U)
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MR.0BYR<>I...]>8:G_R%KS_KN_\ Z$:]$^'7PZLM=TW^V-8\Q[=W*P0*Q4.
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M'-3WNLZIJ2*E]J5Y=(O*K/.S@?F:ZITG*5[G#2KJ$'&Q2KZSM@ZVL*RY\P(
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MSI1A*6R*G5A#XF>JT5YSI'QBT6]F6+4;6?3]W_+3/FH#[D 'T[?E7H4$\-S
MD]O*DL+C<DD;!E8>H(ZTI1<=QPJ1G\+.?\??\B)K'_7#^HKYZT+_ )&#3?\
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MCZL#VKR7X:7#6_C_ $PKG$A>-AGJ"C?UP?PKIOC8\AU324)/EB!RH[9+#/\
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M2U15^"E_*+_5-/)S$\2S@>C [3CZAA^0J?XW_P#,"_[>/_:=9OP6_P"1EO\
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MS_D7]2_Z]9?_ $ UXK7M97\$O4^:SW^)#T/;:***\8^D"BBB@ HHHH ****
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M,44/A88KXXGN'Q:#'P)-MS@3Q[N>V?\ '%>#6MI<WUREO:6\MQ.^=L42%V;
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MKWWQ=,]Q\,KV>0@O)9([$#N=I->!:%_R,&F_]?47_H8I4/A96*^.)[W\3_\
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MU .4S[YK:"YXN/4QF^22GTV+7B(_\);\0;71(V)L[/\ U_S<$CE\>^,+]:-
M!\(?$.XT>0N+.^&(23P<\H>G/\2_6M'X9Z4\=C=:S<@F>\<A2PP=@.2?Q/\
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M#^A)_"I/ FJQZGX5M%#@RVJ""1>XV\+^F/UH32I;7U$TW5WMH9?_  G.N?\
M0E:C^;__ !NL_7/$>KZYH]QI\W@S44$J_*^'.QAR#CR_6O2:RO$&NVWA[2GO
M9\.P(6.+=@R-Z#^=3&2OI'4J479WEI\C&^'4=];^&WMK^"Y@DBG8(D\;*=A
M/&1TSNKD?%^I'2/B2-0$?F&!$8(3C)V8KT_2=2CU?2K>_BBDB2==P208(YQ7
MG'B&R@U'XK0V=RF^&941QG'&PU=-WFVR*BM3BD^Q-H/AV^\97BZ]XAEWVK#$
M,2M@. <8P/NKD'W/ZUZ9'&D4:QQHJ(@"JJC  '0 5Y9-#J_PVU(30%KW1YB
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MD'AGXKSM<-LMK_=B1EP,28;\@XQGVKT^JJ2BK75]"*<9.]G;4X;_ (3G7/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"O'?CM_S /\ MX_]I5[%7COQV_Y@'_;Q_P"TJUH_&C#$_P )F%\&/^1PN_\
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M:A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MWP7X.MO".F&,,)KZ8 W$_8D=%7T49/UZ^P4W&G#E15-2JU.=K0VM7_Y M_\
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MCP(GBRQ"^@(!./\ >''TKT:BG&=E9ZHF5.[YD[,\\NO$/C360;;3M!FTX/\
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M7X5M_$UBJ,WE7<63#-CIZ@CN#^GZ'F[/5?&?AM197VC2:K#'Q'+"2S%>@^8
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M%%% !1110 4444 %%%% !1110 4444 <'XV_Y#,/_7NO_H35-X,_Y??^V?\
M[-4/C;_D,P_]>Z_^A-4W@S_E]_[9_P#LU>+3_P!_^;_(XU_'.JHHHKVSK"BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"EJ_\ R!;_ /Z]Y/\ T$U\
MJ5]9W,"W5K-;N2$E0HQ7K@C'%>?_ /"F/#O_ #^ZI_W]C_\ B*WHU%"]SEQ%
M*51KE.^L?^0?;?\ 7)?Y"IZ9%&(84B4DJBA1GKQ3ZP.I!1110 4444 %%%%
M!1110 5E^(_^0!=?\!_]"%:E9?B/_D 77_ ?_0A6.(_@S]'^1,_A9Q6E?\AB
MR_Z^(_\ T(5ZK7E6E?\ (8LO^OB/_P!"%>JUP97\$O4QPVS"BBBO4.D****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MK_Z$U3>#/^7W_MG_ .S5XM/_ '_YO\CC7\<ZJBBBO;.L**** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %>._';_F ?\ ;Q_[2KV*O'?CM_S /^WC_P!I5K1^
M-&&)_A,PO@Q_R.%W_P!>#_\ HR.O<Z\,^#'_ ".%W_UX/_Z,CKW.JK_&1A?X
M84445B=(4444 %%%% !1110 4444 %%%% !5+5_^0+?_ /7O)_Z":NU2U?\
MY M__P!>\G_H)IK<3V/E2OK&Q_Y!]M_UR7^0KY.K4?Q)KLD)A?6M1:(C&PW3
ME<>F,UVU:?/8\RA65.]T:/Q %@/'&I_V=L\C>,^6?EW[1OQ_P+/XYKU7X0!A
MX).[.#=R;>>V%_KFO'/#_AK4_$M^EMI]NS G#S,,1QCN2?QZ=:^C] T:#P_H
MEKIEN=R0)@OC!=NI8_4YK.LTHJ)MAHN4W.VA/J>IV>CZ?-?7TRPV\0RS'^0'
M<GTKQ_6_C)J4\SQZ+:Q6L&?EDG7?(1],[1^M4OBSX@EU+Q*=*1_]%L.-HZ-(
M0"Q/KCI[<^M/\ _#@>([;^U-4DDBT\DB%8F :4@X)SSA<@CU/M2A",8\TQU*
MLYSY*9FQ_%'Q>C[FU19!_=:VBQ^BBNZ\*_%NWU*ZCLM;@CM)I&VI<1DB+/8-
MDY7GODCZ5LS_  J\)36QB2QF@?&/-CN'+?7YB1^E>/>,O"-SX1U5;>1_.M9@
M6MYL8W =01V(R,_44U[.IHE8E^VH^\W='TK7E/C'XFZUX>\5WNEVEK8/!!LV
MM+&Y8[D5CG#@=2>U;'PG\02ZOX:>RN7+SZ>PC#'J8R,IGW&&'T KS/XG_P#)
M1-5_[8_^BDJ*<%SN,C2M5?LE*/4Z76?B[J/]F646GI;)>R0B2YF5=RQL3]U5
M)/8#.<]:Z/X?^)->U?PSJVIZI-'.+?(MW,:J2RJ68$+C(Y7MZ\UQ_P ,O UC
MXCBN=2U5'EM89/)2%7*AVQDDD'/ *],=:]671K+0/"5WI]A&4MT@F8 G))()
M.3WZX^@%.IR+W4M0HJI+WY/0\H_X7/XB_P"?+2_^_4G_ ,77MUM(9K6&5@ S
MH&..G(KY,KZJ6ZBL-!%Y.2(H+;S7(Z[57)_045X)6LA86I*5^9F9XJ\9:7X3
MM@UVQDNI%)AMH_O/[G^Z,]S[XSC%>2:C\6_$UW,6M)+>QCZ!(X@Y_$OG)_ ?
M2N4UK5[OQ!K-QJ%T2TL[Y5!R$'91[ <5ZOX5^$FGI80W6O\ FSW,J!S;!C&L
M61]TD<EAWY'/'/4UR0IJ\MR'4J5I6AHCD;#XM>)[656NIH+V/=EEEA521Z H
M!C]?QKU?PGXYTOQ9#MA)M[Y1F2UD;+ <9*G^(<]>OL*YWQ%\(M)N;*230Q):
M7:KE(FD+QN?0[LD9]<_A7CUA?7N@ZS%=VY,-Y:2]#V(X*GV/((]":.6%1>[N
M'/5HRM/5'U56!XJ\7:=X3L1/>$R3R9$-NA&Z0_T'J?Y]*TM(U*+6-'M-1A!6
M.YB60*3DKD<C\#Q^%?.'B_79/$7B:\OFD9H=YCMP?X8@3M'MZ_4FLJ5/FE9G
M17K<D;KJ;^H?%OQ/=RYM9+>R3& L4(8_4E\\U8T?XO:[:3K_ &FL5_!T;Y!&
M_7J"HQT]JU/!'PMMM0TR#5==:4K.-\5HN4^7/!8]>1S@8X/7TZ+5_A'X=O+5
MAIR2V%P!\C+(TBD_[08DX^A%:N5)/EL<\85VN:YY/XXU6UUOQ?>ZE9.6MYUB
M92PP1B) 01Z@@C\*]7^#W_(E2?\ 7Y)_Z"M>(ZCI]SI6HW%A=ILN('*.N<\^
MWM7MWP>_Y$J3_K\D_P#05IUDE3LB<.VZK;/0****Y#T0HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MOVFR2YUV\F@>0!A;6X 9 1_$S \^V/Q](?%'PB;3[":^T6[EN%A0NUM, 9"
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MM^M2IU']DT=*BOM$?PCTK5M,UN_^W:;>6L,EL,-/ Z L&& "0!G!-<E\3_\
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M3S[KQS=Q7/4QP;_+S^#+_P"@UR?@'QMH/A/3;@7EM?S7]Q)NDDBC0C:.@!+
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M$?'T9P/YFB/P2'/2K%^IZ]11161N%%%% !1110 4444 %%%% !1110 4444
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M !5 '0?$?_D7K?\ Z^U_] >O+ZWM;\6W^O626MU#;(B2"0&)6!R 1W)]:P:
M"NC\,^+)]"D\F8/-8L>8P>4]US_+O7.44 >[V-_;:E:)=6DHDB?H1_(^AJS7
MB>BZ_?:%<^9:R9C8_O(6Y5_\#[UZUHVN66N6@FM9!O 'F1$_,A]Q_6@#2HHH
MH **** "BBB@#@_&W_(9A_Z]U_\ 0FJ;P9_R^_\ ;/\ ]FJ'QM_R&8?^O=?_
M $)JF\&?\OO_ &S_ /9J\6G_ +_\W^1QK^.=51117MG6%%%% !1110 4444
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MF/%WI&IC<KP7EI,#@\,CJ?Z$44-8M!BM)J70^KJ*XWP[\2M!UFR0W=Y#I]X
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MY5I7_(8LO^OB/_T(5ZK7!E?P2]3'#;,****]0Z0HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "O'?CM_S /^WC_VE7L5>._';_F
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M(KSGX:^";C0=9U6\U"%P\+FVM79<"1<Y9P.O("X/N12A-*.NZ'4IMSLMGO\
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M.OV'B33!?Z<[M#N*$.A4JPQD'\QTXKS2_G\5?$R86,%@VEZ*'!=YE/)'0DD
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MQG/:KLXQ:D9WC*:=/?J>ANZQQM(YPJ@DGT KR7X*J9;G7;E@0Q\D<=.2Y/\
M(5Z/XFO?[/\ "^J7?>.UD*\XYVD#]<5QOP9M#%X7O+IACS[HA?<*HY_,G\JF
M.E-ESUJQ7J>CT445D;A1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 51UG_D!:A_U[2?\ H)J]5'6?^0%J'_7M)_Z":NG\
M:]3.M_#EZ,\@J"IZ]I_L'1_^@38_^ Z?X5Z>:_8^?Z'AY#_R\^7ZGC>D_P#(
M9L?^OB/_ -"%>Z5131-)C=733+)74Y5EMT!!]1Q5ZO(/H3C_ (C_ /(O6_\
MU]K_ .@/7E]>]7-I;7D8CNK>*= =P65 P!]<'ZU5_L'1_P#H$V/_ (#I_A0!
MX?17N']@Z/\ ] FQ_P# =/\ "C^P='_Z!-C_ . Z?X4 >'UN>#_^1LT__?;_
M -!->J?V#H__ $";'_P'3_"I(=(TRWE66#3K2*1?NND"J1]"!0!<KS_XF_\
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M6+=W<Z8QY4D@HHHI#"BBB@ HHHH **** "BBB@ HHHH *R_$?_( NO\ @/\
MZ$*U*R_$?_( NO\ @/\ Z$*QQ'\&?H_R)G\+.*TK_D,67_7Q'_Z$*]5KRK2O
M^0Q9?]?$?_H0KU6N#*_@EZF.&V84445ZATA1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %>._';_ )@'_;Q_[2KV*O'?CM_S /\
MMX_]I5K1^-&&)_A,PO@Q_P CA=_]>#_^C(Z]SKPSX,?\CA=_]>#_ /HR.O<Z
MJO\ &1A?X84445B=(4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 <C\3_^2=ZK_P!L?_1J5X;X2_Y'/0O^
MPA;_ /HQ:]R^)_\ R3O5?^V/_HU*\-\)?\CGH7_80M__ $8M=5'X&<&)_BK^
MNI]64445R'H!1110 4444 %%%% !1110 4444 %%%% !1110!0US_D7]2_Z]
M9?\ T UXK7M6N?\ (OZE_P!>LO\ Z :\5KVLK^"7J?-9[_$AZ'MM%%%>,?2!
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 >/_$?.A?$71==!*QN$9R1D91L-_P".D5Z^K!E#*05(R".AK$\3^%=/
M\6645KJ#3H(I/,1X& 8'&".01C\.U:EA:+I^GV]FDLLJP1K&KRD%V & 20!D
MU<I)Q7=&4(.,Y/HRQ1114&H4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% 'GWQ?U5;/PDFG@CS+Z8+C_8
M0AB?S"_G71>"=+.C^#=,M'4+)Y(DD'<,YW$'Z9Q^%0>(? VF^)M4MK[4+B\/
MV< ) CH(\9R<@J3SWYKIJMR7(HHRC!^T<F%%%%0:A1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MHTSEY[5FMI&)R3MY7/\ P$K795Q25G8].$E**D@HHHI%!1110 4444 %%%%
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M/0]MHHHKQCZ0**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBJ%WK>DZ?*8KW5+*VD&,K-<(AY]B:
M+ VEN7Z*KVE]:7\7FV=U!<1_WH9 X_,58H **** "BBB@ HHHH **** "BBB
M@ HHHH ***IV>KZ9J,KQ6.HVES)&,ND$ZN5^H!XH"Y<HJH-4T\Z@=/%_:F]'
M)MO.7S!QG[N<].?I5N@+A1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 51UG_D
M!:A_U[2?^@FKU4=9_P"0%J'_ %[2?^@FKI_&O4SK?PY>C/(*]YKP:O>:]/-?
ML?/]#P\A_P"7GR_4****\@^A"BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH X/QM_R&8?^O=?_0FJ;P9_R^_]L_\ V:H?&W_(
M9A_Z]U_]":IO!G_+[_VS_P#9J\6G_O\ \W^1QK^.=51117MG6%%%% !1110
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MHBG3DY4_=W%6@HU;S6C.R_X4AXE_Y_M)_P"_LG_QNC_A2'B7_G^TG_O[)_\
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M>F75_.<16T32O]%&:\3T7XV:K8V:P:GI\6HN@P)EE\EV_P![Y2"?H!6!XO\
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M?\P#_MX_]I5K1^-&&)_A,PO@Q_R.%W_UX/\ ^C(Z]SKPSX,?\CA=_P#7@_\
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MHHH **** "BBB@#D?B?_ ,D[U7_MC_Z-2O#?"7_(YZ%_V$+?_P!&+7N7Q/\
M^2=ZK_VQ_P#1J5X;X2_Y'/0O^PA;_P#HQ:ZJ/P,X,3_%7]=3ZLHHHKD/0"BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@"AKG_(OZE_UZR_^@&O%:]JUS_D
M7]2_Z]9?_0#7BM>UE?P2]3YK/?XD/0]MHHHKQCZ0**** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_ =![#US5P]Q7>[,ZG[QN*V6YG?!C_D3[O\ Z_W_ /1<=>BUYU\&/^1/N_\
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M .RUZK//#;0//<2I%"@W/)(P55'J2>E>/:?JEGHWQ?UZ^OYUAMXDE)8]_N\
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M>:/2****R-PHHHH **** "BBB@ HHHH *R_$?_( NO\ @/\ Z$*U*R_$?_(
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH Y'XG_ /).]5_[8_\ HU*\-\)?\CGH7_80M_\ T8M>Y?$__DG>J_\
M;'_T:E>&^$O^1ST+_L(6_P#Z,6NJC\#.#$_Q5_74^K****Y#T HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH H:Y_R+^I?]>LO_H!KQ6O:M<_Y%_4O^O67
M_P! ->*U[65_!+U/FL]_B0]#VVBBBO&/I HHHH **** "BBB@ HHHH ****
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M/E^H4445Y!]"%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110!P?C;_ )#,/_7NO_H35-X,_P"7W_MG_P"S5#XV_P"0S#_U[K_Z
M$U3>#/\ E]_[9_\ LU>+3_W_ .;_ ".-?QSJJ***]LZPHHHH **** "BBB@
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M!1114E!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MC"_PPHHHK$Z0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH Y'XG_\ ).]5_P"V/_HU*\-\)?\ (YZ%_P!A
M"W_]&+7N7Q/_ .2=ZK_VQ_\ 1J5X;X2_Y'/0O^PA;_\ HQ:ZJ/P,X,3_ !5_
M74^K****Y#T HHHH **** "BBB@ HHHH **** "BBB@ HHHH H:Y_P B_J7_
M %ZR_P#H!KQ6O:M<_P"1?U+_ *]9?_0#7BM>UE?P2]3YK/?XD/0]MHHHKQCZ
M0**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MET;1[DV^E0_ZV=1]\#@L<=03T7//4^Q"',$Y\OJ=Y)KNCQ2>7)JMBDG]UKA
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M%2,@CH:Y/_A6_AO[,(OL\V\?\MO.;<?_ &7].U8.A3W?@[QD/#D\S3:?=$&
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MKMQCGTK6LH\^YE0<N38Y7PZQ;XM:H3_>F'Y$"O3J\4TCPO97_CB]T266X%M
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MZ=7:*#RG8( 6( [9Q6M#5OT,J[LEZGK5%<-_PM70_P#GTU'_ +]I_P#%T?\
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MDGH*HKKFD--Y*ZK8F4G&P7";L_3-<+H]E?\ CBSMA=RRV>A6D2PI%$^&G=5
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MK(\9?\E/\/\ _;O_ .CFK=?Q7\S!_P */R.F^(/_ "(^H_\ ;+_T8E2>!/\
MD2M-_P!U_P#T-JD\:6KW?@[4XD7<PB$F/96#'^54?AS>Q77A"WA1\RVS/'(O
M&1EBP_#!'Y&L_P#EU\S3_E[\CK*\S^)?_(?T3\?_ $(5Z97F?C79JGQ T;38
MGW/&4$H'.S+;C^.WG\J*/QW"O\%CM/%=S)9^%-3FB.'$#*"#@C/&1[C-8/PO
MM8H?#$EPH'FSSMO/?"X '\S^-=3J]@-4T>\L3C]_$R GH"1P?P.#7#?#/4S:
MM>>'[P>5<QR&2-'X.>CK]1@''UIQUIM():54V>C4C*&4JP!4C!!Z&EJGJFI6
M^D:;/?7+A8XE)P3C<>RCW/2L4K[&S=MSSWP#;1V?CS7+6+/EPB6-,]<"4 ?R
MKTZO*OAI<M>>+=3NG^]-"\AYSR9%/7\:]5K:O\9C0^ \S\&_\E/\0?\ ;Q_Z
M.6NU\4W)M/"VIS '<+=U&.Q8;0?PS7%>#?\ DI_B#_MX_P#1RUZ#JMBNIZ3=
MV+' GB://H2.#^=.I\:OY"I:P=O,\M\%R^*;/2I9-#TBSN()9/GFE<!B0.GW
MQP/IWKI/[4^(G_0!T[_OX/\ X[5/X::G]D:\\/7@\JZCE:1$;J>@9?J,9_$^
ME>BTZL[2=TA4H7@K-G"MJ7Q#92K:!II4C!!=<'_R+47P^\/ZSH>H7S:A9?9X
M)XQMQ*K#<#P.&)Z$]:[+5M4MM&TR:^NFVQQ+G'=CV ]R:S?".NW?B'1_MMU9
M"W^<JK*3MDQU(!Z#/'?D&IYGR.R5BN1<ZNW<WZ***Q-C \:_\B;J?_7+_P!F
M%9GPR_Y%$?\ 7P_]*T_&O_(FZG_UR_\ 9A69\,O^11'_ %\/_2ME_"?J8O\
MBKT+GQ!_Y$?4?^V7_HQ*;\/;=(/!=DRJ TI>1R.YWD9_( ?A3OB#_P B/J/_
M &R_]&)4G@3_ )$K3?\ =?\ ]#:E_P NOF'_ "^^7ZG15YIX^8Q>-M!E3AU,
M9!^DF17I=>9_$+_D<-"_X!_Z,HH_$%?X#M?%-R;3PMJ<P!W"W=1CL6&T'\,U
MYSX+E\4V>E2R:'I%G<02R?/-*X#$@=/OC@?3O7J6JV*ZGI-W8L<">)H\^A(X
M/YUPOPTU/[(UYX>O!Y5U'*TB(W4] R_48S^)]*J#M3>@JBO45W8N?VI\1/\
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MIO\ UZQ?^@"K]<\MV=,=D>::@QC^,MHR<$A03CKF,@_I7I=>9ZI_R6.S_P"
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M^L5D./S=OY5WE%7[5O=(CV26S:.)T7P&\6J?VMKU[_:%[G<%.2@;L<GKCL,
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M%FW\+CIC'ZUV%%%5*3=KDQBHWMU"BBBI*"BBB@ HHHH **** "BBB@ HHHH
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M!^HS4M>.U;0^B335T%%%% PHHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M6G_O_P W^1QK^.=51117MG6%%%% !1110 4444 %%%% !1110 4444 %%%%
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M[P%.SM<5U>QHT444AA1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 5X[\=O^8!_P!O'_M*O8J\=^.W_, _
M[>/_ &E6M'XT88G^$S"^#'_(X7?_ %X/_P"C(Z]SKPSX,?\ (X7?_7@__HR.
MO<ZJO\9&%_AA1116)TA1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M (2_7?\ G^_\A)_\31_9E7NOQ_R#^V\/V?X?YGJ5%>6_\)?KO_/]_P"0D_\
MB:/^$OUW_G^_\A)_\31_9E7NOQ_R#^V\/V?X?YGJ5%>6_P#"7Z[_ ,_W_D)/
M_B:/^$OUW_G^_P#(2?\ Q-']F5>Z_'_(/[;P_9_A_F>I45Y;_P )?KO_ #_?
M^0D_^)H_X2_7?^?[_P A)_\ $T?V95[K\?\ (/[;P_9_A_F>I45Y;_PE^N_\
M_P!_Y"3_ .)H_P"$OUW_ )_O_(2?_$T?V95[K\?\@_MO#]G^'^9ZE17EO_"7
MZ[_S_?\ D)/_ (FC_A+]=_Y_O_(2?_$T?V95[K\?\@_MO#]G^'^9ZE17EO\
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M9E7NOQ_R#^V\/V?X?YGJ5%>6_P#"7Z[_ ,_W_D)/_B:/^$OUW_G^_P#(2?\
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M )"3_P")H_X2_7?^?[_R$G_Q-']F5>Z_'_(/[;P_9_A_F>I45Y;_ ,)?KO\
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M (2_7?\ G^_\A)_\31_9E7NOQ_R#^V\/V?X?YGJ5%>6_\)?KO_/]_P"0D_\
MB:/^$OUW_G^_\A)_\31_9E7NOQ_R#^V\/V?X?YGJ5%>6_P#"7Z[_ ,_W_D)/
M_B:/^$OUW_G^_P#(2?\ Q-']F5>Z_'_(/[;P_9_A_F>I45Y;_P )?KO_ #_?
M^0D_^)H_X2_7?^?[_P A)_\ $T?V95[K\?\ (/[;P_9_A_F>I45Y;_PE^N_\
M_P!_Y"3_ .)H_P"$OUW_ )_O_(2?_$T?V95[K\?\@_MO#]G^'^9ZE17EO_"7
MZ[_S_?\ D)/_ (FC_A+]=_Y_O_(2?_$T?V95[K\?\@_MO#]G^'^9ZE17EO\
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M9E7NOQ_R#^V\/V?X?YGJ5%>6_P#"7Z[_ ,_W_D)/_B:/^$OUW_G^_P#(2?\
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M )"3_P")H_X2_7?^?[_R$G_Q-']F5>Z_'_(/[;P_9_A_F>I45Y;_ ,)?KO\
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M (2_7?\ G^_\A)_\31_9E7NOQ_R#^V\/V?X?YGJ5%>6_\)?KO_/]_P"0D_\
MB:/^$OUW_G^_\A)_\31_9E7NOQ_R#^V\/V?X?YGJ5%>6_P#"7Z[_ ,_W_D)/
M_B:/^$OUW_G^_P#(2?\ Q-']F5>Z_'_(/[;P_9_A_F>I45Y;_P )?KO_ #_?
M^0D_^)H_X2_7?^?[_P A)_\ $T?V95[K\?\ (/[;P_9_A_F>I45Y;_PE^N_\
M_P!_Y"3_ .)H_P"$OUW_ )_O_(2?_$T?V95[K\?\@_MO#]G^'^9ZE17EO_"7
MZ[_S_?\ D)/_ (FC_A+]=_Y_O_(2?_$T?V95[K\?\@_MO#]G^'^9ZE17EO\
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M]M4YEMT/:P&%^K4>5[O5A1117,=H4444 %%%% !1110 4444 %%%% !1110
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M32]3GNM3M'T?S01;JHW[#(-@SL'(^7OV[U!X6L/&<WARTDTG5[*WL3O\N.1
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M_=GOD]:TY/W=K]3/G_>WL]C?^)O_ "*)_P"OA/ZUL>$/^11TO_KW6L?XF_\
M(HG_ *^$_K6)I/B#5-1TK3] \-HJSQ6X^TW<@^6+CH.#^?KT%)1<J:]1N2C5
M=^QZ;17!2>#?%(B\Z/Q=<-<]?+9G$?Y[C_Z#5GPCXJO;K4I]"UQ0NI0YVN%
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MPZ^:)E!+'!QCY&KHA']V]3FG+]XM#V2BJFEQWT6F01ZE,DUXJ_O9(QA6.>W
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MHHH **** "O'?CM_S /^WC_VE7L5>._';_F ?]O'_M*M:/QHPQ/\)F%\&/\
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MBB@ HHHH **** "BBB@ HHHH **** "BBB@"&YM;>\A,-S#'-&>JNH(K N/
MNB3N66.:'/:.3C]<UTM%:0JU(?"[&-7#TJO\2*9R7_"N](_Y^+W_ +[3_P")
MH_X5WI'_ #\7O_?:?_$UUM%:_6Z_\S,?[/PO\B.2_P"%=Z1_S\7O_?:?_$T?
M\*[TC_GXO?\ OM/_ (FNMHH^MU_YF']GX7^1')?\*[TC_GXO?^^T_P#B:/\
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MO_?:?_$UUM%'UNO_ #,/[/PO\B.2_P"%=Z1_S\7O_?:?_$T?\*[TC_GXO?\
MOM/_ (FNMHH^MU_YF']GX7^1')?\*[TC_GXO?^^T_P#B:/\ A7>D?\_%[_WV
MG_Q-=;11];K_ ,S#^S\+_(CDO^%=Z1_S\7O_ 'VG_P 31_PKO2/^?B]_[[3_
M .)KK:*/K=?^9A_9^%_D1R7_  KO2/\ GXO?^^T_^)H_X5WI'_/Q>_\ ?:?_
M !-=;11];K_S,/[/PO\ (CDO^%=Z1_S\7O\ WVG_ ,31_P *[TC_ )^+W_OM
M/_B:ZVBCZW7_ )F']GX7^1')?\*[TC_GXO?^^T_^)H_X5WI'_/Q>_P#?:?\
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M^^T_^)H_X5WI'_/Q>_\ ?:?_ !-=;11];K_S,/[/PO\ (CDO^%=Z1_S\7O\
MWVG_ ,31_P *[TC_ )^+W_OM/_B:ZVBCZW7_ )F']GX7^1')?\*[TC_GXO?^
M^T_^)H_X5WI'_/Q>_P#?:?\ Q-=;11];K_S,/[/PO\B.2_X5WI'_ #\7O_?:
M?_$T?\*[TC_GXO?^^T_^)KK:*/K=?^9A_9^%_D1R7_"N](_Y^+W_ +[3_P")
MH_X5WI'_ #\7O_?:?_$UUM%'UNO_ #,/[/PO\B.2_P"%=Z1_S\7O_?:?_$T?
M\*[TC_GXO?\ OM/_ (FNMHH^MU_YF']GX7^1')?\*[TC_GXO?^^T_P#B:/\
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MO_?:?_$UUM%'UNO_ #,/[/PO\B.2_P"%=Z1_S\7O_?:?_$T?\*[TC_GXO?\
MOM/_ (FNMHH^MU_YF']GX7^1')?\*[TC_GXO?^^T_P#B:/\ A7>D?\_%[_WV
MG_Q-=;11];K_ ,S#^S\+_(CDO^%=Z1_S\7O_ 'VG_P 31_PKO2/^?B]_[[3_
M .)KK:*/K=?^9A_9^%_D1R7_  KO2/\ GXO?^^T_^)H_X5WI'_/Q>_\ ?:?_
M !-=;11];K_S,/[/PO\ (CDO^%=Z1_S\7O\ WVG_ ,31_P *[TC_ )^+W_OM
M/_B:ZVBCZW7_ )F']GX7^1')?\*[TC_GXO?^^T_^)H_X5WI'_/Q>_P#?:?\
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M^^T_^)H_X5WI'_/Q>_\ ?:?_ !-=;11];K_S,/[/PO\ (CDO^%=Z1_S\7O\
MWVG_ ,31_P *[TC_ )^+W_OM/_B:ZVBCZW7_ )F']GX7^1')?\*[TC_GXO?^
M^T_^)H_X5WI'_/Q>_P#?:?\ Q-=;11];K_S,/[/PO\B.2_X5WI'_ #\7O_?:
M?_$T?\*[TC_GXO?^^T_^)KK:*/K=?^9A_9^%_D1R7_"N](_Y^+W_ +[3_P")
MH_X5WI'_ #\7O_?:?_$UUM%'UNO_ #,/[/PO\B.2_P"%=Z1_S\7O_?:?_$T?
M\*[TC_GXO?\ OM/_ (FNMHH^MU_YF']GX7^1')?\*[TC_GXO?^^T_P#B:/\
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M_P!":IO!G_+[_P!L_P#V:H?&W_(9A_Z]U_\ 0FJ;P9_R^_\ ;/\ ]FKQ:?\
MO_S?Y'&OXYU5%%%>V=84444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M7FFJ(UW\8K*-,$Q!"<=@%+'/X44=WZ!6V7JCK/&O_(FZG_UR_P#9A69\,O\
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M[*Y\<6>MZ2D\!W)YPF11DYPW0G@KP?QKT/Q_J;Z9X3N#$Q66X80*P.",\G]
M:T9?$FFP^($T225A>.H91M)4D_PY'0XYYXK&^)-D]WX1DD3'^C3),1ZCE>/^
M^JTYE*44U8SY7&,K.Y9\!Z1%I?A:UD" 3W:B>1^YSRH^@7''U]:Z:L#P5J$>
MH^$K!D(W01B!P!T* #^6#^-;]8SOS.YK3MRJPV2-)8VCD171P596&00>H(I4
M18T5$4*JC 4#  ]*6BI+.9^(/_(CZC_VR_\ 1B4?#[_D1]._[:_^C'H^(/\
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M:RQY),)/_D2KA?V<OD9SM[6/S*OQ+U%)?$5CI\\K_8H46298P"P+$YQG&3M
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MZ^8[?O?D;\\RV]O+.^=D:%VQUP!FO-_AQ;-J^M:EX@O</<!L(<=&;.XCTP,
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH Y'XG_ /).]5_[8_\ HU*\-\)?\CGH7_80
MM_\ T8M>Y?$__DG>J_\ ;'_T:E>&^$O^1ST+_L(6_P#Z,6NJC\#.#$_Q5_74
M^K****Y#T HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** .#\;
M?\AF'_KW7_T)JF\&?\OO_;/_ -FJ'QM_R&8?^O=?_0FJ;P9_R^_]L_\ V:O%
MI_[_ /-_D<:_CG54445[9UA1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 5E^(_P#D 77_  '_ -"%:E9?
MB/\ Y %U_P !_P#0A6.(_@S]'^1,_A9Q6E?\ABR_Z^(__0A7JM>5:5_R&++_
M *^(_P#T(5ZK7!E?P2]3'#;,****]0Z0HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ KEO&7A$>(H([FU<0ZC ,1N>
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M.O\ @F/['?V3ZGI,0Q!=0_>1>,!NN .F#^!(%+<?%"UD0QZ9I5[/<X.%E4*
M?^ DD_I7?44^>+U:)Y)+2,M#S_P]X5U'5-9/B#Q.,S @PVQ &,="1V [#N>3
M[]IJW_('OO\ KWD_]!-7*S=:N[>'1-29YHQY4#AP6'RDKP#[G(Q]:3DY20U%
M0BSD?A/_ ,@>_P#^O@?^@BMOQEX57Q+IZ^4PCO8,F%CT;/53[<?A6-\*8W70
M[V0KA&N< ^N%&?YUWU74DXU&T33BI4DF><V?C;5O#J"Q\3:9<.T6%6Y0<N/<
MGAOJ#]><FGW7Q'N=1!M_#VD7,L[_ "J\BYVG']U<_J:]#HI<\=^4?)/;F.-\
M'>$KC3+B;6-882:I<9.,AO+SR3GIN/MVX[UU\L23PO#*H:.12K*>A!X(I]%1
M*3D[LN,5%61YK-H.N^"M4DOO#\;7NGS</;<LP] 0.3CL1SZ^]Y?BGIJ1$7.F
MWT4_]P!2/S)!_2N\HJ_:)_$KD*FX_"['FVH:]XD\7P-8Z-I4UI9R_+)<2'!8
M>F[@ >H&3^>*[C0M,DTC1[>RENI+EXUP9'/Z#T [5HT5,IW5DK(J,+.[=V<]
MXYMI[OP=?P6T,DTS>7MCC4LQQ(I. /:CP-;3VG@ZP@N89(9E\S='(I5AF1B,
M@^U=#12YO=Y0Y/>YCD?%6N>(-$U*VN+/3A=:6J?OM@)9F)[D<KCC!QCGOT&7
M<?$U;NT^SZ5IEVVIR?(B,H*J3QD8R6/3C KT*BJ4XVU0G"5])'*> _#L^@Z3
M(]YD7=TP>1,YV =!]>3FNKHHJ92<G=E1BHJR"D90RE6 *D8(/0TM%24>=>$?
M!TVE^,K^XGC=8+,D6SD$"3>#@@]\*<'GJ:]%HHJIS<W=D0@H*R."^(?A:XU>
M6QO-/A,EP7$$H5>=IZ,3Z#G.?45VMA90Z=8065N,10($7/4@#J?<]35BBAS;
MBH]@4$I.7<I:S&\NAZA'&C.[VTBJJC))*G  KFOAK97=AX<N(KRUFMY#=LP2
M:,H2-B<X/;@UV5%"E:+B-QO)2.>\<VT]WX.OX+:&2:9O+VQQJ68XD4G 'M1X
M&MI[3P=807,,D,R^9NCD4JPS(Q&0?:NAHHYO=Y1<GO<QRGQ#M+F]\+F&TMYK
MB7ST.R)"[8YYP*U/"T,MOX7TV&>-XI4@4,CJ593Z$&M>BCF]WE#D][F"N \3
MZ=?7'Q(T2ZAL[B2WC6'?,D3%%Q(Q.2!@<&N_HHA+E=QSCS*P4445)1B>+X)K
MGPGJ,,$3RRO'A4C4LS<CH!5+X?VES9>%(8;JWE@E$CDI*A5ASZ&NHHJN;W>4
MCD][F"O/-1TV^?XKVEXEE<-:KLS.(F*#Y#_%C%>AT41ERW"<.:P5@^-+>:Z\
M(ZA!;PR32NJ[8XU+,?G7H!6]123L[E25TT<O\/[2YLO"D,-U;RP2B1R4E0JP
MY]#2>,_"7_"16\=Q:N(M1M_]6Q. PZ[2>WJ#_C74T57.^;F1/(N7E9YW:>/-
M2T,+9>)M)N1)'P;B,#+#H#@_*>1U!Q2W7Q#O-4!MO#FD7$DS_*LTJYVG']T9
M'YG'M7H=%5SQWY2>2>W,<AX-\)2Z*T^I:G(LVIW/+'.[RP>3SW8GJ?;CWZYT
M61&1U#*PP5(R"/2EHJ)2<G=EQBHJR/-KG0=<\&:O-J/AZ+[78SL=]J%+%1V!
M Y.,G!'/K[W5^*5@$VRZ7?)<DX$0"D'\<@_I7>45?M$_B5R/9N/PNQYZ]IKW
MCN>(7UN^EZ(C[C&>))O3@_AR1COS1\+]-OM/_M7[;97%MO\ )V>=$R;L;\XR
M.>H_.O0J*'5?*XVT!4DI*5]3&\3>'X?$>DM9R-Y<BG?%)C.UO\/6N,T_Q%KW
M@R)=.US39;BTB7$,\?.U>PW="!Z'!'Y"O3**49V7*U=#E3N^9.S//[CXG1W
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MIZ>L16XTR]CNL?ZH;2,XX&20?TK.NE\1?$*>.,VK:;HZ."3)GYCTSSC>>N,
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M^)W$50JA5 "@8 '04M%%9&H4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '!^-O^
M0S#_ ->Z_P#H35-X,_Y??^V?_LU0^-O^0S#_ ->Z_P#H35-X,_Y??^V?_LU>
M+3_W_P";_(XU_'.JHHHKVSK"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ K+\1_\ ( NO^ _^A"M2LOQ'
M_P @"Z_X#_Z$*QQ'\&?H_P B9_"SBM*_Y#%E_P!?$?\ Z$*]5KRK2O\ D,67
M_7Q'_P"A"O5:X,K^"7J8X;9A1117J'2%%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%5GU"RCNTM)+NW6Y?[L
M+2 .WT7.30!9HHHH **** "N7UGP%I&N:F^H7+W4<TF-_E2 !L  <$'L.U=1
M13C)Q=T3**DK,IZ7I=IH]A'9647EPI^)8]R3W-7***3=RDK:(**** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** .1^)_P#R3O5?^V/_ *-2O#?"7_(YZ%_V$+?_ -&+7N7Q/_Y)WJO_ &Q_
M]&I7AOA+_D<]"_["%O\ ^C%KJH_ S@Q/\5?UU/JRBBBN0] **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M=L^FUP'Q7:#^P[%6QYYN<IZ[=IW?KMJX3<WRRUN9U(*$>:.C1W]%4M'+G1+
MR'+FVCW$^NT9J[6#-UJBAK.K6^B:7-?W1^2,<*",N>P'O7*?#G4;G5CK-]=O
MOFEG0D^@P< >P'%<]XBOY_&_B![.Q8_V;8(\AD'0X'+GZD87Z^YK6^$W_'AJ
M7_75/Y&NCDY:;ON<_M.:JK;'HM%%%<YTA17,3>+FM/&$6@W=AY2S8\JY$I(8
M$';\NWN1MZ]:Z>FXM;B4D]@HJEJ^IQ:/I-SJ$P+) F[:#@L>@'XD@4:1J<6L
M:1;:A!PDZ;MO7:>A7\""/PHL[7"ZO8NT45S,/B[[7XQDT"TL?.2+/FW0EX3
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MZ0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH Y'XG_ /).]5_[8_\ HU*\-\)?\CGH7_80M_\ T8M>Y?$_
M_DG>J_\ ;'_T:E>&^$O^1ST+_L(6_P#Z,6NJC\#.#$_Q5_74^K****Y#T HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MHK$V,S0] L/#UHUO8(X5VW.SN6+'U/;\L5PVO?\ )7-,_P"V7]:],KS/7O\
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M+^62/?ZFLKX3_P#('O\ _KX'_H(KL]9<1Z'J#M]U;:0G_ODUQGPG_P"0/?\
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M:5J#]S.H_)?_ *]-/W)6$U[\;GH5%%%8'0%%%-DD2*-I)'5$0%F9C@ #J2:
M&7-Q#:6TEQ<2+'#&I9W;H *\M3S_ (C>+Q(5DCTBSQ@'LOIZ;F(_ #OBI-:U
M*]\?ZVND:.77383F25N%;G[Y]O0=_P"7HFC:1;:'I<5A:K\B#YF(&7;NQ]ZW
M7[M7ZO\  P?[UV^ROQ+]<+\0?$4EO"FA:>6:^N\*XCY(1N-OKEOY?6NF\0ZW
M!X?T::^F^9A\L2?WW/0?U/L#7DOASQ%IUGK]QK>MI=7-X[%HQ$BE58]6Y8=!
MP!T'Y44H7]ZVP5JB7NWW/0]&\.)X<\'WD+8-W+ [W#@Y!.TX ]A_C6+\)O\
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MQPVS"BBBO4.D**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M[:',>#=&OM6UV;Q5K,;([G=;1L,9R,9 /\(7@>O7MSV'B/\ Y%?5O^O*;_T
MUIUF>(_^17U;_KRF_P#0#2<N:28U!1BT>4>$K[4O#<#:W';/<:5(QBNE3JI7
MH3Z?>X^I%>FV?C'P_>Q*Z:K;QY&2L[B,CV.[%8WPP4-X2E5@"ING!!Z'Y5K6
MN? _ANZE,LNE1AB<GRW=!^2D"M*DHN3YC.E&:BN4P/$GCZ&:'^S?#IDNKVX^
M02QH1LSQ\O<M].!6SX)\,MX<TEA<;3>W!#S;3D*!]U??&3SZD^U:NF:%I>C[
MO[/L8H&;@N!EB/3<><<=*T:SE-6Y8[%Q@^;FEN<GX\\-2:]ID<UFN;ZU):,9
MP74]5^O (_\ KU2\-?$"SFM5L];<VE]"NUI)00LF.Y]&]0?P]!W-9FI^'=(U
MAM]_81328QYF"K8]-PP:(S7+RR"4'S<T2G?^-/#^GQ%VU*&=L9"6["0G\N/S
M(KD=+M[WQYXHCUF\B>'2K1OW*9ZD=%![\\D_AZ5UD'@7PU;R!TTJ,D$'$CNX
M_)B170(BQHJ(H55& H& !Z4^>,5[NX<DI/W]ALT,=Q!)!*NZ.12CKZ@C!%>7
MP?VC\-M;D\R)[G1+EQF15Z=<<]F'/'<?IZG3)8HYXFBFC22-AAD=<@CW!J83
MY='L5.'-JMT8]GXO\/WL(E35;6/(!*SR"-A[8;'Z5E:W\0](L+9ET^47UXPQ
M&D8.P'L6/I[#GZ=:O3>!?#-Q(TCZ5&&))(CD=!^2D 5=T[PUHVE,'LM.@C<=
M'(W,/^!-DU5Z:UU)M4>FA7\)7.M7>BI/K:(LSG,>%VL5[%AT'^%<AKW_ "5S
M3/\ ME_6O3*JR:;8RWBW<EE;O<IC;,T2EUQTPV,THS2DW8<H-Q2OL-U738-7
MTNXL+@?NITVDCJIZ@CW!P?PKSK1-:N_ -[+HVN0R&R9B\,T8R/J/4'TZBO4:
M@N[*UO[<P7EO%/$>2DBAAGUY[T0G9<KV"<+OF6YFCQ9X?,!F_MBSVCL91N_[
MYZ_I7'^(M?N/%\,VEZ'#(;"+Y[N[884A<D >W&>>2?2NE'@+PP)/,_LM<YSC
MS9,?ENQ6[#9VMO;&VAMH8X""#$D8"X/7@<4U*$7="<9R5I'#?"?_ ) ]_P#]
M? _]!%>@57M+"SL$9+.T@ME8Y988P@)]3BK%3.7-)LJG'EBD%<;X\\+SZO##
MJ6G _P!H6@X5>LBYS@>X.2/J?:NRHI1DXNZ'**DK,XKP_P#$*PN[<6^KO]BO
MHAB0R#",1P<>A]C6KJ/C7P_IT!D;48KA@,B.V82,WY''YD5<U/PWH^L-OO\
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M %%%% !7COQV_P"8!_V\?^TJ]BKQWX[?\P#_ +>/_:5:T?C1AB?X3,+X,?\
M(X7?_7@__HR.O<Z\,^#'_(X7?_7@_P#Z,CKW.JK_ !D87^&%%%%8G2%%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% '(_$__DG>J_\ ;'_T:E>&^$O^1ST+_L(6_P#Z,6O<OB?_ ,D[U7_M
MC_Z-2O#?"7_(YZ%_V$+?_P!&+751^!G!B?XJ_KJ?5E%%%<AZ 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% '!^-O^0S#_P!>Z_\ H35-X,_Y
M??\ MG_[-4/C;_D,P_\ 7NO_ *$U3>#/^7W_ +9_^S5XM/\ W_YO\CC7\<ZJ
MBBBO;.L**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M444 %%%9=QXCTFTU>/2I[OR[V4J$C,;<ENG.,<_6FDWL)M+<U****0PHHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110!R/Q/_ .2=ZK_VQ_\ 1J5X;X2_Y'/0O^PA
M;_\ HQ:]R^)__).]5_[8_P#HU*\-\)?\CGH7_80M_P#T8M=5'X&<&)_BK^NI
M]64445R'H!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 <'XV
M_P"0S#_U[K_Z$U3>#/\ E]_[9_\ LU0^-O\ D,P_]>Z_^A-4W@S_ )??^V?_
M +-7BT_]_P#F_P CC7\<ZJBBBO;.L**** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MR^B7WC"?4TCUG2K.WLRIW21,"P../XS_ "K8UG6;30M.>^O681*0H5!EF8]
M!ZUDXM.QLI)JYH45Y[:ZWXT\3XFTJWMM.LB6V32C.X?4@YZ=EZTMQ<_$'1%-
MQ/\ 9=3A4_,L: \8R3A0IJ_9/:ZN1[5;V=CT&BL'PSXKLO$UL[0J8;F/'FP.
M<D>X/<>_Z5#XU\07?AO1H;RSCA>1[A8B)E)&"K'L1S\HJ.1\W+U*YX\O-T.D
MK/UO2HM<T:YTZ61HTF4#>O52""#[\@5RO_"2ZYXC6*W\-QPHR1*;J\E7]VDA
M RJYSTY['^IVK!]>TWPY?W&LW%O<7D*R21E%PN%7C. ,Y(ST'7\JY''6^HN=
M2TMH0^$_!\/A?[0XNVN99PH+%-@ &>@R?7]*Z:N7\)>(=0\0^';N^EAMQ=1R
MO'$D8(5B$4C.2>Y]:SO[4^(G_0!T[_OX/_CM.492D^9ZBC*,8KE6AW-%>>:C
MXE\<Z59/>7VCZ;# F-S%P>IP.!+DUM>"]<UGQ!:RWNH6]M#:YVP^5&P,ASR<
MECP.G3KGTI.FTN8:JIOE.IHK!\4>*;3PS9J\JF6YE!\F$=\=R>PZ5SUO-\0=
M;07,+6>EPN-R+(@R1]"&/YXI*FVK[()5$G;=G?T5YY<:[XT\,YFU>U@U"R!^
M>:( ;1TZJ!C.>XKL]%UJSU[3EO;)V,9)5E889&'4$>O(_.B4&E?H.-12=NIH
M4445!845RGCCQ->^&K6TELXK>1IG96\Y20, =,$55OO&5[=78TOP]8B[OPJ^
M=*<^7"3U'X>Y_.K5.35S-U(IV.UHKA'L_B,J&<:C8,1S]G"KD^V2F/\ QZGZ
M#XYF;4AH_B&V^Q7W"B0_*K' P".Q/KTI^S=KIW#VJO9JQW%>;Q_\EME_W?\
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M#&H)7C '0'J<]3T_ MTG'<2JJ6QUE%<5=^-9K#QO<Z5=+;1Z;;Q[VEVGS/\
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M(@-P,]P:]AKR_1?^2P7O^_-_*BDVN9^0JR3Y4^YKGX5Z* 2EYJ"MV/F)P?\
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MS"$DZCNNQU-%%%<YTA1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %>._';_F ?\ ;Q_[2KV*O'?CM_S /^WC_P!I5K1^-&&)
M_A,PO@Q_R.%W_P!>#_\ HR.O<Z\,^#'_ ".%W_UX/_Z,CKW.JK_&1A?X8444
M5B=(4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 <C\3_\ DG>J_P#;'_T:E>&^$O\ D<]"_P"PA;_^C%KW
M+XG_ /).]5_[8_\ HU*\-\)?\CGH7_80M_\ T8M=5'X&<&)_BK^NI]64445R
M'H!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 <'XV_Y#,/\
MU[K_ .A-4W@S_E]_[9_^S5#XV_Y#,/\ U[K_ .A-4W@S_E]_[9_^S5XM/_?_
M )O\CC7\<ZJBBBO;.L**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "LOQ'_P @"Z_X#_Z$*U*R_$?_ " +
MK_@/_H0K'$?P9^C_ ")G\+.*TK_D,67_ %\1_P#H0KU6O*M*_P"0Q9?]?$?_
M *$*]5K@ROX)>ICAMF%%%%>H=(4444 %%%% !1110 4444 %%%% !1110!XG
M\1YYY?&5S'*S&.)(UB!Z % 3C\2:P]#NKJTURRELV=9_.55VC).3C&.^<XQ7
ML?BCP99>)=DK2&VND&!,B@[AZ,.^/K5+PY\/++0KX7L]P;V=/]5NCV*A]<9.
M3Z>E=D:T%"QQ2H3=2YV5%%%<9VA1110 4444 %%%% !1110 5Y7X8 /Q8U/?
M]X2W.W/^\?Z5ZI7EOB4-X6^(MKK01A:7)#N5Y[;9!]<?-^/Y;4=;Q[HQK:6E
MV9ZE13(9H[B".>%P\4BAT8=&!&0:?6)L%%%,:6-94B:1!(X)5"W+ =<#OC(H
M P_&O_(FZG_UR_\ 9A7.?"S28$TVXU5U5KB20Q(2.44 9Q]2?T%='XU_Y$W4
M_P#KE_[,*H_#;_D38/\ KK)_.MD[4GZF#5ZR]#K:\T^(R_8/$NAZI$ LN[J!
MR2C*1G_OJO2Z\W^*O_'QH?\ O2_SCI4?C0Z_P,]&DD2&)Y9&VHBEF)[ =:\R
M\#V[>)?%-_XBOU#&%P8D)R%8YQ_WRHX_ ]17I%Y ;FQN(%(#2Q,@)Z#(Q7GO
MPIN50:GI[G;,K+(%/IRK?D<?G3AI"305-9Q3/2:BN;>&[MI+>XC62&12KHW0
M@U+16)L>1>&=+.C?%+^SR<B$R!2>ZF,E3^1%=)\5?^17MO\ K]7_ - >LFQN
MH[SXS331,K)ED!4Y!VQ;3_*M;XJ_\BO;?]?J_P#H#UU-MU(M]CD22I22[FSX
M(L$L/"-@JKAIH_/<^I?G/Y8'X5<\1ZFVC^'KV_3'F11_)G^\2 /U(J305"^'
M=,4< 6D0'_? K.\<V[W/@O4XXQE@BR'Z*P8_H#6.\]>YOM3T[&'\--&5=/EU
MRX&^ZNG8([<D*#@GZE@?RKO:Y+X<7J77A""$'Y[:1XG'U.X?HP_*NMHJMN;N
M%))05C-UW1X-=T>XL)@/G7,;'^!QT8?YZ9%>?_"E&CU35(W&&6-01Z$,:]0D
MD2*-I)'5$0%F9C@ #J2:\R^%T@EUG6)!T=0P_%C50;]G)$32]I%E[XEW]Q*=
M/T&U8[[QPSJ/XOF 0?\ ?63^ KL]'TFUT33(;&T0*D8^9L<NW=C[FN!^( -A
MXST+5I%S FS)S_SSDW$>W#"O2T=9$5T8,K#(8'((]:)Z0BD.&LY-BU3U#2=/
MU40B_M(K@0OO02+G!_J/;I5RBL4[;&S5]Q%4*H50 H& !T%>8?$K_D:-'_W!
M_P"AUZA7E_Q*_P"1HT?_ '!_Z'6U#XS&O\!ZA7E'C#4K:_\ 'T%EJ<ZQZ78L
MN_AF#9 9A\N3D\+[5ZO7E;6=M;_%V2#4H(I8+IB4$JAE)9<KP1Z\?6BC:[?D
M*O>R7F=:GC[PK&BHFI!548"BWD  ]/NTO_"P?"__ $%/_)>7_P")K3_X1S0_
M^@+IW_@*G^%'_".:'_T!=._\!4_PJ?W?F7^\\CS"\UC3;+Q_:ZKH$ZO;S,OG
MH(V0 L=KC! ZCGZ_2NI^*O\ R*]M_P!?J_\ H#UM-9^%(M473FL=*2]90ZQ&
MW0,1VQQUXZ=:Q?BK_P BO;?]?J_^@/6JDI3B9.+C"5V;/@BP2P\(V"JN&FC\
M]SZE^<_E@?A6CKG_ "+^I?\ 7K+_ .@&DT%0OAW3%' %I$!_WP*77/\ D7]2
M_P"O67_T UBW>=S9*T+>1ROPJ_Y%>Y_Z_6_] 2NYKAOA5_R*]S_U^M_Z E7?
M'?B0Z'I/V>V8_;KL%(]K8:->[?T'O]*N<7*HTB*<E&DFSG/$5W/XU\5PZ#I\
MC'3[=LS2IRN1]YOP^Z/?ZUZ19VD-A9PVEN@2&) B*/05SO@;PT- T<23J/MU
MT \O'*#'"?AW]S["NIJ:DE\*V0Z<7\4MV>/Z?KFFWOCVYUC7;E8HH&/V9#&S
M\@X3[H/0<Y]:[K_A8/A?_H*?^2\O_P 37'_#_3[%==U;2=4L;:>>/&P3HK[=
MC$,!D>XZ>E>A_P#".:'_ - 73O\ P%3_  K2KR<UG<SI<_+=6,J3Q[X4EC:.
M345='!5E:VD((/4$;:X_P5?P67CZ>QTR?SM-N]^PX8<!2Z\$#D8(Y'K7HO\
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M5)/^OI__ $%:R_&TDNO^,=-\-1R.L *O*%]3DD_@G\S6I\+O^14D_P"OI_\
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MGRR@,ARGE@D'CAAGGTK>-O:R?J<\KNE%>AU$/COPG;P1P0ZB$BC4(BBWEPH
MP!]VG_\ "P?"_P#T%/\ R7E_^)K3_P"$<T/_ * NG?\ @*G^%'_".:'_ - 7
M3O\ P%3_  K*]/S-K5/(\O\ $6MZ7!XNM-<T"Z5V)W3J(W0;@><Y R&!YQ[U
M['6!/9>$[;4(;">PTJ.ZG&8XVMD!;G'''KVK>50JA5 "@8 '04ZDDTK"IQ:;
MNSS#6O\ DL%E_OP_RKU"O+]:_P"2P67^_#_*O4*=7:/H*EO+U/-_"?\ R5/7
M_P#=F_\ 1J5/\2[^XE.GZ#:L=]XX9U'\7S (/^^LG\!4'A/_ )*GK_\ NS?^
MC4J/X@ V'C/0M6D7,";,G/\ SSDW$>W#"M/^7B]#*_[I^IWVCZ3:Z)ID-C:(
M%2,?,V.7;NQ]S5ZD1UD171@RL,A@<@CUI:YF[O4ZDDE9%/4-)T_51"+^TBN!
M"^]!(N<'^H]NE1ZS8O?:#>V-O\CRV[QQ@':,E< ?3M]*T**$V#2/-/ 7BBTT
MJ!M!U4?8YHY6V/+P"2>5;^Z0?7C^OI2L&4,I!4C((Z&L+Q!X0TOQ"I>XC,5U
MC"W$7##TSV(^OZ5R&@WNI^#_ !7#X<U&X\^SN-HA;)(7=D*5ST!;@CI_75I5
M+RCN8Q<J=HRV[GIM%%%8FX5YC\*T$^HZQ=D_-A!C']XL?_9:].KS/X1_\QC_
M +8_^U*UA_#E\C&?\2/S/3*\>.G7&J?$W4+6UU"6PE:60B>+.X8'3@CK]:]A
MKR_1?^2P7O\ OS?RIT7;F?D*LKN*\S87P/K>?F\::D1[;Q_[4J?3/AUIEI=K
M=W]Q/J,ZMN'G'Y/Q'?GU./:NQHJ?:S[E^RAV"O%?&EC<ZC\0[^UM(C+.RHRH
MO4[858X]\ U[57F?_-</\_\ /M54'9M^1%=727F;7@#Q):ZCI4>F&.*VO+5=
MOE*,!U'\0'KZ^_/>NRKSOQGX1GMKIO$6AEH[F-C+-&AYSU+K_4=ZZ#PAXJ@\
M1Z< [JNH1+^_BQC/^TOM_(_AE3BFN>(Z<FGR2W.DK#\8J'\'ZH#_ ,\"?RYK
M<K"\9N(_!^J,>\.WKZD#^M1#XD:3^%F1\+V+>$V!_AN7 _)3_6NTKC/A@NWP
MFQS]ZY<_HH_I79U57XV32^!!7$?$[59;'0(K.$[3>.5<]]@Y(_$X_7UKMZ\Z
M^+-K(]CIMV%S'%(\;'/0L 1_Z":**3FKBK-JF['5>%-$CT+0+:W$86=T$DYQ
MR7(YS].GX5MU!9W<5]907<#9BF0.I]B,U/42;;NS2*25D<3\2M&2\T(:G&H%
MS9$'<."4)P1^!(/MSZUN>$M4DUCPQ97DS S,I60CN5)7)]SC/XU5\>W,5MX-
MOO,;!E"QH/5B1_0$_A4/P[M'M?!UL9!@S.\H'L3@?H,_C6N]+7N9+2KIV.9^
M*7_(7TC_ '&_]"%>H5Y?\4O^0OI'^XW_ *$*]0HG\$?F%/\ B2^04445B;!1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>.
M_';_ )@'_;Q_[2KV*O'?CM_S /\ MX_]I5K1^-&&)_A,PO@Q_P CA=_]>#_^
MC(Z]SKPSX,?\CA=_]>#_ /HR.O<ZJO\ &1A?X84445B=(4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 <C
M\3_^2=ZK_P!L?_1J5X;X2_Y'/0O^PA;_ /HQ:]R^)_\ R3O5?^V/_HU*\-\)
M?\CGH7_80M__ $8M=5'X&<&)_BK^NI]64445R'H!1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 <'XV_Y#,/_ %[K_P"A-4W@S_E]_P"V?_LU
M0^-O^0S#_P!>Z_\ H35-X,_Y??\ MG_[-7BT_P#?_F_R.-?QSJJ***]LZPHH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MH$9DZO<P#DDD_,<=P<Y/<'GZ>AT4H3<6$X*2.-T_XEZ'<PC[:9;&8#YD9&<
M^@*CG\0*JWWCBXUICIOA6TFFN)%PURR[5A![\]/J?UKK[G1],O93+=:=:3R'
M^.6!6/YD58M[:"TB$5M#'#&.B1H% _ 5?-!:I$\LWHV>4>&=*;1/B?#I[R^:
M\49+N.A9H=QQ[9)KH_BK_P BO;?]?J_^@/7<T4.K>2D^@E2M!Q3W*&A_\B_I
MO_7K%_Z *O.BR(R.H96&"I&01Z4M%9MZW-4K*QYA-8ZK\/-8FOK"![O19O\
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MN_\ KP?_ -&1U[G7AGP8_P"1PN_^O!__ $9'7N=57^,C"_PPHHHK$Z0HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH Y'XG_P#).]5_[8_^C4KPWPE_R.>A?]A"W_\ 1BU[E\3_ /DG>J_]
ML?\ T:E>&^$O^1ST+_L(6_\ Z,6NJC\#.#$_Q5_74^K****Y#T HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** .$\;#_B;P'U@ _\>:I/!I^:
M]'J$/_H52>.(<2V<X'560GZ8(_F:I>$9@FIR1$_ZR/CZ@_X9KQ5[F/U[_FCC
MVKG:4445[9UA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 5E>)#C0;GWVC_QX5JU@^+9A'I219YDD''L.
M?\*PQ3M1D_(BH[09RNDC.LV(_P"FZ?\ H0KU2O-/#</G:_:#'"L7/X FO2ZX
MLK7[N3\S+#+W6%%%%>F=(4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% &+XA\,V7B6&"*\EN(UA8LODL 3GUR#6O%
M&(84B4DJBA1GKQ3Z*=W:PK).X4444AA1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH XKXK3^5
MX!NTS_KI8D_\?#?^RUXYX&@^T>.M$3TO(W_[Y.[^E=Q\9]:22:QT6)\F+-Q.
M!V)&$'UQN/XBLGX.Z2;_ ,9&]8?N["%I,_[;?*!^18_A77#W:3;//J^_721]
M!4445QGHA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 8GBNS
M-UH<C*,M 1(/H.#^A_2N#T^Z-E?PW _@;)]QW_3->K.BR(R, 588(/<5Y=J^
MGMIFI2VS [0<H3W4]*\?,:;C.-:)R8B+34T>BHZNBNI!5AD$=Q2US?A;51+#
M]@E;]Y&,QD]U]/PKI*]2A556"FCHA)25T%%%%:E!1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7$>*KT7&I"!3
ME(!@_P"\>O\ 2NGUC4DTRQ:3(,K?+&OJ?7Z"O/@)+B; R\DC?B237E9E7T5)
M;O<YL1/3E1U/@FS+3W%X1\JKY:_4\G^0_.NTJCI&GKIFF0VPQO RY'=CUJ]7
M9A:7LJ2B]S:E'EBD%%%%=!H%%%% !1110 4444 %%%% !1110 4444 %%%%
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M4E'FFG>%/$T'CK^TIG A^T%Y+CS1B1"<E=HYYZ8Q@5Z76%!XJL;CQ++H*17
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M1D.#P1V-:0IR4E=&<ZD7%V9TOA">:Y\)Z=-/*\LKQY9Y&+,W)ZDUMU@>"O\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M331P :A$I>*1!\SD#[I]<@8'IQ4'P\UZ76=":"Y8O<696,N1]Y"/ER>YX(_
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M9L?08'XFF^,_^2D>'?\ >@_]'&NXT/2UT;1+33U.[R4PQ]6)RQ_,FN'\9_\
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M$7>_X#FIS5K?B==I^H0ZCI=OJ"?)%-$)/FXV@C)!^E>;Z7:M\0O%=S?WQ?\
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MJMGT1OUR?C/P\+FU;6=/_<:K9CS5ECX+A1R#Z\#C\N]=937=8XVD<X5023Z
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MJ4;,XSX3_P#('O\ _KX'_H(KM-6_Y ]]_P!>\G_H)KB_A/\ \@>__P"O@?\
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M , H_P#XFC_A$O#7_0O:3_X!1_\ Q-'UE=@^IR[GRG17U9_PB7AK_H7M)_\
M */_ .)H_P"$2\-?]"]I/_@%'_\ $T?65V#ZG+N?*=%?5G_")>&O^A>TG_P"
MC_\ B:/^$2\-?]"]I/\ X!1__$T?65V#ZG+N?*=%?5G_  B7AK_H7M)_\ H_
M_B:/^$2\-?\ 0O:3_P" 4?\ \31]978/J<NY\IT5]6?\(EX:_P"A>TG_ , H
M_P#XFC_A$O#7_0O:3_X!1_\ Q-'UE=@^IR[GRG17U9_PB7AK_H7M)_\  */_
M .)H_P"$2\-?]"]I/_@%'_\ $T?65V#ZG+N?*=%?5G_")>&O^A>TG_P"C_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_KG_ +_-_C1_:>H?\_US_P!_F_QKO?\ A%M&_P"?/_R*_P#C1_PBVC?\^?\
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MGJ'_ #_7/_?YO\:[W_A%M&_Y\_\ R*_^-'_"+:-_SY_^17_QH^H8G^9?>_\
M(/85.YP7]IZA_P _US_W^;_&C^T]0_Y_KG_O\W^-=[_PBVC?\^?_ )%?_&C_
M (1;1O\ GS_\BO\ XT?4,3_,OO?^0>PJ=S@O[3U#_G^N?^_S?XT?VGJ'_/\
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MPD>A_P#0:T[_ ,"D_P :S/\ A7WA?_H%_P#DQ+_\51_PK[PO_P! O_R8E_\
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MM-C_ ,@^V_ZY+_(53U/P]I6L6\%O?6BR0P?ZI%9D"<8XVD=A6BB+'&L:#"J
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M<G-39I4445B;!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !5'6/[1_LJ;^R?+^W?*8O,^Z?F&<_AFKU%-:":NCSF#P[XEU_P 5
M6FJ>(+>WMH;4J0B,K A3D* ">IZY/K]*]&HHIRFY$P@HA1114EA1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 5!>PM<V%S A :6)D!/3)!%3T4 <O
MX(\-WGAJPN8+R2"1I90ZF%B1C&.<@5U%%%.4G)W9,8J*L@HHHI%!1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 5'<7$-K;R3SR+'%&I9W8X %25YEX^U*YU?Q!:^%[-]BET\W/ +MTR?0 @__
M *A5PAS.Q%2?(KEBY\::UXAOFLO"EHRHIYN9%&<>OS?*H^N2?TJQ%X-\43KN
MO/%US"_I SL/_0E_E77Z/I-KHFF0V-H@5(Q\S8Y=N['W-7JIU+:01"IWUFSS
M^71?'&BAI[#6?[21>L4QRS#Z-G]&S]:O>&O'<>J7?]F:K;_8=2#; IR%=O3!
MY4^Q_/M795CWWA?2-2U>#4[JU#W,7O@/CH6'?&/\<\4<ZDK20^247>+&>+YY
MK;PGJ,T$KQ2I'E7C8JR\CH15+X?W=S>^%(9KJXEGE,C@O*Y9CSZFK/C7_D3=
M3_ZY?^S"L#P?K=AH7@&"YOYMBF:0*HY9SN[#O32O3T[B;M4U['?45P7_  L6
M]DB-Q;^%KV6T_P">^X@8_!"/UK?\.>+-.\2HPMM\=P@R\,@Y XY!'!&3C^E0
MZ<DKM%JI%NR9O4452U35['1K,W5_<)#&.F>K'T4=2:A*^B*;MJR[17!+\2)K
MR5QI7AR]O8U/+*QS^(56Q^=:&D^/["^O?L-_;S:;>%MJI.."?3.!@_4#ZUHZ
M4UT(56#ZG6T5B#Q18MXI;P\(KC[6HR7VKY?W-_7.>A]*F\0>(+3PW8)>7D<S
MQO*(@(5!.2">Y''RFIY7>Q7,K-]C5HKE]4\;6EDMM'9VEQ?WMQ$LRVT0^9%8
M C=C."<C@9_EG2\/:Q<:U8/<7&F36#+(8_+E.2<=3R >N1T[4.$DKL%.+=D:
MU%9&N>)M+\/1!KZ?]XPRD,8W.WT'8>YP*YF+XB7]S&9[7PK>SVXZRH[$#\D(
MZ>]-4Y-72%*I&+LV=[17.^'_ !GIOB"4VR![>] )-O,,$XZX/?Z=?:I=#\56
M/B"\NK:TBN$>V^^954 \D<8)]*3A);H:G%VLS=HHKE=9\?Z/I,YMHR][<@XV
M6^" ?0MZ_3-*,7+1!*2BKLZJBN$;Q_JD:>=+X1OTM^"926Q@]#]S'ZUK:'XX
MT?6Y5MU=[:[;@0SC!8^@/0_H?:J=.25[$JK!NUSI:\Y^(.IW]EXCTJ*UO;F"
M-U&](I64-\_< \UW>J:C#I.F3W\ZNT4*[F$8!8\XXR17C_B[Q19:_K-A>6L5
MPD=NH#B55!/S9XP36E"+<KVT(KR2C:^I[717+Z)X\TO7M32PM8+Q)64L#*BA
M>!GLQKI9IHK>%YIY$BB099W8*JCU)-9.+B[,UC)25T/HKB;CXD6LEU]FT?2[
MS4I 3_JUV@X[C )/Y"HE^)!M9@NKZ!?6*DXW')Q^#!:KV4^Q/MH=SNZ*JZ?J
M5GJMHMU8W"3PMQN7L?0CJ#[&JGB#Q!:>&[!+R\CF>-Y1$!"H)R03W(X^4U"3
M;L6Y)*YJUE>);.]O_#M[:Z=)Y=U(F$.[;GD$C/;(R/QK,U3QM:62VT=G:7%_
M>W$2S+;1#YD5@"-V,X)R.!G^6;FD^();[1+K4KS2[BQ%OOS$YRS!1DXR!WR.
M?2J49+WK$N49>[<QOA]H.LZ'#=KJ?[J&0J8X/,#X;G+<$@<8^OX5VM8NC^)K
M+6]'N=3MHKA(+=F5ED4!CM4,<8)'0^M8'_"U=#_Y]-1_[]I_\752C.<F[$QE
M"$4KG<T5PW_"U=#_ .?34?\ OVG_ ,76YX>\5V?B5I_L5K=HD(&^295"Y/0#
M#$YX/^<5+IR2NT4JD&[)F[1534M3M-)LGN[V98H5[D\L?0#N?:N0/Q':[E9=
M'\/WU^BGEAD?HJM2C"4M@E.,=V=U17$6OQ)LQ<_9]7TVZTV3.,N"P'KG@$?D
M:[2&:*XA2:"1)8G&5=&#*P]011*$H[CC.,MF/HHHJ2@KSWX7ZE?:A_:OVV]N
M+G9Y.SSI6?;G?G&3QT'Y5O>(/&NF^&[]+.\@NWD>(2@PHI&"2.[#GY37G?@;
MQ58^&?M_VV*XD^T>7L\E5.-N[.<D?WA6\(-P>G8YYU(JI'7N>O:F[1Z5>.C%
M66!R&!P0=IYKD?AE?WE_I5Z]Y=SW++. K32%R!M' S6\FJP:WX2GU&V21(9K
M>7:L@ 88W*<X)[BN.^'.I6FD^&=3O+V98H4G&2>I.WH!W/M2C'W)+J5*7OQ?
M0]+HKA#\1;BX,DFF>&[Z\MD)_? D#'KPIQ^=:OAWQMI_B"<VGERVMZ,_N9><
MXSG![XQSG%0Z<DKM%*K!NR9TU%%5-2U.TTFR>[O9EBA7N3RQ] .Y]JA*YHW8
MMT5PI^([7<K+H_A^^OT4\L,C]%5J?:_$FS%S]GU?3;K39,XRX+ >N> 1^1K3
MV4^QG[:'<[>BF0S17$*302)+$XRKHP96'J"*?69H%%%8OB'Q-9>&H8);R*XD
M69BJ^2H)&/7)%-)MV0FTE=FU16!K/C#2]%BC\YGEN945H[:(9<@],]A_GK6&
M_P 0=0C0SOX3OUM1UF)8 #I_<QU]ZI4Y/5(EU(K1L[NBL'P_XNTOQ$NRVD,=
MR%RT$G##IDCU%;U2TT[,I24E='GFB:E?2_%'4;22]N'MD\W;"TK%%QC&%SBO
M0Z\QT-UC^+.JN[!543$L3@ <<ULW?Q$A:\:VT;2[K573AFBR!WZ8!)''7%;5
M(-M670PIS44^9]3M:*XK3_B-:27PL]6T^XTR8G \SYE'7[W (].E=K64HN.Y
MM&<9;!12,P52S$!0,DGH*XS5/B1IUI=FUTZWEU*8$C]T<(3['!S^ Q1&+EL$
MIQCN=I17"_\ "Q)K22/^U_#E_80N2/,;)_1E7-;FH^,-*T_1(-7#R75I-((D
M:W4$YP3R&(Q]T^]-TY+H)5(OJ;U%54OXGTI=1"OY)@\_;@;MNW=CKUQ6!;^/
MM&GTB?4B+B..*01"-U7?(Q&<* QS246]D-SBMV=317+:'XMO-8U1;270+NTB
M>,R+/(3C;V."HZ^Q-7?^$JL!XG?0#'.MTB[FD(41@;-_7.>GM0X23L)3BU<W
M**X^^\?1"[>UT73+K5WC^^]N#L'T(!S]<8]S3='^(=E?WZV%_9RZ=<N<*)6R
MN3T!) ()X[4_9SM>PO:PO:YV5%9.N^)-.\/0*][(QD?_ %<,8W._T'^.*YB7
MXC7=L%FN?#%[#:-R)G8C([$90#N._>B-.4M4ARJ1B[-G>T5G:+K=CK]@+NQD
M)3.&1N&0^C"M&I::=F4FFKH**YKQ!XWTK0',#N;F['6&$@[?]X]!].OM61_P
ML/4%A-Q)X4OEM1SYVYMN,XZ[,?K5*G)J]B'5@G9L[RBL+3_%^DZGI-UJ%K([
M"UB:6:$KB10 3TS@].QQ[U9T'7K7Q%I[7MI',D8D,>)@ <@ ]B?6DXM;HI3B
M]F:E%-DD2*-I)'5$0%F9C@ #J2:XZ^^(VG177V73+6XU*?<% A&%;Z'DG\J(
MQ<M@E.,=V=G17!O\0[ZUPU_X5OK:+!^=F;MUZH/YUT>A^*-*\0)_H5QB4#+0
M2#:Z_AW_  S3=.25VA1J1D[)FS116#X@\7Z7X<Q'=.\ERPRL$0RV/4]@/\\U
M*3;LBG)15V;U%<'_ ,+"U HTR^%+XVR]9=S8'U^3'ZUM>'_&>E^()?L\)D@N
MPN3!,,$XZ[3T./S]JITY)7:(56#=DSHJ**1W6-&=V"JHR6)P /6H-!:*XF_^
M)-C'>BTTJRGU.7.,Q_*I/HO!)Y]OIFHQ\1VM)576/#]]8(QX8Y/Z,JUI[*?8
MS]M#N-^)VH7MA9:>UG>7%LSR.&,,A0G@=<&NRTQVDTJS=V+,T"$L3DD[1S7G
MGQ+O[74]%TJZLITF@>5\.OT'Y5VC:I%HWA2WOYXI98HK>(N(@"P! &>2/6JE
M'W(HB,OWDGT-FBL_1=8M==TR._LRWE.2"KXW*0<8(!.#W^A%:%9-6=F;)W5T
M%%8_B'Q+8^&K:&:]65_-?8B0@%C@9)Y(XZ?F*DOM=@T[P^=9N8+A80B.8@%,
M@W$ <9QW'>GRL7,M?(U**P)/&.DP:!;ZQ.\D4-QGRHF4>8Q!(. "?3UQTK";
MXB7NQ9X_"U\UHQXF)(!'M\A'8]Z:IR?0EU8+J=Y16+X>\3Z?XDMWDM"Z2QX\
MR&089??W'O6U4M-.S+335T%%9>M>(=-T"W$M_.%+?<B7EW^@_KTKEH?B+>WI
M+V'A:]NH <>8C$_R0C]:J-.4E=(F52,79L[VBN8T#QQINN3BT=9+.^/ @F_B
M_P!T]_H<&KFF>*+'5=;O=*@BN%GLRXD9U4*=K;3@@D]?:DX26Z!3B]F;=%9F
MNZY;>'].^W7:3/%O"8B +9/U(K/O?&NE66DVM\YE9[M \-L #*P/3(SP..M"
MC)[(;G%;LZ.BN"D^(]S:,DE_X:O;:U<\2LQR1[ J >/>NNTW6;'5=+74;:=3
M;;269CCR\=0WH1_GBG*$HZL4:D9:)E^BN*G^(2S3O'HFBWNJ*APTD:E5_#"D
M^G4"K&@^/K'5[X6%S;RV%XQPJ2G*D_W<\'/L1^O%'LYVO82JP;M<ZF=9&MY5
MA<)*4(1B,A6QP:\\\%^%O$6D^)'N[[]W;E6$I\X/YWIP">_/.*]'K"T;Q58Z
MYJ5W8VT5PDMKG>954*<''&":<9246D$XQ<DVS=HHKD=6^(>D:?,UO:B34+@<
M!8,;,^F[_ &IC%RT14I*.K.NHKA)/'^IV_SW/A'4(8<XWL6'TZH/YUM:%XST
M?7R(H)C#<G_EA,-K'Z'H?P.?:FZ<DKV$JD6[7.AHHHJ"PHHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBFR2)#$TLC!$0%F8G  % ;#J*\XUKQY=3RM%I?[B$''FE07;\^@_6N=;7M7
M8Y.J7GX3L/ZUZ%/+:LE>3L>/5SJA"7+%-GM-%>*_VYJ__04O?_ A_P#&C^W-
M7_Z"E[_X$/\ XUI_9<_YD9?V[3_D9[517BO]N:O_ -!2]_\  A_\:/[<U?\
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M?_ A_P#&C^W-7_Z"E[_X$/\ XT?V7/\ F0?V[3_D9[517BO]N:O_ -!2]_\
M A_\:/[<U?\ Z"E[_P"!#_XT?V7/^9!_;M/^1GM5%>*_VYJ__04O?_ A_P#&
MC^W-7_Z"E[_X$/\ XT?V7/\ F0?V[3_D9[517BO]N:O_ -!2]_\  A_\:/[<
MU?\ Z"E[_P"!#_XT?V7/^9!_;M/^1GM5%>*_VYJ__04O?_ A_P#&C^W-7_Z"
ME[_X$/\ XT?V7/\ F0?V[3_D9[517BO]N:O_ -!2]_\  A_\:/[<U?\ Z"E[
M_P"!#_XT?V7/^9!_;M/^1GM5%>*_VYJ__04O?_ A_P#&C^W-7_Z"E[_X$/\
MXT?V7/\ F0?V[3_D9[517BO]N:O_ -!2]_\  A_\:/[<U?\ Z"E[_P"!#_XT
M?V7/^9!_;M/^1GM5%>*_VYJ__04O?_ A_P#&C^W-7_Z"E[_X$/\ XT?V7/\
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M7_Z"E[_X$/\ XT?V7/\ F0?V[3_D9[517BO]N:O_ -!2]_\  A_\:/[<U?\
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M?_ A_P#&C^W-7_Z"E[_X$/\ XT?V7/\ F0?V[3_D9[517BO]N:O_ -!2]_\
M A_\:/[<U?\ Z"E[_P"!#_XT?V7/^9!_;M/^1GM5%>*_VYJ__04O?_ A_P#&
MC^W-7_Z"E[_X$/\ XT?V7/\ F0?V[3_D9[517BO]N:O_ -!2]_\  A_\:/[<
MU?\ Z"E[_P"!#_XT?V7/^9!_;M/^1GM5%>*_VYJ__04O?_ A_P#&C^W-7_Z"
ME[_X$/\ XT?V7/\ F0?V[3_D9[517BO]N:O_ -!2]_\  A_\:/[<U?\ Z"E[
M_P"!#_XT?V7/^9!_;M/^1GM5%>*_VYJ__04O?_ A_P#&C^W-7_Z"E[_X$/\
MXT?V7/\ F0?V[3_D9[517BO]N:O_ -!2]_\  A_\:/[<U?\ Z"E[_P"!#_XT
M?V7/^9!_;M/^1GM5%>*_VYJ__04O?_ A_P#&C^W-7_Z"E[_X$/\ XT?V7/\
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M7_Z"E[_X$/\ XT?V7/\ F0?V[3_D9[517BO]N:O_ -!2]_\  A_\:/[<U?\
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M?_ A_P#&C^W-7_Z"E[_X$/\ XT?V7/\ F0?V[3_D9[517BO]N:O_ -!2]_\
M A_\:/[<U?\ Z"E[_P"!#_XT?V7/^9!_;M/^1GM5%>*_VYJ__04O?_ A_P#&
MC^W-7_Z"E[_X$/\ XT?V7/\ F0?V[3_D9[517BO]N:O_ -!2]_\  A_\:/[<
MU?\ Z"E[_P"!#_XT?V7/^9!_;M/^1GM5%>*_VYJ__04O?_ A_P#&C^W-7_Z"
ME[_X$/\ XT?V7/\ F0?V[3_D9[517BO]N:O_ -!2]_\  A_\:/[<U?\ Z"E[
M_P"!#_XT?V7/^9!_;M/^1GM5%>*_VYJ__04O?_ A_P#&C^W-7_Z"E[_X$/\
MXT?V7/\ F0?V[3_D9[517BO]N:O_ -!2]_\  A_\:/[<U?\ Z"E[_P"!#_XT
M?V7/^9!_;M/^1GM5%>*_VYJ__04O?_ A_P#&C^W-7_Z"E[_X$/\ XT?V7/\
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M7_Z"E[_X$/\ XT?V7/\ F0?V[3_D9[517BO]N:O_ -!2]_\  A_\:/[<U?\
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M?_ A_P#&C^W-7_Z"E[_X$/\ XT?V7/\ F0?V[3_D9[517BO]N:O_ -!2]_\
M A_\:/[<U?\ Z"E[_P"!#_XT?V7/^9!_;M/^1GM5%>*_VYJ__04O?_ A_P#&
MC^W-7_Z"E[_X$/\ XT?V7/\ F0?V[3_D9[517BO]N:O_ -!2]_\  A_\:/[<
MU?\ Z"E[_P"!#_XT?V7/^9!_;M/^1GM5%>*_VYJ__04O?_ A_P#&C^W-7_Z"
ME[_X$/\ XT?V7/\ F0?V[3_D9[517BO]N:O_ -!2]_\  A_\:/[<U?\ Z"E[
M_P"!#_XT?V7/^9!_;M/^1GM5%>*_VYJ__04O?_ A_P#&C^W-7_Z"E[_X$/\
MXT?V7/\ F0?V[3_D9[517BO]N:O_ -!2]_\  A_\:/[<U?\ Z"E[_P"!#_XT
M?V7/^9!_;M/^1GM5%>*_VYJ__04O?_ A_P#&C^W-7_Z"E[_X$/\ XT?V7/\
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M7_Z"E[_X$/\ XT?V7/\ F0?V[3_D9[517BO]N:O_ -!2]_\  A_\:/[<U?\
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M?_ A_P#&C^W-7_Z"E[_X$/\ XT?V7/\ F0?V[3_D9[517BO]N:O_ -!2]_\
M A_\:/[<U?\ Z"E[_P"!#_XT?V7/^9!_;M/^1GM5%>*_VYJ__04O?_ A_P#&
MC^W-7_Z"E[_X$/\ XT?V7/\ F0?V[3_D9[517BO]N:O_ -!2]_\  A_\:/[<
MU?\ Z"E[_P"!#_XT?V7/^9!_;M/^1GM5%>*_VYJ__04O?_ A_P#&C^W-7_Z"
ME[_X$/\ XT?V7/\ F0?V[3_D9[517BO]N:O_ -!2]_\  A_\:/[<U?\ Z"E[
M_P"!#_XT?V7/^9!_;M/^1GM5%>*_VYJ__04O?_ A_P#&C^W-7_Z"E[_X$/\
MXT?V7/\ F0?V[3_D9[517BO]N:O_ -!2]_\  A_\:/[<U?\ Z"E[_P"!#_XT
M?V7/^9!_;M/^1GM5%>*_VYJ__04O?_ A_P#&C^W-7_Z"E[_X$/\ XT?V7/\
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M7_Z"E[_X$/\ XT?V7/\ F0?V[3_D9[517BO]N:O_ -!2]_\  A_\:/[<U?\
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M?_ A_P#&C^W-7_Z"E[_X$/\ XT?V7/\ F0?V[3_D9[517BO]N:O_ -!2]_\
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M]-5BN]9C6"&!@ZQ;U<R,#D XR,>OY?3MC.G[.S.&4*GM;H]4HHHKB.X****
M"BBB@ HHHH **** "O*O#B^?\6]0D?DQ37)7\"5_D:]5KRR4CPW\6O-E(6WO
M'W;CP,2<9_!\_E6U+:2\C&MO%^9ZG1116)L%%%% &!XU_P"1-U/_ *Y?^S"N
M*^'/AU-3']J7X:6&U?9:Q-]W=U+8]LC\?I7:^-?^1-U/_KE_[,*S_AJH'@Z(
M@<F:0G\ZWC)JD[=S"44ZJOV.OKS'Q?$OA[QYI>KVJ^6+A@TH7@,00'_-3S^=
M>G5YO\5?^/C0_P#>E_G'4T?CL.O\%^QZ17E=E&?B%XUFN;DL=)LAA4&1E<G:
M/8L02>^!CTKTO44>33+M(@3(T+A0.I.TXK@_A,Z&PU.,??65">>Q!Q_(TZ>D
M926X5-9QB]CT*&&*WA2&"-(HD&%1%"JH] !6?KN@V7B#3VM;N,;L'RY0/FC;
MU'Z<=ZTZ*R3:=T:M)JS/'O"*7D7Q*CAOY&DN8?,B=F.2=L94<_0"NH^*O_(K
MVW_7ZO\ Z ]9T#K)\;)BIR "/Q$ !_45H_%7_D5[;_K]7_T!ZZ6[U(OR.5*U
M*2\RY\/=)CL?#<5XRAKJ\_>/(>3MZ*N?3 S]371:IJ$6E:7<WTW*0(7(]?0?
MB>*A\/KL\-Z6N<[;2(9_X *S/'RLW@C4@F<XC/'IYBY_2L7[U37N;KW:>G8Y
M;P7HQ\3ZC=>(]9 N 9"L4;C*EO<>@& !_A7IM<Q\/98Y/!5BJ'F,R*P]#O8_
MU!_&NGHJMN378*44H)]SF_%GAM-6LFO+1?*U:V'F6\\?#DCG:2.OMZ'\<\C\
M*7:35-4D<Y9HU)/J2QKU*O,OADP;7=:8<@@$?]]&KA)NG)$3BE4BS:^(FO3:
M7I,5C:,5NKTE0R'YE08SCW.<?G5_PEX2M?#MBCO&DFH.H,LQ&2I[JI[ ?K^0
M'+^.6$?Q"T%YR/LX\DG<,CB4[OTQ7IE*7NP274<5S5&WT"N8\0>!],UZZAN2
M6M9U;,CP* 9%Z\^^?XOY]NGHK*,G%W1K**DK,:B[(U3<S;0!ECDGZUYC\2O^
M1HT?_<'_ *'7J%>7_$K_ )&C1_\ <'_H=:T/C,J_P'J%><^-;VXU[Q+9^%+1
MF2+>K7+!<]1NS]%7GMS^%>C5Y#=:1%KGQ2O=/U&69%D=B#&0&P$RH&0>PHHI
M7;?0*[=DEU9ZCI6DV6C626EC L<:CD_Q,?4GN:GN;6WO8&@N84FB88*.N0:X
MS_A56A_\_>H_]_$_^(H_X55H?_/WJ/\ W\3_ .(I6A>_-^ [SM;E_$QH _@/
MQ]'9Q/(=+OMORGGAB0#]5;\<?6MGXJ_\BO;?]?J_^@/3H_A=HD4J2+=ZAN1@
MP_>)U'_ *;\5?^17MO\ K]7_ - >M%*,IQ:,G&4:<DRY\/=)CL?#<5XRAKJ\
M_>/(>3MZ*N?3 S]36]KG_(OZE_UZR_\ H!IOA]=GAO2USG;:1#/_   4[7/^
M1?U+_KUE_P#0#6+=YW-HJT+'*_"K_D5[G_K];_T!*[FN&^%7_(KW/_7ZW_H"
M5T/B;7H?#NC2WCE3,?E@C;/SOVZ=NYJJB;J-(5-I4TV<IX_UB>_O8/"NFC?/
M.RF?!QUY5?IT8_A78Z#H\.A:-!80@'8,N^.7<]3_ )[ 5RGP\T"54E\0:D&>
M\NR3$9!DA3R7^K9_+ZUWM%1I+D705--OG?4\PDW>/?';6TA<Z3IY/RC@, 0#
MR.?F(^N*]*M[:&TMTM[>)(H8QA408 %>.>#/#%CXEO-1BU*XN$GA*LHA8 MD
ML&)RI[X_.NO_ .%5:'_S]ZC_ -_$_P#B*TJJ-^5O8BDY6YDKW.KU;1['6K)[
M6^@61&! ;'S(?53V/ KA? ][=:'XEO/"MVS/&'9H3MZ$#.?8,O/_ .LU?_X5
M5H?_ #]ZC_W\3_XBKND?#[2M%U2#4+6YOC-"3M$CH5.00<_+Z$U*<%%J]RFI
MN2E:QUE%%%8&X5YG\(_^8Q_VQ_\ :E>F5YG\(_\ F,?]L?\ VI6L/X<OD8S_
M (D?F>@:M_R![[_KWD_]!->2^ /#ZZ]>R&\W-I]H1(8L_*\AZ _@.?P]:]:U
M;_D#WW_7O)_Z":XGX3J!I.H-CDSJ#_WS_P#7JJ<FJ<FA5(J52*9Z"JA5"J %
M P .@KSCXFV8L;C3M=M1Y5RLNQI%&,D<J3[\'\/I7I%<-\5?^17MO^OU?_0'
MJ:+]]%5E[C.SM+@7=G!<J,++&L@&<X!&:\VDW>/?';6TA<Z3IY/RC@, 0#R.
M?F(^N*] T/\ Y%_3?^O6+_T 5Y-X,\,6/B6\U&+4KBX2>$JRB%@"V2P8G*GO
MC\ZJFDN9]B*K;Y5W/8[>VAM+=+>WB2*&,85$& !5;5M'L=:LGM;Z!9$8$!L?
M,A]5/8\"N4_X55H?_/WJ/_?Q/_B*/^%5:'_S]ZC_ -_$_P#B*FT$[\WX%MS:
MMR_B4/ ][=:'XEO/"MVS/&'9H3MZ$#.?8,O/_P"LUZ17)Z1\/M*T75(-0M;F
M^,T).T2.A4Y!!S\OH3764JLE*5T.E&48V85YU\6?^/#3?^NK_P A7HM>=?%G
M_CPTW_KJ_P#(4Z/QH5?^&S5\%>&TM[*/6-143ZG=@2[W&3$I^Z!Z'&/3'3M7
M85#:/')9P/""(FC4H#U"XXJ:HE)R=V7"*BK(\[\>^'%T]5\2:1FVN8'4S"+@
M<\!P/7. 1WS]<]AX<UA==T*VU !5>1<2(IX5P<$?U^A%1>+6B7PEJIF7<OV9
MP!_M$?+^N*Q?A@K+X2);HURY7Z8 _F#6C?-3N^AFERU;+J<5>:=-J_Q)O=.A
MD>-;BX9967M&.6_0?GBO7M.TZUTJQCL[.(1PQC  [^Y]37GFA*#\7=2)'(,I
M'Z5Z;3K2>B\A4(K5^9S'CW2X=1\*W4C1@S6JF:-P.5Q][\",_D/2CP!J#ZAX
M0M3*Q9X"T)8G.0#Q^A _"M3Q'_R*^K?]>4W_ * :YWX7?\BI)_U]/_Z"M2M:
M7S&]*J]"M\1]8N!]E\/6.?/OL&3'4J6PJCZD'/T]ZZ7PYX<L_#NG)!!&IN"H
M\Z?'S2-WY]/0?US7%:Z3#\7=.>8$(YAV9/7.0,?\"KTZG/2"2"'O3E)C9(TE
MC:.1%='!5E89!!Z@BO'O'VA-H%PJV;LNEWC^:(,_*DJ@CC\&_7':O8ZX3XK.
MH\-VD9/S-=J0/8(^?YBBA)J:05XIP;.@@_Y$>/\ [!H_]%5Y]\,-(2^U6>^G
M >.R ,:-R!(W\6/8+_+TKT&#_D1X_P#L&C_T57+_  G3&EZB^>LRC'T7_P"O
M51=H2)DKSB>AUX]XEMI[[XHW%E!,T+7+10LZ]0C1*&_3->PUYJJAOC<Y/\*Y
M'_@.!_6IHNS;\AUU=)>9Z!IVFVFDV,=G90K%"@X ZD^I/<^]<A\3].MYO#Z7
MYC7[3!(JB0=2ISE?<9Y_R:[FN9^(/_(CZC_VR_\ 1B5--OG3+J)<C1C^ ]-?
M5PWB35RUS>%A%;M*.%5 !N'OG(SZ@]R:[R2-)8VCD171P596&00>H(KGO 2A
M?!.F@?W7/_C[5T=%1WDPI*T$>9^$PNC?$G5-*MPRVL@<+&&X7&&7ZX!(_&NN
M\8:ZWA_P]+=Q?\?#L(H,C(#G//X $_A7&Z?_ ,EGG_WY/_1=7OBPCG2M/< ^
M6)V!/;)7C^1K5Q4JD;F,9.-.5NC+/@#PQ#;:?'K5]&)K^Z_>1M)R8U/0C/\
M$>N?0_7/<U3TETDT:QDC^XUO&5YSP5&*N5A.3E*[-X148I(X#Q_X>%O:3:[I
MG^CSA6CNQ'P)8WX)(]>>?7/M5KX7?\BI)_U]/_Z"M=!XF=8_"VK%C@&TE'XE
M2!^IKG_A=_R*DG_7T_\ Z"M:\S=+4SY4JJL4/'5_=ZOKEGX4T^0KYI#7!&<'
M/(!]@!N/U'I78Z'H5CH%@MK9Q@' \R4CYI#ZD_G]*X33BR_&6Z$Y^<E]F[KC
MR\C_ ,=KTZE4T2BATO>;D]Q&4,I5@"I&"#T-<PW@73AXFAUFWDDMC&PD,$0
M5F'?V![CO[5U%%9*36QHXJ6YD>)M9&@Z!<WV,R*-L2^KG@?EU_"N5\!>'([R
M!O$6K*+FZNG9H_-&<#/+8]2>GH.G6K?Q1W_\(K%M/'VM-WTVM_7%=#X8,9\*
MZ3Y94K]DBSMZ9VC/XYS6J?+3NNIFUS5;/H:M<-X]\-1/8MKFG1^1J%HPF=XA
M@N <ECC^(=<^@/MCN:I:P5&B7Y<@*+:3)/3&TUG"3C)-%SBI1:9G>$-<;Q!X
M>ANY/^/A"8IC@ %P!R/J"#^-<S\0=3N;[4K/PQ8MAKAE,V#C))^53[#K^52?
M"@2_V-?DD^5]H&T=MVT9_3;5.5Q!\;%:;A7P$)/K!@?KQ6RBHU';H8N3E3C?
MJ=SH6@V7A_3UM;2,;L#S)2/FD;U/Z\=JT)H8KB%X9XTEB<89'4,K#T(-/HK!
MMMW9T))*R/$_'6@?\(]J2Q6S.-/N298HRQ(1APP_4?ABO7;&".Y\/VT$R!XI
M;54=3T92@!%<7\664:9IRG[YF8CZ <_S%=OI/_('L?\ KWC_ /016U23<(MF
M%.*C4DD<%X&FDT#Q5J/AFX<[&9G@+*1O9>X';*<_\!ZUZ37G7Q'LI=/O].\2
M68VRQ.$D88QD'*''?^(?E72:WXDM[7P:^L6[G]_"/L_/.]AQ^(ZGZ&E-<]I+
MJ.#Y+Q?3\CD+P#QE\2TM<^9I]@<-\N00OWA]"WR_2NJ^(/\ R(^H_P#;+_T8
ME9_PUT<V>B2:C.#]HOFW98Y^0=/S))_*M#X@_P#(CZC_ -LO_1B4V_WBBMD)
M)^SE)[LYWX<Z +NVCUK4-TODDQV2/]U #RP'^\3CWR>M>D5SG@)0O@G30/[K
MG_Q]JZ.HJR;FS2E%*"/,M8A3PY\3]-N;0+##>E?,5>!\S%6_#H:]'N[F.RLY
M[J8D10QM(Y R0H&3_*O.?B%_R.&A?\ _]&5V'C%'?P?J@C!+>02<>@()_3-7
M)74;D0?*YV.+\*::WC37[SQ!J\8DMXWVQPGE"W9?<*,<=R>>^?3U4*H50 H&
M !T%<=\,71O".%ZI<.&Y[\'^1%=E4U7[UNQ5%6C?N8/BCPU!K]BS*HCU"(;K
M>X7AE8<@9],_EUKA_AE)--XKU*6X8M.\#-(3U+%US^M>K5YKX(=9/B)X@D0Y
M5C,0?4&454)/DDB:D4JD6;'Q-_Y%$_\ 7PG]:J?#G0XSIB:U>*)KF4>7 7&?
M*C4[>/3D=?\ &K?Q-_Y%$_\ 7PG]:UO!RA/!^E@?\\ ?SYHNU2T[A9.MKV-B
MXMX;JWD@GC62*12KHPR"*\7L-/N)/%EWX6MIY4TZ:\(F53R8XRQY/T_7'7BO
M;*\RT)0?B[J1(Y!E(_2BB[*05E=Q]3T:SLK;3[5+:TA2&%!A408__6?>N%^*
M6FVXTVVU6--EVDZQ&1>"5()Y]P0,?C7H-<5\4?\ D5(_^OI/_06J*3?.BJJ7
MLV=3I-RU[HUC=.<O/;QR-]64'^M>?_#W_D<-=_X'_P"C*[+PA_R*.E_]>ZUQ
MOP]_Y'#7?^!_^C*N*LIHF3NX,T_B+K5Q!!:Z)8,PNK]L/LSG83@+_P ")Q^!
M'>MOPQX7M/#=BJ(JR7CK^^GQRQ]!Z+[5Q_B(LOQ:TLS'Y"8?+W=,9(X_X%FO
M3J4_=@DNHX>]-R?0*Y;6/ FF:KJ<%^CO9RHP,GV< >9CH?8^]=31649..J-)
M14E9A1112*"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH *Y'X@7[V^D0VL9(^TO\V.ZKR1^9%==7!_$G
M_F&?]M?_ &2NK!14J\4SAS.3CA)M?U=V.4T+2'UO58[17V+@M(^,[5'7_#\:
M]&C\$Z"B!6LVD(_B:9\G\B!7*?#S_D8)_P#KU;_T-*],KJQ]>I&KRQ=D<&4X
M6C.ASSBFV^NI@_\ "%^'_P#H'_\ D:3_ .*H_P"$+\/_ /0/_P#(TG_Q5;U%
M</UBM_._O9ZOU3#_ //M?<C!_P"$+\/_ /0/_P#(TG_Q5'_"%^'_ /H'_P#D
M:3_XJMZBCZQ6_G?WL/JF'_Y]K[D8/_"%^'_^@?\ ^1I/_BJ/^$+\/_\ 0/\
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M-)_\56]11]8K?SO[V'U3#_\ /M?<C!_X0OP__P! _P#\C2?_ !5'_"%^'_\
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M_P 56]11]8K?SO[V'U3#_P#/M?<C!_X0OP__ - __P C2?\ Q5'_  A?A_\
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M\(7X?_Z!_P#Y&D_^*K>HH^L5OYW][#ZIA_\ GVON1@_\(7X?_P"@?_Y&D_\
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M*K>HH^L5OYW][#ZIA_\ GVON1@_\(7X?_P"@?_Y&D_\ BJ/^$+\/_P#0/_\
M(TG_ ,56]11]8K?SO[V'U3#_ //M?<C!_P"$+\/_ /0/_P#(TG_Q5'_"%^'_
M /H'_P#D:3_XJMZBCZQ6_G?WL/JF'_Y]K[D8/_"%^'_^@?\ ^1I/_BJ/^$+\
M/_\ 0/\ _(TG_P 56]11]8K?SO[V'U3#_P#/M?<C!_X0OP__ - __P C2?\
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M (JMZBCZQ6_G?WL/JF'_ .?:^Y&#_P (7X?_ .@?_P"1I/\ XJC_ (0OP_\
M] __ ,C2?_%5O44?6*W\[^]A]4P__/M?<C!_X0OP_P#] _\ \C2?_%4?\(7X
M?_Z!_P#Y&D_^*K>HH^L5OYW][#ZIA_\ GVON1@_\(7X?_P"@?_Y&D_\ BJ/^
M$+\/_P#0/_\ (TG_ ,56]11]8K?SO[V'U3#_ //M?<C!_P"$+\/_ /0/_P#(
MTG_Q5'_"%^'_ /H'_P#D:3_XJMZBCZQ6_G?WL/JF'_Y]K[D8/_"%^'_^@?\
M^1I/_BJ/^$+\/_\ 0/\ _(TG_P 56]11]8K?SO[V'U3#_P#/M?<C!_X0OP__
M - __P C2?\ Q5'_  A?A_\ Z!__ )&D_P#BJWJ*/K%;^=_>P^J8?_GVON1@
M_P#"%^'_ /H'_P#D:3_XJC_A"_#_ /T#_P#R-)_\56]11]8K?SO[V'U3#_\
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M_P#D:3_XJMZBCZQ6_G?WL/JF'_Y]K[D8/_"%^'_^@?\ ^1I/_BJ/^$+\/_\
M0/\ _(TG_P 56]11]8K?SO[V'U3#_P#/M?<C!_X0OP__ - __P C2?\ Q5'_
M  A?A_\ Z!__ )&D_P#BJWJ*/K%;^=_>P^J8?_GVON1@_P#"%^'_ /H'_P#D
M:3_XJC_A"_#_ /T#_P#R-)_\56]11]8K?SO[V'U3#_\ /M?<C!_X0OP__P!
M_P#\C2?_ !5'_"%^'_\ H'_^1I/_ (JMZBCZQ6_G?WL/JF'_ .?:^Y&#_P (
M7X?_ .@?_P"1I/\ XJC_ (0OP_\ ] __ ,C2?_%5O44?6*W\[^]A]4P__/M?
M<C!_X0OP_P#] _\ \C2?_%4?\(7X?_Z!_P#Y&D_^*K>HH^L5OYW][#ZIA_\
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M'_\ H'_^1I/_ (JMZBCZQ6_G?WL/JF'_ .?:^Y&#_P (7X?_ .@?_P"1I/\
MXJC_ (0OP_\ ] __ ,C2?_%5O44?6*W\[^]A]4P__/M?<C!_X0OP_P#] _\
M\C2?_%4?\(7X?_Z!_P#Y&D_^*K>HH^L5OYW][#ZIA_\ GVON1@_\(7X?_P"@
M?_Y&D_\ BJ/^$+\/_P#0/_\ (TG_ ,56]11]8K?SO[V'U3#_ //M?<C!_P"$
M+\/_ /0/_P#(TG_Q5'_"%^'_ /H'_P#D:3_XJMZBCZQ6_G?WL/JF'_Y]K[D8
M/_"%^'_^@?\ ^1I/_BJ/^$+\/_\ 0/\ _(TG_P 56]11]8K?SO[V'U3#_P#/
MM?<C!_X0OP__ - __P C2?\ Q5'_  A?A_\ Z!__ )&D_P#BJWJ*/K%;^=_>
MP^J8?_GVON1@_P#"%^'_ /H'_P#D:3_XJC_A"_#_ /T#_P#R-)_\56]11]8K
M?SO[V'U3#_\ /M?<C!_X0OP__P! _P#\C2?_ !5'_"%^'_\ H'_^1I/_ (JM
MZBCZQ6_G?WL/JF'_ .?:^Y&#_P (7X?_ .@?_P"1I/\ XJC_ (0OP_\ ] __
M ,C2?_%5O44?6*W\[^]A]4P__/M?<C!_X0OP_P#] _\ \C2?_%4?\(7X?_Z!
M_P#Y&D_^*K>HH^L5OYW][#ZIA_\ GVON1@_\(7X?_P"@?_Y&D_\ BJ/^$+\/
M_P#0/_\ (TG_ ,56]11]8K?SO[V'U3#_ //M?<C!_P"$+\/_ /0/_P#(TG_Q
M5'_"%^'_ /H'_P#D:3_XJMZBCZQ6_G?WL/JF'_Y]K[D8/_"%^'_^@?\ ^1I/
M_BJ/^$+\/_\ 0/\ _(TG_P 56]11]8K?SO[V'U3#_P#/M?<C!_X0OP__ - _
M_P C2?\ Q5'_  A?A_\ Z!__ )&D_P#BJWJ*/K%;^=_>P^J8?_GVON1@_P#"
M%^'_ /H'_P#D:3_XJC_A"_#_ /T#_P#R-)_\56]11]8K?SO[V'U3#_\ /M?<
MC!_X0OP__P! _P#\C2?_ !5'_"%^'_\ H'_^1I/_ (JMZBCZQ6_G?WL/JF'_
M .?:^Y&#_P (7X?_ .@?_P"1I/\ XJC_ (0OP_\ ] __ ,C2?_%5O44?6*W\
M[^]A]4P__/M?<C!_X0OP_P#] _\ \C2?_%4?\(7X?_Z!_P#Y&D_^*K>HH^L5
MOYW][#ZIA_\ GVON1@_\(7X?_P"@?_Y&D_\ BJ/^$+\/_P#0/_\ (TG_ ,56
M]11]8K?SO[V'U3#_ //M?<C!_P"$+\/_ /0/_P#(TG_Q5'_"%^'_ /H'_P#D
M:3_XJMZBCZQ6_G?WL/JF'_Y]K[D8/_"%^'_^@?\ ^1I/_BJ/^$+\/_\ 0/\
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M-)_\56]11]8K?SO[V'U3#_\ /M?<C!_X0OP__P! _P#\C2?_ !5'_"%^'_\
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M_P 56]11]8K?SO[V'U3#_P#/M?<C!_X0OP__ - __P C2?\ Q5'_  A?A_\
MZ!__ )&D_P#BJWJ*/K%;^=_>P^J8?_GVON1@_P#"%^'_ /H'_P#D:3_XJC_A
M"_#_ /T#_P#R-)_\56]11]8K?SO[V'U3#_\ /M?<C!_X0OP__P! _P#\C2?_
M !5'_"%^'_\ H'_^1I/_ (JMZBCZQ6_G?WL/JF'_ .?:^Y&#_P (7X?_ .@?
M_P"1I/\ XJC_ (0OP_\ ] __ ,C2?_%5O44?6*W\[^]A]4P__/M?<C!_X0OP
M_P#] _\ \C2?_%4?\(7X?_Z!_P#Y&D_^*K>HH^L5OYW][#ZIA_\ GVON1@_\
M(7X?_P"@?_Y&D_\ BJ/^$+\/_P#0/_\ (TG_ ,56]11]8K?SO[V'U3#_ //M
M?<C!_P"$+\/_ /0/_P#(TG_Q5'_"%^'_ /H'_P#D:3_XJMZBCZQ6_G?WL/JF
M'_Y]K[D8/_"%^'_^@?\ ^1I/_BJ/^$+\/_\ 0/\ _(TG_P 56]11]8K?SO[V
M'U3#_P#/M?<C!_X0OP__ - __P C2?\ Q5'_  A?A_\ Z!__ )&D_P#BJWJ*
M/K%;^=_>P^J8?_GVON1@_P#"%^'_ /H'_P#D:3_XJC_A"_#_ /T#_P#R-)_\
M56]11]8K?SO[V'U3#_\ /M?<C!_X0OP__P ^'_D:3_XJN6\6^$K?2[07]@6$
M(8+)&QSMST(/Z5Z/6#XT_P"12OO^V?\ Z,6ML-B:OM8IR;NSEQN"H>PFU!)I
M-Z*VQP7@^_>Q\1VP!.R<^2X]<]/UQ7K=>*Z'_P C!IO_ %]1?^ABO:JWS.*5
M1/R.;(Y-T91?1A1117F'MA1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !7,>-?"P\1Z:&@P+ZW!,). 'SU4GWQQ[UT]
M%.,G%W0I14E9GG?AGQU]@QHOB-7M[BW_ '0G<'M@ /[_ .UT/?U/>V][:78S
M;74,PQG,<@;C\*JZIH6EZT@74+**?' 8\,!Z!A@@?C7-2_"W09'++-?1@_PI
M*N!^:DUHW3EKL9)5(Z;G0ZGXDTC2(W:\OH5=<_NE8,Y/IM'-<=I_B+Q#XJ\4
MQ2Z2K6NE0'#&5,JR]]WJQ[ 'CUZFMBS^&_AVU<.\,]S@=)I>/KA<5U4$$-M"
ML,$211(,*D:A57Z 4<T(K35CY9R>NB,3QK_R)NI_]<O_ &851^&W_(FP?]=9
M/YUTM[96^HV<MI=Q^9!*,.FXC(^HYIFFZ99Z19K:6,/E0*20FXMR>O))-3S+
MDY1\KY^;R+=>;_%7_CXT/_>E_G'7I%9NJZ!IFMM VHVWG& DQ_O&7;G&?ND9
MZ"BG)1DFQU(N46D:5>67$<WP]\9-?+$TFD7F<[!]U2<[>>ZG&/4?CCU.HKFV
M@O+9[>YB26&089'&0:(3Y=]F$X<VVZ*^G:OI^K0":PNXIU(SA3\P^H/(_$5E
M>(/&.FZ);E4E2YO6'[JWB.XL3TR1T%9]U\,?#]Q,9(S=VP/\$,HV_P#CP)_6
MM/1O!NB:'(LUM;>9<+TFG.]A].P/N *K]VM2;U'IH>>^$HKZ'XE0C4@PO'5Y
M)0W4%HRW/O@CCM74?%7_ )%>V_Z_5_\ 0'KIQH&F#6SK(MO^)@1@S>8W]W;T
MSCIQTJ35='L-;M5MM1@\Z%7$@7>RX8 C.5([$U3JIS4NQ*I-0<>XFA_\B_IO
M_7K%_P"@"K%[:0W]C/9SC,4\9C<#K@C''O3X(([:WB@A7;%$@1%SG  P!S4E
M8MZW-DM+'EGA[4YO 6M7&C:R&6RF??'.%.W/3</4$8!]"*]+M[ZTNX//M[F*
M6+;NWJX( ]3Z5'J6E6.KVQM[^UCGBZ@,.5/J".0?I7*O\+=!>4NLU\BD_<65
M<#\U)_6M7*$]7HS)1G#1:HD\4>+XUB;2=#D:[U2X_=J;<Y$6>^[IGZ=.IQBL
M#X5QF'5=6B8@LB*IQTX8UWNC^'-*T)2-/M%C=EVM(26=OJ3_ "'%+IGA[2]'
MN)Y["U\F2?\ UC>8S;N<]R<4<\5%Q0O9R<U)F/X\\.3:]I44EIS>6C%XUSC<
M#C('OP,?2JWA/QQ:WULECJLJVNHP_NR920)<#KD]&XY![_7 [2L36?"6C:ZQ
MDO+7%P0!Y\9VO_@?3D&IC-./+(J4&I<T37>XABB$LDT:1GH[, #^-<=K'C^&
M+4[73]#A74YWD DV'Y<?W5(ZGWZ#W[-7X6:"'W&XOR,_=,B8_P#0<UT>D^'-
M)T0?Z!91QOC!D/S.?^!'FFO9KS!^TEIL:2%FC4NNQB 2N<X/IFO,?B5_R-&C
M_P"X/_0Z]0K+U+P[I6L74-S?VOG30C$;>8RXYST!'>E3DHRNQU(.4;(U*\]\
M?Z5>66I6OB?358RV^/.P,A=IX8CTYP?;%>A4C*&4JP!4C!!Z&IA+E=QSAS*Q
MB:#XJTS7[5'@G2.XP-]O(V'4^@]1[C^?%6M5U_3-%A:2^NXXRH_U8.7;V"]:
MQM2^'>@:C.TPAEM78Y;[,X4$_0@@?@*AM/AGX?MI5DD%U<X.=LTHP?\ OD"K
MM3WNR;U=K(R_#$NI^*?%TVOM)-:Z="/+C16($@'1#S@]=Q]_TN?%7_D5[;_K
M]7_T!Z[:&&*WA2&"-(HD&%1%"JH] !535='L-;M5MM1@\Z%7$@7>RX8 C.5(
M[$T>T7.I=$'LWR.-]6)H?_(OZ;_UZQ?^@"C7/^1?U+_KUE_] -6X(([:WB@A
M7;%$@1%SG  P!S1/!'<V\L$R[HI4*.N<9!&".*SOK<NWNV.)^%KK'X4NW=@J
MK>.2Q. !L3FN=O=2M?&7C14O+^*VT:U)V&64('4'DC=CECCW ^E>CVWAS2K/
M29]+M[9H[.X),L:S/\V0 ><YY  QFL[_ (5]X7_Z!?\ Y,2__%5LJD>9R,73
MGRJ/8TD\0:!&BHFL::JJ,!1<Q@ >G6K-IJFGW[LEG?VMRRC++#,KD#U.#6)_
MPK[PO_T"_P#R8E_^*K0TGPUI&AS23:=:>1)(NUCYCMD=?XB:S?);2YJN>^MC
MAM<BN_!7C,Z]!$\NGWC'SL>K'+*?0Y^89_H:] TO6=/UFV6>PNHYE(R5!^9?
MJO45;G@AN86AGB26)QADD4,K?4&N1NOAEX?N)2\?VNV!_@BE&!_WT":KFC->
M]N1RR@_=U1I:_P"+]*T.U9FN8YKDJ?+AB8,2<<9P>![UC^ +/59FO-=U&>0"
M^8E(,D*>>7V]NF![?A5[3?A[X?TZ99?(DNG7I]I8,,^N  #^5=50Y12M$:C)
MRYI!11161J%>9_"/_F,?]L?_ &I7IE9FD>']+T+SO[-M?(\[;YG[QFSC./O$
M^IJXR2BUW,Y1;FI=B?5O^0/??]>\G_H)KB_A/_R![_\ Z^!_Z"*[V6))X7AD
M7='(I5AG&0>#5+2=#T[0X9(=.M_(21MS#>S9/3^(FA22@X@XMS4C0KAOBK_R
M*]M_U^K_ .@/7<U1U71[#6[5;;48/.A5Q(%WLN& (SE2.Q-$)<LDV.I%RBTA
M-#_Y%_3?^O6+_P! %>?ZY%=^"O&9UZ")Y=/O&/G8]6.64^AS\PS_ $->EP01
MVUO%!"NV*) B+G. !@#FB>"&YA:&>))8G&&210RM]0:<9V;[,4H<R2ZHJ:7K
M.GZS;+/874<RD9*@_,OU7J*SM?\ %^E:':LS7,<UR5/EPQ,&)..,X/ ]ZS;K
MX9>'[B4O']KM@?X(I1@?]] FK&F_#WP_ITRR^1)=.O3[2P89]<  '\J=J>]Q
M7J;611\ 6>JS->:[J,\@%\Q*09(4\\OM[=,#V_"NXHHJ)2YG<N$>56"O.OBS
M_P >&F_]=7_D*]%KSKXL_P#'AIO_ %U?^0JZ/QHBO_#9/X1\5I80)H6O,;6Z
M@ 6&67(5T_ARQ_0],8KMY+VTBMOM,EU"EO\ \]6D 7\^E9EUH&F:[I%M%J%J
MLA$*[)!PZ<=F'/X=*PA\+=!$@;S[\C^[YJX_]!S0^23N]!+GBK+4R/%?B"7Q
M;>1>'O#^Z:)FS-*.%?'_ +*.N>YZ=L^@Z1ID6CZ3;:?"2R0)MW$8+'J3^))-
M1Z3H>FZ)!Y6GVJ1 _>?JS?5CR:T:4YIKECL5"#3YI;GF>@_\E<U/_MK_ $KT
MRLRW\/:7:ZO+JL-KMO9<[Y?,8YSUX)Q^E:=*I)2:L%.+BG<S/$?_ "*^K?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 5P?Q)_P"89_VU_P#9*[RN#^)/_,,_[:_^R5UX#_>(_/\ )GGY
MK_ND_E^:,_X=_P#(P3_]>K?^AI7IE>9_#O\ Y&"?_KU;_P!#2O3*O,?X_P C
M+)_]U7JPHHHKA/5"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBJU
M]J-CID(FO[RWM(F;8'GE6-2V"<9)Z\'\J V+-%9MIXAT74+A;>RUC3[F=LE8
MH;E'8XY. #FM*AJPDT]@HHHH&%%%% !1163)XJ\.Q2-')KVEI(A*LK7D8*D=
M01FFDV)M+<UJ*BM[F"\MTN+::.>%QE)(F#*P]01P:R-;\8>'_#DR0ZKJ4<$K
MC(C"L[8]2%!('N>M"3>B!R25VS<HJM8:A9ZI9I=V-S%<6[_=DB8,#[?7VJS2
M'N%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4452O=7TS32!?ZC:6I(R!/.J9'3/)H!NVY=HJI9:KIVI FPO[6Z ZF"97Q^
M1JW0"=PHHIKND<;.[!44$LS'  '<T .HK*'B?0&F$(US3#*> @NX\G\,UJ*R
MNH92"I&00>"*=FA)I["T444AA1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !6#XT_Y%*^_[9_\ HQ:WJP?&G_(I7W_;/_T8M;8?^-#U
M7YG/B_\ =ZGH_P CS/0_^1@TW_KZB_\ 0Q7M5>*Z'_R,&F_]?47_ *&*]JKN
MS3XX^AY61?PY^H4445Y9[H4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!7*>./#-[XEM;2*SEMXVA=F;SF(!R!TP#75T549.+NB914E9D5M&8;6&)B"R
M(%..G J6BBI*"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#FO&FB:
MEX@TN*QL)+:-#)OE:9V&<= ,*>YS^ K8T?3H](TBUL(@ L$84D=VZD_B<G\:
MNT57,[<I*BN;F"BBBI*"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ K@_B3_S#/\ MK_[)7>5P?Q)_P"8
M9_VU_P#9*Z\!_O$?G^3//S7_ '2?R_-&?\._^1@G_P"O5O\ T-*],KS/X=_\
MC!/_ ->K?^AI7IE7F/\ '^1ED_\ NJ]6%%%%<)ZH4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !6#XT_Y%*^_[9_\ HQ:WJP?&G_(I7W_;
M/_T8M;8?^-#U7YG/B_\ =ZGH_P CS/0_^1@TW_KZB_\ 0Q7M5>*Z'_R,&F_]
M?47_ *&*]JKNS3XX^AY61?PY^H4445Y9[H4444 %%%% !1110 4444 %%%%
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M"^M+JT^U07,4EOC=YBN"H'N>U4XR6Z)4HO9EBBJ]I?V=^C/9W<%RJG#-#('
M/H<58J2@HK/U/7=+T8*=0O8H"WW58Y8^^T<X]ZSK?QSX:N9!''JL08]Y$:,?
MFP JE&35TB7.*=FQWC#7+GP_H1OK1(7E\U4Q*"5P<^A%7/#VHS:MH%G?SJBR
MS)N81@A1R1QDFN?^)3K)X.#HP96GC(8'((YYK4\%?\B;IG_7+_V8U;2]G?S(
M4G[2WD;]%58]2L9;QK2.]MWN4SNA652ZXZY7.:M5D:W"BFR2)%&TDCJB("S,
MQP !U)-16E[:7\1EL[J&XC#;2\,@< ^F1WY% '*:AXMO[3QY;Z%'#;&UE:,%
MV5M_S#GG./TKLJ\OUK_DL%E_OP_RKT>[U"RL%5KR\M[97.%,T@0'Z9-:U(I*
M-NQE3DVY7[G+:?XMO[OQY<:%)#;"UB:0!U5M_P HXYSC]*[*O)M(U&RB^*EY
M>27ENEJS2XF:50AR./FSBO4+34+*_5FL[RWN50X8PR!P/K@T58V:LN@J4KIW
M?4LT445D;!161JGBC1=&F$-_?I%*0#L"L[#/J%!Q4VEZ[I>M*S:?>Q3E>649
M# >I4X./PI\KM>Q/,KVN:-%07=[:6$0EO+J&WC+;0\T@0$^F3WX-2QR)+&LD
M;JZ. RLIR"#T(-(JXZBBJLFI6,5XMI)>VZ7+XVPM*H=L],+G- 7&ZM=R6&C7
MUY$%,D%O)*H8<$JI(S[<5E>#->NO$6B/>W<<*2"9H\0@@8 ![D^M7O$?_(KZ
MM_UY3?\ H!KG/A@P7PE*S$!1=.23T'RK6B2]FV9-OVB1VU%<_<^./#=K*8I=
M5C+ X/EH[C\U!%7M-U_2=7R+"_AF89^0-AO^^3SCWQ4N,DKM%J<6[)FE7F_C
M/Q7XATGQ.MG8?N[?:IC7R0WG9'/)&>O'&.E>D55N-2L;.:.&YO;>"63[B2RJ
MK-VX!/-.#2>JN*I%M63L6$+-&I==C$ E<YP?3-.HJ*XN8+2(RW,T<,8ZO(X4
M#\34%DM%<Y)X\\,QR>6VJH3ZK$[#\PN*UM.UC3M6CWV%Y#<#&2$;YA]1U'XU
M3C):M$J<7HF7:***DH**S=1\0:1I)VWVH00OD#86R_\ WR.?TK.B\>>&9GV+
MJJ _[<3J/S*@52A)ZI$N<5HV='14<$\-S"LT$J2Q.,J\;!E;Z$4R[O;2PB$M
MY=0V\9;:'FD" GTR>_!J;%7.7_X2J^_X6-_PCOE6_P!D_O[6\S_4[^N<=?;I
M77UY5_:5C_PN+[=]MM_LG_/QYJ^7_P >^/O9QUX^M>F6FI6.H;_L5[;W.S&_
MR95?;GIG!XZ'\JUJ1M:RZ&5*5[W?4LT5FZKK^E:(%_M&\2 N,JI!9B/7 !-,
MTOQ+HVLR&.POXI9!_P LR"C'Z!@":SY7:]B^97M<U:***10455.IZ>M[]B:^
MMA=Y \@RKOZ9^[G/3FK5%@N%%%,AFBN(4F@D26)QE71@RL/4$4 /HHJM-J-C
M;W4=K->6\=Q)C9"\JAVR<# )R>10!P?C?Q5KVC^((;33QY4&Q67,0?SCWZCI
MT&!S^==_9RRS64$LT?E2O&K/&?X6(R1^%1W.I6-E(D=W>V\#R?<6655+?0$\
MT^[O;2PB$MY=0V\9;:'FD" GTR>_!JY.Z22(BK-MLY?_ (2J^_X6-_PCOE6_
MV3^_M;S/]3OZYQU]NE=?7E7]I6/_  N+[=]MM_LG_/QYJ^7_ ,>^/O9QUX^M
M>F6FI6.H;_L5[;W.S&_R95?;GIG!XZ'\JJI&UK+H32E>]WU.8TSQ5?7OCJ\T
M.2*W%M#OVNJMO.,8R<X[^E=A7F>@_P#)7-3_ .VO]*[74O%.B:1+Y5[J$4<G
M= "[#ZA0<45(ZI1705.>C<GU->BLG3/$VBZQ)Y5AJ$4LO:,Y1C]%8 GIVK6K
M-IK<U33U04444AA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 5P?Q)_YAG_;7_P!DKO*X/XD_\PS_ +:_^R5U
MX#_>(_/\F>?FO^Z3^7YHS_AW_P C!/\ ]>K?^AI7IE>9_#O_ )&"?_KU;_T-
M*],J\Q_C_(RR?_=5ZL****X3U0HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M4_\ =Y'G?PE_Y*)8_P#7.7_T6U>J?%3Q)+X?\*&*UE\N[OG,",.JICYV'OC
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MT\0>'/$UM9Z3J'V>![-963R8WRQ=P3EE)Z 5S)2=1\IV2<%17.M-"'_A1/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "L'QI_R*5]_P!L_P#T8M;U8/C3_D4K[_MG_P"C
M%K;#_P :'JOS.?%_[O4]'^1YGH?_ ",&F_\ 7U%_Z&*]JKQ70_\ D8--_P"O
MJ+_T,5[57=FGQQ]#RLB_AS]0HHHKRSW0HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ KDOB1<FW\'3H/^6\J1_KN_\
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M?:M+4/!7A_482C:=# V,![91&1^7'YBL7^R_B)_T'M._[]C_ .-4?V7\1/\
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M0XWX3_\ ('O_ /KX'_H(K<\:>)#X<T;?#@WDY*0 C('JWX?U%8?PG_Y ]_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K!\:?
M\BE??]L__1BUO5@^-/\ D4K[_MG_ .C%K;#_ ,:'JOS.?%_[O4]'^1YGH?\
MR,&F_P#7U%_Z&*]JKQ70_P#D8--_Z^HO_0Q7M5=V:?''T/*R+^'/U"BBBO+/
M="BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M/;UQ7K-%:0FH]-3.<'+KH%%%%9F@4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<'
M\2?^89_VU_\ 9*[RN#^)/_,,_P"VO_LE=> _WB/S_)GGYK_ND_E^:,_X=_\
M(P3_ /7JW_H:5Z97F?P[_P"1@G_Z]6_]#2O3*O,?X_R,LG_W5>K"BBBN$]4*
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MI61<>%M$N]3_ +1GT^)[K()<DX)'0E<X)^HJX.*?O$34FO=9KT445!84444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %5-4U&'2=,GO
MYU=HH5W,(P"QYQQDBK=8'C7_ )$W4_\ KE_[,*J*O)(F3M%LN:%KEMX@T[[=
M:),D6\IB4 -D?0FM.N-^&7_(HC_KX?\ I794324FD*#<HIL****DL**** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ K@_B3_S#/^VO_LE=Y7!_$G_F&?\ ;7_V2NO ?[Q'
MY_DSS\U_W2?R_-&?\._^1@G_ .O5O_0TKTRO,_AW_P C!/\ ]>K?^AI7IE7F
M/\?Y&63_ .ZKU84445PGJA1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %8/C
M3_D4K[_MG_Z,6MZL'QI_R*5]_P!L_P#T8M;8?^-#U7YG/B_]WJ>C_(\ST/\
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MK*ZG!4A#@@]C7 ^+%31/B1I>HPLT8G,;3!>_S;6_-?ZUWGB/_D5]6_Z\IO\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !7!_$G_F&?\ ;7_V2N\K@_B3_P PS_MK_P"R5UX#_>(_
M/\F>?FO^Z3^7YHS_ (=_\C!/_P!>K?\ H:5Z97F?P[_Y&"?_ *]6_P#0TKTR
MKS'^/\C+)_\ =5ZL****X3U0HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M(.XXY[#D<TXQ<G9$SG&"O([RBH;2YCO;."ZA),4T:R(2,':1D?SJ:D4%%%%
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MS(69U&?NDL_Y?=^M=YXC_P"17U;_ *\IO_0#6=X2\)0^&K>1WD$][.!YLN.
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MY^<!]KA!_P"._P!:<H<SO$4:G*N6:.B\6:G#I7AJ]GF8@O&T48'4NP( _K]
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M/S7_ '2?R_-&?\._^1@G_P"O5O\ T-*],KS/X=_\C!/_ ->K?^AI7IE7F/\
M'^1ED_\ NJ]6%%%%<)ZH4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 <7\3O$8\/\ A&9(GVW=[F"''4 _>;\!Q]2*X;X-
MZ[)IVKW/AZ\W1)= 3P+(-N),#/7^\N#_ ,!%+K3GXC?%>'2XG+:7I^5<@\%5
M/[QAU'+84'H0%J[\6=)GT;5M+\7:6OER0NL4A4<*R\QDCT(!4]L #O73%)1Y
M'NSBE*3DZJV7],]?HJAHNK0:YHMGJ=L1Y5S$' SG:>ZD^H.0?<5?KF>AV)W5
MT>;?&W_D3+/_ +""?^BY*['PE_R)FA?]@^W_ /1:UY!\1/".KZ!X?@NK_P 5
MWVK1/=+&()P^U6*.=W+MSP1T[UT_A+P1K?V+0M4_X3/4/LOEV]Q]AP^S9A6\
MK_68QCY>F,=NU;N,?9K4Y8RE[5^Z>H4445@=9XW\7?\ D<_#O^Z/_1@KV2O&
M_B[_ ,CGX=_W1_Z,%>QLRHI9B H&22> *UG\$3"E_$G\A:*\ENO$7B/XA:_-
MIGA>Z-AI%JW[R_0LK-UP<\'G!PHP>Y]KW_"EM)>)7GUC5)+L=9MR 9SG@%2?
MUI<B7Q,?M7+X%='IE%>/7K^+?A=<1W!O9-8T!WVLLQ),8SP,G)0XZ$?+GJ.E
M>JZ5J=IK.EV^HV,GF6TZ[D;]"#[@Y!]Q2E"VO0J%3F=FK,N45R7CWQK%X.TI
M'C1)M0N"5@A?...K-CL...Y/U(Y*Q^'>O>+$34?&&M74?F_,+*+@H.HSGY4/
ML ??G(H4-+MV0I5+2Y8J[/6J*\RD^%M[H9^U^$O$5[:W4:\17+!DD.<X)  Q
M[%2,_IR?BKQ_J]__ &1:>;>:5JMI-)#J$,$K1JYRFT\'D<-QVY[')I4^9^ZR
M95N1>^K'O-%4M7U!-)T:]U%UWK:P/-LW;=VU2<9]\8KRCPWX1N/B3:2>(/$N
MK71221DMX+=@H0 \_>! '4  >^:F,;J[>A<YM-12NSV2BO/O#?A#Q)X6\2QP
M6NL_:?#I0ETN.64] JKG@].1@8!R.@.YXL\-:EXA^Q_V=XBN]'\C?O\ LX;]
M[NVXSM=>F#Z]:'%7M<%.3C>VIP7P_P#^2S>*?^WO_P!*%KV*OGCPOX:U+4OB
M!K.EVWB*[LKJV\_S+Z,-OGVRJISAP?F)W<D\COUKVOPMHE]H&F26M_K5QJTK
MS&03S[MRJ54;>6;C@GKWJZR5]S+#-VM;N;E5[^6Y@T^XEL[?[3<I&QBAW!=[
MXX&3P.>]6**Q.D\N\#_#^^.KWFO>,+5);YY/W4,S+*,]2YP2/8#MCZ5Z#JNA
MZ9K5@UEJ%G%-"5*J"HRG^Z?X3TZ>E:%>=ZY\8= T^"1=-$NH70.T)L:- ?4E
MAG\A6EYS=T8VITHV9@?#NZG\-_$/4_"0G>>Q+R>4'/W67D-C'4KP>G3VKV.O
M*_A=X>O[K4;KQIJS@S7P?R%[G<WS/[#C 'IGVKU2G5:YA8=-0U_I'CWB.)/$
M7QTT_3)HTD@M8T5T=-RL AE((.0<[L?E7I/_  B7AK_H7M)_\ H__B:\9T?Q
M'+;_ !.UC7+;1[S5O,>:.".W!)'S#!X!_@4\>_XUV2?%TV5RL>O^%]1TM&.
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M3NBHU+OEDK,Z&BBBH-3RCXY?\@C2?^N[_P#H(KT^P_Y!UM_UR3^0KS#XY?\
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M;0%T^[U%KQMY90!A(@?X5SSC.3^/0=^EHHK%MMW9TQBHJR$9E12S$!0,DD\
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MZ HKAOB?XHO?#NAV\6FD)>7TAB27(S&!U(SWY SVS6/'\&;>2T$]UKM^=88
MM<J04#_0C<?3.X?A5J"M=NQE*H^;EBKV/4:*YCP38>)=.TZ>W\1WT=VR2;;=
M@=SE!GYF;OGC&>1W]!7\>>-X_!]A$L,2W&I7.1;PMDJ,8RS8YQST[_G2Y6Y<
MJ*YTH\TM#KZ*\JL? 7B/Q9"M]XNUV[@CF^86$!QL4\\@_*I]L$],GM5B7X-V
MEHIET37=2L[H#*N[@@L.5Y4*1S]:KDBM&R/:3>JC^)Z;17F?A37?%VF>*_\
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M)+I^H,=HAN,89L_=5NY]B :[6LI*2TD;P<)*\0HHHJ2PHHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K!\:?\BE??\ ;/\ ]&+6
M]6#XT_Y%*^_[9_\ HQ:VP_\ &AZK\SGQ?^[U/1_D>9Z'_P C!IO_ %]1?^AB
MO:J\5T/_ )&#3?\ KZB_]#%>U5W9I\<?0\K(OX<_4****\L]T**** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ K,\1_P#(KZM_UY3?^@&M.FR1QS1/%*BO&ZE61AD,
M#U!'<4T[.XFKJQQGPN_Y%23_ *^G_P#05KM:@M;.UL8C%:6T-O&3NV0QA!GU
MP*GISES2;%"/+%(****DH**** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MSC+J,$>P9./P)KUZRO(-1L8+VV</!/&)$8=P1D4JJO::ZCH-J]-[H\]^-O\
MR)EG_P!A!/\ T7)78^$O^1,T+_L'V_\ Z+6N.^-O_(F6?_803_T7)78^$O\
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M\#TK%\;Z5)K7@O5;"%2\SP[HT'5F0AP!]2H%5'XE<B=^5V,'X1:3%8>"(;P
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MR.I!'4<]>.AJ7+W'9:%*'[Q-RNSB?CA_R+FF_P#7V?\ T UWWAS_ )%C2?\
MKRA_] %<#\</^1<TW_K[/_H!KOO#G_(L:3_UY0_^@"B7\-!'^-+Y'FWQT_X\
M]$_ZZ3?R2O1/%O\ R)FN_P#8/N/_ $6U>=_'3_CST3_KI-_)*]$\6_\ (F:[
M_P!@^X_]%M3?PQ$OCG\OR.'^"-A%'X;O]0V?OYKKRMW'W%52/U9OTKU"O._@
MO_R(\G_7[)_Z"E>B5-7XV705J:/)_CDH&G:-,!B1)Y K#J 0"?Y#\J]/%V$T
ML7LW"K#YK[1_LY.*\Q^.7_((TG_KN_\ Z"*]+MX4N-'BA?[DEN$;Z%<4Y?!'
MYDP_BS^1X-X#\1:IIVJ:GK$'AR_UR[N?DDFA9\1Y.X@X1N20/RKO/^%D^)?^
MB=:M^<G_ ,:K(^$]S_8'B;6O"U\=ER9,Q;AMWE,AL?5<,/8$U[!5U9)2U1G0
MC)PTE;[CS;_A9/B7_HG6K?G)_P#&JP?AS:ZQ:?$.[NGT+4M,T^^24F*:%Q&G
M.Y1N*@<<@=.N/K[+))'#$\LKJD:*69V. H'4D]A7->$_&UGXMN-0BM+6>-;.
M3;YK8*2*20I![$XSC'XFH4O==D6X>\N:6IQ?QEN)KR_T'08V*I/(9&/4%B0B
MG\,M^=>J65G!IUC!96R!(((Q&BCL ,"O+?C3ITZ)I&NVZY^S2&*0GH"2&3CZ
MAOTKTO1M5M];T:TU.U8&*XC#C!SM/=?J#D?A1+X(V'#^+*_D7JX3XN:5%J'@
M:>Z8*)K&19D8KS@D*RY[ AL_@*[NO/?C!K,%CX-?3O,'VF_D550'D(K!F;Z<
M ?C4T[\ZL56M[-W-'X5_\DWTG_MM_P"CGKL:X[X5_P#)-])_[;?^CGKL:4_B
M8Z7P1]$%>->(],BUCX[V%E.H:)EC=U;HP1"^/QVXKV6O$?&6KIH/QKM-2E)$
M,*Q>81G(0J58\=>">.]71O=V[&>(MRJ_='MU%-1TDC5T8,C %64Y!![BG5D=
M!Y/\:K!8(-)UZ %+N&?R/,&.F"Z_D5;'U->F64R:KHMO/+&-EW;J[)VPZ@D?
MK7EWQBU)M2OM)\+6)\VY>42R1K@X8_+&/8X+''H0:]5L+46.G6UFK;E@B2('
M&,A0!_2M9?!&YA#^+*WD>4?#^:3PA\0-4\)73N+>=F:U9Q]\CE3T[IGVR,5Z
M+XMUQ/#GA>^U)FQ)'&5A'!)D;A>#UY()]@:X3XNZ7/8W&F>+-/!2YM'$<K@X
MXSE">?7<#ZY'I63XUU[_ (3_ %?P]H&CR'R;E$GF&3\CL,X;'=%!)Z]:OEYV
MI?>9\[IJ4.O3YG1?!W1'M="N=;N03<ZE)E2PY\M2>?Q8D^^!7I-16MM#96D-
MK;H(X((UCC0'.U5& /R%2UC.7,[G13AR140KR#XI^9K'CKP[X=9V6WEV,V .
M/,D*$_@%]:]?KR#XOV]QI?B+0?$T,9<0,L9/8.C^8H/URWY&KH_$9XC^&>N0
MPQV\$<$*!(HU"(HZ* , 4^J]A?6^I6$%[:R"2"= Z,.X-6*R-UY'FGQJTR"X
M\+6^HD 7%K<!%;'56!R/S /X>]=7X%_Y$71/^O1/Y5QWQKUFWAT&UT<,3=7$
MPF*CH(UR,GZDC'T-=CX%_P"1%T3_ *]$_E6KO[-'/&WMW;L=!115'5]7LM#T
MR;4-0F$-M%C<V"3DG   ZG-9;G0W;5EFYMH+RVEMKF))8)5*O&XR&![$5XSX
MO\$ZAX(OAXE\*33QVT9W2QJ<F$9S_P "CZ9!SCOGMZWHFLV?B#28-2L7+6\P
M.-PPP(."".QXJW<I!):3)<A#;LC"4.<+MQSGVQ5QDX,RG3C45_Q,+P7XK@\7
M:"EZBB.YC/EW,0_@?';_ &3U'Y=C715XM\$-XUC6EB+FV\I,G'!.X[<^^-WZ
MUWOQ%\1?\(YX0N9HS_I5S_HT'LS Y;\!D_7'K53A:?*B:=6]+GD>2>,_$]CK
MGQ&2:_$\FCV$@A$<(!+JIRQ ; ^9OTQZ5WW_  NWPU_SXZM_WZC_ /CE3_"+
MPW_9'A?^TID(NM2Q)R.5B'W!^.2V?1AZ5Z%53E&_+;8BE"I;FO:_D?.>K^,M
M.'Q$M_%&AP7<2Y1[F&8*A<CY7 VDC#+CKW)-?0]M<0WEK#<V\@DAF021N.C*
M1D'\JQ/&OAX>)_"UWIRX^T8\RW).,2+R/SY'T-<G\'/$1OM$FT2X;_2+ YC!
MZF,GIC'8_P Q2E:<+KH."=.IRM[_ )E[XQ?\B%)_U\Q_UK8^'O\ R(&C?]</
MZFL?XQ?\B%)_U\Q_UK8^'O\ R(&C?]</ZFD_X2]2E_'?H=-11161N>._';_F
M ?\ ;Q_[2KV*O'?CM_S /^WC_P!I5[%6L_@C\S"G_%G\@HHHK(W.*^)?A2Y\
M3Z#&U@<WUDYEB3.-X(Y /KP,?2L+PI\5$C=='\61R6=_"?+:YD7"L1_?'53T
MYZ'VKU*L'Q+X0TCQ5:F/4+<>>%VQW*#$D?T/<>QXK2,E;ED8SIRYN>#U-R.2
M.:))8G5XW4,KJ<A@>A![BO(-*5/%'QVOYKC#1:6',:,.,Q$1C\G8M]:N_![4
MKV.35O#UT[RQV#YB8G(3YBK*/8D9_.LZ.9?!GQONI+MO+L]3W8E8!5Q*0V<G
MC <8)]JN,>5R7D9SGSQC)[7/9:***P.H*\W^-.HO:^$;>TCD93=W0#@=&15)
M(/X[:]#^TP?:OLOG1_:-GF>5N&_;G&['7&>,UP7QATB34/!HNXE9GL9A*P S
M\A^5ORR#] :TI_&KF5:_LW8Z;P?ID6C^$=+LX0.+=7<X^\[#<Q_,FMRN=\#:
MW!KWA#3[J)EWQQ+!,H_@D4 $?R(]B*Z*IE>[N7"W*K'+_$/2XM5\":K'(!N@
MA-RC?W6C&[CZ@$?C67\(=0DOO <4<DC.;2=X 6[#A@/P#?T[5>^).MPZ-X)O
MU=E,UY&UK$AZL7&&/X*2?RJ#X5Z3)I/@6U\Y2LMV[7+*RX(#8"_FJJ?QJ_\
MEWKW,O\ E]IV.*^$MM')X]URX907B20(2.FZ3DC\L?C7M5>0?"#_ )&CQ-_O
M#_T-J]?HK?&&&_AGA'B;5KB;XRO<1:;=:L-.=!!:0E@V44'(P&X#Y/2NN_X6
M3XE_Z)UJWYR?_&JQ-8=/!_QM@U.Z.RPOQN,C#"J&78W/LP!/L:]DJIM)+2^A
MG3C)N5I6U/-O^%D^)?\ HG6K?G)_\:KC]7N/$.M>.--\00>$=7TV6%XQ*5AD
M??M;J3Y8_A.#UX%>\URI\=Z>?'"^%XH)9YBOS3PD,J. 258=L <GUXQ2C+^6
M)4Z;=E*1U5%%%8G217%S!9V[W%S-'!"@R\DK!54>I)X%><Z]\8-/MY/LGAZV
M?4[MCM5]K"//'0?>;OTQ^-:?BWP!)XO\1VMS=ZE)%I=O %^SQDEF?<2Q&>%R
MI SR>!70:%X6T7PW#LTNPBA<KM:8C=(XXZL><9&<=/:M%R)7>K,9>TD[+1'F
ML?A#QMX\9)_$VH-I]CD%;;;@]3TC& #[MS@]Z[WP]X#\/^&MKV5D)+E?^7FX
M.^0_T'_ 0*Z6BE*HWIT'&C&+ONPJGJ.DZ?K$ @U&R@NHE.Y5F0-M/J,]*YO4
M/'7]F>/K3PS=:<$BN@OE7GG]=P('R;?[XV_>]_:NPI-..I:E&5T>:>+?A5IT
MU@]]X<A:RU.#]Y&D;G;(5[#)^5N!@C'/7KD7_A;XNF\2Z%):WTADU"Q(5Y&Z
MR(<[6/OP0?H#WKN9IH[>"2>9PD4:EW8]% &2:\H^#-O)/>>(-5 (@FE6-#C@
MG+,>?8%?SK1-R@[]#%Q4*JY>NYZM)!%*Z/)$CM&<H64$J?4>E25S&C>.M,UK
MQ)=Z#'!=V]]:[]XN%0*Q5MI"D,<^OTYKIZR::W-HR4M4>9_%_P ,6USH+>((
M$6*^LV7S'1<&5"0O..I!VD'L,UU?@?69=?\ !NG:A<$&X="DI'=E8KD^YQG\
M:QOBWJ45CX#N;=G EO)$BC'<X8,3CTPI_,5<^&-A+I_@#34F^],K3@8Z*[$K
M^A!_&M'K35^YBM*[MV.NHHHK(Z HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ K!\:?\BE??]L__1BUO5@^-/\ D4K[_MG_ .C%
MK;#_ ,:'JOS.?%_[O4]'^1YGH?\ R,&F_P#7U%_Z&*]JKQ70_P#D8--_Z^HO
M_0Q7M5=V:?''T/*R+^'/U"BBBO+/="BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MMO!^CFTBD\ZYE;?//MQO/8 =@!_4]ZUM8U6VT32+K4KM@L-O&7;G&3V ]R<
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MK>+M<\CLO!7B3QMKT6L>,MMK:0D;+%?XE&/E !.Q3W).X_D1ZVJJBA5 "@8
M X I:*F4W(N%-0V"BBBI+"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "L'QI_R*5]_VS_]&+6]6#XT_P"12OO^V?\ Z,6ML/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** *4NCZ7/?I?S:;9R7B$%;AX%,
MBD=,,1D8J[110%@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MCPWK%U%,HXBE?&\=<9&!U[$8JQ_PG.N?]"5J/YO_ /&Z/^$YUS_H2M1_-_\
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MWFF76/*D<GY,G&1G.,'J.G.:]+KSGXLJ/LFER#AEDD /U"_X"O0;:0S6L,K
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M^YZ$_CUJW>65MJ%L]M=P1SPOU21<C_\ 7[UG:CIMW#X9;3M"E2VFCB$<+-V
MX//8D9Y]?SKE;3Q1XPTR,6VI>&KB^=!@2PJV3[DJ&!_#%0H\VL31SY=)&<+,
M^#/B-8VVGO(;.^V*8V;/#$K@^N#R/_UU?^*5C(L>G:M$"?(<QOQD#/*D_B#^
M8J70M!U?6O$:>(_$,0A\H#[/;8((QG'&<@ \\]2:[:_L;?4[&:RNDWP3+M9<
MXK24^6:?;<SC3YH-;)[#=,U"#5=,M[ZW.8ID##GH>X^H.1^%6Z\U@TCQ5X)N
M7_LI/[3TR1BQAZD?AU!QW&1Z]JMS>,?%5Q$([3PG<PS%>7E1RN?4 J/YFH=*
M[]UZ%*K9>\M3H/$GBRS\-&U2:-IY)WYBC8;E3^]COSP!QGGGBMU&WQJ^UEW
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MVCV,$R[98K>-'7.<$* 1Q4MKV:123]HV7*\W\&?\E(\1?[T__HX5Z17$^&=
MU/3_ !MK6H75MY=K<M*8I/,4[LR;AP#D<>M$&E&05$W*)VU>?_%C_D#V'_7P
M?_037H%<?\0M#U'7--M(=.M_/>.8LPWJN!C'\1%%)I338ZR;@TC=TJ%;CPO8
MP/G9)91HV.N"@%<)\-[DZ5KNI:#=@).S?(">K)D$#UXY^@KT+2H)+;1[&"9=
MLL5O&CKG."% (XKG?%G@XZS<)JFFS_9M4A VL/E$F#QDCD$=C]!51DM8O9DR
MB])+='74C,%4LQ 4#))Z"N!@\3^,-+_T;4_#<U](H_UL /S>Y*!E_+%)+#XN
M\8*+>Z@&CZ8X'F@_ZR0>F.OX' ^M+V3ZO0?M4]D[F/H.I1ZO\66OHB3'(9 A
M(QE1&5'Z"M_XJ_\ (KVW_7ZO_H#U7TKP?=Z1\04N[6T*Z3%'M24R*23Y0!)&
M<Y+9[5K?$#1[_6]!@MM.@\Z9;I9"N]5PH5AG+$=R*T<H^TBUL9*,O9R3W-S0
M_P#D7]-_Z]8O_0!4?B/_ )%?5O\ KRF_] -3Z5!);:/8P3+MEBMXT=<YP0H!
M'%-UJWEN]!U&V@7?--:R1HN0,L5( R?>L/M'1]D\M\/>#H_$/A%KNVD\G4H;
MAQ&^>' "D ^G/0^];_A;QM/%=C1/$8,%U'^[2>7@L1V?W]^];/@+2+[1?#[V
MNH0>3,;AG"[U;@A><@D=C5GQ/X4L_$MKB0>5=QJ1%.!R/8^H_P BMI5$Y.,M
MC"-.48J4=S?KS"*0>&?BO.UPVRVO]V)&7 Q)AOR#C&?:MWPBOBK3"FFZM8>;
M9)E8KE9D+(!T!^;)7TXR/Y:7BOPK;^)K%49O*NXLF&;'3U!'<']/T,QM"33>
MC+E><5)+5'045YW9ZKXS\-J+*^T:3588^(Y8268KT'S 'CZC-)=:UXUUY?LM
MAHTNF([8,T@96 _WFQC\!GTI>R?=6'[9=G<Z.U\7V=YXJET.")Y"BG_2$(*9
M R0?3'3//-<Y\6?^/#3?^NK_ ,A71^$_"L/AJS?<XGO9L&6;'_CH]LY^O\L[
MXAZ%J6NV=C'IMMY[12,7&]5P"!_>(JH.*J*VQ,U-TW?<ZRQ_Y!]M_P!<E_D*
MGJ&U1H[."-QAEC4$>A K)\56VM7.D;="G6*Y5PS#.&=1V!/ YQUZ^OKBE=V-
M6[*Y?U/2;'6+1K:_MTFC/3(Y4^JGJ#7G_AE)O#7Q&N= BD>2RF!(#'./DWJQ
M]\#;^/TJ[%XO\6V\!@NO"L\]R%PLL<;A<^I !!_ C\*M>$O#>H#5Y_$6NX^W
MSC]W'W0$8R?3C@#L*V2<(M2>ABVIR3BM3MJ***P.@IZMIT>KZ3=6$IPD\93=
MC.T]C^!P?PKQY/$5U8^$;SPS)'(+O[3Y8#9)5#]Y0.QW#_Q\^E>VUQ%[X,-S
M\08-6\H&P($TO('[U1@#&<G) )X]?6MJ4TKJ7J85H-V<?0W?"FCC0_#EK:$?
MO2OF3'&/G;D_ET_"N,\2*?"7Q L]<1?]#NR3*%]>C\?B&'O]*]-K!\8Z&^O^
M'9K6$9N$(EA&0,N,\9/J"1^-*$_>O+J5.'N6CT.5\#02:_XHU'Q/<H0%<I#Z
M;B,8_!,#\:](K)\-:.-#T"ULL 2JNZ4@Y!<_>_P_"M:IJ2YI:#IQY8Z[GF_A
M/_DJ>O\ ^[-_Z-2N\U;_ ) ]]_U[R?\ H)KE?#V@:G8^/M7U.YMMEG<+*(I/
M,4[LR*1P#D< ]176ZA$\^FW4,:[I)(751G&200*JHTY*Q---1=_,X/X3?\>&
MI?\ 75/Y&NR\1_\ (KZM_P!>4W_H!KG_ (>:%J6A6=]'J5MY#2R*4&]6R #_
M '2:Z76K>6[T'4;:!=\TUK)&BY RQ4@#)]Z*C3J704TU2LSF/A=_R*DG_7T_
M_H*UVM<OX"TB^T7P^]KJ$'DS&X9PN]6X(7G()'8UU%34=YNQ5)-029YU\6?^
M/#3?^NK_ ,A7?6/_ "#[;_KDO\A7)_$/0M2UVSL8]-MO/:*1BXWJN 0/[Q%=
M;:HT=G!&XPRQJ"/0@54FO9Q0HI^TD_0FHHHK(U/,_!O_ "4_Q!_V\?\ HY:]
M,KS&+1O%VC^+=4U73-*AF6YEE"F:5,%&DW XW@@\#K6K_:GQ$_Z .G?]_!_\
M=K>I'F=TU]YSTY<JLT_N.YK(\3:,-=T"YL00)&&Z(GLXY'^'XU@1:G\03,@E
MT+3UC+#<0XR!W_Y:UVU9M.#3N:IJ::L>>_#O7Q!&_AO4?W-U;NPA5^">263Z
M@Y/X^U>A5R_BGP7;:^PO+>7[)J48^691PY'3=CGCU'(]\ 5CQ:IXXT!4@O=*
M7585.!-#EG8#W7G\2N3[U<DI^]'<SBW3]V6W<UO&OA,>(;)9[7"ZC;C]T2<!
MQUVGT]CZUB^'?B#'#H5S'K3-]NLEPH8X>?G '^\#@'\_6IIO%_BNZ4I8^%)[
M=R,;IU=@/?D**YG6_!?B V5SKU_Y+W+/YDL$8RRCN>!CCVSQSFM(1TY9D3D[
M\U->ITGP\TNYN;J\\37X_>W;,(@1U!.68>@SP/H:] KGO"/B2U\0:4GE)'!<
M0*$EMTX"8Z%1_=]/3I70UA4;<G<VI)**L4-<_P"1?U+_ *]9?_0#7*_"K_D5
M[G_K];_T!*ZW58)+G1[Z"%=TLMO(B+G&25( YK ^'^CW^B:#/;:C!Y,S732!
M=ZME2JC.5)[@TTU[-H33]HF=77F>N-_PCWQ3L]2?"VUV%WGL,CRV_+AJ],K#
M\4^&H/$NF?9W;RIXSNAEQG8>^1W!HIR2>NS'4BY+3=&Y6?KFHII.AWE\[;?)
MB)4XS\QX4?B2!7%6.L^,?#L8L;[0YM3CC^5)8MS-C']Y0<]NHS3+G3/$WCF[
M0:C =*TN)\B)L[F_ \EL'J0!Z=ZI4K.[>A+JW5DM2Y\+-.>VT2ZOG!7[5* @
M*XRJ \Y[\L1^%=Y4-K:P65K%:VT2Q0Q*%1%Z 5-6<Y<TFRX1Y8I'F_Q;_P"/
M?2O]Z7^2UZ17$_$30-3UV'3UTVV\\Q-(7_>*N,[<?>(]#7;54FN2*]28)\\G
MZ!11169J%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5P?Q)_P"8
M9_VU_P#9*[RN#^)/_,,_[:_^R5UX#_>(_/\ )GGYK_ND_E^:,_X=_P#(P3_]
M>K?^AI7IE>9_#O\ Y&"?_KU;_P!#2O3*O,?X_P C+)_]U7JPHHHKA/5"BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH *P?&G_ "*5]_VS_P#1BUO5@^-/^12O
MO^V?_HQ:VP_\:'JOS.?%_P"[U/1_D>9Z'_R,&F_]?47_ *&*]JKQ70_^1@TW
M_KZB_P#0Q7M5=V:?''T/*R+^'/U"BBBO+/="BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH KWUJ;VPGMEFE@:1"JRQ,59#V(((Z&O/M)\
M3:AX2U*72?%#W$T3/NBNV)DP/7)Y9>GN.>*])J"[LK6_MS!>6\4\1Y*2*&&?
M7GO5QDDK-:$3BV[IZF=%XK\/S0F5=8LPH[/*%;_ODX/Z5S'BCQW!- =*\/EK
MR\N1Y9DC4D*#QA?5OIP*VW\ ^&';<=+4'_9FD _1JU-.T+2])'^@V$$#?WU7
M+?\ ?1YJDZ:=U=DM5&K.R,SP7X=;P[H@BGV_:YF\R;:<A3V7\!^N:Z.BBLY2
M<G=FD8J*L@HHHI#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH J6FE:=82-)9V%K;NPVEH85
M0D>F0*MT447N"5@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "N#^)/_ ##/^VO_ +)7>5P?Q)_YAG_;
M7_V2NO ?[Q'Y_DSS\U_W2?R_-&?\._\ D8)_^O5O_0TKTRO,_AW_ ,C!/_UZ
MM_Z&E>F5>8_Q_D99/_NJ]6%%%%<)ZH4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MBLM5L;F0YPD%PCDXZ\ UPWQM_P"1,L_^P@G_ *+DJX1O))F56=H.43O=(O\
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MO'H( !_*O8:UG:*2L84FY2<F]F%%%%9&YR/A[QQ_;WBW5]"_L[R/[/:1?/\
M/W>9LDV?=VC&>O4UUU>1_#W_ )*WXM_ZZ7'_ */KT^]U?3--(%_J-I:DC($\
MZID=,\FM*D;2LC*E-N-Y%VBJUEJ%EJ,/FV-Y;W473?!*KC\P:LUF:A1152]U
M73M- -_?VMJ#T,\RIG\S0#=BW15*RU?3-2)%AJ-I=$#)$$ZO@=,\&KM )WV*
MNIWHTW2KR_,;2"V@>8HO5MJDX'UQ7 ?#[XDWWBS6[G3KZQ@CQ$9HGMPWR@$
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MI&944LQ 4#))/ %99\3Z LQA.N:8)1P4-W'D?AFG9L3:6YJT4U'22-71@R,
M593D$'N*=2&%%%5+W5=.TTH+Z_M;4N<+Y\RIN/MD\T W8MT4V.2.:))8G5XW
M4,KJ<A@>A![BLY?$>AO<BV36=.:<G B%TA;/TSFG9B;2-.BBBD,**** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *X/XD_\
M,,_[:_\ LE=Y7!_$G_F&?]M?_9*Z\!_O$?G^3//S7_=)_+\T9_P[_P"1@G_Z
M]6_]#2O3*\S^'?\ R,$__7JW_H:5Z95YC_'^1ED_^ZKU84445PGJA1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M3GO;VZFL?#<$A2*%.&<>@Z@G@$L<X)X'IT?QDNVM_ GE MBYNXXFQZ ,_/\
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MXB>,;CP];6VFZ2I?6K]@L"A ^P$XSCN2> ,'OZ5?^'WA\^'/!]I:RH4N9?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M]#CBMS;3;-SLK;QG.<'..WI785YGKW_)7-,_[9?UHI)-N_8*K:2MW.Y\1_\
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MB@MCB6[E4$9SCN#@<' P2<$_076/&7A_4((-7M8]4M[APB26R@'=CH" ,?\
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M;AY?^IQUW?W.?O=?RKTSP[=>(KG[3_;]A;VFW;Y/DL#NZ[L_,W3Y?3K7'_\
M-</\_P#/M7IE56EHE;H31CJW?JSRBSU*UTCXFZQ>WDFR&,2DGN3Q@ =R:V8]
M3\:>),7.DQ6^FV#Y\J2?!+C)YY!/IVQ7.II<6L?%:YM9P# +EY)%/\049Q^)
MQ^%>OJH50J@!0, #H*JI)1MIK85*+E?6RN>=S>(O%GA2XC;Q!##>V,C[?/B
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M]A=<"/>WF_ZD)TVXZCUZ5W5.HT[6[!2BUS7[LI:S_P @/4/^O:3_ -!->=_
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M:6.J*ORI<2R(6 ]02Z$_\"!/%2HJ6J9HYN%DTV95O91^$OC?;V.D#9:7B@/
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MD,_F,;AF4$;2.,*?6NKL('M=.M;=R"\4*(Q7H2 !Q0VN1((Q:J2?H>5_ O\
MX\];_P"ND/\ )Z]<KA?AMX+U'P=!J,>H36LIN6C*?9W9L;0V<Y4>M=U15:<V
MT.A%QII,X'XQ?\B%)_U\Q_UK>\"_\B+HG_7HG\J@\>^'+SQ3X9;3;&2".8S(
M^Z=B%P,^@)_2M/PWILVC^&].TZX:-IK:!8W:,DJ2!VR ?TH;7)82B_:M]+'E
MWAB=/AY\2-3T?4#]GTW4"#;S2#"X!)C.<=,,RD] >O2O9:QO$GA?2_%6GBSU
M*(D*=T<L9Q)&?53_ $.17$6_@CQYH*?9=!\5VYLT&(TND^Z.N "K@<^GZ4W:
M>M[,45*EHE='I=S<P6=M+<W,J101*6>1S@*!W)KPC2]=_P"$D^-EGJ:*RP23
ME8 W_/-4*@_CC/U)KLU^'6MZ[-$_C#Q(]Y!&V[[+:C:C'ZX''_ <^A%8J6ML
MWQ\M+.R@6*VL8@NV( *NV G^; &K@HJ_70SJN4G&ZLKH]CHHHKG.LYGQQKVI
M>']$BGTFQ-[>W$XMXXPC,02K'=M')QMZ5PT7@'Q=XQG6Z\7:JUM;[MRVB,"5
MX."%'R+UZ\GKFO7Z*N,^5:&4J2F[R>G8PO#_ (.T/PR@_LVQ19L8-Q)\TK>O
MS'I]!@5NT45+;>K-$DE9&?KUG+J/AW4[&''FW-I+"F?[S(0/YUP'P3O[=O#U
M]IO"74-T970X!*LJ@''7JI!_"O3Z\W\0?#O4(/$#>(?"%\EC?,2\L#G".>^,
M CGNIXSW%7!IIQ9E434E-*]CTBO'/'<BZW\7-!TRS7S);9HA,R8)7Y][9'^R
MHS^=:DES\6KR+[+_ &?IUGE=INE=,GW^^W/T7O6WX(\ 0>%6EOKNX-YJ\X(D
MG.<*"<D+GDY/4GD^U5&T-6R9MU;12LO,[2BBBL3H.!^,7_(A2?\ 7S'_ %K>
M\"_\B+HG_7HG\J@\>^'+SQ3X9;3;&2".8S(^Z=B%P,^@)_2M/PWILVC^&].T
MZX:-IK:!8W:,DJ2!VR ?TK1M<EC%1?M6^EC4KR#PS_R7?6_]V;_V6O7ZX31_
M!6I:?\2M1\22SVC6=R) B([&0;L8R-N.WK1!I)W"K%MQMW.[KSOXT?\ (CQ_
M]?L?_H+UZ)7*_$'PS>^*_#B:=8RV\<PN%EW3L0N &'8'GFE3=I)LJJFX-(L>
M"467P#H\;C*M9HI'J"*\^^'5W_PA_C?5?">H'RQ/)_HSOCYF&=O/^TI!'N .
MIKT_PWILVC^&].TZX:-IK:!8W:,DJ2!VR ?TK'\:> ['Q?%',96M=1@7;#<H
M,\9SM8=QDGT()^H-*2NT]F1*$K1E'='65#=74%C:2W5U*L4$*EY'8\*!U->:
M6R_%?0T^S)#8ZS$N526:120!C!)+(Q_')ZU%/X3\=>,YEC\3ZA#IVFAM[6ML
M02><XPN0<8ZLQQVSS2]FNK5A^U=M(NY6^'XE\5_$C5_%CQNMM'E(3P.2 J@^
MN$'/OBM;XV_\B99_]A!/_1<E=SHNC6.@:5#IVGQ>7!$.YRS'NS'N36#\1/"U
M]XN\/P6%A+;QRQW2S$SLP7:$<=@>?F%4IIU$^A+IM4G'=LV_#G_(L:3_ ->4
M/_H K3JGI-I)8:-8V<I4R06\<3%3P2J@''MQ5RLGN;QV/(-8_P"3@--_W4_]
M%M7K]<)?^"M2NOBA:>)DGM!90A0T;.WF'"D<#;COZUW=7-II6[&5*+3E?N>-
M^(?^2^:9_O0_^@FO9*X#5/ ^IWWQ-L_$L4]H+*$QED9V\P[1@X&W'ZUW]%1I
MI6[!2BTY7[GD</\ R<9<?]<Q_P"DRUZY7"Q^"]17XL2^*C-:_877 CWMYO\
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M-2DVBJ47&"3"BBBH- HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@"M:6TO0QJ[Q]33^*O\ R*]M_P!?J_\ H#UU6A_\B_IO_7K%_P"@"N5^*O\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\C
MA_Y.,N/^N8_])EKURBJC+EN1.'-;R=PHHHJ2PHHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \DUSP]
MK/@/Q3)XF\-6K7>G3[C<V4:GY,\D8'\.>01]W&#QUW=/^,'A6[B!NIKBQ?'*
MS0LPSZ IG/Z5WU9UUH&C7TADO-)L+AR<EIK9')/U(K3G4OB1C[.47[C^1PVM
M_%[31;M;>'(;C4-0DRL7[E@@/K@_,?7 'Y59^'/@V^TJ6Z\0:ZV[5[[)*-@M
M&I.22?[Q..!T ^H';66E:=IH(L+"UM0>H@A5,_D*MT.:2M% J;<N:;N%%%%9
MFP4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M*?:V5I8QF.TM8;=#U6*,(/R%3T4[O85EN%%%%(84444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !4%U96E]&([NUAN$'198PX_(U/10!5M-,T^P9FL
M[&VMV88)AA5"1^ JU111>X6L%%%% !4%S96EZH6[M89U&<"6,,!GZU/10!2M
M]&TNT??;:;9POG.Z.!5/Z"KM%%#=Q)6V*>K?\@>^_P"O>3_T$UQ?PG_Y ]__
M -? _P#017>7$*W-M+ Y(65"A(ZX(Q67X>\-V?AJVF@LY)Y%E?>QF8$YQCC
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M>0G)=K="2?KBKZ(L:*B*%51@*!@ >E+13NV))(****0PHHHH **** "BBB@
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M .3/_P!C1_PLG_J$_P#DS_\ 8T?4,1_+^*_S#^U<)_/^#_R.\HK@_P#A9/\
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MY'>45P?_  LG_J$_^3/_ -C1_P +)_ZA/_DS_P#8T?4,1_+^*_S#^U<)_/\
M@_\ ([RBN#_X63_U"?\ R9_^QH_X63_U"?\ R9_^QH^H8C^7\5_F']JX3^?\
M'_D=Y17!_P#"R?\ J$_^3/\ ]C1_PLG_ *A/_DS_ /8T?4,1_+^*_P P_M7"
M?S_@_P#([RBN#_X63_U"?_)G_P"QH_X63_U"?_)G_P"QH^H8C^7\5_F']JX3
M^?\ !_Y'>45P?_"R?^H3_P"3/_V-'_"R?^H3_P"3/_V-'U#$?R_BO\P_M7"?
MS_@_\CO**X/_ (63_P!0G_R9_P#L:/\ A9/_ %"?_)G_ .QH^H8C^7\5_F']
MJX3^?\'_ )'>45P?_"R?^H3_ .3/_P!C1_PLG_J$_P#DS_\ 8T?4,1_+^*_S
M#^U<)_/^#_R.\HK@_P#A9/\ U"?_ "9_^QH_X63_ -0G_P F?_L:/J&(_E_%
M?YA_:N$_G_!_Y'>45P?_  LG_J$_^3/_ -C1_P +)_ZA/_DS_P#8T?4,1_+^
M*_S#^U<)_/\ @_\ ([RBN#_X63_U"?\ R9_^QH_X63_U"?\ R9_^QH^H8C^7
M\5_F']JX3^?\'_D=Y17!_P#"R?\ J$_^3/\ ]C1_PLG_ *A/_DS_ /8T?4,1
M_+^*_P P_M7"?S_@_P#([RBN#_X63_U"?_)G_P"QH_X63_U"?_)G_P"QH^H8
MC^7\5_F']JX3^?\ !_Y'>45P?_"R?^H3_P"3/_V-'_"R?^H3_P"3/_V-'U#$
M?R_BO\P_M7"?S_@_\CO**X/_ (63_P!0G_R9_P#L:/\ A9/_ %"?_)G_ .QH
M^H8C^7\5_F']JX3^?\'_ )'>45P?_"R?^H3_ .3/_P!C1_PLG_J$_P#DS_\
M8T?4,1_+^*_S#^U<)_/^#_R.\HK@_P#A9/\ U"?_ "9_^QH_X63_ -0G_P F
M?_L:/J&(_E_%?YA_:N$_G_!_Y'>45P?_  LG_J$_^3/_ -C1_P +)_ZA/_DS
M_P#8T?4,1_+^*_S#^U<)_/\ @_\ ([RBN#_X63_U"?\ R9_^QH_X63_U"?\
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MQH_X63_U"?\ R9_^QH^H8C^7\5_F']JX3^?\'_D=Y17!_P#"R?\ J$_^3/\
M]C1_PLG_ *A/_DS_ /8T?4,1_+^*_P P_M7"?S_@_P#([RBN#_X63_U"?_)G
M_P"QH_X63_U"?_)G_P"QH^H8C^7\5_F']JX3^?\ !_Y'>45P?_"R?^H3_P"3
M/_V-'_"R?^H3_P"3/_V-'U#$?R_BO\P_M7"?S_@_\CO**X/_ (63_P!0G_R9
M_P#L:/\ A9/_ %"?_)G_ .QH^H8C^7\5_F']JX3^?\'_ )'>45P?_"R?^H3_
M .3/_P!C1_PLG_J$_P#DS_\ 8T?4,1_+^*_S#^U<)_/^#_R.\HK@_P#A9/\
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MY'>45P?_  LG_J$_^3/_ -C1_P +)_ZA/_DS_P#8T?4,1_+^*_S#^U<)_/\
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M^H8C^7\5_F']JX3^?\'_ )'>45P?_"R?^H3_ .3/_P!C1_PLG_J$_P#DS_\
M8T?4,1_+^*_S#^U<)_/^#_R.\HK@_P#A9/\ U"?_ "9_^QH_X63_ -0G_P F
M?_L:/J&(_E_%?YA_:N$_G_!_Y'>45P?_  LG_J$_^3/_ -C1_P +)_ZA/_DS
M_P#8T?4,1_+^*_S#^U<)_/\ @_\ ([RBN#_X63_U"?\ R9_^QH_X63_U"?\
MR9_^QH^H8C^7\5_F']JX3^?\'_D=Y17!_P#"R?\ J$_^3/\ ]C1_PLG_ *A/
M_DS_ /8T?4,1_+^*_P P_M7"?S_@_P#([RBN#_X63_U"?_)G_P"QH_X63_U"
M?_)G_P"QH^H8C^7\5_F']JX3^?\ !_Y'>45P?_"R?^H3_P"3/_V-'_"R?^H3
M_P"3/_V-'U#$?R_BO\P_M7"?S_@_\CO**X/_ (63_P!0G_R9_P#L:/\ A9/_
M %"?_)G_ .QH^H8C^7\5_F']JX3^?\'_ )'>45P?_"R?^H3_ .3/_P!C1_PL
MG_J$_P#DS_\ 8T?4,1_+^*_S#^U<)_/^#_R.\HK@_P#A9/\ U"?_ "9_^QH_
MX63_ -0G_P F?_L:/J&(_E_%?YA_:N$_G_!_Y'>45P?_  LG_J$_^3/_ -C1
M_P +)_ZA/_DS_P#8T?4,1_+^*_S#^U<)_/\ @_\ ([RBN#_X63_U"?\ R9_^
MQH_X63_U"?\ R9_^QH^H8C^7\5_F']JX3^?\'_D=Y17!_P#"R?\ J$_^3/\
M]C1_PLG_ *A/_DS_ /8T?4,1_+^*_P P_M7"?S_@_P#([RBN#_X63_U"?_)G
M_P"QH_X63_U"?_)G_P"QH^H8C^7\5_F']JX3^?\ !_Y'>45P?_"R?^H3_P"3
M/_V-'_"R?^H3_P"3/_V-'U#$?R_BO\P_M7"?S_@_\CO**X/_ (63_P!0G_R9
M_P#L:/\ A9/_ %"?_)G_ .QH^H8C^7\5_F']JX3^?\'_ )'>45P?_"R?^H3_
M .3/_P!C1_PLG_J$_P#DS_\ 8T?4,1_+^*_S#^U<)_/^#_R.\HK@_P#A9/\
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MY'>45P?_  LG_J$_^3/_ -C1_P +)_ZA/_DS_P#8T?4,1_+^*_S#^U<)_/\
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M^H8C^7\5_F']JX3^?\'_ )'>45P?_"R?^H3_ .3/_P!C1_PLG_J$_P#DS_\
M8T?4,1_+^*_S#^U<)_/^#_R.\HK@_P#A9/\ U"?_ "9_^QH_X63_ -0G_P F
M?_L:/J&(_E_%?YA_:N$_G_!_Y'>45P?_  LG_J$_^3/_ -C1_P +)_ZA/_DS
M_P#8T?4,1_+^*_S#^U<)_/\ @_\ ([RBN#_X63_U"?\ R9_^QH_X63_U"?\
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MQH_X63_U"?\ R9_^QH^H8C^7\5_F']JX3^?\'_D=Y17!_P#"R?\ J$_^3/\
M]C1_PLG_ *A/_DS_ /8T?4,1_+^*_P P_M7"?S_@_P#([RBN#_X63_U"?_)G
M_P"QH_X63_U"?_)G_P"QH^H8C^7\5_F']JX3^?\ !_Y'>45P?_"R?^H3_P"3
M/_V-'_"R?^H3_P"3/_V-'U#$?R_BO\P_M7"?S_@_\CO**X/_ (63_P!0G_R9
M_P#L:/\ A9/_ %"?_)G_ .QH^H8C^7\5_F']JX3^?\'_ )'>45P?_"R?^H3_
M .3/_P!C1_PLG_J$_P#DS_\ 8T?4,1_+^*_S#^U<)_/^#_R.\HK@_P#A9/\
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MY'>45P?_  LG_J$_^3/_ -C1_P +)_ZA/_DS_P#8T?4,1_+^*_S#^U<)_/\
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M^H8C^7\5_F']JX3^?\'_ )'>45P?_"R?^H3_ .3/_P!C1_PLG_J$_P#DS_\
M8T?4,1_+^*_S#^U<)_/^#_R.\HK@_P#A9/\ U"?_ "9_^QH_X63_ -0G_P F
M?_L:/J&(_E_%?YA_:N$_G_!_Y'>45P?_  LG_J$_^3/_ -C1_P +)_ZA/_DS
M_P#8T?4,1_+^*_S#^U<)_/\ @_\ ([RBN#_X63_U"?\ R9_^QH_X63_U"?\
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MQH_X63_U"?\ R9_^QH^H8C^7\5_F']JX3^?\'_D=Y17!_P#"R?\ J$_^3/\
M]C1_PLG_ *A/_DS_ /8T?4,1_+^*_P P_M7"?S_@_P#([RBN#_X63_U"?_)G
M_P"QH_X63_U"?_)G_P"QH^H8C^7\5_F']JX3^?\ !_Y'>45P?_"R?^H3_P"3
M/_V-'_"R?^H3_P"3/_V-'U#$?R_BO\P_M7"?S_@_\CO**X/_ (63_P!0G_R9
M_P#L:/\ A9/_ %"?_)G_ .QH^H8C^7\5_F']JX3^?\'_ )'>45P?_"R?^H3_
M .3/_P!C1_PLG_J$_P#DS_\ 8T?4,1_+^*_S#^U<)_/^#_R.\HK@_P#A9/\
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MO3**/[1K^0?V/A>S^\\S_P"%=ZO_ ,_%E_WV_P#\31_PKO5_^?BR_P"^W_\
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M^W_^)KTRBC^T:_D']CX7L_O/,_\ A7>K_P#/Q9?]]O\ _$T?\*[U?_GXLO\
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M?BR_[[?_ .)KTRBC^T:_D']CX7L_O/,_^%=ZO_S\67_?;_\ Q-'_  KO5_\
MGXLO^^W_ /B:],HH_M&OY!_8^%[/[SS/_A7>K_\ /Q9?]]O_ /$T?\*[U?\
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MT?\ "N]7_P"?BR_[[?\ ^)KTRBC^T:_D']CX7L_O/,_^%=ZO_P _%E_WV_\
M\31_PKO5_P#GXLO^^W_^)KTRBC^T:_D']CX7L_O/,_\ A7>K_P#/Q9?]]O\
M_$T?\*[U?_GXLO\ OM__ (FO3**/[1K^0?V/A>S^\\S_ .%=ZO\ \_%E_P!]
MO_\ $T?\*[U?_GXLO^^W_P#B:],HH_M&OY!_8^%[/[SS/_A7>K_\_%E_WV__
M ,31_P *[U?_ )^++_OM_P#XFO3**/[1K^0?V/A>S^\\S_X5WJ__ #\67_?;
M_P#Q-'_"N]7_ .?BR_[[?_XFO3**/[1K^0?V/A>S^\\S_P"%=ZO_ ,_%E_WV
M_P#\31_PKO5_^?BR_P"^W_\ B:],HH_M&OY!_8^%[/[SS/\ X5WJ_P#S\67_
M 'V__P 31_PKO5_^?BR_[[?_ .)KTRBC^T:_D']CX7L_O/,_^%=ZO_S\67_?
M;_\ Q-'_  KO5_\ GXLO^^W_ /B:],HH_M&OY!_8^%[/[SS/_A7>K_\ /Q9?
M]]O_ /$T?\*[U?\ Y^++_OM__B:],HH_M&OY!_8^%[/[SS/_ (5WJ_\ S\67
M_?;_ /Q-'_"N]7_Y^++_ +[?_P")KTRBC^T:_D']CX7L_O/,_P#A7>K_ //Q
M9?\ ?;__ !-'_"N]7_Y^++_OM_\ XFO3**/[1K^0?V/A>S^\\S_X5WJ__/Q9
M?]]O_P#$T?\ "N]7_P"?BR_[[?\ ^)KTRBC^T:_D']CX7L_O/,_^%=ZO_P _
M%E_WV_\ \31_PKO5_P#GXLO^^W_^)KTRBC^T:_D']CX7L_O/,_\ A7>K_P#/
MQ9?]]O\ _$T?\*[U?_GXLO\ OM__ (FO3**/[1K^0?V/A>S^\\S_ .%=ZO\
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M%=ZO_P _%E_WV_\ \31_PKO5_P#GXLO^^W_^)KTRBC^T:_D']CX7L_O/,_\
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MKTRBC^T:_D']CX7L_O/,_P#A7>K_ //Q9?\ ?;__ !-'_"N]7_Y^++_OM_\
MXFO3**/[1K^0?V/A>S^\\S_X5WJ__/Q9?]]O_P#$T?\ "N]7_P"?BR_[[?\
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M_"N]7_Y^++_OM_\ XFO3**/[1K^0?V/A>S^\\S_X5WJ__/Q9?]]O_P#$T?\
M"N]7_P"?BR_[[?\ ^)KTRBC^T:_D']CX7L_O/,_^%=ZO_P _%E_WV_\ \31_
MPKO5_P#GXLO^^W_^)KTRBC^T:_D']CX7L_O/,_\ A7>K_P#/Q9?]]O\ _$T?
M\*[U?_GXLO\ OM__ (FO3**/[1K^0?V/A>S^\\S_ .%=ZO\ \_%E_P!]O_\
M$T?\*[U?_GXLO^^W_P#B:],HH_M&OY!_8^%[/[SS/_A7>K_\_%E_WV__ ,31
M_P *[U?_ )^++_OM_P#XFO3**/[1K^0?V/A>S^\\S_X5WJ__ #\67_?;_P#Q
M-'_"N]7_ .?BR_[[?_XFO3**/[1K^0?V/A>S^\\S_P"%=ZO_ ,_%E_WV_P#\
M31_PKO5_^?BR_P"^W_\ B:],HH_M&OY!_8^%[/[SS/\ X5WJ_P#S\67_ 'V_
M_P 31_PKO5_^?BR_[[?_ .)KTRBC^T:_D']CX7L_O/,_^%=ZO_S\67_?;_\
MQ-'_  KO5_\ GXLO^^W_ /B:],HH_M&OY!_8^%[/[SS/_A7>K_\ /Q9?]]O_
M /$T?\*[U?\ Y^++_OM__B:],HH_M&OY!_8^%[/[SS/_ (5WJ_\ S\67_?;_
M /Q-'_"N]7_Y^++_ +[?_P")KTRBC^T:_D']CX7L_O/,_P#A7>K_ //Q9?\
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M67_?;_\ Q-'_  KO5_\ GXLO^^W_ /B:],HH_M&OY!_8^%[/[SS/_A7>K_\
M/Q9?]]O_ /$T?\*[U?\ Y^++_OM__B:],HH_M&OY!_8^%[/[SS/_ (5WJ_\
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M=ZO_ ,_%E_WV_P#\31_PKO5_^?BR_P"^W_\ B:],HH_M&OY!_8^%[/[SS/\
MX5WJ_P#S\67_ 'V__P 35^P^'3"0-J%ZI0'E( >?Q/3\J[VBE+,*[5KE1RC"
MQ=[7^9!:6=O86R6]K$L42=%7_/6IZ**XVVW=GI))*R"BBBD,**** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MXY110%O,/M/B'_GJW_CE'VGQ#_SU;_QRBB@+>8?:?$/_ #U;_P <H^T^(?\
MGJW_ (Y110%O,/M/B'_GJW_CE'VGQ#_SU;_QRBB@+>8?:?$/_/5O_'*/M/B'
M_GJW_CE%% 6\P^T^(?\ GJW_ (Y1]I\0_P#/5O\ QRBB@+>8?:?$/_/5O_'*
M/M/B'_GJW_CE%% 6\P^T^(?^>K?^.4?:?$/_ #U;_P <HHH"WF'VGQ#_ ,]6
M_P#'*/M/B'_GJW_CE%% 6\P^T^(?^>K?^.4?:?$/_/5O_'*** MYA]I\0_\
M/5O_ !RC[3XA_P">K?\ CE%% 6\P^T^(?^>K?^.4?:?$/_/5O_'*** MYA]I
M\0_\]6_\<H^T^(?^>K?^.444!;S#[3XA_P">K?\ CE'VGQ#_ ,]6_P#'***
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AU;_QRBB@+>9TVEM</IL+71S.<[CQZG'3VQ1114FB/__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>img268224062_9.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img268224062_9.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 5##RX# 2(  A$! Q$!_\0
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M!0 M'>BCO0,=2TE+0 4444 **6D%+0 M%%% Q12T@I: "EI*6D 4HZTE*.M
MA:***!A3J;3J "BBB@!:6DI: %HHHI#%%% HH 6EI*6@!110** %I324IH *
M6DI:!BBB@44""EI*6@8M+24M !WHH[T4 +2TE+0 4HI*44 %+24M(8M+24M
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M4HH&%+24M( I:2EI@ I12"E%(!310:* %%**04HH **** %I:2EH& I:04M
M!2TE+2 6E%)2B@ I:2EH 6E[4E+VH *44E** "NR\)_\@N7_ *[G_P!!6N-K
MLO"?_(+E_P"NY_\ 05J9[&E/XCSKX[?\P#_MX_\ :5>.U[%\=O\ F ?]O'_M
M*O':Z:/P(XL3_%84445J8!1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %+24M "&E'2D-*.E "THI*44@%-%!HH !2BD%**
M%HHHH&%*.E)2CI0(44=Z!1WI#%I:2EI@+1112 *6DI:8"TM)2TAA2BDI10 M
M+24M !2BDI10,*6DI:0"T444 +0**!0(6BBBF,6EI*6D =J!1VH% "TII*4T
M +2BDI12 *6DI:8Q:***0"T"B@4#%I:2EH$%*.E)2CI0,6BBB@0M%%% Q:!1
M0*0"T444P%I1TI*4=*0"T"B@4#%I:2EI@% HH%(8X44"B@!:6DI: "E'6DI1
MUI +1113 *4=*2E'2@!:***0"T444 +0**!0 M'>BCO0,=2TE+0 4444 **6
MD%+0 M%%% Q12T@I: "EI*6D 4HZTE*.M A:***!A3J;3J "BBB@!:6DI: %
MHHHI#%%% HH 6EI*6@!110** %I324IH *6DI:!BBB@44""EI*6@8M+24M !
MWHH[T4 +2TE+0 4HI*44 %+24M(8M+24M  *6D%+0 M%%% "BE%(*44AA111
M3 6EI*6D HHH%% !2TE+0 HI:04M P[T"CO0* %I:2EH 44HI!2B@84M)2T@
M"EI*6F "E%(*44@%-%!HH 44HI!2B@ HHHH 6EI*6@8"EI!2T %+24M(!:44
ME** "EI*6@!:7M24O:@ I124HH *[+PG_P @N7_KN?\ T%:XVNR\)_\ (+E_
MZ[G_ -!6IGL:4_B/.OCM_P P#_MX_P#:5>.U[%\=O^8!_P!O'_M*O':Z:/P(
MXL3_ !6%%%%:F 4444 %%%% !1110 4444 %%%% !1110 4444 %%206\UU,
ML-O#)-*V=J1J68\9X K37PIXC<970-58>UG(?Z4FTAI-[&115Z[T75;",R7N
MF7EL@."TT#(!^)%4:!-6W"BBBF 4444 %%%% !1110 4444 %%%:EOX;UV[A
M6:VT749HG 97CM796!Z$$#I2;L"3>QET59O=.OM.D$=]9W%JYZ+/$R$_@15:
M@-@HHHI@%%%:%IH.L7\*S6>DWUS$V=KPV[NIQUP0*5[ DWL9]%:-UX?UJRC,
MEWI%_;HHR6EMG0 >N2*SJ+W!IK<****8!1110 4444 %%%% !1110 4444 %
M%%% !17467PZ\5:AI\-_:Z5YEM,@D1_M$0RI[X+9KEZ2:>PW%K=!1113$%%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%:>A^']3\1WWV/2[5IY0,L<@*
M@]23P!2;MN"3;LC,HKT?_A2GB;RM_P!ITS=C[GG/G_T#'ZUR7B#PKJWAG4([
M+48%$LPS$8G#B09QQCGKZ@5*G%Z)ERI3BKM&+17?1_!_Q3)I@O-MFKE-XM6E
M(E^GW=H/U-<)+%)!,\4L;1R(Q5T<8*D<$$=C34D]F*4)1^)#****HD**** "
MBBB@ HHHH **W=#\':]XDMI+C2;#[1%$^QV\Z-,-C./F8>M9VJZ5>Z)J4VG:
MC#Y-U#C?'N5L9 8<J2.A%*ZO8;BTKVT*=%%%,04444 %%:.B:)?^(=4BT[38
M#+._)[*B]V8]@/\ ZW4BN@\1_#/Q!X:TXW]S]FN;=3B1K5V;R_=@5''O4N23
MLV4H2:YDM#CJ***HD**** "BBB@ HHHH **** "BBM_1/!?B#Q'9/>:3I_VB
M!)#$S^=&F& !(PS ]"*3:6XU%MV1@459O["YTN_FL;R+RKF!MDB;@VT_49%5
MJ!;!1113 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BMW0_
M!VO>)+:2XTFP^T11/L=O.C3#8SCYF'K6;JFF7FC:C-I]_#Y-U"0)(]P;&0".
M02.A%*ZO8;BTKVT*E%%%,04444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !174>%_ &M^+89+BQ6&&WC.WSKEBJL?08!)_*J/B7PMJGA34!::E$HWC
M=%-&28Y!WVG Z=P<'\Q4\RO:Y7))1YK:&+1115$A1110 4444 %%%% !1110
M 4444 %%%% !1110 445:TW3;O5]1AL+&+S;J8XC3<%R<9ZD@=J0)7*M%;VN
M>#-?\.6D=UJUA]GADD\M6\Z-\M@G&%8GH#6#0FGL-IIV84444Q!1110 4444
M %%%% !1110 445T>D> _$NNZ>E_INF^?:N2%?SXUR0<'AF!I-I;C47+1(YR
MBI;JVFL[N:UN$V30R-'(N0<,#@C(XZBHJ!!1113 **** "BBB@ HHHH ****
M "BBB@ HHJYI6E7NMZE#IVG0^==39V1[E7. 6/+$#H#2!*^B*=%;>N^$==\-
M10RZO8_9DF8K&?-1\D=?NL:Q*$T]4-IIV84444Q!1110 445U-O\.?%=UIT5
M_#I6ZUEB$R/]HB&4(R#@MGI2;2W&HN6R.6HHHIB"BBB@ HHHH **** "BBB@
M HHHH **ZBR^'7BK4-/AO[72O,MID$B/]HB&5/?!;-<O233V&XM;H****8@H
MHHH ***U]"\,:QXEDFCTBS^TM" 9!YJ)M!Z?>(]*3:6K!)MV1D45I:WH&I^'
M+U+/5K;[/.\8E5/,5\J20#E21U!J[X7\':MXMN)(M.CC6.(9DGF)6-?09 //
ML!2YE:XU&3?+;4P*6NB\4^"-8\(O"=02*2"7A+B!BT>[^Z20"#]1SVS@USM-
M--702BXNS$-*.E(:4=*8A:44E**0"FB@T4  I12"E% "T444#"E'2DJ>SM9K
MZ\@M+9-\\\BQ1ID#<S' &3P.30!$*.]=!J_@CQ%H-B;W4]/\BW#!-_G1MR>G
M"L37/]Z2:>PW%Q=FA:6DI:8A:***0!2TE+3 6EI*6D,*44E** %I:2EH *45
M:TS3+S6=1BL+"'SKJ7.Q-P7. 2>20.@-7M:\*ZUX=BBDU6R^SI*Q5#YJ/DC_
M '2:5U>Q7*[7MH8]+24M A:*** %H%% H$+1113&+2TE+2 .U H[4"@!:4TE
M*: %I16SH_A+7->M'NM,L?/A20QLWFHN& !QAB#T(K/O["YTN^ELKR+RKB(X
M=-P;!QGJ"1WI)J]BN5I7:*U+24M,0M%%%(!:!10*!BTM)2T""E'2DI1TH&+1
M110(6BBB@8M HH%(!:***8"THZ4E*.E(!:!10*!BTM7-+TF^UJ[^RZ?!YT^T
MOMWJO Z\D@=ZFU?P_JFA&$:E:^09@2G[Q6SC&?ND^HHNKV'RNU[&;0**!0 X
M44"B@!:6DI: "E'6DI1UI +1113 *4=*2E'2@!:***0"T444 +0**!0 M'>B
MCO0,=2TE+0 4444 **6D%+0 M%%% Q12T@I: "EI*6D 4HZTE*.M A:***!A
M3J;3J "BM33?#NJZO;M<6-KYL2N4+>8J\X!QR1ZBJ5Y9SV%W):W,?ES1G#+D
M''XCBBZV'9VN0TM)2T"%HHHI#%%% HH 6EI*6@!110** %I325;L-.N]4N?L
M]G%YLNTMMW!>!]2*&-*Y5I:O:EHNH:1Y7VZW\KS<[/G5LXQGH3ZBH+*RN-0N
MX[6UC\R9\[5R!G R>3QT!HNMQV=[$(HK1U#0=2TF));VV\I';:IWJV3^!-9U
M).XFFMPI:2EI@+2TE+0 =Z*.]% "TM)2T %**2E% !2TE+2&+2U=T[1[_5?,
M^Q0>;Y>-_P ZKC.<=2/0U%>V-SIUR;>ZC\N4 $KN!X/THNMAV=KE<4M(*6@0
MM%%% "BE%(*44AA1113 6EI*6D HHH%% !2TE+0 HI:04M P[T"CO0* %I:2
MEH 44HI!2B@84M)2T@"EI*6F "E%(*44@%-%!HH 44HI!2B@ HHHH 6EI*6@
M8"EI!2T %+24M(!:44E** "EI*6@!:7M24O:@ I124HH *[+PG_R"Y?^NY_]
M!6N-KLO"?_(+E_Z[G_T%:F>QI3^(\Z^.W_, _P"WC_VE7CM>Q?';_F ?]O'_
M +2KQVNFC\".+$_Q6%%%%:F 4444 %%%% !74_#?_DH6C_\ 75O_ $!JY:NI
M^&__ "4+1_\ KJW_ * U3/X673^->I]%ZSK>G>'[ WVIW'D6P8)OV,W)Z<*"
M:Y[_ (6IX+_Z#/\ Y*S?_$51^,7_ "(;_P#7S'_6OGJN6E2C.-V=M?$2IRY4
M?2?_  M3P7_T&?\ R5F_^(H_X6IX+_Z#/_DK-_\ $5\V45I]7B8_7)]D>K?%
M3QCH/B31+*WTF_\ M$L5SO=?)D3"[2,_,H]:\IHHK6$5%61A4FYRYF36EG<W
M]W%:VD#SW$K;4CC7)8U[)X3^#=M% MUXE8S3.H/V.)RJQ_[SJ<L>G3 '/)KH
M?AOX)3PMI'VR]B0:M<KF5CSY*=0@/Y$^_K@5QWC_ .*LTT\NE>')]ENH*37J
M?>D/<1GL/]KOVP.3C*<IOE@=,:4*4>>IOV/1[S6_"G@VW6WEN+&P"CY;>%1O
MP2?X%&>N><=<USUS\:/"\$NR.+4;A<9WQ0J!]/F8']*\!DD>61Y)'9Y')9F8
MY+$]23ZTVFL/'J2\7/[*L?2>G_%'PE?OL_M+[.Y[7,;(.N.O3]:EUOP%X8\4
M0^>UI%',ZG;=6A"DY[G'#?CFOF>N@\,^,]8\+7*O8W+-;Y^>UD.8W'T['GJ*
M3H6U@RHXI2TJ+0L^+_ >J^$;C,RFYL6/[N[C0A?HPYVGV/7L3S7+5]1Z%KFD
M>._#CR+$LD,H,=S:S8+(?0X_,'^1Z>#>/O"$GA'7C"@9K"XR]K(QR2!C*GW!
M/Y$>M53J-OEEN9UJ*BN>&QRM%%%;G.>S_#_Q+X)\): L4VKQG49SON9%M9CS
MV7.SH!^N?6O2]$U_3/$=D]YI-S]H@20Q,_ELF& !(PP!Z$5\FU[W\$O^1,O/
M^P@__HN.N6M327,=V&K.34+:'EOQ(_Y*%K'_ %U7_P! 6N6KJ?B1_P E"UC_
M *ZK_P"@+7+5O#X4<E3XWZA5_1=&O=?U:#3;"/?/,V!GA5'=B>P JA7NGP8\
M.QVFARZ]*JM<7K&.(X^Y&IP>W!+ Y_W5I5)\D;CHT_:3L;_AOP'X?\&V/VN9
M89KJ)"\U]<@?)@<E<\(,9]\=2:IZC\7_  K83F*-[N]()5FMH@5&/=BN1[C/
M3Z5YW\5/&4^M:Y-HULY73K&0HP!/[V4<,3[ Y ^A/?CSRLHT>;WIG1/$<CY:
M:T/IW2O%?ACQG$]E#-#<E@=UK<QX9ACGY6Z]>U>:_$;X9)I$$NM:&CFT!S/:
M@9\D<Y=3UV],CMUZ=/+XI9()DEBD:.1&#(Z'!4CD$'L:^D/A[XI7Q?X9(O-K
MWMO^YNU8#]YD</CT89_$&E*+I>]'8J$XUURS6I\V58L+"ZU.^ALK*!Y[F9ML
M<:#DG^@]^U;'C;P^/#/BN]TY ?LX;S("?^>;<@>^/NY[XKTCX): B6M[K\T9
M\QV^S0%@1A1@N1V.3@9[;3ZFMI32CS'-"DY5.1G0>$OAKHWABR2[U1+>\U%1
MODGEYBB/!^0-P,8^\1GZ9Q2ZE\7/"FG2&**:XO2C%#]EBRHQZ%BH(]QFN"^+
M?C&?4=8DT"SGQ86I G"'_6RCD@GN%X&/[P/H,>9UE&ES^]-F\ZZIODIK8^D=
M&^*/A?69D@6ZDM)G.%2[0)DYP!N!*\_6J7C;X9:=K]I)>:3!#::H/G!C&U)^
M^& X!/\ >_.OGNO9?@[XONKF1_#E]*9$BB\RT=CRH!YCSW&#D>F".F %.FX>
M] =.LJON5$>/7%O+:7,MM/&T<T3F.1&ZJP."#^-1UZE\:]%BM-:LM6A3!O49
M)L#C>F,$^Y! _P" UY;6\)<T;G+4AR2<0HHHJR HHHH *['X5_\ )2-)_P"V
MW_HEZXZNQ^%?_)2-)_[;?^B7J)_"RZ7QQ]4?0&N>(=+\.6D=UJUU]GADD\M6
M\MGRV"<84$] :P?^%J>"_P#H,_\ DK-_\16'\;_^13L/^OY?_1;UX17-3HQE
M&[.VMB)4Y\J/I:/XB>"KXE?[7MST'[Z%T'_CRBEO?!O@_P 6V7VB*UM'60$+
M=V#*I!'&<KP2/<&OFBNB\%^*;GPIK\-W'(WV21@EU%GAT]<>HSD'K^9JW0MK
M%F<<5S.TTK$WC7P5>>#M16.1_/LILF"X QG'56'9A^OYXY>OIWX@Z1'K?@?4
MHB@>2&(W,) R0R#=Q[D97_@5?,5:4I\\=3+$4E3EIL?4/@S_ ))]I'_7BO\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M%% !1110 4444 %?1GPC_P"2>V?_ %UE_P#0S7SG7T9\(_\ DGMG_P!=9?\
MT,UAB/@.K"?Q/D>$>)_^1LUG_K^G_P#1AK*K5\3_ /(V:S_U_3_^C#656L=C
MFENPHHHJA!1110 4444 %%%% !1110 4444 %=C\*_\ DI&D_P#;;_T2]<=7
M8_"O_DI&D_\ ;;_T2]1/X672^./JCO/CG_R"=(_Z[O\ ^@BO$J]M^.?_ ""=
M(_Z[O_Z"*\2J*'P(TQ7\5A1116Q@%%%% !7U)H'_ "3S2_\ L%1?^BA7RW7U
M)H'_ "3S2_\ L%1?^BA7-B-D=>#W9\MT445TG(%%%% !1110 4444 %%%% !
M1110!]0^#/\ DGVD?]>*_P#H-?+U?4/@S_DGVD?]>*_^@U\O5ST-Y'7BOAA_
M78****Z#D"BBB@ KUOX%_P#(0UG_ *Y1?S:O)*];^!?_ "$-9_ZY1?S:LJWP
M,VP_\5&=\;?^1SL_^P>G_HR2M#X0^+])TBPN](U*YCM'DG\^.:4A4;*JI4L>
MGW<\^IK/^-O_ ".=G_V#T_\ 1DE>:THQ4J:3*G4=.LY(]D^+?C+2-0T2'1]-
MO(KR9YEED>%@Z(JYXW XR3CUX!Z<5XY24M7""@K(RJ5'4ES,0THZ4AI1TJR!
M:44E**0"FB@T4  I12"E% "T444#"MGPG_R.&A_]A"#_ -&+6-6SX3_Y'#0_
M^PA!_P"C%I2V''XD>T_%[_D17_Z^8_ZU\_\ >OH#XO?\B*__ %\Q_P!:^?\
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M  D8M+24M:G.+1112&***!10 M+24M "BB@44 +74^ ?^1C/_7!OYBN6KJ?
M/_(QG_K@W\Q4S^%ET_C1J?$G_F&?]M?_ &2L+P9_R-EC_P!M/_1;5N_$G_F&
M?]M?_9*PO!G_ "-EC_VT_P#1;5,?X9I+^+]QU'Q$_P"05:?]=_\ V4UYU7HO
MQ$_Y!5I_UW_]E->=44_A)K?&%+24M:&8M+24M !WHH[T4 +2TE+0 4HI*44
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M'G7QV_Y@'_;Q_P"TJ\=KV+X[?\P#_MX_]I5X[731^!'%B?XK"BBBM3 ****
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MUSZ8K*ES3]V^AO7Y*?OVU/8-0^(W@Q]'O@MY;WBPQE?LC0G$I/ 50P 8?3(
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MUNCQ_P""=,=+*+5;2)5 55MX6,:CH!E%V@?CQ7BWCOQO=^+M3*AC'ID#G[/
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M#I..L&"Q$9Z5$9&MZ#J'AZ_-GJ,'EOU1@<JZ^JGN/U]<5G&OH?Q+H=GXR\-
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MJ])4;[LIXEK2*T/?KO0/"OBZV>2%;25SP;BT90ZG&!DCK@$<'VK@!X(F\/\
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M^1W6S.Q^%_\ R-I_Z]G_ )BNA^)6G76JZIHEG9Q&2:02@ =ON<GT%<]\+_\
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MM(\*Z5H%D+O53!). "\DQ'EQGT /'X]?3%6KOQ;X>;3[D"XBN!&N/(,9^?L
M 1@BN!\5:[)K6JR;9";2)BL*CIC^]^-85-4[ZR)=51TBM![OYDKOM5=Q)PHP
M!]!Z5U?AOP5-JJ)>7S-!:'E5 ^>0?T'O_P#KJKX.T!=9U,R7"YM+?YI!S\Y[
M+_4UW'BKQ*F@VJPPA6O)5_=KV0=-Q'\OI[4YR=^6(J<%;FEL6A:Z#X?@5FCM
M+4=F?&YOQ/)J,>+] DD\K^T$R3CYHV"_F1BO);FZGO;AI[F9Y96.2S')J*E[
M+NQ^W:V1[#<Z)H6O6YE$4$F_I/;D!L].HZX]\]*\_P#$7A6YT-O.0F>S8X$H
M'*^@;_&LO3=4O-)N1/9S-&V?F7/RN/1AW%>JZ/JEIXFT<EXU;(V3PL. ?\.X
M/]:3O#T*7+5TV9X_74^ ?^1C/_7!OYBLG7=)?1=6EM"2R?>B8]60]/\ #\*U
MO /_ ",9_P"N#?S%7)WB905II,U/B3_S#/\ MK_[)6%X,_Y&RQ_[:?\ HMJW
M?B3_ ,PS_MK_ .R5A>#/^1LL?^VG_HMJ4?X9<OXOW'4?$3_D%6G_ %W_ /93
M7G5>B_$3_D%6G_7?_P!E->?V]O)=7,=O"I:21@JCW-%/X15OC+FC:-=:W>B"
MW&%7F20_=0>_OZ"O1K'POHNC0>=-''(R<M/<D$#\^!4UO#9^%/#Q+8VPKND8
M#!D?_P"N>!^%>::OK5[K-R9;F0[ ?DB!^5![#U]^M*[F]-B[1IK75GI3^*=!
MML)]NB ](T9A_P".BI([G0M=4(&M+HD;@C@%A[X/(KR&G*2I#*2"#D$=J/9+
MN+V[ZH[C7? RK&UQI&[(Y:W9LY'^R>N?8_G7#D%6*L""#@@]J[OPAXIDN)4T
MR_<NYXAE;J?]D_XU!X[T589%U6!,"1MLX'0-V;\>A]\>M$9-/ED*<5*/-$XN
MI(89+B9(849Y'.%51DDU'7HG@G1%MK0:G,,S3+B,'^%/7\?\]:N4N57(A#F=
MAFC>!H(46;5#YLO7R5.$7ZGJ?Y?6MR2^T315$1EM;8J/N(!N'X#FN7\5>*YC
M</I^GR&-$)6653RQ[@'L/\_7C!6:BY:R-7.,-(H]63Q%H%_NC:\MV!&")D*@
MC_@0 JAJ_@VROHVFT_;;S8R O^K;\.WX5YQ6QH?B"ZT6<;6,EL3\\)/!]QZ&
MFX-?"Q>U4M)(Z7P);S6EQJL$\;1RH8PRMV^_6-XU_P"1CD_ZYI_*O1+62WNH
MUO;?:PF1?G P649QGZ9->=^-?^1CD_ZYI_*I@[SN547+3L<\*6D%+6QSBT44
M4 **44@I12&%%%%,!:6DI:0"BB@44 %+24M "BEI!2T##O0*.] H 6EI*6@!
M12BD%**!A2TE+2 *6DI:8 *44@I12 4T4&B@!12BD%** "BBB@!:6DI:!@*6
MD%+0 4M)2T@%I124HH *6DI: %I>U)2]J "E%)2B@ KLO"?_ ""Y?^NY_P#0
M5KC:[+PG_P @N7_KN?\ T%:F>QI3^(\Z^.W_ # /^WC_ -I5X[7L7QV_Y@'_
M &\?^TJ\=KIH_ CBQ/\ %84445J8!1110 4444 %=3\-_P#DH6C_ /75O_0&
MKEJZGX;_ /)0M'_ZZM_Z U3/X673^->I[)\5K^\T[P4T]C=SVLWVB,>9!(4;
M!SQD<UX5_P );XE_Z&'5O_ V3_XJO;?C%_R(;_\ 7S'_ %KYZK&@DX&^*DU4
MT9L?\);XE_Z&'5O_  -D_P#BJ/\ A+?$O_0PZM_X&R?_ !58]%;<J['-S2[E
MZ^UG5-41$U#4KR[5#E!<3M(%/MDG%>U?!&13X1OH_P");]F/T,:?X&O!Z]3^
M"6LQVNM7VDRO@WD:R0@G@LF<@>Y4D_\  :SK1]QV-L/*U57,+XLP/#\1+]W^
M[,D3I]/+5?YJ:XFO9OC7X=>6*T\0PJ2(E%O<8[+DE6_,D?B*\9JJ3O!$UXN-
M1A4]G8W>H7 M[*UGN9B"1'#&78@=>!S4%6+&^N=-OH;VSF:&YA8/'(O4'_/;
MO5LR5KZEJ[\/:W86S7-YH^H6T"XW2S6SHHR<#)(QUK-KZ;\+>)-.\>^&Y?-B
MC+E?)O;1CG;D?^@GG!^O<5X=XZ\&W'A'660!GT^<EK:;!QC^X?\ :'Z]:RA4
MN^66C-ZM'EBIQ=T<K7U'X$A,'@314((S:(_/^T-W]:^;_#^B7/B+7+32[4'?
M.X#.!GRT_B8\C@#)]^E?1WBO5(/"G@F[GA41B" 06R*!PQ&U !QP.#] :BOK
M:*-<(K<TWL?-6K7$=WK-]<PDF*:XDD0D8X+$BJ=%%=!QO4*][^"7_(F7G_80
M?_T7'7@E>]_!+_D3+S_L(/\ ^BXZQK_ =&$_B'EOQ(_Y*%K'_75?_0%KEJZG
MXD?\E"UC_KJO_H"URU:0^%&53XWZA7T_\049_ .LA1D_9R?P!!-?,%?4.HXU
M[X<W#0G<;S2R\?7JT>1V]<=JRK[Q9T876,D?+U%%%=!R!73_  [B,WQ T90>
MD^[IGHI/]*YBNZ^$5B;SQ_;2[L"TADG(QG/&S\.7!_"HF[19=)7FEYGH'QN8
M?\(=9+W.H(?_ "')7@M>T_'.]VV.CV  /F2R3-STV@ <>^\_E7BU107N&N*?
M[QA117I7PX^'#Z[)'J^KQLFF*<Q1'@W!'_LO\ZTE)15V8P@YNR+GPO\ AV]Y
M-!X@UB'%HOSVMNZ_ZX]G8'^$=1Z]>G7H_BEX]71[-]$TNX(U.88FDC/-NA]^
MS$?B <\<5I>/_']MX2L_L5EY<FJR)^[C_AA7LS#^0_I7SQ//+=7$MQ.Y>65R
M[N>K,3DG\ZPA%U'SRV.JI.-&/LX;]2.BBBNDXPHHHH **** "NQ^%?\ R4C2
M?^VW_HEZXZNQ^%?_ "4C2?\ MM_Z)>HG\++I?''U1['\1?%=]X1T2VO=/BMI
M));D1,+A688VL>,$<\"O-?\ A=OB7_GQTG_OU)_\<KK?C?\ \BG8?]?R_P#H
MMZ\(K&C"+C=HZ<15G&I9,]%?XT^)VZ0Z:G/\,+?U:N:UCQQXDUU62^U6<PL"
M##$1&A![$+C</KFN?HK90BMD<TJLY:-A1115D'U)X&_Y$71/^O2/^5?-WB/4
M&U7Q+J5\SA_.N'96'3;GY<>V,5]'^"6V> M&;&=MDAQ^%?+M<U!>])G9B7[D
M$%%%%=)QG?\ P<E,?CQ5 _UEK(IY^A_I71?'90'T%NY%P/\ T7_C7,_"#_D?
M[?\ ZX2_^@UV'QS53IFCN5&X32 ''(!49_D/RKFE_&1UQ_W9_P!=C@_AC8#4
M/B!IJM$)(H2\SY (7:I(//\ M;:](^->K/:>&K33(W*F^F)<8SN2/!(]OF*'
M\/K7!_"&Y6#Q_;HQ \^"6,9[G&[_ -EKK_CI:.^GZ->#/EQ2RQ'CC+A2.?\
M@!HGK55QT],/)H\5HHHKI.,**** /IOX=:I)JW@33)Y<^9'&8&).<["5!_$
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ML'FL,]7<^GL%'YFK_P "7 DUY/XB("/P\S_&L#XR0&+QWO)R)K6-QQTY9?\
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M\%W09B0M^X4$]!Y<9X_$FO*/B#"L'C[644  W!?@8Y8!C^IKU;X)?\B9>?\
M80?_ -%QUY;\2/\ DH6L?]=5_P#0%KFI_P 61UU?X$3N?@3_ ,Q__MW_ /:M
M<_\ &;_D>E_Z](_YM70? G_F/_\ ;O\ ^U:Y_P",W_(]+_UZ1_S:A?QF$O\
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MB,_[1/\ *I_^%J>-/^@S_P"2L/\ \17.ZQK.H:]J#7^IW'GW+*%+[%7@=.%
M%.G3E&3;%6K0G!1BMCH$^%WC*2-9$T?*L 0?M,/(/_ Z=_PJOQI_T!O_ ":A
M_P#BZZV#XY>3;QQ?\([G8@7/VWK@?]<ZD_X7M_U+?_D]_P#:Z7-6[?U]X^3#
M_P S_KY''?\ "J_&G_0&_P#)J'_XNN7O["YTN_FL;R+RKF!MDB;@VT_49%>L
M_P#"]O\ J6__ ">_^UUY=K^J_P!N:]>ZIY/D?:93)Y>[=MSVS@9_*K@YM^\C
M.K&DE[CN?2'@N01> -'D/1+)&/X+7S/J-]/JFHW-_<MNGN)&D<C.,DYXSVKZ
M3\*P&Y^&FG6X!)ETX(,''5<5\R,K([(ZE64X((P0:SH;R-<2WRP$HHHKI.0*
M],^"NJS6_B>YTS=_H]U 7V^CH1@_D6_3TKS.NZ^$5F]U\0;:93@6L,LS<=05
MV?S<5G4^!FE%M5%8Z3XYV(%SH^H*@RR20.W?@AE'_CS?Y-,^!?\ R$-9_P"N
M47\VJW\=+@"VT6VQDL\LF<],!1_7]*J? O\ Y"&L_P#7*+^;5C_RY.E_[S_7
M8SOC;_R.=G_V#T_]&24?!+_D<[S_ +![_P#HR.CXV_\ (YV?_8/3_P!&24?!
M+_D<[S_L'O\ ^C(ZK_ER1_S$?,T?CG_R$-&_ZY2_S6N.^&__ "4+1_\ KJW_
M * U=C\<_P#D(:-_URE_FM<=\-_^2A:/_P!=6_\ 0&IP_A"J?[Q\T>R?%?4&
ML/ -VJ.$>Y=( >Y!.2!]54U\Y#I7O'QN;'@^R7'6_4Y^D<G^->#CI1AU[@\6
M_P!X+2BDI16QRGT/\(I3)X!MU/\ RSGE4<_[6?ZUXAXJ4)XOUM1T%_./_(C5
M[7\'_P#D1$_Z^9/Z5X]XZ54\=:T%4*/M3G &.3R?UKGI?Q)'96_@Q/5O@OIZ
MV_A6ZOBH$EU<D;O5$  _4O\ G7F_Q)U9M6\<WYSF.U;[*G'0(2#_ ./;J]3^
M#]RD_@1(E/S07$B./<X;^3"O&_&5I)8^--9@DZ_:Y''^ZQW+^A%$-:DKA5TH
MQ2,.BBBN@Y KI? .J2:5XUTN:,MMEF6WD4,0&5SMY]<9!QZ@5S5;7A*WDN?%
M^CQ1+N?[9$V/8,"3^ !-3+9E0;4E8]H^+W_(BO\ ]?,?]:\%M;=[N\AMHL>9
M-(L:Y.!DG KWKXO?\B*__7S'_6O#-'F2WUNPFD.$CN(W8D] &!-94/@-\5_$
M/J&XT]CH;Z=8S"S/V?R(9$3(B^7 (7(Z>E>8?\*/_P"IB_\ )+_[97>>.+[4
M=-\'W][I4IBNX%5U8(K87<-W# C[N:\4_P"%G^,?^@Q_Y+0__$5E24VKQ9T5
MY4DTIH[#_A1__4Q?^27_ -LH_P"%'_\ 4Q?^27_VRN0_X6?XQ_Z#'_DM#_\
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MI_Y+Q?\ Q-8VJ:Q?ZW=BZU&?SI@@0-L5?E!)QA0!W-$(24KL*E2$H<L4=/\
M"_\ Y&T_]>S_ ,Q6]\6+Z5+;3[!#B.5GE?KR5P!^')_2L'X7_P#(VG_KV?\
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MB_<=1\1/^05:?]=__937/^!;=9_$BNP!\F)I!GUX7_V:N@^(G_(*M/\ KO\
M^RFL7X?,!X@F![VS ?\ ?2U,?@'+^*=GXAT237;:*W6]^SQJVYAY>[>>W<=.
M:YW_ (5Q_P!17_R7_P#LJM>--9U/2+BT^Q7/E1RJV1Y:MD@CU!]:Y?\ X3+7
M_P#G_P#_ "#'_P#$T14[:,J<J?-[R-[_ (5S_P!17_R7_P#LJ/\ A7/_ %%?
M_)?_ .RK"_X3+7_^?_\ \@Q__$TO_"8Z]_S_ /\ Y!C_ /B:=I]R.:EV-^+X
M?/!,DL>K[71@RG[-T(Y'\5=)X@MA=>'KZ)EWD0LX _O*,C]17G?_  F.O?\
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M*RRZB08U88Q$N<'IW))^FT]ZA\-_!K3].NENM9NAJ#(04@5-L8(_O<DL.G'
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M%2,1,W)4#L.A ]#Z8K.G64W:QM5P[IQYKG(T445L<X5V/PK_ .2D:3_VV_\
M1+UQU=C\*_\ DI&D_P#;;_T2]1/X672^./JCT;XW_P#(IV'_ %_+_P"BWKPB
MO=_C?_R*=A_U_+_Z+>O"*BA\!KBOX@4445L<X4444 ?4/@S_ ))]I'_7BO\
MZ#7R]7U#X,_Y)]I'_7BO_H-?+U<]#>1UXKX8?UV"BBBN@Y#N_A!_R/\ ;_\
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MCU(^<I)'ED>21V>1R69F.2Q/4D^M123E)S9IB&H05)=#6\)?\CGH7_80M_\
MT8M>V_&+_D0W_P"OF/\ K7B7A+_D<]"_["%O_P"C%KVWXQ?\B&__ %\Q_P!:
M*G\2(4?X,SYZHHHKH.0*^I?%G_(@ZQ_V#Y?_ $ U\M5]2^+/^1!UC_L'R_\
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M;:-#H,3YN+MA+,H_AB4\9^K 8_W3[5X;5[6-7O==U2?4;^4R7$S9/HH[*!V
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MKS-RY&0BCDL?H*^BM4OM-^'O@L&*-5AM4\JWA)P99#D@?4G))^IK%^%?@_\
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M$X1ML\Z&"!5.""1@D'M@9/Y5X=6KXA\0WGB+43=71VHN1%"#\L:^@]3ZGO\
MD!E55.'*B:M3GEIL>\:1>6_BOPFIE8/Y\)AN IQM?&&'MZCV(KQC6=(N-#U6
M:PN0=R'*OC =>S#_ #ZU?\*>*9_#5^6VF6SE($\7?_>7W'Z_J/6;FRT3QEI2
M.WEW$3 ^7-&</&3Z'J#['TY%9_PWY&NE:/FCPBBO1+WX57(9S8ZE$XS\BSH5
MP/<C//X?E3+/X57K,/MNHV\:YZ0J7)'XXQ6GM(]S'V,^QQ&G:==:K?1V=G$9
M)I#@ =O<^@KW"-;+PCX8&X_N+2+)( !D;_$D_K46FZ-HG@^PDF5EA7 \VYG?
MYF]L_P!!7FWC'Q>_B&<6]KOCT^(Y"MP9&_O$?R'^1D[U'9;&Z2HQN]SFKFXD
MN[J:YE.9)7:1SZDG)J*BBMSD%HHHH ]A^'>L)?>'TLG<&XM,J02,E,Y4_0=/
MPKBO'/AQ]&U9KJ)/]"NF+(1G"-U*G]2/;Z5AZ/JUSHFIQ7UL?G3AE).'7N#[
M5[%I.O:3XLT^2(!267;-:R]1_B..H_2L6G"7,MCJBU5ARO='A]'>O4-3^&%K
M-*TFFWC6P//DR+O7/LV<@?7-9"?"_53, ][9"+/W@6+8^FW^M6JD69.C-=#B
M*Z30?!M_K]C/=1,L,:C$1D'$K=P#V ]?_KUV.D_#:PLY%FOYVO'4Y$878GXC
MDG\_PK0\2^+K+P]:M;6QCEO@H5(%Z1\<%L= /3J>/K4NI?2)I&C97F>17EE<
M:?=R6MW$8IXSAD/;C/\ (UVGPTU9;>_N--E? N 'BS_?'4?4C^5<3<W4][<R
M7-S(TDTC;G=NI--AE>"9)8F*R(P96'4$<@U<ES*S,HRY971Z%\1?#SF4:U;(
M64@)<@#D8Z-],<'Z"O/*]>\+>+K77K86EZ8X[[&UHV^[,,=0/YBJNL?#FQO9
M3-I\QLW8Y:/;N3\!U'\O85E&?+[LC:=/G]Z!Y917;?\ "LM4\X#[99^5D9;+
M;L=^,?UK?T?X=:?92":_E-ZX.53;MC'U&<G\\>U6ZD40J,V]BE\._#SPAM9N
MHBK.NVV5@/NGJ_KST'L3ZUG?$;5TN]3AT^%R4M03)@\%SVQ[ =?<UTGBKQE;
M:1#)963B6^92 4P5A[9/OZ#\_?RAW>61I)&9W8EF9CDDGJ2:F"<GS,JI)1CR
M1+^@?\C'I?\ U]Q?^ABO2OB'_P BLW_79/ZUYKH'_(QZ7_U]Q?\ H8KTKXA_
M\BLW_79/ZT3^-#I_PY'DM*.M)2CK6IS"UZ?\-?\ D!77_7R?_05KS"O3_AK_
M ,@*Z_Z^3_Z"M9U?A-Z'QG'>-/\ D;K_ /WD_P#0%K#K<\:?\C=?_P"\G_H"
MUAU<?A1G/XF>H_#?_D7;C_K[;_T!*XGQ?_R-FH?[X_\ 017;?#?_ )%VX_Z^
MV_\ 0$KB?%__ "-FH?[X_P#016</C9M/^$C%KVOQ+_R+6H_]<&_E7BE>U^)?
M^1:U'_K@W\J*NZ"CM(\6HHHK0P.\^'.J(CW.F2,JF0^;$#U8XPP_( _@:B\?
M:$\-W_:\()BEPLP ^ZW0'Z'C\?K7&VUQ+:W$=Q Y26-@R,.Q%>K>'O$MGXBL
MS;W*QK=;=LL##*R#U /4'T[?K64DXOF1T0:G'D9Y-2UZ/J?P]M+B8RV%R;4$
MY:-EWK^'.1W]?PK)7X<ZF9</=V@CS]X%B<?3']:I5(LATIKH<>*])\"Z$]C;
M/J%U&4FF&(U8<JGK[9_I4^C^!;#3G6:Z<W<ZG(W#:BGZ=_Q_*HO%'C"&QBDL
MM/D$EVPVM(ARL7KS_>_E^E1*7-I$TA#D]Z1SOCG54O\ 6A;Q-NBM 4SV+G[W
M\@/P-+X!_P"1C/\ UP;^8KERQ9BS$DDY)/>NH\ _\C&?^N#?S%7)6C8SC+FJ
M)FI\2?\ F&?]M?\ V2L+P9_R-EC_ -M/_1;5N_$G_F&?]M?_ &2L+P9_R-EC
M_P!M/_1;4H_PRI?Q?N.H^(G_ ""K3_KO_P"RFN(T:_\ [,UBUO/X8W^;C/RG
MAOT)KM_B)_R"K3_KO_[*:\ZHIZQ%5=IW/6?$NEC7M"Q;,'D7$T!4C#\=,^A!
M_E7E+HT;LCJ5=3AE88(/H:['PCXKCLXQIVHR$1 XAE;HG^R?;W[?2NDUKPKI
M^MDSY,-RP_UT?.[CC(Z'^?O4I\CLRY1]HN:.YY32UUTOP]U!7Q#=VKIZON4_
MD ?YU>LOAZBR!KV]+H.J1+C/XG_"KYXF:I3['+Z#HLNMZB(%RL2_-+)C[H_Q
M/:MGQ;X:L=(@6ZM9FC$C[1 WS=NQZ_GGK78SSZ7X8TO&%AB4?)&O+.?;N3[U
MYCK.L7&M7[7,_P JCY8XP>$7T]_K4Q;D[]"Y1C"-GN4*]8\.ZA'K6@1^:%=U
M4PSH1P2!CD>XP?QQ7D]:NA:U-HE_YZ#?$XVRQY^\/\1VJIQNB*<^5ZB:[HTN
MBZB\#!C"QS#(?XE_Q'0UFBO7$DTKQ-IW1+B'/*GAD/\ ,&N9O/A\P9FL;T%>
M-J3KS^+#_"IC46S+E2>\=CB:DAADN)DAA1GD<X55&2376VWP_NV<?:KV%%SS
MY0+''XXKH['1](\-0-<,RJW0SSL,_0>GX?K3=1=!1I2>^A8\/Z6-(TF*W('F
MGYY2/[QZ_ET_"N'\:_\ (QR?]<T_E78:#KW]MWE_Y:;;>'8(L]3G=DG\A7'^
M-?\ D8Y/^N:?RJ(7YM32I;DT.>%+2"EK8YA:*** %%**04HI#"BBBF M+24M
M(!110** "EI*6@!12T@I:!AWH%'>@4 +2TE+0 HI12"E% PI:2EI %+24M,
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M:A?S>==3$&23:%S@ #@ #H!52BG97N)R;5KZ!1113$=#HGCCQ'X>41V&IRB
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M6)124(K9#E5G+1L****L@*569'5T8JRG((."#244 =GI7Q2\5:5$(OMJ7<8
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MXOBEKR+AH;&0^K1-G]&%<30*3BGNBHSE'9G9W7Q,\0W$96,VML3_ !119/\
MX\37*W=[=7]P9[NXDGE/\<C%C]/I4 HH44M@E.4MV+2TE+3)"K5AJ-[IEP)K
M*ZE@D!!S&V,X[$=Q[&JM*.M(>QV5O\2]?@B5)/LEPPSEY8B"?^^2!^E.E^)V
MO2)A8[*(_P!Y(FS^K&N,HI<D>Q7M9]R]J6LZCK$HDO[N2<CH#PH^@' JD.E)
M2CI36A+=]Q:***!"T444 +3XI9(9!)$[(Z]&4X(_&F4"@#I[+Q]X@LD"&Z6X
M4  "= Q'XC!/XFKY^)VMD8^S6 ]Q&_\ \57%4=ZGDCV-%4FNITE_XWU[4 R&
M\,$9_AMQL_7[WZUSU)2TTDMB7)O<****8A170Z?XUUW3E"+>&>,=$N!O_7[W
MZUSPI:32>Y2DUL=G_P ++UK;C[/8?7RW_P#BJS=0\::[J*LCW?DQMU2!=GZ]
M?UKGZ*2A%="G4D^HHI:04M4026\\EK<Q7$+;98G#HV <,#D'FM34?$^L:K:F
MVO;SS82P;;Y2+R/< &L>EI60[M:!2CK24HZT$BUJ:9XBU71X&@L+KR8W;>P\
MM6R<8[@^E9=%#5]RDVMBQ>WMQJ-Y)=W4GF3R8W-M S@8Z#CM4--IU &IIOB+
M5=(MVM[&Z\J)G+E?+5N< 9Y!]!5*\O)[^[DNKF3S)I#EFP!G\!Q4%%%EN%W:
MPM;ESXMUR\MI+:>^WQ2*5=?*09!]PM8=+2:3!-K86BBB@!12JQ5@RD@@Y!':
MD%% '06'C/6[%0GVH3Q@$!9UW?K][]:T/^%B:OC'V>R^NQO_ (JN0I:7)'L6
MJDEU-N_\6:SJ,9CENRD9ZI$ H/XCG]:Q:!10DEL2VWN+5NPU&[TNY^T6<OE2
M[2N[:&X/U!JI2FFP3L7]2UK4-7\K[=<>;Y6=GR*N,XST ]!4%E>W&GW<=U:R
M>7,F=K8!QD8/!XZ$U7I:++8=W>YI:AKVI:M$D5[<^:B-N4;%7!_ "LZ@44DK
M";;W"M/3M>U/2UV6EVZQYSY;89?R/3\*S*6FU<:;6QU:^/\ 5P.8;-OJC?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "EI*6@!#2CI2&E
M'2@!:44E**0"FB@T4  I12"E% "T444#"E'2DI1TH$**.] H[TABTM)2TP%H
MHHI %+24M,!:6DI:0PI124HH 6EI*6@ I124HH&%+24M(!:*** %H%% H$6;
M&Y^Q:A;76S?Y,JR;<XW8(.,_A7<>)_B;_P )'H,^E_V1]G\TJ?,^T[\;6#=-
M@]/6O/Z*3BF[LTC.44TNHM+24M,@.U H[4"@!:4TE*: %I124HI %+24M,8M
M%%%(!:!10*!BTM)2T""E'2DI1TH&+1110(6BBB@8M HH%(!:***8"THZ4E*.
ME(!:!10*!BTM)2TP"@44"D,<**!10 M+24M !2CK24HZT@%HHHI@%*.E)2CI
M0 M%%%(!:*** %H%% H 6CO11WH&.I:2EH **** %%+2"EH 6BBB@8HI:04M
M !2TE+2 *4=:2E'6@0M%%% PIU-IU !1110 M+24M "T444ABBB@44 +2TE+
M0 HHH%% "TII*4T %+24M Q110**!!2TE+0,6EI*6@ [T4=Z* %I:2EH *44
ME** "EI*6D,6EI*6@ %+2"EH 6BBB@!12BD%**0PHHHI@+2TE+2 444"B@ I
M:2EH 44M(*6@8=Z!1WH% "TM)2T **44@I10,*6DI:0!2TE+3 !2BD%**0"F
MB@T4 **44@I10 4444 +2TE+0,!2T@I: "EI*6D M**2E% !2TE+0 M+VI*7
MM0 4HI*44 %=EX3_ .07+_UW/_H*UQM=EX3_ .07+_UW/_H*U,]C2G\1YU\=
MO^8!_P!O'_M*O':]B^.W_, _[>/_ &E7CM=-'X$<6)_BL****U, HHHH ***
M* "BBB@ HHHH **** "BNM\"^"/^$TN+V+^T/L?V9%;/D^9NW$_[0QTJOXW\
M)_\ "&ZU#IWVW[9YENL_F>5Y>,LRXQD_W>OO4\ZYN7J7[.7+SVT.:HHHJB H
MHHH **** "BBB@ HHHH **** "BBNM\"^"/^$TN+V+^T/L?V9%;/D^9NW$_[
M0QTJ6U%78XQ<G9')45T?C7PK_P (?K<>F_;?M>^!9O,\KR\9+#&,G^[Z]ZYR
MFFFKH)1<79A1113$%%%% !1110 4444 %%%% !1110 45Z)X(^%EQXEL5U/4
M+EK.Q<GRE109)1R,\\*,^N<X/'0UVDGP1\/D?N]0U-3ZL\;?^R"LI5H)V-HX
M>I)72/!Z*U_$^B?\(YXCO-)^T?:/LY4>;LV;LJ&Z9..OK616B=U=&+33LPHH
MHI@%%%% !1110 45ZEH7P<_MK0K+4_[>\G[5"LOE_8]VW(Z9WC/Y5Y;4QFI;
M%RIR@DY+<**]*\*_";_A)O#=IJ_]M_9OM&_]U]EW[=KLO7>,_=ST[UY[J%K]
MAU*ZL]^_R)GBWXQNVDC..W2A33=D$J<HI-K<KT4451 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%=;X%\
M$?\ ":7%[%_:'V/[,BMGR?,W;B?]H8Z5+:BKL<8N3LCDJ*Z/QKX5_P"$/UN/
M3?MOVO? LWF>5Y>,EAC&3_=]>]<Y3335T$HN+LPHHHIB"BKFD6']JZU8Z=YG
ME?:KB.#S-N[;N8+G'&<9Z5VWC'X7_P#"):"=4_MC[5B58_+^S;.N><[SZ>E2
MYI.S*C3E).2V1Y[1115$A1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 445Z;X,^$LNO:;%J>JW;VMM,-T,40!=U[,2> #]#4RDHJ[*A"4W:)YE17N
MTWP0T!DQ!J.I(WJ[1L/R"BO&M?TK^P]>O=+\[S_LTIC\S;MW8[XR<?G4PJ1G
ML54HSIJ\C.HHHK0S"BBB@ HHHH **** "BBB@ HHKMO WPZN_%^^[EG^R:;&
M^TR[=S2-W51].YZ9Z'G$RDHJ['&#F[1.)HKW@_!'P_Y8 U#4P^.27CQGZ;/Z
MUY9XY\*IX0\0#3H[MKF-X1,K,FTJ"S *>3D_+UX^@J8U8R=D:3H3@KLYJBBB
MM#(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBMCPKH/_"3>)+32/M/V;[1O_>[-^W:C-TR,_=QU[TF[*[!)MV1CT5W/CCX
M=?\ "&:;;7G]J_;/.F\K9]G\O;P3G.X^E<-2C)25T5.#@[2"BBBJ)"BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **[GP/\
M#K_A,]-N;S^U?L?DS>5L^S^9NX!SG</6N>\5:#_PC/B2[TC[3]I^S[/WNS9N
MW(K=,G'WL=>U2IIOEZENG)1YFM#'HHHJB HHHH **** "BBB@ HHHH ****
M"BBB@ HHKK? O@C_ (32XO8O[0^Q_9D5L^3YF[<3_M#'2I;45=CC%R=D<E17
M2^-_"?\ PANM0Z=]M^V>9;K/YGE>7C+,N,9/]WK[US5---702BXNS"BO5/!'
MPF@US1(]4UFZN(4N!NMXK8J&"_WF+ ]>P';OS@<QX^\%'P;JD,<=P9[.Y4M
MS_?&,9#8^HY]ZA5(N7*BW1FH\[6AR5%%%:&84444 %%%% !1110 4444 %%%
M% !1110 4444 %%%>F^ ?A=!XET?^UM4NIX;:4E8$MR S;202201C((QCM4R
MDHJ[*A"4W:)YE17:_$'P&?!UU!+;7#3Z?<Y$9DQYB,.H;& ?4$?EZ\51&2DK
MH4HN+LPHHHJA!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%>I:%\'/[:T*RU/^WO)^U0K+Y?V/=MR.F=XS^53*:CN7"G*
M;M%'EM%%7-)TRYUG5;;3;0*9[B0(FXX ]S[ <TR$KZ%.EKVZ3X'Z7_9A6+5+
MS^T G$C;?*+_ .[C('XFO&+RUEL;ZXLYP!+!(T3@'(W*<']14PJ1EL:5*4J?
MQ%<THZ4AI1TJS,6E%)2BD IHH-%  *44@I10 M%%% PI1TI*4=*!"BCO0*.]
M(8M+4]A:_;M1MK3?L\^5(MV,[=Q SCOUKO\ Q1\*_P#A&_#MUJW]L_:/L^S]
MU]EV;MSJO7><?>STI.23LRU3E)-KH>=4444R I:2EI@+2TE+2&%**2E% "TM
M)2T %**2E% PI:2EI +1110 M HJ2&*2>9(8E+22,%51W). *!#**]ALO@Y8
M?V:GV[4+K[<5RYA*^6I] "N2!]1GVKRW6M)FT/6;G3;AE:6!MI9.A! (/Y$5
M,:D9.R-9TI05Y%&EI*])OOA1]BT&YU/^VM_DVS7'E_9<9PI;&=_MUQ0Y*.Y,
M82EL>;]J!1VH%42+2FO1-=^%G]B:'=ZE_;/G?9TW^7]EV[N<==YQ^5>=FE&2
MEJBYPE!VD+2BDI100%+24M,8M%%%(!:!10*!BTM)2T""E'2DI1TH&+1110(6
MBBB@8M HH%(!:***8"THZ4E*.E(!:!7H.K_#'^RM(N[_ /MCS?L\9DV?9MN[
M';.\XKB-.L)]4U&"QM@#-.X1=QP![GV'6DI)ZHN5.479HK4M>K/\)[#[ 5CU
M"Y^V;/OMM\LM_NXR!^->77-O):7<UM+@20NT;X.1D'!I1FI;#G3E#<BH%% J
MB1PHH%% "TM)2T %*.M)2CK2 6BBBF 4HZ4E*.E "T444@%HHHH 6@44"@!:
M.]%'>@8ZEI*6@ HHKLO#W@/^W=(CO_[2\C>S+L\C=C!QUW"I<DM65&+D[(XX
M4M3WMM]CU"YM=^_R96CW8QG!(SC\*Z_PIX&BUK3OM]]/+'#(2(EA(#'!())(
M/<42DDKL<8.3LCBJ*Z7Q;X5_X1V>)X93+:39"%\;U(Z@XZ_7_)YJFFGJA.+B
M[,44M(*6F(*6DI:0!2CK24HZT"%HHHH&%.IM.H **** %I:2EH 6BBBD,444
M"B@!:6DI: %%% HH 6E-)2F@ I:2EH&***!10(*6DI:!BTM)2T '>BCO10 M
M+24M !2BDI10 4M)2TABTM)2T  I:04M "T444 **44@I12&%%%%,!:6DI:0
M"BB@44 %+24M "BEI!2T##O0*.] H 6EI*6@!12BD%**!A2TE+2 *6DI:8 *
M44@I12 4T4&B@!12BD%** "BBB@!:6DI:!@*6D%+0 4M)2T@%I124HH *6DI
M: %I>U)2]J "E%)2B@ KLO"?_(+E_P"NY_\ 05KC:[+PG_R"Y?\ KN?_ $%:
MF>QI3^(\Z^.W_, _[>/_ &E7CM>Q?';_ )@'_;Q_[2KQVNFC\".+$_Q6%%%%
M:F 4444 %%%% !1110 45T&D^!_$NN6ZW&GZ1/) W*R.5C5AZ@L1D?2G:KX$
M\3Z+:M=7VD3) GWG1ED"C&<G83@>YXJ>:-[7*Y)6O8YVBBKEAI&I:KYG]G:?
M=WGEXW_9X6DVYSC.T'&<'\J9*5]CT_X%_P#(0UG_ *Y1?S:L[XV_\CG9_P#8
M/3_T9)6]\&M'U32[[5FU#3;RT62.,(;B!HPV"V<9 S5#XP:'J^I^+;6:PTJ^
MNXEL40O!;O(H;S)#C('7D?G7.FO;7.QI_5TCR:BK]]H>KZ9")K_2KZTB9M@>
M>W>-2V"<9(Z\'\J+'0]7U.%IK#2KZ[B5MA>"W>10V <9 Z\C\ZZ+HY.5WL4*
M*EN;6XL[A[>Z@E@G0X>.5"K+]0>145 @HHIT<;RR)'&C/(Y"JJC)8GH /6F
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MMYKB*WE>"#;YTBH2L>XX&X]!D\#-("&BBBF 445<L-)U+5#(-/T^[NS'C?\
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M=UL*VG:5=3QMG$H3$9P<??.%_6AM+<$F]$9%%=A_PJWQGMW?V,<8S_Q\P_\
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M30M5T67R]2T^XM3G ,B$*WT/0_A24HO9C<)+=&?1115$A7T[\/;:*S\ :0J
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M?.GYG8?'#_D6]-_Z^_\ V1J\,KWWXQ:9?ZGH&GQZ?8W-W(MUN9;>)I"!M/)
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M%>V_$:TN;[P'J5M:6\MQ._E;8HD+LV)4)P!R> 37/5:YXG903]G,^;Z*U_\
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M0 "EI!2T +1110 HI12"E%(84444P%I:2EI ***!10 4M)2T **6D%+0,.]
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MZ6VH1/I<SYP\KAH<YX&_C''.2 /?U\>\:Z9=Z5XPU.&\1@\EP\R.<XD1F)#
MGKU_,$=JP*A4(.)<L544V>L_%[PYX?T\1:G9R1VVI7+Y>VCY$P[OC^'Z]#]<
MUA_#7QOIO@W^U/[1@NY?M7E;/LZ*V-N_.=S#^\*X::>:X*&:620H@12[$[5
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M-XE_Y)SJ?_8,?_T6:^7JYJ5.,D[G;B*TJ;7*7]<OHM3\0:E?PJZQ75U+,@<
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M,VZ21SR3_0>W:J]$:$?M:CEBI;0T1[UI7QIT*[<)J-K<V!('SX\U!Z\CYO\
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M%M]JUFDJ03^7M68 ,-L:J<@$CJ#WK HK>%*,7='+4KSJ*T@HHHK0R"BBNG\
M^&D\4^*H+*8_Z+$IGN!D@LBD# QZD@=NII-I*['&+D[(Z?X??"\ZY"FK:XLD
M=@PS! "5:<?WB>H7T[GKP,9]-U3Q+X6\"6BVCM#;$*62SM8P7/4_='3)SR<#
MWJC\1O%X\(:!'!8;$U"Y'EVRA>(E&,MCIP" !ZGH0#7SM//-=3O/<2R2RN<M
M)(Q9F/N3UKFC%U?>EL=DIQH>[!:GLUW\<[-' L]#GF7G)FG$9'X -5S3OC9H
MMQ(B7]A=V>[[SJ1*J_7&#CKT'X5X316GL(&7UJK?<^G=3T+PUX^TGSLP7*N,
M1WEN1YB'CH?7IP:\!\6^%+WPCJYLKK,D3#=!<!<+*.,X]"#P1_0BCPGXLU#P
MGJT=S;2LUL6 N+<G*R+WX_O>A_ID5L^/OB$WC'RK2"Q2WL8'\R-I!F9FP0<D
M< 8/0>G7T4(3A*W0JI4IU(7>DCAZ[OX??#V7Q9,;V]9H=)B;:S+]Z9O[J^@]
M3^ [XY?P[H\OB#Q!9:7$<-<2;2W]U0,L?P )KZ,U[5K#P#X-$D,0$=NBV]I!
M_??'R@G\"2>N >].K-KW8[LFA24KSELA;O4O#/@#2(H':&Q@ _=01@L\F.^.
MK'U)_$UQ-W\=+-),6>A3S1Y/S37 C/Y!6_G7D6K:M>ZWJ4VH:A.TUQ*<ECT
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MZX3=-*HYBC.1\I[,<'GL/0D&G4DW+DB*C",8^UF;?B+XD^'?#$OV-I'NKI,
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M:,GK!]"L3%-*I'J9M%%%=!RA7L7P)_YC_P#V[_\ M6O':]B^!/\ S'_^W?\
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M/FHJ?VC8!\$!PCE<@]LX;![=.U?+U.C)M6?06)@HR3CLPHHHK8YPKWOX)?\
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ME>4MD-N=0\,?#_2(X7>"QA"XCA0;I)<>W5C[GUY-<7=_'.P0_P"A:)<S#/\
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MQKY'KZD\#?\ (BZ)_P!>D?\ *IK4U%71>&JRF[,Y;_A=OAK_ )\=6_[]1_\
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M?<^G WACXA:,VTP7T."N2NV6$^V1E3_/W%>'>-_!-WX/U$#+3:=,3]GN,?\
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M4V2QG#"H:]%\?:6LVG)J2 "6W(5S_>0G _(X_,UYU5QES*YG./*["TM)2U1
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MO&;H[KX16B7/C^VD<D?9X9)5 [G&WG_OK/X5U_QSOI$L='T]<>5+)),_'.5
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MK\%_] ;_ ,FIO_BZ/^%5^"_^@-_Y-3?_ !=?-E%5[*7\QG]8A_(OZ^1])_\
M"J_!?_0&_P#)J;_XNC_A5?@O_H#?^34W_P 77S911[*7\P?6(?R+^OD?7%[9
M12Z+<6.W]R]NT.&.?E*D<YSGCUKY'HHJZ=/DOJ9UJWM;:6L?4GB2;^PO >H-
M:D0FVL3'"4& AV[5QCTXKY;KZDU:/_A)O 5R+8;C?Z?OA!'4LFY?UQ7RXRLC
MLCJ593@@C!!K/#[,UQFZ["4445TG(%>M? RZD&H:O:;CY311R8SP""1_7]*\
MEKU_X&6$GG:OJ)5A$%2!3V8\LWY?+^=95O@9MAOXJ,;XU?\ ([0?]>,?_H;U
MYS7HWQJ_Y':#_KQC_P#0WKSFG2^!"K_Q&%%%%:&1L>$O^1ST+_L(6_\ Z,6O
M:?C->-;>!U@4G_2KN.-L'L S_P U%>+>$O\ D<]"_P"PA;_^C%KV_P"+^F2:
MAX%>:($FRG2X90N25Y0_3&_)/M7/4_B1.NC?V,['SQ11170<@4444 >^_!:\
MDN/!MQ;R/N%M=LL8Q]U2JMC\RQ_&O*?B):QVGQ UF*(85I_,(R?O.H=OU8UZ
MY\'=,>Q\$_:9 0;VX:901C"C"C]5)_$5Y!X_O$OO'FL3QL&7[08P1T.P!?\
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M?+M<U#J=>*VC?<^D_A7_ ,DWTG_MM_Z.>O _%5P]UXMUB>1F8M>2X+') WD
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M,B"9)"!WVL#_ $I,%N?6=Y8VU_I\UC<Q[[::,QR)N(RI&",@YKEO^%5^"_\
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MU2?''_D.Z7_U[-_Z%2_ _3W?6M3U$J=D-N( >V78'\\)^OO2?''_ )#NE_\
M7LW_ *%7-_R^.S7ZL>5UZW\"_P#D(:S_ -<HOYM7DE>M_ O_ )"&L_\ 7*+^
M;5I6^!F.'_BHSOC;_P CG9_]@]/_ $9)7FM>E?&W_D<[/_L'I_Z,DKS6G2^!
M"K_Q&>Y_ _\ Y%O4O^OO_P!D6O/?BI_R4C5O^V/_ *)2O0O@?_R+>I?]??\
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M0UI$-9G*B%XUVLL:GDMC@CL ?7CI7B=7M7U>^UW4YM0U"8RW$IY.,  = !V
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MP+_Y"&L_]<HOYM7DE>M_ O\ Y"&L_P#7*+^;5O6^!G+A_P"*C.^-O_(YV?\
MV#T_]&25YK7I7QM_Y'.S_P"P>G_HR2O-:=+X$*O_ !&>Y_ __D6]2_Z^_P#V
M1:\]^*G_ "4C5O\ MC_Z)2O0O@?_ ,BWJ7_7W_[(M>>_%3_DI&K?]L?_ $2E
M90_BLVJ?[O'^NY:^%7BB+P]XE:WNVVVFH!8F;LK@_(3[<D?C7H_Q0\#/XEL8
M]2TZ/=J=JI!0?\MH^NW_ '@>1]2/2OGVO6/ 7Q633K6/2_$3R- GRPW8!8HN
M/NN!R1Z$9-54@T^>.XJ-2+C[.>QY5+%)!,\4L;1R(Q5T<8*D<$$=C3*^G;_P
MYX4\;P)>R0VM[S@75M)AN.Q93SCT/2L$_!?PO]H$OG:D$!!\KSEVG';[N<'Z
MTEB(]0>$G]EW1X'%%)/,D44;22.P5$09+$\  =S7T-\-? Y\*:;)>:@L?]IW
M2C?CGR4Z[,_7DXXR!UQFM:PT#PKX(MI+N*"UL5Z/=3OEN<#&YCD \<#BO,O'
MOQ5.K6\NDZ#N2QE0I/<NI#R@]54=EQUSR<]N\RE*K[L=BXTXT/>F]3"^)WBE
M/$OB8I:NKV-D##"RD$.<_,X/H2 !VPH/>L+PE_R.>A?]A"W_ /1BUCUL>$O^
M1ST+_L(6_P#Z,6M^51C9'+S.4^9GMOQB_P"1#?\ Z^8_ZU\]5]"_&+_D0W_Z
M^8_ZU\]5GA_@-L7_ ! HHHK<YCW?X(?\BG?_ /7\W_HM*\U^)W_)1=7_ -Z/
M_P!%I7I7P0_Y%.__ .OYO_1:5YK\3O\ DHNK_P"]'_Z+2N:'\5G75_@1.2HH
MHKI.0*]B^!/_ #'_ /MW_P#:M>.U[%\"?^8__P!N_P#[5K*M\#-\-_%1S_QF
M_P"1Z7_KTC_FU'P9_P"1Z;_KTD_FM'QF_P"1Z7_KTC_FU'P9_P"1Z;_KTD_F
MM3_RZ^17_,1\S=^.O^OT/_=G_FE>05Z_\=?]?H?^[/\ S2O(*JC\"(Q/\5A1
M116IB?3WP\_Y$#1O^N'_ +,:^:]3_P"0M>?]=W_]"-?2GP\_Y$#1O^N'_LQK
MYKU/_D+7G_7=_P#T(US4?BD=F)^"!5HHHKI.,*][^"7_ ")EY_V$'_\ 1<=>
M"5[W\$O^1,O/^P@__HN.L*_P'1A/XA;^)?@1O%-G'?Z?C^U+5"JH2 )TSG;D
M]""20?<@]<CY]G@FM9W@N(I(I4.&CD4JRGW!Z5ZPWQ&NO"?C[6K*[1[K2FNV
M/EJ?GA)ZE,\8/=>F>>.<]])9^#_B#9B;;:W^!]]&*2Q].N,,.W!J(SE35I;&
MLZ<*S;B[,^9:?%%)/,D44;22.P5$09+$\  =S7O;?!;PPT_F"?4E7(/EB9-O
MTY3/ZUT.G^'?"O@N![N*"TL1T:YN)/FYQQO<\<@<#O5/$1Z$+"3^T[(P?A?X
M&D\-6<FI:BFW4KI HC/_ "QCZX/^T3C/T'O7!?%OQ4NM:^FEVK[K/3R58@\/
M*?O'K@@8 'ON]:V_'7Q:6>&;2_#;N WR2W_W3CN(^X]-Q]\=C7D%%.#<N>05
MJD5'V<-BUIFHW&DZG;:A:/MGMY!(AYQD'H?8]".X-?32OI7C_P 'D EK.]BP
MP!&^)NN.X#*<?E7RW75>"O'-]X.O6V W%A,<SVQ; )_O+Z-_/OVQ56FY:K=$
M4*J@[2V9G^)?"^I>%=2-GJ$6%;)AF7[DJCN#^61U&:Q:^G=,\1^&/'.G?9UD
MMKD. 9+*Y4;U(P?NGK@D<C(SWK&O?@WX5NI T(OK,#^""?(/_?88_K4JO;2:
MU-)86^M-W1\]UWWP\^'UUXAU&"_U"W>/1XF#L7&//QR%7U4]SZ9 .:]1T_X9
M^$-$4W$MFMQL S)?2;U'N1POZ5D>+OBUINE0-9>'VCO;S!3S5'[F+CJ#_&>F
M,<>_:DZKGI!!&A&G[U5GI@    P!7R+J?_(6O/\ KN__ *$:^F? MS/>>"=+
MN;F5I9Y8B\CL<EB6.2:^9M3_ .0M>?\ 7=__ $(TL.K-HK%N\8LJU]2>!O\
MD1=$_P"O2/\ E7RW7U)X&_Y$71/^O2/^5/$?"B<'\3/ENBBBNDY#ZDU__DGF
MJ?\ 8*E_]%&OEROJ/7_^2>:I_P!@J7_T4:^7*YL/LSKQFZ/H3X5>)8=<\+II
M<Q!N]/01.C?QQ=%(]1@8/T]Q7FGQ#\"7'AC49+VV3?I-Q(3&RC_4DG.P^GL>
M]<KHNLWOA_5H-2T^0)<0GC<,JP/52.X(_P YKZ!\,_$/0?%-HEO<216MZZXD
MM+@\-_ND\,/;K[424J<N:.Q4)1K04).S1\X4HKZ*U+X3^%-1D:1+6:R=NIM9
M=H_ ,"!^ J&R^$'A2U!\Z*[O,G/[^<C'M\@6G]8B1]4J7/%?#?AC4O%.I"ST
M^+*K@S3-]R)3W)_/ ZG%>XZ[H?A;PWX!-MJ-FLUE9H1%YG,CRMGHPY#$GMP/
M8"M#5?$GAGP1I_D,]M;[03'96JC>Q.3P@Z9(/)P,]Z\*\9>,[[Q?J/F3?NK.
M(G[/;CH@/<GNQ_\ U5*YJK[(MJ%"+6\F<T*]Q^"7_(N:C_U]_P#L@KPX5[C\
M$O\ D7-1_P"OO_V05=?X#/"_Q$>>?$O_ )*'JW^]'_Z+6N3KK/B7_P E#U;_
M 'H__1:UR=:0^%&53XWZA5O3/^0I9_\ 7=/_ $(54JWIG_(4L_\ KNG_ *$*
M;(6Y]'?$#_D0]8_ZX?U%?-'>OI?X@?\ (AZQ_P!</ZBOFCO6&'^%G7C/C1HZ
M#_R,6F?]?<7_ *&*]]^)_P#R3K5?^V/_ *-2O M!_P"1BTS_ *^XO_0Q7OOQ
M/_Y)UJO_ &Q_]&I15^.(4/X<SYTJ[IND:AJ\DJ:?9RW+11F1Q&N<*/\ /3J>
MU4J]0^%GC/2=&MY=)U%([1I9/,6[)^5SC&UR>F,<'IUZ'DZS;2ND<]**E*TG
M8\OIR*SNJ(I9F.  ,DFOHO6/ 'AGQ+*;YX-DL@YGM)-N_P!^ZD^^*-"^'OAW
MPW.MY#$\UQ'G;/=.&*>X& H/OC-9?6(V.CZI*^^A/&DFD_#4)>(R26NDXE3.
M2"L7(^O&*^;J]2^)WCRUU.U_L/2)UF@9@US.G*M@Y"*>XR 21Z#WKRVJHQ:5
MWU)Q$TY)+H%**2E%:G.+3E9D<,K%64Y!!P0:;2T ?2?AS4;;Q;X2M+BZ2.?S
M%47",O'FH03Q_O $?A7,_%OQ#]@T:+1X),7%Z=TNUN5B'KSGYCQZ$!A7/_!_
M71;:E=:--(1'<CSH03P'4?-^:C_QVN1\8Z^?$?B:ZOE)-N#Y=N",8C7IV[\G
MGUKFC3M4\D=TZUZ7FS!IR,R.K*Q5E.00<$&FTM=!Q'T?X7U6#Q;X0@FN4CE,
MB&"ZB;!&\<-D>_!QZ,*P/BQK?]G>'(],@<+-?/M8#(/E+R<$=,G:/<$URWPC
MU[['K4NCS-^ZO1NB]I%&?U7/X@5SGCG7/[?\5W=RC[K>(^1!C!&Q>X(Z@G<W
MXUSQI_O/([95KTO-Z'.T"B@5T'"?2?@S_D3-'_Z]4_E7S;7TEX,_Y$S1_P#K
MU3^5?-M84=Y'7B/AC_786OI'7/\ D1-2_P"P9+_Z*-?-U?2.N?\ (B:E_P!@
MR7_T4:*VZ##;2/F_M0*.U K<Y3Z*\=_\B1JW_7'^HKYW-?1'CO\ Y$C5O^N/
M]17SN:PH?"=6+^)"THI*45L<IZC\&_\ 7ZQ_NP_S>LOXM?\ (WP_]>:?^A/6
MI\&_]?K'^[#_ #>LOXM?\C?#_P!>:?\ H3UBOXK.M_[NCA****V.46NF\"^(
M1X=\1QRS,19SCR9_8'HW7L<<^A-<S0*35U9E1DXNZ/??&GAB/Q5HJ&W9/M</
M[RVDR-K9ZJ3Z$?KBO"[RSN-/O);2[A:&>)MKHW4'_/>NT\&_$2?14BT[4PT]
M@/E20<O"/_9E'IU';H!7I3Q^&_&=BI86M_&,8(.'CS@XR,,O09'%8)RIZ/8Z
MI1C6]Z+LSYZI1TKVJX^%/AV:4O&]] O]R.4$?^/*3^M:%E\/_#.G-YOV$3%1
MUN7+@?@>/TJO;1(6&F>;^#? ]UKUU'=WD31:8K99FX,W^RO?!]?ZTGCOPG9^
M&;N!K.[W1W.XK;OR\8'?/=><<\_7FN_\1?$/2=$B:"R9+V\4;5CB/[M/]YAQ
MQZ#GC'%>-ZEJ5WJ]_+>WLIEGD.23T'L!V%.#G)W>PJBIPCRK5AIM]+IFIVU]
M"3YD$BR 9QG!Z?0]/QKW>]M;#QQX34(P\JY021.0&,+_ ('J#D'GU%?/U=1X
M/\97'A>=XVC\^QF8&2('!4]-R^^.W>G4@WJMQ4:BC[LMF8VK:1>:)J,EC?1;
M)4Z$<JX[,I[@_P">:HBOH**Y\.^,]/\ +#6]]$.3&W#QDY&<<,IZ\_E6+<?"
MSP]-*7C>]@7^Y'*"/_'E)_6H59?:+EAWO!W1XQ7<^!?!,NK7<>HZC 5TU/F0
M-_RW.>!C^[QSZ_G7H&G^!/#FER"X6R621.0]PY<#WP>/QQ5'Q+\0M-T>&2WT
M^2.\O@,*J',:'U8CKCT'Z4.HY:10XT5#WJC,+XIKHT(A5+:,:O*V]G3@[.F6
MQP<XP,^]>9CI4UY>7&H7DMW=RM+/*VYW;N?Z?3M4(Z5I"/*K&%2?/*Y]!^+?
M^11U7_KV?^5?/HKZ"\6_\BCJO_7L_P#*OGT5G0V-\5\2/H+6?^1*U#_L'2?^
MBS7S_7T!K/\ R)6H?]@Z3_T6:^?Z*.S#$[H]C^''B%-2T9=,GD'VNS7:H)Y>
M+^$CZ=/R]:Y7QUX-GTV]FU.QA9["4EY-O/DL3SQ_=YXKD-.U&ZTJ^CO+.4QS
M1G(([^Q]17L'AWX@:7K,:PWKI97AX*2-\C_1CQ^!_6B2<)<T1QE&I'EEN>+B
MBO<=1\!^'M4<S?93 [Y)>V?;G/?'(_2J=K\,O#UNY:07=R/[LLN /^^0#3]M
M$GZO,\KTC1+_ %R\%M80&1N-[GA4![L>U>[:+I%OH>E0V%N/EC'S,>K,>I-9
M&H^)/#OA*U:WA\D2KRMI:@9SQ]['"]<\_AFL[P+X@O?$6JZM<W3;458A%"I^
M6-<MT]_4]_R%9S<I*_0UIQC3E:]VSE_BA_R-,7_7HG_H35S.BZD^CZQ:W\8R
M87R1Z@\$?D373?%#_D:8O^O1/_0FKBQUK:&L485':;9[W=V]AXO\-[%DW6]R
M@:-UZHPZ?B#P1]17BFKZ-?:'>FUOH=C]58'*N/4'TK4\,>,+SPY)Y6//LF;+
MPDX(]U/8_P _UKU2UU?0/%5H;<26]RK#)MY@-X[9VGG\16>M-^1J^6LNS/"*
M4=*]CNOAKX?G.8TN;;VBES_Z$#4EG\._#UH4+P2W+*<YFD)S]0, _E5>VB3]
M7F>9>'_#5_XAN@ELA6!6Q+<,/E0?U/L/TZUTOC/P7I^C::NH65P8@NU#!(<^
M8Q[J?7J2/;M78ZIXHT+PS;?9U>(R(,):6P&1TX..%ZYY_#->3:_K]YXAU$W-
MR=J+D10@_+&OH/4^I[_D*47*3OL@E&$(VW9E4445J<XM.1VC=71BKJ<JRG!!
M]13:!0![IHFIVOBGP\'D56\Q#%<1'G#="/QZCZUY1XE\-77AV^*.K/:.W[F;
M'!'H?1J@T'7[SP_?BYM6RC<2Q,?ED'O[^A[?G7K6D^)-&\36GD[H][C$EI<
M9_(\,/I^E86=-W6QU)QJJSW/$J6O8+OX=Z!<L6CCGMB3D^3)Q_X\#4MCX#T"
MP(=K=[EER=UP^X?B!@'\JKVT2?J\[GG?A;PM=:_>([(T=@AS+,0<-_LKZG^7
MY ^T11)#$D42*D:*%55& H'0"N0UOQSI>CVOV72O*N9PFV,0X\J/TR1_(>G:
MK_@BZGOO#4=S<RM+-)+(SNW4G<:SGS25V;4E&+Y5JSR;6_\ D/ZC_P!?4O\
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M>S,O4=.N=*O7M+J/9(O?LP[$'N*K5["D^B^)K/8&ANH^I1N&0].G4=^:S)O
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M*N:ITH\L;"KU.>;84445H9!1110 5])_"O\ Y)OI/_;;_P!'/7S97TG\*_\
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M=7=S>S&:[N);B4C!>5R[?F:AHHH$%%%%, HHHH **** "BBB@ HHHH ****
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M0@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "NLE^)?B
M^:T>U;6"(7C,9"6\2G:1C@A<CCN.:Y.BI<4]QJ4H[,****H04444 %%%% !7
M2Z5X_P#$^B:;#IVG:GY-K#G9'Y$38R2QY92>I-<U12:3W&I..J8^61YIGED.
M7=BS''4GK3***!!1113 **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K=T/QCKWANVDM])O_
M +/%*^]U\F-\MC&?F4^E85%)I/<:;3NBWJFIWFLZC-J%_-YUU,09)-H7.  .
M  .@%5***!-WU84444P"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K?T3QIX
M@\.63V>DZA]G@>0RLGDQOEB "<LI/0"L"BDTGN-2:=T6;^_N=4OYKZ\E\VYG
M;?(^T+N/T&!5:BB@6X4444P"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M I:2EH 0THZ4AI1TH 6E%)2BD IHH-%  *44@I10 M%%% PI1TI*4=*!"BCO
M0*.](8M+24M,!:***0!2TE+3 6EI*6D,*44E** %I:2EH *44E**!A2TE+2
M6BBB@!:!10*!"T444QBTM)2T@#M0*.U H 6E-)2F@!:44E**0!2TE+3&+111
M2 6@44"@8M+24M @I1TI*4=*!BT444"%HHHH&+0**!2 6BBBF M*.E)2CI2
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M% "BE%(*44 %%%% "TM)2T# 4M(*6@ I:2EI +2BDI10 4M)2T +2]J2E[4
M%**2E% !79>$_P#D%R_]=S_Z"M<;79>$_P#D%R_]=S_Z"M3/8TI_$>=?';_F
M ?\ ;Q_[2KQVO8OCM_S /^WC_P!I5X[731^!'%B?XK"BBBM3 **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I:2EH 0THZ4A
MI1TH 6E%)2BD IHH-%  *44@I10 M%%% PI1TI*4=*!"BCO0*.](8M+24M,!
M:***0!2TE+3 6EI*6D,*44E** %I:2EH *44E**!A2TE+2 6BBB@!:!10*!"
MT444QBTM)2T@#M0*.U H 6E-)2F@!:44E**0!2TE+3&+1112 6@44"@8M+24
MM @I1TI*4=*!BT444"%HHHH&+0**!2 6BBBF M*.E)2CI2 6@44"@8M+24M,
M H%% I#'"B@44 +2TE+0 4HZTE*.M(!:***8!2CI24HZ4 +1112 6BBB@!:!
M10* %H[T4=Z!CJ6DI: "BBB@!12T@I: %HHHH&**6D%+0 4M)2T@"E'6DI1U
MH$+1110,*=3:=0 4444 +2TE+0 M%%%(8HHH%% "TM)2T ***!10 M*:2E-
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M?_"DO#7_ #_:M_W]C_\ C='_  I+PU_S_:M_W]C_ /C='MX!]4J'@E%>]_\
M"DO#7_/]JW_?V/\ ^-T?\*2\-?\ /]JW_?V/_P"-T>W@'U2H>"45[W_PI+PU
M_P _VK?]_8__ (W1_P *2\-?\_VK?]_8_P#XW1[> ?5*AX)17O?_  I+PU_S
M_:M_W]C_ /C='_"DO#7_ #_:M_W]C_\ C='MX!]4J'@E%>]_\*2\-?\ /]JW
M_?V/_P"-T?\ "DO#7_/]JW_?V/\ ^-T>W@'U2H>"45[W_P *2\-?\_VK?]_8
M_P#XW1_PI+PU_P _VK?]_8__ (W1[> ?5*AX)17O?_"DO#7_ #_:M_W]C_\
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M?_"DO#7_ #_:M_W]C_\ C='_  I+PU_S_:M_W]C_ /C='MX!]4J'@E%>]_\
M"DO#7_/]JW_?V/\ ^-T?\*2\-?\ /]JW_?V/_P"-T>W@'U2H>"45[W_PI+PU
M_P _VK?]_8__ (W1_P *2\-?\_VK?]_8_P#XW1[> ?5*AX)17O?_  I+PU_S
M_:M_W]C_ /C='_"DO#7_ #_:M_W]C_\ C='MX!]4J'@E%>]_\*2\-?\ /]JW
M_?V/_P"-T?\ "DO#7_/]JW_?V/\ ^-T>W@'U2H>"45[W_P *2\-?\_VK?]_8
M_P#XW1_PI+PU_P _VK?]_8__ (W1[> ?5*AX)17O?_"DO#7_ #_:M_W]C_\
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M?_"DO#7_ #_:M_W]C_\ C='_  I+PU_S_:M_W]C_ /C='MX!]4J'@E%>]_\
M"DO#7_/]JW_?V/\ ^-T?\*2\-?\ /]JW_?V/_P"-T>W@'U2H>"45[W_PI+PU
M_P _VK?]_8__ (W1_P *2\-?\_VK?]_8_P#XW1[> ?5*AX)17O?_  I+PU_S
M_:M_W]C_ /C='_"DO#7_ #_:M_W]C_\ C='MX!]4J'@E%>]_\*2\-?\ /]JW
M_?V/_P"-T?\ "DO#7_/]JW_?V/\ ^-T>W@'U2H>"45[W_P *2\-?\_VK?]_8
M_P#XW1_PI+PU_P _VK?]_8__ (W1[> ?5*AX)17O?_"DO#7_ #_:M_W]C_\
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M?_"DO#7_ #_:M_W]C_\ C='_  I+PU_S_:M_W]C_ /C='MX!]4J'@E%>]_\
M"DO#7_/]JW_?V/\ ^-T?\*2\-?\ /]JW_?V/_P"-T>W@'U2H>"45[W_PI+PU
M_P _VK?]_8__ (W1_P *2\-?\_VK?]_8_P#XW1[> ?5*AX)17O?_  I+PU_S
M_:M_W]C_ /C='_"DO#7_ #_:M_W]C_\ C='MX!]4J'@E%>]_\*2\-?\ /]JW
M_?V/_P"-T?\ "DO#7_/]JW_?V/\ ^-T>W@'U2H>"45[W_P *2\-?\_VK?]_8
M_P#XW1_PI+PU_P _VK?]_8__ (W1[> ?5*AX)17O?_"DO#7_ #_:M_W]C_\
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M?_"DO#7_ #_:M_W]C_\ C='_  I+PU_S_:M_W]C_ /C='MX!]4J'@E%>]_\
M"DO#7_/]JW_?V/\ ^-T?\*2\-?\ /]JW_?V/_P"-T>W@'U2H>"45[W_PI+PU
M_P _VK?]_8__ (W1_P *2\-?\_VK?]_8_P#XW1[> ?5*AX)17O?_  I+PU_S
M_:M_W]C_ /C='_"DO#7_ #_:M_W]C_\ C='MX!]4J'@E%>]_\*2\-?\ /]JW
M_?V/_P"-T?\ "DO#7_/]JW_?V/\ ^-T>W@'U2H>"45[W_P *2\-?\_VK?]_8
M_P#XW1_PI+PU_P _VK?]_8__ (W1[> ?5*AX)17O?_"DO#7_ #_:M_W]C_\
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M?_"DO#7_ #_:M_W]C_\ C='_  I+PU_S_:M_W]C_ /C='MX!]4J'@E%>]_\
M"DO#7_/]JW_?V/\ ^-T?\*2\-?\ /]JW_?V/_P"-T>W@'U2H>"45[W_PI+PU
M_P _VK?]_8__ (W1_P *2\-?\_VK?]_8_P#XW1[> ?5*AX)17O?_  I+PU_S
M_:M_W]C_ /C='_"DO#7_ #_:M_W]C_\ C='MX!]4J'@E%>]_\*2\-?\ /]JW
M_?V/_P"-T?\ "DO#7_/]JW_?V/\ ^-T>W@'U2H>"45[W_P *2\-?\_VK?]_8
M_P#XW1_PI+PU_P _VK?]_8__ (W1[> ?5*AX)17O?_"DO#7_ #_:M_W]C_\
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M?_"DO#7_ #_:M_W]C_\ C='_  I+PU_S_:M_W]C_ /C='MX!]4J'@E%>]_\
M"DO#7_/]JW_?V/\ ^-T?\*2\-?\ /]JW_?V/_P"-T>W@'U2H>"45[W_PI+PU
M_P _VK?]_8__ (W1_P *2\-?\_VK?]_8_P#XW1[> ?5*AX)17O?_  I+PU_S
M_:M_W]C_ /C='_"DO#7_ #_:M_W]C_\ C='MX!]4J'@E%>]_\*2\-?\ /]JW
M_?V/_P"-T?\ "DO#7_/]JW_?V/\ ^-T>W@'U2H>"45[W_P *2\-?\_VK?]_8
M_P#XW1_PI+PU_P _VK?]_8__ (W1[> ?5*AX)17O?_"DO#7_ #_:M_W]C_\
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M?_"DO#7_ #_:M_W]C_\ C='_  I+PU_S_:M_W]C_ /C='MX!]4J'@E%>]_\
M"DO#7_/]JW_?V/\ ^-T?\*2\-?\ /]JW_?V/_P"-T>W@'U2H>"45[W_PI+PU
M_P _VK?]_8__ (W1_P *2\-?\_VK?]_8_P#XW1[> ?5*AX)17O?_  I+PU_S
M_:M_W]C_ /C='_"DO#7_ #_:M_W]C_\ C='MX!]4J'@E%>]_\*2\-?\ /]JW
M_?V/_P"-T?\ "DO#7_/]JW_?V/\ ^-T>W@'U2H>"45[W_P *2\-?\_VK?]_8
M_P#XW1_PI+PU_P _VK?]_8__ (W1[> ?5*AX)17O?_"DO#7_ #_:M_W]C_\
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M ']C_P#B*/\ A46@?\_FI?\ ?V/_ .(I>VB'U:H>,4"O9_\ A4>@?\_>I?\
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M4?\ OXG_ ,11_P *JT/_ )^]1_[^)_\ $4>VB'U>9Y"**]>_X57H?_/WJ/\
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M_P _5_\ ]_$_^(I>UB/V$SRD4M>J_P#"LM%_Y^K_ /[^)_\ $4O_  K/1?\
MGZO_ /OXG_Q%'M8A["9Y517JO_"L]&_Y^;__ +^)_P#$4?\ "L]&_P"?F_\
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M_P!]K_\ $T>TB/V,CSZBO0O^$%TO_GO>?]]K_P#$T?\ ""Z7_P ][S_OM?\
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M>UU_WVO_ ,32_P#"&:=_SVNO^^E_^)I<Z#V4CAC17<_\(9IW_/:Z_P"^E_\
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MJ9231<(-.[+=%%%9FH4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M<****104444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M#WFBO!J*/[*_O_A_P0_M[_IW^/\ P#WFBO!J*/[*_O\ X?\ !#^WO^G?X_\
M />:*\&HH_LK^_\ A_P0_M[_ *=_C_P#WFBO!J*/[*_O_A_P0_M[_IW^/_ /
M>:*\&HH_LK^_^'_!#^WO^G?X_P# />:*\&HH_LK^_P#A_P $/[>_Z=_C_P
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MFC_A-/$'_00_\@Q__$T?V96[K\?\@_MS#_RO\/\ ,];HKR3_ (33Q!_T$/\
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M-'_":>(/^@A_Y!C_ /B:/[,K=U^/^0?VYA_Y7^'^9ZW17DG_  FGB#_H(?\
MD&/_ .)H_P"$T\0?]!#_ ,@Q_P#Q-']F5NZ_'_(/[<P_\K_#_,];HKR3_A-/
M$'_00_\ (,?_ ,31_P )IX@_Z"'_ )!C_P#B:/[,K=U^/^0?VYA_Y7^'^9ZW
M17DG_":>(/\ H(?^08__ (FC_A-/$'_00_\ (,?_ ,31_9E;NOQ_R#^W,/\
MRO\ #_,];HKR3_A-/$'_ #__ /D&/_XFGCQMKXZWBGZPI_A1_9E;NOQ_R'_;
M>'[/\/\ ,]8HKRZ/Q]K2$;OLTG^]'_@16A!\1YAC[1IT;>ICD*_H0:B67UUL
MKFD<XPLMVU\O\CT&BN2MOB#I<I GAN(#Z[0P'Y'/Z5NV>N:7?X%M?0.QZ*6V
MM^1YKGGAZL/BBSLIXNA5^":9H4445B= 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !117.ZYXPL-(W0Q$7-T./+0\*?\ :/\
M3K5TZ<JCY8*YE5K4Z,>:H[(Z%F5%+,P50,DDX KE]6\<Z=8[H[3_ $R8?W#A
M!_P+O^%<%JNOZCK#DW4Y\O.1$G"#\._XU9TGPIJFK;72'R(#_P M9> 1[#J:
M].& ITUS5Y'B5<UJUI>SPL?G_6WS'ZCXQUC4,K]H^SQG^"#Y?UZ_K65:V-[J
M4Q6VMY9W)Y*J3^9[?C7I&F^!M*L@K7"M=RCO)PN?]T?US72111P1B.*-(T'1
M44 #\*<L?2IKEHQ%#*J]=\V)G^O_  #S.S\ :M/@W#0VR]PS;F_(<?K6_:_#
MS3XP#<W4\S?[.$'Y<G]:["BN2>/KRZV]#T*6586G]F_J8D'A#0K?&+!7/K(S
M-_,XK0BTO3X0!%8VR8_NQ*/Z5;HKGE5G+XI-G9"A2A\,4OD-6*-?NHH^@IU%
M%9FH4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 $9ZU&\$+C#Q(P]U!J2BBXFD]RC-HNEW Q+IUJWOY2Y_.
MLV?P5H4V2+1HB>\<C#]"<5T%%:1K5(_#)F4\-1G\4$_D<1>?#F!LFROI$/\
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M:U%NM9?W@&6B?AU_#O\ 45IUYDHRB[25F>W"<:D>:#N@HHHJ2PHHHH ****
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M_P 56]11]8K?SO[V'U3#_P#/M?<C!_X0OP__ - __P C2?\ Q5'_  A?A_\
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M\(7X?_Z!_P#Y&D_^*K>HH^L5OYW][#ZIA_\ GVON1@_\(7X?_P"@?_Y&D_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "FR21PQM)*ZHBC+,QP *J:IJMIH]F;F[DVKT51]YSZ 5Y=KWB:
M\UR0JQ,5J#E85/'U/J:ZL-A)UW?9=S@QN84\,K/67;_,Z#7O'C$O;:0,#H;A
MAU_W1_4UQT4-[JUZ5C66YN9#D_Q$^Y-;7A[PA=:P5N+C=;V77?CYG_W1_7^=
M>DZ=I=GI5OY-G L:]SU+>Y/>N^=>CA%R4E=_UN>33PN)Q[]I7=H_ULOU.3T?
MX?Q(%EU64R/U\B,X4?4]3^&*[*VM;>SA$-M"D48Z*BX%345YE6O4JN\V>[A\
M)1PZM37^84445B= 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M&T\5&\='U1)1117.=@4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M%?"2::J7U\H:\(RB'D1?_9?RKK:VQ6,27LJ.B_K8YL#EK;]OB=9/H_U$
M& .@%+117F'N!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !15+4]7T_1K0W6I7D5M"/XI&QGV
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5'/!%<P/#
M/&LD3C#*PR"*DHH3L)I-69YCXH\(OI6Z\L0TEE_$O5HOKZCWJEX<\3W&A3>6
MV9;-SEXL]/=??^=>M,H92K $$8(/>O./%OA/[!NU#3T/V4G,D0_Y9^X_V?Y?
MR]?#8J-:/L:W]?\ !/G\;@9X:7UC#:6W7;_@>1Z#9WD%_:1W-M()(I!E6'^>
MM3UY+X8\22:'=[),O92G]XG]T_WA[_SKU:&:*Y@2:%U>-QN5E/!%<.*PTJ$K
M=.AZ>!QL<5"_VENB2BBBN8[@HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MDQOC8.N?4'-?7EK.+JTAN%&%EC5P/J,UEB5JF;X-Z-$M%%>1W7QP^S7D]O\
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M6%OIMG':VL>R)!QZD^I]ZLT45XS;;NSZ6,5%66P4444AA1110 4444 %%%%
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MO8J\=^.W_, _[>/_ &E11^-!B?X3/':^M]&_Y >G_P#7M'_Z"*^2*^M]&_Y
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M"O-/BAX_ET"/^Q=*<+J$T>Z693S AZ >C']!@]P1Z1--';P232MMCC4NQQG
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M7A_7_#'AY95EAZ\L+4^7K_P4=E1117D'T(4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 5Y-XNUS^V-5*1-FUM\I'CHQ[M^/\A7;>--6_LW
M1&BC;$]UF-<=0O\ $?RX_&O/O#ND'6M8BMCGR1\\I'91_CT_&O5P%)0BZ\^A
MX.;5Y5)QPM/=[_HOU.O\!Z'Y%N=5G3]Y*-L(/9>Y_'^7UKM::B+'&J(H5% "
M@= !3J\^M5=6;FSU\-AXX>DJ<>@4445D;A1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MLD< @LI'Y '\:SI_Q7\S:M_NZ^1YW'(\4BR1NR2(0RLIP5(Z$&M;_A+?$O\
MT,.K?^!LG_Q55-'AL[G6;*#4))([.694F>,@,JDX)&0>G7I7MW_"DO#7_/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MUL$^86TGRR3'/0CJJ^N<$]NN:/=IH/WE:1WWPGTF72_ L#3+M:\D:Z Y^ZP
M4_B%!_&N5^.W_, _[>/_ &E7L*JJ*%4 *!@ #@"O'OCM_P P#_MX_P#:5<M-
M\U6YW5H\M!Q]#QVOK?1O^0'I_P#U[1_^@BODBOK?1O\ D!Z?_P!>T?\ Z"*T
MQ.R,<%NSQ+XV_P#(YV?_ &#T_P#1DE<+H'_(QZ9_U]Q?^ABNZ^-O_(YV?_8/
M3_T9)7"Z!_R,>F?]?<7_ *&*UI_PT85?XK]3ZTHHHK@/6/FSXJ?\E(U;_MC_
M .B4JO\ #C_DH6C_ /74_P#H#58^*G_)2-6_[8_^B4JO\./^2A:/_P!=3_Z
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M,J])5:<J;ZH\E\(WQL?$EJ<X28^2_N&Z?KBO7:\,E22RO7C)Q+!(5SZ,I_\
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METS_ *Z5$_\ 9O\ V6N0\"VXF\3Q.1D0QO)^F/\ V:MWXCSXMK"WS]YW<_@
M/ZFJOPX@W7=]<8^Y&J9^I)_]EKUZ7N8*3[W_ ,CY[$?O<TC'M;\-3T*BBBO(
M/H0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH YGXA?\B!K/\ UP_J*^8:^H_'5M/>
M>"-6M[:&2>9X<)'$I9F.1P .37SI_P (EXE_Z%[5O_ *3_XFNO#M*+//Q:;F
MK'M'P7_Y$>3_ *_9/_04KT2N$^$FGWNF^#I(+ZTN+68W;MY<\91L;5YP1TKN
MZYZGQLZZ/\-!1114&H4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M3AWO_F=I1117D'T(4444 %>'?'/_ )#FE?\ 7LW_ *%7N->'?'/_ )#FE?\
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MY=(T$(]Y$VV>Z<;EB8'E5'<^I/ Z<GIY7<^-_%-W,TLGB#459B21%<-&/R7
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M?$ZU\+2MI]A''>:GC+!C^[A]-V.2?8$5X_J/Q#\5ZG+ODUJYA&,!;9O) '_
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MN.GB83=MF=S1116)T!1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MU-\%]<DLO%,NDLQ\B_B)5?21 6!]OEW?IZ5WOQCFCB\ R(^-TMS&B9]>6X_
M&O)/AC"\WQ%T@)_"[N3Z 1L:UBW.D^8YYQ5/$+E/1_CE_P BYIO_ %]G_P!
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M9C8C[K@Y4_F!42ERUKEPI\^'2/*O@EX@%OJ-WH$T@"7(,\ />11\P'N5&?\
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MYCCE21TQ705Q2T>AZ<6W%-A1112*"BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH \&KWFO!J]YKU\U^Q\_P!#Y[(?^7GR_4****\@^A"BBB@
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MO_7K%_Z *]?,/X,/ZZ'SV4?[Q5_KJ7Z***\@^A"BBB@ HHHH **** "BBB@
MHHHH **** "BBB@#S/XB?\C!!_UZK_Z&];_P[_Y%^?\ Z^F_] 2L#XB?\C!!
M_P!>J_\ H;UO_#O_ )%^?_KZ;_T!*]>M_N4?D?/8?_D9S^9UM%%%>0?0A111
M0 4444 %%%% !1110 445SWC?73X=\(WVH1D>>%$</\ OL<#\LY_"FE=V0I-
M15V=#17RG_PEOB7_ *&'5O\ P-D_^*KI_ 'CC5+;QC9IJVL7MQ97!,#BXN&D
M52WW3AC@?-CGL,UN\.TKW.6.+BVE8^A:***YSK"BBB@ HHHH **** "BBB@
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M]<\,>+M)\669FTZ8^:@'G0.,/&3ZCN/<<5G.E*.YO3KPGHC=HHHK,U"BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH \S^(G_(P0?]>J_^AO6_\._^1?G_ .OIO_0$K ^(G_(P0?\ 7JO_
M *&];_P[_P"1?G_Z^F_] 2O7K?[E'Y'SV'_Y&<_F=;1117D'T(4444 %%%%
M!1110 4444 %%%% !1110 4444 <E\1/^1?@_P"OI?\ T!ZP/AW_ ,C!/_UZ
MM_Z&E;_Q$_Y%^#_KZ7_T!ZP/AW_R,$__ %ZM_P"AI7KT?]RE\SY[$?\ (SA\
MCTRBBBO(/H0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M.1!H&EQEAO:Z9@/4!3G^8_.N0^#'_(]G_KTD_FM5#^"S.I_O*^1[#XY\-_\
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MFL1*5Y.R.AHHHKF.T**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M$\.:W<:3>6NH//!MW-#&A4[E##!+@]".U,T3XKZ%KVLVVEVMIJ*3W#%4:6-
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M7I?A#XQ0WLJV7B..*VD/"7<8(C/'\8_A/N..>@HE0DM0ABH2=GH>KT5\V?\
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MNHHHK(W"BBB@ HHHH **** "BBB@#S/XB?\ (P0?]>J_^AO6_P##O_D7Y_\
MKZ;_ - 2L#XB?\C!!_UZK_Z&];_P[_Y%^?\ Z^F_] 2O7K?[E'Y'SV'_ .1G
M/YG6T445Y!]"%%%% !1110 4444 %%%% !1110 4444 %%%% ')?$3_D7X/^
MOI?_ $!ZP/AW_P C!/\ ]>K?^AI6_P#$3_D7X/\ KZ7_ - >L#X=_P#(P3_]
M>K?^AI7KT?\ <I?,^>Q'_(SA\CTRBBBO(/H0HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** .2^(G_ "+\'_7TO_H#U@?#O_D8)_\ KU;_ -#2M_XB
M?\B_!_U]+_Z ]8'P[_Y&"?\ Z]6_]#2O7H_[E+YGSV(_Y&</D>F4445Y!]"%
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110!\X_%3Q*-?\6/!!)NL[ &"+!R"V?G8?4@#Z**[_ .#'AS[!
MH4VMSIB>^.V+(Y$2G^I_D*]/HK:56\.5(YX8>U3VC=PHHHK$Z HHHH ****
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MZN;2VM9IWD@MMWDHQSL#') ]LCI_C5:NC\;^%Y/"?B2:PR6MG'FVSD\M&2<
M^X((/TSWKG*Z$TU='%)-.S/L2O!?C;_R.=G_ -@]/_1DE>]5X+\;?^1SL_\
ML'I_Z,DKCH?&>EB_X9P&E?\ (7LO^N\?_H0KZYKY&TK_ )"]E_UWC_\ 0A7U
MS5XG=&>"V9\V?%3_ )*1JW_;'_T2E<K9WMSI]VEU9S/#<1YV2(<%<C''YUU7
MQ4_Y*1JW_;'_ -$I7)VMM+>7<-K A>:9UC11U+$X _,UT0^!')4_B.W<=;VU
MU?W(AMH)KF=SPD2%V8_0<FI+W2]0TU@+^PNK4G@">%DS^8KZ=\*^%['PIHT=
ME:(IE(!GGQ\TK^I/H,G ["KNLZ3:ZYI-SIUY&KPSH5Y&2I[,/<'D5@\1KMH=
M*P;Y=7J?)5>^_"/Q9<:YI$^FW\K2W=CMV2-U>(\#)[D$'GT(]Z\(NK:2SO)K
M67'F0R-&V#D9!P?Y5W_P7F>/QM-&/NR63AA]&4_TK6LDX&.'DXU$CW^O,_B?
M\09-"0Z+I3[=0E3,TXZP*>@'^T?7L/<C'I,TT=O!)-*VV.-2['&< #)KY,UG
M4Y=9UJ]U*;[]S,TF/[H)X'T P/PKGH04G=G9BJKA&RW92)+$DDDGDD]ZL6>G
MWNHR^58V=Q=2?W((F<_D!['\JZ'P%X0?Q?KOV>0R1V, $ES*@Z#LH/8GG\B>
MU?2&G:;9:39)9Z?:Q6UNG1(UP/J?4^YY-;U*RAHCDHX=U%=Z(^4K[2-3TP*=
M0TZ[M WW?M$#1Y^F0*CCU"[BT^:P2X<6DS!WAS\I8=#CL?>OKB:&*XA>&>))
M8G&&1U#*P]P:\#^*7@:#PW=1:IIJ[+"[D*-#CB&3&<#V(!P.V#4TZRF[,JKA
MG37-%GG5?3WP]_Y$#1O^N']37S#7T]\/?^1 T;_KA_4T8CX4/!_&_0Z:BBBN
M,]$**** /E/Q;_R.>N_]A"X_]&-6_P#"7_DHEC_USE_]%M6!XM_Y'/7?^PA<
M?^C&K?\ A+_R42Q_ZYR_^BVKT)?PWZ'D0_BKU/HVBBBO//7,7Q9H:>(O#%_I
MK(&DDB)AZ#$@Y0Y[<@?@37RL05)!!!'!![5]AU\DZU&L.NZA$@PJ7,BCZ!C7
M5AGNC@QD=F>E_ W4634]5TP\K)"MPOL5;:?SWC\J]KKYX^#S%?'T0!X:WE!_
M('^E>[:_JJ:'H%]J;XQ;0LZANC-CY1^)P/QK.NO?T-L++]UKT.!^)?Q'.C^;
MH>CR$:@1B>X'_+ $=%_VB#U[?7IX6[M([.[%F8Y+$Y)/K3[BXEN[F6YN)#)-
M,YDD=NK,3DD_C7H'PO\  L/B6ZEU+4T+:=;,%6/D"9^N,^@[_45TI1I1.*4I
M5YV.(LM&U34@38:;>70'4P0,^/R%1WFGWNGR!+VSN+9SG"S1E"<=>HKZXAAB
MMX4A@B2*)!A410JJ/8"J^I:78ZQ9/9ZA;1W%N_5''?U'H?<5E]9UV.AX+3?4
M^4-/U&]TJ\2[L+F6VN$^[)&V#]/<>W0U]$_#_P <1>,--=9E$6I6P GC'1@>
MCK[''(['\*\2\<^%7\)>(GLU8O:RKYMLY.24)(P3CJ,?R/>JGA'7I/#?B:SU
M)2?+1]LP_O1GAA^7/U K2<%4C=&-*I*C.SV/JFOFWXE>)YO$/BJXA#L+&Q=H
M((SQR.&;ZDC\L5](JRNH92"I&00>"*^4/$=E+I_B;4[288>*YD'3J-QP?H1@
M_C6.'2YFSHQC:BDBC:VES>W"V]I;RW$S?=CB0NQ^@'-.O+"\TZ;R;ZTGM9>N
MR>,HWY$5U_PU\9V7A'4KLW]LSV]VBJ9HUR\97.,#N#GGZ"O;9XO#GCW0WB\R
MWO[5APZ$;XFY 89Y5N#_ /7%;3JN#U6ASTZ"J1T>I\^^")-=C\4V@\/[S=EA
MO3<1&R C(DQ_!Z_ISBOJ%=Q4;@ V.0#D9KGO"/@[3O"&GM!:9EN).9KEQAI/
M0>P'I715S59J;T.W#TG3CJ<_XQ\5VOA'1&OIU\V9V\N"$'!=\9Y] .Y_Q%?-
M>M:W?Z_J4M_J,[2S2'./X4'HH["NH^*VMMJ_C6X@5]UO8#[.@SQN'WS]=V1_
MP&N?\+Z79ZQX@MK74+Z"RLL[YYII5C&P=0"W&3T'USVKHI04(\S..O4=2?*M
MB#2M U;7)&33+">Z*_>,:\#IU/3N*VKGX:>,+6+S)-$E9<XQ%+'(?R5B:]XL
M->\'Z791V=CK.C06\8 5$O(P!_X]R?<\U9_X2WPU_P!##I/_ (&Q_P#Q50Z\
MKZ(U6%IVUD?*TL4D$K131M'(IPR.,$'W!KTGX:_$6YTR_@T;5[@R:=,P2*65
MN;=CTY_ND\<].O S72_$>T\)>)-)FO[76M)&KVT9>-DNX\S ?P'!Y..GOCM7
MAU:JU2.J,&I4)W3/L2BN1^&NMMKG@BSEE<O/;$VTI('5>G_CI6NNKADK.QZ<
M9*2304444B@HHHH **** "BBB@#Q77/^1@U+_KZE_P#0S7K>A_\ (OZ;_P!>
ML7_H KR37/\ D8-2_P"OJ7_T,UZWH?\ R+^F_P#7K%_Z *]?,/X,/ZZ'SV4?
M[Q5_KJ7Z***\@^A"BBB@ HHHH **** "BBB@ HHHH **** "BBB@#S/XB?\
M(P0?]>J_^AO6_P##O_D7Y_\ KZ;_ - 2L#XB?\C!!_UZK_Z&];_P[_Y%^?\
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M=6H3^&?A/K>OVD=[<21Z=:R8:-I5W.ZG^(*/TR1GZ<UM7WP-OXH6:PUFWN)
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M'I@_IFL85Y)^\=%3"P:]W1GRC7L7P)_YC_\ V[_^U:\>=2CLC##*<$>]>P_
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M_!+4G@\1WVG%P(KFV\P*>[HPQC\&;\J]TKDJQY961Z%"?/!-A11169L%%%%
M!1110 4444 >9_$3_D8(/^O5?_0WK?\ AW_R+\__ %]-_P"@)6!\1/\ D8(/
M^O5?_0WK?^'?_(OS_P#7TW_H"5Z];_<H_(^>P_\ R,Y_,ZVBBBO(/H0HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH Y+XB?\B_!_U]+_Z ]8'P[_Y&"?\
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MK_#C_DH6C_\ 74_^@-6R_A_(YG_&^?ZGTW1117 >L?*7BM53QCKBJ %&H3@
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M046%%%%2:!1110 4444 %%%% 'BNN?\ (P:E_P!?4O\ Z&:];T/_ )%_3?\
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M@D5#7HEI\&?$EW9P7(NM-C$L:R;))7W+D9P<(1D>QKOE*,=SR8PE)^ZCD_\
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MBO1TO;1P)5 6XA/WHG]"/0]CW_.MVL'7FG9HZEA*;5TV?-G_  JOQI_T!O\
MR:A_^+H_X57XT_Z W_DU#_\ %U]!:WKNG^'M-DO]1G6*)!PO\3G^ZH[FL_P_
MXVT#Q, NGWR_:#_R[2_)+Z\*>O SD9I^VJ6O8/JU)/EOJ>;_  [\">)M!\96
MM_J.G&"U1)%=_/C;JI X5B>N*]IHHK&<W-W9T4Z:IJR"BBBH- HHHH ****
M"BBB@#S/XB?\C!!_UZK_ .AO6_\ #O\ Y%^?_KZ;_P! 2L#XB?\ (P0?]>J_
M^AO6_P##O_D7Y_\ KZ;_ - 2O7K?[E'Y'SV'_P"1G/YG6T445Y!]"%%%% !1
M110 4444 %%%% !1110 4444 %%%% ')?$3_ )%^#_KZ7_T!ZP/AW_R,$_\
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MS&1_>/3'I^7UYW2=7N]&O!<6CX/1T/*N/0BO5M$U^SUVW+VY*2H!YD3=5/\
M4>]=>)EB*$W4B[Q?X'!@H83%TE1DK37WL70-%CT+3A;([.['?(Q/!;'8=NE:
ME%%>1.3G)RENSZ&G3C3BH15DBO?7:6%A/=R8VPQER"<9P.GX]*\3N)Y;NZDG
ME.Z65R[''4DYKT'XA:D(;"#3T8AYFWN ?X!T!^I_]!KE_"&F#4O$$(=-T,/[
MV0'&..G7KSBO7P,52HRK2_JQ\]FDWB,3'#PZ?F_\D9-C>2:??P7<6"\+AP#T
M..U>VP3)<V\4\9S'(@=3[$9%>1>)]-.F:_<Q;<1NWFQ_[K'^AR/PKM? 6I?:
MM&:S=\RVSD $\[#R/UR/RI8^"J4HUH_U<>4U'1KRP\_Z:.LKB/B/_P >EA_O
MO_(5V]<1\1_^/2P_WW_D*X<%_'C_ %T/4S3_ '2?R_-'*^&=)@UG5Q:7#R+&
M8V;,9 .1]0:ZV?X<V;?\>]_/'Q_RT4/S^&*P? 7_ ",J_P#7%_Z5ZE79CL15
MIU;0=M#S\KP="MA[U(W=SQO6O#][H4RK<J&C?[DJ?=;V]C6WX'U][2\72YVS
M;SM^[SU1S_0_S_&NYUS3EU31KFU*AG9"8^G#CD=?>O%U8JP93@@Y!K>A46+H
MN,]_ZU.3$TGEV(C4I[/^FCWBBH+*X^UV%O<X \V)9,#W -3UX;5G9GU*::N@
MKF_&VIRZ=H6V!RLMP_E[AG(7!)(/X8_&NDK!\8::^I^'I4B&986$RCUP#G]"
M:UP[BJL>;:YSXQ3>'GR;V/+]-TZXU6_CL[8*9'[L< #N33]6TFYT:]-K=!=^
MT,"AR&'J/R-+HVIOI&JPWJ+NV'YE_O*>HIVKZG/KFJO<NK9<[8XQSM7LH_SU
M-?17J>U_NV_$^.2H^PZ\]_E8]!\#:C+?:&8IF+/;/Y:L?[N!@?A73UA^%-'?
M1M%6*;'GRMYLF!]TD# _ #\\UN5\[B'%U9.&Q]C@XSC0@JF]@HHHK$Z0KR[Q
M]<>=XC\K&/)A5/KG+?U_2O4:\;\2SM<>)=0=CDB9D_!?E'Z"O1RV-ZK?9'C9
MW.U!1[LSH)GM[B.>,XDC8.I]"#D5[=9W27ME!=1_<E0..>F1TKQ2XM)+:*WD
M<?+/'YB'VW$?TKT?P#?_ &G0WM6.7M7P/]UN1^NZNG,H*5-5%T.+):KA6=*7
M5?U^!T&J7JZ;I=S>-C]U&6 (X+=A^)P*\29BS%F.23DFO1OB'J'DZ;;V*-\T
M[[W ;^%?4>Y(_P"^:\^CMI);:>=5/EP[=Q]"3@#^?Y5674^2DYOJ3G-5U*ZI
MK[*_X/Y'7_#F?;J-[;Y^_$'Q_NG'_LU>B5Y-X*G$'BBV!Z2!D_-3C]0*]9KB
MS&-JU^Z/3R:?-AK=F_\ /]0KCOB#J1M],AL(V :Y;<_/.Q?\3C\C78UX]XHU
M(:IK]Q,C%H4/EQ\Y&!QD?4Y/XTL!2YZMWLM1YM7]EAW%;RT_S_KS,?'&>U=C
M\/M2,&I2Z>V-EPNY/9E_^MG\A4NB^&S>>"[R7RLW5P=\)XSA>@'U.X?E7(6=
MU)97D-U$2'B<..?2O5FXXB$Z:Z:'@4XSP=2G6>SU^7_#'N5%16UQ'=VT=Q"P
M:.10RD>AJ6OG&K:,^R335T>->)/^1DU#_KNU=#X:\(:?K.CI>7$URLA=EQ&R
M@<'W4USWB3_D9-0_Z[M7H'@3_D6(_P#KH_\ .O=Q-25/#1<79Z?D?+8&C"KC
M)QJ*ZU_,Q+WX=2)$7LKT2..D<J;<_B._X5Q<L4]G<M%*KQ3Q-@@\%2*]TK@?
MB)IRJ;7444 L3#(>.3C*_P F_(5C@\;.<_9U-;G3F66TZ=)U:*M;='0^%==.
MMZ7NF(^U0G;+@8!]&_'^AK=KRWP'<F#Q(L(Z3Q,A_#YOZ5ZE7%C**I56EL]3
MTLMQ#KX=2ENM HHHKE.\**** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MR?X5^#=?\-Z]>7.K6'V>&2V\M&\Z-\MN4XPK'L#7K%16:<]#7#)JG9E+6?\
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M^BZO$23M9F>$C**=U8^;/BI_R4C5O^V/_HE*K_#C_DH6C_\ 74_^@-76^/\
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MXG_EI]!V^N>PK0\*?!RVLWCO/$,BW4HPPM(S^[!Q_$>K8/8<<=Q7JJJJ*%4
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M2_\ H9KUO0_^1?TW_KUB_P#0!7DFN?\ (P:E_P!?4O\ Z&:];T/_ )%_3?\
MKUB_] %>OF'\&']=#Y[*/]XJ_P!=2_1117D'T(4444 %%%% !1110 4444 %
M%%% !1110 4444 >9_$3_D8(/^O5?_0WK?\ AW_R+\__ %]-_P"@)6!\1/\
MD8(/^O5?_0WK?^'?_(OS_P#7TW_H"5Z];_<H_(^>P_\ R,Y_,ZVBBBO(/H0H
MHHH **** "BBB@!&944LQ 4#))/ %?+'C'6QXA\5ZAJ2,S0R2;8<_P#/-?E7
MCMD#./<U]/ZA9KJ.G7-D\LL27$31-)$0'4,,$@D'!KS_ /X4EX:_Y_M6_P"_
ML?\ \;K:C.,;MG-B*<ZB2B>6?#[0CX@\965LR!K>%OM$X/38I'!^IP/QKZ<K
MF/"G@32O!\UU+I\MU+)<*JLUPZMM R<#:HZY_05T]*K/G>A6'I.G&SW"BBBL
MC<Y;XB:(NN^";^'8&FMT^TPDD\,@)X]RNX?C7S)7V)7G=U\&/#5S=S3_ &G4
MHO-=G\N.5-JY.<#*$X'N3711JJ*LSDQ%!S:<3-^"FO-<Z7>:),X)M2)H <YV
M,3N'T#8/_ JI?&N/76>U<!CH2J/]7T67)Y?\" .W7O78>'/AII/A?6$U/3[[
M4C*J,C))*A1U(Z, @)&<'KU KL)H8KB%X9XDEB<89'4,K#W!J7-*IS(J-*3I
M<DCX^K0?7M8DM'M'U:^:V<8:$W#E&'NN<'I7M^L_!O0-1N&GL99].9LYCCP\
M>?4 \CZ X],5AK\"5##?XB)7N!98/_H=='MH/<Y'AJJV/'*^@/A+X4FT'0Y=
M0OHO+O+_ &D1LN&CC&< ^A.<X^G>M'P]\,?#OA^9+D0O>7: 8ENB&"GN0H&!
M^.2/6NSK&K6YE9'30P[@^:6XC*KJ58 J1@@C@BOG[XA_#JY\/WDVI:7;M)HS
MG=A3N-N>X/?;GH?P/O\ 05(RJZE6 *D8((X(K*G4<'=&U6DJBLSX\K0M=>UB
MQ4+::M?6Z@8 BN'0 >G!]A7OVM_"OPSK,K3+;R6,S#[UH0BD^I4@C\L5RTWP
M*B:3,/B%T3T>T#'\PX_E74J\'N<+PM6+T/)+W4[_ %)P]]?7-TPZ-/*SG]35
M9$:1U1%+,QP% R2?2O:K7X&62.IN]<N)4_B$4 C)^A);%=OX?\#>'_#+K+I]
MD/M(!'VB5B\G/H3P... *'7@EH..%J2?O:'.?"OPOKF@Z?+/JMQ+#%./W6GL
M<B/.#O/HQ]/SYZ>BT45R2DY.[/0A!0CRH\W^)WP_D\11KJVDQ*=3B4+)%D+Y
MZ#I[;A[]1QV%>#2Q202M%-&T<BG#(XP0?<&OL&N>\0^"=!\3_/J-D/M &!<1
M'9(/J1UZ=\XK6G6Y59G-6PW.^:.Y\]:5XU\2:)$D5AJ]Q'$@PD3D2(H] K @
M4_4O'?BC5HS'=ZU<F,]5C(B!^H0#->E77P,LG=C::Y<1)_")8!(1]2"N:9;_
M  +MU?-SK\LB^D=J$/YEC6WM*6YS^QK[=/4\7KVKX2^#=4T]O[<OI[BUAD4B
M*S#%?-!&-[KZ>@Z]_3/6:#\-?#7A^43PVK75PO*RW9$A7Z# 4?7&:ZZLJE;F
M5HF]'#<KYI!7@OQM_P"1SL_^P>G_ *,DKWJN1\4_#O2/%VIQW]_<WT<L<(A
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 <E\1/^1?@_Z^E_\ 0'K ^'?_ ",$_P#UZM_Z&E;_ ,1/^1?@_P"O
MI?\ T!ZP/AW_ ,C!/_UZM_Z&E>O1_P!RE\SY[$?\C.'R/3****\@^A"BBB@
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M]#J\QDI5K+HB,FIN&&N^K;_3] HHHK@/5"BBB@ HHHH **** "BBB@ HHHH
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MO_0$KUZW^Y1^1\]A_P#D9S^9UM%%%>0?0A1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 <E\1/^1?@_P"OI?\
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M3W)]ZLT45Y;;;NSW8Q459;!1112&%%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 >#5[S7@U>\UZ^:_8^?Z'SV0_\O/E^H4445Y!
M]"%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 (RJZE6 *D8((X(K-N/
M#FAW;[[G1M.F;^]):HQ_45IT4[V$TGN9</AG0;=MT.B:;$WJEI&I_05J444-
MW!)+8****0PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /%=
M<_Y&#4O^OJ7_ -#->MZ'_P B_IO_ %ZQ?^@"O)-<_P"1@U+_ *^I?_0S7K>A
M_P#(OZ;_ ->L7_H KU\P_@P_KH?/91_O%7^NI?HHHKR#Z$**** "BBB@ HHH
MH **** "BBB@ HHHH **** /,_B)_P C!!_UZK_Z&];_ ,._^1?G_P"OIO\
MT!*P/B)_R,$'_7JO_H;UO_#O_D7Y_P#KZ;_T!*]>M_N4?D?/8?\ Y&<_F=;1
M117D'T(4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 <E\1/^1?@_P"OI?\ T!ZP/AW_
M ,C!/_UZM_Z&E;_Q$_Y%^#_KZ7_T!ZP/AW_R,$__ %ZM_P"AI7KT?]RE\SY[
M$?\ (SA\CTRBBBO(/H0HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH \&KWFO!J]YKU\U^Q\_T/GLA_Y>?+]0HH
MHKR#Z$**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#Q77/^1@U+_K
MZE_]#->MZ'_R+^F_]>L7_H KR37/^1@U+_KZE_\ 0S7K>A_\B_IO_7K%_P"@
M"O7S#^##^NA\]E'^\5?ZZE^BBBO(/H0HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH \S^(G_(P0?\ 7JO_ *&];_P[_P"1?G_Z^F_] 2L#XB?\C!!_UZK_
M .AO6_\ #O\ Y%^?_KZ;_P! 2O7K?[E'Y'SV'_Y&<_F=;1117D'T(4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% 'F?Q$_P"1@@_Z]5_]#>M_X=_\
MB_/_ -?3?^@)6!\1/^1@@_Z]5_\ 0WK?^'?_ "+\_P#U]-_Z E>O6_W*/R/G
ML/\ \C.?S.MHHHKR#Z$**** "BBB@ HHHH **** "BBB@ HHHH **** .2^(
MG_(OP?\ 7TO_ * ]8'P[_P"1@G_Z]6_]#2M_XB?\B_!_U]+_ .@/6!\._P#D
M8)_^O5O_ $-*]>C_ +E+YGSV(_Y&</D>F4445Y!]"%%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MZE^BBBO(/H0HHHH **** "BBB@ HHHH **** "BBB@ HHHH \S^(G_(P0?\
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ME\SY[$?\C.'R/3****\@^A"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M $,U56DH*Z)H8B527*T=S1117.=84444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 <E\1/\
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M1HEW+?:9>SW!=&@;=*CJ/F!/W0.01C\ZEN/(U>Y24N=.UA?B#_R(^H_]LO\
MT8E3^"O^1-TS_KE_[,:@^(/_ "(^H_\ ;+_T8E3^"O\ D3=,_P"N7_LQI?\
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MX48;[=W1QGD98L/T:NMJ:K?-;L.E%<J?<\Z\8>&_[!9/$F@+]EEMW#31Q\*
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M3M-2TE$N/+@\EX#($(PQ.1NP/XO7M70_#;PM>^%?#DEMJ$B_:9YS,T:-E8^
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MBMD^>&O4YY+V=2RZ'U[1574YI+?2KR:)MLD<#NIQG!"DBOG;_A:GC3_H,_\
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M#@_7K7;U+G.-TRXTZ4[2B%%%%9&X4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 >*ZY_R,&I?]?4O_ *&:];T/_D7]-_Z]8O\ T 5Y
M)KG_ ",&I?\ 7U+_ .AFO6]#_P"1?TW_ *]8O_0!7KYA_!A_70^>RC_>*O\
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M]L?_ $<E>)>"_#%WXPU=--6:2*QBS-.XY"#@<#IN/ 'T]J]M^*G_ "3?5O\
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MZBX^-'BB:$I'#IT#'^..%B1_WTQ'Z5PECIU]J<S0V%G<7<JKO*01-(P7(&<
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MO"O@A_R,^H?]>1_]#6O=:UK_ !F&%_AH*I:S_P @/4/^O:3_ -!-7:I:S_R
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M[_\ M6MH_P *1S3_ (\?F>Q5XO\ &G0FM[ZQ\16VY3)B"8J,8=>4;/J1D?\
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M)X@MXE2^M=OG,O\ RUCSCGW&0<^@(],1?!36IKS1K[2IGW+9.KPY/.U]V1]
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M[RVL+22ZNYXX+>,9>21@JJ/<US':87CZ]2P\":S(Q4;[9H1N/4N-O'OS7#?
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MJP5.2E#1GOU%%%<YUA1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MUZK_ .AO6_\ #O\ Y%^?_KZ;_P! 2L#XB?\ (P0?]>J_^AO6_P##O_D7Y_\
MKZ;_ - 2O7K?[E'Y'SV'_P"1G/YG6T445Y!]"%%&1G&>?2B@ HHHH **** "
MBBB@ HHHH **** "BBB@#DOB)_R+\'_7TO\ Z ]8'P[_ .1@G_Z]6_\ 0TK?
M^(G_ "+\'_7TO_H#U@?#O_D8)_\ KU;_ -#2O7H_[E+YGSV(_P"1G#Y'IE%%
M%>0?0A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %?(VJ_\ (7O?^N\G_H1KZYKY&U7_ )"][_UWD_\
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M&(/ZBNHKPOX4^.[71-^AZK((;6:3?#<,<+&QZAO0''7L>O7(]R1TDC5T8,C
M%64Y!![BN>K%QD[G90FI05AU>,_'6=&N=#MQG>B3.?3#% /_ $$UZMK&MZ;H
M%BUYJ=W';Q#IN/+GT4=2?85\T>+_ !)-XJ\1W&IR I&?W<$9_P"6<8Z#Z]2?
M<FKH1;ES&>+FE#EZLPJ^M)[:1O#TEJ01(;4QX R<[,?C7SG\/="?7O&=A#Y9
M:W@<7$Y[!%YY^IP/QKZ<JL1+5(C!QT;/CNO7_@5*@FUV(L/,98&"^H'F G]1
M^=<#XVT&3PYXLO;(QE(&<RV_& 8F)VX^G(_"F^#?$TGA/Q'#J2QF6(J8IXP<
M%D.,X]P0#^%;S7/#0Y:;]G57-T/J6BJ&DZSI^N6*7FG74<\+ 'Y3ROLPZ@^Q
MJ[))'#$\LKJD:*69V. H'4D]A7GV/6335T<Q\2)4A^'NL.^<&)4X]6=0/U-?
M,E>F?%7QU;Z\\6CZ5,);&%O,FF4<2OC@ ]U&3]3] :\VBBDGF2&)"\CL%51U
M)/ %=U&+C'4\S$S4YZ=#W_X,J5\#,2.&O)"/IA1_2N'^-O\ R.=G_P!@]/\
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M_P"AO6_\._\ D7Y_^OIO_0$K ^(G_(P0?]>J_P#H;UO_  [_ .1?G_Z^F_\
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M0A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_0!7KYA_!A_70^>RC_>*O]=2_1117D'T)R7Q$_Y%^#_KZ7_T!Z\SKTSXB?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% ')?$3_D7X/^OI?_ $!ZP/AW_P C!/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'F?Q$_Y&"#_KU7_P!#
M>M_X=_\ (OS_ /7TW_H"5@?$3_D8(/\ KU7_ -#>M_X=_P#(OS_]?3?^@)7K
MUO\ <H_(^>P__(SG\SK:***\@^A/,_B)_P C!!_UZK_Z&]<E76_$3_D8(/\
MKU7_ -#>N2KZ7"?P(^A\5F'^]3]0KO/ >O?\P>Y?U:W)_,K_ %'X^U<'3HY'
MAE26-BDB,&5@<$$=#55Z*K0<&9X7$RP]55(_/T/=Z*QO#6MKK>EK*2!<1_),
MH&/F]?H:V:^:G!PDXRW1]M3J1J04X[,****DL**** "BBB@ HHHH Y+XB?\
M(OP?]?2_^@/6!\._^1@G_P"O5O\ T-*W_B)_R+\'_7TO_H#U@?#O_D8)_P#K
MU;_T-*]>C_N4OF?/8C_D9P^1Z91117D'T(4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MN-/B^Q_:/MC,N?-V;,%?8Y^]^E.,7)V0I245=G14444AA1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 >9_$3_D8(/\ KU7_ -#>M_X=_P#(OS_]?3?^@)6!
M\1/^1@@_Z]5_]#>M_P"'?_(OS_\ 7TW_ * E>O6_W*/R/GL/_P C.?S.MHHH
MKR#Z$\S^(G_(P0?]>J_^AO7)5UOQ$_Y&"#_KU7_T-ZY*OI<)_ CZ'Q68?[U/
MU"BBBN@XC5\/ZS)HFJ)<#)B;Y94_O+_B.M>PPS1W$*30N'C=0RL.A!KPFNZ\
M":_M;^R+E_E;)MV)Z'NO]1^->;F&&YX^TCNMSV\HQGLY^QGL]O7_ ()W]%%%
M>(?3A1110 4444 %%%% ')?$3_D7X/\ KZ7_ - >L#X=_P#(P3_]>K?^AI6_
M\1/^1?@_Z^E_] >L#X=_\C!/_P!>K?\ H:5Z]'_<I?,^>Q'_ ",X?(],HHHK
MR#Z$**** "BBB@ HHHH **** "BBB@ HHHH **HZOK%AH6G27^HW"P6Z<9;J
MQ[ #N?85X=XI^+FL:M)+;Z.S:=8DX5U_U[CW;^'_ (#T]36D*<I[&52M&GN>
MWZGKNE:,N[4M1MK7(R%ED 9A[#J?PK!D^)_@V)]K:TI/^S!*P_,+7S7)(\LA
M>1V=VY+,<DTVMUAUU9R/&2Z(^GK7XA^$KS'E:[;+DX_?;HO_ $,"NCBECFC6
M2*19(VY#(<@_C7Q]6EI&OZMH,XFTN_GMF!R0C?*WU4\'\12>'71CCC']I'UE
M17F7@SXMVNL31:?K:)9WCG:DZ\0N?0Y/RD_E].E>FUSRBXNS.R%2,U>(4445
M)84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MR]3\2:/H[;+_ %"&*3O'RSC_ ("N36/XZ\23Z'I\-M8\W]XQ6/ R47N0/7)
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MW:U.DO?&/A_3Y6BN-4B#J<%4#28/_ 0:=8>+M!U.=8+34XFE;A4<%"QSC W
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MO_0!5^L7HS9.Z"BBBD,**** "BBB@ HHHH **** /!J]YKP:O>:]?-?L?/\
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M\&']=#Y[*/\ >*O]=2_1117D'T)R7Q$_Y%^#_KZ7_P! >O,Z],^(G_(OP?\
M7TO_ * ]>9U[^7?P/F?)9Q_O3]$%%%%=QY04444 =WX$U\JPTBY?Y3DV['L>
MI7^HKOJ\(1VBD61&*NI#*1U!%>O>&M;76]+64D"XC^290,?-Z_0UXN88;E?M
M8[/<^FR?&\\?83>JV]/^ ;-%%%>8>X%%%% !1110!YG\1/\ D8(/^O5?_0WK
M?^'?_(OS_P#7TW_H"5@?$3_D8(/^O5?_ $-ZW_AW_P B_/\ ]?3?^@)7KUO]
MRC\CY[#_ /(SG\SK:***\@^A"BBB@ HHHH **** "BBB@ HHHH **** ./\
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M#+(S[!'GINW8*_CBGRNU["YHWM<Y'XT?\B/'_P!?L?\ Z"]6_A'_ ,D]M/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M\S^(G_(P0?\ 7JO_ *&];_P[_P"1?G_Z^F_] 2L#XB?\C!!_UZK_ .AO6_\
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M$_\ UZM_Z&E>O1_W*7S/GL1_R,X?(],HHHKR#Z$**** "BBB@ HHHH ****
M"BBB@ HHHH *RM?\/V/B*P^RWBD%3F.5?O1GV_J/_K5JURFO>,9/#NNPV][I
MTO\ 9LD?%RG)+>PZ8'<=>_UJ"DW[NY,W%+WMCG7/B;X?E&:7^TM%4@'/\ SC
M'.2G7CJ*[N/4;?5O#S7UHQ:&:!F7(P1P00?<$$?A7&>*O'6EZEHDVFZ6);JX
MNE"<1$!,GD<C)/';UZUT/A[2I=&\$):3KMG\AWD'H6R<?4 @?A6LU[J<E9F,
M'[SC%W1A_"?_ ) ]_P#]? _]!%0^*%#?%700?^><1_\ (CU-\)_^0/?_ /7P
M/_0147B;_DJV@_\ 7*/_ -#>J_Y>R)7\*)Z+6!XU_P"1-U/_ *Y?^S"M^L#Q
MK_R)NI_]<O\ V85A#XD=$_A9!\/O^1'T[_MK_P"C'K ^')VZ_P"(DN/^/OS1
MG?RWWGW<_7&:W_A]_P B/IW_ &U_]&/6+XBTC5-!\2'Q-HD1G23BYMU!)QWX
M[@XS[&M=Y2CW,=5&$NQZ!17'V?Q*\/7$2M/+-:OCYEDB9L'TRN<U2U/QC-X@
M1]*\+VL\TLN4DNG3:D:'C([CKU.,?6H5*5]4:.K"VC*/PW97\1:ZR?<8Y7Z;
MS4UQ_P EJM?^N1_]$M47PMM1!J&N+OW-"8X@PZ'E^?\ QVI;C_DM5K_UR/\
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M(OAZ2<@0CR^6. #YAY_#BO1:YWQCX:'B/2U2)E2\MR7@<_JOMG Y]A7/Z/\
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MS?1_^2P:E_N/_):*>TO0*N\?4G^+$9.D:?+@X6<KGMRO_P!:N_1UDC61#E6
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M'<@>ON>!6:I3O:QHZT+7N1^")8YO'GB*6$YC=G93ZYDZTOQ4_P"8+_UUD_\
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MJ3W)]:NU?MDM(K0S6';UE)W/$/#GQ<U;3+Y;'Q/"T\60KRF/RY8?<J!\W;C
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% 'F?Q$_Y&"#_KU7_P!#>M_X=_\ (OS_ /7TW_H"5@?$3_D8
M(/\ KU7_ -#>M_X=_P#(OS_]?3?^@)7KUO\ <H_(^>P__(SG\SK:***\@^A/
M,_B)_P C!!_UZK_Z&]<E76_$3_D8(/\ KU7_ -#>N2KZ7"?P(^A\5F'^]3]0
MHHHKH.(**** "NU\":]]GG_LFX?]U*<P$]F[C\?Y_6N*I58JP920P.01U%95
MJ2JP<&=&&Q$L/552)[Q16%X6UU=:TP&1A]JAPLJ^OHWX_P \UNU\U4A*G)QE
MNC[:E5C5@IPV84445!H%%%% ')?$3_D7X/\ KZ7_ - >L#X=_P#(P3_]>K?^
MAI6_\1/^1?@_Z^E_] >L#X=_\C!/_P!>K?\ H:5Z]'_<I?,^>Q'_ ",X?(],
MHHHKR#Z$**** "BBB@ HHHH **** "BBB@ KPKXWSEO%&GV^3M2R#@=OF=A_
M[+7NM>%?&^W9?%&GW)/RR60C''=78G_T(5M0^,Y\5_#/-+>$W%S%"OWI'"#Z
MDXKZ\@@BM;>*WA0)%$@1%'90, 5\AV\QM[F*9?O1N''U!S7UY;SI<VT5Q'G9
M*@=<]<$9%:8GH8X*WO$E%%%<IW!1110 4444 >?_ !8\52:!X>2QLY"E[J!*
M!U."D8^\01T/( ^I]*^>Z[[XP7SW7CN6W+DI:01QA>P)&\_^A#G_  KE_#&F
MQZOXHTS3YAF&>Y19!DC*9^89'?&:[J2487/*KR<ZEOD=OX&^%$FN6L.J:U))
M;V,HW10Q\22KV8D]%/YD>G!KT$_";P<8#&--D#'_ ):BYDW#_P >Q^E=JJJB
MA5 "@8  X I:Y959-WN=\,/"*M:Y\_\ CSX82^&;=M3TV9[G35(\Q7QYD.3@
M9QU'09__ %UYX"5(()!'(([5]?SP175O+;S('BE0HZGNI&"*^2=3LFTW5KRQ
M<Y:VG>$GW5B/Z5TT:CDK,XL324&G'9GT7\./%)\3^&(VN'#7UIB&XYY; ^5S
M]1^H-:_BW_D3-=_[!]Q_Z+:O(/@E>-%XIOK0N1'/:%]N>"RLN/T9J]?\6_\
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ME"E_/D7@=.%8"OF_Q%:PV'B;5K.V39!!>311IDG:JN0!D\G@=Z^LJ^4_%O\
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M/_UZM_Z&E>O1_P!RE\SY[$?\C.'R/3****\@^A"BBB@ HHHH **** "BBB@
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M44UW&-PBD0L''<#!'..1],=ZP?#_ (RTOQ#8?9M3-M#=X_?03 "-\'^'=UZ
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M52=ZI%=-4+/R/6/"T,=OX2T>*-0JK90]!C)V#)^I/-:]9GAS_D6-)_Z\H?\
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M4C((/!%>7_%OPAIKZ#<>(;>%8+Z!T,K(,"8,P7YAZ@D'/UZUL_";4;C4? D
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M_7TW_H"5@?$3_D8(/^O5?_0WK?\ AW_R+\__ %]-_P"@)7KUO]RC\CY[#_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M^2;ZM_VQ_P#1R5<^'VGRZ9X#TFUF4K((C(0<9&]B_;_>JG\5/^2;ZM_VQ_\
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M%^#_ *^E_P#0'K ^'?\ R,$__7JW_H:5O_$3_D7X/^OI?_0'K ^'?_(P3_\
M7JW_ *&E>O1_W*7S/GL1_P C.'R/3****\@^A"BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **X/Q=J%[;>./#UO!>7$4$LD8DCCD*J^9 #D X/%
M=Y52C9)]R8RNVNP4445)04444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110!X-7O->#5[S7KYK]CY_H?/9#
M_P O/E^H4445Y!]"%%%% !1110 4444 %%%% !1110 5E^(=#MO$>AW.EW6
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %ZK_P"AO6_\._\ D7Y_^OIO_0$KUZW^Y1^1\]A_^1G/YG6T445Y!]"%%%%
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M+4O$/A5++2[;[1<"Y20IO5/E 8$Y8@=Q5CX=:/?Z#X.M[#4H/(N4DD9DWJV
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M *]6_P#0TKUZ/^Y2^9\]B/\ D9P^1Z91117D'T(4444 %%%% !1110 4444
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MTP?3M,\/:-HQ)T[3+6V8]7CC 8_CUK3K.==M61M2PJB[RU"L?Q;_ ,B9KO\
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M:PVT"DD1PQA%!/7@<5M4K*:M8YZ.'=.5VR>N(^(O@4>+=/2XM"J:I;*?*+'
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M2,$?E7R3J$$5KJ5U;P2^;#%,Z1R?WU!(!_$5]%?$SQ$OA_P?<!' N[S_ $>
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MW+&&9 Z[EP<?2K-(JA5"J % P .@I:P-T%%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 >#5[S7@U>\UZ^:_8^?Z'SV0_P#+SY?J%%%%>0?0A111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M10 4444 %%%% !1110!R7Q$_Y%^#_KZ7_P! >L#X=_\ (P3_ /7JW_H:5O\
MQ$_Y%^#_ *^E_P#0'K ^'?\ R,$__7JW_H:5Z]'_ '*7S/GL1_R,X?(],HHH
MKR#Z$**** "BBB@ HHHH **** "BBB@ HHHH *\]^(T4MEJFBZZJ%X[:4!QC
M@$,&'Y\UZ%5;4+"VU2PFLKN/S()5PR_J#]0<&KA+EE<BI'FC8=97D&H64-W;
M2"2&50RL#_GFIZ\ZC\,>*O"\KCP]>1W=F^3Y$I .?H>,].014\R_$/5OW#QV
MFF1MPTD;@'UZAF/Y53IKHU8E5';6+N9OBK4XKWXE:+:PL&%I<0HY'3>9 2/P
M&!]<UVWBZPEU/PIJ%K NZ5H]RJ 26*D-@8[G&!7%?\*_O=,UW1)K)&NDBFCE
MNYRZK@AP3A2<X 'N:]/JIR2Y>7H33BWS<W4Y'X<ZI#?>%XK53^^LR8Y%SS@D
ME3]#R/P-==7$:SX)NX=5;6?#5V+2\+;W@8X1CWQ]?0\<]147VSXCE%A_LZQ4
M]Y]R9/U&_'Z4I14GS18XR<%RR19^)6J1VGALV 8&XO'553J=H.2?T _&MWPQ
M82:9X:L+.5=LL<0WKGHQY(_,US^B^";EM5_MGQ)=K?7O5(QRB'L>W3T P/>N
MFUS3I-6T:YL8KI[9Y4VB1/Y'V/0^U*35E!,<5)MS:(M:\.:9K\.R^ME9P,+,
MO$B_1O3D\=*XWPG+>>'O&ESX7><W-I@M&3_ =H8'VXX(]?UEBC^(FE6QLH8K
M6]C4!8YV=2R@>F67/X@UI>$?"EWIM[/K&L3"?4YP5XYV ]3GU.!TZ#ZU7PQ:
M;NB/BDFE9F)XPMX-/^(&F:E?0I)I\X5)?,C#(,94Y!R. 0:[=?#V@LH9='TT
MJ1D$6R8/Z4_6]&M=>TR2QNP=C<JR]48="*X^WTOQOX:'V;3);;4[)3^Z28@%
M1^)!'T#$4K\T4KV:';DDW:Z9UW_".:'_ - 73O\ P%3_  K,T.[\+WNL7,&E
M6-HEW9D_O8K95R.A*NHZ<X]^>U8EQ8^/?$"M;7CVNF6KC#B-AR.A'!8_AD"N
MJ\.^';/PWIYMK7+NY#2RL/F=L8_ >@[9I.R6KNQIMO161K,H92K %2,$'H:\
M_P#&/@^RLK*;7=(8V%U:@2%8CM5N1R/[IQZ<>U:?B/0M??68]9T+4<3)'Y;6
MTI^7'?'&,'J0?3(/3&->Z=X[\2QK8:C';6%FV/-9&7#8YR<,2?IP.E.FK--2
M%4=TTXG6>$M6GUOPU:7URN)F#*Y P&*DC</KC\\UMU3TK38-(TNWL+<?NH$V
M@GJQZDGW)R?QJY64K-NQM&Z2N%%%%(84444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% '@U>\UX-7O->OFOV/G^A\]D/_+SY?J%%%%>0?0A1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 >*ZY_R,&I?]?4O_H9KUO0_^1?TW_KU
MB_\ 0!7DFN?\C!J7_7U+_P"AFO6]#_Y%_3?^O6+_ - %>OF'\&']=#Y[*/\
M>*O]=2_1117D'T)R7Q$_Y%^#_KZ7_P! >O,Z],^(G_(OP?\ 7TO_ * ]>9U[
M^7?P/F?)9Q_O3]$%%%%=QY04444 %%%% !1110 4444 %>K^#=7GU71O](1O
M,MV\KS>SC''X^OX>M>9Z;I\^J:A#9P#+R-@G'"CN3["O9--T^'3+"&T@4!(U
M )Q@L>Y/N:\S,YPY%![GNY)2J>T=1?#MZGGOQ$_Y&"#_ *]5_P#0WK?^'?\
MR+\__7TW_H"5@?$3_D8(/^O5?_0WK?\ AW_R+\__ %]-_P"@)45O]RC\C3#_
M /(SG\SK:***\@^A"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \
MS^(G_(P0?]>J_P#H;UO_  [_ .1?G_Z^F_\ 0$K ^(G_ ",$'_7JO_H;UO\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH Y+XB?\B_!_P!?2_\ H#U@?#O_ )&"?_KU;_T-
M*W_B)_R+\'_7TO\ Z ]8'P[_ .1@G_Z]6_\ 0TKUZ/\ N4OF?/8C_D9P^1Z9
M1117D'T(4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 >#5[S7@U>\UZ^:_8^?Z'SV0_P#+SY?J%%%%>0?0A111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MWH?_ "+^F_\ 7K%_Z *]?,/X,/ZZ'SV4?[Q5_KJ7Z***\@^A.2^(G_(OP?\
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M1/\ D7X/^OI?_0'K ^'?_(P3_P#7JW_H:5O_ !$_Y%^#_KZ7_P! >L#X=_\
M(P3_ /7JW_H:5Z]'_<I?,^>Q'_(SA\CTRBBBO(/H0HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \&KWFO!J]Y
MKU\U^Q\_T/GLA_Y>?+]0HHHKR#Z$**** "BBB@ HHHH **** "BBB@ HHHH
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MSF60#[B^M>Q6UO%:6T=O"@2*-0JJ.P%>=C\3R1]G'=GLY3@O:S]M->ZOQ?\
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M "^^W-=%2J24I-H=&+C!)A7A?Q(\47/BWQ!#X9T4/+;Q2["(^?/EZ9XZJO\
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M /=Q_%^'\_I7HM>/F&)N_91^9])D^"Y5[>:U>W^84445Y1[P4444 <E\1/\
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M1110 4444 %%%% !1110 4444 %%%% ')?$3_D7X/^OI?_0'K ^'?_(P3_\
M7JW_ *&E;_Q$_P"1?@_Z^E_] >L#X=_\C!/_ ->K?^AI7KT?]RE\SY[$?\C.
M'R/3****\@^A"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MTV.2?48M2F:!8H1(V4<X(7!S@+GIVS70_P#"3?%C_GWU;_P4+_\ &Z3Q/O\
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MJW_;'_T<E?-E?2?Q4_Y)OJW_ &Q_]')7S971A_A./&?&O0^B_A'_ ,D]M/\
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MF\/VD+#38[B_FP=OR&-,]LEN?R%<UJM[:G=S4+7T-?\ X57X+_Z W_DU-_\
M%T?\*K\%_P#0&_\ )J;_ .+KR!/BGXJCUN745O@4D;)M'7="%[*%ZCZ@@^_-
M>M^ _'W_  F0FBDTR6VGMT#22J=T)/3 /4$\D#G@'GBG.-2*O<BG.C-V4?P.
MPMK>*TM8;:!=D,*"-%R3A0, 9/M7R7JO_(7O?^N\G_H1KZYKY&U7_D+WO_7>
M3_T(U6&W9&,VB=_\$O\ D<[S_L'O_P"C(Z]4^(7_ "(&L_\ 7#^HKROX)?\
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M6T^^BU+3[>]@$@AGC$B"1"K8([@U9K Z=PHHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** .2^(G_(OP?\
M7TO_ * ]8'P[_P"1@G_Z]6_]#2M_XB?\B_!_U]+_ .@/6!\._P#D8)_^O5O_
M $-*]>C_ +E+YGSV(_Y&</D>F4445Y!]"%%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH \&KWFO!J]YKU\U^Q\_T/GLA_Y>?+]0HHHKR#Z$**** "
MBBB@ HHHH **** "BBB@ HHHH ^>_%]C?^ OB+_;%G"%@DG-S;-@A&W??CXZ
M=2,>A'K7KWA[Q[H'B*U1X;Z*WN2!OM;APCJ?09^\/<9_#I6OK&C6&O:;)8:E
M;K/;O@X/!4CH01R#7E6J? Z0S,^DZNGE$DB.Z0@J,\#<N<_D.E;\T)JTM&<O
M)4I2;@KIGK-_JNGZ5 TU_>P6T:C),L@7C^M>#>//%<OC[7K/3=%AFDM8CM@C
MQAII#U8CL !@9Z#)XSQ>@^"&NM)BXU+3HX_[T;.Y_(J/YUZ5X0^'^D^$5\V'
M=<W[+M>ZE4 CU"C^$'ZD^]-<E/5.[%)5:ONM61L>'-'30/#MAI:E3]GB"NRC
M 9^K$?5B3^-3ZS_R ]0_Z]I/_035VJ6L_P#(#U#_ *]I/_036%[NYTVM&R/E
MK1AJ=O<MJFE!_.T[%PSH,E%!QN([KR ?8\\9KWGPI\3]%U^VCBO9XM/U' #Q
M3-M1V]48\8/H>?KU/!?!%5?Q+J2L 5-D001P1O6NJ\2_!O2]2E-SHT_]FRG[
MT)7?$WT&<K^H]A755<7+ED<5"-2,.:&OD>CFY@6 SF:,0CDR%AM_/I7GWC7X
MJ:?H]K+9Z)<17FI,-HD3#Q0Y[YZ,1Z#OUZ8KCC\$-?\ .(&HZ88NS%Y ?RV?
MUKJ/#GP9T[3YEN=:NCJ$BG*P(NR+O][NW8]AV.16:C3CJW<U<ZT]%&QB?"3P
MC/>:B?%&I(YC0L;8R<F60Y#/SU R>?7Z5[538XXX8DBB14C10JHHP% Z #L*
M=6<YN;N;4J:IQL@HHHJ#0*\"T[_DO3_]A*;^35[[7 VWPT^S^/6\3_VONS<O
M/]F^S8^]GC=O]^N*UIR2O<PK0E)QMT9WU9'BC08?$WAV[TJ9MAE7,<F,['!R
MI_,<^V1WK7HK-.SNC9I-69\]^$?%.H?#?7;K2=8MIA:,_P"_@')1\<2)V.1C
MZC'H*]QTKQ%H^N1))INI6]SN&0B/\X^JGYA^(JEXG\&Z/XLM@FH0$7"+MBN8
MSB2/\>X]CD<GOS7F%[\#M421OL.K6<L?\)G5HS^. WO6S<*FKT9RI5:6B5T>
MOZGKNE:-"TNHZA;VRKVDD 8]\ =2?85X;XV\97GC[6+?1M'AE^PB7$,>/FG?
MD;R,<#!Z=N2?;1LO@=JSR?Z=JME$F1_J \A([]0M>F^%O ^B^$XR;*$R73##
MW4V&D(] <?*/8>V<T)PIZIW8-5:NC5D3^$/#D7A7PW;:8A5Y1EYY%'WY#U/T
MZ >P%;M%%8MW=V=222L@HHHI#"BBB@#'\6_\B9KO_8/N/_1;5Y1\#?\ D.:K
M_P!>R_\ H5>QZO8?VKHM]IWF>5]JMY(/,V[MNY2N<<9QGI7)^!OAY_PAE]=7
M/]J?;//C$>W[/Y>W!SG.XYK6,DH-&$X2=6,ELCN*\"^(&CW?@OQS%K^FJ4@G
ME^T1-M)5)>KH?KR<>AQVKWVJ>JZ59:UILUA?P+-;RC#*>WH0>Q'K4TY\K*JT
M_:1MU,3PMXZT;Q1:1^3<QQ7N )+61@KAL<[0?O#/<5I:WXDTCP[;--J=[%#\
MN5CSEW_W5ZGI7ENK_ ^Y^T.^C:I"82<K'=@J5'IN4'/Y"H-.^!^I/,/[3U6T
MBB[_ &8-(Q_[Z"XK3DI[W,O:5DK<NIALU_\ %/X@@JCQVN<8Y(@MU/4\]3[=
MS7T-!!%:V\5O"@2*) B*.R@8 K,\/>&=+\+V)M-+M_+5SNDD8[GD/JQ_ITK7
MJ*D^;1;(THTW"[ENPHHHK,V"BBB@#YI^(GA]_#7B^[BA#):7>9X,'C:QY7CT
M;(QZ8]:]A^%_AW^P?"$,DJ;;J^Q<2Y&" 1\JGZ#GZDUI>*O!MAXL?3FNR%-I
M.)&^3/FQ_P 49.00#QS71UM.KS02.:G0Y*CE]P4UT22-D=0R,"&5AD$'L:=1
M6)TGSQJ=CJOPJ\;K>68=[)V/DLQ^6>(D$QL1W''X@''2O8?#_CWP_P"(K97M
M[Z*"X/WK:X8)(I]@?O?49K9U72-/URP>QU*U2YMV.2CYX/J".0?<5Y1JOP.<
MSE](U9!$2<1W2'*_\"7KW["M^:%1>]HSEY*E)^YJNQZ[=7EK91&6[N8;>, D
MO+($  ZG)KR/XB_%"WN+*71O#\WF"4;;B\7[NTY!1<CG/=O3IG.1F0?!#7FE
M N-1TV./NT;2.?R*C^==SX5^%6C>'Y8[N[)U&^3!#2J!&C>JIZ^YST!&*$J<
M-;W!NM4]U*Q6^$_@Z30M*DU:^CVWU\H"(RX:*+K@Y&02<$CV6NN\6_\ (F:[
M_P!@^X_]%M6Q5/5[#^U=%OM.\SROM5O)!YFW=MW*5SCC.,]*S<N:7,S9048<
MJ/(?@9_R$=9_ZY1?S:O7]4L(]5TF\T^4XCN87B)QG&X$9_#K7*^!?A__ ,(7
M<7DO]I_;/M**N/L_E[<$G^\<]:[6G5DG.Z)H0<::C(^=O!^OW7PY\77-AJT4
MBP,1#=1C)V=UD [\'/N#Q7O>FZQINKPK-IU];W2%0W[J0$@>XZCZ&L7Q9X#T
MCQ='ONE:"]5<)=0XW=\!@?O+D].OH17FES\#]:1R+75+"5,\&7?&2/H WMWK
M1N%35NS,HJI1T2NCU?7_ !=HOANT>>_O8]XSM@C8-*Y] N?U. .YKQ?PY%??
M$7XEC4[J,""*1;B8 _+'&A&U ?? 'O\ ,?6MG3O@=?-(AU/5K>.//S+;*SDC
MV+ 8_*O5M \.Z;X9TU;'38=D>=S,QR[MZL>YI<T()\KNQ\M2K)<ZLD:M>._'
M;_F ?]O'_M*O8JX[QWX$_P"$V_L__B9?8OLGF?\ +#S-^_;_ +0QC;^M12DH
MS39K7BY4VD:/@7_D1=$_Z]$_E705GZ%I?]BZ%9:9YWG?985B\S;MW8[XR<?G
M6A42=VRXJT4F%>"^&?\ DOD__80OO_09:]ZK@M,^&O\ 9WCY_%']K>9NN)Y_
MLWV;&/,##&[=VW=<<XK2G)).YE6A*3BUT9WM>7?'#_D7--_Z^S_Z :]1KEO'
M'@[_ (3/3K:T^W_8_(F\W=Y/F;N",8W#UJ:;2DFRZT7*#2&_#3_DG>C_ /7-
M_P#T8U=763X:T7_A'?#MGI/VC[1]F4KYNS9NRQ/3)QU]:UJ4G>394$U%)G@W
MC32K_P"'_CF/Q'IBK]DN)C+%G[H8_?C(&.#DX]C[5ZAX;\?Z#XDME:*[CMKK
M WVUPX5@3_=S]X>X_'%=!?Z?::I926=];QSV\@(9'&0?\#[CFO*]:^",4LSR
MZ+J?DH3Q!<J6"\=G'/7U'XUKS1FK2T9SN$Z<FX:I]#UF:>*WCWS2I&G]YV '
MZUY]XO\ BMI6DVDEOHT\=_?LI"/&0T49Y&2W1L>@KC%^"/B R@/J&F"//+!Y
M"<?39_6NJ\._!G3=/G2YUFY_M%UY$"J4B![9YRWZ#U%"C3CJW<'.M/11L5?@
M_9^()OM6KWU]<_V;,7*0R'(GE8Y:3GMUY'4GV.?6*;'''#$D42*D:*%5%& H
M'0 =A3JRG+F=S>G#DCRG@&O6-_\ "[QY'JEA&'L)F9H W"NAQOC..F,\?@?:
MO7/#WCC0?$=LLEK?113XR]M.P21#WX/4>XR*U]3TJQUFPDL=1MDN+:3[R/\
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MV[75NF1G[N.O>HY[SYF:>SY:3@NQQWP2_P"1,O/^P@__ *+CKTFN:\$>$_\
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M!/*!^0;%;^EZ)IFB0M#IEC!:HW+>4@!;KU/4]3UJE.G'6*U(=*K/2<M/(R?
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MP5B'W1^/+>A!6O0I(XYHGBE17C=2K(PR&!Z@CN*(XXX8DBB14C10JHHP% Z
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MJH] !P*?M(1^!:D^QJ3?[QZ>06MM#96D-K;H(X((UCC0'.U5& /R%<G\5/\
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M87C"XUBV\,7CZ%;M-J!4*@3&Y03RP'<@=J\O\-?&6XL+9+/Q!:277E847$1
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M_P"AO7)5]+A/X$?0^*S#_>I^H4445T'$%%%:>A:/+K>IQVJ;ECZRR 9V+_\
M7Z4I248N4MD7"$JDE"*U9TO@/03)+_:]PAV(<6X[,>03^';W^E>@U'!!%;0)
M##&L<2#"JHX J2OFL16=:;DS[;"8:.&I*FOGZA1116!TA1110 4444 <E\1/
M^1?@_P"OI?\ T!ZP/AW_ ,C!/_UZM_Z&E;_Q$_Y%^#_KZ7_T!ZP/AW_R,$__
M %ZM_P"AI7KT?]RE\SY[$?\ (SA\CTRBBBO(/H0HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M% !1110 4444 %%%% !1110 4444 %%%% '@U>\UX-7O->OFOV/G^A\]D/\
MR\^7ZA1117D'T(4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !5+6
M?^0'J'_7M)_Z":NTR:&.X@DAE7='(I1AG&01@T(3V/#?@A_R,^H?]>1_]#6O
M=:PM#\&Z!X;NI+G2;#[/-(GENWG2/E<@XPS'N!6[6E22E*Z,Z--PARL****S
M-0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#Q77/\ D8-2_P"O
MJ7_T,UZWH?\ R+^F_P#7K%_Z *\DUS_D8-2_Z^I?_0S7K>A_\B_IO_7K%_Z
M*]?,/X,/ZZ'SV4?[Q5_KJ7Z***\@^A.2^(G_ "+\'_7TO_H#UYG7IGQ$_P"1
M?@_Z^E_] >O,Z]_+OX'S/DLX_P!Z?H@HHHKN/*"N]\"^'\ :O<J#D$0(R]/]
MO^@KG/#&A-KFIA'#"UB^:9@<8'.!^)'\Z]=C18HUC10J* J@= !7F9AB>5>R
MCN]SW,HP7/+V\UHMO7_@#J***\4^F"BBB@ HHHH **** /,_B)_R,$'_ %ZK
M_P"AO6_\._\ D7Y_^OIO_0$K ^(G_(P0?]>J_P#H;UO_  [_ .1?G_Z^F_\
M0$KUZW^Y1^1\]A_^1G/YG6T445Y!]"%%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 >&W&@ZPWQF%\-)OC9_VFC_ &@6S^7MR.=V,8]Z]RHH
MJYSYK&=.FH7\PHHHJ#0**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MC/( Y_+UKYM_XF7B+6?^6U[J-W)]6=C_ "'Z #T%>F?'6XD.I:/;%OW2PR2
M>Y(!_P#014?P-TV&?6-4U&0*TMK$D<8*YQYA;)!['"8^C&HIVA3YS2M>K6]G
MT#3?@;J,]L)-1U>"TE(!$<4)FQZ@G*C(]LCWK#\4_"O6O#=F;Z.2._M%_P!8
MT*D/'[E?3W!/OBOHRBLUB)WU-WA*;5D>/_"7P[XKTNZ:[G'V/2)AF2WN =\I
MQPRK_">G)QQV/;U#7-7M]!T2\U2Z_P!5;1ER,XW'HJCW)('XUH5YS\:YY(O
M\*(<+-?1H_N-KM_-14W]I-7+Y?8TG;H>(ZUK%_XEUN:_O&:2XG?"(N2$&?E1
M1Z#H/\:[[1?@GJM]9K/J>H1:<[C(A6+SG7_>^8 'Z$UA?"JQAOOB!8>>H=8%
M>95(R-RJ=I_ X/U KZ3K:M4</=B<N'HQJ)SGJ?-GB_X::OX3MFO6DCO-/#!3
M/&""F3@;E/3/'<C)QFKOPM\:2Z#K<6EW<['3+QPFUCQ%(3@,/0$G!_/M7ONH
MV,6I:;<V,X!BN(FB;(SP1BOD($J002".01VJJ<O:Q:D36A[":E ^N=9_Y >H
M?]>TG_H)KY%KZPN)GN?!\L\A!DEL"[$#')CR:^3ZG#;,K&ZN)WO@[X6ZCXJL
M!J,MVEA9.2(G:/S'DQQD+D<9R,D]JS/&G@6^\&7, GF2YM;C=Y4Z+MR1U##L
M<$'O]>#7T?HUK#9:'86L"[8HK>-$'L%%<)\;8E?P7;2<;H[Y"#CG!1QC^7Y4
MHUI.=NA53#0C2OU.*^"^K2VGBV73MQ,%[ V5SP'3Y@?RW#\:]D\6:^GAGPS>
M:J55Y(EQ$C'AW)PH]QDY..P->$_"3_DHMA_USE_]%M7>_'*XD3P]IENK8CDN
MBS#U*J<?^A&BI%.JD%&;C0;['BTTU]K>JF25I;N^NY0,]6D<G  _0 5Z5I7P
M/U*ZM%EU/5(;&5@#Y,<7G%?9CN S],UE?!RRM[OQV'G"DVUL\T08 Y?*J,>X
M#$_A7T/3K57%\L2<-0C-<TSYF\7?#[5_!RK<S/'<V3G8+B'(VDCHP/3//J/?
MM7+VO_'Y!_UT7^=?5?BBRBU#PKJMK, 4DM9.V<$*2#^! /X5\J6O_'Y!_P!=
M%_G6E&HYK4SQ%)4Y*VS/L&OF/Q_XLG\4^(IG$I-A;NT=K&#\NT'[WU;KGTP.
MU?0_B:>2U\*:Q<1'$D5C,ZGT(0D5\IVD2SWD$+ML6215+>@)QFLL/%:R-\9-
MZ11VGA+X7:OXHM%OI)8["P?_ %<LB[FDYQE5&...I(]LUIZ[\%M7TZT:XTR]
MCU((NYHO*,<A_P!T9(/YY]J]VMX(K6VBMX(UCAB0)&BC 50, #\*DJ'B)WNC
M182GRV>Y\<DECDDD].:^C/A%_P D\M/^NLO_ *&:\;^(UC%I_P 0-7@A "&5
M9< 8 +HKG]6->R?"+_DGEI_UUE_]#-:UW>FF<^%CRU6CY]U7_D,7O_7Q)_Z$
M:[7PG\,=2\8:5+K$VHK:I*S>2TB&1IF!Y8\C W9&>3D'CUXK5?\ D,7O_7Q)
M_P"A&OISP+"8/ NB(5VYLXWQG/WAN_K55IN$58C#THU)M2V*FK>#X[OX='PU
M#M+Q6R+"Y&<R)@@]L9(Z^YKYST75+C0M=L]2@+++:S!R,D9 ^\I]B,@^QKZW
MKYO^*VA?V+XVN)D.8-0'VI?9F)WC_OH$_0BLZ$KMQ?4WQ=.R4X]#Z)LKN+4+
M"WO8"3#<1+*A/7:P!'Z&O)/C;XBVI:>'H'Y;%Q<8/;D*I_4_E5[X3>+(1X.O
MK6_FVC2 9=S$9\DY/'K@@C\0*\=UK5+GQ#K]WJ,RLT]W,6" [B >%4>N!@#Z
M44J5IN_0*]>])6ZG>?!KPX=0UZ36ID!@L!MCR,@RL/Z Y_$5[U6!X+\/KX9\
M*V6G$#SPOF7!R#F5N6Y'4#H/8"M^L:L^:5SHH4_9P2"N*^*U[)9?#Z_\I]K3
MLD)..Q89'X@$5VM<3\6+-KOX>W[+G= \<N .H#@']"3^%*G\:*K7]G*W8\(\
M(Z9'K'B[2["49BEN%\P8SE1R1^(!%?5M?*G@V_BTSQEI-Y,Q6*.Y3>W]U2<$
M_K7U76V)W1S8*W*PHHHKF.T\8^.>F1)/I6J(N)9 \$AXY P5_FWZ5G?!"\:+
MQ3?69=A'/:%]N>"RLN/T9JTOCGJ4;2:3IB.AD3S)I5[J#@+^?S?D*R_@C9M-
MXLO+O^""T(_X$S+C] U=B_@ZGG2_WG0U_CQ_S+__ &\?^TJ\BLK*YU&]AL[.
M%YKB9ML<:#)8UZ[\>/\ F7_^WC_VE6=\#[*&;Q!J-Y(BM+;VX6,D9V[CR1Z'
M"X^A-.G+EI7)JPY\1R_UL3V7P,O9;(27FM0V]R1GR4@,@''0MN'Z _C7$^+/
M!.K>#[B-;X)+;RY\JXAR48^AR!AL<X_+-?4=<I\2;*&^\ :JLQQY48F1O1E(
M(_/I^-90KRYM3>IA8*#<=SSGX-^+);74SX;NI,VUSNDML_P2 9*^P(!/U'N:
M]%^)G_).M8_ZYI_Z,6OGGPQ/);>*](FB.'2\B(YZ_../I7T-\3/^2=:Q_P!<
MT_\ 1BU56*51/N30FY49)]#P+P1_R/.A_P#7[%_Z$*^G]3U"WTG2[K4+IB(+
M:)I7QC) &<#/<]![U\P>"/\ D>=#_P"OV+_T(5[?\7KB2#X?7*QM@3311O[C
M=G^8%%97FD+#2Y:4I'A/B+Q#J'BG69+^^<L[G;%$OW8USPJC_.>M=OH?P5U;
M4;..YU*_BT[S$W+%Y1DD7V894 X]S_AYS87USIE_!?6D@CN('#QN5#;6'0X(
M(KJO^%J^-?\ H-?^2L/_ ,16TE.UH:'-3E3NW4NR_P")_A)K&@6,E]:SQZC;
M1 M)Y:%)%7UV\Y&.3@\<_6L_X>>,I_"NNQ)+*QTNY<+<Q$\#/ <9Z$<9]1^&
M%_X6KXU_Z#7_ )*P_P#Q%<<[%W9SC+')P !^0Z4*,FK3"4X1DI4KH^QJ^<?B
M1XWG\3:Q+96TV-(M9"L*H>)6'!D/KGG'H/<FO8HM2FE^$QU%6(N!HK2;C_?$
M)R?S%?-5I!]JO(+?=M\V14W8SC)QFL:$%=M]#JQ=1V45U.M\*?#36_%5N+Q/
M+L[ G"SSYR_KL4<GZG ]^*Z>^^!=[% 6L=;AN)0#\DL!B!_$,U>S6=I!864%
MI;($@A01HH&, #%3U#KSOH:1PE-*SW/F#3/!GBMO$9LK*PN8;ZTE&Z;.Q(3U
M#;^G3D8ZCIFO?-6T;5M8\"7&DW5Q:OJD]OY;S %(BV>O0D=/3KV%='14SJN3
M3[%T\/&":ON?*/B?PU>>%-6_LV^E@DF\M9-T#$K@Y]0#V]*T?"?@'5?&-M<S
MZ?<6<2V[A&%P[*22,\84UL_&?_D>Q_UZ1_S:NL^!?_('U?\ Z^$_]!-=,IM4
M^;J<,:476Y.AE_&FW>UTWPK;R%2\4,R,5Z$@1#BJGP._Y&C4?^O(_P#H:UJ?
M'C_F7_\ MX_]I5E_ [_D:-1_Z\C_ .AK4+^":/\ WK^NQH?&[P_LFLO$$*J
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M8Q::J02(QRDH R=I]<9.#Z=Z[NN6JY.7O'?AXP4/<=PHHHK(W"BBB@ HHHH
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MHHKR#Z$**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#S/XB?\C!!_
MUZK_ .AO6_\ #O\ Y%^?_KZ;_P! 2L#XB?\ (P0?]>J_^AO6_P##O_D7Y_\
MKZ;_ - 2O7K?[E'Y'SV'_P"1G/YG6T445Y!]">9_$3_D8(/^O5?_ $-ZY*NM
M^(G_ ",$'_7JO_H;UR5?2X3^!'T/BLP_WJ?J%:_AS1GUO54@Z0IAYCT^7/0>
MYK+BB>>9(8E+22,%51U)/ %>O^'-&31-*2#K,^'F/^UCH/85&,Q'L8:;LTRW
M!_6:OO?"M_\ (U(HD@A2&)0L<:A54= !P!3Z**^=/L4K!1110 4444 %%%%
M!1110!R7Q$_Y%^#_ *^E_P#0'K ^'?\ R,$__7JW_H:5O_$3_D7X/^OI?_0'
MK ^'?_(P3_\ 7JW_ *&E>O1_W*7S/GL1_P C.'R/3****\@^A"BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH Y+XB?\B_!_U]+_Z ]8'P[_Y&"?\
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MW8'&)HF0Y].15M1JJZ=C).6';4HW1]%:Z/A]X<AD?4M-T-)$&1;K:1-*QQD
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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ML3H"BBB@ HHHH **** "BBB@#DOB)_R+\'_7TO\ Z ]8'P[_ .1@G_Z]6_\
M0TK?^(G_ "+\'_7TO_H#U@?#O_D8)_\ KU;_ -#2O7H_[E+YGSV(_P"1G#Y'
MIE%%%>0?0A1110 4444 %%%% !1110!Q/Q'\8:AX/L+&?3X;65KB5D87"LP
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M8Y,D1^Z22<D@@@_\!]:PJT5%71U8?$.;Y9;GH5%%%<YV!1110 4444 %%%%
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M4 %%%% !1110 4444 %%%% !1110 4444 >#5[S7@U>\UZ^:_8^?Z'SV0_\
M+SY?J%%%%>0?0A1110 4444 %%%% !1110 4444 %%%% !1110 45C^*/$5K
MX7T*?4KHCY?EBC[R2$':H_+\@:/"VJSZYX8T_4[E(TFN(M[K$"%!R>F23^M.
MSM<GF7-R]38HHHI%!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 455U.:2WTJ\FB;;)' [J<9P0I(KS'X5^,M?\2:]>6VK7_VB&.V
M\Q%\F-,-N49RJCL35*#:;[&<JBC)1?4]8HHHJ30**** "BBB@ HHHH ****
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MHH **** "BBB@ HHHH \S^(G_(P0?]>J_P#H;UO_  [_ .1?G_Z^F_\ 0$K
M^(G_ ",$'_7JO_H;UO\ P[_Y%^?_ *^F_P#0$KUZW^Y1^1\]A_\ D9S^9UM%
M%%>0?0A1110 4444 %%%% !1110 4444 %%%% !1110 45E^(==M/#>BW&IW
MC#9$/E3(!D;LH]S_ (GM7 _"36+K7]9\4:G>L#-.]NQ Z*/WF%'L!@?A5J#<
M7(S=1*:AU9ZE1114&@4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M1110 4444 %%%% !1110 4444 <E\1/^1?@_Z^E_] >L#X=_\C!/_P!>K?\
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MY/W=#T>R^.&K),IO]*LIHNX@+QM^9+5Z+X=^(>B>)+:3[+(T5['&7-G/\KG
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MJ.I:Q8:0D;7T_E+(2%.QFSCZ THQ<G:*NPE.,%S2=D7J*P?^$T\/_P#00_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \
M&KWFO!J]YKU\U^Q\_P!#Y[(?^7GR_4****\@^A"BBB@ HHHH **** "BBB@
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M>1RP#'JJY_A'0?GWHG!16XJ=24W\-D;E%>>?$#XEQ>&F.FZ6([C4R/WA;E(
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M?3F94TUS094*LE+DJ*S/3Z^?/&O_ "6M_P#K[M/_ $".OH.OGSQK_P EK?\
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M7&K77V>*5]B-Y;/EL9Q\H-)X:UE/$/ARQU55"?:(LNHZ*X.& ]@P-<'\</\
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M]<Z9:&PTFSLV(+00)$2#P2J@?TK;$[(PP2U;/FGQ_P#\C[K7_7RW]*N_"O\
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M*@4'@.P#,?KRH_X#7IOPGF>7X=V ;GRWE0'VWL?ZUXK\06+^/M9+')^T$?D
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MNKVNF64#+C:8K=%(QTZ"B5=1=K!#".45*Y\[^%/AWK7BB6.40-::<2"UU,N
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M_P#(CR?]?LG_ *"E=9XM_P"1,UW_ +!]Q_Z+:L)_Q#JI_P %>A\IU[;\#?\
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M&L<4:A411@ 5S_CW2(=9\%:G!+@-%"UQ&Q'W70%A^>"/QKI*I:S_ ,@/4/\
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MYV^>-O-0>JG@_D<?G7*6FARW7AZ]U4$A;=U55_O?WOR!%,\/:E_9.N6UT?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MGC#UT4I/DDCDKQ2J0EYGO]%%%<YUA1110 4444 %%%% !1110 4444 %%%%
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M.<_[(]:WE#FFFMF<L*O)3:>Z.9\"^&I/'_B#5M2U8LT.QV=QP#-)D+@>B\G
M/&%'0U:^%VIS^&/'%WX?ORJ"Y<V[C/ F0G;@^_S#WR*]0^'_ (>_X1OPC:6T
MJ!;N4>=<?+@AVYVG_=&!^%>;_&#1)M)\16?B.R+QBX(#2(,>7.G(.1T) !'?
M*FJ4U.3AT,W3=.$:G5;GM[,J*68@*!DDG@"O HU/Q'^+CL5WZ?&Y)P00((^
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MXCFMZ&E_0Y<4KJ*\SWZBBBL#J/F:SU/3-7^(S:KKURL>GO=/.[&-F#*,E%P
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M4CJ"*U= \4ZSX9F:32[QHE?EXB-R/]5/'X]:ZJM/GU1Q4*WLG9['U77)^/\
MQ7;>&/#LY\Q#?W"&.VA/)8G@L1Z '/Y#O7E<OQH\420A%BTZ)AC]XD+;C^;$
M?I7#ZGJM]K-ZUYJ-U)<W#  O(<\#H!Z"LH4'>\C>IBX\MH;E.O8O@3_S'_\
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M7B3_ )&34/\ KNU>@>!/^18C_P"NC_SKS_Q)_P C)J'_ %W:O0/ G_(L1_\
M71_YUZ&-_P!UC\OR/(RS_?I_/\SI:Y'XAHIT&!R!N6Y !QSRK9'\ORKKJX'X
MB:@C&UTY&RZDRR 'IQA?QZ_Y->?@HMUXV/6S.2CA9WZF'X+)'BRR [^8#_WP
MU>M5Y=X"M6G\1"< ;;>-F)/J?E'\S7J-;9DTZR]#GR6+6&;?5O\ 0****\\]
M<**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \&K
MWFO!J]YKU\U^Q\_T/GLA_P"7GR_4****\@^A"BBB@ HHHH **** "BBB@ HH
MHH *Y3QMX1N_&%K!9IK!L;1#NDC6 OYK=LG>.!Z8ZUU=%--IW1,HJ2LSQW_A
M1/\ U,G_ )(__;*/^%$_]3)_Y(__ &RO8J*T]M/N9?5J78^;/'?@3_A"?[/_
M .)E]M^U^9_RP\O9LV_[1SG=^E=#X9^$?]LZ+I^L?VYY/GJ)?*^R;MO/3.\>
MGI6A\=O^8!_V\?\ M*N\^'O_ "(&C?\ 7#^IK6527LT[F$:,'6E&VB.FHHHK
ME.X**** / _$BO\ #WXKIJ=O'(+.9_M(1<?,CY$BCMUW8';Y?K4GPZLIO&/Q
M$N=?OT#I;/\ :7ST$AXC'3MC(_W:[CXN^'SJ_A/[="A:XTUC+@?\\SC?^6 W
MT4UI_#?P_P#\(_X-M8Y$*W5U_I,^[J&8# _!0!]<UTNHO9WZ['$J3]K;IN=;
M7B7QFT-['6K/Q%;+L6XVQRN,Y$J_=/H,J /^ 5[;6)XOT(>(_"U]IN!YLB;H
M3QQ(O*]>G(Q]":QIRY97.BM#G@T>(M=W7Q1^(%A'*C1P&-%D102L:JH,A'/
M+;L'W7O7T0JJBA5 "@8  X KROX+^'&L]/N];N8F2:X8V\08<[%/S'U'S#'_
M  &O5:NLU?E6R(P\7R\TMV5-4L(]5TF\T^4XCN87B)QG&X$9_#K7B?POU@^%
M?%][H.J8@%TPA+.=H25"=O7UR1^(KW>O./B1\.&\2-_:VDK&NIJN)8V.T7
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MUG_D!ZA_U[2?^@FO'?@;_P AS5?^O9?_ $*O8M9_Y >H?]>TG_H)KQWX&_\
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MS\'KV74$O?$\Z>4K;FMD<N\OLS=A],GZ5<8P@^;F,ISJ5(\BC8]!^']M/:>
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M"?\ Z]6_]#2O7H_[E+YGSV(_Y&</D>F4445Y!]"%%%% !1110 4444 %%%%
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M?#+3O"TJ7UQ)]MU(#B4KA(\_W1Z]>3^E=U11*M*2L$,/"#N@HHHK(W"BBB@
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M510J@!0,  < 4M%%(84444 %%%% !2,JNI5@"I&""."*6B@#+_X1G0?/\_\
ML33?.SGS/LD>[/UQ6FJJBA5 "@8  X I:*=VQ));!1112&%%%% &6WAG07F$
MS:)IIE!R'-I'N!Z]<5I(B1QJB*%10 JJ,  =A3J*=VQ));!1112&,EBCFC:.
M6-9(VX*N,@_A68WA?P^\IE?0M,:0G)<VD9.?7.*UJ*:;0FD]R&VM+:SB\JUM
MXH(\YV1(%&?H/I4U%%(84444 %%%% !56[TVPU 8O;*VN1C&)HE?CTY%6J*
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_#O_ )%^?_KZ;_T!*]>M_N4?D?/8?_D9S^9UM%%%>0?0A1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH Y+XB?\B_!_U]
M+_Z ]8'P[_Y&"?\ Z]6_]#2M_P"(G_(OP?\ 7TO_ * ]8'P[_P"1@G_Z]6_]
M#2O7H_[E+YGSV(_Y&</D>F4445Y!]"%%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% '@U>\UX-7O->OFOV/G^A\
M]D/_ "\^7ZA1117D'T(4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M 'BNN?\ (P:E_P!?4O\ Z&:];T/_ )%_3?\ KUB_] %>2:Y_R,&I?]?4O_H9
MKUO0_P#D7]-_Z]8O_0!7KYA_!A_70^>RC_>*O]=2_1117D'T(4444 %%%% !
M1110 4444 %%%% !1110 4444 >9_$3_ )&"#_KU7_T-ZW_AW_R+\_\ U]-_
MZ E8'Q$_Y&"#_KU7_P!#>M_X=_\ (OS_ /7TW_H"5Z];_<H_(^>P_P#R,Y_,
MZVBBBO(/H0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M>C_N4OF?/8C_ )&</D>F4445Y!]"%%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MG\SK:***\@^A"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M110 4444 %%%% !1110!R7Q$_P"1?@_Z^E_] >L#X=_\C!/_ ->K?^AI6_\
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MS)^?;_=45REKK%[J/C.;Q#%HMSJ4<3GRXHD)"<83)"GD#GZ\UUW_  G.N?\
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M?^S"HA\2-)_"S@?#4FN^(=)M="TV9K"QM0WVFZ4G+%G9@.,'H>@//.370_\
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M/KQGW-9_BZW2?XH:'&R*RNL)<$#YL2-U]>!7I=$Y62DMV.$+MQ>R/+KJUO\
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M9I:5HNI>.+]-9UUFCTP-F"T!(##V]!ZGJ:T_B;&D7A"&.-%1$N45548  5L
M"NV50JA5 "@8 '05Q?Q1_P"14C_Z^D_]!:E&;E-=BIP4:;[G3:'_ ,B_IO\
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M77TW%K<F,E+8****104444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M $VX6>W?(R."I'4$'D&B5.4=QPJPG\++]%%%0:!1110 4444 %%%% !1110
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MM\TUM'([8 RQ4$G ]ZIP:BI=R(U$Y./8O4445)84444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 445RGQ%UB_P!!\'7%_IL_D7*21JK[%; +
M 'A@132N[$RDHIMG5T5QGPQUW4O$/A5[W5+G[1<"Y>,/L5/E 4@84 =S79T2
M7*[,(R4HJ2"BBBD4%%%% !1110 4444 %%%% !1110!YG\1/^1@@_P"O5?\
MT-ZW_AW_ ,B_/_U]-_Z E8'Q$_Y&"#_KU7_T-ZW_ (=_\B_/_P!?3?\ H"5Z
M];_<H_(^>P__ ",Y_,ZVBBBO(/H0HHHH **** "BBB@ HHHH **** "BBB@
MHHHH Y+XB?\ (OP?]?2_^@/6!\._^1@G_P"O5O\ T-*W_B)_R+\'_7TO_H#U
M@?#O_D8)_P#KU;_T-*]>C_N4OF?/8C_D9P^1Z91117D'T(4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MS9:3K%]J<$MPT]ZS-(LC J,MN., 'K[FMJBI)2=T%.+C&S/.O$W_ "5;0?\
MKE'_ .AO7HM8M]X9LM0\06FM2RW"W-JJJBHP"'!)Y&,_Q'O6U1.2:5@A%IMO
MJ<5\4?\ D5(_^OI/_06KH](B2?PS80R+NCDLXU89QD% #3=>T&U\1:>ME=R3
M)&)!)F$@'(!'<'UJ]:6R6=G!:QEBD,:QJ6ZD 8&?RH<ER) HOG;/-M$OG^'^
MNW.D:IO_ +-N&WPW&"1Z;L#U& >XP*](@O+6Z@,]O<PS0CK)'(&4?B.*BU+2
M;#6+7[-J%LD\6<@-P5/J".1^%<HWPMT%GW">_4?W1*N/U6J<HSU>C)49PTCJ
MBOXX\86[64VC:5(+FYN%*2O$=RQI_$,CJ<9SZ#.:M?"[_D5)/^OI_P#T%:U[
M'P?HNFV<]O:VNQIXFB><G=)AA@X)Z=>W%6M!T&U\.Z>UE:23/&9#)F8@G) '
M8#TIN<>3EB"A/GYI''>++"\\.^*8?%EE%YMOD"Y1>,<;3GV([]C^O8Z5XCTK
M68$DL[R)F;&8F8*ZGT*]?Z>E:;HLB,CJ&5A@J1D$>E<G??#CP]>N72&:U)Z_
M9Y,#\F! _"ES1DDI=!\LHMN/4W=5US3M%MVEOKJ.+:NX1[AO?_=7J:R_"GB2
M[\2+=3R:<;>T1R(9MWWQZ8]1W(XJI9?#;P]:2;Y([BZXX$\O ]_E KK(HHX(
MEBAC2.-1A41< #V I/D2LM1KG;N]$<+X^TJ[MKNT\4:>!YMEM$R@<[0>&]QR
M0?8^@KH]#\4:9KUJDEO.B38&^!VPZ$]O?ZBMJN4U+X=Z!J,[3"&6U=CEOLSA
M03]""!^ IJ49*TN@G&49<T>IL:MK^F:+ \E[=QHRC(B# NW'0+UKD/!MG=Z[
MXEN_%EY$T43Y6U4GKQM_$!1C/<UJ6/PV\/6<HD>.>Z(Z+/)D9]<*!G\:ZR.-
M(HUCC141 %55&  .@ HYHQ34>H<LI-.70XCXJ_\ (KVW_7ZO_H#T[5_!XUK2
M-/U#3I/LNK0P1%)5)7?A1C)'((['\/IT7B#P_:>)+!+.\DF2-)1*#"P!R 1W
M!X^8UHV\*VUM% A)6) @)ZX Q0JEHJVX.GS2=]CC_"7B^2ZF.BZV/(U6$[ 9
M./-_^R_GU%)\4?\ D5(_^OI/_06K6U_P?I?B*:*>Z$L4\?'FP,%8CT.0<U+J
M?AJVUC1(=+O;N[D2)@WG;E\QB 0,G;@]?2FI04E)"<9N+BRWH?\ R+^F_P#7
MK%_Z *XGX8_\?_B'_KK'_.2N_M+9+.S@M8RQ2&-8U+=2 ,#/Y5EZ%X9LO#TU
MY+:2W#M=LK2>:P(&-W3 ']XU*DK27<IQ?-%]C:KSKXG?\?\ X>_ZZR?SCKT6
ML77?#-EXAFLY;N6X1K1F:/RF !SMZY!_NBE3DHRNPJQ<HM(O:MIT>KZ3=6$I
MPD\93=C.T]C^!P?PKB/!WB%="\SPUKC"UGMI"(9'X1@3G&?J203P0?;GT.LO
M6/#NEZ\@74+59&4$)("59?H1_(\4XR5N66P3B[\T=R^US D*S/-&L3#(<N I
M'7K7$ZSXUN;O6K72?"_EW,_F RRD;HV'=<_W>Y8?@:D'PMT$2!O/OR/[OFKC
M_P!!S72Z1H.F:'"8]/M$BW?>?J[?5CS^'2FN2.NXG[26FQHKG:-Q!;') P*\
M[N/^2U6O_7(_^B6KT6L5_#-D_BB/Q 9;C[6B[0@8;/NE>F,]#ZU,))7OV'4B
MY6MW-JO-_AW_ ,C1X@_WS_Z&U>D5B:-X7LM#O[R\MI;AY+LY<2LI Y)XP!ZT
MXR2BUW"46Y)]CF?'&F7FF:W:^*]-CWF# N%&>W&3[%3M/ICWKJ-%\4:5KEM'
M);74:RMP8)& D4^F._U'%;#*&4JP!4C!!Z&N7U'X>^']0D,@MY+5R26-N^T'
M/L<@?@!34HR24N@G&46W'J;>I:QI^D6[37UU%" NX*S#<WL!U)K'\,>*+CQ)
M>7K)I[1:=$<0W#-RQX^4CUZGCIP/>JEG\-/#]K*'D6YN<'.V:48_\= KK+>V
MAM+=+>WB2*&,85$& !2?(E9:L:YV[O1&8_BC1X];DTF2\2.Y10Q+G:F?[NX]
M\8./>L'XE7.F?\(Z]O<-$U]N4VZY&]3D9/L-N:V];\)Z1X@827L!$X&!-&VU
ML>GH?QK,T[X<:#I]VMP1<710Y5+AU9<_0*,_C3BX)J1,U-IQT-3PC%<0^$M,
M2YW>:( ?FZA3RH_ 8K:HHK-N[N:I65@KSKX5_NUUFW[QRQ_7^(?TKT6O./"X
M&E_$W6M/<+&)P[QH.G)#J!CC[I)_"M(:QDC.II.+/1Z\Z^$W_'AJ7_75/Y&O
M1:Q?#WAFR\-0SQ6<MQ(LS!F\Y@2,>F *F,DHM=QRBW-/L;5%%%0:'&_$W_D4
M3_U\)_6MWP_&DOA/2XY$5T>QB5E89!!09!%.UW0[;Q!IWV&[>9(MX?,1 ;(^
MH-7+*TCL+"WLXBQC@B6)2QY(4 #/OQ5N2Y$C-1?.V>;ZI8W?P]UX:MI<32Z3
M<86:(\A>?NY[>Q_ Y[^A:5JMIK6GQWME+OB?MW4]U([$59N+>&ZMY()XUDBD
M4JZ,,@BL+0_!]EX>O9+BPN[T)+P\#R*8SZ<;<\=CG/ZU3DI+7<48N$M-B?Q=
M/]F\(ZJ_'-NR<_[7R_UK.^',!A\&6S$8\V21_P#QXC^E4_BA??9_#4=H,[KJ
M8 ^FU?F/Z[:Z;0+(Z=X?L+1@0\4"AP1_%C)_7-&U/U8;U?1&C11161J%%%%
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M?^0'J'_7M)_Z":XNR^)_VSQTWAG^Q]FV[EMOM'VG/W"PW;=G?;TSWKM-9_Y
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MY]XS^)__  B.N_V9_8_VO]RLOF?:?+ZYXQL/IZUZ#4.+23?4UC.,FTNA7O\
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M\'_7TO\ Z ]8'P[_ .1@G_Z]6_\ 0TK?^(G_ "+\'_7TO_H#U@?#O_D8)_\
MKU;_ -#2O7H_[E+YGSV(_P"1G#Y'IE%%%>0?0A1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 <E\1/^1?@_Z^E_\ 0'K ^'?_ ",$_P#UZM_Z&E;_
M ,1/^1?@_P"OI?\ T!ZP/AW_ ,C!/_UZM_Z&E>O1_P!RE\SY[$?\C.'R/3**
M**\@^A"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MB)\RU;/;N5ST/4=_6M_P-\68KSR=,\1.L-QPD=YT23H ']#[]/I7J]>3^/\
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M#&5&W\NE<'XR^%NE:U:2W.DV\=CJ2J2@B 6.4^C+T'U&.O.:Y[_A>W_4M_\
MD]_]KH_X7M_U+?\ Y/?_ &NLXTZL7=&TZU":LV-^$/BJYM[^3PGJ&[C>;;=U
MC9<ET^G!/M@^O'LE?,%QXF2Y\?1^([6T%EFZCG:$R>8 1C=S@<'D_C7TS=W
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M*7S/GL1_R,X?(],HHHKR#Z$**** "BBB@ HHHH **** "BBB@ HHHH ****
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M$JE_%F>"_%7_ )*7_P!LX:^@J^??BK_R4O\ [9PU]!4ZOPQ"A\<_4*I:S_R
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M1?@_Z^E_] >L#X=_\C!/_P!>K?\ H:5O_$3_ )%^#_KZ7_T!ZP/AW_R,$_\
MUZM_Z&E>O1_W*7S/GL1_R,X?(],HHHKR#Z$**** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M.K\;%1^!!7GD2FU^,TBQ?(MQ#EPO /[L$Y_%<UZ$S!5+,0% R2>@KSKPV_\
M;_Q)U/68CFUMU*1N!PW 1?S 8TZ>TGY"J[Q7F>B21I-$\4B[D=2K ]P>M<!\
M*&<:9J4+'A)U.,]"1@_R%>@UY[\*27LM4DQ@-,I_0T1^"7R"7\2/S/0J***R
M-3B_B!K=W:06FCZ:S+>:@VS<IY"YQ@>Y)QGV-:?ASPAIWA^U0"*.>\ZO<.H+
M9_V<]!7->,G%E\1- OIR4MMJ+O/W1ASG\@PKT:MI/E@DNIC%<TVWT,_5=#T[
M6K=HKZUCEW+M$FT;T_W6ZBN*\,377A3Q?+X8NI"]G<?/:NYQC@D$?7!!']X<
M>_HM><Z^XO?BQI$$&3);+'YA Z8+/C_ODC\Z*;NG%[!55FI+<[K5O^0/??\
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MO2-0\7)XEEN;Y;U9HI@B.@CW1A0O&W./E&>:ZZBA2:V"45+<****105PFO\
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M]Q1BH[!1112*"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@!KHDD;(ZAD8$,K#((/8UER>%_#\S[Y="TQV/\
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M>3 J8SUZ"KM%% TK;!1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 >9_$3_D8(/\ KU7_ -#>M_X=_P#(OS_]?3?^@)7/_$(Y
M\0Q#TME'_CS5T/P]&/#TQ];EC_XZM>O6_P!RC\CY[#_\C.?S.LHHHKR#Z$**
M** "BBB@ HHHH **** "BBB@ HHHH **** .2^(G_(OP?]?2_P#H#U@?#O\
MY&"?_KU;_P!#2N@^(0SX>A/I<J?_ !UJY[X>G'B&4>MLP_\ 'EKUZ/\ N4OF
M?/8C_D9P^1Z;1117D'T(4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M $B<#\%))_2N]HK1SB]7'4S5.2T4M#Q+4]-U6TU[2KW69"U]>SB1D)R4 90
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M5,IW5DK(J,+.[=V9^NW*V>@:A<,?]7;N1]=IQ^M<Q\+K;R?#$LQ',]RQ!]@
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M]J>5A^1:NDL-,L-*@\C3[.WM8NZPQA ?<XZFK5%#DWNQ*$8[(****104444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%,ED$,+RM]U%+'\* ;L>)ZF_F:K>/G.Z=S_P"/&O9-,3R]
M)LT/\,"#_P =%>*@/<7 '5Y'Q^)->YQH(XU0=%  KU\STC")\]DGO3J3]/U'
M4445Y!]"%%%% !1110 4444 %%%% !1110 4444 %%%% 'G?Q&3&H64G]Z)E
M_(__ %ZO_#F3-A?1_P!V56_,?_6I/B/!NLK&XQ]R1DS_ +PS_P"RU1^',^W4
M+VWS]^)7_P"^3C_V:O7^+ >G^9\]_#S7U_R/1****\@^A"BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MH0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MRUZ]7]Y@HOM;_(^=P_[G,Y1?VK_CJ=Y1117D'T04444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %9?B.?[/X<U"3.#Y+*#[MQ_6M2N2^(%YY.AQVP/S7$HR
M/]E>3^NVML/#GJQCYG-C*GLZ$Y>1POAZ#[3XAT^/&1YZL1[ Y/\ *O9Z\O\
M 5I]H\0^>1\MO$S9]S\H_F?RKU"NO,Y7JJ/9'GY)3Y:#EW84445YQ[(4444
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M5/\ \*JT/_G[U'_OXG_Q%;FF>(-%CTJS1]8T]66! 5-R@(.T<=:M?\)'H?\
MT&M._P# I/\ &J<ZER53I6Z$VDZ9#HVEP:?;M(T4((4R$%CDD\X ]:YKQ?XM
MN;"[BT;18_.U2;&2%W>7GI@'@D]>> .M=2]_;+ITE^DJS6R1M+OB8,&4 DX(
MX/2N!^&UHVI7^I^(KL;YWE,<;''#'YGP.W!4?0D4H+><N@YO:$>I9L/ANMU_
MI?B*_N+N\?!95DX'L6/)XQZ8K0O/AMX=N(=D$$UJ_9XIF;]&)%==12=6=]QJ
ME"UK'F+SZ_\ #NYB2>4ZCHCMM4G/R>PS]PX[=#_+T>SNX;^SAN[=P\,J!T8>
MAJ+5=,M]7TR>QN5!CE0KG&2I[,/<=:XGX77TJPZCI$[?-;.'1?3)(;]0/SJG
M[\>;JB5[DN7HST%U+(RABI(P&&,CWYXKR+QYX3LM!MH;V"YNYY[F=A(UPZMD
MD$D\*.<UZ]7G_P 6/^0/8?\ 7P?_ $$T4&U-(*\4X-L[FQ_Y!]M_UR7^0IUU
M<1V=I-<S'$4*-(Y] !DTVQ_Y!]M_UR7^0KG_ (@S^1X+O@,YD*(,>[C/Z UF
ME>5C23Y8W.7TK2[KXAZA/JNJS31:9%(4M[=&_0?08R<<GZ<;&K_#?3);4R:.
M'LKR,;HR)&968<@')R.<<@\5L^"X#;^#M,0C&8M_3^\2W]:WJTE4DI>[LC.-
M*+C>6[.0\">)+C5[2:PU DZA9G:['JZYQD]LCI4/CC7;^&[LM TAS'>7N,R@
MX*J3@8/;)!R>V*SK1!IOQDGBC/RW<;,1]4WG]5S7:MH6FMK::PUMF_0867>W
M P5Z9QT)[4Y<L9\UO,4>:4.6^SL<]IWPVT.WM@+Z.2]N" 7=I649[X"D<?7-
M86N:'<^ [J+6]#GD^QEPD]N[9'L#_>!Y]P?T]/KCOB7J$5KX4DM&YENY%1!G
MLK!B?T _&E"<I2L];A4IQC"ZTL=387D>H:?;WD1_=SQK(O/3(SBK%9'A:SEL
M/"^G6TZE95A!92,%2><'W&<5KUD]'H;1=TFPHHHI#"BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M5O3-3M-8TZ&_L)O.M9@3&^TKD D=" >H-%G:X<RO:^I;HHHI#"BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH *X3XBZ@-MIIRGG/G/_)?_9J[
MOI7C&OZC_:FN75T#E"^V/_=' _Q_&N_+J7/5YNQY.<5_9T.1;R_(Z/X=V1>]
MNKYE^6-!&I]R<G]!^M>B5B^%-._LWP];1LN))!YLGU;_ .M@?A6U6.+J>TK-
MHZ<OH^QP\8O??[PHHHKF.T**** "BBB@ HHHH **** "BBB@ HHHH **** "
MO._B)9%+VUO57Y9$,;'W!R/T/Z5Z)6+XKT[^TO#US&JYDC'FQ_5?_K9'XUTX
M2I[.LF<684?;8>45OO\ <<]\.M0&V[TYCSGSD_DW_LM=W7C&@:C_ &7KEK=$
MX0/MD_W3P?\ '\*]GZUMF-+DJ\W<YLGK^TH<CWC^04445P'K!1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M2YO9+V:/=NN),[GRQ(SDGH#CKVJ]114-WU+2LK!1112&%%%% !1110 4444
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M7 'J05/_  $TY6J1YNJ)A>E-0;T>QZUK/_(#U#_KVD_]!->+_!#_ )&?4/\
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M^'\OI7HX#$<DO9RV9X^;81U(>VA\4?R_X!TFAZM'K.E17:8#'Y9$'\+#J/\
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M:_4G;GI_$:QI+7F?0WQ$G906[/5_ ?A__A&_"-G9R(4N9!Y]P#C(D8#(X]
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MD<Y[XXQW[BO0QX*\," 0C0--VCN;92W_ 'UC/ZUR?_"[?#7_ #XZM_WZC_\
MCE'_  NWPU_SXZM_WZC_ /CE.2JR=Q0="*LFBOXK^#VGW=M)<^'LVEVH+"V9
MB8Y/8$G*G].V!U%#X3>,[A;H^%M6:0R M]E>4G<A'WHCGZ$CTY'IC7_X7;X:
M_P"?'5O^_4?_ ,<KR[7_ !+93^/1XCT2*XA7S8[@QS!5/F#&[[I/!QS]35QC
M.2<9F4YTX24Z;]3Z:KY\\:_\EK?_ *^[3_T".OH&-UEC61#E6 8'U!KYX^(5
MRME\7;N[=2RP36TA ZD+'&?Z5%#XGZ&N*^!>I[WJVKV&AZ?)?:C<I! G\3'E
MCCH!W)QT%>%ZIK>O_%7Q FEV$9BL%?>D1X6->GF2$=3_ (X'7EG_ !4GQ=\0
M?P06=O\ 7R;=3_Z$YQ^..P''MWASPWIWA?2TL=/B  YDE(^>5O[S'_.*-*7J
M*\J[TTC^93\(>#M/\'Z:;>V_?7,G,]RRX:0_3L!V%<M\:M1N+7PS9V<+E([J
MXQ+@_>51G;],D'\!7IE<E\0_";^+/#A@MB!?6[^=!N. QQ@J3VR/U [9J(2]
M].1K4A^[<8&7X#\ Z#;^%["]O-/M[Z[O(%G=[F,2!0X#!0",# QSUZ\U7\4?
M"#2M5*SZ*R:9<;AO3!:)QGGC/RD#TX/XYKD?!WQ'OO"#?V%K]I.UM"P0;@1+
M;^V#U'/ XQVKVC2=:TW7;,7>EWD5S#T)0\J?1@>5/L0*N;G"5S.FJ52'+8DT
MNP32M*M+".221+:)8@\C99L#&2:MT45@=25@K)UWPUI'B6&&+5[3[2D+%D'F
M.F">/X2*UJ*:;6J$TFK,^<+W0=,B^+:Z&EMC33>Q1>3YC?=(7(W9SW/>O9+3
MX;>$K"]@O+;2=D\$BRQO]IE.UE.0<%L'D=Z\MU'_ )+TG_82A_DM>^UO5DTE
MKT.6A"+<KKJ5M1O[?2M-N;^Z?9!;QM(Y[X SQ[^@KY[?^W?BMXO;R]R0*3MW
M<QVD6>_J?U)]NGHGQJU![;PE;6:,P^UW0#XZ%%!.#_P+:?PJ]\)-)CT[P/!<
MA5\Z^=IG;;@X!VJ,]Q@9_P"!&E#W(<_4=1>TJ>SZ+<MZ+\,O#&CP(KV$=],.
M6ENU#Y.,'Y3\H'MBK.I_#SPKJD6R31K: CH]JODD?]\X!_'-=/167/*][F_L
MX6M8^=O$GAO6/AEKMOJ.G7CM;.W[BX'RDXY,<@'7I]"/R'MWA/Q'!XI\/P:G
M"%1VRDT0;/ER#JO\C]"*7Q;I,.N>%=1L)ESOA9D/]UU^93^8%>8_ W4)!>:K
MII;,31K.H]"#M/YY'Y5JW[2%WNCGBO95>5;,ZKXQ?\B%)_U\Q_UJ'X+_ /(C
MR?\ 7[)_Z"E3?&+_ )$*3_KYC_K4/P7_ .1'D_Z_9/\ T%*/^77S*_YB/D9G
MQR_Y!&D_]=W_ /0176?#3_DG>C_]<W_]&-7)_'+_ )!&D_\ 7=__ $$5UGPT
M_P"2=Z/_ -<W_P#1C4I?PD$?]XEZ$?Q#\8?\(CH(>#:=0NB8[8'G;@<N1W R
M/Q(KS#P1\/;SQE/)K.M33I8NY;>3^\N6SS@GMURWKT[X/BA)-K?Q.CTE78>6
M(+6,8R 7PV0._P!\?E7N]G:0V%E#:6R!(84"(H&, #%5?V<%;=D\OMJCYMD8
MMGX%\+6,(BCT*QD  &Z>%96.!ZMFL3Q#\)_#VKP2O80#3;PY*R0Y\O.>Z9QC
MKTQUKO**Q4Y)WN=#I0:LT?/?A?Q!JOPX\62:1JN_[$7"7$.\E$SC$J?A@^XX
M/.,?02.DD:NC!D8 JRG((/<5Y7\;M(ADTBPUA1B>*;[.Q]48,P_(C_QZNL^&
M^HR:GX!TJ:5MTD<9@8_[C%1_XZ!6M2THJ9A1O";IO;H>6^)8G\ ?%>+4H 4L
MYI!<[4! ,;'$B?\ H7'TKWF*5)H4EC8-&ZAE8=P>0:X'XO:#_:OA'[=&!Y^G
M/YO3DQG <>W9O^ T_P"$FO\ ]K^$5LI7+7.G$0MNZ[#DI^  V_\  :4_>@I=
MAT_<JN'1ZH[ZOF+QIXFDUSQI<:I;S9C@D"6CKGA$/RD ^IRWXU[5\3_$']@^
M#KA(I-MU>_Z-%A@& (^9A]%R,]B17!>#_AZFL?#C4[V:-?MMX"UBV,E1&>/I
MN8,O3I]:JC:*YF1B+SE[./J>M^&];B\1>'[/5(MH\^,%T!SL<<,OX'-:M>-?
M!37VCGO?#UPQ /\ I%NI'0CAQ_Z"<>Q]:]2\0ZO%H/A^^U24@"WB+*&!(9^B
MKQZL0/QK.<.67*C>E44H<S/'OB?J$_BCQU9^'+'#_9F$*[6!!E?!;/T&!UXP
M:]JTW3[?2=,M=/M5(@MHEB3.,D 8R<=SU/O7C_P?TB75?$%_XGO1YAC9U21B
M<F9^6;W^4D?\#KVJJJNUH+H105[U'U"BBBL3H/'?CM_S /\ MX_]I5Z%X%_Y
M$71/^O1/Y5Y[\=O^8!_V\?\ M*O0O O_ "(NB?\ 7HG\JVE_"B<T/X\CH***
M*Q.D^?-%_P"2ZR_]A:Y_]">OH.OGS1?^2ZR_]A:Y_P#0GKZ#K>ONO0YL+M+U
M/G/XCW+67Q7OKM%#-!+;R 'H2L49_I6[X4\#7_CR\D\2>)KB86LS;HT!PTPS
MT']U!T&/PQUK'\?67]I?&&XL<D?:;BUAR.OS1QCO]:^@[>"*UMXK>"-8X8D"
M1HHP%4#  _"KG/E@K;V,J5-3J2YMDS$M? _A:TB$<6@:>R@ 9E@$AX]VR:PO
M$'PG\.ZO#*]C -.O#DJ\&?+S[ITQ],=:[RBN=3DG>YUNG!JS1\[^&]=U;X:^
M+'T[5!(+/=MN8 <J5/21/Y^XX//3Z&1TDC5T8,C %64Y!![BO+?C;H\4VC66
ML* )X)?(8XZHP)'/L1_X\:Z3X7W[7_P_TXR.S20!X&)]%8[1^"[16M2THJ9A
M1O";I].AV%%%%8'4%%%% !1110 4444 %%%% !1110 5RGCC7/[/T_[! ^+B
MY'S$'E4[_GT_.M[5M4@T?3I+R<\+PJCJ[=@*\>O+NZUC4FGES)/,^ H_(*/Y
M5Z& P_M)<\MD>1FN,]E#V4/BE^"+OAK16UO5DA8'[/'\\S?[/I]3TKV!55$"
M* JJ, #H!6/X9T1=$TI8F -Q)\\S#GGT^@_QK9K+&8CVU339;&V6X3ZO2][X
MGO\ Y!1117(>B%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M (RJZ%& 96&"#T(KQ_Q+HK:)JSPJ#]GD^>%O]GT^HZ5[#6-XFT1=;TIHE %Q
M'\\+'CGT^A_PKLP>(]C4UV9YV983ZQ2]WXEM_D9O@?7/[0T_[!.^;BV'RDGE
MD[?ET_*NKKQ&SN[K1]26>+,<\+X*G\BI_E7L.DZI!K&G1WD!X;AE/5&[@UIC
ML/[.7/'9F.58SVL/93^*/XHNT445YYZX4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %9VN:M'
MHVE2W;X+#Y8T/\3'H/\ /I5^21(HVDD8*B@LS'H .]>2>)]??7-1)0L+2+B)
M#W]6/N:Z\)AW6GKLMS@S#&+#4M/B>W^9FQI=:MJ009EN;B3J>Y)ZU[%I.FQ:
M3IL-G#R$'S-_>;N:Y?P)H)MX3JMRF))5Q #V7NWX_P OK7:UMC\1SR]G'9'-
ME.$=.'MI_%+\O^"%%%%><>P%%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<IXS\._VE:_;[5/]
M*A7YE YD7_$5U=%:4JLJ4U.)C7H0KTW3GLSQG0M9FT34DN8\M&?EECS]]?\
M'TKV"TNX;ZUCN;>0/%(,JPKS[QEX8:UE?4[),V[G,J*/]6?7Z']*SO"_B630
M[GRIB7LI#\Z]=A_O#_/->KB*4<5356GN>#A,1/ 57AZ_P]_U]#UBBF0S1W$*
M30NKQN-RLIR"*?7C'TB=]4%%%% !1110 4444 %9VN:S:>']&N=3O6Q# F<#
MJ[=E'N3@5HUS?BOP78^,%MX]0O+Z** DK';NBJ6/<Y4DFG&U]297M[NYX3;Z
MK9>*?&QU/Q5?FVLF8R. KO\ */NQ* "0/Z9[FO9T^*/@F.-435PJ* %5;28
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MV,6EZ9:V$ Q%;1+$OT48JU117(>@M HHHH ^?O&ZE?C421PUU:$?3;&/Z5]
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M_P!M>#Y;F)&:ZT\^?&%')7HX_+G_ ("*\O\ A;H#^(?&$=U<[I+73E65R_S
ML.(T_3/T3%=4&G%3?0X*BE&3IQVD>U^#= 'AKPK9::W^N5-\YSG]XW+<^@/
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M)8KF2V39=*I .P'*N/<9(/MCTJ:,K.W<TQ,6XIKH=-_PJOP7_P! ;_R:F_\
MBZ/^%5^"_P#H#?\ DU-_\763X(^*6G:M9PV.M7$=GJ*#;YLAVQS8'7<> Q]#
MWZ=<5Z&D\4D(F25&B(SO5@5QZYJ9.I%V;94(TIJZ2.2_X57X+_Z W_DU-_\
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MNI_&OQ+M] LFWQ6TGV5,9PK=96/TP<\=$[U[C96D5A86]G "(;>)8D!Z[5
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M&:.XA2:%U>-QE64Y!%<>)PTJ$K/;H>E@L;#%0NMUNA]%%%<QVA1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@LRIXE<LM)=O\C8HHHKB/2"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M +['^%'_  E\7_/F_P#WV/\ "MS^SK'_ )\[?_OTO^%']G6/_/G;_P#?I?\
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M )\W_P"^Q_A6Y_9UC_SYV_\ WZ7_  H_LZQ_Y\[?_OTO^%&@6EW,/_A+XO\
MGS?_ +['^%'_  E\7_/F_P#WV/\ "MS^SK'_ )\[?_OTO^%']G6/_/G;_P#?
MI?\ "C0+2[F'_P )?%_SYO\ ]]C_  H_X2^+_GS?_OL?X5N?V=8_\^=O_P!^
ME_PH_LZQ_P"?.W_[]+_A1H%I=S#_ .$OB_Y\W_[['^%'_"7Q?\^;_P#?8_PK
M<_LZQ_Y\[?\ []+_ (4?V=8_\^=O_P!^E_PHT"TNYA_\)?%_SYO_ -]C_"C_
M (2^+_GS?_OL?X5N?V=8_P#/G;_]^E_PH_LZQ_Y\[?\ []+_ (4:!:7<P_\
MA+XO^?-_^^Q_A1_PE\7_ #YO_P!]C_"MS^SK'_GSM_\ OTO^%']G6/\ SYV_
M_?I?\*- M+N8?_"7Q?\ /F__ 'V/\*/^$OB_Y\W_ .^Q_A6Y_9UC_P ^=O\
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MP_\ A+XO^?-_^^Q_A1_PE\7_ #YO_P!]C_"MS^SK'_GSM_\ OTO^%']G6/\
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M)?%_SYO_ -]C_"C_ (2^+_GS?_OL?X5N?V=8_P#/G;_]^E_PH_LZQ_Y\[?\
M[]+_ (4:!:7<P_\ A+XO^?-_^^Q_A1_PE\7_ #YO_P!]C_"MS^SK'_GSM_\
MOTO^%']G6/\ SYV__?I?\*- M+N8?_"7Q?\ /F__ 'V/\*/^$OB_Y\W_ .^Q
M_A6Y_9UC_P ^=O\ ]^E_PH_LZQ_Y\[?_ +]+_A1H%I=S#_X2^+_GS?\ [['^
M%'_"7Q?\^;_]]C_"MS^SK'_GSM_^_2_X4?V=8_\ /G;_ /?I?\*- M+N8?\
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M .^Q_A6Y_9UC_P ^=O\ ]^E_PH_LZQ_Y\[?_ +]+_A1H%I=S#_X2^+_GS?\
M[['^%;.F:@NI6GGK&4&XK@G-/_LZQ_Y\[?\ []+_ (5-%#% FR*-(USG"* *
M- 2?4?1112*"BBB@ HHHH .M<9XC\$1W6^[TL+'.>6@Z*_T]#^GTKLZ*UI5I
MTI<T&88C#4\1#DJ(\0BFO=(ORT;26UU$<'C!'L17>:'X\@N=L&J!8)>@F7[C
M?7T_E]*W]7\/V&M18N8L2@?+,G#+^/<>QKSC6_"=_HQ:4+]HM1_RV0=!_M#M
M_*O456ABURSTD>#*AB\O;E2?-#^MU^J/6E974,C!E(R"#D$4M>-Z5XBU+1R!
M;3DQ9R89/F0_AV_"NZTGQUI][MCO ;.8]V.4/X]OQ_.N.M@*M/5:H]+#9K0K
M:2]U^?\ F=5138Y$EC#QNKH>C*<@TZN(],**** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *KW\#W6G75NA >
M6%T4MT!((YJQ10!YM\.?A]JWA#6;J\U"XLI8Y;?RE%N[L0=P/.5''%>DT454
MI.3NR(04%RH****DL**** "BBB@ HHHH **1F"J68@ <DGM7.ZMXTTO3LI"_
MVN<?PQ'Y1]6Z?EFKITIU':"N95:].BN:H['1URVN>-K+3MT-EMNKD<$@_(I]
MSW^@KB]7\5ZGJ^Z-Y?)MS_RRBX!'N>IJ+1O#FH:TX,$>R#.&F?A1]/4_2O3I
M8"--<]=GB5\UG5?L\+'7O_7ZE74-2O=8NQ+=2M+(>$4#@>P%==X=\#%MMWJZ
MD#JMMW/^]_A71Z+X6T_10'1/.N>\T@Y_ =JVZC$8_3DHZ(UPF56E[7$N\NW^
M?<:B+&BHBA548"J, "G445YA[84444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !371)$9)%5D88*L,@BG4
M4 <!XA\"LI:ZT@;@>6MR>G^Z?Z5R%M=WNDWGF0226\Z'!&,'Z$'^1KVZLK6/
M#VGZU'_I$6V8#Y9DX8?XCV->E0Q[2Y*JNCQ<5E*D_:8=\K[?Y=C#T3QY;7(6
M'5 +>;H)1]QOKZ?RKKXY$FC62)U=&&0RG(/XUY3J_@[4]++.D?VJW'_+2(9(
M'NO4?K6;INLZAI,FZSN709Y0\JWU!XK6>!IUEST'_7Z&%+-*^'?L\5'Y]?\
M)GM5%<3IOQ#MY J:C;-$W>2+YE_+J/UKJ[+5+'4DW6=U%,.X5N1]1U%>=5P]
M2E\2/8H8NC7_ (<O\RW1116)TA1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M*+YZGO2_!!1117 >L%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%5+W5+'34W7
MEU%".P9N3]!U-<IJ7Q#MXPR:=;-*W:27Y5_+J?TK:EAZE7X4<U?%T:'\27^9
MVDDB0QM)*ZHBC)9C@#\:Y#6_'EM;!H=+ N)NAE/W%^GK_*N&U+6=0U:3=>7+
MN,\(.%7Z <5I:1X.U/5"KO']EMS_ ,M)1@D>R]3^E>C# TJ*YZ[_ *_4\>KF
ME?$/V>%C\^O^2,FYN[W5KSS)Y)+B=S@#&3] !_(5U_A[P*S%;K5QM Y6W!Z_
M[Q_I75:/X>T_18_]'BW3$?-,_+'_  'L*U:RKX]M<E)61OA,I47[3$/F?;_/
MN-1$C14C5511@*HP *=117FGM!1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M'_":>(/^@A_Y!C_^)H_LRMW7X_Y!_;F'_E?X?YGK=%>2?\)IX@_Z"'_D&/\
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M\0?]!#_R#'_\31_9E;NOQ_R#^W,/_*_P_P SUNBO)/\ A-/$'_00_P#(,?\
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MX@_Z"'_D&/\ ^)H_LRMW7X_Y!_;F'_E?X?YGK=%>2?\ ":>(/^@A_P"08_\
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M ,31_P )IX@_Z"'_ )!C_P#B:/[,K=U^/^0?VYA_Y7^'^9ZW17DG_":>(/\
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MU\1_SZ_,];_MS2/^@I9?^!"?XT?VYI'_ $%++_P(3_&O)/[#U?\ Z!=[_P"
M[_X4?V'J_P#T"[W_ ,!W_P */[/H_P _Y!_:^(_Y]?F>M_VYI'_04LO_  (3
M_&C^W-(_Z"EE_P"!"?XUY)_8>K_] N]_\!W_ ,*/[#U?_H%WO_@._P#A1_9]
M'^?\@_M?$?\ /K\SUO\ MS2/^@I9?^!"?XT?VYI'_04LO_ A/\:\D_L/5_\
MH%WO_@._^%']AZO_ - N]_\  =_\*/[/H_S_ )!_:^(_Y]?F>M_VYI'_ $%+
M+_P(3_&C^W-(_P"@I9?^!"?XUY)_8>K_ /0+O?\ P'?_  H_L/5_^@7>_P#@
M._\ A1_9]'^?\@_M?$?\^OS/6_[<TC_H*67_ ($)_C1_;FD?]!2R_P# A/\
M&O)/[#U?_H%WO_@._P#A1_8>K_\ 0+O?_ =_\*/[/H_S_D']KXC_ )]?F>M_
MVYI'_04LO_ A/\:/[<TC_H*67_@0G^->2?V'J_\ T"[W_P !W_PH_L/5_P#H
M%WO_ (#O_A1_9]'^?\@_M?$?\^OS/6_[<TC_ *"EE_X$)_C1_;FD?]!2R_\
M A/\:\D_L/5_^@7>_P#@._\ A1_8>K_] N]_\!W_ ,*/[/H_S_D']KXC_GU^
M9ZW_ &YI'_04LO\ P(3_ !H_MS2/^@I9?^!"?XUY)_8>K_\ 0+O?_ =_\*/[
M#U?_ *!=[_X#O_A1_9]'^?\ (/[7Q'_/K\SUO^W-(_Z"EE_X$)_C1_;FD?\
M04LO_ A/\:\D_L/5_P#H%WO_ (#O_A1_8>K_ /0+O?\ P'?_  H_L^C_ #_D
M']KXC_GU^9ZW_;FD?]!2R_\  A/\:/[<TC_H*67_ ($)_C7DG]AZO_T"[W_P
M'?\ PH_L/5_^@7>_^ [_ .%']GT?Y_R#^U\1_P ^OS/6_P"W-(_Z"EE_X$)_
MC1_;FD?]!2R_\"$_QKR3^P]7_P"@7>_^ [_X4?V'J_\ T"[W_P !W_PH_L^C
M_/\ D']KXC_GU^9ZW_;FD?\ 04LO_ A/\:/[<TC_ *"EE_X$)_C7DG]AZO\
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M++_P(3_&C^W-(_Z"EE_X$)_C7DG]AZO_ - N]_\  =_\*/[#U?\ Z!=[_P"
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M:^(_Y]?F>M_VYI'_ $%++_P(3_&C^W-(_P"@I9?^!"?XUY)_8>K_ /0+O?\
MP'?_  H_L/5_^@7>_P#@._\ A1_9]'^?\@_M?$?\^OS/6_[<TC_H*67_ ($)
M_C1_;FD?]!2R_P# A/\ &O)/[#U?_H%WO_@._P#A1_8>K_\ 0+O?_ =_\*/[
M/H_S_D']KXC_ )]?F>M_VYI'_04LO_ A/\:/[<TC_H*67_@0G^->2?V'J_\
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M7_@0G^-']N:1_P!!2R_\"$_QKR3^P]7_ .@7>_\ @._^%']AZO\ ] N]_P#
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M_/K\SUO^W-(_Z"EE_P"!"?XT?VYI'_04LO\ P(3_ !KR3^P]7_Z!=[_X#O\
MX4?V'J__ $"[W_P'?_"C^SZ/\_Y!_:^(_P"?7YGK?]N:1_T%++_P(3_&C^W-
M(_Z"EE_X$)_C7DG]AZO_ - N]_\  =_\*/[#U?\ Z!=[_P" [_X4?V?1_G_(
M/[7Q'_/K\SUO^W-(_P"@I9?^!"?XT?VYI'_04LO_  (3_&O)/[#U?_H%WO\
MX#O_ (4?V'J__0+O?_ =_P#"C^SZ/\_Y!_:^(_Y]?F>M_P!N:1_T%++_ ,"$
M_P :/[<TC_H*67_@0G^->2?V'J__ $"[W_P'?_"C^P]7_P"@7>_^ [_X4?V?
M1_G_ "#^U\1_SZ_,];_MS2/^@I9?^!"?XT?VYI'_ $%++_P(3_&O)/[#U?\
MZ!=[_P" [_X4?V'J_P#T"[W_ ,!W_P */[/H_P _Y!_:^(_Y]?F>M_VYI'_0
M4LO_  (3_&C^W-(_Z"EE_P"!"?XUY)_8>K_] N]_\!W_ ,*/[#U?_H%WO_@.
M_P#A1_9]'^?\@_M?$?\ /K\SUO\ MS2/^@I9?^!"?XT?VYI'_04LO_ A/\:\
MD_L/5_\ H%WO_@._^%']AZO_ - N]_\  =_\*/[/H_S_ )!_:^(_Y]?F>M_V
MYI'_ $%++_P(3_&C^W-(_P"@I9?^!"?XUY)_8>K_ /0+O?\ P'?_  H_L/5_
M^@7>_P#@._\ A1_9]'^?\@_M?$?\^OS/6_[<TC_H*67_ ($)_C1_;FD?]!2R
M_P# A/\ &O)/[#U?_H%WO_@._P#A1_8>K_\ 0+O?_ =_\*/[/H_S_D']KXC_
M )]?F>M_VYI'_04LO_ A/\:/[<TC_H*67_@0G^->2?V'J_\ T"[W_P !W_PH
M_L/5_P#H%WO_ (#O_A1_9]'^?\@_M?$?\^OS/6_[<TC_ *"EE_X$)_C1_;FD
M?]!2R_\  A/\:\D_L/5_^@7>_P#@._\ A1_8>K_] N]_\!W_ ,*/[/H_S_D'
M]KXC_GU^9ZW_ &YI'_04LO\ P(3_ !H_MS2/^@I9?^!"?XUY)_8>K_\ 0+O?
M_ =_\*/[#U?_ *!=[_X#O_A1_9]'^?\ (/[7Q'_/K\SUO^W-(_Z"EE_X$)_C
M1_;FD?\ 04LO_ A/\:\D_L/5_P#H%WO_ (#O_A1_8>K_ /0+O?\ P'?_  H_
ML^C_ #_D']KXC_GU^9ZW_;FD?]!2R_\  A/\:/[<TC_H*67_ ($)_C7DG]AZ
MO_T"[W_P'?\ PH_L/5_^@7>_^ [_ .%']GT?Y_R#^U\1_P ^OS/6_P"W-(_Z
M"EE_X$)_C1_;FD?]!2R_\"$_QKR3^P]7_P"@7>_^ [_X4?V'J_\ T"[W_P !
MW_PH_L^C_/\ D']KXC_GU^9ZW_;FD?\ 04LO_ A/\:/[<TC_ *"EE_X$)_C7
MDG]AZO\ ] N]_P# =_\ "C^P]7_Z!=[_ . [_P"%']GT?Y_R#^U\1_SZ_,];
M_MS2/^@I9?\ @0G^-']N:1_T%++_ ,"$_P :\D_L/5_^@7>_^ [_ .%']AZO
M_P! N]_\!W_PH_L^C_/^0?VOB/\ GU^9ZW_;FD?]!2R_\"$_QH_MS2/^@I9?
M^!"?XUY)_8>K_P#0+O?_  '?_"C^P]7_ .@7>_\ @._^%']GT?Y_R#^U\1_S
MZ_,];_MS2/\ H*67_@0G^-']N:1_T%++_P "$_QKR3^P]7_Z!=[_ . [_P"%
M']AZO_T"[W_P'?\ PH_L^C_/^0?VOB/^?7YGK?\ ;FD?]!2R_P# A/\ &C^W
M-(_Z"EE_X$)_C7DG]AZO_P! N]_\!W_PH_L/5_\ H%WO_@._^%']GT?Y_P @
M_M?$?\^OS/6_[<TC_H*67_@0G^-']N:1_P!!2R_\"$_QKR3^P]7_ .@7>_\
M@._^%']AZO\ ] N]_P# =_\ "C^SZ/\ /^0?VOB/^?7YGK?]N:1_T%++_P "
M$_QH_MS2/^@I9?\ @0G^->2?V'J__0+O?_ =_P#"C^P]7_Z!=[_X#O\ X4?V
M?1_G_(/[7Q'_ #Z_,];_ +<TC_H*67_@0G^-']N:1_T%++_P(3_&O)/[#U?_
M *!=[_X#O_A1_8>K_P#0+O?_  '?_"C^SZ/\_P"0?VOB/^?7YGK?]N:1_P!!
M2R_\"$_QH_MS2/\ H*67_@0G^->2?V'J_P#T"[W_ ,!W_P */[#U?_H%WO\
MX#O_ (4?V?1_G_(/[7Q'_/K\SUO^W-(_Z"EE_P"!"?XT?VYI'_04LO\ P(3_
M !KR3^P]7_Z!=[_X#O\ X4?V'J__ $"[W_P'?_"C^SZ/\_Y!_:^(_P"?7YGK
M?]N:1_T%++_P(3_&C^W-(_Z"EE_X$)_C7DG]AZO_ - N]_\  =_\*/[#U?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** *D^F6%SGS[*WDSW>($_P JI/X6T.3[VFPC_=RO\C6Q15JI
M..S9E*C2E\44_D81\&Z >NGC\)7'_LU)_P (7X?_ .@?_P"1I/\ XJMZBK^L
M5?YG][(^J8?_ )]K[D8/_"%^'_\ H'_^1I/_ (JC_A"_#_\ T#__ "-)_P#%
M5O44?6*W\[^]A]4P_P#S[7W(P?\ A"_#_P#T#_\ R-)_\51_PA?A_P#Z!_\
MY&D_^*K>HH^L5OYW][#ZIA_^?:^Y&#_PA?A__H'_ /D:3_XJC_A"_#__ $#_
M /R-)_\ %5O44?6*W\[^]A]4P_\ S[7W(P?^$+\/_P#0/_\ (TG_ ,51_P (
M7X?_ .@?_P"1I/\ XJMZBCZQ6_G?WL/JF'_Y]K[D8/\ PA?A_P#Z!_\ Y&D_
M^*H_X0OP_P#] _\ \C2?_%5O44?6*W\[^]A]4P__ #[7W(P?^$+\/_\ 0/\
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MW\[^]A]4P_\ S[7W(P?^$+\/_P#0/_\ (TG_ ,51_P (7X?_ .@?_P"1I/\
MXJMZBCZQ6_G?WL/JF'_Y]K[D8/\ PA?A_P#Z!_\ Y&D_^*H_X0OP_P#] _\
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MTG_Q5;U%'UBM_._O8?5,/_S[7W(P?^$+\/\ _0/_ /(TG_Q5'_"%^'_^@?\
M^1I/_BJWJ*/K%;^=_>P^J8?_ )]K[D8/_"%^'_\ H'_^1I/_ (JC_A"_#_\
MT#__ "-)_P#%5O44?6*W\[^]A]4P_P#S[7W(P?\ A"_#_P#T#_\ R-)_\51_
MPA?A_P#Z!_\ Y&D_^*K>HH^L5OYW][#ZIA_^?:^Y&#_PA?A__H'_ /D:3_XJ
MC_A"_#__ $#_ /R-)_\ %5O44?6*W\[^]A]4P_\ S[7W(P?^$+\/_P#0/_\
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MI116;DWNS6,8QTBK!1112*"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
,* "BBB@ HHHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>img268224062_10.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img268224062_10.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 56$!H# 2(  A$! Q$!_\0
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M@W_H,?\ DK-_\11_PM'P;_T&/_)6;_XBOG"BCZO$/K<^R/H__A:/@W_H,?\
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M /):;_XBOG:BE["(?6Y]D?1/_"S?!_\ T%__ "6F_P#B*/\ A9O@_P#Z"_\
MY+3?_$5\[CK2T>PB'UN?9'T/_P +-\'_ /07_P#):;_XBC_A9OA#_H+_ /DM
M-_\ $5\\4"CV$0^MS[(^A_\ A9GA#_H+_P#DM+_\11_PLSPA_P!!?_R6E_\
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M_P#$T?\ "R_"/_07_P#):7_XFOGRBCV$0^MS[(^@_P#A9?A'_H+_ /DM+_\
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MT!_PLGPE_P!!;_R6E_\ B:/^%D^$O^@M_P"2TO\ \37S_11["(?6I]D?0/\
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MPL7PI_T%?_)>7_XFO!J*/81#ZU/LCWG_ (6)X5_Z"O\ Y+R__$T?\+$\*_\
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MT%/_ "7E_P#B:\*%+3]A$/K,^R/=/^%A>%O^@I_Y+R__ !-'_"PO"W_04_\
M)>7_ .)KPN@4>PB'UF?9'NG_  L'PO\ ]!3_ ,EY?_B:/^%@^%_^@I_Y+R__
M !->&44O8Q#ZS/LCW/\ X6#X7_Z"G_DO+_\ $T?\+!\+_P#04_\ )>7_ .)K
MPRBCV,1_69GN?_"P?"__ $%/_)>7_P")H_X6#X7_ .@I_P"2\O\ \37AE+3]
MC$/K,SW+_A8/A?\ Z"G_ )+R_P#Q-'_"P?"__04_\EY?_B:\-HH]A$/K,SW+
M_A8/A?\ Z"?_ )+R_P#Q-'_"P?"__03_ /)>7_XFO#J*7L8A]9F>X_\ "P/"
M_P#T$_\ R7E_^)I?^%@>%_\ H)_^2\O_ ,37AHI:/8Q#ZS,]Q_X6!X7_ .@G
M_P"2\O\ \31_PL#PO_T$_P#R7E_^)KPZ@4>QB'UF9[C_ ,+ \,?]!/\ \@2_
M_$T?\+ \,?\ 03_\@2__ !->'T4>QB'UF9[A_P + \,?]!/_ ,@2_P#Q-'_"
MP/#'_03_ /($O_Q->'T4>QB'UF9[A_PL#PQ_T$__ "!+_P#$T?\ "?\ AC_H
M)_\ D"7_ .)KP^E'2CV,0^LS/;_^$_\ #'_03_\ ($O_ ,31_P )_P"&/^@G
M_P"0)?\ XFO$:*/8Q#ZS,]N_X3_PQ_T$_P#R!+_\31_PG_AC_H)_^0)?_B:\
M1HH]C$/K,SV[_A/_  Q_T$__ "!+_P#$T?\ "?\ AC_H)_\ D"7_ .)KQ&BC
MV,0^LS/;O^$_\,?]!/\ \@2__$T?\)_X8_Z"?_D"3_XFO$:!UH]C$/K,SV__
M (3[PS_T$_\ R!)_\31_PGWAG_H)_P#D"3_XFO$J*/8Q#ZS,]M_X3[PS_P!!
M/_R!)_\ $T?\)]X9_P"@G_Y D_\ B:\1[TM'L8A]9F>V_P#"?>&?^@G_ .0)
M/_B:/^$^\,_]!/\ \@2?_$UXE2T>QB'UF9[9_P )]X9_Z"?_ ) D_P#B:/\
MA/O#/_03_P#($G_Q->)T4>QB'UF9[9_PGWAG_H)_^0)/_B:/^$^\,_\ 03_\
M@2?_ !->)T4>QB'UF9[9_P )]X9_Z"?_ ) D_P#B:/\ A/?#/_02_P#($G_Q
M->)TM'L8A]9F>U_\)[X9_P"@E_Y D_\ B:/^$]\,_P#02_\ ($G_ ,37BE%'
ML8A]9F>V?\)[X:_Z"7_D"3_XFC_A/?#7_02_\@2?_$UXI11[&(?69GM?_">^
M&O\ H)?^0)/_ (FC_A/?#7_02_\ ($G_ ,37BE%'L8A]9F>U_P#">^&O^@E_
MY D_^)H_X3SPU_T$O_($G_Q->*4HZ4>QB'UF9[5_PGGAK_H)?^0)/_B:/^$\
M\-?]!+_R!)_\37BU%'L8A]9F>T_\)YX:_P"@E_Y D_\ B:/^$[\-?]!+_P @
M2?\ Q->+BBCV,0^LR/:/^$\\-?\ 02_\@2?_ !-'_">>&O\ H)?^0)/_ (FO
M%J44>QB/ZQ(]H_X3OPU_T$O_ "!)_P#$T?\ "=^&O^@E_P"0)/\ XFO%Z*7L
M8A]8D>T_\)WX;_Z"7_D"3_XFC_A._#?_ $$O_($G_P 37B]%/V,0^L2/:/\
MA._#?_02_P#($G_Q-'_"=^&_^@E_Y D_^)KQ>EH]C$/K$CV?_A._#?\ T$O_
M "!)_P#$T?\ "=>&_P#H)?\ D"3_ .)KQBBE[&(?6)'L_P#PG7AO_H(_^0)/
M_B:/^$Z\-_\ 01_\@2?_ !->,T4>QB'UB1[-_P )UX;_ .@C_P"0)/\ XFC_
M (3KPW_T$?\ R!)_\37C-%/V,0^L2/9O^$Z\-_\ 01_\@2?_ !-'_"=>&_\
MH(_^0)/_ (FO&:4=*/8Q#ZQ(]F_X3GPY_P!!'_R!)_\ $T?\)SX<_P"@C_Y
MD_\ B:\:HI>QB'UB1[+_ ,)SX<_Z"/\ Y D_^)H_X3GPY_T$?_($G_Q->-44
M>QB'UB1[+_PG/AS_ *"/_D"3_P")H_X3GPY_T$?_ "!)_P#$UXU2T>QB'UB1
M[)_PG/AS_H(_^0)/_B:/^$Y\.?\ 01_\@2?_ !->-T4>QB'UB1[)_P )SX<_
MZ"/_ ) D_P#B:/\ A.?#G_01_P#($G_Q->-T4>RB'UB1[)_PG'AS_H(_^0)/
M_B:/^$X\.?\ 01_\@2?_ !->."EH]E$/K$CV+_A./#G_ $$?_($G_P 31_PG
M'AS_ *"/_D"3_P")KQVD%'L8A]8D>Q_\)QX<_P"@C_Y D_\ B:/^$X\.?]!'
M_P @2?\ Q->.T4>QB'UB1[%_PG'AS_H(_P#D"3_XFC_A./#G_01_\@2?_$UX
M[11[&(?6)'L7_"<>'/\ H(_^0)/_ (FE_P"$W\._]!'_ ,@R?_$UXY3J/8Q#
MZQ(]A_X3?P[_ -!'_P @R?\ Q-'_  F_AW_H(_\ D&3_ .)KQZBCV40^L2/8
M?^$W\._]!'_R#)_\31_PF_AW_H(_^09/_B:\>HH]C$/K$CV'_A-_#O\ T$?_
M "#)_P#$T?\ ";^'?^@A_P"09/\ XFO'A2T>QB'UB1[!_P )OX=_Z"'_ )!D
M_P#B:/\ A-O#O_00_P#(,G_Q->/T"CV40^L2/8/^$V\._P#00_\ (,G_ ,31
M_P )MX=_Z"'_ )!D_P#B:\@HH]E$/K$CU_\ X3;P]_T$/_(,G_Q-+_PFWA[_
M *"'_D&3_P")KR 44>RB'UB1Z]_PFWA[_H(?^09/_B:/^$V\/?\ 00_\@R?_
M !->0FBCV41_6)'K_P#PFWA[_H(?^09/_B:/^$V\/?\ 00_\@R?_ !->044>
MRB'MY'K_ /PFOA[_ *"'_D&3_P")H_X37P]_T$/_ "#)_P#$UY#11[*(>WD>
MO?\ ":^'O^@A_P"09/\ XFC_ (37P]_T$/\ R#)_\37D(I:/91#V\CUW_A-?
M#W_00_\ (,G_ ,31_P )KX>_Z"'_ )!D_P#B:\BH%'LHA[>1Z[_PFOA__H(?
M^09/_B:/^$U\/_\ 00_\@R?_ !->1T4>RB'MY'KG_":>'_\ H(?^09/_ (FE
M_P"$T\/_ /00_P#(,G_Q->1"EI>R0>WD>N?\)IX?_P"@A_Y!D_\ B:/^$T\/
M_P#00_\ (,G_ ,37D=+1[)![>1ZW_P )IX?_ .@A_P"09/\ XFC_ (33P_\
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M>WD>K?\ "8Z#_P __P#Y!D_^)H_X3'0?^?\ _P#(,G_Q->4T4>R0>WD>K_\
M"8Z#_P __P#Y!?\ ^)H_X3'0?^?_ /\ (+__ !->4T4>R0>WD>K?\)AH/_/_
M /\ D%__ (FC_A,-!_Y__P#R"_\ \37E5%'LD'MY'JO_  F&@_\ /_\ ^07_
M /B:/^$PT'_G_P#_ ""__P 37E5%'LD'MY'JO_"8:#_S_P#_ )!?_P")H_X3
M#0?^?_\ \@O_ /$UY511[)#]O(]5_P"$PT'_ )_O_(+_ /Q-'_"8:#_S_?\
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M /$T?\);H?\ S_?^0G_^)KR^BE[-![:1ZA_PENA_\_W_ )"?_"C_ (2W0_\
MG^_\A/\ X5Y@**?LT'MI'I__  ENA_\ /]_Y"?\ PH_X2W0_^?W_ ,A/_A7F
M%**/9H/;2/3O^$MT/_G]_P#(3_X4?\);H?\ S_?^0G_PKS T4>S0>VD>G_\
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M1Z3_ ,)3HO\ S^?^0G_PH_X2G1O^?S_R$_\ A7FPI:/9H?MI'I'_  E.C?\
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M)]'_ .?S_P A/_A1_P )/H__ #^?^0G_ ,*\[HH]F@]K(]$_X2?1_P#G\_\
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M+2"EH *6DI: "BBB@!:*** "BBB@84444 %%%% A12T@I: "EI*6@ I*6DI
M+1113&%+24M !0**!2$+1110 4444#"@44"F M%%% "T444@"EI*6@84444P
M"BBBD HZTM(.M+0 4"B@4 +1110 4444#"EI*6@ HHHH 6BBBD(*6DI:!A11
M10 4444P%HHHI""EI*6@ HHHI@%%%% PI:2EI %%%% "T444Q!1112&%**2E
M% !1113 4=*6D'2EI )2TE+2 ****8"T444#"EI*6@ I124HH ****0!1113
M *44E**0!1110,6BBB@04M)2T %%%% PHHHH 44M(*6@ HHHH ****!"T444
M#"BBB@ HHHH 6BBBD "EI!2TP"BBB@ HHHH 6BBBD 4[M3:=VH *#10:8!11
M12& I:04M, H%% H 6BBBD 4444#"EI*6@ HHHI@+1112 !2T@I: "@44"@!
M:*** "BBBD 4HZ4E*.E,!:*** "BBB@ HHHH *!UHH'6D ZBBBF G>EI.]+2
M *6DI: "BBB@84444""EI*6@ HHHH 6BBB@84444 %*.E)2CI0 M%%% "BB@
M44 )2BDI10 4444@%HHHI@%+24M !1112 6BBB@ HHHIC"E'2DI1TH 6BBBD
M 4444 %+24M !1110(****0"BEI!2TP"D%+2"@8M%%% !1110 4ZFTZ@ HHH
MH ****  4M(*6@ H%% H 6BBBD HHH%%  :*#10,**** %HHHH !2T@I: "@
M44"@!:***  4M(*6@ I:2EH **** %HHHH 2EI*6@84"B@4 +1110 4M)2T"
M"BBB@84444 +1110 4M)2T %%%% "T444 )2TE+2 ****8"T444 +1110 44
M44 %%%% "T444#"EI*6D 4444 +1113 444"B@ I124HI#"BBB@0HHH%% !1
M110,**** %HHHI ***!13 *44E** $-%!HH 444"B@ I:2EI %%%% "T444
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M^)_BL****U, HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 444"B@ HHHI )1W
MHH[TP'4444 %+24M( I124HH *0TM(:  4M(*6@ I:2EH **** %HHHH ***
M*!A1110 4444"%%+2"EH *6DI: "DI:2D M%%%,84M)2T % HH%(0M%%% !1
M110,*!10*8"T444 +1112 *6DI:!A1113 ****0"CK2T@ZTM !0**!0 M%%%
M !1110,*6DI: "BBB@!:***0@I:2EH&%%%% !1113 6BBBD(*6DI: "BBBF
M4444#"EI*6D 4444 +1113$%%%%(84HI*44 %%%%,!1TI:0=*6D E+24M( H
MHHI@+1110,*6DI: "E%)2B@ HHHI %%%%, I124HI %%%% Q:***!!2TE+0
M4444#"BBB@!12T@I: "BBB@ HHHH$+1110,**** "BBB@!:***0 *6D%+3 *
M*** "BBB@!:***0!3NU-IW:@ H-%!I@%%%%(8"EI!2TP"@44"@!:***0!111
M0,*6DI: "BBBF M%%%( %+2"EH *!10* %HHHH ****0!2CI24HZ4P%HHHH
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M4 +1110 E+24M( HHHI@+1110 M%%% !1110 4444 +1110,*6DI:0!1110
MM%%%,!110** "E%)2BD,****!"BB@44 %%%% PHHHH 6BBBD HHH%%, I124
MHH 0T4&B@!110** "EI*6D 4444 +1110 &B@T4 %**2E%, HHHI#%%% HH
M*6DI: "DI:2@!:*** "EI*6@ I124HH ****  4M(*6@84"B@4 +1110 M%%
M%( I>U)2]J $H%% I@+1112 !2T@I: "@44"@!:2EI* %HHHH *6DI: "@44
M"@!:*** "BBB@ HHHH&+1110 M%%% !2TE+0 4E+24 +1110 4M)2T@"BBB@
M!:*** %HHHI@%+24M( HHHH 444"B@ I:2EH 0T4&B@!:*** "EI*6@ I124
MHH M:;_R%+3_ *[I_P"A"O1*\[TW_D*6G_7=/_0A7HE9U#>EL>._';_F ?\
M;Q_[2KQVO8OCM_S /^WC_P!I5X[771^!'GXG^*PHHHK4P"BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MY:LFI:,[Z$(N%VCYQ\3V5OIWB;4+.UC\N"&8JB9)P/J>:R:W?&G_ ".>K?\
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M_H'?^1Y/_BJ\FUB".UUN_MX5VQ17,B(N2<*&( YKWNO"-?\ ^1DU3_K[E_\
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M@!:*** "EI*6@ H%% H 6BBB@ HHHH ****!BT444 +1110 4M)2T %)2TE
M"T444 %+24M( HHHH 6BBB@!:***8!2TE+2 **** %%% HH *6DI: $-%!HH
M 6BBB@ I:2EH *44E** +6F_\A2T_P"NZ?\ H0KT2O.]-_Y"EI_UW3_T(5Z)
M6=0WI;'COQV_Y@'_ &\?^TJ\=KV+X[?\P#_MX_\ :5>.UUT?@1Y^)_BL****
MU, HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M-.U*"]D7D1/'Y18>QR1GIU('O7G%[97.G7LMG>0/!<1-M>-Q@@U]:5PGQ/\
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M*!CS/]EO4'U[?F#4*SO:1%3#*UX'@-;WAGPG?^*I;B.QFMHS JLWGLPSG/3
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MD:K?649D$G3=&.64^O&2/?ZFO#*Z(3YE<XZM-TY6"BBBM#(6BBB@9Z=\'/\
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M[K**WHMN6'_H0JIJ'PKU*"/?8WD%V0"2C+Y3'T Y(_,BO5;BZM[6,R7$\4*
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M4^@KU*LZE5IV1K2H*2YI'F;?"=PORZRI;T-M@?GNKF=<\&:OH2M++")[8?\
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ML;E[>ZA>&5#@JXP?_P!7O4(KWG6="L-=M/(O80Q .R5>'C/J#_3I7B.IV/\
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MD:R]I,V=&GL>+0^'M0DUN+2)8A;W4F=HFR%P 3G(SD<'D5O?\*TUG_GYL/\
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M)%#!)&8,,^HV]:@U7PC?:-8-=W5S:% 0H5';<Q/8949[GZ UZP!@8%><>/\
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M]_U_QH_MK2O^@G9_]_U_QJ>>1?LH'$?\(%JO_/Q9_P#?;?\ Q-'_  @6J_\
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M896Z$4\   #H*;J,2HJYY?JWAV[T:".:XD@97;:!&Q)SC/<"JNC_ /(;L/\
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M4 %%%% !1110 4444 %%%% !1110 4444 ***!10 4444@$H[T4=Z8#J***
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M"#^AK2I%2BS&C-QFK'TM7@GQ@_Y'<?\ 7I'_ #:O>Z\$^,'_ ".X_P"O2/\
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MQI=6=Y_8NEW#0NBYNI4X;)&0H/;@Y)'J!GK7E5:GB65YO%&JO(Q9C=RC).>
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MNC6FHW,0085!(2N/3:>/TKUSP1XQ/B6&:WNTCCOH &(3A9$Z;@,Y&. ?J/7
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MJ]K\$Z0NE>&K?*XGN1Y\I(YY' _ 8_'->*LI5BK A@<$$<@U]%QJJ1JJ_=
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M\C-JO_7Y-_Z&:RP^[-\7LC.'2O9/@]_R +__ *^O_917C8Z5[)\'O^0!?_\
M7U_[**TK? 88;^(>AS?ZB3_=/\J^6:^IIO\ 42?[I_E7RS6=#J:XOH=+X;\;
MZGX7M)K:Q@M)$ED\QC.C$@XQQAAZ5M?\+>\0?\^>F?\ ?J3_ .+K@**V<(O5
MHYU5FE9,] _X6]K_ /SYZ9_WZD_^+KD]?UVZ\1:HVH7<<*3,JJ5A!"X'U)K,
MHIJ$5JD$JDI*S9Z=\'/^/[5O^N<?\VKUJO)?@Y_Q_:M_USC_ )M7K5<M;XV=
M^'_AH^;?$_\ R-FL_P#7]/\ ^AFOH31KY-3T6ROD)*SPJ_/4$CD'WSFOGOQ/
M_P C9K/_ %_3_P#H9KOOA7XHCC1O#]Y)MRQ>U9CQSU3\^1]3[5K5C>"9ST)J
M-1I]3J?B'H<NN>%I!;*SW-JXGC11DO@$%?R)/N0!7@E?4U<?X@^'&CZY<FZ0
MO97#$EVA VN2<DE3W]QCWS6=*HHZ,UKT7-\T3PFNZ^%^ASWWB)=4(*VMEDEB
MO#N5("@^V<G\/6NCL?A!8PS![[5)KE 0=D<0BR.X)R>OMBO0+"PM=+L8K*RA
M6&WB&%1?\\GWJZE96M$SI8>2E>19KQ'XJ_\ (XC_ *]D_FU>W5XC\5?^1Q'_
M %[)_-JSH_$:XGX"?X1_\C7=?]>+_P#H<=>SUXQ\(_\ D:[K_KQ?_P!#CKV>
MBM\0\-\!X7\1M"FTKQ--=[";:]8RHX7 #'[R_7//XUQ]?3.IZ99ZQ8265]"L
ML#]5/4'L0>QK@+SX06DDI:SU:6!"2=DD(DQZ '(K2%56LS&KAY<UXGDRJSN%
M4%F)P !DDU]!>"M$?0?#%M:S+MN'S-,,8PS=C]!@?A57P]X T?P_.+I0]U=K
M]V6;'R?[H' /OUKJZBK4YM$:4*+AK+<Q_%=^NF>%=2NC(480,B,.H=AM7]2*
M\9\ WZZ?XTT]WD*1RL86]]P(4?\ ?6VNB^)_BB.]G71+*4-%"VZY93P7'1??
M'?W^E>=([QR+)&S(ZD%64X(([@UI3A[FO4RK5/WBMT/J&O'_ (C7.N:-XE,E
MOJM_%:72!XECN'55( #* #Z\_P# J[WP;XGB\3:,LK%5O8<)<1@]#V8>Q_Q'
M:M/6M%L=?TY[&_CW1MRK+PR-V93V-8Q?)+4Z9KVD/=9X"/$NO?\ 0;U+_P "
MY/\ &E_X277O^@WJ7_@6_P#C7:7WPAO4<G3]3@D0MP+A2A ^HSD_@*LZ9\(]
MLBOJFHJR#!,5NIY]?F/^%;\],Y/95;V."_X277O^@WJ7_@6_^-'_  DNO?\
M0;U+_P "W_QKWAO#>C2:3'I;Z? UG&NU$*\K[@]0>3SG/->3^/?"VD>')8?L
M%ZYFF8L;1_F*)S\P/89X /)]>#2C4C)VL.I2G!7N8/AZ1YO%^E22.SR/?PLS
M,<EB9!DD^M?1=?.7AK_D:M'_ .OV'_T,5]&U%?=&N%V9Y3\7O^/W2O\ KG)_
M,5YK7I7Q>_X_=*_ZYR?S%>:UK2^!'/7_ (C"BO7;?X86%UX:LTG\RUU01;I)
M5.?F.3M9>AQG'&#QUKSGQ'X>N?#6I?8[F6&4LN]&C;JN2!D=0>/_ -=5&I&3
MLA3I2BKLR****HS%KWW1=%T&_P!$L;L:-I[>= CDM:)DD@9SQZUX%7KGPN\0
MK<Z<^BW$@\ZW):#)Y:,\D#UP<_@1Z5C53M='1AVN:SZE[QMX3L9O#%Q)INFV
MD%S 1,## J,RC.X94>A)Q[5XM7T]7+:K\/= U6=IF@DM9&ZFV8("<]<8(S^%
M9TZO+HS:M0YG>)X6JL[!5!9B<  9)-?1'AFQETWPSIUI.I6:.!=ZDYVL>2/P
MS5'1? ^AZ%,D]O;M-<IG;-<-N8<]0. #[@9KHZ52HI:(=&BX:LY;XBL%\#:@
M#U8Q ?\ ?Q3_ $KPJO1/BAXCAO;B+1K5UD2VDWSL.T@!&W\ 3GW..QKD_#?A
M^Y\1ZO'9P#;&,--+VC3/)^OH/_KUM27+"[,*[YZED=-\./"IU&^&KWD9^R6[
M?N0PXED_P'\\>AKV"H+.S@T^SAM+6,1P0J$10<X KE?'WBP:#IWV.T=?[0N5
MP.>8DZ%OKV'XGM6#;J2.F*5*&IU=O=07:.]O*LBH[1L5.<,IP0?QK&\6^&XO
M$FCM#@"[BR]O(>,-CH3Z'C/T'I7EG@7Q4?#VJ>3<,387+!91G_5GLX_K[?2O
M<4=9$5T8,K#(8'((HE%PD$)JK'4^:)H9+:>2"9"DL;%'4]5(."*[KX86VFWU
M]J%K?6EO<R&-)(UFA#X )#$9''WE_P BMGXD>%!<0MKEE'^^C'^E*/XE X?Z
MC'/M]*X+PMKC>']?M[WDP_ZN91W0]?RX/X5O?GAH<G+[*HK['M__  C>A?\
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M5LGCKT /O7?@ # X%8U.5OW3II*:5IGE'Q1L(H-9M;V-</<QD2>Y7 S^1 _
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M<W"J<J)I6< ^V37K/B/P5H-W;S7KD:<Z*6::/A/JR]#^&":\>D"K(RHV]02
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M'_(RQ?\ 7LO_ *$U>K5Y3\2/^1EB_P"O9?\ T)JQI?$=%?X!_P -?^1CN/\
MKT;_ -#2O4Z\L^&O_(QW'_7HW_H:5ZG15^(*'P'BWC'_ )&W4/\ KH/_ $$5
MZYH]ZFHZ/:7:8Q+$I(!S@]QGV.17D?C'_D;=0_ZZ#_T$5O?#_P 1K:RG2+N3
M$4K9@9CPK'JOL#V]_K5SC>*,J<^6HT^IU/C727U7P\XA1GG@82HJ]6QP1[\$
M_B!7CU?0=<QK/@;2]5FDN(R]K</DLT?*LQ[E3_3&:FG44=&76I.3NCR.NJ\
MZ3+>Z\EX01;VGS,V.K$8 _K^'O706OPSM(W!NM0FF4'[L:!,_J:[&RL;73K5
M;:SA6&%>BK_,^I]S53J*UD33HM.\BQ7DGCZ^%YXF>)3E;:-8O;/4_P \?A7H
M?B/7X- TYIG*M</Q#%GECZ_0=_\ Z]>+RRR3S/-*Q>21BS,>I)Y)I4H]1UYZ
M<IZ?\-O^1=N/^OMO_0$KJ-1_Y!=W_P!<7_\ 037+_#;_ )%VX_Z^V_\ 0$KJ
M-1_Y!=W_ -<7_P#0343^(UI_ CP6G4VG5U' >P^"/^1/L/\ MI_Z,:I_%O\
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M:[F.9)6W'V'8?@,"II1UN76E9<IZ7X(_Y%>#_??_ -"-:.O_ /(O:C_U[O\
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MY&***!10 4M)2T %)2TE "T444 %+24M !2BDI10 4444  I:04M PH%% H
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M8NX1+'KVGJI&0)9UC;\FP:^8:*RE0B]4=4,5.*L]3Z7O_'WA;3H]\NM6LO.
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M+SQ/9@YL=%0DRLREI'^4XSMS@9QP/Q/IY;10J,4$L3-['OO_  L?PG_T%?\
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M?N=?O%FF CCC&(HE.0@/7GN3BLFBJC!1)G5E/1BBO7_^$V\/?]!#_P @R?\
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M^H%7=7\5Z+=:/>00WNZ62%U1?*<9)''45YI16;IJ]S15I)6"EI*6M#(****
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MSZ9+XKN+V\N0EH)WF3Y&/F'<2O09'8\^F*P*6DH);#E4<MSU/_A+]"_Y_O\
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M2O.]-_Y"EI_UW3_T(5Z)6=0WI;'COQV_Y@'_ &\?^TJ\=KV+X[?\P#_MX_\
M:5>.UUT?@1Y^)_BL****U, HHHH **** "BBB@ HHHH *='%)/((XU+,>PIM
M=)X=@195<J"Q[^E<6.K^RI.V[*BKLW?#'AJ*U*W%R \O4#TKT6U^XH'Y5S=D
M0%!) 'J:HZ]XTBT^$VMB0\Y&">P_&OF'=LT9O^(_%4&B6S11,'NV& !_#]:\
MJGNYKZZ>XG<L['/-5I;B6ZF::>1G=NK-3D(SU%7"FV[(RF[#+MIBFV-3CN16
M6<YYZUT4?3!Z5%<Z:EPNZ,;7]!7O8.I"E'DL<ZJI.S,*BGRPO"Y1Q@BF $G
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MO2T@"EI*6@ HHHH&%%%% @I:2EH **** %HHHH&%%%% !2CI24HZ4 +1110
MHHH%% "4HI*44 %%%%(!:***8!2TE+0 4444@%HHHH ****8PI1TI*4=* %H
MHHI %%%% !2TE+0 4444""BBBD HI:04M, I!2T@H&+1110 4444 %.IM.H
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M**!3 6BBBD "EI!2T % HH% "TE+24 +1110 4M)2T % HH% "T444 %%%%
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M0IQ;M<MTY)7:,&BBBJ)"EI*6@ HJ:TMVO+V"V3.^:18UP,\DXKUG_A56A_\
M/WJ/_?Q/_B*F4U'<N%.4]CR&BO7O^%5Z'_S]ZC_W\3_XBL3Q9X#TO0?#\U_:
MSWCRHRJ!*ZE>3CLHJ55BW8IT)I79YX*6NV\$^#M/\2:=<W%Y-=(\4NQ1"R@8
MP#W4^M=1_P *KT/_ )^M1_[^)_\ $4.I%.S"-&<E='D- KU[_A5>A_\ /UJ/
M_?Q/_B*/^%5Z'_S]:C_W\3_XBE[:(_J\SR*BNWMM+\/:;XVN=#U*V,]J658;
MB69E9&*@X8J5&#G'3TKM+GX>>');:2.&R,,K*0D@FD)4]C@L0:;JI;BC1E+8
M\4HJ>]LY]/O9K2Y0I-"Y1Q[C^E059D%*.E)2CI3 6BBB@ HHHH **** "@=:
M*!UI .HHHI@)WI:3O2T@"EI*6@ HHHH&%%%% @I:2EH **** %HHHH&%%%%
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M1K&7+\$$;1R<@D<5ZAJOC[Q=/I4T5OX/O[*5D(:Y:.5@@QRP&P8(]23BN%\
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MV!\:+FZ>39;NZ0W![;&C3D^P.&_"LZ=U)V-ZR3A%,X2ZT+5[& SW>E7UO""
M9)K=T49Z<D8JA7T]K>E1:WHMWILW"3Q[<^AZ@_@0#7S+/!+:W$MO.ACEB<HZ
M-U5@<$'\:VIU.<YJU+V;5AL:/+(L<:,[L0JJHR23T %:O_"+^(/^@%J?_@))
M_A70_"[0AJOB?[9+&&M[!?-.0"#(>$&#^)_X#7J?CG7O^$>\+7-RC8N9?W%O
M_OMGGIV&3SQQCO2G4:ERHJG14H.<F?.[H\4C1R(R.I*LK#!!'4$4VBBM3G.[
M^%FAKJGB4WTR!H=/428/_/0YV?E@GZ@5ZUXIUK_A'_#=YJ04-)&F(E(R"['"
MY]LG)]@:YKX26)M_"<ERP7-U<,RD==J@+S^(:LGXR:@ZP:9IJ[=CLT[^N0-J
M_P#H35RR]^K8[H?NZ%SRB21YI7EE=GD=BS.QR6)ZDGN:;17I7PT\%0:HIUK5
M(5EM5;;;PN,K(1U9AW Z =SGTYZ)R45=G)3@YNR.0TWPAX@U>/S;+2KAXR 0
M[@1JP/0@L0#^%37W@?Q)IL#376DRB->2T;+)C_ODFOH.\OK/3;8SWEQ%;0+@
M;Y&"C/8<UC6'CGPUJ5P(+;5H3(2 JR*T>XGH!N R:P5:3U2.IX:FM'+4P/A!
M_P BE=?]?S_^BXZQOC-_K]&_W9OYI7I]GIUIIYN/LD"PBXE,T@3@%R "<=L[
M1_.O,/C-_K]&_P!V;^:4H/FJ7+JQY:-CRX=*V=,\*Z[K"!['3)Y(STD(V(?H
MS8!KI_AOX,BUN9M5U%-]E ^V.(CB5QSSZJ/3N?Q!]BN+FTTRS,UQ+#;6T0 W
M.0BJ.@'],5I4J\KLC"EA^9<TMCY_O/ GB>PA::?2)=B\DQLLAZXZ*2:RK/2-
M3U&-I+'3KNY13M9H(6< ^A(%>^6OCKPS>W?V:'5X?-S@;U9%)SCAF !_.MFV
MLK6UEGFMHDC:X8/(4& S8QGZXQ4>VDMT:?5H2^%GS7=:/J=CY?VS3KNW\QMJ
M>= R;CZ#(Y-6/^$8\0?] /4__ 23_"O2?C'_ ,@S2_\ KL__ *"*ZSP9K?\
M;_A>TNWDWW"+Y5P>_F+U)^HP?QJG5:BI6(5"+FX7/GAT>*1HY%9'4E65A@@C
MJ"*;7:?$W1/[*\4M<QH1!? S ]M^?G'YX/\ P*N0MK>6\NH;:!-\TSK'&N<;
MF)P!S[UK&5U<PE%QEREJUT/5KZ 3VFEWMQ"20)(K=W4X]P*CO--OM.9%OK*Y
MM2X)43Q,F[Z9'-?1^CZ9#HNCVVGPX$<$84M@#<>['W)R:\EMVC\?_$[?*=VG
MQDE5Z;H4Z#D9^8\D=1N/I6<:MV^R-YT%%)7U9S.E>%-<UN 3Z?ITDT))42$J
MBDCK@L14FH^#?$.DVS7%YI<J0K]YT*R!1C.3M)P/<\5[_>WUEHVGM<W<L=M:
MPJ 21P!T  'Z 5%I6M:;KMJT^G727$0.UL @@^ZD C\14>VEO;0T^K0VOJ?-
M-%=5\0$T>/Q1.FD#!'_'P%QY8D[[?Z^]<K6Z=U<Y)+E=@KJ?#_CO4?#>G_8[
M&RT\J6+/))&Q=S[D,.G05RU%-I-68HR<7='O?@3Q->^*-,NKF]BMXWBF\M1"
MI Q@'G)/K6!\8/\ D&:9_P!=G_D*E^$'_(!O_P#KZ_\ 9147Q@_Y!FF?]=G_
M )"N5)*K9'=)MT+L\DHHHKJ.$6BBB@05K:!KLWA[4/MUM:VL\X4JAN$+;,]2
M,$8/;/UK)I:&KZ#3:=T>K^$_B)J^N^)K33;JVL4AFW[FB1PPPC,,98CJ/2NU
M\5?\BEJ__7G+_P"@FO'/AS_R/FF_]M?_ $4]>Q^*O^12U?\ Z\Y?_037+424
MU8[J,G*FVSYSHHJ:UMGO+R"UBQYDTBQKGIDG _G74<)[YX&LOL'@O3(\[C)%
MYQ.,??);] 0/PKD?$OQ*U/2O$5Y86,-A+;P.$#.K,V<#<"0P'!R.G:O3(HUA
MB2)!A$4*H] *XJ]^%VD7UU<74E[?B>>1I6(9-N6.3QM]_6N.+CS-R/1G&?*E
M Y+_ (6UKW_/IIO_ '[?_P"+KB[Z[DU#4+F]E"K)<2M*X08 +$DX]N:Z/Q7X
M%OO#2_:5?[38%L><HP4YX##M]>F?PKE*Z8*.\3BJ.>TPHHHJS(6M_P %Z2FL
M^*K*UF3? K&64=BJC.#[$X'XU@5>TK6+[1+LW>G3^3.4*;MBMP<9X8$=J4KV
MT+BTFFSZ'U/4+?2-+N+^Y.V&!"Q QD^@'N3@#ZUX[<_$_P 0RWYG@DA@@!.V
MW$088YQDD9)^A'3I65J/C/Q!JUA+8WU_YMM+C>GDQKG!!'(4'J!6#6=.DE\1
MM5KN3]W0^A_"VOIXDT.._5!')N,<J Y"N/\ ZQ!_&O-/BIID5IXAAO8L WD6
M9!_M+QG\1M_+WKOO 6C2:+X4@CG4I/<,;B13G*E@, @]#M"Y'KFN ^*FI+=>
M)(K)"I%G" QP<[VY(_+;^M9T_P")H:U7>DN;<] \!Z;%IWA&R** ]R@GD;N2
MW(_3%<YXY\>WVDZLVE:5LC>)09IF3<=Q&0%!XX!!SSS].>H\$WL=]X.TUXS_
M *N(0L#U#)\I_EG\:X?XA^#]2FUR35M/M9;J&=5,BQ#<R, %^Z.<$8Z9[]*F
M-G-\Q4^94ER&[X!\:W/B"6;3]1"&ZC3S$E1<;U& <CH#DCIZ].*=\4=*BNO#
M:ZAC$UG(,-CJC$*1^94_A[U0^&OA6_TRYGU74(7MR\7E11.,,02"6([= .??
MVK4^)]^EKX2:V/W[N5$ ]E.XG_QT?G3T53W1*[HOG/%:***ZCA"BBB@!:Z_X
M?^&!KVK?:;I,V%H0SAAD2-V7Z=S[<=ZYK3=/N-5U&"QM$WSS-M4'IZDGV R?
MPKZ#T72+;0=(AL+;_5Q#YG/5V/)8UC5GRJR-Z%/F=WLC0KA?BO\ \BM;?]?J
M?^@/5_P[XF_X2'Q-JJP-FQM8T2'_ &SD[G_' Q[ =.:H?%?_ )%:V_Z_4_\
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M4%XW1H)5)&<;2"?TR/QKPNE2=XCKQM._<*4=*2E'2M3 6BBB@ HHHH ****
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MB@ %+2"EH *!10* %HHHH !2T@I: "EI*6@ HHHH 6BBB@!*6DI:!A0**!0
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MP1Z2\9N0BM>KG]YYN.2PZXSG';'XUJWO@;PSJ%^+VYT>W:</O++E0S9SEE!
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M>&+>VD7;=2_OKC_?;M^  ''IGO7EWQ.UT:MXE^R0ONM[!3$,8P9"?G/Z ?\
M :YTE.IIL=DI.G15]SBJ[#X<MHJ>)D?5V575<VIE_P!6),]2?7TSQGWQ7'TM
M=4E=6.*,N5W/IK4](T_6;?R-1M(KB,9P''*Y[@]0?<4S2-#TW0K9K?3+5;>-
MFW-@EBQ]R22:\%T[QGXBTJW6WM-4F6%>%1PL@48Q@;@<#V'%+?\ C/Q%JD7E
MW6JSE.ZQXC!^NP#/XUS^QEM?0Z_K,-[:G0?%#Q';:OJEO8V<@DAL@V^13\K2
M'&0/7&.ON:X*BBMXQY59').3G+F844451)[#\(/^0#?_ /7U_P"RBHOC!_R#
M-,_Z[/\ R%>7V>K:EI\;1V6H7=LC'<RPS,@)]2 :+S5=1U%%6^O[JZ5#E1/,
MSA3[9-8^S?/S'1[9>SY+%2NI\ :$-<\40K/ LMG;@RSAP=IQ]T>^6QQW -<M
M7LOPSLK32/"-QJ\TL>Z<M),X;/EHF< \]>I['YAZ5525HDT8\T]3 ^)>@:#H
MR6\UE"UO>W#G]S&<1[1U;&..<# QU]J\ZK7\2Z[+XBUVXU"3(1CMA0_P1C[H
M^O<^Y-9%.":CJ14DI2;04M)2U1!U/PY_Y'S3?^VO_HIZ]C\5?\BEJ_\ UYR_
M^@FOGBVN;BSN%GM9Y8)DSMDB<JPR,'!'/0U<E\0:U/"\,VKZA)$X*NCW+D,#
MU!!/(K*=-RE<Z*=90@XV,ZNU^'OBV+P]>RVEZ2+*Z8$O_P \FZ;C['O]*XJB
MM)14E9F49.+NCZ;GM[34[,Q3Q0W-M* =K .K#J#6;IOA/0M)NS=V6FQ13DY#
MDLQ7K]W<3MZGIBO#-*\2ZSHR&/3]0FACSGR\AESZ[3D5H3>/_%$\31OJT@5@
M02D:(?P*J"*Y_8R6B9U?6(/5K4]6\8^+[;PU8LD;I)J4BYAA.>.VYO0#]<?7
M'@[N\DC22,SNQ)9F.22>Y-$DCS2O)([/(Y+,S')8GJ2?6KVAV*:GKMC92NB1
MS3*KLS;1MSSSZXZ>IQ6L(*",*E1U&>G^#/!.FW/A"-]5L4EFO#YP<\.B?PX8
M<@$<_CSZ5Y9JL=C#JMS%ILDDMFCE8I)"-S =^,=>WM7KWQ#\0KH.@IIMIA;B
M[0QJ ?\ 5Q 8)^O8?CZ5XK2I7=Y,JORQM!=!:[;X<>&K/7M2N+F^_>0V6P^0
M1Q(S;L;O8;>G?Z<'B:M6>IW^G;_L-[<VWF8W^1*R;L=,X//4_G5R3:LC*#2E
M=GTL  ,#@55O-,L-1*&]L;:Y*9V>?$K[<]<9''2OGW_A)=>_Z#>I?^!3_P"-
M'_"2Z]_T&]2_\"G_ ,:P5!]SJ^M1?0]X_P"$:T'_ * FF_\ @*G^%><_%73+
M#3O[)^PV5M;>9YV_R(E3=C9C.!SU/YUQO_"2Z]_T&]2_\"G_ ,:JWFIW^H[/
MMU[<W/EYV>?*S[<]<9/'0?E5QIRB[MD5*T91LD16\2SW,432+$KN%,C=%!.,
MGV%?1NCVMG9:/:V^GM&UJD8$;1D%6'7=D=<G)_&OFZKUCK.I:;#-#9WLT,4Z
ME)(U;Y6!&#QTSCOUIU(.1%&JJ;U1K>-O$!\0>(I98VS:0?NH,'@J#RWXGGZ8
M]*YRD%+6B5E8RE)R=V;W@W1O[<\36ML\>^W0^;..VQ>Q^IP/QKK?B1X?T#2K
M..[MH3;7T[[4BAP(V QN)7M@8Z8Y(XJ_\*["WMM#O-5=X_,D<HQ#9V(HSSZ<
MY/TQ7!>+?$#^(]=ENAD6Z?NX%/9 >I]SU_\ U5E=RJ:;(WLH4M=V85%%%;'.
M+1112 ])^$7_ !^ZI_USC_FU;7Q7_P"16MO^OU/_ $!Z\EL]1OM/9VLKRXMB
MXPQAE9-WUP:ENM6U*_A$5YJ%W<Q@[@DTS. ?7!/7DUFZ;<^8W55*GR6+WA;7
MV\.:Y'?;#)$5,<R#J4.,X]^ ?PKW>SO+/5]/2XMI$N+:9>O4$=P1_,&OFZKE
MAJ^HZ5)OL+V:W.<D(Y /U'0_C14I\VJ"E6Y-'L>X?\(3X;^U"X_LF#>.W.S_
M +XSM[^E:.IZI8Z)8-=7LR0PH,*.[''"J.Y]J\8_X6#XH*X_M0X_ZX1__$UA
MWVHWNIS^=?74UQ)S@R.3C/8>@]A4>RD_B9J\1%+W46_$.MS>(-:FOY1M5OEB
M3^X@Z#^I]R:RZ04M;I65CE;;=V3V=RUE?6]T@RT,JR 9QR#G^E?0VDZK;:SI
ML-]:N&2102N>4/=3[BOG*KFGZK?Z5,9;"[EMW/WO+; ;ZCH?QJ*E/F-:57D9
M[E)X-\/2WOVQ]*@,V23UVD^ZYVGKZ5I37%CI-D&FD@M+6(!1DA%4= !7BC>/
M_$[+M.J-CVAC!_/;6)>ZA>:C+YM[=37#CH97+8^F>E9>RD]V:O$17PH^A;>Y
ML]8TT36\JSVEPA&Y21D'@CU![>HKQ/Q9X3N?#-[_ !2V,I_<SX_\=;T;^?4=
MP,FTU74;",QV>H75O&QW%89F0$^N :=<ZUJMY T%UJ=Y/"V,QRSLRG'/0FKA
M3<7H]"*E6,UJM2C2TE+6I@>X^#_%MOXBLEAE81ZC$H$L9/W_ /;7U'KZ?D3I
M:IX:T;67$E_81RR#'[P$HQQZLI!(]J^?HY'BD62-V1T(964X*D="#700^.O$
MUO&(TU60@ #,D:.?S8$UBZ+O>+.F.(5K31[9:6=GI5GY-K#%;6Z98A1@#U)_
MQKR;Q]XLCUVYCL;%]UC;MNWC_EJ^,9Y[#)'XGVKG]3\1ZQK*!+^_EFCSG9PJ
MY]=HP*RZ<*=G=DU*W,N6.QJ>';"WU+7K2VNYXX;9GS*TCA05'.W.1R>@^M>\
MW]Y#I>FSWDHQ#;QERJXY '0>_85\Y"K_ /;&HG2VTTWDILF()A8Y''3&>@]A
M3G3YF*E54$U8BU"^GU+4)[VY;=-.Y=NN!GL,]AT'L*K"B@5H8BUW?PLLFFUV
MZO,+LMX-O/7<QXQ^"M7"JK.P502Q.  .2:]U\':$= T"*"1<7,O[V?V8]NO8
M8''I6=65HV-J$;SOV(_'=\+'P??$,H>8"% W?<<$#WV[C^%>&UZ!\4-9\_4+
M?28F!2W'FRX/\9Z#\!_Z%[5Y_2I*T1UY7GZ!2CI24HZ5J8"T444 %%%% !11
M10 4#K10.M(!U%%%,!.]+2=Z6D 4M)2T %%%% PHHHH$%+24M !1110 M%%%
M PHHHH *4=*2E'2@!:*** %%% HH 2E%)2B@ HHHI +1113 *6DI: "BBBD
MM%%% !1113&%*.E)2CI0 M%%%( HHHH *6DI: "BBB@04444@%%+2"EI@%(*
M6D% Q:*** "BBB@ IU-IU !1110 4444  I:04M !0**!0 M%%%(!110**
MT4&B@84444 +1110 "EI!2T % HH% "T444  I:04M !2TE+0 4444 +1110
M E+24M PH%% H 6BBB@ I:2EH$%%%% PHHHH 6BBB@ I:2EH **** %HHHH
M2EI*6D 4444P%HHHH 6BBB@ HHHH **** %HHHH&%+24M( HHHH 6BBBF HH
MH%% !2BDI12&%%%% A110** "BBB@84444 +1112 444"BF 4HI*44 (:*#1
M0 HHH%% !2TE+2 **** %HHHH #10:* "E%)2BF 4444ABBB@44 %+24M !2
M4M)0 M%%% !2TE+0 4HI*44 %%%%  *6D%+0,*!10* %HHHH 6BBBD 4O:DI
M>U "4"B@4P%HHHI  I:04M !0**!0 M)2TE "T444 %+24M !0**!0 M%%%
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MBB@04444@%%+2"EI@%(*6D% Q:*** "BBB@ IU-IU !1110 4444  I:04M
M!0**!0 M%%%(!110**  T4&B@84444 +1110 "EI!2T % HH% "T444  I:0
M4M !2TE+0 4444 +1110 E+24M PH%% H 6BBB@ I:2EH$%%%% PHHHH 6BB
MB@ I:2EH **** %HHHH 2EI*6D 4444P%HHHH 6BBB@ HHHH **** %HHHH&
M%+24M( HHHH 6BBBF HHH%% !2BDI12&%%%% A110** "BBB@84444 +1112
M 444"BF 4HI*44 (:*#10 HHH%% !2TE+2 **** %HHHH #10:* "E%)2BF
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MHHHH&%+24M( HHHH 6BBBF HHH%% !2BDI12&%%%% A110** "BBB@84444
M+1112 444"BF 4HI*44 (:*#10 HHH%% !2TE+2 **** %HHHH #10:* "E%
M)2BF 4444ABBB@44 %+24M !24M)0 M%%% !2TE+0 4HI*44 %%%%  *6D%+
M0,*!10* %HHHH 6BBBD 4O:DI>U "4"B@4P%HHHI  I:04M !0**!0 M)2TE
M "T444 %+24M !0**!0 M%%% !1110 4444#%HHHH 6BBB@ I:2EH *2EI*
M%HHHH *6DI:0!1110 M%%% "T444P"EI*6D 4444 ***!10 4M)2T (:*#10
M M%%% !2TE+0 4HI*44 6M-_Y"EI_P!=T_\ 0A7HE>=Z;_R%+3_KNG_H0KT2
MLZAO2V/'?CM_S /^WC_VE7CM>Q?';_F ?]O'_M*O':ZZ/P(\_$_Q6%%%%:F
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M'OCC0X?"U[9VFH6U[=7D+0QQV\H< '@LQ7(& <X/7\\>!U-*4FO>-*\81E:
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M,5W?3V<D<DOE 0.Q.<$]U''%=?\ !?\ YC?_ &P_]J5I?&'_ )%FR_Z_!_Z
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M/38VUC28B+4L3<0@\19Q@J/[N>H[?3IYU6T9*2NCEG!P=F%%%%42**6D%+0
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M@ HHHH *!UHH'6D ZBBBF G>EI.]+2 *6DI: "BBB@84444""EI*6@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@!110** "BBBD E'>BCO3 =1110 4M)2T@"E%)2B@ I#2TAH
M !2T@I: "EI*6@ HHHH ^I_"VLPZ_P"&K'4(6!,D0$BC^"0<,OYY_#![UYE\
M2?AS<_;+KQ!I"^;%)F6ZMQ]Y6[LOJ#R2.HYZYXY#P3XVN_"&H?Q3:=,P^T6^
M?_'U]&'Z]#V(^B-+U6RUFPCOM/N$GMY!PR]CZ$=0?8UQR4J4KK8]*+C7ARO<
M^6O[7U :1_9(NY18>9YI@!^4MQR?7H..G>J5>W>/_AC%J*SZOH4?EWWWY;5<
M!)O4J.S?H?KU\1KIIS4E='%4IR@[2/HFU^&/@^2TA=]'RS1J2?M,W)(_WZ\/
M\6V-MIGBS4[*SC\NWAG*1IN+;1]3S7T]9?\ 'A;?]<E_D*^:O'G_ "/6L_\
M7RU8T)-R=V=.*A&,%9%GX=:-8:[XNBL=2@\^V:)V*;V7D#CE2#7IGBGX=^%=
M-\*ZG>VFE^7<06[O&_VB4[6 X."V*X+X1_\ (^P?]<)?Y5[+XW_Y$?6O^O1_
MY4JLFJB284(1=)MH\H^"O_(XWG_8/?\ ]&1UZWXMT%_$OAV?2DG6 S/&3(R[
MMH#ACQW/%>2?!7_D<;S_ +![_P#HR.O9=>UFW\/Z)=:I=9,4"9VCJS$X51]2
M0*FK?VFAIA[>QUV,72?ASX7TF$(-,BNY"!NENQYI;'L>!^ %6+_P'X8U&!HI
M-&M(<C >WC$3#W!7%>':Q\0?$NKWK3_VG<6<>3LAM)6B51Z<')Z=\]ZZ_P"'
M_P 2=2FUF#2=;G^U17+".&9@ T;GH"1]X$\<\YQ3E3J)<UR8UJ3?+8Y;QOX&
MN?"%U$XE-Q83DB*;;@J1_"W;./SP?0U)\,]"TWQ!XGEL]4MOM%NMJ\@3>R?,
M&4 Y4@]S7NGB;1H_$'AR^TUP"9HSY9/\+CE3^8%>.?!K_D=)_P#KR?\ ]#2J
MC4<J;[F<J*A579G2^/\ P+X;T3P;>7^G:;Y-U&T85_/D;&74'AF(Z$UX[:VL
M][=16UM$\L\K!4C09+$U]"?%3_DGNH?[T7_HQ:XWX+Z'%-<WNMS1JS0$06Y/
M\+$9<_D0/Q-%.;5-R8ZM)2JJ,=#8\,?"+3K.W2?7O],NFPWDJQ6./VX.6_E[
M>O9KX1\-JFP:!IF,8YM$)_/&:J>,]=U+1=* TC2[J^OI\K&88&D6+&/F; ]^
M!W_"O'[B\^)5S<_:'7Q&'SG$<$J+_P!\J OZ5"4IZMFLI4Z7NJ-STK7OA5X?
MU:-WLHO[-NF.0\.2G3&"F<8^F*\/UK1;[P_JDNGZA#Y<T?((Y5U[,I[@_P">
M17M7@'Q)XFNY_P"S?$FDWZ,5)BO9+1XP<<[7.T <=#QZ=32?%W0X[_PL-35?
M](L'#9 ))C8A6'Y[3GM@^IJH3E&7+(BK3C.'/!69X?8V-UJ5[#9V<+S7$S;4
MC0<D_P">_:O:O#OPBTFR@CEUHF^NN"T:L5B4^@Q@M^/7TJO\'- CM])GUV50
M9[EC%$<?=C4\_FW_ *"*VOB'XV?PG8PPV21OJ%SG9Y@)$:CJV.Y[ ?X8).<I
M2Y8BI4H0A[29N+X1\-JFP:!IF,8YM4)_/&:QM9^&/AK5HCY5F+"?&%EM?E ^
MJ_=/Y9]Z\7G\;>)[FY^T/KM\'SG$<I1?^^5POZ5UOAWXOW]C;S1:U"=0(3,$
MB81MWHQZ8]\9&.ASPO95%JF4J]*6C1QWBCPO?^%=5-G>+NC;+03J/EE7U'H?
M4=OI@GZ&T/PMHWAQIVTFS^SF<*)/WKONQG'WB<=37@/BGQKJOBR4+>,D=HC[
MHK:,?*IY&2>I.#U_05Z=\+/%.L^(Y=475KS[0(%B,?[I$VYW9^Z!GH*JJI.%
MV10E351I==CM]:T+3?$-FEIJEM]H@202JN]DPP!&<J0>A->.S^ 8-3^)]]HF
MGHUIIEJL<DK LY12B$@%L_,23C/N>V*[_P")NNZEX>\-V]WI=S]GG>\6)FV*
M^5*.<88$=0*YSX3:Y-JVO:[-J5P)=0NHX7W;54LJ!E/  ' *]!40YHQ<D:U>
M2510:U.VL/ WAG3[9(4T:SEVC&^XB65C[DL#6?K_ ,-?#^L6KBWM(]/NL'RY
MK9-H!]U'!'Z^]2>/=,\2:CID)\.W\EO)$S&6&.3RVE'&,/V(P>,@'/M7!P_$
M[7]#TFZTS5[.0ZM& L$TR;2 <Y+C^+'&,#GO[J*F]4RIRIQ]V4=#S[5]*NM$
MU6XTV\51<0-M;:V0>,@@^A!!_&J=+++)-*\LKM)([%G=CDL3U)/<TE=B/-TO
MH>P?"'0-,N=+?6IK;=J%O>/'%-YC#:OEKQM!P?O-U'>O3[RT@O[*:SN4\R"=
M#'(F2-RD8(R.:\,^%^OZG;>)++18;G;I]Q*\DL/EJ=S>6>=Q&1]U>A[5[-XD
MNY[#PSJ=Y;/Y<\%K))&^ =K!20<'BN.JGSGI4)1]GL>4_%#PIHGAVPT^72K+
M[.\LK*Y\UWR !C[Q-5?!/PSGU^&+4]4D:VTYCE(U_P!9,/7_ &5]^IQ[@U2T
MO4=9^(7B32])UF\-Q;+*9& A1,*!EN5 Z@8SVS7O%W=6VDZ;+=38BM;:(LVU
M>%51V _E5RE*"4>IE"G"I)SMH95GX)\,V4"Q1:)9.J]YHA*Q^I;)JMJGP^\,
MZI T;:7#;,>DMHHB93[8X_,&O'M;^(WB+6;IFCO9;"WW92&U<IM';+#DGU[>
MPK5\'_$S5+#4H+;6;M[O3Y"$9Y>7B[;MW4CUSGBE[.HE>Y2K4F^6VAD>,? U
M[X2F65G%Q82OLBG P<XSM8=CU^N/PK3^$7_(ZG_KUD_FM>TZSI5MKFD7.FW8
MS%.A4D=5/9A[@X/X5XW\++:2S^(-Q:S "6&"6-P/4, ?Y52J<T'<B5)0JQ:V
M9Z?X]_Y$75_^N']17/\ P;_Y%"[_ .O]_P#T7'70>/?^1%U?_KA_45S_ ,&_
M^10N_P#K_?\ ]%QUDOX;]3=_QEZ&+\:_]?HO^[-_-*X?PKX3O_%FH-;VA2.*
M+!GG?I&#[=R<' ]NU=Q\:_\ 7Z+_ +LW\TKO_!NA1^'_  Q9V:J!,R"6=L<M
M(W)^N.@]@*T4^2FK&+I>TK.^Q0T;X<>&])@57L4O9\?-+=#?N/\ NGY0/P_.
MM*X\'>&[F(QOH=@%(()C@6,\^Z@$5YYX_P#B-?V^K3:1HDX@CMVV37"@%V<=
M5!/0 \>N1Z=>/TSQYXETNX\U-5N+@'&Z.Z<RJ?\ OHY'7L125.<E>Y3K4HOE
ML=7XO^%36,$NH:"\DT* O):.<NHY/R'^( =CSQU)KBO"<6G7'BBPM]6@$UG/
M)Y3J79<%N%.5(/WL5]">'=;A\0Z%:ZG"I03+\R'G8PX8>_(/->(_$?1$T#Q>
M[6@,<-RHN8]N1L8DA@#_ +P)]LBJIS;O"1%:G&-JD=CT?6_AAX?DT6[73+ P
M7PC+0.)I&^8<@8+$<XQT[UX37TSX5UC^WO#%AJ+,#+)&!+@8^<<-QVY!KP_Q
M9X>EM?'\^EVZ@?:[A3;YZ8D/'X DC\**4G=QD&(@K*44=7\.? FEZQH$FI:S
M9M/YTI6W!E91L7@D;2.K9'/]W\^4\?>'(O#?B5[>U0K9S()8!R=H.05R2<X(
M/YBO?=+L(]+TJTL(B2EO"L0)ZG QDUQ7Q:T07_AM-3129K!\G'>-B ?R.T^W
M-1"HW/R+J44J6BU1YAX)T%/$7BFULIT9K49EGVMCY%'K[G XYYKTWQ-X*\(:
M%X;O]1_LI0\,1\O=<3$%SPH(W?WB*H_!S2/+L;_5Y$^:9Q!$2F#M7EB#W!)
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M^)GKR(*=VIM.[5N<H4&B@TP"BBBD,!2T@I:8!0**!0 M%%%( HHHH&%+24M
M!1113 6BBBD "EI!2T % HH% "T444 %%%%( I1TI*4=*8"T444 %%%% !11
M10 4#K10.M(!U%%%,!.]+2=Z6D 4M)2T %%%% PHHHH$%+24M !1110 M%%%
M PHHHH *4=*2E'2@!:*** %%% HH 2E%)2B@ HHHI +1113 *6DI: "BBBD
MM%%% !1113&%*.E)2CI0 M%%%( HHHH *6DI: "BBB@04444@%%+2"EI@%(*
M6D% Q:*** "BBB@ IU-IU !1110 4444  I:04M !0**!0 M%%%(!110**
MT4&B@84444 +1110 "EI!2T % HH% "T444  I:04M !2TE+0 4444 +1110
M E+24M PH%% H 6BBB@ I:2EH$%%%% PHHHH 6BBB@ I:2EH **** %HHHH
M2EI*6D 4444P%HHHH 6BBB@ HHHH **** %HHHH&%+24M( HHHH 6BBBF HH
MH%% !2BDI12&%%%% A110** "BBB@84444 +1112 444"BF 4HI*44 (:*#1
M0 HHH%% !2TE+2 **** %HHHH #10:* "E%)2BF 4444ABBB@44 %+24M !2
M4M)0 M%%% !2TE+0 4HI*44 %%%%  *6D%+0,*!10* %HHHH 6BBBD 4O:DI
M>U "4"B@4P%HHHI  I:04M !0**!0 M)2TE "T444 %+24M !0**!0 M%%%
M!1110 4444#%HHHH 6BBB@ I:2EH *2EI* %HHHH *6DI:0!1110 M%%% "T
M444P"EI*6D 4444 ***!10 4M)2T (:*#10 M%%% !2TE+0 4HI*44 6M-_Y
M"EI_UW3_ -"%>B5YWIO_ "%+3_KNG_H0KT2LZAO2V/'?CM_S /\ MX_]I5X[
M7L7QV_Y@'_;Q_P"TJ\=KKH_ CS\3_%84445J8!1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M^6K=A%<]"R/GBOJ6'_41_P"Z/Y5Y9HOPDN(-4CFU6]MI+6)PPCA!8R@=FW
M#IGKW^M>EZIJ-OI&EW.H738A@C+MR 3Z 9[DX ]S16DI-)!AX.";D>*Z9<I#
M\73+)D*VJ2J,<\L[*/U(KVG5K:2\T:^M87*2S6\D:,.Q*D _K7S6+VX&H"_$
MF+D2^=YF!]_.<XZ=:^B/#7B"U\1Z/%>0.OF@ 3Q9YC?N#_0]Z=:+5F+#R3O$
M^<65D8JRE6!P01@@T"O<?$?PUTO7;J2\@E>QNY3ND9%W([9Y)7(Y/L1SSS46
M@_"_2])NH[J\N'OYHSE59 D8/8[><_B<>U7[:-C+ZM.]CI_#EO+:^&=+@F4I
M+':QJZGJ#M&17A_CW_D>-4_ZZ#_T$5]!U\^>/?\ D>-4_P"N@_\ 016='63-
ML2K02/H.OFOQ#_R,NJ_]?DW_ *&:^E*^:_$/_(RZK_U^3?\ H9HH;L6+V1T/
MPN)'C6( D9AD!]^*]3\<_P#(E:K_ -<?ZBO+/A?_ ,CM#_UQD_E7J?CG_D2M
M5_ZX_P!114_B(*/\)_,^>J***Z3C.X^%7_(X'_KV?^:UZ;XX_P"1*U7_ *X_
MU%>9?"K_ )' _P#7L_\ -:]=US3/[9T6ZT[SO)^T)M\S;NV\^F1FN:H[31VT
M%>DTCYKJS8V4^HWT%E:H7GF<(B^Y]?;WKTR+X.Q!LS:V[KCHEL%.?Q8UUOA[
MP7I'AMO.M8WENBNTSS'+8[@8X%:2K12T,8X:;>NAN6=LEG906L?W(8UC7C'
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M4 %%%% !1110 4444 %%%% !1110 4444 ***!10 4444@$H[T4=Z8#J***
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M "@44"@!:*** "BBBD 4HZ4E*.E,!:*** "BBB@ HHHH *!UHH'6D ZBBBF
MG>EI.]+2 *6DI: "BBB@84444""EI*6@ HHHH 6BBB@84444 %*.E)2CI0 M
M%%% "BB@44 )2BDI10 4444@%HHHI@%+24M !1112 6BBB@ HHHIC"E'2DI1
MTH 6BBBD 4444 %+24M !1110(****0"BEI!2TP"D%+2"@8M%%% !1110 4Z
MFTZ@ HHHH ****  4M(*6@ H%% H 6BBBD HHH%%  :*#10,**** %HHHH !
M2T@I: "@44"@!:***  4M(*6@ I:2EH **** %HHHH 2EI*6@84"B@4 +111
M0 4M)2T""BBB@84444 +1110 4M)2T %%%% "T444 )2TE+2 ****8"T444
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MZ%[2?_ */_XFC_A$O#7_ $+VD_\ @%'_ /$T?65V#ZG+N?*=%?5G_")>&O\
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M/_XFC_A$O#7_ $+VD_\ @%'_ /$T?65V#ZG+N?*=%?5G_")>&O\ H7M)_P#
M*/\ ^)H_X1+PU_T+VD_^ 4?_ ,31]978/J<NY\IT5]6?\(EX:_Z%[2?_  "C
M_P#B:/\ A$O#7_0O:3_X!1__ !-'UE=@^IR[GRG17U9_PB7AK_H7M)_\ H__
M (FC_A$O#7_0O:3_ . 4?_Q-'UE=@^IR[GRG17U9_P (EX:_Z%[2?_ */_XF
MC_A$O#7_ $+VD_\ @%'_ /$T?65V#ZG+N?*=%?5G_")>&O\ H7M)_P# */\
M^)H_X1+PU_T+VD_^ 4?_ ,31]978/J<NY\IT5]6?\(EX:_Z%[2?_  "C_P#B
M:/\ A$O#7_0O:3_X!1__ !-'UE=@^IR[GRG17U9_PB7AK_H7M)_\ H__ (FC
M_A$O#7_0O:3_ . 4?_Q-'UE=@^IR[GRG17U9_P (EX:_Z%[2?_ */_XFC_A$
MO#7_ $+VD_\ @%'_ /$T?65V#ZG+N?*=%?5G_")>&O\ H7M)_P# */\ ^)H_
MX1+PU_T+VD_^ 4?_ ,31]978/J<NY\IT5]6?\(EX:_Z%[2?_  "C_P#B:/\
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M_ */_"CZRNP?4Y=SY4HKZK_X1+PW_P!"]I/_ (!1_P"%'_")>&_^A>TG_P
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M^$4\.?\ 0 TK_P  X_\ "G]878?U.7<^6Z6OJ/\ X13PY_T -*_\ X_\*/\
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ME_\ @''_ (4?\(MX>_Z .E_^ <?^%'UA=@^J2[GS)17TW_PBWA[_ * .E_\
M@''_ (4?\(MX>_Z .E_^ <?^%'UA=@^J2[GS)2U]-?\ "+>'O^@#I?\ X!Q_
MX4?\(MX>_P"@#I?_ (!Q_P"%'MUV#ZI+N?,M%?37_"+>'O\ H Z7_P" <?\
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M_P#H!Z9_X"1_X4?\(QX?_P"@'IG_ ("1_P"%'MUV#ZI+N?-E%?2?_",:!_T
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MZ=_X"I_A1_PC>A?] 73O_ 5/\*/;KL'U5]SYVIW:OH?_ (1O0O\ H"Z=_P"
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M 45[_P#\([HG_0'T_P#\!D_PH_X1W1/^@/I__@,G^%/VZ[!]6?<^?^]+7O\
M_P ([HG_ $!]/_\  5/\*/\ A'=$_P"@/I__ (#)_A2]LNP?5GW/ *6O?O\
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M^$?T7_H$6'_@,G^%'MEV#ZL^YX-2U[Q_PC^B_P#0(L/_  &3_"C_ (1_1?\
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MYX93J]Q_L'1_^@38?^ R?X4?V#H__0)L?_ =/\*/;+L'U=]SPZBO<?[!T?\
MZ!-C_P" Z?X4?V#H_P#T";'_ ,!T_P *7MEV#ZN^YX=17N/]@Z/_ - FQ_\
M =/\*/[!T?\ Z!-C_P" Z?X4_;+L'U=]SPX4M>X?V#H__0)L?_ =/\*/[!T?
M_H$V/_@.G^%'MEV#ZN^YX?0*]P_L'1_^@38_^ Z?X4?V%H__ $"K'_P'3_"E
M[9=@^KON>(45[?\ V%H__0*L?_ =/\*/["T?_H%6/_@.G^%'M5V#ZN^YXB**
M]N_L+1_^@58_^ Z?X4?V%H__ $"K'_P'3_"CVJ[!]7?<\1-%>W?V%H__ $"K
M'_P'3_"C^PM'_P"@58_^ Z?X4>U78?U=]SQ&BO;O["T?_H%6/_@.G^%']A:/
M_P! JQ_\!T_PH]JNP?5WW/$J*]M_L+2/^@58_P#@.G^%']A:1_T"K'_P'3_"
MCVJ[!]7?<\2%+7MG]A:1_P! JQ_\!T_PI?["TC_H%6/_ (#I_A1[5=@^KON>
M)4"O;?["TC_H%6/_ (#I_A1_86D?] JQ_P# =/\ "CVJ[!]7?<\3HKVS^P](
M_P"@58_^ Z?X4?V'I'_0*L?_  '3_"CVJ[!]7?<\3%+7M?\ 8>D?] JQ_P#
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M[+_8FD_] RR_\!T_PH_L32O^@99?^ Z_X4O:H/8/N>-45[+_ &)I7_0,LO\
MP'7_  H_L32O^@99?^ Z_P"%/VJ#V#[GC=%>R?V+I7_0,LO^_"_X4?V+I7_0
M,LO^_"_X4>U0>P?<\<HKV/\ L72O^@99?]^%_P */[%TK_H&67_?A?\ "CVJ
M#V#[GCE%>Q_V+I7_ $#++_OPO^%']BZ5_P! RR_[\+_A1[5![!]SQRBO8_[%
MTK_H&67_ 'X7_"C^Q=*_Z!EE_P!^%_PH]JA^P?<\=HKV+^Q=*_Z!EG_WX7_"
MC^Q=*_Z!EG_WX7_"CVJ#V#[GCM+7L/\ 8NE?] RS_P"_"_X4?V+I7_0,L_\
MOPO^%+VJ#V#[GCU%>P_V+I7_ $#+/_OPO^%']BZ5_P! RS_[\+_A1[5![!]S
MQ^BO8/[&TK_H&V?_ 'X7_"C^QM*_Z!MG_P!^%_PI^U0>P?<\@%%>O_V-I?\
MT#;/_OPO^%']C:7_ - VS_[\+_A1[5![!]SR"E%>O?V-I?\ T#;/_OPO^%']
MC:7_ - VS_[\+_A2]J@]@^YY#17K_P#8VE_] VS_ ._"_P"%']C:7_T#;/\
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MI>U>H_V3IO\ T#[7_ORO^%']DZ=_T#[7_ORO^%'M$'L7W/+:!7J7]DZ;_P!
M^U_[\K_A1_9.G?\ 0/M?^_*_X4_:(/8ON>745ZC_ &3IW_0/M?\ ORO^%']D
MZ=_T#[7_ +\K_A2]H@]B^YY<*6O4/[*T[_H'VO\ WY7_  I?[*T[_GPM?^_*
M_P"%'M$'L7W/+J!7J/\ 96G?\^%K_P!^5_PH_LK3O^?"U_[\K_A1[1![%]SR
M^DKU'^RM._Y\+7_ORO\ A1_96G?\^%K_ -^5_P */:(?L7W/+Z*]0_LK3O\
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M_P */[+T_P#Y\;7_ +\K_A1[1![)]SS2EKTK^R]/_P"?&U_[\K_A1_9>G_\
M/C;?]^5_PH]H@]D^YYK17I7]EZ?_ ,^-M_WY7_"C^R]/_P"?&V_[\K_A1SA[
M)]SS:BO2O[,T_P#Y\;;_ +\K_A1_9FG_ //C;?\ ?E?\*.</9/N>;45Z3_9F
MG_\ /C;?]^E_PH_LS3_^?&V_[]+_ (4>T0>R9YM2UZ1_9FG_ //C;?\ ?I?\
M*/[,L/\ GQMO^_2_X4<X>R9YO17I']F6'_/C;?\ ?I?\*/[,L/\ GQMO^_2_
MX4<X>R9YP**]'_LRP_Y\;;_OTO\ A1_9EA_SXVW_ 'Z7_"CG#V3/.*6O1O[,
ML/\ GQMO^_2_X4?V98?\^5M_WZ7_  HYP]DSS@T5Z/\ V98?\^-M_P!^E_PH
M_LRP_P"?&V_[]+_A1SA[)GG-%>C?V98?\^5M_P!^E_PH_LRP_P"?*V_[]+_A
M1SA[)GG-+7HO]FV'_/E;?]^E_P */[-L/^?*V_[]+_A1SA[)GG5**]$_LVP_
MY\K;_OTO^%']FV'_ #Y6W_?I?\*.</9,X73?^0I:?]=T_P#0A7HE5ET^R1PZ
M6ENK*<@B, @_E5FHE*YI"/*%%%%26%%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M  A7B'_H'_\ D:/_ .*H_P"$*\0_] __ ,C1_P#Q5'U?"_S?B'UW,?Y'_P"
ML[?_ (69HO\ SZW_ /W[3_XNC_A9FB_\^M__ -^T_P#BZXC_ (0KQ#_T#_\
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M"SM_^%F:+_SZW_\ W[3_ .+H_P"%F:+_ ,^M_P#]^T_^+KB/^$*\0_\ 0/\
M_(T?_P 51_PA7B'_ *!__D:/_P"*H^KX7^;\0^NYC_(__ 6=O_PLS1?^?6__
M ._:?_%T?\+,T7_GUO\ _OVG_P 77$?\(5XA_P"@?_Y&C_\ BJ/^$*\0_P#0
M/_\ (T?_ ,51]7PO\WXA]=S'^1_^ L[?_A9FB_\ /K?_ /?M/_BZ/^%F:+_S
MZW__ '[3_P"+KB/^$*\0_P#0/_\ (T?_ ,51_P (5XA_Z!__ )&C_P#BJ/J^
M%_F_$/KN8_R/_P !9V__  LS1?\ GUO_ /OVG_Q='_"S-%_Y];__ +]I_P#%
MUQ'_  A7B'_H'_\ D:/_ .*H_P"$*\0_] __ ,C1_P#Q5'U?"_S?B'UW,?Y'
M_P" L[?_ (69HO\ SZW_ /W[3_XNC_A9FB_\^M__ -^T_P#BZXC_ (0KQ#_T
M#_\ R-'_ /%4?\(5XA_Z!_\ Y&C_ /BJ/J^%_F_$/KN8_P C_P# 6=O_ ,+,
MT7_GUO\ _OVG_P 71_PLS1?^?6__ ._:?_%UQ'_"%>(?^@?_ .1H_P#XJC_A
M"O$/_0/_ /(T?_Q5'U?"_P WXA]=S'^1_P#@+.W_ .%F:+_SZW__ '[3_P"+
MH_X69HO_ #ZW_P#W[3_XNN(_X0KQ#_T#_P#R-'_\51_PA7B'_H'_ /D:/_XJ
MCZOA?YOQ#Z[F/\C_ / 6=O\ \+,T7_GUO_\ OVG_ ,71_P +,T7_ )];_P#[
M]I_\77$?\(5XA_Z!_P#Y&C_^*H_X0KQ#_P! _P#\C1__ !5'U?"_S?B'UW,?
MY'_X"SM_^%F:+_SZW_\ W[3_ .+H_P"%F:+_ ,^M_P#]^T_^+KB/^$*\0_\
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M (0KQ#_T#_\ R-'_ /%4?\(5XA_Z!_\ Y&C_ /BJ/J^%_F_$/KN8_P C_P#
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J&[N[>QMGN+J58H4
M&6=CP*FKRCXA:W)>:P=-C<_9K7&0.C2$<G\,X_.M\/1=:?*<F-Q2PU+GZ]#4
MU+XG!92FFV(9 >))SU_X"/\ &LS_ (6;K/\ SZV'_?M__BZQ] \,7FOEWB98
M;=#AI7&>?0#N:Z/_ (5I_P!1?_R6_P#LJ]&4<)2?++?YGAPGF6(7M(7M\D5/
M^%F:U_SZV'_?M_\ XNC_ (69K7_/K8?]^W_^+JY_PK/_ *B__DM_]G1_PK/_
M *B__DM_]G4\^#_I,KV>:^?WK_,I_P#"S-:_Y];#_OV__P 71_PLS6O^?6P_
M[]O_ /%U<_X5G_U%_P#R6_\ LZ/^%9_]1?\ \EO_ +.CGP?])A[/-?/[U_F4
M_P#A9FM?\^MA_P!^W_\ BZ/^%F:U_P ^MA_W[?\ ^+JY_P *S_ZB_P#Y+?\
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M ,EO_LZ.?!_TF'L\U\_O7^93_P"%F:U_SZV'_?M__BZ/^%F:U_SZV'_?M_\
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MEO\ [.C_ (5G_P!1?_R6_P#LZ.?!_P!)A[/-?/[U_F4_^%F:U_SZV'_?M_\
MXNC_ (69K7_/K8?]^W_^+JY_PK/_ *B__DM_]G1_PK/_ *B__DM_]G1SX/\
MI,/9YKY_>O\ ,I_\+,UK_GUL/^_;_P#Q='_"S-:_Y];#_OV__P 75S_A6?\
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M8>SS7S^]?YE/_A9FM?\ /K8?]^W_ /BZ/^%F:U_SZV'_ '[?_P"+JY_PK/\
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M +.CGP?])A[/-?/[U_F4_P#A9FM?\^MA_P!^W_\ BZ/^%F:U_P ^MA_W[?\
M^+JY_P *S_ZB_P#Y+?\ V='_  K/_J+_ /DM_P#9T<^#_I,/9YKY_>O\RG_P
MLS6O^?6P_P"_;_\ Q='_  LS6O\ GUL/^_;_ /Q=7/\ A6?_ %%__);_ .SH
M_P"%9_\ 47_\EO\ [.CGP?\ 28>SS7S^]?YE/_A9FM?\^MA_W[?_ .+H_P"%
MF:U_SZV'_?M__BZN?\*S_P"HO_Y+?_9T?\*S_P"HO_Y+?_9T<^#_ *3#V>:^
M?WK_ #*?_"S-:_Y];#_OV_\ \71_PLS6O^?6P_[]O_\ %U<_X5G_ -1?_P E
MO_LZ/^%9_P#47_\ );_[.CGP?])A[/-?/[U_F4_^%F:U_P ^MA_W[?\ ^+H_
MX69K7_/K8?\ ?M__ (NKG_"L_P#J+_\ DM_]G1_PK/\ ZB__ )+?_9T<^#_I
M,/9YKY_>O\RG_P +,UK_ )];#_OV_P#\73D^)NKAOGM+%E]%5Q_[,:M?\*S_
M .HO_P"2W_V=1R_#658R8=41W[*\)4'\=Q_E1S8-_P##,/9YJM=?O1T>@>.[
M#6)EMKA#9W+<*&;*.?0-Z^QKJZ^?KRSN-/O)+6X0QS1'##^M>N^"=:DUG05,
M[;KFW;RI&/5AC@_E_(UABL+&"]I3V.S+LPG5DZ-;XD=)1117 >R%%%% !112
M,RHI9F"JHR23@ 4 0WM[;:=:275Y.D,$8RSN< 5YCK?Q?VR-%HEDK*.!/<YY
M^BC^I_"N2\<>+9O$VK,L;LNG0,5@CSPW^V?<_H/QJ#PQX,U'Q,3+"5@M%;:T
M\@R,^BCN:[Z>'A"/-4.J-*,5S3+DOQ-\5R-E=02,>B6\?]0:C_X63XM_Z"W_
M )+1?_$UVD/PDTA4 GO[YW[F,H@_(J:E_P"%3:#_ ,_>I?\ ?Q/_ (BJ]KA^
MWX![2EV_ X;_ (63XM_Z"W_DM%_\31_PLGQ;_P!!;_R6B_\ B:[G_A4V@_\
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MT7_Q-'_"R?%O_06_\EHO_B:[G_A4V@_\_>I?]_$_^(H_X5-H/_/WJ7_?Q/\
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M *U=)]F@_P">,?\ WR*/LT'_ #QC_P"^11=!:7<YO_A,&_Y\A_W]_P#K4?\
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M>,?_ 'R*/LT'_/&/_OD4706EW.;_ .$P;_GR'_?W_P"M1_PF#?\ /D/^_O\
M]:ND^S0?\\8_^^11]F@_YXQ_]\BBZ"TNYS?_  F#?\^0_P"_O_UJ/^$P;_GR
M'_?W_P"M72?9H/\ GC'_ -\BC[-!_P \8_\ OD4706EW.;_X3!O^?(?]_?\
MZU'_  F#?\^0_P"_O_UJZ3[-!_SQC_[Y%'V:#_GC'_WR*+H+2[G-_P#"8-_S
MY#_O[_\ 6H_X3!O^?(?]_?\ ZU=)]F@_YXQ_]\BC[-!_SQC_ .^11=!:7<YO
M_A,&_P"?(?\ ?W_ZU'_"8-_SY#_O[_\ 6KI/LT'_ #QC_P"^11]F@_YXQ_\
M?(HN@M+N<W_PF#?\^0_[^_\ UJ/^$P;_ )\A_P!_?_K5TGV:#_GC'_WR*/LT
M'_/&/_OD4706EW.;_P"$P;_GR'_?W_ZU'_"8-_SY#_O[_P#6KI/LT'_/&/\
M[Y%'V:#_ )XQ_P#?(HN@M+N<W_PF#?\ /D/^_O\ ]:C_ (3!O^?(?]_?_K5T
MGV:#_GC'_P!\BC[-!_SQC_[Y%%T%I=SF_P#A,&_Y\A_W]_\ K4?\)@W_ #Y#
M_O[_ /6KI/LT'_/&/_OD4?9H/^>,?_?(HN@M+N<W_P )@W_/D/\ O[_]:C_A
M,&_Y\A_W]_\ K5TGV:#_ )XQ_P#?(H^S0?\ /&/_ +Y%%T%I=SF_^$P;_GR'
M_?W_ .M1_P )@W_/D/\ O[_]:ND^S0?\\8_^^11]F@_YXQ_]\BBZ"TNYS?\
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MN<W_ ,)@W_/D/^_O_P!:C_A,&_Y\A_W]_P#K5TGV:#_GC'_WR*/LT'_/&/\
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M_P \8_\ OD4?9H/^>,?_ 'R*+H+2[G-_\)@W_/D/^_O_ -:C_A,&_P"?(?\
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MND^S0?\ /&/_ +Y%'V:#_GC'_P!\BBZ"TNYS?_"8-_SY#_O[_P#6H_X3!O\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KG/&>DPZAH4\
MY0?:+5#(CXYP.2/IC-='6?KO_(O:E_UZR_\ H!K2E)QFFC'$PC.C*,MK'CFF
M7;6&J6MVAP8I5?\ (\U[_7SM7T37=F2UB_4\?(I.U1>GZA1117F'OA1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 >7_$1%7Q%"0,%K92?<[F']*V/A:QVZJO8&(_^AUD
M_$;_ )&&W_Z]5_\ 0WK6^%G_ #%O^V/_ +/7JS_W/[OS/FZ7_(U^;_)GHE%%
M%>2?2A1110 5RGQ&U%].\%7AC)#W&VW!!Z!CS_XZ#75UY_\ %\D>$;4 ];Y
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M?^./6^'DU45C6B[31SGPCU%[;Q-/8DGR[N G&?XEY!_+=^=>V5\__#4D>/\
M30#U\T'_ +]/7T!58Q6J%5U[X4445RF(4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'SM7MNA?\ (O:;_P!>
ML7_H KQ*O;="_P"1>TW_ *]8O_0!7K9C\,3YK(_XD_0T****\H^D"BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ K@_BS_ ,BK:_\ 7ZG_ * ]=Y7!_%G_ )%6U_Z_4_\
M0'K6A_$1I2^-'#?#;_DH&F?]M?\ T4]?0-?/WPV_Y*!IG_;7_P!%/7T#6N,_
MB+T-,1\04445R& 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MQJWZP/!7_(HV/_;3_P!&-6_7)7_BR]6>GA/]WI^B_(****R.@**** "BBB@
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MZT;5+C3KU-EQ VUP.A[@CV(((^M?5E?/GQ5N8;CQW<B$@F**.-R#D%L9/Y9
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110!\[5[;H7_(O:;_UZQ?^@"O$J]MT+_D7M-_Z]8O_
M $ 5ZV8_#$^:R/\ B3]#0HHHKRCZ0**** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH *S]=_Y%[4O^O67_ - -:%9^N_\ (O:E_P!>LO\ Z :J'Q(SK?PY
M>C/$J^B:^=J^B:]',OL_/]#Q,B_Y>?+]0HHHKRSZ **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ KP?Q!_R,FJ?]?<O_ *&:]XKP?Q!_R,FJ?]?<O_H9KT<N^*1X
M>>?PX>IZ;X*_Y%&Q_P"VG_HQJWZP/!7_ "*-C_VT_P#1C5OUR5_XLO5GIX3_
M '>GZ+\@HHHK(Z HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M:_@;Q=_PEVD2W,MNL%S!)Y<B(25/ (89Z9YXYZ5/XG\%Z1XL6$WZRQS0\)/
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MT//OB%\4;J>\FTGP_<M!;Q,4ENXFP\C _P ##HO'4=?IU\K5))Y0J*TDCG@
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MT!!'X5\U^+M>;Q)XGO=2);RY'VPJ3G;&O"X].F?J365&%YZ]#?$U$J>G4M>
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6
M?KO_ "+VI?\ 7K+_ .@&M"L_7?\ D7M2_P"O67_T U4/B1G6_AR]&>)5]$U\
M[5]$UZ.9?9^?Z'B9%_R\^7ZA1117EGT 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !7@_B#_D9-4_Z^Y?\ T,U[Q7@_B#_D9-4_Z^Y?_0S7HY=\4CP\\_AP]3TW
MP5_R*-C_ -M/_1C5OU@>"O\ D4;'_MI_Z,:M^N2O_%EZL]/"?[O3]%^04445
MD= 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 >8_$;_D8;?\
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MEXJB\,>(93>2^7I]S"PG)!."H+*0!U.<@?[U>X^,M!_X23PK?::JH9W3? 6
MXD7E>>V>F?0FOED@J2"""."#VKLI-3ARL\[$)TZO.B[K.J3:WK-WJ=P );F4
MR%1T4'H![ 8'X5[W\*/#G]B>%%NY5Q=:CMF?/9,?(.GH2?QKQ7P7X?/B7Q79
M:<P_<%O,N#G'[M>6'X]/J:^I%544*H 4#  ' %37E9***PD+MS8M%%%<IWA7
M)?$K2'UGP-?QQ*S30 7$:COLY/\ X[NZ5UM%.+L[DRCS)IGQ['(\4BR(Q5T(
M92.Q%?4WA/Q+:^*M!@U" J)<!;B(?\LY,<CZ=Q[8KQ#XD>")?#.K/>6L)_LF
MY?,3*.(F/6,^GMZCZ&N;T#Q%J?AJ_%YIER8GZ.AY20>C+WZ_A79.*JQNCSJ<
MW0FU(^KZ*\CTOXXVS(JZMI$R..KVCA@?^ MC'YFI;_XXZ>D;#3M(N97Q\IN'
M6, ^I"[ORKF]C/L=GUBE:]SOO$_B.S\,:)-J%W(H8*1#&3S*^.%'^>!7RO--
M)<3R3RL7ED8N['N2<DUJ^(_$VI^*=1^V:E*&91MCB082,>BC_)K6\ >"YO%N
MLJ94==,@8&XE X;OL!]3[=!SZ5TP@J<;LXJM1UYI1/8/A1I4FE^!+9IDV/>2
M-=8S_"V I_%54_C7/?'+_D$:3_UW?_T$5ZJB)'&J(H5% "JHP !V%>5?'+_D
M$:3_ -=W_P#016%-\U2YV58\M%Q. ^&-S':_$/2FDV[79XP3V+(P&/Q('XU]
M+5\?12R03)-$Y21&#*PZ@CD&O;_#'QCTV>PCB\0[[:[0!6GCC+)+_M87E3ZC
M'T]*UKTVW=&&%JQBG&1ZE7SW\9+J*X\=F.-0&M[6..0CNQR_\F%=WKOQDT*S
MM9!HZR:A=$80LC1Q@^I+ 'CT Y]1UKPR_OKC4[^XOKN0R7$\ADD;U).?P^E*
MA3:?,QXJM&4>6+N>F? Z*4Z]JDH!\I;558\XW%@1_)JU/CI_QYZ)_P!=)OY)
M6[\)?#<FB>&&O;@;;C4BLNW^[&!\@/OR3^(K"^.G_'GHG_72;^24KWK:#<7'
M#6?]:G ?#C_DH6C_ /74_P#H#5[9\4(WD^'&KJBEB!$V!Z"5"?T%>)_#C_DH
M6C_]=3_Z U?2.I6,6J:9=6$XS%<Q-$WT88HK.TTPPRYJ4D?(R*7=5&,L<#)
M'YGI78?\*K\:?] ;_P FH?\ XNN<UC2;O0]6N-.O8RD\#;3Z,.Q'L1S7J7@[
MXP06NGPZ?XACF9XAL2[B4-E0.-XZY[9&<\<=36\Y22O#4Y:48-M5'8Y#_A5?
MC3_H#?\ DU#_ /%T?\*K\:?] ;_R:A_^+KUR;XM>#XK?S$U"69_^>26SAO\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110!\[5[;H7_(O:;_UZQ?^@"O$J]MT+_D7M-_Z]8O_
M $ 5ZV8_#$^:R/\ B3]#0HHHKRCZ0**** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH *S]=_Y%[4O^O67_ - -:%9^N_\ (O:E_P!>LO\ Z :J'Q(SK?PY
M>C/$J^B:^=J^B:]',OL_/]#Q,B_Y>?+]0HHHKRSZ **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ KP?Q!_R,FJ?]?<O_ *&:]XKP?Q!_R,FJ?]?<O_H9KT<N^*1X
M>>?PX>IZ;X*_Y%&Q_P"VG_HQJWZP/!7_ "*-C_VT_P#1C5OUR5_XLO5GIX3_
M '>GZ+\@HHHK(Z HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M:_\ 7ZG_ * ]=Y7!_%G_ )%6U_Z_4_\ 0'K6A_$1I2^-'#?#;_DH&F?]M?\
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M\JVAD+2/]HB; VD= Q/>O=**M59*/*1*A&4^=[A7$>.OAU9^+5%W;NMIJB#
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M]E>&%TN$_P"DZD2A_P!F)<%C^.0/H3Z5XGX=T67Q#K]GI<.09Y,,W]U1RQ_
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!\[5[;H
M7_(O:;_UZQ?^@"O$J]MT+_D7M-_Z]8O_ $ 5ZV8_#$^:R/\ B3]#0HHHKRCZ
M0**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *S]=_Y%[4O^O67_ - -
M:%9^N_\ (O:E_P!>LO\ Z :J'Q(SK?PY>C/$J^B:^=J^B:]',OL_/]#Q,B_Y
M>?+]0HHHKRSZ **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KP?Q!_R,FJ?]?<O_
M *&:]XKP?Q!_R,FJ?]?<O_H9KT<N^*1X>>?PX>IZ;X*_Y%&Q_P"VG_HQJWZP
M/!7_ "*-C_VT_P#1C5OUR5_XLO5GIX3_ '>GZ+\@HHHK(Z HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MLG_Q%'_"F/$7_/[I?_?V3_XBLC_A9_C'_H,?^2T/_P 11_PL_P 8_P#08_\
M):'_ .(K2U7NC&]#LS7_ .%,>(O^?W2_^_LG_P 17N=?.O\ PL_QC_T&/_):
M'_XBO:/'.LR:%X/O[R%]EP4$4+=PS'&1[@$G\*QJJ;:4CHH2II2<3QSXF>(_
M[>\4R0PONL[',$6#PS9^=OQ(Q[A15SP#X]T[PG:2VESILKF>0-+<Q2 DCH!L
M..G/?O7.^$?#,WBO74TZ*40H$,LLI&=B# R!D9.2!^-=IXR^%=KHNA3:GI-W
M<R_9P&EBN"I)7/)4@#IUP>V?I6SY$E39SQ]JVZL3UK2=7L=;T^.^T^X6:!^,
MCJI[@CL?:KM>#?"36IK'Q8NG&0_9KY&4H3\H=1N#?7 (_&O>:Y:D.25CNHU/
M:1N%%%%0:A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7!
M_%G_ )%6U_Z_4_\ 0'KO*X/XL_\ (JVO_7ZG_H#UK0_B(TI?&CAOAM_R4#3/
M^VO_ **>OH&OG[X;?\E TS_MK_Z*>OH&M<9_$7H:8CX@HHHKD, HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M6Q_"H[+_ )/;'4445#;;NS6,5%604444AA1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_P!&-6_7)7_BR]6>GA/]WI^B_(****R.@**** "BBB@ HHHH **** "BBB@
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M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5Y'\;_^8%_V\?\
MM.O7*Y'QQX'_ .$R^P?\3'[']D\S_EAYF[=M_P!H8QM_6KIR49)LRKQ<J;2,
M'X+?\B_J/_7T/_0!74>/O^1$UC_KA_44WP5X1_X0_3[FU^W?:_.E\S=Y7EXX
M QC<?2M37])_MS0;S3/.\C[2FSS-F[;SUQD9_.G*2=2XH0:I<KWL>#_##_DH
MFE?]MO\ T4]?0-[I]EJ4(AOK.WNHE;<$GB#J&Z9P1UY/YUP?ACX6?\(WXBM=
M6_MG[1]GW_NOLNS=N1EZ[SC[V>E>BTZTU*5XDX>FX0:DC(_X13P[_P! #2__
M  #C_P */^$4\._] #2__ ./_"M>BL^9]S;ECV,C_A%/#O\ T -+_P# ./\
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M9BT%Q$LJ$]<$9&?>M)TW%)LRIUE-M+H6:***S-0HHHH **** "BBB@ HHHH
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M_(A1_P#7S)_2KY5R<QESOVO)TL=]1114&H4444 %%%% !1110 4444 %%%%
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M-^0JX\EGS;F4W4YER[=3T6BBBH-0HHHH **** "BBB@ HHHH **** "BBB@
MHHHH ^=J]MT+_D7M-_Z]8O\ T 5XE7MNA?\ (O:;_P!>L7_H KULQ^&)\UD?
M\2?H:%%%%>4?2!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6?KO\
MR+VI?]>LO_H!K0K/UW_D7M2_Z]9?_0#50^)&=;^'+T9XE7T37SM7T37HYE]G
MY_H>)D7_ "\^7ZA1117EGT 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_P /-*+')Q*/RE<5Y%\3_P#DHFJ_]L?_ $4E>Y>%M);0_"^G::X DAA'F =
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M **** "BBB@#S'XC?\C#;_\ 7JO_ *&]:WPL_P"8M_VQ_P#9ZR?B-_R,-O\
M]>J_^AO61H5G<W?VC[-;S3;=N[RT+8SGKBO6G_N?W?F?-TO^1I\W^3/<:*\G
M_LC4_P#H'7?_ 'X;_"C^R-3_ .@==_\ ?AO\*\FQ]'<]8HKR?^R-3_Z!UW_W
MX;_"C^R-3_Z!UW_WX;_"BP7/6*\_^,'_ "*5K_U_)_Z+DK'_ +(U/_H'7?\
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MB[^3/1:\=^.W_, _[>/_ &E73?"CQ++K_A=K>ZD+W=@XB9V;+.A&48^_!'_
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MXWQG\1--\)#[,%^UZD0"+96QL!'!<]OIUY_&M_Q%K$>@>'K[59%#"VB+*I.
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MY;V<=O;PR.C0HP8E9%49)8CHQ[5Z*JJBA5 "@8  X KQ'X3?\E*UG_KVG_\
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MD_0T****\H^D"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "L_7?^1>
MU+_KUE_] -:%9^N_\B]J7_7K+_Z :J'Q(SK?PY>C/$J^B:^=J^B:]',OL_/]
M#Q,B_P"7GR_4****\L^@"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M?]>L?\VKWNJ%YH>D:A/Y][I5C<S8V^9-;H[8],D5-.?([E5J;J1Y4<G\(_\
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MPJ<E[H\X;P]_PE7Q6U?2I;T6C27ER5D,>[.UF( 7(SP/6NK_ .%$_P#4R?\
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M]J$(7R?,+AMV3]X8Q@>O6OHC1O\ D!Z?_P!>T?\ Z"*\3MII/A9\3)HYU?\
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M_HE*[[X5_P#)-])_[;?^CGK@=5_Y.%C_ .OF#_T2E*/QR^83_AP^1Z3\0O\
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M*O@3_P Q_P#[=_\ VK57XYK(-4T=B#Y1AD"G'&[<,_S6K7P)_P"8_P#]N_\
M[5KK?B?X7E\2^%R;2,O?63^=$@&3(,89![D8/U4#O70Y)5KLXXQ<L-9?UJ=C
M!Y7V>/R2#%M&PJ<@KCC![\5)7FOPS\>6=]I5MH6IW(AU.W AB$@VB9!PH!Z;
MAP,=3[\UZ56$HN+LSJA-3C=!7B?C8J?C?HFW&1/9[N._F#^F*]3\1^)],\,:
M<]WJ$ZA@N8X P\R4^BC^O05X!9:I=:Y\3],U6[C,<EWJ=O(JG. OF*% /<
M#/M6M&+UD88F:TCUN?3%%%%8'4%%%% !1110!\[5[;H7_(O:;_UZQ?\ H KQ
M*O;="_Y%[3?^O6+_ - %>MF/PQ/FLC_B3]#0HHHKRCZ0**** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH *S]=_P"1>U+_ *]9?_0#6A6?KO\ R+VI?]>L
MO_H!JH?$C.M_#EZ,\2KZ)KYVKZ)KT<R^S\_T/$R+_EY\OU"BBBO+/H HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MG]I6D_V.ZGQ(T\(#QR@C[Q7(!SP<@C/OFN67X9^/+6(V]GXI1+;D;!>SH/\
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MO;="_P"1>TW_ *]8O_0!7K9C\,3YK(_XD_0T****\H^D"BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "L_7?^1>U+_KUE_] -:%9^N_\B]J7_7K+_Z
M:J'Q(SK?PY>C/$J^B:^=J^B:]',OL_/]#Q,B_P"7GR_4****\L^@"BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_P!!W3/_  +C_P :/^$H\/\ _0=TS_P+C_QKYHHH^I1[A]77<^E_^$H\/_\
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M/FZ7_(U^;_)GHE%%%>2?2A1110 5Y_\ &#_D4K7_ *_D_P#1<E>@5Y_\8/\
MD4K7_K^3_P!%R5K0_B(NE\:/._AW_P CWIO_ &U_]%/7O%>#_#O_ )'O3?\
MMK_Z*>O>*WQGQKT+Q'Q!1117(8!1110 4444 %%%% !1110 4444 %%%% !7
ME7Q,\5>)/#>OV\>FWY@LY[<.H\F-OG#$-RP)Z;?SKU6N?\7>%+3Q9I/V6=C'
M/'EK>8?P-[CN#W%73:4M3.K&4H6B]3$^'7C=?$&FFTU.\0ZM$YSN"H95)X(
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MN^>7^@Z#_P"L*]=IS:BN1?,FDG.7M)?(\(\61'7?B^-.U&9TMVN(;9<<%8R
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M$]2*]GIUVG+0G"Q<8--=0HHHK$Z0HHHH **** "BBB@ HHHH **** "BBB@
MK@_BS_R*MK_U^I_Z ]=Y7!_%G_D5;7_K]3_T!ZUH?Q$:4OC1PWPV_P"2@:9_
MVU_]%/7T#7S]\-O^2@:9_P!M?_13U] UKC/XB]#3$?$%%%%<A@%%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %4;[1=*U21'U#3
M+.[=!A6N(%D*CT&0<5>HH$U?<155%"J % P !P!2T44#"BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ JO>6-GJ-O]GOK6"ZAR#Y<\8=<CO@\58HH @L[*TT^W%O96
ML-M I)$<,8103UX'%3T44 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% %34-+L-6MS;ZA9P747/RS(&Q[C/0^XKG)/AAX-E?<
MVBJ#_LSRJ/R#5UU%-2:V9+A&6Z,;2O"6@:+)YFGZ3;0R]I-FYQ]&.2*V:**&
MV]QI):(****0PHHHH **** /G:O;="_Y%[3?^O6+_P! %>)5[;H7_(O:;_UZ
MQ?\ H KULQ^&)\UD?\2?H:%%%%>4?2!1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !6?KO_ "+VI?\ 7K+_ .@&M"L_7?\ D7M2_P"O67_T U4/B1G6
M_AR]&>)5]$U\[5]$UZ.9?9^?Z'B9%_R\^7ZA1117EGT 4444 %%%% !1110
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MYNZGV/3\O2M93Y:FNQA&EST=-T>=>(/%7_"4?"N)IV7[?:WD4=P!W^5]K?B
M?Q!IOP6_Y&6__P"O,_\ H:UYS(LMN\D$@9&5MLB'CD'H1[&O1O@M_P C+?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** /%/C!_R-MK_UXI_Z,DJ_\'O^8S_VP_\
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M@5YU_P (IXB_Z &J?^ <G^%?4-%;1K.*M8YIX93DY7/E[_A%/$7_ $ -4_\
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M,[&Y13)IH[>"2:5ML<:EV.,X &365H/BK1?$WVC^R+W[3]GV^;^Z=-N[./O
M9^Z>GI46=KFMTG8V**X[6_B?X8T29X'NY+NXC8J\5JF\J0<'DD+^M0:3\6?"
M^JW:6QFN+)WX4W<852<]-P) _' JO9RM>Q'M87M<[BBD5E=0RD%2,@@\$4M0
M:!15#5M:TW0K,W>J7D5M#T!<\L?10.6/L :XF?XT^&(I2B0:E,H_CCA0 _\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M>7M)1@CW#2]/BTK2K33X<>7;1+$"!C.!C/U/7\:MT45S'<E;0**** "BBB@
MHHHH **** "BBB@ K/UW_D7M2_Z]9?\ T UH5GZ[_P B]J7_ %ZR_P#H!JH?
M$C.M_#EZ,\2KZ)KYVKZ)KT<R^S\_T/$R+_EY\OU"BBBO+/H HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \4^,'_(VVO_
M %XI_P"C)*O_  >_YC/_ &P_]J50^,'_ "-MK_UXI_Z,DJ_\'O\ F,_]L/\
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M3_K[E_\ 0S7O%>#^(/\ D9-4_P"ON7_T,UZ.7?%(\///X</4]-\%?\BC8_\
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MEFMM0MBQ@N,O$QP)%SGKZ$=_>O3H[3P#X_MHH+%8M(U$,,1I$L+D9Y&!\KY
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MH7['+Z!H.I_%/7Y]<UJ9X]-B?8%0]ASY:>@&1DX[^IKU2S\"^%K&$11Z%8R
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MJEYIV[[8+B2.+:NX[G0IP.Y^;CWKU'PM\+M*TVV6ZUR%-3U24[Y6F)=%)Y(
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MHMK"2I >U00LOO\ +@$_7->474&M?"/Q3')#-)<:3</N"[L"=!U5AV<9Z_\
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MQR#CMWS7,?$R\N[OXI>1#;F\>S$*0VVPMOX$FW"\G)8].:WO^%@?$G_H4/\
MRFW'_P 56JBU!<O4P<XRJ-SUML>B/X)\+O L)T#3MJC (MU#=,?> R?SKSGQ
ME\-V\-H?$?A2:: V9\UX-Y8QJ.K(3R0!U!SQGGM3O^%@?$G_ *%#_P IMQ_\
M53)?'?Q&FA>*3P>&C=2K*=-N>0>"/O4HQG%[CG*E)6M^!W?@'Q;_ ,)=X?\
MM,J+'>0/Y5PJ]"<9##V/I]:ZJO&_@[INMZ3KVH0WVEWUI:SVP8O/;O&I=6
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M^]B=G_Y8LP$BG&2"O7CVXXJCJ>G>"M&A\W4=.T.V7&1YEM$"WT&,G\*\-O/
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M445Y9] %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MZSJMNMRGF&*"%_NC ^9B._7 !Z8)],4/C/\ \CA:?]>"?^C)*[WX4 #P%;$
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MGKZ!K7&?Q%Z&F(^(****Y# **** "BBB@ HHHH **** "BBB@ HHHH ****
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M3A8_^OF#_P!$I5T_BE\S.K\$/5'L6L_\@/4/^O:3_P!!->5? G_F/_\ ;O\
M^U:]5UG_ ) >H?\ 7M)_Z":\J^!/_,?_ .W?_P!JTH_PY?(JI_&A\SV*BBBL
M3H/$/A-_R4K6?^O:?_T<E=7\9-)DOO!\=Y$K,UC.)'Q_<8;2<?4K^&:Y3X3?
M\E*UG_KVG_\ 1R5[7<0175O+;SQK)#*A21&&0RD8(/X5O4ERU$SDHQYZ+B<G
M\,M:BUCP38HKYFLD%M*IQD;1A>!VVX_(UV%>&:CH'B+X7^('U30EEN]*DZY4
MNNW^[*!TQV;C]2*Z"U^..D/ 3=Z3?138X2)DD4GZDK_*E*FV^:.J*A645RU-
M&CU.N1T_XA:9J/C*X\.0P7#21L42X0;D9E!W9QRH!XST/MW\_P!9^*&M>*RV
MC>&=,FA,XVET)>8KWQCA!ZGG [BNU^'?@%/"ED;N]V2:K<*-Y&"(5_N*?7U/
M? ],E."C&\MQJJYR2AMU9W-%%%9'0%>$>!9_^$,^*5YHUZPAAF+VP:3 '7=&
MV3ZC&/\ >%>[UP'Q(\ OXHBBU'3-J:K;C;@G:)DSD#/8CG!]\'MC6G)*\7LS
M"M%NTH[H[^BO%]&^+&J^'P=,\4Z;<330C:)?N2\<?,#PW3[V?SK5O_CAI*V[
M?V?IE[)/@[1<;$4'MG#,30Z,[[ L13M=LW_BCK<6D>"+N$R;;B^'V:) >6!^
M^?IMS^8'>J/P=TJ2P\&-<S1A7O;AI4/<Q@!1^H;\ZY#3/#OB/XFZ['J^OA[;
M2D/RC!4%,_<C'OCEC^N,5[=##';P1P0H$BC4(BCHH P!3G:,>3J33O4G[1[=
M#Q3XWL4U_274X9;=B#[[J]<\/ZQ!K^A6>IP,I$\09E4YV/CYE_ Y%>1?'+_D
M.:5_U[-_Z%5BZL_$OPIU*:?28Y-0\.RDR,C@D1],[\?=8  ;NAX^@MQ4H174
MA3<*LGT/9Z1F5%+,0% R23P!7F$/QPT-K?=/IFH)-_<0(R_]]%@?TKFM8\;>
M)/B*S:)H.F/!;2']Z(VW,R_[;\!5]OPR:S5&770U>(A;35BZ1<#QK\;!J%ON
M-I;OYRGTCC4!3^+;?^^J]TKE/ O@JW\':4T999M0GYN)US@X)PJYZ  _B<^P
M'5TJDDWILAT8.,;RW>IXA\6?^2E:-_U[0?\ HYZ]OKQ#XL_\E*T;_KV@_P#1
MSU[?55/AB31^.9X[\=O^8!_V\?\ M*O5=&_Y >G_ /7M'_Z"*\J^.W_, _[>
M/_:5>JZ-_P @/3_^O:/_ -!%$OX<?F%/^-/Y'CNE?\G"R?\ 7S/_ .B7KV^O
M$-*_Y.%D_P"OF?\ ]$O7M]%;=>@8?:7JPKPWX<?\E=U3_MY_]&"O<J\-^''_
M "5W5/\ MY_]&"BG\,@K?'#U/<JKW_\ R#KG_KD_\C5BJ]__ ,@ZY_ZY/_(U
MBC=['COP,_Y".L_]<HOYM6_\:M+>Z\+6NH1@G[%<?/[(XQG_ +Z"C\:P/@9_
MR$=9_P"N47\VKV2\M+>_LYK2ZB66WF0I(C=&4C!%;U)<M6YRT8<]#E.;^'FO
M1:]X.LI%;,]LBVTX/7<H S^(P?QKJJ\*U#0?$GPNUN75M&#76E,3N."RA,G"
MR@="/[W _/%=%8_'#27MP=0TJ]AF[BW*2*?Q)4TI4V]8:HJ%917+4T:/4Z^?
M?B#KD6L_$R!+=U>"RDBME9?XF#9;\F)'X5NZC\0O$/C82:1X4TF:%95VR3EO
MG"]_FX5!SUR3SQ7)>(_"R>$/%.B:?YYFF>*&:=_X=YE8$+[ *!^OM5TH<KUW
M,J]3GC[NW<^DJ\0\&_\ )<M6_P"OF\_]#:O;Z\0\&_\ )<M6_P"OF\_]#:HI
M[2]#:O\ %#U/;Z***Q.@*\0^$W_)2M9_Z]I__1R5[?7B'PF_Y*5K/_7M/_Z.
M2MJ?PR.>M\<#V^BBBL3H/!_%L,G@+XJV^LVPQ:W#BYV@<;6)65.F/4^VX=Z3
MP5;R>.?BA<ZW=J#! YN65E!''RQ)^'!_X!7H'Q6\/_VUX/EN8D9KK3SY\84<
ME>CC\N?^ BI?A?X?.A>#H'F0K=7O^D2@]0#]P?\ ?.#]2:Z?:+V=^NQQ>R?M
M>7IN=I1117,=H4444 >7?&W2I;K0;#4HT+)92LLA'\*R8&?IE5'XBNK\ :[!
MKW@ZPFC8>=!$MO.F<E748Y^H (^M;][9VVHV4UG=PK-;S(4DC;HP->'7>D^*
M/A3J\U_I>ZZTF0_.Y3<C(#P)0/ND%L \=\=2*VC:<>7J<T[TZGM.CW/>**\L
MM?CCI#P$W>DWT4V.$B9)%)^I*_RK,O\ XA^(?&[2:/X5TJ6W27"27&XEU4]R
MPXC'49Y]N:7L9=2GB*?1W.?\>ZS'K/Q0C,+!H;26*U1AWVMEO_'F8?A7T%<0
M)<VTMO)G9*A1L=<$8-?./B/PLGA#Q3HFG^>9IGBAFG?^'>96!"^P"@?K[5])
M55:UHV(P]W*7-N>&_"N]?PUXYU'P_J#")KC,/S8&98V.T9]P6QCKD5[E7F_Q
M(^'\^N2IKFBG;JL(&] VTRA?NE3V8?K^'.'H_P 7[[2 -/\ %&ESO<0G8TL8
M"2<<?,AP"?H11*/M/>CN$)>Q]R>W1GLE>?\ Q>UR+3O![Z>) +J_=45 >=@(
M9F^G '_ JR=1^.&FK;M_9FEW<DV!M^T[44'/.=I)K(T+PGK_ (_UZ+7O% >.
MP4C$;C9YBJ?N*O55/<]^>YS2A3<7S3T'4JJ:Y*>K9V_PITN73/ =J9HPCW;M
M<X[E6P%)^J@'Z$5VU(JJBA5 "@8  X KQNZ\>>*_!WBV]7Q#:&XL9Y"8T3A%
M7^$Q-CIC&0?QP<U*3J-M%N4:44GL=IXV\ Z;XGT^>6*W2#554M%/&H!=A_"_
M3(/3)Z?I6!\%=;NK_1;_ $VYD:1+!XS"S')5'#?+] 4./K6=XB^,<6HZ:]AX
M>L+M;JY'E"2=5RN>/E52<GT^M=)\*_"5UX:T.>XOT,=Y?E7:(]8T7.T'W^8G
MVSBK::IM2^1FG&59.'S.,^(JR>&?BII_B%HW-O,T4Y*X^;R\*ZC/?:!_WT*]
MLMYXKJWBN()%DAE0/&ZG(92,@C\*P_&'A6U\7:(]C.WE3*=\$P7)C?\ P/<5
MY3HWBKQ+\,Y&TG6M-DN-.5R(]Q("\]8WQ@J>3M_ES1;VD5;=!?V,VWLSW:J>
MJZG;:-I5SJ-XQ6WMT+OCJ?8>Y/ ^M>=2_'#11;[HM+U!I_[C[%7_ +ZR3^E<
MO<WOBGXMZC%;06WV/2(GR2,^6G^TS'&]O0#\AR:E4GO+1%2Q$;6AJSU?P=XO
MMO&.EO>6]K/;M$P259!E0^,X5NC=O0\CCFNBK,T#0K/PYHT&F62XCB'S.0-T
MC=V;'4G_  K3K.5KZ&T.;E7-N%%%%(H**** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M:_\ 7ZG_ * ]=Y7!_%G_ )%6U_Z_4_\ 0'K6A_$1I2^-'#?#;_DH&F?]M?\
MT4]?0-?/WPV_Y*!IG_;7_P!%/7T#6N,_B+T-,1\04445R& 4444 %>#^(/\
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M$-&Q]<>H_0U?L8O9F7UF:UE$^I:*\^^'7CZX\2E]-U*(F^BCWBXC3Y9%'!W
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M>#_#O_D>]-_[:_\ HIZ]XK?&?&O0O$?$%%%%<A@%%%% !1110 4444 %%%%
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M %ZR_P#H!JH?$C.M_#EZ,\2KZ)KYVKZ)KT<R^S\_T/$R+_EY\OU"BBBO+/H
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MX<O)(Q9F.3U)Y-:2IN,5+N8PK*4W&VQOT445F;!1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<'\6?^
M15M?^OU/_0'KO*X/XL_\BK:_]?J?^@/6M#^(C2E\:.&^&W_)0-,_[:_^BGKZ
M!KY^^&W_ "4#3/\ MK_Z*>OH&M<9_$7H:8CX@HHHKD, HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% 'BGQ@_Y&VU_Z\4_]&25?^#W_ #&?^V'_ +4JA\8/^1MM?^O%/_1DE7_@
M]_S&?^V'_M2O1E_NW]=SJE_!/4****\\Y HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH ***I:OJD&BZ3<ZE<K(\-NF]UC +$>V2!^M&X-VU9=HKA]*^*O
MA[5;X6P2[M1M9S-=*B1J ,\D.:R=3^-&FVUR8]-TV:]C4X,LDGDAO<#!./J
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MV:)!K,,8,MFVR4CKY3'K^#8_[Z-8OP:UT0WUWH<SMMG'G0 G@,OWACU(P?\
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M/7T#6N,_B+T-,1\04445R& 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M3WG8L\>^+<3DD*Q _3 _"KK*Z4T98:3C)TV=91117.=@4444 %%%% !1110
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M@2RE%X1 V6/L/_K5].5->*3T*PLI2B[A1116)U!1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %<'\6?^15M?^OU/_0'KO*X/XL_\BK:_]?J?^@/6
MM#^(C2E\:.&^&W_)0-,_[:_^BGKZ!KY^^&W_ "4#3/\ MK_Z*>OH&M<9_$7H
M:8CX@HHHKD, HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** /G:O;="_Y%[3?^O6+_ - %>)5[;H7_ "+VF_\
M7K%_Z *];,?AB?-9'_$GZ&A1117E'T@4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% '&?%"QN]0\&O!96L]S-Y\9\N&,NV.><"N2^$>C:IIOB"]EO
M]-O+6-K7:K3P,@)WKP"1UKV"BM%4:CRF4J*=13N%%%%9FH4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M'AF(Z&NAJZLU.5T9T*;IQLSY>\5_\CAK?_7_ #_^C&KZ4TC_ ) MA_U[Q_\
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M?XEU>\T/1Y=0M--^WB'YI8A*48)W8?*<X[^V37S[X+U2;2/%^FW$+$!YUBD
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** /G:O;="_P"1>TW_ *]8O_0!7B5>VZ%_R+VF_P#7K%_Z *];
M,?AB?-9'_$GZ&A1117E'T@4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 5GZ[_R+VI?]>LO_H!K0K/UW_D7M2_Z]9?_ $ U4/B1G6_AR]&>)5]$U\[5
M]$UZ.9?9^?Z'B9%_R\^7ZA1117EGT 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 >*?&#_D;;7_KQ3_T9)5_X/?\ ,9_[
M8?\ M2J'Q@_Y&VU_Z\4_]&25?^#W_,9_[8?^U*]&7^[?UW.J7\$]0HHHKSSD
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K@
M_BS_ ,BK:_\ 7ZG_ * ]=Y7!_%G_ )%6U_Z_4_\ 0'K6A_$1I2^-'#?#;_DH
M&F?]M?\ T4]?0-?/WPV_Y*!IG_;7_P!%/7T#6N,_B+T-,1\04445R& 4444
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M $4]?0->"?#" R^.[-P#B*.5S_WP5_\ 9J][K3&?Q%Z&F(^(****Y# ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** /G:O;="_Y%[3?^O6+_ - %>)5[
M;H7_ "+VF_\ 7K%_Z *];,?AB?-9'_$GZ&A1117E'T@4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 5GZ[_ ,B]J7_7K+_Z :T*S]=_Y%[4O^O67_T
MU4/B1G6_AR]&>)5]$U\[5]$UZ.9?9^?Z'B9%_P O/E^H4445Y9] %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MO_ I_P#&CZG+N'U9]SZ,HKYS_P"$EU[_ *#>I?\ @4_^-'_"2Z]_T&]2_P#
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M31_$$1DTK4(KD+]Y5R&'3JIP1U':M2OD2SNKS3[V.>SFE@NHV^5HR0P/I_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %9^N_\B]J7_7K+_Z
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M_P#%4?\ "MO"7_0)_P#)F7_XJNKHH]K4_F?WASR[G*?\*V\)?] G_P F9?\
MXJC_ (5MX2_Z!/\ Y,R__%5U=%'M:G\S^\.>7<Y3_A6WA+_H$_\ DS+_ /%4
M?\*V\)?] G_R9E_^*KJZ*/:U/YG]X<\NYRG_  K;PE_T"?\ R9E_^*H_X5MX
M2_Z!/_DS+_\ %5U=%'M:G\S^\.>7<Y3_ (5MX2_Z!/\ Y,R__%4?\*V\)?\
M0)_\F9?_ (JNKHH]K4_F?WASR[G*?\*V\)?] G_R9E_^*H_X5MX2_P"@3_Y,
MR_\ Q5=711[6I_,_O#GEW.4_X5MX2_Z!/_DS+_\ %4?\*V\)?] G_P F9?\
MXJNKHH]K4_F?WASR[G*?\*V\)?\ 0)_\F9?_ (JC_A6WA+_H$_\ DS+_ /%5
MU=%'M:G\S^\.>7<Y3_A6WA+_ *!/_DS+_P#%5Y[;>&])DU2&%K3,;3*I'F/T
MW8]:]MKR>S_Y#5O_ -?"_P#H5-59_P S^\3J2[G6_P#"MO"7_0)_\F9?_BJ/
M^%;>$O\ H$_^3,O_ ,575T4O:U/YG]X^>7<Y3_A6WA+_ *!/_DS+_P#%4?\
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MO1M@YR?4****@D**** "BBB@ KP?Q!_R,FJ?]?<O_H9KWBO!_$'_ ",FJ?\
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M_P 51_PK;PE_T"?_ "9E_P#BJZNBCVM3^9_>'/+N<I_PK;PE_P! G_R9E_\
MBJ/^%;>$O^@3_P"3,O\ \575T4>UJ?S/[PYY=SE/^%;>$O\ H$_^3,O_ ,51
M_P *V\)?] G_ ,F9?_BJZNBCVM3^9_>'/+N<I_PK;PE_T"?_ "9E_P#BJ/\
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M*?\ "MO"7_0)_P#)F7_XJC_A6WA+_H$_^3,O_P 575T4>UJ?S/[PYY=SE/\
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M_H$_^3,O_P 575T4>UJ?S/[PYY=SE/\ A6WA+_H$_P#DS+_\51_PK;PE_P!
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MG\\?UKP"P:--1M7E($:S(6)Z8R,U]1>+=&;7_"FI:8@!EFB_=@G +J0RY/\
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M-\N3],YHH_P] Q"3K:^1].:;IMII&GPV-E"L5O"@554>@QD^I]3WJRRJZE6
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M].L;VWU1' DEEC15DCQT;#$DCC!],CTK+^'.J2:5X\TMT=@EQ*+:10>&#_*
M?^!%3]0*Z#_A27B7_G^TG_O[)_\ &ZMZ5\'?$=AK%E>-?:9MM[B.4[)9-V%8
M'CY.O%5S4U'E3(Y*KFIM'H_Q$U9]'\"ZG<1.4F=!#&0<'+D*2#Z@$G\*^9HH
MGGF2*,;G=@JC.,D\"OHGXMVSW'P^O'4_ZB6*0C'4;@O_ +-G\*^?=-N%L]4M
M+EONPS)(>,\!@?Z4L/\  RL7_$29]/\ A7PU9^%M$AL+9$,@4&>8+@ROW8^W
M7 ["MNFQR1S1)+$ZO&ZAE=3D,#T(/<4ZN1MMW9Z"22LC-U+P_I&L7-M<:CI\
M%S+;',32+G'L?4>QR,\UHJJHH50 H&  . *6BE<++<I:S_R ]0_Z]I/_ $$U
M\D5];ZS_ ,@/4/\ KVD_]!-?)%=6&V9PXW='T]\/?^1 T;_KA_4UY%\9?^1Z
M'_7I'_-J]=^'O_(@:-_UP_J:\B^,O_(]#_KTC_FU32_BLNO_  %\B]\$/^1G
MU#_KR/\ Z&M>QZ_I$.O:#>:7/PEQ&5S_ '6ZJ?P(!_"O'/@A_P C/J'_ %Y'
M_P!#6O=:FL[3N7AE>E9GR!<VTUG=S6MPACGA=HY$/56!P1^8KZ7\!^(EU_P9
M:W]Q*/.@4PW+NP^^@&6)]QAOQKROXQ>'_P"S?$L>JPH!;Z@I+$9XE7[V?3(*
MG\_2N7T/Q9>:%H>LZ9;EMFHQ! V[B,YPQ QW4D=NQ[5O*/M8)HY:<O85&F,\
M9:Z?$?BN_P!1&/*:39"!_P \UX7\2!D^Y->L_!C0#9:!/K,R+YM\^V(XY$:$
MCKVRV>/]D&O%M'TR;6=9L]-M^);F58PQ&0N3R3[ 9/X5]7V%E!INGV]E;+MA
MMXUC0>P&*FN^6*BB\+%RFYLY+XK:J^E^ [I8R0]XZVH8-C ;);ZY56'XU\Z0
M"$W$8N&=82X\QHU#,%SR0"0"<=LBO>_C3!)+X(A=!E8;Z-W]AM=?YL*\*TZR
M;4M2MK%)8HGN)5B5Y20@+' R0"0,^U50LH$XJ[J6/9-*^+/@[1=-AL+#2]4A
MMXAA5$4?/J2?,Y)]:N_\+M\-?\^.K?\ ?J/_ ..5QW_"DO$O_/\ :3_W]D_^
M-T?\*2\2_P#/]I/_ ']D_P#C=1RT>Y:GB%HD<WXXU;0-;UH:AH5G<VOFKFXC
MEC1%+_WE"D]>_OSW-=1\%-4>W\2W6FL[>3<VY=5SQO4CG'T+<_2H_P#A27B7
M_G^TG_O[)_\ &ZZ+P-\,=;\,>*K?5+R[L'@C1U98)'+'*D#@H!UQWJI2AR.*
M9%.G4]HI-&E\8?#T^K^'(+^UC,DVG.SLBY)\I@-Q [X*J?H#7BOA_P 07WAG
M5X]2T]D\Y 5*R+E74]01Z?3%?6%>:>+/A!I^KR2WNBRK87;G)A8?N&/T RGX
M9'M6=*JDN61M7H2<N>&XW2?B3X:\8V?]D^(K5+1YL I.<PN>V'XVGOSC'J:]
M*A2)((T@5%A50$5  H7'&,=L5\I:[X=U7PW>BUU6T:!V&4;(*N/56'!_IWKT
MCX.^+KIK\^'+V8RP/&7M2[9*%1R@S_#M!..V/>G4I+EYH["HXA\W+-:GM%%%
M%<QVA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 ?.U>VZ%_R+VF_]>L7_H KQ*O;="_Y%[3?^O6+_P! %>MF/PQ/
MFLC_ (D_0T****\H^D"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "L
M_7?^1>U+_KUE_P#0#6A6?KO_ "+VI?\ 7K+_ .@&JA\2,ZW\.7HSQ*OHFOG:
MOHFO1S+[/S_0\3(O^7GR_4****\L^@"BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MF0I&R-QG*G?R*?LYWM8E5J;5[G=U\V:SXGU^+7-0CCUS4T1+F155;N0  ,<
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MWPU\%X+29+GQ!=I=,AR+6WR(SSQN8X+#VP/J:]6CCCAB2*)%2-%"JBC 4#H
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M'^5<IJWP6UVUD9M,N;:^AR H+>5)[Y!^7C_>_"L<?"GQD9-ITE0/[QN8L?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M,B_Y>?+]0HHHKRSZ **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MC!,]2,*.<9'T)KLJTK5%-Z&6'HNFFY;A1116)TA1110 4444 %%%% !1110
M4444 %%%% !1110 5QGQ+\2:CX7\.VM]ICQK,UXL3>8@8,I1SC\U%=G6-XF\
M,6'BS2UT_46F6))1*K0L%8, 1W!'1CVJH-*6I%1-Q:CN?/'BGQQK'B_R5U$P
M1PPDLD,"%5W'C/)))_&K?PPT^2_\?Z;L5BEN6GD91G:JJ<$^Q8J/QKMV^!4)
MF!7Q!((L\J;0%L?7?_2N^\*^#]+\(V3P6"N\LAS+<2X+O[9 & .PKIE5@HVB
M<4,/4<^:9T%%%%<AZ 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M967KRO  /3KFO-9A*)6\X.)#\S;\Y.><G-?0.D?"WPSI-PLY@FO9%.5^UN&
M_P" @ '\0:O7_P /_"^IWTU[>:9YEQ,VZ1_M$HR?H&Q51JPCLC.6'JSUDR_X
M4_Y$_1/^O"#_ -%K7S;KO_(P:E_U]2_^AFOJ.TM8;&S@M+=-D$$:Q1KDG:JC
M &3R>!7-S_#?PG<W$L\VD[I97+NWVB49).2>&J*=11;;-:U&4XI+H='8_P#(
M/MO^N2_R%?+US_R,,W_7TW_H=?4R(L<:QH,*H  ] *Y=OAOX3>X:=M)S*S[R
MWVB7KG.?O4J510O<=>E*HE;H7O%OAY/$_AVXTTN(Y6P\,C=%<=,^QY!]C7S]
MIFJZSX*UZ1X0;>\B/ES0RKD,,@E6'IP.1^!KZ=K'UWPMHWB- -3LDE=5VI*"
M5=1[,.??!XHIU.56>P5J+FU*+LSS;_A=MQ]GV_V%'Y^/O_:3MS_N[<_K6/IW
MQ0\5S:]YD:1W7VA@JV*1';TP O\ $/7J:[8_!KPV7W?:M3 _NB5,?^@9KI]!
M\(:'X;RVG62I,PPT[DO(1Z9/0>PP*MSI):(S5.O)^](V86D>"-I4$<A4%T#;
M@IQR,]_K7S#XK_Y'#6_^O^?_ -&-7U#7+W?PZ\*7UY/=W&E;YYY&ED;[1*-S
M,<DX#8')J*4U!MLTKTI5$DCH;'_D'VW_ %R7^0KQWXU_\AK3/^O=O_0J]G1%
MCC6-!A5  'H!6/K?A+0_$4\4VJV7VB2)=J'S73 SG^$BIIR4979=6#G#E1RG
MP8_Y$^[_ .O]_P#T7'7$_%__ )'<?]>L?\VKVK1="TWP]9O::7;?9X'D,K+O
M9\L0!G+$GH!5'6/!?A_7K[[9J>G^?<; F_SI%X'085@.]7&HE-R,Y49.DH=3
M)^%/_(@VO_767_T(UQGC7XC:W9>+GM=//V6'3Y"A1ESYYQ@EAZ<\#\>N,>MZ
M3I%CH=@ECIT'DVR$E4WLV"3D\L2:H^(/">C^)H@NI6VZ51M2=#MD09S@'T]C
MGJ:2G'G;:*E3G[-1B[-'D>O_ !5N]>\.S:5)I<$3SJ%EF$A8=0?E4CCIZFIO
M@[I4]QXDGU+:PM[:%DWXX9VQQGZ9/Y>M=C%\'?#4<V]IM0E7_GF\R[?T4']:
M[;3].L])LH[.PMT@MX_NH@X_^N:N52"CRP,X4:CFI5'L6J***YSK"BBB@ HH
MHH **** /,?B-_R,-O\ ]>J_^AO6M\+/^8M_VQ_]GK)^(W_(PV__ %ZK_P"A
MO6M\+/\ F+?]L?\ V>O5G_N?W?F?-TO^1K\W^3/1****\D^E"BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MU\4:%!JEJCQJ^5>-^J..HSW^O_ZJIP:7-T(52+ERIZFO1114EA1110 4444
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MAS63J?QHTVVN3'INFS7L:G!EDD\D-[@8)Q]0#[5X]I]A<:IJ%O8VJAIYW$:
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M>AI[67L>?K_P3M1\4?#G]B?VF[W$>9#&ELRJ9G(QR%#$ <]20.#7.+\;;<W
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MKL6Z***YSK"BBB@ HHHH **** "L_7?^1>U+_KUE_P#0#6A6?KO_ "+VI?\
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M3_M;3?\ H(6G_?Y?\:/[6TW_ *"%I_W^7_&CVD.Z#F7<N453_M;3?^@A:?\
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MTT45<YN6YG3I1I_"%%%%0:!1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'F/Q&_Y&&W_P"O5?\
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M4VU=Z&<JR3Y8J[/:J*\3NK7XH^$(C>-?2ZA:PDM(1+]H  ]0WSX[Y'3VKN/
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MUNP\0:7%J.G3"2"3\&1NZL.Q'^>*F4''7H5"JINVS-"O$/&7_)<M)_Z^;/\
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MO[+T_2%E5KDS_:'0<E5"LH)],[C^5%*<G*SU"O3A&',E9H]+T;5(=;T6SU.
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M/QJ _MS3#@9-LPS_ ,"KVFO%OC7_ ,AK3/\ KW;_ -"J*/QFN)_A,ZGX/?\
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M\B5'_P!?D?\ Z"U:3_BHQI?[O(Y'X+?\C+?_ /7F?_0UKVZO$?@M_P C+?\
M_7F?_0UKVZLJ_P 9MA?X84445D= 4444 %%%% !1110 5GZ[_P B]J7_ %ZR
M_P#H!K0K/UW_ )%[4O\ KUE_] -5#XD9UOX<O1GB5?1-?.U?1->CF7V?G^AX
MF1?\O/E^H4445Y9] %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MQJWZP/!7_(HV/_;3_P!&-6_7)7_BR]6>GA/]WI^B_(****R.@**** "BBB@
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M'[D4.BOWDV4M9_Y >H?]>TG_ *":\J^!/_,?_P"W?_VK7JVK*7T:^11EFMY
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MM^ZQ/#M'3,<G!YYZ!OSKTOQWKK^'?!]]?PL!<X$4)()^=CC/X#)_"O,_!O\
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M+)UCCYFL-?\ K<Z?X?2>%?#/AJW#ZUI*:A<();IFO(]P8\[?O<8X&/45UO\
MPEOAK_H8=)_\#8__ (JN*A^"_A>X@CFBO]6:.10ZGS8QD$9'_+.I/^%)>&O^
M?[5O^_L?_P ;J)<C=VS2/M8I)11U-]X@\(ZE9365[K6C3VTR[9(WO(\$?]]?
MKVKRWX9W\>@?$6]T*&[2YL;HR112HX*N4RR/D<<J"..YKJ?^%)>&O^?[5O\
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MD\B/T0>^>@ [T[0O@[H.F2+-J$LNIRJ?NR#9%_WR,D_B2/:O0T1(XU1%"HH
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M+M1#ZJF3S[DGVQ7<U,^7:)=-3U<_N.!^,7_(A2?]?,?]:N_"O_DF^D_]MO\
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M8G+2-_>8]S^GIBM2IG)-Z;%TH.*O)ZL\0^!O_(<U7_KV7_T*O;ZX?P-\//\
MA#+ZZN?[4^V>?&(]OV?R]N#G.=QS7<4ZLE*5T*A!P@E(\H^.7_((TG_KN_\
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M_+_Y8>7LV;O]HYSN_2J<X<CBB53J.JIR_P"&-/QEX=3Q1X8NM-R%F.)('/\
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MV\?^TZM?!3_D$ZK_ -=T_P#033]FO9\Q/M9>V]GT/4J***R.@**** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110!YC\1O^1AM_^O5?_0WK6^%G_,6_[8_^SUD_$;_D8;?_ *]5_P#0
MWK6^%G_,6_[8_P#L]>K/_<_N_,^;I?\ (U^;_)GHE%%%>2?2A1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MP5'13ZY.!CTSZ5]'UO6?*E!')AHN4G49PGC'X<-XNUI-0;5_LP2%85C^S;\
M$G.=P[L:W_"7AJ+PIH2:;'-Y[>8TDDVS9O8GKC)[ #KVK<JAK.LV.@Z9+J&H
M3".&/\6=NRJ.Y-9<TFN4Z.2$6Y]3A?C-?0Q^&K2R+#SYKD.JYYVJK9/YD"L/
MX*6DC:IJE[M/EI"L6[L2S9Q_X[7$ZUK&I^-/$0F="\\["*WMT/" GA1GZ]?4
MFO>_!GAJ/POX=ALN&N7_ 'EPX[R$#('L.@^E;2]RGR]6<U/][6YULCH****Y
MCM/G_P"+/_(]S?\ 7"/^55K7XB:OIGA:ST/2]EJ(0_F7  9VW.S8&>%&&^N1
MU%6?BS_R/<W_ %PC_E7;_";PU90^'H]<EACEO+EV\MV&3$JL5P,C@D@\CVKL
M;2IIM'G*,I5I*+L>76OC;Q-:7(G37+YV!SMEF,BG_@+9%>X>!/%R^+=&:65%
MCOK8A+A%Z'(X8>@.#QZ@UR7QGT>V2QL-6BA1)O.,$CJH!?<"PSW.-I_,U1^"
M<I&IZM%SM:&-CSQPQ']:F?+.GS)%TW*G5Y&[H]0\0^(;#PUI3W]_)A1PD8^]
M(W95'^<5X=K?Q-\2:O(XANS86Y.5BMOE(_X'][]:T/B_JLEWXL73PQ$-E"HV
M[L@NPW$X[<%1^%=;\+?"%A;:)!KMS"DU[<9:)G7(A4$@;0>A.,Y_+OE1480Y
MF.<IU:CA%V2/,;#QUXGT^?S8M:NY.F5N)#*I]L-G]*]<\"_$2'Q.XT^]B$&I
MJFX;?N38ZE?0]\5T^N^'M-\0V+VM_;))E2$D(^:,X."#UXS7S<QO/#/B1_*D
M*7>GW)4-ZLK8_(XZ=P::Y:J>EF2^>@U=W1]%>+[^YTOPGJ5]9R^5<PQ;HWVA
ML'([$$5YMX \<^(];\86MAJ.H^=;.DA9/(C7.%)'*J#U%=WXUG%S\.=2N%&%
MEM0X'UP:\C^%?_(_V7_7.7_T U%.*]FVS2K)JK%)Z'T+7@.K?$CQ9;:Q?00Z
MMMBBN)$1?L\1P Q '*U[]7RMKO\ R,&I?]?4O_H9HH)-NX8N4HI69]$^)-2N
M]/\  ]WJ-K-Y=W';+(LFT'#<<X(QWKR&P^*WB2!;LW=X+EG@*0 P1J(Y"R_.
M=H&<+NXZ9(XKU7QHC1_#C48W&&6T4$>A&*\/\$Z7%K/C+3+&<!H7E+NK#(94
M4N5/L=N/QJJ2BXMM$XB4U-*+.U^&.J^(->\6RS7FK7DUK!"7EC>4E&)^51MZ
M#J3QC[M4_&7Q0U2ZU*>RT6X^RV,3%/.C'[R7!ZY/*CCC&#Z^E>VK%&ARB*IV
MA<@8X&<#Z#)_.OFCQ!I%YX6\4217,*L8YO.B+C*2INR#[CL?Q%%-QG)NPJRG
M2@DF2:?X[\3Z=<":/6;N;D92YD,JL/3#9Q^&#7N_@[Q&?%/AZ+46MFMY-QCD
M4CY2PQDJ>Z\_GD=JXJ+Q=X0\?00V/B*U%C>*P\N1FXZ]%EQP#CD' YX).#7I
M]M;0VEM';V\210Q*%1$& H'85-5JVJLS3#Q:=U*Z):***P.H**** "BBB@ K
M/UW_ )%[4O\ KUE_] -:%9^N_P#(O:E_UZR_^@&JA\2,ZW\.7HSQ*OHFOG:O
MHFO1S+[/S_0\3(O^7GR_4****\L^@"BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MXFOKAII-;O8R23M@F:-1[ *179> /B1J;:Q;:1K$S7<%RXBBF?'F1N3QD_Q
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M_P @"Y_X!_Z$*QQ'\&?H_P B:GP,XS2?^0S8_P#7Q'_Z$*]4KRO2?^0S8_\
M7Q'_ .A"O5*X,K^"7J8X;9A1117J'2%%%% !1110 5Y/9_\ (:M_^OA?_0J]
M8KR>S_Y#5O\ ]?"_^A4T2SUBBBBD4%%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5X/X@_Y&35/^ON7_
M -#->\5X/X@_Y&35/^ON7_T,UZ.7?%(\///X</4]-\%?\BC8_P#;3_T8U;]8
M'@K_ )%&Q_[:?^C&K?KDK_Q9>K/3PG^[T_1?D%%%%9'0%%%% !1110 4444
M%%%% !12,P52S$!0,DGH*X?7/BKX?TF22"V,NH7"<$08$8/H7/\ , TXQ<MB
M93C%7DSN:*\F7XW1F4!M 81YY87>3CZ;/ZUTFA?%#P]K,J02226-PYP$N  I
M/LPX_/%6Z4UNB(UZ<G9,[6BBBLS4**** "BBB@ HHHH **** "BBB@ HHHH
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M "(_^-']GXG^9?>_\A^PJ=SC/[6U+_H(7?\ W^;_ !H_M;4O^@A=_P#?YO\
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M_P#?YO\ &NS_ .$;TG_GT_\ (C_XT?\ "-Z3_P ^G_D1_P#&C^S\3_,OO?\
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M)_Y]/_(C_P"-'_"-Z3_SZ?\ D1_\:/[/Q/\ ,OO?^0>PJ=SC/[6U+_H(7?\
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M/[6U+_H(7?\ W^;_ !H_M;4O^@A=_P#?YO\ &NS_ .$;TG_GT_\ (C_XT?\
M"-Z3_P ^G_D1_P#&C^S\3_,OO?\ D'L*G<XS^UM2_P"@A=_]_F_QH_M;4O\
MH(7?_?YO\:[/_A&])_Y]/_(C_P"-'_"-Z3_SZ?\ D1_\:/[/Q/\ ,OO?^0>P
MJ=SC/[6U+_H(7?\ W^;_ !H_M;4O^@A=_P#?YO\ &NS_ .$;TG_GT_\ (C_X
MT?\ "-Z3_P ^G_D1_P#&C^S\3_,OO?\ D'L*G<XS^UM2_P"@A=_]_F_QH_M;
M4O\ H(7?_?YO\:[/_A&])_Y]/_(C_P"-'_"-Z3_SZ?\ D1_\:/[/Q/\ ,OO?
M^0>PJ=SC/[6U+_H(7?\ W^;_ !H_M;4O^@A=_P#?YO\ &NS_ .$;TG_GT_\
M(C_XT?\ "-Z3_P ^G_D1_P#&C^S\3_,OO?\ D'L*G<XS^UM2_P"@A=_]_F_Q
MH_M;4O\ H(7?_?YO\:[/_A&])_Y]/_(C_P"-'_"-Z3_SZ?\ D1_\:/[/Q/\
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M/_Z+:OG_ ,"?\CSH_P#U\"OH/Q+%)/X5UB&&-Y)9+*941%)9F*$  #J:\/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M-UJJDEHCO:***Y3O/#/C/_R.%I_UX)_Z,DKOOA3_ ,B#:_\ 767_ -"-<?\
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M-C_U\1_^A"O5*X,K^"7J8X;9A1117J'2%%%% !1110 5Y/9_\AJW_P"OA?\
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M,H_0G^E8UYN%*4EV(F[1;.# >:4 9:1VQ[DFO1=+T^/3;)(4 WXR[?WFKB=
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MO7J\(^$K_P!G_$6_L<':T$T0!XP5=3_(&O=ZNLO?,L,[TTNP4445D= 4444
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M_?AO\*+!<]8HKR?^R-3_ .@==_\ ?AO\*/[(U/\ Z!UW_P!^&_PHL%R35O\
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M"1YM\;?^1,L_^P@G_HN2MCX7626?P^TTJH#S[YG/]XEC@_\ ?(4?A6/\;?\
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M208_G78_&+_D0I/^OF/^M<=\&O\ D<]7_P"O9O\ T8M=C\8O^1"D_P"OF/\
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M[^[U$X.#LS:E551704445!H%%%% !1110 4444 %%%% !1110 4444 %%%%
M!65XD_Y %S_P#_T(5JUE>)/^0!<_\ _]"%8XC^#/T?Y$U/@9QFD_\AFQ_P"O
MB/\ ]"%>J5Y7I/\ R&;'_KXC_P#0A7JE<&5_!+U,<-LPHHHKU#I"BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "O!_$'_(R:I_U]R_^AFO>*\'\0?\ (R:I
M_P!?<O\ Z&:]'+OBD>'GG\.'J>F^"O\ D4;'_MI_Z,:M^L#P5_R*-C_VT_\
M1C5OUR5_XLO5GIX3_=Z?HOR"BBBLCH"BBB@ HHHH **** "BBB@#.UK0M.\0
M6)L]2MUFBZJ>C(<8RI[&O)-9^#>J6\C/I-W#=Q9X24^7(/Z'\Q7ME%7&I*.Q
ME4HPGN?.X^%WB\OM_LI0/[QN8L?^A9KH]"^#5Y),LFN7<<,/4PV[;G//0DC
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M "!H?^OA?_06KFQ?\"7H9U?@9S'AO_D/VW_ _P#T$UW]<!X;_P"0_;?\#_\
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M7:QM7\)Z#KSF34]+MYY2,&7&UR/3<N#^M:J::Y9(PE2DI<U-V9SU[\7?"5K
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M>6N"V.FX]3U/6GS4UJD1RUI:2:2\CY^B\/S^&?B5H.GW4PEN/M=K)*R] S2
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M[DUNY/\ XX&'ZUVEQ;07EN]O<PQSPN,/'*H96'H0>#7,3_#/P=<.7?1(P?\
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MW#_T,_E7KVDWZ:IH]EJ"8VW,"2X';< <5M4UA%G-1TJ3C\S%^(7_ "(&L_\
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M+>. ' :[+.S#UPI 7Z9/UKSO1=*GUS6;73+; EN'V@D$A1U)..P )_"O;_\
MA4OAC^S1;>5<?: N/M?G-O)]=OW?T[5TRC3@]4<4)UZBT92\'_%2'7+^+3=4
MMDM+J4A8I8V/ENW9<'E2>W)]*[^_G:UTZYN$ +Q1,ZANF0">:^59X9;&^EA9
MMLT$A0LAZ,IQP?J*^IUDAO-)$EP5\F:#=(2=HVE>>>PP:BM!1::-</5E--2W
M1XO_ ,+G\1?\^6E_]^I/_BZ/^%S^(O\ GRTO_OU)_P#%UUW_  C?PL_Y[Z7_
M .#5O_CE'_"-_"S_ )[Z7_X-6_\ CE5S4_Y3/EK?SK[SD?\ A<_B+_GRTO\
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MS=QU%%%<YV!1110 4444 %%%% !1110 4444 %%%% !1110 5E>)/^0!<_\
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MX;_Y#]M_P/\ ]!-=_7 >&_\ D/VW_ __ $$UW]<^5_P7Z_HC+#? %%%%>D=
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M_/\ ^C&KU#P;\+=)ET.VOM<BDN+FY02^3YC(L:D94?+@YP03SUX[<^7^*_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M?@J7Q%" Z&U$T0/(+,!M!Z?Q$ UM4II6Y>IS4:S=U/H9C_$O0X_$IT)H[P7
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M*4*2J 2Q .<[F)[<DU5UWXFZ+X>UJXTN[M;]YX-NYHHT*G<H88RX/0CM6/\
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M#GEU!5^TV\WEF1$VJXP"#]>N<8'2M_6O#ND^(H(X=5LDN5B)9"259<]<,I!
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@#YVKVW0O\ D7M-_P"O6+_T 5XE7MNA?\B]IO\ UZQ?^@"O6S'X
M8GS61_Q)^AH4445Y1](%%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M9^N_\B]J7_7K+_Z :T*S]=_Y%[4O^O67_P! -5#XD9UOX<O1GB5?1-?.U?1-
M>CF7V?G^AXF1?\O/E^H4445Y9] %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 4M7_Y M__ ->\G_H)K@/"G_(RVG_
M_P#T!J[_ %?_ ) M_P#]>\G_ *":X#PI_P C+:?\#_\ 0&IK8E[GIE%%%(H*
M*** "BBB@ HHHH \KU;_ )#-]_U\2?\ H1KL_#?_ " +;_@?_H1KC-6_Y#-]
M_P!?$G_H1KL_#?\ R +;_@?_ *$:\7+_ />9>C_-''0_B,U:***]LZPHHHH
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MQJWZP/!7_(HV/_;3_P!&-6_7)7_BR]6>GA/]WI^B_(****R.@**** "BBB@
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M_F!?]O'_ +3K5_QD<\?]W?\ 78T/@M_R+^H_]?0_] %<#\3_ /DHFJ_]L?\
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M?1-<YX],(\"ZP9RH3R"!N_O9&W]<5Y;X=^+>I:/I\=E>V2:A'$NV-S*8W [
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M>X M&\SR '[P5",#\^WTKLO OBG4?$MK?#5=.%C=6DHC9 K+U'=6Y!&#7#_
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M***]0Z0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KP?Q!_P C)JG_ %]R
M_P#H9KWBO!_$'_(R:I_U]R_^AFO1R[XI'AYY_#AZGIO@K_D4;'_MI_Z,:M^L
M#P5_R*-C_P!M/_1C5OUR5_XLO5GIX3_=Z?HOR"BBBLCH"BBB@ HHHH ****
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MBM#\:W\'@K1_"_AB!I];E\T2.%_U(,CD8SQG!!R> /T[7XQ?\B%)_P!?,?\
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M.\N;=+>8I%-.SJI$J $ G X)'XUZ^[I'&SNP5%!+,QP !W->)?";_DI6L_\
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M!W#GKU_&O/\ X4^*=1?5]0\.ZY=7$UVK,\9NI2[JR\.F3D]LXSV/K7INC?\
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M/CKXG7+30SM8:4KY4[C'$.>@QS(PYYZ?2I/'SR^+_BE9>'$E*6]NRP9Q]TL
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M8%AD%0<'/>O0O&.EZOK&@M::)?\ V&\,BL)O.>+Y1U&Y037E_C+_ )+EI/\
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M*;DMD>3_ !.UK5;#X@Z3;6>IWEM;O;PEXH9V16)E<$D X/  _"O8:\0^+/\
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MY'71?^OR/_T(4J/P20\3I4BSZ<HHHKF.T**** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@M725S?C;_D#0_\ 7PO_ *"U<V+_ ($O0SJ_ SF/#?\ R'[;_@?_ *":[^N
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MI\(?$;2/$ME&EQ<0V6I@8DMY'VACZH3U!].H[^I<W)Q4HLFG&$9.$UKT'?\
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M\S%N7E_') /?+>U=K\0O^1 UG_KA_45K-KG45T.>FG[.4GUN<Y\$O^1,O/\
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M* "BBB@ HHHH **** *6K_\ (%O_ /KWD_\ 037 >%/^1EM/^!_^@-7?ZO\
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MEI_P/_T!J](KS?PM_P C):?\#_\ 0&KTBN;+/X+]?T1&&^ ****]$Z HHHH
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MAM6C'!!R S9^89]A7I-%%5*3EN1"$8?"@HHHJ2PHHHH **** "BBB@ HHHH
M^=J]MT+_ )%[3?\ KUB_] %>)5[;H7_(O:;_ ->L7_H KULQ^&)\UD?\2?H:
M%%%%>4?2!1110 4444 %%%% !1110 4444 %%%% !7.^-?"Z>*] >S!1+J-A
M);ROD!6]\<X(R#^![5T5%--IW0I14E9GD7ASX<>+?#.M1:E:7NE%ERLD9FD
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M_@?_ * U=_J__(%O_P#KWD_]!-<!X4_Y&6T_X'_Z U-;$O<],HHHI%!1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MB@ HHHH **** "BBB@ HHHH I:O_ ,@6_P#^O>3_ -!-<!X4_P"1EM/^!_\
MH#5W^K_\@6__ .O>3_T$UP'A3_D9;3_@?_H#4UL2]STRBBBD4%%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %>#^(/^1DU3_K[E_P#0S7O%>#^(/^1DU3_K[E_]#->CEWQ2/#SS^'#U
M/3?!7_(HV/\ VT_]&-6_6!X*_P"11L?^VG_HQJWZY*_\67JST\)_N]/T7Y!1
M1161T!1110 4444 %%%% !1110 4444 %%%% !1110!FR^'=#GF\Z;1M/DEZ
M[WM4+?F15Z""&VA6&")(HEX5(U"J/H!4E%%V))(****!A1110 57N[&TOXO*
MO+6"XC_NS1AQ^1JQ10!0M-$TG3Y1+9:796T@SAH;=$//N!5^BBBX));!1110
M 53O-)TW42#?:?:W1 P#/"KX'7'(JY10#5RE9Z-I>G.7L=-L[9CU,$"H?T%7
M:** 2ML%%%% !1110!EOX:T*23S'T336?KN:U0G\\5HQQ1PQK'$BHB\!5& /
MPI]%%V))+8****!A3719$9'4,C##*PR"/0TZB@#-3P[H<4XGCT;3TF'(D6U0
M,/QQ6E111>XDDM@J.>"&YA:&>))8FX9)%#*?J#4E% S-B\.Z'!-YT.C:?'+U
MWI:H&_,"M*BBB]Q));!1110,**** "BBB@ HHHH **** "BBB@ HHHH ****
M /,?B-_R,-O_ ->J_P#H;UK?"S_F+?\ ;'_V>LGXC?\ (PV__7JO_H;UK?"S
M_F+?]L?_ &>O5G_N?W?F?-TO^1K\W^3/1****\D^E"BBB@ KF_&W_(&A_P"O
MA?\ T%JZ2N;\;?\ (&A_Z^%_]!:N;%_P)>AG5^!G,>&_^0_;?\#_ /037?UP
M'AO_ )#]M_P/_P!!-=_7/E?\%^OZ(RPWP!1117I'0%%%% !1110 4444 %%%
M% !1110 4444 %<[XJ\9Z=X0^R?VA#=2_:M^S[.JMC;MSG+#^\*Z*N1\<>!_
M^$R^P?\ $Q^Q_9/,_P"6'F;MVW_:&,;?UJH<M_>V(J<W*^3<R/\ A<_AW_GR
MU3_OU'_\71_PN?P[_P ^6J?]^H__ (NLC_A2'_4P_P#DE_\ ;*XWQKX0@\'W
M-K:C5/MEQ,AD9/L_E[%S@'.XYR0WY5O&%*3LCDE4KQ5Y(]:T+XFZ+XAUJWTN
MTM;])Y]VUI8T"C:I8YPY/0'M77W-S#:6TEQ<2I%#$I9W<X"@=S7CWP<\/">_
MN->G0[;<>3;Y'!=A\Q_!3C_@7M5OXSZY.C66AQ-MBD3[1-S]_DA1] 0Q]^/2
MHE33GRQ-8UI*ESR+^J_&;3+2Z>+3M.FOD7CS6D\I6/MP3CZ@?2K6@_%S1M4N
M$M]0@?39'. [N'BSGNV!CZD8]ZX?P#\.U\4V\FH7]Q)!8JQC18<;W8=3D@@
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MT!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M .(-P##D'[W(R.1@UV<TT=O!)/,X2*-2[L>B@#)-?+?BO7I_$GB.\U<AQ$9
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MOA]]=CO6;38VV/.().#D#[NW=U(YQ5S1M<T[Q!8?;=+N1<6^\IOV,OS#J,,
M>XK'E:.A2B]$S0HHHI%!16#IOC/P_J^K/I=A?^=>)NW1B&0 ;3@_,5Q^M;U-
MIK<2DGL%%%%(84444 %%%% 'SM7MNA?\B]IO_7K%_P"@"O$J]MT+_D7M-_Z]
M8O\ T 5ZV8_#$^:R/^)/T-"BBBO*/I HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ K/UW_ )%[4O\ KUE_] -:%9^N_P#(O:E_UZR_^@&JA\2,ZW\.
M7HSQ*OHFOG:OHFO1S+[/S_0\3(O^7GR_4****\L^@"BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** *6K_P#(%O\ _KWD
M_P#037 >%/\ D9;3_@?_ * U=_J__(%O_P#KWD_]!-<!X4_Y&6T_X'_Z U-;
M$O<],HHHI%!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MU9.3A/<Z^BBBL#J"BBB@ HHHH **** "BBB@ HHHH **** "BBB@#S'XC?\
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MTV9K1FY1L]T>=?%_Q-_97AU=(MY,76HY5]IY6$?>Z'C<<+Z$;O2N1\3^#O\
MA'_A+IKR1[;XWBSW6>"N]"-OKQA1CUW&I=%C?XE?%2;5)D+:58D.JL./+4_N
MT.01\QRQ![;Z]"^)UJ+KX>ZJ. 8U252?]EU/\LC\:U3Y'&/WF#7M%*?W%OP#
M=?;/ 6BR[@VVV6+(_P!CY/\ V6NCK@/@[=?:/ :19)^S7,D7/;.'_P#9Z[^L
M)JTFCII.\$PHHHJ30***BNIQ:VDUPPRL4;.1]!F@#R/XC>*]1UG7D\'>'V)+
M,([AD.UGD_N9[*.Y^O8<]!X;^$NAZ5;*^J1KJ-X5^<R9\M3QPJ]^1U-<M\%+
M87VNZSJUQB2XC11O;KF1F+$?]\_K[U[56]23A[D3EI153]Y(P;CP5X7N83%)
MH&G!3WCMUC/YJ :\X\5?#*]T"ZAUGP:]UO20$VZON>,D\%#_ !+V(.3W.1G'
MLM%9QJ2B:SHPDMBCH[ZC)H]JVK111:@4'GI$V5#>U>)>*4'B?XTIITK.ULL\
M5MCN$4 N!^._\Z][KP349?[$^.HN+H%8S>HVXCC;(H&?H-WZ?A6E'=OR,\1\
M,4]KGO=%%%8'2%%9GB'^U/[ O?[%_P"0EY?^C_=^]G_:^7\Z\P_XO/\ Y^QU
M<8<W5&<ZG*[6;]#V*BO"];U[XJ^';);S5;H6]NT@C#[+5LL02!A03T!_*O3/
MA[JFI:SX-M-0U64RW,S2'>45<J&('"@#M3E3<5>Y,*RE+ELTS;U?3(=9T>[T
MVX)$5S$T;,O5<CJ/<=?PKQSX4:I<>'_%]YX9O@4^T,RA6X"RH#TR.X!_(5[A
M7B7Q<TF71/%&G^)K(*GG,I8CM-&003]1C_ODU5+6\'U)KKEM470]MKQ_XU:\
M7:Q\.6Q+.Q%Q.JC.>R+ZY^\<?[M>F:5KEKJ7AJWUL2*MO);^=(PY"8'S _0@
M@_2O'?!%M-XY^)MSK]RK?9[67[3M9B=AS^Z3..V!Z?=-%)6;D^@J\N9*$?M'
MK7A#05\-^%[+30JB5$WSD ?-(W+9(ZXZ?0"MRBBLF[N[.A))61\^:3J]CH7Q
MFU*_U*?R+6.^O S[&;!)<#A03U->I?\ "U/!?_09_P#)6;_XBO+=)TBQUWXS
M:E8:E!Y]K)?7A9-[+D@N1RI!ZBO4O^%5^"_^@-_Y-3?_ !==%3DNN:^QQT?:
M6?):U^H?\+4\%_\ 09_\E9O_ (BN(^*7C3P_XC\,VUGI.H?:)TO%E9/)D3"A
M'!.64#J17;_\*K\%_P#0&_\ )J;_ .+KB/BEX+\/^'/#-M>:3I_V>=[Q8F?S
MI'RI1R1AF(Z@4J?L^96N55]MR/FM;YG>_#3_ ))WH_\ US?_ -&-6#\;?^1,
ML_\ L()_Z+DK>^&G_).]'_ZYO_Z,:L'XV_\ (F6?_803_P!%R5,?XOS+G_ ^
M1T?P]_Y$#1O^N']3735S/P]_Y$#1O^N']3735G/XF:T_@7H%<M\1M-34_ >J
M(45G@B-PA/\ "4^8D?\  0P_&NIK#\9S)!X)UQWZ&QF3\60@?J:(_$@FKQ=S
MC/@C?&;PW?V39/V>ZW@Y[.HX_-2?QKT^O)?@9&PT[692/E::-1]0&S_,5ZU5
M5OC9&'_A(****S-@IKND<;.[!44$LS'  '<TZN5^)%W)9_#W6)8CAFB6(\]G
M=4/Z,:<5=V)D^6+9Y??7FJ_%GQB=/LYVM])@)*$J=J1@_?8=V/89]N.37IVC
M_#?POI%LL?\ 9D-Y(.6ENT$A8XQT/ ^F*P?@KI\5OX3N;X<S75R0QQT5!@#\
MRQ_&O2JUJ3:?+'9&%&FFN>6K9R&M?#3PQK%NZ+IT5C,1\DUHHCVG_='RG\J\
M8\5)KGARQ;P?J;^=:17"W5I+SC;AQ\OL=W([$'UKZ6KS#XVZ?%+X;L=0VCSX
M+H1!O]AE)(_-5_6G2F^9)BQ%)<KE'1G4_#W_ )$#1O\ KA_4UYMXR_Y+EI/_
M %\V?_H:UZ3\/?\ D0-&_P"N']37FWC+_DN6D_\ 7S9_^AK1#XY?,57^%'Y'
MM]%%%8'6>*_'/_D(Z-_URE_FM>Q6'_(.MO\ KDG\A7COQS_Y".C?]<I?YK7L
M5A_R#K;_ *Y)_(5M/^'$YZ?\6?R/F?3+?4-1\7W>CZ=*8WU.9[:5@.D7F!V/
MT 3)]0".]>[Z=\._"^GZ:EFVDVUR0!OFGC#2.1SG/;Z# [5YE\+K<3?%&_D(
M4^1'/(,]OG"\?]]5[M55I-.R,\-33BY,RM?UJU\-:#<:E< >7 GR1@A=[=%4
M?6O'= T#5?BIKTVMZW.\6FQML_=G'3D1Q@YP!GD^_<FNA^.-U+'HVE6BL1%+
M.\C#U*J /_0C7=^#M.CTKP=I-G'G"VRLV?[S#<WZL:E/DAS+=ER7M*G*]D0V
MG@7PK8Q>7%H-@R^LT0E/YODUS?B;X3:3?6TESH2?V=J*?/&$<B-F'8C^'ZC&
M/0UZ+14*<D[W-72@U9H^8=3U;5-4\3Z9'K(;[?8&.SD9OO-ME8Y;W^;&>^,]
MZ^GJ\+^*5C%:_$K39XD5?M20R28&,N)"N?R"U[I6E9W46C'#IJ4DSYX\?:E/
MH_Q<O]0MMOGP-"\>X9 ;R4P:['PK\,/[2W:WXR,US?7+>9]F9RN >[XYS_L@
M@ <'T&'K-G%?_M K;S*&C-Q Y4C(.V%&P?;BO<J=2;C%)=B:5-2G)R[LP#X(
M\+&W$']@:?L'0B!=W_?77]:\X\:_#/\ X1^%O$'A>:>$6O[V2 2$M$HZLC=<
M#J02>_/:O9J1E5U*L 5(P01P164:DHLWG1A)6L<?\._&7_"6Z(?M.T:C:X2X
M P _HX'OW]\US/QR_P"01I/_ %W?_P!!%8GP[3^P_BWJ.DQ,PAS<6X7/4*V5
M)_!?UK;^.7_((TG_ *[O_P"@BM5%*JK&#FY4'?='?^$O^1,T+_L'V_\ Z+6O
M*-*_Y.%D_P"OF?\ ]$O7J_A+_D3-"_[!]O\ ^BUKRC2O^3A9/^OF?_T2]*&\
MO1E5=H>J.^^*G_)-]6_[8_\ HY*I?!W_ )$*/_KYD_I5WXJ?\DWU;_MC_P"C
MDJE\'?\ D0H_^OF3^E)?POF4_P".O07Q;X \,?V+KNK_ -F?Z?\ 9[BZ\WSY
M?];M9MV-V.O.,8KBOA3X0T+Q+IVHRZO8_:7AF54/FNF 1G^%A7K7BW_D3-=_
M[!]Q_P"BVK@/@;_R"-6_Z[I_Z":<92]FW<F<(^VBK'?0>%='M/#UQH5M:>5I
M\ZNKQ[V8_,.2"Q)SZ>E>5?"Z_E\,^-M0\,7[A//9HU]/.3ISZ%<_7BO;J\:^
M,&D3Z9K6G>*;$LCDK'(RY&V1.4;.>XX_X#[TJ;YKQ?4=:/+:<>GY'LM<SX^\
M0'PWX1N[R)]MS(/(MR,9$C9P1]!D_A6MH6KP:]H=GJEO@1W,0?;G.QNC+GO@
M@C\*\A^)5Y/XM\?:?X8L9!L@81$X.!*WWR?4*H'Z^M33A>5GT+K5+0O'KL;W
MP8\/&RT6XUJ=")KUMD09<8B7N/J?_017J%5["R@TW3[>QM4V06\:QQKG.% P
M/K5BIG+FE<NG#DBHA1114EA1110 4444 ?.U>VZ%_P B]IO_ %ZQ?^@"O$J]
MMT+_ )%[3?\ KUB_] %>MF/PQ/FLC_B3]#0HHHKRCZ0**** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH *S]=_Y%[4O^O67_T UH5GZ[_R+VI?]>LO_H!J
MH?$C.M_#EZ,\2KZ)KYVKZ)KT<R^S\_T/$R+_ )>?+]0HHHKRSZ *R+WQ1HFG
MR&.YU&%7'55RY'U"YQ7&^._%<XNGTBPE,:)Q<2(<%C_=!]!WKA(+:>Z?9;P2
M3/\ W8T+']*]"A@>://4=CQ,7FWLZCIT5=H]B_X3OPW_ -!+_P @2?\ Q-'_
M  G?AO\ Z"7_ ) D_P#B:\H_L+5_^@5??^ [_P"%']A:O_T"K[_P'?\ PK;Z
ME0_F_%'+_:V,_D7W/_,]7_X3OPW_ -!+_P @2?\ Q-'_  G?AO\ Z"7_ ) D
M_P#B:\H_L+5_^@5??^ [_P"%']A:O_T"K[_P'?\ PH^I4/YOQ0?VMC/Y%]S_
M ,SU?_A._#?_ $$O_($G_P 31_PG?AO_ *"7_D"3_P")KRC^PM7_ .@5??\
M@._^%']A:O\ ] J^_P# =_\ "CZE0_F_%!_:V,_D7W/_ #/5_P#A._#?_02_
M\@2?_$T?\)WX;_Z"7_D"3_XFO*/["U?_ *!5]_X#O_A1_86K_P#0*OO_  '?
M_"CZE0_F_%!_:V,_D7W/_,]7_P"$[\-_]!+_ ,@2?_$T?\)WX;_Z"7_D"3_X
MFO*/["U?_H%7W_@._P#A1_86K_\ 0*OO_ =_\*/J5#^;\4']K8S^1?<_\SU?
M_A._#?\ T$O_ "!)_P#$T?\ "=^&_P#H)?\ D"3_ .)KRC^PM7_Z!5]_X#O_
M (4?V%J__0*OO_ =_P#"CZE0_F_%!_:V,_D7W/\ S/5_^$[\-_\ 02_\@2?_
M !-'_"=^&_\ H)?^0)/_ (FO*/["U?\ Z!5]_P" [_X4?V%J_P#T"K[_ ,!W
M_P */J5#^;\4']K8S^1?<_\ ,]7_ .$[\-_]!+_R!)_\31_PG?AO_H)?^0)/
M_B:\H_L+5_\ H%7W_@._^%']A:O_ - J^_\  =_\*/J5#^;\4']K8S^1?<_\
MSU?_ (3OPW_T$O\ R!)_\31_PG?AO_H)?^0)/_B:\H_L+5_^@5??^ [_ .%'
M]A:O_P! J^_\!W_PH^I4/YOQ0?VMC/Y%]S_S/5_^$[\-_P#02_\ ($G_ ,31
M_P )WX;_ .@E_P"0)/\ XFO*/["U?_H%7W_@._\ A1_86K_] J^_\!W_ ,*/
MJ5#^;\4']K8S^1?<_P#,]7_X3OPW_P!!+_R!)_\ $T?\)WX;_P"@E_Y D_\
MB:\H_L+5_P#H%7W_ (#O_A1_86K_ /0*OO\ P'?_  H^I4/YOQ0?VMC/Y%]S
M_P STW4O&OAZ?2[N&+4-TDD+JH\F09)4@?PUR'A_6M/L=<MKFYN-D2;MS;&.
M,J1T ]36#_86K_\ 0*OO_ =_\*/["U?_ *!5]_X#O_A3^I4/YOQ0?VKC/Y%]
MS_S/5_\ A._#?_02_P#($G_Q-'_"=^&_^@E_Y D_^)KRC^PM7_Z!5]_X#O\
MX4?V%J__ $"K[_P'?_"E]2H?S?B@_M;&?R+[G_F>K_\ "=^&_P#H)?\ D"3_
M .)H_P"$[\-_]!+_ ,@2?_$UY1_86K_] J^_\!W_ ,*/["U?_H%7W_@._P#A
M1]2H?S?B@_M;&?R+[G_F>K_\)WX;_P"@E_Y D_\ B:/^$[\-_P#02_\ ($G_
M ,37E']A:O\ ] J^_P# =_\ "C^PM7_Z!5]_X#O_ (4?4J'\WXH/[6QG\B^Y
M_P"9ZO\ \)WX;_Z"7_D"3_XFC_A._#?_ $$O_($G_P 37E']A:O_ - J^_\
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M:"J0V84445!J%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 5X/X@_P"1DU3_ *^Y?_0S7O%>#^(/^1DU3_K[E_\
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M&,H!U([UZM55I*4KH6&A*,&I+J%%%%8G0%%%% !1110 4444 %%%% !1110
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M^18TG_KRA_\ 0!6TOX<3GA_&G\CS#X[?\P#_ +>/_:5>JZ-_R ]/_P"O:/\
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M%KXLT**^A*K./EN(0?\ 5OW'T/4'_P"O6O>V=MJ-E-9W<*S6\R%)(VZ,#7A
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MF6XECBB& 7D8*!DX')]R!7F=U\<-$2(FTTO4)9,'"R[(QGMR&;^5<O//XO\
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MR*W4[A&_7>S?Q-G\!UR>SC!4_>D*=1U5RP6G<ZKX?^'W\-^#[2SG0+=29GN
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M.4'"@T]SO_"7_(F:%_V#[?\ ]%K7E&E?\G"R?]?,_P#Z)>O5_"7_ ")FA?\
M8/M__1:UY1I7_)PLG_7S/_Z)>E#>7HQU=H>J.^^*G_)-]6_[8_\ HY*I?!W_
M )$*/_KYD_I5WXJ?\DWU;_MC_P"CDJE\'?\ D0H_^OF3^E)?POF4_P".O0Z;
MQ;_R)FN_]@^X_P#1;5P'P-_Y!&K?]=T_]!-=_P"+?^1,UW_L'W'_ *+:N ^!
MO_((U;_KNG_H)HC_  V$_P"-'YGJ]8WBO0X_$?AF^TQU!>6,F$GC;(.5.?J!
MGVS6S162=G<W:35F>&_#CQM'X;T36].U @-:HUS;QL0-S_=9,YZD[>/][TK1
M^#FC3WNH:CXIOF=Y'9HHW;^-V.Z1C^@S[MZ5R_Q2TB*W^(<L5B?,DOECE,0&
M-LC'!'/7) ;_ (%7NGAO1(O#OA^STN+:?(C =P,;W/+-^)S714:4;KJ<=&,G
M/EEM$U:***YCM"BBB@ HHHH **** /G:O;="_P"1>TW_ *]8O_0!7B5>VZ%_
MR+VF_P#7K%_Z *];,?AB?-9'_$GZ&A1117E'T@4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 5GZ[_R+VI?]>LO_H!K0K/UW_D7M2_Z]9?_ $ U4/B1
MG6_AR]&>)5]$U\[5]$UZ.9?9^?Z'B9%_R\^7ZA1117EGT!\]W,[7-U-.Y)>5
MV=B>Y)S7KWA33X+#P[9F) 'GB661L<L6&>?IG%>.5[;H7_(O:;_UZQ?^@"O7
MS!V@DCYG)4I5I2>]C0HHHKR3Z4**** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "N&^(VGP"SMM05 L_F^4S ?>!!(S],?K7<UR'
MQ&_Y%ZW_ .OI?_0'KHPK:K1L<68Q3PL[G,?#^=HO%ULBD@2I(C>XVEOYJ*]B
MKQCP)_R.=A_VT_\ 1;5[/6N8?Q5Z?YG+DC_V=^K_ "04445PGL!1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M/MO^N2_R%?+%Q'%/JDL=@I\F28K I/\ "6^4<^V.M?5JJ%4*H 4#  Z"C$=
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MO;*VN1C&)HE?CTY%4X_"_A^%]\6A:8C#^);2,'^5:U%.[%RIC41(XU1%"HH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%9^N_P#(O:E_UZR_^@&M"L_7?^1>U+_KUE_] -5#XD9UOX<O1GB5?1-?.U?1
M->CF7V?G^AXF1?\ +SY?J%%%%>6?0'SM7MNA?\B]IO\ UZQ?^@"O$J]MT+_D
M7M-_Z]8O_0!7K9C\,3YK(_XD_0T****\H^D"BBB@ HHHH ***Y37OB+X>\/W
M#VT]Q)<7*'#PVR[RIST))"@^V<TTF]$3*2BKMG5T5P^F_%CPQJ$_E22W-D3T
M:ZB 4_BI;'XXKMHY$FB26)U>-P&5E.0P/0@]Q0XN.X1G&7PL=1112*"BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MA^-=Y1142DY.[-(0C!6B%%%%(H**** "O+_B?X$N]6N%UO28C-<! EQ OWG
MZ,OJ<<$>P]Z]0HJHR<7=$5(*<>5GS!I?B37O#CM%87]Q:@$EH3RH)')*,",_
MA4NJ^-?$>M6YM[_59I(2,-&@6-6'H0H&?QKZ.O-)TW42#?:?:W1 P#/"KX'7
M'(J.UT'1[&42VFDV-O(/XXK9$/Y@5O[:.]M3E^K3V4M#R'X<> ;N\U*#6=3@
M:"RMWWQ1RKAIG'3@]%!YR>OYX]8\1^(;+PUI$M_>.. 1%%G#2OV4?X]NM:U%
M8RGS.[.B%)4XVB?+G_$P\6>)>TE]?S_103_)0/R KZ4T72H-#T:TTRV_U5O&
M$SC&X]2Q]R23^-7Z*=2ISZ$TJ/LVW>[84445F;A1110 4444 %%%% !1110
M4444 %%%% !1110!YC\1O^1AM_\ KU7_ -#>M;X6?\Q;_MC_ .SUD_$;_D8;
M?_KU7_T-ZUOA9_S%O^V/_L]>K/\ W/[OS/FZ7_(U^;_)GHE%%%>2?2A1110
M5S?C;_D#0_\ 7PO_ *"U=)7-^-O^0-#_ -?"_P#H+5S8O^!+T,ZOP,YCPW_R
M'[;_ ('_ .@FN_K@/#?_ "'[;_@?_H)KOZY\K_@OU_1&6&^ ****](Z HHHH
M **** "BBB@ HHHH **** "N>U7QSX<T34'L-1U'R;E "R>1(V,C(Y52.AKH
M:^>OBI_R/][_ -<XO_0!6E*"F[,QKU'3C='O>FZC::OI\-_8R^;;3 E'VE<X
M..A /4&K5<M\.?\ D0-)_P"N;_\ H;5U-1)6;1I!WBF%%%%(H**** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M?Q=I?BRP$]A+B90/.MW^_$??U''!%;U9M-.S-TU)71XA\)O^2E:S_P!>T_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MLH]SA<#OS^/2]:.AQ)\N(=^IZ;XD<1^%M7<YPME,3C_<-?/O@,$^.M' !/\
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M4@M_[*/Q-3*/-4L:0ER45+R..^'MH_BOXA7>NW:$) [7149*B1C\BY]N2/\
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M *+:O9ZWS#^*O3_,Y,D_W=^OZ(****X#V HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O!_$'_(R:I_U]R_^AFO
M>*\'\0?\C)JG_7W+_P"AFO1R[XI'AYY_#AZGIO@K_D4;'_MI_P"C&K?K \%?
M\BC8_P#;3_T8U;]<E?\ BR]6>GA/]WI^B_(****R.@**** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** /,?B-_P C#;_]>J_^AO6M\+/^8M_VQ_\
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M]EI_PBMO(^'UK)E?W\TLG ]&*\_]\U4^-'_(CQ_]?L?_ *"];'PS 7X=Z0
M!L<\?]=&K;_EU\SG7\?Y'65X.(I_BE\39DDED_LBU+$;6R%A4X^7W<X/XGKM
MKVW52PT>]*9WBWDVX&>=IKR3X%>5]HUS)'F[8-HSSMR^>/KMHIZ1<A5O>G&#
MV9[!:6=M86D=K:01P6\8PD<:A54>PJ:BBL3I/&?BGX/&C31^*]$#6S+,#<B(
M[?+<GY9%QTR>#[D>IKTOPAKP\2>%[+4R%$LB%954YVNIP?ITS]"*H?$GRO\
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MZE"!_.N#^!O_ ""-6_Z[I_Z":(_PF.?\>/H>KT445B= 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% 'SM7MNA?\ (O:;_P!>L7_H KQ*O;="_P"1>TW_
M *]8O_0!7K9C\,3YK(_XD_0T****\H^D"BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "L_7?^1>U+_KUE_] -:%9^N_\B]J7_7K+_Z :J'Q(SK?PY>C
M/$J^B:^=J^B:]',OL_/]#Q,B_P"7GR_4****\L^@/G:O;="_Y%[3?^O6+_T
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MG-V]SX>EC,+MG[+,V#'GKANX^O/UKOO&NEZGJGAZ1='OKFUOH#YL?D2M&9<
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M HHHH **** "BBB@ HHHH **** "BBB@ K \7_\ ()B_Z[C_ -!:M^L#Q?\
M\@F+_KN/_06KFQG\"7H9U?@9A>%O^1DM/^!_^@-7I%>;^%O^1DM/^!_^@-7I
M%<V6?P7Z_HB,-\ 4445Z)T!1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110!\[5[;H7_(O:;_ ->L7_H KQ*O;="_Y%[3?^O6+_T
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M/_1;5[/7C'@3_D<[#_MI_P"BVKV>M\P_BKT_S.3)/]W?K^B"BBBN ]@****
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M /037?USY7_!?K^B,L-\ 4445Z1T!1110 4444 %%%% !1110 4444 %%%%
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MYK(_XD_0T****\H^D"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "L_
M7?\ D7M2_P"O67_T UH5GZ[_ ,B]J7_7K+_Z :J'Q(SK?PY>C/$J^B:^=J^B
M:]',OL_/]#Q,B_Y>?+]0HHHKRSZ ^=J]MT+_ )%[3?\ KUB_] %>)5[;H7_(
MO:;_ ->L7_H KULQ^&)\UD?\2?H:%%%%>4?2!1110 4444 %%%% !1110 44
M44 %%%% !1110 445S7CGQ#=^&?#;:C91P23"5$VS*2N#GT(II7=D*4E%79T
MM%>.:7\9[P&X;5K&V<+'^XCM59"SY_B9F.%QGMFL"]^*_BNYG,D%W#:)VCA@
M1@/Q<,?UK54)F#Q5-*Y]!45YIX$^)LFN:@FDZQ'%'=2?ZB>,;5<C)VD=CZ>O
M3Z]3X[U2\T;P9J&H:?-Y-U%Y>Q]H;&9%4\$$=":AP:ERLT56,H<Z.BHKYU_X
M6?XQ_P"@Q_Y+0_\ Q%'_  L_QC_T&/\ R6A_^(K3ZO(Q^N0[,^BJ*^=?^%G^
M,?\ H,?^2T/_ ,17O/A^ZFOO#>EW=P^^>>SBED; &YF0$G X')J)TW#<TI5X
MU'9&C7A'Q2\7?VSJW]E64VZPLV^8J?EEE[GZ#D#\37H'Q*\7?\(YHGV2TEVZ
ME> K&5/,2?Q/[>@]^>U>(:?HESJ&F:CJ$>%MK"-7E8]RS !1[]_H*UHP^TS#
M$U&_W<3H?A7_ ,C_ &7_ %SE_P#0#7T+7SU\*_\ D?[+_KG+_P"@&OH6IQ'Q
M%X3^'\PHHHK Z@HHHH **** "BBB@ HHHH **** "BBB@ HHHH *Y#XC?\B]
M;_\ 7TO_ * ]=?7(?$;_ )%ZW_Z^E_\ 0'K?#?QHG'F'^[3]#D_ G_(YV'_;
M3_T6U>SUXQX$_P"1SL/^VG_HMJ]GK?,/XJ]/\SDR3_=WZ_H@HHHK@/8"BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH *\'\0?\C)JG_7W+_Z&:]XKP?Q!_P C)JG_ %]R_P#H9KT<N^*1X>>?PX>I
MZ;X*_P"11L?^VG_HQJWZP/!7_(HV/_;3_P!&-6_7)7_BR]6>GA/]WI^B_(**
M**R.@**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /,?B-_R,-O
M_P!>J_\ H;UK?"S_ )BW_;'_ -GK)^(W_(PV_P#UZK_Z&]:WPL_YBW_;'_V>
MO5G_ +G]WYGS=+_D:_-_DST2BBBO)/I0HHHH *YOQM_R!H?^OA?_ $%JZ2N;
M\;?\@:'_ *^%_P#06KFQ?\"7H9U?@9S'AO\ Y#]M_P #_P#037?UP'AO_D/V
MW_ __037?USY7_!?K^B,L-\ 4445Z1T!1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %1SSQ6UO)<3R+'#$A=W8X"J!DD_A4E>6_&379;:QL]%@<K
M]IS-.0<90'"K]"<G_@(JH1YI6(J3Y(N1!K_QD\F[>#0[**:-"1Y]SG#^A500
M<=>I_*J>F?&F]%R@U;3;=H"?G:URK >P9B"?Q%8GP]\"+XKEFN[V5X].MVV$
M1\-(^,[0<8  QGOR/7(]'U'X3^&+NT:.SMY;&;^&5)7?!]PQ.?TK>7LH^ZT<
MD?;S7.F>1^/-2M=7\9WU_92B6VG6%D8?]<D!'L001^%>X^ ?^1$T?_KA_4U\
M\:MID^C:M=:=<X\ZWD*,5Z''0CV(Y_&OH;P$P7P%I+,0%%ODD]!R:=96@DA8
M9MU)-DOBKQAIOA.T62[8R7$G^JMXS\[^I]A[FO,9?C1KAFS#IVGI%_=<.S?F
M&'\JXWQ)K-QXE\1W5^^YC-)MAC'.U!PJ@?3\R2>]>M^'OA)HUKIZ'6XVO;QQ
MEP)61$/HNT@GZG]*7)"FO>W'[2I5DU#1(K:=\8[.?3;E[NQ\F^AC+QQB3$<Q
M'\(;&5./4'I5GPQ\4_\ A)/$5KI/]C?9_M&_][]JW[=J,W38,_=QUKF_B#\-
MK71=-?6-'9UMHR/.MW;=L!. 5)YQD@8.?7-<]\,/^2B:5_VV_P#13T^2FXN2
M#VM6-10DSTWQA\1Y?"6M"PDT7[0CQ++'-]JV;@<@\;#C!!'6NC\*^(HO%.@Q
M:G%%Y+,S))#NW;&!Z9P,\8/3O7,?%S0O[1\,+J48'GZ>^YO4QM@$?@=I^@-<
ME\'-;^R:[<:/(,I>IOC/HZ G'XKG_OD5')&5/F6YI[24:W+)Z,]M9@JEF("@
M9)/05Y7/\9U%_);6F@M<IYICB=;K!E&<*0NP\GCCGK70?$_Q!_8GA22"*3;=
MWQ\F/#8(7^-ORX^K"O.?A3X>.J^)EU":/=:Z?B3)!P9/X/R/S?@**<(\KE(*
MM27.H09[!KWB:T\-:(NH:HI1VPH@B.YF<C.T'C..>>.GX5Y=<_&G6&N-UKIE
MC'#_ ')=[M_WT"H_2M#XVVUP?['N@K&V7S(RW.%<[2 ?<@'_ +Y/I7/^!+/P
M3J5C-9^(',6I.Y$4LDK1H%V\;2#MR#G[W7(Z]*J$(J',U<BK4FZG)%V/1?!W
MQ)L/$\XL;B'[%J!'RH7W)+QSM/'/7@]NYYKMZX+PE\,K/PYK$VHW$XO)$<_8
MP5QY:_WF]6[>@Z]3QWM8SY;^Z=-+GY??W"BBBH- HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "L#Q?_ ,@F+_KN/_06K?K \7_\@F+_ *[C_P!!
M:N;&?P)>AG5^!F%X6_Y&2T_X'_Z U>D5YOX6_P"1DM/^!_\ H#5Z17-EG\%^
MOZ(C#? %%%%>B= 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M $ 5XE7MNA?\B]IO_7K%_P"@"O6S'X8GS61_Q)^AH4445Y1](%%%% !1110
M4444 %%%% !1110 4444 %%%% !7"?%S_D1G_P"OB/\ K7=UPGQ<_P"1&?\
MZ^(_ZU=/XT9UOX;/)_ OAM/%'B>*RG)%M&AFGVG!* @8_$D#\:]GUKP%X?O-
M!N+6VTFU@G6!A!+%%AU8#Y22.6Y ZYS7GOP7 _X2:_.!D69&?^!K7MU:UIM3
MT,,-3BZ>JW/E;0IC;^(--G!(,=U$X('HX-?3&NW.E6>BW$^MK$VG+M\T2Q>:
MO+ +E<'/S8[5\Q:9_P A:S_Z[I_Z$*^D?&.BW/B'PI>Z7:/$D\^S:TI(4;75
MCG )Z ]JJO;F5R,*WR2L<O\ \))\+/\ GAI?_@J;_P"-T?\ "2?"S_GAI?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH *\'\0?\C)JG_7W+_Z&:]XKP?Q!_R,FJ?]?<O_ *&:]'+O
MBD>'GG\.'J>F^"O^11L?^VG_ *,:M^L#P5_R*-C_ -M/_1C5OUR5_P"++U9Z
M>$_W>GZ+\@HHHK(Z HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH \Q^(W_ ",-O_UZK_Z&]:WPL_YBW_;'_P!GK)^(W_(PV_\ UZK_ .AO6M\+
M/^8M_P!L?_9Z]6?^Y_=^9\W2_P"1K\W^3/1****\D^E"BBB@ KF_&W_(&A_Z
M^%_]!:NDKF_&W_(&A_Z^%_\ 06KFQ?\  EZ&=7X&<QX;_P"0_;?\#_\ 037?
MUP'AO_D/VW_ _P#T$UW]<^5_P7Z_HC+#? %%%%>D= 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !7BGQJC8>(-.E(^5K4J/J'.?YBO:ZY/X@>$C
MXJT();A1?VQ,EN6. V?O(3VS@?B!VS6E*2C*[,:\'.#2,CX.W=O-X2FM8V'G
MP7+&5>^& VGZ'!'_  $UZ'7R[IVJ:QX3UAY;5Y;.\CS'+&Z]1W5E/7_)KH[_
M .+/B>]M/LZ26MH2,-+;Q$.1C'5B<?48-:SHMRNC"EB8QARRW12^)5U!=^/M
M2>W8,J%(V8?WU0*P_ C'X5[)X)C,WPZTV)2 SVI49Z<YKYVO+2YLKIH+R)XI
M\*[(_P!X!E##/U!!KZ-\ _\ (B:/_P!</ZFG65H)$X9\U239\]Z)<16/B+3K
MBZ!\F"[B>4$?PJX)X/L*^ID=9$5T8,C#*LIR"/45X1\2O!4^C:K-JME"6TVY
M<NVP9\ESR01V4G./RK.T#XD>(/#]DEG!)!<VR#$<=RA;8/8@@_AG%.<?:)2B
M*E/V$G&9[+\0+F"V\"ZJ9V #P^6@/=F. !^/\LUXU\,/^2B:5_VV_P#13U4U
MGQ#XA\9%WNW:6"T0RF.)-L<0X!8_XDGK@>E6_AA_R432O^VW_HIZ<8<E-IBG
M4]I5BUL?0UQ;Q7=M+;3H)(9D,<B'HRD8(_*OF.\M[OPEXK:+.+G3[D,C=C@A
ME/(Z$8/XU]05X[\9]%6.YL=;C"#S1]GF P"6&2I]^,C/; K*A*SL^IOBH7CS
M+H<CX\\4CQ5KJW,(9;2&)4A1NW=C]<\?@*]J\!>'_P#A'?"EK;R)MNYAY]QD
M8(=OX3]!@?@:\:^'/A_^WO%D E0M:VG[^8X.#@_*,^YQ^ -?1=.LTDH(G#1<
MFZDBIJ>F6>L:?-8WT*S6\HPRG^8/8CUKQSQ+\(M0L/,N=$E^VVXRWD-Q*H]!
MV?\ 0^@-;WQ?U?6;.TMK.T26+3IUS/<(#\S9XC+=N!G'?\#7&V/Q5\465D;8
MSP7)QA9;B/<Z_B",_CFBG&:5XL*\Z3ERS7S)OAYXUO\ 1=9M-*NKAGTR:01&
M.4_ZEF. 5)^Z,]1TY/>O?*^;/!FB7?B3Q7;!4=XHYEGNI1T50<G)]3T'_P!:
MOI.E724M"L(Y.+OL%%%%8'4%%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 5@>+_^03%_UW'_ *"U;]8'B_\ Y!,7_7<?^@M7-C/X$O0SJ_ S"\+?
M\C):?\#_ /0&KTBO-_"W_(R6G_ __0&KTBN;+/X+]?T1&&^ ****]$Z HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** /G:O;="_Y%[3?^O6+_ - %>)5[;H7_ "+VF_\ 7K%_Z *];,?AB?-9
M'_$GZ&A1117E'T@4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5GZ[_
M ,B]J7_7K+_Z :T*S]=_Y%[4O^O67_T U4/B1G6_AR]&>)5]$U\[5]$UZ.9?
M9^?Z'B9%_P O/E^H4445Y9] ?.U>VZ%_R+VF_P#7K%_Z *\2KVW0O^1>TW_K
MUB_] %>MF/PQ/FLC_B3]#0HHHKRCZ0**** "BBB@ HHHH **** "BBB@ HHH
MH **** "N$^+G_(C/_U\1_UKNZ*<79W)G'FBXGB/P6_Y&6__ .O,_P#H:U[=
M1153GS.Y-*G[./*?*.F?\A:S_P"NZ?\ H0KZNHHIU*G/T)HT?97UN%%%%9FP
M4444 %<M\1O^1 U;_KFG_H:UU-%-.SN*2YDT?/7PK_Y'^R_ZYR_^@&OH6BBJ
MJ3YW<SHT_9QM<****@U"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KD/
MB-_R+UO_ -?2_P#H#UU]<A\1O^1>M_\ KZ7_ - >M\-_&B<>8?[M/T.3\"?\
MCG8?]M/_ $6U>SUXQX$_Y'.P_P"VG_HMJ]GK?,/XJ]/\SDR3_=WZ_H@HHHK@
M/8"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH *\'\0?\C)JG_7W+_P"AFO>*\'\0?\C)JG_7W+_Z&:]'+OBD>'GG
M\.'J>F^"O^11L?\ MI_Z,:M^L#P5_P BC8_]M/\ T8U;]<E?^++U9Z>$_P!W
MI^B_(****R.@**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /,?
MB-_R,-O_ ->J_P#H;UK?"S_F+?\ ;'_V>LGXC?\ (PV__7JO_H;UK?"S_F+?
M]L?_ &>O5G_N?W?F?-TO^1K\W^3/1****\D^E"BBB@ KF_&W_(&A_P"OA?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@#YVKVW0O\ D7M-_P"O6+_T 5XF
MRE6*G@@X->UZ"P;P[II!R/LL8_\ '17K9C\,3YK(_P")/T-&BBBO*/I HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M]NZ1_P!!6Q_\"$_QH_MW2/\ H*V/_@0G^->)44?V='^8/[<J?R(]M_MW2/\
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MT%;'_P "$_QH_MW2/^@K8_\ @0G^->)44?V='^8/[<J?R(]M_MW2/^@K8_\
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M *"MC_X$)_C7B5%']G1_F#^W*G\B/;?[=TC_ *"MC_X$)_C1_;ND?]!6Q_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M11_9T?Y@_MRI_(CVW^W=(_Z"MC_X$)_C1_;ND?\ 05L?_ A/\:\2HH_LZ/\
M,']N5/Y$>V_V[I'_ $%;'_P(3_&C^W=(_P"@K8_^!"?XUXE11_9T?Y@_MRI_
M(CVW^W=(_P"@K8_^!"?XT?V[I'_05L?_  (3_&O$J*/[.C_,']N5/Y$>V_V[
MI'_05L?_  (3_&C^W=(_Z"MC_P"!"?XUXE11_9T?Y@_MRI_(CVW^W=(_Z"MC
M_P"!"?XT?V[I'_05L?\ P(3_ !KQ*BC^SH_S!_;E3^1'MO\ ;ND?]!6Q_P#
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MZU_S]C_O\U']@ZU_S]C_ +_-18.9]CKJ*Y'^P=:_Y^Q_W^:C^P=:_P"?L?\
M?YJ+!S/L==17(_V#K7_/V/\ O\U']@ZU_P _8_[_ #46#F?8ZZBN1_L'6O\
MG['_ '^:C^P=:_Y^Q_W^:BP<S['745R/]@ZU_P _8_[_ #4?V#K7_/V/^_S4
M6#F?8ZZBN1_L'6O^?L?]_FH_L'6O^?L?]_FHL',^QUU%<C_8.M?\_8_[_-1_
M8.M?\_8_[_-18.9]CKJ*Y'^P=:_Y^Q_W^:C^P=:_Y^Q_W^:BP<S['745R/\
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MR/\ 8.M?\_8_[_-1_8.M?\_8_P"_S46#F?8ZZBN1_L'6O^?L?]_FH_L'6O\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
:%%% !1110 4444 %%%% !1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>img268224062_11.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img268224062_11.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" =4$,D# 2(  A$! Q$!_\0
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M%%% !
M1112 2E'6DH'6F ZBBB@ I:2EI %**2@4 +0:*0T ***04M !2TE+0 4444
M+1110 4444#"BBBF 4444A!3J;3J "BB@4 +110:0"4M)2TQA1110 M%%% A
M110**0!1110,****8 *6D%+0 4M)2T@"BBB@!:***8PHHHI %%%% #J*** "
MEI*6@ HHHH ****!A2TE+0 4444 +1112$***04M PHHHH ****8"T444A!2
MTE+0 4444P"BBB@84M)2T@"BBB@!:***8@HHHI#"BBB@!:***8!3J;WIU(!*
M44AI10 4444@%%%(*6F,*!10* %HHHH 6BBBD 4444 %%%%,!110**0PI:2E
MH$%%%% "T444 %%%% PI1UI*!UH =1110 4444""E%)0* %HHHH&%%%%, H%
M% I +1112 6BBBF 4444 %%%% "T444@"G4VG4P"BB@T %%%%(84M)2TP"BB
MB@!:***0!1110,*44E H 6BBBF "EI!2T@"EI*6@ HHHH 6BBB@ HHHH ***
M*0#J***8!1110 4444 %%%%(!1UI::.M.I@%%%)WH 6BBBD HHI!2T#"BBB@
M04444  I:04M !2TE+0 4444#"BBB@ IU-IU !1110 M!HH- "4M)2T %%%%
M(!:***8!2TE+0 4444@%HHHH ****8PI124HZT +1112$%%%% PI:2EH ***
M*!!1110 4ZFTZ@ H-%!H&%%%% !1110 4HZTE ZT .HHHH **** "E%)0* %
MHHHH !2T@I: "@44"D M%%% !1110,*44E** "BBB@!:*** "EI*6@ HHHH
M6BBB@ I:2EH **** %HHHH 2EI*6@84HI*44 %%%% !2T@I:!!1110,****
M%HHHH *44E** "BBB@!:*** $I:2EI %%%%,!:*** "EI*6@ HHHH **** %
M%% HH&% HH% "T444@ 4M(*6@ I:2EI@%%%%(!110** "E%)2B@ HHHH ***
M*!A2TE+2 **** %HHHI@%+24M "4444 +1110 HHH%%( H%% H 6BBB@ [T4
M=Z*8!2TE+0 4444ABBB@44 %+24M !24M)0 M%%% !2TE+0 4444 +1110 4
MM)2T#"BBB@!:***  4M(*6D 4"B@4 %%%%,!:*** "E%)2BD 4444 ***!10
M E+24M, HHHI +1110 4M)2T %%%% !1110,*6DI: "E%)2B@ HHHH !2T@I
M: $HHHH 6BBB@!:***0!2BDI10 4444 +1113 *6DI:0!1110 M%%% !2TE+
M0 AHH-% "T444 %+24M !0**!0 M%%% 'IU%%%<YV!1110 4444 %<=\5/\
MDF^K?]L?_1R5V-<=\5/^2;ZM_P!L?_1R54/B1G5^"7HSYLHHHKTCQPHHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@!:*** "BBBD E ZT4#K3 =1
M110 4M)2T@"@44"@!:0TM(:  4M(*6@ I:2EH **** %HHHH ****!A1113
M****0@IU-IU !0**!0 M!HH-(!*6DI:8PHHHH 6BBB@0HHH%%( HHHH&%%%%
M, %+2"EH *6DI:0!1110 M%%%,84444@"BBB@!U%%% !2TE+0 4444 %%%%
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M110 4444A@.M.IHZTZF(*3O2TG>@!:***0 *6D%+0,****!!1110 "EI!2T
M%+24M !1110,**** "G4VG4 %%%% "T&B@T )2TE+0 4444@%HHHI@%+24M
M!1112 6BBB@ HHHIC"E'6DI1UH 6BBBD(****!A2TE+0 4444""BBB@ IU-I
MU !0:*#0,**** "BBB@ H'6B@=: '4444 %%%% !0**!0 M%%%  *6D%+0 4
M"B@4@%HHHH ****!A2BDI10 4444 +1110 4M)2T %%%% "T444 %+24M !1
M110 M%%% "4M)2T#"E%)2B@ HHHH !2T@I:!!1110,**** %HHHH *44E**
M"BBB@!:*** $I:2EI %%%%,!:*** "EI*6@ HHHH **** %%% HH&% HH% "
MT444@ 4M(*6@ I:2EI@%%%%(!110** "E%)2B@ HHHH ****!A2TE+2 ****
M %HHHI@%+24M "4444 +1110 HHH%%( H%% H 6BBB@ [T4=Z*8!2TE+0 44
M44ABBB@44 %+24M !24M)0 M%%% !2TE+0 4444 +1110 4M)2T#"BBB@!:*
M**  4M(*6D 4"B@4 %%%%,!:*** "E%)2BD 4444 ***!10 E+24M, HHHI
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M** "BBBF,*4=:2E'6@!:***0@HHHH&%+24M !1110(**** "G4VG4 %!HH-
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M%%%  *6D%+0 4M)2T %%%% PHHHH *=3:=0 4444 +0:*#0 E+24M !1112
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M 2BBB@!:*** %HHHI %**2E% !1110 M%%%, I:2EI %%%% "T444 %+24M
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M% "BB@44@"@44"@!:*** #O11WHI@%+24M !1112&***!10 4M)2T %)2TE
M"T444 %+24M !1110 M%%% !2TE+0,**** %HHHH !2T@I:0!0**!0 4444P
M%HHHH *44E**0!1110 HHH%% "4M)2TP"BBBD M%%% !2TE+0 4444 %%%%
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MH**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M?A=_R+-S_P!?C?\ H"5M>,?^10U+_KE_45BZC4K'4J,7#F/"Z***V.4****
M 4M(*6@ I:2EH ****!A6W8>$=<U.RCO+.Q\VWDSM?S47."0>"P/4&L2O:_
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M^@*\\^*7D^5IN<>?NDQZ[>,_KBIA4;E9E5*,8QNCSBBBBMSE"EI*6@ HHHI
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M 2BBB@!:*** %HHHI %**2E% !1110 M%%%, I:2EI %%%% "T444 %+24M
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M]MXY[2SC^Y*FY6D;@<'@X )_*E*2BKLN$'.2BCSRBOJS_A%_#_\ T ]-_P#
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MKT7PEX M["**^U:-9KPC<L+<I%]1_$WZ#MTS7=@8&!TJ)5K:(N&';5Y'AK^
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M^9?0'U'M[]CS7B>HV%QI>H3V-TH6:%MK8Z'T(]B,'\:UA-2.>I2<#U'X7?\
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M646=1M4RP7K+&.H^HZC\1Z5X/793FIJYYE6DZ<K"BB@459D%>W?!;_D6K_\
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M_H"5T<]H7.-4[U'$\FHKZ.IDO^I?_=-1[;R-?JWF?.E>U^ O^1+T_P#[:?\
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M\N+I]T?XG)_&LJK@K(RJ2YI!2BDI15D!1110 4444#"EI*6D 4444 +1113
M*6DI: $HHHH 6BBB@!110**0!0**!0 M%%% !WHH[T4P"EI*6@ HHHI#%%%
MHH *6DI: "DI:2@!:*** "EI*6@ HHHH 6BBB@ I:2EH&%%%% "T444  I:0
M4M( H%% H ****8"T444 %**2E%( HHHH 444"B@!*6DI:8!1112 6BBB@ I
M:2EH **** "BBB@84M)2T %**2E% !1110 "EI!2T )1110 M%%% "T444@"
ME%)2B@ HHHH 6BBBF 4M)2T@"BBB@!:*** "EI*6@!#10:* %HHHH *6DI:
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M%J"+F2QE!)_V&X/Z[:YZ,K2.O$PYH7['A0HH%%=IY85[=\%O^1:O_P#K\/\
MZ M>(U[=\%O^1:O_ /K\/_H"UC6^ Z<+_$/2Z^9?''_(\:S_ -?3U]-5\R^.
M/^1XUG_KZ>L\/\3.C%_"C %+2"EKK//"EI*6D!<TG4I](U:UU"W;$MO(''OZ
MCZ$9'XU]3P3+<6\<R?=D0./H1FODROJ/PW_R*VD?]>4/_H KFQ"V9VX-[HEU
MRT2^T&_M9%W++;NN .?NGI[U\L=*^M6^Z?I7R;-_KY/]X_SIX=[CQBV8RBBB
MN@X@HHHH =1110 4M)2T %%%% !1110,ZWX9_P#)0M+_ .VO_HIZ^AJ^>?AG
M_P E"TO_ +:_^BGKZ&KDK_$>AA?@?J?.7Q!_Y'S5O^NH_P#05KFJZ7X@_P#(
M^:M_UU'_ *"M<U73#X4<53XV+1113,SZ4\%_\B7H_P#UZI_*N7^,?_(L67_7
MZ/\ T!ZZCP7_ ,B7H_\ UZI_*N7^,?\ R+%E_P!?H_\ 0'KCA_$/3G_!^1XI
M7;?"K_D>8/\ KC)_*N)KMOA5_P CS!_UQD_E73/X6<-+XT>]5\T:O<R67C2_
MNHL&2#49)%STRLA(_E7TO7S%XC_Y&?5O^OV;_P!#-8X?=G5B]D?2UG=PW]C!
M>6[;H9XUD1L'E2,CK7FOQ9\+SW2Q:_:(\AAC\NY11G:@)(?UXR0?;![&JWPO
M\:Q01+H&IS[!N_T.5^@SUC)^O(SZD>@KUJL]:<C1<M:F?*%7M(TF\UO4H;"Q
MB,DTAQT.$&>68CH!W->_W_@7PSJ5P9[G2(3(Q)9HV:/<3U)VD9-:NG:1IVDP
MF+3[*"V0]?*0 M]3U/XUJZZMHC!81WU>@NDZ=%I&DVFGPG*6\2QAB,;L#D_B
M>?QKA_C%_P BQ9?]?@_] >O08I8YXUDB=71NC*<@UY]\8O\ D6++_K\'_H#U
ME3^-'16TINQXU;6T]Y<QVUM$TLTC!41!DL:T=;T#4_#.H"WOHC&_WHI4)V/C
M'*M[<>XKT;X/V>DM:W5V"KZLKE6#CF./ P5]B<Y/X?7TJ\L;34;<V][;17$)
MY*2H&&?7![UO.MRRM8YJ>'YH7OJ>2^ _B%JAU6UTC4W>]AN'$4<K<R1D],G&
M6&<9ST]:]BK#TSP?X?T>\-W8Z9%%<$Y$A+,5Z_=W$[>IZ8K1U/4;;2=-GO[N
M01PPH68D]?0#W)X K";4G[J.JG&4(^^SPF2>'PO\3I)HPB6UM?MD!3A(V/(
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MEB/=CR?Q-7HY8Y=WENK;6*MM.<$=12J5.;1%4:/L]7N<M\2O^1$O_P#>B_\
M1BUY1X"_Y'C2_P#KH?\ T$UZO\2O^1$O_P#>B_\ 1BUY1X"_Y'C2_P#KH?\
MT$UI2_ALQK?QH_(^@Z\ ^(7_ "/6I_[R?^BUKW^O /B%_P CUJ?^\G_HM:BA
M\1IBO@1S->X?"W_D3%_Z^)/Z5X?7N'PM_P"1,7_KXD_I6M;X3'#?&6?B3_R(
MM]_O1?\ HQ:X3X4:FMIXDFL790MY#A<@Y+KR!Z=-W7_]?=_$G_D1;[_>B_\
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MI_Z ];O@C_D2]+_ZX_U-87Q9_P"15M?^OU/_ $!ZXX_Q#OE_!^1XY74?#O\
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M5-VL)T&HW<CPZ[U&^U H;V]N+DIG;YTK/MSUQD\=*]]\.:DNK>'K&]# M)$
M^ 0 XX8<^X-?/+$,Y(4*"<X'05W'P^\6IHURVG7\NVQG;*.W2)_?T4]_3 ]S
M5U87CH9T*G++7J==\1?#DVLZ5%=VB/)=6>X^6O)=#C.!W(P"/Q]J\9KZ9!#*
M&4@@C(([UCZEX4T+5IC->Z=%)*3EI%)1F/3DJ1G\:SIU>569O5H<[YD>"6UM
M/>7,=O;1/+-(<*B#))KWWPSHW]@Z!;6!8-*H+2LO0N3DX]AT^@J?3=#TO2%V
MV%C# <8+*N6(]V/)_.KR2))NV.K;6*G!S@CJ*52IS:(=*CR:O<YCXB?\B3>_
M[T?_ *&M>'U[A\1/^1)O?]Z/_P!#6O#ZUH_"88GXPH%>V>$_"]I#X/@M=1LX
MI7N?W\JNN2"W0<\@A0OXYKS7QGI>EZ/KSV6F/*P1095<Y",1G:#WXY_&JC44
MG8F=)QBI,YZBBBM#(FM;A[2[AN8\;X761<],@Y%?1EK<Q7MG#=0-NBF19$/J
M",BOFT5Z5\._%T<,8T349MHW?Z+(_09ZH3]>GU(]!6-:-U='1AYJ+L^I8^)O
MAV:Y6/6K5'<Q)Y=PB\X09(?\,G/MCT->7U]+5A7O@WP]?SF:XTR(R$DDQLT>
M2>I.TC-9PJV5F:5*',[Q/$M,TRZU?4(K*SC+RR''0X4=V/H!ZU] :981Z9IE
MM8Q'*01A V,;L#D_CUI+'3+'3(C'8VD-NIZ^6@!/U/?\:LQR)-&)(W5T/1E.
M0:FI4YBZ5+D]3A_BI_R+UI_U]C_T!JQ?A7J0BU"\TYSQ,@E3ZKP1^1_2MKXJ
M?\B]:?\ 7V/_ $!J\KLKR?3[V&[MG*30N'0^X_I6L(\U.QC4ERU;GT5<01W5
MM+;RKNCE0HX]01@UX#KNAW>@:D]G=*>.8Y .)%[$?X=J]H\-^);/Q'8++"RI
M<J/WT!/S(?ZKZ'^O%:%]IUEJ<'DWUK%<1@Y D7.#ZCT-90DX.S-JD%55T?.E
M>B?#;PU,;Q=<NHRD**1;ANKD\%OH!D?C[5V<'@KPY;3F9-*A+'/$A9U_[Y8D
M?I6Z %4   #@ =JJ=6ZLB*=#E=Y#998X(GEE=4C12S,QP% Y))KY\U>_.J:Q
M>7QW8GE9U#=0N>!^ P*[WQ_XPB:&31=.EW%CBYF1N /[@/?W_+UQYK5T8V5V
M9XB:D^5'T!X<N/M7AK3)B<EK:/<?4A0#^H-<K\4M.>?2K2_121;2%7QV5\<G
M\0!^-5/AKXDB6 Z)=RA6#%K4MT.>2GUSR/7)KT=E5T9'4,K#!!&0163O"9NK
M5*=CYMKU?X7Z;+;:5=WLJ.@NG4(&&-RJ#R/Q8_E6ZO@KPXMU]H&E1;\YP68I
M_P!\YV_I6\JJB*B*%51@ #  JIU5)61%*@XRNS)\4S+!X5U1W8*#;.F2<<L-
MH_4UX'7I/Q*\21N@T.U?<0P>Y8$$#'1/KG!/X>]>;5=)6B98B2<K+H?2=<-\
M1O#TVI6<6I6B!Y;52)4"_,R=<CZ<\>Y_'N:9YL?G>3O7S=N[9GG'3./2L(R<
M7='9.*DK,^<:L6-A<ZG>Q6EI$TDTA  49Q[GT [FO<+[PGH.HR&2YTR$N6+,
MR9C+$]22I&:N:?I&G:4K"QLX8-WWBB\M]3U-;.LK:(Y5AG?5D>A:6FBZ+:Z>
MIW&)/F;U8\L?IDFN6^)^HB#1;>P4C?<R[B/]E>?YD?K77ZEJ5KI-C)>7DHCA
M0=>Y/8 =S7B'B/7IO$.K27D@*1CY8HLYV+_B>IJ*<7*5V:5I*,.5'HGPN_Y%
MFY_Z_&_] 2MKQC_R*&I?]<OZBL7X7?\ (LW/_7XW_H"5M>,?^10U+_KE_44I
M?Q"H_P +Y'F_PZU 67BE(G)"74;0]>,\,/Y8_&O8I$\R-D+,NX$94X(^AKYT
MBE>"9)HF*R1L&5AU!'(->T^$O%D'B*T\N3;'?Q+^]B_O#^\OM_+\B;JQ^T9X
M>:MRL\WUR?Q+H.HO:76K:CZQR"Y?$B]B.?\ ]59O_"0ZW_T&-0_\"7_QKW>Z
ML[6^A,-W;Q3QG^&1 P_6L8>"/#@G$PTN/<.Q=RO_ 'SG'Z4*JK:H)4)7]UGE
MEA?>*=4E:.QOM5N&49;9.Y"_4YXZ5!-K>OV\S13:IJ<<J'#(]Q("#[@FO=+:
MTM[*$0VL$4$0Z)&@4?D*Y?QW?Z+;:8\=]!!<WS(1;QD NF?XL]0N?SQ0JEW:
MPI47&-^8\DNKRZO91+=W,UQ(!M#RN7./3)K1TOQ-J^C6K6^GW?DQ,YD*^6C9
M8@#.2#V K(I:WLGH<R;3NCI/^$]\2_\ 02_\@1__ !-(?'GB5@0=2X/'^HC_
M /B:YRBIY8]BO:2[A7M?@+_D2]/_ .VG_HQJ\4KVOP%_R)>G_P#;3_T8U16^
M$UPWQEOQ1HQU[09[)"@FX>)G&0&'\LC(S[UX?/!+:SO!/&T<L9VLC#!!KZ%D
MECBV>8ZIO8*NXXR3V^M4M0T/2]5YOK&&9MNW>5PP'IN'/ZUG"IRZ,VJTN?5;
MG@BJ68*H)8G  ZFO8/ ?A^71=)>>Z4I=795F0]44#Y01V/)S_P#6K6L/#6C:
M9*LMII\*2+]USEF'T+9-:C,J(7=@JJ,DDX %$ZG,K(*5'D=V9GB/4!I?AZ]N
MB1N6,JF?[S<#]37GGPQ_Y&2X_P"O-O\ T-*B\;^*UUJ=;*R8_8H6)+?\]6]?
MH.WUJ7X8_P#(R7'_ %YM_P"AI5*/+!W,Y34JJL>KUX'_ ,Q__MZ_]GKWRO _
M^8__ -O7_L]*CU*Q'0]\KRCXF_\ (RVW_7FO_H;UZO7E'Q-_Y&6V_P"O-?\
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MBB@ HHHH&%+24M !2BDI10 4444  I:04M "4444 +1110 M%%%( I124HH
M**** %HHHI@%+24M( HHHH 6BBB@ I:2EH 0T4&B@!:*** "EI*6@ H%% H
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M["IV/,**Z#Q;X1O/!]_!:7EQ!,\T7FJ82< 9(YR!Z5S]6FFKHSE%Q=F%>S_
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M;1%S.B^=#SCYUYQ^(R/QKAIRY9'IUH<]-V/F*@44"N\\D6D-+2&@ %+2"EH
M*6DI: /J+P5_R)&B?]><?_H(K7N_^/.?_KFW\JR/!7_(D:)_UYQ_^@BM>[_X
M\Y_^N;?RKSG\1[4?A1\CT445Z)XH4444#"BBBF![[\';(6_@MKC;AKFY=LYZ
M@84?J#7H-<M\.(DB\ :2$4+NC9CCN2QR:ZFO.J.\F>O25H)'SW\6[]KSQU-
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M /BZP-7\476MZU;:G>VMF\D"*@AV-Y;@,6^8%LGDGO6'10H16R!U)/1L[O\
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MN/-'/%;(?LJCT<M!-#L&TO1+.R<*'BC ?;TW=3^I-<I\3+E5LK&U_B>1I/H
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M=;IWQ!U.TC$=U''=@8 9OE;'U'7\JY 4M)Q3W*C)QV.^;XF,1\ND@'WN,_\
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MBB@ HHHI# =:=31UIU,04G>EI.] "T444@ 4M(*6@84444""BBB@ %+2"EH
M*6DI: "BBB@84444 %.IM.H **** %H-%!H 2EI*6@ HHHI +1113 *6DI:
M"BBBD M%%% !1113&%*.M)2CK0 M%%%(04444#"EI*6@!4=HW5T8JRG(8'!!
M]:ZK3OB#K-FH2<Q7: ]91AL>F1_4&N4HI-)[CC)QV/0E^*!VC=I )[D7./\
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MBBBF M%%% !2BDI12 **** %%% HH 2EI*6F 4444@%HHHH *6DI: "BBB@
MHHHH&%+24M !2BDI10 4444  I:04M "4444 +1110 M%%%( I124HH ****
M %HHHI@%+24M( HHHH 6BBB@ I:2EH 0T4&B@!:*** "EI*6@ H%% H 6BBB
M@#TZBBBN<[ HHHH **** "N.^*G_ "3?5O\ MC_Z.2NQKCOBI_R3?5O^V/\
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MXPM/AB>>>.&-2TDC!54=R3@"F5W7PHT'^V/&$=S*FZVL%\]LC(+]$'Y\_P#
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M*8PI1UI*4=: %HHHI""BBB@84M)2T %%%% @HHHH *=3:=0 4&B@T#"BBB@
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M@9\D0-N/MR-OZUY)XFUZ7Q'K<M_(GEH0$BCZ[$'09_,_C7L/_"NO"G_0*_\
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MZ5X@%S"H6"]!D"@8 <?>'Z@_C7J7A;4&U3POI]W(Y>1X@KN>K,ORD_F#7/\
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M'2/AUHU@B->(U[<#DF0D(#[*.WUS6Z/#>AA=HT>PQTYMT)_/%9.LC=8:3W/
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MHHI  I:04M !2TE+3 ****0"BB@44 %**2E% !1110 4444#"EI*6D 4444
M+1113 *6DI: $HHHH 6BBB@!110**0!0**!0 M%%% !WHH[T4P"EI*6@ HHH
MI#%%% HH *6DI: "DI:2@!:*** "EI*6@ HHHH 6BBB@ I:2EH&%%%% "T44
M4  I:04M( H%% H ****8"T444 %**2E%( HHHH 444"B@!*6DI:8!1112 6
MBBB@ I:2EH **** "BBB@84M)2T %**2E% !1110 "EI!2T )1110 M%%% "
MT444@"E%)2B@ HHHH 6BBBF 4M)2T@"BBB@!:*** "EI*6@!#10:* %HHHH
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MNVB:0CUP,X_&O.J2YY7/7I0]G!)GAWQBU[^T?%$>F1-F'3TVM_UT;!;]-H_
MUYS5B^O)M0O[B\N'+S3R-(Y/<DYJO7=&/*DCRYSYY.0E ZT4#K5D#J*** "E
MI*6D!Z%\(-=_LSQ6=/D;$&H)L_[:+RO_ +,/Q%>_U\AVMS)9W<-S"VV6%UD0
M^A!R*^KM%U2'6M%L]2@QLN(@^ <[3W'X'(_"N3$1L^8]#"3O%Q['G'QIT+S]
M.L];B7Y[=O(F/^PWW3^!S_WU7B9KZRUO3(]:T2]TV0@+<Q-&"?X21P?P.#7R
MG=6\MG=2VTZ%)8G*.IZ@@X-:4)7C8RQ<+2YNY"*6D%+6YR!2TE+0!]1>"O\
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M9_O/_P"BVHE\+"G\:/?*\ \=_P#([:I_UT'_ *"*]_KP#QW_ ,CMJG_70?\
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M+232?ZN%,;F]_8>]<)<?%/4F?-M86D:>DA9S^8(KK=8\":;K>IR7]W=WWFN
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MI*6@ HHHI +1110 4444QA2CK24HZT +1112$%%%% PI:2EH ****!!1110
M4ZFTZ@ H-%!H&%%%% !1110 4#K10.M #J*** "BBB@ H%% H 6BBB@ %+2"
MEH *!10*0"T444 %%%% PI124HH **** %HHHH *6DI: "BBB@!:*** "EI*
M6@ HHHH 6BBB@!*6DI:!A2BDI10 4444  I:04M @HHHH&%%%% "T444 %**
M2E% !1110 M%%% "4M)2T@"BBBF M%%% !2TE+0 4444 %%%% "BB@44#"@4
M4"@!:***0 *6D%+0 4M)2TP"BBBD HHH%% !2BDI10 4444 %%%% PI:2EI
M%%%% "T444P"EI*6@!**** %HHHH 444"BD 4"B@4 +1110 =Z*.]%, I:2E
MH ****0Q110** "EI*6@ I*6DH 6BBB@ I:2EH **** %HHHH *6DI:!A111
M0 M%%%  *6D%+2 *!10* "BBBF M%%% !2BDI12 **** %%% HH 2EI*6F 4
M444@%HHHH *6DI: "BBB@ HHHH&%+24M !2BDI10 4444  I:04M "4444 +
M1110 M%%%( I124HH **** %HHHI@%+24M( HHHH 6BBB@ I:2EH 0T4&B@!
M:*** "EI*6@ H%% H 6BBB@#TZBBBN<[ HHHH **** "N.^*G_)-]6_[8_\
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M#7R#7HGPT\?GP[=C3-4F8Z5,?D8\_9W)Z_[I[C\?6LJE!6O$WHXI\UIGOEQ
MMS;20.SJLBE2T;E6&?0CD&OFKQYX1O?"VM$3S27-K<$M!<N<LP[AO]H?KUKZ
M8!# $$$'D$50UO1+'Q!I<NGZA")()!_P)#V93V(K&G4Y&=-:BJD?,^2Z*Z+Q
MAX/OO"&J&WN 9+:0DV]P!\L@_HP[BN=KO335T>5*+B[,****8@HHHH ****
M"M;1_$^M: ^=,U&>!<Y,8;*$^ZG@UDT4FD]P3:U1Z9IWQKUVW"K?65I> =6
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MBZ]X;TM=.LGMVMU8LHFCW%<\D#D<9Y_&N2H%)I/1E1DXNZ9Z#_PN/Q3Z6/\
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M 4#H *56HFK(*%&49<TC*\67@L/"6JW!<(1;.JL?[S#:OZD5YW\&?^/[5O\
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M5=7\+O\ D7[O_KZ/_H"U4OX:(A_&9N^,?^11U+_KE_45X97N?C'_ )%'4O\
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M2TE+0 4444 %%%% PI:2EH *44E** "BBB@ %+2"EH 2BBB@!:*** %HHHI
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MLRGL17S/XK\,7GA36I+&Y5FB)+038P)4[$>_J.U?2G_"2Z%_T&]-_P# I/\
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MRBD%+2C%15D5.;F[LN:5/';:Q8SS-MBBN(W=L9P P)/%>P?\)]X9_P"@G_Y
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MHHHH **** "BBBD,!UIU-'6G4Q!2=Z6D[T +1112 !2T@I:!A1110(****
M4M(*6@ I:2EH ****!A1110 4ZFTZ@ HHHH 6@T4&@!*6DI: "BBBD M%%%,
M I:2EH ****0"T444 %%%%,84HZTE*.M "T444A!1110,*6DI: "BBB@0444
M4 %.IM.H *#10:!A1110 4444 % ZT4#K0 ZBBB@ HHHH *!10* %HHHH !2
MT@I: "@44"D M%%% !1110,*44E** "BBB@!:*** "EI*6@ HHHH 6BBB@ I
M:2EH **** %HHHH 2EI*6@84HI*44 %%%%  *6D%+0(****!A1110 M%%% !
M2BDI10 4444 +1110 E+24M( HHHI@+1110 4M)2T %%%% !1110 HHH%% P
MH%% H 6BBBD "EI!2T %+24M, HHHI ***!10 4HI*44 %%%% !1110,*6DI
M:0!1110 M%%%, I:2EH 2BBB@!:*** %%% HI % HH% "T444 '>BCO13 *6
MDI: "BBBD,444"B@ I:2EH *2EI* %HHHH *6DI: "BBB@!:*** "EI*6@84
M444 +1110 "EI!2T@"@44"@ HHHI@+1110 4HI*44@"BBB@!110** $I:2EI
M@%%%%(!:*** "EI*6@ HHHH ****!A2TE+0 4HI*44 %%%%  *6D%+0 E%%%
M "T444 +1112 *44E** "BBB@!:***8!2TE+2 **** %HHHH *6DI: $-%!H
MH 6BBB@ I:2EH *!10* %HHHH ].HHHKG.P**** "BBB@ KCOBI_R3?5O^V/
M_HY*[&N.^*G_ "3?5O\ MC_Z.2JA\2,ZOP2]&?-E%%%>D>.%%%% !1110 44
M44 %%%% '0:)XJN=,VPSYGM>FTGYD^A_I7H%A?VNHVXGM91(G?U4^A':O'ZL
MV-_<Z=<">UE:-QZ="/0CO7E8S*Z=;WX:2_!E1G8]A9ML;-Z FN$\43XMH(<\
MNQ8_A_\ KK4T[Q=:ZC:-#<XM[HC&"?E?Z'M]#6;K'V<7:RSD8C0 ;NGKTKSL
MNP=18Q1J*UKL=6HHPN8-K82W&&/R)ZGO]*T'FM=,CV@9?^Z/O'ZU0NM89LI;
MC8O]X]?_ *U9A)8DDDD]2:^LYXP^'<X^2=36>B[%B[OIKMOG.$'1!T%5J**Q
M;;=V;I**L@HHHH*"BBB@ HHHH **** +5I?S6APIW1]T-:X>UU./'1QVZ,*Y
MZE5F1@RD@CH15QJ-:/5&,Z2D[K1E^YL9;<DXW)_>']:Z'PO<;K%X\\Q29'T/
M/^-8=KJY "7(W#^^.OXBMS1A )Y'@(VR+SM/''\JX<THQJ863CTU*I5)1DHS
M7S.ZSD ^HS5+4M2M-+M_.NI0@_A7JS?05A:IXQM[*V6&RVSW.W!;^!#_ %-<
M+=WEQ?7#3W,K22-W8_R]*\+"97.M[U32/XLZ93ML:NM>)[K52T4>8+7_ )YJ
M>6_WC_2L.BBOHZ5&%&/)35D9-W"BBBM0"BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!:*** "BBBD E Z
MT4#K3 =1110 4M)2T@"@44"@!:0TM(:  4M(*6@ I:2EH **** %HHHH ***
M*!A1113 ****0@IU-IU !0**!0 M!HH-(!*6DI:8PHHHH 6BBB@0HHH%%( H
MHHH&%%%%, %+2"EH *6DI:0!1110 M%%%,84444@"BBB@!U%%% !2TE+0 44
M44 %%%% PI:2EH **** %HHHI" 4M(*6@84444 %%%%,!:***0@I:2EH ***
M*8!1110,*6DI:0!1110 M%%%,04444AA1110 M%%%, [TZF]Z=2 0THI#2B@
M HHHI  I:04M,84"B@4 +1110 M%%%( HHHH ****8"BB@44AA2TE+0(****
M %HHHH ****!A0.M% ZT .HHHH ****!!0**!0 M%%% PHHHI@% HH%(!:**
M*0"T444P"BBB@ HHHH 6BBBD 4ZFTZF 4&B@T %%%%(84M)2TP"BBB@!:***
M0!1110,*!10* %HHHI@ I:04M( I:2EH **** %HHHH **** "BBBD,=1113
M$%%%% !1110 4444A@.M.IHZTZF(*3O2TG>@!:***0 *6D%+0,****!!1110
M "EI!2T %+24M !1110,**** "G4VG4 %%%% "T&B@T )2TE+0 4444@%HHH
MI@%+24M !1112 6BBB@ HHHIC"E'6DI1UH 6BBBD(****!A2TE+0 4444""B
MBB@ IU-IU !0:*#0,**** "BBB@ H'6B@=: '4444 %%%% !0**!0 M%%%
M*6D%+0 4"B@4@%HHHH ****!A2BDI10 4444 +1110 4M)2T %%%% "T444
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MB@44AA2TE+0(**** %HHHH ****!A0.M% ZT .HHHH ****!!0**!0 M%%%
MPHHHI@% HH%(!:***0"T444P"BBB@ HHHH 6BBBD 4ZFTZF 4&B@T %%%%(8
M4M)2TP"BBB@!:***0!1110,*!10* %HHHI@ I:04M( I:2EH **** %HHHH
M**** "BBBD,=1113$%%%% !1110 4444A@.M.IHZTZF(*3O2TG>@!:***0 *
M6D%+0,****!!1110 "EI!2T %+24M !1110,**** "G4VG4 %%%% "T&B@T
M)2TE+0 4444@%HHHI@%+24M !1112 6BBB@ HHHIC"E'6DI1UH 6BBBD(***
M*!A2TE+0 4444""BBB@ IU-IU !0:*#0,**** "BBB@ H'6B@=: '4444 %%
M%% !0**!0 M%%%  *6D%+0 4"B@4@%HHHH ****!A2BDI10 4444 +1110 4
MM)2T %%%% "T444 %+24M !1110 M%%% "4M)2T#"E%)2B@ HHHH !2T@I:!
M!1110,**** %HHHH *44E** "BBB@!:*** $I:2EI %%%%,!:*** "EI*6@
MHHHH **** %%% HH&% HH% "T444@ 4M(*6@ I:2EI@%%%%(!110** "E%)2
MB@ HHHH ****!A2TE+2 **** %HHHI@%+24M "4444 +1110 HHH%%( H%%
MH 6BBB@ [T4=Z*8!2TE+0 4444ABBB@44 %+24M !24M)0 M%%% !2TE+0 4
M444 +1110 4M)2T#"BBB@!:***  4M(*6D 4"B@4 %%%%,!:*** "E%)2BD
M4444 ***!10 E+24M, HHHI +1110 4M)2T %%%% !1110,*6DI: "E%)2B@
M HHHH !2T@I: $HHHH 6BBB@!:***0!2BDI10 4444 +1113 *6DI:0!1110
M M%%% !2TE+0 AHH-% "T444 %+24M !0**!0 M%%% 'IU%%%<YV!1110 44
M44 %<=\5/^2;ZM_VQ_\ 1R5V-<=\5/\ DF^K?]L?_1R54/B1G5^"7HSYLHHH
MKTCQPHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!:*** "BBBD
ME ZT4#K3 =1110 4M)2T@"@44"@!:0TM(:  4M(*6@ I:2EH **** %HHHH
M****!A1113 ****0@IU-IU !0**!0 M!HH-(!*6DI:8PHHHH 6BBB@0HHH%%
M( HHHH&%%%%, %+2"EH *6DI:0!1110 M%%%,84444@"BBB@!U%%% !2TE+0
M 4444 %%%% PI:2EH **** %HHHI" 4M(*6@84444 %%%%,!:***0@I:2EH
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M+24M, HHHI +1110 4M)2T %%%% !1110,*6DI: "E%)2B@ HHHH !2T@I:
M$HHHH 6BBB@!:***0!2BDI10 4444 +1113 *6DI:0!1110 M%%% !2TE+0
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M_P#A5?@O_H#?^34W_P 71_PJOP7_ - ;_P FIO\ XNCZQ$/J<^Z/FRBOI/\
MX57X+_Z W_DU-_\ %T?\*K\%_P#0&_\ )J;_ .+H^L1#ZG/NCYLHKZ3_ .%5
M^"_^@-_Y-3?_ !='_"J_!?\ T!O_ ":F_P#BZ/K$0^IS[H^;**^D_P#A5?@O
M_H#?^34W_P 71_PJOP7_ - ;_P FIO\ XNCZQ$/J<^Z/FRBOI/\ X57X+_Z
MW_DU-_\ %T?\*K\%_P#0&_\ )J;_ .+H^L1#ZG/NCYLHKZ3_ .%5^"_^@-_Y
M-3?_ !='_"J_!?\ T!O_ ":F_P#BZ/K$0^IS[H^;**^D_P#A5?@O_H#?^34W
M_P 71_PJOP7_ - ;_P FIO\ XNCZQ$/J<^Z/FRBOI/\ X57X+_Z W_DU-_\
M%T?\*K\%_P#0&_\ )J;_ .+H^L1#ZG/NCYLHKZ3_ .%5^"_^@-_Y-3?_ !='
M_"J_!?\ T!O_ ":F_P#BZ/K$0^IS[H^;**^D_P#A5?@O_H#?^34W_P 71_PJ
MOP7_ - ;_P FIO\ XNCZQ$/J<^Z/FRBOI/\ X57X+_Z W_DU-_\ %T?\*K\%
M_P#0&_\ )J;_ .+H^L1#ZG/NCYLHKZ3_ .%5^"_^@-_Y-3?_ !='_"J_!?\
MT!O_ ":F_P#BZ/K$0^IS[H^;**^D_P#A5?@O_H#?^34W_P 71_PJOP7_ - ;
M_P FIO\ XNCZQ$/J<^Z/FRBOI/\ X57X+_Z W_DU-_\ %T?\*K\%_P#0&_\
M)J;_ .+H^L1#ZG/NCYLHKZ3_ .%5^"_^@-_Y-3?_ !='_"J_!?\ T!O_ ":F
M_P#BZ/K$0^IS[H^;**^D_P#A5?@O_H#?^34W_P 71_PJOP7_ - ;_P FIO\
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M>$_^@5_Y,2__ !5'_"N/"?\ T"O_ "8E_P#BJ/;Q#ZK/NCP*BO??^%<>$_\
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M\F)?_BJ/^%=^%?\ H%?^3$O_ ,51[>(?59]T>#T"O>/^%=^%?^@5_P"3$O\
M\51_PKOPK_T"O_)B7_XJCV\0^JS[H\(HKW?_ (5WX5_Z!?\ Y,2__%4?\*[\
M*_\ 0+_\F)?_ (JE[:(?59]T>$T5[M_PKOPK_P! O_R8E_\ BJ7_ (5WX5_Z
M!?\ Y,2__%4_;Q#ZK/NCPBBO=_\ A7?A7_H%_P#DQ+_\51_PKOPK_P! O_R8
ME_\ BJ/;Q#ZK/NCPBBO=_P#A7?A7_H%_^3$O_P 51_PKSPK_ - O_P F)?\
MXJCV\0^JS[H\)HKW;_A7GA;_ *!?_DQ+_P#%4?\ "O/"W_0+_P#)B7_XJE[:
M(?59]T>$TZO=/^%>>%O^@7_Y,2__ !5'_"O?"W_0+_\ )B7_ .*I^WB'U6?=
M'A=!KW3_ (5[X6_Z!?\ Y,2__%4?\*]\+?\ 0+_\F)?_ (JCV\0^JS[H\+HK
MW3_A7OA;_H%_^3$O_P 51_PKWPM_T"__ "8E_P#BJ7MHA]6GW1X72U[G_P *
M]\+?] O_ ,F)?_BJ7_A7OA;_ *!?_DQ+_P#%4_;Q#ZM/NCPNBO=/^%>^%O\
MH%_^3$O_ ,51_P *]\+?] O_ ,F)?_BJ/;Q#ZM/NCPRBO<_^%?>%_P#H%_\
MDQ+_ /%4?\*^\+_] O\ \F)?_BJ7MHA]6GW1X917N?\ PK[PO_T"_P#R8E_^
M*H_X5]X7_P"@7_Y,2_\ Q5'MHC^K3/#*!7N?_"OO"_\ T"__ "8E_P#BJ/\
MA7WA?_H%_P#DQ+_\53]M$/JTSPVBO<O^%?>%_P#H%_\ DQ+_ /%4?\*^\+_]
M O\ \F)?_BJ/;Q#ZM,\-%+7N/_"OO"__ $"__)B7_P"*H_X5]X7_ .@9_P"3
M$O\ \51[:(?5IGAU+7N'_"OO"_\ T#/_ "8E_P#BJ/\ A7_A?_H&?^3$O_Q5
M+VT0^K3/#Z*]Q_X5_P"%_P#H&?\ DQ+_ /%4?\*_\+_] S_R8E_^*H]M$/JT
MSP^BO</^%?\ AC_H&?\ D>7_ .*H_P"%?^&/^@9_Y'E_^*H]M$/JTSP^BO</
M^%?^&/\ H&?^1Y?_ (JC_A7_ (8_Z!G_ )'E_P#BJ/;1#ZM,\/HKW#_A7_AC
M_H&?^1Y?_BJ/^%?^&/\ H&?^1Y?_ (JCVT0^K3/$:*]N_P"$ \,?] S_ ,CR
M_P#Q5'_" >&/^@9_Y'E_^*H]M$/JTSQ&BO;O^$ \,?\ 0,_\CR__ !5'_" >
M&/\ H&?^1Y?_ (JCVT0^K3/$:*]N_P"$ \,?] S_ ,CR_P#Q5'_" >&/^@9_
MY'E_^*H]M$/JTSQ&BO;O^$ \,?\ 0,_\CR__ !5'_" >&/\ H&?^1Y?_ (JC
MVT0^K3/$1UIU>V?\(!X8_P"@9_Y'D_\ BJ7_ (0'PS_T#/\ R/)_\51[:(?5
MIGB5)WKV[_A ?#/_ $#/_(\G_P 51_P@/AG_ *!G_D>3_P"*H]M$/JTSQ*BO
M;?\ A ?#/_0,_P#(\G_Q5'_" ^&?^@9_Y'D_^*H]M$/JTSQ(4M>V?\(#X9_Z
M!G_D>3_XJC_A ?#/_0,_\CR?_%4>VB'U:9XG17MG_" ^&?\ H&?^1Y/_ (JC
M_A ?#/\ T#/_ "/)_P#%4>VB'U:9XG17MG_" ^&?^@9_Y'D_^*H_X0'PS_T#
M/_(\G_Q5'MHA]6F>)BEKVO\ X0+PS_T#?_(\G_Q5'_"!>&?^@;_Y'D_^*H]M
M$/JTSQ2EKVK_ (0+PS_T#?\ R/)_\51_P@7AG_H&_P#D>3_XJCVT0^K3/%:*
M]K_X0+PU_P! W_R/)_\ %4?\(%X:_P"@;_Y'D_\ BJ/;1#ZM,\4HKVO_ (0+
MPU_T#?\ R/)_\51_P@7AK_H&_P#D>3_XJCVT0^K3/%*=7M/_  @7AK_H&_\
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M\(7X?_Z!_P#Y&D_^*H_X0OP__P! _P#\C2?_ !5'M8A["1Y+17K7_"&>'_\
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MP_\ (TG_ ,52_P#"':#_ ,^'_D9__BJ/:H/82/*:6O5?^$.T'_GP_P#(S_\
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M'_"(:%_SX_\ D5__ (JCVJ#V$CRVBO4O^$0T+_GQ_P#(K_\ Q5'_  B&A?\
M/C_Y%?\ ^*H]J@]A(\N%%>H_\(CH7_/C_P"17_\ BJ/^$1T+_GQ_\BO_ /%4
M>T0>PD>74HKU#_A$="_Y\?\ R*__ ,51_P (CH?_ #X_^17_ /BJ/:(/82/+
MZ*]0_P"$1T/_ )\?_(K_ /Q5'_"(Z'_SX_\ D5__ (JCVB#V$CR^BO4/^$1T
M/_GQ_P#(K_\ Q5'_  B.A_\ /C_Y%?\ ^*H]HA^QD>7TM>G_ /"(Z'_SX_\
MD5__ (JC_A$M#_Y\?_(K_P#Q5+VB#V,CS"BO4/\ A$M#_P"?'_R*_P#\51_P
MB6A_\^/_ )%?_&CVB#V,CS"BO3_^$2T/_GQ_\BO_ (T?\(EH?_/C_P"17_QI
M^T0>QD>84M>G?\(EH?\ SY?^17_QH_X1/1/^?+_R*_\ C1[1![&1YA17I_\
MPB6A_P#/C_Y%?_&C_A$M#_Y\O_(K_P"-'M$'L9'F-%>G?\(GHG_/E_Y%?_&C
M_A$]$_Y\O_(K_P"-'M$'L9'F0HKTW_A$]$_Y\O\ R*_^-'_")Z)_SY?^17_Q
MI>T0>QD>94"O3?\ A$]$_P"?+_R*_P#C1_PB>B?\^7_D5_\ &CVB#V,CS.BO
M3?\ A$]$_P"?+_R*_P#C1_PB>B?\^7_D5_\ &CVB#V,CS+O17IG_  B>B?\
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MX1C1_P#GS_\ (K_XT>T0>RD>=T5Z)_PC&C_\^?\ Y%?_ !H_X1C1_P#GS_\
M(K_XT>T0>QD>>45Z'_PC&C_\^?\ Y%?_ !I?^$9T?_GS_P#(K_XT>T0>QD>=
MTM>A_P#",Z/_ ,^?_D5_\:/^$9T?_GT_\B/_ (T>T0>QD>>45Z'_ ,(SH_\
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M<'17>?\ ".Z5_P ^O_D1O\:/^$=TK_GU_P#(C?XT<Z#V3.#I:[O_ (1W2O\
MGU_\B-_C1_PCNE?\^O\ Y$;_ !HYT'LF<)0*[O\ X1W2O^?7_P B-_C1_P (
M[I7_ #Z_^1&_QHYT'LF<+17=_P#"/:5_SZ_^1&_QH_X1[2O^?7_R(W^-'.@]
MDS3HHHK(W"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_P#OVG_Q='_"S-%_Y];_ /[]I_\ %T?5:W\H?VAA?YT=G17&?\+,T7_GUO\
M_OVG_P 71_PLS1?^?6__ ._:?_%T?5:W\H?VAA?YT=G17&?\+,T7_GUO_P#O
MVG_Q='_"S-%_Y];_ /[]I_\ %T?5:W\H?VAA?YT=G17&?\+,T7_GUO\ _OVG
M_P 71_PLS1?^?6__ ._:?_%T?5:W\H?VAA?YT=G17&?\+,T7_GUO_P#OVG_Q
M='_"S-%_Y];_ /[]I_\ %T?5:W\H?VAA?YT=G17&?\+,T7_GUO\ _OVG_P 7
M1_PLS1?^?6__ ._:?_%T?5:W\H?VAA?YT=G17&?\+,T7_GUO_P#OVG_Q='_"
MS-%_Y];_ /[]I_\ %T?5:W\H?VAA?YT=G17&?\+,T7_GUO\ _OVG_P 71_PL
MS1?^?6__ ._:?_%T?5:W\H?VAA?YT=G17&?\+,T7_GUO_P#OVG_Q='_"S-%_
MY];_ /[]I_\ %T?5:W\H?VAA?YT=G17&?\+,T7_GUO\ _OVG_P 71_PLS1?^
M?6__ ._:?_%T?5:W\H?VAA?YT=G17&?\+,T7_GUO_P#OVG_Q='_"S-%_Y];_
M /[]I_\ %T?5:W\H?VAA?YT=G17&?\+,T7_GUO\ _OVG_P 71_PLS1?^?6__
M ._:?_%T?5:W\H?VAA?YT=G17&?\+,T7_GUO_P#OVG_Q='_"S-%_Y];_ /[]
MI_\ %T?5:W\H?VAA?YT=G17&?\+,T7_GUO\ _OVG_P 71_PLS1?^?6__ ._:
M?_%T?5:W\H?VAA?YT=G17&?\+,T7_GUO_P#OVG_Q='_"S-%_Y];_ /[]I_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M]>HH_M"KV7]?,/[$P_=_A_D>0_\ "%>(?^@?_P"1H_\ XJC_ (0KQ#_T#_\
MR-'_ /%5Z]11_:%7LOZ^8?V)A^[_  _R/(?^$*\0_P#0/_\ (T?_ ,51_P (
M5XA_Z!__ )&C_P#BJ]>HH_M"KV7]?,/[$P_=_A_D>0_\(5XA_P"@?_Y&C_\
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MU%']H5>R_KYA_8F'[O\ #_(\A_X0KQ#_ - __P C1_\ Q5'_  A7B'_H'_\
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M_P#%5Z]11_:%7LOZ^8?V)A^[_#_(\A_X0KQ#_P! _P#\C1__ !5'_"%>(?\
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ME2>*/#T+;9==TQ&]&NXP?YTTFQ-I;FM16/\ \);X:_Z&'2?_  -C_P#BJ/\
MA+?#7_0PZ3_X&Q__ !5'*^PN:/<V**Q_^$M\-?\ 0PZ3_P"!L?\ \51_PEOA
MK_H8=)_\#8__ (JCE?8.:/<V**Q_^$M\-?\ 0PZ3_P"!L?\ \51_PEOAK_H8
M=)_\#8__ (JCE?8.:/<V**Q_^$M\-?\ 0PZ3_P"!L?\ \51_PEOAK_H8=)_\
M#8__ (JCE?8.:/<V**Q_^$M\-?\ 0PZ3_P"!L?\ \51_PEOAK_H8=)_\#8__
M (JCE?8.:/<V**Q_^$M\-?\ 0PZ3_P"!L?\ \51_PEOAK_H8=)_\#8__ (JC
ME?8.:/<V**Q_^$M\-?\ 0PZ3_P"!L?\ \51_PEOAK_H8=)_\#8__ (JCE?8.
M:/<V**Q_^$M\-?\ 0PZ3_P"!L?\ \51_PEOAK_H8=)_\#8__ (JCE?8.:/<V
M**Q_^$M\-?\ 0PZ3_P"!L?\ \51_PEOAK_H8=)_\#8__ (JCE?8.:/<V**Q_
M^$M\-?\ 0PZ3_P"!L?\ \51_PEOAK_H8=)_\#8__ (JCE?8.:/<V**Q_^$M\
M-?\ 0PZ3_P"!L?\ \51_PEOAK_H8=)_\#8__ (JCE?8.:/<V**Q_^$M\-?\
M0PZ3_P"!L?\ \51_PEOAK_H8=)_\#8__ (JCE?8.:/<V**Q_^$M\-?\ 0PZ3
M_P"!L?\ \51_PEOAK_H8=)_\#8__ (JCE?8.:/<V**Q_^$M\-?\ 0PZ3_P"!
ML?\ \51_PEOAK_H8=)_\#8__ (JCE?8.:/<V**Q_^$M\-?\ 0PZ3_P"!L?\
M\51_PEOAK_H8=)_\#8__ (JCE?8.:/<V**Q_^$M\-?\ 0PZ3_P"!L?\ \51_
MPEOAK_H8=)_\#8__ (JCE?8.:/<V**Q_^$M\-?\ 0PZ3_P"!L?\ \51_PEOA
MK_H8=)_\#8__ (JCE?8.:/<V**Q_^$M\-?\ 0PZ3_P"!L?\ \51_PEOAK_H8
M=)_\#8__ (JCE?8.:/<V**Q_^$M\-?\ 0PZ3_P"!L?\ \51_PEOAK_H8=)_\
M#8__ (JCE?8.:/<V**Q_^$M\-?\ 0PZ3_P"!L?\ \51_PEOAK_H8=)_\#8__
M (JCE?8.:/<V**Q_^$M\-?\ 0PZ3_P"!L?\ \51_PEOAK_H8=)_\#8__ (JC
ME?8.:/<V**Q_^$M\-?\ 0PZ3_P"!L?\ \51_PEOAK_H8=)_\#8__ (JCE?8.
M:/<V**Q_^$M\-?\ 0PZ3_P"!L?\ \51_PEOAK_H8=)_\#8__ (JCE?8.:/<V
M**Q_^$M\-?\ 0PZ3_P"!L?\ \51_PEOAK_H8=)_\#8__ (JCE?8.:/<V**Q_
M^$M\-?\ 0PZ3_P"!L?\ \51_PEOAK_H8=)_\#8__ (JCE?8.:/<V**Q_^$M\
M-?\ 0PZ3_P"!L?\ \51_PEOAK_H8=)_\#8__ (JCE?8.:/<V**Q_^$M\-?\
M0PZ3_P"!L?\ \51_PEOAK_H8=)_\#8__ (JCE?8.:/<V**Q_^$M\-?\ 0PZ3
M_P"!L?\ \51_PEOAK_H8=)_\#8__ (JCE?8.:/<V**Q_^$M\-?\ 0PZ3_P"!
ML?\ \51_PEOAK_H8=)_\#8__ (JCE?8.:/<V**Q_^$M\-?\ 0PZ3_P"!L?\
M\51_PEOAK_H8=)_\#8__ (JCE?8.:/<V**Q_^$M\-?\ 0PZ3_P"!L?\ \51_
MPEOAK_H8=)_\#8__ (JCE?8.:/<V**Q_^$M\-?\ 0PZ3_P"!L?\ \51_PEOA
MK_H8=)_\#8__ (JCE?8.:/<V**Q_^$M\-?\ 0PZ3_P"!L?\ \51_PEOAK_H8
M=)_\#8__ (JCE?8.:/<V**Q_^$M\-?\ 0PZ3_P"!L?\ \51_PEOAK_H8=)_\
M#8__ (JCE?8.:/<V**Q_^$M\-?\ 0PZ3_P"!L?\ \51_PEOAK_H8=)_\#8__
M (JCE?8.:/<V**Q_^$M\-?\ 0PZ3_P"!L?\ \51_PEOAK_H8=)_\#8__ (JC
ME?8.:/<V**Q_^$M\-?\ 0PZ3_P"!L?\ \51_PEOAK_H8=)_\#8__ (JCE?8.
M:/<V**Q_^$M\-?\ 0PZ3_P"!L?\ \51_PEOAK_H8=)_\#8__ (JCE?8.:/<V
M**Q_^$M\-?\ 0PZ3_P"!L?\ \51_PEOAK_H8=)_\#8__ (JCE?8.:/<V**Q_
M^$M\-?\ 0PZ3_P"!L?\ \51_PEOAK_H8=)_\#8__ (JCE?8.:/<V**Q_^$M\
M-?\ 0PZ3_P"!L?\ \51_PEOAK_H8=)_\#8__ (JCE?8.:/<V**Q_^$M\-?\
M0PZ3_P"!L?\ \51_PEOAK_H8=)_\#8__ (JCE?8.:/<V**Q_^$M\-?\ 0PZ3
M_P"!L?\ \51_PEOAK_H8=)_\#8__ (JCE?8.:/<V**Q_^$M\-?\ 0PZ3_P"!
ML?\ \51_PEOAK_H8=)_\#8__ (JCE?8.:/<V**Q_^$M\-?\ 0PZ3_P"!L?\
M\51_PEOAK_H8=)_\#8__ (JCE?8.:/<V**Q_^$M\-?\ 0PZ3_P"!L?\ \51_
MPEOAK_H8=)_\#8__ (JCE?8.:/<V**Q_^$M\-?\ 0PZ3_P"!L?\ \51_PEOA
MK_H8=)_\#8__ (JCE?8.:/<V**Q_^$M\-?\ 0PZ3_P"!L?\ \51_PEOAK_H8
M=)_\#8__ (JCE?8.:/<V**Q_^$M\-?\ 0PZ3_P"!L?\ \51_PEOAK_H8=)_\
M#8__ (JCE?8.:/<V**Q_^$M\-?\ 0PZ3_P"!L?\ \51_PEOAK_H8=)_\#8__
M (JCE?8.:/<V**Q_^$M\-?\ 0PZ3_P"!L?\ \51_PEOAK_H8=)_\#8__ (JC
ME?8.:/<V**Q_^$M\-?\ 0PZ3_P"!L?\ \51_PEOAK_H8=)_\#8__ (JCE?8.
M:/<V**Q_^$M\-?\ 0PZ3_P"!L?\ \51_PEOAK_H8=)_\#8__ (JCE?8.:/<V
M**Q_^$M\-?\ 0PZ3_P"!L?\ \51_PEOAK_H8=)_\#8__ (JCE?8.:/<V**Q_
M^$M\-?\ 0PZ3_P"!L?\ \51_PEOAK_H8=)_\#8__ (JCE?8.:/<V**Q_^$M\
M-?\ 0PZ3_P"!L?\ \51_PEOAK_H8=)_\#8__ (JCE?8.:/<V**Q_^$M\-?\
M0PZ3_P"!L?\ \51_PEOAK_H8=)_\#8__ (JCE?8.:/<V**Q_^$M\-?\ 0PZ3
M_P"!L?\ \51_PEOAK_H8=)_\#8__ (JCE?8.:/<V**Q_^$M\-?\ 0PZ3_P"!
ML?\ \51_PEOAK_H8=)_\#8__ (JCE?8.:/<V**Q_^$M\-?\ 0PZ3_P"!L?\
M\51_PEOAK_H8=)_\#8__ (JCE?8.:/<V**Q_^$M\-?\ 0PZ3_P"!L?\ \51_
MPEOAK_H8=)_\#8__ (JCE?8.:/<V**Q_^$M\-?\ 0PZ3_P"!L?\ \51_PEOA
MK_H8=)_\#8__ (JCE?8.:/<V**Q_^$M\-?\ 0PZ3_P"!L?\ \51_PEOAK_H8
M=)_\#8__ (JCE?8.:/<V**Q_^$M\-?\ 0PZ3_P"!L?\ \51_PEOAK_H8=)_\
M#8__ (JCE?8.:/<V**Q_^$M\-?\ 0PZ3_P"!L?\ \51_PEOAK_H8=)_\#8__
M (JCE?8.:/<V**Q_^$M\-?\ 0PZ3_P"!L?\ \51_PEOAK_H8=)_\#8__ (JC
ME?8.:/<V**Q_^$M\-?\ 0PZ3_P"!L?\ \51_PEOAK_H8=)_\#8__ (JCE?8.
M:/<V**Q_^$M\-?\ 0PZ3_P"!L?\ \51_PEOAK_H8=)_\#8__ (JCE?8.:/<V
M**Q_^$M\-?\ 0PZ3_P"!L?\ \51_PEOAK_H8=)_\#8__ (JCE?8.:/<V**Q_
M^$M\-?\ 0PZ3_P"!L?\ \51_PEOAK_H8=)_\#8__ (JCE?8.:/<V**Q_^$M\
M-?\ 0PZ3_P"!L?\ \51_PEOAK_H8=)_\#8__ (JCE?8.:/<V**Q_^$M\-?\
M0PZ3_P"!L?\ \51_PEOAK_H8=)_\#8__ (JCE?8.:/<V**Q_^$M\-?\ 0PZ3
M_P"!L?\ \51_PEOAK_H8=)_\#8__ (JCE?8.:/<V**Q_^$M\-?\ 0PZ3_P"!
ML?\ \51_PEOAK_H8=)_\#8__ (JCE?8.:/<V**Q_^$M\-?\ 0PZ3_P"!L?\
M\51_PEOAK_H8=)_\#8__ (JCE?8.:/<V**Q_^$M\-?\ 0PZ3_P"!L?\ \51_
MPEOAK_H8=)_\#8__ (JCE?8.:/<V**Q_^$M\-?\ 0PZ3_P"!L?\ \51_PEOA
MK_H8=)_\#8__ (JCE?8.:/<V**Q_^$M\-?\ 0PZ3_P"!L?\ \51_PEOAK_H8
M=)_\#8__ (JCE?8.:/<V**Q_^$M\-?\ 0PZ3_P"!L?\ \51_PEOAK_H8=)_\
M#8__ (JCE?8.:/<V**Q_^$M\-?\ 0PZ3_P"!L?\ \51_PEOAK_H8=)_\#8__
M (JCE?8.:/<V**Q_^$M\-?\ 0PZ3_P"!L?\ \51_PEOAK_H8=)_\#8__ (JC
ME?8.:/<V**Q_^$M\-?\ 0PZ3_P"!L?\ \51_PEOAK_H8=)_\#8__ (JCE?8.
M:/<V**Q_^$M\-?\ 0PZ3_P"!L?\ \51_PEOAK_H8=)_\#8__ (JCE?8.:/<V
M**Q_^$M\-?\ 0PZ3_P"!L?\ \51_PEOAK_H8=)_\#8__ (JCE?8.:/<V**Q_
M^$M\-?\ 0PZ3_P"!L?\ \51_PEOAK_H8=)_\#8__ (JCE?8.:/<V**Q_^$M\
M-?\ 0PZ3_P"!L?\ \51_PEOAK_H8=)_\#8__ (JCE?8.:/<V**Q_^$M\-?\
M0PZ3_P"!L?\ \51_PEOAK_H8=)_\#8__ (JCE?8.:/<V**Q_^$M\-?\ 0PZ3
M_P"!L?\ \51_PEOAK_H8=)_\#8__ (JCE?8.:/<V**Q_^$M\-?\ 0PZ3_P"!
ML?\ \51_PEOAK_H8=)_\#8__ (JCE?8.:/<V**Q_^$M\-?\ 0PZ3_P"!L?\
M\51_PEOAK_H8=)_\#8__ (JCE?8.:/<V**Q_^$M\-?\ 0PZ3_P"!L?\ \51_
MPEOAK_H8=)_\#8__ (JCE?8.:/<V**Q_^$M\-?\ 0PZ3_P"!L?\ \51_PEOA
MK_H8=)_\#8__ (JCE?8.:/<V**Q_^$M\-?\ 0PZ3_P"!L?\ \51_PEOAK_H8
M=)_\#8__ (JCE?8.:/<V**Q_^$M\-?\ 0PZ3_P"!L?\ \51_PEOAK_H8=)_\
M#8__ (JCE?8.:/<V**Q_^$M\-?\ 0PZ3_P"!L?\ \51_PEOAK_H8=)_\#8__
M (JCE?8.:/<V**Q_^$M\-?\ 0PZ3_P"!L?\ \51_PEOAK_H8=)_\#8__ (JC
ME?8.:/<V**Q_^$M\-?\ 0PZ3_P"!L?\ \51_PEOAK_H8=)_\#8__ (JCE?8.
M:/<V**Q_^$M\-?\ 0PZ3_P"!L?\ \51_PEOAK_H8=)_\#8__ (JCE?8.:/<V
M**Q_^$M\-?\ 0PZ3_P"!L?\ \51_PEOAK_H8=)_\#8__ (JCE?8.:/<V**Q_
M^$M\-?\ 0PZ3_P"!L?\ \51_PEOAK_H8=)_\#8__ (JCE?8.:/<V**Q_^$M\
M-?\ 0PZ3_P"!L?\ \51_PEOAK_H8=)_\#8__ (JCE?8.:/<V**Q_^$M\-?\
M0PZ3_P"!L?\ \51_PEOAK_H8=)_\#8__ (JCE?8.:/<V**Q_^$M\-?\ 0PZ3
M_P"!L?\ \51_PEOAK_H8=)_\#8__ (JCE?8.:/<V**Q_^$M\-?\ 0PZ3_P"!
ML?\ \51_PEOAK_H8=)_\#8__ (JCE?8.:/<V**Q_^$M\-?\ 0PZ3_P"!L?\
M\51_PEOAK_H8=)_\#8__ (JCE?8.:/<V**Q_^$M\-?\ 0PZ3_P"!L?\ \51_
MPEOAK_H8=)_\#8__ (JCE?8.:/<V**Q_^$M\-?\ 0PZ3_P"!L?\ \51_PEOA
MK_H8=)_\#8__ (JCE?8.:/<V**Q_^$M\-?\ 0PZ3_P"!L?\ \51_PEOAK_H8
M=)_\#8__ (JCE?8.:/<V**Q_^$M\-?\ 0PZ3_P"!L?\ \51_PEOAK_H8=)_\
M#8__ (JCE?8.:/<V**Q_^$M\-?\ 0PZ3_P"!L?\ \51_PEOAK_H8=)_\#8__
M (JCE?8.:/<V**Q_^$M\-?\ 0PZ3_P"!L?\ \51_PEOAK_H8=)_\#8__ (JC
ME?8.:/<V**Q_^$M\-?\ 0PZ3_P"!L?\ \51_PEOAK_H8=)_\#8__ (JCE?8.
M:/<V**Q_^$M\-?\ 0PZ3_P"!L?\ \51_PEOAK_H8=)_\#8__ (JCE?8.:/<V
M**Q_^$M\-?\ 0PZ3_P"!L?\ \51_PEOAK_H8=)_\#8__ (JCE?8.:/<V**Q_
M^$M\-?\ 0PZ3_P"!L?\ \51_PEOAK_H8=)_\#8__ (JCE?8.:/<V**Q_^$M\
M-?\ 0PZ3_P"!L?\ \51_PEOAK_H8=)_\#8__ (JCE?8.:/<V**Q_^$M\-?\
M0PZ3_P"!L?\ \51_PEOAK_H8=)_\#8__ (JCE?8.:/<V**Q_^$M\-?\ 0PZ3
M_P"!L?\ \51_PEOAK_H8=)_\#8__ (JCE?8.:/<V**Q_^$M\-?\ 0PZ3_P"!
ML?\ \51_PEOAK_H8=)_\#8__ (JCE?8.:/<V**Q_^$M\-?\ 0PZ3_P"!L?\
M\51_PEOAK_H8=)_\#8__ (JCE?8.:/<V**Q_^$M\-?\ 0PZ3_P"!L?\ \51_
MPEOAK_H8=)_\#8__ (JCE?8.:/<V**Q_^$M\-?\ 0PZ3_P"!L?\ \51_PEOA
MK_H8=)_\#8__ (JCE?8.:/<V**Q_^$M\-?\ 0PZ3_P"!L?\ \51_PEOAK_H8
M=)_\#8__ (JCE?8.:/<V**Q_^$M\-?\ 0PZ3_P"!L?\ \51_PEOAK_H8=)_\
M#8__ (JCE?8.:/<V**Q_^$M\-?\ 0PZ3_P"!L?\ \51_PEOAK_H8=)_\#8__
M (JCE?8.:/<V**Q_^$M\-?\ 0PZ3_P"!L?\ \51_PEOAK_H8=)_\#8__ (JC
ME?8.:/<V**Q_^$M\-?\ 0PZ3_P"!L?\ \51_PEOAK_H8=)_\#8__ (JCE?8.
M:/<V**Q_^$M\-?\ 0PZ3_P"!L?\ \51_PEOAK_H8=)_\#8__ (JCE?8.:/<V
M**Q_^$M\-?\ 0PZ3_P"!L?\ \51_PEOAK_H8=)_\#8__ (JCE?8.:/<V**Q_
M^$M\-?\ 0PZ3_P"!L?\ \51_PEOAK_H8=)_\#8__ (JCE?8.:/<V**Q_^$M\
M-?\ 0PZ3_P"!L?\ \51_PEOAK_H8=)_\#8__ (JCE?8.:/<V**Q_^$M\-?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH ^=J]MT+_ )%[3?\ KUB_] %>)5[;H7_(O:;_ ->L
M7_H KULQ^&)\UD?\2?H:%%%%>4?2!1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 >0^-?^1NOO^V?_HM:[?X9_P#(MW'_ %]M_P"@)7$>-?\ D;K[_MG_ .BU
MKM_AG_R+=Q_U]M_Z E>KB/\ =8_(^;P7_(QGZR_,[.BBBO)/I0HHHH ****
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MOC_Y\W_[['^%'_"7Q_\ /F__ 'V/\*+,.9'2T5S7_"7Q_P#/F_\ WV/\*/\
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MZ6BN:_X2^/\ Y\W_ .^Q_A1_PE\?_/F__?8_PHLPYD=+17-?\)?'_P ^;_\
M?8_PH_X2^/\ Y\W_ .^Q_A19AS(Z6BN:_P"$OC_Y\W_[['^%'_"7Q_\ /F__
M 'V/\*+,.9'2T5S7_"7Q_P#/F_\ WV/\*/\ A+X_^?-_^^Q_A19AS(Z6BN:_
MX2^/_GS?_OL?X4?\)?'_ ,^;_P#?8_PHLPYD=+17-?\ "7Q_\^;_ /?8_P *
M/^$OC_Y\W_[['^%%F',CI:*YK_A+X_\ GS?_ +['^%'_  E\?_/F_P#WV/\
M"BS#F1TM%<U_PE\?_/F__?8_PH_X2^/_ )\W_P"^Q_A19AS(Z6BN:_X2^/\
MY\W_ .^Q_A1_PE\?_/F__?8_PHLPYD=+17-?\)?'_P ^;_\ ?8_PH_X2^/\
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MOC_Y\W_[['^%'_"7Q_\ /F__ 'V/\*+,.9'2T5S7_"7Q_P#/F_\ WV/\*/\
MA+X_^?-_^^Q_A19AS(Z6BN:_X2^/_GS?_OL?X4?\)?'_ ,^;_P#?8_PHLPYD
M=+17-?\ "7Q_\^;_ /?8_P */^$OC_Y\W_[['^%%F',CI:*YK_A+X_\ GS?_
M +['^%'_  E\?_/F_P#WV/\ "BS#F1TM%<U_PE\?_/F__?8_PH_X2^/_ )\W
M_P"^Q_A19AS(Z6BN:_X2^/\ Y\W_ .^Q_A1_PE\?_/F__?8_PHLPYD=+17-?
M\)?'_P ^;_\ ?8_PH_X2^/\ Y\W_ .^Q_A19AS(Z6BN:_P"$OC_Y\W_[['^%
M'_"7Q_\ /F__ 'V/\*+,.9'2T5S7_"7Q_P#/F_\ WV/\*/\ A+X_^?-_^^Q_
MA19AS(Z6BN:_X2^/_GS?_OL?X4?\)?'_ ,^;_P#?8_PHLPYD=+17-?\ "7Q_
M\^;_ /?8_P */^$OC_Y\W_[['^%%F',CI:*YK_A+X_\ GS?_ +['^%'_  E\
M?_/F_P#WV/\ "BS#F1TM%<U_PE\?_/F__?8_PH_X2^/_ )\W_P"^Q_A19AS(
MZ6BN:_X2^/\ Y\W_ .^Q_A1_PE\?_/F__?8_PHLPYD=+17-?\)?'_P ^;_\
M?8_PH_X2^/\ Y\W_ .^Q_A19AS(Z6BN:_P"$OC_Y\W_[['^%'_"7Q_\ /F__
M 'V/\*+,.9'2T5S7_"7Q_P#/F_\ WV/\*/\ A+X_^?-_^^Q_A19AS(Z6BN:_
MX2^/_GS?_OL?X4?\)?'_ ,^;_P#?8_PHLPYD=+17-?\ "7Q_\^;_ /?8_P *
M/^$OC_Y\W_[['^%%F',CI:*YK_A+X_\ GS?_ +['^%'_  E\?_/F_P#WV/\
M"BS#F1TM%<U_PE\?_/F__?8_PH_X2^/_ )\W_P"^Q_A19AS(Z6BN:_X2^/\
MY\W_ .^Q_A1_PE\?_/F__?8_PHLPYD=+17-?\)?'_P ^;_\ ?8_PH_X2^/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "LCQ7_R)^M_]>$__HMJUZR/%?\ R)^M_P#7A/\
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M^?.W_P"_2_X4?V?9?\^=O_WZ7_"K-% 6*W]GV7_/G;_]^E_PH_L^R_Y\[?\
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M^%6:* L5O[/LO^?.W_[]+_A1_9]E_P ^=O\ ]^E_PJS10%BM_9]E_P ^=O\
M]^E_PH_L^R_Y\[?_ +]+_A5FB@+%;^S[+_GSM_\ OTO^%']GV7_/G;_]^E_P
MJS10%BM_9]E_SYV__?I?\*/[/LO^?.W_ ._2_P"%6:* L5O[/LO^?.W_ ._2
M_P"%']GV7_/G;_\ ?I?\*LT4!8K?V?9?\^=O_P!^E_PH_L^R_P"?.W_[]+_A
M5FB@+%;^S[+_ )\[?_OTO^%']GV7_/G;_P#?I?\ "K-% 6*W]GV7_/G;_P#?
MI?\ "C^S[+_GSM_^_2_X59HH"Q6_L^R_Y\[?_OTO^%']GV7_ #YV_P#WZ7_"
MK-% 6*W]GV7_ #YV_P#WZ7_"C^S[+_GSM_\ OTO^%6:* L5O[/LO^?.W_P"_
M2_X4?V?9?\^=O_WZ7_"K-% 6*W]GV7_/G;_]^E_PH_L^R_Y\[?\ []+_ (59
MHH"Q6_L^R_Y\[?\ []+_ (4?V?9?\^=O_P!^E_PJS10%BM_9]E_SYV__ 'Z7
M_"C^S[+_ )\[?_OTO^%6:* L5O[/LO\ GSM_^_2_X4?V?9?\^=O_ -^E_P *
MLT4!8K?V?9?\^=O_ -^E_P */[/LO^?.W_[]+_A5FB@+%;^S[+_GSM_^_2_X
M4?V?9?\ /G;_ /?I?\*LT4!8K?V?9?\ /G;_ /?I?\*/[/LO^?.W_P"_2_X5
M9HH"Q6_L^R_Y\[?_ +]+_A1_9]E_SYV__?I?\*LT4!8K?V?9?\^=O_WZ7_"C
M^S[+_GSM_P#OTO\ A5FB@+%;^S[+_GSM_P#OTO\ A1_9]E_SYV__ 'Z7_"K-
M% 6*W]GV7_/G;_\ ?I?\*/[/LO\ GSM_^_2_X59HH"Q6_L^R_P"?.W_[]+_A
M1_9]E_SYV_\ WZ7_  JS10%BM_9]E_SYV_\ WZ7_  H_L^R_Y\[?_OTO^%6:
M* L5O[/LO^?.W_[]+_A1_9]E_P ^=O\ ]^E_PJS10%BM_9]E_P ^=O\ ]^E_
MPH_L^R_Y\[?_ +]+_A5FB@+%;^S[+_GSM_\ OTO^%']GV7_/G;_]^E_PJS10
M%B**UMX&+0P11L1@E$ _E4M%% !1110!\[5[;H7_ "+VF_\ 7K%_Z *\2KVW
M0O\ D7M-_P"O6+_T 5ZV8_#$^:R/^)/T-"BBBO*/I HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** /(?&O_(W7W_;/_T6M=O\,_\ D6[C_K[;_P! 2N(\:_\
M(W7W_;/_ -%K7;_#/_D6[C_K[;_T!*]7$?[K'Y'S>"_Y&,_67YG9T445Y)]*
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5
M\V?%3_DI&K?]L?\ T2E?2=?-GQ4_Y*1JW_;'_P!$I6^'^(Y,9\"]3T+X,?\
M(GW?_7^__HN.O1:\Z^#'_(GW?_7^_P#Z+CKT6HJ_&S6A_#04445!J%%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !61XK_ .1/UO\ Z\)_
M_1;5KUD>*_\ D3];_P"O"?\ ]%M3CNB9?"SY>K[$KX[K[$KHQ/0Y,%]KY!11
M17*=P4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'SM7MNA?\B]IO_7K%
M_P"@"O$J]MT+_D7M-_Z]8O\ T 5ZV8_#$^:R/^)/T-"BBBO*/I HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MK:E2C4]M=/0]&HJG?:OIFF,BW^HVEHS@E!/.L9;'ID\U4_X2OP[_ -!_2_\
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M^M_]>$__ *+:G'=$R^%GR]7V)7QW7V)71B>AR8+[7R"BBBN4[@HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OFSXJ?\
M)2-6_P"V/_HE*^DZ^;/BI_R4C5O^V/\ Z)2M\/\ $<F,^!>IZ%\&/^1/N_\
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MWU[YK3A^'?BR>U^T)HLP3&<.Z(__ 'R2&_#%=3\&]#@NM0O=7G4.UH%C@!Y
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M\0>,=19X8KC4+@  N2-J#L,G 4<].*Q54NZHHRS' %?4GA_1+;P]HEOIULH
MC7YV Y=^['U)_P *VJU.1>9ST*7M&]=#YVU;P;XAT.$S:AI4\<(&6D7$B*,X
MY920/QJSX0\8WWA74D=)'DL6;]_;9X8>HST8>OYU](R1I-$\4J*\;@JRL,A@
M>H([BOF?QGHZ:%XMU"PB4+"LF^)0<A48;@.?0''X5-.I[3W9(NK2=&THL^EK
M>XBN[:*Y@<20S()(W'1E(R#^5>%?%O3;Z#Q>]_*DC6=Q'&(9-IVKA<%,^N03
MCWKT/X4WLEYX%MTDY^S2O"I]1G</_0L?A7;5SQE[.;.J4?;4UT/-_@]IFH6.
MAWL]W$\4%S*K0*_!. 06QZ'C\J](HHJ92YG<TA#DBHA1114EA1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %9'BO_D3];_Z\)_\ T6U:]9'B
MO_D3];_Z\)__ $6U..Z)E\+/EZOL2OCNOL2NC$]#DP7VOD%%%%<IW!1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 ?.U>VZ%_R+VF_P#7K%_Z *\2KVW0
MO^1>TW_KUB_] %>MF/PQ/FLC_B3]#0HHHKRCZ0**** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@#R'QK_R-U]_VS_\ 1:UV_P ,_P#D6[C_ *^V_P#0$KB/&O\
MR-U]_P!L_P#T6M=O\,_^1;N/^OMO_0$KU<1_NL?D?-X+_D8S]9?F=G1117DG
MTH4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MJ<=P?\*N*]I3Y3*;=*MS/8^H=8N8K/1;ZYG;;%% [L?8*:^555G=412S,<
M9)-;>L>,?$&O6XM]2U*2:#(/EA5121TR% S^-;GPX\'7&O:S#J%Q"5TRU<.S
ML"!*PZ*OKSR?3\:<(^RBVR:L_;R2BCWNUB\BTAA.,QQJOR].!CBOF/Q7_P C
MAK?_ %_S_P#HQJ^H:^7O%?\ R.&M_P#7_/\ ^C&K/#[LVQGPH]]\ _\ (B:/
M_P!</ZFIO&W_ ")&L_\ 7J_\JA\ _P#(B:/_ -</ZFIO&W_(D:S_ ->K_P J
MR^W\S=?POD?-^F?\A:S_ .NZ?^A"OJZOE'3/^0M9_P#7=/\ T(5]75MB-T<^
M#V9YG\:?^1?T[_KZ/_H!KD/A!_R.Y_Z]9/YK77_&G_D7]._Z^C_Z :Y#X0?\
MCN?^O63^:TX_P634_P!X7R-WXV6;>9I%\ 2A$D+'T/!'Y_-^58WPEU^VTGQ!
M/9W<@BCOT5$=C@>8I^4'ZY(SZX]:]A\2:%;^(]"N--N,@2#*.#]QQ]T_G7S=
MK6A:CX?OFL]1MFBD&=K8^5QG&5/<44FIPY&%=2IU/:(^IZX7XJZW!IOA&:QW
MK]JOB(T3/.T$%FQZ8&/QKR:U^('BJSMA;PZS-Y87:/,57('U8$_K69+'JVMQ
MWVKSM/=+;A6N+B1LXW,%49/N1@>@]!2C0L[MCGBE*-HK4M>#/^1UT7_K\C_]
M"%?1^K_\@6__ .O>3_T$U\X>#/\ D==%_P"OR/\ ]"%?1^K_ /(%O_\ KWD_
M]!-*O\2*PGP,^558HZNIPRG(-?4GA_6K;Q!HEMJ-LZ,)4'F*ISY;X^93[@_X
MU\M5MPWOB#P=J#Q0W%U83<,4!^60=FP>&'7!P:VJT^='/0J^S;=M#Z;DD2&)
MY975(T!9F8X"@=23V%?,WC/6(M>\6ZAJ$&?(D<+'GNJJ%!_'&?QI-6\8^(-<
M@,&HZG++"3DQ@*BGZA0!5SP9X,O/%>HJ K16$1!GG(XQ_=7U8_I4TZ?L[RDR
MZM5UFHQ1ZY\++%[+P+:M(NUKF1YP#UP3@?F%!_&NTJ.""*VMX[>"-8X8D"(B
MC 50, #\*\+^+>I:A+XNDL)I)%LH8HS#$&^5LC);'KDD?A7/&/M)LZY25&FN
MI[Q17F_P>U2^OM#O;>ZEDEAM956%GYP""2N?;CZ9KTBIE'E=BX3YXJ04445)
M84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !61XK_P"1/UO_
M *\)_P#T6U:]9'BO_D3];_Z\)_\ T6U..Z)E\+/EZOL2OCNOL2NC$]#DP7VO
MD%%%%<IW!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?.U>VZ%_R+VF_
M]>L7_H KQ*O;="_Y%[3?^O6+_P! %>MF/PQ/FLC_ (D_0T****\H^D"BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *R/%?\ R)^M_P#7
MA/\ ^BVK7K(\5_\ (GZW_P!>$_\ Z+:G'=$R^%GR]7V)7QW7V)71B>AR8+[7
MR"BBBN4[@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /G:O;="_Y%[3?
M^O6+_P! %>)5[;H7_(O:;_UZQ?\ H KULQ^&)\UD?\2?H:%%%%>4?2!1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 >0^-?\ D;K[_MG_ .BUKM_AG_R+=Q_U
M]M_Z E<1XU_Y&Z^_[9_^BUKM_AG_ ,BW<?\ 7VW_ * E>KB/]UC\CYO!?\C&
M?K+\SLZ***\D^E"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH *^3?CN__%R[Y/01G_R#'_A7UE7R/\<,R_%S4X\X^6!?SB3_
M !JD]&1):I_UL>P_ U/+\!2IZ7A'_D*.O2Z\Z^"X \'78'07[_\ HN.O1:JH
MK29-%W@F%%%%0:!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 5D>*_P#D3];_ .O"?_T6U:]9'BO_ )$_6_\ KPG_ /1;4X[HF7PL^7J^
MQ*^.Z^Q*Z,3T.3!?:^04445RG<%%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110!\[5[;H7_(O:;_UZQ?\ H KQ*O;="_Y%[3?^O6+_ - %>MF/PQ/FLC_B
M3]#0HHHKRCZ0**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#R'QK_ ,C=??\
M;/\ ]%K7;_#/_D6[C_K[;_T!*XCQK_R-U]_VS_\ 1:UV_P ,_P#D6[C_ *^V
M_P#0$KU<1_NL?D?-X+_D8S]9?F=G1117DGTH4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !7R!\3[D:A\9]7<$86ZCC_ ._:
M*I_]!KZ_KXGO[IM4^(6K7S8/FWMQ-P<@ LV,'TYJH*\DB*CM!L^A_@Q_R)]W
M_P!?[_\ HN.O1:\Z^#'_ ")]W_U_O_Z+CKT6JJ_&R*'\-!1114&H5XM\*_\
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MK4;N*VA7^)SR?8#J3["N,G^,7AJ*3:D.H3#^_'"H'_CS TU"4MD3*I&/Q,]
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M?K[5E_![_D2I/^OR3_T%:=OW;]2')^U23TL>@445@Z[XRT+PZ_EZC?*L^ 1
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M7PL^7J^Q*^.Z^Q*Z,3T.3!?:^04445RG<%%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M\E>'$Q'._J0/R_\ UUK15YHPQ+M29]'?!C_D3[O_ *_W_P#1<=>BUYU\&/\
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M0O\ KE;_ /HYZ[GQCXXL/"EJR$K/J+ &*V!]?XF]!Q]3^H\[^+TLMOXZTZ:
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M6AZ%X>_Y%K2O^O.'_P! %:59OA[_ )%K2O\ KSA_] %:58O<Z8[(*\C\!_\
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M^<<>N:XGQN)/%_Q/L?#\#_N;8"-R&R%R-\C?4+@8]5Q7L2(L:*B*%11A548
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M/^%(?]3#_P"27_VRM?\ X7/X=_Y\M4_[]1__ !='_"Y_#O\ SY:I_P!^H_\
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M,&1SU8_YZ 5T5IPE&R./#4ZD9MR->BBBN8[0HJM>:C8Z<BO?7MO:JV<-/*J
MXZ]345EK6E:DY2QU.RNF'58)U<_H:=F*ZO8O445!=WMI80&>\NH;:$'!DFD"
M+GZFD,GHK.M-?T:_D\NSU:PN7R!MAN4<Y/3@&M&BUA)I[!1110,**HWNM:5I
MKA+[4[*U8]%GG5#^IIUEJVFZEG[#J%I=8&?W$ROQ^!IV8KJ]BY1112&%%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_9Z\CM[46=G:Q $;H(Y>1C[Z!_\ V:M\/\9RXM_N_F>[_!C_ )$^[_Z_W_\
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MX8\*:UIWQ-U75[JR\NPGDN#'+YJ'<&?*\ Y&1[5I!I)F-5-RC;N>EU@^-O\
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M/A\ZZE\O8FX+G$BL>20.@--R3DDMD)0DJ<F]V4_AA_R3O2O^VW_HUZX_7_\
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M@D="*Z*B3]YV%"/N)-=#(_X13P[_ - #2_\ P#C_ ,*/^$4\._\ 0 TO_P
MX_\ "M>BES/N5RQ[&;;^'=$L[A+BVT?3X)D.5DBM45E^A R*TJ**5[C22V"O
M'/AK_P E1UW_ *Y7'_HY*]CKS3P/X4UK1_'FK:E?V7DV=Q',(I/-1MQ:56'
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /G:O;="_
MY%[3?^O6+_T 5XE7MNA?\B]IO_7K%_Z *];,?AB?-9'_ !)^AH4445Y1](%%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110!Y#XU_Y&Z^_[9_\ HM:[?X9_\BW<
M?]?;?^@)7$>-?^1NOO\ MG_Z+6NW^&?_ "+=Q_U]M_Z E>KB/]UC\CYO!?\
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M H_"%Q>7#7YO9[A54.8O+V*"21]XYR<?E7845FI-*QLXIM-] HHHI%!1110
M4444 >.:EJOB#X>>,3)=W-]J.BSDB,7$[R H3G +' =<?B/K7?:;X^\,:G )
M$U>W@)&3'=.(F7V^;@_@36]>65KJ%L]M>6\4\+_>CD4,#^!KB[SX1^%[J1GC
M2[M<_P ,$W ^FX-_DUKS0E\6YAR5(/W-5YFKJ7Q!\+Z9$SOJT$[#HEJ?-+'V
MV\?F0*\YM%O_ (I^-8KZ:U:'1[/ *DY4*#G;G&"[9Y]OH*["S^$7ABU?=(+R
MZP0<33#'_CH6NUL[*UT^V2VL[>*"%/NQQJ% _ 4<T8_#N+DG-^_L3T445D=
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M_P"C&KYFKZ9^&G_).]'_ .N;_P#HQJZL1\*.#!_&_0\P^-O_ ".=G_V#T_\
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MLD ]<'J/<9'-;]8U9N6C5CHH4HP3<7>X4445D= 4444 %%%% !1110 4444
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MU?/=UXT\2W<[2OKE^A8D[8IVC49] I  K8LOB5K TG4=,U20WT%W;2Q+(_\
MK(V9"!@]QD\@_AZ';V$EJ8?6X.ZL9?@3_D>='_Z^!7TO7S1X$_Y'G1_^O@5]
M)75U!96LMU<RK%!$I=W8\*!U-&(^)!@_@9+17A?B;XL:MJ,[PZ,QL+-3\K@
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M$?[K'Y'S>"_Y&,_67YG9T445Y)]*%%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !6=K]X=/\.:I>ARAM[267>.J[4)S^E:-<;\5[W[
M!\+?$,V]DW6WDY7_ *:,$Q^.['XT >1?LUV6_P 0ZY?;?]3:)#G'3>^?_:=:
MGQGTB2T\51:D%)@O85&[' =."/RVFKG[-=F$\.:W>[ #+=I%O[G8F<?AO_6O
M5_$_ANR\4Z++IUX,9^:*4#+1/V8?X=Q6E.?)*YE6I^TA9'BGPP\96OAZ[GT_
M46\NSNV#+-VC<#'/L1W[8%>Y07,%U&)+>:.:,]&C8,#^(KYK\2^#M8\+73)?
M6S&WW8CN8QF-Q]>Q]CS6!73*DIOF3.*&(E27))'UQ17R/14?5_,OZY_=_$^N
M**^1Z*/J_F'US^[^)]<45\CT4?5_,/KG]W\3ZXHKY'HH^K^8?7/[OXGUQ17R
M/11]7\P^N?W?Q/KBBOD>BCZOYA]<_N_B?7%%?(]%'U?S#ZY_=_$^N**^1Z*/
MJ_F'US^[^)]<45\CT4?5_,/KG]W\3ZXHKY'HH^K^8?7/[OXGUQ17R/11]7\P
M^N?W?Q/KBBOD>BCZOYA]<_N_B?7%%?(]%'U?S#ZY_=_$^N**^1Z*/J_F'US^
M[^)]<45\CT4?5_,/KG]W\3ZXHKY'HH^K^8?7/[OXGUQ17R/11]7\P^N?W?Q/
MKBBOD>BCZOYA]<_N_B?7%%?(]%'U?S#ZY_=_$^N**^1Z*/J_F'US^[^)]<45
M\CT4?5_,/KG]W\3ZXHKY'HH^K^8?7/[OXGUQ17R/11]7\P^N?W?Q/KBBOD>B
MCZOYA]<_N_B?7%%?(]%'U?S#ZY_=_$^N**^1Z*/J_F'US^[^)]<45\CT4?5_
M,/KG]W\3ZXHKY'HH^K^8?7/[OXGUQ17R/11]7\P^N?W?Q/KBBOD>BCZOYA]<
M_N_B?7%%?(]%'U?S#ZY_=_$^N**^1Z*/J_F'US^[^)]<45\CT4?5_,/KG]W\
M3ZXHKY'HH^K^8?7/[OXGUQ17R/11]7\P^N?W?Q/KBBOD>BCZOYA]<_N_B?7%
M%?(]%'U?S#ZY_=_$^N**^1Z*/J_F'US^[^)]<45\CT4?5_,/KG]W\3ZXHKY'
MHH^K^8?7/[OXGUQ17R/11]7\P^N?W?Q/KBBOD>BCZOYA]<_N_B?7%%?(]%'U
M?S#ZY_=_$^N**^1Z*/J_F'US^[^)]<45\CT4?5_,/KG]W\3ZXHKY'HH^K^8?
M7/[OXGUQ17R/11]7\P^N?W?Q/KBBOD>BCZOYA]<_N_B?7%%?(]%'U?S#ZY_=
M_$^N**^1Z*/J_F'US^[^)]<45\CT4?5_,/KG]W\3ZXHKY'HH^K^8?7/[OXGU
MQ17R/11]7\P^N?W?Q/KBBOD>BCZOYA]<_N_B?7%%?(]%'U?S#ZY_=_$^N**^
M1Z*/J_F'US^[^)]<45\CT4?5_,/KG]W\3ZXHKY'HH^K^8?7/[OXGUQ17R/11
M]7\P^N?W?Q/KBBOD>BCZOYA]<_N_B?7%%?(]%'U?S#ZY_=_$^N**^1Z*/J_F
M'US^[^)]<45\CT4?5_,/KG]W\3ZXHKY'HH^K^8?7/[OXGUQ17R/11]7\P^N?
MW?Q/KBBOD>BCZOYA]<_N_B?7%%?(]%'U?S#ZY_=_$^N**^1Z*/J_F'US^[^)
M]<45\CT4?5_,/KG]W\3ZXHKY'HH^K^8?7/[OXGUQ17R/11]7\P^N?W?Q/KBB
MOD>BCZOYA]<_N_B?7%%?(]%'U?S#ZY_=_$^N**^1Z*/J_F'US^[^)]<45\CT
M4?5_,/KG]W\3ZXHKY'HH^K^8?7/[OXGUQ17R/11]7\P^N?W?Q/KBBOD>BCZO
MYA]<_N_B?7%%?(]%'U?S#ZY_=_$^N**^1Z*/J_F'US^[^)]<45\CT4?5_,/K
MG]W\3ZXHKY'HH^K^8?7/[OXGUQ17R/11]7\P^N?W?Q/KBBOD>BCZOYA]<_N_
MB?7%%?(]%'U?S#ZY_=_$^N**^1Z*/J_F'US^[^)]<45\CT4?5_,/KG]W\3ZX
MHKY'HH^K^8?7/[OXGUQ17R/11]7\P^N?W?Q/KBBOD>BCZOYA]<_N_B?7%%?(
M]%'U?S#ZY_=_$^N**^1Z*/J_F'US^[^)]<45\CT4?5_,/KG]W\3ZXHKY'HH^
MK^8?7/[OXGUQ17R/11]7\P^N?W?Q/KBBOD>BCZOYA]<_N_B?7%%?(]%'U?S#
MZY_=_$^N**^1Z*/J_F'US^[^)]<45\CT4?5_,/KG]W\3ZXHKY'HH^K^8?7/[
MOXGUQ17R/11]7\P^N?W?Q/KBBOD>BCZOYA]<_N_B?7%%?(]%'U?S#ZY_=_$^
MN**^1Z*/J_F'US^[^)]<45\CT4?5_,/KG]W\3ZXHKY'HH^K^8?7/[OXGUQ17
MR/11]7\P^N?W?Q/KBBOD>BCZOYA]<_N_B?7%%?(]%'U?S#ZY_=_$^N**^1Z*
M/J_F'US^[^)]<45\CT4?5_,/KG]W\3ZXHKY'HH^K^8?7/[OXGUQ17R/11]7\
MP^N?W?Q/KBBOD>BCZOYA]<_N_B?7%%?(]%'U?S#ZY_=_$^N**^1Z*/J_F'US
M^[^)]<45\CT4?5_,/KG]W\3ZXHKY'HH^K^8?7/[OXGUQ17R/11]7\P^N?W?Q
M/KBBOD>BCZOYA]<_N_B?7%%?(]%'U?S#ZY_=_$^N**^1Z*/J_F'US^[^)]<4
M5\CT4?5_,/KG]W\3ZXHKY'HH^K^8?7/[OXGUQ17R/11]7\P^N?W?Q/KBBOD>
MBCZOYA]<_N_B?7%%?(]%'U?S#ZY_=_$^N**^1Z*/J_F'US^[^)]<45\CT4?5
M_,/KG]W\3ZXHKY'HH^K^8?7/[OXGUQ17R/11]7\P^N?W?Q/KBBOD>BCZOYA]
M<_N_B?7%%?(]%'U?S#ZY_=_$^N**^1Z*/J_F'US^[^)];LRHI9B%4<DDX KS
M3XF>.+"'1Y]$T^=+FZN1LF:-MRQ)W!([GICZ^U>)U=TS2-0UJ[6UTVSEN9C_
M  QKG'N3T ]S51H*+NV3/%2FN6*+?A72)-<\4:=I\:DB293(0/NH#EC^0-?5
ME<1\/? ,7A*T:ZNRDNJSKB1UZ1+UV+Z\]3W_  KMZQK34GH=.&I.$==V%%%%
M8G0%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110!YK\0_ OB+QAJ\,EK=V$5A;Q[8H
MYI9 Q8\LQ 0CT'T%5O ?PMO?#GB$:IJT]G-Y*'R%MW9L.>,G<H[9Z5ZG16GM
M9<O*8^P@Y\[W"BBBLS8**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M;) '8#CBHJSBXV1I0ISC-R>QL4445SG8?*.I_P#(6O/^N[_^A&OJZOE'4_\
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M%ICMZM:1D_RK6HIIM":3W,?_ (1+PU_T+VD_^ 4?_P 31_PB7AK_ *%[2?\
MP"C_ /B:V**.9]Q<L>QC_P#")>&O^A>TG_P"C_\ B:/^$2\-?]"]I/\ X!1_
M_$UL44<S[ARQ[&/_ ,(EX:_Z%[2?_ */_P")H_X1+PU_T+VD_P#@%'_\36Q1
M1S/N'+'L8_\ PB7AK_H7M)_\ H__ (FC_A$O#7_0O:3_ . 4?_Q-;%%',^X<
ML>QC_P#")>&O^A>TG_P"C_\ B:/^$2\-?]"]I/\ X!1__$UL44<S[ARQ[&/_
M ,(EX:_Z%[2?_ */_P")H_X1+PU_T+VD_P#@%'_\36Q11S/N'+'L8_\ PB7A
MK_H7M)_\ H__ (FC_A$O#7_0O:3_ . 4?_Q-;%%',^X<L>QC_P#")>&O^A>T
MG_P"C_\ B:/^$2\-?]"]I/\ X!1__$UL44<S[ARQ[&/_ ,(EX:_Z%[2?_ */
M_P")H_X1+PU_T+VD_P#@%'_\36Q11S/N'+'L8_\ PB7AK_H7M)_\ H__ (FC
M_A$O#7_0O:3_ . 4?_Q-;%%',^X<L>QC_P#")>&O^A>TG_P"C_\ B:/^$2\-
M?]"]I/\ X!1__$UL44<S[ARQ[&/_ ,(EX:_Z%[2?_ */_P")H_X1+PU_T+VD
M_P#@%'_\36Q11S/N'+'L8_\ PB7AK_H7M)_\ H__ (FC_A$O#7_0O:3_ . 4
M?_Q-;%%',^X<L>QC_P#")>&O^A>TG_P"C_\ B:/^$2\-?]"]I/\ X!1__$UL
M44<S[ARQ[&/_ ,(EX:_Z%[2?_ */_P")H_X1+PU_T+VD_P#@%'_\36Q11S/N
M'+'L8_\ PB7AK_H7M)_\ H__ (FC_A$O#7_0O:3_ . 4?_Q-;%%',^X<L>QC
M_P#")>&O^A>TG_P"C_\ B:/^$2\-?]"]I/\ X!1__$UL44<S[ARQ[&/_ ,(E
MX:_Z%[2?_ */_P")H_X1+PU_T+VD_P#@%'_\36Q11S/N'+'L8_\ PB7AK_H7
MM)_\ H__ (FC_A$O#7_0O:3_ . 4?_Q-;%%',^X<L>QC_P#")>&O^A>TG_P"
MC_\ B:/^$2\-?]"]I/\ X!1__$UL44<S[ARQ[&/_ ,(EX:_Z%[2?_ */_P")
MH_X1+PU_T+VD_P#@%'_\36Q11S/N'+'L8_\ PB7AK_H7M)_\ H__ (FC_A$O
M#7_0O:3_ . 4?_Q-;%%',^X<L>QC_P#")>&O^A>TG_P"C_\ B:/^$2\-?]"]
MI/\ X!1__$UL44<S[ARQ[&/_ ,(EX:_Z%[2?_ */_P")H_X1+PU_T+VD_P#@
M%'_\36Q11S/N'+'L8_\ PB7AK_H7M)_\ H__ (FC_A$O#7_0O:3_ . 4?_Q-
M;%%',^X<L>QC_P#")>&O^A>TG_P"C_\ B:/^$2\-?]"]I/\ X!1__$UL44<S
M[ARQ[&/_ ,(EX:_Z%[2?_ */_P")H_X1+PU_T+VD_P#@%'_\36Q11S/N'+'L
M8_\ PB7AK_H7M)_\ H__ (FC_A$O#7_0O:3_ . 4?_Q-;%%',^X<L>QC_P#"
M)>&O^A>TG_P"C_\ B:/^$2\-?]"]I/\ X!1__$UL44<S[ARQ[&/_ ,(EX:_Z
M%[2?_ */_P")H_X1+PU_T+VD_P#@%'_\36Q11S/N'+'L8_\ PB7AK_H7M)_\
M H__ (FC_A$O#7_0O:3_ . 4?_Q-;%%',^X<L>QC_P#")>&O^A>TG_P"C_\
MB:/^$2\-?]"]I/\ X!1__$UL44<S[ARQ[&/_ ,(EX:_Z%[2?_ */_P")H_X1
M+PU_T+VD_P#@%'_\36Q11S/N'+'L8_\ PB7AK_H7M)_\ H__ (FC_A$O#7_0
MO:3_ . 4?_Q-;%%',^X<L>QC_P#")>&O^A>TG_P"C_\ B:/^$2\-?]"]I/\
MX!1__$UL44<S[ARQ[&/_ ,(EX:_Z%[2?_ */_P")H_X1+PU_T+VD_P#@%'_\
M36Q11S/N'+'L8_\ PB7AK_H7M)_\ H__ (FC_A$O#7_0O:3_ . 4?_Q-;%%'
M,^X<L>QC_P#")>&O^A>TG_P"C_\ B:/^$2\-?]"]I/\ X!1__$UL44<S[ARQ
M[&/_ ,(EX:_Z%[2?_ */_P")H_X1+PU_T+VD_P#@%'_\36Q11S/N'+'L8_\
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M H__ (FC_A$O#7_0O:3_ . 4?_Q-;%%',^X<L>QC_P#")>&O^A>TG_P"C_\
MB:/^$2\-?]"]I/\ X!1__$UL44<S[ARQ[&/_ ,(EX:_Z%[2?_ */_P")H_X1
M+PU_T+VD_P#@%'_\36Q11S/N'+'L8_\ PB7AK_H7M)_\ H__ (FC_A$O#7_0
MO:3_ . 4?_Q-;%%',^X<L>QC_P#")>&O^A>TG_P"C_\ B:/^$2\-?]"]I/\
MX!1__$UL44<S[ARQ[&/_ ,(EX:_Z%[2?_ */_P")H_X1+PU_T+VD_P#@%'_\
M36Q11S/N'+'L8_\ PB7AK_H7M)_\ H__ (FC_A$O#7_0O:3_ . 4?_Q-;%%'
M,^X<L>QC_P#")>&O^A>TG_P"C_\ B:/^$2\-?]"]I/\ X!1__$UL44<S[ARQ
M[&/_ ,(EX:_Z%[2?_ */_P")H_X1+PU_T+VD_P#@%'_\36Q11S/N'+'L8_\
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M H__ (FC_A$O#7_0O:3_ . 4?_Q-;%%',^X<L>QC_P#")>&O^A>TG_P"C_\
MB:/^$2\-?]"]I/\ X!1__$UL44<S[ARQ[&/_ ,(EX:_Z%[2?_ */_P")H_X1
M+PU_T+VD_P#@%'_\36Q11S/N'+'L8_\ PB7AK_H7M)_\ H__ (FC_A$O#7_0
MO:3_ . 4?_Q-;%%',^X<L>QC_P#")>&O^A>TG_P"C_\ B:/^$2\-?]"]I/\
MX!1__$UL44<S[ARQ[&/_ ,(EX:_Z%[2?_ */_P")H_X1+PU_T+VD_P#@%'_\
M36Q11S/N'+'L8_\ PB7AK_H7M)_\ H__ (FC_A$O#7_0O:3_ . 4?_Q-;%%'
M,^X<L>QC_P#")>&O^A>TG_P"C_\ B:/^$2\-?]"]I/\ X!1__$UL44<S[ARQ
M[&/_ ,(EX:_Z%[2?_ */_P")H_X1+PU_T+VD_P#@%'_\36Q11S/N'+'L8_\
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MM!%#&.B1H%'Y"I:*&VQI);!1112&%%%% !1110 4444 %%%% !1110 4444
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MJ***R-PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M<XSM)QG!_*KE>._ G_F/_P#;O_[5KV*KJ1Y96(I3YX*3"BBBH- HKQWX[?\
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M%;2:7KT^92!^E6M-^-#P7(MO$.BR6S;OF>#(*CW1N?U_"O6E544*H 4#  '
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MLH[RQN(Y[>0 JZ'(/^!]CS5FO#O!-[?^ OB!+X7U!BUK=2B(8 P7;'ER#ZY
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MF/?Y6_=MYQC.!G\J\[\6?%G^SM0U70O[$\SR]\'G?:L9R,9V[/?IFNQ^'O\
MR(&C?]</ZFMG6?\ D!ZA_P!>TG_H)J%RJ3NC5J4H)IV/GGP)X[_X0G^T/^);
M]M^U^7_RW\O9LW?[)SG=^E>W>"/%G_"9:+-J/V+['Y=PT'E^;YF<*K9S@?WN
MGM7!? G_ )C_ /V[_P#M6O8JNNUS-6U,\-&7(G?3L%%%%8'4>._';_F ?]O'
M_M*O5=&_Y >G_P#7M'_Z"*\J^.W_ # /^WC_ -I5ZKHW_(#T_P#Z]H__ $$5
MM+^''YG/3_C3^1=I&574JP!4C!!'!%+16)T'@GC_ ,.R>!/%%EKNB?N;>63S
M(E RL4@ZK_ND=OJ.U>V:+JL&N:+9ZG;@B*YB#A3U4]U/T.1^%<M\6[5;CX>W
MDK$@V\L4J^Y+A/Y.:A^#US)/X"CC<_+;W,D:?0D-_-C6TGS4U)[HYH+DK.*V
M>IWDDD<,3RRNJ1HI9G8X"@=23V%>6ZW\9[:.Y:U\/Z<][(&VB:7(5O\ =4?,
M1]<50^*OB"_U37K;P=I;.-[(LZ @>;(^"BD_W0"#Z<^U=]X.\%Z?X1TY8X%6
M6]=?W]T5^9SZ#T7CI_6A1C&/-+J-SG.3C#1+=G -\3O'%FGVJ^\*JED.2YM)
MHQCK]\DCI[5VO@_XAZ3XN_<(&M-0 R;65@=WJ4;^(?@#[5U]>:?$3P-&;<^)
M=!0VNJ66)F6W7'F@'.[ _B'7/?%"<):6L#52G[R=S3\#?$/_ (3.^NK;^R_L
M?D1B3=]H\S=DXQC:,5+XY\=S>"Y+,G2/MD%R&Q*+CR]K+C*D;#V(/7U]*X/X
M&_\ (<U7_KV7_P!"KTGQ]X?/B3PC=V<2;KF,>?;@8R9%S@#ZC(_&B48QJ6Z"
MA*<Z/,GJ;UA>P:EI]O?6K[X+B-9(VQC*D9'TJQ7EWP7\0B\T:XT.9_WUFWFP
M@MRT3'G ]F_]"%>HUG./+)HVISYXJ1A^+?$D/A3P_-JDL/GLK*D<._;YC$],
MX..,GIVIOA#Q#-XHT%=4ETXV*R2,L2&7S-ZCC=G:.^1^%>8?%"^E\3^.-.\+
MV$BD0NL;$_=$KD9)([*N/_'J]DTZPM]*TVVL+5-D%O&L:#O@#'/OZFJE%1@N
M[(A-RJ.VR_,LT445F;'D^M>"]=USXKQ:I=6).C1S18D\Z/[B*#C;G=@L#VSS
M7K%%%5*3E;R(A346VNH5X?XQ"V?QOTR2S3][)/:LZCC<Q8 C\1C\Z]?US6K/
MP_I$^I7T@2&)>!W=NRCW)KR#P%87GC;X@7/BJ]3;;V\OF\-_'C"(..=H _(>
MM:4M$Y/8QKN[C!;W.P^,DDJ>!"L;,%>ZC60#H5Y.#[9 _(5I_#**WB^'NE&W
M"X='9R.[[VW9_'C\*UO$^A1^)/#MYI4CA#.HV2$9V,""I_,5XWX4\8:E\-[V
MXT/7=/F:T+ER@QOC/3<F>&4X]<=P>N2*YJ?*MPF_9U>:6S1[W7EWQPA@;PWI
ML[;?M*7>Q.1G8R,6_54_2MEOBWX/6T,POYFDQGR!;/O^F2-OZUY9XC\07_Q-
M\66%C9PM# 6$5M"WS;<\M(V/89..@7ZDNE"2E=Z6%7JP<.5.[9[9X(N);KP1
MHTLY8R&U0$MU.!@'\A6_4%E:16%A;V< (AMXEB0'KM4 #]!4]8MW=SIBK)(*
M***0PHHHH **** "BBB@ HHHH **** "BBB@ HHHH ^=J]MT+_D7M-_Z]8O_
M $ 5XE7MNA?\B]IO_7K%_P"@"O6S'X8GS61_Q)^AH4445Y1](%%%% !1110
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M/_1*5[?15VCZ#H;S]0KPSPY"G_"_+K&1MN[MQ]2KY_F:]SKQ#PW_ ,E\O?\
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MGC'6.3'((_E[8JW-J":,XTXNI)2W/-_^%?\ Q)_Z&_\ \J5Q_P#$T?\ "O\
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M%)>..( G&=\BJ?R!)_"N1_9NLO+\':K>E<&>_P#+!QU"(I_FY_6@#VBBBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M7Q'EI=(,QMD_=R>4'3J2.,DBO3*^8O%EOH]KXCN8M!F\W3Q@H=VX D9(!/)
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 8.J>#= UO5(]2U*P^T7<854=II  %.0-H;&,D\8[UO444VVQ)):H****
M0PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M&?\ R+=Q_P!?;?\ H"5ZN(_W6/R/F\%_R,9^LOS.SHHHKR3Z4**** "BBB@
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M%% !1110 4444 %%%% 'SM7MNA?\B]IO_7K%_P"@"O$J]MT+_D7M-_Z]8O\
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MBL=2U#S[9HG8IY,:\@<<JH->P4IP<'9E4ZBJ*Z"BBBI+"BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MX>-"<22'^XV.@'<CKQC';U5$6-%1%"HHPJJ, #T%<G_PL_P=_P!!C_R6F_\
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M<6GB;45ZF)_]Y/\ "K">++D??MX6_P!TD?XTO9R'[2)UE%<VGBU"/WEHP/\
MLOG^E6$\56+8WQSH>_R@C^=+DD5SQ[FY166GB+3'ZSE3_M(?\*G35]/DZ7D(
M_P!YL?SI<K'S+N7:*C2XAD^Y-&V?[K U)2&%%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 ?.U>VZ%_R+VF_]>L7_H KQ*O;="_Y
M%[3?^O6+_P! %>MF/PQ/FLC_ (D_0T****\H^D"BBB@ HHHH **** "BBB@
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M>YK45036M.?I=QC_ 'LC^=6$O;23[EU"WTD!I68[HGHI 01D$$>U+2&%%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M'S+N:-%5DU"RDX2[@)]/,&:G5T<91E8>QS2L5<=1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M1[O[.RP^9.?*1\EC\H^8'H!GC^]4/P@\0P0:3J>G7<RQK:@WBE@>(\8<_0$
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M_P!!:N/KL/%7_(+B_P"NP_\ 06KCZWI_"<]3X@HHHK0S"BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J1+B:/[DTBX_NL
M14=% RXFJZ@G2\F_%R?YU83Q#J:=9PP_VD'^%9=%+E0^9FXGBF^7AHX&_P"
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 ?.U>VZ%_P B]IO_ %ZQ?^@"O$J]MT+_ )%[3?\
MKUB_] %>MF/PQ/FLC_B3]#0HHHKRCZ0**** "BBB@ HHHH *^:/'?_(\ZQ_U
M\&OI>N9O_A_X7U.^FO;S3/,N)FW2/]HE&3] V*UI34'=F%>DZD4D:GA[_D6M
M*_Z\X?\ T 5I5';V\5I;16\"[8HD$:+DG"@8 R?:I*R>YLE96"BBB@84444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%<MXN\>Z3X101W!:XOG&Y+6+[V/5CT4?KZ \UYE/\;]
M=:3-OING1Q_W9%=S^88?RK2-*4E=&,Z\(.S9[M17DWA_XUVUS<K!KEB+56.!
M<P,653Q]Y3R!UY!/T[UZK!<0W4"3V\L<T,@W))&P96'J".#4RA*.Y<*D9_"R
M2BBBI+"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M* ,/Q5_R"XO^NP_]!:N/KL/%7_(+B_Z[#_T%JX^MZ?PG/4^(****T,PHHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M^&2=+TO9+JK+EV<96W!&02.[8(('3N?0^':EK>J:Q,9M1O[BY<_\]9"0!G.
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M7_((TG_KN_\ Z"*QI3ESZLZ<13BJ3LMCS_X93R0?$/22AQO9T89X(*-_^O\
M"OH;7M471= O]28 _9H&D4$$@L!P./4X%?.OPX_Y*%H__74_^@-7M?Q28I\.
M-6*G!Q$/P,J"JK*]1(C#.U*3_K8^<;NZFO;N:ZN)#)-,Y=V8Y)).37L?P_\
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M.6P/,V8VX]CZU+X;UX^(;*6Y^R_9UCD\L#S-^> ?0>M<A\29MVJ64']R$O\
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M)%GD] 3D<?2NWH **BGNK>U3?<3Q0KZR.%'ZU%;ZG873;;>^MIF](Y58_H:
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M6;<1_"/EZ'GG\U"E&#NV.IB)58V2T&^"?^1XT3_K]B_]"%?1WBW_ )$S7?\
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MZCBI]<\3Z/X=M9)M1O8HR@R(0P,CG&0 O7G\J^4W1HW9'4JRG!4C!!]* "Q
M ))X '>J^KJ^Y'UR5K6U-7Q+KL_B3Q!=ZK."OG/\D><[$'"K^  ^IR>]>O\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /G:O;="_Y%[3?^O6+_
M - %>)5[;H7_ "+VF_\ 7K%_Z *];,?AB?-9'_$GZ&A1117E'T@4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MPK7@@CMK>.")0L<:A54#H!7E'CJ[>Y\43QM]RW58U'X9/ZDT 9[-J_B:_/\
MK[R?DX'1!_)12WWAK6=-A,UU82+&.KJ0X'UVDX_&O3O"6EQZ9X?ML*OG3H)9
M6'4D\@9]@<5MLH92K %2,$'H: /-_!?BFXCOH],OI6EAF.V)G.2CGH,GL?YX
MKK/&4OD^$[]AU*JOYL!_6O*K]18:W<K;-M%O<L(B.<;6..OTKT7XB2^7X<C0
M?\M+A5/TPQ_H* .8^'L'F^)3)VA@9OSP/ZUWGB/7HM TTSLH>=SMAC/\1]3[
M"N3^&D&;K4+CLJ(@_$D_^RU0^(5V\WB%;<_<MXE 'N>2?Y?E0!BS3ZKXCO\
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MQ,YZL, @GWY_2F>+/%"Z';B"WP]]*N5!Y$8_O'^@JO\ #R#R_#KR9R99V/T
M ']#7">*;M[SQ-?N^?DF,2C.<!?E_IG\: (H[?5O$5[(Z)/>3]78G.!]3P!Z
M"I[C1==T$K=R6\]OMZ2Q.#M^I4G'XUZSI.FPZ5ID-I FT(OS'NS=R?>K<B++
M&T;J&1@58'H0: /"]0OIM2O9+N<@RR8W$#&2 !_2O;--A^SZ7:0?\\X43\E
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M$8?/\5:>GHY?_OE2W]*]DH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 5ES^&]"NG+W&BZ=*YYW26J,?U%:E%
M-.PFD]RO:6%GI\7E65I!;1_W(8P@_(58HHI#"BBB@"K=Z;8:@,7ME;7(QC$T
M2OQZ<BJL/AG0;=MT.B:;$WJEI&I_05J44[L7*@HHHI#"BBB@"K>:9I^H@"^L
M;:Y &!Y\2O@?B*J1>&- A.8M#TR,]<I:1C^E:M%.[%RH****0PHHHH SKO0-
M&OY/,O-)L+E\D[IK9'.3UY(J:STK3M/.;*PM;;C'[F%4X].![#\JMT4[L5EN
M%%%%(84444 %%%% !1110 54O=*T[4@!?V%K= =!/"KX_,5;HH!JY2LM(TS3
M238:=:6I(P3! J9'7' J[110"5M@HHHH *K7FG6.HHJ7UE;W2KG"SQ*X&>O4
M59HH#<HV6BZ5IKE['3+*U8]6@@5#^@J]111<226P4444#"BBB@ K/US5[?0=
M$N]4N?\ 56T9<C.-QZ!1[DD#\:T*\\^*6D>)/$%G::9HM@9[4,9;A_.C0%AP
MJ_,0>.3Z<BJ@DY69%23C%M+4\&OKV?4;^XO;I]\]Q(TLC8QEB<GCM7TC\._#
MG_"-^$;:&6/;>7 \^XRN&#-T4]_E&!]<UYAX4^%>O#Q+9R:WIP@L(G\R0F:-
M]VWD+A6)Y/%>]5O7FFE%'+A:33<Y(****YCM"BBB@ HHHH *H7>B:3?DF\TN
MRN">IFMT?W[BK]%%Q-)[F9!X<T.V8-;Z-IT3 Y!CM44@_@*TZ**+W!)+8***
M*!A1110!ES^&=!N93+<:)ILLAZO):1L3^)%7+6PL[%66SM(+=6ZB&,(#^7U-
M6**=V*R04444AA1110 4444 075C:7R!+NU@N$'(6:,.!^=4$\+>'HSF/0=+
M4],K9QC^E:U%.[$TGN-1$CC5$4*B@!548  ["G444AA1110!1O=&TO4CF^TV
MSNCP<SP*_P#,46FBZ5I[A[+3+*V8=&A@5"/R'N?SJ]13NQ66X4444AA1110
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MYQ\UU, TA]<'' ]ABLIUHQVU.BGAIRWT1Y_X)^$1W)J'B9!C :.R#?CER/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 ?.U>VZ%_P B]IO_ %ZQ?^@"O$J]MT+_
M )%[3?\ KUB_] %>MF/PQ/FLC_B3]#0HHHKRCZ0**** "BBB@ HHHH ****
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M"<]3X@HHHK0S"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M<0/#[F+LQNP#^6S^M4J4VKI$RKTXNS9Z]17)^%_B)H7BF06]O(]M>;<_9[@
M%O7:0<-_/VIUOX^TJY\9'PNEO>"^#NGF%%\O*J6/.[/0>E3R2VL4JD&D[[F[
MK/\ R ]0_P"O:3_T$UY5\"?^8_\ ]N__ +5KU76?^0'J'_7M)_Z":\J^!/\
MS'_^W?\ ]JUI'^'+Y&53^-#YA\=O^8!_V\?^TJ]5T;_D!Z?_ ->T?_H(KRKX
M[?\ , _[>/\ VE7JNC?\@/3_ /KVC_\ 011+^''YA3_C3^1=HHHK$Z#S/XR:
MIJ&EZ7I;Z??W5HSS.&:WF:,L-HX.",USND^$?B'K&DVNHV_BR18;F,2(LFHW
M 8 ^N%(_6M?XY?\ ((TG_KN__H(KM_ O_(BZ)_UZ)_*NCFY:::.1P4ZS3//)
M/!?Q/LX=\/B4W# Y"+?RDG_OM0/UIWA_XEZUHNNC0O&4(&'$;7#*%>(GH6Q\
MK+[CMSDU[#7CGQTMH ^BW0 %PPEC)SU4;2/R+'\Z4)<[Y9(*D'2CSP>Q['16
M/X2EEG\':++,")&L8223G/R#G\>OXUK221PQ/+*ZI&BEF=C@*!U)/85BU9V.
MI.ZN.HKS?6_C+H>G3O!IUO-J3IP9%81QD^S')/UQCTS67;?'2V:91=:#+%%D
M9:*Y#D#OP57^=6J4VKV,GB*:=KGKE%87ASQAHOBJ-SIEUNE09D@D7;(@]<=Q
M[C(YK=J&FM&:IJ2N@HK%\3>*--\*Z;]LU"0Y;(BA3EY6] /YGH*\^B^.EH;L
M+-H4R6V>9$N SX_W=H'_ (]51IRDKI$3JP@[29ZW167H/B#3?$FG+?:9<"6(
M\,I&&C;^ZP[']/3-5_%/BFQ\(Z9'?W\5Q)%),(0(%4MN*L>Y''RFIY7>Q7,K
M<U]#<HK!_P"$PT=/#$'B"YG-K93)O03 >8><8"@G)^F:X6]^.5C',RV.B3SQ
M#H\TXB)_ !OYU2IRELB95H1W9ZQ17FFD?&G1+V9(M1M)]/W=9,^:@/'< '].
MU>C6US!>6T5S;2I+!*H9)$.0P/<&E*$H[H<*D9_"R6BBJNHZE9:18R7NH7*6
M]M']Z1SQ_P#7/M4EMV+5%>5ZC\;],@F=-/TJXNU4X5Y)!$&]^A--L/CCITLJ
MK?Z/<VR'@O%*)<?@0M:>QGV,?K%*]KGJU%4M*U?3]<L$OM-NDN;=C@.F>#Z$
M'D'V-7:S-D[ZH**Y74_'VE:5XKM_#L]O>->3O$BNB*8P9" ,DL#WYXI?%'C_
M $/PHX@NY7FNR,_9[<!G'3&[D!>O>JY)=B'4BKN^QU-%>0K\=83,0WA^019X
M878+8^FS^M>A^&_%FD>*K0S:9.2Z &2"0;9(\],C^H)%.5.4=6A0K0F[19MT
M45P?BSXJ:5X:OFL((&U"[CXE6-PJ1G^Z6P>?H#BE&+D[(J4XP5Y,[RBO--"^
M,^CZC<K;ZG:2Z:7.%E+^;&/]XX!';MCUQ7I2LKJ&4@J1D$'@BB47'<4*D9J\
M6+14<]Q#:P//<2QPPQC<\DC!54>I)X%>;ZO\:M%LIC%IME<:AM)!D+>4A],$
M@D_D/QHC"4MD$ZD8?$STRBO)+3XZ6CS 7FA30Q?WH;@2'\BJ_P Z]"\/^*M'
M\3P/+I=V)6CQYD; JZ9Z9!_G3E3E'="A6A/2+-FBBBH- KGO'5S/9^"-6N+:
M:2"9(<I)$Q5E.1R".170US/Q"_Y$#6?^N']151^)$5/@9Y)X5TSQUXOLI[K3
M_%-S%'#)Y;"XU"=23@'C /K70#P'\2X@S+XL#''W3J$YS^:XK0^!_P#R+FI?
M]?8_] %>HUM4J.,FD<]*C&4%)MGB!\7^._ -]##XBC-[:2_=\U@VX#KMD7G/
MLV?ISFO8M)U2UUK2K;4K)]]O<)O0GJ/4'W!R#[BN:^*EM!<?#S46F S"8Y(S
MG&UMX'\B1^-9'P3EE?P==HX/EQWS!#GU1"1C\<_C4RM*'-;4J#<*GL[W1Z31
M17(^)OB-H/AF9[::5[F]3&ZW@&2O3J>@X.<5DHMNR-Y245=LZZBO(3\=8O.(
M'A]S%V8W8!_+9_6NR\+_ !$T+Q3(+>WD>VO-N?L]P "WKM(.&_G[53I32NT1
M&O3D[)G645RMOX^TJY\9'PNEO>"^#NGF%%\O*J6/.[/0>E;&OZW;>'-$N-6O
M$E>"#;N6$ L=S!1@$@=2.]+E=[%J<6F[['E_QV_Y@'_;Q_[2KU71O^0'I_\
MU[1_^@BO!?B5XWTWQE_9G]G07<7V7S=_VA%7.[9C&UC_ '37<Z1\8/#ZVUA8
M&SU/S0D<.?*CV[L ?W^E;2A+D2L<L*L/:R=]['IU%%8/B3QAHWA6 /J5SB5A
MF.WB&Z5_H.PX/)P/>L$FW9'6VHJ[-ZBO(9_CK"LI%OX?DDC[-)=A#^00_P Z
MV-&^,N@7\BQ7\-QISLV SCS(_;+#D?ECWJW2FNADL13;M<]&HIL<D<T22Q.K
MQNH974Y# ]"#W%.K,V"BBB@ HILDD<,3RRNJ1HI9G8X"@=23V%>=:S\9=!L)
MC%I\$^HLIP77]VGX$C)_*JC%RV(G4C#XF>CT5Y):?'2T>8"\T*:&+^]#<"0_
MD57^==]9^+]'U'P[=:W8W!N+:UA>69$&)%VJ6*E3C!X..Q]<4Y4Y1W0HUH2V
M9NT5SWA3QAI_C"VN)]/ANHEMW",+A54DD9XPQJMXK\?:5X/NK>WU"WO)7G0N
MIMT5@ #CG+"ERN]NH_:1Y>:^AYUI7_)PLG_7S/\ ^B7KV^OG"R\7Z?;?%-O%
M#PW)L3-*_EA5\S#1LHXW8ZGUKV'PM\1-(\7:G)86%M?1RQPF8F=$"[0RCLQY
M^85K6A+1VZ'/AZD=5?=G74445@=9RGQ)N[FP\ :G<V=Q+;SIY6V6%RC+F5 <
M$<C@D5YCX:T+Q]XIT@:E8^*IXX2[)MGU"<-D?0$?K7I'Q4_Y)OJW_;'_ -')
M5+X._P#(A1_]?,G]*WB^6G==SEJ1YZRB^QS$G@CXG6PW1>)7G)XPNHRG'_?8
M JM<:G\5/":&XO0]U:*V6+JDZ'IU*_,H_$5[=14^U?5(KZNOLR:.%\%_$W3_
M !1)'8W,8LM3(XC+924@<[#Z]3M/YFNZKQGXI^!HM-7_ (2;1D-OMD!N8XOE
M",3Q(N.G.,^Y!]:[SX?>)_\ A*?"T-Q,P-[ ?)N0.[#HWXC!^N?2B<5;FCL.
MG.7-[.>YU5%%<OXF\?:%X6<P7D[2WFW<+:!=SCCC/9>W4YYZ5FDV[(VE)15V
M=117D+_'6(283P^[1_WFNP#^6P_SKK/#'Q+T+Q-<+:(TEG>M]V"XP-_^ZPX/
MTX/M5NE-*[1G&O3D[)G945RMQX^TJV\9#PN]O>&^+HGF!%\O+*&'.[/0^E;.
MNZS#X?T>?4[B">:"  NL 4L 3C."0._K4<K+4XN^NQHT5B>&/%6G>+=->]T_
MS55)#&\<P4.I]P">#VK;H::=F---70445R?A_P"(6D^)M;ETO3K:^9XE9FF9
M$\K:IQG(8G!XQQ0DWJA.232?4ZRBBBD49VN:S:>']&N=3O6Q# F<#J[=E'N3
M@5X]%/XV^*5T\EK,-/TJ-P.'*1J1VR/F=L'Z=.G%=#\9+75]2MM*L--TZ\NX
M0[S3&W@:0!@ %SMSC@O7=>&-(CT/PUI^GQJ%,4*^80NW<Y&6)'N<UM%J$>;J
MSFDG4J.+V1Y?+\$=0MH1+8>((C=<?*\+1*/^!!F/7':E\*>/-<\.^(U\-^+G
M=T+B(33L"\+'H2_\2'/4G@'.<#%>S5Y'\<K*W^Q:5?X N1(T.>[)C/Z'^=.$
MW-\LB:E)4EST]+'KE>1>+?'^L:QX@/AGP@#YF_RWN8\%W8==IZ*H[M[=0.O=
M6.J73_#F'52S?:QI0GWN,DN(L[N>N3S7!? ZS@?^V-1;#70*0ACU53EC^9 _
M[YI022<GT+J2<G&$7:Y$OP7U74(3<:KXC'VU\L5,;3<GU<L#G/7BL]K[QA\+
M-4A6_F-_I4KGJY:.3U )Y1\#Z?6O=:YWQY8Q:AX%UF*8<1VKSJ?1HQO'ZK1&
MJV[2V%*A&*YH:,U=)U2UUK2K;4K)]]O<)O0GJ/4'W!R#[BKM>9?!.]DG\+WM
MHYRMM<Y3CH&4''Y@G\:]-K.<>631M3GSP4@HHHJ2PHHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ^=J]MT+_D7
MM-_Z]8O_ $ 5XE7MNA?\B]IO_7K%_P"@"O6S'X8GS61_Q)^AH4445Y1](%%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110!Y#XU_P"1NOO^V?\ Z+6NW^&?_(MW
M'_7VW_H"5Q'C7_D;K[_MG_Z+6NW^&?\ R+=Q_P!?;?\ H"5ZN(_W6/R/F\%_
MR,9^LOS.SHHHKR3Z4**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M+N ?]JW<?TI68[HLT4U7#C(#?BI'\Z=2&%%%% !1110 4444 %%%% !1110
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M@3_S'_\ MW_]JU,?X<OD74_C0^8?';_F ?\ ;Q_[2KU71O\ D!Z?_P!>T?\
MZ"*\J^.W_, _[>/_ &E7JNC?\@/3_P#KVC_]!%$OX<?F%/\ C3^1=HHHK$Z#
MRCXY?\@C2?\ KN__ *"*@\-_%O0-'\-Z=IUQ::DTUM L;M''&5) [9<']*G^
M.7_((TG_ *[O_P"@BHY? %GXA^%^E7&GVL$&JQVJRJ\<84SG'*N0,DGMGO\
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MJ\(_>7,RAB3P<#/0<"NCN["SU"+RKVT@N8_[DT8<?D:\E_XO/_G['1_Q>?\
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MIK;<\H^*=W-I_P 31>V[!9[=()8V(SAEY!Q]17?>!_A]:6]HFM:_"+_6+O\
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MN[QMUS(93(Q&"6$+@D^_%?0=U:6U_;/;7EO%<0/C=%,@=6P<C(/!Y ->+:7
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M/L+J[9)G++;PM(5&T<G .*[#P9;S6O@S2(+B*2&:.U17CD4JRG'0@\BMI/\
M=HYXI^VD_(\[^*GA":QNAXNT8M#(C!KD1#:R-GB48_7\_6NT\!>,8?%NB*[L
MJZC;@+=1XQSV<#T/\\BNJDCCFB>*5%>-U*LC#(8'J".XKQ&]\.>(/A_XZ6_\
M/6-Y?:?+EMD$3R#83\T;A>XZ@_0]C1%J<>5[H4DZ4^>.SW/<*\)24?#_ .,D
MSW0\JPNG8[MQ"B&4Y!]PK#'_  '\:]PL[D7EG#<B*:(2H'\N9"CID=&4]"*Y
MSQQX*M?&.EB-F$-_ ";:?L">JMZJ<#W'7V,TY*+L]F76@Y)..Z.H5E=0RD%2
M,@@\$4M>'6'B#QU\/+<6&H:2UUI\9"QM(I94'8+(O&#Z'.,=N:L3_&K5;X&#
M2= C2X887=(TY^H4!:?L9=-B?K,+>]HSOO'GC./P?HZS1K%-?S,%@@=NH[L0
M.<#^9%:WAS6&U_0+35'LWM#<)O$3.&P,\$$=0?H/I7EWA[P!KGBS6QKWC,R+
M"<$6\GRR2 =%VC[B^W!]N<U[*JJBA5 "@8  X I348JRW*IN<FY/1"UG:WH6
MG^(=-DL-1@66)QPW\2'^\I[&O-/%L7CCPYXSF\1:<9M0L74#9&A9$C'/EN@Y
M ')W#USD9(JA=_&'6]6M&L-)T,PZ@Z[#)&S3,#P,JFT8.>F<]135*6CBR95X
MJ\9K_@DOPBDN-,\9Z[H'GB2VB21C@Y4O'($W#ZAC]<"MWXV_\B99_P#803_T
M7)4WPQ\$77AV&XU75N-2NUV^62&,:9R<G^\2 3SV'>H?C;_R)EG_ -A!/_1<
ME7=.JK$<KCAVF6?A)XAAU7PG'ISRK]LT_,;)W,><JWN.<?A[BO0*\.L? VJK
MX;T7Q1X2F>+4_(S-$' W\GE<\'I@J>#_ #N)\8=<TD+;ZYX<!N%RI.YH"Q'L
M5/XX]>U*5/F;<1TZW)%*H>RUX1XSO1X]^)5EI&G_ +VV@86_F(=P;G,C@CL!
MQ_P'/>I;WQCXV\>))IVC:6]M9R_+(8%/*GL\K8 &/3&>?I7?> OA_;^$+=I[
MAX[G5)1AYE'RQC^ZF><>IXS0E[/5[A*3K6C';JSH];TM-6\/WVEX55N+=HDS
MP%)'RG\#@_A7E'P?U@Z1K&H>&=1+032ONBCDR,2KD.N/4@#_ +Y^E>T5YO\
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M7\O;Y+ '>1@Y/?/)->UTZS3:MV%ADU%W[GCOQV_Y@'_;Q_[2KU71O^0'I_\
MU[1_^@BO-OC1I&I:K_8G]G:?=WGE^?O^SPM)MSY>,[0<9P?RKTK24>/1[%'4
MJZV\896&""%'!I2_AQ'!?OI?(X_XN:+)JO@M[B!-TMA(+@XZ^7@A_P @=W_
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MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ^=J]MT+_D7M-_Z]8O\
MT 5XE7MNA?\ (O:;_P!>L7_H KULQ^&)\UD?\2?H:%%%%>4?2!1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 >0^-?^1NOO\ MG_Z+6NW^&?_ "+=Q_U]M_Z
ME<1XU_Y&Z^_[9_\ HM:[?X9_\BW<?]?;?^@)7JXC_=8_(^;P7_(QGZR_,[.B
MBBO)/I0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M^<?VE+#R]?T/4<?Z^UD@)_W&W?\ M2O>_#E__:OAC2=0SDW5G%,3[L@/]:\L
M_:/L/.\&:9?@9:VOMA]E=&S^JK75?!J__M#X5:*Q.7A1X&]MCL!^F* .\HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KS;XV_\
MB99_]A!/_1<E>DUA^*?"UCXNTR.POY;B.*.83 P,H;<%8=P>/F-7!I239G5B
MY0:15^'O_(@:-_UP_J:Z:J.C:5!H>CVVF6SR/#;IL1I2"Q'O@ ?I5ZID[MLJ
M"M%)A1112*"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M IZMJ4&CZ3=:C<Y\FVB:1@.IP.@^O2O(/A/IL_B#Q9J/BG4=LC1,Q4D=9GY)
M'H%7/'^T,=*]3\2^'+7Q3I/]FWD]S# 9%D8V[*&;&< [@>,\_@*D\/:!9>&=
M'BTRP\PPQEFW2L"S$G))( 'Z=JTC)1BTMV8R@Y5$WLC4HHHK,V"BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M9--.S.B,E)704444AA1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 ?.U>VZ%_P B]IO_ %ZQ?^@"O$J]MT+_ )%[3?\ KUB_] %>MF/PQ/FL
MC_B3]#0HHHKRCZ0**** "BBB@ HHHH \F^+WBJ:!HO#UG*\8>/S+IE.-RG[J
M?ID_4>]<SX"^'[^*6:^O9'@TV)L?*OS3GN%/8#N>?3Z8GC:Z>[\;ZS*Y)*W3
MQ\^B'8/T45]">&+*+3O"VEVL*J%2V3.T8RQ&6./<DG\:ZI/V<$EU."$?;56Y
M;(KVG@KPS9P+$FB6+A0!NFA61CCN2P/-8/B#X5:#JEN[:=%_9UV =C1DF-CZ
M,I[?3'7OTKO**YU.2=[G8Z4&K-'C_@3X<:QI_B,:CJ4C6<=G(0@B?YIR/_9#
MWSUZ8]/8**Y7Q_XI?PKX>,]L ;VX?RH-PR%.,EB/8?J1VIN4JDB8QC1@RYKO
MC+0O#K^7J-\JSX!$" N_/3@=/QQ7.V_QB\-33K')%J$"D\R20J57Z[6)_(5Y
M'HFA:MXRUIXK<F69R9)[B8G:N>['U/ZUV]Y\%+R*S,EIK$4]P!GRG@,8/'0-
MN/\ *MO9TXZ2>ISJM6GK!:'K&F:MI^LV@NM.NXKF$\;D/0^A'4?C5VOF/1M7
MU/P=XB\Q/,AE@D\NY@)X< _,I'0]^?Q%?2>GWT&IZ=;WUJ^Z"XC$B'O@CO[U
ME4I\GH;4:WM%KN<]!\2/"=S<100ZMNEE<(B_9Y1DDX Y6DU[XB^'O#]P]M/<
M27%RAP\-LN\J<]"20H/MG-?.:LR.KHQ5E.00<$&O1]%^$&HZEI"7MWJ$=E+*
MF^* PES@C(WG(VGVP<?7BMI4H1U;,(XBK/2*U/0]!^(_A[Q!=K:0S2VURYQ'
M%=(%+GT!!(S[9S76U\K:QI=SH6LW.G7) GMGVEER >X(SV(((^M?1G@W49]6
M\'Z9>W+%YI(<.QZL5)7)]SC-9U::BDT:T*TIMQENC9GGAMH'GN)4BA0;GDD8
M*JCU)/2N*O\ XL^%[&5HXY+J\*MM)MXLC\"Q&1]*\X^(WC&XU_69K""5ETRU
M<HJ*<"5@<%SZ\]/3\35GP[\)M5UBRCO+VZCT^&5=T:LADD(/0E<@#\\^U4J4
M4KS9,J\Y2Y::._T_XL>%[Z7RY)KFS)'!N8N#[94MC\:[2">&Y@2>WE26%QN2
M2-@RL/4$=:\.U[X1:MI=H]SI]RNI*G+1I$4D(]0N3GZ YKL?AGX8\1^'XI6U
M*=(;.89^PGYV#?WL@X4_GGO@CB9PA:\653J5>;EG$]$KF=<\?>'O#\LD%U>&
M6Y3AH+==[@^A[ _4BL?XG^,+CP[IL-CI[E+V\#?O1UBC'!(]&). >V#WQ7E'
MA7P=J?B^[D%L1%;QG][<RYV@^@]6]OSQ1"DFN:6P5:[4N2"NSUBR^+WABZG$
M4OVVT4_\M)X1M_\ '&8_I7:V5]:ZC:I=6=Q'/ XRKQMD&O'-6^#.H6=DTVG:
ME'?2H"3"T/E,W^Z=Q!/7KBN9\%>*[GPIKD;O)(+"1MMU".01TW8_O#K^G>J=
M*,E>#(5><)6JH^B[NZAL;.>[N'V001M+(V"=JJ,DX')X%8.G>/O#.JW\-C9:
MGYMS,<1IY$BY.,]2H':K?BAUD\&:RZ,&1M/G*LIR"/+;D5\RVYG$Z"V,@F;Y
M%$>=QSQ@8]<X_&II4U-.Y=>NZ;21[_J_Q2\,Z3<- )YKV13AOLB!@/\ @1(!
M_ FK_AWQWH7B:;[/93O'=8+"WG3:Y ZXZ@_0'/!KSJV^"VI2:>)9]4MX;LJ#
MY'EEE!]"X/IZ \_G7GC+>:+JK+E[>]M)L9'!1U/^(JU2A)6B]3*5>K!IR6A]
M'>(?&>B>&2$U"Z/GD B"(;GP<\X[#CO6%8_%WPS>7*PR?;+0-QYEQ$-OX[68
MC\J\_P##?@/5_'0FUF^OS!%,Y_TB5"[RL.I R. >.O; Z5B^+_"%YX0U".WN
M)4G@G4M#.BE0P!P00>A''&3U'-$:4+\K>H2KU;<Z6A]*1R)-$DL3J\;@,K*<
MA@>A![BO,/&=E\/+CQ),=8U&YLM23;]H6W1\/E003\C#ICICKSS5KX.:G)=>
M&[JQD8M]CG^0DDX5QG'YAC^->>?$_P#Y*)JO_;'_ -%)4TX6FXW+K54Z2E;<
M]J&O>'/#WAFQO%G2UTB0+';,D+D'()' !/(!.2/K7SGJT\=SK%]/"VZ*6XD=
M&QC(+$@\U[%=>&+WQ7\*O#]C8RV\<L8BF)G8A=H1AV!Y^85XO=VSV=Y/:R%2
M\,C1L5Z$@X./RK2BDK]S'$RDTKK0^DO#7BG1=>B6UTV\\^:"%3(OE.NWMU8
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH ^=J]MT+_D7M-_Z]8O\ T 5XE7MNA?\
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M, 0+@/R,\J"1^HKWOQ-&D/@K6(HU"HFG3*JCL!&<5X/\//\ D?M(_P"NI_\
M06I4G[LF.NK3@CZ2KYK\?QK%X[U=5'!GW?B0"?U-?2E?-OQ#_P"1^U?_ *ZC
M_P!!6IP_Q,O&? O4]W\'0B#P7HJ CFSB?@8^\H/]:X?XV*#IFDMCYA-( ?JH
M_P *[SPI_P B?HG_ %X0?^BUKA/C7_R"=*_Z[O\ ^@BII_Q"ZO\ !(O@E_QZ
M:S_UTB_DU<9\3_\ DHFJ_P#;'_T4E=G\$O\ CTUG_KI%_)JXSXG_ /)1-5_[
M8_\ HI*VC_%9S3_W>/K_ )GMG@G_ )$C1O\ KU3^5?.FN_\ (P:E_P!?4O\
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M0A(_45P/P2_X]-9_ZZ1?R:O0/%?_ ")^M_\ 7A/_ .BVK.I_$.BC_!^\^?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M=)VO%W'&NK\LE9GI%%%%9&X4444 %%%% !1110 4444 %%%% !1110 4444
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M=.X*NKVDK'JE%%%9&X4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M:*;DVK,%"*?,EJ4]4TFPUJQ:RU&V2XMV.2C=CZ@CD'W%><WGP4L))&-EK%Q
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M\%/^03JO_7=/_036OLU[/G,/;/VOL['J5%%%9&X4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 >0^-?^1NOO\ MG_Z+6NW^&?_ "+=
MQ_U]M_Z E<1XU_Y&Z^_[9_\ HM:[?X9_\BW<?]?;?^@)7JXC_=8_(^;P7_(Q
MGZR_,[.BBBO)/I0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH *;)&LL3QN-R.I5@>X-.HH ^8/@9(VB?%N]TF0G,D$]J0>[(P;_V0
MU]/U\O'_ (IO]I[^X)-6_2X7_P"VU]0T %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M2^./R,X?PY_,I?!W_D0H_P#KYD_I73>+?^1,UW_L'W'_ *+:N9^#O_(A1_\
M7S)_2NF\6_\ (F:[_P!@^X_]%M6<OXGS-J?\%>AP'P-_Y!&K?]=T_P#037J]
M>4? W_D$:M_UW3_T$UZO16^-AA_X2/(/C1H31/8>)+4%9$(@G88ZCE&^OWAG
M_=KT?PMKL?B3PW9:HFT/*F)47HD@X8?3.<>V*GU_28M=T&]TN8+MN8B@)_A;
MJK?@P!_"O$?!?C*;P39:_I-\K)-&K/;(^?EG!VE<8[\'M]P^M6ESPMU1G)JE
M5N]F7O&LLOCKXGVOA^V=_LMH_D.57.PYS*_Z <]U%>VV\$5K;Q6\$:QPQ($C
M11@*H& !^%>4?!;0#Y-[XCN?FEG8P0,QR<9R[?B<#U^4^M>MU-5ZJ*Z%4$VG
M-[L****R.@\6^.=S(;_2+7<?*6*23;G@DD#/Z?K7L5G:QV5C;VD0 C@C6-0!
M@ *,#C\*\R^-FARW6E6.L01EOLC-'.0.0C8P3[ C'_ J[#P+XAB\2>%;.Y$N
M^YB18;D$DD2*!DG/KU_&MI:TTT<\-*TD^ITE%%,FFCMX))YG"11J7=CT4 9)
MK$Z#Q/Q !IGQZLIH&,9GN;?=L&/O@(WY\Y^IKV^O"_#9E\;_ !BEUF%6^QV\
MOG[F'1$&V,>Q.%./J>U>Z5M5TLO(Y\/KS-;-GB&E?\G"R?\ 7S/_ .B7KV^O
M$-*_Y.%D_P"OF?\ ]$O7M]%;=>@8?:7JPHHHK$Z#QKXYV4GG:1?!?W6V2%FS
MT/! _G^5>G^&+M+_ ,*Z3=1XQ):1D@'.#M&1^!R*I>.?#A\4^%KG3X]OVE2)
M;<MT\Q>@SVR"1^-><?"CQBFD3R>&-6?R%:4_9V?@))G#(?3)Z>^1WK>W/3TZ
M'+?V=;7:1[51116!U!117&:W\3-#T/Q#!I,K/,22MQ+#\PMVZ $#DGKD#D>A
M/%-1<MB92C%7DSH/$5S)9^&-6NHF*RPV<TB,IP00A((/X5YK\#+:,6FL76T&
M4R1Q[L<@ $XS^/Z5ZI>VL>I:9<6DF1%<PM$V1SAE(/!^M>,?"S49/"_C'4/#
MFJDPO<,(E4YQYRG  ]F!.#WX]16L-822,:FE6+>Q[A1116)T'#_%NU2X^'MY
M*V,VTL4J\9Y+A/PX<T?"6Y>X^']HKNS>3))&-W8;B0/UK!^-.OQ)IMKX?A;?
M=3R":55_A09V@^Y;_P!!]Q7:>!='ET'P9IMA.H$ZH7D&,$,S%L'W&<?A6STI
M*_<YUK7;71'EOQAA%Q\0M+A;[LEG$A^AED%>Z5XA\6?^2E:-_P!>T'_HYZ]O
MHJ?#$*/\285X3XIM8YOCQ;1N RR7=HSJPR" J<8]"!7NU>(>)/\ DOEE_P!?
M-K_Z"M%'=^@8GX5ZH]OHHHK$Z#Q#PW_R7R]_Z^;K_P!!:O5_%O\ R)FN_P#8
M/N/_ $6U>4>&_P#DOE[_ -?-U_Z"U>K^+?\ D3-=_P"P?<?^BVK>I\4?D<M'
MX)>K.!^!L"+HVK7  WO<(A/LJY'_ *$:]6KP[X+^(8;+4[O1;F546\Q) 6[R
M#@K]2/\ T&O<:FLFILO#-.FK!7!_%ZQCNO -Q<,H+VDT<J'N,L$/_H==Y7DW
MQG\1Q"QM_#EN0]S+(LTX5L[%'W5(]22#]![TJ2;FK%5VE3=SI/A1/)/\/-/$
MASY;2HI)YQO./YXKA=*_Y.%D_P"OF?\ ]$O7J'@G1VT+P=IMA*FR98M\HQR'
M8EB#[C./PKR_2O\ DX63_KYG_P#1+UI%W<VO,QFFHTT^Z.W^+=S);_#^Z6-B
MOG2QQL0<<;LD?I7G'A"W^)$'A^.3PS&%TV=VD4C[-\S9VL3O^;JN.?2O6_'N
MBR:_X,U"R@3?<!!+"O<LIW8'N0"/QKD/@QXAAN-&FT&60+<6SF6)6;[T;')P
M/8_^A40E:F[*X5(WK*[MH4/^+S_Y^QT?\7G_ ,_8Z]BHJ/:_W4:>P_O/[SP'
M6_!_Q*\1745SJMCY\T*[$<36R$#.?X6'>O>+0SFR@-R +@QKYH&.&QST]ZX6
MX^):CX@1>';&R6]MV80O-%( PDZDC/!"C.1QSGGC!] HJ2DTKJP48Q3;B[GE
M'QR_Y!&D_P#7=_\ T$5W_A+_ )$S0O\ L'V__HM:X#XY?\@C2?\ KN__ *"*
M[_PE_P B9H7_ &#[?_T6M.7\-"A_&E\CD_C/<R0>!XXT8A9[R.-P#C("LV#Z
M\J/RKBO#%O\ $ZW\/VP\/QA--<&2+'V7YLDY)W_-U]:])^)VBR:WX'NT@3?/
M:D72+Z[<[L>^TM63\'O$,.H>%_[(=P+O3V(VELEXF)(;\"2O'3 ]:J,K4]%<
MB<;UK-VT,/\ XO/_ )^QT?\ %Y_\_8Z]BHJ/:_W4:>P_O/[SP+4_"'Q)UC5H
M=4U#3Q->0A0D@FMTP%.1PK 'DU[[7 6GQ*&H?$(^'K"Q6ZLR?+6YCD&=R@EW
M]"H''KQWR!7?T5')V35@HQBKN+N%%%%9&YXA\<O^0YI7_7LW_H5:WC[X>VMU
MX9M]6T6SA@N;6!6FA@C""9,9)PHY8=?<9]JR?CE_R'-*_P"O9O\ T*O9[#_D
M'6W_ %R3^0KH<G&,6CC4%.I-/R/-/A3JNA:QI_V"?3-/CU>V7EUM44SQCHV0
M.2._X'O7J=>'>/\ PY>>"?$4/BC06\FVDESMC7 AD[J0.-C<\?4>E>K>%?$M
MGXJT2+4+4X?[LT1ZQOW'T[CVJ:D;^^MF:496_=RW1I:A.UMIMU.GWHH7<?4
MFOG+P1#XPFO;Z\\*KON554N)6,);#$D?ZSU*D\>G-?2<L230O%(H:-U*LI[@
M\$5X=\/[L^"?B)?Z#J3>6D[?9][,0NX',;?\"!X_WJ=)^[*Q.(5YQN[(TO\
MB\_^?L='_%Y_\_8Z]BHJ?:_W47[#^\_O/#=9T/XK>(+#[%JEL+BWWA]F^U7Y
MAT.5(/<UZ1\.],U71O!UOI^KP^3<0R.%3>K80MD<J2.YJEX]^(,?@][."WAB
MN[N5MTL+/C9$/IT)[?0\&NOL+EKW3[>Z>!X&FC5S$Y!*9&<$CBB<I.*NK(5.
M$5-V;;//_B+\/+C7;E-<T1RNJQ[0\>_;YFW[I5OX6''M],<XGA_XLZAI5T-+
M\7V4@:/Y3<",I*O7[Z=^W(QTZ&O8ZP/%WA;3_%&C36]W&BS(I:"X/!B8#@Y_
MN^H]/?%$9IKEEL.=)I\]-V?YFU;7,%Y;17-M*DL$JADD0Y# ]P:\B^.W_, _
M[>/_ &E5KX':A<3:9JUA(Y:"VDCDB!/W2X;<![?(#^)JK\=O^8!_V\?^TJJ$
M>6K8BK/GH<W];GJNCP):Z)86Z !(K:-% ] H%7:YCP!XAA\1>$K.82JUS @A
MN4[JZC&3]0 ?QKIZQDFG9G1!IQ305X?X[@_LKXRZ5=VX"/</;3M@GD[]AS]0
MG/\ ]>O;I)(X8GEE=4C12S.QP% ZDGL*\+LYSX^^,D=[!&38VTBR GD>7%T)
M_P!YNW^UBM:.[9CB-4H];G??%NYDM_A_=+&Q7SI8XV(..-V2/TH^$EK';_#R
MRE0 -<22R/@8R0Y3GUX45J>/=%DU_P &:A90)ON @EA7N64[L#W(!'XUQ_P8
M\01RZ5<>'[B0BYMY&EA1B>8SC<!]&R?^!?6A:TM.X/2NF^J/5****Q.@\B^.
MEK&;71KO $BO+&3CD@A3R?;!_,UZ7X>N7O/#6E74CL[S6<,C,W4DH"2??FO(
M/BCJ#^*O&FG^'-,_>O;L83UQYSD;L^R@#)[<^E>U6=LME8V]JARL,:Q@XQP!
MC^E;3TA%,YZ>M636QXA:VL=W\?VBD *K>R2#(SRB%Q^JBO=J\0TK_DX63_KY
MG_\ 1+U[?16Z>@8?:7JPKQ#QB2OQSTD@D'[19CC_ 'A7M]>(>,O^2Y:3_P!?
M-G_Z&M%'=^@8GX5ZH]KG@BNK>6WF0/%*A1U/=2,$5XCJ?AGQ-\--8EU;PZSW
M.EL1NXW_ "]=LJCG _O#\P3BO<J*B$W$TJ4U/R9PO@OXFZ?XHDCL;F,66ID<
M1ELI*0.=A]>IVG\S73^(KF2S\,:M=1,5EALYI$93@@A"00?PKROXP>&K+2C9
M^(=. M;F6<1RK$=N6P65U Z$;>2/;ODUZ?8$^(?!EJ;O&=1T]/.P/^>D8W<?
MB:J48Z26Q$)2;<);H\%\"V_C3;>7/A*,8)6.=_W&>Y _><_E_2NP_P"+S_Y^
MQU3^%.I-X:\7:EX:U/$4EP_EJ6;@3(2,#M\P)P>^%'<5[=6E6=I;(QH4E*'Q
M-?,\=_XO/_G['69KGA[XI^)+2.UU:T%S#&_F(N^U0AL$=5(/0GBO=:X/QQ\1
MX_">IV5A;6T=[<.=]S'OP43' &.C$D'GL.G((F-1M^[%%U*48QO*3MZFWX'L
M=0TSP9IMEJL7E7D",CIN#8 =MO()'W=O>NAID+O)!&\D1B=E!:,D$H<<C(X.
M/:GUBW=W.F*LD@K@?C%_R(4G_7S'_6N^K@?C%_R(4G_7S'_6JI_&C.M_#9SO
MA+P3IWBGX5(AMX(=1:20Q78C ?<&.T,V,E>Q%8GPZOM-T;Q%-X?\2:79^<9M
MD,\]LC/%+TVEB,[3V]_K7H7PC_Y)[:?]=9?_ $,UF_%7P2=6LSKVG(!?VJ9F
M5%YF0=^.K+_+Z"MN?WG!['/[.T(U(K5(](BBCAC6.*-8XUX"H, ?A3Z\_P#A
MCXX'B+3!IM_,6U6U7EFZS1]FSW([_@>YKT"L)1<79G7":G&Z/#[N#^V/V@5@
MN '2.X5@I)QB.+>!^:YQWR:]PKP_XAQS>%/B=8^)(X2T$S1S$+P&*X5USC )
M4#_OJO9]/O[;5+""^LY5EMYT#HZG.1_CV/O6E751?D8T-)2B][EFBBLKQ%KM
MKX<T.YU*Z<!8U^12>9'[*/4G^6:R2OH;MI*[/)?A/ EK\3-:MT "16TZ*!Z"
M9!7M]>$?!B:2X\=:A/*Q>62QD=V/<F6,DU[O6M?XS#"_PSQ#XL_\E*T;_KV@
M_P#1SU[?7B'Q9_Y*5HW_ %[0?^CGKV^BI\,0H_',\6^.=S(;_2+7<?*6*23;
MG@DD#/Z?K3K:W^,5G:PVUO&(X84$<:#['A5 P!^5:7QMT62YTFQUB%,BT<Q3
M$=0KXVD^P88_X%79^"?$,/B3PO:7:2 SH@BN%+;F60#!SGUZ_C5<UJ::5S/D
MYJTDVUZ'G_\ Q>?_ #]CH_XO/_G['7L517-S!9VTMS<RI%!$I9Y'. H'<FH]
MK_=7W&OL/[S^\\9\,>$/&]KX_M->U.P"EIF:YF\Z'D,"&.U6]^PKVNN$\$?$
M*7Q?J]_:?V;Y4$&7CG5_X,X4,#_$>3D?D.I[NE5<F_>'0C%1]UW"BBBLS8**
M** "BBB@ HHHH ^=J]MT+_D7M-_Z]8O_ $ 5XE7MNA?\B]IO_7K%_P"@"O6S
M'X8GS61_Q)^AH4445Y1](%%%% !7GGQ!\;:YX1U*T2SM[&2TN8BRM-&Y;>I^
M8<,!C!7\Z]#KB?BEHAU?P?+-&!YU@WV@>Z@'</RY_"KIVYE<SK<W(^7<T/ O
MB=_%?AX7MPL274<K13)$"%!'(P"2>A'?KFH/B!XMF\):/!/:)!)=SS;$2925
MV@$L>".G Z]Z\]^#NLBSUZZTN60+'>1AHP6_Y:+V'U!/Y"L[XJ:V=5\826L<
MN^VL%\A0"<;^KGZY^4_[HK54OWENASNN_8WZ['J/P^\83>+M+N9+R.".[MY0
MKK""%VD94X))[,/PJYXW\2/X6\-R:A"D;W+2+%"L@)4L>3G!!^Z&->/?"_63
MI7C2WA9RL%Z#;N,\;CRAQZ[@!^)K3^,6L-=^(X-+1SY5E$&=>WF/S_Z#M_,T
M.E^\MT!5W[&_78ZSX?\ CC7?%VJW,5W;645I;Q;G>&)P=Q.%&2Q _B/X5S^M
M_%K7M-U[4;&&TTUHK:ZEA0O&Y8JK$#.'Z\5V'PMT8:5X,@G= L]\QN')7!VG
MA!GN,#(_WC7B?BO_ )'#6_\ K_G_ /1C54(QE-JQ-2<XTXN^K/5/B-XUU+1H
M+6QMX+5HM0LF,ID1BR[A@[<,,=>^:\?TS4)=*U2UU"!4:6VD65 X)4D'/.".
M*]^\2^&M(UCPTU_?VGG7-KI[&%_,==N$R. 0#SZUX7X9LX-0\4:99W4?F6\]
MRD<B9(W*3R,CFJI./*R,0I<ZU]#VOPMXGO?%?@?5KZ^BMXY8S-"! I"[1&I[
MD\_,:\.T.\BT[7]-OIPQBMKJ*9]HR=JN"<>^!7T6NA:;X>\,ZE::7;?9X'BE
ME9=[/EBF,Y8D] *^;;&TDU#4+:RAQYMQ*L29_O,0!_.E2L^:VP\0I+EON=WK
M7Q?UV\G(TM8M/MP?E^022'ZEAC\AW[U9\-_%W4[>\CAU[9=6K'#SI&%D3WPN
M 1[8S7HFF_#[PUI^F+9OI=O<MM DGG0,[GN<GE?H,5X/XKTE-#\4ZCIT61%#
M,?+!SD(1N4<]>".>]$/9S]U(*GMJ=I-GT\CK(BNC!D895E.01ZBO&--^+VOW
MFJ6EK)9Z8$FF2-BL4F0"P!Q\_O7I7@F8S^"-&<DG%JB<C^Z-O]*^=="_Y&#3
M?^OJ+_T,5%*"?-<UKU)+E<7N?0GCGQ#=^&?#;:C91P23"5$VS*2N#GT(K@=+
M^,]X#<-JUC;.%C_<1VJLA9\_Q,S'"XSVS74?%S_D1G_Z^(_ZUY/X%\-IXH\3
MQ64Y(MHT,T^TX)0$#'XD@?C13C%PO(FM.:JJ,6:-[\5_%=S.9(+N&T3M'# C
M ?BX8_K7;^!/B;)KFH)I.L1Q1W4G^HGC&U7(R=I'8^GKT^N_K7@+P_>:#<6M
MMI-K!.L#""6*+#JP'RDD<MR!USFO M"F-OX@TV<$@QW43@@>C@U24*D79$R=
M6E-<SO<^J:***Y3O"BBJ]_>P:;83WMRX2&!"[G(Z#Z]Z /+OC'XC*1VWAZW<
MC?B>YP>V?D4\^H+$$=E-1?!SPZ&:Y\03J#MS!;Y]?XF_D/Q->>7,]]XN\5-(
M06N]0N %4<A<G 'T P/H*^E-'TR#1M(M=.MQ^ZMXP@/J>Y_$Y/XUTS]R"B<5
M+][5<WLCF?B'X4U3Q98V5KI]Q;1)#*TD@G=E!.,+C /JWYU7^'G@6Z\)27UQ
MJ$EM+<3A4C:!F(5!DD<@=3C\J[ND9@JEF("@9)/05CSOEY3I]E'GY^ISGC]X
M4\!ZN9PI3R<#<,_,6 7_ ,>Q7C'PSADF^(&F;"1L,CL1V C;^?3\:T?B5XW'
MB*]&FV#?\2VU<G>#_KWZ;OH.<?4GTQU_PE\*RZ98RZW>1M'<7:;(488(BR#N
M_P"!$#\ #WK9+DIN_4Y9/VM9<NR/2Z***YCN/(_C?_S O^WC_P!IUR_@_P =
M#PAHM_#!:"XO+B0-&7.$3 QDXY/T&/K74?&__F!?]O'_ +3K$^%WA"S\0W]S
M?:E&);2TVA82>))#SSCL .G?(]Q77&WLO>//GS>W:CO_ , HM\5/%K7!E%_$
MJ9SY0MTV_3D9_6O4O ?CR/Q;#+;W$20:E N]T3.QUSC<N>1R0"#ZCGGC*^(W
M@S1HO"5Q?Z?I]O:7-IL8-!'MW+G!! X/7.3SQ7!?"R7R_B!8KS^\25?_ "&Q
M_I2:A.#:5K%*52G449.]SZ#DD2&)Y975(T!9F8X"@=23V%>1^)/C#,MU);>'
MX(C"IV_:IU)+>ZKQ@?7\JT?C)K4EIH]GI,+LIO'+RX[HF.#]20?^ UR?PT\$
MVWB6XGO]1RUC:L$\D''FN1GDCD <?7/UJ*<(J//(NK4FY^S@4[?XJ>+H9UDD
MU".=0>8Y+>,*WUV@'\C7H_@[XG6?B&=+#4(UL]0?A,']W*?0$]#['K^E;UYX
M'\,WMF;9]%LXU(P'AB$;CC&=PY_.O O$NC3>%/%$]BDI)MW62"4=2IPRGZCO
M[@U:Y*FB5F1)U:-FW='T[7BVF_%[7[S5+2UDL],"33)&Q6*3(!8 X^?WKU#P
MIJ[Z[X6T_4I0!+-%^\QT+J2K'VR0>.U?-^A?\C!IO_7U%_Z&*BE!.Z?0NO4:
MY7%[GU37EGC7XE:SX<\47&F6=M8/#&J$--&Y;E03T8#OZ5ZG7SU\5/\ D?[W
M_KG%_P"@"IHQ4I69>)DXPO$]DT+7KK5/ \6MSQPK<M!)*50$)E2V."2<<#O7
MG&F?&74S?+_:=G8BT".6$$;ARP0E0"6(&6VC..]=GX1!'PF@!!'^AS'GZO7@
MNG6;ZCJ=I8QD![F9(5)[%B /YUI3A%N5S*M4G%0LSTGPQX_\4^)/&=E:">&.
MUEDS+"D"E1&,LW)^8' QG/I72^/?B/\ \(U<_P!F:;#'-J&T-(\G*0@]!@<E
MB.>V,CKFNKTOPSHNC&)[#3K>"6*,Q"54&]E.,[FZD\#DUXA\4-,N;#QO=SRH
M?)N]LL+XX8;0"/J""/R/>E'DG/8=3VE*GO=BP_%7Q;'<B5[Z*5,Y\E[= OTX
M ;'XUZQX(\;V_B^TD5H?L]_  9H@<J1_>4^F>W4>_6N(T*\\ >(] @T:^LX-
M+OUB"?:&54+. 1N$O?UPV,DXYKTGPQX8L/"VE+9V:[G;!FG8?-*WJ?0>@[?F
M2JO+:UK,=!3O?FNC:HHHK ZPHHHH **** /(?&O_ "-U]_VS_P#1:UV_PS_Y
M%NX_Z^V_] 2N(\:_\C=??]L__1:UV_PS_P"1;N/^OMO_ $!*]7$?[K'Y'S>"
M_P"1C/UE^9V=%%%>2?2A1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 ?,'QUC?1?BS9:M&.9+>"Y!'=D8K_[(M?3L4B31)+&<
MHZAE/J#7@7[2UAQX>U%1_P ]H'/_ 'RR_P#LU>N^ ;_^T_A_H%V3EGL8@Y]6
M50K?J#0!T5%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M8OA;PQ8^%-&33[++$G?-,WWI7QR3Z>P[?K6U1163;;NS=))604444AA1110
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M?LU7_F:+KVG$_P"IN(YP/]]2I_\ 18H ]SHHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MA170T44VVW=BC%15D%%%%(84444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5S7BSP1IOC+['_:,]
MW%]EW[/L[JN=VW.=RG^Z*Z6BFFT[H4HJ2LR*V@2UM8;="2D2*BENI &.:EHH
MI#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MS(&V#_QY: /J&BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MR<+)_P!?,_\ Z)>O;Z=2*C:W85&;FG?N%%%%9FP4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M1_NL?D?-X+_D8S]9?F=G1117DGTH4444 %%%% !1110 4444 %%%% !1110
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M7F__  E.L_\ /Y_Y"3_"C_A*=9_Y_/\ R$G^%']IT>S_  _S#ZS ](HKS?\
MX2G6?^?S_P A)_A1_P )3K/_ #^?^0D_PH_M.CV?X?YA]9@>D45YO_PE.L_\
M_G_D)/\ "C_A*=9_Y_/_ "$G^%']IT>S_#_,/K,#TBBO-_\ A*=9_P"?S_R$
MG^%'_"4ZS_S^?^0D_P */[3H]G^'^8?68'I%%>;_ /"4ZS_S^?\ D)/\*/\
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M**\W_P"$IUG_ )_/_(2?X4?\)3K/_/Y_Y"3_  H_M.CV?X?YA]9@>D45YO\
M\)3K/_/Y_P"0D_PH_P"$IUG_ )_/_(2?X4?VG1[/\/\ ,/K,#TBBO-_^$IUG
M_G\_\A)_A1_PE.L_\_G_ )"3_"C^TZ/9_A_F'UF!Z117F_\ PE.L_P#/Y_Y"
M3_"C_A*=9_Y_/_(2?X4?VG1[/\/\P^LP/2**\W_X2G6?^?S_ ,A)_A1_PE.L
M_P#/Y_Y"3_"C^TZ/9_A_F'UF!Z117F__  E.L_\ /Y_Y"3_"C_A*=9_Y_/\
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M)3K/_/Y_Y"3_  H_X2G6?^?S_P A)_A1_:='L_P_S#ZS ](HKS?_ (2G6?\
MG\_\A)_A1_PE.L_\_G_D)/\ "C^TZ/9_A_F'UF!Z117F_P#PE.L_\_G_ )"3
M_"C_ (2G6?\ G\_\A)_A1_:='L_P_P P^LP/2**\W_X2G6?^?S_R$G^%'_"4
MZS_S^?\ D)/\*/[3H]G^'^8?68'I%%>;_P#"4ZS_ ,_G_D)/\*/^$IUG_G\_
M\A)_A1_:='L_P_S#ZS ](HKS?_A*=9_Y_/\ R$G^%'_"4ZS_ ,_G_D)/\*/[
M3H]G^'^8?68'I%%>;_\ "4ZS_P _G_D)/\*/^$IUG_G\_P#(2?X4?VG1[/\
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M_A*=9_Y_/_(2?X4?\)3K/_/Y_P"0D_PH_M.CV?X?YA]9@>D45YO_ ,)3K/\
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M_P A)_A1_P )3K/_ #^?^0D_PH_M.CV?X?YA]9@>D45YO_PE.L_\_G_D)/\
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M9_Y_/_(2?X4?\)3K/_/Y_P"0D_PH_M.CV?X?YA]9@>D45YN/%.LY_P"/S/\
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M6HR6WABW>TM(VR6CP"!G@O(> ?8>AZXJP_@OXGVR?:(_$C32'GREU"4GUZ,
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M!YYZ!OSKVZE4BHRT+HS<X7>X4445F:GB'@W_ )+EJW_7S>?^AM7M]>(>#?\
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M<>R@^I. /<UDXM.QLI)QYNAYQXX\:ZXOCBS\.>&KT0R'9%,?)1P9'/\ M*>
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M#11Z;K>EO/;1 +&+D%'"]@L@R".#V/3VQ1;VD5;= I>QF^;9GN]>&I,NI_M
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M.4/3^=?1VF:99Z/I\-C8PK#;Q#"J/YD]R?6N4^)^@VNJ>$KJ]:-1>62^;%*
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M16^F:9(8;JY0O).!RB9QA3V).>>W;FO.?AM?36/CO3O*<A9V,$@'\2L.A_$
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MM589 );\0I(_45XN/;J5XTNFGXG'7;E-1->R\(AH@][,ZN1G9'CY?J3FK?\
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MS_WTO_Q-'_"(:?\ \]KG_OI?_B:WZ*/J=#^5![*'8P/^$0T__GM<_P#?2_\
MQ-'_  B&G_\ /:Y_[Z7_ .)K?HH^IT/Y4'LH=C _X1#3_P#GM<_]]+_\31_P
MB&G_ //:Y_[Z7_XFM^BCZG0_E0>RAV,#_A$-/_Y[7/\ WTO_ ,31_P (AI__
M #VN?^^E_P#B:WZ*/J=#^5![*'8P/^$0T_\ Y[7/_?2__$T?\(AI_P#SVN?^
M^E_^)K?HH^IT/Y4'LH=C _X1#3_^>US_ -]+_P#$T?\ "(:?_P ]KG_OI?\
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M/_Y[7/\ WTO_ ,31_P (AI__ #VN?^^E_P#B:WZ*/J=#^5![*'8P/^$0T_\
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M:?\ \]KG_OI?_B:WZ*/J=#^5![*'8P/^$0T__GM<_P#?2_\ Q-'_  B&G_\
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M_P#GM<_]]+_\31_PB&G_ //:Y_[Z7_XFM^BCZG0_E0>RAV,#_A$-/_Y[7/\
MWTO_ ,31_P (AI__ #VN?^^E_P#B:WZ*/J=#^5![*'8P/^$0T_\ Y[7/_?2_
M_$T?\(AI_P#SVN?^^E_^)K?HH^IT/Y4'LH=C _X1#3_^>US_ -]+_P#$T?\
M"(:?_P ]KG_OI?\ XFM^BCZG0_E0>RAV,#_A$-/_ .>US_WTO_Q-'_"(:?\
M\]KG_OI?_B:WZ*/J=#^5![*'8P/^$0T__GM<_P#?2_\ Q-'_  B&G_\ /:Y_
M[Z7_ .)K?HH^IT/Y4'LH=C _X1#3_P#GM<_]]+_\31_PB&G_ //:Y_[Z7_XF
MM^BCZG0_E0>RAV,#_A$-/_Y[7/\ WTO_ ,31_P (AI__ #VN?^^E_P#B:WZ*
M/J=#^5![*'8P/^$0T_\ Y[7/_?2__$T?\(AI_P#SVN?^^E_^)K?HH^IT/Y4'
MLH=C _X1#3_^>US_ -]+_P#$T?\ "(:?_P ]KG_OI?\ XFM^BCZG0_E0>RAV
M,#_A$-/_ .>US_WTO_Q-'_"(:?\ \]KG_OI?_B:WZ*/J=#^5![*'8P/^$0T_
M_GM<_P#?2_\ Q-'_  B&G_\ /:Y_[Z7_ .)K?HH^IT/Y4'LH=C _X1#3_P#G
MM<_]]+_\31_PB&G_ //:Y_[Z7_XFM^BCZG0_E0>RAV,#_A$-/_Y[7/\ WTO_
M ,31_P (AI__ #VN?^^E_P#B:WZ*/J=#^5![*'8P/^$0T_\ Y[7/_?2__$T?
M\(AI_P#SVN?^^E_^)K?HH^IT/Y4'LH=C _X1#3_^>US_ -]+_P#$T?\ "(:?
M_P ]KG_OI?\ XFM^BCZG0_E0>RAV,#_A$-/_ .>US_WTO_Q-'_"(:?\ \]KG
M_OI?_B:WZ*/J=#^5![*'8P/^$0T__GM<_P#?2_\ Q-'_  B&G_\ /:Y_[Z7_
M .)K?HH^IT/Y4'LH=C _X1#3_P#GM<_]]+_\31_PB&G_ //:Y_[Z7_XFM^BC
MZG0_E0>RAV,#_A$-/_Y[7/\ WTO_ ,31_P (AI__ #VN?^^E_P#B:WZ*/J=#
M^5![*'8P/^$0T_\ Y[7/_?2__$T?\(AI_P#SVN?^^E_^)K?HH^IT/Y4'LH=C
M _X1#3_^>US_ -]+_P#$T?\ "(:?_P ]KG_OI?\ XFM^BCZG0_E0>RAV,#_A
M$-/_ .>US_WTO_Q-'_"(:?\ \]KG_OI?_B:WZ*/J=#^5![*'8P/^$0T__GM<
M_P#?2_\ Q-'_  B&G_\ /:Y_[Z7_ .)K?HH^IT/Y4'LH=C _X1#3_P#GM<_]
M]+_\31_PB&G_ //:Y_[Z7_XFM^BCZG0_E0>RAV,#_A$-/_Y[7/\ WTO_ ,31
M_P (AI__ #VN?^^E_P#B:WZ*/J=#^5![*'8P/^$0T_\ Y[7/_?2__$T?\(AI
M_P#SVN?^^E_^)K?HH^IT/Y4'LH=C _X1#3_^>US_ -]+_P#$T?\ "(:?_P ]
MKG_OI?\ XFM^BCZG0_E0>RAV,#_A$-/_ .>US_WTO_Q-'_"(:?\ \]KG_OI?
M_B:WZ*/J=#^5![*'8P/^$0T__GM<_P#?2_\ Q-'_  B&G_\ /:Y_[Z7_ .)K
M?HH^IT/Y4'LH=C _X1#3_P#GM<_]]+_\31_PB&G_ //:Y_[Z7_XFM^BCZG0_
ME0>RAV,#_A$-/_Y[7/\ WTO_ ,31_P (AI__ #VN?^^E_P#B:WZ*/J=#^5![
M*'8P/^$0T_\ Y[7/_?2__$T?\(AI_P#SVN?^^E_^)K?HH^IT/Y4'LH=C _X1
M#3_^>US_ -]+_P#$T?\ "(:?_P ]KG_OI?\ XFM^BCZG0_E0>RAV,#_A$-/_
M .>US_WTO_Q-'_"(:?\ \]KG_OI?_B:WZ*/J=#^5![*'8P/^$0T__GM<_P#?
M2_\ Q-'_  B&G_\ /:Y_[Z7_ .)K?HH^IT/Y4'LH=C _X1#3_P#GM<_]]+_\
M31_PB&G_ //:Y_[Z7_XFM^BCZG0_E0>RAV,#_A$-/_Y[7/\ WTO_ ,31_P (
MAI__ #VN?^^E_P#B:WZ*/J=#^5![*'8P/^$0T_\ Y[7/_?2__$T?\(AI_P#S
MVN?^^E_^)K?HH^IT/Y4'LH=C _X1#3_^>US_ -]+_P#$T?\ "(:?_P ]KG_O
MI?\ XFM^BCZG0_E0>RAV,#_A$-/_ .>US_WTO_Q-'_"(:?\ \]KG_OI?_B:W
MZ*/J=#^5![*'8P/^$0T__GM<_P#?2_\ Q-'_  B&G_\ /:Y_[Z7_ .)K?HH^
MIT/Y4'LH=C _X1#3_P#GM<_]]+_\31_PB&G_ //:Y_[Z7_XFM^BCZG0_E0>R
MAV,#_A$-/_Y[7/\ WTO_ ,31_P (AI__ #VN?^^E_P#B:WZ*/J=#^5![*'8P
M/^$0T_\ Y[7/_?2__$T?\(AI_P#SVN?^^E_^)K?HH^IT/Y4'LH=C _X1#3_^
M>US_ -]+_P#$T?\ "(:?_P ]KG_OI?\ XFM^BCZG0_E0>RAV,#_A$-/_ .>U
MS_WTO_Q-'_"(:?\ \]KG_OI?_B:WZ*/J=#^5![*'8P/^$0T__GM<_P#?2_\
MQ-'_  B&G_\ /:Y_[Z7_ .)K?HH^IT/Y4'LH=C _X1#3_P#GM<_]]+_\31_P
MB&G_ //:Y_[Z7_XFM^BCZG0_E0>RAV,#_A$-/_Y[7/\ WTO_ ,31_P (AI__
M #VN?^^E_P#B:WZ*/J=#^5![*'8P/^$0T_\ Y[7/_?2__$T?\(AI_P#SVN?^
M^E_^)K?HH^IT/Y4'LH=C _X1#3_^>US_ -]+_P#$T?\ "(:?_P ]KG_OI?\
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M/_Y[7/\ WTO_ ,31_P (AI__ #VN?^^E_P#B:WZ*/J=#^5![*'8P/^$0T_\
MY[7/_?2__$T?\(AI_P#SVN?^^E_^)K?HH^IT/Y4'LH=CGSX0L,<37/\ WTO^
M%8>L:#+I8$JOYL!.-V,%3[_XUWE4M7C631[Q6&0(6;\0,C]16-?!473?*K,F
M=&+CHCDO#.IO8:K'$6/D3D(XSP">AKT:O(%8HZL.H.17K]8Y7-N$HOI^I.&D
MVF@HHHKU#I"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH X[XJ?\
M)-]6_P"V/_HY*I?!W_D0H_\ KYD_I5WXJ?\ )-]6_P"V/_HY*I?!W_D0H_\
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M'?CG_P A'1O^N4O\UKV*P_Y!UM_UR3^0K2?\.)C3_BS^18HHHK$Z#QWX[?\
M, _[>/\ VE7JNC?\@/3_ /KVC_\ 017E7QV_Y@'_ &\?^TJ]5T;_ ) >G_\
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MGC'_ (1C0_L]I)MU.\!6$CK&HQN?]<#W^AKK-5U.TT;2[C4;Z3R[:!=SM^@
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MZ *\2KVW0O\ D7M-_P"O6+_T 5ZV8_#$^:R/^)/T-"BBBO*/I HHHH ****
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M$]_8L<H%QYJ#T([_ %'Y"M:<HN/)(YZT)QG[2![?+J%E!:?:YKNWCMO^>SR
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M)0653_LL.1^.?K7JM%5&<H[$3IQG\2/'4^&7C>[5;;4?%G^B9 *BZFE 'LK
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MB3/"C]YV_7K61_PHG_J9/_)'_P"V5[%16BK36B9B\/3;NU^9X[_PHG_J9/\
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M3UL>1V_P+MU?-SK\LB^D=J$/YEC77>'?AOX=\.2QW$-NUU=I@K/<D,5/JHP
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH *JZG_ ,@F\_ZX/_Z":M55U/\ Y!-Y_P!<'_\ 0345/@?H*6S/
M-:]@KQ^O8*\K*OM_+]3FPO4****]<ZPHHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH 9+%'-&T<L:R1MP5<9!_"LQO"_A]Y3*^A:8TA.2YM
M(R<^N<5K44TVA-)[D-K9VMC#Y5I;0V\6<[(D"#/K@5-112&%%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MIM_K73V'Q*T&_P!&N;]&E66VB\R6T('F8XSMR0&&3ZU3I36Z,XUZ<MF=C17
M6GQ>T"\O(+6.SU,/-(L:EHH\ DX&?G]Z[^IE%QW+C.,OA8455U'4[+2;)[R_
MN8[>W3J[GOZ#U/L*\]U+XSZ5;R%-/TZXO /XY'$2GZ<$_F!3C"4MD*=2$/B9
MZ917E5M\;;5G NM$FB3/)BN Y ^A5:[O0/%>C^)8BVFW8>11N>%_ED0>Z^GN
M,BG*G*.Z%&K">D6;5%%0W=W;V-K)=7<\<$$8R\DC;54?6H-":BO-]5^,FCVD
MICT^RN+[:2"Y81(?3!Y)_(52M?C;:O*!=Z)-%'_>BN!(?R*K_.M/93[&+Q%-
M.USU6BLG0O$ND^)+8S:;=+(5^_$>'3ZKU'UZ5K5FTUHS5--71\Z_$_\ Y*)J
MO_;'_P!%)7I7P>_Y$J3_ *_)/_05KS7XG_\ )1-5_P"V/_HI*[/X>^)])\->
M 'GU*Y"%KR3RXE^:23Y5Z+_7I[UUS3=))>1P4FE7DWYGJ]%>47'QMMUE86VA
M2R1Y.&EN0A([<!3_ #KH_#GQ-T3Q!<BU??8W+?<2<C:_T;IGV-<[I32NT=:K
MTV[)G:4445!J%%<UXE\=:)X7/E7<S37>,BV@ 9Q[MV4=.ISZ UQ;?&Z,2D+H
M#&//#&[P<?39_6KC3E+5(RE6IQ=FSUFBN+\/?$[0=>F6V=WL+ICM6.XP%<\]
M&''IP<<G S7:5+BXZ,N,XR5XL**J:IJ5MI&F7.H7;%8+="[XZGV'N3P/K7!:
M3\8-.U#5TL[C3I;2&5PD<YD#\GIN4#CG'0GK34)25T*52,79L](HHHJ2PHHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ JKJ?_()O/\ K@__ *":M55U/_D$WG_7!_\ T$U%3X'Z"ELSS6O8*\?K
MV"O*RK[?R_4YL+U"BBBO7.L**** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M7!R!^/K4OA_X2:KJ]E'=WUTFG1R#*HT9>3'8E<C&?KFN%G69]3E1%=IVF(
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ME2._DCCMT.Y8(%*IG&,G)))^IXR:ZCX1>&KFXUL:]+&Z6ELKK"YX$CD%3CU
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ME]W<^=M"_P"1@TW_ *^HO_0Q7U+//%;6\EQ/(L<,2%W=C@*H&23^%?+6A?\
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M35=6O=;U![_4)A-<R !Y!&J;L# R% '0"O9_@W=M-X1N+=B3Y%VP7T"E5/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 55U/\ Y!-Y_P!<'_\ 035JJNI_\@F\
M_P"N#_\ H)J*GP/T%+9GFM>P5X_7L%>5E7V_E^IS87J%%%%>N=84444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MK^)Q[5WJJ%4*H 4#  Z"IG4CR\L"Z5&7/SU-SYV^)_\ R435?^V/_HI*]F\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MCYO!?\C&?K+\SLZ***\D^E"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** .;\;?\@:'_ *^%_P#06KF/#?\ R'[;_@?_
M *":Z?QM_P @:'_KX7_T%JYCPW_R'[;_ ('_ .@FO%Q/^^Q]4<=3^,OD=_11
M17MG6%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !574_^
M03>?]<'_ /035JJNI_\ ()O/^N#_ /H)J*GP/T%+9GFM>P5X_7L%>5E7V_E^
MIS87J%%%%>N=84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'SM7MNA?\
MB]IO_7K%_P"@"O$J]MT+_D7M-_Z]8O\ T 5ZV8_#$^:R/^)/T-"BBBO*/I H
MHHH **** "BBB@ HHHH **** "N)^)WB5] \-&"V<I=WVZ*-AU5<?.PYX."!
MGL2*[:O ?BQJAO\ QI);!V,5E&L0!Z!B-S$?F!^%:4H\TC#$3Y(:%#P!X5/B
MG7PDRM]@ML27++_XZOXD?D#7OVI7]IH&B3WDJB.UM(LA$&  . H Z=@*YCX5
MZ0FF^"X+@H5GO6:9\^F2%_#: ?QK2\<Z#?\ B3PVVFZ?-#%))*C.9F95*CG'
M /?';M55)<T[/8FC#DI76[/"-;U_6/&.KJ9WEF=WVV]K'RJ9/"JH[]!GJ<4N
MI^"_$6CV OK_ $N6*V.,N&5MN?[P4DK^..>*]0\!?#B^\,ZZ^I:G-9S;82D(
M@=B58D9)RH[9'XUWNLO#'H>H/<A6@6VD,@89!7:<Y'TK1UE%VCL8QPSE%RF]
M3R/X7>-;R+58= OYFFM9\K;LYR8G R!G^Z<8QV..G->TU\N^%X9+CQ9I$41(
M<WD6&'5<."3^'6OJ*HKQ2EH:X23E"SZ!117*?$#Q/>^%-!@OK&*WDEDNEA(G
M4E=I5CV(Y^45BDV[(Z)245=G5T5X]IOQFNA:7DFIV=LTRA1;16ZLF]B3DL23
M@ 8]_P"G.W/Q6\63W'F1WL-NG_/**W0K_P"/ G]:U5";,7BJ:1]!T5YCX3^+
M%O>6\\7B$Q6T\*%TFC4A90!R,<_/].#[=^8UKXNZ[=W+?V5Y=A;@X3,:R.1G
MJ=P(Z8X I*C-NPWB::5SW6BO#M ^+NL6MXBZULO;1CAW6-4D0>HVX!^A'XBO
M;8)X[FWCGA8/%*@=&'=2,@U,Z;AN73JQJ+W22BN+\;_$&U\*!;2WC2ZU)QGR
MBV%B'8MCU[#\>.,^73_%3Q;+<&1+^*%"<^5';H5'M\P)_6JC2E)7(GB(0=F?
M0M%>,V'QDO5TBYCO+6!M150;>4(?+<YY#J""..A%:?@KXE:SXC\46^F7EM8)
M#(KDM#&X;A21U8CMZ4.C))L%B*;:2ZGJ=%%8WBK6T\/^&;[42V)(XRL(X),A
MX7@]>2"?8&LTKNQLVDKL\BUYW\>?%1-/C;_1HY/LP92"/+0DNP/O\Q'X5W7Q
M918_ 91%"HL\055& !SP*YWX-:(SS7NO3<XS;1;ADECAF.?R'XFNC^+G_(C/
M_P!?$?\ 6MY/WU%=#DBG[*4WNSA_@Q_R.%W_ ->#_P#HR.O<Z\,^#'_(X7?_
M %X/_P"C(Z]+\:>-+3PEI^3MFU"4'R+?/_CS>BC]>@[D*LFZED5AY*-*[.HH
MKR#0/B1XQ\2:K'86&G:6SMR[F*3;&O=F._@5ZX"4B!E=<JN78#:/<]>!^-92
M@XZ,VIU%-70^BO)?%7Q>D@O)+/P]%#(B':UW*"P8_P"PO''N<Y].]<I;_%3Q
M;!*KR7\5PH()26W0 ^WR@']:T5";5S.6*IIV/H6BO'-0^,]X;6T;3K&V2<JP
MN4N%9@&XP4(8<'GKS_,]G\/?%=]XLTN[NK^*VC>&;RU$"L 1M!YR3ZU,J4HJ
M[+C7A*7*CSWXJ^$%TC41K-D@6SO'(E10?W<IY)^C<GZY]JW_ (/>)#<6<^@7
M#Y>W!EM\_P!PGYEZ]B<_B:[SQ1HZZ]X:O].*AGEB/E=.)!RO7W KYZ\':DVD
M^,-+NP^Q1<*DAQGY&^5N/H36L7[2FT^AS37LJRDMF?3E%%%<QW!1110 4444
M %%%% !1110 4444 %%%% 'D/C7_ )&Z^_[9_P#HM:[?X9_\BW<?]?;?^@)7
M$>-?^1NOO^V?_HM:[?X9_P#(MW'_ %]M_P"@)7JXC_=8_(^;P7_(QGZR_,[.
MBBBO)/I0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@#F_&W_(&A_P"OA?\ T%JYCPW_ ,A^V_X'_P"@FNG\;?\ (&A_
MZ^%_]!:N8\-_\A^V_P"!_P#H)KQ<3_OL?5''4_C+Y'?T445[9UA1110 445Y
MAXB\6:Y<_$FV\.:'?FWAW)%,4B20Y/S.WS*?NJ>G^R:J,7+8B<U!79Z?1114
MEA1110 4444 %%%% !1110 45@>+O%-MX2T?[=-'YTKN(X8 ^TR'OS@X &3G
M'IZUQVE?&'^T]8L=/_L+ROM5Q'#O^U[MNY@N<;!G&:M4Y-72,Y581?*WJ>H4
M445!H%%8'BKQ=IWA.Q$]X3)/)D0VZ$;I#_0>I_GTKSY?B?XOU!7N-*\-I):@
MD[A;RS!1[LI ]>U7&G*2NC*=:$79[GL%%>?>&/BG9:O>KIVJ6W]G7C-L0ELH
MS>AR 5.>,'/UKT&E*+B[,N$XS5XA167K_B#3_#>F-?:C*5C!PB+R\C>BCN:\
MU'Q4\3ZK*YT+PVLL*GIY4DY'U*8IQIREJB9U8P=GN>O45YEH7Q;CEO5L?$5A
M_9\V0IF7(4,?[RGE1[Y/]:],5@RAE(*D9!'0TI0<=QPJ1FKQ%HKDOB+?ZQI/
MA@ZEHUT8)+>53-B-'!C/'1@>Y7I[U<\$:Z_B+PG9WT[A[H Q3D+CYU.,XZ<C
M!XXYHY7R\P<ZY^3J=#1114EA1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 55U/_D$
MWG_7!_\ T$U:JKJ?_()O/^N#_P#H)J*GP/T%+9GFM>P5X_7L%>5E7V_E^IS8
M7J%%%%>N=84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MO 'A5/%7B#R+ABMG;IYLVTX+#( 4?7U] ?:O;D\#^%X[,VHT.R,9&-S1Y?\
M[[/S?K7DGPGUZUT?Q)-;WDBQ17L7EK(Q  <'*Y)Z \CZXKWNKKRDI&6%C!PO
M;4^>OB/X0A\*ZQ"UED6%XK-$C-DQLI&Y<]2!E2"?7VS7<_!;_D7]1_Z^A_Z
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M?^5&X_\ B:/^$#^(O_0V?^5&X_\ B:KV<?YB/:R_E9ZY17D?_"!_$7_H;/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "JNI_\ ()O/^N#_ /H)JU574_\
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M6C(]: "BC(]:,CUH **,CUHR/6@ HHR/6C(]: "BC(]:,CUH **,CUHR/6@
MHHR/6C(]: "BC(]:,CUH **,CUHR/6@ HHR/6C(]: "BC(]:,CUH **,CUHR
M/6@ HHR/6C(]: "BC(]:,CUH **,CUHR/6@ HHR/6C(]: "BC(]:,CUH **,
MCUHR/6@ HHR/6C(]: "BC(]:,CUH **,CUHR/6@ HHR/6C(]: "BC(]:,CUH
M **,CUHR/6@ HHR/6C(]: "BC(]:,CUH **,CUHR/6@ HHR/6C(]: "BC(]:
M,CUH **,CUHR/6@ HHR/6C(]: "BC(]:,CUH **,CUHR/6@ HHR/6C(]: "B
MC(]:,CUH **,CUHR/6@ HHR/6C(]: "BC(]:,CUH **,CUHR/6@ HHR/6C(]
M: "BC(]:,CUH **,CUHR/6@ HHR/6C(]: "BC(]:,CUH **,CUHR/6@ HHR/
M6C(]: "BC(]:,CUH **,CUHR/6@ HHR/6C(]: "BC(]:,CUH **,CUHR/6@
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MJ>OXU@WRT[=SK2<ZS?1%NN$^+G_(C/\ ]?$?]:[NBLHNSN;3CS1<3PSX,?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M[L7_ 'W7;T47#D1AZ'HDVFSM-+(A+Q[=J]CD&MRBBD4E8****!GSM7MNA?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "JNI_\ ()O/^N#_ /H)JU57
M4_\ D$WG_7!__0345/@?H*6S/-:]@KQ^O8*\K*OM_+]3FPO4****]<ZPHHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** /G:O;="_Y%[3?^O6+_ - %>)5[
M;H7_ "+VF_\ 7K%_Z *];,?AB?-9'_$GZ&A1117E'T@4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% 'D/C7_D;K[_ +9_^BUKM_AG_P BW<?]?;?^@)7$>-?^
M1NOO^V?_ *+6NW^&?_(MW'_7VW_H"5ZN(_W6/R/F\%_R,9^LOS.SHHHKR3Z4
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH YOQM_P @:'_KX7_T%JYCPW_R'[;_ ('_ .@FNG\;?\@:'_KX7_T%JYCP
MW_R'[;_@?_H)KQ<3_OL?5''4_C+Y'?T445[9UA1110 5Q4/P_P#LOCQ_$UKJ
M?E*\AD>U$&0VY<,-V[N23TKM:*:DUL3*"E:_0****104444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 <AXV\$S>,3:+_:QLX+?<?*$&
M\,QQR?F'0#'XGUKIM.L8M-TVVL8!B*WB6)?H!BK-%-R;5B5!)N2W84444B@H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH *JZG_P @F\_ZX/\ ^@FK55=3_P"03>?]
M<'_]!-14^!^@I;,\UKV"O'Z]@KRLJ^W\OU.;"]0HHHKUSK"BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH ^=J]MT+_D7M-_Z]8O\ T 5XE7MNA?\ (O:;
M_P!>L7_H KULQ^&)\UD?\2?H:%%%%>4?2!1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 >0^-?^1NOO\ MG_Z+6NW^&?_ "+=Q_U]M_Z E<1XU_Y&Z^_[9_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *JZG_ ,@F\_ZX
M/_Z":M5E>(+V.TTJ9"P\R92B+GDYX)_*LJTE&G)OL3-VBVS@*]@KR6U@:YNX
M8%&3(X4?B:]:KS<J6DWZ?J887J%%%%>L=04444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M^U_^)H^K8W^9_>'LZW?\3F/^$DU;_G[_ /(:?X4?\))JW_/W_P"0T_PKI_\
MA"=-_P">]W_WVO\ \31_PA.F_P#/>[_[[7_XFCZMC?YG]X>SK=_Q.8_X235O
M^?O_ ,AI_A1_PDFK?\_?_D-/\*Z?_A"=-_Y[W?\ WVO_ ,31_P (3IO_ #WN
M_P#OM?\ XFCZMC?YG]X>SK=_Q.8_X235O^?O_P AI_A1_P ))JW_ #]_^0T_
MPKI_^$)TW_GO=_\ ?:__ !-'_"$Z;_SWN_\ OM?_ (FCZMC?YG]X>SK=_P 3
MF/\ A)-6_P"?O_R&G^%'_"2:M_S]_P#D-/\ "NG_ .$)TW_GO=_]]K_\31_P
MA.F_\][O_OM?_B:/JV-_F?WA[.MW_$YC_A)-6_Y^_P#R&G^%'_"2:M_S]_\
MD-/\*Z?_ (0G3?\ GO=_]]K_ /$T?\(3IO\ SWN_^^U_^)H^K8W^9_>'LZW?
M\3F/^$DU;_G[_P#(:?X4?\))JW_/W_Y#3_"NG_X0G3?^>]W_ -]K_P#$T?\
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M^%'_  DFK?\ /W_Y#3_"NG_X0G3?^>]W_P!]K_\ $T?\(3IO_/>[_P"^U_\
MB:/JV-_F?WA[.MW_ !.8_P"$DU;_ )^__(:?X4?\))JW_/W_ .0T_P *Z?\
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M^$)TW_GO=_\ ?:__ !-'_"$Z;_SWN_\ OM?_ (FCZMC?YG]X>SK=_P 3F/\
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MA[.MW_$YC_A)-6_Y^_\ R&G^%'_"2:M_S]_^0T_PKI_^$)TW_GO=_P#?:_\
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M_P AI_A1_P ))JW_ #]_^0T_PKI_^$)TW_GO=_\ ?:__ !-'_"$Z;_SWN_\
MOM?_ (FCZMC?YG]X>SK=_P 3F/\ A)-6_P"?O_R&G^%'_"2:M_S]_P#D-/\
M"NG_ .$)TW_GO=_]]K_\31_PA.F_\][O_OM?_B:/JV-_F?WA[.MW_$YC_A)-
M6_Y^_P#R&G^%'_"2:M_S]_\ D-/\*Z?_ (0G3?\ GO=_]]K_ /$T?\(3IO\
MSWN_^^U_^)H^K8W^9_>'LZW?\3F/^$DU;_G[_P#(:?X4?\))JW_/W_Y#3_"N
MG_X0G3?^>]W_ -]K_P#$T?\ "$Z;_P ][O\ [[7_ .)H^K8W^9_>'LZW?\3F
M/^$DU;_G[_\ (:?X4?\ "2:M_P _?_D-/\*Z?_A"=-_Y[W?_ 'VO_P 31_PA
M.F_\][O_ +[7_P")H^K8W^9_>'LZW?\ $YC_ (235O\ G[_\AI_A1_PDFK?\
M_?\ Y#3_  KI_P#A"=-_Y[W?_?:__$T?\(3IO_/>[_[[7_XFCZMC?YG]X>SK
M=_Q.8_X235O^?O\ \AI_A1_PDFK?\_?_ )#3_"NG_P"$)TW_ )[W?_?:_P#Q
M-'_"$Z;_ ,][O_OM?_B:/JV-_F?WA[.MW_$YC_A)-6_Y^_\ R&G^%'_"2:M_
MS]_^0T_PKI_^$)TW_GO=_P#?:_\ Q-'_  A.F_\ />[_ .^U_P#B:/JV-_F?
MWA[.MW_$YC_A)-6_Y^__ "&G^%'_  DFK?\ /W_Y#3_"NG_X0G3?^>]W_P!]
MK_\ $T?\(3IO_/>[_P"^U_\ B:/JV-_F?WA[.MW_ !.8_P"$DU;_ )^__(:?
MX4?\))JW_/W_ .0T_P *Z?\ X0G3?^>]W_WVO_Q-'_"$Z;_SWN_^^U_^)H^K
M8W^9_>'LZW?\3F/^$DU;_G[_ /(:?X4?\))JW_/W_P"0T_PKI_\ A"=-_P">
M]W_WVO\ \31_PA.F_P#/>[_[[7_XFCZMC?YG]X>SK=_Q.8_X235O^?O_ ,AI
M_A1_PDFK?\_?_D-/\*Z?_A"=-_Y[W?\ WVO_ ,31_P (3IO_ #WN_P#OM?\
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M/\*Z?_A"=-_Y[W?_ 'VO_P 31_PA.F_\][O_ +[7_P")H^K8W^9_>'LZW?\
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MC?YG]X>SK=_Q.8_X235O^?O_ ,AI_A1_PDFK?\_?_D-/\*Z?_A"=-_Y[W?\
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M][O_ +[7_P")H^K8W^9_>'LZW?\ $YC_ (235O\ G[_\AI_A1_PDFK?\_?\
MY#3_  KI_P#A"=-_Y[W?_?:__$T?\(3IO_/>[_[[7_XFCZMC?YG]X>SK=_Q.
M8_X235O^?O\ \AI_A1_PDFK?\_?_ )#3_"NG_P"$)TW_ )[W?_?:_P#Q-'_"
M$Z;_ ,][O_OM?_B:/JV-_F?WA[.MW_$YC_A)-6_Y^_\ R&G^%'_"2:M_S]_^
M0T_PKI_^$)TW_GO=_P#?:_\ Q-'_  A.F_\ />[_ .^U_P#B:/JV-_F?WA[.
MMW_$YC_A)-6_Y^__ "&G^%'_  DFK?\ /W_Y#3_"NG_X0G3?^>]W_P!]K_\
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M_P#(:?X4?\))JW_/W_Y#3_"NG_X0G3?^>]W_ -]K_P#$T?\ "$Z;_P ][O\
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MF_\ />[_ .^U_P#B:/JV-_F?WA[.MW_$YC_A)-6_Y^__ "&G^%'_  DFK?\
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MZW?\3F/^$DU;_G[_ /(:?X4?\))JW_/W_P"0T_PKI_\ A"=-_P">]W_WVO\
M\31_PA.F_P#/>[_[[7_XFCZMC?YG]X>SK=_Q.8_X235O^?O_ ,AI_A1_PDFK
M?\_?_D-/\*Z?_A"=-_Y[W?\ WVO_ ,31_P (3IO_ #WN_P#OM?\ XFCZMC?Y
MG]X>SK=_Q.8_X235O^?O_P AI_A1_P ))JW_ #]_^0T_PKI_^$)TW_GO=_\
M?:__ !-'_"$Z;_SWN_\ OM?_ (FCZMC?YG]X>SK=_P 3F/\ A)-6_P"?O_R&
MG^%'_"2:M_S]_P#D-/\ "NG_ .$)TW_GO=_]]K_\31_PA.F_\][O_OM?_B:/
MJV-_F?WA[.MW_$YC_A)-6_Y^_P#R&G^%'_"2:M_S]_\ D-/\*Z?_ (0G3?\
MGO=_]]K_ /$T?\(3IO\ SWN_^^U_^)H^K8W^9_>'LZW?\3F/^$DU;_G[_P#(
M:?X4?\))JW_/W_Y#3_"NG_X0G3?^>]W_ -]K_P#$T?\ "$Z;_P ][O\ [[7_
M .)H^K8W^9_>'LZW?\3F/^$DU;_G[_\ (:?X4?\ "2:M_P _?_D-/\*Z?_A"
M=-_Y[W?_ 'VO_P 31_PA.F_\][O_ +[7_P")H^K8W^9_>'LZW?\ $YC_ (23
M5O\ G[_\AI_A1_PDFK?\_?\ Y#3_  KI_P#A"=-_Y[W?_?:__$T?\(3IO_/>
M[_[[7_XFCZMC?YG]X>SK=_Q.8_X235O^?O\ \AI_A1_PDFK?\_?_ )#3_"NG
M_P"$)TW_ )[W?_?:_P#Q-'_"$Z;_ ,][O_OM?_B:/JV-_F?WA[.MW_$YC_A)
M-6_Y^_\ R&G^%'_"2:M_S]_^0T_PKI_^$)TW_GO=_P#?:_\ Q-'_  A.F_\
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M -]K_P#$T?\ "$Z;_P ][O\ [[7_ .)H^K8W^9_>'LZW?\3F/^$DU;_G[_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 ?.U>VZ%_P B]IO_ %ZQ?^@"O$J]MT+_
M )%[3?\ KUB_] %>MF/PQ/FLC_B3]#0HHHKRCZ0**** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !RE^S>,O^@M9_\ ? _^-UTE%5];?\D?_ 4+ZDOYY?\ @3.;^S>,O^@M9_\
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MW_X%_P  /98K_GZO_ ?^"<__ ,+!TG_GWO?^^$_^*H_X6#I/_/O>_P#?"?\
MQ5=!11[7#?\ /M_^!?\  #V6*_Y^K_P'_@G/_P#"P=)_Y][W_OA/_BJ/^%@Z
M3_S[WO\ WPG_ ,57044>UPW_ #[?_@7_   ]EBO^?J_\!_X)S_\ PL'2?^?>
M]_[X3_XJC_A8.D_\^][_ -\)_P#%5T%%'M<-_P ^W_X%_P  /98K_GZO_ ?^
M"<__ ,+!TG_GWO?^^$_^*H_X6#I/_/O>_P#?"?\ Q5=!11[7#?\ /M_^!?\
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M5'_"P=)_Y][W_OA/_BJZ"BCVN&_Y]O\ \"_X >RQ7_/U?^ _\$Y__A8.D_\
M/O>_]\)_\51_PL'2?^?>]_[X3_XJN@HH]KAO^?;_ / O^ 'LL5_S]7_@/_!.
M?_X6#I/_ #[WO_?"?_%4?\+!TG_GWO?^^$_^*KH**/:X;_GV_P#P+_@![+%?
M\_5_X#_P3G_^%@Z3_P ^][_WPG_Q5'_"P=)_Y][W_OA/_BJZ"BCVN&_Y]O\
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MX3_XJC_A8.D_\^][_P!\)_\ %5T%%+VN&_Y]O_P+_@![+%?\_5_X#_P3G_\
MA8.D_P#/O>_]\)_\51_PL'2?^?>]_P"^$_\ BJZ"BCVN&_Y]O_P+_@![+%?\
M_5_X#_P3G_\ A8.D_P#/O>_]\)_\51_PL'2?^?>]_P"^$_\ BJZ"BCVN&_Y]
MO_P+_@![+%?\_5_X#_P3G_\ A8.D_P#/O>_]\)_\51_PL'2?^?>]_P"^$_\
MBJZ"BCVN&_Y]O_P+_@![+%?\_5_X#_P3G_\ A8.D_P#/O>_]\)_\51_PL'2?
M^?>]_P"^$_\ BJZ"BCVN&_Y]O_P+_@![+%?\_5_X#_P3G_\ A8.D_P#/O>_]
M\)_\51_PL'2?^?>]_P"^$_\ BJZ"BCVN&_Y]O_P+_@![+%?\_5_X#_P3G_\
MA8.D_P#/O>_]\)_\51_PL'2?^?>]_P"^$_\ BJZ"BCVN&_Y]O_P+_@![+%?\
M_5_X#_P3G_\ A8.D_P#/O>_]\)_\51_PL'2?^?>]_P"^$_\ BJZ"BCVN&_Y]
MO_P+_@![+%?\_5_X#_P3G_\ A8.D_P#/O>_]\)_\51_PL'2?^?>]_P"^$_\
MBJZ"BCVN&_Y]O_P+_@![+%?\_5_X#_P3G_\ A8.D_P#/O>_]\)_\51_PL'2?
M^?>]_P"^$_\ BJZ"BCVN&_Y]O_P+_@![+%?\_5_X#_P3/TWQ;I6J3B".5XI6
M^ZDR[=WT.2*W*YS7-#M]6LW_ ':K<J"8Y .<^A]14_A+4I=4T&.2<[I8F,3-
M_>QC!_(BE4ITY4_:TM+:-/H.E5JQJ^QK6=U=-=>^G<W****Y3L"BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ )P,FN=OO&NCV4[1;Y9V4X/DJ" ?J2 ?P
MJ+QG>3I:6NG6[;9+^3RB?]G@$?B2*NZ9I-II5LL5O&-P'S2$?,Q]2:ZX4Z<*
M:J5=;[):;=6SBJ5:M2JZ5*RMNWKOT2,W_A8.D_\ /O>_]\)_\51_PL'2?^?>
M]_[X3_XJN@HH]KAO^?;_ / O^ 'LL5_S]7_@/_!.?_X6#I/_ #[WO_?"?_%4
M?\+!TG_GWO?^^$_^*KH**/:X;_GV_P#P+_@![+%?\_5_X#_P3G_^%@Z3_P ^
M][_WPG_Q5'_"P=)_Y][W_OA/_BJZ"BCVN&_Y]O\ \"_X >RQ7_/U?^ _\$Y_
M_A8.D_\ /O>_]\)_\51_PL'2?^?>]_[X3_XJN@HH]KAO^?;_ / O^ 'LL5_S
M]7_@/_!.?_X6#I/_ #[WO_?"?_%4?\+!TG_GWO?^^$_^*KH**/:X;_GV_P#P
M+_@![+%?\_5_X#_P3G_^%@Z3_P ^][_WPG_Q5'_"P=)_Y][W_OA/_BJZ"BCV
MN&_Y]O\ \"_X >RQ7_/U?^ _\$Y__A8.D_\ /O>_]\)_\51_PL'2?^?>]_[X
M3_XJN@HH]KAO^?;_ / O^ 'LL5_S]7_@/_!.?_X6#I/_ #[WO_?"?_%4?\+!
MTG_GWO?^^$_^*KH**/:X;_GV_P#P+_@![+%?\_5_X#_P3G_^%@Z3_P ^][_W
MPG_Q5'_"P=)_Y][W_OA/_BJZ"BCVN&_Y]O\ \"_X >RQ7_/U?^ _\$Y__A8.
MD_\ /O>_]\)_\51_PL'2?^?>]_[X3_XJN@HH]KAO^?;_ / O^ 'LL5_S]7_@
M/_!.?_X6#I/_ #[WO_?"?_%5-;>.M'N)0C?:(,G&Z5!C]":VJKWEA;:A T-S
M"LB,,<CD>X/:FJF&>C@U\_\ @"=/%K55$_\ MW_@FDCK(@=&#*PR&4Y!%.KD
M?"<LMAJE_H,CEXX/WD1/4 XS_P"A _G775C7I>RGRWNNGHS?#UO;0YK6>S7F
MMPHHHK$W"BBB@ HHHH ***YKQOXL_P"$-T6'4?L7VSS+A8/+\WR\95FSG!_N
M]/>FDV[(4I**NSI:*\LT3XR?VSKECIO]@^3]JF6+S/MF[;DXSC8,_G7J=.4'
M'<F%2,U>+"BBBI+"BBB@ HHK#\9:A=:5X0U.^LI?*N88=T;[0VTY'8@BFE=V
M$W97-RBOFS_A:GC3_H,_^2L/_P 17T3IDTEQI5G-*VZ22!'8XQDE035SIN&Y
ME2K1J7L6J***S-@HHHH **** "BBB@ HILCK%&TCG"J"Q/H!7S3K/Q&\2ZKJ
MCW<6J7-G$&S%!;R%%50> 0/O>^<Y^F!6E.FY[&-6LJ=KGTQ17"_"[Q9>>)]#
MG342)+NS<(TV,>8K9() XSP1^%=U42BXNS-(24XJ2"BBBD4%%%% !1110 44
M44 %%%% !16/XJU[_A&?#=WJ_P!F^T_9]G[K?LW;G5>N#C[V>G:O-?\ A>W_
M %+?_D]_]KJXTY25TC.=:$':3/8J*\>'QV&1GPX0.Y%[G_VG6E9_&[197"W>
MG7MN#U9-L@'Z@_I3=&:Z$K$4GU/3Z*RM#\2Z/XCMS-I5]%/@9= <.G^\IY']
M>U:M0TUN:IIJZ"BBN6\7>/=)\(H([@M<7SC<EK%]['JQZ*/U] >:$FW9!*2B
MKLZFBO"9_C?KK29M]-TZ./\ NR*[G\PP_E6[X?\ C7;7-RL&N6(M58X%S Q9
M5/'WE/('7D$_3O6CHS2V,5B:;=KGK-%1P7$-U D]O+'-#(-R21L&5AZ@C@U)
M61N%%<IXY\;+X+L[28V/VQKF1D">=Y> !DG.#GJ*X^S^.,5Q?6\,^A>1#)(J
M/+]LSY:DX+8V#.!SU%6J<I*Z1E*M"+Y6]3UNBBBH-0HK/US5H=#T.\U2<;DM
MHB^W.-Q[+GMDX'XUY;_PO;_J6_\ R>_^UU<:<I;(SG5A!VDSV*BL_0]536]"
MLM32/RQ=0K)Y>[=M)'(SWP>*T*AJQ:=U=!116)XA\6Z+X7A#ZG=JDC+N2!!N
MD<>R^GN<"FDWH@;25V;=%>-ZG\<G\PKI6CJ$!XDNI,DC_=7I_P!]&LN/XW>(
M1(#)I^ELG<+'("?QWG^5:JA,P>*IKJ>\45Y/I'QOLYI4CU;2Y+93P9H)/,'U
MVD @=.YKTK2M8T[6[-;O3;N*YA;^)#R/8CJ#['FHE"4=T:0JPG\++U%%%0:!
M1110 45Y'=?'#[->3V__  CN[RI&3=]MQG!QG_5U#_PO;_J6_P#R>_\ M=:^
MQGV,/K-+N>Q45Y?8_&_1YI%6]TR\ME) WH5D YZGH<?0'Z5Z'I>K6&M6*7NF
MW4=S;OP'0]#Z$=0>>AYJ)0E'=&D*D)_"R[1114EA1110 4444 %%%% !1110
M 445!?72V-A<W;@E((FE8#N%!/\ 2@">BOF/4?B'XHU'4FO/[7N;;YB4AMY"
MD:#TVCK^.37MGPW\4W/BKPSY]]@WMO*897  $G (; &!P<8'<'IG%:SHRBKL
MPIXB-27*CL****R-PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **K:AJ
M-GI5E)>7]S';V\8RTDC8'T]S[#DUY#X@^,UY<SFT\-66Q2<"XG3?(_3[J#@=
M^N<CL*N$)2V,ZE6,/B/9Z*\#%I\5]:<R[M7C)^;!F%J/RROY4UXOBKH8:5GU
M=PGS$F470_++<5?L?[R,OK'7E=CWZBO&_#WQGGCN/LOB6S4*#M-Q;J59#_M(
M>O/IC'H:]>M;JWOK6.ZM9DF@E7<DD;95A[&HE"4=S6G5C4^$FHHHJ#0****
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M_P!;_L35+F2\CEC+0RRG+H5&2">I!'KZ4_8RY>8GZQ'GY#V2BBBLCH"BBB@
MHHHH **** "BBB@ HHHH **\'\7_ !%\5:7XNU.QL]5\JV@G*1I]GB;:/J5)
MKM_A3XEU?Q+IVHRZO=_:7AF54/EHF 1G^$"M94I*/,81Q$93Y%N>@T445D;A
M1110 4444 %%%% !1110 4444 ?.U>VZ%_R+VF_]>L7_ * *\2KVW0O^1>TW
M_KUB_P#0!7K9C\,3YK(_XD_0T****\H^D"BBB@ HHHH **** "BBB@ HHHH
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MRN3^'W_( G_Z^F_]!2NLKJQW^\S]3CR[_=8>@4445R':%%%% !1110 4444
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M45R':%%%% !1110 4444 %%%% !1110 4444 %%%% ')>+O^0WX=_P"OD_\
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M:*^1;+4K[39EFL;R>VE7D-#(4/Z5[A\-OB-<>(YO[(U5-U^J%TN$3 D Q]X
M84^_ /UZN=!Q5T*EBHS=FK'I5%%%8'2%%%% !1110 4444 ?.U>VZ%_R+VF_
M]>L7_H KQ*O;="_Y%[3?^O6+_P! %>MF/PQ/FLC_ (D_0T****\H^D"BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH \A\:_\ (W7W_;/_ -%K7;_#/_D6[C_K
M[;_T!*XCQK_R-U]_VS_]%K7;_#/_ )%NX_Z^V_\ 0$KU<1_NL?D?-X+_ )&,
M_67YG9T445Y)]*%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %<9X$_Y DW_7RW_H*UV=<9X$_Y DW_ %\M_P"@K772
M_P!VJ>L?U.*M_O5+TE^AT]%%%<IV!1110!R/Q/\ ^2=ZK_VQ_P#1J4?##_DG
M>E?]MO\ T:]'Q/\ ^2=ZK_VQ_P#1J4?##_DG>E?]MO\ T:]:_P#+KYF'_+_Y
M?J==4%[96VHV4MG>0I-;S+M>-QP1_GO4]%9&YX_X)DF\'_$B^\+S3,;.X)$>
M\@98#<C?4KQQU)'H!7L%>0^/P+?XL>'9XE!D;[.61."Q$Q'/U''X5Z)XLUL^
M'O#%]J:@-+$F(@>[L0J\=P"<GV!K6HN9I]SGI/D4D]D9'BKXAZ=X=N/[/MXG
MO]4)"BWBZ(3T#'U/H,GZ<5CQ>)/B5/$;F/PK:+;X+!),K)C'H9 <_P# :/A5
MX="V,GB:_!FU"^=C'))RRKDAFY[L<\^F/4Y])HDXQ=DKCBIU%S-V./\ #?CR
M'5[_ /LC5+&;2M749\B<8$G'\).#GO@CIT)J7P1XT_X3&*]D_L_[']F9!CSO
M,W;L_P"R,=*?XY\,IX@T-Y(5*ZE: RVDJ<.&'.T$<\X_/!KD/@E_QZ:S_P!=
M(OY-1:+@Y(7-.-10;T.H3QR$\=OX8O-/^SDG$-SYQ829&5^7:,9'OP1BNOKS
M/XMZ3-';V'B:RW+=6$BJ\BX^5=V4;\'Q_P!]5W>A:M%KFAV>IP\)<1AL>AZ$
M?@014R2Y5)%PD^9QE_2+TTT=O!)-*X2.-2[L>@ &2:Y;P;XT?QA+?-'IHMK:
MV(42F?>9"<X^7:,<#)Y[BL[XKZZVF>&%T^ N+C4F,0*]=@QO_/('T)K=\%Z$
M/#WA6RLBI$Y7S9\]?,;DC\.!^%%DH7?4.9NIRK9;G04445!J%%%% ',>._\
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MH **** "BBB@ HHHH **** ,+QE_R*E[_P!L_P#T-:\GKUCQE_R*E[_VS_\
M0UKR>OI<F_@/U_1'RN>?[Q'_  _JSM? '_,1_P"V?_LU=I7%^ /^8C_VS_\
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M?<LI8)Y,B\#KRR@5X?XJ\%ZMX/8&=Q+93GRQ/$2%8\-M8=CQG!]/:M#X3?\
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M_P!T7^)_DCB7^^/_  K\V7:***Y3L"BBB@#RWXU_\@G2O^N[_P#H(KT72/\
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M445R':%%%% !1110 4444 %%%% !1110 4444 %%%% '&>!/^0)-_P!?+?\
MH*UT]<QX$_Y DW_7RW_H*UT]=F._WF?J<67_ .ZP] HHHKD.P*YOQ]_R(FL?
M]</ZBNDKF_'W_(B:Q_UP_J*J/Q(BI\#,CX1_\B,G_7Q)_2N[KA/A'_R(R?\
M7Q)_2N[IU/C8J/\ #1D>(?#6F^)=/>UOX%+$8CF &^,^JG^G0UYW\/M3O?#/
MBRZ\%ZBZO&78PMG[K[=W'LR\X]?<FO6Z\?\ B:O]E^/M"U6 F.5@A9AT)1_3
MZ'!]154W>\&9UERVJ+H>P51U76=.T2T-UJ5W%;0] 7/+'T ')/L*FO[V#3;"
M>]N7"0P(7<Y'0?7O7DOAG1YOB1X@N_$.N[VTZ%_+AM]Q /<*/8 Y..I/UJ8Q
M3U>QI4FTU&.[.@?XQ^&UDVBWU)Q_?6%,?J^?TKJ=!\5:/XDC9M-O%DD49>%A
MMD4>I4]O?I6C;6-I9VQM[6U@@@/_ "RBC"K^0XKC?%G@Z."-O$'AN-;'6;/,
MH$"[5G4<LI4<9QGMST.<\/W'IL3^\CJ]3I-)\3:/KMS<VVFW?GRVW$J^6Z[>
M2.K 9Y!Z4@\3Z0WB#^POM9&I\_N&B<9^7=PQ&#QSUKS;X-3-<:QKDS@!I%1R
M!TR68U?^*VFOI]YI?BRR 6>VF6.7W(.Y#T]B#GU%-TUS\I*JR=/G/4:*IZ5J
M,.K:3::A 08[B)9  V<9'(SZ@\'W%9?C77AX=\*WE\KJ)R/*@![R-P,?09/X
M&LTFW8W<DES%C3_%&CZKJEQIMC=F:ZMRPE587PN#@_,1MZ^_/:MBN ^$^@_V
M;X:;4YAFZU%O,R3DB,9"C\3D_B/2N_IS23LB:<I2BG(****DL*Q?%O\ R+%Y
M_P  _P#0UK:K%\6_\BQ>?\ _]#6M\+_'AZK\SGQG^[U/\+_(U]$_Y &G?]>L
M7_H(J_5#1/\ D :=_P!>L7_H(J_6=7^)+U9K1_AQ]$%%%%9F@4444 %%%% !
M1110 4444 %%%% !1110 5Q]M_R4?5/^O9?Y1UV%<?;?\E'U3_KV7^4==>%V
MJ?X7^:.+&?%2_P 2_)G24445RG8%%%% !7D?@/\ Y+!XF_[>O_2A:]<KR/P'
M_P E@\3?]O7_ *4+6D/AD85?BAZGKE1W%O!=P/!<PQS0N,/'(H96'N#P:DHK
M,W/%O$&GS?##Q?:ZQI.XZ9=$AX"W;/S1Y],8*GM[XY]E@GCN;>.>%@\4J!T8
M=U(R#7(?%2R2[\!7DC E[:2.:/!Z'<%/_CK-5CX;7;WG@'3&D<N\:O$2>P5R
M%'_?(6M9>]!2,(+DJ."VW.GGGAMH'GN)4BA0;GDD8*JCU)/2N(OOBYX8LYVB
MC-Y=A3C?!$-I^FXBN<U^YNOB+XY7P[9W#1Z19,6F=#D,5X9N.#S\J_7/<UZ9
MH_A_2M!MUATVQA@PNTN%^=N_S-U/XTN6,5[VX^>4V^31&/H7Q#\/>()UMK>Y
M:"Y<@)#<KL9B>P.2"?;-:DWB;1X->CT.2[VZC)@I#Y;G.1G[V,=!ZU4\1^#-
M'\1VT@GMDAO#S'=Q*!(C=B2/O#V/Z'FO)]#FU23XLZ=#K+[[ZUD^SR/W?:C
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MG_A]_P @"?\ Z^F_]!2NJE_NU3UC^IQU?]ZI>DOT.LHHHKD.T**** "BBB@
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M?%3_ )*1JW_;'_T2E98>3<FF;XN$5%-([KX&32-I>L0%CY:31NJYX!92"?\
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M_K[E_P#0S7UI7R7K_P#R,>I_]?<O_H9K/#[LVQBM%6/</@O_ ,B/)_U^R?\
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M6@&P\.S:O,F)K]L1Y'(C4D#'U.?K@5Z765>7-*W8Z,+#EA?N?(-U_P ?D_\
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M6S'X8GS61_Q)^AH4445Y1](%%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!Y#
MXU_Y&Z^_[9_^BUKM_AG_ ,BW<?\ 7VW_ * E<1XU_P"1NOO^V?\ Z+6NW^&?
M_(MW'_7VW_H"5ZN(_P!UC\CYO!?\C&?K+\SLZ***\D^E"BBB@ HHHH ****
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MZG'EW^ZP] HHHKD.T**** "BBB@ HHHH **** "BBB@ HHHH PO&7_(J7O\
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M_A3_ (M,&\4^'H[C)M>K*>G+C=UXZ 5V/@#PH?"N@>5<!?M]P?,N"IR!Z+^
M_4FJ/Q1\,S:_X>2YM%+W5@6E"#JZ$?.![\ _ACKBM5->T\CG=.7L7WW.YHKC
M_ 7C.T\1Z/!;S7"+JL*!)H7;YI,#[ZY^\"!D^A_ GKV8*I9B H&23T%8RBT[
M,Z8R4E=''_%$1GX>ZB7"E@T13/4'S%Z>^,_AFK'PY_Y$#2?^N;_^AM7#?$_Q
M8FL0/I&CO]HM;7$U]/'@I]X*H!]-S#/N1[UW/PY_Y$#2?^N;_P#H;5JTU3U[
MF,9*59V[%'XIZ%_;'A)[F)2US8-YR!5)++T<?E\W_ :TO WB :_X1M;V:4&>
M(&&Y)SPZ]R3ZC:WXUT;HLB,CJ&1AAE89!'H:^?M0O+WP)>>(_#L(?[/>+MA9
MF&50GALCJ2A([<_3%$%SQY0J2]G/GZ,Z?PLK>-?B=>>()-S6%@3]G)7@XR(Q
MT],OZ@XKURN6^'N@_P!@>$;:*2/;=7'[^?UW-T'X+@?GZUU-14=WILBZ,6HW
M>[U"BBBH-0HHHH YGQ)_R'_#O_7U_P"S)795QOB3_D/^'?\ KZ_]F2NRKJK_
M ,&EZ/\ -G'A_P"/6]5_Z2@HHHKD.T**** "BBB@ HHHH **** "BBB@ HHH
MH **** .,\"?\@2;_KY;_P!!6NGKF/ G_($F_P"OEO\ T%:Z>NS'?[S/U.++
M_P#=8>@4445R'8%<WX^_Y$36/^N']1725S?C[_D1-8_ZX?U%5'XD14^!F1\(
M_P#D1D_Z^)/Z5W=<)\(_^1&3_KXD_I7;3W-O;*&N)XXE/0R.%'ZTZGQL5'^&
MB6O(/B(5U?XE:%I,3Y*>4LGRYV%WR>._RX-=;XG^(^BZ#:.+6YAO[\@>7#"^
MY1GNS#@ >G7IZYK%^&_AN_FU"X\7:VI^U7>6MPPVG#=7('0$< >F?:K@N5<S
M,ZK4VJ<?F=#\2V=/A[JIC)#;8P<>AD4'],U'\,!"/A]IIB !)E+],EO,;K^G
MX8KHM7TV+6-'N].F)6.YB:,L!DKD<'\#S^%>7_#_ %T^$-4O/"FOL+8^:7BE
M=L(&('&3_"P (/\ C2CK!I#D^6JI/9JQZ[12*P90RD%2,@CH:Y3QKXQM_#VG
MO;6LJRZS.-EO;Q@.RL>C,OISQGJ?QK-)MV1K*2BKLY#X1!%\0^(1&%" J%"]
M,;VQBO3-:TN+6]%O--F.U+F(INQG:>S8[X.#^%>7?!E)(]6UN.7/F*B!\G/(
M9LU[!6E729EAU>E9GF?PEU6:*+4/#-[E+FQ<O'&P.0I;#CV ;'_?54?'TLGB
MSQUIOA2TD;R("&N65<[&/+'IV3'MDXIGCD2^#?B!8^*+2(F"Y'[] 0 S 89>
MG&5P<^N35SX3:7+=SZEXIOEW7%W(R1.3ZG+GKZX'X'UK31?O/ZN8J[M1_JQZ
M=##';P1PQ($CC4(BCH !@"GT45S':%%%% !6+XM_Y%B\_P" ?^AK6U6+XM_Y
M%B\_X!_Z&M;X7^/#U7YG/C/]WJ?X7^1KZ)_R -._Z]8O_015^J&B?\@#3O\
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MR5\V5V8?X3S<9\:]#Z3_ .%J>"_^@S_Y*S?_ !%96I_&;PY:12?88[J^F'"
M)Y:-]6;D#\#]*\!JY;:1J=Y($M=.NYW/ 6*!F)XSV%'L(+</K=1[$_B#7KWQ
M)K$VIW[*99. JC"HHZ*/85Z'\&?#$L^J2>(9XV6"W5H[<D8WN00Q''( )'U-
M4O"GPBU34Y8[G6PUA9YR8C_KG'/&/X>G4_E7N=C8VNFV4-E90)!;0KMCC0<
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M0^GXU\KZ1H6IZ]=K;:992W$A."47Y5]V;H![FOH#X?\ @2/PA8O+<.LVIW
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M1110 4444 %%%% !1110 4444 %%%% '&>!/^0)-_P!?+?\ H*UT]<QX$_Y
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M5_Z2@HHHKD.P**** .4\3_#_ $KQ7J4=]?7%['+'"(0('4+M!)[J>?F-8O\
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M6/5IH%<G\Q[#\J;::%H]@X>STJQMV!SF&W1#GUX%:%%.[%RK<****0PHHHH
M**** "BBB@ HHHH *J7FE:=J!S>V%K<\8_?0J_'IR/<_G5NB@&KE"TT/2-/;
M=9:78VS9SF&W1#G\!5^BBB]Q));!1110,**** "BBB@ HHHH ^=J]MT+_D7M
M-_Z]8O\ T 5XE7MNA?\ (O:;_P!>L7_H KULQ^&)\UD?\2?H:%%%%>4?2!11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MUI#7M[%H%E%I,!^62XD#OMR!DA9.Y[ <9_&NH\':U<^(?"EEJEVD23S[]RQ
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBJ5UJ^F6-S';7>HVEO<2X\N*:=49\G P"<GGB@&[%VBBB@ HJK?:G8:9&L
MFH7UM:1N=JM<2K&"?0$D58CDCFB26)U>-U#*ZG(8'H0>XH"XZBBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHJI?:II^EHCZA?VMHKG"M<3+&&/H,D9H!NQ;HJM9ZC8ZB
MC/8WMO=*N,M!*K@9Z=#5F@ HK+/B30EN#;G6M.$X.TQ&Z3=GTQG-7KB\M;6T
M:ZN+F&&V4 M-(X5 #T))X[T[,5T345!9WMIJ%N+BRNH;F!B0)(9 ZDCKR.*G
MI#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH ^=J]MT+_D7M-_Z]8O\ T 5XHZ&.1D;J
MI(->T^'I%E\.::R'(%LB_B% /ZBO6S#X(GS61_Q)KR-*BBBO*/I HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** /(?&O_ "-U]_VS_P#1:UV_PS_Y%NX_Z^V_
M] 2N&\8R++XLOV0Y 95_$(H/ZBNZ^&B%?#4Q/1KIB/\ OE1_2O5Q'^ZQ^1\W
M@=<QFUWE^9V5%%%>2?2A1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !7&>!/^0)-_U\M_Z"M=G7&>!/^0)-_P!?+?\
MH*UUTO\ =JGK']3BK?[U2])?H=/1117*=@4444 %%%% !1110 4444 <M\1O
M^1 U;_KFG_H:U%\,/^2=Z5_VV_\ 1KU+\1O^1 U;_KFG_H:U%\,/^2=Z5_VV
M_P#1KUI_R[^9C_R^^7ZG74445F;!1110 4444 %%%% !1110!S'CO_D"0_\
M7RO_ *"U=G7&>._^0)#_ -?*_P#H+5V==57_ ':GZR_0XZ/^]5?2/ZA1117(
M=H4444 %%%% !1110 4444 %%%% !1110 4444 <?;?\E'U3_KV7^4==)7-V
MW_)1]4_Z]E_E'725V8O>'^&/Y'%@OAG_ (I?F%%%%<AV!1110 4444 %%%%
M'E'@O_DLOB7_ *YS_P#HY*]7KRCP7_R67Q+_ -<Y_P#T<E>KUI5W,:'POU85
MY+99UGX\7,I!,=BK8 [;$"<X_P!IL_CBO6'=8XVD<X5023Z 5XAX5'B^UUK4
M=9TOPZT\M^7P]V-BJ"VX\L5SV[\XITUHV36>L5YGN-%>8S_$#Q7X=D5_$_AI
M$MF.T2VK$!3]=S*3UXR/TKO]'UBQU[38[_3YQ+ _'H5/=2.Q%1*#6IK&I&3L
MMR_1114EA1110 4444 %%%% '/\ P^_Y $__ %]-_P"@I765R?P^_P"0!/\
M]?3?^@I765U8[_>9^IQY=_NL/0****Y#M"BBB@ HHHH **** "BBB@ HHHH
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MO+EV/G+.H>*?$8W,)+Z_G R>!N)_0#^0KTZ[^"UNND?Z)J4S:DJ9/F ")V]
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M_D"6'_7M'_Z"*ZW_ +HO\3_)'$O]\?\ A7YLNT445RG8%%%% !1110 4444
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M8O\ T$5?JAHG_( T[_KUB_\ 015^LZO\27JS6C_#CZ(****S- HHHH ****
M"BBB@ HHHH **** "BBB@ KC[;_DH^J?]>R_RCKL*X^V_P"2CZI_U[+_ "CK
MKPNU3_"_S1Q8SXJ7^)?DSI****Y3L"BBB@ HHHH **** "FR2)#$\LKJD: L
MS,<!0.I)["G5Y[\5_$9T_1$T6T9C>ZC\K!,Y$6>>G=C\N.XW548\SL3.:A%R
M9A>'(SX_^)5UKMPI;3-/QY"..#C(C&,^NYSUYX[UZ_6!X-\/KX:\,VM@0/M!
M'FW!'>1NOY<+] *WZ=25WIL12@XQUW9!??\ (/N?^N3?R->:?!3_ )!.J_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M^*KD_P#A!/$G_0-_\CQ__%4?\()XD_Z!O_D>/_XJCV&%_F_$/KF8_P C_P#
M6=9_PL;2/^?:^_[X3_XJC_A8VD?\^U]_WPG_ ,57)_\ "">)/^@;_P"1X_\
MXJC_ (03Q)_T#?\ R/'_ /%4>PPO\WXA]<S'^1_^ LZS_A8VD?\ /M??]\)_
M\51_PL;2/^?:^_[X3_XJN3_X03Q)_P! W_R/'_\ %4?\()XD_P"@;_Y'C_\
MBJ/887^;\0^N9C_(_P#P%G6?\+&TC_GVOO\ OA/_ (JC_A8VD?\ /M??]\)_
M\57)_P#"">)/^@;_ .1X_P#XJC_A!/$G_0-_\CQ__%4>PPO\WXA]<S'^1_\
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M_(__  %G6?\ "QM(_P"?:^_[X3_XJC_A8VD?\^U]_P!\)_\ %5R?_"">)/\
MH&_^1X__ (JC_A!/$G_0-_\ (\?_ ,51[#"_S?B'US,?Y'_X"SK/^%C:1_S[
M7W_?"?\ Q5'_  L;2/\ GVOO^^$_^*KD_P#A!/$G_0-_\CQ__%4?\()XD_Z!
MO_D>/_XJCV&%_F_$/KF8_P C_P# 6=9_PL;2/^?:^_[X3_XJC_A8VD?\^U]_
MWPG_ ,57)_\ "">)/^@;_P"1X_\ XJC_ (03Q)_T#?\ R/'_ /%4>PPO\WXA
M]<S'^1_^ LZS_A8VD?\ /M??]\)_\51_PL;2/^?:^_[X3_XJN3_X03Q)_P!
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MK3R8C=,))E[,=V'_  93S^)KV.O'/'3KXI^)FEZ+9L7%L5CF=!NV$MN<_P#
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M-IPC-69\[?#V^N=2^+&GW=XVZYD,ID8C!+"%P2??BOHFO$-+@2W_ &AI$0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KC/ G_ "!)O^OEO_05KLZX
MOP+QH]PA^\MRV1Z?*O\ A772_P!VJ>L?U.*M_O5+TE^AU%%%%<IV!1110 44
M44 %%%% !1110!0UK2+?7='N-,NGE2&< ,T1 88(/&01V]*;H6BVWA[1;?2[
M1Y7@@W;6E(+'<Q8YP .I/:M&BG=VL+E5[]0HHHI#"BBB@ HHHH **** "BBB
M@#F/'?\ R!(?^OE?_06KLZXOQUSH]N@^\URN!Z_*W^-=I755_P!WI^LOT..C
M_O57TC^H4445R':%%%% !1110 4444 %%%% !1110 4444 %%%% ''VW_)1]
M4_Z]E_E'725S=M_R4?5/^O9?Y1UTE=F+WA_AC^1Q8+X9_P"*7YA1117(=@44
M44 %%%% !1110!Q/A_P?J&D^/]7UZ>:U:UO%E$:1LQ<;G5AD%0.BGN:[:BBG
M*3>Y,8J*LC,U_0;/Q'I$NG7RGRWY5E.&1AT8>XKSZQT/XA^$#]ETB6UU73US
MY<<K  #)[,5*GG. Q'UKU2BJC-I6)E34G?9GE=YX;\?>,G6WUZXMM-T[?N>&
M(JW3I@*3N_%L=^M>A:%H=EX=TF+3K!"(8\DLV"SL>K,>Y_\ K#M6E12E-M6"
M--1=]V%%%%2:!1110 4444 %%%% '/\ P^_Y $__ %]-_P"@I765R?P^_P"0
M!/\ ]?3?^@I765U8[_>9^IQY=_NL/0****Y#M"BBB@ HHHH **** "BBB@ H
MHHH **** "HY_N#ZUD>+99(?#%Y)%(T;C9AD."/G7O7EYU/4#UOKD_\ ;5O\
M:]'"9?+$P<U*VMCS,;F4<+44'&]U<]?HKC_ MS/<?;_/GDEV^7C>Y;'WO6NP
MKEQ%%T*KIMWL=>%KK$4E52M?_.P4445B;A1110 5B>+M)N]=\+7NF6,R0W%P
M%57D8JN X+ D GD CIWK;HIIV=Q-75F>&?\ "F/$7_/[I?\ W]D_^(H_X4QX
MB_Y_=+_[^R?_ !%>YT5K[>9S_5:9X9_PICQ%_P _NE_]_9/_ (BO7?#&ESZ+
MX:L--N6C>:WCV.T9)4G)Z9 /Z5K45$JDI*S-*=&--WB<YXS\*?\ "6Z0ED+Z
M2U:.3S%(7<K'&/F'?J>_&>]<]\.O 5UX9O+V]U186NO]5 8VW#9U+#C(ST['
M@\5Z)10IM1Y1NE%RY^H4445!H%%%% !1110 4444 9>L:%:ZWY/VF29/)W;?
M+(&<XSG(/I5"/P!I3KDW%[U_OK_\371Y&<9YJQ!]P_6NB&+K4X\L)-(YJF#P
M]23G.*;(-,T^+2M/BLH&=HX\X+D$\DGL!ZU;HHKGE)R;D]V=$8J,5&.R"BBB
MD4%%%% !1110 4444 %%%% !1110 4444 87C+_D5+W_ +9_^AK4FC_\@2P_
MZ]H__014?C+_ )%2]_[9_P#H:U)H_P#R!+#_ *]H_P#T$5UO_=%_B?Y(XE_O
MC_PK\V7:***Y3L"BBB@ HHHH **** "N$\;^"M2\2Z]I=]9SVL<5H '$SL&/
MS9XPIKNZ*<9.+NB9P4U9A7$^+_ 1UN_36=(O#I^LQX_>@D"3 P,D<@@<9&>.
M,5VU%$9.+N@E!25F><)>_%2V4VYTO3;LCC[460$^^ Z_^@T:=X"U;6=7BUCQ
ME?BY>)LQV<9^1>>AQP!P#@=>YKT>BJ]H^BL1[%=6V%%%%0:A1110 4444 %%
M%% ',^)/^0_X=_Z^O_9DKLJXWQ)_R'_#O_7U_P"S)795U5_X-+T?YLX\/_'K
M>J_])04445R':%%%% !1110 4444 %%%% !1110 4444 %%%% '&>!/^0)-_
MU\M_Z"M=/7,>!/\ D"3?]?+?^@K73UV8[_>9^IQ9?_NL/0****Y#L"BBB@ H
MHHH S-?T&S\1Z1+IU\I\M^593AD8=&'N*\^L=#^(?A _9=(EM=5T]<^7'*P
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M-_R4K6?^O:?_ -')7M]>/?#'1=5L/B#JUS>:9>6UN]O,$EF@9%8F5" "1@\
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M1117,=H4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M\\+S_OA?_BJ[.BCVN&_Y]O\ \"_X >QQ7_/U?^ _\$XS_A.]+_YX7G_?"_\
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MW_OM/_B:/^%?:3_S\7O_ 'VG_P 31[+#?\_'_P" _P#!#VN*_P"?2_\  O\
M@'045S__  K[2?\ GXO?^^T_^)H_X5]I/_/Q>_\ ?:?_ !-'LL-_S\?_ (#_
M ,$/:XK_ )]+_P "_P" =!17/_\ "OM)_P"?B]_[[3_XFC_A7VD_\_%[_P!]
MI_\ $T>RPW_/Q_\ @/\ P0]KBO\ GTO_  +_ (!T%%<__P *^TG_ )^+W_OM
M/_B:/^%?:3_S\7O_ 'VG_P 31[+#?\_'_P" _P#!#VN*_P"?2_\  O\ @'04
M5S__  K[2?\ GXO?^^T_^)H_X5]I/_/Q>_\ ?:?_ !-'LL-_S\?_ (#_ ,$/
M:XK_ )]+_P "_P" =!17/_\ "OM)_P"?B]_[[3_XFC_A7VD_\_%[_P!]I_\
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M )^+W_OM/_B:/^%?:3_S\7O_ 'VG_P 31[+#?\_'_P" _P#!#VN*_P"?2_\
M O\ @'045S__  K[2?\ GXO?^^T_^)H_X5]I/_/Q>_\ ?:?_ !-'LL-_S\?_
M (#_ ,$/:XK_ )]+_P "_P" =!17/_\ "OM)_P"?B]_[[3_XFC_A7VD_\_%[
M_P!]I_\ $T>RPW_/Q_\ @/\ P0]KBO\ GTO_  +_ (!T%-DD2)"\CJBCJS'
M%8/_  K[2?\ GXO?^^T_^)IR> -(5@3+=N/1I%P?R6G[/#?\_'_X#_P0]KBO
M^?:_\"_X!228>)?%MJ;4;K/3SYC2]B<YX^I _(UV]5[*QMM.MEM[2%8HU[#O
M[D]S5BLZ]6,VE!6BM$:8:C*FG*;O*3N_Z\@HHHKG.D**** "BBB@ HHHH **
M** "BBB@ HHHH **** .%T>X7PYJUUH]Z1''))YD$I/RD'@9/N /Q!KK58,
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M+#?\_'_X#_P0]KBO^?2_\"_X!T%%<_\ \*^TG_GXO?\ OM/_ (FC_A7VD_\
M/Q>_]]I_\31[+#?\_'_X#_P0]KBO^?2_\"_X!T%%<_\ \*^TG_GXO?\ OM/_
M (FC_A7VD_\ /Q>_]]I_\31[+#?\_'_X#_P0]KBO^?2_\"_X!T%%<_\ \*^T
MG_GXO?\ OM/_ (FC_A7VD_\ /Q>_]]I_\31[+#?\_'_X#_P0]KBO^?2_\"_X
M!T%%<_\ \*^TG_GXO?\ OM/_ (FC_A7VD_\ /Q>_]]I_\31[+#?\_'_X#_P0
M]KBO^?2_\"_X!T%%<_\ \*^TG_GXO?\ OM/_ (FC_A7VD_\ /Q>_]]I_\31[
M+#?\_'_X#_P0]KBO^?2_\"_X!T%%<_\ \*^TG_GXO?\ OM/_ (FC_A7VD_\
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M2?\ GXO?^^T_^)H]EAO^?C_\!_X(>UQ7_/I?^!?\ Z"BN?\ ^%?:3_S\7O\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%<I9^.K%[I[:^1K9U=E\P?,AP2
M/J.U:0I3J)N*O8QJXBG2:51VN=713(I8YXEEAD22-AE70Y!^A%/K,V3N%%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MG&-A_G76>%=>_P"$F\-VFK_9OLWVC?\ NM^_;M=EZX&?NYZ=Z\/^+_\ R/\
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M +&M?J&(_E_%?YG/_:N$_G_!_P"1WE%<'_PLG_J$_P#DS_\ 8T?\+)_ZA/\
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M ,^=K_X]_C1_PL74?^?.U_\ 'O\ &C^SZ_;\0_MC"]W]QZ117F__  L74?\
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MF]%<];"TZWQ+7N=F&QU?#_ ].SV/=HI8YXEEAD22-AE70Y!^A%/KQ33=8O\
M29=]E</&"<LG56^H/%=UI'C^TN=L6I1_9I>GF)DQG^H_7ZUY-;+ZE/6.J/H,
M-F]&KI/W7^'WG8T4R*6.>)989$DC895T.0?H13ZX#UD[A1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!7!_$G_F&?\ ;7_V2N\KAOB+!--_9OE1/)CS<[5)Q]RNO Z8B/S_ "9Y^:)O
M"3MY?FCS^BK'V&[_ .?6?_OV:/L-W_SZS_\ ?LU]#S+N?'\DNQ7HJQ]AN_\
MGUG_ ._9H^PW?_/K/_W[-',NX<DNQ7HJQ]AN_P#GUG_[]FC[#=_\^L__ '[-
M',NX<DNQ7HJQ]AN_^?6?_OV:/L-W_P ^L_\ W[-',NX<DNQ7HJQ]AN_^?6?_
M +]FC[#=_P#/K/\ ]^S1S+N')+L5Z*L?8;O_ )]9_P#OV:?_ &5J/_/A=?\
M?EO\*.:/<?LYOH5**M_V5J/_ #X77_?EO\*/[*U'_GPNO^_+?X4N>/</9S[,
MJ45;_LK4?^?"Z_[\M_A1_96H_P#/A=?]^6_PHYX]P]G/LRI15O\ LK4?^?"Z
M_P"_+?X4?V5J/_/A=?\ ?EO\*.>/</9S[,J45;_LK4?^?"Z_[\M_A1_96H_\
M^%U_WY;_  HYX]P]G/LRI5_0_P#D8--_Z^HO_0Q4?]E:C_SX77_?EO\ "KVC
M:;?QZ[I[O97*JMS&2QB8 #<.>E34G'D>II2IS]I'1[H]@HHHKY8^["BBB@#F
M?B%_R(&L_P#7#^HKQ+X5_P#)2-)_[;?^B7KVWXA?\B!K/_7#^HKQ+X5_\E(T
MG_MM_P"B7KII?PY'%7_C1^7YGTG7G?QBT:*^\('4O+)N+&12&4#.QB%(/?'(
M/X5Z)7&_%2ZBMOAYJ*R, TQCBC']YBX/\@3^%8T_C5CIK).F[GF/P:U"2U\:
M-:!OW5W;NK+[K\P/Z'\Z]9\<>,;?P=HPN&037DY*6T). S <L?\ 9&1G'J!W
MS7CGPAADE^(%LZ*2L4,KN0.@V[<_FPJY\9[V2X\916I/[JVME"KCNQ))_E^5
M=$X*56QQTZCA0;7<Y.6;7_&FM'/VG4;V0E@BC(4<=!T5>GH*LZKX%\3Z%:_;
M+[2I8H4Y,L;K($]SL)Q]37L'P?TFVL_!46H)$OVF]D=GD_B*JQ4+]/E)Q[UZ
M RJZE6 *D8((X(I2K\LK):%0PJG'FD]6>'?#CXD7MKJ5MHNLW'GV4Q$<4\K?
M-"W102>J]N>F>O:O4/'.O3>&_"-[J-LH-PH$<1/168@!C],YQWQ7SQXPTR'1
M_%^J6%NH6"*<^6H_A4\@?@#C\*^@)-+'C'X;6MI=2L);VPAD\T\E9-JL&/K\
MW7U&:56,4U+HQT)S<90ZH^?-/TK7/&&K3+:1RW]\RF65GD&2.!DLQ ]!UK0T
M2S\5^'?&,-CI]O<6^K%MOD'[LBYYW=F3CKG'&<\9J,CQ+\.]>)4R65T 5#;0
MT<R9[9&&7^7L:]/\)_%K3=6O8H==M8;&_*^6EV@S&V3]TD\H/N]21QDD5K.4
MDM%='/3C%NTG9G4>/?,_X5WJWG!1+]F&\(>,Y&<9[5XW\)?^2B6/_7.7_P!%
MM7L_Q"_Y$#6?^N']17C'PE_Y*)8_]<Y?_1;5E3_AR.BO_&C_ %U.V^.7_((T
MG_KN_P#Z"*\JTC5-;CMI]&TB2<?;V DBMU.^7 /RY'.,$Y Z]^*]5^.7_((T
MG_KN_P#Z"*S?@;IT,M[JVHR1@RP)'%$QQQNW%OQ^5?S-5"7+2NR*D7*ORK^M
M#@M9\%^(O#]L+G4],DA@R!Y@=74$],E2<?C78?"'Q7>6NOQZ!/*TEE=AO*5C
M_JI N[C/8@$8]2/?/J_CBUCN_ VMQ2 %5LY)!D9Y0;Q^JBOG_P"'S%/'VC%3
M@_: /S!%-2]I!W%*'L:L>5GT5XCUZV\-:%<ZK= LD(&V,'!D8G 4?C^0R>U?
M->MZ]K'C#6?-N6EGFE?;!;1 E4ST5%_R37J_QPN)$\/Z;;JV(Y+HLP]2JG'_
M *$:QO@=IMM-?ZKJ4BJUQ;)''%GG8'W;CCL?E S]1WJ*=H0YRZS=2JJ=]#C_
M /A7?B]+07@T2Y" ;@ R^8,?[&=V>/2LC6-7U/5'MXM4E>2:SC^SJ9%PZJ"?
ME;N2#GKS7UE7@_QJTVVM/$MG>0(J27<!,P7^)E.-Q'J00/PJJ=7GE9HFMAU3
MA>+.T^"__(CR?]?LG_H*5Z)7G?P7_P"1'D_Z_9/_ $%*]$KGJ_&SKH?PT%?/
MOQ6\)3Z-X@EU>&-FL+^0R%QSLE/+*?3)R1^/I7T%4%Y96VHV<MI>0)/;RKM>
M-QD,**<^1W"M252-CPGX??$R;07BTO697ETG&V.3&YK?\N2OMV[>A]XMKF"\
MMHKFVE26"50R2(<A@>X-> >/OAM<>&3)J6G[I])9^1U>WST#>HSP#],^\_PI
M\97&DZU#H=U(SZ?>/LB4G_52D\$>Q/!'J<^N=ZD%-<\3FI594Y>SJ'MFN:S:
M>']&N=3O6Q# F<#J[=E'N3@5\X^(_%^M^,K_ &3R2F%F_<V4.2@Y./E'WFYZ
M]:]'^.5[+'IFD6*L1%/+)*PQU*!0/_0S5#X(:1;RW&I:O*H:>';!#D?<W9+'
MZ\ 9],^M*FE"'.QUG*I4]DGH<;'\-?&$EL+A=$E"'D!I$5NN/NEMWZ55T?4/
M$OA775M[ 7<%\)-ILRA82$\;2G\6?S]*^HZB^S0?:OM7DQ_:-GE^;M&_;G.W
M/7&><4OK#>Z']42UBROI%U=7NDVUS?6365U(@,ENS!BA^H_/UYYP:^4]5_Y"
M][_UWD_]"-?7-?(VJ_\ (7O?^N\G_H1JL/NR<9M$Z :1XR\>22:K]FNK\#.)
M78(@&>53<0, ]EK"5M2\/:OD&>RO[9^1]UD(]?;]#7U;I]C;Z9I]O8VJ!(((
MQ&@P.@'MWKP?XS6L=OXY25  UQ9QR/@8R063GUX455.KS2Y;:$5J')'GOJ>R
M^#]=;Q)X4L-4D4+-*A651T#J2K?0$C('H17%?%+X@7&BR#1-&G\N]9=US.N"
M8E(X5?1B.<]AC'7C4^#[%O ,0)X6XE _//\ 6O#_ !3=2WOBS5KB=MTC7<@^
M@#$ ?@ !44Z:=1^1K5JR5)6W8_2_#?B#Q/))/86-Q>'=\\S, "3ZLQ )_&G:
MEX;\1^%9H[F]L;JR9'!2X0_*K=1B121G\<\5TNG_ !?US2[""QL],T>*W@0(
MB+#(,#_OOKW/O2:C\7M<U73KBQN]-TB2"="CJ89#P>XR_4=1[BMKSOMH<MJ5
MMW<[KX8?$"7Q IT?57#:A$FZ*8D SJ.H/^T/;J.>Q)ZWQ?XEA\*>'9]3E4/(
M"(X(B<>9(>@^G!)]@:^<_!UZVG>,M'N4+#;=1JVTX)5CM8?D37HGQTN)/.T6
MVS^ZVRR8]3\H_P _6L94E[1+HSIA7E[%M[H\VOM1UGQ;K.^=I[V]G;"1(I./
M95'08';TK4G\ >,-)MQJ#:3<1+'\^^&56=.,YPK%A^5>@?!#2(/[.U'6616G
M:;[,C$<HJJ&./3.X?]\UZU3G6Y7RI$TL,IQYI/5GR5JVL7NMW276H2^=<+$L
M1D/5@O )]3[]Z^A/A7_R3?2?^VW_ *.>O(/BGI<&E^.[M;9%CCN$2?8HP 6&
M&_,@G\:]?^%?_)-])_[;?^CGIUFG33089-5FF>">+?\ D<]=_P"PA<?^C&KZ
MDL/^0=;?]<D_D*^6_%O_ ".>N_\ 80N/_1C5]26'_(.MO^N2?R%37^&)6%^*
M1XE\;_\ D9]/_P"O(?\ H;5V/P7_ .1'D_Z_9/\ T%*X[XW_ /(SZ?\ ]>0_
M]#:NT^#2;/ N[.=]W(WTX4?THE_!00_WAGD'C_\ Y'W6O^OEOZ5]%^'W2/PI
MI;NP5%L8BS,<  (.37SIX_\ ^1]UK_KY;^E>T:]=36?P:::!MKG3(4S[,JJ?
MT)IU5>,4*@[2FSRWQY\0[_Q'?SV=E<20:.AV+&AQYP'\3D=0?3IT[\UEV7P]
M\6:A:"YM]%G,14,#(RQDC&<@,03^%8^CZFVC:K!J"6MM<O VY([E2R9[$@$=
M.H]Z[S_A=OB7_GQTG_OU)_\ '*U:E%6@CG4HS;E49R5E?^(/!&L9C%S870P7
MAE4J)%!XW*?O+UY_(U]%>$?$]MXLT&+480(Y?N3P[LF-QU'T/4>QKP'Q5X[U
M#Q?;01:A8Z?&T#[DF@B8.!CE<ECP>#CU KL/@;>.NJ:M8[F\MX4FQG@%6Q_[
M-^E9U8WAS-:FN'J<M3EB[IC_ (N>&-?U'Q#!J%I97%[:&!8D6WC+M&022"H&
M><YS^'I7;_#'2-4T7P;%:ZL"DK2O+%"QYAC;&%/H<[FQVW<\Y%=C16#J-QY3
MKC149N84445F;'@%YKUSX?\ BOKMS96QN+Z9WM[:,#(,CE0,CO\ 3N<"NZT[
MX6PWQ^W^+[V?5=2D W#S65(Q_=!&"1^0]!6%X<L8[SX\:Q+(H;[+YLRY['Y4
M_P#9Z]BK>I-JR78Y*--2NY=V>=:S\(-$N(#)HC3:9>(N8V65G0MSUW$D?4'\
M#4'@+QEJ2:Q+X2\4;EU.$D0S2')DQSM)[G'(;N/PSZ97COQ:A.E^,O#NMVY"
M3N<94<DQNI!/K]_'X4H-S]V152*I^_'3N>P.Z1QL[L%102S,<  =S7CMSJ&M
M_%3Q%<Z9IEW)8^';?B611_K!V+8^\6[+G  SU%=U\2+N6R^'VKS0LRN8UCRI
M(.'=5/3V8U1^$UA!:> +.:,#S+IY)96'<ARH'X!1^.:4/=CS%5/?FJ?3=B6W
MPC\(06QBDLY[E_\ GM+<.&_\=(7]*QK[P_J/PS8ZWX?N;B\T=#_ING3MG:I/
MWE(]/7&1WR,X]2IDT,=Q!)!,@>*12CJ>C C!%)5)==2G1C;W59GC_P &)EN=
M?\0SH"%D"N >N"S&NY\5^ =*\875O<:A<7D3P(446[JH()SSE37#?!B%;;7_
M !# A)6,*@)ZX#,*]CJJK:G=&="*E22D?._@7P5IOB?Q!JMA>SW<<5H"8S"Z
MAC\^.<J:]>7PY9^%O .JZ;8R3R0BVN'W3L"V2A] !^E<+\(O^1S\1?[I_P#1
MAKU'Q'_R+&K?]>4W_H!IU9/GL30A'V?-;74XGX)?\B9>?]A!_P#T7'5KXB>,
M;W2I+70-!5GUJ](VE5#&-2<#&?XB1WZ#)]*J_!+_ )$R\_["#_\ HN.N,%QK
MEY\7]9O-"TZ#4+^UEE"QW3 *BH1%N&67IP!SWI\J=1M]!<[C1BEU.TT3X0Z6
MD0N/$<TVIW\G,O[YEC!]B,,?J3^ IVK_  @T:6,S:%+/IEZGS1,)6=,@<9R2
MPYQR#QZ4S^VOBQ_T+&D_]_5_^/4?VU\6/^A8TG_OZO\ \>I7G>_-^)5J5K<K
M^X7X?>,-2EU2Y\*^)2?[5MLB*0@$R!1R&(X) P0>XSWZZ_Q4_P"2;ZM_VQ_]
M')7$_P#".^.=3\>Z9XBU'0+>W:&:'SS;3Q@%%;DX,A.=O''H.*[;XJ?\DWU;
M_MC_ .CDH:7.F@BY>RDGTN<'X.CUCQKH5CH%O-+I^A:>I%[<1-B2X8L6V#VP
M?IW.>!7:#X1^$!:K";*<N.LQN'WGZ\[?T[5-\*K6.V^'FG,J@/,9)9"/XB78
M _D%'X5V=3.;4FHZ%4J47!.6K/(O#5Q?> /B OA*XN6N=*O<-;%^J%L[2.PR
M00<=3S7I^LZ5!KFCW.F7+R)#<)L=HB P'MD$?I7E_P 3V,7Q$\*RI@2*\9#8
M])017KU%3I(=)?%#HCYW\=>"M-\,>(-*L+*>[DBNP#(9G4L/GQQA17JOAOX9
MZ-X7UA=3LKF_DF5&0+/(A7!Z]$!_6N.^+O\ R.?AW_='_HP5[)53G+D6NY%*
MG'VDM-CR+7HI/''Q7;PY=W4D>DV$>\Q1$CS"%5FS[Y;&?0<=<UL:W\(M'FMQ
M+X?:32[^/F-Q,[(3[Y)(^H/YU5\>^#]9B\0)XN\,.YOU"^="AR[%1M!4=&!4
M %?;ODU<\)_%6QU>X73=9A&FZGN\O!SY;OT(YY0Y[-],YIWERIP$E#F<:BU?
M4[K3[>6TT^WMY[J2[FCC"O/( &D('4@?Y^M6:**YSK,CQ+X<L_%.D'3;Z2>.
M$NK[H& ;(^H(_2O#M"\%:;JGQ'U+P[//=K9VQE".CJ)#M8 9)4COZ5]$5XWX
M0_Y+EKG^]<_^ABMJ4FHNQS5X1<HW74]%\*^$K#PA93VNGS7,L<TGF,;AE8@X
M XPH]*X?Q)XBU?QEXH?PEX:F:VMHF(O+Q20< X;D'[O;'\1XZ5Z/KMVUAX>U
M.\0L&@M)905ZY5">/RKSSX'V,2:!J6H ?OI;KR"?144,/U<_E2B]'-[CFM53
MCHC5TWX0>%K2V1+R":^F ^:1Y60$^P4C%8NO?#>Y\,AM=\&WMS#/;+YCVA;=
MYBCDX/\ %Q_"0<_H?6**2JROJRW0A:R5CF/ WB^'QAH?VG8(KR$B.YB'0-C[
MR_[)[9]QSC)X3X[?\P#_ +>/_:5-\#K'H_QDUS3( 1;R"944'A<,''Y#(_&G
M?';_ )@'_;Q_[2K2,4JJL83FY4'?=?YGI7BW_D3-=_[!]Q_Z+:N.^"7_ ")E
MY_V$'_\ 1<==CXM_Y$S7?^P?<?\ HMJX[X)?\B9>?]A!_P#T7'4+^&S67\9>
MA;^(?C6ZT9[?0]$C,NLWH 4J,^6I.!@?WB>G;O5+1?A%8LAN_$US/J6H38>7
M]ZP4'N-V=S?7(K'\+QQZS\==:NI\LUD9VCW<\HRPC]"<?A7L=.3<$HQ)A%56
MY2^1YQK/P?T>6+SM!FFTN]3YHF$C.F0/<[A]0>/0T_X?^,K^YOY_"WB)2NL6
M>Y4E;K*J]03W;OD?>'/N?1*\;^(RQZ3\4O#^JQ AY#$TH4_>VR8_5>/PH@W/
MW9!4BJ5IQT[E[XN:;)IUYI/BVQ"K/:SJDI Y)!W(>G/0@Y]17I>EZA#JVE6F
MH6Y_=7,2RKSG&1G!]QTJ+7-)AUS0[S2YSM2YB*;L9VGLV.^#@_A7 _!_5)8K
M/4?#-ZK)=:=*756)X4G##';#<_\  Z7Q0]"O@J^4OS.O\::Z/#GA._U $^<$
M\N$#_GHW"G\"<_0&N/\ @UXD;4-'N=&N92]Q:.98BW),;')Y[X8GJ?XAZ50^
M(D[>+O'>D^$+1R(H7WW+KSM+#)_[Y09^K8-5_$EI%\._B5I6MV<*Q:5=CRY(
MDX"@ *XQGL"K#MGZ5<8KDY>KU,Y3?M.=;+0]FKQ^+_BNOC,SM^\TS1ONE?ND
MH>,GH<R$GW5?;-=YXX\1+X=\(7=_%*HGD416Q'.9&Z$?09;\*QOA+X?_ +'\
M(I>RH5N=1(F;./\ 5C.S]#N_X%40]V+E\C2I[\U#YLW?&7BB'PEX?EOW423L
M?+MXC_'(0<9]AC)KA/#_ ,/KWQ<$U_QG>W$K7 WPVB-LVJ>F[CY00 <+CMDY
MR*H_&!Y[WQIH6EP0B>3RE:*%SA7>23:%/(QG8 >16^NL?%=%"KX7T@*!@ 2+
M@#_O]5I.,4T]69RDI5&I)M(OW_PB\)W5NR6UI-9RX.V2*=VP>V0Y(-<WIFLZ
MS\-_%,&@:[=M=Z'<G_1KAOF* \ CN #@%>W4>^M_;7Q8_P"A8TG_ +^K_P#'
MJY_Q7I/Q&\86EO!J/ANQC\ARZ203HK#(P1S*1@\=NPHC=Z2::]13LO>IQ:?H
M>TUY+XB\1ZSXT\5/X4\,W!M[*(D7=Y&3R!PQW#^'M@?>/L:[AIKW2?ARTT\9
MBO[/2BSJ6!VR)%SR">XZYKDO@E8Q+X=U#4>&N9[HQ,V<D*JJ0/S8G\JB"44Y
M=C6HW)J&U]S1TWX0>%;.W"7<$]_*0-TDLS)SWP$(P/8Y^M9>J_#Z\\)E]<\%
MWUQ'-"-TUE*VY94') Z9Z=#G/8@X!]2HI*I*^K*=&%M%8\)^'VJ_VY\7)=3,
M7E&YCED*9SM.T9&:]VKQ?PO8Q:;\==0M8,^4IF90>VY0V/PSBO:*JM:ZMV(P
MU^5W[A61XF\0VOA?0I]4NU9U3"I&IP9'/11_GH#6O7C_ ,:)?M6J^']+)94=
MG9B.^YE4?E@_G44X\TK,TK3<(-H-"\(ZI\177Q%XJO94LY23;6<.5&WID9)V
M+Z=2W7/<]-=?"/PE/;&.&SFMY-I E2X<G/KAB1^E=M!!%:V\5O"@2*) B*.R
M@8 J2FZDKZ:$QHP2U5V>.VFI:Q\*M?@TK5;B2^\/7/$,Q!S$.^T$_+C(RO3'
M(KV%65U#*05(R"#P17"_%VQBNO %S<2#]Y:2QRQGW+!#^CG\JT_AS=M>?#[1
MY6+$K"8N?1&*#_T&G/WHJ8J?N3=/INCB_A[_ ,E;\6_]=+C_ -'UZY7D?P]_
MY*WXM_ZZ7'_H^O7**OQ!A_@^;.?\=?\ (BZW_P!>C_RK!^#O_(A1_P#7S)_2
MM[QU_P B+K?_ %Z/_*L'X._\B%'_ -?,G]*%_#?J#_C+T.>^(OP[TC3]%UGQ
M+%<WS7K3"8H[H8]TDH#<;<X^8XYJMX+^%NB>(_"5CJUY=:@D\_F;EAD0*-LC
M*, H3T [UV_Q4_Y)OJW_ &Q_]')1\*_^2;Z3_P!MO_1SU7/+V=[]3/V4'6M;
MI^IV-%%%8'6<KXK\ Z5XPNK>XU"XO(G@0HHMW5003GG*FO(? O@K3?$_B#5;
M"]GNXXK0$QF%U#'Y\<Y4U]$5XW\(O^1S\1?[I_\ 1AK>G.7(]=CEJTXNI'3<
M]-\->'+/PMI TVQDGDA#L^Z=@6R?H /TKSK6-:U;XC^)9?#GA^X:STBVS]JN
MQG+X.">#RI_A7OU/'3T#QG>-8^"]9N%SN%I(JD'D%AM!_ G-<I\%[*&#P?-=
MJ/WUS<MO;V4  ?S/XU,=$YO<J:O)4UL6[+X0^$[>T$5Q;3W<NT S23LISCJ
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M1!,@>*2R5'4]&!&"*X/X>RR^$/'VI^$;N1O(G8M;,RXWL.5/3^),^V1BO0/
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MC_&CZ_A_YOP8?V3B_P"7\5_F>?T5Z!_PK>'_ *";_P#?D?XT?\*WA_Z";_\
M?D?XT?7\/_-^##^R<7_+^*_S//Z*] _X5O#_ -!-_P#OR/\ &E'PWAR,ZE)C
M_KD/\:/K^'_F_!A_9.+_ )?Q7^9Y]17HG_"N;3_G_G_[X%'_  KFT_Y_Y_\
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M?\_EU_X[_A1_PKK3O^?RZ_\ '?\ "C^T*'?\ _L?%=E]YYO17I'_  KK3O\
MG\NO_'?\*/\ A76G?\_EU_X[_A1_:%#O^ ?V/BNR^\\WHKTC_A76G?\ /Y=?
M^._X4?\ "NM._P"?RZ_\=_PH_M"AW_ /['Q79?>>;T5Z1_PKK3O^?RZ_\=_P
MH_X5UIW_ #^77_CO^%']H4._X!_8^*[+[SS>BO2/^%=:=_S^77_CO^%>=W$8
MAN98@<A'*Y]<&MJ.)IUK\G0YL3@ZN&2=1;D=%%%;G(%%%% !110 20 ,D]J
M"E52S!5!+$X '4UTNC^"=1U$K)<K]DMSSEQ\Y'LO^-=_I7A[3=&4?98!YN,&
M9_F<_CV_#%<5?'4Z6BU9Z>%RJM7UE[J\_P#(Y+PMX>\06\JW'VE]/@)RT;C<
M7^J'@?4\BO0:**\6O7E6ES2/IL+A88:')%M^H4445B=(4444 %%%% !1110
M4444 %%%% !1110 4444 %%%%  >1BN1_P"$2NO^?J+\C7744[B:3W.1_P"$
M2NO^?J+\C1_PB5U_S]1?D:ZZBB[%R(Y'_A$KK_GZB_(T?\(E=?\ /U%^1KKJ
M*+L.1'(_\(E=?\_47Y&C_A$KK_GZB_(UUU%%V'(CD?\ A$KK_GZB_(T?\(E=
M?\_47Y&NNHHNPY$<C_PB5U_S]1?D:/\ A$KK_GZB_(UUU%%V'(CD?^$2NO\
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M?\(E=?\ /U%^1KKJ*+L.1'(_\(E=?\_47Y&C_A$KK_GZB_(UUU%%V'(CD?\
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MX1*Z_P"?J+\C774478<B.1_X1*Z_Y^HOR-'_  B5U_S]1?D:ZZBB[#D1R/\
MPB5U_P _47Y&C_A$KK_GZB_(UUU%%V'(CD?^$2NO^?J+\C1_PB5U_P _47Y&
MNNHHNPY$<C_PB5U_S]1?D:/^$2NO^?J+\C774478<B.1_P"$2NO^?J+\C1_P
MB5U_S]1?D:ZZBB[#D1R/_")77_/U%^1H_P"$2NO^?J+\C774478<B.1_X1*Z
M_P"?J+\C1_PB5U_S]1?D:ZZBB[#D1R/_  B5U_S]1?D:/^$2NO\ GZB_(UUU
M%%V'(CD?^$2NO^?J+\C1_P (E=?\_47Y&NNHHNPY$<C_ ,(E=?\ /U%^1H_X
M1*Z_Y^HOR-==11=AR(Y'_A$KK_GZB_(T?\(E=?\ /U%^1KKJ*+L.1'(_\(E=
M?\_47Y&C_A$KK_GZB_(UUU%%V'(CD?\ A$KK_GZB_(T?\(E=?\_47Y&NNHHN
MPY$<C_PB5U_S]1?D:/\ A$KK_GZB_(UUU%%V'(CD?^$2NO\ GZB_(T?\(E=?
M\_47Y&NNHHNPY$<C_P (E=?\_47Y&C_A$KK_ )^HOR-==11=AR(Y'_A$KK_G
MZB_(T?\ ")77_/U%^1KKJ*+L.1'(_P#")77_ #]1?D:/^$2NO^?J+\C77447
M8<B(+* VME# S!C&@4D=ZGHHI%!1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ',_$+_ )$#6?\
MKA_45X-X U6RT3QMIVHZC-Y-K#YF^3:S8S&RCA03U(KZ'\4Z5/KGAC4-,MGC
M2:XBV(TI(4'(ZX!/Z5X[_P *2\2_\_VD_P#?V3_XW731E%1:DSCQ$)NHI15[
M'HEQ\6?!T,)>/49)V'\$=M("?^^@!^M>2>/O'LWC&ZCAAC>WTR!BT<+'YG;D
M;VQQG'&.<9//-;47P0U\G][J.F*/5'D;_P!D%=3X<^#6FZ=<+<ZQ='4)%Y6!
M4V1=_O=2W8]O<&FO90U3N3)5ZONM60WX->&I=.TNXUNZCVR7P5;?)Y\H<D_\
M"./^^1ZUB_&[1)EU"QUQ%!MVB%M(0.C@LP)^H)'_  &O:5544*H 4#  ' %0
M7UC:ZE9365[ D]M,NV2-QP1_GOVK)57S\QNZ"]E[-'C7PO\ B%8Z-8'0]9E,
M$"LSV]P<E5SR4('3G)!Z<FO0]8^(OA?2+1ICJMO=R8RD-I()6<^F5X'XD5YK
MK_P7U6WN7DT2>*[MF;Y(I7V2*/<GY3CUR/I6/:?"3Q?<3!);&&U7^_-<(1_X
MX6/Z5JXTI/FN<\9UX+DY3G)&U#Q9XG+*@DOM0N.%48&6/Z #OZ#-?34EQI_A
M3PW&;J<0V5C D09NI"@* /4G'2L'P1\.[#PBIN7D^UZFZ[6G*X5 >JH.WUZG
MVZ5L^*O#5KXKT1]-NI9(AN$D<D?57 .#@]1ST_EUJ*DXR:70UHTI0BY/=G-:
M?\0?!_B^Q>SU;R+?<3F#4,;"!G#!C\H./<$$\>M>+>+[;1;3Q+=1:!/YVG#!
M0[BP!(R0">2 >_\ .N@U#X0^*[6X9+6VAO8AC;)%.B9_!R#6KX:^#>ISWL4V
MOF.VM%(+P1R!I']LKP![YK6/)#5,PFJM2T7'7N=CJ-Q<W?P.,]WGSWTU"Q/5
MAQ@GZC!_&O-/A+_R42Q_ZYR_^BVKW/Q+HLFJ^$KW1[$Q1/+"(HO,)"KC&,X!
M/:N!\#_##6O#/BJVU2]NM/D@B5PRPR.6^92!C* =_6LX37)(UJ4Y>TBUTL+\
M<O\ D$:3_P!=W_\ 0147P+_X\];_ .ND/\GKIOB/X/U#QA86,&GS6L36\K.Q
MN&9001CC"FH_AMX+U'P=!J,>H36LIN6C*?9W9L;0V<Y4>M+F7LK=1\DOK'-;
M3_@'1>+?^1,UW_L'W'_HMJ^=_ '_ "/NB_\ 7RO]:^D=<L9=3\/ZE80LBRW5
MK+"A<D*&9"!G';FO*O#'PEU[1?$VGZE<W>FO#;3!W6.1RQ'ME /UITI)1:85
MX2E.+2.K^*^@R:UX.>6WB:2YLI!.JKU*]&'Y'/\ P&O'/ WB^3P?K371B::U
MF39/$I )'8@GN#_6OIRO,?%/P>L=5NWO-'N%L)9&W/"RYB[Y*XY7Z=/I2I5(
MVY9;!7I2<E4AN:S?%OP>MH9A?S-)C/D"V??],D;?UKQ3QGXJF\7Z\VH21>3"
MB"*"+.=J D\GN223_P#JKKK;X'ZXTRBZU/3HHLC+1%W('?@JO\ZYWX@Z%I/A
MK6K;2=,=Y)(;93=2.V2TA)/(Z#Y2O [$=3FM::IJ7NZLPK2JRC[ZLCU/X+_\
MB/)_U^R?^@I7HE<'\(('A\ 0.R!1-/*ZGCYAG;G\U(_"N\KFJ?&SMH_PT07E
MR+.RFN3%)*(D+E(@"S #/ )&37CB_&NY?Q+%*UD(M%&4>$8:4@_QY]1UVCCM
MGO7M5>3^,OA!_:%[+J'AZ6"W:3+26DF53=W*$=,^G3W Z52Y+VD3752R<#K=
M2\=^$O[!N+B35K2Y@DB93;I)F23((V[!\PSTR0,=:^>?#MM->>)-,M[=6:5[
MJ,+M&2/F'/X=?PKH4^%'C)YMC:6B+S^\:YBQ^C$_I7J'@'X:P^%I%U*_E6YU
M0KA=H^2#(P0OJ3TSQQQ]=DX4T[.YS.-2M)<RM8B^,>B3ZEX5BOK=0S:?*9)%
M[^6PP2/H=I^F?2O./AMXVB\):G/%?!VTZ[ \PH,F-QG# =QR0>_3TP?HME5U
M*L 5(P01P17D/BSX-M<74E[X<EBC#MN:SE.U5_W&^O8_GVJ*<X\O)(UK4IJ?
MM(;GH*>-O"[P-,-?T[:HR0;A0W3/W2<G\JYT_%_PW_;ZV"M*UFR@?;PI"!_0
MJ1G;_M>O;'->7M\*/&2RE!I2LN<;Q<Q8^O+9_2NF\-_!:Z>>.X\0W*1P#DVM
MNV7;V9N@'TSQW%/DI+5L2JUY.RC8]F@N(;J!)[>6.:&0;DDC8,K#U!'!KY*U
M7_D+WO\ UWD_]"-?6EM;06=M%;6T2101*%2-!@*!V KQ"]^#'B.YO[B=+W2@
MLDK. 99,X)S_ '*5"48MW'BH2FE9'NE>"_&W_D<[/_L'I_Z,DKWJO,OB)\.]
M7\7>((+^PN;&.*.U6$B=W#;@[GLIX^85%&24KLTQ,7*%D7_@[_R(4?\ U\R?
MTKR+X@Z//HGC?45DCVQSS-<PMM^5E<[N/H21^%>Z> O#EYX6\,KIM])!),)G
M?= Q*X./4 _I4_BWPAIWB_3EMKW='+%EH)T^]&3U^H.!D=\=NM5&HHU&^AG*
MBYTDNJ.0\,^(?AWK5A&;W2]#T^^"@317%I%&F[')5B,$9SCG-2Z[X@^&NBV[
M-'INBZA<<;8;2UB?=_P(+M'YUPNI?![Q19S%;..WOXNJO%*$/7N'Q@_B?K3+
M#X0>*[N8+<V]O9)GEYIU;CV"%JOEI[\QGSU;6Y-?0]4\,S>!/$8$VD:7I8N8
ML2&)K*-)8\'@XQZXY'M7/_&S1IKO1K#588]RV;LDVT<A7QAC[ KC_@5==X/\
M%Z?X.L7BMF::ZFQY]RXP7QT '\(Y/'YDUT%S;07EM+;7,22P2J5>-QD,#V(K
M'G49W1T^S<J?++1L\"^%_CJ#PQ=3:?J3%=.NFW^: 3Y4F,9('8C ./05Z_=^
M/O"MG9_:7URS="NX)#()'/3C:N2#SW'\C7FGB7X,W\-TTWAZ5+BV=L_9YGVO
M'[ GA@/<@_6L;3OA!XKN[D)=6\%C%D;I)9E?CO@(3D_7'UK:2IS]ZYS0E6IK
MDY;G/>+_ !$_BGQ)<ZHR&.-\)#&>J(. #[]S[DU[O\*_^2;Z3_VV_P#1SUPF
MK?!/4#=(-(O+/[,L2AFN9'#N_P#$<!2 ,]!FO3?!>B7/ASPE8Z3>/$\\'F;F
MA)*G=(S#!(!Z$=J5647!*)6'ISC4;DCY^\?63V/CS68G4KON6F'N'^<'_P >
MKVOPIX_\/7GANT-QJEI:7$$"I-#/*$(8#'&[&X<9XSU]:=X]\ 0>,88IXIA;
M:C I6.5AE77.=K=\9S@]LGKFO);GX2^,()F2/3XKA02 \5S& ??YB#^E.\*D
M4F[6)Y:E&;<5=,B^)OB.T\2>+//L)#):V\*P))@@.0221^+8_"O7_A79/9?#
M[3S(I5YR\Q!]"QQ^8 /XUPWAKX,7SW<=QX@FBAMT(;[/"V]WP>A/0#Z9KVI$
M2.-410J* %51@ #L*FK./*H1-*%.?.ZD^I\P^/\ _D?=:_Z^6_I7NL^E2:W\
M+H]-BQYL^F1B//0N$!4>W('-<-XG^$NO:UXFU#4K:[TU(;F8NBR2.& ]\(1^
MM>L:3:26&C6-G*5,D%O'$Q4\$JH!Q[<45)KEC;H%&G)2ES+1GS%X;U&UT'Q'
M%-JNFQW=LA,=Q;3PAR!T.%;C<#Z_2O<+*]^&5];K-''X;C! .V>"&)A]0P!J
MKXW^%MKXEN9-2TZ=;/47^^''[J8^IQRI]QGITSS7F<_PG\8Q2E$TR.91_''<
MQ@'_ +Z8']*MN%36]C)1J4=.6Z.ZO?&'PSM-2BM8]$T^YA8'S+F+3DV1GL,%
M06_#V_#O=!M?#K6XU'0+33DCE!7SK2%$W 'D$@ ]1TKR/0/@OJMQ<I)K<\5I
M;*WSQ1/OD8>Q'RC/KD_2O:M-TZUTC38-/LH_+MH$V(N<\?7U[UE4Y5I%F]'G
M;O-6*&M^*]#\.&-=6U".W>0;E3:SL1TSM4$X]ZT+#4+/5+-+NQN8KBW?[LD3
M!@?;Z^U>7?$[P!KNOZ[%JNE*+M6B6)H#*J-'C)R-Q P<_F:Z_P"'GAJ\\+>%
MELK^4/<R2M.Z*<K%D ; >_3)[9)Z]3+C%033U+C.;J.+6AU=%%%9FQX,-?@\
M.?&R_O;HXMFN'BE;)^56 &[CK@X->\*RNH92"I&00>"*\3L='L=>^,?B#3M0
MA\VWE27(S@@@K@@]B*W8_#OC[P>PM_#M]!JVF YCM[H@-&/[O)&!]&_ 5T5$
MG;76QR4I2C?2ZNSU"O&-<N5\?_%?3K#3P9+'32#-,AR"JL"[ YQC[J@^OK6C
M>:=\4/%*FSOFL]&LI/EE$,@^9>_*LS'OQD YP>*[3PCX.T[PAI[06F9;B3F:
MY<8:3T'L!Z5*M#6^I<N:JTK619\6:0VO>%-2TR, RSPGRP>A<?,O_CP%<1\'
M->1])N/#MTQCO+.5GCB<$'83\PP>X;.?J*]0K@O%OPX75]1&MZ'>'3-94[C(
MI(20XQDD<J?<9SW'.:F$E9Q952,E)3B=[67XBUVU\-Z'<ZG=D%8E^2/=@R/V
M4>Y_Q/:N%BO/BU9K]E.EZ;>!0$%R[ID\?>^^OZKVZ59L? .JZWJ4>I^-]16]
M\O#16$)/DH>.O0=L$ <^IHY$M6P]I*2M%._F<[\$9&FU?7)7.6=(V/U+-7L]
M<)X$\%:EX7UG6+R]GM)([T@QB%V)'S,><J/7WKNZ*K3E=!0BXP29XW\(O^1S
M\1?[I_\ 1AKU'Q'_ ,BQJW_7E-_Z :Y/P+X'U/PQX@U6_O9[22*[!$8A=BP^
M?/.5%=GJUI)?Z-?6<1423V\D2ECP"RD#/MS3J23G="HQ:IV?F<%\$O\ D3+S
M_L(/_P"BXZQ-0E'@7XS'4;G<FFZF"6E)X ?&XGV#@''IBNV^'?A:^\(^'Y["
M_EMY)9+II@8&8KM*(.X'/RFM/Q1X6T[Q9I9LKY"&7YH9T'SQ-ZCV]1W_ "(;
MFN=]F2J<G2CW1M*RNH92"I&00>"*6O*K+1OB3X/!LM)DL]9T]/\ 4K.P&T=
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MRJMJ.H6VE:=<7]Y*(K>!"[L?0>GJ3T [FO.;>3XLZ1']F^QZ?JRK\JS2R+G
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M:5K(Y?XVV,L_AFRNXQF.VN<2>P88!_, ?C7=>'+^WU3PWIU[:D&&6W3 '\)
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M$.^8?\MI/F;\/3\*UZ*FMC*M71NR[&F&RZAA]4KONPHHHKE.X**** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
&HHHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>img268224062_12.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img268224062_12.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" ?M#ZX# 2(  A$! Q$!_\0
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M1110(****!H****!BT444""@44"@!:***0 *6D%+0(****8!1112 *44E**
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M+2"EI""BBB@!U%%% PI#2TAH ****!"T444#"@44"@!:***0@I:2EI@%%%%
M!1112 *6DI:8PHHHH !2T@I: "BBB@!:***1(4M)2T#"BBB@ HHHH ****!!
M1110,!2T@I: "BBBD(6BBBF 4444 %%%%(!:***8!0**!0 M%%%(84M)2T %
M%%% A:*** "BBB@ HHHH **** "BBB@!:***0!3J;3J "BBB@!#10:* "BBB
MF M%%% @%+2"EH&%%%%(!:***!!2BDI10 4444 %%%% !1110,**** "G4VG
M4 %%%% A:*** "BBB@ HHHH **** "BBB@!:*** "EI*6D 4444 ***!10 4
M444 %%%% !1110 4444P'4444@"BBB@ HHHH 6BBBD 4"B@4 +1113 ****0
M!1110 M%%% !2BDI10 4444 %%%% !1110 M%%%, I:2EI %%%% !1110(**
M** %HHHH& I:04M @HHHH ****0PI124HH$%%%% "T444 %%%% !1110 4M)
M2T %%%% "T444 %**2E% !1110 4444 %%%% "T444 %+24M( HHHH ****!
M!1110 M%%% !1110 4444 +1110 4HI*44 %%%%(!110**8!1110 4444@"E
MI*6@ HHHI@+1112 **** "BBB@04M)2T %%%% Q:*** "BBB@ HHHH 444"B
MD 4444 +1110(**** "BBB@8M%%% @I124HH **** "BBB@ HHHH 6BBB@ I
M:2EH ****0!1113 *44E** "BBBD 4M)2T""BBB@ HHHH&%+24M @HHHH 44
M4"B@ HHHH 6BBB@ HHHH **** %HHHI %%%% !1110 HHH%% !1110 M%%%
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MHH *=3:=0 4444"%HHHH **** "BBB@ HHHH **** %HHHH *6DI:0!1110
MHHH%% !1110 4444 %%%% !1113 =1112 **** "BBB@!:***0!0**!0 M%%
M%, HHHI %%%% "T444 %**2E% !1110 4444 %%%% "T444P"EI*6D 4444
M%%%% @HHHH 6BBB@8"EI!2T""BBB@ HHHI#"E%)2B@04444 +1110 4444 %
M%%% !2TE+0 4444 +1110 4HI*44 %%%% !1110 4444 +1110 4M)2T@"BB
MB@ HHHH$%%%% "T444 %%%% !1110 M%%% !2BDI10 4444@%%% HI@%%%%
M!1112 *6DI: "BBBF M%%%( HHHH ****!!2TE+0 4444#%HHHH **** "BB
MB@!110**0!1110 M%%% @HHHH ****!BT444""E%)2B@ HHHH **** "BBB@
M!:*** "EI*6@ HHHI %%%%, I124HH ****0!2TE+0(**** "BBB@84M)2T"
M"BBB@!110** "BBB@!:*** "BBB@ HHHH 6BBBD 4444 %%%% "BB@44 %%%
M% "T444 %%%% !1110 M%%% !2BDI10 4444 %+24M !1110 4444 %+24M
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M*6DI:8!1110 4444@"EI*6F,****  4M(*6@ HHHH 6BBBD2%+24M PHHHH
M**** "BBB@04444# 4M(*6@ HHHI"%HHHI@%%%% !1112 6BBBF 4"B@4 +1
M112&%+24M !1110(6BBB@ HHHH **** "BBB@ HHHH 6BBBD 4ZFTZ@ HHHH
M 0T4&B@ HHHI@+1110(!2T@I:!A1112 6BBB@04HI*44 %%%% !1110 4444
M#"BBB@ IU-IU !1110(6BBB@ HHHH **** "BBB@ HHHH 6BBB@ I:2EI %%
M%% "BB@44 %%%% !1110 4444 %%%%,!U%%%( HHHH **** %HHHI % HH%
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M+F1M%J2N@I:2EJAA1110(4=:6D'6EI %%%% "T444 %)2TE !1110 M%%%,
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M;S6Y_O13,3_X]D5A]:@1[:)XY176>(_ E]HD375N_P!KM!RS*A#QCU8>GO\
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M@ HHHH ****!!1110,!2T@I: "BBBD(6BBBF 4444 %%%%(!:***8!0**!0
MM%%%(84M)7HW@'3;"\T*>2ZLK:=Q<LH:6)6(&U>,D>]1.?(KDSERJYYU17LU
M]HFDII]RRZ79*PB8@BW0$'!]J\9I4ZBGL*$^86BBBM"@HHHH **** "BBO5O
M!V@6MAI,%ZT:R75S&)"[#.U2,@#TX//K^514J*"NR9RY5<\IHKVW5]&M-:LV
MM[F,9Q\D@'S(>Q'^%>+3PO;W$L$@P\;E&QZ@X-*G54Q0GS#****LL*=3:=0
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MZZ([>&.%/)4[8U"C.3V%<]5Q=U<M.ZN+1113&% HH% "T444P"BBBD 4444
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MN"0.!TK/VL;V(YT<52BDI16A84444@%%% HI@%%%% !1112 *6DI: "BBBF
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MBNC\2VT$$$!A@CC)8Y*(!GCVKG*<9<RN-.ZN%+24M,84444 %%%% !2TE+0
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M^IW,DF/F%N%0 ^V0:4Z].*U8G5BNIY#17K]]\'M/>+_0-3N8I,_\MU60$>G
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M]NN.O&:%6IM7N+VD6KW.4HKUR/X4Z.%'FWM\S>JLBC_T$UEZI\*9$1I-*O\
MS"!Q%<#!/_ AQ^E2L33;M<2JQ/.!UI:?/;S6ES);W$;1S1DJZ,,$&F5L:!13
MHXWED6.-&=W(5549))Z "NYT;X8ZA>1I-J4ZV2'!\H#?(1[]E_7W%1.<8:R9
M,I*.YPM%>N#X6:)CF[U GVD3_P"(K*U/X5R(K/I=^)"!Q%<#!/\ P(?X5FL1
M3?4E58L\XI*ZO0/!%UJ^H7MC>3/I\UJ%)5X=V[)(]1QQUYS70?\ "I/^HW_Y
M*?\ V=5*M"+LV-U(K1L\THJ:\M_LE[<6V[?Y4C1[L8S@XSBH:U+%HHHI@% H
MK5T7P[J6OS^78VY9!]Z9N(U^K>O/3K2;25V)NRU,NBO3[#X4VXC!U'497<@9
M6W4*%/?ELY_(5<?X6:,5^2\OP?5G0_\ LHK!XFGW,_:Q/)!2UV^L?#/4K)6E
MT^5;V,?P8V2 ?3.#^?X5Q3HT;LCJ5=3AE88(/H:TC.,]8LN,E+8;7MOP_4+X
M*L".K&0G_OXP_I7E?AG0?^$BU;[#]I^S_NVDW^7OZ8XQD>M>T:!I/]AZ);Z;
MY_G^3N_>;-N<L6Z9/KZUSXJ2MR]3*O)6L.UR_?2]#O;V,*9(8BR!AD;NV?QK
MR&X\=:]=VEU:W%S')#<(493$HV@]<$ ?KFO8-9T[^U]'N;#S?*\]-N_;NV\^
MF17FVL_#C^R-'N;_ /M7S?(3=L^S[=W/KN-9X=TUI+<BDX]3A****[SI"O6?
M!^BZ=K/@>VBU"TCG >3:QX9?F[,.1T'2O)J[KP=XZM]%LDTR_MV^SAB5GCY*
MY/\ $O<<GD?D:QKQDX^[N153:T)=;^&-W;YET>;[5'_SQE(60=.AX![GM^-<
M)/;S6LS0W$,D,J_>212K#Z@U]"6&HV>J6PN+&YCGB/\ $AS@XS@CJ#ST/-1:
MIHNG:U!Y-_:I,!]UB,,OT8<CH*YX8F4=)F4:S6DCY\I1UKO-;^&5Y;;IM(F^
MU1?\\9"%D'T/1N_I^-</-!-;3M#<1/%*O#)(I5A]0:ZXU(S7NLW4E+891115
M#.W\"W_A_11+?:C?!+U\HB>4[>6G<Y"XR?Y?4UV\?CKPW+(L::CEF(4#R).2
M?^ UXC5FQ_Y"%M_UU7^8K"=",GS-F<J:;NSZ'KS_ .*G_(/T[_KJ_P#(5Z!7
MG_Q4_P"0?IW_ %U?^0KCH?Q$<]/XD>7T445Z9V&YX5_LB/64N=9N1%;P8=4V
M,WF.#P#@'@=3GZ5ZA_PGOAG_ *"7_D"3_P")KQ.EK*=&,W=LB5-2=V?1%G>0
M:A9Q7=K)YD$HW(V",CZ'FLKQC_R*.I?]<OZBCP=_R*.F_P#7+^IH\8_\BCJ7
M_7+^HK@2M4MYG,E:5CPP4M(*6O4.QG6^ _#J:SJC7-W$'L[;!*L#AW[#W ZD
M?3UKV$# P.E<QX LA9^$K=BFU[AFF;GKDX!_[Y K<U6^73-*NKYE#>1$SA2<
M;B!P,^YXKS:TG.=CDJ-RD0ZEKNEZ1_Q_WT4+8!V$Y<@G&=HR<?A3].UG3=64
MM87D4^!DJI^8#W4\BO!KN[GOKJ2ZNI6EFD.YW;J34NF:C/I.HPWMLQ62)@<
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M:Z^'X9::L8$][=N^.3'M0'\"#_.B5:$=V)U(H\OHKT;4/ADFPMIU^P8#A+@
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M:[RY^&<L5K+)#J?G2JA9(_(V[R!P,[N,UP=:1G&?PE1DI;!112JI9@J@EB<
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M7,\<4?\ >9L9KS30O#/]M37L?VOR?LS!<^7NW9+>XQ]VMG_A77_45_\ )?\
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M6P>H]/UK6_X5]_U%/_)?_P"RK&I&'-JS.2C?<YK6]0&J:O<7:@A&(" G^$#
M_EG\:SZEN8?L]U+#NW>6Y3.,9P<5U&G^"?MVGP77]H;/-0/M\G.,^^ZMW*,$
MKFMU%')45U&K^#CI>G278O3,5*@1B'&<D#KN/K2Z9X(O+E1)>R"V0]$ W/\
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M$_><_>;ZFKO2HYYX[6WDGF8+'&I9B>PKSS6?$EUJCM'&3#:YX13@L/\ :/\
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ME+8::>P@HH%=/_PB'_3]_P"0?_LJ)24=P;2W.8HK9D\.S#4ULXI/,&P.\I7
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MF<CZBLJK33V&G<*])KE;3PU]JM(I_M>WS%#;?+SC]:ZJL*LD]C.;3.?\5?\
M'O;_ .^?Y5R]=QJNF?VG'&GG>7L).=N<_K7,:KI?]F/$OG>;O!/W=N,?B:NG
M)6L5!JUC.I:2M>R\/W=V \F((SW<?-^5:-I;E-V,FBNK3PO:!1OGF+8Y*D ?
MR-,E\+0%3Y5Q(K=MX!_PJ/:1%SHY>BKU]I-U89:1-T>>)%Y'_P!:J-6FGL5>
MX4M6+"T^W7L=MOV;\_-C., GI^%;?_"*_P#3[_Y"_P#KTG)+<3DEN<Y16O9:
M#+=3RAGV01N4WXY?!QP*TI/#5DD3.9YEV@DL2, ?E2<XH3DCEJ***H84444
M+7::%_R!;?\ X%_Z$:XNNTT+_D"V_P#P+_T(UE5V(GL:-%%%8&84444 %%%%
M '*?$G_DG^I_]LO_ $:E?/U?0/Q)_P"2?ZG_ -LO_1J5\_5Z6#_AOU.S#_"+
M11176;A75_#;_D?],_[:_P#HIZY2NK^&W_(_Z9_VU_\ 13UG5^"7HR)_"SZ
MKQ'XN?\ (WP_]>:?^A/7MU>(_%S_ )&^'_KS3_T)Z\_"?Q#EH?&<%74?#O\
MY'W2_P#>?_T6U<O74?#O_D?=+_WG_P#1;5Z-7X'Z'5/X6?0=>(_%S_D<(?\
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M7N32E9V-7P'_ ,BI;_[[_P#H1KI"JL5)4$J<@D=#T_J:YOP'_P BI;_[[_\
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M&58 8RRXY/X,!^%=-X%_Y%6#_??_ -"-;59<U),TF[P3-37?^1>U+_KUE_\
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M9VR,SMSZ8 _G7"55*DFN9CA!-79VWP^_YB/_ &R_]GKMJXGX??\ ,1_[9?\
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MU[?06R]9'"Y]!W/Y5ZLJJB*BC"J, >@K6O+2Q=1]"&ZNH[2-'DSAY%C 'JQ
M_KFIZY#QE?M'/:6T38:,^<?8]%_K77(P=%8=",U@XV29FU9)G#>,X2FK12XP
MLD0Y]2"<_IBN<%=EXWAS;VD^?NNR8]<C/]*XT5U4W>"-X/W0HHHJRA178^%-
M&58AJ-PF7;_4J1]T?WO\/_KUREG ;J\AMQG]XX7CMDUZI&BQ1K&BA44!5 Z
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MHH-ZNY (88('X?3]:B\43%KN&'^%4W?B3_\ 6K"JH05KL<8]0HHHK4L****
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ME_R*&I_]<OZBO"JUPGPLJC\(4445U&P445Z1X$\(:9?Z6FJWR&X=W8+$W"*
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MO0G\+.J7PL]LKRKXF?\ (R6__7FO_H;UZK7E7Q,_Y&2W_P"O-?\ T-ZX</\
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MUDC5T.58 @CN#7(>/M$FU"QAO;:,O+;9WJO4H>_X$?J:X:#2FKG+3=I:GF%
MHH%>@=1UOP\+#Q(^,X-NV?IE:]3KB?A]HCVMO)JLZE7G79$IR#LSDG\2!CZ>
M]=JS!5+,< #)->?7:<]#FJN\CQ[QD /%E^!_>4_^."NS^'/_ "+UQ_U]M_Z
ME>=ZK?'4M5NKPYQ-(64$ $+V''MBO1/AS_R+UQ_U]M_Z E;U5:DD:U%:!TVH
M?\@RZ_ZXO_(UX57NNH?\@RZ_ZXO_ "->%5.&V9-'9GM/AE0OAG3@!QY"G\ZU
M:YGP)>"Y\,QQ<[[=VC;/UW#\,-C\*T_$&FG5=#NK1?\ 6,NY.?X@<C]1BN>2
M]]IF37O69IT5X(Z/'(R.I5U)#*PP01V--KH^J^9K['S/?:*\%AAEN)5BAB>2
M1NB(I)/X"FNC([(ZE64X*D8(-+ZMYA['S/2?B.H.C6CXY%Q@?BI_PJ_X%_Y%
M6#_??_T(UY-7K/@7_D58/]]__0C3JPY*=@G'EA8U-=_Y%[4O^O67_P! ->)5
M[;KO_(O:E_UZR_\ H!KQ*GAMF.CLSWVN*^)#8TVR3'68G/T'_P!>NUKB/B1_
MQXV'_71OY"N>C\:,J?Q(\ZK1T/\ Y&#3?^OJ+_T,5G5HZ'_R,&F_]?47_H8K
MOELSJ>Q[77G/Q'_Y"5E_UQ/\Z]&KSGXC_P#(2LO^N)_G7%0^,YJ7Q'*Z=J-S
MI5]'=VK[9$]>C#N".XKU/0_%=AK2I'O$%V1S YZ_[I[_ ,Z\C1&DD5$4L[$!
M549)/H*EO+*YL+EK>ZA:*5>JM754IQGON;3@I'NE8.N^%;'68WD$:PWA'RS*
M,9/^T._\ZXO0/&E[ITR0WTKW-F>#NY=/<'J?H?PKU+.1D5R2C*DS!IP9X9>V
M<^GWDMI<ILFC.&%05VOQ&MXTO[*X50'EC96([[2,?SKBJ[H2YHIG1%W5P%+2
M"EJBCV7PY_R+>G_]<%_E57QI_P BE??]L_\ T8M6O#G_ "+>G_\ 7!?Y55\:
M?\BE??\ ;/\ ]&+7G+^)\SE7QG(_#T ^()_:U;_T):],KR;P9>+9^);??PLP
M,.<]">GZ@#\:]9J\0O?'5^(\?\5%CXGOR_7S/TP,?I60*[+Q[HLD5Z-5A0M#
M* LQ'\##@$^Q&/Q'O7&BNJFTXJQM!WB@KT/X=%O[/O0?N^:,?7'/]*\^1&D=
M412SL<*JC))]!7K7A;1WT;1EAESY\K>;("?ND@#'X #\<U&(:4+$U7[MC6N?
M^/67_</\J\-KW*Y_X]9?]P_RKPVHPW4FCU/=@   .@I:I:/>+J&CVETO_+2,
M9YS@C@C\P:Q?'&EOJ&C+-"A>:V;?@#)*G[V/T/X5S*-Y<K,DM;,Z>BO"**Z/
MJWF;>Q\SW>BO#8;:>X#F&&238,ML4MM'J<=*91]6\Q>Q\SL/B%&HU>UD'WF@
MP?P8_P"-='X(_P"18@_WW_\ 0C7EE>I^"/\ D6(/]]__ $(TZL>6FD.:M"QI
M:Z=N@:B?^G:0?^.FO&Z]CU[_ )%_4/\ KW?_ -!->.48?9A2V"O8?#O_ "+N
MG_\ 7!?Y5X]7L/AW_D7=/_ZX+_*C$?"@J[%/QI_R*UU]4_\ 0Q7E5>J^-/\
MD5KKZI_Z&*\JIX?X1TOA/8?#O_(NZ?\ ]<%_E5/QI_R*UU]4_P#0Q5SP[_R+
MNG_]<%_E5/QI_P BM=?5/_0Q7.OXGS,E\1Y57NE>%U[I6V)Z%U>AR'Q"_P"0
M5:_]=_\ V4U5^'7_ #$O^V7_ +/5KXA?\@JU_P"N_P#[*:J_#K_F)?\ ;+_V
M>DOX(?\ +L[FO$[O_C]G_P"NC?SKVRO$[O\ X_9_^NC?SHP^["CU.S^'7_,2
M_P"V7_L]=S7#?#K_ )B7_;+_ -GKN:SK?&R*GQ,\@*AO$Y4C(-[@_P#?=>OU
MXQJ!*ZM=LI((G<@CM\QKV"SN5O;*"Z0$++&' /;(SBKKK1,NKT)Z*Y/QUICW
M6G17D2LS6Q.\#^X>I_# _6O.JF%'G5[DQI\RO<]QHKPZI([>:9)'BAD=(QEV
M520H]_3I5_5_,KV7F>VUYKX[4+X@4CJT"D_F1_2N8HK2G1Y'>Y4:?*[W/<
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MVG_?]?\ &C^U],_Z"-I_W_7_ !I*4TK(2<D0Z3HEOHWFBWEG=9<9$C @8],
M>M:=4O[7TS_H(VG_ '_7_&K<<B2QK)&ZNC#*LIR"/K4N[U8G?J>;^*[$66N2
M%%Q',!(N!QSU_4'\ZQ:]"\96!NM($Z+E[=MW_ 3U_H?PKSVNRE+FB;P=T=WX
M&_Y!MS_UV_H*ZFN6\#?\@VY_Z[?T%=37-5^-F,_B9Y#=?\?<W_71OYU%4MU_
MQ]S?]=&_G45=BV.@OZ)<"UUNSE.,"4 D]@>"?UKU2O'*]/T'5%U73$E)_?)\
MDH_VO7\:PKQV9E574Q/&]D6CM[Y1D+^[? ['D?U_.N,KUZX@BNK>2"9=T<@V
ML/45YWK/ARZTMVD16FM<\2 9*C_:]/KTIT9JW*QTY:6,6BBBMS4**M6.GW6H
MSB*UB9SD9;'RK[D]J[>R\)64.G207($LTH^:4#!3TV^G]?TJ)U%'<F4DCS^B
MKVJZ5<:3=F&894\QR <./\]JIQQO-*D48W.[!5'J35)IJZ'<[3P58&.UFOG
MS*=B<<[1U.?<_P JZNH+*TCL;*&VB^Y&N/KZFG3W,%JH:XGCB4G ,CA03^-<
M,WS2N<\G=W,B^\+66H7LEU--<B23&0K+C@8]/:J__"$Z;_SWN_\ OM?_ (FM
MC^UM-_Z"%I_W^7_&C^UM-_Z"%I_W^7_&JYIH+R'V%DFGV<=K&\CHF=ID()ZY
M["IIHDGA>&10R.I5@?0U775-/=@JW]JS$X $RDD_G5NH=[W8G<\DNK=[6ZEM
MW^]&Y4_@:C4%F  ))X %=/XTL3%?1WJK\DR[6/\ M#_ZV/RK%T6'[1K5G'V,
MJD_0<_TKMC*\;FZ=U<].@B$%O%"O2- H_ 8KG/&TVW3K>'."\N[KU '_ -<5
MT]<1XVGW7]M #_JXRQ_$_P#UJY:2O,RAK(C\&WGD:I);,0%N$X_WEY'Z9KNZ
M\FM+EK.\AN$SNC<-@'&<=J]7CD66))$8,C@,I'<&JK1L[CJ+6YS>C:,+3Q%?
MS%,1Q'$/RX'S<\?0<?C7345E^(;XV&C32(V)'Q&GU/\ ];-9MN;)UDS@]8O/
MM^K7$X.5+X3_ '1P/Y5Z!H4JS:'9.IR!$%_%>#_*O,:[[P?,9=$V$?ZJ5E'T
M.#_6MZR]U&DUH2>+8EDT"5R,F-U8>QSC^M>?"O4]3A-QI=U$N-SQ,!GUQQ7E
M@HHOW;!3V"BBBMC0T_#P!UZT!_OY_0UZ57E5C<?9;Z"XYQ'(K$#J0#R*]4!#
M $'(/(KGKK5,QJ;G#>,RQU>($\" 8'_ FKG:[KQ9I;WEHEU"I:2#.Y1W7_ZW
M^-<+6M)IQ+@] KH?!N?[9DQ_SP;/YK7/5W'A+2Y+2W>[G4J\P 53_=]?QI5'
M:(3>ATE>7ZK_ ,AB]_Z^)/\ T(UZA7E^J_\ (8O?^OB3_P!"-9T-V13W+&C:
MU-I$Y('F0/\ ?CS^H]#7>V.I6FHQ[[:4/C[R]&7ZBO-;:UGO)?*MXFD?!.%]
M!3$>6"4.C/'(IX*D@@UI.FI>I<H)GK! (((R#7,:WX8BEB:XT^,)*.6B7HWT
M'8TGAWQ%-=SK97AWR-GRY ,9P,X-=17/[U-F6L6>2T5HZ["EOK=W&@ 7?N '
M;(!_K6=76G=7-]T%3V0#7]N#T,J@_G4%*"5(()!'((I@>LUR7C4M_H2_P_.?
MQ^6NGM;A;JTAN%X61 P![9%9WB+36U'32(AF:([T'KZBN.#M+4PB[,\]HI2"
MI((((X(-)78=!K>&\_V_:X]6_P#037H=<EX2TR02-J$JE5V[8L_Q9ZFNMKEK
M.\C"H[L\]\3?\C#=?\ _] %9-:WB;_D8;K_@'_H K)KHA\*-H[(****H9;T^
M_FTV[6XA(R.&!Z,/0UW>F:W::F@",(Y\?-$QY'T]:\\BB>:18XU+.QPJCJ33
MI8I;6=HI5:.5#@@]0:SG!2]2)13/4ZQM7\/6^H(TL*K%=8X8<!O8C^O6L/1?
M$ES%<1V]VYFA8A0Q^\OISW%=K7.U*#,FG%GEDT,EO,\,J%)$.&4]JZCP7_R_
M?]L__9JJ>+H5CU2.10!YD0)QW()Y_+%6_!?_ "_?]L__ &:MIN].YI)WC<ZN
MO+KG_CZE_P!\_P Z]1KRZY_X^I?]\_SJ:/45,]&TO_D$V7_7!/\ T$50\5-C
M0W&.KJ/UJ_I?_()LO^N"?^@BJ/BD Z%+[,O\ZSC\9"^(X.M_PCC^UY,]?);'
MYK6!6KX=NA:ZU"6("R?NR?KT_7%=,U>+-I;'H%>>Z^2==NLG/S#^0KT*N/\
M%>G.EU]NC0F-P!(1V;H,_7BL*3M(R@]3FZ**4 D@ $D] *Z38ZOP:S^7>*<[
M 4(],\Y_I745E:!I[:?IJK(,2R'>X]/0?E5S4+H66GSW!ZHA(^O;]<5R3UEH
M82U9YO,H2>15& &('YUZC7E=>J5I6Z%5.AS?C!O]#MEQUD)_2N0KKO&/_'M:
M_P"^?Y5R-72^$J&Q:TS_ )"UG_UW3_T(5Z37FVF?\A:S_P"NZ?\ H0KTFLZV
MZ)J;G(>+_P#C\M_^N9_G5SPAC[%<=,^9_2J?B_\ X_+?_KF?YT>$;I8[J>V9
ML&50RCU(Z_C@_I3M^[']@ZXYP<=>U>7DDDDG)/4FO4:XCQ#I,EG=O<QJ3;RG
M=D?PD]0:5%I.PJ;,2E%)5BSM)KZX6"!=SM^0'J?:NAFIV?AK/]APYZ;FQ^9I
M_B/_ ) -S_P'_P!"%7;.U2RM(K>/[L:XSZ^IJEXC_P"0#<_\!_\ 0A7(G>=S
M"]Y'!4M)2UU&P4444 >H5RWC#.ZS],/_ .RUU-9/B#3GO[#]T"98CN51W]17
M+!VDC&+LSA:6@@@D$8(Z@T5U&QJ>'B1KEOCON!^FTUW=<QX6TYU9KZ12 1MC
MSW]3_GWKIZYJKO(RF]3B_%  UC([QJ3^M=I7 :U<"YUBY=<[0VP9]AC^E=_3
MJ?"@ELCGO%K?Z';KZR$_I7)5UWBT?Z# >_F?T-<C6E+X2X;'2>$@//N3W"J/
MU-=57%^&9Q#JP0YQ*A0?7K_3]:[2LJJ]XSGN%%<)KMDUGJ<IP?+E)=#]>H_
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M/^;5ZW7@_@'Q98>%;F^DOHKF03HBKY"J<8)ZY(]:[G_A;WA__GSU/_OU'_\
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M8)ZY(]:[C_A;N@?\^>I_]^H__BZPQ%*<JC:1E5A)RND>6^)O^1KUC_K^G_\
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M_P#?M/\ XNKQ%.<IW2'5A)RT.%^(/_(\ZC_VR_\ 125W7PJ_Y%>Y_P"OUO\
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M"\6679M,B*%&'!YPQ]*YE2G[2]NIBH2YKV//ZW?!O_(W:=_UT/\ Z":PJTM
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MC_R-NH?[X_\ 017;_P#"R]&_Y]K_ /[]I_\ %5Y]K^H1:IKEU>P*ZQ2L"H<
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M %Q?_P!!->=Z%\0+BRC6WU1'N8E "RI_K!]<\-_/ZUR0A*2O'H81BWJCH?\
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M]+* >B($S^IKJ+'3[73;806D*QQCDXZD^I/<UE-XRT)1D7A;V$3_ -163?\
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M[8S[XK.I'FC8B:NCTZ:))X9(I!E'4JP]0>*\EO;5[&]FM9/OQ,5)'?WKM_\
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M'#.<G_"HU\0::PR9ROL4;^@ILOB+3T7*N\A]%0C^>*CW]B?>-6N7\0:JL_\
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M%%% @HHHH&@HHHH&+1110(*!10* %HHHI  I:04M @HHHI@%%%%( I124HH
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M@!:***8!1112 **** %HHHH *44E** "BBB@ HHHH **** %HHHI@%+24M(
MHHHH ****!!1110 M%%% P%=;X(TT374M_(N5A^2,G^\>OY#'YUR:C+ #'/J
M<5Z;I-QI.F:9!:KJ-GE%^<^>O+'J>OK65:34;(SJ/0V20 23@#J37E>O:B=3
MUB><',8.R/G/RCI^?7\:['Q)KUK%H\D=G=0RS3?NQY4@8J#U/'MQ^->>5%"%
MO>9-./4****W-@I124HH$%%%% "T444 %%%% !1110 4M)2T %%%% "T444
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MA2TE3VUG=7C%;6VFG8=1$A8C\J!D-%37-G=6;A+JVF@8]%E0J3^=0T %%%%
M!1110(****!@*6D%+0 4444A"T444P"BE52S!5!))P .]6Y=)U*"$S3:?=1Q
M#J[PL /Q(I-H"G1110 M%%%, H%% H 6BBBD,*6DI: "BBB@0M%%% !1110
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M(!110**8'K'PQ_Y%JY_Z_&_] 2NONO\ CTF_ZYM_*N0^&/\ R+5S_P!?C?\
MH"5U]U_QZ3?]<V_E7F5?XC..?QL^>****],[ %+2"EI""BBB@!U%%% SO_A=
M_P ?>I?]<T_F:]*KS7X7?\?>I?\ 7-/YFO2J\[$?Q&<E7XV>":Y_R']2_P"O
MJ7_T(U0J_KG_ "']2_Z^I?\ T(U0KT([(Z5L+1113*"@44"@!:***0@I:2EI
M@%%%% !1112 *6DI:8PHHHH !2T@I: "BBB@!:***1(5[KH^E6VC:;%:6Z!0
M!EV[NW<FO"J]:\.^,]/O["..^N(K6[C4*_FL%5L=P3_*N?$J32L954VM#6U_
M2(-9TF:WE13($)B<CE&QP1_6O$*]6\2>,]/M-/F@L+F.XO)%VJ8_F5,\9)Z?
MASV[5Y31AE)1=QTDTM3WZV_X](?]Q?Y5R/Q*_P"0%:_]?(_]!:NNMO\ CTA_
MW%_E7(_$K_D!6O\ U\C_ -!:N:E_$1C#XD>7U[GH/_(NZ9_UZ1?^@"O#*]ST
M'_D7=,_Z](O_ $ 5OBMD:5MD8OQ"_P"17;_KLG]:\FKUGXA?\BNW_79/ZUY-
M5X;X"J/P@*6D%+6YJ%%%%(0M%%%,#T+X<Z5;O!/JDB!YTD,49/\ !P"2/<[O
M\Y-=\RJZE64,K#!!&017EO@KQ-#HTLEG>?+;3-N$@YV-TY]C7>W'B?1+: S/
MJ=LRXSMC<.Q_ <UP5HRYSFJ)\QYEXPTN+2?$,L5NH6&11*B#^'/4?F#6#6IX
M@U=M;UB:\*E8S\L:D<A!TS[]_P :RZ[(745<Z(WMJ+1115C"@44"@!:***0P
MI:2EH ****!"T444 %%%% !1110 4444 %%%% "T444@"G4VG4 %%%% "&B@
MT4 %%%%,!:***! *6D%+0,****0"T444""E%)2B@ HHHH **** "BBB@85[!
MX6_Y%FP_ZY_U->/U[!X6_P"19L/^N?\ 4USXGX495MB#QG_R*=[_ -L__1BU
MY17J_C/_ )%.]_[9_P#HQ:\HHP_P!2^$****Z#06O8?#O_(NZ?\ ]<%_E7CU
M>P^'?^1=T_\ ZX+_ "KFQ'PHRJ[%/QI_R*UU]4_]#%>8V-N+O4+:V)($TJQY
M';) KT[QI_R*UU]4_P#0Q7ET$SV\\<T?#QL'7Z@YIT/@8Z7PGM5I:06-K';6
MT8CBC&%45B^+]+AOM$GG**)[=/,1\<X')'TQG\:DTOQ7IFH6JR2W,5M-CYXY
MG"X/L3U%8WBSQ5:/I\EA83+-)+\LCJ,JJ]\'N3TX]^]80C/G,HJ7,<!1117>
M=(4444 +1110 4M)2T@"BBB@!110** "BBB@ HHHH **** "BBBF ZBBBD 4
M444 %%%% "T444@"@44"@!:***8!1112 **** %HHHH *44E** "BBB@ HHH
MH **** %HHHI@%+24M( HHHH ****!!1110 M%%% P%+2"EH$%%%% !1112&
M%**2E% @KM/ ^G0/%-J#H&E5_+0G^'@$D>_-<772>%=>BTR1[6Z^6"5MP<?P
MMTY]JSJIN.A$[VT/064,I5@"I&"#T->9^)M/CT[6I(X0%B=1(JC^'/4?F#7=
MS:_I4$)E:_@8>B.&;\AS7G>LZDVJZG+=$;4/RHIZA1TS[UE14DR*:=RA1117
M2;!1110 4M)2T %%%% "T444 %**2E% !1110 4444 =#X1TZ&]U)Y)U#I H
M8*>A8GC^M>@UYCH&J_V3J0F<$PN-D@'7'J/<?XUWRZ[I;0B7[?;A2,X+@-^7
M6N6LI<QA43N<MXRTV&VN8;N% GGY$@'3<,<X]_Z5R];GB768]6NXQ!S!""%8
MC!8G&3^@K#K>FFHJYK&]M0I:2EJB@HHHH ****!!1110!=TG_D,V/_7Q'_Z$
M*]3KRS2?^0S8_P#7Q'_Z$*]3KFK[HQJ;G&>./^/BS_W6_F*Y.NL\<?\ 'Q9_
M[K?S%<G6M+X$:0^$****T*%HHHH *44E** "BBBD HHH%%, HHHH ****0!2
MTE+0 4444P%HHHI %%%% !1110(*6DI: "BBB@8M%%% !1110 4444 ***!1
M2 **** %HHHH$%%%% !1110,6BBB@04HI*44 %>HP_ZB/_='\J\NKU&'_41_
M[H_E6%;H9U#!\8?\@R'_ *[#^1KC*[/QA_R#(?\ KL/Y&N,JZ7PCAL%%%%:%
MBT444 %+24M %W2;5+W5(+>3.QB2P'< $X_2O0T18T5$4*JC  & !7FUE=-9
M7D5R@!:,YP>_K7=V^MZ?<0B3[5''D<K(P4C\ZPJIW,JB9G>*K&)[+[8J@2QL
M S#^('CG]*Y_0?\ D.6O^\?Y&M/Q%K<-W$+2U;>F[,CXX..@%9F@_P#(<M?]
MX_R-5%-0=RHWY=3T&N+\6?\ (73_ *XK_,UVE<7XL_Y"Z?\ 7%?YFLJ7Q$0W
M+'A2QBE:6[D4,T9"IGL>YKK*X;0-633;ATFSY$H&2!G:1T-=8^L:='&9#>0D
M>BN"?R'-.HGS!-.YR7B*QCL=2'DKMCE7>%'0'/('M635_6-0&I:BTRC$:C8F
M1S@>OYFJ%;QO;4T6VH4444QA1110,*6DI:!!1110 HHH%% !1110 M%%% !1
M110 4444 +1112 **** /3*YWQ9_Q[6W^^?Y5T5<[XL_X]K;_?/\JYJ?Q(QC
MN8VB6B7NII'*,Q@%F'KBNZ "@   #@ 5Y]I]VUC>QW"C.T\CU!ZUVL6KV$T0
MD%U$H]'8*1^!JZJ=RIIW,GQ18Q^2EXBXDW!7([CL3[UR];OB#5HKT);VYW1H
MVYFQU/3C\S6%6E--1U*C>VHM%%%44%%%% !1110 M%%% !2BDI10 4444 %=
M7X6_X\IO^NG]!7*5U?A;_CRF_P"NG]!45/A)GL;C_<;Z5YS7HS_<;Z5YS44>
MI-,****V- I:2EH **** "BBB@04444 +7::%_R!;?\ X%_Z$:XNNTT+_D"V
M_P#P+_T(UE5V(GL:-%%%8&84444 %%%% '*?$G_DG^I_]LO_ $:E?/U?0/Q)
M_P"2?ZG_ -LO_1J5\_5Z6#_AOU.S#_"+11176;A116GH&B7'B'6K?3;;AI#\
M[XR(U'5C]!^9P.])M)78F[*XNA^'M2\17AMM.MS(5P9')PD8)ZL?Z=3@X!KU
M'2/A#IENJOJMW-=R@Y,<7[N/&.A_B//<$?2NTT/0['P]ID=A81[8UY9C]Z1N
M[,>Y_P#U=*DU76-/T2T-UJ-TEO%T!;JQ] .I/TKSJF)G-V@<DJTI.T3!_P"%
M:^$MN/[*.<=?M$O_ ,56-JWPCTJXC+:7<S6DN.%D/F(?ZC\_PJT?BUX<%P8A
M'?%!_P M1"NT_P#CV?TKJM'UW3=>M/M.FW23(#AAR&4^A!Y%0Y5X:NY-ZD=6
M?/>O>&M4\.77DZA;E5/W)DYC?Z-_3K5+3K=+O4[2VD+!)IDC8KU + '%?2NJ
MZ59ZUITMC?0B2"0<CNI[$'L17@.J:5)X1\7QP709XK>=)D=<9DB#9!'O@?F#
M771K^T5GN=%.KSJW4]K\,>$-/\*?:OL,US)]IV;_ #V4XVYQC"C^\:Z"N?\
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M!ZU[O7DOQC_X_M*_ZYR?S6L\/5G*HDV12G)RLV<!I6DWNM7\=C80F6=\G&<
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MV;QG:GS,T_#WPJA$*7&NRNTK#/V6%L!.O#,.IZ=,<CJ:Z(_#CPJ4V_V:P/\
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M*Z.I.ZN=)X+\,KXFU5X9WECM(8R\KQXSD\* 3G'KT/0UWO\ PJG0O^?O4?\
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M<3[F>3_XJJ%[\-](G4_9)9[5^WS;U_(\_K5!_BC")L1Z4[19'S-. WOQM/\
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M:Y61F8$1LH'!QW!JWJ7@G3;/2[JYCGNR\43.H9UP2!GGY:T_!7_(LP?[[_\
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M"NA3P?HBJ ;1G/JTKY_0UH:AJEEI<0DO)UC#?='5F^@'-8Z^.-),VPK<A?\
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M?3K]*R_"]DE]KL"2C*1YD(]<=/UQ7I]75J..B+J3:T1B+X1T4+@VA)]3*_\
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M9 ZY]0:T?''_ !\6?^ZW\Q1X'_X^+S_<7^9JDVJ5T4G:!?\ ^$*TW_GO=_\
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MM\T9_P!G_P"M5WPE_P AD_\ 7)OZ5O)^[=&K?NW1L_\ "'Z?_P ]KK_OI?\
MXFL@^&9IM5F@MRRVL9 \V3GL#VQGK7;TUW6-&=V"JHR68X %<ZJ21DILQ;?P
MKIT2_O1),WJS$?RQ4DGAC2G4A8&0D=5D;(_,FF3^*M-A8A6EEP<9C3C]<5;L
M=;L=08)#+B0C[CC!_#U_"AN>XO>W.;U/PK-;*9;-C/&!DH1\X_QKGQ7JE<AX
MITI8'%] @".<2@=F]?Q_G]:TIU+NS+C.^C.:KU&'_41_[H_E7EU>HP_ZB/\
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MB#E5;<%;^)<^QR/PKYFKWWX;HZ>!-.#@C)D(!]#(U<F,BN52,L0E9,7XD?\
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M!?\ MO\ ^TZ\PBD>&59(W9)$(964X*D="#ZUK2AST%'^MRX1YJ5CZ?(#*58
M@C!![UYCK_PH5BT^AS[>_P!FF/'X-^?7\ZG\+?$^WGCCL]>/E3_=%T%^1O\
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MM2-:C]P[0]..M>:ZIX$\0ZMJ,U[<WE@9)&SCS'PH[ ?)T%>D22)#&\DCJD:
MLS,<!0.I)]*H?\)!HO\ T%[#_P "4_QKDIRE'6)C&36QYU_PK/6O^?JP_P"_
MC_\ Q%.C^&VN12+)'>6*.I#*RRN"".A!VUZ'_P )!HO_ $%[#_P)3_&C_A(-
M%_Z"]A_X$I_C6OMJI?M)EFQ6Z6QA6]:-KD(!(8\[2?49KEOB/8K<>'X[O^.V
ME&#C^%N"/SV_E70?V_HW_07L/_ E/\:QO%FK:3>>%[^"/4;.61D!5$N%))#
MC !]JSIW4T[$1NI)F#\,]3CCFN]-D=5:7$L0/\1 ^8?E@_@:]%EBCGA>&5 \
M;J592."#P17S]!/+;3I/!(T<L9W*ZG!!KTWP]\0+:\5+?5BMO<=/. Q&WU_N
MG]/ITK:O2=^:)I4@[\R,_6OAO(F^;2)MZ\G[/*>>_"M^0Y_.N/O)M4L[;^Q[
MMIXH8W+_ &=^ #Z_3]._>O=D=9$#HP92,@@Y!JAJ^BV.MVI@O(58X(20#YXS
MZJ>W;ZU,,0UI/4F-5_:/"**T=<T:?0M3>RG96P-R.O1U/0X[?2LZNU--71TI
MW"EI*6F,]#^&6HC_ $W36([3QC'7HK?^RUWUU;1WEI-;2C,<R%&'L1@UXAH&
MI'2=<M+S=M1) ).OW#PW3VS7N@.1D=*X,1'EG==3EJJTKG@T>F3OK0TOCS_/
M\@XY .[!/TKW2WMX[6VCMX5"QQJ%4#L!6*OAY1XU?6=J^6;<#W\W[N?^^1_G
MONNZQQM(YVJH))/8"E6J<]K"J3YK#JX'XEZ8'MK74T7YD;R9"%['E23[$$?\
M"K2\&^)6UN;4(IVQ*)3+&IQQ&<  ?0_S%;^K6":II-U9.%_>QE5)&=K=C^!P
M:F-Z4]1*\):G&_#33ML-YJ3KRY$,9QV'+?\ LOY5W%Y=1V5E/=2G]W#&SM]
M,U4T#3?[)T*TLR )$3,F.?G/+?J36'\0]1^R: MHK8DNG"D9YV#D_K@?C3?[
MRH#]Z9YA>W;WU]/=R_?FD9SSTR<XKVCPS_R+&F_]>Z_RKQ"O;_#/_(L:;_U[
MK_*M\3\*-:NR*?CC_D3[_P#[9_\ HQ:\=KV+QQ_R)]__ -L__1BUX[3PWP/U
M'1^$]^MO^/2'_<7^5<C\2O\ D!6O_7R/_06KKK;_ (](?]Q?Y5R/Q*_Y 5K_
M -?(_P#06KFI?Q$8P^)'E]>YZ#_R+NF?]>D7_H KPRO<]!_Y%W3/^O2+_P!
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MMC>174#8EC;*Y_E7K&DZG#JVGQW41 )&'3.2C=Q7D%>@^!],N+:SDO)794N
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MWKTVVNH+R$2V\R2QG^)3FG3P17,+13QI)&W57&0:RC5:T9"FUHSQVNO\!_\
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M_D9+3_@?_H#5Z37FWA7_ )&2T_X'_P"@-7I-<E?XC"IN>?\ C+_D.C_KBO\
M,UL>!_\ D&W/_7;^@K'\9?\ (='_ %Q7^9K8\#_\@VY_Z[?T%7+^$BG\!U%>
M8:WJ#ZEJDTI<F-6*Q#/ 4=/SZUZ<QPI/H*\@J:"U;%205Z7X<N7NM!MGD.6
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M3)[+_C_M_P#KJO\ ,5Z77FEE_P ?]O\ ]=5_F*]+I5MT*H<MXR_Y<O\ @?\
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MQV.K\+S,]E+$3D1OD>P/_P"HUNUS?A/_ )>_^ ?^S5TE<]3XF92W/.Y@!/(
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M:5H>IZY++'IMH]PT2[GVD */J>,^WL?2O7K;X5>'()-TAO+@9^[+, /_ !T
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M6JZDKLQG-S=SR[XQ?\P7_MO_ .TZ\PBC>:58XT9Y'(5549+$] !ZUZ?\8O\
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M_P C1;?]>2_^AO47PP_Y&T_]>S_S6I?BK_R-%M_UY+_Z&]1?##_D;3_U[/\
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M[VUS%/'C?$X=<],@Y%1#K2TF!]'6%Y%J%A;WD!!CFC#K@^HZ5@>./#C^(=%
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MN+<QR078KUS]TG _*MN&"*VA6&")(HD&%1%"J![ 5M/%)JT4:2K::#P H
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M_D5M0_ZY?U%>,4\-\+'1V"O<-!_Y%[3/^O2+_P! %>'U[AH/_(O:9_UZ1?\
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MIES'*A1A[&O&]8T>ZT6^:VN4.,GRY,<./4?YXKV.TNX+ZUCN;:020R#*L/\
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M3K0;5T%2-U<G\;:3)/''J,$98Q+MEQUV]0?PY_/VKA:]IZUAWGA'2+MF80-
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MD;1P,?7K^-=MX0_Y%V'_ 'W_ )UYQ7H_A#_D78?]]_YUM65H)&E16B7]:_Y
M=]_UP?\ D:\JKU76O^0'??\ 7!_Y&O*J*&S"EL%>IZ%_R K+_KBO\J\LKU/0
MO^0%9?\ 7%?Y45]D%78J^+/^1<N/JG_H0KS>O2/%G_(N7'U3_P!"%>;TZ'PC
MI[!1116QH;/A7_D9+3_@?_H#5Z37FWA7_D9+3_@?_H#5Z37)7^(PJ;GG_C+_
M )#H_P"N*_S-;'@?_D&W/_7;^@K'\9?\AT?]<5_F:V/ _P#R#;G_ *[?T%7+
M^$BG\!TS_P"K;Z&O(:]>?_5M]#7D-*AU%2ZA7HGA+_D7X?\ ?;^=>=UZ)X2_
MY%^'_?;^=56^$JIL7M9_Y E]_P!<'_E7EM>I:S_R!+[_ *X/_*O+:5#9BI[!
M1116YH7=)_Y#-C_U\1_^A"O4Z\LTG_D,V/\ U\1_^A"O4ZYJ^Z,:FYQGCC_C
MXL_]UOYBJG@V4)K3(6QYD+ #/4@@_P @:M^./^/BS_W6_F*YJSNI+*\BN8OO
MQMN'O[5I%7IV+BKQL>L5YQXFLGL]:F;81'.?,0]CGK^M=_97D-_:1W,#91QT
M[J?0^]/N+6"[C\NXACE0'(#J#@UA"7(S*+Y6>35Z)X6LGL]%7S%*O,QD(/4
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M#?6XEA8'^\O=3Z&BZLK:]0+<1*X'0]"/H:SA+E=F1%\IY[3XHI)Y5BB0N['
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MHHH 6NTT+_D"V_\ P+_T(UQ==IH7_(%M_P#@7_H1K*KL1/8T:***P,PHHHH
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MJ%S=;-GG2M)MSG&23C/XU!116A19L;^ZTVY6YLYWAF7@,OIZ'U%=QI_Q.E1
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M*G%#G=I'9W8L[$EF8Y)/J:;116I98L[VYT^X6XM)FBE' 9?3T/K78V/Q$D5
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MXSCVVUQU%3*"EN)Q3W.JUKQG_:^E2V7V#RO,*G?YV[&"#TVCTKE:**(Q459
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M:*4HJ6X.*>YJZSK']K-"?(\KRP?X]V<X]AZ5-I&O_P!E6CP?9O-W.7W>9M[
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MOK6=2T*$4)12"BBBJ*"BBB@04444 +7::%_R!;?_ (%_Z$:XNNTT+_D"V_\
MP+_T(UE5V(GL:-%%%8&84444 %%%% '*?$G_ ))_J?\ VR_]&I7S]7T#\2?^
M2?ZG_P!LO_1J5\_5Z6#_ (;]3LP_PBT445UFX4444""BBB@ HHHH ****!BT
M444""EI*6A@%%%%( %+2"EH$%%%% !11104%+24M @HHHH 6BBB@04"B@4 +
M1110,****!!1110 4444#"E%)2B@ HHHH$+1112&% HH% "T444Q!1110 44
M44#%HHHH *6DI:0@HHHH !2T@I: "BBB@ HHHH$%%%% T%%%% Q:***!!0**
M!0 M%%%( %+2"EH$%%%%, HHHI %**2E% !1113&+1112$% HH% "T444 %%
M%% !7K/A3Q/X6T#P_;V;:D!.?WDY$$IRYZ_P]N!^%>345G4IJHK,B45)69[#
MK_Q"T?\ L.[72K[S;UTV1CRG7&>"V2 .!D_45X]1113I1IJR'""AL%+24M:%
MA1110(4=:6D'6EI %%%% "T444 %)2TE !1110 M%%%, H%% H 6BBBD(!2T
M@I:!A1110 M%%% @HHHH ****!A1110 4HZTE*.M "T444A!2TE+0 4444 )
M1110 4M)2T %%%%,8"EI!2TA,****!"T444#"BBB@ HHHI ***!13 **** "
MBBB@ %+2"EI""BBB@!U%%% PI#2TAH ****!"T444#"@44"@!:***0@I:2EI
M@%%%% !1112 *6DI:8PHHHH !2T@I: "BBB@!:***1(4M)2T#"BBB@ HHHH
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M444 %%%% "T444@"BBB@ HHHH 444"B@ HHHH 6BBB@ HHHH **** %HHHH
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M2T@I:0F%%%% A:***!A1110 4444@%%% HI@%%%% !1110 "EI!2TA!1110
MZBBB@84AI:0T %%%% A:***!A0**!0 M%%%(04M)2TP"BBB@ HHHI %+24M,
M84444  I:04M !1110 M%%%(D*6DI:!A1110 4444 %%%% @HHHH& I:04M
M!1112$+1113 **** "BBBD M%%%, H%% H 6BBBD,*6DI: "BBB@0M%%% !1
M110 4444 %%%% !1110 M%%%( IU-IU !1110 AHH-% !1113 6BBB@0"EI!
M2T#"BBBD M%%% @I124HH **** "BBB@ HHHH&%%%% !3J;3J "BBB@0M%%%
M !1110 4444 %%%% !1110 M%%% !2TE+2 **** %%% HH **** "BBB@ HH
MHH ****8#J***0!1110 4444 +1112 *!10* %HHHI@%%%%( HHHH 6BBB@
MI124HH **** "BBB@ HHHH 6BBBF 4M)2T@"BBB@ HHHH$%%%% "T444# 4M
M(*6@04444 %%%%(84HI*44""BBB@!:*** "BBB@ HHHH *6DI: "BBB@!:**
M* "E%)2B@ HHHH **** "BBB@!:*** "EI*6D 4444 %%%% @HHHH 6BBB@
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MHHH$%%%% !1110,**** "E'6DI1UH 6BBBD(*6DI: "BBB@!**** "EI*6@
MHHHIC 4M(*6D)A1110(6BBB@84444 %%%%(!110**8!1110 4444  I:04M(
M04444 .HHHH&%(:6D- !1110(6BBB@84"B@4 +1112$%+24M, HHHH ****0
M!2TE+3&%%%%  *6D%+0 4444 +1112)"EI*6@84444 %%%% !1110(****!@
M*6D%+0 4444A"T444P"BBB@ HHHI +1113 *!10* %HHHI#"EI*6@ HHHH$+
M1110 4444 %%%% !1110 4444 +1112 *=3:=0 4444 (:*#10 4444P%HHH
MH$ I:04M PHHHI +1110(*44E** "BBB@ HHHH ****!A1110 4ZFTZ@ HHH
MH$+1110 4444 %%%% !1110 4444 +1110 4M)2T@"BBB@!110** "BBB@ H
MHHH **** "BBBF ZBBBD 4444 %%%% "T444@"@44"@!:***8!1112 ****
M%HHHH *44E** "BBB@ HHHH **** %HHHI@%+24M( HHHH ****!!1110 M%
M%% P%+2"EH$%%%% !1112&%**2E% @HHHH 6BBB@ HHHH **** "EI*6@ HH
MHH 6BBB@ I124HH **** "BBB@ HHHH 6BBB@ I:2EI %%%% !1110(****
M%HHHH **** "BBB@!:*** "E%)2B@ HHHI ***!13 **** "BBBD 4M)2T %
M%%%,!:***0!1110 4444""EI*6@ HHHH&+1110 4444 %%%% "BB@44@"BBB
M@!:***!!1110 4444#%HHHH$%**2E% !1110 4444 %%%% "T444 %+24M !
M1112 ****8!2BDI10 4444@"EI*6@04444 %%%% PI:2EH$%%%% "BB@44 %
M%%% "T444 %%%% !1110 M%%%( HHHH **** %%% HH **** %HHHH ****
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MBBB@!:***!!1110 4444#"BBB@ I1UI*4=: %HHHI""EI*6@ HHHH 2BBB@
MI:2EH ****8P%+2"EI"84444"%HHHH&%%%% !1112 444"BF 4444 %%%%
M*6D%+2$%%%% #J***!A2&EI#0 4444"%HHHH&% HH% "T444A!2TE+3 ****
M "BBBD 4M)2TQA1110 "EI!2T %%%% "T444B0I:2EH&%%%% !1110 4444"
M"BBB@8"EI!2T %%%%(0M%%%, HHHH ****0"T444P"@44"@!:***0PI:2EH
M****!"T444 %%%% !1110 4444 %%%% "T444@"G4VG4 %%%% "&B@T4 %%%
M%,!:***! *6D%+0,****0"T444""E%)2B@ HHHH **** "BBB@84444 %.IM
M.H ****!"T444 %%%% !1110 4444 %%%% "T444 %+24M( HHHH 444"B@
MHHHH **** "BBB@ HHHI@.HHHI %%%% !1110 M%%%( H%% H 6BBBF 4444
M@"BBB@!:*** "E%)2B@ HHHH **** "BBB@!:***8!2TE+2 **** "BBB@04
M444 +1110,!2T@I:!!1110 4444AA2BDI10(**** %HHHH **** "BBB@ I:
M2EH **** %HHHH *44E** "BBB@ HHHH **** %HHHH *6DI:0!1110 4444
M""BBB@!:*** "BBB@ HHHH 6BBB@ I124HH ****0"BB@44P"BBB@ HHHI %
M+24M !1113 6BBBD 4444 %%%% @I:2EH ****!BT444 %%%% !1110 HHH%
M%( HHHH 6BBB@04444 %%%% Q:***!!2BDI10 4444 %%%% !1110 M%%% !
M2TE+0 4444@"BBBF 4HI*44 %%%%( I:2EH$%%%% !1110,*6DI:!!1110 H
MHH%% !1110 M%%% !1110 4444 +1112 **** "BBB@!110** "BBB@!:***
M "BBB@ HHHH 6BBB@ I124HH **** "EI*6@ HHHH **** "EI*6@ HHHH *
M***!!1110 M=IH7_ "!;?_@7_H1KBZ[30O\ D"V__ O_ $(UE5V(GL:-%%%8
M&84444 %%%% %34M-M-7T^6POX?.MI<;TW%<X((Y!!Z@5S__  K;PE_T"?\
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MW.5_X5OX2_Z!/_DQ+_\ %4?\*W\)?] G_P F)?\ XJNJHH]K/^9ASR[G*_\
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M .*H_P"%=>%/^@5_Y,2__%5U%%'M9]V'/+N<O_PKKPI_T"O_ "8E_P#BJ/\
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MO_0+_P#)B7_XJC_A7?A7_H%_^3$O_P 57444>UGW8<\NYR__  KOPK_T"_\
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MW_0+_P#)B7_XJC_A7OA;_H%_^3$O_P 573T4>UGW8<\NYS'_  KWPM_T"_\
MR8E_^*H_X5[X6_Z!?_DQ+_\ %5T]%'M9]V'/+N<S_P *]\+?] O_ ,F)?_BJ
M/^%>^%O^@7_Y,2__ !5=-11[2?=ASR[G,_\ "O?"W_0+_P#)B7_XJC_A7WA?
M_H%_^3$O_P 57344>TGW8<\NYS/_  K[PO\ ] O_ ,F)?_BJ/^%?>%_^@7_Y
M,2__ !5=-11[2?=ASR[G,_\ "OO"_P#T"_\ R8E_^*H_X5]X7_Z!?_DQ+_\
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M?^1Y?_BJZ6BCVD^[#GEW.:_X5_X8_P"@9_Y'E_\ BJ/^$ \,?] S_P CR_\
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M/^$"\,_] S_R/)_\57244>TGW8<\NYS?_"!>&?\ H&?^1Y/_ (JC_A O#/\
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M (0/PU_T#?\ R/)_\571T4>TGW8<\NYSG_"!^&O^@;_Y'D_^*H_X0/PU_P!
MW_R/)_\ %5T=%'M)]V'/+N<Y_P ()X:_Z!O_ )'D_P#BJ7_A!/#7_0-_\CR?
M_%5T5%'M)]V'/+N<[_P@GAK_ *!O_D>3_P"*H_X03PU_T#?_ "/)_P#%5T5%
M'M)]V'/+N<[_ ,()X;_Z!O\ Y'D_^*H_X03PW_T#?_(\G_Q5=%11[2?=ASR[
MG._\()X;_P"@;_Y'D_\ BJ/^$$\-_P#0-_\ (\G_ ,57144>TGW8<\NYSO\
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M-+N8/_"%^'_^@?\ ^1I/_BJ/^$+\/_\ 0/\ _(TG_P 56]11[2?<.:7<P/\
MA"_#_P#T#_\ R-)_\51_PA?A_P#Z!_\ Y&D_^*K?HH]I/N'-+N8'_"%^'_\
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M/_"&:!_SX?\ D:3_ .*H_P"$,T#_ )\/_(TG_P 56]11[2?<.:7<P?\ A#-
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M )\?_(K_ /Q5'_"(Z%_SX_\ D5__ (JMNBCGEW#F?<Q/^$1T/_GQ_P#(K_\
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M^-'_  B>B?\ /E_Y%?\ QK:HHYY=PYGW,7_A$]$_Y\O_ "*_^-'_  B>B?\
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M\(QH_P#SY_\ D1_\:UZ*.>7<.9]S(_X1C1_^?/\ \B/_ (T?\(QH_P#SY_\
MD5_\:UZ*.>7<.9]S(_X1C1_^?/\ \B/_ (T?\(QH_P#SY_\ D1_\:UZ*.>7<
M.9]S(_X1C1_^?/\ \B/_ (T?\(QH_P#SY_\ D1_\:UZ*.>7<.9]S(_X1C1_^
M?/\ \B/_ (T?\(QH_P#SY_\ D1_\:UZ*.>7<.9]S)_X1G1_^?/\ \B/_ (T?
M\(SH_P#SY_\ D1_\:UJ*.>7<.9]S)_X1G1_^?/\ \B/_ (T?\(SH_P#SY_\
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M_D1_\:/^$;TG_GT_\B/_ (UJT4<TNX<S,K_A&])_Y]/_ "(_^-'_  C>D_\
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M ,B-_C1_PCVE?\^O_D1O\:TZ*.:7<+LS/^$>TO\ Y]?_ "(W^-'_  CVE_\
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M?^%P>(/^?/3/^_4G_P 71_PN#Q!_SYZ9_P!^I/\ XNO/J*/84^P>RAV/0?\
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M='_"X/$'_/GIG_?J3_XNO/J*/84^P>RAV/0?^%P>(/\ GSTS_OU)_P#%T?\
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M!X@_Y\],_P"_4G_Q='_"X/$'_/GIG_?J3_XNO/J*/84^P>RAV/0?^%P>(/\
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M?\^>F?\ ?J3_ .+KSZBCV%/L'LH=CT'_ (7!X@_Y\],_[]2?_%T?\+@\0?\
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MJ3_XNO/J*/84^P>RAV/0?^%P>(/^?/3/^_4G_P 71_PN#Q!_SYZ9_P!^I/\
MXNO/J*/84^P>RAV/0?\ A<'B#_GSTS_OU)_\71_PN#Q!_P ^>F?]^I/_ (NO
M/J*/84^P>RAV/0?^%P>(/^?/3/\ OU)_\71_PN#Q!_SYZ9_WZD_^+KSZBCV%
M/L'LH=CT'_A<'B#_ )\],_[]2?\ Q='_  N#Q!_SYZ9_WZD_^+KSZBCV%/L'
MLH=CT'_A<'B#_GSTS_OU)_\ %T?\+@\0?\^>F?\ ?J3_ .+KSZBCV%/L'LH=
MCT'_ (7!X@_Y\],_[]2?_%T?\+@\0?\ /GIG_?J3_P"+KSZBCV%/L'LH=CT'
M_A<'B#_GSTS_ +]2?_%T?\+@\0?\^>F?]^I/_BZ\^HH]A3[![*'8]!_X7!X@
M_P"?/3/^_4G_ ,71_P +@\0?\^>F?]^I/_BZ\^HH]A3[![*'8]!_X7!X@_Y\
M],_[]2?_ !='_"X/$'_/GIG_ 'ZD_P#BZ\^HH]A3[![*'8]!_P"%P>(/^?/3
M/^_4G_Q='_"X/$'_ #YZ9_WZD_\ BZ\^HH]A3[![*'8]!_X7!X@_Y\],_P"_
M4G_Q='_"X/$'_/GIG_?J3_XNO/J*/84^P>RAV/0?^%P>(/\ GSTS_OU)_P#%
MT?\ "X/$'_/GIG_?J3_XNO/J*/84^P>RAV/0?^%P>(/^?/3/^_4G_P 71_PN
M#Q!_SYZ9_P!^I/\ XNO/J*/84^P>RAV/0?\ A<'B#_GSTS_OU)_\71_PN#Q!
M_P ^>F?]^I/_ (NO/J*/84^P>RAV/0?^%P>(/^?/3/\ OU)_\71_PN#Q!_SY
MZ9_WZD_^+KSZBCV%/L'LH=CT'_A<'B#_ )\],_[]2?\ Q='_  N#Q!_SYZ9_
MWZD_^+KSZBCV%/L'LH=CT'_A<'B#_GSTS_OU)_\ %T?\+@\0?\^>F?\ ?J3_
M .+KSZBCV%/L'LH=CT'_ (7!X@_Y\],_[]2?_%T?\+@\0?\ /GIG_?J3_P"+
MKSZBCV%/L'LH=CT'_A<'B#_GSTS_ +]2?_%T?\+@\0?\^>F?]^I/_BZ\^HH]
MA3[![*'8]!_X7!X@_P"?/3/^_4G_ ,71_P +@\0?\^>F?]^I/_BZ\^HH]A3[
M![*'8]!_X7!X@_Y\],_[]2?_ !='_"X/$'_/GIG_ 'ZD_P#BZ\^HH]A3[![*
M'8]!_P"%P>(/^?/3/^_4G_Q='_"X/$'_ #YZ9_WZD_\ BZ\^HH]A3[![*'8]
M!_X7!X@_Y\],_P"_4G_Q='_"X/$'_/GIG_?J3_XNO/J*/84^P>RAV/0?^%P>
M(/\ GSTS_OU)_P#%T?\ "X/$'_/GIG_?J3_XNO/J*/84^P>RAV/0?^%P>(/^
M?/3/^_4G_P 71_PN#Q!_SYZ9_P!^I/\ XNO/J*/84^P>RAV/0?\ A<'B#_GS
MTS_OU)_\71_PN#Q!_P ^>F?]^I/_ (NO/J*/84^P>RAV/0?^%P>(/^?/3/\
MOU)_\71_PN#Q!_SYZ9_WZD_^+KSZBCV%/L'LH=CT'_A<'B#_ )\],_[]2?\
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M_P#BZ\^HH]A3[![*'8]!_P"%P>(/^?/3/^_4G_Q='_"X/$'_ #YZ9_WZD_\
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MYZ9_WZD_^+KSZBCV%/L'LH=CT'_A<'B#_GSTS_OU)_\ %T?\+@\0?\^>F?\
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M2?\ Q='_  N#Q!_SYZ9_WZD_^+KSZBCV%/L'LH=CT'_A<'B#_GSTS_OU)_\
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M?^%P>(/^?/3/^_4G_P 71_PN#Q!_SYZ9_P!^I/\ XNO/J*/84^P>RAV/0?\
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M='_"X/$'_/GIG_?J3_XNO/J*/84^P>RAV/0?^%P>(/\ GSTS_OU)_P#%T?\
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M!X@_Y\],_P"_4G_Q='_"X/$'_/GIG_?J3_XNO/J*/84^P>RAV/0?^%P>(/\
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M?\^>F?\ ?J3_ .+KSZBCV%/L'LH=CT'_ (7!X@_Y\],_[]2?_%T?\+@\0?\
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M/U>E@_X;]3LP_P (4445UFX4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !7T#\-O^1 TS_MK_P"C7KY^KZ!^&W_(@:9_VU_]&O7)C/@7J88C
MX3JZ***\TXPHHHH **** .4^)/\ R3_4_P#ME_Z-2OGZOH'XD_\ )/\ 4_\
MME_Z-2OGZO2P?\-^IV8?X0HHHKK-PHHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "OH'X;?\ (@:9_P!M?_1KU\_5] _#;_D0-,_[:_\ HUZY
M,9\"]3#$?"=71117FG&%%%% !1110!RGQ)_Y)_J?_;+_ -&I7S]7T#\2?^2?
MZG_VR_\ 1J5\_5Z6#_AOU.S#_"%%%%=9N%%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 5] _#;_D0-,_[:_^C7KY^KZ!^&W_ "(&F?\ ;7_T
M:]<F,^!>IAB/A.KHHHKS3C"BBB@ HHHH Y3XD_\ )/\ 4_\ ME_Z-2OGZOH'
MXD_\D_U/_ME_Z-2OGZO2P?\ #?J=F'^$****ZS<**** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MWX>.H6=Q>R2B54Q,Z%<'/HHK)UHJ?)U,W4BI<IYM1116IH%%*JL[!54LS'
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M$^'M&\(W=]8:?Y-S&T85_.D;&7 /!8CH:\AJJ555%=#A-35T%%%%:%A1110
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ME. HHK7\,:7!K7B2RTZY>1(9W*LT9 8?*3QD$=O2M6[*[+;LKF117L]Q\(]
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M0>I)/>BG7C4ERH(5%)V1B45[IX)\%:+!X:L[JZL;>\N;N%)G>XB#@!AD  Y
MP#C(Z_H.#^)GAJST#5[:73XQ#;W:,WE G"N#SC/0<CCM2AB(RGR(4:JE+E.'
MHHHK<U"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OH'X;?\B!IG_;
M7_T:]?/U?0/PV_Y$#3/^VO\ Z->N3&? O4PQ'PG5T445YIQA1110 4444 <I
M\2?^2?ZG_P!LO_1J5\_5] _$G_DG^I_]LO\ T:E?/U>E@_X;]3LP_P (4445
MUFX4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5[+\'?^0!J'_7U_[*
M*\:KV7X._P#( U#_ *^O_917/BOX3,:_P$/QE_Y!FE_]=G_]!%>05Z_\9?\
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M:]!NQU'K7PO\(QV=BFO7L2M=3C-L#SY<?][ZM_+ZFNH\4^+K#PK9B2XS+<R
M^3;H<,_N3V7W_0UNJJ00A54)&BX  X %?-7B+69=?UVZU&5FVR.?*5OX$'W1
M[<?KFO-IQ>(J.4MCD@O:R;9TE_\ %7Q)=2$VTEO9)N) BB#''8$OG/X 59TK
MXMZU;2J-1A@O(>-Q"^6_U!''Z5Y]17;["G:UCH]G"UK'TCHOBO2-<TM[^VNE
M1(EW3I*0K0CG[W/ X//2O$/&NLZ=KGB*6ZTRT6&#&TR8P9B/XR.W\_7T'/J[
MHKJKLH<;6 .-PR#@^O(!_"FU-+#QIR<DQ0I*#N%=Y\*='74/$TE[*FZ*QCWC
M_KHW"_H&/X5P=>__  YT4Z/X1MS+'LN+LF>3(YP?N@_\!QQZDTL3/EI^H5I6
MB=;D#'/6N#^*NBKJ'AD:@BL9[!MWR@G,;$!A_(Y[8-9_CGQ@-+\:Z-;Q29BL
M'$UTH&?OC;C'J$)(_P!^O1IHH;VT>*55E@F0JRD9#*17 E*DXS.5)P:D?+-%
M7-5TZ72=6N]/F#;[>5H\LNW< >&QZ$8(^M4Z]=.ZNCN/2/@[9^9KFH7F[B&W
M$>W'4NV<_P#CA_.O9*\W^#EJB:%J-V%_>2W(B)SU"J"/_0S^==\]_#'JD.GL
M<32PO,OT4J#_ .A?I7E8E\U5G%6=YL\-^)>D_P!F>,KB1%Q%> 7"\<9/#?CN
M!/XUQ]>T_%W2?M7A^WU)%^>SEVN?]A\#_P!""_F:\S\':3_;7BNPLV3=#YGF
M2@KN&Q?F(/L<8_&NZC43I<SZ'33G[EWT/<_!^E'1?"FGV3J5E$6^4$@D.WS,
M./0G'X5'XXM1>>"=7B(SMMS+_P!\8?\ ]EK8OKV'3K.2ZN'"QIC))[DX _$D
M"GW,(N;6:!N%E0H?H1BO,YGS<[[G'=WYCY8HITD;12O&XPZ,58>A%-KVCT0K
MJ_AM_P E TS_ +:_^BGKE*ZOX;?\E TS_MK_ .BGJ*O\.7HR)_"SW+7+Z73-
M!O[Z%4:6WMWE0."5) )&<=J\C_X7!X@_Y\],_P"_4G_Q=>OZM8?VIH]Y8>9Y
M7VF%XM^W=MW#&<<9KS7_ (4O_P!1_P#\D_\ [.O.H.DD_:'+2<+>\8-_\5-<
MU'3KFRFM=.6*XB>%RD;@@,"#C+]>:L_!_P#Y&VZ_Z\7_ /1D=6M4^$G]FZ3>
MW_\ ;?F?9H'FV?9,;MJDXSOXZ55^#_\ R-MU_P!>+_\ HR.NF3INE+V9LW#D
M?*=[\3?^1"O_ />B_P#1BUX#7OWQ-_Y$*_\ ]Z+_ -&+7B&C:3<ZYJUOIUHN
M9)F +8X1>['V YHPC2IMON*@[096MK2YO9A#:V\L\IZ)$A9C^ KHHOAUXLEC
M#KI# '^]-&I_(MFO;/#OAK3O#5@MO91+YA \V<J-\I]SZ>@[56OO'7AG3IO)
MN-7AWCJ(@TN/J4!Q4/%2D[4T)UY-^ZCPG5/#.M:*-VH:;<0H "9-NY!DX^\,
MC/MFLJOI^RU'3=;M&DL[FWO(#\K["&'T([?0UY'\1_ \6BM_;&F)MLI7VRPJ
M.(6/0CT4_H<#N -*6)YI<LE9E0K7=I;G$V>CZGJ,32V.FWEU&K;2\$#. ?3(
M'6F7NF7^FE!?6-S:E\[//B9-V.N,CGJ*[CX3:V;+7IM*EDQ!>IE <G]ZO3'8
M97=GUP*[SXCZ&=:\)S-$,W%F?M$>!RP ^9?RR?J!3G7<*G(UH.55QGRL\!JS
M9Z=?:B[)8V=Q=.HRRP1,Y ]3@56KW7X7Z)_9?A9;R1"MQ?GS6S_<&0GX8.?^
M!5I6J^SC<JI/D5SQF[T35K"#S[S2[VWBSCS)K=T7/IDBJ%>F?%[7//U"VT6)
M_DMAYTRC^^P^7\E)_P"^JROAUX/3Q%?R7E\N=.M2 5S_ *U^H7Z8Y/U'K2C5
M_=\\] 4_<YI'.Z7X9UK6ANT_3;B9""1)MVH<''WC@9]LU?NO 'BFSA:6;2)-
MB@L?+D20X'LI)KZ =[33+'<QAM;2! .<(D:CI[ 5B0^/O"T]T;9-9@#@D9=6
M1./]L@+^M<WUJI)WC'0Q]O-[(\"M-)U*_:5;/3[NY:(@2"&%G*$YZX''0_E2
MWFCZGIT2RWVFWEK&S;0\\#("?3)'6OI6WL+."\N+ZWA19KM4\V1/^6FW.TGW
M^8\_3TKA?C#_ ,BS9?\ 7X/_ $!ZN&*<YJ-BHU^:5K'%?#K2M1/BW2[\6%U]
MBW2?Z1Y+>7]QA][&.O'UKV;Q'%)/X8U:&&-I)9+*941!DL2A   ZFN<^&VJZ
M</!^F6!O[7[;^]_T?SE\S_6.?NYSTY^E=G++'!"\TTBQQ1J6=W. H')))Z"N
M:O-NIJMC&K)N?H?,-[I>H:;L^WV-U:^9G9Y\+)NQC.,CGJ/SJI7I?Q;U33]2
M_L?[!?6MUY?G;_(F5]N?+QG!XZ'\JU_AWX#@MK.'6=5@$EU*-\$,JY$2]F(/
M\1X(]/K7;[=*FIR.GVMH<S/.]/\ !?B/5(_,M=)N"AZ-)B,'Z;B,U-=^ ?%-
ME"TTNCS%%Z^4RR'\E)->[ZKK^E:(@;4K^&W)&X*S99AZA1R?P%5=+\8>']9G
M$%AJD,DQ.%C8&-F/L& )_"L/K55ZJ.AE[:>]M#YP='BD:.1&1U)5E88((Z@B
MFU[_ .,_!%IXFLFEA1(-3C!,<P&-_P#LOZCW[?F#X%)&\,KQ2HR2(Q5D88*D
M=01V-=5&LJJNC:G44T-K;TWPAX@U>/S++2KAXR 0[@1JP/0@L0#^%=?\-/!4
M&J*=:U2%9;56VV\+C*R$=68=P.@'<Y].?6;R^L]-M3/>7$5M N!OD8*,]A6-
M;$\LN6*NR*E:SM$^?+_P/XETV!I[K29A&HR6C99,?]\DUZ9\'_\ D4KK_K^?
M_P!%QUOV'CGPUJ5P(+;5H3*2 JR*T>XGH!N R:U[/3K33S<?9(%A%Q*9I G
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M_K5U D]OI%_-"XRLD=L[*P]B!S56[LKNPF\F\M9K:7&[9-&4;'K@U]!^!/\
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M2?\ KG)_-:B-=NK[.PE5;GRGF*JSL%52S,<  9)-=+;_  ^\574*RQZ1(%8
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MGYIF5%/\**<*/R%==\'KJ2/Q%?6@;$4MKYA'JRL /T9JX/4?^0G=_P#79_\
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MU+J_BVZB+DP63&WB3D $'YCCU+9Y] /2O;O#]X-0\.Z;=@@^;;1L<=FVC(_
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M+TW3KRY25_-G>"%G "_=4X!ZDY_X"/6N.\!V>O:#XLM9Y=%U)+>;_1YF:T<
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MY&,\<_XUYM\&KN--1U6T+8DEBCD5?4*2#_Z&*[SQIJ^KZ'H?]H:3:PW#1O\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH *^@?AM_R(&F?]M?_ $:]?/U?0/PV
M_P"1 TS_ +:_^C7KDQGP+U,,1\)U=%%%>:<84444 %%%% '*?$G_ ))_J?\
MVR_]&I7S]7T#\2?^2?ZG_P!LO_1J5\_5Z6#_ (;]3LP_PA11176;A1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M+NZ5#E1/,SA3[9-<T\.YU.9O0QE2<I\S*=%%%=)L>F_"#6E@OKO1I7P+@":
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M*,(NKL0/[T,;'\RN:SJ8:;GS09,Z4G+FBSW>ZNK#0M*::9H[6RMD X&%4#@
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M2G3Y$%%%%;&H4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *<@0R*)&94R-Q49('? R,
M_G3:* /9+'XJ>&=.L(+.WL=36&",1H/+0\ 8_OUYAXDUJ3Q!K]UJ+[@LCXB1
MC]Q!PHZ^G7'<FLJBLH48P=T9QIQB[H****U- HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#T/P'X\TOPOH<]E>P7DD
MLERTP,"*1@JH[L.?E-4/B!XNL/%<FGM8PW,8MQ('\]5&=VW&,,?0UQ=%9*C%
M3Y^IG[./-S=0HHHK4T"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH *],\&_$32/#OAN'3KNVOGF1W8M$B%>6)'5@?TKS.BHJ
M4XU%:1,HJ2LSKO'WBFQ\5:A:7%C%<1I#$483JH).<\8)KD:**<(J*Y4$4HJR
M"BBBJ*"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M**ZO_A6WBW_H$_\ DS%_\51_PK;Q;_T"?_)F+_XJCVM/^9?>'/'N<I175_\
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MM_Z!/_DS%_\ %4>UI_S+[PYX]SE**ZO_ (5MXM_Z!/\ Y,Q?_%4?\*V\6_\
M0)_\F8O_ (JCVM/^9?>'/'N<I175_P#"MO%O_0)_\F8O_BJ/^%;>+?\ H$_^
M3,7_ ,51[6G_ #+[PYX]SE**ZO\ X5MXM_Z!/_DS%_\ %4?\*V\6_P#0)_\
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MH_X5MXM_Z!/_ ),Q?_%4>UI_S+[PYX]SE**ZO_A6WBW_ *!/_DS%_P#%4?\
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M_P"%;>+?^@3_ .3,7_Q5'_"MO%O_ $"?_)F+_P"*H]K3_F7WASQ[G*45U?\
MPK;Q;_T"?_)F+_XJC_A6WBW_ *!/_DS%_P#%4>UI_P R^\.>/<Y2BNK_ .%;
M>+?^@3_Y,Q?_ !5'_"MO%O\ T"?_ "9B_P#BJ/:T_P"9?>'/'N<I175_\*V\
M6_\ 0)_\F8O_ (JC_A6WBW_H$_\ DS%_\51[6G_,OO#GCW.4HKJ_^%;>+?\
MH$_^3,7_ ,51_P *V\6_] G_ ,F8O_BJ/:T_YE]X<\>YRE%=7_PK;Q;_ - G
M_P F8O\ XJC_ (5MXM_Z!/\ Y,Q?_%4>UI_S+[PYX]SE**ZO_A6WBW_H$_\
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M ,51_P *V\6_] G_ ,F8O_BJ/:T_YE]X<\>YRE%=7_PK;Q;_ - G_P F8O\
MXJC_ (5MXM_Z!/\ Y,Q?_%4>UI_S+[PYX]SE**ZO_A6WBW_H$_\ DS%_\51_
MPK;Q;_T"?_)F+_XJCVM/^9?>'/'N<I175_\ "MO%O_0)_P#)F+_XJC_A6WBW
M_H$_^3,7_P 51[6G_,OO#GCW.4HKJ_\ A6WBW_H$_P#DS%_\51_PK;Q;_P!
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M_P 51[6G_,OO#GCW.4HKJ_\ A6WBW_H$_P#DS%_\51_PK;Q;_P! G_R9B_\
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M *!/_DS%_P#%4>UI_P R^\.>/<Y2BNK_ .%;>+?^@3_Y,Q?_ !5'_"MO%O\
MT"?_ "9B_P#BJ/:T_P"9?>'/'N<I175_\*V\6_\ 0)_\F8O_ (JC_A6WBW_H
M$_\ DS%_\51[6G_,OO#GCW.4HKJ_^%;>+?\ H$_^3,7_ ,51_P *V\6_] G_
M ,F8O_BJ/:T_YE]X<\>YRE%=7_PK;Q;_ - G_P F8O\ XJC_ (5MXM_Z!/\
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MB_\ BJ/^%;>+?^@3_P"3,7_Q5'M:?\R^\.>/<Y2BNK_X5MXM_P"@3_Y,Q?\
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MZ!/_ ),Q?_%4?\*V\6_] G_R9B_^*H]K3_F7WASQ[G*45U?_  K;Q;_T"?\
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M5_\ "MO%O_0)_P#)F+_XJC_A6WBW_H$_^3,7_P 51[6G_,OO#GCW.4HKJ_\
MA6WBW_H$_P#DS%_\51_PK;Q;_P! G_R9B_\ BJ/:T_YE]X<\>YRE%=7_ ,*V
M\6_] G_R9B_^*H_X5MXM_P"@3_Y,Q?\ Q5'M:?\ ,OO#GCW.4HKJ_P#A6WBW
M_H$_^3,7_P 51_PK;Q;_ - G_P F8O\ XJCVM/\ F7WASQ[G*45U?_"MO%O_
M $"?_)F+_P"*H_X5MXM_Z!/_ ),Q?_%4>UI_S+[PYX]SE**ZO_A6WBW_ *!/
M_DS%_P#%4?\ "MO%O_0)_P#)F+_XJCVM/^9?>'/'N<I175_\*V\6_P#0)_\
M)F+_ .*H_P"%;>+?^@3_ .3,7_Q5'M:?\R^\.>/<Y2BNK_X5MXM_Z!/_ ),Q
M?_%4?\*V\6_] G_R9B_^*H]K3_F7WASQ[G*45U?_  K;Q;_T"?\ R9B_^*H_
MX5MXM_Z!/_DS%_\ %4>UI_S+[PYX]SE**ZO_ (5MXM_Z!/\ Y,Q?_%4?\*V\
M6_\ 0)_\F8O_ (JCVM/^9?>'/'N<I175_P#"MO%O_0)_\F8O_BJ/^%;>+?\
MH$_^3,7_ ,51[6G_ #+[PYX]SE**ZO\ X5MXM_Z!/_DS%_\ %4?\*V\6_P#0
M)_\ )F+_ .*H]K3_ )E]X<\>YRE%=7_PK;Q;_P! G_R9B_\ BJ/^%;>+?^@3
M_P"3,7_Q5'M:?\R^\.>/<Y2BNK_X5MXM_P"@3_Y,Q?\ Q5'_  K;Q;_T"?\
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M9B_^*H]K3_F7WASQ[G*45U?_  K;Q;_T"?\ R9B_^*H_X5MXM_Z!/_DS%_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **9+*D,+RR,%
MC12S,>P')-?*FL^._&?Q0\7#2="N+FWMII"+:SMY?* 09.Z1AC/ R<G ["@#
MZNHKY*\0>#OB)\-[6+6)-2GC@WJK3V5ZY"-V#C@X/T([=^?;O@YX^NO''AJ=
M=3*-J>GNL<TB@#S5895R!T)PP../ESWP #T>BOF'X_:[<W'Q#ATVSN9E%G:1
MQM'$Y!\QR6Z#OM9*=_PHKXA_]!6R_P# V7_XF@#Z<HKSSX2^#=<\&:1J%MKM
MS#/-/.)(S%,T@"A<=6 QS7FWQ@^)>M7?BF3PEX<N9[>&"18)7MF*R7$QQ\H8
M<@ G;@8R<YR,4 ?1E%?)>N>"?B+X#TI/$5QJ$\*!E\U[:^9GA+'C?^)QP2,G
MWKV[X/>/Y_''AJ9=196U6P<1W#* /-4CY7P. 3A@0.,C/&<  ]&HKY^^-?Q0
MU:TUU_"N@7,EJ(57[7/ 2)'=AD(I'( !&2.23CMSQNK> /B/X5T/_A)9[RYB
M" /-]GOG,\ /=L>^,X)Q^!H ^LZ*\M^"WQ$NO&>CW-AJSA]4L-I:7 'G1G.&
M('<$8/U%<]\<?B;J.B7J>&="N6M9S$)+NYC.'4-]U%/53CDD<\C!ZT >YT5\
MFW7P]^)&F>'6\5RW=S&$B^T2*MZ_VB-.NXCV')YR/3BO4O@?\2+[Q5;W6AZW
M/Y^HVB"6&X;[TT6<'=ZE21SW!YY!) /8**\:^-_Q+O\ PO\ 9] T2;R+ZYB\
MZ>Y7[T49)"A?0G#<]0![Y'F*?#WXD3^&_P#A+%N;E@8OM*I]M<W+)C.\#Z<X
MSGVSQ0!]9T5XC\#?B7J&OS2^&]<N'N;J*+S;6ZD.7=1@,C'JQ&<@GDC.:]NH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** &R1I+&T<B*Z,"K*PR"#U!%9=CX7\/Z9??;
MM/T33K2ZP5\ZWM4C8@]<E0*UJ^>/BS\8KJYOKCPQX7F,,2/Y-S?(^&D;H40]
ME[%NIYQ@<D L_'?XCZ==Z:_A'2I4N93*K7LR'*1[#GRP>[;@,^F,=3QUGP+\
M'77A?PA->:C"8;W5'64Q,,,D2@A WORQQVW>N:YOX:?#KPEX>$&K^(];TB\U
M88>.W-W&T5L>W?YV'KT!Z=,U[79ZII^I"3^S[^UNC'C?Y$ROMSG&<'CH?RH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M3_H^[O8_/CT^_C/O^E?0%% ',>"? >C>!-,>TTN-VEF(:XN93F24CIGT R<
M<<GN2:Z>BB@ KR#]H[_DGEA_V%8__14M>OUY!^T=_P D\L/^PK'_ .BI: $_
M9Q_Y)[J'_85D_P#145>P5X_^SC_R3W4/^PK)_P"BHJ]@H **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\@_:.
M_P"2>6'_ &%8_P#T5+7K]>0?M'?\D\L/^PK'_P"BI: $_9Q_Y)[J'_85D_\
M145>P5X_^SC_ ,D]U#_L*R?^BHJ]@H **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M^!*?XT?\)!HO_07L/_ E/\:+!=&C16=_PD&B_P#07L/_  )3_&C_ (2#1?\
MH+V'_@2G^-%@NC1HK._X2#1?^@O8?^!*?XT?\)!HO_07L/\ P)3_ !HL%T:-
M%9W_  D&B_\ 07L/_ E/\:/^$@T7_H+V'_@2G^-%@NC1HK._X2#1?^@O8?\
M@2G^-'_"0:+_ -!>P_\  E/\:+!=&C16=_PD&B_]!>P_\"4_QH_X2#1?^@O8
M?^!*?XT6"Z-&BL[_ (2#1?\ H+V'_@2G^-'_  D&B_\ 07L/_ E/\:+!=&C1
M6=_PD&B_]!>P_P# E/\ &C_A(-%_Z"]A_P"!*?XT6"Z-&BL[_A(-%_Z"]A_X
M$I_C1_PD&B_]!>P_\"4_QHL%T:-%9W_"0:+_ -!>P_\  E/\:/\ A(-%_P"@
MO8?^!*?XT6"Z-&BL[_A(-%_Z"]A_X$I_C1_PD&B_]!>P_P# E/\ &BP71HT5
MG?\ "0:+_P!!>P_\"4_QH_X2#1?^@O8?^!*?XT6"Z-&BL[_A(-%_Z"]A_P"!
M*?XT?\)!HO\ T%[#_P "4_QHL%T:-%9W_"0:+_T%[#_P)3_&C_A(-%_Z"]A_
MX$I_C18+HT:*SO\ A(-%_P"@O8?^!*?XT?\ "0:+_P!!>P_\"4_QHL%T:-%9
MW_"0:+_T%[#_ ,"4_P :/^$@T7_H+V'_ ($I_C18+HT:*SO^$@T7_H+V'_@2
MG^-'_"0:+_T%[#_P)3_&BP71HT5G?\)!HO\ T%[#_P "4_QH_P"$@T7_ *"]
MA_X$I_C18+HT:*SO^$@T7_H+V'_@2G^-'_"0:+_T%[#_ ,"4_P :+!=&C16=
M_P )!HO_ $%[#_P)3_&C_A(-%_Z"]A_X$I_C18+HT:*SO^$@T7_H+V'_ ($I
M_C1_PD&B_P#07L/_  )3_&BP71HT5G?\)!HO_07L/_ E/\:/^$@T7_H+V'_@
M2G^-%@NC1HK._P"$@T7_ *"]A_X$I_C1_P )!HO_ $%[#_P)3_&BP71HT5G?
M\)!HO_07L/\ P)3_ !H_X2#1?^@O8?\ @2G^-%@NC1HK._X2#1?^@O8?^!*?
MXT?\)!HO_07L/_ E/\:+!=&C16=_PD&B_P#07L/_  )3_&C_ (2#1?\ H+V'
M_@2G^-%@NC1HK._X2#1?^@O8?^!*?XT?\)!HO_07L/\ P)3_ !HL%T:-%9W_
M  D&B_\ 07L/_ E/\:/^$@T7_H+V'_@2G^-%@NC1HK._X2#1?^@O8?\ @2G^
M-'_"0:+_ -!>P_\  E/\:+!=&C16=_PD&B_]!>P_\"4_QH_X2#1?^@O8?^!*
M?XT6"Z-&BL[_ (2#1?\ H+V'_@2G^-'_  D&B_\ 07L/_ E/\:+!=&C16=_P
MD&B_]!>P_P# E/\ &C_A(-%_Z"]A_P"!*?XT6"Z-&BL[_A(-%_Z"]A_X$I_C
M1_PD&B_]!>P_\"4_QHL%T:-%9W_"0:+_ -!>P_\  E/\:/\ A(-%_P"@O8?^
M!*?XT6"Z-&BL[_A(-%_Z"]A_X$I_C1_PD&B_]!>P_P# E/\ &BP71HT5G?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "O(/VCO^2>6'_85C_P#14M>O
MUY!^T=_R3RP_["L?_HJ6@!/V<?\ DGNH?]A63_T5%7L%>/\ [./_ "3W4/\
ML*R?^BHJ]@H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH SO$'
M_(MZI_UZ2_\ H!KRGPMX6_X2;[7_ *9]F^S[/^66_=NW>XQ]W]:]6\0?\BWJ
MG_7I+_Z :XSX6?\ ,6_[8_\ L]4G9&<E>23#_A5G_49_\E?_ +.C_A5G_49_
M\E?_ +.O1**.9CY(GG?_  JS_J,_^2O_ -G1_P *L_ZC/_DK_P#9UZ)11S,.
M2)YW_P *L_ZC/_DK_P#9T?\ "K/^HS_Y*_\ V=>B44<S#DB>=_\ "K/^HS_Y
M*_\ V='_  JS_J,_^2O_ -G7HE%',PY(GG?_  JS_J,_^2O_ -G1_P *L_ZC
M/_DK_P#9UZ)11S,.2)YW_P *L_ZC/_DK_P#9T?\ "K/^HS_Y*_\ V=>B44<S
M#DB>=_\ "K/^HS_Y*_\ V='_  JS_J,_^2O_ -G7HE%',PY(GG?_  JS_J,_
M^2O_ -G1_P *L_ZC/_DK_P#9UZ)11S,.2)YW_P *L_ZC/_DK_P#9T?\ "K/^
MHS_Y*_\ V=>B44<S#DB>=_\ "K/^HS_Y*_\ V='_  JS_J,_^2O_ -G7HE%'
M,PY(GG?_  JS_J,_^2O_ -G1_P *L_ZC/_DK_P#9UZ)11S,.2)YW_P *L_ZC
M/_DK_P#9T?\ "K/^HS_Y*_\ V=>B44<S#DB>=_\ "K/^HS_Y*_\ V='_  JS
M_J,_^2O_ -G7HE%',PY(GG?_  JS_J,_^2O_ -G1_P *L_ZC/_DK_P#9UZ)1
M1S,.2)YW_P *L_ZC/_DK_P#9T?\ "K/^HS_Y*_\ V=>B44<S#DB>=_\ "K/^
MHS_Y*_\ V='_  JS_J,_^2O_ -G7HE%',PY(GG?_  JS_J,_^2O_ -G1_P *
ML_ZC/_DK_P#9UZ)11S,.2)YW_P *L_ZC/_DK_P#9T?\ "K/^HS_Y*_\ V=>B
M44<S#DB>=_\ "K/^HS_Y*_\ V='_  JS_J,_^2O_ -G7HE%',PY(GG?_  JS
M_J,_^2O_ -G1_P *L_ZC/_DK_P#9UZ)11S,.2)YW_P *L_ZC/_DK_P#9T?\
M"K/^HS_Y*_\ V=>B44<S#DB>=_\ "K/^HS_Y*_\ V='_  JS_J,_^2O_ -G7
MHE%',PY(GG?_  JS_J,_^2O_ -G1_P *L_ZC/_DK_P#9UZ)11S,.2)YW_P *
ML_ZC/_DK_P#9T?\ "K/^HS_Y*_\ V=>B44<S#DB>=_\ "K/^HS_Y*_\ V='_
M  JS_J,_^2O_ -G7HE%',PY(GG?_  JS_J,_^2O_ -G1_P *L_ZC/_DK_P#9
MUZ)11S,.2)YW_P *L_ZC/_DK_P#9T?\ "K/^HS_Y*_\ V=>B44<S#DB>=_\
M"K/^HS_Y*_\ V='_  JS_J,_^2O_ -G7HE%',PY(GG?_  JS_J,_^2O_ -G1
M_P *L_ZC/_DK_P#9UZ)11S,.2)YW_P *L_ZC/_DK_P#9T?\ "K/^HS_Y*_\
MV=>B44<S#DB>=_\ "K/^HS_Y*_\ V='_  JS_J,_^2O_ -G7HE%',PY(GG?_
M  JS_J,_^2O_ -G1_P *L_ZC/_DK_P#9UZ)11S,.2)YW_P *L_ZC/_DK_P#9
MT?\ "K/^HS_Y*_\ V=>B44<S#DB>=_\ "K/^HS_Y*_\ V='_  JS_J,_^2O_
M -G7HE%',PY(GG?_  JS_J,_^2O_ -G1_P *L_ZC/_DK_P#9UZ)11S,.2)YW
M_P *L_ZC/_DK_P#9T?\ "K/^HS_Y*_\ V=>B44<S#DB>=_\ "K/^HS_Y*_\
MV='_  JS_J,_^2O_ -G7HE%',PY(GG?_  JS_J,_^2O_ -G1_P *L_ZC/_DK
M_P#9UZ)11S,.2)YW_P *L_ZC/_DK_P#9T?\ "K/^HS_Y*_\ V=>B44<S#DB>
M=_\ "K/^HS_Y*_\ V='_  JS_J,_^2O_ -G7HE%',PY(GG?_  JS_J,_^2O_
M -G1_P *L_ZC/_DK_P#9UZ)11S,.2)YW_P *L_ZC/_DK_P#9T?\ "K/^HS_Y
M*_\ V=>B44<S#DB>=_\ "K/^HS_Y*_\ V='_  JS_J,_^2O_ -G7HE%',PY(
MGG?_  JS_J,_^2O_ -G1_P *L_ZC/_DK_P#9UZ)11S,.2)YW_P *L_ZC/_DK
M_P#9T?\ "K/^HS_Y*_\ V=>B44<S#DB>=_\ "K/^HS_Y*_\ V='_  JS_J,_
M^2O_ -G7HE%',PY(GG?_  JS_J,_^2O_ -G1_P *L_ZC/_DK_P#9UZ)11S,.
M2)YW_P *L_ZC/_DK_P#9T?\ "K/^HS_Y*_\ V=>B44<S#DB>=_\ "K/^HS_Y
M*_\ V='_  JS_J,_^2O_ -G7HE%',PY(GG?_  JS_J,_^2O_ -G1_P *L_ZC
M/_DK_P#9UZ)11S,.2)YW_P *L_ZC/_DK_P#9T?\ "K/^HS_Y*_\ V=>B44<S
M#DB>=_\ "K/^HS_Y*_\ V='_  JS_J,_^2O_ -G7HE%',PY(GG?_  JS_J,_
M^2O_ -G1_P *L_ZC/_DK_P#9UZ)11S,.2)YW_P *L_ZC/_DK_P#9T?\ "K/^
MHS_Y*_\ V=>B44<S#DB>=_\ "K/^HS_Y*_\ V='_  JS_J,_^2O_ -G7HE%'
M,PY(GG?_  JS_J,_^2O_ -G1_P *L_ZC/_DK_P#9UZ)11S,.2)YW_P *L_ZC
M/_DK_P#9T?\ "K/^HS_Y*_\ V=>B44<S#DB>=_\ "K/^HS_Y*_\ V='_  JS
M_J,_^2O_ -G7HE%',PY(GG?_  JS_J,_^2O_ -G1_P *L_ZC/_DK_P#9UZ)1
M1S,.2)YW_P *L_ZC/_DK_P#9T?\ "K/^HS_Y*_\ V=>B44<S#DB>=_\ "K/^
MHS_Y*_\ V='_  JS_J,_^2O_ -G7HE%',PY(GG?_  JS_J,_^2O_ -G1_P *
ML_ZC/_DK_P#9UZ)11S,.2)YW_P *L_ZC/_DK_P#9T?\ "K/^HS_Y*_\ V=>B
M44<S#DB>=_\ "K/^HS_Y*_\ V='_  JS_J,_^2O_ -G7HE%',PY(GG?_  JS
M_J,_^2O_ -G1_P *L_ZC/_DK_P#9UZ)11S,.2)YW_P *L_ZC/_DK_P#9T?\
M"K/^HS_Y*_\ V=>B44<S#DB>=_\ "K/^HS_Y*_\ V='_  JS_J,_^2O_ -G7
MHE%',PY(GG?_  JS_J,_^2O_ -G1_P *L_ZC/_DK_P#9UZ)11S,.2)YW_P *
ML_ZC/_DK_P#9T?\ "K/^HS_Y*_\ V=>B44<S#DB>=_\ "K/^HS_Y*_\ V='_
M  JS_J,_^2O_ -G7HE%',PY(GG?_  JS_J,_^2O_ -G1_P *L_ZC/_DK_P#9
MUZ)11S,.2)YW_P *L_ZC/_DK_P#9T?\ "K/^HS_Y*_\ V=>B44<S#DB>=_\
M"K/^HS_Y*_\ V='_  JS_J,_^2O_ -G7HE%',PY(GG?_  JS_J,_^2O_ -G1
M_P *L_ZC/_DK_P#9UZ)11S,.2)YW_P *L_ZC/_DK_P#9T?\ "K/^HS_Y*_\
MV=>B44<S#DB>=_\ "K/^HS_Y*_\ V='_  JS_J,_^2O_ -G7HE%',PY(GG?_
M  JS_J,_^2O_ -G1_P *L_ZC/_DK_P#9UZ)11S,.2)YW_P *L_ZC/_DK_P#9
MT?\ "K/^HS_Y*_\ V=>B44<S#DB>=_\ "K/^HS_Y*_\ V='_  JS_J,_^2O_
M -G7HE%',PY(GG?_  JS_J,_^2O_ -G1_P *L_ZC/_DK_P#9UZ)11S,.2)YW
M_P *L_ZC/_DK_P#9T?\ "K/^HS_Y*_\ V=>B44<S#DB>=_\ "K/^HS_Y*_\
MV='_  JS_J,_^2O_ -G7HE%',PY(GG?_  JS_J,_^2O_ -G1_P *L_ZC/_DK
M_P#9UZ)11S,.2)YEJ'PW^PZ;=7G]K;_(A>79]FQNV@G&=W'2K/PL_P"8M_VQ
M_P#9Z[/Q!_R+>J?]>DO_ * :XSX6?\Q;_MC_ .ST[W1/*E)6/1****@U"BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KR#]H[_DGEA_V%8_\
MT5+7K]>0?M'?\D\L/^PK'_Z*EH 3]G'_ ))[J'_85D_]%15[!7C_ .SC_P D
M]U#_ +"LG_HJ*O8* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M ,[Q!_R+>J?]>DO_ * :XSX6?\Q;_MC_ .SUV?B#_D6]4_Z])?\ T UQGPL_
MYBW_ &Q_]GJE\+(?QH]$HHHJ2PHHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH SO$'_ "+>J?\ 7I+_
M .@&N,^%G_,6_P"V/_L]=GX@_P"1;U3_ *])?_0#7&?"S_F+?]L?_9ZI?"R'
M\:/1****DL**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O(/V
MCO\ DGEA_P!A6/\ ]%2UZ_7D'[1W_)/+#_L*Q_\ HJ6@!/V<?^2>ZA_V%9/_
M $5%7L%>/_LX_P#)/=0_["LG_HJ*O8* "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** ,[Q!_P BWJG_ %Z2_P#H!KC/A9_S%O\ MC_[/79^(/\
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M?Z7?RRJ<8.T*B8]^5/YT >L4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!G>(/^1;U3_KTE
M_P#0#7&?"S_F+?\ ;'_V>NS\0?\ (MZI_P!>DO\ Z :XSX6?\Q;_ +8_^SU2
M^%D/XT>B4445)84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M>0?M'?\ )/+#_L*Q_P#HJ6O7Z\@_:._Y)Y8?]A6/_P!%2T )^SC_ ,D]U#_L
M*R?^BHJ]@KQ_]G'_ ))[J'_85D_]%15[!0 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110!G>(/^1;U3_KTE_P#0#7&?"S_F+?\ ;'_V>NS\0?\
M(MZI_P!>DO\ Z :XSX6?\Q;_ +8_^SU2^%D/XT>B4445)84444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 5=3O!IVDWE\0"+:!YB#T^
M52?Z5XO^S58F/0]>O]IQ-<QP[NQV*3_[4_6O2/B7>"Q^&?B.8@'=8R0\_P"V
M-G_LU<O^S_8FT^&*3%2/M=Y-,">^,1_^R4 >I4C*&4JP!4C!!Z&EHH ^?+&
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ME<>-6_:K<[ 4TVUZ^O[C&3QV:7]!7:_&:^%C\*=;;< \RQPJ#WW2*#^F3^%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ KR#]H[_DGEA_V%8__ $5+7K]>0?M'?\D\L/\ L*Q_^BI: $_9Q_Y)
M[J'_ &%9/_145>P5X_\ LX_\D]U#_L*R?^BHJ]@H **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_$7P7;6WGOXITDIC.([M';_OE23^E &YJ6H6^E:9=:A=OLM[:)II&]%49/\
M*O'/V<K.4Z/X@U>2/:+R[2,'L2@+''/3]Y_^OM2\1>*=7^,NH#PMX0@FM]!5
MP;_4Y4(5E'(!'8=PO5B!T ->S>'-!L_#'AZRT6P#"VM(]BECDL<Y9C[EB2>W
M- 'D7Q4C^V?&SP):/@1B2)SZG]_DC_QW]:]QKQ_XW:+J-O+H?C;283-/HDP:
M=%&3Y88.K''\(((/L^>@-=7H'Q7\&Z]IL=U_;EE82D?O+>]F6%XVP,CYL!NO
M49!_ X +OQ(OO[.^&WB*XW%2;&2,$=07&P?JPKFO@+I[67PNMIF3:;RYEG^H
MSL!_\<KD_B5XV_X6+-;>!O!0;4!<RH]Y=(K>6JAA@$X^Z#AF;&!@8S7M&@:-
M!X>\/V&CVS,T-G L*NW5L#EC[DY/XT <I\9KQK/X3ZXR$!Y%CB&1G(:5 ?\
MQTFG?!RR^P_"G0TR"TD;S$C_ &Y&8?D"!^%<]^T1>?9_AW;VXZW.H1H1[!7;
M^8%>@>#;/^S_  1H5H?O0Z? C?4(,_KF@#C_ (\W?V;X5WL6?^/FXAB_)P__
M +)71_#>U6S^&OAR)<8;3XI>/5U#G_T*O//VD[O9X4T>SS_K;XRX_P!Q"/\
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M\6>!],UR[O\ 5DN+I7,BPRQJ@*NR\ QD_P /K72?\,X^#_\ H):Y_P!_X?\
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M>&-%LB^'FO&E"YZA$()Q_P #'YU[+I]JMCIMK:+C;!"D0QTPH _I0!8HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** ,[Q!_R+>J?]>DO_ * :XSX6?\Q;_MC_ .SU
MV?B#_D6]4_Z])?\ T UQGPL_YBW_ &Q_]GJE\+(?QH]$HHHJ2PHHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HK&\0^*-+\,0P2ZI*\:3,50I&6Y'TK!_X6UX1_
MY_)__ =_\* .WHKB/^%M>$?^?R?_ ,!W_P */^%M>$?^?R?_ ,!W_P * .WH
MKC(_BKX.=<MJCQG/1K:7/Z*:OV?C_P *WT@CAUNV#'IYI,7ZN!0!TE%(K!E#
M*05(R"#P12T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %>0?M'?\D\L/^PK'_P"BI:]?KR#]H[_DGEA_V%8__14M "?LX_\ )/=0
M_P"PK)_Z*BKV"O'_ -G'_DGNH?\ 85D_]%15[!0 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MPQ@,_P#O-U;\2:U*** *.I:+I6M1I'JNF6=]'&=R+=0+*%/J P.#5U5"J%4
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M!:W7VB/PY 7SG$DTLB?]\LQ7]*[&TLK73[9+:RMH;:!!A(H8PBJ/8#@5/10
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M 1SP0W,#P7$22PN-KQR*&5AZ$'K7&7GP?\ WT[33>'(%9B21!+)"O/\ LHP
M^F*[>B@#(T/POH7AJ)X]&TJUL@X =HHP&<#IN;J>_4]ZUZ** *$FB:3+JJ:K
M)I=D^HQC"7;6Z&91C'#XR.">_>K<\$-S \%Q$DL+C:\<BAE8>A!ZU)10!PS_
M  <\ /<K<'PY"'4Y 6>4+USRH;:?IBNPL-/L]+LX[.PM8;6VC&$BA0(H_ 59
MHH **** ,C7O"VA^*($AUK3(+Q(SE#(,,OT88(_.LC1OA=X*T"\%WI^@6Z7
M(*O,[S%2.Z^8S8/N*ZZB@ J.>"&Y@>"XB26%QM>.10RL/0@]:DHH XB\^#_@
M&^G::;PY K,22()9(5Y_V48 ?3%=!H?A?0O#43QZ-I5K9!P [11@,X'3<W4]
M^I[UKT4 %%%% &!KW@CPSXG<R:QHMI=3%=IF*[9<=AO7#?K69IOPG\"Z3<+/
M:^'+4R*<@W#/. ?I(S"NRHH *BN;:"\MI+:Z@CG@E4I)%*@974]00>"*EHH
MK6&GV6EVBVFGV=O:6R$E8;>)8T&3DX4 #K5FBB@"AJ.B:3K#0MJ>EV5ZT!)A
M-S;I*8R<9V[@<9P.GH*OT44 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!G>(/^
M1;U3_KTE_P#0#7&?"S_F+?\ ;'_V>NS\0?\ (MZI_P!>DO\ Z :XSX6?\Q;_
M +8_^SU2^%D/XT>B4445)84444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!S7C/PS
MI/B/38VUB[GM;:S+2F2)U0 8YR6!XKPRT\,)XF\2R6'A6.Y>R3&;B\8?*O\
M?;"C /88)_IZ3\:-;DM-&L])A=E-XY>7'=$QP?JQ!_X#^?2?#O08M"\'605,
M7%U&MS.Q7#%F&0#] 0/SH YO3O@II$4/_$QU&[N)B.?)VQJ/P()_6H]4^">F
MR0L=*U*Y@F )"W $B$]AP 1]>?I7J=% 'S-'X>M=#\4#2O&"7=K"PXFM77@$
M\/RIW+P>G(^HQ7H=_P#!/3I;<OI6K7*/MROV@+(K'MRH&![\_C6I\7]$CO\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M($DV(^!M9CPP(Z+CIW% 'H=%8OA"[O;_ ,&Z+>ZE)YE[<64,TS[0N69 QX
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M$49W'R-^=VTL/F91U'0T >L4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% &=X@_Y%O5/^O27_ - -<9\+/^8M_P!L?_9Z[/Q!_P BWJG_ %Z2
M_P#H!KC/A9_S%O\ MC_[/5+X60_C1Z)1114EA1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% 'B_QPMY!J6D7!7]TT+H#[@@G_P!"%>J^&[E+SPQI5Q&05DM(CP<X
M.T9'U!XK&^(GAE_$_A>2"V4&]MV\^ 'JQ .4S[@_GBO/OAAX]AT=!H&L.(K4
MR$P7#G A8]5;/12<G/8DYX/ ![;134=9$5T8,C %64Y!'J*266.&-I)9%C1>
M2S' 'XT <Q\2+A+?X?ZLTA^]&L8 ZDLX _G7+_!&)AH6J2D?(URJ@^X7)_F*
MYSXC>,3XMU*WT'1!)-;)+MW(?^/F0\# ]!V]<Y]*]6\*:+'X4\)VME-(BM#&
M9;F1F&T.?F8Y]!TSZ"@#G?C'/'%X)6-F^>6Z14'K@,3_ "J?X1Q-'X!@9A@2
M3RLON-V/Y@UY[\0_$9\:^);/2='#3P0.8HBO2:1B 6'L,  _4]#7M>@Z2FAZ
M#9:9&VX6\00M_>;J3^))- &C1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !7D'[1W_)/+#_ +"L?_HJ6O7Z\@_:._Y)Y8?]A6/_ -%2
MT )^SC_R3W4/^PK)_P"BHJ]@KQ_]G'_DGNH?]A63_P!%15[!0 4444 %%%%
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MH0OZD5SGP0M/LOPGTEB,-.TTI'UD8#] *D^-5[]B^%&L[3AYO*A7GKND7/\
MX[F@#&_9ZL%M?AQ)<[ 'N[Z23=CD@!4 SZ94_F:]8KB_A):BS^%?A^( C=;F
M7D?WW9__ &:NTH \,_:+9[IO"NDQD;KJXE/;(/[M1Q_P,]^U>Y*H50J@!0,
M#H*\+^)P.I_'KP5IO!2(03, ?^FS%A[<1C\Z]B\27G]G^%]7O2<?9[*:7_OE
M"?Z4 >0? $'4]=\8Z^Y9C<W*[7)/.YI';/'NM,_:%+7^I^$M$0G-Q/(6 /.6
M,:+_ #;M6I^SE9K#X#O[K^.XU!AU_A5$ _4M^E9GQ <ZE^T3X/L%^9;58)2,
MGAA([D\>RK_^J@#W&*)((4BB4+&BA54= !P!3Z** /"_AXAO_P!H?QE?#[EN
ML\60"/F$J(!^2M7NE>%?L^1_;M7\7:VY+&>=%1N<'<SNW7_@/O7NM !7@_QI
MV:O\4O!.@LOF*SHSH5RNV68*<]1C$9SQVKWBO#-5 U?]JC3H$4E=/MU\T@?=
MQ"T@/YNH_&@#W.O&/VC[R6+P=I=JCLL<]]N< XW;4; /J,G/X"O9Z\[^-/A2
MX\4^ )A91F2]T^47<<:IEI  0ZCO]UB<#J5 H [70[*#3= TZQM4V06]M''&
MN<X4* /K5^O/_A/X\L?&'A>WMO-1-6L85CN8,;20. ZC/*GCZ'TXSZ!0!D^*
M;B"T\):S<7./(CLIF?(SD!#D8[UYS^SM9M;_  \NKA@/])U"1E(/50B+_,-6
M%\;OB7:W6DS^%M N!<LY!U&XA^9(T# ;-P[EL ]NW?%=]\&K/[%\*-#0_>D2
M28GUW2,1^A% '"W)_M/]J^&*91LL( $!YS_HQ<?3#/G\*]UKP?XKPWG@GXIZ
M)\0+6W>:S.V*YP,@, 49?0%HVP/<$U[/HFNZ9XCTN+4M)O([JUD'#H?NG .U
MAU5AD9!Y% &C13)98X(FEED6.-1EG<X ^IKAM)^*^AZ[X[/AC2H[B\7RBWV^
M!=T.X<D'N%Z#=TR<>A(!6^.-]+9?"O4A"<&X>*!F]%+@G\P,?C7">!_"OQ8M
M_!VFMX=\2Z+9:7/%]HAADB4N _S?,3 Q)Y]3Z=!7K7Q!\-/XN\#:GHT) N)D
M#P$M@>8K!E!/H2,?C7#?!#QQ:W>@1^$M2;[+K&FEHDBF&PRQACP!@?,N=I7K
MP#SS@ 3_ (1[XY_]#GH?_?E?_D>D?PU\<9(VC?QEH95@01Y2\@_]N]>PUYKX
MF^+4&F^,M-\,:!8C6;^:=8[I8I,",'^$-TW#J2>  <]\ $_PC\!ZKX"T74+/
M5;JTFDN+@2H+5V95&T#G<J\_AV%>AT44 %>%_!EO[3^*/CC5YE43F5E&!]U7
ME8D#_OA?RKW2OG]+X_"+XVW\FI;UT#7]THF&2$W/N#'CG8Q8$=0K@\\9 /H"
MBHX)X;F!)[>5)87&Y)(V#*P]01UK+\2>)](\)Z5)J.L7D<$2@[$)&^5A_"B_
MQ'_]9P.: /)?BE!%J?QQ\#Z<44L/*EDR/O)YQ.#^"-W[_G[=/,EO;R3R'"1J
M78^P&37S/X"U:^\:_M!PZU?QM&RB6586R/*C$15%_#*GW.3WKWWQS>_V?X"U
M^Z!PT>GS[#G^(H0OZD4 >5?LY6QN(O$FM3#,UQ/''NY_VF;\RP[]A7NE>5?L
M^6IM_AF9=N/M%]++GGG 5/\ V2O5: /*?VA+@0?#18R1^_OXHQD>SM_[+7<>
M"+1K'P'X?M7SOCT^ -G^]L&?UKRW]HYY)[+PUID1^>ZNI"J\\D!5'3_?_6O:
M[:!+6UBMXL^7$@1<G)P!@4 >&_LZDW]YXLUB<*;FXFBW$ \;C(S8R>A)'Y5[
MO7S]X0OHOA-\6M8\/ZLQM-$U1M]I<2X6-0"3&2QX PS(2. 0,\#(]_1TEC62
M-E=& 964Y!!Z$&@!U>&:]''J'[4NBPPD%K>W5IMO\)6.1^<>Q7KZCVKU+Q?X
MTT;P7I3WNJ74:R%"8+8,/-G8=E7KUP">@SS7AWP=N+_Q'\;-5UC58V2\2WFE
ME5DV^6VY8PF,<$ D8X/% 'TE1110!YO\=;J2V^%6H)'@">6&)CSG;O#<?]\X
M^A-;7PNM8[/X8>'8H@ K6:RG QR^7/ZL:E^(WAMO%G@/5-*B7-RT?F6_./WB
M'<H_'&/QKCO@EXUMKWPU%X7U*<6^LZ8S0""<A'D0$[0 <$E?ND=1M&>M 'K5
M-=TBC:21E1%!9F8X  ZDFG5Y%\8OB1:Z=H-[X=T.=;O5[A'BNO(^?[)#C]X6
M(SAL<8ZC)/&!D ROV<;=3:>)M0C4K%/<Q1HN, !0[8_\B"G_ +1\S2Z3X=TR
M(,T]S=N\: ?>*J%Z_60?G6Q^SU9?9OAL\Y'-U?2R9QV 5/\ V4_K6%\7-VI_
M&3P-I"+N*O%*PQG"M-R??B,GKVH ]N2VA2S6UV*T*QB/8P!!7&,$=.E>'>)/
MA=XA\#ZI<>)OAS=S!<$RZ<HWN%SDJH.1(O\ LGYO3)KU;7?&^@>&M8TW2]5O
MEM[G4"1%N'RJ/[SGHH)X!/?V!(Z!6#*&4@J1D$=#0!PGPT^)=KX]L9H9H!9Z
MQ:?\?-KSC&<;U)[=B#R#^!/ ?M"FZU37O"N@0,B"X=]I<D*7=E12< \#G\S1
MX/>VO?VE]=N]!<'3O*D:=X.4D)5 ^3TP9<MGN16Y\?/#=Y>Z%I_B73@QN-%D
M+N%&2(V*_-C!SM90?H23TH :GAKXX11K''XPT%$4!558$  '0 ?9Z7_A'OCG
M_P!#GH?_ 'Y7_P"1Z[KP/XVTSQQH$-_92(MR% NK7=\T,F.1[KZ-W'OD#HIY
MX;:!Y[B5(H4&YY)&"JH]23TH \2UWX?_ !@\2Z3+I>K^*=#N;*4J7CV[,E3D
M<K #U'K7?P6=YX,^$$MO/)'/>:5I$I+(249DC8X!(SCC'3\*R_"OQ3'C'Q[>
MZ-H^F//HUM#N;4MVW# XS@_PL>%'7@GIG'?7UG%J&GW-E/N\FXB:)]IP=K @
MX_ T >4_LZ6J0_#Z\N  9)]0?<<<X"( /YG\:]>KP/X3^(?^%?>)-4\ >)91
M;,;DO:SN<1LY '!/0. I7/TZFO?* "O#- @BU']J;7;E8UQ9VQ<<=&$441/_
M (\?S_&O1/'GC_3O!>E.3(EQJ\HV6=@AW222'[I*@Y"YZG\!R17E/[.GGZEX
MD\3ZQ=2-+<LD?FR-U9I'9B3]2F: /=]8TBQU_2+G2]3MUGL[E-DD;=^X(/8@
M@$'L0*\'OO#7C3X*W<FJ^&[F35/#;.'N;=UW8&.3(H^[@#_6+CH,\<'V0>.?
M#Q\8R>%3?HNJHBMY;<*Q/.P-T+XP<>A]CC:OI[2UL+B>_DBCM(XV:9YB @3'
M.[/&,4 8W@OQCIWCCP_'JNG;DY\N>!_O0R  E3Z]00>X/X#Q#QS;:YXF_:(_
ML_1;BUMM1T^*+[)-=#<B;8Q-G&UN<N<<'G%;G[.T;&?Q7/:^:NDM<1+;(V=N
M<R'C/<*4S]1GI2?%6WN_!/Q0T3XAV\#SV1Q#=*O56"E".1@;HS@>ZGIQ0!J_
M\(]\<_\ H<]#_P"_*_\ R/1_PCWQS_Z'/0_^_*__ "/7J&BZWIWB'2H-3TJZ
MCN;2895T/0]P1V([@\BC6M;T[P]I4^IZK=1VUI",L[GJ>P [D]@.30!XIXB^
M%OQ4\7?9%U[Q-HMREJY>(KF,H3C)&R%<G@=37O=<+\./']UX^CU.[.C/9Z?!
M/LM9V?/FKCH1_>'4XX^8#MD]U0 56U"PM=4T^XL+Z!)[6X0QRQ/T93U%6:YV
MZ\<^'K+Q=%X8N;](M3EB\P*_"#T4MT#$9('M[C(!X_JO@KQ?\(KZ;7?!EW+?
MZ*7#W-FR[V"#^^H^\!S\ZX('H.:]8\ ^.M/\>Z +^T4PW,1"75LQR8GQZ]U/
M8_R((KIY98X(7FFD2.*-2SN[ *JCDDD]!7A7P,6.3Q[XTN-)RFAF4B!$7"%3
M*QB_),X]C0!C^.;;7/$W[1']GZ+<6MMJ.GQ1?9)KH;D3;&)LXVMSESC@\XKL
M/^$>^.?_ $.>A_\ ?E?_ )'K*^*MO=^"?BAHGQ#MX'GLCB&Z5>JL%*$<C W1
MG ]U/3BO9=%UO3O$.E0:GI5U'<VDPRKH>A[@CL1W!Y% 'E__  CWQS_Z'/0_
M^_*__(]8GB+X6_%3Q=]D77O$VBW*6KEXBN8RA.,D;(5R>!U->UZUK>G>'M*G
MU/5;J.VM(1EG<]3V '<GL!R:Y7X<>/[KQ]'J=V=&>ST^"?9:SL^?-7'0C^\.
MIQQ\P';) .ZKP75<_#K]H>WU0Q[=+\0?NV*@#!D*A^_:0*Y/H3U->]5Y1^T!
MX>_M;P"NIQ1[I]*G$N0N3Y3X5Q[#.QC[+^0!#\<_%UQ8Z5:^$=)#R:IK6$9(
MC\XB+;=H'?><K] PKN? GA*W\%>$[31X=C3 >9=2KG$LQ W-SVX 'L!7EGP<
MT+4/%WB6[^(GB+$K_P"ILP5X+@;2X!Z!0-H]R3U%>[T >&_M(74[V'AO28R!
M'=7,LI)/&Y JK_Z-:KMIX3^-EC9P6=KXNT&*W@C6**-85PBJ, #_ $?H *TO
MCQX4N/$/@E+ZR1I+G2I#.8QU:(C#X'J,*WT4UT/PY\?6'CGP]#,DR+J<*!;R
MV) 97'!8#^Z>H(XYQU% '(_\(]\<_P#H<]#_ ._*_P#R/5+6/ WQDU[2;C2]
M3\5Z'/97 "RQ[ NX @]5MP1R!T->UNZ11M)(RHB@LS,<  =237G.C_%:/Q+\
M1SX=T'3C?:9#$QGU%7P%8'[P[%/X?4DC' Y -+P[I=WX ^$AL]1N(Y;C2[.Y
MFDE@+,O!>0;<@'@$#MTKC?V;K%8O!^JW^P!Y[[RMV.65$4CGN,NWZUV_Q6O$
ML/A;XAF?HUKY/3/,C!!^K5G?!&R:R^%&DEU*O.TLQ!]#(P!_%0#^- 'H5>&_
M"$'5?BYXZUMBS%9'A5B3PKS$@=/2(?E7MEU<+:6<]R_W8HVD/T S7BW[-UMN
MT7Q!J3G,US=I&Y]=JENGUD- 'K?B:]_LWPIK%_@G[-8S38'4[4)_I7F7[.5F
M\/@._NG7;]HU!MAQ]Y51!G/UW#\#77?%F\^P_"SQ!,3C=;B+_OME3_V:L_X(
M6GV7X3Z2Q&&G::4CZR,!^@% 'H=>#:R1X#_:/L=1!$>GZ\H67#87,GR-D^TB
MJY[<]NWO->6?'OPZNL?#YM12-3<Z5*)E;^+RVPK@>W*L?]R@"7XU^,G\/>%5
MTC3Y'_M?5R885BR76/@.PQW.0H[Y;CI6Q\+?!$?@CP?!;2J/[2N@)[U_]L]$
M^BCCZY/>O*_A5I.H_$GQLWC/Q'^_MM,2.&'(^629%&T8.?NYWG_:8'U%?15
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M -<9\+/^8M_VQ_\ 9ZI?"R'\:/1****DL**** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH XCXG>%9O$GAY);.,R7UBQDB0=74CYE'OP"/ICO5#X8^-K?4M*@T34)U
MCU.U7RHQ)A?.0<#'JP'!'7C//-=UJFJ6>C:=-?W\ZPV\0RS'] !W)]*^<_%W
MB"T\4:T+K3-&6RE+$EXR3),>Q8#C/7H,\]30!],45\YV%_\ $:")19C7VC3Y
M0/(DD QVY!K47Q)\554*(-6P!CG2@3^?ET >\45X1_PDOQ6_Y]]5_P#!2O\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 9WB#_D6]4_Z])?_ $ UQGPL_P"8M_VQ_P#9
MZ[/Q!_R+>J?]>DO_ * :XSX6?\Q;_MC_ .SU2^%D/XT>B4445)84444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110!Y#\;M3E5=+TM<B)MUQ)S]XCY5_+YOSKL/A_X6
ML] \-V<PMT^WW,2S3S'!;+#.T'L #CCWKF_C3HDMUI5CJ\$9;[(S1SD#D(V,
M$^P(Q_P*NM\!Z]!K_A*RFC8>=!&L$Z=U=0!^1&"/K[4 =+1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MA[K5A)!'Y*V,C1+M&(V1"4(';! _*OF35_\ B2_'R:>\*HD/B(7+$G "&<2
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M^>M__P"# ?\ Q=']B>/O^>M__P"# ?\ Q='+YASOL>K45Y3_ &)X^_YZW_\
MX,!_\71_8GC[_GK?_P#@P'_Q='+YASOL>K45Y3_8GC[_ )ZW_P#X,!_\71_8
MGC[_ )ZW_P#X,!_\71R^8<[['JU%>4_V)X^_YZW_ /X,!_\ %T?V)X^_YZW_
M /X,!_\ %T<OF'.^QZM17E/]B>/O^>M__P"# ?\ Q=']B>/O^>M__P"# ?\
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M_P#X,!_\71R^8<[['JU%>4_V)X^_YZW_ /X,!_\ %T?V)X^_YZW_ /X,!_\
M%T<OF'.^QZM17E/]B>/O^>M__P"# ?\ Q=']B>/O^>M__P"# ?\ Q='+YASO
ML>K45Y3_ &)X^_YZW_\ X,!_\71_8GC[_GK?_P#@P'_Q='+YASOL>K45Y3_8
MGC[_ )ZW_P#X,!_\71_8GC[_ )ZW_P#X,!_\71R^8<[['JU%>4_V)X^_YZW_
M /X,!_\ %T?V)X^_YZW_ /X,!_\ %T<OF'.^QZM17E/]B>/O^>M__P"# ?\
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M_P#X,!_\71_8GC[_ )ZW_P#X,!_\71R^8<[['JU%>4_V)X^_YZW_ /X,!_\
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M^>M__P"# ?\ Q=']B>/O^>M__P"# ?\ Q='+YASOL>K45Y3_ &)X^_YZW_\
MX,!_\71_8GC[_GK?_P#@P'_Q='+YASOL>K45Y3_8GC[_ )ZW_P#X,!_\71_8
MGC[_ )ZW_P#X,!_\71R^8<[['JU%>4_V)X^_YZW_ /X,!_\ %T?V)X^_YZW_
M /X,!_\ %T<OF'.^QZM17E/]B>/O^>M__P"# ?\ Q=']B>/O^>M__P"# ?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_P#"OO"?_0#M?U_QK5TG0M,T..2/3+..U24AG"9Y(H T**** "BBB@ HHHH
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MTT![MU(>[DW#(Q\J\#]<G\?SI:(AZR2.PHHHJ2PHHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MAZZ!_9NIV\[G_EF&VOTS]PX;]* ->BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7D'[1W
M_)/+#_L*Q_\ HJ6O7Z\@_:._Y)Y8?]A6/_T5+0 G[./_ "3W4/\ L*R?^BHJ
M]@KQ_P#9Q_Y)[J'_ &%9/_145>P4 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %>;?$/X1P?$#6[;4I=8DLC!;"W$:P!\X9FSG</[WZ5Z
M310!X1_PS19_]#//_P" 8_\ BZ/^&:+/_H9Y_P#P#'_Q=>[T4 >$?\,T6?\
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MNC_AFBS_ .AGG_\  ,?_ !=>[T4 >$?\,T6?_0SS_P#@&/\ XNC_ (9HL_\
MH9Y__ ,?_%U[O10!XYX;^ 5KX=\2:?K">(9IVLYEE$1M0H;';.[BO8Z** "B
MBB@ HHHH **** "BBB@ HHHH *YWQQ?_ &#PK=8.'N,0+[[NO_CH:NBKS/XE
MW[3ZE9Z9%EO+7>P"\EFX _(?K^3BM29NR-7X::=Y&D3W[IA[B3:A(_@7_P"O
MG\J[>J6CV TS1[2RZF&(*Q'=NY_/-7:&[L<596"BBBD,**** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@(_CE(%_>^'T9L]5NRHQ_P!\&K]G\;].DD O=(N8$/5HI5DP?H0M<CK&AO\
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M7-?#'3]EK>ZBZ\R,(8R1V'+?F2/RJEHKD2UDD=_1114EA1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M* "BBB@ HHHH **** "O(/VCO^2>6'_85C_]%2UZ_7D'[1W_ "3RP_["L?\
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MA1114F@4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MB@ HHHH **** "BBB@ HHHH **** "BBB@ K@/C9_P DAUW_ +8?^CXZ[^N
M^-G_ "2'7?\ MA_Z/CH X+]F?_CW\2_[UM_*2O?*\#_9G_X]_$O^];?RDKWR
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KR362?$OQ"
M%HIS$)1;C&3\B_>_]F/'_P!>O3]6OETW2;N\8X\F)F'N<<#\\5Y]\-+%KC5+
MS4I"6\I-@)/)9CDGWX'ZU4=-2)ZM(],    & .@%+114EA1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MBHJ]@H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ K@/C9_R2'7?^V'_H^.N_K@/C9_R2'7?^V'_H^.
M@#@OV9_^/?Q+_O6W\I*]\KP/]F?_ (]_$O\ O6W\I*]\H **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH XCXE:D(-'@L%8;[F3<PSSM7GI]
M<?E^6GX%T\6'A:W8KB2Y)G;\?N_^.@5QGBR1M>\=QZ?&V41DMEP>G=C^!)_*
MO58XUBB2-!A$ 51Z 53T5C..LFQU%%%2:!1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 8OBJRTG4]"GT_5[J"VAN!A))75=KCD%<]Q7CGACQ7=?#K6I]*O7BO=,D
M?<3;2B0#MYB$''('(.#P.F*]-\?^#KGQA964%M=16YMY&<F0$YR,=JX+_A2&
MJ?\ 07L_^^&H ]3T[Q=X>U6(R6>L6C@=5>38P^JM@_I1J/BW0-*@:6ZU:T7
M)")*&=OHHY->6?\ "D-4_P"@O9_]\-1_PI#5/^@O9_\ ?#4 9_BGQ7<_$/6[
M?2K&2.RTQ'RK74@C!/=W.<#'.!S^)->K^'YO#/AS1+?3+36-/,<0^9S<IEV/
M)8\]S_AVKSC_ (4AJG_07L_^^&H_X4AJG_07L_\ OAJ /6_^$BT/_H,Z?_X%
M)_C5Z">&ZA6:WECEB?E7C8,I^A%>+?\ "D-4_P"@O9_]\-7K'AK2I-#\.6.F
M2R+(]M'L+J, \F@#5HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ KR#]H[_ ))Y8?\ 85C_ /14M>OUY!^T=_R3RP_["L?_ **EH 3]
MG'_DGNH?]A63_P!%15[!7C_[./\ R3W4/^PK)_Z*BKV"@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"N ^-G_)(==_[8?^CXZ[^N ^-G_)(==_[8?^CXZ ."_9G_X]_$O^];?RDKWR
MO _V9_\ CW\2_P"];?RDKWR@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "J]]=QV%C/=RD!(8RYR<=!TJQ7(?$743:>'1;(2'NY AP<?*.3_0?
MC32NQ-V5SG/A];2:EXGNM4FY,2L['_;<G^FZO4JY3X?:=]B\-+.PQ)=.9#SG
MY>@_EG\:ZNB6XH*R"BBBD4%%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %>0?M'?\D\L/\ L*Q_^BI:]?KR#]H[_DGEA_V%8_\ T5+0 G[./_)/
M=0_["LG_ **BKV"O'_V<?^2>ZA_V%9/_ $5%7L% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<!\;
M/^20Z[_VP_\ 1\==_7 ?&S_DD.N_]L/_ $?'0!P7[,__ ![^)?\ >MOY25[Y
M7@?[,_\ Q[^)?]ZV_E)7OE !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %>5>/;E]6\5V^F6[!O*"PJ,\>8YY_FH_"O49YH[:WDGE;;'&A=B>P
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 5Y!^T=_P D\L/^PK'_ .BI:]?KR#]H[_DGEA_V%8__ $5+0 G[./\
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M?$)[YA^[21[G![*.$Z^A*UZQ7"?#+3_*T^[U!AS,XC3GLO7]3^E=W52W)@M
MHHHJ2PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MYT:/%\TDI[?*/\_E5*\E\Z[D<'(S@?05W?P\)YR?X(^7_P!\SW^[1C_Y,_\
M@/\  @HHHKA/J K6\+_\C=HO_7_!_P"C%K)K6\+_ /(W:+_U_P '_HQ:J'Q(
MPQ7\"?H_R/IVBBBOI#\5"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M5?/5_P"++U9^QY7_ +C1_P $?R04445D=P4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%2V\7G7$<?9CS].].,7)I(SJU(TH2J2V2N_D:Z?Z'I6>C;<_B:PZUM8EPD<
M0[G<?Z5DUV8Z24U36T58^>X8I2EAYXN?Q59-_*^GZA1117$?2A6MX7_Y&[1?
M^O\ @_\ 1BUDUK>%_P#D;M%_Z_X/_1BU4/B1ABOX$_1_D?3M%%%?2'XJ%%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 45@^(/&6A^&E(U"]7SP,BWB^:4_\  >WX
MXKRO6?BQK^NR&QT"S:T$GRCRE,L[9XP...O89Z8- 'KFN>)M'\.P>9J=['"Q
M4E(LYD?Z*.3]>E>6:]\8]0O)6M?#EGY ;A9Y4WRGG^%>0/QS7+ZWX(U_3]#D
M\0ZY($>211Y<LADF8MW8]N/?/L*]*^#VF6(\*C41:Q?;6G=#.5R^!T /;J>E
M ''Z5\,_%'BFX%_KUU+:(_62[)DG8=L*3QZ88C'H:]=\->%=,\*6+VNFI+^\
M.Z225]S.>Q/8>G %;5% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110!\<V?\ R7BW_P"QF7_TJK[&(!&",@UG
M#0-&6Z%T-(L!<!_,$HMDW[\YW9QG.><UHT ?(WBSP_XB^%7C]=6M%E,$<YEL
M;QU+HZ'(V,3WVDJ03G'(Z@UI^*_CGK?BW0)-#MM*@L_M8$4[QNTCR _PJ,#&
M>G<\U]2211S1M'*BNC##*PR#]15.UT;2[&4RV>FV=O(>KPP*A_,"@#R[X%>
M+[PQIEUK6KP-;WM^JI%;OPT<0Y^8=B3CCL .Y(KSGXM^#M6\'>.I/%>G1/\
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MA_V%8_\ T5+0 G[./_)/=0_["LG_ **BKV"O'_V<?^2>ZA_V%9/_ $5%7L%
M!1110 4444 %%%% !1110!\\_$W_ )*%JG_;+_T4E<E76_$W_DH6J?\ ;+_T
M4E<E7SU?^++U9^QY7_N-'_!'\D%%%%9'<%%%% !1110 4444 %%%% !1110
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M(>E^+?!#VL<<MKJ FC=K>3Y@0,Y*L.#VZX/M77_"#_D1$_Z^9/Z4 =[1110
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M#_L*R?\ HJ*O8*\?_9Q_Y)[J'_85D_\ 145>P4 %%%% !1110 4444 %%%%
M'SS\3?\ DH6J?]LO_125R5=;\3?^2A:I_P!LO_125R5?/5_XLO5G['E?^XT?
M\$?R04445D=P4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MH@Q^-4:=(YDD9VZL<TVL:U3VE1S[GHY?A5A,+3H+[*7W]?Q"BBBLSL"BBB@
MK6\+_P#(W:+_ -?\'_HQ:R:UO"__ "-VB_\ 7_!_Z,6JA\2,,5_ GZ/\CZ=H
MHHKZ0_%0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0M4_[9?^BDKDJ^>K_P 67JS]CRO_ '&C_@C^2"BBBLCN"BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** -C2(PL,DQ_B./P%94TGFS/)_>)-;-Q_HFE[!UV[?Q/7^M8==V+_=PA1[
M*[^9\OD'^U8G$9@]I2Y8^B_I?<%%%%<)]0%%%% !1110 5K>%_\ D;M%_P"O
M^#_T8M9-:WA?_D;M%_Z_X/\ T8M5#XD88K^!/T?Y'T[1117TA^*A1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 5%<VT%Y;26US$DL,JE7C<9# ]C4M% 'BOBGX/W=M,UW
MX;?SX<Y%J[8D3C^%CPWZ'ZUSL/BGQYX8 MY9]1@0+D1WL&_Y1D<%P2!]..*^
MC** /GH_$[QKJ&(;6YPYXQ;VJLQS^!_2ET[P'XO\87HO-2\^%&'-S?EMVWGA
M5/./0<"OH2B@# \*^$-,\)6+06*L\TF#-<28WN?3CH/0?SZUOU7OKZVTVRFO
M+R416\*[I'()"C\*J:-XATKQ!'+)I5XMRD1"N55A@GIU H TZ*** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O(/VCO^2>6'_85
MC_\ 14M>OUY!^T=_R3RP_P"PK'_Z*EH 3]G'_DGNH?\ 85D_]%15[!7C_P"S
MC_R3W4/^PK)_Z*BKV"@ HHHH **** "BBB@ HHHH ^>?B;_R4+5/^V7_ **2
MN2KK?B;_ ,E"U3_ME_Z*2N2KYZO_ !9>K/V/*_\ <:/^"/Y(****R.X****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ JQ8Q>;>1KV!W'\*K@$G &36OI$!422LI!/RC(KHPM+VE6*Z'D9
M[C5A,!4G?WFK+U>GX;D>L2YDCB'\(W'\:S*FNI?.NI'[$\?2H:G$5/:592-<
MGPGU3 TZ+W2U]7J_Q"BBBL3T@HHHH **** "M;PO_P C=HO_ %_P?^C%K)K6
M\+_\C=HO_7_!_P"C%JH?$C#%?P)^C_(^G:***^D/Q4**** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BLW7]:M_#NB7.JW<<TD%OM+K"H+G+!> 2!W]>E&@
M:U;^(M$MM5M(YHX+C<4690'&&*\@$CMZ]* -*BBB@ HHHH ***Y?PKX\TOQA
M<W4&G07B&V4,[3HJ@@G QAB>WI0!U%%%% !1110 4444 %%%<O-X\TN#QFOA
M8P7C7Y95WJB^6"4#]2V>A]* .HHHKS[Q7\5K/PQXC.D'39;HQ!3/(L@39N 8
M!00=W!'<4 >@T5#:7,=[9P74))BFC61"1@E2,C^=34 %%%% !16)XI\4V/A'
M2X]0U".XDB>80JL"AFW$$]R!C"GO5[2-3AUG2+74K=)$AN8Q(BR@!@#TS@D?
MK0!=HK!\7^*;;PAHG]HW$#S[I5ACB0XW,03R>PPIJKX(\:0>--.GN([5K6:"
M0))$7W@9Y!!P,Y^@Z4 =11110 4444 %%%% !1110 4444 %%%<MX<\?:5XH
MUBZTVQM[Q9;9&=Y)50(0&"\$,2>OI0!U-%%% !1110 445F>(=;M_#N@W>K7
M*.\5NH)5.K$D*!^)(H TZ*XOP/\ $.W\9W%W;BQ>SG@ <*90X=,XSG P<]L=
M^M=I0 4444 %%%% !1110 4444 %%%<UXT\8VW@W2XKN:V>YDFD,<42MMR<$
MY)P<#I^?2@#I:*YWP9XMM_&.B'4(;=K>2.4Q2PLX;:P /!XR"".<#OZ5J:QK
M%EH.ES:CJ$OE6T(^8@9)).  .Y)H O45Y*GQTLC>['T.X%KG_6B=2^/]S&/_
M !ZNYUCQA8:3X1C\1F.:6VE2-H8PNUGWXQUZ<'/X4 =#17(^!O'=OXU@N]MF
MUG<6Q7?$9 X*MG!!P/0YXXX]:ZZ@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** .:^(/_(A:Q_UP
M_J*X_P""'_()U;_KNG_H)KL/B#_R(6L?]</ZBN/^"'_()U;_ *[I_P"@F@#U
M6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KR
M#]H[_DGEA_V%8_\ T5+7K]>0?M'?\D\L/^PK'_Z*EH 3]G'_ ))[J'_85D_]
M%15[!7C_ .SC_P D]U#_ +"LG_HJ*O8* "BBB@ HHHH **** "BBB@#YY^)O
M_)0M4_[9?^BDKDJZWXF_\E"U3_ME_P"BDKDJ^>K_ ,67JS]CRO\ W&C_ ((_
MD@HHHK([@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH *GM+9KJ;8#@#ECZ"H*U]& V2GOD"NC"TE5JJ,MCR<\
MQL\%@9UJ?Q*R7S=KE^&"*!=L: >I[FI",C!Z445]&HJ*LC\=J59U)N<VVWU>
MYBZA8B#][%_JR>1Z5GUT5\ UE,#TVYKG:\''T8TZGN[,_4^%LPJXS!OVSNXN
MU^ZMI?S"BBBN(^E"BBB@ HHHH *UO"__ "-VB_\ 7_!_Z,6LFM;PO_R-VB_]
M?\'_ *,6JA\2,,5_ GZ/\CZ=HHHKZ0_%0HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ K&\4V6KZCX?N+31+R.SO9<!9W9EVC/.",D$],X[ULUC>*KO6+#P[<W6
MA6T=S?1@%8G5FR,\[5');'0?_JH \RUKQ1KUIX2U'P_XRTV:*XEMR+>_5 R2
ML#D!BORYZ#(Z<9 ZTFC^*M?O?">F:!X-TZ=YHH5BN=0DC^2%CR0I/&>>I[=!
MWHUGPMKUYX3U/7_&>I3--%$TEK8))A(G)P"P'&>>@[=3VI-&\+^(+3PIIOB'
MP9J4D<TMN#<6#/N21@2"RAOES['IS@]J /3_  M9ZO8>'K6UUNZ2YOHQAI58
ML2.VXGDGMFMFL?PM=ZM?^';2ZUNV2VOI%R\2J5VC/&0>0<<X]Z\PU3QOXG\9
M^(I]'\&LT-I&#^^3"LZ@\N7/*@\8 P?SQ0![/17B-]I'Q.\(Q_VF-8FU"*(;
MI%2X>X55&<DI(.F.X'%>H>#O$,GB?PU;:I+:/:R295E/W6(X+)_LD^ON.<9(
M!>UZX^R>'=3N?^>-I+)^2$UYG\"[0+8ZS>$<O+'$/;:"3_Z$/RK,\:7/Q*AL
M-7EU#]UH3.R$8MSB)GVJ.,OW ]:RO!D'Q&AT'?X77&G32L^<V_+\*3^\Y_A
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MP;#@<=>,>O//I'@KQI9^,M,::-/(O(3B>W+9V^C ]U/^(^H!T]%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!6U&9[;3+N>,@
M/'"[J2.X4D5X'_PLWQO_ ,_/_DHG_P 37T+10!\]?\+-\;_\_/\ Y*)_\31_
MPLWQO_S\_P#DHG_Q-?0M% 'SU_PLWQO_ ,_/_DHG_P 31_PLWQO_ ,_/_DHG
M_P 37T+10!\X:EX\\7:OIT]A>3%[>==LBBU4$CZ@5WOP3BDBTG5?,C9,SIC<
M,9^6O4J* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ KR#]H[_DGEA_V%8__ $5+7K]>0?M'?\D\L/\ L*Q_^BI: $_9Q_Y)
M[J'_ &%9/_145>P5X_\ LX_\D]U#_L*R?^BHJ]@H **** "BBB@ HHHH ***
M* /GGXF_\E"U3_ME_P"BDKDJZWXF_P#)0M4_[9?^BDKDJ^>K_P 67JS]CRO_
M '&C_@C^2"BBBLCN"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ J[IMTMO,5<X1^_H:I45=*HZ<U..Z.7&X2G
MC*$J%7:7]?@=517/0WUQ H57RHZ!AFGOJ=RZXW!?]T5["S*E:[3N?GD^#<:J
MG+&47'OK^5B[JMR%B\A3\S?>QV%8U!))))R3U)HKRL17=:?,S[K*<MAEV&5"
M#N]V^["BBBL3TPHHHH **** "M;PO_R-VB_]?\'_ *,6LFM;PO\ \C=HO_7_
M  ?^C%JH?$C#%?P)^C_(^G:***^D/Q4**** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0P1+M2.-<*H]A4U%% '$?%'P[;ZSX0NKLQJ+NP0SQ2[<L%'++]"/Y9KE_@5
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MYKQ^UBD^*WQ)G>XDE.BVF2JJ2H$0.% ]"Y&3WZ^@KV76<VWAO4/(!!BLY/+
MR>B''O7F?P*2,6.M2#/FM)$&^@#8_F: /6+:V@L[:*VMHDB@B4(D:# 4#H *
MEHHH \\^+^@6NH>$9=5,8%[8%2D@'+(6"E2?3YMWU'N:J_!&T,7A2]NF!'G7
MA4>X55Y_,G\JV_BGJ$=A\/\ 4 Y&^YV01@GJ2P)_\=#'\*;\*;5K;X>:<6&&
MF:23&,<%R!^@!H P/CE<;?#NF6V[_679DQZ[4(_]FK6^%/ABWT;PK!J+Q#[?
MJ">:\A'(C/**/08P?J?85R?QM=[K7-#TY,%O+=E!]78+_P"RU[+!"MO;QPI]
MR-0B_0#% $E>6?'&TMV\/:;>D#[3'=>4IXR49&)_55_.O4Z\E^.EP%TS1[;)
MS)-)(!C^ZH'_ +-0!WO@N9Y_!.B2/RWV*($^N% _I7F7Q3/]H_$K0-,4 Y6%
M#]7E(Q^0'YUZOX<MOL7AC2K;&/*LXD(QW"#->3ZAG4_VA8(@0RP31[>,?<B#
MG]0: /:Z\2U#.K?M!P1%<K!/'M!'_/.+?G\P37MM>)>"&.K?&S5KT<K$US(I
M_P!G=L'?T84 >VUX_P#'6Z AT6T&"6:64^V H'\S^5>P5XI\4\ZC\3=!TU2"
M"D*8QCYGE(//TVT >NVBQZ3H4"SL(XK2V42,>=H1>3^E>,>$M.E^)GCJ\UO6
M!OL;4JWDD#!Y/EQ_0 $GUQSUS7J7CYY$\!:T8B0WV5@<>AX/Z9KE_@DL \'W
M;)M,QO6\SU^XF!].OYF@#TE$6-%1%"HH 55& !Z"G444 8_B/PQI?BFQ2TU.
M NJ.'CD0[70]\'T/0_\ UA5^PL+72[&&RLH5AMH1MCC7HHZU9JKJ;R1Z5>/$
M2)%@<H5Z@[3C% 'BLZR?%'XHR6K2L-(L=V-I_P"62D D=.7;'N >^VO;K6UM
M[&UCM;6%(8(EVI'&N%4>PKR/X$QQ$:[)@&8>0N<<A3OZ'W(_05[%0 5Q'Q1\
M.V^L^$+J[,:B[L$,\4NW+!1RR_0C^6:[>N>\=7D=CX$UN63[K6CQ#ZN-@_5A
M0!P/P*@ M];N"O+/"@/T#$_S%=]X[N/LW@36Y-V,VCQY_P!X;?ZUS?P7MO(\
M$238YGO'?..H 5?Z&K7Q?N3!\/KB//\ Q\3Q1_DV[_V6@#C/@OX8M[ZZNM>N
MXA(+5Q%;!AD"3&6;Z@%<?[Q/7%>W5QWPLM/LGP\TW(PTWF2M^+G'Z8KL: .=
M\>6EO>>!=:CN0-J6KRJ3CAT&Y?U KD_@?,[>%;^(_=2])7\47_"NF^(UP+;X
M?:S(20#"(^!G[S!?ZUA?!>V\CP1)-CF>\=\XZ@!5_H: #XO>)IM%\/1:=:2[
M+C42R,1U$0'S?3.0/SJ_\-_!MOX:T&&YFB1]3NT$LLA7F,$<1@]L=_4Y[8KB
M/BUMD^(VAQ7)_P!$\B+<&'RX,S;OT KVV@ HHHH YVU\$:!9^)9-?AL@MZ_(
MY^16/5E7H":K?$3Q,_A?PI-<VY O)V\BW/=6(/S?@ 3Z9Q75UX_\=VD$.A("
M?++3EAVR/+Q_,T :?PC\(16&DKXBO%$E]> F$L,F*/)&1[MUSZ8'K7IM>+VO
MP.%U:0W"^(\++&K@?8>Q&?\ GI4O_"A_^ID_\D?_ +90![$RAE*L 5(P01P1
M7B%C /!?QO6QM/ELKN0((U) V2+D#O\ =;'Y=JN_\*'_ .ID_P#)'_[95_1/
M@U_8VN6.I?V]YWV699?+^Q[=V#G&=YQ^5 'JE%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@#G_%'C+2?"26IU%W+W+[42-=Q"Y&YS
M[#/U/:MJTO+:_M([JTGCGMY!E)(V#*P]B*H>(?#NG>)]+>PU*(M&3E'0X>-O
M[RGL:\P/PE\4:3.X\/>)A# Y).9I;=L<=0@(/_UA^ !:^.&HV!TK3]-\Q6U
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M/A+XKTAG&A^)TB1CSMEEM\CU(3/-'_"HO$VJ7"MKGB5)$/WV\R2=O8#?CVH
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M=S%OZBE\<^##XTL+6U_M'[&L$ID)\GS-QQC^\,=ZWM)L!I>CV.GK(9!:V\<
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH *Y#Q%\2- \/!HS<"\NQQY%L0V#Q]YN@ZUUDL2
M31/%(H9'4JRGN#U%>5>)/@S;RA[CP]<&%^3]EG8LIZ\*W4=ASGZT <UJ/CSQ
M?XTNFL='AFMX6X\BR!+8_P!N3K_Z"/:MKP[\%Y'VS^(;ORQU%M:G+?\  G/
M[\ 'ZUR]EJWB[X:WC6TD#0PNVYH9T#12X[JP_P#93]:],\-_%C1-9*07X.FW
M38 \QLQL>.C=N3WQ]: */Q*T+2]#^';0:98PVR"XC!*+\S=>K'D_B:T/A!_R
M(B?]?,G]*;\7'63P 71@R-<1%64Y!'/(IWP@_P"1$3_KYD_I0!WM%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5Y!^T=
M_P D\L/^PK'_ .BI:]?KR#]H[_DGEA_V%8__ $5+0 G[./\ R3W4/^PK)_Z*
MBKV"O'_V<?\ DGNH?]A63_T5%7L% !1110 4444 %%%% !1110!\\_$W_DH6
MJ?\ ;+_T4E<E76_$W_DH6J?]LO\ T4E<E7SU?^++U9^QY7_N-'_!'\D%%%%9
M'<%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6MX7_P"1NT7_ *_X
M/_1BUDUK>%_^1NT7_K_@_P#1BU4/B1ABOX$_1_D?3M%%%?2'XJ%%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110!4U33;?6-+N=.NPQ@N(S&^TX(![CWKQ5/^$K
M^$FI3)'"U]H4DFXG;^[?WR,F-\#![<=P!7NM% 'F%O\ '#0FA!N=-U*.7NL8
M1Q^98?RK*U+XRW^I,+'PUHTOVF481Y!YDF>^V-0<\>Y^E>GR^&/#\[9ET/3)
M#UR]I&?Z5<M-.L=/0)96=O;*!@+#$J#'X"@#SCX>_#V_L-5;Q'XC<MJ+$M%$
MS!RI8<NY_O<GCM_+U"BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M<-)&TT5MN&9(CYMO)UZ@]._4 UZQ\/\ QE/XPTRXFN;2.WFMG5',;$JY(SD
M\CZ9- '7T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M*A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 UT61&1U#(P(96&01Z
M&J6G:+IND/<-I]G';?:&#RB,85B.^.@_"K]% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 5Y!^T=_R3RP_["L?_ **EKU^O
M(/VCO^2>6'_85C_]%2T )^SC_P D]U#_ +"LG_HJ*O8*\?\ V<?^2>ZA_P!A
M63_T5%7L% !1110 4444 %%%% !1110!\\_$W_DH6J?]LO\ T4E<E76_$W_D
MH6J?]LO_ $4E<E7SU?\ BR]6?L>5_P"XT?\ !'\D%%%%9'<%%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !6MX7_Y&[1?^O^#_ -&+636MX7_Y&[1?
M^O\ @_\ 1BU4/B1ABOX$_1_D?3M%%%?2'XJ%%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 45P_Q*\2ZOX7L=/O=+V[6G*S"2+<C#&0">HZ'H16?H'QBT;4 D.JPR
M:=.>"_WXCQUSU&3GC'IS0!Z1145O<P7=NEQ;31S0N,I)&P96'L1P:EH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH *UO"_\ R-VB_P#7_!_Z,6LFM;PO_P C=HO_ %_P
M?^C%JH?$C#%?P)^C_(^G:***^D/Q4**** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!
MKHLB,CJ&1@0RL,@CT-<-K_PH\/ZR9)K57TVZ;)W0#,9)/4H?Z$5W=% '@-UX
M1\;^!)FO-+EFD@&"TMD2X/?YXSS@8[@CWK?T'XT%2MOX@L,,#AKBVX[=T/?/
M7![]*]?KS_QY;> 0C?VZ88;X\@VG%QD\Y(7K]7&/SH Z_2=>TK78!-IE_!<K
MC)"-\R_[RGE?Q K1KY-CD>'5 VC27BMN'D,ORRY_X">N?2O0-(^+'B#1)A9:
M_9FZ$9P_FIY4Z\8P>QY'<9Z\T >Y45S>@^._#WB+8EG?+'<-C_1YQLD!].>&
M/^Z3724 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 5Y#X_^.FF>'9+S2M#A:]U:%WAD>12L,#J2#G/+D$=!Q[UZ]7'Z5\,
MO#&E^([S7Q9&ZU.ZN9+GSKEM_E,[%CL7H,$\'&?>@#Y:\+7=[?\ Q6T.[U&2
M22]EUJW>=I!ABYF7.1VY[=J^U:^.;/\ Y+Q;_P#8S+_Z55]C4 ?*7Q#\3:U\
M1_B*?#FG3-]A2[-G:6X;:C,#M,CXZ\@G/9?QS'XW^#NL^ =&AUZ+4X[N**11
M,\*F-[=B1M8<\C=QG@@D<>E'X+_OOC!H;2$N2T[$DY)/D2'/YU]$?%]5?X4:
M^&4,/)0X(SR)%(H SO@QXVN?&/A%TU&3S-1T^00RR'K(I&4<^YY!]=N>]>2?
M%WQ?JOC#QX_A/39G^PP7*V<=NC8$\^X*2WKA^!G@8SWK:_9HD<:IXAB'W&AA
M8_4,^/YFN-\' 3?'JU,GS$ZO*Q)]0SG/YT 7_%_P2UGP=X9.O+J<-W]G*M<1
MPQLK19(&Y3_$ 2.<#UKU7X%^.+SQ3X=NM-U2=I[_ $QE F<Y:2)L[2Q[L"I!
M/IC/.378?$90WPV\1A@"/[/F//\ NFO#/V;YI%\<:I /]4^FL[?421@?^A&@
M!WQP\;:IJ_BU_".G32)8VQ2.2*(X-S,P!P<=0-P 'J"?3&?XD^!&N>'?"4NM
MG4+:ZEMH_-NK6-"/+3^(JQ^]CJ>!P#^.1+^^_:#*R$N#XIVG)[?:L8_*OJCQ
M6JOX/UM'4,K6$X((R"/+:@#S'X">.[WQ!I]YH.JW#7%U8(LD$TC9=XB<$$]]
MIQSZ,/2N9^/WCR^.L_\ ")6%P\-I#$KWOEM@RNPR$/\ LA2#CONYZ"L']GN1
MT^);*O22PE5OIN0_S K-\=@3_':\27YE;4X5(/<?(,?E0!K:C\ ]>T[P?+K3
M7UO)>0P&>6P6,[E4#) ;NP';'7@$UU_[/_CN^U)KKPOJ=S)<&"+S[.21MS*@
M(#)D]0,J1Z<]L >WWJAK"Y5@"#$P(/?@U\F? V:2+XM:2B?=E2='^GE.W\U%
M '?_ !_\>:A875OX5TRX>W22$3WDD9PS@DA8\CD#@D^N1[YY6#X!>()_!RZT
ME[;_ &UX!<)IVP[BI&0N_H'QVQC/&>]8WQN9F^+NM@L2%%N%!/0>1&?ZFOKU
M%5$5%&%48 ]J /GO]G_QW>R:DWA+4+AIK=H3)8F1LF,KUC'^SMR0.VT^M?0M
M?'_PQ8V_QITH0J !>2H%48 4JX[>QKZPUW4_[$\/:GJOD^=]AM);GRMVW?L0
MMMS@XSC&<&@#0KR#]H[_ ))Y8?\ 85C_ /14M<]_PTU_U*/_ )4O_M5<A\1_
MC!_PL#P];Z3_ &%]@\F[6Y\W[7YN<(Z[<;%_OYSGM0!Z?^SC_P D]U#_ +"L
MG_HJ*O8*\?\ V<?^2>ZA_P!A63_T5%7L% !1110 4444 %%%% !1110!\\_$
MW_DH6J?]LO\ T4E<E76_$W_DH6J?]LO_ $4E<E7SU?\ BR]6?L>5_P"XT?\
M!'\D%%%%9'<%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6MX7_Y&
M[1?^O^#_ -&+636MX7_Y&[1?^O\ @_\ 1BU4/B1ABOX$_1_D?3M%%%?2'XJ%
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M+*JH?KM4'\B* ,[]G'09;/P[JFMS*RK?S+%#GND>[+#_ ($Q'_ :\M\1)/\
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M0 G[./\ R3W4/^PK)_Z*BKV"O'_V<?\ DGNH?]A63_T5%7L% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MK6\+_P#(W:+_ -?\'_HQ:R:UO"__ "-VB_\ 7_!_Z,6JA\2,,5_ GZ/\CZ=H
MHHKZ0_%0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M7L% !1110 4444 %%%% !1110!\\_$W_ )*%JG_;+_T4E<E76_$W_DH6J?\
M;+_T4E<E7SU?^++U9^QY7_N-'_!'\D%%%%9'<%%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !6MX7_ .1NT7_K_@_]&+636MX7_P"1NT7_ *_X/_1B
MU4/B1ABOX$_1_D?3M%%%?2'XJ%%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!X_\
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MZX_ =!R>?;?"_A^#PQH%OID!WE!NED_YZ2'[S?X>P% &Q1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5Y!^T=_P D\L/^PK'_
M .BI:]?KR#]H[_DGEA_V%8__ $5+0 G[./\ R3W4/^PK)_Z*BKV"O'_V<?\
MDGNH?]A63_T5%7L% !1110 4444 %%%% !1110!\\_$W_DH6J?\ ;+_T4E<E
M76_$W_DH6J?]LO\ T4E<E7SU?^++U9^QY7_N-'_!'\D%%%%9'<%%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !6MX7_P"1NT7_ *_X/_1BUDUK>%_^
M1NT7_K_@_P#1BU4/B1ABOX$_1_D?3M%%%?2'XJ%%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 5E:[X=TKQ)9BUU2U695R4;)5HR>ZD<C^1QS6K7.ZYXY\.^'I6@O
M]047 &?)B4N_XXX'XXH XF_^"%I),S:?K4T,>/ECGA$AS_O KQ^%-L?@?;JX
M:_UN61>Z00!#_P!]$G^5:LGQH\-(^U;;4Y!_>6%,?JXIG_"Z_#?_ #Y:K_WZ
MC_\ CE '9Z'X<TGPY:"WTRS2$8^9^KO[LQY/\O2M6O-_^%U^&_\ GRU7_OU'
M_P#'*ZCPKXOT_P 7V]Q/I\-S$L#A&%PJJ22,\88T =!1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 5Y!^T=_R3RP_["L?_HJ6
MO7Z\@_:._P"2>6'_ &%8_P#T5+0 G[./_)/=0_["LG_HJ*O8*\?_ &<?^2>Z
MA_V%9/\ T5%7L% !1110 4444 %%%% !1110!\\_$W_DH6J?]LO_ $4E<E76
M_$W_ )*%JG_;+_T4E<E7SU?^++U9^QY7_N-'_!'\D%%%%9'<%%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !6MX7_Y&[1?^O\ @_\ 1BUDUK>%_P#D
M;M%_Z_X/_1BU4/B1ABOX$_1_D?3M%%%?2'XJ%%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MJ%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110!R'Q&\,2>)_##1VREKVV;SH%!'SG&
M"O/J/U KF_A?XV@6Q7PYJ\HMKNV8I;F;Y=R_W#GHP/'/7\*V_B5>>)+33[$^
M&UO&E:5O.^RP>8<8XSP<"O&M1T7Q=JUZ]Y?:)JLMP^-\GV!U+?7"C)]Z /IV
MBOG6RG^)&GQB.VA\1*@Z*UO*X'T# XJW_;/Q1_YY:Y_X -_\10![_17@']L_
M%'_GEKG_ ( -_P#$5Z-\-;OQ)=V-^WB-;U9A(HB^U0F,[<'. 0,\T =S1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5Y!^T=_
MR3RP_P"PK'_Z*EKU^O(/VCO^2>6'_85C_P#14M "?LX_\D]U#_L*R?\ HJ*O
M8*\?_9Q_Y)[J'_85D_\ 145>P4 %%%% !1110 4444 %%%% 'SS\3?\ DH6J
M?]LO_125R5=;\3?^2A:I_P!LO_125R5?/5_XLO5G['E?^XT?\$?R04445D=P
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %:WA?\ Y&[1?^O^#_T8
MM9-:WA?_ )&[1?\ K_@_]&+50^)&&*_@3]'^1].T445](?BH4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M6LFM;PO_ ,C=HO\ U_P?^C%JH?$C#%?P)^C_ "/IVBBBOI#\5"BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M  ?^C%K)K6\+_P#(W:+_ -?\'_HQ:J'Q(PQ7\"?H_P CZ=HHHKZ0_%0HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M3-YUP0.C$#Y<]\=/3J>] '44444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %>0?M'?\D\L/^PK'_P"BI:]?KR#]H[_DGEA_V%8_
M_14M "?LX_\ )/=0_P"PK)_Z*BKV"O'_ -G'_DGNH?\ 85D_]%15[!0 4444
M %%%% !1110 4444 ?//Q-_Y*%JG_;+_ -%)7)5UOQ-_Y*%JG_;+_P!%)7)5
M\]7_ (LO5G['E?\ N-'_  1_)!11161W!1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 5K>%_^1NT7_K_@_P#1BUDUK>%_^1NT7_K_ (/_ $8M5#XD
M88K^!/T?Y'T[1117TA^*A1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!#=VXN[.>V+%1+&
MT9([9&*\P_X4AI__ $&;K_OTO^->JT4 >5?\*0T__H,W7_?I?\:/^%(:?_T&
M;K_OTO\ C7JM% 'E7_"D-/\ ^@S=?]^E_P :FA^"6C*1YVJ7[COLV+G\P:]/
MHH YWP]X(T+PPYET^T)N",&>9M[X] >WX8KHJ** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MLD\20:G9E4NHD^Z<_==>X!P>#T(-8GQ>^*\O@DPZ1HZ1OJ\\?FM)*NY8(R2
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 5Y!^T=_R3RP_["L?_HJ6O7Z\@_:._P"2
M>6'_ &%8_P#T5+0 G[./_)/=0_["LG_HJ*O8*\?_ &<?^2>ZA_V%9/\ T5%7
ML% !1110 4444 %%%% !1110!\\_$W_DH6J?]LO_ $4E<E76_$W_ )*%JG_;
M+_T4E<E7SU?^++U9^QY7_N-'_!'\D%%%%9'<%%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !6MX7_Y&[1?^O\ @_\ 1BUDUK>%_P#D;M%_Z_X/_1BU
M4/B1ABOX$_1_D?3M%%%?2'XJ%%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %>0?M'?\D\L/^PK'_P"BI:]?KR#]H[_DGEA_V%8__14M "?LX_\
M)/=0_P"PK)_Z*BKV"O'_ -G'_DGNH?\ 85D_]%15[!0 4444 %%%% !1110
M4444 ?//Q-_Y*%JG_;+_ -%)7)5UOQ-_Y*%JG_;+_P!%)7)5\]7_ (LO5G['
ME?\ N-'_  1_)!11161W!1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 5K>%_^1NT7_K_@_P#1BUDUK>%_^1NT7_K_ (/_ $8M5#XD88K^!/T?Y'T[
M1117TA^*A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !11533M3L=6M!=:==PW4
M&XIYD+AAN!P1QW% %NBO(/A_XN\4:Q\7?$VAZIJ33Z9IWV@0Q?9XDP5F54Y"
MAC\I/>O59-2L8=1AT^2[@2]G1GBMVD =U7J0O4XH M4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>0?M'?\ )/+#_L*Q
M_P#HJ6O7Z\@_:._Y)Y8?]A6/_P!%2T )^SC_ ,D]U#_L*R?^BHJ]@KQ_]G'_
M ))[J'_85D_]%15[!0 4444 %%%% !1110 4444 ?//Q-_Y*%JG_ &R_]%)7
M)5UOQ-_Y*%JG_;+_ -%)7)5\]7_BR]6?L>5_[C1_P1_)!11161W!1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 5K>%_\ D;M%_P"O^#_T8M9-:WA?
M_D;M%_Z_X/\ T8M5#XD88K^!/T?Y'T[1117TA^*A1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% $%Y;"]L;BU:22)9XVC,D3;77<,94]B,\5X5_PK;QO\,+Z35_!
MNJIJ-@,-<V4S",N@Y.Y2=IP ?F!##/ ZU[GJ'VS^SKG^SO)^V^4WD>>"4WX^
M7< 0<9]#7A&C^"_'OQ.OS>>.+^ZT_14D8?8A^Z:3#?=6,<  C[SY/ QGJ #E
M?#GQ$U1_&^NW?AK2%?6?$6Q+>.210L+X)<\X#'=TR0.Y]*]%\'?!_6H/%$'B
MWQ3XBG?5XY?.\NU;.3DY5G(^Z02"J@#!(!KD/#?@'PWXF^('C3PN(6@M[08L
MIHVRT#1GRSSGY@2>0>N.QKI_"&G?$_PAXZL?#EU=-J?A]\M]JE!DC6%1CAB=
MR-]T!<XSTR.: /;:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "O(/VCO^2>6'_85C_P#14M>OUY!^T=_R3RP_["L?_HJ6
M@!/V<?\ DGNH?]A63_T5%7L%>/\ [./_ "3W4/\ L*R?^BHJ]@H **** "BB
MB@ HHHH **** /GGXF_\E"U3_ME_Z*2N2KK?B;_R4+5/^V7_ **2N2KYZO\
MQ9>K/V/*_P#<:/\ @C^2"BBBLCN"BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ K6\+_\ (W:+_P!?\'_HQ:R:UO"__(W:+_U_P?\ HQ:J'Q(PQ7\"
M?H_R/IVBBBOI#\5"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#SSPC\+W
M\+>/M6\4'6_M9U$3!K<VNPIYDBR??WG."N.G->AT44 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MU?4]% 'RQ_PI#XB_WX/_  .H_P"%(?$7^_!_X'5]3T4 ?+'_  I#XB_WX/\
MP.H_X4A\1?[\'_@=7U/10!\L?\*0^(O]^#_P.KZ4\-V5QIOAC2K&[Q]IMK.*
M*7#;OG5 #SWY%:=% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5Y!^T=_R3RP_["L?_
M **EKU^O(/VCO^2>6'_85C_]%2T )^SC_P D]U#_ +"LG_HJ*O8*\?\ V<?^
M2>ZA_P!A63_T5%7L% !1110 4444 %%%% !1110!\\_$W_DH6J?]LO\ T4E<
ME76_$W_DH6J?]LO_ $4E<E7SU?\ BR]6?L>5_P"XT?\ !'\D%%%%9'<%%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !6MX7_Y&[1?^O^#_ -&+636M
MX7_Y&[1?^O\ @_\ 1BU4/B1ABOX$_1_D?3M%%%?2'XJ%%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110!\B?"S_ )+;I?\ U\S_ /HN2OKNOD3X
M6?\ );=+_P"OF?\ ]%R5]=T %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 445YA
M8_&[P_)XUU+P_J7^@PP7#06][*<1N5PI#_W/FW8)XP.<4 =[-XAT6WU1=+FU
MC3X]0<A5M'N4$I)Z (3GGMQ6E7AOB'3Q+^U#X>=2NVXM5N0RXY"1R]^_^KKI
M?&'QL\/>&-8BTNW_ .)C.)52Z>%_W=NNX!LD [F S\H[C!(/% 'IM%,BE2>%
M)8F#1NH96'0@\@T^@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M-+_,S]M/N>X_\-$_]2M_Y4/_ +51_P -$_\ 4K?^5#_[57AU%'^K>5_\^O\
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M %*W_E0_^U5X=16%#A;+Z<6IQ<GW;:^6C0W7F]CW'_AHG_J5O_*A_P#:J/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %>0?M'?\D\L/^PK'_P"BI:]?KR#]H[_DGEA_V%8__14M "?LX_\
M)/=0_P"PK)_Z*BKV"O'_ -G'_DGNH?\ 85D_]%15[!0 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** ,V;P]HMQJBZI-H^GR:@A#+=O;(901T(
M<C/';FM*BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** /L3P1_R(7A[_L&V_P#Z+6MZL'P1_P B%X>_[!MO_P"BUK>K\5Q7\>?J
M_P STH[(****P&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1145SO\ LLWEY\S8=N.N<<4 2T5\LO>?&W>V
M%\1XSQ^X/^%)]L^-W]WQ'_WX/^% 'U/17RQ]L^-W]WQ'_P!^#_A1]L^-W]WQ
M'_WX/^% 'U/17RQ]L^-W]WQ'_P!^#_A1]L^-W]WQ'_WX/^% 'U/17RQ]L^-W
M]WQ'_P!^#_A1]L^-W]WQ'_WX/^% 'U/17RQ]L^-W]WQ'_P!^#_A1]L^-W]WQ
M'_WX/^% 'U/17Q[JGCWXEZ)>?9-4UG5;.Y"AO*G&UL'H<$5L1ZC\:YHDEC_X
M2)T<!E80$@@]^E 'U517RQ]L^-W]WQ'_ -^#_A1]L^-W]WQ'_P!^#_A0!]3T
M5\L?;/C=_=\1_P#?@_X4?;/C=_=\1_\ ?@_X4 ?4]%?+'VSXW?W?$?\ WX/^
M%'VSXW?W?$?_ 'X/^% 'U/17RQ]L^-W]WQ'_ -^#_A1]L^-W]WQ'_P!^#_A0
M!]3T5\L?;/C=_=\1_P#?@_X5['\()?%LOAZ^/B\7PO!=D1?;$VMY>Q>G'3.:
M /1**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M /HM:WJ_%<5_'GZO\STH[(****P&%%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% 'RG^T!_R4M_^O2+^1KZ=T/_ ) &G_\ 7M'_ .@BOF+]H#_DI;_]
M>D7\C7T[H?\ R -/_P"O:/\ ]!% %^BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ K6\+_\C=HO_7_!_P"C%K)K6\+_ /(W:+_U_P '
M_HQ:J'Q(PQ7\"?H_R/IVBBBOI#\5"BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** /*_C[_R(=E_V$H__ $7+7SC7T=\??^1#LO\ L)1_^BY:
M^<:_3>%?^1<O5G%7^,****^D,0HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** /L3P1_R(7A[_ +!MO_Z+6MZL'P1_R(7A[_L&V_\ Z+6MZOQ7
M%?QY^K_,]*.R"BBBL!A1110 4444 %%%% !1110 4444 %%%% !1110 4444
M 9^O?\B[J?\ UZ2_^@&O :]^U[_D7=3_ .O27_T UX#7S^<_''T/E\__ (D/
M1A1117C'@!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &%J
MOA2QUB]-U<2W"OM"XC90./J#6U%&(HDC7)"@ 9I]%:2JSG%1D]%L:SK5)Q4)
M.Z6P4445F9!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'H
MOPJ_UNJ_[L7_ +/7I->;?"K_ %NJ_P"[%_[/7I-?599_NL?G^;/M<H_W.'S_
M #84445WGI!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M U[]KW_(NZG_ ->DO_H!KP&OG\Y^./H?+Y__ !(>C"BBBO&/ "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH ]%^%7^MU7_=B_P#9Z])KS;X5
M?ZW5?]V+_P!GKTFOJLL_W6/S_-GVN4?[G#Y_FPHHHKO/2"BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MW_DH6J?]LO\ T4E<E76_$W_DH6J?]LO_ $4E<E7SU?\ BR]6?L>5_P"XT?\
M!'\D%%%%9'<%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6MX7_Y&
M[1?^O^#_ -&+636MX7_Y&[1?^O\ @_\ 1BU4/B1ABOX$_1_D?3M%%%?2'XJ%
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 >5_'W_D0[+_L)
M1_\ HN6OG&OH[X^_\B'9?]A*/_T7+7SC7Z;PK_R+EZLXJ_QA1117TAB%%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110!]B>"/^1"\/?]@VW_\
M1:UO5@^"/^1"\/?]@VW_ /1:UO5^*XK^//U?YGI1V04445@,**** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@#/U[_D7=3_ .O27_T UX#7OVO?\B[J
M?_7I+_Z :\!KY_.?CCZ'R^?_ ,2'HPHHHKQCP HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** /1?A5_K=5_W8O_9Z])KS;X5?ZW5?]V+_ -GK
MTFOJLL_W6/S_ #9]KE'^YP^?YL****[ST@HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBOG?Q5\>O%.A^+-7TJVL-'>"SNY8(VEAE+%58@$D2
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MQSD8KQ_X%?#?4=%NYO$VMVLEK*\1BM+>48<!L;G8=5Z8 //)XZ5[I0!\P?\
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M7/\ P>K_ /'J^GZ* /F#_A#?CG_S]:Y_X/5_^/4?\(;\<_\ GZUS_P 'J_\
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M^GZ* /E74/AU\8]6@6#4H]3O(5;>([G6(Y%#8(SAI2,X)Y]ZS?\ A3/Q)_Z
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M !RC_A3/Q)_Z ;_^!\'_ ,<KZ\HH^M5_YW][#E78^0_^%,_$G_H!O_X'P?\
MQRC_ (4S\2?^@&__ ('P?_'*^O**/K5?^=_>PY5V/D/_ (4S\2?^@&__ ('P
M?_'*/^%,_$G_ * ;_P#@?!_\<KZ\HH^M5_YW][#E78^0_P#A3/Q)_P"@&_\
MX'P?_'*/^%,_$G_H!O\ ^!\'_P <KZ\HH^M5_P"=_>PY5V/A31=*U;Q#K$&D
MZ4CW%]/N$<7FA-VU2QY8@#@'O77_ /"F?B3_ - -_P#P/@_^.5]267A/PWIM
MXEY8>']*M;J/.R:"RC1UR"#A@,C@D?C6Q1]:K_SO[V'*NQ\A_P#"F?B3_P!
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M1_PAOQS_ .?K7/\ P>K_ /'J^GZ* /F#_A#?CG_S]:Y_X/5_^/4?\(;\<_\
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MQO?_  :1?_'*^L:*/90_E7W![&G_ "K[CY._X59\6/\ GQO?_!I%_P#'*/\
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M?CG_ ,_6N?\ @]7_ ./5]/T4 ?,'_"&_'/\ Y^M<_P#!ZO\ \>H_X0WXY_\
M/UKG_@]7_P"/5]/T4 ?,'_"&_'/_ )^M<_\ !ZO_ ,>H_P"$-^.?_/UKG_@]
M7_X]7T_10!\P?\(;\<_^?K7/_!ZO_P >H_X0WXY_\_6N?^#U?_CU?3]% 'S!
M_P (;\<_^?K7/_!ZO_QZC_A#?CG_ ,_6N?\ @]7_ ./5]/T4 ?,'_"&_'/\
MY^M<_P#!ZO\ \>H_X0WXY_\ /UKG_@]7_P"/5]/T4 ?,'_"&_'/_ )^M<_\
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MO?\ D[;_ /QROK^B@#Y _P"%)?$/_H7O_)VW_P#CE'_"DOB'_P!"]_Y.V_\
M\<KZ_HH ^1[/X/\ Q.TZ[CN['2)K6YC.4F@U&!'7C'#"3(X)K9_X0WXY_P#/
MUKG_ (/5_P#CU?3]% 'S!_PAOQS_ .?K7/\ P>K_ /'J/^$-^.?_ #]:Y_X/
M5_\ CU?3]% 'S!_PAOQS_P"?K7/_  >K_P#'J/\ A#?CG_S]:Y_X/5_^/5]/
MT4 ?,'_"&_'/_GZUS_P>K_\ 'J/^$-^.?_/UKG_@]7_X]7T_10!\P?\ "&_'
M/_GZUS_P>K_\>H_X0WXY_P#/UKG_ (/5_P#CU?3]% 'S!_PAOQS_ .?K7/\
MP>K_ /'J]+^$&B^/=)NM6;QG+?O'(D0MOM6H"Y (+;L8=L=1Z5ZI10 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 <AKGPO\
M!OB35YM5U;1_M%[,%$DOVF9,[5"CA7 Z =JZY5"J%'0# I:* "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M8B^\%#W#8'?MC\Z .OHHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MH[C*K<3K&6'J,FK-M=6][;I<6L\4\#\I)$X96[<$<&@"6BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M%>*2/XA7[29VR)$T?^[Y:C^8-6[#X1ZWJ=A!>VFI:1+;S('1UFD.1_WQU[4
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MCE((F=@NR09P!TY'YU#\']-O],T+4([^RN;1VN=RK/$T9(VCD BO1:* .?\
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M^(/B/_A&_"EQ/#(%O)_W-OS@ACU8?[HR?KBO.O@UX=^V:K/KDZ Q6G[J'/\
MSU(Y/X*?_'A0![!HNE0Z)HMIIEN28[:,(&/5CW8_4Y/XU?HHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHK-U_6[;P[HMQJMVDKP0;=RP@%CN8*, D#J1WH TJ*Y/PQ
M\1-%\5ZA)8V274-PL?F!;E%7>!UVX8\C/3_ UUE !17$Z_\ %#1/#NM7&E7=
MKJ#SP;=S0QH5.Y0PP2X/0CM79Q2":%)5!"NH89ZX- #Z*** "BBB@ HHHH *
M*** "BBN;\5^-=-\'_9/[0@NY?M6_9]G16QMVYSEA_>% '245YP/C5X;) -G
MJHSW,4?'_C]=1X>\9:'XGWKIUV#,G6"0;),>H!ZCW% &_1110 4444 %%%%
M!1110 4444 %%%<?XZ\=?\(7]@_XEWVS[7YG_+?R]FS;_LG.=WZ4 =A16'X2
M\1?\)3X?BU7[+]E\QV7RO,WXVG'7 _E6Y0 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MWZUG?#F#PKH6G:O?V&M2:B\$:O=W!M9(Q%'\Q&$(R>C$XST[50\2>%/^$/\
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MMI8P-Y0D="Y)ZX5<@8YYY'7O67XL\+7G@_6$L[B990\8EBFC! 89(_ @C^5
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MBR=SR2JY''8*3G\Z />K.\MM0LXKNSG2>WE7<DB'(85\WWW_ "52Y_[#;?\
MH\U] >&_#MEX7T=-.L=Y0,7>1S\TCGJ3^0'T KR6[^'WBB7Q_/J::9FS;5&N
M!)]HBYC,N[.-V>G;&: .Z^+7_)/[O_KK%_Z&*Y?X&?\ ,>_[=_\ VI7:_$/1
M[_7?!]Q8:;!Y]R\D;*F]5R P)Y8@5@_"CPMK/AK^U_[7L_LWVCR?*_>H^[;O
MS]TG'WAU]: *?QH\/FXTZUUZ%<M;$03XQ_JV/RG\&./^!5Y7J'B"^U72-+TJ
M9BT-@K)$!_%N/'3T& /_ *]?3NJ:=!JVEW.GW*YAN(S&WX]Z\=\'?"_6K3Q;
M;7&LVB1V-HQEWB5'$K+]T  DXS@\@<#L: /3_!N@#PWX7L]/95$X7?.5[R-R
MWUQTSZ 5XK\6;.6W\?W<SJ0ES'%)&<=0$"']5-?1%<WXQ\'67B_31#,WDW46
M6@N% )4XZ'U4\9'M0!Y?H7PLTWQ#I\5W8>+(Y-R@O&+0;XSW##S,@BG7'PLT
M:TOX["X\;VD5U(<+$]NH;/3'^LX.>F>M9=[\)?%EM.R6]I#=Q[B!)'.BY'8X
M8CK5_0O@YK5W= ZP\=A;#[P5Q)(WL,9 ^I/X&@#T[P1X./@VQNK7^T/MBSR"
M0'R?+V\8_O'-=35;3["WTS3[>QM4*00((XU))( ]S5F@#,UOQ!I?AVS^U:G=
MI"ASL4\M(1V4=3_]>H5.C^-/#2L56YT^\CR5/53Z<=&!_(BL;X@>!U\76$<E
MNZQ:C;9\IWSM=>Z'TYYS_C7CB^'/'&C226EOI^L0"08D%IO*,#QR4RI_.@"I
MY;>&_'8CL;@R_8KX+%)&<EE#]#CJ2."/J*]P^*7_ "3C5O\ MC_Z.2N#\ _#
M'47U6#5-<M_LUK PD2WD +RL.F5[#/KR?3G->D>/=+O=:\%:AI^GP^==3>7L
MCW!<XD5CR2!T!H \\^!W_(0UC_KE'_-J]GKYP_X5;XR_Z W_ )-0_P#Q==A\
M-?!/B+P_XJ-[JFG^1;_9W3?YT;<DC PK$]J ./\ BE_R4?5O^V/_ *)2OH>Q
M_P"0?;?]<E_D*\<\>^ O$VM>-=0U#3]-\ZUF\O9)Y\:YQ&JG@L#U!KF_^%6^
M,O\ H#?^34/_ ,70!]'T5YO\*/"VL^&O[7_M>S^S?:/)\K]ZC[MN_/W2<?>'
M7UKTB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M #:O9Z\8^!W_ "$-8_ZY1_S:O9Z "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M]/MAR[F19&//0!2>?K0!B>"I?/\ B)I<VT+YEWNVCH,Y.*[GXY_\P'_MX_\
M:=9?A7X=^)]*\8Z?>W.F%+2"X#-(;B(X7GG ;/Z5U?Q7\+:SXE_LC^R+/[3]
MG\[S?WJ)MW;,?>(S]T]/2@#1^$O_ "3^T_ZZR_\ H9KMZY7X>:/?Z%X/M[#4
MH/(N4DD9DWJV 6)'*DBNJH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M\A#6/^N4?\VKV>O,OA7X3UOPW>:E)JUE]G6:-%C/FH^2"<_=)]:]-H ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH K
MW\#76G75NA >6)T4MT!((YKQ#_A2GB3_ )_=*_[^R?\ QNO=Z* /&O#WPEU[
M2?$6G:A/=Z:T-M<)*ZQR2%B <G&4'-=#\1? 6J>+M1LKBPN+.-((BC"X=E))
M.>,*:]$HH Q?".CW&@>%K'2[IXGGMU8.T1)4Y8GC(![^E)XL\.0^*?#\^FRD
M+(?G@D/_ "SD&<']2#[$UMT4 >4^"/AEK7AKQ3;:I>75A)!$KAEAD<MRI ZH
M!W]:]6HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
3 HHHH **** "BBB@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>img268224062_13.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img268224062_13.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 4,#YP# 2(  A$! Q$!_\0
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% &MX7_Y&W1O^OZ#_ -&+7TM7
MS3X7_P"1MT;_ *_H/_1BU]+5Y^-^)')B-T%%%%<1SA1110!XI\8/^1MM?^O%
M/_1DE>?5Z#\8/^1MM?\ KQ3_ -&25Y]7L4/X:.^E\""BBBM30**** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110!K>%_\ D;=&_P"OZ#_T8M?2U?-/
MA?\ Y&W1O^OZ#_T8M?2U>?C?B1R8C=!1117$<X4444 >*?&#_D;;7_KQ3_T9
M)7GU>@_&#_D;;7_KQ3_T9)7GU>Q0_AH[Z7P(****U- HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MK%UX*?)U,W5BI<IY31116QH%%%% !1110 4444 %%%% !1110 4444 %%%%
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MXGT4^'O$5WINYGCB8&-V'+(0"/QP<'W!K(K1--71:=U<****8PHHHH ****
M"BO0?#7PQ_X2'P_:ZK_:_P!G\_?^Z^S;]NURO7>,],]*YWQ=X:_X176$L/M?
MVK="LN_R]F,DC&,GTK-582ERIZD*<6[(P****T+"BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HKMO!_P^_X2S29;_P#M3[+Y<YAV
M?9]^<*ISG</[WZ4GB[X=7/AC3DOX[T7MONVRGRO+,>>AQDY!/'Y5G[:'-R7U
M(]I&_+?4XJBBK>EV7]I:M96'F>7]IG2'?MSMW,!G'?K6C=M2BI17JW_"E_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MX^7Q1!#8V,$L%DC^8YE(W2-C R!G &3W.?PKK?@[_P @#4/^OK_V45#\9?\
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M =2216=7T_9ZQI>H2&.RU*SN7')6&=7(_ &N<\7^ K#Q%;23VT<=MJ8Y28#
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M_M6_ZYQ_S:LJ-2,82E&.WF13G%1;2/4=(_Y MC_U[Q_^@BO _'__ "/6J_\
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M13@D_P"R05^G)^O#R2O9?<<W*[V/-O'_ (KT?Q0UN]C9SI<P,5^T2!5WQ^F
M2>O(STR?6N(KT+XI^([35-2BTZR6"5+7YI+E0&)<C[H;T QGW^E>>UZ-%6@M
M+'73^%!1116IH%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MQ9\2W-O+#H5I(T221>;<,K8+@D@)]."2.^17DU>D?%_3)XM;M-3V9MIH1#N
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M\PH/XUQ7QAO8IM=L;-.7@@+.?3<>!^2Y_&N*CI7:CMJ<U/2J['KUG_QXV_\
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M>'M/L92#+!;HCXZ;@.<?C3QJ5D^H\0EH>&_$7_D?=4_WD_\ 1:UR]=1\1?\
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M=JPJ[::2@DMCI@ERJQ]%>!]=D\0^%[:[G96N4)AF([LO<^A((/XUY_\ &/\
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M#YY\;?\ (ZZO_P!?#5[QX7_Y%+1O^O&#_P!%K7@_C;_D==7_ .OAJ]X\+_\
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M?X3W[X9?\B%8?[TO_HQJX+XP?\C;:_\ 7BG_ *,DKT#X;121> ].$B,A;S&
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MXZS/B[=3V6HZ#=6TK13Q>:Z.O4$%*T_@_P#\BE=?]?S_ /HN.L;XS_Z_1O\
M=F_FE>?'_>?Z['(OXQWWA7Q##XET*&^CPLOW)X\\HXZ_@>H]C7#^*O"O]F^/
M=$UFSAQ:76H0B<+_  2F0'/T;^8/J*X[P)XG?PUKZ-(W^@W)$=R#V'9_^ D_
MD37O[I!=PIN"2Q$K(IZ@D$,I'X@$5,TZ%339BDG2EIL2U\IU]65\IUI@OM?(
MK#]3Z?T?3TTK1K.PC^[;PK'GU(')_$Y-<'XO\%^*O%.J-(U]IR64;$6T)DD&
MU?4C9]X]_P J]$MITNK2&XC9625%=64Y!!&017G6J_%>72=6N]/F\/MOMY6C
MRUUMW 'AL;.A&"/K7/1]HY-P6IG3YN:\=SGT^$7B.*19([[3D=2&5EFD!!'0
M@[*]6\/PZO;:1%!K<UO->1G;YL+$AU[$Y Y]?IGO7GO_  NC_J ?^3G_ -A1
M_P +H_Z@'_DY_P#85M4A7J*TE^1<HU9;HQ_BUIJVGBB*]10%O(0S<]77Y3^F
MVNN^#_\ R*5U_P!?S_\ HN.O//&?C+_A+WLV^P?9/LP<?Z[S-V['^R,=*]#^
M#_\ R*5U_P!?S_\ HN.KJJ2PZ4MRIIJE9C?BGXFNM(L;;3K&0Q2W89I)4;#*
M@P,#TR3U]O>O%:]7^,6FS,-.U-%)B0-#)@?=)Y7\^:\HK7"I*FK%T4N30]5^
M$WB2XDN)="N92\2QF2VW=5P>5!].<X]C73?$[3EOO!5S+MS):.DR?GM/Z,?R
MKAOA'ITT_B6:_P#+/V>W@93)VWL1@?EN_P XKT#XCW0M? NH\C=+LC4'OEQG
M],US54EB%R^1E/2JK'GWP?\ ^1MNO^O%_P#T9'7J7BS5VT+PQ?:@F?-CCVQ\
M9P[$*I^@)!_"O+?@_P#\C;=?]>+_ /HR.N]^)O\ R(5__O1?^C%HKI.ND_(*
MBO52/ Y)'FE>65V>1V+,[')8GJ2>YKZ ^'5_-J'@JRDN)3++&7B+$Y.%8XS^
M&!7S[7NOPI_Y$I?^OB3^E;XQ?NS2NO=.3^,:J-<TYMHW&V()QR0&/^)KT?P;
M_P B9I'_ %ZI_*O.?C'_ ,AK3?\ KW;_ -"KT;P;_P B9I'_ %ZI_*N>K_ B
M93_AQ/+?BW?2S^*HK0L?)MK==J]@S<D_C\H_"N6\+_\ (VZ-_P!?T'_HQ:V_
MB<CKX\O2[95TB*#/0; ,?F"?QK$\+_\ (VZ-_P!?T'_HQ:[*:M17H=$?X?R/
MI2;_ %$G^Z?Y5\K5]4S?ZB3_ '3_ "KY6KGP7VC+#]3Z@TC_ ) MC_U[Q_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 :WA?_ )&W1O\
MK^@_]&+7TM7S3X7_ .1MT;_K^@_]&+7TM7GXWXD<F(W04445Q'.%%%% 'BGQ
M@_Y&VU_Z\4_]&25Y]7H/Q@_Y&VU_Z\4_]&25Y]7L4/X:.^E\""BBBM30****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M $(UX+6_I?C3Q!HMBEEI^H>3;H253R8VP2<GDJ36E>FZD;(NK!SC9'5_&/\
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MX1/HHX%9E=%"DZ:U=S6G!Q6K/I?PO_R*6C?]>,'_ *+6O$/B+_R/NJ?[R?\
MHM:;:_$#Q196D-K;ZGLAAC6.-?L\1VJ!@#)7/05AZCJ-WJU_+?7TOFW,I!=]
MH7.  .  .@%11H2A-R9-.FXR;9J^"?\ D==(_P"OA:^@=7_Y M]_U[R?^@FO
MF>QO;C3KV&\M)/+N(6W1OM!P?H>*Z";XB>*IX9(9-5W1R*58?9XAD$8/\-%>
MA*I)-!4IN331R]>M_#'QG";1-!U*9(Y(SBTD=L;P3]S)[@GCU!QVY\DHK:K3
M52/*S2<%-69]*Z[X9TGQ'"J:E:B1D^Y*IVNOT([>QXK#TWX7^&].N%F:*>\9
M3D+=.&7\5  /XYKS/2/B/XCTB 0"Y2[B'W1=J7*^V[(/YGMQBKUQ\6O$<\12
M-+&W8_QQ0DD?]],1^E<?L*T?=3T,/95%HF>NZ[KUAX<TQ[R]E5%4'RXP?FD/
M]U1W_IWKYUUC5)];U>ZU*Y(\V=]Q Z*.@ ]@ !^%-U'5;_5[C[1J%W+<2]C(
MV<?0=!^%4ZZ:%!4U?J:TZ?)ZGU+9_P#'C;_]<U_E7SSXV_Y'75_^OAJM)\1_
M%D:*BZKA5  'V>+I_P!\USU]>W&HWLUY=R>9<3-ND?:!D_0<5%"A*G)MDTJ;
M@[LN^%_^1MT;_K^@_P#1BU](7G_'C<?]<V_E7R_:W,UE=PW5N^R:&19(VP#M
M8'(.#QU%=(_Q'\62(R-JN58$$?9XNG_?-&(H2J--!5IN;31RU>E?!S_D-:E_
MU[K_ .A5YK6EHWB#4_#\TDVEW/D22KM<^6K9&<_Q UM5@YP<4:3CS1:1[1\4
M/^1%NO\ KI'_ .A"O!:W]4\:>(-:L7LM0U#SK=R"R>3&N2#D<A0:P*FA3=.-
MF*E!PC9GNOPI_P"1*7_KXD_I7*?&/_D-:;_U[M_Z%7):3XRU_0[(6>G7_DVX
M8ML\F-N3UY92:J:SX@U/Q!-'-JESY\D2[4/EJN!G/\(%9QH255SZ$1IM3YCU
MWX7:/I5OX?&HVTB7%[< I</WCY_U>.W8GUX/3%6]1^&'AO4+L7"PS6AW9:.V
M<*C?@0<#_=QUKQ/2M9U'1+O[5IMW);RXP2O(8>A!X/XBNQ3XO>(57!MM-8^I
MB?\ H]1.C5YW*#W)E3GS7BSV-GL]'TS+LEM9VL0&2<*B*, 5\V:WJ']K:Y?:
M@ P6XG>10V,A2> <>@Q5[7/&&M^(E\N_N\P;@P@C4*@(]AU_'-85:X>@Z=V]
MV72I\FK"KND:A_96KVM_Y$<_D2!S%( 0WMST/H>QYJE170U=69KN?3^EZI9:
MWIL=[92B6"4?B#W!'8^U<U?_  P\-WU]]J$,]MEMS0V[A8V]L8.!],5XQHWB
M'5= N/.TV\>')^9.J/\ 53P?YUU:_%[Q"J;3;:<Q_O&)\_H^*X'AJD'^[9S>
MQG%^ZSV*WM[#0]*6&%8[6QMD)Y.%11R22?Q))KP'QOX@C\1^)IKR#_CV11#"
M2N"RC/)^I)/TQ3-=\::YXB1HKV[Q;$@_9XEV)QZ]SSSR36!6U"@X/FEN:4J7
M*[O<]?\ @U_R#-4_Z[)_Z":F^,7_ " -/_Z^O_937F6C>*=9\/Q2QZ7>?9TE
M8,X\I'R1_O TNL^*];\06\<&IWOGQQMO5?*1<'&,_*!2]A+VWM.@O9OVG,5]
M"UB?0=9M]1M^7A;)3) =>ZGZBOH[2=6L]:TZ*^L9EDBD&>#RI[@CL17S!6CH
M^NZEH-U]HTZZ>%SC>!RK@=B.AJJ]#VFJW'5I<^JW/:=5^&7AW5+I[GR[BUDD
M;<WV:0*">_!! _"M?2/#^B>%;<BSAC@,K*C32-EW9B %W'U., <9[5Y8OQ=\
M1"/:;?3B?[QB?/\ Z'BN>U+QCKNJWT%W=7[%K>830(J@)&X.00N,''OFL%AZ
MTERR>AG[*H]&]#Z,F_U$G^Z?Y5\K5U1^)'BUE*G5N",'_1XO_B:Y6ML/1E2O
M?J:4J;A>Y]2V?_'C;_\ 7-?Y5\\^-O\ D==7_P"OAJM)\1_%D:*BZKA5  'V
M>+I_WS7/7U[<:C>S7EW)YEQ,VZ1]H&3]!Q2H4)4Y-L5*FX.[.@^'7_(^Z7_O
M/_Z+:O:_%O\ R)^L?]><O_H)KYVT[4;O2;^*^L9?*N8B2C[0V,@@\$$=":V[
MOQ_XGOK.:TN=3WP3(8Y%\B(94C!&0N:*U"4YJ2Z!4IN4DT8FFZA<:5J5O?VK
M;9H) Z\G!QV..QZ$=P37T?H.NV7B+2HKZSD!# "2//S1-W4^_P#/K7S-5W3-
M7U#1KH7.G7<EO+T)0\$>X/!_&KKT%56FY52GS^I[CK/PW\/ZU>/=O'/:SR-N
MD:V<*'/J001^0%:&C>&-#\*Q/+:0+$[</<2MN?!/3)Z#..!UXKR]/B[XB5-I
MM].8_P!XQ/G]'K U;QIKVLW$4MU?$+"XDCBC4*BL#D';WP1WS7.J%:2Y9/0R
M5*H]&]#Z-KY<U'_D)W?_ %V?_P!"-=%_PLGQ;_T%O_):+_XFN6DD:65Y'.7=
MBS'U)K;#T94[W+I4W"]SVWX;>+HM6TI-*NY56_M5VIN;F6,=#SW'0_G72:_X
M6TGQ(D8U&W+/']R5&VNH],^GL:^;D=XI%DC=D=2&5E."".A!KM+#XI^)+*!8
MG:VN]HQNN(R6_$J1FLZF&ES<U-DSHN_- ]'TCX:^'=(N5N!#-=RH<H;IPP4_
M[H !_$&NLAFBN$WPR+(FYEW*<C()!'X$$?A7@NJ?$OQ)J<)B%S'9H00PM4VE
ML_[1)(_ BJ&F^-_$6CZ?%86&H^3;19V)Y,;8R23R5)ZDU$L-5FKR>HG1G+5L
MW?B[_P CA#_UYI_Z$]>I^#?^1,TC_KU3^5?/VKZUJ&O7BW>I7'GSJ@C#;%7Y
M020,* .YK5LO'OB;3[*&SM=3\N"%0D:>1&< =LE<UK4H2E3C!="Y4FX*)H?%
M/_D>)_\ KC'_ "KC%9D8,K%64Y!!P0:N:KJU]K=\U[J$_G7#*%+[%7@=.  *
MI5TTXN,5%FL5:*1]!^!_%D/B71XQ)(BZA"H6>+/)]&&>Q_0U8\0>"M%\22B>
M]@=+@+M\Z%MK$=L]0<>XKYZM;JXLKJ.YM9GAGC.Y)$."#7:6OQ9\1VT*QNME
M<%0!OFB;<?<[6%<<\-*,N:FS"5&2=X'I6A> = \/3BZ@@>>X3[LURP8K[@8
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MCKSZM#1]<U'0+M[K3+CR)GC,;-L5LJ2#C# CJ!75*E^[Y(FSA[G*CVKXH?\
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MG)P.!UKS.7XN^(I(RJV^G1D_Q+$^1^;$5RFL>(-4UZ?S=1O))L'*IG")]%'
MJ50JRE><A*E-N\F4+CR?M,OV;S/(WGR_,QNVYXSCC.*]H^#_ /R*5U_U_/\
M^BXZ\3KVSX/_ /(I77_7\_\ Z+CK7%_PBZ_P'<7<%K>PR6-TD<J3(=T3\[E[
M\?B.?I7'R?"CPR]V)E6[CC'_ "P6;Y#^)!;]:Q?BW>W6GZAHES9W$D$RK-AX
MV*GJE8%O\6O$<$021+&X8?QRPD$_]\L!^E<U.E5Y%*#W,80GRWBSV;3M-LM'
ML$L[&!(+>,<*O\R>Y]S7C7Q*\7PZ]?1Z?I\GF6-JQ+2 <22=,@^@' /?)]C6
M1KGCS7]?A,%Q="&V(PT-L-BMUZG.2.>A./:N:K>AAW%\\]S6G2L^:6YZ#\'_
M /D;;K_KQ?\ ]&1UWOQ-_P"1"O\ _>B_]&+7B.CZYJ.@7;W6F7'D3/&8V;8K
M94D'&&!'4"K^I^-O$.LV$EC?ZAYUM(063R8US@Y'(4'J*<Z$I55-;!*FW-2,
M"O=?A3_R)2_]?$G]*\*K=TGQEK^AV0L].O\ R;<,6V>3&W)Z\LI-:5Z;J0Y4
M75@Y1LCK?C'_ ,AK3?\ KW;_ -"KT;P;_P B9I'_ %ZI_*O =9\0:GX@FCFU
M2Y\^2)=J'RU7 SG^$"M*R\>^)M/LH;.UU/RX(5"1IY$9P!VR5S64\/*5.,%T
M,Y4FX*)H?%/_ )'B?_KC'_*L#PO_ ,C;HW_7]!_Z,6J^JZM?:W?->ZA/YUPR
MA2^Q5X'3@ "J]K<S65W#=6[[)H9%DC; .U@<@X/'45O&#5/E\C51M&Q]23?Z
MB3_=/\J^5JZH_$CQ:RE3JW!&#_H\7_Q-<K66'HRI7OU(I4W"]SZ@TC_D"V/_
M %[Q_P#H(KP/Q_\ \CUJO_71?_014D/Q$\500QPQZKMCC4*H^SQ'  P/X:P-
M0U"ZU2^EO;R7S;B4Y=]H7)QCH !VI4*$J<W)BITW&3;/>/AM_P D_P!,_P"V
MO_HUZ\[^+O\ R.$/_7FG_H3UA:;XW\1:/I\5A8:CY-M%G8GDQMC))/)4GJ36
M=J^M:AKUXMWJ5QY\ZH(PVQ5^4$D#"@#N:*="4:KF]M0C3:FY'N?@G0M&L_"D
M0LO*O([V,&YE8!A,<8*D'L,D;3TYSSFJTGPN\-/J*7:PW"(K;C;+)^Z;G/((
M)Q[ BO&]#\2:KX=G,NFW;1!L;XR-R/\ 53Q^/7WKJO\ A;WB'85^S:;G'WO*
M?/\ Z'6<J%92;B]R73J)W3/7M9U>UT/2I]0NW"QQ*2!GEV[*/<U\R22-+*\C
MG+NQ9CZDUIZUXDU;Q#(K:E>-,$)*( %5<^@%95;X>C[):[LTI4^1:A1116YJ
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% &MX7_Y&W1O^OZ#_ -&+7TM7S3X7_P"1MT;_ *_H/_1BU]+5Y^-^)')B
M-T%%%%<1SA1110!XI\8/^1MM?^O%/_1DE>?5Z#\8/^1MM?\ KQ3_ -&25Y]7
ML4/X:.^E\""BBBM30**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH *W/"#Z5#XEM;G6+D06EN?.^XS;V7[JX4'O@^F :
MPZ*4E=6$U=6/=-7^)WA^+2+I]-OS/?>61 GD./G/ )W*!@=3]*\,9F=BS,69
MCDDG))I**SI48T_A(A34-@HHHK4T"BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ JW
MI4T=MJ]E/*VV..>-W;&< ,"352BAJXCZ!_X63X2_Z"W_ )+2_P#Q->"WLBRW
M]Q(ARCRLRGU!-045E2HQIWL1"FH;!1116IH%%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M]>*?^C)*\^KV*'\-'?2^!!1116IH%%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110!K>%_^1MT;_K^@_P#1BU]+5\T^%_\ D;=&_P"OZ#_T8M?2
MU>?C?B1R8C=!1117$<X4444 >*?&#_D;;7_KQ3_T9)7GU>@_&#_D;;7_ *\4
M_P#1DE>?5[%#^&COI? @HHHK4T"BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M]_8__B*/^%/^'_\ G\U/_O['_P#$5Z!11[>IW#VL^YY__P *?\/_ //YJ?\
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M_#__ #^:G_W]C_\ B*/^%/\ A_\ Y_-3_P"_L?\ \17H%%'MZG</:S[GG_\
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M>@44>WJ=P]K/N>?_ /"G_#__ #^:G_W]C_\ B*/^%/\ A_\ Y_-3_P"_L?\
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M_-3_ ._L?_Q%>@44>WJ=P]K/N>?_ /"G_#__ #^:G_W]C_\ B*/^%/\ A_\
MY_-3_P"_L?\ \17H%%'MZG</:S[GG_\ PI_P_P#\_FI_]_8__B*/^%/^'_\
MG\U/_O['_P#$5Z!11[>IW#VL^YY__P *?\/_ //YJ?\ W]C_ /B*/^%/^'_^
M?S4_^_L?_P 17H%%'MZG</:S[GG_ /PI_P /_P#/YJ?_ ']C_P#B*/\ A3_A
M_P#Y_-3_ ._L?_Q%>@44>WJ=P]K/N>?_ /"G_#__ #^:G_W]C_\ B*/^%/\
MA_\ Y_-3_P"_L?\ \17H%%'MZG</:S[GG_\ PI_P_P#\_FI_]_8__B*/^%/^
M'_\ G\U/_O['_P#$5Z!11[>IW#VL^YY__P *?\/_ //YJ?\ W]C_ /B*/^%/
M^'_^?S4_^_L?_P 17H%%'MZG</:S[GG_ /PI_P /_P#/YJ?_ ']C_P#B*/\
MA3_A_P#Y_-3_ ._L?_Q%>@44>WJ=P]K/N>?_ /"G_#__ #^:G_W]C_\ B*/^
M%/\ A_\ Y_-3_P"_L?\ \17H%%'MZG</:S[GG_\ PI_P_P#\_FI_]_8__B*/
M^%/^'_\ G\U/_O['_P#$5Z!11[>IW#VL^YY__P *?\/_ //YJ?\ W]C_ /B*
M/^%/^'_^?S4_^_L?_P 17H%%'MZG</:S[GG_ /PI_P /_P#/YJ?_ ']C_P#B
M*/\ A3_A_P#Y_-3_ ._L?_Q%>@44>WJ=P]K/N>?_ /"G_#__ #^:G_W]C_\
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M]_8__B*/^%/^'_\ G\U/_O['_P#$5Z!11[>IW#VL^YY__P *?\/_ //YJ?\
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M_#__ #^:G_W]C_\ B*/^%/\ A_\ Y_-3_P"_L?\ \17H%%'MZG</:S[GG_\
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M>@44>WJ=P]K/N>?_ /"G_#__ #^:G_W]C_\ B*/^%/\ A_\ Y_-3_P"_L?\
M\17H%%'MZG</:S[GG_\ PI_P_P#\_FI_]_8__B*/^%/^'_\ G\U/_O['_P#$
M5Z!11[>IW#VL^YY__P *?\/_ //YJ?\ W]C_ /B*/^%/^'_^?S4_^_L?_P 1
M7H%%'MZG</:S[GG_ /PI_P /_P#/YJ?_ ']C_P#B*/\ A3_A_P#Y_-3_ ._L
M?_Q%>@44>WJ=P]K/N>?_ /"G_#__ #^:G_W]C_\ B*/^%/\ A_\ Y_-3_P"_
ML?\ \17H%%'MZG</:S[GG_\ PI_P_P#\_FI_]_8__B*/^%/^'_\ G\U/_O['
M_P#$5Z!11[>IW#VL^YY__P *?\/_ //YJ?\ W]C_ /B*/^%/^'_^?S4_^_L?
M_P 17H%%'MZG</:S[GG_ /PI_P /_P#/YJ?_ ']C_P#B*/\ A3_A_P#Y_-3_
M ._L?_Q%>@44>WJ=P]K/N>?_ /"G_#__ #^:G_W]C_\ B*/^%/\ A_\ Y_-3
M_P"_L?\ \17H%%'MZG</:S[GG_\ PI_P_P#\_FI_]_8__B*/^%/^'_\ G\U/
M_O['_P#$5Z!11[>IW#VL^YY__P *?\/_ //YJ?\ W]C_ /B*/^%/^'_^?S4_
M^_L?_P 17H%%'MZG</:S[GG_ /PI_P /_P#/YJ?_ ']C_P#B*/\ A3_A_P#Y
M_-3_ ._L?_Q%>@44>WJ=P]K/N>?_ /"G_#__ #^:G_W]C_\ B*/^%/\ A_\
MY_-3_P"_L?\ \17H%%'MZG</:S[GG_\ PI_P_P#\_FI_]_8__B*/^%/^'_\
MG\U/_O['_P#$5Z!11[>IW#VL^YY__P *?\/_ //YJ?\ W]C_ /B*/^%/^'_^
M?S4_^_L?_P 17H%%'MZG</:S[GG_ /PI_P /_P#/YJ?_ ']C_P#B*/\ A3_A
M_P#Y_-3_ ._L?_Q%>@44>WJ=P]K/N>?_ /"G_#__ #^:G_W]C_\ B*/^%/\
MA_\ Y_-3_P"_L?\ \17H%%'MZG</:S[GG_\ PI_P_P#\_FI_]_8__B*/^%/^
M'_\ G\U/_O['_P#$5Z!11[>IW#VL^YY__P *?\/_ //YJ?\ W]C_ /B*/^%/
M^'_^?S4_^_L?_P 17H%%'MZG</:S[GG_ /PI_P /_P#/YJ?_ ']C_P#B*/\
MA3_A_P#Y_-3_ ._L?_Q%>@44>WJ=P]K/N>?_ /"G_#__ #^:G_W]C_\ B*/^
M%/\ A_\ Y_-3_P"_L?\ \17H%%'MZG</:S[GG_\ PI_P_P#\_FI_]_8__B*/
M^%/^'_\ G\U/_O['_P#$5Z!11[>IW#VL^YY__P *?\/_ //YJ?\ W]C_ /B*
M/^%/^'_^?S4_^_L?_P 17H%%'MZG</:S[GG_ /PI_P /_P#/YJ?_ ']C_P#B
M*/\ A3_A_P#Y_-3_ ._L?_Q%>@44>WJ=P]K/N>?_ /"G_#__ #^:G_W]C_\
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M]_8__B*/^%/^'_\ G\U/_O['_P#$5Z!11[>IW#VL^YY__P *?\/_ //YJ?\
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M_#__ #^:G_W]C_\ B*/^%/\ A_\ Y_-3_P"_L?\ \17H%%'MZG</:S[GG_\
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M>@44>WJ=P]K/N>?_ /"G_#__ #^:G_W]C_\ B*/^%/\ A_\ Y_-3_P"_L?\
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M_-3_ ._L?_Q%>@44>WJ=P]K/N>?_ /"G_#__ #^:G_W]C_\ B*/^%/\ A_\
MY_-3_P"_L?\ \17H%%'MZG</:S[GG_\ PI_P_P#\_FI_]_8__B*/^%/^'_\
MG\U/_O['_P#$5Z!11[>IW#VL^YY__P *?\/_ //YJ?\ W]C_ /B*/^%/^'_^
M?S4_^_L?_P 17H%%'MZG</:S[GG_ /PI_P /_P#/YJ?_ ']C_P#B*/\ A3_A
M_P#Y_-3_ ._L?_Q%>@44>WJ=P]K/N>?_ /"G_#__ #^:G_W]C_\ B*/^%/\
MA_\ Y_-3_P"_L?\ \17H%%'MZG</:S[GG_\ PI_P_P#\_FI_]_8__B*/^%/^
M'_\ G\U/_O['_P#$5Z!11[>IW#VL^YY__P *?\/_ //YJ?\ W]C_ /B*/^%/
M^'_^?S4_^_L?_P 17H%%'MZG</:S[GG_ /PI_P /_P#/YJ?_ ']C_P#B*/\
MA3_A_P#Y_-3_ ._L?_Q%>@44>WJ=P]K/N>?_ /"G_#__ #^:G_W]C_\ B*/^
M%/\ A_\ Y_-3_P"_L?\ \17H%%'MZG</:S[GG_\ PI_P_P#\_FI_]_8__B*/
M^%/^'_\ G\U/_O['_P#$5Z!11[>IW#VL^YY__P *?\/_ //YJ?\ W]C_ /B*
M/^%/^'_^?S4_^_L?_P 17H%%'MZG</:S[GG_ /PI_P /_P#/YJ?_ ']C_P#B
M*/\ A3_A_P#Y_-3_ ._L?_Q%>@44>WJ=P]K/N>?_ /"G_#__ #^:G_W]C_\
MB*/^%/\ A_\ Y_-3_P"_L?\ \17H%%'MZG</:S[GG_\ PI_P_P#\_FI_]_8_
M_B*/^%/^'_\ G\U/_O['_P#$5Z!11[>IW#VL^YY__P *?\/_ //YJ?\ W]C_
M /B*/^%/^'_^?S4_^_L?_P 17H%%'MZG</:S[GG_ /PI_P /_P#/YJ?_ ']C
M_P#B*/\ A3_A_P#Y_-3_ ._L?_Q%>@44>WJ=P]K/N>?_ /"G_#__ #^:G_W]
MC_\ B*/^%/\ A_\ Y_-3_P"_L?\ \17H%%'MZG</:S[GG_\ PI_P_P#\_FI_
M]_8__B*/^%/^'_\ G\U/_O['_P#$5Z!11[>IW#VL^YY__P *?\/_ //YJ?\
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M_#__ #^:G_W]C_\ B*/^%/\ A_\ Y_-3_P"_L?\ \17H%%'MZG</:S[GG_\
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M>@44>WJ=P]K/N>?_ /"G_#__ #^:G_W]C_\ B*/^%/\ A_\ Y_-3_P"_L?\
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M_-3_ ._L?_Q%>@44>WJ=P]K/N>?_ /"G_#__ #^:G_W]C_\ B*/^%/\ A_\
MY_-3_P"_L?\ \17H%%'MZG</:S[GG_\ PI_P_P#\_FI_]_8__B*/^%/^'_\
MG\U/_O['_P#$5Z!11[>IW#VL^YY__P *?\/_ //YJ?\ W]C_ /B*/^%/^'_^
M?S4_^_L?_P 17H%%'MZG</:S[GG_ /PI_P /_P#/YJ?_ ']C_P#B*/\ A3_A
M_P#Y_-3_ ._L?_Q%>@44>WJ=P]K/N>?_ /"G_#__ #^:G_W]C_\ B*/^%/\
MA_\ Y_-3_P"_L?\ \17H%%'MZG</:S[GG_\ PI_P_P#\_FI_]_8__B*/^%/^
M'_\ G\U/_O['_P#$5Z!11[>IW#VL^YY__P *?\/_ //YJ?\ W]C_ /B*/^%/
M^'_^?S4_^_L?_P 17H%%'MZG</:S[GG_ /PI_P /_P#/YJ?_ ']C_P#B*/\
MA3_A_P#Y_-3_ ._L?_Q%>@44>WJ=P]K/N>?_ /"G_#__ #^:G_W]C_\ B*/^
M%/\ A_\ Y_-3_P"_L?\ \17H%%'MZG</:S[GG_\ PI_P_P#\_FI_]_8__B*/
M^%/^'_\ G\U/_O['_P#$5Z!11[>IW#VL^YY__P *?\/_ //YJ?\ W]C_ /B*
M/^%/^'_^?S4_^_L?_P 17H%%'MZG</:S[GG_ /PI_P /_P#/YJ?_ ']C_P#B
M*/\ A3_A_P#Y_-3_ ._L?_Q%>@44>WJ=P]K/N>?_ /"G_#__ #^:G_W]C_\
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M]_8__B*/^%/^'_\ G\U/_O['_P#$5Z!11[>IW#VL^YY__P *?\/_ //YJ?\
MW]C_ /B*/^%/^'_^?S4_^_L?_P 17H%%'MZG</:S[GG_ /PI_P /_P#/YJ?_
M ']C_P#B*/\ A3_A_P#Y_-3_ ._L?_Q%>@44>WJ=P]K/N>?_ /"G_#__ #^:
MG_W]C_\ B*/^%/\ A_\ Y_-3_P"_L?\ \17H%%'MZG</:S[G#V'PKT/3M1MK
MV&ZU%I;>5)D#R(02I!&?DZ<5W%%%1*<I_$R92<MPHHHJ20HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M\*X_Q%_R'KKZK_Z"*RZ:I)JXU!-'HG_"0:5_S^)_WR?\*/\ A(-*_P"?Q/\
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M_P"?Q/\ OD_X4?\ "0:5_P _B?\ ?)_PKSNBCV,0]FCT3_A(-*_Y_$_[Y/\
MA1_PD&E?\_B?]\G_  KSNBCV,0]FCT3_ (2#2O\ G\3_ +Y/^%'_  D&E?\
M/XG_ 'R?\*\[HH]C$/9H]$_X2#2O^?Q/^^3_ (4?\)!I7_/XG_?)_P *\[HH
M]C$/9H]$_P"$@TK_ )_$_P"^3_A1_P )!I7_ #^)_P!\G_"O.Z*/8Q#V:/1/
M^$@TK_G\3_OD_P"%'_"0:5_S^)_WR?\ "O.Z*/8Q#V:/1/\ A(-*_P"?Q/\
MOD_X4?\ "0:5_P _B?\ ?)_PKSNBCV,0]FCT3_A(-*_Y_$_[Y/\ A1_PD&E?
M\_B?]\G_  KSNBCV,0]FCT3_ (2#2O\ G\3_ +Y/^%'_  D&E?\ /XG_ 'R?
M\*\[HH]C$/9H]$_X2#2O^?Q/^^3_ (4?\)!I7_/XG_?)_P *\[HH]C$/9H]$
M_P"$@TK_ )_$_P"^3_A1_P )!I7_ #^)_P!\G_"O.Z*/8Q#V:/1/^$@TK_G\
M3_OD_P"%'_"0:5_S^)_WR?\ "O.Z*/8Q#V:/1/\ A(-*_P"?Q/\ OD_X4?\
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M_P"?Q/\ OD_X4?\ "0:5_P _B?\ ?)_PKSNBCV,0]FCT3_A(-*_Y_$_[Y/\
MA1_PD&E?\_B?]\G_  KSNBCV,0]FCT3_ (2#2O\ G\3_ +Y/^%'_  D&E?\
M/XG_ 'R?\*\[HH]C$/9H]$_X2#2O^?Q/^^3_ (4?\)!I7_/XG_?)_P *\[HH
M]C$/9H]$_P"$@TK_ )_$_P"^3_A1_P )!I7_ #^)_P!\G_"O.Z*/8Q#V:/1/
M^$@TK_G\3_OD_P"%'_"0:5_S^)_WR?\ "O.Z*/8Q#V:/1/\ A(-*_P"?Q/\
MOD_X4?\ "0:5_P _B?\ ?)_PKSNBCV,0]FCT3_A(-*_Y_$_[Y/\ A1_PD&E?
M\_B?]\G_  KSNBCV,0]FCT3_ (2#2O\ G\3_ +Y/^%'_  D&E?\ /XG_ 'R?
M\*\[HH]C$/9H]$_X2#2O^?Q/^^3_ (4?\)!I7_/XG_?)_P *\[HH]C$/9H]$
M_P"$@TK_ )_$_P"^3_A1_P )!I7_ #^)_P!\G_"O.Z*/8Q#V:/1/^$@TK_G\
M3_OD_P"%'_"0:5_S^)_WR?\ "O.Z*/8Q#V:/1/\ A(-*_P"?Q/\ OD_X4?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %=CXF_P"1=M/]]/\ T$UQU=CXF_Y%
MVT_WT_\ 036<_B1$MT<=1116A84444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% '3>#?^/NZ_ZYC^=8NJ_\A>\_Z[O_ #-;7@W_ (^[K_KF
M/YUBZK_R%[S_ *[O_,UFOC9"^)E.BBBM"PHHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH *['Q1_P @"T_ZZ)_Z":XZNQ\4?\@"
MT_ZZ)_Z":SG\2(ENCCJ***T+"BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#J/!G^O
MN_\ =7^9KKJY'P9_K[O_ '5_F:ZZN6K\1A/X@HHHK,D**** ,+Q;_P @8?\
M75?Y&N&KN?%O_(&'_75?Y&N&KJI?";0V"BBBM"PHHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ KL;#_ )$B7_KG)_,UQU=C8?\ (D2_]<Y/YFLZ
MFR(F<=1116A84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4459L+5KV_@M
ME!_>, <=AW/Y9HV $TZ^D172SN&5AD,L3$$?E4,L,L#[)HWC?^ZZD']:]2
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M%%%%:%A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6]X2_Y#)_ZY-_
M,5@UO>$O^0R?^N3?S%3/X63+8J^(O^0]=?5?_01676IXB_Y#UU]5_P#01673
MC\*''8****8PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M2^$VAL%%%%:%A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !78V
M'_(D2_\ 7.3^9KCJ[&P_Y$B7_KG)_,UG4V1$SCJ***T+"BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "NI\'V>7GO3T'[I1[\$_TKEJ]*TNS%AIL%O_ !*N
M6_WCR?UK*K*T;$3=D+>:A#926R2'F>0(O^/TZ?G3K^U%[83VQP/,4@$]CV/Y
MXKC?$U\UQJYC1ODM_E4@_P 7<_GQ^%==I5X+_3()\@L5P_\ O#K63CRI,S:L
MDSSAT:-V1AAE."/0TVMKQ/9"UU8R*/DG'F?CW_Q_&L6NF+NKFR=U<[WPO_R
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!78^)O\ D7;3_?3_ -!-<=78^)O^1=M/]]/_ $$UG/XD1+=''4445H6%%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!TW@W_C[NO^N8_G
M6+JO_(7O/^N[_P S6UX-_P"/NZ_ZYC^=8NJ_\A>\_P"N[_S-9KXV0OB93HHH
MK0L**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MPJ;\M346TM3@J]0M/^/*#_KFO\JXZR\*7TLR_:@L$0/S?,"Q'MC-=K\L<?)
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M4?\ K%^HKK?&7_'M:_[[?RK.7Q(A_$CD****T+"BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **UO^$:U?\ Y]/_ "(G^-(?#>K 9^R?^1%_QJ>:
M/<7,C*HJQ<V%W9X^T6\D8/ +#@_C5>JO<84444 %%%% !1110 4444 %%%%
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MU&TC\SRUF4=3$<D?AUJ>>.UQ<R,BBBBJ&%%%% !1110 4444 %%%% !1110
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M !78^*/^0!:?]=$_]!-<=78^*/\ D 6G_71/_036<_B1$MT<=1116A84444
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MB@ HHHH ZCP9_K[O_=7^9KKJY'P9_K[O_=7^9KKJY:OQ&$_B"BBBLR0HHHH
MPO%O_(&'_75?Y&N&KN?%O_(&'_75?Y&N&KJI?";0V"BBBM"PHHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ KL;#_D2)?^N<G\S7'5V-A_R)$O\
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M]OYTFBZ))JKERQCMT.&?')/H*.96N%]+F317HT&AZ9;KM6SB;OF0;S^M,N]
MTZZC*_9TB;LT0"D5'MD1[1'GE%=S9^%[".U5+J$2S G+AV&X9..,^F*YWQ'9
M6]AJ2Q6T>Q#$&QN)YR?6JC44G9%*2;L=-X7_ .0%%_O-_.L?QE_Q^VW_ %S/
M\ZV/"_\ R HO]YOYUC^,O^/VV_ZYG^=91_B$+XSFJ*ZCPWI%C?Z=)+=0>8XE
M*@[V'&!Z'WJMXGTVTT][86L7E[PV[YB<XQZGWK7G7-RE\RO8P***[]?#>DE
M3:=O^>C_ .-.4U'<)22. HJQ?Q)#J-U%&,(DKJHSG !.*L:5I,^JSE(_DC7[
M\A&0O^)IW25QWTN9]%>A6OA[3;51_HZRMW:7YL_ATJ=](TZ1"K6-N 1CY8PI
M_,5E[9$>T1YM174ZQX6$437&G[B%Y,)Y./8_TKEJUC)25T6FGL%%%%,84444
M %%%% !1110 4444 %%%% !1110 4444 %;WA+_D,G_KDW\Q6#6]X2_Y#)_Z
MY-_,5,_A9,MBKXB_Y#UU]5_]!%9=:GB+_D/77U7_ -!%9=./PH<=@HHHIC"B
MBB@ HHHH **** "BBB@ HHHH **** "NK\(Z>C))?R#+!MD>1TXY/ZX_.N4K
ML/!]XK6LUHS?.C;U'J#_ /7_ )UG5ORZ$SV-?4M8M=+">>7+/RJ(,G'K3]/U
M.UU.(O;/DK]Y&&&7ZU5UW1AJMNI1@L\>=A/0Y[&N(#W>F7,B O!, 4?UP?\
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M^)O^1=M/]]/_ $$UQU=CXF_Y%VT_WT_]!-9S^)$2W1QU%%%:%A1110 4444
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MURUH/D7Y09'Y;L.OK7$4HR4MA*5PHHHJB@HHHH **** "BBB@ HHHH ****
M.F\&_P#'W=?]<Q_.L75?^0O>?]=W_F:VO!O_ !]W7_7,?SK%U7_D+WG_ %W?
M^9K-?&R%\3*=%%%:%A1110 4444 %%%% !1110 4444 %%%% !1110!V?@[_
M )!]Q_UU_H*V;W4+73U1KJ7RPYPORDY_(5C>#O\ D'W'_77^@IGC+_CUM?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ KL;#_D2)?^N<G\S7'5V-A_R)$O_7.3^9K.ILB)G'4445H6%%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M=27EFLLL$D$G1D=2,'VSVKB_$MDMGJ[E!A)AY@'H3U_7G\:ZG_A)=(_Y^_\
MR&_^%<[XFU&TU![9K67S-@8-\I&.F.H^M%--2V"%TS HHHKH-0HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH *WO"7_(9/_7)OYBL&M[PE_P AD_\ 7)OY
MBIG\+)EL5?$7_(>NOJO_ *"*RZU/$7_(>NOJO_H(K+IQ^%#CL%%%%,84444
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M&5&6/JQZUES^Y8CF]VQG>*;[[+I?D*?WEP=O7HO?_#\:YOPU_P C!:_\#_\
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M'V2K",-@'&2P[_6NITZ5Y]-MI9&W.\2LQQC)(KD?%W_(83_KBO\ ,UU>D_\
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M:C@?XFL^BJ4(IW*Y4G<[/P=_R#[C_KK_ $%,\9?\>MK_ +Y_E3_!W_(/N/\
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MHH **** "BBB@ HHHH **** "BBB@ HHHH [/P=_R#[C_KK_ $%='7.>#O\
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M1X,_U]W_ +J_S-==7(^#/]?=_P"ZO\S775RU?B,)_$%%%%9DA1110!A>+?\
MD##_ *ZK_(UPU=SXM_Y P_ZZK_(UPU=5+X3:&P4445H6%%%% !1110 4444
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M('W>9N[$8Z#UHC[2^H+GOJ9^GZ?/J5R(8![LQZ*/4UU$?@ZS$8$EQ.SXY*X
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M:A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 .C_UB_45UOC+_CVM?]]OY5R4?^L7ZBNM\9?\>UK_ +[?
MRK.7Q(A_$CD****T+"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MC(^E<Y&_ERH^,[6!Q6=.+2=R8)I:GJE>8WW_ "$+G_KJW\S71_\ ":?]0_\
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M44 ;7AB\-KJRQ$XCG&PY..>WZ\?C7>5Y7'(T4BR(<.A#*?0BNI_X33_IP_\
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M]WYC/]:SZW?%J@:R#ZQ*?U-85:0=XHN.P44450PHHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ='_K%^HKK?&7
M_'M:_P"^W\JY*/\ UB_45UOC+_CVM?\ ?;^59R^)$/XD<A1116A84444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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ME8****H84444 %%%% !1110 4444 %%%% !1110!TW@W_C[NO^N8_G6+JO\
MR%[S_KN_\S6UX-_X^[K_ *YC^=8NJ_\ (7O/^N[_ ,S6:^-D+XF4Z***T+"B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KL?%
M'_( M/\ KHG_ *":XZNQ\4?\@"T_ZZ)_Z":SG\2(ENCCJ***T+"BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M,UQU=C8?\B1+_P!<Y/YFLZFR(F<=1116A84444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 5O>$O^0R?^N3?S%8-;WA+_D,
MG_KDW\Q4S^%DRV*OB+_D/77U7_T$5EUJ>(O^0]=?5?\ T$5ETX_"AQV"BBBF
M,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MA84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5V-A_R)$O_ %SD
M_F:XZNQL/^1(E_ZYR?S-9U-D1,XZBBBM"PHHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** +NDWOV#4X;@D
MA </_NG@_P"/X5Z++''<V[QN-T<BE2/4$5Y;76:%XBMH+ 6U[*4:+A&VD[E_
M =JQJQ;U1G-=4<Y?V4FGWLEM)R5/#8QN'8U6KJ-?O-(U.V\R&Y'VJ,?(?+8;
MA_=Z?E7+UI%MK4N+NM2:VN[BSE\RWE:-O53U^OK4NH:E<:E,LEPP)5=H"C _
M*JE%597N%@HHHH&36UW<6<HEMY6C?U!Z_4=ZV5\7:BJX*6['U*'^AK HI.*>
MXFDS3OM?U"_3RY)=D9&"D8V@_7N?ITK,HHH22V!*PJ[2PW$A<\D#) ^E=2/$
MUC::;]FL+>975<)O  !]3R?K7*T4I14MP:N*S,[%F8LQ.22<DFDHHJAEBSOK
MBPF\VVD*-T/<$>XK7_X2_4=N/+M\^NP_XU@44G%/<329-=7<][.9KB0R2'C)
M]/Z5#113&%%%% !6A9ZU?V("PSDQCHC_ ##_ .M^%9]%#2>XK7.@'B_4 ,&*
MV/N5;_&J]SXFU.X7:)5B'0^4N"?QZ_E6/14\D>PN5#G=Y'+NS,QZLQR33:**
MHHU5\1ZLJA1=\ 8'[M/\*SIYY+F=YI6W2.<L<8R:CI5 9@"P4$XW'H/RI));
M"LD;'AO3FO=265E/DP$.Q]3V'^?2NUOKM+&REN7Z(N<>I["L;3=5T33;);>.
M[R>KMY3_ #-Z]*R?$>M)J#QP6LA:W4;F."-S?CZ?UK!ISEY&;3DS"=VD=G8Y
M9CDGU--HHKH-0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** '1_ZQ?J*ZWQE_Q[6O^^W\JY*/_6+]176^
M,O\ CVM?]]OY5G+XD0_B1R%%%%:%A1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !6]X2_Y#)_ZY-_,5@UO>$O\ D,G_ *Y-_,5,_A9,MBKXB_Y#UU]5
M_P#01676IXB_Y#UU]5_]!%9=./PH<=@HHHIC"BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "NQ\3?\ (NVG^^G_ *":XZNQ\3?\
MB[:?[Z?^@FLY_$B);HXZBBBM"PHHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** .F\&_P#'W=?]<Q_.L75?^0O>?]=W_F:VO!O_ !]W7_7,
M?SK%U7_D+WG_ %W?^9K-?&R%\3*=%%%:%A1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 5V/BC_D 6G_71/_037'5V/BC_ ) %
MI_UT3_T$UG/XD1+=''4445H6%%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '4>#/\
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M]'_"&1_\_K?]^_\ Z]'M8ASHY&BNN_X0R/\ Y_6_[]__ %Z/^$,C_P"?UO\
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M_P (9'_S^M_W[_\ KT?\(9'_ ,_K?]^__KT>UB'.CD:*Z[_A#(_^?UO^_?\
M]>C_ (0R/_G];_OW_P#7H]K$.='(T5UW_"&1_P#/ZW_?O_Z]'_"&1_\ /ZW_
M '[_ /KT>UB'.CD:*Z[_ (0R/_G];_OW_P#7H_X0R/\ Y_6_[]__ %Z/:Q#G
M1R-%==_PAD?_ #^M_P!^_P#Z]'_"&1_\_K?]^_\ Z]'M8ASHY&BNN_X0R/\
MY_6_[]__ %Z/^$,C_P"?UO\ OW_]>CVL0YT<C177?\(9'_S^M_W[_P#KT?\
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M$,C_ .?UO^_?_P!>C_A#(_\ G];_ +]__7H]K$.='(T5UW_"&1_\_K?]^_\
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M_"&1_P#/ZW_?O_Z]'M8ASHY&BNN_X0R/_G];_OW_ /7H_P"$,C_Y_6_[]_\
MUZ/:Q#G1R-%==_PAD?\ S^M_W[_^O1_PAD?_ #^M_P!^_P#Z]'M8ASHY&BNN
M_P"$,C_Y_6_[]_\ UZ/^$,C_ .?UO^_?_P!>CVL0YT<C177?\(9'_P _K?\
M?O\ ^O1_PAD?_/ZW_?O_ .O1[6(<Z.1HKKO^$,C_ .?UO^_?_P!>C_A#(_\
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M$,C_ .?UO^_?_P!>C_A#(_\ G];_ +]__7H]K$.='(T5UW_"&1_\_K?]^_\
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M  AD?_/ZW_?O_P"O1[6(<Z.1HKKO^$,C_P"?UO\ OW_]>C_A#(_^?UO^_?\
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MD?\ S^M_W[_^O1_PAD?_ #^M_P!^_P#Z]'M8ASHY&BNN_P"$,C_Y_6_[]_\
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M,C_Y_6_[]_\ UZ/^$,C_ .?UO^_?_P!>CVL0YT<C177?\(9'_P _K?\ ?O\
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M(V!W!<YP"/ZU,IQ;3)<E='G5%==_PAD?_/ZW_?O_ .O1_P (9'_S^M_W[_\
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M_P _K?\ ?O\ ^O1[6(<Z.1HKKO\ A#(_^?UO^_?_ ->C_A#(_P#G];_OW_\
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M0R/_ )_6_P"_?_UZ/^$,C_Y_6_[]_P#UZ/:Q#G1R-%==_P (9'_S^M_W[_\
MKT?\(9'_ ,_K?]^__KT>UB'.CD:*Z[_A#(_^?UO^_?\ ]>C_ (0R/_G];_OW
M_P#7H]K$.='(T5UW_"&1_P#/ZW_?O_Z]'_"&1_\ /ZW_ '[_ /KT>UB'.CD:
M*Z[_ (0R/_G];_OW_P#7H_X0R/\ Y_6_[]__ %Z/:Q#G1R-%==_PAD?_ #^M
M_P!^_P#Z]'_"&1_\_K?]^_\ Z]'M8ASHY&BNN_X0R/\ Y_6_[]__ %Z/^$,C
M_P"?UO\ OW_]>CVL0YT<C177?\(9'_S^M_W[_P#KT?\ "&1_\_K?]^__ *]'
MM8ASHY&BNN_X0R/_ )_6_P"_?_UZ/^$,C_Y_6_[]_P#UZ/:Q#G1R-%==_P (
M9'_S^M_W[_\ KT?\(9'_ ,_K?]^__KT>UB'.CD:*Z[_A#(_^?UO^_?\ ]>C_
M (0R/_G];_OW_P#7H]K$.='(T5UW_"&1_P#/ZW_?O_Z]'_"&1_\ /ZW_ '[_
M /KT>UB'.CD:['Q1_P @"T_ZZ)_Z":9_PAD?_/ZW_?O_ .O6OJ>DKJ5C%:F8
MQB-@VX+G. 1_6HE.+:9+DKH\ZHKKO^$,C_Y_6_[]_P#UZ/\ A#(_^?UO^_?_
M ->K]K$KG1R-%==_PAD?_/ZW_?O_ .O1_P (9'_S^M_W[_\ KT>UB'.CD:*Z
M[_A#(_\ G];_ +]__7H_X0R/_G];_OW_ /7H]K$.='(T5UW_  AD?_/ZW_?O
M_P"O1_PAD?\ S^M_W[_^O1[6(<Z.1HKKO^$,C_Y_6_[]_P#UZ/\ A#(_^?UO
M^_?_ ->CVL0YT<C177?\(9'_ ,_K?]^__KT?\(9'_P _K?\ ?O\ ^O1[6(<Z
M.1HKKO\ A#(_^?UO^_?_ ->C_A#(_P#G];_OW_\ 7H]K$.='(T5UW_"&1_\
M/ZW_ '[_ /KT?\(9'_S^M_W[_P#KT>UB'.CD:*Z[_A#(_P#G];_OW_\ 7H_X
M0R/_ )_6_P"_?_UZ/:Q#G1R-%==_PAD?_/ZW_?O_ .O1_P (9'_S^M_W[_\
MKT>UB'.CD:*Z[_A#(_\ G];_ +]__7H_X0R/_G];_OW_ /7H]K$.='(T5UW_
M  AD?_/ZW_?O_P"O1_PAD?\ S^M_W[_^O1[6(<Z.1HKKO^$,C_Y_6_[]_P#U
MZ/\ A#(_^?UO^_?_ ->CVL0YT<C177?\(9'_ ,_K?]^__KT?\(9'_P _K?\
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MO\S775DZ/HBZ0\K+.9?, '*XQBM:L)M.5T92=V%%%%02%%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **YZ^\=>&=-U,Z==ZO#'=*<,NUF"GT9@"H/L3Q6_'(DT22Q.KQN
MH974Y# ]"#W% #J*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH ***HW>M:58.4O-3L[9AU6:=4(_
M,^X_.@"]16?:Z]H]](([35K&X<G 6&X1R3] :T* "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MHH **** "BBB@ HHHH \J^-__()TG_KN_P#Z"*Y7X.?\CR?^O23^:UU7QO\
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ML3POX7L/"FE+962[G;#33L/FE;U/H/0=OS)VZ (+R[AL+*:[N'"0PH7=B<8
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M_P#D3;/_ +""?^BY*](HH ^=?A1_R4*Q_P"N<O\ Z :^BJ** "BBB@ HHHH
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M(?\ KHO\Z /KJBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M=>UJV\/:)<ZG=9,<"Y"@X+L> H^IK2KR3XWZB5MM*TQ2V'9YW ;CC 7C\6H
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M,%_B8,1N^I&/R^M 'KOA'Q)#XJ\/0:E&H20DQSQ@_P"KD'4?3D$>Q%;E>1?
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M=U6/1-"O=3EP5MH6< _Q-_"/Q.!^-?+5[>7>KZE-=W+M/=7,A9CCEF)Z ?H
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M;E/\P*ZCXWSA=(TF#(W/.[@=_E4#_P!FKF?@Q"9/&D\G($5D[=.N608_7]*
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M#QOW*'D9]_6@#ZB5@RAE(*D9!!X(I:X7X2ZM+J?@F.*9]SV4S6X).3L #+^
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M%W1M]X9) ZA3SZ'UH S?@SK:W7A^XT>1_P!]9R%XUY_U;<_^A;OSJ_\ %_\
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M(TFB>*5%>-U*LC#(8'J".XH ^:?!GC6]\(:@7C!FL93^_MBV ?\ :7T;^?\
M+V[2_B-X6U6%'758K5VZQ79$3+[$GY?R)KB_%'P;,DSW7AV=%5FR;2=B O\
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M,]B.Q]CS5ROG?X5Z9?:AXQ@EM;B:"WM?WUR\;E=RCHA]0QX(],U]$4 %%%%
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M6XMLI'+,=J.F>/FZ C..>P!JM\4?'FFWFC-H>DW:733N#<2Q'**JD$*&Z')
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M#$@1$48"J!@ ?A4E !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %>'?&/Q']NUB'0X) ;>S^>;:<AI2.G_ 1^K&O<:Y2Y^&WA.\NI;F
MYTMI9Y6+N[74Q+$]3]^@#B/@OX=#277B"=/NY@MB?7^,_E@?B:]BJIINFV>C
MZ?#86$ @M800D8).,DD\GD\DFK= !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %5[^[33].N;V7_5V\32MSV4$G
M^56*Y?XBW#6OP_UB17*DQ"/(ST9U4CCU!Q0!\W7EW-?WD]W<N7GF<R.Q[DG)
MKZ;\%Z-_87A#3K%DVS"(23 K@[V^9@?H3C\*^</#UJ+[Q+I=HV=LUW%&V!G
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MM8ZEJ/D7*J&*>1(W!Z<JI%4/^%I>#?\ H,_^2LW_ ,10!V%%<?\ \+2\&_\
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MH: "L/QD\L?@K6FA)#BSEY4<@;3G],UN5#=6T5[9SVLZ[H9HVC=?52,$?D:
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M>.?$FBF(6NJSM#$ JP3,9(PH& H!Z#'IBO=/!/C6T\7Z:6 $-_"!]HM\]/\
M:7U4_IT/8D ZFO-/C/HPNO#MOJR(/-LI0KMCGRWX_P#0MOYFO2ZQ?%]K]M\'
M:S!M+$V<I4#J6"DC]0* /"/AIJQTGQU8$G]W='[*X]=^ O\ X]MKZ1KY%M;A
MK6[AN$Y:*17'..0<U]<JP90RD%2,@@\$4 +1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M?@SHDEUX@N-8=2(+.,QH?61N,>^%S^8KUWQ'X@L_#.C2ZE>[VC0A51,;G8]
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH *CN($N;:6"3.R5"C8ZX(P:DHH ^3-6TV;2-6NM.N
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M6O./^&:]'_Z&"^_[])0!Z9_PL#P=_P!#5HO_ ('1_P"-'_"P/!W_ $-6B_\
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M!Z9_PL#P=_T-6B_^!T?^-'_"P/!W_0U:+_X'1_XUYG_PS7H__0P7W_?I*/\
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MPL#P=_T-6B_^!T?^->9_\,UZ/_T,%]_WZ2C_ (9KT?\ Z&"^_P"_24 >F?\
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M_P#H8+[_ +])0!Z9_P + \'?]#5HO_@='_C1_P + \'?]#5HO_@='_C7F?\
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MU:+_ .!T?^->9_\ #->C_P#0P7W_ 'Z2C_AFO1_^A@OO^_24 >F?\+ \'?\
M0U:+_P"!T?\ C1_PL#P=_P!#5HO_ ('1_P"->9_\,UZ/_P!#!??]^DH_X9KT
M?_H8+[_OTE 'IG_"P/!W_0U:+_X'1_XT?\+ \'?]#5HO_@='_C7F?_#->C_]
M#!??]^DH_P"&:]'_ .A@OO\ OTE 'IG_  L#P=_T-6B_^!T?^-'_  L#P=_T
M-6B_^!T?^->9_P##->C_ /0P7W_?I*/^&:]'_P"A@OO^_24 >F?\+ \'?]#5
MHO\ X'1_XT?\+ \'?]#5HO\ X'1_XUYG_P ,UZ/_ -#!??\ ?I*/^&:]'_Z&
M"^_[])0!Z9_PL#P=_P!#5HO_ ('1_P"-'_"P/!W_ $-6B_\ @='_ (UYG_PS
M7H__ $,%]_WZ2C_AFO1_^A@OO^_24 >F?\+ \'?]#5HO_@='_C1_PL#P=_T-
M6B_^!T?^->9_\,UZ/_T,%]_WZ2C_ (9KT?\ Z&"^_P"_24 >F?\ "P/!W_0U
M:+_X'1_XT?\ "P/!W_0U:+_X'1_XUYG_ ,,UZ/\ ]#!??]^DH_X9KT?_ *&"
M^_[])0!Z9_PL#P=_T-6B_P#@='_C1_PL#P=_T-6B_P#@='_C7F?_  S7H_\
MT,%]_P!^DH_X9KT?_H8+[_OTE 'IG_"P/!W_ $-6B_\ @='_ (T?\+ \'?\
M0U:+_P"!T?\ C7F?_#->C_\ 0P7W_?I*/^&:]'_Z&"^_[])0!Z9_PL#P=_T-
M6B_^!T?^-'_"P/!W_0U:+_X'1_XUYG_PS7H__0P7W_?I*/\ AFO1_P#H8+[_
M +])0!Z9_P + \'?]#5HO_@='_C1_P + \'?]#5HO_@='_C7F?\ PS7H_P#T
M,%]_WZ2C_AFO1_\ H8+[_OTE 'IG_"P/!W_0U:+_ .!T?^-'_"P/!W_0U:+_
M .!T?^->9_\ #->C_P#0P7W_ 'Z2C_AFO1_^A@OO^_24 >F?\+ \'?\ 0U:+
M_P"!T?\ C1_PL#P=_P!#5HO_ ('1_P"->9_\,UZ/_P!#!??]^DH_X9KT?_H8
M+[_OTE 'IG_"P/!W_0U:+_X'1_XT?\+ \'?]#5HO_@='_C7F?_#->C_]#!??
M]^DH_P"&:]'_ .A@OO\ OTE 'IG_  L#P=_T-6B_^!T?^-'_  L#P=_T-6B_
M^!T?^->9_P##->C_ /0P7W_?I*/^&:]'_P"A@OO^_24 >F?\+ \'?]#5HO\
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M9_\ #->C_P#0P7W_ 'Z2C_AFO1_^A@OO^_24 >F?\+ \'?\ 0U:+_P"!T?\
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M\,UZ/_T,%]_WZ2C_ (9KT?\ Z&"^_P"_24 >F?\ "P/!W_0U:+_X'1_XT?\
M"P/!W_0U:+_X'1_XUYG_ ,,UZ/\ ]#!??]^DH_X9KT?_ *&"^_[])0!Z9_PL
M#P=_T-6B_P#@='_C1_PL#P=_T-6B_P#@='_C7F?_  S7H_\ T,%]_P!^DH_X
M9KT?_H8+[_OTE 'IG_"P/!W_ $-6B_\ @='_ (T?\+ \'?\ 0U:+_P"!T?\
MC7F?_#->C_\ 0P7W_?I*/^&:]'_Z&"^_[])0!Z9_PL#P=_T-6B_^!T?^-'_"
MP/!W_0U:+_X'1_XUYG_PS7H__0P7W_?I*/\ AFO1_P#H8+[_ +])0!Z9_P +
M \'?]#5HO_@='_C1_P + \'?]#5HO_@='_C7F?\ PS7H_P#T,%]_WZ2C_AFO
M1_\ H8+[_OTE 'IG_"P/!W_0U:+_ .!T?^-'_"P/!W_0U:+_ .!T?^->9_\
M#->C_P#0P7W_ 'Z2C_AFO1_^A@OO^_24 >F?\+ \'?\ 0U:+_P"!T?\ C1_P
ML#P=_P!#5HO_ ('1_P"->9_\,UZ/_P!#!??]^DH_X9KT?_H8+[_OTE 'IG_"
MP/!W_0U:+_X'1_XT?\+ \'?]#5HO_@='_C7F?_#->C_]#!??]^DH_P"&:]'_
M .A@OO\ OTE 'IG_  L#P=_T-6B_^!T?^-'_  L#P=_T-6B_^!T?^->9_P##
M->C_ /0P7W_?I*/^&:]'_P"A@OO^_24 >F?\+ \'?]#5HO\ X'1_XT?\+ \'
M?]#5HO\ X'1_XUYG_P ,UZ/_ -#!??\ ?I*/^&:]'_Z&"^_[])0!Z9_PL#P=
M_P!#5HO_ ('1_P"-'_"P/!W_ $-6B_\ @='_ (UYG_PS7H__ $,%]_WZ2C_A
MFO1_^A@OO^_24 >F?\+ \'?]#5HO_@='_C1_PL#P=_T-6B_^!T?^->9_\,UZ
M/_T,%]_WZ2C_ (9KT?\ Z&"^_P"_24 >F?\ "P/!W_0U:+_X'1_XT?\ "P/!
MW_0U:+_X'1_XUYG_ ,,UZ/\ ]#!??]^DH_X9KT?_ *&"^_[])0!Z9_PL#P=_
MT-6B_P#@='_C1_PL#P=_T-6B_P#@='_C7F?_  S7H_\ T,%]_P!^DH_X9KT?
M_H8+[_OTE 'IG_"P/!W_ $-6B_\ @='_ (T?\+ \'?\ 0U:+_P"!T?\ C7F?
M_#->C_\ 0P7W_?I*/^&:]'_Z&"^_[])0!Z9_PL#P=_T-6B_^!T?^-'_"P/!W
M_0U:+_X'1_XUYG_PS7H__0P7W_?I*/\ AFO1_P#H8+[_ +])0!Z9_P + \'?
M]#5HO_@='_C1_P + \'?]#5HO_@='_C7F?\ PS7H_P#T,%]_WZ2C_AFO1_\
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M+_X'1_XT?\+ \'?]#5HO_@='_C7F?_#->C_]#!??]^DH_P"&:]'_ .A@OO\
MOTE 'IG_  L#P=_T-6B_^!T?^-'_  L#P=_T-6B_^!T?^->9_P##->C_ /0P
M7W_?I*/^&:]'_P"A@OO^_24 >F?\+ \'?]#5HO\ X'1_XT?\+ \'?]#5HO\
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ME 'IG_"P/!W_ $-6B_\ @='_ (T?\+ \'?\ 0U:+_P"!T?\ C7F?_#->C_\
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M1_XT?\+ \'?]#5HO_@='_C7F?_#->C_]#!??]^DH_P"&:]'_ .A@OO\ OTE
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M>9_\,UZ/_P!#!??]^DH_X9KT?_H8+[_OTE 'IG_"P/!W_0U:+_X'1_XT?\+
M\'?]#5HO_@='_C7F?_#->C_]#!??]^DH_P"&:]'_ .A@OO\ OTE 'IG_  L#
MP=_T-6B_^!T?^-'_  L#P=_T-6B_^!T?^->9_P##->C_ /0P7W_?I*/^&:]'
M_P"A@OO^_24 >F?\+ \'?]#5HO\ X'1_XT?\+ \'?]#5HO\ X'1_XUYG_P ,
MUZ/_ -#!??\ ?I*/^&:]'_Z&"^_[])0!Z9_PL#P=_P!#5HO_ ('1_P"-'_"P
M/!W_ $-6B_\ @='_ (UYG_PS7H__ $,%]_WZ2C_AFO1_^A@OO^_24 >F?\+
M\'?]#5HO_@='_C1_PL#P=_T-6B_^!T?^->9_\,UZ/_T,%]_WZ2C_ (9KT?\
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M_P"_24 >F?\ "P/!W_0U:+_X'1_XT?\ "P/!W_0U:+_X'1_XUYG_ ,,UZ/\
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M='_C7F?_  S7H_\ T,%]_P!^DH_X9KT?_H8+[_OTE 'IG_"P/!W_ $-6B_\
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M^-'_  L#P=_T-6B_^!T?^->9_P##->C_ /0P7W_?I*/^&:]'_P"A@OO^_24
M>F?\+ \'?]#5HO\ X'1_XT?\+ \'?]#5HO\ X'1_XUYG_P ,UZ/_ -#!??\
M?I*/^&:]'_Z&"^_[])0!Z9_PL#P=_P!#5HO_ ('1_P"-'_"P/!W_ $-6B_\
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M!Z9_PL#P=_T-6B_^!T?^-'_"P/!W_0U:+_X'1_XUYG_PS7H__0P7W_?I*/\
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MPL#P=_T-6B_^!T?^->9_\,UZ/_T,%]_WZ2C_ (9KT?\ Z&"^_P"_24 >F?\
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M_P#H8+[_ +])0!Z9_P + \'?]#5HO_@='_C1_P + \'?]#5HO_@='_C7F?\
MPS7H_P#T,%]_WZ2C_AFO1_\ H8+[_OTE 'IG_"P/!W_0U:+_ .!T?^-'_"P/
M!W_0U:+_ .!T?^->9_\ #->C_P#0P7W_ 'Z2C_AFO1_^A@OO^_24 >F?\+ \
M'?\ 0U:+_P"!T?\ C1_PL#P=_P!#5HO_ ('1_P"->9_\,UZ/_P!#!??]^DH_
MX9KT?_H8+[_OTE 'IG_"P/!W_0U:+_X'1_XT?\+ \'?]#5HO_@='_C7F?_#-
M>C_]#!??]^DH_P"&:]'_ .A@OO\ OTE 'IG_  L#P=_T-6B_^!T?^-'_  L#
MP=_T-6B_^!T?^->9_P##->C_ /0P7W_?I*/^&:]'_P"A@OO^_24 >F?\+ \'
M?]#5HO\ X'1_XT?\+ \'?]#5HO\ X'1_XUYG_P ,UZ/_ -#!??\ ?I*/^&:]
M'_Z&"^_[])0!Z9_PL#P=_P!#5HO_ ('1_P"-'_"P/!W_ $-6B_\ @='_ (UY
MG_PS7H__ $,%]_WZ2C_AFO1_^A@OO^_24 >F?\+ \'?]#5HO_@='_C1_PL#P
M=_T-6B_^!T?^->9_\,UZ/_T,%]_WZ2C_ (9KT?\ Z&"^_P"_24 >F?\ "P/!
MW_0U:+_X'1_XT?\ "P/!W_0U:+_X'1_XUYG_ ,,UZ/\ ]#!??]^DH_X9KT?_
M *&"^_[])0!Z9_PL#P=_T-6B_P#@='_C1_PL#P=_T-6B_P#@='_C7F?_  S7
MH_\ T,%]_P!^DH_X9KT?_H8+[_OTE 'IG_"P/!W_ $-6B_\ @='_ (T?\+ \
M'?\ 0U:+_P"!T?\ C7F?_#->C_\ 0P7W_?I*/^&:]'_Z&"^_[])0!Z9_PL#P
M=_T-6B_^!T?^-'_"P/!W_0U:+_X'1_XUYG_PS7H__0P7W_?I*/\ AFO1_P#H
M8+[_ +])0!Z9_P + \'?]#5HO_@='_C1_P + \'?]#5HO_@='_C7F?\ PS7H
M_P#T,%]_WZ2C_AFO1_\ H8+[_OTE 'IG_"P/!W_0U:+_ .!T?^-'_"P/!W_0
MU:+_ .!T?^->9_\ #->C_P#0P7W_ 'Z2C_AFO1_^A@OO^_24 >F?\+ \'?\
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M^_[])0!Z9_PL#P=_T-6B_P#@='_C1_PL#P=_T-6B_P#@='_C7F?_  S7H_\
MT,%]_P!^DH_X9KT?_H8+[_OTE 'IG_"P/!W_ $-6B_\ @='_ (T?\+ \'?\
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M^!T?^->9_P##->C_ /0P7W_?I*/^&:]'_P"A@OO^_24 >F?\+ \'?]#5HO\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M=G&?)DV_]];<?K7F=A9:K\6O%%Q=75P]KIEN> !N$:Y^5%[%B.I_'T%>@?\
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M9!S_ '* /1*Q_P#A+/#?_0P:5_X&Q_XUL5YO_P *4\-_\_NJ_P#?V/\ ^-T
M=A_PEGAO_H8-*_\  V/_ !H_X2SPW_T,&E?^!L?^-<?_ ,*4\-_\_NJ_]_8_
M_C=<=\0O!/A[PAIMN;2ZOY;^X?$<<LB%0@^\Q 0'T'7O[4 >UV.M:5J<K16&
MIV5W(J[F2"=9"!ZD ]*O5PGPL\,_V'X:%Y/&5O;_ !(^X<JG\*]..N?QKNZ
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M3K(0/4@'I5ZN$^%GAG^P_#0O)XRM[?XD?<.53^%>G'7/XUW= !1110 4444
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MJ/8BMNO%_A;JL_A[Q5?^%=0.Q9)&"!C@+,O''^\H_':N*]HH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7!?%[47LO!#
M01MM:\N$A.#SMY8_A\H'XUWM>6?&]R-$TM.,&Y8_DO\ ]>@#H_AAIR:?X"L"
MJX>YW7$AQC)8\?\ CH4?A785B^$$6/P7H:J, V$+?B4!/ZFMJ@#E/B1I::IX
M%U)3&&DMD^TQG^Z4Y)_[YW#\:R/@[J37G@QK61P6L[AHU'<(0&'ZEORKK_$8
M#>%]6! (-E,"#W^0UYS\#B?L6M#)P)(CC\&H ]9HHHH *\.\-W5KJ'QGU#4[
MB>&.W@DN)5DF?:"!^[4_-CGD'V_"O;IO-\B3R-GG;3LWYV[L<9QVS7E&G_!&
M$JKZKK,KR$Y=;:, ?@S9S]<4 >CP>(]"NI/+M]:TZ9^NV.Z1C^0-:=>5ZE\$
MM.:V?^R]3NDGQ\HNMK*3[[5!%9?@OQ;JOA3Q$/"OB,MY!D$2/*V3 Q^Z0W=#
MD?3.>.: /:**** &NZQHSNP5%!+,QP /4UX;9(WQ.^*#W4B$Z5:X;:PX\E#\
MJ_5R22/=O2NP^+?B8Z3X?&DV[8N=0!5B"<K%_%^?W?H36E\-?#0\.^%HGEC"
MWM[B:<D<@?PK^ /YDT =E1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 5P7Q>U%[+P0T$;;6O+A(3@\[>6/X?*!^-=[7EGQO<C1-+3C!N6/Y+_ /7H
M Z/X8:<FG^ K JN'N=UQ(<8R6/'_ (Z%'X5V%8OA!%C\%Z&JC -A"WXE 3^I
MK:H Y3XD:6FJ>!=24QAI+9/M,9_NE.2?^^=P_&LCX.ZDUYX,:UD<%K.X:-1W
M"$!A^I;\JZ_Q& WA?5@0"#93 @]_D-><_ XG[%K0R<"2(X_!J /6:*** *-]
MHVEZFZ/?Z;9W;H,*UQ LA4>@R*N(BQHJ(H5% "JHP /04ZL_7+6\OM#O;73[
MC[/>2Q,L,N\IL8]#D<C\* 'ZKJ]CHFGR7VHW"00)W8\L?0#N>.@KQ7P&DOB7
MXK3:U' 5MDEFNG!/W P8("?7)'Y&J.N?#KQJ@:[NXI-2(!9GCN/.<?@?F)^@
M-=A\*_%^E&-/#S6$>GWIY5DSMN& YW$\AN/IZ8Z4 >I2QB:%XF)"NI4XZX->
M%_#&^3POXXO-*U;%M+*IMLL>!*K# STP><'OQZU[O7B?Q;N_#EYJJV]I%)-K
MB8CEDMR OLK\'<PZ<<CH3Q@ 'ME>>?%_6[6S\)/I1D4W=\Z;8@?F"*P8L?09
M4#\?8XY+28OBS'IRP6:W:P!1M%QY(<#& ,R?,.G3M7.V'DV/B]9O'EIJ+DMO
M;S.Y[%@1EE]@1^/2@#U_X66$]AX#L_/4JUPSSJIZA6/RG\0 ?H:[.H;2>WN;
M2&>TDCDMW0-&T9RI7MBIJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \-^,'_(
M^Z;_ -><7_HV2O<J\-^,'_(^Z;_UYQ?^C9*]RH **** .<\?%AX#UG9G/V8]
M!VXS^E<O\$_*_P"$5OL$>;]N.X9YV[$QQ_WU7HE[:17]C<6<X)AN(FB<#KM8
M8/Z&O$_!NJ/\.O&M[HFLMLM;A@CS=%!&=DG3[I!Q^//2@#W.BFHZR(KHP9&
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MEH__ "!+#_KVC_\ 016%\0_#P\1>$+J%%!NK<?:+<_[2CD?BN1]2/2MW1_\
MD"6'_7M'_P"@BKM 'FOP<\0&_P! ET>9LS6#9C]XF.?T.?P(KF-8/_"QOBO'
MI\+%]-M#Y;.G3RT.7;(S]YN ?=:H>+X+[P!X[N;O2V,4=[%(\+D' $@(8 ^J
MMR/3Y<UVOP<\/?8=#EUJ9,37QVQ9'(B4_P!3_(4 >DHBQHJ(H5% "JHP /05
MXM\;RW]KZ2#G8('QQWW<_P!*]KK@/BSX<DUKPPM[;*6N-.9I=H_BC(&_'N,
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MR5T7P\4)X!T<*,#R2?S8FN=^-?\ R)MG_P!A!/\ T7)71_#[_D0M'_ZX?U-
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_#GA&SLIQBY<&:<8^Z[<[?P&!^% '2T5FZSX@TKP_;I/JM[';(Y(3<"2Q'7
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MW:GK,H8(X%O&QS\YSN8_HOZUZ]0 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'G
M'CSX?ZKXH\36FI6-Q91PPVZ1,L[L&)#LQQA2,88=Z]'HHH **** "N;\6^"M
M,\76JK= PW<8Q%<QCYE'H1W'M^6*Z2B@#QF'PC\2?"^(=$U!;BW'*K',I4?\
M EX!^E$_A;XF^)A]FUF^6WMBWS"29 I&,?=BSGCL:]FHH Y/P=X"TWPC%YJ$
MW&H.FV2Y<=/4*/X1_/%=)?64.HV%Q97(8P7$;1R!6*DJ1@\BK%% 'C4GP[\8
M>%+Z2Y\*:D)XFZ)O5'(ST97^0X]<_@.E \!>-?%VH0R>++_R+:,DXWHS#I]U
M$^4$X'/X\]*]EHH K:?86VE:?;V%G$([>! B*/0>OJ>Y/<UPE[X"U2Y^**^)
MTN+,60EB?RR[>9A8U4\;<=1ZUZ)10 5YWXV\!:IXD\6V&K6=Q9QP6\4:.LSL
M&)61F. %(Z,.]>B44 %<'\2/!6I>,/[,_L^>TB^R^;O^T.RYW;,8PI_NFN\H
MH KV$#6NG6MNY!>*)$8KT)  XJQ110!ROCKP<GC#3K2!9$AG@G#+,V3MC/#@
M#OQ@XXY4<BNEMK>*TM8K:WC$<,*".-!T50, ?E4M% !1110!YEXE^$_VK5#J
MOAN]73KDOO\ *.517_O(R\KSVQ],=*R/L/Q?MHOLT<TDL?\ ?\ZW8_\ ?3?-
M7LE% 'CNG?"K7=;U 7OBW5'*]T64RRM[9/RJ/IGZ"O6K*RMM-LH;.SA2&WA7
M:D:#@#_/>K%% !1110 5B>)O"NF>*[ 6VH1G>F?)G0X>(G&<?7 R*VZ* /%D
M\!^/O"MPW_".ZE]H@W958Y@@;W:.3Y<_B:LMX;^)_B)3;ZMJ:V=N5PX,J*&&
M>F(AS^->P44 >>2_"^VLO!6HZ1I4D;ZE>>6'N[KY<A9%;;P#M7Y3QSSC/MN^
M _#MWX7\-+IM[)!),)7?= Q*X./4 _I7344 <E\0_"][XMT""PL);>.6.Z68
MF=F"[0KCL#S\PK6\+Z5/HGAFPTVY>-YK>/8[1DE2<GID _I6O10 5@^,]$N?
M$7A.]TJT>))Y_+VM,2%&V16.2 3T![5O44 <SX#\.W?A?PTNFWLD$DPE=]T#
M$K@X]0#^E;U_ UUIUU;H0'EB=%+= 2".:L44 <'\-_!6I>#_ .T_[0GM)?M7
ME;/L[LV-N_.<J/[PKO*** /._!/@+5/#?BV_U:\N+.2"XBD1%A=BP+2*PR"H
M'13WKT2BB@ HHHH BN;:"\MI+:YB26&52KQN,A@>QKR?5_A-J6FZA_:/A'4F
MA8'Y8GD,<D8. 0KCJ.O!QQZUZ[10!XX++XONBVS3.L8./,,MOGZEA\QK8\-?
M"QHK]=6\4WO]I7@(80LS.@8="S-R_P!,8^M>ET4 >=Z#X"U32_B->^(9[BS:
MTGEN'5$=C( [$C(*@=^>:Z#QIX0M_&&E+;23-!<0L7@E'(4GJ"O<'\Q^8/24
M4 >,P^'?BCX=B.GZ5=B>T PICFB95'HOFX*]>U:WA/X9WB:U_;WBFY6ZO _F
M)#NWY?LSMWQV ]N>U>H44 %>/:A\+_%3>)]1U?3-5L[0W%S++&Z7$L<@5V)P
M2J>AYYKV&B@#R#_A ?B/_P!#;_Y4KC_XFJ__  J;Q9>@QZCXA@:'T\^67OZ,
M!7L]% 'G7A[X0:/I4J7&IRMJ4RX(1TVQ ^Z\[OQ./:O1%4*H50 H&  . *6B
M@ KS/PC\.]7T#QI)K-U<6+VS>;A8G<O\W3@J!^M>F44 %%%% ",H92K %2,$
M$<$5R&@>!XO#GC&_U2P:--/NK?8MN,@Q/N!(';;QGVSC%=A10!ROC[0=8\2Z
M$NEZ7-:1))(&N&N'9<JO( PI[X/X"IO!'A<>$_#L=B[1R73N9;B1,[6<\<9Y
MP  /PSWKI** "BBB@ KS?Q'\/M5N/'$7B3P_<V<#@I+(EP[+F0<' 53P0!GW
M)]:](HH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M:U:* /%_^%?>-_"]S,?#6I^; _.$E$9;_>1OES[YJ6;2OBUK"?9;VY^SPO\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M^%K^!/\ H9;+_P >_P * .RHKC?^%K^!/^AELO\ Q[_"C_A:_@3_ *&6R_\
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M-_X6OX$_Z&6R_P#'O\*/^%K^!/\ H9;+_P >_P * .RHKC?^%K^!/^AELO\
MQ[_"C_A:_@3_ *&6R_\ 'O\ "@#LJ*XW_A:_@3_H9;+_ ,>_PH_X6OX$_P"A
MELO_ ![_  H [*BN-_X6OX$_Z&6R_P#'O\*/^%K^!/\ H9;+_P >_P * .RH
MKC?^%K^!/^AELO\ Q[_"C_A:_@3_ *&6R_\ 'O\ "@#LJ*XW_A:_@3_H9;+_
M ,>_PH_X6OX$_P"AELO_ ![_  H [*BN-_X6OX$_Z&6R_P#'O\*/^%K^!/\
MH9;+_P >_P * .RHKC?^%K^!/^AELO\ Q[_"C_A:_@3_ *&6R_\ 'O\ "@#L
MJ*XW_A:_@3_H9;+_ ,>_PH_X6OX$_P"AELO_ ![_  H [*BN-_X6OX$_Z&6R
M_P#'O\*/^%K^!/\ H9;+_P >_P * .RHKC?^%K^!/^AELO\ Q[_"C_A:_@3_
M *&6R_\ 'O\ "@#LJ*XW_A:_@3_H9;+_ ,>_PH_X6OX$_P"AELO_ ![_  H
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M!/\ H9;+_P >_P * .RHKC?^%K^!/^AELO\ Q[_"C_A:_@3_ *&6R_\ 'O\
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M^%K^!/\ H9;+_P >_P * .RHKC?^%K^!/^AELO\ Q[_"C_A:_@3_ *&6R_\
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M-_X6OX$_Z&6R_P#'O\*/^%K^!/\ H9;+_P >_P * .RHKC?^%K^!/^AELO\
MQ[_"C_A:_@3_ *&6R_\ 'O\ "@#LJ*XW_A:_@3_H9;+_ ,>_PH_X6OX$_P"A
MELO_ ![_  H [*BN-_X6OX$_Z&6R_P#'O\*/^%K^!/\ H9;+_P >_P * .RH
MKC?^%K^!/^AELO\ Q[_"C_A:_@3_ *&6R_\ 'O\ "@#LJ*XW_A:_@3_H9;+_
M ,>_PH_X6OX$_P"AELO_ ![_  H [*BN-_X6OX$_Z&6R_P#'O\*/^%K^!/\
MH9;+_P >_P * .RHKC?^%K^!/^AELO\ Q[_"C_A:_@3_ *&6R_\ 'O\ "@#L
MJ*XW_A:_@3_H9;+_ ,>_PH_X6OX$_P"AELO_ ![_  H [*BN-_X6OX$_Z&6R
M_P#'O\*/^%K^!/\ H9;+_P >_P * .RHKC?^%K^!/^AELO\ Q[_"C_A:_@3_
M *&6R_\ 'O\ "@#LJ*XW_A:_@3_H9;+_ ,>_PH_X6OX$_P"AELO_ ![_  H
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M!/\ H9;+_P >_P * .RHKC?^%K^!/^AELO\ Q[_"C_A:_@3_ *&6R_\ 'O\
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M^%K^!/\ H9;+_P >_P * .RHKC?^%K^!/^AELO\ Q[_"C_A:_@3_ *&6R_\
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M-_X6OX$_Z&6R_P#'O\*/^%K^!/\ H9;+_P >_P * .RHKC?^%K^!/^AELO\
MQ[_"C_A:_@3_ *&6R_\ 'O\ "@#LJ*XW_A:_@3_H9;+_ ,>_PH_X6OX$_P"A
MELO_ ![_  H [*BN-_X6OX$_Z&6R_P#'O\*/^%K^!/\ H9;+_P >_P * .RH
MKC?^%K^!/^AELO\ Q[_"C_A:_@3_ *&6R_\ 'O\ "@#LJ*XW_A:_@3_H9;+_
M ,>_PH_X6OX$_P"AELO_ ![_  H [*BN-_X6OX$_Z&6R_P#'O\*/^%K^!/\
MH9;+_P >_P * .RHKC?^%K^!/^AELO\ Q[_"C_A:_@3_ *&6R_\ 'O\ "@#L
MJ*XW_A:_@3_H9;+_ ,>_PH_X6OX$_P"AELO_ ![_  H [*BN-_X6OX$_Z&6R
M_P#'O\*/^%K^!/\ H9;+_P >_P * .RHKC?^%K^!/^AELO\ Q[_"C_A:_@3_
M *&6R_\ 'O\ "@#LJ*XW_A:_@3_H9;+_ ,>_PH_X6OX$_P"AELO_ ![_  H
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M!/\ H9;+_P >_P * .RHKC?^%K^!/^AELO\ Q[_"C_A:_@3_ *&6R_\ 'O\
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M^%K^!/\ H9;+_P >_P * .RHKC?^%K^!/^AELO\ Q[_"C_A:_@3_ *&6R_\
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M-_X6OX$_Z&6R_P#'O\*/^%K^!/\ H9;+_P >_P * .RHKC?^%K^!/^AELO\
MQ[_"C_A:_@3_ *&6R_\ 'O\ "@#LJ*XW_A:_@3_H9;+_ ,>_PH_X6OX$_P"A
MELO_ ![_  H [*BN-_X6OX$_Z&6R_P#'O\*/^%K^!/\ H9;+_P >_P * .RH
MKC?^%K^!/^AELO\ Q[_"C_A:_@3_ *&6R_\ 'O\ "@#LJ*XW_A:_@3_H9;+_
M ,>_PH_X6OX$_P"AELO_ ![_  H [*BN-_X6OX$_Z&6R_P#'O\*/^%K^!/\
MH9;+_P >_P * .RHKC?^%K^!/^AELO\ Q[_"C_A:_@3_ *&6R_\ 'O\ "@#L
MJ*XW_A:_@3_H9;+_ ,>_PH_X6OX$_P"AELO_ ![_  H [*BN-_X6OX$_Z&6R
M_P#'O\*/^%K^!/\ H9;+_P >_P * .RHKC?^%K^!/^AELO\ Q[_"C_A:_@3_
M *&6R_\ 'O\ "@#LJ*XW_A:_@3_H9;+_ ,>_PH_X6OX$_P"AELO_ ![_  H
M[*BN-_X6OX$_Z&6R_P#'O\*/^%K^!/\ H9;+_P >_P * .RHKC?^%K^!/^AE
MLO\ Q[_"C_A:_@3_ *&6R_\ 'O\ "@#LJ*XW_A:_@3_H9;+_ ,>_PH_X6OX$
M_P"AELO_ ![_  H [*BN-_X6OX$_Z&6R_P#'O\*/^%K^!/\ H9;+_P >_P *
M .RHKC?^%K^!/^AELO\ Q[_"C_A:_@3_ *&6R_\ 'O\ "@#LJ*XW_A:_@3_H
M9;+_ ,>_PH_X6OX$_P"AELO_ ![_  H [*BN-_X6OX$_Z&6R_P#'O\*/^%K^
M!/\ H9;+_P >_P * .RHKC?^%K^!/^AELO\ Q[_"C_A:_@3_ *&6R_\ 'O\
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M^%K^!/\ H9;+_P >_P * .RHKC?^%K^!/^AELO\ Q[_"C_A:_@3_ *&6R_\
M'O\ "@#LJ*XW_A:_@3_H9;+_ ,>_PH_X6OX$_P"AELO_ ![_  H [*BN-_X6
MOX$_Z&6R_P#'O\*/^%K^!/\ H9;+_P >_P * .RHKC?^%K^!/^AELO\ Q[_"
MC_A:_@3_ *&6R_\ 'O\ "@#LJ*XW_A:_@3_H9;+_ ,>_PH_X6OX$_P"AELO_
M ![_  H [*BN-_X6OX$_Z&6R_P#'O\*/^%K^!/\ H9;+_P >_P * .RHKC?^
M%K^!/^AELO\ Q[_"C_A:_@3_ *&6R_\ 'O\ "@#LJ*XW_A:_@3_H9;+_ ,>_
MPH_X6OX$_P"AELO_ ![_  H [*BN-_X6OX$_Z&6R_P#'O\*/^%K^!/\ H9;+
M_P >_P * .RHKC?^%K^!/^AELO\ Q[_"C_A:_@3_ *&6R_\ 'O\ "@#LJ*XW
M_A:_@3_H9;+_ ,>_PH_X6OX$_P"AELO_ ![_  H [*BN-_X6OX$_Z&6R_P#'
MO\*/^%K^!/\ H9;+_P >_P * .RHKC?^%K^!/^AELO\ Q[_"C_A:_@3_ *&6
MR_\ 'O\ "@#LJ*XW_A:_@3_H9;+_ ,>_PH_X6OX$_P"AELO_ ![_  H [*BN
M-_X6OX$_Z&6R_P#'O\*/^%K^!/\ H9;+_P >_P * .RHKC?^%K^!/^AELO\
MQ[_"C_A:_@3_ *&6R_\ 'O\ "@#LJ*XW_A:_@3_H9;+_ ,>_PH_X6OX$_P"A
MELO_ ![_  H [*BN-_X6OX$_Z&6R_P#'O\*/^%K^!/\ H9;+_P >_P * .RH
MKC?^%K^!/^AELO\ Q[_"C_A:_@3_ *&6R_\ 'O\ "@#LJ*XW_A:_@3_H9;+_
M ,>_PH_X6OX$_P"AELO_ ![_  H [*BN-_X6OX$_Z&6R_P#'O\*/^%K^!/\
MH9;+_P >_P * .RHKC?^%K^!/^AELO\ Q[_"C_A:_@3_ *&6R_\ 'O\ "@#L
MJ*XW_A:_@3_H9;+_ ,>_PH_X6OX$_P"AELO_ ![_  H [*BN-_X6OX$_Z&6R
M_P#'O\*/^%K^!/\ H9;+_P >_P * .RHKC?^%K^!/^AELO\ Q[_"C_A:_@3_
M *&6R_\ 'O\ "@#LJ*XW_A:_@3_H9;+_ ,>_PH_X6OX$_P"AELO_ ![_  H
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M!/\ H9;+_P >_P * .RHKC?^%K^!/^AELO\ Q[_"C_A:_@3_ *&6R_\ 'O\
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M^%K^!/\ H9;+_P >_P * .RHKC?^%K^!/^AELO\ Q[_"C_A:_@3_ *&6R_\
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M /'_ /AG#PC_ -!+7/\ O]%_\;H_X9P\(_\ 02US_O\ 1?\ QNO8** /'_\
MAG#PC_T$M<_[_1?_ !NC_AG#PC_T$M<_[_1?_&Z]@HH \?\ ^&</"/\ T$M<
M_P"_T7_QNC_AG#PC_P!!+7/^_P!%_P#&Z]@HH \?_P"&</"/_02US_O]%_\
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M]!+7/^_T7_QNO8** /'_ /AG#PC_ -!+7/\ O]%_\;H_X9P\(_\ 02US_O\
M1?\ QNO8** /'_\ AG#PC_T$M<_[_1?_ !NC_AG#PC_T$M<_[_1?_&Z]@HH
M\?\ ^&</"/\ T$M<_P"_T7_QNC_AG#PC_P!!+7/^_P!%_P#&Z]@HH \?_P"&
M</"/_02US_O]%_\ &Z/^&</"/_02US_O]%_\;KV"B@#Q_P#X9P\(_P#02US_
M +_1?_&Z/^&</"/_ $$M<_[_ $7_ ,;KV"B@#Q__ (9P\(_]!+7/^_T7_P ;
MH_X9P\(_]!+7/^_T7_QNO8** /'_ /AG#PC_ -!+7/\ O]%_\;H_X9P\(_\
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M\(_]!+7/^_T7_P ;H_X9P\(_]!+7/^_T7_QNO8** /'_ /AG#PC_ -!+7/\
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M'_\ AG#PC_T$M<_[_1?_ !NC_AG#PC_T$M<_[_1?_&Z]@HH \?\ ^&</"/\
MT$M<_P"_T7_QNC_AG#PC_P!!+7/^_P!%_P#&Z]@HH \?_P"&</"/_02US_O]
M%_\ &Z/^&</"/_02US_O]%_\;KV"B@#Q_P#X9P\(_P#02US_ +_1?_&Z/^&<
M/"/_ $$M<_[_ $7_ ,;KV"B@#Q__ (9P\(_]!+7/^_T7_P ;H_X9P\(_]!+7
M/^_T7_QNO8** /'_ /AG#PC_ -!+7/\ O]%_\;H_X9P\(_\ 02US_O\ 1?\
MQNO8** /'_\ AG#PC_T$M<_[_1?_ !NC_AG#PC_T$M<_[_1?_&Z]@HH \?\
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M /'_ /AG#PC_ -!+7/\ O]%_\;H_X9P\(_\ 02US_O\ 1?\ QNO8** /'_\
MAG#PC_T$M<_[_1?_ !NC_AG#PC_T$M<_[_1?_&Z]@HH \?\ ^&</"/\ T$M<
M_P"_T7_QNC_AG#PC_P!!+7/^_P!%_P#&Z]@HH \?_P"&</"/_02US_O]%_\
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M]!+7/^_T7_QNO8** /'_ /AG#PC_ -!+7/\ O]%_\;H_X9P\(_\ 02US_O\
M1?\ QNO8** /'_\ AG#PC_T$M<_[_1?_ !NC_AG#PC_T$M<_[_1?_&Z]@HH
M\?\ ^&</"/\ T$M<_P"_T7_QNC_AG#PC_P!!+7/^_P!%_P#&Z]@HH \?_P"&
M</"/_02US_O]%_\ &Z/^&</"/_02US_O]%_\;KV"B@#Q_P#X9P\(_P#02US_
M +_1?_&Z/^&</"/_ $$M<_[_ $7_ ,;KV"B@#Q__ (9P\(_]!+7/^_T7_P ;
MH_X9P\(_]!+7/^_T7_QNO8** /'_ /AG#PC_ -!+7/\ O]%_\;H_X9P\(_\
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M\(_]!+7/^_T7_P ;H_X9P\(_]!+7/^_T7_QNO8** /'_ /AG#PC_ -!+7/\
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M'_\ AG#PC_T$M<_[_1?_ !NC_AG#PC_T$M<_[_1?_&Z]@HH \?\ ^&</"/\
MT$M<_P"_T7_QNC_AG#PC_P!!+7/^_P!%_P#&Z]@HH \?_P"&</"/_02US_O]
M%_\ &Z/^&</"/_02US_O]%_\;KV"B@#Q_P#X9P\(_P#02US_ +_1?_&Z/^&<
M/"/_ $$M<_[_ $7_ ,;KV"B@#Q__ (9P\(_]!+7/^_T7_P ;H_X9P\(_]!+7
M/^_T7_QNO8** /'_ /AG#PC_ -!+7/\ O]%_\;H_X9P\(_\ 02US_O\ 1?\
MQNO8** /'_\ AG#PC_T$M<_[_1?_ !NC_AG#PC_T$M<_[_1?_&Z]@HH \?\
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M /'_ /AG#PC_ -!+7/\ O]%_\;H_X9P\(_\ 02US_O\ 1?\ QNO8** /'_\
MAG#PC_T$M<_[_1?_ !NC_AG#PC_T$M<_[_1?_&Z]@HH \?\ ^&</"/\ T$M<
M_P"_T7_QNC_AG#PC_P!!+7/^_P!%_P#&Z]@HH \?_P"&</"/_02US_O]%_\
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M]!+7/^_T7_QNO8** /'_ /AG#PC_ -!+7/\ O]%_\;H_X9P\(_\ 02US_O\
M1?\ QNO8** /'_\ AG#PC_T$M<_[_1?_ !NC_AG#PC_T$M<_[_1?_&Z]@HH
M\?\ ^&</"/\ T$M<_P"_T7_QNC_AG#PC_P!!+7/^_P!%_P#&Z]@HH \?_P"&
M</"/_02US_O]%_\ &Z/^&</"/_02US_O]%_\;KV"B@#Q_P#X9P\(_P#02US_
M +_1?_&Z/^&</"/_ $$M<_[_ $7_ ,;KV"B@#Q__ (9P\(_]!+7/^_T7_P ;
MH_X9P\(_]!+7/^_T7_QNO8** /'_ /AG#PC_ -!+7/\ O]%_\;H_X9P\(_\
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M\(_]!+7/^_T7_P ;H_X9P\(_]!+7/^_T7_QNO8** /'_ /AG#PC_ -!+7/\
MO]%_\;H_X9P\(_\ 02US_O\ 1?\ QNO8** /'_\ AG#PC_T$M<_[_1?_ !NC
M_AG#PC_T$M<_[_1?_&Z]@HH \?\ ^&</"/\ T$M<_P"_T7_QNC_AG#PC_P!!
M+7/^_P!%_P#&Z]@HH \?_P"&</"/_02US_O]%_\ &Z/^&</"/_02US_O]%_\
M;KV"B@#Q_P#X9P\(_P#02US_ +_1?_&Z/^&</"/_ $$M<_[_ $7_ ,;KV"B@
M#Q__ (9P\(_]!+7/^_T7_P ;H_X9P\(_]!+7/^_T7_QNO8** /'_ /AG#PC_
M -!+7/\ O]%_\;H_X9P\(_\ 02US_O\ 1?\ QNO8** /'_\ AG#PC_T$M<_[
M_1?_ !NC_AG#PC_T$M<_[_1?_&Z]@HH \?\ ^&</"/\ T$M<_P"_T7_QNC_A
MG#PC_P!!+7/^_P!%_P#&Z]@HH \?_P"&</"/_02US_O]%_\ &Z/^&</"/_02
MUS_O]%_\;KV"B@#Q_P#X9P\(_P#02US_ +_1?_&Z/^&</"/_ $$M<_[_ $7_
M ,;KV"B@#Q__ (9P\(_]!+7/^_T7_P ;H_X9P\(_]!+7/^_T7_QNO8** .+\
M#?#/1O $][-I5U?S-=JJR"Z=& "DD8VJOK79HH1%4= ,4M% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%9.C^(]/UNZU"UM787%A</;S128#94XW  GY20<'VH UJ**
M* "BBN5T7Q]I6N^(I]$M;>\2Y@W[GE10AV'!P0Q/Z4 =51110 445DVOB/3K
MSQ'>Z##(QOK.-9)!M^4@XS@]R,KG_>'O@ UJ*** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HILDB0Q/+*ZI&BEF=C@*!U
M)/85YQK7QET:PN&ATVTFU';P90WE1GZ$@D_E],T >DT5Y?IGQLTRXF":EID]
MFISB2.03 ?7A3Z] >WX>E6EW;W]K'=6D\<\$@RDD;!E8?6@":BBB@ HHILCK
M%&TCG"J"Q/H!0 ZBO-_^%U^&_P#GRU7_ +]1_P#QRC_A=?AO_GRU7_OU'_\
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M10 4444 %%%% !1110 4444 %>0?'/\ Y@/_ &\?^TZ]?KR#XY_\P'_MX_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MK-\0ZNF@^'[[5)%#"WB+*I. S=%&?<D#\:TJ\Y^,]VT/A"WMU)'VB[4-Z%0K
M'^>V@#F/A[X4/C+4KSQ+XA!N83,=J,<"67J<C^Z,@8Z=N@(KV7[!9_9#:?9(
M/LQ&##Y8V$?[N,=A^58'P[M4M/ .D(@ WP^:<=RQ+?UKIZ /%/B'X5_X0[4;
M+Q-X>!MHQ, T:?=ADZ@@?W6P00>.W?%>K^'-83Q!X>LM4C7:+B/++Z,#AA^8
M-4_'%D+_ ,#ZS >UJ\H&,Y*?./U45R?P4O/-\,WUF228+K<.>BLHX_-3^= '
MIE%%% !7B/B55\1_&ZUL&47$$,L43(1D%%&]U^GWL_C7MU?/7A_Q5IME\2=0
M\0ZFTWDLT[PB)=Y)8X4=N-I//L* /;?^$3\-_P#0OZ5_X!1_X4J^%?#J.KIH
M.EJRG(86<8(/Y5R<'QF\,32;7AU& ?WY(5(_\=8G]*[C3=3LM7LDO-/N8[BW
M?HZ'OZ'T/L: +=<1\6+[[%X"ND#;6NI8X![\[B/R4UV]>2_'"_VVFDZ<K??=
MYW7/3 "J<?\  F_*@#5^&OA729O!%I=:AI-C<SW#O)OGMTD;;N(')'3 SCWK
MK?\ A$_#?_0OZ5_X!1_X5PFD_%;PSHNB:?IJ0:C-]GMDC9HXEQN P?O.._/X
MUUWA_P >^'_$DQM[*[*7/:"==C-].Q^@.: -RRTZRTV$PV%G;VL3-O*01*BE
MN!G '7@?E5FBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "LWQ#JZ:#X?OM4D4,+>(LJDX#-T49]R0/QK2KSGXSW;0^$+>W4D?:+M0WH5
M"L?Y[: .8^'OA0^,M2O/$OB$&YA,QVHQP)9>IR/[HR!CIVZ BO9?L%G]D-I]
MD@^S$8,/EC81_NXQV'Y5@?#NU2T\ Z0B #?#YIQW+$M_6NGH \4^(?A7_A#M
M1LO$WAX&VC$P#1I]V&3J"!_=;!!!X[=\5ZOX<UA/$'AZRU2-=HN(\LOHP.&'
MY@U3\<60O_ ^LP'M:O*!C.2GSC]5%<G\%+SS?#-]9DDF"ZW#GHK*./S4_G0!
MZ91110 4UW6-&=V"HH)9F. !ZFG5Y5\6_%YMH/\ A&K%CY\Z@W3 =$/1![GJ
M?;'K0!S6L7EY\4?'D6G6+.FG0DA"1D1Q@C?*1ZGC'_ 17N.GV%MI6GV]A9Q"
M.W@0(BCT'KZGN3W-<O\ #KP@/"V@A[A!_:5V!)<'KL'\*?AGGW)ZC%=C0 5Q
M'Q8OOL7@*Z0-M:ZEC@'OSN(_)37;UY+\<+_;::3IRM]]WG=<], *IQ_P)ORH
M U?AKX5TF;P1:76H:38W,]P[R;Y[=)&V[B!R1TP,X]ZZW_A$_#?_ $+^E?\
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M=!3O=)8V;MA2I _\>:NZ^'.D0Z1X(TX(B>;=1"YE=>K%_F&?HI _"N/^./\
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M#/\ Y*S?_$5P7Q0\0^%?$VFVL^F7XFU*WDV@>1(A:(@Y!+*.AP1SW/K7>_\
M"K?!O_0&_P#)J;_XNHY?AKX'@"&;3(X][A$WWDHW,>@&7Y)]* +_ (!U=M:\
M%:;=2-NF2/R93WW(=N3[D '\:\W^-_\ R&]+_P"O9O\ T*O7M'T73] L!8Z9
M;^1;!BX3>S<GKRQ)KR'XW_\ (;TO_KV;_P!"H ]4\)Z3#HGA;3K&%<;(59S_
M 'G;YF/YDULT44 ?/?Q1L0?B/-%"H1KI83D\ L0%S^G\Z]YTS3H-)TNVT^V0
M+#;QB-0!C.!U^IZGW->-_$7_ )*UI?\ V[?^C#7M] !7B5@PT_X_2I""$EN9
M XSUWQDG_P >.:]MKQ#_ )N _P"WK_VE0!Z=XXUE]"\':C>Q,RS^7Y<3+U5V
M.T$?3.?PKR[X8:YX5\-VMU>:M?)%J4K[$'D2.4C [$*0,G.?H*[KXM6\DW@&
MY:-<B*:.1_8;L?S(KGOAYX*\+>(?!]O>7NFF:\622.:0SR+DAB1PK ?=*]A0
M!U/_  M+P;_T&?\ R5F_^(H_X6EX-_Z#/_DK-_\ $4?\*M\&_P#0&_\ )J;_
M .+H_P"%6^#?^@-_Y-3?_%T >6>+=?T:+Q_:>(O#=R)AN2:=1&Z R X;@@<,
MN,^Y/K7T!%*DT22QL&1U#*P[@]#7'?\ "M? _P!H%O\ V9'YY3?Y?VR7=MSC
M.-^<9XS78PPI;P1PQ+MCC4(HSG  P* /GK6-*_MOXP7.FG&R>_VOSCY.K?H#
M7T+##';P1PPH$BC4(BCHH P!7BNE?\G!2?\ 7S/_ .B7KVV@ KQ37]NF?'>Q
ME@&PSW%ONV<<N C?GDY^IKVNO$O&/_);])_Z^;/_ -#6@#VVO$OC?_R&]+_Z
M]F_]"KVVO$OC?_R&]+_Z]F_]"H ]MHHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O"/#7_)>9_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MK_CS^(-=C7COP-:7S=<0#,6(23GHWSX_K^5>Q4 %%%% !1110 4444 %%%%
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M /1:UL5S'P\O5OO >DNKAS'#Y+<\J4)7!_ #\,5T] &;XB_Y%G5O^O.;_P!
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M$'W!!!^E7:\I^"%[))IFKV+,3'!+'*HQT+A@?_0!7JU !1110 4444 %%%%
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M[, #WZUY1\0OB-:WU@^@^'I7N9;D^7-/$,@J?X%_O%LX./ISGA%^!L8E!?Q
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M #)ED<*N/J>*Y/Q-\,]"\1SO=[7LKUVW/-!T<]]RG@GW&#ZYKE5^!L8E!?Q
MQCSRHM,''UW_ -* (_B'\0X=5MF\/^'B;H7'RSSQJ3N&?N)ZY[GTX%=I\/?"
M;>%/#WDW.TWURWFW!4Y"G& @/? _4GM4WACP'H?A4^;:0M->8P;J<AG'LO91
MUZ#/J373T >0?'/_ )@/_;Q_[3KU+1_^0)8?]>T?_H(K(\5^"M-\8?9/[0GN
MXOLN_9]G=5SNVYSE3_=%;]M MK:PVZ$E(D5%+=2 ,<T >+>+=,O_ (?>.$\2
MZ9!NT^>0OC'RJS??C/IGDCZ\=*]0\/\ C'1?$=I'+9WL2S-@-;2.%E5O3;W^
MHX-:]Y9VVH6<MI>0)/;RKM>-QD,*\ZU3X+:-=2%].OKFQR3E&'G(/3&2#^9-
M '>:EKFE:/"TNHZA;VRKVDD 8]\ =2?85XWX@U>^^*?BBVTC2(F33K=R1(R]
M!T:5_08Z#KSZG%;EK\#K1)0;S7)I8_[L-N(S^99OY5Z)H?A[2_#EE]ETNU6%
M#C>W5Y#ZLQY/4_3/&* +EA:+8:?;V:.[K!&L89V))P,9)/->-?&__D-Z7_U[
M-_Z%7MM<MXI\!:7XNNK>XO[B\C>!"BBW=5!!.><J: .IHHHH \0^(O\ R5K2
M_P#MV_\ 1AKV^N5UKP#I6N^(H-;NKB\2Y@V;4B=0AV'(R"I/ZUU5 !7B'_-P
M'_;U_P"TJ]OKE?\ A =*_P"$P_X2;[1>?;?,\SR]Z^7G;MZ;<]/>@#H=1L+?
M5-.N;"Z3?!<1F-QWP1V]_0UXEX?U6^^%GBNYTK5XF;3KAAND5>JYPLJ^HQU'
M]17NU9>N^'=+\268M=4M5F1<E&R5:,GNI'(_D<<T 3Z=K&FZO"LNGWUO<H5#
M?NI 2![CJ/H:R]>\:Z%X>MGDNK^%Y@N4MXG#2.>W Z9]3@5Q5[\$+*29FL=:
MG@C/1)H!*1^(*_RJQI?P5TFUF634M0N+X*<^6B>2K>QP2?R(H P?"5EJOC_Q
MT?%%ZK6]E;."I0D#*_=C4Y!]R?\ &O;*AM+2WL+6.UM((X((QA(XU"JH^E34
M >):5_R<%)_U\S_^B7KVVN6M_ 6EVWC$^)TN+PWI=W\LNOEY92IXVYZ'UKJ:
M "O$O&/_ "6_2?\ KYL__0UKVVN6U+P%I>J>*K?Q#/<7BW<#Q.J(ZB,E"",@
MJ3VYYH ZFO$OC?\ \AO2_P#KV;_T*O;:Y;Q3X"TOQ==6]Q?W%Y&\"%%%NZJ"
M"<\Y4T =31110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MS(.#G&[9C[O0]<X[5Z37FZ_!W2E\1_VC]NG-D)?-%EL&<YSMWYY7/MG'?/-
M'H5U;)>6<]K+GRYHVC;'7!&#_.O"_"6I2?#;QO>:;K2R):S#RGD4';PWR2@=
MUQGW&X]QBO>JQ/$GA/2/%5JL.I0$O'GRIHVVR1YZX/\ 0@B@#2M-0L[^T%U:
M74,]OC/F1N&4<9Z]JX'X@_$;3].TJ?3=(NX[G49U,9>%MRP*>"2PXW=0 .AY
M/ODR? V,OF+Q RKZ-:;C^>\5T/A[X4:#HEREU<-)J-PARGG@"-3ZA!U/U)H
MI_"+PO-I&CS:K>(4GOPOE(>JQ#D'_@1.?H!ZU>^*GAR;7?"XGM4+W5BYE5%7
M)=",,![]#^%=U10!YS\-_'MAJ.CVNCZA.EOJ%L@B3S#A9D X()[@#!'X]^.\
MO-3L=.M3=7EW#!!M+;W< $8SQZ_A7'>(OA3H6N74EY \NGW,A+.8<%')[E3W
M^A%8%M\#K995-UKTLL>1E8K8(2._)9OY4 8.L7LWQ2\>VMII\+C3K?Y/,(.1
M%G+R-Z9[#Z#K7NZJ%4*H 4#  ' %9>@^'-+\-6/V73+81*V#(Y.7D([L>_\
M(9X K5H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M#;PS+X:\+JEVNV]NG\Z93U3C"K^ &3[DUV-%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %9OB#1XM?T"]TN8X6XCVAO[K#E3^! -:5%
M'B7P\\5?\(9J=[X;\0$VL/G$AV&1%+P#DC^$@#!Z=^AS7LOV^S^R"[^UP?9B
M,B;S!L(_WLX['\JP_%'@C1_%<0-Y$8KI00ES%@... ?[P]C^&,UQ'_"C8?/S
M_;\GDY^[]E&['UW_ -* ,_XB^+1XNOK3PUX?#74?G!GDC!Q+)C "_P"R,DD_
MX9/JWAO1(?#OA^STN$AO(3YW'\;GEF_$D_3I5#PQX'T7PHN^RA:2Z*E6N9CE
MR#V'8#Z#ZYKI* .4\;>.;;P9#;>9:O=7%SNV1JX0 +C))YQU';U]*N^$?%5K
MXNT;[?;Q-"Z/Y<L+')1L \'N.>#@52\:^!;7QE! 7NGM;JWR(Y0N\;3C(*Y&
M>GJ*N^$O"MIX1T@V%K(\S/(9)97 !=B .G88 XH P_BIX<FUWPN)[5"]U8N9
M515R70C# >_0_A5/X;^/;#4='M='U"=+?4+9!$GF'"S(!P03W &"/Q[\>C5P
MGB+X4Z%KEU)>0/+I]S(2SF'!1R>Y4]_H10!V-YJ=CIUJ;J\NX8(-I;>[@ C&
M>/7\*\1UB]F^*7CVUM-/A<:=;_)YA!R(LY>1O3/8?0=:WK;X'6RRJ;K7I98\
MC*Q6P0D=^2S?RKT70?#FE^&K'[+IEL(E;!D<G+R$=V/?^0SP!0 OB#1UUOPY
M>Z4&$7GPE$..%;JO'H"!7D?PV\3IX/U2_P!!U\26B22 AI/NPR 8.X>C#;S[
M#L<CW"N9\4^!=&\6*)+N-X;Q5VI<PG# =@1T8?7\"* -];RU>U%TES"UL1D3
M!P4Q]>E>4_$SX@V=UISZ#H=PMR\Y"W,\1R@7^XI_B)XR1QCCOP'X&)OR/$+!
M/0V?/Y[_ .E=9X9^&VA>&IUNT62\O5^[-<8.S_=4<#Z\GWH /AMX9E\->%U2
M[7;>W3^=,IZIQA5_ #)]R:[&BB@ HHHH **** "BBB@ HHHH **** "BBB@
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MY#)+*X +L0!T[# '% &]1110!2UC_D"7_P#U[2?^@FO)?@=_R$-8_P"N4?\
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MO%LC<3'[28&$>#$P!W8QU.*]?HH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "FR2)#$\LKJD:*69V.
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MT>T\1WVBW1F@ELH?.FGD51$%VJW!SDGY@,8ZT =+7">&/B;:^)?$LFD1Z;/
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MO8YY(0ZIM@4%LGZD#]:PM5^*'AS2$@\U[B::6))3! @9HPP! 8DA0<'IG^E
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M<"@#>HHK!\3>++#PK':/?0W,@NI#&GD*IP??)% &]139)$AB>65U2-%+,['
M4#J2>PK@KCXP^%X+PP+]MF0''GQPC9^I!_2@#OZ*JZ=J5GJUC'>V%PEQ;R?=
MD0\?_6/M5J@ HJ*YG6UM9KAP2D2,[!>I &>*YNQ^(.@7?A\ZW-/)96?G& ?:
M5&]F !X52V>#VH ZFBO._P#A<WAGS_+\C4MN<>9Y*[?K][/Z5V^E:O8:W8I>
MZ;=)<6[' =<\'T(/(/L: +M%%<?K?Q-\,Z'=/:R7,EU.A(=+1-^T^A8D+GMP
M>.^* .PHKA-.^+GA?4+A89'NK,L<!KF(!?S4G'XUW*.LB*Z,&1@"K*<@CU%
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MBMZ@ HKG_$/B_3_#=Y86=S#<W%S?/LABME5FSD 9!8=2<#\:Z"@ HKF/$'Q
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M\$C]:P_B3_R3W5_^N:?^AK4OP^_Y$+1_^N']30!TM%8__"6>&_\ H8-*_P#
MV/\ QH_X2SPW_P!#!I7_ (&Q_P"- &Q160OBKPZ[JB:]I;,QP%%Y&23^=:]
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M<M<:@0(FC52BY./F)(/Y UEZU\3_  SHEP]NUQ-=SHQ5TM8]VPCU)(7\CVH
M[*BN0T#XE>'?$-VMI!--;7+G$<5T@4N?0$$C/MG)KKZ "BBB@ HKG?$/C?0O
M##B+4+LFX(R((EWOCU([?CBN?MOC+X8GE5)(]0MU) +RPJ0/?Y6)_2@#T*BN
M8U3Q[HFF6VF7(>6\@U%RD,EJ%8 C&=V2,?>''4<ULZQJL&B:1<ZE<I(\-NF]
MUC +$>V2!^M %ZBN7?X@>'X- M-8NKE[:&[5FAAD3,K;20?E7/<=<XYZUBP?
M&7PQ-<")X]0@0G!EDA4J/?Y6)_2@#T*BH+.\MM0LXKNSG2>WE7<DB'(85/0
M45Q>L_%+PSHUR]N9YKR5#AA:(' /IN) _(T[1?B?X9UNX2W6XFM)W8*B74>W
M>3Z$$K^9[T 6(?&?F_$*?PI]@QY48?[5YW7Y%?&S;_M8Z]JZJO*K3_DX2_\
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MX[TN"SU?PPT%X;TQJGF!%\O+!7'.[/0^E ':^%M=_P"$E\.6FK_9OLWVC?\
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M\MRQR5R.,D#COPN>/KGO_#F@V_AK0K;2[9BZQ EI& !=B<DG'N?P&!VK5HH
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M_P#).-)_[;?^CGKS:;09/$OQ>U32_-ECM7G9[HQDC,:X//X[0,]R*])^%O\
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M /*_B9X'M8=+GU[18?LMS$#]J2 [%DC(PQP.,^N.H)SFND^%O_).-)_[;?\
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M1U31I-P.)1=Q"1#C&5;.0?\ "F+\+_!;*&72 5(R"+J;!'_?=+_PJWP;_P!
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M07=[;+/K$^)YYYUW.CGG )&1C//<G\,8/QG :ST,$ @W3 @]^!7J% ')^/\
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MSY&/WC<D?APOX4 4OB-XEE\,^%GFM7"WEPXAA.1E2026 [X _,BL+P/8^#-
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M=&#*?M,QP1T_CK$_X5QXD_Z*'JOY2?\ QVI(/AYXBAN(I'\?ZI(J.&*$288
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MN)G0GASYI"J?4<Y_"O<Z\O\ AV!_PL3QH<#(NG&?^VKT >F;8;>(-B...),
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M0?\ ?AH Z?PAX)T[PUIL):VBFU)@'GNI%#/O/4*>P!]/K6?\3O#EAJ7A.^U
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M(T X]SU/U/6O-OA]J$$/Q+\7V$FT37-U*\3$@$[)7RH]?O9_X#7JM '#>./
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M K@?@I_R)MY_V$'_ /1<=>@7W_(/N?\ KDW\C7G_ ,%/^1-O/^P@_P#Z+CH
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MA7+6O@'6)%;:3!Y><XX9@I'ZUTU<?\4O^2<:M_VQ_P#1R4 2_#6W6W^'VDJ
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MF5'^9>C$8/3M7HM% !7FOQ:TO4-2_L/[#8W-UY4SF3R(6?8/DZX''0UZ510
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M(DD]B#R2.V0H'N17IFFZ=:Z3IT%A91^7;P+L1<YX^OK5JB@#SKQ#IM_-\9-
MOHK*YDLXK8+)<)$QC0YEX+8P.H_,5Z+110 54U/3K?5M,N=/NTW07$9C<<9
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M88.#@J>H(/8@\UYQ91^.?A^&L;;3QKFC(Y,/E@F15SD@ 9*YST(89Z>_JU%
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MF)A&Q\N,8#8P>0?RKT6B@ KS7QCI>H77Q1\-7EO8W,MK#Y?FS1PLR)B0D[F
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MXMRQ+CL2RJP/'?@^O->HT4 >2W5CXR^(US;V^J6)T71(W#R(00[<>C<D]<<
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MNNK:+)*'))X'0#D@X( )!KU2B@#S"X^+R7]N;70=$OYM5=<+'(@*HW3.%))
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MSIYNZ*9"C+F5R,@\C@@U-XT\(6WB_2!;.PBNX26MYR,[">H/L<#/T![5TE%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M'44 6Z*SKS7]&T^X-O>ZM86TP )CFN41@#TX)S4'_"6>&_\ H8-*_P# V/\
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M(\6:%KUW-:Z7J,=S/""7158< XR,@9&2.1D<T ;-%%% !1110 4444 %%%%
M!1679^(M*O\ 6+K2;:Z\R^M 3-%Y;#;R!U(P>HZ&M2@ HHHH **RM5\2Z+HC
M!-2U.WMW(W!&?+8_W1S6/'\3?!TK[5UE0?\ :@E4?F5H ZVBJUCJ-EJEL+BP
MNX;J$G&^%PPSZ<=^>E6: "BBB@ HHHH **** "BBB@ HK*T/Q)I/B2&672;O
M[0D+!7/ENF"?]X"M6@ HHHH **** "BBB@ HHHH **S;KQ#HEC<O;7>L:?;S
MIC=%-<HC+D9&03D<$&H?^$L\-_\ 0P:5_P"!L?\ C0!L451L=:TK4Y6BL-3L
MKN15W,D$ZR$#U(!Z4ZTU?3=0FDALM0M+F6+_ %B0S*[)VY /% %RBBJE]JFG
MZ8B/J%];6BN<*UQ,L88^V2,T 6Z*;'(DT22Q.KQNH974Y# ]"#W%.H ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M\9:3&Q@E?;>1@';N/!S[,/R89[BO6ZJ:GIMMJ^F7&GWB;[>="C@'!^H]QUH
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MQ<,@\ S[&(4SQ;P#C(W=_7G%=U5'6=*M];T>[TRZ&8;B,H3C)4]F'N#@CW%
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M>6/$*+'+"O&YMZC!Z]6"G(]2.YS[!H6DPZ'H=GID  2WB"$C^)NK-^))/XT
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MDWPE6+;L[B2YR>OYUCZU\5[>YC:P\*6US?ZC+E8I/).U?]H*>2?J /7TKH_
MGA^_\/Z$T>J7DEQ>7$AFD4N66(G^$>_<D=S[9H Y#QC&LGQK\-*Z@@0PM@^H
MDD(_45ZO7E7B[_DMOAK_ *X1?^C):]5H \L^-B&33='08RURP&?<"O48T6*-
M8T&%4!0/0"O,OC+_ ,>FA_\ 7V?Y"O3Z .(^+7_)/[O_ *ZQ?^ABM#PPT[?#
M73S"7,_]G 1X/.X)\N/TK/\ BU_R3^[_ .NL7_H8K7\#_P#(C:+_ ->B?RH
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M'ULLX)C,LHC##@IN.?PSN_6N:UG7]2^)TZZ%X=M9H-(W W=W/'@'!R,XS@<
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MK_DN7B/_ *]&_G#6W\1?"<WB'2XKS3OEU:P;S(-N 7&02N>QXR/?ZYH R_\
MA7'B3_HH>J_E)_\ ':/^%<>)/^BAZK^4G_QVET3XL6"1_8O$T4^FZE!\DQ,3
M,K$#K@#*GVQ^-&L?%K3FA-KX;M[C4=1ERD($+!0?7!^9O7 'Y4 7_"7@"Y\,
M^(+C5I]=DU&2XA:*02P$,Q)4[BQ<Y/R_K6)\0(4N/B;X2BE4,C2)N4C((\T<
M'VKI/A_H.K:/IES<ZU>2RWM_)Y\D+/E82<D\=-QSSCV':N?\=?\ )4O"'_71
M/_1E 'I]<K\2?^2>ZO\ ]<T_]#6NJKE?B3_R3W5_^N:?^AK0 OPX8O\ #[2"
MQR?*8?D["N3^(7_)3?!__7>'_P!'"NK^&W_)/=(_ZYO_ .AM7*?$+_DIO@__
M *[P_P#HX4 >J,H92K %2,$$<$5YCJ7@+6O#>H2ZMX)OF0.2TEA)C:1UPN>"
M.P!Y'K7H>K75S8Z3=75G9M>7,49:.W4X+GT_SSZ<UQ>F?%SP_-IV_5'EL;Z,
M8EMS"[98=0I /ZXH T/!/C?_ (28W%A?VALM8M!F: @@$9P2 >1@G!!Z9')K
ML*\J^'_G^)/'^L>+OLC6UD\?E1 C 9OE'7N<)DX[FO5: ,W7X=6N-%N(M#N8
MK;46V^3-,,JOS#=GY6_AR.AZUQ/]C?%;_H9M*_[]K_\ &:](HH P?"UKXDM+
M*=?$NH6U[<&3,3P* %3 X.$7OGM6]110!S?Q !/@+60 3_HY/'U%4_A;_P D
MXTG_ +;?^CGKI=4L(]4TF[T^4X2YA>(G&<;@1G\*\P\#>+H/"$4WA7Q-OLIK
M69O*E924VMSCCMG)!Z$-V[@'K5>6>'HO,^.NO-G'EV[-TZ_ZH?UKJ]6^(7AC
M2;1YCJUM=.!\D5K()6<\X'RY Z=3@5@_#'3[V\NM6\6:A#Y,FJ2?N$QC$><D
MCV/ '^[GO0!Z-7F$/_)?Y_\ KT'_ **6O3Z\PA_Y+_/_ ->@_P#12T >GT44
M4 %07EG;:A9RVEY D]O*NUXW&0PKF?B$GB!= 6Z\/7$J36T@DEBB4;I$'IWX
M]!U%1>'OB5X?UC3$EN[^WL+M4S-#.^P CKM)X8>F.: .)N[>Y^%'C2VFM)G?
M0=1;#QL<X4$;@?=<@@\9SCUKN_B;O_X5WJWEDAML><'''FIG],UPGC+5X?B)
MXITK0-$9Y[6%RTTZH0.<;F&1G"@=>Y/?BO7KO3[6]TR73YX@]K)'Y3(>?EQB
M@#$^'PB'@+1_)4*GD<@?WLG<?SS72UY#INJZE\*;^32-8@FO-"E8O;74*C*9
MZ]?PRI/'49SST\WQ9\(Q6OG)>S3/C/DI;N'Z=,D!?UH S/C5Y'_")V6\?OOM
MJ^6<<XV-GGTZ?I6E\01.WPGO!.&,_DVYDSUW>9'G/ZUSVGV>J_$KQ1:ZWJ%L
M]GH%B^^TBD7!EY!X]<X&3TXP.YKTK6],36=$O=-D8JMS$T>X=B>A_.@#-\"L
M'\"Z*5.1]E4?EQ70UY'X6\9R>!D?PSXKMYH1;,?L]PBEP5)SCU(YX(]<'&*V
MM9^+N@VUJRZ.9=1O7&(E6%D0-VW;@#^ !STXZT 4OAQ\_C[QI(OS)]K;YAR.
M99,<UV_BS_D3=<_[!]Q_Z+:N?^&7AB[T#1+BZU)2FH:A()9$;JBC.T'WY8GZ
MX[&N@\6?\B;KG_8/N/\ T6U '-?"#_D1$_Z^9/Z5D_%R)+C6_"4,@#))<R(P
M(SD%H@:UOA!_R(B?]?,G]*S?BM_R,7@[_K[?_P!#AH ]/KG_ !Q_R(VM?]>C
M_P JZ"N?\<?\B-K7_7H_\J ,GX3NS_#VR5CD))*J^PWD_P R:RM6/_"(_%FR
MU0MLT_6U\B;: %60;1D\^NPD\=6Z\UJ?"7_DG]I_UUE_]#-7/B+H1USP==K%
M@75H/M,+=\KR1^*Y'UQ0!SOC'_BJ_B)H_A="/LUG_I5YP"#P#M(_W<#_ ('3
M/B# _A?Q5HOC"SB B1Q;72J,9&"!^:;AG'&T>U6/A-I]S/:7_B?4',MUJ4A5
M9&.3L4D'\"W'_ 177^*]$3Q#X9OM.9 TDD9,/08D'*G/;D#\": .+^)5^=<O
MM#\*:?<*W]H2++,Z$,!'GY3GN/O-_P !'K7H]K;165G!:P+MAAC6-%]% P!^
M0KR?X0Z1=W6HWFN:@\C-:QBP@#_P[0 0/]T #\37KU 'A'A'PYJ7B'7_ !";
M7Q)=Z3<PW'[TP[BTVYGY)#KG!'OUKK_^%<>)/^BAZK^4G_QVJOBC2]4\&>+V
M\8:):FYLKC/V^U3CKC).!G!/S9P<-G/!Q6S:_%OPG/;"6:[FMI-N3%) ['/I
ME01^M &;-\,M?N(9(9O'^IR12*4='20JRG@@@R\@UUO@_P -MX5T%=+:]^UA
M9&=9/+V8![8R>^?SK@]9\7ZE\0)!H'A2UGCM96Q=7LJ[0%Z]1G:/U/0>_H]O
M;SZ'X<2"+S]2N+6WPNY\/.P'J3QD_E0!Q&L?#_5-*U:;6_!=^;6XE;=+9L0$
M8DY(7MC_ &3T['H*T_!/CJ77;N;1M8LS8ZU;KN=""HD ZD \@\CCGU'M5TGX
MM:++9LNMB73=0B^62 PNP9L<[< XY[-C\>M8_A*>7Q?\4KOQ/!:O!IUO$8T=
MUP7.W8,GIG&3CMP/J =I\0?^1"UC_KA_454^%O\ R3C2?^VW_HYZM_$'_D0M
M8_ZX?U%5/A;_ ,DXTG_MM_Z.>@#C_B-93ZC\4=!LX[Z2R,UNBQ7"<F-_,?D#
M(Y^[W%;'_"N/$G_10]5_*3_X[6I\1?"<WB'2XKS3OEU:P;S(-N 7&02N>QXR
M/?ZYK,T3XL6"1_8O$T4^FZE!\DQ,3,K$#K@#*GVQ^- "?\*X\2?]%#U7\I/_
M ([6AX2\ 7/AGQ!<:M/KLFHR7$+12"6 AF)*G<6+G)^7]:H:Q\6M.:$VOANW
MN-1U&7*0@0L%!]<'YF]< ?E6Q\/]!U;1],N;G6KR66]OY//DA9\K"3DGCIN.
M><>P[4 <[<(&_:!M2<_);$C_ +\L/ZUZC7F$W_)?X/\ KT/_ **:O3Z /+/"
M4*/\9_$LK*"T<;[<CH2R<_7''XFO4Z\P\'_\EB\4_P#7-O\ T-*]/H \L^,K
M%'\.NIPRW#D'_OBO4Z\K^,__ #+W_7>3_P!DKU2@ KS7XTW+)X8L;1,[I[P$
M@=PJMQ^9'Y5Z57F/Q+W7_B_PCI2YVO<[W ]"Z#/X -WH [:_\/P:GX3?0;C
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M02?%#P@#GB6,\>TH/]*U?A_I&O\ VN^\1>(+B:.XU  "R.5" 8P67L0  !U
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MH/S+[9'K0![#13(9H[B".:%P\4BAT8=&!&0:?0 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 5%<VMO>V[V]U!%/ _#QRH&5N_(/!J6B@"*VM;>RMTM[6"*"!.$CB0*J]^
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M4,C AE89!'H:=10!E?\ ",>'_-$O]AZ9Y@((?[)'D$=.<5J*H50J@!0,  <
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MVI:9;7#Y!\PIA^/]H8./;-8\?PQ\'1N'71E)'3=<2L/R+8KKJ* *MCIUEID
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MZ.@ HHHH ***Y/P'=W&H6>L7EQ<33++JMQY(DD+".,$!57/0#GCB@#K****
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MQ=DW)UQE02.W;MB@#H**AM(Y8;."*>4RRI&JO(?XF Y/XFIJ "BBB@ HHHH
M**** "BBB@ HK/UZ\_L_P]J5X&*F"UDD!!P<A21CWS57P@9W\'Z1)=3R3S2V
ML<KR2.69BPW<D\GK0!M4444 %%%% !1110 4444 %%%% !17G_AN#4_%&H7/
MB ^(+^""+462WLXR!"T*'!#KG!+#C/8Y/->@4 %%<IK&L:C'\0= T:TG\NUF
MBFFNU"*VY0#MY/(Y&.,=>]=70 4444 %%%% !1110 4444 %%%% !17)^/\
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MTBS.I:W,I86ZMM2%<?>D;L/;OZC(S431O'=T6DN?%=G8L3D16FGK*@]LO@T
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MKM* "BN5\?\ BI?"OAR2:)P+^XS%:C .&[MSQ\HYY[X'>NJH **** "BBB@
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M\)!^8^WXUW- !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!17-ZOI&NW?BO2K^QU7[/IEN"+JVWL/,YST PV>!SC';K724 %%%% !1110
M4444 %%%<E=WMU)\4]/T])YUMHM,>YDB5R$<ER@+ <'&.] '6T444 %%%<GI
M5W=7?Q)\00M/,;2RMK>-83(=@9UW[@N<9]\4 =91110 4444 %%%% !1110
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MDD]S0!8HHHH **** "BN2TJ]NKKXEZ_;M/.;6RMK>-8BY\L,XW9 Z _K76T
M%%<;\0?%LOA2WTJ2!ES/>+YJD EH5Y<#CCJ!GMFNP1UD171@R, 593D$>HH
M=16/XG\06_AG0+G4Y\,4&V*/_GI(?NK_ )[9J;P]=37WAK2KNY??//9PRR/@
M#<S("3@<#DT :5%%% !1110 45R4-]<W/Q5N;3SIQ:6NE*3#O/EF1I =^.F=
MIQS5JQT?7(/&U_JEQJWFZ3-"$@L]S'8WR\[?NCH>1G.: .CHHHH **YWQCI&
MMZSIMO!H>JG3IDG#R.'9-R8/&5Y_#H:Z%<A1N(+8Y(&!F@!:*** "BBB@ HH
MHH ***\_BN?$WB/Q;X@M=.\0G2[/3I8XHXS913[B5.[DX(Y7/?[WM0!Z!17
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MP""6.<DD]3C'%'BB)K?X0Z;IB862YCL[7('\1VD]/]TUZ)&BQ1K&@PJ@*!Z
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MN)(4\QKB+3U\I"",#?MZ\YX_.@"#XIZ1IESX2N]4N[;S+JSC"V\F]AL+NHZ
MX/7N*V?#7@[1_#:+/8V0ANY(5CFD\QVW=">"Q Y':L[XD(;C1]+L0P7[9JMM
M;\YQR2>WTKLJ (+V[BL+&XO)R1#;Q-*Y'7:HR?T%</I.@77C:S76/$UW<FSN
MOGM=,AD:*)(OX2^,%F(/7/0]><#K/$6G2:OX<U'3X6"RW%N\:$],D<5SGA+Q
MCID>B6^F:Q=PZ;J=A&MO/!>.(CE0 ""V <C!XH R?%GA*/PKX=OM3\,S36BK
M"T=Q:-*TD4D;_*Q 8G##.X'/:K7B&+^S?@HEM& '-E;1!<@;F9D#?S)K/^(7
MC6TU/1Y-$T23[7]IE2*XNHQF*,%ONANA8D#ID8S6]\0XTGL="TP85;O5K>(@
M#@(,D^W''% '6V=LMG8V]JARL,:Q@XQD 8_I4]8-WXNTRR\5VOAV;SA>W*;T
M8(/+&<X!.<Y./2KFNZ[9^'M/%Y>>8RM*D*1Q+N=W8X 4=SU./0&@#2ILD:31
M/%*BO&ZE61AD,#U!'<4JL&4,,X(SR,'\JJZGJ5IH^FSZA?2B*V@7<[G\@/<D
MD ?6@"KJFI:7X4T%[F40VMI N(XHU"@GLB@=S[?6L3P3I]_/+?>)]8C,5_JA
M79;G_EA"O"+]3U/X=#FN;TS5-+\6Z[%XA\0ZMIUK9VK'^SM-ENXPP.?]9(">
M#QT]AV'/I5CJ5AJ<;26%[;7:*=K-!*L@!]"0: .1^&D/GV&K:U(2T^I:A*Y9
ML9"*2%'X9;\ZD^);@Z)IULN6FN-3MXXD'5CDG^E9_@K6]/\ #5MJ/A[6[R&R
MN[*ZD<&=@BRQL<AD)ZYZXZ\BI(91X[\:V=_;)(VA:,2T<[#"W%P3U7(Y"X'/
M;\: /0*XSX?;;G_A(M3&[_2]7FV$_P!Q<!?YFNON)TMK:6>3.R)"[8ZX R:Y
M7X9PLG@2QE?_ %EPTL[^Y:1OZ8H /'&M:A;QVFAZ&,ZQJA9(W#8\F,#YG)[>
MQ^IZC%8VG^$O%G@_2BVBZM9WI7,DME)9A/.;J?WF=S'J!DCM5WQ7<+X>\:Z/
MXENXG;3?(>SN)D4M]G).58@<X)./S[X!TM1^(/ANPL3/%J<%Y*P/E6]L^]Y&
M[+@9QD^M &GX<UZW\2:)!J5NCQA\J\3]8W!P5-:M<!HM^O@'P"E_KL,ZR7-R
MTK6\2Y=&D)(7D@< 9/3N.M=S9W45]907<#;H9XUEC/JK#(_0T 35Q/PXB%W8
MZEKTRJ;W4KV5G?D[44X5![#G\Z[:O.;"];X<:E?V6J0S?V!=7#7%K>QH76 M
MUC< <>W]<G !Z-16"WC;PNEJ;DZ]8>6!G F!?_O@?-^E,T#Q9#XDOKA+"QN_
M[/B3*W\B;(Y6S]U0>>A!S]>G&0#.\0WNI:SXFB\*Z5=O8QK!]IO[V+_6(F<*
MB'LQXY]#[$%K?"_PZ(@UO]MM[X8*WR73^;N'(;DXSG';M534+UO"/Q$N=7U)
M2NCZK!'"+E5)6*5, !\#C//^0<;6I^/?#FFVC3+JEM>2GB."TE65Y&[ !2<9
M]Z (O!&JWUS;ZAI.J3"XOM)N#;O<#_ELF/E8^_7/T[G-<MX2\-'Q-)KE[J=U
M.=,GU2=EM(9#&LQS@ER.=N. ,CO71>%;2^TG0M6UW5HQ#?7\DE]) >D*A?E0
M^X ^O.#R*E^&MJ;7P!I@;)>57F8G/.YV(_0B@#G-4TJX\)>)M-TGPE<M:QZT
MDD<EO(YD6 I@F5=V2#M+>W'Y:6H?#C1[72[F^CN-1&K11M-_:/VM_.9PN<GG
M'49Z9]ZMW3"Y^+VGP@;C::5),>1A=S[?S_Q%:?C>Z^Q^"-9E!P3:N@/H6&W^
MM $>A:S<S^ +;6+O#7 LC,YP0&*@\_CC/XUR7@KP5)J_A'3SK]W</I^PO;:=
M%(8X]C$MN?&"Q.21SP#QUXV=85M&^#<D*\,FEI"W'=E"MU_WC1X3\9:9#HMK
MIFM7,>F:G91K;S0WC"+.T8# G@@@?G^&0"AKOAB+P18MX@\+RS6GV1@]Q9-,
MSPW"$@$$,3@^_P#]:F>-I+CQ%JG@ZQTVX-K+>L]T)>\2A =P]PI;'N!TJQXG
MUV/Q?$?"_APM>&Y=5O+V(9AMXPV6^;H2<=NH/K5J.%5^*>GV$()ATW13@G/!
M+A0/3. /\B@!-2L-&^'6C7OB"TAFEOS%Y/F3SM(T[,1MW9..",G&. :R+;2_
M"^J0)<^+O%=GJE\_SO'_ &FJ0Q''W456&,9Z]ZZ+XC:7<ZIX3<VD(GEM)DNO
M)(SY@3.5QWX)X[]*I65_\-;VR%R(/#\''S17-O#%(I[@JPSGZ9'IF@#.TR^L
M/#?C"QL=#UN'4-&U1FC:S2Z$[6LF,AE.2=IZ<^_7BK'B6UU'5/BEIEEI]S]E
M:'37FDN ,M'&SE&* \;CP!QQG/:M?PX_@_5[Z>71-'L]UFRXNX[!8U+'/W'V
MCD8_7C-0:,INOBEXDN@<K:VUO;#ZL-YQ]".: *>N?#_2K+1[S5+">_@U:V@D
MG2]-V[2.X!;YB3CDCG '6KLGC*2P^&<'B.ZC5[N2W3:FW >5N!QGIGGZ5I>.
M;LV7@?69EZFU:,>V_P"7_P!FK \1Z%<3_"W3;>TMUFFT^*WN# 5SY@1?F&,<
MY!)QWH S[;2_"^J0)<^+O%=GJE\_SO'_ &FJ0Q''W456&,9Z]ZDTR^L/#?C"
MQL=#UN'4-&U1FC:S2Z$[6LF,AE.2=IZ<^_7BM&RO_AK>V0N1!X?@X^:*YMX8
MI%/<%6&<_3(],U>\./X/U>^GET31[/=9LN+N.P6-2QS]Q]HY&/UXS0!B^*;>
M_P!3^*.DV%A<M;,NG.\DZ*2T,;,RLR]@QQM![$Y]*EU;X<Z/INBW6H:;->VN
MJ6L+S)>_:7+LRC/S=L<8X XJ]HRFZ^*7B2Z!RMK;6]L/JPWG'T(YK4\<736?
M@?69EQDVKH"3C&X;?SYH P-7U;6-2^%5MJ5N9DN)XHVNWMUPZQ9Q(RCMQSQV
MYHT+PCX8NQ::QX8U.YBDCE#RSPW#,TPSDI(K=,_0?0UHP>(--\(Z'X>L=2\R
M"*6T2/S_ "SY:,J+PQQP3S6"6T1?B5I$OA.6W>><2_VDMFX,)BVCEMIVYSSQ
MWQGGJ ;6LJMW\3_#<) /V2VN;G''\0"#]14?@O&C^(?$/AH[52&X^VVJC/\
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MC_1X;:V!&.<KN/Y8'^17,>%/#LGBN779]0NIX]*DU2=Q! Q3[0YX.X]=@'
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M6AXF@2?QMX-L$"K'')//M4#Y1&@*\>F>*+<?;/B_=RGE;'2DB YX9WW9_+-
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M'U//_P!ED2^,<W7CGP;8IRWVF6X8=,!%!_HU=I<VT%Y;26US$DL,JE7C<9#
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MT^65R,$,Q4(3SSU&: '7[W_C'Q/?:);7TUAH^FA5NY;<[9+F1AG8&[*!G/\
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MZ\/SZ=HU[!J.IZC&UO;P6KB1LL,$G:?EP"3SCI[&KTFM:;X)T_1=+U)FAB,
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M;O\ L^),K?R)LCE;/W5!YZ$'/UZ<9Q]19;GXR:-#R3::=+-PW +;EZ?3^8H
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MSVIEMXW\4ZO<WVGZ;X5MX;ZS?9,+F_4B,]LKA2P]P<'UJUXD*WGQ.\)61!Q
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M6GFO)',CY!X)//''/]*V/AA&Q\&K>/\ >O;F:XYSGER.?^^:/')-QJGA73\
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M"_PZB![3[;:7H.X7L-T_F[O7DXZ\].U7&O\ 4/"'@BXO-=NDOY[-2%EC0@R
MD*F[/?)&3_/J5U3X@>'--AS'J4-].W$5O9,)GD8]%&W('XU7\766H^)OAZ_V
M:TDM[]TCN!:R8+!E(8I]>N/P!QV *EEX'DU^WBO_ !C>W5[<RCS#9+*T5O "
M.%"C!R.,G/4=^IL6_@>70M4M+GPUJ4UG:B3%S8W$C2PM&>NT$Y#?C^/7-G1O
MB!H&I62/<ZA;V%VHVSVUVXB:-Q]X?-C//^<@@/TSQK8:YKJZ=I$%Q>P*K&>]
M1"(H3C*@D]<\CC]>< &=XV\136^J6/AZTU2WTJ2[0RW%].RJ(8>1\I)^\<$#
MZ=1U&:?#OPYD5GGU^">]//VV36 9L^N=V,_AWJ7Q7;6&E>.[77-;L8;G1;FT
M^RRR36XF6"4-E6(P<9'&?K5N[O?AG9VAN7C\..N.%A@BD<\9^ZH)H F\ ZS/
M=G5='N-134SIDJ"*_1PXGB<$KD@G+#:<G/MU!K%T374\.> ]>\1.BRSW6ISR
MQJ<8=V8*HX[9!/TSBNML3I5EX9N-7TG2X].22V:<J+587.T$C< /KCKU]ZXD
M:!<7'P4TQ;2!9YK=A?F$J#YHW,Q&._RMT[XQ[4 3VVE^%]4@2Y\7>*[/5+Y_
MG>/^TU2&(X^ZBJPQC/7O4FF7UAX;\86-CH>MPZAHVJ,T;6:70G:UDQD,IR3M
M/3GWZ\5HV5_\-;VR%R(/#\''S17-O#%(I[@JPSGZ9'IFKWAQ_!^KWT\NB:/9
M[K-EQ=QV"QJ6.?N/M'(Q^O&: ,#6-'F\3_%>:V%U+;6EIIL:7+P'#NI?>$!Z
MC)/7T!'>KVI6T'@Z&S\/^$+>.WU36)B%DE9I!&JK\TAW9Z#MC'7CC%6_"2>?
MXQ\87[8+-=16X/' C3']1^5-\9F;2-=T/Q.+:2XM+$RQ7BQC+1QNN-^/0<Y_
M#IUH 1/AAH,L9DU1[W4;YE^:\GN7#AO50#@<G@'/XUB1:/?Z;\3= TJ>_EO=
M-MHY[FT,[;I$!3:58]P"!CV.*Z]O'?A5+(79UVR\LC.T29?_ +X'S?I7-^&]
M6?Q-\3;S4?(FBL[73_*M5E4J6#./GQVSAL9[8H /B=X>TR\_LR[>T+ZA>7]O
M8B7S&'R,6.,9QV//7GK5G7/[,^'6A>3X?MX;.[U*X2&-IYF:-&/'F,7)P%'X
M<C/&:M>+7\_QCX/L%P6:ZEN"..!&F?ZG\JB^(MAN31]8DLQ>6>FW6Z[MS&)-
MT+X#':?O8P/Y]LT 9<.A^![E4GU[Q/;:O?=7FFU4* QQG8%<;1QP*L>$]2BT
MKQ:_ARRUF/5M)N(#/:.LZS-;,#S&6!Z8Y'X>YJY'=_#.2S%TJ^&Q&1D*T$2O
M_P!\$;OPQ6EX7/AG4DDU+0](M[<1N8DN%L1"7&!RIP"5.?TZ4 9E_-J/B[Q1
M>:+9WTUAH^FA5O9K<[99Y&&=BMV QS^/7(J63X8Z D3/IYN[&^W;TO([ERX?
MG!()P>3[?6J%CJ4?@OQ?K-MK;?9[+5;@W=I=D?NR2/F4GL1QU_J*VM5\>:)9
M0A+&\BU.^E^6WM;)A,SOS@':>!0!D_#1+V:?Q)?:EL-\]_\ 9IW0 !FB7!Z?
M[WZUWU<7\+O-F\'G4)L>=J%W/<R,/XF+;2?_ !VNTH \ZUG38_%GQ+GTV>-3
M:Z?I;HSD[MDLHP#CUVMD?3.>E;GP]U"6]\(P07087>GNUC.&&"&C. /^^=M9
M_P .@NHRZ]XB*8;4;]EB/7,2<+C\S^7TK$\1MJOA[Q3JFFZ3 "?$ZI]EDR<1
M3 A9"?\ @+,Q/./EH B\6.?&(UZ\#YT?08)(X,9Q/<E?F;/<+QCZ@CJ:Z;_A
M($\,?"G3=3*"22/3K=8D/1G**!GV[GV!IVM:+;>'OA9J.F6N3'!9."Q&"[$9
M+'ZFLS6M+N=4^$.C&TA$\MI:VMUY)&?,"1C*X[\$\=^E %2VTOPOJD"7/B[Q
M79ZI?/\ .\?]IJD,1Q]U%5AC&>O>I-,OK#PWXPL;'0];AU#1M49HVLTNA.UK
M)C(93DG:>G/OUXK1LK_X:WMD+D0>'X./FBN;>&*13W!5AG/TR/3-7O#C^#]7
MOIY=$T>SW6;+B[CL%C4L<_<?:.1C]>,T 5]8NM3\1>*I/#>F7TVGV=G&DNHW
M4'$I+<K&C?PDCG/UZXP5?X8>'/*8P)>07A!Q>)=2>;GUY./T[52%^O@WQ[JL
MVK'RM+UGRW@NROR)(BX*,1TSD\GT^M;6H^/?#MC:B6'48;Z9Q^ZMK-Q+)(>P
MP.G7OB@##^'T5^_B;Q/<:M(L][!)#9^<JA=X0$;L _Q *346DZ_'H^E^-/$D
MRAU&IR1PKD_O"H54'T)(^G/I5WX:3RW&BZOK%\@CN+O4999<#[H 'R]^!\U8
MVGZ5=:U\&)7MHV>]N)Y+U8\$EF68G;ZG(7CZB@#:L_ [:[ E_P",;F>^O)1N
M-HDK100#J%"K@DC/)S^?4VK?P2VAZM:7?AN^DL[7S +RRFD:2*2/&/ER20WI
MSW]L&;2?B#X=U+3Q/-J%O83J/WUM=2A'C;G(YQNZ=O;ITI^F^-;'6O$']F:3
M;W%[ BDSWT:XAB..!D]<X/3\,\X *?BAS<>.?"%@HS^^GN7Z\;$X_K_DUBS:
M?>>(?BKK,-O?2VEE;6L,%W) <.ZD!@BM_#DYR>ORD=ZVY7^U_%VWBYVV6D/+
MGG[SR!<?E@TG@9A<ZMXKOE&5DU5X0V0<^6 /RY_6@#)\4^#M.\+Z)/X@T"2>
MPU&R(E\WSW<3<@$.&)!SD_G6WXM\5RZ/X;LY[?RH+_4FCB@,[ )"6&2[D]E'
M?UQD8S3/B:Y;P9):*<->7,-N,=>7!X_[Y]ZK_$/3QY6C:LUDMW9:9<[KJV\L
M/F%L*Q"'@XP./Q[4 9D.A^![E4GU[Q/;:O?=7FFU4* QQG8%<;1QP*L>$]2B
MTKQ:_ARRUF/5M)N(#/:.LZS-;,#S&6!Z8Y'X>YJY'=_#.2S%TJ^&Q&1D*T$2
MO_WP1N_#%7_#LOAB\M9]7T31HH5@+(LT6GB-Y0!DE, %@>GKGM0!RT>G:-X@
M\7ZM8^+YISJ7VITT^VEE:.,V_P#RS:/;@$_>[\^F<UW^A:0=$TP6)OKF\578
MH]RVYE4GY4SZ 8'^ X'(:MXB\"^*_#,D^J7%NCI$3Y4A"W,+^BC@D@]AP>_%
M=!X%>^D\$:2^I%C<M#DER22N3L)SWV[: .AKRCPCJ^OI=:_?Z5X:_M.WO-2E
M?S?M\<.W!X7!ZX!'/O7J%Y<K9V-Q=.,K#&TA&<9 &?Z5ROPMMQ!\/[!\DO.T
MDKDG.27(_D!0!6N-*\2>+[VUCURRM]*T>WE6=[5)Q-+.PZ*6 P%SG.,=>_43
M:Q=:GXB\52>&],OIM/L[.-)=1NH.)26Y6-&_A)'.?KUQ@]I7GXU!?!WC_59=
M6)BTO6?+D@NRIV)(H(*,>W?\A[T 77^&'ASRF,"7D%X0<7B74GFY]>3C].U9
M'@Q[ZVU?QAJ.K2)/>V02W,P4*'6)&^;&?X@%)KI=2\>>'M/M]\6HP7\[<16U
ME()I)&] %SC\:XO2K^XF^%?BW5KD(EQ?7-PS@8P P5-H// R0/\ )H ?X$^'
M]GJWA6RN]?:>YB<%K>T\QDCC4LV#\I!).2<YZ$"KGCOPKHDVL^'\6(^T7M_%
M!,XE<;H$7!3&<#@#D8/%=SX?M18^'-,M0,>3:Q(?<A1DUSVNK]J^)GA> D;+
M>&YN"O/)*A1^H_G0!E>.M$T[PS\-[^PT6T\A+NXB!16=V9BR]"23T7&.G7UK
M1B^'.GZA$MSXAEN;[4'3DB9D2W.!@1J#P!@#G.<9-/\ '@^U:AX6T[M-JL<K
M#GE8P21Q]:[.@#C/ TMS::CK_A^6ZENK;2YXQ;2RDLP1U)"%CUVX Z<9],5@
M0ZQI_C2]N[C6?$\.GZ-'(T5MIR7BP/,!_'+SD@]A_+ON^"XOMUYXMNW^[<:I
M+;AE.<J@V@@_0U@>$T\+:5:OH'BBPTFWU:SD=3+>VT8$Z$DJX=A@\''7/% #
M=6L_#'A^Q?5?!WB"RLK^U'F?9DU$2I=*.2C*7))/;'IZX(O^.;F?Q%I/A"*P
M_<3ZE>0W418!C%\F<D=]H?)^E7ENOA]/K%OI=EI>E7UU,V/]#L8Y508SN9@,
M >_;O4FIV\;_ !,\,V<4:)!86<\R1(H"J" @ '8# Q]* *6L>#8O#7AK4-3T
M!+N?Q L 47CRL\K E0Y SC.W=C R.U,T+PEX4U:V@U/PUJE[%=Q2*9+N.X8S
M'D$JZMP,C(Z8^O?K=>\26/AP6;Z@)4@N9O*,ZH2D7!(+'MZ?GZ&N)U*709?'
M/A^Z\*SV[ZI/<C[6+)\H]OC+E]IP#CGU/?H* -#X@QWUYXA\)V&FND=U)<RS
M1R2#*H8U!W$9YP"3COBKEQ\-='NXS+<W.HRZF?F_M![IO-#8QD#.T8XXQV I
M+I3=_%ZP0'*V.E/,?8N^S'UQS]*ZK4+K[#IMU=X!\B%Y<'I\H)_I0!Q>A>(+
MVY^%%[J%_(9+JVM[B+S#G,A0$*<]R>!FJ6K!K#X&VUN!^^GM+>-$[LTC*<<]
M\$U39FTWX J "9;B+'?+&2;_  /Z5K_$<R67AS1-/M(OM-P;Z!8H.\H0$X_,
M*/QH FT[X>07MA;OXIGGU"Z6%4\@3-'#  !A45".@ &>_6J=Q8/\/-9TN;3;
MRX;0[^Y2SGLYW,@B=A\KIW'0Y^G?@#H-.\>^&[^Q%P^J6UI(!^\M[J01R1MW
M4@]2,=JQ9[T?$#Q!ID>FJSZ%IEP+N>[>,A9YEQMC0$ \;CGMS[#(!W]<_P".
M-4.C>#-4O$8+*(3'&>X9SM!'TSG\*Z"N'^*@\SPM;6[9\N>_AC?!ZJ23_2@#
MH?"NFKI'A73+%0!Y5NN['=R,L?Q8DUSWQ&U\6UI;^'[>[AM;O53Y;SS.$2"'
MHS$D\9Z#\>^*Z[4M0MM)TVXO[N0);V\9D<^P[#U)Z =R:XGPAX?C\0M=^*O$
M5C#<SZDP-M!<Q!UA@'W< \<C'..@SW- &/XCNO#VA'PQJ6AZK83#1Y1#)%%=
M(\CPOPQPIR3][I_>/%>KJP90RD%2,@@\$5S^H^"?#][IEU:Q:+IT$DL3(DL=
MJBLC$<,"!D$'FLGPWXE:#X927]SC[7I4,EO,CG/[R(84''<_+^?XT <O>Z7)
MXD3QIX@AC'VFUND6PF0[O^/<?,5'N .?4\=Q7IFG:U;7OAN#6G<1V[VPN)&/
M1!MRV?IS^59'P\TL:=X%T^.2/]Y<H;B;?R6+\\_\!VC\*XBVT_4I[R3X;A6C
ML(+QKF6X4GFS)#JH/J2?S^AR 5-?BFUW3X?&%Z&7[5JD,&GPG/[JW4L,_5B,
MG\^_'<?%2Y,'@*[A49>YDBA7D=2X/\E-0?$N&.W\,:7#"@2*/4;=$4=% ! %
M/^(NRYF\,Z8^0+G5XF;#8^5<@C_QX4 /MM9\9P6<5K'X(1/+B$:N^JQ$# P"
M0!FKOAC0-0M=1OM=UR6&35KX*A2'_5P1CH@]>V3[=^2>HHH XG3 )/B_KCJV
M?*T^&-@!T)P?Y5VU<5X")U&_\1^( 28M0O?+A);.Z.(%5/TY/Y5KW?B[3++Q
M7:^'9O.%[<IO1@@\L9S@$YSDX]* -ZBBB@ HHHH **** "BBB@ HHHH 1E#*
M58 J1@@C@BJ=KH^EV,[3VFFV=O,V29(H%1CGKR!5VB@".>"&Z@>"XBCFAD&U
MXY%#*P]"#UIT<:0Q)%$BI&BA511@*!T '84ZB@"K>Z;8:DBI?V5M=(O*K/$K
M@?3(J--%TJ.SDLTTRS6UDQO@6!0C8Z97&#T%7J* ()[*TNHHXKBUAFCC8.BR
M1A@C#H0#T([&IZ** (8K6W@EFEAMXHY)F#2NB &0@8!8CJ<>M%M9VUE$8K2W
MA@C+%RL2!06/4X'<U-10!3O=(TW4B#?:?:71 P#/"KX'7'(J2TL+/3XO*LK2
M"VC_ +D,80?D*L44 <]XPO-3ATA;/1[>XDO[Z06Z2Q(Q%N#]Z1F PN!ZD<GV
M-:&A:-;:!HMKIEH/W<" %L<NW=C[DY-:-% !1110!0O-#TC4)3+>Z78W,AQE
MYK=')QTY(JU;VT%I$(K:".&,=$C0*!^ J6B@"&>SMKIX7N+>&9H7\R(R(&*-
M_>7/0^XJ:BB@ JE?:/IFILK7^G6EVRC"F>!9"![9%7:* *?]DZ;]FCM_[/M/
M(CD$J1>2NU7'1@,8!]ZFFL[:YEAEGMX99(&WQ,Z!C&WJI/0_2IJ* *[V-I)>
MQWKVL#7<:E$G,8+JIZ@-U Y/YUGW^@1ZEX@L-2NIB\5@K&"VVX E)'[PG/.
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M(H"JHX  '0"GT44 (RAE*L 5(P01P145K:6UC;);6EO%;P)G;%"@15R<G '
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M0, SPJ^!UQR*DM+"ST^+RK*T@MH_[D,80?D*L44 0M9VSW:7;6\+7,:E$F*
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M2:;0],DED8N[O:1EF8\DDD<DU)9Z!HVGW N++2;"VF ($D-LB, >O(&:T:*
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MB)!\N5 ZY'(.#4%]H^F:FRM?Z=:7;*,*9X%D('MD5=HH AMK6WLX1#:P101
MY"1(%7/T%<[XUEU*XL(=%TF&X^T:E)Y,ETD;%+:+^-F8< XX R,Y-=110!4T
MS3;;2-,M]/LTV6\"!$!.3]3[GK5NBB@!&4,I5@"I&""."*CMK6WLK=+>U@B@
M@3A(XD"JO?@#@5+10!#;6=M9HZ6MO# KN9'$2!0S'JQQU)]:+BTMKOROM-O%
M-Y,@EC\Q VQQT89Z$>M344 %9A\.:$9A,=%TXRCD/]E3</QQ6G10 BJ%4*H
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K HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>img268224062_14.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img268224062_14.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" :M$$@# 2(  A$! Q$!_\0
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 % HH% "T444 %+2"EH$%)2TE T+1110,.]%)WI:!!2BDI1TH 6BB
MBD M)1VHIB"EI*.U !1112&+1113$%+24M( HHHH 6BBB@ I:04M @I*4T@H
M&A:***!AWHI.]+0(*<.E-I1TH 6BBB@!>U)1VHH$%+VI*.U !1110,6BBB@
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M4VG#I0 4444"%HHHH **** "BBB@!:*** %%% HH *!10*0!1110 "EI!2T
M!HH-% !1113 6BBB@!*<.E-IPZ4 %%%%(!:*** "BBB@ HHHH 6BBB@ I:2E
MH *!10*0!1110 HHH%% !1110 4444P%HHHI %+24M !1110 M%%% !1110
M4444 +1110 4M)2T""@44"D 4444#%%% HIB"BBBD 4444P'4E+24@"EI*6@
M HHHH 6BBB@ HHHH *!10* %HHHH *6DI: "BBBD M%%% !1110(**** "BB
MB@!1TI:0=*6@8&B@T4""BBB@!:***0!1113 *!10* %HHHI  I:04M !0**!
M0 M%%% !1110(*6DI:!A1110 HHH%% "&E%(:44 %%%% "T444@"BBBF 444
M4 +1112 444"B@ H%% H$+1110 "E-(*4T )2TE+0 4444 +1110 E+24M !
M1110 M%%% !1110 4444 +1112 *6DI: "E%)2B@04444 **#0*#0 E HH%
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M7'S1>S_X]#[5QX:OJZ2-)8VCD171AAE89!'H17E'C'X5<O?^'$']Y[(G_P!
M)_\ 03^'I7?1Q-])G53K=)'E8-+3722"5HI4:.1#M9&&"I]"*4&NY,Z!:***
M!A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M**!!1110,**** %%% HH 3O3J;WIU @HHHH 6BBBD 4444P"E%)2B@ HHHI
M%%%%, H%% H8"T444@%HHHH$%%%% PHHHH 6BBB@!*<.E-IPZ4 %%%% A:**
M* "BBB@ HHHH 6BBB@!110** "@44"D 4444  I:04M  :*#10 4444P%HHH
MH 2G#I3:<.E !1112 6BBB@ HHHH **** %HHHH *6DI: "@44"D 4444 **
M*!10 4444 %%%%,!:***0!2TE+0 4444 +1110 4444 %%%% "T444 %+24M
M @H%% I %%%% Q110**8@HHHI %%%%,!U)2TE( I:2EH **** %HHHH ****
M "@44"@!:*** "EI*6@ HHHI +1110 4444""BBB@ HHHH 4=*6D'2EH&!HH
M-% @HHHH 6BBBD 4444P"@44"@!:***0 *6D%+0 4"B@4 +1110 4444""EI
M*6@84444 ***!10 AI12&E% !1110 M%%%( HHHI@%%%% "T444@%%% HH *
M!10*!"T444  I32"E- "4M)2T %%%% "T444 )2TE+0 4444 +1110 4444
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M$%**2E%)@+1112 !2T@I:8@HHHI#"BBB@ HHHH *6DI: "@=:*!UH$.HHHH
M2BBB@ HHHH 6BBB@84444 %*.E)2CI0(6BBBD HHH%%,04@I:04ABT444 +2
M&EI#0 4M)2T %%%% AW:BCM10,2BBB@04444 +1112&%+24M, I:2EH ****
M0A110** "@44"@ HHHH 6BBB@8E.IM.H$%%%% A:***0Q*6DI:8@H%% H 6B
MBBD,****8!1110 M%%%(!:***!!1110,**** %%% HH 3O3J;WIU @HHHH 6
MBBBD 4444P"E%)2B@ HHHI %%%%, H%% H8"T444@%HHHH$%%%% PHHHH 6B
MBB@!*<.E-IPZ4 %%%% A:*** "BBB@ HHHH 6BBB@!110** "@44"D 4444
M I:04M  :*#10 4444P%HHHH 2G#I3:<.E !1112 6BBB@ HHHH **** %HH
MHH *6DI: "@44"D 4444 ***!10 4444 %%%%,!:***0!2TE+0 4444 +111
M0 4444 %%%% "T444 %+24M @H%% I %%%% Q110**8@HHHI %%%%,!U)2TE
M( I:2EH **** %HHHH **** "@44"@!:*** "EI*6@ HHHI +1110 4444""
MBBB@ HHHH 4=*6D'2EH&!HH-% @HHHH 6BBBD 4444P"@44"@!:***0 *6D%
M+0 4"B@4 +1110 4444""EI*6@84444 ***!10 AI12&E% !1110 M%%%( H
MHHI@%%%% "T444@%%% HH *!10*!"T444  I32"E- "4M)2T %%%% "T444
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M** "BBB@ H%% H 6BBB@ %+2"EH$%)2TE (6BBB@H3O2TG>EH$%*.E)2CI0
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M HHHH **** %HHHH 444"B@ H%% I %%%%  *6D%+0 &B@T4 %%%%,!:***
M$IPZ4VG#I0 4444@%HHHH **** "BBB@!:*** "EI*6@ H%% I %%%% "BB@
M44 %%%% !1113 6BBBD 4M)2T %%%% "T444 %%%% !1110 M%%% !2TE+0(
M*!10*0!1110,444"BF(****0!1113 =24M)2 *6DI: "BBB@!:*** "BBB@
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M/G:V]1G!QW/M2;2W$W8SJ*U)O#NJV\+S2VF(T4LQ\Q3@#Z&LNA-/8$TPH%%
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ME-(*4T )2TE+0 4444 +15_2--_M2Z:#SO*VH7W;=W<#U'K6U_PAW_3_ /\
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M@>K(<C]"U>>UH^']4;1?$%CJ()Q!,&?'=3PP_(FHJQYH-$3CS1:/INBD5E=
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MTT:#JX&Y1]2N0*HVEG=7LIBM+::XD W%(D+G'K@4<R:NF%UN145I?\(]K?\
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MNI\!?\AV?_KV;_T):BK\#)G\+/1*\J\4?\C)>_[X_P#017JM>5>*/^1DO?\
M?'_H(KGP_P 3,J6YZ1HW_(#T_P#Z]H__ $$5F^,O^1;F_P!]/_0A6EHW_(#T
M_P#Z]H__ $$5F^,O^1;F_P!]/_0A41^/YD+XC+\ 3Q>5>6^0)=ROC/5>G3V/
M\Q79UX]IK7Z7@DTU9C<(,_N4+$#IR!VYKIY-?\5R0E%TR2-C_&MJ^[]<C]*U
MJ4VY73-)PN[E7QS+%)K<:)@ND(#D'H<D@'\/YUS%2W7V@W4ANQ(+@G+^8"&S
M[YJ6'3;ZYB$D%E<2QGHR1,P_,"MXI1BD:)615HJV^E:C%&TDEA=(BC+,T+
M>I.*A@MYKJ8101/+(>BH,FJNAW(J*V5\*:VZ;A8MCWD4'\B:H7FFWNGMB[MI
M(N<;F7Y2?8]#24HO9A=%:BBBF,*6DJS:6%W?-MM;:24]RJ\#ZGH*&["*]%;7
M_")ZWC/V'_R*G^-9]YIM[8-BZMI(N<99?E)]CT-2I)[,$TRM14UO9W5WN^S6
MTTVW&[RT+8STSBI_['U/_H'7G_?AO\*=T%T4J***8PKH_!/_ "'S_P!<6_F*
MYRK-C?W.G7'GVDGER;2N[:#Q^-3-7BT3)75CU^BO,O\ A+-;_P"?W_R$G^%>
MA:7-)<Z5:3RMNDDA5F.,9)%<<Z;AN<\H..Y;HK,\0W<]CH=S<VS[)4V[6P#C
M+ =#[&N&_P"$LUO_ )_?_(2?X40I.:NAQ@Y*Z$\6?\C+>?\  /\ T!:QA6A-
M!JNK2M>M:W-PTO61(3AL<=ACMBH9-,OX8VDEL;F-%Y+-$P _'%=:LDD;K16*
MM%%%44***!5P:3J1 (T^[(/0B%O\*+I"93HJS-I][;1^9/9W$29QN>,J/S(H
MATZ]N(Q)!9W$J'HR1,P_,"E="N5J*MOI>H11L\EA=(BC+,T+  >_%5XH99Y!
M'#&\CGHJ*2?R%.Z"XE)6PGA?674,+(X/K(H/Y$U6NM$U*R3?/9RJF"2P&X#Z
MD=*GFCW!-%"EI*6J&%%%% "T5:M-,OKW'V:UED!.-P7Y?SZ5>'A;6B,_8O\
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M1U_@?_E__P"V?_LU==7(^!_^7_\ [9_^S5UU<U7XV8S^(\LU+_D*WG_7=_\
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MJX0O!;32J#@LD989_"O0])1X])M4D5E=8P"K#!%8UMC.IL5/$_\ R 9_JO\
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MI'H154I75BH.ZL)1116A84M)2T %**2E% @HHHH 44&@4&@!*!10* %HHHH
M6BBB@ -%!HI %%%% "T444 %%%% !1110 M%%% !2TE+0 4HI*44 %%%% "B
M@T"@T )2BDI10 4444 +1110 &B@T4"-KPQ_R$I/^N)_F**/#'_(2D_ZXG^8
MHKGJ?$93W//_ (P?\C;:_P#7BG_HR2O/J]!^,'_(VVO_ %XI_P"C)*\^KU*'
M\-';2^!!1116IH%%%% !1110 4444 %%%% !1110 4444 %%%% !2&EHH ^@
M?AUK(UCP?:[FS/:C[/)_P'[I_P"^<?K75UX9\*]<&F>)C82OB"_78,]!(.5_
M/D?B*]SKR,1#DFS@JQY9!1116)F%%%% !1110!X)\8[40>-8Y@.)[1')]2"R
M_P @*Z[X,ZQ]IT*[TIV^>TE\R,'^X_\ @P/_ 'U7._&QO^*BTY<=+3/_ (^?
M\*I?""\^S>-?()XNK9X\>XP__LIKN:YJ!TM7IGOE%%%<)S%74K"'5-,NK"X&
M8KB)HV]@1C-?*MS;O9WD]K+Q)#(T;?4'!_E7UI7S;\1+'^S_ ![JD8&%ED$Z
M^^\!C^I-=>$EJT;T'JT<XM:UD_EZ'J8[R-"F?;);_P!E%9*UH6F3:7J?P^6K
MX]PZC^IKO.DK"EHJ>SLYKZX$,"AF())) "@=22> !ZFKV*(:U[/PQJMW;K=&
M 6UH?^7F[<0QX]06QG\,TOVNRT@[;%8[N['6[E3*(?\ IFAZ_P"\P^@'6LZ\
MOKO4)S/>7,MQ*>KRN6/ZU-V]A:O8V$T;086Q>^)8R1U6SM))/_'FVC^=/DTC
MPS,2+3Q*\;=A=63A3_P)2<?E7.4Z.&6;/E1N^T9.U2<"EROO^0K/N:>H>';_
M $^W^UXBN;(G NK602QY]"1]T^Q -957M)U>\T:\%Q:28S\LD3<I*O=77H0:
MU/$>EVHM+37=*C,>G7V082<FWE'WDSZ=Q[4*33LQW:=F<]124M64%%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !16KX:TR'6?$5EIT[ND4\FUFC(# 8)XSGTJ[XV\/VOAKQ ;"TEFDB\I7W2D
M%LG/H!Z5/.N;EZD\RO8YVBG11M-*D2#+NP51G')KT#Q/\-%\/^&GU1-1,TD&
MWSD,> VY@OR\]B>_Z4I5(Q:3Z@Y)-)]3SVBC-%64% HH% "T444  I:04M @
MI*6DH!"T444%"=Z6D[TM @I1TI*4=* %HHHI ':BCM13$%':BCM0 4444ABT
M444Q!2TE+2 ]B^$'_(!O_P#KZ_\ 917HE>=_"#_D W__ %]?^RBO1*\G$?Q&
M<-7XV?+5=Y\.O#6I2>)K?4)[2:"UM@7,DL94.2" %SUZYX]/<5[316L\6Y1:
M2+E7;5D@KQ#XI7,<_C(I&V6@MTC?V;EOY,*]:\0>(++PYIK7EX_/2.('YI&]
M!_CVKYYU"^GU/4;B^N6S-/(9&QG R>@SV'0>U/!P?-S!0B[W/5_A#_R ;_\
MZ^O_ &45Z&Z[T9<XR,5YY\(?^0#?_P#7U_[**]$K'$?Q615^-F-H'A?3/#EM
MY5E /-(_>3OR[GW/8>PXK9KS3QY\0+G3KY])T>01S18\^XV@D''W5SD=^37#
M67C;Q'8W?VA=5N)<MEHYW,B-[8/0?3%:+#U*BYFRU1E)<S/H,@,I5@"",$'O
M7C?Q$\%Q:,XU;3DVV<S[9(0O$3'N/13Z=CTZX'J^C:G'K&C6FHQA0+B(.55M
MP5NZY]CD?A6?XUMDN_!FJQR#(6 R#ZK\P_45G1FZ<[$4Y.,CYYKI/!_A.X\4
M:@4W&*RAP9Y@.1_LK_M'].OL>;KZ*\*:&GA[P];60"^=MWSL!]Z0\GZXZ#V
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MX,.M=F'FY0UZ&]*3<=1U%%%;FHE+24M 'JWPK_Y E[_U\_\ LHKO*X/X5_\
M($O?^OG_ -E%=Y7EU_XC.*I\3/FVM_PKX7G\27Y3)BM(L&:4=?\ =7W/Z?H<
M"O>_#.C)H6A6]F /-V[YF'\3GK^70>P%=M>IR1TW9TU9\JT+>FZ59:1:BVL;
M=(8^IQU8^I/<U<JCJ^JVNBZ;+?7;$11]E&2Q[ >YKR'5O'FN:G*_EW+6<!X6
M.W.T@9R/FZY_+Z5QTZ4JNISQA*>I[81D8/2L>V\-Z?9:ZVK6D8@EDC:.2-!A
M6R0<X['CMUS7DMAXU\0:?(K+J$DZCJEP?,#?4GG\C7K7AOQ#;^(],^U1)Y<B
M-MEB)SL/U[@TZE*=)7Z!*$H&Q7AWC7_D<=2_ZZ#_ -!%>XUX=XU_Y''4O^N@
M_P#01587XV50^(ZGX4?\Q?\ [8_^SUZ17F_PH_YB_P#VQ_\ 9Z](J,1_$9-7
MXV8^B^&M/T4O+#&'NI"2\[CYCDY('H/;^=;%<1XR\;OHT[:;IRJUWLS),W(B
MST '=L<\\=.O;SZ7Q3KTTXE;5KL,.R2%5_[Y&!^E5&A.I[S8U3E+5GO%<]XD
M\(V/B"%GV+#?!<).HZ^S>H_E7(>&?B'<QW*6NM.)('.!<;<,A]\=17J .1D=
M*B49TI$M2@SYWO;.?3[V:TN4*30L593_ )Z=\U!7IGQ.T56MX-8B4!T(AFP.
MH/W3^!X_$>E</X=TO^V=>M+$Y\MWS(1V0<G]!C\:[X5%*',=49IQYCH/!O@E
MM8Q?ZBK)8_P)G!E/]%]^]>K6]M!:0+#;Q)%$HP$1< 4Z**."%(8D"1QJ%15'
M"@< "N(\;>-)=*F_LS32HNMN99B,^7D< #^]W]N/PXG*=:5D<S<JDCNJ*^>+
MJ]NKZ7S+JXEF?).9&)QGKCTK3T;Q3JNC3HT-T\D*X!@E8LA [8[?A6CPKMHR
MW0=MSU3Q!X1T[7HV=D$%YCY;B->2>/O?WAP.M>/:GIMSI&H2V5V@66,\X.0P
M[$'T->XZ+K%MKFF1WML<*W#(3RC#J#_GH17.?$718[S1?[2CC_TFTQEE7):,
MGD?0$Y]N?6E1JN,N20J<VGRLXGP'_P CII__ &T_]%M7M->+> _^1TT__MI_
MZ+:O::6*^->@5OB/(?B3_P C4/\ KW3^9KD*Z_XD_P#(U#_KW3^9KD*ZZ7P(
MWI_"A:***T+/2/ 7A.!K9-8U"(2.QS;1N#A0/XB.^>WY_3T2LSPX5/AG2]O3
M[)%^>T9K/\:/K*:)NT8R"3?^^,7WPF#T[]<=.?UKS)MU)V;.*3<I:G1UA^(O
M#%CK]LWFJ(KI1\EPH&1Z!O5?:O-]'\<:SI5T%NIY+N '$D4YRPYYPQY!^O%:
M/B[QQ_:D/V#2V=+5U'G2$;6DS_#[#U]?IUT5"I&2L6J<E+0M_#.,Q:CJL996
M**J[D;*G!/(/<5Z17S[:W]Y8EC:7<]N6X8PR%,_7%>J_#R\NKWP_/)=W,UQ(
M+IE#2N7(&Q.,GMR:>(IN_..K#[1UM9/BC_D5]3_Z]V_E5W4&9--NG1BK+"Y!
M!P0<&O#9=;U6>)HIM3O9(W&&1[AB"/0@FHHTG-W[$4X<VIZ1\,_^1;N/^OMO
M_0$KJ=2_Y!=W_P!<7_\ 037+?#/_ )%NX_Z^V_\ 0$KJ=2_Y!=W_ -<7_P#0
M34U?XC%/XSP"BBBO2.P]N\(?\BGIW_7+^IH\7_\ (IZC_P!<OZBCPA_R*>G?
M]<OZFCQ?_P BGJ/_ %R_J*\W_EY\SC^W\SQ&ND\)>%W\0W;/*62RA(\QQU8_
MW1[^OI^-<['&\TJ11KN=V"J!W)Z5[QHNEQ:-I-O8Q8/EK\[ ??8]3^===>IR
M1TW9T59\JT)K&PM=-M4MK.%8HE' 4=?<GN?>K-9VM:S;:%ISWET20#M1!U=N
MP%>4ZEXUUO496*W;VL9Z1VY*8_'K^M<D*4JFISQ@Y:GLQ 8$$ @\$&LJP\/6
M.EZI->V48A$T>QXE^[G.<CT^G2O+].\::YI\B$WCW,0.6CG._=^)Y_6O4]"U
MJ#7M+2\A4H22LD9.2C#J,]_7Z&G.E.FO(<H2@:=>*W5^^E^.+J]C)!AOY&('
M<;SD?B,C\:]JKPG7_P#D8]4_Z^Y?_0S6F&5VT51W9[E!-'<6\<\3!HY%#HP[
M@C(-<)\2M*WP6VJ1J,QGRIB!R0?NG\#D?C6C\/=5^VZ$;21P9;1M@&>=AZ?U
M'X5T>J6$>J:7<V4H&V9"N3V/8_@<'\*R5Z50A>Y(\$HJ2>&2VGD@F4I+&Q1U
M/8@X(K3\-:0=:UVWM""80=\V#_ .OY\#\:]!M)79UMV5ST;P'I/]G>'TN)$Q
M/=_O2>,[/X1GTQS^-;.MZFFD:/<WK8S&GR ]V/ 'YXK0 P,#I7FGQ(U?SKV#
M2HV'EP#S)<'JYZ#\!_Z%7!!.K4U.6*YYG#N[RR-)(S.[$LS,<DD]2324E+7H
MG6%%%:WAO2O[9UVWM&_U6=\O^X.2/QZ?C4MI*[$W97-OPCX..K8OM05DLOX$
MS@R_X#WKTVUM+>RMUM[6%(8EZ(@P*E1%C140!548 '85R_BOQ<FA;;6V19;U
MUW8;[L8[$^I]O_K9X)2E5E9'*W*;.IHKQ&?Q-KEP^Y]4N@?^F<A0?DN*V]"\
M?7]I<+'J;FZMB<%B!O3W'K]#5/#22N-T78ZOQ#X*L=5CDFM$2VO<9#*,(Y_V
M@/7UZ_6O*KJUGLKJ2VN8FBFC.UD;J#7O44L<\22Q.KQN RLIR"#W%<3\1=&6
M:S35XQB2'$<O/5">#^!/Z^U50JM/ED.G-WLSJ=!_Y%W3/^O2+_T 5H5YEX U
M"]FUU;:6\N)($MV"Q/*Q5<8 P,XXKTVL:L.65B)QY78*\<\9_P#(W7_^\G_H
M"U;\7:OJ=MXIO88-1NXHE*[4CG95'R#H :YJ:>:YF::>5Y96^\\C%F/U)KIH
M4G'WNYK3A;4CHHHKI-3K/A[_ ,C,?^N#_P Q7JM>5?#W_D9C_P!<'_F*]5K@
MQ'QG/5^(\_\ ^:O_ .?^?>O0*\B\83S6OC:]FMY9(I5V;7C8JP_=J."*Z'X>
MZA>WMS?"[O+B<*B%1+*6QR>F355*;<%/R0YQO%2.\HHKQO5M:U6/6;Z--3O5
M1;B0*JSL  &/ &:RITW/8B$.8Q54LP5022< #O7H_ACP1!! EWJ\(DG;#+ W
M*H/]H=S[=*ROA[I"W6H2ZC,N4ML+&#W<]_P'\QZ5Z96]>JT^5&E6;V0@ 4
M  < "EKS_P 3>.I8[B6QTDA=AVO<X!R1U"@\8]_R]:Y0>)-:$PE_M2[W#L93
MM_[YZ?I6<</*2N2J3:N>T2Q1S1-%*BR1L,,CC((]Q7!^*/ Z+"][H\;!ERTE
ML.<CU3_#\O0S>%?&SWMPEAJA3S7XCG&%#'T8=,GV^E=S4^_2D3[U-G@-=_\
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MJ1Y;78>$_"8U!5U#4%/V;/[N+IYGN?;^?\^<T?3SJFK6UD&VB5\,?11R<>^
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MPQXL_M63['>A4N^J,HP)!_0UU59^]3D1K!GA==9X @ADUJ:20 R10DQ@]LD
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M'_H:UYE7IOBS_D6;O_@'_H:UYE3H?"%+X3N? ^H&2UFL'(S$=\?/.T]?R/\
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M_P#Z$:JU:U+_ )"MY_UW?_T(U5KK6QLMA:]%\,?\B[:_\#_]#:O.J]%\,?\
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MXS]3AE_$^9X'X?C$WB32XF *O=Q*0>ARXKZ3KYJT2X2TU[3KF0A4ANHI&)Z
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M)_A1_P (]HO_ $!]/_\  9/\*\X_X6?K?_/KI_\ W[?_ .+I1\3]:_Y]=/\
M^_;_ /Q=:^PJFGLYGJ-K96MC&8[2VAMT)W%8HP@)]<"F:G;"\TJ[MB2!-"\>
M1VRI%>9?\+.UK_GUT_\ []O_ /%TC?$W6F4J;6PP1C_5O_\ %TOJ]2]Q>RF9
MW@/_ )'33_\ MI_Z+:O::\6\!_\ (Z:?_P!M/_1;5[33Q7QKT'6^(\A^)/\
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MJ]E4*Y)'8_V1IO\ T#[3_ORO^%6HXXX8UCB141> JC 'X5PG_";ZE_SPM/\
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MF1X:ADM]&6&52LB2.K*>QR:N:K_R![W_ *]Y/_035H #. !GDU5U7_D#WO\
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MSI[ESPC_ ,A67_K@?_0EKLZXSPC_ ,A67_K@?_0EKLZ57X@GN>>:U_R&;O\
MZZ&I]"U8:9<D2Y,$F ^/X3ZU!K7_ "&;O_KH:HUT))QLS6UT>GQR)+&LD;JZ
M-R&4Y!J&ZLK:]CV7$2N.Q/4?0UP=AJMWIS?N)/D[QMRI_#_"NLTOQ#;Z@XA=
M3#.>BDY#?0USRIRCJC)Q:,;5/#4MJ'GM6\R$<E#]Y1_6L"O4*XCQ)8I::B)(
MP%CF&[:.Q[_X_C6E.HWHRH2OHS&JQ8G&H6Q])5_F*KU8L!NU&V'K*H_45J]C
M1GI%<OXPZV7_  /_ -EKJ*Y?Q@>;(?[_ /[+7+3^)&$/B.8HHHKJ-PI:2EH
M*44E**!!1110 HH- H- "4"B@4 +1110 M%%%  :*#12 **** %HHHH ****
M "BBB@!:*** "EI*6@ I124HH **** %%!H%!H 2E%)2B@ HHHH 6BBB@ -%
M!HH$;7AC_D)2?]<3_,44>&/^0E)_UQ/\Q17/4^(RGN>?_&#_ )&VU_Z\4_\
M1DE>?5Z#\8/^1MM?^O%/_1DE>?5ZE#^&CMI? @HHHK4T"BBB@ HHHH ****
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M**]8[@%+2"EH$>P?"'_D W__ %]?^RBO09O]3)_NG^5>??"'_D W_P#U]?\
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M4*]J^'/_ ")MM_UTD_\ 0C7BM>U?#G_D3;;_ *Z2?^A&M,5\'S*K?":WB?\
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M^8KU6O*OA[_R,Q_ZX/\ S%>JUP8CXSGJ_$>/>-_^1PO_ /MG_P"BUK<^&?\
MQ]:A_N)_,UA^-_\ D<+_ /[9_P#HM:W/AG_Q]:A_N)_,UO/^#\D:2_AGHM>&
MZS_R'=0_Z^9/_0C7N5>&ZS_R'=0_Z^9/_0C6>&W9%'=F_P"!=<73=3:SN'"V
MUU@ D\(XZ'V!Z?E7J=> 5WGAOQYY$:6FL,S(HPER 20/]KN?J/Q]:JO2;?-$
MJI3OJC1\1^!DU.X:\TZ2."=^9(W&$<^N1T/X<^W-<LO@37VF*&VC50<"0S+M
M/Y'/Z5ZM;W,%W$);::.:,]&C8,/S%2UC&O.*L9JI):'*^&?!D6BRB\NI5GO
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M>2>:QVQ1*7=O-0X &2>&K.T^Z-CJ-M=C)\F57P.X!SBO8]<_Y%_4O^O67_T
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MY\[M([.[%G8Y9F.23ZFMJ//;WC2'-U.D\"?\C"?^N#?S%>EUYIX$_P"1A/\
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M %<?KWC2-4>UTLEG.5:X[+_N^OU_G2]^JP]Z;*OCC5TN)H]-A(80MOE/^UC
M'X _K4'@+_D.S_\ 7LW_ *$M<N268LQ))Y)/>NH\!?\ (=G_ .O9O_0EKIE%
M1IM(V:M"QZ)7E7BC_D9+W_?'_H(KU6O*O%'_ ",E[_OC_P!!%8X?XF9TMSTC
M1O\ D!Z?_P!>T?\ Z"*S?&7_ "+<W^^G_H0K2T;_ ) >G_\ 7M'_ .@BLWQE
M_P BW-_OI_Z$*B/Q_,A?$<WX#_Y#D_\ U[-_Z$M>AUYYX#_Y#D__ %[-_P"A
M+7H=57^,JI\1Y5XG_P"1DO?]\?\ H(KMO!O_ "+</^^_\S7$^)_^1DO?]\?^
M@BNV\&_\BW#_ +[_ ,S6E7^&BI_ C0US_D W_P#U[O\ R->1UZYKG_(!O_\
MKW?^1KR.GA]F.EL%>M:!_P @"P_ZXK_*O):]:T#_ ) %A_UQ7^5&(V05=BIX
MO_Y%JY^J?^A"O-(I7@F26-MLB,&5AV(Y!KTOQ?\ \BU<_5/_ $(5YC10^$=+
MX3UW2M2AU73X[J(C)&'0'.QNXJ:\L[>_MFM[F,/&W4'M[CT->7:/K=UHTY>
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M6?\ (LW?_ /_ $-:\RIT/A"E\(4Z*1X94EC.UT8,I]".E-H%;,T/7-.O%O\
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M@5L>HX_I2:[:&]T6YA49;9N7ZCG^F*XH^[,YUI(\R'2EI!TI:[3I.O\  _\
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ME.K:+J&AWC6NHVLD$@/!8?*X]5/0CZ5GAVDN1[HBD[+E[%(4Y59W5$4LS'
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MVHH[4P"K=KJNHV(Q:7]U;CTBF9/Y&JE%*U]P-&;7M8N8FBGU:^EC8$,DEP[
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M5(T&69CP*\Y\2^(#K$XA@R+2(Y7/5S_>/]*B$7.5V3%.3N8-%%%=ITA1110
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M2"EH$!I!2FD% T+1110,3O2TG>EH$%*.E)2CI0 M%%% !VHH[44""CM11VH
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M444#"BBB@!:*** $IPZ4VG#I0 4444"%HHHH **** "BBB@!:*** %%% HH
M*!10*0!1110 "EI!2T !HH-% !1113 6BBB@!*<.E-IPZ4 %%%%(!:*** "B
MBB@ HHHH 6BBB@ I:2EH *!10*0!1110 HHH%% !1110 4444P%HHHI %:MC
MXBU33T6.&Z9HEZ1R#<,>G/('TK*I:32>XFD]SIE\=:H!@PVA]RC?_%4V7QOJ
MTBD*+>(XZI&<C\R:YNBI]G#L+DCV+5YJ%Y?OONKB24]@QX'T'056HHJDK#"B
MBBF,**** %HHHH *6DI:!!6E9:_J>GVPM[6Y$<0)(7RU/)]R*S:!2:3W"U]S
M7E\3ZS-$\3WA*.I5@(T'!]P*R***226P));"BB@450!6E9Z_J=A;BWMKGRX@
M20OEJ>OU%9M%2TGN)JYK3^)=7N()(9;O='(I5AY:#(/X5DT44TDM@22V'4E+
M24#"EI*6@ HHHH 6BBB@ HHHH *!10* %HHHH *6DI: "BBBD M%%% !1110
M(**** "K]EK6H:?"8K6Y*1DYV[5;G\15"BDTGN*US9'BC6?^?S_R$G^%4+R]
MN+^?SKEP\F-N[:%X_ 56'2EH44MD-)(#10:*8!1110 M%%%( HHHI@% HH%
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M +1110 M%%%  :*#12 **** %HHHH **** "BBB@!:*** "EI*6@ I124HH
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M@N5&%H7@_1/#@#6%H//Q@SRG=(?Q/3\,5Y#\2_%2Z_K8M+23=86>50@\2/\
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M4ABT444 +2&EI#0 4M)2T %%%% AW:BCM10,2BBB@04444 +1112&%+24M,
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M,2EI*6F(*!10* %HHHI#"BBBF 4444 +1112 6BBB@04444#"BBB@!110**
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M***0"T444 %%%% @HHHH **** %'2EI!TI:!@:*#10(**** %HHHI %%%%,
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M2=Z6@04HZ4E*.E "T444@#M11VHIB"CM11VH ****0Q:***8@I:2EI %%%%
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M*#10 4444P%HHHH 2G#I3:<.E !1112 6BBB@ HHHH **** %HHHH *6DI:
M"@44"D 4444 ***!10 4444 %%%%,!:***0!2TE+0 4444 +1110 4444 %%
M%% "T444 %+24M @H%% I %%%% Q110**8@HHHI %%%%,!U)2TE( I:2EH *
M*** %HHHH **** "@44"@!:*** "EI*6@ HHHI +1110 4444""BBB@ HHHH
M 4=*6D'2EH&!HH-% @HHHH 6BBBD 4444P"@44"@!:***0 *6D%+0 4"B@4
M+1110 4444""EI*6@84444 ***!10 AI12&E% !1110 M%%%( HHHI@%%%%
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M4ABT444 +2&EI#0 4M)2T %%%% AW:BCM10,2BBB@04444 +1112&%+24M,
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MZ4VG#I0 4444@%HHHH **** "BBB@!:*** "EI*6@ H%% I %%%% "BB@44
M%%%% !1113 6BBBD 4M)2T %%%% "T444 %%%% !1110 M%%% !2TE+0(*!1
M0*0!1110,444"BF(****0!1113 =24M)2 *6DI: "BBB@!:*** "BBB@ H%%
M H 6BBB@ I:2EH ****0"T444 %%%% @HHHH **** %'2EI!TI:!@:*#10(*
M*** %HHHI %%%%, H%% H 6BBBD "EI!2T % HH% "T444 %%%% @I:2EH&%
M%%% "BB@44 (:44AI10 4444 +1112 ****8!1110 M%%%(!110** "@44"@
M0M%%%  *4T@I30 E+24M !1110 M%%% "4M)2T %%%% "T444 %%%% !1110
M M%%%( I:2EH *44E**!!1110 HH- H- "4"B@4 +1110 M%%%  :*#12 **
M** %HHHH **** "BBB@!:*** "EI*6@ I124HH **** %%!H%!H 2E%)2B@
MHHHH 6BBB@ -%!HH$;7AC_D)2?\ 7$_S%%'AC_D)2?\ 7$_S%%<]3XC*>YY_
M\8/^1MM?^O%/_1DE>?5Z#\8/^1MM?^O%/_1DE>?5ZE#^&CMI? @HHHK4T"BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M2TE+0(*!10*0!1110,444"BF(****0!1113 =24M)2 *6DI: "BBB@!:***
M"BBB@ H%% H 6BBB@ I:2EH ****0"T444 %%%% @HHHH **** %'2EI!TI:
M!@:*#10(**** %HHHI %%%%, H%% H 6BBBD "EI!2T % HH% "T444 %%%%
M @I:2EH&%%%% "BB@44 (:44AI10 4444 +1112 ****8!1110 M%%%(!110
M** "@44"@0M%%%  *4T@I30 E+24M !1110 M%%% "4M)2T %%%% "T444 %
M%%% !1110 M%%%( I:2EH *44E**!!1110 HH- H- "4"B@4 +1110 M%%%
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M^:G_ -_8_P#XBO0**/;U.X>UGW//_P#A3_A__G\U/_O['_\ $4?\*?\ #_\
MS^:G_P!_8_\ XBO0**/;U.X>UGW//_\ A3_A_P#Y_-3_ ._L?_Q%'_"G_#__
M #^:G_W]C_\ B*] HH]O4[A[6?<\_P#^%/\ A_\ Y_-3_P"_L?\ \11_PI_P
M_P#\_FI_]_8__B*] HH]O4[A[6?<\_\ ^%/^'_\ G\U/_O['_P#$4?\ "G_#
M_P#S^:G_ -_8_P#XBO0**/;U.X>UGW//_P#A3_A__G\U/_O['_\ $4?\*?\
M#_\ S^:G_P!_8_\ XBO0**/;U.X>UGW//_\ A3_A_P#Y_-3_ ._L?_Q%'_"G
M_#__ #^:G_W]C_\ B*] HH]O4[A[6?<\_P#^%/\ A_\ Y_-3_P"_L?\ \11_
MPI_P_P#\_FI_]_8__B*] HH]O4[A[6?<\_\ ^%/^'_\ G\U/_O['_P#$4?\
M"G_#_P#S^:G_ -_8_P#XBO0**/;U.X>UGW//_P#A3_A__G\U/_O['_\ $4?\
M*?\ #_\ S^:G_P!_8_\ XBO0**/;U.X>UGW//_\ A3_A_P#Y_-3_ ._L?_Q%
M'_"G_#__ #^:G_W]C_\ B*] HH]O4[A[6?<\_P#^%/\ A_\ Y_-3_P"_L?\
M\11_PI_P_P#\_FI_]_8__B*] HH]O4[A[6?<\_\ ^%/^'_\ G\U/_O['_P#$
M4?\ "G_#_P#S^:G_ -_8_P#XBO0**/;U.X>UGW//_P#A3_A__G\U/_O['_\
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M_-3_ ._L?_Q%'_"G_#__ #^:G_W]C_\ B*] HH]O4[A[6?<\_P#^%/\ A_\
MY_-3_P"_L?\ \11_PI_P_P#\_FI_]_8__B*] HH]O4[A[6?<\_\ ^%/^'_\
MG\U/_O['_P#$4?\ "G_#_P#S^:G_ -_8_P#XBO0**/;U.X>UGW//_P#A3_A_
M_G\U/_O['_\ $4?\*?\ #_\ S^:G_P!_8_\ XBO0**/;U.X>UGW//_\ A3_A
M_P#Y_-3_ ._L?_Q%'_"G_#__ #^:G_W]C_\ B*] HH]O4[A[6?<\_P#^%/\
MA_\ Y_-3_P"_L?\ \11_PI_P_P#\_FI_]_8__B*] HH]O4[A[6?<\_\ ^%/^
M'_\ G\U/_O['_P#$4?\ "G_#_P#S^:G_ -_8_P#XBO0**/;U.X>UGW//_P#A
M3_A__G\U/_O['_\ $4?\*?\ #_\ S^:G_P!_8_\ XBO0**/;U.X>UGW//_\
MA3_A_P#Y_-3_ ._L?_Q%'_"G_#__ #^:G_W]C_\ B*] HH]O4[A[6?<\_P#^
M%/\ A_\ Y_-3_P"_L?\ \11_PI_P_P#\_FI_]_8__B*] HH]O4[A[6?<\_\
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M11_PJ+0/^?O4O^_L?_Q%=]11[>IW#VD^YP/_  J/0/\ G[U+_OY'_P#$4?\
M"H] _P"?O4O^_D?_ ,17?44>WJ=P]I/N<#_PJ/0/^?O4O^_D?_Q%+_PJ/0/^
M?O4O^_D?_P 17>T4>WJ=P]I/N<#_ ,*CT#_G[U+_ +^1_P#Q%'_"H] _Y^]2
M_P"_D?\ \17?44>WJ=P]I/N<%_PJ/0/^?O4O^_D?_P 11_PJ/0/^?O4O^_D?
M_P 17>T4>WJ=P]K/N<#_ ,*CT#_G[U+_ +^1_P#Q%+_PJ30/^?O4O^_B?_$5
MWM%'MZG</:3[G!?\*DT#_G[U+_OXG_Q%'_"I-!_Y^]2_[^)_\17>T4>WJ=P]
MI/N<%_PJ70?^?O4O^_B?_$4?\*ET'_G[U+_OXG_Q%=[11[>IW#VD^YP?_"I=
M!_Y^]2_[^)_\12?\*ET'_G[U+_OXG_Q%=[11[>IW#VD^YP7_  J70?\ G[U+
M_OXG_P 12_\ "I=!_P"?O4O^_B?_ !%=Y11[>IW#VD^YP7_"I=!_Y^]2_P"_
MB?\ Q%'_  J70?\ G[U+_OXG_P 17>T4>WJ=P]I/N<'_ ,*ET'_G[U+_ +^)
M_P#$4?\ "I=!_P"?O4O^_B?_ !%=Y11[>IW#VD^YP?\ PJ70?^?O4O\ OXG_
M ,11_P *FT'_ )^]2_[^)_\ $5WE%'MZG</:3[G!_P#"IM!_Y^]2_P"_B?\
MQ%'_  J;0?\ G[U+_OXG_P 17>44>WJ=P]I/N<)_PJ;0?^?O4O\ OXG_ ,11
M_P *FT'_ )^]2_[^)_\ $5W=%'MZG</:3[G"?\*FT'_G[U+_ +^)_P#$4?\
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M !%=U11[:IW#VD^YPO\ PJG0O^?O4?\ OXG_ ,11_P *IT+_ )^]1_[^)_\
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M</\ \*KT/_GZU'_OXG_Q%'_"J]#_ .?K4?\ OXG_ ,17<44>VJ=P]I+N</\
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MQT7_ )^M0_[^)_\ $4?\*QT7_GZU#_OXG_Q%=I11[:IW#VDNYQ7_  K#1?\
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M\W__ '\3_P")H_X5IHW_ #\W_P#W\3_XFNRHH]M/N'M)=SC/^%::-_S\W_\
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MG_Q-'_"OM)_Y^+W_ +[3_P")KJZ*/:S[ASR[G*?\*^TG_GXO?^^T_P#B:/\
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M'I?_ #WO/^^U_P#B:ZBBCVL^X<\NYR__  @>E_\ />\_[[7_ .)I/^$#TO\
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M_P#B:Z>BCVD^X<\NYS/_  @VF?\ />[_ .^U_P#B:/\ A!M,_P">]W_WVO\
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M7?\ WVO_ ,37244>TGW#GEW.;_X0K3?^>UW_ -]K_P#$T?\ "%:;_P ][O\
M[[7_ .)KI**/:2[ASR[G-_\ "%:;_P ][O\ [[7_ .)H_P"$*TW_ )[W?_?:
M_P#Q-=)11[27<.>7<YS_ (0K3?\ GM=?]]K_ /$T?\(5IO\ SVNO^^U_^)KH
MZ*/:2[AS,YO_ (0K3?\ GO=_]]K_ /$T?\(5IO\ SVNO^^U_^)KI**/:2[AS
MR[G.?\(5IO\ SVNO^^U_^)H_X0K3?^>UU_WVO_Q-='11[27<.9G.?\(7IO\
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MY[_A#M/_ .>UU_WTO_Q-+_PA^G_\]KK_ +Z7_P")KH**/:2[AS,Y[_A#M/\
M^>UU_P!]+_\ $T?\(=I__/:Z_P"^E_\ B:Z&BCVDNX<S.?\ ^$/T_P#Y[77_
M 'TO_P 31_PA^G_\]KK_ +Z7_P")KH**/:2[AS,Y_P#X0_3_ /GM=?\ ?2__
M !-'_"'Z?_SVNO\ OI?_ (FN@HH]I+N',SG_ /A#]/\ ^>UU_P!]+_\ $T?\
M(?I__/:Z_P"^E_\ B:Z"BCVDNX<S.?\ ^$/T_P#Y[77_ 'TO_P 31_PA^G_\
M]KK_ +Z7_P")KH**/:2[AS,Y_P#X1#3_ /GM<_\ ?2__ !-'_"(:?_SVN?\
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M_P">MQ_WTO\ A6U11SR[AS,Q?^$8LO\ GK<?]]#_  H_X1BR_P">MQ_WT/\
M"MJBCGEW#F9B_P#",67_ #UN/^^E_P */^$8LO\ GK<?]]#_  K:HHYY=Q<S
M,^QT>WT^=I8GE9BNW#D$8R#Z>U%:%%)MO<3=PHHHI %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 51;6-.1
MV1KN,,IP1FKU8<GA6RDD9S-<98DG#+_A0)WZ%W^V]-_Y_(Z/[;TW_G\CJA_P
MB5C_ ,]KC_OI?\*/^$2L?^>UQ_WTO^%/05Y%_P#MO3?^?R.C^V]-_P"?R.J'
M_")6/_/:X_[Z7_"C_A$K'_GM<?\ ?2_X4:!>1?\ [;TW_G\CH_MO3?\ G\CJ
MA_PB5C_SVN/^^E_PH_X1*Q_Y[7'_ 'TO^%&@7D7_ .V]-_Y_(Z/[;TW_ )_(
MZH?\(E8_\]KC_OI?\*/^$2L?^>UQ_P!]+_A1H%Y%_P#MO3?^?R.C^V]-_P"?
MR.J'_")6/_/:X_[Z7_"C_A$K'_GM<?\ ?2_X4:!>1?\ [;TW_G\CH_MO3?\
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MO3?^?R.C^V]-_P"?R.J'_")6/_/:X_[Z7_"C_A$K'_GM<?\ ?2_X4:!>1?\
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M+_A1H%Y%_P#MO3?^?R.C^V]-_P"?R.J'_")6/_/:X_[Z7_"C_A$K'_GM<?\
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MR.J'_")6/_/:X_[Z7_"C_A$K'_GM<?\ ?2_X4:!>1?\ [;TW_G\CH_MO3?\
MG\CJA_PB5C_SVN/^^E_PH_X1*Q_Y[7'_ 'TO^%&@7D7_ .V]-_Y_(Z/[;TW_
M )_(ZH?\(E8_\]KC_OI?\*/^$2L?^>UQ_P!]+_A1H%Y%_P#MO3?^?R.C^V]-
M_P"?R.J'_")6/_/:X_[Z7_"C_A$K'_GM<?\ ?2_X4:!>1?\ [;TW_G\CH_MO
M3?\ G\CJA_PB5C_SVN/^^E_PH_X1*Q_Y[7'_ 'TO^%&@7D7_ .V]-_Y_(Z/[
M;TW_ )_(ZH?\(E8_\]KC_OI?\*/^$2L?^>UQ_P!]+_A1H%Y%_P#MO3?^?R.C
M^V]-_P"?R.J'_")6/_/:X_[Z7_"C_A$K'_GM<?\ ?2_X4:!>1?\ [;TW_G\C
MH_MO3?\ G\CJA_PB5C_SVN/^^E_PH_X1*Q_Y[7'_ 'TO^%&@7D7_ .V]-_Y_
M(Z/[;TW_ )_(ZH?\(E8_\]KC_OI?\*/^$2L?^>UQ_P!]+_A1H%Y%_P#MO3?^
M?R.C^V]-_P"?R.J'_")6/_/:X_[Z7_"C_A$K'_GM<?\ ?2_X4:!>1?\ [;TW
M_G\CH_MO3?\ G\CJA_PB5C_SVN/^^E_PH_X1*Q_Y[7'_ 'TO^%&@7D7_ .V]
M-_Y_(Z/[;TW_ )_(ZH?\(E8_\]KC_OI?\*/^$2L?^>UQ_P!]+_A1H%Y%_P#M
MO3?^?R.C^V]-_P"?R.J'_")6/_/:X_[Z7_"C_A$K'_GM<?\ ?2_X4:!>1?\
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M+_A1H%Y%_P#MO3?^?R.C^V]-_P"?R.J'_")6/_/:X_[Z7_"C_A$K'_GM<?\
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MR.J'_")6/_/:X_[Z7_"C_A$K'_GM<?\ ?2_X4:!>1?\ [;TW_G\CH_MO3?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M(/B!K21J #<;R .[ $_J37IWP-_Y%S4O^OL?^@"NJL[T[G#AERUK>IRWQO\
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MOA__ $$5YI\/_P#D?M%_Z^5_K7;3_A?>>96_WC[CZCKSKXT_\B-'_P!?L?\
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M:21ZGX,TI]$\':7I\H(EC@#2*5P5=B688]BQ'X5\_P#Q(_Y*'K/_ %U7_P!
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M *^'_P#017INEV<NGZ7;VD]Y->2Q(%>XF^](?4_Y_$]:\R^.G_('TC_KX?\
M]!%94OXB.C$?PF>:?#__ )'[1?\ KY7^M?3=_P#\@ZY_ZY/_ "-?,GP__P"1
M^T7_ *^5_K7TW?\ _(.N?^N3_P C6F(^)&.#^!GR!7TW\,_^2=:/_P!<W_\
M1C5\R5]-_#/_ ))UH_\ US?_ -&-5XGX48X+XWZ'65\P?$'0/^$=\8WMK'&$
MMI3]HMU7H(V)X'L""/PKZ?KS3XS>'_[0\-Q:O$@,^GO\Y Y,3$ _D<'VYK&A
M+EE;N=6*I\U._8\$)) !)(' ]J]Z^#'A\Z?X=FU>9,3:@^(\CD1*2!CZG/UP
M*\3T32I]<UNSTRW4F2YE"9 SM'=C[ 9)]A7UC96D6GV%O90 B&WB6) >NU0
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M\C6S/8O@7&!I.KR;3EIT7/KA3_C^M>LUS/@/PN?"7AB*PE</<R.9[AE.5WD
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M3L7Z*K0:C973;;>\MYF](Y58_H:LTFFMQJ2DKIA1112&%%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_P"SHYL-_5PYJ)0_X7!X@_Y\],_[]2?_ !='_"X/$'_/GIG_ 'ZD_P#BZO\
M_"GO^H[_ .2G_P!G1_PI[_J._P#DI_\ 9T<V&_JX<U$H?\+@\0?\^>F?]^I/
M_BZ/^%P>(/\ GSTS_OU)_P#%U?\ ^%/?]1W_ ,E/_LZ/^%/?]1W_ ,E/_LZ.
M;#?U<.:B4/\ A<'B#_GSTS_OU)_\71_PN#Q!_P ^>F?]^I/_ (NK_P#PI[_J
M._\ DI_]G1_PI[_J._\ DI_]G1S8;^KAS42A_P +@\0?\^>F?]^I/_BZ/^%P
M>(/^?/3/^_4G_P 75_\ X4]_U'?_ "4_^SH_X4]_U'?_ "4_^SHYL-_5PYJ)
M0_X7!X@_Y\],_P"_4G_Q='_"X/$'_/GIG_?J3_XNK_\ PI[_ *CO_DI_]G1_
MPI[_ *CO_DI_]G1S8;^KAS42A_PN#Q!_SYZ9_P!^I/\ XNC_ (7!X@_Y\],_
M[]2?_%U?_P"%/?\ 4=_\E/\ [.C_ (4]_P!1W_R4_P#LZ.;#?U<.:B4/^%P>
M(/\ GSTS_OU)_P#%T?\ "X/$'_/GIG_?J3_XNK__  I[_J._^2G_ -G1_P *
M>_ZCO_DI_P#9T<V&_JX<U$H?\+@\0?\ /GIG_?J3_P"+H_X7!X@_Y\],_P"_
M4G_Q=7_^%/?]1W_R4_\ LZ/^%/?]1W_R4_\ LZ.;#?U<.:B4/^%P>(/^?/3/
M^_4G_P 71_PN#Q!_SYZ9_P!^I/\ XNK_ /PI[_J._P#DI_\ 9T?\*>_ZCO\
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MZ9_WZD_^+H_X7!X@_P"?/3/^_4G_ ,75_P#X4]_U'?\ R4_^SH_X4]_U'?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@"IJET]EI-[=QA3)! \BANA*J2,^W%>:?\
M"S-:_P"?6P_[]O\ _%UZE<0175M+;S+NBE0HZY(RI&".*P?^$$\-_P#0-_\
M(\G_ ,5750J48I^TC<\_&4<54DG0G9?UY,XO_A9FM?\ /K8?]^W_ /BZ/^%F
M:U_SZV'_ '[?_P"+KM/^$$\-_P#0-_\ (\G_ ,51_P ()X;_ .@;_P"1Y/\
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MT'=3_P# N3_&C_A*/$'_ $'=3_\  N3_ !KV/_A7?A7_ *!7_DQ+_P#%4?\
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MT'=3_P# N3_&C_A*/$'_ $'=3_\  N3_ !KV/_A7?A7_ *!7_DQ+_P#%4?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110!\K2R-+*\C?>=BQ^IKZ%\)P1V
M_A+24C4!3:1N0/5E#']2:^=Z^C/#7_(JZ/\ ]>4/_H KT<9\*.K$;(U****\
M\Y HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@#Q?XJP1Q>+8W10&FM$=SZG<R_R45T/P8D8
MQ:S'_"K0L/J=_P#@*POBS_R-5K_UY)_Z&];7P7_YC?\ VP_]J5Z$_P#=OZ[G
M6_X)ZM1117G'*%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110!X/X?_P"1DTO_ *^XO_0Q
M7O%>#^'_ /D9-+_Z^XO_ $,5[Q7HYC\43P\C_AS]0HHHKSCW HHHH **** "
MBBB@ HHHH *\4^,'_(VVO_7BG_HR2O:Z\4^,'_(VVO\ UXI_Z,DKIPG\0VH?
M&7_@]_S&?^V'_M2O4*\O^#W_ #&?^V'_ +4KU"EB?XK)K?&PHHHK R"BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110!5O]/M=3MC;7D7F0DAMNXKR/H1573_#NE:7
M<FXL[01RE2N[>S<'ZD^E:E%6JDU'E3T,W1IRESN*OWMJ%%%%0:&9J/A_2]6N
M%GO;7S9538&\QEXR3C@CU-6K#3[73+46UG%Y<()(7<3R?<FK-%6ZDW'E;T,U
M2IJ7.HJ_>VH4445!H%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M;_\ []I_\71]5K?RA_:&%_G1V=%<9_PLS1?^?6__ ._:?_%T?\+,T7_GUO\
M_OVG_P 71]5K?RA_:&%_G1V=%<9_PLS1?^?6_P#^_:?_ !='_"S-%_Y];_\
M[]I_\71]5K?RA_:&%_G1V=%<9_PLS1?^?6__ ._:?_%T?\+,T7_GUO\ _OVG
M_P 71]5K?RA_:&%_G1V=%<9_PLS1?^?6_P#^_:?_ !='_"S-%_Y];_\ []I_
M\71]5K?RA_:&%_G1V=%<9_PLS1?^?6__ ._:?_%T?\+,T7_GUO\ _OVG_P 7
M1]5K?RA_:&%_G1V=%<9_PLS1?^?6_P#^_:?_ !='_"S-%_Y];_\ []I_\71]
M5K?RA_:&%_G1V=%<9_PLS1?^?6__ ._:?_%T?\+,T7_GUO\ _OVG_P 71]5K
M?RA_:&%_G1V=%<9_PLS1?^?6_P#^_:?_ !='_"S-%_Y];_\ []I_\71]5K?R
MA_:&%_G1V=%<9_PLS1?^?6__ ._:?_%T?\+,T7_GUO\ _OVG_P 71]5K?RA_
M:&%_G1V=%<9_PLS1?^?6_P#^_:?_ !='_"S-%_Y];_\ []I_\71]5K?RA_:&
M%_G1V=%<9_PLS1?^?6__ ._:?_%T?\+,T7_GUO\ _OVG_P 71]5K?RA_:&%_
MG1V=%<9_PLS1?^?6_P#^_:?_ !='_"S-%_Y];_\ []I_\71]5K?RA_:&%_G1
MV=%<9_PLS1?^?6__ ._:?_%T?\+,T7_GUO\ _OVG_P 71]5K?RA_:&%_G1V=
M%<9_PLS1?^?6_P#^_:?_ !='_"S-%_Y];_\ []I_\71]5K?RA_:&%_G1V=%<
M9_PLS1?^?6__ ._:?_%T?\+,T7_GUO\ _OVG_P 71]5K?RA_:&%_G1V=%<9_
MPLS1?^?6_P#^_:?_ !=/B^).AR.%:*\C']YXUQ^C$T?5JW\H?VAAOYT=A157
M3]2L]4M1<64Z31'NO4>Q'4'ZU:K%IIV9UQDI*Z=T%%%%(84444 %%%% '@_A
M_P#Y&32_^ON+_P!#%>\5X/X?_P"1DTO_ *^XO_0Q7O%>CF/Q1/#R/^'/U"BB
MBO./<"BBB@ HHHH **** "BBB@ KQ3XP?\C;:_\ 7BG_ *,DKVNO%/C!_P C
M;:_]>*?^C)*Z<)_$-J'QE_X/?\QG_MA_[4KU"O+_ (/?\QG_ +8?^U*]0I8G
M^*R:WQL****P,@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH X/XL_\BK:_P#7ZG_H
M#UPWPV_Y*!IG_;7_ -%/7<_%G_D5;7_K]3_T!ZX;X;?\E TS_MK_ .BGKT*7
M^[OYG73_ (3^9] T445YQRA1110 4444 %%%% !1110 4444 %%%% !1110
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M$FK77Q&N]*FN]UE'),JQ>6@P%SCD#/ZUW]>1Z'J%E#\4;V[DN[=+9I9RLS2
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M0**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_P#D:/\ ^*KUZBC^T*O9?U\P_L3#]W^'^1Y#_P (5XA_Z!__ )&C_P#BJ/\
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M ,C1_P#Q5>O44?VA5[+^OF']B8?N_P /\CR'_A"O$/\ T#__ "-'_P#%4?\
M"%>(?^@?_P"1H_\ XJO7J*/[0J]E_7S#^Q,/W?X?Y'D/_"%>(?\ H'_^1H__
M (JC_A"O$/\ T#__ "-'_P#%5Z]11_:%7LOZ^8?V)A^[_#_(\A_X0KQ#_P!
M_P#\C1__ !5'_"%>(?\ H'_^1H__ (JO7J*/[0J]E_7S#^Q,/W?X?Y'D/_"%
M>(?^@?\ ^1H__BJ/^$*\0_\ 0/\ _(T?_P 57KU%']H5>R_KYA_8F'[O\/\
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M_P#0/_\ (T?_ ,57KU%']H5>R_KYA_8F'[O\/\CR'_A"O$/_ $#_ /R-'_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M?$44D<T1\LW&.00<?.O7(YR1^52N9P7)TW*?*JCY^NQJ>$?"VK>'-6NTDO\
MS-,VYC0=)&/?&?E(QSZ\5G_$_4+H#3])@?9%=$M(<XW8( !]LG/Y>E=_;W,-
MW;I<6\J2PR#*NAR"*Y;QYX9EU[3HI[/_ (_;0DHN<>8IZCZ\#'X^M3"=ZB<B
MYPM3:B,@^&GA^/3Q!,DTL^/FN?,*MGV'W0/P-,\(^%M6\.:M=I)?^9IFW,:#
MI(Q[XS\I&.?7BLOP_P#$9K4C3?$44D<T1\LW&.00<?.O7(YR1^5>AV]S#=VZ
M7%O*DL,@RKH<@BB;J1NI=105.5G'H2T445B;F+XA\,V7B6&"*\EN(UA8LODL
M 3GUR#7EE]X9LK;Q]%H*2W!M7>-2[,-^&4$\XQW]*]MKRO5O^2QV_P#UUA_]
M %=%&3U7D<]>$=';J==H7@;3/#^H_;K2>[>784Q*ZE<'Z**X_P"*C;-<TYL9
MVP9Q_P "->K5Y1\5P3K.G@#),!X_X$:*,G*I=A6BHT[(LZ;HFH^/[DZMK5Q+
M!IH8B"",_A\N> /4]3C\NBE^''AN2W$2VLT3XQYJ3-N^O)(_2NDL;2.PL+>T
MB "0QJ@P,=!BK%1*K*^FB+C2C;WM6>1:>]YX"\;)ILEP7L;AE!SG:R,<!\=B
M",9]C7KM>7?%F,I>:5.,#<DB@CKP5/\ 6O38)?.MXY<8WH&QGID4ZNL8R[DT
MO=E*'8X'QYXHO%OD\.Z.7%U+A9F3[V6Z(/3(()/N.>M2:-\,+"*W275Y);BY
M/S/&C[4'MD<GZY%<-HWB9=,\2W&MW%G]LFD+LH,FS:S'EN >Q(Q[UU?_  MS
M_J!_^3?_ -A6KA.*48(RC.G)N4V;6H?#/0;J+%HLUE(!PR2%QGW#$_H17+Z7
MJ.J?#_7AIFI,TFF2,<$#*X/\:>GN/_K&KW_"W/\ J!_^3?\ ]A6!XK\:0^*+
M&&%M*^SRPR;DF\_>0",$8VC@\?D*(1J/W9K0)RIKWH.S/:E8,H92"I&01T-+
M7/\ @BY>[\&Z;+(26",F2<\*Q4?H*Z"N62LVCKB[I,*\IGLI?&GQ&O+&]G:.
MUL]X"H?X%8+A<YP22"37JU>8^*]&U3PYK[^)]'):)R7F&,^63][<.ZGKGL?P
M-:T7JUU,JRT3Z=37U?X9Z1=6K?V8&LK@#Y279T8^AR21]1^1K=\*V6I:?H$%
MOJMPTUR"3\QR47LN[^+Z^^.U9?A[X@:9K3);W'^AW;?PNWR,?9OZ&NNJ9N:7
M+(<(P;YH'*>-O%G_  CEDL-L U_< ^7D9$:_WCZ^P_R>:\/?#^;6$_M3Q!<3
M[I_F$>?G8$=6)Y'T]JKSQ#7OBZ8+D;H8I<;?]F-,X_$C]:]8JV_9Q2CNR(Q]
MI)N6R.4E^'/AJ2$1K:2Q-_ST2=MWZDC]*Y+4;#5?A^\I@F-WH]XK0L&XVD@]
M1V/7D=<5ZQ6=K]E'J.@7]K*H*R0MC/9@,J?P(!_"IA5=[2U14Z4;7CHSB/A)
M_P >^J_[T7\FK;\9>$[#6(KC5;B:Y6>VM&"+&RA3MW,,@@GJ?6L3X2?\>^J_
M[T7\FKN=<_Y%_4O^O67_ - -54;570FFDZ*3/*/ WA.P\317K7LUS&8&0+Y+
M*,YSG.0?2O4]"T.V\/Z=]AM'F>+>7S*06R?H!7%?"3_CWU7_ 'HOY-7>:M<M
M9:-?72'#P6\DB_55)_I16E)S<0H1BH*1Y[XNU_4=>U[_ (1G168(&,<Q7CS&
M'WLGLJX.?7!Z\5KZ9\,=&MH4-^TUY-CY_G*)GV Y_6N!\)^*(_#%Q<W#:?\
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M]#C\*Y'3?^2S/_U\3?\ HMJ<%RN2\F*I+F4'YH]4N)XK6VEN)WV11(7=L=%
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M9?#74I;#4;WP[>#8^]GC4CD.O#C\@#^!]:]-KRWQ[9OH'BFP\0V:C$CAF4#
M\Q<9SCLP_D:]+LKR'4+*&[MVW13('4Y['^M*JKVFNHZ+M>#Z&!X[U@Z/X8G,
M;8GN?W$9!P1D')'T&?TJC\-=&%AX?^WR >?>G=G'*H.%'X\G\1Z5SOBB1_%O
MC^VT6 [K>V?RV9>W>0_AC'U%>J1QI#$D4:[410J@=@.E$O<@H]Q1]^HY=%H.
MHHHK$W.<\9>)U\-:6KQA7O)R5@5LXXZL?ID<>]<=X>\#W?B,_P!L>(+F<+-\
MRH3^\D&."2?NCI@8Z>@Q3/$J#6?BI;:?< O!&T413IE<!R/QW'WKU95"J%4
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MQYSS@"N5^%W_ "*DG_7T_P#Z"M=K4UI-R:8Z,4HIH****R-CRSX3?\A#4O\
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MB@ HHHH **** "BBB@ HHHH **** /&_BS_R-5K_ ->2?^AO6U\%_P#F-_\
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MY0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M&#3/^N7_ +/7JE>5_%'_ )&#3/\ KE_[/10^,,1\!ZI1116)L>9_%S_F#_\
M;;_VG7HMC_R#[;_KDO\ (5YU\7/^8/\ ]MO_ &G7HMC_ ,@^V_ZY+_(5M/\
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MI8II"ZJ.-@Z?NR>J]./ZYJX0<MB)S4+7-;QMX)L;G3KK5+&(6]W"AE=8QA)
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M#_D4=+_Z]UK:K%\(?\BCI?\ U[K6U6$_B9O#X4%07W_(/N?^N3?R-3U!??\
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M'#'.6_+C\ZZKQW_R)6I?[J?^AK6MI>F6NCZ=%8V:;88QQDY)/<D^IK)\=_\
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M_P!J5Z$O]V_KN=;_ ()ZM1117G'*%%%% !1110 4444 %%%% !1110 4444
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MVO\ Z*>O0I?[N_F==/\ A/YGT#1117G'*%%%% !1110 4444 %%%% !1110
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M=A:W#>LL*N?U%6Z*+V!JY5M=,L+%BUG8VUN2,$PQ*F1Z<"K5%%%[A:P4444
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M\9?^#W_,9_[8?^U*]0KR_P"#W_,9_P"V'_M2O4*6)_BLFM\;"BBBL#(****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_"0Z,FH?9_L^YV7R]^_&#CK@4^5VYNA/,K\O4UZ***104444 %%%% !1110
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M.6$;1;LJ<$C.2<],=NM>AT3@X.S%":FKH****DL**** "BBB@ HHHH ****
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M_=_Z3">^#A6'Y[<?4UTU::4;HXL/6DYVD]SU>BBBN4[PHHHH **** "BBB@
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M?_A-_P CW#_UPD_E7T!3K_&+"?PSY>\5_P#(X:W_ -?\_P#Z,:O=/&=E+?\
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MDJ2D^9,RIXATUR26IH?$+6K?7?&-U<VCB2VC588W'1@HY(]LDX]L5[-\.?\
MD0-)_P"N;_\ H;5X#K>BW?A_4VT^^\O[0B(S"-MP&Y0<9]1GZ5] _#U/+\!:
M0,YS$3^;$_UHK)*"2'AFW5DWN=-1117*=P5GZ[_R+VI?]>LO_H!K0K/UW_D7
MM2_Z]9?_ $ U4/B1G6_AR]&>)5]$U\[5]$UZ.9?9^?Z'B9%_R\^7ZA1117EG
MT 4444 %%%% '@_A_P#Y&32_^ON+_P!#%>\5X/X?_P"1DTO_ *^XO_0Q7O%>
MCF/Q1/#R/^'/U"BBBO./<"BBB@ HHHH **** "BBB@ KQ3XP?\C;:_\ 7BG_
M *,DKVNO%/C!_P C;:_]>*?^C)*Z<)_$-J'QE_X/?\QG_MA_[4KU"O+_ (/?
M\QG_ +8?^U*]0I8G^*R:WQL****P,@HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ K@/%OPVF\5ZXVH2:X8(PBQQ0_9=_E@#GG>,Y.3T[UW
M]%.,G%W1,X1FK2,?POX?A\,:#!ID+B4H2TDNW;YC$\G&3CL.O:MBBBAN[NQI
M)*R(;RW^UV4]MNV^;&T>[&<9&,XKS?1OA#_9&M66H_VYYOV:99?+^R;=V#G&
M=YQ7IU%.,W%61,J<9--K8****DL**** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH X/XL_\BK:_P#7
MZG_H#UPWPV_Y*!IG_;7_ -%/7<_%G_D5;7_K]3_T!ZX;X;?\E TS_MK_ .BG
MKT*7^[OYG73_ (3^9] T445YQRA1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MX;U#2-4,]GK4(C\J9,HSC>I.2.AVYY'!'ZOV5_A=Q>VY?B5CU:H+[_D'W/\
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MHH **** "BBB@ HHHH *\4^,'_(VVO\ UXI_Z,DKVNO%/C!_R-MK_P!>*?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5A>,=)FUGPQ=V
MEOS. )(U_O%3G'XC('OBMVBFG9W0I*ZLSSCP/XTL[6RBT35#]EE@)2.1P0K<
M_=;^Z1GOQ_7T9'61%=&#*PR&!R"/6N<\0^"M*\0;I73[/>'I<1#D_P"\.AZ_
M7WKBM(U+5? GB*/2-2D\S3Y6'<E0I.!(O<8[CZ^QK9QC4UCOV,%*5.REMW.Z
M\:_\B;J?_7+_ -F%9/PN_P"14D_Z^G_]!6MCQE&TG@_5%12Q$); ] 03^@K&
M^%K ^%90.UVX/_?*TE_"?J4_XR]#MJS/$?\ R*^K?]>4W_H!K3K)\42"+PKJ
MS,#@VDB\>ZD?UK*.Z-)?"SE?A/\ \@>__P"O@?\ H(J]\3?^11/_ %\)_6JG
MPIB9=!O)3]U[G:/P4?XU;^)O_(HG_KX3^M;O^-\S!?P/D1_#71HK+0!J+(#<
M7A)W$<J@. /Q(S^7I7;5S/@"ZCN?!MD$;+0[HG&.A#'^A!_&NFK*HVYNYK22
M4%8*\DUBW7P?\1[6[MODM9W$NU<8"L2KKCIZX';BO6Z\I^(TBWOC'3K&'YI5
M1$('.&9^!]<8/XU=#XK$5_AOU/1]<_Y%_4O^O67_ - -<3\)O^/#4O\ KJG\
MC7;:Y_R+^I?]>LO_ * :XGX3?\>&I?\ 75/Y&B/\*0Y?Q8F=\4-0\_6[/2S,
M$MXD$DAQG:S$C)[\* ?QKI]/\9>#],L(+*UU';#"NU08)2?J?EZ]ZY7QS:01
M_$*QDOP&LK@1&3DCY-VUN1ST&>/6NS_X5]X7_P"@7_Y,2_\ Q57+DY(J5S./
M.YR<;!_PL'PO_P!!3_R7E_\ B:S=>\5>$M<T:XL)=27+KF-C;R?(XZ'[G'^!
M-:7_  K[PO\ ] O_ ,F)?_BJ1O 'A55+-IH"@9)-Q)@?^/5"=).ZO^!;55JS
MM^)@?"G4GDMK[39'RL166)<= <AOU"_F:K_$:ZGU/Q#IOA^!AM)5B!_ST<[1
MGZ#G_@1KM=$\/Z)I1:ZTB!$\Y,&1)FD#+GMDD5P/C*0:7\2K"_GYA_<S';U"
MAL'\?E/Z5<6I57)$33C246>FZ;IUKI-A%96<8CAC& .Y]2?4FK5%%<S=SJ2L
M-DC26-HY$5T<%65AD$'J"*KZ?IEEI=N(+&VC@C]$'7ZGJ?QJU11<+=2"^_Y!
M]S_UR;^1KSKX1_\ ,8_[8_\ M2O1;[_D'W/_ %R;^1KSKX1_\QC_ +8_^U*V
MA_#E\C&?\6/S/3*\CTG49_A_XHO;348&:UN2/G4?P@G:X]1@MD?X5ZY5#5M%
MT_7+7[/J%NLJ Y4Y(93Z@CD5,)I73V952#E9K=$MAJ5GJEL+BQN8YXCW0]/J
M.H_&K5>1:SX>U3P'=+JNDWCM9EPI)/([A7'1@?7^7%>EZ#J\>N:+;:A&-OFK
M\Z?W6'##\Q^6*)P27-%W0H5&WRR5F:5%%%9FIY3XF1_"?Q"MM8@79;7+>:V.
MC9XE'UYS]6%>J1R)-$DL;;D=0RD=P>E<QX_T;^UO#,SQINN+3]]']!]X?EG\
MJYS2?&'V?X:3DS 7UKBTB&<-\P^0_@N['^Y6[7M(IK?8YT_9S:>VY1OT/C?X
MCFT#,;*V)C)4\"-#\Q!'JQX/N*G\ 7DNA>*;WP_>-M$C,J@CK(O^*Y_2MCX8
M:.;31I=2E7$EXV$R.0BY'ZG/Y"LOXDV$NF:S9>(+/Y&9@KN"?]8O*D_51C_@
M-:73;I]#/E:BJO7]#T35-1BTG2[F_G_U<"%B/4]A^)P*X+X:V$U]?ZAXBO/F
MEE=HT8J.68[G(].PX]2*B\=^(_[6TC2M/T\.6U%5G:,#+$$X5/?Y@?Q45WNA
MZ6NC:)::>IW>2F&/JQ.6/YDUE\%/S9K?GJ>2.=^)O_(HG_KX3^M:'@3_ )$K
M3?\ =?\ ]#:L_P")O_(HG_KX3^M:'@3_ )$K3?\ =?\ ]#:A_P +YC7\9^@>
M._\ D2M2_P!U/_0UK/\ AE_R*(_Z^'_I6AX[_P"1*U+_ '4_]#6L_P"&7_(H
MC_KX?^E"_A/U!_QEZ'95XO\ #;2XM0\3^=,H9+2/SE!_OY 7\LY^H%>T5Y7\
M)@/[1U(XY\I.?Q-.F[0D*JKSB>J4R:&.X@D@E7='(I1U]01@BGT5@;GEOPLE
M:'6-4L\D(8PQ4CG*MC_V:O4J\K^&W_(X:K_UR?\ ]&"O5*VK_&8X?X HHIDD
ML<(4R2(@9@J[FQDGH![FL38RO$'ANP\16GE7<>)5!$4Z_>C/]1[5YFCZW\-]
M:5)/WUE,<D*3Y<R]\?W6'^<CK[)5#6=)MM;TN:QND!613M8C)1NS#W%:TZEO
M=>QE4I\WO1T8[2M5M-:T^.]LI=\3]NZGNI'8BH?$?_(KZM_UY3?^@&O/?A7=
MS1:Q?Z<6S$T/FD=MRL%S_P"/5Z%XC_Y%?5O^O*;_ - -$H<D[!"?/3N<;\)O
M^/#4O^NJ?R->BUYU\)O^/#4O^NJ?R->BT5OXC"A_#05Y/\6/^0Q8?]>Y_P#0
MC7K%>3_%C_D,6'_7N?\ T(T\/\9.(_ALN?\ "H_^HY_Y*?\ V='_  J/_J.?
M^2G_ -G7IE%+V]3N/V%/L<CX4\$?\(QJ$UU_:/VGS(O+V^3LQR#G.X^E==11
M42DY.[-(Q459!7#?$[1Q>:''J,<>9K1_F88_U;=<^N#C\S7<U'<0175M+;SI
MOBE0HZYZJ1@C\J(2Y9)A./-%HQ?!NL'6_#-K<22;[B,>3,><[U[GW(P?QKF?
MBEJ[):VNC0EM]P1+(%[J#A1CW;G_ ("*S_!%T_AGQ9J&AW\BQ1OD!G( W+RI
MR<<%23^5,\.(_B[XAW&KR*?LULWFKQP,<1CZ\9_ UT*"C-RZ+4YW-R@H]7H4
M+[3+CP%X@T>^4LRM&K2G'!;I(@//8]??VKV.&:.X@CGB;='(H=&]01D&N<\=
MZ,-7\,7&Q,W%M^_B/?C[P_%<\>N*YKPYXQ-I\/KO>Y-W8 0PEN<[\^7^6#QZ
M**F5ZD4^I4;4I./3<JZGGQE\28[%"7L;,[6(' 5?OG\6^7/TKU6N"^&&D-;Z
M9<:M.&\Z[?:A;^X._P")S^0KO:BJ]>5="J*=N9[L\L^$W_(0U+_KDG\S7J=>
M6?";_D(:E_UR3^9KU.G7^-AA_P"&CRSX?_\ )0-7_P"N4W_HU:]3KRSX?_\
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MU!KR7P_;CQ?\0KJ^O0KPQ,9C&PR"JD*B],'''UQ7JMC_ ,@^V_ZY+_(5Y?\
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MR_\ 9A63\+O^14D_Z^G_ /05K6\:_P#(FZG_ -<O_9A63\+O^14D_P"OI_\
MT%:S7\)^IH_XR]"Q\2?^1-G_ .NL?\Z/AM_R)L'_ %UD_G1\2?\ D39_^NL?
M\Z/AM_R)L'_763^='_+GYB_Y??(O>--2?2O"E[/$^V9E$49]V(!_3)_"N'\
MZQX<T&RFN+^]\N_F8J1Y3MMC&,#A2.3S^5=9\1K9[CP=<,G_ "QD20CU&<?U
MS^%8O@SPKX<UKPS;W5S8^;<AG29O.D'S!CC@$#[NWI50Y52U[DSYG5T[&_\
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M_$UR7P_\.Z#KNCW#7]IYUU#/@GS77"$#;T('7=^5=;_PK[PO_P! O_R8E_\
MBJNJZ?,^:YG25107+8/^%@^%_P#H*?\ DO+_ /$UYYXIU;3%\4VVM^'[I7D)
M$DJB-DPX/7E1G<.O7OGK7H?_  K[PO\ ] O_ ,F)?_BJC/@7PBLZP-8H)F!9
M8S=2;B!U(&ZE"=.+NKE3A5DK.QT\4J3PI-&VZ.10RG&,@\BBB*)((4AC7;'&
MH51G. .!17.=!\K5]&>&O^15T?\ Z\H?_0!7SG7T9X:_Y%71_P#KRA_] %>C
MC/A1U8G9&I1117GG(%%%% !1110 4444 %%%% !1110 4444 %%%% !7S_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% '!_%G_D5;7_ *_4_P#0'KAOAM_R4#3/^VO_
M **>NY^+/_(JVO\ U^I_Z ]<-\-O^2@:9_VU_P#13UZ%+_=W\SKI_P )_,^@
M:***\XY0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MX^7!_P![H1^/UQ722Q1SQ-%-&DD;##(ZY!'N#7)WOPV\/W<K2(EQ;%CG$$@
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MM$]#] :6Z^&7A^XE+Q_:[8'^"*48'_?0)JQIOP]\/Z=,LOD273KT^TL&&?7
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MC%U; G.V&48_\>!K;GA->_N8<DX/W-BUJGC[0--A9DNUNYAD+%;_ #9/^]T
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MH?R_@@_LG&?SK[W_ )'E']NZO_T%;[_P(?\ QH_MW5_^@K??^!#_ .->K_\
M"">&_P#H&_\ D>3_ .*H_P"$$\-_] W_ ,CR?_%4?7:'\OX(/[)QG\Z^]_Y'
ME']NZO\ ]!6^_P# A_\ &C^W=7_Z"M]_X$/_ (UZO_P@GAO_ *!O_D>3_P"*
MH_X03PW_ - W_P CR?\ Q5'UVA_+^"#^R<9_.OO?^1Y1_;NK_P#05OO_  (?
M_&C^W=7_ .@K??\ @0_^->K_ /"">&_^@;_Y'D_^*H_X03PW_P! W_R/)_\
M%4?7:'\OX(/[)QG\Z^]_Y'E']NZO_P!!6^_\"'_QH_MW5_\ H*WW_@0_^->K
M_P#"">&_^@;_ .1Y/_BJ/^$$\-_] W_R/)_\51]=H?R_@@_LG&?SK[W_ )'E
M']NZO_T%;[_P(?\ QH_MW5_^@K??^!#_ .->K_\ "">&_P#H&_\ D>3_ .*H
M_P"$$\-_] W_ ,CR?_%4?7:'\OX(/[)QG\Z^]_Y'E']NZO\ ]!6^_P# A_\
M&C^W=7_Z"M]_X$/_ (UZO_P@GAO_ *!O_D>3_P"*H_X03PW_ - W_P CR?\
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MH?R_@@_LG&?SK[W_ )'E']NZO_T%;[_P(?\ QH_MW5_^@K??^!#_ .->K_\
M"">&_P#H&_\ D>3_ .*H_P"$$\-_] W_ ,CR?_%4?7:'\OX(/[)QG\Z^]_Y'
ME']NZO\ ]!6^_P# A_\ &C^W=7_Z"M]_X$/_ (UZO_P@GAO_ *!O_D>3_P"*
MH_X03PW_ - W_P CR?\ Q5'UVA_+^"#^R<9_.OO?^1Y1_;NK_P#05OO_  (?
M_&C^W=7_ .@K??\ @0_^->K_ /"">&_^@;_Y'D_^*H_X03PW_P! W_R/)_\
M%4?7:'\OX(/[)QG\Z^]_Y'E']NZO_P!!6^_\"'_QH_MW5_\ H*WW_@0_^->K
M_P#"">&_^@;_ .1Y/_BJ/^$$\-_] W_R/)_\51]=H?R_@@_LG&?SK[W_ )'E
M']NZO_T%;[_P(?\ QH_MW5_^@K??^!#_ .->K_\ "">&_P#H&_\ D>3_ .*H
M_P"$$\-_] W_ ,CR?_%4?7:'\OX(/[)QG\Z^]_Y'E']NZO\ ]!6^_P# A_\
M&C^W=7_Z"M]_X$/_ (UZO_P@GAO_ *!O_D>3_P"*H_X03PW_ - W_P CR?\
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MH?R_@@_LG&?SK[W_ )'E']NZO_T%;[_P(?\ QH_MW5_^@K??^!#_ .->K_\
M"">&_P#H&_\ D>3_ .*H_P"$$\-_] W_ ,CR?_%4?7:'\OX(/[)QG\Z^]_Y'
ME']NZO\ ]!6^_P# A_\ &C^W=7_Z"M]_X$/_ (UZO_P@GAO_ *!O_D>3_P"*
MH_X03PW_ - W_P CR?\ Q5'UVA_+^"#^R<9_.OO?^1Y1_;NK_P#05OO_  (?
M_&C^W=7_ .@K??\ @0_^->K_ /"">&_^@;_Y'D_^*H_X03PW_P! W_R/)_\
M%4?7:'\OX(/[)QG\Z^]_Y'E']NZO_P!!6^_\"'_QH_MW5_\ H*WW_@0_^->K
M_P#"">&_^@;_ .1Y/_BJ/^$$\-_] W_R/)_\51]=H?R_@@_LG&?SK[W_ )'E
M']NZO_T%;[_P(?\ QH_MW5_^@K??^!#_ .->K_\ "">&_P#H&_\ D>3_ .*H
M_P"$$\-_] W_ ,CR?_%4?7:'\OX(/[)QG\Z^]_Y'E']NZO\ ]!6^_P# A_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M.#^+/_(JVO\ U^I_Z ]<-\-O^2@:9_VU_P#13UW/Q9_Y%6U_Z_4_] >N&^&W
M_)0-,_[:_P#HIZ]"E_N[^9UT_P"$_F?0-%%%><<H4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'F/B;4_&<[
MZAI4>F3-9RS.B30VS%FBR0!N'&",=LUTG@'09]#T B[C\NZN)/,=3U48PH/Z
MG\:ZJBM'4O'E2L91IVES-W"BBBLS4**** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M8$_ZYM7HM-B04444AA1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MPWPV_P"2@:9_VU_]%/7H4O\ =W\SKI_PG\SZ!HHHKSCE"BBB@ HHHH ****
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MU"BBBD,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#Y3KZ,\-?\ (JZ/_P!>
M4/\ Z *^<Z^C/#7_ "*NC_\ 7E#_ .@"O1QGPHZL3LC4HHHKSSD"BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** /&_BS_P C5:_]>2?^AO6U\%_^8W_VP_\ :E8OQ9_Y&JU_
MZ\D_]#>MKX+_ /,;_P"V'_M2O0E_NW]=SK?\$]6HHHKSCE"BBB@ HHHH *S/
M$/\ R+][_P!<ZTZS/$/_ "+][_USH XWP;_R,"?]<VKT6O.O!O\ R,"?]<VK
MT6FQ(****0PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M'XM?\??AK_KZ;^:5<?XOWF<OX"]$>BWW_(/N?^N3?R-<#\&/^1/N_P#K_?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!\IU]&>&O^15T?_KR
MA_\ 0!7SG7T9X:_Y%71_^O*'_P! %>CC/A1U8G9&I1117GG(%%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 >-_%G_D:K7_KR3_T-ZVO@O\ \QO_ +8?^U*Q?BS_ ,C5:_\
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M .C6K:^%7_(KW/\ U^M_Z E9_P 4]/G5[#6(02L7[IR!]PYRI^G7]/6NA/\
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M;/4(DW+;.R2X'(5L8)]@1C_@5;1DG6N82@U1L>@T5A^%O$-OX@TB&59D-VB
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MB#_GSTS_ +]2?_%T?\+@\0?\^>F?]^I/_BZO_P#"GO\ J._^2G_V='_"GO\
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M !='_"X/$'_/GIG_ 'ZD_P#BZO\ _"GO^H[_ .2G_P!G1_PI[_J._P#DI_\
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MJ3_XNK__  I[_J._^2G_ -G1_P *>_ZCO_DI_P#9T<V&_JX<U$H?\+@\0?\
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M'B#_ )\],_[]2?\ Q='_  N#Q!_SYZ9_WZD_^+J__P *>_ZCO_DI_P#9T?\
M"GO^H[_Y*?\ V='-AOZN'-1*'_"X/$'_ #YZ9_WZD_\ BZ/^%P>(/^?/3/\
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M2?AW#I7C27Q$-2FE+O)(L+)@@N#G+9^;J>PKMJ<DEL3!R:]Y6"BBBD4%%%%
M!1110 4444 %%%% '!_%G_D5;7_K]3_T!ZX;X;?\E TS_MK_ .BGKN?BS_R*
MMK_U^I_Z ]<-\-O^2@:9_P!M?_13UZ%+_=W\SKI_PG\SZ!HHHKSCE"BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ JAK>F?VQHUUI_G>3YZ[?,V[MO(/3(STJ_
M133L[B:NK,P_"OAW_A&=+ELOM7VG?,9=_E[,951C&3_=_6M:[M+>^M);6ZB6
M6"5=KHW0BIJ*')MW8**2LCS:]^%]Q!.TVBZJ8B<X27*D#TW+U_*H9/A[XFU%
MD35-=26)3QNFDFQZX# ?SKT^BM/;S,O80,7P[X9L/#=JT5J&>5_]9,^-S>WL
M/:MJBBLVVW=FJ22LCRK2U#?&&Y5@"IEF!!Z'Y#6QK'PT@FNOM>BW1L92V?+)
M.U?7:1R/I61I/_)8[C_KK-_Z :]4K>I-Q:MV.>G",D[]SRZ3P!XLNXA;W>NQ
MR6XQ\C7,K@?@1CI73^&_ FG>'Y/M+N;N\!^65UVA/]U><?7)KJJ*SE5DU8TC
M1@G<*CN+>&ZMY()XUDBD4JZ,,@BI**S-3SG4/A>R7!GT74F@.>(Y<_*/9QS^
MGXU5E^'_ (IOP(]1UU)81SA[B67]& KU"BM56F8NA P?#7A2Q\,P.("9KF3B
M2=QR1Z#T'M_]:MN:&.X@D@F0/%(I1U/1@1@BGT5FY-N[-5%)61YQ?_#.XM[L
MW.@:H;8_PI(S*5^CKS^E%E\-;V[O1<^(=6:YP1E8W9V<>A=N1V[?E7H]%:>V
MG;<S]A"^PR*)((4AB4+'&H55'0 < 4^BBLC4*Y7Q!X-_MWQ!::K]O\C[.B+Y
M7D[MVURW7<,=<=*ZJBG&3B[HF45)684444BCE?%'@S_A)=0M;K[?]F\A-NWR
M=^[G/7<,5U5%%4Y-I)]"5%)MKJ9FMZ#8>(+/[-?1;@.4D7AXSZJ?\BN%;X;Z
MYI\K'1]<$:ELC+O">G^SGGM7IM%.-2459$RIQD[L\P'PVUO4+A7U?6TD7/S-
MO>5L>V[%=UH?AW3O#UKY-C#AF^_,^#(_U/\ 3I6K13E4E)681I1B[H*\J\,Q
MI+\4M7CD171Y+I65AD$%SD$5ZK7EGA7_ )*MJO\ UUN?_0ZJE\,O0FK\4?4T
MM5^&2&Y^TZ'>M9N3GRW)PO\ NL.1VX.?K5"7X?\ BJ_Q'J&NQRPCL]Q+)C\"
M,5ZA125::!T(,YKPUX*T[PY^^4FYO2,&>10-O^Z/X?U/O72T45G*3D[LUC%1
M5D<KX@\&_P!N^(+35?M_D?9T1?*\G=NVN6Z[ACKCI75444.3:28E%)MKJ%<K
MXH\&?\)+J%K=?;_LWD)MV^3OW<YZ[ABNJHIQDXNZ"45)69#=P?:K.>WW;?-C
M9-V,XR,9K!\)>$_^$6CNU^V_:OM!4Y\K9MQGW.>M=)10I-*P.*;N%<KX@\&_
MV[X@M-5^W^1]G1%\KR=V[:Y;KN&.N.E=512C)Q=T$HJ2LPKE?%O@W_A*+BVE
M^W_9O(0KCR=^[)_WA75441DXNZ"45)685SOBWPM_PE%O;1?;/LWD,S9\K?NR
M/J*Z*BB,G%W0Y14E9E:SLUMM,@LG(E6*%822O#@+CI[^E<)J?PS=+PW>@Z@;
M1]VY8G+#9]''(_+\:]$HJHSE%W1,J<9*S/-;?X;:G?7:S:_K)F53TC=I&8>F
MYP,?D:]%MK:&SM8K:WC$<,2A$0=@*EHHE.4MPA3C#8****@L**** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** /E.OHSPU_R*NC_]>4/_ * *^<Z^C/#7_(JZ/_UY0_\
MH KT<9\*.K$[(U****\\Y HHHH **** "O,]'^*+DZU+K<=M%!8L$@6W1@\K
M$L O+')POMW->F5X9\/?#\&L^/;ZYNE#P6$C3!#_ !2;SMS[#D_4"M::BTVS
M"M*2E%1ZG6)J'Q$\2I]JTR&ST6S<_NA<C,A7&<G*MU_W1_6JMWKOQ \($7.M
M0VVJZ<N/,F@4#:"1W !'IRN*]1ILD:31/%*BO&X*LK#(8'J".XI<Z[:#=)_S
M.YF>'O$-AXETI+^PDRIX>,_>C;NK#_.:U:\>TA3X)^+TFDV[,NFZ@0!'GC#
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M&-R3]GGDB7/IG=_[-7<5G)6;1K"7-%2"BBBD4%%%% !1110!XW\6?^1JM?\
MKR3_ -#>MKX+_P#,;_[8?^U*Q?BS_P C5:_]>2?^AO6U\%_^8W_VP_\ :E>A
M+_=OZ[G6_P"">K4445YQRA1110 4444 %9GB'_D7[W_KG6G69XA_Y%^]_P"N
M= '&^#?^1@3_ *YM7HM>=>#?^1@3_KFU>BTV)!1112&%%%% !1110 5R7Q)U
M!]/\$W?EG#W!6 'V8\_H"/QKK:\_^,!QX2M?>^3_ - DK6BKU$735Y(\BT33
M6UC6K/3U)7SY0I8=E[G\!FOHNTM8+&TBM;:-8X8E"HB] !7AOP[ /CO3<_\
M37_T4]>\5T8R3YDC3$/5(****XSG"BBB@ HHHH **** "BBB@ HHHH ****
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M>,[^(W%_XTN;:X8;O*MR^T$]OE90/P&*YZ"3Q&/BAX@O-$TZVU"]BD>,_:F
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M>6G8A3YJJ:VL=3XK_P"1/UO_ *\)_P#T6U<C\&/^1/N_^O\ ?_T7'77>*_\
MD3];_P"O"?\ ]%M7(_!C_D3[O_K_ '_]%QTE_#94OXR]#<^(W_(@:M_US3_T
M-:I_#V#[5\+;*W!P98[A,_61Q5SXC?\ (@:M_P!<T_\ 0UJ+X8?\D[TK_MM_
MZ->C_EW\P_Y??+]3BOA/INEW<FKZ=JNFVD]Y ZL%N(4D('*L!D'H0,_45Z9_
MPBGAW_H :7_X!Q_X5PGBWPWJ_A[Q2/%WAJ$R[F+7-LBD\D?,2!]Y6ZGN#S[C
M6TSXM>&KNV1[V66PFQ\\;QM( ?9E!R/P%5/FE[T2*;C!<D^ATO\ PBGAW_H
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M)!1112&%%%% !1110 5Y_P#&#_D4K7_K^3_T7)7H%>?_ !@_Y%*U_P"OY/\
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M?E SU _ U7(^7F(=1*?)U.ZHKP;Q!\1?%=CXDU2TM]5V007DL4:_9XCM57(
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M+CD_L?3)?.N+MEVASD< 'D9VX'?DG'%7"R=TB*O-*/*W\D>J4445SG6%%%%
M'!_%G_D5;7_K]3_T!ZX;X;?\E TS_MK_ .BGKN?BS_R*MK_U^I_Z ]<-\-O^
M2@:9_P!M?_13UZ%+_=W\SKI_PG\SZ!HHHKSCE"BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **S/^$CT/_H-:=_X%)_C2KXAT1CA=8T\GT%RG^-/E?87
M,NYI45!;7EK> FUN89PO4Q2!L?E]*GI#"BBB@ HHHH **** "BBLK3_$FDZI
MJ$UA97?FW,(8R)Y;K@ @'D@#J132;$VEN:M%%%(84444 %%%% !1110 4444
M %%%% !1110 445EZ[K]CX>L1=7SMAFVI&@R[GV'%-)MV0FTE=FI165H/B*P
M\16KSV)DQ&P5TD7#*<9^E:M#33LP335T%%%%(84444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%95OXDTFZU>32H;O=>QEE:+RW&"O
M7DC'ZUJTVFMQ)I[!17+/\0-"CU@Z:9)BP<1^>J Q[LXQG.>O?&*ZFAQ:W$I*
M6P4444B@HHHH **** "BBB@ HHHH **** "BLG4O$ND:1?1V5]=^5<2J&1/+
M=L@D@<@$=0:UJ;30DT]@HHHI#"BBB@ HHHH **** "BBF2RI!"\TC;8XU+,<
M9P!R: 'T5FZ1K^F:ZLK:;<^>(B _[MEQG./O >AK2IM-:,2:>J"BBBD,****
M "BBB@ HHHH **** "BBB@ HHK*U+Q)I.D7D5I?7?E3R@,B^6[9!..H!'44T
MF]A-I;FK1112&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1165:^)-)O=6ETNWN]]Y$
M6#Q^6XP5.#R1CK[TTF]A-I;FK1112&%%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 45DQ>)=(FUHZ1'=YOPS*8O+?J 2><8Z ]ZUJ;36XDT]@HHH
MI#"BBB@ HHHH **** "BBB@ HHHH **** "BLFV\2Z1>:M)I<%WOO8V96B\M
MQ@K][DC';UK6IM-;B33V"BH+V[AL+&>\G.(H(S(Y'7 &>/>LGP[XJL_$WV@V
M5O=1K!MW-,J@$G. ,,?2CE;5P<DG8W:***0PHHJCK&J1:+IDM_-#-+%%C>(0
M"P!.,\D4TKZ";LKLO45EZ#KUIXBT]KVS658UD,964 ," #V)]16I0TT[,$TU
M=!1112&%%%% !1110 4444 %%<MJ_P 0-$T>]>TD^T3S1G;(($!"'T))'/TK
M2T'Q'8>(X));'S0(R XD7:03VZU3A)*[1*G%NR>IKT445)04444 %%%% !11
M10 4444 %%%% !1110!\IU]&>&O^15T?_KRA_P#0!7SG7T9X:_Y%71_^O*'_
M - %>CC/A1U8G9&I1117GG(%%%% !1110 5Y-\)O^1E\2?[P_P#0VKUFN>\/
M>#=.\-7U[=V<UU))>',@F92!R3QA1ZU<9)1:,YQ;G%KH:MYI.FZB0;[3[6Z(
M& 9X5? ZXY%.L],T_3@18V-M:@]1!$J9_(5:HJ+LNRO<****!C719$9'4,C#
M#*PR"/0UG1^'-"AG$T6BZ<DH.1(MJ@8'ZXK3HHNQ-)[A1110,**** "BBB@
MK/NM!T>^E,MWI-C<2'^.6V1S^9%:%%%[":3W*]I86=@A2SM(+9#@%88P@XZ=
M![U8HHH&%%%% !1110 4444 %4[S2=-U$@WVGVMT0, SPJ^!UQR*N44 U<KV
M=A9Z?%Y5E:06T?79#&$'Y 58HHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M PHHJG>:MING$"^U"UM21D">94R.F>30#=BY15*SUC3-0.++4;2Y/3$,ZO\
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M\J]2^&'_ "3O2O\ MM_Z->E4_A(='^/(E^(W_(@:M_US3_T-:\C^%?\ R/\
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M==QIW@H./-<5IN:ERV^9VM>6?#__ )*!J_\ URF_]&K7J=>6?#__ )*!J_\
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MX^TE6&0880?^_KT8=VD/$*\#T#P]H=OH&D16<*+OP#,XZN_<Y_E[5J,H92K
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MWTW_ *]XO_1CUZQ7D_Q'_P"1WTW_ *]XO_1CUZQ2J?!$=+XY!45S&9K6:)2
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MR!+-G'^Z:*6TO0*V\?4]4KROXD_\CAI7_7)/_1AKU2O*_B3_ ,CAI7_7)/\
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M= ^'(UW1+;4AJWD^<&_=_9MVW#%>NX9Z>E:7_"H_^HY_Y*?_ &=.HH2EK+\
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M?97D%'[3\SS3XIP.EWI-ZT6^W4LC\<9R#@]N1G\C7?Z9JEIK%A'>64HDB?\
M-3W!'8T[4=.M=5L9+.\B$D,@P0>WN/0UYKJ7@[7/"EP^I>'KN66 ?,R+PZJ#
MG!7HXZ?X4+EG%1;LT$N:$G)*Z9Z7#IUG;WMQ>0VZ)<7  ED4<OCIG\ZLURG@
MSQBGB2![>X01ZA"NYPOW9%Z;AZ<D9'N/PZNLY)Q=F:PDI*\3R;Q"/*^+MFPQ
ME[BV)X_W17K->4>)03\6K# S^_MOYK7J]:5=H^AE1^*7J%%%%8FYQ7Q)UN72
M]$CL[=BDM\60L.R #</QW 5-X$\*PZ-ID=]/'G4+A-S,W/EJ>BC\,9KF_BJA
M&KZ8\@/DF)AGMPW/Z$5ZDCK(BNC!E89# Y!'K6\GRTTEU,(KFJMOH+65X@\/
MV?B+3FM;I=KCF*8#+1MZCV]1WK5HK%-IW1LTFK,\R^'.I7.G:Q>>&[UL;&<Q
MJ>=LBG# 'T(R?3CWKT:^_P"0?<_]<F_D:\RL"#\:)-GW?-ESC_KDV?UKTV^_
MY!]S_P!<F_D:UK?$GW,:/PM=CS/X3?\ (0U+_KDG\S7J=>6?";_D(:E_UR3^
M9KU.BO\ &QX?^&@HHHK$V"BBB@ HHHH **** "BBB@ HHHH **** /E.OHSP
MU_R*NC_]>4/_ * *^<Z^C/#7_(JZ/_UY0_\ H KT<9\*.K$[(U****\\Y HH
MHH **** "BBB@ HHHH **** "N7\=>+$\)Z&9DVO?3DI;1MT)[L?8 _F0.]=
M17D7B]5U?XQZ/IUUS;1"(;"WRMR7/'OP/? JZ<4WJ95I.,=-V6M"^'=SXC1-
M;\87UU-<7 WI;!MNU3R-WI_NKC'Z#;OOA1X:N(A]BBN-/G7)26&9FPW8D,3T
M/ICZUW%%#J2ON"HP2LU<\%\<:EK5GI"^%==W7$]M<K<6]]G_ %T6UUYSR3DC
MGV.>F3[1X>_Y%K2O^O.'_P! %<)\:;.%O#^GWQ7]_'=>2K?[+(Q(_-!^M=MI
M,XM?!UC<%2PBT^-R!WQ&#5S=X(SIKEJ23.+\8^+=6O\ Q"GA3PLQ%WG%Q<H1
M\IQDJ#_" .IZYX[<W=+^$NA01!]6:?4KIA^\=Y61<^H"D'\R:R/@Y$+N;6]7
MG)>[EE56<GGG+-^9Q^5>JT3DX>[$=.*J+GGJ>?ZI\)-"N(R^EM/IUROS1LLC
M.H(Z<,<]<=ZL^ G\7P37>G>(H7DM[<;8;N1@6=L],]7!!SD^F*[>BH<VU9ZF
MBI14N:.ARGB?X?Z5XKU*.^OKB]CECA$($#J%V@D]U//S&O*_AUX,T[Q?_:7]
MH3747V7RMGV=E7.[?G.5/]T5[_7D?P0_YCO_ &[_ /M2M(3ER/7:QC4IQ=6.
MF]SN7T6V\/> +W2[1Y7@@L[C:TI!8[@S'. !U)[5SOP8_P"1/N_^O]__ $7'
M79^(?^1:U7_KSF_] -<9\&/^1/N_^O\ ?_T7'4IW@V6TE5BEV,:T;_A /BN]
MH6$>DZKC:,G"AB=IZ_POE<G^$D]Z]>KAOBGH)U;PO]L@0F[TYO.0KG.P_? Q
M] ?^ UJ^!=?_ .$B\*6MVY)N(OW$^><NH'/X@@_C1/WHJ04_<FX?-&7\4O$!
MT;PLUK"Y6YU F%2.H3C>?R('_ JT? /A[_A'/"MM;R(5NY_W]QD8(=@/E_ 8
M'U!/>N&CS\0/BNTN-^E:7P/1@IXZ'^)\G_='M7K5U.+6SGN"I811LY [X&:)
M>[%1"G[\W/ILCSCQ;K^K^(O$A\(>&I3%M4B]N!Q@<9&X<A1D XY)./KIZ=\)
MO#5K!MOHIM0G/+2RRLG/L%(_7->>_#^;Q5#)J%]X>TFTOY)"$FEN' *]3@9=
M>O4]>@KM_P"V/BG_ -"WI?\ W\7_ ./5<DX^[%V,H2C/WYIOY%?6OAD^EC^U
M/"%W<VM] ,K#YF?,]0&/<^AR#TK>^'_C ^*=+DCN@$U*TPLX P'!SA@/?!R.
MQ^HK)_MCXI_]"WI?_?Q?_CU9_@KPUXGT_P >3ZQJ>E1V<%TLOF^5,A12QW8
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M\_R/.V_O-F[&&#=,CT]:VE-.<7VL81A)0DN]S%^&W_(FP?\ 763^=<S\0/\
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M-O\ 6*.)3W)!_A ]??VII^'&OZA(IU76TD7<"29))3]?F YKMO#_ (7T[PY
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M>E=#J5I_:&EW=EO\O[1"\6_&=NY2,X[]:<Y)N-N@H1:4K]6SB/A/_P @>_\
M^O@?^@BO0*Y_PGX8_P"$7L[BW^V?:?-D#[O*V8XQCJ:Z"IJ-2FVBJ47&"3.-
M^)O_ "*)_P"OA/ZUH>!/^1*TW_=?_P!#:K/B?0?^$CTC[!]I^S_O%??Y>_IG
MC&1ZU8T'2O[$T2VT[SO.\@$>9MV[LL3TR?6FY+V?+UN)1?M.;I8T:\S^+G_,
M'_[;?^TZ],KF?%WA'_A*OL?^G?9?LV__ )9;]V[;_M#'W?UHI249IL=:+E!I
M&_8_\@^V_P"N2_R%>57@N?A]XV>\CA9].N2VT <-&3DJ#ZJ<?D/6O6((O)MX
MXLYV(%SCK@57U32K/6;![*^B$D+\^A4]B#V-$)\K=]F$X.25MT+INIVFK627
M=E,LL+=P>5/H1V/M5B::*WA>:>1(HD&6=V"JH]237FMQ\,=1L[LRZ)JXC7.5
M,C-&Z_\  E'/UP*$^'&N:A.IUG7!)&&R<2/*Q_[ZQ@]JKDAOS$^TJ;<NID^/
M/%*^()UM+#<UA:G>TF.)'Z9^@S@?4UZ#X$_Y$K3?]U__ $-JKWO@6PE\-_V-
M8R?9%,BR-,R>8SD9Z\C/7\*V=!TK^Q-$MM.\[SO(!'F;=N[+$],GUISG%PY8
MBA":FY2/./B/_P COIO_ %[Q?^C'KUBN3\2>"O\ A(-<MM2_M#[/Y,:IY?D[
M]V&+9SN'KZ5UE3.2<8I="H1:E)OJ%17-Q#:6TEQ<2+'#&I9W;H *EJ&ZM8+V
MUEM;F)9895*NC="*R1J_(J:-KEAKUD+JQEW*#AD;AD/H1VKE_BC/9CP]%!*Z
M_:FF#0K_ !8&=Q^F#_*L^Z^&E]9W9N- U<P$DX$C-&R#TWKG/?L*DTWX:3S7
MRW?B#4?M9!R8T9FW\]W;G'X=^M=$53B^9,YY.I*/*XG3>"HI(?!NF+*"&,6X
M9]"21^A%<*+AO!OQ-N)KH;+.Z=R7"\>7(=V1QV8#./[IKUA5"J%4 *!@ =!6
M/XA\,V'B2U6.[4K*F?*F3[R?XCVJ(37,[[,J=-\JY=T:T,T5Q"DT$B2Q.,JZ
M,&5AZ@BJ&N:Y9Z!ISWEX^ .$C'WI&]!7!_\ "NO$.G2L-(UU8XCW\V2$GZA<
MT^U^&-[=W8GUS5O-_O>4S.[<]-S#^E-0ANY:"<ZCT4=1?AA9SSWNI:U,@ ES
M&K8(R2=S8]NE=]JW_('OO^O>3_T$U-:6EO8VD5K:Q+%!$NU$7H!1=P?:K.>W
MW;?-C9-V,XR,9J9SYI7+A#EARGA_A#6Y?#FI?VBT+R6+$03E1TSR/Q^4G'?!
MKVZROK74K5;FSN(YX6Z.AS^!]#['FN;\/>!K71[&^L[R9-0ANRNY7AVA<9]S
MSSUXQ6%<_#.^LKKS]!UAH"<X$C,C*/\ >7K^0K6;A4>]C*FJE..UST6>>&VA
M::>5(HD&6>1@JK]2:\F\1ZK+X[\26NE:7N^QQM@2%3S_ 'I".P Z?_7Q5]?A
MQKFH3 ZQKBN@.20[S'_Q[%=OH/AO3O#ML8[*+]XX'FS.<LY_H/85*<*>J=V-
MJ=31JR-"RM(;"Q@LX!B*",1H#UP!CGWKRG6;:Z\#>-!JMM"S6,SEE]&#?>3/
M.#Z?A7KM5K_3[35+-[2]@6:!_O(W^(Y!]Q40GRO79FE2GS+3=$&D:U8:Y9BY
ML)Q(O&Y>C(3V8=C6A7FM]\+IX9VFT;5/*SG"394KSTW+U_+M44O@+Q9>Q^3?
M:^DL.<[7N99!GZ$57)![2)]I-:.)M>)OB#:Z1-':Z:L5[<[AYF&RBCTR.I/Z
M?I786LS7%I#.T3PM(BN8W&&0D9P?<5R_AWP!INA3I=2NUY=H<K)(N%0^H7GG
MWR:ZVIGR;1*AS[R/)]6D?PE\31J,RG[)<.9-P7JCC#?B#D_@/6O4[:Y@O+9+
MBVE26&095T.0:H:]X?L?$-A]FO$Y7F.5?O1GU'^'>N%;X<:YI\Q.CZXJ(3D$
MN\)_\=S5WC42N[-$)2IMV5TST'5=5M-%T^2]O9=D2=N['LH'<FO/_AY;S:MX
MFU3Q!-$ A+!3@@;W.2!]![_Q"E@^&>IWUXLVN:QYH_B,;M([>VYQQQ['Z5Z%
MIVG6NE6,=G9Q".&,8 '?W/J:3<81:3NV"4IR3DK)%JO*_B3_ ,CAI7_7)/\
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MZ?GFO4D=9$5T8,K#(8'((]:P/$GA#3O$B;Y@8;M0 MQ&.<>A'<?YS7(K\/\
MQ18$QZ;KZQPY[3RQ9].%!%4^2IK>S)CST_=M='H.IZM8Z/:-<W]PD,8Z9/+'
MT4=2:X?PMKVN^(_%]Q=Q.T>D+D/$PRJK@[0/]H]21[]N*@M/A?=W%TLNLZKY
MB@?,(BS,?;<W0?A7H.FZ9::39):64*Q0KV Y8^I/<^])\D$TM6-<\VF]$BW5
M+5]-BUC2;K3YN$G0KNQG:>H;'L<'\*NT5BG;4V:OH?/L%MJ5U=0^&SE2+IOW
M1 ^60X5C^ 6O>[*TAL+&"S@&(H(Q&@/7 &.?>LN'PQ9P^*I=>4_OI(MGE[0
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MF6ZN?$5^&,D^X0LW5RQR[_T_.O0+[_D'W/\ UR;^1J6.-(HUCC141 %55&
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M_P"1JM?^O)/_ $-ZVO@O_P QO_MA_P"U*]"7^[?UW.M_P3U:BBBO..4****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% 'EGQ _Y*!I'_7*'_T:U>IT45<I\R2[$1ARMON%%%%0
M6%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M^'_^@%IG_@)'_A3^NQ[#^L+L?-%%?2__  B_A_\ Z 6F?^ D?^%'_"+^'_\
MH!:9_P" D?\ A1]=CV#ZPNQ\T45]+_\ "+^'_P#H!:9_X"1_X4?\(OX?_P"@
M%IG_ ("1_P"%'UV/8/K"['S117TO_P (OX?_ .@%IG_@)'_A1_PB_A__ * 6
MF?\ @)'_ (4?78]@^L+L?-%%?2__  B_A_\ Z 6F?^ D?^%'_"+^'_\ H!:9
M_P" D?\ A1]=CV#ZPNQ\T45]+_\ "+^'_P#H!:9_X"1_X4?\(OX?_P"@%IG_
M ("1_P"%'UV/8/K"['S117TO_P (OX?_ .@%IG_@)'_A1_PB_A__ * 6F?\
M@)'_ (4?78]@^L+L?-%%?2__  B_A_\ Z 6F?^ D?^%'_"+^'_\ H!:9_P"
MD?\ A1]=CV#ZPNQ\T45]+_\ "+^'_P#H!:9_X"1_X4?\(OX?_P"@%IG_ ("1
M_P"%'UV/8/K"['S117TO_P (OX?_ .@%IG_@)'_A1_PB_A__ * 6F?\ @)'_
M (4?78]@^L+L?-%%?2__  B_A_\ Z 6F?^ D?^%'_"+^'_\ H!:9_P" D?\
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M  B_A_\ Z 6F?^ D?^%'_"+^'_\ H!:9_P" D?\ A1]=CV#ZPNQ\T45]+_\
M"+^'_P#H!:9_X"1_X4?\(OX?_P"@%IG_ ("1_P"%'UV/8/K"['S117TO_P (
MOX?_ .@%IG_@)'_A1_PB_A__ * 6F?\ @)'_ (4?78]@^L+L?-%%?2__  B_
MA_\ Z 6F?^ D?^%'_"+^'_\ H!:9_P" D?\ A1]=CV#ZPNQ\T45]+_\ "+^'
M_P#H!:9_X"1_X4?\(OX?_P"@%IG_ ("1_P"%'UV/8/K"['S117TO_P (OX?_
M .@%IG_@)'_A1_PB_A__ * 6F?\ @)'_ (4?78]@^L+L?-%%?2__  B_A_\
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M^'_^1DTO_K[B_P#0Q7O%>CF/Q1/#R/\ AS]0HHHKSCW HHHH **** "BBB@
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M;CQ'IUQ!J$/DZI82"&Z7&,GG#8['(8$>H/TKA_B;<7UM\2=*DTS/VXV:1P8
MSO9Y%&,\9YHC3O+E83JI04T>KWFLZ7ISA+[4K.V8]!/.J']34UK>6M_ )[.Y
MAN(B<"2&0.OYBN)TOX5Z0L1FUYYM5U"7YII9)G4;N,XP03]36!XBT5?AKK.G
M:_HDDL>G33B&ZMFD)!!R<#/)!4-C.<%0><T*,7HGJ#J3BN:2T/5;N^M-/@\^
M]NH+:'('F32!%SZ9->6:!K.EP_&#7KZ74K..TEMBL<[3J(W.8N V<'H?R->E
MZOHUAKMB;+4K?S[<L&V;V7D=.5(->3Z)X1T.\^*6LZ-/8[]/MK<O%#YKC:<Q
M\Y#9/WCU/>G3Y;.Y-;FYHV[GL-K=VU];)<6EQ%<0/G;+$X=6P<'!'!Y!%354
MTO2[/1M.BT_3X?)M8L[$W%L9)8\DD]2:MUD_(W5[:A5&\UK2M.D$=]J=G:N>
M0L\ZH3^!-<9X[\2:H^K6OA/P\2FHW:[I)PVTQKR< ]N 23U Z<U)IGPF\/6\
M .I+/J-TPS))),R#=W("D'\R:M125Y,S<Y-V@MCM[:[MKV+S;6XBGCSC?$X8
M9],BO.?@[_QZ:W_U]#^1J;4O!,WA+?KOA&XFCD@R\UA+)NCEC[@9YX'J2>."
M".:WP9?S-/UB3&-URIQZ9!J[)0;1#DW4BI+74]%74K%[][!;VV:]0;FMQ*ID
M48!R5SD<$?G5JO,]/_Y+WJW_ %ZK_P"BHJ],K.4;6-83YK^3*MWJ5CIYB%[>
MV]L93MC$TJIO/H,GGJ*M5YG\6O\ C[\-?]?3?S2NW\1ZY!X=T&ZU.?D1+A$[
MNYX4?G^F33Y=%;J)3UDGT+]S=VUE%YMU<101YQOE<*,^F356UU[1[Z416FK6
M-Q(?X(KE'/Y UYSX>\%7/C0#Q%XLN9Y!<C=;6R,5"IG@^RGL!ZYSS6Y?_"?P
MW<1?Z D^GW P4EBF9]I'?#$_S%-Q@M&R5.I)72T.ZHK@?!&O:G:ZO<>$->.^
M\M$W07'/[Z,?7KP<@^G7D5WU1*/*[&D)*2NAKNL:,[L%11EF8X 'J:\G\=:S
MI=WXX\)W%MJ5G-!!<HTLD<ZLL8\Q#EB#@< ]:]7FB2>"2&5=T<BE6&<9!&#7
MC?C'PCH>E>,/#-A96/E6U[<*EPGFNV\&11C)8D<$],5I2M?4RQ'-RZ'KECJN
MG:GYG]GW]K=^7C?]GF63;G.,X)QG!_*K+NL:,[L%11EF8X 'J:R-&\-Z)X72
MY?3+46B2@&9FE=@0N<$[B<8R:\]BBU+XK:S=,UW-:>&K60*J(,&4CGZ;L<Y.
M=N1Q4J*;;Z%.;BDFM6>CCQ+H32B(:WIID/ 0729_+-::L&4,I!4C((Z&N,/P
MJ\)& 1_890X_Y:BX?<?UQ^E<S"^H_"SQ!;6D]R]WX<OFVH7/,)[GT4C.3V8>
MXX?+&7PO43J2CK-:'K5%%%9FP4444 %%%% '!_%G_D5;7_K]3_T!ZX;X;?\
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M #XZM_WZC_\ CE'_  N_PU_SXZM_WZC_ /CE'LI]@]O3[GI=%>:?\+O\-?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M^@/_ .3,/_Q=?1E%'UB0?4Z?=GSG_P *O\8_] ?_ ,F8?_BZ/^%7^,?^@/\
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MBBB@ HHHH **** /E.OHSPU_R*NC_P#7E#_Z *^<Z^C/#7_(JZ/_ ->4/_H
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M&N;F^NKR.XAN#'L@=0-FU2"<J><EORHIVY7)L*MW.,4CW%$6-%1%"HHPJJ,
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!X/X?
M_P"1DTO_ *^XO_0Q7O%>#^'_ /D9-+_Z^XO_ $,5[Q7HYC\43P\C_AS]0HHH
MKSCW HHHH **** "BBB@ HHHH *\4^,'_(VVO_7BG_HR2O:Z\4^,'_(VVO\
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MB!D!U"X4-<R=P?[@]A^IYKJJ**Y6VW=G=&*BK(****104444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6-XG\-V?BC1I;
M"Z4!OO0R@<QOV(_J.XK9HIIM.Z$TFK,^3+VSN-,U">SN%,=Q;R%''H0>U?2O
MP]\2GQ1X3@N9CF[@/D7'NZ@?-^((/US7EWQFT@6NO6FJ1H MW$4D('5T[G_@
M)'Y58^"&JM!KM_I3$^7<PB5?9D./U#'\JZJGOT^8\^C>E6Y#W.BBBN,](***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *P/&O\ R)NI_P#7
M+_V85OU@>-?^1-U/_KE_[,*J'Q(F?PLR?A=_R*DG_7T__H*UTVN?\B_J7_7K
M+_Z :YGX7?\ (J2?]?3_ /H*UTVN?\B_J7_7K+_Z :N?\1D4_P"$O0XGX3?\
M>&I?]=4_D:[V_F>WTZZFC.'CB=U)]0"17!?";_CPU+_KJG\C7HC*&4JP!4C!
M!Z&BM_$8J/\ #1YG\)84)U6<C+CRT!]!\Q/\A^5>FUY+X;N/^$+\<W>EWK%+
M:8^4'+87KF-SVQ@X]MQ]#7K5.O\ %?N%#X+=@KC_ (F1+)X0=F',<Z,OL>1_
M(FNPKS7XF:Y'<"#0;0B68R!YMO.#T5/J<Y_+UJ:2;FK#K-*#N=-X!<OX(TTM
MUQ(/RD85Q?AG_DK5_P#]?%U_Z$U>B^'M,.C^'[*P8@O%'\^.FXG)_4FO.O#/
M_)6K_P#Z^+K_ -":M(N_.T9R5N1,Z;XF_P#(HG_KX3^M:'@3_D2M-_W7_P#0
MVK/^)O\ R*)_Z^$_K6AX$_Y$K3?]U_\ T-JE_P +YEK^,_0Z"21(HVDD=41
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M,A9L((F(SV);!/Z"E^$W_(0U+_KDG\S6O\4=(>[T>#48EW-9N1)@<[&QS^!
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_P#0A7K%-DQ"BBBD4%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_P#(Z6?_ &#D_P#1DE:?P._YCW_;O_[4KL?\$\Z/^]?UV/7:***Y#T HHHH
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M<GDMUY]_QKM:*;JNUDK J2O=NX5Y[H?AK5[/XAWFJ3VFRRDFG99?,0Y#$[>
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M*.IM2Q,)NVS.\HHHK$Z0HHHH **** /!_#__ ",FE_\ 7W%_Z&*]XKP?P_\
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M_P"1TL_^P<G_ *,DK3^!W_,>_P"W?_VI78_X)YT?]Z_KL>NT445R'H!1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110!YS\:/^1.M/\ L()_Z+DKSSX5?\E*TG_MM_Z)>O0_C1_R)UI_V$$_
M]%R5YY\*O^2E:3_VV_\ 1+UUT_X3^9Y];_>%\CZ5HHHKC/1"BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH ^4Z^C/#7_(JZ/_ ->4/_H KYSK
MZ,\-?\BKH_\ UY0_^@"O1QGPHZL3LC4HHHKSSD"BBB@ HHHH **** "BBB@
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MH \;^+/_ "-5K_UY)_Z&];7P7_YC?_;#_P!J5B_%G_D:K7_KR3_T-ZVO@O\
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M /"*>'/^@!I7_@''_A6O17+S/N=W)'L9'_"*>'/^@!I7_@''_A1_PBGAS_H
M:5_X!Q_X5KT4<S[AR1[&1_PBGAS_ * &E?\ @''_ (4?\(IX<_Z &E?^ <?^
M%:]%',^X<D>QD?\ "*>'/^@!I7_@''_A1_PBGAS_ * &E?\ @''_ (5KT4<S
M[AR1[&1_PBGAS_H :5_X!Q_X4?\ "*>'/^@!I7_@''_A6O11S/N')'L9'_"*
M>'/^@!I7_@''_A1_PBGAS_H :5_X!Q_X5KT4<S[AR1[&1_PBGAS_ * &E?\
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M<_Z &E?^ <?^%:]%',^X<D>QD?\ "*>'/^@!I7_@''_A1_PBGAS_ * &E?\
M@''_ (5KT4<S[AR1[&1_PBGAS_H :5_X!Q_X4?\ "*>'/^@!I7_@''_A6O11
MS/N')'L9'_"*>'/^@!I7_@''_A1_PBGAS_H :5_X!Q_X5KT4<S[AR1[&1_PB
MGAS_ * &E?\ @''_ (4?\(IX<_Z &E?^ <?^%:]%',^X<D>QD?\ "*>'/^@!
MI7_@''_A1_PBGAS_ * &E?\ @''_ (5KT4<S[AR1[&1_PBGAS_H :5_X!Q_X
M4?\ "*>'/^@!I7_@''_A6O11S/N')'L9'_"*>'/^@!I7_@''_A1_PBGAS_H
M:5_X!Q_X5KT4<S[AR1[&1_PBGAS_ * &E?\ @''_ (4?\(IX<_Z &E?^ <?^
M%:]%',^X<D>QD?\ "*>'/^@!I7_@''_A1_PBGAS_ * &E?\ @''_ (5KT4<S
M[AR1[&1_PBGAS_H :5_X!Q_X4?\ "*>'/^@!I7_@''_A6O11S/N')'L9'_"*
M>'/^@!I7_@''_A1_PBGAS_H :5_X!Q_X5KT4<S[AR1[&1_PBGAS_ * &E?\
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M<_Z &E?^ <?^%:]%',^X<D>QD?\ "*>'/^@!I7_@''_A1_PBGAS_ * &E?\
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MS/C?_P CI9_]@Y/_ $9)6G\#O^8]_P!N_P#[4KL?\$\Z/^]?UV/7:***Y#T
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH \Y^-'_(G6G_ &$$_P#1<E>>?"K_ )*5I/\ VV_]$O7H?QH_
MY$ZT_P"P@G_HN2O//A5_R4K2?^VW_HEZZZ?\)_,\^M_O"^1]*T445QGHA111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?*=?1GAK_ )%71_\
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M*** "BBB@#QOXL_\C5:_]>2?^AO6U\%_^8W_ -L/_:E8OQ9_Y&JU_P"O)/\
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M:LU**YS3_'OA?4[@06NL0F4D!5E5HMQ/0#>!DUT=-IK<%)2V84444AA1110
M445DMXH\/H[(^NZ8K*<$&[C!!_.A)L3:6YK454L=5T[4_,_L^_M;OR\;_L\R
MR;<YQG!.,X/Y5;H&G?8**** "BBJFI:I9:19M=ZA<I;VZD*7?IDG % -VW+=
M%,AFBN(EEAD22-QE71@01[$4^@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **@O+R#3[*>\NI!';P(9)'()PH&3P.36=HGBG1O$;3KI-X;@P!3)^Z=
MN<X^\!Z'\J=G:XN9)VN;%%<O=_$7PI8WD]I<:KLG@D:*1?L\IVLIP1D+@\BN
MEAE2>".:)MT<BAE.,9!&10XM;B4HO9CZ***104444 %%%% !1110 4444 %>
M%?&C_D<;3_L'I_Z,DKW6O"OC1_R.-I_V#T_]&25M0^,YL7_#-[X#_P#,P?\
M;O\ ^U:]CKQSX#_\S!_V[_\ M6O8ZFO_ !&5A?X2_KJ%%%%9'0%%%% '@_A_
M_D9-+_Z^XO\ T,5[Q7@_A_\ Y&32_P#K[B_]#%>\5Z.8_%$\/(_X<_4****\
MX]P**** "BBB@ HHHH **** "O%/C!_R-MK_ ->*?^C)*]KKQ3XP?\C;:_\
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M;X;?\E TS_MK_P"BGKT*7^[OYG73_A/YGT#1117G'*%%%% !1110!X'\;_\
MD=+/_L')_P"C)*T_@=_S'O\ MW_]J5F?&_\ Y'2S_P"P<G_HR2M/X'?\Q[_M
MW_\ :E=C_@GG1_WK^NQZ[1117(>@%%%% !1110 4444 %%%9NOZW:^'=%N-3
MNR3'$.$'5V/ 4?4_XT)7T$VDKLTJ*\,_X7/XB_Y\M+_[]2?_ !=>@?#SQ=?^
M+;&]FOX;:-H)%11 K $$9YRQK25*45=F4*\)OE1V=%%%9FP4444 %%>=_$3Q
M]<^&=0L;'3/*:X_UUP'7<-G14]L\GUX'K72>#_$Q\5Z)_:!LI+7#F,ACE6(
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M_803_P!%R5YY\*O^2E:3_P!MO_1+UUT_X3^9Y];_ 'A?(^E:***XST0HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /E.OHSPU_R*NC_]>4/_
M * *^<Z^C/#7_(JZ/_UY0_\ H KT<9\*.K$[(U****\\Y HHHH **** "BBB
M@ HHHH *\\^+NA#4/#::G%&#/8OEFXR8FX(_ X/YUZ'151ERNY,X*<7%G,>
M=!&@>$K.!U N9E\^<@8.YN<'Z# _"NBN;:&\M)K6X0/#,C1R(3C<I&"/R-2T
M4FVW<(Q45RH\=^'?@R>Q\=:A)>*=NDL41BIP[L#M()Q_"<_B/:O8J**<YN3N
MR:=-4U9'E'QM_P"/31O^NDO\EKU>BBARO%+L.,+2<NYY#K__ "733?\ >A_]
M!->O4442ES6\@A#E;?<\HA_Y.#G_ .N8_P#29:]7HHHE+FL$(<M_-W*6K_\
M(%O_ /KWD_\ 037 ?!;_ )%_4?\ KZ'_ * *],HH4K1:!PO-2['+^.O":>+-
M#,*;4OH"7MI&Z ]U/L0/S /:N4T+XB7/AQ$T3QA8W4-Q;C8ER%W;E' W>O\
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M_P!J5ZA7E_P>_P"8S_VP_P#:E>H4L3_%9-;XV%%%%8&04444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 >9_!;_D7]1_Z^A_Z *],KS/
MX+?\B_J/_7T/_0!7IE:5?C9C0_AHX3XN?\B,_P#U\1_UK3;P]9>)? >GV%X@
MYLHC%+C+1/L&&'^'?I69\7/^1&?_ *^(_P"M=3X>_P"1:TK_ *\X?_0!1>T$
MUW%9.HT^QP?@_7[WPIJR^#?$A5 O_'E=%OE923@9/53S@]C\OT=\6O\ C[\-
M?]?3?S2NI\8^$;7Q9I+0N$CO8P3;3D?<;T/^R>_YUX_K.MZI<SZ-H.MP,E_I
M-T(VD)R74[-N?4X'7N"#[G2%I2YE\S*JW"+@]NG^1]!T445SG8>6>)C/XW^(
M<7A99'BTRP7S;K:2"YP"3^&Y5&>A)/>O1=,T?3M&MDM].LXK>-1@!%Y/U/4G
MW->?-=Q>%?C+<S7[>59ZM;@1S.0%5CMZG_>0CVW GCFO3ZTF]$EL8TDFY-[W
M.&\=^"++4]+FU+3XEM-4M$,T<D(V;]O.#COZ'J#CG%3>&/$$GB/X<3W=PVZZ
MB@E@G;'WF5>OU(*D^Y-;'BS6[70?#MY=W+J&,3)$AZR.1@#\^_:N5^'^FS:?
M\+[QYE*F[6:X4'^Z4"C\]N?QIK6&O<3253W>VIB?!_P[:WD=WK5Y$DS0R?9[
M=7 (0XW,<'O\P_7UKU\* 20 "3DX[UP'P= '@N4@ 9O)"??Y4KT"E5=YL="*
M5-6"BBBLS8**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** .#^+/_(JVO_7ZG_H#UPWPV_Y*!IG_ &U_]%/7<_%G_D5;7_K]3_T!ZXWP
M=;?V1JMCKF_S?+#'R<;<[E9?O<^N>E=U.2CAW?K<ZHR4:6I[U17'#QXG?3C_
M -_O_L:=_P )Y'WT]_\ OZ/\*X;'+='7T5R(\=P=[&3_ +^#_"E_X3NV[V4O
M_?8HL%T=;17*#QU:][.;_OH4H\=67>TG_,?XT6"Z/+?C?_R.EG_V#D_]&25I
M_ [_ )CW_;O_ .U*YSXL:M%K'BFUN(8W15LD0A\9SO<]OK71_ [_ )CW_;O_
M .U*ZW_!//C_ +S_ %V/7:***Y#T HHHH **** "BBB@ K+UOPYI7B***+5;
M8W$<3%D7S70 GC/RD9_&M2BA-K832:LSQ#XI>%=%\.6^F/I-E]G:9Y!(?-=]
MV N/O$^IK=^"G_()U7_KNG_H)J+XV_\ 'IHW_727^2U+\%/^03JO_7=/_037
M2VW1NSC22Q%E_6AZE1117,=H56U"^@TS3KB^NGVP6\9D<]\ =O>K->4?&/Q'
MY=O;^'K=_FEQ/<X/\(/R*?J1G\%]:J$>:5B*L^2+D>;7$M_XP\5,X7=>:A<
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MT&X#/X5/J6J6.D6;7>H74=M IQOD.,GT'J?85)965MIUE%9V<*0V\*[4C0<
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /E.OHSPU_R*NC_ /7E
M#_Z *^<Z^C/#7_(JZ/\ ]>4/_H KT<9\*.K$[(U****\\Y HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@#QOXL_\C5:_P#7DG_H;T?#;03KG]IXN?)\GROX-V<[_<>E'Q9_
MY&JU_P"O)/\ T-ZVO@O_ ,QO_MA_[4KT)?[M_7<ZW_!.B_X0-^VHK_WY_P#K
MTW_A Y?^@@G_ 'Z/^-=M17GW.2R.(_X02;M?Q_\ ?L_XTG_""7'_ #_1?]\&
MNXHHN%D<-_P@EU_S^0_]\FD_X06\[7<'Y&NZHHN%D<'_ ,(+>]KJW_\ 'O\
M"J]]X0O+&RENGN(&2-=Q"DY/Z5Z)69XA_P"1?O?^N=%PL>96T#75U#;H0'E=
M44MT!)QS70_\(/J?_/>T_P"^V_\ B:QM(_Y#5A_U\1_^A"O6*;8DCS__ (0C
M5/\ GK:_]]M_\32?\(3JG]^V_P"^S_A7H-%*X[(\\_X0K5?6W_[[/^%)_P (
M9JWI!_W\_P#K5Z)11<+'G7_"&ZO_ '8?^_E)_P (=J__ #SB_P"_@KT:BBX6
M/.#X/UC_ )XQ_P#?P5QWQ'T*_P!+\/6\UU$JQM=J@(<'G8Y[?0U[Q7FGQO\
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MX1 &) )VDCD@\_GGK7A_@S_D==%_Z_(__0A7N'CKQ;8>']#NX3<(VH31-'#
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MPRMVX(X-35)04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /E.OHSPU_R*NC_]
M>4/_ * *^<Z^C/#7_(JZ/_UY0_\ H KT<9\*.K$[(U****\\Y HHHH ****
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M[B_]#%>\5X/X?_Y&32_^ON+_ -#%>\5Z.8_%$\/(_P"'/U"BBBO./<"BBB@
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MBB@#@_BS_P BK:_]?J?^@/7#?#;_ )*!IG_;7_T4]=S\6?\ D5;7_K]3_P!
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M[W&XIKEZ'->%O ^F>$IKF6PGNY&N%57\]U(&,],*/6I-7\;>'-&O9-/U._\
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MBMD80C^+'7M1[&=[6#ZQ3MS7/3Z*Y#P)XY_X3:&^D_L[[%]E9%QY_F;MV?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH ^4Z^C/#7_ "*NC_\ 7E#_ .@"
MOG.OHSPU_P BKH__ %Y0_P#H KT<9\*.K$[(U****\\Y HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@#QOXL_\ (U6O_7DG_H;UM?!?_F-_]L/_ &I6+\6?^1JM?^O)/_0W
MK:^"_P#S&_\ MA_[4KT)?[M_7<ZW_!/5J***\XY0HHHH **** "LSQ#_ ,B_
M>_\ 7.M.LSQ#_P B_>_]<Z /.M(_Y#5A_P!?$?\ Z$*]8KR?2/\ D-6'_7Q'
M_P"A"O6*;)B%%%%(H**** "BBB@ KS3XW_\ (EV?_813_P!%R5Z77"_%S3WO
MO -R\8R;65)R/8':?R#$_A5TW::,JZO39Y#\+_\ DHNE?]MO_13U]&5\M^%M
M670O$^GZD^?+@F!DQUV'AOT)KZBBD2:))8G5XW4,K*<@@]"*VQ"]Y,Y\$UR-
M#J***YSL"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** /.?C1_R)UI_V$$_]%R5YY\*O^2E:3_VV_\ 1+UZ
M'\:/^1.M/^P@G_HN2O//A5_R4K2?^VW_ *)>NNG_  G\SSZW^\+Y'TK1117&
M>B%%%% !1110 4444 %%%% !1110 52U?2;37-)N=,OD+VUPFUP#@CN"/<$
MCZ5=HH6@FKJS/E7Q5X4U'PIJCVMY"QA9CY%P!\DJ^Q]>F1V_*MSP)\1[WPK,
MEG=F2ZTEB 8BV6A]2F?SV]#[=:]^UK1;#Q!IDFGZE )K=^<="I[,I[$5\]>-
MOA[J/A&8SKNNM,9ODN%'W.>%<=CTYZ']*[(5(U%RR/.J49T9<\-CZ)TK5;+6
MM-AU#3YUFMI1E6'Z@CL1W%7*^6_!_C"_\'ZJ+FV)DMI,"XMB<+(O]&'8_P!,
MBOIO3[^WU33K>_M)!);W$8DC;U!'Z'VK"K3<'Y'70KJJO,XGXJ>,9O#6BQ6>
MGRF/4+[(61>L48^\P]"<@ _4]17S_9V=UJ=]%:6D3SW,[[41>2Q/^>M=G\7[
MV6Z^(%S [$I:0Q1(,= 5#G]7-8?A7Q9=^$;R:\L;.RFN)4\L/<HS%%SDA=K#
MKQGKT^N>FE'EAIN<->?/5M)Z([G3O@9J$T&_4=8M[60@$1PPF;'L22O/TS6%
MXI^%6M>&[)KZ)X]0M(QF5H5(>,#J2O\ =]P3COBM#_A=_B7_ )\=)_[]2?\
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M>)8HP>N ,#/O55WRQ441A8N<W49R?Q,\72>%?#H%HVW4+PF.!N#L QN;'L"
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 ?*=?1GAK_D5='_Z\H?_ $ 5\YU]
M&>&O^15T?_KRA_\ 0!7HXSX4=6)V1J4445YYR!1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M 'C?Q9_Y&JU_Z\D_]#>MKX+_ /,;_P"V'_M2L7XL_P#(U6O_ %Y)_P"AO6U\
M%_\ F-_]L/\ VI7H2_W;^NYUO^">K4445YQRA1110 4444 %9GB'_D7[W_KG
M6G69XA_Y%^]_ZYT >=:1_P AJP_Z^(__ $(5ZQ7D^D?\AJP_Z^(__0A7K%-D
MQ"BBBD4%%%% !1110 5%<VT-Y:RVUQ&LD,R%)$;HRD8(J6B@#Y:\9>%+KPEK
MLEG*"]L^7MIL<2)_B.A'^(K5\(_$O4_#,"V4T0O=/7[L;MM>/_=;GCV(_*OH
M#6=$T_7].>QU*V6>!O7JI]5/4&O(-<^"-]%*\FAW\4\.<K#<G8X'IN P?TKK
MC5C-6F>=/#U*<N:F;<?QI\/E 9+#4U;N%2,C\]XIW_"Z/#G_ #Y:K_WZC_\
MBZ\^?X4>,T;"Z2KCU6ZBQ^K4W_A57C7_ * O_DU#_P#%T_9TN_XA[7$=OP/0
M_P#A='AS_GRU7_OU'_\ %T?\+H\.?\^6J_\ ?J/_ .+KSS_A57C7_H"_^34/
M_P 71_PJKQK_ - 7_P FH?\ XNCV=+O^(>VQ';\#T/\ X71X<_Y\M5_[]1__
M !='_"Z/#G_/EJO_ 'ZC_P#BZ\\_X55XU_Z O_DU#_\ %T?\*J\:_P#0%_\
M)J'_ .+H]G2[_B'ML1V_ ]#_ .%T>'/^?+5?^_4?_P 71_PNCPY_SY:K_P!^
MH_\ XNO//^%5>-?^@+_Y-0__ !='_"JO&O\ T!?_ ":A_P#BZ/9TN_XA[;$=
MOP/0_P#A='AS_GRU7_OU'_\ %T?\+H\.?\^6J_\ ?J/_ .+KSS_A57C7_H"_
M^34/_P 71_PJKQK_ - 7_P FH?\ XNCV=+O^(>VQ';\#T/\ X71X<_Y\M5_[
M]1__ !='_"Z/#G_/EJO_ 'ZC_P#BZ\\_X55XU_Z O_DU#_\ %T?\*J\:_P#0
M%_\ )J'_ .+H]G2[_B'ML1V_ ]#_ .%T>'/^?+5?^_4?_P 71_PNCPY_SY:K
M_P!^H_\ XNO//^%5>-?^@+_Y-0__ !='_"JO&O\ T!?_ ":A_P#BZ/9TN_XA
M[;$=OP/0_P#A='AS_GRU7_OU'_\ %T?\+H\.?\^6J_\ ?J/_ .+KSS_A57C7
M_H"_^34/_P 71_PJKQK_ - 7_P FH?\ XNCV=+O^(>VQ';\#T/\ X71X<_Y\
MM5_[]1__ !='_"Z/#G_/EJO_ 'ZC_P#BZ\\_X55XU_Z O_DU#_\ %T?\*J\:
M_P#0%_\ )J'_ .+H]G2[_B'ML1V_ ]#_ .%T>'/^?+5?^_4?_P 71_PNCPY_
MSY:K_P!^H_\ XNO//^%5>-?^@+_Y-0__ !='_"JO&O\ T!?_ ":A_P#BZ/9T
MN_XA[;$=OP/0_P#A='AS_GRU7_OU'_\ %T?\+H\.?\^6J_\ ?J/_ .+KSS_A
M57C7_H"_^34/_P 71_PJKQK_ - 7_P FH?\ XNCV=+O^(>VQ';\#T/\ X71X
M<_Y\M5_[]1__ !='_"Z/#G_/EJO_ 'ZC_P#BZ\\_X55XU_Z O_DU#_\ %T?\
M*J\:_P#0%_\ )J'_ .+H]G2[_B'ML1V_ ]#_ .%T>'/^?+5?^_4?_P 71_PN
MCPY_SY:K_P!^H_\ XNO//^%5>-?^@+_Y-0__ !='_"JO&O\ T!?_ ":A_P#B
MZ/9TN_XA[;$=OP/0_P#A='AS_GRU7_OU'_\ %T?\+H\.?\^6J_\ ?J/_ .+K
MSS_A57C7_H"_^34/_P 71_PJKQK_ - 7_P FH?\ XNCV=+O^(>VQ';\#T/\
MX71X<_Y\M5_[]1__ !='_"Z/#G_/EJO_ 'ZC_P#BZ\\_X55XU_Z O_DU#_\
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M ":A_P#BZ/9TN_XA[;$=OP/0_P#A='AS_GRU7_OU'_\ %T?\+H\.?\^6J_\
M?J/_ .+KSS_A57C7_H"_^34/_P 71_PJKQK_ - 7_P FH?\ XNCV=+O^(>VQ
M';\#T/\ X71X<_Y\M5_[]1__ !='_"Z/#G_/EJO_ 'ZC_P#BZ\\_X55XU_Z
MO_DU#_\ %T?\*J\:_P#0%_\ )J'_ .+H]G2[_B'ML1V_ ]#_ .%T>'/^?+5?
M^_4?_P 71_PNCPY_SY:K_P!^H_\ XNO//^%5>-?^@+_Y-0__ !='_"JO&O\
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M+H\.?\^6J_\ ?J/_ .+KSS_A57C7_H"_^34/_P 71_PJKQK_ - 7_P FH?\
MXNCV=+O^(>VQ';\#T/\ X71X<_Y\M5_[]1__ !='_"Z/#G_/EJO_ 'ZC_P#B
MZ\\_X55XU_Z O_DU#_\ %T?\*J\:_P#0%_\ )J'_ .+H]G2[_B'ML1V_ ]#_
M .%T>'/^?+5?^_4?_P 71_PNCPY_SY:K_P!^H_\ XNO//^%5>-?^@+_Y-0__
M !='_"JO&O\ T!?_ ":A_P#BZ/9TN_XA[;$=OP/0_P#A='AS_GRU7_OU'_\
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ML1V_ ]#_ .%T>'/^?+5?^_4?_P 72-\:?#P4[;'5"?0QQC_V>O/?^%5>-?\
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M_72'^3U%\>/^9?\ ^WC_ -I5+\"?^//6_P#KI#_)ZB^/'_,O_P#;Q_[2J/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% 'RG7T9X:_Y%71_^O*'_ - %?.=?1GAK_D5='_Z\H?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M!6/JRXP3[C!KMZ*<9..J%*$9*TD>/?\ "B(_-)_X2)_+R<+]CYQVYW_TKI=
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M4# %:WY8)K=F%O:5&GLC%F\%>&)[7[.^A6(3&,I"$?\ [Z&&_'->:>,M O\
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MQ9_Y&JU_Z\D_]#>MKX+_ /,;_P"V'_M2L7XL_P#(U6O_ %Y)_P"AO6U\%_\
MF-_]L/\ VI7H2_W;^NYUO^">K4445YQRA1110 4444 %9GB'_D7[W_KG6G69
MXA_Y%^]_ZYT >=:1_P AJP_Z^(__ $(5ZQ7D^D?\AJP_Z^(__0A7K%-DQ"BB
MBD4%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 >#^'_ /D9-+_Z^XO_ $,5[Q7@_A__ )&32_\ K[B_]#%>\5Z.8_%$\/(_
MX<_4****\X]P**** "BBB@ HHHH **** "O%/C!_R-MK_P!>*?\ HR2O:Z\4
M^,'_ "-MK_UXI_Z,DKIPG\0VH?&7_@]_S&?^V'_M2O4*\O\ @]_S&?\ MA_[
M4KU"EB?XK)K?&PHHHK R"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#@_BS_R*MK_
M -?J?^@/7#?#;_DH&F?]M?\ T4]=S\6?^15M?^OU/_0'KAOAM_R4#3/^VO\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110!X/X?\ ^1DTO_K[B_\ 0Q7O%>#^'_\
MD9-+_P"ON+_T,5[Q7HYC\43P\C_AS]0HHHKSCW HHHH **** "BBB@ HHHH
M*\4^,'_(VVO_ %XI_P"C)*]KKQ3XP?\ (VVO_7BG_HR2NG"?Q#:A\9?^#W_,
M9_[8?^U*]0KR_P"#W_,9_P"V'_M2O4*6)_BLFM\;"BBBL#(**** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M.?\ 0?TK_P #(_\ &C_A*_#G_0?TK_P,C_QKY;HH^K+N'UV78^I/^$K\.?\
M0?TK_P #(_\ &C_A*_#G_0?TK_P,C_QKY;HH^K+N'UV78^I/^$K\.?\ 0?TK
M_P #(_\ &C_A*_#G_0?TK_P,C_QKY;HH^K+N'UV78^I/^$K\.?\ 0?TK_P #
M(_\ &C_A*_#G_0?TK_P,C_QKY;HH^K+N'UV78^I/^$K\.?\ 0?TK_P #(_\
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M.?\ 0?TK_P #(_\ &C_A*_#G_0?TK_P,C_QKY;HH^K+N'UV78^I/^$K\.?\
M0?TK_P #(_\ &C_A*_#G_0?TK_P,C_QKY;HH^K+N'UV78^I/^$K\.?\ 0?TK
M_P #(_\ &C_A*_#G_0?TK_P,C_QKY;HH^K+N'UV78^I/^$K\.?\ 0?TK_P #
M(_\ &C_A*_#G_0?TK_P,C_QKY;HH^K+N'UV78^I/^$K\.?\ 0?TK_P #(_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M ),__8T?4,1_+^*_S#^U<)_/^#_R.\HK@_\ A9/_ %"?_)G_ .QH_P"%D_\
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M .QH_P"%D_\ 4)_\F?\ [&CZAB/Y?Q7^8?VKA/Y_P?\ D=Y17!_\+)_ZA/\
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M\+)_ZA/_ ),__8T?\+)_ZA/_ ),__8T?4,1_+^*_S#^U<)_/^#_R.\HK@_\
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M<H4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 >$Q?ZY/\ >%>[5X3%_KD_WA7NU>MFGV/G^A\_D.U3
MY?J>:^/],%MJD5]& $NEPP'9UZ_F,?K6_P" M2^UZ*UHP^>T;&?56R1^N1^
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M 'VW_P 37HE%']H5_(/['PO9_>>=_P#"!:I_S\6?_?;?_$T?\(%JG_/Q9_\
M?;?_ !->B44?VA7\@_L?"]G]YYW_ ,(%JG_/Q9_]]M_\31_P@6J?\_%G_P!]
MM_\ $UZ)11_:%?R#^Q\+V?WGG?\ P@6J?\_%G_WVW_Q-'_"!:I_S\6?_ 'VW
M_P 37HE%']H5_(/['PO9_>>=_P#"!:I_S\6?_?;?_$T?\(%JG_/Q9_\ ?;?_
M !->B44?VA7\@_L?"]G]YYW_ ,(%JG_/Q9_]]M_\31_P@6J?\_%G_P!]M_\
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MUE6I1J+J%%%%9FP4444 >#^'_P#D9-+_ .ON+_T,5[Q7@_A__D9-+_Z^XO\
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M "*MK_U^I_Z ]<-\-O\ DH&F?]M?_13UW/Q9_P"15M?^OU/_ $!ZX;X;?\E
MTS_MK_Z*>O0I?[N_F==/^$_F?0-%%%><<H4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 >$Q?ZY/\
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M[[PBD%U"DT1D?*N,CKU]C[UZJJJEA8N2NCP)8>5?'U(PE9K5/[CD[_QKK%_
MT.^*W1AAO(4@D?4DD?A4/AG0)=:U%-R,+.,[I9,<$?W1[G]*]!7P?H*R!QIZ
MY'K(Y'Y9Q6S%%'!$L44:QQJ,*B#  ]A7/+'4X0<:$;7.R&5UJE13Q4^9(CNK
M.&[LI;25!Y,B%" .@]OI7D6J:7?>'=3P3(FUB8+A<KN'J#Z^HKV2HY[>&YB,
M5Q#'+&>JR*&'Y&N7#8IT6TU=,[L=@8XE)IVDMF>9Q>/]:CAV,+:1O^>CQG=^
MA _2L]-?UR\U6.>*ZF>Z.$1(QP1G.-HX(KT-O!N@,<G3Q^$KC^1K1L=)L-,!
M^QVD4)/!91\Q'N3S74\9AHIN$-?D<"R[&3:56KHNS?\ P!^G_:_[/@^W;/M6
MP>9L'&:LT45YC=W<]V*LDA&940N[!549))P *\7UF^;5M;N;I<L)9,1@C!VC
MA1^0%>SNBR(R.H9&&&5AD$>AJI'H^EQ2+)'IMFCJ0RLL"@@CH0<5U83$1H-R
M:NS@S#!SQ2C%2LD4M,\-Z=:Z9;0W%A:RS+&/,>2)6);J><>M6_[#TC_H%V7_
M (#I_A5^BL'5FW=LZHT*44HJ*T/-_'FBQ6,]M>6EO'#!(/+=8U"J&'(X'J/Y
M5I_#S43+97&GN^3"WF1@_P!T]0/8'_T*NPN+:WNXO+N8(YH\YVR(&&?H:BM]
M,L+27S;>QMH9,8WQQ*IQ]0*Z7BE.A[*:U[G%' .GB_;TW9/=?U]Y:HHHKB/3
M/'/$.FS:3K<\;*RHSF2%O52>#FKY\=:W]D2%9(590!YPCR[?7.1^E>EWEA::
MA#Y5W;QS(.0'&<?0]JRT\': C9&GC/O*Y_F:]6..I3BE6C=H\&65XBG.3P\[
M)^J/+([>]U*::6.*6XDYDD95+'U)-:WA+6;71]4+W<*M'* OG8RT7N/;U[_R
M/JT%O#;1"*WACBC'18U"C\A50Z)I).3I=EG_ *]T_P *)9A"<7"4=&%/**E*
M<:D)^\NZ+J.LB*Z,&1AE64Y!'J*=3(88K>)8H(DBC7[J(H4#Z 4^O*?D>ZKV
MU*NI_P#(*O/^N#_^@FO%()I+:XCGA;;+$X=&QG!!R#S7NC*KH4=0RL,$$9!%
M4?[#TC_H%V7_ (#I_A7;A,5&@FI*]SS<PP$\5*,HRM8\MN?%.MW<?ERZA)M.
M00@5,_\ ?(%6?"WAR?5[^.:2,K91,&D=AP^.=H^OZ?E7I2Z+I2'*Z99J?40*
M/Z5=551 B*%51@ #  K:>/BH.-*-KG/3RF;J*=>?-;^NHM%%%>8>V%%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M*X4444AGG_QA_P"1*C_Z_(__ $%JZGPI_P B?HG_ %X0?^BUKEOC#_R)4?\
MU^1_^@M74^%/^1/T3_KP@_\ 1:UH_P"&C&/\9^AKUC^)O$%MX9T.;4;GDK\D
M48ZR2'HH_F?8&M9W6-&=V"HHRS,< #U-?/\ XL\6V?BCQ= ]\;D:':L46.
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MO3]6<62?[O+U_1!1117G'L!1110 4444 %%%% !1110 4444 %%%% !1110
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MA9XE^6%<=3^G'?G'2F[I174E<LG*3^%G)Z=\1+_0)H=*\9Z=/;2CY1?*N5D
M_BP!SVR5SUZ"NO\ $6J>7X+U'4].N%;_ $1Y(9HSD<KPP-8OBGQ9X2O/"5V)
MM0L[U)HB(X$?=(7P=ORCE>>YQBD^'FERR_#6&RU!6$-VDNU#P1$Y/J.^21]1
M2:5N:UAQ;OR)WT.)\"^(=3\.Z&5L?!E_?_:'+M=Q;]LF. !B,C Y'7UKJ/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'RG7T9X:_Y%71_
M^O*'_P! %?.=?1GAK_D5='_Z\H?_ $ 5Z.,^%'5B=D:E%%%>><@4444 %%%%
M !1110 5RGC_ ,)_\)5H/EP;1?VQ,EN3CYN.4SV!X_$"NKHIIM.Z)E%25F>:
M>$OB+%:1)H?B@266H6W[HS2KA6 '&[T.._0]<\UU5YXZ\,65J9WUJTD&W(2"
M02.?;"\@_7%7]5\/Z3K:J-2T^"Y*C"LZ_,H] PY'YUEV7P^\*6$XF@T:$N.G
MG,\H_)R15MP>IFHU8Z)IGEWCG4]6\76+:W]F>UT&UD\NT$@PTS,<%O?I]!T&
M3FO4_ /_ "(FC_\ 7#^IK<NK"SOK86UW:07$ P1%+&'7CIP1BI+>W@M($@MH
M8X84&$CC4*JCV X%$IIQY4@A2<9N3=[GG/Q!\+ZA%JUOXMT!&:^M]IGC09+;
M1PX'?CY2/3'O6MX?^)F@:Q:J;JZ33[H "2.X8*N3_=;H1]<5VE8.J>"_#FM3
M&:^TF!YF.YI$S&S'U)4@G\:%)-6D#A*,G*'4H:U\1_#ND6[&&\34+@\)!:,'
MW'MEAP!^OL:\HU:VUC_A,M)U37(_)N]0NDE$'>- ZJH]NG3T ]:]ITGPAX?T
M.3S-/TJ"*4'(D;,CCZ,Q)'X5H76E:=?3Q3W=A:W$T7^KDEA5V3G/!(R.:<9Q
MCLB9TIS7O,MUB>+M#'B+PS>:< OFNN^$D [77D8],],^A-;=<QX^UX:!X2O)
MT8"YF7R( 3@[FXR/H,G\*B-^96-IVY7?8\H\ 6-YXF\5:;%>,[VFCQ[PI7A0
MKEE4^Y8]^P]!7OU</\+-!&D>$TNY$ N=0(G8]]F/D'Y$G_@5=Q5U97EH98>'
M+#7=A11161N%<M\1O^1 U;_KFG_H:UU-17-M;WEN]O=013POPT<J!E;Z@\&G
M%V:9,E>+1RWPP_Y)WI7_ &V_]&O775#:VEM8VR6]I;Q6\"9VQ1($5<G)P!P.
M234U$G=MA"/+%(****11Y?\ %2POK/5='\4VD)F2P9?-!&50JX92<<X))!].
M/6NJTOQ_X:U.Q%S_ &K;6S;07AN9!&ZGTP?O?AFNDDC2:)XI45XW!5E89# ]
M01W%<Q<?#CPC<SM-)HT89CDB.62-?P56 'X"M.:+24NABX3C)RAU.8\3?%!K
MB;^R?"43W=W+E/M*H3@^B+C)/N>.._6N7OOAOX@TC1%\0/.'U&&3[1- /G9
M#G=NY#$'DCI[FO9M*\/Z3HBL--T^"V+##,B_,P]"QY/YUI4U44=(HET'/6;U
M_(X_P)XX@\661AF"Q:G F9HAT<=-Z^V2,CL3]*["L^VT+1[*Y%S:Z58P7 SB
M6*W16&>O(&:T*B33>AM!22M(****DH\_^,/_ ")4?_7Y'_Z"U=3X4_Y$_1/^
MO"#_ -%K5^\L+/48/(OK2"ZB!W>7/&'7/K@]ZEBBC@A2&&-(XHU"HB* JJ.
M !T%4Y>[RF:A:;D/HHHJ30*\C_YN(_S_ ,^E>N54_LK3O[1_M'[!:_;O^?GR
M5\SIM^]C/3CZ5<)<MS.I#FMY.Y;K@?$WC'5+7QUIOA_0TAGE8#[3'(F1\W/7
M((VJ"WX]Z[ZN&\'^$]0LO$>KZ_KHB:_GD*0^6P90AP2P/Y*,@'"GUHA97;"I
MS.RB=S1114&@4444 %%%% !1110 4444 >-_%G_D:K7_ *\D_P#0WK:^"_\
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M%%%(HR/$?B.Q\,:4U_?,Q&=L<:8W2-Z#/YUXWJ?Q<\27=PS63P6$/\*)&LA
MSW+ Y/T 'M4WQ@U.2Z\5QV&XB&T@7"Y.-S?,3CZ;1^%=+\-/ ^E2^'HM7U.R
MBNKBY+-&DZAU1 2!\IXR>3SGMTKIC&,(<TD<4YSJ5'"#M8YC1_B[K]G<K_:?
ME7]N3\X,:QN![%0!^8KVG1]7L]=TN#4;&0O!,,C(P5/0@CL0:\D^+'A32]'C
MM-4TV!;4SR&*6&,80G&0P'1>A&!P?;G.A\$[V9H-6L2"8$:.93Z,P(/YA1^5
M*<8RASQ'2G.-3V<W<]9HHHKG.P*Q_%'B"W\,Z#/J4^&9?EACSCS)#]U?ZGV!
MK79@JEF("@9)/05\\?$/Q:WB;762W<_V=:$QP 'ASGF3\>WL![UI3ASLQKU?
M9Q\Q#\3_ !@22-7 ]A;1<?\ CM?0=J[26<$CG+-&I)]217R<RLCLCJ593@@C
M!!KZPL?^0?;?]<E_D*TKQ2M9&.$E*3=V3T445SG8%%<JWQ(\)I<- VK8E5]A
M7[/+USC'W:?X@\?>'_#DS6]W=--=+]ZWMUWNOUZ 'V)SR*KDEV(]I"U[G3T5
MQNC?$_PWK-VEJLL]I-(VR-;J,*&/;E20/Q(K?UOQ!IGAVT%SJ=TL*MG8O5G(
M&<*._P#]<4.,D[- JD6KIFG17GZ?&+PT\XC:'4$4_P#+1H5VC\F)_2NVT_4;
M/5K*.\L+A)[>3[KH>/\ ZQH<)1W01J1E\++5%%<EK?Q)\-Z),\$ET]U<(<-%
M:+OVGT+$A<^V<TE%O8<I**NV=;17%:5\4_#.J726YEGLW?A3=1A5)]-P) _'
M K1U'Q]X9TJ_FL;W4_*N83B1/(D;!QGJ%([T^25[6$JL&KW.DHJO8WMOJ-C#
M>6DGF6\R!XWVD;@>^#S5BI+.?\:Z\?#OA6\OHY ER5\JWR 3YC<# /!QRW_
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MIZ***DL**** "O._'O\ R'8/^O9?_0FKT2O._'O_ "'8/^O9?_0FKNR_^/\
M(\O./]U?JC4^&W_,3_[9?^SUWE<'\-O^8G_VR_\ 9Z[RL\?_ +Q+Y?DC7*O]
MTA\_S84445R'H!1110!X/X?_ .1DTO\ Z^XO_0Q7O%>#^'_^1DTO_K[B_P#0
MQ7O%>CF/Q1/#R/\ AS]0HHHKSCW HHHH **** "BBB@ HHHH *\4^,'_ "-M
MK_UXI_Z,DKVNO%/C!_R-MK_UXI_Z,DKIPG\0VH?&7_@]_P QG_MA_P"U*]0K
MR_X/?\QG_MA_[4KU"EB?XK)K?&PHHHK R"BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MQC'7YB,?K0DV)M+<V****!A1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 >-_%G_D:K7_ *\D_P#0WK:^
M"_\ S&_^V'_M2L7XL_\ (U6O_7DG_H;UM?!?_F-_]L/_ &I7H2_W;^NYUO\
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M^BGKT*7^[OYG73_A/YGT#1117G'*%%%% !1110 4444 %%%% !1110 4444
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M/BK_ ,BO;?\ 7ZO_ * ];_A#_D4=+_Z]UI2DW!2>]RHQ2FXK:QQO_"&^.?\
MH9/_ ">G_P#B:S=<TGQ;X?TXWM[XE?R]P15CO9BS,>PR!V!/X5ZZS!5+,0%
MR2>@KR74YYOB!XUBL;9_^);;D@. <!!]Y_J> /P]Z=.<I/79$U*<8K3=FY\.
MK75[R-]7U+4;V6 YC@AEG=@Q[O@G!'4#\?05?\:>-!X?"V5DJ3:A*N>3D0CL
M2.Y/8?B??J(HK;3;!8XU6&VMX\ #HJ@5X[X:U;3)?%L^M>(+GRV!,L0V,V9"
M>/NCL/Z4HKGDY-:(<FZ<5!/5]36@\#^)O$,:W.M:FT(?!$<S%V4?[O 7Z9^N
M*6?X<Z[I/[_1=5\UU&=JDP.3TP.2.GJ176_\+!\+_P#04_\ )>7_ .)H_P"%
M@^%_^@I_Y+R__$T^>KV_ .2CWU]3'\(^.+F[U#^QM=41WH)5)64(68'[K#@
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M] *KF4:47U)Y7*K)7T.-D^%=Z\9G.MJ]X>2&B;!/^_G/3VIGA_Q%J_AG7X]
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MP>#T->AS7$P\ 27(FD$XTLR>;N.[=Y6=V>N<\YKAOBEHT5K?VVJ0KM^U928
M<%UQ@_4C_P!!KM9_^2;R?]@@_P#HFKGRN,6C.',I24CSS0_%&O7-A)HUE-<7
M.I7DN%FFE+&) O.TD\=^>V/7IT.G_#>\BU:TU"^UAIY%D\R8*7#'TP^<G)ZG
MCO53X362&;4KXYWJJPKZ8)R?_05KT^BK/EDU$=*GS14I'D*^+KS1_&.LR7-W
M<SP123I#;/,Q0MOPHQT ']*T4\,>)O&*B]UC4?L5O+\T=N%)VCJ/DR .W4Y]
M:R-,TU-3^*EU%* T4=]/,X(R"%=B!^>*]DIU)\EN7<5*'/?FV/(-4\.:]X&*
MZEIU^TMN#M>2-<;>GWT.1@GZ_AFN@N?B(9?#UFVGP"36;LF,0*"PC8'!..^>
M,#WYZ5UVOPK<>'=2B90P:UDP#Z[3C]:\V^%6GQSZS=WSIN-K$%0G^%GSS]<
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MV/,'^%5[;?O+'6D,P'!:(Q\_4$U%:^*/$7A#4X[+Q"LES:M_$QW-MZ;E?O\
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M.WL:Z/Q'_P BOJW_ %Y3?^@&O/\ XD:8ND:O8ZY8#R997)?8,#S%((;ZGO\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_M2O0E_NW]=SK?\ !/5J***\XY0HHHH **** "LSQ#_R+][_ -<ZTZS/$/\
MR+][_P!<Z .-\&_\C G_ %S:O1:\Z\&_\C G_7-J]%IL2"BBBD,**** "BBB
M@ KDOB)_R+\'_7TO_H#UUM<E\1/^1?@_Z^E_] >NC"?QX^IQYA_NL_0X[PA_
MR-%G_P #_P#0&KU*O+?"'_(T6?\ P/\ ] :O4JZLS_BKT_5G%DG^[OU_1!11
M17G'L!1110!YK\4_!DFKVR:UIT)>\MUVSQH.9(QSD>I'Z@^P%>9^%_&&J>$;
MMS:D/ [?OK:7.UL=_9O?\\U]+5RGB'X>:!XBE>XF@>WNWY:>W.TL?4@Y!_+/
MO6\*J2Y9;'+5H-RYX.S.?MOC3HSQ W6FW\4F!E8MD@SWY)7^5<YXE^+M]J4!
MMM&@:PC;[TY;,I]ACA?U-:LGP1C+YBU]E7T:TW'\]XK2TSX.:+:S"2^O+F]V
MD$1X$:'ZXR3^8JDZ*U(:Q$M&<Y\(KOQ!_:<L-M&9M'9B;EI6PL;XX*G^]TR!
MU[XX-=1\5?"LVMZ3#J-C$\EW99W1H,EXSR<#N01G\37>6EI;V-K':VD$<$$8
MPD<:[54?2IJR=3W^9&T:/[OD;/G+P5XXNO"%U(HB^TV,YS+!NVG/9E/8_P _
MR([K4?C38K:?\2S3+A[DC_EY*JBG_@));OZ5M>(?A9H>MW4EW TMA<R$LYAP
M48GN5/?Z$5@V_P $K=95-SKLLD>1E8K8(2._)8_RK5RI2U9@H5X+ECL>;:9I
MVH^,/$H@C)DNKN1I)96Z*,Y9C[#_  %?1MW:Q6/A>>S@!$4%DT2 ]=JI@?H*
MCT#PSI7AJT-OIMN$W<O*QW.Y]S_3I6E<P+=6LUNY(25"C%>N",<5G4J<STV-
MJ-'D3ONSYC\*?\CAHG_7_!_Z,6OJ&N#T_P"$N@Z;J5K?0W>I-+;3),@>1"I9
M2",X3IQ7>4ZTU)JP8>G*FFI'SK\3_P#DHFJ_]L?_ $4E>S> ?^1$T?\ ZX?U
M-9^N_#+1?$.M7&J7=U?I//MW+%(@4;5"C&4)Z =ZZ?2-+@T72;;3;9I'AMTV
M(TA!8CWP /THG-."2%2I2C4E)[,^>_&WA:X\*Z_(BHXLI6+VLW8CKC([CI^1
M[UVGA_XQQP6$<&NV=Q+-&N/M%OM)D],J2,'W!_"O3]7T>QUW3WL=1MUF@?G!
MX*D="#U!KSJ\^"EE),S66LSP1GHDL(D(_$%?Y52J0FK3(=&I3E>EL<IXW^(T
MWBJU73[6U-K8AP[;FR\A'3.. /;GH.:Z+X/>&9DDF\0W*%8V0PVH/\63\S_3
MC ^I]*V-%^$&BZ?.D^H7$VHNG(C8".,GW49)^F<>N:]"1%C1410J*,*JC  ]
M!2G4BH\L!TZ,W/GJ'@/Q9_Y'N;_KA'_*O4OAA_R3O2O^VW_HUZ;XB^'&C^)=
M6;4KVYOHYF14*PN@7 ^JD_K6_H6BVWA[1;?2[1Y7@@W;6E(+'<Q8YP .I/:E
M.:<%%%4Z4HU7)[,Q_B-_R(&K?]<T_P#0UKR/X5_\C_9?]<Y?_0#7NVM:1;Z[
MH]QIET\J0S@!FB(##!!XR".WI7.>'_AKHWAS6(M3L[F_>:,, LTB%>00>B@]
M_6B$TH.+"I2E*I&2V1V5%%%8G2<IXG^'^E>*]2COKZXO8Y8X1"! ZA=H)/=3
MS\QK%_X4QX=_Y_=4_P"_L?\ \17HM%6JDDK)F;HP;NT>"?$3P3IOA&#3WL)[
MN0W#.'\]U.-H7&,*/6IOAAX1L/$4MS>W<URDEA-$\0B90">3\V5/]T=,5ZIX
MI\'Z?XNCMDOYKJ,6Y8IY#*,[L9SE3Z4>%O!^G^$8[E+":ZD%P5+^>RG&W.,8
M4>M:^V]RU]3#ZO\ O;VT'>+?%5KX2TI;VXB:=Y)!'%"C %C@DGGH !UYZCUK
M/\&>/[3Q?)-;BT>TNX4\PQEPZE<XR#P>XSQW%:'BWPI:>+=*%I<2/#)&V^&9
M1G8V,<CN/:L[P7X M/"$D]S]J>\O)E\OS2FP*F0<!<GJ0,DGL.G.<UR<FNYJ
M_:>TT^$["BBBLS8\H^)'Q$-NT^A:+*1,"4NKE3RG8HOOZGMTZ]/(K=H4N(VN
M(WDA# NB/L+#N <''UP:]XU#X2Z#J6I75]-=ZDLMS,\SA)$"AF))QE.G-5O^
M%,>'?^?W5/\ O['_ /$5U0J4XJR."I1JSE=F#9?&*VTZRBL[/PND-O"NU(TO
M. /^_?ZUU_@KQ_\ \)A>W5M_9GV3R(Q)N\_S-V3C&-HQ6=_PICP[_P _NJ?]
M_8__ (BM[POX%TOPE=3W%A/>2/,@1A.ZD  YXPHK.;I-:;FM-5U)<ST*'C+X
MC6OA._CL5LFO+EHQ(P$H14!) !."<\$XQZ>M;.A:Y9>,O#KW-NLL44H:"5&(
MW(V.1QD=""/J.*QO&7PXM/%E['?)>O9784([>7YBNHZ<9&#[YK=\,>'+3PMH
MJ:=:,[_,9)97ZR.<9..W0 #T Z]:E\G*K;FD?:<[O\)R?_"F/#O_ #^ZI_W]
MC_\ B*/^%,>'?^?W5/\ O['_ /$5Z+12]K/N/V%/L?*.I6R6>J7=K&6*0S/&
MI;J0&(&?RKZ)\&^$[#PO8R&RFN9/M:H\GGLIP0#TP!ZFL6[^$.@7EY/=27FI
MAYI&D8++'@$G)Q\GO7>11B&%(E)*HH49Z\5I5J*221E0H.$FY#Z***P.H^5[
MG_D89O\ KZ;_ -#KZHK@)/A#H$EXUT;S4][2&0@2QXSG/]RN_K:K-2M8YL/2
ME"_,>(_&G_D9;#_KS'_H;5V?PC_Y$9/^OB3^E:7B?P%I?BR^AN[^XO(Y(H_*
M40.H!&2><J>>:T_#OAZT\,Z4-.LI)Y(0[/NF8%LGZ 42FG341QI259SZ&/\
M$_\ Y)WJO_;'_P!&I7F7P@_Y'<_]>LG\UKVK7=%MO$.BW&EW;RI!/MW-$0&&
MU@PQD$=0.U87AOX=Z1X7U3^T+*YOI)O+,>V9T*X./11Z40FE!Q8JE*4JJDMD
M9OQ5\+3ZYHT.H64?F75CN+1JN6DC.,X]2,9Q]>_7R?PKXOU'PE=R2V6R2&4
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M8_%$\/(_X<_4****\X]P**** "BBB@ HHHH **** "O%/C!_R-MK_P!>*?\
MHR2O:Z\4^,'_ "-MK_UXI_Z,DKIPG\0VH?&7_@]_S&?^V'_M2O4*\O\ @]_S
M&?\ MA_[4KU"EB?XK)K?&PHHHK R"BBB@ HHHH **** "BBB@ HHHH ****
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MP;\5HKXXCTW6XRDSOPL<F>3G/J%))[.WI2^!(V\2^,-8\7S@^4&^S68(. ,
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M7,[F\(\L4@HHHJ2@HHHH **** "BBB@ HHHH **** "BBB@ HHHH X/XL_\
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M<BAE8="#R#3Z\Q\/^*[GPE/_ ,(_XAA=8H6Q',!NV*<_]]+Z$<CI[#ME\5Z
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M]1_[9?\ HQ*Z:N9^(/\ R(^H_P#;+_T8E13^-%U/@?H4? <!N?A^8%(#2F9
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MG6-%8P:@AWNB';YA'.Y2.C?S^O6ZDE*3A(BG&48J<?FCNJ\K^*/_ ",&F?\
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M9R_PI=3X;NXP?F6[8D>Q1,?R-=W7G/PEES9:G%_=DC;\P1_2O1JNM\;(HO\
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M?KD<=GJ3K9:H/E97^5)3ZJ>Q]CZ\9KNJY#Q5\/-(\2K).L8M-1(XN(EP&/\
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M ,C5:_\ 7DG_ *&];7P7_P"8W_VP_P#:E>A+_=OZ[G6_X)ZM1117G'*%%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 5CZIX5T76=S7EA$93G]ZGR/D]\CK^.:V**:;6J$T
MGHSB'^%F@LV1<7Z#T61,?JM6[+X<^';-P[02W) X\^3(^N!@&NLHJO:S[D*E
M!=!D44<$2Q0QI'&HPJ(N ![ 42Q)/"\,B[HY%*L,XR#P:?14&AFZ1H&F:$LJ
MZ;;>0)2"_P"\9LXSC[Q/J:TJ**;;>K$DEH@K*TGPWI.A22R:;:>0TH <^8[9
M _WB:U:*+O8+)ZA6%K'A#1=;?S;JT"S9R98CL8_7'7\:W:*$VM4#2:LSB$^%
MF@JV3<7[CT:1,?HM=5IFD6&CVWD:?:QP1]]HR6^I/)_&KM%.4Y2W9,81CLC*
MTGPWI.A22R:;:>0TH <^8[9 _P!XFBX\-Z3=:O'JLUINO8RK++YCC!7IP#C]
M*U:*7,[WN/EC:U@HHHI%&3K'AK2==7_3K56D'25/E<?B/ZUSW_"K-!WEOM%_
MC/W?,3 _\=S7;T5:J26B9#IQD[M&9H_A_2]"B*:?:I&S##2'YG;ZL>>W3I[4
MVU\-Z39:M+JEO:;+R4L7D\QSDL<G@G'7VK5HJ>9]Q\J[!6?JFB:;K4:QZA9Q
MSA?NDY##Z$8-:%%";6PVD]&<0_PLT%FR+B_0>BR)C]5K2TWP'X?TR83):&>0
M?=:X;>!^'3]*Z6BJ=2;ZD*E!:V"HYX([FWE@F7=%*A1USC((P1Q4E%0:&=I.
MA:;H4<L>FVWD+*07&]FR1_O$UHT44VV]6))+1%6_TZSU2U-M?6Z3PDYVN.A]
M1Z'W%<K/\+] ED+(][""3\D<H('_ 'TI-=I13C.4=F*4(RW1RVG?#WP_ITRS
M>1)<NO3[0VX9]<  &NH50JA5 "@8 '04M%$I.6[",5'9&5JGAO2=:N(I]0M/
M.EB&U&\QUP,Y[$5JT44KMZ#22U*.JZ/8:W:K;:C!YT*N) N]EPP!&<J1V)JM
M=>&-(O=.MM/N+5GM+;_51><X"\8[-S^.>IK7HH4FMF#BGNCF?^%?>%_^@7_Y
M,2__ !5'_"OO"_\ T"__ "8E_P#BJZ:BJ]I/N3[.'9&)IOA'0](O%N[&Q\J=
M00'\UVX/7@L16S)&DL;1R(KHX*LK#((/4$4ZBI;;U92BEHCD;[X;^'KR0ND4
M]J3U$$F!^3 XJ.V^&/A^"0,YNYP#G;+*,'V^4"NRHJO:S[D>RAO8AM;2WL;=
M8+6".&)>B1J *FHHJ#0**** ,J;PWI,^LKJ\EINOE*L)?,<<@8'&<?I6K113
M;;W$DEL93^&])DUH:PUIF_!!\WS'Z@;1QG'0>E:M%%#;>X));!65<>&])NM7
MCU6:TW7L95EE\QQ@KTX!Q^E:M%";6P-)[A5'5-&T[6H%AU&T2=%.5W9!7Z$<
MBKU%"=M@:3T9Q$GPMT%VRL]^@]%E7'ZJ:U-*\#:#I,WG16IFE'W7N#OV_0=/
MTKHZ*IU)O1LE4H)W2"BBBH+"O*_BC_R,&F?]<O\ V>O5*X#Q[X;U;6M8L9]/
MM/.BBCVNWF(N#NSW(K6BTIW9C73<+([#5=&T_6K?R+^V291G:2/F3/<'J*Y=
MOA;H+2;A/?J/[HE7'ZKFNWHJ(SE'9ERIQENC$T;PEHVA,)+.US< $>?(=S_X
M#TX K;HHI-MN[*225D9FK^']+UWR?[2M?/\ )W>7^\9<9QG[I'H*T418XUC0
M850 !Z 4ZBB[M8+*]PK.U;0M-UV.*/4K;SUB)*#>RX)_W2*T:*$VM4#2>C(X
M(([:WB@A7;%$@1%SG  P!S1/!#<PM#/$DL3C#)(H96^H-244AG'7?PS\/W,K
M21BZMLG.V&48'_?0-3:;\.] TZ=9C#+=.IROVEPP!^@ !_$5U=%7[2=K7,_9
M0O>QFZKH&EZU##%J%J)8X3F-0[(%[?PD59:PMFTTZ>8\VIA\@Q[C]S&W&>O3
MOUJS14W9=EN9^DZ'IVAPR0Z=;^0DC;F&]FR>G\1-:%%%#;>K!)+1&5:^&])L
MM6EU2WM-EY*6+R>8YR6.3P3CK[5JT44-M[@DEL,EB2>%X9%W1R*589QD'@U0
MTC0-,T)95TVV\@2D%_WC-G&<?>)]36E11=VL%E>X56U#3[75;&2RO8O-MY,;
MTW%<X((Y!!Z@59HI;#:N5--TRSTBS6TL8?*@4DA-Q;D]>22:M.BR(R.H96&"
MI&01Z4M%%[Z@E;0Y/4/ASX?OYFE6*:U9N2+9PJY]@00/PJ.S^&GA^TF$CK<W
M6#D+/(-OY*!FNPHJ_:3M:YG[*%[V*%]HNG:EIZV%U:HUHI!6)"4 (Z8VD5-8
M6%MIEE%9V<?EV\0(1-Q.,G/4\]35FBIN[6+LKW"N8U/P!X?U.1I3;/;2L26>
MW;;G\#D?I73T4*3CL$HJ6Z.)C^%N@H<M-?2>S2K_ $45T^F:)INC1&/3[..
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M],''O7I=%5SIJTE<GV33O!VN>2:EXB\2_$%3I6AZ5+9:;, L]Q,/O*><EL8
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M_P!_V_QH_MG5/^@E>?\ ?]O\:/[,G_,@_MRG_(SU^BO(/[9U3_H)7G_?]O\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M(84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110!\IU]&>&O\ D5='_P"O*'_T 5\YU]&>&O\ D5='_P"O*'_T 5Z.
M,^%'5B=D:E%%%>><@4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110!XW\6?\ D:K7_KR3_P!#
M>MKX+_\ ,;_[8?\ M2L7XL_\C5:_]>2?^AO6U\%_^8W_ -L/_:E>A+_=OZ[G
M6_X)ZM1117G'*%%%% !1110 5F>(?^1?O?\ KG6G69XA_P"1?O?^N= '&^#?
M^1@3_KFU>BUYUX-_Y&!/^N;5Z+38D%%%%(84444 %%%% !1110 55O--LM07
M;=VL4WH74$CZ'J*M44TVG="E%25I*YA-X-T!CDZ>/PE<?^S4G_"%^'_^@?\
M^1I/_BJWJ*U^L5?YG][,/JF'_P"?:^Y&#_PA?A__ *!__D:3_P"*H_X0OP__
M - __P C2?\ Q5;U%'UBM_._O8?5,/\ \^U]R,'_ (0OP_\ ] __ ,C2?_%4
M?\(7X?\ ^@?_ .1I/_BJWJ*/K%;^=_>P^J8?_GVON1@_\(7X?_Z!_P#Y&D_^
M*H_X0OP__P! _P#\C2?_ !5;U%'UBM_._O8?5,/_ ,^U]R,'_A"_#_\ T#__
M "-)_P#%4?\ "%^'_P#H'_\ D:3_ .*K>HH^L5OYW][#ZIA_^?:^Y&#_ ,(7
MX?\ ^@?_ .1I/_BJ/^$+\/\ _0/_ /(TG_Q5;U%'UBM_._O8?5,/_P ^U]R,
M'_A"_#__ $#_ /R-)_\ %4?\(7X?_P"@?_Y&D_\ BJWJ*/K%;^=_>P^J8?\
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M)_\ %4?\(7X?_P"@?_Y&D_\ BJWJ*/K%;^=_>P^J8?\ Y]K[D8/_  A?A_\
MZ!__ )&D_P#BJ/\ A"_#_P#T#_\ R-)_\56]11]8K?SO[V'U3#_\^U]R,'_A
M"_#_ /T#_P#R-)_\51_PA?A__H'_ /D:3_XJMZBCZQ6_G?WL/JF'_P"?:^Y&
M#_PA?A__ *!__D:3_P"*H_X0OP__ - __P C2?\ Q5;U%'UBM_._O8?5,/\
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M?_Y&D_\ BJWJ*/K%;^=_>P^J8?\ Y]K[D8/_  A?A_\ Z!__ )&D_P#BJ/\
MA"_#_P#T#_\ R-)_\56]11]8K?SO[V'U3#_\^U]R,'_A"_#_ /T#_P#R-)_\
M51_PA?A__H'_ /D:3_XJMZBCZQ6_G?WL/JF'_P"?:^Y&#_PA?A__ *!__D:3
M_P"*H_X0OP__ - __P C2?\ Q5;U%'UBM_._O8?5,/\ \^U]R,'_ (0OP_\
M] __ ,C2?_%4?\(7X?\ ^@?_ .1I/_BJWJ*/K%;^=_>P^J8?_GVON1@_\(7X
M?_Z!_P#Y&D_^*H_X0OP__P! _P#\C2?_ !5;U%'UBM_._O8?5,/_ ,^U]R,'
M_A"_#_\ T#__ "-)_P#%4?\ "%^'_P#H'_\ D:3_ .*K>HH^L5OYW][#ZIA_
M^?:^Y&#_ ,(7X?\ ^@?_ .1I/_BJ/^$+\/\ _0/_ /(TG_Q5;U%'UBM_._O8
M?5,/_P ^U]R,'_A"_#__ $#_ /R-)_\ %4?\(7X?_P"@?_Y&D_\ BJWJ*/K%
M;^=_>P^J8?\ Y]K[D8/_  A?A_\ Z!__ )&D_P#BJ/\ A"_#_P#T#_\ R-)_
M\56]11]8K?SO[V'U3#_\^U]R,'_A"_#_ /T#_P#R-)_\51_PA?A__H'_ /D:
M3_XJMZBCZQ6_G?WL/JF'_P"?:^Y&#_PA?A__ *!__D:3_P"*H_X0OP__ - _
M_P C2?\ Q5;U%'UBM_._O8?5,/\ \^U]R,'_ (0OP_\ ] __ ,C2?_%4?\(7
MX?\ ^@?_ .1I/_BJWJ*/K%;^=_>P^J8?_GVON1@_\(7X?_Z!_P#Y&D_^*H_X
M0OP__P! _P#\C2?_ !5;U%'UBM_._O8?5,/_ ,^U]R,'_A"_#_\ T#__ "-)
M_P#%4#P9X?!R-/'XRN?_ &:MZBCZQ6_F?WL/JF'_ .?:^Y%*STC3M/.;2SAB
M;^\%^;\^M7:**R<G)W;-HQC%6BK(****104444 %%%% '@_A_P#Y&32_^ON+
M_P!#%>\5X/X?_P"1DTO_ *^XO_0Q7O%>CF/Q1/#R/^'/U"BBBO./<"BBB@ H
MHHH **** "BBB@ KQ3XP?\C;:_\ 7BG_ *,DKVNO%/C!_P C;:_]>*?^C)*Z
M<)_$-J'QE_X/?\QG_MA_[4KU"O+_ (/?\QG_ +8?^U*]0I8G^*R:WQL****P
M,@HHHH **** "BBB@ KR?3O^$F^(T]]J5KKTVCZ=#*8;>*W+98@ \X*GH023
MZ\#BO6*\RNO#WB7P1JEUJ7A<+?Z;<.9)M/8$E.I^49R<= 1ST!!Q6E-[]S&L
MGIVZFYX1?Q=:ZG=Z7KZ)<VD"[HM0S@OGH!_>[^A'<G(K-EU*^'QKAL!>W LC
M;;C;^:WED^63G;G'6MOPCXVL_%(EM_)DM-2MQF>UDZC!P2OJ >.<$5SEPNSX
M\VA8CY[0E?\ OVW^!JEN[KH2VN6/*[ZGI=>>?%S4K[3=#L)+"]N;5VN=K-!*
MR$C:>"0:]#KS/XT_\B_IW_7T?_0#4TOC1==VIL[7Q7_R)^M_]>$__HMJ\K\&
M:QXCO_#D/A_PQ;K%)$SO<W\^-D88D@#KS^!/MQFO5/%?_(GZW_UX3_\ HMJP
M/A3;V\7@.UEA">;-)(TQ&,[@Y S_ ,!"TXNT&R)Q<JJ2=M#.;P'XN$9N%\<W
M9NNHC.\1Y^N[I_P&ET'QEJ^D:\GASQBBK/)M%M>*/E<G@9(X(/3(Q@]?;T:O
M._C';P-X5M;ICMN(;M1$P//S*<C] ?\ @-$9<[Y9!.'LUS1>QWMY>6^GV<UW
M=RK%;PJ7D=N@ KS=-7\8>/)YWT"1=)T56*)<2#$DN#V."<_3 '3)JW\3+JZ/
MPUMW+N'G>$3D<9RI)R![@5V>@VL%EX?TZVME ACMT"X&,_*.?J>I]S25HQOU
M*=YRY;V1Q,G@3Q?;$S67CF[FFY(6XWA,_3<P_2M#PEXCU]]8F\/^)+!_MD2;
MTNXH_D=<D9;' S@X(P#C& :[>BDYW5F-4E%WBSSSXD:E?6.N>%8[.]N;=)[E
MUE6&5D$@W1<, >>IZ^IKT.O-/BFN-;\)2D@*MVP.?=HO\*]+HE\,0A\<OE^1
MS?CZYN+/P/J=Q:SRP3(BE9(G*LOSKT(Y%1^&/M>K_#FU5[Z=+NYLW3[66+2(
MQR ^<Y)'7KVI/B-_R(&K?]<T_P#0UJ7P#_R(FC_]</ZFG]B_F+_E[;R/+M=\
M+ZI9>.]&TR;Q->7-U<J#'>N&WP_,PXRY/;/4=:]6\+Z#?Z#;W$=_KMSJS2N&
M5Y]V4 '099JY+Q=_R5[PO_N+_P"AO7<^(Y)8?"^K2PDB5+*9D('(8(<?K53D
MVDB*<(QE)]CA]2\8ZYXFUV70_!GEQQPY\_4)%X'T)!P.V<$GMC&:D_X0/Q<D
M33IXYNS='GRVW^7G/KN.!_P&K?PCMX8O!"RQ@>9-<2-(<\DC@?H!7>4I2Y7R
MQ'"'/'FD]SQ+Q7XM\5:7ITFA:Q++!J:S++#?6;^6)HL,#RN.,X[#W Q7J_G2
M_P#"(^?YC^;]@W^9N.[=Y><Y]<UQ_P 9;>%_"MI<.!YT5V%C;/9E;(_\=!_"
MNM_YDK_N'?\ M.G)IQ3L$$U.2;OH>4^%/$_BW6K :#I,TDEVSO)<:A=2%S%&
M<  $YQCGU// [UT\G@7QA!%]IMO&]W+=J,B&3>(R<=.6(_-?>G?!JUCC\*W=
MR%'FS795F_V55<#]3^=>C43G:32%2I\T$Y,X_P  ^*KOQ!:7EGJJ"/5=/E\N
M=0NW<.0#CL<@@@>@]:F\;>,5\+64,=M"+G4[H[;>#K^) Y([8'4USWA%B/BW
MXI7/RE"2/HR_XUC^)CK,GQBWZ59PWUY:P(UO#<D! -G)&67H6)'/7FGR)S_$
M7M)*GYWL:]KX2\<ZU$+O5?%EQITD@#>1;YRGH"$90./3-13S^,_ #)=W]X=;
MT4,HG8DF2,=,\\CZY(/'3-7/[8^*?_0MZ7_W\7_X]4-W??$V^LYK2X\+Z2\,
MR%'4R*<@C_KM3UZVL+1+2]_F>@Z=J%MJVG07]G)YEO.NY&QCC_&N*\5>,]4.
MN?\ "->%;<3ZGM_>SG#"'OQGC([D\#..M7?AKI&L:'X<EL-8MC ZW#/"/,1_
MD(']TGOG\ZQ/A)"LLNOZA-E[V2ZV.[CY@.6//N3S]!4**3;WL:.4I**VN2)X
M"\7RQ"6X\<W:7/4QQ-(8_P ]P_\ 0:BL_%/B#P9K<.F>+W%SI]P2(=04?=YQ
MDD=1Z@\C.>17IU<?\4+6&X\ W[RJNZ!HY8V/\+;PO'U#$?C1&?,[2"=/D7-%
MZHT/&MU+;^"=4N;2=XI%@W1RQ.5(Y'((J/P#<W%YX'TRXNIY9YG1BTDKEF;Y
MVZD\FL.:2>\^")DF8F7^SADMU(7I^@K7^'!!^'^DD$'Y'''_ %T:DU:'S&I7
MJ)^1U->>?#?4KZ^USQ5'>7MS<)!<HL2S2LXC&Z7A03QT'3T%>AUYG\+/^1@\
M8?\ 7TG_ *'+1'X9#F_?C\_R%U:]U[Q=XVO/#^DZH^E66GH#-/$2'=N,]"#U
M. ,@8!R><5=T6U\;>'_$5OIUU<?VUI,^2UU*2&A [DG)STX.0>QZFE\2>$]:
MMO$+^)_"MP@OI%"SVDA 688QWXZ <''3.<U-X9^( U+4AHNMV$FF:OV212J2
M'J ,\@D=,]>QJMX^[L9I6G[S:=_D=O1116)TA1110 4444 %%%% !1110!P?
MQ9_Y%6U_Z_4_] >N&^&W_)0-,_[:_P#HIZ[GXL_\BK:_]?J?^@/7#?#;_DH&
MF?\ ;7_T4]>A2_W=_,ZZ?\)_,^@:***\XY0HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M^+]0N?'TN@O#;"U1Y%#JK;\*I(YW8[>E.#EKRBJ*%US':5Y9\/\ _DH&K_\
M7*;_ -&K72>*M?\ $>E:I%!H^D?;+=H0[2?9I),-N8$94@= ./>O./#^K:UI
M_B"[N]-T_P"TWLB.)8?)=]@+@GY5.1@@#GUK6G!\C\S*K47.O(]VHKF_"6L:
MWJT=V=9T[[$T941#R'CW9SG[Q.>@Z5:\1^)['PW:"6Y)DF?/E0(?F<_T'O\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M  [=:2^(UE3$; ?<8<J?H"!QZ<5Y[H'C&]\#I%X>\56$T<,19;>[0%@4!_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MIK>S.=<]/2UT>AZGJUCH]HUS?W"0QCID\L?11U)KQ#7]9G\0:^-1D1DA9A'
MI_A13T_7)]R:[73_ (8RRW(GUW4C<8&/+B9B3]7;G'X?E6QX@\"0ZS<63V]T
MEE#:1^6L20;AC.?[PQ54Y4Z;WN34C4J+:QT>K?\ ('OO^O>3_P!!-<'\)/\
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M[3YL@?=Y6S'&,=370551J4VT32BXP293U;_D#WW_ %[R?^@FN#^$G_'OJO\
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M:=23N]$0W'B/2[77$TB>Y5+ITWC<?E'HI/8GJ!_B,Z<DB11M)(ZHB LS,<
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MS[+XRD\0?;]V]W;R/)QC<"/O;O?TK2G))._8RJ1;<;=SJJ\L^'__ "4#5_\
MKE-_Z-6O4ZY7P_X-_L+Q!=ZK]O\ /^T(Z^5Y.W;N<-UW'/3'2B$DHR3"<6Y1
M:Z'4LH92K %2,$'H:\CLY9?AWXSEBN49M.N!M#A3RA.0P]U/!_'VKUVL[6=$
ML=>L3:7T6Y,Y5E.&0^H/:BG-1T>S'4@Y6:W1:L[VVU"V2YM)XYX7Z/&V1_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@#Y3KZ,\-?\ (JZ/_P!>4/\ Z *^<Z^C/#7_ "*NC_\ 7E#_ .@"O1QG
MPHZL3LC4HHHKSSD"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** /&_BS_P C5:_]>2?^AO6U
M\%_^8W_VP_\ :E8OQ9_Y&JU_Z\D_]#>MKX+_ /,;_P"V'_M2O0E_NW]=SK?\
M$]6HHHKSCE"BBB@ HHHH *S/$/\ R+][_P!<ZTZS/$/_ "+][_USH XWP;_R
M,"?]<VKT6O.O!O\ R,"?]<VKT6FQ(****0PHHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MX4445!84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MOY5Z14-M:6UE"(;6WB@B!R$B0*H_ 5-53ES2N33AR1L%%%%06%%%% !1110
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M3MGT.>+S[>2(2/'O0KOC.&7(QD'U%8'ACP5I?A1[F2Q:XFFN,!Y;AE9@!V!
M& 3R?7CTJXN*U9G-2=E'1'*W$/Q5T^#[9]ML;X!=S6L<:%AWQ]Q<GV!/XUT'
M@GQQ;>+()(9(Q;:E "9;?.05SC<OMR ?0UUM>.V3!OCY.=-9?)\QQ-M)"G$6
M),^OSY_'%4K33NMC.5Z<E9WOH>P22)#$\LKJD: LS,<!0.I)["O,G\=>(_%>
MHRV7@ZQ2.VCX>]N%SCK@\\+G' ()K2^+>K2:=X1%K"2'OI1$Q!_@ );\\ ?C
M6]X+T6+0?"EC:QJ!(\8FF8#[TC $G^0^@%))1CS,J3<I\B=DMSC[W4_B-X3A
M:^U(V.KV2#,IB4#RQGV52/K@@9KM_#?B.R\4:2E_9$CG;)$WWHV]#_0^E:[*
M&4JP!4C!!Z&O)?#"MX3^+5]H,>$L;W<8DW':!MWIC/<#*\T])IZ:H3O3DM;I
MGK=%%%9&X4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'C?Q9_P"1
MJM?^O)/_ $-ZVO@O_P QO_MA_P"U*Q?BS_R-5K_UY)_Z&];7P7_YC?\ VP_]
MJ5Z$O]V_KN=;_@GJU%%%><<H4444 %%%% !69XA_Y%^]_P"N=:=9GB'_ )%^
M]_ZYT <;X-_Y&!/^N;5Z+7G7@W_D8$_ZYM7HM-B04444AA1110 4444 %%%%
M !7%>)_'<>FR/9::J372DJ\C<I&?3W/Z5I>--<;1=$/D,5N;@^7&PZKZM^ _
M4BO(K2TGU"]CMH%+S2MA1_6N'%XB47[.&YC5J->ZBQ>ZWJFHN6NKZ>3_ &=^
M%'T X%4"<G)KU32? ^F6,2M=QB[N,?,7^Z#[+_C6N-"T@#_D%67_ (#I_A6"
MP-66LF9^QD]6SQ2BO;/[#TC_ *!5C_X#I_A1_8>D?] JQ_\  =/\*?\ 9\OY
MA^P?<\3HKVS^P](_Z!5C_P" Z?X4?V'I'_0*L?\ P'3_  H_L^7\P>P?<\3H
MKVS^P](_Z!5C_P" Z?X4?V'I'_0*L?\ P'3_  H_L^7\P>P?<\3HKVS^P](_
MZ!5C_P" Z?X4?V'I'_0*L?\ P'3_  H_L^7\P>P?<\3HKVS^P](_Z!5C_P"
MZ?X4?V'I'_0*L?\ P'3_  H_L^7\P>P?<\3HKVS^P](_Z!5C_P" Z?X4?V'I
M'_0*L?\ P'3_  H_L^7\P>P?<\3HKVS^P](_Z!5C_P" Z?X4?V'I'_0*L?\
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MZ!5C_P" Z?X4?V'I'_0*L?\ P'3_  H_L^7\P>P?<\3HKVS^P](_Z!5C_P"
MZ?X4?V'I'_0*L?\ P'3_  H_L^7\P>P?<\3HKVS^P](_Z!5C_P" Z?X4?V'I
M'_0*L?\ P'3_  H_L^7\P>P?<\3HKVS^P](_Z!5C_P" Z?X4?V'I'_0*L?\
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MZ!5C_P" Z?X4?V'I'_0*L?\ P'3_  H_L^7\P>P?<\3HKVS^P](_Z!5C_P"
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M3UZ%+_=W\SKI_P )_,^@:***\XY0HHHH **** "BBB@ HHHH **** "BBB@
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M;NC:'/<P5:]3DL>ET445@;A1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M+3=GH,GQ;B$F(]&=H_[S7 !_+:?YUM:9XZTO7[2>V^>UO&B?$,O(;@_=;O\
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MZBNG^%7_ "-%S_UY-_Z&E*5&"@Y(<:TW-19T?C'6O"J:H++6]+N;FXA0$21
M#@\XW!P:Z#PGJ&EZAHH?2+1[6TCD:,1NH4YX)/!/KZUYA\2?^1RG_P"N4?\
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M;7S2P.48HB%21Z985-=>/]%MM(@OV:4O<*6CM@!YN 2,L,X4<=S],UY5XO\
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MPN+"830R(0#Q_">.5/''M3A4Y59[$5:/.U);FI11169N%%%% !1110 4444
M9OB&SNM0\/WUK8SRP7;Q'R9(I#&P<<K\P((R0 ?8UQ_PP\5-J.G2:/JEU*=5
MMI& %RY,DBDD_P 7)*G(([#'X>A5R7B3X>:-XBNOMQ,MG?Y!-Q;G!8CH6!X)
M]Q@^]7%JW*S*<9<RE$ZVO(_&5Y'X[\8Z7X=TIA/;VSE[F>-LJ <;B#G!"J/S
M.*U&^&&J7$7V>^\:ZE<6I&#"5;'Y&0C]*Z_P]X6TGPQ;-%IMOM9_]9*YW._I
MD_CT%4G&&J=V3)3J>ZU9&=\0- ?7?!MS:VT1:X@*SP1H.I7L!_NE@!ZXJG\-
M?$\&K^'+?3YIE&HV2"%XF.&95X5@._ P?<<]:[:N)\0?#/2M8OQJ%E/+I=[N
MW,]L!M8_WMO&&]P1^-*,DURR*G&2ESQ.KU/4[/1]/FOKZ98;>(99C_(#N3Z5
MYI\/;6X\2>,M3\8W<12+)2WRO5B-O'/\*#!_WO:M%/A6;RXCDU_Q)J&JI&?E
MC<E?PR68_EBN^L[.VT^TBM+2%(;>(;4C08 %%XQ32W8N64Y)R5DB>BBBLS8*
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#QOXL_\C5:_]>2?^AO6
MU\%_^8W_ -L/_:E8OQ9_Y&JU_P"O)/\ T-ZVO@O_ ,QO_MA_[4KT)?[M_7<Z
MW_!/5J***\XY0HHHH **** "LSQ#_P B_>_]<ZTZS/$/_(OWO_7.@#C?!O\
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M!1110 4444 %%%% !6?K&MZ=H%D+S4[CR+<N(P^QF^8YP,*">QK0KS_XP_\
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M!'J*3BX[A&<9?"QU%%%(H*\Z\)>)]8U/XD:[I-Y>>;8VOVCR8O*1=NV957D
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M4/B1XHC%Y8I9:-:.N8O/3EQG@_,K'IWP 15>Z\4>-_!=Q%)XD@@U'3Y'V&>
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M?Q<_Y@__ &V_]IU!\)O^0AJ7_7)/YFDOX']=QO\ WC^NQZG7SCJ:A=6O%48
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M#@_3-6X1A.,D9QG*=.47T/.M)76#-(VC"^\T+AS9A]V/?;VXK6_XKG_J8O\
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M/_URC_\ 0:['X;P)=>"KJWDSLEGD1L=<%%!I3_A+Y#A_&?S/(XU=Y%6,,7)
M4*.2>V*Z3_BN?^IB_P#(]8E]9W.D:G+:3J8[BW?!_#D$>QX(KU[P_P"/])U.
MTB2^N4L[P+B03':C$=PW3\#CKBM*DFDFE<SI13;3=CSS_BN?^IB_\CUGRZ#X
MAGE>6;2=3DD<[F=[>0ECZDD<UZ]JOCK0M,MV=;V.[E'"Q6[!R3CU' 'O5'0?
MB+IFK.EO=J;*Z<A5#'<C$X'#=N3W_.LU4G:ZB:.E"]G(FTW0SK7P]M-,U-)H
M)?*VCS 0\;*2%.#[8X]*\LUGP]JOAN[_ -)C=5#?N[B(G:WT/:O<M5U6TT73
MY+V]EV1)V[L>R@=R:P-+\<Z!KEJ8KN2*U=AAX;LC8?Q/!Z5G3J35VEH:5*<'
M9-V9QGA[XDW]C(D&JDW=KT,F/WJCZ_Q?C^=>LVMU!>VL5U;2K+#*H9'7H17A
MGC%-%CU]QH;*UOL&\(<H'YSM/<8Q[=<5Z+\+Y99/";K(Q*QW3K&">BX4_P R
M:JM"/+SI6%1G+FY&[G:45DZGXETK1[^"SO[GR9)E+J2IV@>Y[9Y_*M2.2.:,
M21.KHW1E.0?QKF::U.E-/0=6!XU_Y$W4_P#KE_[,*WZS]=M&OM U"U5"[RV[
MJBCJ6VG'ZXIQ=I)BDKQ:/#O"W_(UZ5_U]1_^A"OH&OF^SN7L-0M[I!^\MY5D
M /JIS_2O<[7QEX?NK);D:I;QJ>L<KA'4^FT\_ED5TXF+;31RX:22:9P/Q6_Y
M&"S_ .O4?^AM6I\)5/V756[%XQ^C5R?C?7X/$&O^?:9-M#&(HV(P7P22V/J:
M[GX66;P^'KBZ=2HN)SLR/O*H R/QW#\*<URT;,4'S5[H\AKZ-TN/RM(LH_[D
M"+Q[**^<J^D;'_D'VW_7)?Y"EB=D/"[L\G^*O_(T6W_7DO\ Z&];_P )_P#D
M#W__ %\#_P!!%8'Q5_Y&BV_Z\E_]#>M_X3_\@>__ .O@?^@BB7\!!'^.S@?%
M_P#R-VJ?]?#5ZO\ #Z%(?!5B5',F]V/J=Y'\@!^%>4>+_P#D;M4_Z^&KUSP)
M_P B5IO^Z_\ Z&U%;^&@H?Q6)X]4-X)U('^ZA_\ 'UKR'PM_R->E?]?4?_H0
MKU_QW_R)6I?[J?\ H:UY!X6_Y&O2O^OJ/_T(4Z'\-BK_ ,1'1_%5F/B6U3/R
MBS4@>Y=_\!6Q\)H8Q9:E/@>:9$0GN  3_7]*C^*VENR66JQJQ5,P2GLHZK_[
M-^E<QX*\4_\ "-:BXG4M97.T38ZJ1G##Z9/%"7-1L@;4*]Y'N->?_%>")M%L
M+@G]\EP449_A923^JK73KXL\/M;?:!K%GLQG!E ;_OG[WZ5Y;XX\6)XCNXH;
M0.MC!RN\8+L>K8[>@K*C"7/<VKSCR-7+GPJ_Y&BY_P"O)O\ T-*P/%__ "-V
MJ?\ 7PU;_P *O^1HN?\ KR;_ -#2L#Q?_P C=JG_ %\-70OXK]#E?\)>IZQ\
M/XEB\%:?M !?>S$#&3O;K^&!^%='-#'<0202KNCD4HZ^H(P16!X$_P"1*TW_
M '7_ /0VKHJXY_&SNI_ O0^=M9TZ31M:NK%M^8)"$9A@LO\ "WXC!KTV_P#&
M6_X<)?B3_3KA?LIQCB3'S'';@$_B*S?BKI&V2TUB->&_<2X Z\E3^61^ KS@
MRR&%82[&-6+*F> 3@$_CM'Y"NQ)58ILXFW2E**-?PKHQUWQ#;69!,(/F3$#H
MB]?SX'U(KWU5"J%4 *!@ =!7#_#+1?L.BOJ,JXEO#\N1R(QG'YG)_*NYKFKS
MYI6['3AX<L;]PHHHK$W"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH ^4Z^C/#7_(JZ/_ ->4/_H KYSKZ,\-?\BKH_\ UY0_
M^@"O1QGPHZL3LC4HHHKSSD"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /&_BS_ ,C5:_\
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M?_A&]8_Y\9/S'^-'_"-ZQ_SXR?F/\:+!=GI'V^S_ .?N#_OX*/M]G_S]P?\
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M1VVK]JC"@G_>4D#\2*\WT3X3Z_J-Y)'J*C3(8^LCXD+'G[H4X/3U'XUF^,?
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M92WJ B8_F?SHAI%RZCJ+FG&'0[S3M)T_2;9+>PM(K>-!@!%Y_$]3^-<WXN\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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ME%2YCE?%W@NW\2*+B)Q!?HNU9#]UQGHP_/D?K7E]]X,\0V$I1]+GE'4- OF
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M5O=W.,\,^']2^(&N?\)+XB_Y!Z-^Y@(^60 \*H_N ]3W.>O)'L"J%4*H 4#
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110!SNJ^!]!U:0RRVGDS$Y,ENVPGZCI^E
M9/\ PJO0MV?M.H8ST\Q,?^@5W%%6JDULR'2@]6C!T?P=HFB3">UM-TXZ2S'>
MR_3/ ^HYK>HHJ6V]64HI*R"BBBD,**** "BBB@ HHHH **** "BBB@ HHHH
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MO_![_F,_]L/_ &I7J%>7_![_ )C/_;#_ -J5ZA2Q/\5DUOC84445@9!1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M445RG6%%%07-Y:V2;[JYA@0_Q2R!1^M $]%4[;5],O9!':ZC:3R'HL4ZL3^
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MH:L"=PHHHH **@N;RULDWW5S# A_BED"C]:BMM7TR]D$=KJ-I/(>BQ3JQ/X
MT[,5UL7*SM=OY=+T*]OH%1I8(BZAP2I(]<8K1K%\7_\ (HZI_P!>[4XZR0I.
MT6<-I/Q*UF_UFQLY;:P$<]Q'$Q6-\@,P!Q\W7FO4Z^>O#G_(T:3_ -?L/_H8
MKZ%K;$146K&.'G*2=PHHJA-K>DVTC1SZI912*2"LEPBD'TP36"3>QNVEN7Z*
MC@N(;F,26\T<L9_BC8,/S%24AA114%U>VEC&)+NZAMT/1I9 @_,T 3T5#;7=
MM>1>;:W$4\><;XG##/U%34 %%%% !16<VOZ,C[&U:P5O[IN4!_G5^.2.:,21
M.KHW1E.0?QIM-"33V'4444AA139)(X8S)*ZHB]68X _&L\^(=%#;3K&GAO3[
M2F?YTTF]A-I;FE13(IHITWPR)(O]Y&!'Z4^D,***KW-]:68S=74$ QG,L@7^
M= %BBL^+7='G;;%JMC(Q[)<(3_.M"FTUN)-/8****0PHHHH **** "BD9@JE
MF("@9)/05GG7]&$AC.K6 <?P_:4S^6::38FTMS1HI$=9$5T8,K#(8'((]:6D
M,***HW&M:5:2&.YU.SAD'59)U4_D30E<3:6Y>HJ*WNK>[C\RVGBFCSC=&X89
M],BI:!A1110 45%<7,%I$9;F:.&,=7D<*!^)J"VU?3+V01VNHVD\AZ+%.K$_
M@#3LQ71<HHHI#"BF2S10)OFD2-?[SL /UJ@/$.BEMHUC3RWI]I3/\Z:38FTM
MS2HIL<D<T8DB=71NC*<@_C3J0PHHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ^4Z^C/#7_ "*NC_\ 7E#_
M .@"OG.OHSPU_P BKH__ %Y0_P#H KT<9\*.K$[(U****\\Y HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@#QOXL_\ (U6O_7DG_H;UM?!?_F-_]L/_ &I6+\6?^1JM?^O)
M/_0WK:^"_P#S&_\ MA_[4KT)?[M_7<ZW_!/5J***\XY0HHHH **** "BBB@
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MY]K[_OA/_BJ/K-'^8/:1[G745R/_  L72/\ GVOO^^$_^*H_X6+I'_/M??\
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MB0)'&H5%'0 < 5S8*$I2=5D44VW)CZ***](Z HHHH \'\/\ _(R:7_U]Q?\
MH8KWBO!_#_\ R,FE_P#7W%_Z&*]XKT<Q^*)X>1_PY^H4445YQ[@4444 %%%%
M !1110 4444 %>*?&#_D;;7_ *\4_P#1DE>UUXI\8/\ D;;7_KQ3_P!&25TX
M3^(;4/C+_P 'O^8S_P!L/_:E>H5Y?\'O^8S_ -L/_:E>H4L3_%9-;XV%%%%8
M&04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 <'\6?^15M?^OU/_0'KAOAM_R4#3/^
MVO\ Z*>NY^+/_(JVO_7ZG_H#UPWPV_Y*!IG_ &U_]%/7H4O]W?S.NG_"?S/H
M&BBBO..4**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MI[F0:'>OOVH3;2-UP.J'UXY'T(]*FK2O[Z=RZ-6SY)*QZ11117*=1\]>(_\
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M8Q@ =_<^IJEXCT"V\0Z3+:S(@F"DP2D<QOV.?3@9]14K$J]K:%/#.U[ZG'>
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M;(@/0#9N 'XAOSI5HJ45-#HR<9.$BAXZ\<7#WDNDZ5<>7!'\LTT9^9V[J#V
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M_H KT<9\*.K$[(U****\\Y HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M^1X__BJ/^$%\2?\ 0._\CQ__ !5>RT4OJ%/N_P"OD'L(GC7_  @OB3_H'?\
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M6M=N[]VRLDA\L>B#A1^0%9M:_AC2CK/B*SL]NZ,N'E_W!R?TX_&OH!5"J%4
M*!@ =!7;4JJG:*1PTZ3JWDV?-%%?3%>;?%722T5GJZ?P?Z/(/8Y93^>[\Q4P
MQ'-*UBJF'Y8WN='X"U4:IX4M0S[IK8>1)T_A^[_X[C]:XWXL?\ABP_Z]S_Z$
M:K_#'5ELM>EL)7VQWB87/3S%Y'Z%A]<58^+'_(8L/^O<_P#H1J8QY:Q4I<U
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MY;\.?"DS7::W?1%(HP?LR,.6;INQZ#G'OSVKOO$6K#1-!N[_ (+QIA 3U8G
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M+'KQ_=)[]NGIGE]+U[5-%8G3KV2 ,<E1@J3C&2IR#^57.*K13B1";HR:DCZ
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ML1LC6HHHKSSD"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** /&_BS_R-5K_UY)_Z&];7P7_Y
MC?\ VP_]J5A_%=U?Q9 JD$I9HK>QWN?Y$5N_!A2$UI\<$P ?AO\ \:]"?^[?
MUW.M_P $]5HHHKSCE"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M%%%><<H4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M1Q(L:#T &!4M%%<QU!1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_P"3,7_Q5/V6'[_B'LZ7?\3N?^%LZ#_SZ:E_W[3_ .+H_P"%LZ#_ ,^FI?\
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M_$[G_A;.@_\ /IJ7_?M/_BZ/^%LZ#_SZ:E_W[3_XNN&_X5MXM_Z!/_DS%_\
M%4?\*V\6_P#0)_\ )F+_ .*H]EA^_P"(>SI=_P 3N?\ A;.@_P#/IJ7_ '[3
M_P"+H_X6SH/_ #Z:E_W[3_XNN&_X5MXM_P"@3_Y,Q?\ Q5'_  K;Q;_T"?\
MR9B_^*H]EA^_XA[.EW_$[G_A;.@_\^FI?]^T_P#BZ/\ A;.@_P#/IJ7_ '[3
M_P"+KAO^%;>+?^@3_P"3,7_Q5'_"MO%O_0)_\F8O_BJ/98?O^(>SI=_Q.Y_X
M6SH/_/IJ7_?M/_BZ/^%LZ#_SZ:E_W[3_ .+KAO\ A6WBW_H$_P#DS%_\51_P
MK;Q;_P! G_R9B_\ BJ/98?O^(>SI=_Q.Y_X6SH/_ #Z:E_W[3_XNC_A;.@_\
M^FI?]^T_^+KAO^%;>+?^@3_Y,Q?_ !5'_"MO%O\ T"?_ "9B_P#BJ/98?O\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 17433VDT2D!GC903TR1BO+O
M^%9ZU_S]6'_?Q_\ XBO5J*WI8B=*_+U.3$X*EB6G4Z'E/_"L]:_Y^K#_ +^/
M_P#$4?\ "L]:_P"?JP_[^/\ _$5ZM16OUZL<W]CX7L_O/*?^%9ZU_P _5A_W
M\?\ ^(H_X5GK7_/U8?\ ?Q__ (BO5J*/KU8/['PO9_>>::7\/-6LM6LKN2XL
MC'!.DC!7?)"L"<?+UXKTNBBL*M:=5IR.O#86GADU3ZA11161TA1110 4444
M%%%% !1110 5Y;\7]%FECL]9B0M'"IAG(_A!.5/TR2/Q%>I5%=6L%[:RVUS&
MLL$JE'1NC UI2GR24BH2Y97/G;PIXGG\+ZF;A(_-@E 6:+.-P[$'U%>BCXM:
M%@9L]1![XC3_ .+K*\0?"2Z2=IM"F26 \^1.^'7V#="/KC\:YT_#7Q:#C^RL
M^XN8O_BJ[I>PJ^\V=+]E/5L[C_A;.@_\^FI?]^T_^+H_X6SH/_/IJ7_?M/\
MXNN&_P"%;>+?^@3_ .3,7_Q5'_"MO%O_ $"?_)F+_P"*I>RP_?\ $7LZ7?\
M$[G_ (6SH/\ SZ:E_P!^T_\ BZ/^%LZ#_P ^FI?]^T_^+KAO^%;>+?\ H$_^
M3,7_ ,51_P *V\6_] G_ ,F8O_BJ/98?O^(>SI=_Q.Y_X6SH/_/IJ7_?M/\
MXNC_ (6SH/\ SZ:E_P!^T_\ BZX;_A6WBW_H$_\ DS%_\51_PK;Q;_T"?_)F
M+_XJCV6'[_B'LZ7?\3N?^%LZ#_SZ:E_W[3_XNC_A;.@_\^FI?]^T_P#BZX;_
M (5MXM_Z!/\ Y,Q?_%4?\*V\6_\ 0)_\F8O_ (JCV6'[_B'LZ7?\3N?^%LZ#
M_P ^FI?]^T_^+H_X6SH/_/IJ7_?M/_BZX;_A6WBW_H$_^3,7_P 51_PK;Q;_
M - G_P F8O\ XJCV6'[_ (A[.EW_ !.Y_P"%LZ#_ ,^FI?\ ?M/_ (NC_A;.
M@_\ /IJ7_?M/_BZX;_A6WBW_ *!/_DS%_P#%4?\ "MO%O_0)_P#)F+_XJCV6
M'[_B'LZ7?\3N?^%LZ#_SZ:E_W[3_ .+H_P"%LZ#_ ,^FI?\ ?M/_ (NN&_X5
MMXM_Z!/_ ),Q?_%4?\*V\6_] G_R9B_^*H]EA^_XA[.EW_$[G_A;.@_\^FI?
M]^T_^+H_X6SH/_/IJ7_?M/\ XNN&_P"%;>+?^@3_ .3,7_Q5'_"MO%O_ $"?
M_)F+_P"*H]EA^_XA[.EW_$[G_A;.@_\ /IJ7_?M/_BZ/^%LZ#_SZ:E_W[3_X
MNN&_X5MXM_Z!/_DS%_\ %4?\*V\6_P#0)_\ )F+_ .*H]EA^_P"(>SI=_P 3
MN?\ A;.@_P#/IJ7_ '[3_P"+H_X6SH/_ #Z:E_W[3_XNN&_X5MXM_P"@3_Y,
MQ?\ Q5'_  K;Q;_T"?\ R9B_^*H]EA^_XA[.EW_$[G_A;.@_\^FI?]^T_P#B
MZ/\ A;.@_P#/IJ7_ '[3_P"+KAO^%;>+?^@3_P"3,7_Q5'_"MO%O_0)_\F8O
M_BJ/98?O^(>SI=_Q.Y_X6SH/_/IJ7_?M/_BZ/^%LZ#_SZ:E_W[3_ .+KAO\
MA6WBW_H$_P#DS%_\51_PK;Q;_P! G_R9B_\ BJ/98?O^(>SI=_Q.Y_X6SH/_
M #Z:E_W[3_XNC_A;.@_\^FI?]^T_^+KAO^%;>+?^@3_Y,Q?_ !5'_"MO%O\
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M;>+?^@3_ .3,7_Q5'_"MO%O_ $"?_)F+_P"*H]EA^_XA[.EW_$[G_A;.@_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MK+EA/7[OS-NBBBN<[ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MZ@\&O%=1LY-*U6XM"S;H9"H;&TD=C^(P?QHP35:C*A+^OZ8\R3PV(ABH?/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MZX]B%->FWE[;:?:O<W<R0PH,L[G'_P"L^U>5^"0^M_$.YU9(]D2&6<@]M^5
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M%A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MXUTW7X8XWD2VO\8:!SC<?]DGKGTZUTU<+XC^'%G?;[K2"+2[Y;R\_NW.<_\
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M7]B7)Q^1!_&O5:WJMN,6S"BDI22/)_AQ_P COJ7_ %[R_P#HQ*]8KR?X<?\
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M12S$]@.M>3^!['_A)_%EYK%^%D$#"4HP!!=L[?RP?R%>IWD!N;&X@4@-+$R
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M\K_^AM1?]S\Q6_??(Z.O*_AM_P CAJO_ %R?_P!&"O5*\K^&W_(X:K_UR?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M2#C=NEPN?+;&"3_LL,@__7KHM%^(&BZG;)]IN$LKG WI,<+GV;IBNJ90RE6
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M8-2L)[*Y4M#,A1@#@_A5FBLS0\@TZ_U+X<:[)9WT1FL)CD[!]\=G3/<=Q_\
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MN9>1TY!!I]A86VF645G9Q^7;Q A$W$XR<]3SU-+F7)RE<C]IS>19KROX;?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M RLIR"#T(-1.#AN7"HIK0=1114%A17)?$+6_[)\./;QMBYO<PI[+_&?R./\
M@0J/X<ZV-3\/K9R/FXLL1X/4I_"?P''X5?LWR<YG[1<_(=C1114&@45Y/\6/
M^0Q8?]>Y_P#0C7K%7*%HI]R(SYI./8****@L*9--%;Q-+/*D4:_>=V"@?4FL
M[Q#K4.@:--?RC<5&V-/[[GH/\?8&O.-,T#6O'TIU35+UH;3.V,[<@XX(1>@
MQR?7UYK2%.ZYF[(SG4L^5*[/2X]=T>63RX]5L7D_NK<(3^6:T*\_NOA1IK0G
M['?W<<N#@S;77/X 5D:%K&J^#/$*:%J[,]G(P52S$J@)P'0_W?4?7N#5>SC)
M>XR?:2B_?1ZO117D_AG_ )*U?_\ 7Q=?^A-41AS)OL7.?*TNYZQ139)$BC:2
M1U1$!9F8X  ZDFO+O$7BB\\77RZ#X?1S;N<22=/, [GT3^?Z40@Y,)S4$>IU
M2U35K+1K3[5?RF*#<$WB-GP3TSM!Q]:S?"_A2S\-6I$?[V[D \V=AR?9?1<_
M_7[5<\16']J>';^S";WDA;8/5QROZ@4K1YK=!WERWZEG3M2M-6LDO+&830.2
M%8 CH<'@X(JU7G'PHU%GMK_36)(C83)SZ\'^0_.O1Z=2/+)H5.?/%,****@L
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH ***HZSJ4>CZ/=:A*,K"F0/4] /S(
MII7=A-V5RCXB\5:=X;A4W3,]PXS'!'RS>Y]![GWQFN,7XB>)-0D+:7H221]<
M"&28X^JD?RJMX0T"7Q=JEQKFM,TT(D^ZP.)&]/\ =' Q^%>K1QQPQB.)%1%Z
M*HP!^%;/DIZ6NS!<]36]D>>V7Q,EM[D6^O:5):MN(+H&!7ZHW/Z_A6MXA\=0
MZ+<6206BWL5W&)$E6?:,$X_NG-=%J>E66L6;6M];I+&PXR.5/J#V->'Z_I-S
MH.O#39I'DAC8/;LW0HQSD?J#[@U5.-.H]K$U)5*:WN>^5REMXT%QXPET%K$1
MK&S@W!FX^52<[=OMZUU=>&:[;W%YX^OK2U8B:XNFB&#C[W!S[8-12@I73-*T
MW"S1V^K?$F)+LV6A63:A/G:LF#M)]E RWIV_&LMOB+XBTZ5#JVAI%&QZ&*2$
MGZ%B?Y5WF@Z#9>']/6UM(QN(!EE(^:1O4_X=JOW%M#=V\EO<1)+#(,,CC((H
MYZ:TY0Y*CU<M2CH6NV7B#3Q=V;G .V1&&&1L9P?\:TZ\H\'*^@?$:[T<-NBD
M\R(>X4;U/UP/UKT^_O8=.L)[VX.(H$+MCJ0!T'N>@J:D.65D53GS1N^AGZ_X
MET[PY:B6\D)D<?NX4Y=_\![FN(_X6-X@U"9O[)T)9(QR%\N29L=\E<=_:J/A
MK2IO'7B&YU75F8VT3 LBDX8]HQSPH'7_ .OFO6H88K>)8H(DBC7[J(H4#Z 5
M;4*>C5V9ISJ:IV1YW:_$N\M)UAUW1W@R<%XU9".>?E;K^=5/BC=V]]::%=6L
MJRP2K,R.O0CY*](U#3K35+-[2^@2:!^JM_,'J#[BO$/%FBW'A[5#I[2N]GEI
MK;)R-K<'\?E /T%72Y)236C(K<\8--W1[E8_\@^V_P"N2_R%3U!8_P#(/MO^
MN2_R%3US/<ZEL%>1>,6FT/XCQ:M)$6B9XIDQ_&JJJL/KP?S%>NUEZ]H%EXAL
M#:WB'@[HY%^]&WJ/\*NE-1EJ15@Y1TW+6G:C:ZK8QWEG*)(9!D$=O8^AJU7C
M1&O_  XU7((FLY3[^5+_ /$L/S^HKU#P_P"(++Q%IXNK1L,O$L3'YHV]#[>A
M[_G3G3Y=5JA4ZO-H]&:M>3_$?_D=]-_Z]XO_ $8]>L5Y/\1_^1WTW_KWB_\
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MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "LS5O#VEZZ8C
MJ5L9_*SL'FNH&>O"D>E:=%--K5":3T9';P16MM%;P)LBB0(BYZ*!@#\JDHHI
M#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "HS<0*2#-&".""PJ2N8E\*>9,[_ &W&
MYB<>5_\ 7IB;?0Z+[3;_ //>+_OL4?:;?_GO%_WV*YK_ (1'_I^_\A?_ &5'
M_"(_]/W_ )"_^RHT)O+L=+]IM_\ GO%_WV*/M-O_ ,]XO^^Q7-?\(C_T_?\
MD+_[*C_A$?\ I^_\A?\ V5&@7EV.E^TV_P#SWB_[[%'VFW_Y[Q?]]BN:_P"$
M1_Z?O_(7_P!E1_PB/_3]_P"0O_LJ- O+L=+]IM_^>\7_ 'V*/M-O_P ]XO\
MOL5S7_"(_P#3]_Y"_P#LJ/\ A$?^G[_R%_\ 94:!>78Z7[3;_P#/>+_OL4?:
M;?\ Y[Q?]]BN:_X1'_I^_P#(7_V5'_"(_P#3]_Y"_P#LJ- O+L=+]IM_^>\7
M_?8H^TV__/>+_OL5S7_"(_\ 3]_Y"_\ LJ/^$1_Z?O\ R%_]E1H%Y=CI?M-O
M_P ]XO\ OL4?:;?_ )[Q?]]BN:_X1'_I^_\ (7_V5'_"(_\ 3]_Y"_\ LJ-
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M *?O_(7_ -E1H%Y=CI?M-O\ \]XO^^Q1]IM_^>\7_?8KFO\ A$?^G[_R%_\
M94?\(C_T_?\ D+_[*C0+R['2_:;?_GO%_P!]BC[3;_\ />+_ +[%<U_PB/\
MT_?^0O\ [*C_ (1'_I^_\A?_ &5&@7EV.E^TV_\ SWB_[[%'VFW_ .>\7_?8
MKFO^$1_Z?O\ R%_]E1_PB/\ T_?^0O\ [*C0+R['2_:;?_GO%_WV*/M-O_SW
MB_[[%<U_PB/_ $_?^0O_ +*C_A$?^G[_ ,A?_94:!>78Z7[3;_\ />+_ +[%
M'VFW_P">\7_?8KFO^$1_Z?O_ "%_]E1_PB/_ $_?^0O_ +*C0+R['2_:;?\
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M_P#3]_Y"_P#LJ- O+L=+]IM_^>\7_?8H^TV__/>+_OL5S7_"(_\ 3]_Y"_\
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M.E^TV_\ SWB_[[%'VFW_ .>\7_?8KFO^$1_Z?O\ R%_]E1_PB/\ T_?^0O\
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ME1H%Y=CI?M-O_P ]XO\ OL4?:;?_ )[Q?]]BN:_X1'_I^_\ (7_V5'_"(_\
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M )"_^RH_X1'_ *?O_(7_ -E1H%Y=CI?M-O\ \]XO^^Q1]IM_^>\7_?8KFO\
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M0+R['2_:;?\ Y[Q?]]BC[3;_ //>+_OL5S7_  B/_3]_Y"_^RH_X1'_I^_\
M(7_V5&@7EV.E^TV__/>+_OL4?:;?_GO%_P!]BN:_X1'_ *?O_(7_ -E1_P (
MC_T_?^0O_LJ- O+L=+]IM_\ GO%_WV*/M-O_ ,]XO^^Q7-?\(C_T_?\ D+_[
M*C_A$?\ I^_\A?\ V5&@7EV.E^TV_P#SWB_[[%'VFW_Y[Q?]]BN:_P"$1_Z?
MO_(7_P!E1_PB/_3]_P"0O_LJ- O+L=+]IM_^>\7_ 'V*/M-O_P ]XO\ OL5S
M7_"(_P#3]_Y"_P#LJ/\ A$?^G[_R%_\ 94:!>78Z7[3;_P#/>+_OL4?:;?\
MY[Q?]]BN:_X1'_I^_P#(7_V5'_"(_P#3]_Y"_P#LJ- O+L=+]IM_^>\7_?8H
M^TV__/>+_OL5S7_"(_\ 3]_Y"_\ LJ/^$1_Z?O\ R%_]E1H%Y=CI?M-O_P ]
MXO\ OL4?:;?_ )[Q?]]BN:_X1'_I^_\ (7_V5'_"(_\ 3]_Y"_\ LJ- O+L=
C.DT4APDB,>N%8&BL;2= _LV\\_[3YGRE=OEX_K12*7F?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>24
<FILENAME>eq-20221231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2023-03-23T11:19:39.0414+00:00 -->
<!-- Copyright (c) 2023 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" xlink:type="simple"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" xlink:type="simple"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" xlink:type="simple"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" xlink:type="simple"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" xlink:type="simple"/>
  <link:roleRef roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity" xlink:href="eq-20221231.xsd#Role_StatementConsolidatedStatementsOfStockholdersEquity" xlink:type="simple"/>
  <link:roleRef roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" xlink:href="eq-20221231.xsd#Role_StatementConsolidatedStatementsOfCashFlows" xlink:type="simple"/>
  <link:roleRef roleURI="http://equilliumbio.com/20221231/taxonomy/role/DisclosureOrganizationAndAccountingPronouncementsAdditionalInformationDetails1" xlink:href="eq-20221231.xsd#DisclosureOrganizationAndAccountingPronouncementsAdditionalInformationDetails1" xlink:type="simple"/>
  <link:roleRef roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" xlink:href="eq-20221231.xsd#Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfPotentiallyDilutiveSecuritiesNotIncludedInCalculationOfDilutedNetLossPerShareDetails" xlink:href="eq-20221231.xsd#Role_DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfPotentiallyDilutiveSecuritiesNotIncludedInCalculationOfDilutedNetLossPerShareDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfAssetsThatRequireFairValueMeasurementsOnRecurringBasisAndTheirRespectiveInputLevelsBasedOnFairValueHierarchyDetails" xlink:href="eq-20221231.xsd#Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfAssetsThatRequireFairValueMeasurementsOnRecurringBasisAndTheirRespectiveInputLevelsBasedOnFairValueHierarchyDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetails" xlink:href="eq-20221231.xsd#Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureShortTermInvestmentsScheduleOfCompanySShortTermInvestmentsDetails" xlink:href="eq-20221231.xsd#Role_DisclosureShortTermInvestmentsScheduleOfCompanySShortTermInvestmentsDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureShortTermInvestmentsAdditionalInformationDetails" xlink:href="eq-20221231.xsd#Role_DisclosureShortTermInvestmentsAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosurePropertyAndEquipmentScheduleOfPropertyAndEquipmentDetails" xlink:href="eq-20221231.xsd#Role_DisclosurePropertyAndEquipmentScheduleOfPropertyAndEquipmentDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://equilliumbio.com/20221231/taxonomy/role/DisclosureAcquisitionAdditionalInformationDetails" xlink:href="eq-20221231.xsd#DisclosureAcquisitionAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://equilliumbio.com/20221231/taxonomy/role/DisclosureAcquisitionSummaryOfPurchasePriceAllocationDetails" xlink:href="eq-20221231.xsd#DisclosureAcquisitionSummaryOfPurchasePriceAllocationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://equilliumbio.com/20221231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails" xlink:href="eq-20221231.xsd#DisclosureLeasesAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://equilliumbio.com/20221231/taxonomy/role/DisclosurePartnershipsAdditionalInformationDetails" xlink:href="eq-20221231.xsd#DisclosurePartnershipsAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureNotesPayableAdditionalInformationDetails" xlink:href="eq-20221231.xsd#Role_DisclosureNotesPayableAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://equilliumbio.com/20221231/taxonomy/role/DisclosureNotesPayableScheduleOfAggregateCarryingAmountsOfTermLoanDetails" xlink:href="eq-20221231.xsd#DisclosureNotesPayableScheduleOfAggregateCarryingAmountsOfTermLoanDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetails" xlink:href="eq-20221231.xsd#Role_DisclosureStockholdersEquityAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquitySummaryOfStockOptionActivityDetails" xlink:href="eq-20221231.xsd#Role_DisclosureStockholdersEquitySummaryOfStockOptionActivityDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquitySummaryOfStockOptionActivityParentheticalDetails" xlink:href="eq-20221231.xsd#Role_DisclosureStockholdersEquitySummaryOfStockOptionActivityParentheticalDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquitySummaryOfTotalNonCashStockBasedCompensationExpenseDetails" xlink:href="eq-20221231.xsd#Role_DisclosureStockholdersEquitySummaryOfTotalNonCashStockBasedCompensationExpenseDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquitySummaryOfCommonStockReservedForFutureIssuanceDetails" xlink:href="eq-20221231.xsd#Role_DisclosureStockholdersEquitySummaryOfCommonStockReservedForFutureIssuanceDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" xlink:href="eq-20221231.xsd#Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails" xlink:href="eq-20221231.xsd#Role_DisclosureIncomeTaxesAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureSubsequentEventsAdditionalInformationDetails" xlink:href="eq-20221231.xsd#Role_DisclosureSubsequentEventsAdditionalInformationDetails" xlink:type="simple"/>
  <link:definitionLink xlink:type="extended" xlink:role="http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_ATMMember" xlink:label="eq_ATMMember"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_BionizTherapeuticsIncMember" xlink:label="eq_BionizTherapeuticsIncMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_RegisteredDirectOfferingsMember" xlink:label="eq_RegisteredDirectOfferingsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssued" xlink:label="us-gaap_SharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueOther" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="eq_ATMMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="eq_BionizTherapeuticsIncMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="eq_RegisteredDirectOfferingsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesIssued" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_BusinessAcquisitionAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueOther" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesOther" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_RetainedEarningsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTax" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_FollowOnOfferingMember" xlink:label="eq_FollowOnOfferingMember"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_BionizTherapeuticsIncMember" xlink:label="eq_BionizTherapeuticsIncMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_LincolnParkCapitalFundLLCMember" xlink:label="eq_LincolnParkCapitalFundLLCMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet" xlink:label="us-gaap_InterestPaidNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentInProcess" xlink:label="us-gaap_ResearchAndDevelopmentInProcess"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="us-gaap_RepaymentsOfNotesPayable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOfAssetsAcquired" xlink:label="us-gaap_FairValueOfAssetsAcquired"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireShortTermInvestments" xlink:label="us-gaap_PaymentsToAcquireShortTermInvestments"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAndAmortization" xlink:label="us-gaap_DepreciationAndAmortization"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAssumed1" xlink:label="us-gaap_LiabilitiesAssumed1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" xlink:label="us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockPlans" xlink:label="us-gaap_ProceedsFromStockPlans"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAcquiredFromAcquisition" xlink:label="us-gaap_CashAcquiredFromAcquisition"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossUnrealized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:label="us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:label="us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_IncreaseDecreaseInRightOfUseAssetsAndLeaseLiabilitiesNet" xlink:label="eq_IncreaseDecreaseInRightOfUseAssetsAndLeaseLiabilitiesNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssued1" xlink:label="us-gaap_StockIssued1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="srt_CounterpartyNameAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="eq_FollowOnOfferingMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="eq_BionizTherapeuticsIncMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="eq_LincolnParkCapitalFundLLCMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_InterestPaidNet" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ProfitLoss" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentInProcess" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_RepaymentsOfNotesPayable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_FairValueOfAssetsAcquired" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquireShortTermInvestments" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_DepreciationAndAmortization" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_BusinessAcquisitionAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_LiabilitiesAssumed1" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ShareBasedCompensation" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromStockPlans" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_CashAcquiredFromAcquisition" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ForeignCurrencyTransactionGainLossUnrealized" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_CapitalExpendituresIncurredButNotYetPaid" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AmortizationOfFinancingCostsAndDiscounts" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="eq_IncreaseDecreaseInRightOfUseAssetsAndLeaseLiabilitiesNet" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_StockIssued1" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInDeferredRevenue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://equilliumbio.com/20221231/taxonomy/role/DisclosureOrganizationAndAccountingPronouncementsAdditionalInformationDetails1">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:label="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:label="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="us-gaap_TypeOfAdoptionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdate201613Member" xlink:label="us-gaap_AccountingStandardsUpdate201613Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="us-gaap_TypeOfAdoptionMember_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:to="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TypeOfAdoptionMember" xlink:to="us-gaap_AccountingStandardsUpdate201613Member" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="us-gaap_TypeOfAdoptionMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="us-gaap_TypeOfAdoptionMember_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_SummaryOfSignificantAccountingPoliciesLineItems" xlink:label="eq_SummaryOfSignificantAccountingPoliciesLineItems"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_SummaryOfSignificantAccountingPoliciesTable" xlink:label="eq_SummaryOfSignificantAccountingPoliciesTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="srt_RangeMember_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameDomain" xlink:label="us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AustralianTaxationOfficeMember" xlink:label="us-gaap_AustralianTaxationOfficeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameAxis" xlink:label="us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameDomain" xlink:label="us-gaap_IncomeTaxAuthorityNameDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardAxis" xlink:label="us-gaap_TaxCreditCarryforwardAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardNameDomain" xlink:label="us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardNameDomain" xlink:label="us-gaap_TaxCreditCarryforwardNameDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_AustralianResearchAndDevelopmentTaxIncentiveProgramMember" xlink:label="eq_AustralianResearchAndDevelopmentTaxIncentiveProgramMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_ResearchAndDevelopmentTaxIncentiveRevenueCriteria" xlink:label="eq_ResearchAndDevelopmentTaxIncentiveRevenueCriteria"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_PercentageOfTaxBenefitToBeRealizedUponUltimateSettlementWithTaxAuthority" xlink:label="eq_PercentageOfTaxBenefitToBeRealizedUponUltimateSettlementWithTaxAuthority"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_PrepaidAndOtherCurrentAssetsTaxIncentive" xlink:label="eq_PrepaidAndOtherCurrentAssetsTaxIncentive"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="us-gaap_AccountsReceivableNetCurrent"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="eq_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="eq_SummaryOfSignificantAccountingPoliciesTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxAuthorityNameDomain" xlink:to="us-gaap_AustralianTaxationOfficeMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeTaxAuthorityNameAxis" xlink:to="us-gaap_IncomeTaxAuthorityNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeTaxAuthorityNameAxis" xlink:to="us-gaap_IncomeTaxAuthorityNameDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TaxCreditCarryforwardAxis" xlink:to="us-gaap_TaxCreditCarryforwardNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_TaxCreditCarryforwardAxis" xlink:to="us-gaap_TaxCreditCarryforwardNameDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TaxCreditCarryforwardNameDomain" xlink:to="eq_AustralianResearchAndDevelopmentTaxIncentiveProgramMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="eq_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="eq_SummaryOfSignificantAccountingPoliciesTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="eq_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="eq_ResearchAndDevelopmentTaxIncentiveRevenueCriteria" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="eq_SummaryOfSignificantAccountingPoliciesTable" xlink:to="us-gaap_IncomeTaxAuthorityNameAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="eq_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="eq_PercentageOfTaxBenefitToBeRealizedUponUltimateSettlementWithTaxAuthority" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="eq_SummaryOfSignificantAccountingPoliciesTable" xlink:to="us-gaap_TaxCreditCarryforwardAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="eq_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="eq_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="eq_PrepaidAndOtherCurrentAssetsTaxIncentive" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="eq_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_AccountsReceivableNetCurrent" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfPotentiallyDilutiveSecuritiesNotIncludedInCalculationOfDilutedNetLossPerShareDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_WarrantMember" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfAssetsThatRequireFairValueMeasurementsOnRecurringBasisAndTheirRespectiveInputLevelsBasedOnFairValueHierarchyDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasurySecuritiesMember" xlink:label="us-gaap_USTreasurySecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByAssetClassAxis" xlink:label="us-gaap_FairValueByAssetClassAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsFairValueDisclosure" xlink:label="us-gaap_InvestmentsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CertificatesOfDepositMember" xlink:label="us-gaap_CertificatesOfDepositMember"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="us-gaap_USTreasurySecuritiesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByAssetClassAxis" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByAssetClassAxis" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_InvestmentsFairValueDisclosure" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel1Member" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="us-gaap_CertificatesOfDepositMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByAssetClassAxis" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:label="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTable" xlink:label="us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesPayable" xlink:label="us-gaap_NotesPayable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:label="us-gaap_FinancialLiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_FairValueByBalanceSheetGroupingTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_NotesPayable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_FinancialLiabilitiesFairValueDisclosure" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureShortTermInvestmentsScheduleOfCompanySShortTermInvestmentsDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_USTreasurySecuritiesMaturingInOneYearOrLessMember" xlink:label="eq_USTreasurySecuritiesMaturingInOneYearOrLessMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTerm" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTerm"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_USTreasurySecuritiesMaturingBetweenOneAndFiveYearsMember" xlink:label="eq_USTreasurySecuritiesMaturingBetweenOneAndFiveYearsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_CertificatesOfDepositMaturingInOneYearOrLessMember" xlink:label="eq_CertificatesOfDepositMaturingInOneYearOrLessMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="eq_USTreasurySecuritiesMaturingInOneYearOrLessMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="us-gaap_FinancialInstrumentAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleTerm" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="eq_USTreasurySecuritiesMaturingBetweenOneAndFiveYearsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="eq_CertificatesOfDepositMaturingInOneYearOrLessMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureShortTermInvestmentsAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_AvailableForSaleSecuritiesDebtMaturitiesPeriod" xlink:label="eq_AvailableForSaleSecuritiesDebtMaturitiesPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:label="us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="eq_AvailableForSaleSecuritiesDebtMaturitiesPeriod" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosurePropertyAndEquipmentScheduleOfPropertyAndEquipmentDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="us-gaap_FurnitureAndFixturesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MachineryAndEquipmentMember" xlink:label="us-gaap_MachineryAndEquipmentMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComputerEquipmentMember" xlink:label="us-gaap_ComputerEquipmentMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_FurnitureAndFixturesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_MachineryAndEquipmentMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_ComputerEquipmentMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_LeaseholdImprovementsMember" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://equilliumbio.com/20221231/taxonomy/role/DisclosureAcquisitionAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_BionizTherapeuticsIncMember" xlink:label="eq_BionizTherapeuticsIncMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationTypeDomain" xlink:label="us-gaap_ContingentConsiderationTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_ContingentConsiderationForAchievementOfRegulatoryEventsMember" xlink:label="eq_ContingentConsiderationForAchievementOfRegulatoryEventsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityInterestIssuedOrIssuableTypeDomain" xlink:label="us-gaap_EquityInterestIssuedOrIssuableTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_EighteenMonthsAfterClosingMember" xlink:label="eq_EighteenMonthsAfterClosingMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:label="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityInterestIssuedOrIssuableTypeDomain" xlink:label="us-gaap_EquityInterestIssuedOrIssuableTypeDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:label="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationByTypeAxis" xlink:label="us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationTypeDomain" xlink:label="us-gaap_ContingentConsiderationTypeDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_ContingentConsiderationForAchievementOfCommercializationEventsMember" xlink:label="eq_ContingentConsiderationForAchievementOfCommercializationEventsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:label="us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_TermsOfMergerAgreement" xlink:label="eq_TermsOfMergerAgreement"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:label="us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="eq_BionizTherapeuticsIncMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ContingentConsiderationTypeDomain" xlink:to="eq_ContingentConsiderationForAchievementOfRegulatoryEventsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_BusinessAcquisitionAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityInterestIssuedOrIssuableTypeDomain" xlink:to="eq_EighteenMonthsAfterClosingMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:to="us-gaap_EquityInterestIssuedOrIssuableTypeDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:to="us-gaap_EquityInterestIssuedOrIssuableTypeDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ContingentConsiderationByTypeAxis" xlink:to="us-gaap_ContingentConsiderationTypeDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ContingentConsiderationByTypeAxis" xlink:to="us-gaap_ContingentConsiderationTypeDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ContingentConsiderationTypeDomain" xlink:to="eq_ContingentConsiderationForAchievementOfCommercializationEventsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_ContingentConsiderationByTypeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="eq_TermsOfMergerAgreement" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessCombinationAcquisitionRelatedCosts" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://equilliumbio.com/20221231/taxonomy/role/DisclosureAcquisitionSummaryOfPurchasePriceAllocationDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_BionizTherapeuticsIncMember" xlink:label="eq_BionizTherapeuticsIncMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" xlink:label="eq_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" xlink:label="us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_BusinessCombinationAcquiredInProcessResearchAndDevelopment" xlink:label="eq_BusinessCombinationAcquiredInProcessResearchAndDevelopment"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="eq_BionizTherapeuticsIncMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_BusinessAcquisitionAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract" xlink:to="eq_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="eq_BusinessCombinationAcquiredInProcessResearchAndDevelopment" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://equilliumbio.com/20221231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionLineItems" xlink:label="us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionTable" xlink:label="us-gaap_LesseeLeaseDescriptionTable"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_LesseeOperatingLeaseExpirationYear" xlink:label="eq_LesseeOperatingLeaseExpirationYear"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_LaboratorySpaceMember" xlink:label="eq_LaboratorySpaceMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseExpense" xlink:label="us-gaap_OperatingLeaseExpense"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_OfficeSpaceMember" xlink:label="eq_OfficeSpaceMember"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_LesseeOperatingLeaseExpiredDate" xlink:label="eq_LesseeOperatingLeaseExpiredDate"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LesseeLeaseDescriptionTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="eq_LesseeOperatingLeaseExpirationYear" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_LesseeLeaseDescriptionTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="eq_LaboratorySpaceMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_OperatingLeaseExpense" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="eq_OfficeSpaceMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="eq_LesseeOperatingLeaseExpiredDate" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://equilliumbio.com/20221231/taxonomy/role/DisclosurePartnershipsAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis" xlink:label="srt_ProductOrServiceAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain" xlink:label="srt_ProductsAndServicesDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain" xlink:label="srt_ProductsAndServicesDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_OnoPharmaceuticalCoLtdMember" xlink:label="eq_OnoPharmaceuticalCoLtdMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_OneTimeNonRefundablePaymentReceivableUponExercisesTheOption" xlink:label="eq_OneTimeNonRefundablePaymentReceivableUponExercisesTheOption"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_AssetPurchaseAgreementMember" xlink:label="eq_AssetPurchaseAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_ResearchAndDevelopmentServicesMember" xlink:label="eq_ResearchAndDevelopmentServicesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_BioconMember" xlink:label="eq_BioconMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_OneTimePaymentReceivableUponExercisesTheOption" xlink:label="eq_OneTimePaymentReceivableUponExercisesTheOption"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollaborativeArrangementMember" xlink:label="us-gaap_CollaborativeArrangementMember"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_UpfrontPaymentAmortizationMember" xlink:label="eq_UpfrontPaymentAmortizationMember"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_UpfrontNonRefundableAndNonCreditablePaymentReceivableUponExchangeOfOption" xlink:label="eq_UpfrontNonRefundableAndNonCreditablePaymentReceivableUponExchangeOfOption"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_EligibleToReceivePaymentOnAchievementOfCertainDevelopmentMilestones" xlink:label="eq_EligibleToReceivePaymentOnAchievementOfCertainDevelopmentMilestones"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossRealized" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossRealized"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_UpfrontPaymentReceived" xlink:label="eq_UpfrontPaymentReceived"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_UpfrontNonRefundableAndNonCreditablePaymentInvoiced" xlink:label="eq_UpfrontNonRefundableAndNonCreditablePaymentInvoiced"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_UpfrontAndNonCreditablePaymentInvoiced" xlink:label="eq_UpfrontAndNonCreditablePaymentInvoiced"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_EstimatedResearchAndDevelopmentFunding" xlink:label="eq_EstimatedResearchAndDevelopmentFunding"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_InitialTransactionPrice" xlink:label="eq_InitialTransactionPrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenue" xlink:label="us-gaap_DeferredRevenue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="us-gaap_DeferredRevenueCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenueNoncurrent" xlink:label="us-gaap_DeferredRevenueNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_ProceedsFromResearchAndDevelopmentFees" xlink:label="eq_ProceedsFromResearchAndDevelopmentFees"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_OptionPeriodExpiryCondition" xlink:label="eq_OptionPeriodExpiryCondition"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_RegulatoryMilestonePaymentsUponAchievementOfCertainRegulatoryApprovals" xlink:label="eq_RegulatoryMilestonePaymentsUponAchievementOfCertainRegulatoryApprovals"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_SalesMilestonePaymentsUponTheAchievementOfFirstCommercialSaleOfProductAndSpecifiedLevelsOfProductSales" xlink:label="eq_SalesMilestonePaymentsUponTheAchievementOfFirstCommercialSaleOfProductAndSpecifiedLevelsOfProductSales"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="eq_OnoPharmaceuticalCoLtdMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="eq_OneTimeNonRefundablePaymentReceivableUponExercisesTheOption" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="srt_ProductOrServiceAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="eq_AssetPurchaseAgreementMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="eq_ResearchAndDevelopmentServicesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="eq_BioconMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="eq_OneTimePaymentReceivableUponExercisesTheOption" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="srt_CounterpartyNameAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="us-gaap_CollaborativeArrangementMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="eq_UpfrontPaymentAmortizationMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="eq_UpfrontNonRefundableAndNonCreditablePaymentReceivableUponExchangeOfOption" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_TypeOfArrangementAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="eq_EligibleToReceivePaymentOnAchievementOfCertainDevelopmentMilestones" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ForeignCurrencyTransactionGainLossRealized" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_SubsequentEventTypeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="eq_UpfrontPaymentReceived" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="eq_UpfrontNonRefundableAndNonCreditablePaymentInvoiced" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="eq_UpfrontAndNonCreditablePaymentInvoiced" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="eq_EstimatedResearchAndDevelopmentFunding" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="eq_InitialTransactionPrice" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_DeferredRevenue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_DeferredRevenueCurrent" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_DeferredRevenueNoncurrent" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="eq_ProceedsFromResearchAndDevelopmentFees" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="14" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="15" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="eq_OptionPeriodExpiryCondition" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="16" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="17" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="eq_RegulatoryMilestonePaymentsUponAchievementOfCertainRegulatoryApprovals" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="18" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="eq_SalesMilestonePaymentsUponTheAchievementOfFirstCommercialSaleOfProductAndSpecifiedLevelsOfProductSales" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureNotesPayableAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtLineItems" xlink:label="us-gaap_ShortTermDebtLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShortTermDebtTable" xlink:label="us-gaap_ScheduleOfShortTermDebtTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit" xlink:label="us-gaap_LineOfCredit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis" xlink:label="us-gaap_VariableRateAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain" xlink:label="us-gaap_VariableRateDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain" xlink:label="us-gaap_VariableRateDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="us-gaap_LongtermDebtTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="us-gaap_LongtermDebtTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="us-gaap_LongtermDebtTypeDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrimeRateMember" xlink:label="us-gaap_PrimeRateMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_LoanAgreementMember" xlink:label="eq_LoanAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember" xlink:label="us-gaap_LineOfCreditMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityExpirationDate1" xlink:label="us-gaap_LineOfCreditFacilityExpirationDate1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_TermLoanMember" xlink:label="eq_TermLoanMember"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_LineOfCreditFacilityFrequencyOfPaymentsPrincipalAndInterest" xlink:label="eq_LineOfCreditFacilityFrequencyOfPaymentsPrincipalAndInterest"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFrequencyOfPeriodicPayment" xlink:label="us-gaap_DebtInstrumentFrequencyOfPeriodicPayment"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateBasisForEffectiveRate" xlink:label="us-gaap_DebtInstrumentInterestRateBasisForEffectiveRate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:label="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaidAsPercent" xlink:label="eq_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaidAsPercent"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_RequiredNoticePeriodForDebtPrepayment" xlink:label="eq_RequiredNoticePeriodForDebtPrepayment"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_DebtPrepaymentFeeAsPercentOnYearOne" xlink:label="eq_DebtPrepaymentFeeAsPercentOnYearOne"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_DebtPrepaymentFeeAsPercentOnYearTwo" xlink:label="eq_DebtPrepaymentFeeAsPercentOnYearTwo"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_DebtPrepaymentFeeAsPercentFromYearThree" xlink:label="eq_DebtPrepaymentFeeAsPercentFromYearThree"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:label="us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShortTermDebtLineItems" xlink:to="us-gaap_ScheduleOfShortTermDebtTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShortTermDebtLineItems" xlink:to="us-gaap_LineOfCredit" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_VariableRateAxis" xlink:to="us-gaap_VariableRateDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_VariableRateAxis" xlink:to="us-gaap_VariableRateDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShortTermDebtTable" xlink:to="us-gaap_DebtInstrumentAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VariableRateDomain" xlink:to="us-gaap_PrimeRateMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="eq_LoanAgreementMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="us-gaap_LineOfCreditMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShortTermDebtLineItems" xlink:to="us-gaap_LineOfCreditFacilityExpirationDate1" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShortTermDebtTable" xlink:to="us-gaap_LongtermDebtTypeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="eq_TermLoanMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShortTermDebtLineItems" xlink:to="eq_LineOfCreditFacilityFrequencyOfPaymentsPrincipalAndInterest" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShortTermDebtTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShortTermDebtLineItems" xlink:to="us-gaap_DebtInstrumentFrequencyOfPeriodicPayment" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShortTermDebtTable" xlink:to="us-gaap_VariableRateAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShortTermDebtLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShortTermDebtLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateBasisForEffectiveRate" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShortTermDebtLineItems" xlink:to="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShortTermDebtLineItems" xlink:to="eq_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaidAsPercent" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShortTermDebtLineItems" xlink:to="eq_RequiredNoticePeriodForDebtPrepayment" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShortTermDebtLineItems" xlink:to="eq_DebtPrepaymentFeeAsPercentOnYearOne" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShortTermDebtLineItems" xlink:to="eq_DebtPrepaymentFeeAsPercentOnYearTwo" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShortTermDebtLineItems" xlink:to="eq_DebtPrepaymentFeeAsPercentFromYearThree" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShortTermDebtLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShortTermDebtLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="14" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShortTermDebtLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateEffectivePercentage" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://equilliumbio.com/20221231/taxonomy/role/DisclosureNotesPayableScheduleOfAggregateCarryingAmountsOfTermLoanDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable" xlink:label="us-gaap_DebtInstrumentTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="us-gaap_LongtermDebtTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="us-gaap_LongtermDebtTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="us-gaap_DebtInstrumentCarryingAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember" xlink:label="us-gaap_LineOfCreditMember"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_AccretedLiabilityForFinalPaymentFee" xlink:label="eq_AccretedLiabilityForFinalPaymentFee"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt" xlink:label="us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_LongtermDebtTypeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentCarryingAmount" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="us-gaap_LineOfCreditMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="eq_AccretedLiabilityForFinalPaymentFee" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscount" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LongTermDebt" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_TwoThousandEighteenEquityIncentivePlanMember" xlink:label="eq_TwoThousandEighteenEquityIncentivePlanMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="us-gaap_InvestmentTypeCategorizationMember"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_PurchaseRightMember" xlink:label="eq_PurchaseRightMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_LincolnParkCapitalFundLLCMember" xlink:label="eq_LincolnParkCapitalFundLLCMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis" xlink:label="us-gaap_InvestmentTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="us-gaap_InvestmentTypeCategorizationMember_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VestingAxis" xlink:label="us-gaap_VestingAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VestingDomain" xlink:label="us-gaap_VestingDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VestingDomain" xlink:label="us-gaap_VestingDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_PurchaseAgreementMember" xlink:label="eq_PurchaseAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheOneMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityUnitPurchaseAgreementsMember" xlink:label="us-gaap_EquityUnitPurchaseAgreementsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_TwoThousandSeventeenEquityIncentivePlanMember" xlink:label="eq_TwoThousandSeventeenEquityIncentivePlanMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_EmployeeStockPurchasePlanMember" xlink:label="eq_EmployeeStockPurchasePlanMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_PurchaseAgreementExpirationDate" xlink:label="eq_PurchaseAgreementExpirationDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="us-gaap_SharesIssuedPricePerShare"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_GrossProceedsFromIssuanceOfCommonStock" xlink:label="eq_GrossProceedsFromIssuanceOfCommonStock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_EstimatedMaximumAmountOfCommonStockIssuable" xlink:label="eq_EstimatedMaximumAmountOfCommonStockIssuable"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_TermOfPurchaseAgreement" xlink:label="eq_TermOfPurchaseAgreement"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_FairMarketValueOfCommitmentShares" xlink:label="eq_FairMarketValueOfCommitmentShares"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_EquityIncentivePlanDescription" xlink:label="eq_EquityIncentivePlanDescription"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_MinimumOptionsExercisePriceAsPercentageOfFairMarketValueOfCommonStock" xlink:label="eq_MinimumOptionsExercisePriceAsPercentageOfFairMarketValueOfCommonStock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRemainingVestingPeriod" xlink:label="eq_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRemainingVestingPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_EmployeeStockPurchasePlanDescription" xlink:label="eq_EmployeeStockPurchasePlanDescription"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_WithholdPercentageOfEmployeesEarningsToPurchaseSharesOfCommonStock" xlink:label="eq_WithholdPercentageOfEmployeesEarningsToPurchaseSharesOfCommonStock"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_MinimumStockPricePerShareAsPercentageOfFairMarketValueOfCommonStock" xlink:label="eq_MinimumStockPricePerShareAsPercentageOfFairMarketValueOfCommonStock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_UnvestedStockLiability" xlink:label="eq_UnvestedStockLiability"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_DividendsPaidOnCommonStock" xlink:label="eq_DividendsPaidOnCommonStock"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_NumberOfInstitutionalInvestors" xlink:label="eq_NumberOfInstitutionalInvestors"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="eq_TwoThousandEighteenEquityIncentivePlanMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="eq_PurchaseRightMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="eq_LincolnParkCapitalFundLLCMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeCategorizationMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeCategorizationMember_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_VestingAxis" xlink:to="us-gaap_VestingDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_VestingAxis" xlink:to="us-gaap_VestingDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="eq_PurchaseAgreementMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VestingDomain" xlink:to="us-gaap_ShareBasedCompensationAwardTrancheOneMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_EquityUnitPurchaseAgreementsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="eq_TwoThousandSeventeenEquityIncentivePlanMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_WarrantMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_InvestmentTypeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="eq_EmployeeStockPurchasePlanMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_VestingAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_StatementEquityComponentsAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_TypeOfArrangementAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_CounterpartyNameAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="eq_PurchaseAgreementExpirationDate" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharesIssuedPricePerShare" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="eq_GrossProceedsFromIssuanceOfCommonStock" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="eq_EstimatedMaximumAmountOfCommonStockIssuable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="eq_TermOfPurchaseAgreement" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="14" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="eq_FairMarketValueOfCommitmentShares" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="15" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="eq_EquityIncentivePlanDescription" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="16" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="17" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="eq_MinimumOptionsExercisePriceAsPercentageOfFairMarketValueOfCommonStock" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="18" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="19" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="eq_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRemainingVestingPeriod" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="20" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="21" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="22" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="23" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="24" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="25" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="26" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="27" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="eq_EmployeeStockPurchasePlanDescription" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="28" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="eq_WithholdPercentageOfEmployeesEarningsToPurchaseSharesOfCommonStock" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="29" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="eq_MinimumStockPricePerShareAsPercentageOfFairMarketValueOfCommonStock" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="30" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="31" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="32" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="33" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="eq_UnvestedStockLiability" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="34" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="eq_DividendsPaidOnCommonStock" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="35" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="eq_NumberOfInstitutionalInvestors" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="36" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="37" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquitySummaryOfStockOptionActivityDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_TwoThousandEighteenEquityIncentivePlanMember" xlink:label="eq_TwoThousandEighteenEquityIncentivePlanMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="eq_TwoThousandEighteenEquityIncentivePlanMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="14" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="15" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquitySummaryOfStockOptionActivityParentheticalDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockMember" xlink:label="us-gaap_EmployeeStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_EmployeeStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharePrice" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquitySummaryOfTotalNonCashStockBasedCompensationExpenseDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_IncomeStatementLocationAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquitySummaryOfCommonStockReservedForFutureIssuanceDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_StockOptionsIssuedAndOutstandingMember" xlink:label="eq_StockOptionsIssuedAndOutstandingMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_AwardsAvailableUnder2018PlanMember" xlink:label="eq_AwardsAvailableUnder2018PlanMember"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_EmployeeStockPurchasePlanMember" xlink:label="eq_EmployeeStockPurchasePlanMember"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="eq_StockOptionsIssuedAndOutstandingMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_StatementEquityComponentsAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_WarrantMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="eq_AwardsAvailableUnder2018PlanMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="eq_EmployeeStockPurchasePlanMember" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_CommitmentsAndContingenciesLineItems" xlink:label="eq_CommitmentsAndContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_CommitmentsAndContingenciesTable" xlink:label="eq_CommitmentsAndContingenciesTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementExpense" xlink:label="us-gaap_LitigationSettlementExpense"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="eq_CommitmentsAndContingenciesLineItems" xlink:to="eq_CommitmentsAndContingenciesTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="eq_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_LitigationSettlementExpense" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardLineItems" xlink:label="us-gaap_TaxCreditCarryforwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardTable" xlink:label="us-gaap_TaxCreditCarryforwardTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="us-gaap_IncomeTaxAuthorityDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCountryMember" xlink:label="us-gaap_DomesticCountryMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain" xlink:label="srt_SegmentGeographicalDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_CA" xlink:label="stpr_CA"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis" xlink:label="srt_StatementGeographicalAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain" xlink:label="srt_SegmentGeographicalDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="us-gaap_IncomeTaxAuthorityAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="us-gaap_IncomeTaxAuthorityDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCountryMember" xlink:label="us-gaap_ForeignCountryMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_AU" xlink:label="country_AU"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="us-gaap_StateAndLocalJurisdictionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_OperatingLossCarryforwardsExpirationYear" xlink:label="eq_OperatingLossCarryforwardsExpirationYear"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="us-gaap_OperatingLossCarryforwards"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsLimitationsOnUse" xlink:label="us-gaap_OperatingLossCarryforwardsLimitationsOnUse"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_OperatingLossCarryforwardsLimitationRateOnTaxableIncome" xlink:label="eq_OperatingLossCarryforwardsLimitationRateOnTaxableIncome"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_TaxCreditCarryforwardExpirationYear" xlink:label="eq_TaxCreditCarryforwardExpirationYear"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_CumulativeChangeInOwnershipPercentage" xlink:label="eq_CumulativeChangeInOwnershipPercentage"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_CumulativeChangeInOwnershipPeriod" xlink:label="eq_CumulativeChangeInOwnershipPeriod"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_ResearchAndExperimentalExpendituresCapitalizedCostAmortizationPeriod" xlink:label="eq_ResearchAndExperimentalExpendituresCapitalizedCostAmortizationPeriod"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="us-gaap_TaxCreditCarryforwardTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_DomesticCountryMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="stpr_CA" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_TaxCreditCarryforwardTable" xlink:to="srt_StatementGeographicalAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefit" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_ForeignCountryMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="country_AU" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_TaxCreditCarryforwardTable" xlink:to="us-gaap_IncomeTaxAuthorityAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_StateAndLocalJurisdictionMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_TaxCreditCarryforwardTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="eq_OperatingLossCarryforwardsExpirationYear" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="us-gaap_OperatingLossCarryforwards" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="us-gaap_OperatingLossCarryforwardsLimitationsOnUse" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="eq_OperatingLossCarryforwardsLimitationRateOnTaxableIncome" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="eq_TaxCreditCarryforwardExpirationYear" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="eq_CumulativeChangeInOwnershipPercentage" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="eq_CumulativeChangeInOwnershipPeriod" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="14" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="eq_ResearchAndExperimentalExpendituresCapitalizedCostAmortizationPeriod" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureSubsequentEventsAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventLineItems" xlink:label="us-gaap_SubsequentEventLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTable" xlink:label="us-gaap_SubsequentEventTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsHeldInTrust" xlink:label="us-gaap_AssetsHeldInTrust"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_SiliconValleyBankMember" xlink:label="eq_SiliconValleyBankMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SubsequentEventTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_AssetsHeldInTrust" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="eq_SiliconValleyBankMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventTypeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsequentEventTable" xlink:to="srt_CounterpartyNameAxis" priority="2" use="optional"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>25
<FILENAME>eq-20221231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2023-03-23T11:19:41.0976+00:00 -->
<!-- Copyright (c) 2023 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:title="labelLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:label="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOfAssetsAcquired" xlink:label="us-gaap_FairValueOfAssetsAcquired"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCountryMember" xlink:label="us-gaap_DomesticCountryMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_EstimatedResearchAndDevelopmentFunding" xlink:label="eq_EstimatedResearchAndDevelopmentFunding"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_UnaccretedLiabilityForFinalPaymentFee" xlink:label="eq_UnaccretedLiabilityForFinalPaymentFee"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit" xlink:label="us-gaap_LineOfCredit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:label="us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock" xlink:label="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_OtherOperatingLeaseInformationAbstract" xlink:label="eq_OtherOperatingLeaseInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_AcquiredInProcessResearchAndDevelopment" xlink:label="eq_AcquiredInProcessResearchAndDevelopment"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_OperatingLossCarryforwardsLimitationRateOnTaxableIncome" xlink:label="eq_OperatingLossCarryforwardsLimitationRateOnTaxableIncome"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_DebtInstrumentCarryingAmountIncludingUnaccretedLiabilityForFinalPaymentFeeMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="eq_DebtInstrumentCarryingAmountIncludingUnaccretedLiabilityForFinalPaymentFeeMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermNotesPayable" xlink:label="us-gaap_LongTermNotesPayable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable" xlink:label="us-gaap_DebtInstrumentTable"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_FairMarketValueOfCommitmentShares" xlink:label="eq_FairMarketValueOfCommitmentShares"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtLineItems" xlink:label="us-gaap_ShortTermDebtLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments" xlink:label="us-gaap_OperatingLeasePayments"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAssumed1" xlink:label="us-gaap_LiabilitiesAssumed1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MachineryAndEquipmentMember" xlink:label="us-gaap_MachineryAndEquipmentMember"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_TaxCreditCarryforwardExpirationYear" xlink:label="eq_TaxCreditCarryforwardExpirationYear"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorFirmId" xlink:label="dei_AuditorFirmId"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationDisclosureTextBlock" xlink:label="us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssued" xlink:label="us-gaap_SharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="us-gaap_IncomeTaxAuthorityDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_UpfrontNonRefundableAndNonCreditablePaymentInvoiced" xlink:label="eq_UpfrontNonRefundableAndNonCreditablePaymentInvoiced"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_BioconMember" xlink:label="eq_BioconMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis" xlink:label="srt_ProductOrServiceAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockMember" xlink:label="us-gaap_EmployeeStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementExpense" xlink:label="us-gaap_LitigationSettlementExpense"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_CollaborationAndLicenseAgreementAbstract" xlink:label="eq_CollaborationAndLicenseAgreementAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:label="us-gaap_DeferredTaxLiabilitiesLeasingArrangements"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockPlans" xlink:label="us-gaap_ProceedsFromStockPlans"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenue" xlink:label="us-gaap_DeferredRevenue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_NumberOfInstitutionalInvestors" xlink:label="eq_NumberOfInstitutionalInvestors"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="us-gaap_OperatingLossCarryforwards"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAcquiredFromAcquisition" xlink:label="us-gaap_CashAcquiredFromAcquisition"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_WithholdPercentageOfEmployeesEarningsToPurchaseSharesOfCommonStock" xlink:label="eq_WithholdPercentageOfEmployeesEarningsToPurchaseSharesOfCommonStock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis" xlink:label="us-gaap_VariableRateAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="us-gaap_InvestmentTypeCategorizationMember"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_AccruedClinicalDevelopment" xlink:label="eq_AccruedClinicalDevelopment"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_UpfrontAndNonCreditablePaymentInvoiced" xlink:label="eq_UpfrontAndNonCreditablePaymentInvoiced"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_PurchaseAgreementExpirationDate" xlink:label="eq_PurchaseAgreementExpirationDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShortTermDebtTable" xlink:label="us-gaap_ScheduleOfShortTermDebtTable"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_EmployeeStockPurchasePlanDescription" xlink:label="eq_EmployeeStockPurchasePlanDescription"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax" xlink:label="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_AU" xlink:label="country_AU"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:label="us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:label="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InProcessResearchAndDevelopmentPolicy" xlink:label="us-gaap_InProcessResearchAndDevelopmentPolicy"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_DebtInstrumentCarryingAmountIncludingUnaccretedLiabilityForFinalPaymentFeeMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="eq_DebtInstrumentCarryingAmountIncludingUnaccretedLiabilityForFinalPaymentFeeMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_ShortTermInvestmentsTextBlock" xlink:label="eq_ShortTermInvestmentsTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheOneMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_SiliconValleyBankMember" xlink:label="eq_SiliconValleyBankMember"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_ATMMember" xlink:label="eq_ATMMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventLineItems" xlink:label="us-gaap_SubsequentEventLineItems"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_DebtPrepaymentFeeAsPercentFromYearThree" xlink:label="eq_DebtPrepaymentFeeAsPercentFromYearThree"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_DebtInstrumentCarryingAmountIncludingUnaccretedLiabilityForFinalPaymentFeeMaturitiesRepaymentsOfPrincipalInYearThree" xlink:label="eq_DebtInstrumentCarryingAmountIncludingUnaccretedLiabilityForFinalPaymentFeeMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="us-gaap_StateAndLocalJurisdictionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="us-gaap_LongTermDebtNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_ContractAssetsPolicyPolicyTextBlock" xlink:label="eq_ContractAssetsPolicyPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_EighteenMonthsAfterClosingMember" xlink:label="eq_EighteenMonthsAfterClosingMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CertificatesOfDepositMember" xlink:label="us-gaap_CertificatesOfDepositMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesAbstract" xlink:label="us-gaap_DeferredTaxLiabilitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="us-gaap_InvestmentIncomeInterest"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_BionizTherapeuticsIncMember" xlink:label="eq_BionizTherapeuticsIncMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesPayable" xlink:label="us-gaap_NotesPayable"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_OneTimeNonRefundablePaymentReceivableUponExercisesTheOption" xlink:label="eq_OneTimeNonRefundablePaymentReceivableUponExercisesTheOption"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_CA" xlink:label="stpr_CA"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_IncreaseDecreaseInRightOfUseAssetsAndLeaseLiabilitiesNet" xlink:label="eq_IncreaseDecreaseInRightOfUseAssetsAndLeaseLiabilitiesNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain" xlink:label="srt_SegmentGeographicalDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorLocation" xlink:label="dei_AuditorLocation"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_CommonStockReservedForFutureIssuanceTableTextBlock" xlink:label="eq_CommonStockReservedForFutureIssuanceTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesPayableCurrent" xlink:label="us-gaap_NotesPayableCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="us-gaap_FairValueDisclosuresTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="us-gaap_LongtermDebtTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_MinimumOptionsExercisePriceAsPercentageOfFairMarketValueOfCommonStock" xlink:label="eq_MinimumOptionsExercisePriceAsPercentageOfFairMarketValueOfCommonStock"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_RegulatoryMilestonePaymentsUponAchievementOfCertainRegulatoryApprovals" xlink:label="eq_RegulatoryMilestonePaymentsUponAchievementOfCertainRegulatoryApprovals"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="us-gaap_ConcentrationRiskCreditRisk"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionLineItems" xlink:label="us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:label="us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_FollowOnOfferingMember" xlink:label="eq_FollowOnOfferingMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_MinimumStockPricePerShareAsPercentageOfFairMarketValueOfCommonStock" xlink:label="eq_MinimumStockPricePerShareAsPercentageOfFairMarketValueOfCommonStock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComputerEquipmentMember" xlink:label="us-gaap_ComputerEquipmentMember"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_PercentageOfTaxBenefitToBeRealizedUponUltimateSettlementWithTaxAuthority" xlink:label="eq_PercentageOfTaxBenefitToBeRealizedUponUltimateSettlementWithTaxAuthority"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnDispositionOfAssets1" xlink:label="us-gaap_GainLossOnDispositionOfAssets1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:label="us-gaap_FinancialLiabilitiesFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis" xlink:label="us-gaap_InvestmentTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenueNoncurrent" xlink:label="us-gaap_DeferredRevenueNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAndLiabilitiesLesseeAbstract" xlink:label="us-gaap_AssetsAndLiabilitiesLesseeAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:label="us-gaap_AccruedLiabilitiesCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_LesseeOperatingLeaseExpirationYear" xlink:label="eq_LesseeOperatingLeaseExpirationYear"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationTypeDomain" xlink:label="us-gaap_ContingentConsiderationTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VestingAxis" xlink:label="us-gaap_VestingAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_LineOfCreditFacilityFrequencyOfPaymentsPrincipalAndInterest" xlink:label="eq_LineOfCreditFacilityFrequencyOfPaymentsPrincipalAndInterest"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" xlink:label="us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollaborativeArrangementMember" xlink:label="us-gaap_CollaborativeArrangementMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesTaxDeferredIncome" xlink:label="us-gaap_DeferredTaxLiabilitiesTaxDeferredIncome"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityUnitPurchaseAgreementsMember" xlink:label="us-gaap_EquityUnitPurchaseAgreementsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_PrepaidExpensesAndOtherCurrentAssetsPolicyPolicyTextBlock" xlink:label="eq_PrepaidExpensesAndOtherCurrentAssetsPolicyPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorName" xlink:label="dei_AuditorName"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_TwoThousandSeventeenEquityIncentivePlanMember" xlink:label="eq_TwoThousandSeventeenEquityIncentivePlanMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_USTreasurySecuritiesMaturingBetweenOneAndFiveYearsMember" xlink:label="eq_USTreasurySecuritiesMaturingBetweenOneAndFiveYearsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentInProcess" xlink:label="us-gaap_ResearchAndDevelopmentInProcess"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_AustralianResearchAndDevelopmentTaxIncentiveProgramMember" xlink:label="eq_AustralianResearchAndDevelopmentTaxIncentiveProgramMember"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_AccruedNonClinicalResearch" xlink:label="eq_AccruedNonClinicalResearch"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="dei_IcfrAuditorAttestationFlag"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember" xlink:label="us-gaap_LineOfCreditMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrimeRateMember" xlink:label="us-gaap_PrimeRateMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_SummaryOfAdditionalInformationRelatedToLeasesTableTextBlock" xlink:label="eq_SummaryOfAdditionalInformationRelatedToLeasesTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTerm" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTerm"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByAssetClassAxis" xlink:label="us-gaap_FairValueByAssetClassAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_ContingentConsiderationForAchievementOfRegulatoryEventsMember" xlink:label="eq_ContingentConsiderationForAchievementOfRegulatoryEventsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:label="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:label="us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="us-gaap_TypeOfAdoptionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdate201613Member" xlink:label="us-gaap_AccountingStandardsUpdate201613Member"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_SalesMilestonePaymentsUponTheAchievementOfFirstCommercialSaleOfProductAndSpecifiedLevelsOfProductSales" xlink:label="eq_SalesMilestonePaymentsUponTheAchievementOfFirstCommercialSaleOfProductAndSpecifiedLevelsOfProductSales"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract" xlink:label="us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_EffectiveIncomeTaxRateReconciliationTransactionCostsAmount" xlink:label="eq_EffectiveIncomeTaxRateReconciliationTransactionCostsAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireShortTermInvestments" xlink:label="us-gaap_PaymentsToAcquireShortTermInvestments"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseDebt" xlink:label="us-gaap_InterestExpenseDebt"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_LoanAgreementMember" xlink:label="eq_LoanAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_OptionPeriodExpiryCondition" xlink:label="eq_OptionPeriodExpiryCondition"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_PurchaseRightMember" xlink:label="eq_PurchaseRightMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:label="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:label="us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAndAmortization" xlink:label="us-gaap_DepreciationAndAmortization"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="us-gaap_NonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:label="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_ContractLiabilitiesPolicyPolicyTextBlock" xlink:label="eq_ContractLiabilitiesPolicyPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:label="us-gaap_CollaborativeArrangementDisclosureTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="us-gaap_AccountsReceivableNetCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateBasisForEffectiveRate" xlink:label="us-gaap_DebtInstrumentInterestRateBasisForEffectiveRate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssued1" xlink:label="us-gaap_StockIssued1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityExpirationDate1" xlink:label="us-gaap_LineOfCreditFacilityExpirationDate1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock" xlink:label="us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:label="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_AccretedLiabilityForFinalPaymentFee" xlink:label="eq_AccretedLiabilityForFinalPaymentFee"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaidAsPercent" xlink:label="eq_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaidAsPercent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionTable" xlink:label="us-gaap_LesseeLeaseDescriptionTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_GrossProceedsFromIssuanceOfCommonStock" xlink:label="eq_GrossProceedsFromIssuanceOfCommonStock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseExpense" xlink:label="us-gaap_OperatingLeaseExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_StockOptionsIssuedAndOutstandingMember" xlink:label="eq_StockOptionsIssuedAndOutstandingMember"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_EligibleToReceivePaymentOnAchievementOfCertainDevelopmentMilestones" xlink:label="eq_EligibleToReceivePaymentOnAchievementOfCertainDevelopmentMilestones"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityInterestIssuedOrIssuableTypeDomain" xlink:label="us-gaap_EquityInterestIssuedOrIssuableTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_DebtPrepaymentFeeAsPercentOnYearOne" xlink:label="eq_DebtPrepaymentFeeAsPercentOnYearOne"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_EmployeeStockPurchasePlanMember" xlink:label="eq_EmployeeStockPurchasePlanMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis" xlink:label="srt_StatementGeographicalAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet" xlink:label="us-gaap_InterestPaidNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_CommitmentsAndContingenciesLineItems" xlink:label="eq_CommitmentsAndContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:label="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTable" xlink:label="us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:label="us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" xlink:label="eq_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPayableCurrent" xlink:label="us-gaap_InterestPayableCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesPolicyTextBlock" xlink:label="us-gaap_ReceivablesPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="us-gaap_DeferredRevenueCurrent"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_CumulativeChangeInOwnershipPeriod" xlink:label="eq_CumulativeChangeInOwnershipPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameDomain" xlink:label="us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasurySecuritiesMember" xlink:label="us-gaap_USTreasurySecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_DebtInstrumentCarryingAmountIncludingUnaccretedLiabilityForFinalPaymentFee" xlink:label="eq_DebtInstrumentCarryingAmountIncludingUnaccretedLiabilityForFinalPaymentFee"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain" xlink:label="us-gaap_VariableRateDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFrequencyOfPeriodicPayment" xlink:label="us-gaap_DebtInstrumentFrequencyOfPeriodicPayment"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" xlink:label="us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameAxis" xlink:label="us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_CommitmentsAndContingenciesTable" xlink:label="eq_CommitmentsAndContingenciesTable"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_DebtPrepaymentFeeAsPercentOnYearTwo" xlink:label="eq_DebtPrepaymentFeeAsPercentOnYearTwo"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeasesPolicyTextBlock" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardAxis" xlink:label="us-gaap_TaxCreditCarryforwardAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock" xlink:label="us-gaap_SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_BusinessCombinationAcquiredInProcessResearchAndDevelopment" xlink:label="eq_BusinessCombinationAcquiredInProcessResearchAndDevelopment"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_AssetPurchaseAgreementMember" xlink:label="eq_AssetPurchaseAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_UpfrontNonRefundableAndNonCreditablePaymentReceivableUponExchangeOfOption" xlink:label="eq_UpfrontNonRefundableAndNonCreditablePaymentReceivableUponExchangeOfOption"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="us-gaap_DeferredTaxAssetsGross"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent" xlink:label="us-gaap_LongTermDebtCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueOther" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_ContingentConsiderationForAchievementOfCommercializationEventsMember" xlink:label="eq_ContingentConsiderationForAchievementOfCommercializationEventsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgageNotesPayableDisclosureTextBlock" xlink:label="us-gaap_MortgageNotesPayableDisclosureTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_AustralianResearchAndDevelopmentTaxIncentivePolicyTextBlock" xlink:label="eq_AustralianResearchAndDevelopmentTaxIncentivePolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_OfficeSpaceMember" xlink:label="eq_OfficeSpaceMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_AvailableForSaleSecuritiesDebtMaturitiesPeriod" xlink:label="eq_AvailableForSaleSecuritiesDebtMaturitiesPeriod"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_PrepaidAndOtherCurrentAssetsTaxIncentive" xlink:label="eq_PrepaidAndOtherCurrentAssetsTaxIncentive"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsHeldInTrust" xlink:label="us-gaap_AssetsHeldInTrust"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTable" xlink:label="us-gaap_SubsequentEventTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:label="us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_IncomeTaxReconciliationFederalResearchAndOrphanDrugCredits" xlink:label="eq_IncomeTaxReconciliationFederalResearchAndOrphanDrugCredits"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:label="us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_UpfrontPaymentReceived" xlink:label="eq_UpfrontPaymentReceived"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardNameDomain" xlink:label="us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:label="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_RequiredNoticePeriodForDebtPrepayment" xlink:label="eq_RequiredNoticePeriodForDebtPrepayment"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_ProceedsFromResearchAndDevelopmentFees" xlink:label="eq_ProceedsFromResearchAndDevelopmentFees"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_DeferredTaxAssetsCapitalizedResearchExpenditures" xlink:label="eq_DeferredTaxAssetsCapitalizedResearchExpenditures"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:label="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_ShortTermInvestmentsPolicyTextBlock" xlink:label="eq_ShortTermInvestmentsPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_TermLoanMember" xlink:label="eq_TermLoanMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsLimitationsOnUse" xlink:label="us-gaap_OperatingLossCarryforwardsLimitationsOnUse"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_UnvestedStockLiability" xlink:label="eq_UnvestedStockLiability"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_InitialTransactionPrice" xlink:label="eq_InitialTransactionPrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="us-gaap_UnrecognizedTaxBenefits"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:label="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_OneTimePaymentReceivableUponExercisesTheOption" xlink:label="eq_OneTimePaymentReceivableUponExercisesTheOption"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_ResearchAndDevelopmentTaxIncentiveRevenueCriteria" xlink:label="eq_ResearchAndDevelopmentTaxIncentiveRevenueCriteria"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_AwardsAvailableUnder2018PlanMember" xlink:label="eq_AwardsAvailableUnder2018PlanMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt" xlink:label="us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_PurchaseAgreementMember" xlink:label="eq_PurchaseAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationByTypeAxis" xlink:label="us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationDateOfIncorporation" xlink:label="dei_EntityIncorporationDateOfIncorporation"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_SummaryOfSignificantAccountingPoliciesLineItems" xlink:label="eq_SummaryOfSignificantAccountingPoliciesLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_AccruedResearchAndDevelopmentExpensePolicyTextBlock" xlink:label="eq_AccruedResearchAndDevelopmentExpensePolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" xlink:label="us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VestingDomain" xlink:label="us-gaap_VestingDomain"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_TermsOfMergerAgreement" xlink:label="eq_TermsOfMergerAgreement"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardTable" xlink:label="us-gaap_TaxCreditCarryforwardTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:label="us-gaap_CompensationAndEmployeeBenefitPlansTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsFairValueDisclosure" xlink:label="us-gaap_InvestmentsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_SummaryOfReconciliationOfExpectedStatutoryFederalIncomeTaxProvisionToActualIncomeTaxProvisionTableTextBlock" xlink:label="eq_SummaryOfReconciliationOfExpectedStatutoryFederalIncomeTaxProvisionToActualIncomeTaxProvisionTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_DividendsPaidOnCommonStock" xlink:label="eq_DividendsPaidOnCommonStock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="us-gaap_SharesIssuedPricePerShare"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_ResearchAndDevelopmentServicesMember" xlink:label="eq_ResearchAndDevelopmentServicesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_UpfrontPaymentAmortizationMember" xlink:label="eq_UpfrontPaymentAmortizationMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="us-gaap_IncomeTaxAuthorityAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="us-gaap_DeferredTaxAssetsNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_CertificatesOfDepositMaturingInOneYearOrLessMember" xlink:label="eq_CertificatesOfDepositMaturingInOneYearOrLessMember"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_USTreasurySecuritiesMaturingInOneYearOrLessMember" xlink:label="eq_USTreasurySecuritiesMaturingInOneYearOrLessMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossUnrealized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_RegisteredDirectOfferingsMember" xlink:label="eq_RegisteredDirectOfferingsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesOther" xlink:label="us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:label="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="us-gaap_RepaymentsOfNotesPayable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentDisposals" xlink:label="us-gaap_PropertyPlantAndEquipmentDisposals"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_OperatingLossCarryforwardsExpirationYear" xlink:label="eq_OperatingLossCarryforwardsExpirationYear"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain" xlink:label="srt_ProductsAndServicesDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossRealized" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossRealized"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_CumulativeChangeInOwnershipPercentage" xlink:label="eq_CumulativeChangeInOwnershipPercentage"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRemainingVestingPeriod" xlink:label="eq_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRemainingVestingPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_OnoPharmaceuticalCoLtdMember" xlink:label="eq_OnoPharmaceuticalCoLtdMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:label="us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="us-gaap_FurnitureAndFixturesMember"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_LaboratorySpaceMember" xlink:label="eq_LaboratorySpaceMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:label="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities" xlink:label="us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_TermOfPurchaseAgreement" xlink:label="eq_TermOfPurchaseAgreement"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCountryMember" xlink:label="us-gaap_ForeignCountryMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNetAbstract" xlink:label="us-gaap_DeferredTaxAssetsNetAbstract"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_IncomeTaxReconciliationPermanentItems" xlink:label="eq_IncomeTaxReconciliationPermanentItems"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_ResearchAndExperimentalExpendituresCapitalizedCostAmortizationPeriod" xlink:label="eq_ResearchAndExperimentalExpendituresCapitalizedCostAmortizationPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="us-gaap_DebtInstrumentCarryingAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="us-gaap_DeferredTaxAssetsOther"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_SummaryOfSignificantAccountingPoliciesTable" xlink:label="eq_SummaryOfSignificantAccountingPoliciesTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AustralianTaxationOfficeMember" xlink:label="us-gaap_AustralianTaxationOfficeMember"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_TwoThousandEighteenEquityIncentivePlanMember" xlink:label="eq_TwoThousandEighteenEquityIncentivePlanMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_LincolnParkCapitalFundLLCMember" xlink:label="eq_LincolnParkCapitalFundLLCMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_EquityIncentivePlanDescription" xlink:label="eq_EquityIncentivePlanDescription"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_LesseeOperatingLeaseExpiredDate" xlink:label="eq_LesseeOperatingLeaseExpiredDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_EstimatedMaximumAmountOfCommonStockIssuable" xlink:label="eq_EstimatedMaximumAmountOfCommonStockIssuable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_PatentCostsPolicyTextBlock" xlink:label="eq_PatentCostsPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="us-gaap_LongtermDebtTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardLineItems" xlink:label="us-gaap_TaxCreditCarryforwardLineItems"/>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Ex Transition Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Ex Transition Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueDisclosuresAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Disclosures [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounting Standards Update and Change in Accounting Principle [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueOfAssetsAcquired_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair value of Bioniz assets acquired</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueOfAssetsAcquired_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value of Assets Acquired</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Level 1</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Accrued Expenses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Accrued Liabilities [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DomesticCountryMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Federal</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DomesticCountryMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Domestic Tax Authority [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Acquired in-process research and development</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Value, New Issues</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and Development</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Research and Development Expense, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Financing activities:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expected dividend yield</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_EstimatedResearchAndDevelopmentFunding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Estimated research and development funding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_EstimatedResearchAndDevelopmentFunding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Estimated Research And Development Funding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_EstimatedResearchAndDevelopmentFunding_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Estimated research and development funding.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_UnaccretedLiabilityForFinalPaymentFee_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Unaccreted balance for Final Payment fee on Term Loans</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_UnaccretedLiabilityForFinalPaymentFee_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Unaccreted Liability For Final Payment Fee</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_UnaccretedLiabilityForFinalPaymentFee_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Unaccreted liability for final payment fee.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LineOfCredit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Borrowings under loan agreement</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LineOfCredit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Term Line of Credit</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LineOfCredit_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Long-term Line of Credit, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CapitalExpendituresIncurredButNotYetPaid_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amounts included in accounts payable for purchases of property and equipment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CapitalExpendituresIncurredButNotYetPaid_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Capital Expenditures Incurred but Not yet Paid</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Purchase Price Allocation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination, Separately Recognized Transactions [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Fair value of stock options vested</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of shares authorized for issuance under purchase rights granted to employees</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Subsequent Event Type</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Event Type [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_OtherOperatingLeaseInformationAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Other operating lease information.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_OtherOperatingLeaseInformationAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Operating Lease Information [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_OtherOperatingLeaseInformationAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other information</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Right-of-use assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/label">ROU assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Operating lease right-of-use assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_AcquiredInProcessResearchAndDevelopment_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Acquired in-process research and development</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_AcquiredInProcessResearchAndDevelopment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Acquired in-Process Research and Development</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_AcquiredInProcessResearchAndDevelopment_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Acquired in-process research and development</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_OperatingLossCarryforwardsLimitationRateOnTaxableIncome_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating loss carryforwards limitation rate on taxable income</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_OperatingLossCarryforwardsLimitationRateOnTaxableIncome_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Loss Carryforwards Limitation Rate On Taxable Income</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_OperatingLossCarryforwardsLimitationRateOnTaxableIncome_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Operating loss carryforwards limitation rate on taxable income.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_DebtInstrumentCarryingAmountIncludingUnaccretedLiabilityForFinalPaymentFeeMaturitiesRepaymentsOfPrincipalInYearTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Year ending December 31, 2024</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_DebtInstrumentCarryingAmountIncludingUnaccretedLiabilityForFinalPaymentFeeMaturitiesRepaymentsOfPrincipalInYearTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Carrying Amount Including Unaccreted Liability For Final Payment Fee Maturities Repayments Of Principal In Year Two</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_DebtInstrumentCarryingAmountIncludingUnaccretedLiabilityForFinalPaymentFeeMaturitiesRepaymentsOfPrincipalInYearTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Debt instrument carrying amount including unaccreted liability for final payment fee maturities repayments of principal in year two.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermNotesPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Long-term notes payable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermNotesPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Notes Payable, Noncurrent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermNotesPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Notes Payable, Noncurrent, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Foreign tax loss carry forwards</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Operating Loss Carryforwards, State and Local</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt Instrument [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Long-Term Debt Instruments [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_FairMarketValueOfCommitmentShares_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair market value of commitment shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_FairMarketValueOfCommitmentShares_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Market Value Of Commitment Shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_FairMarketValueOfCommitmentShares_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Fair market value of commitment shares.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShortTermDebtLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Short Term Debt [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShortTermDebtLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Short-Term Debt [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Less: imputed interest</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net Loss per Share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statement [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Liability, Noncurrent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Long-term operating lease liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Lease liabilities, non-current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Change in Accounting Principle, Accounting Standards Update, Immaterial Effect [true false]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Change in accounting principle, accounting standards update, immaterial effect</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeasePayments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Payments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeasePayments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating cash flows from operating leases</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Shares, Employee Stock Purchase Plans</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock under employee stock purchase plan, Shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesAssumed1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Bioniz net liabilities assumed</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesAssumed1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities Assumed</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Acquisition [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MachineryAndEquipmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Machinery &amp; Lab Equipment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MachineryAndEquipmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Machinery and Equipment [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_TaxCreditCarryforwardExpirationYear_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Tax credit carryforward, Expiration year</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_TaxCreditCarryforwardExpirationYear_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Tax Credit Carryforward Expiration Year</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_TaxCreditCarryforwardExpirationYear_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Tax credit carryforward expiration year.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Total common stock reserved for future issuance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of shares available for issuance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Capital Shares Reserved for Future Issuance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AuditorFirmId_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Auditor Firm ID</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred revenue</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Deferred Revenue</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Acquisition</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination Disclosure [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Balance, Shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Balance, Share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Shares, Issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxAuthorityDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Tax Authority</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxAuthorityDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Authority [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Tax credit carry forwards</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Credits</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Tax Credit Carryforwards</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Deferred Tax Assets, Tax Credit Carryforwards, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_UpfrontNonRefundableAndNonCreditablePaymentInvoiced_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Upfront non-refundable and non-creditable payment invoiced</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_UpfrontNonRefundableAndNonCreditablePaymentInvoiced_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Upfront Non-Refundable and Non-Creditable Payment Invoiced</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_UpfrontNonRefundableAndNonCreditablePaymentInvoiced_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Upfront non-refundable and non-creditable payment invoiced.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_BioconMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Biocon</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_BioconMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Biocon [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_BioconMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Biocon.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ProductOrServiceAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Product and Service [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock Options</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Employee Stock [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LitigationSettlementExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Litigation expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LitigationSettlementExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Litigation Settlement, Expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_CollaborationAndLicenseAgreementAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Collaboration And License Agreement [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_CollaborationAndLicenseAgreementAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Collaboration and license agreement.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued payroll and other employee benefits</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Employee-related Liabilities, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Employee-related Liabilities, Current, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Leases [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Leases</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeStockOptionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Common Stock Options</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeStockOptionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common Stock Options</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeStockOptionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Option [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted average remaining lease term</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total liabilities and stockholders' equity</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities and Equity</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxLiabilitiesLeasingArrangements_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Liabilities, Leasing Arrangements</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxLiabilitiesLeasingArrangements_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Operating lease right-of-use asset</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PlanNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Plan Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PlanNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Plan Name [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fixed assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Assets, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Change in Accounting Principle, Accounting Standards Update, Adopted [true false]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Change in accounting principle, accounting standards update, adopted</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">State of incorporation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation, State or Country Code</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation, State or Country Code</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Statement [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromStockPlans_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from ESPP purchases</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromStockPlans_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Stock Plans</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredRevenue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred revenue</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredRevenue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Revenue</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredRevenue_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Deferred Revenue, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Sale of Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Sale of Stock [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total current liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_NumberOfInstitutionalInvestors_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of institutional investors</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_NumberOfInstitutionalInvestors_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Number Of Institutional Investors</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_NumberOfInstitutionalInvestors_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Number Of Institutional Investors</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_NumberOfInstitutionalInvestors_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Purchased of issued and outstanding share capital</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Value, Employee Stock Purchase Plan</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock under employee stock purchase plan</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLossCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Federal net operating loss carryover</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLossCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Loss Carryforwards</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLossCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Operating Loss Carryforwards, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2025</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAcquiredFromAcquisition_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash acquired in Bioniz acquisition</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAcquiredFromAcquisition_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash Acquired from Acquisition</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Allowance for credit losses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounts Receivable, Allowance for Credit Loss</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivable_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Accounts Receivable, Allowance for Credit Loss, Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivable_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Accounts Receivable, Allowance for Credit Loss, Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Taxes</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock, shares authorized</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock, Shares Authorized</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_WithholdPercentageOfEmployeesEarningsToPurchaseSharesOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Withhold Percentage of employees earnings to purchase shares of common stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_WithholdPercentageOfEmployeesEarningsToPurchaseSharesOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Withhold Percentage Of Employees Earnings To Purchase Shares Of Common Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_WithholdPercentageOfEmployeesEarningsToPurchaseSharesOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Withhold Percentage of employees earnings to purchase shares of common stock.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted average discount rate</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_VariableRateAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Variable Rate</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_VariableRateAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Variable Rate [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntitySmallBusiness_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Small Business</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntitySmallBusiness_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Small Business</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TypeOfArrangementAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Collaborative Arrangement and Arrangement Other than Collaborative</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TypeOfArrangementAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts payable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentTypeCategorizationMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Investments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentTypeCategorizationMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Investments [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_AccruedClinicalDevelopment_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Clinical development</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_AccruedClinicalDevelopment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Clinical Development</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_AccruedClinicalDevelopment_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Accrued Clinical Development</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_UpfrontAndNonCreditablePaymentInvoiced_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Upfront and non-creditable payment invoiced</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_UpfrontAndNonCreditablePaymentInvoiced_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Upfront and Non-Creditable Payment Invoiced</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_UpfrontAndNonCreditablePaymentInvoiced_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Upfront and Non-creditable payment invoiced.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_PurchaseAgreementExpirationDate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Purchase agreement expiration date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_PurchaseAgreementExpirationDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Purchase Agreement Expiration Date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_PurchaseAgreementExpirationDate_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Purchase agreement expiration date.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total current assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property Plant And Equipment [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShortTermDebtTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Short Term Debt [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShortTermDebtTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Short-Term Debt [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_EmployeeStockPurchasePlanDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Employee stock purchase plan description</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_EmployeeStockPurchasePlanDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Employee Stock Purchase Plan Description</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_EmployeeStockPurchasePlanDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Description of the plan, including equity stock purchase plan which under the employee stock purchase plan.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted-average number of common shares outstanding, basic</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Weighted Average Number of Shares Outstanding, Basic, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Aggregate Intrinsic Value, Options Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Number of Outstanding Options, Forfeitures and Cancellations</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_lbl" xlink:role="http://www.xbrl.org/2003/role/label">OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment and Tax</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unrealized loss on available-for-sale securities, net</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Liabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Liabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock issuance costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payments of Stock Issuance Costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="country_AU_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Australia</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="country_AU_lbl" xlink:role="http://www.xbrl.org/2003/role/label">AUSTRALIA</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination and Asset Acquisition [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InProcessResearchAndDevelopmentPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Acquired In-Process Research and Development Expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InProcessResearchAndDevelopmentPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/label">In Process Research and Development, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Weighted-average grant-date fair value of options granted</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_DebtInstrumentCarryingAmountIncludingUnaccretedLiabilityForFinalPaymentFeeMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Year ending December 31, 2023</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_DebtInstrumentCarryingAmountIncludingUnaccretedLiabilityForFinalPaymentFeeMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Carrying Amount Including Unaccreted Liability For Final Payment Fee Maturities Repayments Of Principal In Next Twelve Months</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_DebtInstrumentCarryingAmountIncludingUnaccretedLiabilityForFinalPaymentFeeMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Debt instrument carrying amount including unaccreted liability for final payment fee maturities repayments of principal in next twelve months.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Amortized Cost</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale, Amortized Cost</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_ShortTermInvestmentsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Short-Term Investments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_ShortTermInvestmentsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Short Term Investments [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheOneMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Tranche One</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheOneMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Tranche One [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RangeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statistical Measurement</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RangeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statistical Measurement [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_SiliconValleyBankMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Silicon Valley Bank</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_SiliconValleyBankMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Silicon Valley Bank [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_SiliconValleyBankMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Silicon Valley Bank.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_ATMMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">ATM Facility</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_ATMMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">ATM</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_ATMMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">A T M [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_ATMMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">At-the-market offering.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Subsequent Event [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Event [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_DebtPrepaymentFeeAsPercentFromYearThree_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt prepayment fee as percent from year three</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_DebtPrepaymentFeeAsPercentFromYearThree_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Prepayment Fee As Percent From Year Three</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_DebtPrepaymentFeeAsPercentFromYearThree_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Debt prepayment fee as percent from year three.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Assets_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Assets_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_DebtInstrumentCarryingAmountIncludingUnaccretedLiabilityForFinalPaymentFeeMaturitiesRepaymentsOfPrincipalInYearThree_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Carrying Amount Including Unaccreted Liability For Final Payment Fee Maturities Repayments Of Principal In Year Three</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_DebtInstrumentCarryingAmountIncludingUnaccretedLiabilityForFinalPaymentFeeMaturitiesRepaymentsOfPrincipalInYearThree_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Debt instrument carrying amount including unaccreted liability for final payment fee maturities repayments of principal in year three.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_DebtInstrumentCarryingAmountIncludingUnaccretedLiabilityForFinalPaymentFeeMaturitiesRepaymentsOfPrincipalInYearThree_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Year ending December 31, 2024</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StateAndLocalJurisdictionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">State</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StateAndLocalJurisdictionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">State and Local Jurisdiction [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Noncurrent portion</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Term Debt, Excluding Current Maturities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Long-term Debt, Excluding Current Maturities, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net loss per share, diluted</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share, Diluted</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Earnings Per Share, Diluted, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_ContractAssetsPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Contract Assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_ContractAssetsPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Contract Assets Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_ContractAssetsPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Contract assets policy.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Potentially Dilutive Securities Not Included in Calculation of Diluted Net Loss Per Share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_EighteenMonthsAfterClosingMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">18 Months after Closing</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_EighteenMonthsAfterClosingMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Eighteen Months after Closing [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_EighteenMonthsAfterClosingMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Eighteen months after closing.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Fiscal Period Focus</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Fiscal Period Focus</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current income tax expense (benefit)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Current Income Tax Expense (Benefit)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Current Income Tax Expense (Benefit), Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Accounts receivable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Accounts Receivable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Valuation allowance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred tax assets, Valuation allowance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Deferred Tax Assets, Valuation Allowance, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CertificatesOfDepositMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Certificates of Deposit</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CertificatesOfDepositMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Certificates of Deposit [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-based compensation expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">APIC, Share-based Payment Arrangement, Increase for Cost Recognition, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxLiabilitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred tax liabilities:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxLiabilitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Liabilities, Gross [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentIncomeInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Interest income</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentIncomeInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Investment Income, Interest</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Counterparty Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Counterparty Name [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Liability</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total lease liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Total lease liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net cash (used in) provided by financing activities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_BionizTherapeuticsIncMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Bioniz therapeutics, inc.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_BionizTherapeuticsIncMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Bioniz Therapeutics, Inc. [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_BionizTherapeuticsIncMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Bioniz</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NotesPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Carrying amount of notes payable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NotesPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Notes Payable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NotesPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Notes Payable, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_OneTimeNonRefundablePaymentReceivableUponExercisesTheOption_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">One-time, non-refundable payment receivable, upon exercises the option</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_OneTimeNonRefundablePaymentReceivableUponExercisesTheOption_lbl" xlink:role="http://www.xbrl.org/2003/role/label">One-time, Non-Refundable Payment Receivable, Upon Exercises The Option</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_OneTimeNonRefundablePaymentReceivableUponExercisesTheOption_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">One-time, non-refundable payment receivable, upon exercises the option.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="stpr_CA_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">California</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="stpr_CA_lbl" xlink:role="http://www.xbrl.org/2003/role/label">CALIFORNIA</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement of Financial Position [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Securities Act File Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement of Cash Flows [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Shares upon exercise of warrants</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lenders warrants exercisable for shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Warrant or Right, Number of Securities Called by Warrants or Rights</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Assets acquired:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_IncreaseDecreaseInRightOfUseAssetsAndLeaseLiabilitiesNet_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Right-of-use assets and lease liabilities, net</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_IncreaseDecreaseInRightOfUseAssetsAndLeaseLiabilitiesNet_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Increase (decrease) in right-of-use assets and lease liabilities, net.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_IncreaseDecreaseInRightOfUseAssetsAndLeaseLiabilitiesNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase Decrease In Right-Of-Use Assets And Lease Liabilities, Net</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_SegmentGeographicalDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Geographical</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_SegmentGeographicalDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Geographical [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RangeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statistical Measurement</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RangeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statistical Measurement [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Sale of Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Sale of Stock [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AuditorLocation_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Auditor Location</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_CommonStockReservedForFutureIssuanceTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Reserved Shares of Common Stock for Future Issuance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_CommonStockReservedForFutureIssuanceTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock Reserved For Future Issuance Table [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_CommonStockReservedForFutureIssuanceTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Common stock reserved for future issuance.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NotesPayableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current portion of long-term notes payable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NotesPayableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Notes Payable, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NotesPayableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Notes Payable, Current, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Events [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueDisclosuresTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value of Financial Instruments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueDisclosuresTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Disclosures [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other comprehensive income, net:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted Average Remaining Contractual Term, Options Exercisable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from exercise of stock options</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Stock Options Exercised</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from issuance of common stock from follow-on offering, net of issuance costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Proceeds from issuance of common stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Issuance of Common Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongtermDebtTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Long-term Debt, Type</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongtermDebtTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Term Debt, Type [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred income tax expense (benefit)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Income Tax Expense (Benefit)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Deferred Income Tax Expense (Benefit), Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Property and Equipment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_MinimumOptionsExercisePriceAsPercentageOfFairMarketValueOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Minimum options exercise price as percentage of fair market value of common stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_MinimumOptionsExercisePriceAsPercentageOfFairMarketValueOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Minimum Options Exercise Price As Percentage Of Fair Market Value Of Common Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_MinimumOptionsExercisePriceAsPercentageOfFairMarketValueOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Minimum options exercise price, expressed as percentage of fair market value of common stock.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_RegulatoryMilestonePaymentsUponAchievementOfCertainRegulatoryApprovals_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Regulatory milestone payments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_RegulatoryMilestonePaymentsUponAchievementOfCertainRegulatoryApprovals_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Regulatory Milestone Payments Upon Achievement Of Certain Regulatory Approvals</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_RegulatoryMilestonePaymentsUponAchievementOfCertainRegulatoryApprovals_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Regulatory milestone payments upon the achievement of certain regulatory approvals.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Concentration of Credit Risk and Off-Balance Sheet Risk</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Concentration Risk, Credit Risk, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Antidilutive Securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock, par value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unrealized Gains</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeLeaseDescriptionLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Lease, Description [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsAndShortTermInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Cash, Cash Equivalents, and Short-term Investments, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsAndShortTermInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash, Cash Equivalents, and Short-Term Investments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsAndShortTermInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash, Cash equivalents and short-term investments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_FollowOnOfferingMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Follow-on Offering</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_FollowOnOfferingMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Follow On Offering [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_FollowOnOfferingMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Follow-on offering.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Subsequent Events</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Events [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_MinimumStockPricePerShareAsPercentageOfFairMarketValueOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Minimum stock price per share as percentage of fair market value of common stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_MinimumStockPricePerShareAsPercentageOfFairMarketValueOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Minimum Stock Price Per Share As Percentage Of Fair Market Value Of Common Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_MinimumStockPricePerShareAsPercentageOfFairMarketValueOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Minimum stock price per share as percentage of fair market value of common stock.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted-average number of common shares outstanding, diluted</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Weighted Average Number of Shares Outstanding, Diluted, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Organization and Accounting Pronouncements</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">State income tax, net of federal benefit</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ComputerEquipmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Computer Equipment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ComputerEquipmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Computer Equipment [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_PercentageOfTaxBenefitToBeRealizedUponUltimateSettlementWithTaxAuthority_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of tax benefit to be realized upon ultimate settlement with tax authority</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_PercentageOfTaxBenefitToBeRealizedUponUltimateSettlementWithTaxAuthority_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Percentage Of Tax Benefit To Be Realized Upon Ultimate Settlement With Tax Authority</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_PercentageOfTaxBenefitToBeRealizedUponUltimateSettlementWithTaxAuthority_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Percentage of tax benefit to be realized upon ultimate settlement with tax authority.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GainLossOnDispositionOfAssets1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Gains (losses) on disposal of property and equipment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GainLossOnDispositionOfAssets1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Gain (Loss) on Disposition of Assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GainLossOnDispositionOfAssets1_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Gain (Loss) on Disposition of Assets, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">General and Administrative Expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">General and Administrative Expense [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinancialLiabilitiesFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Financial Liabilities Fair Value Disclosure, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinancialLiabilitiesFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Financial Liabilities Fair Value Disclosure</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinancialLiabilitiesFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Financial liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unrecognized compensation expense related to unvested stock options</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current Fiscal Year End Date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Current Fiscal Year End Date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Equity compensation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Compensation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Investment Type</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Investment Type [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Depreciation_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Depreciation expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Depreciation_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Depreciation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Depreciation_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Depreciation, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Financial Instruments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Financial Instruments [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Cash and cash equivalents at beginning of period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Cash and cash equivalents at end of period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Assets, Noncurrent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Other Assets, Noncurrent, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredRevenueNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Deferred revenue long term</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredRevenueNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Long-term deferred revenue</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredRevenueNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Revenue, Noncurrent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredRevenueNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Deferred Revenue, Noncurrent, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentAnnualReport_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Annual Report</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentAnnualReport_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Annual Report</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsAndLiabilitiesLesseeAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets and Liabilities, Lessee [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsAndLiabilitiesLesseeAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Balance sheet information</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccruedLiabilitiesCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Liabilities, Current [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Supplemental cash flow information:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Supplemental cash flow information</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_LesseeOperatingLeaseExpirationYear_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Lessee operating lease expiration year.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_LesseeOperatingLeaseExpirationYear_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee Operating lease Expiration Year</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_LesseeOperatingLeaseExpirationYear_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease expiration year</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ContingentConsiderationTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Contingent Consideration Type [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Income tax expense (benefit)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Expense (Benefit)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Change in federal valuation allowance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Taxes</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Disclosure [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_VestingAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Vesting</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_VestingAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Vesting [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other accruals</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Accrued Liabilities, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Purchases of property and equipment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Payments to Acquire Property, Plant, and Equipment, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Disclosure [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Change in Accounting Principle, Accounting Standards Update, Adoption Date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Change in accounting principle, accounting standards update, adoption date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_LineOfCreditFacilityFrequencyOfPaymentsPrincipalAndInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Line of credit facility frequency of payments principal and interest</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_LineOfCreditFacilityFrequencyOfPaymentsPrincipalAndInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Line Of Credit Facility Frequency Of Payments Principal And Interest</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_LineOfCreditFacilityFrequencyOfPaymentsPrincipalAndInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Line of credit facility frequency of payments principal and interest.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Issuance of common stock for Bioniz acquisition</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Acquisition, Equity Interest Issued or Issuable, Value Assigned</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CollaborativeArrangementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Collaboration and License Agreement</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CollaborativeArrangementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Collaborative Arrangement [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Common stock shares issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock, Shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Shares, New Issues</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxLiabilitiesTaxDeferredIncome_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Deferred revenue</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxLiabilitiesTaxDeferredIncome_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Liabilities, Tax Deferred Income</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityUnitPurchaseAgreementsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Securities Purchase Agreement</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityUnitPurchaseAgreementsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity Unit Purchase Agreements [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityUnitPurchaseAgreementsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Equity Unit Purchase Agreements</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Hierarchy and NAV</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_PrepaidExpensesAndOtherCurrentAssetsPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepaid Expenses and Other Current Assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_PrepaidExpensesAndOtherCurrentAssetsPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Prepaid Expenses And Other Current Assets Policy Policy [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_PrepaidExpensesAndOtherCurrentAssetsPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Disclosure of accounting policy for Prepaid expenses and other current assets.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-Based Compensation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AuditorName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Auditor Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_TwoThousandSeventeenEquityIncentivePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2017 Equity Incentive Plan</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_TwoThousandSeventeenEquityIncentivePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Two Thousand Seventeen Equity Incentive Plan [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_TwoThousandSeventeenEquityIncentivePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Two thousand seventeen equity incentive plan.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted- Average Exercise Price Per Share, Forfeitures and Cancellations</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Loss from operations</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Income (Loss)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt instrument, interest rate, stated percentage</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of shares issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Additional paid-in capital</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Additional Paid in Capital, Common Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Additional Paid in Capital, Common Stock, Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Additional Paid in Capital, Common Stock, Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_USTreasurySecuritiesMaturingBetweenOneAndFiveYearsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">U.S. Treasury Securities Maturing between One and Five years</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_USTreasurySecuritiesMaturingBetweenOneAndFiveYearsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">U S Treasury Securities Maturing Between One And Five Years [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_USTreasurySecuritiesMaturingBetweenOneAndFiveYearsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">U S Treasury Securities maturing between one and five years.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Collaborative Arrangements And Noncollaborative Arrangement Transactions [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Collaborative Arrangement and Arrangement Other than Collaborative [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentInProcess_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Acquired in-process research and development</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentInProcess_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">In-process research and development</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentInProcess_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Research and Development in Process</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFilerCategory_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Filer Category</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFilerCategory_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Filer Category</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_AustralianResearchAndDevelopmentTaxIncentiveProgramMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Australian Research and Development Tax Incentive Program</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_AustralianResearchAndDevelopmentTaxIncentiveProgramMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Australian Research And Development Tax Incentive Program [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_AustralianResearchAndDevelopmentTaxIncentiveProgramMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Australian research and development tax incentive program.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_AccruedNonClinicalResearch_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Non-clinical research</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_AccruedNonClinicalResearch_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Accrued Non-clinical Research.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_AccruedNonClinicalResearch_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Non Clinical Research</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total operating expenses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating expenses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Expenses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCurrentReportingStatus_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Current Reporting Status</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCurrentReportingStatus_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Current Reporting Status</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Asset Class</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Asset Class [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-based compensation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_IcfrAuditorAttestationFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">ICFR Auditor Attestation Flag</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_IcfrAuditorAttestationFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">ICFR Auditor Attestation Flag</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LineOfCreditMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Line of Credit</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LineOfCreditMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Line of Credit [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Aggregate Intrinsic Value, Options Exercisable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrimeRateMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prime Rate</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrimeRateMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Prime Rate [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Short-term investments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Debt Securities, Available-for-sale, Current, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stockholders&#8217; Equity</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total stockholders' equity</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stockholders' Equity Attributable to Parent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_SummaryOfAdditionalInformationRelatedToLeasesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Summary of additional information related to leases.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_SummaryOfAdditionalInformationRelatedToLeasesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Summary Of Additional Information Related To Leases [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_SummaryOfAdditionalInformationRelatedToLeasesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Additional Information Related to Leases</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">AOCI Attributable to Parent [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Effect of exchange rate changes on cash and cash equivalents</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Maturity (in years)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale, Term</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueByAssetClassAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Asset Class</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueByAssetClassAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Asset Class [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Documents Incorporated by Reference</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Documents Incorporated by Reference [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_ContingentConsiderationForAchievementOfRegulatoryEventsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Contingent consideration for achievement of regulatory events.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_ContingentConsiderationForAchievementOfRegulatoryEventsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Contingent Consideration For Achievement of Regulatory Events [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_ContingentConsiderationForAchievementOfRegulatoryEventsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Achievement of Regulatory Events</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Statement Location</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Statement Location [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, $0.0001 par value; 200,000,000 shares authorized as of December 31, 2022 and 2021; 34,414,149 and 29,455,668 shares issued and outstanding as of December 31, 2022 and 2021, respectively</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Value, Issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Common Stock, Value, Issued, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Common Stock, Value, Issued, Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Common Stock, Value, Issued, Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accumulated deficit</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Retained Earnings (Accumulated Deficit)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Retained Earnings (Accumulated Deficit), Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Retained Earnings (Accumulated Deficit), Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Retained Earnings (Accumulated Deficit), Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Foreign rate differential</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Equity Components</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity Components [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationAcquisitionRelatedCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Transaction costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationAcquisitionRelatedCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination, Acquisition Related Costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TypeOfAdoptionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounting Standards Update [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountingStandardsUpdate201613Member_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">ASU 2016-13</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountingStandardsUpdate201613Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounting Standards Update 2016-13 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_SalesMilestonePaymentsUponTheAchievementOfFirstCommercialSaleOfProductAndSpecifiedLevelsOfProductSales_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Sales milestone payments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_SalesMilestonePaymentsUponTheAchievementOfFirstCommercialSaleOfProductAndSpecifiedLevelsOfProductSales_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Sales Milestone Payments Upon The Achievement Of First Commercial Sale Of Product And Specified Levels Of Product Sales</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_SalesMilestonePaymentsUponTheAchievementOfFirstCommercialSaleOfProductAndSpecifiedLevelsOfProductSales_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Sales milestone payments upon the achievement of first commercial sale of product and specified levels of product sales.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash and Cash Equivalents</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeasesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Leases [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_EffectiveIncomeTaxRateReconciliationTransactionCostsAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Transaction costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_EffectiveIncomeTaxRateReconciliationTransactionCostsAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, Transaction Costs, Amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_EffectiveIncomeTaxRateReconciliationTransactionCostsAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Effective Income Tax Rate Reconciliation, Transaction Costs, Amount.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireShortTermInvestments_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Purchases of short-term investments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireShortTermInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payments to Acquire Short-Term Investments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating expenses:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Expenses [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestExpenseDebt_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Interest expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestExpenseDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Interest Expense, Debt</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestExpenseDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Interest Expense, Debt, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_LoanAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Loan Agreement</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_LoanAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Loan Agreement [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_LoanAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Loan Agreement.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Revenue Recognition</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Revenue [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_OptionPeriodExpiryCondition_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Option period expiry condition</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_OptionPeriodExpiryCondition_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Option Period Expiry Condition</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_OptionPeriodExpiryCondition_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Option period expiry condition.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expected term (in years)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_PurchaseRightMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Purchase Right</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_PurchaseRightMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Purchase Right [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_PurchaseRightMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Purchase right.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt Securities Available For Sale [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityVoluntaryFilers_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Voluntary Filers</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityVoluntaryFilers_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Voluntary Filers</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CompensationAndRetirementDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Retirement Benefits [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DepreciationAndAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Depreciation and amortization</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DepreciationAndAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Depreciation, Depletion and Amortization, Nonproduction</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DepreciationAndAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Depreciation, Depletion and Amortization, Nonproduction, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentTransitionReport_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Transition Report</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentTransitionReport_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Transition Report</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepaid expenses and other current assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Components of Loss Before Income Tax Provision (Benefit)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Nonoperating Income (Expense)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total other expense , net</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued Expenses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_ContractLiabilitiesPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Contract liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_ContractLiabilitiesPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Contract Liabilities Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_ContractLiabilitiesPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Contract liabilities policy.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CollaborativeArrangementDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Partnerships</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CollaborativeArrangementDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Collaborative Arrangement Disclosure [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commitments and Contingencies</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Exercise price of repriced options per share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Exercise price of options per share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Foreign</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income (Loss) from Continuing Operations before Income Taxes, Foreign</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accumulated other comprehensive income (loss)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Accumulated Other Comprehensive Income (Loss), Net of Tax, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsReceivableNetCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts receivable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsReceivableNetCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsReceivableNetCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Accounts Receivable, after Allowance for Credit Loss, Current, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Common Stock, Shares Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Common Stock, Shares Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Comprehensive income</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total other comprehensive income, net</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentInterestRateBasisForEffectiveRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt instrument, interest rate, basis for effective rate</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentInterestRateBasisForEffectiveRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Interest Rate, Basis for Effective Rate</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net loss</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net loss</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Income (Loss)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Liability, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current portion of operating lease liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Lease liabilities, current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Additional Paid-in Capital</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Additional Paid-in Capital [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Collaborative Arrangement and Arrangement Other than Collaborative</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssued1_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Issuance of common stock for Bioniz acquisition</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssued1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of commitment shares to Lincoln Park pursuant to agreement</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssued1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityExpirationDate1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Term Loan maturity date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityExpirationDate1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Line of Credit Facility, Expiration Date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net operating loss carryforward</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Operating Loss Carryforwards</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Deferred Tax Assets, Operating Loss Carryforwards, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Line of Credit Facilities [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Aggregate Carrying Amounts of Term Loan</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Maturities of Long-Term Debt [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Future Maturities of Term Loan, Including Final Payment Fee</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_AccretedLiabilityForFinalPaymentFee_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Add: accreted liability for final payment fee</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_AccretedLiabilityForFinalPaymentFee_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accreted Liability For Final Payment Fee</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_AccretedLiabilityForFinalPaymentFee_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Accreted liability for final payment fee.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Foreign currency translation gain</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash and cash equivalents</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Cash and Cash Equivalents, at Carrying Value, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Cash and Cash Equivalents, at Carrying Value, Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Cash and Cash Equivalents, at Carrying Value, Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Weighted-Average Assumptions Used to Determine Fair Value of Stock Option Grants</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaidAsPercent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of final principal payment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaidAsPercent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Periodic Payment Terms Balloon Payment To Be Paid As Percent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaidAsPercent_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Debt instrument periodic payment terms balloon payment to be paid as percent.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeLeaseDescriptionTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Lease, Description [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-based compensation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Share-based Payment Arrangement, Noncash Expense, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Property and equipment, net</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property and equipment, net</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment, Net</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Property, Plant and Equipment, Net, Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Property, Plant and Equipment, Net, Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Less: unamortized discount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Unamortized Discount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Debt Instrument, Unamortized Discount, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Award Type</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Award Type [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statement [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_GrossProceedsFromIssuanceOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Gross proceeds from issuance of common stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_GrossProceedsFromIssuanceOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Gross Proceeds From Issuance Of Common Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_GrossProceedsFromIssuanceOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Gross proceeds from issuance of common stock.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Title of 12(b) Security</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Title of 12(b) Security</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_StockOptionsIssuedAndOutstandingMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock Options Issued and Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_StockOptionsIssuedAndOutstandingMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Options Issued And Outstanding [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_StockOptionsIssuedAndOutstandingMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Stock options issued and outstanding.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_EligibleToReceivePaymentOnAchievementOfCertainDevelopmentMilestones_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Eligible to receive payment on achievement of certain development milestones</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_EligibleToReceivePaymentOnAchievementOfCertainDevelopmentMilestones_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Eligible To Receive Payment On Achievement Of Certain Development Milestones</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_EligibleToReceivePaymentOnAchievementOfCertainDevelopmentMilestones_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Eligible to receive payment on achievement of certain development milestones.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts payable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Accounts Payable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Increase (Decrease) in Accounts Payable, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityInterestIssuedOrIssuableTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity Interest Issued or Issuable, Type [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Award expiration period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_DebtPrepaymentFeeAsPercentOnYearOne_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt prepayment fee as percent on year one</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_DebtPrepaymentFeeAsPercentOnYearOne_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Prepayment Fee As Percent On Year One</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_DebtPrepaymentFeeAsPercentOnYearOne_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Debt prepayment fee as percent on year one.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating activities:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityComponentDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Equity Component</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityComponentDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity Component [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Revenue</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Recognized revenue</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Loss before income tax provision (benefit)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2026</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_EmployeeStockPurchasePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Employee Stock Purchase Plan</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_EmployeeStockPurchasePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2018 Employee Stock Purchase Plan</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_EmployeeStockPurchasePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Employee Stock Purchase Plan [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_EmployeeStockPurchasePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Employee stock purchase plan.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_StatementGeographicalAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Geographical</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_StatementGeographicalAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Geographical [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net increase in cash and cash equivalents</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestPaidNet_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash paid for interest</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestPaidNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Federal tax loss carry forwards</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Operating Loss Carryforwards, Domestic</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_CommitmentsAndContingenciesLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commitments and Contingencies [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_CommitmentsAndContingenciesLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Commitments And Contingencies [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_CommitmentsAndContingenciesLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Commitments and contingencies.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityShellCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Shell Company</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityShellCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Shell Company</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Total non-cash stock-based compensation expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-based compensation expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Significant Accounting Policies</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Significant Accounting Policies [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net cash used in operating activities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity Interest Type [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expected recognition period of unrecognized compensation expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted Average Remaining Contractual Term, Options Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueByBalanceSheetGroupingTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value By Balance Sheet Grouping [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueByBalanceSheetGroupingTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentInterestRateEffectivePercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt instrument, interest rate, effective percentage</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentInterestRateEffectivePercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Interest Rate, Effective Percentage</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued expenses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Accrued Expenses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Business combination recognized identifiable assets acquired and liabilities assumed current liabilities accrued expenses.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestPayableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued interest</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestPayableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Interest Payable, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Maturities of Lease Liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total assets acquired</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WarrantMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Warrants for Common Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WarrantMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common Stock Warrants</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WarrantMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Warrant [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Liabilities assumed:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Stock Option Activity</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Recently Issued and Recently Adopted Accounting Pronouncements</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ReceivablesPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts Receivable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ReceivablesPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Receivable [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, shares outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Shares, Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Common Stock, Shares, Outstanding, Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Common Stock, Shares, Outstanding, Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Acquisition [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accretion (Amortization) of Discounts and Premiums, Investments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Amortization of investments, net</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredRevenueCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Deferred revenue current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredRevenueCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current portion of deferred revenue</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredRevenueCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Revenue, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredRevenueCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Deferred Revenue, Current, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_CumulativeChangeInOwnershipPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cumulative change in ownership period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_CumulativeChangeInOwnershipPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cumulative Change In Ownership Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_CumulativeChangeInOwnershipPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Cumulative change in ownership period.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Investing activities:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Gross increase &#8211; current-period tax positions</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commitments and contingencies</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Commitments and Contingencies</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net liabilities acquired</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxAuthorityNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Tax Authority, Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxAuthorityNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Authority, Name [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, shares issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Shares, Issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Common Stock, Shares, Issued, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_USTreasurySecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">U.S. Treasury Securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_USTreasurySecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">US Treasury Securities [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_DebtInstrumentCarryingAmountIncludingUnaccretedLiabilityForFinalPaymentFee_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Debt instrument carrying amount including unaccreted liability for final payment fee</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_DebtInstrumentCarryingAmountIncludingUnaccretedLiabilityForFinalPaymentFee_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Carrying Amount Including Unaccreted Liability For Final Payment Fee</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_DebtInstrumentCarryingAmountIncludingUnaccretedLiabilityForFinalPaymentFee_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Debt instrument carrying amount including unaccreted liability for final payment fee.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_VariableRateDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Variable Rate</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_VariableRateDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Variable Rate [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_MinimumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Minimum</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_MinimumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Minimum</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_MinimumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Minimum [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentFrequencyOfPeriodicPayment_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt instrument, frequency of periodic payment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentFrequencyOfPeriodicPayment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Frequency of Periodic Payment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Company's Short-Term Investments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash, Cash Equivalents and Investments [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxAuthorityNameAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Tax Authority, Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxAuthorityNameAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Authority, Name [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_CommitmentsAndContingenciesTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commitments And Contingencies [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_CommitmentsAndContingenciesTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Commitments And Contingencies [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_CommitmentsAndContingenciesTable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Commitments and contingencies.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_DebtPrepaymentFeeAsPercentOnYearTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt prepayment fee as percent on year two</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_DebtPrepaymentFeeAsPercentOnYearTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Prepayment Fee As Percent On Year Two</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_DebtPrepaymentFeeAsPercentOnYearTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Debt prepayment fee as percent on year two.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Leases [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Leases</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted- Average Exercise Price Per Share, Exercisable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounting Standards Update [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TaxCreditCarryforwardAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Tax Credit Carryforward</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TaxCreditCarryforwardAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Tax Credit Carryforward [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total accrued expenses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued expenses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Liabilities, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Reconciliation of Unrecognized Tax Benefits</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Summary of Positions for which Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_BusinessCombinationAcquiredInProcessResearchAndDevelopment_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Acquired in-process research and development</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_BusinessCombinationAcquiredInProcessResearchAndDevelopment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination Acquired in Process Research and Development</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_BusinessCombinationAcquiredInProcessResearchAndDevelopment_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Business combination acquired in-Process research and development</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt Instrument</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stockholders' equity:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_AssetPurchaseAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Asset Purchase Agreement</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_AssetPurchaseAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Asset Purchase Agreement [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_AssetPurchaseAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Asset Purchase Agreement.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_CounterpartyNameAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Counterparty Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_CounterpartyNameAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Counterparty Name [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line Two</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line Two</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_UpfrontNonRefundableAndNonCreditablePaymentReceivableUponExchangeOfOption_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Upfront non-refundable and non-creditable payment receivable, upon exchange of option</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_UpfrontNonRefundableAndNonCreditablePaymentReceivableUponExchangeOfOption_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Upfront Non-refundable And Non-creditable Payment Receivable, Upon Exchange Of Option</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_UpfrontNonRefundableAndNonCreditablePaymentReceivableUponExchangeOfOption_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Upfront non-refundable and non-creditable payment receivable, upon exchange of option.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AwardTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Award Type</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AwardTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Award Type [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Subsequent Event</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Event [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total deferred tax assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Gross</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Impairment of Long-Lived Assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Aggregate intrinsic value of stock options exercised</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other income (expense), net</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Nonoperating Income (Expense)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Other Nonoperating Income (Expense), Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtCurrent_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Less current portion</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Term Debt, Current Maturities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Long-term Debt, Current Maturities, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Value, Other</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Issuance of common stock under registered direct offering, net of offering costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock from follow-on offering, net of issuance costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Nonoperating Income (Expense) [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other expense, net:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and development</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Research and Development Expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Research and Development Expense, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total undiscounted lease payments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total minimum lease payment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_ContingentConsiderationForAchievementOfCommercializationEventsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Contingent consideration for achievement of commercialization events.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_ContingentConsiderationForAchievementOfCommercializationEventsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Contingent Consideration For Achievement Of Commercialization Events [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_ContingentConsiderationForAchievementOfCommercializationEventsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Achievement Of Commercialization Events</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Increase in valuation allowance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MortgageNotesPayableDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Notes Payable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MortgageNotesPayableDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Mortgage Notes Payable Disclosure [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounting Policies [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_AustralianResearchAndDevelopmentTaxIncentivePolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Australian Research and Development Tax Incentive</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_AustralianResearchAndDevelopmentTaxIncentivePolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Australian Research And Development Tax Incentive Policy [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_AustralianResearchAndDevelopmentTaxIncentivePolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Australian research and development tax incentive policy.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Investments, Debt and Equity Securities [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Available For Sale Securities [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_OfficeSpaceMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Office Space</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_OfficeSpaceMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Office Space [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_OfficeSpaceMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Office space.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Less accumulated depreciation and amortization</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_AvailableForSaleSecuritiesDebtMaturitiesPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Available for sale Securities debt maturities period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_AvailableForSaleSecuritiesDebtMaturitiesPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Available For Sale Securities Debt Maturities Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_PrepaidAndOtherCurrentAssetsTaxIncentive_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepaid and other current assets tax incentive</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_PrepaidAndOtherCurrentAssetsTaxIncentive_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Prepaid And Other Current Assets Tax Incentive</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_PrepaidAndOtherCurrentAssetsTaxIncentive_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Prepaid and other current assets tax incentive.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Property Plant And Equipment [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expected volatility</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsHeldInTrust_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Assets Held-in-trust with Silicon Valley Bank</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsHeldInTrust_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets Held-in-trust</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsHeldInTrust_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Assets Held-in-trust, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unvested shares issued under early exercise which are subject to repurchase</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Subsequent Event [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Event [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">General and administrative</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">General and Administrative Expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">General and Administrative Expense, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AmortizationOfFinancingCostsAndDiscounts_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amortization of term loan discount and issuance costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AmortizationOfFinancingCostsAndDiscounts_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Amortization of Debt Issuance Costs and Discounts</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AmortizationOfFinancingCostsAndDiscounts_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Amortization of Debt Issuance Costs and Discounts, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_IncomeTaxReconciliationFederalResearchAndOrphanDrugCredits_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Federal research and orphan drug credits</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_IncomeTaxReconciliationFederalResearchAndOrphanDrugCredits_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Reconciliation Federal Research And Orphan Drug Credits</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_IncomeTaxReconciliationFederalResearchAndOrphanDrugCredits_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Income tax reconciliation federal research and orphan drug credits.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Weighted- Average Exercise Price Per Share, Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Weighted- Average Exercise Price Per Share, Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Contingent payments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and Development Expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Research and Development Expense [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_UpfrontPaymentReceived_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Upfront payment received</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_UpfrontPaymentReceived_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Upfront Payment Received</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_UpfrontPaymentReceived_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Upfront payment received.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Right-of-use assets obtained in exchange for lease obligations</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Right-of-use assets obtained in exchange for lease obligations</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Adjustments to reconcile net loss to cash used in operating activities:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accumulated Deficit</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Retained Earnings [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TaxCreditCarryforwardNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Tax Credit Carryforward, Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TaxCreditCarryforwardNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Tax Credit Carryforward, Name [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Business acquisition, common stock shares issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Acquisition, Equity Interest Issued or Issuable, Number of Shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_RequiredNoticePeriodForDebtPrepayment_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Required notice period for debt prepayment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_RequiredNoticePeriodForDebtPrepayment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Required Notice Period For Debt Prepayment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_RequiredNoticePeriodForDebtPrepayment_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Required notice period for debt prepayment.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_ProceedsFromResearchAndDevelopmentFees_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from research and development fees</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_ProceedsFromResearchAndDevelopmentFees_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds From Research and Development Fees</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_ProceedsFromResearchAndDevelopmentFees_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Proceeds from research and development fees.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_DeferredTaxAssetsCapitalizedResearchExpenditures_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Capitalized research expenditures</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_DeferredTaxAssetsCapitalizedResearchExpenditures_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets Capitalized Research Expenditures</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_DeferredTaxAssetsCapitalizedResearchExpenditures_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Deferred Tax Assets Capitalized Research Expenditures.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_ShortTermInvestmentsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Short-Term Investments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_ShortTermInvestmentsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Short Term Investments Policy [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_ShortTermInvestmentsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Disclosure of accounting policy for short-term investments.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_TermLoanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Term loan.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_TermLoanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Term Loan [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_TermLoanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Term Loan</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property and equipment, gross</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment, Gross</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Property, Plant and Equipment, Gross, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Property, Plant and Equipment, Gross, Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Property, Plant and Equipment, Gross, Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Vesting percentage</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Interactive Data Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Interactive Data Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityPublicFloat_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Public Float</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityPublicFloat_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Public Float</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLossCarryforwardsLimitationsOnUse_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating loss carryforwards, Limitation of use</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLossCarryforwardsLimitationsOnUse_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Loss Carryforwards, Limitations on Use</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2023</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_UnvestedStockLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unvested stock liability</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_UnvestedStockLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Unvested Stock Liability</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_UnvestedStockLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Unvested stock liability.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseholdImprovementsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Leasehold improvements</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseholdImprovementsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Leasehold Improvements [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_InitialTransactionPrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Initial transaction price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_InitialTransactionPrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Initial Transaction Price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_InitialTransactionPrice_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Initial transaction price.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Unrecognized tax benefits &#8211; beginning</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Unrecognized tax benefits &#8211; ending</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Unrecognized Tax Benefits</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Assets that Require Fair Value Measurements on Recurring Basis and Their Respective Input Levels Based on Fair Value Hierarchy</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Assets Measured on Recurring Basis [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Expense (Benefit), Effective Income Tax Rate Reconciliation, Amount [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Disclosure [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of Outstanding Options, Exercisable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_OneTimePaymentReceivableUponExercisesTheOption_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">One-time payment receivable, upon exercises the option</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_OneTimePaymentReceivableUponExercisesTheOption_lbl" xlink:role="http://www.xbrl.org/2003/role/label">One-Time Payment Receivable Upon Exercises The Option</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_OneTimePaymentReceivableUponExercisesTheOption_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">One-time payment receivable upon exercises the option.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Retention stock options issued to purchase common shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of Outstanding Options, Granted</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_ResearchAndDevelopmentTaxIncentiveRevenueCriteria_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Revenue for availability of research and development tax incentive</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_ResearchAndDevelopmentTaxIncentiveRevenueCriteria_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Research And Development Tax Incentive Revenue Criteria</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_ResearchAndDevelopmentTaxIncentiveRevenueCriteria_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Research and development tax incentive revenue criteria.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_AwardsAvailableUnder2018PlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Awards Available Under 2018 Equity Incentive Plan</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_AwardsAvailableUnder2018PlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Awards Available Under2018 Plan [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_AwardsAvailableUnder2018PlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Awards available under 2018 plan.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeStatementLocationDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Statement Location</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeStatementLocationDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Statement Location [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total liabilities assumed</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Term Debt</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Prepaid expenses and other current assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Increase (Decrease) in Prepaid Expense and Other Assets, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_PurchaseAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Purchase Agreement</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_PurchaseAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Purchase Agreement [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_PurchaseAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Purchase Agreement.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ContingentConsiderationByTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Contingent Consideration by Type [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityIncorporationDateOfIncorporation_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation, Date of Incorporation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityIncorporationDateOfIncorporation_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Date of incorporation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Repricing of outstanding options</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Number of Outstanding Options, Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Number of Outstanding Options, Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Closing stock price per share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_SummaryOfSignificantAccountingPoliciesLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary Of Significant Accounting Policies [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_SummaryOfSignificantAccountingPoliciesLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Summary Of Significant Accounting Policies [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_SummaryOfSignificantAccountingPoliciesLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Summary of significant accounting policies.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt Instrument, Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Name [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentFiscalYearFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Fiscal Year Focus</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentFiscalYearFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Fiscal Year Focus</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_AccruedResearchAndDevelopmentExpensePolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued Research and Development Expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_AccruedResearchAndDevelopmentExpensePolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Research And Development Expense Policy [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_AccruedResearchAndDevelopmentExpensePolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Accrued research and development expense policy.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Maturities of short-term investments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Maturities, Prepayments and Calls of Short-Term Investments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2024</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_VestingDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Vesting</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_VestingDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Vesting [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_TermsOfMergerAgreement_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Business acquisition, term for finalization after the closing</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_TermsOfMergerAgreement_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Terms Of Merger Agreement</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_TermsOfMergerAgreement_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Terms of merger agreement.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net loss per share, basic</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share, Basic</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Earnings Per Share, Basic, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Vesting of restricted stock liability</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition_lbl" xlink:role="http://www.xbrl.org/2003/role/label">APIC, Share-Based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TaxCreditCarryforwardTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Tax Credit Carryforward [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TaxCreditCarryforwardTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Tax Credit Carryforward [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Retirement Plan</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Compensation and Employee Benefit Plans [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued expenses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Accrued Liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Increase (Decrease) in Accrued Liabilities, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentsFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total short-term investments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentsFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Investments, Fair Value Disclosure</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentsFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Investments, Fair Value Disclosure, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_SummaryOfReconciliationOfExpectedStatutoryFederalIncomeTaxProvisionToActualIncomeTaxProvisionTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Reconciliation of Expected Statutory Federal Income Tax Provision to Actual Income Tax Provision</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_SummaryOfReconciliationOfExpectedStatutoryFederalIncomeTaxProvisionToActualIncomeTaxProvisionTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Summary Of Reconciliation Of Expected Statutory Federal Income Tax Provision To Actual Income Tax Provision Table [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_SummaryOfReconciliationOfExpectedStatutoryFederalIncomeTaxProvisionToActualIncomeTaxProvisionTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Summary of reconciliation of expected statutory federal income tax provision to actual income tax provision.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net deferred taxes</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Net</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_DividendsPaidOnCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Dividends paid</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_DividendsPaidOnCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Dividends Paid On Common Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_DividendsPaidOnCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Dividends paid on common stock.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepaid expenses and other current assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Prepaid Expense and Other Assets, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharesIssuedPricePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Sale of stock, price per share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharesIssuedPricePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Shares Issued, Price Per Share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinancialInstrumentAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Financial Instrument</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinancialInstrumentAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Financial Instrument [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_ResearchAndDevelopmentServicesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and Development Services</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_ResearchAndDevelopmentServicesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Research and Development Services [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_ResearchAndDevelopmentServicesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Research and development services.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Long-Lived Tangible Asset</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Lived Tangible Asset [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Liabilities and stockholders' equity</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities and Equity [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_UpfrontPaymentAmortizationMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Upfront Payment Amortization</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_UpfrontPaymentAmortizationMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Upfront Payment Amortization [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_UpfrontPaymentAmortizationMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Upfront payment amortization.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Shares, Other</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Issuance of common stock under registered direct offering, net of offering costs , Shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock from follow-on offering, net of issuance costs,Shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property and Equipment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Antidilutive Securities, Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities, Name [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxAuthorityAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Tax Authority</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxAuthorityAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Authority [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsNet_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total deferred tax assets, net of allowance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Net of Valuation Allowance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProfitLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net loss</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProfitLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProfitLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_CertificatesOfDepositMaturingInOneYearOrLessMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Certificates of Deposit Maturing in One Year or Less</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_CertificatesOfDepositMaturingInOneYearOrLessMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Certificates Of Deposit Maturing In One Year Or Less [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_CertificatesOfDepositMaturingInOneYearOrLessMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Certificates of deposit maturing in one year or less.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_USTreasurySecuritiesMaturingInOneYearOrLessMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">U.S. Treasury Securities Maturing in One Year or Less</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_USTreasurySecuritiesMaturingInOneYearOrLessMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">U S Treasury Securities Maturing In One Year Or Less [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_USTreasurySecuritiesMaturingInOneYearOrLessMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">U S Treasury Securities maturing in one year or less.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossUnrealized_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Net unrealized loss on foreign currency transactions</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossUnrealized_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Foreign Currency Transaction Gain (Loss), Unrealized</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current assets:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets, Current [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_RegisteredDirectOfferingsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Registered direct offerings.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_RegisteredDirectOfferingsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Registered direct offerings [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_RegisteredDirectOfferingsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Registered Direct Offering</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrants exercisable, per share exercise price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Warrant or Right, Exercise Price of Warrants or Rights</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Significant Components of Deferred Tax Assets and Liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxLiabilitiesOther_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Other</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxLiabilitiesOther_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Liabilities, Other</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Hierarchy and NAV</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Gross increases &#8211; tax positions in prior period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Employer's matching contributions to 401(k) plan</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Defined Contribution Plan, Employer Discretionary Contribution Amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Changes in operating assets and liabilities:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RepaymentsOfNotesPayable_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Principal repayments on note payable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RepaymentsOfNotesPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Repayments of Notes Payable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentDisposals_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Disposal of property and equipment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentDisposals_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment, Disposals</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">U.S.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income (Loss) from Continuing Operations before Income Taxes, Domestic</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_OperatingLossCarryforwardsExpirationYear_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Federal and state net operating loss carry forwards, Expiration year</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_OperatingLossCarryforwardsExpirationYear_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Loss Carryforwards Expiration Year</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_OperatingLossCarryforwardsExpirationYear_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Operating loss carryforwards expiration year.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ProductsAndServicesDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Product and Service [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2027</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid, Year Five</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossRealized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Foreign curreny realized gain</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossRealized_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Foreign Currency Transaction Gain (Loss), Realized</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_CumulativeChangeInOwnershipPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cumulative change in ownership percentage</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_CumulativeChangeInOwnershipPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cumulative Change In Ownership Percentage</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_CumulativeChangeInOwnershipPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Cumulative change in ownership percentage.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current liabilities:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities, Current [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_MaximumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Maximum</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_MaximumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Maximum [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRemainingVestingPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Remaining vesting period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRemainingVestingPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Award Remaining Vesting Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRemainingVestingPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Remaining vesting period of share based compensation arrangement.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Non-cash Stock-based Compensation Expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_OnoPharmaceuticalCoLtdMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Ono</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_OnoPharmaceuticalCoLtdMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Ono Pharmaceutical Co., Ltd [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_OnoPharmaceuticalCoLtdMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Ono Pharmaceutical Co., Ltd.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other-than-temporary Impairment Loss, Debt Securities, Available-for-Sale, Recognized in Earnings</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other than temporary impairment loss investments available for sale securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net cash provided by investing activities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FurnitureAndFixturesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Furniture And Fixtures</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FurnitureAndFixturesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Furniture and Fixtures [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_LaboratorySpaceMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Laboratory Space</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_LaboratorySpaceMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Laboratory Space [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_LaboratorySpaceMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Laboratory space.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Number of Outstanding Options, Exercised</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Exercise of stock options, Shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UseOfEstimates_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Use of Estimates</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UseOfEstimates_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt instrument, basis spread on variable rate</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxLiabilities_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel">Total deferred tax liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Liabilities, Gross</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Deferred Tax Liabilities, Gross, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_TermOfPurchaseAgreement_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Term of purchase agreement</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_TermOfPurchaseAgreement_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Term Of Purchase Agreement</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_TermOfPurchaseAgreement_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Term of purchase agreement.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Exercise of stock options</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property and equipment, useful lives</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment, Useful Life</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ForeignCountryMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Foreign Tax Authority [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ForeignCountryMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Foreign</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsNetAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred tax assets:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsNetAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Net [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_IncomeTaxReconciliationPermanentItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Permanent items</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_IncomeTaxReconciliationPermanentItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Reconciliation Permanent Items</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_IncomeTaxReconciliationPermanentItems_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Income tax expense (benefit) reconciliation permanent items.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_ResearchAndExperimentalExpendituresCapitalizedCostAmortizationPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Research and experimental expenditures capitalized cost amortization period.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_ResearchAndExperimentalExpendituresCapitalizedCostAmortizationPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Research And Experimental Expenditures Capitalized Cost Amortization Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_ResearchAndExperimentalExpendituresCapitalizedCostAmortizationPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and experimental expenditures capitalized cost amortization period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentCarryingAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Principal</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentCarryingAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Term Debt, Gross</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, shares authorized</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Shares Authorized</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Subsequent Event Type</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Event Type [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOther_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOther_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Other</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_SummaryOfSignificantAccountingPoliciesTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary Of Significant Accounting Policies [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_SummaryOfSignificantAccountingPoliciesTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Summary Of Significant Accounting Policies [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_SummaryOfSignificantAccountingPoliciesTable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Summary of significant accounting policies.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Comprehensive loss</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Risk-free interest rate</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts payable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounts Payable, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Accounts Payable, Current, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Unrealized losses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PlanNameAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Plan Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PlanNameAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Plan Name [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AustralianTaxationOfficeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Australian Taxation Office</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AustralianTaxationOfficeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Australian Taxation Office [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_TwoThousandEighteenEquityIncentivePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2018 Equity Incentive Plan</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_TwoThousandEighteenEquityIncentivePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Two Thousand Eighteen Equity Incentive Plan [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_TwoThousandEighteenEquityIncentivePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Two thousand eighteen equity incentive plan.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income taxes at statutory rates</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Long-Lived Tangible Asset</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Lived Tangible Asset [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, par value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Par or Stated Value Per Share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Well-known Seasoned Issuer</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Well-known Seasoned Issuer</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_LincolnParkCapitalFundLLCMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lincoln Park Capital Fund, LLC</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_LincolnParkCapitalFundLLCMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lincoln Park Capital Fund L L C [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_LincolnParkCapitalFundLLCMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Lincoln Park Capital Fund, LLC.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Comprehensive Loss</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Comprehensive Income, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_EquityIncentivePlanDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Equity incentive plan description</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_EquityIncentivePlanDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity Incentive Plan Description</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_EquityIncentivePlanDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Equity incentive plan description.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property and Equipment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment Disclosure [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_LesseeOperatingLeaseExpiredDate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease expired date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_LesseeOperatingLeaseExpiredDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee Operating Lease Expired Date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_LesseeOperatingLeaseExpiredDate_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Lessee operating lease expired date.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted- Average Exercise Price Per Share, Granted</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_EstimatedMaximumAmountOfCommonStockIssuable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Estimated maximum amount of common stock issuable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_EstimatedMaximumAmountOfCommonStockIssuable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Estimated Maximum Amount Of Common Stock Issuable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_EstimatedMaximumAmountOfCommonStockIssuable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Estimated maximum amount of common stock issuable.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of shares available for future issuance under employee stock purchase plan</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_PatentCostsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Patent Costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_PatentCostsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Patent Costs Policy [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="eq_PatentCostsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Patent costs.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt Instrument [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongtermDebtTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Long-term Debt, Type</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongtermDebtTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Term Debt, Type [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Antidilutive securities not included in calculation of diluted net loss per share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TaxCreditCarryforwardLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Tax Credit Carryforward [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TaxCreditCarryforwardLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Tax Credit Carryforward [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:to="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOfAssetsAcquired" xlink:to="us-gaap_FairValueOfAssetsAcquired_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel1Member" xlink:to="us-gaap_FairValueInputsLevel1Member_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DomesticCountryMember" xlink:to="us-gaap_DomesticCountryMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment" xlink:to="us-gaap_IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eq_EstimatedResearchAndDevelopmentFunding" xlink:to="eq_EstimatedResearchAndDevelopmentFunding_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eq_UnaccretedLiabilityForFinalPaymentFee" xlink:to="eq_UnaccretedLiabilityForFinalPaymentFee_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCredit" xlink:to="us-gaap_LineOfCredit_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:to="us-gaap_CapitalExpendituresIncurredButNotYetPaid_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock" xlink:to="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventTypeDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eq_OtherOperatingLeaseInformationAbstract" xlink:to="eq_OtherOperatingLeaseInformationAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eq_AcquiredInProcessResearchAndDevelopment" xlink:to="eq_AcquiredInProcessResearchAndDevelopment_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eq_OperatingLossCarryforwardsLimitationRateOnTaxableIncome" xlink:to="eq_OperatingLossCarryforwardsLimitationRateOnTaxableIncome_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eq_DebtInstrumentCarryingAmountIncludingUnaccretedLiabilityForFinalPaymentFeeMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="eq_DebtInstrumentCarryingAmountIncludingUnaccretedLiabilityForFinalPaymentFeeMaturitiesRepaymentsOfPrincipalInYearTwo_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermNotesPayable" xlink:to="us-gaap_LongTermNotesPayable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eq_FairMarketValueOfCommitmentShares" xlink:to="eq_FairMarketValueOfCommitmentShares_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermDebtLineItems" xlink:to="us-gaap_ShortTermDebtLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasePayments" xlink:to="us-gaap_OperatingLeasePayments_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:to="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAssumed1" xlink:to="us-gaap_LiabilitiesAssumed1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MachineryAndEquipmentMember" xlink:to="us-gaap_MachineryAndEquipmentMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eq_TaxCreditCarryforwardExpirationYear" xlink:to="eq_TaxCreditCarryforwardExpirationYear_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorFirmId" xlink:to="dei_AuditorFirmId_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:to="us-gaap_IncreaseDecreaseInDeferredRevenue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="us-gaap_BusinessCombinationDisclosureTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssued" xlink:to="us-gaap_SharesIssued_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_IncomeTaxAuthorityDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eq_UpfrontNonRefundableAndNonCreditablePaymentInvoiced" xlink:to="eq_UpfrontNonRefundableAndNonCreditablePaymentInvoiced_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eq_BioconMember" xlink:to="eq_BioconMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductOrServiceAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeStockMember" xlink:to="us-gaap_EmployeeStockMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LitigationSettlementExpense" xlink:to="us-gaap_LitigationSettlementExpense_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eq_CollaborationAndLicenseAgreementAbstract" xlink:to="eq_CollaborationAndLicenseAgreementAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="us-gaap_LesseeOperatingLeasesTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeStockOptionMember" xlink:to="us-gaap_EmployeeStockOptionMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:to="us-gaap_DeferredTaxLiabilitiesLeasingArrangements_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameDomain" xlink:to="us-gaap_PlanNameDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromStockPlans" xlink:to="us-gaap_ProceedsFromStockPlans_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenue" xlink:to="us-gaap_DeferredRevenue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eq_NumberOfInstitutionalInvestors" xlink:to="eq_NumberOfInstitutionalInvestors_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:to="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwards" xlink:to="us-gaap_OperatingLossCarryforwards_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAcquiredFromAcquisition" xlink:to="us-gaap_CashAcquiredFromAcquisition_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eq_WithholdPercentageOfEmployeesEarningsToPurchaseSharesOfCommonStock" xlink:to="eq_WithholdPercentageOfEmployeesEarningsToPurchaseSharesOfCommonStock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VariableRateAxis" xlink:to="us-gaap_VariableRateAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_TypeOfArrangementAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_InvestmentTypeCategorizationMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eq_AccruedClinicalDevelopment" xlink:to="eq_AccruedClinicalDevelopment_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eq_UpfrontAndNonCreditablePaymentInvoiced" xlink:to="eq_UpfrontAndNonCreditablePaymentInvoiced_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eq_PurchaseAgreementExpirationDate" xlink:to="eq_PurchaseAgreementExpirationDate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShortTermDebtTable" xlink:to="us-gaap_ScheduleOfShortTermDebtTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eq_EmployeeStockPurchasePlanDescription" xlink:to="eq_EmployeeStockPurchasePlanDescription_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax" xlink:to="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_AU" xlink:to="country_AU_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:to="us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InProcessResearchAndDevelopmentPolicy" xlink:to="us-gaap_InProcessResearchAndDevelopmentPolicy_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eq_DebtInstrumentCarryingAmountIncludingUnaccretedLiabilityForFinalPaymentFeeMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="eq_DebtInstrumentCarryingAmountIncludingUnaccretedLiabilityForFinalPaymentFeeMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eq_ShortTermInvestmentsTextBlock" xlink:to="eq_ShortTermInvestmentsTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:to="us-gaap_ShareBasedCompensationAwardTrancheOneMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeAxis" xlink:to="srt_RangeAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eq_SiliconValleyBankMember" xlink:to="eq_SiliconValleyBankMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eq_ATMMember" xlink:to="eq_ATMMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SubsequentEventLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eq_DebtPrepaymentFeeAsPercentFromYearThree" xlink:to="eq_DebtPrepaymentFeeAsPercentFromYearThree_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eq_DebtInstrumentCarryingAmountIncludingUnaccretedLiabilityForFinalPaymentFeeMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="eq_DebtInstrumentCarryingAmountIncludingUnaccretedLiabilityForFinalPaymentFeeMaturitiesRepaymentsOfPrincipalInYearThree_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StateAndLocalJurisdictionMember" xlink:to="us-gaap_StateAndLocalJurisdictionMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtNoncurrent" xlink:to="us-gaap_LongTermDebtNoncurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eq_ContractAssetsPolicyPolicyTextBlock" xlink:to="eq_ContractAssetsPolicyPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eq_EighteenMonthsAfterClosingMember" xlink:to="eq_EighteenMonthsAfterClosingMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CertificatesOfDepositMember" xlink:to="us-gaap_CertificatesOfDepositMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesAbstract" xlink:to="us-gaap_DeferredTaxLiabilitiesAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentIncomeInterest" xlink:to="us-gaap_InvestmentIncomeInterest_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eq_BionizTherapeuticsIncMember" xlink:to="eq_BionizTherapeuticsIncMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesPayable" xlink:to="us-gaap_NotesPayable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eq_OneTimeNonRefundablePaymentReceivableUponExercisesTheOption" xlink:to="eq_OneTimeNonRefundablePaymentReceivableUponExercisesTheOption_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="stpr_CA" xlink:to="stpr_CA_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eq_IncreaseDecreaseInRightOfUseAssetsAndLeaseLiabilitiesNet" xlink:to="eq_IncreaseDecreaseInRightOfUseAssetsAndLeaseLiabilitiesNet_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_SegmentGeographicalDomain" xlink:to="srt_SegmentGeographicalDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeMember" xlink:to="srt_RangeMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementOfStockholdersEquityAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SubsidiarySaleOfStockAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorLocation" xlink:to="dei_AuditorLocation_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eq_CommonStockReservedForFutureIssuanceTableTextBlock" xlink:to="eq_CommonStockReservedForFutureIssuanceTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesPayableCurrent" xlink:to="us-gaap_NotesPayableCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresTextBlock" xlink:to="us-gaap_FairValueDisclosuresTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromStockOptionsExercised" xlink:to="us-gaap_ProceedsFromStockOptionsExercised_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eq_MinimumOptionsExercisePriceAsPercentageOfFairMarketValueOfCommonStock" xlink:to="eq_MinimumOptionsExercisePriceAsPercentageOfFairMarketValueOfCommonStock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eq_RegulatoryMilestonePaymentsUponAchievementOfCertainRegulatoryApprovals" xlink:to="eq_RegulatoryMilestonePaymentsUponAchievementOfCertainRegulatoryApprovals_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskCreditRisk" xlink:to="us-gaap_ConcentrationRiskCreditRisk_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LesseeLeaseDescriptionLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:to="us-gaap_CashCashEquivalentsAndShortTermInvestments_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eq_FollowOnOfferingMember" xlink:to="eq_FollowOnOfferingMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eq_MinimumStockPricePerShareAsPercentageOfFairMarketValueOfCommonStock" xlink:to="eq_MinimumStockPricePerShareAsPercentageOfFairMarketValueOfCommonStock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:to="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComputerEquipmentMember" xlink:to="us-gaap_ComputerEquipmentMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eq_PercentageOfTaxBenefitToBeRealizedUponUltimateSettlementWithTaxAuthority" xlink:to="eq_PercentageOfTaxBenefitToBeRealizedUponUltimateSettlementWithTaxAuthority_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnDispositionOfAssets1" xlink:to="us-gaap_GainLossOnDispositionOfAssets1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:to="us-gaap_FinancialLiabilitiesFairValueDisclosure_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Depreciation" xlink:to="us-gaap_Depreciation_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsNoncurrent" xlink:to="us-gaap_OtherAssetsNoncurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenueNoncurrent" xlink:to="us-gaap_DeferredRevenueNoncurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAndLiabilitiesLesseeAbstract" xlink:to="us-gaap_AssetsAndLiabilitiesLesseeAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:to="us-gaap_AccruedLiabilitiesCurrentAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eq_LesseeOperatingLeaseExpirationYear" xlink:to="eq_LesseeOperatingLeaseExpirationYear_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContingentConsiderationTypeDomain" xlink:to="us-gaap_ContingentConsiderationTypeDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VestingAxis" xlink:to="us-gaap_VestingAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eq_LineOfCreditFacilityFrequencyOfPaymentsPrincipalAndInterest" xlink:to="eq_LineOfCreditFacilityFrequencyOfPaymentsPrincipalAndInterest_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" xlink:to="us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CollaborativeArrangementMember" xlink:to="us-gaap_CollaborativeArrangementMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesTaxDeferredIncome" xlink:to="us-gaap_DeferredTaxLiabilitiesTaxDeferredIncome_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityUnitPurchaseAgreementsMember" xlink:to="us-gaap_EquityUnitPurchaseAgreementsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eq_PrepaidExpensesAndOtherCurrentAssetsPolicyPolicyTextBlock" xlink:to="eq_PrepaidExpensesAndOtherCurrentAssetsPolicyPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorName" xlink:to="dei_AuditorName_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_EquityAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eq_TwoThousandSeventeenEquityIncentivePlanMember" xlink:to="eq_TwoThousandSeventeenEquityIncentivePlanMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eq_USTreasurySecuritiesMaturingBetweenOneAndFiveYearsMember" xlink:to="eq_USTreasurySecuritiesMaturingBetweenOneAndFiveYearsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentInProcess" xlink:to="us-gaap_ResearchAndDevelopmentInProcess_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eq_AustralianResearchAndDevelopmentTaxIncentiveProgramMember" xlink:to="eq_AustralianResearchAndDevelopmentTaxIncentiveProgramMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eq_AccruedNonClinicalResearch" xlink:to="eq_AccruedNonClinicalResearch_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:to="us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_IcfrAuditorAttestationFlag" xlink:to="dei_IcfrAuditorAttestationFlag_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditMember" xlink:to="us-gaap_LineOfCreditMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrimeRateMember" xlink:to="us-gaap_PrimeRateMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eq_SummaryOfAdditionalInformationRelatedToLeasesTableTextBlock" xlink:to="eq_SummaryOfAdditionalInformationRelatedToLeasesTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleTerm" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleTerm_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByAssetClassAxis" xlink:to="us-gaap_FairValueByAssetClassAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eq_ContingentConsiderationForAchievementOfRegulatoryEventsMember" xlink:to="eq_ContingentConsiderationForAchievementOfRegulatoryEventsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:to="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:to="us-gaap_BusinessCombinationAcquisitionRelatedCosts_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TypeOfAdoptionMember" xlink:to="us-gaap_TypeOfAdoptionMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingStandardsUpdate201613Member" xlink:to="us-gaap_AccountingStandardsUpdate201613Member_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eq_SalesMilestonePaymentsUponTheAchievementOfFirstCommercialSaleOfProductAndSpecifiedLevelsOfProductSales" xlink:to="eq_SalesMilestonePaymentsUponTheAchievementOfFirstCommercialSaleOfProductAndSpecifiedLevelsOfProductSales_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LeasesAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eq_EffectiveIncomeTaxRateReconciliationTransactionCostsAmount" xlink:to="eq_EffectiveIncomeTaxRateReconciliationTransactionCostsAmount_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireShortTermInvestments" xlink:to="us-gaap_PaymentsToAcquireShortTermInvestments_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpenseDebt" xlink:to="us-gaap_InterestExpenseDebt_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eq_LoanAgreementMember" xlink:to="eq_LoanAgreementMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eq_OptionPeriodExpiryCondition" xlink:to="eq_OptionPeriodExpiryCondition_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eq_PurchaseRightMember" xlink:to="eq_PurchaseRightMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="us-gaap_CompensationAndRetirementDisclosureAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationAndAmortization" xlink:to="us-gaap_DepreciationAndAmortization_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:to="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:to="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eq_ContractLiabilitiesPolicyPolicyTextBlock" xlink:to="eq_ContractLiabilitiesPolicyPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:to="us-gaap_CollaborativeArrangementDisclosureTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableNetCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTax_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateBasisForEffectiveRate" xlink:to="us-gaap_DebtInstrumentInterestRateBasisForEffectiveRate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssued1" xlink:to="us-gaap_StockIssued1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityExpirationDate1" xlink:to="us-gaap_LineOfCreditFacilityExpirationDate1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock" xlink:to="us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:to="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eq_AccretedLiabilityForFinalPaymentFee" xlink:to="eq_AccretedLiabilityForFinalPaymentFee_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eq_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaidAsPercent" xlink:to="eq_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaidAsPercent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeLeaseDescriptionTable" xlink:to="us-gaap_LesseeLeaseDescriptionTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentUnamortizedDiscount" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscount_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eq_GrossProceedsFromIssuanceOfCommonStock" xlink:to="eq_GrossProceedsFromIssuanceOfCommonStock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseExpense" xlink:to="us-gaap_OperatingLeaseExpense_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eq_StockOptionsIssuedAndOutstandingMember" xlink:to="eq_StockOptionsIssuedAndOutstandingMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eq_EligibleToReceivePaymentOnAchievementOfCertainDevelopmentMilestones" xlink:to="eq_EligibleToReceivePaymentOnAchievementOfCertainDevelopmentMilestones_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityInterestIssuedOrIssuableTypeDomain" xlink:to="us-gaap_EquityInterestIssuedOrIssuableTypeDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eq_DebtPrepaymentFeeAsPercentOnYearOne" xlink:to="eq_DebtPrepaymentFeeAsPercentOnYearOne_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_EquityComponentDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eq_EmployeeStockPurchasePlanMember" xlink:to="eq_EmployeeStockPurchasePlanMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_StatementGeographicalAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaidNet" xlink:to="us-gaap_InterestPaidNet_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eq_CommitmentsAndContingenciesLineItems" xlink:to="eq_CommitmentsAndContingenciesLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:to="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="us-gaap_FairValueByBalanceSheetGroupingTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:to="us-gaap_DebtInstrumentInterestRateEffectivePercentage_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eq_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" xlink:to="eq_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPayableCurrent" xlink:to="us-gaap_InterestPayableCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantMember" xlink:to="us-gaap_WarrantMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ReceivablesPolicyTextBlock" xlink:to="us-gaap_ReceivablesPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessAcquisitionLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:to="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenueCurrent" xlink:to="us-gaap_DeferredRevenueCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eq_CumulativeChangeInOwnershipPeriod" xlink:to="eq_CumulativeChangeInOwnershipPeriod_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxAuthorityNameDomain" xlink:to="us-gaap_IncomeTaxAuthorityNameDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_USTreasurySecuritiesMember" xlink:to="us-gaap_USTreasurySecuritiesMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eq_DebtInstrumentCarryingAmountIncludingUnaccretedLiabilityForFinalPaymentFee" xlink:to="eq_DebtInstrumentCarryingAmountIncludingUnaccretedLiabilityForFinalPaymentFee_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VariableRateDomain" xlink:to="us-gaap_VariableRateDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MinimumMember" xlink:to="srt_MinimumMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFrequencyOfPeriodicPayment" xlink:to="us-gaap_DebtInstrumentFrequencyOfPeriodicPayment_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" xlink:to="us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxAuthorityNameAxis" xlink:to="us-gaap_IncomeTaxAuthorityNameAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eq_CommitmentsAndContingenciesTable" xlink:to="eq_CommitmentsAndContingenciesTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eq_DebtPrepaymentFeeAsPercentOnYearTwo" xlink:to="eq_DebtPrepaymentFeeAsPercentOnYearTwo_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TaxCreditCarryforwardAxis" xlink:to="us-gaap_TaxCreditCarryforwardAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock" xlink:to="us-gaap_SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eq_BusinessCombinationAcquiredInProcessResearchAndDevelopment" xlink:to="eq_BusinessCombinationAcquiredInProcessResearchAndDevelopment_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eq_AssetPurchaseAgreementMember" xlink:to="eq_AssetPurchaseAgreementMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_CounterpartyNameAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eq_UpfrontNonRefundableAndNonCreditablePaymentReceivableUponExchangeOfOption" xlink:to="eq_UpfrontNonRefundableAndNonCreditablePaymentReceivableUponExchangeOfOption_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_AwardTypeAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncomeExpense" xlink:to="us-gaap_OtherNonoperatingIncomeExpense_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtCurrent" xlink:to="us-gaap_LongTermDebtCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueOther" xlink:to="us-gaap_StockIssuedDuringPeriodValueOther_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_NonoperatingIncomeExpenseAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eq_ContingentConsiderationForAchievementOfCommercializationEventsMember" xlink:to="eq_ContingentConsiderationForAchievementOfCommercializationEventsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:to="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MortgageNotesPayableDisclosureTextBlock" xlink:to="us-gaap_MortgageNotesPayableDisclosureTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eq_AustralianResearchAndDevelopmentTaxIncentivePolicyTextBlock" xlink:to="eq_AustralianResearchAndDevelopmentTaxIncentivePolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eq_OfficeSpaceMember" xlink:to="eq_OfficeSpaceMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eq_AvailableForSaleSecuritiesDebtMaturitiesPeriod" xlink:to="eq_AvailableForSaleSecuritiesDebtMaturitiesPeriod_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eq_PrepaidAndOtherCurrentAssetsTaxIncentive" xlink:to="eq_PrepaidAndOtherCurrentAssetsTaxIncentive_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsHeldInTrust" xlink:to="us-gaap_AssetsHeldInTrust_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:to="us-gaap_AmortizationOfFinancingCostsAndDiscounts_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eq_IncomeTaxReconciliationFederalResearchAndOrphanDrugCredits" xlink:to="eq_IncomeTaxReconciliationFederalResearchAndOrphanDrugCredits_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:to="us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eq_UpfrontPaymentReceived" xlink:to="eq_UpfrontPaymentReceived_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TaxCreditCarryforwardNameDomain" xlink:to="us-gaap_TaxCreditCarryforwardNameDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:to="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eq_RequiredNoticePeriodForDebtPrepayment" xlink:to="eq_RequiredNoticePeriodForDebtPrepayment_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eq_ProceedsFromResearchAndDevelopmentFees" xlink:to="eq_ProceedsFromResearchAndDevelopmentFees_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eq_DeferredTaxAssetsCapitalizedResearchExpenditures" xlink:to="eq_DeferredTaxAssetsCapitalizedResearchExpenditures_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eq_ShortTermInvestmentsPolicyTextBlock" xlink:to="eq_ShortTermInvestmentsPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eq_TermLoanMember" xlink:to="eq_TermLoanMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwardsLimitationsOnUse" xlink:to="us-gaap_OperatingLossCarryforwardsLimitationsOnUse_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eq_UnvestedStockLiability" xlink:to="eq_UnvestedStockLiability_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseholdImprovementsMember" xlink:to="us-gaap_LeaseholdImprovementsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eq_InitialTransactionPrice" xlink:to="eq_InitialTransactionPrice_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefits" xlink:to="us-gaap_UnrecognizedTaxBenefits_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:to="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtDisclosureAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eq_OneTimePaymentReceivableUponExercisesTheOption" xlink:to="eq_OneTimePaymentReceivableUponExercisesTheOption_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eq_ResearchAndDevelopmentTaxIncentiveRevenueCriteria" xlink:to="eq_ResearchAndDevelopmentTaxIncentiveRevenueCriteria_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eq_AwardsAvailableUnder2018PlanMember" xlink:to="eq_AwardsAvailableUnder2018PlanMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_IncomeStatementLocationDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebt" xlink:to="us-gaap_LongTermDebt_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eq_PurchaseAgreementMember" xlink:to="eq_PurchaseAgreementMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContingentConsiderationByTypeAxis" xlink:to="us-gaap_ContingentConsiderationByTypeAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationDateOfIncorporation" xlink:to="dei_EntityIncorporationDateOfIncorporation_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharePrice" xlink:to="us-gaap_SharePrice_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eq_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="eq_SummaryOfSignificantAccountingPoliciesLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="us-gaap_DebtInstrumentNameDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eq_AccruedResearchAndDevelopmentExpensePolicyTextBlock" xlink:to="eq_AccruedResearchAndDevelopmentExpensePolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" xlink:to="us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VestingDomain" xlink:to="us-gaap_VestingDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eq_TermsOfMergerAgreement" xlink:to="eq_TermsOfMergerAgreement_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TaxCreditCarryforwardTable" xlink:to="us-gaap_TaxCreditCarryforwardTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:to="us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentsFairValueDisclosure" xlink:to="us-gaap_InvestmentsFairValueDisclosure_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eq_SummaryOfReconciliationOfExpectedStatutoryFederalIncomeTaxProvisionToActualIncomeTaxProvisionTableTextBlock" xlink:to="eq_SummaryOfReconciliationOfExpectedStatutoryFederalIncomeTaxProvisionToActualIncomeTaxProvisionTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eq_DividendsPaidOnCommonStock" xlink:to="eq_DividendsPaidOnCommonStock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssuedPricePerShare" xlink:to="us-gaap_SharesIssuedPricePerShare_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_FinancialInstrumentAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eq_ResearchAndDevelopmentServicesMember" xlink:to="eq_ResearchAndDevelopmentServicesMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eq_UpfrontPaymentAmortizationMember" xlink:to="eq_UpfrontPaymentAmortizationMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:to="us-gaap_StockIssuedDuringPeriodSharesOther_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsNet_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eq_CertificatesOfDepositMaturingInOneYearOrLessMember" xlink:to="eq_CertificatesOfDepositMaturingInOneYearOrLessMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eq_USTreasurySecuritiesMaturingInOneYearOrLessMember" xlink:to="eq_USTreasurySecuritiesMaturingInOneYearOrLessMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:to="us-gaap_ForeignCurrencyTransactionGainLossUnrealized_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eq_RegisteredDirectOfferingsMember" xlink:to="eq_RegisteredDirectOfferingsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesOther" xlink:to="us-gaap_DeferredTaxLiabilitiesOther_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:to="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfNotesPayable" xlink:to="us-gaap_RepaymentsOfNotesPayable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentDisposals" xlink:to="us-gaap_PropertyPlantAndEquipmentDisposals_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eq_OperatingLossCarryforwardsExpirationYear" xlink:to="eq_OperatingLossCarryforwardsExpirationYear_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ProductsAndServicesDomain" xlink:to="srt_ProductsAndServicesDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionGainLossRealized" xlink:to="us-gaap_ForeignCurrencyTransactionGainLossRealized_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eq_CumulativeChangeInOwnershipPercentage" xlink:to="eq_CumulativeChangeInOwnershipPercentage_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MaximumMember" xlink:to="srt_MaximumMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eq_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRemainingVestingPeriod" xlink:to="eq_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRemainingVestingPeriod_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eq_OnoPharmaceuticalCoLtdMember" xlink:to="eq_OnoPharmaceuticalCoLtdMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:to="us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FurnitureAndFixturesMember" xlink:to="us-gaap_FurnitureAndFixturesMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eq_LaboratorySpaceMember" xlink:to="eq_LaboratorySpaceMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxLiabilities" xlink:to="us-gaap_DeferredIncomeTaxLiabilities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eq_TermOfPurchaseAgreement" xlink:to="eq_TermOfPurchaseAgreement_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCountryMember" xlink:to="us-gaap_ForeignCountryMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNetAbstract" xlink:to="us-gaap_DeferredTaxAssetsNetAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eq_IncomeTaxReconciliationPermanentItems" xlink:to="eq_IncomeTaxReconciliationPermanentItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eq_ResearchAndExperimentalExpendituresCapitalizedCostAmortizationPeriod" xlink:to="eq_ResearchAndExperimentalExpendituresCapitalizedCostAmortizationPeriod_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentCarryingAmount" xlink:to="us-gaap_DebtInstrumentCarryingAmount_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOther" xlink:to="us-gaap_DeferredTaxAssetsOther_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eq_SummaryOfSignificantAccountingPoliciesTable" xlink:to="eq_SummaryOfSignificantAccountingPoliciesTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AustralianTaxationOfficeMember" xlink:to="us-gaap_AustralianTaxationOfficeMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eq_TwoThousandEighteenEquityIncentivePlanMember" xlink:to="eq_TwoThousandEighteenEquityIncentivePlanMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eq_LincolnParkCapitalFundLLCMember" xlink:to="eq_LincolnParkCapitalFundLLCMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:to="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eq_EquityIncentivePlanDescription" xlink:to="eq_EquityIncentivePlanDescription_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eq_LesseeOperatingLeaseExpiredDate" xlink:to="eq_LesseeOperatingLeaseExpiredDate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eq_EstimatedMaximumAmountOfCommonStockIssuable" xlink:to="eq_EstimatedMaximumAmountOfCommonStockIssuable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="eq_PatentCostsPolicyTextBlock" xlink:to="eq_PatentCostsPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="us-gaap_LongtermDebtTypeDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="us-gaap_TaxCreditCarryforwardLineItems_lbl"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>26
<FILENAME>eq-20221231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Schema Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2023-03-23T11:19:40.5243+00:00 -->
<!-- Copyright (c) 2023 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema targetNamespace="http://equilliumbio.com/20221231" attributeFormDefault="unqualified" elementFormDefault="qualified" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:eq="http://equilliumbio.com/20221231" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:srt="http://fasb.org/srt/2022" xmlns:stpr="http://xbrl.sec.gov/stpr/2022" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:xlink="http://www.w3.org/1999/xlink">
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt"/>
  <xsd:import schemaLocation="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd" namespace="http://xbrl.sec.gov/stpr/2022"/>
  <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" namespace="http://xbrl.sec.gov/dei/2022"/>
  <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd" namespace="http://fasb.org/us-gaap/2022"/>
  <xsd:import schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd" namespace="http://xbrl.sec.gov/country/2022"/>
  <xsd:import schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" namespace="http://www.xbrl.org/dtr/type/2020-01-21"/>
  <xsd:import schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd" namespace="http://fasb.org/srt/2022"/>
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="eq-20221231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Labels link" xlink:type="simple"/>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="eq-20221231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation link" xlink:type="simple"/>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="eq-20221231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:title="Definition link" xlink:type="simple"/>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="eq-20221231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:title="Calculation link" xlink:type="simple"/>
      <link:roleType roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" id="Role_StatementConsolidatedBalanceSheets">
        <link:definition>100010 - Statement - Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://equilliumbio.com/20221231/taxonomy/role/DisclosureLeasesScheduleOfMaturitiesOfLeaseLiabilitiesDetails2" id="DisclosureLeasesScheduleOfMaturitiesOfLeaseLiabilitiesDetails2">
        <link:definition>100020 - Disclosure - Leases - Schedule of Maturities of Lease Liabilities (Details) 2</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://equilliumbio.com/20221231/taxonomy/role/DisclosureNotesPayableScheduleFutureMaturitiesOfTermLoanIncludingFinalPaymentFeeDetails2" id="DisclosureNotesPayableScheduleFutureMaturitiesOfTermLoanIncludingFinalPaymentFeeDetails2">
        <link:definition>100030 - Disclosure - Notes Payable - Schedule Future Maturities of Term Loan, Including Final Payment Fee (Details) 2</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical" id="Role_StatementConsolidatedBalanceSheetsParenthetical">
        <link:definition>100040 - Statement - Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" id="Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss">
        <link:definition>100050 - Statement - Consolidated Statements of Operations and Comprehensive Loss</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity" id="Role_StatementConsolidatedStatementsOfStockholdersEquity">
        <link:definition>100060 - Statement - Consolidated Statements of Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" id="Role_StatementConsolidatedStatementsOfCashFlows">
        <link:definition>100070 - Statement - Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureOrganizationAndAccountingPronouncements" id="Role_DisclosureOrganizationAndAccountingPronouncements">
        <link:definition>100080 - Disclosure - Organization and Accounting Pronouncements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies" id="Role_DisclosureSummaryOfSignificantAccountingPolicies">
        <link:definition>100090 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstruments" id="Role_DisclosureFairValueOfFinancialInstruments">
        <link:definition>100100 - Disclosure - Fair Value of Financial Instruments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureShortTermInvestments" id="Role_DisclosureShortTermInvestments">
        <link:definition>100110 - Disclosure - Short-Term Investments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosurePropertyAndEquipment" id="Role_DisclosurePropertyAndEquipment">
        <link:definition>100120 - Disclosure - Property and Equipment</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://equilliumbio.com/20221231/taxonomy/role/DisclosureAcquisition" id="DisclosureAcquisition">
        <link:definition>100130 - Disclosure - Acquisition</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://equilliumbio.com/20221231/taxonomy/role/DisclosureLeases3" id="DisclosureLeases3">
        <link:definition>100140 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureAccruedExpenses" id="Role_DisclosureAccruedExpenses">
        <link:definition>100150 - Disclosure - Accrued Expenses</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://equilliumbio.com/20221231/taxonomy/role/DisclosurePartnerships" id="DisclosurePartnerships">
        <link:definition>100160 - Disclosure - Partnerships</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureNotesPayable" id="Role_DisclosureNotesPayable">
        <link:definition>100170 - Disclosure - Notes Payable</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquity" id="Role_DisclosureStockholdersEquity">
        <link:definition>100180 - Disclosure - Stockholders&#8217; Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingencies" id="Role_DisclosureCommitmentsAndContingencies">
        <link:definition>100190 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxes" id="Role_DisclosureIncomeTaxes">
        <link:definition>100200 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureRetirementPlan" id="Role_DisclosureRetirementPlan">
        <link:definition>100210 - Disclosure - Retirement Plan</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureSubsequentEvents" id="Role_DisclosureSubsequentEvents">
        <link:definition>100220 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" id="Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies">
        <link:definition>100230 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesTables" id="Role_DisclosureSummaryOfSignificantAccountingPoliciesTables">
        <link:definition>100240 - Disclosure - Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsTables" id="Role_DisclosureFairValueOfFinancialInstrumentsTables">
        <link:definition>100250 - Disclosure - Fair Value of Financial Instruments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureShortTermInvestmentsTables" id="Role_DisclosureShortTermInvestmentsTables">
        <link:definition>100260 - Disclosure - Short-Term Investments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosurePropertyAndEquipmentTables" id="Role_DisclosurePropertyAndEquipmentTables">
        <link:definition>100270 - Disclosure - Property and Equipment (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://equilliumbio.com/20221231/taxonomy/role/DisclosureAcquisitionTables" id="DisclosureAcquisitionTables">
        <link:definition>100280 - Disclosure - Acquisition (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://equilliumbio.com/20221231/taxonomy/role/DisclosureLeasesTables" id="DisclosureLeasesTables">
        <link:definition>100290 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureAccruedExpensesTables" id="Role_DisclosureAccruedExpensesTables">
        <link:definition>100300 - Disclosure - Accrued Expenses (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureNotesPayableTables" id="Role_DisclosureNotesPayableTables">
        <link:definition>100310 - Disclosure - Notes Payable (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquityTables" id="Role_DisclosureStockholdersEquityTables">
        <link:definition>100320 - Disclosure - Stockholders' Equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesTables" id="Role_DisclosureIncomeTaxesTables">
        <link:definition>100330 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://equilliumbio.com/20221231/taxonomy/role/DisclosureOrganizationAndAccountingPronouncementsAdditionalInformationDetails3" id="DisclosureOrganizationAndAccountingPronouncementsAdditionalInformationDetails3">
        <link:definition>100340 - Disclosure - Organization and Accounting Pronouncements - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://equilliumbio.com/20221231/taxonomy/role/DisclosureOrganizationAndAccountingPronouncementsAdditionalInformationDetails1" id="DisclosureOrganizationAndAccountingPronouncementsAdditionalInformationDetails1">
        <link:definition>100350 - Disclosure - Organization and Accounting Pronouncements - Additional Information (Details1)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" id="Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails">
        <link:definition>100360 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfPotentiallyDilutiveSecuritiesNotIncludedInCalculationOfDilutedNetLossPerShareDetails" id="Role_DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfPotentiallyDilutiveSecuritiesNotIncludedInCalculationOfDilutedNetLossPerShareDetails">
        <link:definition>100370 - Disclosure - Summary of Significant Accounting Policies - Summary of Potentially Dilutive Securities Not Included in Calculation of Diluted Net Loss Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfAssetsThatRequireFairValueMeasurementsOnRecurringBasisAndTheirRespectiveInputLevelsBasedOnFairValueHierarchyDetails" id="Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfAssetsThatRequireFairValueMeasurementsOnRecurringBasisAndTheirRespectiveInputLevelsBasedOnFairValueHierarchyDetails">
        <link:definition>100380 - Disclosure - Fair Value of Financial Instruments - Summary of Assets that Require Fair Value Measurements on Recurring Basis and Their Respective Input Levels Based on Fair Value Hierarchy (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetails" id="Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetails">
        <link:definition>100390 - Disclosure - Fair Value of Financial Instruments - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureShortTermInvestmentsScheduleOfCompanySShortTermInvestmentsDetails" id="Role_DisclosureShortTermInvestmentsScheduleOfCompanySShortTermInvestmentsDetails">
        <link:definition>100400 - Disclosure - Short-Term Investments - Schedule of Company's Short-Term Investments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureShortTermInvestmentsAdditionalInformationDetails" id="Role_DisclosureShortTermInvestmentsAdditionalInformationDetails">
        <link:definition>100410 - Disclosure - Short-Term Investments - Additional information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosurePropertyAndEquipmentScheduleOfPropertyAndEquipmentDetails" id="Role_DisclosurePropertyAndEquipmentScheduleOfPropertyAndEquipmentDetails">
        <link:definition>100420 - Disclosure - Property and Equipment - Schedule of Property and Equipment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosurePropertyAndEquipmentAdditionalInformationDetails" id="Role_DisclosurePropertyAndEquipmentAdditionalInformationDetails">
        <link:definition>100430 - Disclosure - Property and Equipment - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://equilliumbio.com/20221231/taxonomy/role/DisclosureAcquisitionAdditionalInformationDetails" id="DisclosureAcquisitionAdditionalInformationDetails">
        <link:definition>100440 - Disclosure - Acquisition - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://equilliumbio.com/20221231/taxonomy/role/DisclosureAcquisitionSummaryOfPurchasePriceAllocationDetails" id="DisclosureAcquisitionSummaryOfPurchasePriceAllocationDetails">
        <link:definition>100450 - Disclosure - Acquisition - Summary of Purchase Price Allocation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://equilliumbio.com/20221231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails" id="DisclosureLeasesAdditionalInformationDetails">
        <link:definition>100460 - Disclosure - Leases - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://equilliumbio.com/20221231/taxonomy/role/DisclosureLeasesSummaryOfAdditionalInformationRelatedToLeasesDetails" id="DisclosureLeasesSummaryOfAdditionalInformationRelatedToLeasesDetails">
        <link:definition>100470 - Disclosure - Leases - Summary of Additional Information Related to Leases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://equilliumbio.com/20221231/taxonomy/role/DisclosureLeasesScheduleOfMaturitiesOfLeaseLiabilitiesDetails" id="DisclosureLeasesScheduleOfMaturitiesOfLeaseLiabilitiesDetails">
        <link:definition>100480 - Disclosure - Leases - Schedule of Maturities of Lease Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails" id="Role_DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails">
        <link:definition>100490 - Disclosure - Accrued Expenses - Schedule of Accrued Expenses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://equilliumbio.com/20221231/taxonomy/role/DisclosurePartnershipsAdditionalInformationDetails" id="DisclosurePartnershipsAdditionalInformationDetails">
        <link:definition>100500 - Disclosure - Partnerships - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureNotesPayableAdditionalInformationDetails" id="Role_DisclosureNotesPayableAdditionalInformationDetails">
        <link:definition>100510 - Disclosure - Notes Payable - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://equilliumbio.com/20221231/taxonomy/role/DisclosureNotesPayableScheduleOfAggregateCarryingAmountsOfTermLoanDetails" id="DisclosureNotesPayableScheduleOfAggregateCarryingAmountsOfTermLoanDetails">
        <link:definition>100520 - Disclosure - Notes Payable - Schedule of Aggregate Carrying Amounts of Term Loan (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://equilliumbio.com/20221231/taxonomy/role/DisclosureNotesPayableScheduleFutureMaturitiesOfTermLoanIncludingFinalPaymentFeeDetails" id="DisclosureNotesPayableScheduleFutureMaturitiesOfTermLoanIncludingFinalPaymentFeeDetails">
        <link:definition>100530 - Disclosure - Notes Payable - Schedule Future Maturities of Term Loan, Including Final Payment Fee (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetails" id="Role_DisclosureStockholdersEquityAdditionalInformationDetails">
        <link:definition>100540 - Disclosure - Stockholders' Equity - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquitySummaryOfStockOptionActivityDetails" id="Role_DisclosureStockholdersEquitySummaryOfStockOptionActivityDetails">
        <link:definition>100550 - Disclosure - Stockholders' Equity - Summary of Stock Option Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquitySummaryOfStockOptionActivityParentheticalDetails" id="Role_DisclosureStockholdersEquitySummaryOfStockOptionActivityParentheticalDetails">
        <link:definition>100560 - Disclosure - Stockholders' Equity - Summary of Stock Option Activity (Parenthetical) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquitySummaryOfTotalNonCashStockBasedCompensationExpenseDetails" id="Role_DisclosureStockholdersEquitySummaryOfTotalNonCashStockBasedCompensationExpenseDetails">
        <link:definition>100570 - Disclosure - Stockholders' Equity - Summary of Total Non-cash Stock-based Compensation Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquitySummaryOfWeightedAverageAssumptionsUsedToDetermineFairValueOfStockOptionGrantsDetails" id="Role_DisclosureStockholdersEquitySummaryOfWeightedAverageAssumptionsUsedToDetermineFairValueOfStockOptionGrantsDetails">
        <link:definition>100580 - Disclosure - Stockholders' Equity - Summary of Weighted-Average Assumptions Used to Determine Fair Value of Stock Option Grants (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquitySummaryOfCommonStockReservedForFutureIssuanceDetails" id="Role_DisclosureStockholdersEquitySummaryOfCommonStockReservedForFutureIssuanceDetails">
        <link:definition>100590 - Disclosure - Stockholders' Equity - Summary of Common Stock Reserved for Future Issuance (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" id="Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails">
        <link:definition>100600 - Disclosure - Commitments and Contingencies - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfComponentsOfLossBeforeIncomeTaxProvisionBenefitDetails" id="Role_DisclosureIncomeTaxesSummaryOfComponentsOfLossBeforeIncomeTaxProvisionBenefitDetails">
        <link:definition>100610 - Disclosure - Income Taxes - Summary of Components of Loss Before Income Tax Provision (Benefit) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails" id="Role_DisclosureIncomeTaxesAdditionalInformationDetails">
        <link:definition>100620 - Disclosure - Income Taxes - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesReconciliationOfExpectedStatutoryFederalIncomeTaxProvisionToActualIncomeTaxProvisionDetails" id="Role_DisclosureIncomeTaxesReconciliationOfExpectedStatutoryFederalIncomeTaxProvisionToActualIncomeTaxProvisionDetails">
        <link:definition>100630 - Disclosure - Income Taxes - Reconciliation of Expected Statutory Federal Income Tax Provision to Actual Income Tax Provision (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfNetDeferredTaxAssetsAndLiabilitiesDetails" id="Role_DisclosureIncomeTaxesSummaryOfNetDeferredTaxAssetsAndLiabilitiesDetails">
        <link:definition>100640 - Disclosure - Income Taxes - Summary of Net Deferred Tax Assets and Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfReconciliationOfUnrecognizedTaxBenefitsDetails" id="Role_DisclosureIncomeTaxesSummaryOfReconciliationOfUnrecognizedTaxBenefitsDetails">
        <link:definition>100650 - Disclosure - Income Taxes - Summary of Reconciliation of Unrecognized Tax Benefits (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureRetirementPlanAdditionalInformationDetails" id="Role_DisclosureRetirementPlanAdditionalInformationDetails">
        <link:definition>100660 - Disclosure - Retirement Plan - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureSubsequentEventsAdditionalInformationDetails" id="Role_DisclosureSubsequentEventsAdditionalInformationDetails">
        <link:definition>100670 - Disclosure - Subsequent Events - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:element id="eq_CollaborationAndLicenseAgreementAbstract" name="CollaborationAndLicenseAgreementAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eq_OtherOperatingLeaseInformationAbstract" name="OtherOperatingLeaseInformationAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eq_AccretedLiabilityForFinalPaymentFee" name="AccretedLiabilityForFinalPaymentFee" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="eq_AccruedClinicalDevelopment" name="AccruedClinicalDevelopment" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="eq_AccruedNonClinicalResearch" name="AccruedNonClinicalResearch" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="eq_AcquiredInProcessResearchAndDevelopment" name="AcquiredInProcessResearchAndDevelopment" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="eq_AvailableForSaleSecuritiesDebtMaturitiesPeriod" name="AvailableForSaleSecuritiesDebtMaturitiesPeriod" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="eq_BusinessCombinationAcquiredInProcessResearchAndDevelopment" name="BusinessCombinationAcquiredInProcessResearchAndDevelopment" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="eq_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="eq_CumulativeChangeInOwnershipPercentage" name="CumulativeChangeInOwnershipPercentage" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="eq_CumulativeChangeInOwnershipPeriod" name="CumulativeChangeInOwnershipPeriod" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="eq_DebtInstrumentCarryingAmountIncludingUnaccretedLiabilityForFinalPaymentFee" name="DebtInstrumentCarryingAmountIncludingUnaccretedLiabilityForFinalPaymentFee" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="eq_DebtInstrumentCarryingAmountIncludingUnaccretedLiabilityForFinalPaymentFeeMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" name="DebtInstrumentCarryingAmountIncludingUnaccretedLiabilityForFinalPaymentFeeMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="eq_DebtInstrumentCarryingAmountIncludingUnaccretedLiabilityForFinalPaymentFeeMaturitiesRepaymentsOfPrincipalInYearThree" name="DebtInstrumentCarryingAmountIncludingUnaccretedLiabilityForFinalPaymentFeeMaturitiesRepaymentsOfPrincipalInYearThree" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="eq_DebtInstrumentCarryingAmountIncludingUnaccretedLiabilityForFinalPaymentFeeMaturitiesRepaymentsOfPrincipalInYearTwo" name="DebtInstrumentCarryingAmountIncludingUnaccretedLiabilityForFinalPaymentFeeMaturitiesRepaymentsOfPrincipalInYearTwo" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="eq_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaidAsPercent" name="DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaidAsPercent" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="eq_DebtPrepaymentFeeAsPercentFromYearThree" name="DebtPrepaymentFeeAsPercentFromYearThree" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="eq_DebtPrepaymentFeeAsPercentOnYearOne" name="DebtPrepaymentFeeAsPercentOnYearOne" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="eq_DebtPrepaymentFeeAsPercentOnYearTwo" name="DebtPrepaymentFeeAsPercentOnYearTwo" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="eq_DeferredTaxAssetsCapitalizedResearchExpenditures" name="DeferredTaxAssetsCapitalizedResearchExpenditures" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="eq_DividendsPaidOnCommonStock" name="DividendsPaidOnCommonStock" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="eq_EffectiveIncomeTaxRateReconciliationTransactionCostsAmount" name="EffectiveIncomeTaxRateReconciliationTransactionCostsAmount" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="eq_EligibleToReceivePaymentOnAchievementOfCertainDevelopmentMilestones" name="EligibleToReceivePaymentOnAchievementOfCertainDevelopmentMilestones" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="eq_EmployeeStockPurchasePlanDescription" name="EmployeeStockPurchasePlanDescription" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="eq_EquityIncentivePlanDescription" name="EquityIncentivePlanDescription" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="eq_EstimatedMaximumAmountOfCommonStockIssuable" name="EstimatedMaximumAmountOfCommonStockIssuable" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="eq_EstimatedResearchAndDevelopmentFunding" name="EstimatedResearchAndDevelopmentFunding" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="eq_FairMarketValueOfCommitmentShares" name="FairMarketValueOfCommitmentShares" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="eq_GrossProceedsFromIssuanceOfCommonStock" name="GrossProceedsFromIssuanceOfCommonStock" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="eq_IncomeTaxReconciliationFederalResearchAndOrphanDrugCredits" name="IncomeTaxReconciliationFederalResearchAndOrphanDrugCredits" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="eq_IncomeTaxReconciliationPermanentItems" name="IncomeTaxReconciliationPermanentItems" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="eq_IncreaseDecreaseInRightOfUseAssetsAndLeaseLiabilitiesNet" name="IncreaseDecreaseInRightOfUseAssetsAndLeaseLiabilitiesNet" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="eq_InitialTransactionPrice" name="InitialTransactionPrice" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="eq_LesseeOperatingLeaseExpirationYear" name="LesseeOperatingLeaseExpirationYear" type="xbrli:gYearItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="eq_LesseeOperatingLeaseExpiredDate" name="LesseeOperatingLeaseExpiredDate" type="xbrli:gYearMonthItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="eq_LineOfCreditFacilityFrequencyOfPaymentsPrincipalAndInterest" name="LineOfCreditFacilityFrequencyOfPaymentsPrincipalAndInterest" type="xbrli:integerItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="eq_MinimumOptionsExercisePriceAsPercentageOfFairMarketValueOfCommonStock" name="MinimumOptionsExercisePriceAsPercentageOfFairMarketValueOfCommonStock" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="eq_MinimumStockPricePerShareAsPercentageOfFairMarketValueOfCommonStock" name="MinimumStockPricePerShareAsPercentageOfFairMarketValueOfCommonStock" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="eq_NumberOfInstitutionalInvestors" name="NumberOfInstitutionalInvestors" type="xbrli:integerItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="eq_OneTimeNonRefundablePaymentReceivableUponExercisesTheOption" name="OneTimeNonRefundablePaymentReceivableUponExercisesTheOption" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="eq_OneTimePaymentReceivableUponExercisesTheOption" name="OneTimePaymentReceivableUponExercisesTheOption" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="eq_OperatingLossCarryforwardsExpirationYear" name="OperatingLossCarryforwardsExpirationYear" type="xbrli:gYearItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="eq_OperatingLossCarryforwardsLimitationRateOnTaxableIncome" name="OperatingLossCarryforwardsLimitationRateOnTaxableIncome" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="eq_OptionPeriodExpiryCondition" name="OptionPeriodExpiryCondition" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="eq_PercentageOfTaxBenefitToBeRealizedUponUltimateSettlementWithTaxAuthority" name="PercentageOfTaxBenefitToBeRealizedUponUltimateSettlementWithTaxAuthority" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="eq_PrepaidAndOtherCurrentAssetsTaxIncentive" name="PrepaidAndOtherCurrentAssetsTaxIncentive" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="eq_ProceedsFromResearchAndDevelopmentFees" name="ProceedsFromResearchAndDevelopmentFees" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="eq_PurchaseAgreementExpirationDate" name="PurchaseAgreementExpirationDate" type="xbrli:dateItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="eq_RegulatoryMilestonePaymentsUponAchievementOfCertainRegulatoryApprovals" name="RegulatoryMilestonePaymentsUponAchievementOfCertainRegulatoryApprovals" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="eq_RequiredNoticePeriodForDebtPrepayment" name="RequiredNoticePeriodForDebtPrepayment" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="eq_ResearchAndDevelopmentTaxIncentiveRevenueCriteria" name="ResearchAndDevelopmentTaxIncentiveRevenueCriteria" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="eq_ResearchAndExperimentalExpendituresCapitalizedCostAmortizationPeriod" name="ResearchAndExperimentalExpendituresCapitalizedCostAmortizationPeriod" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="eq_SalesMilestonePaymentsUponTheAchievementOfFirstCommercialSaleOfProductAndSpecifiedLevelsOfProductSales" name="SalesMilestonePaymentsUponTheAchievementOfFirstCommercialSaleOfProductAndSpecifiedLevelsOfProductSales" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="eq_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRemainingVestingPeriod" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRemainingVestingPeriod" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="eq_TaxCreditCarryforwardExpirationYear" name="TaxCreditCarryforwardExpirationYear" type="xbrli:gYearItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="eq_TermOfPurchaseAgreement" name="TermOfPurchaseAgreement" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="eq_TermsOfMergerAgreement" name="TermsOfMergerAgreement" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="eq_UnaccretedLiabilityForFinalPaymentFee" name="UnaccretedLiabilityForFinalPaymentFee" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="eq_UnvestedStockLiability" name="UnvestedStockLiability" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="eq_UpfrontAndNonCreditablePaymentInvoiced" name="UpfrontAndNonCreditablePaymentInvoiced" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="eq_UpfrontNonRefundableAndNonCreditablePaymentInvoiced" name="UpfrontNonRefundableAndNonCreditablePaymentInvoiced" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="eq_UpfrontNonRefundableAndNonCreditablePaymentReceivableUponExchangeOfOption" name="UpfrontNonRefundableAndNonCreditablePaymentReceivableUponExchangeOfOption" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="eq_UpfrontPaymentReceived" name="UpfrontPaymentReceived" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="eq_WithholdPercentageOfEmployeesEarningsToPurchaseSharesOfCommonStock" name="WithholdPercentageOfEmployeesEarningsToPurchaseSharesOfCommonStock" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="eq_CommitmentsAndContingenciesLineItems" name="CommitmentsAndContingenciesLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eq_SummaryOfSignificantAccountingPoliciesLineItems" name="SummaryOfSignificantAccountingPoliciesLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eq_AssetPurchaseAgreementMember" name="AssetPurchaseAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eq_ATMMember" name="ATMMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eq_AustralianResearchAndDevelopmentTaxIncentiveProgramMember" name="AustralianResearchAndDevelopmentTaxIncentiveProgramMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eq_AwardsAvailableUnder2018PlanMember" name="AwardsAvailableUnder2018PlanMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eq_BioconMember" name="BioconMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eq_BionizTherapeuticsIncMember" name="BionizTherapeuticsIncMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eq_CertificatesOfDepositMaturingInOneYearOrLessMember" name="CertificatesOfDepositMaturingInOneYearOrLessMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eq_ContingentConsiderationForAchievementOfCommercializationEventsMember" name="ContingentConsiderationForAchievementOfCommercializationEventsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eq_ContingentConsiderationForAchievementOfRegulatoryEventsMember" name="ContingentConsiderationForAchievementOfRegulatoryEventsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eq_EighteenMonthsAfterClosingMember" name="EighteenMonthsAfterClosingMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eq_EmployeeStockPurchasePlanMember" name="EmployeeStockPurchasePlanMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eq_FollowOnOfferingMember" name="FollowOnOfferingMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eq_LaboratorySpaceMember" name="LaboratorySpaceMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eq_LincolnParkCapitalFundLLCMember" name="LincolnParkCapitalFundLLCMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eq_LoanAgreementMember" name="LoanAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eq_OfficeSpaceMember" name="OfficeSpaceMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eq_OnoPharmaceuticalCoLtdMember" name="OnoPharmaceuticalCoLtdMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eq_PurchaseAgreementMember" name="PurchaseAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eq_PurchaseRightMember" name="PurchaseRightMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eq_RegisteredDirectOfferingsMember" name="RegisteredDirectOfferingsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eq_ResearchAndDevelopmentServicesMember" name="ResearchAndDevelopmentServicesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eq_SiliconValleyBankMember" name="SiliconValleyBankMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eq_StockOptionsIssuedAndOutstandingMember" name="StockOptionsIssuedAndOutstandingMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eq_TermLoanMember" name="TermLoanMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eq_TwoThousandEighteenEquityIncentivePlanMember" name="TwoThousandEighteenEquityIncentivePlanMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eq_TwoThousandSeventeenEquityIncentivePlanMember" name="TwoThousandSeventeenEquityIncentivePlanMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eq_UpfrontPaymentAmortizationMember" name="UpfrontPaymentAmortizationMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eq_USTreasurySecuritiesMaturingBetweenOneAndFiveYearsMember" name="USTreasurySecuritiesMaturingBetweenOneAndFiveYearsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eq_USTreasurySecuritiesMaturingInOneYearOrLessMember" name="USTreasurySecuritiesMaturingInOneYearOrLessMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eq_AccruedResearchAndDevelopmentExpensePolicyTextBlock" name="AccruedResearchAndDevelopmentExpensePolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="eq_AustralianResearchAndDevelopmentTaxIncentivePolicyTextBlock" name="AustralianResearchAndDevelopmentTaxIncentivePolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="eq_CommitmentsAndContingenciesTable" name="CommitmentsAndContingenciesTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eq_SummaryOfSignificantAccountingPoliciesTable" name="SummaryOfSignificantAccountingPoliciesTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="eq_CommonStockReservedForFutureIssuanceTableTextBlock" name="CommonStockReservedForFutureIssuanceTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="eq_ContractAssetsPolicyPolicyTextBlock" name="ContractAssetsPolicyPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="eq_ContractLiabilitiesPolicyPolicyTextBlock" name="ContractLiabilitiesPolicyPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="eq_PatentCostsPolicyTextBlock" name="PatentCostsPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="eq_PrepaidExpensesAndOtherCurrentAssetsPolicyPolicyTextBlock" name="PrepaidExpensesAndOtherCurrentAssetsPolicyPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="eq_ShortTermInvestmentsPolicyTextBlock" name="ShortTermInvestmentsPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="eq_ShortTermInvestmentsTextBlock" name="ShortTermInvestmentsTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="eq_SummaryOfAdditionalInformationRelatedToLeasesTableTextBlock" name="SummaryOfAdditionalInformationRelatedToLeasesTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="eq_SummaryOfReconciliationOfExpectedStatutoryFederalIncomeTaxProvisionToActualIncomeTaxProvisionTableTextBlock" name="SummaryOfReconciliationOfExpectedStatutoryFederalIncomeTaxProvisionToActualIncomeTaxProvisionTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>27
<FILENAME>eq-20221231_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2023-03-23T11:19:40.8432+00:00 -->
<!-- Copyright (c) 2023 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" xlink:href="eq-20221231.xsd#Role_StatementConsolidatedBalanceSheets" xlink:type="simple"/>
  <link:roleRef roleURI="http://equilliumbio.com/20221231/taxonomy/role/DisclosureLeasesScheduleOfMaturitiesOfLeaseLiabilitiesDetails2" xlink:href="eq-20221231.xsd#DisclosureLeasesScheduleOfMaturitiesOfLeaseLiabilitiesDetails2" xlink:type="simple"/>
  <link:roleRef roleURI="http://equilliumbio.com/20221231/taxonomy/role/DisclosureNotesPayableScheduleFutureMaturitiesOfTermLoanIncludingFinalPaymentFeeDetails2" xlink:href="eq-20221231.xsd#DisclosureNotesPayableScheduleFutureMaturitiesOfTermLoanIncludingFinalPaymentFeeDetails2" xlink:type="simple"/>
  <link:roleRef roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" xlink:href="eq-20221231.xsd#Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" xlink:type="simple"/>
  <link:roleRef roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" xlink:href="eq-20221231.xsd#Role_StatementConsolidatedStatementsOfCashFlows" xlink:type="simple"/>
  <link:roleRef roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureShortTermInvestmentsScheduleOfCompanySShortTermInvestmentsDetails" xlink:href="eq-20221231.xsd#Role_DisclosureShortTermInvestmentsScheduleOfCompanySShortTermInvestmentsDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosurePropertyAndEquipmentScheduleOfPropertyAndEquipmentDetails" xlink:href="eq-20221231.xsd#Role_DisclosurePropertyAndEquipmentScheduleOfPropertyAndEquipmentDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://equilliumbio.com/20221231/taxonomy/role/DisclosureAcquisitionSummaryOfPurchasePriceAllocationDetails" xlink:href="eq-20221231.xsd#DisclosureAcquisitionSummaryOfPurchasePriceAllocationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://equilliumbio.com/20221231/taxonomy/role/DisclosureLeasesSummaryOfAdditionalInformationRelatedToLeasesDetails" xlink:href="eq-20221231.xsd#DisclosureLeasesSummaryOfAdditionalInformationRelatedToLeasesDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://equilliumbio.com/20221231/taxonomy/role/DisclosureLeasesScheduleOfMaturitiesOfLeaseLiabilitiesDetails" xlink:href="eq-20221231.xsd#DisclosureLeasesScheduleOfMaturitiesOfLeaseLiabilitiesDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails" xlink:href="eq-20221231.xsd#Role_DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://equilliumbio.com/20221231/taxonomy/role/DisclosureNotesPayableScheduleOfAggregateCarryingAmountsOfTermLoanDetails" xlink:href="eq-20221231.xsd#DisclosureNotesPayableScheduleOfAggregateCarryingAmountsOfTermLoanDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://equilliumbio.com/20221231/taxonomy/role/DisclosureNotesPayableScheduleFutureMaturitiesOfTermLoanIncludingFinalPaymentFeeDetails" xlink:href="eq-20221231.xsd#DisclosureNotesPayableScheduleFutureMaturitiesOfTermLoanIncludingFinalPaymentFeeDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfComponentsOfLossBeforeIncomeTaxProvisionBenefitDetails" xlink:href="eq-20221231.xsd#Role_DisclosureIncomeTaxesSummaryOfComponentsOfLossBeforeIncomeTaxProvisionBenefitDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesReconciliationOfExpectedStatutoryFederalIncomeTaxProvisionToActualIncomeTaxProvisionDetails" xlink:href="eq-20221231.xsd#Role_DisclosureIncomeTaxesReconciliationOfExpectedStatutoryFederalIncomeTaxProvisionToActualIncomeTaxProvisionDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfNetDeferredTaxAssetsAndLiabilitiesDetails" xlink:href="eq-20221231.xsd#Role_DisclosureIncomeTaxesSummaryOfNetDeferredTaxAssetsAndLiabilitiesDetails" xlink:type="simple"/>
  <link:calculationLink xlink:type="extended" xlink:role="http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_Liabilities" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableCurrent" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_LiabilitiesCurrent" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_AssetsCurrent" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_CommonStockValue" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_StockholdersEquity" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_LongTermNotesPayable" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_CommitmentsAndContingencies" order="2" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_DeferredRevenueCurrent" order="2" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" order="2" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_DeferredRevenueNoncurrent" order="2" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="2" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" order="2" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_NotesPayableCurrent" order="3" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="3" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="3" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_OtherAssetsNoncurrent" order="3" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="3" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="4" weight="1" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="us-gaap_AccountsReceivableNetCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermNotesPayable" xlink:label="us-gaap_LongTermNotesPayable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="us-gaap_DeferredRevenueCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenueNoncurrent" xlink:label="us-gaap_DeferredRevenueNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesPayableCurrent" xlink:label="us-gaap_NotesPayableCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://equilliumbio.com/20221231/taxonomy/role/DisclosureLeasesScheduleOfMaturitiesOfLeaseLiabilitiesDetails2">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_OperatingLeaseLiability" order="1" weight="1" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://equilliumbio.com/20221231/taxonomy/role/DisclosureNotesPayableScheduleFutureMaturitiesOfTermLoanIncludingFinalPaymentFeeDetails2">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LongTermDebt" xlink:to="us-gaap_LongTermDebtCurrent" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LongTermDebt" xlink:to="us-gaap_LongTermDebtNoncurrent" order="1" weight="1" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt" xlink:label="us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent" xlink:label="us-gaap_LongTermDebtCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="us-gaap_LongTermDebtNoncurrent"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingExpenses" order="0" weight="-1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_InterestExpenseDebt" order="0" weight="-1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NonoperatingIncomeExpense" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTax" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_InvestmentIncomeInterest" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_NetIncomeLoss" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" order="2" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="eq_AcquiredInProcessResearchAndDevelopment" order="2" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_OtherNonoperatingIncomeExpense" order="2" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="4" weight="1" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="us-gaap_NonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseDebt" xlink:label="us-gaap_InterestExpenseDebt"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax" xlink:label="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="us-gaap_InvestmentIncomeInterest"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_AcquiredInProcessResearchAndDevelopment" xlink:label="eq_AcquiredInProcessResearchAndDevelopment"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_ProfitLoss" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="0" weight="-1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_RepaymentsOfNotesPayable" order="1" weight="-1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_ResearchAndDevelopmentInProcess" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsToAcquireShortTermInvestments" order="1" weight="-1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="2" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="2" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_DepreciationAndAmortization" order="2" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" order="2" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" order="3" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_ShareBasedCompensation" order="3" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_CashAcquiredFromAcquisition" order="3" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromStockPlans" order="4" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_ForeignCurrencyTransactionGainLossUnrealized" order="4" weight="-1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" order="5" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_AmortizationOfFinancingCostsAndDiscounts" order="6" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" order="8" weight="-1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInDeferredRevenue" order="9" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable" order="10" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities" order="11" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable" order="12" weight="-1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="13" weight="-1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="eq_IncreaseDecreaseInRightOfUseAssetsAndLeaseLiabilitiesNet" order="14" weight="-1" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="us-gaap_RepaymentsOfNotesPayable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentInProcess" xlink:label="us-gaap_ResearchAndDevelopmentInProcess"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireShortTermInvestments" xlink:label="us-gaap_PaymentsToAcquireShortTermInvestments"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAndAmortization" xlink:label="us-gaap_DepreciationAndAmortization"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" xlink:label="us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAcquiredFromAcquisition" xlink:label="us-gaap_CashAcquiredFromAcquisition"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockPlans" xlink:label="us-gaap_ProceedsFromStockPlans"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossUnrealized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:label="us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_IncreaseDecreaseInRightOfUseAssetsAndLeaseLiabilitiesNet" xlink:label="eq_IncreaseDecreaseInRightOfUseAssetsAndLeaseLiabilitiesNet"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureShortTermInvestmentsScheduleOfCompanySShortTermInvestmentsDetails">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" order="0" weight="-1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" order="2" weight="1" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosurePropertyAndEquipmentScheduleOfPropertyAndEquipmentDetails">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="1" weight="-1" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://equilliumbio.com/20221231/taxonomy/role/DisclosureAcquisitionSummaryOfPurchasePriceAllocationDetails">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="eq_BusinessCombinationAcquiredInProcessResearchAndDevelopment" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" order="1" weight="-1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:to="eq_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" order="2" weight="1" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_BusinessCombinationAcquiredInProcessResearchAndDevelopment" xlink:label="eq_BusinessCombinationAcquiredInProcessResearchAndDevelopment"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" xlink:label="eq_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://equilliumbio.com/20221231/taxonomy/role/DisclosureLeasesSummaryOfAdditionalInformationRelatedToLeasesDetails">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="1" weight="1" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://equilliumbio.com/20221231/taxonomy/role/DisclosureLeasesScheduleOfMaturitiesOfLeaseLiabilitiesDetails">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" order="2" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" order="3" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" order="4" weight="1" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="eq_AccruedClinicalDevelopment" order="2" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="eq_AccruedNonClinicalResearch" order="3" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent" order="4" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_InterestPayableCurrent" order="6" weight="1" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_AccruedClinicalDevelopment" xlink:label="eq_AccruedClinicalDevelopment"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_AccruedNonClinicalResearch" xlink:label="eq_AccruedNonClinicalResearch"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPayableCurrent" xlink:label="us-gaap_InterestPayableCurrent"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://equilliumbio.com/20221231/taxonomy/role/DisclosureNotesPayableScheduleOfAggregateCarryingAmountsOfTermLoanDetails">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LongTermDebt" xlink:to="us-gaap_DebtInstrumentCarryingAmount" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LongTermDebt" xlink:to="eq_AccretedLiabilityForFinalPaymentFee" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LongTermDebt" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscount" order="2" weight="-1" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt" xlink:label="us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="us-gaap_DebtInstrumentCarryingAmount"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_AccretedLiabilityForFinalPaymentFee" xlink:label="eq_AccretedLiabilityForFinalPaymentFee"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://equilliumbio.com/20221231/taxonomy/role/DisclosureNotesPayableScheduleFutureMaturitiesOfTermLoanIncludingFinalPaymentFeeDetails">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="eq_DebtInstrumentCarryingAmountIncludingUnaccretedLiabilityForFinalPaymentFee" xlink:to="eq_DebtInstrumentCarryingAmountIncludingUnaccretedLiabilityForFinalPaymentFeeMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LongTermDebt" xlink:to="eq_DebtInstrumentCarryingAmountIncludingUnaccretedLiabilityForFinalPaymentFee" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="eq_DebtInstrumentCarryingAmountIncludingUnaccretedLiabilityForFinalPaymentFee" xlink:to="eq_DebtInstrumentCarryingAmountIncludingUnaccretedLiabilityForFinalPaymentFeeMaturitiesRepaymentsOfPrincipalInYearTwo" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LongTermDebt" xlink:to="eq_UnaccretedLiabilityForFinalPaymentFee" order="1" weight="-1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="eq_DebtInstrumentCarryingAmountIncludingUnaccretedLiabilityForFinalPaymentFee" xlink:to="eq_DebtInstrumentCarryingAmountIncludingUnaccretedLiabilityForFinalPaymentFeeMaturitiesRepaymentsOfPrincipalInYearThree" order="2" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LongTermDebt" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscount" order="2" weight="-1" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_DebtInstrumentCarryingAmountIncludingUnaccretedLiabilityForFinalPaymentFee" xlink:label="eq_DebtInstrumentCarryingAmountIncludingUnaccretedLiabilityForFinalPaymentFee"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_DebtInstrumentCarryingAmountIncludingUnaccretedLiabilityForFinalPaymentFeeMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="eq_DebtInstrumentCarryingAmountIncludingUnaccretedLiabilityForFinalPaymentFeeMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt" xlink:label="us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_DebtInstrumentCarryingAmountIncludingUnaccretedLiabilityForFinalPaymentFeeMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="eq_DebtInstrumentCarryingAmountIncludingUnaccretedLiabilityForFinalPaymentFeeMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_UnaccretedLiabilityForFinalPaymentFee" xlink:label="eq_UnaccretedLiabilityForFinalPaymentFee"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_DebtInstrumentCarryingAmountIncludingUnaccretedLiabilityForFinalPaymentFeeMaturitiesRepaymentsOfPrincipalInYearThree" xlink:label="eq_DebtInstrumentCarryingAmountIncludingUnaccretedLiabilityForFinalPaymentFeeMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfComponentsOfLossBeforeIncomeTaxProvisionBenefitDetails">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" order="1" weight="1" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesReconciliationOfExpectedStatutoryFederalIncomeTaxProvisionToActualIncomeTaxProvisionDetails">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="eq_IncomeTaxReconciliationPermanentItems" order="2" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="eq_IncomeTaxReconciliationFederalResearchAndOrphanDrugCredits" order="3" weight="-1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" order="4" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="eq_EffectiveIncomeTaxRateReconciliationTransactionCostsAmount" order="5" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment" order="6" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" order="7" weight="1" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_IncomeTaxReconciliationPermanentItems" xlink:label="eq_IncomeTaxReconciliationPermanentItems"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_IncomeTaxReconciliationFederalResearchAndOrphanDrugCredits" xlink:label="eq_IncomeTaxReconciliationFederalResearchAndOrphanDrugCredits"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:label="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_EffectiveIncomeTaxRateReconciliationTransactionCostsAmount" xlink:label="eq_EffectiveIncomeTaxRateReconciliationTransactionCostsAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfNetDeferredTaxAssetsAndLiabilitiesDetails">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsNet" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsGross" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredIncomeTaxLiabilities" order="1" weight="-1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" order="1" weight="-1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredIncomeTaxLiabilities" xlink:to="us-gaap_DeferredTaxLiabilitiesTaxDeferredIncome" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="eq_DeferredTaxAssetsCapitalizedResearchExpenditures" order="3" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredIncomeTaxLiabilities" xlink:to="us-gaap_DeferredTaxLiabilitiesLeasingArrangements" order="3" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" order="4" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredIncomeTaxLiabilities" xlink:to="us-gaap_DeferredTaxLiabilitiesOther" order="4" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsOther" order="5" weight="1" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="us-gaap_DeferredTaxAssetsGross"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="us-gaap_DeferredTaxAssetsNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities" xlink:label="us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesTaxDeferredIncome" xlink:label="us-gaap_DeferredTaxLiabilitiesTaxDeferredIncome"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_DeferredTaxAssetsCapitalizedResearchExpenditures" xlink:label="eq_DeferredTaxAssetsCapitalizedResearchExpenditures"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:label="us-gaap_DeferredTaxLiabilitiesLeasingArrangements"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesOther" xlink:label="us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="us-gaap_DeferredTaxAssetsOther"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>28
<FILENAME>eq-20221231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2023-03-23T11:19:40.6291+00:00 -->
<!-- Copyright (c) 2023 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" xlink:href="eq-20221231.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple"/>
  <link:roleRef roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" xlink:href="eq-20221231.xsd#Role_StatementConsolidatedBalanceSheets" xlink:type="simple"/>
  <link:roleRef roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical" xlink:href="eq-20221231.xsd#Role_StatementConsolidatedBalanceSheetsParenthetical" xlink:type="simple"/>
  <link:roleRef roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" xlink:href="eq-20221231.xsd#Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" xlink:type="simple"/>
  <link:roleRef roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity" xlink:href="eq-20221231.xsd#Role_StatementConsolidatedStatementsOfStockholdersEquity" xlink:type="simple"/>
  <link:roleRef roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" xlink:href="eq-20221231.xsd#Role_StatementConsolidatedStatementsOfCashFlows" xlink:type="simple"/>
  <link:roleRef roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureOrganizationAndAccountingPronouncements" xlink:href="eq-20221231.xsd#Role_DisclosureOrganizationAndAccountingPronouncements" xlink:type="simple"/>
  <link:roleRef roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies" xlink:href="eq-20221231.xsd#Role_DisclosureSummaryOfSignificantAccountingPolicies" xlink:type="simple"/>
  <link:roleRef roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstruments" xlink:href="eq-20221231.xsd#Role_DisclosureFairValueOfFinancialInstruments" xlink:type="simple"/>
  <link:roleRef roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureShortTermInvestments" xlink:href="eq-20221231.xsd#Role_DisclosureShortTermInvestments" xlink:type="simple"/>
  <link:roleRef roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosurePropertyAndEquipment" xlink:href="eq-20221231.xsd#Role_DisclosurePropertyAndEquipment" xlink:type="simple"/>
  <link:roleRef roleURI="http://equilliumbio.com/20221231/taxonomy/role/DisclosureAcquisition" xlink:href="eq-20221231.xsd#DisclosureAcquisition" xlink:type="simple"/>
  <link:roleRef roleURI="http://equilliumbio.com/20221231/taxonomy/role/DisclosureLeases3" xlink:href="eq-20221231.xsd#DisclosureLeases3" xlink:type="simple"/>
  <link:roleRef roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureAccruedExpenses" xlink:href="eq-20221231.xsd#Role_DisclosureAccruedExpenses" xlink:type="simple"/>
  <link:roleRef roleURI="http://equilliumbio.com/20221231/taxonomy/role/DisclosurePartnerships" xlink:href="eq-20221231.xsd#DisclosurePartnerships" xlink:type="simple"/>
  <link:roleRef roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureNotesPayable" xlink:href="eq-20221231.xsd#Role_DisclosureNotesPayable" xlink:type="simple"/>
  <link:roleRef roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquity" xlink:href="eq-20221231.xsd#Role_DisclosureStockholdersEquity" xlink:type="simple"/>
  <link:roleRef roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingencies" xlink:href="eq-20221231.xsd#Role_DisclosureCommitmentsAndContingencies" xlink:type="simple"/>
  <link:roleRef roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxes" xlink:href="eq-20221231.xsd#Role_DisclosureIncomeTaxes" xlink:type="simple"/>
  <link:roleRef roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureRetirementPlan" xlink:href="eq-20221231.xsd#Role_DisclosureRetirementPlan" xlink:type="simple"/>
  <link:roleRef roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureSubsequentEvents" xlink:href="eq-20221231.xsd#Role_DisclosureSubsequentEvents" xlink:type="simple"/>
  <link:roleRef roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" xlink:href="eq-20221231.xsd#Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple"/>
  <link:roleRef roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesTables" xlink:href="eq-20221231.xsd#Role_DisclosureSummaryOfSignificantAccountingPoliciesTables" xlink:type="simple"/>
  <link:roleRef roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsTables" xlink:href="eq-20221231.xsd#Role_DisclosureFairValueOfFinancialInstrumentsTables" xlink:type="simple"/>
  <link:roleRef roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureShortTermInvestmentsTables" xlink:href="eq-20221231.xsd#Role_DisclosureShortTermInvestmentsTables" xlink:type="simple"/>
  <link:roleRef roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosurePropertyAndEquipmentTables" xlink:href="eq-20221231.xsd#Role_DisclosurePropertyAndEquipmentTables" xlink:type="simple"/>
  <link:roleRef roleURI="http://equilliumbio.com/20221231/taxonomy/role/DisclosureAcquisitionTables" xlink:href="eq-20221231.xsd#DisclosureAcquisitionTables" xlink:type="simple"/>
  <link:roleRef roleURI="http://equilliumbio.com/20221231/taxonomy/role/DisclosureLeasesTables" xlink:href="eq-20221231.xsd#DisclosureLeasesTables" xlink:type="simple"/>
  <link:roleRef roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureAccruedExpensesTables" xlink:href="eq-20221231.xsd#Role_DisclosureAccruedExpensesTables" xlink:type="simple"/>
  <link:roleRef roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureNotesPayableTables" xlink:href="eq-20221231.xsd#Role_DisclosureNotesPayableTables" xlink:type="simple"/>
  <link:roleRef roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquityTables" xlink:href="eq-20221231.xsd#Role_DisclosureStockholdersEquityTables" xlink:type="simple"/>
  <link:roleRef roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesTables" xlink:href="eq-20221231.xsd#Role_DisclosureIncomeTaxesTables" xlink:type="simple"/>
  <link:roleRef roleURI="http://equilliumbio.com/20221231/taxonomy/role/DisclosureOrganizationAndAccountingPronouncementsAdditionalInformationDetails3" xlink:href="eq-20221231.xsd#DisclosureOrganizationAndAccountingPronouncementsAdditionalInformationDetails3" xlink:type="simple"/>
  <link:roleRef roleURI="http://equilliumbio.com/20221231/taxonomy/role/DisclosureOrganizationAndAccountingPronouncementsAdditionalInformationDetails1" xlink:href="eq-20221231.xsd#DisclosureOrganizationAndAccountingPronouncementsAdditionalInformationDetails1" xlink:type="simple"/>
  <link:roleRef roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" xlink:href="eq-20221231.xsd#Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfPotentiallyDilutiveSecuritiesNotIncludedInCalculationOfDilutedNetLossPerShareDetails" xlink:href="eq-20221231.xsd#Role_DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfPotentiallyDilutiveSecuritiesNotIncludedInCalculationOfDilutedNetLossPerShareDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfAssetsThatRequireFairValueMeasurementsOnRecurringBasisAndTheirRespectiveInputLevelsBasedOnFairValueHierarchyDetails" xlink:href="eq-20221231.xsd#Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfAssetsThatRequireFairValueMeasurementsOnRecurringBasisAndTheirRespectiveInputLevelsBasedOnFairValueHierarchyDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetails" xlink:href="eq-20221231.xsd#Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureShortTermInvestmentsScheduleOfCompanySShortTermInvestmentsDetails" xlink:href="eq-20221231.xsd#Role_DisclosureShortTermInvestmentsScheduleOfCompanySShortTermInvestmentsDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureShortTermInvestmentsAdditionalInformationDetails" xlink:href="eq-20221231.xsd#Role_DisclosureShortTermInvestmentsAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosurePropertyAndEquipmentScheduleOfPropertyAndEquipmentDetails" xlink:href="eq-20221231.xsd#Role_DisclosurePropertyAndEquipmentScheduleOfPropertyAndEquipmentDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosurePropertyAndEquipmentAdditionalInformationDetails" xlink:href="eq-20221231.xsd#Role_DisclosurePropertyAndEquipmentAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://equilliumbio.com/20221231/taxonomy/role/DisclosureAcquisitionAdditionalInformationDetails" xlink:href="eq-20221231.xsd#DisclosureAcquisitionAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://equilliumbio.com/20221231/taxonomy/role/DisclosureAcquisitionSummaryOfPurchasePriceAllocationDetails" xlink:href="eq-20221231.xsd#DisclosureAcquisitionSummaryOfPurchasePriceAllocationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://equilliumbio.com/20221231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails" xlink:href="eq-20221231.xsd#DisclosureLeasesAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://equilliumbio.com/20221231/taxonomy/role/DisclosureLeasesSummaryOfAdditionalInformationRelatedToLeasesDetails" xlink:href="eq-20221231.xsd#DisclosureLeasesSummaryOfAdditionalInformationRelatedToLeasesDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://equilliumbio.com/20221231/taxonomy/role/DisclosureLeasesScheduleOfMaturitiesOfLeaseLiabilitiesDetails" xlink:href="eq-20221231.xsd#DisclosureLeasesScheduleOfMaturitiesOfLeaseLiabilitiesDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails" xlink:href="eq-20221231.xsd#Role_DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://equilliumbio.com/20221231/taxonomy/role/DisclosurePartnershipsAdditionalInformationDetails" xlink:href="eq-20221231.xsd#DisclosurePartnershipsAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureNotesPayableAdditionalInformationDetails" xlink:href="eq-20221231.xsd#Role_DisclosureNotesPayableAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://equilliumbio.com/20221231/taxonomy/role/DisclosureNotesPayableScheduleOfAggregateCarryingAmountsOfTermLoanDetails" xlink:href="eq-20221231.xsd#DisclosureNotesPayableScheduleOfAggregateCarryingAmountsOfTermLoanDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://equilliumbio.com/20221231/taxonomy/role/DisclosureNotesPayableScheduleFutureMaturitiesOfTermLoanIncludingFinalPaymentFeeDetails" xlink:href="eq-20221231.xsd#DisclosureNotesPayableScheduleFutureMaturitiesOfTermLoanIncludingFinalPaymentFeeDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetails" xlink:href="eq-20221231.xsd#Role_DisclosureStockholdersEquityAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquitySummaryOfStockOptionActivityDetails" xlink:href="eq-20221231.xsd#Role_DisclosureStockholdersEquitySummaryOfStockOptionActivityDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquitySummaryOfStockOptionActivityParentheticalDetails" xlink:href="eq-20221231.xsd#Role_DisclosureStockholdersEquitySummaryOfStockOptionActivityParentheticalDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquitySummaryOfTotalNonCashStockBasedCompensationExpenseDetails" xlink:href="eq-20221231.xsd#Role_DisclosureStockholdersEquitySummaryOfTotalNonCashStockBasedCompensationExpenseDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquitySummaryOfWeightedAverageAssumptionsUsedToDetermineFairValueOfStockOptionGrantsDetails" xlink:href="eq-20221231.xsd#Role_DisclosureStockholdersEquitySummaryOfWeightedAverageAssumptionsUsedToDetermineFairValueOfStockOptionGrantsDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquitySummaryOfCommonStockReservedForFutureIssuanceDetails" xlink:href="eq-20221231.xsd#Role_DisclosureStockholdersEquitySummaryOfCommonStockReservedForFutureIssuanceDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" xlink:href="eq-20221231.xsd#Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfComponentsOfLossBeforeIncomeTaxProvisionBenefitDetails" xlink:href="eq-20221231.xsd#Role_DisclosureIncomeTaxesSummaryOfComponentsOfLossBeforeIncomeTaxProvisionBenefitDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails" xlink:href="eq-20221231.xsd#Role_DisclosureIncomeTaxesAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesReconciliationOfExpectedStatutoryFederalIncomeTaxProvisionToActualIncomeTaxProvisionDetails" xlink:href="eq-20221231.xsd#Role_DisclosureIncomeTaxesReconciliationOfExpectedStatutoryFederalIncomeTaxProvisionToActualIncomeTaxProvisionDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfNetDeferredTaxAssetsAndLiabilitiesDetails" xlink:href="eq-20221231.xsd#Role_DisclosureIncomeTaxesSummaryOfNetDeferredTaxAssetsAndLiabilitiesDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfReconciliationOfUnrecognizedTaxBenefitsDetails" xlink:href="eq-20221231.xsd#Role_DisclosureIncomeTaxesSummaryOfReconciliationOfUnrecognizedTaxBenefitsDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureRetirementPlanAdditionalInformationDetails" xlink:href="eq-20221231.xsd#Role_DisclosureRetirementPlanAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureSubsequentEventsAdditionalInformationDetails" xlink:href="eq-20221231.xsd#Role_DisclosureSubsequentEventsAdditionalInformationDetails" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://equilliumbio.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="dei_IcfrAuditorAttestationFlag"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorName" xlink:label="dei_AuditorName"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorLocation" xlink:label="dei_AuditorLocation"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorFirmId" xlink:label="dei_AuditorFirmId"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="49.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="50.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="51.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentFiscalYearFocus" order="52.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCurrentReportingStatus" order="53.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityWellKnownSeasonedIssuer" order="54.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityVoluntaryFilers" order="55.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentFiscalPeriodFocus" order="56.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="57.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="58.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="59.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CurrentFiscalYearEndDate" order="60.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFilerCategory" order="61.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntitySmallBusiness" order="62.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="63.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityExTransitionPeriod" order="64.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_IcfrAuditorAttestationFlag" order="65.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityShellCompany" order="66.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCommonStockSharesOutstanding" order="67.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityPublicFloat" order="68.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="69.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="70.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="71.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="72.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityInteractiveDataCurrent" order="73.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="74.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="75.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine2" order="76.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="77.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="78.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="79.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="80.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="81.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentAnnualReport" order="82.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentTransitionReport" order="83.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock" order="84.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AuditorName" order="85.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AuditorLocation" order="86.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AuditorFirmId" order="87.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermNotesPayable" xlink:label="us-gaap_LongTermNotesPayable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenueNoncurrent" xlink:label="us-gaap_DeferredRevenueNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="us-gaap_AccountsReceivableNetCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="us-gaap_DeferredRevenueCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesPayableCurrent" xlink:label="us-gaap_NotesPayableCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_AssetsAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_CommonStockValue" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsCurrentAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableCurrent" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LongTermNotesPayable" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccruedLiabilitiesCurrent" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_DeferredRevenueNoncurrent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AccountsReceivableNetCurrent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_DeferredRevenueCurrent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_OtherAssetsNoncurrent" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_NotesPayableCurrent" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquity" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_Assets" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_Liabilities" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrent" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_CommitmentsAndContingencies" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrent" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockSharesAuthorized" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockSharesIssued" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockSharesOutstanding" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax" xlink:label="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseDebt" xlink:label="us-gaap_InterestExpenseDebt"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_AcquiredInProcessResearchAndDevelopment" xlink:label="eq_AcquiredInProcessResearchAndDevelopment"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="us-gaap_InvestmentIncomeInterest"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="us-gaap_NonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_InterestExpenseDebt" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OperatingExpensesAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="eq_AcquiredInProcessResearchAndDevelopment" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_InvestmentIncomeInterest" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OperatingIncomeLoss" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTax" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_OtherNonoperatingIncomeExpense" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_NonoperatingIncomeExpenseAbstract" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpenses" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_NonoperatingIncomeExpense" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_NetIncomeLoss" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_EarningsPerShareBasic" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_EarningsPerShareDiluted" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_ATMMember" xlink:label="eq_ATMMember"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_BionizTherapeuticsIncMember" xlink:label="eq_BionizTherapeuticsIncMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_RegisteredDirectOfferingsMember" xlink:label="eq_RegisteredDirectOfferingsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssued" xlink:label="us-gaap_SharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueOther" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity_14"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssued" xlink:label="us-gaap_SharesIssued_15"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="eq_ATMMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="eq_BionizTherapeuticsIncMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="eq_RegisteredDirectOfferingsMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesIssued" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_BusinessAcquisitionAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueOther" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesOther" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_RetainedEarningsMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTax" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity_14" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesIssued_15" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_FollowOnOfferingMember" xlink:label="eq_FollowOnOfferingMember"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_BionizTherapeuticsIncMember" xlink:label="eq_BionizTherapeuticsIncMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_LincolnParkCapitalFundLLCMember" xlink:label="eq_LincolnParkCapitalFundLLCMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet" xlink:label="us-gaap_InterestPaidNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentInProcess" xlink:label="us-gaap_ResearchAndDevelopmentInProcess"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="us-gaap_RepaymentsOfNotesPayable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOfAssetsAcquired" xlink:label="us-gaap_FairValueOfAssetsAcquired"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireShortTermInvestments" xlink:label="us-gaap_PaymentsToAcquireShortTermInvestments"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAndAmortization" xlink:label="us-gaap_DepreciationAndAmortization"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAssumed1" xlink:label="us-gaap_LiabilitiesAssumed1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" xlink:label="us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockPlans" xlink:label="us-gaap_ProceedsFromStockPlans"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAcquiredFromAcquisition" xlink:label="us-gaap_CashAcquiredFromAcquisition"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossUnrealized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:label="us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:label="us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_IncreaseDecreaseInRightOfUseAssetsAndLeaseLiabilitiesNet" xlink:label="eq_IncreaseDecreaseInRightOfUseAssetsAndLeaseLiabilitiesNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssued1" xlink:label="us-gaap_StockIssued1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_6"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="srt_CounterpartyNameAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="eq_FollowOnOfferingMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="eq_BionizTherapeuticsIncMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="eq_LincolnParkCapitalFundLLCMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_InterestPaidNet" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ProfitLoss" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentInProcess" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_RepaymentsOfNotesPayable" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_FairValueOfAssetsAcquired" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquireShortTermInvestments" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_DepreciationAndAmortization" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_BusinessAcquisitionAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_LiabilitiesAssumed1" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ShareBasedCompensation" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromStockPlans" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_CashAcquiredFromAcquisition" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ForeignCurrencyTransactionGainLossUnrealized" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_CapitalExpendituresIncurredButNotYetPaid" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AmortizationOfFinancingCostsAndDiscounts" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="eq_IncreaseDecreaseInRightOfUseAssetsAndLeaseLiabilitiesNet" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_StockIssued1" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_6" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInDeferredRevenue" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureOrganizationAndAccountingPronouncements" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstruments" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureShortTermInvestments" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_ShortTermInvestmentsTextBlock" xlink:label="eq_ShortTermInvestmentsTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="eq_ShortTermInvestmentsTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosurePropertyAndEquipment" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://equilliumbio.com/20221231/taxonomy/role/DisclosureAcquisition" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:label="us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationDisclosureTextBlock" xlink:label="us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:to="us-gaap_BusinessCombinationDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://equilliumbio.com/20221231/taxonomy/role/DisclosureLeases3" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract" xlink:label="us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LesseeOperatingLeasesTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureAccruedExpenses" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:label="us-gaap_AccruedLiabilitiesCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:label="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://equilliumbio.com/20221231/taxonomy/role/DisclosurePartnerships" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_CollaborationAndLicenseAgreementAbstract" xlink:label="eq_CollaborationAndLicenseAgreementAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:label="us-gaap_CollaborativeArrangementDisclosureTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="eq_CollaborationAndLicenseAgreementAbstract" xlink:to="us-gaap_CollaborativeArrangementDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureNotesPayable" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgageNotesPayableDisclosureTextBlock" xlink:label="us-gaap_MortgageNotesPayableDisclosureTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_MortgageNotesPayableDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquity" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingencies" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxes" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureRetirementPlan" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:label="us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:label="us-gaap_CompensationAndEmployeeBenefitPlansTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureSubsequentEvents" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="us-gaap_ConcentrationRiskCreditRisk"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_ShortTermInvestmentsPolicyTextBlock" xlink:label="eq_ShortTermInvestmentsPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesPolicyTextBlock" xlink:label="us-gaap_ReceivablesPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_PrepaidExpensesAndOtherCurrentAssetsPolicyPolicyTextBlock" xlink:label="eq_PrepaidExpensesAndOtherCurrentAssetsPolicyPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeasesPolicyTextBlock" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_AccruedResearchAndDevelopmentExpensePolicyTextBlock" xlink:label="eq_AccruedResearchAndDevelopmentExpensePolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_AustralianResearchAndDevelopmentTaxIncentivePolicyTextBlock" xlink:label="eq_AustralianResearchAndDevelopmentTaxIncentivePolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_ContractAssetsPolicyPolicyTextBlock" xlink:label="eq_ContractAssetsPolicyPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_ContractLiabilitiesPolicyPolicyTextBlock" xlink:label="eq_ContractLiabilitiesPolicyPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InProcessResearchAndDevelopmentPolicy" xlink:label="us-gaap_InProcessResearchAndDevelopmentPolicy"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_PatentCostsPolicyTextBlock" xlink:label="eq_PatentCostsPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_UseOfEstimates" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ConcentrationRiskCreditRisk" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="eq_ShortTermInvestmentsPolicyTextBlock" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ReceivablesPolicyTextBlock" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="eq_PrepaidExpensesAndOtherCurrentAssetsPolicyPolicyTextBlock" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="eq_AccruedResearchAndDevelopmentExpensePolicyTextBlock" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="eq_AustralianResearchAndDevelopmentTaxIncentivePolicyTextBlock" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="eq_ContractAssetsPolicyPolicyTextBlock" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="eq_ContractLiabilitiesPolicyPolicyTextBlock" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_InProcessResearchAndDevelopmentPolicy" order="16" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy" order="17" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="eq_PatentCostsPolicyTextBlock" order="18" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" order="19" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_IncomeTaxPolicyTextBlock" order="20" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock" order="21" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesTables" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsTables" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureShortTermInvestmentsTables" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" xlink:label="us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosurePropertyAndEquipmentTables" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://equilliumbio.com/20221231/taxonomy/role/DisclosureAcquisitionTables" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:label="us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock" xlink:label="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:to="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://equilliumbio.com/20221231/taxonomy/role/DisclosureLeasesTables" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract" xlink:label="us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_SummaryOfAdditionalInformationRelatedToLeasesTableTextBlock" xlink:label="eq_SummaryOfAdditionalInformationRelatedToLeasesTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="eq_SummaryOfAdditionalInformationRelatedToLeasesTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureAccruedExpensesTables" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:label="us-gaap_AccruedLiabilitiesCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:to="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureNotesPayableTables" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock" xlink:label="us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:label="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquityTables" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_CommonStockReservedForFutureIssuanceTableTextBlock" xlink:label="eq_CommonStockReservedForFutureIssuanceTableTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="eq_CommonStockReservedForFutureIssuanceTableTextBlock" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesTables" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_SummaryOfReconciliationOfExpectedStatutoryFederalIncomeTaxProvisionToActualIncomeTaxProvisionTableTextBlock" xlink:label="eq_SummaryOfReconciliationOfExpectedStatutoryFederalIncomeTaxProvisionToActualIncomeTaxProvisionTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock" xlink:label="us-gaap_SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="eq_SummaryOfReconciliationOfExpectedStatutoryFederalIncomeTaxProvisionToActualIncomeTaxProvisionTableTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://equilliumbio.com/20221231/taxonomy/role/DisclosureOrganizationAndAccountingPronouncementsAdditionalInformationDetails3" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationDateOfIncorporation" xlink:label="dei_EntityIncorporationDateOfIncorporation"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:label="us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="dei_EntityIncorporationDateOfIncorporation" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_CashCashEquivalentsAndShortTermInvestments" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://equilliumbio.com/20221231/taxonomy/role/DisclosureOrganizationAndAccountingPronouncementsAdditionalInformationDetails1" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:label="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:label="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="us-gaap_TypeOfAdoptionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdate201613Member" xlink:label="us-gaap_AccountingStandardsUpdate201613Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:to="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfAdoptionMember" xlink:to="us-gaap_AccountingStandardsUpdate201613Member" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="us-gaap_TypeOfAdoptionMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:to="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameDomain" xlink:label="us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AustralianTaxationOfficeMember" xlink:label="us-gaap_AustralianTaxationOfficeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameAxis" xlink:label="us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardAxis" xlink:label="us-gaap_TaxCreditCarryforwardAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardNameDomain" xlink:label="us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_SummaryOfSignificantAccountingPoliciesTable" xlink:label="eq_SummaryOfSignificantAccountingPoliciesTable"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_AustralianResearchAndDevelopmentTaxIncentiveProgramMember" xlink:label="eq_AustralianResearchAndDevelopmentTaxIncentiveProgramMember"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_SummaryOfSignificantAccountingPoliciesLineItems" xlink:label="eq_SummaryOfSignificantAccountingPoliciesLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_ResearchAndDevelopmentTaxIncentiveRevenueCriteria" xlink:label="eq_ResearchAndDevelopmentTaxIncentiveRevenueCriteria"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_PercentageOfTaxBenefitToBeRealizedUponUltimateSettlementWithTaxAuthority" xlink:label="eq_PercentageOfTaxBenefitToBeRealizedUponUltimateSettlementWithTaxAuthority"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_PrepaidAndOtherCurrentAssetsTaxIncentive" xlink:label="eq_PrepaidAndOtherCurrentAssetsTaxIncentive"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityNameDomain" xlink:to="us-gaap_AustralianTaxationOfficeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityNameAxis" xlink:to="us-gaap_IncomeTaxAuthorityNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardAxis" xlink:to="us-gaap_TaxCreditCarryforwardNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="eq_SummaryOfSignificantAccountingPoliciesTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardNameDomain" xlink:to="eq_AustralianResearchAndDevelopmentTaxIncentiveProgramMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="eq_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="eq_SummaryOfSignificantAccountingPoliciesTable" xlink:to="srt_RangeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="eq_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="eq_ResearchAndDevelopmentTaxIncentiveRevenueCriteria" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="eq_SummaryOfSignificantAccountingPoliciesTable" xlink:to="us-gaap_IncomeTaxAuthorityNameAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="eq_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="eq_PercentageOfTaxBenefitToBeRealizedUponUltimateSettlementWithTaxAuthority" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="eq_SummaryOfSignificantAccountingPoliciesTable" xlink:to="us-gaap_TaxCreditCarryforwardAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="eq_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivable" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="eq_SummaryOfSignificantAccountingPoliciesTable" xlink:to="eq_SummaryOfSignificantAccountingPoliciesLineItems" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="eq_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="eq_PrepaidAndOtherCurrentAssetsTaxIncentive" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="eq_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_AccountsReceivableNetCurrent" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfPotentiallyDilutiveSecuritiesNotIncludedInCalculationOfDilutedNetLossPerShareDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_WarrantMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfAssetsThatRequireFairValueMeasurementsOnRecurringBasisAndTheirRespectiveInputLevelsBasedOnFairValueHierarchyDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasurySecuritiesMember" xlink:label="us-gaap_USTreasurySecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByAssetClassAxis" xlink:label="us-gaap_FairValueByAssetClassAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsFairValueDisclosure" xlink:label="us-gaap_InvestmentsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CertificatesOfDepositMember" xlink:label="us-gaap_CertificatesOfDepositMember"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="us-gaap_USTreasurySecuritiesMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByAssetClassAxis" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_InvestmentsFairValueDisclosure" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel1Member" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="us-gaap_CertificatesOfDepositMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByAssetClassAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTable" xlink:label="us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:label="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesPayable" xlink:label="us-gaap_NotesPayable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:label="us-gaap_FinancialLiabilitiesFairValueDisclosure"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueByBalanceSheetGroupingTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_NotesPayable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_FinancialLiabilitiesFairValueDisclosure" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureShortTermInvestmentsScheduleOfCompanySShortTermInvestmentsDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_USTreasurySecuritiesMaturingInOneYearOrLessMember" xlink:label="eq_USTreasurySecuritiesMaturingInOneYearOrLessMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTerm" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTerm"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_USTreasurySecuritiesMaturingBetweenOneAndFiveYearsMember" xlink:label="eq_USTreasurySecuritiesMaturingBetweenOneAndFiveYearsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_CertificatesOfDepositMaturingInOneYearOrLessMember" xlink:label="eq_CertificatesOfDepositMaturingInOneYearOrLessMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="eq_USTreasurySecuritiesMaturingInOneYearOrLessMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="us-gaap_FinancialInstrumentAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleTerm" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="eq_USTreasurySecuritiesMaturingBetweenOneAndFiveYearsMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="srt_RangeAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="eq_CertificatesOfDepositMaturingInOneYearOrLessMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureShortTermInvestmentsAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_AvailableForSaleSecuritiesDebtMaturitiesPeriod" xlink:label="eq_AvailableForSaleSecuritiesDebtMaturitiesPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:label="us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="srt_RangeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="eq_AvailableForSaleSecuritiesDebtMaturitiesPeriod" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosurePropertyAndEquipmentScheduleOfPropertyAndEquipmentDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="us-gaap_FurnitureAndFixturesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MachineryAndEquipmentMember" xlink:label="us-gaap_MachineryAndEquipmentMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComputerEquipmentMember" xlink:label="us-gaap_ComputerEquipmentMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_FurnitureAndFixturesMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_MachineryAndEquipmentMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_ComputerEquipmentMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_LeaseholdImprovementsMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosurePropertyAndEquipmentAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentDisposals" xlink:label="us-gaap_PropertyPlantAndEquipmentDisposals"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnDispositionOfAssets1" xlink:label="us-gaap_GainLossOnDispositionOfAssets1"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_Depreciation" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentDisposals" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_GainLossOnDispositionOfAssets1" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://equilliumbio.com/20221231/taxonomy/role/DisclosureAcquisitionAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_BionizTherapeuticsIncMember" xlink:label="eq_BionizTherapeuticsIncMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:label="us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationTypeDomain" xlink:label="us-gaap_ContingentConsiderationTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_ContingentConsiderationForAchievementOfRegulatoryEventsMember" xlink:label="eq_ContingentConsiderationForAchievementOfRegulatoryEventsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityInterestIssuedOrIssuableTypeDomain" xlink:label="us-gaap_EquityInterestIssuedOrIssuableTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_EighteenMonthsAfterClosingMember" xlink:label="eq_EighteenMonthsAfterClosingMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:label="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:label="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationByTypeAxis" xlink:label="us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_ContingentConsiderationForAchievementOfCommercializationEventsMember" xlink:label="eq_ContingentConsiderationForAchievementOfCommercializationEventsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:label="us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_TermsOfMergerAgreement" xlink:label="eq_TermsOfMergerAgreement"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:label="us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="eq_BionizTherapeuticsIncMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:to="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ContingentConsiderationTypeDomain" xlink:to="eq_ContingentConsiderationForAchievementOfRegulatoryEventsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_BusinessAcquisitionAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityInterestIssuedOrIssuableTypeDomain" xlink:to="eq_EighteenMonthsAfterClosingMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:to="us-gaap_EquityInterestIssuedOrIssuableTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ContingentConsiderationByTypeAxis" xlink:to="us-gaap_ContingentConsiderationTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ContingentConsiderationTypeDomain" xlink:to="eq_ContingentConsiderationForAchievementOfCommercializationEventsMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_ContingentConsiderationByTypeAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="eq_TermsOfMergerAgreement" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="srt_RangeAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessCombinationAcquisitionRelatedCosts" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_BusinessAcquisitionLineItems" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://equilliumbio.com/20221231/taxonomy/role/DisclosureAcquisitionSummaryOfPurchasePriceAllocationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_BionizTherapeuticsIncMember" xlink:label="eq_BionizTherapeuticsIncMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:label="us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" xlink:label="eq_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" xlink:label="us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_BusinessCombinationAcquiredInProcessResearchAndDevelopment" xlink:label="eq_BusinessCombinationAcquiredInProcessResearchAndDevelopment"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="eq_BionizTherapeuticsIncMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:to="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_BusinessAcquisitionAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_BusinessAcquisitionLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract" xlink:to="eq_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="eq_BusinessCombinationAcquiredInProcessResearchAndDevelopment" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://equilliumbio.com/20221231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionLineItems" xlink:label="us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_LesseeOperatingLeaseExpirationYear" xlink:label="eq_LesseeOperatingLeaseExpirationYear"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract" xlink:label="us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionTable" xlink:label="us-gaap_LesseeLeaseDescriptionTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_LaboratorySpaceMember" xlink:label="eq_LaboratorySpaceMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseExpense" xlink:label="us-gaap_OperatingLeaseExpense"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_OfficeSpaceMember" xlink:label="eq_OfficeSpaceMember"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_LesseeOperatingLeaseExpiredDate" xlink:label="eq_LesseeOperatingLeaseExpiredDate"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="eq_LesseeOperatingLeaseExpirationYear" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LesseeLeaseDescriptionTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="eq_LaboratorySpaceMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_OperatingLeaseExpense" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionTable" xlink:to="us-gaap_LesseeLeaseDescriptionLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="eq_OfficeSpaceMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="eq_LesseeOperatingLeaseExpiredDate" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://equilliumbio.com/20221231/taxonomy/role/DisclosureLeasesSummaryOfAdditionalInformationRelatedToLeasesDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_OtherOperatingLeaseInformationAbstract" xlink:label="eq_OtherOperatingLeaseInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAndLiabilitiesLesseeAbstract" xlink:label="us-gaap_AssetsAndLiabilitiesLesseeAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments" xlink:label="us-gaap_OperatingLeasePayments"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract" xlink:label="us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="eq_OtherOperatingLeaseInformationAbstract" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAndLiabilitiesLesseeAbstract" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_OperatingLeasePayments" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_AssetsAndLiabilitiesLesseeAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="eq_OtherOperatingLeaseInformationAbstract" xlink:to="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAndLiabilitiesLesseeAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="eq_OtherOperatingLeaseInformationAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAndLiabilitiesLesseeAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAndLiabilitiesLesseeAbstract" xlink:to="us-gaap_OperatingLeaseLiability" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://equilliumbio.com/20221231/taxonomy/role/DisclosureLeasesScheduleOfMaturitiesOfLeaseLiabilitiesDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:label="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_OperatingLeaseLiability" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:label="us-gaap_AccruedLiabilitiesCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_AccruedClinicalDevelopment" xlink:label="eq_AccruedClinicalDevelopment"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_AccruedNonClinicalResearch" xlink:label="eq_AccruedNonClinicalResearch"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPayableCurrent" xlink:label="us-gaap_InterestPayableCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:to="eq_AccruedClinicalDevelopment" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:to="eq_AccruedNonClinicalResearch" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:to="us-gaap_InterestPayableCurrent" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:to="us-gaap_AccruedLiabilitiesCurrent" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://equilliumbio.com/20221231/taxonomy/role/DisclosurePartnershipsAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis" xlink:label="srt_ProductOrServiceAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain" xlink:label="srt_ProductsAndServicesDomain"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_CollaborationAndLicenseAgreementAbstract" xlink:label="eq_CollaborationAndLicenseAgreementAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_OnoPharmaceuticalCoLtdMember" xlink:label="eq_OnoPharmaceuticalCoLtdMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_OneTimeNonRefundablePaymentReceivableUponExercisesTheOption" xlink:label="eq_OneTimeNonRefundablePaymentReceivableUponExercisesTheOption"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_AssetPurchaseAgreementMember" xlink:label="eq_AssetPurchaseAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_ResearchAndDevelopmentServicesMember" xlink:label="eq_ResearchAndDevelopmentServicesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_BioconMember" xlink:label="eq_BioconMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_OneTimePaymentReceivableUponExercisesTheOption" xlink:label="eq_OneTimePaymentReceivableUponExercisesTheOption"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollaborativeArrangementMember" xlink:label="us-gaap_CollaborativeArrangementMember"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_UpfrontPaymentAmortizationMember" xlink:label="eq_UpfrontPaymentAmortizationMember"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_UpfrontNonRefundableAndNonCreditablePaymentReceivableUponExchangeOfOption" xlink:label="eq_UpfrontNonRefundableAndNonCreditablePaymentReceivableUponExchangeOfOption"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_EligibleToReceivePaymentOnAchievementOfCertainDevelopmentMilestones" xlink:label="eq_EligibleToReceivePaymentOnAchievementOfCertainDevelopmentMilestones"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossRealized" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossRealized"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_UpfrontPaymentReceived" xlink:label="eq_UpfrontPaymentReceived"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_UpfrontNonRefundableAndNonCreditablePaymentInvoiced" xlink:label="eq_UpfrontNonRefundableAndNonCreditablePaymentInvoiced"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_UpfrontAndNonCreditablePaymentInvoiced" xlink:label="eq_UpfrontAndNonCreditablePaymentInvoiced"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_EstimatedResearchAndDevelopmentFunding" xlink:label="eq_EstimatedResearchAndDevelopmentFunding"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_InitialTransactionPrice" xlink:label="eq_InitialTransactionPrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenue" xlink:label="us-gaap_DeferredRevenue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="us-gaap_DeferredRevenueCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenueNoncurrent" xlink:label="us-gaap_DeferredRevenueNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_ProceedsFromResearchAndDevelopmentFees" xlink:label="eq_ProceedsFromResearchAndDevelopmentFees"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_OptionPeriodExpiryCondition" xlink:label="eq_OptionPeriodExpiryCondition"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_RegulatoryMilestonePaymentsUponAchievementOfCertainRegulatoryApprovals" xlink:label="eq_RegulatoryMilestonePaymentsUponAchievementOfCertainRegulatoryApprovals"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_SalesMilestonePaymentsUponTheAchievementOfFirstCommercialSaleOfProductAndSpecifiedLevelsOfProductSales" xlink:label="eq_SalesMilestonePaymentsUponTheAchievementOfFirstCommercialSaleOfProductAndSpecifiedLevelsOfProductSales"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="eq_CollaborationAndLicenseAgreementAbstract" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="eq_OnoPharmaceuticalCoLtdMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="eq_OneTimeNonRefundablePaymentReceivableUponExercisesTheOption" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="srt_ProductOrServiceAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="eq_AssetPurchaseAgreementMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain" xlink:to="eq_ResearchAndDevelopmentServicesMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="eq_BioconMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="eq_OneTimePaymentReceivableUponExercisesTheOption" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="srt_CounterpartyNameAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="us-gaap_CollaborativeArrangementMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain" xlink:to="eq_UpfrontPaymentAmortizationMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="eq_UpfrontNonRefundableAndNonCreditablePaymentReceivableUponExchangeOfOption" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="eq_EligibleToReceivePaymentOnAchievementOfCertainDevelopmentMilestones" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="srt_RangeAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ForeignCurrencyTransactionGainLossRealized" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="eq_UpfrontPaymentReceived" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="eq_UpfrontNonRefundableAndNonCreditablePaymentInvoiced" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="eq_UpfrontAndNonCreditablePaymentInvoiced" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="eq_EstimatedResearchAndDevelopmentFunding" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="eq_InitialTransactionPrice" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_DeferredRevenue" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_DeferredRevenueCurrent" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_DeferredRevenueNoncurrent" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="eq_ProceedsFromResearchAndDevelopmentFees" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="eq_OptionPeriodExpiryCondition" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="16" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="eq_RegulatoryMilestonePaymentsUponAchievementOfCertainRegulatoryApprovals" order="17" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="eq_SalesMilestonePaymentsUponTheAchievementOfFirstCommercialSaleOfProductAndSpecifiedLevelsOfProductSales" order="18" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureNotesPayableAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtLineItems" xlink:label="us-gaap_ShortTermDebtLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit" xlink:label="us-gaap_LineOfCredit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis" xlink:label="us-gaap_VariableRateAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain" xlink:label="us-gaap_VariableRateDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShortTermDebtTable" xlink:label="us-gaap_ScheduleOfShortTermDebtTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="us-gaap_LongtermDebtTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="us-gaap_LongtermDebtTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrimeRateMember" xlink:label="us-gaap_PrimeRateMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_LoanAgreementMember" xlink:label="eq_LoanAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember" xlink:label="us-gaap_LineOfCreditMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityExpirationDate1" xlink:label="us-gaap_LineOfCreditFacilityExpirationDate1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_TermLoanMember" xlink:label="eq_TermLoanMember"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_LineOfCreditFacilityFrequencyOfPaymentsPrincipalAndInterest" xlink:label="eq_LineOfCreditFacilityFrequencyOfPaymentsPrincipalAndInterest"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFrequencyOfPeriodicPayment" xlink:label="us-gaap_DebtInstrumentFrequencyOfPeriodicPayment"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateBasisForEffectiveRate" xlink:label="us-gaap_DebtInstrumentInterestRateBasisForEffectiveRate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:label="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaidAsPercent" xlink:label="eq_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaidAsPercent"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_RequiredNoticePeriodForDebtPrepayment" xlink:label="eq_RequiredNoticePeriodForDebtPrepayment"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_DebtPrepaymentFeeAsPercentOnYearOne" xlink:label="eq_DebtPrepaymentFeeAsPercentOnYearOne"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_DebtPrepaymentFeeAsPercentOnYearTwo" xlink:label="eq_DebtPrepaymentFeeAsPercentOnYearTwo"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_DebtPrepaymentFeeAsPercentFromYearThree" xlink:label="eq_DebtPrepaymentFeeAsPercentFromYearThree"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:label="us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShortTermDebtLineItems" xlink:to="us-gaap_LineOfCredit" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VariableRateAxis" xlink:to="us-gaap_VariableRateDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShortTermDebtTable" xlink:to="us-gaap_DebtInstrumentAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VariableRateDomain" xlink:to="us-gaap_PrimeRateMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_ScheduleOfShortTermDebtTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="eq_LoanAgreementMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="us-gaap_LineOfCreditMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShortTermDebtLineItems" xlink:to="us-gaap_LineOfCreditFacilityExpirationDate1" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShortTermDebtTable" xlink:to="us-gaap_LongtermDebtTypeAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="eq_TermLoanMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShortTermDebtLineItems" xlink:to="eq_LineOfCreditFacilityFrequencyOfPaymentsPrincipalAndInterest" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShortTermDebtTable" xlink:to="srt_RangeAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShortTermDebtLineItems" xlink:to="us-gaap_DebtInstrumentFrequencyOfPeriodicPayment" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShortTermDebtTable" xlink:to="us-gaap_VariableRateAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShortTermDebtLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShortTermDebtTable" xlink:to="us-gaap_ShortTermDebtLineItems" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShortTermDebtLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateBasisForEffectiveRate" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShortTermDebtLineItems" xlink:to="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShortTermDebtLineItems" xlink:to="eq_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaidAsPercent" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShortTermDebtLineItems" xlink:to="eq_RequiredNoticePeriodForDebtPrepayment" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShortTermDebtLineItems" xlink:to="eq_DebtPrepaymentFeeAsPercentOnYearOne" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShortTermDebtLineItems" xlink:to="eq_DebtPrepaymentFeeAsPercentOnYearTwo" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShortTermDebtLineItems" xlink:to="eq_DebtPrepaymentFeeAsPercentFromYearThree" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShortTermDebtLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShortTermDebtLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShortTermDebtLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateEffectivePercentage" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://equilliumbio.com/20221231/taxonomy/role/DisclosureNotesPayableScheduleOfAggregateCarryingAmountsOfTermLoanDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable" xlink:label="us-gaap_DebtInstrumentTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="us-gaap_LongtermDebtTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="us-gaap_LongtermDebtTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="us-gaap_DebtInstrumentCarryingAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember" xlink:label="us-gaap_LineOfCreditMember"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_AccretedLiabilityForFinalPaymentFee" xlink:label="eq_AccretedLiabilityForFinalPaymentFee"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt" xlink:label="us-gaap_LongTermDebt"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_LongtermDebtTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtInstrumentTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentCarryingAmount" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="us-gaap_LineOfCreditMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="eq_AccretedLiabilityForFinalPaymentFee" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscount" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LongTermDebt" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://equilliumbio.com/20221231/taxonomy/role/DisclosureNotesPayableScheduleFutureMaturitiesOfTermLoanIncludingFinalPaymentFeeDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_DebtInstrumentCarryingAmountIncludingUnaccretedLiabilityForFinalPaymentFeeMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="eq_DebtInstrumentCarryingAmountIncludingUnaccretedLiabilityForFinalPaymentFeeMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_DebtInstrumentCarryingAmountIncludingUnaccretedLiabilityForFinalPaymentFeeMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="eq_DebtInstrumentCarryingAmountIncludingUnaccretedLiabilityForFinalPaymentFeeMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_DebtInstrumentCarryingAmountIncludingUnaccretedLiabilityForFinalPaymentFeeMaturitiesRepaymentsOfPrincipalInYearThree" xlink:label="eq_DebtInstrumentCarryingAmountIncludingUnaccretedLiabilityForFinalPaymentFeeMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_DebtInstrumentCarryingAmountIncludingUnaccretedLiabilityForFinalPaymentFee" xlink:label="eq_DebtInstrumentCarryingAmountIncludingUnaccretedLiabilityForFinalPaymentFee"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_UnaccretedLiabilityForFinalPaymentFee" xlink:label="eq_UnaccretedLiabilityForFinalPaymentFee"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt" xlink:label="us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent" xlink:label="us-gaap_LongTermDebtCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="eq_DebtInstrumentCarryingAmountIncludingUnaccretedLiabilityForFinalPaymentFeeMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="eq_DebtInstrumentCarryingAmountIncludingUnaccretedLiabilityForFinalPaymentFeeMaturitiesRepaymentsOfPrincipalInYearTwo" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="eq_DebtInstrumentCarryingAmountIncludingUnaccretedLiabilityForFinalPaymentFeeMaturitiesRepaymentsOfPrincipalInYearThree" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="eq_DebtInstrumentCarryingAmountIncludingUnaccretedLiabilityForFinalPaymentFee" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="eq_UnaccretedLiabilityForFinalPaymentFee" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscount" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_LongTermDebt" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_LongTermDebtCurrent" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_LongTermDebtNoncurrent" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_TwoThousandEighteenEquityIncentivePlanMember" xlink:label="eq_TwoThousandEighteenEquityIncentivePlanMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="us-gaap_InvestmentTypeCategorizationMember"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_PurchaseRightMember" xlink:label="eq_PurchaseRightMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_LincolnParkCapitalFundLLCMember" xlink:label="eq_LincolnParkCapitalFundLLCMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis" xlink:label="us-gaap_InvestmentTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VestingAxis" xlink:label="us-gaap_VestingAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VestingDomain" xlink:label="us-gaap_VestingDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_PurchaseAgreementMember" xlink:label="eq_PurchaseAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheOneMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityUnitPurchaseAgreementsMember" xlink:label="us-gaap_EquityUnitPurchaseAgreementsMember"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_TwoThousandSeventeenEquityIncentivePlanMember" xlink:label="eq_TwoThousandSeventeenEquityIncentivePlanMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_EmployeeStockPurchasePlanMember" xlink:label="eq_EmployeeStockPurchasePlanMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_PurchaseAgreementExpirationDate" xlink:label="eq_PurchaseAgreementExpirationDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="us-gaap_SharesIssuedPricePerShare"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_GrossProceedsFromIssuanceOfCommonStock" xlink:label="eq_GrossProceedsFromIssuanceOfCommonStock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_EstimatedMaximumAmountOfCommonStockIssuable" xlink:label="eq_EstimatedMaximumAmountOfCommonStockIssuable"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_TermOfPurchaseAgreement" xlink:label="eq_TermOfPurchaseAgreement"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_FairMarketValueOfCommitmentShares" xlink:label="eq_FairMarketValueOfCommitmentShares"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_EquityIncentivePlanDescription" xlink:label="eq_EquityIncentivePlanDescription"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_MinimumOptionsExercisePriceAsPercentageOfFairMarketValueOfCommonStock" xlink:label="eq_MinimumOptionsExercisePriceAsPercentageOfFairMarketValueOfCommonStock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRemainingVestingPeriod" xlink:label="eq_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRemainingVestingPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_EmployeeStockPurchasePlanDescription" xlink:label="eq_EmployeeStockPurchasePlanDescription"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_WithholdPercentageOfEmployeesEarningsToPurchaseSharesOfCommonStock" xlink:label="eq_WithholdPercentageOfEmployeesEarningsToPurchaseSharesOfCommonStock"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_MinimumStockPricePerShareAsPercentageOfFairMarketValueOfCommonStock" xlink:label="eq_MinimumStockPricePerShareAsPercentageOfFairMarketValueOfCommonStock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_UnvestedStockLiability" xlink:label="eq_UnvestedStockLiability"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_DividendsPaidOnCommonStock" xlink:label="eq_DividendsPaidOnCommonStock"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_NumberOfInstitutionalInvestors" xlink:label="eq_NumberOfInstitutionalInvestors"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="eq_TwoThousandEighteenEquityIncentivePlanMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="eq_PurchaseRightMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="eq_LincolnParkCapitalFundLLCMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeCategorizationMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VestingAxis" xlink:to="us-gaap_VestingDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="eq_PurchaseAgreementMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VestingDomain" xlink:to="us-gaap_ShareBasedCompensationAwardTrancheOneMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_EquityUnitPurchaseAgreementsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="eq_TwoThousandSeventeenEquityIncentivePlanMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_WarrantMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_InvestmentTypeAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="eq_EmployeeStockPurchasePlanMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_VestingAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_CounterpartyNameAxis" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="eq_PurchaseAgreementExpirationDate" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharesIssuedPricePerShare" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_RangeAxis" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="eq_GrossProceedsFromIssuanceOfCommonStock" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="eq_EstimatedMaximumAmountOfCommonStockIssuable" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="eq_TermOfPurchaseAgreement" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="eq_FairMarketValueOfCommitmentShares" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="eq_EquityIncentivePlanDescription" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" order="16" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="eq_MinimumOptionsExercisePriceAsPercentageOfFairMarketValueOfCommonStock" order="17" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" order="18" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="eq_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRemainingVestingPeriod" order="19" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" order="20" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" order="21" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" order="22" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="23" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" order="24" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" order="25" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" order="26" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="eq_EmployeeStockPurchasePlanDescription" order="27" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="eq_WithholdPercentageOfEmployeesEarningsToPurchaseSharesOfCommonStock" order="28" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="eq_MinimumStockPricePerShareAsPercentageOfFairMarketValueOfCommonStock" order="29" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" order="30" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" order="31" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" order="32" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="eq_UnvestedStockLiability" order="33" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="eq_DividendsPaidOnCommonStock" order="34" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="eq_NumberOfInstitutionalInvestors" order="35" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" order="36" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="37" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquitySummaryOfStockOptionActivityDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_TwoThousandEighteenEquityIncentivePlanMember" xlink:label="eq_TwoThousandEighteenEquityIncentivePlanMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_4"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_10"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="eq_TwoThousandEighteenEquityIncentivePlanMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_4" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_10" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquitySummaryOfStockOptionActivityParentheticalDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockMember" xlink:label="us-gaap_EmployeeStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_EmployeeStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharePrice" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquitySummaryOfTotalNonCashStockBasedCompensationExpenseDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_IncomeStatementLocationAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquitySummaryOfWeightedAverageAssumptionsUsedToDetermineFairValueOfStockOptionGrantsDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquitySummaryOfCommonStockReservedForFutureIssuanceDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_StockOptionsIssuedAndOutstandingMember" xlink:label="eq_StockOptionsIssuedAndOutstandingMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_AwardsAvailableUnder2018PlanMember" xlink:label="eq_AwardsAvailableUnder2018PlanMember"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_EmployeeStockPurchasePlanMember" xlink:label="eq_EmployeeStockPurchasePlanMember"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="eq_StockOptionsIssuedAndOutstandingMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_WarrantMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="eq_AwardsAvailableUnder2018PlanMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="eq_EmployeeStockPurchasePlanMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_CommitmentsAndContingenciesLineItems" xlink:label="eq_CommitmentsAndContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementExpense" xlink:label="us-gaap_LitigationSettlementExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_CommitmentsAndContingenciesTable" xlink:label="eq_CommitmentsAndContingenciesTable"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="eq_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_LitigationSettlementExpense" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="eq_CommitmentsAndContingenciesTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="eq_CommitmentsAndContingenciesTable" xlink:to="eq_CommitmentsAndContingenciesLineItems" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfComponentsOfLossBeforeIncomeTaxProvisionBenefitDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="us-gaap_IncomeTaxAuthorityDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCountryMember" xlink:label="us-gaap_DomesticCountryMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain" xlink:label="srt_SegmentGeographicalDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_CA" xlink:label="stpr_CA"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardTable" xlink:label="us-gaap_TaxCreditCarryforwardTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis" xlink:label="srt_StatementGeographicalAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="us-gaap_IncomeTaxAuthorityAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardLineItems" xlink:label="us-gaap_TaxCreditCarryforwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCountryMember" xlink:label="us-gaap_ForeignCountryMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_AU" xlink:label="country_AU"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="us-gaap_StateAndLocalJurisdictionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_OperatingLossCarryforwardsExpirationYear" xlink:label="eq_OperatingLossCarryforwardsExpirationYear"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="us-gaap_OperatingLossCarryforwards"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsLimitationsOnUse" xlink:label="us-gaap_OperatingLossCarryforwardsLimitationsOnUse"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_OperatingLossCarryforwardsLimitationRateOnTaxableIncome" xlink:label="eq_OperatingLossCarryforwardsLimitationRateOnTaxableIncome"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_TaxCreditCarryforwardExpirationYear" xlink:label="eq_TaxCreditCarryforwardExpirationYear"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_CumulativeChangeInOwnershipPercentage" xlink:label="eq_CumulativeChangeInOwnershipPercentage"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_CumulativeChangeInOwnershipPeriod" xlink:label="eq_CumulativeChangeInOwnershipPeriod"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_ResearchAndExperimentalExpendituresCapitalizedCostAmortizationPeriod" xlink:label="eq_ResearchAndExperimentalExpendituresCapitalizedCostAmortizationPeriod"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_DomesticCountryMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_SegmentGeographicalDomain" xlink:to="stpr_CA" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_TaxCreditCarryforwardTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardTable" xlink:to="srt_StatementGeographicalAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefit" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_ForeignCountryMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_SegmentGeographicalDomain" xlink:to="country_AU" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardTable" xlink:to="us-gaap_IncomeTaxAuthorityAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_StateAndLocalJurisdictionMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardTable" xlink:to="srt_RangeAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardTable" xlink:to="us-gaap_TaxCreditCarryforwardLineItems" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="eq_OperatingLossCarryforwardsExpirationYear" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="us-gaap_OperatingLossCarryforwards" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="us-gaap_OperatingLossCarryforwardsLimitationsOnUse" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="eq_OperatingLossCarryforwardsLimitationRateOnTaxableIncome" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="eq_TaxCreditCarryforwardExpirationYear" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="eq_CumulativeChangeInOwnershipPercentage" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="eq_CumulativeChangeInOwnershipPeriod" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="eq_ResearchAndExperimentalExpendituresCapitalizedCostAmortizationPeriod" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesReconciliationOfExpectedStatutoryFederalIncomeTaxProvisionToActualIncomeTaxProvisionDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:label="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_IncomeTaxReconciliationPermanentItems" xlink:label="eq_IncomeTaxReconciliationPermanentItems"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_IncomeTaxReconciliationFederalResearchAndOrphanDrugCredits" xlink:label="eq_IncomeTaxReconciliationFederalResearchAndOrphanDrugCredits"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:label="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_EffectiveIncomeTaxRateReconciliationTransactionCostsAmount" xlink:label="eq_EffectiveIncomeTaxRateReconciliationTransactionCostsAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:to="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:to="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:to="us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:to="eq_IncomeTaxReconciliationPermanentItems" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:to="eq_IncomeTaxReconciliationFederalResearchAndOrphanDrugCredits" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:to="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:to="eq_EffectiveIncomeTaxRateReconciliationTransactionCostsAmount" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:to="us-gaap_IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfNetDeferredTaxAssetsAndLiabilitiesDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesAbstract" xlink:label="us-gaap_DeferredTaxLiabilitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:label="us-gaap_DeferredTaxLiabilitiesLeasingArrangements"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNetAbstract" xlink:label="us-gaap_DeferredTaxAssetsNetAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesTaxDeferredIncome" xlink:label="us-gaap_DeferredTaxLiabilitiesTaxDeferredIncome"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesOther" xlink:label="us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_DeferredTaxAssetsCapitalizedResearchExpenditures" xlink:label="eq_DeferredTaxAssetsCapitalizedResearchExpenditures"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities" xlink:label="us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="us-gaap_DeferredTaxAssetsOther"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="us-gaap_DeferredTaxAssetsGross"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="us-gaap_DeferredTaxAssetsNet"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxLiabilitiesAbstract" xlink:to="us-gaap_DeferredTaxLiabilitiesLeasingArrangements" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredTaxAssetsNetAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsNetAbstract" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxLiabilitiesAbstract" xlink:to="us-gaap_DeferredTaxLiabilitiesTaxDeferredIncome" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredTaxLiabilitiesAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsNetAbstract" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxLiabilitiesAbstract" xlink:to="us-gaap_DeferredTaxLiabilitiesOther" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsNetAbstract" xlink:to="eq_DeferredTaxAssetsCapitalizedResearchExpenditures" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxLiabilitiesAbstract" xlink:to="us-gaap_DeferredIncomeTaxLiabilities" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsNetAbstract" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsNetAbstract" xlink:to="us-gaap_DeferredTaxAssetsOther" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsNetAbstract" xlink:to="us-gaap_DeferredTaxAssetsGross" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsNetAbstract" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsNetAbstract" xlink:to="us-gaap_DeferredTaxAssetsNet" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfReconciliationOfUnrecognizedTaxBenefitsDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="us-gaap_UnrecognizedTaxBenefits"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="us-gaap_UnrecognizedTaxBenefits_3"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_UnrecognizedTaxBenefits" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_UnrecognizedTaxBenefits_3" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureRetirementPlanAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:label="us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:label="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureSubsequentEventsAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventLineItems" xlink:label="us-gaap_SubsequentEventLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsHeldInTrust" xlink:label="us-gaap_AssetsHeldInTrust"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="eq-20221231.xsd#eq_SiliconValleyBankMember" xlink:label="eq_SiliconValleyBankMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTable" xlink:label="us-gaap_SubsequentEventTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_AssetsHeldInTrust" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="eq_SiliconValleyBankMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="srt_CounterpartyNameAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140407548180272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Mar. 16, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">EQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">EQUILLIUM, INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001746466<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34,414,149<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 43.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.0001 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-38692<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">82-1554746<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">2223 Avenida de la Playa<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 105<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">La Jolla<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">92037<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">858<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">412-5302<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentsIncorporatedByReferenceTextBlock', window );">Documents Incorporated by Reference</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">DOCUMENTS INCORPORATED BY REFERENCE</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Part III of this Annual Report on Form 10-K incorporates by reference certain information from the registrant&#8217;s definitive Proxy Statement for its 2023 annual meeting of stockholders, which the registrant intends to file pursuant to Regulation 14A with the Securities and Exchange Commission not later than 120 days after the registrant&#8217;s fiscal year end of December 31, 2022. Except with respect to information specifically incorporated by reference in this Form 10-K, the Proxy Statement is not deemed to be filed as part of this Form 10-K.</span></p><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">KPMG LLP<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">San Diego, California, United States<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">185<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentsIncorporatedByReferenceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Documents incorporated by reference.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentsIncorporatedByReferenceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140407548260864">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 59,107<span></span>
</td>
<td class="nump">$ 50,366<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Short-term investments</a></td>
<td class="nump">11,916<span></span>
</td>
<td class="nump">30,345<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable</a></td>
<td class="nump">2,838<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">2,874<span></span>
</td>
<td class="nump">2,659<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">76,735<span></span>
</td>
<td class="nump">83,370<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">1,191<span></span>
</td>
<td class="nump">1,645<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">391<span></span>
</td>
<td class="nump">237<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">104<span></span>
</td>
<td class="nump">153<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">78,421<span></span>
</td>
<td class="nump">85,405<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">3,977<span></span>
</td>
<td class="nump">1,225<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">7,239<span></span>
</td>
<td class="nump">5,886<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRevenueCurrent', window );">Current portion of deferred revenue</a></td>
<td class="nump">14,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayableCurrent', window );">Current portion of long-term notes payable</a></td>
<td class="nump">5,714<span></span>
</td>
<td class="nump">1,428<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current portion of operating lease liabilities</a></td>
<td class="nump">408<span></span>
</td>
<td class="nump">376<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">32,038<span></span>
</td>
<td class="nump">8,915<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermNotesPayable', window );">Long-term notes payable</a></td>
<td class="nump">3,239<span></span>
</td>
<td class="nump">8,750<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRevenueNoncurrent', window );">Long-term deferred revenue</a></td>
<td class="nump">10,378<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term operating lease liabilities</a></td>
<td class="nump">824<span></span>
</td>
<td class="nump">1,235<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">46,479<span></span>
</td>
<td class="nump">18,900<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.0001 par value; 200,000,000 shares authorized as of December 31, 2022 and 2021; 34,414,149 and 29,455,668 shares issued and outstanding as of December 31, 2022 and 2021, respectively</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">204,268<span></span>
</td>
<td class="nump">176,618<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income (loss)</a></td>
<td class="nump">76<span></span>
</td>
<td class="num">(138)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(172,405)<span></span>
</td>
<td class="num">(109,977)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders' equity</a></td>
<td class="nump">31,942<span></span>
</td>
<td class="nump">66,505<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders' equity</a></td>
<td class="nump">$ 78,421<span></span>
</td>
<td class="nump">$ 85,405<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26626-111562<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140407548258768">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">200,000,000<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">34,414,149<span></span>
</td>
<td class="nump">29,455,668<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="nump">34,414,149<span></span>
</td>
<td class="nump">29,455,668<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140407548898608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Operations and Comprehensive Loss - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 15,759<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">37,547<span></span>
</td>
<td class="nump">$ 26,379<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eq_AcquiredInProcessResearchAndDevelopment', window );">Acquired in-process research and development</a></td>
<td class="nump">23,049<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">17,239<span></span>
</td>
<td class="nump">11,407<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">77,835<span></span>
</td>
<td class="nump">37,786<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(62,076)<span></span>
</td>
<td class="num">(37,786)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other expense, net:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest expense</a></td>
<td class="num">(1,053)<span></span>
</td>
<td class="num">(1,073)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
<td class="nump">420<span></span>
</td>
<td class="nump">57<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income (expense), net</a></td>
<td class="nump">281<span></span>
</td>
<td class="num">(250)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other expense , net</a></td>
<td class="num">(352)<span></span>
</td>
<td class="num">(1,266)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(62,428)<span></span>
</td>
<td class="num">(39,052)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract', window );"><strong>Other comprehensive income, net:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax', window );">Unrealized loss on available-for-sale securities, net</a></td>
<td class="num">(38)<span></span>
</td>
<td class="num">(59)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation gain</a></td>
<td class="nump">252<span></span>
</td>
<td class="nump">218<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Total other comprehensive income, net</a></td>
<td class="nump">214<span></span>
</td>
<td class="nump">159<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss</a></td>
<td class="num">$ (62,214)<span></span>
</td>
<td class="num">$ (38,893)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per share, basic</a></td>
<td class="num">$ (1.85)<span></span>
</td>
<td class="num">$ (1.36)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per share, diluted</a></td>
<td class="num">$ (1.85)<span></span>
</td>
<td class="num">$ (1.36)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average number of common shares outstanding, basic</a></td>
<td class="nump">33,727,945<span></span>
</td>
<td class="nump">28,806,310<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average number of common shares outstanding, diluted</a></td>
<td class="nump">33,727,945<span></span>
</td>
<td class="nump">28,806,310<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eq_AcquiredInProcessResearchAndDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Acquired in-process research and development</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eq_AcquiredInProcessResearchAndDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27357-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140407545161888">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Stockholders' Equity - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Bioniz</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th">
<div>Common Stock </div>
<div>Bioniz</div>
</th>
<th class="th"><div>Additional Paid-in Capital</div></th>
<th class="th">
<div>Additional Paid-in Capital </div>
<div>Bioniz</div>
</th>
<th class="th"><div>Accumulated Other Comprehensive Income (Loss)</div></th>
<th class="th"><div>Accumulated Deficit</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2020</a></td>
<td class="nump">$ 69,854<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 141,074<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (297)<span></span>
</td>
<td class="num">$ (70,925)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance, Shares at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,753,102<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueOther', window );">Issuance of common stock from follow-on offering, net of issuance costs</a></td>
<td class="nump">29,909<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,909<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesOther', window );">Issuance of common stock from follow-on offering, net of issuance costs,Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,285,710<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of common stock under employee stock purchase plan</a></td>
<td class="nump">261<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">261<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of common stock under employee stock purchase plan, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90,402<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">891<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">891<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">326,454<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition', window );">Vesting of restricted stock liability</a></td>
<td class="nump">73<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">73<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">4,410<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,410<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Comprehensive income</a></td>
<td class="nump">159<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">159<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(39,052)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(39,052)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2021</a></td>
<td class="nump">66,505<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">176,618<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(138)<span></span>
</td>
<td class="num">(109,977)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance, Share at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,455,668<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22,542<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22,541<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,820,230<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of common stock under employee stock purchase plan</a></td>
<td class="nump">215<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">215<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of common stock under employee stock purchase plan, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">138,251<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition', window );">Vesting of restricted stock liability</a></td>
<td class="nump">53<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">53<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">4,841<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,841<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Comprehensive income</a></td>
<td class="nump">214<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">214<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(62,428)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(62,428)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2022</a></td>
<td class="nump">$ 31,942<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 204,268<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 76<span></span>
</td>
<td class="num">$ (172,405)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance, Share at Dec. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34,414,149<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for restricted stock unit under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11178-113907<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126961718&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued attributable to transactions classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of shares of stock issued attributable to transactions classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140407552592096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="num">$ (62,428)<span></span>
</td>
<td class="num">$ (39,052)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentInProcess', window );">Acquired in-process research and development</a></td>
<td class="nump">23,049<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">118<span></span>
</td>
<td class="nump">72<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">4,841<span></span>
</td>
<td class="nump">4,410<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossUnrealized', window );">Net unrealized loss on foreign currency transactions</a></td>
<td class="nump">260<span></span>
</td>
<td class="nump">240<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts', window );">Amortization of term loan discount and issuance costs</a></td>
<td class="nump">203<span></span>
</td>
<td class="nump">237<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments', window );">Amortization of investments, net</a></td>
<td class="nump">127<span></span>
</td>
<td class="nump">314<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredRevenue', window );">Deferred revenue</a></td>
<td class="nump">25,078<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="num">(2,838)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="num">(158)<span></span>
</td>
<td class="nump">214<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="nump">2,508<span></span>
</td>
<td class="num">(1,578)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued expenses</a></td>
<td class="nump">432<span></span>
</td>
<td class="nump">3,099<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eq_IncreaseDecreaseInRightOfUseAssetsAndLeaseLiabilitiesNet', window );">Right-of-use assets and lease liabilities, net</a></td>
<td class="nump">75<span></span>
</td>
<td class="num">(37)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(8,733)<span></span>
</td>
<td class="num">(32,081)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="num">(279)<span></span>
</td>
<td class="num">(57)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireShortTermInvestments', window );">Purchases of short-term investments</a></td>
<td class="num">(14,962)<span></span>
</td>
<td class="num">(32,992)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments', window );">Maturities of short-term investments</a></td>
<td class="nump">33,225<span></span>
</td>
<td class="nump">60,455<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided by investing activities</a></td>
<td class="nump">18,684<span></span>
</td>
<td class="nump">27,406<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfNotesPayable', window );">Principal repayments on note payable</a></td>
<td class="num">(1,429)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from exercise of stock options</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">891<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockPlans', window );">Proceeds from ESPP purchases</a></td>
<td class="nump">214<span></span>
</td>
<td class="nump">261<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash (used in) provided by financing activities</a></td>
<td class="num">(1,215)<span></span>
</td>
<td class="nump">31,061<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Effect of exchange rate changes on cash and cash equivalents</a></td>
<td class="nump">5<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase in cash and cash equivalents</a></td>
<td class="nump">8,741<span></span>
</td>
<td class="nump">26,384<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash and cash equivalents at beginning of period</a></td>
<td class="nump">50,366<span></span>
</td>
<td class="nump">23,982<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash and cash equivalents at end of period</a></td>
<td class="nump">59,107<span></span>
</td>
<td class="nump">50,366<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental cash flow information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid for interest</a></td>
<td class="nump">847<span></span>
</td>
<td class="nump">836<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Right-of-use assets obtained in exchange for lease obligations</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,759<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Amounts included in accounts payable for purchases of property and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=eq_BionizTherapeuticsIncMember', window );">Bioniz</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAcquiredFromAcquisition', window );">Cash acquired in Bioniz acquisition</a></td>
<td class="nump">700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental cash flow information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOfAssetsAcquired', window );">Fair value of Bioniz assets acquired</a></td>
<td class="nump">23,049<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAssumed1', window );">Bioniz net liabilities assumed</a></td>
<td class="nump">507<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssued1', window );">Issuance of common stock for Bioniz acquisition</a></td>
<td class="num">$ (22,542)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=eq_FollowOnOfferingMember', window );">Follow-on Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock from follow-on offering, net of issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 29,909<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eq_IncreaseDecreaseInRightOfUseAssetsAndLeaseLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (decrease) in right-of-use assets and lease liabilities, net.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eq_IncreaseDecreaseInRightOfUseAssetsAndLeaseLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCostsAndDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAcquiredFromAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAcquiredFromAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfAssetsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value of assets acquired in noncash investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4313-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfAssetsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossUnrealized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of foreign currency transaction unrealized gain (loss) recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124440516&amp;loc=d3e30840-110895<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=125521441&amp;loc=d3e30690-110894<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossUnrealized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAssumed1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value of liabilities assumed in noncash investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4313-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAssumed1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from maturities, prepayments, calls and collections of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the stock plan during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentInProcess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of purchased research and development assets that are acquired in a business combination have no alternative future use and are therefore written off in the period of acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentInProcess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value of stock issued in noncash financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4313-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=eq_BionizTherapeuticsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=eq_BionizTherapeuticsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=eq_FollowOnOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=eq_FollowOnOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140407548163488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Accounting Pronouncements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock', window );">Organization and Accounting Pronouncements</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1. Organization and Accounting Pronouncements</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Description of Business</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Equillium, Inc. (the Company) was incorporated in the state of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Delaware</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> on </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">March 16, 2017</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. The Company is a clinical-stage biotechnology company </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">leveraging a deep understanding of immunobiology to develop novel therapeutics to treat severe autoimmune and inflammatory (immuno-inflammatory), disorders with high unmet medical need. The Company&#8217;s strategy is focused on advancing the clinical development of its product candidates, including potentially pursuing additional indications and acquiring new product candidates and platforms to expand its pipeline. The Company intends to commercialize its product candidates either independently or through partnerships or otherwise monetize its pipeline through strategic transactions.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company's current clinical-stage product candidates consist of EQ101, EQ102 and itolizumab (EQ001). EQ101 and EQ102 are synthetic peptides engineered to specifically inhibit key disease-driving, clinically validated cytokine targets aimed at addressing unmet needs across a range of immuno-inflammatory indications. EQ101 is a first-in class, selective, tri-specific inhibitor of IL-2, IL-9 and IL-15, and EQ102 is a first-in class, selective, bi-specific inhibitor of IL-15 and IL-21. Itolizumab (EQ001) is a first-in-class monoclonal antibody that selectively targets the immune checkpoint receptor CD6, which plays a central role in the modulation of effector T cell, or T</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:sub;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">eff</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> cell, activity and trafficking that drives a number of immuno-inflammatory diseases across multiple therapeutic areas. The Company's novel and differentiated pipeline of first-in-class immunology assets has the potential to address unmet medical needs in numerous areas, including dermatology, gastroenterology, transplant science, hematology, rheumatology, oncology and pulmonology.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">From inception through December 31, 2022, the Company has devoted substantially all of its efforts to organizing and staffing the Company, business planning, raising capital, in-licensing rights to itolizumab (EQ001), conducting non-clinical research, filing three Investigational New Drug applications (INDs), conducting clinical development of the Company's product candidates, conducting business development activities such as the acquisition of Bioniz Therapeutics, Inc. (Bioniz),  the Asset Purchase Agreement with Ono Pharmaceutical Co., Ltd. (Ono) and other transactions not completed, and the general and administrative activities associated with operating a public company.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Liquidity and Business Risks</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31, 2022, the Company had $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">71.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million in cash, cash equivalents and short-term investments. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company has incurred significant operating losses and negative cash flows from operations. The Company expects to use its cash, cash equivalents, and short-term investments to fund research and development of its product candidates, for potentially acquiring and conducting research and development of new products, and for working capital and other general corporate purposes. The Company does not expect to generate any revenues from product sales unless and until the Company successfully completes development and obtains regulatory approval of any of its product candidates, which is unlikely to happen within the next 12 months, if ever. Accordingly, until such time as the Company can generate significant revenue from sales of its product candidates, if ever, the Company expects to finance its cash needs through a combination of equity offerings, debt financings, and collaboration and license agreements, such as its Asset Purchase Agreement with Ono. However, the Company may not be able to secure additional financing or enter into such other arrangements in a timely manner or on favorable terms, if at all. As a result of the conflict between Russia and Ukraine, bank failures, inflationary pressures on the economy and monetary policy responses taken by government agencies and other macroeconomic factors, the global credit and financial markets have experienced extreme volatility, including diminished liquidity and credit availability, declines in consumer confidence, declines in economic growth and uncertainty about economic stability. There can be no assurance that further deterioration in credit and financial markets and confidence in economic conditions will not occur. If equity and credit markets deteriorate, it may make any necessary debt or equity financing more difficult to obtain, more costly and/or more dilutive. The Company&#8217;s failure to raise capital or enter into such other arrangements when needed would have a negative impact on the Company&#8217;s financial condition and could force the Company to delay, reduce or terminate its research and development programs or other operations, or grant rights to develop and market product candidates that the Company would otherwise prefer to develop and market itself. Management believes that the Company&#8217;s cash, cash equivalents and short-term investments as of December 31, 2022 will be sufficient to fund operations for at least the next 12 months from the date this Annual Report on Form 10-K is filed with the Securities and Exchange Commission (SEC).</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Basis of Presentation</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The accompanying consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (GAAP) and the rules and regulations of the SEC. Any reference in these notes to applicable guidance</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">is meant to refer to GAAP as found in the Accounting Standards Codification (ASC) and Accounting Standards Updates (ASU) promulgated by the Financial Accounting Standards Board (FASB).</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Principles of Consolidation</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The accompanying consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Foreign Currency Translation</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company&#8217;s wholly-owned subsidiary in Australia uses its local currency as its functional currency. Assets and liabilities are translated into U.S. dollars at quarter-end exchange rates and revenues and expenses are translated at average exchange rates during the year-to-date periods. Foreign currency translation adjustments for the reported periods are included in accumulated other comprehensive income in the Company&#8217;s consolidated statements of comprehensive loss, and the cumulative effect is included in the stockholders&#8217; equity section of the Company&#8217;s consolidated balance sheets.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Recently Issued and Recently Adopted Accounting Pronouncements</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In June 2016, the FASB issued ASU No. 2016-13, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Measurement of Credit Losses on Financial Instruments</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, which will require a reporting entity to use a new forward-looking impairment model for most financial assets that generally will result in the earlier recognition of allowances for losses. The ASU, along with related amendments, revised the measurement of credit losses for financial assets measured at amortized cost from an incurred loss to an expected loss methodology. The ASU affected receivables, debt securities, net investment in leases, and most other financial assets that represent a right to receive cash. The Company </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">adopted</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> this standard effective </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">January 1, 2022</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> using the modified retrospective approach. Due to the nature of the Company's investment portfolio, the adoption of the guidance did</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> no</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">t have a material effect on the Company's consolidated financial statements and no allowance was recorded for expected credit losses.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></div><span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">From time to time, new accounting pronouncements are issued by the FASB or other standard setting bodies that are adopted by the Company as of the specified effective date. The Company has evaluated recently issued pronouncements and does not believe any will have a material impact on the Company's consolidated financial statements or related financial statement disclosures. Other accounting standard updates effective for interim and annual periods beginning after December 31, 2022 are not expected to have a material impact on the Company&#8217;s financial position, results of operations or cash flows.</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the organization, consolidation and basis of presentation of financial statements disclosure, and significant accounting policies of the reporting entity. May be provided in more than one note to the financial statements, as long as users are provided with an understanding of (1) the significant judgments and assumptions made by an enterprise in determining whether it must consolidate a VIE and/or disclose information about its involvement with a VIE, (2) the nature of restrictions on a consolidated VIE's assets reported by an enterprise in its statement of financial position, including the carrying amounts of such assets, (3) the nature of, and changes in, the risks associated with an enterprise's involvement with the VIE, and (4) how an enterprise's involvement with the VIE affects the enterprise's financial position, financial performance, and cash flows. Describes procedure if disclosures are provided in more than one note to the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI https://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI https://asc.fasb.org/topic&amp;trid=2197479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI https://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140407550453248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2. Summary of Significant Accounting Policies</span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Use of Estimates</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The preparation of the Company&#8217;s consolidated financial statements requires the Company to make estimates and assumptions that impact the reported amounts of assets, liabilities and expenses and the disclosure of contingent assets and liabilities in the consolidated financial statements and accompanying notes. Significant estimates in the Company&#8217;s consolidated financial statements relate to accrued research and development expense, revenue recognition and the valuation of equity awards. Management evaluates its estimates on an ongoing basis. Although estimates are based on the Company&#8217;s historical experience, knowledge of current events, and actions it may undertake in the future, actual results may ultimately materially differ from these estimates and assumptions.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Concentration of Credit Risk and Off-Balance Sheet Risk</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Financial instruments which potentially subject the Company to significant concentration of credit risk consist of cash and cash equivalents and short-term investments. The Company maintains deposits in federally insured financial institutions in excess of federally insured limits. The Company has not experienced any losses in such accounts, and management believes that the Company is not exposed to significant credit risk due to the financial position of the depository institutions in which those deposits are held. The Company&#8217;s investment policy includes guidelines for the quality of the related institutions and financial instruments and defines allowable investments that the Company may invest in, which the Company believes minimizes the exposure to concentration of credit risk.</span></p></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Comprehensive Loss</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company is required to report all components of comprehensive loss, including net loss, in the consolidated financial statements in the period in which they are recognized. Comprehensive loss is defined as the change in equity during a period from transactions and other events and circumstances from non-owner sources, including unrealized gains and losses on investments and foreign currency gains and losses. Other comprehensive income, net includes unrealized losses and gains on short-term investments as well as foreign currency translation gains and losses.</span></p></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Cash and Cash Equivalents</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cash and cash equivalents include cash in readily available checking and savings accounts, and money market funds. The Company considers all highly liquid investments with an original maturity of three months or less from the date of purchase to be cash equivalents. At December 31, 2022 and 2021, the Company's cash and cash equivalents were primarily comprised of money market funds.</span></p></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Short-Term Investments</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Available-for-sale securities are carried at fair value, with the unrealized gains and losses reported in comprehensive loss. The amortized cost of available-for-sale debt securities is adjusted for amortization of premiums and accretion of discounts to maturity. Such amortization and accretion are included in interest income. Realized gains and losses and declines in value judged to be other-than-temporary, if any, on available-for-sale securities are included in other income or expense. The cost of securities sold is based on the specific identification method. Interest and dividends on securities classified as available-for-sale are included in interest income.</span></p></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Accounts Receivable</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accounts receivable includes trade accounts receivables from the Ono Asset Purchase Agreement (see Note 9). Reimbursable costs that have not been invoiced as of the balance sheet date are recorded as unbilled accounts receivable. As of December 31, 2022, the Company had unbilled accounts receivable totaling $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.8</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million classified as accounts receivable on its consolidated balance sheet. As of December 31, 2021, the Company did </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">t have any amount recorded within accounts receivable on its consolidated balance sheet. The Company makes judgments as to its ability to collect outstanding receivables and provide an allowance for receivables when collection becomes doubtful. Allowance for credit risk for accounts receivables  are established based on various factors including credit profiles of the Company&#8217;s customers, historical payments and current economic trends. The Company reviews its allowance for accounts receivables by assessing individual accounts receivable over a specific aging and amount.  The estimate of expected credit losses is based on information about past events, current economic conditions, and forecasts of future economic conditions that affect the collectability. Accounts receivable are written-off on a case by case basis, net of any amounts that may be collected. As of each of December 31, 2022 and 2021, </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> credit losses have been recorded by the Company.</span></p></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Prepaid Expenses and Other Current Assets</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Prepaid expenses and other current assets primarily represent amounts related to director and officer insurance, preclinical research and clinical study agreements, equity issuance costs and an estimated tax refund from the Australian Tax Office for eligible research and development expenditures.</span></p></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Property and Equipment</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Property and equipment is stated at cost and depreciated using the straight-line method over the estimated useful lives of the assets (generally </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="-sec-ix-hidden:F_25b946aa-ecb7-4d36-9827-13132f6bd5be;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">three</span></span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> to </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">five years</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">).</span></span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Leases</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company determines if an arrangement is a lease at inception. Lease right-of-use assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. For operating leases with an initial term greater than 12 months, the Company recognizes operating lease right-of-use assets and operating lease liabilities based on the present value of lease payments over the lease term at the commencement date. Operating lease right-of-use assets are comprised of the lease liability plus any lease payments made and excludes lease incentives. Lease terms include options to renew or terminate the lease when we are reasonably certain that the renewal option will be exercised or when it is reasonably certain that the termination option will not be exercised. For our operating leases, if the interest rate used to determine the present value of future lease payments is not readily determinable, the Company estimates its incremental borrowing rate as the discount rate for the lease. Our incremental borrowing rate is estimated to approximate the interest rate on a collateralized basis with similar terms and payments, and in similar economic environments. Lease expense for lease payments is recognized on a straight-line basis over the lease term. The Company has elected the practical expedient to not separate lease and non-lease components.</span></p></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Impairment of Long-Lived Assets</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Long-lived </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">assets consist primarily of property and equipment. An impairment loss is recorded if and when events and circumstances indicate that assets might be impaired and the undiscounted cash flows estimated to be generated by those</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">assets </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">are less than the carrying amount of those assets. While the Company&#8217;s current and historical operating losses and negative cash flows are indicators of impairment, management believes that future cash flows to be received support the carrying value of its long-lived assets and, accordingly, has not recognized any impairment losses since inception.</span></p></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Accrued Research and Development Expense</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company is required to estimate its expenses resulting from its obligations under contracts with vendors, consultants and contract research organizations, in connection with conducting research and development activities. The financial terms of these contracts are subject to negotiations, which vary from contract to contract and may result in payment flows that do not match the periods over which materials or services are provided under such contracts. The Company reflects research and development expenses in its consolidated financial statements by matching those expenses with the period in which services and efforts are expended. The Company accounts for these expenses according to the progress of the nonclinical or clinical study as measured by the timing of various aspects of the study or related activities. The Company determines accrual estimates through review of the underlying contracts along with preparation of financial models taking into account discussions with research and other key personnel as to the progress of studies, or other services being conducted. During the course of a non-clinical study or clinical study, the Company adjusts its rate of expense recognition if actual results differ from its estimates. The Company classifies its estimates for accrued research and development expenses as accrued expenses on the accompanying consolidated balance sheet.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Australian Research and Development Tax Incentive</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company is eligible under the Australian Research and Development Tax Incentive Program, or the Tax Incentive, to obtain a cash refund from the Australian Taxation Office for eligible research and development expenditures. To be eligible, the Company must have revenue of less than AUD $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">20.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million during the reimbursable period and cannot be controlled by income tax exempt entities. The Tax Incentive is recognized as a reduction to research and development expense when there is reasonable assurance that the Tax Incentive will be received, the relevant expenditure has been incurred, and the amount can be reliably measured. The Company classifies its estimate for the Tax Incentive as prepaid expenses and other current assets on the accompanying consolidated balance sheet. As of December 31, 2022 and 2021, the Company recorded $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.3</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> within  prepaid and other current assets attributed to the Tax Incentive, respectively.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Revenue Recognition</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company recognizes revenue in a manner that depicts the transfer of control of a product or a service to a customer and reflects the amount of the consideration the Company is entitled to receive in exchange for such product or service. In doing so, the Company follows a five-step approach: (i) identify the contract with a customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, (iv) allocate the transaction price to the performance obligations, and (v) recognize revenue when (or as) the customer obtains control of the product or service. The Company considers the terms of a contract and all relevant facts and circumstances when applying the revenue recognition standard. The Company applies the revenue recognition standard, including the use of any practical expedients, consistently to contracts with similar characteristics and in similar circumstances.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">A customer is a party that has entered into a contract with the Company, where the purpose of the contract is to obtain a product or a service that is an output of the Company&#8217;s ordinary activities in exchange for consideration. To be considered a contract, (i) the contract must be approved (in writing, orally, or in accordance with other customary business practices), (ii) each party&#8217;s rights regarding the product or the service to be transferred can be identified, (iii) the payment terms for the product or the service to be transferred can be identified, (iv) the contract must have commercial substance (that is, the risk, timing or amount of future cash flows is expected to change as a result of the contract), and (v) it is probable that the Company will collect substantially all of the consideration to which it is entitled to receive in exchange for the transfer of the product or the service.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">A performance obligation is defined as a promise to transfer a product or a service to a customer. The Company identifies each promise to transfer a product or a service (or a bundle of products or services, or a series of products and services that are substantially the same and have the same pattern of transfer) that is distinct. A product or a service is distinct if both (i) the customer can benefit from the product or the service either on its own or together with other resources that are readily available to the customer and (ii) the Company&#8217;s promise to transfer the product or the service to the customer is separately identifiable from other promises in the contract. Each distinct promise to transfer a product or a service is a unit of accounting for revenue recognition. If a promise to transfer a product or a service is not separately identifiable from other promises in the contract, such promises should be combined into a single performance obligation.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The transaction price is the amount of consideration the Company is entitled to receive in exchange for the transfer of control of a product or a service to a customer. To determine the transaction price, the Company considers the existence of any significant financing component, the effects of any variable elements, noncash considerations and consideration payable to the customer. If a significant financing component exists, the transaction price is adjusted for the time value of money. If an element of variability exists, the Company must estimate the consideration it expects to receive and uses that amount as the basis for recognizing revenue as the product or the service is transferred to the customer. There are two methods for determining the amount of variable consideration: (i) the expected value method, which is the sum of probability-weighted amounts in a range of possible consideration amounts, and (ii) the mostly likely amount method, which identifies the single most likely amount in a range of possible consideration amounts.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If a contract has multiple performance obligations, the Company allocates the transaction price to each distinct performance obligation in an amount that reflects the consideration the Company is entitled to receive in exchange for satisfying each distinct performance obligation. For each distinct performance obligation, revenue is recognized when (or as) the Company transfers control of the product or the service applicable to such performance obligation.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In those instances where the Company first receives consideration in advance of satisfying its performance obligation, the Company classifies such consideration as deferred revenue until (or as) the Company satisfies such performance obligation. In those instances where the Company first satisfies its performance obligation prior to its receipt of consideration, the consideration is recorded as accounts receivable.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company expenses incremental costs of obtaining and fulfilling a contract as and when incurred if the expected amortization period of the asset that would be recognized is one year or less, or if the amount of the asset is immaterial. Otherwise, such costs are capitalized as contract assets if they are incremental to the contract and amortized to expense proportionate to revenue recognition of the underlying contract.</span></p></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Contract Assets</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company does not have material amounts of contract assets since revenue is recognized as control of goods is transferred or as services are performed. There are a small number of research and development services that may occur over a period of time, but that period of time is generally very short in duration. Any contract assets that may arise are recorded in accounts receivable in the Company&#8217;s consolidated balance sheet net of an allowance for credit losses.</span></p></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Contract Liabilities</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company&#8217;s contract liabilities consist of advance payments and deferred revenue. The Company classifies advance payments and deferred revenue as current or noncurrent based on the timing of when it expects to recognize revenue. Generally, all contract liabilities are expected to be recognized within one year and are included in deferred revenue in the Company&#8217;s consolidated balance sheet. The noncurrent portion of deferred revenue is included and separately disclosed in the Company&#8217;s consolidated balance sheet.</span></p></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Acquired In-Process Research and Development Expense</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company has acquired, and may continue to acquire, the rights to develop new product candidates. Payments to acquire a new product candidate, as well as future milestone payments associated with asset acquisitions in which contingent payments are resolved are immediately expensed as acquired in-process research and development provided that the product candidate has not achieved regulatory approval for marketing and, absent obtaining such approval, has no alternative future use.</span></p></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Research and Development</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Research and development expenses include salaries and related overhead expenses, non-cash stock-based compensation expense, external research and development expenses incurred under arrangements with third parties, costs of services performed by consultants and contract research organizations, and regulatory costs including those related to preparing and filing INDs with the FDA. Research and development costs are expensed as incurred.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Patent Costs</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company expenses all costs as incurred in connection with patent applications (including direct application fees, and the legal and consulting expenses related to making such applications) and such costs are included in general and administrative expenses in the consolidated statement of operations.</span></span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Stock-based Compensation</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company measures employee and nonemployee stock-based awards, including stock options and purchase rights, at grant-date fair value and records compensation expense on a straight-line basis over the vesting period of the award. The Company uses the Black-Scholes option pricing model to value its stock option awards. Estimating the fair value of stock option awards requires management to apply judgment and make estimates of certain assumptions, including the volatility of the Company&#8217;s common stock, the expected term of the Company&#8217;s stock options, the expected dividend yield and the fair value of the Company&#8217;s common stock on the measurement date. As a result, if factors change and management uses different assumptions, stock-based compensation expense could be materially different for future awards.</span></p></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Income Taxes</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company accounts for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the consolidated financial statements. Under this method, deferred tax assets and liabilities are determined on the basis of the differences between the consolidated financial statements and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in income in the period that includes the enactment date.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company recognizes deferred tax assets to the extent that the Company believes these assets are more likely than not to be realized. In making such a determination, management considers all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax-planning strategies, and results of recent operations. If management determines that the Company would be able to realize its deferred tax assets in the future in excess of their net recorded amount, management would make an adjustment to the deferred tax asset valuation allowance, which would reduce the provision for income taxes.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company records uncertain tax positions on the basis of a two-step process whereby (1) management determines whether it is more likely than not that the tax positions will be sustained on the basis of the technical merits of the position and (2) for those tax positions that meet the more- likely-than-not recognition threshold, management recognizes the largest amount of tax benefit that is more than </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">50</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> percent likely to be realized upon ultimate settlement with the related tax authority. The Company recognizes interest and penalties related to unrecognized tax benefits within income tax expense. Any accrued interest and penalties are included within the related tax liability.</span></p></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Net Loss per Share</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Basic net loss per share is calculated by dividing the net loss by the weighted-average number of common shares outstanding for the period. Diluted net loss per share is computed by dividing the net loss by the weighted average number of common shares and common share equivalents outstanding for the period. Common stock equivalents are only included when their effect is dilutive. The Company&#8217;s potentially dilutive securities include outstanding options under the Company&#8217;s equity incentive plan and outstanding warrants to purchase common stock, each of which have been excluded from the computation of diluted net loss per share as they would be anti-dilutive to the net loss per share. For all periods presented, there is no difference in the number of shares used to calculate basic and diluted shares outstanding due to the Company&#8217;s net loss position.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Potentially dilutive securities not included in the calculation of diluted net loss per share attributable to common stockholders because to do so would be anti-dilutive are as follows (in common stock equivalent shares):</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
        <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;">
         <tr style="visibility:collapse;">
          <td style="width:61.855%;"/>
          <td style="width:0.994%;"/>
          <td style="width:1.0%;"/>
          <td style="width:15.388%;"/>
          <td style="width:1.0%;"/>
          <td style="width:1.279%;"/>
          <td style="width:1.009%;"/>
          <td style="width:1.0%;"/>
          <td style="width:15.474%;"/>
          <td style="width:1.0%;"/>
         </tr>
         <tr style="height:8.0pt;">
          <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="7" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
          <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:8.0pt;">
          <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
          <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
          <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Common stock options</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5,102,501</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3,947,025</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Common stock warrants</span></p></td>
          <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,366,141</span></p></td>
          <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,366,141</span></p></td>
          <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6,468,642</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5,313,166</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
         </tr>
        </table></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18726-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140407550241056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value of Financial Instruments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value of Financial Instruments</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3. Fair Value of Financial Instruments</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The accounting guidance defines fair value, establishes a consistent framework for measuring fair value and expands disclosure for each major asset and liability category measured at fair value on either a recurring or nonrecurring basis. Fair value is defined as an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. As a basis for considering such assumptions, the accounting guidance establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value as follows:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="margin-left:3.333%;text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Level 1</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="margin-left:3.333%;text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Level 2</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;Quoted prices for similar assets and liabilities in active markets, quoted prices in markets that are not active, or inputs which are observable, either directly or indirectly, for substantially the full term of the asset or liability.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="margin-left:3.333%;text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Level 3</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (i.e., supported by little or no market activity).</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Financial assets measured at fair value on a recurring basis consist of the Company&#8217;s cash equivalents and short-term investments. Cash equivalents consisted of money market funds and short-term investments consisted of U.S. treasury securities and certificates of deposit. The Company obtains pricing information from its investment manager and generally determines the fair value of investment securities using standard observable inputs, including reported trades, broker/dealer quotes, and bid and/or offers.</span></p><div style="font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following tables summarize the Company&#8217;s assets that require fair value measurements on a recurring basis and their respective input levels based on the fair value hierarchy (in thousands):</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:43.102%;"/>
        <td style="width:1.145%;"/>
        <td style="width:1.0%;"/>
        <td style="width:10.312%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.156%;"/>
        <td style="width:1.0%;"/>
        <td style="width:12.783%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.156%;"/>
        <td style="width:1.0%;"/>
        <td style="width:11.65%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.156%;"/>
        <td style="width:1.0%;"/>
        <td style="width:9.541%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="10" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Fair Value Measurements Using</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Quoted Prices in</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Significant</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Significant</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Active Markets</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unobservable</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">for Identical</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Observable</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Inputs</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Assets (Level 1)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Inputs (Level 2)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(Level 3)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Short-term investments:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S. treasury securities</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11,916</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11,916</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11,916</span></p></td>
        <td style="border-top:0.5pt solid rgba(255,255,255,0.01);background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11,916</span></p></td>
        <td style="border-top:0.5pt solid rgba(255,255,255,0.01);background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
        <td style="border-top:0.5pt solid rgba(255,255,255,0.01);background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
        <td style="border-top:0.5pt solid rgba(255,255,255,0.01);background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="10" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Fair Value Measurements Using</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Quoted Prices in</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Significant</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Significant</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Active Markets</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unobservable</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">for Identical</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Observable</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Inputs</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Assets (Level 1)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Inputs (Level 2)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(Level 3)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Short-term investments:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S. treasury securities</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">29,121</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">29,121</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Certificates of deposit</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,224</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,224</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">30,345</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">30,345</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S. treasury securities and certificates of deposit are valued using Level 1 inputs. Level 1 securities are valued at unadjusted quoted prices in active markets that are observable at the measurement date for identical, unrestricted assets or liabilities. Fair values determined by Level 2 inputs, which utilize data points that are observable such as quoted prices, interest rates and yield curves, require the exercise of judgment and use of estimates, that if changed, could significantly affect the Company&#8217;s financial position and results of operations. Investments in agency securities are valued using Level 2 inputs. Level 2 securities are initially valued at the transaction price and subsequently valued and reported utilizing inputs other than quoted prices that are observable either directly or indirectly, such as quotes from third-party pricing vendors.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The carrying amounts of the Company&#8217;s financial instruments, including cash and cash equivalents, prepaid and other current assets, accounts payable, and accrued liabilities, approximate fair value due to their short maturities. At December 31, 2022 and 2021, the carrying amount of the Company&#8217;s notes payable of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.2</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million, respectively, approximated their fair value as the terms of the notes are consistent with the market terms of transactions with similar profiles (Level 2 inputs). None of the Company&#8217;s non-financial assets or liabilities are recorded at fair value on a non-recurring basis.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company did </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">t hold any Level 1, 2 or 3 financial liabilities that are recorded at fair value on a recurring basis as of December 31, 2022 or 2021.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140407550335776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Short-Term Investments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eq_ShortTermInvestmentsTextBlock', window );">Short-Term Investments</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4. Short-term Investments</span></p><div style="font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following table summarizes the Company&#8217;s short-term investments (in thousands):</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:47.169%;"/>
        <td style="width:0.543%;"/>
        <td style="width:9.997%;"/>
        <td style="width:0.543%;"/>
        <td style="width:1.0%;"/>
        <td style="width:8.01%;"/>
        <td style="width:1.0%;"/>
        <td style="width:0.543%;"/>
        <td style="width:1.0%;"/>
        <td style="width:8.01%;"/>
        <td style="width:1.0%;"/>
        <td style="width:0.556%;"/>
        <td style="width:1.0%;"/>
        <td style="width:8.326%;"/>
        <td style="width:1.0%;"/>
        <td style="width:0.265%;"/>
        <td style="width:1.0%;"/>
        <td style="width:8.035%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Maturity</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Amortized</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unrealized</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unrealized</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Estimated</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(in years)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cost</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Gains</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Losses</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Fair Value</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S. treasury securities</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1 </span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">or less</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12,006</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">90</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11,916</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12,006</span></p></td>
        <td style="border-top:0.5pt solid rgba(255,255,255,0.01);background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
        <td style="border-top:0.5pt solid rgba(255,255,255,0.01);background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">90</span></p></td>
        <td style="border-top:0.5pt solid rgba(255,255,255,0.01);background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11,916</span></p></td>
        <td style="border-top:0.5pt solid rgba(255,255,255,0.01);background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S. treasury securities</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;or less</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">17,122</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">17,115</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S. treasury securities</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&gt;</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;and &lt;</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5</span></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12,049</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">43</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12,006</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Certificates of deposit</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;or less</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,226</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,224</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">30,397</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">52</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">30,345</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">All of the Company&#8217;s available-for-sale securities are available to the Company for use in its current operations. As a result, the Company categorizes all of these securities as current assets even though the stated maturity of some individual securities may be </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">one year</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> or more beyond the balance sheet date. All of the Company&#8217;s securities have a maturity within </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">two years</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> of the balance sheet date.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">There were </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> impairments considered other-than-temporary during the periods presented, as it is management&#8217;s intention and ability to hold the securities until a recovery of the cost basis or recovery of fair value. Unrealized gains and losses are included in accumulated other comprehensive income (loss).</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eq_ShortTermInvestmentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eq_ShortTermInvestmentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140407550453248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Property and Equipment</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5. Property and Equipment</span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Property and equipment consisted of the following (in thousands):</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:65.971%;"/>
        <td style="width:1.472%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.571%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.458%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.529%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Furniture &amp; fixtures</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">60</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">60</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Machinery &amp; lab equipment</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">534</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">282</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Computer equipment</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">26</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">42</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Leasehold improvements</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">20</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Less accumulated depreciation and amortization</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">249</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">147</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Property and equipment, net</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">391</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">237</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Depreciation expense related to property and equipment was approximately $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">118,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">72,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> for the years ended December 31, 2022 and 2021, respectively. During the year ended December 31, 2022, the Company disposed of fully depreciated property and equipment totaling approximately $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">16,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. There were </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> dispositions of property and equipment for the year ended December 31, 2021. </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">No</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> material gains or losses on the disposal of property and equipment have been recorded for the years ended December 31, 2022 or 2021.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99893-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI https://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=SL120174063-112916<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99779-112916<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140407551100912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisition<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">Acquisition</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6. Acquisition</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On February 14, 2022, the Company entered into an Agreement and Plan of Merger with Project JetFuel Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of the Company (Merger Sub), Bioniz and Kevin Green, solely in his capacity as representative of the securityholders of Bioniz (the Securityholders&#8217; Representative).</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As consideration for the acquisition of Bioniz, the Company agreed to (a) issue up to an aggregate of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5,699,492</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of the Company&#8217;s common stock (Merger Shares), and (b) make contingent payments up to an aggregate of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">57.5</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million based on the achievement of certain regulatory events for the Bioniz product candidates commencing on first U.S. approval, and up to an aggregate of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">250</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million based on the achievement of certain commercialization events for product candidate BNZ-1 (now referred to as EQ101) as set forth in the Merger Agreement. The Merger Shares may be adjusted downward after the closing, pursuant to procedures set forth in the Merger Agreement, including with respect to indemnification claims and in connection with the finalization of transaction expenses, debt, net exercise taxes and working capital amounts at closing.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">At the closing, the Company delivered to the transfer agent </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4,820,230</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of its common stock for issuance to former stockholders of Bioniz per the terms of the Merger Agreement. Up to an additional </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">879,252</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of the Company's common stock, pending any adjustments per the terms of the Merger Agreement, will be issued to former stockholders of Bioniz </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> months after closing. The acquisition of Bioniz expanded the Company's pipeline of novel immunomodulatory drug candidates, adding two first-in-class clinical stage assets, BNZ-1 and BNZ-2, now referred to as EQ101 and EQ102, respectively, and a proprietary product discovery platform.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company determined the acquisition</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">constituted an acquisition of assets instead of a business combination as substantially all of the fair value of the gross assets acquired was concentrated in a group of similar identifiable assets, and therefore, the acquisition was not considered a business. As the Company is recording the transaction as an asset acquisition under ASC 805, the contingent payments will be recognized upon achievement and at that time will be expensed to in-process research and development. Transaction costs of approximately $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.4</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million associated with the acquisition were included in the Company&#8217;s research and development expense during the year ended December 31, 2022.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">A summary of the purchase price allocation is as follows (in thousands):</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:80.253%;"/>
        <td style="width:1.792%;"/>
        <td style="width:1.0%;"/>
        <td style="width:15.956%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Amount</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Assets acquired:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cash</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">700</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Prepaid expenses and other current assets</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">28</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Fixed assets</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total assets acquired</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">734</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Liabilities assumed:</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accounts payable</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">265</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accrued expenses</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">976</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total liabilities assumed</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,241</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net liabilities acquired</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">507</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Issuance of common stock for Bioniz acquisition</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">22,542</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Acquired in-process research and development</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">23,049</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI https://asc.fasb.org/topic&amp;trid=2303972<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4946-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140407550352720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7.  Leases</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company&#8217;s leases relate primarily to office and laboratory facilities located in La Jolla and South San Francisco, California. The Company&#8217;s lease of office space in South San Francisco expired in </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">February 2023</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and the Company did not renew that lease. The Company&#8217;s lease of laboratory space in La Jolla expires in </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2025</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, and the Company's leases of office space in La Jolla expire in </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2027</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. The terms of the Company&#8217;s non-cancelable operating lease arrangements typically contain fixed lease payment which increases over the term of the lease at fixed rates, and include rent holidays and provide for additional renewal periods. Lease expense is recognized over the term of the lease on a straight-line basis. All of the Company&#8217;s leases are classified as operating leases. The Company has determined that periods covered by options to extend the Company&#8217;s leases are excluded from the lease term as the Company is not reasonably certain the Company will exercise such options. Operating lease expense, including expenses related to short-term leases, were $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.6</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.3</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million for the years ended December 31, 2022 and 2021, respectively.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company records its right-of-use-assets within other assets (long term) and its operating lease liabilities within other current and long-term liabilities.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><div style="font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Additional information related to the Company&#8217;s leases as of and for the year ended December 31, 2022, is as follows (in thousands, except lease term and discount rate):</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:69.578%;"/>
        <td style="width:3.036%;"/>
        <td style="width:1.0%;"/>
        <td style="width:25.386000000000003%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Balance sheet information</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Right-of-use assets</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,191</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Lease liabilities, current</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">408</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Lease liabilities, non-current</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">824</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total lease liabilities</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,232</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other information</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Weighted average remaining lease term</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3.07</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;years</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Weighted average discount rate</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8.25</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Supplemental cash flow information</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Operating cash flows from operating leases</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">465</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Right-of-use assets obtained in exchange for lease obligations</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Maturities of lease liabilities as of December 31, 2022 were as follows (in thousands):</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:77.265%;"/>
        <td style="width:3.669%;"/>
        <td style="width:1.0%;"/>
        <td style="width:17.066%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year ending December 31,</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2023</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">494</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2024</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">492</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2025</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">219</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2026</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">169</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2027</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">28</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total undiscounted lease payments</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,402</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Less: imputed interest</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">170</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total lease liabilities</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,232</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31, 2022, the Company does not have any leases that have not yet commenced that create significant rights and obligations.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140407550316176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Expenses<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAbstract', window );"><strong>Accrued Liabilities, Current [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock', window );">Accrued Expenses</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8. Accrued Expenses</span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accrued expenses consisted of the following (in thousands):</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.327%;"/>
        <td style="width:1.466%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.322000000000001%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.48%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.406%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accrued payroll and other employee benefits</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,975</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,511</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Clinical development</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3,253</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,627</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other accruals</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">472</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">245</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Non-clinical research</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">465</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">432</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accrued interest</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">74</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">71</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total accrued expenses</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7,239</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5,886</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140407551088960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Partnerships<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eq_CollaborationAndLicenseAgreementAbstract', window );"><strong>Collaboration And License Agreement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementDisclosureTextBlock', window );">Partnerships</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9. Partnerships</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Asset Purchase Agreement with Ono Pharmaceutical Co., Ltd.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On December 5, 2022, the Company and Ono, a Japan kabushiki kaisha, entered into an Asset Purchase Agreement pursuant to which the Company granted Ono the exclusive right, but not the obligation, to acquire the Company&#8217;s rights to itolizumab (the Option). These rights include all therapeutic indications and the rights to commercialize itolizumab in the United States, Canada, Australia, and New Zealand. In exchange for the Option, Ono paid the Company a one-time, upfront payment of an amount</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> equal to JPY </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3.5</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> billion, or $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">26.4</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If Ono exercises the Option, Ono will pay the Company a one-time payment of an amount equal to JPY </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> billion, or approximately $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">37.2</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million based on the currency exchange rate quoted by MUFG Bank, Ltd. on March 16, 2023. The Company is also eligible to receive up to $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">101.4</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million upon the achievement of certain development and commercialization milestones.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company is responsible for conducting all research and development of itolizumab, which will be funded by Ono on a quarterly basis from July 1, 2022, through the option period. Unless terminated early, t</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">he option period will expire three months following the delivery of topline data from the EQUALISE clinical study in lupus nephritis and interim data from the EQUATOR Phase 3 clinical study in acute graft-versus-host disease. </span></span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"/></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Asset Purchase Agreement can be terminated at any time by Ono upon written notice, provided that in limited circumstances Ono will be obligated to continue to reimburse the Company for research and development costs and expenses of itolizumab for a certain period of time following such termination. If Ono does not timely exercise its Option, the Asset Purchase Agreement and the Option will automatically terminate. The Asset Purchase Agreement also contains customary termination rights for both parties for material breach and an outside date (subject to limited adjustments) that permits either party to terminate the Asset Purchase Agreement if the closing has not occurred by December 31, 2025.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Asset Purchase Agreement contains customary representations and warranties with respect to both the Company and Ono. Additionally, the Company is subject to customary obligations and covenants, including affirmative and negative operating covenants on the Company with respect to its business as it applies to the development and exploitation of itolizumab, exclusivity obligations that prohibit the Company, except in limited circumstances, including in connection with the sale of the Company, from pursuing a direct or indirect sale, license or other disposition of all or any portion of the Company's itolizumab program or any of the assets to be purchased pursuant to the Asset Purchase Agreement and indemnification obligations, which, except in limited circumstances, are subject to customary caps and deductibles.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company applied ASC 808, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Collaborative Arrangements,</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> to the Asset Purchase Agreement and determined that the agreement is applicable to such guidance. The Company concluded that Ono represented a customer and applied relevant guidance from ASC 606, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Revenue Recognition</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, (ASC 606) to evaluate the appropriate accounting for the Asset Purchase Agreement. In accordance with this guidance, the Company identified its performance obligations, including its grant of a license to Ono to certain of its intellectual property subject to certain conditions and the conduct of research and development services. The Company determined that its grant of a license to Ono to certain of its intellectual property subject to certain conditions was not distinct from other performance obligations because such grant is dependent on the conduct and results of the research and development services. Accordingly, the Company determined that all performance obligations should be accounted for as one combined performance obligation, and that the combined performance obligation is transferred over the expected term of the conduct of the research and development services.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company also assessed, in connection with the upfront and non-creditable payment of JPY </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3.5</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> billion or $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">25.8</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million, invoiced on December 5, 2022, that there was not a significant financing component in the Asset Purchase Agreement. The Company received payment of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">26.4</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million related to this upfront payment in December 2022 which included a foreign currency realized gain of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.6</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million as the initial invoice for the upfront payment was denominated in JPY.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company also assessed the effects of any variable elements under the Asset Purchase Agreement. Such assessment evaluated, among other things, the likelihood of receiving (i) option fees and (ii) various clinical, regulatory and commercial milestone payments. Based on its assessment, the Company concluded that, based on the likelihood of these variable components occurring, there was not a significant variable element included in the transaction price. Accordingly, the Company has not assigned a transaction price to any option fees or milestone payments under the Asset Purchase Agreement given the substantial uncertainty related to their achievement.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In accordance with ASC 606, the Company determined that the initial transaction price under the Asset Purchase Agreement equals $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">102.6</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million, consisting of the upfront and non-creditable payment of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">25.8</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million and the aggregate estimated research and development funding of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">76.8</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million over the estimated option period. The upfront payment of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">25.8</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million was recorded as deferred revenue and is being recognized as revenue over time in conjunction with the Company&#8217;s conduct of research and development services as the research and development services are the primary component of the combined performance obligations. Revenue associated with the upfront payment will be recognized based on actual costs incurred as a percentage of the estimated total costs expected to be incurred over the expected term of the research and development services. Reimbursable research and development costs will be recognized as revenue as incurred.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company recognized revenue of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15.8</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million under the Asset Purchase Agreement during the year ended December 31, 2022. Such revenue was comprised of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11.8</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million associated with development funding and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million associated with the amortization of the upfront payment during the year ended December 31, 2022. As of December 31, 2022, aggregate deferred revenue related to the Asset Purchase Agreement was $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">25.1</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million, which consisted of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">14.7</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million classified as current and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.4</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million as long-term.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31, 2022, the Company has received $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12.2</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million in cash of aggregate development funding from Ono.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Biocon Collaboration and License Agreement</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In May 2017, the Company entered into a collaboration and license agreement (which was amended in September 2018, April 2019, December 2019, April 2021 and November 2022), clinical supply agreement, investor rights agreement, and common stock purchase agreement (collectively License Agreements) with Biocon SA (subsequently assigned to Biocon Limited, or together, Biocon). Pursuant to the License Agreements, Biocon granted the Company an exclusive license to develop, make, have made, use, sell, have sold, offer for sale, import and otherwise exploit itolizumab and any pharmaceutical composition or preparation containing or comprising itolizumab that uses Biocon technology or Biocon know-how (collectively a Biocon Product) in the United States, Canada, Australia and New Zealand (collectively Equillium Territory). The Company also has the right to sublicense through multiple tiers to third parties, provided such sublicenses comply with the terms of the License Agreements and the Company provides Biocon a copy of each sublicense agreement within 30 days of execution. If the Company grants a third party a sublicense of its rights to develop and commercialize Biocon Products in Australia or New Zealand, the Company will be required to pay Biocon a high double-digit percentage of any upfront payment the Company receives from such sublicensee for such sublicense, as well as a high double-digit percentage of any additional payments the Company receives from such sublicensee for such sublicense, including but not limited to royalty payments on net sales of Biocon Products by such sublicensee. Under the License Agreements, the Company granted back to Biocon a license to use its technology and know-how related to itolizumab and Biocon Products in certain countries outside of the Equillium Territory. Pursuant to the License Agreements, Biocon agreed to be the Company&#8217;s exclusive supplier of itolizumab clinical drug product. Biocon will provide clinical drug product at no cost for up to three concurrent orphan indications until the Company&#8217;s first U.S. regulatory approval and all other clinical drug product at Biocon&#8217;s cost. In addition, we have agreed to co-fund an ongoing Phase 2 clinical study of itolizumab in subjects with ulcerative colitis being conducted by Biocon in India.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In consideration of the rights granted to the Company by Biocon, the Company issued Biocon a total of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,316,134</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of its common stock.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, the Company is obligated to pay Biocon up to an aggregate of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">30</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million in regulatory milestone payments upon the achievement of certain regulatory approvals and up to an aggregate of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">565</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million in sales milestone payments upon the achievement of first commercial sale of product and specified levels of product sales. The Company is also required to pay royalties on tiers of aggregate annual net sales of Biocon Products by the Company, the Company's affiliates and the Company's sublicensees in the United States and Canada at percentages from the mid-single digits to sub-teen double-digits and on tiers of aggregate annual net sales of Biocon Products by the Company and the Company's affiliates (but not the Company's sublicensees) in Australia and New Zealand, in each case, subject to adjustments in certain circumstances. Biocon is also required to pay the Company royalties at comparable percentages for sales of itolizumab (EQ001) outside of the Equillium Territory if the approvals in such geographies included or referenced the Company&#8217;s data including data from certain of the Company&#8217;s clinical studies, subject to adjustments in certain circumstances. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Should Ono exercise its option to acquire our rights to itolizumab (EQ001), as described below, the aforementioned milestone payments and royalties potentially owed to Biocon would become Ono&#8217;s responsibility, and the potential royalties on sales of itolizumab outside of the Equillium Territory would be become Ono&#8217;s right.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  Under the License Agreements, net sales are calculated on a country-by-country basis and are subject to adjustments, including whether the Biocon Product is sold in the form of a combination product. As of December 31, 2022, the Company has not made or received payments in connection with the milestones or royalties within the agreement.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eq_CollaborationAndLicenseAgreementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaboration and license agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eq_CollaborationAndLicenseAgreementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for collaborative arrangements in which the entity is a participant, including a) information about the nature and purpose of such arrangements; b) its rights and obligations thereunder; c) the accounting policy for collaborative arrangements; and d) the income statement classification and amounts attributable to transactions arising from the collaborative arrangement between participants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 808<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6931272&amp;loc=SL5834143-161434<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 808<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6931272&amp;loc=SL5834143-161434<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 808<br> -URI https://asc.fasb.org/topic&amp;trid=5833765<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140407550437840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Notes Payable<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MortgageNotesPayableDisclosureTextBlock', window );">Notes Payable</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10. Notes Payable</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span>&#160;</p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On September 30, 2019 (the Effective Date), the Company entered into a Loan and Security Agreement (the Loan Agreement) with two lenders (the Lenders) pursuant to which the Company borrowed $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million from the Lenders (the Term Loan), which represents the maximum amount the Company is permitted to borrow under the terms of the Loan Agreement.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Term Loan matures on </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">June 1, 2024</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> (the Maturity Date) and is repaid through interest-only payments, which originally extended through June 30, 2021, followed by </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">36</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> equal </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">monthly</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> payments of principal and interest. The Term Loan bears interest at a floating per annum rate equal to the greater of (i) </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8.25</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% and (ii) the sum of (a) the </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">prime rate</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> reported in The Wall Street Journal on the last business day of the month that immediately precedes the month in which the interest will accrue, plus (b) </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3.00</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On April 23, 2021, the Loan Agreement was amended to (i) change the final payment percentage from </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.5</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% to </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% and (ii) extend the interest-only payment period based on achieving the following milestones: (a) the Company achieving positive data in the Company's Phase 1b aGVHD study of itolizumab (EQ001) supporting a formal decision to advance into Phase 2 or Phase 3 development, and as confirmed by the Company's Board of Directors in written board minutes (the Interest-Only Extension Milestone) and (b) the Company initiating a pivotal Phase 3 aGVHD study (the Interest-Only Extension II Milestone). In May 2021, the Company achieved the Interest-Only Extension Milestone, and in March 2022, the Company obtained confirmation from the Lenders that the Interest-Only Extension II Milestone had been achieved, which extended the interest-only payments through September 30, 2022, followed by </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">24</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> equal </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">monthly</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> principal payments and interest.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In February 2022, the Company entered into the Third Amendment to the Loan Agreement (the Third Amendment) which added Bioniz as a secured party to the loan.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Under authoritative guidance, the April 2021 amendment did not meet the criteria to be accounted for as a troubled debt restructuring. In addition, the Company performed a quantitative analysis and determined that the terms of the new debt and original debt instrument are not substantially different. Accordingly, the April 2021 amendment was accounted for as a debt modification. A new effective interest rate that equates the revised cash flows to the carrying amount of the original debt was computed and applied prospectively. The effective interest rate as of December 31, 2022 is </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11.86</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company will be required to make a final payment of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.00</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of the original principal amount of the Term Loan drawn payable on the earlier of (i) the Maturity Date, (ii) the acceleration of the Term Loan in the event of a default, or (iii) the prepayment of the Term Loan (the Final Payment). The Company may prepay all, but not less than all, of the Term Loan upon </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">30</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> days&#8217; advance written notice </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">to the lender, provided that the Company will be obligated to pay a prepayment fee equal to (i) </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3.00</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of the principal amount of the Term Loan prepaid on or before the first anniversary of the applicable funding date, (ii) </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.00</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of the principal amount of the Term Loan prepaid between the first and second anniversary of the funding date, and (iii) </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.00</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of the principal amount of the Term Loan prepaid thereafter, and prior to the Maturity Date (each, a Prepayment Fee).</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In connection with entering into the Loan Agreement, the Company issued to the Lenders warrants exercisable for </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">80,428</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of the Company&#8217;s common stock (the Warrants). The Warrants are exercisable in whole or in part, immediately, and have a per share </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">exercise price of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3.73</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, which was the closing price of the Company&#8217;s common stock reported on the Nasdaq Global Market on the day prior to the Effective Date. The Warrants will terminate on the earlier of September 30, 2029 or the closing of certain merger or consolidation transactions.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The aggregate carrying amounts of the Term Loan is comprised of the following (in thousands):</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:67.108%;"/>
        <td style="width:1.493%;"/>
        <td style="width:1.0%;"/>
        <td style="width:12.883000000000001%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.493%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.022%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Principal</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8,571</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10,000</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Add: accreted liability for final payment fee</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">430</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">310</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Less: unamortized discount</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">48</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">132</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8,953</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10,178</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Upon the occurrence of certain events, including but not limited to the Company&#8217;s failure to satisfy its payment obligations under the Loan Agreement, the breach of certain of its other covenants under the Loan Agreement, or the occurrence of a material adverse change, cross defaults to other indebtedness or material agreements, judgment defaults and defaults related to failure to maintain governmental approvals failure of which to maintain could result in a material adverse effect, the Lenders will have the right, among other remedies, to declare all principal and interest immediately due and payable, to exercise secured party remedies, to receive the Final Payment and, if the payment of principal and interest is due prior to the Maturity Date, to receive the applicable Prepayment Fee. At December 31, 2022, the Company was in compliance with the covenants contained in the Loan Agreement.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Future maturities of the Term Loan, including the Final Payment fee, as of December 31, 2022 were as follows (in thousands):</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:80.253%;"/>
        <td style="width:1.792%;"/>
        <td style="width:1.0%;"/>
        <td style="width:15.956%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year ending December 31, 2023</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5,714</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year ending December 31, 2024</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3,357</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9,071</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unaccreted balance for Final Payment fee on Term Loans</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">70</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unamortized discounts</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">48</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8,953</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Less current portion</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5,714</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Noncurrent portion</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3,239</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MortgageNotesPayableDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for mortgage notes payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MortgageNotesPayableDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140407550349296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders&#8217; Equity<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Stockholders&#8217; Equity</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11. Stockholders&#8217; Equity</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31, 2022, the Company&#8217;s authorized capital stock consisted of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">200,000,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of common stock, par value $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.0001</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> per share, and </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10,000,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of preferred stock, par value $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.0001</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> per share.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company had </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">34,414,149</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">29,455,668</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of common stock outstanding as of December 31, 2022 and 2021, respectively.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Registered Direct Offering and related warrants</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On February 3, 2021, the Company entered into a securities purchase agreement (the Securities Purchase Agreement) with </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">two</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> institutional investors (the Purchasers), relating to the issuance and sale (the Offering) of an aggregate of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4,285,710</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of common stock and warrants to purchase </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,285,713</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of common stock (the Warrants) for aggregate gross proceeds to the Company from this Offering of approximately $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">30.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million, excluding any proceeds the Company may receive upon exercise of the Warrants. No underwriter or placement agent participated in the Offering. The proceeds, net of related issuance costs, were $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">29.9</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Warrants are exercisable immediately upon issuance at an initial exercise price of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">14.00</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> per share and are exercisable on a cashless basis. The Warrants expire on the earlier of (i) the fifth anniversary of issuance or (ii) the 15th calendar date following the date on which the Company closes upon an equity financing that results in not less than $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">25</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million of gross proceeds to the Company at a price per share of common stock equal to or greater than $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">25.00</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, at which time, all remaining Warrants will automatically be exercised on a cashless basis. The exercise price and the number of shares of common stock purchasable upon the exercise of the Warrants are subject to adjustment upon the occurrence of specific events, including stock dividends, stock splits, reclassifications and combinations of the Company&#8217;s common stock. All of the warrants are recorded within equity in accordance with authoritative accounting guidance.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pursuant to the terms of the Securities Purchase Agreement, the Company appointed Dr. Yu (Katherine) Xu, Ph. D. to the Board as a nominee of the Purchasers.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Purchase Agreement</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On March 27, 2020, the Company entered into a purchase agreement (Purchase Agreement), with Lincoln Park, which provides that, upon the terms and subject to the conditions and limitations set forth therein, the Company may sell to Lincoln Park up to $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million of shares of its common stock from time to time over the </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">36-month</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> term of the Purchase Agreement. Upon execution of the Purchase Agreement, the Company issued </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">65,374</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of its common stock to Lincoln Park as commitment shares in accordance with the closing conditions contained within the Purchase Agreement. The commitment shares were valued using the closing price of the Company&#8217;s common stock on the effective date of the Purchase Agreement resulting in a fair market value of approximately $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.2</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million. The fair market value of the commitment shares as well as other issuance costs associated with the Purchase Agreement totaled $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.4</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million. These issuance costs were classified as prepaid expenses and other current assets in the accompanying consolidated balance sheet as of December 31, 2021.  There have been </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> sales of the Company&#8217;s stock under this Purchase Agreement as of December 31, 2022 and through the date of the filing of this Annual Report on Form 10-K. The Purchase Agreement expires on </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">May 1, 2023</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Since the Company believes it is unlikely to sell any shares to Lincoln Park prior to the Purchase Agreement expiring, the capitalized issuance costs were written off as of December 31, 2022 to general and administrative expense.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">2018 Equity Incentive Plan</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In October 2018, the Company adopted the 2018 Equity Incentive Plan (the 2018 Plan) which replaced the Company&#8217;s legacy 2017 Equity Incentive Plan (the 2017 Plan). The 2018 Plan provides for the grant of incentive stock options, non-statutory stock options, stock appreciation rights, restricted stock awards, restricted stock unit awards, performance stock awards, performance cash awards and other forms of stock awards. As of December 31, 2022, the 2018 Plan had a maximum of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">784,331</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> total shares available for issuance. </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The number of shares of common stock reserved for issuance under the 2018 Plan will automatically increase on January 1 of each calendar year through January 1, 2028, in an amount equal to 5.0% of the total number of shares of the Company&#8217;s capital stock outstanding on the last day of the calendar month before the date of each automatic increase, or a lesser number of shares determined by the Board.</span></span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Options granted under the 2018 Plan are exercisable at various dates as determined upon grant and will expire no more than </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ten years</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> from their date of grant. The exercise price of each option shall be determined by the Board based on the estimated fair value of the Company&#8217;s stock on the date of the option grant. The exercise price shall not be less than </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">100</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of the fair market value of the Company&#8217;s common stock at the time the option is granted. Most option grants generally vest </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">25</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% on the first anniversary of the original vesting commencement date, with the balance vesting monthly over the remaining </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">three years</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Stock Options</span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following summarizes stock option activity for the year ended December 31, 2022:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:50.131%;"/>
        <td style="width:0.713%;"/>
        <td style="width:1.0%;"/>
        <td style="width:12.533999999999999%;"/>
        <td style="width:1.0%;"/>
        <td style="width:0.844%;"/>
        <td style="width:1.0%;"/>
        <td style="width:6.307%;"/>
        <td style="width:1.0%;"/>
        <td style="width:0.713%;"/>
        <td style="width:1.0%;"/>
        <td style="width:10.41%;"/>
        <td style="width:1.0%;"/>
        <td style="width:0.844%;"/>
        <td style="width:1.0%;"/>
        <td style="width:9.507%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Outstanding Options</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Weighted-<br/>Average <br/>Exercise Price<br/>Per Share</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Weighted<br/>Average<br/>Remaining<br/>Contractual<br/>Term<br/>(in years)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Aggregate<br/>Intrinsic Value<br/>(in thousands) </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Balances as of December 31, 2021</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3,947,025</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.58</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Granted</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,169,800</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3.63</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exercised</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="-sec-ix-hidden:F_e9cd9fc4-b2d3-4e1c-814b-17b62754d416;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></span></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="-sec-ix-hidden:F_0fa15c8b-e902-4287-b1e7-c4c493e1c465;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></span></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Forfeitures and cancellations</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,014,324</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.90</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Balances as of December 31, 2022</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5,102,501</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.11</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7.71</span></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Options exercisable as of December 31, 2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,483,222</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.23</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6.75</span></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><div style="text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.333%;">(a)</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Aggregate intrinsic value in this table was calculated as the positive difference, if any, between the closing price per share of the Company&#8217;s common stock on December 31, 2022 of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.06</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and the price of the underlying options.</span></div></div></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The aggregate intrinsic value of stock options exercised was </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">none</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.4</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million for the years ended December 31, 2022 and 2021, respectively. Cash received from stock options exercised was </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">none</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.9</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million for the years ended December 31, 2022 and 2021, respectively.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The fair value of stock options that vested in the years ended December 31, 2022 and 2021 was $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.5</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million, respectively. The weighted-average grant-date fair value of options granted was $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.49</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3.94</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> for the years ended December 31, 2022 and 2021, respectively.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31, 2022, unrecognized compensation expense related to unvested stock options was $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6.7</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million and is expected to be recognized over a weighted-average period of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.6</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> years.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">2018 Employee Stock Purchase Plan</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In October 2018, the Company adopted the 2018 </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Equity Stock Purchase Plan (ESPP) whereby eligible employees may elect to withhold up to </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of their earnings to purchase shares of the Company&#8217;s common stock at a price per share equal to the lower of (i) </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">85</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of the fair market value of a share of the Company&#8217;s common stock on the first date of an offering or (ii) </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">85</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of the fair market value of a share of the Company&#8217;s common stock on the date of the purchase right (purchase right). Initially, </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">343,275</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of the Company&#8217;s common stock were approved for issuance under the ESPP pursuant to purchase rights granted to the Company&#8217;s employees or to employees of any of the Company&#8217;s designated affiliates. The number of shares of the Company&#8217;s common stock reserved for issuance will automatically increase on January 1 of each calendar year through January 1, 2028, by the lesser of (1) 1.0% of the total number of shares of the Company&#8217;s common stock outstanding on the last day of the calendar month before the date of the automatic increase, and (2) </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">343,275</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares; provided that before the date of any such increase, the Board may determine that such increase will be less than the amount set forth in clauses (1) and (2)</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31, 2022, the Company had issued </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">307,417</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of common stock under the ESPP, </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">138,251</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> of which were issued during the year ended December 31, 2022. The Company had </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">925,963</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares available for future issuance under the ESPP as of December 31, 2022.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Liability for Early Exercise of Restricted Stock Options</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">All stock option grants under the 2017 Plan provide for exercise of the stock option prior to vesting. Shares of common stock issued upon exercise of unvested options are subject to repurchase by the Company at the respective original exercise price until vested. Consideration received for the exercise of unvested stock options is recorded as a liability and reclassified into equity as the related award vests.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31, 2022</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, there were no unvested shares issued under early exercise provisions subject to repurchase by the Company. As of December 31, 2021, there were </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">43,135</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> unvested shares issued under early exercise provisions that were subject to repurchase by the Company. The balance sheet reflects an unvested stock liability of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">none</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">53,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> as of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022 and 2021, respectively. As of December 31, 2021, the unvested stock liability was considered short-term and was classified as accrued expenses on the accompanying consolidated balance sheet.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Stock-based Compensation Expense</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total non-cash stock-based compensation expense for all stock awards and purchase rights, net of forfeitures recognized as they occur, that was recognized in the consolidated statement of operations is as follows (in thousands):</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.327%;"/>
        <td style="width:1.466%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.322000000000001%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.48%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.406%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year Ended <br/>December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Research and development</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,799</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,976</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">General and administrative</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3,042</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,434</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4,841</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4,410</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The weighted-average assumptions used in the Black-Scholes option pricing model to determine the fair value of the employee and nonemployee stock option grants were as follows:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:67.29%;"/>
        <td style="width:1.502%;"/>
        <td style="width:14.867%;"/>
        <td style="width:1.502%;"/>
        <td style="width:14.838%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="3" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year Ended <br/>December 31,</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Risk-free interest rate</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.93</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.68</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Expected volatility</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">81.60</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">88.55</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Expected term (in years)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.84</span></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6.01</span></span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Expected dividend yield</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
       </tr>
      </table></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Risk-free interest rate. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The risk-free rate assumption is based on the U.S. Treasury instruments, the terms of which were consistent with the expected term of the Company&#8217;s stock options.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Expected volatility. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Due to the Company&#8217;s limited operating history and lack of company-specific historical or implied volatility as a private company, the expected volatility assumption was determined by examining the historical volatilities of a group of industry peers whose share prices are publicly available.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Expected term. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The expected term of stock options represents the weighted-average period the stock options are expected to be outstanding. The Company uses the simplified method for estimating the expected term as provided by the SEC. The simplified method calculates the expected term as the average of the time-to-vesting and the contractual life of the options.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Expected dividend yield. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The expected dividend assumption is based on the Company&#8217;s history and expectation of dividend payouts. The Company has not paid and does </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">t intend to pay dividends.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Forfeitures</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. The Company reduces stock-based compensation expense for actual forfeitures during the period.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Common Stock Reserved for Future Issuance</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Common stock reserved for future issuance consists of the following as of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022 and 2021:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:67.477%;"/>
        <td style="width:1.009%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.204%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.023%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.289%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Stock options issued and outstanding</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5,102,501</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3,947,025</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Warrants for common stock</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,366,141</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,366,141</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Awards available under the 2018 Equity Incentive Plan</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">784,331</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">467,024</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Employee stock purchase plan</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">925,963</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">769,658</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8,178,936</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6,549,848</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI https://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=SL126733271-114008<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140407550276096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12. Commitments and Contingencies</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Leases and Other Commitments</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31, 2022, the Company leased certain office and laboratory space in La Jolla and South San Francisco, California under non-cancelable operating leases. The lease for office space in South San Francisco expired in February 2023 and was not renewed, the lease for laboratory space in La Jolla expires in February 2025 and the leases for office spaces in La Jolla expire in February 2027.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company enters into service agreements with indemnification clauses in the ordinary course of business. Pursuant to such clauses, the Company indemnifies, defends, holds harmless, and agrees to reimburse the indemnified party for losses suffered or incurred by third party claims arising out of the indemnified party&#8217;s</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">performance of service. The Company has not incurred costs to defend lawsuits pursuant to these indemnification clauses.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Litigation</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31, 2022, there was </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> litigation against the Company.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI https://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI https://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140407550400896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13. Income Taxes</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The components of loss before income tax provision (benefit) for the years ended December 31, 2022 and 2021 consisted of the following (in thousands):</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">		&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:65.971%;"/>
        <td style="width:1.472%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.571%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.458%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.529%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year Ended <br/>December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S.</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">60,403</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">37,705</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Foreign</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,025</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,347</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">62,428</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">39,052</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
      </table></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company has </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">t recorded a current or deferred tax expense or benefit for the years ended </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022 and 2021.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following is a reconciliation of the expected statutory federal income tax provision to our actual income tax provision for the years ended </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022 and 2021 (in thousands):</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:65.971%;"/>
        <td style="width:1.472%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.571%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.458%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.529%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Income taxes at statutory rates</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13,110</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8,201</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">State income tax, net of federal benefit</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Stock-based compensation</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">533</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">451</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Permanent items</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">128</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">31</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Federal research and orphan drug credits</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,152</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,713</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Foreign rate differential</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">425</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">72</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Transaction costs</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">89</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Acquired in-process research and development</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4,840</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Change in federal valuation allowance</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8,247</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9,360</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The tax effects of temporary differences that give rise to significant portions of the deferred tax assets and deferred tax liabilities as of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022 and 2021 are as follows (in thousands):</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:65.971%;"/>
        <td style="width:1.472%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.571%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.458%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.529%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Deferred tax assets:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net operating loss carryforward</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">28,222</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">19,344</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Credits</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9,289</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3,940</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Capitalized research expenditures</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7,086</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Equity compensation</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,829</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,134</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,196</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,184</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total deferred tax assets</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">47,622</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">25,602</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Valuation allowance</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">46,317</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">25,215</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total deferred tax assets, net of allowance</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,305</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">387</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Deferred tax liabilities:</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Operating lease right-of-use asset</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">284</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">346</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Deferred revenue</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">945</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">76</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">41</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total deferred tax liabilities</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,305</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">387</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net deferred taxes</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company has established a valuation allowance against its net deferred tax assets due to the uncertainty surrounding the realization of such assets. The Company periodically evaluates the recoverability of the deferred tax assets. At such time as it is determined that it is more likely than not that deferred assets are realizable, the valuation allowance will be reduced. The Company has recorded a full valuation allowance of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">46.3</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million as of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> as it does not believe it is more likely than not that certain deferred tax assets will be realized primarily due to the generation of pre-tax book losses in the current year, the lack of feasible tax-planning strategies, the limited existing taxable temporary differences, and the subjective nature of forecasting future taxable income into the future. The Company increased its valuation allowance by approximately $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">21.1</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million during the year ended </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">At December 31, 2022</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, the Company had federal and California tax loss carryforwards of approximately $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">116.4</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">90.6</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million, respectively. The federal net operating loss carryover includes $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">112.7</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million of net operating losses generated subsequent to 2017. </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Federal net operating losses generated after December 31, 2017 carryover indefinitely </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">but the deductibility of such federal net operating losses is limited</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> to </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">80</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of taxable income.</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> The federal net operating losses generated prior to 2018 as well as the state net operating loss carryforwards, begin to expire in </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2037 </span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">unless previously utilized. The Company has $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.5</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million of Australian net operating loss carryforwards as of December 31, 2022 that are carried forward indefinitely.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">At December 31, 2022</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, the Company had federal and state tax credit carryforwards of approximately $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7.2</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.6</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million, respectively, after reduction for uncertain tax positions. The Company has not performed a formal research and development credit study with respect to these credits. The federal credits will begin to expire in </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2037</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, if unused, and the state credits carryforward indefinitely.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pursuant to the Internal Revenue Code of 1986, as amended (IRC), specifically Section 382 and 383, the Company&#8217;s </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ability to use net operating loss and research and development tax credit carryforwards (tax attribute carryforwards) to offset future taxable income is limited if the Company experiences a cumulative change in ownership of more than </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">50</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% within a </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">three-year</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> testing period. The Company has not completed an ownership change analysis pursuant to IRC Section 382. If ownership changes within the meaning of IRC Section 382 are identified as having occurred, the amount of remaining tax attribute carryforwards available to offset future taxable income and income tax expense in future years may be significantly restricted or eliminated, including those acquired through Bioniz. Further, our deferred tax assets associated with such tax attributes could be significantly reduced or eliminated upon realization of an ownership change within the meaning of IRC Section 382. If eliminated, the related asset would be removed from the deferred tax asset schedule, with a corresponding reduction in the valuation allowance. Due to the existence of the valuation allowance, limitations created by ownership changes, if any, will not impact our effective tax rate.</span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following table summarizes the reconciliation of the unrecognized tax benefits activity during the years ended December 31, 2022 and 2021 (in thousands):</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.327%;"/>
        <td style="width:1.466%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.322000000000001%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.48%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.406%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unrecognized tax benefits &#8211; beginning</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5,487</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,667</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Gross increases &#8211; tax positions in prior period</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,266</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Gross decreases &#8211; tax positions in prior period</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Gross increase &#8211; current-period tax positions</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">392</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">554</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Gross decrease &#8211; current-period tax positions</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Settlements</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Lapse of statute of limitations</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unrecognized tax benefits &#8211; ending</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5,879</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5,487</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The unrecognized tax benefit amounts are reflected in the determination of the Company&#8217;s deferred tax assets. If recognized, none of these amounts would affect the Company&#8217;s effective tax rate, since it would be offset by an equal corresponding adjustment in the deferred tax asset valuation allowance. The Company does not foresee material changes to its liability for uncertain tax benefits within the next twelve months.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company&#8217;s policy is to recognize interest and/or penalties related to income tax matters in income tax expense. The Company had no accrual for interest or penalties on the Company's consolidated balance sheet as of December 31, 2022 and has not recognized interest and/or penalties in the consolidated statement of operations for the year ended December 31, 2022.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">All tax years for both federal and state purposes remain open and subject to examination by tax jurisdictions.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The 2017 tax reform act amended the IRC, effective for amounts paid or incurred in tax years beginning after December 31, 2021, to eliminate the immediate expensing of research and experimental (R&amp;E) expenditures and require taxpayers to charge their R&amp;E expenditures and software development costs (collectively, R&amp;E expenditures) to a capital account. Capitalized costs are required to be amortized over </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">five years</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> (</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15 years</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> for expenditures attributable to foreign research).</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI https://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140407550430576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Retirement Plan<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock', window );">Retirement Plan</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">14. Retirement Plan</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company sponsors an employee savings plan that qualifies as a deferred salary arrangement under Section 401(k) of the IRC. Participating employees may defer up to the Internal Revenue Service annual contribution limit. The Company did </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">t make any contributions for the years ended December 31, 2022 or 2021.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for an entity's employee compensation and benefit plans, including, but not limited to, postemployment and postretirement benefit plans, defined benefit pension plans, defined contribution plans, non-qualified and supplemental benefit plans, deferred compensation, share-based compensation, life insurance, severance, health care, unemployment and other benefit plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI https://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 712<br> -URI https://asc.fasb.org/topic&amp;trid=2197446<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 710<br> -URI https://asc.fasb.org/topic&amp;trid=2127225<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -URI https://asc.fasb.org/topic&amp;trid=2235017<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndEmployeeBenefitPlansTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140407550325584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15. Subsequent Events</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On March 10, 2023, Silicon Valley Bank (SVB) was closed by the California Department of Financial Protection and Innovation, which appointed the Federal Deposit Insurance Corporation as receiver. At the time of the closure, the Company held assets valued at approximately $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8.2</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million in a sweep account with SVB. The Company received full access to those funds on March 13, 2023. As of the date of the filing of this Annual Report on Form 10-K, the Company has full access to and control over all of its cash, cash equivalents and short-term investments. In addition, because a substantial majority of the Company's cash, cash equivalents and short-term investments is held at a financial institution unaffiliated with SVB, the Company does not expect any material impact to the Company's operations directly related to the closure of SVB.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI https://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140407549256256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently Issued and Recently Adopted Accounting Pronouncements</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Recently Issued and Recently Adopted Accounting Pronouncements</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In June 2016, the FASB issued ASU No. 2016-13, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Measurement of Credit Losses on Financial Instruments</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, which will require a reporting entity to use a new forward-looking impairment model for most financial assets that generally will result in the earlier recognition of allowances for losses. The ASU, along with related amendments, revised the measurement of credit losses for financial assets measured at amortized cost from an incurred loss to an expected loss methodology. The ASU affected receivables, debt securities, net investment in leases, and most other financial assets that represent a right to receive cash. The Company </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">adopted</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> this standard effective </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">January 1, 2022</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> using the modified retrospective approach. Due to the nature of the Company's investment portfolio, the adoption of the guidance did</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> no</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">t have a material effect on the Company's consolidated financial statements and no allowance was recorded for expected credit losses.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">From time to time, new accounting pronouncements are issued by the FASB or other standard setting bodies that are adopted by the Company as of the specified effective date. The Company has evaluated recently issued pronouncements and does not believe any will have a material impact on the Company's consolidated financial statements or related financial statement disclosures. Other accounting standard updates effective for interim and annual periods beginning after December 31, 2022 are not expected to have a material impact on the Company&#8217;s financial position, results of operations or cash flows.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Use of Estimates</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The preparation of the Company&#8217;s consolidated financial statements requires the Company to make estimates and assumptions that impact the reported amounts of assets, liabilities and expenses and the disclosure of contingent assets and liabilities in the consolidated financial statements and accompanying notes. Significant estimates in the Company&#8217;s consolidated financial statements relate to accrued research and development expense, revenue recognition and the valuation of equity awards. Management evaluates its estimates on an ongoing basis. Although estimates are based on the Company&#8217;s historical experience, knowledge of current events, and actions it may undertake in the future, actual results may ultimately materially differ from these estimates and assumptions.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration of Credit Risk and Off-Balance Sheet Risk</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Concentration of Credit Risk and Off-Balance Sheet Risk</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Financial instruments which potentially subject the Company to significant concentration of credit risk consist of cash and cash equivalents and short-term investments. The Company maintains deposits in federally insured financial institutions in excess of federally insured limits. The Company has not experienced any losses in such accounts, and management believes that the Company is not exposed to significant credit risk due to the financial position of the depository institutions in which those deposits are held. The Company&#8217;s investment policy includes guidelines for the quality of the related institutions and financial instruments and defines allowable investments that the Company may invest in, which the Company believes minimizes the exposure to concentration of credit risk.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock', window );">Comprehensive Loss</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Comprehensive Loss</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company is required to report all components of comprehensive loss, including net loss, in the consolidated financial statements in the period in which they are recognized. Comprehensive loss is defined as the change in equity during a period from transactions and other events and circumstances from non-owner sources, including unrealized gains and losses on investments and foreign currency gains and losses. Other comprehensive income, net includes unrealized losses and gains on short-term investments as well as foreign currency translation gains and losses.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Cash and Cash Equivalents</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cash and cash equivalents include cash in readily available checking and savings accounts, and money market funds. The Company considers all highly liquid investments with an original maturity of three months or less from the date of purchase to be cash equivalents. At December 31, 2022 and 2021, the Company's cash and cash equivalents were primarily comprised of money market funds.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eq_ShortTermInvestmentsPolicyTextBlock', window );">Short-Term Investments</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Short-Term Investments</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Available-for-sale securities are carried at fair value, with the unrealized gains and losses reported in comprehensive loss. The amortized cost of available-for-sale debt securities is adjusted for amortization of premiums and accretion of discounts to maturity. Such amortization and accretion are included in interest income. Realized gains and losses and declines in value judged to be other-than-temporary, if any, on available-for-sale securities are included in other income or expense. The cost of securities sold is based on the specific identification method. Interest and dividends on securities classified as available-for-sale are included in interest income.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesPolicyTextBlock', window );">Accounts Receivable</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Accounts Receivable</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accounts receivable includes trade accounts receivables from the Ono Asset Purchase Agreement (see Note 9). Reimbursable costs that have not been invoiced as of the balance sheet date are recorded as unbilled accounts receivable. As of December 31, 2022, the Company had unbilled accounts receivable totaling $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.8</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million classified as accounts receivable on its consolidated balance sheet. As of December 31, 2021, the Company did </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">t have any amount recorded within accounts receivable on its consolidated balance sheet. The Company makes judgments as to its ability to collect outstanding receivables and provide an allowance for receivables when collection becomes doubtful. Allowance for credit risk for accounts receivables  are established based on various factors including credit profiles of the Company&#8217;s customers, historical payments and current economic trends. The Company reviews its allowance for accounts receivables by assessing individual accounts receivable over a specific aging and amount.  The estimate of expected credit losses is based on information about past events, current economic conditions, and forecasts of future economic conditions that affect the collectability. Accounts receivable are written-off on a case by case basis, net of any amounts that may be collected. As of each of December 31, 2022 and 2021, </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> credit losses have been recorded by the Company.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eq_PrepaidExpensesAndOtherCurrentAssetsPolicyPolicyTextBlock', window );">Prepaid Expenses and Other Current Assets</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Prepaid Expenses and Other Current Assets</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Prepaid expenses and other current assets primarily represent amounts related to director and officer insurance, preclinical research and clinical study agreements, equity issuance costs and an estimated tax refund from the Australian Tax Office for eligible research and development expenditures.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and Equipment</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Property and Equipment</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Property and equipment is stated at cost and depreciated using the straight-line method over the estimated useful lives of the assets (generally </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="-sec-ix-hidden:F_25b946aa-ecb7-4d36-9827-13132f6bd5be;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">three</span></span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> to </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">five years</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">).</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Leases</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Leases</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company determines if an arrangement is a lease at inception. Lease right-of-use assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. For operating leases with an initial term greater than 12 months, the Company recognizes operating lease right-of-use assets and operating lease liabilities based on the present value of lease payments over the lease term at the commencement date. Operating lease right-of-use assets are comprised of the lease liability plus any lease payments made and excludes lease incentives. Lease terms include options to renew or terminate the lease when we are reasonably certain that the renewal option will be exercised or when it is reasonably certain that the termination option will not be exercised. For our operating leases, if the interest rate used to determine the present value of future lease payments is not readily determinable, the Company estimates its incremental borrowing rate as the discount rate for the lease. Our incremental borrowing rate is estimated to approximate the interest rate on a collateralized basis with similar terms and payments, and in similar economic environments. Lease expense for lease payments is recognized on a straight-line basis over the lease term. The Company has elected the practical expedient to not separate lease and non-lease components.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Impairment of Long-Lived Assets</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Impairment of Long-Lived Assets</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Long-lived </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">assets consist primarily of property and equipment. An impairment loss is recorded if and when events and circumstances indicate that assets might be impaired and the undiscounted cash flows estimated to be generated by those</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">assets </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">are less than the carrying amount of those assets. While the Company&#8217;s current and historical operating losses and negative cash flows are indicators of impairment, management believes that future cash flows to be received support the carrying value of its long-lived assets and, accordingly, has not recognized any impairment losses since inception.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eq_AccruedResearchAndDevelopmentExpensePolicyTextBlock', window );">Accrued Research and Development Expense</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Accrued Research and Development Expense</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company is required to estimate its expenses resulting from its obligations under contracts with vendors, consultants and contract research organizations, in connection with conducting research and development activities. The financial terms of these contracts are subject to negotiations, which vary from contract to contract and may result in payment flows that do not match the periods over which materials or services are provided under such contracts. The Company reflects research and development expenses in its consolidated financial statements by matching those expenses with the period in which services and efforts are expended. The Company accounts for these expenses according to the progress of the nonclinical or clinical study as measured by the timing of various aspects of the study or related activities. The Company determines accrual estimates through review of the underlying contracts along with preparation of financial models taking into account discussions with research and other key personnel as to the progress of studies, or other services being conducted. During the course of a non-clinical study or clinical study, the Company adjusts its rate of expense recognition if actual results differ from its estimates. The Company classifies its estimates for accrued research and development expenses as accrued expenses on the accompanying consolidated balance sheet.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eq_AustralianResearchAndDevelopmentTaxIncentivePolicyTextBlock', window );">Australian Research and Development Tax Incentive</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Australian Research and Development Tax Incentive</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company is eligible under the Australian Research and Development Tax Incentive Program, or the Tax Incentive, to obtain a cash refund from the Australian Taxation Office for eligible research and development expenditures. To be eligible, the Company must have revenue of less than AUD $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">20.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million during the reimbursable period and cannot be controlled by income tax exempt entities. The Tax Incentive is recognized as a reduction to research and development expense when there is reasonable assurance that the Tax Incentive will be received, the relevant expenditure has been incurred, and the amount can be reliably measured. The Company classifies its estimate for the Tax Incentive as prepaid expenses and other current assets on the accompanying consolidated balance sheet. As of December 31, 2022 and 2021, the Company recorded $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.3</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> within  prepaid and other current assets attributed to the Tax Incentive, respectively.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Revenue Recognition</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company recognizes revenue in a manner that depicts the transfer of control of a product or a service to a customer and reflects the amount of the consideration the Company is entitled to receive in exchange for such product or service. In doing so, the Company follows a five-step approach: (i) identify the contract with a customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, (iv) allocate the transaction price to the performance obligations, and (v) recognize revenue when (or as) the customer obtains control of the product or service. The Company considers the terms of a contract and all relevant facts and circumstances when applying the revenue recognition standard. The Company applies the revenue recognition standard, including the use of any practical expedients, consistently to contracts with similar characteristics and in similar circumstances.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">A customer is a party that has entered into a contract with the Company, where the purpose of the contract is to obtain a product or a service that is an output of the Company&#8217;s ordinary activities in exchange for consideration. To be considered a contract, (i) the contract must be approved (in writing, orally, or in accordance with other customary business practices), (ii) each party&#8217;s rights regarding the product or the service to be transferred can be identified, (iii) the payment terms for the product or the service to be transferred can be identified, (iv) the contract must have commercial substance (that is, the risk, timing or amount of future cash flows is expected to change as a result of the contract), and (v) it is probable that the Company will collect substantially all of the consideration to which it is entitled to receive in exchange for the transfer of the product or the service.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">A performance obligation is defined as a promise to transfer a product or a service to a customer. The Company identifies each promise to transfer a product or a service (or a bundle of products or services, or a series of products and services that are substantially the same and have the same pattern of transfer) that is distinct. A product or a service is distinct if both (i) the customer can benefit from the product or the service either on its own or together with other resources that are readily available to the customer and (ii) the Company&#8217;s promise to transfer the product or the service to the customer is separately identifiable from other promises in the contract. Each distinct promise to transfer a product or a service is a unit of accounting for revenue recognition. If a promise to transfer a product or a service is not separately identifiable from other promises in the contract, such promises should be combined into a single performance obligation.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The transaction price is the amount of consideration the Company is entitled to receive in exchange for the transfer of control of a product or a service to a customer. To determine the transaction price, the Company considers the existence of any significant financing component, the effects of any variable elements, noncash considerations and consideration payable to the customer. If a significant financing component exists, the transaction price is adjusted for the time value of money. If an element of variability exists, the Company must estimate the consideration it expects to receive and uses that amount as the basis for recognizing revenue as the product or the service is transferred to the customer. There are two methods for determining the amount of variable consideration: (i) the expected value method, which is the sum of probability-weighted amounts in a range of possible consideration amounts, and (ii) the mostly likely amount method, which identifies the single most likely amount in a range of possible consideration amounts.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If a contract has multiple performance obligations, the Company allocates the transaction price to each distinct performance obligation in an amount that reflects the consideration the Company is entitled to receive in exchange for satisfying each distinct performance obligation. For each distinct performance obligation, revenue is recognized when (or as) the Company transfers control of the product or the service applicable to such performance obligation.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In those instances where the Company first receives consideration in advance of satisfying its performance obligation, the Company classifies such consideration as deferred revenue until (or as) the Company satisfies such performance obligation. In those instances where the Company first satisfies its performance obligation prior to its receipt of consideration, the consideration is recorded as accounts receivable.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company expenses incremental costs of obtaining and fulfilling a contract as and when incurred if the expected amortization period of the asset that would be recognized is one year or less, or if the amount of the asset is immaterial. Otherwise, such costs are capitalized as contract assets if they are incremental to the contract and amortized to expense proportionate to revenue recognition of the underlying contract.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eq_ContractAssetsPolicyPolicyTextBlock', window );">Contract Assets</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Contract Assets</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company does not have material amounts of contract assets since revenue is recognized as control of goods is transferred or as services are performed. There are a small number of research and development services that may occur over a period of time, but that period of time is generally very short in duration. Any contract assets that may arise are recorded in accounts receivable in the Company&#8217;s consolidated balance sheet net of an allowance for credit losses.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eq_ContractLiabilitiesPolicyPolicyTextBlock', window );">Contract liabilities</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Contract Liabilities</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company&#8217;s contract liabilities consist of advance payments and deferred revenue. The Company classifies advance payments and deferred revenue as current or noncurrent based on the timing of when it expects to recognize revenue. Generally, all contract liabilities are expected to be recognized within one year and are included in deferred revenue in the Company&#8217;s consolidated balance sheet. The noncurrent portion of deferred revenue is included and separately disclosed in the Company&#8217;s consolidated balance sheet.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InProcessResearchAndDevelopmentPolicy', window );">Acquired In-Process Research and Development Expense</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Acquired In-Process Research and Development Expense</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company has acquired, and may continue to acquire, the rights to develop new product candidates. Payments to acquire a new product candidate, as well as future milestone payments associated with asset acquisitions in which contingent payments are resolved are immediately expensed as acquired in-process research and development provided that the product candidate has not achieved regulatory approval for marketing and, absent obtaining such approval, has no alternative future use.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and Development</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Research and Development</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Research and development expenses include salaries and related overhead expenses, non-cash stock-based compensation expense, external research and development expenses incurred under arrangements with third parties, costs of services performed by consultants and contract research organizations, and regulatory costs including those related to preparing and filing INDs with the FDA. Research and development costs are expensed as incurred.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eq_PatentCostsPolicyTextBlock', window );">Patent Costs</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Patent Costs</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company expenses all costs as incurred in connection with patent applications (including direct application fees, and the legal and consulting expenses related to making such applications) and such costs are included in general and administrative expenses in the consolidated statement of operations.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Stock-Based Compensation</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Stock-based Compensation</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company measures employee and nonemployee stock-based awards, including stock options and purchase rights, at grant-date fair value and records compensation expense on a straight-line basis over the vesting period of the award. The Company uses the Black-Scholes option pricing model to value its stock option awards. Estimating the fair value of stock option awards requires management to apply judgment and make estimates of certain assumptions, including the volatility of the Company&#8217;s common stock, the expected term of the Company&#8217;s stock options, the expected dividend yield and the fair value of the Company&#8217;s common stock on the measurement date. As a result, if factors change and management uses different assumptions, stock-based compensation expense could be materially different for future awards.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Income Taxes</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company accounts for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the consolidated financial statements. Under this method, deferred tax assets and liabilities are determined on the basis of the differences between the consolidated financial statements and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in income in the period that includes the enactment date.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company recognizes deferred tax assets to the extent that the Company believes these assets are more likely than not to be realized. In making such a determination, management considers all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax-planning strategies, and results of recent operations. If management determines that the Company would be able to realize its deferred tax assets in the future in excess of their net recorded amount, management would make an adjustment to the deferred tax asset valuation allowance, which would reduce the provision for income taxes.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company records uncertain tax positions on the basis of a two-step process whereby (1) management determines whether it is more likely than not that the tax positions will be sustained on the basis of the technical merits of the position and (2) for those tax positions that meet the more- likely-than-not recognition threshold, management recognizes the largest amount of tax benefit that is more than </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">50</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> percent likely to be realized upon ultimate settlement with the related tax authority. The Company recognizes interest and penalties related to unrecognized tax benefits within income tax expense. Any accrued interest and penalties are included within the related tax liability.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Net Loss per Share</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Net Loss per Share</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Basic net loss per share is calculated by dividing the net loss by the weighted-average number of common shares outstanding for the period. Diluted net loss per share is computed by dividing the net loss by the weighted average number of common shares and common share equivalents outstanding for the period. Common stock equivalents are only included when their effect is dilutive. The Company&#8217;s potentially dilutive securities include outstanding options under the Company&#8217;s equity incentive plan and outstanding warrants to purchase common stock, each of which have been excluded from the computation of diluted net loss per share as they would be anti-dilutive to the net loss per share. For all periods presented, there is no difference in the number of shares used to calculate basic and diluted shares outstanding due to the Company&#8217;s net loss position.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Potentially dilutive securities not included in the calculation of diluted net loss per share attributable to common stockholders because to do so would be anti-dilutive are as follows (in common stock equivalent shares):</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
        <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;">
         <tr style="visibility:collapse;">
          <td style="width:61.855%;"/>
          <td style="width:0.994%;"/>
          <td style="width:1.0%;"/>
          <td style="width:15.388%;"/>
          <td style="width:1.0%;"/>
          <td style="width:1.279%;"/>
          <td style="width:1.009%;"/>
          <td style="width:1.0%;"/>
          <td style="width:15.474%;"/>
          <td style="width:1.0%;"/>
         </tr>
         <tr style="height:8.0pt;">
          <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="7" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
          <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:8.0pt;">
          <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
          <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
          <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Common stock options</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5,102,501</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3,947,025</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Common stock warrants</span></p></td>
          <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,366,141</span></p></td>
          <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,366,141</span></p></td>
          <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6,468,642</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5,313,166</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
         </tr>
        </table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eq_AccruedResearchAndDevelopmentExpensePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued research and development expense policy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eq_AccruedResearchAndDevelopmentExpensePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eq_AustralianResearchAndDevelopmentTaxIncentivePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Australian research and development tax incentive policy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eq_AustralianResearchAndDevelopmentTaxIncentivePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eq_ContractAssetsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contract assets policy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eq_ContractAssetsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eq_ContractLiabilitiesPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contract liabilities policy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eq_ContractLiabilitiesPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eq_PatentCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Patent costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eq_PatentCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eq_PrepaidExpensesAndOtherCurrentAssetsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for Prepaid expenses and other current assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eq_PrepaidExpensesAndOtherCurrentAssetsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eq_ShortTermInvestmentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for short-term investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eq_ShortTermInvestmentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomePolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941378&amp;loc=d3e61044-112788<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=109226317&amp;loc=d3e202-110218<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011434&amp;loc=d3e125687-122742<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InProcessResearchAndDevelopmentPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs assigned to identifiable tangible and intangible assets of an acquired entity to be used in the research and development activities of the combined enterprise. An entity also may disclose the appraisal method or significant assumptions used to value acquired research and development assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6420387&amp;loc=d3e23199-108380<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InProcessResearchAndDevelopmentPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32847-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL116659661-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32280-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918666-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99779-112916<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99893-112916<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5033-111524<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10178-111534<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10149-111534<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10133-111534<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI https://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2.Q6)<br> -URI https://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140407552671472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Summary of Potentially Dilutive Securities Not Included in Calculation of Diluted Net Loss Per Share</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Potentially dilutive securities not included in the calculation of diluted net loss per share attributable to common stockholders because to do so would be anti-dilutive are as follows (in common stock equivalent shares):</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
        <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;">
         <tr style="visibility:collapse;">
          <td style="width:61.855%;"/>
          <td style="width:0.994%;"/>
          <td style="width:1.0%;"/>
          <td style="width:15.388%;"/>
          <td style="width:1.0%;"/>
          <td style="width:1.279%;"/>
          <td style="width:1.009%;"/>
          <td style="width:1.0%;"/>
          <td style="width:15.474%;"/>
          <td style="width:1.0%;"/>
         </tr>
         <tr style="height:8.0pt;">
          <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="7" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
          <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:8.0pt;">
          <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
          <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
          <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Common stock options</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5,102,501</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3,947,025</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Common stock warrants</span></p></td>
          <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,366,141</span></p></td>
          <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,366,141</span></p></td>
          <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6,468,642</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5,313,166</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
         </tr>
        </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140407551081840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value of Financial Instruments (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock', window );">Summary of Assets that Require Fair Value Measurements on Recurring Basis and Their Respective Input Levels Based on Fair Value Hierarchy</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following tables summarize the Company&#8217;s assets that require fair value measurements on a recurring basis and their respective input levels based on the fair value hierarchy (in thousands):</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:43.102%;"/>
        <td style="width:1.145%;"/>
        <td style="width:1.0%;"/>
        <td style="width:10.312%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.156%;"/>
        <td style="width:1.0%;"/>
        <td style="width:12.783%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.156%;"/>
        <td style="width:1.0%;"/>
        <td style="width:11.65%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.156%;"/>
        <td style="width:1.0%;"/>
        <td style="width:9.541%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="10" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Fair Value Measurements Using</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Quoted Prices in</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Significant</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Significant</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Active Markets</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unobservable</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">for Identical</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Observable</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Inputs</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Assets (Level 1)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Inputs (Level 2)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(Level 3)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Short-term investments:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S. treasury securities</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11,916</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11,916</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11,916</span></p></td>
        <td style="border-top:0.5pt solid rgba(255,255,255,0.01);background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11,916</span></p></td>
        <td style="border-top:0.5pt solid rgba(255,255,255,0.01);background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
        <td style="border-top:0.5pt solid rgba(255,255,255,0.01);background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
        <td style="border-top:0.5pt solid rgba(255,255,255,0.01);background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="10" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Fair Value Measurements Using</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Quoted Prices in</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Significant</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Significant</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Active Markets</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unobservable</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">for Identical</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Observable</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Inputs</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Assets (Level 1)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Inputs (Level 2)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(Level 3)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Short-term investments:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S. treasury securities</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">29,121</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">29,121</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Certificates of deposit</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,224</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,224</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">30,345</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">30,345</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140407550276096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Short-Term Investments (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock', window );">Schedule of Company's Short-Term Investments</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following table summarizes the Company&#8217;s short-term investments (in thousands):</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:47.169%;"/>
        <td style="width:0.543%;"/>
        <td style="width:9.997%;"/>
        <td style="width:0.543%;"/>
        <td style="width:1.0%;"/>
        <td style="width:8.01%;"/>
        <td style="width:1.0%;"/>
        <td style="width:0.543%;"/>
        <td style="width:1.0%;"/>
        <td style="width:8.01%;"/>
        <td style="width:1.0%;"/>
        <td style="width:0.556%;"/>
        <td style="width:1.0%;"/>
        <td style="width:8.326%;"/>
        <td style="width:1.0%;"/>
        <td style="width:0.265%;"/>
        <td style="width:1.0%;"/>
        <td style="width:8.035%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Maturity</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Amortized</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unrealized</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unrealized</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Estimated</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(in years)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cost</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Gains</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Losses</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Fair Value</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S. treasury securities</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1 </span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">or less</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12,006</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">90</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11,916</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12,006</span></p></td>
        <td style="border-top:0.5pt solid rgba(255,255,255,0.01);background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
        <td style="border-top:0.5pt solid rgba(255,255,255,0.01);background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">90</span></p></td>
        <td style="border-top:0.5pt solid rgba(255,255,255,0.01);background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11,916</span></p></td>
        <td style="border-top:0.5pt solid rgba(255,255,255,0.01);background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S. treasury securities</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;or less</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">17,122</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">17,115</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S. treasury securities</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&gt;</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;and &lt;</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5</span></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12,049</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">43</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12,006</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Certificates of deposit</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;or less</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,226</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,224</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">30,397</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">52</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">30,345</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of cash, cash equivalents, and investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140407550346864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property and Equipment</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Property and equipment consisted of the following (in thousands):</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:65.971%;"/>
        <td style="width:1.472%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.571%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.458%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.529%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Furniture &amp; fixtures</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">60</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">60</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Machinery &amp; lab equipment</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">534</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">282</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Computer equipment</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">26</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">42</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Leasehold improvements</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">20</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Less accumulated depreciation and amortization</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">249</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">147</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Property and equipment, net</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">391</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">237</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140407550400896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisition (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock', window );">Summary of Purchase Price Allocation</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">A summary of the purchase price allocation is as follows (in thousands):</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:80.253%;"/>
        <td style="width:1.792%;"/>
        <td style="width:1.0%;"/>
        <td style="width:15.956%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Amount</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Assets acquired:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cash</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">700</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Prepaid expenses and other current assets</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">28</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Fixed assets</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total assets acquired</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">734</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Liabilities assumed:</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accounts payable</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">265</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accrued expenses</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">976</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total liabilities assumed</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,241</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net liabilities acquired</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">507</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Issuance of common stock for Bioniz acquisition</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">22,542</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Acquired in-process research and development</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">23,049</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of transactions that are recognized separately from the acquisition of assets and assumptions of liabilities in the business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140407550308048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eq_SummaryOfAdditionalInformationRelatedToLeasesTableTextBlock', window );">Summary of Additional Information Related to Leases</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Additional information related to the Company&#8217;s leases as of and for the year ended December 31, 2022, is as follows (in thousands, except lease term and discount rate):</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:69.578%;"/>
        <td style="width:3.036%;"/>
        <td style="width:1.0%;"/>
        <td style="width:25.386000000000003%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Balance sheet information</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Right-of-use assets</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,191</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Lease liabilities, current</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">408</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Lease liabilities, non-current</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">824</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total lease liabilities</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,232</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other information</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Weighted average remaining lease term</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3.07</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;years</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Weighted average discount rate</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8.25</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Supplemental cash flow information</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Operating cash flows from operating leases</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">465</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Right-of-use assets obtained in exchange for lease obligations</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Maturities of Lease Liabilities</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Maturities of lease liabilities as of December 31, 2022 were as follows (in thousands):</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:77.265%;"/>
        <td style="width:3.669%;"/>
        <td style="width:1.0%;"/>
        <td style="width:17.066%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year ending December 31,</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2023</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">494</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2024</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">492</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2025</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">219</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2026</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">169</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2027</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">28</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total undiscounted lease payments</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,402</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Less: imputed interest</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">170</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total lease liabilities</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,232</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eq_SummaryOfAdditionalInformationRelatedToLeasesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Summary of additional information related to leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eq_SummaryOfAdditionalInformationRelatedToLeasesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140407550317408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Expenses (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAbstract', window );"><strong>Accrued Liabilities, Current [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Schedule of Accrued Expenses</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accrued expenses consisted of the following (in thousands):</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.327%;"/>
        <td style="width:1.466%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.322000000000001%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.48%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.406%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accrued payroll and other employee benefits</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,975</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,511</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Clinical development</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3,253</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,627</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other accruals</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">472</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">245</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Non-clinical research</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">465</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">432</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accrued interest</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">74</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">71</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total accrued expenses</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7,239</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5,886</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140407548178224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Notes Payable (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock', window );">Schedule of Aggregate Carrying Amounts of Term Loan</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The aggregate carrying amounts of the Term Loan is comprised of the following (in thousands):</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:67.108%;"/>
        <td style="width:1.493%;"/>
        <td style="width:1.0%;"/>
        <td style="width:12.883000000000001%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.493%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.022%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Principal</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8,571</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10,000</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Add: accreted liability for final payment fee</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">430</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">310</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Less: unamortized discount</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">48</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">132</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8,953</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10,178</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock', window );">Schedule Future Maturities of Term Loan, Including Final Payment Fee</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Future maturities of the Term Loan, including the Final Payment fee, as of December 31, 2022 were as follows (in thousands):</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:80.253%;"/>
        <td style="width:1.792%;"/>
        <td style="width:1.0%;"/>
        <td style="width:15.956%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year ending December 31, 2023</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5,714</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year ending December 31, 2024</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3,357</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9,071</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unaccreted balance for Final Payment fee on Term Loans</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">70</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unamortized discounts</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">48</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8,953</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Less current portion</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5,714</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Noncurrent portion</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3,239</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturity and sinking fund requirement for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140407548857328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Summary of Stock Option Activity</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following summarizes stock option activity for the year ended December 31, 2022:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:50.131%;"/>
        <td style="width:0.713%;"/>
        <td style="width:1.0%;"/>
        <td style="width:12.533999999999999%;"/>
        <td style="width:1.0%;"/>
        <td style="width:0.844%;"/>
        <td style="width:1.0%;"/>
        <td style="width:6.307%;"/>
        <td style="width:1.0%;"/>
        <td style="width:0.713%;"/>
        <td style="width:1.0%;"/>
        <td style="width:10.41%;"/>
        <td style="width:1.0%;"/>
        <td style="width:0.844%;"/>
        <td style="width:1.0%;"/>
        <td style="width:9.507%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Outstanding Options</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Weighted-<br/>Average <br/>Exercise Price<br/>Per Share</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Weighted<br/>Average<br/>Remaining<br/>Contractual<br/>Term<br/>(in years)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Aggregate<br/>Intrinsic Value<br/>(in thousands) </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Balances as of December 31, 2021</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3,947,025</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.58</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Granted</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,169,800</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3.63</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exercised</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="-sec-ix-hidden:F_e9cd9fc4-b2d3-4e1c-814b-17b62754d416;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></span></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="-sec-ix-hidden:F_0fa15c8b-e902-4287-b1e7-c4c493e1c465;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></span></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Forfeitures and cancellations</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,014,324</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.90</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Balances as of December 31, 2022</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5,102,501</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.11</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7.71</span></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Options exercisable as of December 31, 2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,483,222</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.23</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6.75</span></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><div style="text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.333%;">(a)</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Aggregate intrinsic value in this table was calculated as the positive difference, if any, between the closing price per share of the Company&#8217;s common stock on December 31, 2022 of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.06</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and the price of the underlying options.</span></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Summary of Non-cash Stock-based Compensation Expense</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total non-cash stock-based compensation expense for all stock awards and purchase rights, net of forfeitures recognized as they occur, that was recognized in the consolidated statement of operations is as follows (in thousands):</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.327%;"/>
        <td style="width:1.466%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.322000000000001%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.48%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.406%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year Ended <br/>December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Research and development</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,799</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,976</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">General and administrative</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3,042</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,434</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4,841</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4,410</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Summary of Weighted-Average Assumptions Used to Determine Fair Value of Stock Option Grants</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The weighted-average assumptions used in the Black-Scholes option pricing model to determine the fair value of the employee and nonemployee stock option grants were as follows:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:67.29%;"/>
        <td style="width:1.502%;"/>
        <td style="width:14.867%;"/>
        <td style="width:1.502%;"/>
        <td style="width:14.838%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="3" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year Ended <br/>December 31,</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Risk-free interest rate</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.93</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.68</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Expected volatility</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">81.60</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">88.55</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Expected term (in years)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.84</span></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6.01</span></span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Expected dividend yield</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eq_CommonStockReservedForFutureIssuanceTableTextBlock', window );">Summary of Reserved Shares of Common Stock for Future Issuance</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Common stock reserved for future issuance consists of the following as of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022 and 2021:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:67.477%;"/>
        <td style="width:1.009%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.204%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.023%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.289%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Stock options issued and outstanding</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5,102,501</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3,947,025</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Warrants for common stock</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,366,141</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,366,141</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Awards available under the 2018 Equity Incentive Plan</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">784,331</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">467,024</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Employee stock purchase plan</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">925,963</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">769,658</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8,178,936</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6,549,848</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eq_CommonStockReservedForFutureIssuanceTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Common stock reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eq_CommonStockReservedForFutureIssuanceTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140407551349184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock', window );">Summary of Components of Loss Before Income Tax Provision (Benefit)</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The components of loss before income tax provision (benefit) for the years ended December 31, 2022 and 2021 consisted of the following (in thousands):</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">		&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:65.971%;"/>
        <td style="width:1.472%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.571%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.458%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.529%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year Ended <br/>December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S.</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">60,403</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">37,705</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Foreign</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,025</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,347</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">62,428</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">39,052</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eq_SummaryOfReconciliationOfExpectedStatutoryFederalIncomeTaxProvisionToActualIncomeTaxProvisionTableTextBlock', window );">Summary of Reconciliation of Expected Statutory Federal Income Tax Provision to Actual Income Tax Provision</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following is a reconciliation of the expected statutory federal income tax provision to our actual income tax provision for the years ended </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022 and 2021 (in thousands):</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:65.971%;"/>
        <td style="width:1.472%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.571%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.458%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.529%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Income taxes at statutory rates</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13,110</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8,201</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">State income tax, net of federal benefit</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Stock-based compensation</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">533</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">451</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Permanent items</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">128</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">31</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Federal research and orphan drug credits</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,152</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,713</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Foreign rate differential</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">425</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">72</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Transaction costs</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">89</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Acquired in-process research and development</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4,840</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Change in federal valuation allowance</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8,247</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9,360</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Significant Components of Deferred Tax Assets and Liabilities</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The tax effects of temporary differences that give rise to significant portions of the deferred tax assets and deferred tax liabilities as of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022 and 2021 are as follows (in thousands):</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:65.971%;"/>
        <td style="width:1.472%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.571%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.458%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.529%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Deferred tax assets:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net operating loss carryforward</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">28,222</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">19,344</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Credits</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9,289</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3,940</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Capitalized research expenditures</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7,086</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Equity compensation</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,829</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,134</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,196</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,184</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total deferred tax assets</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">47,622</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">25,602</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Valuation allowance</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">46,317</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">25,215</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total deferred tax assets, net of allowance</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,305</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">387</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Deferred tax liabilities:</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Operating lease right-of-use asset</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">284</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">346</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Deferred revenue</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">945</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">76</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">41</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total deferred tax liabilities</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,305</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">387</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net deferred taxes</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock', window );">Summary of Reconciliation of Unrecognized Tax Benefits</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following table summarizes the reconciliation of the unrecognized tax benefits activity during the years ended December 31, 2022 and 2021 (in thousands):</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.327%;"/>
        <td style="width:1.466%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.322000000000001%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.48%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.406%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unrecognized tax benefits &#8211; beginning</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5,487</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,667</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Gross increases &#8211; tax positions in prior period</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,266</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Gross decreases &#8211; tax positions in prior period</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Gross increase &#8211; current-period tax positions</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">392</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">554</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Gross decrease &#8211; current-period tax positions</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Settlements</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Lapse of statute of limitations</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unrecognized tax benefits &#8211; ending</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5,879</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5,487</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eq_SummaryOfReconciliationOfExpectedStatutoryFederalIncomeTaxProvisionToActualIncomeTaxProvisionTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Summary of reconciliation of expected statutory federal income tax provision to actual income tax provision.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eq_SummaryOfReconciliationOfExpectedStatutoryFederalIncomeTaxProvisionToActualIncomeTaxProvisionTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of income before income tax between domestic and foreign jurisdictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of unrecognized tax benefits for which a material change is reasonably possible in the next twelve months, typically including the nature of the uncertainty, the event(s) that could cause a material change, and an estimate of the range of the reasonably possible change or a statement that an estimate of the range cannot be made. An unrecognized tax benefit is the difference between a tax position taken in a tax return and the amounts recognized in the financial statements for which it is more likely than not, based on the technical merits of the position, that the tax position will not be sustained upon examination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140407553997632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Accounting Pronouncements - Additional Information (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">State of incorporation</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationDateOfIncorporation', window );">Date of incorporation</a></td>
<td class="text">Mar. 16,  2017<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsAndShortTermInvestments', window );">Cash, Cash equivalents and short-term investments</a></td>
<td class="nump">$ 71.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationDateOfIncorporation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date when an entity was incorporated</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationDateOfIncorporation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsAndShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the customer may deposit additional funds at any time and effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid Investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Short-term investments, exclusive of cash equivalents, generally consist of marketable securities intended to be sold within one year (or the normal operating cycle if longer) and may include trading securities, available-for-sale securities, or held-to-maturity securities (if maturing within one year), as applicable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsAndShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140407548136896">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Organization and Accounting Pronouncements - Additional Information (Details1) - ASU 2016-13<br></strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted', window );">Change in accounting principle, accounting standards update, adopted</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate', window );">Change in accounting principle, accounting standards update, adoption date</a></td>
<td class="text">Jan.  01,  2022<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect', window );">Change in accounting principle, accounting standards update, immaterial effect</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates (true false) whether accounting standards update was adopted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128293352&amp;loc=SL126838806-209984<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 20<br> -Section 65<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=121483254&amp;loc=SL120254523-199619<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128293352&amp;loc=SL126838806-209984<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128293352&amp;loc=SL126838806-209984<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126986314&amp;loc=SL124402458-218513<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL122642865-165497<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL122642865-165497<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL120254526-165497<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL120254526-165497<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL120254519-210437<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128293352&amp;loc=SL120154346-209984<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL122150809-237846<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126986314&amp;loc=SL124402458-218513<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092918&amp;loc=SL128093175-196984<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092918&amp;loc=SL128093175-196984<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL126732908-238011<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL121967933-165497<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL120320025-210437<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL121967933-165497<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL120320025-210437<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 832<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128342835&amp;loc=SL128342857-244232<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date accounting standards update was adopted, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126986314&amp;loc=SL124402458-218513<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL122642865-165497<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 832<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128342835&amp;loc=SL128342857-244232<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL120254526-165497<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126986314&amp;loc=SL124402458-218513<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092918&amp;loc=SL128093175-196984<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL120320025-210437<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL120320025-210437<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL122642865-165497<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL121967933-165497<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL122150809-237846<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128293352&amp;loc=SL126838806-209984<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128293352&amp;loc=SL126838806-209984<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092918&amp;loc=SL128093175-196984<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL126732908-238011<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128293352&amp;loc=SL120154346-209984<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092918&amp;loc=SL128093175-196984<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 20<br> -Section 65<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=121483254&amp;loc=SL120254523-199619<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL121967933-165497<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL120254519-210437<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL120254526-165497<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128293352&amp;loc=SL126838806-209984<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates (true false) whether effect from applying amendment to accounting standards is immaterial.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=122038215&amp;loc=d3e31010-122693<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126986314&amp;loc=SL124402458-218513<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201613Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201613Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140407553302160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Additional Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eq_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Allowance for credit losses</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eq_PrepaidAndOtherCurrentAssetsTaxIncentive', window );">Prepaid and other current assets tax incentive</a></td>
<td class="nump">1,000<span></span>
</td>
<td class="nump">300<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable</a></td>
<td class="nump">$ 2,838<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eq_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property and equipment, useful lives</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eq_PercentageOfTaxBenefitToBeRealizedUponUltimateSettlementWithTaxAuthority', window );">Percentage of tax benefit to be realized upon ultimate settlement with tax authority</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eq_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property and equipment, useful lives</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Australian Taxation Office | Australian Research and Development Tax Incentive Program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eq_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eq_ResearchAndDevelopmentTaxIncentiveRevenueCriteria', window );">Revenue for availability of research and development tax incentive</a></td>
<td class="nump">$ 20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eq_PercentageOfTaxBenefitToBeRealizedUponUltimateSettlementWithTaxAuthority">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of tax benefit to be realized upon ultimate settlement with tax authority.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eq_PercentageOfTaxBenefitToBeRealizedUponUltimateSettlementWithTaxAuthority</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eq_PrepaidAndOtherCurrentAssetsTaxIncentive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Prepaid and other current assets tax incentive.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eq_PrepaidAndOtherCurrentAssetsTaxIncentive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eq_ResearchAndDevelopmentTaxIncentiveRevenueCriteria">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Research and development tax incentive revenue criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eq_ResearchAndDevelopmentTaxIncentiveRevenueCriteria</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eq_SummaryOfSignificantAccountingPoliciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Summary of significant accounting policies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eq_SummaryOfSignificantAccountingPoliciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_AustralianTaxationOfficeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_AustralianTaxationOfficeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAxis=eq_AustralianResearchAndDevelopmentTaxIncentiveProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAxis=eq_AustralianResearchAndDevelopmentTaxIncentiveProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140407552790240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Summary of Potentially Dilutive Securities Not Included in Calculation of Diluted Net Loss Per Share (Details) - shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities not included in calculation of diluted net loss per share</a></td>
<td class="nump">6,468,642<span></span>
</td>
<td class="nump">5,313,166<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Common Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities not included in calculation of diluted net loss per share</a></td>
<td class="nump">5,102,501<span></span>
</td>
<td class="nump">3,947,025<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember', window );">Common Stock Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities not included in calculation of diluted net loss per share</a></td>
<td class="nump">1,366,141<span></span>
</td>
<td class="nump">1,366,141<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140407545241824">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value of Financial Instruments - Summary of Assets that Require Fair Value Measurements on Recurring Basis and Their Respective Input Levels Based on Fair Value Hierarchy (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Total short-term investments</a></td>
<td class="nump">$ 11,916<span></span>
</td>
<td class="nump">$ 30,345<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_USTreasurySecuritiesMember', window );">U.S. Treasury Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Total short-term investments</a></td>
<td class="nump">11,916<span></span>
</td>
<td class="nump">29,121<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_CertificatesOfDepositMember', window );">Certificates of Deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Total short-term investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,224<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Total short-term investments</a></td>
<td class="nump">11,916<span></span>
</td>
<td class="nump">30,345<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | U.S. Treasury Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Total short-term investments</a></td>
<td class="nump">$ 11,916<span></span>
</td>
<td class="nump">29,121<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Certificates of Deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Total short-term investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,224<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_USTreasurySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_USTreasurySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_CertificatesOfDepositMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_CertificatesOfDepositMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140407547998240">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value of Financial Instruments - Additional Information (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Carrying amount of notes payable</a></td>
<td class="nump">$ 9,000,000.0<span></span>
</td>
<td class="nump">$ 10,200,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Financial liabilities</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialLiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial obligations, including, but not limited to, debt instruments, derivative liabilities, federal funds purchased and sold under agreements to repurchase, securities loaned or sold under agreements to repurchase, financial instruments sold not yet purchased, guarantees, line of credit, loans and notes payable, servicing liability, and trading liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialLiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140407552755856">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Short-Term Investments - Schedule of Company's Short-Term Investments (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule Of Available For Sale Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">$ 12,006<span></span>
</td>
<td class="nump">$ 30,397<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized losses</a></td>
<td class="num">(90)<span></span>
</td>
<td class="num">(52)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Short-term investments</a></td>
<td class="nump">11,916<span></span>
</td>
<td class="nump">30,345<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=eq_USTreasurySecuritiesMaturingInOneYearOrLessMember', window );">U.S. Treasury Securities Maturing in One Year or Less</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule Of Available For Sale Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">12,006<span></span>
</td>
<td class="nump">17,122<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized losses</a></td>
<td class="num">(90)<span></span>
</td>
<td class="num">(7)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Short-term investments</a></td>
<td class="nump">$ 11,916<span></span>
</td>
<td class="nump">$ 17,115<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=eq_USTreasurySecuritiesMaturingInOneYearOrLessMember', window );">U.S. Treasury Securities Maturing in One Year or Less | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule Of Available For Sale Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleTerm', window );">Maturity (in years)</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=eq_USTreasurySecuritiesMaturingBetweenOneAndFiveYearsMember', window );">U.S. Treasury Securities Maturing between One and Five years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule Of Available For Sale Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,049<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(43)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Short-term investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,006<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=eq_USTreasurySecuritiesMaturingBetweenOneAndFiveYearsMember', window );">U.S. Treasury Securities Maturing between One and Five years | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule Of Available For Sale Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleTerm', window );">Maturity (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=eq_USTreasurySecuritiesMaturingBetweenOneAndFiveYearsMember', window );">U.S. Treasury Securities Maturing between One and Five years | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule Of Available For Sale Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleTerm', window );">Maturity (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=eq_CertificatesOfDepositMaturingInOneYearOrLessMember', window );">Certificates of Deposit Maturing in One Year or Less</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule Of Available For Sale Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,226<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Short-term investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,224<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=eq_CertificatesOfDepositMaturingInOneYearOrLessMember', window );">Certificates of Deposit Maturing in One Year or Less | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule Of Available For Sale Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleTerm', window );">Maturity (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26626-111562<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and maturity of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=eq_USTreasurySecuritiesMaturingInOneYearOrLessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=eq_USTreasurySecuritiesMaturingInOneYearOrLessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=eq_USTreasurySecuritiesMaturingBetweenOneAndFiveYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=eq_USTreasurySecuritiesMaturingBetweenOneAndFiveYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=eq_CertificatesOfDepositMaturingInOneYearOrLessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=eq_CertificatesOfDepositMaturingInOneYearOrLessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140407548937760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Short-Term Investments - Additional information (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule Of Available For Sale Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings', window );">Other than temporary impairment loss investments available for sale securities</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule Of Available For Sale Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eq_AvailableForSaleSecuritiesDebtMaturitiesPeriod', window );">Available for sale Securities debt maturities period</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule Of Available For Sale Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eq_AvailableForSaleSecuritiesDebtMaturitiesPeriod', window );">Available for sale Securities debt maturities period</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eq_AvailableForSaleSecuritiesDebtMaturitiesPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eq_AvailableForSaleSecuritiesDebtMaturitiesPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other-than-temporary impairment (OTTI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), recognized in earnings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8A<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=SL6284422-111562<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140407553340192">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Property and Equipment - Schedule of Property and Equipment (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less accumulated depreciation and amortization</a></td>
<td class="num">$ (249)<span></span>
</td>
<td class="num">$ (147)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">391<span></span>
</td>
<td class="nump">237<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture And Fixtures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">60<span></span>
</td>
<td class="nump">60<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery &amp; Lab Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">534<span></span>
</td>
<td class="nump">282<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computer Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">26<span></span>
</td>
<td class="nump">$ 42<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">$ 20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140407549197664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment - Additional Information (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="nump">$ 118,000<span></span>
</td>
<td class="nump">$ 72,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisposals', window );">Disposal of property and equipment</a></td>
<td class="nump">16,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfAssets1', window );">Gains (losses) on disposal of property and equipment</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDispositionOfAssets1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDispositionOfAssets1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisposals">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of divestiture of long-lived, physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisposals</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140407545198640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisition - Additional Information (Details) - Bioniz - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Feb. 14, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Business acquisition, common stock shares issued</a></td>
<td class="nump">4,820,230<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eq_TermsOfMergerAgreement', window );">Business acquisition, term for finalization after the closing</a></td>
<td class="text">18 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts', window );">Transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=eq_BionizTherapeuticsIncMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Business acquisition, common stock shares issued</a></td>
<td class="nump">5,699,492<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=eq_BionizTherapeuticsIncMember', window );">18 Months after Closing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Business acquisition, common stock shares issued</a></td>
<td class="nump">879,252<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=eq_BionizTherapeuticsIncMember', window );">Achievement of Regulatory Events</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh', window );">Contingent payments</a></td>
<td class="nump">$ 57.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=eq_BionizTherapeuticsIncMember', window );">Achievement Of Commercialization Events</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh', window );">Contingent payments</a></td>
<td class="nump">$ 250.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eq_TermsOfMergerAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Terms of merger agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eq_TermsOfMergerAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of equity interests issued or issuable to acquire entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 23<br> -URI https://asc.fasb.org/extlink&amp;oid=123586518&amp;loc=d3e1043-128460<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAcquisitionRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=eq_BionizTherapeuticsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=eq_BionizTherapeuticsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis=eq_EighteenMonthsAfterClosingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityInterestIssuedOrIssuableByTypeAxis=eq_EighteenMonthsAfterClosingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=eq_ContingentConsiderationForAchievementOfRegulatoryEventsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=eq_ContingentConsiderationForAchievementOfRegulatoryEventsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=eq_ContingentConsiderationForAchievementOfCommercializationEventsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=eq_ContingentConsiderationForAchievementOfCommercializationEventsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140407545244496">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Acquisition - Summary of Purchase Price Allocation (Details) - Bioniz<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Feb. 14, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract', window );"><strong>Assets acquired:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash</a></td>
<td class="nump">$ 700<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">28<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets', window );">Fixed assets</a></td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets', window );">Total assets acquired</a></td>
<td class="nump">734<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract', window );"><strong>Liabilities assumed:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Accounts payable</a></td>
<td class="nump">265<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eq_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses', window );">Accrued expenses</a></td>
<td class="nump">976<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities', window );">Total liabilities assumed</a></td>
<td class="nump">1,241<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Net liabilities acquired</a></td>
<td class="nump">507<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned', window );">Issuance of common stock for Bioniz acquisition</a></td>
<td class="nump">22,542<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eq_BusinessCombinationAcquiredInProcessResearchAndDevelopment', window );">Acquired in-process research and development</a></td>
<td class="nump">$ 23,049<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eq_BusinessCombinationAcquiredInProcessResearchAndDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business combination acquired in-Process research and development</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eq_BusinessCombinationAcquiredInProcessResearchAndDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eq_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business combination recognized identifiable assets acquired and liabilities assumed current liabilities accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eq_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of equity interests (such as common shares, preferred shares, or partnership interest) issued or issuable to acquire the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=eq_BionizTherapeuticsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=eq_BionizTherapeuticsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140407549529648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Additional Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Operating lease expense</a></td>
<td class="nump">$ 0.6<span></span>
</td>
<td class="nump">$ 0.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=eq_LaboratorySpaceMember', window );">Laboratory Space</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eq_LesseeOperatingLeaseExpirationYear', window );">Lease expiration year</a></td>
<td class="text">2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=eq_OfficeSpaceMember', window );">Office Space</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eq_LesseeOperatingLeaseExpirationYear', window );">Lease expiration year</a></td>
<td class="text">2027<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eq_LesseeOperatingLeaseExpiredDate', window );">Lease expired date</a></td>
<td class="text">2023-02<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eq_LesseeOperatingLeaseExpirationYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee operating lease expiration year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eq_LesseeOperatingLeaseExpirationYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eq_LesseeOperatingLeaseExpiredDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee operating lease expired date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eq_LesseeOperatingLeaseExpiredDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearMonthItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease expense. Excludes sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=eq_LaboratorySpaceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=eq_LaboratorySpaceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=eq_OfficeSpaceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=eq_OfficeSpaceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140407549515008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Summary of Additional Information Related to Leases (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAndLiabilitiesLesseeAbstract', window );"><strong>Balance sheet information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right-of-use assets</a></td>
<td class="nump">$ 1,191<span></span>
</td>
<td class="nump">$ 1,645<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Lease liabilities, current</a></td>
<td class="nump">408<span></span>
</td>
<td class="nump">376<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Lease liabilities, non-current</a></td>
<td class="nump">824<span></span>
</td>
<td class="nump">1,235<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total lease liabilities</a></td>
<td class="nump">$ 1,232<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eq_OtherOperatingLeaseInformationAbstract', window );"><strong>Other information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted average remaining lease term</a></td>
<td class="text">3 years 25 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted average discount rate</a></td>
<td class="nump">8.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental cash flow information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating cash flows from operating leases</a></td>
<td class="nump">$ 465<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Right-of-use assets obtained in exchange for lease obligations</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1,759<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eq_OtherOperatingLeaseInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other operating lease information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eq_OtherOperatingLeaseInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsAndLiabilitiesLesseeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsAndLiabilitiesLesseeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140407553277888">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Schedule of Maturities of Lease Liabilities (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Lessee, Operating Lease, Liability, to be Paid [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2023</a></td>
<td class="nump">$ 494<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2024</a></td>
<td class="nump">492<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2025</a></td>
<td class="nump">219<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2026</a></td>
<td class="nump">169<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2027</a></td>
<td class="nump">28<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total undiscounted lease payments</a></td>
<td class="nump">1,402<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: imputed interest</a></td>
<td class="num">(170)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total lease liabilities</a></td>
<td class="nump">$ 1,232<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140407554017936">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accrued Expenses - Schedule of Accrued Expenses (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAbstract', window );"><strong>Accrued Liabilities, Current [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued payroll and other employee benefits</a></td>
<td class="nump">$ 2,975<span></span>
</td>
<td class="nump">$ 2,511<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eq_AccruedClinicalDevelopment', window );">Clinical development</a></td>
<td class="nump">3,253<span></span>
</td>
<td class="nump">2,627<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other accruals</a></td>
<td class="nump">472<span></span>
</td>
<td class="nump">245<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eq_AccruedNonClinicalResearch', window );">Non-clinical research</a></td>
<td class="nump">465<span></span>
</td>
<td class="nump">432<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPayableCurrent', window );">Accrued interest</a></td>
<td class="nump">74<span></span>
</td>
<td class="nump">71<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Total accrued expenses</a></td>
<td class="nump">$ 7,239<span></span>
</td>
<td class="nump">$ 5,886<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eq_AccruedClinicalDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued Clinical Development</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eq_AccruedClinicalDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eq_AccruedNonClinicalResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued Non-clinical Research.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eq_AccruedNonClinicalResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140407476405712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Partnerships - Additional Information (Details)<br> &#165; in Billions</strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1">31 Months Ended</th>
<th class="th" colspan="2"></th>
<th class="th" colspan="2"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 31, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Nov. 30, 2019 </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 16, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 16, 2023 </div>
<div>JPY (&#165;)</div>
</th>
<th class="th">
<div>Dec. 05, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 05, 2022 </div>
<div>JPY (&#165;)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRevenueCurrent', window );">Deferred revenue current</a></td>
<td class="nump">$ 14,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRevenueNoncurrent', window );">Deferred revenue long term</a></td>
<td class="nump">10,378,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,378,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Recognized revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,759,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=eq_OnoPharmaceuticalCoLtdMember', window );">Ono | Asset Purchase Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eq_UpfrontNonRefundableAndNonCreditablePaymentReceivableUponExchangeOfOption', window );">Upfront non-refundable and non-creditable payment receivable, upon exchange of option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26,400,000<span></span>
</td>
<td class="nump">&#165; 3.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossRealized', window );">Foreign curreny realized gain</a></td>
<td class="nump">600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eq_UpfrontPaymentReceived', window );">Upfront payment received</a></td>
<td class="nump">26,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eq_UpfrontNonRefundableAndNonCreditablePaymentInvoiced', window );">Upfront non-refundable and non-creditable payment invoiced</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,800,000<span></span>
</td>
<td class="nump">&#165; 3.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eq_UpfrontAndNonCreditablePaymentInvoiced', window );">Upfront and non-creditable payment invoiced</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eq_EstimatedResearchAndDevelopmentFunding', window );">Estimated research and development funding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">76,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eq_InitialTransactionPrice', window );">Initial transaction price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">102,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRevenue', window );">Deferred revenue</a></td>
<td class="nump">25,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRevenueCurrent', window );">Deferred revenue current</a></td>
<td class="nump">14,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRevenueNoncurrent', window );">Deferred revenue long term</a></td>
<td class="nump">10,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eq_ProceedsFromResearchAndDevelopmentFees', window );">Proceeds from research and development fees</a></td>
<td class="nump">$ 12,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Recognized revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eq_OptionPeriodExpiryCondition', window );">Option period expiry condition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">he option period will expire three months following the delivery of topline data from the EQUALISE clinical study in lupus nephritis and interim data from the EQUATOR Phase 3 clinical study in acute graft-versus-host disease. <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=eq_OnoPharmaceuticalCoLtdMember', window );">Ono | Asset Purchase Agreement | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eq_OneTimePaymentReceivableUponExercisesTheOption', window );">One-time payment receivable, upon exercises the option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 37,200,000<span></span>
</td>
<td class="nump">&#165; 5.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=eq_OnoPharmaceuticalCoLtdMember', window );">Ono | Asset Purchase Agreement | Maximum | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eq_EligibleToReceivePaymentOnAchievementOfCertainDevelopmentMilestones', window );">Eligible to receive payment on achievement of certain development milestones</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 101,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=eq_BioconMember', window );">Biocon</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Common stock shares issued | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,316,134<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=eq_BioconMember', window );">Biocon | Collaboration and License Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eq_RegulatoryMilestonePaymentsUponAchievementOfCertainRegulatoryApprovals', window );">Regulatory milestone payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eq_SalesMilestonePaymentsUponTheAchievementOfFirstCommercialSaleOfProductAndSpecifiedLevelsOfProductSales', window );">Sales milestone payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 565,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=eq_ResearchAndDevelopmentServicesMember', window );">Research and Development Services | Ono | Asset Purchase Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Recognized revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=eq_UpfrontPaymentAmortizationMember', window );">Upfront Payment Amortization | Ono | Asset Purchase Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Recognized revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eq_EligibleToReceivePaymentOnAchievementOfCertainDevelopmentMilestones">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Eligible to receive payment on achievement of certain development milestones.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eq_EligibleToReceivePaymentOnAchievementOfCertainDevelopmentMilestones</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eq_EstimatedResearchAndDevelopmentFunding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Estimated research and development funding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eq_EstimatedResearchAndDevelopmentFunding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eq_InitialTransactionPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Initial transaction price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eq_InitialTransactionPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eq_OneTimePaymentReceivableUponExercisesTheOption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>One-time payment receivable upon exercises the option.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eq_OneTimePaymentReceivableUponExercisesTheOption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eq_OptionPeriodExpiryCondition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Option period expiry condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eq_OptionPeriodExpiryCondition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eq_ProceedsFromResearchAndDevelopmentFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds from research and development fees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eq_ProceedsFromResearchAndDevelopmentFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eq_RegulatoryMilestonePaymentsUponAchievementOfCertainRegulatoryApprovals">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Regulatory milestone payments upon the achievement of certain regulatory approvals.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eq_RegulatoryMilestonePaymentsUponAchievementOfCertainRegulatoryApprovals</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eq_SalesMilestonePaymentsUponTheAchievementOfFirstCommercialSaleOfProductAndSpecifiedLevelsOfProductSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sales milestone payments upon the achievement of first commercial sale of product and specified levels of product sales.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eq_SalesMilestonePaymentsUponTheAchievementOfFirstCommercialSaleOfProductAndSpecifiedLevelsOfProductSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eq_UpfrontAndNonCreditablePaymentInvoiced">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Upfront and Non-creditable payment invoiced.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eq_UpfrontAndNonCreditablePaymentInvoiced</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eq_UpfrontNonRefundableAndNonCreditablePaymentInvoiced">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Upfront non-refundable and non-creditable payment invoiced.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eq_UpfrontNonRefundableAndNonCreditablePaymentInvoiced</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eq_UpfrontNonRefundableAndNonCreditablePaymentReceivableUponExchangeOfOption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Upfront non-refundable and non-creditable payment receivable, upon exchange of option.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eq_UpfrontNonRefundableAndNonCreditablePaymentReceivableUponExchangeOfOption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eq_UpfrontPaymentReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Upfront payment received.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eq_UpfrontPaymentReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossRealized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of foreign currency transaction realized gain (loss) recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124440516&amp;loc=d3e30840-110895<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=125521441&amp;loc=d3e30690-110894<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossRealized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=eq_OnoPharmaceuticalCoLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=eq_OnoPharmaceuticalCoLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=eq_AssetPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=eq_AssetPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=eq_BioconMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=eq_BioconMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=eq_ResearchAndDevelopmentServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=eq_ResearchAndDevelopmentServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=eq_UpfrontPaymentAmortizationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=eq_UpfrontPaymentAmortizationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140407551578816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Notes Payable - Additional Information (Details)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>May 31, 2021 </div>
<div>Installment</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($) </div>
<div>Installment </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Apr. 23, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityExpirationDate1', window );">Term Loan maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jun.  01,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFrequencyOfPeriodicPayment', window );">Debt instrument, frequency of periodic payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">monthly<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateBasisForEffectiveRate', window );">Debt instrument, interest rate, basis for effective rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">prime rate<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eq_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaidAsPercent', window );">Percentage of final principal payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eq_RequiredNoticePeriodForDebtPrepayment', window );">Required notice period for debt prepayment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eq_DebtPrepaymentFeeAsPercentOnYearOne', window );">Debt prepayment fee as percent on year one</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eq_DebtPrepaymentFeeAsPercentOnYearTwo', window );">Debt prepayment fee as percent on year two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eq_DebtPrepaymentFeeAsPercentFromYearThree', window );">Debt prepayment fee as percent from year three</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Line of Credit | Prime Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt instrument, basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Line of Credit | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate, stated percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=eq_LoanAgreementMember', window );">Loan Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eq_LineOfCreditFacilityFrequencyOfPaymentsPrincipalAndInterest', window );">Line of credit facility frequency of payments principal and interest</a></td>
<td class="nump">24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFrequencyOfPeriodicPayment', window );">Debt instrument, frequency of periodic payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">monthly<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Debt instrument, interest rate, effective percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11.86%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=eq_LoanAgreementMember', window );">Loan Agreement | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Debt instrument, interest rate, effective percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.50%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=eq_LoanAgreementMember', window );">Loan Agreement | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Debt instrument, interest rate, effective percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=eq_TermLoanMember', window );">Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Borrowings under loan agreement | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eq_LineOfCreditFacilityFrequencyOfPaymentsPrincipalAndInterest', window );">Line of credit facility frequency of payments principal and interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Lenders warrants exercisable for shares | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80,428<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrants exercisable, per share exercise price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.73<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eq_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaidAsPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt instrument periodic payment terms balloon payment to be paid as percent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eq_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaidAsPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eq_DebtPrepaymentFeeAsPercentFromYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt prepayment fee as percent from year three.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eq_DebtPrepaymentFeeAsPercentFromYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eq_DebtPrepaymentFeeAsPercentOnYearOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt prepayment fee as percent on year one.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eq_DebtPrepaymentFeeAsPercentOnYearOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eq_DebtPrepaymentFeeAsPercentOnYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt prepayment fee as percent on year two.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eq_DebtPrepaymentFeeAsPercentOnYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eq_LineOfCreditFacilityFrequencyOfPaymentsPrincipalAndInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line of credit facility frequency of payments principal and interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eq_LineOfCreditFacilityFrequencyOfPaymentsPrincipalAndInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eq_RequiredNoticePeriodForDebtPrepayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Required notice period for debt prepayment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eq_RequiredNoticePeriodForDebtPrepayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFrequencyOfPeriodicPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of the frequency of periodic payments (monthly, quarterly, annual).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFrequencyOfPeriodicPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateBasisForEffectiveRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of any adjustments made to the stated rate to determine the effective rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateBasisForEffectiveRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateEffectivePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityExpirationDate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date the credit facility terminates, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityExpirationDate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_PrimeRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_PrimeRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=eq_LoanAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=eq_LoanAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=eq_TermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=eq_TermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140407552196032">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Notes Payable - Schedule of Aggregate Carrying Amounts of Term Loan (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Less: unamortized discount</a></td>
<td class="num">$ (48)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total</a></td>
<td class="nump">9,071<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Principal</a></td>
<td class="nump">8,571<span></span>
</td>
<td class="nump">$ 10,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eq_AccretedLiabilityForFinalPaymentFee', window );">Add: accreted liability for final payment fee</a></td>
<td class="nump">430<span></span>
</td>
<td class="nump">310<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Less: unamortized discount</a></td>
<td class="num">(48)<span></span>
</td>
<td class="num">(132)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total</a></td>
<td class="nump">$ 8,953<span></span>
</td>
<td class="nump">$ 10,178<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eq_AccretedLiabilityForFinalPaymentFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accreted liability for final payment fee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eq_AccretedLiabilityForFinalPaymentFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140407554017648">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Notes Payable - Schedule Future Maturities of Term Loan, Including Final Payment Fee (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eq_DebtInstrumentCarryingAmountIncludingUnaccretedLiabilityForFinalPaymentFeeMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">Year ending December 31, 2023</a></td>
<td class="nump">$ 5,714<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eq_DebtInstrumentCarryingAmountIncludingUnaccretedLiabilityForFinalPaymentFeeMaturitiesRepaymentsOfPrincipalInYearTwo', window );">Year ending December 31, 2024</a></td>
<td class="nump">3,357<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eq_DebtInstrumentCarryingAmountIncludingUnaccretedLiabilityForFinalPaymentFee', window );">Debt instrument carrying amount including unaccreted liability for final payment fee</a></td>
<td class="nump">8,953<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eq_UnaccretedLiabilityForFinalPaymentFee', window );">Unaccreted balance for Final Payment fee on Term Loans</a></td>
<td class="num">(70)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Less: unamortized discount</a></td>
<td class="num">(48)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total</a></td>
<td class="nump">9,071<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Less current portion</a></td>
<td class="num">(5,714)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Noncurrent portion</a></td>
<td class="nump">$ 3,239<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eq_DebtInstrumentCarryingAmountIncludingUnaccretedLiabilityForFinalPaymentFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt instrument carrying amount including unaccreted liability for final payment fee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eq_DebtInstrumentCarryingAmountIncludingUnaccretedLiabilityForFinalPaymentFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eq_DebtInstrumentCarryingAmountIncludingUnaccretedLiabilityForFinalPaymentFeeMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt instrument carrying amount including unaccreted liability for final payment fee maturities repayments of principal in next twelve months.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eq_DebtInstrumentCarryingAmountIncludingUnaccretedLiabilityForFinalPaymentFeeMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eq_DebtInstrumentCarryingAmountIncludingUnaccretedLiabilityForFinalPaymentFeeMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt instrument carrying amount including unaccreted liability for final payment fee maturities repayments of principal in year two.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eq_DebtInstrumentCarryingAmountIncludingUnaccretedLiabilityForFinalPaymentFeeMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eq_UnaccretedLiabilityForFinalPaymentFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Unaccreted liability for final payment fee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eq_UnaccretedLiabilityForFinalPaymentFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140407475087344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Additional Information (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1">70 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Feb. 03, 2021 </div>
<div>USD ($) </div>
<div>Investor </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 27, 2020 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Oct. 31, 2018 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34,414,149<span></span>
</td>
<td class="nump">29,455,668<span></span>
</td>
<td class="nump">34,414,149<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Number of shares available for issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,178,936<span></span>
</td>
<td class="nump">6,549,848<span></span>
</td>
<td class="nump">8,178,936<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Aggregate intrinsic value of stock options exercised | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from exercise of stock options | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">891,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1', window );">Fair value of stock options vested | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,500,000<span></span>
</td>
<td class="nump">$ 3,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted-average grant-date fair value of options granted | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.49<span></span>
</td>
<td class="nump">$ 3.94<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Unrecognized compensation expense related to unvested stock options | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,700,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Expected recognition period of unrecognized compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 7 months 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eq_DividendsPaidOnCommonStock', window );">Dividends paid | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EquityUnitPurchaseAgreementsMember', window );">Equity Unit Purchase Agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eq_GrossProceedsFromIssuanceOfCommonStock', window );">Gross proceeds from issuance of common stock | $</a></td>
<td class="nump">$ 30,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock | $</a></td>
<td class="nump">$ 29,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eq_NumberOfInstitutionalInvestors', window );">Number of institutional investors | Investor</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Shares upon exercise of warrants</a></td>
<td class="nump">1,285,713<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=eq_PurchaseAgreementMember', window );">Purchase Agreement | Lincoln Park Capital Fund, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eq_PurchaseAgreementExpirationDate', window );">Purchase agreement expiration date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">May  01,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock | Equity Unit Purchase Agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock, Shares</a></td>
<td class="nump">4,285,710<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock | Purchase Agreement | Lincoln Park Capital Fund, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65,374<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Stock issuance costs | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eq_EstimatedMaximumAmountOfCommonStockIssuable', window );">Estimated maximum amount of common stock issuable | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eq_TermOfPurchaseAgreement', window );">Term of purchase agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">36 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eq_FairMarketValueOfCommitmentShares', window );">Fair market value of commitment shares | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember', window );">Common Stock Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Number of shares available for issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,366,141<span></span>
</td>
<td class="nump">1,366,141<span></span>
</td>
<td class="nump">1,366,141<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember', window );">Common Stock Warrants | Equity Unit Purchase Agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Sale of stock, price per share | $ / shares</a></td>
<td class="nump">$ 25.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eq_GrossProceedsFromIssuanceOfCommonStock', window );">Gross proceeds from issuance of common stock | $</a></td>
<td class="nump">$ 25,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrants exercisable, per share exercise price | $ / shares</a></td>
<td class="nump">$ 14.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=eq_TwoThousandEighteenEquityIncentivePlanMember', window );">2018 Equity Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eq_EquityIncentivePlanDescription', window );">Equity incentive plan description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The number of shares of common stock reserved for issuance under the 2018 Plan will automatically increase on January 1 of each calendar year through January 1, 2028, in an amount equal to 5.0% of the total number of shares of the Company&#8217;s capital stock outstanding on the last day of the calendar month before the date of each automatic increase, or a lesser number of shares determined by the Board.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=eq_TwoThousandEighteenEquityIncentivePlanMember', window );">2018 Equity Incentive Plan | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Number of shares available for issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">784,331<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">784,331<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=eq_TwoThousandEighteenEquityIncentivePlanMember', window );">2018 Equity Incentive Plan | Common Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eq_MinimumOptionsExercisePriceAsPercentageOfFairMarketValueOfCommonStock', window );">Minimum options exercise price as percentage of fair market value of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eq_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRemainingVestingPeriod', window );">Remaining vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=eq_TwoThousandEighteenEquityIncentivePlanMember', window );">2018 Equity Incentive Plan | Common Stock Options | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Award expiration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=eq_TwoThousandEighteenEquityIncentivePlanMember', window );">2018 Equity Incentive Plan | Tranche One | Common Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Vesting percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=eq_TwoThousandSeventeenEquityIncentivePlanMember', window );">2017 Equity Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Unvested shares issued under early exercise which are subject to repurchase</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43,135<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eq_UnvestedStockLiability', window );">Unvested stock liability | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 53,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=eq_EmployeeStockPurchasePlanMember', window );">2018 Employee Stock Purchase Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of shares authorized for issuance under purchase rights granted to employees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">343,275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eq_EmployeeStockPurchasePlanDescription', window );">Employee stock purchase plan description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Equity Stock Purchase Plan (ESPP) whereby eligible employees may elect to withhold up to 15% of their earnings to purchase shares of the Company&#8217;s common stock at a price per share equal to the lower of (i) 85% of the fair market value of a share of the Company&#8217;s common stock on the first date of an offering or (ii) 85% of the fair market value of a share of the Company&#8217;s common stock on the date of the purchase right (purchase right). Initially, 343,275 shares of the Company&#8217;s common stock were approved for issuance under the ESPP pursuant to purchase rights granted to the Company&#8217;s employees or to employees of any of the Company&#8217;s designated affiliates. The number of shares of the Company&#8217;s common stock reserved for issuance will automatically increase on January 1 of each calendar year through January 1, 2028, by the lesser of (1) 1.0% of the total number of shares of the Company&#8217;s common stock outstanding on the last day of the calendar month before the date of the automatic increase, and (2) 343,275 shares; provided that before the date of any such increase, the Board may determine that such increase will be less than the amount set forth in clauses (1) and (2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eq_WithholdPercentageOfEmployeesEarningsToPurchaseSharesOfCommonStock', window );">Withhold Percentage of employees earnings to purchase shares of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eq_MinimumStockPricePerShareAsPercentageOfFairMarketValueOfCommonStock', window );">Minimum stock price per share as percentage of fair market value of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod', window );">Number of shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">138,251<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">307,417<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized', window );">Number of shares available for future issuance under employee stock purchase plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">925,963<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=eq_EmployeeStockPurchasePlanMember', window );">2018 Employee Stock Purchase Plan | Purchase Right</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eq_MinimumStockPricePerShareAsPercentageOfFairMarketValueOfCommonStock', window );">Minimum stock price per share as percentage of fair market value of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eq_DividendsPaidOnCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Dividends paid on common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eq_DividendsPaidOnCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eq_EmployeeStockPurchasePlanDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of the plan, including equity stock purchase plan which under the employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eq_EmployeeStockPurchasePlanDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eq_EquityIncentivePlanDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity incentive plan description.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eq_EquityIncentivePlanDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eq_EstimatedMaximumAmountOfCommonStockIssuable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Estimated maximum amount of common stock issuable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eq_EstimatedMaximumAmountOfCommonStockIssuable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eq_FairMarketValueOfCommitmentShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair market value of commitment shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eq_FairMarketValueOfCommitmentShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eq_GrossProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross proceeds from issuance of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eq_GrossProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eq_MinimumOptionsExercisePriceAsPercentageOfFairMarketValueOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Minimum options exercise price, expressed as percentage of fair market value of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eq_MinimumOptionsExercisePriceAsPercentageOfFairMarketValueOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eq_MinimumStockPricePerShareAsPercentageOfFairMarketValueOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Minimum stock price per share as percentage of fair market value of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eq_MinimumStockPricePerShareAsPercentageOfFairMarketValueOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eq_NumberOfInstitutionalInvestors">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Institutional Investors</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eq_NumberOfInstitutionalInvestors</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eq_PurchaseAgreementExpirationDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Purchase agreement expiration date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eq_PurchaseAgreementExpirationDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eq_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRemainingVestingPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Remaining vesting period of share based compensation arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eq_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRemainingVestingPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eq_TermOfPurchaseAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of purchase agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eq_TermOfPurchaseAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eq_UnvestedStockLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Unvested stock liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eq_UnvestedStockLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eq_WithholdPercentageOfEmployeesEarningsToPurchaseSharesOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Withhold Percentage of employees earnings to purchase shares of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eq_WithholdPercentageOfEmployeesEarningsToPurchaseSharesOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of additional shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of vesting of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EquityUnitPurchaseAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EquityUnitPurchaseAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=eq_PurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=eq_PurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=eq_LincolnParkCapitalFundLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=eq_LincolnParkCapitalFundLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=eq_TwoThousandEighteenEquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=eq_TwoThousandEighteenEquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=eq_TwoThousandSeventeenEquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=eq_TwoThousandSeventeenEquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=eq_EmployeeStockPurchasePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=eq_EmployeeStockPurchasePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=eq_PurchaseRightMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=eq_PurchaseRightMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140407475026112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Summary of Stock Option Activity (Details) - 2018 Equity Incentive Plan<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of Outstanding Options, Beginning Balance | shares</a></td>
<td class="nump">3,947,025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of Outstanding Options, Granted | shares</a></td>
<td class="nump">2,169,800<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Number of Outstanding Options, Exercised | shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Number of Outstanding Options, Forfeitures and Cancellations | shares</a></td>
<td class="num">(1,014,324)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of Outstanding Options, Ending Balance | shares</a></td>
<td class="nump">5,102,501<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Number of Outstanding Options, Exercisable | shares</a></td>
<td class="nump">2,483,222<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted- Average Exercise Price Per Share, Beginning Balance | $ / shares</a></td>
<td class="nump">$ 4.58<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Weighted- Average Exercise Price Per Share, Granted | $ / shares</a></td>
<td class="nump">3.63<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercise price of options per share | $ / shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Weighted- Average Exercise Price Per Share, Forfeitures and Cancellations | $ / shares</a></td>
<td class="nump">4.90<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted- Average Exercise Price Per Share, Ending Balance | $ / shares</a></td>
<td class="nump">4.11<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Weighted- Average Exercise Price Per Share, Exercisable | $ / shares</a></td>
<td class="nump">$ 4.23<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Contractual Term, Options Outstanding</a></td>
<td class="text">7 years 8 months 15 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Weighted Average Remaining Contractual Term, Options Exercisable</a></td>
<td class="text">6 years 9 months<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate Intrinsic Value, Options Outstanding | $</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Aggregate Intrinsic Value, Options Exercisable | $</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=eq_TwoThousandEighteenEquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=eq_TwoThousandEighteenEquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140407554027968">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Stockholders' Equity - Summary of Stock Option Activity (Parenthetical) (Details)<br></strong></div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_EmployeeStockMember', window );">Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Closing stock price per share</a></td>
<td class="nump">$ 1.06<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140407548974528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Summary of Total Non-cash Stock-based Compensation Expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total non-cash stock-based compensation expense</a></td>
<td class="nump">$ 4,841<span></span>
</td>
<td class="nump">$ 4,410<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and Development Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total non-cash stock-based compensation expense</a></td>
<td class="nump">1,799<span></span>
</td>
<td class="nump">1,976<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and Administrative Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total non-cash stock-based compensation expense</a></td>
<td class="nump">$ 3,042<span></span>
</td>
<td class="nump">$ 2,434<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140407549511072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Summary of Weighted-Average Assumptions Used to Determine Fair Value of Stock Option Grants (Details)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">1.93%<span></span>
</td>
<td class="nump">0.68%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">81.60%<span></span>
</td>
<td class="nump">88.55%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (in years)</a></td>
<td class="text">5 years 10 months 2 days<span></span>
</td>
<td class="text">6 years 3 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140407552969616">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Stockholders' Equity - Summary of Common Stock Reserved for Future Issuance (Details) - shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Total common stock reserved for future issuance</a></td>
<td class="nump">8,178,936<span></span>
</td>
<td class="nump">6,549,848<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=eq_StockOptionsIssuedAndOutstandingMember', window );">Stock Options Issued and Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Total common stock reserved for future issuance</a></td>
<td class="nump">5,102,501<span></span>
</td>
<td class="nump">3,947,025<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember', window );">Warrants for Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Total common stock reserved for future issuance</a></td>
<td class="nump">1,366,141<span></span>
</td>
<td class="nump">1,366,141<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=eq_AwardsAvailableUnder2018PlanMember', window );">Awards Available Under 2018 Equity Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Total common stock reserved for future issuance</a></td>
<td class="nump">784,331<span></span>
</td>
<td class="nump">467,024<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=eq_EmployeeStockPurchasePlanMember', window );">Employee Stock Purchase Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Total common stock reserved for future issuance</a></td>
<td class="nump">925,963<span></span>
</td>
<td class="nump">769,658<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=eq_StockOptionsIssuedAndOutstandingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=eq_StockOptionsIssuedAndOutstandingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=eq_AwardsAvailableUnder2018PlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=eq_AwardsAvailableUnder2018PlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=eq_EmployeeStockPurchasePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=eq_EmployeeStockPurchasePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140407551143856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies - Additional Information (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eq_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments and Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationSettlementExpense', window );">Litigation expense</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eq_CommitmentsAndContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eq_CommitmentsAndContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140407549528848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Summary of Components of Loss Before Income Tax Provision (Benefit) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic', window );">U.S.</a></td>
<td class="num">$ (60,403)<span></span>
</td>
<td class="num">$ (37,705)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign', window );">Foreign</a></td>
<td class="num">(2,025)<span></span>
</td>
<td class="num">(1,347)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss before income tax provision (benefit)</a></td>
<td class="num">$ (62,428)<span></span>
</td>
<td class="num">$ (39,052)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140407545140384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Additional Information (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardLineItems', window );"><strong>Tax Credit Carryforward [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Current income tax expense (benefit)</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income tax expense (benefit)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Deferred tax assets, Valuation allowance</a></td>
<td class="nump">46,317,000<span></span>
</td>
<td class="nump">25,215,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount', window );">Increase in valuation allowance</a></td>
<td class="nump">$ 21,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eq_OperatingLossCarryforwardsExpirationYear', window );">Federal and state net operating loss carry forwards, Expiration year</a></td>
<td class="text">2037 <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Federal net operating loss carryover</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 112,700,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLimitationsOnUse', window );">Operating loss carryforwards, Limitation of use</a></td>
<td class="text">Federal net operating losses generated after December 31, 2017 carryover indefinitely but the deductibility of such federal net operating losses is limited to 80% of taxable income.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards', window );">Tax credit carry forwards</a></td>
<td class="nump">$ 9,289,000<span></span>
</td>
<td class="nump">$ 3,940,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eq_TaxCreditCarryforwardExpirationYear', window );">Tax credit carryforward, Expiration year</a></td>
<td class="text">2037<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eq_CumulativeChangeInOwnershipPercentage', window );">Cumulative change in ownership percentage</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eq_CumulativeChangeInOwnershipPeriod', window );">Cumulative change in ownership period</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eq_ResearchAndExperimentalExpendituresCapitalizedCostAmortizationPeriod', window );">Research and experimental expenditures capitalized cost amortization period</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardLineItems', window );"><strong>Tax Credit Carryforward [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eq_OperatingLossCarryforwardsLimitationRateOnTaxableIncome', window );">Operating loss carryforwards limitation rate on taxable income</a></td>
<td class="nump">80.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Federal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardLineItems', window );"><strong>Tax Credit Carryforward [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic', window );">Federal tax loss carry forwards</a></td>
<td class="nump">$ 116,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards', window );">Tax credit carry forwards</a></td>
<td class="nump">$ 7,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember', window );">Foreign</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardLineItems', window );"><strong>Tax Credit Carryforward [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eq_ResearchAndExperimentalExpendituresCapitalizedCostAmortizationPeriod', window );">Research and experimental expenditures capitalized cost amortization period</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardLineItems', window );"><strong>Tax Credit Carryforward [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards', window );">Tax credit carry forwards</a></td>
<td class="nump">$ 2,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_CA', window );">California</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardLineItems', window );"><strong>Tax Credit Carryforward [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal', window );">Foreign tax loss carry forwards</a></td>
<td class="nump">90,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_AU', window );">Australia</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardLineItems', window );"><strong>Tax Credit Carryforward [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Federal net operating loss carryover</a></td>
<td class="nump">$ 2,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eq_CumulativeChangeInOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cumulative change in ownership percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eq_CumulativeChangeInOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eq_CumulativeChangeInOwnershipPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cumulative change in ownership period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eq_CumulativeChangeInOwnershipPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eq_OperatingLossCarryforwardsExpirationYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating loss carryforwards expiration year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eq_OperatingLossCarryforwardsExpirationYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eq_OperatingLossCarryforwardsLimitationRateOnTaxableIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating loss carryforwards limitation rate on taxable income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eq_OperatingLossCarryforwardsLimitationRateOnTaxableIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eq_ResearchAndExperimentalExpendituresCapitalizedCostAmortizationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Research and experimental expenditures capitalized cost amortization period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eq_ResearchAndExperimentalExpendituresCapitalizedCostAmortizationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eq_TaxCreditCarryforwardExpirationYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tax credit carryforward expiration year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eq_TaxCreditCarryforwardExpirationYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible domestic operating loss carryforwards. Excludes state and local operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible state and local operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwardsLimitationsOnUse">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A description of the limitations on the use of all operating loss carryforwards available to reduce future taxable income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwardsLimitationsOnUse</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_CA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_CA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_AU">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_AU</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140407475009472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Reconciliation of Expected Statutory Federal Income Tax Provision to Actual Income Tax Provision (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract', window );"><strong>Income Tax Expense (Benefit), Effective Income Tax Rate Reconciliation, Amount [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate', window );">Income taxes at statutory rates</a></td>
<td class="num">$ (13,110)<span></span>
</td>
<td class="num">$ (8,201)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost', window );">Stock-based compensation</a></td>
<td class="nump">533<span></span>
</td>
<td class="nump">451<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eq_IncomeTaxReconciliationPermanentItems', window );">Permanent items</a></td>
<td class="nump">128<span></span>
</td>
<td class="nump">31<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eq_IncomeTaxReconciliationFederalResearchAndOrphanDrugCredits', window );">Federal research and orphan drug credits</a></td>
<td class="num">(1,152)<span></span>
</td>
<td class="num">(1,713)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential', window );">Foreign rate differential</a></td>
<td class="nump">425<span></span>
</td>
<td class="nump">72<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eq_EffectiveIncomeTaxRateReconciliationTransactionCostsAmount', window );">Transaction costs</a></td>
<td class="nump">89<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment', window );">Acquired in-process research and development</a></td>
<td class="nump">4,840<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Change in federal valuation allowance</a></td>
<td class="nump">8,247<span></span>
</td>
<td class="nump">9,360<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense (benefit)</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eq_EffectiveIncomeTaxRateReconciliationTransactionCostsAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Transaction Costs, Amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eq_EffectiveIncomeTaxRateReconciliationTransactionCostsAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eq_IncomeTaxReconciliationFederalResearchAndOrphanDrugCredits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income tax reconciliation federal research and orphan drug credits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eq_IncomeTaxReconciliationFederalResearchAndOrphanDrugCredits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eq_IncomeTaxReconciliationPermanentItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income tax expense (benefit) reconciliation permanent items.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eq_IncomeTaxReconciliationPermanentItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible research and development expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for award under share-based payment arrangement. Includes, but is not limited to, expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140407551424224">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes - Summary of Net Deferred Tax Assets and Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNetAbstract', window );"><strong>Deferred tax assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss carryforward</a></td>
<td class="nump">$ 28,222<span></span>
</td>
<td class="nump">$ 19,344<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards', window );">Credits</a></td>
<td class="nump">9,289<span></span>
</td>
<td class="nump">3,940<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_eq_DeferredTaxAssetsCapitalizedResearchExpenditures', window );">Capitalized research expenditures</a></td>
<td class="nump">7,086<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation', window );">Equity compensation</a></td>
<td class="nump">1,829<span></span>
</td>
<td class="nump">1,134<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOther', window );">Other</a></td>
<td class="nump">1,196<span></span>
</td>
<td class="nump">1,184<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Total deferred tax assets</a></td>
<td class="nump">47,622<span></span>
</td>
<td class="nump">25,602<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">(46,317)<span></span>
</td>
<td class="num">(25,215)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Total deferred tax assets, net of allowance</a></td>
<td class="nump">1,305<span></span>
</td>
<td class="nump">387<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesAbstract', window );"><strong>Deferred tax liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesLeasingArrangements', window );">Operating lease right-of-use asset</a></td>
<td class="num">(284)<span></span>
</td>
<td class="num">(346)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesTaxDeferredIncome', window );">Deferred revenue</a></td>
<td class="num">(945)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesOther', window );">Other</a></td>
<td class="num">(76)<span></span>
</td>
<td class="num">(41)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">Total deferred tax liabilities</a></td>
<td class="num">(1,305)<span></span>
</td>
<td class="num">(387)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Net deferred taxes</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_eq_DeferredTaxAssetsCapitalizedResearchExpenditures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets Capitalized Research Expenditures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">eq_DeferredTaxAssetsCapitalizedResearchExpenditures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>eq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(15)(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from employee compensation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesLeasingArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from leasing arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesLeasingArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesTaxDeferredIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from tax deferred revenue or income classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesTaxDeferredIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140407475875808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Summary of Reconciliation of Unrecognized Tax Benefits (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefits &#8211; beginning</a></td>
<td class="nump">$ 5,487<span></span>
</td>
<td class="nump">$ 2,667<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions', window );">Gross increases &#8211; tax positions in prior period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,266<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions', window );">Gross increase &#8211; current-period tax positions</a></td>
<td class="nump">392<span></span>
</td>
<td class="nump">554<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefits &#8211; ending</a></td>
<td class="nump">$ 5,879<span></span>
</td>
<td class="nump">$ 5,487<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140407552401648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Retirement Plan - Additional Information (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount', window );">Employer's matching contributions to 401(k) plan</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of discretionary contributions made by an employer to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140407554032144">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Subsequent Events - Additional Information (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Mar. 10, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | Silicon Valley Bank</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsHeldInTrust', window );">Assets Held-in-trust with Silicon Valley Bank</a></td>
<td class="nump">$ 8.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsHeldInTrust">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of cash and securities held by third party trustees pursuant to terms of debt instruments or other agreements as of the date of each statement of financial position presented, which can be used by the trustee only to pay the noncurrent portion of specified obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsHeldInTrust</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=eq_SiliconValleyBankMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=eq_SiliconValleyBankMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>eq-20221231_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2022"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:eq="http://equilliumbio.com/20221231"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2022"
  xmlns:stpr="http://xbrl.sec.gov/stpr/2022"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="eq-20221231.xsd" xlink:type="simple"/>
    <context id="C_53fe6a42-e9c0-41f9-a76d-589ed71e0cd6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">eq:BionizTherapeuticsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-02-14</startDate>
            <endDate>2022-02-14</endDate>
        </period>
    </context>
    <context id="C_4ba266ad-8527-41b5-81de-63143638b62c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">eq:TwoThousandEighteenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_c004a059-d1b3-45bc-90d2-29b2939452f6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_c0403c73-e303-4bd7-ae36-cf044f363dc1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">eq:BionizTherapeuticsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">eq:EighteenMonthsAfterClosingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-02-14</startDate>
            <endDate>2022-02-14</endDate>
        </period>
    </context>
    <context id="C_1adba1d3-86e2-48ca-8036-09ebd512337c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">eq:USTreasurySecuritiesMaturingBetweenOneAndFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0dabeff1-f05f-4737-8f45-b0cb38473eb4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">eq:LoanAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-05-31</endDate>
        </period>
    </context>
    <context id="C_0b4db976-5656-4c9e-a811-53098826741a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
        </entity>
        <period>
            <startDate>2019-09-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="C_cba59bb2-f211-4a75-beff-6ddac7dfa0b7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_257b0705-b56f-4bd5-86f9-1add29602d4d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">eq:OnoPharmaceuticalCoLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eq:AssetPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-05</instant>
        </period>
    </context>
    <context id="C_e4e76746-9176-4a76-9703-056a9ff95868">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_07d00b46-0b94-46d4-a9c0-90bd6e6336f4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_d3ce0459-c113-4153-9f4d-e1ca48da2c0b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EquityUnitPurchaseAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-03</startDate>
            <endDate>2021-02-03</endDate>
        </period>
    </context>
    <context id="C_ef6b21dc-276b-4e2a-a0f4-7de1ea76111b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">eq:TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="C_b41b6a74-0d46-45fe-8820-d94fa8d877f1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_944e0e4f-c4c3-48bc-98c4-915a5ff4bfa0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="C_72940a8c-6662-4785-be1e-cde22f293e80">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">eq:PurchaseRightMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">eq:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-10-01</startDate>
            <endDate>2018-10-31</endDate>
        </period>
    </context>
    <context id="C_149d869a-5e0a-4913-9abe-a27afa766de4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_2c8bb5f0-73a3-432f-b12e-cb35048d1783">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EquityUnitPurchaseAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-03</instant>
        </period>
    </context>
    <context id="C_7e0f633d-433f-45b3-b81e-21ab345a28bd">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">eq:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-03-16</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_9c160bc4-2896-4f45-abda-cba01dca2910">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">eq:TwoThousandEighteenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_63b408ff-0cee-4c70-85c3-c4f148eb4da9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="C_b6af3c69-cf78-4826-98db-46603272fd07">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">eq:OnoPharmaceuticalCoLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eq:AssetPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-16</instant>
        </period>
    </context>
    <context id="C_a14519ee-c0f5-4735-a3a2-5d78ee96686f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">eq:TwoThousandEighteenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_68cc81fd-50c1-4591-b9ee-381a6c7b9fe5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">eq:USTreasurySecuritiesMaturingBetweenOneAndFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_6d2cc007-04de-46ef-a689-02aac4462b5a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_2aa60dea-0a24-4f41-b6e1-70e203413f85">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_4640a459-b05e-473c-894a-3d5c68449919">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">eq:TwoThousandEighteenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_6658e49b-c37e-401c-873e-60a833ca00d9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_25c4ee43-e391-45e8-bf6c-c2ae9bfee741">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">eq:BioconMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-05-01</startDate>
            <endDate>2019-11-30</endDate>
        </period>
    </context>
    <context id="C_842e44ed-200a-4457-8510-53e0331535d8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">eq:OfficeSpaceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_be912e1f-de6a-4c8b-a190-56fa543de795">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">eq:CertificatesOfDepositMaturingInOneYearOrLessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_83d4ef1f-863c-4921-aa0e-cb290fba239d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_ad7f8586-d120-48a1-a08d-4f84857dfb6d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">eq:OnoPharmaceuticalCoLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eq:AssetPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_0a2a2736-708e-4c3e-8299-f827f8de0192">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_dd41c6fa-2d24-44bd-8378-e697929d4bb8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">eq:LaboratorySpaceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_4c0fe461-a7c8-4a97-8e27-000bcb673943">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">eq:OnoPharmaceuticalCoLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eq:AssetPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_251e65bb-85a5-4df7-a709-d3e4c8e42ad6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">eq:LincolnParkCapitalFundLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eq:PurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_9cad8da7-5192-43d1-ae8d-b306505ebc15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="C_e6610ebe-288f-4417-8098-af8696e03c7e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_dc409b2a-6dec-4757-a385-691c05150979">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_ea3c06e5-f9a7-4f24-ba11-8679304c0196">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">eq:LincolnParkCapitalFundLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eq:PurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_977951f9-d851-4284-8eb0-cbc7afea37a5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_f789eb1e-5a5d-41b1-8bb7-3d3ed1258e7d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_677e006f-7dec-4e8f-81db-464e67389b27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_e0e5cffb-5c83-464c-b236-5ae5c1b3c851">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_9f870e6c-ab80-49c3-9591-da8f10d045b8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">eq:BionizTherapeuticsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-02-14</instant>
        </period>
    </context>
    <context id="C_c886a389-5f87-408e-8648-17d8507a401b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_900c0b60-4130-48e3-ad64-738fc1374bc7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_90508498-eb7a-4af4-a10b-9b578a529f24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">eq:TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="C_5678bab9-8bd4-4b16-94e3-655278d75cd5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eq:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_8d880863-715e-4b80-9a73-33be4ffa0166">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">eq:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_cf62e2c5-8574-4b02-a168-a9fa58f93586">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">eq:OnoPharmaceuticalCoLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">eq:UpfrontPaymentAmortizationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eq:AssetPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_71653c3b-caef-4b07-8b00-6e7024629fb3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">eq:BionizTherapeuticsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_3170d519-6bfe-4d96-886d-1344675502df">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">eq:LoanAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_1f42c1eb-d268-41b0-9bcf-d37f47a8c53a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_b46e12c4-af83-4e15-baf8-0903ab9bd6b5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_70c8e717-7ae0-400b-a2e5-1384948ea4b2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">eq:BionizTherapeuticsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_be335ae5-27dc-40a0-a672-67f87605ecfa">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_2573431b-071f-404a-987e-c3e834333417">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_b15585d5-5e76-4fec-adb1-0f3694e76b0d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_8a38518a-9c62-4c14-a61d-b505eb2f5458">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">eq:BionizTherapeuticsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_9520a266-f74a-45cf-96ed-ba178f032640">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eq:StockOptionsIssuedAndOutstandingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_c23792dc-2be3-45bf-8cdc-a38a13c8ab6a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">eq:OnoPharmaceuticalCoLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eq:AssetPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_c2f2d003-05db-4149-bb1f-60dc7a7a84c7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:PrimeRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="C_f14aee5f-c103-44b8-acee-a339e014b6d3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
        </entity>
        <period>
            <instant>2023-03-16</instant>
        </period>
    </context>
    <context id="C_28f69ea9-8c53-458e-9ebe-8b9949dd4224">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_b6ed3cd2-aa70-4e39-9223-49223b495228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_b4ad71ba-3e8b-4d50-87b0-1a81a509c6eb">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">eq:USTreasurySecuritiesMaturingInOneYearOrLessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_da6b0f69-4d60-4727-93e2-76b6699fc7cd">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">eq:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-10-31</instant>
        </period>
    </context>
    <context id="C_8a5bef62-cef2-4949-81e3-78ec03bd91d4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">eq:FollowOnOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_69239b5b-2176-4437-a3e8-98a7b914e359">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201613Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_ffafa14c-b663-42ee-861b-6f858b3f4acf">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">eq:BionizTherapeuticsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-02-14</startDate>
            <endDate>2022-02-14</endDate>
        </period>
    </context>
    <context id="C_157bf7c1-6ef7-43ab-b719-f85e3a11f1d5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_292ee269-376c-4392-9f5a-40817da138a6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">eq:BionizTherapeuticsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">eq:ContingentConsiderationForAchievementOfCommercializationEventsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-02-14</instant>
        </period>
    </context>
    <context id="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_73660a62-57e2-407a-a1a0-1c6619629881">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_677cb0dd-b0f9-4917-b6b9-3a7ad67b6397">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">eq:LoanAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-23</instant>
        </period>
    </context>
    <context id="C_565ac908-720e-4507-8d96-ab25dfe4fc94">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_de394fb6-0ca8-4cc8-866d-6ad6f457d88c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">eq:OnoPharmaceuticalCoLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">eq:ResearchAndDevelopmentServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eq:AssetPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_abcb788b-9185-48aa-bc09-238334507b89">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">eq:OnoPharmaceuticalCoLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eq:AssetPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-16</instant>
        </period>
    </context>
    <context id="C_3c1013be-6aec-4534-8322-81766349f268">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_1398193c-be70-4924-b7ab-8d837ee248c4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">eq:SiliconValleyBankMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-10</instant>
        </period>
    </context>
    <context id="C_0d524201-b596-46e6-95bc-8b3b552ccc88">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">eq:TwoThousandSeventeenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_6c924f5d-0e36-4f69-96ed-b71e41b42d0f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">eq:BioconMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-05-01</startDate>
            <endDate>2017-05-31</endDate>
        </period>
    </context>
    <context id="C_4eb35088-1593-4e17-8c6a-8c9e0bdad77b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EquityUnitPurchaseAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-03</startDate>
            <endDate>2021-02-03</endDate>
        </period>
    </context>
    <context id="C_f31a63db-28e5-4d6c-8641-5e09fcfbb9ac">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_acb33667-c8a3-4249-a4a8-738294c5d493">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="C_07b42072-8725-4287-82d7-ff7786912150">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_6c6eb418-4e31-405d-80e2-4eeaa0ed0949">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_1498053c-86a8-4e41-8116-8cb7e9c5b74c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_5c7a06ba-06bd-4791-bb56-70c464bf5ade">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_b03e82a1-d7f8-42dc-a88d-a8edb9f55f3c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_4facbb57-718b-4710-bf34-290be7c869f0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">eq:TwoThousandSeventeenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_9b5e1bd0-1a40-47d8-9914-690c782ec9e9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">eq:USTreasurySecuritiesMaturingInOneYearOrLessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_ea16d6a3-2485-40dc-a25d-8c4cc56dd7fd">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">eq:BionizTherapeuticsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">eq:ContingentConsiderationForAchievementOfRegulatoryEventsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-02-14</instant>
        </period>
    </context>
    <context id="C_266429a4-9ee0-4360-bdef-2bb916cfaeee">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_16cc5d93-7f4c-4d9b-a05e-409bae73f77d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_211f9a22-9355-4cd5-ae5c-f45e20a3dcdc">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_1b636714-e678-4bb2-be3e-3c64ae434607">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">eq:LincolnParkCapitalFundLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">eq:PurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-27</startDate>
            <endDate>2020-03-27</endDate>
        </period>
    </context>
    <context id="C_f45561af-aa60-4d08-8038-0001fb9d29dc">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_09b9a242-1fa2-404a-b6a9-1fc05149e6a4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">eq:USTreasurySecuritiesMaturingInOneYearOrLessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_1074585e-0f9e-4a71-aac7-7580a74d418f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:AU</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_e6cf51a2-311a-4401-b240-c4af424355e4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_2ad7083d-d4d8-4d36-9fad-554b54c6601f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_8f6e6b13-aff0-4ec5-80eb-ec47346f2d4d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">eq:CertificatesOfDepositMaturingInOneYearOrLessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_af77d479-58a1-4eb8-be05-a05f0b6de156">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_593cac69-ae06-423d-93b0-db39a502796a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_22c07448-b3c4-4d7d-8903-20b3a5bbb42d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">eq:USTreasurySecuritiesMaturingBetweenOneAndFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0a414f75-a619-4136-9add-c3356d8e1816">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_58ee8b88-7fcf-463a-aada-7b6967a5d010">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">eq:TwoThousandEighteenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_ff05e412-5d32-4d51-9c1b-fcbe95cea7f7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_c10ac679-9a2b-4cbc-b11a-d6a2b12c4221">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EquityUnitPurchaseAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-03</instant>
        </period>
    </context>
    <context id="C_503c038a-2434-4c52-8c73-7bfdbfb92be8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_32d659e3-aa51-4be5-b51f-bb1491642234">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eq:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_916e47cd-8d5b-46a6-ada5-c452d339e627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_118d4267-0758-4b9a-ac2a-e75bcfe13d76">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:AustralianTaxationOfficeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">eq:AustralianResearchAndDevelopmentTaxIncentiveProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_b6dbee35-e2f1-45ca-95ca-0d1198cb8c23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_b79b178e-6c81-4a59-9acf-58713aad69ee">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eq:AwardsAvailableUnder2018PlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_7b79d852-2622-42ae-b02e-a2784258be60">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">eq:TwoThousandEighteenEquityIncentivePlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_6b91f489-4f82-44f0-b32f-1000032af149">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">eq:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-10-01</startDate>
            <endDate>2018-10-31</endDate>
        </period>
    </context>
    <context id="C_88bc9f46-dcc0-4d03-aa1a-d56bf1d35be2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_bff86cb7-8d58-45e7-9e93-1982cad8799f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EquityUnitPurchaseAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-03</startDate>
            <endDate>2021-02-03</endDate>
        </period>
    </context>
    <context id="C_7a916079-62c8-4cfb-b147-d4a52b2078f5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_c28101d2-ae40-418c-83d4-9715bbaa72e3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">eq:LoanAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-23</instant>
        </period>
    </context>
    <context id="C_ce9aa43c-a54c-413f-ab08-401b60dd98cf">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_6f4556dd-c18e-4dc1-9c4a-842fa90452f5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">eq:USTreasurySecuritiesMaturingInOneYearOrLessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_74785e69-c479-4de9-938d-9e775d1f539a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">eq:LoanAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_d6cbfdc9-1278-4b59-8f64-1c4df657d268">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_9d1df5ec-262f-43c2-9feb-7e49b25fe95f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_1a97b4e1-6653-4a2c-a233-548bf388b221">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">eq:TwoThousandEighteenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_0b2819ec-57f5-46d8-b912-9734d9b101d1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_c197641e-f183-4f80-9bfd-23288c4df7df">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eq:StockOptionsIssuedAndOutstandingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_fae7480f-6d94-4ea1-b4e4-5cde09bbcd56">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_24991024-50f4-435b-ba4f-adcad994e80c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_f54cdfd1-dd2b-4d74-aa9b-16e8ecf08b91">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_48927eeb-5e48-4e18-bce6-146239c106d3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">eq:AwardsAvailableUnder2018PlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <unit id="U_Investor">
        <measure>eq:Investor</measure>
    </unit>
    <unit id="U_JPY">
        <measure>iso4217:JPY</measure>
    </unit>
    <unit id="U_pure">
        <measure>pure</measure>
    </unit>
    <unit id="U_shares">
        <measure>shares</measure>
    </unit>
    <unit id="U_Installment">
        <measure>eq:Installment</measure>
    </unit>
    <unit id="U_USDollarShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="U_USD">
        <measure>iso4217:USD</measure>
    </unit>
    <us-gaap:CommitmentsAndContingencies
      contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94"
      id="F_7b20e3c0-5f9d-4152-8056-9265a122f74d"
      unitRef="U_USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="C_1a97b4e1-6653-4a2c-a233-548bf388b221"
      id="F_e9cd9fc4-b2d3-4e1c-814b-17b62754d416"
      unitRef="U_shares"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192"
      id="F_67670f1b-d32e-411d-94c3-bb52f2db6f60"
      unitRef="U_USD"
      xsi:nil="true"/>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="C_6658e49b-c37e-401c-873e-60a833ca00d9"
      id="F_25b946aa-ecb7-4d36-9827-13132f6bd5be">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <dei:AmendmentFlag
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      id="F_2e4945d0-b4a5-4e03-8b7c-8e13fa8a2580">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      id="F_fe087972-da05-45cf-9bbf-511a325aec83">0001746466</dei:EntityCentralIndexKey>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="C_1a97b4e1-6653-4a2c-a233-548bf388b221"
      id="F_0fa15c8b-e902-4287-b1e7-c4c493e1c465"
      unitRef="U_USDollarShare"
      xsi:nil="true"/>
    <dei:DocumentFiscalPeriodFocus
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      id="F_ce0f5a29-0bcc-4dd4-b7f6-18f9deaf9632">FY</dei:DocumentFiscalPeriodFocus>
    <dei:DocumentType
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      id="F_03e456fe-3401-4774-a22e-5089a2a9ad3b">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      id="F_17e83137-4a3d-4168-b627-3698fa5e6ffd">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      id="F_d15a0136-d0d7-4a1f-82cd-216837a0e7b3">2022-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      id="F_2ff2cb16-b670-4a58-8dd5-fdab43040bd0">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      id="F_eaeff4e0-63ec-4f23-b178-78262c781a24">2022</dei:DocumentFiscalYearFocus>
    <dei:DocumentTransitionReport
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      id="F_5292321d-0a65-434f-879e-7ace341cf9d2">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      id="F_32059148-bff3-40f1-9bf8-ee57a7c56c96">001-38692</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      id="F_5b25706d-ebae-4272-9014-d1dad26e1a59">EQUILLIUM, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      id="F_45e508fb-dadd-4413-b2a0-57870abbe521">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      id="F_15e625fa-c8ed-48d7-9f7d-3b0abf0755b9">82-1554746</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      id="F_f67bb410-2231-4a9b-b011-ff575394ae5f">2223 Avenida de la Playa</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      id="F_cc095359-7efe-44b7-92ce-3ea99aaf5468">Suite 105</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      id="F_fe89a2f0-336d-4fb1-a69b-9e7d2324f4a0">La Jolla</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      id="F_8243b7aa-826a-4d11-9043-2c02a53a7d76">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      id="F_d0d504c6-f9b3-439d-935b-aa70fc4cad86">92037</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      id="F_3691326a-eae1-4795-8087-f4cebb67ec78">858</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      id="F_16424abd-545e-4579-9cd7-0d873089a8eb">412-5302</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      id="F_2f53b1ba-7f72-42cc-a4d1-4e03ae81dee6">Common Stock, par value $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      id="F_2e0bb9f6-9113-448e-a7d4-84d7d71055d8">EQ</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      id="F_5d0a1e64-b97b-4244-beec-d7f559801578">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      id="F_1417e780-2b06-483d-841f-9be63557ca3f">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      id="F_d8b76456-eec9-46b6-a319-b2c2f72b7242">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      id="F_08a3515e-b4e5-43d6-b298-2f7f41bb7530">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      id="F_84af4de9-4157-4124-a403-183a9d1d843d">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      id="F_c554df0e-e502-411e-9812-b4237e9d01d9">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      id="F_329bc41f-2e36-4d5b-b988-fb7111e2b311">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      id="F_15a82305-49a7-4d11-aa1f-e2df659fca2a">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      id="F_e8ae4fa9-fe90-4085-9c31-9918bbb67004">false</dei:EntityExTransitionPeriod>
    <dei:IcfrAuditorAttestationFlag
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      id="F_c00c52d1-f0ff-446b-8268-4ea890d69355">false</dei:IcfrAuditorAttestationFlag>
    <dei:EntityShellCompany
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      id="F_c0c0fa40-46e7-40c9-9332-9998007e47db">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat
      contextRef="C_63b408ff-0cee-4c70-85c3-c4f148eb4da9"
      decimals="-5"
      id="F_b0ec1890-fa02-4bf1-aae4-d766c69c30e8"
      unitRef="U_USD">43100000</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="C_f14aee5f-c103-44b8-acee-a339e014b6d3"
      decimals="INF"
      id="F_0c75fa15-dcaf-4140-89da-0af69e1138b7"
      unitRef="U_shares">34414149</dei:EntityCommonStockSharesOutstanding>
    <dei:DocumentsIncorporatedByReferenceTextBlock
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      id="F_fe72cea6-d31d-47e1-a90e-901041ab32dc">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;DOCUMENTS INCORPORATED BY REFERENCE&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Part III of this Annual Report on Form 10-K incorporates by reference certain information from the registrant&#x2019;s definitive Proxy Statement for its 2023 annual meeting of stockholders, which the registrant intends to file pursuant to Regulation 14A with the Securities and Exchange Commission not later than 120 days after the registrant&#x2019;s fiscal year end of December 31, 2022. Except with respect to information specifically incorporated by reference in this Form 10-K, the Proxy Statement is not deemed to be filed as part of this Form 10-K.&lt;/span&gt;&lt;/p&gt;</dei:DocumentsIncorporatedByReferenceTextBlock>
    <dei:AuditorFirmId
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      id="F_0713d429-af3b-4b29-b79e-6af5ef937b47">185</dei:AuditorFirmId>
    <dei:AuditorName
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      id="F_cf44e8a5-ed65-46b3-a1b3-0475238336d9">KPMG LLP</dei:AuditorName>
    <dei:AuditorLocation
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      id="F_31b3e65f-1316-4ec0-aabe-ba8355e3e460">San Diego, California, United States</dei:AuditorLocation>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192"
      decimals="-3"
      id="F_dd35efc4-0c70-4a7c-a5f2-99d10b490841"
      unitRef="U_USD">59107000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94"
      decimals="-3"
      id="F_1fa15f81-5ec3-4368-93f6-6590a5b1df63"
      unitRef="U_USD">50366000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192"
      decimals="-3"
      id="F_709712c6-ad0e-447b-b4ec-fc2fac73daf0"
      unitRef="U_USD">11916000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94"
      decimals="-3"
      id="F_a1347111-a90c-4f5b-a17f-7130e6005a0d"
      unitRef="U_USD">30345000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192"
      decimals="-3"
      id="F_0d17d78f-5713-427f-9897-846dc6824beb"
      unitRef="U_USD">2838000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192"
      decimals="-3"
      id="F_02a66d84-779d-44a5-9555-95f2ac97a742"
      unitRef="U_USD">2874000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94"
      decimals="-3"
      id="F_45391533-b016-4df2-a2a0-91fa8c50a985"
      unitRef="U_USD">2659000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192"
      decimals="-3"
      id="F_f6694e79-dc3b-4f92-bc6d-7f80e57bcd99"
      unitRef="U_USD">76735000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94"
      decimals="-3"
      id="F_267fff64-e7a1-48bd-a665-b5fdb533f9de"
      unitRef="U_USD">83370000</us-gaap:AssetsCurrent>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192"
      decimals="-3"
      id="F_32e18531-472a-43ac-b94a-69e7cdc03470"
      unitRef="U_USD">1191000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94"
      decimals="-3"
      id="F_01e553b1-defa-4672-bd60-bd66d3f8c30e"
      unitRef="U_USD">1645000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192"
      decimals="-3"
      id="F_01b81547-5f05-4656-89ed-ecb551e761f1"
      unitRef="U_USD">391000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94"
      decimals="-3"
      id="F_a1a0b9ba-d58d-45e4-8f04-21115e76a3fd"
      unitRef="U_USD">237000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192"
      decimals="-3"
      id="F_c3c2e3ed-5dd9-4163-916d-b77692f90bcf"
      unitRef="U_USD">104000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94"
      decimals="-3"
      id="F_d9268628-6abc-4dad-af0f-c2555d3b965a"
      unitRef="U_USD">153000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192"
      decimals="-3"
      id="F_bb9c6b87-b72b-4402-8eee-be08e7c9b8fe"
      unitRef="U_USD">78421000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94"
      decimals="-3"
      id="F_63dd0cf8-e128-40f2-8746-54d2e8ca4c88"
      unitRef="U_USD">85405000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192"
      decimals="-3"
      id="F_e582869d-4836-476f-9020-4cb742e1d2e9"
      unitRef="U_USD">3977000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94"
      decimals="-3"
      id="F_f78c35bc-e686-4a88-9694-d9667d522309"
      unitRef="U_USD">1225000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192"
      decimals="-3"
      id="F_f8be418b-b2c8-4c49-bee8-c3b425442d17"
      unitRef="U_USD">7239000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94"
      decimals="-3"
      id="F_b15a449e-92da-4a00-9bf2-82ce51e16e06"
      unitRef="U_USD">5886000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:DeferredRevenueCurrent
      contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192"
      decimals="-3"
      id="F_474d206b-1127-4e1d-a5e1-6ef6bd83aeaa"
      unitRef="U_USD">14700000</us-gaap:DeferredRevenueCurrent>
    <us-gaap:NotesPayableCurrent
      contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192"
      decimals="-3"
      id="F_2f22fc30-18ed-4c6a-9d6c-d7ac8ef490de"
      unitRef="U_USD">5714000</us-gaap:NotesPayableCurrent>
    <us-gaap:NotesPayableCurrent
      contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94"
      decimals="-3"
      id="F_205e3a0f-87b5-44e4-9980-b032b1ab2b63"
      unitRef="U_USD">1428000</us-gaap:NotesPayableCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192"
      decimals="-3"
      id="F_986f3e83-82d9-47c1-a58d-06de9dae6934"
      unitRef="U_USD">408000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94"
      decimals="-3"
      id="F_134fe571-5c58-4686-acac-fc892a6d67cd"
      unitRef="U_USD">376000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192"
      decimals="-3"
      id="F_fc7f5aa2-da8c-418b-99a7-9f1586d65986"
      unitRef="U_USD">32038000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94"
      decimals="-3"
      id="F_9e9118c1-e0ba-42cc-b37a-baa5d5be638c"
      unitRef="U_USD">8915000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermNotesPayable
      contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192"
      decimals="-3"
      id="F_1b8048d7-f88c-4e33-bf32-78c74d683f54"
      unitRef="U_USD">3239000</us-gaap:LongTermNotesPayable>
    <us-gaap:LongTermNotesPayable
      contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94"
      decimals="-3"
      id="F_d5792190-5d3a-49d3-8526-d01a87dfc37d"
      unitRef="U_USD">8750000</us-gaap:LongTermNotesPayable>
    <us-gaap:DeferredRevenueNoncurrent
      contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192"
      decimals="-3"
      id="F_ed361848-56b2-46aa-a0ba-b5fd925a507f"
      unitRef="U_USD">10378000</us-gaap:DeferredRevenueNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192"
      decimals="-3"
      id="F_30bdfc3e-ff85-47d1-abc9-d7d5ce3b3297"
      unitRef="U_USD">824000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94"
      decimals="-3"
      id="F_b568173b-2293-49d9-83d7-69d83e63d3f3"
      unitRef="U_USD">1235000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:Liabilities
      contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192"
      decimals="-3"
      id="F_234077c4-f2ff-4f3b-962e-cdba03d35917"
      unitRef="U_USD">46479000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94"
      decimals="-3"
      id="F_283d59c5-ec33-4e33-adb2-4bfef6b3a105"
      unitRef="U_USD">18900000</us-gaap:Liabilities>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192"
      decimals="INF"
      id="F_98407b4f-d688-4878-adc1-d36aa1ce1490"
      unitRef="U_USDollarShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94"
      decimals="INF"
      id="F_6e72d5fb-49cd-4bfa-8350-5e6e9771e879"
      unitRef="U_USDollarShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192"
      decimals="INF"
      id="F_7b5606f6-f6c5-4f7e-9c74-e4d77b3cb78a"
      unitRef="U_shares">200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94"
      decimals="INF"
      id="F_51e4ea55-a656-4d22-a0dd-321bd9ae51ce"
      unitRef="U_shares">200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192"
      decimals="INF"
      id="F_c428bbfd-f44f-4f03-95e2-45f729bedf22"
      unitRef="U_shares">34414149</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192"
      decimals="INF"
      id="F_2c6eb3c4-52c6-44a7-b97c-d71170e3940c"
      unitRef="U_shares">34414149</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94"
      decimals="INF"
      id="F_48b03629-52c4-4ad8-b95f-87047f729279"
      unitRef="U_shares">29455668</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94"
      decimals="INF"
      id="F_37b0c05e-e687-401a-95fd-51d02bbda00e"
      unitRef="U_shares">29455668</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192"
      decimals="-3"
      id="F_111485df-b612-432d-b6a9-071b27cb8c08"
      unitRef="U_USD">3000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94"
      decimals="-3"
      id="F_bff68d4a-f2dd-4f34-9800-2faaba100db2"
      unitRef="U_USD">2000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192"
      decimals="-3"
      id="F_73a1fe88-633d-466b-8fbc-4ccfab64c6f0"
      unitRef="U_USD">204268000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94"
      decimals="-3"
      id="F_9c5a0a64-8a81-480f-8e8b-cd655370c593"
      unitRef="U_USD">176618000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192"
      decimals="-3"
      id="F_5b3e77ac-64ca-4158-9146-0120d03f436f"
      unitRef="U_USD">76000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94"
      decimals="-3"
      id="F_9d21dc03-fe23-4280-a74c-cb48b083749f"
      unitRef="U_USD">-138000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192"
      decimals="-3"
      id="F_66ca9752-9e99-4ff1-b337-c05ea499cf9b"
      unitRef="U_USD">-172405000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94"
      decimals="-3"
      id="F_0f1bd330-47fc-4106-9cc7-e5006ac5498a"
      unitRef="U_USD">-109977000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192"
      decimals="-3"
      id="F_65d1fa98-dea6-4c26-8175-42cf63ecda13"
      unitRef="U_USD">31942000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94"
      decimals="-3"
      id="F_964bd1c7-3935-477b-9161-3b0de93fab40"
      unitRef="U_USD">66505000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192"
      decimals="-3"
      id="F_1fb8a7d4-09e8-419b-af49-269ae644a788"
      unitRef="U_USD">78421000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94"
      decimals="-3"
      id="F_27c7db4e-48d8-4ce1-95d0-452d911d1d7f"
      unitRef="U_USD">85405000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      decimals="-3"
      id="F_7322651d-adfc-4d03-9a46-a5acea347189"
      unitRef="U_USD">15759000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      decimals="-3"
      id="F_21d56114-b74b-4731-bd5c-a76cccff49ea"
      unitRef="U_USD">37547000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2"
      decimals="-3"
      id="F_a29aed43-e15e-4f58-8740-d12c9ac9d4ca"
      unitRef="U_USD">26379000</us-gaap:ResearchAndDevelopmentExpense>
    <eq:AcquiredInProcessResearchAndDevelopment
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      decimals="-3"
      id="F_a0acf332-c4eb-46ff-85f4-93d854a51f09"
      unitRef="U_USD">23049000</eq:AcquiredInProcessResearchAndDevelopment>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      decimals="-3"
      id="F_4e01ac6d-ecf0-4be1-b1be-5a96758a3a9f"
      unitRef="U_USD">17239000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2"
      decimals="-3"
      id="F_a9c2676d-d634-4616-940f-f966419d7890"
      unitRef="U_USD">11407000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      decimals="-3"
      id="F_83639d62-6e2e-4cf3-90b7-5ee83340a1b7"
      unitRef="U_USD">77835000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2"
      decimals="-3"
      id="F_b4b305be-ecf6-4b4e-b3fb-5b1d1623b932"
      unitRef="U_USD">37786000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      decimals="-3"
      id="F_154c5251-f010-4b1e-abdd-d6ca5312ab84"
      unitRef="U_USD">-62076000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2"
      decimals="-3"
      id="F_24aa24d5-f5eb-4155-a510-f6d6ee2062e1"
      unitRef="U_USD">-37786000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpenseDebt
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      decimals="-3"
      id="F_a3650ee6-e791-416d-a574-8b0a04500c91"
      unitRef="U_USD">1053000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2"
      decimals="-3"
      id="F_2a721fa4-4a77-43e3-a415-8acaa3af10c8"
      unitRef="U_USD">1073000</us-gaap:InterestExpenseDebt>
    <us-gaap:InvestmentIncomeInterest
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      decimals="-3"
      id="F_70fb4225-108f-4e9f-9619-564aa7396744"
      unitRef="U_USD">420000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2"
      decimals="-3"
      id="F_bb26c8cd-2fdb-4ae6-831f-d4984a94eefb"
      unitRef="U_USD">57000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      decimals="-3"
      id="F_6d4e7c07-92a9-4309-bd75-d0546b96d9af"
      unitRef="U_USD">281000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2"
      decimals="-3"
      id="F_5ac3f4d4-9cc0-4021-9d6c-65dcf9fb090d"
      unitRef="U_USD">-250000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      decimals="-3"
      id="F_c4e5372d-d1a7-48b7-946f-9a569de89202"
      unitRef="U_USD">-352000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2"
      decimals="-3"
      id="F_a2d6dd10-09cb-47d8-8554-08a8a7d3a8be"
      unitRef="U_USD">-1266000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NetIncomeLoss
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      decimals="-3"
      id="F_d5bb3589-d5b6-4e59-b6be-61d2f1d0daa5"
      unitRef="U_USD">-62428000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2"
      decimals="-3"
      id="F_0150caa4-f4bc-4f4a-8caf-605041b942be"
      unitRef="U_USD">-39052000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      decimals="-3"
      id="F_759a5db3-1156-48ef-9619-7aa2873547e2"
      unitRef="U_USD">-38000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
      contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2"
      decimals="-3"
      id="F_c8d3ca62-a793-44f0-8c2a-564ec5df607d"
      unitRef="U_USD">-59000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      decimals="-3"
      id="F_de2f9eb2-935c-4ad3-8ffc-82ebdbc02f60"
      unitRef="U_USD">252000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2"
      decimals="-3"
      id="F_4f28fbd6-c384-4af1-8a63-3e8f5f756790"
      unitRef="U_USD">218000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      decimals="-3"
      id="F_a9f9bbd8-57d3-4d65-aa49-4cd745c2d629"
      unitRef="U_USD">214000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2"
      decimals="-3"
      id="F_d56827c4-3430-4265-ab8b-a02c2af10fb0"
      unitRef="U_USD">159000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      decimals="-3"
      id="F_d4f7bb47-4052-4737-9a63-8e932872890c"
      unitRef="U_USD">-62214000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2"
      decimals="-3"
      id="F_7da57cc7-c30a-418e-b3cd-0cd6e005d044"
      unitRef="U_USD">-38893000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      decimals="2"
      id="F_a063aa55-2caf-4ffd-9368-a3c14394e549"
      unitRef="U_USDollarShare">-1.85</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      decimals="2"
      id="F_1a7794f0-1eda-4eeb-91ff-5d157881f846"
      unitRef="U_USDollarShare">-1.85</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2"
      decimals="2"
      id="F_8329824e-967e-4647-a3b3-c121a77e14b4"
      unitRef="U_USDollarShare">-1.36</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2"
      decimals="2"
      id="F_c6927dae-5421-4090-b899-5744de435bf9"
      unitRef="U_USDollarShare">-1.36</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      decimals="0"
      id="F_fe17d8ff-0607-4d8c-8153-b7b2d649c071"
      unitRef="U_shares">33727945</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      decimals="0"
      id="F_5237cd37-20dd-4d62-a385-691529193387"
      unitRef="U_shares">33727945</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2"
      decimals="0"
      id="F_1b43da46-876a-4180-af52-f3e359e98765"
      unitRef="U_shares">28806310</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2"
      decimals="0"
      id="F_f13f63ad-eb7c-40c7-8839-255bcc39a3ca"
      unitRef="U_shares">28806310</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:SharesIssued
      contextRef="C_af77d479-58a1-4eb8-be05-a05f0b6de156"
      decimals="INF"
      id="F_33cb0246-a70f-4185-9d12-5e07dbf399d3"
      unitRef="U_shares">24753102</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="C_af77d479-58a1-4eb8-be05-a05f0b6de156"
      decimals="-3"
      id="F_369dacca-dfbc-4da6-b55f-5a1f7a60c9af"
      unitRef="U_USD">2000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_b15585d5-5e76-4fec-adb1-0f3694e76b0d"
      decimals="-3"
      id="F_61d6d966-e4a9-498b-bf21-56c62697fdfe"
      unitRef="U_USD">141074000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_83d4ef1f-863c-4921-aa0e-cb290fba239d"
      decimals="-3"
      id="F_d57c7043-af59-47fc-8ec2-cbfbbf7afc3c"
      unitRef="U_USD">-297000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_be335ae5-27dc-40a0-a672-67f87605ecfa"
      decimals="-3"
      id="F_d7b4325f-7a2f-4a9e-9179-f721c137acc2"
      unitRef="U_USD">-70925000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_593cac69-ae06-423d-93b0-db39a502796a"
      decimals="-3"
      id="F_4d0cb6ff-514b-4144-bd02-e2377e399707"
      unitRef="U_USD">69854000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesOther
      contextRef="C_dc409b2a-6dec-4757-a385-691c05150979"
      decimals="INF"
      id="F_af49da5f-4427-460c-9afe-99526e58f617"
      unitRef="U_shares">4285710</us-gaap:StockIssuedDuringPeriodSharesOther>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="C_07b42072-8725-4287-82d7-ff7786912150"
      decimals="-3"
      id="F_580eccd3-e293-4479-87a4-f465c61a8223"
      unitRef="U_USD">29909000</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2"
      decimals="-3"
      id="F_a9796e1e-eb32-4302-aee1-fa42af52bc7a"
      unitRef="U_USD">29909000</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="C_dc409b2a-6dec-4757-a385-691c05150979"
      decimals="INF"
      id="F_29855bcc-2ed8-4a5b-9b93-de554011db99"
      unitRef="U_shares">326454</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_07b42072-8725-4287-82d7-ff7786912150"
      decimals="-3"
      id="F_c222dbfc-088a-4271-a6d0-3f043f111ef8"
      unitRef="U_USD">891000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2"
      decimals="-3"
      id="F_6e9cfb12-49c6-4adc-981a-8a455f47bc47"
      unitRef="U_USD">891000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="C_dc409b2a-6dec-4757-a385-691c05150979"
      decimals="INF"
      id="F_5388a31e-5b0e-4aeb-9121-e66ccde27f29"
      unitRef="U_shares">90402</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="C_07b42072-8725-4287-82d7-ff7786912150"
      decimals="-3"
      id="F_48d99cdc-b411-41c2-9b1c-e06a3c3eeb49"
      unitRef="U_USD">261000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2"
      decimals="-3"
      id="F_b8b5463f-6429-4a68-aab5-f416fa1969ea"
      unitRef="U_USD">261000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
      contextRef="C_07b42072-8725-4287-82d7-ff7786912150"
      decimals="-3"
      id="F_c75fc0e2-2ba5-4f3c-9591-d12a4b2e19a5"
      unitRef="U_USD">73000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
      contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2"
      decimals="-3"
      id="F_7adfa302-e66c-43e7-a042-93d3b6854178"
      unitRef="U_USD">73000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_07b42072-8725-4287-82d7-ff7786912150"
      decimals="-3"
      id="F_8ce11e09-dc70-4156-a26c-2d68b199a99b"
      unitRef="U_USD">4410000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2"
      decimals="-3"
      id="F_2c26d2ae-aad9-4a72-b111-cfc1a3280821"
      unitRef="U_USD">4410000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="C_211f9a22-9355-4cd5-ae5c-f45e20a3dcdc"
      decimals="-3"
      id="F_69159db1-16b3-497f-bda3-b8c35f96a15f"
      unitRef="U_USD">159000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2"
      decimals="-3"
      id="F_90a52a14-d202-427a-888e-6195d4af629c"
      unitRef="U_USD">159000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="C_157bf7c1-6ef7-43ab-b719-f85e3a11f1d5"
      decimals="-3"
      id="F_1974160d-18c5-4c73-9986-2cfca0caf1af"
      unitRef="U_USD">-39052000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2"
      decimals="-3"
      id="F_b4bc43f1-d899-46d9-b8c9-e11ce9a02c9e"
      unitRef="U_USD">-39052000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesIssued
      contextRef="C_b46e12c4-af83-4e15-baf8-0903ab9bd6b5"
      decimals="INF"
      id="F_4606e253-ff57-4147-8b00-22d0d1952750"
      unitRef="U_shares">29455668</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="C_b46e12c4-af83-4e15-baf8-0903ab9bd6b5"
      decimals="-3"
      id="F_ce7f66e9-a793-4b13-a857-02a0cdaf7f0f"
      unitRef="U_USD">2000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_2ad7083d-d4d8-4d36-9fad-554b54c6601f"
      decimals="-3"
      id="F_8fdac0d5-89a5-4a40-94e2-d0da243990e7"
      unitRef="U_USD">176618000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_f31a63db-28e5-4d6c-8641-5e09fcfbb9ac"
      decimals="-3"
      id="F_e605d158-a883-45e4-89c5-a383bbdd7cb7"
      unitRef="U_USD">-138000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_677e006f-7dec-4e8f-81db-464e67389b27"
      decimals="-3"
      id="F_e6dd910f-85e4-4475-a947-40a4d66ff950"
      unitRef="U_USD">-109977000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94"
      decimals="-3"
      id="F_35b4403f-f481-431c-8b62-70877d2bf127"
      unitRef="U_USD">66505000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_71653c3b-caef-4b07-8b00-6e7024629fb3"
      decimals="INF"
      id="F_45ae8d45-860d-43d2-a962-4710ecba9ac5"
      unitRef="U_shares">4820230</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_71653c3b-caef-4b07-8b00-6e7024629fb3"
      decimals="-3"
      id="F_3258674e-8c2b-4474-b39d-4f0f335f2a6c"
      unitRef="U_USD">1000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_70c8e717-7ae0-400b-a2e5-1384948ea4b2"
      decimals="-3"
      id="F_c353ef65-4cff-4b97-bcf9-6884dc630fca"
      unitRef="U_USD">22541000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_8a38518a-9c62-4c14-a61d-b505eb2f5458"
      decimals="-3"
      id="F_dfe35c6a-294b-477b-91ea-2aa6c7be6042"
      unitRef="U_USD">22542000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="C_900c0b60-4130-48e3-ad64-738fc1374bc7"
      decimals="INF"
      id="F_def5a5c3-0fa4-4eb4-b253-cce1a764252f"
      unitRef="U_shares">138251</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="C_149d869a-5e0a-4913-9abe-a27afa766de4"
      decimals="-3"
      id="F_c9f82c36-8cde-4e3d-84a5-0f2aefce1695"
      unitRef="U_USD">215000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      decimals="-3"
      id="F_ed70cf89-d3db-4558-a1bb-c3f160907b41"
      unitRef="U_USD">215000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
      contextRef="C_149d869a-5e0a-4913-9abe-a27afa766de4"
      decimals="-3"
      id="F_2ad28802-e194-4d44-962c-7957ae50a5d3"
      unitRef="U_USD">53000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      decimals="-3"
      id="F_14863160-4aaf-4f92-8bdf-e6506e8533e2"
      unitRef="U_USD">53000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_149d869a-5e0a-4913-9abe-a27afa766de4"
      decimals="-3"
      id="F_65f447d7-54ff-4d9c-8de4-a860f092c06f"
      unitRef="U_USD">4841000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      decimals="-3"
      id="F_cb00919f-3c13-4faf-81bc-2047a7df6edf"
      unitRef="U_USD">4841000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="C_e6cf51a2-311a-4401-b240-c4af424355e4"
      decimals="-3"
      id="F_75788ea5-c177-45c2-81cf-a9f4fcd17616"
      unitRef="U_USD">214000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      decimals="-3"
      id="F_cf154857-9609-43d6-adea-9198847b12af"
      unitRef="U_USD">214000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="C_1498053c-86a8-4e41-8116-8cb7e9c5b74c"
      decimals="-3"
      id="F_fb594f71-bfe5-49c1-9740-91c1828a2e5e"
      unitRef="U_USD">-62428000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      decimals="-3"
      id="F_8a553b4e-b256-4778-a892-96388b340096"
      unitRef="U_USD">-62428000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesIssued
      contextRef="C_6d2cc007-04de-46ef-a689-02aac4462b5a"
      decimals="INF"
      id="F_6f616c1d-c6ad-4fa2-8c2e-53e2d7834c87"
      unitRef="U_shares">34414149</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="C_6d2cc007-04de-46ef-a689-02aac4462b5a"
      decimals="-3"
      id="F_22cbc31d-430d-4e71-860b-026a185ad2b2"
      unitRef="U_USD">3000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_f789eb1e-5a5d-41b1-8bb7-3d3ed1258e7d"
      decimals="-3"
      id="F_90fc1954-3653-40be-8987-bafba62e3999"
      unitRef="U_USD">204268000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_1f42c1eb-d268-41b0-9bcf-d37f47a8c53a"
      decimals="-3"
      id="F_958a9df7-3560-4164-9fe2-044d2dae5628"
      unitRef="U_USD">76000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_3c1013be-6aec-4534-8322-81766349f268"
      decimals="-3"
      id="F_83a50443-8085-4b99-a122-f5f45bb203e2"
      unitRef="U_USD">-172405000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192"
      decimals="-3"
      id="F_885083bd-c245-44be-95f5-4a574920eea2"
      unitRef="U_USD">31942000</us-gaap:StockholdersEquity>
    <us-gaap:ProfitLoss
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      decimals="-3"
      id="F_2eda0e87-357a-4546-8e8e-e1d54fa02638"
      unitRef="U_USD">-62428000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2"
      decimals="-3"
      id="F_6dbdb6c3-e248-4013-abcb-ca50b0f964c6"
      unitRef="U_USD">-39052000</us-gaap:ProfitLoss>
    <us-gaap:ResearchAndDevelopmentInProcess
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      decimals="-3"
      id="F_bf24e39f-333e-4a8d-8d14-17d02d692dc5"
      unitRef="U_USD">23049000</us-gaap:ResearchAndDevelopmentInProcess>
    <us-gaap:DepreciationAndAmortization
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      decimals="-3"
      id="F_d4f20108-ae84-42dd-89d9-fea4e0c79ce8"
      unitRef="U_USD">118000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2"
      decimals="-3"
      id="F_93cad7c9-dabb-4770-bea6-c129c4cbed59"
      unitRef="U_USD">72000</us-gaap:DepreciationAndAmortization>
    <us-gaap:ShareBasedCompensation
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      decimals="-3"
      id="F_e8ae27fd-1d0b-4d6c-b669-dbbe2facf72b"
      unitRef="U_USD">4841000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2"
      decimals="-3"
      id="F_21ee58ec-dae7-4fb6-96d6-e62692f8a938"
      unitRef="U_USD">4410000</us-gaap:ShareBasedCompensation>
    <us-gaap:ForeignCurrencyTransactionGainLossUnrealized
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      decimals="-3"
      id="F_4d342a2b-2d86-47df-8d11-ed974f390627"
      unitRef="U_USD">-260000</us-gaap:ForeignCurrencyTransactionGainLossUnrealized>
    <us-gaap:ForeignCurrencyTransactionGainLossUnrealized
      contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2"
      decimals="-3"
      id="F_d52612af-d4e8-4566-a863-c25093d5b75f"
      unitRef="U_USD">-240000</us-gaap:ForeignCurrencyTransactionGainLossUnrealized>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      decimals="-3"
      id="F_8b91f358-6e4a-4992-a295-7f3e9ea21069"
      unitRef="U_USD">203000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2"
      decimals="-3"
      id="F_a708a469-fabd-4503-a005-3d1a43a8e65e"
      unitRef="U_USD">237000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      decimals="-3"
      id="F_f8027d26-16c4-4461-a6e3-36e5c57f3a9a"
      unitRef="U_USD">-127000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments
      contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2"
      decimals="-3"
      id="F_a926d384-3d94-4f79-8311-bd9e5be3fbc4"
      unitRef="U_USD">-314000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      decimals="-3"
      id="F_03e22572-5612-4363-a3b6-074800ad8ebb"
      unitRef="U_USD">25078000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      decimals="-3"
      id="F_04be2b9f-8040-4655-8c10-d936824a8735"
      unitRef="U_USD">2838000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      decimals="-3"
      id="F_0699e069-ca1c-450a-865c-e8d07c10184b"
      unitRef="U_USD">158000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2"
      decimals="-3"
      id="F_9844029d-1ee7-4114-94cd-e063b1cc961b"
      unitRef="U_USD">-214000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      decimals="-3"
      id="F_bb14faa4-288c-4824-a635-fcc100164e45"
      unitRef="U_USD">2508000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2"
      decimals="-3"
      id="F_f4f0df6c-3395-42fa-b442-5b07209f9610"
      unitRef="U_USD">-1578000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      decimals="-3"
      id="F_648627c5-2b77-4f13-9ed0-ac247ac33fb9"
      unitRef="U_USD">432000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2"
      decimals="-3"
      id="F_d8396eee-2fdd-496b-b9dc-cc9ff86b477c"
      unitRef="U_USD">3099000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <eq:IncreaseDecreaseInRightOfUseAssetsAndLeaseLiabilitiesNet
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      decimals="-3"
      id="F_d0c488fe-b500-492f-8d89-32f829adaf55"
      unitRef="U_USD">-75000</eq:IncreaseDecreaseInRightOfUseAssetsAndLeaseLiabilitiesNet>
    <eq:IncreaseDecreaseInRightOfUseAssetsAndLeaseLiabilitiesNet
      contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2"
      decimals="-3"
      id="F_9d357bc9-24b9-423b-9212-b708083d9921"
      unitRef="U_USD">37000</eq:IncreaseDecreaseInRightOfUseAssetsAndLeaseLiabilitiesNet>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      decimals="-3"
      id="F_64a5a7fa-85af-44c3-bec1-671b71c6efe6"
      unitRef="U_USD">-8733000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2"
      decimals="-3"
      id="F_08bf0511-1bee-44bc-a0d9-39e408f5738a"
      unitRef="U_USD">-32081000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      decimals="-3"
      id="F_e6ebd948-7205-4f97-ae22-482456c95488"
      unitRef="U_USD">279000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2"
      decimals="-3"
      id="F_8922767a-a1a5-4a75-81c7-9627b2deb091"
      unitRef="U_USD">57000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireShortTermInvestments
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      decimals="-3"
      id="F_afe05314-618b-412e-a2b6-2ca3e4567f7b"
      unitRef="U_USD">14962000</us-gaap:PaymentsToAcquireShortTermInvestments>
    <us-gaap:PaymentsToAcquireShortTermInvestments
      contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2"
      decimals="-3"
      id="F_c7cbcdc4-2454-4000-985a-4a38fcfd4048"
      unitRef="U_USD">32992000</us-gaap:PaymentsToAcquireShortTermInvestments>
    <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      decimals="-3"
      id="F_a5f78ab1-1922-4aaa-838e-d7a575ac8491"
      unitRef="U_USD">33225000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments>
    <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
      contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2"
      decimals="-3"
      id="F_2b9d0d3e-a3cf-4a2b-8ddf-70bf51f57b36"
      unitRef="U_USD">60455000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments>
    <us-gaap:CashAcquiredFromAcquisition
      contextRef="C_8a38518a-9c62-4c14-a61d-b505eb2f5458"
      decimals="-3"
      id="F_e5b0d7b1-7c00-48c4-8997-459d6354662d"
      unitRef="U_USD">700000</us-gaap:CashAcquiredFromAcquisition>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      decimals="-3"
      id="F_b32e9bb6-216b-4b28-a566-021ed2674d03"
      unitRef="U_USD">18684000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2"
      decimals="-3"
      id="F_d3eb389a-0439-4d8a-ac3b-f40135dc0582"
      unitRef="U_USD">27406000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="C_8a5bef62-cef2-4949-81e3-78ec03bd91d4"
      decimals="-3"
      id="F_dc49c0d0-f6a2-481e-9b1f-1a95b6582926"
      unitRef="U_USD">29909000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      decimals="-3"
      id="F_7dc9d47b-d879-4bee-962a-865de294ff0c"
      unitRef="U_USD">1429000</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2"
      decimals="-3"
      id="F_ffcb1bcc-2771-43bf-928b-8f842ea18d0d"
      unitRef="U_USD">891000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockPlans
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      decimals="-3"
      id="F_28aa36e9-c858-4b6f-aefa-9cd5b8476dd7"
      unitRef="U_USD">214000</us-gaap:ProceedsFromStockPlans>
    <us-gaap:ProceedsFromStockPlans
      contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2"
      decimals="-3"
      id="F_4e313dda-b820-48c4-81e3-d1024cbc4f88"
      unitRef="U_USD">261000</us-gaap:ProceedsFromStockPlans>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      decimals="-3"
      id="F_139d0111-2efa-4bab-9467-5f61e8aedd4e"
      unitRef="U_USD">-1215000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2"
      decimals="-3"
      id="F_08afe9a0-b009-4841-84bb-aab3eeca2d08"
      unitRef="U_USD">31061000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      decimals="-3"
      id="F_e9eebe71-c48a-43e4-802d-b8660fd917cc"
      unitRef="U_USD">5000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2"
      decimals="-3"
      id="F_fe9b79ab-c3f7-47cb-afcd-66f0e3314ba9"
      unitRef="U_USD">-2000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      decimals="-3"
      id="F_a535ab97-3272-48e3-bf67-660c428ae0a7"
      unitRef="U_USD">8741000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2"
      decimals="-3"
      id="F_30b010b4-b686-4b45-a38c-cc26be61bfa6"
      unitRef="U_USD">26384000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94"
      decimals="-3"
      id="F_3a9b6414-9d1a-49c1-93f6-e861c085fb07"
      unitRef="U_USD">50366000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="C_593cac69-ae06-423d-93b0-db39a502796a"
      decimals="-3"
      id="F_a8b40bc6-9cfc-458e-8b23-071f094621d7"
      unitRef="U_USD">23982000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192"
      decimals="-3"
      id="F_2a12ef6c-8876-40a7-8278-bf3fc985d342"
      unitRef="U_USD">59107000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94"
      decimals="-3"
      id="F_2181bfa3-18f0-49b4-bbef-666b4c6e2eec"
      unitRef="U_USD">50366000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:InterestPaidNet
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      decimals="-3"
      id="F_fe3061c6-8852-432f-8b97-2f46c6861fef"
      unitRef="U_USD">847000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2"
      decimals="-3"
      id="F_04952975-b5ec-4415-b667-5054c7868728"
      unitRef="U_USD">836000</us-gaap:InterestPaidNet>
    <us-gaap:FairValueOfAssetsAcquired
      contextRef="C_8a38518a-9c62-4c14-a61d-b505eb2f5458"
      decimals="-3"
      id="F_210ed8a6-5424-486f-8091-3c0084e4058a"
      unitRef="U_USD">23049000</us-gaap:FairValueOfAssetsAcquired>
    <us-gaap:StockIssued1
      contextRef="C_8a38518a-9c62-4c14-a61d-b505eb2f5458"
      decimals="-3"
      id="F_7b5f0979-e64b-46fc-8ba8-71768c95285a"
      unitRef="U_USD">22542000</us-gaap:StockIssued1>
    <us-gaap:LiabilitiesAssumed1
      contextRef="C_8a38518a-9c62-4c14-a61d-b505eb2f5458"
      decimals="-3"
      id="F_1082750d-9640-40bf-9b55-8dd7f508b09c"
      unitRef="U_USD">507000</us-gaap:LiabilitiesAssumed1>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2"
      decimals="-3"
      id="F_78a3d9dd-3043-44b1-9f5c-f1b2cba4ae01"
      unitRef="U_USD">1759000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2"
      decimals="-3"
      id="F_b8aa8552-c1a6-4eb4-a282-8dfef4890e28"
      unitRef="U_USD">14000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      id="F_c62a4021-9d93-4730-8f35-d576ff9884f1">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1. Organization and Accounting Pronouncements&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Description of Business&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Equillium, Inc. (the Company) was incorporated in the state of &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Delaware&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; on &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;March 16, 2017&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;. The Company is a clinical-stage biotechnology company &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;leveraging a deep understanding of immunobiology to develop novel therapeutics to treat severe autoimmune and inflammatory (immuno-inflammatory), disorders with high unmet medical need. The Company&#x2019;s strategy is focused on advancing the clinical development of its product candidates, including potentially pursuing additional indications and acquiring new product candidates and platforms to expand its pipeline. The Company intends to commercialize its product candidates either independently or through partnerships or otherwise monetize its pipeline through strategic transactions.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company's current clinical-stage product candidates consist of EQ101, EQ102 and itolizumab (EQ001). EQ101 and EQ102 are synthetic peptides engineered to specifically inhibit key disease-driving, clinically validated cytokine targets aimed at addressing unmet needs across a range of immuno-inflammatory indications. EQ101 is a first-in class, selective, tri-specific inhibitor of IL-2, IL-9 and IL-15, and EQ102 is a first-in class, selective, bi-specific inhibitor of IL-15 and IL-21. Itolizumab (EQ001) is a first-in-class monoclonal antibody that selectively targets the immune checkpoint receptor CD6, which plays a central role in the modulation of effector T cell, or T&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:sub;font-size:6.7pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;eff&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; cell, activity and trafficking that drives a number of immuno-inflammatory diseases across multiple therapeutic areas. The Company's novel and differentiated pipeline of first-in-class immunology assets has the potential to address unmet medical needs in numerous areas, including dermatology, gastroenterology, transplant science, hematology, rheumatology, oncology and pulmonology.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;From inception through December 31, 2022, the Company has devoted substantially all of its efforts to organizing and staffing the Company, business planning, raising capital, in-licensing rights to itolizumab (EQ001), conducting non-clinical research, filing three Investigational New Drug applications (INDs), conducting clinical development of the Company's product candidates, conducting business development activities such as the acquisition of Bioniz Therapeutics, Inc. (Bioniz),  the Asset Purchase Agreement with Ono Pharmaceutical Co., Ltd. (Ono) and other transactions not completed, and the general and administrative activities associated with operating a public company.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Liquidity and Business Risks&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;As of December 31, 2022, the Company had $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;71.0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million in cash, cash equivalents and short-term investments. &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company has incurred significant operating losses and negative cash flows from operations. The Company expects to use its cash, cash equivalents, and short-term investments to fund research and development of its product candidates, for potentially acquiring and conducting research and development of new products, and for working capital and other general corporate purposes. The Company does not expect to generate any revenues from product sales unless and until the Company successfully completes development and obtains regulatory approval of any of its product candidates, which is unlikely to happen within the next 12 months, if ever. Accordingly, until such time as the Company can generate significant revenue from sales of its product candidates, if ever, the Company expects to finance its cash needs through a combination of equity offerings, debt financings, and collaboration and license agreements, such as its Asset Purchase Agreement with Ono. However, the Company may not be able to secure additional financing or enter into such other arrangements in a timely manner or on favorable terms, if at all. As a result of the conflict between Russia and Ukraine, bank failures, inflationary pressures on the economy and monetary policy responses taken by government agencies and other macroeconomic factors, the global credit and financial markets have experienced extreme volatility, including diminished liquidity and credit availability, declines in consumer confidence, declines in economic growth and uncertainty about economic stability. There can be no assurance that further deterioration in credit and financial markets and confidence in economic conditions will not occur. If equity and credit markets deteriorate, it may make any necessary debt or equity financing more difficult to obtain, more costly and/or more dilutive. The Company&#x2019;s failure to raise capital or enter into such other arrangements when needed would have a negative impact on the Company&#x2019;s financial condition and could force the Company to delay, reduce or terminate its research and development programs or other operations, or grant rights to develop and market product candidates that the Company would otherwise prefer to develop and market itself. Management believes that the Company&#x2019;s cash, cash equivalents and short-term investments as of December 31, 2022 will be sufficient to fund operations for at least the next 12 months from the date this Annual Report on Form 10-K is filed with the Securities and Exchange Commission (SEC).&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Basis of Presentation&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The accompanying consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (GAAP) and the rules and regulations of the SEC. Any reference in these notes to applicable guidance&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;is meant to refer to GAAP as found in the Accounting Standards Codification (ASC) and Accounting Standards Updates (ASU) promulgated by the Financial Accounting Standards Board (FASB).&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Principles of Consolidation&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The accompanying consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Foreign Currency Translation&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company&#x2019;s wholly-owned subsidiary in Australia uses its local currency as its functional currency. Assets and liabilities are translated into U.S. dollars at quarter-end exchange rates and revenues and expenses are translated at average exchange rates during the year-to-date periods. Foreign currency translation adjustments for the reported periods are included in accumulated other comprehensive income in the Company&#x2019;s consolidated statements of comprehensive loss, and the cumulative effect is included in the stockholders&#x2019; equity section of the Company&#x2019;s consolidated balance sheets.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;  &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Recently Issued and Recently Adopted Accounting Pronouncements&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:&amp;quot;Arial&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;In June 2016, the FASB issued ASU No. 2016-13, &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Measurement of Credit Losses on Financial Instruments&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, which will require a reporting entity to use a new forward-looking impairment model for most financial assets that generally will result in the earlier recognition of allowances for losses. The ASU, along with related amendments, revised the measurement of credit losses for financial assets measured at amortized cost from an incurred loss to an expected loss methodology. The ASU affected receivables, debt securities, net investment in leases, and most other financial assets that represent a right to receive cash. The Company &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;adopted&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; this standard effective &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;January 1, 2022&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; using the modified retrospective approach. Due to the nature of the Company's investment portfolio, the adoption of the guidance did&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; no&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;t have a material effect on the Company's consolidated financial statements and no allowance was recorded for expected credit losses.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:&amp;quot;Arial&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;From time to time, new accounting pronouncements are issued by the FASB or other standard setting bodies that are adopted by the Company as of the specified effective date. The Company has evaluated recently issued pronouncements and does not believe any will have a material impact on the Company's consolidated financial statements or related financial statement disclosures. Other accounting standard updates effective for interim and annual periods beginning after December 31, 2022 are not expected to have a material impact on the Company&#x2019;s financial position, results of operations or cash flows.&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock>
    <dei:EntityIncorporationStateCountryCode
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      id="F_332f8cac-3c2c-4c14-8327-37ae50600e02">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityIncorporationDateOfIncorporation
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      id="F_e4e606cb-1e4f-434d-8c55-44e62f468bc7">2017-03-16</dei:EntityIncorporationDateOfIncorporation>
    <us-gaap:CashCashEquivalentsAndShortTermInvestments
      contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192"
      decimals="-5"
      id="F_e2567229-95dc-4fd6-8b06-a2b2f23a46aa"
      unitRef="U_USD">71000000.0</us-gaap:CashCashEquivalentsAndShortTermInvestments>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      id="F_27991cad-17a8-4131-82ae-da6a0be2f5ee">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Recently Issued and Recently Adopted Accounting Pronouncements&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:&amp;quot;Arial&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;In June 2016, the FASB issued ASU No. 2016-13, &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Measurement of Credit Losses on Financial Instruments&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, which will require a reporting entity to use a new forward-looking impairment model for most financial assets that generally will result in the earlier recognition of allowances for losses. The ASU, along with related amendments, revised the measurement of credit losses for financial assets measured at amortized cost from an incurred loss to an expected loss methodology. The ASU affected receivables, debt securities, net investment in leases, and most other financial assets that represent a right to receive cash. The Company &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;adopted&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; this standard effective &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;January 1, 2022&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; using the modified retrospective approach. Due to the nature of the Company's investment portfolio, the adoption of the guidance did&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; no&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;t have a material effect on the Company's consolidated financial statements and no allowance was recorded for expected credit losses.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:&amp;quot;Arial&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;From time to time, new accounting pronouncements are issued by the FASB or other standard setting bodies that are adopted by the Company as of the specified effective date. The Company has evaluated recently issued pronouncements and does not believe any will have a material impact on the Company's consolidated financial statements or related financial statement disclosures. Other accounting standard updates effective for interim and annual periods beginning after December 31, 2022 are not expected to have a material impact on the Company&#x2019;s financial position, results of operations or cash flows.&lt;/span&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted
      contextRef="C_69239b5b-2176-4437-a3e8-98a7b914e359"
      id="F_dfe66253-788d-4b4d-8dff-866c6c26a95b">true</us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted>
    <us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate
      contextRef="C_69239b5b-2176-4437-a3e8-98a7b914e359"
      id="F_ed27e405-9b75-4173-b6cc-509b674091f8">2022-01-01</us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate>
    <us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect
      contextRef="C_69239b5b-2176-4437-a3e8-98a7b914e359"
      id="F_4ea35248-bbd4-4533-8fc5-a586e33df2bb">true</us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      id="F_968158cc-8932-4a7a-be1e-60718a4912a4">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2. Summary of Significant Accounting Policies&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Use of Estimates&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The preparation of the Company&#x2019;s consolidated financial statements requires the Company to make estimates and assumptions that impact the reported amounts of assets, liabilities and expenses and the disclosure of contingent assets and liabilities in the consolidated financial statements and accompanying notes. Significant estimates in the Company&#x2019;s consolidated financial statements relate to accrued research and development expense, revenue recognition and the valuation of equity awards. Management evaluates its estimates on an ongoing basis. Although estimates are based on the Company&#x2019;s historical experience, knowledge of current events, and actions it may undertake in the future, actual results may ultimately materially differ from these estimates and assumptions.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Concentration of Credit Risk and Off-Balance Sheet Risk&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Financial instruments which potentially subject the Company to significant concentration of credit risk consist of cash and cash equivalents and short-term investments. The Company maintains deposits in federally insured financial institutions in excess of federally insured limits. The Company has not experienced any losses in such accounts, and management believes that the Company is not exposed to significant credit risk due to the financial position of the depository institutions in which those deposits are held. The Company&#x2019;s investment policy includes guidelines for the quality of the related institutions and financial instruments and defines allowable investments that the Company may invest in, which the Company believes minimizes the exposure to concentration of credit risk.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Comprehensive Loss&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company is required to report all components of comprehensive loss, including net loss, in the consolidated financial statements in the period in which they are recognized. Comprehensive loss is defined as the change in equity during a period from transactions and other events and circumstances from non-owner sources, including unrealized gains and losses on investments and foreign currency gains and losses. Other comprehensive income, net includes unrealized losses and gains on short-term investments as well as foreign currency translation gains and losses.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Cash and cash equivalents include cash in readily available checking and savings accounts, and money market funds. The Company considers all highly liquid investments with an original maturity of three months or less from the date of purchase to be cash equivalents. At December 31, 2022 and 2021, the Company's cash and cash equivalents were primarily comprised of money market funds.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Short-Term Investments&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Available-for-sale securities are carried at fair value, with the unrealized gains and losses reported in comprehensive loss. The amortized cost of available-for-sale debt securities is adjusted for amortization of premiums and accretion of discounts to maturity. Such amortization and accretion are included in interest income. Realized gains and losses and declines in value judged to be other-than-temporary, if any, on available-for-sale securities are included in other income or expense. The cost of securities sold is based on the specific identification method. Interest and dividends on securities classified as available-for-sale are included in interest income.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Accounts Receivable&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Accounts receivable includes trade accounts receivables from the Ono Asset Purchase Agreement (see Note 9). Reimbursable costs that have not been invoiced as of the balance sheet date are recorded as unbilled accounts receivable. As of December 31, 2022, the Company had unbilled accounts receivable totaling $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2.8&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million classified as accounts receivable on its consolidated balance sheet. As of December 31, 2021, the Company did &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;t have any amount recorded within accounts receivable on its consolidated balance sheet. The Company makes judgments as to its ability to collect outstanding receivables and provide an allowance for receivables when collection becomes doubtful. Allowance for credit risk for accounts receivables  are established based on various factors including credit profiles of the Company&#x2019;s customers, historical payments and current economic trends. The Company reviews its allowance for accounts receivables by assessing individual accounts receivable over a specific aging and amount.  The estimate of expected credit losses is based on information about past events, current economic conditions, and forecasts of future economic conditions that affect the collectability. Accounts receivable are written-off on a case by case basis, net of any amounts that may be collected. As of each of December 31, 2022 and 2021, &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; credit losses have been recorded by the Company.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Prepaid Expenses and Other Current Assets&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Prepaid expenses and other current assets primarily represent amounts related to director and officer insurance, preclinical research and clinical study agreements, equity issuance costs and an estimated tax refund from the Australian Tax Office for eligible research and development expenditures.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Property and Equipment&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Property and equipment is stated at cost and depreciated using the straight-line method over the estimated useful lives of the assets (generally &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="-sec-ix-hidden:F_25b946aa-ecb7-4d36-9827-13132f6bd5be;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;three&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; to &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;five years&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;).&lt;/span&gt;&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Leases&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company determines if an arrangement is a lease at inception. Lease right-of-use assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. For operating leases with an initial term greater than 12 months, the Company recognizes operating lease right-of-use assets and operating lease liabilities based on the present value of lease payments over the lease term at the commencement date. Operating lease right-of-use assets are comprised of the lease liability plus any lease payments made and excludes lease incentives. Lease terms include options to renew or terminate the lease when we are reasonably certain that the renewal option will be exercised or when it is reasonably certain that the termination option will not be exercised. For our operating leases, if the interest rate used to determine the present value of future lease payments is not readily determinable, the Company estimates its incremental borrowing rate as the discount rate for the lease. Our incremental borrowing rate is estimated to approximate the interest rate on a collateralized basis with similar terms and payments, and in similar economic environments. Lease expense for lease payments is recognized on a straight-line basis over the lease term. The Company has elected the practical expedient to not separate lease and non-lease components.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Impairment of Long-Lived Assets&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Long-lived &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;assets consist primarily of property and equipment. An impairment loss is recorded if and when events and circumstances indicate that assets might be impaired and the undiscounted cash flows estimated to be generated by those&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;assets &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;are less than the carrying amount of those assets. While the Company&#x2019;s current and historical operating losses and negative cash flows are indicators of impairment, management believes that future cash flows to be received support the carrying value of its long-lived assets and, accordingly, has not recognized any impairment losses since inception.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Accrued Research and Development Expense&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company is required to estimate its expenses resulting from its obligations under contracts with vendors, consultants and contract research organizations, in connection with conducting research and development activities. The financial terms of these contracts are subject to negotiations, which vary from contract to contract and may result in payment flows that do not match the periods over which materials or services are provided under such contracts. The Company reflects research and development expenses in its consolidated financial statements by matching those expenses with the period in which services and efforts are expended. The Company accounts for these expenses according to the progress of the nonclinical or clinical study as measured by the timing of various aspects of the study or related activities. The Company determines accrual estimates through review of the underlying contracts along with preparation of financial models taking into account discussions with research and other key personnel as to the progress of studies, or other services being conducted. During the course of a non-clinical study or clinical study, the Company adjusts its rate of expense recognition if actual results differ from its estimates. The Company classifies its estimates for accrued research and development expenses as accrued expenses on the accompanying consolidated balance sheet.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Australian Research and Development Tax Incentive&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company is eligible under the Australian Research and Development Tax Incentive Program, or the Tax Incentive, to obtain a cash refund from the Australian Taxation Office for eligible research and development expenditures. To be eligible, the Company must have revenue of less than AUD $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;20.0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million during the reimbursable period and cannot be controlled by income tax exempt entities. The Tax Incentive is recognized as a reduction to research and development expense when there is reasonable assurance that the Tax Incentive will be received, the relevant expenditure has been incurred, and the amount can be reliably measured. The Company classifies its estimate for the Tax Incentive as prepaid expenses and other current assets on the accompanying consolidated balance sheet. As of December 31, 2022 and 2021, the Company recorded $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1.0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.3&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; within  prepaid and other current assets attributed to the Tax Incentive, respectively.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Revenue Recognition&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company recognizes revenue in a manner that depicts the transfer of control of a product or a service to a customer and reflects the amount of the consideration the Company is entitled to receive in exchange for such product or service. In doing so, the Company follows a five-step approach: (i) identify the contract with a customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, (iv) allocate the transaction price to the performance obligations, and (v) recognize revenue when (or as) the customer obtains control of the product or service. The Company considers the terms of a contract and all relevant facts and circumstances when applying the revenue recognition standard. The Company applies the revenue recognition standard, including the use of any practical expedients, consistently to contracts with similar characteristics and in similar circumstances.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;A customer is a party that has entered into a contract with the Company, where the purpose of the contract is to obtain a product or a service that is an output of the Company&#x2019;s ordinary activities in exchange for consideration. To be considered a contract, (i) the contract must be approved (in writing, orally, or in accordance with other customary business practices), (ii) each party&#x2019;s rights regarding the product or the service to be transferred can be identified, (iii) the payment terms for the product or the service to be transferred can be identified, (iv) the contract must have commercial substance (that is, the risk, timing or amount of future cash flows is expected to change as a result of the contract), and (v) it is probable that the Company will collect substantially all of the consideration to which it is entitled to receive in exchange for the transfer of the product or the service.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;A performance obligation is defined as a promise to transfer a product or a service to a customer. The Company identifies each promise to transfer a product or a service (or a bundle of products or services, or a series of products and services that are substantially the same and have the same pattern of transfer) that is distinct. A product or a service is distinct if both (i) the customer can benefit from the product or the service either on its own or together with other resources that are readily available to the customer and (ii) the Company&#x2019;s promise to transfer the product or the service to the customer is separately identifiable from other promises in the contract. Each distinct promise to transfer a product or a service is a unit of accounting for revenue recognition. If a promise to transfer a product or a service is not separately identifiable from other promises in the contract, such promises should be combined into a single performance obligation.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The transaction price is the amount of consideration the Company is entitled to receive in exchange for the transfer of control of a product or a service to a customer. To determine the transaction price, the Company considers the existence of any significant financing component, the effects of any variable elements, noncash considerations and consideration payable to the customer. If a significant financing component exists, the transaction price is adjusted for the time value of money. If an element of variability exists, the Company must estimate the consideration it expects to receive and uses that amount as the basis for recognizing revenue as the product or the service is transferred to the customer. There are two methods for determining the amount of variable consideration: (i) the expected value method, which is the sum of probability-weighted amounts in a range of possible consideration amounts, and (ii) the mostly likely amount method, which identifies the single most likely amount in a range of possible consideration amounts.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;If a contract has multiple performance obligations, the Company allocates the transaction price to each distinct performance obligation in an amount that reflects the consideration the Company is entitled to receive in exchange for satisfying each distinct performance obligation. For each distinct performance obligation, revenue is recognized when (or as) the Company transfers control of the product or the service applicable to such performance obligation.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;In those instances where the Company first receives consideration in advance of satisfying its performance obligation, the Company classifies such consideration as deferred revenue until (or as) the Company satisfies such performance obligation. In those instances where the Company first satisfies its performance obligation prior to its receipt of consideration, the consideration is recorded as accounts receivable.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company expenses incremental costs of obtaining and fulfilling a contract as and when incurred if the expected amortization period of the asset that would be recognized is one year or less, or if the amount of the asset is immaterial. Otherwise, such costs are capitalized as contract assets if they are incremental to the contract and amortized to expense proportionate to revenue recognition of the underlying contract.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Contract Assets&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company does not have material amounts of contract assets since revenue is recognized as control of goods is transferred or as services are performed. There are a small number of research and development services that may occur over a period of time, but that period of time is generally very short in duration. Any contract assets that may arise are recorded in accounts receivable in the Company&#x2019;s consolidated balance sheet net of an allowance for credit losses.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Contract Liabilities&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company&#x2019;s contract liabilities consist of advance payments and deferred revenue. The Company classifies advance payments and deferred revenue as current or noncurrent based on the timing of when it expects to recognize revenue. Generally, all contract liabilities are expected to be recognized within one year and are included in deferred revenue in the Company&#x2019;s consolidated balance sheet. The noncurrent portion of deferred revenue is included and separately disclosed in the Company&#x2019;s consolidated balance sheet.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Acquired In-Process Research and Development Expense&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company has acquired, and may continue to acquire, the rights to develop new product candidates. Payments to acquire a new product candidate, as well as future milestone payments associated with asset acquisitions in which contingent payments are resolved are immediately expensed as acquired in-process research and development provided that the product candidate has not achieved regulatory approval for marketing and, absent obtaining such approval, has no alternative future use.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Research and Development&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Research and development expenses include salaries and related overhead expenses, non-cash stock-based compensation expense, external research and development expenses incurred under arrangements with third parties, costs of services performed by consultants and contract research organizations, and regulatory costs including those related to preparing and filing INDs with the FDA. Research and development costs are expensed as incurred.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Patent Costs&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company expenses all costs as incurred in connection with patent applications (including direct application fees, and the legal and consulting expenses related to making such applications) and such costs are included in general and administrative expenses in the consolidated statement of operations.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Stock-based Compensation&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company measures employee and nonemployee stock-based awards, including stock options and purchase rights, at grant-date fair value and records compensation expense on a straight-line basis over the vesting period of the award. The Company uses the Black-Scholes option pricing model to value its stock option awards. Estimating the fair value of stock option awards requires management to apply judgment and make estimates of certain assumptions, including the volatility of the Company&#x2019;s common stock, the expected term of the Company&#x2019;s stock options, the expected dividend yield and the fair value of the Company&#x2019;s common stock on the measurement date. As a result, if factors change and management uses different assumptions, stock-based compensation expense could be materially different for future awards.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Income Taxes&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company accounts for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the consolidated financial statements. Under this method, deferred tax assets and liabilities are determined on the basis of the differences between the consolidated financial statements and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in income in the period that includes the enactment date.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company recognizes deferred tax assets to the extent that the Company believes these assets are more likely than not to be realized. In making such a determination, management considers all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax-planning strategies, and results of recent operations. If management determines that the Company would be able to realize its deferred tax assets in the future in excess of their net recorded amount, management would make an adjustment to the deferred tax asset valuation allowance, which would reduce the provision for income taxes.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company records uncertain tax positions on the basis of a two-step process whereby (1) management determines whether it is more likely than not that the tax positions will be sustained on the basis of the technical merits of the position and (2) for those tax positions that meet the more- likely-than-not recognition threshold, management recognizes the largest amount of tax benefit that is more than &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;50&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; percent likely to be realized upon ultimate settlement with the related tax authority. The Company recognizes interest and penalties related to unrecognized tax benefits within income tax expense. Any accrued interest and penalties are included within the related tax liability.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Net Loss per Share&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Basic net loss per share is calculated by dividing the net loss by the weighted-average number of common shares outstanding for the period. Diluted net loss per share is computed by dividing the net loss by the weighted average number of common shares and common share equivalents outstanding for the period. Common stock equivalents are only included when their effect is dilutive. The Company&#x2019;s potentially dilutive securities include outstanding options under the Company&#x2019;s equity incentive plan and outstanding warrants to purchase common stock, each of which have been excluded from the computation of diluted net loss per share as they would be anti-dilutive to the net loss per share. For all periods presented, there is no difference in the number of shares used to calculate basic and diluted shares outstanding due to the Company&#x2019;s net loss position.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Potentially dilutive securities not included in the calculation of diluted net loss per share attributable to common stockholders because to do so would be anti-dilutive are as follows (in common stock equivalent shares):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
         &lt;tr style="visibility:collapse;"&gt;
          &lt;td style="width:61.855%;"/&gt;
          &lt;td style="width:0.994%;"/&gt;
          &lt;td style="width:1.0%;"/&gt;
          &lt;td style="width:15.388%;"/&gt;
          &lt;td style="width:1.0%;"/&gt;
          &lt;td style="width:1.279%;"/&gt;
          &lt;td style="width:1.009%;"/&gt;
          &lt;td style="width:1.0%;"/&gt;
          &lt;td style="width:15.474%;"/&gt;
          &lt;td style="width:1.0%;"/&gt;
         &lt;/tr&gt;
         &lt;tr style="height:8.0pt;"&gt;
          &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="7" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Year Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:8.0pt;"&gt;
          &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Common stock options&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5,102,501&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3,947,025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Common stock warrants&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,366,141&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,366,141&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6,468,642&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5,313,166&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
        &lt;/table&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      id="F_c3898495-bf04-47b4-95bb-0fd4cec04c09">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Use of Estimates&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The preparation of the Company&#x2019;s consolidated financial statements requires the Company to make estimates and assumptions that impact the reported amounts of assets, liabilities and expenses and the disclosure of contingent assets and liabilities in the consolidated financial statements and accompanying notes. Significant estimates in the Company&#x2019;s consolidated financial statements relate to accrued research and development expense, revenue recognition and the valuation of equity awards. Management evaluates its estimates on an ongoing basis. Although estimates are based on the Company&#x2019;s historical experience, knowledge of current events, and actions it may undertake in the future, actual results may ultimately materially differ from these estimates and assumptions.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;</us-gaap:UseOfEstimates>
    <us-gaap:ConcentrationRiskCreditRisk
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      id="F_bf558d1e-1f50-4570-b17e-82ef512803a6">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Concentration of Credit Risk and Off-Balance Sheet Risk&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Financial instruments which potentially subject the Company to significant concentration of credit risk consist of cash and cash equivalents and short-term investments. The Company maintains deposits in federally insured financial institutions in excess of federally insured limits. The Company has not experienced any losses in such accounts, and management believes that the Company is not exposed to significant credit risk due to the financial position of the depository institutions in which those deposits are held. The Company&#x2019;s investment policy includes guidelines for the quality of the related institutions and financial instruments and defines allowable investments that the Company may invest in, which the Company believes minimizes the exposure to concentration of credit risk.&lt;/span&gt;&lt;/p&gt;</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:ComprehensiveIncomePolicyPolicyTextBlock
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      id="F_3425b429-fdaf-4705-b173-33b2a4c8c83c">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Comprehensive Loss&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company is required to report all components of comprehensive loss, including net loss, in the consolidated financial statements in the period in which they are recognized. Comprehensive loss is defined as the change in equity during a period from transactions and other events and circumstances from non-owner sources, including unrealized gains and losses on investments and foreign currency gains and losses. Other comprehensive income, net includes unrealized losses and gains on short-term investments as well as foreign currency translation gains and losses.&lt;/span&gt;&lt;/p&gt;</us-gaap:ComprehensiveIncomePolicyPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      id="F_5bb4a8ef-2802-482d-a6b5-56ef92d67fd3">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Cash and cash equivalents include cash in readily available checking and savings accounts, and money market funds. The Company considers all highly liquid investments with an original maturity of three months or less from the date of purchase to be cash equivalents. At December 31, 2022 and 2021, the Company's cash and cash equivalents were primarily comprised of money market funds.&lt;/span&gt;&lt;/p&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <eq:ShortTermInvestmentsPolicyTextBlock
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      id="F_16578163-1bc5-422a-a219-dfffda919932">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Short-Term Investments&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Available-for-sale securities are carried at fair value, with the unrealized gains and losses reported in comprehensive loss. The amortized cost of available-for-sale debt securities is adjusted for amortization of premiums and accretion of discounts to maturity. Such amortization and accretion are included in interest income. Realized gains and losses and declines in value judged to be other-than-temporary, if any, on available-for-sale securities are included in other income or expense. The cost of securities sold is based on the specific identification method. Interest and dividends on securities classified as available-for-sale are included in interest income.&lt;/span&gt;&lt;/p&gt;</eq:ShortTermInvestmentsPolicyTextBlock>
    <us-gaap:ReceivablesPolicyTextBlock
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      id="F_9c666fef-73e4-40da-8b94-bd92e9125dcd">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Accounts Receivable&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Accounts receivable includes trade accounts receivables from the Ono Asset Purchase Agreement (see Note 9). Reimbursable costs that have not been invoiced as of the balance sheet date are recorded as unbilled accounts receivable. As of December 31, 2022, the Company had unbilled accounts receivable totaling $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2.8&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million classified as accounts receivable on its consolidated balance sheet. As of December 31, 2021, the Company did &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;t have any amount recorded within accounts receivable on its consolidated balance sheet. The Company makes judgments as to its ability to collect outstanding receivables and provide an allowance for receivables when collection becomes doubtful. Allowance for credit risk for accounts receivables  are established based on various factors including credit profiles of the Company&#x2019;s customers, historical payments and current economic trends. The Company reviews its allowance for accounts receivables by assessing individual accounts receivable over a specific aging and amount.  The estimate of expected credit losses is based on information about past events, current economic conditions, and forecasts of future economic conditions that affect the collectability. Accounts receivable are written-off on a case by case basis, net of any amounts that may be collected. As of each of December 31, 2022 and 2021, &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; credit losses have been recorded by the Company.&lt;/span&gt;&lt;/p&gt;</us-gaap:ReceivablesPolicyTextBlock>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192"
      decimals="-5"
      id="F_32866f53-af49-43ee-a3f8-8d2bb29b9ae3"
      unitRef="U_USD">2800000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94"
      decimals="-3"
      id="F_a39562c3-06eb-449a-b7fc-a1555d8eb2bb"
      unitRef="U_USD">0</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94"
      decimals="-3"
      id="F_73a697ad-7281-4309-998f-cc0efd111058"
      unitRef="U_USD">0</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192"
      decimals="-3"
      id="F_7c1a2b48-42cb-4445-93fe-e47c9d9e1d4d"
      unitRef="U_USD">0</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <eq:PrepaidExpensesAndOtherCurrentAssetsPolicyPolicyTextBlock
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      id="F_91540477-194f-45f3-8ea6-214bdbac9b1a">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Prepaid Expenses and Other Current Assets&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Prepaid expenses and other current assets primarily represent amounts related to director and officer insurance, preclinical research and clinical study agreements, equity issuance costs and an estimated tax refund from the Australian Tax Office for eligible research and development expenditures.&lt;/span&gt;&lt;/p&gt;</eq:PrepaidExpensesAndOtherCurrentAssetsPolicyPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      id="F_dd6acc5b-3250-42d7-98f8-1c25dcc17255">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Property and Equipment&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Property and equipment is stated at cost and depreciated using the straight-line method over the estimated useful lives of the assets (generally &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="-sec-ix-hidden:F_25b946aa-ecb7-4d36-9827-13132f6bd5be;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;three&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; to &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;five years&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;).&lt;/span&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="C_6c6eb418-4e31-405d-80e2-4eeaa0ed0949"
      id="F_5ce4fd9d-f20e-4140-ae71-f4e8c899ad6c">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:LesseeLeasesPolicyTextBlock
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      id="F_dd35255a-2855-4b8e-905f-c89a39c1c2ab">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Leases&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company determines if an arrangement is a lease at inception. Lease right-of-use assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. For operating leases with an initial term greater than 12 months, the Company recognizes operating lease right-of-use assets and operating lease liabilities based on the present value of lease payments over the lease term at the commencement date. Operating lease right-of-use assets are comprised of the lease liability plus any lease payments made and excludes lease incentives. Lease terms include options to renew or terminate the lease when we are reasonably certain that the renewal option will be exercised or when it is reasonably certain that the termination option will not be exercised. For our operating leases, if the interest rate used to determine the present value of future lease payments is not readily determinable, the Company estimates its incremental borrowing rate as the discount rate for the lease. Our incremental borrowing rate is estimated to approximate the interest rate on a collateralized basis with similar terms and payments, and in similar economic environments. Lease expense for lease payments is recognized on a straight-line basis over the lease term. The Company has elected the practical expedient to not separate lease and non-lease components.&lt;/span&gt;&lt;/p&gt;</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      id="F_09f8d620-7aa6-4861-a075-763eb14fbb99">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Impairment of Long-Lived Assets&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Long-lived &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;assets consist primarily of property and equipment. An impairment loss is recorded if and when events and circumstances indicate that assets might be impaired and the undiscounted cash flows estimated to be generated by those&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;assets &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;are less than the carrying amount of those assets. While the Company&#x2019;s current and historical operating losses and negative cash flows are indicators of impairment, management believes that future cash flows to be received support the carrying value of its long-lived assets and, accordingly, has not recognized any impairment losses since inception.&lt;/span&gt;&lt;/p&gt;</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <eq:AccruedResearchAndDevelopmentExpensePolicyTextBlock
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      id="F_a3e08e78-3e74-4931-8390-304ed7e97085">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Accrued Research and Development Expense&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company is required to estimate its expenses resulting from its obligations under contracts with vendors, consultants and contract research organizations, in connection with conducting research and development activities. The financial terms of these contracts are subject to negotiations, which vary from contract to contract and may result in payment flows that do not match the periods over which materials or services are provided under such contracts. The Company reflects research and development expenses in its consolidated financial statements by matching those expenses with the period in which services and efforts are expended. The Company accounts for these expenses according to the progress of the nonclinical or clinical study as measured by the timing of various aspects of the study or related activities. The Company determines accrual estimates through review of the underlying contracts along with preparation of financial models taking into account discussions with research and other key personnel as to the progress of studies, or other services being conducted. During the course of a non-clinical study or clinical study, the Company adjusts its rate of expense recognition if actual results differ from its estimates. The Company classifies its estimates for accrued research and development expenses as accrued expenses on the accompanying consolidated balance sheet.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;</eq:AccruedResearchAndDevelopmentExpensePolicyTextBlock>
    <eq:AustralianResearchAndDevelopmentTaxIncentivePolicyTextBlock
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      id="F_77a7033d-f9f3-4987-9bec-88711ee8d928">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Australian Research and Development Tax Incentive&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company is eligible under the Australian Research and Development Tax Incentive Program, or the Tax Incentive, to obtain a cash refund from the Australian Taxation Office for eligible research and development expenditures. To be eligible, the Company must have revenue of less than AUD $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;20.0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million during the reimbursable period and cannot be controlled by income tax exempt entities. The Tax Incentive is recognized as a reduction to research and development expense when there is reasonable assurance that the Tax Incentive will be received, the relevant expenditure has been incurred, and the amount can be reliably measured. The Company classifies its estimate for the Tax Incentive as prepaid expenses and other current assets on the accompanying consolidated balance sheet. As of December 31, 2022 and 2021, the Company recorded $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1.0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.3&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; within  prepaid and other current assets attributed to the Tax Incentive, respectively.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;</eq:AustralianResearchAndDevelopmentTaxIncentivePolicyTextBlock>
    <eq:ResearchAndDevelopmentTaxIncentiveRevenueCriteria
      contextRef="C_118d4267-0758-4b9a-ac2a-e75bcfe13d76"
      decimals="-5"
      id="F_3ac57557-7965-40de-bb87-995b9ba193a2"
      unitRef="U_USD">20000000.0</eq:ResearchAndDevelopmentTaxIncentiveRevenueCriteria>
    <eq:PrepaidAndOtherCurrentAssetsTaxIncentive
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      decimals="-5"
      id="F_08e197e0-eda9-4710-b8b6-6ade26096993"
      unitRef="U_USD">1000000.0</eq:PrepaidAndOtherCurrentAssetsTaxIncentive>
    <eq:PrepaidAndOtherCurrentAssetsTaxIncentive
      contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2"
      decimals="-5"
      id="F_bf14a918-3a7c-4188-8aa9-792c8d934760"
      unitRef="U_USD">300000</eq:PrepaidAndOtherCurrentAssetsTaxIncentive>
    <us-gaap:RevenueRecognitionPolicyTextBlock
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      id="F_9855419a-9e00-432a-9dc7-533b815e7cd2">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Revenue Recognition&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company recognizes revenue in a manner that depicts the transfer of control of a product or a service to a customer and reflects the amount of the consideration the Company is entitled to receive in exchange for such product or service. In doing so, the Company follows a five-step approach: (i) identify the contract with a customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, (iv) allocate the transaction price to the performance obligations, and (v) recognize revenue when (or as) the customer obtains control of the product or service. The Company considers the terms of a contract and all relevant facts and circumstances when applying the revenue recognition standard. The Company applies the revenue recognition standard, including the use of any practical expedients, consistently to contracts with similar characteristics and in similar circumstances.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;A customer is a party that has entered into a contract with the Company, where the purpose of the contract is to obtain a product or a service that is an output of the Company&#x2019;s ordinary activities in exchange for consideration. To be considered a contract, (i) the contract must be approved (in writing, orally, or in accordance with other customary business practices), (ii) each party&#x2019;s rights regarding the product or the service to be transferred can be identified, (iii) the payment terms for the product or the service to be transferred can be identified, (iv) the contract must have commercial substance (that is, the risk, timing or amount of future cash flows is expected to change as a result of the contract), and (v) it is probable that the Company will collect substantially all of the consideration to which it is entitled to receive in exchange for the transfer of the product or the service.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;A performance obligation is defined as a promise to transfer a product or a service to a customer. The Company identifies each promise to transfer a product or a service (or a bundle of products or services, or a series of products and services that are substantially the same and have the same pattern of transfer) that is distinct. A product or a service is distinct if both (i) the customer can benefit from the product or the service either on its own or together with other resources that are readily available to the customer and (ii) the Company&#x2019;s promise to transfer the product or the service to the customer is separately identifiable from other promises in the contract. Each distinct promise to transfer a product or a service is a unit of accounting for revenue recognition. If a promise to transfer a product or a service is not separately identifiable from other promises in the contract, such promises should be combined into a single performance obligation.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The transaction price is the amount of consideration the Company is entitled to receive in exchange for the transfer of control of a product or a service to a customer. To determine the transaction price, the Company considers the existence of any significant financing component, the effects of any variable elements, noncash considerations and consideration payable to the customer. If a significant financing component exists, the transaction price is adjusted for the time value of money. If an element of variability exists, the Company must estimate the consideration it expects to receive and uses that amount as the basis for recognizing revenue as the product or the service is transferred to the customer. There are two methods for determining the amount of variable consideration: (i) the expected value method, which is the sum of probability-weighted amounts in a range of possible consideration amounts, and (ii) the mostly likely amount method, which identifies the single most likely amount in a range of possible consideration amounts.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;If a contract has multiple performance obligations, the Company allocates the transaction price to each distinct performance obligation in an amount that reflects the consideration the Company is entitled to receive in exchange for satisfying each distinct performance obligation. For each distinct performance obligation, revenue is recognized when (or as) the Company transfers control of the product or the service applicable to such performance obligation.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;In those instances where the Company first receives consideration in advance of satisfying its performance obligation, the Company classifies such consideration as deferred revenue until (or as) the Company satisfies such performance obligation. In those instances where the Company first satisfies its performance obligation prior to its receipt of consideration, the consideration is recorded as accounts receivable.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company expenses incremental costs of obtaining and fulfilling a contract as and when incurred if the expected amortization period of the asset that would be recognized is one year or less, or if the amount of the asset is immaterial. Otherwise, such costs are capitalized as contract assets if they are incremental to the contract and amortized to expense proportionate to revenue recognition of the underlying contract.&lt;/span&gt;&lt;/p&gt;</us-gaap:RevenueRecognitionPolicyTextBlock>
    <eq:ContractAssetsPolicyPolicyTextBlock
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      id="F_65ab6737-a827-449c-b3c0-b9e4f74fcaeb">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Contract Assets&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company does not have material amounts of contract assets since revenue is recognized as control of goods is transferred or as services are performed. There are a small number of research and development services that may occur over a period of time, but that period of time is generally very short in duration. Any contract assets that may arise are recorded in accounts receivable in the Company&#x2019;s consolidated balance sheet net of an allowance for credit losses.&lt;/span&gt;&lt;/p&gt;</eq:ContractAssetsPolicyPolicyTextBlock>
    <eq:ContractLiabilitiesPolicyPolicyTextBlock
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      id="F_8383f712-9b44-41c2-8b7c-e0649ac3dfd6">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Contract Liabilities&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company&#x2019;s contract liabilities consist of advance payments and deferred revenue. The Company classifies advance payments and deferred revenue as current or noncurrent based on the timing of when it expects to recognize revenue. Generally, all contract liabilities are expected to be recognized within one year and are included in deferred revenue in the Company&#x2019;s consolidated balance sheet. The noncurrent portion of deferred revenue is included and separately disclosed in the Company&#x2019;s consolidated balance sheet.&lt;/span&gt;&lt;/p&gt;</eq:ContractLiabilitiesPolicyPolicyTextBlock>
    <us-gaap:InProcessResearchAndDevelopmentPolicy
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      id="F_e3faeb9b-d61e-41be-9e26-a832ba32f1eb">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Acquired In-Process Research and Development Expense&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company has acquired, and may continue to acquire, the rights to develop new product candidates. Payments to acquire a new product candidate, as well as future milestone payments associated with asset acquisitions in which contingent payments are resolved are immediately expensed as acquired in-process research and development provided that the product candidate has not achieved regulatory approval for marketing and, absent obtaining such approval, has no alternative future use.&lt;/span&gt;&lt;/p&gt;</us-gaap:InProcessResearchAndDevelopmentPolicy>
    <us-gaap:ResearchAndDevelopmentExpensePolicy
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      id="F_565bfba3-1b5c-416d-b808-95e9507f0e7f">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Research and Development&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Research and development expenses include salaries and related overhead expenses, non-cash stock-based compensation expense, external research and development expenses incurred under arrangements with third parties, costs of services performed by consultants and contract research organizations, and regulatory costs including those related to preparing and filing INDs with the FDA. Research and development costs are expensed as incurred.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <eq:PatentCostsPolicyTextBlock
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      id="F_ec7d2825-a96c-45e6-8cf1-d4340362dddb">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Patent Costs&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company expenses all costs as incurred in connection with patent applications (including direct application fees, and the legal and consulting expenses related to making such applications) and such costs are included in general and administrative expenses in the consolidated statement of operations.&lt;/span&gt;</eq:PatentCostsPolicyTextBlock>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      id="F_0529d847-d62e-4e2b-9611-710a5cc35720">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Stock-based Compensation&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company measures employee and nonemployee stock-based awards, including stock options and purchase rights, at grant-date fair value and records compensation expense on a straight-line basis over the vesting period of the award. The Company uses the Black-Scholes option pricing model to value its stock option awards. Estimating the fair value of stock option awards requires management to apply judgment and make estimates of certain assumptions, including the volatility of the Company&#x2019;s common stock, the expected term of the Company&#x2019;s stock options, the expected dividend yield and the fair value of the Company&#x2019;s common stock on the measurement date. As a result, if factors change and management uses different assumptions, stock-based compensation expense could be materially different for future awards.&lt;/span&gt;&lt;/p&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:IncomeTaxPolicyTextBlock
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      id="F_4bd2f5f8-3da6-4912-b49f-77d108006ab0">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Income Taxes&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company accounts for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the consolidated financial statements. Under this method, deferred tax assets and liabilities are determined on the basis of the differences between the consolidated financial statements and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in income in the period that includes the enactment date.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company recognizes deferred tax assets to the extent that the Company believes these assets are more likely than not to be realized. In making such a determination, management considers all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax-planning strategies, and results of recent operations. If management determines that the Company would be able to realize its deferred tax assets in the future in excess of their net recorded amount, management would make an adjustment to the deferred tax asset valuation allowance, which would reduce the provision for income taxes.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company records uncertain tax positions on the basis of a two-step process whereby (1) management determines whether it is more likely than not that the tax positions will be sustained on the basis of the technical merits of the position and (2) for those tax positions that meet the more- likely-than-not recognition threshold, management recognizes the largest amount of tax benefit that is more than &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;50&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; percent likely to be realized upon ultimate settlement with the related tax authority. The Company recognizes interest and penalties related to unrecognized tax benefits within income tax expense. Any accrued interest and penalties are included within the related tax liability.&lt;/span&gt;&lt;/p&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <eq:PercentageOfTaxBenefitToBeRealizedUponUltimateSettlementWithTaxAuthority
      contextRef="C_6658e49b-c37e-401c-873e-60a833ca00d9"
      decimals="2"
      id="F_917eb0f7-0a59-4eee-a200-c1a8eee51986"
      unitRef="U_pure">0.50</eq:PercentageOfTaxBenefitToBeRealizedUponUltimateSettlementWithTaxAuthority>
    <us-gaap:EarningsPerSharePolicyTextBlock
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      id="F_e65bf5e3-3640-4bdc-ac2d-2c5324a6121a">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Net Loss per Share&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Basic net loss per share is calculated by dividing the net loss by the weighted-average number of common shares outstanding for the period. Diluted net loss per share is computed by dividing the net loss by the weighted average number of common shares and common share equivalents outstanding for the period. Common stock equivalents are only included when their effect is dilutive. The Company&#x2019;s potentially dilutive securities include outstanding options under the Company&#x2019;s equity incentive plan and outstanding warrants to purchase common stock, each of which have been excluded from the computation of diluted net loss per share as they would be anti-dilutive to the net loss per share. For all periods presented, there is no difference in the number of shares used to calculate basic and diluted shares outstanding due to the Company&#x2019;s net loss position.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Potentially dilutive securities not included in the calculation of diluted net loss per share attributable to common stockholders because to do so would be anti-dilutive are as follows (in common stock equivalent shares):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
         &lt;tr style="visibility:collapse;"&gt;
          &lt;td style="width:61.855%;"/&gt;
          &lt;td style="width:0.994%;"/&gt;
          &lt;td style="width:1.0%;"/&gt;
          &lt;td style="width:15.388%;"/&gt;
          &lt;td style="width:1.0%;"/&gt;
          &lt;td style="width:1.279%;"/&gt;
          &lt;td style="width:1.009%;"/&gt;
          &lt;td style="width:1.0%;"/&gt;
          &lt;td style="width:15.474%;"/&gt;
          &lt;td style="width:1.0%;"/&gt;
         &lt;/tr&gt;
         &lt;tr style="height:8.0pt;"&gt;
          &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="7" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Year Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:8.0pt;"&gt;
          &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Common stock options&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5,102,501&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3,947,025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Common stock warrants&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,366,141&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,366,141&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6,468,642&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5,313,166&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
        &lt;/table&gt;&lt;/div&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      id="F_4b2c1c2c-8c56-4b37-91af-e59394302e1b">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Potentially dilutive securities not included in the calculation of diluted net loss per share attributable to common stockholders because to do so would be anti-dilutive are as follows (in common stock equivalent shares):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
         &lt;tr style="visibility:collapse;"&gt;
          &lt;td style="width:61.855%;"/&gt;
          &lt;td style="width:0.994%;"/&gt;
          &lt;td style="width:1.0%;"/&gt;
          &lt;td style="width:15.388%;"/&gt;
          &lt;td style="width:1.0%;"/&gt;
          &lt;td style="width:1.279%;"/&gt;
          &lt;td style="width:1.009%;"/&gt;
          &lt;td style="width:1.0%;"/&gt;
          &lt;td style="width:15.474%;"/&gt;
          &lt;td style="width:1.0%;"/&gt;
         &lt;/tr&gt;
         &lt;tr style="height:8.0pt;"&gt;
          &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="7" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Year Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:8.0pt;"&gt;
          &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Common stock options&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5,102,501&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3,947,025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Common stock warrants&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,366,141&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,366,141&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6,468,642&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5,313,166&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
        &lt;/table&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_b6dbee35-e2f1-45ca-95ca-0d1198cb8c23"
      decimals="INF"
      id="F_e953f4ed-5047-4451-ace2-4777fe850c61"
      unitRef="U_shares">5102501</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_d6cbfdc9-1278-4b59-8f64-1c4df657d268"
      decimals="INF"
      id="F_1c391dda-3401-4d27-a4de-d8ed5dd2618f"
      unitRef="U_shares">3947025</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_266429a4-9ee0-4360-bdef-2bb916cfaeee"
      decimals="INF"
      id="F_e463fbf9-7a12-4d3c-b48e-60f68d034d2a"
      unitRef="U_shares">1366141</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_b6ed3cd2-aa70-4e39-9223-49223b495228"
      decimals="INF"
      id="F_be65e261-768b-4c68-b80c-5137d2eab6ad"
      unitRef="U_shares">1366141</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      decimals="INF"
      id="F_995710ea-64cf-4136-a27f-28548fa1d929"
      unitRef="U_shares">6468642</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2"
      decimals="INF"
      id="F_cbbd40df-433f-4b28-ade8-72f65fbed1c7"
      unitRef="U_shares">5313166</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      id="F_cbd3d599-5b1d-41bb-9056-88dc58cf5e96">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3. Fair Value of Financial Instruments&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The accounting guidance defines fair value, establishes a consistent framework for measuring fair value and expands disclosure for each major asset and liability category measured at fair value on either a recurring or nonrecurring basis. Fair value is defined as an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. As a basis for considering such assumptions, the accounting guidance establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value as follows:&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:3.333%;text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Level 1&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:3.333%;text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Level 2&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;Quoted prices for similar assets and liabilities in active markets, quoted prices in markets that are not active, or inputs which are observable, either directly or indirectly, for substantially the full term of the asset or liability.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:3.333%;text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Level 3&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (i.e., supported by little or no market activity).&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Financial assets measured at fair value on a recurring basis consist of the Company&#x2019;s cash equivalents and short-term investments. Cash equivalents consisted of money market funds and short-term investments consisted of U.S. treasury securities and certificates of deposit. The Company obtains pricing information from its investment manager and generally determines the fair value of investment securities using standard observable inputs, including reported trades, broker/dealer quotes, and bid and/or offers.&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:11.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The following tables summarize the Company&#x2019;s assets that require fair value measurements on a recurring basis and their respective input levels based on the fair value hierarchy (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:43.102%;"/&gt;
        &lt;td style="width:1.145%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:10.312%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.156%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:12.783%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.156%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:11.65%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.156%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:9.541%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="10" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Fair Value Measurements Using&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Quoted Prices in&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Significant&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Significant&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Active Markets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Unobservable&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;for Identical&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Observable&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Inputs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Assets (Level 1)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Inputs (Level 2)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(Level 3)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Short-term investments:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;U.S. treasury securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;11,916&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;11,916&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;11,916&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid rgba(255,255,255,0.01);background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;11,916&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid rgba(255,255,255,0.01);background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid rgba(255,255,255,0.01);background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid rgba(255,255,255,0.01);background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="10" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Fair Value Measurements Using&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Quoted Prices in&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Significant&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Significant&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Active Markets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Unobservable&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;for Identical&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Observable&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Inputs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Assets (Level 1)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Inputs (Level 2)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(Level 3)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Short-term investments:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;U.S. treasury securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;29,121&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;29,121&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Certificates of deposit&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,224&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,224&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;30,345&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;30,345&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;U.S. treasury securities and certificates of deposit are valued using Level 1 inputs. Level 1 securities are valued at unadjusted quoted prices in active markets that are observable at the measurement date for identical, unrestricted assets or liabilities. Fair values determined by Level 2 inputs, which utilize data points that are observable such as quoted prices, interest rates and yield curves, require the exercise of judgment and use of estimates, that if changed, could significantly affect the Company&#x2019;s financial position and results of operations. Investments in agency securities are valued using Level 2 inputs. Level 2 securities are initially valued at the transaction price and subsequently valued and reported utilizing inputs other than quoted prices that are observable either directly or indirectly, such as quotes from third-party pricing vendors.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The carrying amounts of the Company&#x2019;s financial instruments, including cash and cash equivalents, prepaid and other current assets, accounts payable, and accrued liabilities, approximate fair value due to their short maturities. At December 31, 2022 and 2021, the carrying amount of the Company&#x2019;s notes payable of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;9.0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;10.2&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million, respectively, approximated their fair value as the terms of the notes are consistent with the market terms of transactions with similar profiles (Level 2 inputs). None of the Company&#x2019;s non-financial assets or liabilities are recorded at fair value on a non-recurring basis.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company did &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;t hold any Level 1, 2 or 3 financial liabilities that are recorded at fair value on a recurring basis as of December 31, 2022 or 2021.&lt;/span&gt;&lt;/p&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      id="F_47852e37-f8c5-47ea-8fed-9a7b5a5356bd">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The following tables summarize the Company&#x2019;s assets that require fair value measurements on a recurring basis and their respective input levels based on the fair value hierarchy (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:43.102%;"/&gt;
        &lt;td style="width:1.145%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:10.312%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.156%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:12.783%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.156%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:11.65%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.156%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:9.541%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="10" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Fair Value Measurements Using&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Quoted Prices in&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Significant&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Significant&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Active Markets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Unobservable&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;for Identical&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Observable&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Inputs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Assets (Level 1)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Inputs (Level 2)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(Level 3)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Short-term investments:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;U.S. treasury securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;11,916&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;11,916&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;11,916&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid rgba(255,255,255,0.01);background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;11,916&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid rgba(255,255,255,0.01);background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid rgba(255,255,255,0.01);background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid rgba(255,255,255,0.01);background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="10" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Fair Value Measurements Using&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Quoted Prices in&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Significant&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Significant&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Active Markets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Unobservable&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;for Identical&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Observable&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Inputs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Assets (Level 1)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Inputs (Level 2)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(Level 3)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Short-term investments:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;U.S. treasury securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;29,121&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;29,121&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Certificates of deposit&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,224&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,224&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;30,345&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;30,345&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="C_2573431b-071f-404a-987e-c3e834333417"
      decimals="-3"
      id="F_853742af-ff87-471b-bd32-30284f24e671"
      unitRef="U_USD">11916000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="C_07d00b46-0b94-46d4-a9c0-90bd6e6336f4"
      decimals="-3"
      id="F_c8fcfd49-c2be-40e2-8e6f-8ff50fa55c8e"
      unitRef="U_USD">11916000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192"
      decimals="-3"
      id="F_23bcbd9b-25bb-4d49-9fc3-21ad66c774a5"
      unitRef="U_USD">11916000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="C_5c7a06ba-06bd-4791-bb56-70c464bf5ade"
      decimals="-3"
      id="F_235424ff-5427-4230-b84c-59f9ece4270d"
      unitRef="U_USD">11916000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="C_f45561af-aa60-4d08-8038-0001fb9d29dc"
      decimals="-3"
      id="F_f37bc87c-92b8-47ab-90ed-23c3e8c24106"
      unitRef="U_USD">29121000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="C_24991024-50f4-435b-ba4f-adcad994e80c"
      decimals="-3"
      id="F_fb5b3630-606c-4095-bbf6-278fc001f044"
      unitRef="U_USD">29121000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="C_977951f9-d851-4284-8eb0-cbc7afea37a5"
      decimals="-3"
      id="F_06139c31-89d8-4a8b-894c-2e527d12b0f4"
      unitRef="U_USD">1224000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="C_88bc9f46-dcc0-4d03-aa1a-d56bf1d35be2"
      decimals="-3"
      id="F_ab796921-f1be-4cc0-971b-0c0e1dd06c67"
      unitRef="U_USD">1224000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94"
      decimals="-3"
      id="F_033a2aae-ae78-4227-aa23-50be391b8c4f"
      unitRef="U_USD">30345000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="C_e0e5cffb-5c83-464c-b236-5ae5c1b3c851"
      decimals="-3"
      id="F_7c681590-0e67-44c4-92b0-ec4ad02c1754"
      unitRef="U_USD">30345000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:NotesPayable
      contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192"
      decimals="-5"
      id="F_e9515f87-d2af-486c-a022-31a6b0a63e54"
      unitRef="U_USD">9000000.0</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94"
      decimals="-5"
      id="F_1c36fd9b-7566-41b1-b63f-def8ed5ae4b7"
      unitRef="U_USD">10200000</us-gaap:NotesPayable>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192"
      decimals="INF"
      id="F_983cc593-b2f1-43c4-a2ca-d6aef0f25b86"
      unitRef="U_USD">0</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94"
      decimals="INF"
      id="F_dd094ad1-023d-49d3-8d73-de1c8665857b"
      unitRef="U_USD">0</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <eq:ShortTermInvestmentsTextBlock
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      id="F_40e8f37b-751a-4719-b3fc-fc1e66c7f22b">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4. Short-term Investments&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:11.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The following table summarizes the Company&#x2019;s short-term investments (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:47.169%;"/&gt;
        &lt;td style="width:0.543%;"/&gt;
        &lt;td style="width:9.997%;"/&gt;
        &lt;td style="width:0.543%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:8.01%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:0.543%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:8.01%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:0.556%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:8.326%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:0.265%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:8.035%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Maturity&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Amortized&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Unrealized&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Unrealized&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Estimated&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(in years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Cost&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Gains&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Losses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Fair Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;U.S. treasury securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1 &lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;or less&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;12,006&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;90&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;11,916&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;12,006&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid rgba(255,255,255,0.01);background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid rgba(255,255,255,0.01);background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;90&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid rgba(255,255,255,0.01);background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;11,916&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid rgba(255,255,255,0.01);background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;U.S. treasury securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;or less&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;17,122&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;7&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;17,115&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;U.S. treasury securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&amp;gt;&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;and &amp;lt;&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;12,049&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;43&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;12,006&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Certificates of deposit&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;or less&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,226&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,224&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;30,397&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;52&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;30,345&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;All of the Company&#x2019;s available-for-sale securities are available to the Company for use in its current operations. As a result, the Company categorizes all of these securities as current assets even though the stated maturity of some individual securities may be &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;one year&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; or more beyond the balance sheet date. All of the Company&#x2019;s securities have a maturity within &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;two years&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; of the balance sheet date.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;There were &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; impairments considered other-than-temporary during the periods presented, as it is management&#x2019;s intention and ability to hold the securities until a recovery of the cost basis or recovery of fair value. Unrealized gains and losses are included in accumulated other comprehensive income (loss).&lt;/span&gt;&lt;/p&gt;</eq:ShortTermInvestmentsTextBlock>
    <us-gaap:ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      id="F_9e4cabae-5fc0-42dd-980d-ad0460c52199">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The following table summarizes the Company&#x2019;s short-term investments (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:47.169%;"/&gt;
        &lt;td style="width:0.543%;"/&gt;
        &lt;td style="width:9.997%;"/&gt;
        &lt;td style="width:0.543%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:8.01%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:0.543%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:8.01%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:0.556%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:8.326%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:0.265%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:8.035%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Maturity&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Amortized&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Unrealized&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Unrealized&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Estimated&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(in years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Cost&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Gains&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Losses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Fair Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;U.S. treasury securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1 &lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;or less&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;12,006&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;90&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;11,916&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;12,006&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid rgba(255,255,255,0.01);background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid rgba(255,255,255,0.01);background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;90&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid rgba(255,255,255,0.01);background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;11,916&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid rgba(255,255,255,0.01);background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;U.S. treasury securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;or less&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;17,122&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;7&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;17,115&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;U.S. treasury securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&amp;gt;&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;and &amp;lt;&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;12,049&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;43&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;12,006&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Certificates of deposit&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;or less&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,226&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,224&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;30,397&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;52&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;30,345&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock>
    <us-gaap:DebtSecuritiesAvailableForSaleTerm
      contextRef="C_09b9a242-1fa2-404a-b6a9-1fc05149e6a4"
      id="F_7a6d51d4-c8d3-4f86-924c-ebf9517cacca">P1Y</us-gaap:DebtSecuritiesAvailableForSaleTerm>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_b4ad71ba-3e8b-4d50-87b0-1a81a509c6eb"
      decimals="-3"
      id="F_e77249b0-504a-4b18-91ea-6b15ec7b405f"
      unitRef="U_USD">12006000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_b4ad71ba-3e8b-4d50-87b0-1a81a509c6eb"
      decimals="-3"
      id="F_1241a878-c69f-46c7-ae09-027aa7c3aeda"
      unitRef="U_USD">90000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="C_b4ad71ba-3e8b-4d50-87b0-1a81a509c6eb"
      decimals="-3"
      id="F_2967f45f-645b-479d-9934-4e837abfbcbb"
      unitRef="U_USD">11916000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192"
      decimals="-3"
      id="F_cb19f79e-a724-4898-ac26-7f54e6bfc4ca"
      unitRef="U_USD">12006000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192"
      decimals="-3"
      id="F_cb6147bd-f1be-4e7f-8733-c92ff9970e38"
      unitRef="U_USD">90000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192"
      decimals="-3"
      id="F_23bf9dc7-5efb-43b3-9061-f56b7d5c63af"
      unitRef="U_USD">11916000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:DebtSecuritiesAvailableForSaleTerm
      contextRef="C_6f4556dd-c18e-4dc1-9c4a-842fa90452f5"
      id="F_d40c88f1-3a66-40c2-8a07-1eab0c2f6c78">P1Y</us-gaap:DebtSecuritiesAvailableForSaleTerm>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_9b5e1bd0-1a40-47d8-9914-690c782ec9e9"
      decimals="-3"
      id="F_dd6d8828-e7a4-4011-8bad-c25a0a1f4a62"
      unitRef="U_USD">17122000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_9b5e1bd0-1a40-47d8-9914-690c782ec9e9"
      decimals="-3"
      id="F_133c8259-78e3-4dcc-be5b-7d0fd0cc62ab"
      unitRef="U_USD">7000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="C_9b5e1bd0-1a40-47d8-9914-690c782ec9e9"
      decimals="-3"
      id="F_61231e3b-d38d-4609-ae88-bbfd2f97807d"
      unitRef="U_USD">17115000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:DebtSecuritiesAvailableForSaleTerm
      contextRef="C_22c07448-b3c4-4d7d-8903-20b3a5bbb42d"
      id="F_ea6f4312-2f6e-4dad-9dd7-b6f85be9ac92">P1Y</us-gaap:DebtSecuritiesAvailableForSaleTerm>
    <us-gaap:DebtSecuritiesAvailableForSaleTerm
      contextRef="C_1adba1d3-86e2-48ca-8036-09ebd512337c"
      id="F_6f8d5f79-5479-4dd5-a2f2-1b12bba7c52e">P5Y</us-gaap:DebtSecuritiesAvailableForSaleTerm>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_68cc81fd-50c1-4591-b9ee-381a6c7b9fe5"
      decimals="-3"
      id="F_92e36803-75be-4f27-a8ce-ca80a169a276"
      unitRef="U_USD">12049000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_68cc81fd-50c1-4591-b9ee-381a6c7b9fe5"
      decimals="-3"
      id="F_6c0131b7-5d21-4229-9dd2-72e61c1c8889"
      unitRef="U_USD">43000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="C_68cc81fd-50c1-4591-b9ee-381a6c7b9fe5"
      decimals="-3"
      id="F_d5e8b142-2f8b-4d09-ac2e-910cec7ca76e"
      unitRef="U_USD">12006000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:DebtSecuritiesAvailableForSaleTerm
      contextRef="C_8f6e6b13-aff0-4ec5-80eb-ec47346f2d4d"
      id="F_b49b78cc-bb14-422f-876e-4b55607fa9a2">P1Y</us-gaap:DebtSecuritiesAvailableForSaleTerm>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_be912e1f-de6a-4c8b-a190-56fa543de795"
      decimals="-3"
      id="F_955aa26e-c998-4331-b6ac-e4e27b4bd87c"
      unitRef="U_USD">1226000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_be912e1f-de6a-4c8b-a190-56fa543de795"
      decimals="-3"
      id="F_72994be7-725d-4d7e-b5f3-1caaf96d48ce"
      unitRef="U_USD">2000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="C_be912e1f-de6a-4c8b-a190-56fa543de795"
      decimals="-3"
      id="F_a27f9a1a-c45a-49d2-a7d5-d7520bf92e5c"
      unitRef="U_USD">1224000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94"
      decimals="-3"
      id="F_dc3a273c-e07a-402e-8bce-234f7de93dff"
      unitRef="U_USD">30397000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94"
      decimals="-3"
      id="F_1d01875d-1e1c-40ce-a4be-426a3e85cc40"
      unitRef="U_USD">52000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94"
      decimals="-3"
      id="F_62cac7ca-1e20-4169-830e-993e1f9ec454"
      unitRef="U_USD">30345000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <eq:AvailableForSaleSecuritiesDebtMaturitiesPeriod
      contextRef="C_6658e49b-c37e-401c-873e-60a833ca00d9"
      id="F_48376537-e2d7-4947-864f-e8ba73107203">P1Y</eq:AvailableForSaleSecuritiesDebtMaturitiesPeriod>
    <eq:AvailableForSaleSecuritiesDebtMaturitiesPeriod
      contextRef="C_6c6eb418-4e31-405d-80e2-4eeaa0ed0949"
      id="F_1eebb87a-b551-4b13-b1fd-dc7cd2a987f4">P2Y</eq:AvailableForSaleSecuritiesDebtMaturitiesPeriod>
    <us-gaap:OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      decimals="INF"
      id="F_68dbb7be-c2c1-461b-95ee-fbb248be5042"
      unitRef="U_USD">0</us-gaap:OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings>
    <us-gaap:OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings
      contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2"
      decimals="INF"
      id="F_f6322cc5-f5ea-40cf-9d01-05b148ed57fa"
      unitRef="U_USD">0</us-gaap:OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      id="F_583c2745-6a36-428e-a5bd-a6ba386800ff">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5. Property and Equipment&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Property and equipment consisted of the following (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:65.971%;"/&gt;
        &lt;td style="width:1.472%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.571%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.458%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.529%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Furniture &amp;amp; fixtures&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;60&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;60&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Machinery &amp;amp; lab equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;534&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;282&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Computer equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;26&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;42&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Leasehold improvements&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;20&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Less accumulated depreciation and amortization&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;249&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;147&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Property and equipment, net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;391&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;237&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Depreciation expense related to property and equipment was approximately $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;118,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;72,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; for the years ended December 31, 2022 and 2021, respectively. During the year ended December 31, 2022, the Company disposed of fully depreciated property and equipment totaling approximately $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;16,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;. There were &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; dispositions of property and equipment for the year ended December 31, 2021. &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;No&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; material gains or losses on the disposal of property and equipment have been recorded for the years ended December 31, 2022 or 2021.&lt;/span&gt;&lt;/p&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      id="F_5fad6cdc-57ef-4ce3-9b05-afa4dbafe9fb">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Property and equipment consisted of the following (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:65.971%;"/&gt;
        &lt;td style="width:1.472%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.571%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.458%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.529%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Furniture &amp;amp; fixtures&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;60&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;60&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Machinery &amp;amp; lab equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;534&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;282&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Computer equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;26&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;42&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Leasehold improvements&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;20&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Less accumulated depreciation and amortization&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;249&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;147&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Property and equipment, net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;391&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;237&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_0b2819ec-57f5-46d8-b912-9734d9b101d1"
      decimals="-3"
      id="F_c4d56e8c-49a2-487d-8f69-05ce62bd3b63"
      unitRef="U_USD">60000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_e4e76746-9176-4a76-9703-056a9ff95868"
      decimals="-3"
      id="F_c9221b33-aee1-405b-9dde-23eedf3444fb"
      unitRef="U_USD">60000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_ce9aa43c-a54c-413f-ab08-401b60dd98cf"
      decimals="-3"
      id="F_3bddea93-ddd0-4fd7-95fe-1d3dcc99d72d"
      unitRef="U_USD">534000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_28f69ea9-8c53-458e-9ebe-8b9949dd4224"
      decimals="-3"
      id="F_4ab93f50-32a9-4576-b5ce-e77c9d96d2eb"
      unitRef="U_USD">282000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_503c038a-2434-4c52-8c73-7bfdbfb92be8"
      decimals="-3"
      id="F_2363fc1d-c2ef-45db-b034-a927f9f68ac5"
      unitRef="U_USD">26000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_16cc5d93-7f4c-4d9b-a05e-409bae73f77d"
      decimals="-3"
      id="F_30a2b7b0-133c-46b3-b922-79cb58d4ce1d"
      unitRef="U_USD">42000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_b03e82a1-d7f8-42dc-a88d-a8edb9f55f3c"
      decimals="-3"
      id="F_8ffe6b74-4709-4f30-8b7d-11922a351f1a"
      unitRef="U_USD">20000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192"
      decimals="-3"
      id="F_7a571f22-6b9f-47d4-ba84-f03cec040e74"
      unitRef="U_USD">249000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94"
      decimals="-3"
      id="F_58acf986-6d08-4dfe-84af-b128262c1c66"
      unitRef="U_USD">147000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192"
      decimals="-3"
      id="F_300b6e6a-4843-432e-bca9-8fd511864cc3"
      unitRef="U_USD">391000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94"
      decimals="-3"
      id="F_cfffe51d-2a42-418c-9497-f5d05bcca309"
      unitRef="U_USD">237000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Depreciation
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      decimals="0"
      id="F_f04de0b9-4911-4c25-8eaf-1cc0c9927106"
      unitRef="U_USD">118000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2"
      decimals="0"
      id="F_8c114296-ed55-492f-8ae1-30478d4bc864"
      unitRef="U_USD">72000</us-gaap:Depreciation>
    <us-gaap:PropertyPlantAndEquipmentDisposals
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      decimals="0"
      id="F_c63fcdc2-65db-4383-92c0-2979c9baacc9"
      unitRef="U_USD">16000</us-gaap:PropertyPlantAndEquipmentDisposals>
    <us-gaap:PropertyPlantAndEquipmentDisposals
      contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2"
      decimals="INF"
      id="F_fac0e2ad-69d5-4322-913c-9bbcd48b5703"
      unitRef="U_USD">0</us-gaap:PropertyPlantAndEquipmentDisposals>
    <us-gaap:GainLossOnDispositionOfAssets1
      contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2"
      decimals="INF"
      id="F_26c74843-d8b7-498f-9389-96cdb952c663"
      unitRef="U_USD">0</us-gaap:GainLossOnDispositionOfAssets1>
    <us-gaap:GainLossOnDispositionOfAssets1
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      decimals="INF"
      id="F_e7642e92-088c-46ea-aa26-84b1fce74ca9"
      unitRef="U_USD">0</us-gaap:GainLossOnDispositionOfAssets1>
    <us-gaap:BusinessCombinationDisclosureTextBlock
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      id="F_938af2db-5d75-47a4-8097-b4f119adb9d6">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6. Acquisition&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;On February 14, 2022, the Company entered into an Agreement and Plan of Merger with Project JetFuel Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of the Company (Merger Sub), Bioniz and Kevin Green, solely in his capacity as representative of the securityholders of Bioniz (the Securityholders&#x2019; Representative).&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;As consideration for the acquisition of Bioniz, the Company agreed to (a) issue up to an aggregate of &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5,699,492&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; shares of the Company&#x2019;s common stock (Merger Shares), and (b) make contingent payments up to an aggregate of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;57.5&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million based on the achievement of certain regulatory events for the Bioniz product candidates commencing on first U.S. approval, and up to an aggregate of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;250&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million based on the achievement of certain commercialization events for product candidate BNZ-1 (now referred to as EQ101) as set forth in the Merger Agreement. The Merger Shares may be adjusted downward after the closing, pursuant to procedures set forth in the Merger Agreement, including with respect to indemnification claims and in connection with the finalization of transaction expenses, debt, net exercise taxes and working capital amounts at closing.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;At the closing, the Company delivered to the transfer agent &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4,820,230&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; shares of its common stock for issuance to former stockholders of Bioniz per the terms of the Merger Agreement. Up to an additional &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;879,252&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; shares of the Company's common stock, pending any adjustments per the terms of the Merger Agreement, will be issued to former stockholders of Bioniz &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;18&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; months after closing. The acquisition of Bioniz expanded the Company's pipeline of novel immunomodulatory drug candidates, adding two first-in-class clinical stage assets, BNZ-1 and BNZ-2, now referred to as EQ101 and EQ102, respectively, and a proprietary product discovery platform.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company determined the acquisition&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;constituted an acquisition of assets instead of a business combination as substantially all of the fair value of the gross assets acquired was concentrated in a group of similar identifiable assets, and therefore, the acquisition was not considered a business. As the Company is recording the transaction as an asset acquisition under ASC 805, the contingent payments will be recognized upon achievement and at that time will be expensed to in-process research and development. Transaction costs of approximately $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.4&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million associated with the acquisition were included in the Company&#x2019;s research and development expense during the year ended December 31, 2022.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;A summary of the purchase price allocation is as follows (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:80.253%;"/&gt;
        &lt;td style="width:1.792%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:15.956%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Amount&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Assets acquired:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Cash&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;700&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;28&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Fixed assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total assets acquired&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;734&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Liabilities assumed:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Accounts payable&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;265&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Accrued expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;976&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total liabilities assumed&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,241&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Net liabilities acquired&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;507&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Issuance of common stock for Bioniz acquisition&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;22,542&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Acquired in-process research and development&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;23,049&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="C_53fe6a42-e9c0-41f9-a76d-589ed71e0cd6"
      decimals="INF"
      id="F_6b87d4ba-5bcc-4581-b158-cbdac1b9ffaa"
      unitRef="U_shares">5699492</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
      contextRef="C_ea16d6a3-2485-40dc-a25d-8c4cc56dd7fd"
      decimals="-5"
      id="F_7636d535-ef39-411e-9775-0621353d8be4"
      unitRef="U_USD">57500000</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
      contextRef="C_292ee269-376c-4392-9f5a-40817da138a6"
      decimals="-6"
      id="F_45685a56-0e41-4629-9b83-6cf2e3e4f8e1"
      unitRef="U_USD">250000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="C_ffafa14c-b663-42ee-861b-6f858b3f4acf"
      decimals="INF"
      id="F_12b72eca-40e9-4156-8703-de394bebf8ae"
      unitRef="U_shares">4820230</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="C_c0403c73-e303-4bd7-ae36-cf044f363dc1"
      decimals="INF"
      id="F_cf77248f-51a8-43d8-b443-d862dd31f42b"
      unitRef="U_shares">879252</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <eq:TermsOfMergerAgreement
      contextRef="C_ffafa14c-b663-42ee-861b-6f858b3f4acf"
      id="F_2a09163a-bfc6-4bca-b396-ced889640a33">P18M</eq:TermsOfMergerAgreement>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="C_8a38518a-9c62-4c14-a61d-b505eb2f5458"
      decimals="-5"
      id="F_3931002b-9308-4e93-b5bc-14e6cb758eeb"
      unitRef="U_USD">400000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      id="F_891f7c56-7e46-4c49-930e-d7f91eaae3ae">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;A summary of the purchase price allocation is as follows (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:80.253%;"/&gt;
        &lt;td style="width:1.792%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:15.956%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Amount&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Assets acquired:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Cash&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;700&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;28&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Fixed assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total assets acquired&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;734&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Liabilities assumed:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Accounts payable&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;265&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Accrued expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;976&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total liabilities assumed&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,241&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Net liabilities acquired&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;507&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Issuance of common stock for Bioniz acquisition&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;22,542&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Acquired in-process research and development&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;23,049&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="C_9f870e6c-ab80-49c3-9591-da8f10d045b8"
      decimals="-3"
      id="F_dfba0af3-19cb-4dba-9ce9-56b83d8d94a5"
      unitRef="U_USD">700000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets
      contextRef="C_9f870e6c-ab80-49c3-9591-da8f10d045b8"
      decimals="-3"
      id="F_2250d456-37ba-407c-8d28-b5b40ef039ac"
      unitRef="U_USD">28000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets
      contextRef="C_9f870e6c-ab80-49c3-9591-da8f10d045b8"
      decimals="-3"
      id="F_168bcb51-a8a2-4427-9a02-7e38198cfc6a"
      unitRef="U_USD">6000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
      contextRef="C_9f870e6c-ab80-49c3-9591-da8f10d045b8"
      decimals="-3"
      id="F_080d68c4-912d-47a0-80c7-cfd547c46f52"
      unitRef="U_USD">734000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
      contextRef="C_9f870e6c-ab80-49c3-9591-da8f10d045b8"
      decimals="-3"
      id="F_11f74e99-fe7b-424a-9b81-80b2148ee4e1"
      unitRef="U_USD">265000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <eq:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses
      contextRef="C_9f870e6c-ab80-49c3-9591-da8f10d045b8"
      decimals="-3"
      id="F_21e075d5-6b71-4838-b81e-b4cc31ef0ab4"
      unitRef="U_USD">976000</eq:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="C_9f870e6c-ab80-49c3-9591-da8f10d045b8"
      decimals="-3"
      id="F_14ef4e12-9ad0-4649-b375-c1757fd69d74"
      unitRef="U_USD">1241000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="C_9f870e6c-ab80-49c3-9591-da8f10d045b8"
      decimals="-3"
      id="F_850620c0-5803-442b-a091-d055adc9602d"
      unitRef="U_USD">507000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned
      contextRef="C_9f870e6c-ab80-49c3-9591-da8f10d045b8"
      decimals="-3"
      id="F_40970b13-5427-495d-b58d-15d6553025b8"
      unitRef="U_USD">22542000</us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned>
    <eq:BusinessCombinationAcquiredInProcessResearchAndDevelopment
      contextRef="C_9f870e6c-ab80-49c3-9591-da8f10d045b8"
      decimals="-3"
      id="F_08a2597e-2322-4716-b380-ccba8e993e91"
      unitRef="U_USD">23049000</eq:BusinessCombinationAcquiredInProcessResearchAndDevelopment>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      id="F_44240d68-712d-43dc-99c9-a29579956752">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;7.  Leases&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company&#x2019;s leases relate primarily to office and laboratory facilities located in La Jolla and South San Francisco, California. The Company&#x2019;s lease of office space in South San Francisco expired in &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;February 2023&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; and the Company did not renew that lease. The Company&#x2019;s lease of laboratory space in La Jolla expires in &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2025&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, and the Company's leases of office space in La Jolla expire in &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2027&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;. The terms of the Company&#x2019;s non-cancelable operating lease arrangements typically contain fixed lease payment which increases over the term of the lease at fixed rates, and include rent holidays and provide for additional renewal periods. Lease expense is recognized over the term of the lease on a straight-line basis. All of the Company&#x2019;s leases are classified as operating leases. The Company has determined that periods covered by options to extend the Company&#x2019;s leases are excluded from the lease term as the Company is not reasonably certain the Company will exercise such options. Operating lease expense, including expenses related to short-term leases, were $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.6&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.3&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million for the years ended December 31, 2022 and 2021, respectively.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company records its right-of-use-assets within other assets (long term) and its operating lease liabilities within other current and long-term liabilities.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:11.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Additional information related to the Company&#x2019;s leases as of and for the year ended December 31, 2022, is as follows (in thousands, except lease term and discount rate):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:69.578%;"/&gt;
        &lt;td style="width:3.036%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:25.386000000000003%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Balance sheet information&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Right-of-use assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,191&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Lease liabilities, current&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;408&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Lease liabilities, non-current&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;824&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total lease liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,232&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Other information&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Weighted average remaining lease term&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3.07&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Weighted average discount rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;8.25&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Supplemental cash flow information&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Operating cash flows from operating leases&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;465&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Right-of-use assets obtained in exchange for lease obligations&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Maturities of lease liabilities as of December 31, 2022 were as follows (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:77.265%;"/&gt;
        &lt;td style="width:3.669%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:17.066%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Year ending December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;494&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;492&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;219&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2026&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;169&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2027&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;28&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total undiscounted lease payments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,402&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Less: imputed interest&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;170&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total lease liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,232&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;As of December 31, 2022, the Company does not have any leases that have not yet commenced that create significant rights and obligations.&lt;/span&gt;&lt;/p&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <eq:LesseeOperatingLeaseExpiredDate
      contextRef="C_842e44ed-200a-4457-8510-53e0331535d8"
      id="F_2366b5a0-802d-44ce-82ff-3b242c6a8567">2023-02</eq:LesseeOperatingLeaseExpiredDate>
    <eq:LesseeOperatingLeaseExpirationYear
      contextRef="C_dd41c6fa-2d24-44bd-8378-e697929d4bb8"
      id="F_b85cbaf4-3799-4ef2-8267-b55cc30d1e36">2025</eq:LesseeOperatingLeaseExpirationYear>
    <eq:LesseeOperatingLeaseExpirationYear
      contextRef="C_842e44ed-200a-4457-8510-53e0331535d8"
      id="F_8a4614d7-df69-4ac4-8ef6-4ac7d0b47588">2027</eq:LesseeOperatingLeaseExpirationYear>
    <us-gaap:OperatingLeaseExpense
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      decimals="-5"
      id="F_dcd906b7-eeb0-43c7-9b29-bfacffca7e98"
      unitRef="U_USD">600000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2"
      decimals="-5"
      id="F_d71d200b-361e-4373-a0b7-74bb8303d4a8"
      unitRef="U_USD">300000</us-gaap:OperatingLeaseExpense>
    <eq:SummaryOfAdditionalInformationRelatedToLeasesTableTextBlock
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      id="F_d378cb23-764a-4559-9566-3f936b2e4a45">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Additional information related to the Company&#x2019;s leases as of and for the year ended December 31, 2022, is as follows (in thousands, except lease term and discount rate):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:69.578%;"/&gt;
        &lt;td style="width:3.036%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:25.386000000000003%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Balance sheet information&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Right-of-use assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,191&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Lease liabilities, current&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;408&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Lease liabilities, non-current&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;824&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total lease liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,232&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Other information&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Weighted average remaining lease term&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3.07&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Weighted average discount rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;8.25&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Supplemental cash flow information&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Operating cash flows from operating leases&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;465&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Right-of-use assets obtained in exchange for lease obligations&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</eq:SummaryOfAdditionalInformationRelatedToLeasesTableTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192"
      decimals="-3"
      id="F_4b1af21d-67b8-469c-913a-537ea4659b31"
      unitRef="U_USD">1191000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192"
      decimals="-3"
      id="F_baec1d69-75b6-44c5-ab81-4a1252b0af1d"
      unitRef="U_USD">408000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192"
      decimals="-3"
      id="F_044e1325-5e3e-4f1a-81a1-0c08a6422dbb"
      unitRef="U_USD">824000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiability
      contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192"
      decimals="-3"
      id="F_3a11deea-7da5-4c04-b88d-35d27ae2aeae"
      unitRef="U_USD">1232000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192"
      id="F_e05a1b2e-2aa7-4a0c-a7bd-8cad84a93f93">P3Y25D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192"
      decimals="4"
      id="F_743bb37c-d04e-47ba-afff-7564879d01e4"
      unitRef="U_pure">0.0825</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeasePayments
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      decimals="-3"
      id="F_2ed686af-6ce9-48b3-ba1d-7b7c379ba65c"
      unitRef="U_USD">465000</us-gaap:OperatingLeasePayments>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      decimals="-3"
      id="F_840e3255-2739-4999-aa74-14a1f5fe46ba"
      unitRef="U_USD">0</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      id="F_33c06049-c2b2-4735-84be-8f04eef0151b">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Maturities of lease liabilities as of December 31, 2022 were as follows (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:77.265%;"/&gt;
        &lt;td style="width:3.669%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:17.066%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Year ending December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;494&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;492&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;219&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2026&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;169&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2027&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;28&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total undiscounted lease payments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,402&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Less: imputed interest&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;170&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total lease liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,232&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192"
      decimals="-3"
      id="F_747a8e8a-3121-4da0-ac0e-2d5c5ebda2d4"
      unitRef="U_USD">494000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192"
      decimals="-3"
      id="F_5eb30439-8d1f-414e-9ca2-829e06358b67"
      unitRef="U_USD">492000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192"
      decimals="-3"
      id="F_b8e5a1cb-116b-4bc0-9d47-de1849b0fdc4"
      unitRef="U_USD">219000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192"
      decimals="-3"
      id="F_ba2be63a-8615-4b7c-a3ee-f4bab5e0df63"
      unitRef="U_USD">169000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192"
      decimals="-3"
      id="F_fd3db80f-e506-429a-a746-9878f53fbb04"
      unitRef="U_USD">28000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192"
      decimals="-3"
      id="F_3b76ab63-40e3-4130-87b8-0e236a8a0159"
      unitRef="U_USD">1402000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192"
      decimals="-3"
      id="F_da6b7e80-f500-4fb8-ac6d-eda533720d89"
      unitRef="U_USD">170000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192"
      decimals="-3"
      id="F_c98ea04a-bf15-45e2-b20f-4b2ce82b55a7"
      unitRef="U_USD">1232000</us-gaap:OperatingLeaseLiability>
    <us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      id="F_e4155c92-a89d-4627-83a9-c4c58e328641">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;8. Accrued Expenses&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Accrued expenses consisted of the following (in thousands):&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.327%;"/&gt;
        &lt;td style="width:1.466%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.322000000000001%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.48%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.406%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Accrued payroll and other employee benefits&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,975&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,511&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Clinical development&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3,253&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,627&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Other accruals&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;472&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;245&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Non-clinical research&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;465&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;432&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Accrued interest&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;74&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;71&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total accrued expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;7,239&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5,886&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      id="F_88e34ee2-e9d9-44c4-b2c4-173ade74175f">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Accrued expenses consisted of the following (in thousands):&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.327%;"/&gt;
        &lt;td style="width:1.466%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.322000000000001%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.48%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.406%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Accrued payroll and other employee benefits&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,975&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,511&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Clinical development&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3,253&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,627&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Other accruals&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;472&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;245&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Non-clinical research&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;465&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;432&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Accrued interest&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;74&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;71&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total accrued expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;7,239&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5,886&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192"
      decimals="-3"
      id="F_8481044a-a625-4367-8bfe-743055edb943"
      unitRef="U_USD">2975000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94"
      decimals="-3"
      id="F_78a53c1c-801a-4f16-86f0-246559f7c4a7"
      unitRef="U_USD">2511000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <eq:AccruedClinicalDevelopment
      contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192"
      decimals="-3"
      id="F_7f95c2e3-f5a5-4591-b4cb-e8c14c82a23a"
      unitRef="U_USD">3253000</eq:AccruedClinicalDevelopment>
    <eq:AccruedClinicalDevelopment
      contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94"
      decimals="-3"
      id="F_9f74bbc5-c7fd-428f-a33a-86dc32119840"
      unitRef="U_USD">2627000</eq:AccruedClinicalDevelopment>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192"
      decimals="-3"
      id="F_3e467e88-aadb-4c5b-b4f6-bebc157316e3"
      unitRef="U_USD">472000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94"
      decimals="-3"
      id="F_b0b94126-ccce-4709-8a4b-5b7bb222dff9"
      unitRef="U_USD">245000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <eq:AccruedNonClinicalResearch
      contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192"
      decimals="-3"
      id="F_37d035a3-de32-4952-8810-3643563c3b61"
      unitRef="U_USD">465000</eq:AccruedNonClinicalResearch>
    <eq:AccruedNonClinicalResearch
      contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94"
      decimals="-3"
      id="F_d46bf4ab-388f-4915-831a-59679a1a2670"
      unitRef="U_USD">432000</eq:AccruedNonClinicalResearch>
    <us-gaap:InterestPayableCurrent
      contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192"
      decimals="-3"
      id="F_8f967b73-baf0-404e-bfb2-81adef3ff05e"
      unitRef="U_USD">74000</us-gaap:InterestPayableCurrent>
    <us-gaap:InterestPayableCurrent
      contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94"
      decimals="-3"
      id="F_28a6ce80-d413-4d99-a137-8b00e79da363"
      unitRef="U_USD">71000</us-gaap:InterestPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192"
      decimals="-3"
      id="F_a1817a2d-446d-4905-98f7-f41c9959a082"
      unitRef="U_USD">7239000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94"
      decimals="-3"
      id="F_b9c236b2-674b-462f-852d-3fd14e94ed6f"
      unitRef="U_USD">5886000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:CollaborativeArrangementDisclosureTextBlock
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      id="F_b683cd4d-7e25-41b6-9b47-40e460f3d5e8">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;9. Partnerships&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Asset Purchase Agreement with Ono Pharmaceutical Co., Ltd.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;On December 5, 2022, the Company and Ono, a Japan kabushiki kaisha, entered into an Asset Purchase Agreement pursuant to which the Company granted Ono the exclusive right, but not the obligation, to acquire the Company&#x2019;s rights to itolizumab (the Option). These rights include all therapeutic indications and the rights to commercialize itolizumab in the United States, Canada, Australia, and New Zealand. In exchange for the Option, Ono paid the Company a one-time, upfront payment of an amount&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; equal to JPY &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3.5&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; billion, or $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;26.4&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;If Ono exercises the Option, Ono will pay the Company a one-time payment of an amount equal to JPY &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5.0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; billion, or approximately $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;37.2&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million based on the currency exchange rate quoted by MUFG Bank, Ltd. on March 16, 2023. The Company is also eligible to receive up to $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;101.4&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million upon the achievement of certain development and commercialization milestones.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company is responsible for conducting all research and development of itolizumab, which will be funded by Ono on a quarterly basis from July 1, 2022, through the option period. Unless terminated early, t&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;he option period will expire three months following the delivery of topline data from the EQUALISE clinical study in lupus nephritis and interim data from the EQUATOR Phase 3 clinical study in acute graft-versus-host disease. &lt;/span&gt;&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"/&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Asset Purchase Agreement can be terminated at any time by Ono upon written notice, provided that in limited circumstances Ono will be obligated to continue to reimburse the Company for research and development costs and expenses of itolizumab for a certain period of time following such termination. If Ono does not timely exercise its Option, the Asset Purchase Agreement and the Option will automatically terminate. The Asset Purchase Agreement also contains customary termination rights for both parties for material breach and an outside date (subject to limited adjustments) that permits either party to terminate the Asset Purchase Agreement if the closing has not occurred by December 31, 2025.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Asset Purchase Agreement contains customary representations and warranties with respect to both the Company and Ono. Additionally, the Company is subject to customary obligations and covenants, including affirmative and negative operating covenants on the Company with respect to its business as it applies to the development and exploitation of itolizumab, exclusivity obligations that prohibit the Company, except in limited circumstances, including in connection with the sale of the Company, from pursuing a direct or indirect sale, license or other disposition of all or any portion of the Company's itolizumab program or any of the assets to be purchased pursuant to the Asset Purchase Agreement and indemnification obligations, which, except in limited circumstances, are subject to customary caps and deductibles.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company applied ASC 808, &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Collaborative Arrangements,&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; to the Asset Purchase Agreement and determined that the agreement is applicable to such guidance. The Company concluded that Ono represented a customer and applied relevant guidance from ASC 606, &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Revenue Recognition&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, (ASC 606) to evaluate the appropriate accounting for the Asset Purchase Agreement. In accordance with this guidance, the Company identified its performance obligations, including its grant of a license to Ono to certain of its intellectual property subject to certain conditions and the conduct of research and development services. The Company determined that its grant of a license to Ono to certain of its intellectual property subject to certain conditions was not distinct from other performance obligations because such grant is dependent on the conduct and results of the research and development services. Accordingly, the Company determined that all performance obligations should be accounted for as one combined performance obligation, and that the combined performance obligation is transferred over the expected term of the conduct of the research and development services.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company also assessed, in connection with the upfront and non-creditable payment of JPY &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3.5&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; billion or $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;25.8&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million, invoiced on December 5, 2022, that there was not a significant financing component in the Asset Purchase Agreement. The Company received payment of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;26.4&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million related to this upfront payment in December 2022 which included a foreign currency realized gain of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.6&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million as the initial invoice for the upfront payment was denominated in JPY.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company also assessed the effects of any variable elements under the Asset Purchase Agreement. Such assessment evaluated, among other things, the likelihood of receiving (i) option fees and (ii) various clinical, regulatory and commercial milestone payments. Based on its assessment, the Company concluded that, based on the likelihood of these variable components occurring, there was not a significant variable element included in the transaction price. Accordingly, the Company has not assigned a transaction price to any option fees or milestone payments under the Asset Purchase Agreement given the substantial uncertainty related to their achievement.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;In accordance with ASC 606, the Company determined that the initial transaction price under the Asset Purchase Agreement equals $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;102.6&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million, consisting of the upfront and non-creditable payment of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;25.8&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million and the aggregate estimated research and development funding of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;76.8&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million over the estimated option period. The upfront payment of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;25.8&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million was recorded as deferred revenue and is being recognized as revenue over time in conjunction with the Company&#x2019;s conduct of research and development services as the research and development services are the primary component of the combined performance obligations. Revenue associated with the upfront payment will be recognized based on actual costs incurred as a percentage of the estimated total costs expected to be incurred over the expected term of the research and development services. Reimbursable research and development costs will be recognized as revenue as incurred.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company recognized revenue of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;15.8&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million under the Asset Purchase Agreement during the year ended December 31, 2022. Such revenue was comprised of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;11.8&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million associated with development funding and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4.0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million associated with the amortization of the upfront payment during the year ended December 31, 2022. As of December 31, 2022, aggregate deferred revenue related to the Asset Purchase Agreement was $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;25.1&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million, which consisted of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;14.7&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million classified as current and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;10.4&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million as long-term.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;As of December 31, 2022, the Company has received $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;12.2&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million in cash of aggregate development funding from Ono.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Biocon Collaboration and License Agreement&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;In May 2017, the Company entered into a collaboration and license agreement (which was amended in September 2018, April 2019, December 2019, April 2021 and November 2022), clinical supply agreement, investor rights agreement, and common stock purchase agreement (collectively License Agreements) with Biocon SA (subsequently assigned to Biocon Limited, or together, Biocon). Pursuant to the License Agreements, Biocon granted the Company an exclusive license to develop, make, have made, use, sell, have sold, offer for sale, import and otherwise exploit itolizumab and any pharmaceutical composition or preparation containing or comprising itolizumab that uses Biocon technology or Biocon know-how (collectively a Biocon Product) in the United States, Canada, Australia and New Zealand (collectively Equillium Territory). The Company also has the right to sublicense through multiple tiers to third parties, provided such sublicenses comply with the terms of the License Agreements and the Company provides Biocon a copy of each sublicense agreement within 30 days of execution. If the Company grants a third party a sublicense of its rights to develop and commercialize Biocon Products in Australia or New Zealand, the Company will be required to pay Biocon a high double-digit percentage of any upfront payment the Company receives from such sublicensee for such sublicense, as well as a high double-digit percentage of any additional payments the Company receives from such sublicensee for such sublicense, including but not limited to royalty payments on net sales of Biocon Products by such sublicensee. Under the License Agreements, the Company granted back to Biocon a license to use its technology and know-how related to itolizumab and Biocon Products in certain countries outside of the Equillium Territory. Pursuant to the License Agreements, Biocon agreed to be the Company&#x2019;s exclusive supplier of itolizumab clinical drug product. Biocon will provide clinical drug product at no cost for up to three concurrent orphan indications until the Company&#x2019;s first U.S. regulatory approval and all other clinical drug product at Biocon&#x2019;s cost. In addition, we have agreed to co-fund an ongoing Phase 2 clinical study of itolizumab in subjects with ulcerative colitis being conducted by Biocon in India.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;In consideration of the rights granted to the Company by Biocon, the Company issued Biocon a total of &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,316,134&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; shares of its common stock.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;In addition, the Company is obligated to pay Biocon up to an aggregate of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;30&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million in regulatory milestone payments upon the achievement of certain regulatory approvals and up to an aggregate of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;565&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million in sales milestone payments upon the achievement of first commercial sale of product and specified levels of product sales. The Company is also required to pay royalties on tiers of aggregate annual net sales of Biocon Products by the Company, the Company's affiliates and the Company's sublicensees in the United States and Canada at percentages from the mid-single digits to sub-teen double-digits and on tiers of aggregate annual net sales of Biocon Products by the Company and the Company's affiliates (but not the Company's sublicensees) in Australia and New Zealand, in each case, subject to adjustments in certain circumstances. Biocon is also required to pay the Company royalties at comparable percentages for sales of itolizumab (EQ001) outside of the Equillium Territory if the approvals in such geographies included or referenced the Company&#x2019;s data including data from certain of the Company&#x2019;s clinical studies, subject to adjustments in certain circumstances. &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Should Ono exercise its option to acquire our rights to itolizumab (EQ001), as described below, the aforementioned milestone payments and royalties potentially owed to Biocon would become Ono&#x2019;s responsibility, and the potential royalties on sales of itolizumab outside of the Equillium Territory would be become Ono&#x2019;s right.&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;  Under the License Agreements, net sales are calculated on a country-by-country basis and are subject to adjustments, including whether the Biocon Product is sold in the form of a combination product. As of December 31, 2022, the Company has not made or received payments in connection with the milestones or royalties within the agreement.&lt;/span&gt;&lt;/p&gt;</us-gaap:CollaborativeArrangementDisclosureTextBlock>
    <eq:UpfrontNonRefundableAndNonCreditablePaymentReceivableUponExchangeOfOption
      contextRef="C_257b0705-b56f-4bd5-86f9-1add29602d4d"
      decimals="-8"
      id="F_a973658a-69f1-4aa4-947d-24d04f44e7ce"
      unitRef="U_JPY">3500000000</eq:UpfrontNonRefundableAndNonCreditablePaymentReceivableUponExchangeOfOption>
    <eq:UpfrontNonRefundableAndNonCreditablePaymentReceivableUponExchangeOfOption
      contextRef="C_257b0705-b56f-4bd5-86f9-1add29602d4d"
      decimals="-5"
      id="F_ca0be8fd-1988-4633-9e82-4a0e027b8a7b"
      unitRef="U_USD">26400000</eq:UpfrontNonRefundableAndNonCreditablePaymentReceivableUponExchangeOfOption>
    <eq:OneTimePaymentReceivableUponExercisesTheOption
      contextRef="C_b6af3c69-cf78-4826-98db-46603272fd07"
      decimals="-8"
      id="F_fdb9108a-1a8f-46cd-a8e0-62042680a924"
      unitRef="U_JPY">5000000000.0</eq:OneTimePaymentReceivableUponExercisesTheOption>
    <eq:OneTimePaymentReceivableUponExercisesTheOption
      contextRef="C_b6af3c69-cf78-4826-98db-46603272fd07"
      decimals="-5"
      id="F_dd5e77e8-d0b2-4573-ad96-f4973b6015af"
      unitRef="U_USD">37200000</eq:OneTimePaymentReceivableUponExercisesTheOption>
    <eq:EligibleToReceivePaymentOnAchievementOfCertainDevelopmentMilestones
      contextRef="C_abcb788b-9185-48aa-bc09-238334507b89"
      decimals="-5"
      id="F_8f9cdbb4-95f0-4d88-8d6d-1547552075b2"
      unitRef="U_USD">101400000</eq:EligibleToReceivePaymentOnAchievementOfCertainDevelopmentMilestones>
    <eq:OptionPeriodExpiryCondition
      contextRef="C_ad7f8586-d120-48a1-a08d-4f84857dfb6d"
      id="F_0cc2d36c-5b07-4934-863f-5150d654eca5">he option period will expire three months following the delivery of topline data from the EQUALISE clinical study in lupus nephritis and interim data from the EQUATOR Phase 3 clinical study in acute graft-versus-host disease. </eq:OptionPeriodExpiryCondition>
    <eq:UpfrontNonRefundableAndNonCreditablePaymentInvoiced
      contextRef="C_257b0705-b56f-4bd5-86f9-1add29602d4d"
      decimals="-8"
      id="F_be00b6d5-537f-42af-b476-a6e228f3145b"
      unitRef="U_JPY">3500000000</eq:UpfrontNonRefundableAndNonCreditablePaymentInvoiced>
    <eq:UpfrontNonRefundableAndNonCreditablePaymentInvoiced
      contextRef="C_257b0705-b56f-4bd5-86f9-1add29602d4d"
      decimals="-5"
      id="F_5310e859-e8d8-41de-9c82-1aa45bfea536"
      unitRef="U_USD">25800000</eq:UpfrontNonRefundableAndNonCreditablePaymentInvoiced>
    <eq:UpfrontPaymentReceived
      contextRef="C_c23792dc-2be3-45bf-8cdc-a38a13c8ab6a"
      decimals="-5"
      id="F_dc899d99-2091-471d-b737-fa0b076ca82d"
      unitRef="U_USD">26400000</eq:UpfrontPaymentReceived>
    <us-gaap:ForeignCurrencyTransactionGainLossRealized
      contextRef="C_c23792dc-2be3-45bf-8cdc-a38a13c8ab6a"
      decimals="-5"
      id="F_b7c43985-0962-4865-85c3-f02ee5c5ca01"
      unitRef="U_USD">600000</us-gaap:ForeignCurrencyTransactionGainLossRealized>
    <eq:InitialTransactionPrice
      contextRef="C_257b0705-b56f-4bd5-86f9-1add29602d4d"
      decimals="-5"
      id="F_57f7d57a-d729-426e-a57e-2c11cb65f2ff"
      unitRef="U_USD">102600000</eq:InitialTransactionPrice>
    <eq:UpfrontAndNonCreditablePaymentInvoiced
      contextRef="C_257b0705-b56f-4bd5-86f9-1add29602d4d"
      decimals="-5"
      id="F_d9233618-9e87-4cb7-b9cd-de20fc608079"
      unitRef="U_USD">25800000</eq:UpfrontAndNonCreditablePaymentInvoiced>
    <eq:EstimatedResearchAndDevelopmentFunding
      contextRef="C_257b0705-b56f-4bd5-86f9-1add29602d4d"
      decimals="-5"
      id="F_5ab75151-4f8b-4cac-8d45-4de00c829bad"
      unitRef="U_USD">76800000</eq:EstimatedResearchAndDevelopmentFunding>
    <us-gaap:DeferredRevenue
      contextRef="C_257b0705-b56f-4bd5-86f9-1add29602d4d"
      decimals="-5"
      id="F_cfe7fb65-7d71-42d4-82f1-aad4dbdaeeff"
      unitRef="U_USD">25800000</us-gaap:DeferredRevenue>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_ad7f8586-d120-48a1-a08d-4f84857dfb6d"
      decimals="-5"
      id="F_369d0116-9a90-4a9c-9cf7-420cfb780758"
      unitRef="U_USD">15800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_de394fb6-0ca8-4cc8-866d-6ad6f457d88c"
      decimals="-5"
      id="F_8c53d6e4-46d0-4541-b359-968613d99bcc"
      unitRef="U_USD">11800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_cf62e2c5-8574-4b02-a168-a9fa58f93586"
      decimals="-5"
      id="F_6b9932f4-16f6-464a-835e-608e7749e47a"
      unitRef="U_USD">4000000.0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:DeferredRevenue
      contextRef="C_4c0fe461-a7c8-4a97-8e27-000bcb673943"
      decimals="-5"
      id="F_f23f3b85-8f7b-431e-b65d-57d581ae69a0"
      unitRef="U_USD">25100000</us-gaap:DeferredRevenue>
    <us-gaap:DeferredRevenueCurrent
      contextRef="C_4c0fe461-a7c8-4a97-8e27-000bcb673943"
      decimals="-5"
      id="F_e2e19053-b2ed-4ca2-bcf3-ecdd7f5296fd"
      unitRef="U_USD">14700000</us-gaap:DeferredRevenueCurrent>
    <us-gaap:DeferredRevenueNoncurrent
      contextRef="C_4c0fe461-a7c8-4a97-8e27-000bcb673943"
      decimals="-5"
      id="F_af3dbb31-040d-4842-bcc3-950d82d97e6b"
      unitRef="U_USD">10400000</us-gaap:DeferredRevenueNoncurrent>
    <eq:ProceedsFromResearchAndDevelopmentFees
      contextRef="C_c23792dc-2be3-45bf-8cdc-a38a13c8ab6a"
      decimals="-5"
      id="F_6c687b9b-1d9b-487e-879a-3dc8dbbc56e5"
      unitRef="U_USD">12200000</eq:ProceedsFromResearchAndDevelopmentFees>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_25c4ee43-e391-45e8-bf6c-c2ae9bfee741"
      decimals="INF"
      id="F_42a7171d-52e4-481f-8414-e2c79f8bd7da"
      unitRef="U_shares">2316134</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <eq:RegulatoryMilestonePaymentsUponAchievementOfCertainRegulatoryApprovals
      contextRef="C_6c924f5d-0e36-4f69-96ed-b71e41b42d0f"
      decimals="INF"
      id="F_90f3999b-461c-4a1c-a781-2050bf5df1eb"
      unitRef="U_USD">30000000</eq:RegulatoryMilestonePaymentsUponAchievementOfCertainRegulatoryApprovals>
    <eq:SalesMilestonePaymentsUponTheAchievementOfFirstCommercialSaleOfProductAndSpecifiedLevelsOfProductSales
      contextRef="C_6c924f5d-0e36-4f69-96ed-b71e41b42d0f"
      decimals="INF"
      id="F_9b52abd2-dd96-4ba0-9101-e635fe1d8979"
      unitRef="U_USD">565000000</eq:SalesMilestonePaymentsUponTheAchievementOfFirstCommercialSaleOfProductAndSpecifiedLevelsOfProductSales>
    <us-gaap:MortgageNotesPayableDisclosureTextBlock
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      id="F_404d88df-8a54-4f83-ab85-ee429ab62f75">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;10. Notes Payable&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&#160;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;On September 30, 2019 (the Effective Date), the Company entered into a Loan and Security Agreement (the Loan Agreement) with two lenders (the Lenders) pursuant to which the Company borrowed $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;10.0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million from the Lenders (the Term Loan), which represents the maximum amount the Company is permitted to borrow under the terms of the Loan Agreement.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Term Loan matures on &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;June 1, 2024&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; (the Maturity Date) and is repaid through interest-only payments, which originally extended through June 30, 2021, followed by &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;36&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; equal &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;monthly&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; payments of principal and interest. The Term Loan bears interest at a floating per annum rate equal to the greater of (i) &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;8.25&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;% and (ii) the sum of (a) the &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;prime rate&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; reported in The Wall Street Journal on the last business day of the month that immediately precedes the month in which the interest will accrue, plus (b) &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3.00&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;On April 23, 2021, the Loan Agreement was amended to (i) change the final payment percentage from &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4.5&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;% to &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5.0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;% and (ii) extend the interest-only payment period based on achieving the following milestones: (a) the Company achieving positive data in the Company's Phase 1b aGVHD study of itolizumab (EQ001) supporting a formal decision to advance into Phase 2 or Phase 3 development, and as confirmed by the Company's Board of Directors in written board minutes (the Interest-Only Extension Milestone) and (b) the Company initiating a pivotal Phase 3 aGVHD study (the Interest-Only Extension II Milestone). In May 2021, the Company achieved the Interest-Only Extension Milestone, and in March 2022, the Company obtained confirmation from the Lenders that the Interest-Only Extension II Milestone had been achieved, which extended the interest-only payments through September 30, 2022, followed by &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;24&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; equal &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;monthly&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; principal payments and interest.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;  &lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;In February 2022, the Company entered into the Third Amendment to the Loan Agreement (the Third Amendment) which added Bioniz as a secured party to the loan.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Under authoritative guidance, the April 2021 amendment did not meet the criteria to be accounted for as a troubled debt restructuring. In addition, the Company performed a quantitative analysis and determined that the terms of the new debt and original debt instrument are not substantially different. Accordingly, the April 2021 amendment was accounted for as a debt modification. A new effective interest rate that equates the revised cash flows to the carrying amount of the original debt was computed and applied prospectively. The effective interest rate as of December 31, 2022 is &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;11.86&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company will be required to make a final payment of &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5.00&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;% of the original principal amount of the Term Loan drawn payable on the earlier of (i) the Maturity Date, (ii) the acceleration of the Term Loan in the event of a default, or (iii) the prepayment of the Term Loan (the Final Payment). The Company may prepay all, but not less than all, of the Term Loan upon &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;30&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; days&#x2019; advance written notice &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;to the lender, provided that the Company will be obligated to pay a prepayment fee equal to (i) &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3.00&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;% of the principal amount of the Term Loan prepaid on or before the first anniversary of the applicable funding date, (ii) &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2.00&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;% of the principal amount of the Term Loan prepaid between the first and second anniversary of the funding date, and (iii) &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1.00&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;% of the principal amount of the Term Loan prepaid thereafter, and prior to the Maturity Date (each, a Prepayment Fee).&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;In connection with entering into the Loan Agreement, the Company issued to the Lenders warrants exercisable for &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;80,428&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; shares of the Company&#x2019;s common stock (the Warrants). The Warrants are exercisable in whole or in part, immediately, and have a per share &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;exercise price of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3.73&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, which was the closing price of the Company&#x2019;s common stock reported on the Nasdaq Global Market on the day prior to the Effective Date. The Warrants will terminate on the earlier of September 30, 2029 or the closing of certain merger or consolidation transactions.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The aggregate carrying amounts of the Term Loan is comprised of the following (in thousands):&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:67.108%;"/&gt;
        &lt;td style="width:1.493%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:12.883000000000001%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.493%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.022%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Principal&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;8,571&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;10,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Add: accreted liability for final payment fee&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;430&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;310&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Less: unamortized discount&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;48&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;132&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;8,953&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;10,178&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Upon the occurrence of certain events, including but not limited to the Company&#x2019;s failure to satisfy its payment obligations under the Loan Agreement, the breach of certain of its other covenants under the Loan Agreement, or the occurrence of a material adverse change, cross defaults to other indebtedness or material agreements, judgment defaults and defaults related to failure to maintain governmental approvals failure of which to maintain could result in a material adverse effect, the Lenders will have the right, among other remedies, to declare all principal and interest immediately due and payable, to exercise secured party remedies, to receive the Final Payment and, if the payment of principal and interest is due prior to the Maturity Date, to receive the applicable Prepayment Fee. At December 31, 2022, the Company was in compliance with the covenants contained in the Loan Agreement.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Future maturities of the Term Loan, including the Final Payment fee, as of December 31, 2022 were as follows (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:80.253%;"/&gt;
        &lt;td style="width:1.792%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:15.956%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Year ending December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5,714&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Year ending December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3,357&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;9,071&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Unaccreted balance for Final Payment fee on Term Loans&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;70&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Unamortized discounts&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;48&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;8,953&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Less current portion&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5,714&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Noncurrent portion&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3,239&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</us-gaap:MortgageNotesPayableDisclosureTextBlock>
    <us-gaap:LineOfCredit
      contextRef="C_90508498-eb7a-4af4-a10b-9b578a529f24"
      decimals="-5"
      id="F_ed42fe4c-717a-443c-9b03-f294ccd1d324"
      unitRef="U_USD">10000000.0</us-gaap:LineOfCredit>
    <us-gaap:LineOfCreditFacilityExpirationDate1
      contextRef="C_0b4db976-5656-4c9e-a811-53098826741a"
      id="F_3fd64f09-6016-4320-bb97-f2e16d6950c3">2024-06-01</us-gaap:LineOfCreditFacilityExpirationDate1>
    <eq:LineOfCreditFacilityFrequencyOfPaymentsPrincipalAndInterest
      contextRef="C_ef6b21dc-276b-4e2a-a0f4-7de1ea76111b"
      decimals="INF"
      id="F_958e07ed-ab03-41b0-ad62-efd9dfa1c6dc"
      unitRef="U_Installment">36</eq:LineOfCreditFacilityFrequencyOfPaymentsPrincipalAndInterest>
    <us-gaap:DebtInstrumentFrequencyOfPeriodicPayment
      contextRef="C_9cad8da7-5192-43d1-ae8d-b306505ebc15"
      id="F_3ee14ee6-42d9-4926-adee-1075235432f0">monthly</us-gaap:DebtInstrumentFrequencyOfPeriodicPayment>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="C_944e0e4f-c4c3-48bc-98c4-915a5ff4bfa0"
      decimals="4"
      id="F_2e1afc3d-60c2-4ac5-babf-1449de273f9f"
      unitRef="U_pure">0.0825</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateBasisForEffectiveRate
      contextRef="C_9cad8da7-5192-43d1-ae8d-b306505ebc15"
      id="F_9b84ca8d-16e4-45d6-869b-4c7ef610d860">prime rate</us-gaap:DebtInstrumentInterestRateBasisForEffectiveRate>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="C_c2f2d003-05db-4149-bb1f-60dc7a7a84c7"
      decimals="4"
      id="F_5e7806ab-7e47-4f11-ac53-a738312672ca"
      unitRef="U_pure">0.0300</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="C_677cb0dd-b0f9-4917-b6b9-3a7ad67b6397"
      decimals="3"
      id="F_7e8728e7-3e93-4f4d-91a2-5fbf2cc1640e"
      unitRef="U_pure">0.045</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="C_c28101d2-ae40-418c-83d4-9715bbaa72e3"
      decimals="3"
      id="F_ac684ede-4a59-42e0-98fb-2e3365fcfe1f"
      unitRef="U_pure">0.050</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <eq:LineOfCreditFacilityFrequencyOfPaymentsPrincipalAndInterest
      contextRef="C_0dabeff1-f05f-4737-8f45-b0cb38473eb4"
      decimals="INF"
      id="F_6425c307-7190-47c3-8d42-62bf4f279145"
      unitRef="U_Installment">24</eq:LineOfCreditFacilityFrequencyOfPaymentsPrincipalAndInterest>
    <us-gaap:DebtInstrumentFrequencyOfPeriodicPayment
      contextRef="C_3170d519-6bfe-4d96-886d-1344675502df"
      id="F_0b7a9d27-5686-4452-8d08-9e1aa52116d0">monthly</us-gaap:DebtInstrumentFrequencyOfPeriodicPayment>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="C_74785e69-c479-4de9-938d-9e775d1f539a"
      decimals="4"
      id="F_9d26e4bc-6211-460f-b6dd-aa07598d7a85"
      unitRef="U_pure">0.1186</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <eq:DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaidAsPercent
      contextRef="C_9cad8da7-5192-43d1-ae8d-b306505ebc15"
      decimals="4"
      id="F_7840b061-73d5-4db2-9a0f-99d931d2e5b0"
      unitRef="U_pure">0.0500</eq:DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaidAsPercent>
    <eq:RequiredNoticePeriodForDebtPrepayment
      contextRef="C_9cad8da7-5192-43d1-ae8d-b306505ebc15"
      id="F_e6be88e9-ae5f-4a56-a841-18d629664750">P30D</eq:RequiredNoticePeriodForDebtPrepayment>
    <eq:DebtPrepaymentFeeAsPercentOnYearOne
      contextRef="C_9cad8da7-5192-43d1-ae8d-b306505ebc15"
      decimals="4"
      id="F_d81f1d22-559e-4655-8855-3edc33d75df7"
      unitRef="U_pure">0.0300</eq:DebtPrepaymentFeeAsPercentOnYearOne>
    <eq:DebtPrepaymentFeeAsPercentOnYearTwo
      contextRef="C_9cad8da7-5192-43d1-ae8d-b306505ebc15"
      decimals="4"
      id="F_ee6563e5-9c9d-40e6-979b-5be6907deedc"
      unitRef="U_pure">0.0200</eq:DebtPrepaymentFeeAsPercentOnYearTwo>
    <eq:DebtPrepaymentFeeAsPercentFromYearThree
      contextRef="C_9cad8da7-5192-43d1-ae8d-b306505ebc15"
      decimals="4"
      id="F_90bdd24c-b6c1-42ea-b020-4e7e47e83d31"
      unitRef="U_pure">0.0100</eq:DebtPrepaymentFeeAsPercentFromYearThree>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="C_90508498-eb7a-4af4-a10b-9b578a529f24"
      decimals="0"
      id="F_d17551ed-31e1-4a8b-8207-8abe21461e1e"
      unitRef="U_shares">80428</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_90508498-eb7a-4af4-a10b-9b578a529f24"
      decimals="2"
      id="F_5da95eb8-fb0f-4271-8f22-416531ac46bb"
      unitRef="U_USDollarShare">3.73</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      id="F_575e1962-a19d-48c9-bd75-558116cedacf">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The aggregate carrying amounts of the Term Loan is comprised of the following (in thousands):&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:67.108%;"/&gt;
        &lt;td style="width:1.493%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:12.883000000000001%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.493%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.022%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Principal&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;8,571&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;10,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Add: accreted liability for final payment fee&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;430&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;310&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Less: unamortized discount&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;48&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;132&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;8,953&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;10,178&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="C_b41b6a74-0d46-45fe-8820-d94fa8d877f1"
      decimals="-3"
      id="F_382c1a7c-c988-467f-8884-a7b8acebec2b"
      unitRef="U_USD">8571000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="C_916e47cd-8d5b-46a6-ada5-c452d339e627"
      decimals="-3"
      id="F_4c463f3c-a224-4f6b-94b7-8ab8ced8aef0"
      unitRef="U_USD">10000000</us-gaap:DebtInstrumentCarryingAmount>
    <eq:AccretedLiabilityForFinalPaymentFee
      contextRef="C_b41b6a74-0d46-45fe-8820-d94fa8d877f1"
      decimals="-3"
      id="F_79696f80-5429-4b5f-a3aa-ae1e7d2f0777"
      unitRef="U_USD">430000</eq:AccretedLiabilityForFinalPaymentFee>
    <eq:AccretedLiabilityForFinalPaymentFee
      contextRef="C_916e47cd-8d5b-46a6-ada5-c452d339e627"
      decimals="-3"
      id="F_f4cd1eb3-d0df-476b-bdc7-1ae496980767"
      unitRef="U_USD">310000</eq:AccretedLiabilityForFinalPaymentFee>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="C_b41b6a74-0d46-45fe-8820-d94fa8d877f1"
      decimals="-3"
      id="F_5db261b9-afc3-430f-9f60-d4b6963dda01"
      unitRef="U_USD">48000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="C_916e47cd-8d5b-46a6-ada5-c452d339e627"
      decimals="-3"
      id="F_abfb099e-6efe-454f-becc-3c5c706cf820"
      unitRef="U_USD">132000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:LongTermDebt
      contextRef="C_b41b6a74-0d46-45fe-8820-d94fa8d877f1"
      decimals="-3"
      id="F_745d74ea-760b-4ab3-aa99-52d9a46c1747"
      unitRef="U_USD">8953000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="C_916e47cd-8d5b-46a6-ada5-c452d339e627"
      decimals="-3"
      id="F_60b24ef1-0b94-4d94-b7f8-e08a24106099"
      unitRef="U_USD">10178000</us-gaap:LongTermDebt>
    <us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      id="F_43b47ea4-ea26-4544-91f1-34c76829c987">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Future maturities of the Term Loan, including the Final Payment fee, as of December 31, 2022 were as follows (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:80.253%;"/&gt;
        &lt;td style="width:1.792%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:15.956%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Year ending December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5,714&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Year ending December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3,357&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;9,071&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Unaccreted balance for Final Payment fee on Term Loans&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;70&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Unamortized discounts&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;48&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;8,953&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Less current portion&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5,714&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Noncurrent portion&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3,239&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock>
    <eq:DebtInstrumentCarryingAmountIncludingUnaccretedLiabilityForFinalPaymentFeeMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192"
      decimals="-3"
      id="F_eedd0bad-b2bc-493b-8a32-077e6cb08bef"
      unitRef="U_USD">5714000</eq:DebtInstrumentCarryingAmountIncludingUnaccretedLiabilityForFinalPaymentFeeMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <eq:DebtInstrumentCarryingAmountIncludingUnaccretedLiabilityForFinalPaymentFeeMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192"
      decimals="-3"
      id="F_3dff44ea-19ae-494c-a9e0-af5fbad8c727"
      unitRef="U_USD">3357000</eq:DebtInstrumentCarryingAmountIncludingUnaccretedLiabilityForFinalPaymentFeeMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebt
      contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192"
      decimals="-3"
      id="F_93041eeb-88f9-43c6-abb2-1c768b9e9f7f"
      unitRef="U_USD">9071000</us-gaap:LongTermDebt>
    <eq:UnaccretedLiabilityForFinalPaymentFee
      contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192"
      decimals="-3"
      id="F_6421d3d5-8b1e-4296-926e-33169a37a22e"
      unitRef="U_USD">70000</eq:UnaccretedLiabilityForFinalPaymentFee>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192"
      decimals="-3"
      id="F_f4f35d3f-98aa-4fbe-b48d-2b77f2918f7b"
      unitRef="U_USD">48000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <eq:DebtInstrumentCarryingAmountIncludingUnaccretedLiabilityForFinalPaymentFee
      contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192"
      decimals="-3"
      id="F_ec04bc3e-7d83-4bc6-aac0-e9ddcdc4e71a"
      unitRef="U_USD">8953000</eq:DebtInstrumentCarryingAmountIncludingUnaccretedLiabilityForFinalPaymentFee>
    <us-gaap:LongTermDebtCurrent
      contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192"
      decimals="-3"
      id="F_8ab5cfa0-4b7a-4b38-8a13-67d1c2297e6b"
      unitRef="U_USD">5714000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192"
      decimals="-3"
      id="F_8abbfc16-67d4-4e0a-aa82-61b1bd7ad879"
      unitRef="U_USD">3239000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      id="F_1cfba161-5069-4df3-9693-8ee728544074">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;11. Stockholders&#x2019; Equity&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;As of December 31, 2022, the Company&#x2019;s authorized capital stock consisted of &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;200,000,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; shares of common stock, par value $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.0001&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; per share, and &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;10,000,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; shares of preferred stock, par value $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.0001&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; per share.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company had &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;34,414,149&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; and &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;29,455,668&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; shares of common stock outstanding as of December 31, 2022 and 2021, respectively.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Registered Direct Offering and related warrants&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;On February 3, 2021, the Company entered into a securities purchase agreement (the Securities Purchase Agreement) with &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;two&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; institutional investors (the Purchasers), relating to the issuance and sale (the Offering) of an aggregate of &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4,285,710&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; shares of common stock and warrants to purchase &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,285,713&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; shares of common stock (the Warrants) for aggregate gross proceeds to the Company from this Offering of approximately $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;30.0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million, excluding any proceeds the Company may receive upon exercise of the Warrants. No underwriter or placement agent participated in the Offering. The proceeds, net of related issuance costs, were $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;29.9&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Warrants are exercisable immediately upon issuance at an initial exercise price of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;14.00&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; per share and are exercisable on a cashless basis. The Warrants expire on the earlier of (i) the fifth anniversary of issuance or (ii) the 15th calendar date following the date on which the Company closes upon an equity financing that results in not less than $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;25&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million of gross proceeds to the Company at a price per share of common stock equal to or greater than $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;25.00&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, at which time, all remaining Warrants will automatically be exercised on a cashless basis. The exercise price and the number of shares of common stock purchasable upon the exercise of the Warrants are subject to adjustment upon the occurrence of specific events, including stock dividends, stock splits, reclassifications and combinations of the Company&#x2019;s common stock. All of the warrants are recorded within equity in accordance with authoritative accounting guidance.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Pursuant to the terms of the Securities Purchase Agreement, the Company appointed Dr. Yu (Katherine) Xu, Ph. D. to the Board as a nominee of the Purchasers.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Purchase Agreement&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;On March 27, 2020, the Company entered into a purchase agreement (Purchase Agreement), with Lincoln Park, which provides that, upon the terms and subject to the conditions and limitations set forth therein, the Company may sell to Lincoln Park up to $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;15.0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million of shares of its common stock from time to time over the &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;36-month&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; term of the Purchase Agreement. Upon execution of the Purchase Agreement, the Company issued &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;65,374&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; shares of its common stock to Lincoln Park as commitment shares in accordance with the closing conditions contained within the Purchase Agreement. The commitment shares were valued using the closing price of the Company&#x2019;s common stock on the effective date of the Purchase Agreement resulting in a fair market value of approximately $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.2&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million. The fair market value of the commitment shares as well as other issuance costs associated with the Purchase Agreement totaled $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.4&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million. These issuance costs were classified as prepaid expenses and other current assets in the accompanying consolidated balance sheet as of December 31, 2021.  There have been &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; sales of the Company&#x2019;s stock under this Purchase Agreement as of December 31, 2022 and through the date of the filing of this Annual Report on Form 10-K. The Purchase Agreement expires on &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;May 1, 2023&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;. &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Since the Company believes it is unlikely to sell any shares to Lincoln Park prior to the Purchase Agreement expiring, the capitalized issuance costs were written off as of December 31, 2022 to general and administrative expense.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;2018 Equity Incentive Plan&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;In October 2018, the Company adopted the 2018 Equity Incentive Plan (the 2018 Plan) which replaced the Company&#x2019;s legacy 2017 Equity Incentive Plan (the 2017 Plan). The 2018 Plan provides for the grant of incentive stock options, non-statutory stock options, stock appreciation rights, restricted stock awards, restricted stock unit awards, performance stock awards, performance cash awards and other forms of stock awards. As of December 31, 2022, the 2018 Plan had a maximum of &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;784,331&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; total shares available for issuance. &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The number of shares of common stock reserved for issuance under the 2018 Plan will automatically increase on January 1 of each calendar year through January 1, 2028, in an amount equal to 5.0% of the total number of shares of the Company&#x2019;s capital stock outstanding on the last day of the calendar month before the date of each automatic increase, or a lesser number of shares determined by the Board.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Options granted under the 2018 Plan are exercisable at various dates as determined upon grant and will expire no more than &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;ten years&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; from their date of grant. The exercise price of each option shall be determined by the Board based on the estimated fair value of the Company&#x2019;s stock on the date of the option grant. The exercise price shall not be less than &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;100&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;% of the fair market value of the Company&#x2019;s common stock at the time the option is granted. Most option grants generally vest &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;25&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;% on the first anniversary of the original vesting commencement date, with the balance vesting monthly over the remaining &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;three years&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Stock Options&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The following summarizes stock option activity for the year ended December 31, 2022:&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:50.131%;"/&gt;
        &lt;td style="width:0.713%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:12.533999999999999%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:0.844%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:6.307%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:0.713%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:10.41%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:0.844%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:9.507%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Outstanding Options&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Weighted-&lt;br/&gt;Average &lt;br/&gt;Exercise Price&lt;br/&gt;Per Share&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual&lt;br/&gt;Term&lt;br/&gt;(in years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Aggregate&lt;br/&gt;Intrinsic Value&lt;br/&gt;(in thousands) &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(a)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Balances as of December 31, 2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3,947,025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4.58&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Granted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,169,800&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3.63&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Exercised&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="-sec-ix-hidden:F_e9cd9fc4-b2d3-4e1c-814b-17b62754d416;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="-sec-ix-hidden:F_0fa15c8b-e902-4287-b1e7-c4c493e1c465;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Forfeitures and cancellations&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,014,324&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4.90&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Balances as of December 31, 2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5,102,501&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4.11&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;7.71&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Options exercisable as of December 31, 2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,483,222&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4.23&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6.75&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;div style="text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.333%;"&gt;(a)&lt;/span&gt;&lt;div style="display:inline;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Aggregate intrinsic value in this table was calculated as the positive difference, if any, between the closing price per share of the Company&#x2019;s common stock on December 31, 2022 of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1.06&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; and the price of the underlying options.&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The aggregate intrinsic value of stock options exercised was &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;none&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.4&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million for the years ended December 31, 2022 and 2021, respectively. Cash received from stock options exercised was &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;none&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.9&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million for the years ended December 31, 2022 and 2021, respectively.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The fair value of stock options that vested in the years ended December 31, 2022 and 2021 was $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4.5&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3.0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million, respectively. The weighted-average grant-date fair value of options granted was $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2.49&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3.94&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; for the years ended December 31, 2022 and 2021, respectively.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;As of December 31, 2022, unrecognized compensation expense related to unvested stock options was $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6.7&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million and is expected to be recognized over a weighted-average period of &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2.6&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; years.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;2018 Employee Stock Purchase Plan&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;In October 2018, the Company adopted the 2018 &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Equity Stock Purchase Plan (ESPP) whereby eligible employees may elect to withhold up to &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;15&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;% of their earnings to purchase shares of the Company&#x2019;s common stock at a price per share equal to the lower of (i) &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;85&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;% of the fair market value of a share of the Company&#x2019;s common stock on the first date of an offering or (ii) &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;85&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;% of the fair market value of a share of the Company&#x2019;s common stock on the date of the purchase right (purchase right). Initially, &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;343,275&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; shares of the Company&#x2019;s common stock were approved for issuance under the ESPP pursuant to purchase rights granted to the Company&#x2019;s employees or to employees of any of the Company&#x2019;s designated affiliates. The number of shares of the Company&#x2019;s common stock reserved for issuance will automatically increase on January 1 of each calendar year through January 1, 2028, by the lesser of (1) 1.0% of the total number of shares of the Company&#x2019;s common stock outstanding on the last day of the calendar month before the date of the automatic increase, and (2) &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;343,275&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; shares; provided that before the date of any such increase, the Board may determine that such increase will be less than the amount set forth in clauses (1) and (2)&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;As of December 31, 2022, the Company had issued &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;307,417&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; shares of common stock under the ESPP, &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;138,251&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; of which were issued during the year ended December 31, 2022. The Company had &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;925,963&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; shares available for future issuance under the ESPP as of December 31, 2022.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Liability for Early Exercise of Restricted Stock Options&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;All stock option grants under the 2017 Plan provide for exercise of the stock option prior to vesting. Shares of common stock issued upon exercise of unvested options are subject to repurchase by the Company at the respective original exercise price until vested. Consideration received for the exercise of unvested stock options is recorded as a liability and reclassified into equity as the related award vests.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;As of December 31, 2022&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, there were no unvested shares issued under early exercise provisions subject to repurchase by the Company. As of December 31, 2021, there were &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;43,135&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; unvested shares issued under early exercise provisions that were subject to repurchase by the Company. The balance sheet reflects an unvested stock liability of &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;none&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;53,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; as of &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2022 and 2021, respectively. As of December 31, 2021, the unvested stock liability was considered short-term and was classified as accrued expenses on the accompanying consolidated balance sheet.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Stock-based Compensation Expense&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total non-cash stock-based compensation expense for all stock awards and purchase rights, net of forfeitures recognized as they occur, that was recognized in the consolidated statement of operations is as follows (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.327%;"/&gt;
        &lt;td style="width:1.466%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.322000000000001%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.48%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.406%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Year Ended &lt;br/&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Research and development&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,799&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,976&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;General and administrative&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3,042&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,434&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4,841&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4,410&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The weighted-average assumptions used in the Black-Scholes option pricing model to determine the fair value of the employee and nonemployee stock option grants were as follows:&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:67.29%;"/&gt;
        &lt;td style="width:1.502%;"/&gt;
        &lt;td style="width:14.867%;"/&gt;
        &lt;td style="width:1.502%;"/&gt;
        &lt;td style="width:14.838%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="3" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Year Ended &lt;br/&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Risk-free interest rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1.93&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.68&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Expected volatility&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;81.60&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;88.55&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Expected term (in years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5.84&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6.01&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Expected dividend yield&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Risk-free interest rate. &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The risk-free rate assumption is based on the U.S. Treasury instruments, the terms of which were consistent with the expected term of the Company&#x2019;s stock options.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Expected volatility. &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Due to the Company&#x2019;s limited operating history and lack of company-specific historical or implied volatility as a private company, the expected volatility assumption was determined by examining the historical volatilities of a group of industry peers whose share prices are publicly available.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Expected term. &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The expected term of stock options represents the weighted-average period the stock options are expected to be outstanding. The Company uses the simplified method for estimating the expected term as provided by the SEC. The simplified method calculates the expected term as the average of the time-to-vesting and the contractual life of the options.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Expected dividend yield. &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The expected dividend assumption is based on the Company&#x2019;s history and expectation of dividend payouts. The Company has not paid and does &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;t intend to pay dividends.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Forfeitures&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;. The Company reduces stock-based compensation expense for actual forfeitures during the period.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Common Stock Reserved for Future Issuance&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Common stock reserved for future issuance consists of the following as of &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2022 and 2021:&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:67.477%;"/&gt;
        &lt;td style="width:1.009%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.204%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.023%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.289%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Stock options issued and outstanding&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5,102,501&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3,947,025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Warrants for common stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,366,141&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,366,141&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Awards available under the 2018 Equity Incentive Plan&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;784,331&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;467,024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Employee stock purchase plan&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;925,963&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;769,658&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;8,178,936&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6,549,848&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192"
      decimals="INF"
      id="F_3d6611ca-3676-4cdc-83ba-05809425a242"
      unitRef="U_shares">200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192"
      decimals="INF"
      id="F_3e24f5fb-d7df-485a-ab0d-53cb4773c801"
      unitRef="U_USDollarShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192"
      decimals="INF"
      id="F_7feb4b63-ca55-4750-b2da-1ce64d3d1ab8"
      unitRef="U_shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192"
      decimals="INF"
      id="F_d20b2e43-c342-4479-a71b-0a217d88b467"
      unitRef="U_USDollarShare">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192"
      decimals="0"
      id="F_5ae533a4-c513-401b-b329-65df43865f6c"
      unitRef="U_shares">34414149</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94"
      decimals="0"
      id="F_907f8c70-8a23-4816-9d70-f218587e4ba4"
      unitRef="U_shares">29455668</us-gaap:CommonStockSharesOutstanding>
    <eq:NumberOfInstitutionalInvestors
      contextRef="C_bff86cb7-8d58-45e7-9e93-1982cad8799f"
      decimals="INF"
      id="F_3ae290c9-b07c-4d44-9c15-67963c6e305f"
      unitRef="U_Investor">2</eq:NumberOfInstitutionalInvestors>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_4eb35088-1593-4e17-8c6a-8c9e0bdad77b"
      decimals="INF"
      id="F_52230e53-1f7a-43b2-8810-26e96243e293"
      unitRef="U_shares">4285710</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="C_c10ac679-9a2b-4cbc-b11a-d6a2b12c4221"
      decimals="INF"
      id="F_d836840e-2cce-4d4f-a6fe-ee7e2a6d43f6"
      unitRef="U_shares">1285713</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <eq:GrossProceedsFromIssuanceOfCommonStock
      contextRef="C_bff86cb7-8d58-45e7-9e93-1982cad8799f"
      decimals="-5"
      id="F_9eec71dc-a171-4dd5-9a8f-cd94e988b321"
      unitRef="U_USD">30000000.0</eq:GrossProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="C_bff86cb7-8d58-45e7-9e93-1982cad8799f"
      decimals="-5"
      id="F_2ba7faf4-67ff-43d7-8b10-29579a938d3c"
      unitRef="U_USD">29900000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_2c8bb5f0-73a3-432f-b12e-cb35048d1783"
      decimals="INF"
      id="F_f8fc048f-c649-4917-91d9-8858c5810c90"
      unitRef="U_USDollarShare">14.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <eq:GrossProceedsFromIssuanceOfCommonStock
      contextRef="C_d3ce0459-c113-4153-9f4d-e1ca48da2c0b"
      decimals="-6"
      id="F_beab5094-53f2-421d-8e02-5347ceb0fc2a"
      unitRef="U_USD">25000000</eq:GrossProceedsFromIssuanceOfCommonStock>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="C_2c8bb5f0-73a3-432f-b12e-cb35048d1783"
      decimals="INF"
      id="F_81a45000-435c-4145-9783-8c34f54005e3"
      unitRef="U_USDollarShare">25.00</us-gaap:SharesIssuedPricePerShare>
    <eq:EstimatedMaximumAmountOfCommonStockIssuable
      contextRef="C_1b636714-e678-4bb2-be3e-3c64ae434607"
      decimals="-2"
      id="F_003c4199-e516-4237-a0b0-37316a58121b"
      unitRef="U_USD">15000.0</eq:EstimatedMaximumAmountOfCommonStockIssuable>
    <eq:TermOfPurchaseAgreement
      contextRef="C_1b636714-e678-4bb2-be3e-3c64ae434607"
      id="F_1255aa3e-5c80-435c-9ba2-f17af017833b">P36M</eq:TermOfPurchaseAgreement>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_1b636714-e678-4bb2-be3e-3c64ae434607"
      decimals="0"
      id="F_abf6734c-2293-41fa-894c-055a93f80c6f"
      unitRef="U_shares">65374</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <eq:FairMarketValueOfCommitmentShares
      contextRef="C_1b636714-e678-4bb2-be3e-3c64ae434607"
      decimals="-5"
      id="F_2bf46546-14d2-4722-bf4a-c597a34f1c78"
      unitRef="U_USD">200000</eq:FairMarketValueOfCommitmentShares>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="C_1b636714-e678-4bb2-be3e-3c64ae434607"
      decimals="-5"
      id="F_472789f9-f469-4061-9a02-fa30ef8b68cd"
      unitRef="U_USD">400000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_251e65bb-85a5-4df7-a709-d3e4c8e42ad6"
      decimals="0"
      id="F_11c588a5-a866-4a3e-8d13-6129e1d94155"
      unitRef="U_shares">0</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <eq:PurchaseAgreementExpirationDate
      contextRef="C_ea3c06e5-f9a7-4f24-ba11-8679304c0196"
      id="F_88a8e2a1-7709-4503-9a9c-949f3a89ac80">2023-05-01</eq:PurchaseAgreementExpirationDate>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_a14519ee-c0f5-4735-a3a2-5d78ee96686f"
      decimals="INF"
      id="F_551a4fe7-22a7-4954-907b-f5ddd69caf47"
      unitRef="U_shares">784331</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <eq:EquityIncentivePlanDescription
      contextRef="C_1a97b4e1-6653-4a2c-a233-548bf388b221"
      id="F_aa39f005-ec5d-4e9e-b98f-fd69e5292316">The number of shares of common stock reserved for issuance under the 2018 Plan will automatically increase on January 1 of each calendar year through January 1, 2028, in an amount equal to 5.0% of the total number of shares of the Company&#x2019;s capital stock outstanding on the last day of the calendar month before the date of each automatic increase, or a lesser number of shares determined by the Board.</eq:EquityIncentivePlanDescription>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="C_58ee8b88-7fcf-463a-aada-7b6967a5d010"
      id="F_c4e31daa-eabd-4a52-addf-7e89e56472e7">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <eq:MinimumOptionsExercisePriceAsPercentageOfFairMarketValueOfCommonStock
      contextRef="C_4ba266ad-8527-41b5-81de-63143638b62c"
      decimals="INF"
      id="F_e2b83408-a906-465a-a50f-5c14dd36726b"
      unitRef="U_pure">1</eq:MinimumOptionsExercisePriceAsPercentageOfFairMarketValueOfCommonStock>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="C_7b79d852-2622-42ae-b02e-a2784258be60"
      decimals="2"
      id="F_fd633a79-31a8-478b-beb5-a541337be5a1"
      unitRef="U_pure">0.25</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <eq:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRemainingVestingPeriod
      contextRef="C_4ba266ad-8527-41b5-81de-63143638b62c"
      id="F_1acf3ae7-a798-4bec-9630-28850b7c47d1">P3Y</eq:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRemainingVestingPeriod>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      id="F_e6540ba4-1c33-4622-a084-34c8188f8b02">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The following summarizes stock option activity for the year ended December 31, 2022:&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:50.131%;"/&gt;
        &lt;td style="width:0.713%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:12.533999999999999%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:0.844%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:6.307%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:0.713%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:10.41%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:0.844%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:9.507%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Outstanding Options&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Weighted-&lt;br/&gt;Average &lt;br/&gt;Exercise Price&lt;br/&gt;Per Share&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual&lt;br/&gt;Term&lt;br/&gt;(in years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Aggregate&lt;br/&gt;Intrinsic Value&lt;br/&gt;(in thousands) &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(a)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Balances as of December 31, 2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3,947,025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4.58&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Granted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,169,800&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3.63&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Exercised&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="-sec-ix-hidden:F_e9cd9fc4-b2d3-4e1c-814b-17b62754d416;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="-sec-ix-hidden:F_0fa15c8b-e902-4287-b1e7-c4c493e1c465;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Forfeitures and cancellations&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,014,324&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4.90&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Balances as of December 31, 2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5,102,501&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4.11&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;7.71&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Options exercisable as of December 31, 2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,483,222&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4.23&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6.75&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;div style="text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.333%;"&gt;(a)&lt;/span&gt;&lt;div style="display:inline;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Aggregate intrinsic value in this table was calculated as the positive difference, if any, between the closing price per share of the Company&#x2019;s common stock on December 31, 2022 of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1.06&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; and the price of the underlying options.&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="C_9c160bc4-2896-4f45-abda-cba01dca2910"
      decimals="INF"
      id="F_415cebe3-b500-4c21-803c-8d39739c84b1"
      unitRef="U_shares">3947025</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="C_9c160bc4-2896-4f45-abda-cba01dca2910"
      decimals="2"
      id="F_2948110b-6c36-447e-bc0a-a6d1261421db"
      unitRef="U_USDollarShare">4.58</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_1a97b4e1-6653-4a2c-a233-548bf388b221"
      decimals="INF"
      id="F_83f3ff46-668b-4ffb-9bb7-7c00ef203b03"
      unitRef="U_shares">2169800</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="C_1a97b4e1-6653-4a2c-a233-548bf388b221"
      decimals="2"
      id="F_831bf75a-c3f1-4ab9-a0a8-848d2ca6657f"
      unitRef="U_USDollarShare">3.63</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="C_1a97b4e1-6653-4a2c-a233-548bf388b221"
      decimals="INF"
      id="F_0125e25b-21e5-47a4-9db5-ffe833aee1dd"
      unitRef="U_shares">1014324</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="C_1a97b4e1-6653-4a2c-a233-548bf388b221"
      decimals="2"
      id="F_90fe45e0-cb09-4a27-93a1-9a6acbe28e11"
      unitRef="U_USDollarShare">4.90</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="C_4640a459-b05e-473c-894a-3d5c68449919"
      decimals="INF"
      id="F_056d53e9-0364-4776-bcf5-df3211d69903"
      unitRef="U_shares">5102501</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="C_4640a459-b05e-473c-894a-3d5c68449919"
      decimals="2"
      id="F_c51d9d10-b078-4f36-9c26-45c3b2f7af28"
      unitRef="U_USDollarShare">4.11</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="C_1a97b4e1-6653-4a2c-a233-548bf388b221"
      id="F_51eafb38-6b4e-45bc-970e-daa3ff169030">P7Y8M15D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="C_4640a459-b05e-473c-894a-3d5c68449919"
      decimals="-3"
      id="F_bd8784fc-0055-4304-85a2-61493abaaf00"
      unitRef="U_USD">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="C_4640a459-b05e-473c-894a-3d5c68449919"
      decimals="INF"
      id="F_9a4a27bf-0cd7-412f-b4e1-ca0927616d98"
      unitRef="U_shares">2483222</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="C_4640a459-b05e-473c-894a-3d5c68449919"
      decimals="2"
      id="F_0bbe39c3-c328-48f3-bde7-4cbb69fc9371"
      unitRef="U_USDollarShare">4.23</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="C_1a97b4e1-6653-4a2c-a233-548bf388b221"
      id="F_f583764a-67aa-471f-af22-2dcd792339a1">P6Y9M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="C_4640a459-b05e-473c-894a-3d5c68449919"
      decimals="-3"
      id="F_4bccb99b-951a-4290-9052-fd9ccab54601"
      unitRef="U_USD">0</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:SharePrice
      contextRef="C_cba59bb2-f211-4a75-beff-6ddac7dfa0b7"
      decimals="2"
      id="F_89f71c25-12ae-45dc-8607-0e435fd49c2a"
      unitRef="U_USDollarShare">1.06</us-gaap:SharePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      decimals="-6"
      id="F_de3d9dcd-3deb-4600-92bf-1f265bad7d75"
      unitRef="U_USD">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2"
      decimals="-5"
      id="F_af68308e-522d-4e2b-bceb-c2664f192ea7"
      unitRef="U_USD">400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      decimals="-6"
      id="F_88c5fffa-f216-4158-a4e0-8c1d9b01076c"
      unitRef="U_USD">0</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2"
      decimals="-5"
      id="F_17418a12-b280-492f-bf01-bc31b3701d17"
      unitRef="U_USD">900000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      decimals="-5"
      id="F_84e5a6ff-942b-48b7-9493-c486ab7ebca2"
      unitRef="U_USD">4500000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
      contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2"
      decimals="-5"
      id="F_7e4256c2-acb5-4c8e-8940-fa96d4ea9635"
      unitRef="U_USD">3000000.0</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      decimals="2"
      id="F_755ea9b7-cdb9-42ed-88e7-37f686782c8b"
      unitRef="U_USDollarShare">2.49</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2"
      decimals="2"
      id="F_0314ef5c-b691-425c-9099-e1735585597f"
      unitRef="U_USDollarShare">3.94</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192"
      decimals="-5"
      id="F_b5cd9542-e62a-46ea-9945-9454e5771ee4"
      unitRef="U_USD">6700000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      id="F_fff2d060-6cfb-4704-b217-da0a3e47a556">P2Y7M6D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <eq:EmployeeStockPurchasePlanDescription
      contextRef="C_8d880863-715e-4b80-9a73-33be4ffa0166"
      id="F_cd0986cb-7b85-44d0-b503-771339301bc1">Equity Stock Purchase Plan (ESPP) whereby eligible employees may elect to withhold up to 15% of their earnings to purchase shares of the Company&#x2019;s common stock at a price per share equal to the lower of (i) 85% of the fair market value of a share of the Company&#x2019;s common stock on the first date of an offering or (ii) 85% of the fair market value of a share of the Company&#x2019;s common stock on the date of the purchase right (purchase right). Initially, 343,275 shares of the Company&#x2019;s common stock were approved for issuance under the ESPP pursuant to purchase rights granted to the Company&#x2019;s employees or to employees of any of the Company&#x2019;s designated affiliates. The number of shares of the Company&#x2019;s common stock reserved for issuance will automatically increase on January 1 of each calendar year through January 1, 2028, by the lesser of (1) 1.0% of the total number of shares of the Company&#x2019;s common stock outstanding on the last day of the calendar month before the date of the automatic increase, and (2) 343,275 shares; provided that before the date of any such increase, the Board may determine that such increase will be less than the amount set forth in clauses (1) and (2)</eq:EmployeeStockPurchasePlanDescription>
    <eq:WithholdPercentageOfEmployeesEarningsToPurchaseSharesOfCommonStock
      contextRef="C_6b91f489-4f82-44f0-b32f-1000032af149"
      decimals="2"
      id="F_66609d91-e569-4ee4-8d35-4970d1142543"
      unitRef="U_pure">0.15</eq:WithholdPercentageOfEmployeesEarningsToPurchaseSharesOfCommonStock>
    <eq:MinimumStockPricePerShareAsPercentageOfFairMarketValueOfCommonStock
      contextRef="C_6b91f489-4f82-44f0-b32f-1000032af149"
      decimals="INF"
      id="F_d2e15c19-3534-45ad-ba5e-78ed07a91af7"
      unitRef="U_pure">0.85</eq:MinimumStockPricePerShareAsPercentageOfFairMarketValueOfCommonStock>
    <eq:MinimumStockPricePerShareAsPercentageOfFairMarketValueOfCommonStock
      contextRef="C_72940a8c-6662-4785-be1e-cde22f293e80"
      decimals="INF"
      id="F_deddec0f-8d39-475e-8254-b91551739f9a"
      unitRef="U_pure">0.85</eq:MinimumStockPricePerShareAsPercentageOfFairMarketValueOfCommonStock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="C_da6b0f69-4d60-4727-93e2-76b6699fc7cd"
      decimals="INF"
      id="F_28b5cd0a-e42f-4809-ba9d-06d219d48d25"
      unitRef="U_shares">343275</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="C_da6b0f69-4d60-4727-93e2-76b6699fc7cd"
      decimals="INF"
      id="F_f5d60629-d3ed-4e58-84e1-f8c65f0c876d"
      unitRef="U_shares">343275</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
      contextRef="C_7e0f633d-433f-45b3-b81e-21ab345a28bd"
      decimals="INF"
      id="F_73259d40-179a-4882-8a3f-64aa67240992"
      unitRef="U_shares">307417</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
      contextRef="C_8d880863-715e-4b80-9a73-33be4ffa0166"
      decimals="INF"
      id="F_aadc27ba-ac63-4a4f-a61d-1ce635c5fc23"
      unitRef="U_shares">138251</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
      contextRef="C_8d880863-715e-4b80-9a73-33be4ffa0166"
      decimals="INF"
      id="F_807593c4-9069-4103-a2f7-980fce4c0022"
      unitRef="U_shares">925963</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="C_4facbb57-718b-4710-bf34-290be7c869f0"
      decimals="0"
      id="F_e1cc44e2-f82f-4959-a474-70b58b9ad859"
      unitRef="U_shares">43135</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <eq:UnvestedStockLiability
      contextRef="C_0d524201-b596-46e6-95bc-8b3b552ccc88"
      decimals="0"
      id="F_cf511860-e03d-4376-bb0f-ced636e083af"
      unitRef="U_USD">0</eq:UnvestedStockLiability>
    <eq:UnvestedStockLiability
      contextRef="C_4facbb57-718b-4710-bf34-290be7c869f0"
      decimals="0"
      id="F_5dec1a5f-d16a-4a20-86f1-c82af24d438d"
      unitRef="U_USD">53000</eq:UnvestedStockLiability>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      id="F_016868ba-fa7b-4e25-86a7-1cf74d2d87fe">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total non-cash stock-based compensation expense for all stock awards and purchase rights, net of forfeitures recognized as they occur, that was recognized in the consolidated statement of operations is as follows (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.327%;"/&gt;
        &lt;td style="width:1.466%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.322000000000001%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.48%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.406%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Year Ended &lt;br/&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Research and development&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,799&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,976&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;General and administrative&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3,042&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,434&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4,841&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4,410&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_ff05e412-5d32-4d51-9c1b-fcbe95cea7f7"
      decimals="-3"
      id="F_2c09e938-6778-48c1-b977-13e31ff95963"
      unitRef="U_USD">1799000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_c004a059-d1b3-45bc-90d2-29b2939452f6"
      decimals="-3"
      id="F_3de6a73a-8959-42e9-9d83-8c3b9ccd64b8"
      unitRef="U_USD">1976000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_c886a389-5f87-408e-8648-17d8507a401b"
      decimals="-3"
      id="F_9193a7b0-8aca-4e6b-b0ef-da41f81df776"
      unitRef="U_USD">3042000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_fae7480f-6d94-4ea1-b4e4-5cde09bbcd56"
      decimals="-3"
      id="F_0225a541-4b2c-4147-9b8a-bf9184441cc7"
      unitRef="U_USD">2434000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      decimals="-3"
      id="F_ddc72299-75a8-415e-b24f-a2423054db71"
      unitRef="U_USD">4841000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2"
      decimals="-3"
      id="F_be3b2d68-7e9b-4b4e-9fcb-e160db7dc1d4"
      unitRef="U_USD">4410000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      id="F_14f1b332-adb3-4223-a017-e867f2ca1c4e">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The weighted-average assumptions used in the Black-Scholes option pricing model to determine the fair value of the employee and nonemployee stock option grants were as follows:&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:67.29%;"/&gt;
        &lt;td style="width:1.502%;"/&gt;
        &lt;td style="width:14.867%;"/&gt;
        &lt;td style="width:1.502%;"/&gt;
        &lt;td style="width:14.838%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="3" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Year Ended &lt;br/&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Risk-free interest rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1.93&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.68&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Expected volatility&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;81.60&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;88.55&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Expected term (in years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5.84&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6.01&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Expected dividend yield&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      decimals="4"
      id="F_e2b52f8e-c84b-41e1-902b-b4081f32b07c"
      unitRef="U_pure">0.0193</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2"
      decimals="4"
      id="F_f5204ec4-ce7e-4be0-8356-71f55d1bd212"
      unitRef="U_pure">0.0068</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      decimals="4"
      id="F_ee322998-3661-45e2-9e17-844dbe59fd4f"
      unitRef="U_pure">0.8160</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2"
      decimals="4"
      id="F_fd629560-1de1-4d5a-aad5-9a08f38fbc17"
      unitRef="U_pure">0.8855</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      id="F_dc1a667b-8989-4fec-b305-7817bcf938de">P5Y10M2D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2"
      id="F_aee9ddf3-80e6-4667-a4d2-4dfe10fbc260">P6Y3D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      decimals="2"
      id="F_ceb62c59-25c0-48f8-a596-7c1443ef97b2"
      unitRef="U_pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2"
      decimals="2"
      id="F_6896c53b-6da1-4e3d-8c72-928f384ee301"
      unitRef="U_pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <eq:DividendsPaidOnCommonStock
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      decimals="INF"
      id="F_85fc9285-7301-49ac-8222-9077ca62c6c6"
      unitRef="U_USD">0</eq:DividendsPaidOnCommonStock>
    <eq:CommonStockReservedForFutureIssuanceTableTextBlock
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      id="F_f58d385d-aa49-4329-8494-a6f68ea81dc5">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Common stock reserved for future issuance consists of the following as of &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2022 and 2021:&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:67.477%;"/&gt;
        &lt;td style="width:1.009%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.204%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.023%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.289%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Stock options issued and outstanding&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5,102,501&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3,947,025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Warrants for common stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,366,141&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,366,141&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Awards available under the 2018 Equity Incentive Plan&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;784,331&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;467,024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Employee stock purchase plan&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;925,963&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;769,658&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;8,178,936&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6,549,848&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</eq:CommonStockReservedForFutureIssuanceTableTextBlock>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_c197641e-f183-4f80-9bfd-23288c4df7df"
      decimals="INF"
      id="F_a7bc8091-a447-4d73-b50d-b8bcd2458b85"
      unitRef="U_shares">5102501</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_9520a266-f74a-45cf-96ed-ba178f032640"
      decimals="INF"
      id="F_a4be6de3-bbec-450d-9121-3dde4a7902d6"
      unitRef="U_shares">3947025</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_f54cdfd1-dd2b-4d74-aa9b-16e8ecf08b91"
      decimals="INF"
      id="F_1e101c49-f627-462f-bb21-bbe3a60d57cd"
      unitRef="U_shares">1366141</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_0a414f75-a619-4136-9add-c3356d8e1816"
      decimals="INF"
      id="F_cbf388ce-f568-4ce4-90f9-f7eca82681d5"
      unitRef="U_shares">1366141</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_b79b178e-6c81-4a59-9acf-58713aad69ee"
      decimals="INF"
      id="F_ed582681-b275-49b5-8436-88460d4a585a"
      unitRef="U_shares">784331</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_48927eeb-5e48-4e18-bce6-146239c106d3"
      decimals="INF"
      id="F_d851cb98-84c4-4179-81b4-cc7f2ea42af7"
      unitRef="U_shares">467024</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_32d659e3-aa51-4be5-b51f-bb1491642234"
      decimals="INF"
      id="F_3d1cf996-9764-4919-a763-1069d79a272c"
      unitRef="U_shares">925963</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_5678bab9-8bd4-4b16-94e3-655278d75cd5"
      decimals="INF"
      id="F_da38eb7a-cfb5-43aa-8aae-1ef97cf1353b"
      unitRef="U_shares">769658</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192"
      decimals="INF"
      id="F_40257d3e-3405-4545-b2e0-be667740723a"
      unitRef="U_shares">8178936</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94"
      decimals="INF"
      id="F_322d4835-8367-41a6-b838-62332d2dd673"
      unitRef="U_shares">6549848</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      id="F_d136fd30-51c7-4d5d-a388-00ef960f496b">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;12. Commitments and Contingencies&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Leases and Other Commitments&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;As of December 31, 2022, the Company leased certain office and laboratory space in La Jolla and South San Francisco, California under non-cancelable operating leases. The lease for office space in South San Francisco expired in February 2023 and was not renewed, the lease for laboratory space in La Jolla expires in February 2025 and the leases for office spaces in La Jolla expire in February 2027.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company enters into service agreements with indemnification clauses in the ordinary course of business. Pursuant to such clauses, the Company indemnifies, defends, holds harmless, and agrees to reimburse the indemnified party for losses suffered or incurred by third party claims arising out of the indemnified party&#x2019;s&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;performance of service. The Company has not incurred costs to defend lawsuits pursuant to these indemnification clauses.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Litigation&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;As of December 31, 2022, there was &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; litigation against the Company.&lt;/span&gt;&lt;/p&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:LitigationSettlementExpense
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      decimals="INF"
      id="F_7d1ba932-cd08-4f3f-8fad-fe8695bc72aa"
      unitRef="U_USD">0</us-gaap:LitigationSettlementExpense>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      id="F_5b08dff1-1968-4407-8209-bbe4ac6ca4e2">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;13. Income Taxes&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The components of loss before income tax provision (benefit) for the years ended December 31, 2022 and 2021 consisted of the following (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;		&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:65.971%;"/&gt;
        &lt;td style="width:1.472%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.571%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.458%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.529%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Year Ended &lt;br/&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;U.S.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;60,403&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;37,705&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Foreign&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,347&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;62,428&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;39,052&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company has &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;t recorded a current or deferred tax expense or benefit for the years ended &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2022 and 2021.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The following is a reconciliation of the expected statutory federal income tax provision to our actual income tax provision for the years ended &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2022 and 2021 (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:65.971%;"/&gt;
        &lt;td style="width:1.472%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.571%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.458%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.529%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Year Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Income taxes at statutory rates&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;13,110&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;8,201&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;State income tax, net of federal benefit&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Stock-based compensation&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;533&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;451&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Permanent items&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;128&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;31&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Federal research and orphan drug credits&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,152&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,713&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Foreign rate differential&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;425&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;72&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Transaction costs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;89&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Acquired in-process research and development&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4,840&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Change in federal valuation allowance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;8,247&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;9,360&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The tax effects of temporary differences that give rise to significant portions of the deferred tax assets and deferred tax liabilities as of &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2022 and 2021 are as follows (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:65.971%;"/&gt;
        &lt;td style="width:1.472%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.571%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.458%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.529%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Deferred tax assets:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Net operating loss carryforward&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;28,222&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;19,344&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Credits&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;9,289&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3,940&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Capitalized research expenditures&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;7,086&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Equity compensation&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,829&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,134&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,196&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,184&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total deferred tax assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;47,622&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;25,602&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Valuation allowance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;46,317&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;25,215&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total deferred tax assets, net of allowance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,305&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;387&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Deferred tax liabilities:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Operating lease right-of-use asset&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;284&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;346&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Deferred revenue&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;945&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;76&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;41&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total deferred tax liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,305&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;387&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Net deferred taxes&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company has established a valuation allowance against its net deferred tax assets due to the uncertainty surrounding the realization of such assets. The Company periodically evaluates the recoverability of the deferred tax assets. At such time as it is determined that it is more likely than not that deferred assets are realizable, the valuation allowance will be reduced. The Company has recorded a full valuation allowance of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;46.3&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million as of &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2022&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; as it does not believe it is more likely than not that certain deferred tax assets will be realized primarily due to the generation of pre-tax book losses in the current year, the lack of feasible tax-planning strategies, the limited existing taxable temporary differences, and the subjective nature of forecasting future taxable income into the future. The Company increased its valuation allowance by approximately $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;21.1&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million during the year ended &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2022.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;At December 31, 2022&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, the Company had federal and California tax loss carryforwards of approximately $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;116.4&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;90.6&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million, respectively. The federal net operating loss carryover includes $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;112.7&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million of net operating losses generated subsequent to 2017. &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Federal net operating losses generated after December 31, 2017 carryover indefinitely &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;but the deductibility of such federal net operating losses is limited&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; to &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;80&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;% of taxable income.&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; The federal net operating losses generated prior to 2018 as well as the state net operating loss carryforwards, begin to expire in &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2037 &lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;unless previously utilized. The Company has $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2.5&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million of Australian net operating loss carryforwards as of December 31, 2022 that are carried forward indefinitely.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;At December 31, 2022&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, the Company had federal and state tax credit carryforwards of approximately $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;7.2&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2.6&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million, respectively, after reduction for uncertain tax positions. The Company has not performed a formal research and development credit study with respect to these credits. The federal credits will begin to expire in &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2037&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, if unused, and the state credits carryforward indefinitely.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Pursuant to the Internal Revenue Code of 1986, as amended (IRC), specifically Section 382 and 383, the Company&#x2019;s &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;ability to use net operating loss and research and development tax credit carryforwards (tax attribute carryforwards) to offset future taxable income is limited if the Company experiences a cumulative change in ownership of more than &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;50&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;% within a &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;three-year&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; testing period. The Company has not completed an ownership change analysis pursuant to IRC Section 382. If ownership changes within the meaning of IRC Section 382 are identified as having occurred, the amount of remaining tax attribute carryforwards available to offset future taxable income and income tax expense in future years may be significantly restricted or eliminated, including those acquired through Bioniz. Further, our deferred tax assets associated with such tax attributes could be significantly reduced or eliminated upon realization of an ownership change within the meaning of IRC Section 382. If eliminated, the related asset would be removed from the deferred tax asset schedule, with a corresponding reduction in the valuation allowance. Due to the existence of the valuation allowance, limitations created by ownership changes, if any, will not impact our effective tax rate.&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The following table summarizes the reconciliation of the unrecognized tax benefits activity during the years ended December 31, 2022 and 2021 (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.327%;"/&gt;
        &lt;td style="width:1.466%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.322000000000001%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.48%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.406%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Year Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Unrecognized tax benefits &#x2013; beginning&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5,487&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,667&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Gross increases &#x2013; tax positions in prior period&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,266&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Gross decreases &#x2013; tax positions in prior period&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Gross increase &#x2013; current-period tax positions&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;392&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;554&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Gross decrease &#x2013; current-period tax positions&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Settlements&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Lapse of statute of limitations&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Unrecognized tax benefits &#x2013; ending&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5,879&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5,487&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The unrecognized tax benefit amounts are reflected in the determination of the Company&#x2019;s deferred tax assets. If recognized, none of these amounts would affect the Company&#x2019;s effective tax rate, since it would be offset by an equal corresponding adjustment in the deferred tax asset valuation allowance. The Company does not foresee material changes to its liability for uncertain tax benefits within the next twelve months.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company&#x2019;s policy is to recognize interest and/or penalties related to income tax matters in income tax expense. The Company had no accrual for interest or penalties on the Company's consolidated balance sheet as of December 31, 2022 and has not recognized interest and/or penalties in the consolidated statement of operations for the year ended December 31, 2022.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;All tax years for both federal and state purposes remain open and subject to examination by tax jurisdictions.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The 2017 tax reform act amended the IRC, effective for amounts paid or incurred in tax years beginning after December 31, 2021, to eliminate the immediate expensing of research and experimental (R&amp;amp;E) expenditures and require taxpayers to charge their R&amp;amp;E expenditures and software development costs (collectively, R&amp;amp;E expenditures) to a capital account. Capitalized costs are required to be amortized over &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;five years&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; (&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;15 years&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; for expenditures attributable to foreign research).&lt;/span&gt;&lt;/p&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      id="F_59845dca-b725-45f2-a292-80f692aac484">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The components of loss before income tax provision (benefit) for the years ended December 31, 2022 and 2021 consisted of the following (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;		&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:65.971%;"/&gt;
        &lt;td style="width:1.472%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.571%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.458%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.529%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Year Ended &lt;br/&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;U.S.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;60,403&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;37,705&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Foreign&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,347&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;62,428&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;39,052&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      decimals="-3"
      id="F_c5bf9db3-a817-4506-bb93-3d0e1aa4710a"
      unitRef="U_USD">-60403000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2"
      decimals="-3"
      id="F_773c8299-e8a0-4ad0-8d20-aaab52a3bb1c"
      unitRef="U_USD">-37705000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      decimals="-3"
      id="F_9d85a3c2-3145-4d74-a0c3-f5a3666c9764"
      unitRef="U_USD">-2025000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2"
      decimals="-3"
      id="F_48aa031c-d397-4281-8d63-e6d7a6beb46e"
      unitRef="U_USD">-1347000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      decimals="-3"
      id="F_eae49744-6943-4af0-b42d-a95596c37243"
      unitRef="U_USD">-62428000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2"
      decimals="-3"
      id="F_e4ff6293-1b99-4b3a-9c89-17fb54611bf7"
      unitRef="U_USD">-39052000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      decimals="INF"
      id="F_5d188271-f553-4035-af1c-780f69a1bb93"
      unitRef="U_USD">0</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2"
      decimals="INF"
      id="F_ebd817df-f16d-4587-813a-613fa3f675e2"
      unitRef="U_USD">0</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      decimals="INF"
      id="F_ae435fe3-91da-49ca-9d37-e00ccb10447b"
      unitRef="U_USD">0</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2"
      decimals="INF"
      id="F_ad72b777-9802-4fcf-821d-f8f1603f2888"
      unitRef="U_USD">0</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <eq:SummaryOfReconciliationOfExpectedStatutoryFederalIncomeTaxProvisionToActualIncomeTaxProvisionTableTextBlock
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      id="F_877fa89d-2faf-4556-b6a1-0b5c68ac6663">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The following is a reconciliation of the expected statutory federal income tax provision to our actual income tax provision for the years ended &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2022 and 2021 (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:65.971%;"/&gt;
        &lt;td style="width:1.472%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.571%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.458%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.529%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Year Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Income taxes at statutory rates&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;13,110&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;8,201&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;State income tax, net of federal benefit&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Stock-based compensation&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;533&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;451&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Permanent items&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;128&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;31&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Federal research and orphan drug credits&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,152&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,713&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Foreign rate differential&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;425&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;72&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Transaction costs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;89&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Acquired in-process research and development&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4,840&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Change in federal valuation allowance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;8,247&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;9,360&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</eq:SummaryOfReconciliationOfExpectedStatutoryFederalIncomeTaxProvisionToActualIncomeTaxProvisionTableTextBlock>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      decimals="-3"
      id="F_38e9022c-aecb-4bd6-841f-3fdb79f39fa9"
      unitRef="U_USD">-13110000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2"
      decimals="-3"
      id="F_4fa41e32-3b58-442a-b40a-62e4c8e1fef1"
      unitRef="U_USD">-8201000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      decimals="-3"
      id="F_79776f0a-4230-45fe-bb26-54b19b91b52f"
      unitRef="U_USD">533000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2"
      decimals="-3"
      id="F_dd6dae07-0aeb-4f61-94ea-09caed272ee0"
      unitRef="U_USD">451000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <eq:IncomeTaxReconciliationPermanentItems
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      decimals="-3"
      id="F_4ecca56d-b050-49cf-be20-fcc8995d82c0"
      unitRef="U_USD">128000</eq:IncomeTaxReconciliationPermanentItems>
    <eq:IncomeTaxReconciliationPermanentItems
      contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2"
      decimals="-3"
      id="F_66128e8f-df76-4060-b6cf-6188b9ee6004"
      unitRef="U_USD">31000</eq:IncomeTaxReconciliationPermanentItems>
    <eq:IncomeTaxReconciliationFederalResearchAndOrphanDrugCredits
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      decimals="-3"
      id="F_b546acb8-c49a-4386-8c3b-c5fbfdc3bca8"
      unitRef="U_USD">1152000</eq:IncomeTaxReconciliationFederalResearchAndOrphanDrugCredits>
    <eq:IncomeTaxReconciliationFederalResearchAndOrphanDrugCredits
      contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2"
      decimals="-3"
      id="F_d5173624-a1f8-421b-b9a6-3f6837480750"
      unitRef="U_USD">1713000</eq:IncomeTaxReconciliationFederalResearchAndOrphanDrugCredits>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      decimals="-3"
      id="F_339a8659-0bb8-4fbc-8e87-5549deed7cd1"
      unitRef="U_USD">425000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential
      contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2"
      decimals="-3"
      id="F_fb654f0b-c8b0-4535-9896-3403e6c78e30"
      unitRef="U_USD">72000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <eq:EffectiveIncomeTaxRateReconciliationTransactionCostsAmount
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      decimals="-3"
      id="F_b8162cf8-818b-455a-afdf-ceb52d44113a"
      unitRef="U_USD">89000</eq:EffectiveIncomeTaxRateReconciliationTransactionCostsAmount>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      decimals="-3"
      id="F_c5706dc0-8f7b-48de-bb4d-5243b66bac85"
      unitRef="U_USD">4840000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      decimals="-3"
      id="F_874153ff-8cac-4b26-b713-90b8a26ef207"
      unitRef="U_USD">8247000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2"
      decimals="-3"
      id="F_ee9679b1-82e4-428b-9196-8e3e92101898"
      unitRef="U_USD">9360000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      decimals="-3"
      id="F_c962d1bd-9ceb-4702-b9ab-804fe495cb6f"
      unitRef="U_USD">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2"
      decimals="-3"
      id="F_94da8225-5332-439d-a4d5-1661d7695345"
      unitRef="U_USD">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      id="F_97b8386b-a204-4abe-a196-828496f746f4">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The tax effects of temporary differences that give rise to significant portions of the deferred tax assets and deferred tax liabilities as of &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2022 and 2021 are as follows (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:65.971%;"/&gt;
        &lt;td style="width:1.472%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.571%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.458%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.529%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Deferred tax assets:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Net operating loss carryforward&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;28,222&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;19,344&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Credits&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;9,289&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3,940&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Capitalized research expenditures&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;7,086&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Equity compensation&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,829&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,134&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,196&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,184&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total deferred tax assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;47,622&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;25,602&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Valuation allowance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;46,317&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;25,215&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total deferred tax assets, net of allowance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,305&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;387&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Deferred tax liabilities:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Operating lease right-of-use asset&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;284&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;346&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Deferred revenue&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;945&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;76&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;41&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total deferred tax liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,305&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;387&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Net deferred taxes&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192"
      decimals="-3"
      id="F_4590dab1-a11c-44f5-b30a-ed70f4fe9349"
      unitRef="U_USD">28222000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94"
      decimals="-3"
      id="F_c8400e7d-6a76-47b5-a299-271cc3b1ca40"
      unitRef="U_USD">19344000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards
      contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192"
      decimals="-3"
      id="F_e1bf5fe0-73b8-4891-868a-ca942d0221c5"
      unitRef="U_USD">9289000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards
      contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94"
      decimals="-3"
      id="F_d1d339da-1c06-439a-b568-41178483ceb7"
      unitRef="U_USD">3940000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
    <eq:DeferredTaxAssetsCapitalizedResearchExpenditures
      contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192"
      decimals="-3"
      id="F_046bbc79-5e9d-4aab-9115-9f69c0ac00ba"
      unitRef="U_USD">7086000</eq:DeferredTaxAssetsCapitalizedResearchExpenditures>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
      contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192"
      decimals="-3"
      id="F_7423c846-a534-4f33-ae04-a52bb120807a"
      unitRef="U_USD">1829000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
      contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94"
      decimals="-3"
      id="F_dda97600-2359-4af6-bbd2-e90373ea80a1"
      unitRef="U_USD">1134000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192"
      decimals="-3"
      id="F_a8e06f82-3133-435e-8db7-4d4152f426c0"
      unitRef="U_USD">1196000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94"
      decimals="-3"
      id="F_d12688b5-7f2f-43c4-8f1c-46caec1be897"
      unitRef="U_USD">1184000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192"
      decimals="-3"
      id="F_3779fa89-140d-423e-8661-b9ac000fe12e"
      unitRef="U_USD">47622000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94"
      decimals="-3"
      id="F_97a7adcc-8569-4639-8d54-0e10f2e15d5b"
      unitRef="U_USD">25602000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192"
      decimals="-3"
      id="F_4a02ecc4-46b3-486a-8b1a-7e2167ed53c8"
      unitRef="U_USD">46317000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94"
      decimals="-3"
      id="F_5189b5b3-174d-4458-af22-3ed979b2e65f"
      unitRef="U_USD">25215000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192"
      decimals="-3"
      id="F_253ef32f-6dfa-4972-85ca-10ab4d4b9bea"
      unitRef="U_USD">1305000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94"
      decimals="-3"
      id="F_5d506720-0a1d-48bd-96d6-54b22dbb5831"
      unitRef="U_USD">387000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxLiabilitiesLeasingArrangements
      contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192"
      decimals="-3"
      id="F_08a576dd-bed0-41b1-abaf-19ed4977e004"
      unitRef="U_USD">284000</us-gaap:DeferredTaxLiabilitiesLeasingArrangements>
    <us-gaap:DeferredTaxLiabilitiesLeasingArrangements
      contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94"
      decimals="-3"
      id="F_550e17cf-ebee-4f3c-821a-96898d20e652"
      unitRef="U_USD">346000</us-gaap:DeferredTaxLiabilitiesLeasingArrangements>
    <us-gaap:DeferredTaxLiabilitiesTaxDeferredIncome
      contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192"
      decimals="-3"
      id="F_f12e5571-9e9a-4aae-940a-741fe6ae68fe"
      unitRef="U_USD">945000</us-gaap:DeferredTaxLiabilitiesTaxDeferredIncome>
    <us-gaap:DeferredTaxLiabilitiesOther
      contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192"
      decimals="-3"
      id="F_9e8e7d11-b914-43f0-b9e6-0582a8016f69"
      unitRef="U_USD">76000</us-gaap:DeferredTaxLiabilitiesOther>
    <us-gaap:DeferredTaxLiabilitiesOther
      contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94"
      decimals="-3"
      id="F_daee637d-4bd2-451b-82f2-15c4342a6965"
      unitRef="U_USD">41000</us-gaap:DeferredTaxLiabilitiesOther>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192"
      decimals="-3"
      id="F_6e8c003f-bca5-45c5-ae1b-7812e8e07220"
      unitRef="U_USD">1305000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94"
      decimals="-3"
      id="F_d64c8433-3b04-49ab-907d-d0eeee71540a"
      unitRef="U_USD">387000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192"
      decimals="-3"
      id="F_cb513720-6774-47a7-987c-9a0464bb55c6"
      unitRef="U_USD">0</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94"
      decimals="-3"
      id="F_2e5a2f31-dc6a-46ee-bae9-0f4ef3ae1684"
      unitRef="U_USD">0</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192"
      decimals="-5"
      id="F_74374b06-2f14-4317-bca8-545fc2b7394f"
      unitRef="U_USD">46300000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      decimals="-5"
      id="F_33914755-b009-41a4-b7d7-8ee894cbe536"
      unitRef="U_USD">21100000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic
      contextRef="C_e6610ebe-288f-4417-8098-af8696e03c7e"
      decimals="-5"
      id="F_4cb00f7b-1574-46c2-b51e-2f3513becef6"
      unitRef="U_USD">116400000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
      contextRef="C_73660a62-57e2-407a-a1a0-1c6619629881"
      decimals="-5"
      id="F_9fac22f5-913a-49d1-bf39-585e170958f2"
      unitRef="U_USD">90600000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal>
    <us-gaap:OperatingLossCarryforwards
      contextRef="C_acb33667-c8a3-4249-a4a8-738294c5d493"
      decimals="-5"
      id="F_766aa7bc-5ef5-4346-902d-8b93d66a18e0"
      unitRef="U_USD">112700000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwardsLimitationsOnUse
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      id="F_6040f3f9-f458-4aa4-8982-4ab5aa6e6a1b">Federal net operating losses generated after December 31, 2017 carryover indefinitely but the deductibility of such federal net operating losses is limited to 80% of taxable income.</us-gaap:OperatingLossCarryforwardsLimitationsOnUse>
    <eq:OperatingLossCarryforwardsLimitationRateOnTaxableIncome
      contextRef="C_6c6eb418-4e31-405d-80e2-4eeaa0ed0949"
      decimals="2"
      id="F_9e1e3f7a-298b-4ab6-b48d-3f1e43da5cb6"
      unitRef="U_pure">0.80</eq:OperatingLossCarryforwardsLimitationRateOnTaxableIncome>
    <eq:OperatingLossCarryforwardsExpirationYear
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      id="F_38413c41-a3a4-4e24-9e42-442718c20952">2037</eq:OperatingLossCarryforwardsExpirationYear>
    <us-gaap:OperatingLossCarryforwards
      contextRef="C_1074585e-0f9e-4a71-aac7-7580a74d418f"
      decimals="-5"
      id="F_d5017a25-0fb3-4674-830e-7287b4a877c3"
      unitRef="U_USD">2500000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards
      contextRef="C_e6610ebe-288f-4417-8098-af8696e03c7e"
      decimals="-5"
      id="F_40d38f84-f179-4e1c-a078-782d919f3f6c"
      unitRef="U_USD">7200000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards
      contextRef="C_2aa60dea-0a24-4f41-b6e1-70e203413f85"
      decimals="-5"
      id="F_55504a32-a6ed-43e9-971a-088aaba8ca5b"
      unitRef="U_USD">2600000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
    <eq:TaxCreditCarryforwardExpirationYear
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      id="F_5df710b5-6cf2-4769-a224-65c1055a8947">2037</eq:TaxCreditCarryforwardExpirationYear>
    <eq:CumulativeChangeInOwnershipPercentage
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      decimals="2"
      id="F_67fe6309-f2f8-4cfe-b737-5c964c6e8e76"
      unitRef="U_pure">0.50</eq:CumulativeChangeInOwnershipPercentage>
    <eq:CumulativeChangeInOwnershipPeriod
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      id="F_ae793328-0071-4a5a-85e7-c1bebb9f7e8d">P3Y</eq:CumulativeChangeInOwnershipPeriod>
    <us-gaap:SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      id="F_3a1fd49c-cc54-4551-8747-2792d9bbbc65">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The following table summarizes the reconciliation of the unrecognized tax benefits activity during the years ended December 31, 2022 and 2021 (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.327%;"/&gt;
        &lt;td style="width:1.466%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.322000000000001%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.48%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.406%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Year Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Unrecognized tax benefits &#x2013; beginning&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5,487&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,667&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Gross increases &#x2013; tax positions in prior period&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,266&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Gross decreases &#x2013; tax positions in prior period&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Gross increase &#x2013; current-period tax positions&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;392&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;554&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Gross decrease &#x2013; current-period tax positions&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Settlements&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Lapse of statute of limitations&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Unrecognized tax benefits &#x2013; ending&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5,879&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5,487&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94"
      decimals="-3"
      id="F_6bdddbe7-4df9-4e15-b147-4ddb20f7dd26"
      unitRef="U_USD">5487000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="C_593cac69-ae06-423d-93b0-db39a502796a"
      decimals="-3"
      id="F_2ac8a6bb-fe35-4196-8792-54a38b90af8b"
      unitRef="U_USD">2667000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2"
      decimals="-3"
      id="F_3468a98a-f2b9-4f6a-a0d0-455137ff1292"
      unitRef="U_USD">2266000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      decimals="-3"
      id="F_09ec7db9-fb67-45ff-8a77-9013def69069"
      unitRef="U_USD">392000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2"
      decimals="-3"
      id="F_be3d2078-55ad-4251-be01-d04eaaa7a84a"
      unitRef="U_USD">554000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="C_0a2a2736-708e-4c3e-8299-f827f8de0192"
      decimals="-3"
      id="F_1a6bdbbe-2166-4bd8-b6d2-eee178c4b52d"
      unitRef="U_USD">5879000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="C_565ac908-720e-4507-8d96-ab25dfe4fc94"
      decimals="-3"
      id="F_b4c6d273-c955-4306-9b3e-63eaadbe267c"
      unitRef="U_USD">5487000</us-gaap:UnrecognizedTaxBenefits>
    <eq:ResearchAndExperimentalExpendituresCapitalizedCostAmortizationPeriod
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      id="F_d7a467f0-32a0-44c5-ad78-756ed729f71e">P5Y</eq:ResearchAndExperimentalExpendituresCapitalizedCostAmortizationPeriod>
    <eq:ResearchAndExperimentalExpendituresCapitalizedCostAmortizationPeriod
      contextRef="C_9d1df5ec-262f-43c2-9feb-7e49b25fe95f"
      id="F_fa8566cc-accb-4d90-876d-b210f5cd66d1">P15Y</eq:ResearchAndExperimentalExpendituresCapitalizedCostAmortizationPeriod>
    <us-gaap:CompensationAndEmployeeBenefitPlansTextBlock
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      id="F_c3388e02-8511-4333-b912-036f4ef5d0f6">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;14. Retirement Plan&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company sponsors an employee savings plan that qualifies as a deferred salary arrangement under Section 401(k) of the IRC. Participating employees may defer up to the Internal Revenue Service annual contribution limit. The Company did &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;t make any contributions for the years ended December 31, 2022 or 2021.&lt;/span&gt;&lt;/p&gt;</us-gaap:CompensationAndEmployeeBenefitPlansTextBlock>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      decimals="INF"
      id="F_078fde81-44ee-4b64-950b-82cd50a9cf32"
      unitRef="U_USD">0</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount
      contextRef="C_93b8c3ff-3013-4820-b8af-f45ad5324ef2"
      decimals="INF"
      id="F_0186d00f-d59b-484a-8c73-1215673394cb"
      unitRef="U_USD">0</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
    <us-gaap:SubsequentEventsTextBlock
      contextRef="C_7a916079-62c8-4cfb-b147-d4a52b2078f5"
      id="F_a9e3ade7-2790-430b-a318-2d0c0e8a6f8f">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;15. Subsequent Events&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;On March 10, 2023, Silicon Valley Bank (SVB) was closed by the California Department of Financial Protection and Innovation, which appointed the Federal Deposit Insurance Corporation as receiver. At the time of the closure, the Company held assets valued at approximately $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;8.2&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million in a sweep account with SVB. The Company received full access to those funds on March 13, 2023. As of the date of the filing of this Annual Report on Form 10-K, the Company has full access to and control over all of its cash, cash equivalents and short-term investments. In addition, because a substantial majority of the Company's cash, cash equivalents and short-term investments is held at a financial institution unaffiliated with SVB, the Company does not expect any material impact to the Company's operations directly related to the closure of SVB.&lt;/span&gt;&lt;/p&gt;</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:AssetsHeldInTrust
      contextRef="C_1398193c-be70-4924-b7ab-8d837ee248c4"
      decimals="-5"
      id="F_4c28e568-3dcf-41fa-bcd6-e4b00c76bfc8"
      unitRef="U_USD">8200000</us-gaap:AssetsHeldInTrust>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>96
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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M!,/((4^ WQ>,B?R+O$#QKMK=OU!+ P04    " "R@7=6.OT_D-P%  #H&
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M41AYP0#A6"KVO&AB8>,68NR$^%=!!5$LOP<IU8P!A*&&!=\M2CV81AQ;XW0
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M]1J9\YQ "[U:*YF=P**L667*ZWQ_.&%>.&G!M-FY@)[I,77W'+,%=1K'UT2
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MN0'^OY;2G![R#]3'IXM_ %!+ P04    " "R@7=6YA1\"T '  "J0@  &
M 'AL+W=O<FMS:&5E=',O<VAE970U+GAM;+V<:V^;2!B%_PKR5KM;*:Z9,1?3
M32RU-C=I+U'3=C]3/(Y1@7$!Y[*_?@=,[#!@BK.GJTHUV+S/88;C >8$7][S
M[&N^8:Q0'I(XS:]&FZ+8OIU,\G##DB!_P[<L%9^L>98$A5C-;B?Y-F/!JBI*
MX@E556.2!%$ZFE]6[UUG\TN^*^(H9=>9DN^2),@>W[.8WU^-R.CIC0_1[:8H
MWYC,+[?!+;MAQ:?M=2;6)@?**DI8FD<\53*VOAJ](V]]JI<%U1:?(W:?/UM6
MRJ9\X?QKN>*OKD9JN4<L9F%1(@+Q<L<6+(Y+DMB/;S5T=- L"Y\O/]&=JO&B
M,5^"G"UX_'>T*C97H]E(6;%UL(N+#_S>8W6#JAT,>9Q7_ROW^VU-:Z2$N[S@
M25TL]B")TOUK\%!WQ+,",CU10.L".K1@6A=,AQ9H=8$F%5#U1(%>%^AR@7FB
MP*@+#*E@JITH,.L"4RK0C!,%L[I@-K0-5EU@57;8'[_JX"^#(IA?9OQ>R<JM
M!:U<J!Q458MC'J6EV6^*3'P:B;IBON!ISN-H%11LI=P4XD4XN<@5OA9K//RZ
MX?&*9?DOBOUM%Q6/RECY=+-4?GWU6GFE1*GR<<-W>9"N\LM)(?:F9$["6OG]
M7IF>4/[(BR#N*%OTE[T77Y'HGXZZ97_=@B>)^')5C>JHMH=7*R=WP>F'O%NM
MHO(;'L3*=1"MQJ+_%L$VZNX&]Z6LT[OG?0<9AKMD%U=.^*O8L$P1K18CZ*8<
MVNZ8XJ<A3YCRZ^\\SU]WX/WA^"5;1V%4-"$38=V#?^G!O[2B:J?L$,1!&C(E
M* 0T?*-,R85"5:IV^7%/,BM2>1*XFQO63-<N)W?/[=>K5YY[WN;;(&17(]$U
M.<ONV&C^\T_$4'_K\F1;DC;E;*2<TY8C&E%-J8DN4M-K:XZI9385_8Z-3-6B
M^F&SQL&?'@[^=,C!OU!N-H'8TT$FZ"6>V?8%$K;<P_3G7M%,?4I4V3)(50<)
M<Y$P#PGS0;"&3;6#3;5>F_IYOJL&*7%2#?<GDKPZD:PSGBAK'HLKSK%XDZ_7
M+(O2VPLE%5>Y8N/HJ3#D>=%YBM7:GK$LU9*&M-[=.]>F2)B-A#F#.L-%2GI(
MF ^"-3RJ'SRJ_Q\>O=B/Q%U6[=4_=^!%PI9ZRS<:G>DF4:5Q%RGJ(&$N$N8A
M83X(UO"T<?"T\3)/[U)Q3Z.P9!OS1\;J-[>[+-R(VV9E*RXJN@QLM(<7@T@C
M;>\.G>M+),Q&PIP!7>$B!3TDS ?!&IXT#YXT?Y0GGRYSN[S9*WKNX(J$+<V6
M52Q5:UW2(B4=),Q%PCPDS ?!&C:>'6P\Z[6Q_<"R,,HK&^^MRK?E=$2G.6<M
M"\PL>>#LE3O7<TB8C80Y [K"10IZ2)@/@C4<9QT<9[W,<7W#8B_RW&$1"5M:
M+2-,J:')DU$V4M-!PEPDS$/"?!"LX5*B'N?3U5Z??F9Y(>Z/2IL*?)%%83GA
MN7=L' 5?HC@J'CMGR]66)<RI-$KV:Y_K02C-AM*< ;WA0A4]*,U'T9HN?);J
MD%X75D'%N$P!5^5EYI:E>5"%B^RA7&:=!B3M^V!-O@E>] N?;4$DS8;2G$']
MX4(U/2C-1]&:)CQ&,Z0_FVG&1U$5'W4:C[8ZFNCR'&:_UMF^0])L*,V!TEPH
MS1MRJ'R49--VQU"(]*="?[)"B7G>'4FW0Y;QU%)U*KL-FNQ :3:4YD!I+I3F
M06G^]X]]TW#'>(?TYSLG,FC2:<!V2&$8NJK+_H-&-C6M+X:&"CH=K22F89"9
M?/*$AC$=JF,RG<FC4]=6JF69Y@D?'",4TI^A-./H87: IB)0VI*T<Q%J:;IN
M&#/9/-!D!$ISH30/2O-1M*9?C_$(>5D^TFE4Y S\HJ8U!B2J:]*@M(2*VAVB
MTM2; Q5T3[12$O6@HCZ*UO34,=X@+\LW^F;I^I%G>PL:7T!I-FFG(=I,G!NF
MJFQ$:(8!I7E0FH^B-?UZS#%(?Y !SHA)>X*?DM;%'33L@-)L*,T9TATN5-*#
MTGP4K>G.8^9!^D./'Y06]ZN>/>!"@Q'23D;$-3S5B7S-"8U&H#072O.@-!]%
M:_ZU]C$>H3\H'J'M0$"7XY%^[;/_=AL:CT!ISH#><*&*'I3FHVA-%Q[C$8J/
M1VA''#"3+^87_<)G6Q :CT!ISJ#^<*&:'I3FHVA-$Q[C$8J)1VA[SIV2UE,K
MV,=6H/$(E.9 :2Z4Y@TY5#Y*LFF[8SQ"7QZ/T(XI<H-J=":[#1J/0&DVE.9
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M=C#-H6X!Q3+G:]JI<\05\K;.>4SB\;"C<R56G,F9SKJH6W_8L_)=5N.GK?,
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M$H7YN&$T8U(;P.\K(=3K%WV#PRN,L_\#4$L#!!0    ( +*!=U9>K"N4GPX
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MSLR5J"%+J1#Y4/BX=RC3,Y<+<+3BMG7 .QA2@7A"C8M+E+O5TJ+P(6O64N0
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M"WFQD(U7-YL]".5(YVCR;-A?JTU<NC(O'[/>2@LH32E;9M (-)I^#@Q#2Y[
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MM6HA?@ =LD8+O"#'[[-D2H%CG<60(:>*=\KX]EA.YH,JKA&EF=?H=JI"(UV
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M'VK G]?T@%8)!;1S W$Q*WABN"[P&>Q>?L)T^M#5T8;<#ICS;#0,_ @__T8
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MF0T8\N4RPZN*'!/@?FYMV&U80/U.F_X#4$L#!!0    ( +*!=U;!QU%9;P,
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M?*)D:"_UBI);\7M*LMMA_$LV.QK-T):4HF"H.Q8,#S'*M12WL4:P-1?68T0
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M=V]R:W-H965T<R]S:&5E=#$S+GAM;(57VVX;-Q!]UU<,%#=- %F7E6PICFW
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M-UIE8NW"3F7-G<(.(DXBRQ2W5*%C&/ /Y,IDKLE,I@)]&UQP(J9F6:K_8.@
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M;AB=TYIT1Z,!'"NH?]!W!>I-/5W<QZND;5JPM;8#;-[T[1_W9OI=,;WATH#
M-87V>\/$ ]U,E.9@55EW\4I9F@GU-J<AC-HYT/U:*;L_N ?:L3[[#5!+ P04
M    " "R@7=6H198./T/  !K,   &0   'AL+W=O<FMS:&5E=',O<VAE970Q
M-2YX;6R]6VV3V[81_BN8BR?QS>ATDN[%3F)[YNPZK3-.X_CB=MI./T D)")'
M$C1 GJS\^CZ[ $F0DNZ4::<SF41' HO%OCS[QKS8&'OG,J5J\:7(2_?R)*OK
MZKOS<Y=DJI!N:BI5XLW*V$+6^-.NSUUEE4QY4Y&?+V:SZ_-"ZO+DU0M^]L&^
M>F&:.M>E^F"%:XI"VNUKE9O-RY/Y2?O@HUYG-3TX?_6BDFMUJ^I/U0>+O\X[
M*JDN5.FT*855JY<G-_/O7E_2>E[P-ZTV+OHMZ"9+8^[HCW?IRY,9,:1RE=1$
M0>(_]^J-RG,B!#8^!YHGW9&T,?[=4O^![XZ[+*53;TS^=YW6V<N3YR<B52O9
MY/5'L_F+"O>Y(GJ)R1W_6VS\VLMG)R)I7&V*L!D<%+KT_Y5?@ARB#<]G!S8L
MPH8%\^T/8B[_)&OYZH4U&V%I-:C1#[XJ[P9SNB2EW-86;S7VU:\^2%N7RKI,
M5^[%>0V*]/P\";M?^]V+ [OG"_&3*>O,B;=EJM(A@7.PTO&S:/EYO7B0XI]4
M,A47\XE8S!:+!^A==/>[8'H7!^A!6[E<&BO9!F[*5+S7"6Q*B9NU50KF58M_
MW2Q=;6$?_]XG 4__<C]]\IGO7"43]?($3N&4O5<GK[[^:GX]^_X![B\[[B\?
MHOZH=A[>_>U4Q 3$C7/P\@^-33(Y$,!&UYGXN33B0R9AZ8EJ:IW(7+PQTXEX
M7Z=3O!30C"J6RHHKKYR)J#.%)44ERZV0D"PH3(04/TH\$7=RV>#8.XU?VF5R
M(G"2LBH5NJP-UA]FIVJL:R1^8-TFTTDV.&EM\4KQ:?Q<?4GRQL&UA24/G(AE
M4XO2U/S2+'.]9MU/B)I,/C?:JIC>UU\]7\R??>_\;D>K=&UR_7M3R*5X2BM_
MKHC Z53\FD'#[4)=XMQ4"9GG1,_*BL6&YRF$1SL<2X4H]+034Q3*)EKB!!6?
MI$M>^:G4=+G;6M;*3<0;6<H4LKMIR$)SC9]$\Z] NW\JF>/W5+PK20:9+-=*
M *5%S_*$A51)G0YU)4RISFI@ZT0TU<H:DKG<LNS-BE0C"]/@#_6Y@16 ZQ\_
M_$-<3*_$4N<YT\4Q3\3B>GH)3.)'8&/%IZDO=#VGW X?&ZRD<P[P<@0+5]/9
M@ 595=9\T<!FE6_!T,6SZ:)EB+$Z!74^+FFL566R[24%1%#B<V-(VLNM^.G3
M#W\6KV5Y%PP>^WZ2L$PQOV9SOV#M=VQKZ#9WN"W,2R]S11Q:. B985/17T_$
M?#;OY8.G@1699%K=J_:JB;(U8B<BR3TB9,6/2<6QH7CP B6%>% JM\,+D ?D
M'7-")I"8,FT0[\HUFR<!$U^&",<'X?S>!"?!V5A/2Q!J"--).*0]BJ"0%_!$
M60@;TL6YL)U"_-C@[WD/"M8T:^^RAK4O*F6U@4P_E;@ [$)9!#))@@=7^19[
MQ'BQ9T)]J;RW AE$X0/-"H!N-G0S.B&% NZ5W=)-:E,1 HH4<=!S1BO>_O+I
MYOV[V[<BP4M&-5<WZ9;\+6^JQHE259G5M?;>J@FD=+&'R*\_?R1\! !<[*$E
MDP;V!&Q:U6=@R#7N+#.N%BE< 7N\Q@XB7@*#A\0CR4BR K@*.4;0 %O0!JS6
MJB2 0QR;"#C O28UU1FVT*5TP0B2:)LTA:MEF< 7._];=IA(>PB/2IA)$PQ8
M%TM@[P ?V9X.&E"".WK!05<45MW0IGBW[(P\*)>411?K=>D:0OEP_1A.4@.2
MC.;8D&\[>,$9KD.7^B'9MACL%WLIR 9YE>0@!YJ=V!_1$GL\"0Q7<2$Y0R(;
M\]TB/5U[:1!5*SB,5OX!X92%0XLETN<@3"@>J;*#"LGDE'CJFN5OR%A)'ZTJ
M9?H;SB(6W*G7<T4GXABE*?+P(5O:T=WD89'HE0?%W#@2/MZRB$W",,DNWT7[
MD(M=/6;!NV*QBC,B/.^#X49:"M\D$4XZ"+C";5E<>U**J;A)4TTD2%G#K -.
M&\FK/[H/^RZ Z;TJ<2XBJ@_;C(RKE::\GC";%I5J[?] Q4/Y(I9T^]HXTAX\
M9IZ4@7P'\ . @SAU3<$IIWO6)B#5$-_A+[G17C9C'&Y3&ET/K^)U;TVFE[J.
M^>$MJCH, /&]L0;:*D-9Q#<A4DXB>)C5D"PC(.=C+#' F:4;PY@IS>'?M&^"
M4WU6C3>&;1+ 5\&\VNM1&"(H@.PJ8]NGT5G?N!@V<$E@:=%N"4LE61]+%#!6
M!2-,!_GBHU  OE51ZE7(T6+YA@!XA# EHM)>PTMDY0)(<@!&0!Y%:V\6J;BY
M?2.>SYXCQ>LK%-C>#?G'FMEUDZ,NE"KO]6T,8$'UKN[\B8D,60HC[;K1*5UE
MR!JL@E/:0(C@M_-A@J%P3V4]<H6+6%38]R3]EJ@W&KK?]0S)TT<8/@68CRHQ
MZ](;Q$0\#>]/B2?LSYL6M3BIJX"3->5*"66!9'MM9GM(%IP'TWKKF0AVC?NW
M?(V@(\4FF $5)+ IN#QW.&CKP"0BO\$R+C[8GCN+!_]<BI@NRK$W.TXE<NH^
M4 9+=U*$TK'9A/64K>EAP1 2.")U,/92L0D>1O8U-H?_!]>;$$#@\] 5EK$%
M>!PX(%AX<"(;IX(],H/05:J01:2<FI8#0=#E(8DFKUV+!D<(YH;M <H;!XZQ
ME B>#G'J,M/D*4%.,$=LXK2&H@)Q6"R9T/[]DZ#3X)F/K"89H- KW4IQ)$;\
ML:'*I5!#[(+O5@*1E1PID $243I#D(I_TLFAL- 6B!PA37F6@"V$+4*3J& ;
M%8BA/KR:/F_K'Z)_;\ $EV3[>@E>0 #6UIJD<'KMD1J'K)#7E(D/R@4R80:W
M\A%(B*\;RK,T9GM8PQ*4M7DQ(\>X.-81Y\1V*)AT"YN2[$*!Z;[>1*9'E7XJ
MUL''GHC9]+H[4?HR61,NPM^"C#JP&S- HH%WF+9* $E(_@&U>MM9K:!5YPOK
MK;B7 %?2'X";XXR@0N\Q=+TE/_5DF946LV$Y*-6A%N_ND%NY=M[9<GV'\BPS
M/N/W\B<%/M6G;;6W4LJ#WE.-A\2904G6EE<3;%HWT(FQVU%1W%?#K7!@W:_;
MDI^ K.=UZ/K#*#<9]@F&+-?<[^GDU1F>"ZDR+C-YT&C'HNY-)9@N^[KT+H>8
M1Q'Y(&:U:3HNAB/8W':V<Y.+$J9(O%1Y[ CK")V+-=S%LPGXI]R';;0I0P2H
MMT.'4=K&S8V] ;G+"AX"X]@C=F]X!./<-'+<@EGTSC8AU3L.4>L6,H]#MR&4
M=4%:KG$B5=("PN4N5'H8@ZF;$@Y^(IY=1^1ZC.^HC!HGO^Z!@EVVR 3A9) W
MV08!10@B-F1@G/Y2Y"4^K$_'?O=KVR6>%ZK-?3CX#=H>QH-QV_2/9"HMW!VQ
M,#1IH7*?5W>8WX6^!^,HP*#-.^$N)M$LUIV@UN%J:(U$0NE@0?I4R'<ZX+^^
M1,9-))V=4'V[[@JG7H6UJ;M=??#FRJ4C\G!T/R*<?PP=&S;81YHT>^X8*5[V
M=]L)F^WRSDC(].:QZ1WADVECVZ;=%FP*Q<W%<9MA$0)->Q39-.G>:M8&'SR/
M77&DW'T>1^)X(BZGLX.[V)D+*DM_EW%I.C:3H^]PP\%VY\4D@HP=[QQBZ0/#
M&NF\Y\][8/-Y2("W3E"7TV?=E9.<P@:7.R123D_J()KY+,J!\#9'.#\C2WS@
M(N/ U&57(+>(NO $(])EG'M$=]_5$I<,W.YYK0UN(H:3.[EW<O>.NO1;L#1_
M-F1I.&N"9,:TVCJHKY2?ANXW>7;A-0OF;U55MPG?'-7Z#4PQI]_?3N)<D/YL
M7RWF?D8#[^XRQ=-)U#-N4#EO^Y,Y-:;P;-ON8?2JS7K -E8D=UW;(^:<KJ=X
MO VZ.U)RI][*@UQO;[C)Z! D\9(8:?,)B"JL>>_;'CQDJ<U:48XS"2]/IV25
M@X;+[I'MXFY:-VSL14.[J" -9C$1A;Q#M9Y)O"YD2E,JAW\YU*7AJ3,Y,8>\
MUG*N['M0NJ#6$HN,D]$-]8E#GRUN+OF^ZU94PVDGQYBV8X7"U:I*!HL)W4V.
MW[8%)-\3Z*ARZM)0!SQ<O59)5IK<K+>T*3R\*\WF+#.;D=)D^_Z#-11.3X^=
M!X['@2.Z;S\WY(A-(7X%VFA*I$_WE M9&YC)_GR7:-DI)@QT"M3>NJ(FDE8V
MM#6U3=L.=S2*X)*^I^ 1/-_V6$O8TI7QN\;3)5@MCX%R)UERZ(J[@MQ'CYB5
M@YDV9'@Q$ZG<\F'JBTJ:;KBP,U*F@-[?B%02T0W-D7Z.&VQU9U2G1HJDL!II
M"X80*6N(67V YB$U^R.-2[M+9SA=I 9<J;-4KW4]2D"(R#ADU=E.!1S&=B,M
M^:)S]'!"X6"C:&+BCF1 =LWZOM;X;YGH>W#M;+_MR]+4RFQE#GUUIT%6I?)]
M:=;[6"'+[<ZQ-)ML,YA]8+;O^X.E!!KWD#EHK35A0!5! !E*Y_Q1K!_ATA[K
MZ1MN35E;&BFT$Z/@07N<_ ]A-#M-FYSNR_%[M.;8!?\?3?FZV);:9DWN2LQW
MD=P/_KT/[U]*X\[2<*+*%N!'Z'[N2_5Z2%>,!627@R\LJ#N<[V5ZI2VH?9K>
M3@==!.HNW^-X#@(TE."VQ4&N_!6B:L>%PC:8.7(OY6-2+\7$G%%6P[.]<FW(
M;OW@>#$>' ^E"!V'/FN8CC5YHL)< *C.,VI?O(6BRX_J@I2Q^QT$(YD]3@53
M90?I;$"O+B2;@5UWE,8C-M>HM+=R7]> XF)R,;^>S"\NA4,<;0>_;I"MC$0U
M&MT-!M$1TGGMTS<@7<;(">W%+$XK(Z7N:V\\\KG%'I/P<>?0X5?75_'I'EW^
MP,'>'*,&5CMOZXP-A],\T2?I.<47%[_G$_=_A3*.&!X2&2G*$*X'^;<L2RII
M'T/)P21P.*JCV6E.%=1.L/[&Q<#J]N8QO,>G,D+&0<3UGUP4.CVC% M"XE#C
M0EJ"PD25@R#DR?VO;KKG/M%EG\8?E^V_\>DPXH_R,^ZS<]:"LHB2VGZP$HWY
M![ ?CQX[3#VD^D&H[<Q LN51.LN=K5C>(7L>?[?Q].TOL]G\](A0TWY-T+L1
MXQA-=10-<:M,*]<W/OEK$N3MJDR&94&'L?SI31_R^R]QHDG5WDY4C*V<D?YA
MX=[Z44_\'1MC6NC'15\0FL8>^&+0"V[B.W NL7I),$U?/WLGDC0C($9 $6_V
M0 C/NCK=5:96W'E%!FTV@S)M$P93T*TBIOMO&=OOP6"W]7;2V71':P@1^PS@
M",6WQ^_E@&3S6%K5NR7U^Z"ZI/%Y4<CQ*=_9GBVW9^%G^.J,0_=P A^I-TX7
M-YD*4XEQ7LZ?CJ"*;/&)>HA^0NH[BS)TG$,F<W0?A+"!:E9OY\.)DSLT8^N_
M[.-MG6I"#3.8Z$_W?59\'GT COBRYL_<G9>@_Q:\>]I]27_C/R#OE_O/\'^2
M=DW?\>1JA:VSZ;.K$Z_,]H_:5/PY^=+4M2GX9Z9P8TL+\'YE8&3A#SJ@^_\+
M7OT'4$L#!!0    ( +*!=U:"\MVM3@H  $H:   9    >&PO=V]R:W-H965T
M<R]S:&5E=#$V+GAM;)U9:V\;-Q;][E]!J&G7 K2R7HX=US9@Y]&F:%*W21HL
M%ON!FJ$D-C/#"<FQHOSZ/?>2,YJ19*<H$,3S(._[GG,YNEP;^\FME/+B2YX5
M[JJW\KZ\.#EQR4KET@U-J0J\61B;2X];NSQQI54RY4UY=C(9C9Z>Y%(7O>M+
M?G9GKR]-Y3-=J#LK7)7GTFYN56;65[UQKW[PAUZN/#TXN;XLY5*]4_Y#>6=Q
M=])(276N"J=-(:Q:7/5NQA>W,UK/"_[4:NU:UX(\F1OSB6Y>IU>]$1FD,I5X
MDB#QYUX]5UE&@F#&YRBSUZBDC>WK6OHK]AV^S*53STWV4:=^==4[[XE4+625
M^3_,^F<5_3DE>8G)'/\OUF'MY*PGDLIYD\?-L"#71?@KO\0XM#:<CQ[8,(D;
M)FQW4,16OI!>7E]:LQ:65D,:7;"KO!O&Z8*2\LY;O-78YZ_?&J^<N),;.<_4
MY8F'2'IQDL3MMV'[Y('MXXEX8PJ_<N)ED:JT*^ $MC0&36J#;B>/2GRADJ&8
MC@=B,II,'I$W;1R<LKSI@_+F7KS0+LF,JZP2_[V9.V]1#/\[Y&V0-3LLBQKD
MPI4R45<]=(!3]E[UKG_X;OQT].,CELX:2V>/2?]V*A[=?MBX\6@H.G+%;X5X
MITJO\KFR8CJB.(^?B6._4N+E8J&X201*2?4'@AX^-WDIBXU0A5=6I4(7W@@I
M?C42+56D$)945ON-N%E:I="N/@CC!<VS/LK:KX1?&Y$I5(IU<56XZ8NRLJZ2
MV SIZY5.5AWE<V,13&A_(N#1"(V09=33"VMRT9(3A+Y7-F?]<"'(LHI#4GC'
MJ]$_.J]R(7-3D<J6)NU$B>W:>VB#+4&SJ$@\+T04<B?,0NP[.13OV]JAQJ/B
ML+@0OU2%$J&H9\'(-_22XL:QYE!"-PR5&HI7UE3+%04;07?^WZ;(-J*4&U+C
M:J^,U4M=R ROU!=/$=CN9(4AO1/H79@LXP#.-V+Z5*C/E<Q$3IW;DDM>E587
MB2[QEBV*^G<]FRN)8-=OA<0_L<B,]+I84ORPN4!\+5R+NA!*\AJAPC-+FHYU
M7YP/)Z?B>U9UK'%/2T /_%J&6QB4JR )P3'6<PVR/1_AND +$'?]8BJ+4%"L
M:5<F8=:\<N@1YT0J-W7&V&=<P62=YRK5$$PAL"I1J7*M-5"R+<3&U34J#U22
MV$H-1)E5*+EY7TR'HY'X?DC-=0.#,S&9UI'?+Q.QE@ZE%_-E.!#)2A9+Q8L7
ME-(Z)Q3,!'_!CZ'89T,*&':=H@U:D0L%T+&U4S0D2)N4&2P53(<KK>XI7ZR4
MZX/NT%K8:Q"WBR8'=7-L]Y3&:4:*%*1#H6HM^Q? 9@4U8CP7\J<_?WXAG*]2
MSH#V)M-?JUS.Q?'+WT>C<1_I+BFK)!0U1$2;@543S:Q/4)/>RR)1 7>"W DJ
M/UY.L?8>DT5)/@XX' AN8HJ%MGDH]ZYEMT;:E$QYH9%R;[B,Q=I2PZ.N^2UH
MMB+(Y#Y]74?S-XKF2PHSF_:FCE/H7:J"#HX4B(^,;I7ZWGCX5=O<CLJC2EZ_
M;ND98AE@8],JK&YB5,C_-RT>Q-Z&,(OZ)J+MBC-SCW$.XF(@I3\(MMQ%?]=\
ML9)(AU)%8VP-8RWL>J!X70-KN]1%EK>Q#>BZ@VT-GC6RNL"&F+Y2<UMA(CT0
MB0[K,;>L-"KDAKJ7VRH^WNGPXP-+^]%=F9*OMXB/_DK%*H4C"L6S4EKP090(
M-"V&X@/SCJS\"F#O);?<LM(IM42P-.(-2B)@"NM/P2&%\2(G:*15"78# "13
MFB( (^:#3G1<,,(CP)@/4C04!B:*C:T2HJABR4&"V9K*H!L?H KU++9)\9GX
MNS92 L0V3H=HIXI8DRNJJ9D.CQ:8WEDOK:YI+3S1!5G"7DF,;^25JS#"D2ZF
MOE1C;+%,OS=PRZ:P.-L\$AR&W_T L+;<0)Q.N. ACPU3S5C4L #3$;M"U>8C
M;UA@(Z%K(MV*Z'#MZF0FTMH-8T&8.*+;74_7C%QY69%9C&1EF6FJ"VM<&4S(
M-H&*'[))<D@Q0\<FB7,TC1;C\?#\*9'4^U;^F,[F9/KG2MO 1[G\I B+.SP$
MJ:=,<GNVMR:&CG/;:2&U<EV0)!Y (T-C@H!SS22P-Q(-MA,!DH53G THM"<]
MD@\0)>B6]:%L0#0!(;H>)%3+F:X,[M=7[,Y=6-/OQBF7FRA H.@&&"T\EV)&
MXP4*H0B/]P17)4R>CF@"<3]\=SX9G_W8,%I-.I"C<5OW/8/K@))^K]-VQ^SF
MS,PSO91Q3F7+VCXN5&OTH@A/.^G[=M;*.(M2S''R56B4>D"Q-/,5!<K/.L+-
MN)?K->$D+S P4[VGVTQ._J'^N?)KHHVVZI0PTU"+[%O151T').@?_T/]>(JA
M=>$I*20-.Q&/F*U.R8IC!6[#*G&WS<,K%9D;]A;Q4P2?A9A:R-"&6[HDT@5:
M[5P5,MUFX#5P11*GJ2^8$[4+L8=YYZ/!;'(NW$KR 631EA7KD,$&-(DYQ"2?
M0@M\C/)B]=>WC+QM%3P;&VIF2]=$7(/V/!TBM9)$!'P>8$-J$1Q]5#S,>H*R
M/)N*>A0@"&2\Q&&=Q\QZW3?-;\X&$5[>2I?*S^*GS,R18PPZG\"$\5W*S=S*
M8O?@N^,[MUO@+\KQ/GSMS23/*"QM-[ H499F*C"R7=(V2_7@, VG =8\E#G)
MY>&" 7*)2J#^WF4/=P # W-8II^Z#YJ1_I@ATE0.27']BZ,V/1PQ/1!#'MTU
M+?%$G ].S\9\VAZ,1J.CFS2]X%./HA!G6LYU1E5/I=;E"8*=&0!O.AX=_0IP
MO,#1&69CP/]*LX5VS+OB6,S.11]_QM.)Z!^]Y_&8U#X[G0:UX[/SHP]EC+9)
M,"&!XT,QU+%DR,=I&&9G%?=\ \L:)_AMN^Q6SD+JC+X%X;5#^-T"_86P-O00
M@)52T3KX'^K.N:6.;]O$AQQDB% #.8&%7$0/BXFETO50TK<#FM<R8@MTNHHG
MQ $F.4,GVD!Q/& $7;J@(4*E?."%T*V 6A<B]5>5+L. 6.\/XUF\L2JK^:05
M(OJTR[XMX8XM:#^)+8FA9+:-)NR.!^;6'J0[2VF<A *"B@.>A5EFT 4V:CK&
M#QZLZ-/J@,J?FHG=M8K 1L$G:,-Y,2-\H>\!AS]@= [[::4"DH>)A$4TT-0=
MQCMJZ!N!CB9UA@62AC*,S+(=,AZRQ;$)#Q/)GK86LW:I!3.JWQ_WNM1!H,J9
MR"$D3![\+8X JBE0H%$\\\5Y:O?3UJN*/F:%;UHX"*A]%&HWXGZ(  R#!\?3
MM;(\NP;,<GN(]1_ +0B31>_N)KPX'9R-9X^NFHGI8'IZ=O1L,#H;'WTH&C #
M/7!,",KV+":T;_R#6>)L!+3Z< #17(2T(X8PACX1.MH+_KX!2<?!3BQZ:XK=
MEV#"P63Z3!SZD'S2^K[/!$*_8E#.H#A\ZF^>-C^4W(3?![;+PZ\L8$*,[0YC
MY@);1\.STUYHK_K&FY)_+9@;[TW.ERLET92T .\7QOCZAA0T/Q]=_Q]02P,$
M%     @ LH%W5B*W81R3$   73(  !D   !X;"]W;W)K<VAE971S+W-H965T
M,3<N>&ULM5MK<]O(L?VN7S&E[*:D*@@B^*;7=I4?VF23.%99N]F;NG4_#(&A
M.#$(,!A M/+K<[IG,  H@+(W-U7KE4C,]/2[3_= +P]Y\=ELE2K%EUV:F5?G
MV[+<O[B^-O%6[:0)\[W*\&23%SM9XF-Q?VWVA9();]JEU^/1:'Z]DSH[?_V2
MO[LM7K_,JS+5F;HMA*EV.UD\OE5I?GAU'IW77WS2]]N2OKA^_7(O[]6=*G_9
MWQ;X=.VI)'JG,J/S3!1J\^K\3?3B[936\X*_:74PK=\%2;+.\\_TX:?DU?F(
M&%*IBDNB(/'C0;U3:4J$P,8_'<US?R1M;/]>4_^198<L:VG4NSS]52?E]M7Y
M\EPD:B.KM/R4'_ZHG#PSHA?GJ>'_BX-=.\:)<67*?.<VX_-.9_:G_.+TT-JP
M' UL&+L-8^;;'L1<OI>E?/VRR ^BH-6@1K^PJ+P;S.F,C')7%GBJL:]\?5?F
M\>=MGB:J,+__W7(<+7X0-_^L=/GX\KH$?5IU'3M:;RVM\0"M:"P^Y%FY->(F
M2U32)7 -QCQWXYJ[M^.3%-^K.!23*!#CT7A\@M[$2SMA>I,!>E8R\;]OUJ8L
MX!#_UR>D)3'M)T%!\L+L9:Q>G2,*C"H>U/GKW_\NFH]^.,'@U#,X/47]&\UQ
MDE8_IU$4BN%#Q!LC\HV VM5NK0JO^D"46R7>Y;N]S![=%B-D56[S0O]+)2*6
M>UW*5!@B+>(<06M*? ]B2 _!R/X39BO!"7T;Y[L=@I+7!V(O"_$@TTJ)[\0H
MQ,I(['$\+P^$S!(1]1&!6!M5%#CG*^B$XN=&!K&5B9A,@VDT#:+IBH\8KX+I
M;!;,Y\L!/@62FBFQ5&?W0O9KRE(:C?$1%/:*DT[Z&(I/ZIY40LR^UP6^%Q\W
M8)Y)84NA4DD*.\BBD%EIQ,=,_*C6185,*2:!(]FR@E"9I::S,A=2&!57A2XU
MV-Y71;Q%IA+ROE *&;04%[3SKEER6R]Y4R^Y1.(IMZ(\Y*!H2EU6E#5A4IT]
M*(A?&$NDWEF8R\!R32* !7JHC:ED%BL6R<A4V3VUI)>D,HE4?(]3[R$O?9X&
MX^4L6$1#WL&TO%IPD!<O<CLG0SOY\%_=UDN!$M8Z^K[(#715Y+%2B:DEJ+6[
M*?(=OM"F,1/QOL?Z+QK% #:%CTW@9,C*:0I5!4)]B=/*.@<H-)1;9'?R$4J+
M%9Q"5'LPJKZH(M:&-='F-A1_S46%-%H<8#(X&'C?IPAF-B?*)?X/;R]UK/?L
M.#H3;55;;Z]Y"$2&^HXC:C?SAHIS4^+Q :X$><:K<%7+8RG4_ @HN&96KF%8
MO=NI1%M%L"2-[4NRL<[@:7 ?+^"^T#&+^9V(IHC-)C+9PL?TJ6(CK9AMJF F
M%%YMCCA27_8()%I(@BM9I)KTM!$7^I*_VN@-/%IF&;1=& HD//1L0J$7VJV,
M9E@8PU^S!!DD(??8Y"D "_LV%O!7..FPU?&V8]$XS0U<CU4 L97-HQN=X1"[
M&_J <P(E&#)2EI>"1<*#C%0^JQ5.W)UV2M*LTV.CO&.G!P=0.W9"0/BZ).?Q
M9Y'> Z+C! &^PL<T!8>$X(AAK]\#V*(<G\/=-90#0Z^]C2BW#UGHR.1D79(B
MJSA3@M^!<'6!S>9G?99M8D<!P@YCJO4_*)52!DS^ ;3$T>'WYC$27J$RZW>4
MC?5&QT(]8!6<7F=UO-KS$_V@$[@ 'MDOS#[5M! 1FTIC:+.DK&A8)O"^AIGM
M%XZ[XQ+9EB\4;Z!0M_#0%@/T\R*A[(\4K+T3:0*M](3]E=.S*[FEI++"3ZN,
M$_!]I7E92 F:/+RLG0?VWWG^3I: ;GU!KLM16ZA>%:'X>R4N_BSQ',E%78K_
MJ0)QNPW%^[ ^YFTNBX2JHH2+ Z@J;[&F8H0]AU*A^R#QK1@ON,R-3I:YOMK6
M4\P"JZZ_P,1YFHE;60 =6)]'<)&9.0 ALG<6JR<N7(U7T0.@F40W9D_UCO5/
MGPVR*JI*R2FA4#H+GF1[-" <C6U6<"A]A40X:^I'-S#@=]W@L 4)\<ILT<_\
M@2-;B<G\:D>XFT4XUGJCE%#\XBI.S+5]>&57"LJ8,,!\%DP6TU,L'DLI[7-M
MH])M['%J5C+2*/EQ2]GXM41.:L)B2*R?V4C'!W%)8S"8B,K4B;P^QU>CYZ+6
MUQ<45@9SKA8,Z<[E>CJ#1!4;J0LX0O$9KF*A:0^.&(7C;MGMW57VRBE)5,K4
M, IYX5%MQ_<FC[4%E[6V>]@N<^!WK"%FIAUFC#HFR:JM4Z+BJ <4WTN=4%%&
MQZYLJ%A^; XNB1%E:R"Q0$[ 6G=6-WFJ$^9R+5,^RPXE^G%VQ)R!BZV$1=9*
M46%EQ#F8BJTU&5)98->CA%.@OMP6>76_;<&!C4,9J4.'3/5-EE']_:3VR OD
M/#0\0/MR]6=KV9Y3+9 QM/@#,H8]="+0J&G20SL6UPH@YX'"J(11($VJ/Y,+
M(?0XT= :YQ?'T0B/!R)P.6V("TAB@]\U=-S<]5F?4&FI*(=L!K6&LX!352%3
MB_ 2E 5-C3>'D?.4$&NC9=U__H1C,GY\"R? 1_$Q+G.B2JN."E22[\E?Z+L3
M-"[\<_IXZ:H W)70=-+K*BDZA/B1-BV>(;JP1*UI_2%-C:&6@Y;>4['GI.GI
MN.RRYV0'@)YG5V@NT7;E *I'#UTCA*RA*)1Y($;C)L8FT*B.R[H)%A+0(NE[
M4 &1^Z? CSS1XT#K[&L_(73G'K0"FAZSR=L;P].S@T8WU'E+&F'I7<75:K&<
M!I-)9#.0SVH/4J>,!$F%M0=:/3\+)-VT(^GL]:'?9J8'X\)"0,V&X?Z?9,8-
M>$1'*!FWFH1'-!P^)_AU+/(RX-2/_W8$SQI$CFK_?9TVK+1]HO16I,Y\I3V'
M<.4)R;A$6GKT=:+FTR*#M8(J5"=WL3A>="]V0'V#Y!8%C#WA+U$$,K@JKQ\;
MX!>*C]97K:=3R>W1]G&/)ZFX(2U5AKGB6M8Z@*&9C1R> 9"M7-.'9+^S H$L
MY2$RAZF[=J4++R;O[^U+:AW8*",!01\=SH"(//Q-/!PP)9?OQ);J3HWNKSQN
M8[MTN).'6;0\4<L(OIJN,4(7YQUI$"J<1#50/7LA \J&%>T-&(H/R/8=%DV=
MSA$E-!.BWO7[6JZ-+DQYW&PS960J38,DVF*+_6Y'/1E7'5)'T "3NO;7:]E[
M<9S'NDV?BMA#CV'M[F::W@D90OD&WEXXH)293EZU-P+<K;LLS3&M:';]-(V]
M./O8BKKZH%]YZJ^2*_\;*FH]8;J0EV=OK4!F",>(2;":+H(15/F=F(:SY=D?
M7 "-@VB^"I8P]7=B$LXG9S>^\[["5U=G !8;I<NJ<&@KIH/2U+4F%TA&HPB9
M=3P5ETQ[-7J.F[&8!=%H',Q&$>^((K$(%Q&?5DO<B=\!*N-@NIP$8_Q&5 !E
MYN&"Y+LBE;04A)X.B,,@^UC'96@(%RR9^H'Z!YG&E1U923M)VP._6QBN:=1%
MCH1T2V/%QP!14AX("SY%^IUYR==@_J=2V=%5.)K[B4:GB>"$ES*<=77;AK0<
M%-=7T+RK6QX#&T($=GC2@>0=9S5#WCHXAGY'%=U-(!.;+[^:A]7_$P^^P1E0
M X_,* ,T8\VO.XA9YC#RG%K>)^TQ[5-F#G44HYDHY+V#:U=V#MAA-#^J<O;
M<>BN$.BDU?0_5,\@CJHR&A3=9_;&!?X+_&S!H,/2?KQ;TNS8:;"K6\LPXK&C
M(<W35!6[O6L[DG(G<>Z53Y6$D-*YO>()YU;6&LSO]FG^B.QLL[)O-GX[IN\C
M='%S=WM+>!Y9 (4:G=&]IKRAW.F&YR]\_TM"48VA2R\W?(EFOH3"P&">BDKW
M?N$92'943I].9CWN8X"6'YKI]'+V3/V6WY:LF@)<PPO)K9F[N'"3[O_&J6TX
MXQ7'O8FXZ'Y&D_23O1-(D:DG4Q0(%(5OT#'WG3PY.0'MR2>($3\"[3+11&YW
MM.Y/;)S'-LNMSUQCACA%LZ?O,UNH-C02(#P[W*X\*VQ_"_/?:E<<SG6@GYPT
MNJ12]UN[E:%+T]_<K/#$J*=7H>1U,;X\<J<?Z@8\L;6DAR /2BIHJ*'5('W*
M&[X+L"0Z:ZT=.I"<&;3M7C,41O&*4UG1.(P46C/[3*O<OJ)VL]?):!%,H\50
MO]MU_T!$DV4PGK$7V&D'AXZCE51%/0P]A7>?7I>OQK-@-9_T=^B;BH#H8$0.
M(,50_$7+-:+%@? ;"00E;EI7/I^:*487XM-=2@?-NQ:ETW<N.N,8/N+X/JE#
MP\_(7/^!OJ)?XTZ73ZYP?=6MZ^W1+56A?#YR,=>ZV[/]30T%FL;IJ"FD&Y_4
MX2, .GK7 B*[J9!'=@Z"]#+7A00H_OX"BN]O4F\3^V9":]++MS#N>LH!\AIS
M\!B(V1J>!8G 7I18A\S:*,7=#CB]LA$5>T-+>EC1V'N7K]#H$!-1AP?DC6@R
M^ZU\<&I@.E_'T<^M%M>.MPNU(8!"'=RQ?1HS0(H6$)]-^#68;WT!Y90VAH_F
M)LRY&*L'B>V*[YGL:QGFZ!Y QG%!FO/W /DWC?M=(W]E9RWOVACWQF'<GVTI
MRK,KGDZ:UOI>3,QO??ADT1IF'B$#_X[$IM57MV"P=?='>ZD<.-/+SA+7K'3$
MHYFN'75P^^ "E:-.&C>D0'G@K7EEP)BY?''V=\K,_!;=F>VH8:DSY$+%-Z7$
M?:)@UGS/E-&6!HO5BG^N%O.S/PQ/W>$[4V[0)],SJTGT2\%RR@T_:LRHOR&"
MB:N=RQ>5:41]FTIH_RX&L"9;^RP:V^%-HAC_MFOI<4?%2:KN%XAA\O3Z<U^"
MMS#0JVY(5]I\OMK0A$CS!3( 1T&E/PI7$Z#@43A?BN_/;NJFYR&GN0E[_#(*
MYS1>6R[#V:R]AKV>#,6MSJ68A<LI.JE1U"RIWR 0CUJATR R]&^ &9L/"O^0
M&6PT32[2F3G^$MYA"R&0JGCDM[2*:F=?92C;%_VMFE^_B0<G\3,VU1'H],RR
M'F3T*"H4[RLU!*/YDIS+(#L\G&&K#=]L\!6Z)-I<4FG7E7\SPRXB9$OP6\,-
M=-<X7)_@7P^D*K<]Z$K56>UU>9#'LVOU1>[J2:)JG^P):(?ZZ:T<-(U\>Y-4
MT/HCFCR%SOZPS>LVT=9F6^_WU3K5,4J&AT@M!1(+]:SWR [=LHPR0DT O_36
M%Y*N_3[&,/6;6IUNOH7!N[B.L2F38&5S%M\I9"*+(-R4NU92EV.^]74PVQ6Z
MNYMWEOY3<GZ29_I)<9%PHM5-A]ZIJS*_JH?!]=B-7@R@MW>IN\8A1^/TMK=V
MX_%([?[AB9 []NNV%UM"LGZ5PI/;RT?2]S& -CS'YTMRSM^YHF]$R3DA8TOM
MJ>^H7T(*17O VZ6&4ES%]3C[V>)G-=4N:ZT>P+H1X4B&MQ9D?VIWGS]::/]3
M#>W?#?:IQTV RSZ^3VQ&\L^!EQ=G[6>MO'YW!%T9IO'59*O-;*;8?KI^YM\;
M(T8[6#X*)O-Y$*$$^M_.WCB8X'N<H^NL_EOA^B9S.J<SIV<WW3KF <>>%M?M
MU&*^"N:SI:O&RR!:+(/59"[FP6RZ0F5>BK[WRJ];K_SO5''/?]A 4 W=@7W[
MWW_K_W;BC?V3@6:Y_<.+#[) GT&WWAML'86+V;F%1/6',M_S'Q"L\Q(=./^Z
M51+ZH 5XOLGSLOY !_B_*'G];U!+ P04    " "R@7=6F*L-UI<#  ">"
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M]]D,/^%>SX7'*XRB\ M#M+W($BAZ<J;=.S.#5NKX+Y[W>3APN)J_X9#M';+
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MAG@2A&7%HQ>M=^#STA@Z&CY /\RGOP%02P,$%     @ LH%W5EVUF82@ P
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M>A'@^XWC-NPW8N#XP,__ 5!+ P04    " "R@7=6^Y*QB5 ?  #1:P  &0
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MZ4RS+=[9VI1&N^+,?SK_[G$'4R. QZ5,\XJG69V89KDJ?K9-MW/%#TVEJQS
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MB<]I$I^3/<X#\#A($!'.]>O?M8AH(MPNX?]RB()8W1;G0=XWCKTYU).($GU
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MYWE\SP45/G!#32EY&<D*54)FJIN')0R3)!LT"^[.+AA*3H]R7),UR_61$>>
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M,XG =(VNFSC=A.:RTHY:51A6]&] XPUH?ZVI /J)#S#\;>9_ 5!+ P04
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M[EE\TGFPK//_,_J=./Y#XE$W5DK01@V8J/'P9=>C)5^(OV_4HUS$81W4X$P
M!GU!:$+L7*.4=6$2*1WYYDAQ9<GP#G/<5>I$O)1W$GG09MF/NOVS49OE4-6!
M^=7!<%_/ACM#IT"WK$<K06*KDIOYTZZVT_NR&5J_S)O1?Z?=TA]KC@MQC7JC
M80"N&:>-PG95C["Y91F(M9C)'PB=-Y#]A;7\K'B"]I\V_0E02P,$%     @
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M3V!;I<.-!I5H%LT8LO2BM7)MKW:GW:2[:!O\S;T=DW?,++BR(+"@T.CHY#@
MTXZ>UG"Z:MI]KAT-CV9;TK1&XQWHOM#:K0V?H)O_Z3]02P,$%     @ LH%W
M5J2$/Y4* P  ?@8  !D   !X;"]W;W)K<VAE971S+W-H965T,C<N>&UL?551
MC],X$'[/KQB%%0)I;Y.ZZ78I;:5T 1T2H(KE[AX0#VXR;:QU[& [V^5^/6.G
M"45T^])Z[)GOF_D\GLSWVMS;"M'!8RV57<25<\TL26Q18<WME6Y0T<E6FYH[
M,LTNL8U!7H:@6B8L3:^3F@L5+^=A;VV6<]TZ*12N#=BVKKGYL4*I]XMX%/<;
MG\6N<GXC6<X;OL,[=/\T:T-6,J"4HD9EA59@<+N(\]%LE7G_X/"OP+T]6H.O
M9*/UO3?>EXLX]0FAQ,)Y!$Y_#WB+4GH@2N/[ 3,>*'W@\;I'?Q=JIUHVW.*M
MEO^)TE6+^":&$K>\E>ZSWO^-AWHF'J_0TH9?V'>^DRR&HK5.UX=@RJ 6JOOG
MCP<=C@)NTB<"V"& A;P[HI#E&^[X<F[T'HSW)C2_"*6&:$I.*'\I=\[0J: X
MM\R+[ZVP(BCTX@O?2+0OYXDC9'^>% >458?"GD 9,?BHE:LLO%4EEK\#))32
MD!?K\UJQLXAOL+B"\>@26,K8&;SQ4.<XX(V?P%NUEG:LA5M=;X3B74NH$G)K
MJ?6/9?B:;ZPSU"[?3@G1T62G:?P3FMF&%[B(Z8U8- \8+Y\_&UVGK\\4D0U%
M9.?0EW?=RP&]A75KBHJZ$=9&% BYE+H(19W*^2SJZ9SS_IEZ,E<A-#UA$PCY
M0 C" K>PU;2SM_!"*/+7K25Q[<M9E->Z52X*,I.CU]E@.8MNN:W@ J9I&JT-
M-ER4@(\T:BS:<"^:2 V] &-0.2((X>PF>B<>L>SMZ^B+=ESV9H\.TW$6?1!\
M(R1=J0>T5(UGS8O"IV.AX3]\LP.[GOA-T^(1_ZMI#RS_!('1)<M&T2?JFM].
M>^X+F*33Z#TY<T5"D7R%KFO2B=YR<4\Z&5B1;.+_+N30=(Q=3C(6Y3V*4'\U
M1A>^8_V=<!(_R%+B PW2IO:B7  ;7Z;9*SC56LG13*C1[,+DLQ#*[\;#L#L,
MU[R;*;_<N\G\D9N=4!8D;BDTO9I.8C#=M.L,IYLP83;:T;P*RXH^$&B\ YUO
MM7:]X0F&3\[R)U!+ P04    " "R@7=63:<-+ZT#  #2"   &0   'AL+W=O
M<FMS:&5E=',O<VAE970R."YX;6R%5FUOVS80_NY?<5"[H@$22Z)?X]@&DG3#
M"C1HD'0KAF$?:.EL$Z5(E:3BY-_O2-J*LSC>EX04[YY[[NXAS].--C_L&M'!
M8R65G25KY^I)FMIBC16W75VCHI.E-A5WM#6KU-8&>1F<*IFR+!NF%1<JF4_#
MMULSG^K&2:'PUH!MJHJ;IRN4>C-+\F3WX4ZLULY_2.?3FJ_P'MT?]:VA7=JB
ME*)"98568' Y2R[SR=7 VP>#/P5N[-X:?"8+K7_XS>=REF2>$$HLG$?@].\!
MKU%*#T0T?FXQDS:D=]Q?[]!_"[E3+@MN\5K+[Z)TZUDR3J#$)6^DN].;WW&;
M3R!8:&G#7]A$VP%+H&BLT]76F1A40L7__'%;ASV'<?:& ]LZL, [!@HL/W''
MYU.C-V"\-:'Y14@U>!,YH7Q3[IVA4T%^;OX%*24+'[_QA41[,DT=@?JCM-@"
M7$4 ]@9 SN!&*[>V\*LJL7P)D!*;EA+;4;IB1Q$_8=&%7GX*+&/L"%ZO3;$7
M\'K'4_S[<F&=(17\<RC)"-$_#.%OQL36O,!90M*W:!XPF7]XEP^SBR,$^RW!
M_C'T^7V\$*"7<%F6PJN52_BLXI7SVKU#R1V6X#3$; ZE<#3(X13VPHF]<.8Y
MG%LC7.NJYNKIP[LQRT<7%F0L*+>>,5<ED&<P?$)N +T,@)J(U0)-V\A3$,%E
MJ24]!*0XH<A'-Y8 ["G@8X&UB]#@T%0!N!2VT(UR8(C/R:3S"K5SQ257!4)\
MP?:2Z(3WY4POSQI"Y-:BL_ >\M/\/.^$(H(4?"$D%0")0-$8@Q3I/?2S\2$#
MI=79SFC,^IUOVE'9Y'\-0PS68YVO5!'S@M'W\$10<?@#&GKQJ,[^V11JM9]W
MKYN-0B7M:X<7]8!QEPW@E\Y]4]<2Z:'T? INU["D"K^(_+4F?^<#M>?4":,K
MT.W)MJN4_W!PL'AZX8@ML:'.4;O67!$CW_I(7B^D6(5P'B2(A5W D>LQ:*_'
MX/CUH$%4-A*]VFZX:TRL,^UBE[X\%__0M3@*?OA:O(SRNL51^:_$"!LT^*;&
M2;Y_;>^'+_>^=X>\>] _[_M%GQ;,+P; \G._&$(^#(L1L/%6=XW::8$:$AG6
M_,F+P)+^^ADC"5L[ 5'5C0L](W&A=? 1\E$&)_\GWX.-2_?F3(5F%::IA4 C
MCISV:SNP+^.<>C:/T_Z&FY50_BU9DFO6'5&;3)R@<>-T':;60CN:@6&YIA\=
M:+P!G2^U=KN-#]#^C)G_"U!+ P04    " "R@7=6U"RZ9<$"  #C!0  &0
M 'AL+W=O<FMS:&5E=',O<VAE970R.2YX;6R%5%%OVC 0?N=7G+)J:B76D)
M98 $M-,FK5O5=MO#M >3',2J8V>V4]I_OW-",E91]A+;Y_N^^\Z7N\E6Z0>3
M(5IXRH4T4R^SMAC[ODDRS)DY5P5*NEDKG3-+1[WQ3:&1I14H%W[8ZPW\G''I
MS2:5[4;/)JJT@DN\T6#*/&?Z>8%";:=>X#6&6[[)K#/XLTG!-GB']EMQH^GD
MMRPISU$:KB1H7$^]>3!>1,Z_<OC.<6OV]N R62GUX Z?TJG7<X)08&(= Z/E
M$9<HA",B&;]WG%X;T@'W]PW[ARIWRF7%#"Z5^,%3FTV]D0<IKEDI[*W:?L1=
M/K'C2Y0PU1>VM6_4\R IC57Y#DP*<B[KE3WMWF$/,'H-$.X 8:6[#E2IO&26
MS29:;4$[;V)SFRK5"DWBN'1%N;.:;CGA[&R>)+K$%*Z>J,P&#9S>LY5 <S;Q
M+=$[)S_942UJJO 5JB"$:R5M9N!*IIC^2^"3KE9<V(A;A$<9+S$YAW[0A; 7
MAD?X^FVR_8JO_Y]D/W.VXH);CJ8+RU)KE!9^SE?&:OI+?AU*O2:.#A.[SAF;
M@B4X]:@U#.I']&9OWP2#WOLCLJ-6=G2,?79'G9B6 D&MX66]#FD]RG98:T.+
MS6^0*.H[8\E$06V&L%:"&IC+#9QR2195&B93<S;N4)4P7Z%VE>JX2KER!9V&
MLF#/FK! WJ"(20/FA5#/B+!"B6MN#9Q V+T8QM4:!T%G2:)YP@3UUR/-C2)W
M!>IWP[A/#H-PV/E:$3$7@@D#T9""1G'GBY+OD@;KDF,ZR2 :Q!#UPU81EQ;I
MTL(P@F'0N5>6O-G+%SB!83?L7] :=T>C 1PJI+_7>#GJ335>W..5TM8]V%K;
M"3:O&_>O>SW^KIG><&E X)J@O?-A[(&N1TI]L*JHVGBE+ V%:IO1%$;M'.A^
MK91M#BY .]=G?P!02P,$%     @ LH%W5DY7!!MM P  [@<  !D   !X;"]W
M;W)K<VAE971S+W-H965T,S N>&ULC55M;]LV$/[N7W'0BB(!A.C-CAW7-N D
M"U:@*8PFV3 ,_4!+9YLH1:HD5=?[]3M2LFJWCK$OHDC>/?<<G^-QLE7ZB]D@
M6OA>"FFFP<;::AQ%)M]@R<R5JE#2SDKIDEF:ZG5D*HVL\$ZEB-(XOHY*QF4P
MF_BUA9Y-5&T%E[C08.JR9'IWBT)MIT$2[!<^\?7&NH5H-JG8&I_0OE0+3;.H
M0REXB=)P)4'C:AK,D_'MP-E[@S\Y;LW!/[A,EDI]<9/WQ32('2$4F%N'P&CX
MAG<HA ,B&E];S* +Z1P/__?H#SYWRF7)#-XI\1<O[&8:C (H<,5J83^I[1_8
MYN,)YDH8_X5M8WM]$T!>&ZO*UID8E%PV(_O>GL.!PRA^Q2%M'5+/NPGD6=XS
MRV83K;:@G36AN1^?JO<F<EPZ49ZLIEU.?G;V45DTL& [MA0(%\]N,)>3R!*V
MLXCR%N>VP4E?P4E2>%32;@S\+@LLC@$B(M4Q2_?,;M.SB/>87T&6A)#&:7H&
M+^LRS3Q>]BK>TL(]-[E0IM8(_\R7QFJJBL^GLFVP^J>QW$T9FXKE. WH*AC4
MWS"8O?TMN8[?G6':[YCVSZ'/GNCF%37)H58P7Z\UKIE%N&-:[[A<P[Q4M;3&
M[3ZC+N&#8O)4"N>#/&\06 >>[\'9#W!+%ET X 9R55::&RSVNRLEZ%([MPLN
M:475ALG"7(Y[)!Z62]1.P)X3T*F8]!::RYQ73, ;&(6#84)C$H=Q'/?F13&F
M.YIKM!1 <+;D@ML=Q="PXI)<*K:C;F!AA0C]+";HN/<!C1E#+8FVMOQ?\BQ(
M89<"7$!_!)<T)%D*E[UG9=NP-X.L"9L,1V?4&G1J#?Z?6@^U=77UR&C@EN.Q
M0B&\E[FH"W=:#SZ?19O/ ^(I^<Y&/5V!+8/RB,&1C"'PCH7;.&9")QL"\UZ'
M OH;"%LD:-IL1#>_2/XW,@TH/?3/WN[ !^$PZ9^UZD,69H-A[R:,ATGO17;5
ML&2"R1Q]+?S"&*BW=_D1+1C&)/?+B9(P;4WT? WXVJ$6J[4#JIPQ(5TT/,GH
MHY(_;[XA@FEV Z>J)CKHP27JM7]IW)VAP$T[[E:[QVS>]/ ?YLU+^,CTFE,J
M E?D&E\-J11T\[HT$ZLJW]&7RM+[X'\W]""C=@:TOU+4U=N)"] ]\;/_ %!+
M P04    " "R@7=6H3"5",<%  "=#0  &0   'AL+W=O<FMS:&5E=',O<VAE
M970S,2YX;6R-5]MNVS@0??=7$&Z[VP"*K9ME.4T,.&G:[4.W0=(+%HM]8*2Q
M380259*RD_WZG:%D12D<;QX24Q+GS!G.G!GI=*OTG5D#6'9?R-*<#=?65B?C
ML<G64' S4A64^&2I=,$M7NK5V%0:>.Z,"CD.?3\9%UR4P_FINW>EYZ>JME*4
M<*69J8N"ZX=SD&I[-@R&NQO78K6V=&,\/ZWX"F[ ?JNN-%Z-.Y1<%% :H4JF
M87DV7 0GYU/:[S9\%[ UO36C2&Z5NJ.+3_G9T"="("&SA,#Q9P,7("4!(8V?
M+>:P<TF&_?4._8.+'6.YY08NE/PA<KL^&Z9#EL.2U])>J^T?T,8S(;Q,2>/^
MLVV[UQ^RK#96%:TQ,BA$V?SR^_8<7F(0M@:AX]TX<BS?<\OGIUIMF:;=B$8+
M%ZJS1G*BI*3<6(U/!=K9^8U5V=U:R1RT^9U=_JR%?6!OO_);">;H=&S1!6T<
M9RW<>0,7/@,7A.RS*NW:L,LRA_PIP!BY=03#'<'S\"#B>\A&+ H\%OIA>  O
MZ@*.'%[T#%X;XM^+6V,UUL0_^X)L(.+]$*23$U/Q#,Z&* 0#>@/#^6^O@L1_
M=X!@W!&,#Z'/;QIY,+5D+CGL2^7J=T'UB]3W\3V,^'4-;*DDZD^4JU9^XE\P
MS#A\53WJ@XX&E<XLFCP UPPHC0R3 ,4MZ"X1)X,OM366ESE!-@P-^^$T /EQ
MMV*+U4K#BEM@;_G1X)Q+7F;HF1N*[U?8@$7>+)YZ?CAAKUD\FJ2#CYJ7A!-Z
M03+S4M_'!]$HB0:7]Z S8?#1,=XZ'J!&ER!LK0F]S%E&CJ3D#;.W+/#\(/:B
M,&9'#GOF_Q^;D$V\P ^]B1\XBR!@T]$T<-YV$4/#@N3R+$KHQ6GDA;@BE#!B
MR6A*\1W3D?0.2)16"^QV&=MP6=,UID$89AWZ%N$S+K,:0\*@\8IR5"DCJ*VQ
M7"R7H '#\9A8X@D\>.P6[!:@=!LSB3LQ5946&9HA/[/F&H@Q/;Y0184VO[U*
MPV#Z#CVIHL":: NDW!,5&KYFP<A/W&D[+@ZZ!:RQ;K1\()=-?9G1 6U,.FU,
M7JJ-/U5YG'&S;D1R3)TY=V'@P'!)9Y?WM(9]>CGH9;^^ORK+)2MW7DW/:];W
M"HU7IR(N97N$?,MUWA1F5>MLC79,DT2,QTH<O1C0LE? &C*U*E&CNT1CR%E6
M:P_7W+I:Z&T1;8KQD)44N:L/U*8%')X.&D>X;H4@7+4WW0!EX4Q5;9"8.3H9
M_$62=YU[T)0N:G)PC4? D;-CG\,&!WGED#'_WG0V<[^S:3+X""7ZD6X?SW%8
M"6JQKCPCSX^=$J)XT)PD:L%+8Z<L+PY\=J ZDJXZDI=61]>)%ANDM *V,-CW
M6M%^HZ19A45M02--8!^XT.R[4]VO;=<U(+.OB Z3H::[W;'@+0O>8U&;Q]2=
M2X[5=)/A(,;LMPV9]$3Z*50.DOCF'5^R61+GS8XSW8&BDNH!P"4 *[6[?M+G
M5RX@Y*:A5PK/Y5Z8N^.E!M>=T,)8IJE7!:-9Q-XP?Y2D[,V E)91U6T4-5Q)
M4R0-1HF/6])T-)GT]U ,KO!HOI@C-AFE,;9$/WC<DN,@RG'RL <!,F<$@W\'
M*F3:5<CTI15RW0@[9S?4!UWKOFB:7I-^TN^'FN3(/F'6:%#L*X*#_O9WDHM^
M;]4[&N1OV?@3K3^G:-20V27X<8@_-VLH\Y2XDT'_62^A-[U2,,X3]1BT4KUY
M_CCWNGD\^,%U4SA$],EX"+PH2;P M=RM!HNVWVVXD&Y\N7G@@@C](-V]:'["
M*$O7(*YP%+-IBA,Z"EB<D,]X</FT@+O.6='F63CQ9DG$IOA>D.";0M-64B^8
MIMXL2ECB36)\8XC3O:UEW'ME+D"OW(<!S;VZM,W;<W>W^_98-*_<C]N;#Y?/
M7*]P;C,)2S3U<;@/F]Z^N["J<B_@M\KBZ[Q;KO'["31MP.=+I>SN@AQT7V3S
M_P!02P,$%     @ LH%W5L ^(Q3[!0  QP\  !D   !X;"]W;W)K<VAE971S
M+W-H965T,S(N>&ULK5=;;]LV%'[WKR#<H$@ .=;-DITF!G)IMP+M&C1IAV'8
M RW1-E%)5$DJE_[Z?4>29;MUW'380QR*.O?S?3SBZ;W27\Q2",L>\JPP9_VE
MM>7)<&B2I<BY.5:E*/!FKG3.+1[U8FA*+7A:*^79T'?=:)AS6?2GI_7>M9Z>
MJLIFLA#7FIDJS[E^O!"9NC_K>_W5QD>Y6%K:&$Y/2[X0-\)^*J\UGH:=E53F
MHC!2%4R+^5G_W#NYB$F^%O@LQ;W96#/*9*;4%WIXFY[U70I(9"*Q9('CWYVX
M%%E&AA#&U]9FOW-)BIOKE?4W=>[(9<:-N%39GS*UR[/^N,]2,>=59C^J^]]%
MF\^(["4J,_4ONV]EW3Y+*F-5WBHC@EP6S7_^T-;A.0I^J^#7<3>.ZBBON.73
M4ZWNF29I6*-%G6JMC>!D04VYL1IO)?3L]&V1J%RP6_X@##N\Y;-,F*/3H85I
M$A@FK9F+QHS_A!G/9^]589>&O2Y2D6X;&"*F+C!_%=B%O]?BE4B.6> YS'=]
M?X^]H$LTJ.T%/TV474F39,I46K"_SV?&:D#CGUTY-Q;#W1:)+B>FY(DXZX,/
M1N@[T9^^?.%%[JL]\89=O.$^Z].;AB5,S=FERDM5B,(:>GJGC&$7 GP4;".I
M:ZWN9$V5PPM1B+FT.]NXW^GM4K!DRUM&WF:--]EXL_!6KKW-6F\,,LS"P*/@
MVC!!.&#HHLAG0G>=9+Q(:>'!#YAM+(3@AO3F*L,1(8L%.Y0%=E1E(&R.3GI_
MP6(#K%YM@_1[GXYOCMDABUPG= -VA&40.[$[8D<]\!5L1&S,=UQ_5+_TG"",
M\>Z ='PG],?8IH=@XK@CGQWMZ=FHZ]GHN3W[*)!?(C/)Z\,'.Z\?2IQ$2/?&
M<EM9!;DW(A6:9[O;:!4[3VSUQ.M=O=T;W&ZXWF[571K&<=)^'SDU1ZRB-UWT
M\S;ZG;! ]*K2=.A63XG\(EZ>!8JWG2,<9]QN1*NYQ18UW L<SW/;[H\=W_4
M"VK*)L(=5F B(OE5EBW,V8 -(*R2+P,:!FE-%\RHIEBC(&#AR.M="PP,XA"3
M5N2&>4!;X/56_:;R<YTLZ^24+I>\8*FN%BS1(I4@'L'5(U#6J]@+-D!-B;!4
MSN="PX&$N1 0C_W>K>:(HQEVB3(P,YX@V//D:R5A%\D-4/Q$@-!; :3B#K.Y
MS"G<T!F'+I0N$=*"ZM'E?\>SJDF2$UQXD0@J'C@U<8+(!:\&C/[VT"CJ:!3M
MIQ'2E'.9< 2T??9="61-N1 7SHT1V*84WDD^ V*M%&87,?:Z>YH8!%>!.B>-
M<W2R5)KXO:H^:@E( F8+?%DP+8T@W)N-\*% -3,K&J6K!,@V7R>PM9^MLX%,
MD_>3M. XF"'4D-C\P))-S0V>7/T8QTGO#T)\B6Y;.@SJDS_A6C^"J/=<IVBO
MCX[#Q 'ST/0P[%VV>)TX/K 6.)/0[5WR4EJ>R6^PWN&,CH\"HIBYAL6..XX
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M?IG3J$?M'.A\K90];%R"YN>1_ -02P,$%     @ LH%W5A'@[^EB @  1P8
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M#L#W,RG-<\-.T'QR&?T'4$L#!!0    ( +*!=U9)EKF.4P,  )T,   9
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M[8X>^P:9VGC]M&9U6K&*GF$51N1*"K/6Y%Q@ %T 'R5J=(KN=3J-=B*>07I
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M[CWWXAQY<63\FP@!)/H11XE86J&4Z85M"S^$F(@!2R%13W:,QT2J)=_;(N5
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M*?%A::EM0@ _@.7]_AN>.'^V*66(K*';L-)MV,7NW3.I!E>$C,N/$GBLIN(
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M0R !<!V@GN\8D\\+?2!5'4!Z_P-02P,$%     @ LH%W5@1I76EM @  ]04
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M;M!0#]@!14>:@&E8!&%-%X![!@$VWP? O_+R2YRN4B,CZXRNZ[\IM*H^VA?
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M,,%>'*39@-_G0NC-Q 2HNOOP-U!+ P04    " "R@7=61LYJKWT#  "Z$
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M($F[E1]7A&8E(7J&4$C)9RE,JLE?(H'D&,!'=;5$^B)Q1CL1[R&^)E'XGM"
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MQ8\>4'8!OE]):5X&=H/Z,VKZ'U!+ P04    " "R@7=6T%>&=+L"  ![!P
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MDE8,$%^BWO3Q#!2A3)YHPX?Y#!T?G: C1 MTG_%*DB*58U=I+J/N)BW#=<.
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M@_-(!RB:!ZSI*%[6;\""*_VBU,U,O_D@C(&>7W*NMAWSK'3_(N*_4$L#!!0
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M;4L4-4_143S-RX8Y5[H(R9LK72>", %Z?,%UZ5!V3"5259[A7U!+ P04
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MP<+BN@LLY:#L IR?22P']<!6E^;/0?(;4$L#!!0    ( +*!=U9<6VN;E!
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MM;"&RZ?^S$JWZJ+U#!VH*0RE42@MA-(B%$W7A#*%;;,IW*G!4#TVZ.17*"V
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MLR2I I-SZ9H(W-]9NF'Y$[%D$IS-ET0<P],%RZN=2@0LSS;W2W5<M;W[[%1
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M=09XF$31*Q8OBF],?_; %79[YG&-_343>@)^7W*N]B]:0=6Q3_\%4$L#!!0
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M0"!?HA6\?^>VG,]UQ3D0V$:I_+)4_C[T(-<C7>M15/085BN'N1[K:I$':)L
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M?5NO)X)N]87WB0IY?=;#%(@\]Y6!?+^F5+Q,U!VZ_682_0=02P,$%     @
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M[Y>U?65 .0=[OI/2G P7H'^W\C]02P,$%     @ LH%W5D2A\R;  @  *@<
M !D   !X;"]W;W)K<VAE971S+W-H965T-C N>&ULK55=;],P%/TK5IC0)K'F
M.QTCC;2V("8QJ5HW>$ \N,EM8Y'8P7;:\>_Q1YIU559XX"7QQSW'Y]B^U^F.
M\9^B!)#HJ:ZHF#BEE,VUZXJ\A!J+$6N JIDUXS66JLLWKF@XX,* ZLH-/"]Q
M:TRHDZ5F;,&SE+6R(A06'(FVKC'_/86*[2:.[^P'[LFFE'K S=(&;V )\K%9
M<-5S>Y:"U$ %811Q6$^<&_]ZENAX$_"5P$X<M)%VLF+LI^[<%A/'TX*@@EQJ
M!JQ^6YA!56DB)>-7Q^GT2VK@87O/_LEX5UY66,",5=]((<N)<^6@ M:XK>0]
MVWV&SD^L^7)6"?-%NR[6<U#>"LGJ#JP4U(3:/W[J]N$ X">O ((.$!P#HE<
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MPS ,0'_%T)XP!] AB#-E\18$^0%6H@_8$@6*19V_K]JE<9 +&7D]/!+<'FE
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M_ER6^=2)YL_Z$Y8D;9:HYW59GL*^:_/#RF+SH>GF(]GC?P%02P,$%     @
MLH%W5A[?F5X< @  /2<  !H   !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L
M<\W:2VZC0!2%X:U8+"#E^ZHDK3BCGF3:R@:04WXHMD$4K4YVWY8SL _J04\B
MS@@5B,L_X1,"GGZ50SONNU/=[?NZ^#@>3G75[,:Q_Y%27>_*L:UW75].YR.;
M;CBVXWDY;%/?KM_;;4FZ7.8TW,YHGI]N9RY>/_OR/Q.[S6:_+C^[]>]C.8W_
M&)S^=,-[W94R-HO7=MB6<=6DC\-U=TV7C=R=)S>+E[=5,[R\29/F#E((TOF#
M#()L_B"'()\_*" HY@_*$)3G#[J'H/OY@QX@Z&'^H$<(>IP_2)8HXY(@:8(U
M@=:"7 N!UX)@"X'8@F0+@=F": N!VH)L"X';@G +@=R"= N!W8)X"X'>BGHK
M@=Z*>BN!WCIYV";06U%O)=!;46\ET%M1;R706U%O)=!;46\ET%M1;R706U%O
M)=#;4&\CT-M0;R/0VU!O(]#;)B]+"/0VU-L(]#;4VPCT-M3;"/0VU-L(]#;4
MVPCT-M3;"/1VU-L)]';4VPGT=M3;"?1VU-L)]/;)RVX"O1WU=@*]'?5V KT=
M]78"O1WU=@*]'?5V KT#]0X"O0/U#@*] _4. KT#]0X"O0/U#@*]8_*QDD#O
M0+V#0.] O8- [T"]@T#O0+V#0.^,>F<"O3/JG0GTSJAW)M [H]Z90.^,>F<"
MO3/JG0GTSI.?3;Y3[SI^'DJ]]GRM\?K?2?5X/K=<+W]9?NV<W.,7G--M17W^
M"U!+ P04    " "R@7=6I7\.<>X!  "0)@  $P   %M#;VYT96YT7U1Y<&5S
M72YX;6S-VLM.PS 0!=!?J;)%C>LG#]%N@"VPX =,,J51D]BR72A_CY,"$@@J
M4)&XFT:M[;D3CW16/;][]A0GVZ[MX[Q8I>3/&(O5BCH;2^>ISRM+%SJ;\M?P
MP+RMUO:!F)C-#*M<GZA/TS34*!;GE[2TFS9-KK;YY]BX?EX$:F,QN=AM'++F
MA?6^;2J;\CI[[.M/*=/7A#*?'/?$5>/C4=Y0L"\3AI7O U[/W3Q2"$U-DUL;
MTK7M\BZV;5E,SRW%<G^)+WITRV534>VJ39>/E-$'LG5<$:6N+7=%C_8GIWS#
MM/OD!^>/9?8%YIVWP?F8)Q;H]W%O(QE.3WTN1"$U^U_Q/3&7/OC]:)AV3?4/
ML_/U/KFP'N<1V?@X_(X_SOB]_B_[$"!]2) ^%$@?&J0/ ]+',4@?)R!]G(+T
MP6<HC:"(RE%(Y2BF<A14.8JJ'(55CN(J1X&5H\@J4&05*+(*%%D%BJP"15:!
M(JM D56@R"I09!4HLDH4626*K!)%5HDBJT215:+(*E%DE2BR2A19)8JL"D56
MA2*K0I%5H<BJ4&15*+(J%%D5BJP*15:%(JM&D56CR*I19-4HLFH4636*K!I%
M5HTBJT:15:/(:E!D-2BR&A19#8JL!D56@R*K^4]9[YU;_W'\^"P[V_1O^6S\
M(]KB!5!+ 0(4 Q0    ( +*!=U8'04UB@0   +$    0              "
M 0    !D;V-0<F]P<R]A<' N>&UL4$L! A0#%     @ LH%W5J2 UB;M
M*P(  !$              ( !KP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#
M%     @ LH%W5IE<G",0!@  G"<  !,              ( !RP$  'AL+W1H
M96UE+W1H96UE,2YX;6Q02P$"% ,4    " "R@7=6A %DE0L)  "W-@  &
M            @($,"   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#
M%     @ LH%W5CK]/Y#<!0  Z!@  !@              ("!31$  'AL+W=O
M<FMS:&5E=',O<VAE970R+GAM;%!+ 0(4 Q0    ( +*!=U8[PP' BP(  "\'
M   8              " @5\7  !X;"]W;W)K<VAE971S+W-H965T,RYX;6Q0
M2P$"% ,4    " "R@7=6[]PV;#$%  !*%0  &               @($@&@
M>&PO=V]R:W-H965T<R]S:&5E=#0N>&UL4$L! A0#%     @ LH%W5N84? M
M!P  JD(  !@              ("!AQ\  'AL+W=O<FMS:&5E=',O<VAE970U
M+GAM;%!+ 0(4 Q0    ( +*!=U:>V+E=+@@  ,XH   8              "
M@?TF  !X;"]W;W)K<VAE971S+W-H965T-BYX;6Q02P$"% ,4    " "R@7=6
M7JPKE)\.   5)0  &               @(%A+P  >&PO=V]R:W-H965T<R]S
M:&5E=#<N>&UL4$L! A0#%     @ LH%W5G'< B3"&P  7ED  !@
M     ("!-CX  'AL+W=O<FMS:&5E=',O<VAE970X+GAM;%!+ 0(4 Q0    (
M +*!=U9B$]];_@<  !T6   8              " @2Y:  !X;"]W;W)K<VAE
M971S+W-H965T.2YX;6Q02P$"% ,4    " "R@7=6 E]UZ50$  "S"0  &0
M            @(%B8@  >&PO=V]R:W-H965T<R]S:&5E=#$P+GAM;%!+ 0(4
M Q0    ( +*!=U;!QU%9;P,   <(   9              " @>UF  !X;"]W
M;W)K<VAE971S+W-H965T,3$N>&UL4$L! A0#%     @ LH%W5J&$%WO]!@
M9A   !D              ("!DVH  'AL+W=O<FMS:&5E=',O<VAE970Q,BYX
M;6Q02P$"% ,4    " "R@7=6HP2#V)@%  "N#0  &0              @(''
M<0  >&PO=V]R:W-H965T<R]S:&5E=#$S+GAM;%!+ 0(4 Q0    ( +*!=U9G
M.84*LP(  .(%   9              " @99W  !X;"]W;W)K<VAE971S+W-H
M965T,30N>&UL4$L! A0#%     @ LH%W5J$66#C]#P  :S   !D
M     ("!@'H  'AL+W=O<FMS:&5E=',O<VAE970Q-2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( +*!=U:6/TW]J0(  -@%   9              "
M@?:U  !X;"]W;W)K<VAE971S+W-H965T,C N>&UL4$L! A0#%     @ LH%W
M5EVUF82@ P  [ <  !D              ("!UK@  'AL+W=O<FMS:&5E=',O
M<VAE970R,2YX;6Q02P$"% ,4    " "R@7=6^Y*QB5 ?  #1:P  &0
M        @(&MO   >&PO=V]R:W-H965T<R]S:&5E=#(R+GAM;%!+ 0(4 Q0
M   ( +*!=U;+"C97^ (  'D&   9              " @33<  !X;"]W;W)K
M<VAE971S+W-H965T,C,N>&UL4$L! A0#%     @ LH%W5D,+E3AV P  C@@
M !D              ("!8]\  'AL+W=O<FMS:&5E=',O<VAE970R-"YX;6Q0
M2P$"% ,4    " "R@7=6@6(Z\"(#  #?!@  &0              @($0XP
M>&PO=V]R:W-H965T<R]S:&5E=#(U+GAM;%!+ 0(4 Q0    ( +*!=U8M9:VJ
MPP(   L&   9              " @6GF  !X;"]W;W)K<VAE971S+W-H965T
M,C8N>&UL4$L! A0#%     @ LH%W5J2$/Y4* P  ?@8  !D
M ("!8^D  'AL+W=O<FMS:&5E=',O<VAE970R-RYX;6Q02P$"% ,4    " "R
M@7=63:<-+ZT#  #2"   &0              @(&D[   >&PO=V]R:W-H965T
M<R]S:&5E=#(X+GAM;%!+ 0(4 Q0    ( +*!=U;4++IEP0(  .,%   9
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M970S,RYX;6Q02P$"% ,4    " "R@7=6$>#OZ6("  !'!@  &0
M    @($K!@$ >&PO=V]R:W-H965T<R]S:&5E=#,T+GAM;%!+ 0(4 Q0    (
M +*!=U;GT)2_,P0  'X1   9              " @<0( 0!X;"]W;W)K<VAE
M971S+W-H965T,S4N>&UL4$L! A0#%     @ LH%W5DF6N8Y3 P  G0P  !D
M             ("!+@T! 'AL+W=O<FMS:&5E=',O<VAE970S-BYX;6Q02P$"
M% ,4    " "R@7=6%5%&I],#  ",%   &0              @(&X$ $ >&PO
M=V]R:W-H965T<R]S:&5E=#,W+GAM;%!+ 0(4 Q0    ( +*!=U8$:5UI;0(
M /4%   9              " @<(4 0!X;"]W;W)K<VAE971S+W-H965T,S@N
M>&UL4$L! A0#%     @ LH%W5IE-AP?K!   _1\  !D              ("!
M9A<! 'AL+W=O<FMS:&5E=',O<VAE970S.2YX;6Q02P$"% ,4    " "R@7=6
M\?]LP!4#  #I"P  &0              @(&(' $ >&PO=V]R:W-H965T<R]S
M:&5E=#0P+GAM;%!+ 0(4 Q0    ( +*!=U9&SFJO?0,  +H0   9
M      " @=0? 0!X;"]W;W)K<VAE971S+W-H965T-#$N>&UL4$L! A0#%
M  @ LH%W5H66<=RB @  )@<  !D              ("!B",! 'AL+W=O<FMS
M:&5E=',O<VAE970T,BYX;6Q02P$"% ,4    " "R@7=6K[X-\NL#   0$P
M&0              @(%A)@$ >&PO=V]R:W-H965T<R]S:&5E=#0S+GAM;%!+
M 0(4 Q0    ( +*!=U;92SO],@,  &P)   9              " @8,J 0!X
M;"]W;W)K<VAE971S+W-H965T-#0N>&UL4$L! A0#%     @ LH%W5KX&8V4(
M P  ,0P  !D              ("!["T! 'AL+W=O<FMS:&5E=',O<VAE970T
M-2YX;6Q02P$"% ,4    " "R@7=6L/(2@+<#  !2#0  &0
M@($K,0$ >&PO=V]R:W-H965T<R]S:&5E=#0V+GAM;%!+ 0(4 Q0    ( +*!
M=U;05X9TNP(  'L'   9              " @1DU 0!X;"]W;W)K<VAE971S
M+W-H965T-#<N>&UL4$L! A0#%     @ LH%W5BP$>GSE @  40@  !D
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M=#4R+GAM;%!+ 0(4 Q0    ( +*!=U9<6VN;E!   &^I   9
M  " @;13 0!X;"]W;W)K<VAE971S+W-H965T-3,N>&UL4$L! A0#%     @
MLH%W5B5ITMA2!   O0\  !D              ("!?V0! 'AL+W=O<FMS:&5E
M=',O<VAE970U-"YX;6Q02P$"% ,4    " "R@7=6W']\C4D"   9!0  &0
M            @($(:0$ >&PO=V]R:W-H965T<R]S:&5E=#4U+GAM;%!+ 0(4
M Q0    ( +*!=U9>1$F0. ,  /P+   9              " @8AK 0!X;"]W
M;W)K<VAE971S+W-H965T-38N>&UL4$L! A0#%     @ LH%W5N*D^(7S @
M'0@  !D              ("!]VX! 'AL+W=O<FMS:&5E=',O<VAE970U-RYX
M;6Q02P$"% ,4    " "R@7=6)DA?U:X#   _$0  &0              @($A
M<@$ >&PO=V]R:W-H965T<R]S:&5E=#4X+GAM;%!+ 0(4 Q0    ( +*!=U99
MIDNW, (  ,,$   9              " @09V 0!X;"]W;W)K<VAE971S+W-H
M965T-3DN>&UL4$L! A0#%     @ LH%W5D2A\R;  @  *@<  !D
M     ("!;7@! 'AL+W=O<FMS:&5E=',O<VAE970V,"YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( +*!=U8TK4"Q9P(  , %   9              "
M@4^- 0!X;"]W;W)K<VAE971S+W-H965T-C4N>&UL4$L! A0#%     @ LH%W
M5F/PR7@U @  # 4  !D              ("![8\! 'AL+W=O<FMS:&5E=',O
M<VAE970V-BYX;6Q02P$"% ,4    " "R@7=6K]ZUFUT#  #J%0  #0
M        @ %9D@$ >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( +*!=U:7BKL<
MP    !,"   +              "  >&5 0!?<F5L<R\N<F5L<U!+ 0(4 Q0
M   ( +*!=U;(:"L/!P4  *@K   /              "  <J6 0!X;"]W;W)K
M8F]O:RYX;6Q02P$"% ,4    " "R@7=6'M^97AP"   ])P  &@
M    @ '^FP$ >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4
M" "R@7=6I7\.<>X!  "0)@  $P              @ %2G@$ 6T-O;G1E;G1?
@5'EP97-=+GAM;%!+!08     2@!* #T4  !QH $    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>136</ContextCount>
  <ElementCount>376</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>61</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>7</UnitCount>
  <MyReports>
    <Report instance="eq-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://equilliumbio.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="eq-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>100010 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="eq-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>100040 - Statement - Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="eq-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>100050 - Statement - Consolidated Statements of Operations and Comprehensive Loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss</Role>
      <ShortName>Consolidated Statements of Operations and Comprehensive Loss</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="eq-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>100060 - Statement - Consolidated Statements of Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity</Role>
      <ShortName>Consolidated Statements of Stockholders' Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="eq-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>100070 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="eq-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>100080 - Disclosure - Organization and Accounting Pronouncements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureOrganizationAndAccountingPronouncements</Role>
      <ShortName>Organization and Accounting Pronouncements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="eq-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>100090 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="eq-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>100100 - Disclosure - Fair Value of Financial Instruments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstruments</Role>
      <ShortName>Fair Value of Financial Instruments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="eq-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>100110 - Disclosure - Short-Term Investments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureShortTermInvestments</Role>
      <ShortName>Short-Term Investments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="eq-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>100120 - Disclosure - Property and Equipment</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosurePropertyAndEquipment</Role>
      <ShortName>Property and Equipment</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="eq-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>100130 - Disclosure - Acquisition</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://equilliumbio.com/20221231/taxonomy/role/DisclosureAcquisition</Role>
      <ShortName>Acquisition</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="eq-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>100140 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://equilliumbio.com/20221231/taxonomy/role/DisclosureLeases3</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="eq-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>100150 - Disclosure - Accrued Expenses</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureAccruedExpenses</Role>
      <ShortName>Accrued Expenses</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="eq-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>100160 - Disclosure - Partnerships</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://equilliumbio.com/20221231/taxonomy/role/DisclosurePartnerships</Role>
      <ShortName>Partnerships</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="eq-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>100170 - Disclosure - Notes Payable</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureNotesPayable</Role>
      <ShortName>Notes Payable</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="eq-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>100180 - Disclosure - Stockholders??? Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquity</Role>
      <ShortName>Stockholders??? Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="eq-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>100190 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="eq-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>100200 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="eq-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>100210 - Disclosure - Retirement Plan</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureRetirementPlan</Role>
      <ShortName>Retirement Plan</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="eq-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>100220 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureSubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="eq-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>100230 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureOrganizationAndAccountingPronouncements</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="eq-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>100240 - Disclosure - Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesTables</Role>
      <ShortName>Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="eq-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>100250 - Disclosure - Fair Value of Financial Instruments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsTables</Role>
      <ShortName>Fair Value of Financial Instruments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstruments</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="eq-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>100260 - Disclosure - Short-Term Investments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureShortTermInvestmentsTables</Role>
      <ShortName>Short-Term Investments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureShortTermInvestments</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="eq-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>100270 - Disclosure - Property and Equipment (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosurePropertyAndEquipmentTables</Role>
      <ShortName>Property and Equipment (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosurePropertyAndEquipment</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="eq-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>100280 - Disclosure - Acquisition (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://equilliumbio.com/20221231/taxonomy/role/DisclosureAcquisitionTables</Role>
      <ShortName>Acquisition (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://equilliumbio.com/20221231/taxonomy/role/DisclosureAcquisition</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="eq-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>100290 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://equilliumbio.com/20221231/taxonomy/role/DisclosureLeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://equilliumbio.com/20221231/taxonomy/role/DisclosureLeases3</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="eq-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>100300 - Disclosure - Accrued Expenses (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureAccruedExpensesTables</Role>
      <ShortName>Accrued Expenses (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureAccruedExpenses</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="eq-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>100310 - Disclosure - Notes Payable (Tables)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureNotesPayableTables</Role>
      <ShortName>Notes Payable (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureNotesPayable</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="eq-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>100320 - Disclosure - Stockholders' Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquityTables</Role>
      <ShortName>Stockholders' Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="eq-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>100330 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxes</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="eq-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>100340 - Disclosure - Organization and Accounting Pronouncements - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://equilliumbio.com/20221231/taxonomy/role/DisclosureOrganizationAndAccountingPronouncementsAdditionalInformationDetails3</Role>
      <ShortName>Organization and Accounting Pronouncements - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="eq-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>100350 - Disclosure - Organization and Accounting Pronouncements - Additional Information (Details1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://equilliumbio.com/20221231/taxonomy/role/DisclosureOrganizationAndAccountingPronouncementsAdditionalInformationDetails1</Role>
      <ShortName>Organization and Accounting Pronouncements - Additional Information (Details1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="eq-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>100360 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="eq-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>100370 - Disclosure - Summary of Significant Accounting Policies - Summary of Potentially Dilutive Securities Not Included in Calculation of Diluted Net Loss Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfPotentiallyDilutiveSecuritiesNotIncludedInCalculationOfDilutedNetLossPerShareDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Summary of Potentially Dilutive Securities Not Included in Calculation of Diluted Net Loss Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="eq-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>100380 - Disclosure - Fair Value of Financial Instruments - Summary of Assets that Require Fair Value Measurements on Recurring Basis and Their Respective Input Levels Based on Fair Value Hierarchy (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfAssetsThatRequireFairValueMeasurementsOnRecurringBasisAndTheirRespectiveInputLevelsBasedOnFairValueHierarchyDetails</Role>
      <ShortName>Fair Value of Financial Instruments - Summary of Assets that Require Fair Value Measurements on Recurring Basis and Their Respective Input Levels Based on Fair Value Hierarchy (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="eq-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>100390 - Disclosure - Fair Value of Financial Instruments - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetails</Role>
      <ShortName>Fair Value of Financial Instruments - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="eq-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>100400 - Disclosure - Short-Term Investments - Schedule of Company's Short-Term Investments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureShortTermInvestmentsScheduleOfCompanySShortTermInvestmentsDetails</Role>
      <ShortName>Short-Term Investments - Schedule of Company's Short-Term Investments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="eq-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>100410 - Disclosure - Short-Term Investments - Additional information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureShortTermInvestmentsAdditionalInformationDetails</Role>
      <ShortName>Short-Term Investments - Additional information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="eq-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>100420 - Disclosure - Property and Equipment - Schedule of Property and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosurePropertyAndEquipmentScheduleOfPropertyAndEquipmentDetails</Role>
      <ShortName>Property and Equipment - Schedule of Property and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="eq-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>100430 - Disclosure - Property and Equipment - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosurePropertyAndEquipmentAdditionalInformationDetails</Role>
      <ShortName>Property and Equipment - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="eq-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>100440 - Disclosure - Acquisition - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://equilliumbio.com/20221231/taxonomy/role/DisclosureAcquisitionAdditionalInformationDetails</Role>
      <ShortName>Acquisition - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="eq-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>100450 - Disclosure - Acquisition - Summary of Purchase Price Allocation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://equilliumbio.com/20221231/taxonomy/role/DisclosureAcquisitionSummaryOfPurchasePriceAllocationDetails</Role>
      <ShortName>Acquisition - Summary of Purchase Price Allocation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="eq-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>100460 - Disclosure - Leases - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://equilliumbio.com/20221231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails</Role>
      <ShortName>Leases - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="eq-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>100470 - Disclosure - Leases - Summary of Additional Information Related to Leases (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://equilliumbio.com/20221231/taxonomy/role/DisclosureLeasesSummaryOfAdditionalInformationRelatedToLeasesDetails</Role>
      <ShortName>Leases - Summary of Additional Information Related to Leases (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="eq-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>100480 - Disclosure - Leases - Schedule of Maturities of Lease Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://equilliumbio.com/20221231/taxonomy/role/DisclosureLeasesScheduleOfMaturitiesOfLeaseLiabilitiesDetails</Role>
      <ShortName>Leases - Schedule of Maturities of Lease Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="eq-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>100490 - Disclosure - Accrued Expenses - Schedule of Accrued Expenses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails</Role>
      <ShortName>Accrued Expenses - Schedule of Accrued Expenses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="eq-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>100500 - Disclosure - Partnerships - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://equilliumbio.com/20221231/taxonomy/role/DisclosurePartnershipsAdditionalInformationDetails</Role>
      <ShortName>Partnerships - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="eq-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>100510 - Disclosure - Notes Payable - Additional Information (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureNotesPayableAdditionalInformationDetails</Role>
      <ShortName>Notes Payable - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="eq-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>100520 - Disclosure - Notes Payable - Schedule of Aggregate Carrying Amounts of Term Loan (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://equilliumbio.com/20221231/taxonomy/role/DisclosureNotesPayableScheduleOfAggregateCarryingAmountsOfTermLoanDetails</Role>
      <ShortName>Notes Payable - Schedule of Aggregate Carrying Amounts of Term Loan (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="eq-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>100530 - Disclosure - Notes Payable - Schedule Future Maturities of Term Loan, Including Final Payment Fee (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://equilliumbio.com/20221231/taxonomy/role/DisclosureNotesPayableScheduleFutureMaturitiesOfTermLoanIncludingFinalPaymentFeeDetails</Role>
      <ShortName>Notes Payable - Schedule Future Maturities of Term Loan, Including Final Payment Fee (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="eq-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>100540 - Disclosure - Stockholders' Equity - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetails</Role>
      <ShortName>Stockholders' Equity - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="eq-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>100550 - Disclosure - Stockholders' Equity - Summary of Stock Option Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquitySummaryOfStockOptionActivityDetails</Role>
      <ShortName>Stockholders' Equity - Summary of Stock Option Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="eq-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>100560 - Disclosure - Stockholders' Equity - Summary of Stock Option Activity (Parenthetical) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquitySummaryOfStockOptionActivityParentheticalDetails</Role>
      <ShortName>Stockholders' Equity - Summary of Stock Option Activity (Parenthetical) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="eq-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>100570 - Disclosure - Stockholders' Equity - Summary of Total Non-cash Stock-based Compensation Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquitySummaryOfTotalNonCashStockBasedCompensationExpenseDetails</Role>
      <ShortName>Stockholders' Equity - Summary of Total Non-cash Stock-based Compensation Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="eq-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>100580 - Disclosure - Stockholders' Equity - Summary of Weighted-Average Assumptions Used to Determine Fair Value of Stock Option Grants (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquitySummaryOfWeightedAverageAssumptionsUsedToDetermineFairValueOfStockOptionGrantsDetails</Role>
      <ShortName>Stockholders' Equity - Summary of Weighted-Average Assumptions Used to Determine Fair Value of Stock Option Grants (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="eq-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>100590 - Disclosure - Stockholders' Equity - Summary of Common Stock Reserved for Future Issuance (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquitySummaryOfCommonStockReservedForFutureIssuanceDetails</Role>
      <ShortName>Stockholders' Equity - Summary of Common Stock Reserved for Future Issuance (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="eq-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>100600 - Disclosure - Commitments and Contingencies - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails</Role>
      <ShortName>Commitments and Contingencies - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="eq-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>100610 - Disclosure - Income Taxes - Summary of Components of Loss Before Income Tax Provision (Benefit) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfComponentsOfLossBeforeIncomeTaxProvisionBenefitDetails</Role>
      <ShortName>Income Taxes - Summary of Components of Loss Before Income Tax Provision (Benefit) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="eq-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>100620 - Disclosure - Income Taxes - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails</Role>
      <ShortName>Income Taxes - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="eq-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>100630 - Disclosure - Income Taxes - Reconciliation of Expected Statutory Federal Income Tax Provision to Actual Income Tax Provision (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesReconciliationOfExpectedStatutoryFederalIncomeTaxProvisionToActualIncomeTaxProvisionDetails</Role>
      <ShortName>Income Taxes - Reconciliation of Expected Statutory Federal Income Tax Provision to Actual Income Tax Provision (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="eq-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>100640 - Disclosure - Income Taxes - Summary of Net Deferred Tax Assets and Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfNetDeferredTaxAssetsAndLiabilitiesDetails</Role>
      <ShortName>Income Taxes - Summary of Net Deferred Tax Assets and Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="eq-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>100650 - Disclosure - Income Taxes - Summary of Reconciliation of Unrecognized Tax Benefits (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfReconciliationOfUnrecognizedTaxBenefitsDetails</Role>
      <ShortName>Income Taxes - Summary of Reconciliation of Unrecognized Tax Benefits (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="eq-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>100660 - Disclosure - Retirement Plan - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureRetirementPlanAdditionalInformationDetails</Role>
      <ShortName>Retirement Plan - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="eq-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>100670 - Disclosure - Subsequent Events - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureSubsequentEventsAdditionalInformationDetails</Role>
      <ShortName>Subsequent Events - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[dq-0542-Deprecated-Concept] Concept ResearchAndDevelopmentInProcess in us-gaap/2022 used in 1 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. eq-20221231.htm 4608</Log>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 1 fact(s) appearing in ix:hidden were eligible for transformation: us-gaap:PropertyPlantAndEquipmentUsefulLife -  eq-20221231.htm 8</Log>
  </Logs>
  <InputFiles>
    <File doctype="10-K" original="eq-20221231.htm">eq-20221231.htm</File>
    <File>eq-20221231.xsd</File>
    <File>eq-20221231_cal.xml</File>
    <File>eq-20221231_def.xml</File>
    <File>eq-20221231_lab.xml</File>
    <File>eq-20221231_pre.xml</File>
    <File>eq-ex10_29.htm</File>
    <File>eq-ex10_31.htm</File>
    <File>eq-ex21_1.htm</File>
    <File>eq-ex23_1.htm</File>
    <File>eq-ex31_1.htm</File>
    <File>eq-ex31_2.htm</File>
    <File>eq-ex32_1.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>img268224062_0.jpg</File>
    <File>img268224062_1.jpg</File>
    <File>img268224062_10.jpg</File>
    <File>img268224062_11.jpg</File>
    <File>img268224062_12.jpg</File>
    <File>img268224062_13.jpg</File>
    <File>img268224062_14.jpg</File>
    <File>img268224062_2.jpg</File>
    <File>img268224062_3.jpg</File>
    <File>img268224062_4.jpg</File>
    <File>img268224062_5.jpg</File>
    <File>img268224062_6.jpg</File>
    <File>img268224062_7.jpg</File>
    <File>img268224062_8.jpg</File>
    <File>img268224062_9.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="521">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="41">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>102
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "eq-20221231.htm": {
   "axisCustom": 0,
   "axisStandard": 28,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2022": 521,
    "http://xbrl.sec.gov/dei/2022": 41
   },
   "contextCount": 136,
   "dts": {
    "calculationLink": {
     "local": [
      "eq-20221231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "eq-20221231_def.xml"
     ]
    },
    "inline": {
     "local": [
      "eq-20221231.htm"
     ]
    },
    "labelLink": {
     "local": [
      "eq-20221231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "eq-20221231_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "eq-20221231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd",
      "https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd"
     ]
    }
   },
   "elementCount": 573,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2022": 5,
    "http://xbrl.sec.gov/dei/2022": 3,
    "total": 8
   },
   "keyCustom": 71,
   "keyStandard": 305,
   "memberCustom": 27,
   "memberStandard": 31,
   "nsprefix": "eq",
   "nsuri": "http://equilliumbio.com/20221231",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_7a916079-62c8-4cfb-b147-d4a52b2078f5",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document and Entity Information",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://equilliumbio.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_7a916079-62c8-4cfb-b147-d4a52b2078f5",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_7a916079-62c8-4cfb-b147-d4a52b2078f5",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "eq:ShortTermInvestmentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100110 - Disclosure - Short-Term Investments",
     "menuCat": "Notes",
     "order": "10",
     "role": "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureShortTermInvestments",
     "shortName": "Short-Term Investments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_7a916079-62c8-4cfb-b147-d4a52b2078f5",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "eq:ShortTermInvestmentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_7a916079-62c8-4cfb-b147-d4a52b2078f5",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100120 - Disclosure - Property and Equipment",
     "menuCat": "Notes",
     "order": "11",
     "role": "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosurePropertyAndEquipment",
     "shortName": "Property and Equipment",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_7a916079-62c8-4cfb-b147-d4a52b2078f5",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_7a916079-62c8-4cfb-b147-d4a52b2078f5",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100130 - Disclosure - Acquisition",
     "menuCat": "Notes",
     "order": "12",
     "role": "http://equilliumbio.com/20221231/taxonomy/role/DisclosureAcquisition",
     "shortName": "Acquisition",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_7a916079-62c8-4cfb-b147-d4a52b2078f5",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_7a916079-62c8-4cfb-b147-d4a52b2078f5",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100140 - Disclosure - Leases",
     "menuCat": "Notes",
     "order": "13",
     "role": "http://equilliumbio.com/20221231/taxonomy/role/DisclosureLeases3",
     "shortName": "Leases",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_7a916079-62c8-4cfb-b147-d4a52b2078f5",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_7a916079-62c8-4cfb-b147-d4a52b2078f5",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100150 - Disclosure - Accrued Expenses",
     "menuCat": "Notes",
     "order": "14",
     "role": "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureAccruedExpenses",
     "shortName": "Accrued Expenses",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_7a916079-62c8-4cfb-b147-d4a52b2078f5",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_7a916079-62c8-4cfb-b147-d4a52b2078f5",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CollaborativeArrangementDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100160 - Disclosure - Partnerships",
     "menuCat": "Notes",
     "order": "15",
     "role": "http://equilliumbio.com/20221231/taxonomy/role/DisclosurePartnerships",
     "shortName": "Partnerships",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_7a916079-62c8-4cfb-b147-d4a52b2078f5",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CollaborativeArrangementDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_7a916079-62c8-4cfb-b147-d4a52b2078f5",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MortgageNotesPayableDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100170 - Disclosure - Notes Payable",
     "menuCat": "Notes",
     "order": "16",
     "role": "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureNotesPayable",
     "shortName": "Notes Payable",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_7a916079-62c8-4cfb-b147-d4a52b2078f5",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MortgageNotesPayableDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_7a916079-62c8-4cfb-b147-d4a52b2078f5",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100180 - Disclosure - Stockholders\u2019 Equity",
     "menuCat": "Notes",
     "order": "17",
     "role": "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquity",
     "shortName": "Stockholders\u2019 Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_7a916079-62c8-4cfb-b147-d4a52b2078f5",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_7a916079-62c8-4cfb-b147-d4a52b2078f5",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100190 - Disclosure - Commitments and Contingencies",
     "menuCat": "Notes",
     "order": "18",
     "role": "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingencies",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_7a916079-62c8-4cfb-b147-d4a52b2078f5",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_7a916079-62c8-4cfb-b147-d4a52b2078f5",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100200 - Disclosure - Income Taxes",
     "menuCat": "Notes",
     "order": "19",
     "role": "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_7a916079-62c8-4cfb-b147-d4a52b2078f5",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_0a2a2736-708e-4c3e-8299-f827f8de0192",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100010 - Statement - Consolidated Balance Sheets",
     "menuCat": "Statements",
     "order": "2",
     "role": "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets",
     "shortName": "Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_0a2a2736-708e-4c3e-8299-f827f8de0192",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_7a916079-62c8-4cfb-b147-d4a52b2078f5",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100210 - Disclosure - Retirement Plan",
     "menuCat": "Notes",
     "order": "20",
     "role": "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureRetirementPlan",
     "shortName": "Retirement Plan",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_7a916079-62c8-4cfb-b147-d4a52b2078f5",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_7a916079-62c8-4cfb-b147-d4a52b2078f5",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100220 - Disclosure - Subsequent Events",
     "menuCat": "Notes",
     "order": "21",
     "role": "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureSubsequentEvents",
     "shortName": "Subsequent Events",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_7a916079-62c8-4cfb-b147-d4a52b2078f5",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_7a916079-62c8-4cfb-b147-d4a52b2078f5",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100230 - Disclosure - Summary of Significant Accounting Policies (Policies)",
     "menuCat": "Policies",
     "order": "22",
     "role": "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies",
     "shortName": "Summary of Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_7a916079-62c8-4cfb-b147-d4a52b2078f5",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_7a916079-62c8-4cfb-b147-d4a52b2078f5",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100240 - Disclosure - Summary of Significant Accounting Policies (Tables)",
     "menuCat": "Tables",
     "order": "23",
     "role": "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesTables",
     "shortName": "Summary of Significant Accounting Policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_7a916079-62c8-4cfb-b147-d4a52b2078f5",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_7a916079-62c8-4cfb-b147-d4a52b2078f5",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100250 - Disclosure - Fair Value of Financial Instruments (Tables)",
     "menuCat": "Tables",
     "order": "24",
     "role": "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsTables",
     "shortName": "Fair Value of Financial Instruments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_7a916079-62c8-4cfb-b147-d4a52b2078f5",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "eq:ShortTermInvestmentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_7a916079-62c8-4cfb-b147-d4a52b2078f5",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100260 - Disclosure - Short-Term Investments (Tables)",
     "menuCat": "Tables",
     "order": "25",
     "role": "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureShortTermInvestmentsTables",
     "shortName": "Short-Term Investments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "eq:ShortTermInvestmentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_7a916079-62c8-4cfb-b147-d4a52b2078f5",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_7a916079-62c8-4cfb-b147-d4a52b2078f5",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100270 - Disclosure - Property and Equipment (Tables)",
     "menuCat": "Tables",
     "order": "26",
     "role": "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosurePropertyAndEquipmentTables",
     "shortName": "Property and Equipment (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_7a916079-62c8-4cfb-b147-d4a52b2078f5",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_7a916079-62c8-4cfb-b147-d4a52b2078f5",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100280 - Disclosure - Acquisition (Tables)",
     "menuCat": "Tables",
     "order": "27",
     "role": "http://equilliumbio.com/20221231/taxonomy/role/DisclosureAcquisitionTables",
     "shortName": "Acquisition (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_7a916079-62c8-4cfb-b147-d4a52b2078f5",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_7a916079-62c8-4cfb-b147-d4a52b2078f5",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "eq:SummaryOfAdditionalInformationRelatedToLeasesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100290 - Disclosure - Leases (Tables)",
     "menuCat": "Tables",
     "order": "28",
     "role": "http://equilliumbio.com/20221231/taxonomy/role/DisclosureLeasesTables",
     "shortName": "Leases (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_7a916079-62c8-4cfb-b147-d4a52b2078f5",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "eq:SummaryOfAdditionalInformationRelatedToLeasesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_7a916079-62c8-4cfb-b147-d4a52b2078f5",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100300 - Disclosure - Accrued Expenses (Tables)",
     "menuCat": "Tables",
     "order": "29",
     "role": "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureAccruedExpensesTables",
     "shortName": "Accrued Expenses (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_7a916079-62c8-4cfb-b147-d4a52b2078f5",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_0a2a2736-708e-4c3e-8299-f827f8de0192",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unitRef": "U_USDollarShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100040 - Statement - Consolidated Balance Sheets (Parenthetical)",
     "menuCat": "Statements",
     "order": "3",
     "role": "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical",
     "shortName": "Consolidated Balance Sheets (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_0a2a2736-708e-4c3e-8299-f827f8de0192",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:CommonStockSharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_shares",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:MortgageNotesPayableDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_7a916079-62c8-4cfb-b147-d4a52b2078f5",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100310 - Disclosure - Notes Payable (Tables)",
     "menuCat": "Tables",
     "order": "30",
     "role": "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureNotesPayableTables",
     "shortName": "Notes Payable (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:MortgageNotesPayableDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_7a916079-62c8-4cfb-b147-d4a52b2078f5",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_7a916079-62c8-4cfb-b147-d4a52b2078f5",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100320 - Disclosure - Stockholders' Equity (Tables)",
     "menuCat": "Tables",
     "order": "31",
     "role": "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquityTables",
     "shortName": "Stockholders' Equity (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_7a916079-62c8-4cfb-b147-d4a52b2078f5",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_7a916079-62c8-4cfb-b147-d4a52b2078f5",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100330 - Disclosure - Income Taxes (Tables)",
     "menuCat": "Tables",
     "order": "32",
     "role": "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesTables",
     "shortName": "Income Taxes (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_7a916079-62c8-4cfb-b147-d4a52b2078f5",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_7a916079-62c8-4cfb-b147-d4a52b2078f5",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityIncorporationStateCountryCode",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100340 - Disclosure - Organization and Accounting Pronouncements - Additional Information (Details)",
     "menuCat": "Details",
     "order": "33",
     "role": "http://equilliumbio.com/20221231/taxonomy/role/DisclosureOrganizationAndAccountingPronouncementsAdditionalInformationDetails3",
     "shortName": "Organization and Accounting Pronouncements - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_7a916079-62c8-4cfb-b147-d4a52b2078f5",
      "decimals": null,
      "lang": "en-US",
      "name": "dei:EntityIncorporationDateOfIncorporation",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock",
       "div",
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_69239b5b-2176-4437-a3e8-98a7b914e359",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100350 - Disclosure - Organization and Accounting Pronouncements - Additional Information (Details1)",
     "menuCat": "Details",
     "order": "34",
     "role": "http://equilliumbio.com/20221231/taxonomy/role/DisclosureOrganizationAndAccountingPronouncementsAdditionalInformationDetails1",
     "shortName": "Organization and Accounting Pronouncements - Additional Information (Details1)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock",
       "div",
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_69239b5b-2176-4437-a3e8-98a7b914e359",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:AllowanceForDoubtfulAccountsReceivable",
       "span",
       "p",
       "us-gaap:ReceivablesPolicyTextBlock",
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_0a2a2736-708e-4c3e-8299-f827f8de0192",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100360 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Details)",
     "menuCat": "Details",
     "order": "35",
     "role": "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails",
     "shortName": "Summary of Significant Accounting Policies - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:AllowanceForDoubtfulAccountsReceivable",
       "span",
       "p",
       "us-gaap:ReceivablesPolicyTextBlock",
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_0a2a2736-708e-4c3e-8299-f827f8de0192",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "div",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_7a916079-62c8-4cfb-b147-d4a52b2078f5",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100370 - Disclosure - Summary of Significant Accounting Policies - Summary of Potentially Dilutive Securities Not Included in Calculation of Diluted Net Loss Per Share (Details)",
     "menuCat": "Details",
     "order": "36",
     "role": "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfPotentiallyDilutiveSecuritiesNotIncludedInCalculationOfDilutedNetLossPerShareDetails",
     "shortName": "Summary of Significant Accounting Policies - Summary of Potentially Dilutive Securities Not Included in Calculation of Diluted Net Loss Per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "div",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_7a916079-62c8-4cfb-b147-d4a52b2078f5",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_shares",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
       "div",
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_0a2a2736-708e-4c3e-8299-f827f8de0192",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:InvestmentsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100380 - Disclosure - Fair Value of Financial Instruments - Summary of Assets that Require Fair Value Measurements on Recurring Basis and Their Respective Input Levels Based on Fair Value Hierarchy (Details)",
     "menuCat": "Details",
     "order": "37",
     "role": "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfAssetsThatRequireFairValueMeasurementsOnRecurringBasisAndTheirRespectiveInputLevelsBasedOnFairValueHierarchyDetails",
     "shortName": "Fair Value of Financial Instruments - Summary of Assets that Require Fair Value Measurements on Recurring Basis and Their Respective Input Levels Based on Fair Value Hierarchy (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
       "div",
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_0a2a2736-708e-4c3e-8299-f827f8de0192",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:InvestmentsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_0a2a2736-708e-4c3e-8299-f827f8de0192",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:NotesPayable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100390 - Disclosure - Fair Value of Financial Instruments - Additional Information (Details)",
     "menuCat": "Details",
     "order": "38",
     "role": "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetails",
     "shortName": "Fair Value of Financial Instruments - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_0a2a2736-708e-4c3e-8299-f827f8de0192",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:NotesPayable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock",
       "div",
       "eq:ShortTermInvestmentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_0a2a2736-708e-4c3e-8299-f827f8de0192",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100400 - Disclosure - Short-Term Investments - Schedule of Company's Short-Term Investments (Details)",
     "menuCat": "Details",
     "order": "39",
     "role": "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureShortTermInvestmentsScheduleOfCompanySShortTermInvestmentsDetails",
     "shortName": "Short-Term Investments - Schedule of Company's Short-Term Investments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock",
       "div",
       "eq:ShortTermInvestmentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_0a2a2736-708e-4c3e-8299-f827f8de0192",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_7a916079-62c8-4cfb-b147-d4a52b2078f5",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100050 - Statement - Consolidated Statements of Operations and Comprehensive Loss",
     "menuCat": "Statements",
     "order": "4",
     "role": "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss",
     "shortName": "Consolidated Statements of Operations and Comprehensive Loss",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_7a916079-62c8-4cfb-b147-d4a52b2078f5",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "eq:ShortTermInvestmentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_7a916079-62c8-4cfb-b147-d4a52b2078f5",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100410 - Disclosure - Short-Term Investments - Additional information (Details)",
     "menuCat": "Details",
     "order": "40",
     "role": "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureShortTermInvestmentsAdditionalInformationDetails",
     "shortName": "Short-Term Investments - Additional information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "eq:ShortTermInvestmentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_7a916079-62c8-4cfb-b147-d4a52b2078f5",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "div",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_0a2a2736-708e-4c3e-8299-f827f8de0192",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100420 - Disclosure - Property and Equipment - Schedule of Property and Equipment (Details)",
     "menuCat": "Details",
     "order": "41",
     "role": "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosurePropertyAndEquipmentScheduleOfPropertyAndEquipmentDetails",
     "shortName": "Property and Equipment - Schedule of Property and Equipment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "div",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_0a2a2736-708e-4c3e-8299-f827f8de0192",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_7a916079-62c8-4cfb-b147-d4a52b2078f5",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100430 - Disclosure - Property and Equipment - Additional Information (Details)",
     "menuCat": "Details",
     "order": "42",
     "role": "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosurePropertyAndEquipmentAdditionalInformationDetails",
     "shortName": "Property and Equipment - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_7a916079-62c8-4cfb-b147-d4a52b2078f5",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_ffafa14c-b663-42ee-861b-6f858b3f4acf",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100440 - Disclosure - Acquisition - Additional Information (Details)",
     "menuCat": "Details",
     "order": "43",
     "role": "http://equilliumbio.com/20221231/taxonomy/role/DisclosureAcquisitionAdditionalInformationDetails",
     "shortName": "Acquisition - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_ffafa14c-b663-42ee-861b-6f858b3f4acf",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_shares",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock",
       "div",
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_9f870e6c-ab80-49c3-9591-da8f10d045b8",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100450 - Disclosure - Acquisition - Summary of Purchase Price Allocation (Details)",
     "menuCat": "Details",
     "order": "44",
     "role": "http://equilliumbio.com/20221231/taxonomy/role/DisclosureAcquisitionSummaryOfPurchasePriceAllocationDetails",
     "shortName": "Acquisition - Summary of Purchase Price Allocation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock",
       "div",
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_9f870e6c-ab80-49c3-9591-da8f10d045b8",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_7a916079-62c8-4cfb-b147-d4a52b2078f5",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeaseExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100460 - Disclosure - Leases - Additional Information (Details)",
     "menuCat": "Details",
     "order": "45",
     "role": "http://equilliumbio.com/20221231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails",
     "shortName": "Leases - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_7a916079-62c8-4cfb-b147-d4a52b2078f5",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeaseExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_0a2a2736-708e-4c3e-8299-f827f8de0192",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100470 - Disclosure - Leases - Summary of Additional Information Related to Leases (Details)",
     "menuCat": "Details",
     "order": "46",
     "role": "http://equilliumbio.com/20221231/taxonomy/role/DisclosureLeasesSummaryOfAdditionalInformationRelatedToLeasesDetails",
     "shortName": "Leases - Summary of Additional Information Related to Leases (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "eq:SummaryOfAdditionalInformationRelatedToLeasesTableTextBlock",
       "div",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_0a2a2736-708e-4c3e-8299-f827f8de0192",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "div",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_0a2a2736-708e-4c3e-8299-f827f8de0192",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100480 - Disclosure - Leases - Schedule of Maturities of Lease Liabilities (Details)",
     "menuCat": "Details",
     "order": "47",
     "role": "http://equilliumbio.com/20221231/taxonomy/role/DisclosureLeasesScheduleOfMaturitiesOfLeaseLiabilitiesDetails",
     "shortName": "Leases - Schedule of Maturities of Lease Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "div",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_0a2a2736-708e-4c3e-8299-f827f8de0192",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "div",
       "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_0a2a2736-708e-4c3e-8299-f827f8de0192",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100490 - Disclosure - Accrued Expenses - Schedule of Accrued Expenses (Details)",
     "menuCat": "Details",
     "order": "48",
     "role": "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails",
     "shortName": "Accrued Expenses - Schedule of Accrued Expenses (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "div",
       "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_0a2a2736-708e-4c3e-8299-f827f8de0192",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_0a2a2736-708e-4c3e-8299-f827f8de0192",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredRevenueCurrent",
      "reportCount": 1,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100500 - Disclosure - Partnerships - Additional Information (Details)",
     "menuCat": "Details",
     "order": "49",
     "role": "http://equilliumbio.com/20221231/taxonomy/role/DisclosurePartnershipsAdditionalInformationDetails",
     "shortName": "Partnerships - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:CollaborativeArrangementDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_257b0705-b56f-4bd5-86f9-1add29602d4d",
      "decimals": "-5",
      "lang": null,
      "name": "eq:UpfrontNonRefundableAndNonCreditablePaymentReceivableUponExchangeOfOption",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_593cac69-ae06-423d-93b0-db39a502796a",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100060 - Statement - Consolidated Statements of Stockholders' Equity",
     "menuCat": "Statements",
     "order": "5",
     "role": "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity",
     "shortName": "Consolidated Statements of Stockholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_593cac69-ae06-423d-93b0-db39a502796a",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:MortgageNotesPayableDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_0b4db976-5656-4c9e-a811-53098826741a",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LineOfCreditFacilityExpirationDate1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100510 - Disclosure - Notes Payable - Additional Information (Details)",
     "menuCat": "Details",
     "order": "50",
     "role": "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureNotesPayableAdditionalInformationDetails",
     "shortName": "Notes Payable - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:MortgageNotesPayableDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_0b4db976-5656-4c9e-a811-53098826741a",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LineOfCreditFacilityExpirationDate1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "div",
       "us-gaap:MortgageNotesPayableDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_0a2a2736-708e-4c3e-8299-f827f8de0192",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DebtInstrumentUnamortizedDiscount",
      "reportCount": 1,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100520 - Disclosure - Notes Payable - Schedule of Aggregate Carrying Amounts of Term Loan (Details)",
     "menuCat": "Details",
     "order": "51",
     "role": "http://equilliumbio.com/20221231/taxonomy/role/DisclosureNotesPayableScheduleOfAggregateCarryingAmountsOfTermLoanDetails",
     "shortName": "Notes Payable - Schedule of Aggregate Carrying Amounts of Term Loan (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock",
       "div",
       "us-gaap:MortgageNotesPayableDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_b41b6a74-0d46-45fe-8820-d94fa8d877f1",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "div",
       "us-gaap:MortgageNotesPayableDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_0a2a2736-708e-4c3e-8299-f827f8de0192",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "eq:DebtInstrumentCarryingAmountIncludingUnaccretedLiabilityForFinalPaymentFeeMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100530 - Disclosure - Notes Payable - Schedule Future Maturities of Term Loan, Including Final Payment Fee (Details)",
     "menuCat": "Details",
     "order": "52",
     "role": "http://equilliumbio.com/20221231/taxonomy/role/DisclosureNotesPayableScheduleFutureMaturitiesOfTermLoanIncludingFinalPaymentFeeDetails",
     "shortName": "Notes Payable - Schedule Future Maturities of Term Loan, Including Final Payment Fee (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "div",
       "us-gaap:MortgageNotesPayableDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_0a2a2736-708e-4c3e-8299-f827f8de0192",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "eq:DebtInstrumentCarryingAmountIncludingUnaccretedLiabilityForFinalPaymentFeeMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_0a2a2736-708e-4c3e-8299-f827f8de0192",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:CommonStockSharesAuthorized",
      "reportCount": 1,
      "unitRef": "U_shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100540 - Disclosure - Stockholders' Equity - Additional Information (Details)",
     "menuCat": "Details",
     "order": "53",
     "role": "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetails",
     "shortName": "Stockholders' Equity - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_7a916079-62c8-4cfb-b147-d4a52b2078f5",
      "decimals": "-6",
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "div",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_9c160bc4-2896-4f45-abda-cba01dca2910",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100550 - Disclosure - Stockholders' Equity - Summary of Stock Option Activity (Details)",
     "menuCat": "Details",
     "order": "54",
     "role": "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquitySummaryOfStockOptionActivityDetails",
     "shortName": "Stockholders' Equity - Summary of Stock Option Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "div",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_9c160bc4-2896-4f45-abda-cba01dca2910",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_shares",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "div",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_cba59bb2-f211-4a75-beff-6ddac7dfa0b7",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "us-gaap:SharePrice",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USDollarShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100560 - Disclosure - Stockholders' Equity - Summary of Stock Option Activity (Parenthetical) (Details)",
     "menuCat": "Details",
     "order": "55",
     "role": "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquitySummaryOfStockOptionActivityParentheticalDetails",
     "shortName": "Stockholders' Equity - Summary of Stock Option Activity (Parenthetical) (Details)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "div",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_cba59bb2-f211-4a75-beff-6ddac7dfa0b7",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "us-gaap:SharePrice",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USDollarShare",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "div",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_7a916079-62c8-4cfb-b147-d4a52b2078f5",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100570 - Disclosure - Stockholders' Equity - Summary of Total Non-cash Stock-based Compensation Expense (Details)",
     "menuCat": "Details",
     "order": "56",
     "role": "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquitySummaryOfTotalNonCashStockBasedCompensationExpenseDetails",
     "shortName": "Stockholders' Equity - Summary of Total Non-cash Stock-based Compensation Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "div",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_7a916079-62c8-4cfb-b147-d4a52b2078f5",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "div",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_7a916079-62c8-4cfb-b147-d4a52b2078f5",
      "decimals": "4",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100580 - Disclosure - Stockholders' Equity - Summary of Weighted-Average Assumptions Used to Determine Fair Value of Stock Option Grants (Details)",
     "menuCat": "Details",
     "order": "57",
     "role": "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquitySummaryOfWeightedAverageAssumptionsUsedToDetermineFairValueOfStockOptionGrantsDetails",
     "shortName": "Stockholders' Equity - Summary of Weighted-Average Assumptions Used to Determine Fair Value of Stock Option Grants (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "div",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_7a916079-62c8-4cfb-b147-d4a52b2078f5",
      "decimals": "4",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_pure",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "eq:CommonStockReservedForFutureIssuanceTableTextBlock",
       "div",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_0a2a2736-708e-4c3e-8299-f827f8de0192",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance",
      "reportCount": 1,
      "unitRef": "U_shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100590 - Disclosure - Stockholders' Equity - Summary of Common Stock Reserved for Future Issuance (Details)",
     "menuCat": "Details",
     "order": "58",
     "role": "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquitySummaryOfCommonStockReservedForFutureIssuanceDetails",
     "shortName": "Stockholders' Equity - Summary of Common Stock Reserved for Future Issuance (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "eq:CommonStockReservedForFutureIssuanceTableTextBlock",
       "div",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_c197641e-f183-4f80-9bfd-23288c4df7df",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_shares",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_7a916079-62c8-4cfb-b147-d4a52b2078f5",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:LitigationSettlementExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100600 - Disclosure - Commitments and Contingencies - Additional Information (Details)",
     "menuCat": "Details",
     "order": "59",
     "role": "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails",
     "shortName": "Commitments and Contingencies - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_7a916079-62c8-4cfb-b147-d4a52b2078f5",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:LitigationSettlementExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_7a916079-62c8-4cfb-b147-d4a52b2078f5",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100070 - Statement - Consolidated Statements of Cash Flows",
     "menuCat": "Statements",
     "order": "6",
     "role": "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows",
     "shortName": "Consolidated Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_7a916079-62c8-4cfb-b147-d4a52b2078f5",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_7a916079-62c8-4cfb-b147-d4a52b2078f5",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100610 - Disclosure - Income Taxes - Summary of Components of Loss Before Income Tax Provision (Benefit) (Details)",
     "menuCat": "Details",
     "order": "60",
     "role": "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfComponentsOfLossBeforeIncomeTaxProvisionBenefitDetails",
     "shortName": "Income Taxes - Summary of Components of Loss Before Income Tax Provision (Benefit) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_7a916079-62c8-4cfb-b147-d4a52b2078f5",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_7a916079-62c8-4cfb-b147-d4a52b2078f5",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:CurrentIncomeTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100620 - Disclosure - Income Taxes - Additional Information (Details)",
     "menuCat": "Details",
     "order": "61",
     "role": "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails",
     "shortName": "Income Taxes - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_7a916079-62c8-4cfb-b147-d4a52b2078f5",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:CurrentIncomeTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "eq:SummaryOfReconciliationOfExpectedStatutoryFederalIncomeTaxProvisionToActualIncomeTaxProvisionTableTextBlock",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_7a916079-62c8-4cfb-b147-d4a52b2078f5",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100630 - Disclosure - Income Taxes - Reconciliation of Expected Statutory Federal Income Tax Provision to Actual Income Tax Provision (Details)",
     "menuCat": "Details",
     "order": "62",
     "role": "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesReconciliationOfExpectedStatutoryFederalIncomeTaxProvisionToActualIncomeTaxProvisionDetails",
     "shortName": "Income Taxes - Reconciliation of Expected Statutory Federal Income Tax Provision to Actual Income Tax Provision (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "eq:SummaryOfReconciliationOfExpectedStatutoryFederalIncomeTaxProvisionToActualIncomeTaxProvisionTableTextBlock",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_7a916079-62c8-4cfb-b147-d4a52b2078f5",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_0a2a2736-708e-4c3e-8299-f827f8de0192",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100640 - Disclosure - Income Taxes - Summary of Net Deferred Tax Assets and Liabilities (Details)",
     "menuCat": "Details",
     "order": "63",
     "role": "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfNetDeferredTaxAssetsAndLiabilitiesDetails",
     "shortName": "Income Taxes - Summary of Net Deferred Tax Assets and Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_0a2a2736-708e-4c3e-8299-f827f8de0192",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_565ac908-720e-4507-8d96-ab25dfe4fc94",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "reportCount": 1,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100650 - Disclosure - Income Taxes - Summary of Reconciliation of Unrecognized Tax Benefits (Details)",
     "menuCat": "Details",
     "order": "64",
     "role": "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfReconciliationOfUnrecognizedTaxBenefitsDetails",
     "shortName": "Income Taxes - Summary of Reconciliation of Unrecognized Tax Benefits (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_593cac69-ae06-423d-93b0-db39a502796a",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_7a916079-62c8-4cfb-b147-d4a52b2078f5",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100660 - Disclosure - Retirement Plan - Additional Information (Details)",
     "menuCat": "Details",
     "order": "65",
     "role": "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureRetirementPlanAdditionalInformationDetails",
     "shortName": "Retirement Plan - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_7a916079-62c8-4cfb-b147-d4a52b2078f5",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:SubsequentEventsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_1398193c-be70-4924-b7ab-8d837ee248c4",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:AssetsHeldInTrust",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100670 - Disclosure - Subsequent Events - Additional Information (Details)",
     "menuCat": "Details",
     "order": "66",
     "role": "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureSubsequentEventsAdditionalInformationDetails",
     "shortName": "Subsequent Events - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:SubsequentEventsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_1398193c-be70-4924-b7ab-8d837ee248c4",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:AssetsHeldInTrust",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_7a916079-62c8-4cfb-b147-d4a52b2078f5",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100080 - Disclosure - Organization and Accounting Pronouncements",
     "menuCat": "Notes",
     "order": "7",
     "role": "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureOrganizationAndAccountingPronouncements",
     "shortName": "Organization and Accounting Pronouncements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_7a916079-62c8-4cfb-b147-d4a52b2078f5",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_7a916079-62c8-4cfb-b147-d4a52b2078f5",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100090 - Disclosure - Summary of Significant Accounting Policies",
     "menuCat": "Notes",
     "order": "8",
     "role": "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies",
     "shortName": "Summary of Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_7a916079-62c8-4cfb-b147-d4a52b2078f5",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_7a916079-62c8-4cfb-b147-d4a52b2078f5",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100100 - Disclosure - Fair Value of Financial Instruments",
     "menuCat": "Notes",
     "order": "9",
     "role": "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstruments",
     "shortName": "Fair Value of Financial Instruments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "eq-20221231.htm",
      "contextRef": "C_7a916079-62c8-4cfb-b147-d4a52b2078f5",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 61,
   "tag": {
    "country_AU": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "AUSTRALIA",
        "terseLabel": "Australia"
       }
      }
     },
     "localname": "AU",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditorFirmId": {
     "auth_ref": [
      "r636",
      "r637",
      "r638"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PCAOB issued Audit Firm Identifier",
        "label": "Auditor Firm ID"
       }
      }
     },
     "localname": "AuditorFirmId",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "nonemptySequenceNumberItemType"
    },
    "dei_AuditorLocation": {
     "auth_ref": [
      "r636",
      "r637",
      "r638"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location"
       }
      }
     },
     "localname": "AuditorLocation",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_AuditorName": {
     "auth_ref": [
      "r636",
      "r637",
      "r638"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name"
       }
      }
     },
     "localname": "AuditorName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r636",
      "r637",
      "r638"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report",
        "terseLabel": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r639"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "verboseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r634"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]",
        "terseLabel": "Documents Incorporated by Reference"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r633"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r633"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r642"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Entity Ex Transition Period",
        "terseLabel": "Entity Ex Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Securities Act File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r633"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationDateOfIncorporation": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date when an entity was incorporated",
        "label": "Entity Incorporation, Date of Incorporation",
        "terseLabel": "Date of incorporation"
       }
      }
     },
     "localname": "EntityIncorporationDateOfIncorporation",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureOrganizationAndAccountingPronouncementsAdditionalInformationDetails3"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code",
        "verboseLabel": "State of incorporation"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureOrganizationAndAccountingPronouncementsAdditionalInformationDetails3",
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r640"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float",
        "terseLabel": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r633"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r633"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r633"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r633"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers",
        "terseLabel": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r641"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer",
        "terseLabel": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_IcfrAuditorAttestationFlag": {
     "auth_ref": [
      "r636",
      "r637",
      "r638"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag",
        "terseLabel": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "localname": "IcfrAuditorAttestationFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r632"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r635"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "eq_ATMMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "At-the-market offering.",
        "label": "A T M [Member]",
        "terseLabel": "ATM",
        "verboseLabel": "ATM Facility"
       }
      }
     },
     "localname": "ATMMember",
     "nsuri": "http://equilliumbio.com/20221231",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "eq_AccretedLiabilityForFinalPaymentFee": {
     "auth_ref": [],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureNotesPayableScheduleOfAggregateCarryingAmountsOfTermLoanDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accreted liability for final payment fee.",
        "label": "Accreted Liability For Final Payment Fee",
        "terseLabel": "Add: accreted liability for final payment fee"
       }
      }
     },
     "localname": "AccretedLiabilityForFinalPaymentFee",
     "nsuri": "http://equilliumbio.com/20221231",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureNotesPayableScheduleOfAggregateCarryingAmountsOfTermLoanDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "eq_AccruedClinicalDevelopment": {
     "auth_ref": [],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Clinical Development",
        "label": "Accrued Clinical Development",
        "terseLabel": "Clinical development"
       }
      }
     },
     "localname": "AccruedClinicalDevelopment",
     "nsuri": "http://equilliumbio.com/20221231",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "eq_AccruedNonClinicalResearch": {
     "auth_ref": [],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Non-clinical Research.",
        "label": "Accrued Non Clinical Research",
        "terseLabel": "Non-clinical research"
       }
      }
     },
     "localname": "AccruedNonClinicalResearch",
     "nsuri": "http://equilliumbio.com/20221231",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "eq_AccruedResearchAndDevelopmentExpensePolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued research and development expense policy.",
        "label": "Accrued Research And Development Expense Policy [Text Block]",
        "terseLabel": "Accrued Research and Development Expense"
       }
      }
     },
     "localname": "AccruedResearchAndDevelopmentExpensePolicyTextBlock",
     "nsuri": "http://equilliumbio.com/20221231",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "eq_AcquiredInProcessResearchAndDevelopment": {
     "auth_ref": [],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Acquired in-process research and development",
        "label": "Acquired in-Process Research and Development",
        "terseLabel": "Acquired in-process research and development"
       }
      }
     },
     "localname": "AcquiredInProcessResearchAndDevelopment",
     "nsuri": "http://equilliumbio.com/20221231",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "eq_AssetPurchaseAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset Purchase Agreement.",
        "label": "Asset Purchase Agreement [Member]",
        "terseLabel": "Asset Purchase Agreement"
       }
      }
     },
     "localname": "AssetPurchaseAgreementMember",
     "nsuri": "http://equilliumbio.com/20221231",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosurePartnershipsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "eq_AustralianResearchAndDevelopmentTaxIncentivePolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Australian research and development tax incentive policy.",
        "label": "Australian Research And Development Tax Incentive Policy [Text Block]",
        "terseLabel": "Australian Research and Development Tax Incentive"
       }
      }
     },
     "localname": "AustralianResearchAndDevelopmentTaxIncentivePolicyTextBlock",
     "nsuri": "http://equilliumbio.com/20221231",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "eq_AustralianResearchAndDevelopmentTaxIncentiveProgramMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Australian research and development tax incentive program.",
        "label": "Australian Research And Development Tax Incentive Program [Member]",
        "terseLabel": "Australian Research and Development Tax Incentive Program"
       }
      }
     },
     "localname": "AustralianResearchAndDevelopmentTaxIncentiveProgramMember",
     "nsuri": "http://equilliumbio.com/20221231",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "eq_AvailableForSaleSecuritiesDebtMaturitiesPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Available For Sale Securities Debt Maturities Period",
        "terseLabel": "Available for sale Securities debt maturities period"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesPeriod",
     "nsuri": "http://equilliumbio.com/20221231",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureShortTermInvestmentsAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "eq_AwardsAvailableUnder2018PlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Awards available under 2018 plan.",
        "label": "Awards Available Under2018 Plan [Member]",
        "terseLabel": "Awards Available Under 2018 Equity Incentive Plan"
       }
      }
     },
     "localname": "AwardsAvailableUnder2018PlanMember",
     "nsuri": "http://equilliumbio.com/20221231",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquitySummaryOfCommonStockReservedForFutureIssuanceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "eq_BioconMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Biocon.",
        "label": "Biocon [Member]",
        "terseLabel": "Biocon"
       }
      }
     },
     "localname": "BioconMember",
     "nsuri": "http://equilliumbio.com/20221231",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosurePartnershipsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "eq_BionizTherapeuticsIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bioniz therapeutics, inc.",
        "label": "Bioniz Therapeutics, Inc. [Member]",
        "terseLabel": "Bioniz"
       }
      }
     },
     "localname": "BionizTherapeuticsIncMember",
     "nsuri": "http://equilliumbio.com/20221231",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureAcquisitionAdditionalInformationDetails",
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureAcquisitionSummaryOfPurchasePriceAllocationDetails",
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows",
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "eq_BusinessCombinationAcquiredInProcessResearchAndDevelopment": {
     "auth_ref": [],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureAcquisitionSummaryOfPurchasePriceAllocationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business combination acquired in-Process research and development",
        "label": "Business Combination Acquired in Process Research and Development",
        "totalLabel": "Acquired in-process research and development"
       }
      }
     },
     "localname": "BusinessCombinationAcquiredInProcessResearchAndDevelopment",
     "nsuri": "http://equilliumbio.com/20221231",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureAcquisitionSummaryOfPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "eq_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureAcquisitionSummaryOfPurchasePriceAllocationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business combination recognized identifiable assets acquired and liabilities assumed current liabilities accrued expenses.",
        "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Accrued Expenses",
        "terseLabel": "Accrued expenses"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses",
     "nsuri": "http://equilliumbio.com/20221231",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureAcquisitionSummaryOfPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "eq_CertificatesOfDepositMaturingInOneYearOrLessMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Certificates of deposit maturing in one year or less.",
        "label": "Certificates Of Deposit Maturing In One Year Or Less [Member]",
        "terseLabel": "Certificates of Deposit Maturing in One Year or Less"
       }
      }
     },
     "localname": "CertificatesOfDepositMaturingInOneYearOrLessMember",
     "nsuri": "http://equilliumbio.com/20221231",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureShortTermInvestmentsScheduleOfCompanySShortTermInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "eq_CollaborationAndLicenseAgreementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaboration and license agreement.",
        "label": "Collaboration And License Agreement [Abstract]"
       }
      }
     },
     "localname": "CollaborationAndLicenseAgreementAbstract",
     "nsuri": "http://equilliumbio.com/20221231",
     "xbrltype": "stringItemType"
    },
    "eq_CommitmentsAndContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commitments and contingencies.",
        "label": "Commitments And Contingencies [Line Items]",
        "terseLabel": "Commitments and Contingencies [Line Items]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesLineItems",
     "nsuri": "http://equilliumbio.com/20221231",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "eq_CommitmentsAndContingenciesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commitments and contingencies.",
        "label": "Commitments And Contingencies [Table]",
        "terseLabel": "Commitments And Contingencies [Table]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesTable",
     "nsuri": "http://equilliumbio.com/20221231",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "eq_CommonStockReservedForFutureIssuanceTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common stock reserved for future issuance.",
        "label": "Common Stock Reserved For Future Issuance Table [Text Block]",
        "terseLabel": "Summary of Reserved Shares of Common Stock for Future Issuance"
       }
      }
     },
     "localname": "CommonStockReservedForFutureIssuanceTableTextBlock",
     "nsuri": "http://equilliumbio.com/20221231",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "eq_ContingentConsiderationForAchievementOfCommercializationEventsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contingent consideration for achievement of commercialization events.",
        "label": "Contingent Consideration For Achievement Of Commercialization Events [Member]",
        "terseLabel": "Achievement Of Commercialization Events"
       }
      }
     },
     "localname": "ContingentConsiderationForAchievementOfCommercializationEventsMember",
     "nsuri": "http://equilliumbio.com/20221231",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureAcquisitionAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "eq_ContingentConsiderationForAchievementOfRegulatoryEventsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contingent consideration for achievement of regulatory events.",
        "label": "Contingent Consideration For Achievement of Regulatory Events [Member]",
        "terseLabel": "Achievement of Regulatory Events"
       }
      }
     },
     "localname": "ContingentConsiderationForAchievementOfRegulatoryEventsMember",
     "nsuri": "http://equilliumbio.com/20221231",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureAcquisitionAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "eq_ContractAssetsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract assets policy.",
        "label": "Contract Assets Policy [Policy Text Block]",
        "terseLabel": "Contract Assets"
       }
      }
     },
     "localname": "ContractAssetsPolicyPolicyTextBlock",
     "nsuri": "http://equilliumbio.com/20221231",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "eq_ContractLiabilitiesPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract liabilities policy.",
        "label": "Contract Liabilities Policy [Policy Text Block]",
        "terseLabel": "Contract liabilities"
       }
      }
     },
     "localname": "ContractLiabilitiesPolicyPolicyTextBlock",
     "nsuri": "http://equilliumbio.com/20221231",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "eq_CumulativeChangeInOwnershipPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cumulative change in ownership percentage.",
        "label": "Cumulative Change In Ownership Percentage",
        "terseLabel": "Cumulative change in ownership percentage"
       }
      }
     },
     "localname": "CumulativeChangeInOwnershipPercentage",
     "nsuri": "http://equilliumbio.com/20221231",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "eq_CumulativeChangeInOwnershipPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cumulative change in ownership period.",
        "label": "Cumulative Change In Ownership Period",
        "terseLabel": "Cumulative change in ownership period"
       }
      }
     },
     "localname": "CumulativeChangeInOwnershipPeriod",
     "nsuri": "http://equilliumbio.com/20221231",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "eq_DebtInstrumentCarryingAmountIncludingUnaccretedLiabilityForFinalPaymentFee": {
     "auth_ref": [],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureNotesPayableScheduleFutureMaturitiesOfTermLoanIncludingFinalPaymentFeeDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt instrument carrying amount including unaccreted liability for final payment fee.",
        "label": "Debt Instrument Carrying Amount Including Unaccreted Liability For Final Payment Fee",
        "totalLabel": "Debt instrument carrying amount including unaccreted liability for final payment fee"
       }
      }
     },
     "localname": "DebtInstrumentCarryingAmountIncludingUnaccretedLiabilityForFinalPaymentFee",
     "nsuri": "http://equilliumbio.com/20221231",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureNotesPayableScheduleFutureMaturitiesOfTermLoanIncludingFinalPaymentFeeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "eq_DebtInstrumentCarryingAmountIncludingUnaccretedLiabilityForFinalPaymentFeeMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": {
     "auth_ref": [],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureNotesPayableScheduleFutureMaturitiesOfTermLoanIncludingFinalPaymentFeeDetails": {
       "order": 0.0,
       "parentTag": "eq_DebtInstrumentCarryingAmountIncludingUnaccretedLiabilityForFinalPaymentFee",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt instrument carrying amount including unaccreted liability for final payment fee maturities repayments of principal in next twelve months.",
        "label": "Debt Instrument Carrying Amount Including Unaccreted Liability For Final Payment Fee Maturities Repayments Of Principal In Next Twelve Months",
        "terseLabel": "Year ending December 31, 2023"
       }
      }
     },
     "localname": "DebtInstrumentCarryingAmountIncludingUnaccretedLiabilityForFinalPaymentFeeMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
     "nsuri": "http://equilliumbio.com/20221231",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureNotesPayableScheduleFutureMaturitiesOfTermLoanIncludingFinalPaymentFeeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "eq_DebtInstrumentCarryingAmountIncludingUnaccretedLiabilityForFinalPaymentFeeMaturitiesRepaymentsOfPrincipalInYearThree": {
     "auth_ref": [],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureNotesPayableScheduleFutureMaturitiesOfTermLoanIncludingFinalPaymentFeeDetails": {
       "order": 2.0,
       "parentTag": "eq_DebtInstrumentCarryingAmountIncludingUnaccretedLiabilityForFinalPaymentFee",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt instrument carrying amount including unaccreted liability for final payment fee maturities repayments of principal in year three.",
        "label": "Debt Instrument Carrying Amount Including Unaccreted Liability For Final Payment Fee Maturities Repayments Of Principal In Year Three",
        "terseLabel": "Year ending December 31, 2024"
       }
      }
     },
     "localname": "DebtInstrumentCarryingAmountIncludingUnaccretedLiabilityForFinalPaymentFeeMaturitiesRepaymentsOfPrincipalInYearThree",
     "nsuri": "http://equilliumbio.com/20221231",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureNotesPayableScheduleFutureMaturitiesOfTermLoanIncludingFinalPaymentFeeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "eq_DebtInstrumentCarryingAmountIncludingUnaccretedLiabilityForFinalPaymentFeeMaturitiesRepaymentsOfPrincipalInYearTwo": {
     "auth_ref": [],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureNotesPayableScheduleFutureMaturitiesOfTermLoanIncludingFinalPaymentFeeDetails": {
       "order": 1.0,
       "parentTag": "eq_DebtInstrumentCarryingAmountIncludingUnaccretedLiabilityForFinalPaymentFee",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt instrument carrying amount including unaccreted liability for final payment fee maturities repayments of principal in year two.",
        "label": "Debt Instrument Carrying Amount Including Unaccreted Liability For Final Payment Fee Maturities Repayments Of Principal In Year Two",
        "terseLabel": "Year ending December 31, 2024"
       }
      }
     },
     "localname": "DebtInstrumentCarryingAmountIncludingUnaccretedLiabilityForFinalPaymentFeeMaturitiesRepaymentsOfPrincipalInYearTwo",
     "nsuri": "http://equilliumbio.com/20221231",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureNotesPayableScheduleFutureMaturitiesOfTermLoanIncludingFinalPaymentFeeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "eq_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaidAsPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt instrument periodic payment terms balloon payment to be paid as percent.",
        "label": "Debt Instrument Periodic Payment Terms Balloon Payment To Be Paid As Percent",
        "terseLabel": "Percentage of final principal payment"
       }
      }
     },
     "localname": "DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaidAsPercent",
     "nsuri": "http://equilliumbio.com/20221231",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureNotesPayableAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "eq_DebtPrepaymentFeeAsPercentFromYearThree": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt prepayment fee as percent from year three.",
        "label": "Debt Prepayment Fee As Percent From Year Three",
        "terseLabel": "Debt prepayment fee as percent from year three"
       }
      }
     },
     "localname": "DebtPrepaymentFeeAsPercentFromYearThree",
     "nsuri": "http://equilliumbio.com/20221231",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureNotesPayableAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "eq_DebtPrepaymentFeeAsPercentOnYearOne": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt prepayment fee as percent on year one.",
        "label": "Debt Prepayment Fee As Percent On Year One",
        "terseLabel": "Debt prepayment fee as percent on year one"
       }
      }
     },
     "localname": "DebtPrepaymentFeeAsPercentOnYearOne",
     "nsuri": "http://equilliumbio.com/20221231",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureNotesPayableAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "eq_DebtPrepaymentFeeAsPercentOnYearTwo": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt prepayment fee as percent on year two.",
        "label": "Debt Prepayment Fee As Percent On Year Two",
        "terseLabel": "Debt prepayment fee as percent on year two"
       }
      }
     },
     "localname": "DebtPrepaymentFeeAsPercentOnYearTwo",
     "nsuri": "http://equilliumbio.com/20221231",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureNotesPayableAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "eq_DeferredTaxAssetsCapitalizedResearchExpenditures": {
     "auth_ref": [],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfNetDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Assets Capitalized Research Expenditures.",
        "label": "Deferred Tax Assets Capitalized Research Expenditures",
        "terseLabel": "Capitalized research expenditures"
       }
      }
     },
     "localname": "DeferredTaxAssetsCapitalizedResearchExpenditures",
     "nsuri": "http://equilliumbio.com/20221231",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfNetDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "eq_DividendsPaidOnCommonStock": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Dividends paid on common stock.",
        "label": "Dividends Paid On Common Stock",
        "terseLabel": "Dividends paid"
       }
      }
     },
     "localname": "DividendsPaidOnCommonStock",
     "nsuri": "http://equilliumbio.com/20221231",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "eq_EffectiveIncomeTaxRateReconciliationTransactionCostsAmount": {
     "auth_ref": [],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesReconciliationOfExpectedStatutoryFederalIncomeTaxProvisionToActualIncomeTaxProvisionDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Transaction Costs, Amount.",
        "label": "Effective Income Tax Rate Reconciliation, Transaction Costs, Amount",
        "terseLabel": "Transaction costs"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationTransactionCostsAmount",
     "nsuri": "http://equilliumbio.com/20221231",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesReconciliationOfExpectedStatutoryFederalIncomeTaxProvisionToActualIncomeTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "eq_EighteenMonthsAfterClosingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Eighteen months after closing.",
        "label": "Eighteen Months after Closing [Member]",
        "terseLabel": "18 Months after Closing"
       }
      }
     },
     "localname": "EighteenMonthsAfterClosingMember",
     "nsuri": "http://equilliumbio.com/20221231",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureAcquisitionAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "eq_EligibleToReceivePaymentOnAchievementOfCertainDevelopmentMilestones": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Eligible to receive payment on achievement of certain development milestones.",
        "label": "Eligible To Receive Payment On Achievement Of Certain Development Milestones",
        "terseLabel": "Eligible to receive payment on achievement of certain development milestones"
       }
      }
     },
     "localname": "EligibleToReceivePaymentOnAchievementOfCertainDevelopmentMilestones",
     "nsuri": "http://equilliumbio.com/20221231",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosurePartnershipsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "eq_EmployeeStockPurchasePlanDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of the plan, including equity stock purchase plan which under the employee stock purchase plan.",
        "label": "Employee Stock Purchase Plan Description",
        "terseLabel": "Employee stock purchase plan description"
       }
      }
     },
     "localname": "EmployeeStockPurchasePlanDescription",
     "nsuri": "http://equilliumbio.com/20221231",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "eq_EmployeeStockPurchasePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee stock purchase plan.",
        "label": "Employee Stock Purchase Plan [Member]",
        "terseLabel": "2018 Employee Stock Purchase Plan",
        "verboseLabel": "Employee Stock Purchase Plan"
       }
      }
     },
     "localname": "EmployeeStockPurchasePlanMember",
     "nsuri": "http://equilliumbio.com/20221231",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetails",
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquitySummaryOfCommonStockReservedForFutureIssuanceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "eq_EquityIncentivePlanDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity incentive plan description.",
        "label": "Equity Incentive Plan Description",
        "terseLabel": "Equity incentive plan description"
       }
      }
     },
     "localname": "EquityIncentivePlanDescription",
     "nsuri": "http://equilliumbio.com/20221231",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "eq_EstimatedMaximumAmountOfCommonStockIssuable": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Estimated maximum amount of common stock issuable.",
        "label": "Estimated Maximum Amount Of Common Stock Issuable",
        "terseLabel": "Estimated maximum amount of common stock issuable"
       }
      }
     },
     "localname": "EstimatedMaximumAmountOfCommonStockIssuable",
     "nsuri": "http://equilliumbio.com/20221231",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "eq_EstimatedResearchAndDevelopmentFunding": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Estimated research and development funding.",
        "label": "Estimated Research And Development Funding",
        "terseLabel": "Estimated research and development funding"
       }
      }
     },
     "localname": "EstimatedResearchAndDevelopmentFunding",
     "nsuri": "http://equilliumbio.com/20221231",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosurePartnershipsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "eq_FairMarketValueOfCommitmentShares": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair market value of commitment shares.",
        "label": "Fair Market Value Of Commitment Shares",
        "terseLabel": "Fair market value of commitment shares"
       }
      }
     },
     "localname": "FairMarketValueOfCommitmentShares",
     "nsuri": "http://equilliumbio.com/20221231",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "eq_FollowOnOfferingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Follow-on offering.",
        "label": "Follow On Offering [Member]",
        "terseLabel": "Follow-on Offering"
       }
      }
     },
     "localname": "FollowOnOfferingMember",
     "nsuri": "http://equilliumbio.com/20221231",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "domainItemType"
    },
    "eq_GrossProceedsFromIssuanceOfCommonStock": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross proceeds from issuance of common stock.",
        "label": "Gross Proceeds From Issuance Of Common Stock",
        "terseLabel": "Gross proceeds from issuance of common stock"
       }
      }
     },
     "localname": "GrossProceedsFromIssuanceOfCommonStock",
     "nsuri": "http://equilliumbio.com/20221231",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "eq_IncomeTaxReconciliationFederalResearchAndOrphanDrugCredits": {
     "auth_ref": [],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesReconciliationOfExpectedStatutoryFederalIncomeTaxProvisionToActualIncomeTaxProvisionDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income tax reconciliation federal research and orphan drug credits.",
        "label": "Income Tax Reconciliation Federal Research And Orphan Drug Credits",
        "negatedLabel": "Federal research and orphan drug credits"
       }
      }
     },
     "localname": "IncomeTaxReconciliationFederalResearchAndOrphanDrugCredits",
     "nsuri": "http://equilliumbio.com/20221231",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesReconciliationOfExpectedStatutoryFederalIncomeTaxProvisionToActualIncomeTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "eq_IncomeTaxReconciliationPermanentItems": {
     "auth_ref": [],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesReconciliationOfExpectedStatutoryFederalIncomeTaxProvisionToActualIncomeTaxProvisionDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income tax expense (benefit) reconciliation permanent items.",
        "label": "Income Tax Reconciliation Permanent Items",
        "terseLabel": "Permanent items"
       }
      }
     },
     "localname": "IncomeTaxReconciliationPermanentItems",
     "nsuri": "http://equilliumbio.com/20221231",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesReconciliationOfExpectedStatutoryFederalIncomeTaxProvisionToActualIncomeTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "eq_IncreaseDecreaseInRightOfUseAssetsAndLeaseLiabilitiesNet": {
     "auth_ref": [],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (decrease) in right-of-use assets and lease liabilities, net.",
        "label": "Increase Decrease In Right-Of-Use Assets And Lease Liabilities, Net",
        "negatedLabel": "Right-of-use assets and lease liabilities, net"
       }
      }
     },
     "localname": "IncreaseDecreaseInRightOfUseAssetsAndLeaseLiabilitiesNet",
     "nsuri": "http://equilliumbio.com/20221231",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "eq_InitialTransactionPrice": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Initial transaction price.",
        "label": "Initial Transaction Price",
        "terseLabel": "Initial transaction price"
       }
      }
     },
     "localname": "InitialTransactionPrice",
     "nsuri": "http://equilliumbio.com/20221231",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosurePartnershipsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "eq_LaboratorySpaceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Laboratory space.",
        "label": "Laboratory Space [Member]",
        "terseLabel": "Laboratory Space"
       }
      }
     },
     "localname": "LaboratorySpaceMember",
     "nsuri": "http://equilliumbio.com/20221231",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "eq_LesseeOperatingLeaseExpirationYear": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee operating lease expiration year.",
        "label": "Lessee Operating lease Expiration Year",
        "terseLabel": "Lease expiration year"
       }
      }
     },
     "localname": "LesseeOperatingLeaseExpirationYear",
     "nsuri": "http://equilliumbio.com/20221231",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "gYearItemType"
    },
    "eq_LesseeOperatingLeaseExpiredDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee operating lease expired date.",
        "label": "Lessee Operating Lease Expired Date",
        "terseLabel": "Lease expired date"
       }
      }
     },
     "localname": "LesseeOperatingLeaseExpiredDate",
     "nsuri": "http://equilliumbio.com/20221231",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "gYearMonthItemType"
    },
    "eq_LincolnParkCapitalFundLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lincoln Park Capital Fund, LLC.",
        "label": "Lincoln Park Capital Fund L L C [Member]",
        "terseLabel": "Lincoln Park Capital Fund, LLC"
       }
      }
     },
     "localname": "LincolnParkCapitalFundLLCMember",
     "nsuri": "http://equilliumbio.com/20221231",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetails",
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "domainItemType"
    },
    "eq_LineOfCreditFacilityFrequencyOfPaymentsPrincipalAndInterest": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line of credit facility frequency of payments principal and interest.",
        "label": "Line Of Credit Facility Frequency Of Payments Principal And Interest",
        "terseLabel": "Line of credit facility frequency of payments principal and interest"
       }
      }
     },
     "localname": "LineOfCreditFacilityFrequencyOfPaymentsPrincipalAndInterest",
     "nsuri": "http://equilliumbio.com/20221231",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureNotesPayableAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "eq_LoanAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loan Agreement.",
        "label": "Loan Agreement [Member]",
        "terseLabel": "Loan Agreement"
       }
      }
     },
     "localname": "LoanAgreementMember",
     "nsuri": "http://equilliumbio.com/20221231",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureNotesPayableAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "eq_MinimumOptionsExercisePriceAsPercentageOfFairMarketValueOfCommonStock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum options exercise price, expressed as percentage of fair market value of common stock.",
        "label": "Minimum Options Exercise Price As Percentage Of Fair Market Value Of Common Stock",
        "terseLabel": "Minimum options exercise price as percentage of fair market value of common stock"
       }
      }
     },
     "localname": "MinimumOptionsExercisePriceAsPercentageOfFairMarketValueOfCommonStock",
     "nsuri": "http://equilliumbio.com/20221231",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "eq_MinimumStockPricePerShareAsPercentageOfFairMarketValueOfCommonStock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum stock price per share as percentage of fair market value of common stock.",
        "label": "Minimum Stock Price Per Share As Percentage Of Fair Market Value Of Common Stock",
        "terseLabel": "Minimum stock price per share as percentage of fair market value of common stock"
       }
      }
     },
     "localname": "MinimumStockPricePerShareAsPercentageOfFairMarketValueOfCommonStock",
     "nsuri": "http://equilliumbio.com/20221231",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "eq_NumberOfInstitutionalInvestors": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Institutional Investors",
        "label": "Number Of Institutional Investors",
        "terseLabel": "Number of institutional investors",
        "verboseLabel": "Purchased of issued and outstanding share capital"
       }
      }
     },
     "localname": "NumberOfInstitutionalInvestors",
     "nsuri": "http://equilliumbio.com/20221231",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "eq_OfficeSpaceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Office space.",
        "label": "Office Space [Member]",
        "terseLabel": "Office Space"
       }
      }
     },
     "localname": "OfficeSpaceMember",
     "nsuri": "http://equilliumbio.com/20221231",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "eq_OneTimeNonRefundablePaymentReceivableUponExercisesTheOption": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "One-time, non-refundable payment receivable, upon exercises the option.",
        "label": "One-time, Non-Refundable Payment Receivable, Upon Exercises The Option",
        "terseLabel": "One-time, non-refundable payment receivable, upon exercises the option"
       }
      }
     },
     "localname": "OneTimeNonRefundablePaymentReceivableUponExercisesTheOption",
     "nsuri": "http://equilliumbio.com/20221231",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosurePartnershipsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "eq_OneTimePaymentReceivableUponExercisesTheOption": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "One-time payment receivable upon exercises the option.",
        "label": "One-Time Payment Receivable Upon Exercises The Option",
        "terseLabel": "One-time payment receivable, upon exercises the option"
       }
      }
     },
     "localname": "OneTimePaymentReceivableUponExercisesTheOption",
     "nsuri": "http://equilliumbio.com/20221231",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosurePartnershipsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "eq_OnoPharmaceuticalCoLtdMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ono Pharmaceutical Co., Ltd.",
        "label": "Ono Pharmaceutical Co., Ltd [Member]",
        "terseLabel": "Ono"
       }
      }
     },
     "localname": "OnoPharmaceuticalCoLtdMember",
     "nsuri": "http://equilliumbio.com/20221231",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosurePartnershipsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "eq_OperatingLossCarryforwardsExpirationYear": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating loss carryforwards expiration year.",
        "label": "Operating Loss Carryforwards Expiration Year",
        "terseLabel": "Federal and state net operating loss carry forwards, Expiration year"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsExpirationYear",
     "nsuri": "http://equilliumbio.com/20221231",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "gYearItemType"
    },
    "eq_OperatingLossCarryforwardsLimitationRateOnTaxableIncome": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating loss carryforwards limitation rate on taxable income.",
        "label": "Operating Loss Carryforwards Limitation Rate On Taxable Income",
        "terseLabel": "Operating loss carryforwards limitation rate on taxable income"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsLimitationRateOnTaxableIncome",
     "nsuri": "http://equilliumbio.com/20221231",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "eq_OptionPeriodExpiryCondition": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Option period expiry condition.",
        "label": "Option Period Expiry Condition",
        "terseLabel": "Option period expiry condition"
       }
      }
     },
     "localname": "OptionPeriodExpiryCondition",
     "nsuri": "http://equilliumbio.com/20221231",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosurePartnershipsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "eq_OtherOperatingLeaseInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other operating lease information.",
        "label": "Other Operating Lease Information [Abstract]",
        "terseLabel": "Other information"
       }
      }
     },
     "localname": "OtherOperatingLeaseInformationAbstract",
     "nsuri": "http://equilliumbio.com/20221231",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureLeasesSummaryOfAdditionalInformationRelatedToLeasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "eq_PatentCostsPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Patent costs.",
        "label": "Patent Costs Policy [Text Block]",
        "terseLabel": "Patent Costs"
       }
      }
     },
     "localname": "PatentCostsPolicyTextBlock",
     "nsuri": "http://equilliumbio.com/20221231",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "eq_PercentageOfTaxBenefitToBeRealizedUponUltimateSettlementWithTaxAuthority": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of tax benefit to be realized upon ultimate settlement with tax authority.",
        "label": "Percentage Of Tax Benefit To Be Realized Upon Ultimate Settlement With Tax Authority",
        "terseLabel": "Percentage of tax benefit to be realized upon ultimate settlement with tax authority"
       }
      }
     },
     "localname": "PercentageOfTaxBenefitToBeRealizedUponUltimateSettlementWithTaxAuthority",
     "nsuri": "http://equilliumbio.com/20221231",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "eq_PrepaidAndOtherCurrentAssetsTaxIncentive": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prepaid and other current assets tax incentive.",
        "label": "Prepaid And Other Current Assets Tax Incentive",
        "terseLabel": "Prepaid and other current assets tax incentive"
       }
      }
     },
     "localname": "PrepaidAndOtherCurrentAssetsTaxIncentive",
     "nsuri": "http://equilliumbio.com/20221231",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "eq_PrepaidExpensesAndOtherCurrentAssetsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for Prepaid expenses and other current assets.",
        "label": "Prepaid Expenses And Other Current Assets Policy Policy [Text Block]",
        "terseLabel": "Prepaid Expenses and Other Current Assets"
       }
      }
     },
     "localname": "PrepaidExpensesAndOtherCurrentAssetsPolicyPolicyTextBlock",
     "nsuri": "http://equilliumbio.com/20221231",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "eq_ProceedsFromResearchAndDevelopmentFees": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from research and development fees.",
        "label": "Proceeds From Research and Development Fees",
        "terseLabel": "Proceeds from research and development fees"
       }
      }
     },
     "localname": "ProceedsFromResearchAndDevelopmentFees",
     "nsuri": "http://equilliumbio.com/20221231",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosurePartnershipsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "eq_PurchaseAgreementExpirationDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchase agreement expiration date.",
        "label": "Purchase Agreement Expiration Date",
        "terseLabel": "Purchase agreement expiration date"
       }
      }
     },
     "localname": "PurchaseAgreementExpirationDate",
     "nsuri": "http://equilliumbio.com/20221231",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "eq_PurchaseAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchase Agreement.",
        "label": "Purchase Agreement [Member]",
        "terseLabel": "Purchase Agreement"
       }
      }
     },
     "localname": "PurchaseAgreementMember",
     "nsuri": "http://equilliumbio.com/20221231",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "eq_PurchaseRightMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchase right.",
        "label": "Purchase Right [Member]",
        "terseLabel": "Purchase Right"
       }
      }
     },
     "localname": "PurchaseRightMember",
     "nsuri": "http://equilliumbio.com/20221231",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "eq_RegisteredDirectOfferingsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Registered direct offerings.",
        "label": "Registered direct offerings [Member]",
        "terseLabel": "Registered Direct Offering"
       }
      }
     },
     "localname": "RegisteredDirectOfferingsMember",
     "nsuri": "http://equilliumbio.com/20221231",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "eq_RegulatoryMilestonePaymentsUponAchievementOfCertainRegulatoryApprovals": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Regulatory milestone payments upon the achievement of certain regulatory approvals.",
        "label": "Regulatory Milestone Payments Upon Achievement Of Certain Regulatory Approvals",
        "terseLabel": "Regulatory milestone payments"
       }
      }
     },
     "localname": "RegulatoryMilestonePaymentsUponAchievementOfCertainRegulatoryApprovals",
     "nsuri": "http://equilliumbio.com/20221231",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosurePartnershipsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "eq_RequiredNoticePeriodForDebtPrepayment": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Required notice period for debt prepayment.",
        "label": "Required Notice Period For Debt Prepayment",
        "terseLabel": "Required notice period for debt prepayment"
       }
      }
     },
     "localname": "RequiredNoticePeriodForDebtPrepayment",
     "nsuri": "http://equilliumbio.com/20221231",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureNotesPayableAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "eq_ResearchAndDevelopmentServicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research and development services.",
        "label": "Research and Development Services [Member]",
        "terseLabel": "Research and Development Services"
       }
      }
     },
     "localname": "ResearchAndDevelopmentServicesMember",
     "nsuri": "http://equilliumbio.com/20221231",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosurePartnershipsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "eq_ResearchAndDevelopmentTaxIncentiveRevenueCriteria": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research and development tax incentive revenue criteria.",
        "label": "Research And Development Tax Incentive Revenue Criteria",
        "terseLabel": "Revenue for availability of research and development tax incentive"
       }
      }
     },
     "localname": "ResearchAndDevelopmentTaxIncentiveRevenueCriteria",
     "nsuri": "http://equilliumbio.com/20221231",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "eq_ResearchAndExperimentalExpendituresCapitalizedCostAmortizationPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research and experimental expenditures capitalized cost amortization period.",
        "label": "Research And Experimental Expenditures Capitalized Cost Amortization Period",
        "terseLabel": "Research and experimental expenditures capitalized cost amortization period"
       }
      }
     },
     "localname": "ResearchAndExperimentalExpendituresCapitalizedCostAmortizationPeriod",
     "nsuri": "http://equilliumbio.com/20221231",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "eq_SalesMilestonePaymentsUponTheAchievementOfFirstCommercialSaleOfProductAndSpecifiedLevelsOfProductSales": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sales milestone payments upon the achievement of first commercial sale of product and specified levels of product sales.",
        "label": "Sales Milestone Payments Upon The Achievement Of First Commercial Sale Of Product And Specified Levels Of Product Sales",
        "terseLabel": "Sales milestone payments"
       }
      }
     },
     "localname": "SalesMilestonePaymentsUponTheAchievementOfFirstCommercialSaleOfProductAndSpecifiedLevelsOfProductSales",
     "nsuri": "http://equilliumbio.com/20221231",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosurePartnershipsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "eq_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRemainingVestingPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Remaining vesting period of share based compensation arrangement.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Award Remaining Vesting Period",
        "terseLabel": "Remaining vesting period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRemainingVestingPeriod",
     "nsuri": "http://equilliumbio.com/20221231",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "eq_ShortTermInvestmentsPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for short-term investments.",
        "label": "Short Term Investments Policy [Text Block]",
        "terseLabel": "Short-Term Investments"
       }
      }
     },
     "localname": "ShortTermInvestmentsPolicyTextBlock",
     "nsuri": "http://equilliumbio.com/20221231",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "eq_ShortTermInvestmentsTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Short Term Investments [Text Block]",
        "terseLabel": "Short-Term Investments"
       }
      }
     },
     "localname": "ShortTermInvestmentsTextBlock",
     "nsuri": "http://equilliumbio.com/20221231",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureShortTermInvestments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "eq_SiliconValleyBankMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Silicon Valley Bank.",
        "label": "Silicon Valley Bank [Member]",
        "terseLabel": "Silicon Valley Bank"
       }
      }
     },
     "localname": "SiliconValleyBankMember",
     "nsuri": "http://equilliumbio.com/20221231",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "eq_StockOptionsIssuedAndOutstandingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock options issued and outstanding.",
        "label": "Stock Options Issued And Outstanding [Member]",
        "terseLabel": "Stock Options Issued and Outstanding"
       }
      }
     },
     "localname": "StockOptionsIssuedAndOutstandingMember",
     "nsuri": "http://equilliumbio.com/20221231",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquitySummaryOfCommonStockReservedForFutureIssuanceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "eq_SummaryOfAdditionalInformationRelatedToLeasesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summary of additional information related to leases.",
        "label": "Summary Of Additional Information Related To Leases [Table Text Block]",
        "terseLabel": "Summary of Additional Information Related to Leases"
       }
      }
     },
     "localname": "SummaryOfAdditionalInformationRelatedToLeasesTableTextBlock",
     "nsuri": "http://equilliumbio.com/20221231",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureLeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "eq_SummaryOfReconciliationOfExpectedStatutoryFederalIncomeTaxProvisionToActualIncomeTaxProvisionTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summary of reconciliation of expected statutory federal income tax provision to actual income tax provision.",
        "label": "Summary Of Reconciliation Of Expected Statutory Federal Income Tax Provision To Actual Income Tax Provision Table [Text Block]",
        "terseLabel": "Summary of Reconciliation of Expected Statutory Federal Income Tax Provision to Actual Income Tax Provision"
       }
      }
     },
     "localname": "SummaryOfReconciliationOfExpectedStatutoryFederalIncomeTaxProvisionToActualIncomeTaxProvisionTableTextBlock",
     "nsuri": "http://equilliumbio.com/20221231",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "eq_SummaryOfSignificantAccountingPoliciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summary of significant accounting policies.",
        "label": "Summary Of Significant Accounting Policies [Line Items]",
        "terseLabel": "Summary Of Significant Accounting Policies [Line Items]"
       }
      }
     },
     "localname": "SummaryOfSignificantAccountingPoliciesLineItems",
     "nsuri": "http://equilliumbio.com/20221231",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "eq_SummaryOfSignificantAccountingPoliciesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summary of significant accounting policies.",
        "label": "Summary Of Significant Accounting Policies [Table]",
        "terseLabel": "Summary Of Significant Accounting Policies [Table]"
       }
      }
     },
     "localname": "SummaryOfSignificantAccountingPoliciesTable",
     "nsuri": "http://equilliumbio.com/20221231",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "eq_TaxCreditCarryforwardExpirationYear": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tax credit carryforward expiration year.",
        "label": "Tax Credit Carryforward Expiration Year",
        "terseLabel": "Tax credit carryforward, Expiration year"
       }
      }
     },
     "localname": "TaxCreditCarryforwardExpirationYear",
     "nsuri": "http://equilliumbio.com/20221231",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "gYearItemType"
    },
    "eq_TermLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term loan.",
        "label": "Term Loan [Member]",
        "terseLabel": "Term Loan"
       }
      }
     },
     "localname": "TermLoanMember",
     "nsuri": "http://equilliumbio.com/20221231",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureNotesPayableAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "eq_TermOfPurchaseAgreement": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of purchase agreement.",
        "label": "Term Of Purchase Agreement",
        "terseLabel": "Term of purchase agreement"
       }
      }
     },
     "localname": "TermOfPurchaseAgreement",
     "nsuri": "http://equilliumbio.com/20221231",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "eq_TermsOfMergerAgreement": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Terms of merger agreement.",
        "label": "Terms Of Merger Agreement",
        "terseLabel": "Business acquisition, term for finalization after the closing"
       }
      }
     },
     "localname": "TermsOfMergerAgreement",
     "nsuri": "http://equilliumbio.com/20221231",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureAcquisitionAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "eq_TwoThousandEighteenEquityIncentivePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two thousand eighteen equity incentive plan.",
        "label": "Two Thousand Eighteen Equity Incentive Plan [Member]",
        "terseLabel": "2018 Equity Incentive Plan"
       }
      }
     },
     "localname": "TwoThousandEighteenEquityIncentivePlanMember",
     "nsuri": "http://equilliumbio.com/20221231",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetails",
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquitySummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "eq_TwoThousandSeventeenEquityIncentivePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two thousand seventeen equity incentive plan.",
        "label": "Two Thousand Seventeen Equity Incentive Plan [Member]",
        "terseLabel": "2017 Equity Incentive Plan"
       }
      }
     },
     "localname": "TwoThousandSeventeenEquityIncentivePlanMember",
     "nsuri": "http://equilliumbio.com/20221231",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "eq_USTreasurySecuritiesMaturingBetweenOneAndFiveYearsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "U S Treasury Securities maturing between one and five years.",
        "label": "U S Treasury Securities Maturing Between One And Five Years [Member]",
        "terseLabel": "U.S. Treasury Securities Maturing between One and Five years"
       }
      }
     },
     "localname": "USTreasurySecuritiesMaturingBetweenOneAndFiveYearsMember",
     "nsuri": "http://equilliumbio.com/20221231",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureShortTermInvestmentsScheduleOfCompanySShortTermInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "eq_USTreasurySecuritiesMaturingInOneYearOrLessMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "U S Treasury Securities maturing in one year or less.",
        "label": "U S Treasury Securities Maturing In One Year Or Less [Member]",
        "terseLabel": "U.S. Treasury Securities Maturing in One Year or Less"
       }
      }
     },
     "localname": "USTreasurySecuritiesMaturingInOneYearOrLessMember",
     "nsuri": "http://equilliumbio.com/20221231",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureShortTermInvestmentsScheduleOfCompanySShortTermInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "eq_UnaccretedLiabilityForFinalPaymentFee": {
     "auth_ref": [],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureNotesPayableScheduleFutureMaturitiesOfTermLoanIncludingFinalPaymentFeeDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unaccreted liability for final payment fee.",
        "label": "Unaccreted Liability For Final Payment Fee",
        "negatedLabel": "Unaccreted balance for Final Payment fee on Term Loans"
       }
      }
     },
     "localname": "UnaccretedLiabilityForFinalPaymentFee",
     "nsuri": "http://equilliumbio.com/20221231",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureNotesPayableScheduleFutureMaturitiesOfTermLoanIncludingFinalPaymentFeeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "eq_UnvestedStockLiability": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unvested stock liability.",
        "label": "Unvested Stock Liability",
        "terseLabel": "Unvested stock liability"
       }
      }
     },
     "localname": "UnvestedStockLiability",
     "nsuri": "http://equilliumbio.com/20221231",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "eq_UpfrontAndNonCreditablePaymentInvoiced": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Upfront and Non-creditable payment invoiced.",
        "label": "Upfront and Non-Creditable Payment Invoiced",
        "terseLabel": "Upfront and non-creditable payment invoiced"
       }
      }
     },
     "localname": "UpfrontAndNonCreditablePaymentInvoiced",
     "nsuri": "http://equilliumbio.com/20221231",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosurePartnershipsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "eq_UpfrontNonRefundableAndNonCreditablePaymentInvoiced": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Upfront non-refundable and non-creditable payment invoiced.",
        "label": "Upfront Non-Refundable and Non-Creditable Payment Invoiced",
        "terseLabel": "Upfront non-refundable and non-creditable payment invoiced"
       }
      }
     },
     "localname": "UpfrontNonRefundableAndNonCreditablePaymentInvoiced",
     "nsuri": "http://equilliumbio.com/20221231",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosurePartnershipsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "eq_UpfrontNonRefundableAndNonCreditablePaymentReceivableUponExchangeOfOption": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Upfront non-refundable and non-creditable payment receivable, upon exchange of option.",
        "label": "Upfront Non-refundable And Non-creditable Payment Receivable, Upon Exchange Of Option",
        "terseLabel": "Upfront non-refundable and non-creditable payment receivable, upon exchange of option"
       }
      }
     },
     "localname": "UpfrontNonRefundableAndNonCreditablePaymentReceivableUponExchangeOfOption",
     "nsuri": "http://equilliumbio.com/20221231",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosurePartnershipsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "eq_UpfrontPaymentAmortizationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Upfront payment amortization.",
        "label": "Upfront Payment Amortization [Member]",
        "terseLabel": "Upfront Payment Amortization"
       }
      }
     },
     "localname": "UpfrontPaymentAmortizationMember",
     "nsuri": "http://equilliumbio.com/20221231",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosurePartnershipsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "eq_UpfrontPaymentReceived": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Upfront payment received.",
        "label": "Upfront Payment Received",
        "terseLabel": "Upfront payment received"
       }
      }
     },
     "localname": "UpfrontPaymentReceived",
     "nsuri": "http://equilliumbio.com/20221231",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosurePartnershipsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "eq_WithholdPercentageOfEmployeesEarningsToPurchaseSharesOfCommonStock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Withhold Percentage of employees earnings to purchase shares of common stock.",
        "label": "Withhold Percentage Of Employees Earnings To Purchase Shares Of Common Stock",
        "terseLabel": "Withhold Percentage of employees earnings to purchase shares of common stock"
       }
      }
     },
     "localname": "WithholdPercentageOfEmployeesEarningsToPurchaseSharesOfCommonStock",
     "nsuri": "http://equilliumbio.com/20221231",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "srt_CounterpartyNameAxis": {
     "auth_ref": [
      "r197",
      "r198",
      "r307",
      "r327",
      "r598",
      "r600"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Axis]",
        "terseLabel": "Counterparty Name"
       }
      }
     },
     "localname": "CounterpartyNameAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosurePartnershipsAdditionalInformationDetails",
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetails",
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureSubsequentEventsAdditionalInformationDetails",
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r291",
      "r292",
      "r293",
      "r294",
      "r351",
      "r538",
      "r553",
      "r595",
      "r596",
      "r614",
      "r622",
      "r631",
      "r672",
      "r716",
      "r717",
      "r718",
      "r719",
      "r720",
      "r721"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureAcquisitionAdditionalInformationDetails",
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosurePartnershipsAdditionalInformationDetails",
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails",
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureNotesPayableAdditionalInformationDetails",
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureShortTermInvestmentsAdditionalInformationDetails",
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureShortTermInvestmentsScheduleOfCompanySShortTermInvestmentsDetails",
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetails",
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r291",
      "r292",
      "r293",
      "r294",
      "r351",
      "r538",
      "r553",
      "r595",
      "r596",
      "r614",
      "r622",
      "r631",
      "r672",
      "r716",
      "r717",
      "r718",
      "r719",
      "r720",
      "r721"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum",
        "verboseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosurePartnershipsAdditionalInformationDetails",
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails",
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureNotesPayableAdditionalInformationDetails",
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureShortTermInvestmentsAdditionalInformationDetails",
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureShortTermInvestmentsScheduleOfCompanySShortTermInvestmentsDetails",
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r247",
      "r539",
      "r615",
      "r629",
      "r667",
      "r668",
      "r674",
      "r724"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosurePartnershipsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r247",
      "r539",
      "r615",
      "r629",
      "r667",
      "r668",
      "r674",
      "r724"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosurePartnershipsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r291",
      "r292",
      "r293",
      "r294",
      "r344",
      "r351",
      "r380",
      "r381",
      "r382",
      "r514",
      "r538",
      "r553",
      "r595",
      "r596",
      "r614",
      "r622",
      "r631",
      "r666",
      "r672",
      "r717",
      "r718",
      "r719",
      "r720",
      "r721"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureAcquisitionAdditionalInformationDetails",
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosurePartnershipsAdditionalInformationDetails",
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails",
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureNotesPayableAdditionalInformationDetails",
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureShortTermInvestmentsAdditionalInformationDetails",
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureShortTermInvestmentsScheduleOfCompanySShortTermInvestmentsDetails",
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetails",
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r291",
      "r292",
      "r293",
      "r294",
      "r344",
      "r351",
      "r380",
      "r381",
      "r382",
      "r514",
      "r538",
      "r553",
      "r595",
      "r596",
      "r614",
      "r622",
      "r631",
      "r666",
      "r672",
      "r717",
      "r718",
      "r719",
      "r720",
      "r721"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureAcquisitionAdditionalInformationDetails",
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosurePartnershipsAdditionalInformationDetails",
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails",
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureNotesPayableAdditionalInformationDetails",
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureShortTermInvestmentsAdditionalInformationDetails",
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureShortTermInvestmentsScheduleOfCompanySShortTermInvestmentsDetails",
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetails",
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "auth_ref": [
      "r197",
      "r198",
      "r307",
      "r327",
      "r599",
      "r600"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Domain]",
        "terseLabel": "Counterparty Name"
       }
      }
     },
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosurePartnershipsAdditionalInformationDetails",
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetails",
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureSubsequentEventsAdditionalInformationDetails",
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r248",
      "r249",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r616",
      "r630",
      "r674"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r248",
      "r249",
      "r581",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r616",
      "r630",
      "r674"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "stpr_CA": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CALIFORNIA",
        "terseLabel": "California"
       }
      }
     },
     "localname": "CA",
     "nsuri": "http://xbrl.sec.gov/stpr/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingStandardsUpdate201613Member": {
     "auth_ref": [
      "r264"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounting Standards Update 2016-13 Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments.",
        "label": "Accounting Standards Update 2016-13 [Member]",
        "terseLabel": "ASU 2016-13"
       }
      }
     },
     "localname": "AccountingStandardsUpdate201613Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureOrganizationAndAccountingPronouncementsAdditionalInformationDetails1"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period.",
        "label": "Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block]",
        "terseLabel": "Accrued Expenses"
       }
      }
     },
     "localname": "AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureAccruedExpenses"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r13",
      "r628"
     ],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "order": 0.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable",
        "totalLabel": "Accounts Payable, Current, Total"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r251",
      "r252"
     ],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable",
        "totalLabel": "Accounts Receivable, after Allowance for Credit Loss, Current, Total"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments": {
     "auth_ref": [
      "r51"
     ],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Accretion (Amortization) of Discounts and Premiums, Investments",
        "negatedLabel": "Amortization of investments, net"
       }
      }
     },
     "localname": "AccretionAmortizationOfDiscountsAndPremiumsInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r18"
     ],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Accrued expenses",
        "totalLabel": "Total accrued expenses"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails",
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued Liabilities, Current [Abstract]"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r73",
      "r165"
     ],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosurePropertyAndEquipmentScheduleOfPropertyAndEquipmentDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedLabel": "Less accumulated depreciation and amortization",
        "periodEndLabel": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Ending Balance",
        "periodStartLabel": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Beginning Balance",
        "totalLabel": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Total"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosurePropertyAndEquipmentScheduleOfPropertyAndEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r27",
      "r28",
      "r29",
      "r169",
      "r548",
      "r561",
      "r565"
     ],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive income (loss)",
        "totalLabel": "Accumulated Other Comprehensive Income (Loss), Net of Tax, Total"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r26",
      "r29",
      "r119",
      "r504",
      "r556",
      "r557",
      "r646",
      "r647",
      "r648",
      "r654",
      "r655",
      "r656"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "auth_ref": [
      "r8"
     ],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
        "label": "Additional Paid in Capital, Common Stock",
        "periodEndLabel": "Additional Paid in Capital, Common Stock, Ending Balance",
        "periodStartLabel": "Additional Paid in Capital, Common Stock, Beginning Balance",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r386",
      "r387",
      "r388",
      "r654",
      "r655",
      "r656",
      "r706"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-in Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": {
     "auth_ref": [
      "r155",
      "r156",
      "r157",
      "r158",
      "r159",
      "r205",
      "r206",
      "r207",
      "r208",
      "r218",
      "r254",
      "r255",
      "r268",
      "r269",
      "r270",
      "r271",
      "r273",
      "r274",
      "r386",
      "r387",
      "r388",
      "r411",
      "r412",
      "r413",
      "r414",
      "r428",
      "r429",
      "r430",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r462",
      "r463",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r479",
      "r480",
      "r484",
      "r485",
      "r486",
      "r487",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r540",
      "r541",
      "r542",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by amendment to accounting standards.",
        "label": "Accounting Standards Update [Axis]"
       }
      }
     },
     "localname": "AdjustmentsForNewAccountingPronouncementsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureOrganizationAndAccountingPronouncementsAdditionalInformationDetails1"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for restricted stock unit under share-based payment arrangement.",
        "label": "APIC, Share-Based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition",
        "terseLabel": "Vesting of restricted stock liability"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r98",
      "r99",
      "r353"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Stock-based compensation expense",
        "totalLabel": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition, Total"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net loss to cash used in operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r384"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-Based Payment Arrangement, Expense",
        "terseLabel": "Stock-based compensation expense",
        "verboseLabel": "Total non-cash stock-based compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquitySummaryOfTotalNonCashStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivable": {
     "auth_ref": [
      "r170",
      "r253",
      "r275",
      "r277",
      "r278"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable.",
        "label": "Accounts Receivable, Allowance for Credit Loss",
        "periodEndLabel": "Accounts Receivable, Allowance for Credit Loss, Ending Balance",
        "periodStartLabel": "Accounts Receivable, Allowance for Credit Loss, Beginning Balance",
        "terseLabel": "Allowance for credit losses"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfFinancingCostsAndDiscounts": {
     "auth_ref": [
      "r319",
      "r481",
      "r612",
      "r613",
      "r649"
     ],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.",
        "label": "Amortization of Debt Issuance Costs and Discounts",
        "terseLabel": "Amortization of term loan discount and issuance costs",
        "totalLabel": "Amortization of Debt Issuance Costs and Discounts, Total"
       }
      }
     },
     "localname": "AmortizationOfFinancingCostsAndDiscounts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r226"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Antidilutive securities not included in calculation of diluted net loss per share"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfPotentiallyDilutiveSecuritiesNotIncludedInCalculationOfDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r60"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetails",
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfPotentiallyDilutiveSecuritiesNotIncludedInCalculationOfDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "terseLabel": "Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfPotentiallyDilutiveSecuritiesNotIncludedInCalculationOfDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r60"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetails",
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfPotentiallyDilutiveSecuritiesNotIncludedInCalculationOfDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative"
       }
      }
     },
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosurePartnershipsAdditionalInformationDetails",
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r132",
      "r146",
      "r167",
      "r193",
      "r238",
      "r241",
      "r245",
      "r263",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r436",
      "r440",
      "r461",
      "r628",
      "r670",
      "r671",
      "r714"
     ],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsAndLiabilitiesLesseeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets and Liabilities, Lessee [Abstract]",
        "terseLabel": "Balance sheet information"
       }
      }
     },
     "localname": "AssetsAndLiabilitiesLesseeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureLeasesSummaryOfAdditionalInformationRelatedToLeasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r161",
      "r171",
      "r193",
      "r263",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r436",
      "r440",
      "r461",
      "r628",
      "r670",
      "r671",
      "r714"
     ],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "order": 0.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsHeldInTrust": {
     "auth_ref": [
      "r650"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of cash and securities held by third party trustees pursuant to terms of debt instruments or other agreements as of the date of each statement of financial position presented, which can be used by the trustee only to pay the noncurrent portion of specified obligations.",
        "label": "Assets Held-in-trust",
        "terseLabel": "Assets Held-in-trust with Silicon Valley Bank",
        "totalLabel": "Assets Held-in-trust, Total"
       }
      }
     },
     "localname": "AssetsHeldInTrust",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AustralianTaxationOfficeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the government of Australia.",
        "label": "Australian Taxation Office [Member]",
        "terseLabel": "Australian Taxation Office"
       }
      }
     },
     "localname": "AustralianTaxationOfficeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "auth_ref": [
      "r68"
     ],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureShortTermInvestmentsScheduleOfCompanySShortTermInvestmentsDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax",
        "terseLabel": "Unrealized Gains"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureShortTermInvestmentsScheduleOfCompanySShortTermInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
     "auth_ref": [
      "r69"
     ],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureShortTermInvestmentsScheduleOfCompanySShortTermInvestmentsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax",
        "negatedLabel": "Unrealized losses"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureShortTermInvestmentsScheduleOfCompanySShortTermInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": {
     "auth_ref": [
      "r258",
      "r283"
     ],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureShortTermInvestmentsScheduleOfCompanySShortTermInvestmentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost",
        "totalLabel": "Amortized Cost"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureShortTermInvestmentsScheduleOfCompanySShortTermInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent": {
     "auth_ref": [
      "r67",
      "r283"
     ],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureShortTermInvestmentsScheduleOfCompanySShortTermInvestmentsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      },
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.",
        "label": "Debt Securities, Available-for-Sale, Current",
        "terseLabel": "Short-term investments",
        "totalLabel": "Debt Securities, Available-for-sale, Current, Total"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecuritiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureShortTermInvestmentsScheduleOfCompanySShortTermInvestmentsDetails",
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r355",
      "r356",
      "r357",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r426",
      "r620",
      "r621"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureAcquisitionAdditionalInformationDetails",
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureAcquisitionSummaryOfPurchasePriceAllocationDetails",
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows",
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r112",
      "r113",
      "r426",
      "r620",
      "r621"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureAcquisitionAdditionalInformationDetails",
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureAcquisitionSummaryOfPurchasePriceAllocationDetails",
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows",
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned": {
     "auth_ref": [
      "r116"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of equity interests (such as common shares, preferred shares, or partnership interest) issued or issuable to acquire the entity.",
        "label": "Business Acquisition, Equity Interest Issued or Issuable, Value Assigned",
        "terseLabel": "Common stock value",
        "verboseLabel": "Issuance of common stock for Bioniz acquisition"
       }
      }
     },
     "localname": "BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureAcquisitionSummaryOfPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued": {
     "auth_ref": [
      "r116"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of equity interests issued or issuable to acquire entity.",
        "label": "Business Acquisition, Equity Interest Issued or Issuable, Number of Shares",
        "terseLabel": "Business acquisition, common stock shares issued"
       }
      }
     },
     "localname": "BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureAcquisitionAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureAcquisitionAdditionalInformationDetails",
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureAcquisitionSummaryOfPurchasePriceAllocationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationAcquisitionRelatedCosts": {
     "auth_ref": [
      "r110"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.",
        "label": "Business Combination, Acquisition Related Costs",
        "terseLabel": "Transaction costs"
       }
      }
     },
     "localname": "BusinessCombinationAcquisitionRelatedCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureAcquisitionAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination and Asset Acquisition [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationAndAssetAcquisitionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh": {
     "auth_ref": [
      "r117"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid.",
        "label": "Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High",
        "terseLabel": "Contingent payments"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureAcquisitionAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "auth_ref": [
      "r118",
      "r427"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).",
        "label": "Business Combination Disclosure [Text Block]",
        "terseLabel": "Acquisition"
       }
      }
     },
     "localname": "BusinessCombinationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureAcquisition"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets": {
     "auth_ref": [
      "r115"
     ],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureAcquisitionSummaryOfPurchasePriceAllocationDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets",
        "totalLabel": "Total assets acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureAcquisitionSummaryOfPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets [Abstract]",
        "terseLabel": "Assets acquired:"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureAcquisitionSummaryOfPurchasePriceAllocationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": {
     "auth_ref": [
      "r115"
     ],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureAcquisitionSummaryOfPurchasePriceAllocationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents",
        "terseLabel": "Cash"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureAcquisitionSummaryOfPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets": {
     "auth_ref": [
      "r115"
     ],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureAcquisitionSummaryOfPurchasePriceAllocationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureAcquisitionSummaryOfPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable": {
     "auth_ref": [
      "r115"
     ],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureAcquisitionSummaryOfPurchasePriceAllocationDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureAcquisitionSummaryOfPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities": {
     "auth_ref": [
      "r115"
     ],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureAcquisitionSummaryOfPurchasePriceAllocationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities",
        "totalLabel": "Total liabilities assumed"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureAcquisitionSummaryOfPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities [Abstract]",
        "terseLabel": "Liabilities assumed:"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureAcquisitionSummaryOfPurchasePriceAllocationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet": {
     "auth_ref": [
      "r114",
      "r115"
     ],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureAcquisitionSummaryOfPurchasePriceAllocationDetails": {
       "order": 0.0,
       "parentTag": "eq_BusinessCombinationAcquiredInProcessResearchAndDevelopment",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net",
        "totalLabel": "Net liabilities acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureAcquisitionSummaryOfPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets": {
     "auth_ref": [
      "r115"
     ],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureAcquisitionSummaryOfPurchasePriceAllocationDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Assets",
        "terseLabel": "Fixed assets",
        "totalLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Assets, Total"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureAcquisitionSummaryOfPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock": {
     "auth_ref": [
      "r111"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of transactions that are recognized separately from the acquisition of assets and assumptions of liabilities in the business combination.",
        "label": "Business Combination, Separately Recognized Transactions [Table Text Block]",
        "terseLabel": "Summary of Purchase Price Allocation"
       }
      }
     },
     "localname": "BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureAcquisitionTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CapitalExpendituresIncurredButNotYetPaid": {
     "auth_ref": [
      "r54",
      "r55",
      "r56"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred.",
        "label": "Capital Expenditures Incurred but Not yet Paid",
        "terseLabel": "Amounts included in accounts payable for purchases of property and equipment"
       }
      }
     },
     "localname": "CapitalExpendituresIncurredButNotYetPaid",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAcquiredFromAcquisition": {
     "auth_ref": [
      "r40"
     ],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business).",
        "label": "Cash Acquired from Acquisition",
        "terseLabel": "Cash acquired in Bioniz acquisition"
       }
      }
     },
     "localname": "CashAcquiredFromAcquisition",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r52",
      "r163",
      "r597"
     ],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "order": 0.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "periodEndLabel": "Cash and Cash Equivalents, at Carrying Value, Ending Balance",
        "periodStartLabel": "Cash and Cash Equivalents, at Carrying Value, Beginning Balance",
        "terseLabel": "Cash and cash equivalents",
        "totalLabel": "Cash and Cash Equivalents, at Carrying Value, Total"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r53"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash and Cash Equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsAndShortTermInvestments": {
     "auth_ref": [
      "r645"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the customer may deposit additional funds at any time and effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid Investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Short-term investments, exclusive of cash equivalents, generally consist of marketable securities intended to be sold within one year (or the normal operating cycle if longer) and may include trading securities, available-for-sale securities, or held-to-maturity securities (if maturing within one year), as applicable.",
        "label": "Cash, Cash Equivalents, and Short-Term Investments",
        "terseLabel": "Cash, Cash equivalents and short-term investments",
        "totalLabel": "Cash, Cash Equivalents, and Short-term Investments, Total"
       }
      }
     },
     "localname": "CashCashEquivalentsAndShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureOrganizationAndAccountingPronouncementsAdditionalInformationDetails3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": {
     "auth_ref": [
      "r47",
      "r52",
      "r57"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations",
        "periodEndLabel": "Cash and cash equivalents at end of period",
        "periodStartLabel": "Cash and cash equivalents at beginning of period",
        "totalLabel": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations, Total"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r47",
      "r127"
     ],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net increase in cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CertificatesOfDepositMember": {
     "auth_ref": [
      "r140"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Short to medium-term investment available at banks and savings and loan institutions where a customer agrees to lend money to the institution for a certain amount of time and is paid a predetermined rate of interest. Certificates of deposit (CD) are typically Federal Deposit Insurance Corporation (FDIC) insured.",
        "label": "Certificates of Deposit [Member]",
        "terseLabel": "Certificates of Deposit"
       }
      }
     },
     "localname": "CertificatesOfDepositMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfAssetsThatRequireFairValueMeasurementsOnRecurringBasisAndTheirRespectiveInputLevelsBasedOnFairValueHierarchyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted": {
     "auth_ref": [
      "r155",
      "r156",
      "r204",
      "r254",
      "r255",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r411",
      "r428",
      "r429",
      "r442",
      "r445",
      "r446",
      "r456",
      "r462",
      "r464",
      "r465",
      "r466",
      "r469",
      "r470",
      "r479",
      "r483",
      "r484",
      "r485",
      "r486",
      "r499",
      "r500",
      "r540",
      "r541",
      "r554",
      "r555"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates (true false) whether accounting standards update was adopted.",
        "label": "Change in Accounting Principle, Accounting Standards Update, Adopted [true false]",
        "terseLabel": "Change in accounting principle, accounting standards update, adopted"
       }
      }
     },
     "localname": "ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureOrganizationAndAccountingPronouncementsAdditionalInformationDetails1"
     ],
     "xbrltype": "booleanItemType"
    },
    "us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate": {
     "auth_ref": [
      "r155",
      "r156",
      "r254",
      "r255",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r411",
      "r428",
      "r429",
      "r430",
      "r442",
      "r445",
      "r446",
      "r447",
      "r450",
      "r456",
      "r462",
      "r464",
      "r465",
      "r466",
      "r469",
      "r470",
      "r479",
      "r483",
      "r484",
      "r485",
      "r486",
      "r499",
      "r500",
      "r540",
      "r541",
      "r554",
      "r555",
      "r657"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date accounting standards update was adopted, in YYYY-MM-DD format.",
        "label": "Change in Accounting Principle, Accounting Standards Update, Adoption Date",
        "terseLabel": "Change in accounting principle, accounting standards update, adoption date"
       }
      }
     },
     "localname": "ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureOrganizationAndAccountingPronouncementsAdditionalInformationDetails1"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect": {
     "auth_ref": [
      "r205",
      "r217",
      "r256",
      "r272",
      "r415"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates (true false) whether effect from applying amendment to accounting standards is immaterial.",
        "label": "Change in Accounting Principle, Accounting Standards Update, Immaterial Effect [true false]",
        "terseLabel": "Change in accounting principle, accounting standards update, immaterial effect"
       }
      }
     },
     "localname": "ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureOrganizationAndAccountingPronouncementsAdditionalInformationDetails1"
     ],
     "xbrltype": "booleanItemType"
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "auth_ref": [
      "r340"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding.",
        "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights",
        "terseLabel": "Warrants exercisable, per share exercise price"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureNotesPayableAdditionalInformationDetails",
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": {
     "auth_ref": [
      "r340"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.",
        "label": "Class of Warrant or Right, Number of Securities Called by Warrants or Rights",
        "terseLabel": "Lenders warrants exercisable for shares",
        "verboseLabel": "Shares upon exercise of warrants"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureNotesPayableAdditionalInformationDetails",
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CollaborativeArrangementDisclosureTextBlock": {
     "auth_ref": [
      "r431",
      "r432",
      "r434"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for collaborative arrangements in which the entity is a participant, including a) information about the nature and purpose of such arrangements; b) its rights and obligations thereunder; c) the accounting policy for collaborative arrangements; and d) the income statement classification and amounts attributable to transactions arising from the collaborative arrangement between participants.",
        "label": "Collaborative Arrangement Disclosure [Text Block]",
        "terseLabel": "Partnerships"
       }
      }
     },
     "localname": "CollaborativeArrangementDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosurePartnerships"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CollaborativeArrangementMember": {
     "auth_ref": [
      "r433"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual arrangement that involves two or more parties that both: (i) actively participate in a joint operating activity and (ii) are exposed to significant risks and rewards that depend on the commercial success of the joint operating activity.",
        "label": "Collaborative Arrangement [Member]",
        "terseLabel": "Collaboration and License Agreement"
       }
      }
     },
     "localname": "CollaborativeArrangementMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosurePartnershipsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]",
        "terseLabel": "Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]"
       }
      }
     },
     "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosurePartnershipsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r22",
      "r137",
      "r151"
     ],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r77",
      "r289",
      "r290",
      "r582",
      "r669"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "auth_ref": [
      "r23"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate number of common shares reserved for future issuance.",
        "label": "Common Stock, Capital Shares Reserved for Future Issuance",
        "terseLabel": "Number of shares available for issuance",
        "verboseLabel": "Total common stock reserved for future issuance"
       }
      }
     },
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetails",
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquitySummaryOfCommonStockReservedForFutureIssuanceDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r654",
      "r655",
      "r706"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetails",
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetails",
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetails",
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued",
        "totalLabel": "Common Stock, Shares, Issued, Total"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r7",
      "r80"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "periodEndLabel": "Common Stock, Shares, Outstanding, Ending Balance",
        "periodStartLabel": "Common Stock, Shares, Outstanding, Beginning Balance",
        "terseLabel": "Common stock, shares outstanding"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetails",
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r7",
      "r628"
     ],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "order": 0.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "periodEndLabel": "Common Stock, Value, Issued, Ending Balance",
        "periodStartLabel": "Common Stock, Value, Issued, Beginning Balance",
        "terseLabel": "Common stock, $0.0001 par value; 200,000,000 shares authorized as of December 31, 2022 and 2021; 34,414,149 and 29,455,668 shares issued and outstanding as of December 31, 2022 and 2021, respectively",
        "totalLabel": "Common Stock, Value, Issued, Total"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CompensationAndEmployeeBenefitPlansTextBlock": {
     "auth_ref": [
      "r87",
      "r88",
      "r89",
      "r100"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for an entity's employee compensation and benefit plans, including, but not limited to, postemployment and postretirement benefit plans, defined benefit pension plans, defined contribution plans, non-qualified and supplemental benefit plans, deferred compensation, share-based compensation, life insurance, severance, health care, unemployment and other benefit plans.",
        "label": "Compensation and Employee Benefit Plans [Text Block]",
        "terseLabel": "Retirement Plan"
       }
      }
     },
     "localname": "CompensationAndEmployeeBenefitPlansTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureRetirementPlan"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CompensationAndRetirementDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retirement Benefits [Abstract]"
       }
      }
     },
     "localname": "CompensationAndRetirementDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r30",
      "r176",
      "r178",
      "r184",
      "r544",
      "r550"
     ],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive loss"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomePolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for comprehensive income.",
        "label": "Comprehensive Income, Policy [Policy Text Block]",
        "terseLabel": "Comprehensive Loss"
       }
      }
     },
     "localname": "ComprehensiveIncomePolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ComputerEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems.",
        "label": "Computer Equipment [Member]",
        "terseLabel": "Computer Equipment"
       }
      }
     },
     "localname": "ComputerEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosurePropertyAndEquipmentScheduleOfPropertyAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "auth_ref": [
      "r143",
      "r231"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for credit risk.",
        "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
        "terseLabel": "Concentration of Credit Risk and Off-Balance Sheet Risk"
       }
      }
     },
     "localname": "ConcentrationRiskCreditRisk",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContingentConsiderationByTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of contingent consideration.",
        "label": "Contingent Consideration by Type [Axis]"
       }
      }
     },
     "localname": "ContingentConsiderationByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureAcquisitionAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ContingentConsiderationTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of contingent payment arrangement.",
        "label": "Contingent Consideration Type [Domain]"
       }
      }
     },
     "localname": "ContingentConsiderationTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureAcquisitionAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r109",
      "r408",
      "r419",
      "r653"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.",
        "label": "Current Income Tax Expense (Benefit)",
        "terseLabel": "Current income tax expense (benefit)",
        "totalLabel": "Current Income Tax Expense (Benefit), Total"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r1",
      "r2",
      "r3",
      "r133",
      "r135",
      "r145",
      "r199",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r482",
      "r609",
      "r610",
      "r611",
      "r612",
      "r613",
      "r651"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureNotesPayableAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "Debt instrument, basis spread on variable rate"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureNotesPayableAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "auth_ref": [
      "r3",
      "r135",
      "r145",
      "r321"
     ],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureNotesPayableScheduleOfAggregateCarryingAmountsOfTermLoanDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
        "label": "Long-Term Debt, Gross",
        "terseLabel": "Principal"
       }
      }
     },
     "localname": "DebtInstrumentCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureNotesPayableScheduleOfAggregateCarryingAmountsOfTermLoanDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFrequencyOfPeriodicPayment": {
     "auth_ref": [
      "r21",
      "r141"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of the frequency of periodic payments (monthly, quarterly, annual).",
        "label": "Debt Instrument, Frequency of Periodic Payment",
        "terseLabel": "Debt instrument, frequency of periodic payment"
       }
      }
     },
     "localname": "DebtInstrumentFrequencyOfPeriodicPayment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureNotesPayableAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentInterestRateBasisForEffectiveRate": {
     "auth_ref": [
      "r20",
      "r129"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of any adjustments made to the stated rate to determine the effective rate.",
        "label": "Debt Instrument, Interest Rate, Basis for Effective Rate",
        "terseLabel": "Debt instrument, interest rate, basis for effective rate"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateBasisForEffectiveRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureNotesPayableAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentInterestRateEffectivePercentage": {
     "auth_ref": [
      "r20",
      "r129",
      "r323",
      "r482"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.",
        "label": "Debt Instrument, Interest Rate, Effective Percentage",
        "terseLabel": "Debt instrument, interest rate, effective percentage"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateEffectivePercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureNotesPayableAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r20",
      "r305"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Debt instrument, interest rate, stated percentage"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureNotesPayableAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureNotesPayableScheduleOfAggregateCarryingAmountsOfTermLoanDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r21",
      "r199",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r482",
      "r609",
      "r610",
      "r611",
      "r612",
      "r613",
      "r651"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureNotesPayableAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r21",
      "r81",
      "r82",
      "r83",
      "r84",
      "r128",
      "r129",
      "r130",
      "r142",
      "r199",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r482",
      "r609",
      "r610",
      "r611",
      "r612",
      "r613",
      "r651"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "terseLabel": "Debt Instrument [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureNotesPayableScheduleOfAggregateCarryingAmountsOfTermLoanDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscount": {
     "auth_ref": [
      "r128",
      "r130",
      "r673"
     ],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureNotesPayableScheduleFutureMaturitiesOfTermLoanIncludingFinalPaymentFeeDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": -1.0
      },
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureNotesPayableScheduleOfAggregateCarryingAmountsOfTermLoanDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt discount.",
        "label": "Debt Instrument, Unamortized Discount",
        "negatedLabel": "Less: unamortized discount",
        "totalLabel": "Debt Instrument, Unamortized Discount, Total"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureNotesPayableScheduleFutureMaturitiesOfTermLoanIncludingFinalPaymentFeeDetails",
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureNotesPayableScheduleOfAggregateCarryingAmountsOfTermLoanDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTable": {
     "auth_ref": [
      "r262"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale [Table]",
        "terseLabel": "Debt Securities Available For Sale [Table]"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureShortTermInvestmentsAdditionalInformationDetails",
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureShortTermInvestmentsScheduleOfCompanySShortTermInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTerm": {
     "auth_ref": [
      "r707"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period between issuance and maturity of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Debt Securities, Available-for-Sale, Term",
        "verboseLabel": "Maturity (in years)"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleTerm",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureShortTermInvestmentsScheduleOfCompanySShortTermInvestmentsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r50",
      "r109",
      "r409",
      "r418",
      "r419",
      "r653"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "terseLabel": "Deferred income tax expense (benefit)",
        "totalLabel": "Deferred Income Tax Expense (Benefit), Total"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilities": {
     "auth_ref": [
      "r4",
      "r5",
      "r134",
      "r144",
      "r402"
     ],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfNetDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences.",
        "label": "Deferred Tax Liabilities, Gross",
        "negatedTotalLabel": "Total deferred tax liabilities",
        "totalLabel": "Deferred Tax Liabilities, Gross, Total"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfNetDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredRevenue": {
     "auth_ref": [
      "r644"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.",
        "label": "Deferred Revenue",
        "terseLabel": "Deferred revenue",
        "totalLabel": "Deferred Revenue, Total"
       }
      }
     },
     "localname": "DeferredRevenue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosurePartnershipsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredRevenueCurrent": {
     "auth_ref": [
      "r643"
     ],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Deferred Revenue, Current",
        "terseLabel": "Current portion of deferred revenue",
        "totalLabel": "Deferred Revenue, Current, Total",
        "verboseLabel": "Deferred revenue current"
       }
      }
     },
     "localname": "DeferredRevenueCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosurePartnershipsAdditionalInformationDetails",
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredRevenueNoncurrent": {
     "auth_ref": [
      "r644"
     ],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent.",
        "label": "Deferred Revenue, Noncurrent",
        "terseLabel": "Long-term deferred revenue",
        "totalLabel": "Deferred Revenue, Noncurrent, Total",
        "verboseLabel": "Deferred revenue long term"
       }
      }
     },
     "localname": "DeferredRevenueNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosurePartnershipsAdditionalInformationDetails",
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "auth_ref": [
      "r403"
     ],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfNetDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Gross",
        "totalLabel": "Total deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfNetDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsLiabilitiesNet": {
     "auth_ref": [
      "r703"
     ],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfNetDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.",
        "label": "Deferred Tax Assets, Net",
        "totalLabel": "Net deferred taxes"
       }
      }
     },
     "localname": "DeferredTaxAssetsLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfNetDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "auth_ref": [
      "r703"
     ],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfNetDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Net of Valuation Allowance",
        "totalLabel": "Total deferred tax assets, net of allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfNetDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Net [Abstract]",
        "terseLabel": "Deferred tax assets:"
       }
      }
     },
     "localname": "DeferredTaxAssetsNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfNetDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "auth_ref": [
      "r108",
      "r704"
     ],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfNetDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards",
        "terseLabel": "Net operating loss carryforward",
        "totalLabel": "Deferred Tax Assets, Operating Loss Carryforwards, Total"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfNetDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic": {
     "auth_ref": [
      "r108",
      "r704"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible domestic operating loss carryforwards. Excludes state and local operating loss carryforwards.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards, Domestic",
        "terseLabel": "Federal tax loss carry forwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsDomestic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal": {
     "auth_ref": [
      "r108",
      "r704"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible state and local operating loss carryforwards.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards, State and Local",
        "terseLabel": "Foreign tax loss carry forwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOther": {
     "auth_ref": [
      "r108",
      "r704"
     ],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfNetDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.",
        "label": "Deferred Tax Assets, Other",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "DeferredTaxAssetsOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfNetDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwards": {
     "auth_ref": [
      "r106",
      "r108",
      "r704"
     ],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfNetDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.",
        "label": "Deferred Tax Assets, Tax Credit Carryforwards",
        "terseLabel": "Credits",
        "totalLabel": "Deferred Tax Assets, Tax Credit Carryforwards, Total",
        "verboseLabel": "Tax credit carry forwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxCreditCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails",
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfNetDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation": {
     "auth_ref": [
      "r108",
      "r704"
     ],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfNetDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from employee compensation.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Compensation",
        "terseLabel": "Equity compensation"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfNetDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r404"
     ],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfNetDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "negatedLabel": "Valuation allowance",
        "terseLabel": "Deferred tax assets, Valuation allowance",
        "totalLabel": "Deferred Tax Assets, Valuation Allowance, Total"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails",
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfNetDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Liabilities, Gross [Abstract]",
        "terseLabel": "Deferred tax liabilities:"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfNetDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesLeasingArrangements": {
     "auth_ref": [
      "r108",
      "r704"
     ],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfNetDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from leasing arrangements.",
        "label": "Deferred Tax Liabilities, Leasing Arrangements",
        "negatedLabel": "Operating lease right-of-use asset"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesLeasingArrangements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfNetDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesOther": {
     "auth_ref": [
      "r108",
      "r704"
     ],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfNetDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences classified as other.",
        "label": "Deferred Tax Liabilities, Other",
        "negatedLabel": "Other"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfNetDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesTaxDeferredIncome": {
     "auth_ref": [
      "r108",
      "r704"
     ],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfNetDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from tax deferred revenue or income classified as other.",
        "label": "Deferred Tax Liabilities, Tax Deferred Income",
        "negatedLabel": "Deferred revenue"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesTaxDeferredIncome",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfNetDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of discretionary contributions made by an employer to a defined contribution plan.",
        "label": "Defined Contribution Plan, Employer Discretionary Contribution Amount",
        "terseLabel": "Employer's matching contributions to 401(k) plan"
       }
      }
     },
     "localname": "DefinedContributionPlanEmployerDiscretionaryContributionAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureRetirementPlanAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r50",
      "r71"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation expense",
        "totalLabel": "Depreciation, Total"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosurePropertyAndEquipmentAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationAndAmortization": {
     "auth_ref": [
      "r50",
      "r71"
     ],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.",
        "label": "Depreciation, Depletion and Amortization, Nonproduction",
        "terseLabel": "Depreciation and amortization",
        "totalLabel": "Depreciation, Depletion and Amortization, Nonproduction, Total"
       }
      }
     },
     "localname": "DepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DomesticCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile.",
        "label": "Domestic Tax Authority [Member]",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "DomesticCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r185",
      "r209",
      "r210",
      "r211",
      "r212",
      "r213",
      "r219",
      "r221",
      "r223",
      "r224",
      "r225",
      "r227",
      "r454",
      "r455",
      "r545",
      "r551",
      "r605"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Net loss per share, basic",
        "totalLabel": "Earnings Per Share, Basic, Total"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r185",
      "r209",
      "r210",
      "r211",
      "r212",
      "r213",
      "r221",
      "r223",
      "r224",
      "r225",
      "r227",
      "r454",
      "r455",
      "r545",
      "r551",
      "r605"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Net loss per share, diluted",
        "totalLabel": "Earnings Per Share, Diluted, Total"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r60",
      "r61"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "terseLabel": "Net Loss per Share"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": {
     "auth_ref": [
      "r711"
     ],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations",
        "terseLabel": "Effect of exchange rate changes on cash and cash equivalents",
        "totalLabel": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations, Total"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r18"
     ],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Accrued payroll and other employee benefits",
        "totalLabel": "Employee-related Liabilities, Current, Total"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r385"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Expected recognition period of unrecognized compensation expense"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": {
     "auth_ref": [
      "r701"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost to be recognized for option under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount",
        "terseLabel": "Unrecognized compensation expense related to unvested stock options"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An Employee Stock Purchase Plan is a tax-efficient means by which employees of a corporation can purchase the corporation's stock.",
        "label": "Employee Stock [Member]",
        "terseLabel": "Stock Options"
       }
      }
     },
     "localname": "EmployeeStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquitySummaryOfStockOptionActivityParentheticalDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-Based Payment Arrangement, Option [Member]",
        "terseLabel": "Common Stock Options",
        "verboseLabel": "Common Stock Options"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetails",
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfPotentiallyDilutiveSecuritiesNotIncludedInCalculationOfDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r80",
      "r157",
      "r180",
      "r181",
      "r182",
      "r200",
      "r201",
      "r202",
      "r206",
      "r214",
      "r216",
      "r228",
      "r271",
      "r341",
      "r386",
      "r387",
      "r388",
      "r413",
      "r414",
      "r453",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r477",
      "r504",
      "r556",
      "r557",
      "r558"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetails",
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquitySummaryOfCommonStockReservedForFutureIssuanceDetails",
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityInterestIssuedOrIssuableByTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of equity interests that are issued or issuable in a business combination.",
        "label": "Equity Interest Type [Axis]"
       }
      }
     },
     "localname": "EquityInterestIssuedOrIssuableByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureAcquisitionAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityInterestIssuedOrIssuableTypeDomain": {
     "auth_ref": [
      "r116"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of equity interest issued or issuable to acquire an entity in a business combination.",
        "label": "Equity Interest Issued or Issuable, Type [Domain]"
       }
      }
     },
     "localname": "EquityInterestIssuedOrIssuableTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureAcquisitionAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityUnitPurchaseAgreementsMember": {
     "auth_ref": [
      "r60"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contracts and securities that allow the holder to buy equity units from the entity.",
        "label": "Equity Unit Purchase Agreements [Member]",
        "terseLabel": "Securities Purchase Agreement",
        "verboseLabel": "Equity Unit Purchase Agreements"
       }
      }
     },
     "localname": "EquityUnitPurchaseAgreementsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfAssetsThatRequireFairValueMeasurementsOnRecurringBasisAndTheirRespectiveInputLevelsBasedOnFairValueHierarchyDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r457",
      "r458",
      "r460"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfAssetsThatRequireFairValueMeasurementsOnRecurringBasisAndTheirRespectiveInputLevelsBasedOnFairValueHierarchyDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock": {
     "auth_ref": [
      "r121",
      "r122"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Fair Value, Assets Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Summary of Assets that Require Fair Value Measurements on Recurring Basis and Their Respective Input Levels Based on Fair Value Hierarchy"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain": {
     "auth_ref": [
      "r123"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class of asset.",
        "label": "Asset Class [Domain]",
        "terseLabel": "Asset Class"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfAssetsThatRequireFairValueMeasurementsOnRecurringBasisAndTheirRespectiveInputLevelsBasedOnFairValueHierarchyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]",
        "terseLabel": "Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]"
       }
      }
     },
     "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByAssetClassAxis": {
     "auth_ref": [
      "r121",
      "r124"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by class of asset.",
        "label": "Asset Class [Axis]",
        "terseLabel": "Asset Class"
       }
      }
     },
     "localname": "FairValueByAssetClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfAssetsThatRequireFairValueMeasurementsOnRecurringBasisAndTheirRespectiveInputLevelsBasedOnFairValueHierarchyDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByBalanceSheetGroupingTable": {
     "auth_ref": [
      "r121",
      "r125",
      "r126"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.",
        "label": "Fair Value, by Balance Sheet Grouping [Table]",
        "terseLabel": "Fair Value By Balance Sheet Grouping [Table]"
       }
      }
     },
     "localname": "FairValueByBalanceSheetGroupingTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r312",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r458",
      "r511",
      "r512",
      "r513",
      "r610",
      "r611",
      "r617",
      "r618",
      "r619"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfAssetsThatRequireFairValueMeasurementsOnRecurringBasisAndTheirRespectiveInputLevelsBasedOnFairValueHierarchyDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r459"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Fair Value of Financial Instruments"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstruments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r312",
      "r345",
      "r350",
      "r458",
      "r511",
      "r617",
      "r618",
      "r619"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfAssetsThatRequireFairValueMeasurementsOnRecurringBasisAndTheirRespectiveInputLevelsBasedOnFairValueHierarchyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r312",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r511",
      "r512",
      "r513",
      "r610",
      "r611",
      "r617",
      "r618",
      "r619"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfAssetsThatRequireFairValueMeasurementsOnRecurringBasisAndTheirRespectiveInputLevelsBasedOnFairValueHierarchyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueOfAssetsAcquired": {
     "auth_ref": [
      "r54",
      "r55",
      "r56"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value of assets acquired in noncash investing or financing activities.",
        "label": "Fair Value of Assets Acquired",
        "terseLabel": "Fair value of Bioniz assets acquired"
       }
      }
     },
     "localname": "FairValueOfAssetsAcquired",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r259",
      "r260",
      "r276",
      "r279",
      "r280",
      "r281",
      "r282",
      "r284",
      "r285",
      "r286",
      "r320",
      "r338",
      "r443",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r608",
      "r662",
      "r663",
      "r664",
      "r725",
      "r726",
      "r727",
      "r728",
      "r729",
      "r730",
      "r731"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureShortTermInvestmentsScheduleOfCompanySShortTermInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinancialLiabilitiesFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial obligations, including, but not limited to, debt instruments, derivative liabilities, federal funds purchased and sold under agreements to repurchase, securities loaned or sold under agreements to repurchase, financial instruments sold not yet purchased, guarantees, line of credit, loans and notes payable, servicing liability, and trading liabilities.",
        "label": "Financial Liabilities Fair Value Disclosure",
        "terseLabel": "Financial liabilities",
        "totalLabel": "Financial Liabilities Fair Value Disclosure, Total"
       }
      }
     },
     "localname": "FinancialLiabilitiesFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile.",
        "label": "Foreign Tax Authority [Member]",
        "terseLabel": "Foreign"
       }
      }
     },
     "localname": "ForeignCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignCurrencyTransactionGainLossRealized": {
     "auth_ref": [
      "r709",
      "r710"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of foreign currency transaction realized gain (loss) recognized in the income statement.",
        "label": "Foreign Currency Transaction Gain (Loss), Realized",
        "terseLabel": "Foreign curreny realized gain"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionGainLossRealized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosurePartnershipsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyTransactionGainLossUnrealized": {
     "auth_ref": [
      "r51",
      "r709",
      "r710"
     ],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of foreign currency transaction unrealized gain (loss) recognized in the income statement.",
        "label": "Foreign Currency Transaction Gain (Loss), Unrealized",
        "negatedLabel": "Net unrealized loss on foreign currency transactions"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionGainLossUnrealized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
        "label": "Furniture and Fixtures [Member]",
        "terseLabel": "Furniture And Fixtures"
       }
      }
     },
     "localname": "FurnitureAndFixturesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosurePropertyAndEquipmentScheduleOfPropertyAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainLossOnDispositionOfAssets1": {
     "auth_ref": [
      "r649"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee.",
        "label": "Gain (Loss) on Disposition of Assets",
        "terseLabel": "Gains (losses) on disposal of property and equipment",
        "totalLabel": "Gain (Loss) on Disposition of Assets, Total"
       }
      }
     },
     "localname": "GainLossOnDispositionOfAssets1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosurePropertyAndEquipmentAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r35"
     ],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 4.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General and Administrative Expense",
        "terseLabel": "General and administrative",
        "totalLabel": "General and Administrative Expense, Total"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "auth_ref": [
      "r34"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing general and administrative expense.",
        "label": "General and Administrative Expense [Member]",
        "terseLabel": "General and Administrative Expense"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquitySummaryOfTotalNonCashStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": {
     "auth_ref": [
      "r70",
      "r75"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.",
        "label": "Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]",
        "terseLabel": "Impairment of Long-Lived Assets"
       }
      }
     },
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InProcessResearchAndDevelopmentPolicy": {
     "auth_ref": [
      "r102"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for costs assigned to identifiable tangible and intangible assets of an acquired entity to be used in the research and development activities of the combined enterprise. An entity also may disclose the appraisal method or significant assumptions used to value acquired research and development assets.",
        "label": "In Process Research and Development, Policy [Policy Text Block]",
        "terseLabel": "Acquired In-Process Research and Development Expense"
       }
      }
     },
     "localname": "InProcessResearchAndDevelopmentPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": {
     "auth_ref": [
      "r194",
      "r420"
     ],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfComponentsOfLossBeforeIncomeTaxProvisionBenefitDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Domestic",
        "terseLabel": "U.S."
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfComponentsOfLossBeforeIncomeTaxProvisionBenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r32",
      "r131",
      "r138",
      "r153",
      "r238",
      "r240",
      "r244",
      "r246",
      "r546",
      "r607"
     ],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfComponentsOfLossBeforeIncomeTaxProvisionBenefitDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Loss before income tax provision (benefit)"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfComponentsOfLossBeforeIncomeTaxProvisionBenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": {
     "auth_ref": [
      "r194",
      "r420"
     ],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfComponentsOfLossBeforeIncomeTaxProvisionBenefitDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Foreign",
        "terseLabel": "Foreign"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfComponentsOfLossBeforeIncomeTaxProvisionBenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r287",
      "r288"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquitySummaryOfTotalNonCashStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r288"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquitySummaryOfTotalNonCashStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "auth_ref": [
      "r104"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by tax jurisdiction.",
        "label": "Income Tax Authority [Axis]",
        "terseLabel": "Income Tax Authority"
       }
      }
     },
     "localname": "IncomeTaxAuthorityAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority [Domain]",
        "terseLabel": "Income Tax Authority"
       }
      }
     },
     "localname": "IncomeTaxAuthorityDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityNameAxis": {
     "auth_ref": [
      "r104"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of taxing authority.",
        "label": "Income Tax Authority, Name [Axis]",
        "terseLabel": "Income Tax Authority, Name"
       }
      }
     },
     "localname": "IncomeTaxAuthorityNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Named agency, division or body that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority, Name [Domain]",
        "terseLabel": "Income Tax Authority, Name"
       }
      }
     },
     "localname": "IncomeTaxAuthorityNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r195",
      "r396",
      "r400",
      "r407",
      "r416",
      "r421",
      "r423",
      "r424",
      "r425"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r196",
      "r215",
      "r216",
      "r237",
      "r394",
      "r417",
      "r422",
      "r552"
     ],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesReconciliationOfExpectedStatutoryFederalIncomeTaxProvisionToActualIncomeTaxProvisionDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "totalLabel": "Income tax expense (benefit)"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesReconciliationOfExpectedStatutoryFederalIncomeTaxProvisionToActualIncomeTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Expense (Benefit), Effective Income Tax Rate Reconciliation, Amount [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r179",
      "r392",
      "r393",
      "r400",
      "r401",
      "r406",
      "r410"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax, Policy [Policy Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r702"
     ],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesReconciliationOfExpectedStatutoryFederalIncomeTaxProvisionToActualIncomeTaxProvisionDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.",
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount",
        "terseLabel": "Change in federal valuation allowance"
       }
      }
     },
     "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesReconciliationOfExpectedStatutoryFederalIncomeTaxProvisionToActualIncomeTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential": {
     "auth_ref": [
      "r702"
     ],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesReconciliationOfExpectedStatutoryFederalIncomeTaxProvisionToActualIncomeTaxProvisionDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount",
        "terseLabel": "Foreign rate differential"
       }
      }
     },
     "localname": "IncomeTaxReconciliationForeignIncomeTaxRateDifferential",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesReconciliationOfExpectedStatutoryFederalIncomeTaxProvisionToActualIncomeTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r395"
     ],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesReconciliationOfExpectedStatutoryFederalIncomeTaxProvisionToActualIncomeTaxProvisionDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount",
        "terseLabel": "Income taxes at statutory rates"
       }
      }
     },
     "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesReconciliationOfExpectedStatutoryFederalIncomeTaxProvisionToActualIncomeTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment": {
     "auth_ref": [
      "r702"
     ],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesReconciliationOfExpectedStatutoryFederalIncomeTaxProvisionToActualIncomeTaxProvisionDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible research and development expense.",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Amount",
        "terseLabel": "Acquired in-process research and development"
       }
      }
     },
     "localname": "IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesReconciliationOfExpectedStatutoryFederalIncomeTaxProvisionToActualIncomeTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost": {
     "auth_ref": [
      "r702"
     ],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesReconciliationOfExpectedStatutoryFederalIncomeTaxProvisionToActualIncomeTaxProvisionDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for award under share-based payment arrangement. Includes, but is not limited to, expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Amount",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesReconciliationOfExpectedStatutoryFederalIncomeTaxProvisionToActualIncomeTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes": {
     "auth_ref": [
      "r702"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount",
        "terseLabel": "State income tax, net of federal benefit"
       }
      }
     },
     "localname": "IncomeTaxReconciliationStateAndLocalIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesReconciliationOfExpectedStatutoryFederalIncomeTaxProvisionToActualIncomeTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r49"
     ],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Accounts payable",
        "totalLabel": "Increase (Decrease) in Accounts Payable, Total"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r49"
     ],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilities": {
     "auth_ref": [
      "r49"
     ],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.",
        "label": "Increase (Decrease) in Accrued Liabilities",
        "terseLabel": "Accrued expenses",
        "totalLabel": "Increase (Decrease) in Accrued Liabilities, Total"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDeferredRevenue": {
     "auth_ref": [
      "r601"
     ],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.",
        "label": "Increase (Decrease) in Deferred Revenue",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "IncreaseDecreaseInDeferredRevenue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r49"
     ],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedLabel": "Prepaid expenses and other current assets",
        "totalLabel": "Increase (Decrease) in Prepaid Expense and Other Assets, Total"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseDebt": {
     "auth_ref": [
      "r38",
      "r317",
      "r324",
      "r612",
      "r613"
     ],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 0.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt.",
        "label": "Interest Expense, Debt",
        "negatedLabel": "Interest expense",
        "totalLabel": "Interest Expense, Debt, Total"
       }
      }
     },
     "localname": "InterestExpenseDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r186",
      "r189",
      "r190"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Cash paid for interest"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPayableCurrent": {
     "auth_ref": [
      "r18"
     ],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Interest Payable, Current",
        "terseLabel": "Accrued interest"
       }
      }
     },
     "localname": "InterestPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeInterest": {
     "auth_ref": [
      "r36",
      "r236"
     ],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.",
        "label": "Investment Income, Interest",
        "terseLabel": "Interest income"
       }
      }
     },
     "localname": "InvestmentIncomeInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentTypeAxis": {
     "auth_ref": [
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of investments.",
        "label": "Investment Type [Axis]",
        "terseLabel": "Investment Type"
       }
      }
     },
     "localname": "InvestmentTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentTypeCategorizationMember": {
     "auth_ref": [
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset obtained to generate income or appreciate in value.",
        "label": "Investments [Domain]",
        "terseLabel": "Investments"
       }
      }
     },
     "localname": "InvestmentTypeCategorizationMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments, Debt and Equity Securities [Abstract]"
       }
      }
     },
     "localname": "InvestmentsDebtAndEquitySecuritiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentsFairValueDisclosure": {
     "auth_ref": [
      "r457"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.",
        "label": "Investments, Fair Value Disclosure",
        "terseLabel": "Total short-term investments",
        "totalLabel": "Investments, Fair Value Disclosure, Total"
       }
      }
     },
     "localname": "InvestmentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfAssetsThatRequireFairValueMeasurementsOnRecurringBasisAndTheirRespectiveInputLevelsBasedOnFairValueHierarchyDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "auth_ref": [
      "r72"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements [Member]",
        "terseLabel": "Leasehold improvements"
       }
      }
     },
     "localname": "LeaseholdImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosurePropertyAndEquipmentScheduleOfPropertyAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Lessee, Lease, Description [Line Items]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "auth_ref": [
      "r492"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about lessee's leases.",
        "label": "Lessee, Lease, Description [Table]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "auth_ref": [
      "r491"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.",
        "label": "Lessee, Leases [Policy Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeLeasesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r713"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Schedule of Maturities of Lease Liabilities"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureLeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r497"
     ],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureLeasesScheduleOfMaturitiesOfLeaseLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureLeasesScheduleOfMaturitiesOfLeaseLiabilitiesDetails2": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "terseLabel": "Total minimum lease payment",
        "totalLabel": "Total undiscounted lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureLeasesScheduleOfMaturitiesOfLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r497"
     ],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureLeasesScheduleOfMaturitiesOfLeaseLiabilitiesDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureLeasesScheduleOfMaturitiesOfLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r497"
     ],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureLeasesScheduleOfMaturitiesOfLeaseLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five",
        "terseLabel": "2027"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureLeasesScheduleOfMaturitiesOfLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r497"
     ],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureLeasesScheduleOfMaturitiesOfLeaseLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureLeasesScheduleOfMaturitiesOfLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r497"
     ],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureLeasesScheduleOfMaturitiesOfLeaseLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureLeasesScheduleOfMaturitiesOfLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r497"
     ],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureLeasesScheduleOfMaturitiesOfLeaseLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureLeasesScheduleOfMaturitiesOfLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r497"
     ],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureLeasesScheduleOfMaturitiesOfLeaseLiabilitiesDetails2": {
       "order": 0.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedLabel": "Less: imputed interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureLeasesScheduleOfMaturitiesOfLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r498"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureLeases3"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r17",
      "r193",
      "r263",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r437",
      "r440",
      "r441",
      "r461",
      "r606",
      "r670",
      "r714",
      "r715"
     ],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "order": 0.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r12",
      "r136",
      "r149",
      "r628",
      "r652",
      "r665",
      "r708"
     ],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and stockholders' equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "Liabilities and stockholders' equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesAssumed1": {
     "auth_ref": [
      "r54",
      "r55",
      "r56"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value of liabilities assumed in noncash investing or financing activities.",
        "label": "Liabilities Assumed",
        "terseLabel": "Bioniz net liabilities assumed"
       }
      }
     },
     "localname": "LiabilitiesAssumed1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r19",
      "r162",
      "r193",
      "r263",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r437",
      "r440",
      "r441",
      "r461",
      "r628",
      "r670",
      "r714",
      "r715"
     ],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "order": 0.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCredit": {
     "auth_ref": [
      "r3",
      "r135",
      "r145"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.",
        "label": "Long-Term Line of Credit",
        "terseLabel": "Borrowings under loan agreement",
        "totalLabel": "Long-term Line of Credit, Total"
       }
      }
     },
     "localname": "LineOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureNotesPayableAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityExpirationDate1": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date the credit facility terminates, in YYYY-MM-DD format.",
        "label": "Line of Credit Facility, Expiration Date",
        "terseLabel": "Term Loan maturity date"
       }
      }
     },
     "localname": "LineOfCreditFacilityExpirationDate1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureNotesPayableAdditionalInformationDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_LineOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.",
        "label": "Line of Credit [Member]",
        "terseLabel": "Line of Credit"
       }
      }
     },
     "localname": "LineOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureNotesPayableScheduleOfAggregateCarryingAmountsOfTermLoanDetails",
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureNotesPayableAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LitigationSettlementExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees.",
        "label": "Litigation Settlement, Expense",
        "terseLabel": "Litigation expense"
       }
      }
     },
     "localname": "LitigationSettlementExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r3",
      "r135",
      "r147",
      "r311",
      "r322",
      "r610",
      "r611"
     ],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureNotesPayableScheduleFutureMaturitiesOfTermLoanIncludingFinalPaymentFeeDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureNotesPayableScheduleFutureMaturitiesOfTermLoanIncludingFinalPaymentFeeDetails2": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureNotesPayableScheduleOfAggregateCarryingAmountsOfTermLoanDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.",
        "label": "Long-Term Debt",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureNotesPayableScheduleFutureMaturitiesOfTermLoanIncludingFinalPaymentFeeDetails",
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureNotesPayableScheduleOfAggregateCarryingAmountsOfTermLoanDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtCurrent": {
     "auth_ref": [
      "r16"
     ],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureNotesPayableScheduleFutureMaturitiesOfTermLoanIncludingFinalPaymentFeeDetails2": {
       "order": 0.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-Term Debt, Current Maturities",
        "negatedLabel": "Less current portion",
        "totalLabel": "Long-term Debt, Current Maturities, Total"
       }
      }
     },
     "localname": "LongTermDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureNotesPayableScheduleFutureMaturitiesOfTermLoanIncludingFinalPaymentFeeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r168"
     ],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureNotesPayableScheduleFutureMaturitiesOfTermLoanIncludingFinalPaymentFeeDetails2": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.",
        "label": "Long-Term Debt, Excluding Current Maturities",
        "terseLabel": "Noncurrent portion",
        "totalLabel": "Long-term Debt, Excluding Current Maturities, Total"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureNotesPayableScheduleFutureMaturitiesOfTermLoanIncludingFinalPaymentFeeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermNotesPayable": {
     "auth_ref": [
      "r21"
     ],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.",
        "label": "Notes Payable, Noncurrent",
        "terseLabel": "Long-term notes payable",
        "totalLabel": "Notes Payable, Noncurrent, Total"
       }
      }
     },
     "localname": "LongTermNotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r21"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-Term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureNotesPayableScheduleOfAggregateCarryingAmountsOfTermLoanDetails",
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureNotesPayableAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r21",
      "r79"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-Term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureNotesPayableScheduleOfAggregateCarryingAmountsOfTermLoanDetails",
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureNotesPayableAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MachineryAndEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.",
        "label": "Machinery and Equipment [Member]",
        "terseLabel": "Machinery &amp; Lab Equipment"
       }
      }
     },
     "localname": "MachineryAndEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosurePropertyAndEquipmentScheduleOfPropertyAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MortgageNotesPayableDisclosureTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for mortgage notes payable.",
        "label": "Mortgage Notes Payable Disclosure [Text Block]",
        "terseLabel": "Notes Payable"
       }
      }
     },
     "localname": "MortgageNotesPayableDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureNotesPayable"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r188"
     ],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash (used in) provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r188"
     ],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash provided by investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r47",
      "r48",
      "r51"
     ],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "order": 0.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash used in operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r33",
      "r51",
      "r139",
      "r152",
      "r160",
      "r174",
      "r177",
      "r182",
      "r193",
      "r205",
      "r209",
      "r210",
      "r211",
      "r212",
      "r215",
      "r216",
      "r222",
      "r238",
      "r240",
      "r244",
      "r246",
      "r263",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r455",
      "r461",
      "r607",
      "r670"
     ],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss)",
        "terseLabel": "Net loss",
        "totalLabel": "Net loss"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss",
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureOrganizationAndAccountingPronouncementsAdditionalInformationDetails1"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable": {
     "auth_ref": [
      "r59",
      "r155",
      "r156",
      "r157",
      "r158",
      "r159",
      "r203",
      "r205",
      "r206",
      "r207",
      "r208",
      "r211",
      "r218",
      "r227",
      "r254",
      "r255",
      "r268",
      "r269",
      "r270",
      "r271",
      "r273",
      "r274",
      "r386",
      "r387",
      "r388",
      "r411",
      "r412",
      "r413",
      "r414",
      "r428",
      "r429",
      "r430",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r462",
      "r463",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r479",
      "r480",
      "r484",
      "r485",
      "r486",
      "r487",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r540",
      "r541",
      "r542",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summarization of the changes in an accounting principle or a new accounting pronouncement, including the line items affected by the change and the financial effects of the change on those particular line items.",
        "label": "Accounting Standards Update and Change in Accounting Principle [Table]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureOrganizationAndAccountingPronouncementsAdditionalInformationDetails1"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recently Issued and Recently Adopted Accounting Pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r37"
     ],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 0.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "totalLabel": "Total other expense , net"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nonoperating Income (Expense) [Abstract]",
        "terseLabel": "Other expense, net:"
       }
      }
     },
     "localname": "NonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NotesPayable": {
     "auth_ref": [
      "r3",
      "r135",
      "r147"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer.",
        "label": "Notes Payable",
        "totalLabel": "Notes Payable, Total",
        "verboseLabel": "Carrying amount of notes payable"
       }
      }
     },
     "localname": "NotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NotesPayableCurrent": {
     "auth_ref": [
      "r16"
     ],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.",
        "label": "Notes Payable, Current",
        "terseLabel": "Current portion of long-term notes payable",
        "totalLabel": "Notes Payable, Current, Total"
       }
      }
     },
     "localname": "NotesPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 0.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "terseLabel": "Operating expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating expenses:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r238",
      "r240",
      "r244",
      "r246",
      "r607"
     ],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Loss from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseExpense": {
     "auth_ref": [
      "r712"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating lease expense. Excludes sublease income.",
        "label": "Operating Lease, Expense",
        "terseLabel": "Operating lease expense"
       }
      }
     },
     "localname": "OperatingLeaseExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, to be Paid [Abstract]"
       }
      }
     },
     "localname": "OperatingLeaseLiabilitiesPaymentsDueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r489"
     ],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureLeasesScheduleOfMaturitiesOfLeaseLiabilitiesDetails2": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      },
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureLeasesSummaryOfAdditionalInformationRelatedToLeasesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "terseLabel": "Operating lease liabilities",
        "totalLabel": "Total lease liabilities",
        "verboseLabel": "Total lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureLeasesScheduleOfMaturitiesOfLeaseLiabilitiesDetails",
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureLeasesSummaryOfAdditionalInformationRelatedToLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r489"
     ],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureLeasesSummaryOfAdditionalInformationRelatedToLeasesDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      },
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Current portion of operating lease liabilities",
        "verboseLabel": "Lease liabilities, current"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureLeasesSummaryOfAdditionalInformationRelatedToLeasesDetails",
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r489"
     ],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureLeasesSummaryOfAdditionalInformationRelatedToLeasesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      },
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Long-term operating lease liabilities",
        "verboseLabel": "Lease liabilities, non-current"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureLeasesSummaryOfAdditionalInformationRelatedToLeasesDetails",
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r490",
      "r493"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "terseLabel": "Operating cash flows from operating leases"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureLeasesSummaryOfAdditionalInformationRelatedToLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r488"
     ],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "ROU assets",
        "terseLabel": "Right-of-use assets",
        "verboseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureLeasesSummaryOfAdditionalInformationRelatedToLeasesDetails",
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r496",
      "r627"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Weighted average discount rate"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureLeasesSummaryOfAdditionalInformationRelatedToLeasesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r495",
      "r627"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Weighted average remaining lease term"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureLeasesSummaryOfAdditionalInformationRelatedToLeasesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingLossCarryforwards": {
     "auth_ref": [
      "r106"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Operating Loss Carryforwards",
        "terseLabel": "Federal net operating loss carryover",
        "totalLabel": "Operating Loss Carryforwards, Total"
       }
      }
     },
     "localname": "OperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLossCarryforwardsLimitationsOnUse": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A description of the limitations on the use of all operating loss carryforwards available to reduce future taxable income.",
        "label": "Operating Loss Carryforwards, Limitations on Use",
        "terseLabel": "Operating loss carryforwards, Limitation of use"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsLimitationsOnUse",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r0",
      "r58",
      "r65",
      "r120"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the organization, consolidation and basis of presentation of financial statements disclosure, and significant accounting policies of the reporting entity. May be provided in more than one note to the financial statements, as long as users are provided with an understanding of (1) the significant judgments and assumptions made by an enterprise in determining whether it must consolidate a VIE and/or disclose information about its involvement with a VIE, (2) the nature of restrictions on a consolidated VIE's assets reported by an enterprise in its statement of financial position, including the carrying amounts of such assets, (3) the nature of, and changes in, the risks associated with an enterprise's involvement with the VIE, and (4) how an enterprise's involvement with the VIE affects the enterprise's financial position, financial performance, and cash flows. Describes procedure if disclosures are provided in more than one note to the financial statements.",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]",
        "terseLabel": "Organization and Accounting Pronouncements"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureOrganizationAndAccountingPronouncements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r18"
     ],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "terseLabel": "Other accruals"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r166"
     ],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets",
        "totalLabel": "Other Assets, Noncurrent, Total"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r25"
     ],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "terseLabel": "Foreign currency translation gain",
        "totalLabel": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Total"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r31",
      "r80",
      "r175",
      "r178",
      "r183",
      "r471",
      "r476",
      "r477",
      "r543",
      "r549",
      "r646",
      "r647"
     ],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 0.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Comprehensive income",
        "totalLabel": "Total other comprehensive income, net"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss",
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]",
        "terseLabel": "Other comprehensive income, net:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax": {
     "auth_ref": [
      "r172",
      "r173",
      "r261"
     ],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 0.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment and Tax",
        "terseLabel": "Unrealized loss on available-for-sale securities, net"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r39"
     ],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "terseLabel": "Other income (expense), net",
        "totalLabel": "Other Nonoperating Income (Expense), Total"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings": {
     "auth_ref": [
      "r257"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other-than-temporary impairment (OTTI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), recognized in earnings.",
        "label": "Other-than-temporary Impairment Loss, Debt Securities, Available-for-Sale, Recognized in Earnings",
        "terseLabel": "Other than temporary impairment loss investments available for sale securities"
       }
      }
     },
     "localname": "OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureShortTermInvestmentsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfStockIssuanceCosts": {
     "auth_ref": [
      "r46"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security.",
        "label": "Payments of Stock Issuance Costs",
        "terseLabel": "Stock issuance costs"
       }
      }
     },
     "localname": "PaymentsOfStockIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r42"
     ],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "order": 0.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchases of property and equipment",
        "totalLabel": "Payments to Acquire Property, Plant, and Equipment, Total"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireShortTermInvestments": {
     "auth_ref": [
      "r43"
     ],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.",
        "label": "Payments to Acquire Short-Term Investments",
        "negatedLabel": "Purchases of short-term investments"
       }
      }
     },
     "localname": "PaymentsToAcquireShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r675",
      "r676",
      "r677",
      "r678",
      "r679",
      "r680",
      "r681",
      "r682",
      "r683",
      "r684",
      "r685",
      "r686",
      "r687",
      "r688",
      "r689",
      "r690",
      "r691",
      "r692",
      "r693",
      "r694",
      "r695",
      "r696",
      "r697",
      "r698",
      "r699",
      "r700"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetails",
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquitySummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [
      "r675",
      "r676",
      "r677",
      "r678",
      "r679",
      "r680",
      "r681",
      "r682",
      "r683",
      "r684",
      "r685",
      "r686",
      "r687",
      "r688",
      "r689",
      "r690",
      "r691",
      "r692",
      "r693",
      "r694",
      "r695",
      "r696",
      "r697",
      "r698",
      "r699",
      "r700"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetails",
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquitySummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r6",
      "r325"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, shares authorized"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r645"
     ],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrimeRateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate charged by financial institutions to their most creditworthy borrowers.",
        "label": "Prime Rate [Member]",
        "terseLabel": "Prime Rate"
       }
      }
     },
     "localname": "PrimeRateMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureNotesPayableAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "auth_ref": [
      "r44"
     ],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the additional capital contribution to the entity.",
        "label": "Proceeds from Issuance of Common Stock",
        "terseLabel": "Proceeds from issuance of common stock from follow-on offering, net of issuance costs",
        "verboseLabel": "Proceeds from issuance of common stock"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetails",
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments": {
     "auth_ref": [
      "r41",
      "r43"
     ],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from maturities, prepayments, calls and collections of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.",
        "label": "Proceeds from Maturities, Prepayments and Calls of Short-Term Investments",
        "terseLabel": "Maturities of short-term investments"
       }
      }
     },
     "localname": "ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r44",
      "r97"
     ],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds from Stock Options Exercised",
        "terseLabel": "Proceeds from exercise of stock options"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetails",
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockPlans": {
     "auth_ref": [
      "r44"
     ],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from the stock plan during the period.",
        "label": "Proceeds from Stock Plans",
        "terseLabel": "Proceeds from ESPP purchases"
       }
      }
     },
     "localname": "ProceedsFromStockPlans",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r160",
      "r174",
      "r177",
      "r187",
      "r193",
      "r205",
      "r215",
      "r216",
      "r238",
      "r240",
      "r244",
      "r246",
      "r263",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r435",
      "r438",
      "r439",
      "r455",
      "r461",
      "r546",
      "r607",
      "r625",
      "r626",
      "r648",
      "r670"
     ],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "order": 0.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net loss",
        "totalLabel": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Total"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r74"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Long-Lived Tangible Asset"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails",
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosurePropertyAndEquipmentScheduleOfPropertyAndEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "auth_ref": [
      "r76",
      "r583",
      "r584",
      "r585"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment Disclosure [Text Block]",
        "terseLabel": "Property and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosurePropertyAndEquipment"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentDisposals": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of divestiture of long-lived, physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property, Plant and Equipment, Disposals",
        "terseLabel": "Disposal of property and equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentDisposals",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosurePropertyAndEquipmentAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r72",
      "r164"
     ],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosurePropertyAndEquipmentScheduleOfPropertyAndEquipmentDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "periodEndLabel": "Property, Plant and Equipment, Gross, Ending Balance",
        "periodStartLabel": "Property, Plant and Equipment, Gross, Beginning Balance",
        "terseLabel": "Property and equipment, gross",
        "totalLabel": "Property, Plant and Equipment, Gross, Total"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosurePropertyAndEquipmentScheduleOfPropertyAndEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property Plant And Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosurePropertyAndEquipmentScheduleOfPropertyAndEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r74",
      "r150",
      "r547",
      "r628"
     ],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosurePropertyAndEquipmentScheduleOfPropertyAndEquipmentDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "periodEndLabel": "Property, Plant and Equipment, Net, Ending Balance",
        "periodStartLabel": "Property, Plant and Equipment, Net, Beginning Balance",
        "terseLabel": "Property and equipment, net",
        "totalLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosurePropertyAndEquipmentScheduleOfPropertyAndEquipmentDetails",
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "auth_ref": [
      "r74",
      "r583",
      "r584"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "terseLabel": "Property and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r74"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Schedule of Property and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosurePropertyAndEquipmentTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r72"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Long-Lived Tangible Asset"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails",
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosurePropertyAndEquipmentScheduleOfPropertyAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property, Plant and Equipment, Useful Life",
        "terseLabel": "Property and equipment, useful lives"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ReceivablesPolicyTextBlock": {
     "auth_ref": [
      "r658",
      "r659",
      "r660",
      "r661"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.",
        "label": "Receivable [Policy Text Block]",
        "terseLabel": "Accounts Receivable"
       }
      }
     },
     "localname": "ReceivablesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RepaymentsOfNotesPayable": {
     "auth_ref": [
      "r45"
     ],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for a borrowing supported by a written promise to pay an obligation.",
        "label": "Repayments of Notes Payable",
        "negatedLabel": "Principal repayments on note payable"
       }
      }
     },
     "localname": "RepaymentsOfNotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r101",
      "r154",
      "r722"
     ],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 0.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Research and development",
        "totalLabel": "Research and Development Expense, Total"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.",
        "label": "Research and Development Expense [Member]",
        "terseLabel": "Research and Development Expense"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquitySummaryOfTotalNonCashStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "auth_ref": [
      "r101"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.",
        "label": "Research and Development Expense, Policy [Policy Text Block]",
        "terseLabel": "Research and Development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ResearchAndDevelopmentInProcess": {
     "auth_ref": [],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of purchased research and development assets that are acquired in a business combination have no alternative future use and are therefore written off in the period of acquisition.",
        "label": "Research and Development in Process",
        "terseLabel": "In-process research and development",
        "verboseLabel": "Acquired in-process research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentInProcess",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r9",
      "r85",
      "r148",
      "r560",
      "r565",
      "r628"
     ],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "periodEndLabel": "Retained Earnings (Accumulated Deficit), Ending Balance",
        "periodStartLabel": "Retained Earnings (Accumulated Deficit), Beginning Balance",
        "terseLabel": "Accumulated deficit",
        "totalLabel": "Retained Earnings (Accumulated Deficit), Total"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r157",
      "r200",
      "r201",
      "r202",
      "r206",
      "r214",
      "r216",
      "r271",
      "r386",
      "r387",
      "r388",
      "r413",
      "r414",
      "r453",
      "r556",
      "r558"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Accumulated Deficit"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r234",
      "r235",
      "r239",
      "r242",
      "r243",
      "r247",
      "r248",
      "r250",
      "r342",
      "r343",
      "r539"
     ],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Recognized revenue",
        "verboseLabel": "Revenue"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosurePartnershipsAdditionalInformationDetails",
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueRecognitionPolicyTextBlock": {
     "auth_ref": [
      "r602",
      "r603"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.",
        "label": "Revenue [Policy Text Block]",
        "terseLabel": "Revenue Recognition"
       }
      }
     },
     "localname": "RevenueRecognitionPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r494",
      "r627"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "terseLabel": "Right-of-use assets obtained in exchange for lease obligations",
        "verboseLabel": "Right-of-use assets obtained in exchange for lease obligations"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureLeasesSummaryOfAdditionalInformationRelatedToLeasesDetails",
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.",
        "label": "Sale of Stock [Domain]",
        "terseLabel": "Sale of Stock"
       }
      }
     },
     "localname": "SaleOfStockNameOfTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquitySummaryOfStockOptionActivityParentheticalDetails",
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows",
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accrued liabilities.",
        "label": "Schedule of Accrued Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Accrued Expenses"
       }
      }
     },
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureAccruedExpensesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r60"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "terseLabel": "Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfPotentiallyDilutiveSecuritiesNotIncludedInCalculationOfDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "auth_ref": [
      "r60"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "terseLabel": "Summary of Potentially Dilutive Securities Not Included in Calculation of Diluted Net Loss Per Share"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Securities, Available-for-Sale [Line Items]",
        "terseLabel": "Schedule Of Available For Sale Securities [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureShortTermInvestmentsAdditionalInformationDetails",
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureShortTermInvestmentsScheduleOfCompanySShortTermInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r112",
      "r113",
      "r426"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureAcquisitionAdditionalInformationDetails",
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureAcquisitionSummaryOfPurchasePriceAllocationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of cash, cash equivalents, and investments.",
        "label": "Cash, Cash Equivalents and Investments [Table Text Block]",
        "terseLabel": "Schedule of Company's Short-Term Investments"
       }
      }
     },
     "localname": "ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureShortTermInvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": {
     "auth_ref": [
      "r705"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]",
        "terseLabel": "Schedule Of Collaborative Arrangements And Noncollaborative Arrangement Transactions [Table]"
       }
      }
     },
     "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosurePartnershipsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r105"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "terseLabel": "Significant Components of Deferred Tax Assets and Liabilities"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "auth_ref": [
      "r95"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]",
        "terseLabel": "Summary of Non-cash Stock-based Compensation Expense"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": {
     "auth_ref": [
      "r653"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions.",
        "label": "Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]",
        "terseLabel": "Summary of Components of Loss Before Income Tax Provision (Benefit)"
       }
      }
     },
     "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.",
        "label": "Schedule of Line of Credit Facilities [Table Text Block]",
        "terseLabel": "Schedule of Aggregate Carrying Amounts of Term Loan"
       }
      }
     },
     "localname": "ScheduleOfLineOfCreditFacilitiesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureNotesPayableTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": {
     "auth_ref": [
      "r78"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt.",
        "label": "Schedule of Maturities of Long-Term Debt [Table Text Block]",
        "terseLabel": "Schedule Future Maturities of Term Loan, Including Final Payment Fee"
       }
      }
     },
     "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureNotesPayableTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r74"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Schedule Of Property Plant And Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosurePropertyAndEquipmentScheduleOfPropertyAndEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r352",
      "r354",
      "r355",
      "r356",
      "r357",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "terseLabel": "Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetails",
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquitySummaryOfCommonStockReservedForFutureIssuanceDetails",
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquitySummaryOfStockOptionActivityDetails",
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquitySummaryOfStockOptionActivityParentheticalDetails",
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquitySummaryOfTotalNonCashStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r90",
      "r91",
      "r92"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]",
        "terseLabel": "Summary of Stock Option Activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r94"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Summary of Weighted-Average Assumptions Used to Determine Fair Value of Stock Option Grants"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShortTermDebtTable": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to borrowings under which repayment was required in less than twelve months (or normal operating cycle, if longer) after its issuance. It may include: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date and measures of the maximum and average amount outstanding during the period; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation.",
        "label": "Schedule of Short-Term Debt [Table]",
        "terseLabel": "Schedule Of Short Term Debt [Table]"
       }
      }
     },
     "localname": "ScheduleOfShortTermDebtTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureNotesPayableAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r49"
     ],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock-based compensation",
        "totalLabel": "Share-based Payment Arrangement, Noncash Expense, Total"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r381"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "terseLabel": "Expected dividend yield"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquitySummaryOfWeightedAverageAssumptionsUsedToDetermineFairValueOfStockOptionGrantsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "auth_ref": [
      "r380"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "terseLabel": "Expected volatility"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquitySummaryOfWeightedAverageAssumptionsUsedToDetermineFairValueOfStockOptionGrantsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r382"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "terseLabel": "Risk-free interest rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquitySummaryOfWeightedAverageAssumptionsUsedToDetermineFairValueOfStockOptionGrantsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "terseLabel": "Share Based Compensation Arrangement By Share Based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetails",
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquitySummaryOfCommonStockReservedForFutureIssuanceDetails",
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquitySummaryOfStockOptionActivityDetails",
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquitySummaryOfStockOptionActivityParentheticalDetails",
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquitySummaryOfTotalNonCashStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of additional shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized",
        "terseLabel": "Number of shares available for future issuance under employee stock purchase plan"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "auth_ref": [
      "r624"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized",
        "terseLabel": "Number of shares authorized for issuance under purchase rights granted to employees"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "auth_ref": [
      "r96"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant",
        "terseLabel": "Unvested shares issued under early exercise which are subject to repurchase"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r361"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number",
        "terseLabel": "Number of Outstanding Options, Exercisable"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquitySummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r361"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Weighted- Average Exercise Price Per Share, Exercisable"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquitySummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "auth_ref": [
      "r374"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value",
        "terseLabel": "Aggregate intrinsic value of stock options exercised"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "auth_ref": [
      "r365"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period",
        "negatedLabel": "Number of Outstanding Options, Forfeitures and Cancellations"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquitySummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [
      "r363"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross",
        "terseLabel": "Number of Outstanding Options, Granted",
        "verboseLabel": "Retention stock options issued to purchase common shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquitySummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r373"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "verboseLabel": "Weighted-average grant-date fair value of options granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r96"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value",
        "terseLabel": "Aggregate Intrinsic Value, Options Outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquitySummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r359",
      "r360"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Number of Outstanding Options, Ending Balance",
        "periodStartLabel": "Number of Outstanding Options, Beginning Balance",
        "terseLabel": "Repricing of outstanding options"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquitySummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r359",
      "r360"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Weighted- Average Exercise Price Per Share, Ending Balance",
        "periodStartLabel": "Weighted- Average Exercise Price Per Share, Beginning Balance"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquitySummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod": {
     "auth_ref": [
      "r96"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued under share-based payment arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period",
        "terseLabel": "Number of shares issued"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r355",
      "r356",
      "r357",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r364"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Exercise price of options per share",
        "verboseLabel": "Exercise price of repriced options per share"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquitySummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r365"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "terseLabel": "Weighted- Average Exercise Price Per Share, Forfeitures and Cancellations"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquitySummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r363"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Weighted- Average Exercise Price Per Share, Granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquitySummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationAwardTrancheOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "First portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period.",
        "label": "Share-Based Payment Arrangement, Tranche One [Member]",
        "terseLabel": "Tranche One"
       }
      }
     },
     "localname": "ShareBasedCompensationAwardTrancheOneMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "auth_ref": [
      "r358",
      "r377",
      "r378",
      "r379",
      "r380",
      "r383",
      "r389",
      "r390"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.",
        "label": "Share-Based Payment Arrangement [Policy Text Block]",
        "terseLabel": "Stock-Based Compensation"
       }
      }
     },
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SharePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Price of a single share of a number of saleable stocks of a company.",
        "label": "Share Price",
        "terseLabel": "Closing stock price per share"
       }
      }
     },
     "localname": "SharePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquitySummaryOfStockOptionActivityParentheticalDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage": {
     "auth_ref": [
      "r675"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of vesting of award under share-based payment arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage",
        "terseLabel": "Vesting percentage"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "auth_ref": [
      "r623"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period",
        "terseLabel": "Award expiration period"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r379"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Expected term (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquitySummaryOfWeightedAverageAssumptionsUsedToDetermineFairValueOfStockOptionGrantsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "auth_ref": [
      "r96"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value",
        "terseLabel": "Aggregate Intrinsic Value, Options Exercisable"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquitySummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r96"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted Average Remaining Contractual Term, Options Exercisable"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquitySummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r93"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted Average Remaining Contractual Term, Options Outstanding"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquitySummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1": {
     "auth_ref": [
      "r374"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value",
        "verboseLabel": "Fair value of stock options vested"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharesIssued": {
     "auth_ref": [
      "r80"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.",
        "label": "Shares, Issued",
        "periodEndLabel": "Balance, Share",
        "periodStartLabel": "Balance, Shares"
       }
      }
     },
     "localname": "SharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SharesIssuedPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or per unit amount of equity securities issued.",
        "label": "Shares Issued, Price Per Share",
        "terseLabel": "Sale of stock, price per share"
       }
      }
     },
     "localname": "SharesIssuedPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShortTermDebtLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Short-Term Debt [Line Items]",
        "terseLabel": "Short Term Debt [Line Items]"
       }
      }
     },
     "localname": "ShortTermDebtLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureNotesPayableAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r58",
      "r191"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "Summary of Significant Accounting Policies"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StateAndLocalJurisdictionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity.",
        "label": "State and Local Jurisdiction [Member]",
        "terseLabel": "State"
       }
      }
     },
     "localname": "StateAndLocalJurisdictionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r24",
      "r80",
      "r157",
      "r180",
      "r181",
      "r182",
      "r200",
      "r201",
      "r202",
      "r206",
      "r214",
      "r216",
      "r228",
      "r271",
      "r341",
      "r386",
      "r387",
      "r388",
      "r413",
      "r414",
      "r453",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r477",
      "r504",
      "r556",
      "r557",
      "r558"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetails",
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquitySummaryOfCommonStockReservedForFutureIssuanceDetails",
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows",
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r200",
      "r201",
      "r202",
      "r228",
      "r539"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows",
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssued1": {
     "auth_ref": [
      "r54",
      "r55",
      "r56"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value of stock issued in noncash financing activities.",
        "label": "Stock Issued",
        "negatedLabel": "Issuance of common stock for Bioniz acquisition",
        "terseLabel": "Issuance of commitment shares to Lincoln Park pursuant to agreement"
       }
      }
     },
     "localname": "StockIssued1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": {
     "auth_ref": [
      "r6",
      "r7",
      "r80",
      "r85"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan.",
        "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans",
        "terseLabel": "Issuance of common stock under employee stock purchase plan, Shares"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [
      "r6",
      "r7",
      "r80",
      "r85"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new stock issued during the period.",
        "label": "Stock Issued During Period, Shares, New Issues",
        "terseLabel": "Issuance of common stock, Shares",
        "verboseLabel": "Common stock shares issued"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosurePartnershipsAdditionalInformationDetails",
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetails",
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesOther": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued attributable to transactions classified as other.",
        "label": "Stock Issued During Period, Shares, Other",
        "terseLabel": "Issuance of common stock from follow-on offering, net of issuance costs,Shares",
        "verboseLabel": "Issuance of common stock under registered direct offering, net of offering costs , Shares"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r6",
      "r7",
      "r80",
      "r85",
      "r364"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "negatedLabel": "Number of Outstanding Options, Exercised",
        "terseLabel": "Exercise of stock options, Shares"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquitySummaryOfStockOptionActivityDetails",
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan": {
     "auth_ref": [
      "r6",
      "r7",
      "r80",
      "r85"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.",
        "label": "Stock Issued During Period, Value, Employee Stock Purchase Plan",
        "terseLabel": "Issuance of common stock under employee stock purchase plan"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlan",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [
      "r6",
      "r7",
      "r80",
      "r85"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.",
        "label": "Stock Issued During Period, Value, New Issues",
        "terseLabel": "Issuance of common stock"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueOther": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of shares of stock issued attributable to transactions classified as other.",
        "label": "Stock Issued During Period, Value, Other",
        "terseLabel": "Issuance of common stock from follow-on offering, net of issuance costs",
        "verboseLabel": "Issuance of common stock under registered direct offering, net of offering costs"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r24",
      "r80",
      "r85"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Exercise of stock options"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r7",
      "r10",
      "r11",
      "r66",
      "r628",
      "r652",
      "r665",
      "r708"
     ],
     "calculation": {
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Balance",
        "periodStartLabel": "Balance",
        "totalLabel": "Total stockholders' equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets",
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders' equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r86",
      "r192",
      "r326",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r339",
      "r341",
      "r444"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "Stockholders\u2019 Equity"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsequentEventLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.",
        "label": "Subsequent Event [Line Items]",
        "terseLabel": "Subsequent Event [Line Items]"
       }
      }
     },
     "localname": "SubsequentEventLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r478",
      "r506"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosurePartnershipsAdditionalInformationDetails",
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTable": {
     "auth_ref": [
      "r478",
      "r506"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.",
        "label": "Subsequent Event [Table]",
        "terseLabel": "Subsequent Event [Table]"
       }
      }
     },
     "localname": "SubsequentEventTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r478",
      "r506"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosurePartnershipsAdditionalInformationDetails",
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r478",
      "r506"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosurePartnershipsAdditionalInformationDetails",
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r505",
      "r507"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "Subsequent Events [Text Block]",
        "terseLabel": "Subsequent Events"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureSubsequentEvents"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of sale of the entity's stock.",
        "label": "Sale of Stock [Axis]",
        "terseLabel": "Sale of Stock"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquitySummaryOfStockOptionActivityParentheticalDetails",
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows",
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock": {
     "auth_ref": [
      "r103"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of unrecognized tax benefits for which a material change is reasonably possible in the next twelve months, typically including the nature of the uncertainty, the event(s) that could cause a material change, and an estimate of the range of the reasonably possible change or a statement that an estimate of the range cannot be made. An unrecognized tax benefit is the difference between a tax position taken in a tax return and the amounts recognized in the financial statements for which it is more likely than not, based on the technical merits of the position, that the tax position will not be sustained upon examination.",
        "label": "Summary of Positions for which Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Table Text Block]",
        "terseLabel": "Summary of Reconciliation of Unrecognized Tax Benefits"
       }
      }
     },
     "localname": "SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Supplemental cash flow information:",
        "verboseLabel": "Supplemental cash flow information"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureLeasesSummaryOfAdditionalInformationRelatedToLeasesDetails",
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxCreditCarryforwardAxis": {
     "auth_ref": [
      "r107"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by specific tax credit related to an unused tax credit.",
        "label": "Tax Credit Carryforward [Axis]",
        "terseLabel": "Tax Credit Carryforward"
       }
      }
     },
     "localname": "TaxCreditCarryforwardAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxCreditCarryforwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Tax Credit Carryforward [Line Items]",
        "terseLabel": "Tax Credit Carryforward [Line Items]"
       }
      }
     },
     "localname": "TaxCreditCarryforwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxCreditCarryforwardNameDomain": {
     "auth_ref": [
      "r107"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name of the tax credit carryforward.",
        "label": "Tax Credit Carryforward, Name [Domain]",
        "terseLabel": "Tax Credit Carryforward, Name"
       }
      }
     },
     "localname": "TaxCreditCarryforwardNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TaxCreditCarryforwardTable": {
     "auth_ref": [
      "r107"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A listing of tax credit carryforwards available to reduce future taxable income including descriptions, amounts, expiration dates, limitations on use and the related deferred tax assets and valuation allowances.",
        "label": "Tax Credit Carryforward [Table]",
        "terseLabel": "Tax Credit Carryforward [Table]"
       }
      }
     },
     "localname": "TaxCreditCarryforwardTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r259",
      "r260",
      "r320",
      "r338",
      "r443",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r662",
      "r663",
      "r664",
      "r725",
      "r726",
      "r727",
      "r728",
      "r729",
      "r730",
      "r731"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureShortTermInvestmentsScheduleOfCompanySShortTermInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TypeOfAdoptionMember": {
     "auth_ref": [
      "r155",
      "r156",
      "r157",
      "r158",
      "r159",
      "r205",
      "r206",
      "r207",
      "r208",
      "r218",
      "r254",
      "r255",
      "r268",
      "r269",
      "r270",
      "r271",
      "r273",
      "r274",
      "r386",
      "r387",
      "r388",
      "r411",
      "r412",
      "r413",
      "r414",
      "r428",
      "r429",
      "r430",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r462",
      "r463",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r479",
      "r480",
      "r484",
      "r485",
      "r486",
      "r487",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r540",
      "r541",
      "r542",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amendment to accounting standards.",
        "label": "Accounting Standards Update [Domain]"
       }
      }
     },
     "localname": "TypeOfAdoptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosureOrganizationAndAccountingPronouncementsAdditionalInformationDetails1"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TypeOfArrangementAxis": {
     "auth_ref": [
      "r705"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative"
       }
      }
     },
     "localname": "TypeOfArrangementAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/DisclosurePartnershipsAdditionalInformationDetails",
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_USTreasurySecuritiesMember": {
     "auth_ref": [
      "r604",
      "r617",
      "r619",
      "r723"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This category includes information about debt securities issued by the United States Department of the Treasury and backed by the United States government. Such securities primarily consist of treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years).",
        "label": "US Treasury Securities [Member]",
        "terseLabel": "U.S. Treasury Securities"
       }
      }
     },
     "localname": "USTreasurySecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfAssetsThatRequireFairValueMeasurementsOnRecurringBasisAndTheirRespectiveInputLevelsBasedOnFairValueHierarchyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r391",
      "r397"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits",
        "periodEndLabel": "Unrecognized tax benefits \u2013 ending",
        "periodStartLabel": "Unrecognized tax benefits \u2013 beginning"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfReconciliationOfUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": {
     "auth_ref": [
      "r399"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions",
        "terseLabel": "Gross increase \u2013 current-period tax positions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfReconciliationOfUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions": {
     "auth_ref": [
      "r398"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions",
        "terseLabel": "Gross increases \u2013 tax positions in prior period"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfReconciliationOfUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r62",
      "r63",
      "r64",
      "r229",
      "r230",
      "r232",
      "r233"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": {
     "auth_ref": [
      "r405"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.",
        "label": "Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount",
        "terseLabel": "Increase in valuation allowance"
       }
      }
     },
     "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureNotesPayableAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureNotesPayableAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VestingAxis": {
     "auth_ref": [
      "r675",
      "r676",
      "r677",
      "r678",
      "r679",
      "r680",
      "r681",
      "r682",
      "r683",
      "r684",
      "r685",
      "r686",
      "r687",
      "r688",
      "r689",
      "r690",
      "r691",
      "r692",
      "r693",
      "r694",
      "r695",
      "r696",
      "r697",
      "r698",
      "r699",
      "r700"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by vesting schedule of award under share-based payment arrangement.",
        "label": "Vesting [Axis]",
        "terseLabel": "Vesting"
       }
      }
     },
     "localname": "VestingAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VestingDomain": {
     "auth_ref": [
      "r675",
      "r676",
      "r677",
      "r678",
      "r679",
      "r680",
      "r681",
      "r682",
      "r683",
      "r684",
      "r685",
      "r686",
      "r687",
      "r688",
      "r689",
      "r690",
      "r691",
      "r692",
      "r693",
      "r694",
      "r695",
      "r696",
      "r697",
      "r698",
      "r699",
      "r700"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vesting schedule of award under share-based payment arrangement.",
        "label": "Vesting [Domain]",
        "terseLabel": "Vesting"
       }
      }
     },
     "localname": "VestingDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WarrantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.",
        "label": "Warrant [Member]",
        "terseLabel": "Common Stock Warrants",
        "verboseLabel": "Warrants for Common Stock"
       }
      }
     },
     "localname": "WarrantMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetails",
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureStockholdersEquitySummaryOfCommonStockReservedForFutureIssuanceDetails",
      "http://equilliumbio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfPotentiallyDilutiveSecuritiesNotIncludedInCalculationOfDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r220",
      "r225"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Weighted-average number of common shares outstanding, diluted",
        "totalLabel": "Weighted Average Number of Shares Outstanding, Diluted, Total"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r219",
      "r225"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Weighted-average number of common shares outstanding, basic",
        "totalLabel": "Weighted Average Number of Shares Outstanding, Basic, Total"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://equilliumbio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 7
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "https://asc.fasb.org/topic&trid=2122149",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "https://asc.fasb.org/topic&trid=2228938",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "730",
   "URI": "https://asc.fasb.org/extlink&oid=6420387&loc=d3e23199-108380",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123586518&loc=d3e1043-128460",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "37",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123455525&loc=d3e2207-128464",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(4)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(3)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "https://asc.fasb.org/topic&trid=2303972",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "https://asc.fasb.org/topic&trid=2197479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13467-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13476-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "405",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=116652737&loc=d3e64164-112818",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Subparagraph": "(c)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126941378&loc=d3e61044-112788",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(15)(b)(2))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21728-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31010-122693",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(d)(1)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=124260329&loc=SL6284422-111562",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL120269820-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27357-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "https://asc.fasb.org/topic&trid=2196928",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL82887624-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL120254519-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL120320025-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL120320025-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124258926&loc=SL82898722-210454",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(4))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4534-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(b))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2.Q6)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "https://asc.fasb.org/topic&trid=2228938",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "https://asc.fasb.org/topic&trid=2144680",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "808",
   "URI": "https://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "808",
   "URI": "https://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "808",
   "URI": "https://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "808",
   "URI": "https://asc.fasb.org/topic&trid=5833765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=121483254&loc=SL120254523-199619",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL126732908-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL120254526-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL120254526-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL120254526-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL122642865-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL122642865-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "832",
   "URI": "https://asc.fasb.org/extlink&oid=128342835&loc=SL128342857-244232",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "832",
   "URI": "https://asc.fasb.org/extlink&oid=128342835&loc=SL128342857-244232",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL120154346-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918666-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/subtopic&trid=77888251",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL122150809-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "https://asc.fasb.org/topic&trid=2122774",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4313-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4332-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column B)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column C)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column A))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column B))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column C))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "https://asc.fasb.org/topic&trid=2122369",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column D))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99779-112916",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99893-112916",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=SL120174063-112916",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226049-175313",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(ii)(A))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r632": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r633": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r634": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r635": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r636": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r637": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r638": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r639": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r640": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r641": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r642": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(c))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "https://asc.fasb.org/topic&trid=2134479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(b))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5033-111524",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10149-111534",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10178-111534",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "https://asc.fasb.org/topic&trid=2127136",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=124260329&loc=d3e26626-111562",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r674": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r675": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r676": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r677": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r678": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r679": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r680": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r681": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r682": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r683": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r684": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r685": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r686": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r687": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r688": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r689": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r690": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r691": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r692": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r693": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r694": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r695": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r696": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r697": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r698": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r699": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226317&loc=d3e202-110218",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r700": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r701": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r702": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r703": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r704": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r705": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "808",
   "URI": "https://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r706": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r707": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r708": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r709": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=125521441&loc=d3e30690-110894",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r710": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=124440516&loc=d3e30840-110895",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r711": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r712": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r713": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r714": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r715": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r716": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r717": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r718": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r719": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r720": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r721": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r722": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r723": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62557-112803",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r724": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r725": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r726": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r727": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r728": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(3)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r729": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(i)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r730": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(ii)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r731": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(iii)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.CC)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=27011434&loc=d3e125687-122742",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "https://asc.fasb.org/topic&trid=2155823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "https://asc.fasb.org/topic&trid=2144648",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=d3e1835-112601",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "https://asc.fasb.org/topic&trid=2208762",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "710",
   "URI": "https://asc.fasb.org/topic&trid=2127225",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "712",
   "URI": "https://asc.fasb.org/topic&trid=2197446",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "715",
   "URI": "https://asc.fasb.org/topic&trid=2235017",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=SL79508275-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11149-113907",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11178-113907",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>103
<FILENAME>0000950170-23-009492-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000950170-23-009492-xbrl.zip
M4$L#!!0    ( +*!=U8$=0/&G7X$ #HG-@ /    97$M,C R,C$R,S$N:'1M
M[+UY<]Q&EB_Z__T4N)J>"3L>DT("B8VR?8.B* _;DJ@FJ>[I^^(%(S>0:(-
M&4"1JO[T[YQ,H!:RN%BL(E$48J9E5A66W,XYO[/_]'^^7N3.I:[JK"Q^?D6W
MW5>.+F2ILN+LYU>[QWL'!Z_^SR\__6]"G'?O#SXYG_25LRN;[%*_RVJ9E_6X
MTLX/QQ]_= Z*/"NT\S]OCSXX[THYOM!%XQ#GO&E&.Z]?7UU=;:LT*^HR'S?P
MJGI;EA>O'4+LL_<JS?%KYQUOM+/CN9Y/7)]X_@FE.S39872;^4GR_[CNCNO.
M[BI'DRH[.V^<'^2/#MX$;RX*G><3YWU6\$)F/'>.NU=NP1CEMK.;Y\X1WE4[
M1[K6U:56V_C(__73>0-K >M1U#^_FAOWE;]=5F>O:9(DK[_B-:_L13M?196K
M;'HM?C17>JX;OK8_+ES:++TTL)<V\Y=F"P.8O]I_#8O8P-1T=STL^^]W7(X_
M"UY/+_]ZX_J%^>&OW:79U]N>2W$8N-^XW=WE15E\@FVO,KG\-M54KYO)2+^&
M"TEAKYR]JEE^T^PUKYN*%W5:5A?FJ. H N)ZQ OG'D)JO?AV^+Q]5E[>^YR8
M^'2Z1'6V;(%@.>GK__GXX5B>ZPM.KN^#TM>.0O=J^ 'N];SNPKH95<NOQ%\6
M+AW7Y(SST?3JE-?"C*7]8>'BK"Z91Z.[CHZ]8CKBIB*X(?4]^P4O<8E+B3==
M(?W']!;]QSC+\VQ\(;+2$#4.B7JSU93EN&BJR?(9MS\NKD_5W)PP?+FX,DUU
MZT23U_#KJU_^E_/3N>8*_NO\U&1-KG^A+OGMI]?V;_SV0C?<<"B"L[C\^=5>
M633 M\@)3/N5(^VGGU\U^FOSVE+^:WSLZ_:Y/XE239RZF>3ZYU<7O#K+BAV'
MCYOR?V<7H[*"X]&\&7&%S'3'B4=?W[PRKU7997>3RNI1SB=(.QI^_2G[NH//
MUI7],U-*%^9/N.!]Q:5ADIGZ^=7[TTAXKO:E2X(T4831P".Q&X0D\<* 4\]+
M(Z9>.06_@->TQV5GK[RXR!IDS?5NH7"V,#3@]YFNV^E^;8YT"@MQ&L!39 )T
M$<%K" O<B,0J"0D77J!2S5*9L%?.N,CL#5].OQR_@\VILYTBRV')JK&&^;Q>
M'/HM4]&)5$DJ&1&>\@G35)*8,D%H)$(O"IAB-+P^E>.FE+\?U/58JW?C"J;Q
M&?A)J8[/>:5K\^/AR+#]_:^ZDEFMU?494IY$ EY&PC" MW)/$N[Y/@E8+%(_
MCH6'!WYNAK5Y]K=.,HS"R$VI(,KW8$$I521ATB="!%[J*1&FH?N(_7*YQ[W(
M#TGDQO!XZ6L2>TE"TMB+TEAIER;>-^]7R]?;F7B!2%C(.=%21(0I>&D";R'4
MI[Z7AD(%0E^?R>>J'.FJF7S.@2A@+OM <".<V)=:I^/\0Y;JZS.";8DU2P21
M?@0S<O%41#"MT.6Q[TONNBIYY5A&_O.KEOGOJ'%U55:JUL6K7YKS2FMGHGG5
M3:R=R"WS@K>Q0+E$,![ ,00$$HL(WJJIG_*8>T$\W2%@ZCN[,'Z%<WB?\[/K
MHX]X0D,W2DCHR1CV(Q5$4!81!<_V@'2C. U>_9+RO-8/&ERJW3A*(H\H[L+@
M IF21(B4!)1RWPNXEK$_/[A]."O-9 ]&5_'\H%#ZZV]Z\FV#=$'P12QD87C+
M2*^==#?E-)"Q(#H!^<R\.(*GZHA()EGB W6S,+A!SDA;;P&GP"F_&.FB-L)Y
MMP)9?:8- ;R=S*[YS"?XW>X5K]0U,J\/"LL)_J$1Y&FU"^B6G^GN]\\P[AM'
M[4^S B">,L]Y98;TC60DM9L&W$N(*Z0$,E+ _Z(T)#0&AJYYFH2^-[^C':I^
M#\B;YW:2[^&[&ZS@8;OZ_I\W=O/UHLRI=*HKX#:Z_N4GQ(4[M4$^\!;'X,0=
M1 <_OZI!V.6X".8[(#D8A/Z#=#A@^VNM<$D6GV!?-O\&\[$NQY7Y9%#P3CLO
MLV @DOQ4AYQY<*Y [#&:)H1'H2)!G&@54>U*%;[J;M7F_'>?,H6?TTQ7CAF"
M7@H2]PY^6SSMUV_N'E?K,]P)^U'!R[Z.\DQFS4=](> 5*H-?K4;5G>^WXQKP
M9UWO2F!\=68.]]>L?O6+_F/G+7S(_GUR#N=TI$%7D7"&I7W43Z^7ON$!+P;
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M4^9)J@51'D@D1@7 "B%3HOPH91&/9>!O>D;5<P=QKM N*UBHJ2<9NI--KZF
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M?,9'GVNGIU7T-MP"'PZ28' TWLR0;_2%0[?[QQ_ZO.=3Z0_3N#BEIUTR[I/
M@#4?B*[B>#^AP" U!JGQ$CC(AI\**S5V!['Q&+'!3ZNL_OTTY;(IJQ<A.XY@
M/LY[.Y]!?@SR \;/W$& # +D%@'R=A @CQ$@XG1<5+HN\TNM3NN&I^DIE@3
MV)&7($V^3">'\8%I:C))%P)C!M'R/8N6Q!M$RR!:EHL6;Y LCY LWNFH*D<X
M>OTB),GGZ6P&T3&(CD%T#*+C#M'A#Z+C$:+#/\WU&<]1@$BM<< O0H)\P$EA
M"9AN4H,@&03)($@&07*'(&&#('F$(&&GL+CZM.:I;B:G*JNQ@N^X>AD*R4>8
MFG-LIN:\FTUM$"J#4!F$RA"K.4B-85,'MGXG6Q\R*5X(_5[+I'@QJ11#+L7
MR@=6_E(1NC\(@\'LL]SL$PQFGT>8?8)3VUCM-"VKTUDU^/K4-CLYU7^,7X0!
MR':/PTK]1TM*WMO&.<Z^:1FW!9?DW)9)FU;N=SYB'^_*UMH_P.ZUE?-Y7,ES
M7MNF,?;>N:K\_<0C@^@:1->+8&,;?BR,Z H'T?7MHBL$<05K?*D?5T[]3PHH
M,RJE)38RP3JQ\!9=Y5FAUW92_M^C=IK_WR!1!HDR2)1!HMPA4:)!HCQ"&8I
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M@,4Y,\4&5Y"V.Y#I0*8OBDS_8>7G.;S+&!)&VNQ %X#6IA&FX\4L^2Z[%S4
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M^)IEQ+;K%9=569M2JB81<"HK%OCY/(_LYI7A36D&8@8N)3+GZ*JI=6[#<K:
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MKP,[H@SM;-XB0<N/-\.%F8BJURX)PI8WR4D&I#9S5X0+TR#@!.G2JJ@S?$Y
MB.-Z9= @G%L^QMA=\71ES>>F.-&\16'JMRO-:9)=(:2*/+G,U</,*R0.G1L\
MAG>E&77P<-<)IRHSF:M[22]&>C'RG=>4C^ B2[,H87I@@)/'V42Z""Z.QP.O
MURH.I&.:9.B*YF"<N %0H-:S*FAP8D >B62)I=X'OF RR6W_$CT0HJ\91!%/
M:51<)\?)=>\=,1C:E@F@K3:TXST@SR)ZZ"@X3@6@ZW,@6&DY\,6B!GE\8?5
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MQV):F0E7WTD=GLC#R9P+GQR276"? *$-Q+RC9> B+U&2%@QO/D-2(E^? 3^
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M6&)W?N(J+9$ S9 '71N0*&1Q$#_\NN%)Y%K6/H"4<M$*Y@OX,ZSCQT66(+Y
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M/9/VPIV&>CB6K1*7S R4(T>*>@"K2T0AU&8U@OH(]P^TB1#:;8F"06XB3%9
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M.H,VDRBTNY>(B,X01!NJY@=*1%\E'!YE!@%!%D$LM<1Y]3E+]&?' ^6XCRS
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M5D=&+;GE0;MB:B?Z0]_3'K./[^^(&0LK18VJFF!#JW6/&X2BHR"X0*6L&%_
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M\%P^\7WI!6Y#8SOR!7<G,O%L1[X(F;@[\DV4.+'= ,*S4+?/AMG*=>P-OV^
MZ>(N+XEM V,;O03G4O@%L=^!Z(O3FX3-]B7]V[& _4'\=FOZFAPGB24W($$[
MAN':%8WN8;BN32W[6>6KVL?NXD266B.7ARSFV57*<3#4#TFOKM-'P^,W)\=O
MV1V^"E=^$5'=7<D%U+2+$_ZW=[ONQ(9BKTO=+90M:T\U%'<!G!<7ZG6Y0"A7
M@X717'8AR),M)N&BKM7F/\Q7RPSU[RAK8W9JKCFF%SB$J?D,FG&)UZ (+(UI
MQLAU: [:[N59DBU,7H'.PS+\K"?-6U7G8<K4T4/:PL'B>"RT[V#JR(8;4+6\
MM:4TW\W*"^R#PMW$:97'2I@M&3>;N..B^7 B'%^#X))4Q<3K&^^2;MW':E-S
M.K9R4/ WSA(EV1]K ;DSF')K,+E&:'37G!Z36H@F1LL-\\"@6,SK).(=V\M?
M;U[]DE5Y*KT 3^QN.TLOD7Z=R5>Y8U/?--%F<>B!D"#0W541Y?&RK(%%A9Q!
MNG,:YPN[$UGC0SS;D!JV.Y\I)?9<WZJZ=3QTN 93&78N H!.;Y77&_.:QN(D
M(ACMFR2K(*63U\RZ\-'!N<9X>^^U-YJ_^YHZ[Q1\CI646Y266Q+-3K3SS\]9
M5910!'HB+%)'BL^",ZPZ5TXK59-2V+W.44KM&K3*+]T[CY,D!B9DP$:;VFO0
M?<V$I%9UTY%D=&)1C4'TP=0LAH%>3"T"RLT\3B$YY( +90P]37Y4*)@>=UQJ
MH'C(,N27M!7D*#@WWTZA?)/N"?L[HB-8*8!SC(TPZ>A:*P9!$WEBF&P@VK"A
MM-BQ.3"K*#;JA#5084^Y<K-@\/W6@O:4*]^0<N7V6X<<;&P=<O"EUB&'1WLW
MV#KD]J=ZN'&JAU_LDK+_N'.JI=#!RWTZ/NR_9X>CPZ=/?GH^SO*)R7GCD2GY
M;.\YWS!,PE56E;1M/IO)<WG=TX=8(+V>! '393TKS#*$KTFSHM?1^]SANR07
M61K^/;-7ZT5TU:0YE?T]7GU:F0?E1![TH,S;3]2I2I>-]4=]079=T<A%&#P3
MD8!?=$NO2_ ZDF>DWXT^/H:V:=?83>&U +F+]N&W:#BS_TQMJ%CB* S<ATDV
MCNEA^2?FRMMDM.U&JQIQ1&?TTKFVURJ\X@)='=^T5+P/+\' _O->FJ5#CK/<
M1S (5*7Z%QL:FAL2(W- ^=*2;!2N*GWYYNS\>*0O0=P#M@ZY_AQC<K:Q1VT(
MQ*:/EY86]WP74RJE:Z^1Z8G4T4:)P@JU-#F7<&MMM[6P-7@4R-=GJ[I1ZHHB
M$3>R>^_^SY.G]\4+<!.6WS_:XYC0\30'Z=+P>&'X'[P4/\?8,L JVA9R";L/
M)E^5TM2>.S%:3+BG%]?$$?TOIM9;#[WS?)-+ZD5(F:U4?.$Z5#J0P'$=-ZI=
M5"<YA?B3*\TMF:IZ*[;XSGJWY!XC Z*!JHW153G*XLLB@D4*T>O@6W$ 7$04
M!ZP@D>+T,N2BJB3^HXHG&-RR6%GW2#%,""3'$UJD"J'E(.,P0)7BN31WW^$"
MY'$F,$B.!=.D)#P@Z18.@'44;1W7BS*<T3#,Q.=_M6%ZF0#]/AF6],W<@I9:
MBK+1IZ-!3M 9:*%M68.<O44W#F6R$D)7?G_]>@F0:S=*OW*1 Q<-AQ/OB5,M
M7^)DY-P*SW!R2?]DV=CFKY#P((:85S/'4*?,%XZ33IQ9AG?KL+4YZ_G21'Q-
M H+3[J!(O>-J8O$B2RJ(?%DIT):?/AHHC'Q,:PMV<LS'?KZZV2M8T95WM\P<
M'2^N7=N6W,%2&V4J_E5HA+TS8)NFAFG#7<_+NN-E'9YEZMIPP:L#Y21?P++U
MCD/+EFL^+Q-I'AI"CQ7(+G"3)S ^@&S0LU\<'GY#YJ*'PO<QY9U1B]^85._4
M.[L?DC"]8:Q33Q'8'[ M.V"W;W?^4B7(D.X_'7!J\NS=*:L\]I >D&_%C+M1
M9)9>[O/5Z;%M@>%3 ^\_M7^%?YN6W8WO7X6D\2\X7R+]6#TPP-PSE21YRNB!
M<[S=O83A.Z*D\0KT>B6_EGQ@9A,F<V!_#,V>3;D5"_J4+\MV)]CNQ.M:[,$Z
MTYW< !=SOZWW!=JY' <,S*3I\+(%;X]/]852I0P3XO!ATZ7N;OY-%G^6D$$G
M!O<@^/ K_?^I<O_:N3AX$2 A)W67]HZIT?=@Q@7VG?=&1]K%'8WE1K8U_3\/
M?I=99>DLXPI-S.F%FY-:4*X[>+8T:4 ^@6'[\L>R:_K\B\N_'/3YESZ"\KUW
M(7I@JF>(L 2W*SG8 ^4ZJ;=)'*+W";KEYG[KCV:P,W/.(^L@6QO2(4PG_*RP
M#/9'CU1VDO@E\<E:3%]^1&K*?-* J!9DUD*TOA,/8W4QMOU\60UF,!Y+%SOI
MU@K0!A]^??#A5%+8&C>VJLCS>D5F,XBA 1 , 9PM35C9>[F@S X4$$&NXB^J
M'!VQ&J3YXTPK5)M3:<#].)C%HU^05AG_1XI2"X'#YJ8]X X],Z@OJ!41?R>.
M=(5%@=8S=="D4S=NQ ^ZK^_6W@,SVK \%IDT]NGQV?#@UZ"(LAS]S8Y3;K#J
M=YT7<\;O00^[I-:7$NX7D.%.X4$.=@4/LKTB^8?53U],FA]M3)H??3%I_OC1
M#>(#[HPJ_A:9WH-GWP](?*,3>M\2\DZLMSQ*$?[;<69Z ;)[!BY956\Y]R>M
MCJY@JBE^=AI>9M(CB!8,_9V\JA+/O,*$EYNLDZ[(QQ4W-6++!L\#K+8[I'-E
MRYO$.J4QM8H^NFSHIAD*TW%(!I+A;=$T0QLF*&Q2SPRE_Y/6261X7UB:,(X,
M3Y#RS+ACK.3"7,&*ML]U%3%H^]3!K[+%UL V;M ^/GLKA]Z/?1X<\,$/TY1F
M$;$C4:).#&G3*D'JN7'D7["+TQ6\DY/]I5-I-5P":GLZ'.D,Y%^V#YE "0"6
M7GE>4P14/?P\=7SM"%F".(E%X]D_]%IU\C'<WZ]E$#JPS3GA6I(;AHCQ_H'X
MTSR11C?71QVW'3RQ5TM4F<0*;E27$MU(WY^/@A?.ZW/U7YRO3[CLS37N#M-P
M9KQZ'K?*+ZL\6]+*!&],.*M(QJ*1-(WUX]Q4:%91+.1=_WIS_%&<=7?'1ZZ1
M.U8>"OI 0_>G4]L8E?FM74M4_V)Y[,?CX<O3B^-!A],K?K$K(&3TB'QZT*1.
MLZCR8@T*LZ#K_O7AY*-,#PXQEN$YOJVWAUK8O."$)C8Q4[IR(LUX?\+09AQ
MR3TQ;A^..27<+1;HL;W1P^'>Z'$P>S 32IL-+\-7-9>:@$=;US#Q^N'1"S_\
MM6&,@G/=I:YF6/<I?6M9?(=T:VUOG;=='SX9,C4:\,/1$\QEY&KK-AT=?GHV
M!A6BI%6P6[%K[]'&O.]U*#_$8Q\%]VA&]]W1:JP'O?D>O_\?2?D\T-6\/P@.
M],[#PTUW?G!WSNA.K)E;J/O\-8[T$8\>=S_"KB]_RR?^_?5"PPY@]:UWHU5*
MS'=SWT.^-8/)DN%3/L$;Z:AWOA+'TW_CPZXWLH1T*PL$(!H)SUJ1K4=TJ]V2
M]Q#'"0X9\>.%?^YKW9X.H8Q5*J+:-(LG$K<K,UGVQZ.'B(%-PM6:=<&G_X$]
MK)A_MJ"#*< NM)1>E\)>Q2YM9M2PY[R5FC:6/#Y5J _Z%_/P:!MG0%9-4'1%
MDN]26-]R[ZF3N(".H7G:0?S.L3V:*&9D]<MUYN1:5JAE4*Z+"D%KKK6:UO,W
MC?,"U-_)%+>2JCO:DCJ9.P6EV&Q'E+1UZ/-6)#@_0,_DY6J[<!-;GJ[;$8/R
M?96SJG.;8:F; ?'I" P"D2 /@048 R()7<UE\K =\U@(85E,DK"(RX&GJTB-
M96-TK67UPAV)I(NMDDPJY*XT3F!K>2CDUGE)%RC7 '1QJE7\B3#+8CS:- D,
MEQ, 8T',P**,)-V*$QD,XAMHO?0X=CT [%4Q;C%+,GR7^%?=D+=)X:#CJ+,*
MZDU"5HH=EW&I8)Q"N#(^TG7SK5&'K54<!:^NF8<OY'D!% 0I6$38(%4.QH+U
M992)T0H#BY 5L8R'A"A9H%"5_"%,.<\FA>!VP4@QIVT[FV=5V56ROFF,S9$Y
M)*YZ^2"H(%.'7U)O@_7Q\DI="<&PA_6UW;%8.^815ET9A_TM%B5A#)BF8XV0
M!)\.!K3_WBHP93RC7!?B9GC+(.&ZQJ]</3UW[*IGU0#62J>*'PS$V4M/6<UC
MWB<2ACL<P$HY%-24W>5T\J=DWV3.&FOBF&4?PV\'^\A$;U-A8YBCQ#Z*1%&-
MV3>?Z;Y"Z'SIMR:%\\;VV(LXBS:(TD%P7,&33T#+<D)^S43I63#I?QLT49@,
MW&L;,K>'\_S <)[#'LYSA\NI=T32.DE4E/#=NX3BE/NR,HVY[6R,:TXR&+2"
M*>5>\A+O^W!R,5#3PP395:IUB@9%'^K!JBQ](P*6C3G8C57!8!^&NY"<_<?_
M?#[8VX^>OU"S3GX^>OXAS$LRX8IYO'2_.T'=\SCS>G3:AQ_/<F-J3BYYM=PV
M>?Z#>;ZWO)6:)4WA)A7N]&HNI%"^>OV"-D\1(VFI]&Z-7,2?.R[T]/040UF_
MPJKO[OL;"OU+ML3?-17(?8'SI^Z!#N)?H_-1;<7D-H@D2T7_C@7C1:O\)+@7
MC@L)V:_LP'#\Z#+Z=V$AX+F9H9\/T'D36O55<5]=0EYK:_^[CLZ*+W-=H@OS
M1V7;1WN?JN4#P4W$6ZRQ+Z6 _O5@U(/80-OG;#&.%:3.AU5\/Q)+BMZ6,L3+
M4.)NDH2TO8 GMKY/C#SZ@?D3"L^E>?W;SZ=:SNA"_;GYCU'RO(NK[.\N^N'1
MWU[TP1=7W3I+KB]$$24FSYAL,V_VYQYG5R9QA8YM4"66V.3P%^N(H?GLNA38
M$D@Z9A728-^E!U^+$**HQIZX>C1Z?'/2:G?([VTRGG.-WD=6;6N/H]UC6A/+
MI-9OA@>''[TL_RAX7V__MJB*PW1-6'WI>(Q->05F5Q),C_E>'!9YRW5ZP(XU
MO$;"!K)VOLYH1%]:DL;)#RZXL=2S^J*",R/KQ[XAY&](NG_0%9.N:J"N8H9,
MGCZ[N,Y1'+HEZM(O7U[Q)[KB1_LTC&[Q%$[^0T->V,R%DU9]X.7'M.&.730.
M-IQ8\'PV;N[\%6@;#"J#<KX(W3DLO'W_=T_6V=26PPV\C:XGS3MEG*37">DD
MKM7N3__&\4&BCX'S;@%U>N0?-5:QV^2=9$J:, ,Y<3$(M-TJW>"S M#X+N,R
MSYA+(4BR$G@$,BMD<<QG^NMEYML[$F*-@:O_2ZO5'O5UZ_5?B9O^%-],9S/>
M>U$V;&^_S>>8S<6--*+!.5/ZV/,JNY:M<JWY0=#>GG\NSMDH )2H=YN/_-%>
MOX6W, -02C:-S:0P^J.*)?V$*\EP3.,_665=S3/DN;#SP_6$@>];V106CL>R
M!'\,;:5P1D\J!%8'>))2U+!IYI[B[$8$"KP4EK_%. =:NY]T- KCBWML>5C@
M _SW*?]W_V''2(*7_]S?VP_NP9E&)\'@4\IS*X(7[_X]1!L%?1+=C0."9^YO
M>L[!IN<<T'/$X;9W6A>_D8EUXS?1/.6TKP+X[%W:)U@_"SNMP[I%'JK0$ZQ&
M@OQ>XKB\__$_GP_'A\^C^E(]I;P#[XXQVENC-PJBL+Q#.&7KA[4^936P2;>-
M.Y\:48FJ'$1W7*)ZS?DOZB0_'[J.3#;^QF1,]I;!>N)_[9J_';VZYX$^JC)(
M,W X+6(=_\?C@?9J'[H'S<,XY\;N.JX5Y^B+^RK.='WJ]:@E&0!LG@]L=2F+
M76/6H@)I?8'G/-M(@?ZQ\;<7>?AGG&SXX\D<47[C_G3XQ(^\.LQNH<8!Q_&N
M,GOW+R'M]/IVE(W" '*N.QR.+[OO,L#:W,"8Z'_DY0,RA>A1O])_Y/7\SLTF
MB$4#_P5'XV"7_?1>--[D<DJM.UH M#88 G]DJJQ+RP[CY5KA*/J^I<#U)1WF
MTJ#1>FEN2 IY,E%13A)H]^20&XIWEIMA]W3B10'Y3]Y!OM'3=]2?OO[T??WI
MH^V5=T5F;]8$.1!?F0OG?&CA+5D4](@XC.K6&IR;VI1ANK_I+/OV@G^:!_XQ
M[S(D#HZN5?J>N>!T<9<MT;(&U'^I__YKEAOWVK]G*G0$)S9;"V?TZ%!&)6/A
M =RH\'JTR\*KEUTW++N ?N .=1-RFZ;TKU;<HIV0[I1=5V$^*9I@Z)8GY'+7
M5D9U('P]@33HD$@#0 0 + FQ_U$>(XWO$BOC1*S=%YB1SJMM$:WG^-:$SR@
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MU#4SPJ30ZD6CHW/!V[)0KJLUC'(XIANSM)9*]5?U/SBJ17CE>JORAJW*FDK
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MU_F'B_>#9G-Q%UX$FXFU4H1',A3Z9"B=W,R1^;QT=$5>9(WTWZ?"K^[*-A&
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MN*8IE@8/F-&P8]N##IV)(X4QDPE6&F<UM)X1+E"OSR:$!:"LF]C6I%4$@1A
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M6*A!#L!KD\@S-#MP[YUKXFT0&RG>9."(&-U.EHSPU^ DEC]C_(#(0RG=^B)
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M56B,(1^4X93F@XL/^CN=CIH-Z'U<N&=E6R^82:UE]5_&&3)&0"*8P'6!MJS
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MA]"GK%LF5JU&A D+!!.,4QQ2'!I5O]#=BO/A3USX1WI3#DZ.#ZV[9M&@5VY
MWUK']HI(S#6-7 _NA?;52N$J^%3!ES'MK5SVA=?TWB]$)/=P7L:GB1,EKH<.
M?#Z\[BD8\=$,1IS!B+>]"D/ PZ"IL;V*/>''V1FW?E.QWO 4(#Y4"5,F3%30
MC.8-(D</]8F2P(%M%Z>_]M4F+QKEY,6OR2^;7?M[N2J?4@:%N;04HF&I/\1A
M*9HU%SM<F[CUIM1JSO])S>"":T)M!X'AM<NOB&3B.:_Q 7_8AJ8PD&*D#=(2
M/]M<65SSPT%$]=U\63/\!M_G6%=XS*CY@A/",:<,;^@03K)O.<@9<VZ8H-W@
M:*+SK$3_("P3?AP 1Q813"/>6FZHO:Z<O9S 7<C'K%CZL+VH&WYCP(XU15M+
M44!X(:D(!U\L%*P$4))R6KY?BVFBPZY)=NVEE*;<T#VI.)UEPQR9R[WE';NF
MMLC2+9$D5WG?K,JW 4\]Z")MW*9OI145,F;]L(AIGDC17^TB_-B#2%SFS_N[
M?:?E3?(Z%\-97_8^[*TPQT%U@1)TA23?9-TXEJ"&/G5H%C/)H="K*@XS>-5I
M-GS(>$TE^A6"JKB0:*<T)!G6<7?-!</R0NDUI)CBKUA:%'0SZ *-4J#4VSBA
M(=<JRYB6F_U^\ =4J3= [:-7E;IZN%$769+)XG2:R'-3'8AS3CC A/2,6M3P
M=9= +WE*^B:H?M"MPFWF8^EN'DL?F=OS7. UBU"\9UDV _&8:4L_B87S@;?A
MZVF>87\0%JTH"M72L"IU<G94+%8(W1*M.AM!LL)_D"1"DW*6N &"Z35T2U%Z
M=XI(56H=="$_*Y7$ *VP8P[N/+B?XF<F;B9(M"!=C)0IN*T8$KV(G'7"M :,
M"PX/U1P9=M\JJBR=L)@'"QH<Z1R6!._CD2<2/]/SL9BZL4*Q;W3SHM>BG@B3
MR:VS YCM J*J-D/I#[N+O!*MYI:$D<R#'G@\>%.)N_A^9!T#$MHI*(#B\<);
M5/Q"PS1@R(KY%T;9U) B75&=DX[W^;R\EV;O1>IGQ=5#,MV)+?%+DO"7W/2.
MHH(Q$&H?#IF'&XRFX/9:4Q;B#TE)G8">&E,RV5ZL_P]VDV[5/&$WMMS0<;>_
M]Z[^B^D-,B33\?-3Q .A^G[#W>1WVQQMGJ(O;VX-"ALRH$'524DT6P8,83YV
MN5(R6N,Z95,'!BK]"+#1HR<1P#7><+\#>6'DT]QH?TR*4!U=)((OUH[H2HO*
M$,8(1TN><(06[3>?JC7R$:H.5PP(&8IO3H]/3T\_^W9DHGP(OBOS_3>;TKT=
MFZ>?B7U[L]?;X5/>-_13^RV,T!$:+[\A:LG2AT23)BL.W([A=V3#DCD-$UI4
M-"-'F-<;[SLT^S?,N9W*1X^^^OKDZY-'CT\>?'GZ]5>?(?7]]N'C/ _);[,4
MTE%]\E/^A_^*/6/*S,)0K*)K;8_;MW%[^-F0_YVWR;Q-[LDV(>[<A9%R-$5S
MV] R;Y,[\\[F;7(;IPFE(;RK##"F0'<#"8JTY,Q[Y,Z\L'F/W 8*H&Z[HW"2
M?(NC9-X1=^3US#OB%G9$Y0KD7XB$MBDDFUJA,\&0.E(F_< ^F3.'O[(=?Y57
M06)=6W_2M-)$RDZ@%(%8F+YT[4:91ZHY;&[*&P)?H)<E%A9I0D&RBSN\)T9B
MDF!H7&2%2VY]"&IPVN\06/!C'<4R!1=&'-?HU-;"8MSH\Z)28ZLN,8UXG)8B
MAQJ=S"A-UPA]6]S8J12IEK0X%'IN*"I]JFFU>:O^.E+^48V,=D]1@2&=26U7
MEX3^8,FKL,X64.4K*OVE KXY<H7\%V],4K'1#Z6>2B6,;?I52_% &5_-I;=!
M"7$@WXB6,O^S7+Y@M2$AFW*D.)BO]L?9"RQZ;DL<EA?JW@A/"_HJ"@^5>[13
MT3^Z(6_XI7\]L0N7NZB&C#[+)@?;$??WHHF"?[*\()'PN.UW]*A*CY4PD@C%
M"3%&<C6F$MW?G:M:H+D8XUX[90Y3 +]EA?16@Z0^&F9%GGAK@9YH_)KL5(U>
MA;[=E-5"S V9/K4S0:MH5 %7T:(EXTRIQ.HF<R)L1NT0[3N^Z5S0FC9/KAI(
MEDPQM:+8;3>J>@!R2,WH1XR%5=B(H!#]-6F0TNHJ[8#<R])KPP,JWP0PR[EW
M%>7LG0*[HFREZ<4X\%+0WJ!1L2Q-\Y984@IW(,4IOA4DI[BKEUJ&_(J5;E<9
M\KOKU'IP\\MU:U)!N+&RL^(5;9X^W(8I5'2\0:VK !R4$9+5H7%@$0<O0DY;
MPQ! JG'O7W%Z_\%ARF2^>)F(X<18X#9,7BJ1-#C39[(C;$8'ONR'Z",!F,@-
MSBW3IQ658740B$3;D]$J H9//:?,IE-$\Y!L3:^>L3*$AX=F1B56GW@^=)P*
MF9 P.MD@\=\5%82CF"X/+R!=]>GDP9(R\L%R<S09P4%,OBA#IBFVC?#73)1'
M K)UZ4='0$AZ:98W2KJ _(RLB_RBJDG@-NO0+ZQM0=@W_BJSMW1/^WX>SWT_
M<]_/;:_"L?=$P>M!XZ4NR$WX1-+V5L*@''@=^$7O@#7*N58TQG8.FBW)YQ@W
M4A]GKT6<6J,+;H:MW\./6PR80 \RQ?&!K"T64]8]8L'G=?D;K,LGX)[@SH\(
MJ1ZL-(B<M(R>C5QW@?<HH#F?]J0/X^?CGQ6:6HPL/#&LE+UCMS4F/FZ@#;1=
MWD5SP_":7IOH@OS,)A+661;$=M^"W!Q>"!'->6?1+^@+%T@7-2CBGVN+8^,0
M#LUTK33E_]PW1;LNI+E%VQIV=5N$ G&%'HPKRD?YJ^H .( 4+AP;R\+]@BP;
M08'!M4),F(,GYMD+\LUH__!^]$]US!;9C]=F]B2>6G '/S\Q"6\%#BL:A>5E
M0,^(T[ZK4:^YQ""4(7-Q]D:1:*(-/.$6UI:Y,[K.FE1003%F=8ED"-3[DW3F
M;XJWLE[JZ\IRC2$HI4Z3;-D3C4!5=(*STT7#U]EK9P^S*Z[]9:Y)S89ZU!%$
MU%6RI#B"YE>!_AW@_UHG+)7<S;)(LS.4A_!17=. ?)GI.>GEN(:IH"4X][/!
M9(H&XSODI0DL;?K^J(6L;EMOMI! 4,8RG Q^MHXP)=IN2EO:-1 L-4!C\Z2Z
M;(24(I?[[.?4X[T\+'ZZ5,ND*./W[([XI=T*9(0H(J85O!D3^H\2H!MO,283
M H>3(H.-Y+:[2TA[,Y%*Z!U0B63=ON8<B_S<-Z!^>0"A'3"PCUR!9 4^U!3\
M'Q9%[JKD3M<JT<A>$KV6HNH=Z\3S)X6-:V2KI"$!FYD-VW/_&)Q'>47$B_B)
M%+W\0SU\\/ A*A3/7YTI(3YI/>]R* *COY*TCOVXS_H+XOCA;TBG!F=,@^EH
M'#&KR4$!)A8,4?O7F1=&^P6E6C+H%[PARU!/)R;9KE,NCS1&G/)TL6_KCVFL
MQK7PM@U2</$RX>%Q)3W)TV%&Z8B#QP7N73!!2:+LV3([D1#=+](LMI"BL(A[
M.+T6(?\KK'O"R]P$7]U;=W#&&$A[ -TO[$$%Z;AP6H5"VJXNBT#J,LZFCA-Z
M[#+P8LYREMVE=.MQ]E3XD#;4Y8T#_=WM5I2,ZCA+R=G^"ED@93/[99U0"[S^
MJ?LG3WGHF:CO7"D276C3X6[?^02\FR?@1V[;_#[NYU<P='/_Z2>Q3#X\5=YT
MMR><=441).$CEU!=5$I>A.A$3_FE6P0]+>M(&)(-LG[J5]"OJ790TZFMOV3E
M+:WNFN.(0U-;!O,3=R7AX]J5I*T=.&IL66[JW R,R5%I#'&Q?\WZS0$UF5(%
M0)P@'OT<C'G;#7F&\F9'<V)\Y-#%HA?DB&#ZH3^NO5NAT_3 2W-EZT#MK._(
M7]62?"A'J91AMC43PD7W;C3-0PZXM?=QB245DD25YM.&S@+3>M30.? >;2G%
M7^()\8XAS0@].GREPPVV;IA\\WO;^W#-WN03;+"^J5=]&Q,%0@$J*@'R!3,9
M@?1!J;Q_]J.SB]4_FO?[0"TWGZ'WTC@^PWK-R;,ZK"Q,:ZOMEZ X9IHKWD^)
MR-:FH)A+LX)!#UE%X9+.;+:&W,"IG9MJ$@X- INM5085SJ5PY;V>VDECDD+9
M6\4$$H:SB_#0KRDX&) 4,=,O_,V:TES^(><VRAG"/$.8[^J4_^&_"*P!7O,%
MD2VM.:T"U*A#'H "8\=ZPO"R#%4N<[!+KC;0$@>9-P6E)3F!B%#38IT*&^8,
M3:HIAL[5P+6&D=7["+4X@;6DR]EWRMI+QA*RHWJSNL;<Q'-G%M^\WV]GOVO>
M56,'5EBF((S0HMM^&T1K4M4QID8GMH<();U1R,OOTX>GQR>?8;^?G'ZFM<H\
MP-_-Q;D\B*H7%>/4>D!IDW*-Q"[-TAW>GNRX4%<*^G?EC8=C)KBN[HS@UY8J
M/[AH454^MNJ"@(\W92</'H0AG<F0?K1#>AD%B'Y\.1N..[.*9\-Q*WP+J4KA
MDYB7OLAW0?1*#]I%U*V>$ ZKZFL&  "+@Y+95WXS[NK"C[7>'*E@@NIH;:B>
M?%%WC'D/6'@+T('!D,U-Z%451HSRC!#Y94K(+HI,ZP,PE?UB2@!PJ+$7E79'
MFGY,_*K,% -!39ZWV9#<F54]&Y);,"0@YM+>D^EM%;P*.<?+(B$(X\W%&XZF
MAXJ!:ZXH1T$H$CYA18>F+DNNA(7K)D1[2?%[WIUW9JG,N_-6=J<?O^Y./D1Y
MYQ%_H_\F-P)%M5H5K5R2*XZP/;0T,:NTY &-BBZ?]^$2X10&J"* 3A)Q-]&_
M7"/\)V195-M,QNAO<5$WJJ^2F(,"Y'< $>0H\2P= ?%.3F-<HFR=.QJ1OQS:
M2*1\0AIN1K[ 8&M^H0F;#<R=6>VS@;EM R.(44[P):+TT?F/R88H@_U$HPU)
M-1S<5',?TJ_L0_IR[D/Z+?J09N,^&_=[8-SS["6G0X[.80%]B/6B[\CI:K-7
MKG5YLX+RL;?X/7=00%#$D<KE&OWHA"$ME.&XB'@B!M PJ0D#D;6I(VW;:.0N
MY'G6T@2 KAERU0*ENWYJ=L;NS.*9]^MM.V,6H]+D/==>\F4?U'92ENUGYV=!
M?T<CIS._A8_^5JS>T%P O]635BA%;*8L:]BQB% $ DJ\T5UU25"5==2,PIZM
MZBJJ ,U[]LXLH'G/WLH9BP2(ZR[K-0.VEGNIM&C=UN\H 3+:RLM[5FV!W,S+
M5<_J!YM0,F6>%" M+O/209)ET[?\@W]S)?]N2[3;$'='"N9GP"KG37MG5M"\
M:6]ATR:RY^#*(;130$T))I3@F",)RT#.)=U-Q.<$H'7=[J@_8BY9W)T7/>^M
M6SD0S>Y"%0& QG(_W&7^N**1H*X?6TK0^-D"V=V.,([2;+$F*9]BV7=650R4
M(+HWYTUX9U;$O EO(Y)4X2<F[R#R#$X!F7KA6$3N.:/R()'59><_O@:VE[N2
M^"\4(.;[T$8O')VQ;6);KXF)CKJ[*8X\>"=""=!VGVG+[]3"F??JK1R8I=]#
M:">B3,_67=?-&^Q3;MLAW'^ YT<.E[M58OM=+'^PD]C^6>HZU+ZONA3%S)2Z
M3+V9'"CH-B"8QZU@1'Y&C5]_]?X,\=D^?'#R%3>O_=3TV]U0I) :(MTZ-.NZ
MMV[5PP"#E<>2,ZR+AE/ND*GGKX'UUV\34H5O5OV6NG"1 BCKFL@L=-A)),0P
MCDA>/OD0+ZKLKWWE,AK\PP</3[A%]/BU?[Q^1U?*SNO>NWE^GVX+L'WD<<J8
M$(@))OQ#\>H(N8R+7F#C4XUT!:5,B#T+U0I%I4!@C$H5#3% *UDS74-UY(U(
MO#Q?D)0G1A+OE#I*G] SG]?518/.UY=4]= 6O8F':WIO?"X6&3U/>)]_Y@DA
M96G7HH"2?4?_\4-O>X#GAV^1'US:63%3:-BAUPV<'#-U 0H+@Q#XYXEO9)GV
M^')'(EH+(X8GTI]-SBEW['ASNG),/C(<'WAM*9U$^NV$T)-ED[9%7KAJ)>19
MS/PM[>1*Z"P 7W"_%=H^'9@S^N#I@S!6NH_I8C$%;K/=!M>$]H/(2![<BTAX
M7?""^]FIC.AU3IY*1$K)&V"!8%A>NR468>^O(E,9<:$XOQ@C-74@XDJX#(</
M<M,;"D,7@//DUDO8ANI G7/RY4+H<X8+3XT!D?6\.HNT.YR?G *( 0ZZ;F/J
MGQIHB_44ALLOQM4E@ZX./Q\1_-R\\"))'V4JL[W+&WJ:Q\(QY(>-1>AH<50,
M6C.[>UU7?9==UF7<U</$:H3(RTOW9L(?914S,>%>M/G3!G2XKUI;B:!U2N*^
M15-.W0,:OZM7U/,&QCK41FEQX.4K,"XVL Q!^?Z%PJSY+=T6S%4GDA534Z:<
MU_Z%_ R6@SK[N2=*'V8D4MO%AM&<42GEC-S26]*2)AKE5_-AK2"9XA.3+V5;
ME[?<9<@''"^PP9F%,1JYBJGGP+EE68\^U9;DV=/ZE6HQU):_*G:!T_O BEF,
MN<J8$M&VPQ.;U11Q5L(6%5E#E4-<B9]4A";(MXB?K8 'XC*AYZG[EL@7\V8[
M8.XZJRB_I2QH(_I,<"<&<Q1=-U.&#2<2LV>&!_2&B2ESD\M+%"ZLC$I*P"PD
M;#D#[50>B#?)2 DW"'/-ASVMT@>C?<_#41J77N['7)/*Q,OD8R#'\Y_JB7>@
M$W9Z9EX!TG:1)21] ^8UHD-E* C?E:<<CCBT (!+$7 )-T+KVEGK;74J1NPN
M^K*9$7!,&I^)I$[D P.-ZD'1'%;MS)6E!(^!9>97:2P=Q*8E+MR'C@F]ZP2=
M\VQA?DN.$):$B,PQM L"EU !XT"+#-HO"%0,<=%HBR\.OEK>J^R3@[Z79>)?
MI#<W9(TQO S42DSQ6.]H.;>%,AQ/N@$Y.6<Y>>/'64*#8KD43Y(HY,4RW^;J
M# 8G$*=XO[[P[HMW'L!?&]@;Z?O8#=-M!.P"LT']*W4)9J]=25OAW._OHNN8
MK. )G*;.L$/"=,,&5 A1U6F1B2"ODDD+&" 6+)Z8M%]R*[^E6*9B=5DXLB)9
M1RS--.JU?#@:5$J0^O##F\,N^^/)\<.L:_R1HPV'&^^W^;=.GFE+<_,P>*P<
M[OD/7UQ$;]&LMZ@[DO=^J^5$SM[8V=#H?N(<H$<N6@U-_!4N+JA* C.KTT*7
M"*=*.!(BB6F#5=GOT/O]&462]F$"-R6C@*A-DPU:](\IR/"'2YF=4(AQ<LHA
M%!W';4?*9)5^)<[(Z8GW+L&9:,[FU#O-Y1CS0\W?N.HX^R=<=J%O3C8L&M2]
M_XPN<G/^C9\:H[HB%QWGP,EGXMP_I(?G*7CT6?"&"QJ'F0MV:XF4RT%?RC5#
M*1%_WQ\!F#PY.13GFW#K;$L]\CE1H[8K?S:]I-@FDJ.>A&VH+V$0WT06@!C4
M4F5,^E=6^6YAZ*Y;OX=-"WV.SYK%=[##?\$@3.*4]O?T]F[%WDGLS]]ZVU;L
MXE^EZS\N$4U_\*P\0I1J4ERGBW0^?LK?^E?F[__*/[';&)/S$+9M8*5N-$,;
ML?!8&?Y+DUM!MUBWWW'T$O:&32J$\CU!9G*(GG'7@!#!4E1K:%#UCPN9+2'9
M-:\.G+!(:/"!8-,X]"FSX\4J4EJ"_F=Z'XLN@S1I;^@\@4&Z(S[#[Z?%XJNY
MQ6*6>KGM59@>/<KJ*52)IMMQ2.'I"%.Q$ITN0RDY)J4$F$FX6V F.?'L0Y2$
M>GO7T&&](OF$UR+ GHY)75DULQ11^YLC9YZ>^D5%>55-^P;75\'*]M0W98QI
MR[^$MP5&YZ[)JY:D(ZH5AU=F^ LY&A)-C@D&K)098J%9;&;\YC&UE\7./VEW
MS7Y[%!))#U6AGU G3N4PD4(;.WE#[;> (M5\*X;G/9$NP75+)VQ!E9ARKU[H
MH:2<?P(^G,;UAT7(H[X,G*.D*.2Z0AVMY/!^"I7)_2)64&@5!1?!<!WF?M6O
MR2<9SS8\!%IY_G,XS##JZ*V,QNB_^-KYT BZ'5^K\_7]]Z_-HV'8C;L464RX
M6S2!?B-A!?H'^YXD,P"Q?<F,):SEUW<E-#W\._71'6!'.O,# GJ!/%"HUY/@
MQ161F+" 0>2BMSLRK1N$8$>H<?UK]XZAW]37Q$I+Y/CA(O8-7CGQEUL\,KT&
M\IJ%]%Y$'!U49O0!!I4"2?]/[Z3/3[Z0 B)?WU\V<+ND,CN!4P[>XI'U!Q,*
MN?80X0I]Z/.'7X"DK@6/,..CIWA9OL.GAPE\\HBH%8&21SPN=;WBVR2;#84%
MK'X$CFVR-!$H8 HE=L%FI$4"8G[@$Z0V8 ,$O^I.J8W);U$IJ>V5X=VDY+E@
M'#/JFG"/OKJFWB_KZU"8T=R^I8HGC1G_Q;)XXUC)BI-A*6NPB A4-Y'R&G',
M][(1)FP;E@/])U^LNIKVX<DC+3I)^9EV&*\?/QVHXRG@CR0DY&&G0$CQ1:<0
M)%KI2Q><_-)Q%+,.H"046!APM$%E6THVV+HLC7#X1@D1T; L<GWI=).,[%&&
M@(E3LL(#;?B()U_EL 03*])"PW! OH/>-^N1BRR0$0 "][7C5'";^@*2EPHC
M8 NF6:\4)*#*10<UM.)1&H,E,0GQN$N/L1777@O43T/G>&3T9C+<B$'0.TF]
ME ]5I>'&J4T7*6OD])''MT>^)K$7HA&O:D9D%!;)L_J/>YN%JB33\#*E% 56
M S4RMF=]^<84.><ZU=WTQ#^RR 'E(9\)^?YYW33]CF@/Q$FF;,:LWO!)+)N/
M('-UXS)!.>S9^4OOEGG[=UDL"P!4]APY&=!2'6L04N'*][#'(.[AGQK*+U_6
M3?%OF&=!Z%)53SXC(EMP^NAGJ!;IT5WN,X%V\+\6C-K?!Y&)&KK2D!<**#@6
M]*&27E#@"W+7C%("W[DH77&PA%.+M2!6A24=T1LYIC:VVO5TN+6=*&A-3@I]
M.F!N4.#1?Z3"2C39?)[6RY+:75UKA/^NP:7>^J->NMW)8R#!Q7A^I\>S:(OZ
MR4,01'S(/9^UQM=D+!']<B#<O:SK-ZH<1$3*BH%;^?O[RY=[+DKF18/&B0U*
M'E1@Q-FG 4%0F_03SIZ</::1  @BE@+DR9L@E\&U2"*.YR-7AF:UUT71 V\2
M%ROM@XKSH- @>S=3"9O/S3MI #_R\1(S6MFKX(O.9^4GL50^O-)1JFK!!\)%
MC<,-(1);0TU_Y==6A,A55T53*QC5&]_.K4(0=)G_VW^L[H,2R,J-J!->>*.[
M4\/U.M\XUL3)6)B+#VOZW"LG.8]SREPUE'OA#[[BZLT^X-L ZJ[?%JOL=;BK
M+;(O+'0D.:5:BP["@W+6$)_L29WQTO^]#'HE18NZ.9_IP"<9W>U%1JK+05>D
MR==%+7%CG VZZCIPNUSG+1UN"NE9@TD0 !<#;7B^&?S*X)6 +T(E,R$5"Z\H
M8Z6ANK7G.8-D)U_5M8LP#6+M4T*R?)LK8#$!(V]H+H^S?U%:ND3E7^$_HDJP
MS4&<R&*]S&$A)WAD+TZ7%%X#O]:\"SBTM;T LN&X"N)_ AY(NB;<;HQA2E_^
MORAFK>B;?@^2HM>"LB:4], / ZE/80$9PI XQ3"?OG?>I'[D ^LOL?3PRF2"
M7CEFE?"[CU/[9+'\@L9?Y\/YDUA)'WA?OJ0R1<XH!3UAF'_(I!2%+FC0HK2(
MW3,_-<C2[;,GC@)'6HBQX/."PDN$BQHQG[4HL\B)B0#WQ;.S\T5(6RLN0^J=
M;>9T^4I^<.V/.%W(;+<URN804;0%0_=64!+DL\!ME_[MUC#R015=+^C6@263
M']S\P9YIZ-BQ*GC\<)(TIB_&X(SC3@KU\C;@W=J5-^1ZAL;'N6+R_*1A8<&:
M],!D<2_+*BF(#7.O(A2TP%F,'Y@&:HL^,8X]5P19#>>X#C\)0/V7ZO**^QW,
M+%A5RH5&]2R;W-)O3-&KJJLC\TW^A+[<H#74"1AMZ2[S<D/#.7"W=A&_AAO6
MNW(6VKV?INM%Y;C!A>!Q?LG8&DC!,+OS?ID/S8T](6%ZSL_.7_&&I)],N@ZF
M35<L<G.NNF#PF+<IWH7LF/ABE+>)VX9@$&"WEEUN, +^-S0\C ##5&O!HPK?
M#,H>A[]/J;?T&D"3&*7MC,'1C#T&JN#/B^SDZR]/_0?7^%2 DW JD:Y$KN:U
MMZUMS6XJ)Q!M,M&[M<")B'W=H]U)YB_VF=*T+GCN%+K"+RY\#3(E/@+0-"=_
M-U?=<PQ=X"G23>VGHLDKN0D='OP&J6]@6:_WC/.L1.,(4H]%YPWSO_MMOLP^
M?_J/!P].OH 5.OOA__WSQ[,EP(D"W:<#X*VWLE(Q7@XG5[SY4/)MZ%,4D(;Q
MZA@EL\@3P% 35E3#!8_\HUY0@2RIS+7(S[(!3_DXE8.S[7IT[-D+CI]NMHKW
MTBH^K[*_>R,!, TY8 OL#@I962BPUU0T01PAR;'IT?* 5EY),K/!$5<#*Y#B
M?VT"%%GB9T_.Y.)KYZ^U+2KML3"+<>.-(SM=LA<(G5\5ZG4H/NF&_1# 2*C_
M0O.5 ,.PANEV@\5K)3OT^.3Q\>-'7WV^Y&W^^>H+M<&P\L'22(:=MQC!8(:[
M#,EO\T#C*DCKW!N_#>?]=D\AQ7^>(<4SI/BV5V'H7E0#!9B4M!7 6).'U+>D
M/!M 5VH%<VW8$7*$-7\1QAV=N^1/DQM)%T=NN$+ZGJ&^95Z1Z1]93BHK!L-Y
M1QH9?J<)0.Y&-)'-G-W[));)1^C";P1E:%"L5;]U#67ZI.1FJW!EO8HUN!A?
M(%[;YAVGYKP3EF^83T6  ES?\]8EXN63_H+%P3H>==ZBU8#*0XHY6(S*7[%\
M1,&Q$8>:JBLA0)-L6=\DF%H&C@[0'7BZ4 >RB032SD3 :R&>LZ=W)S?3;V*J
M#LWE4[]:ZKUS=\RRSJ_^H_1KP9EYXE8<5Y^>*#C^VF6.%\8Z._U2?W8LQ4??
MN;[T?M0UY<B(D^((3A0GOR\ =@<%A4BUP.1Q"HHI.$/58F%*OLI4X!81(V>_
M1?G !/T/8\@D2[AIUCE*+E$#;QBO)IH0YE-S*J7NG3\=UK/?]MLMHW,!\KGL
M>21'OE_S^^$='FPVSB2I>*1.^YJ6]9GW82J@'[\;-D7XO?6\6A$\U^]U[PX(
MI(1Y 8C/D<N!WLU =IEROPS;8,JK*M^B;^NICZ'*LNBW\7(_YDP(>9R] "D.
M6KG2#AQ420676J]XM%WV\.'#T^SLRE7%.O?;W#LIU/RVSQ?9Z]Y/=7;RX/$B
M^R'/_EJ7I?_E^5GV]<,'IU]ASP.B@E9R;X7\5!S5UU6D?!.DJ)^$JO@W)<_]
MJ\(\R"QX$Q9G(8&@AN?+SJ@#R2\@/ZANG_WPTQ/RV^)OF0&%NNC(V*!;'MG$
MZ6NM_(\M9P9?]\MW#>*GQG]I=_E+OT8O4+_ZHVLNO#5_Y[?XI76N=+O+NG+D
M/M,IX&/BS__\^,]?9(].'AX]/GWPD#]W[?STDC/-K8GT,>LR_*(M=MO;Z?KZ
M^MCI&UH6];%WFH.]^L5/<Q<-QN"=";C/<M<+HQ;M\6K!_(UYI]UKW-.$O#<(
M4C@OK9<+8+$EY;W=EJ$X2Y?:I"40X*Y!N4J!>K0$Z9N:F*?:.35)UIL%IV/.
M0+OO0W[MP7M&+:PG#X[^QH^4_+TU'^!\^LFW?UMD_^C])1U!T ]_[!_>J AQ
MR_!#?PZ7XB$3[4_DY6"Z+_[&IB *5N+:Z1OOF%PZZ8\5X,EKR=F?G'Z><[K^
MY/'GZY"P?QU1^T_?LL%57I&3KT\?H2B FXL,#GW'?G#!0?!57I0,,"26#4KU
M7Q)ED$+UPAKP@61-U;Q6T!K^.WL-9 GHA\().7X$VO<1+;?,XQE#F,R80(HM
M%^:QLZ)#RSL>ZNGY'$?>2Q_EC#I(&\8';1G' D03-46V!%/UT8!@#-ZQT[&N
MN8D[@1D4C5(_T.'OSWZ":QUG_VS1U2D,ZV1W>J8U0_(04"87-;7CF!:"N,)Y
MIN $L/J]SQB+%H:,\ 6T0YGS@2*=VN$O+&*U1S^QX6((>\=_JY;6TY:! /X3
M_C?T(;*&!(EFG$$8<9A2'G)&?L^=H=+YG:QB32U6H8;K7U$#<(Q_DNON4IJO
M]K%^VW+Q-W9<_?7%=Z^9^OA?<E@V;BL]2@>NEE%O4LFH\[PI"P=J+V(Y #<;
M,;RM\P"WL0W^=+0PX[XV!FR*#>'"JXHHHT'T7#/RG1N^2W]&+<MB%;OL/B^.
MW?$H#7#ZQ2*C,G, ZER+Z]W5H,_FK>$? X*IS&4Y9*0[?9PMA9+.KUTJ5MNK
MT40G_D/NGY2.+G(_2D'RT_D3.-^V+J\8 L6MUMP1J,]'%'U$0=_5JS=2L6^S
M2U?"%R'$7NZ#D;) 'YQ[NW)NW69__.K!@VPK8\Q#;QKT8YDQ_O1!=QE((%"!
MHB"K'LZ*L*4SN8L_H^GY'X2G]X]- _#KS+^3#K3):[?T+[4/!'Q\2W!E'>'-
M,O76'=G>OY^R]M=S6?OVRMJ_T61DQ?K__(&D;_[G)/^?IFC?_ _59OSI^:FG
MTIY3W^K)V7'VJOA8D>@'?9[V3?:,W\R]LV,?N<+\ZOGKOV7/SLY_>O'J]=V8
MZD_,(WS_J?Z_=9^UEVCO$Z A94R-:HAQR,@X96*<D@X"^AA'*#8KHX$'9QB(
ML)0:&, \@,;/0/%3*\<+]5;ZE880@B[=^NB?02I#EXBAQ/6*$;[<ND*N9V S
ML&..7.;OPRB]F*:3)K?I3WY@XNOZ\$KEA@BB29(W=.5 E,M7H/[^@ES3D' H
M]PKX(61B3%P5($LC\ORCLJY1LD?!7YAUQ3';4L"4SJLDQ.AJ0IN^)6(MODG!
MV6[Z[W%F7[6^8"F!8<[XQ1)?SZHIEIR)?^<;1LMCF$0S9,W3-=+@YL-(J6%I
M,/)C7@G:/#8B/?'10 ^Z0D9^5WFY;PN\BF?A+N<)^?>K^+9>A+<5Z?$NG0]4
MR+5FG$3:\?G\QE7#+Y. X[3.VL6O6CO:&#I:/]=X(T(RMG1VI3 G.9I62VTR
M)=+QY]J RLI2H5/7!!.!,VX43"3W\YN1N/=PI[U?'[1^2EI+6!B-)C3I;XWI
M3VHM-;/.5D5T<]+.A4R@=-*V7(9Y4_D8'TS0;4C17EN,/H5/6;&-[;I4#P5"
MQ(>519/,_E1_[?TX(3ZHB_,*;]+TI%*:.FZ\EW4;]]W?G8BAFY5PGH/"^3=Y
M(^^A;OA[>B7O?V1KV1# J09R!1$[Y3=OB\Y$'(K8M"NWDR[ MTHU.\9<R?<4
MF4HG=>L<Y^+9<*GD1D6=1H'4G_C)E;8F$1OY;;;E''!^Z,FXPU[LN_*: <Y,
MBJ87CF@W.K>ZK(A\8Q^RD4DA;PP52&DTT-A%2;$%[S$X2F"@HJ.TN<@K)O@"
MR*"C')SX%'(W _@!YIH9D/,"]) KMH[4Z'O$_3#L:_@I:Z<;Q!;:]D(?1-)-
M =R*2"(WI.2T&Y7,GO_]29M\*7PAP1]MWG6O2=B2:='FWL!6Q"%B>=]?6= *
M?J:?N64C(@0/'P:'$*V>V4OQ^+.SB\9QRR%@GB^JFK$=*^V/(@R7TGO:!S(0
M]J?_.'EP@AO03P\7X5[:?<2.U(C15QXF;]MZQ?*/&(-H*VEN65YMQ&NP!00X
MU:D&RV!Z:>&-U(6"1 =HR)1>4[L"A/TEN4<D@<FA;F54EMJ\Y(<GLK"!9M8Q
M\^,( &81+UHCZ^SO2@UEQC_M=R$'3"R=["Z[@;_+G.%.V[RS?$DDS(;S1)2=
MZ$RX*E1N"4<&U]>I!BSL:K)V]I%9IMCP,(E)VD<W$-Z@QJT)M2C=@%;*"HOV
M$(/J?>-@^2 'Q:?@&F7S:?L!NE4UZB/#?)BEV%I JE7YL1&7MW<Y>R%C5VW@
MHB.&B+PH0S\ 2GG]SALV@O_S,0EWE>)JZ./AP#7^*G)1W"4[86A1J-SD5(6L
MLXM#(G+4=LZ\SM&2^"%?@>-J:.XG37'[;EL<S+I02_FY++8\1J0!E(<3Y5*2
M?NTT:A>KRIXY*XW1AU@$BPOU([@S;L;L_( [NN#9 W/YQR\?'C^*)4+_V3^>
M?GU\HK]9&$Q"Z0^\FS#53$H @[[M.5Y452__G3^>?&7NA+D<1A]R_!!M]KMC
M#Z3 &(DIHH4D+V (^.EW[X'25E4CP@?!:6R3AF+S)7+;MCN2K3KD0HV\#O]
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MUKJ.HD]M#[U,ND X.)-0Y>::KA_E;Q&8*-SK4'D++T.(.TS]-K9:Z^OG4.6
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M7@PKTVC !1+\\O7-\[)X<WUS[2/8JE.%@#*.)C@ ; C032&0BJ5"1\9J0Y-
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MU:X5T8.K"2N)8C+=ZW+.04"]Q_G\5B!9%\T-:PH:,<1T*CG!81*1QS5E2$,
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MN?R+[[Y)4*+T.W 'ZCB7]Q>]]1CB9QE2[KKX^[ZJ;3!> A-+/WB:&U?L6G!
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M:IJN:^\P!4OW=,,J<(+0RL*4P.+Z0ZUBM%B:S<:V;W7JL2<5?R://\"X1;$
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MWA<=:W[O D0<N0\>YV$&H:=;[OA7O 83\KD_#B!O6X%Q\<@*+2KT* U,KRJ
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M*2KBV$"]QWG.1B@;H4?:TK^+JSM@?O,GBKP%_2D8"CS&>-E_@#FAU"P-DXJ
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M#OR$6XNL+G6QPW&5A@:Y]W",:I0&W/!N9R4)0:*C60@J?,&&@-5SO2Q9$67
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MPZ&HLD&5U$B%8YEC3@Z9E6"49KC^V-=(B&!#WVK4 T'-L>-V6-;EZ-/@3]@
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M[YQ!9%*9%8'E?MONB &.C)KBX0\U&G:3T'&;^',9"RN+Y$<GDH]LBUE<$*Z
M\H>[SE I:$G"HA(A12*ON83VXOL7K\HEI)6'7MS%5Z<4:]MSC?%(>0I?9IK#
M<_A>OD?W</X6T=(Q+"(0+9_?BPM,=,VBPU]K=,?. (-344+ETT_@I7WR20C?
MI*_U;PUAS[_IR2AKKII3*-RUFGZ=6BWA:8?>-V3AV.M:"L?@-]!\CV+IDLJ+
M0 M'XV'1=N#S@:,4MM<5FY:N+Y,/N)-NW55'VA%Z 1 1=_"0^K@F;?O7\C?#
M_VN%@*+G\9R_5$@%,H7+>KUYAUGT3:7<-I)H D=O5^ET@-XRS7'[HH.CYE^N
M0_^*XVVY.B(%TY.X7T?EB*6CV]B*4O!2?W"3'  8($OT'=.Y$_H3%=0G7AA]
M8T>P(/3"_.\)@=A/;,E1F5ZZ[:(&"*Y5)E0!"H:TL0DX:UPQ5YE9DR;"G+7D
M['TMG39C7-%&X"3#E?\**S";2L'P*$NBF0OZG&QJP%G"U55](#)0L:+4/0_*
M\%TQV3^'_<:0FF^I''\P_Z1R3!,&Z(A'DCUZ!@&B1"2O(BDKF899*9RO]<<'
M(,R)(VE%,JCAW* (4R:FE81##JJFUQ)[<CDL<GE,:J2OL+87J@B[<=/4#KWR
M2*<PX*@,;222FCR4;SH?/1F^Y)I&$L?[CG^M,&"@I"YLO^/44RP V)<1=5%N
MK+R),3?(PJ(VK>5BBVCCH*JIUX%.''?D:U6--=#H'/G23W26HI-I8*NV5#_J
MIX>3HJFE]<&[H;V2A!\QC(37G2"UVH;AQAFGZR"WQD(=OCE%BN6 3375PJA1
M",%"O\-":1 '#*HH.1_*@Z,W@!-6<W*4@  %73#>8#.WQ8J*-N\9^ZDI:C74
M^;=-LGS<U[IU/DIU>T/S&#O03;7T-B^\FQQ2/EW_]0.'2G]!B"=D\7B[Y+=J
MQ(E6@11A;0WY709.OV/E&A4&YMR!.9M]N6\U'_&/.T33BI 'DMS.G_'MK&J?
MKT"E-:>7L6=;19UW\]^E];8#A3H0#]BK?D^=O8T,Y&V"P>#HC2\<=3>Z:4)6
M<KE@L@]@7 YV0XT>[%?Q,JBQL8E[7?7*&GJ0WP1!"W?HD&\RNU7B8'-\-_N)
MA%<O9O*<TQ&B LHY]4!=K!T'=CRR(ZTNN#KZX@;<4!<"6+PI+FS3F;NE-\V^
MMQ3W(P\P^0PZ:V"P"5,-T0LQZJ$>R="@FLRMST#_9:7V=)7:![;;4<0K>FX&
M?V")[3)Q[E,D\ON(9[4!<6BFT_IB])72D89OKW#X]L3Q@=EI_U@\ '<$[;N>
MX+E@F$O!<H5!)HXTHWH:7$0?>,\B ^) %L>G*XZ/[&-\XQ&IDM/M)QC28YY@
MT ?/@1,!Q0ZOT*CWS FH6'Z.YM1VW"^,>;4K8DH]:&83,Y[U26TJVS:%MN<<
M)@N.\*>J:<.OA^GV,I@UO6;(/%$;&QM!<6\0\FE1_F24AU:MD*Z2QHQQ #:V
M-B?&4?%[*02DB^J".EOM73VE*I-TJ?^NW)!2:,IU*N@N%L=#CJV;X!)'#IV_
M?#SB$3J!.<G!H\/<&+VX9)\%PHF,DZ;/_.B/= @?3<7.(S;^PJ_6E$\7-MJB
M\R-/=",G(\.NCYE)/?AC623(C^B;U@@R/7#PA7"1IQ@0TI:$O#5E3V6."*)%
MQW:>ZC!Z-)EJEI<2O0E&O,%4..'#^.R<G_KRN4-R\FZE'9US]YKUCD>N8,VP
M7DIH?9<L@7UC_/@MPAZ8];KM:#/D$,I!C=^N>MEAGLCV/4_ZR%F061N'+=QR
MCGP;P^P.F!K<>01[L'Q$F?*7A"B!$9*+4;,#P=P2"##21;R#?>>4VHF!+K9>
M$PC_,;R%KQ%3K<-_QUA)'H]-:4A6F ]M-K[S;BW<TQB8KVB_8EBG2/GL/81\
M@+)N Y@Q"32\72$+E(F?VMPYEC!:_QC!JE*<TO1;"/+VSM/&T#7H?&.YQ0H+
M )[$-<D-T:IAKCC6F_18!'UR1RJ&6G95S[1(1=K+BY!5,)OR3 4JNPG937BD
M+?U>1WUBRQ>-]WD.(]%7%5CV#F&M[C,I3+0T9P31W([\!A0<6 Q3CP\0]R/*
M>T5"[F]!7KB,2[("8HDV'HU(=>22]TZE653QVCQ6=33P>;#]OMVX!(?.NRH&
ME\G"/%W3C"65$@ZOZKKXW*YYJ$=RZEJGDQ$=!+9+7#,&OIMB<%#52+RC,)\S
M-QLE.&?:+*S&FTQ4R[A^L.-7J],5NVQ@-2KDD&KLU)\+@[')<\6>FE\^>XU<
MH%5W(B['">$+OVY:E4=@2JYSCX>JGAU7Q&\\$3J"]YE[5I\;HY]F8_0?/LF-
MT=F\GOL4;L0$W*,UE:MF-@YKEM0A15RJWP.EU8QUY;XHJO^" <)TVAY'RIJ=
MFB/R/B%D?&<.H9<DI.O1$BI6 :?#]3,8/URE03C.8\HW0[05.%$(9D["A9)"
M2='CN#_4XP#_ELM7G: E,)">P&5E5SC+ZB-MZ8MESPYCPYF,%Q-)TE R.:[Q
M6++,'L?Y#Z:6>JB;A?(OV8&XE/?GT3O/W/:9V_XI<-L;MIN8$Y)!'P:\P $"
MS@O1L&10B2F-?1:3+"9/04S092JCGEP&<2*/C-#H!7\WB\FEO+(L)F>Q)A@Q
M0>"#493OML7Q5032EH[O+".7\KZRC)Q#1M+P_C,T)5DB+N3M9(DXAT3HP!FW
MCQ)29DW38E5SB[DK1F0S]?6"G%Q0?B8GJS[NH_AW&DST_2I=W'Y#?'(C;J*0
M*_;3;N-"HE8/Q^V6&^J7N:?N20.->EELE)3F96H^F=8S927716A1NZ?F%P%E
M^$:2A)0E]&"N[-I$_31";2#-%5QD-LZU:P:IIE[Q56=X7C@F*)<&G.@7&X+?
MZ"G],'A8:3<<,9>M<,6F..Y/KH++-]?%&Q[8PNJD7]8R"(G_XE5RJZK! 33<
M5>3WM?#8RW51GR'LP2YN::<D0ZFMM?J&L%L*;F V B_M[\C],;*2T+0C=]MH
M3\]M%;*988J@"[WOH5$I?F3I6&+8EZI18@LNC!R.V%(C-&4/*0=S7Q65YFFH
M/'0)76T'>J5,BQ9W!OD3/TO F53.'XHLC ^(#6M&F@^(0(XQ^:('[ S2'Z_-
ML>IE D+'!V))2SJQZ,*X#2 K,_1@N0R2+<LC;6G:OSB"KMW8 Q'6M8++ZNN'
MH #+Q)HD!!F+_(,(2RZMPN%CHP(ICN(W_KKSI9B8P'&F#4AZAD(SINI$52ZB
M*K4A>=U>^49';OO3(7"0130!9HU !40:B&;FNOC"K/<S%:)HJOMN;\EY).Q;
MU--L".^O"HLUE=8@_QUS$G2I:!;>3W9)/=DP5"Y;XXJ+4I@LKT'7^]XCQ&S&
MF6X"9(8K'-"HGDI_IQ5!$*ZYM(Q]6$P Q\U$]]2RHDL1 K#,IT<C[O$F^Z9C
MP0=@,&AASJ19B\!A.7Y$ADCH6BIM(Z;C0&-=;-G:HW9P4N.V?F]U"B^4S(0:
M/7==?.O'_?<MVV8&V%A93:1RS]GL(!V7K;V6=EY("-:?KY-861?O#W7 4>EO
M4L0G$!$YTM1_C?86F]/$UY'.Y)%WPV"1T:JCQS,T3!^(J48>"H[MT0RX/Y>5
M"SUH4Q\06])5F'S/M"S4),V%U-L?"!ZH"3F%/7?2E ];;,L'>0,X2(ATKVN>
M/(R:O0N15#@32/DJE]KXSKQQ"3>9,K#P)ML#HE?WV*_<;40;0&!+\T5)5SDS
M'C D1L3ZEW9;1VXE[ Z(0T,<@OPZM$L[N.@(KN!1 VKTQ]8(+!ZY<FDC'(];
MM=JMKBR%>(*"9T,LA @64YE= XN"I8!:E)9N/ ;W0.:5(DCT^0@]7($2^(TN
M3U-)8Z7W9;GMTG=9ON?K\&Q$L+0,H/?+ 8)]%.U^V8'+#MQ<:H#!IPH:W/"3
MSCH(B88(,P;4-[U&BE F:/#X-C1LL\Q$(3.68OR(]PS1C(1[=!--:932,J[-
M9Y%]ALM+U1[!6F#EU%/>=CO033^)B66%[ZD$:KNK7,V<J\P,)4/6F_:NH17H
MDZ$1C69%V#C"PXJI';&Z)@A:9"S112E](QMH3C\D E?W? 4RZ!T1SGI?@&@<
MG*IKT&<GGL!W=LS#$S?FH2=9K$P'[TOZ]ICAQW8>2:P/S)-(]3BAX9;6^\B2
M>MKWQ"-*B(+\-Z/YEQ!/4]CI/'U2.@4H[Y!L]4'PBGH>]8W9?J.W./NR0ABA
M@3A_G\>&E\+V7R8(_K=;IC^J^>W%J*]R;UWQ71CV>.UC"YWCQ+S-=PCH2Y+:
M<*\I.)1$7YQ?Q2..TG^?QGHT:3:>8]-F6T)89CPPI5?!)L240DP$##0QQI4(
M?J%)U(K-@ER/<#.2D4N:P81#0#IMT480 ,F+U]\D[8_/JW9-<&0(PB504A8_
MM8!S4D;K(Z\S7N0DQQ9/#]?W$2G-<UJ/KK:8L"C5NYY^.*(6FUV$GSL5\AT/
M-$:#QAPJ.!"#8^;]S-[A8WJ'E-9N$M\0CJ]GJCU,-+] CN*\7*OY;NN)..2O
MP><<?PXNAK*BT.>!MC*Z3XE'WX=]L<IAKC!+X\=$IL$N'2HS I?FZ)V\DC1U
M@OKGHPD'\_C7+SS^]2R/?V5E>^Y3",H0PK0MYLD29"Y& KG?74C<J9B:T6?1
MB/PNUM7_LE-84NQ9GZX$)$E2O%%B[X!N%WR4""%A06\&XC6,[PZ7XZO ]QSA
M. N8DSY0W3H7443V1H==8($_#A4#E6U-51/D!X2GA 6"(^?@'M?&LTARO95#
M5O_%$L+L9M-VX1/P#]MU6!M"/(O&88T;B7;!UITJ6V]@!VY-5ZDC%[Q>S"YT
M\%CP:IUO"!A[R YV.$S0J;<\ GR&!Z0B$/)B<]4 LYQ\Z,;O;L1J&X)GA<V(
M[J+K#T!\6^LKQPS*P4<*#&DW'$,Z17HB*"-"3OJA6G?MJD+']K;J3!U"^^0-
M<3J"L#JX:B0M'I%IE],;UZ0D6QQ]B&IO4MA9(<1)Z_Q(.\_%8WDA0(433#=R
MA/D&*\T+'^SF)/GBY"3%,%WD6,\X^V%OX_T@4'8<88^!6 *!'LI62JLRP?A]
M_X[0-M;MFD2L'7JD.M5*2 +Y42*^;Z4(Y-@]X(G!%E A/8]8.3J3[XG@%I2&
M5"1<.T[O$Q9*1+2IU#W\+A#RY'1=W#0GS=$IHLG2]P([.'V7W+WXV";1:-'Z
MUILCC[*2@/BLQ<ZVB/G CU(Y-S!(D0X(8;//@73?ASD@ 9 IPOL>(WU/SHA0
MH')(>92$"V5G&2Y\NH_IE"$6_3A_1_!?7[[^U@5(>2YXP>M!GF"/>,'L\%SA
M9^BC=255*>$]XOB4P/R8:W52@*ZX'0:OZXD'HC\K46SR6#G0S;[7(VUIHIQ[
M@KDA>'-*=(XKY35LB26;;D=V>2Y=Q*#_P7VCKWD)++%= \'F\::D:K#"#>+8
M#4W,1XUJ!#RD@S +^-HH7NUJ.);^-R!QI' $T U#9>^TD(HK)XI"A+Y60FUQ
M?:@; 3:S]D5FOLS8)B!2K7:]I>05DNN*$+03Z,"%G)LD\*6V,%=6[A6'J!$B
M!]-H-0"OB;%\:&%5KH8H)4K5C5%]@- X9:A'O1CMV_$E+-2)WN>)'VL 1=I5
MG&OT3BRA?J+W-V&7P&,1\T=(*U$ 2TOQD6LS--@@F4*_M9V_1OBH[!JW7D4%
M':[Q-SVYJIM$V;*C%>5WTC.-B<9]=23NF<2O%><<S!]<G#">"-ZY$G@V$TI7
M5&@R<#TLZ52.()3QP&'# ?[B.-!K'1K'NQVLLFW T6P;*9-A/FA8U=5:;;0]
M5FRCV7<T[ *]^.:'EY]?/?L3^DP4NC-QQ,AR:E>+20(/N_"VEB1[FTBW%-;*
MF5J;W6X)^.U.$[G8*(>P=>J%WD5=I,U"]Z@Z"^5<FZ=Z(NQ+:MS#YA_4\1VK
M#6:@SZ8TF])'VM(W$NL.QW&TL!##SF8< K":%,V/F"/ DLVI 1D'(U4RAFSH
MZ"?JHB9P3[FWI>^.)I.@O9R>$M1/.&.[-9LWT<R:,N:>A+3VS?9O@O]..!ZL
M;GV\CWL0A5:@'1NW17+J9A?'*9@&Y^]5I BIP;0Q!+I3,0:T?A07NI92DAAG
ML<7TG!3J2#A)A"^EAGDS0:"W9(NFMOA5"!7XHSXC1%]GXQ, _M'F?#19],N5
M^JP"/VX5"-'$:] UGW[R[(^$64]U$D7'C1C,8MA>SE&876=U\ GL-5?!(QI?
M_#/E+NB2<Q><)(KG+REY%I;\:_UMY!^YV;01C0R1&QR2OY+$HJ3H<]/L3$VM
MN"]!B1@>X-&J&[>"R+TD4^0$T%M5IX1<L2XGI1SE;485]9^7-)_AA2W^@MG?
M=P;5/ &-O?Z_['W];]Q&MN6_TECL+!* UK.=[QA8P.-XYF5WYL4O3MX ^QN[
MNUIBS";[\4-RSU^_=>Y'U:TB6U(RD25'! 832^HFB\6J6_?CW'- /.U?W_.G
MA06P]0= ;F/ZRCNFI7=/1TF8T ,WEH)867^Y9PPN=LLH[.=?JKI9=D1&L;/0
M61919DS-J=C7/>'9^G!9O5E(P&+7[H"R<HGVXGM*;&W))S:CFGQ=/\@959P"
M;A9W$8Z=$].K-Y8T'1S>*8;!#+8^AE/;O&1LKJH94\G&V?O9]!8U1C7G+:6V
M)HF[*8U[K?TK4M-(@6G_8OYW%_:>%2*D(S2-3;@GQ42$G\@BG'M5>HA?5;W[
ME'HQ+B0,0@*^<\'!& >)T](;D?(55<)77 G79?>+G[7!3Y;C7C]LIFKP/TE2
M4-*2%#9?5+OAALO:JI1X0;J1LG!S%\$%EH2_)*BBAK!9Y4#;98R1F/=WC-2&
MY,@IB#N=:E"!2=><#Q<\.55SV=:7*?V_P2Q*N237\%3=2>E)J,'Q7JM4Z#8D
M<F9F1/U+R9.>F@)A>&0%4"V;-.Z\'2JF?_3?%D6"F0M0S!E.BEV6LY*3A 1^
M->.LCO:5F^1:",B*APT7Q!KT"R;/J8P"<P+=<IV52&2S8#7KK3H<WM+?4FZX
M^RH>?=D&XL^>1(OA]5!%/UO^0:[8OW%"*._:NFZ)QI*D8W=^I"15K @UCMZQ
M*:9"+]070KH#&" =V^<,6SDFZ)-);];<ZA4EC5)/T"6&_]T=V 42$R QSQ=(
MS!)(/31L\S](:^,H6O,D4Y@XAW0RX._^X'CUXP^2RFDX73[.9' YL]110T+?
M[D,GBZK/"#& R[^HWG/OS.%!27'&-_;E@+8_L+I6*#V7'6HEXQ";/ND(AHC-
M=N2R ; L(?5TE-,^Z,ZD,J3&-]0L3)"0W_H8I>:FE':<*!6R#HJZY,8/CW5[
MJ__;\QVN@@11=%Q/%W?\Z5IRN2*>C7>4UUX2VHL1^@ @:-G5(7%L E/,IF"*
M27V0C0V:F4M>F1&I%ZV(()17LT4E=+#Z^*+/NK\TD ".6OSM*9HYV*',\&D0
M3'P,&NU,K!IG328#2E/)$@;,0HJ2NNWM+T]1&:M^S, 9T= R5'L)#H<@=1^2
M\9*LCWWBWK[HU6FJ!FT0#WQ )4M%>BOLO7N6CI*F?SN)TQ2 R+Q)$FK.MB[Y
M[\5B/G:+^59Q%,0S<!5:C.&2&6W&B-,DZ0G:R0UV6MEPE ]"P(P0PN]7I\GK
M8.#R3:\IK$B'0/P&TKK,AJJLCWW%:;QR*$UZ2O,9F<BL&(O<LK,_1\E<*AY"
MU\Y?QO^Z)G]&K+:W(!"IKI1*S4$9BP%XY<#N4F(8CRN1NQXW+*LG8H 1M",8
M%G4/O?D9VDW+B>_:G<,+LZX9I9A4'S-25,0*:6>:-0E$ ??9="MG7J[(CW0L
M0HT<?O"<C9\J#RV%U;/5VPL".5!%%M>7=(A_O+%Q_A8;#-M//H^?R&^:)PI7
M&LPT"UAX[?R17%&R"M>-^5=A(4HSL $,T_,P_+M1$067 &3@EE,J$7[F1770
MU)L?,[T]NC=#SKO*">H'6<TJ2)*T4IIVE&/$%SEMZE=TH:GP)'<[';Q@?<X[
M*2X/B<PC%@EW.#5F0GFMB1YB%DS\]=6;)'30U!5_)\)L"2\R5EMB3,4[\H^\
M2<1#BZ0URY2+JV964!PZEW-8*;VV;-]\@/[7WNZ=7PC$VZ_;JJ&=IVA@WBDB
M_VXMBVRAJ7U)/T#E=@KEF C%9(=I-G/W3+YQ4Z@VG6A*QT-REDD%9$O/1J0A
M- -HW6\+VI=$E:A638&YF2"N1+$V$YU?>\U.$,=I6A])VE;K2/Z3)&/GASKV
M9"*CG5)L(JT+ 50I"2)0AG:=<6E0.CCRV>0%85?E](E1.L*D_!O15QX<&"TG
M-1Z+K6( -R?8\U;=T(OQ<!V!Q2OZN+VBGPQJ]7PL_7F!:II(=TG\D7E(<W8L
M%=4.1W+;1 8]Y08C/\;;X78P['74)<,M 5P0G UGXE%+J$LU+KT](^NP([F:
M+.9S+BVF%O-DJJK<LNQMFYH:=6MBGNM$'JPP)ZF,EHZCDIQ <7=09VD(#=O%
MD[\G2 -[(A$FH45]PEC1.:B(Y>L2:J$IB1JY0G+MFLG5&O38'\(WP]"V ;@Z
M<PS9)U#2$^3MJ";E<DPO-=6T@E*CBA:*C17.WWVI+'T!DN$:B8L)O3QU3H7N
M+:MMAL(N=Y6$JQ%&A=>L7X*U]T#=[%%L:VD$&- R&@IB^X,??26,M.9DNG:O
MZ#O+/H0;0%G.84$;M]B[8%4O>RP+149IQ],>L["++/?,INPO\%VLR^%(!YIW
M]'EZ9^B3:&:C(';(*%O7LP]Y%:UM)U>-F0G_IFD0M(+$A_4WW/D3G2.5BD!(
M_5!H6Q3\"/\)0G9(=Q%!@D(&-G&!8Q*7,K<"::&+>F,::8$H[L(L%^$#YQUF
M0_Z6N4%R4^,]S2UU61$J^B?H#'QQ'#@3-^L?6WYC__5?7'N LNX_(^@Z;Y_D
MIJ::^9 []XN\+LE1S;I*1#0WKO?58#QD;FIC(I+IY?BN?MHN80UT:5G,..YQ
M&_SFM8T2BR^S^#)W-*422N];X6V;'/C8<E%".[5H3!E)YX&3_HHB5-^2(X"#
M<F_O_*?4GE]=,/[M&.\18Y YH%?TF-95.]_ >NIT%II\;LP01)>.A]![0G%[
M8SDPL+#=LAAXPD^2@^ET/7,F471-X9"@>P/9X>!HG4R <;VO4/9C4SY$**OL
M_,5,;,7O[5\V9['TD8[LU)# '"5--_A0^@X2,O6$3O;AVHG%:/ZQT P_9&E7
MTY^G]D-VK(*D^POXVUBN_H-HAG% >(8TAU;N>^D?["7WJ@+1QI9*;"@<#80G
M9K]0>BB3ZX>"X[[JC1C:5KKOF9AAV3B/=^/<L;?Q9Q%%,:F-F;W"O:@$VRGT
M0"\D1C-TB">HJA$R(Y_)6RQ?_IR29,A] -?.?3163!!\55MIR[6!=KI+T>_
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MQ ^T1T/?F1G8$B8L[MD=MY#-FI5F)M%*:6J"L@Q1<#C*W)K>+B)?R66H65J
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MAH].Z^VR>A_OZKUC<_\70@L744=.&UDIE**?T#\WTQ:L37<-?P+H(>+9FUO
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M0QJ'F4[SYKS5)*HVR^=^M&:ZK25L;\X%W^Q:$X&C_Y&JUOXI_(>.[2CJYAF
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M[1='JQ#"5_J0\CVYS_.G3[^1^_ST^M6_GZV^(YE4VF"BI5EJIF)3=9MQ#P-
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M;G<9E\5,X6W"^0/")/9NZ9EH+7-Z@:=0\QULQ5@DC"DC-U8;IVZ<5J!E>A?
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MTP0YZV^_!:?9VNGRX6!?Y,;[4:C$6HA1)]]V>WW;)\Z8_>+L6,FD*73);@/
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MS\J,0O;X, ;X%(#J+E. +V?344]X(.$[F0#01V2"G9SYZ'74C@9>M@&BOW:
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MH(,('&2,7K;6(O!'=_5B2B0<SIN?K.U&K"U*:*^KTK60_(%<C?#6[8GF.*=
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M-RQ-3Q'XY[()[;4:M!2?? ^I+GO"L;WDLWLN]&HLET!U\6LZL/3-]6Z/'\D
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M7"OM$*^8VOYVS>UU"]CRQ/[$ZE4G#Z2/RMNGJX<UJGL/^F!C^J[H#8RU-+'
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MT^9MQZZ[*],@6VPO@&>A?[B!6_4\*?F:5J/78(_21%+[+;;#^CL831!\B&D
M^=):E&)-G7)$F7.RE#P3UHO<!M%\V#3IW7!H#E(<D!3R:XBR:\)+2(O@ NIB
M_E#R'"XX!$V(5DM=8GPY"6K,#?KL<1_FY_VLX.XT..&QI(C=%;1SQ6CJ8@6V
M( HG,?$<YBL8LW1G4H#1:49D>8FZW(*_2QO(PA)X&4T^V-X=!;F.260]_<RE
M&6@/CC3IF>C5\EF2N6TC%))I#''8Q1OS&.#/4*/RD$'3AIP91-K&KU/A[%:<
MWSI>Q<]&(.L327=.(FE?^AJ0[U]%G/.5'.@/:RE<??BW;'%<-VU?-=,4YON
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MDF)ISKX522V+47RN>0\)]X?!-::5>RM7[B\1TE7 IM;-4\[VXLQ^3M_-GI5
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MF<NZL)ITR75A^YEU(=.(>:>^=&'SK-;D8[I4F"XOII+8/'L9 P =L=7@4K8
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M'YC!,:**;SC#C!<P8CN-5I>CKLQ1U>0HUB[,"\P+M=4NG&W*S%1-9F+%PKS
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M14^P<0;$Z>#?RDVR !UJ>5VX"GP]AD-A7>J*FC";'D61T@%-;PSV08P9MC#
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MM7%4N.5R"< -N9G!MH_!3$2;8OYDIF>PM&&A:B-KOD\&+EZ6D1><+' ^W(#
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ME60:VA%-;7MO40S>*$8/(]Q<BFDWQ:K'QW8'S.RJHCF545P7JKB+/EY\._2
M[L6>K7^8[912KD8W9IG*2E?M7$C!$3A><G$+C'2!57:Y$;[P>AD;&LEZZV+K
MJPA7""-,GV^)\,XHG$H_F6F/O<JR;P+P_"RH<L-A!/PP4"E)@D[3I01[ R:*
MRR-<M7"3:+@B<N3E=WLO3,4M"P+<%MA9O 3HD_FRX=J2R07V8&[XWK[1)61#
MN1](NEAG7AW;'+G<5\Q"H-D)E+E^EQ[O/S'#,PC:UFK1-E>+\@V#54/C!,(_
MHK7Y(MOL;"K\_CYS<4I".(Z:8N<W_^:M.;.N?>3"S-MTHA, 73P2[[PR&LE<
MTU*^0'@ UOR5>$UJ!S0WC!"_.9@CI'WWS=BQ3)/PW8!0'VT4]O-JO:/'=WPY
M#=,$UG2MO'=F??M$?/L\^?XFL3J(L?P'%&%&5W+FF:%?X>OA_;F8NP0%;;RP
M!]GW[4/PE)=+&'K;[FZSN[>/X<^_ODV\)0\YS>[^[IW/M.YZHM-L[_4>/\S+
M309^B.8W>V2.^3X=ZIN[O)BEVKU>(_L?,A$0V^BE Z.=\ ^+68O"5*[T+1<;
M]E[$U\OD2L9ZQ(O[:]=EBW'$'=IL_TF5V4(",UTJ1A>@ G[RMU>[KYZ71E;2
MYAO7F]#=Y1HLFAE-5W5:/@-(6NMY^)>2D3C&^ZK^.H@ @&>N_.>ZQF/%M1W!
MG@\BG:])!O'.BA9=15;P(.ITG$8U1.@=[%E^'3!*#?BT&C*WLE!F57+U\22\
MM!EN)K&!P(6I<!=,:3-,V0J8@DD%U>!)UH0;(ER9+BQN6=PN%;=.-;B4Q>US
M&QXV,K"RY='::[2[+:! ^UDQ+]]+NXSJ7U1B(BHV3X;ZF[].8XK8SP1,[L/7
MFTWFEPWT/E3;KIDF"V772U&)0FM5)A.3ADG#DHPE&;,+DZ;B$'W6)BOOL1UI
MK4*PG'53SGAB('_?HH8%U5_5L,I9YST3'8*P/E1X (<](S/]5 W.J;[ZJZ&@
M?+W?V.MTF"5KQI)OJL&2%:,9*[,J4*':G,/*;(.56:?=:.T_5_B->?))M=F3
MQ=G8B*\).Y\$ERI>CQ'/CNMJX)[[TJ%.,G8C-IQARPM4?.\W=O>[S%%;R5$5
MVW)6)56@PD9L.*N2YU<E[;U&M[7+'%4!CN(@]+;;KQ_S%KL<A-X0T+')/L*-
MV' &'2_@=G<:;:?''+4)7G?61:R+*D"%C=APUD7/KXLZ3J.URQ'@*G 4%TIN
MKFE[;"_X& IU[8[P)EU!%W&9GZDS,]915L/36#%RUP=AK-4AN&I#@HI1:R,(
ML_Y>$8Q8UG40'FHX/R=SWNP5P5S*:HS5&*NQ*C$(J[&7= (_M,D<Z[%Z>XR?
M+,Z]:0JSADR-_9!TX$9X\1E=;8N]D>A"*OP![Y:ZE+Z:O9&/0PGU0TAK=7S.
MRN!VLXU"V M3NL*WRABIVL*W(H5KJU.78=83G(+]QEZW$N&-.\]!Y;'61DAB
MUHC5H -K1-:(K!%?).5]M]%Y</44J\2*) G OWB?X#9<W+DF?C#?QVG>=75G
MT0SM\$8>>GFQ]5A-1>X;KMEIN;/CM6UR+<(%G?/$E8S%3_O-/;Q]W,>;L[TT
MRB[JGN(U: JO01/9#6BBXS0$WCO2%*N-;X?#K]C;3F%9\S=W!S"4'\9T[>E/
MN^UF-YM-0TCOWVF,C^)-J$$8[!C_U/6$;CG'Y]N=9BN?_=Q-W_EM[K!'DRAT
M58RWAL>P+M=XNSQUJ?QP0E>TNR,X%_"=)(GT()V]+YQN$B_N%V\44XF3T/VQ
M,Y!T#7HXQGE)NH*\/,=N<S^?(KXVR/9.!T.\>%<,HW LI$VRP<WTU%!%./,(
M9ABD=JF]IE.,$\>AJVFU='4[SC0,U$X"AP6^Y2H]H30>W.!T B\HKDXWKSL-
M0O/<I:$?')U N31W&I!P#!*/KH?'X0]CO'?V:PJ[AV[#P^R.>?QV?D+H=%1-
M"+'(J9C(Z;1+1WDUF>.L*$ Z_6+H90)D1:[MWI-K<2ZE-<=TW3-^U=>2KCW&
M]>/03B%QFWP$GQ15%+UF&"-MZVFYUZT@>D%S(B.TG <!I3^4F%B5Z<$8W68_
M'P-$03P*HV0'-.W8OA@5JA$:/W4ZS7;Y610O2YX?RR1%N%":E;DKOIGK:Y(\
ML%#X>S*E%V"8SV ?%(YWK02$+9Q-7$.KV<FE%X "$($ JE(_R6ZI7P28KDIH
MC+:<1L.YPG L#*MPO-M[)86WHDZ>/]Z=,AJ_XWCOMIJ]RAQOIWR\'3Z/SZ/.
MBD)Z5L[;>EI6MB:&"[HN%%SKE'3E?73S0%W -HWE#_P&6!CPAHGT,U.9"EX(
MUJ=)G(!4P:>",($WPQ/HV(0=EE%B[&1QZB9A9@0+V$!W5)Y@M]":WT<*K(S\
M)5<J0IMCB/8UR&CR52C/6A@ZCE-8N#+R5(*N%4!'%=&\U'CBAU.EC$F3BV(Q
M\6%591W;9IGV;#KV]I/:<>YO^])1S;TU:(G.GA'\?@S#E\[(G(T<J0L-AC!I
M44!A5.,U- Z>XIBT^R5TBCIT]BU 2^-H>OB1O#DHCJ>N5>1J8W>;;X43Q(UQ
M:6[.UA[AN5M-UWRARG"X\U[Z1,VSD8*3=1A%Z- 8E]/_'JV,GW0-K'C7N9L@
M:3SMH983(WFI;H)NT'WH18?GO08Q-!AW7DA?<-,H@@_\*7T5/YVBG-D9V!,6
MTPF3I1,&S\3H[M8!2"8C1,Z.CT24^BHVH\<:5B0C&#.;%KGNPV*&^)81'#"8
M9HQJ^%)&FG2S1A\V6!'HS"8I3'(4ODI?<\%4D,;SC0J<@@ @<T"*1\8;6';;
MP7.X V!*C,G2"'&W-" %F!R\(0Q*ZCP925PDOM_U4\\Z0T$T@F4,;Q"?M$M>
M1ER'_62LH@M8NLQ]ZN2#MY:T01(X("XY4D,?Y'<QZLSF-L7_A%?J4D4-8?R;
M%L!8RI3\DRB/C2F&GZ.W,H[IU=:,!S$],.LW]E2QY 0H @.@L$YA8MFZR<H?
M*%_#ZV&$L(1P&D(/D4P-6D6DQC 6#3J"$PV430-?_U#P V@K-QSCH5.T!7;;
M ^ RX8 " %*-XHK(_^>[U_JI^]2V.G,[.LHS_B?R0IG4B1TYA.4>2/]*3N-W
MK\3;1^S]!B:A;8'B>5(E?A1I2KT1AZX+TR81]34$>QNE+XJ*XQCD#D#:>+LV
M_:DOU$/E(P-IU/%__>6ZW7+Z[T EZ]A-XS@S!. )?QKK.'/461,'R 5#>>3D
MI>>,)]@\-K%Z%)1G/*>,X(]8O$4&2C$4F-))A@J,SB,]/5 J0,@QD2:6#U:5
M&T8>Z3Q2DZ"ZX54^J _X1$UP4%D<(FO4^X42_SW0^,P9OBXF8]P.;]2^7>*=
MDX3%DD<;C!\T5-") *9,=DK-MH&A-,Y,&4(%IK\&S@+>&$8TUS%.E?;,Q P;
M,\B#?)DF+FE^P2\C>?PP3LEO4$8P2Z*.>L6--[-V,2@*ZCKW=A!N4I?23[$9
M2$+>BV*E1'OX[T6(7P!*:_,%I+DQ"<N/CL .#2-B=5Q6I!40LB%^!.$5D =
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M\;.?;<>4N@N-$UBGV#MLBM]*"R4Y_9M=[*(S5+MEXJ(^Y#UN@-^HT<IG&?T
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MO\EL;_(EQV)Q^-1N%Z;H+OV>R<=%HV0$,[]2OE^<+,J9IP["2%WL164++0
MTJ71>2-PDY8(KQK$H9\FE "31EG-J'1A"R_SU<#PU LOM,7"5%P"NQ[33D18
MF6Q*]DHO\+%4P^9YF(%GEAPH/(/F+FN\>[-\\$TJ'T:S\W0^S/Z8W6*LL=O)
M0LH4_47"C?1DOD'(HEVD>4O/TT69J-G#O+/.-$8P473VP4*'."S:^%-1#-A[
M%)E>D%98ZHM.(6T]"DTJI<WZR5J[VSQ!*A6D3H- WH(4^6FPLZ-8-C 37AYF
MNC!F=,+=(GO7$Q<A5MR8U"9LZ5?<6I,U&"SZGXM32OJ$X]\H5HJU/P-%P7#@
M(0\H@U%W^(NT/4[=PH JQFID5>.>0FO*[-UXXNNB263>23N,RA*2VKECSH0.
M(\J!?%^\"@?4P<BD)/IZ3.$>V_]6FD-@TH)L&30=4$,].&\Z+OD \$(=%+U1
M%%*AYS"2J2ET"D$413E+#$P6%-6*L.)<9Y$&I:?<N(32U)[+*$*]@DPC"V9'
M[BR2].)T@H41^94<1=46U3/HR<SM%6M6'O8PYJ<M*-5P6?8LQ&]I&JOH@M(%
M8'"NOY$>=3IRQ^F]5F_H::?GV=^*[3B#^4<F:^XX:VYS2-<:"J??Z1I]-Z8J
M-6+.\D/ 9-EU).3%*F_X [>(POS&:49R:[7%FYL_"QZ6V=4@A:K*Q:'1*7+Q
M,=HR7GUFB^/S@@MR"I?G"<;W C@*1QE$0+52G)!O60QUNVCTK!<7&9 ?3[#=
MA6U=B<4/P$(Z'F4X-3-<Z/=,L^N,>FZ9>H4?O51C%ALH;ZXGGQ%:,Q(()5@F
MP(8S FSXIEF<ECO?IVVC6LJVS%'N^A5"<>NQRB5>6))XQ>?%+,-,,0"FR%#V
M0JDUV]4:H&J>8#Y3)%O:95L[LK2>M@1JB,K7=C]MV_%X48/NQ==!+;@W:M$-
M4?CZ0\PP=>66B=F7@D2SY]7>3:F\Q1 $'UZ=B4V&/=E0@!ZP\ <S:O$DP3&Q
MU>5'8(QK,#()@Y^A3 FI9OJTW-4@0S_?L1GQ%>!H^I:Y,0U.T7,Y7Y_]EOMY
M;;>#?[@@HUM\C !Q7871#_$:M&2G^!WD7LTV9-GR9X%C<6OJC4,[BP<;RX!;
MXY[G%]T%!5X<%+/!Y/;L2&^9F'IF-%B*H#+T>Z%$!^J81I?HE?TQ]V,E8Z>Y
MMJ56Z9IK (81NAC)>+S)LJ4:M5+MJ+G9T1J;,Q</3DMU'3>^<$_^KQ1GET*J
M@_,P.B_YN.O"];='4]_;[F8;$4D%8963A^.H6R@V9U(R.'G[88+./2^\>N>Y
M<7L.G 7;LB%B[Z@IX/\V!+!O1AI,*<OA6^Y1^6@.W48L4/P"^"OVM%LJS/U*
M_3P34%S4W&U=MY0^257!>H[^37GUF"U=8_'!D^Q9#:4)%DH5#<$K@L8WJ,)H
MERN,:EQAE!U$PDL4A="Z[I#HZ^&W[^+DY(0MID? 9J<%L#E2U,SK/(\RG5,,
M*3YWPV@2UOV<$'2&(<6';*&-V0R"C8!I1#"3!X%$HW:P_T!G%7JJUFA=;@^3
MU%YI'U]C[)2BXT4@3?GA5</FKRU(\)VI.,N:_>"0,HNH4_X,!M@U\<\D"J^G
M1>@W3[?[2G\_*_YN4H<Q"=B;RP*^V8,</[(%;)^52FS[66H:BDU^\*3;7&"G
MW1(>H(U209R)[\2E"/L0;#08BCIS+7,=EZ+WRIHZ*KNQR^26N.^.?3M)RF[/
MA(GYU'N7/U9RYY5L0FI-&<(O,]]>RK&K#IN'1/.X)[WDYM=O)$W%^2,XA__Z
M2Z?[[H/R=8 -WQ+,XJ(W.;NOY1L;+HGI(7/U.S5AR>;MW=Y^Q50=8J*O[8/&
MSJZM%$A_V ;.T@LIIT/"Z?4HEO\^NY?]R/1#IS-V#"?*S2H5T+13L<V-S[)<
M0)-[,YR4M;.-[Y%*T[@]CZ;XL)2KDF7AA/E=53XE8T:V(WS>(IN:YVK8.(EM
M2P/7YC=_IV2&N]>.D>R\>5]HA.^5&L0ZH93$FGD"5X_D7EU=-5$E^;Y.QP,=
M-MUP7+/%+EN:(7Y9^<[1U=[]/"->R\+3W%1P1Y$W74B+U\UBLV$J'<AN(T?^
MP^Q;DZAE[RQ8Y2S"X:;6SC&-=R7U9=8W7II,LTSE&B7LF<N%@^F"Y#6\0=;R
M+:59$]# JZHG"37[->5%-)"M;<^Z/6<SQR'L%.:VCYI\T:7&Y3*D?'/V86^J
M)-1+IIA3,L#*G9$WPP!SFKG5M1$&EYII7,\&UA;BF7E!?@\K:H&)=-,$66"!
MY*+4M(@P,G3F),Z@^GO!=,$X?=TBO7T>FVJ8Z7EX%0 T'.G)N:W+.Z<RP<T0
M[NUF5O8S%:?90E%I']D:Q/=4$FGJ<JXV0OX'F;_M<RD?.L!K]4SQ<,E; 8]@
M92PW26 EL7XEL<!/=0]67'"*;[J%2A5]AZ:)]9^V&^5)'*=4S&&F=0Q+2Z:S
M-_I\]67P4,?1+1JI"F>S).@[N50O%WW'Y[8!^'FR&1W[G$XS/T??R@N=$7T;
M(=^_XV7DTK5%Y#-PZP2.&5VSR)$5ENG/)-/+Q]$$23)N^VH]CGA$\62. SW$
M?B7SM@#)X+7$)C9>FG?/<Z_O>>'U/1\J%9^;2Q W0YIWFW 6,_>VZ<2W$;(;
M'9WBH[)M?\[LM94LJEE4/X./9IZC%A_&)W'35"/)K/9GQFGM<;;C)F4[GNO+
MNBMLS';<"-TL3O[)>O@QX+1WKJY'>J"3>-$U >>Q.ZK[63?@M(<!0[/04FOH
MC>"!F?L.Q)D[4AXVUV* 6D6 ^J1[^5J^>>V\J5LBS](&#.6;VSXN: QTL%U'
MYQELFR5;?E;T8@J'Y)>G5*J&. G<IG76&J-B6')G)N@3TC%>1>F)K^G UVZY
M0?]''2V]AN(LNX8BWJ![*#9 N+0W1K@L.-R%ZF3!LF;!$BL19YM;NO8[I&1S
M+V^[:WK'69?*7"OM^2O"%W:*"R/,=J2&Y"!UL,%V5!Y\2O(FF"GNM-_)W\M9
M*M4\I$\NVSH;(]LR0^=%2L+[+^?(>](C8C>5\,WUW,XF)$CLRNQV(%\<R#0)
MWPWP3H*()@[PY*#UCA[?\>4T3!-XR[7RWIDW.BTBA_T"[($O)[$ZB$V+3)7M
M=$2KI;%?X?MA KE'$1.G3>?-@^S[]B%XRLN=>?2Z?K.__S,2YFWB+7G$:;9:
M[3N>V0>2.[,#P0_1_,Q&ADB6*C?GM/A$M'O=1O8_/ .P-<9A>F#<IOB'Q2?C
M4F%[5.G;8VB.9[:WN33;ZTT209A7S)ZV!2)N&0-EA^RIW+&;Q4$EWN$=?62;
MBA3+#LL;NHA+J\%8[5ZOD?T/-@%>^8(<]72M7=:,\6X$0BI,81:=3W8./JC8
MC?1DKC?20G7[W(<#R%0U3G[94.4+<BC3@>E073I4T"A@X35/K"IM10U=+V9#
MS7_;30=^Z'3?F?_^=U6WN2+B8>O%=!7/<Z4,D K02XI1I(:@MY)D$A^\?8NM
M)6+E-B_"R[>'D3O""R/?*N]"1F\]F<BWSEYWM[N[^[;5:CE.O^.T>^UVJ]OI
M=_IOO4Z[U>^V/77==IJC9/PHX8=6]3V."ZW,P]M2*;YR0(FHO@[4DQVDP^SV
M>7-KKR^IN<-G%5U@JQ,;<%:#*)715#C=[-:,P92>E^,PN+#A9.P:T1#O8=KZ
M3^Q^ 4M4*9R6V(2C&YAEBW=WBE]4\C%5OGV).$L'I8#UKWBEI/@'3"IHH!&+
MC?OA#QAD=B5Z:I,I]KK*BM]LHZCL7C",0$<JAN5(K)]NW-)? W[)7,>@$++6
M$\52BJO&CFR/B6\W>DPT;G2Z*FKHJ*=&=B]5Z7(:_'J^G[OSU\?)>AJ0G2HH
MQ,ZVZT.F E/A>:G IF,-@'R5MJ+VIF.;S<7JGS*VG)D.VTZ'=5C$[<[^_GX'
M+.+.[O[N+EO$N45\AM?54FOAW846\:PIV8!O)]*-8-;6TLU3M<6A"S_&FK(I
M<TNX(;Y'\.%DM.QC?%/VR+P97;YZ'6=UF'=3_!(VA8/]&E=9XJF;A+C =K["
MY;8T#+FB+9W]S2PHS_#-;.JSG:YX_1%L:IIKI]/9:>_NM]K=-]AU5<.QIZO[
M'F1TY^O98YN[=G9&=24X4X&IP#9W]6SNFAN:G:;SPAR(-*U\PMCV&1@58;7'
M6Q?.?J<%R&[WK;?;Z7:=/E@7G6VP+BPP-\695"+E4;,]T\Y+F5+-#&B7>JV7
MS8F5D'CGH5$MBZ]+F-G$J9Q]QLPUP@DUT17K)\F#5,5F$H7Y@O'SEN+G=@78
MC_%SK:5B[?!S>TOQ\_NI+Z_B1R#E]J.0\JTP^99,TGMN]I/EDM:Y=&F;D$M-
MM!<C>N8+1O25@!D;A.B[[!%G1%]A5EL'HF_W6\YN_ZW7@Y\Z74#TW2WPB!.8
MQIN+PO&8DD)"]\>\1_Q!L+[[R%049SX5I;W7V=][4\ZO>7Q:2I%)Y.RQD[UV
MT*,FZH<A.?,%0_)*X(2-@N3L9&=(7EU6>PPD[^UV>X#&^ZTN0/'.6_6?'4#C
M[?-N;_,!^1\R0J2,4/IK"MLD8S4#SF\FP7=:!%W[ ,SC.(6/X*NGUT,X+N*?
M (W5U/8L5^+3IZ.5T?NM3OG?4AD!KP'LOMET_+<'UF5_"2\M%&^;]3 4KQ'D
MJ(G:82C.?,%0O!+X8*.@>*<"[,=0O-92L4Y0O'/>[3 47PV*GVE?PY@9%G\O
M@Q\K@_ .@W &&[67;$P")@%#[@K@@(V"W-T:L1]W?-EL(CP>8+?AITZ[M6<!
M=O>\T]N"?/+2#0[S22@K8^3N;1AY^=68#P3(GR60,VO+TF)T7"-<4!-W#+NH
MF2\8+U="K6\47NY5@/W815UKJ5@A!(W(^2:(=EJMKM/O6A#MG.]M/H3.$KBM
MLSKW/.=M[GL$59WUI&T_73=^<[F!PXBZ1LBA)MJ#$37S!2/J2JCYC4+4NQ5@
M/T;4M9:*%4+4BWW276>_E\/I]A;@Z9G"Q&\XE[CHV)UE?$AJ=V)]P::E=2MO
M0CY0R952P1R&IH\^(0;W _%51C_$D9SH1/KB(RRJ<:_<[$>W%C0S-]DJ[,6N
M%;:HB7YAS,U\P9B[$D"@YI@;1G/^;P68CI%VK65A19%VWGQDK]=MMTK-1YS6
M%G4?.8$WC0.\7;:X'.=N-*T!FGLZ4FX21L;)' Z'VE51O"*21M'"34H8F&R2
M/&3 7D&B,%\P8-\FP-YFP,Z O;H,]D2 ?0L2MO.K,^U5FH!&]^@^38#N\ =X
M"/;.W&F)B!9A,KG*3TV.]S\(NW\)X4RH1O;'V?LPS8?XG>-K%;DZ5@B5(T5K
M6QW7W]J^A'$]XY>ZB4W&]14D"O/%<EP/_\J!K^C'99OT\ZWZOO\T)[66D'J_
MM-6XHZ/<9IK("V5.\(X<PG(/I'\EI_&[5^+M(_9^ ^L3<3/H2&;3L2O F1[(
M- G?#8#W5403U,'%0>L=/;[CRVF8)C#\M0+10*]R6K2#]@MP9'PYB=5!K"82
MH4FV.1$=#AK[U;RM>ZEC "L^(*>#[/L++%[SNGZSO_\S[N8B.6=GU&RUVG<\
MLP\<Y<P.Q%;XYEKA';;"V0JO+H.MZQ:N/;J%J]WJ.6"%]_O;9(63U;B*_6WZ
M^C^O%=[O/](*W[]IA>_W^F\>9FWS;;HUMBEJHK/8UF:^X!A:)<!%_=%[E]$[
MH_?J,M@3H?<M:"NZ((8&&'X\\<.I4A:IY_U&$<JOCK=O[1=:(;Q=IBY?R\L0
MJ#Z2ETV#"A*%^8)-@VTR#7I ]DZW"IS']D&M!6+%[8,%.7:[FV\?'&$T>&#?
M9\O&X7"#,7"C#OVSG(JVZ=2_MTK]^7L=XE4$9X?B-:S?'8DK&8LX'<3J/RD,
MZ\,  . O G-S@7WZDQYK?)D:#I5+\05;^ ZH_LWJ&7F[G)''D&>3A"R; A4D
M"O,%FP+;9 KLLBG ID#%N>R)3($M:$9U!*,C/<59.IGXTWH; 'ML ##0V231
MR@9 !8G"?,$&P#89 'L5X#F&_K46A?6#_ON;#_T! P>>C#QQ2CVMQ"<E8]4H
M87#3@S:_/\$Q>'6E+K12_((Q!G$V"B.8V5=?_BGOTX$65KK/8)Y!RR8)2P;S
M%20*\P6#^6T"\_N<\\]HOKH,]D1HOK_Y:!Y /.#03RI)L'S6^.Y_20-U']C^
M009:^>)S4[R/I#=(H^GJ<+W/<)UAR29)0X;K%20*\P7#]6V"ZWV&ZPS7J\M@
M3W4O16L[\;I)>G'ZJR/V7V2,G76:XE<U5?>YE*+%<)UAR29)0X;K%20*\P7#
M]6V"ZTZ+\3KC]>IRV%/A]2VX2&X=_O7W40I(_$,3,+52_CW0.M\AQZADHV0A
MH_4*$H7Y@M'Z5J%UOO69T7J%.>RIT/H6]*\_-+"6 .LW%2>$L)="^+W5(3P@
M]\D(/CH*@T !6&Z(KZ/FA^8]L#S?&\>89:,D)6/Y"A*%^8*Q_%9A^78%F(ZA
M?*UE886@/$+X16B^WW)V^[-HOKOY:/ZCCN)$$*8G. R(>J46EO.EK 6N;>_?
MPVL_TZ/F'DB_6WVDG_70;S/,KQV<J8ER8YC/?,$POQ(H9 -@?J<"3,<PO]:R
ML+HPO[?;[?5;;?BITV[MO57_V2&$WSMW]K8@(QX0:PA(];XPWSKR#R>1]K-.
ME?TGQ?6]VW#]81"DTH>/8*0"SCNMG5\;#X/HMA,F77+5;C%"KQ$281(P"9@$
MC,<W&(]W*\!TC,=K+0NKCL>=?JO;[G<Z.1X_[VZ!S_U3* W@MBAUNIICO=.:
M ^!R' 87<VBY(4ZOAW"4Q$<=2 38GSX=F7=I7R,F_Z?T?345[V7PXQZX_#98
M_ELJ(^!,?[H F?_V,&#^);RT23+6Z. +:!E ;9'<9A(P"=B,J #*V0 SPMXW
MRU=-L4E1<69[&A?__KFSNP5-*K^/='1_#W^6J_]!N19PSQL93^'EO[7_/'OY
M&9A47 8R"9@$#,\K@!@V )[O<J$L8_+J<MC38/+^>:>WK8UM9&"N?+I'*\JC
M402_PDS%_U.>\L=RBN.M#+=O[1^_'&XSVGX^Y<7RC8G 1*@0$1AS;S#FWF/,
MS9B[NASV))B[W3KO=+? #[Z@H'46AL\GV.2 W"#6I[[,J7UK>WAV?K/;K^*"
MCTG )&#G=P5@P@8 <;XRE8%XA3GL:8!X&X#X/@/Q=0#QAW9];]_:*9)!.,./
MB@L])@&3X 5 ./PK![ZB'Y=MTL^WZN;^TT"D6N+??FFK<4='N8$SD1?*G. =
M.83E'DC_2D[C=Z_$VT?L_0;&:W SZ$AFT[$KP)D>R#0)WPV ]U5$$]3!Q4'K
M'3V^X\MIF"8P_+4"T4"O<EJT@_8++B;/3F)U$*N)1$"1;4Y$AX/&?C5OF%[J
M&""&KY/I0?;]!>:I>5V_V=__&7=SD9RS,VJV6NT[GMD'CG)F!V*3>8--9KZV
MF$WF"G/8TYC,G?-.;PO:-#V'R?RX7+)VAPUG-AEJ+/J8!$P"CEY5 "C4'XJW
M6Q5@.D;BM9:%=4#B76>_5S1H:N]N/@[_FL+^R$5UTA:0[JV.MS\AM/8#\55&
M/\21G.@$$/)'6$,#6S.MJ07341I%:##,(>_]QQ5QF(93C+MKA3B8!$P")@'C
M[@W&W4Z-F&XKHG!;3(2UW#Z&**[=;O??>KM.K]W'R\>VH3IZH@AI_E").)/^
M K1MG=RI/Q5.=W7(_0NZR2.$N/= V \%V _T;,\LB@%VC:!%31P\?#<8\P5#
M[DI@A V W.TJ9)U4C)2,N6N"N1<![DZ[W=D#P+W?W6_W]\UUOUL N1<T)"I:
M?_;N40$=^JX4WT?PZK@A/C<_-)_<D_U H)TOK^TPV*X=J&"PS41AOF"PO55@
MNPH7\5:,DHRUZX>U6_U>R]EKM=NM5K=;)'.?MSN;#[079'+?<NO7/."> ]LW
M;_2ZB=WW,^Q>[4SN#DVSS1B\1EB#,3@3A?F",?A68? N.[P9A%>%"(]Q>-L\
M;@=^<EKY1;OM_?-^?PMP."%PS"0!9/I-Q0FAXF4UE5DUI:TW=%;*-0D5P.0P
M&<&4[@&^7^0&+)-MXM0>?+.XJR#\YH(BYHUG)P)#\ V&X#V&X%7EN^TCPE/X
MP7N;C[^/_Y-JW]?IN"%. K<IOH3!SO%XXH=3I<0''0'R#B-$JQ,5Q.:>VJ^A
MK]UI Y._I4'O]\#5/79JL_.N@A*,G=H5) KS!2/JK4+4NS5B.@;4FTV$-0!J
M!WYLM[L(J-&OV>IT'(.LM\"Q_3%,(\"J,QDF1]AR=F#G8)N/@+HO]S&Y(]/D
MO0[A%?"U,:S;R[),#B>1]K-B1><6-.[-P?%;4TQ^2V4$2,2?+@#DOST8D$^%
MT]D0-_<VP0Z&XTP4Y@N&XUL%Q_=JQ'0,QS>;"$\)Q[N;#\<!GH8 2Y\\X=M
M<>MQO@V*SR'Q[DTD_G\8@C/4J+[,8Q(P"1AP5P A; #@WJ\1TS'@WFPB/$5"
MR1;<*OM]I*-GP-D?U2 R-^L8KW?[<;G=_X>33QAD5%[:,0F8! RU*X --@!J
ME^^VK=1^,N!E(FPO$3*K(S<9^IMO,GS4P^?*E/D27L[T8V%87B= PB1@$C )
M&)9O+BSO5.'*RHI1DK'H!GG MP#.'H7!4".MM/3%F9I(BV(+Y(KX]!\J4!'Y
MFWV%-UF&0W'H^^+(EWH<WW!R=S(G]^V@]S%=O]M]=HLS\JBC"&02, D8?U<
M,&P _G: [IWN._/?&C$@8_'-)L*\7[BS!9?A',:Q2L3RN][SYMJ])>AX03O
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M39"@,(@5A?C4#6DHU'!HT%R TG*9R+W/NNG,P8\(V'!;K2 .0H#'[BA[/\N
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M+,N6^) ':3'Y> KZ^7(1AKS+AN!L% 2TJ6XV402@"*@K9E $3$X$1,N44<R
M<CZ B"Z"RR1#*&M&1NZMDFZ0SI;#B0#)401, M"P 6:Z*9_=+!2<@3*!E,^@
M>>Y/49(]8#U,QN7&SU/=>N\6,7B'X?:G.F+LZ[V+DK%"T+Y:,GIO@_)&@]?,
M@Q"$@4DI@4_$)!VL-_E2,_3M![,,,Y'%S 2KL^?FBR&"0K$"(*L?GE _H'Y
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MN]-BA##T>KEV\R9<O@.BCFI&90X>CP;$='KE!A_]?@@UV_E(DJ"S=(Y!=";
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M2 0H-9/#5=I0!$SEC..TNXQ&B#Z[!-"\=;Z=M^NVO$ _*7O A-"T/3X>+7C
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M7,:?4^&P]-J]&[@,46>/3658/,)Z H)YM7L5%)B3]<.80&T2!A\])HU06*'
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M/J.$#77-+.+-N/&F,I,CT=;@A5M ]!VB\9_JB!QDZO$PM;+1A> @9A] 1*?
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M*C,YLD@-7IB$P9%%D$4PF)!%D$5PX1\QBV"*>9]B5C(+H:,&*7(&$6T $Y,
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M($AC]TAC/YZO 6S4NJ)1*WMI1=84?$X2A T4K!8$+ W4,.-8DNF*FT0,D3R
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MNWIYTN]7",(M.;S(?^O2KN?ZT2+^VG_E@D)\GM;#EN6TK+(F]X60NOC+RFI
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MVPB!\K;=5QA,XPZFRDR.+%*#%R9A\-&S");JSDMU0=A (H&L7'_-%4U@/<U
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M_DA#I(2)X(/(QAPDES,@Y:O!$CA(^5/)^$R[+#-"^/DP]OW'3;>]R>ZG3P;
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M=?EY"^^Y0&< 6H&@938U  6/C2O=<K7&R5#JK92?M(NB!H1:+%2E=2CK::B
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MO+?RWNCL37'C?4!0S1TI/E2H:O#:["8@S!'USE>8VS$O&8:;C"=]7F,*B>C
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M!:U_&('!*5R'HN<W>YT474,#_0&H+L (98E]L4Q7RKF=/=,/4F X$JC== V
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ME$N@$U(7A?:4H&];X;V9_V,*NXGRV\%P79F!?A^FJ/'^79@:8:2*8CCO:-?
MG,&U[L3*+6(E#5F2ITR"B,@"4,?\G.1Y5A A?%7(( C\>*NMSG>)E8Z$?JZ;
MMY9W;(N:PPB8/2<5 :,\RDA$!0K0*"9Y6"BBHE3D,E>!C+9\(M^E>#[B27>*
MTM.4K1N<;VA/WHO8]1K]282^\B"._"A-29!'!5!*$9),L830(.(2@)#S8&N$
M[S>&OG['&K%2_F0KKLXKJ;.HK,9F.DZ[!-2GF*2@X>+]-"Z%,PEN%C:V';C+
M2YT^[CPP;^MP9:ULTC9%M[ABZR2'R/^H(>55IV^90@$<8%@"5URBKHH+X<1
M'6>RLS9G&';#.)=6C=?J&/N_MLN5O%F;'FN32[%GB5:%C8O.-/CH=55X._N"
M0V]PR$WO!>R[YE?>!_CX-[TATY@)P%BBAGA[-24P?MV'9 H\7<H$E/J8DY!B
M.1V5*0&%*2.!P+"*"%(:QX>(K?S>8)>2Y<WO<VS\4$E,4-)7\FU=RN^R7=>E
M_ '8OX&>F9/9@>XD>/TAP[L'19]][;'N3 )'+T9&.*<ZG/-,ZU8[ $1G%1@>
MBT*@U'\?>EPBG\:M$LR"L"D$QE^Q''DD\!O XN?>O+P>7#%61+T<>E,_4-_*
M\7)H$I'R"[DL)6#<ZY__26.>1PEC1 F>DDB"\9:#M4:", AID7 9<W4"*H/.
M2NRI<NU_1WXRU%\>L>%I+%14R%R20CLS@L@G3*4!*2*5B2S/F4RVZ@(3D2@>
M!2#)51B0R(\ER7Q%X5?%F*^DGT=;#4_WBO./FI1^*0NU;>O+53-X-8X<K@6F
MDV$/Y"$K\"0[F[[ZMB9R4SS"(\__D3*,000S0K,X)A'/%,G]N"! ?BS,!8AI
MMA7:^AZ-^A<%$DK]HMO^.V?(8^J/YLZ=P^!0!#H.5$F%A8XF:;70P;RFP8+0
M3O=C9M %*G]EA4/'<6ZCIR%B)EF0NB!Z,HG1WP;'0KUJAED7^HG*]/F9ZTY+
M^OF^:X%YB:ZYU#FU^M=Q2Z?U=6L.\#!*>M>*RGQEB-0UI59+>R^"_ER/HNOZ
M=\*G9HA'7\%18ILE-C?[N&@4MA?""%+E!=36<*SG'?35MNWFHCLO1_M3-IX;
M'W(M,[<[KTDD!BUYXX2]7CV^NRZH=G6E;$=8VT_VM[MLKU'K)2'#ZMTN;[S%
M?-6:MAOKV[G2Z5QFOJ#)\#(/E+JS VKZ'=K@3H<2GKIK&(95U-B/%S%"HZ3N
MF-7O0(>2/W?)6:RM*\:QA 7[1NFB:-8U&H-% (:V'[[N>LNQVX1JA#E78]8J
MEZ:*>_]2W39T3OEH.9-.-BQIL6JUC5DZNQN7ZA.><6(B4H-QM'7$MQO@-HRZ
M<=&V64E7\M2M@6&A=>0<-2XS)5-FY [<#:^;IOZLH_HZWZWMNZR9M /\XQIE
M OZLFMN6*-NQ$Z\V8PV^F #T]OE- !?'4R[1UM,)]3J$:RBQ+8'#L<8BBDXV
ML(<WL6;L]&(?Z4/,JKHNF[JRC6H,HEF'J)E7M'6)0Z6\V<^Z\6JVLX/&=K1F
MGML^PQJ&&#?KVJ')4IDYW@BPUG3CZ]8R;><K8GX;N@9,PDOIYT4F$^J3E+&$
M1%D2$.:G,4F34(&B5'">'Z1-Z+M^<-5OS=NR7=0MF_]6_%)7%[\ QY#C^)-3
MMAY'V1I @BP(04$T+#;B34X+NZ\6IJ]VKJ_V1&Q7JT9T;<:&:),NU=KE73SS
MSJOQ]+JN1TD?E=<ZJ30">V^S$4R8$D;2L#[6=:553Q#39GD[ZM.4LG623LE1
M]_9U 09?-)[(OG]_W:JCM,!=<Q'77&3K(/E6<Q'77N2>[46<-#R [#@1\F+:
M;&M;XSS0)CEK&N/W,*G=VKJN>]O[S/N_E^5<[4M*MED<(,!&6<DC8W,H0:[4
MA1E0/Q)LIOI6RTC,BH97#R)WMK]#IC4_1PL9N6CGEDJO72UTV[.U\_76*QJ=
M\T''&5P@,YW6W&!>]OQFUK?U'-ECNL/:NE: ]<OH2AAYH:9@*+%0^9E*,Q*J
M-")1CK.3PMPGH1\IF:H\];-[I7.H?V-)!78,_\.FN)Q7\NV0X&+SPYR)],CE
ML[J'^Q_CK*,14+JLO9/(USAQU'FZGI%]@8;NS=_E[IE.][WG&C\;G-VM<:!K
M?H*.)NLO [M(UEBR@I87?)OU9I)];LB/JYL+5MG>%Z;M)#Q3V>H<O1C6:JS$
MTI3\[,FJ0Q_7M799&V_8T*G2N.R,ZUB[M;J-H@SJ^U?7**;J9=EMP_2PO,:!
M.?K4_;Y-:V#SL^GF?#.:5FZ]>9UP0IDEC:\-[M4V(>[FAFE/GGE/-S5 ]V,"
M\%V7PG;7L#5-TEZS;B?='V&SP*= MU_[U4$.NAG(5H76SMZ>_,9LW*33U(,'
MLQWZL&PV_ASV7^DA<B"/S5E,YJ-:;RH]%!19]^[X';U4[CI<PW5<-+9%MQY+
M6U=]AB<6:VUD>X[&M-MD>D!P7 Z^WE5F,3WX=IA_I[\Y&B6WB5D[PE1Z@@8Z
M6'OW]O*RT8,K3-%5M_8HUC1"PV%*_<9XE $B5[54@!Q+]LE48YFI'5IK0\?!
MJFTU*=I1]R/HFYS;3^H&H=0B7<UM?=WF;>*Y]5SY899@!T>N[(Z1"A%\;TT_
M5A/7635FU@_3ON,-"&S!9#T>8%KIF&A ,ZH,0Q?Y>,@(^ES6QVZ,AVNL31+9
M:)C6U?MNSANQ=6]W&GS2VEIA_7#_-QL36YO5<DO)XU$Z:ESCFZ=N?).F+/7#
M4)(B+T+0YK.4Y%P)DF5I$"B5R9QNE;-]JS;?)[/O5N@_L"_ONHBI:XKSJ%K]
M4&:P5[''^H,>/!-M%#-)/N=:ZSRH7=$7PAC%=:-JYF[H[/V."@J[TDH)KK#V
MZ0S5F)KK! EF?$*WU^D8Q>K[BW6\#]K9U'UK796Y@E>9(LYN2IK.C^D<;N<?
MW[H^.K?WT6$B3N,X)6F>Q-CB31'.4=SE,<\Y"_*0;755#8),1C1)B9_&(.EX
MS@@3E!&5QEP4*@AEFHPDW=?EVQ\&=F^:4AMDA^FK Y=WLD7,76,=.9@$S;CO
ME34.3>O?RJ8I:>.GUHVG^$W7+A+K[-07=;4 J@-8# ;7.DM83Y-!Q1Q^U^X!
MDWGW-67>!&[1P%%KR5;:[6W*"8=TJ_57=XE;G;=YUHTS4M=LG5=H#[)M[Z5=
MY7+6QWJMMQUNPZR%>6PX.- :JG>R7_I4J/4-LM:8D'>JO/Q&^V5?4['=+9^'
M<+EC>K<Q/3]309XJGRC)<A*E@4]XQA.2,*EHXN=)GM^K/?]03[^SCG[,^@["
MZX(39G6(Z Z;;\-F7@01(&=&0I8*$@591C(&>)WF@*DR#Z,T\3>Q.0]Y)L*B
M(*$?A#B@ BF %:2(8B;CD$:JH$^%S?Y9>++8;/MW]0)CKYQ@RV53\I5-0MJA
MA8/$10\J_#R_<6XNY^;ZKKXR61Q' :CON?)]$H6@P^=2I"0.@3T$L4J%O-=(
MA:&_L];O_QA\R\ZC]9@>+7O_W@@ $_7 N#;/1RS=/ESN+(CJ/#/:802+5::6
M:HF] TJQ-#4G>G >QI;TK$1MJ)KPUJ*IT<Y$7Q3K@F.ZL*1OT:B%:!^&'1E[
M-O[7C>^Q96(;#C,T>N?=\$9M8=J1Q&8<(II\.OP[VH?=!<Y$\&2-%EQ;K]MA
M13TW"5<>EBL#D:J%J81AXO*U][)\U4U9N.EV:$+;IOZL/]D,'MU\%DQ[K3NA
MC3A."!@&1^JE]%?AN^N51:/IC9B5C3U\7I;7KW1G2M&5Z&P]U <N=[_:&-DO
M89D>Z#W,M=G_$F'7OC+[ZX!F7(CM&-@V.+IUS;MG,76%6:W!D[7T )S3U'L(
M"A/PW<H6UWL#J)C0L'$JF%V/@Z"Z[REK-L/G\+52M5_]UGC0I8Y%VZ@M++&C
M0LAF;I0M$M3\9ISUL%$1!=B)?P5R;&&-=K,::NV@9Q/E<([7'S&O/Q\H61<'
M+QC6=-A.^YJMJD:/>#&L>HW!C3@EIOR@3U"3_JK!L>LCMFV^4[9K(8?= @%?
MC!NIL%?Q8M4S_ZT<6IW9@@E&0X;)%L-?DQA= *+[(_H_U]CLJ_7MZI $/*_Y
M/2:\OL0<'1R04UU@2 5;VNC0BNWCW$C-4/7-=*8@WBSND6-+'8QF6&:AVE=6
M)NB.M?K2AZ/I4EZ4MQ>LZ3G.Z+ITHLT@0?D@=1M= *-=H]WX'W2>&A&B5[$9
M5H;A=G[0^ZU]O>OB="Q'ERTW)BMJQ0T;\UY:&%O_;]E^FO5Y1<U(Y&]G*Y?M
MT/@86:H!M'5BZQRR#91[-8@T4QP,!^5F.L/FT'OMG>[:9-O-8NDXSB"<S_>H
M(+7-V3*+WT4%V521]M_^<?H")L2,G5@Z:K&T6TG=F'>NI<A5:>9L]G1U%V-C
M70WL&5IK&?+=5]5*,3#X2LZ5K8O$A]9R46?]5TK3'ZU_2 \S[3(%3;6CR:L=
M\1_-%-B5J3#7?+7_RX(M@9/K=,=NGZ]Z&2I1IZP$!I]V;WWT#.8( DI=#F*P
MTPH,RZ_@SI=#9L >@:%*+??L!(/Z<Z4?J"^4_O-(,@*[-@/DAS-O3WRUULJ:
M>?BR$V1;^L ND-TNV]86QZYXMIY_/N"#WH<^M=FW?<F6E7;F_81HT]_F-^"/
MUKK0VZ[M"9.6JK/%=1+MED4"QFKQ;6AOVTO<XW2SWG(V'[>7]6HNC2YUQ34M
M6OT0.[3,]QF83J(=MT2;0&VDJSN>VD$"WQ4>3Z/PV*F.@_=ZV_59;GJ4[^U-
MOJ>W6[LCONK5'>]KW66JOFCWHNC]D"W 4(_[15>IJ7W1.4FV#Y%92^E!/6WW
M':SBT5J FG=]W;$F"$WNM?OIJ\]&5[9@-[O4-*N@?&4W9OO6![ 36FMSHFWM
MD1J*D?5P>_.NJMM]5Y?4=38;OV,MT;1/!-NVZ<NE]3&T8]CCZ5=MKZX:)+)=
MMDQC*3LH2[O-3:F=4=WL0WNTT+)=<Z]L7>4'[51#]7CYN;;]E\V[.LSIW$,#
M8O<P73O8ZUZS[UTHYB[-HEW)GB63=G5ES11N+],2KY+]? 'MQ-.M!?6C==N6
M6V_M'IZM*^]7=8MN\7GY"=51N_6-C0P6F=Z042SQBQM?^Y9M. WTN*7DA&[B
M" 7CN[7P&GKWK[ R>;'78-M@G5UPL=W#M+$$>MT*WN/"J71;4D.^FJ&N!7WO
M'^:%;[:%#@;>93^FV>-=GIP-(?"U-.JMX&BWX8ZWWQ8='8L#'8T4G50U1K<S
MI1TC<XQLG9%5MIJ^K$8Y ,U:LQU0.IMVV?&(=E/+ _XCKYG5GD<, _V6^XA_
M31<?*@NZI@)C=4,[J8U.U[$,=.O-=W()\_I^J7U<ZAM./:RX_SS(M+5WUI2/
MXSTMM@VCV2X5>=3.;_<8:,>>''MZONQI'%@:]0P96BV;46E :B87HIOV6ZSF
M!=:#X:^C-*AV:)C9E4-U3:A[4PZ4J69IN\!T16/C,3Q&S?K<N>U'N@OV1*[,
M( Y/=U5N3;3*OF$] \^L!5\IK[J>*V=FB.'GLE6SCA6V7>MQMM )K;;4;'0D
MG1IO7G%CNYD-U]-9P6N)8.: MM&.K47#%J3XY]IT%J]W9G#M;QYRAWYC$R*$
MDT]B3V+&DS1,"</Y3%&4"\)#X1.>JZA(HT(P=:^Q'^K?K]]8R#_\&-1[HP Z
MO\KBY@23V#L@N'FG#X4D3GLX$>U!ULH$[W761R=R>P]L%W08R5334G.WFX*M
MN2$N:G0E;SB@M76RT4+-6 ^VM-IZHYG77F%:7+72U<RPW-["\?7L%NSW5@N!
MDS6N3<K"H*S ;<T\OK+*ROH'N-%AD"!\]0:S$!KM_I6K+L'SW$1)UFZD?RT.
MD.FFC73-R*M=UDN7_K#=MG5O?;=7*9._46DOF9[W;C)0QU/*G<(Q*84C"[.P
M2 -*<AY%) H$)1E/!5%^$N5,A+*0R8$4CE^&F4!.ZWA:K6,$B@D(+2?!3UJ"
MK\D.@W_C\6#=8 V4'-8=.<P[TW)TW8FXM[O)G;ZM%0!;G0ZB"0/]]K>U,65#
MC\]NJM9Z0'R],NS,^WLGEF<Z4W[G0;O^I6(8QC&.GYAB^MX/H0U^XQ3 A!@M
MI[<.\^U"VMS>Z-C6>8!'W5Z^'5YODG3[]$GL&0H"W>SK6_=P5"K %*EK1^>Y
MAU<55%@PQ7-.9!+@5&"N2*YH0E@64LY"6@3W\TWTX[.JWYL:E.5V=Z\MHS5,
M15DXT2+[<V%;>K^KB(7&G1O#3TQX'@G]3NC&CEO=T$D=S.+OK&^PCL^6*-1T
MXVO]:5=\IPL-]>!*C=,>SNOLDA,$?%_+L/;,^[U3+(8EL&7UKJ=GJ&=\5G/=
M*ML6\<$95;M$ 3]H*&U;BU)+2%,MKV,+>NVV[$OA33*8.<"%EMG#/%C=>+*>
MZUDDJ"U<78&M;42TC1#8^*2E9[B_A:7GO=Z*OF%\7R"X=;Y^O@D3ESA<!76&
MB]4<1['<V&)1-M?&/^#?)[6TX1VX%F[&W?9!'QTNZ;[1S4T!)0I+>LS,%WM]
MJU9-8CA*G,2\ 'E' AYCAZI$$I[Y&<ECE<=^6O@J+0[39^:KHU&F,A'E="WF
M?3+O&3OLW1"4':BQ9T2&&0;=@O&CBQY-;Q<S$P)=OY>*#6TV9V;X ::=@Y00
MGX@Q2#%;'#XW46W[[ Q^T/QQ?J=!'39>;KHHCR:A]P,XRD;J\GL]O*$/S/=.
MZ][[C:U6Q;=.8S&'[H6#67[<2*36DQKFW8Q*,\&BSP<H=2[ NU_?CL:%_/SV
M_,S;>_]#['TL ;MK.,ZTG*<2=DJDDF8T)BQ/0-C%*B&9* (07&'DAPF54MXW
M'OT[PP._0:#=[A#N53AYOKSKWOX9N#EA!Q8A!EZ>!MA)B,%#>J .BC2:)"W2
MLU&/U#LC_I%+V)TY9,:]JCG\2+;M&/FU,'AJT\F-,?5RD#L2S"&Q]K%7*-4.
M3;;GZ@+#S+;DRXXO&TTTZP76E1FIU!DR_=M>&9_I>CK8V)UK8[G&U2NQC@E'
M#6B;9SQFJTL^[9VI_7 MG3ZWZ,K3!NMH VUV-IR=(L#=A.<'NMC3J;0.MBJM
M79WUO>JL'UZ']&.:RPP5P(0J$BG*29X$ 4D#G\5"A'%*MUIZ?X_#Y/TE,-@?
MT6AZ,[*9?M-C=<\K.0R@FK.JG98#Y415Q?<C.W8,$^>$> @5R8[_:#UUM9C7
M-\I4; ,Y]K^/_0KL,VMD.V[IJ3\%?6*H=5^LP+YF;><C!]UHZ5TT8/H3[0,N
M6-G8 FICY&-&6;O38X%Q=>:A>H,KD3E6^YN:<9T"ARK.-1:DPS8V,O<_;[4K
MM37HROMQ#@ C[\5E/<>.4HN^#!.7T?,N43TS&\3ZGO$![?G/O)],&7Q70CXZ
MDYYHN?6-;MIM.QXQC@$![+WJ_6LE+\PP61UV^*1&\R(Q4U$UIO%CVZZN%OVX
MVG%3U>L:%$M3NK^OZR-V%-1M66%SL_4:"*R'W_N]-0!O?!'$ %:;2^^F5'/9
M*\'KU_'5W73I$Q85]4T@JNC1+UV#PAD6/6 ?6QS;WO4OU-?5WZ<&L9G/J<P8
M@>&ZON8<PWFBIL*CRQ75Z0K=6AB3L!$%BP)3\+-$7-(B+C(22I:0* \HX5%>
MD#25@9_Y?L+X063D.STHZ0/[XF:K/Z8@-->.4R\.D7!W-+?\B,)O;03T, Y,
MM:/A@3:Z"JQFWK='66^XT?-VTPI[K8"JSX["*6/=8)/16NC@[]JT]&S5<AK\
M"IKPL+S21:LXI/C:Q))-EV&P^;MA7[U_8,OPWS5?^\S[: ]8MOUI[K)7]$;T
MK7?ZQ#<KE VO[[BFF>"\_*S4'3=EY >\NU]NSR:P)?"%IRIFI!=\H]&R$ML9
MZ"X]_97JI+@^&+ZYN\W<.LQ@:UJ;*VA7,IW5C;S!V^U?5E=WNK#U0H*RZM#,
M0LKJ+:;QI(&B;5*$IQM$H:/_AZ#_T8B&7;"TY908-NOZ;8PKQKF:8Q:#AE>K
M>@3 I(T:_K'-=O043DQZZ)(W35FGKDI?<P+V=&7+QT>:S="_"AV90Y_/18T)
M'[;+4J4NK!M0*V78 VM0$BU+,1C.YH:7?"F-\@Q'-ITS0.>O&^RZ/:*2&>9Q
M_&N3,=EJ#T3E&?Y.%F ?F]0,]$:JBU+U43PS.%U7N@CM?QR<C]B%:G3.T6C[
M[3;3G8+6-?FP-ZF5]%W0LQ1F]VQ:G=B9\_!WT%"Q\F0HQ]>506NW;MZH]7&L
M3M%=M3K%7;.2K9=JI=<V,NB*63HI85;3(R-5EQYS7;;:A;PA?1RU/QBUHRVV
MJCJ+"@%G: B-UTUAQK!UF)E<TF4_Z;81_,9[&;S:@[?PA.X(:QJ;[V8$'6JO
MO[Z;\MD"FK&]TG6IQ&6E9V:@);#L_]ZM8]J%T5=6!&*8?/TUIJI+J:7M)P9
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M<]N[-ENR!T&D>LU6R[I+)<!- F!>^S_HQ\F<W=2K);SBBY(_F-<%OKY(^P7
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MX<%] ;%G-H^,?)%E14!"EB0$?J$D8WY* L4X_%(D(MU*P4R**(X3"? (,*-
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MIC7=([5O@4_[0BP79=<8"!\2=/Z+\$=W.)F*VW*Y@%M\,OK'YG8 &G 5VQ.
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M7B:.;M&/7B:\<6Z-LPQESFB4$J44&-HLS D73))$9E)&4:2MW9H,\"7I)=_
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M9@+^B3GA@L8DS315491G)CU(4'*8_?FJ,6A/H%[;1R)])-)#XT<A_F_E['#
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ME9>Y0&^R '8MP%'M==V\*I33>%[CW-F CUL5,C3Z*<L)R\%/S*G.P<%,N$K
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MS48 @+?+PGX)YBOP*I9-U-/+]]'WL>^9M >S!Q_!4WS5**J;G<-KPUV6MNH
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MV'+IRLFTZ*N@BG5@LV4YGXB:CY?E?,U6VNN>6)D[M\T\>EI6_<RF6+T=D.<
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ME$#:T-(%SX-5_*E5.U$GC/.LVE-6[0\>ALT^GT,03*]!+-1Y!OV1 , \CO,
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M+&B!M:"HK#Q%'%<:::(Q(A880 FJI"3WV.?OIB"@7HW=+PULZ[UL=H5/=W<
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M;-UG/?2^E*$>?O75P<)L9B.W[?'ZNO7U9RMF$UCZ:V7\VTA_*_KUM%]]\:'
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M@I$>PQX=A@-;@+'KD@C-/KZN8?K)LUKZ89=QOV/=>CPEX&JQ(&@!JCAQ"-F
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M.ZU[^<8X*5U= GT/"6:I!I.K3<4O<B5C#P#TB; S!Y<H_G>[9P^#>^GX"_0
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M_+5-\'>SZJ6W=_,K='#(DM@&3>^AYG^V(_S;CW+P6YIV =[%82V@5(YG'^I
M5AVNRBDL86$3V*Y;%:AAJ:G!!(!B[ZH)5(G*!" MN#>%99F;KH9"0JT16)W5
MEJ 1DIC0-\J!(.5(CS9 ]>YR$ZA:ZIZ.2K?U<\L!VM8U&-,A0C^V19>(Z$T8
M/AU]564+V*$18W0@<>1:]'I,84(_*_*>+UP;]DZ^9_][<BCZX?]02P,$%
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M\)*<14$VG<T@C0QCD<Q3=;"QXC3# %/C>FLH[*YUO8D%$K?FT3V(6,K$*LI
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M7($VER@S!?PM0F $ Y:/X&]U@9X8[&0]^%LS0/\(Z9TNX6^-@)X@J5,I_*T
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M6R%R9?80)\'G&(+^OD/0^E)'^!J]XR%HK;"?<O,W^$8#,T?!L*K'#N)8.*Q
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M/M;R579P?5$$S"YNZQ.OV<P>W)>_RES4O<9.D-WIE+&)_"1']-KIAK12'[R
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M4'& >,]TM(/+?Z;_H6\._^W_ 5!+ P04    " "R@7=6Z3_"LN"^   \C @
M$P   &5Q+3(P,C(Q,C,Q7VQA8BYX;6SLO7ESY#B2)_K_?@J\FF<S5?9"59E9
M/3W3-3.[%KJJM:-4R'14;6_;LS**@9 XC2"C2(:DZ$^_[K@(,GA%$."1N68S
M74J)=+@#(.#GS__]?[RO&7FE<1)$X7]\\_'[#]\0&OK1,@B?_^.;Q_N3^?W9
MU=4W_^.__[=__W].3LCYY=4-N:%O9.ZGP2L]#Q*?1<DVIN3;^\_?D?]U>G=-
MKH/P;T]>0LEYY&_7-$S)"7E)T\U//_SP]O;V_7(5A$G$MBD,F'SO1^L?R,F)
M)'\64P]_3\Z]E)*?/GWX]./)AQ]//OWX\/'C3Q__]-,?@+\__<L?_[\/'W[Z
M\,%X+=KLXN#Y)27?^M\1? O&#D/*V(Y<!J$7^H''R+T:=$:N0O][,F>,W.%;
M";FC"8U?Z?)[09.!!#\Q)<9[$OR4^"]T[5U'/F?O/[XQY'E_BMGW4?S\PZ</
M'W[\0;]5^03^ZT0]=H*_.OGXZ>3'C]^_)\MO"*Q&F/"Q6PRB'G_?>_[M1_[T
MQS_]Z4\_\+_J1Y.@[$$@^_&'__7Y^I[+>0(KE,*LT6_^^W\C1$Q''#%Z1U<$
M__MX=U7)W9]^P"=^".DS+.'RVGNB#,;F)%YBNBI_C\5Q[C6<EC_AM'S\(T[+
M/Y112W<;^A_?),%ZP^@W/W1E]"%*/6:7VWV252PS? @_&_D<$J]9?CZV7%1!
M-TCQ!4TF/QY]3VFXI$N^F'K(R,\]Q'!K1_&^\ FPP(=/J/_]<_3ZPY(&P,:G
M3_C#"?[ 989__'81 B.[^7(9TR0Y@Q\7\4/T%BJ:G+W_^*;NR1_Z8?'B_2'V
MPB3 ;_F6QD&TK.2QY-&.3*Z\Y(FOY38Y>?:\C>"4LC11O\E8EK_X[=(+XE\\
MMC4.W&3^E*2QYZ<%UEN],H (<&G,?3_:PJR&S[=Q%,*//L7K(5G$9R]>^$RO
M0O.) $YM^$X>O"=&*V3L1G/(=5RLYDE"TV3N_[X-8EK<?\W/#\#\A1>',(L)
M? ;W+UY,&S9@Y>-#SOM5N-FFR35]I>SC9[I^HG'3S)>\,8  >"\OMPSW@>_'
M6[@* ^\I8' LT83OY@<XY4]A[+]5R', @0'$.X_6-$D#_PR_U'A7NS+ESP[
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MK5X>7\ZY[V_76PZG_',,&FQ68H>U=4V%>G9H#P8,=BT\9+IV^KHA:;?IK8%
MO_#_\2J$HY/;C^&R+/>^ZA1K3\#*S7,985+( LX#^%YJLL$JGAN!.=^8D5?Y
M_"#7FH:!?Z4F)K+ [/ K_FQVQ6[Z*JP.85-_$T=Q+#)1^/EK07OK1'0\V PR
M<7</7J%BC0^E,H37)W[V0HG3 ZI9$K%@J8I3X79.<(&$(J*#K-K]G62N*SS\
M@N>0YX&!D9$5<V).<=#L#>N=C2%! #%X!B*P( -T5DGY^IG*7))#J0QR>J+^
M2N-V7=2JGK8#?V2<,3 ?TGQ_B$[IG52JT,!Z9&F K1FS=B0(!&AV+MH_V*Q1
M'F"!,@ (^'0V,F=BL1(1SBKG8\-+0X@!<QY[#,OHEVNX9Y)47)?25U.[Z]J]
M.T0L09UO1H2Y)%90%55H^?:0K5)$FFMY52AH/J@YPY7)T8\?HM1CYM^Q./<F
M2O]"TRP#P73U5A7@]#*V>W@E$9T3-0E8?U8-1%+YZ!B2Y.$']3OYO>7B&>%2
MGJ:Z%ZOYY[;Y]-T&&1Q[L<:#5/+@(*NZB:D?U*^)\<@0.*=H+,$6X+8Y__1!
M%S14R*Q2-,&93,K_5(NB;76(<7A"[F!S@:4&!R%'.@^7^5\83^J*6J$1>.SG
M.-IN$.T$T8)1\][2I4SDKCZ<>V5AJ,"Z.).:VZB7/MMO"9_\#WH7BKI@_;/#
M=T9IG-_JYWNK/IR'X=9C=W03Q44N*Q\;##@@G\,I/+D-F1XM7AQ"'($%O-^H
MI4F:QO<&\:UN-L*:! U5YF9?A:LH7GMM$N=;OFW% "_K =+4P;S%.\.$.I$;
M7E(5)L%27BEXJ]=J",WO#>F+:I4-,:(LB KWEX*1.[X>UP+A(:>C?0OTVE>&
M:.D JAW6P-5T<S">&$Q_J[H':A6YRI<&1 1]B&2!1F5>4%6POCV!<7P)K?H2
MEK\QQ/UR;/O*<BA_:V3MJ %@("Q6(M7GTO,%YE+,X[W^;K%26TO#*\%NJBC3
M[DALP'HM ^95E(HHID1+NT7,TSR?&.7.6KAE@N>P,M>U(]$1Q=0;@D.U+PU2
M.%3:A% $<V_H&_]39<%-NY='@_5@^%#%:=GL?*U]>XBP _\J'L,@W>MLDM2W
M:F]^<<A2D].=_O'/ =@4P.+N&D&&:Q2IEB_;B;PB'F*@7._H#Q E(&;?Z99@
M9<>3&@U>J@@1\8L(H\9PF/%FPK4PTL=0ZJMN#Y%$2IQ7YE\'^]8;U+[.99HE
MF_WA+7IXB;:)AT$ 3%^C5%_'QBI59>T=]OIH-K69M79X2XY"<E0NL?^@+\(A
M&T.BY&3U<54F9LF3@V@.)N2J4C^Q\Z)(Y<X292J5A]8$QKCUJ[:<4.J$LN>J
MX4WI&(. KI4"GC57N;5XT<H!_7C_@( .VWB7)=H+A-_P^92F;W#@+D+,G[N$
MLQ8]S.6Z81=*@\*I6L@V;M?ZS=I  TQ7>;L.W<VC0O:FMWJ$((K/1-_-HD99
M]90=:/DM:E(L\,+RF0 K,--B8@0C65="T1]-RHXDPEV+33F9:!FJV"AAM?K9
M(94&92,UJ0SZN9YVI[351#A;.!S34MS=VL>'M+>%F?F9'_UTN4 $)&!2ME9,
M'L/H":% \.BZ"C?;-!]%.MWQUSG85&VPT-EPXPG5P2>SA,L"SGI@7N[#<@4(
M$RX/B]8=2-OYYK_R5[&TB>=I"EHM'_N2><6*D8:'AZCU,YSLM7ZRD@>G#=*1
M;[79 Q9'<<!!JGB#-463JW:IBT^-H"XW4\+S5;0-W:(/I#)4G"&'+(8X3>W#
M_.W?'X5PK:6PU)5INUY[\6ZQR@Q0(P7JCO+RZX>(IQXE38!@78@-DPJG"LRK
M4)EJ3X'V[P_A EZMJ)\N5A?O/@]\XVFU"$>0Y3P"Q@9R#AK0!H5C%TOE:YR"
M#2\.&WW+-.QV ;?"\[VE&^,NB>(-NEP0P/8. [(4$0HKSK/#WK76P:@D0Q+6
M.H=\DT'>"(2 *B]"-W(]&<3HRI#(N0+?L@$^NNKYP>PZ77Y]+0$Z:PN6JM\8
MICY9>9?K6GKL/3:(2Q+!GNA2H0 9=^\YA:U0F;+;XL7QN 3@TZ3!<YC]U4--
M=<5/FS3PV&%.@$9J0\(-"R465:8HY&[Q&G3>VG?& 3QNI)])/;>NP_P!!(:H
M%@3:J,.+W,=:%;CTT6%4^?(,SD\?/O[QXX]-:GR+=^U86Z"R):70=@\O-'<I
M7P9QDN+!B\X1CPE8ZMLX0I\>5EANJ \W(%WR9*5$_XD/4&*8]3/N0&6;P%?!
M(*C/I#KLW4'@Q=! ;DC?*3QD97\*VTQ;K_+.R-\J1H22GU"BI^S^GNM :PQ%
M 0=@H+5[MR=]^@*^W&<XR\ $?DM?\*[TPNHP:/G3@T;H2Q*Z$[ :LW^UB[^W
M)#.&&&438GCE\X,HKB(K2?*"WHE*I73_23LE%)$7Z@SD*MNW[*%!S!9>7FTT
M,6QW-36_9V4J10A&I$OQPE)0KD/ANMV?TKJ'IQ3H,D/+V[4*0H%B@\YI%Z#S
MS0/:2327V?F\4T_5=U'VT)!G8+&'D+I+S[=-56L'D1B?Q[?F$FOS9D_:Q"\1
M X7,BT6^5'6>2O&Y@<#V#%"C.YJ")H8;H74=Y"$4!L890KBV-:8$_;TM[%#Q
MC=[\[ES'EWZ-!JB/O4?'X=LYNL=;OC G5[RC:G?$W]J[B7K@95#M7QB+ MP[
MJTN&_R1IX&,RL?!IUD:B;5$=I%E5&.6K&>0:58A8_?QP3CC50FN_Z%]M-.-7
MV=$J-VC3HEH>Q%K<#F\%4PEI5]'7^LT1U2FW3[TYA,) X:\@54GY.EKJYW9,
MLXP'$1ECX4Y3L9ANSSQDQ=IA3 P6TL/B,]&ZA*>=( :BSCLIW#\TD==.;53O
M*(+C3*8R6]P=GU*5HS+@+9>U,,>N]O59EG6O]%5XD 7QFU#[6[XT% +1<3MK
MK-NINNB3%SC %ZT#*7?5X#:'4AE"M:5I8R5O_IG1^*5V#1!7]2^-IPRU/@Q>
M^\X00NP537KE=9+U8AU(95@DG4K?L_G(U+TB(NQNA-S[<'_L#SIP+9$"[,H
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MA_*3L]'_T?5DW=&$8H@+P:\P<!9MA!5Q&T<^/=SJRP<^9?(ZWC8G&T&0Q')
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M8./4#>),&+T?JWKF]@Y!C:GV0:KZ!6LP'#]WR%HZ3/1((L?:'&NJ K(6L@V
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M3I^]9WH3I321C1^SWKM6 C"<M&HJ.3E)Y"HJZB0G3:Y-<2^!%*.\"\,WW;&
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M_(6;[H"3$\/X$#FUJ*G6B-D=+>%SO/RSD_097!*8@ -.-?G/+&5YS-&HL,*
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M1W?F<IE7-4B?L][)A(!D:C@_MF:PRB['X95[V&S'6VA;YK% S([ >MN-K9;
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M"@\L9R]) =\@\+]*<K8LH=V:Y2+I+F6E2']5/T#WHBPBO3*GM"0-$#'?@HA
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M"&V[OS?&OBMAZULH$]=4+C^?*3'0Y3@Q.^J==+ 1VBL[*3M-![KA2=*.-/&
M248</L7%^O<8,^[*17Z?O+R6NO27B PQ#POUM/@XADE-3%?[DE7>3!2-*0(6
MJBCZ41G7PCJ.A2*J(HA7M*!HJODI7#>K36$:A;3A&]SF'0-(LXK"A&'M%@88
MII^!V"*8115FQW#2+IMP\BNA/5H67O4 MH]:@-CBWYK"?@X=IRP7V$4WQ;P[
M+'F-U*C K)AT&[N.M_G1E.$>[YMP%?<6F^_K^6\GRA[OY^P(;@I/77N=?E?<
MLZ+BB!" <$UP]&>Y])YBND4FT5-&66U%!3],AI##17__=W_^Y>/'?Y5Y$7H
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M@F.BHA?KR(,S$>G91-?2.6WF(S"[=TI3A2\[0[M\O+5RV8"56[=7+B-:N2X
M(?%PL171!CI'8FPN884?)G*[J,JBA -9!C6(,>I,C(!AL $Y=@5VZM02#5D;
M99I74FRH21AU:.]>F]KSN[O(&%JHSG8W@ B##&52,Q'1!5I 0#[;8/KZJ!@D
M^88-K;G.F;NG2P/XA+I9C;J+Y0N+AVW.XM4B_2W.$SSY[F%VHS+=A-*:F$%D
MH<H"[G,<!V,RW]1($=ST0;%MPO#*+39O+#;%"-&#85,/$MT'9E-FZYAHN$-*
M)C4OCL=NF")^C,2T2=@:FM<DTD9.@Q=;V^]A*"3.#5;57:SOX.$K7"Z3E%(6
MI=$Q/%@1K2OUSID#;DT>1'%-[PB5DB>8O*-4LOL-'!\^5>2P'4\V/&'^M$C8
M@18K!CM39635>,<0_+V1]R -K2M^FZQ'*<YWSD2"LZ@2U.&>>B.!0#V<.=[D
MRY-7(.E'.$#X^#QT]>7OXXR!*A*OA=<8S#8U)0N.2,GCHC%.$8QUM0LR&3 8
M:THN7)*;C2T9.*7!"&S-LG)PK&YBQ&^X*=EFE!)K*$4)DCH=)M2+L9!86Z4$
M:\YN3HNSEDQT4Q?64T6KHC\]RU3JG]H5_+;-MQD*5\B41\$0C3P1D^4B7&,E
M?"Z%%:V!L2(VT/Y$D4A6^11F34(ND9I%M*RG(5#)&X#\*GCIQUDC]468M4'/
MG3UX9(]N!]1$.'ZS"D/ P#:*I?%62QJW=XYE.A+I3NBY'HTY8+*43V/JVJV(
M57B$;HC$@UM+K"J*TG"N9,:1>2Z75C6%,QDP642Q(7T2_/ &*P^2%576[CP@
M*YB'^IC'Z#AZ>-\\9WR4G4<2BB2E&4Z6'V>>QD!0/1>@O,+7^ND-_IBB"%A-
M,A(T(R0Z>PYXQ^2/#^\_NI3+\7"_1DRX2\$*Q(!=KMM"Q3M?+O&.0@,9.L0T
MY-P4$>"+=63#[]4C17JH<%[_L-SROQ5&_574"XOAN&9XJT8+:+E&QWO.7D$G
M3-X4&,575B[6\ V-\>HTR :N03$A"]PU^U;)!E4.!*B?[11KN(N/4!KYD(P>
M@] 'YV*UD<;S^Z3XXSIG3)>40!?O**T(Z'U8 \$H410#.\=GMQKZ)!L?V&)!
M(%IS/(MPEA%.TQ0"">R95T>?!H.:H'RZIA@>T6J:N?/6M!6U(Q1"GVCMK6/9
MRT0P-[OAI95"T4JP6"YE%CE;"<6\QL?'0U<B)>USG#MC")^:M0A"NM6.RZTC
MIJ<OW\::@C2%6"4)5-Z.@HF"B01T/T)'+#XW5E=$.H%K\HV9*F_-,K@B>%ZA
M1XDG<0JO3\4L@W@Y03Y!33G2I"-)^U2XX7V,A,TX>/R6/;YF51&GJT^($,]8
M*LM*@Y@)!S$(G+A-QK^H7W[^^&==L-J0%K[XDV-+V[*^99$>(]*#N%D\W5?8
MCF8"GDO-,],\R[+J"!&M>$9LW^!@ACL^2O.S2K-6Z,SGI4*X>P N*LR#J?N/
M5#%J1R;:O4L!GR=&$)I&<(Q*HA50^__3>LV6I:61"H\UX@>VW-:P,!ICT$R@
MW><L./JQ-[0(3:'CX>^%0^<65@/M?>E+@AJX,/J=%$>\AYDCH.Q9KIT[+'R&
M6X;)T#Z=WC2=RVH;Y]$;DCXI?IPNJSM9KDV25[JZR< *XQ'Z!*=]^?X[X_PO
M:?8M?6!QD:5L)>(E1PD+DG"$E#_\@:0C35L&8P:PH$_.#R=C!?-(X2[.> I[
MX@\5>7!=I:O;V\L),G@E:=QO?QB0<Z1^%@']4^"&]S 2W<+_709.])V6I7;*
M;^<[.J[Y7J9BR3\GP2!J6L-OCVW+GX2?#L/^<9/88"LZ=(4K5BSS1!AY1QWC
M+KT@6M7$3X ?WF"EI=9=G10KK4.B]^T$/">ZR@<L>8:5G"8Y*QK9#)]HRR*,
MY8LW67(F,D3U.-&_ASXX7"C2 KF<K:Y&*M:"E@0GQZJ<05Q*TW.@!0M!M8UZ
M'2G"T=6)<-.6*2175EV G7<4,J.MS[=:^)RK*C7KLRB$>:.B;7^7MJO5^1MP
M\\(:M3K'[%M-]T.D*+>+<AJ-#$,^849!(2+FNV;J2QGBF2Z&8B[(V=: "V>1
MGK'G982YLA48P4KA\4JSUF)MF0%0[QL;AF6&B38*]S>6")+9&L%*C8DC2M1@
MI\8L;_.I\8T54N9B'=GVC^CF1/EL"V7[OE?*,]=W?$ATG,7Z?+42M0YC/F70
M>8V]HP/.&^B#ZTI@I(GU =$V JT76C,%$*M6SV1CAZU".*,5W./$[3EPZ_6O
M9W>,@'GX#N_@RTA+@=4[H4%!4A4I0V%RZJ:;-M^=L3$7A!;WI^.B=>8I;C E
M*61H:3.+YS9)V>A4TQ9>3?3O2%4F9QX-<.A@1C@E#^AA@I7<X.@3.N#*.J,J
M;'K&-/.WW6V/S:D?P=,V$F1P?.I> UZP!@S& J-HEI(0@R#/+V.^%#5=),"@
MZ )/L$R=@"(&E53* C_86G'',AV.PAC>Q?X8?[_,&<@$=C&[20Y:#!.0I!MU
M^HYT6$W+%Y^(I?-\V6 BSI=Z&O#/GIFH%O^$@1IL6WZ0DU+=<3_9'E&0\V"%
MBDOXYR)_S+ZE9O6RSF9B9?Z)<.*?OHL"94F=9NV>^6X[HJD;F!6=$5#;<PL-
MRV&S,*0],2M?V3<K7RG/4OCG4EIV%KDN V:W$.G<7&+8NG@=17 N[Q54.Y$1
M>+[\KPKMIYTOM=V8F(F=RZUC8_K:SN4]W*1P:1:W[(WQC]+UWODF=IL3,V)!
M1B^7><56%F2AV/!&27/Q-;PW,9NZ''0#=\K%D;,A\>0]P9I?LQ2$MVI98GB=
M"MBTD$2N<)-EPJOG8G0T4>J-VP'A!R>\>%(X]^R0CL3,N5=<O0YI/'&Q-J ;
M^67N+$1RG:0Q[$&[$$G7I; _%>K-.F5F)[[/)>BO5PERGZXP_-FYT4,/2K2H
MMC_%O>,Q4@VV@;TH@SO1,?64QG")LK*^1=^OLQPW-5=OYYJQ%D^#^A!O?M1'
M%VNIJKKVJ?V<4.,[A]5:B17C<6/K[#PD7D\5CVFC@\%ECGFOJXNJ_)J5?V4E
MUD-WK?70OL0L7E0%;(JB@(/K&?8RGD /;!MC4@Q_KZN56=7#!PBKHXG.X1)Y
M[C_/GSW1&%CW%*])*>^80_ZC]^X(,-8<EG",/[7M19WTWO4-0KUHNTA2TK7@
M9-[7F.Y>%9!)S:BVFW2=Y1OY7AQRYN!.Q&^F.;][#%9:K$$6%M8>U]OI[$#W
MAK1="LZ+/%O"$=VOQ@[O1;CQS&IG<.M8-OKB-MDDTM6"<O1"Y('#32-U\O9.
M/(P*'=M=:)<WPBL'_SE(</T2E\I7=0\7];LTT:X-8.=-^E=XWX_?LM:*'7\"
MU!)VEKZ@^Q?D-Z;159R2MJ,=M6%N!S'/N]U%9B)\V[?9,N8N]@ZE1;X$]G;U
MNBT<S>B^<93HOL3Y'ZQ4#@:,9$Q$-5\IO;0^R=[VU#(.B%KEHXK'N-6>6;=T
MYVI)?0 X(O?-L?8$FEXAO%EL]>D[7I3R*'2>$(<0FID[J15<-L2KY(I'HS1M
MP^'4>18T6\Q*"C6[Y6LF#0ONC=;;B=K(XO<#US\]8.%.O$Z>MIB^<K-!\V*>
MQ%Q"6S@-,!/0G=7[5L*2\ZQTMR3_NCKJ@7Y28=X2;D$%>6.>W#ZNI#Y2U)=%
M[:,5!GZV<IJ ',UF8A44BI\,MD'<L2Y;7ZLI,0-?XN4K3"M_MS,[_;[HCN9T
MDI\SEDUD"0I-%!6BENPWH ?U85^GX2@#N?R$T:"0O[$5*H8B*^1&)84X3_9]
MB5#Z.D %+E';S3<W.R%MC8?TH0\YWAU73/Y]DVHE[YZ]L;1ROHG>3C,YQRQ'
MA".]>Z +PY<83FQD+^2UZ+6/J^?TVTL&P9@2>'[+MJ\MN?6@9?1P'K?.2W)@
M5T*/^!;^F9:@%-RS=04B,2@[<!?"?\MIXG\KJ?(F?<N297/#'4:!CMV+)(,&
MN_) ZQ'1!(N\1'@*C U;Y ]PI<%BM<4O7QMJ"X$MBOOE+4<S<E&]3%Z4I[HL
M.;/"N=PBN[<YW:Z^S#@\R*2PAR97V!.I51_9XX ;VFTF6^N>"?!I2VFZ]!L_
M>CM1;SN'%;#H%$RZ>\SD'5F5G0<> G;C65E=6E@:]PPE$?T0K=-.E7Y?&M3;
MT+) I"OQ0EXSOF)Y(:&G^JP6KC[SD=:LF>**HX?2 BWID=>Z.Q,SJ:'E_;)T
ML\7\U+$Z&NQFA>!FZT0(CHTD&G$GM4UDM?U:-AZHQ$TV'K4AY0#K]ODJVY9N
M37$$.?+40507\ZV27X2_1J647&:KAO VL,LL-&7C=^J*SO<TI3Z4,$:(K0I,
MM98F>9]5W]UR)A='A]EK7D8NK,NR6(OUPY-^L;;B:CO"!WM[S4<FZ1#P9R/1
M@R*EHTHQ=B0I*XFW<Y.^L:+,\G:<1G=CZBW5D;GE];;MX;?K)C0;^;\=R]0M
MZ;=;4W\_70$FVD-\53$16/>:,[>=8U\BU&)17+QJ,0YO%<LKZ11[_,UG(BK;
M;E4YT0YAO[<3,5/GG&??T"%WG>576?5<KBNN"\N!8,Z2-U\8SK">LY#<0&<<
M$!?E:TLNNRG1QEFPW2W#=?6@NXQ_3\I7M$? A8.HV?$+B#CZQBET5-ICIN\=
M.?$&3F3KPAY/<#;WFL,F=:7B#3&^77&XMUW+08.8Y=_B7.CW."-? $N[#;D^
M^[").=='N5M_;30A7F-,/%JL+:.8;Z&=#6=RS4YA(5+ZA_V@688UM(FJ=P+D
M]R-J-[KLU25\;R]X2\3=;H+^7I3I5 *+Y1)^398Q[\J@\C4D]_D?Y.:?K6=?
M7[_&>UF'OUVUT!OZ6U.+R^*3[S!^-!J02XZ>>AJW73D>_;VH+2$&=ZF1CN+/
M%^AH3XCBX3.U6#5J6I_&D"[$[Z8E?C:3NA=56:"_ F35B[A(EJZ7M1<!0KD0
M<1K/<Q:['!KV,^IOY=!T? 5E8*WX35KF20JK+BR%S@\MU& GOHC76;YF&F]D
M%TDSX##4ZBWB"#BJP-7EZ7\%[1U>]^<X2=%8NTAKA-[S/$'7OFVCOA!5[!_C
M[TX].-1@U$;C6G?H\;80'H=7"I1>+MVG=-66[+R-J&4DD]A>%R*!3@*HWRD=
M=;0G8F4I_>3_<?YD3[C^=7[Z/$B50DZVC>(=/O7]*)"#_!T&L-LIDX\F2FYF
MZ$0I\8,Z#NIXXN)!9Z$P\1#/20,C%4)TV',*?Q/P*E_9]_+Q&^-O[$N6EJ_M
M8 '"F5#;0'3%*& %0U9P)2Q):@,Z-DI;>"6BEN8\T/:E0;?CC,V@-GJZH\'[
MVL[SE,)# ,.,EJ]LD3*_R7>/[H0I.O=XWKGR<LP#PHT$GS^T@ .4L_>+.'7D
MXOA;$=K3'[\X)VI^I][73<R]3C'*UY;V/KO+];$/E\%YH=RT&/OBC ,:WHOZ
MGO &@9.&:Q-@I'E>X;&G0/VEVK!C_Q?F7*R29;>CL:<+M65&(<KAN^P&_'&W
MI,X,:^% 7<G*8*[Y>YI2YE6F0MF7)XE4 SM"O(;UH/X^ZGHBX^JE#:U:,M$H
MA#XTH:>R5*I%Y^N2Y9<\0T.N4V3I:TX>9J1J@-V!UA/S_Y=L_=DRKI8S,/]>
M)P4<U KW&G[;B97R-J0.4I8GL@D!58GC%RQE:S=P?W</<GM;&P1F6$SOD'XS
MR04RN!UHD9+*J Y(=G$VH!OU%F0Y!I8M0>(!^>V*;>%DZL#'ZFA.+?>O_K/2
MQH^LKG*-E15N4AL=:@=B_YY):SY3Z!GR?%#!=]C :P -/>9\-KT=2MCA,^GN
M07X\:?.8/#YO4KB*X1?WD>1N2VEE8MMVD)K(567Y-L[+=W?V]UX=J?WV[N0B
MI]?=W93<"3>T1I;;VS:T-RE<4IK\]^,KK/Z6@0B_Q%(V/O0D7TOJM]2#V#X#
MI'8L09"RQV3#&BA:ROI2"T5/VRS]])WERP2A7U[9PA6_-X(2U6E7;O/_N#QO
MG&/R)VI=62?8+];JLX3+/NL/)1C2CUP-O$ZX"GQT*W_U\_F\!3PPKT&0[A1*
MNMI32]\\+D"._CU&GWFYR$5Y&!-]:JPCE^B7@1M!M2M40^<U,I+D_,)V#LZ"
M44WV"_&9:#2ZBV-7F6[5'$*0IH;8!#Q\9>T\E4/)$ K(#^P%O_+/+'L!H>-5
MI-<X!6)O0VH?\JXDU7HTGY-W%^9KX!'L[TC-7/5<)*LDSM\M1!1?"J.W,3W"
M-'JMVF*@XS&E%\4D0GN!NOVE)0\B,".5HR.+R]%L!M^$%;K0+69YVA*S8,('
M:]3N;ES-S@[4)A)/M@$F%L#ENU@+'(E<Z!5EF2?/E4C*?,SNXKP'0FPBTM0;
M=F015:4#(V<^K$[MTJUB[D7]))@&=49#&\&MR8D/,J2GTXR8TA>+%QED<*<9
MQ(^4.AL51O*).*YV,W%([.$P[>E"O\'<6<^=-U1_+SKA[@L<3IMJT_J0[W)$
MI2]LQ!QG>4(WX,XD-.F6Y)Z]5#P&T?O]2\(1U2\U=;G0['J^?$W8FS90P7N%
M\[WN<K[=YME;S-N) -,0I39_81.\QH3E)2G^D#@2^"^G:<O?G-KY/"ZHZ>+=
M3<!W- <<COQ M$'$0+1<Y,)V(($B-0/N0W%(3^I]TIV LEQ6FTK4)_B<@]A=
MYQ!C\G!G&O(DA*D%$P$Q>2NMC@9:XK8KM+ZG"_7Q%A>O^/]X/\-I*Y3B=.5*
MUW&>=H-[TUUMUQF&,2W@C(%OSQ< Z6Y$K2BVK!7=T:N^QM0;K"[8\L;L:@02
ME6GI>6P!/!>=G]>4],E%4GDOY#+82EP&8P72,13GB9BC(NQW<&]<FV-/$M26
ML_PE3A58',B11<:3E<[I!]&AP'<FI27CH3=.BZ*V!.()G+RD(@02=*\Z]QUC
M^I,>R^*QYT >;Z=4;O2I C<\J:LLZ.P:T\8=$[4G"?+C&(5NE@^H,^MI2@B7
M9YU;L);*//*87;![)2JB6OG$RP0+8]>USA ,UR[0V#HIIR)+_&9K\![X#+<J
M<F>QEHYPIP6XNP<U._ :\I@CG,EJ W=94<H[7-G&_-MV4$=JAX\^.ZW !(=/
MQ^GZ&=:5.H-. _+)T'%WCCR(9Z@?P/4L2A \9F7,[>>(<? U*__*RCKBQ3;!
MNY;G* -3HNM)GZO,$L+\50^BE*_=3*SC=FU9_9OZ0!O>J'2ECN-"OUC[<9<Q
M?9H1R,43&T[89VK;;47^EK<Y6R8=[ZA^3@T(CGH@[ YAMQ!G!DBIEG!;9Z(7
MN+B%^Y&_RL64]*E%QUUCSSWL.] MX205Q4G25?,'JZ7)W)>B1LP_YUFU1<PJ
MQ.%'W:!B*Y4RX3G:CSD^M2:(@0[R^.I.GW<V) _35CFXZB\TKWQLWT_>AN1'
M5Z-:6O?J>QO/(.'X/$VKF-^S;9:7[<5WM:'V.IAX7;N$*5K.NP*"^GM1LR6A
M]'<+OW5RU=>)W"Z]W4H5&,1FE:UPDZZS?!/W9ID,ZTIG8W#5$*MQ]E&0;ED/
M^CM07]OB=GL1&95ID:S4%8?2AE]LZ>U$+A@/CJZ99U2-QVJH$4L/S.4?3W4N
MRU);,H95)G.TIR[G!*(HIL3Z*CG5CV<A;/KN'+_4Z>M!'9ZA0HP>,Y4+Y0U%
M<X9H#.X]OR^EO_JRLSGU_71H-6]'E9RI:!+*'Z #+=8R:.PZ7DIDNUPX]I?O
MB[7>G@;$#G:D"R-B'*69)%A:$.8R"TO/3];H7>0B=/F9,V'[AALM>4G=0=SC
M*%)_()X0AB[/75</:NW!7659.N._LF_BD3NA;5#/F1@0FO REA%:GL0]INNN
MKM2N'?'A/*5)N5.0K/!OR?Y>U"XY[4.[>#?__#4!O0=F^WZ+P/H^26Y83T*W
M.>+A)MKY@=82F4>E; J#<2(/ID-]X#A]@-*5)RX]]/[#08D27N$ON'  &?I$
M6P1.:EO_K$>S.$JZQ-999%_#WG_\ECV^9E41HQ<'XRL9,Q*$]=Z=L:5[]9WE
MMV*'5>Y?:JL5A-?(C1G^H86; [7ZK4V'=2ZK4^?>;48NZ=A W5J2QLK4,JFA
MCJMR"SM#>\_]D_#M1BF72GDU2'4[UP#4_@XWP&1/.FI_+[J3_^GA$<%EJOR]
MSE61P/+IRP4KO\%AOD@QT/,:SG$T]SN$X!%DJ#>_P<2>(,Y^0!W:J48A7C9W
M32Y3LLNU!CU=R'WZ"*V6JX+F#?G8TX2P+DN%TB)/XM2]IJ!0UX)7COA*&W<=
MET/I$+(N;?)8[9S+XNUZZFW>O WG(@UI-;-3%M*-R+\.I03+4 II6RYW,=Z[
MVL[%_"'U^"_BKF*K!8+-P7Q57>GB*<V>$<T(S]B;=%N534?CQ;OH+O#]_,[E
M4&/-Q2/3G"=\8RNXW>!R C[4AG6+?!AVO(=7=S_"A)_(S7*=*Z/#>5F"E"\F
M=<WCE_8'XF])G?=K.5/\1L[=5M3BVW08/\VZXZ$1A5JC4;N4\V3#4#7UO_I6
M$VHUK)5J7^L<S:3[#A__GB2H-_H.8B,"U0T,(AG<>79,#N.&L+)CM=G$^?MB
M76OX5K3?/1-P#X^9")HK.O$41U"B_A9K8 L??IW_6!G<F=J2OUZS9;E8?_J^
M%*$7>!(N4NJ, ?I9S<!$:T&LM(YTA.CPF6:[>\U%6;%U@ 'NV6;C&03IXW;*
M\BT:M!#H_![]_ R185VGX%X=:0L0.D*'8?<T +]JI"^)5^(TP8RB16X40 .1
M FB7>,9=I0L\C6>ATQJ$!PW,[,]$]#8G#Z(RO@1OJ:QV&W(C,B+BL96&1K-D
M@2L&N\0=[M[?:Q9;:L>: =\T2U[2^FF,(OA:G&ME$G/_=MN;%+D8KSX/*9VC
M2)>EPL?A W+OZC"36$VK/(459*GD<K0_.3D;WILZ31BHH^XA0X3]\KJK';W^
MX0YX_N7GC__SXS]WZA[]'0EU2Y!%"R>PZ.,K:X@'UTE>E'BXHWDIYK(:PEV>
MH>T4T[*W; FW+EN)6+W"/!(#M-70HPQ*?5=*':BE^70$!^[5D=J2*RP$73%G
MS19T&UQJKT;/5Q=9\ZJS'-_BF#S?X"?;VK2'$Z*VN[:3<8;B4@[J2*X??(*S
MX06.U\]Y]JU\Q6L]3CVN=6=3:CG&1&TXTBL*T+;K_QH0^3&,QMR\TYW5*GR-
MR05P&6NGIH76'K=PO=.,,"TJBU.3,. T%3A:D.MO A7"*I@\X KM[43W#J27
M3H89B@QWT$12:8QOO8N.EM1GUJ$N2CMFH=IH?R4(<>AVF+S$2N]HA-DD*GU'
ME-IS?HF.%G,YMMO% +6<<%5U)L_NTW_>%G_?/3R@&[FX]%O&022-<QEGZ FN
M:C6BUJ2:2'/WK 19%'?,L*3M/;J3;[L:T0V1-S<8VO;?@P#@6LUGX)41NI"R
M0'7!)[7;S<\4=W"EV&927R/Q3^?]R6<#K7KA)T(M6!A%1BK9LF!%C;H ?Q5E
MLL0 ?VF=]D<[3$22O)YDFC53EM1K<['J;3P/VZDN>+D+>:+WH/53?3:KO=OY
MDJ<=@=;KB_>0+1P-R"D>VHW\'G?GG0P,,-NC.SFCFTU2ZHP;XWY?-G9=#Z_[
M4* ^M<>FFNI$4KIDU[UF0&YYTJFKLOZ7")="/%P3+]6ZXUBAKC:_]_<0:O2W
M2E]0GUW1UG-M[$."GF%QR8$4R!*1SP$3ZXH][FA/KH9:42*=-6B&]:"VC!RX
M_TY@T_D3S$5V$1P%QB]V[X$1VY,$M<3-RFX(@48#ZHWG-*F]=X$.=O:@/N'<
M&>P=P15=':B9V<F[CMVIUAWL[4>"6@RL@<7<=GSK^8]DY)'A&E:H1G!KSLZ(
MU-$@#I#$&KT9H2"=&V) -_+;KP7U6Q^?</A?PM?X#K*Q*'_COOD&=Z?^=HV5
MS/%2^JK=#>X\&R8E9@C.#>:<I2_H#40Q91]SXC :M"@&K*RM8.\@:&%5%*[4
MWVO6D-:&]2#7&^[9BZA%EI8N4#97&VH1K4/&5XJT%+Z6[]:-#L>[^"\N#1FK
M_ZQDN-6AVL3A(U&;TIS!D.>E.#SA(/6G(0SI.)L#R0--955+JT'FZV"&?8ZK
M*4:@.\R:.J0TT25+Q0F>O,5%S'F6I?JG[(*A2F#*]+:.NM'TJ"4N9SET;V!"
M1W/J3\!IN1UNXZ6.K?7AVL/QZ6*BJSVYK&M_$D]I+,,)F,S)K7RUFWHZS7)[
M#7$,B#\P$05+-L/;0E'"#\838ASJI3/YAUV%XW=;T5T2GW.0= 32&UL);X;
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M-_#XCW_['_H7^ ,KA?[;_P=02P,$%     @ LH%W5I /#MZ,40  (1L& !,
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M!R+V5Q"&_Q7%WZ)GX"58ZP[(A0P@+K6\]@.1^_<XS+!0PVH=#/%%DTMFL]W
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M8ZO)8%:'611E7IB;D 0&AUJSX6RM>WU?2F"KZ6!$)@== 027NR?B"P-X.[Z
MM_02?^@W =7ROOV;DO,+"^<4K/XZ%"EEQF(^.?L60Y%T"]'ZCG4SK?]>(Z?J
M1IFA.FD>\LO!\!]KWIUVYN2BQ8<-C5Q[[Z]@N"=E@>(URQU2?BUF>"?>Q2@
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M/DL^GBT%RO*Y8R94/E1M8D,\SQXSB"W&ZP+_N8/(E8_*]LX"P3],"++VLM#
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MRW$NSH5"3!$%UB,*6$6@A4= KG23OST"+/"#!MWZ_1T)&SB:6VB)A)>5%[V
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M3'>NJJ@TD6$_A3A9N]1[C1%-A?&\\7QV+E%N,PN0MF0#L85P0&2W-0+;?+&
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MTI\0Z>W4$&J'DDY&H/^R6: X2@OH9NL8I?!W>JGB\:2TATFZ:H=$?OQ=(1#
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MJJ&DEN"+IPA@,8FM!T-B&,3G%]7 >I;YK<\92E"3G]ITS^^?0;<E"J>=F81
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MIR2[7>?)/N^80NG@.+#:W*AX\+K^:FBR>8S6YM&(T)DE2;;.0Q&^8+Q>XFN
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M7@WK7"M0\0/YGU<L(?_C_P-02P,$%     @ LH%W5MX7NYIE"@  =F(   X
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M&G]FZQS8-&[+^N^!-4,63!E6W&\+4'))- RDT ED9'*NW2VAHJT\$?CY9W@
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MHAO]::J[T=]%+GA79$E>H:/')\?M%& *DB;KBJ64IA-/0TW<$#JEO?'22&]
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MAL@"B7)G5OQ$U8JYJB9'%>L>MNGZY!_1QK4N,2&6A.<?B"1(_0?7;_H.+5T
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M<K"58T4KQP>,/A/(Z<UVCE9,ZH<ULG,L6;RUI:-14I4.H/7-W0=M$O"_; M
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MYDE +?F9)PJM7;$TA7-B>C>R=]S.C @YJ%&[@K_NA,+ 6<RH P6LCO>#(PZ
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MG4(\5GD(NFQ^4XQAR$=C9 $U"@[&<T9(=_%MG;'JVNW9_P$P8-"6]F>LV4W
MF+$29F0#[$G(CVK=&?<QM73VMU]MJ$TN0L<"OPX"?W[2-AD/IO3H,?'NO%VR
M]*RR729^';53B"C,QDA1."\1M.C6L2VBIIRFJJ)&A'/&*--664?<UN!02)25
M%+T)?VB#?(S.W8UI2BZ59HS'78L<W2[92=QJE03NE427 W("^49$&Z3OUY]]
M.NF06&$I#XG4<XFO<)\'DH@B\ ZJJI76Y;-0&PA/VGRP?_# O\[WD8BKQ$1^
MJ7^@KJ<IAOF$]WL%A.ZMEP_#$,/02C D)YD_\&(P2-O0Z#%J>Z^W?; A'N?N
MY?2L1\_!F^<QGNN<#L+I6<]S@7%ZUHN01U:;6&WZK-I$I)*L-[$HL2A]NR@1
M'4E[+2'HG:/P-3C-%R(;57FB*JL^8NI!0:[_WTL,GJ._H6NC:;<FPT);AD@D
M6BB,='FDWN9@HXV[L71I" );07E % ",QHD)_*0Q4ZJBL'1_;HWU'73FD\*Z
M@\AD:Y0D6IA"VJ*9\>H271N!LKF+/< 68O !W*'O5?719;56_##+'K;IJ66*
MZOK?2Y?]ZO,9Z(YN]6XTHD@;&Y4'&GX]+*@TAQO:$0;YC2=U"?-0 IU&1P\C
M6&%$$QS+-+7N'[+QN+1?4(JP00JY_B<ZD:GG(1M/K>O?0%6=0R/-6$[H;WBJ
M1)7MB#RLW;FL8VP>%@P)W, NA2*!E:38;,.@N9+OY;R=8#D;+'6N,] [<H"E
M0IAI="XX2('E9C5EHY!DQ"\=XQ=L>>U3W4F2WI).\64-H<P:GXE5UU_FM ?8
M@),R!K6_T)4BLDE%B>N0X(J6C+9,>AK&_],?(2^YCN+WWR?*QJFVI2&]1H_<
M2\E#XQ*@,<8?73G6YR)9@@2+WI+&!UL.*OXRET10J*P4RSX".&RA=PF5"O<$
M2C& UMBJ<4;*>YB(K$FXIH='+G,;E2^LOFQI)FXQD=%_='I9@N5_,%MJI*OO
M,H L:L@DQV[YCVLC;PF5F1Z45E$Y,]&ZJ"":4%HZ0TS2AV$M;9CEV54-ZR&S
M:5B9(A%Y$3[ +*C;AHC :AG,KT%_8@@*.)(6W"GD2O#D@BBB>"6^J]MD!/#O
M,(WHX;#6,WE'V309"DKF#_754XZ(9C#6^91X:P@@L'06+6?_I7VR5R6;($SV
MDWO#4SU4;D8W)(;7[L@$7PVI2\I/6G4 DY.!3I3#,_S!%_-RR DON /U7MZZ
MR@(3Q$8,D"TG>(R!29B!0[P=SA -WD;\)LSQK1]$\G8OJ<E^Y$XPHTUZL!MD
M!%];2J28Q$*$\'8\9_Q>AH1RRJ5&+DKX>UAB17FX8(BLGM(YND.N)+13*..^
M6_[Z9E!J15F$[S<REI2GF2*7IHZE3'S'Q$2,I%^GF(+%&AIK:*MH:*BQ:--.
MK<RA1>BB"]=VRA4*VS':+#"&ULMT14E[A[*%Z(.9V'##3.@X//'W$NL@A$H(
M,X\2KDQI/I,L K>/D+&,0G,:;P(5IAPYG<I%T1CW31X:,L24[3&T&/<?C*#'
M4HI85@41 94? _@4C"*D!,:?Q(AP!0>_L@G-&(ALB4CO$1F[X\"J>HP+RVE>
ME!/#+8S:0$:EK7@P;#FI63#J>A ^!CX$RM, *1,"_PG41H3<P4[C>NO3;&:[
M7*G'8YD2YR\^DF;%AS,-1:P"BQOE$S2B\!UPDR*@ZH2#^H)9^Q'&^X39!$T9
MY_J$4O/E/1+HAT5#&FSA%X2SSY_>^[_[UDJFCV- 7@F0+[F\S*/*R[RB2C*.
M 2=!W9GECN5N!;DK=*K^54[$('KGS\]MD[_'^)CW0*YB+-:TL<\"Q0*U0D?_
M#N?;(CH+%M%U$J;%\F6<H\8ROS8R?TDN!Q9XEB.6HV_KZ =QUS;QJ8.SD/&P
M1,-**NZ03R%1F:N.Y0D+*:G+E$@H'>N$## R+AW- J9MH=GFMS+S',V_E<G(
MY;PEZ'0@(]J%R^X:?I:>E9BO[<.5DY:Z2:%5MMG0RH&4IXI,>%@4B]RH,R36
M9*RG9<-)+T^[OEYP4@)GO7#6"V>]/)_AXJR7EP'YZZ,%*C% YY9J'[M/[9U-
MY ##6M*ZKUW'.UW4X1UZD'IN$-NM/((BCDWI?)%#=8].6C&P.BT=D[X+11N1
M8C@1&*.1N/ [_P'5Q0(I<SVM?_CD"IFDZO>2^/3]3?5G"E^7IOHE?'(1_IG[
MDOZDEF;D1D:.?7U'?PJC[$+<AT;OH_LAHF4U5Z<D^%+[<7![UAKN _JM"[=9
M]F1XSC$,#@87DB8K3))BL!@\+ PM^4AQ8NIYF39GQ=$ ASF)[G29)N@;-HY#
M,?&N8B.'&/N)0Y5!0P<B)179CJ7$ZF 22=OH^(R5R8TCDB!5&XNT.ZX*"EJL
MS]B9+F05 ,E'; ;75<#5XLKTYIK$&ZU:![2/I5%+V-O#XK2Z.%U0F1R6)7;W
ML-"OC="SN+,4L11]NQ1I_0D[1.&F;1,B=]#_G[_\Y2__RU+"4K**E-@U9;GN
M];9WF?:%Q6>ECGX463D4,=H^VR9#ZU2'O)Y&0(NV362C(CGF";D$J[F<K4ES
M !:RK^83N3RZ4GJ/*^)=%?"H4[)"RF_3)C_[&DSZK-*G2BM#;4QIJ*RE%>@S
MP'1WEY;E<J9\BA?2\;A:EXFCX+'*=BOV'6%M:<CPO823IPO;0Y:DX6Y;P#H;
MR2]TVCE,,LHNQ5 ;9[VG9H0\WJHLZ/)A7I:GRIL/;SY/A%JP<&WK@D,?J'#T
M.3FM(<8YR.H"Y77NTV :PDHQEQ'+ 0Z'*J5*4<Z;AR^@PU4T3X;5<&\N\;"Y
M>S#M-!$& ]AL0=>4Y#6E"N*Q(E<;YEQ2@OMR+YT+?\LL6H*R HG:*6\TX2,?
MP\;JL.$RDJ-^@@5J970Z',JV5@5%:*":!ECD3&3(&1@K$Y<3EQL.>DL<E\8X
MPD!) Q'H^JA4.)81I_QI@!1;T>,A>4\"6D4Z#=G06+9A-$*_/X;@XOE35*G?
MD? #[9X?*C9<E@::9*L$YZ@0G["X&MYZ-]:I/(I>V)RX^[&9;U4!^! _.$OA
M0-X-$1S=%];5!ST_;HD\(&.^&H9C4Z3L]F]9H,L6YDP6O5N_N.,DRL -89E6
MGR@J>Z.WZ5]IHY',I*'U+.@5@3@%[@& -ZC7PYI4\?@!4H(<[BZ:SZ$# 34)
MQD9/IN'CD*+2E2.@M!*ZYA1EI*#R;*!TW:^90KWYNJ#'^CW^-[C:)BH.A5,^
MTR*40,\ 4>#;*O(FUU07\^0?ZQL-DU,6"44;.35]5(4 A6]^2*LV=C?I9;HL
M*/R30H@$A3O17&-;I#$:WCJ!J_?J6827?\#@_Q#HXTN4UT%/#5TD*"DVS(S"
MT'40F9 \7AW?-O8WJQ?_K)/ZP7!L WFAZ6N0JMZI%&FD8 UNPH+-0<HG*L:;
M<I'1W]VH8D:D5=FD2D0-J0C\I$0)E=:U9.P\K8_,1L*3 WFZ#.J>6ZYC4+ZJ
MT+<0@D7'RPR9X 823V$TJ!A=2\_#4+0H='L)BUQ>&F1SJW10V+9349>R%77'
MH%$&EE5,ZQXFKQ*'6IK=-U04AX+E&C^X#(L)MAX)(_%"/^&@-18%H"+,RL&F
MX^3U?%&T=SQ$&@+:YD6FZSJ9GA<JN@/I@]=[F*#$CXU#M_J&0J5(P>0;L_!(
M&(()!ISY^4N)>3<.BP>GV^C? JW AELP@(U9$_":T#:DP+EJK@,:XI,\ZCG-
MB+C**9+.M_ !)A&<+WKKG<*=][[F%2G&RL+4(2-*F+D'X!J)$%ZY86Z(6 5A
M2_>L9[DI/8]8^_9DQ_2>QX"^H&A\SH[A[!C.CFFQ/+;9-#00V2?RBRP[LJ!*
MX$\0,X1VH#0DRIHRK_D\/?\I_21CJLU8D;6I6O'S[YB& X9[$9[%Y'WXSFM'
M1%HG;T$3PG>2+H9U"N@P!LK+:Z>\H)R P@3:(6B!X2T5';$[W(!.U!\965%M
M4N5+\<F[@^K:[%[?#,\RT<8;IS"*+(-)C:7+&O;)Q;XXIDP5Z%73Q3=]9L2@
M:QL:N0(IB6(S4.>9FK;8&Q$,5:TO,J>G6P6S+<Q<P7D_:OYAH)[GJ9Y*:=G$
M\GR[^ED3BU?U4?'WBX46%IS'T)&(:[(VM> !>.J.!W!CKDUU8".*[B9GFC^N
M(6.:\Q>*8.J?DY#9PT;5(C@AYI@<! ^G,TKC9?3Y,V]39,41"?%O._\JK%[Y
M>RDI[[VVZ;B4>GJYE[%N0\+,C" N2MQ:K/AA:1"L7EA/'^I7UZVO>2^86^L6
M[7AD-");D#?7('7?*V2X=W8K9$R.BVH5KFYOQ!.TLEC5PBUP^!%MA_[T[(5C
MWF: 9.)S)FZ*)2!:>9_?YC89#^+P2*N*TI<M1NYY,N; )9GKB.]776.8'@_;
MH ZF+A3=X+,CZY2WZ-!^3/:X@<06/60"8%<;N]I6<+6I%-0Q#7K>Z>V:<3<U
MF0\YRI+%Z&G$Z +3HW5;-O8Y7S4=TF"+A8-5-X2+S42GV.KXB&<OGV/+G&@L
M6T\B6Y=B.N%-B@6)!>G;!$FCY<&%\K1-AAKI9BPC+"/?W-%S.=*%<K:O2[A2
M)VV3E*\A@U>\X[ TK2)-.MM:1E/U+^?X:)MHU7E,J3OY8&4F-.P55 G;%*Y6
MG3\E>6_5S(ATG4F="GO>"3284^U,.<EKTEF1H\ABO:9&S-)G1IE%F$7XVSMZ
M,1QB(9XK;$7;Y/612=CP=A8A%J%O%Z%,1V<869P!_A-MCFDCM2=3&CR'B5@3
M>0JFY;8)49T3=C-6QF$%18;<C?4D!#2!OE?G@SIS_$-Y-",,W4!GMM=(J9*[
M_[O.DZBJ#Y_>YZE6Q6PR_4!.-9'*HFR;1JWBW.>'A4NMB_SPK9QQ#+#$L\2O
M(/$NANKT'HD7JL@'+ S27NJL*MU'AX0ME"OIA\#.)&A&%U60V7RR=MAY=[?W
M6 99!E>6P78:16N1RZE_(0V/@HNS);)("6@E,M9,*(@KI%_FL -2)33R5$8;
MJ:.%P7#JJM:UJRLTUJEGG$F6LBP$P7VS?;")T6RY4!1_5L>L?5;:=\E6)+.D
MT04I#,8G8V-!"?<)BDEH.T"I@(9C(7$97<E;!6/I9MM%ZPW\'17V)E[]\ 3Z
M(8QT+@YU22O[</Z)4QD]\F#->5^/S_O:?1X#NLYY)ISW]3P7&.=]O0AY9 64
M%=#E"BB6OFFGXNGS[4!EZH92EW5Y2Z1 Z$;B3IADM@(FK."\JIM9U3$*.J9W
M)*)&!I^0=^&!BD%\+&2I7$DJ8=$9K"U5&I=7]LYSQK125A>Y_LA62NE#74>@
M$D8DKD:D8M&I&?/<8R@MM6:_<8^I65!R88LH!J'0$\\MBLFM,?-N/>.N?CXI
M5'B^&9<'ANG#>H(,-\DF+"D!DP_KP-5PPZ1M#6?OH:"%HFG)D1U>1\<7_S@[
MV>J]J?/*$CQM)]%GI!':IZ-48QJS=;EIHN*^H5983+6VF\3ZV&C+_)*E6^<7
MZ@./<KW,C<)T;=TPHRRS$KC^N>2\JH..O*[Y$XI;!D-?7?(1VEH:9+Z9Y"D]
M#:LZZS35=X&&Z8&7#LJB;MQQJBT3WO)NN-IN6!9;>KAUJ6/D0SB]SRD*K"4(
MQL'6+"U/+2T#8DCVWOS6"<IC*TF-.2*&!6F%CKI";"Y(LW5"Y'8;=%@178HG
ML*02QH[*TFG+,R2=KC"=.S.YL?&G+*>F#E7JZ=$;C)S>#7:G39HT67\J&J+J
MP3,/ZY)G#)OV\)NDHC ;BHYQK"M?:*#V%XLEOR*MAIJXEBE7\YFN]2]QW;!R
MGKC(%<8NO;FH^0G@90OYB;H1LD9;^KW1:;KXUI6^;HZ%9X#'Q[A?;"!4FAT>
MSVQ$K+*JP#+=<\,7.PXHWU,X/.#SYD_9-8OUL$3J_'"=&R9Z?C6NLV-9#T-9
MN)H8$YW(E&+SBV(Z,Q>)M "!,U_-Q.UCOG.&1 G43?2*)I[D% /ST]31[=@P
MATAUY5' H@E.WBM7% 3GUW6CNF'N>ECVR'ZB[&2&5!:IM%*L2.[&SD@:!OI+
MWHM@_W,M;[1E8W8M$%,5G8'PK A35_C-:"%) 0<\59_DYD)ED&J0B#AW8=AY
M0^,-;84-C;)F$'%.L[B<#*A43CMWMK>TM2%[44FU>7R)(1#&5-R![$G<1>#+
M&W'?K,N!M&%3.&,BKU:&%%Q$@C1_^4"BI-*KJ6+KG%%I# ,W&KN,(MA,T$I"
MI8PD(H4# 'R6YPM/Y._(=(0H)<TM/'TL;J5C)Y)8<"A5=KR\Z@C2?1_1/OGY
M?B)WL;C5M(G%PAA%^4]WT-\QYBX#8'4#+L:N>:&" ?T$VP0Q$TJW1;J!2,5
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MFPRO[IO %!OVC"\M%,H$D7 @JP]IL"\1NR :@W#'@#7G"/>"9:?F7YU]5N"
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MSF%P^/$):4=DA4/"G\FKQJBL3M'?_;MTBK>5%ZV8W".;N5^*=_#F)>QB1^_
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M2BH3$GI=@$<ZK] '!I?9Z[/P!RK]!D?K7S*# ^-TJ];[Q"L3408V4W-0Q5G
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M!O/\?BSH X+=AS*84 83RF FO!^G'&&P.6:.O1Y4]G#^R\RVW' E#'Z<V40
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M6E@$_+4N<[)F"W]/,'K:P95?BCE%K#E&]N])YGPZN(R?[L>"GG(>.. R[J>
M!5S&@]B/P:HX3>[&G68%%E655%:'* ,/]2I%7'VS(^Z4HIFRTUX!&!J[&S&]
MO_@AB)\'0WV.:^V"*2H+LGY\69^.L"/#9*7J-F<R1]<7MES$Q-+D@H_4"F"1
MX*447H>_OYP9VDBZ->7X#$F?UZ&IM!Q/W=I*K\,M/.O5+%I2H'&[?)5^(96/
M' 3LL46!6PI6?,9H@U69V>QPC(%-E=NJ2,2R@].<Y\9OA1>_GF%8O+RA[:17
M?A$QOG>!@"E,OJDBR;E=L9DS^=.PS8A7AOL["9;?KT_AV";-K=*UG: N4DPH
M8CYWV28(JE#X;SM>3D6:ULNPDE(JPQPYNLFEJM*TP.*5ZO;YQ3CHK_X')L\=
M7NM/\'4!/M"\HF#".2][<Y44HN-P'-X5-2$N//VS5:#;^:J=,GJ\ZR7V2 0/
MK*D2#/,=V(8D:*=;:*?K22FG*6_-7^[5UOR :(>DRNSV#/'IXTOT?#*;\VVY
M9:<B&*<RB1O82PN-U&G4$1:I:JC%(HF:[=X@R6ES5HO1@& 7,C#6).>Q;UA8
MNP#M;]Y'MA#L/[  NL"]A_@;BU2 E\(#"L'J6;JB(P37NZ;XE^;\I4I[7T0]
M9!V/GW5\>M97DA/9G1?1KW@PMA5W_3.B:P"K,/-8.(QV8GR)JB"QX,%A@"\A
M_+NGV^#QL^\YX;P)^=#=^=#^@2/()P)K6M!31!:8@93([XAFZ J6ND,"['$'
M@?&S)+ZVOMC&T0+DD]EHX"G5%]IF0;B#,34^E<O&KV*(I>:? -FITB+B/N2+
M&W!PY-&(^_D^>:?""#(UT.;G@.%LM_0'L3V^V*:3$=N/NT0'61O7Y%8/J5GA
M:FOQ^A$#W1*X$>0D83O#H5<7SF[VN.4[W&]!>N^$GWDBTGN)+6E'I;>\*3C.
M0ZJ4T=,#N1D2RKJIVK1I*ZK'J'$18EM$XCA9+5][=,XSBV[0GB#QQG]PMR:5
MS1AIGX$G;4BZ4*9;:=_-?B05MXV/GHINX>>P ^Z$?'0B.^ U]P>C-A04[BSG
M=9DK!)IGR2I9\@;(U$) X&\*K#]",G#2QY9<R+3;*!<4D$&/LKI&\G\NIK)[
MQH&P5B5RBBG$.T4+78"-C#532"TNL5.,'65\%F"]!VR%"NP8:H5 G-*PBW[%
M8I!'WW_W7^[(^+.@I@-4Y$;>;EMIRV(*LP4#?<DM2C3U((B(_/]:K>9@OC\"
MG_CQ]X\?,\NEFRN20-]@@5PJH2U3,4=S7R5@8<'_\3F&@WB'5.QX0KTLVXHQ
MC29+&QL^92(#A#]8UP7YC6%TC= )$Z_HWU.(/EU0VI.'BQD*H+0 2@N@M/NS
M7'_7?@RFVFUYC"=BJGT<BJA+B85SM MJ%94;_O9-#';49V4)W$M+N&H*9#<V
MV\OU<]3+P<]M=<*EQ3;5><A*'3\K]>P,+-1UKETYYF_)S0N)+$\F0Q747<CV
MC'NF2:<,S>(+8J$@(Q>MH2>#9Y4RX.>WLOR$<R46(*]XG>*+=D-)WL<P:)BT
MI322P3]1;;*'[=W.;0IK22_<R"E5#!Q5]95>VR9]WI6_^-PE$M492YB&'1)2
M1K?#WQ38]-WG G0!E_\T?(0^4TRWQ/]]MYM53#M($E#9Z#;#IW7;K0I\!RV(
M2P[I$^/B#H0.;#JUY+XJTI%A"%J$IDYW*UOD#T5#<=N&/1/R5;?>,Z,[PG17
MBZ-,PT9 ,HK8,$XD.0,^;4,XV"VA6CE4*X]-A=#(!".VC#PQXZNH"8O.C) 1
MUUN$E"[\4RQE&7J..OF33DGYU@X,:2A5!-7,?\&WT;],URWR[ZZ3O+4P9Z>,
MHW<HZ&@,G7/#ZZ3HUE\T A:C/G<6<VEZ;HFWB.%Q5:>F10'IY(%WS(;RO0P.
M%;!VI<P/<Z]$"H958T ?CQP$@Y.+&R79-4;-J?/9SBRR9-&, 19J#T(5X*ZY
M#.]%ZD3)Z"[<05P9Z 'V/:<!*P7)G.$.FY2ZI4U<;1#07"%WDM0DK<I"81L+
M"LIP^SCB9&:PSI\7'PC-"=,NL'X&;P2I1E1P"H\%$RMZ]-/SY_$M-T"PE*:
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MS.I68S.;*?N&<L],EJ$/6\:]/D"'3U-(; ]W )"/O"W$L[#?F.5)VJ*XKWV
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M\$,'<!*D8-/ X*I-!!>N\*XGL^@#=1I17,Z3I$P <_Z4B]Y?N48[7F,S+_*
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MG1;W=Q6+Q4XBE6'ZE%U%N!C*[N'41?PZ.%CZ:*!39&[T(>&?F1 0XH<A1*5
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MT,*X;2>C;1%OA@6UU-S<J3?6;K"%TK:J!)Y%;=G1/"W33UST::IJL?E.N5C
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MMZ2P=S8H[I@ =A [1*W<.-RHG0&-F4TI+5P#$C/=PN=MC=RDFX9K!=G8T[E
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MWA#QEL?,GCEF]HRS*=P PW[QOD**DJQ<RX<D7H9%@F.19M';G7"9V!W5D>4
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M81DN$V86B#_ -A,^>!D8/2YJ 1^K"-".S)>L)ZA<&LQ 51MT!#6OR93M#,H
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MK63W5_%PDNM29Z:$."O;N30-\6?*HL +-,:7WV]3P'Q0N-CX!"="Y*K TOD
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MQT]!_W &NR!O:WT-RSZ1+1X\AY!NWI%N'D G291%L(D;CD@ZE_;<V3QMX;D
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MJ8U7T4QDV4(5; "W]+LM HL@=,<7NN7L[+UJVHH4VRO$C[;II*!=;UCOLN%
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MH>GJ?-L0&'I^DW4)J$@3K-N#4!"^+Z.3]!IK^/(R)F/<X,#'=440./%'V -
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M[LV@_N+)^FI3@Y>2]U%A.KO:>(E8!)Q%W.,MY"T%9G-]Z@?I:6>@/EYD2,V
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M9)Y4AH6#4+^^[I6@TYX__4&OA#>O3T^BPV?'G7$\?_XR(8W@K!YZ2O:HY;1
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M[H(/1[9.3VPL+-D'6[+3T7'N+EFD35XWQE*3-2>43--C]A1AK_F&3C?_$]5
M]9@3). ;P]FFLFL8ZR'KUN<4(,!*E)]F5%YF]/.@G><K(7J)<!NUCSB"AUN
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MC>QM!LV$(S;\N&/<$9N0@%1^7,?H[A?K^%)Q+TIR\MWXI[.O0A.M$]\!D?H
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M-A,0Y&:$@BRX:P3N3*,VKC"7T <:3>X\_)UV;  .[@X<_/%Q3.AW!%0*P,$
M' S P<>S'X-_=B?_[/CI@7L0OVG)C9F,>V;31+HPL>0G] IZ)J?L3L5I63=(
MMT<Z-.FP#W*[Q.1^A=K374JV;CVB-C8@M^;*CA&!0"@R! 3/^*.<-"BF43=2
M-IXKQ+ARNAU#HJ6N@>7P8U)%_[=-*O /^L1V#O.IRV.W'"((L-UIL9N-Q[+
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M+11'[W^FCP]^$W6?T[+@V&0JSC(CT,7MI)XR)Q,I_,T84'GP R[@KS0$0#>
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MJK0GJ:43ES_\M;PEB\&$Q&5(7.Z8N!2^J+^4L@P)QY!PO'VMG=1UN_H+^<:
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M::\)0]MM4F<Q)VS3PJ' ?QGM>X,DH:$!:T\;L$93U*'AXU%-1FC ^ML76&C
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M7& !/K2?^W'*\"&D7!J+9:R+LF/H8IV23@#C7NF6> 6]EF^/5%#<BKVZQ&
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MLO; 3J9'D_'Q>'@^'DW0]Z]H]',Z/CD93T];:'SVI?TZL&9DMD+A?X(RY#+
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M&1W9 B9J-C=M\QGUFY9UND4M;-/J?@=02P,$%     @ LH%W5L%8S.)$"
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M]&,Y?@H(\:"$%I!+J[#*P=*%3:7+<(&VA,0;2'I+-$T+7.8$APD6SU;=L*>
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MIUC,1EQ-^<QZS Q:] \@G'TW:/E_..'_4$L#!!0    ( +*!=U;1U8,JQ@4
M %(N   -    97$M97@S,E\Q+FAT;>U:;6_;-A#^WE_!M6AA Y8MV4F:2%Z
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MN]7)'WQATU;-!,TR_WKJZA[<6^I7*C76I1?<$@W"U58-7,V%5)8P@!(8R;G
MSW7]Q$8EF-NAUH41YZHLN3'MX^Y*!^I/W:-RIC1.3ET%5[K$F7+0(#/7@Q)4
M+MTL;I?[0BF6+^S:G?JZ]FRR67LV(*O*DZTBM=Z\ &S4I*3,E6OE2H,3I+E=
M:69H6?ORO'9.WS]LFQJ]TUBW?HS>#**'$25DAX7%>E^JZ R:C27P_HBIF-.E
M\3O4=.1JPD^?3$>^EOP?4$L#!!0    ( +*!=U9-&JN^6<,% *#,!P 2
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M4Q]-Z$M6. N9UUEW7^LW5&/IYW&5?8"+*]7_]";(PE-#G+BHGWD?7*JGPK'
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M]<Q*/Y&LZH]2RB]S>"QO4@5[F!8&);#/<M^M=.A%2.IY*-:A>0:;RNIO$AQ
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M? ,!UW[O,Y \KDN5[<+(1]9&L3Q27%"SB5>^.Y:(/XB$R!O32F\F2*O([-#
M4_SD2^>\H@Q_C,*8/_5VO:+K#A4Z2#]AA7$5B"2":6?C*Q039ARV<07@A7XD
M9I>/OMB\)I[?VM+FI>X=8YB<HA\D) =7/A^[@\BPP$K&:RQP/-9T1 C+W5I3
M_X %#IY70,XWY\_Q]4;<>W"3XOH"AFC3;VC_$49% (8Y@ISS\\645B]YHN-,
MS"[7<87%4(_3Y %*HTUK.2"G1$BC9MC]D;_<4*^ZP^)@H(+SY'+9NJ*3FK])
M]B;EYC0X+8N"[=$7S>?D&C^LB6;UNH^/8*UG+&8A#/)*V]L$A21,2$XGHD&
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M6AB6;;"ER%8\_ETQ?,@T*]^+2[E>X8'">$R:O((R_:E6I\R74B*#09BP:I3
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MAO4U0]O=K.2K65RM;",#)J5?UB /Y^@60T3&6;V!H:BH(L@=> VC\ "8_GV
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MN"U;3RZGPU9<I)-9PD[D\BNL^])*9=AV6:NH9+"%<T%<ZB*YK(.L $"I;!0
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MG2P=$4R$J?7JWZTA3->SB#"J./XXUM9+X _;6TM'A*],T3O_9;O=_YUA @Y
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MC4Q>J_1L(']^0%UBS58:E!JM\^.<YA*$<VR$F8(@ @YY@@&C@^\2Z89^OQR
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MSCK&!!V.#^"T9,FG)V$F2S^;D0=-++6N/I<-/Y^I9@OEZ;Q.G1VO0M]AQTT
M(;_2JW0JMXPJ!!$F;*N-F<%$=5^,]>V7E<]G;S@(K*J<0',('F.[C\E+==1+
M8-9:Z <WE/R&P4"+.F-"U_7=)V#5@";$5>&&R[!2PA(M'QHDQ_;T4-C1V4:^
M?9+(FL>41SQ:T"C#"4/HU:!Y-R/&%(2.K<Y_;!<)/I3K=I/V21M9@5RNA>3!
M[K6W>\LP6ANZT],9<]\!*-#!---)HT4R-87&JVXJ#)H.3:EF))QBQ!&QGA[]
MI/JH<)S2-P+2:OA2'X2,KQ6?96R@L%G+?ZQ$$L<E>/:=BC%S'1FXR&/,UX=U
MC?DVFGX(651H'M)I+2H;Q<@2K2=31C3@)8^JVPIW)N/A8:^(,MA,,+-Z=J&,
M.ZIQ9^?\#@2CDW:J,1/<.!S!^+6O#=;?P&0<-!N2T.Y?-NKB250COU) ,Z[;
M9R9^J.".Q/(U4,/[$N+_VL?G#='&_B7AXE2HW3QM&)LB=_]K8+90UY-\?$VC
MO-*!N)M:\NPR.8!^^.FLSE=9+4$5*2+9"PKND-!Z03E+A]%JRD*W%X'!56\1
M/#$G_7<,/.?AAK.W,$5SY(RW\Y4N[:H][SQY1%B-SOJ^*PUT7FK6G**(9_71
ME;!FT6E]P$>Q#MIL*CPD96+38_- U#&BV_;&X1N/@)^>.%CZQ=B_^W_(G%[E
MIZG'SU]7W?Q)OT0O]K/EO$RZ!1YH+/C.D29IY&YWRR'F?M!$M"4QV]B7<1SR
M5@UR<C7V3,ZBSLSC4ET/KJ5O /@\T%/$1*J;*#_VHEPL_%S%&_$+(XF9_+."
M8(:56L;I'23&O%5_47!0'E![&%5*(=ZTUQQT!+:9Y21>*X"^*MXPJZIX_?<]
M'JH%G3$B5+0);AB5^,V"M6\(\66M*V+^_?YF XIA:QG("$-[.\UN-N2L'<4'
MBGB8*]BZ\'":WKY H\=B1346!NR'<7\5 H4A.8)=F(R,@R=,R?6X8;:Z;[ZT
MJ700L*O+NC0TI(9@R+O#/R=<Z"S*X'BE0_+DG+?!%8)EZ]_51WB)H-MS9UO<
M[/,,6Y(?Z8D*6+XT2#E37\OL]"/;1885S9<\XRV,%";W[;VOS3\5'W+:'_$L
M\$+;E*H :S%6/)&H'CS9S#\CZ36&57,\TK, T]0^9;3<XUQ@CK:E Q'@WQ$?
M81E1>)E_KJ]4,_$A6Y_H/?OU\;;?.MWUF*F4F+6H\E75IC>"KQ]%^%.1:)T9
M4'#?BI2Y;0AS7527U BR=R&9Z1:Y&51W4=Q,TB^Z&)9.=8_@F:HQY;-KH03E
M.?N18U/>+I#J>%D@;PY3,$?6:_1013II'+R<X2L3D5&;W#Q%-[JZPBLE;W^5
MJ%.W.N &$1YX0>T@W805Z-P+>O*%7IE+48[4GY/H>>$)U+ $A4OD>Y_W@-4?
MW)9:PQ5%()IIW!TNB(BCNM;>)/7":Z^M%MSUO1!]]LO/B7_F(5.,"#;\72C#
M1^UEWHR.U?+LI^CHUH1!_O'!P6WP+"5S._A>+=477^GML$84,GRW[]JWLGV>
M+B'8%:.NR&5OV*HTU?:*T>[_*4$9M5EG1?L0P^J(>3;;QCZ5JWA -<]+.:R!
MI(XJB?.T>2C=/SH[8-6'$0]TW2. I+4"^#(E1'VLVY1\N$@HFFZEXF#P4.]C
MYX/HLL_G!B4 38\#38QAVNG>=Q].M8? !/39817L%FXS''1-$VEW_Z=1FY<X
MR>'U/02#C410X*1+X==@<9'XWLMRT[X> 88-%UQ.[K:DW:JJ'2GVZ2/^7J:*
M,Y(QJ+YT)SW-=[0(;&G/FL;K"=VMVK7U"C^MC&+XU\HHRXC?'J4W<?O7@R9T
ML'+/S!?&<VR%F_K_06LII ^JKS6:? 5W;;!PL]R>;_:"\ER,3-_M\299UAL.
MUF/JV69W8K7C:N[6_]I,:!I'8.E=RH/PC0I<J,>R##>LYAZ:#Y&KD 7QSIZ)
M'Y=;D'AR2>#@C3['-*5>]WWTY]2\U;ON(A\/D^?'>R+:OXAI:>K<;B),3"N?
M;2TG+0FD^4MZ(](!#P3E3S<<41#@:^$45@$F&H[<*->\MNHV^O+P\U"OJ>BX
MOL/1=8;>0,.X:J&V7L&P3P+0%:H@T+9&V=9!#H'714)$QSY[2:.W@IW!9[];
M'T5ESYLH#M)&=\:4))J)Z[*^I\EV_NDLV-REZ&;__A,Z''=?E'#GMWB@R!W<
M CKDK%8Z'H0O5Q1/S>I'>8G/4I$+1[W+.SRXY>R==C^\L=?=\DSM06-2:EKD
MG+JD5D-R5WE02M>MP6]?[EP'"%-[&/YHW%+OC8G%T)#\*M>OL:,-"*I<BA8/
MR"&P\<EXX!7R OISMG4!ID.GH22QISQ)UMP[^Z6(7[^OYR.M<)T1!K,E>KG'
M:?DH,$ZA3@U7CP?V%9#:R,L8_3DFTA8/]HWZ(OB^NV759/A\YZ%)NM7"PQ43
MGW*T9HN2?#VN>Q0^^W0>_+UA@.!''T<G;MV2F$/2T-S@$+6P5LQB53=Y#6N9
M$8Y^Q;\P7+:&_&BJZJ8:)*K$"O<D/JNRZ=Z7\U*3UPHE^1":P5\.5=YH<7BB
MY_84<0\@95ZLAE_ F@X*BYD'&(*_'U2V*"MM&A\%C/B$[ B/1M-A+-I!.&I*
M?M+1C;N'5D*''SKD7FKE;UV!P5O&X<'.>;LG$KPER*^;';RLY@GFJXXXFC@T
M:=L=C'F+Z,72O(8J>9H/5HL_8?P1S%>O'UD1USV#!<Q.A92]3>5AEXC_!N)J
MB:$3Z^Q.$]CM@>E5%4,PX;J)VL//=CCB?$G/AW]_Y$I@%,CA.(W4VRJ3]XI,
M[T3S4*P>_?@U3%6O@LQP[@N=I*H8?#&=J/^#S>&FQ$F2N?]58BQ-SDW>; OS
MP#=F$Q-1YO_OWK;^.Y@Y3K&'$=>03M P_QI(N S7@)?Z2<Q)C.<^XM/AI/UF
MJLCF]^C:<SXK*RO&?$%.E(A7SMT%(=\I1!U56)^D<#JH-"ZE?\A)RGUF9:@R
M6KTM4X9,K><G+"T\X(@'C&_B@7[H*'C&!L:/"P ?<A-4\K+I733H\=#>%ITZ
M/,?8?;_GJ@W(G)_%J06 ,ER.3<A;:=,0#(H3$*)\9D^U]MFCJ#HD=N+@!0>1
M'\EEA(,R,K^L2&?(<'!CCY'^?L).\8)T1YY,(#/9/C)F+0<5$KD')IT0^"SC
MDA+B/%KL4.@8$8#E^.G2V.MHI)O;6UPACMH[2?[T;;^/T4OJ(QIF%!2W[A%&
M<2%(O:DC,^KNNE/,UF#M$=CO:*#FPJW\)Y\GYDT6.D 3C4SP<3QP?JO,/BR-
M=B3F?D5P\TOQJ&5;X*#E9&K8F]NQ%C*332]S8[#A0F??7K$+U^O^M3><PUYM
M8%(,MP;*.USIQ8.#EWY+)A(SB&]4,Q#[)7TO[5ENR(5E?8;X+ATM,[KP)]TW
MEC./C@!-FT7AK? TIL%9EX\QY=PQC<IRCT@G.MMEWB&OHOG#7#1I5L]LZ<1K
M-'WF-"=1HMLJL]C;U-"<O]W\)F?KIHU^D-AV8W=-==+1MF=-X@Y'FF*"4B/C
MNRB5N9]CPY.GWNWN/3SPT;L!%VYXJ%'OA]IJ19 ;P*Q4/E6-?-8\FR*@C'CV
M9L-2EJS3F%G)9K362+6S@YPMZ^>[Q%\[\>5A]="N0;,F8(UPY?ICM1;NLH O
MSHTLYEN<2+Z"C*2@=PGLN=IE5[45;,S^_T^R1?KWEYF2O>M3L;=PW!T//ZV
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MX:Y=RTB#W^?XR_/]Y16%[#.S'F9B"/>=W]4O_'6*OSS?#R%)< NVY9CJ,G8
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M(,98^UF,Y))XTUK:5#1SKA-!_PW'O;/WND5-:OS;6-QD?BB)[PL1-<&;(_!
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M(L>*W8CXY%TB4SWFX^+0!4S]DNQ9_+FN!&XMO/N;-EA08QRR-N?;P/32B\N
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M?4%<P=@2+C-.^MDKOP4:(NG4<W?S=R:^7#?U'(D%SYHK7H+(G0]2;<Q!/AY
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MN]%IJ#:QNRYK92,NX+)>RL/Y8/1W!F:U7DOOB296Y^F\4KB\/>="IQJ2P.<
M&:<HC&[0B#!LS/1:7\_7L(5%!K^-56R!AO-,K^X]^MW=%TAS,$%$O3*0Q@7?
M ]Y]<:K<WLE-U0,6R_:.\N_B1;A/?SZM-L?!&4+/%E&MLD0%F$@PA1"2M;.L
M]K'WWCT,RQ5-/_5!J_??D:\HH8>H (='4556!!\YK_AKC$+ZY:&%6&?HB(:_
MD1H8/JQ@XC5Z];.%Q2\-9V?V2=$OBK?4EW5FF-IQTKGG2V>DCNW;RLA57^85
MV+%EH@>WA5HR'VA-/H*WN!:.^VR2W]A7=)V9\G+>.L=?O?U#L1>P)QD0,36O
M'BVJGO)B_WKYEX,*,QM&1GW"=;?3VA)D&8Q;F;U;ABV-7'\GGQF)B'+ZZ2[,
MF!()/[F6&9J99[5'!@)<<1(4'=4,*F!A>UAHP#+!\M]=^;<$ >[.:9[JJ-F'
MVQ(ZU5,.]:D695N2]!NV7W_=G7:M:_1"RA$1& 6\0IO%O85K(:,W;9UD$S]?
MT=0:7G<F<@$>$( DESX=GW'O:VP5,H7['4AQZ\TL)%F!= Q9@I @TG\H>(M;
M\N3(_3&\X!.U<(;SM2$5B*^@ L$F)0:,O6:%JSN8GDDSPKJ*EL;)/J6N#P5I
MPK(<L@?(!C2")(D+_# #/UZ=7-P+DVJN\ZDQE[VR=D9M_K4 SL\D> 7,VP"'
ME4U/M"+6HB7>GN1>=1$0?P+,2_P*9"6FF>"AP1.&H^64$2\9T4B=^1S_;.EC
MG'2_^AD0,4+GAQO$9B3>Z^LD*6XH_\28"M*OLKAH,\:2U85&-K6'G3TM IE[
M;ZS#2M^*W1C\/O^3U%I;WH.!)C3HE:R,[T8X>T(4;H?>>WNV9E/$HE0@EMV)
MB6>&;I@,Z[-.S$D1O1EQ@U?_ R?=[AK7YFZ(JK3W@@F^(Z80"LMTS.^=<]4%
MCPE;?-,7.4,'#@NXJ<; -3O-CE0YGQP@G3+[<*8N_>P#\Z5 N]87Q^GVD(TJ
MLJ,--.G%0..J>$E+),/B7%_S'U;0@]\JN=O9H"H[1%QE5DRFXJ"8SBG+KW4:
M*UP+&RD1 AR_",O'54GH_L,8GCU2V<A:6??QQXZ,]%_(!U;7*VUW+OK0HX_V
M,^:@OT' 5&"ND,:7+&G07 1J8O*7*VI\AQMI2?%\*+(W?$T#D4W2+>C]2#0Q
M&5P;E\\D?(-YC]^X$>YQ\423&*]J.-*?G &?<QFA BNM5,#A<'=PC$RY7-^Q
ME32"F\^+!W4!;?W(?J^ZCO:[(,:C;)5T6YU_\48!K+,JYP,86Z[?3?; -Q"\
M*EI%;NG<^W:)-CW@,'\:T62NP8#)+)"]<\Z')9J6P0P."F:H$#D]S7WHU?7?
M/Z[9)-M9?+_/X0+0X[)9ER7F94[Z6^/7$J*J8$J.?D_9+?4X[0F*;",FPBRO
MNV<>.).DIR/AVS3_-Y>"H@+\V2#$(N(59-:+=),*?*!Y1-$R&F.9!./J \]0
M@7[:1R71*"S)*4@5E?.ARBOIQPF!^71YT?TDB7D5:ZQ"PIIG_8&W)[E"P_WL
M67(\?1B+FD ^$&"CX;/;C.)8IDC@E!RNCTR/E[?/)9Y0KM1_S=#4$J24OLT'
MB"-2E4WQ\$Y?V]BJ'F:5%SU55</29\)4N^G&8T08>"_06(O9#B+$4G*49#'[
M_L:61>/!([RECS;EGE;8ST(>-<9[=O1#=@A)XC2&_**%[WR:ZP=H0)+INJFH
M\SG17Q_<$][?E>AM8,5_::-O*Z)(H.^DWW+YMJDI]>2!%Y-7<)5Z]W/K+ 0G
MW?8\UZ9M-$61^ 7:X%IH<37!"K0^6PUI$*FPOYZ\W438>$1XCY?MJ+/IR@2?
M<KCW262^]GVA$16@\X\&#NY%X\G,V*D82(C8<)7G2=C5#]9^/#]8>UZY#"SD
MO!-86#^8=\=FGB&V8RT"O9S7?#P695]'Z)]G1^'.;(';^AE_>IAT['.W]_';
M*1RYA9:6L9ZL_3#,\P.QEJH41 4\HO=CF@+EON#1X4]&RG(O=?&TN])=NZP-
M=/6Y=@GO\P%+17\-Q4/EO:>Q!$1 @'QAF.GSYR=Q:7H\]@7T2/XPQB'>SD<>
MV:#\143D;V(P]L*\/;3=K.O9M3,R>>I$0 T<9K\$/4URS_N& $=*.W&R<-:W
M-4<(OGA*6&:#RZJ!GZ+/X'4I.A&1\)4!U)L2. M2=,)???"WS/&J$:G+A P7
MMSR!V?[,;&RA06!V1A8G:NZ-=P2ED7\O&B BD8NX0E+4OAC96YT*Y(PBN1%0
M-.7:<E2._;Y,&$W*<JJKHGD1IC=U1(ZWO,J.%?_A,Y<)ZE$#&QA".1!M^KQE
M7>^\"TVFV%R<!1#DK7>!*<LHMD#ER>H/;"E8WB=^/JK:.^S!O/S*/MG^];ZL
M32S6[S;5&/NKMJC &G@V!3R6*19\_$E@NYOF)=]*VY7=9LAZ].[.OU6#$F1U
MF^;PD,.#6GL=VH.FI-+MXG^]PI-6$HH?!9S(!HF0WY.>6M?5XN)^A3[-_O5P
MX:"5_,1OSK]U".:+[A_!I4541?E#,"I*)B]M5M<Y'%%3P";J<+?M>LQA\:_'
MM36NHK+"20J"O-I=D!1 ][]"YO^$D#E@"#6A.<N$\"I0N.^YR8T(CXR,MV>?
M;.G9\-<+KEY[4BO_$]YR8H8*['/)04C<-,M&4[8V+AIV^B)#ZH40:,BGJO0G
M9/8H#DYF2@=3F&G&& .[>:>_,N!4+Z5[\.-SY56?K*<UVC58Q1_]LK&9R((@
M17#"<ZV6B>P3P*\6-B72R*9G !Q?WKDVS>3I?\02=-&3"@1UT1A+IZY)%\T5
M%KPN2M=(TIQ(M(J]\,/M:JQQW8(_0VEG.9'YUO!9T2BIDU#%V?[GKIT'MV&V
M!JBJP>V#F(.E069SCRNZ$MO&@GJ *>(\^0/6A.C,?*E;3_,\U+JB<_-\HXSN
MJ$>O6[_%D@D!_0F,#5&; =^,C_BY9:EPH+,\<#XB9[$I61(MY:'6<20GA7=_
M+P)\4PU\S61Z!Y<5X5$SVJ!38!_%K^U4GAM9LM-L=8+0U-WG</ Y2%:R02EW
M:3]_JA!6J"Y(GG#.7'!ZZD[!SX$>MS\FW:/-R&,,>'_;^;<$HOPF)HV4#&*G
MB4<N_+(:F!L]*<1)!1(AMZ@ XCADVPS=LK.K%0:9TQ^ K+2 R*<KZ6S-GM2=
MSOZF_=CQS%%/\ 5$:.F&H^9D^79/_=.#P19\0O$]B9ET8)\*S*21D@29*5.0
M[9S;B\HO:,YHJPU%8*JCP3>]1PM-2TG0E^G7+_P^_YY_94$)?E;"#R,ZI=4*
MYU"];ZOW7M69\ JQDPV*@JV!P[Z;ST9$Z'+H_QQV)Z+;1PB=K9'^">%3 GKU
M[H4MQ!^!F^%]*VI\[M[N6K5H+-I);O'\,";J<31&X]= D62KD[=1JI.6\D[9
M;?%L4)#$GZ.\>T+_+A*<#=+ZP_H^_0(5&(=1;)P/:&A@7'[F4.XJT:1OTX1=
MVB^P;E7PA/D42;U?JCP[VL_'V=KT; J]1+'385TZ^HP<Y#05>'FJF4:[+]K!
MB=(TCQR52V'79Z29R6*:F,[4@2GG@U2%$36D$X?CTPHE,%71QD=7BR2<":*Y
M<".:M#=[0$AZ3NI'KU;CS2?:!2[="A:)EV<JRK8"& &Z#G'ZW]!QE3<DM2&T
MF-U@KK!MT)W/-.']*!-<%(>':4O_M-'YQK*CJAL;>(MB/$(93#T+.6GG&\YF
M6^E]8FU3=8-<;.F':WT0<XN8ECWU73OVT9ZDIB+'A02(.DIL/$AU,"?ZVPA)
M-\<[T-QN)^#>:'MYS'&]MF#ZM0X?9=>OGCO9K&9[YH0P#6B4W7VKQI<:C3\6
MP%U,^^\%S\4]C4L9"+*QN794Z"7?'CWV*D((@==Z8*=S>3REZBAV0[@5CITH
MHM>?822])J)6!IWG))95=/6^C,J-;1\0;Q&2R[NM18-:A^)AOZ?'^N[X90E
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M*XL)8[D4]<RS5*"\'RZ6S3:-!;\4Q;\(%C,WEH);33O4& 12Z%C>*Q4K"GV
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M!=)8C&>IPJ?"/.)RQPSJR!X,)0GYN.P_^#6TG+I9VB?B\F8DB3?/8; 0Y;/
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M9Q$-1(_\57FA3>R=R[]I'J#2B!"XF^(A3[0EL]^>A9W+UQRN(KRE1ACVIF!
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MU>1QRRWFA+'13]Q/WCUO)=X2V#0'?1F[3W"SB2O*($],WZ7['3C:7EOA=5V
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M)!]C 6?P>6+C3G71T,!*ZWF)QA_J9N'Y79;.6./O/4!%^6A*T0(X)5'C'YI
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MN([C331IHG""CT.A#7)X #^@@%IIX$'I-Z[V(GD6)NUCH[S3,EBC UH4\29
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M7W]B>G[?MJT9C!:#S"N\3<0"E,VHOUWT[#^3\ C_&N:VI&SW6E7TYSR.J&<
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MS%7/G@U?UT[O%WNJ=ZQZPE/O?%%^FU,62Q^HT!NU)W-%FA9<T8]^]0:^!1;
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MEV(>/ZLTBS\8M:_Z*NE0M%](]OV)8R.#!Q':)^+;?[W#]@]U!D_.'Z-#5[%
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M]32DJ<TB.-(]F6,XV2^&V'1&WKV;)WTJ\V!N.4S2&P17[0\W94UJ30.EV1G
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M,+MKG)A6IOSC\&Q^R,<!/ZFJ.]=[;YPF1>2M7FI_UGQUC0V)WVI*,[!5N6E
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MRWEZHG\!D%3YY%7R%J0D9/T:3VH54;F@CW" L9=_3/>EP98KKM1!IG7R<0?
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M)=$'224% 92;D]ZV&QU-;$8-(I1ZSSF(@L.S(CV&03WOL#^AK'/;3]/+,Y6
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M&7BIXI&.KY0\+3>M3*$ GZ*%Z@5!OS_7ZJ)4'6%!:[, !D^Q"N]=U_8S!_.
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M3GX&WZ^[6+\ _CDP- O3=33>.(L0_*/Q<7QAZ3D]?P'[-5(3VEB) "+0]D\
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MMNENF$$71 A65]"K:<;[N?=63:>MKY<?Y6U;R37O9V K\D2<H=YTZ\@7"+<
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M&A4[G)X<L]*TM*9_"/G0O.T:])K T^,6/W%E1:9:%#O5TS0(4$6?O7FWR5;
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MZUP"GJI R7%'=V_O(R6 ^H-#WW4S9HEE5M\+GQ[8;R 4.7LAGH9=$24271E
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M$80\Y7FB4??THW*F=KS\RR>RHBB,>I!$5&A= 0DH*IK$K*D=A*$BJH<S9*B
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MNE=T=!S:IMG2%F!62^/&,&L"WIO5.'[4;(DW"!M7,3D8GO[*J&5&KGB(PNB
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M%P\ 7_E[)\,\MP< $6E4B 73J6RAU&\_M$6L?6EGTJZ(9:;D<"2M.D[ST%V
M"..S,ZJ,'>T#EH&0ZX15:K%U\.N,Z1K;R&.GU\MKTB3J;/^:2?/_Q46&R_KY
M+ 3QM>_>V>3 T+TD]VUAMR$@2:&M*=X-:_06:L,0IO8C_+4&V0 3T*AYQ*'X
M3VW^]:"!J=BH5YC.<'#%P:5XR8[<%;6.@D7HB)?Y33L.'4O<H2SI(1+MC WY
M<FR++*+,X],:]5<T1R]M&M==V34#F>S$H)RP2)W^J>2=9;;3X)60_ M$;T-5
M3!0C78+P[C+R_N [+-M-28):1[&A,A6=ZBQ>S%4\] \6AD_834OR5)C$6_1
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M!_NKN!L )]9'0D28PBD*DHVG+Z\:@@!MY#>?UYI\SJ8;9EOQ#;QRCD0FQ]^
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M(MQR6E,GZ@'0B>)U10X/ *:V.R/0:4O;O@'*Z#]!SNC=45P+W/[BV*G4&7X
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M85IIOY]F="N!;/V(3"XQVM,!6_W\,9AD;;3PUM$OE+^Z5? ,[0'P/03Y&OH
M^%;^FN&J:%I!K4B=92S.A+?<]972LIK2+:7Z8DOWN1*K?:P,6Q_Y !-CM+@Z
ML49W0DQ>69:#GSTAA6TF@//6NSL#H>0B8=D"M&S19!+RY>AUR</-H-*XDD&9
MG=2*FI]-6QHNS+07'_<8 M,"KDKS8S-YM!1;9*9_X2TNRA)#3P3!2?IV@PY&
MNI.FRB)ZG/5[ZV>)#;8.5$]7[*+HL<.W:-O1 <XUR>7P5N2)RD*)#;9=3%=D
M?ZC@^\_]Z)-GNN[J-DB:N*'1ZCF@V.JR81"5XK%HQF#3$\*UH[RT3I,#WC3E
M>R^C@]#L!X ;N*@L3_BU?NE*WM4#X/.%V,UT%IDWE]*?V@S(#=5TY%J+;,\Y
MVXP\^]>05,0*6]W;63<M\%?;R=+#H^H[H3)V6CF[=:,B2GQ,4B$ ZD40H&:H
M92N\]].(P-)+,47YT-593!V'J/;G);_MG?H%T@>RD8-@22/E*E'''8TSCDA^
MP[-D6,5^/SSV?3/..3W'Z@& 6T3_C<1B\WVQ2)QR,644I8&T/QV/RU5'#X%Z
M$:??(K&:/FV79BV]>7^Q-R_MH](1IB0[^I+?4VSB>^?Z"_Q5]NCVRTI:$ZUV
M$EPK7#<!(VX#?7LZZDD,WW,D3!,I7346OEG0+MU\I*,??TM>,4E?IWT_P7C:
M^C7:8$GO$7N^">O/-BW4*357:VP:XDLWATU51A"^5G:C';"HER'>9F_.:TV@
ML"ERL!/(_D7K7/F55I/*G_';RY3.-3H/3JI4#F4Y_K@\#N,/DU.'>NQZ\PL5
MXY:1A","-"8ET3DW4YU3F,V@>>-7XZ6U<53O9M0? (V91R@XNIY:W;M3.(-^
MKR3>S)W;=:_\7KH:V9AK4W!*RD^B,Y/^CWE8.G$K"WXA1E/L@,Z\(;F,XW[T
M!X  W2E,%R9R]@5D>::3XG\T51R#/.?&NK0H=<*]3!X*C]Q;J>PWCDS9JKKV
MU(,\;7\ Z$^I-+*4YWV:>=ZQCE+I%W1_Z H1,M)*=BR_[&.S!AL#68>]<T<8
M6.7C_DH-_U?.2;Q@J&CM&-=^Q_ VX1,Z]'=UVQKS-&3GX@% RP37EB95<(X:
M+ORM-C<[\P#XDJ/W ,@807S)6)-%,%".()"037K4X^W/+ID?:0+5%"%&3OBA
MWVJ"'@"<(:>1D,X2(YO;X/6C]&-9D^,= /)1D9K\9-S2M\D?2Q7982PX_WX@
M*[<_DZ"J_?HNOZ6)[C@X6 4I!DE!:LUI$P:MGC>+DX24'I_?OQ8R0;CB+L,^
MI'J]CSE4A;+SH;10"?^_/]C"(63E')2!;$$9<V\4+E/^Y7,%Y'BJA6S?2_?D
M3S$0=BG.^+^L(PCAWR96VZV/W%"_1-FD)K];&%O8/$ZM;B$Q6Q8HV8$A.2]P
M_\,HX2M;\#GZ)/A@7N4>8V;8_VE%[9284;[NLO3V@HJ0_#,GHZY];/[+[:H'
M (WX6V1+[@-@5,EW;I7P!N1J<GMC<F#$)T%!I5MF^6SA ;"F!>=$!JS<\ L^
M ,@,_WQ#$EA7S<ISAM0M&&6R5<C3FB?=I]:Q^!'XM];L:VJSY$ZT_/ZFEC]5
MZMNS!GU*B&-SWE.X.UWG]$U A;0;UR*TJ&->KI^.FI#*G_\R/ZW0P*;1K>4^
M-=O :U2$ZU*B]8LK727L%;QC=73@ 8##_D629\V!2"=N5OZ><.U$=P4;87J?
M4$Q-</N^5L?NN]["HU=^$I$3^UA%9=L)<A=EOVW472T/MRI/2-=!5&V;PGF0
MF2K(KM;1U=\^IA%&+) B&#W:<!-DN_R8 ]#,N(6H55*NYOZU7D)O9/UC?"OV
M+5#T; 'Y'G1]]@"H+LF%B_X5 X%<73!=ECMLU"':P4<;#P!K'?E3#Z04\P/@
M8%MESP"\FI,./N&\/?1RZ/$R5@EM#!/@)NX,OSQ'D6D>&R71];;0RQ:!^<ZY
M3U+/Q]CDORL[YE!=3.?"V\ROER72W=6?[Y-O:1P$S_WE$:KQY%2#:IU^C'-Y
M<0S^*+<R-VGG,$G9(,\L7>,B]$:]A#X-2HEB'D/K,$7"NU,(O/CWC#^#[?++
M<<8)SL3AA4'-2CFY]V\?<;GT*=RJ%^[/]V9DZ?Y84E@U6/B*;5ADKX(>@%,Z
MI;LBES+XY:CT4LQVU8=HW4B:]_R'6,PQ-:1[1NNL#BDU!/ZWG,XF(U"WMT0K
M/7)HDK:1.\"05EC5VQQH&P9'B<I+BXS[+\\> -(#;Y+X-><K%DF8^=(&'P H
ME;5I.-EV< C9?=0BTURR^BES-Z74T,)>J_$6AE).+=K9L-Y?7 ^ +MDT! H+
M8H#@V[_*=%Y[#\-?H&0TT@#95( ,M!GI/>C?.&V)3$<H\J\ZMA87SMWKV=2U
MK]Q@V*Q<+8$OG^ESKGYO^Q/_"?$!M0FNRNT-]':&]Y2!9  F)SN<C8DU>Y.,
M?-/H$&%R3BO_ ##A1GWW-A+% X<AR*4'P'49'IR- 7G>5KY3J1.%<$>9!5CW
MS9 CEFN6LY6HE0O  Z .>I^G)KLA4Y^QQOLW0;BM!P6UG=/^E:[* U$X*;;Q
M_50,[I)%F;,H$WX3DH&LET:4+/D*HZ[H1<F7L>H#8/=1,^OZ P !1>G1&>RV
M!!]8"'A3=QQR, BZ!VC70$*>48)ZDDVZT]G&Q5BM&"=W:!>?41%%CLM'U8,F
MHUF''5J%C?B^Z%I59+OS#AIFM)N!TIPDF"<YQ#0V2O(Y(#YNUY[H&YN2"YJ0
M# WCDTQ?\.EUD 7)6Y6ZI@95P<5%*>JY%AF7.MCKHYDR J[\)(%2!3>6@4)1
M>B]>7\VS6IA@4D&I6K\<&MN16%=ZV@L/_4V$3,KZOFGS&WO_!7K3D'D#CF=,
M5.Z[GK#B[# A,]WU2+-(3]P@@#_I15M/4_]Q,\0YIL*AJH?JG6PYCRQ2/*Q1
M0UE;H==M3ZCS/&'$]I03$=K(=._-=%XNNA&""$]QN/?+N ?,F*V:W!"YJMQ>
MJFP9>O01WI#QK=S>@6_12K,0&MD%IQ*O3\%(Z5^*R-8^9 !K-CR+KN]T0\?\
M0VYH$MWH8 #R:\/*YP? .8>-R=4U^!+-R*2;E:GME* 2PT;OBX0]UAT^Z %@
MD6W2<Q,&:K_A'?;'?OT"'J>6EL0C:UVCDJ]K>:/3J!/@2SY)/-,;J]] =^1>
M'HKEKHX2PM=/C%&"#8G@:NO"O3G8(+%)%W=7&TX<J_+S O7CWCYOM8/G%<D6
M>=[>#0HKOJ^]&5'/V49\CX%K="'>]+0MI6^M6NL[/-J-F.NOCO0B7\4G'-4)
M]/1 *OA![X.QD!&P+#'VC_.0+Y<_=.[.]*5>W!_E@,MM=]K^'H/1;!TCO?Y\
MR1EF[ME,6R87H37>Z:XN2O1"YPN"(5"XE6:N.CR#19C:OTD.67,R/Y5C0TF0
M8Q[D8F@@_Y2B5_$5:+K5'6[KV^C03<V=/UA:/GTHNC59#+W;+6,QP0@)'2]]
M(9&4'<::>BBFN!%OPV_W4E7BX^?)>W1\"*\182#',C@PR9EZMJZN::%]5U 0
MV!QGF-1;IB *(S70[77^=-2+].9-W3B?AU!>@D)NY<%X[*6;8LNON<5638?,
MZK)()]A?R>R0\,-8W<5RUD2^PL,+8H4UXZ&PQ*[;F;&K"]!G&+C"G\9ZW AY
M,)26&2_@;]2>]5L<YYYU;S!5MCM95_"8?YOTHJ"G/Q8<JF/?,%PI=70UBW7^
MJ#4<ENQ/M^^TWRHV61 \M2:CJY;PDZ '5PZL:M6%>!WAOWXE$3G6MHE5@#IH
MU9!;;)@H?"8;+^WQA&X4]_:\XM9@A]?Y2KY*YGMNY!E,ZI]7YDZ[%O*W4)XH
M-8 :ZR.R)$(J$02$:WJ]AC\;FM=&5.(O5@)31N:K\5I>R@[-#6W+X$&&! ^Q
MJAY!5K7(>I<L^\<.73T7GKC0IKR#.(F@7S&!3RG7)5[L/_-T6:<7\*#-N5@J
MM7SG3)Z*-G)G"M&']OT9A^>LBUU?YTK,J7<NN@2^1FG5K,2] R.JC)8VI=]@
MV[LHXR9@Y*GE:SMPEX9-%0WQ/N&Y]XUUM$2R*'2"=$]+1ZDR7'&"_1,->=@\
MPS?_,&[MDA3G[3A+.R%G:2GF[+#8SO]L&_8_^AYX&64U+ZQF+$!N81HM6P\C
M@N=A!7_:,1*4F\@,UV #KAM\4#,U.4[ LM^X7/63]CX)/71PXR18T;.> 5DV
MI?!4*M:73UQ100MAE"I?6EF\W'EF97(W^V<8VD!-<4;D_E(W^8=.&^(Y4':A
MY7L?H#6;C'!@D:4[N='D!EE\EJS-+K\?WMVS;C(!3O<ZE4\8]KL_-(4IWO/.
M4*"#]0>:(HXUWSFX?$;R[[)8=Z6YB7EHJV54)2D-5OR\+Q-T5?D.]9^L>FJ_
M19=%V\8M._>%9V?P DL&J^@/UG3JWL>#1NK52S!WO\1Z$NM6%6>Z&&+P1/%I
MY.ZAAM5B/?NB^B/9 <H=:OE=9M.7=#R(?:S1L)\OB:30=A_+%ZI]:M",<#O6
MGMTYD9.]RR')YB+P8II,G8BH!,9R[L@:O^Z_SOLP^0,7N[^#2D/*V(E-]GCF
M\['UFV!R]$?A7(V[K]S/Q1(Q1YT+X-%WWA-T$8M<CQA6(FJ/ ;D8;8^5RNY'
MN2 BL8(&OJE75\*,*1ZV/S[H.ZG$.<5*?H@S@R7"^UD\^?D$B=].\T$<9PO5
M' 6)+H#R>='/WU9'>T>HY@V>$-47<>CMR]-'\O7*J#8 WE-=YD],XQC3TMM1
MA?KL6 .[U=G8?MWUX8H_B[N9<(KS,"_J8.4(LBH9LK/<K#4S1(L=]@+>E%[2
M9^],M AW=,Z0BA3G'8U2O'V?GI-%+<UFFL+PP5GNM[6-HC0[W=N(PA>?+Z^+
M(AQ82=65N1O0;O+ZS)&NN8+?2W/Q7?M_$Y8IN88EL6 MSUWX^T+TPU.#M=CZ
M,DD4!!(">;;#HE/IPUF)Y<"\0'GJ?=M"*?6>%5KH>:''(_=T0C?3()D;JNY@
M>7.CT)S8Q2ND)F/IJ%"K!4,ETQPT!K]?L^D59]R,.)@E?!A7SI>5H'M";8G[
M-YD_;E#,%2A2/$VMP[[MW>B\CY50$>N**D&$(_FS/3D=]@2[LA5J9$W6HQXW
M(FW< T1;YW?V5:)F8AI"BALC&1RLK#+Q<)L_W+>#2OEA!N;BAH29F:PR_F^C
MO;\6.)>KA=([8Q^_LGU!3=9(E,?^3&K5@=X,F.9RJSXF+;"P&!\[BXWQ/B+,
M,K$YRE&&.QU3*%HD6J*Z.NRE87:U7Y]*5GE3YP1<CSX*1+Q@$D_E-:IT]Q,\
M+XF.=LFT9Y@30$$O!G!<4:AAB7N*D]KOSOI^X^+V8]&;O9+9;YI.L3:"-R!M
MZRIK[\3(IQ.;@3O*5LW5YPO.\;T"2,/W,YBG(UW/=I$T,SL)%._KXN<,J@A;
ML^J>W7P"I7EY!"$TW-:>&!VS;S*.#H7_,$3\I&FG)SPAZ#N%Y;]/% VE2V%\
M0A5&K>N!84ZY7H2CWNS-.Y&C3AZN/ ^;C$7I/X+,_U7Z[S_4BX)P% %X:53P
M7ZQJXYB_UU=5YYWEL*"LYH_0S@? #9.^SGTMRDH8D0;AH6S.-&N3:Q1ZR(J3
M%)QQC\/I=C_NHPPC]9P' *P$LIFPQ[\]WX:(+T3QE?V5&P9O)0\4B0F113!?
M_%Q9UWD //N/V>7_:X[I Z 7R.Y!)B(=*.;)R!H>Z.@W!8X!)Q5>X,$CASHP
MV+)5N-"@:^3"B!!PL,_13$BU[=R\3QK'N)[!B6AG;D;1B6%!E*N3K;6#A^VU
MJ &>YGM3FE[!6BY)+6$F\K_J>X;LCXB7V8L%L@F0"0K]BR]./X1OXYRS"DQ+
MY*+#M=J..(\HCC9BF;._RF!^;W7F3G4]B="*?,,JU.9%G^.AI>60FO$)(@+(
M<J,>7%3DJQTO;D)/19\EZ+[5,LP7[!6L%%(E=.E;T_BQ4"0@*VIO-M8'RWH
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M,A8A]LBR*[-=]%0=DQ[C!<$GP"CY\"Z-S&[LXR\:VGZP2FSP9T@0ZK+R3%I
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M+EX!&B+(A3\#NX$#5042U3/&N"0FUKY*/\DE.:N5C*#SB)S U.$D@<JJB L
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MD4I/%C_;>U!J9G[,ZVL]"A\--L8/K_DX)"GE7R+^Z%)2+LDEO7))8919%\E
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M@:'=7.G:Q<[8R\7(S:*"O(FN^A[#W &^@'LVY-_L5?JWG;2Y*\ :L(F&_H7
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M;<[OZ *_[.6[)^$U$?*-UN*!]T:\]QL.Y.7]11'TI9O[]Z$_*Z\7]60B^ *
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M^2TDD('O>4'#]>HNJ\:B5V(# VQG:2_9^E;OIWE".8]:@^UH$:9Q?=,_%3;
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M_VL(3 B66Z/G68::H/Y9T[\W^>QO#X68Z.7Q:JT4D]W(]&?'F]_(:0E U2'
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M7L<[22<>KK"#<C^F4V0-#K# XH!?1R+^!9#F]'7:RHG&QHER.0F]]6QEK?V
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M*B(Z:S/4[NC^-CWXH[R5"Q%DB^_4[E\O2Q<?OO,IIK.\//Q1^+6TBY',WA1
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M/V,%/M695W+N<M+R1KD/IB/7* +IHK<M=0!_DNR^\?J[2RIPD/<?NM21*63
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M&1=MMXUL1C+>_V_ZJ/\I9W<O@KAP%O<QT CF+%M>42,7Q=POC"]D.^XOJ:]
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M*ZJW?6)$.&^:5HU/C7]SF:P]_L<&P'>AP/ ./SA^UXE(+])G]^M7RKO6&NQ
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M:4CBEO!C)P.?Y?K0ZY6D:"_A7\_HS86$1R<W@F](_WH0+U)JD S,YU+P =2
MTIB"QM!@@AQD1CT]B0RPH'&O=?^9VTW_CRK_91FR_Y'R"[C==F*#=RRS$S^1
MW)8EERW00>K]A!@1,9(B' O_UQEPJFG$MAD9V/AY;NUP_7 @O(L"+JMB2)UF
M^\8&RTLNCTC#^7]H5L#_5M$+?]KRI]QW\*<N2"F<+QDX0X$5JX/HG;\8F5]_
MT*(EK1OW^N4E1I,!KZP5,G"CS_H/H]>_*+L?DY?(0%R?V*$E8;7/KJ\=?BPF
M[X#/ $KP(@.S9.!?9]"I?R'V2!HRD$K1.,Y@8E+]1D51?\^/9B*2\AXBIW+^
ML%6<_T[)6?^LY>^T7=_O+DZ#5R@)2RC.OO=7N)?]M[GH7I'.RT%I?!DG_C;;
M7-W8KTBPF #'+)&!8#YW8P+E+K./5$\;IGK]4Q,"_)]2_G]-Z?(+1/I5WW75
M/20# CG0O<Z#X9SAW&@2$UAG2^$#&K=+!EI)_SH#3ONW6,^,G@Q(;I)F(8>B
MWA,.QGE97:&'9I2W,!#2^,.0_6^*#NF%/(H[1^G:]$5BT!094%,WOH\3=#$@
M"8*\_E =_&<N?^)8CC]U^>^RK^ G2/I5X;V!E9+4-=#KR=L42*K%2^!20LQ[
M/H1C5\G 2\*_SHB#?@%[=:=(=E/$%OB>T7[-:*7.C3>@O?KK?VA&G=]UG=GN
MKXE^*O(P&C^*"!I\NW^H$OXSES]KSN$_=?&L;-X\ '63 ;,B,I#UT\C\]L,#
MR+[MY,M=A0\>AX,@0SQ?PA\&N&A_47526"M"=!Q\3&R1 D63Y'$2OI".K4]D
M8&Z8#+ ?_'7$7[FE&S"!U*L'-NZIATQ(U[10/5;\I$RT>T%A!&,SR /L('IS
M $YX7EMO=2O(I'?#M3,Y[DR5=G3O"0Z0?2#DU@QD1A-F1X*7.QT>@BF<I>C,
M9R=8&[(<707&U/I(D@$EN4HB/H8,1%-F(D-E,W1[KA ^13'(N 55%XQQ<^QH
MU\7)E=PXSA#+&$YJXA?*M&2T>69G=KY_9RPI[DSU:X&R)\>HQ_AC^BHB+VA*
M17L.(H\E5.11WJ)I'3-,P*U,[:] 2++JA,M33/#N:$J'^V53WO 5O"F><ID,
MV$[M[T%(TNJ$"V*4ZWN4ZW +RG4W<+48,;OC9XS!1[FF?U0)?U+0FI6',-C0
MWD-%>YYA+J@X>O237PYHJ'PU -=*D=+3B-UM\.[[P+KX)WH)D=QJ4R\(-GFP
M-OD""9SC6[;6&\0L5I=:F38.O*&ZF3I&C*2PB\8O@[:\=K^XG<T^'R?Q9/'H
M>0K[4_F=$E#=V3;XV/^C,G!C0_A==9Q%B+B?U>-G5^1(BD=-D"D[#(?U6K..
M*2[>+J(M7?G\8@)L,E,->WR#.ZTV]WB2KF8;CII2!OOAFZ,W/#P='MF<&QS'
M-CIQ='X6.*K/]^,=$J$DC"M>-<4*CDJ6:ERRS[T2EDPR^LK,&;;Y31EO56\J
MXU++:?"^H&W1[3W!NL?^Q]4'8R93<[*Q5%S@+ 528C2:]]7'J9D^]FKV:@C^
MZ$/,<..;HQ\CYJ"IGHXY=]LFSW^/6RQ1U"2$;A='D4[A9+.N1EWM+8FYZOAD
M8G>A!&]0^;:L_.N]%BWC',->I<LP)X-$_FI/U^4W 7NQ"G6+AW,!NS*LDR(B
M^9;\!9PT?'1(>NQ44\D,47;7].SLP_6SLJD7PJ:XL!T"W"&^GV16NZP)/%A7
MM"V<R>S+M^AW6N(M\3F,919CP,?E2+#1O3QV/FMFUG=YG^_NV?Y; L%_?UBI
MVY0XR<"+4A4'L76XY=>70BD+F\MCG.!O:0Z^FND'T,OS2J>PJ#=S8A5P*Q4/
M]A%WI\/K%Q?=URSLP!NIRW;1&*$ R P]J8>B8)/'_(87R$ G2.QIU]0ZSZ+'
MLFF4[-;4Q'>]@VI#I1G5TWI)_^CB $R(,(P^#",#:^6;;K\LA@\-UGCQ?(>7
MKYS^0^,K8&*-8@<\FY U/C* %Y?;?_];X$<Y)%!=TFE6>?^]\-L2N7\%;/7?
MKM1-S5D1PMT1>R=TB.SGO%1_=03V);=%%I(!IE0( QF83[>![HV1 77%TSY_
MNQ9^#]'2KC4=D_7FM^7N-[84M'"/HB61A?#YQ&7)J1@2+QB3_:T3'@XEW!;^
MEXEW^N]6_L7#VY!P,L"_BL#/DX&.X:\D@()#]RGW0":2RG<HQHT05 Q?3:#@
M?^@U'#5)?8*=A#+$#ZN"0]3YA"@ZFJ(73!8?!<QI.RXV9["@!C_T"66 Q&R_
MTM^O4;T?2Z=(OVG"G(@-F:E3+(#:5NPA[*+ZY&5$!Y._/J8_]ZD]P-_;KWS(
M1X\R09T*X6-@(D_BK-D1S+C?!:P)&SLWJB.BW\1>1IZ]PO>S+FY85;BUL9K'
M;>6.I)[%0*_32[,KTDS"Z!=GED]4:&?O=*^:S<V(/MXVPN1F%!;<8*KKSY:_
M]"1X+"'HLTP'L"MY#095MA,K26=K7L,UZ)06TRX/3Q7I80U2X)"@8HGT(S+9
MB;/&L$;?ESR^=&#,R4ILP:ML$<$/-G=.!8^G?Q-HF>(Z4UH3WZ]2&OU_L?>>
M44V&W;9H$"4H4A6D!P5%Z55Z BI=I/<2%) FO4,@= 0I @(B305$I$GOA-Y[
M"[TC-9!0 X1PXK?'..?[]CG[CCWNN/>,?<<]/_+G'2^#-\_[K+GF7,_*7#M]
MXF+:I0<]^Y6*'.X;[%L+M7(8LA46-,U, QYJTF)>2+FB@U1<H@Q#>C+.53=Q
ME+WO<@1.9_,5%U\!%IIE@-_V_ NFN-*_D=/44H<911TDQ64Y$#)@_:M:'83
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MC'25Q'^-;7=G.R#W>52.6=09WOALBKUU(&69^DTUTO&+2.+UI>#776QW)BO
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MR)+$B6/6 JAJ:ZJ:(M?&]I3>"D97O!*? SK[Q;V.>[[M!C-"P_3P;^QH^J\
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M[54OD!Y:[K9-*$J?KR[4P_^Y^6N?/5;\C=)W>:619[\>-VM( J1N91?:? E
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M2/</617\26YH98C;L_0D24Z(I)4]QD'0I>B\<(O*=/Y9:R?)M6 *>O1=D"P
M9))Y/*$I;S[KN+L5K:/[D2!3HJ3_R3/T7Z;%V<W+4+R#S!S?^G_5KZOAWE(*
M+M8KZX02?LG XC?Q[VS$9K):V+]48]C\)NYJ&F3<_]_E*0U919QQ9CZ\ OS6
M1>*C[-"4TUUX%59" )GG0X[>Z>[CI?YJ\17HQ0U3^.:/D@PPD=V,8\QJP4Z,
MMD9%:5!%#[5E7>H;K85WBH!28O'KJU/#P EW?<@5X.;?'M9-^V$"^%A07@%H
M=9V:'GISO@H<@$2)5&O.+"R]6CSMM<1_(EH&5?"%V.9B!\<T*Y16)&-J?>(!
M#/'&-X9JKWMNW]QXU-BVK(:K2VF]O+;B).Q=+7B'4XLZE0CW+-I/?^ *0(6#
MNF&D.@DR?CK9]8SK1FXTB]G+TK/WN_WJKYHI7R(G6/].>UMF1">G9-_3]U/U
MB%4TB[XTB 4R17XEE59?A5-@P0\=G+2C%A1-1YJ)?$S\'O=T*@AYGQ:3(VP0
M))%59#)6*6P^P0O2\,U^?-(:F+$<1-?$V^U1D&\1CLK-"!:@H);C9MP0;VX^
M)SXN@4&#%P!T;Z8V[_^N.21OK^\Y'MQ#Y"W+,N+IL6'+\'N(I.SM^#Y7HD<S
M\H*]@)V#WPS,QPRT8\B^!1&L:HFW>B=="NOMJG&^)8N-V3X:.GMKO8O"J2Z7
MZ&.&H>=0Y4WD/2_?AV$=E^7&9JJ.<=*WY02[=1S-9"ALB,Z3\RRRIY3]\TW;
M;.VI^OJ$PS2W>O;\*([_G$>@B)?2&&;$7V7#[J[Z5];,^'>>F'%W24-+[!!T
M> [YW*W!_;?6 @;/U'O?@X]"*37([FP*SC1FRV*IE^8?#6AK5"7JU7$1#TA'
M?\B\T%0"^+OZ;Q(_;UMD@-U;>9)=_4'+GCM5@(YI"E>F+-ZYIR\A(Z;O;T:,
MX5XRR[+Z3E#::H^B5*WX13](*;$ .;Y).+0-)\9O^BY@R3 D.WKA4#*[\E3K
MR@_]94D]/".QM^XL.M$/B8NC9%GC5N$@6S.BLLKZ"8?]1[%_GC.2Z>BQ!65Z
M"6$,9U(Z$+>VP,QCE6D]>^R,H6#_RJ_1(KM-VQ1 :<N/,N?(>Q<J\.[J[W#D
M+&$7TO;C6+&V%JOV3!EN[7TR SD\556_?:*#@A_W<)@O70.T[-0%RNBWPND;
M>%?)C7CYNE"3IV7!%E%_ &*K'($ZOS=OGM^*N@*L\D>X[S.(A?TIFV#$FCXL
M^1RO8+'0#G"%BJ]Y%L60+5>'P41+6*P5Q]2*1D+;PI)2 1R6@>U+Z!NPG96L
M,W%ER*XH$!_Z]R3N#3:BHPX89JY<.:!%)IHH1=O#A]VI)#%8G?*BS?=PKDIV
MFZN3*A2L"+,P[9=E:&89JH1E+>]3V!'BJ.FQ";E/L4-#AWU!%7?EZGMS+K;7
M7;J:72\S7619JR$HVJ6IG,?)7]K[+K&H5< 58%&+^%QO, 13T")YW._9]U/9
M0B1DW7@35YJE-LU%N:K5AH8V4\WZ0*;(..GY3FF2I2TDYKN6HS"(Z*Q;1XLW
MC(SL)7G*BI+:5Q94;8V]DM=5KQ6-!]]%NX4LI@,H?]K]R,V?VCRA@=KI.\\8
MM0L=]"_K^+KZ9;8U.B]>KRS(L%].BJ^/7TL>5:P\9%XKR^_%JS0'T*Y#*_0:
M/3Q69F7^&WGO'=;4VZT);T0%Z2)()TH1I"J]!T2:*%5ZB0I(D]Y"#56*= 24
MCH" ")'>07H116JDE]!K0@T0PL1W9LZ\_N;]OCG?-^<]<V;FNMA_L*]])3OK
M6<]:][V>52A]^9,S&[Y_864TX.+S=\XA6$\YS*%\V'J>*W/#&IP*C.ZFXGQ,
MIH#6D^MO<<D%.=A7*(U&J:DW)Z^X7"]Q'I@;OH!-7B["JGZ:I/PZ=WE]TD_=
MZ\5D9IM"B_?JJ_L;CS[% P=(B5W3\,X+()C1O^:- 'R!E#>Y(:PM23.B:?9%
M(L%>#W^\ADN&A5QPH.SZO^3&FD)BY;C6L@B:JFK&'#RN96T(LS$9#@4"R,P?
MU>]1QH+4OS"25:W4AM-3HOEU5?;1ENW*#Y#P?C=$.6&U]^ V[P5P^YP4UVR)
M9UIA@"\NLD0!;I-B7/U)-=[\0:5R12 ]+UETH.H@4@^KL!ASHWW<WJMTX]Y$
M9V?HK)HU>]D8P\L-*4*C"X "O)0.=<.UH? ZS-;BA;:LP"I@MDZ5#D<Z[$0I
MM]90L+'NZ*?;@YZWX\9:28!#/,BU@5_MNOVP:OP.9+?'B9X(=QH/&F[()L/J
MHL*C=J@1FF.7S"7;ITQS8WZ=DJ%Z0K[>*9KTHT&1E[ZK=;BQ3719I-)4U:R5
MJ@,42+L,OB%'JID[:VR.D?IQNC/KQ7,T]#IY_ID0\2UKV[:E+ I9&\)U.]XL
ME&AWM=O\=U&LH@-_RZ?R=SLW=4COZSR]WW,<2(0N>QTH _M+<:J/9AAX27,(
MO-E.>7ZS>F7NSU+A8;\_,AMR**^?IWG*Y2X:@=PT+$+(O.??"R<ARGC7C$_:
MQQ=P5%B79H>'_0UW/IE^7I7VJZ>_]XIL*<^OL$7(=_] -OGP8X$MRTSR@,'-
M/:"/3X/!D!7*%LBG;6Z%#E_DAX?)2+H53)@+;=8F;$4^>R5#XM.KN@S],7NR
MY,[AZ'>/]3:,<-(,FK9GDG[VP?K24Y(A97GB0L"3J7YU)8?RW@60WG0!@/<7
M(/(&@Q? OE?V*LZ/=XT$X&T'OXP[N0I]@VM4P&8USS:Q']E< /'6$:V;5:"^
M-<*9S7:P+0S_@!>N41.;^+<'4G\_$ [;K+H ^K@)I_E@2R"'"\ T]80D*P<O
MEWC_VG-7R!*/#X 2#(+L:6$M<.@+8*C4_,S\"HH7]P@4#9L%GXJ6S-G\NTWC
M^6MK;O,$<R=T)>YAH^;O J8WB54%Z#R>"Z#C9=R?DPE ?_;L+$3?'\:PK[W<
M^+,KY\KD'X,+O) 70+@*EGN_8F[1X *X0?*OJK"5F'O#Z#W:<A,:#*C>=5A%
M">.*0[//.*&[6S-%/911HOZ207-N-A7%/2#V9W%8V $6EY#"D447I4?.5*RO
M^S.DC19]T%?L=QM3Y!G);/3D[4R\@$-ZX6/"9"PAI1UP1AW5BUJ-K,JF7;]N
MYZ,TJ4D8]UZ!:=%Q XDQ] E@OQ5B? #H4\0@G<B@P1"N1P@^QY?L;)QOB=C/
M1T+FANM!;RZ ZZ^:>!>F2GDFK9*,6\(^Q')*WLLC8V :"?8\S7 )M/_>:AU'
M\L1[43KNAN8-_M+HE[Q>MV+V)=K:NBG&IBG/-N59X'])<:\\DX7UB<)._U9M
MI/ (,DG]<QHK8J3LX@"C*61=&+D K#_/37PSJDYO-WX=LWJKN:;1%EL6VKF1
M(]XZ\)E"RB4K[Q;K$(0#ZXG?L? B&((>?&",&-<=)*^BE.TLIN$6ETF\IZ>]
MH;8.H<,^0M/(W<4$E=BE##".Y5^7[\AC X*:O;MW_&T(MQ^=J'1G[[G@E?BY
MB>9Y(<3 H&]6-L$!9J/V,9TG84,_40QZXL(P*#=*<!CCG"6'*?D I;PYPI?:
MD)?C7AF*!%:O_$+EQ;EMQ]HWPF/*'C+.==M^0/.5I>QO\I,/>76/43M,FD0#
M@"DZZ""'8A)Y]!IM7B 1KO3SE59"9AA'':RHS1Q,\JJAMAOO,A5NJ=MO\AH\
M@+]QKR)PZ2.;%]>8/^==F^)E>B(V+*W.:U.ZC230X8[G*6)VON(&HI:!6"R
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M99(E=(T()3HT) _B@):USST]SWDYLO.SN7J\\C)U$0=U=&^^I?M\VH8H94B
M+"HV3V269&PY:_R!9X1CRZ# G,KE4(G#08D?1(^^CE\ 2\ML>'IY#L=%/SIM
M")2SJ<#P(N=H-]3<%F?42G\Z#YM.GW_2$AZ2?P%< $%D!JT8ZPXIZU!WU:K,
M.S=C)X4,4QT&MGPJ65=JN',HQ?'4U,&Z:Y:\\LO/+1S"@S4G2<B[F)5*Y1:7
M@/Q&QWY)*W&3]"<,Y*O6>MIW^ 3\IK=ISPHO2I.(1_7<OA'O<D^F%@<[0/30
M]$7RE>)\6Y!M1:)$,L?9X[N)5(0=$K(J!?XWE #:%1AU *4M3B)C(\7K4H?1
M)&T![[M5X!D1BRL W-MN(XKVL<*;+68(1<!]C _7EV&!G9B/JB"+,5KV@_[7
M5NQ@>6B)C\I7)UK[TYQF].N2I3QNH?*,:=-RY')??RQVZ6#-?IV1FU!:\>?!
M+OD:RM98KZZV,I E@KY6-U%-)E%-= 7$(G-C49#^ GB&_\.#O5=G@I,RNW,J
MK#.SYG,M'9*3,[*\O[AS*-S^7U:OT3V&,P.=\TWD%7#(\714BRC(CQ'CLCA(
M IU]HF(RW/+-YM52A-I11/8*7SX9[XU?B)8A_';RZIX+QW&C89$BF\VDC\],
MJ29.-.9LHF3$CB0ZOL@2PXU0F3'=[^=G*-KWP (;",W:UY;3% C#T7N]\_,A
MP[_7Z!)Z]ZMZ8Z:Y@TF[L )C_ZR]T:-EDA;OO:F/TO,)L<X^!.E."W&Q/6(O
M<:<2AK3"?<6=O^B[O:X*R.5E9(T=^-,0+.!8,9>['#U M!O9DU*?RR540RJ5
M8Y^&67N>9,2]/0"N8Q^48.E1@M%-3(M3[ZMC:-J>>]@-R7S8N//KZVO=:M.D
MG[&9F[/_EEGZ4PO'V/#5"P"NCR>XB<UW_GJ##W16[:1TFJ4O?;X17G).J?;_
M*PS\KXHF?F\RN@#8\R%'WTX0^8AT:"5.1;5U.W4?K@979\$RRF4O>1O!T)L7
MP!OLOQ*N_P>X*/%<)NWX G !G:<T[S3]74W&9*VF8CKE4?.#?VK(%GX%\_N4
M+G/U/&3N E!6,3_\,Y)<4XA272G%JK(>*M'H<ZG^:PKX_PTN@G"DZIT&E&"$
MP_9BHNWRB(".!%)G8.O%,X P40U)NP@"FD3A-K-2+75C(D\>=5\=X5!*W!A;
M_%O=Q9>_U5T@AMS_6U7'#YP4ANFST:;KIMRUVQ^\A$D?QBMR-EKG6]]RV R*
MET>F_8CK@C&_&IU@(C=7(;))J$JX Y[WO1=0*'KP'6_M6.+:YR(@5(?E1=":
M15\)%7+9A2OMAU/,BF&;(\O,685L+;%#!^FR1"K5PU68IA)UPTZ7,E=GZ:3I
MK/S3M&8EP)NK"QQBCR3].%ZE]J%FK(: 3X=,Q2TV-.'8A-GZ,C-%IOV/5P(X
M$8S K*S ;(>>KTWJ*Y?2M)D/!+^D7G\]8.CR5\2CF[I98DPQ6E"G-JD3;!L\
MHW(ZA;JM&N[ZI8C(I<?JH(_%?J[I^GR,\-<TJI&J\^'>5?^N@2C" 1QF2YJB
M8W0I*R4*0.].$BF->902JL0]&A$4S(]=?S\^?O5MT<1H&-&EANS0FW1IUNTS
MC#]PP[[J1=ASU"!##$*X5_GIGA Q.,8++TK(/6A2>PM;-C(_+53J:C%GY-A"
MTO9=Z]MQSRR_.1+2S^]#-(?D:3QB[B#,AN B)6,O:QHC/R39M@'1EB#M48,!
M1#9YP&VL%)HF+>ZU17U#+'\[4R.G$<//"X"TTU5M/2%8.-J:]E 6+_%$:"4R
MMO)Z1>W0+G]FH*ZP;3OA(,A'GL9?1=,N1!_#"2\,%851V1T+VV5QQJMPZ-<L
M%SB:>:4XEIUYD1$$Q8I;6JP_XB;LP3/DLR<F:BA<:8%=@W+>LV_N A;VC0:1
MEA1!&L-?+>/XK#=X%1=;V\/0_3W%ZXD]3I_ET^5<0NLT<@UC%0E_GLT?L8_B
MMVCJ9R8D.(@--U!5/L99'7U%=?B7N7)>T:3\*\IG 1\2]]4Q/>CK%A5CMUIC
M^^;>UD<ZL)DR+[^]PD?T*MB?=X.'FS "8XO:F%HX>L-WQZIAM"S"MR2P484P
M5/M\*&E01TW&F2@SX*<YZ_AAJ9-RTJ.A0]*#V(FQR?&)91(OBFM:+N8G2H!;
M"T%-UN "+LC!XW*\)FVT&H=.KKXRB1"Q3(@Y!*TX7[!2_OG[(HBDZL6.Y[X
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M]] ],="&W/L]D47KX (XNX*'6'E6.91X4!8VA=K'O09A$^OP"XPGL=L8[PM
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MULS)*Z7T#L8=W+R6^E$UXY:_>I@:8N77HX##A^X)ZNR\P*-E#6^BRP&7KVO
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M:-X^H[[.MZ38D5,RT4"@9SH#48;QZ3@3?U!5RQLIYI2TW#;M+7EJ#0KSORD
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MTD/.,G'ZJ14F7 "R@?#G<%[1/!*/I.#JH2W+PU7]$%VO2I(_CAA>-J4__5W
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MZN%^$/A ]6C^?%L.&VV_?L5E3Z61C[;4^L.[8B7Y\<>A8Z= )^SC*>,;71R
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M^A%C'!6^7+FQ(?5*FV2Z\@#63''V" 4=SYWO HV._O56FV1TM!T"OAID.'[
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M4R!6Y.0N?:NQ[Z_64?]V^PH'F"WRY1LY*)W?UY,!;_AJ_'=C:F%U7!HX8WF
MMR!P_Y5]_%60RM=P?^'/$1YD]O3B # P!KR&?W2?_.__[U_4E+,]DP7:RI-?
M_"6*8M<A;Y:Q^0%-_\TXW_4X*2O@"WJ&6JD'-B+$O_MVH1V2]&'R3$D'[)U)
M0;(^%$U_!OW2R1;VL!*3;/$V7V=>U&X++PG!LFZ;^R_"2;?-I4?6/[^1(G2J
M::QY&+8\/9HV?0;ZL8D@@?#9,= [N/MSOAQ2TPX@$,#T.2UK,JD;N'U/^KY]
MFRK& 374MW+M\&D&^P#'W:#[G8.A6,\Y-+2#"1B1@P-$."Y5-%MGQ3G&0PG'
MD5TE7CIHF46'FD_&*JZ6'#,\2@(N%(44Z9>"DN_@;"BY]Y6P:_:E:E:6=)=C
MU8.K;BILEV,GF(BORNE'L=$L:B.5&07G3I&+ 7?1^]@[]2053=PB#M:S'(!K
M>@.W2-Y:$1ZSUK",ON:JJ1?Z3JUKVL65':GT'TT3E6E_<E6YJ?C#!\KO;HX$
M"OURQ;*@,[/1:491ZF65(VP9VK^,;0?Y>D@EVA*GA^IB;+#RON&7?E<'MU+/
M\""8#_-1'7B^SH>-LA^CU.1M"I<Q3HA>IATY%\47*;&!_UF5WM_4ON!_JY"J
MBH<'U]HNX=K_*=U@_V&76$L *;1KW0<'>(7_YS_QXXW_;%0K+L3<D2B"WB%I
MU%&BC1CZ'Q'0_ZU+UVQ(?'(V.#O8Z-,"0"JU&Y^KJ]O 1_R;<NB[0!R 5H.C
M?<HDC49/M/K=^$FWNXTK;3O%E[+6Q=&?+BXJ)'%*DCZ+E:'?:I+%LS6-5EY]
ME\T=8NGF^E'3H)$U(![,ZZR18.'"IE[32WW49Z]K]Y4CHT7)QMSA7/2+B^.^
MI]]-NT"B3ID>-H O,W6J9VQMKKV[L"A3<<S,]_H>!9<$?M.@=,+A^+,_;YA[
M3FH#(A\E:M V"&K\BT;(ZXI&Z%:"Z@;Q?5AV*=X$>9'CE[<DM;#7\:CNE][A
M]KE(90,]]=8)E:(+:9CJ$QT#><DD]H5EMOQB*4&?%'?ER,Y_OJH*YF$3$P[P
M-1QOULT3. #ZNP3XU1K,W2*R!TR]07$KH:3VF[#.@E1439?I4?< XS=HJ\DB
M_)S!(Q-S&X8#1.8DG9#;GHK^U_SLO]OUOZI<VK^];A )<4;M1S0 BS;Y;8U3
M)MDR2'SHNV(UVD4)SD:6D7 '>#K4#GQ&L0$^WN;$ON>Z!@X%TF'4B[T/QM50
M=(4G]29=<^+C.RB5,FVQ1ST%,C1PS,V#<XXF0=3U1+Z0O09.N.&U[+V.*2R'
M4[!'QV('A78Q#G!M&_QJT_@C4T>\3>%4U<:3!=5EN9V?1%!)0*UI2CN"1G61
M@F!+,J\BBF7OS^U"[KMW))K%I9EO54M#&L]!)E>:4;XS*:G?HA8=7IIUGK^(
M+[)Q+YUDZ"RXBP/L?T4'NLVQH#N7I_>I[0R\)$_0G UACZAW7&[W]!,PDL:W
MP(L<EJ;][]D"Z1X?P81^7[#";SW$ 1H,E(BPGL?['Z15\KQ-7F"'_B_VWC.J
MR6Y;&XZ"!%2((KT%!:2#(+T%Y:$+" A(%P$1D-YK*%*D%P&E!>E%B/0.4J3W
MWDOH/:$&".&-^WQC?/MYSSC[V_O]SC[GC/'N'_-'<L-]WRMKK3FO:ZY9)FP9
M%OI$(GI^-/@K;L6$*="9LD8LN3SR$WS_78W8O?XYRB=[4H\<61],>;AJQ[["
M,37P9(DAH5KZ%GD" G1_2XIBE"2GV#!<7QH!>9(%Z?.\R\9:NO<"N1$F *6P
M/(!F&E:.%RJ\Y:<RB[ %D!*<4&^+O23X14[^JX\B\<#!2<"^-9"7.8+\E5?\
MSQ+^@Q60']<:7R]"A-J_PR185WX]3!;@1J8M]0G1B-=NI1I=-+WPA)J=+,OS
M2B<?(_L!AYZ8GFAQM=_"8TX/J-E31G3Z.Z<$!^RTN^;*BCR:-[('30B:2-,G
MD/=N-M_'@!%$VMS"[12.+SKOD'ULWSO6 <!^ZN"@!P0UVK'P".EV"CHE^':*
M8X=9 U=]CK:S:WN7VPZ1_:,3]= 0FL;31N2EPKB@*.9R-G0Z)_YM"8(^1!9
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M%SN!E&S@N<PM-?TP_2$MZ_/*CQF<Z?*;)$?5ZQY5*A,S")W;K#SM@<S8 C
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M";?RNQZ.AUU'&D@]13M$7^'&Z+>**,HO/8&@=<@-Q3E?Y"8DMF0SH)D@E#%
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MVMXPBN")IZ->Y:2*.RW,2->HRF-PVP%!VY(=D?X6$6.B8X?U5WGY!#_\Z#<
MO*G;@.U_5OS'WQTGTO^[WY O].+$[HH(9Z3^_+'E&E"O?6Q<L&;:O)#OV3QT
MG/Q_7$_K_TLD_I3YY5$=#EEU#L=.0\6.DX]+%UNRMK#R"3@LS-",;N[#O?B1
MVJN_>XB)J,Z 8F_3G-#IC\+(FS9YNT3;Q=MY>',NIY(J9*.6\[?5-;0M^BB2
MTIG0'@B"5LGBGE3%NX%\?4U77[P"CQ\U@E71*V^&V<:.4[ZLWCD2+.<,6&@)
M6W+9=SB8:.34'#[>LYJ:W=9^.2\[@!\>URPSYDO>8>1-BRSNRUFFG AS.'PF
MP@A=-(G>T;]44%O12PV+U(.V>5)=)'72LD1$\BK4Q,D,EZ2]!'GS.)V''847
M#9)ZRTR::I,:&< 2158,2]N;N^4+(&F>5WDMS;=G:_BOZC8MQ-^EWC@^OSEI
MF6M)XQKYP>9XEHW[+2O+6^GZZ((3B)YD]D,D][/A(DUTM P,"0Q8009':1O&
M60E367_2$:':#)PR.UH\+*D*XR282YL>I\HO8EJ[!N#(3M=E,72R%ZIT$5#K
M([,\&>2B? Z'"\"%UET7F:XRM>9\_?U*,BL*!)GC-LWEXC]F+[Z$ITAQ0+L5
MQIOWHK&?E"Y4:XMU?C)039RP5]++OS@JR>TXESC7$;DA?_NG\\TPS9<)4SJY
MVW)=\SA6&.-2?>6HMLK9B>5Q?^S@BF4>75[$8[M\R[A&N.(+?"L&,[*>SI(-
M$XPD()=^*0G(,=?1^'Y#X\DSNON:1#7UF=N:6DP]@Q1(XU]3 OT<Q+P&U5\G
MYF_*NH#ZE*+\/\<.N0%'HTZ:OV,LAO:*:2\YV ]XOJKVHW8CU6RF5Z\ &%GK
M;9P^D^ NZGMWR9SH6,J2/'R*!SM5X(  ."+S6F!W]/L8M)OKC/=51/!P)% +
M4FSIJ3+_A0U!NJ;"8+K,2V+%((727S &>FGR)9\N!13.K68P^:FZXV5<Z S1
M=$1;%V\FZ:GT(!;<,<V??0;W8_<)\7TXO(BE!I7_$K!8O#>ZWTD:A+>X<Z!M
MQ:K>/>\LF"/[G%O2KO;HH8K;<EYX0EBA0=N9(G44XNG6-F@=](U\>P),W2#L
M\(ZY0;E(\>=Y)M]Y(&3WQ[94A@]GU7B%H;!AN5!R3JK.DY,;G1P^KZ)>709P
M?H(M-0>MQSNJY/^$U-+UR&,ELK&56:FLJ'VS JW<:X#KL:@:'>:UH;%:O/)0
M5C+58\/RN>[#>M!^/M#/*WZ2^6VQ-S/RCVN -0/3V+?W*Q%O!X2-#-+OQ'C>
MF)V$VWI%TB[G!57H4KP^QAF:ON):LWJ[)]%M^ZCC?I=Q_OS/'F]>O>_N3<]B
M_QM^3YUA31GZ=E(9COTH6;8VD2XF@MHKUI^^-$.55 ?'\\)==1'WX!M=4_AO
MD'WR,DH/U,/5"K38157Y#8EW4MSMN-]5U40HWNTRC07):3R17S,60H=(CS<Q
MN&>R+[D2QE%SE93&++E*E@'QH3+&RN/65U*#K\J]E'?>EW O'LAS! -Q/[]2
MFJK\JMA88^:1?/IF,_6Q<I$@=B+8BS,'S[>=7ZYS7&'5AW!E;$(G7(IO5B6W
M,2_$-%6-(\&Z0,<BD7#;CV[_;(7AI-$-:=TZR6\;NC@3 8NC;@&C+TJOK/83
MD'FMR08!<N5Q)RWXM-4+!)!I #OF65$C\[YY;ZAU0H5'-8Z#X<]9>[9[]F->
MU+F4VVD^VAB,<01*OG)A15YX[7#4);RY'1M N!3VQQ]1@G^\S,^XI44%(&G-
M&+/+'!7HK3]/F.%\;61!>.-M87:J13-YZOKZOHU2<@XM6,I]L9422S39\>V-
M.06!.G=ESUT/[KCG#[;Y.O,QTMO'L"C"*DL&>(["V>T:2YM4D\&2T=$CP=GW
MOF+(Q?!U'Z'YZ35G+IO]-\MC+B>:Q_V4$&()L,M3Y<>?2,M)%<(4F<!Q/VY6
M.JGH93YYE0T3I'X_R(OB;:<W[91UYJ942V2S,*EC&S@WI[=76&(399UR=$A>
M;>![,(O>D0M"-4FJXG_P_"0-SSZ>!\DBYRO@>5.STQV4SB7A1^1TA_.JG!LP
M_ X7WM +_3>EUH.0O#/'\RM.)4=5;I9O"7J.&N'Q]1:CSNJR#NF?CH0CC[]*
ML*Z$=^TI*LQ]W9O%-Z%C  [M&UP#R@UA+<1D$C-1U8_PUA SI/+/?2VNA+#O
MRGP%K(3.?+FJ*S]R2N;4Z!K0I?4ISO@& K&WC*J7(@G1;JU"8MY^'LLOXJ%-
MG:R' Y#;VZF+Y3KSJ60%\ ][96(T;)FUJLA_I:7^9PHY DPK(!2H4SZ1&7&N
MPW?._P-X4W8+5HA3+/:3U1.N]9FZZ!"YFE%>36=-'CR2_'F<:>XW%#WL6=<J
MN%0020<BVW[9NUNTVR:5:'2<X&M(V3.]\=61:F/VLNWWH8B*DRN)H*:Z^3V/
M,7!.IX^! ZD*7Q:/JX[Y:D/4[N9PT]1.6@U977J\PI0<J(!*"G6F^JAG6R3!
M1Q*;*@;*_,&HHZ*DE-=(X3!2LN45+S].?K31P?U\\"4J]?' .GL[A?7=8*&[
MY&VUG+%S9CJ2A>XK[3-]H%NGI?;(9A#-6T&3B#=!@/M[NIZV\?G6E(\65<N3
MUS4Q? 4B%^F!J,PT'OF^*>UV+]E>,D^UGXOG)%;-)[O-%^1>9J7,0PT:;._G
ME<K2EY"R]L;$$D"G99&\QK''!*=;-ZD>W#(%;,3/'6_]/(-+EWB6J;K)&S'P
M"(Q8=#<]'%X;$KR<Y_FP7_TYGQ7]^3 /A0_NJ&@P17SUUO0RE8 ='EC0<4^N
MQU.[;EQE0A^>E*RLN :7SDU9E_)(S,VJ8)'4,N>VF""/X.C<[N_60GK.\B G
M_G90KBH1!B@X39!#_MAC_-$R*[X7K&7^SN735IO\+JA/@13&4RZ[,'K0X>*^
MT2=UO5D9<TOBXCK"I0#!* &@N)8< !.D;,"?]/3#"7MG' =KI\L)JS]T5788
MLC,,2?"N-M9PI\3^8?@ V_C@7$>5:5F>!(2P>&9$CFK&ROE L TAV.#Q_<IE
M8]IKP*K%[[9"7=!-&]V7Z(%4'>2T\%_]=)YJ[;SG]P1A%\M7LA[5_\$%,=BO
MR]"_\J)._<[V;6\^?K*]B*9EO0:0ZX_G;EC3C7%RZ-3-7>1:9E8'K:>_"F.F
MMG"]72C9#?^*?>@>#"9%-R$.IWMG.HKP[SH=<6RD>]Y4A$2:+.R(Y68#FL?@
M/'Z;K&DP\-=BG-7#2$UX:PIH,(-L\DB%YWMJ-&HWWD"\D9X.Z=FO6I/S#A03
MM"N*O$KE,S#WAR/$WGW[KE C3,(8+GI9U M^0?K[R"GYQ+,XS_)T1CO-SL3B
M7M@"/F&8)!!>(*FX;]7O.& P\F$_AT2![?.)F8> UZHLUYX=HY9ZG*+F3WBJ
M@(UXQP*X^=(V*<MJXHSVMAUVT.)<33U80UQGU%GK>1Z'5?MXUAZ-6V4$Z-:\
MU60Z:6G-)(76&*SOZ./0N4I[!"6G?_1GDO%F67+B^;D)CIX663(-ZM7F^X(0
MNL?U+GF;$V>'6QJS'TUN^26HKK41SQ)=68LO84.*MM*YZW#\5*FIXM-W0[Q!
M6U2!'?_3B-C)P'.=RF&]2V.WQ Z&UJ.-#X@&W:640?*=JN 5;?=CD?$75=:I
MY0$>]+5 :M%'U=[R5OHM=94YV?CQ>?UD3]K3H*[/"_,Q@)M5;/GKGAXTCMS>
M@U^/Q2%T:-MMY316A?'B]5B):KO==>^29QW4('O.3= =M?QY=U,UF+8NQ16B
M#_$:4S4?/V[/=Z[]BURS8' H[)4/[+<*?FKZ!;6W7FNZG)C2UBMN?-X%"+CQ
MU&8#P@X\U_EH-:,6<3(OIWRE+#N>5Q<#&+Q*WXDA -[.<"8_/B'_SG'('<$Q
M=!JMC5-H9K;_Y1KT7U5;?@LY\=ACQ(#[LY8X(6E'>?6H3+^'XR[B*K1*M6/P
MG-?%-EG\"KO22ZX;M9M 1UGO>63N )3>V[P!)3C&/#NKR'*T2E^XJ_#IZ?;3
MV&N 0;]VTC+E+TD-EQ_-'@S#"C?UTQ0DF!9M$8OH ZLS>$@Z0062,GA2]5.B
M=:U^7UWMG4#.4X8>(,!'3>,]WO?_KMC/?SA65 CM<PUX>(Y3J./-QW]Q7?_Y
M"V4@=D]_V#<O(>H:X/D-1YMD1M[_0PS\'Y$C.PIHUQ;E51G694OPSWFM(YU0
M@NB\<P9M8XPG;M5= _Z+@FSS2VQ6ZBN29]2_Y,I%=N8S$>1D^DF9CSG/.RUW
MAJU\Y8][OE:\S_?Y*XD<Y'Z,O/'09,8TQK'L/7#6V?KC%Q+OK^2?848.T7F"
MVSJNVDE(*EYND]J/J5_6(\0V-JV_Q"^'!)K[]&?F0W8'.:*[!.WV'O)&TH5%
M*D#F&T&\*.@OZT72UU))>;I741-VB=KO%ID#+[,BV##=)W1AVTT/T#0;BMQP
M*X<O>8F2B<@GYPDD1*:;:B]T7++1\FT7M,#1BI3W9O3,G(V=&*(RJ-Y,#D=X
M4B)'5[YZDK"DO"OYBC",%IZA:!,OXV^[\C98/K7,C%1J$W -6!G?'>^=]Q9%
M)JP=+0QFR8W6'[QEB7WV837N6^GD3"[)'81<@JDZAJ0SUAN"O-J(:'@S4Y7!
MH/R:Y5*V'9ZJ^-CQ'M@(^].'<U,/;FYBF3N34QQ9H3W$.A_%?#L+2?XV+'[#
M1"ZI/+(NB$Q=-_D?B3=@^.M68W\*:*BT30\1 N]YXN[V.NWA/RWI^T]%+ANW
M&RC_^BC/1FTIME\?'2.Y_4^MO?DWY$;))^8/4=]B_>]^YR>4C'1R:P9YLT*9
M%*5"/E#72BF^;_[C49T5>^Y$JX/&/%U.<YL:<%9J\UCATS4@-ZZ;$?,UTKEJ
M(G'B)1=%%>K9[:LIA'2AE-^KL9>K"[M*?%%_*1%TSTA7SXIB?>%T@O8+58!I
M\I-MA:T61*&>NY?LZ#X%HE=^="_/("B1UDR.>FG)/WDD,VWJ>_5MMLR8/BCZ
MCP;!:\#SWW7T_=2O 2C!@EL-0C^8*5#R=_DB"^BLR%]Y D3(6<AF/RBR_-"Z
ML_= <6Q-UX68IV=?UK#PC&+K(=X0*8C<-TR'('XNRS1S2\\@ZL+WJ\7[_2?]
M=C<[7GO2W4@N=["YM58_.]=&AZQIZ^0(UF;XR$"L+$MYASOBWSU> -K*L@R_
MH*R 86Y&7P,^%8>Q'TDAUJ)-^4$D[UW[:!;E1C/?.-YUS<\&_]1.(]-H[(C3
M_[T&6_\'E'_]=]*PN&*!^>0*.[VG=D7)XBG[YY/-D:2.B*)K '$RY,]M%;S_
M.NU! ];>J;P4_2WE?\ML2+'Z<].%Q6@L/1B9-= +_62,>?&/>6/_IGQWE]!=
M[DTY^5&-(DC@7A%]9D>_:O/09,P&*'I:_(_<)QQ$[NZF5:^O(FX\<L#SFO3'
M[((\4XRHB!;S1.._(29MV>:P!G$W7R[NRBL>ZY%?MQK<8BN"0M0KZ%;?8+7@
M_Z_.(8_U0,!)ML[Z3;W@6ZZ3H=+6'G FQ1N,]Q-8)0) *WK'_W:FJBL6$B8A
MF3U/:ZAL.,JU#[C[MK8^2KAET[Z=3CM33)FFFY8S"]#3XT@H22CPV^W_]SG&
M.40W@B<6],,_F083QC3$*;1HD=V-4UP"B/:_'/66_[;S5$+,J#S/6"F\-FYB
MB\7<Z.M#Q9\9Q&(<)=\*7EL*Y>ZH-U:55^.S)R*T(F]($KSV?S'J$OE4-VA]
MY(16>3.VZNG,0%EAU=. 5ZD,L@##?X&/_X'@XS]!_N5^^A\@1K2FE]+;R9GU
M.#H&.N 9)R2QV9^1SEN\E_H26*MNI(F AU_ 0R3DG7)DEL)[-Y=?=]4H3LO8
M1AI$$$8_;W?9,SB9W"/W,BW?2[]54[V8UN2"4IG:B6@;Q"&B UGW (SW!+T,
M;UO]N@8_89TCX36@6;#< >6D%]V6;%0$](/OLS3&.<?-B*9^D2C[PAP:O3#G
M\/.R<1-O/!\NBK9#J3<Q;NL%I;P/4;46&>\6-K)\J\H7&1YV;/7/60[_&S'5
MR=9)P7S +0>>46PK#M]EKA:S>[_O:49.9_TI$4_^SQV"V#$OG)L(+ZCK_M0"
MR*/J3VEZANAKP/+P->"VQ&XU&G>C]M;_M KOH)B&![A'3?1B6\NN 4)PN/4J
M[^^6URZX3S^^-_<7[<P V. /D/".-'EU5%-6KG5!CNX6A:+]@7WH]I*</;]R
MC-,FD#7'S!I:8;-:#0<&.[,E/W&@J\Y)RZ8?3/QHVHP"&UL!+DC"SE=DKK(.
M1JX>HB@^V9TZNG:S)*ZZG^]4=@^.,NW,-!XHC7.=-'),:HZNZQ;SF)+*/CH#
M3@Y%?73!OR]-!_VU2&Z5#D**6XG)=-+/)1$!8H>D?K9$24M81"U%6PV@R0N,
MK18 R0?J#>G[RP=K?>5=AM%WYB8_8PQ0&Y\J/5P@("LQK08:E9+<'3O'JD-.
MA?MIFNOO.!P;D*)[N@NWT+$K8"*T^]8,0XB=Q[M1@:8/B?$*;O=N4,OA_<@
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M7ZJIV]>(TWZ SU-9]^B/D/?6]*I8<=[[6SMY'M_)>99]AMDAB\ $ZH/XR52
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M05\9K6886;D])5XVRJAL5$"S>?9WS_V%-"4_/U837U);B=T^L:W*N3VZ:B)
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M+;\$X6)3)\\?0_F(?[:"L8@Q'4X8\VE]_\CC^B:NDO;&U7&:+V)8'G=0&RB
M;XEJJ- BML7Z>]4%YR_1;#@F<D[V'P#J&8>D"R<'/-LRR2<Z][%Y]F2+O478
M!6XN4B92\"KPP5WLZQ*$89U @][^E>LM;<FIR-!??)P3"[KG-[P??D)KW6PC
M#<(@GT38/#C>&1V4YH8.O[4842*U>-_EMP:<:*^$HH7T1P_%AO'>19TNY:58
MZ*JEL=S:H/@,&RVCM)N6+ <,#78%,3H73KA^M;M1++W:Z=J'5!MM2,+,X6/[
MB%@_?F_S'% 0@U:$HE%MLTRX)H[2-QD%:_T;(DRS4GEQ K4)AD'\=)=GA*?H
M=\#\Q57#>-8B73W4BI&1Y=&5YF3?Z6W6B\S2U#&2_>2!A%Z3/= 8;',4<G9Y
M;&!D$4XF?7'1GGSCI.QD)QFKO.IW[>'^4JPC30Q840)O/;E&VOQ_7]'E8UV*
M"A [!YATUP;6'H*L/2UY+)52V3SEJ*(:6F3H5#=\&-:2HD+ ;):2+PKML9YK
MTKLB ANG;L^V'FG*S0<TI=-2PB)U)NU;U7!*A]XB7;^:J48K:JKVV3\:RU=)
M Z+!RQP026R9<X)8S$,=19+XN.4K'E>L>\&WO3A+,<-++TNJ&21KTA5=R5 B
MD<F-RU<DKQX\6N(P)6]!AJ>Q:9<,[!3I#XM?&-)Z%16Y8!07?D:N"AS017K0
M!5]O'$LJ[(W_P5+YQ7\2.J*I9\8O0@'RLIU6?M1.\0,RD2$8G+QXETU\@L6"
M070*2H<\N'NB30-O K'CDM6#8?0;[=Q4^RI.SG8Y&F<#G2 <EF_.2W@A5;Q9
MDJ8A*ENQVYY6Q9RS+MR=OY4D!M9(#5P$O$8PAU_!=Y6[5'^6!?K37I8>&S F
MQW@G1GB)6G^?K*$(NUCCIWN=&MF:Y=+^0=$CG.5X:.D<P,<=PS8'0<O6^6.$
MRSAXRV1K#=S7Y1$#@U3,C-TS4=38;VIE'9,/<JMD'"K D8RGT1!>/--PHR9E
MDZ;LLFZ,HN%2D+I'\1JYQW'(0FI07V2#2%&Q]//?2JXGJ4V=-R^_[:@&;6\O
M19*<:'_'<^%2%S?'SX$%7B3TC>+I4>6WI=<[&E>_P.X=F9!!6571M\-MG/MW
MN;-D>EOA'N:DS*@W8X!SWY(L$Y(5MOQY$XDELI'LJV-73Q_ .D1;30XGZ98/
MU\Z!_V1?"Z"EFI+.@8 MER^'FW0E,CW1#Q[_BGS>>*EOVC0RLQ!P%T<5%%03
M[LP\=C#IK*P,$FB2MKG#%'T.7! XUAGTH1DHDV%M81"VN/J$/RN(_;TLU?/H
MU)Z9SD[PQ&(U+ Q"65CG2>U6X<234W[!1L6L+_'>!WGP(R;N!5\9-?+*!%T<
MU9)XT/"$1:FA=[13N>TA$SXC-K;<*)C6.PCPIB^T]G +*<L_E-'>D+)65M2;
M/I3Q9>_<(K_=H(">+3M!M'N+ZCJW&&^&"O:<S8F\0?DD(U4/DD'^L\(8[?1*
M8TG,#?^+G,<JC]*T-A@AMVC5N*2QNWJ$6[C'B[9<BP\\X(%E/'"5LH19SU>,
MT1D]5E_)/4E3NUZX;Z:L^(+]1\^!99*\<V#L!_*$ I%\#IB#CN]XA)SY9Q%Y
M8+'.H$>*II'%V.?6D-Z$F1'US[2+621I\8NPBV!V7$$S6*0..?8 4:+?F5MW
M[QP@ GYUC,BEJZ%KN7OI=% $TUD6;/G9('*+$W)@,%8Z]M7+%IU6N;A+O8[U
MH$^<7 W;[W7>UY06;&?N_BP9+4N!IB.HN"#/O)^? QDZ0J=/^=CY6GH#RM3N
M\[*1EL,:Q]S0GUIJ$$'XB[1??TR>)6',XWM\WB+)T!^RHD9S<!GS:C@U+P$L
MD[FN4&'6_G9JP[K-U>)ZDCZ-?E_W-=F;.#%)-72RO!G$A5M>YG)\FYO+7F%4
M\V[8"4V3D<B@<Z@9[1.6.$NV0-.8AM<=2VQA)]DJ]R@NJK#3:<A2&3._.979
MT#?Y>@9?.JV%B+(2^MX/[+0[ICP3#8?_JO\5!I@IFP9=3:F]YZM["#XX(?JZ
M*B0(RJN)B<+"L+ PP0-(R7$RX5?XK.MVU2]V#ULPTK/<-4Z=/-7K$4Z?0#(B
MQKHN-CJ\7"];6#/5S1G<R;UK$YMTH/]OZ=?_61=?&]&>C?A>2H+C$98Q+T+?
M[BE\>/V>^ON":S%*X:(R[UFQ\<!S9Q53B^57SJ]?Q0?+D>?=\I5^NH!L/Z.1
M%K?,QGW;\[0^?;E'&+DEG2^Y2JEB^'F\W0G%W"?!SE"+F6OR>!<^:'D4]=TH
M[VRF3ECRDDS)5A7IM/GZ9/8H^!(4I%T=XUR2UK3,_;,D^:V_4X<F)<+8EZ1Q
M,5_7I\^'HA3>D[+AUGT.2.\(RIK@@[_#]($]9-#)I0(,Z:(]GOLDD'4KO4X\
MT8DM<-_=+,)IC*8RLNO1%MV(F-;S(7YGS\M;SE/*M@)OF90S9+_+0-G[G&8+
M^__G2_'_4<NV19\2'N\3\:@ MJ9B'/L/KQ/HSB8KOYVI\;$3#A^/$$*R!OY5
M35%)_II=Z*W3.P>XLDRPW<=C66/9D00:D-J>] \DCAB)M!'^O]3/X#\Y?N$/
MZ_4\!ZJB"-W&1\9_+XUN:Y";T1MR:DS\+[1YE?]E;63_(:V \$!<Q/$0IS9U
M]2Q@CLCQE0RT<-Q.V@1N.H]_:<;C7W$=*_T]F]K8V-]E\N) 'T6XK(R*\?6^
MX N.,.6SY;?Z8IPB<AW>7G_I?WA/Q/]'UU\[&*__TRDC51,6$03^H07^[^%?
MXR]Z JJPZ^Q"_N!@N[\H!AC;_H-O\('@G&'-45("!!X8YE^=GBL]?&Z%4@I4
M<;M/=C8^EFB?3JCGBZS&A3KW$3Z94@I"?A<P0'+XO@=3EKM !6BE%<'![),?
MQHK7'NBD*&&H-,F/$BK"96[<)^34V#*V825K/[*Q6L<X%%=WV&<0XET^X!7N
M[*M*NE]5$FG13N1_A_C:3X2B5K?_D)5ZJ2/JG39JB=W9&X SMSN(/N>KO2G^
MSO6I@@,277P.;-"? [&@LPC7BB'O;Z/,V.W]JR;,OT1$#4:;1]-C\PIAC]."
M12)OEJOJ5"(VGBHX)LZ"3]G/>A'8]^? ;>TH-WCX?'2*+;8H5G$867[P1:@.
MP=<[LV<W$R[,[B!SIR"P4)7225NM_Z5C'-_SH5R^\N7N PT%IU2Y?^Y]$K0(
MN7H.-$.P]@=J9>ZGR-\YO;6.6][6JB]SM:VNZ-C\*M35"$B9B1&W*&(D,$#.
MY)%[IN= <>;?_5Z$W.K1V2/PX7\);=N ]@ET^,B-L"7;AIL3M8LK71:)[!H!
M^R<ZK]YY6^=-47U22= -;5\8/[GB?JEZ\XVUQF@6D>ZW]2.R'QD6*]!W;H+%
M"!TCN<6$OGVO0B0DM?*1.I$KE>7UY^L;EHU,O,+<6%-**BB1[.+C;9F<PQX&
M)IJ8[SU4-9U"NCJ0_'*0L=;_EOU(*S:P4F$HGR5:*Z"&B,PO&?[[DY#& MGK
MI59CF(G&@1^1%)?D9>?-?X+CIP*;^>7CL@5?@82T E@CH);RPE&BB:FU[NYI
M0PJ.]@NL6'29AV[25)\!0J)B9:K2$C3SR_V@"*:%=LW(MMR;[1,K4.(0N?HE
M39E]V&,T[J>S%=C$NG"K; XC4A")>.[DR6AMM%FYT'^HRM?Q0(W.:',6-F'F
M)YU:6S?*]>B7L*\WG\=88TT*E0.+I^C*$_4W4_E<9W"KFBK*!U/AWS?7SP&R
ML$<1'OFJ#XS@!N= H\RE,$R]N4)U_T[,[.]%-^=9ZB?1X='3=*J'1M<)LBQN
M9QY$;I,>AJ(/B&!2S#+O@2?BKWO=EGRUH9J2T366>@[(G]W0,.1-_U=)M/U;
M ^]??/UOJ8&W#\,9^;"> X'=A*NP8BND':&?B!+2>7BD:,_>/EQ4RFF.&65U
M\-_KK>LVE^RR85EXB;3-%_75I56,PG<29K4C&GFCXSG[R;\-&"NAD<UI=\B5
M,(J92T9*&B75Y?OZS8MZNN^&PG<^T%(<;$^6^_!ZJ9M<%&N(S='WKC6J>];"
M0*%;XIK_^M';%PZ915*.G^F4OM6)")%Z&6,X3^T*E\@'NF,V;>T=-K1D/D91
M^4VM0'Z5'M*8+YHT2W5+17S 6Y]P]^3M_!HT9>[:?<ULDD^VS.;6!)"N2?+%
M(S_CY7">*SA[O>07DOY<39X,OZ$5'51T<?YT71T.WAYC$9;G #H>9[!D]VFA
M5ZGM)">?M".2\&ZXEEU/I4GQ+9TJ< +^VSP>9S9[P,*]O!=-KDX90'=UAQ*:
MY[=-RGHV7J6V [3"$>5KQCPXER4C_9-)6W&46X*P@B4U;:BCR&ZT#O4RGXMI
M7R'@44B_S]A*0X6:!08+7:C@(*M$2T=(#(/4Q'! 686[O:G1[41TWZ)@;I:>
M":(U0E[8Y<*S*S/3[+5Q;.9N]8!G+_UO*O14>]2";EDESL\GL=/CB,:C])E>
MYIWO7+_0#I=-Q]@.BJSGL=D(1%LA3'ZD3BYOPU'7P/ )>,B)*U/:J3VYN92-
M YD*>/[^KU:GDVKH98[^7=[S4R;AN[[X'>4P:3,VF,]WX0_CH2_NX[ZNE6G[
MA/PPV#P1J\BWBLEB!.+T9*GO*Z^21<Z69VB.A+W86",:QJ7_,5O0T#P4?-MB
MEG&4]5E]!3+FG<*'?L4@!P\7!YBJE:#^K7<\].[LJ?1]4*UV%EBX0!'OT$)-
MJ.TT%U70*^[HM/OM-2PLEA.1(IHZ1(^MR?0?U-DQC1OW-1-JHFLK@ITDJ,33
M=\NQT#>MCS2=W<VKM@B-BWNU[.JL([.@QF1)N%]1!5<+WN"I= @7I'\9HPAM
M85FSL,Q]+]&I8G217M/V1?N<>N70[]I0>T'1W[(&JPXDW$M%]W/34E[5/*[2
M,.0HQEC+#;AX%CY<&=)T+TS)+'/,T/0NF2?$#^*L6UU][@Y>RC9EPS0;Q=IL
MD)IY4X *M0)C:I_<BXXM\4@B,@V5-_^58'CM+IYYMCY&3<8'!9?F*]+,Q5,+
MS]3<X04 $6!Y+!LO-B2MEPNS@C5K\$P=I^E,$ 9<>=O%=]J9BT>\17':)=G=
MK-/-],?97=&S \8J2WUA^Y9'0Y9@#N'C:/928Y&0R9;OZ=*._;%I>+>BMS)2
MBZEGN5,Q1C9/W%%3U,\\T<E^N^O/-5QK76\44T@I&)Y0AJ'A-%ZO1@^\]6R\
MGIFEC>BBA+XR3&2 <WU?2 7T[16=+O)$A;H8B:N!Z9.68%_T%2MJK^S(2ZPZ
M=.0[)[F^4ZR),_Q6L>9V0^<7BV#EXB=[]O6:]YD_-CR'-(*9%SS'7"!U)''X
MUJM3@PU1WQR6V>\U#)Y<_#-XE#@8SKZA_SZ5.'A.(XGIYM,Q!5#=S9=>C213
M@Q\?I]P;P;KV$W?H7J'H$\R6,>F8@%TV4K*UI-EFHASX=4,D8?*48"PZ_;Y:
MJIYN,3XH[BA1W*-$CLR6/^KL.^V(1HP#=^>\:TX^+S::ME8%K.U-JN#5^\T$
MNM3JAC#/VC@I;UUGCH\]58BEO$SV.X4V2^=-!M1ST8RE3M/J^L;[<?[D@ VK
M)1XF(8XWNV%V$95O(V]V6Y1.6B"2788PI"TJI!LG.84VI3%<D$F%HZOA9V,2
M&WP3!%:CZ3D<Z;/JNJJ$1;=]MZ>BB>];BRZI+*.!;$FO[T?5+S>=NA-&)6ON
M?"L1__]A%/*])N+ PRY59AGY@6<F2FO<AY<44_ *A9>OGLB>G/(C5&BVKI9$
MPG%H?(&7@)"M_GWO%UY&]J;RKQB?."0%X4]2#RK=:!*=4EPUQNG>&"E&S:L(
M;@\NJ:<T1Y+R.^Z-@[/0=*NZ/LRE!KM7)^1QXR#/"R*T_09,1^U\8YM3/8X?
M6O8&LW-"_.+G,T)7"@V,8-<_(G&>=#&]N3.=*R3-:OY,9[),^ B'TL<"9;LW
M\@:Z66W?R<C1[XB%NB\\OW<.:%I/?4E-#>GQJ\B7:(>N0B*<WHCJR6_4UN!?
MU-FI,4\LC,"-6[QX?SQ$9 :(VE4';GU.(X3L$5[5ON)_4"L@S,Y?&'-EF6%J
M>"E'9:6D[M4B:.NIF/+#Y.K24NDM]O&HW^? * *L_FJS7,&^>%W1GB9$L^CP
MJ;;-M/'D) S5VW,? Y]59CP>XAS^(9AU=6IV2G7U&^I>,<17;*F3'8OP+">K
M%*>+@7U,2E0?.&3GSJBOL' [&^UX_5_8>\^PIKYO732(BHB(J'0D*$T)B-)[
M!*3WWHF*U$CO-2H*TIN =&F&'BFA0^B]5^F]]QY"2$[\[WO/WK_G/.?N>\YS
MS_UP[OU(6"MK9LTQWO&^<XXY!NR>0I\W;))_+(,S[7 %9J?KD6)S68"9-Y_,
M+\[! YAK49@% BDA+08WX9XE0;^.\*S8D*UW)4YSI]4J2OBA>.!O\V"=S_=Q
M56#<9VA?05 :4^F7 :,(=MJDNX[B6O4(53P@RA1^Y:A^=5T_1!^YB3HB(QAI
M,>E?2GU:A@@$\K5U^HM@6.(;#BBF>?;L4>5G7L/ER;YARZPIA.CGFB28?!6=
MW62^=M&@MY]N/[,:O!F[;:;Y]VP7[._9KCS8"8M9[,+\!147:A>."QP+E$RU
M7EQ:%ROB+S6E&TK0S>!2659+!Y6-[YZ:DD\5",+?VK=9-E2$?VJBX,PC.13H
M0$^W\K4X\_>(F'%G\?&F/(ANQD'ZJ\7(:33'B 3=8Y1^+L.(7#9CVZR">G0V
M\Y$6W8F_. 0<\S>&@OCDB]KR;8ZK#!QVW[]SO*:2'8NFKS3CR;41PAA_K:_P
MK'3EN [,8*3?JJ,HGI78/[/H+>)2^=)JL))!_,OO)39OB;?MMEK1,]/';\NL
M1//#K9TK/$;#NK^9_N',[6)=(-*8FY.!3RI[B#QYFN!BGG?&=+J"F4-Y%<V4
M*>W$7UPPDQ\A"% \5_W;\]F261+;Z':'^>)7I:W=$XG7VZ(&=G"ML@%X&FI9
M;RGIV8@O+VMHBKW<=?^X%2=/*Z.DZ5U2>+?Y>2/'1O8*3M>H1;-^: \[;6CT
MC*@ECQ%H235SE.2L/JE3*Y]6EA0%G=8NA4V8#EAGYF[2?_>N2"!?\76@M<!M
MW\W"GK69(>@UG6+#*N5K2?/:E,1>%-,L@;$MX%T$KLMTS!%%$,QK= 3(@9TI
M[?: Y[*.L8E-R;#J@=6+K+C!$\1NJB97W3Z'<RS*?N>-U2]9-^Z#E5TQ-PTU
MX9OSP$L!<S0+3LX3-@-;-8.;7L3SUM-W\Z]:V'<>.]?=9:HG$8VN17FL>$F6
M+*K*R ?L4I1:WR06][KPS\*,F9(8)K\>C5^2-'>(UP&W5N/\X[:/7\>VL/+F
M6J]H%<*K6*[K?YN1'C_G;6X,#.^^Y_WY+BB+.!BS*J*='^';<NNW+HM6:.7&
MT.YA9^SKF/:FZ%'>Z!FFN.YMR=NXB3%X V[PJ&X6Q1%;2ZLANL<4!VLZ9U]O
M$:Q^9R0QE))R(N[_H_A!.^1(8 X/F 9?$4'[FC1S2_C@:B9%$&-(OH2XG[=6
M<W..@@N''8]]V D/A77Z'\'[1E=9 _//8MW[JCJ):;M.BFQ7<$!8YS48!N-P
M=8,3'EXG(U&>I5SN0L=);T/#?#PD?PR&%%F("RC]R=.NG]=SN*/+22L\AHPK
M-\9&5-@I-4]6#/C8/7!MZ<Z':2O>S8//""LX%&6_<Z1BUU)?@79Q\=LIZ_88
M3BERKM] DZ7G+?-#-FHBXHGJRF/8.!C0H'25"%#E)6?XA02\_@@;0;$;<K9^
M9K;O!Q-CZI-U9"([9,0#H*K/C_1B1&X^]A#A?'59+5$R,G^MMBM'X7&,C0&7
M4YZE^1^B&&A/ZR)<&EX6O?W62:-U^"QZ!!6U9O'Z^0Z5SOL81T"^E>%PBYUH
MW _['WS%L%2OB/HEL2+;U0;WB%%@S#U/3+JVILQB_3L?=:3L6]!K.:F%^Q+2
MZQP'5!LMG&%O<HQ\B]+>'P<KV?,_[HW>'NJ,^>DY:THAIQUE,[;LK8;TR9PE
MY5ZQ2[Q89-V%Y9Z>(XQ']C-'R]$\CR]CBAU]F)8/1*BZPAI[[HS4CVRY+[C<
M>A>K5YX@W:>;K/V[\ET9Q%BN<2$H3B< G;2,M5NB6ZRFMTA!4 \E)JJ1=B["
M>-9-4@-#<[<^)HLILFDXH3Y6GW0M5;:LYKN.&96NJJRUKA53F=*_6+,^K4*J
M2GJ0D5\5AJD!%+_'P(CUMMM.R=GQ &7'RHH!ZKTO"P$G+ &F^I].I^'UN-[J
MN)S@J!^AC-^970=^@>/$Y0PR%,=R0-E<@A_6=36+[NKU8S+3UN8F94S4'[XZ
MX14VP;DE+ZF:;-2(S60&)OZ1IY9GB%!37R#WLN0Y#1UV$ACK.?(N,\>"N)B(
M)D)34C,=(GKCZ952S/O8O9>V18U?Z(X6=DD 4F'MQ2R%(72TO&E?U62]'G5\
M1=8:],9L'MD1LV:!EG$7[,D9VQ-&;%-=##0?T^>DU>^ ,\Z+$RTT4AASU7^L
M1#@)J\I3JL>!(:-GMSF%V963/>%AJZROMOR^=19SM)MQQ#]+5RZ)M1P*7M7N
MA]5($-0MC]&Q(]IF(F]G&0^XXUV5HBLNP6/#DY XT9=O<[:GY;-M_8/1SBM.
M?<O6V*<6^EL5V:I---J^6'*A'VE@0Q]1V/MA-^T#,+$4,% MKLT6@@?(H9[B
M[(I&_<9^RP]&9-;+?Q_Q7['UZ8@JR\\?B0-[H+"/(FTSJ_=OH[]LNX<S+G#/
M,#MT$'6<?\3!KKPWH!T%2CJ_%B6&=H>*;@_J/BZ[?82X >L<@>*V\8 -]GJ]
MNH(FR!'_%!Y0\S<H(N1Y<#=@ZD-I9A:XXZ#3*\TMY-=EG@LJ'MAN.BZ0\.K,
M>/& :*USW"3A;JB),&2Y9<S?*BL,#_#(P]%<T$+N@M<X_BZ@G'GO%7Q%.^$!
M+\&7%GA V82;*5WZY6@#)$:D-/U<V!</$/3J:.6YN#,-FZC" P:3:L/_X]+4
M(NXQK--R&E??@?LR-F.=?@0806V/\UQ=U_N#..>4EZ2XPI3XASQ%/#W[O[=V
M\#^S13J]>(X-6B<$9#W"^/YU1/:?'W !+Y$.LI@T/;&KK:""*PK%_V5,DOB?
MFT_)GF4X>074;L(Q0A&A_ A++YF^XF4(.R3,:"BV^3\MRDLA6H4>6.R!)K[Q
MX=8IM]>(?NC9*8R[DL<#R"I;(,?+!;#Y7#P O>J); 6Y+-F\<9;N\M2(GKAQ
M:#:"!]Q6)EQR1;CD#^&263>EA\O5+;>1^9#OX$5W-!3GZ^9P>0K$ Q@+*B T
M=<^\GK#&FAKM+?.U-&+BV/-@S3$'$U@\P';^_ R,$S(P8T8_._.AL^<7NX G
MO2#H>\XU]3<MQ,)GZU._1LV^5GXSFF1"6?E <Z=R^N):]>^!9V/8[U L<7I?
M9#5*<E4?P+^]HV A(YV1=WOPX"-I.];UCH0?+VC3NS]'4@XJEY];3!#CEA_^
MM>+8/.FK-XA ;I1[%@E0.G%W3(XE\4_6"G>)'4<VU^9?Q+:@CK1W8#M/P2<6
M4*7;BC/K""T-ITKMS;_:1?1_Q&[NTKQ&(S*@4WT5"5";W.SS.[KT!H-/A3E2
M1"3J036(1$E&6)?T$!ZPG4<P(OJ&Y"*HE-0D(]H[)H]ZA3#2]Z[_TVN9_YNU
M.29>H;BH@EPFX0%G>PTH1!1X;1&V!R5PCQH,[M\4(Z@%#[#V\S 8 B\RXKK&
M' K%]\LOTM]7>58N=[>[1Z>\/ST5V "2\=@C*0*]V69W>R>$>%^WK25)[W7X
MW#4XLB;^G1ERX7_<9O8$$@F%/T?EDP'1"BQ!.\U'ZJ >OJ>@2N'IB)=A&B2C
M#W6YW\YQW\<I3$:/3\GI:7^^I?V9W+=R 1$ZU1%8Y!::*J-5/X9@_7J_FVP[
MD2T<XM3#F 9X].GZR8 CT6DXU;%J0^QA0;L&[ -[%LSJ>E;O5^KSG8RQ:@9-
M!>'-SW-9L;KEJ! S<;3/DM0OSWK[Y[M--Z$^145/M;%.G9+G:B*<7HQN *#Z
MD$YYJEZ/R; =4E7TK4!.-^D3QY?1)Q(4'_0_8OT.G]=G>6ZUSRN/GX)H&53"
MI\2,X<'*7J5A4=EW%HC2W[X"R@X9^M/'*V)!67W\D:REAM+]>ZUE+U\ILIX*
MY+VZ076$!S3O4WF&:J [X'_FMC$Y?<D]SO1ST"XFWNM:E'$<C/<H%B%RZ""3
MLH.)H'UD\MF3J6$6%J*Q2%G-/46 3_0K>E?]GJ+E@1#(?239MSKA!,&S@HXX
M^!+;-Z;D7\)B!%.TMKK^D=.X"+CL\'41-P3=-?-<ODBV.ZB=CG#6*'OOMB-?
M!/ 3,S,_/,8ING5<^<G@ 1EZZLV0,'TFKM&@H-.-)5/9Z+2Y);8ICNF8;OV?
M;ZI%"&.2"=OV]?U;/X(0:B :A*"D0S2"%29\8+=(L,26O['D$ \(/ 128WTG
M3J<7+"X?J+**=<R*?=&,$+[09CD@00CL /]1<K<.MJC30KCSD:]BIDG\O.L$
MY6MO$A#[@=/>IW" 'X5A#2[(8LGTYK'<J&;2^!YO9"510I5%)POS1WF2*)!2
MOFU2>$5DCNF6?IC>U#!-DM9-M;'K*7?7([X3R;<PT8R(/\X*YU$TU!M5&";B
M^MJO;J8^7.?0!CYR%05>_B8\GMNL=A%(MX$3'+%H&,I.S K&5E\O><CYIU^"
M@J1$8,7L&1X0FS&(!\P&X0%2MH#S*8(GB',L@+$1:4($%=J#!V2Q(MP1I&@*
M0L2 AQ. II3PK5V@V5SB?Y3J.-UB>D@(Y>#7A'AV"WQB-)& &P8?L=M SNX!
M,=S;H^*$!SWQ#\8#S.[!-I _R;TO\(!%*VP*3SAL]Q(/4!IN^(A(QU'#NIK1
M$[AYU$G14^*-_[J6<\&@2Q#)]?M7'K%X@+3 :9]O>#Y!WIJ=XVJ["--*O]EB
MW\]EWXD16X1C8^N!N.J_9:"VMK^C;?  UGU")"IV^%L&JJ:F&?9 - ]+-DA
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MY\QAZ;@J66S>6QQO":Q%#/@)=71K#+5= R,H'[.&=X0Y"1?@N6OMD>0>GY]
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MF:WD;>70[;R]7Y>O WK3I'<_1?!ZY>7F=!:?/ \-0KH;I=93K:8_P#TQM4X
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MET%RW>&Q(DD%$<<!(N6$XH+V9 !S29AJ&:I]"$V&ES]PIN;3MU_!\VG3%7B
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M6Q$@ZX2 =C%Z\,:\(7NW'I?4O:BJD^8$$CQ FDK?-N)+=AI[[YDB2X1U&H$
M"&D5AO'2,OV,6&IX>[@71!%49P%[:YMCYUPJ3=I/]5$8<TUA/0VT=?MB8FGG
M&QYPSS[.X'Y4:Z'$W1D"/H*XQ'S'!=O9.A,W8#=.26H.7,<C)B_91C@I7K]A
M(#R.V\SO$(:3_UL@_0NDNQ;R:; &#=-.^;1:/_C*95;C 1Z0<7NI@8<P;#P
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M>C!;DT=6ZI.6,KWJ@S;F;M&XMUOD7E5UYJVZ6K9='[RKQ&^W:#JJ[>X-W$%
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M]$,3P<*PA^T/9[?DLAA;R6[P1.#H_, G?I/RXOR6R\FF*(WEG[TY6HM$]\S
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ML6LNR#Q\C[WA043OVVM#"6_<OS$_<95TEUN. FCNMQ+:IW::D89\+KPWS.$
M\X$_3"NM_"IO1J&^PN2H*SH30 "OQ6)PI0Z54B3*-\E(32O.B_A9S7DG+Y/.
M=\!7(?E&<FUM^?#.:DUM9>C<% D'P\\B-:4MF>SMU;"@I*<-!Q6M6(OYW%+F
M0N811CBRK4^'8_!_28D?N2=?W#E+)M(<]00[T\LGM-T9G_IR1[4LL:$;0L86
ML?=<PYXH1!]_?(]TQNR!IL(*CAP25=1Z#93>5D)&[,;U(#H:#? WM=TATXI\
MN5DDOPH.?[;FN7Y2H_=&CT$]!0E5ECJ:$IEE$2<=GX5Y'TY309/6AMT$?S[
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MO$HW6+ ]D%$A5!O^JNRO1!!\92 ?;XSK=7.J8O5UJNAS>,7D:,@9=?4'(Y=
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M%$1V2P\? *M-#+-M<$Q;V^[WUB#C(L&8'V\SP,FH%U!%_P&"0G5U-)ZKP%3
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M A)TEC^V_0\Y2#HHN4$;J#O+F/VU>'7C#1\?>9(RU!C5*SN'3\F&'H(K2?[
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M*@;G:)"_R*<&<O+#0/C,/8.1$I$Z+K@F#HE@:8^19K_NN?)I\HI[-;;OZ+G
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M$)>W=@QH]<IT#.DD0Q\+L0YM7''^#C6_W.8VD$LHG=?!J$.%3[JU].ZG10Z
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M(-LX2R(A5+%X"YR&P.LEPE1?3>GP\)EN\MA\=V;X)UD[+CH8+U>4R7L',&,
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M4.%_,*WYOWR-*@N)P>$EQ4[U9H[TB,!FZ=Y99K(_'BI!-)-<=&B*"+R9(4Q
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M#1K<7\V".9>_XZ+K2=TP]&/V+4SX\)[49+[IYCLBX*@_R*3[X*4))WN+#6U
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MC1=^2ZN#G-V'NV4B>JY# 5T2?6OJ:,_O<)X1D7]AUIY6DNE%SRO^LU:<X&G
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M37?HSUVYOX=6_Q%7<H#^!%TM6YW(O'QH\M%J @@\=L_J770LJ:ZJ;(WUL[K
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M)Y2;;42Q9)_"%=S,X\AP==4<5=026[QX^8FB170H]+5R!_DLR?=4/-ZZ?_P
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MX4Q0E_;CL@;XNL(<E"0$ 0$^6\1O(Y'U3T$@AYH#Q9&[CL*E-:\N+(" _$2
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MQ*L))7OO-H%#SLP'?G;R5VC_%MG_6F A_T>1_8_ _C.N10 >*@JR\U") )*
MK0XPYPG7'9Y(XSW&$ +0IX$ 8+M$ O?,9SJ@ NKW[-5[5<I)7F)J=MX"DO\=
M,R_)B^"!]\![X#WP'G@/O ?> ^^!]\![X#WP'G@/O ?> ^^!]\![X#WP'G@/
MO ?> ^^!]\![X#WP'G@/O ?> ^^!]\![X#WP'G@/O ?> ^^!]W_+DZB"MDXN
M^RC+I=G1*UI6!Z^L1%I;4"<HBBOFIH*YKDGXN&XPEQ" O?K<UGWG,6M)' FM
MW"B.*;&WN5%L@ <\X $/^&^ "AG#!@ZFY@#G)=80 -D*4A_E^S<CN/==EP@
MG-.VBL>P=C&N.^[;7F[4^1@I6VX4X $/>, #_CO :[M-3UEL32\)&Q& "0=9
M>F($()Y7&@'X$=AQ_\6 XW?RG\L\:-ZV"%MN&V\?#EONQ_\* A3=04Q6>.T,
M,TKQ7V4SODL6,/EH]=H6@%[/Z,AK.FX!@I(N^.-N0P\[#A(0@"=&TPPD8G3N
MK,EIR^9MEE%O&-+9R(;+AO[$[H:%K,J/)"ZI.["FN.)]';I;("VYC9$UU1]S
MRO>)4UMB-[ 7<!:2?!$5V,7P6R_X]@V4QD<.+OI%+D'UY?J&@!NNW.TV814J
M(P(0KO;MX+FH.%6,D6C(CMK>!C+>^=U_%<+_,3HL<B#P#$[^\*1 ;^*&;JAA
M:Q0-8)/1<RO(4[KM>#WE-C(%=/D8>$=!9Z,9$-]<06V?WZP/3FF@2'.\E[W(
MOZPU$TP1LZ*A;V(2*KW8,Z7JV/(SA9_'7=?['FJ;\FD]S?>UW"#5D-5X(DOZ
M%@4)3!,0;JL5L\-3VVM=0.CE=U_,>TRCOIB8T8) _"1D.W[_)A::*Y'<[;"'
MSP[<2UVN70P!OU9]#R I-[2EYYZJ%^U4;57KEL;P"M?\6;U&4PO3)84H*5[3
M\1?W$X@<V3NLX=[*@N^>U',$.XD1G;$O-5M' WU"\N(*7<\K>=JC3[SCQ$0Q
M/U6I4"<5_&E\R\<MA??ER;/IX&:I08TL]SBU5KU13^V"YUP^:=!/U&_-94EU
M"U'^O>5_ :,_#!QHTSLBLD\.M'N%SA-T0>+L'M<JYT?-OX9[($%E2Z%7>\.=
MP1UW57Q3'7TWZ3JMEW>+@P"85@)_8I[Y28@@ %7C", *Z+K XI"A;DM$/#HP
MKNX  4 #MW*NB]OT3:@*9#'&KK+,3QD)ZZQ$KYL1JW$O-94?/_;Q?PL=+5WT
M*J N[Y(I>S+<DA5-6(061 ;IP+ZUR%V >>Q=77UXMRS#-$CMC553(CRZ^1%K
ME#OCY-K=E$),N?!@<22S/9U]-%D!<E:((\I-^_P(0^1FO.AED&X=ME9AR7/6
MDEUM#5E']S!2C=?H?X?2\J/B*/WOZP >Q:J<5B9HA_R$Q[23[B2^S-L/U+JI
MJ+D,1Z59K\3539U#A:??&J1I%K#'#EYO1,&]=6#^X$"#B>Q ^MF%SZ)6=='2
M@Q_D@HQLJF3B#TW%?!)?-T-'V]P+EC,/B8852(OC"9^$ T>EZ$JT2HNJ=6R5
MLJHL6*+8*E2DZYS$)"OLR3<V?BE,OS1[_SJ!QL93Z&"0LAP"YP4SW"8N2<(/
MN.[#'402M_3X\U2UDU+!0&BD3\I]V*$A @#(1P V[,-FTP,M$ "&9#WR:Z&[
M<Y6,>Z;YN2EJ4%P ;QZDQBX%_CWDB"=GO.<);M,C";.F/7F_R>H9CYB@F?8^
M7[M ; 81#LQ;*O\@_KC&A)F\/,@/O^?V :FR?@A ;U5XPVRRVT$+J83FP)G1
M8C8*&?>O[,/8S34FRMU!#A]556/:^N<MSK^1<[CF411;-D&< I0ATG-%G.M\
M17"LWDVZ T2]%1K:\XH_U3O77D!D8:*24]^3D-OBE"R4>"0F^[&"\.#Q:MO9
MWT8Z*J98VI-SZYRNV13W.QSW<VHG!/-;'M.RC628.76"F^L?C]%H"ZSAFV^>
M+F$FS!/G=I["?>7QW6';452X(FP0A4XT@E82(]E KK);:>A(5<1V^Q>=^A8N
MAJ/#C:]\T0KKI)#V:U2R,UD1S6^).RQM0E*5<LA)[&B&_ ?XOP%9GAWXSN%M
M(P6Y@5R..RHQVM<ET9(!D]=]-GH3("P$8"MK 0&8TP>>\^I/@Y[^6[8I'\.5
M(#YA1 ,10K()X6Z)MQP".[,;HZ;L$&RS1*H%=C(A.#7<_>W)6GA=IH'J2P1
M^QW7T_YS6Q!N$IZ$TT\_HM7R Q&6^$W\QU(>U<N&P^GK3=$A0UDR>4$F ^VR
MEF7U)TPYX/?'OSC5D]C*%D=3)"++5_93*'F6E"Q>B B($/V1(]S4=LASCRRS
M[8YB^[ML@*)4.@KY7) :"T!E3JLOV$\Q&"UR*5J0WS$:7=)PCW-3/$=E:8^&
MNGSTZ,!>S,\R,+*W<N6<PCO;^W@W <^Z2%**PJ@K'LZ;LNCY$T3OTZCQ4=4E
M5^WQJ=C.N\A;VE!E7^A!W^RKNEK;%'2]JH1?SV^_)JZVY>G#"L QU."*Q1W#
M(:UCSEQ,P"[E$*/-2?YD$#M,2R?^J6"<%4?"HU66KH&R1]I!+#67]8+5$W_8
M#D=*SK[%MVJ*N3$Q?U:J^=&E*1(B;M^?7K@"@4<+D'/[-FK1RJ6';&V**Z+6
M![)NK*'MT[^H<7>EEO$C(3+)ODZDX[W;OI1HM:CPB?MH=L/5NR*P-A)ERKX]
M]3NRD0G\SDK]@S_U)+]V[N*>A0@!B>*?X;3&CZVJ.?N3]M2QZ5L&_:]]Q6!+
M5(P$9)$06='N5=39 &/2*;L-K,,-IQC^GB3C^5$,%.9-NI]1EU51","I6CW#
M50ZRL'\Q&NL&4NXU!-&)B-\MDPL^'CS%R.Q^4:KFWK3^B#?:1BSH;>E03RJ3
MO#11:>YJLEA9+SW]M!AO:4-FB5S9J[>00;?*HCS4_2Z&,"N]W%NCDY?I50X"
M7G#',A%]IK+1[VQ_>C\4-5$>')MX&DHUDBZ,:;+SVHLB,Y_N:SV;[%NN$XK/
M?/G3V>2S4 7LST;-NE_]/I)"_6T8DER3SN6#;UW!^P%,15T2!796KG;.7Y7)
M>G-YDVC<>*-#HT^RZI/TE=A/!'*PU'03)8#MU<U3+H4UK6$YS6%1BC2>F+=7
MQSH'>2>KS0X;7)0F$ 'E+S:+\=7&!=W%Q@,'L>+51ML&3A4J^0E.C+E1[)_^
MQQ1R5YJL\FQ3HA-5BQAM21=E6B[+>#20S.B!43)G :VZ5Y)+1 "<.LZ5IX<6
M.9/01YA30>4PFMX@AA^"BUF96X88V!UC,<WB0KHLS1 XQ2;%[6<79'WB1@ ,
MKB&YWY8WO>Q,THI>:B._RO[]/YO"J@YV[D"WY%FOTV6UZR52-N-T5%: FP_:
M;,KM4Y-G"$".ORX"T/E<$I:V --# )XQ*2( #6OP9P=[QJ;O?HS7775,%YUR
MOOTX5IV.ED% 2O).NW23@]EC(H>J;^@GPXN5/8-V$(FR?X&IH5R;B8/W:TEB
M\8%=_8L+YR\;@22]GQ& !;T3HS]4'EVZJ(5*/S 9PGP)^ZK0]??<I,KWXYG)
MYWA\-3M#<1+,OFI; !X3TB]KX,P%U.CB? ]Z=R:[0BL7"C9VZ%VSO1^LN5%?
MN+SN:'NS]%/HIM?F*"OK6]IQ.'\<OB*>7QMH(<U,Q6)$?AG3M$6]PL^T$W0=
MAP L==S/%$N(  =EY!" 2DT$@+_HKR).41U7?9D)7,]21,J% 2$-65+ ?P7=
M;IAZKV-.2@^\1),'JS81\[Q, M<8S2><(XYHA5GW,>&K_@FQ+'<O(S8QF\2L
MI@$_.(/,27CHAN)VJ&+[C4K\RRO39U.H0O?/R&*48D69<F,HIU?FKV,1 (7I
MNBJN&WGUG[5GO+6'C^O\JZ,W/U#UR^]J'\RWBP)_H]ZO2EXF^1P:"[O+[7B:
M#PF2(OM2__N_:NO>IJ^EPJ:<+VV8CD9"[SG ;[;Q'WLX]#52<B<J(T5-4\<Y
MMZGNRHJ,N97X]J\_(5B+^@QHASI4K*B)G8?O9HK7)Q7V<F2U51NK3\M7J>8.
MIP+@+ 7$\+;\*$D-?<\+9'X&XA\T*CL4V5<K?UA8HN&0&PE._-AI$W>P;^3=
M%X=F8&S'"POO)XNZ7-MIPGK%HG*J< \===_/:M7NKVW++]>&#LFG$>S&V:9A
M%&V(SM5..K5/B,A969Z1O<K^J/8N>#JJL=)'U 2Z4N=-71^QL)%TR>0[T6Y(
M-3 \,-FR%F)Z*KP*G!=' ,XM/:=O/R"C<E%%1M5Q%U^:*5?JEDC-[9$!SZ+Z
M[_MW-@;,Z=^+93EY/K3[F=:W]:G-E/MC7MAL8P\0IR@J0*7$C=?"-M=NX.KZ
M6NM$/##XLLI_UG.%IIM:Q6U5Q&#I)5,X96)B'%B'[N,MNKEF%<=VU/1>GI2J
MN^("@X3)K?"),\CY;"SWMX54XK:($I"9>8[+5,W'<&"1]8M5,BYY%L?W_N.G
MX$>U7 RONAAC ]T/C1CZ37$,#?LP/SOF$/T<?-KR;BI\4-0([C'0+K^1HW/F
M-D2F14A&X".:-["7&[4G+(T4*(_^*S3\3S[)8FZN0?*4L $Y'91OPRQT\\)B
M]C1T7+P"JEG#6F6(CQ*E9H@"#49?2R99\=2(,I7H:H5@=6&T9T[=/_'1TFY1
M=E!]SY(Z__1%?*M_Y![&.H^#X(9@"*>8?)Z1J11.884358(PJ=DP8)MF+G@@
M9\!QNO3H,J$Z_T=9,M1;(G#*8ZG-5".\NY]+ &+Q>>J#489-":-719M>)SWK
M!-]"/9V\RJF3>?^U&"R=ZHD\3N_%TWP8,M<]PY5'-K<" <CF]]?K4[]F@3?>
M52,+S9".2"ROAK%"D1Q/X1:<04!#EJQZ]%^+F7Q;@\JV#V:3?ZQ;/&]6#6Y+
M,C;=Z2ER('9\XBQ.WH:UD^M/+)N_L6Q.R'M==0X-U >*NB"=H&A/='7IXOZE
M:XI7O^*%Q7)UN;WVUH2SBUQ<W4\_YH ;=^A</WG#CB^?8BI@]&D\L\O-]CO0
M9+.NKKRE)_OP!RE*QKDI>CI89+9/NF:@Q+!^7C--:WVFP'6G)\?0&.WZ^J;8
M!X=XV!#8T&8JI==KXH4W=\N A[;%;ZWNZBM,U+W ,!7V=F=])J7O/J?N4]YB
MFE%LE:%?_W?==]KLY,[]-F?YX793YED#V]N? AAJ@"TH=@47[$TK,B-(7R*?
M\$=-X E_[=\6I;GQEO9J\QR[8V")^I9!#@K(0@!;B):-Y4>)3K^NPGZ>-.^7
M1"\)_9_C]8$2+,E72NT-,7ZMLT<?@YC]XT9K#R K%+UPUD@B!*"F:J-YGF<_
MI!Q3)<F,0!+GE.&+"4[M^%:H_M13!<Y*R]."8 PRYB[&XGX ([UX4RY9Y;5E
M.=FKV^J=+RUB2"%7,6KV'ZN4E1%R4,'/MU)F7'4CHF,-+[2 (.I3$>AO?/>9
M<ZZNM>O'4_?MEO=)2?I-<GN+8?R:1N703 NY:3XZJ7)^4>#3;6UN5<@R?4;)
MTV(][Q/@O?Q-'!Q,<1]J],S(>",U4Z%X*/]O#?#_Y]"K:Z/1G#T*&BO45_5D
MHWK*/Z@!47\M46^PB-G2$KXJ>9'0)#M6(D1V\3(F;S\+'[J[ %XBJZ^S-HP<
MW!ZDLG'Y!:4E2$I2ROB\&,9@>[% C^H.G>HG_R$VN5=#*OLBH#G//7B/+%)2
MRJC\']6FPSX#X:T*]/AS/6_1TI 8!=K&$[?@-RM!^VAG S*A(ZZ25$ PS1G3
MJ1?0Y8C>)3ZN.>[:X3C:HEV\6@.GQFT[@:]$&H<6&K\C(A%3[+ 8,F^7?!_X
MZ[E9^HP/G>][=#L'"8P3AH@_^)=%1;[D72$N9YO.ZFIDD155GQA.)9>0O@(;
M>$Y]7A5M>OJDXRY@X,Z^0*.D.!&'.XE5L$7"+S>*PR+CKY'-D3\9@+[AY*X6
M]W:J;DUB5EI:<;>_N8L1^IOPK4-Z5;X$*7!(9*IC-1T!D..WTG4F:A'(^<MS
MGLV6%)K8+D8O!MY*J$XS8S,MTU !8J68<L@T6]8BUTXU/(%7><@\8V>49&0\
M:>UN5&.'E)G:"G]70PS::<:=Q92K%O=U1YGLOA_%ATNS4;T HL R<."LRC @
M.(9]6-1SDM-97X[:L#A9SQVBR/"++$FIE"9=,X<]+6^'FF//A2+@Y81GC(@^
M7YF"QYTL!7<=1X-@?Y"NQH P!,//$^GKEO^Q9^RZ<]/&T^H*5!=BD,]!YE5%
M&!3T>4&&*^)",]^2R(:%</_=Q<7A?RZ!(2LZV,*/5,=P!?2B,4Q,+DK_'%]'
MVY-E]#7FOG[M/RR !;)B]HYA&@UM%S92NN@_C<?<&49W^F=+8MK^OER1-(&Z
M/#!+I+?V0@"(Q#!6B=IC-R;R$Y6;A&(R0B8ZA&4..@<EP8F]NB<)"2W"K!28
MUG\WNXSG8?(;H#^)@=N&S@L=?]K-S^*H^KFC;ZR;?M'$VQ0;&O.]U\ K>R+M
M^A.--DBHJH!D@R$,)'<_>3_7@/.X^F,3B260,#G(<7=IK8@_1G]88%M>%N=#
MYO7"&1V9B_9/PSN3RQ.2]\MJIV'W>]:L#!7:%6I>R.]_]<_6UD00 )C.*L_I
M%0)@<=LT&C1%J'YSU*SL[^M\]+XA1"#!SDB>FDOW_0? K<,!Z!HI.AI,)]L-
MH)5E!!$;F:+_YNRQ0X7H7N_''_&"NG\4:6JI[%?(\2T[7@E>_/_+UO]W"-3_
M^^WDN+_;$B+;4?;RUX!IG&:2:IBD;OS/*U#_"0:3>01@4&+IOIGKE.R4+-#?
M @%@O'&!;W4,Z@WJ_(J >&T*1,X%B)\8CX6WRC_RC75\F?_NZ"EM:!8J"H3W
M6J\5-B:GZMTM$O.%/17OV0;GHNQU2M9R="!V53+'P>[P@L!9")-HI,2TGFY"
M CW9F9R&/ST%-+V[A2NRHQX!J/_3/G4)9!V^.RA<63J[4AA;H0ODF'AQ3^[S
M?NI=PM6-./WCTA]+"G_VBC)_RY DN(]OX?G-L4)9[Y&MO#Q&OM\>&$M=T2O@
M9YU$DA2RWEIK%M_A_"@4PJ.XVT3_K>@WQ*U0Q)XHMW & 0"/^F^@-T0',>W#
MQ<-!#BYH3GC>'"X,*<V9P8R;J$=)^Q#?\\-65>A:MQ\PK-[PES'KKZ:0244F
M8)V2UP]-J2Y'ZA-C8GV6$XE4YAJ^6&?P+^XA2:%C4R6?L?LWF>[WK=8(P#B^
M2,J7*!5M7^LBEKBD@Y56&NA9=TMCZ/FOFQ6ND>8TSDG)Q6?& ZP_S#BZ'?:/
M(T"GC+9K%ST(@#6_YY*&+F^WK)+:WO5QWRSYHND73U$:H=8R6];GU,Z<=8%J
MJEX@0@E*?"_TF?J^!%$,AJ9@M=GTNUR_L/,C/ZC(F01'I*=DI$%2G2;*KCT&
M?J^': -H<&ZBT7W)EAKM"I><TY$SM5<!<$WDH[&4W5E2(I";L!(;PS;LYF*I
M$=IE0M'8^([D]504VR)>,N005OM(\8KE!S_AIU7:G[.<5>\;'[\N#YJP+>]Z
MAF9F@4;*N'[2584_%Z!<!HL]4KS@6+#2"SP@.-N6GT<W6C=S/3C(2#N4(/?Y
MI=EP\JP]QMN=LR\&S%;V(JRUJ(NQ,E =S7^W@E7-54^EWN#;5NYFSD2 -)0B
MW$,2?15"[96^92PW\2EQ++XZY:V/-5,.?\^M"/3U25 1[TIK_/YL-I72A]&!
M7-2E'&8$X#/_ 8@, =C*M)<\ED$ \LB;3$-:[BJ2[H[BW YH4ZPL&RTZK:G0
MW;/R'\N/WVA@*R\(3K-+TZ^PU(E++'714]0W/I;/MOOST8*GLT;P[GQ!LL+W
MN-<E/$TU/-ZUTNY%LAQ#FJ$W<*6)%>8^4?,!4^TCREKNR57/S1C)FB&DQ;K0
MJ:KBZPO70065\$$K\V%!U@S:=8\#$_5-)_6^FK;"U W/9";[T/>/!8:![0K,
MHF:;C"=C =N:JG73494;B6H2$<]D2?7T=__5[/R7\%_K0N8 +LD_C @ _*4(
M5.FJ VF[6$R \U)(VV7D&0;\N-<-? QNYP4.GG=<[#.<V1^(H:P3XCD$84_]
MI>7/*@O/!(=VAYM[H_/"S$10C$#]+M?T*?=M3/=.)GE(D:G8_O^*3/=IU7K%
M=XL9VF5#?%J3]\0PKU^:S:W-H8=LIR3HM<FG8+6>Q!2)K<VL#.M&K@!<L,.-
M=8@Q3C^_RT8(663$1 I&*W!C+I*KZE;+-1\[/[9[S/ZSC+DQE+*68#>#\+6H
MY9P65%W_Y\^ZZ?.ER*QW%:V-$?[D;%B,Q6.RUWH _^EAWNU=QR8UD&2MAMAF
M_SUQ2C?U2>T9M8.^WN_&;]'D1IN8#> U^H'HC3AT'Y&#?I%:P_Y[U7( ?R]L
MM-,/()H8&I=S7GF\68/R\M/=\*B(GR]PTQC8G<G#*=JIZU9:E>XU(E:.+<R\
M#MS,#JK/*YWA?UG('N*9X<<DKP;%#*M;L@H7)Y\,\/3_GJPK^0556TP*.M"3
M-I/^K"W#P',0;8"_% T .F9;CQ4)>J.7%J!YDG29MT'31KVXG3=503-L&?GY
MS!35Z]:S:W"@WFV5ZL2Z!.PD+?KE^7+73YXE\KOEO.@M#TS4*@TM:G>'-'@*
M^WGBUO8X/&J1%[^<FQL]_E&&Q[K>L E=?3@"T+NHFCGL$N(_^#Z>1V[;!A =
M*X]9'VB*5R)&-$(UK)#S#1["P['M@BP&N\AB((TL!G*<[#0*/A7@.R]Q_WY3
M0C&.?)BD5D?-Y&W9]_<K-'>YNHMNHN1/6_64)H\N*M36U*J_C#1G-N3NTM4H
M7@*(@Y+.4WHEKQ_S@^!@!* 69T,"<Y\(UUA9WXQ:B[$^;GO[-4HZ*/ 7 A!P
M,U6D4>JLHF/W7$?#@":(&B:?L_^JO"47:+=JL7,F%*DNZ>D/!7X1Y^$VEO&1
M['F13AAQWFI!:\ HF<5K1-@W1FU/K=/7'EFP+%X[1)'IRA? K:F@@UF\IW@K
M?&#"E]*H853_VYN7^8^BG:XT98*;HKC?F1+?+O_O^5W=3-;!7'_OJ"!"NY3D
M&O5LZ]$3MV[R]Q-#AT/#H*"LU2PZ5Q?.@M\-4_T3(R3?M^0@Y018DC&>@B#B
M5IW _($BB?S!*"S?]S16WVR8W E\]OMY1'9*?!A4(MZ=5"99N.7D^#:*Q'_M
MDGI?-'\XL&DHI?3\C#<K[]-6,UF<+)2P.]VF-D+WA%3EF#TB:J@F!\,-%Y[
M?7J)"7)YXX(!L\J;#Y LM)@VR$;&J;AQYP-SZ)Y;S"VV>__ZJ2X5^GR8470L
MCUM@<-7WXPLG&>T.P;FY1'4/M8 Y]Z1=1L+7A*^%Z,JP2F9F+T5LV#V(H_3$
M%R4_T=/$&3DDX@X5M;[HL/ %;25RA.NB";RB"5$W_94(*UD_Q.SQ>Y;4GVA^
MZ6O5/'^XJW!MG+^Y8[%OR( E9@XL4_3,A7AS?H#V/FN,OP[,#K-B[=#I]SV
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M2(.P]ZU2I"ZB,]I>5-O)6Z)FPI,M0 I\HWS"<%0)QIMHVLS"8IHJKOK>JEH
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MO)6XPQG(N:$JK<K:(Y)YRTCE=)CU9DRUD]9FB=_3*'=2)0J'5_-;?$^ [$0
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MZ&_?-)WX*HO:ILVIQ#1^G@\Y;;1V]!@PDV@]";.;3G!Z)UPR$:KA[3@)>X8
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M7E<0I0(:4P_<>9P[T3&LXSB7%SZ7>*L"\RWR<1OA#V0WQ_^IP.2@:#F$%BM
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MA^4J?KK"OP(N=B<;/1@BZ6E.\)>]O.8T93Q9E\,W> IB15"'=Y<D5>9$3[C
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M? 8E#:V1BY)MM(@6N@7W-'2O=:Y7B'V+IC@S\_39B'=U\5+$LLK1 1[VE@<
M6,\-FFWU@ANDPA879-,M;7\'OW4R'WLT5L@=XWV-@\PH_]"@7D.(W0_(S!I
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M$'94>K!BBX0>*("&<L-;CI*"?X186_.X6TP^7U)RS><?_8Y0X/OID53Q\K4
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MW:D,'<DT+0W;._PB%,B4?X(TF 0O,OQZYF.8-W3V;V;OU0B_C?=S?@=TCO>
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M1XD7&2XE^\<IE(+BHO8HF;J<FIHT;?K23G,02^:=_\4UGW^GX&STXT,[OZ9
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M 4QG3XXA:'YI)"OG#6C_<0$&@&)?<]%^G4<]9MMHZJ3>3ZPC[O\;K(3%BEY
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M,_*S.)8W2:,]P36%MQ5/67S0-6$HX*6$D;TDF3+E_P$#_.\HEWX@9M&/K3$
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MG4<O04M86Z:R^D=4+=6*2M="Z$!SJP'L!;!S&<5L!74BS2?4.!LI5E NTZS
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M =:P'XXHA<+)RV6ZRM\-K*0)M/',JMDT4KAQ&^D;62[H"#TR=Z5=BZ#\EA+
MR >IPZ,]/U=/0U@JQ:CO]<5E*^3>KZJ4920<MJ9=A!<QPZ4#.3U8]":,Q6A+
MX[;P[T1H+.NDB?+SIWHJTLF*<@<=TSUH%@7+E@XO"(9.D 72Z@L_ID*Z# IG
M,Y[0@84B/CN(U,[I(9TWH4=#H*6C]9C8G? LN;?UH^_-TRF[%:T"I5RLY)U
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MF=%F&Z=4;:$;G2REUSNY@1:X,:$7A]HH0%.2I4;7.B"$\)@)=B_K/*72]@X
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M4Z??BB&G\^Q,ZXU"KYC<=PTQ]UZAP@7]#C#.?NU3D79[C_Z!DB7_)*$1N7S
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M)[S])Z]I0KX2+V"@?1NQAP Q6XF!(0@!@W7=5T[+H"$N.PNR;9K&\A,9@!/
M:>^)U;CD<C%%(6+Y73AS-@]U5POY'Y@ZQ.GX_3"^>P1MTT?T++Q-FNB@:(FU
M&>]K_^)J((Z6FXOW>Z4[RG)2 UKW: R7(LH?;7T]@#VV_,P"V4P=VDOSK*Q]
M_@:26*M<31:2J_UJ5XJXI;@36?J[E&9)8I$H-C::4L]N']P)A(&=#4GF+'YU
M8V*T# 4;0)KNNQ0>IFU' SE+[F0#MJ2L9JSV.YMC []!^AY>+./X@%/_R'*
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M;(&#UW6-),KK&J:V$XGK =*&J^V!UW,N3).3996I-(F1JH53<7)*XS] SYW
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M92^"JKFN1!*X3B()M[?."L'.0F@A;F*.>D70QH[$%/Z0E-8TXNG+6UN+39&
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MW.I%&=9W$ADQ/]4/N11^_;J\%#COF%& WOQ!Q;9OQI;U_V+OK:/B_*)LP2)
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M9$7P(L?^IL#5T?_(CE^"9V7_"'4<%_ZUE.4?"Z_Q4DI'KQ[WQ7B4GU15L6?
MGXGC)>KKP-[Y%G*S5ZX=U(]X*$'Y=C*X43RA4:22&X)9[@NY;_(#]W:=]8&>
M/@+YBED@!)-]51-6O0[\KO^J-W>D@Z*7>HA947T5B9C<^TBSUYL"7PMI/+9/
M]DHQ)LH9J<4=43WD3@(RG:P>%L\G-YW"IB?[LR@B9F9A"3X1T$? 78PM5<I^
M^FIG(SY@!J^KU8#YD*>OJWZG%3";,YO0GG02,2M ?H&!-#I-\  (5Y _V-6T
M#!DF\RW0J$Z-=K//>AJ ]O,5AP]NVB-Z:2\$T[>U&,&O&Z-DQI4?  ;%#P R
M38^(ML2I.C2'PN[1.S ]8E@10?S1 D&VNRO*\1IT?W&X.N,/!<DVFY;2V&KC
M6&3."M+ M#__BGZNS2YRJ627-B0JXEI )4:4P:#P[4E!* !-5\M4;!$!0AX$
M&\T9E2X/@*]69YK9?QS&_\QG,6#E&(!S69"'M5";\6W_SG"3?B>$&B.=DH#B
M-0<ZCFL_1DSOQVXF/LW%[CPA,^,3+1E^FI8G=16B'DC.L+E!/YEL-.VF/UL0
M,JAG:8DZ1(=W0&%3Y0E\.]4,]Q<JY#^9ZCYM23(K<.90##C"+7(<96=#H(DP
M%V%;IL6)N?;!I$Q96LCF)48L:>+DGO6>QB(DF=)@2:?H@W=T&\+CEDK;+K,6
M0]"4?A*C@@"25\YH>>W4Q4YD:-4?/-'&=:E1%J@C=U4L$56<TT W'YM8"S[J
MR%-*[>?NBA,.4Q$6.44!$[O>7L04EB 8Y'H!C!7?F_J6#!^Z&=W5MKI$3C?^
M_OD[L95>:[Y[:_YI4+ K]U6K=\FR F%14(/P8:O;8TQE!B-IM/I,W/4B:&M/
MR8I^54Q\#V>RY^T<P<77/0@8]&3D[9:3Z):XH*TEY!$K6<V?@X.@]=#10$5+
M]H6P^?/CI>24W@P$\N5HL<MH6)-4SA+\JXK#G.4CVBLOM_B-U-3__CDS!M+4
MVOGXQV.S);.!4LO)-FV\8P<6(143OB&5UZ&1K^'UHR1KX;Z5$9_>RL=N+BXQ
M]L:A,WU6UPY+)11!KR'*^_8>$"" ]   ,W%T:>,)O%W'?'+])4EFJB^5ZF65
M+#P"SH*H+&\O5?(YF]F?TUA<ZN1$T9<B\8XGJR=1(LO<*,4V22PN26*Y[7>P
MH0AE)F\ZZU^SZOUJ<S*:3;/A0<7[5EV5R17<SB&(JS7HLH;!]K;?>]-?0B 6
M,_(&.:*C/BU@P:"E<@.,XQRNKWQ6LJ3^]*8FWI &@>$E6+U?&\]DH&=CO\'T
MPH*2L!=@=*N,"C5D=OZP[D@N<%W!:\E[HP 6EDF2D*KC6?@6LNM*ZQ+31AYQ
MA5#;P*<?H@Y;I;;U  >>E4J7<D!/[\ ])SB:L906Q7Z,V-\%JD<1?*LITH(M
M_HHK3$/:0172)<ZEG0ALY4@6RV0-S6>C[[S2!I$T;HW0JEU)P\)*D@PP8V.>
MHU8QU?",6:/=G*PT;:SSU(T):/Z&=?"0F;G)7KF%)0R4R&S]/!1L4O;(,FO0
M:C2M);(XY$8?>%/ LY0ZU"RTDYZAO*4T1S$K4-JZJ_TONL*9AA!XA7L-.\%5
M#/UN_/Q-/4*0K]O:0_[:=]L-('SG:PGH=')!+8ZFJ4:14N2'[=7)[=YEPLN=
M$L;<1^"G;;R@N))>^%131B%I-$']A&'3:_7(X%=:"=^V7S&:9SI=MJQZ>MBI
M%H='L;.4E!R'G;,061JG6?0J.1N\</)@R)/N9 (N"P&_'"9N]B_NZ1\XK]S&
M3':-3+O;;GXU*U?>7'6G6;WY6OUHQ4 "Z1M0XF@,H2 %"1*&1=V0H/6(G5]8
MD'_1.&F<(G@#](D,]=#P5)QR'NT<70<]7S91&BJ7;%<C@3;&^"!=D'RONQ>3
MK3UM[2;%[_UJQY(:?&0GL,N>W2[?/DIMFS=:O\]4.2.@E['+UQV7D+?TBZY1
M;N"P+@SMHVKC$R'R4>1$RST1EFM:V_[^YM1 4LAJD*VQZ&KG"FMYM$R#MQ)-
M7=O9W ND9.NGH"!]FX5FQB7U7_!%*^9>[A/NWE!!L96^@\APL[33G]#[';]C
M@QFM^<,KMF"YMI\PGK/1Z[JCV=3YHE6_5=,'@#_8T%(JEEUB\YCWAEM';TR?
M2$ZB-\%8@3BTGKA^<5P$[T]OR7]IGQ72,.Q_5:HD=]H*]]IX#(,'CU&QVL6\
M]4#[?D,K1_E4'&HWZD.6R9 1?"63]%_EU_#_WG@,A"]@AA:V&T/1]HZR::E?
M#\$-+0^ @8QL\<F0F-2 F/RO15,4)7/.1IT<9O%D^DF9%:'P,R>]^^EKA.)^
MS15T0;W7RHJH%U</O7 ,G>4(4E4;OK+"%<[0@Z?\&X_%_8K^->/9F6 GJD\
M/KY:_W'''XN]NO]87QKKF@?&MW'!U:O=.!#_X'P@9K+EJ$Q>2</_WA*W_W_4
M,*EZ4HY':XV_X[P",]>ADM\580D52[[--;*GBU8R"@9WU)[2+PR!C ('ER-
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M#8M.]0,+GX2_"?6RJP[\Q*$>(R==_$="&E=6A#)5]U1&9AHN7&B<2!H6N[C
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M%AH:WM+-=,;HL8S-C7\/TQ/R_X:+_9&I'?'A ="W8_0 T+EX (Q'*3<KHVZ
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M7D:DD&K#MG<.++AMWM1QD%-3X4+?7(_1C6@BP^^H+%%:-=56$!VF\X5DR=1
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M&F[%</\Z[K LVONYNKI5*N%EGHG>QP0%9A<L&1%@8:.A@MS0QV_L$@)(WU3
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M8T>7(0K%?%JYI^K>N(I0A K%A@Z'W &@(!-I]=5E,KLLKF\]633S[]]I\1U
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M8OI^6,&OOLA!C$-@%DFW_6M/,N.T+8Y?V)Q]S!J^P&&DKEQC?43:BS_=!"-
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M5QG+#-"-U]7WT#X4NM/ DX@P_%1+"K#X^]?QX5".0]*S057X$[$?3V:8,_&
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MVYES40J[Y!N#W_L^_6EO@I>271(G!(;7+E_."7>)39Z+Y.NRMPZXZ=PH)Z#
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M-=0,R4^!5'^QZU?WPRE=:N=S3/SC? X"H@;GNZ_#<^?L+H B'UUR!3,1'N>
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M,K/= 11/V-_5-7('-E!%;62UG^,7LC&^;2IJ=EWUY45OSYR=?'^?4G+O%1M
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M13<'E*(:Y;^I1-55/R=@+2"=L;6XW"G,WYSE<;3SD5'[1Q J]-^2G$A<>^\
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MC<%-13Y,\[NO77XX#/;V Z:^4+RAU2Y%32UC(RU-:N^$'T]L3E8$%1U@@+?
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M5&0WK%I$9I!&UEH5[?J';W971H9,;<5-,J\<:O>?#7M/]09*(:RS*"?>95R
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MO20U@9>CS<>3%\O0TBE[DA_#G-A>=F #M=[W[>"+YQ_D!Q@Y-/,&I+>1?!Y
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M>SLDA2!IM.#,>/R7_U)DKI6?DYU+/[B72:Q_T"(I"NT(D-$H&9J^QK*6E3@
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M.72IZ=K=KG;<&(5S4<83#,# N%X"H3_7Y\#_(921>]N+E8*Y ?PC&6K1@!!
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M,M"F+)?O14HO*45HRM6.[!GV2"5KR3'OS&6(?A\2;<$U'PYW+I8OTFV95?W
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M+^GD/?E2LKR/BR:!!H+VE0_!Y]COEI%:85.G?\*KKEA?;5J:'LIQ+Y-C$"T
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M[GOH3$)ZKXKBRST%T$?/I_J<6RE9\$C=;;&Z&Q]O<]-41CU&(0!P!3DE"M=
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M .,2G&$>_T(1"M?3J\I?D[RY #Z1LYZR@A43;*22C6F,MI(25WB41Q_T+O0
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M6TWLKB/>B,#M$BORWCJ%$/667SY7MVD[X;4/UGSL'^UG[UL./YQ()SE*BOA
M7CZ]L"#'^HNE[BL O=1(, [!L2JS\1,<>UXJU,37KR>Y$8J?6^97U[-BK,91
MR*8%8*, $ )@!7WJ%1$OK=H0/.S-1%]7;P%!'3\]8AUL]@3KC]%VHZ#\_:C)
MEQLPFP5QHM)M"<;#8R-K+Y?I(6I[Q(M* M\SW!B0JO36B*J=@VM$TB,YOB)<
MM6?WL$)?\2_D%N>I*=L5C"I^_G'J1>=]Q(@@!AL2JXRY"Q5P''!/F?O[RN_W
ME('TCL5\Q;KIA&,&J:RI8M9\ILTDWO6(>?#B2Z2?X49SYS0>#=4R!27J]S%2
MBBP3CEZQP0*5D8TP*U&[F@R+/"MV!P>**/*^^._[?GX*VZK.-EDOG"+6]%)=
M\O.$AW8CO]FA3)?8/WQ#S_X(<7Y4%!(5MBO)K#IR5FJ.]%R!'_FF)EXHT>CE
MULT_8WWPS'4ANY;ICD1Z]=I57E>SP[LQ;H'K03$%;^\@MB49!I#:]5!VR4<?
M(3C36)-O;H40F:=X*%UF-RB=:%G1T?FSLUYTF@Q>+JXK!L1%M1Z+8+QJ"@@Z
M-4O8!/T5+AKY'M6BY<1 U[AYZ,@X#/"A1\7/JE[M\*!#K%E13#:J-PBY $PD
MZ.TANO$M18<:JR#CC:L/AX*="@U1 X_:9:GOR0%)(.D UFJ?+IM; ",-Z.R\
M]8K6JZ='*5'I(16<;)JIHE<6S/S*_T\+2T/Y^A>U-+SC5\YR:=MHMB/6R#.>
MI^MU24.V,J9VC18C##O=GB) Z]](C1X)RL!KE0><.P(/FM-GWLJK#?_*5\!.
M=P:Z+#1"_:_,"ZK@U;)1>IOR#'*,"09WG,YZ4463UA8ZL<>YF9J'Z-_BQUX9
M3#M4S>N-A4H%Q@W-\$R<Z$)R]W%\0EQ:$M?2W*8'&(S#C2$ 1N&HHC8TL]7$
ME074C8WK+=,;];>?WK.;$S@AXXT&L^;[3 Y#J#%N$"AOA7&#;GFTIO8$;YE)
M*55<?0]*$IGGYN K 5V^) ,Q1RB#)3YRC10&O. ='ARN$4VG&FM/YSMZ\^I<
M3&RV=_4R:)(80#]';I)<NA0E]-"AN\$\87TR1%=)GN9P6;.&:)("9;/-K"6#
M__TN-@#K)XF*8L*7MQJ!G48:7O2\?;< O-!/!\\6)F=L7-90LUD0M7EJF-.P
MP603F-X8[B.WO-H$/]VH3!6:[S3Y2'&]3<3@EQXZ]CU]9F&+E)LAVER;,.LU
M 39AD$6SDJY*5O*L1E8"N?+F*3Y;/H_%-5=PUT]*WM?#4(,[-HPN/7Z,J#?-
MAHJ^Y%)U+Z2)^H!PY9-&#WQ($.$WF@T0E#@7*=>5_LQXCYKS0=$GU.=P)KS6
M&FD1ZN:7A72TE=!W1]HI%NZZ*_6-K[^LKOF;-&9H# N>F3GU$"B0R!=0L6G)
M4.#C2N*:&+K$Y<1%B%\Y@D/66#-/R$I+P.G#2O$=>K,&GOIQ6M&[3[:B4]Z=
MU,[&]E"L-Y0&T!_S;].?K4).!6$#*RP9#BY+Y>!-\6L%>#=R]=Y+DU-Q^I\Z
MU(?2:%E?:703%!U2Y<*N;M_^UA$6[_%'//R8_T^5:A5T*@2K7?;=]7)HW_E\
M*66YE^[YE3"'K0^MU?='(C<V0Q63MI]B3+7:'83/E=6,M#VOA&U:)%K.^VJ%
MW$=%O6D-^AQZW5GLR;5?CC"FMRD">,)8OD'CK8CWHNZ) (@_\<(S5)05;--Y
M#XUJ'6P(/&J2G%\\_BGA^G75$=#?*O'E%O (:6QX2%C#_33.+9RBNAI%"0CL
M8?(=&[H/=)G3T5ENC>2VYT(<">9HW#^I.&?K^1H4:5:J$A182^->HC\VKR/[
M6"EET4[^G),=!JGXGJ$N7[+O$W.!7_HEJCQQ8\0%+;B<SH_,+;2^"IRQ]"#6
MG6*TDPO:2S0=$PMEH/L)N6H&(>B^$R_#"CQL6%:3<;3<7A+$B<+\@@1]SC)M
MGFQ2=5*EDDU,$DLJ1-EK5MSKYO\DQUB;N5Z1C3,6+R?+DJTLQ6_- P /G=/7
MW +,#%/I*D5SOMT"W,+LT0DNTD<;X4W4A8)I)\/BO!+3Q; ^9L@\:\++K=G4
MI8D,%/?BDUO <#0FK?OEW )6$GZ!2[MU6E[$+1B^&NIG_WY76\G5[4->^0 =
MOUXNNY5@YM <8XF(6(;BEEX:AF?.;@OQ>6)XYJK#2. ^H=0%Z=HBL033_+M%
MI4Q+%T]UF:[!WS1E#OOL>]$;,/ *J?=28B83FJ:EW+U_9NZ>ZON5O'4\E$W/
M4]"L!'/DT"^_6;!PN3CJH._J1%?CQY?Y*UI2&X6QJ(9D*H]@E :B_:*F1D>G
M,9P%804@=!D>6C7;6,@=%P216<ZX#8>ZA38JV22HFS0.O.>\=Y?BO'\E,+IY
M9\M;_]USNV?5U>$? DCQJ-B6)3<YH<C2//T%)/ZYYUM*.WRE!RL)8@$9OXBO
MO#2B[*V8)@(2J1,?YA6L&]]K7?4"G6VQGNCM2G AQ]Z.FM6,NO:ES^@B3GZD
M$=*P,P'R:CF<Y8"8#Q3$!-E1C)$J@)(GO8^4?DY*,-6&:HQI L\*22R=?I5O
MO,2%/P$?Q"\62!A;UP<K*XSX-*;+V"T[D"Q:?2[5GYH?M(O3=O6I;UOU3^MT
M6\4_Q>18JLEP-_G]9ZT\+KFOZJ+7/W@4'1UCHZ1I?5]NE)^T$H$W.HT>QN]:
M[DZ,9B3W;ZF0BZ=Z&.4<=:O("^X9W3N")2!2A )^8UEXX!\DP]GP^3S-&?.9
M;IRM)M;7/%YUY+MPBDET&8>E XWO3_?86!:Q%#CG9C_L[VP6+CL8DJ3K&</M
M_A#8A19)^P:J$GQ.0_910IW^32K'U4I$$D(9G@1YY/81LA3S.EL$P.%_PX^<
M"(DZTM<=<4WQ%>I1^9UXG]R2A5V8=W\P=#6^KS"(YD.J=@X\/T_HQVYLBM,/
M\,#/7[4J20W.JVQQ(E*1\4._-1. HE1GK:'TCUJ7.<)W!7DX@.JD!/B'K$:[
MN!]I>UKD',6O3E;(&B$6@KD3*3E*#GPDL53LCOVRF+2I:[ 8($@IT$IM1<XV
M*U4OGWIV2;/G,!KU)/"+,1_\;7[!H#.0J, R*P(!_%><"?Q_?4W"?\SZ!*R'
M<[< \XKT%?L##B'?^FY'_HB>P^%PT/*SZ#5TWSF$*;_G6ZO(<-EI"9<^6G)R
M\>R %1U@ T5:W +HKJ#7&!K \IWP^#] 0O3^/O,Q5VX*=<U36PO*GX,F2-/.
M6\!A[$W1#=$N6G;XTJ;5??>:P+7D\RW@$M<0,LF*EJV#A!B?D-P":HRO@0"O
M?U=]M;]M2-@O"F[^HW:?<38!^L^?\(SZ^RE58\C?Y]S>J+K4_ZO&[GK&?;BR
M=I+.:QO28NK3)^FT+^FMES;V ZM.)ADVFFW59,3*F1+SV?XGMDOP"ZH2;LY,
M$.;^T#<HVSR@F ,M&=H0^/ <6L:#1W6 GG5?H /NG*59!8I*'Y6"C$I(!6ZX
M.Q1JR:Y\4\G*G8[;_5WVG>#7R;4RI,S,[_]G@T3Q0[DV":KQ'"L> 1N=V!#*
M49\:D'J=R$7)%?N/B78G59<O-4BKI6O=Q'>G\M^^!.!4*#"@OH4)PJ4)M ]S
M7KR.?1V('Y:I)5=&<L7F[.#.3-%CAO'?9P'_HTY1(5CZ8'/A6=S\F0VHZB8U
M_A%?0_X0_T\&NL 2FU%EH1IBA2)>4BT2CD\D! !<@/KH_Z 4H:>'OYNA[ $"
M$L'%[?:@H"33L_/M #^?7'B94,%+"IH_XGERAQ=HQ<7/D)W<'C2TY.EA;W?1
M1?:V.^B)_;ZM.%;!W/2<DH.HI[YY<#_?NB8NCO-+)K7#F?WU6\!/*O/!M<Y:
MXM:4!MW41B%F1SY5UD]WI?_:.*]V6(IY@8$Q=JVG+F.W@"0(K_'%^?&-2G<$
M6W'4'ZU"0N,N/\H)<2E@?=F18'<L@:)SXE'-Q@>O1,)ZBNY[0%^;&*1"@762
MUT2]3;YU4M* />G;N3=#6 0_8_!>#G&.[_1*/(+TCB(<+D+1(>/%ADNCPP()
M[ZKA9U=L^?;[9$/]WDG=O:96U*PT6,F]F^+NCTO!LPCN9@MSA)VT<F7UQQF3
MA B?XD> PB67 )>] WU,%"II4KH%R)!KH_X@K^I?/B^.9$,S98JM11>R8@R-
MAKX_C-R5G.M<EF)XLICK50-%[&$;?^GZ81VCRD9Y7"_'".<$J)["(J+5W)54
MI>/B@L97S_Q,48(Y1I;)DI4MXWGC+(2#Y^$G=8&SB:8]$]6;667V^QOJ"IR,
M_LAZ&'?2TD:%@M#<]L,U-EIW G+0F_>0GT46/QLD1\2)\_3E[\A_.%E_[L7O
MTP-ZLW((P^TLA[1;'46/R0[M< $E4_PCB=)N 7Q:G!."2D)PU\^S)%]_3KX0
M?_:6[VU%;",E+7]Z=4Y5!/17.]WIFL0,G:Y3T4X&\=E.E+!T8[SR2$F++DQN
M(3X=#Q#@$GU/CG(XUQ+49B?PRBQ0'Y[=(OYMJ@#G;&@$:P<][F:$?_C%CW T
MITR_M%H\GM+(@?.C,P";$LB[8\A,F)N66;8BHV#TH_AX\3XR6V^D2=N''E$0
MN3^G-\]O_URA?PW*)/R2-<91(CW72/J(]E<KB3C/P[QA#^K7LYIFT(55BV.6
M9J\$F:K&Z,\>3KN>!U%-@J7]#>F-#HCK@9=<)>F:%34Z,NWL+WOC"WH,/+8T
M4$QP'C<>7 7@V7P7O'UO\E?ZJ[VHHFZ%+4/ZSY#5-Y.077JG6T#63#TH ,-N
M&#$$T;@"LLFN<I%7(*184:OIQ4RBIDO[3VT4?UD:!=NNTP6M9A%=;8-.L93Q
MTL9)U.1-WL[/RGA; (MW&BA7_BOI498!^%1ZVQ0@R;MFG;6WN]\?R6L&Q[IT
MF#;$WLAXL\0>A7;H)!:Z4;*,[=^)VC[B+["_5@QP.KO34/H(K"]_!*SH*-1[
MGBL2K75IIII-Z+3WN^GX8,DP^Y=R>J, +\3=QNDIJH/G&);T4MG[.E4Q04_Y
M&J@FU'Q4V#[]&T@X6GH?LJ#TDC?3^%S.(,.1=].F\; G?-=')]>WI8OE]</R
M"<TV[9],%ID[,W6#K$NP*(L726HM=:T<4H^#'S\]Z\6)OXPX]582LWD@OV?'
M$/T W/WD)9PC_YPT]2:MA-A:L>2 ?^,@ DV=(G=D<!7PVJ\C7S@9ENW_]'K;
M]R3QBM[4D#S4QVZ)NH@MWN#P/,4<7!3.9"A(QRJ1;1TG\?5@HME!;<RVVIOR
M>?4#L[J:^ /9%2BZ_*)4 "Z!NU7Y9CAO^X(L?S FKI,9'XC5GS%\5A0EWR\4
M^R5_Z(ES7DG_3&NT!,WT:TBEC[!)_L#4 YQPT).^C-\-D'L+2+'.65A5U)V)
MF75X$:_-_=%LT]1'_;SI8C23(/-#8=5H&>&&P5^;HL4OPBJ1<0OC6WK:L7F;
M[GBF/V9RJQM2@]X<^RJ(Q^];?URVD:G8ZLY.6(^3"_?Y,RHY-(QNPY#A;*92
MJ;\/&/WI%W@(6>:;R(1#JEMZUF:+Z8RGFWXM?ZM,Z[B>!Q9E'D)#(<NDAZ=Z
M.C,MXVN-M2EKNT,KZ=] 0ZEYY,IR^9DJBI7Q>O0">O]6+S+:.S+MB-]I(=/=
M7;&R+S8[>6W--Q1D\HFNF0B%,T%BC(,J4>"^!2P_'9H.:I3HFL1].?S-J%HE
M5\MU9219@"F;;=#>9_[PHH>U;2:HSX58.6_>[B1!XOAQ*E^ TV+L(E3QS.;@
M<PM);;E5"2RW,<-AX,ZK386>5^\ ]\##H"C^SE:\*F6O;:4!*Z8Q6 YS:J>P
M[*[W%R"A[_V#N?5RVY9[4SU\U>>UXD>$!01WGD&>Z%]J?"E07?@0:3-F4#Y.
M)U-B?2&Z7^E6:+@R5.?[B_REV@A6^D\ "/\*U$XV:H02^;UG83@R_)[1[4S;
MX/$EU:H;-"#1XRJGEHPJ:^N\^)&<;<T/Y:]O\]:Y\?IP5J\FLRSUC,^Y@\U_
M>"YX3)N\:QIL]#!MX7.Z_%VDSA>Q1HNO$30;>Z*\!\M;,B:WZ],OH@SL>JI.
M)C/\,'I;[HQT-UFNF_ZAD5X!W"Q%M0Y?N*AS*+=QCP.O!XZ_W22U;,?8>3Y
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MP3ZJ[C/R)X^)Q9WIM6;PZ*6O)MF/6!'*M6'/6\M/'??,W@F<U'&8,1P"T >
MD[V?/6(Z]'?V]%;<:IH%'#?V%6QIRS,.[F'G55NRMD71<1&NCW.OV;URS'1@
M5FY__H+5^HZH?[0"*+^$.">#C]?F,=MQ9>C?2DFYR ,$5VT04VUU;3CWP7S"
M:E#YVU@/INA(;S^+&ALP_W(HZIGHP7G&><_,+<!YU!/R\?AJ)?5 (CVA%5%Z
MUXJ.V_\NRC[I<:2,"QX6W*TGDZYGD:(@-9-]?M=0U(U1<4#6L87UJ-9?7&,Y
M?&9?!%05]%H_LU;"U6&6\-Y\_6KDL9C.T\-HL21DL.6(_?%O=CT?U^DR_PR[
M+I#B#F191GIC _T$3SSU9KCBX=35 3IA$:G?=J435+Q *R%D9=:6Z'F?&WFQ
M"RQ,7::HZRG 3U 85+2>$(]?(0K)*SMZ/)$9=!-QRGVAM<R,C4.?#]BH'\XU
M.BR-$G_(DG(7UKI\(S&S+SAU@:VJP!B#U4%SIPWJ1R2^,3;M\+RDFEK$CH=!
M86_-\,_T,^EZ<EX;+<>Z1[PR'/8\(?JU?8"YD1>A5(]*3H:+HN"SE8&G0Y$K
MPAQ><R6%R-GEZK3&ZM#074&\5G]B%7GXC6X2@Q_NEG[Z0[@/*:+6- _I/#1S
M/*TMIU,6:2NR#;LG>KKIO0+CM9.XI\L8Z DS>%._17"''UK 903-VA2U""WV
MZ\F=*7YLP149MP&/[Q/XL920->VZHM9_HL"HB"$?A/^*?6[_?ZTZ_;^K/&'I
MJ$>M_]Y'1'F(M6]_]V!6X4P^9(F%Y$K[U$[LX<7&P.1%NEU&)HW_%7OEX@_I
MH/E6H!EZ^QI+GT6>CY@_O7LJ@6CD^/=]UO]KKMS4 NHI;5:E% AT1BC!PY-)
MOCPI_FF&'4 $%!TAJ)=Q6B1J^HCF'F,5#B<0#:Y*,8]@T+0#WL>)WY;(:J1R
M5N'^];5/P? N:3MRH[LA.K#82D\HW,[.*7\A]MB G0-;:'RS@U)D9\NP\X/4
M$SQ=/<EL%XX]G L&LR5OLS$G*Q9\JYHD*;A.!A**"&X.R9I1"3;A+BW@M#7_
MS$QR@6W)'+;E?SG.@U3P8V,"6<>W)RK;B[ %77Z]!7C\8@4=4N6J:-<35CF8
M%VQ5Z9 NJX9-Z-T<G&N=527;P^JU:U,^_1+U3Y?:.4X''QB6O,Y"[ Y$?DD8
M_?OPW=G5,5$0_;$ ..5F^<\QEVL26A!>XL>F!S9GJ!+2N,O%R.@9R*&*ZR[F
MI5W];$W8%)]?[4?IW/YF5M'BT'F#VW@[P(C-$"[\2I(UN7/KN9J!14<&V2*R
M5:&Q ?ZT)D+>XABN7\3&:"F^!BW1.I*+=G EHK<2?582-V7(I"H^%D")+=_O
M./L)&U\THD7.3P-D0Z?%'>HMXUE\"WA\EO81[>UP;Q/W;0C9E/T&TU/[.;/W
M;MO.OH5-K8]0NLL#8;-=Z53RQ6DUWTI$>FBQ%OI5:^2\_/I?7X-]H.HP"P0Y
M*HQJ^,81G57KNO=J5FNLY&!W[<GLD/]H:.;9*6,F;91G7B>M-(;E3%\-EH_N
M0LH<Y69JH?P#O1MT%L9(HF7%QTVAV@I2*9"_'I$;#H*3_-UXZ&?!>O>K'A*V
M'Z@27C-_^_G!@^86,*!UL&<TR13;03S 62@;H9L6?<<?'C^E45C"PO&DZ0FM
MC&?:9->#/8VW<3WM5 0-L5'U=?%/[].88442IL9)?(D'5R)DDR@SU ^CJLK\
M?X]^?G$A9C@$P@>F!L[*Y:UZV9$.@I6Z9XP_[Z7.D$5L<YO7Q$1M ^7R+^BC
M7*L?"NP.FC(SNY+H$".&P\Z-Z)JI#!-RDM,+O=KPEH%?/ZEX+Q'U5X2&H=E>
M6HVUNS_#BB]/(8JTR(QG/2[4G-7A=_N0EIB7.VIPS_](B+I9S=47HIHD!_\:
MK)7TE"(], 9_(](B,+UZ\?<7 P]N_LCQ$34C&:NCD'V1LY<.Q>^3P:N/IJ6L
M(ZETGG>L,T-I" -%!'\C/?2/%C*+)1MJ0TN>5_5II?;5A4KB2I_0.<OA$/)K
M;O79O[:1U:?M(MU('NY\J YYHOP=+*>@++L_ZUB7:%I-FA0@6BK=K4 I3MB=
M-=;R;(>,:@T&1<SC3"N[SCY+GGU>W+D$J+<]EES*R!-H3BVFFR$OW_HC=Y2O
MDP!N?#LNKK,R?FB4EB^8\,62:ONU>/ULW>GJTB.A#<J=,:A6*<51X?!2:820
M'VN4;O%^+Q]6JN](=&O2+R ZH82Y]%NPAR5L<G(DI;.5Z,?AQR2AUF6,-8J4
M')[D5! T;."L @CY1P+3_4)'Q6E+Z9\@M0<TW!X(1&B;8T=M.W9Z/^&3J&Y#
MJ1T%B48%MX94B=Q=Z[J,6GOAL_BTXUFDAVG5#6ZS1PO1*'5'"\G8:9_0Y:A<
M@P'$-_SC1@M>MV_!T#[>@+/5M*8UM=^/M3^=U4^-E(\TWHZ;'&F'FN1M3R:R
MNV92S/[JY3.F9'B<^K'Y8U,@(@,%72"_!7B"3BU++%&R%-!/$[> 8#N$\15;
M0^T:ZRV MGC0:*RG!:?64/VAN[)U-\L-RN7I!W)X@ (V/+#+:^T#LN'\=T>[
M:/%D<1:QS3,[TXL!=BRY>E82CJA&X"O-#_$VJE_3B8]HZ-@/452I3]5FV06D
M*M=Z14N/0:\X[9N&EQ*:8I'JY^X4"@Z$PSX<J[> #,5=E (BBJ>] =P$SV7@
MG:51B^Q[>JIVHW+WS8I575;!T"D\QW;42-]NI91V9W7X.UB%M,JDGFXS]<49
M@2X6BKT#H=W\?;Z'_#/JY419_>SYY_>*&\ *>7&+3].(C(J8YB;AK4VO8$:^
MK,0/=_SC%);P [JO)M4K0L[[7=-GS.=IPL",J/,] ]QNH)<R?\>+K;*X"FON
M_D[(L&";"3(N>U/YS8<U;O4-08IZ$C<HO8T1TR2]U*&XXBQDPCCF/H#N'?%/
MHVF&^-D:\UJDQ.1H$?)SIU?P[G3?XU9\WV\7Q,,^1+EN1G</.R7(#N%D;;@S
MZVI<8[%]SA('HUY$Z&;7<7N?!LDA@?HD067==7Z?IT(4&1TMS^#/]]4@'NNM
ME ?]=W^"I)'C0/Z>JX.@LYP1E-TC\)"0,=LJ^V8/C>CUTN,A9W"I7J$HAKE9
ME]I.GK^=JZY*-V.1&<($+&"#(_ N?NYI^O?-63TO/YE.USA!U_>]/TG-17#H
M$&DRI+'U/WTT#[MK$89\70(NZV%,IERU7XE_]5+KQ^$.!$Y>C_\&2ZO"75OQ
MK<[UBKMMIK*?R?*T4GYXM=&"A7U82/_(1]E[6960)=N4M"F>.OBS[;;B4@@P
M;"-B=N0@%XX"_5C\E5\QK]?%'X3#]E%2A7\V>;2V-TF:*7N/>MLXJRFO8Y&\
M:9Y<O74R;IRYUDS)VUOFZ?ISZDK>E>AFW%6.=G M0BB7:*9J&$]?SE9VC?RY
M!ZEXI/E(.O N7;^2$\>AC;*J2E8=$0%*WOO&TE*"8<Q8:5RWYCM#D&FD_XDS
MWAZ<WNC;P;8Y.?E'*[R"HN]9$1R*^)QA1\*=*5ST;T55DBR$2HOL9^R6AAY=
M/<%BN@9XT2 J>L):V/H)1I'J;28T>^X=*T=?Z'^7:+C7QY>0[%:? KDC3J)X
M$-]#U0SYN_0,&H"C*X,BO!LU4I1JO1NQVY*ELMHZ;_NEU/GNBS]65'.:RU?A
MG]+C3#[RB*I:O#_;<_YIDCP>4E =%O4+J/I]F!+EOUX/]M$]8M14K=I*)ZZ*
MGFXQ(^<*X?#RW7ASXZ0L5>VD6*Q1LWLZPSG(Y<<VO]7PQ5V">V3]]Z^O#T0#
M-.:6SFA%B8WB_VF9ACHF^-*P4NYZ\OS#?A@-1%[0&29EIHDJT_/WW-L[1UN^
M$:9PJONDP@>46]']!_DW6!Y"^+,#ZFG.C*'5X:P2T]BE+3?I5ZRJ]!<=OVL:
M581$]LCR!JL';P&$N@M;:-JR2OC'D]*GP=JZPF1]5^DMWTH42TW$YJTF:@D!
MGB9R[YNQ&.@XOQUY= (YVZ'GVCI-\*]W:LII3('"PH<;1\"7/8)1J>FATE],
MJ&LS)]6,3,C#T:P+K^RYFE@M: Q0E0'06X!/501$L3;'1R56,#,'G*?@2[<V
M^[B_\]+L>N/[+<#RB<B>UNZJ8@E= UVXC&,K(<HJ'UGC^T$,:6=*IDP![96E
MG#,6&:#?ARKNV=N_KZQ)7%_7C+C_I;)W TMR7_G-_P%]X-F_PBU+!>J0:?G6
MD\ZS8%#'R;82,6!2G1,'5=?M;1:XIYS414\L<,:_"%;OER=5>E%K6X-[72%\
M7'CNO"U7 U7VD_LQ:@ -:F'8\N.(F;'UYE+&6K3B75V!C:'>G?X4I^,U=)-6
M%N-;^9.$U=0,YMHL[+@&?Q60/&:WB!VZXS^7+/-DU,C$XTCQ%J %9ZHX= ]E
MR5X[M&>6G=YUCWQ/0_<.FBN/YD$&Y_@[%8-?499\8D9W7K[']:,\BFZ"KB6/
M3<OWS'9D$O4079(++%Y=@ZZP8.L4W-Q-M+3-Q>L/OKD>QK[!NYG]>D@-E0XT
MTC\2[J(RCFBB_+%@51%'=F(;*\_+9&&R''I&2;K3((SZ='H+N#K_T^M/JJXL
M9?!5D"/.ID+\9!D2)*ZPW&S\-D7[9C G=O==T')GA3V.!!80P,B*NU[Z%D:^
MO!@E2$\V7"P'>5C\H2_[\>7]#K'/&R*F-Z-;2H@,NKFMF5,CVD-TVDUVL<2#
M;#,F3\ G+XO .&< [0T)/%<,V*/R-EA@HL=%QC/01^:(-=0^4Y4"Z<:U]\,W
M"S%:00Z]^,I[WGO#.:;6&5OT2?+]_;D<^DXZF==9*_4Y'.RVHA$(C%_1#71,
M9BM55,5KC*N^>RK.6OD(;]@'ZU+[[1%]%^Y#4;!*IR2?.[_)4>0IGQE:<UQH
MO.__,;QYAV8\DDA:MA,WW'8A)9"/9J).?R7&ALX#.,4;<-5&HUP0=\:0WNUE
M-V$G-$FOES^M//W,('YE07.61R$$>U/8S3VOJI[5U-S"!(9V7#SF^>S#9[<W
MEV#S6=U19&\ ^W0.:'U6VDD=)8W0^A%L?LY^^ODKJK-.R_0IG8)?8SG<E.*,
MUNI:Y,&LM.E(?K$#"3AQN#V9*3EAR8*ZJ2[+J$($)WC8/FACA#[7<6M%-4S5
MG*ZXA;C&CA?>2ZK ]V4U,.IR:]$!%):+N1<1K4A#J%I6_2W@/KABLNM*I*4V
MX!TE_4"B,"4^$A>K/&0)NGW7TL9K/C3TM-Z-5M:$YC'Z^=ZTI@<KZD@=,5:N
MJ "S#PDF73M$21Y!PM[U+4/QB_2B<6KM.NB:/=AHW/NN1D&=/&1(<!$RHSV3
MJ_)DV%)!:UC%>2 U%A[1:LX(<GAXY467*6.Q.3,>TOI#+M]J+/R['Q _?;NC
MG#13M]I4<TQ'2H;D[;];BTPI(_+/4*Y#5^O9[Y5;@-PD3"<6!<1$P%K$XM66
M$R8"[KSSX7M1=-0!WT9S0/J$QUOWH.AH10G26T"?\&_(7BTZVDOBOW<!M#;Y
M"[2&P?IG8E29OC K*K-VZAOM[M_:ALNL=?)3,/DAO*TV5.'->QN_!X>W@+ #
M]1/M,?2HJ.PSG9.<-VQ,_L'O1>-UBXPU=%WTYS&X+*BVP_CTQ18(24U_"R#5
MBS&0=KNCZO#<19IA+DZV+2$TGS'0( G%T7KW%C!"?0M@^7$+0.P4E)?7C#UG
MJ*B"#M3ZWY%-"9_)_MZW.I;$(R67L?>NW$CJ,! M"R6&-(%.A?Y(M2"E;@&,
M<N&M"_17U%H=2[%IJ@CI=:\;+7CQLW&!V90' 0CJL%_.MK9/\@+X3XNTHGP1
M)>3*$WM5-@.+'.@-A_C'X4,W/=:HGW:K :(35A(A@SG5'%-(W/8&'TX:/=K4
MKQ3S3A1?,KI.#/*@$C1;HUODHA/^>&5P+I+AFOF(HORU,E"0?QSO5J2+49IN
M^K/ZB+$.O;3.(3*!ZI@XR+RXKW6VB-$%?]K+E]6FU,N3X3E'<L'/ZNH9%O3+
M:U-O ;Z?<(01]U$N^@T3>71164;;ZLXU(U5?T4?8_LA4_)/% ++?/<M[LLLQ
M8;GU^$$7,TVW -"&AH_%>/)BQT2RN(A5-9X_6SU3UOL5[/$(M)8*'GSMM6RV
MIN?"FFI@XI/YOF)D\NY'[_I(ZZF=^.;><Z;2-:,270G*T3')P[60Y(C,S/#7
MP9+4&92FR-2)ZC=K@RR#[-)Q>'=-D*5=9$8DHSDMC;:]SF6O1/N12[Y 51.D
MY@+C$5W&<A2+LO3;>/R7T8+7OVO-U7901;]<:7$UD-]*H(^1D0)ZXK8RU?E,
MN(";\5N Q7A#_,]SQZB;+5N.!*H+TWJ7Y=;0@[,2>PCU3O^"3V>*EOE/VT@'
M[#+LX%O F4ZQ^K_UR.<6I-:G]>?=O3_5<^2 "D\^N G<!YWJZ[ >&J-?>X)V
MSE5O[G(6_W<O<4P>3J>V1C83O<Z*X&1T_.>BSW\3@M=Q^\MA\7_RJ/O_+F+^
M]4?'=9!O1:M1W]OMP@+XR"OY'M7';TZ%\R7-#=>5Z6% 9:^$W-9IKF>U)W2J
M7*\.7.*L'_*_J?U=0K8P[SL_K"/Q P:O4=?&_X>MX??M-ZZYOEQ0>WBJ5>X-
M\?NG:H-"?!1N 7@D'CSGJI67S++B@Y=#OJ&Y5M:+Q_=:;@&E&.Y); #I "$O
MX)!%Z*4@P./+?\"_*^?$$VOW?&J^_('IRZ%[-D0=='^"*'3/>!-B<2P$&3"\
MKK68,LVU-;X%](KNH.M!QX(=*+Y;P->\FXI;P/0F]LB_[_C,7QKI,!["=8#Z
M\AIC1G^4$N\D$XL5_B?N8L?YA_6I;G/"\R#%913>+8"^%G+V"R+ZP3MM\$^7
MQ_^%N 8NU"@#J7,+(%]IU*A4G(!,8(UZT*>4OI&@GE:YZ[5[TF7CP-4Y](0M
MIK%\][M9\JH?"]@#_83HO@%%-I>'14J8)$Z\_PD;-DP60J.3;MT"]#5>CL[(
M?K6NK+<N9<47\(#DS?OT2]OO='7VX))+WZPW:QOGW I[#4(2]%(\GU%NA>#^
M_6=EG6C#BM3WO!38VP61IVO^L$:$43-/*(K<1;#1KJ[>Q([8=#\1)_YLAIH.
M66*,MZFPW$KP;BL"]QN-Y[>ZRQSQ\F$_!>PI_/46WG?*GDL:3/+O].9R#J('
M0@QN 2N(!'@A=Y=SG9IO'YH"J3?[ZG"P^>3UPQN4TO.XV!,.88[ $5.<J_3F
MNQZDPTA&S9IQ%'7NL.U24*V\F<%Q]"=.;&3DS7W@SO?B]=GX^A*!+Z10863U
M<KZ]JS2"6NNXFOJ>MA7CI>X8@[.<B$8 (9@25MDV\RL98ZJN\RK&9V,RX2J\
M2>I:T!K%^'>W )(S>8&#.T8][+^24NP0QMJLK,> C%Z/(OJ'KEM5PUA697.,
M3!7WOB74=:\S^7TM\AK3V?]85;PWM?*7SC"X#?VQ(Y7#=<&?-B#H7XNZ8EWF
MKHO15*2K4^\LY$-.4LT255J3UCGE4'*;[UN#Z8WA9S.YQ1AW(7J+\6(KC!?K
MV(@9)XM!"*U=%-O4N,R9XJ'+@D.U8N;E&[< ;$Q<-("W[NQ"-N^4^7%.210=
M\<B.C>S9%%F:/-QJL+H'(9A4.E29ZEI^4##D(KAB.H:E"1&?</@'QIH)6JAQ
MJO9ZK-I[>L.J6#DJT"MP??^U]B&,A# /GJ'N%:^V,_'"6N_N35H_;L0[BD=^
MWW /&:A&"R]N <>$&"P+4T5%N2SJIT5QOCLI#?"H4%WVGI43T;=)S:/%9GN)
M:@-%N=X"'K6N2DY =D+/2'M\'MX"8F1+;@&&8W_V6DRA7MT"8K%U,1]$#]>N
M1+,/JR+I&?G_,N]D0[ZBTLP,2[+(DF90K8EGVL#=9Z>@/,4$&ZF2TK^N3;19
MX2J2*K04;8KQK'&JCWB+ 2)M 3&^L@>]8U'-L)R^UJ(B=]D)_Q4H .PA6SMF
M6_V^O#/;Y;."?^S10$8\YFGMN)+FW0(>:+1!3BDQ0%.W%1DQ5GVX$710\JRA
M>N34\_TWZ>X="SH*NM!]^.)A.-@&';R'N0U -@8)6E,'G]47:CVI*%])YSGB
M#K1#W( ZT<1-.HT$RG//6*.,Y_;5+OS?.^UZK4Z6@I.,J4"!I8+YCHJ2=+0=
MC"[O69QFGW-2:SI@65ZM)4(]LJT"C@_N""H#Z:U8\:D?Q-8=OMR;*?61'#.Z
M6#XOLK AY\1OD VDD>U'8F\V<Z2H)KP+*Y!17MS?]^SI,'Z$5)6JKH=7I[U^
M:+VM/3>($ZT&#%/G4U'8&/O=>(#42_^C<SV,5AR\!71JL[;?@#J\%@/?$UN)
MVG6=559Y/.0JMKU\KA@GSQ20X[(K9[T'6GYR.'GS8$85C26'><M8_O*O \><
M0F=N?3JW(^S.!=PCG=#<=]6"=HKS2C.MT[GJJJY]*J&+D8B&Q1"]W:M;0,#>
M6H/=)-G0Q-#E]:PD0X9OCI_N@89-@T>@N$C.0(&U*-F7&%G)]NG7NE/I=R*=
M(3_3QTN65[('LJ7=,F>E'$Q=KL??O7\4 L3C]!^F&*Y^D[Q:(2/+=YYD1R=W
M6*D8<8$@+/+E"[E^')N-X^KNC(6J]7/;)_W'XQ5.D,\[<VN+SV!]H\\89XP2
M+&$UE NA[NO(_:E1Y3R+\?T*J6W^ (FZ,R1+^;C=<H/_4D/88R9U;AKLZ/O
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M5)57M]7/@BA*K;AYND=R@Z7WH!<A]K:GUT6VM+)H\;U/N:W"#-(JB(G1J'K
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M$NSY4,LOQZ8COV$O5PW4D_*WV9GW)TV81LJ8W.R)/28"73NS2PYJ3V1T.1]
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M+CTOT?2,!%?M+[R2 ]$0]/"/5V7I-M[ A)[O-L#%!HX?] -5HDJ/"-+2OLA
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M._[$D\)CE@X'JDH_\!]%F54O OXK.5%M6GHKQH9W9W4E<MYP*9JV=DJ^="Q
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M@D'KS7N@PZ'?Y.'RZ3.&J;A]I_$"$H85-T=1"H1)]K;VV"Y7OVB.7XA#XGI
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M+B)N .&:^+8KN+R&GV:\FJ$(:RL-YY<-X<;J#XB%]*!:X6H1B/N#=$T^Q1I
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MLT.'EX8 %[_VNDRRP+!*PBBL\+5O_C47%&\8^$D[94^(MH:[*#AHE9_^K*!
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M@L7BT1KFU248GG']D%7WVN/K#: 9=,VMQ>:LIHES [@;5W0#$%4"+U;? ,B
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M8L4>LCBC6U$RQN6*56^CLKGES;\U4K/X "F;*J*W24541A:7DU)$O_#R[1B
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M3L 7@X6U<^6LEN9Y^7?3[<(\[6I[.NT'<8Y;1 1-B9BUD3IE'Q5X6#FO:FX
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MZKLMERFE[O)4C$[OC*G=-I63OUA1 O'LPP1'3['%(V:[G;B L5P"R(MVRL4
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M&^'X+DM[0 4$E2QR[A!D#UC1& =E^'PQH6DQ?;N;D;BJV%ER[VXPCN?KW!M
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M\"5O:DCHG)SOTU(AFZ32<K_ZU E* N'O2MJO*O@:9TM%\/>ZTG@EG3Z[B98
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M96O)R*$K-R%)TCE+QF03SHM27,+ 6:-)-$".6_M5T_I"Z@/5KY"&EX,H(O#
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MBQ>> "OZM.KGIOUU^G"=BLQ',(?%PUH%HEIENE:_(%(2SR-<F?YLH=/VH'?
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M3^.M,P.BUD6=RN]1#8DV8Z1:;\/NHBU(: 9D,@/"GAA;0V(V7+RC4$![S]S
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MS;Q.FNRP#'FG)POWZM!#E@!OB4F%"MA[._89_J&!L -&T1E@ D:#NVKP#;
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M5D>0GZY&I)!!SG:W=&[$T^?U'X6&/U))=!7EZ[$*:[]:"YL(4)?#MZ91+W2
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M&G+*ONUO%6.QDA?3SC1XC20W\D.;\=]<SIJ0(Y?N&P<IY0A_&^JHA]L0@G0
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M4Q?O];_D8WT>J7]&#-A#VB[36)1)]-U3Y8W$F1I8ITZY0ZX:B!G#U<G86>^
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MF&ZN$2*,[8;U?P74L 1.R%JQ'F3*%GA+P[%=.TIZ[H-&V%U'=C=?$@]O_0^
MIWK@@50J^/AF2(7=WBZ5<80=9]:\^(-JRE/,BU-8UHT>&OR_1R-$XVOH[</Q
MDUQ_"744 #NB[C;W'%B!7,\XOEGD+A8=),K-%J-8=YW;[' \Z4IZI_K W<@
M_C3;FKD]E";\I,7%^G&GG#[-7>SN?</K)1M?51)WV3ZU9']'Z0B?@D\-*OR(
M,#I)Z]8;Z]6^(>H>FT>ZS$7UF+&!C[P>2O89NS9W<LP@:;:^BA'Y[>W;D67W
M!^:X=Z\+TP1*(3I]3F2LC[ELVHCL+,:D2-MNQ%$ 9JDN9"M:$&3!HR['_E:D
MEH;L,6I5>)MZ\^5?ZDU->1F?5 JJ$KDO:I2+'>2:YZE2]EU&5_7[4PWV'ZA_
MVKH'4O0>,)@*$:PA5="_,@R!-P4L\(Z].\*D)IAO&S)S+'Q" KSZ"JC"/!=A
MI,ORE?(_>M09ODQ+QVM!7/&H5)MV[G/SSII;IRQ6_GF'4V^,QKK8JB%?L.CT
ML!'7K&4JVU''6M6#-K>\;KW-N"E,+%IA7ER1?6U!*@F#91N^U5?CC#5!G?M"
MV+GBJY?RHK*886&$P>E7VJEMV6=\5Q-?UW]=684<$?U1@;&DDNF1A4C=.6Y]
M23O2Q\<(4V]R))&$=]&=QN'U%.P)AY1K%=6<V9"OT^-Y,\,LQ6[/LXM:GCU5
M,L/9Z*;I[I^>LU=E8,.2"%\XVY!Z4N/%_9FZ8NSMZTBK&/GT6A)F)O/CK'R6
MIS$T)82\&@YS5_$AEV6:O^I=5L2U)[GW#HN_OVU0XEEV2(N66.,B>AMB'NC[
M>)>.(FAE091@H*Y=FS7G0Z$J-"ZXJNINVD_7X9BSK+3Z0FAV'BSA\$9\U<:V
MIV)V5WPW3\?M,EJ$Q98_,F%PCJZ-O $.Z_2,@WVV*5=*^L+UC.O+*QWZIP];
M&/(EOU!V-7J>T=)RI731**_%:-<<:H&I_LGYNP=6)JRDT1@J.> +>X8%-GH8
M?'SN,.KT(#-BG">[OW@^"L21IQ3'4;;#SK%A(*M*X:[WNGI84/[@;4F=LA_;
M( *I0:C^B9$1(WW+-V[\AN!W7U4!"F#8AP*D@Q3#,]8=3;YL)(9#[3+J-U>,
MVMGJ>4Q&3C.IQLR4#QD)%EZDWL=ZT063!&PY<O06E7-3(H9]9R(7=K 'GR=:
M?M2/J.9Z?KZZK2A0_'L?O+A\ZR%U4DD9C68AFQU(P+B)K+"K1DP47LK1:RS*
M3L4J?8=1B7>-@<,N'H)$1-(_C'3Z<LMD-A3(YM4(<R=I.^T=9G*<+UT:>K-U
M5+8+!*R&C201L*Z9Q= SZ-XM<7%&*7<IGI?W%Q84P+*D9\B@ 6LYL=\NN%&P
M KIO(E^CF5K2FXTVL+-UGJ ?8EZ#G7:DL)I':4K#AOSPQ16A[R[NY;2^RQLZ
M>KU^'DT33"EW>7>F)4Q/TD;=5M&*)!YR_N!W)%6NU$J_<!BLDI2XY:E,OKZ(
M@=9B^F--NWMHURC]+^G?<U_T+6V;]=V=>7/F>8E6F4C%BJ';H$440"YQKYXS
MVW 7@NEB\+>)3(FG'Z".Q?9'O.N?:>_ N&*4ZT)!-IPK'2N#-OU>P23W9\,V
M:=T''?1&_$(]DZM#(A2Y%LQ_&9'6LT!6B@CGG>?#7:S9'$AYC'B(_>Y(8(P6
M8^D6P<M:KKX&?JC <9&1SZVW.,*MM@E)JHWJ5%G]=5Y, ?HE""3T9H@?TJZ\
MEC@L_ *2Z/#._PQPS(KX/JD %T9*4U?=NJG>8HX)C O%_!KA4RFUT9DZ\^3H
M;&2\46ZL&ML<%F +P+LS[>"<YEV]\P,23(NS&S7FMK("5PT[VX*4$Z:X.982
M\0]4)[P4811]-$6:^&UXY-B5ZTV24CS[YJ@ >-#WT1%WJ 3CBLAI5\BYTP9F
MC'*2$]H\V-,L76#:N^]PS%<4^1(0M3E9"ZN+/7/ >E"#NPY])?E<5.104\R6
MDVM]M# G:::S@OSD86:Q>U)78DF83\;VX$;$R!QM%,S[SNSWGAME ZC2T>1'
M*A=B:Q?KNSR60B+1C$-'@4S&2X0.LS/EY[0+.4:ZC3^XND;(5YMHFS;NH !V
M]->*U<"[HC$KA%&/.W6W2*'>DQY'LTAC^M_Q[O+\SC3F5U]2C"QE5;HTX5"D
MPC[:VJ*-\$O!N4F"O_Y[0E!*R'D82>/S7Y=71B_\$\)80\V"&PMD[P2L_'"/
M2'BOBD1ZPZ?,=K\0+#+ED.S\(_1H6HD 2?O8*\HK!@7XKMW8Z1-&]R1Z9//G
ML*%/YHTQ?".;)VA+W_) !4/E>^[MJ9@O _@[!T>>&4,^%28==EZLOIM@V"HP
M,%2&3"OV[SLYAFAK@S>+S&ZZ244!]EW4 [)+DG<ZZ4DE0T*.L9%BG48D"(\X
M'^T3AYM*W!T!HI!4FDE;DO&L^-X-V9DOCM_O2WXTEK\YTMI6M@VD/EW;2Y@=
MEB%/R/OK2_H<4:P\0Q+75(Z>7K_):8CGY1=8^C:.PP"X@QFM=;%*>]*9UH8"
M4 F'.7ODI&+Z'4RW*I;$5)3R49I'+49XNA2L?>46?BFHS>6=HE(;PIHG\'>)
M@-A3B]R8@\)]/!YH,CT\5DP/QOP1S;_?X0$.0'+LUEZ$?!"H*U 69:AV+!Z6
M7?XXHTKE*.X)ZB14*#<7*_%7.),,"FD[LON\ H<%YXXS!>:8/68,H[%U&F7Y
M64S?O$AN5_]RA;4\16-DA+O\_G%6%7ZU,4X+OJH:T6H(&=,D'PXHS#3CPOP'
M&@K>__0O]X+_#RY#HA44X',C^\B-0?[4]$XCJ)PT-EQJB-2&7B-KLA[<A_R3
MPZ@!,SEE4%\_^5UA7Q.\0L(2C6;2;N*"T7^@J G;6^9(.W]EGZ_S!'1BDYO,
M].7<_:O]5>#]AJ]M:<?/+(%GZT1H'UOE"RAB+IV:=/BD:7>#?$-*"%%V'^K
ME92>H;_PF./98;]#FC2TOAF)07O9V=1!3ZJP?(A;[EJL<7Y9_VW*169G?W04
MBG@@6=#K2^TN!B2WAC+O/!S]T&SY\8.=R87F)!:6R)ZXJ;H*[MSQ% ?H*U\N
M06]F.U+\B+P=:NE3,">R'MTL%D@K)GM?;*P2*734%71 ;@OC_B1Z.Y$1=MV
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M&GL\#FL<I5'C^'ZLSN-F@M#2KOIS>KW#XE]*90K6XX1&2OPV \TH.%(79<C
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M".)M2SAXZL*NVTY!1:;QIC2IPX_*+.1<\O>K\_E(=\%6CDV$8NYTLQ:87BE
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MM;,6XM5%%O0=OBT&E/,'%E)!K3SQVB_3J4OI^YF3'&=Q356QR]<.@X:T"[1
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MQML9OW8I\I0< M"+#?[$J" S<P*N)^67K)EH+4N.[QQ$#WH3<+SA<\.OIX_
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M<H8ZI+EJ2XEA,N^[0)A^B7=3YSDC]82'@ZTULQ5I"QQSW16BGO<21=5A]'Z
MA&'VRDS0.M\CL 3 ,!RMO82M7+G+O^H*O_[%7Z[KC&.F:!H<?K[.[(M0+/6G
MGM@IG0^0T(E]XDY_\-CLJ<3X?7F,:O[FN)%$89+]F,EH3%A#R7\_/\U*U=$0
MNO*P[Q[RNK=@QP+#O)W1+ /-3OR I?LR75SL^0>B%?H-HL78IU"3$PA]+=^
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M4("W2R'G@/SW@_M_.\A>,:-#T2R$'/=ZR&A_JABX9XUBP^^6(V"*9KZ 91R
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MA^7$(L?*<)*L8YWJ(8+P_+9*K<\EO*W)TW_&X:"G-=XH#/S)TKC'?7<JO;I
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M2BK<]&S\-B%Z4:+(WO7$1&%TK^WU"NNK%N4(N9S557+K%CQ"Y#*4Y!FZ0CD
M=,HKOT R<)KM_T:EXMO^.2)D"TJ&,5TJ>ZAF=;V[5_>QH9'/BUFW$?]^7XB"
MP\86=X@AZ=6RFQ,_]OS'_,56*BA,5)A_959*Z=*8X0"#MU+W4W:/*IXA"3N]
MF[G7=5J3!,0D-'/L,1\))GCV(-,K,7)N"SI:^GD<CA\*PJ)81'YD0E#!6JT3
M& X'TI",[MD2_QC=FVG*Q+]Z1=Y*NX*E.]!B.?9IIMC2Z=#//K85U):D7:1T
M+XB&A&\X(&QSBT%:NAG46WX:4!GT1:?O[GJ,AW&D*:U.)F$B=3R?X4O+&G=6
M"T3V=DK:9 JR6OWKN.CVF1C/CF6])6E3]4/96O(F MZY,/]+OI&-_*WYOK+W
MA<_["AH.:@)I4(]T[\=M2'>HOA>NFNJ_%3<2'#&) T3BI?]3&^QCPS%W_6;%
M )))"OY<5Q926"U>;%%H[\+J ZJ'_2_K(:GU40%[+F9^*[$ATN\9$J?#PI8D
MQ!.$/.MU);JZ#@![S:C90/H*E^QJ?::7@]$OE87?16[X]TY+Q)0[&CZ.AYO[
MF2S*LVG\(F$Z @L:'8'#6$CV:J(5Y)Q-]-16"'=.IF9UPB\&5>@)))G.CVFV
MJ?75J^T'%.Z&1IF+>$GM,QMK^RQ&&\U/TW.E+G6H4":_DF("2(FM0DG\Y<KL
ML#+5WUI&CXEM:3A([T\.10B_)XD7,CM3>FPOV0UO<,O.$Y/9H3FD&0YI5IC&
MC)$2Z@E]SK?H&'I,T53N8JXUJB0=<\4@HLBAY5TS^W)F4.D62")M>4 5UO"^
MDXY2_O5>;E!O+UV%5W8B5^^>OI%]KL_S08Q<[;<J)&>2L\>UKUKA[<M)MZHP
M.SZ$<282L8'4FAX^G"5+O2.IPH=3>S.'OOG>Z^,'1T"8TJT<W36%).[^6_?/
M,A&JJ,L(9M#0>-<=9+P;$YM>+%>%=C*TR%\*)9?\F?2X.Z3KE);RMN.B<IH2
MLY>421 4!S#CVS3BTRX%]8#UHFMM4OSIQVJ9!1"&#*%0#UMK[PCB<".YGZ3X
MA34IV$-*_M_8>^^PIKMM3SP*"** 2!$4" J"@H#T3A ,57KO*+WW$EH$!*0+
M"$@-O1?I+8#T)B U]!9Z#S5 @,%SSS/SON>>\YOYW3EGYGGNW#_6'_GN)'M_
M]UY[K<_:>Q6-48R.%7=@K+?;PXF,1WZSRXISQD&46*5TAZ56&=EJ7IC."#_G
MRY3!I/=HR%*M<ZCWAX&!%=.9EC3\(5VP_T?7Y(=$-=SZ:V]0XU4<;9Y&);-D
M(+:I<;',=8.0<\N0TIM10%4C)2"E;8.!9FTC!#J:+QDRP\#X*7UW/))/[7XY
M(6JRE< F+_D%*S(>A)%ED"J!I?\2XO('QY"2S5HMT'(&T?DFZ'<]Q)2Q_T1A
M,+B\?RK*N<8U>(;;]9=JG9+_H&&\LC=PI?Y%1A77__6,YW\E^D +EA6M#Q]*
M&O%*2O]X'5$BEO4_FO*_VC*4N)&JL0@J15RQ]C%=+E]E3I6,$VAVO\@($?U'
M?N220B^=[%X]-#/^K%2&P/Y046E -+G^DF,R0>JKWYR168YWXY;ZOZ:0JG%9
MT9"0W:F>3++'XY]#0H(F:9!K@!$'3-!VC]UW(]DHTDE[])_+#G\.2&LH^*-#
M]O]N?,![=)<B3';?M1!BW<$8,5O-MYFUCW=*.;BH?V]_7FJX"D8A;E/8[4<F
M3N_ _R-55()D/I]OKX;L*'RLDK<Z1GN&-OHNTGQ9S*%.TS"R&_')JOE.U19S
MG( X.$^'Y.#V%E4(:(K %^T_($ 8.R0A,\ RL=PN)B\CK??,+E2?=,2Y<*A@
MXY1G2+C-E_NSB;I*9%,A K>Y;M"'KP]&9C45%VF1T>?-5?WEP;//WJNTF+2H
M/J/O.UUI)2%M"]> D-UE)2><JF@SG.P4'2S$W<2:8LP3A#5!\XE*3@XUU-/O
M^U>[3%ZZ>1$X_A2'GS2O4Z)B/L,*Q21-\P+ZN!O.;9GZU-ESGY\N;GJ"?W<N
MRR>7H<8J=O_MU<O';A-PI5PN)[$T2;<UB2OS(\,B^<6M^69ACP)DW%HF48!/
M.IA4->[_:/K._Z+_(#&EI!;G;#[L(XM+MW"B-]AZ2!G;ZRTJI!:\^[3*=ZTV
MCN]]F"V$WK @<S3F1T9K/7U&>A6\JJE&)U3PF^U3VVBQQ=$KNI!$WP!2)5$<
M4G6;P<^5LKQW78HV]OF77]5(Y1YS:2_9L/0S_5LWK]2[%"OK#!L^^YDXXI;B
M9NNF6<S\67Y\.P13174>9,"S/H]]N[U\/YD0<]O\UM'?L,K_NQ%!3N]N/GA!
M_Q(8[?P/6ZS>Y=GJ9(0PJ_Q'HCO^571;RC1Z3BV.@6GK5\CFT8Z$(+KA5>%I
MS'FDY3+3'YH2))8LUQS RB-5%'M+V^6E<PJ;P@4[AF-A?B$OLOZ>_,>14TO@
M"AU7%L>C\B.BW>'NQO E:J6-WB^'?^)R9VU'!I;4W$S*%^[32\\;KDE+1%Y1
M7@.ZFC*O,-">/"SXO^)-&U%T"G6T"Y^3L+T)'* $N8G0'1"/%GU7;/BVO,BE
M:_PUX("P_H9?%3#A]M> ^\VK+Z\!ULTG'H"C?^K>_I=&)OUOT7]%$/W+R5&?
M$W4"6Z08)PC<4_YJRFS,U]5 TS92=RDNW3-)\O)%845Q!KQ^ J.)P)V*]F1Y
MS' 6_3)3T>&(:1M$I<(JI(0<O"-'U41?5C-ZU.K:V)\'B( OWXHT2!#EZY3D
M]ND_,A^<9IER%58..=@C0*\I(GP8^XWNI*^91SZ1ON^C?)_@XW'GMG]J3CU;
ML,!<>IH[>*^R+_+9LOQGX(<:7/Y%7](4GL1(AX(R!T<=NM(,>.+T$FM#T:1%
MO4802]PU0-/*Q7,ZGZ[U;1?E@J&W@L*[L<)0@U#7[U53FP(N/3T@DW 2>YK)
M-["++:&1$QO;;3;KU)Z*D?42T(\F?@5R20<;%YL38>71JW-">TFY-J$(=]HC
MY'@.2B\HK&2W>+I-H"KE*_XGF1J\NZ:#V*8\.RJ](Q6_FLV3(9GY'7_)W9K9
M/K]'=$E0V(S*#:)'*03:<G678#^L8,ZLF>U-7FQL/A]#ZF.7HUP&*HH8@XYE
M966SZ'84./SHSY)RE!K6OI=JPV$&0R)4^KJ6O$.RQ3HZO3M.^ 0--0^S;J?9
MUU(+JH^1Y3H/>+ (N%K)2?E0HT7V6L[!_8T[HRH*#FS?WO*_^'C__L-;])<X
MKMS=7CSCQP30UI?>^3.04P8WL0LR=XHN?$!)4UG*6<I B"X\--ZPP*.DT"1C
MH\)@?N#[=#O'3\]S@&#,A@9SMPBK@>X-CAOR>FG',)8R-/^KH0P\*%P'"N>3
M3%0GTSJ06%;216<N5>VTZNB*Q"ZV.X9)."*!SLB]U&4S\\$187!D*_#N5&NA
M@XV#^X+CH7Q?S)%8U<2&ATU)9([.QHE%^=SL;5I&QDWO0>T:N5%/R;?OS(O7
M"H6VU-#"Z0/A#%'< PG._.%QXL^P(IU@X^651.3HF-:KEZ&M5R^D2XUB_=XX
M%NB+$4G@%I;JKJU2G7]HM/SVJ_V0OO\A5YD?<:]?+R&G_S0?,!8_TW)XE)HT
M93$]=FG^C(1[_@)W!KI>74J']MZ?ET09! &5FNJ:(M[;#]GX_F(%J,PJ""%*
MW&NNWO:[7;6< L]9"F/0;+\K$\..+QBO_&(58Q1M2)29U)2]0\J]R(:1_-_'
M79A=CS\4#RZ05[C< ]%@A,)+;5S4QRN_M9Z%\KU2$MW-BB[LN2B>9B3;)@TK
MV%3[R"2!1^?'I*;E,IHK!C*3>(_6Z%"G81E6/^G^&N6CM3/AA^)-/\8MVQ4F
M%)TM?3R2?@WX] CY>J2XCR$I_R,YMS[ :YOJG*_3FU._3\9!>J."^F4=LZPS
MAT5FC9_TJGV41/9L)!A@G(CR5'%"R2Z]KO]9ME[__HP^DLG5/W:M@IWR&."I
MGMO!1C+HZ4+D7_EA6$]7(#2&A.IP6$38G7$:5;+5*D)9LU_B2PA[H)ZT-R.3
M26,<E'_N2M-:[!G5K/ZVV5-$K7QF]@8CD*3]_ZQ)]/<-OS1X8^7(3G_'SBC/
MKY> 'BY?4I*1F Z  EBQ;/PH15X]5&'L5<FRVDR/G7WT V$I;)3&^O<8!<,;
M7?#O9;RJ354*Z\G&CHT+,_\NR=.E$!<S79=NW&>EBO1[O_,]_G4(^?.;Y[:Q
M*]< \TWR.!]35^\,DTA7]F1;.KYNS/J=G3K'D$*C_ E+A\I$[^.J&7/7"IW>
M<H#W7>RQ@MNG_S&L''!2D[417:0=F&]B0<>Z(AOZ*2QJ\Q9=2)F9IT6>3F@H
M<YZMX0?1:$JL?+I2NA#7#_6-P>M%6_U0B9$2@L;=TO<VKP'?UNK>&A*)^SEI
ML)04[]D,+XV[Y_J>27^P[YVMI?,'?].SEOV?ZSWCYA AD1@NMI*-4*;JX<#=
MUS^..CG'$^6"*VNX\_X7+"3^YK_O15T/^OO/JW)4>5F&P&3Y:?_W]=J?Z!8]
MI[0=4Q\)F<LZV,7#-9,:HQ>G=M%S*5GE2/:'IG>9#MQ.M1GY%E-A;BA7+8T]
MQF.:,=?OEIUO;N;ZWZ$W_D79)(AAC""]6'A$+1U92@;:9_"-=-S/WK=9Y(=/
MA#EW]K0K_R6'6EC/PTV#D=#Z357DKW'3X,5I%JS!"\JO9]-ND#"B=T@JS\3Q
M?[+U]U\(\?]9THC \-<8/')?TT()7P/VPN$?IPL_BL4QV@&W"SZ"1*JVU9!0
M0EO0(C%JKG0Q]/)[:-#M.[98'#&5MQU2>F<\%M0KKRAUG/";J=AJCHTF7\:(
M4[<_?,.!&P)^L>GQF@Y;92-&CAK^4('S4P@WZ[;'"RSZ<8FU8#2;Y&/<SJ1&
M]C?$/\K/#)-3PM)C&!$69'^JH@=<F-7CW@MW\_CZ]INIEE>Y4[2O6/Y:+L!A
MJH$HS.#@J?0UP(#]&J"]$7N99;?L(#;7Z3JMC&C=>3POLP].'DH[W).$<7U;
M*9<?.KH7(9);5S)<=PVX?2/80C.@B PHTSKSW8:>%-5A16D:Z;ODP$JA*)U(
M%M:E9VKRMWX^&1#=BE/T@2.*$5']UP!&2KMK@.[@50RWQXJ>?FJ@LPBB4,A_
M$1<33L-P#7"'KMOH70,BFI?!OR/EAZX!L?9 /-"R.8KWHNT:(&ZYAW&Y01VL
M-=< _4A,_B :YL#5['^:/-^:E&<M\K@'XGA!ZZ>5';4O/Z84;<\O1#CVNWB1
M2@OTZ,9"[=%J1H<,HB7O:P")A!(RI9]%0Y2&1LE,^+ ?>/CK*6">Z3^^!J1[
MWDS&CQ?7 '2BRLJJ&[4(U(Q&QUI]".ZP./_ X#)4=M1GR.%[T^"SMV>2*G&*
M@HA4][1*(/61V[<'$8;$,3,/-2+1Y%9CKRJI@7*PP;)A:Q;3%@..>\8273FB
M_?9 "KBP@TONE-6)U+LIR+,/S>X24D^;%QBO 6*,:;ER78E]>6K*RPVSEA[>
M9+Z+1*13[A7B$2?DX%I%\E4 )/AF9,>X& *[<3FN[?ZET=\)70PW:=A_'37Z
M3(,;X'<]'3Z2WO]$_S']\T766B2"REBZT;>RA@%EAPE.W+OTWP4=Z6@P[AM<
MO86 MDX4+G&8B_YQ$QC#8\2&9!,?>I&17E]?4U85O;EI'(@7[]1#]U[5,[%[
MYD#A\TK24G- 9K!??Y)CUA'V@/WOK)9+Q0Y>@HM).XH+E2\_C\+@RXN2JV!(
M:8#7'C5&N1;U,D3S:)J&]I7P'6(/%_Y7DM;'&WI$G9HY,3_2,V;+!6NG= EY
M%H-$ID.N8AOTCSX,:/;D#63PE>)@!)I0AC$&XVR[+(NUKB;F PS?8/!)NEOR
M4GNI[EUZQ0:+-M> H*<"N9^X=4:<[ XO4[KGD%0[M "%"WJG<Z#8OE?UH3NG
MA*<N!&04+"'X((WXN)O_M#CG=]$M'"SZF!^DV>JZ;8$T5*'-3M%HSZ43E.M'
MDUK\FI/!E1D<"H)936_)32)K#3W]-_M!!$O-),*%IGWVT]]3<EFGB7+?+37Z
M9&3(J$M\-5[!GE "D]U)_^]'Z?_3VZ.>G(BYNXP)K>#'\:["I+>BS6\=:?BC
M_9$,%2X>6QEXVT6C7\)005%=^0.BQS^ P7G.=F$^3ROJ%'84F!5K&-?N<(?_
M.&$"8#ILMAFMDN>U<SUI+L$./ISCW$X+4L=[A+JRUBW*B^U?THWN4BWS\='1
MHM8]$&S[74N$A<5;AQ8>LPNU%AFSUG/:#..Z<< 7E-UKS;/YJM.A49G%9-RX
MH\>]+TKQ44$=!!X@LCGM=>V@&!.LLQ?8Q$TG^I3E;P9T^-9R7HH1VG:[,'4F
M-@B/AR"/V1[JHCE_5"/JCYJMQ[1NQ]Y2\2J.J5E!WANA^S[H<:#3')K*6EO+
M(0XAJ(1TAP@ZT]$D&"ILJ3U6CFM7(,:S]2;3Y>T8/&.L@1Z/LUW>UQ!>4 A!
M));DVV5N\?2]0A"4,W][A"L$2_'PH:,XVM/=Z[ CL2):LE%HVX&DL-Q_]1TB
MW7(PU'3"ZT)_7!#P\N5DE#*<F@&A=_<*#]H]F =%1%T#?HTWCC<I_,* "]"V
MF[(I#%O;AU*I.C5QI;'=?&U8,_CG.K+C#T$X&^>=A<Z?'W>^W&6T)S5.HU_P
MB/E%B";=ZCC437X.[NN;F,J "^JC1_(5'.BUJ2O5QQ<631/<NML0E%,BR>/4
M-1VE%&\XX(F?-/#QGC^O#L/:.?@(U8X5LR%'.8^4'=F0M:"!2WJPD%4]D4UB
MBP+#6%''Z(\<KJEI2$;<[YN0KC=(%K$MF?W 7&\3MEBG^X*9WNG5R1'MQ%JU
M7&=:Y?F/:$S*ZL!>9QD8711!3E:%)<+&VSQOLD8S(]+3<.?,;_D^$D,@[HER
MZZA1X6QQP4FDB6JS+<)=6@RW.H;,M&TY[SBM)S)WPNE0$7:"VTT,$Q^F9.8D
MOM%^E*<4;1EXS1ZAH/ NW W)VNCIV":E67EAZ".F9!P5= $N!P'X!E7&X[^G
M;*MTJ*S4[<5&+25Y;C7?L[2W".OS.-E^-C&M"1/U)!E!E3[YY<.^5>WVF3N2
M]6HL@NJ3YBQD$S^,RL,(IJ0_E+>)=44<VBC3:B@YD;IT5[0;]-3$%HJEPN3H
MK\%$]EZ9M6O Y][WL:3.*<M)G7>L++M?^K[22J1AIB_O<!HH(/S1_[#VPLYY
M1+I%UL:A@<&[I]4!;M)/L1>\<1GW"TO=GCL)L3&%6L29EQ(AKK@M.0>&S-7+
MM*?]1!-=YND\D1F7_.<($1@9QCC&SD:)&G(YK0..''IS:<%$8N1>;S%Q+A9R
M,(_KI1^D6A^J@'@?,;XD1L9JQ-CGROCQQ^7<S')DMD>LV0N^!DYSU;"Q)3)D
M,W7SZJUK@!WP0J8Q!.Z&K,'\ .T@KP$6:D/HH51&]+LA-/!&GZUFWRA@H]^(
M<9-[91[K&K"L.]J\M0U=O_T=#KWY.LEZ*L^H\XZ@RH'-^X,3R>6W$S\MN^*4
M/6+47O"/6A#CAZ105'NZD$4NRFZE*+1ZZ.W,I)JTGVP>B/SB9:=*)L2QAY)Y
MO2]!VZE]#Y)NNN!R_#& [)'LF8U<4M'J)%1>D1C)RR1T]<@FZ_1B1[BP/4"K
M[;G(PBIU[\6'B70H?,6A?2]*W0]!A%X]0Q?*HEQSC<P*SM1_R2MS70C)57K+
MQ,@IV\K3]\*-R'A'3T.86UQ 85/+X_OBN6"R.JE168=GN! JHF_(W3S&:B)$
ME=FDEQ[*IG+S])'];%<M"=7W9\MNE(H"8YYWOZ"<=[W)P$ZI#U 1,"0!UXR.
MS^JJ"&.U:9^$3V/+MA7N4DVP"Y3 8LJY'CP_F6J1H'MF?@8P0_L6C3Z)9U/1
M4&:BNB1ZDP'?6I0,/HY\.&T963CGG9WFWF[6^W8*S_KR%^<OC3?(2_73M_OR
MF7D;(Q!>Q3-/^JGBL.X"=T-),8M:;E9%-9(@D'AV!MQM$18A!%XB(G_"HJ)T
M 6Z>G#V!$.?^Q&OIS1/>RD('H8BNB-F8.CM?K(Z:RIW%? V& +[PTZ?Z)64_
M9U56<Z]U.A+<9%XC1IEU/C-B/ DS4<!47'!Y2F[ QAL-%F\0^&"84>+<TF!W
M8XWH 1>$G8^1RNR+=S#7BH22QH?<SY]FHZ9OC,.H6B5=:#@&:K2 5G_@MZ44
MZQBW6%;I:B8<Z.G"O8QH?N2EX\(I]$A1*WV#BF?SAP\KQ?CW[)?,F?C?/K^9
MA+T=TB?(\#(;WV$$CRT&7LUGEJ=%O-G%.X/>=]IDGG+6,^TR&$X?=3[SZGY.
MW4FIX/)^(B1AY"LO4XJYZL2O#+ADUQ4()1*,M)&4'ZD",8P#V8Q]WLJ%=19!
M3!CSN655T*5+-AKJ(=-OONADEG<\Q%-:3HBD%/0%1'L0)JL5/+3@H&&Z6S5Q
M6L_<AK%:FJ=":[3?Z3C^^,$]6C/!)KT%^WU9[.!]"J<!@/#6F-?3DDABM':7
M<O>AL5P%(5^4NVT*/^4YL1*3[4NI6O6P+.38$V<-?B2,&-K*OJA3B)ZX%W?9
MWR0*@ELO+!QWWL4P]PM1+ET#'KL'*398N#C:O-I)A30/I5,^E1\Z?;-\#6!R
MR%FA,4PQ[Y01EA+AO<&M@S>P$/'E1A-,-0Q^@AXHV-Q8:,WGE*5X"*$;I1"]
M*9BBO;5#(I&JS1N7']##U^H[D[CI0X6NT*E&.*?@/YFMMXZG,/?*XA^0/OL\
MBYBK9Y2[$'3ERQ^/K';<9>RX!IP!UZX!)<10IN/Y0-B!_!'T?/4:<,Y>V-W$
M=M/[-0!T:1]ZIEIM0+I7:8>W<<X:91LU>/MUW.K[ANAV3.%(LPHL^^6;WF1E
M)C(Z^<KDR+3UTI2B)C;W\JEM60<7G!FM54I#,,4)TZU+JQDO]B5!!=)U^TW7
MCWD?E*6^+7<B"V _@?9OBAAE%,=25+=:<SY/9-1!'[O/M;6<R)C0>!^EG9'W
MVBM<O/-D:_:912T_N@8\PFBXL5M9A7K2#]Z]CS_C&4_P]J6,S#K3AZ>XIMY$
M8'?R*%1\.X\3T0Y]S>A3>MM>O!FB#W ?PRNR'1$@Z@YLR>8Y-[6 A+EFK(E#
M8'B0VON) Y  H[SBC/.66$YG-MG*/Y0_NOW-G7JV\V(7@D5NVDDR[;/O0LA(
ML !,1HS\_*"H[3%*;N=W9:_#D@W$Y_)*DXW0%4C2VH<\V4_2MDAT)"NO9(BV
M].K08^9"'*P^-_8!270GJ,)61/,'$#X;V3 XN]7).9>4SO5B*;^9;FR]-#D7
M786\6W(_/P]\FR2*U'4HEF;^->-QJ3C:#<6J\%"?@$XMXL5>"'F()IK$*)KG
MA-;X> TW^Z725[56BF]R!YG#>06).;D6F1L5FX^&/Q>GZ0VL'6#-1(MBS<$E
M]=#]Q7/R&YF29 '?+\*ZZ;]>.L5BV-&CK<FY92[,$K!VSWZRP_&$&R3%X[0+
MCYN[HAM['J#HNZUX'UABD0CK@)$,YBNPPO*XBS.KC7S3@L.,J#DT&+>TO?7=
M.,YG!77/GS4IC8&6;1NO :6GUX"AP,;<+AK&<2YHD =KX7O(\MP,_+:65Y9-
M2X:IT /19:P?I7?B5BU*:78E9P6[C4U_4'YPE!=P*7X!+JR@TAVQ !HHZ=OL
M)W5H(X)_.\Y5[?F,G$ 9>R^'&6:G#T]%!V>IO9GLJ+R4JO9']W(MOF>O9L&E
MX3!6DG6'/J"A)*+J_?9*?Z]+P:_E-4^:(+ 7DJT#1M'#^RWQJP,;YE#6O/>J
M0&%+CS?0AVN&OL=NB=DYFJYK:@=AQ::O)<!K^ZTKO<"9(?8G,B1G-M(\([,F
ME;G0O80VRCA0E>A)?K<)'6UD*SRR<YZ\])6+Q5$_SC,EVTY^UBR]E61[L8AO
M-#D5850I4<4R47X-PGXA9U-M2Z>A++9DNZQI\#!@(K\A&-M;\39H4/OD&H"/
MC@"2F2M9?GGS"O]G]U#/9) N#7*NP#F;0(MKJS6SG">O--56A '=R)UO@]!H
ME[579)O,N&@HBZPS$%=.X;VGZ[S9F;WSZT4I,>I&:&,4,MRGE48J=Q1ZJH+Z
M)H%1)$;LA31:TIMR'J[^Q9SNY'W:8V8X39V,M5_S=%'1]J]!M^15IZ1/\<;#
MLI;JJ7'(%@3F.T$/]/5 )THAK1/ V:L=?3'.L5!CLW4FN7M(UAHSYSOE4?/3
M0+@:MB-;;>>M<V)T2.E[0=W!+><]H[F\O)TUG23S7-&6YZ*;%(8?)2#4X=*:
M*4__DSAO_9'^V8Y<JF-:,5*-)O2O?;MI#PA'="/;@K,3"43[F+O%)?VVY?DL
MMUSLSK ,H @X[/QN"6@1AO'<!.UU81(_"O;^"UZ/>?XAUT4T(5[P=\E?B$?[
M4Y#<JY%#D^AW$,VY=N0>P@)Z#:#=*CV_T5S="*+]OJL/L).^:X!9&M$_U?N@
MA/ST2N89%*%Y#3BZI3?VIXA$\W>[__#8^]WPL.*M1$XP*< T; @,H,SDTDCT
MDD('.:7IAM-),=4$8/5SWC\S/ )X(&&]E=DR:L_[2 2JC&2$AH59PQ#])\"'
M<#4CUXKJG%,FHG[23?SO1QM=B_K'BXT>\^WU9$VYMCS!$C0<CDI=V.JQWT<R
M2DXXTD,"S$SJBF_Z)!MP#C3O)_V;_I5$[_Q''E8JXVO_NXL7B8O<#5V0+PAY
MLG=5%[FFU_8W3E0YC'4S0_^)O&'^3Q-9#WKDAZL(6PA_6+%5WH^&]W5O4CE3
MB@3#8M;?@!0]>E_FC-0S*"FKF\5/YW;8X(CTD:H__BGU.D;NQ2M)?5D.=N&Z
M?K##H@$-NKWC43#W/6^0 O:CZAK:"H_+&?^NP@?"S&/FA2>1&1(^'=;392M-
ME/L,Z3> .[A\KL7PP]!#G@C*=]WMF(^.G WT:U7.T(?.<N(&^Z$3&W%7WCTI
M5 S'^G><^AXPEV;$Y$TK;W/+,+$RFQJAE3O7WNVGQINX >,=<.JS@FNIBW#I
MZ/QU2)649V?['Y:7K2F[&VG:A;]&?]2Z!K07J]R!<@N<X8CLNGDC(V+7*Y7D
ME1VK>L)([6SK4QWVD:U3 _ZE5O$"*; H@A&L>Y"\Z2938=)D>TGM+8R&D5,^
M6D&UO#+R9VWJ;#37S)U5.M^8'\4A+YQL=5L>6[*O2#[=GWX[RD6$EQV1:[>L
M&SS;:Z>^@*3*?U9__B*;T<VAD^DE&(='"IG(&**J$3Y:2'<_$#>/KC9722JS
MCYLM<*K:OZ"I=,'S&E#1X+W%_R3,+(WQ:5"%<Y=V'!NU^^J/2NUXWUW6%!&]
M\?0?C A:/KJ-#@\7LMS*YO82HVV;?4$:+:<EN\]31S[RL8MQP[$]*MP_VO*.
M^W:P(D\4JBS=08O)VBRG)YU5+I?9A7%SU,'&X<V-<2M)EYF1.9"2JQ!J22N6
M._G,<_*K=I^+39OW!XK-K)/64@?,,]_YUB7@83'Z]NSIZRV&@H)328>3Y,OV
M=\*^)+QKR$VX9_Q14(9OJ3$B1"DEMHA_1-D+4;:JO DC7VTM\<]IF7:4"D*M
MJJ@N[^.&"6G9ERXU.CRKTNBN\<<%B@*4IF-B+KU-0WR&BJ/?7I!>,4S",LVK
M']])H('EBC[UY3]^Y5E!LSR:6))@4[2A(>"R%%=3*Q89D3GCZ=]]KM;+Q+KG
MI,.L>7#OGL(3+][:Z.&!EJI^ZIE*JP<?>@47[G^E=VVAW%#9U"Z-A%M9GYM$
M!BT/L3P_8TQ<27ABYQ!]:\IS1]G3 U&DI.TI7SW:-;'1F[5MZ YJ'9][^"M&
M(0 SJ07O6:5[,A,!)7R-8S<$-IVVW9Y\3F9\LUN>_IL7X W9ET-[W@*/1Z%_
M\<<U_ET^ K25=V/!X' QN*G^_J;*6)%$;J:!Q4IU:"'DZ>Q&G<S:<>%710+=
M,]->;\D?32S2MM9&O''R3@2M*_(2''@G_-B>-%:C7(UN/U+YQXML7>[AE(]E
M?)C3G2#^.>O/*WE,"4!%)%-O)35CH<]/D+)UYHSP:M< RH@N$=3WBS:1A(T1
M7-ACU%K #IQQB>2]E>?)MT1VVON2"31.!TV"1\*UPLQEW$J3ZX/\N=)Z6NWG
M'U;GGO1I%9?0/13GH%@6'_H:1GRFT5>C.(MFZRP)K3,;*?%_.NNW2:@1-?DU
M\L=1:5H3<)-7(-?7N;"A_%T_L831F!^[HL+H"^X;T^J)D(BZ+(L/'MKNR#..
MIE'Q&K N#E+0'@A=B0GE:6?UL,Q8=_7A0(4]=OL(K=HV>2:+CK6>SKR]E3+K
M3FM\\8"YIXD,[73AUE$V(_-IR@*=*C[1Y /&2#&NY]3I%'\X.90I&S&+=RF.
MN 8\%^9-3H42M38%H"T6%]/<>2:DOM7#KP'2WY(=:KTR]W4=-N54X\O]];22
M#6KRDB9)?5C</?9T]^$JFNV'"B9LB1_D99]B\^ Z\H%2( :^<.>FA[SDIX^M
M-5S=)$]S 5)WV#\J8'L^/B?1'-L^8F'REKB2B]LOD1<HVP;L2B]H$'LNLN&@
MKUKE5-ZE\C'8):Q5/Y4!GEM0;HQ,I-;EY7+W]3U/S]:V&4PD4E[S-=K76]E9
M+5SL'A:LJXLC?Z*-<Z1V1<:8RG<EBJZ[!M#?:+3Z&^,T/00%)-+7-=?GK(@;
M4(N3LFU_D\FOI5H]$JGX!I3BZ?:'TU>5K_R6+&#\Y".3[")[*#9HV6P4M'5C
MOZY;Z0"IN"&9-2-<G[.823O6$B111K?XCWJ,(G.SC3 /K@%1L)M%*:6[Z:W8
MVLM^V-C3FU,CC%VJ3Z=OO6Y%87T^%RD_-ZU,!RT4I-+P=6G&-V?CGFO(U3/0
M)V]G^IX5U0FGGC %\GC7=E%;-3:A*Q8:Y7].Z:]/?=HG>UFVLT1[F[UKL&M1
M5\,7+KQP#7@PW7.GK$!O8O/%I-IA9@3_H^KA7A\[)5BNEYN& 2[\J0EQW)[&
M* L2$'TPT_[QUNAR-O^!DR>B-I\)GKI3Y+XS-EN<^YGF4,SJ<S'RFZS5&D$Y
MHSWAW77W 4BGU3H;A0%#[G[)R25I@9YF5F_6$4$E\KA$4 KMMG^A9RK'V\Z+
M>,A,QAZ,U$#FXQMA1]JSZT%#G2><H0$:YRX-4K^FM3X/9=&6 2)J 3ZQW/19
MR _Y8DIA29.9;9A[&2U+1)064]Z_&":3X9D7O04Z=L@P'^ZCV+F@'/WUP:P^
M$]P)2GP\]=<%_F.B%UDNV,[<"P9WH<L9-Y@-P0\]TM$8JBPC.'SV/4HW'$;;
M;[T_UV.)9R9]'T+=S5=:P$5$N#%'/?QL9'L'B?_@5;GUK1QKQ_Y-!9!\"O,J
M<^D9Q>K-$E7?R)"M+8$B<=>W"TNE#%XC*#;IZB&,DR=.QBM[*7*3<(U;]PA%
M3P84D/I5BW6/#?QZ?T(>6V^A 0L^?O#!/^;6]= (N 8LAQ!=X,Y< [:/%#3?
MJL86]+-Q=GG=^EU:-_0:8,!\:56'GB^2/6D4!$L\(P9.96&A@Y]K'+3YN+2Y
M8UU)SCZZ:M(X1SB@FB63=NI=*T/Z;X5NEQ,/X3V//YR9/^W7+=Y1^[D(?<_L
MQH*AW]>'B<1> ^[>2;>M>=B[';?!M$*LNE!-A!T3M1-R;+&]8UL<7M51R2DJ
M<5]9@M)AP[\#HM%J\'CCNWF;Z"BK457B(U/?5?O\9V4#OZ1_6,=T>5U:C;':
M;6\7!_2/S3P0A:X4E>,8_$3I'D/JC@5?.'IR&Z4.7=&X6[T=U;\:_\%U<=II
M^F$)>'IKXWCY J&B.Q>$;"9R#SRW$GPRM"8QK6;R1&AH,V$39&"YP?2\'^H^
M3!5WRH./FH^8/P1< VHB+[/U._0%4=-7AL"3&^NRLF =8SY(@F$PQQ#=;!\G
MY9NU*?L-Q0_G0V 'RMQV%T;7@ SEQGL+4$QH8ORE=^0E0(,$Y3<@"Z7IYV0@
M7\5;5MD$3&+&JX-0"?U*T(KV$^@?KF@/B2(,#JB&F[<FFX^8]GPHK=0]8'Y'
M%^ZY8;/:'2NR>'8)KLE8D6*OG482#]G"M#OB<I<\W5^M2C?UX,8S9][16PEF
MCIIQ.UW*2/09':Z,_VY U_ G![!E']#-J$^U;T8==Q6[?;,L+#33/\A_KFL,
MQDE+2'!P?H2BIE"1P)L1711#$7U0F7IH>U2*W4+[*1$ +2Z_?^5K9E^]?OYI
MOZA"]W7?[39!U1,L/F0Q6Z30TQRT?]NI8R4QV!M;[A4O?AJ/*.-]247/2R?)
MCQB#WXTG4:]0-XVRI./;/WA$L9B(%#V]':116!WGT*"C>WU.0G9Y@R1@@OIJ
M37**F;;O@+741F8@%/9SXW*^_$#(;#$UES4!.2MH%"L;QS,<9N98\^8:X(T#
M"G#[FUKU]J#[E?DN"M0;*Z1GKL4G"3J44X]R5Z<ED?JQJ/+^U?V4[&%6<./$
M?!?8A Z4.H0>/ZRIDF3ANBJE$UPPP$"VH,?#P.7C,8SJC?JV*X1. R^I8G]@
MR!"OMNVJ6 0VW1<]TR+OND[7EFR'I:)IK^[4[X5.]:?D^K-R=<42K" EZ#Z_
MGB'E^]#NX?5M,+]H%5;-G?O\V&U]4!C-?;/#AF[F7AJ4.)[;"272ZRH"EX))
M&I/+7BG7+DLL?.%<Q^M"PBS]%P(RI9="+QH_=1$DB$V[JYOI.DTLZAR7:J+8
M@BM9[@BZ<]<I2KIW8-O0H&KJ3*[VWJ!#\GL*ZDGD\559&(VZ,>PH$JE0T<BV
M)OJAC"0%\!1]\"V0N@K&8 <K\;CTSL0ZN0@PV(L/U6>\',-1O>JZJWD\6-;)
M/ AWVC]MLUCLP8AGS'98?TX:4U;<[Q]XG2M$,HU].%7F<V^3][5[N14V_;3N
MC_YGYV3+O)N22!DEY="O8LG9\I8DB)^G]2\RZB*0RSMNZC%Z*(*Y3!=F7AB[
MM6]*?BH ^X0"8%;ED1J$8O[11%T9,2\WY$)1G3,>OXV"1'M6V/64LHTY9_V"
MJSCD6-[CC;)Q*I?[A&M>D5PBP:&!;>Q&MIDHV7H-P-JJ+G3(V?((:"T/9(HG
MME4PU4O 30ULL'34,C#ZF;G##V,I<?+A0YGY>RGEQE>,L!6[2*%6Y-^#U:G'
MJIOIYK$C!XHQ).,T\P;P8:UO;2Y$B9E"N JVD]B'V\R2JFC/_4-P[+-1(4E/
M[(CIVT\^3_J>WN;TW;5GSMW/;6LF-)_Z^G@N*E]O]JLZ7J?[<K@_*RA TFA+
MZ:5X=/<XUZ9 @7Q7S%\8)^HOC/,P=MN P-E3ENBV1<?[L!['C"6-Z;XR?MW+
M.^Q'I=3H_-]UZ-6O =6@\^?,LW R.MD%;^)O /!7V:XT1=R#;+6KW:=OV&S8
M8*N.4$JN6WGNEBSJ%!4.AM< P?O0 EM";WM7F*VW50J:L?2SW1[7RY3J@2;O
M6L:/?:>!PE(MUX"/B H]'7%/"^[BUKNTJ3P1;QF?Q ;B8<*]:AQHTA>:']4_
MG83DZIK<I7I-Y;]+*84A(&U$\Q$V[VXR?=YL>NT>>J'1OI7=NCQMT69DE"D#
M,4+?9RLCV-*/V6]H:YX0>1"H]:5X]HKU^:":L@CX&M $Z?K0";=J$:!/94%E
MO9Y9E3JMZA^A<DQ;7HM8]D4C1IP+133SGBZ.)*>HNVMT7@/.*(^N ><'P/,G
M&I _5=IIP=C]QB8*-UOEZ0TVJ7*#X=WHK-0I*$(+>L0I#VT1R[U"T?T4^<,Q
MO09T/ZB-QU7_2:AN-+WG5NNT,1T#7PNS[T;R0Y_,X5JB&[UV !J\!N@^NU+;
M:B8 +:>L7P..^Z\!1T8J>5-9 =*,^AI\;.%3X$J2C<2B!T5."DTO$R1XD3C2
MIRMUYQ[XP^C'[>OU!68KC_!%STNO =HQR'B,'Q?L?/?F%? R%^PP?MQVY[NP
M\[O9GD./U=LW+LTA06''D*K21YMNCMUZ7B<1M.[3CZ-)C6JP#ND1:6BGI4>^
M7ISO2<FU13+7F!9WY2KUC8/J6)J%!ZEQ(-> T*.8#/=!Q?):+:%T>SUYB=7P
MB(4W&\G @4:@.-IJP8!86_)F%VB'-<0X@4\^P[LO$UR-U6-65C0F.F&5:UX-
MWZZX4# _C%J.#-WPWL+H*+G?6G>8U]R-U4-EE(SD)]-9F"M]'A]&F"Q+8;=H
M,IV*E3;S!"C:ABK>T5E$M.W<Q;+4?]KT,6Z*9# \.17F8L2XZ=#A3$.)MEGT
MI)9!Z R[R#:T846'L3Z+YG (>UBX[FU)E98VS*6Z*1 BCY"D0_5=B2=J7'KR
M7@5H&^!@^(U84UQ*9EJH$&+(GH_=:6=O1)_'_XJ>&#2(GQFWZV([([0P.-Z>
M/R=S@>+<K+1DS%7SC?'T2SEP!TSX4DBV3@$I'VK!%I0V-DZJT\VH^3/M?0H%
M\.OYPD<)#Z<M76!K,]&4U15;!T:6NRJ+@#^X4UVB6Y'"#<@#O4]3M3'_/\JJ
MMWO]&?0^L)MD5PUQ_^31'.JLPZ+1JC'N](9"<R>YU95HEJ-$M33GM8#K4I/'
M_JOP1Q&5$BH]#6#,W99+ F^6HAO.(_K]-Q:@(Q(#3G?&*\EPDJOF#S>##F "
MW0\*-H"'"M,A(W*9WF1;1-41=^M;J (;PW"N;,[5#/ROB+Z/LJPAJBB,:ME[
MW]>$@.\7B&+7X>8OW]KP\V:W0P;&T,=-F18_+I-**%X125B!QOC$JMP@Z-!M
MK@N+(Q:))4$G^APK"/U3M6  V2L/FCO"D!/2L<O(>L)YS=-!K=$C.4ZM\@N:
M="."]B>N 287F9?1_/K^42%GT/9$T5]>DM#L(-;J@U@)89EC[(N%D/,@]?%7
M7+)WV5R>?/4C57;LBCO!JCLA.]C[? S=F2>>WTS"9_G9,:2@V$@*]+J5J.FY
M-<&>7*TWF.O%?X,M.F.N ?J_;;O;3<9_NOMH2MI?PX0^5KB$B/]&2&<Q-W(Q
MJO[TJGG^&B#QV%F$@:(TD'&$YL7H\A"<+7_S-7+ ;S:10T+4^CU45V- GW"(
M* 1C8&7D1%?IV"!KO]+T(8W<UEOAW05B:(YA>%I[?R []^DSZ9U)HQ:LU4Z-
M4FM? WYW09UKP">-CI,:A!*?5$I&K1B>B3)^#4UFB7"^$EJOAH81';4Z<:[=
M)SU2N<56-CDQW6*M81%.!WA]>HRQZA1A0\LJ#*U4CE5./)QEU>WB8@]CV.>@
M()RD[*:R%S[<X?&(C<LT9GNUFYXZ$7;V><&W$W*$'(=K+)V&%KDD['"E")BD
M"FI8,"3P*R\;X@CO<\+RCO(R^P<L@I=/H%$C&+)Q^L;]G=6$EZ8\#_T^I7X^
MH_6Q[$*5OD8%!D,6#2CD33Y]TUZ8T8;[._8FE7-.G!-?<6\TXW %%V% GOGO
M G"."N@&4<^,;3&308MZY#4E:)#2V'S;X]&XX7>D/(P4HETIZ=> @.^X#J-$
MEDT^VA%]XB"S00FA@9^+Z:B:3UXV-CA!(94K9;5BZ:P?%E4)[9_L,:5^6W9"
MU!Y?\-D4;Z<']M/)JHH^TRRK9.7K%-3P]9+=YTE:Y*VN'2F9Z'+<%NECOKWA
M.TJ3[>DT$B'G9H!3]22I^9[NU#M9L(7(A.;)?0Z-?7Y0.%.4/-701 %G='X/
M=_X2PN" _4;,&MC<[#?$N,M!;G!QUC#&J$"L%TL<\E11XM:38)5(!W^#=QL>
MNRF%&W?SI_7$;'[Z&%6C+IHXQ#V,</F/<@U4$_@DS>@'84U,T!ZIL>:=R*M@
MF>,=9ED;NT6<DL3P:MEPKF=4R!LN$)GL<(=%NNC86'4]SC[.Q*V!D!&W=!M^
MSH_:=EWVMEH?))RF%FRMUZOL6^$B=WCE&SB;13L+DW=*9-K "_%3SA?IZC]G
MS?=>@))"#C4E$.KM7?2/[HVL>P+%]0O3+>>P4;#/.]R4K^)&M".CL--P$@;%
MNPC;J$C\!\5]PZ6!/^8?FB1.5"K/M6J1^1ZLT@+A0>CXL-,N>TY]-B3U;> ]
M]T0;GO$CW:SW>KK$=7>OR+LD@(L:V9)FF4__[?0E.J1C/R+=H0 M*]M4?S-I
MW/7QH#EA3C02%&ZC0:?N*HR]6_+[P"EY/OQ&3.("+]T,+G$*DT= RT#@[ZIH
M>L"__UQ[A.E)W'I&R.BO?T7H^S^#_I#&N+[QCS=%=?A_S'"L5)M8-Z.D6OG'
M,,H&36XCVHR0E__=.9YJ/[L?_ETZ)?JI1)<N<<C D!?(+"VKS]3DF?(]2'AJ
MPLEIL?:_QGD[NK/B+:IYUH7)8=V*\^W^3ISOVF58K]=. [P3-\<A0KC?ZJ\'
MA?\L^M-UT&[A'RO6_G\54%96'OZK]ST96?]/'M=AW1F9,O&'<6Y.']/<N&ZQ
M>)VBC-[5EJ.*3I69(8]"RM]>1@"PO=\ >QL:FL,?4_&:OGA5ROH,E\8>/^WB
MH[Q5=B5\?ZV=A;C9C7JVEL\]F\(]Z<Q_E[D\LK*M+U7IUU+Q-HI].:Q*Q+04
M@N9XLZ_[@T<*[A6I$&N5B(*U&N5.]>6M$]%_[[PG;;GFE'>L,K\..1]C^]3$
MY"\Q9CI<:DP\K?_%R)7O'NT"UCJ10@ES.3S6@V!DW>']TO[Q</[HJ>6+#+C3
MU'_TFN^6K-1+\W^F&_ZMEBT@>27U(XWZ$5L;;L;$R5Y!R<=DC-.L1!NJ09WS
M! ]OE8^)"O]4^GU9/:X0"%UNV(+NWHC(<D0I1V&^.B"?@C8"KS@K_0DSU;X+
MHRM,OXM[\1H =/=LCX&0\S;8.D1A;Y4-C@@!TQCJ+0\40ILH*\HJ:E"L*135
MC1'.TO<U%=NBGP#GL F]+PN',+QY?85H,[E11C4279VL:)R-V@@']&@O4Z\2
M*TD\YZ<:"39?+X=KP-TBWG*HF7?D=E%H).CG; -H.\RYI!X>^0>+>",^<3<J
M5^9#XYBU319%KX+]9PD/>SDR.HO*  E;U=&L?GPF9L\DS]JWU2-=7)*9G8N^
M&+"L5A(.J?J[U!?[&+9R/;=W$L!6A(,_9B-K(DG623LDXMYG6Z-#EM4(U0%>
MB99 GXS"B<UZUQP3\L<!Q9.AM]]@]S'\7*-L0:9C\C590[^JZ WS3<[Z9?AI
M?5L ""9F6I1L/#J],S>H5E;W#=K'9TL\?8#+I<D:?K.LO@%D"4Y++(0#IB%;
M6B-IL=(XS^O!M!&9V&/3G@U6[?,V#J0;"&=Y"I^OVQW.<K]74MVUH7@2[28%
M4VDV??!69!/I%#.D^I!#SGQ(C*2QDH^:;6G7MW"SNMZE,36K0K>WC$Z:]/T;
M1BP^IPZWL>7?(>G1B,7(\[4;RR4SJU2WF"&Z0N]=OHQ<%6N L/XUX((9W#3J
MU<R[77V@L+([W6 9UPGI=!@O]WJT!$/+'O&,-G6=R%5PZ1LDK3H#UOAHFF*M
M.IH/&*R:3XAJ;\"4C2ZL!7I&O'R#K29!1Z3I8$<>7L8=4@_-(QEFCK5V;>KD
M?K+QBMPW3-'XLLXA;Z@E[A:.G_*<V@?;Y$:81TJ&MV&A0T(Y97/^&F2EUC2Z
MS=4]MK=77$Q<JYZJ%@;,D;OE29Z7QW)C;2Z03,Z*.]WE>RA.ZS(XJJIQWI24
M#8%."01DPQ)28.8)1K-A9D\^#W" !%XQ%^JN>0DC(W?VR#?/'YVX15VF#K/!
MUG8/>:0K=G<H!O5SZC=1=K>W'IODME\#2/5F-GGLI]\=?LN)<U&-X32V^6#O
MR+_4Z$&@HE!7YKG.MF-2&<8.029H<V-%RV+Y1AQG2TVNFTAX#8W%K1><: ?$
M9=]*[=R=VWPP[=5-3UAWU"ULV6%J3:HFN*,A/W)?[!J@6%7)L2S!F& T'V9&
M*70,3-%-8R55TE)8\K[-+U2#X.J(R1EO" /V<0U;RV77%>I&^OV%]\.FDJ&3
M\\87]YZM#1[R[LY>=7?-GF[IZ2IW<5G1*[^*JGGZ91G8"4]:@&%\W).NZM]@
M5@K"5$)-G6)40G0$4^O *OYJ(R6E)N4UHRPF#:$,4G0)VF];6GK]H_Q$,98K
M;XIW2?^&=8N-"BS.,P0W3D]J+(/NCQ^^\E5(;^%+8]7YB_S)3'6W>6]1\CSB
M14P<A((I,I\;]BB8BSD8_LVE6$#:PUHVB^4,2_[GS2OD@Y^5UP<JXT=]>;,0
MHBW^C]):J&IX7(6_9XR'%&KJB$A-<_<^[=YJX=KN<*G+!(M;0:R\B9(LG C:
MM3K1R7R#.6 1BXR:0.F<*+H0;M;=[=L%OM'2PH L]B,U66\-^89*JP:K"ZWB
MKXLY(2;&N+^^\^V^K!;HC,^O8(7E:\V6AWVO23&F]5Q(=/U0SSH$-AE<LKDS
MI4+669/30;L9K=>9Y8/]*\9P2B?QJRH/PA41!:FN(5:@<6ABO,]Y#-1._#(@
M=M@%,D;[VBP:;.]<V:N<P$ 4O7$7#=Z-EHAPC-8U ,\VE##SA*T:$G\/-W[U
MS+VWPHP/-+NQI\M:=@U@O)5S#:B'G;,4ZB#M,,%QT),'"I>/GMMTUV4T) ]D
MU3'L50CH677LKZ<2!+5S:C><#4GTV)9BY&\!J@4\D?LY:.9.1?=!N<150<FJ
M:-R[]-87772T_KZP;M7QN"F7^8_6AF/C)(;C#Q+@JU,?L56B/0T_.JF@S11^
M<5VR]>TO5/&\6XZOB>^_/WLP20_+7TH_.&CDYM+%],S+/N%28R_8Z%(6L!]E
MD=M?GH;TK49PGCJE)A]M@'>+<S9J+US3+:RB8/,_\[N6+*W[;^2=FBR+AORH
M+\^CDQI1E]?O2B.[Q^K%Y1?!9#(7FL-'G6JCW,R"$N]C'Y$4&4=:1XGRVO15
M_ON?#%-KR#_^,A*1;LD6^6QZP( +!6M(/EK+E?F]/DK_"7TD_E>RI)#I*)6%
MJHS86IM9D#-_GN)EYU<'A-F#M3(^SIQ= S30_$N"@D&/[:+RWL"BXMX\0<ZP
M WRP1RH5_%-IX?4*.TID =]!\,LE^">SC(#NP5%$LY*.)V2JBW?LY=R*C4CK
MO.S(SK8-'?'T="==N#< F']:XK2D&\>.QE*]<+]?Y/M>;X)!-_S;.8W4T9WZ
MWGU86!/]A4\-89#=T]>:F$/#_>'OF(BQ2ZT N1=U[^H/%',&G!;G@Z"+="CO
MRH=Y5CK0H]"P4S4Z+-0'W!&1V*-^>]!=+P%G _S+:A-FE[PHYMNOQ>YO _-!
M^TQ[^>,PKN VE>6@)'X#:C2WETE6U^W9JL;^AD<!$3(/)24,MD:==HDB=#'/
M49](."1S.^S3OM P?_LA<@U@QSTJS33/(#,A,Q;XYJ[J9A:#)EE\>ZZ>3UY<
MTD,BBV7G-\4P@^7?QGZR"3A9JW)I)G;VO/1L09 _MJ;Q[NMYPF2GUGW_[LIG
MLK$AY4WIOH2O>9VO[?44&-$:"[/0-H_CE8'B]R?NQM4'0_#U>98Z^==%GECZ
MZ=Y&5OE:<B:>MQ5L.':B>:F(KSQ/"DF5O\ZD3"KFI-.HNKM]%KEGJ7[*PA#@
M0#960?4YQR::49]S*$C>?6NDT1"\G]FI+%UU5/D9"MG]0'?TP6H#GQFL;T$!
M?\ZS"XGWO2)E"/ D+"R2CW]41CTD3NY5.UWQT%XS,@>W67O;RR1WUK+IP>BV
M=<:AK6F0M44M*S)JY@NS8T@0SSPG=_B+3J$\E$%0*A:*-0 I*'LI*W? 8B2-
M!8(],?Q*:U^DH*(_!B:5M[7=?CFB.A9UV-_5QO:HJ8JE=8,RN.1>X,4[ S=7
MI].M]1N\ZD*UXZ"2_=BM1J73A][]47OB-2!TI6F$:T]D,AU,M-8)]QV\_P-A
ME[:>&!#?BLJ<T=ENOJ!"071&,?W-6+3(VCT];])9B6$]/ZX/62LS^U \+P&4
M>OS2#L?YH<Q!<5JR4.3)YR3S\SL,C15JPT55Q3Q6]]#D5A )2@4[,:(/PI8K
MI+E*/;,! DHYB9*!6S <%UE(JASY+G,MAVL7I_47PC:^*1^X-_,=4  -A]O4
ME'(G"(Y@-SHR,I!24B_LI_S+9$(_B3P0S])OR[/2>.GB<"\H L]IY;; 0RF<
M[YZ&A(*(/"6PV<LZP0ISE3"R#++5>7(OYF+WI NZBV=].R"S0_C\7(;-; 70
M/>QR9&2XD2&$CO&1,XE?,D2KQ8MY?[5XL9'\?%Z]ZD*H?,8.?$AVT" ZV"MG
MB9YN44]E'U'GA3X[N9\$026;%7S?S04&K7N$O*QKLK7-4%U*[_EU-K"WR!BZ
MLVH<V,F<A>U+KX%WBW(KD/90^XH:S5DP,TN?N!UL9HG'0FI+(W&";2*)8&@<
M#ZG1MZ%\]9QK5](.6[T:I=/RN.N^U$,NI8\%=P#  *\NY&]_<9?2\S.[#0-%
MC;ZK/UZD:4*#H\+0Q$.SF*=C)B.OJ@C(W7>'EV:?FS\WC"CJO@N ?0V[%(@L
M5OF.%E_J*PR0#=5\A61<C=8:^@A\2P\['&Z<;H,=O+( ':\077UDEH^O2?R5
M'9!SS+^'AQ9K:SFWTM$FC[.0LMBE>I]%QX?\3LE'LS9>=<PB@- 8,1O9NP'0
MN7(1=5U  _UCRY".ZMF! -)XIHE]8;N%N48SQS5I=H-IEW?=9=UW/*@G*+N\
MQIB)/HF\JJ]5K:WR&^#PL7B>0G'K2$SZ&B#,O)[(;%<DWTET5_[TM=?S11T0
MWOI2ZUA8R4]]K4E1BR?[VX+XRU=/O3AK4=QG8T=]53JMOC3W @4I;G6.#(SL
MA%&MT26?JY$E)G^M"S>1X8ADU@;RL;5"*2I;"!,>EV*.>-EW+I^ LCT&VZX!
M02AW$4I;6Q/9<'F7B0,&UV=F@AI"R5_N,OYRZ!*N(E,I?LG,\7)Q$=?Y1J0;
MVSK2<*.A[Y%XT<K7 )-1.@K9 -U=X.S[&9\,>,3>(C!T)VN:[.LC<<:UP,7?
M59E[8<--H1E5 5I@+0K5ME;;[;/3=S<RW:KAD\Z0C='=B]V#NQ2$ DQKC"BL
MB*H=&HK]_J  KH"1;7$>^3,3:"/=.4SAO8ZJ<HJ6@L-(.KY'9KL7=(&(9,N'
M9]2%6O#=8;'IP8GT6GM=NV5NH*&'OW[QHNR3%,Y6#[W8&1^]=O+-:(8%U^]4
M81$$UDHR:E31H>M\RF'TR_4!7A>H")V[0E:ABB*_OKRH-YS$N2#Z\(AL5WNU
M]&:KQWMD#YX7FO=%)=L*WXYTE *&>TVG;2!\>%!9B@.[@V[L<:MO8JH$RDZ0
MOL>WJ]**9F#B5*HE7\FWC_<^T5 _U@@8R&6*K-QD@=-L/5B41/9@)+,]GG.\
MB*90?C'ZRCQ=3=*0[S9,LU=W8.TM;3H9*034H7!GZXH>4;3KG$14*4Y=$[>S
M)O'-YJ=#X/N)D"T?:O/3<R+_XFWN%T*A7Z,EC.>*/VI&]48S%V8DY<U I%4S
M<M;&4CE1=#^:Z!$8 Y:3A%S(23_^"Z@(]S*AN^F=QD<_SDWF(A?Z>5JO@ R;
MI.^?V1+XZ44J2JV#G;F4F,([WM+)L"<E;D)..^P(+*^>CU2N5X8J5,(Y.?D.
MB5_C=:&()5MA-PV/1ZHHJCP5*H1&F&D/B0\ 7?LQ^OY@FJ&#@Z#R2%#EIA,-
MQ[Y("O+)6ZV)Z3EP.Z]4'1.H7O))_#1('"$BZ+D?U%%='NLW-8=R:FNS+\"[
M!OCNE&:8Y^*7AY23O1-B$JQ8*P8MG(;89K]Q(:OZ:HSIIV_IC=1E<#J[4MMN
M(MX/C_S$55U9:1JG]<1YI+;ERPGR.W7 #4\*E*>&O?P5P.L,,>@PP-UJHA^S
M9ABV]AFA4N3@/XQZ[6:&_J8AOM\E-@H77M0H'V-I&K2WU1=-&KM2)L6*I7?E
MGAR2'K45RE3-R!T<71:A7T\,;%Y\5#;"@KF($>"3VX3?7XNCU6#9+VVIOP8$
M'F_UI6BW;>_WV*QD0H::=!R3WVN>W&G\$$(FD=E+^%5W]#S6A<^X=KCT:;";
M-#UA"&=8=!;^_OP]+SZ4:<I2,>O)GLS!SD*=-#VT\JUK'C_CK7*K^1<99%0J
M4DS*85-VZ?KGG0CE\L3>$^S4*9-I>EL^.LSICO[S)2)_@:KBOI[T'NJ=BH?*
M_%3T(8*W%7"WHHY*73(^JW[EP?]OY+UG5)-=MRX<'D5 !*1))RA-N@A()Z!T
M!*3WHG20&GH+'8'0!92J]!Z1WGN77H)T0N^A!PCAX#O.^/;[O-_>YYQOC'W&
M/M\X/^:/.[G'NG-GK77->:VYUC4_YV@@)#PG6AY[%A^X&10R5$2!^ 9?MN"X
M_$6:-9ZH@5)&> JP(29.SQNJ9+O 54=L<6;E^.9^'%N1'*JE*ALFF@5V9*X&
M7O;\="*S;K_Y7XWU[,8YM4LR,BXV<=\"5F!1^4=T4_/>*EOT^VO:UV_?L!O&
M.3?>P10[^U.U[IIH6S7HN.HWG0S4W(I%P:<#ILFJ_H1!-7]S;6##EZMTEX))
MZ.:$&#Q;38-*J#%[$W=(7V[HV/?Y48+$U'BRU,UZ?12PY.$V6A"IO[))ZAFY
M8A:JBO:9J]&[<G/HA*GX=?LHD^? 7D$90_(S^O:7(Z<7.3P9=5<B_I*-?$$N
MV78/"2,_DFM?>&=+:F0-SILGJ8>P>[T:"$E0_>7Y_D!>[%3<;JZP,&2>;JQ,
M4:VP="2C5.(QZN?.,O-0Z1.U-4L%*UG*<]P[U#V#UWF:=+K[DX\]F_C8;XKG
M9>'P*,8Y62(#T/N-O%)&>.KSJ?D_0&@$#4'.@LCE!6CPU)<TM&:O3WZ:X@"N
MZ(,EDM8/[\(>A5?=XV/PV$6N7[HWNL#QEKCL=#M%]JX1 KS&RCY?"F2D#P=*
M /18X<F6H9B[<]QR_(37-ASG'LAX:OMJ,9&P,7MA.X5$B5:'K2*39;83?>4J
M3F"2G:_Q.>-W+ILL\;K<2&I!^Q+I[_F7,[G4(:"VHX&*!+X%0R@]FD1\9RF\
MA6!74">^I<;L9Y7&5V)S(HY'IS0N.' QJ^\PSVS8W/#T2UU%CWKRZJ97[C_F
M#'H8P\B(>X*S"RGO'1=99U>(O(Y\_HW0L><6<'PO%M,(PP1-#=MD'1/%[BQ=
M$9?'_ON?E]DD$0RZJLG86O]74X[_D2D\&C<8^-G5;>1-;&2<4=@+H;!(\C^&
MJ.T;AO[35QK/YY4-#YX7Z_^SF(M1*75%W!U="?BS0EY47,D2[ST@__Y>G-0:
M77X],)Q4B9\Z,%DG+BP6>R;=:6IZ9^GX0<M=1.(%.B4UA'2"4!>3D*782P&
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M=CK4AT'E'G(<%,E=<;C#G@!T>0[KO<)5JN+\"YU*EI\>*G#YF4J492IKY+Z
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M_YO2 T-\%X#/I9OV-OO"ZDCSYT_IF^UR\H19[=SIGM<MWA@(WP+H('U19;<
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ML8)^L7K9D1SW2O^KE1?^L^U_L90F<@2ZR&0W]('N 1[1[WU @BD1 0<AUBW
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MRI)TZ_^9\F[_W<@/(ZC]^G'N2\\P;ME%H\ >8+>;O/.H",NY=?L3VAJ)NVD
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MMV<'MZ\Z@YB*>49$7ZU%@.8\WO;\JC$-0Q"Y-#],QT,0EG::U4>$4?>"LIQ
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MH0\\7SMDJA0ZY*J_)%)W!C@39?,0D,E$XHSW/?"/-A_BVQ8.8BKA/?N/\$V
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M6<5I5FG8;BS.IDLQV#ZJ7X+QI7&R/!C\\R&V'S1U4Z+6;_*)XOH6ZNT\+=!
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MJ;^3&=5G_R.$[;\*F__/%39_ -;J_$8;UA%;P71OHY+B!M:.AO)F6;#N0W&
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M<WIENF^,U.],0F9XL)2^5:-8;^CQ0GUC\3(,=&Q8;X[& 1*@(ZN>=&GV93A
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M$[N(LH<*\C\<>$0UE-?L,QO:UL?G X)OE?JFKFZJ@NRW^.^T3.ZVCE3\10-
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M$U2";=WWI+I[.&VQ'KZT&:[^/'KJ;#Z16>J2 .(R6*T,70N?X/)]L,JEH$[
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M>1>$Y2S+C!;-4#!Q]9B2YLIK>^IUQ3L4"4&K&[+B &D;[%AL.P[0LC91FJ3
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MAZ--O'3(%9+%<^M>]L;<1M >1:>3[!FKFG3?.F-H2P6D^=F\44/H\O>51,:
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MIC8[;X<N%R1GQ48^$@^_P6&X9"#C,1*%^NSHX,E68FX_P G[_KY45GFCQUU
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M&O<F2M^1=K,/0*!F/[N(1%=[!IU4"J[>C\^MW "L;-VBG][OGE)3_BG%$%?
MH.%3+=/F+GPQ(66Z7HOD1#$8U@\WD7NX6C\.6>UKI_4O<A!G\5H6/RZ#_X!3
M/$:>4%4-:$_P\JU)O8EA>NXPFX@;!:?W+GZTK/FY;*D^J+V8EL$B 6\OJ2_C
MB>@9%:YX=Y^4=KAH7NR#^*S->H5TQVQ;P_5@5T5U ;:&9@7!2H],9>J5A+=2
M&:8GOV JM:W5!_G^7\>OAFIRQ.Z8B9R)PMW'5TX[G5O(49:W$0K_6M/88DV"
MRMO#+\;<3^XRHOPDEAJ!(89Q4]V!5PP%,SP0D9\/E;>I'LLR\26Q8*K'N(_*
MNLD\O.,:;P _),T^W@ .^>S,3D[!QUBFV:8F!V",PH :IJ4;X\M=CM(/$V[%
M^\US-C@DG$0\W=W?HW1(?S*@)::5XZX5$\[R^]9**5U1[48>O95CPNC,G4K'
M6_#HORK6F%]VBE6M>W4\'J1ET!OP@Q^_-M.4&GH&#J!O>VN0[%BX(ZP?BV98
M\JE><B0WLG6O:8"]5RU[E1G>#BM2[C*.F(L?@2FA C,7+O&IC]'VEI#@5U2W
M9P<@0 62I4EP.B<4*_P8RIS6,I7(O7H7_6&[_A9?+1H)LJ;P=6W:B=PIK'C#
MG(9]Z+K,88[(L.]E:7F?*_OBHVID&EMSP6\$9:HUZ_?&]3,VP13'W$/ H0(S
MW*KZFBF6:FPA90VGU>/9L1:!^0C-1UZH=GTOOW?"C51O=BK_P.)+G[AXZMIR
M[0X=U3/IOI"C#.RKE_X=B9MY=J+%MEYLL'S%Z^F%#RLK#+*#D'Q47JW+XM!]
M,[M)VX=#N(G55MB%LTR%/=CTG\YND?G\E6J));UE>:L"M"48588J6Y%<+<V:
M*E&(,WR&,6]1Q/VY@H5$Y+YL1"^6@CI^;[H1=U[_KNV!/]$_U_6Z/S.T_7+7
M*WU=P:/U$X;/=JJAEZ@B>A,IT#7JD5))YDN0ZDX8,;-.YZ4/+H$Y-ERJL87F
M/674Z4A,LG+";$77'@G'<]9"R%!DH\U#-EE-H>UP&ID);[J:9DN"^]Q<I9WU
MCU^D"_X(7IX'>2'+QON(^+47M87T/VL9XX;Y<-G.T31ZRPP":^?9GOG*_%IR
ME'OO[/WTPH)FB0D]C[C_(U%CS)#V\',%-\G)##S>V&:@.*F?1(-O('WWEE"5
MHFJL*BMBE;X%2@7.\64VZKW_,EV5S<TGV^]*O9R/4%HTH]M*7O=SG;5;PQ>N
M'QM5#'ZKB-=I/B-VI^/DF"DVEZ6LJ[A-H^=H/ZSU4!IX<1QY7NW9W:YYSNX)
MOG:!7U--_,EE-JEY+)4:72I><#"G]!N<?L_AP_%6D;Z&M*+-EDLUU'64#PK]
MAG8854'?P]<.RJ[=S0N.-XW&_4]MW21L=2-K'.MWX_2L&A&;+;1CR6<Z=22*
M@N2>5>%ANUHSR%@[,UK'J;?"S6Q3XD& 62$I>L]%Y>XQ]FUC5#[G.]?!JL<H
MH6D.!.6HC[AQ\(1K&A?;I^OU2M97/B$=ZT?DVX:*Y6_*-D?F-Y'XTHVH^*W\
M.N;R4V'5U.RZ1;V'Z%>>(8<(>MCS21C_DH=P/S?D_F.#Z';-1PF]M,?OP:H#
M$RVB,U]K(U7*:Z([5*T37.WSY+!>%^$QWHV.\;B2R%74&"!&D8W9'DNGAQP"
MR:Y448Z!KE2\9<+7//=WL^N>CJC$S\A8@L&ZK]L/<.^*;+20(KN#FX2LB^R?
MQ>@RO92/*KN/[?5A:#@D2<=)W[*KQ)*=O+[Z3Q7^JZ#V"\*U?-%1QK!X;:?F
MU@#XPY C33R8.@H<?*5FF^<=^MS@5>W@YD._\L@F18OM7ZXKQUE/G/5EN<K#
MXDQW3K8XLKX._Q>)G_TG"J)17Y15FV=UTR:."O)\*HK*K;_BFBW]J9]0;OQ]
M.BM>/I.9&J=NZ-^OU/E*J/HOK/5XW.!K\FK(P<@F053N3\.E65"3!# H.XTI
M7:5IZ3X?H$L((U+]G].QJP22@[)\3L75SHGX354")T+;,1!=Y_?5Q3B"'=Q]
M!6K!RT;_6HV,__]*0("8,:1&X =7;R:K'VWDQ]"-*M7<NU?A=A$EY8G4%>N:
M)<[C.6[6L(U\YOH,%T70?8Q0SZIV"9VEXM()/[=$T\OG;M#L=S"0&T&#.MRL
MAE1K[_96OWY91^N+M8Z=FB"M=+=&<OZON<=&&D[)1-M33FU57C,]YXR_59WH
M:V_$*/9L45,1][4S^O\:*RAPV%OM=.YD[ED[. OVH8,D4F*HJNW5E!L8>VTH
M71#&!$30=0+I]PHV\+;-46U6E6-O;:G*2;H"19>(^Z_AJL=]7.=CZ.CDG.4#
M*>8>!YU.,)GCX]KD/GN&]H++U+K'N=3+96(,SPF_'KIT>I9EO'',W3P]%8W^
MO+N[3-+5X@L<OYQ(YE1U'\M\D=]?[&Z=CM[_7IN<D W\W"3!43OY]<?K1XYI
M'WUE-QMI77[0TL=G0%!VZRIA1FC$T^::!IVJ)H'78G1/G<%R"I[Q9./'5?$=
MFU)'LK\.BX<^W_J?X&P(&,]&S,XX0"R6_^*;)\->X1D+4F31!,>,$&8]5M6[
M_FHUG"X-*<Y:^BO5>MOT1$%$BV7T60.?NJKFRY<3PM,FYL_KQO8?>C>WD;TG
M HY[152O4J@L[0><\3O4.);8 -D61NX\-P>E$KVX\'L0.WR">)N5)U23AI\F
M8_UA9TC0,=Q0I[MB6G%\M6$0E%6$NW9?)JTX$649&0+3R39%AYKZ;B;HX1'F
MQK)1APKZ1WG0NK)/WRWU*B57S0IMTB+-Y2Q65:([0&!46FZC0?O68Q>DN0)Y
M:MJT57DDC_8.^='0IV,Z-5UD=?\L!:JTVD323'0^NN9YY9V@+5P?*?IZAC^5
M'8PW@.CLCOE]X#5AL:'#2*Q *3EG)UA( QR"E'QZ"-)=;+R4BJ=MNA_GXQ1%
M%2%Y R#9/-=J00<CH.4,&@<^H:X,*8<IOZ$<DK3FJ_)[*J?K.,UV(>G0_3Z=
M?+%\T2#6!?Y["@N[G*-**M7X?C0>L>++665>1!Y[FL/X+4\.2A&A54KE:4V%
M<?M^K^L%6M'T2PT/N#PRQ,2T)\0+#HWD>X5;*:#9W[]UYT$3G]4UEON3*'@X
M" 5\_SY[9A3A&^5MMS)/M="L%_1TV/51?V5X 2K,6N:S 3)_1'>(LO@9EXMJ
MGR&]X\(^KEVMX1&TMK-$(TO#OC086T[@!W/4$R#^=.%Z?HZ6PO.<E;W^3V3D
MT2OO;P"]7<9PI, -(*??M%Z!3-5X$D\^ >.P'K^-(4>"V)=>@307\61&:*=;
M)MY22FMHD+V.TA2G]=_544(5/P\A;8@(+30R<3V,XP8ZJ.A<Z.=KZ0YF=)0I
M5=A>1G1';-$@0GW8S)]_&\T9/;9^LS[T!"SHGV[P,=UWUZQC.?GX!@#<T$NG
M';$_;F2$%7SL%YMS R7(W,8I ;8CJCH-%2/D#V"(I,;*GC\PRHIH9S@9G+\!
M**G\^:>YW#F-1,2K]F?<MR_U2*YCZL&'(FM_3[LWDW$:\DFWO6@:;Z1U[]0\
M9[OX1PEXKPY,^ 80XYY] T"*W3X/-S$A<_%JRNS=/SHW. 1'9*#6L^!(E=88
M_5))EN@*R4!%;,%O/8RGPEL<SDW:.R0!.:LSAU*MA-"4Q=-&IR*H]EUXKG&Y
MH('OX M/>]I4Z]4WL=O[WCXBMBKT_6F/=$*VQ0_]"AF2&"].;WU9<1HXV#C2
MXH^'Z'95N=)'L8C4C^6,7(&ICDSR=!K4FTX8'61\WPN,+Y7^4XW UK&.*S^]
MT7VMJO'I1E#D_ZM.($Y+B].$]=?HGU5Y< C^;':H=\5Z^V'>V[>]/5?)Y(S+
M%K5IM[J%4/B89X36F#JXUJL,O!O 2OH4'/D*?BQD,O!ORW#/@Z&#_YS;A_36
MG2?<1N$RS<XAC_GTWQ<2N;[%GY:R5^R#2-7I03RB<J)K%7&:$GC!G:WX"#;,
M0(VWM6Q<$HT(=MS9<OP[(J-[FHO=WT8T;OW /4D[PULW8!:>+!Z@9\*NK58Y
MR5B@#S;Y?GQ:LBNWWP4G90D9'-)(?#92N^>1QY-[X'Q?_%[CFY?FTIK4],T*
M,M!2;=:QN*JX*NY?AM7QGRB&G$3ZGWU\/B9J,E0H4[W*@ =>L4&)7;;? .3M
M3BXX.5^)S!3J-&5=THIUP'%,H#&3DS< U?<-I<&\Q+RU/ZEQ >E8V!8/#1+
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MS,V+TOABGVTM_UX?Y>FA.?I+-2":LOJ^EZ';5@#[#E?M2"+(J-08VM_EHNE
MHYN@Y6A)A<LJ] E _RDVU;,<D=4DEJ6P. _\O>ED+_/LM=3'\#T/JRN-6[,B
M1+M?RG>0;@NQO?Y&%<G,V/<]<M@"P]2\EM=4X[=A&Q#J7G#V1H&\_TJQ.47S
M *?4R6$GQ@-"92G.*%64[A,&P2[;<54YS!MB1.<OE4IU-,QPYC]#T"576>V#
MMRL\@:=*XM*'7JZKPMBC*\B2,<,8Y>-EQJ,IF:_P0*=4E[#EY(T6*JAG>X<I
M#_$6JR$^- RC MY69@1XU_=>Z"NAK+]_V_R-HO@23-X40;%V#TNN?&-[1Q/;
M,_5,?%<[S*P25'M_0#*_\COO0L7GI^9&%F$>EII]Q$1/O 5T]/N&EG8=- GS
M?)&C<.ML:RN?M\U1Z;E*^6@"K_RV-230?X&FSSX,WITB(6.N,/U>NEFZN3S=
M8_2]_KO=W,^ZK'W14R-_I 9@E<N.Y_0BK1?7?VJ71(YQBF\ +&UGF.^C\(U8
M,S!Z^A8)'#&MEK<[(=P;J^@&T/ND^98C"&=<L"!U3;+>OYBS'C0DBF6K+_MM
M&UVG6!_'MGS%7']5::8(;VLZ0)RJV;8KUI!4[![5K+W98P&+PAE&F_@7NZ_B
M>!DP#1G76,6;#0;!PJ/R;7)\O%6P2 _L9(U*)X?[1[Q\U()0"<7N8X0SNMO<
M9HX8LE;M.ULRTE7YI?L+)<LN(9(VG;L+9O2'PS3^X3"1UU03N_-4K2MRL9@6
M<TRUB\_QJS36O9=F2)VA%J+-&IJ,S_M9XSRE9<M&ZGV))#R^=-L]V/00ZV7O
M)M%O4&=\:'8@56=;CE.!KM9E&8#V0>:!/$;16Q[3%(D)K,Y'36->,YRB;@!5
MA>!EIA@S/<>+F9%_*L-?DP%-K"-!D()^9J$2'9$J_(W/'0"9IHQ"A,8_';DR
MQU:1J(@*S'VWL!>XF>1.X*#MSGDEBXO*Q_=2>:C5:OYP!L9YT/]LI*I.(]?<
M$5Y0$9BTKL7$37*FJTE%7]>[O8&#VY$1)/G<D+RK.L>(-ZVS=I\UA(\Y6FB0
M$JT\"/W^'?2A.]M&<C;C\P>H"#<G^7*TCR4NF^A>_@S\Y!(IAI(WK1R%T7G8
MLH0X[&<_:2?R>*U,,/]4"+W@7L+,>92F$P"V.+Z-P#ZU'FKQP+=36R]XBVO0
MJS< QG!V3&,KQH\[^._E<8V.$6:'>+>QS.VEV&"J241%#P#//. F$9J+FI]X
M8.I%IL9;3N>3":IUGV+N-EI3,Q=@:=(OUT#JT$D+:610Q76M;V.E)7L[!PO3
M7<Q$]5C^6#\6UJ6A9R)I!_P8T$GKQ2;PT'.WY3&\YV/)#0 )W.)B9]]5MQV+
M_-;<F"$#E9>G9T'I!B;L:7.F)AFXXGVM-!^.PJ-?T1_69P#">$5CICQM)J,Y
MY0H%E2XGI"-N $W*9R++X+^I&8Q4;?<6L@1\^F3\R.:<ZV=_'N1T16R_U"$N
M4.=*=39R7'\XXZ_]K[#+OR@R>-]#Z6!46DIO ._@Q\ZZNN@L:WFT"Z8Q_?&"
M)E!A"4YAN'E&H%!#\ZKFA"M;G#Y)G/H,X3SI0X=VNWR:W(54KJ[]H@@+SGI:
M@0O8[3]AEG96]]#_@3BGC[SV5+F:;/$O0+#E9Y91I)J(?8!]M+\[:R+O2 _J
M-=%RV=*XY\V;"Y,Z&$S*XTVQU:M]KO,N=N89W<QRS/W+UD !,TD;AD.!S8R3
M,TI,(/>V:LFSY(IGKY?2II7ZZ05'LF^CN-!J.L&'EU\L< 1BWH=EQEE<X-P]
M0+B8>'I++1+0M#$<?SGN.158/TN1"]P<$A=',/[IQ6)E_D<O%BOWF/6W6!TT
M<<+(';-+28FG=!IM# SH7<GD+C%R?C<7K2,0O,V4(;&SA<U?4TB0YU,O*#_A
M@83YB;3$'F1#"@Y ZTWU[X1F_FYP]S '/KY%D8R40Y%%.&%UO\G=+C>D6%GY
MM&HX?M_LP_<+&>]\98)$CBLJ&@*U'T1'R2Z$)!_&N&V8D@HXV>_!=E%"/]PP
M#R=X5\?.0O&_=Y)$+#_DI#8^88X..T*6<5>C.0GTZ2DF,I.%8SCYW"0E_4IR
M 8S^XS1MZ#&$H=F6FZ%N23#W;T>ABM1=M^_3)U3KVQ$3PU? VWC61?L&@"C_
MT[KN;#_2R/: FWC<3=PLE(+"TS&L@T(TRK#]U&"ZW^]):&JM^%WR+3C!L;<
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MZQ+[B\*R*>+O\[N*1XR6W[;? .[?(],3"P9IY:+U-2F3XW)PI,Q#!))89$+
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M>MV,Q4C/98E+[F9LIZC1<]CZ$8Y:_],MIPR/'1.)/!<G%+L>OP&,V&NB*6\
M])[SUQ^"SJ6%#&X L;YC\%G-:XJ)1@Q+,Y'"%94G)A\Q8LP>? 4I0)MU)5NF
MK5!D_-*O8[!A#)(_,^)MI-+6C:0#EKJ[#BZ-/M\)&[/G^Z@@[^%*'A[?N=IN
M'X@W]0J85=![?<^9 0C3+4$WX&]O;T.4><QC^VH/H_VE7"58(Y_JU[)<_J%Y
MM*,QD2[5MW&?Z@.NP/*27S:2[Q(OXMM^.'RA!B6P?P4XJWNLP$F:=):X V\
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M>P7,6B3-A2^2P%I!\P@UHP!*V03;ZY1)X89(I0F!BV@Q#J)^?XY:C!D*24^
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MQ_F^MA8RB:9^[.SE-5<R@B+B(0"/-F?= 59)P$@EC4E''IQ=7:?NV]^!6>B
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M'""Z[I8'L-J XD-P-:F=J333PFV<FN[K83ZRB/JVPQ[WQ%W@FA6(!^4'O.)
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M;S.3O:JYS_MBYO<70@^B?8/ P*H0HX<@P^6^K""&ZA#/KBY_M=F!>JD45TE
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M][7<;(EV)Z=-"YZ_?I7-V1&A?2KHC+1SUA#Y&O9.T=@AB\:Y QA'YA/"EW>
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MO==PI^3QET?VS+$)D]X?07=)^<%*N5^TG:O#3=.[#2 ."'?%M4"//$A)4;_
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MND@[<?M_:M.G<(">>N*F2CMK\VG=5,NPR*/TEQZYZ9N?4PB ;T*XA4HLLMF
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MZM<0'<Y$%EW\ ='_:.'O_A CY<^10$])$\C"8&^D()?>+_UU&1M_L1@4NT8
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M.D@<">KU$^ 1.6#K;;%)H_K?@F.$P-A_Y1X'M%%5@W/^3V3.+-O\B0P'(3)
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M]==4$1!(P@@>3! 3)02W"[43) ILI6$]4:I"4 3HY^ \J<M(^7I"*9_O"VI
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MUOG^@<N@@FY&?8T/UB:N$,/$_KC6LPP>Z:Q<";_\#Y!V40PM_<6(6<UM%M<
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M]V1Q2E[J^@KO+FQ,-]*L3=[;MQ8T\<2-6O95[,C2MPT:L[I%_5VLY@2[MNY
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M;#MIH[L"E;J4HWC@Q]H,IE_Z$M">8M]XT")85S:E594UY=6*-G*D5,3&JKB
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MJ#M%%(P$)4RQ@GLHV$/&NK U?W$B5G1U:TU4-"@D;=<4]6R$[8N&+UB&"X=
MC4_[H)Y*2*+C'%:BH37Y:VH&9&]/VG7/III$%D#.[3QD,+3Q3LA)MB<$]1*3
M]18P6:+&" /+1_SH%[@W M_&N)G5N(5= \1B?L7T-^W\M6N4XF(,:0;1]I*%
M^25A-ZGJE(H%2O22;,^0-$90P*G;I]IP^.WD\<3$L>( ;K=Y9%'"KQ>:P(\
MV'#M?PB[C.2XN+(:GKTSCI7L92YWO0;@;8&9[)^O,8C&/F,/7:K8]*;I3U,V
MI*ZV-K@H'<8O52&R_+XS/4[!N\I"/UJ.QL%;!QJI.'$U12R)-PR]GJZ"$KV3
MDZI=ET=K3EE.XZ9]FSY_3HS#"CA\P?-(M )U55_*IJDO366\!O$8P\;&SO6$
M=AF^(C/->XP3.?SP1R^:_!1]MF6(SB_4VZ(@G0?+L83S+A0SM'DE@ E+K8]V
M4DO.CE:IB?I3>F5VL[(B[?9M0M.R!V8SU8L-K6">ZH+5/T$%_2*,ZUPC/EB+
MR-?/=I*7S,S/2[.V*?$.&"&2-Q=;P,U+XER=V+[CLJ(?GCUE%H+T5* @][2B
MBY2[>3/9:;\:!;>PS#Y!3-N\,PNJHY1TZ(=,8_M+!!Q!WY3=@BT9)FK[*Z9)
M6>WU2,A%,@&U^E:@+XF:W1<!SX3(HY2UKL;RXE.U4M88'[QG#M"M;HYR...-
M8Z\WN(=^1=2F[;S8.-X"_Y2^K6P:T_?6FWSE'.L<AH^0?A.]HE_S/=+?UH2M
M5YRZW/$< *$)63H(2Y!KM179"ZUN=*R.D5O=2MCUP+DD\JJEV,HF%Z0I.6:D
M^N'](KC,2"7=P^YM9Y%Q;/8S1@]'6"1B^[;')H*B-N/\WC8C$A.T5XQ>:A-!
M?80JQ\O,&LLS=N/K9T<2?YI=NAO!MM25K2P'2I75)MF_0MIE;A1YIC>*O&0,
M&@ N,4]B4!EO 601D\"C7%5]GHS_7%6"6,:YF<T.GA,#T]S\Z.%V:4OPT:=V
M=FEN5:-8;3U,H+<0L@.]_AR*;MY<U687L0@T*;<]\)!J' A_? WH+I[;=C_;
M+O;T=G8H<LJRTFV3F!+<D6"!:P6XVPONQ.6+/#9/E2#;'OB%IGK4Y/6RF(7S
M^0G.A]_=H++'[0IZ69Q2;T8JJJH2J\V-P6.+=Y<\EVC-YO44W2R-Q,N=\*X.
MM9KT&EIO(1,MO5)JZ]_K&A+3ART_WYW_O NYF"!G\?BBFO&D6AS867/F#F9H
M4L1?"]Y2][$E(S?1V #XBWR,Z6XR0I/2VZ,#:$+0.*U(6"MV7-QHW0(Q2OS[
MQ'[ZX:BSA2/3SP^/5IUW,.0,NC5?D2]092%C[?2I0FSXKQ\<O0:T2_]M,+=6
MD/I%U'+Q%X.FNP-U&0/8YS#CI06<K6D<_\6*AD; QR<8<K93[0V1L $)L=P9
M+9AO8,"$ _S[M1@ %26- 5!&*.N[I>IO6B)![A!7AP_[=P5^+C(:D('KH1X\
M4N,LG[8U*?@XGAYU2D4ZR;_U.&,/.  +BX#H.\/NM;Q76&7]XG9 O;AX/)RK
MP9I;(<C$8?D[KONPMZ([<K^3LR@R7N7E;24;3_<\0_Q2\T_S+D+]I/E0Z7,7
MP6T_?'B@GF&57MIO79[<E[TBH1K1"WNFA2@\GTV;%H+1ZKY[NU&V+EX#1+2M
M\_1$,&BS8C'M[VHI@UK]SWYDB,N%.9G\[1\XH\1QR@&T,]_NB:L4K$PW7BR[
MQ(10>-GETJ^>?3<X5V;@:'\/"(AK3$B?3P,2[!53'R[,B5@YSRR(6?2<\NH@
MRTQ)]_0#R>+0([W %!RTX/8%]^&V'EO2<I+$>TY]JU["2!(D7?BA/<,VR0*R
M#,+A_VF[W Y/F"7A(AY(\!OIOORJ,G'SS#XTSZ>M)ZM^NZ7M].QB,C["X74[
MF6H!S+D441/QJ'KI3 YW)Y1*B6;CX"TQ:%5E^38&;5$;3%8O1K'K?IWEZ[-W
MZ%GWD*-M^89 CH\5#F0_K:9D=_'HS270]2]@"VO#+H2"C(+BPIRF&ZD._53M
M \[WT4FCENE$HU7".+]D1V?O)[R6-#[>%9DL*]'"!)OG)V*J(W_WG)0$+T"1
M^DJPE3FG8-$@ ^YVAS;O4Y8=I$D3^!"GNCGU3AE+G=QLT0"#6]T)X\91/GXA
M0>X+["D4O4=MRX-R5W;>GM5R\7 $ZD,Q \OH4.4WPRFFSNC&[&N !]U'Y IC
ME.=&QS6 Y%&*WX7KV%Y-P\-LLG;Y@UT/Q@]0G3+/?&IZC>FO3WSV-Q%R([TE
MT3G%7/>(06]DGC<7@^%N*5!@&G,5I>%Z!+7=PK,#U,XMQJ#) 5Y^Z_@FPR1F
M@@X$ZS6 <TXSJEIX#C\_LP\)!'W10MQN:7OU?+]2X=()@/?05YGW_$*[>D*<
M7Z%R9+>K-)*9X[O.47SG&7NS00F[A+G+:'YOC" R^Z;SH/V5,V2=XR]=""W_
MRWX;E7,WX__WXL2IW/FGF;EZ<YFLBJ2UXL[1H V=^1>CK!,HL>7;W.*-GKW?
MS&JP</Q>9120#_N((@B8TRC63E>3:\S%G"> $J"5/7#$F[' *),).4;1T>BD
MG0O81Y=FL+-#T!Z[B6+52ULG[[B=?2Z^X:6D'#6[QG&V-$D\:UF6X0*QC#'R
MVNJH: LI]V=H1BLRPYV( F*M^3'6"C!UZ$,.U-&Y%ZQXG,+-[<(WQZVFXLF;
M[F=%P&'V^?P2]J<6SD5?A5E,^UJ8KP&]0\"=.6!*R0$>I'<F'P*3OJE:'?E?
M5(R9/G@L:)Z?IT6'&6&,AWQ=&/(]< W(%/2J]E3IC#FG-L%\ZD:/DEJ1BZ G
M1V-@/B%DU?3F!H<L9N]HLW)3Y1(4%>G.>+*Y<$&C73BBO4S B+4\SXO!*[68
MX%86<"-&WDD5W[86$<^=-B7MS/G@'#!K\7M5.P[9@Y:=DT8W$%WA:)W=3+S2
MDGRYQ@02A:F/G^$E7M!R\69TM7/4<F3A\*=LE<)Q)$S>5[MCB$G6<]&8D_/D
MO0.H%0?]4#M&^Y?K3QL)W-$3W9RZR.;2CM5*4'\EPYK*<;>UU;CJ2+)>0D*#
M6'0#%+#%-[_3YR%)<9K!_URD@@K[ LUP\DL/Q5\5]:-A_%&*Y&7%M]?HO$9:
M+EI#D0G;DB4=8W!XZ\^+#&=-D?#)5V-98TT1Y*OI$BV4Z8\\$M=LLW6:*\<Q
MZ,N/?-./!;;X2V ]I;^Z W%/=RT&^LL=PS5A$0-/$GX>_3_LO658E-_W/CHF
M@@A2$@*CT@RA=(^TM.30*-U(-Z.HH$.W(MT](MW2+=TE)1U##C ,_QGT$]]?
M7.=<Y\5Y<\Z+Y[H8G^VS:^VU[K7WVNN6;UV*".*FS4B2RY07E37T<DI*WIU"
M2T^%G9XYG%\!Y0Q#E\@QQ?6-L'OWW9>,H6Z+Z/HI#."77^<%GMR8P3B2Y-B@
M("DTG2[TJLB]1*5LB.IW;T)_\)+*5PPH3#Y]D@?])RJ1E? ZM",9(_9VX ,3
M#30[YH,0[%P8#4- 2+2%%QK8@?!B3JL.Q5+#E]?RIM0WY'K26L3AF_C Y^R]
M")W1OLSV79M6?)O!R:PJS K%M=^F)!>##]M\;1QD$/:YZ5LA#/M;@;2*TZ_!
M$Z*R>T=P#73;4&ALM55I\"3K3QG9C:2JXPW]LKEF&SEZ\[*&V!M,P@;7%J=R
M"NHR#(/GQG\(M:SS^!K.Z0U%[DT]("D;/I39)ES1J#4RH]D)<+C^EI%T/_R4
M;.7$U(_707K KA1$^&TR[H5V34U"K,D%8)U,I8V\TV3^2UV+_6>?:/U%ADIP
M>"<*1(:P= &_G17Q^!/(.%@A20U6#T#&7 !H^8"'(PTQGB->G/\DV,O_D;>&
M8G2MY_-N3<@7C29AN6$:HDVT*F,3BPRZUIG2S.HOI>X_^]V?^^2G'Z_)]]/J
M=2HJ/6Y"L?Y;'7V::)(31R1$5H3(X.FN"E4G24A!@<"CKTA35Y]7(E05(@^O
MJ2Q\N9OW3(:CQ0U TK=V,J;NNCL[LMQ;E,K&<CY!1WBZ!!%/15HWBQ.,-B99
MW-?5(= .$U\%-Y7%2-L1>*C&\66U>KJW,!$N\#QW_C:C<>;4?CJ6K<3CMBO'
M4T0L,%SR9!6P;M/*F_ATO;JN=\T@#=(5.B][30QY-2MR]%?,7(U)&=+!+6OP
MJ">JRI3XS?JM1K3D?M%\-%<,W8-@(D/.%.N=-&N$(4#WR5[76V3X(;#C_"G<
MS-^C*$7N)\9Y;%LV$R&23RNI7.U"%"^<_OC,$9:G9/% 0#+:6.S4#;Q2;_W>
MV[ P;7R##ZVYI/<!QS2HF:E_C&WN3BKWU>H$?[:]K =R0/T+@/P@KV895PRN
MD>3;TK+XHVV0Y=W:;WPC &@2:(KG3.6K5?GHEPK/)ZSV;=QO@A=R5NOO?^UO
MM'&Q^!PP&B\92R<JVD HKGN8L-);7,;J$U^2@.A#P88N /7)IW?A+'"M__A9
MR&)K8K3 N5H=9*7;6C:9P"HPMQT8 (RUF52-&3!XQMK\('2AEK8.TBB4?!3@
M'UY#R#?\X<-.!9 %58EBT320E=#=^Z*0/564=?HZV#<UC>C>$0YX9955+^C#
MEEUF9?2"0'@-M0O =+BL%24^(I)/43H^M_)I)QS?M[$?F+N"OJ;#T+/I(I?3
M6O)NV"%CN(QRA^%LK\K6BZ!YEX),-S*V.O1.TV7JFSKG)DB0YWR^1.4,\8GB
ME1]X"-17*-6>T)H/#;PHRF_TF#!(P?\*_6[(1%T@?'Y-58U?IC2SFUWEZ5CI
M8IYE'%_0\813\@Z![%ZKQT:ZS&9HIH$RI?:+MZLV,]P1$=I>[>]Y9LR-Q#0]
MB@AU'@FP'^*\16TPJ\3)V&DE\^7LZ8[O_HACS"ULI'J[+-4DIT=] P<,5VFK
M_B!&_1W^^9"2QI?NPT-4)^^(U:1!4I3=DDX3G6&!5RPV13-&,/'G92#'03$K
MR7=WI.*.RJVAPZENIQ4J_7YE4];5F?41+QE&F@&D+R$B-6Y7:_W01P8R:)NJ
M4-.8"N#+<;]K5[.B7:M<,\VZO(PP>@OR]OP8RR=HN8&QPIS6X,/M"\ I;L'.
M_QISJ89^M+CK$W8_,R.S*.H#E@#C$'P=H_**_Y0>PC@C2]>P49@%#9@/]?WO
M[XH@")H!I)AL\-C7?_A2X;3PE[L[J*!JZ/DKHV5=S?&F@,WL1943LJ*&66Q\
MSJ=)93N'!Y6W*UL?U7,'__Q5)]R6O <R@-9BA0^4K3!/!OUP?"M#+DW.Y$7'
M.J6VRX.#(KUV+Y,9JP%#J8)>6^5=<*57<O.UPQP?$CC;Z*)\)72VC3!2^WP9
MO3,,Y<QTDS)],:K;)'.J\7%^&))A+79SJ&@FHRQBBZ9J,MW)=25L5R"G '7%
MY':^@7[W*QQ-U:] N/KIZ.P@$[@XIN<"<,4JDG>X.BI8"F:B&%;;#E\")[H/
M=[R$S9+!*$8%^E]JR@#(WB\D^O)\N>?/= %0_/SL*2$SN X-/+=NK1"DP65U
M'/Z)DO7@K!7WY$I(\0TZ4 U;2VZK,YY#BZ9= %Y!61&L1U-0Y%'0>2,J;QU$
M'[PJ7/[#XC]X7'N1WAC<Q3^WS;3/F[EX 3BY(GX!, )A($B9.4KT A#V9>>8
MY"2>?+?M @ +W:OUUKT A&^G7C+ K<K4!?R7?X#I?85_8^CGB1OE?;:U*P7:
MEV_^%H980XX5YN4]D :P!@.$\9IVLT+.HS(#8AR=Q6A5CF3-4#CK2O9?C=^Q
M7"ENI!/@Y8Z9<$GM"B5O%VK_S+KVO'CRG<AX1V?;TV/JE;V#(JZ:7)_K^SW[
M"OGVD3)L/7:G49U@K\\7 +QC=%KR"><%8$(K(EJM.#A54'A\0=J+\PW#7&I'
M(+ F\?7I74+D&&@!2 A]<?[E'-2W7P'M%JUL$^TK--R5R2F/#YJ01X:NW.?R
M(!#R\P6S.A^GN[#Z;6[^V$-?<\TVT'O[EDWY]:) QZ-:6_^,_*NW!!X<P6V+
MG+5V76/37QT3R1\-@=G+Q"6\$QP[3T=?1>I]T7P;V_X%\G4MG+<\QNI:L,BK
MM*_' /-BEX:;.N/Z#"U[=3TY3BE%(SC%[> ?U;I,]$=DS +K/QS:]CX< !*7
M/D-.DM<,'0V,0@ZEJ^I"V^BB*SK#PW:2YEZCS:OD!_$&GN3MT$UNA"&.49X3
MF$4B@]8<AP 7=Y#[)1A+&8+*I_"155)YG\"@-]BP] 0#!XV(L%&#>9IU(+3D
M/:-#!!#]#I2ZZ<3>]Z*(#B,2&VQBD=#-LJDQ(HP4',8"Y<!'NDU HA'(3PLJ
MD%XS>._)!+0>&E$0H3M+B<$FH=WG^Z@0VR/!= 3=\$9?K>L%X&$E=&,">L (
M%X>+(<90 ?-_P]!L# RM)_%N= ?QO7N(\\M?1DTT##P\NKS\;59'Q7;E-BLI
MTQ!=H6=[@.N;C'637GJ]GJMR6ZMS@7N,=;S:7 %J>!'ALI)2(XGMROH#Q8L5
M?(,3TYT.0C&1?)--:7#-D5(0^TNPWWNS:[=97S5/36L1(V]R\K/G"(:=I3T@
M7$E>TV4-R@U*!ZTZZ9HG<^1":0IT;H3UC'=H;BMY+>1HX@E=>:-16O=HZ-F[
M=NM/["';[6QS1KOY(PG+/;VYS3'4V?][FK@-U/\<M:G9//\D%Y%4IA\8<C#!
M$'H?.?PUV#;\2K\KSAJ:=VP0TZ."*VJ/Q5=MZ#>W7>1%NMI#J$#U=;O2,<TE
M4XI'+1<  GYFE!"Z= -X0T?OV3?]KF,&9;>(,I5AZ.&&@Q5)\GC7$BWND"$%
M0T/$*[/[=!UHVA4$N*MZ-AJ6JL'ZFA0?((3W':'\K=KWK9[4!6!-O0B $V.X
MM;5U 1@M*(OBUWJG3*Y>11Z?.?+=N)N^0"-Y>R5LB$P-!DI9,OX[^/'_#\W\
M;V&9:H",I7! I\@5>>Q1#'%["MDJ^LZNO'_<::1%M907T.L$Y<<YJ1 I3*>=
M#RJNO[G+K4+O%9OQ[L$O@8X5!-F&8UK;&R*)' J IB4ILZ;J:R&,AZT">SE@
M%TQT]UA9P$A\PU#=7O'^(P04IJ[X>E+WJTT<A0 :6.CY]ME@C0(=<<M2E&+\
M@E[NK.=T:;"3]JC9UI$SM6SHK^I72$^M.#9%TRGCV3G33PM@=9TJX6_*EFGU
M, K6)X$,1;Q9+8BOO&[DH';K[NMO([2V?N&[5=RLK36\,J2_.T+F'9\?J$\K
M7E"S(7EM&_@*'>,VUALY;QQR.U8 @+]O&)." I,\ZLL+%3HQ$"^RI;$:2!R=
M>592]:N:,X"7W=Y,P5('XZATR^ XK!@FI_MP?RM[KYS1IA-X3$@VK3LQ-?[T
M0=E'XV 733*6PF*/B>%CK0^C_*'M(.C/\P=/ 6]I?T+N%""IAGYYWS/S:WBR
M4*>N5AE @1OY],IQ$=>9>@F;1(?*O#YI79I/?Z5@J^7$4D4L]WB/R>=G[3ZO
MK,O<3S/X3M^Q95\_<I"?+RJ<G#2Y[[9F)/NVS=NLFYW^@TW>0VSFH_\W,N/]
M/\B(%[@+;ZF6#=CA9>&U:2@I&$@)/K$_>9!PWN]K,P2=MT3RH]\"3T#\&"?;
M2$!51S[8=/O'!V.&6WOI"BW\S^<\XC1KRGUW53QYBNMO31<LO7W;\7/4CE0K
M5[OMV!V;EH#V_>_O;Q\RC12A?Y3(4OQ??K]W_D,T75?('?M?H+Z[UI#G8DCS
MZMAG4]?-%"()"$7OJ&:0EJ4]MM]>R?9A1YA_G.\%JP9IU9T)][)^(V29>W M
MN?J.^S>4\JZWU#IOJ'PX>" +R[6W(J_;I6'"Y.: KSA/JT$*XA*J?O([PQ%,
M?GA%U*$)2H[ZI-778KE3"HASY%!^@C*I.@;&>1TH.% AC;>)V+R.DO)DGL:Z
MAC0P-L(_619D2G!JN$J2">2+JF3NH'SG[81$]S:TONV_+M]:(;D ^)A7:B(K
M.6MUC''YJ$AM%7M6=>7$)$.FG-\DO *3C'N2L1.EDA*W*FWZ8@S9;7#CW '%
M!:#3J@$)V^/\2#6;"$=F&*[%T?HV3 SP;YHMD40$ (Z+)-XH\Z23NT@K2N5Q
M:+F)W4&^@<Y+V$W<F4UH9[QI2\J4JSZUUC_VU2J92(0S3R*T.D/KQXQQM9@>
MYW 2^)'-KU,6Y6BSG+4%IAMV X?7D#7-EC6A#5E$Z-Y!X)(-#,'4=D=L=B:U
MGVB[B.*%RB/2$*']MYVB M]IS_-;F3.IB/3BV/0GO_5'+GC:%YE5)O9$R2_/
M3.4_$:1'\U*DO=%+R$[UD%R(.0HDUK'.93B/3 !M]Q2'/569I7T=<=A.MGX/
M>!?%GB-#R>OQTF2$@YL2F R,@'_)*3"3X1I>#6!TU)H^?8TL:89QN9YS[M8$
M7P!T6X?1S!Y&RG+7W0L]N4R(IF3T! ],WN]LG"*,1%75<F1S'<@Y/JS7&BSV
M*K0&/XS0&FV][Z1'9\$T$G8_["<H-B.S,"U22Y8G8VF["<:<=_</F[#[_%R(
M"#C50].VC%VRHY)$>'//U)[@25<NV9)D(;OBSXR"7I;A5^ZR]>M&1"@FQ\R9
MYGOYU7(/752//&7DU'!VQ]Y@C$KJC3N!:OFYE66C*,'1TG.<UIO[:I5[[.@?
M:PTF_/3!^,Q,94X:FG(&VA\Z6V> DM"FGMW \QL8S*MKA'Y418<PU?'(.\"?
M6W5Z_/C;0QV29<JI&DK*/IQ=T; H51W6)S([)'R^=":+#?C61#M!.N5A"625
M#LQA9QMDO'W!M;PVN+%*3HW1^ LL[P+W].-/TF*SUS>JC/3B3$9JU1$VO>^W
M1$3O,_[4+%K6OPL>IPFK0M6,Q7!S%YL;][331T4J,9"5OD@K"&924W?')E'M
M:<*8OC>QMKRWZSCVA&ON?V1?"5XV("#L/PTS:83K[5X 6J<H%[3+.G1'7P#V
M%]00%577(I#FM?:PC^(*SL\TH_G$8H-:9ZD_NW-49;]!SS3EHCZ2D:V$H+C-
MB"(-K >^;^$G6:'B>/==R9)'QIRAA=W%Z[1,R!+>+CFK%)E^&0]^)\*$?11=
MN:QSG^@5^!-S"^._\M7)@[1;9:6<E3.R=A[\5R9>^.?\M>3_##ND.J-+QT5P
M<R[<A'NF>KCRWJ;D4Z+I\971#!14$WZK,XG3RDZN]IY$S6'SK/Z=F"[W]GUJ
M/_#G;!3&"XE@:-A8 &\8DL@G\@I8&U@/9JM+KCDN-!!RV5-M?PFV^)*!L]?[
M8@-*@@)GMC_2[7&]'3.O=F7/@I+2N4WL,_QF6N'S,#5:5B7+D&0B9-QSA%CZ
M4<W*%0T[&.E91)B#\_0QZG4[1B(+8C_\LJMP(YOR4%C >#:!@\+"+38SHJ^N
MQIXO2895JSS'V4WN@9!(,Y$QF OT8F7':NYN+7=."BB7H>8G<1Q=-V@KJA$L
M82.+)DXFM.L[PK8-+3:$LOD5#R(/#'-.-5X> 3Y=!Q.AGF2G&U\ MKBN1-!4
MW^M#W=Y&ERTG<2 .,3X4^69.LME0LT6G5F=XZ/LP:+8*G*QC $*E&IKE#!?,
MO^&>C(^2SO3PVU#U5=O8W.!Z(+E<LN3O?"Q^6$00K=G%*M_S@_A5')?8ZPO
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M2[Z$YX<=I^;5'O:E,TS-N2(D(*NCKW>*@N^SI@^[,IV,O;,1*CB=+72$@N^
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M3@6--:D80\L-E'<A1JVW1JT=TSJUA%)OFK4]:W_.O'NO(MNR@KPP1]\3Q/I
MLOB+ )/HE2()F$]07'2RY4E5G\4%X-U&,_2 ".-=$$,1O$N3+8@9&_?CN^6K
MF541 Y>X=E\C)^VQZKASWDIE7JLV5R0%M;\0[("0$"6]MZCG:Z93_+J"*#@!
M6BI\+KMLZ"LM*"UGK<BXF"?Z@Y#$TIWH(XEF*> H\GG@GBT5;*>UFBS>WE<9
M9X7B?6WS!2#T5ZU,M$O!.4:)M=30!H@]O V_J_OVBQ(++M<]@Q\7 )8VQR3N
MT!LNT-T$I#/:'WQR507-6&L-LX_68:T=&/ 84B\9*9MW-N'_0AB97V-E*"[Z
M@4RA&1)NA7Y44ET=U1W SS!U?=%?B,"&%59C9<+/U-OCS8EB$J/&X)@P]-,H
M+#0$(\ISS?(W/CIBOG+WS?/RP5K_V10OV*]<:Q,EZ1ERH6^1)4)&U];+=<7*
M>%M1LXI*]AWW3?A[JY0%</K'H!< W+Y \"K=!2"<_@*P8-.VFJ8QG#B>JJNJ
M)0/_R/E@6$32T]6&Z3-^*![?K3Z B\BH)JDF@QW^5$W5)!+:?LQWJWPR7G3X
M]O=HX"SG&-B[PM&@#A[$ RJ=CH_&_?&$9:\/+0I#B"L\7\NRH=H+#:R46V"_
MQ\,V61AQ[:PD']A!M7(8]D'K7O$WJ_RCW),KXV0A*JLJ\R=C<8-X\I'2(E))
MK76R:C4C#E3K>^KTA6U> %' )FLAJ586?]4LDJ[%2SDBK=?!UWU9?@Q_WJ?"
M(<XZ>)<PM7!CCLK#S^;VAZ'GW;6*>2*?!>F!1S:=S 4S/#.]FE8,+[+5K492
M/ZZ)W4,H!V4A[0<'M_>[DT3/XKJ<@VN(.BA6I146@/<LXR9O+!>6;9]D*#XZ
M4>9R$HZ [5.!P.9P9P<[#L/GV/RO=\D<5(8Y2FM:JDNCVUF/-V53:5HU2$L)
MCD05GB'0B1YO.!M+/A%DLX4<B,HNGHRN;YP*,]-I?FL\K%0]MVEA)HO*J+[/
M)A6[\M6:EF> C71A8XO+Y.&#^R7(@W.;WK)SOQ6C6IVLJP*+%# &P5N$AMY1
ML,ZTO,>JC*YFHA1I=5 TB0,AM%_R O"@$XMHP_&8,1:8E%7 UBU)8*QTQGAP
M@(W#YU?(^-?Q[C=AKT!!*0/*K%U-&"T\X: T7%3Z9;BF-,HT:-CMY331-"1C
MS5!X<,=$L\;$"BQ!3?SNC'8NQ-. -/,&>]=[V3MA=@;>LF;7K<NUQ4IRT&5J
MQZVG#-'>(7N*+<3$A D)O@+ CV2+PQK>]%:'']V$5(@]RA<QQD+V(_Z]%ROF
M3J8'[&A@'VR%Y0:[=:1\1Y.:D_M+O5E:A/3L.[0VK6LZG^$C+^_<39N;;R3E
M5AOY$@<VCL0>#SA$0[/8"&>83IX@D\"ZE9/HT*"H/)W%25=PQQAL0,>;WK:8
M>-.+KV3QS#+MR=J#WB?4\NL2G#]?R9V#8PR&:BW2B[[8<O)>.XH@/JGZV-<;
MZL4A-!:+I^OW0_CVE/RQ*$ZK'\,@+_M5/1N%!BYSLX<^%32$(I@Y/I77S6F5
ME9+ZA56..X%:7'DS<]Q$),8,1CM$G>! E98Q7'PN?17J)RQ6]"]@Z55, $B9
ME:Z/EU:<@QEEQ\=7>F>]P\DMO[+ROQ5GWIJ%L)>PT@G?)9.1$WWO45^66P_/
MUS?D<ZLQY@4WO4U!->B/I2!7-,\(0HZT?S#6,(A]$#O>OX8X@G/F9E2'UI8M
M$\=&QI8__OL(1<CN6AN_EWQF7=.7+^+?KZ,Z1,.R*_:*9OM:X]D7[,ES;[\P
M,S^YA4*"W\ ?918L*W$_&XEV$?VT42WAKYQKT9ZQ#BTTM384&-RB>S02,EWG
M[T_J*X>.P6 WC0CEVJ36<XAV[:B]U+'3M=*71#)D.%\O (PYJM+6&#!57["#
M8E]08E+J-RZOJ=G[I64,Z78>/GT#<862K5;HBB[=G=V.?6:@ZI--2>\X#(E7
MU:FV/N;1S(CQQ_2@E N;^$!XYS8R3&ZHE+FP:!M5%?,I9F_Z4"Q%<TN]U8NA
M+<+[.J0F(Q)'RHBE34X-L&9H)6VQ.;)MG2\'PC6,2O?(EBD=*-A:J9U@<V3]
M=J*,S81OIZ#)G&NOR+BP'8J1?S3]H"O-36\;O08N"U"93P5E\U7/1Y68>I^H
M:DDD3">.'[B%C S JA/R61IQAB$6Z1Y;:=)O-4(2"*YC]UK>$%P 5$\@9-($
M+-M$7T+;X>(+HK3SU[+2[5..(HZ '0O)C T94C5?U,KHSC]+ @=K_6!AIB&^
M-9ONDPVA\R%4HNPB$X2HLHAGJ@<T2J_&R$D,ID5;6T+HOU&7\'O!8)6MLB:"
M2MVOX&J!K9/$C51E1[>>$VXG#YU/[DVRR+/JO6.<+Y[R:# <<E5B9&;;]IFX
M]VK9I]R0[^LV3DZ>V)V1 I?<[<DC*/.S//(E\Q^X!S>K8,Q+6E_/TW_]$E5'
MD]S!04,;]FY? !"\K3I]60H+-4%3W>&Q_NZ?Q63$7D[+'U#2A(E]*L#3E<>U
M%=1PFCX$(Q4..$_0&+O)^9L6#M?O_04 /'=RXP* C-_K8O&FAU1$K"?OQJT:
M[9]CS(,1QMBDHXG/;_]=T7*TZF:XMR<-)-C5FP:R:62<W+MWO'-"Z9A8N8Z3
M6J1/C,TFZ'1KZQESOGQ7FU-45(VP'7G;>G$!58X@->ZP!1VP1=2WU67 9E(1
M@S_OO[C5U_M _81J3T@58RVLJ :?'5:YGC.2LDV&%%]+CGS:OD=99*.-J*Y5
MN?DI]#8^Y5PPM!J<6\0((^-YSSIH'*D=:RS'1)]T\!P#>,.>8X!!#48S)N^@
MWF&I4IV3.$==SM4F)]BV149E&0+:]/&]W^C'D.'A"L=7%\GWL/Y(9A7/U>U^
M./F1BYO: G!722LMI^<0B%1P 5^.D@I6PX(6SG6[-;PES<#Q=(0U2V9MCJ$I
M7A!N:<SB^A69MU302I:>JM]L4:@[K2_6$?'1O%'@YZG6JS2XBX2;NR@833Q#
MB!T\C"OSWG$6-&SG*JK&4K"\3Z<M05(:ZOYD6[3UQ2 LYGIB=XPL@_G#HD )
MA,:I6F'MNGDI#0Z":6AJLFI16EUN6R)*>?50P8C8BMRJRL$D^%A'N0DL%*OD
M+O_Q-E^Z[5/*$U-\Z$-#9>:"\TC>HYXMWC J_P :-NHD_.VZA@G@HAYHH9>4
MN7='8.58!4WV2Z-TAH=!"U(UBBS1'3H4IJ KJ=RG,9V6::.@$$NKZN4SK1AA
M9XPI;Z?NV'1, 'R/SY?F*2B0C+)?R88VZ:1!^W;0$M#=@A#9-J+F7'&&X+2%
M*7,&B4S//M5PP59''C6-0?;1*%&^OE8JI<FK]EKDBR#^[K#V3#T["P75J)Q)
M- D+NFSI%\RPEW"*NW8896-';#O4W_<0S:^6!R;(JORXS5"=N)(D25_DU.,]
MK)%6]$3A<AFEP5@^J$I?_4-;]I_\8]$8> O A@]=IEUY^33MS>7A+_8P^36+
MMYK:4<KU%-6G69>_?V=FN0S;BHR-_-?Y\E\*]P\=V)N@/U_ TI;U7Y%3D/O[
M0/G991:8/YG@7URF?L%6_G?KKMPAI?JO%&OL5O]YW+Q?QX^6B$W&9EQY:/A1
M9Y@_LWBQX=^GS75!BQ6H[^"MQ0N %21TS #XAM:/"5F J6CX.[:V?S\L ZWT
M>[<6U7J\\>Q<DFC>W--T2BG>6=/77D=W195OYN27N#?34L&&"UL["#F?BX(&
M[/P6WIQ ^$V?/I<#>,6GPST&V<5(;(PE?\C@;H*I3@+=>BD;%L!DXFEZ/*J/
MO<LI %#"T=H\[RIX4=*".]NF<Z]6[()>;KS5DH7;>J^R!/>P9M,7^XXN^V:.
M2>,O)NJA2UHZ/SPW#$A]'WMI0(2L]3E6V\8.R'9>K$M$>[(YY^4*<^/!?+[6
M<JBVW<H"R'VGY%UC<K9K*N<!WEFG.A]LM2*YWM?+ F0=/7XG<L6UZ%D%_\O4
M$IRH:339EJYYC$6&+GM= HCJC?_3-AN\LFC-\(&0>3B.]NI=$*D.A^.^X!)$
M5MXZ<^N\[AVCSAS C<:F/7Y3<U-Q,R?ST^OT7-ZN#4-VV+"(VSONL!.K8;RF
M,90FP_<7P.Z@ 15Z2*+U9,90@HQ\^[KPB&I3FYK^"D^^O$-L\JRM]2P+EW+K
M3*;SC!XLI;JKDW;A7>CA#XW1O1MVA<=*7E$IZ83.3FOS:Q56A_S!*[2F#N'6
MH2G2/7J(_=#2;C75)+ICV9DT-1E?9)%VD4L>.WWPR&IOXZ:YJGPS_M,,N))P
M?N(5:5+U:QF[X$"2%O1# S'9\20]0;#\ 48]J^NZHX[ GXNX?^Z@PC"J6!]X
M NF/Z=1U"B[X/!.0B2NQ18L!7W@VRA> I/9]'FA3_%##2C&J5\$= 54NJTN:
M274R#D\55C&!!:+)Q;Y< $2,T"<\#5Z0,X&&W:S2G9--*+<LBJ50&.T-[!F$
M-JT,05>"+@!SC&%(_5,'% )ZMC1P]O,"8"$ _V"(6[Z;6)<1+K8C"$ORS?<O
M.EX@#]FJU;F1X;;:O51L$A$ZT@A1$MX[:Z>Q-X0ZOTB#'80%)A-,&9@-E]WM
M- _9@[O330TF9*05=;ZCGHGH6C6\.W)X\EQW2N!]PW*Q430DW0IZP^?K?=5:
M.6X4\ZU6K];,F+)W5^]KJS&W[Z9\+PAQ;Q/B#XSCKP#S'YN<A#A5#T65*B/G
M<QL-+80)FPCOY)QO.A4?A0]#@#BE]W Z]N\>=4=IVHMQ6[WLFUB(B!.Y)\':
M&M;&3@"9<F$($\5+Q0R#\/Q1_[)KV%O^H]7]\9EVUM"(+>'\'ZXTK&?R7[KJ
MRR-Q^F0I>GTULZR/=.N^]5D(=026>P+?JR-P GAVB'3D;DR#Z@*NI_AT'V13
M;0D_^SQOPN !9!TP( SR ;G.VZD69JD-T)I$%9/U072M\M/]51W=7AJ$O:YE
MP8%Q)E%.6</K'$?6C6Y"ES@Y%U%YK'QIDQS!&EE1? [HNVM'HR0_2F@ZJJCC
M$?F5[\B=6H3HR. %O,DGUS 3/L9MQ+)NM$=2A=$K@2>C+O3+WE\6<MON+4MC
M%%DUP=.BH,9J?,.'H]()A66O")SUM]R-\!J6K(';82NJ_);E05E1\8K;]$C^
MK S[)I.F2$'>1:^Z^'%K9SV6#LDW1CH8"TB[=P&HA,;X%"Y 3R@X&F8++)75
M[%>461->Q+%R853/FD 3C&4@-5+Z*9?VFZ<T?:]%;HFHKB@YR4_EG*CD%LW4
MW[$ZNV_;[D8@*&I3M,L7P /$U],-YZ_XH>+G611^UXMJ/M'*V;)/.8F6.O^S
MM4\B?(W8TJOGB/A\M=<<4NACUB_%_]AZ@%&QW?8=P2>RI;(Q7&=I;O\"0<9^
MK97W/$\6[E@+\[V">=*/TKC0$H[^['<MK:V\GD(38-5UU/])[[.1R0AA8R&_
MB"*46^Z?]<'[!-F=MO(N#HW$K)3E 6@5Y_FN3=QQ._1,D/"O13#PK^)E\SL?
M=8T^\+H,_=2Y'IKA#Z$!5>1$K\O*Z%NI1M:J+L_]MR4T<BZ[T!:1O4ZB^^P;
M^<<N/I+*O+G=*A>C;84+@ ]5S<BC<2>271OEQG,$JM=CN^Y%M6&-IW$@"/^]
M.-P"3,FC#XPT.OLY%HST1XNJ&];5?[@;]4S'":2K?WP<ZH7NZ@[OA4LBH3]!
M4+*U,7YWXBTBN:\$OJ ^T(P?+K2C"ILPX]J)IF94L/V'YE;YS$_)_ZU]8RDV
M7AE>'"&N.5U<X8P+H#[9-CM^X#I&*?#V4FK$MMNF2A ,TOQ/&H4)Q6''C_9H
M.-^S L\[6S7LMUX =J(TSP;!$YB_WO-F0_M,3N+W&BA6(Y#>+5%6 WRJ@ ?G
M-L,7@']*&^HLTMB#[R)#[60>2 @ KCX9+,W<XMRAA!SIU__Z14:J:H#SX)(K
M]#<YJ:3",TOLK8;8WYR@S&FPO^STF_?8 #3,\_Z?URP8FXN-*7OR_C(P#8^9
M]!W[GU+88.U/_P #C&VF4)4FQ5K3I\P;"L^$!ONO_ 4=L"$[CR^QQ6]3SW+K
MK^+8R+3OF/K#_>L_[S:@8$*<YQ[B%X"TT7KSS()U]16^=,A$^:9W12OTA%@/
M74^'+IOG4=54IH8UY:M/RA]A6EW0@_F6U664&[:=F)8]>RG/PB(-(%65?DSJ
MDIE!@WD;_0=5O, VOND2H*C*R3,#,$VY; $VU]QET-L3#,ZX?AD_A]UCO<0A
MES2M6'"$>>Z6KBYYF,K1N<G=#=!2]\]P>7 Z9)EBDC@K1R5'^7D\$AMV,!UO
M]R=(Z2^ ]'=XV^^1FLDMW1X&/+=,&<+6C_^[!':HB OVZ;DD(JM;&?E3C,F*
MA^CJ685^-^NOP?MOH.MW$KV,*_)":FJAT=]U_TW BJ/+3&,%6&=.^X0[&QM5
MQ_[@KPF_B1F:J_^>_=\SS[PF)R_T&Z2EP6Z0 J+_A"&J_0W,L(/R^D\=GYJB
M73(R:7[S]Y#^%76(*7#K4@(R,TA+O[-@6OJ;OA8[/>JYI>M_@ZS_Z$/&93P7
M !MFV/0'#/X1T;]@Y&^R7.PH$+1_IU*9=,7EI21?JC@Q.78"IZ!=U\A^#FLY
M9??L.%MJ+FD5ERTD/K>>W!QZV/,$O<Z]GMZP( <.,5&5UM72XK+?7L#NH?\F
MWOT+\V)CUA[_Q:5["3/_^B'_)SX2&VSYN_R?!_OVYM]H%<N_B\VT^3LZ,@ [
MP+]9>/\,[FWL,$J3XK&\5H/)J_Z.J/Q=_B_27NSW 0/B:9>2R?(:,V !F/_[
M/Y#^]E_Y2[Q_A[@]_JLGOV>B+I?%^_G5Y\PIZK^9E2ZCX"X7XK]!]],;5V$W
M '\M9>S3^A_=_[='D/&7Z&(7V.._ T;_:5T [,Z_"8JQ';Q7.G>"IPL=<[D
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M&] /B:U0F/*:]KX%]F&:5W-BW0V4M&CP#+7P@=K10P$K\D0"JYVFB&COLUM
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M#!C_41A??W'*=.F:9][)Q)L<'%,:9]52T_MHT&^6=[6C4<;5X\05+,0GAUO
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MU&*1KWRF+E2X&*FK2OYX3:LQP7$6^6H5M7X0A,'^NEOU)\WZ,EZIY\%PYRT
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M1=H$U8G'JRU$VT#0I.64I6&7M5B=WSI#')SEC@T$YWH/?MVG*$O"7!>RMF?
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M$^U:FFLHKZSYADR8CZ>C(=LJ=216,XH)"ZL0VQD<,AQ@6Y+ WP;.7!/9OI(
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MQ]5(E+0U,!0A2<\C45]8P?4\OFR=+EIJ4$O!7F5=O2SS63)/C[Z^Y%1"C7#
M/8D67?IRW7,!#I?H8HAYBK 4<XK<.V4!PH^OJ[VA$6Z5*W?5N?%2_O5RBR$#
MLF:9MD,8P;99MQY+KJZ;%OO6],^NHV;4%YKN,N,]_;)L[* ;C::&4 /'.]AZ
MYVUU!ULHMX@=%X4M:1'$-Z>7T#'_QU-0D^/<^$7D*3VV%3/Y*3' &4OIV/^+
MSF"\=[_>)-]T,ANUPLF4@%T77=HWHKU/WC M=:IM3=L;09=R>'5)6?:JY_X'
MOU%=V5]W%8#,1NOK[..RAVGL%:J\@WR1C!7<5A["ELRQ\N+* D7<&]J\J?4Y
MZS[1'4LT;27ZTKFVZNSZ$0J$ F:?';'0:0^\HY"RCB+-.ATBKVINSJD%'JW/
MU0XPX$4K=V"=0W[L997#H*%GV^J4?A_ ' ^)Y9XIX:G^H.C6=&O2&\=1J,XK
M\RF+7\'#VZYX])&OCN&[P$9,)4-AMY E8W3[+W]&VUG,O$B.FDP,4N_ S&?'
MZ4:/,+ 8G0%(4+^]Q'//LMT74<J66MID+QCEAC=_$AC.QXI5\,6*BM:SW_OP
M3\2]M6Y<5&(.B>9DQY^];$7S/)SK%'#2,_Y3OEM>H$[V>6O9;^-RC1%OP_B1
MHK[*8]MNXJ(&^^UK,ZWCLJ^E]7Y22@$VN+QTF%1KR-PVI/58$T?F=@2EZCA=
MT/]B[ZW#HORZMN%1$ P0*>D0$ 3$H#L$&4) N@<1E!*0;H:0D&Z0&ND&D9+N
M;J1[Z&;H 8:9;[!N?_?[/<_[?7^\Q_$^QW'_<?T!UP4S^]I[G>M<>YU[+;&A
M9[>^H0">W J;(!*3Q5VB"8GBY_E]JLY.N5]I>CTY=1U1@%:>\*A8C3AF3!IF
M-8[3;.+0XN0Q?O=B!1=39V KKGHS;%W!R,X2=S1W0^**.X(,R=X<QDOI</:V
M)JMI;I_'N!Y-[["105I=;XU>][1^"I%F8HBW5>K$[.1DY[1N:PP?@$:%B&':
M<I7J=U-0'N3T/S*C495#IBJ<*.P7Q>076=ANCA<]7#&VH#/OI$M&VZ10]<@N
M7$905/)V=4X8>'U'82\_-][VU-(Z3TV5S<)OT!UOSRXKH'1^3<*A&,#DD2R&
MA!TIZ_BU@*\\#'Q4G2[J.KU352'6?'O_RN:&P-%1?[062%=#GJFD,G[VU76"
M9\ND&#NLXDB"T#LHP("#,@K04"G2%I&^R-H:M9G3'&-\=@L=^.XSHX<%Q48&
M:L%0 /_Z?1%3R"X3^J=N!8+-P=14,^>(U""6@BD/[,\KV3K3TR =H=;A?06.
MB_7[UCTSE4R1\D33AA-<9LRMSVG+O\4,H>V>,GW@6P0/35/#$DU?'>2[12\R
MUL31P+@'ENY#^BJ'EE*]'X0[@.>/D#,S[$ZP$S9OO[ !I14Z01V11R[(LERQ
ME+4*K2#X_GQ06"T/M2=P>%Y%?22]@KLI,S)R?!\2"*(]!Q7<#;SUEO6%]".!
M#B!&UAOA^M9MD)62SG2WDP/72/-NO)$)PSL#&\((QQ,N*G/2_3S*,J9^)MK4
M !9_H3SHM1,(M+N:VZW7TNK;(_>-+Z07XNYERHO4R?L:)E4!./GLG(]#CSUH
M48#%K(-"$6A?':<(D42D\)1VC]@](:+(_8IYQS-"T$S!^A.S>*Z^)*L3QA=8
M;3(5KX5]*XUV5"IG%$ZBG!3B-H>$R1U'<1]PA^:^*-;B(/%2FY=LSS88IUF%
M:!V<GU,$LR-=6-.9!6\KCDT[NSB3%^D2!$04=][X)K-V%G#<UJU:PGT2LZ<S
M52^@@X4]$+J7GT>#";>4KSY7+8^\V4/QWNCAN<)+T=>B"-9FVWJ2S3-..@I<
M>>,%['NDV(IMO#BW6;11  IXI/*'9IL\>0.FZ*"'FHND H".XWQB,C9"_F1&
M/+4R8>^283;+R7FMGJ\7R0:8&<ZL'C?(=H.;]Q;+G,!_4MI%_"6C=G+\A+@Q
M&4[F^#_AZSLO=A'&?B9HP^$L7-S-S<9664#P5/-XM9#=<8T%"HQ1KR1^>O/]
M<O$$@GOO S_N<)5]"F/WK9CIK_@M2N_9W?P!-"_P;$"]5I9&N9JD60$4>9JB
M]S6PU:C$BF*!,N-#-<H%:^%QAQ>2&@:;RXGL(;485[&5G\OH]*VI%%/FQ6A3
M+YK-6^),3%^D4M'1<-A#:TH\W+P)KKUK=#&W$VIY(O-5J!HSBKEOM,WJJ-45
M!7!:K"><:WH-48^[M[G,TJ*P\)F\JV3D2(B?.Z1=L;I<4N#3JT]AA!NB7-1M
M"O8F1W% *##'U> R QI[F0%%AT'$2US6!VK#=L2J=<./"J-OJRAP\"IO1ZIL
M&@-CN/ER^Y-UVK\BZ(<S*P=VMAAP#$JC2.-" *X1G\_O*"!N5N%1;L[!0N%O
MG1;?Z?2>QPG%>?>+#Q@BJ0]W,==$8*&.KV<GGT_9/=XM%)FSF/, 6*TG'RW/
M$98-YCG&;H75;;I<>XIC@/7,W>;L"@IPI= V:L.D>(*9WU;UA#=W2YBR/""9
M$3@RH3IB8_H&!5!CZ%=R<^-H<]O3<6.SD];56 BJU.W/+!.B5Q@U1P1+#K'Z
MM[VGM*[<P7OIULHA-7 X<W.BX+!;M2(XP>95S$.W3H9XF*Y FSO=4,'H['>5
M3_H@8LJ'GI)//;]1XNFWLJ$ 08CGN<^79TQ+HG:*%YZX5P/Z%W60;=IZXD6;
M3V8GD[!;\?"G3,\R:H,3O:3>>5N&*W0-41KBZ1@451;>#&!U;(_6I(R,3*R\
MC'DEDIMAWDA1'K3'1R/KUX# 16R$-V?_I8*@0SUV8F,R!D(!?).M.T5/U?.E
MI^/&$2WY8RY=H.)S[<WSO SQ:,*>/J)SPU'AWH,#*NH)%V%9XLMC'!^X^HF>
ME31\G9CR?@AMG+0Z =9I4SH QMA W;"^KN]2L."V(L[BG<322-YWI\:?&@2/
M-EQHXIQ55:)3Y4@/%)0Q%D">G]<Z+;FBV"Q=WJ^>/$T$EMJ],PAY_^3IV&3-
M1AE"MK![@<U^\67D/=)M'SR8I/#:V8GPTNAS7L:T'&*&#,8!I2&ED3O_778\
MF:W0XN'.71?-92_#O@DZZWSV)^^!0K@ZL2WDP[ :#M.S#^&\+&LGC\31P8\"
MW=<D'F:=M2S-9[>Y.?+*X"X+XS5"+FP9ZW1=ZYZ/40#!A,S%+9<+UH#4TBB5
MZ$]1E\VM,U<K2H>W>I1;<7M+/U/E8^3=_CQJD0 5NB5=S6.O]4Y17EX\HD>]
M:&9:?C8KD[69LXA@DY^=]/#BF;%!GVN-K\[9-A]Q"D\H0E%0CF)C",WKF,GO
M(6YFTU5>!,5\3-+3\!XI4%#;"PW<KN%ZW4F1'A\5&*?/MUB^<HAQU#Y&?7MG
M7VI(JF>G)09-[)*7!AE".8L80OKI(WIZK#62TR%:M2GCF5F%XQ,R:^&]['DE
MW(,5@@>;(<E9Q/FTGX-85.S(UI$X,/D$&^CU.=5BZ;<UPN]MFE/!MTFMKU B
M!<_48TR+QYMSIULS.QG*C9=?1SSC>4(%;P?-CFS.W4$\J[KM%6^>>7=A&\<4
M;2_J=TB9-L?=A:,72G-T9U_D(HI+2<3,RN%6T#PA%Z5OE7472]S:>&%  @Z+
MMEW]BBQP%O;'/#7G)&12_19/!??L6YY3@J\6[2_F#X:1=M9R>?0/.#/LW1X"
M,# \52TYNW$E4FJ+RRN9DY)=9<YMQL@H;8L@8.C]L?HUGASP/-KG!M/ (C;G
M#BF&ZV'HF+7MBPJ-3=ZFHAL>FHU\,$-S@,^,"2B 1PZ2>%6$V+8;5^"<:8M;
M;736**F^XZ.R/;<!+^612))5_3_^2>ZLJ<-92'\%:'KZU&EBM:N_0L@JLEWL
M5+4M,75G@IA54O&KA-K>PY.G$D,/97:(.F:("(,@^GJ2:\?E]EI"!77)@V6Y
MDICF9-<T[&;"QYB8]HH2<H]"2G),OO3B)FT-M/)'17!91GN2"MKV"1QE*=V6
M4,S-J54L6+2\0W/',4#3X-VDV'GV$T<6/#9XLGO<8:%UF-+H1TV-+B5KA[<G
MWK:6V_V$6E."+ML#IR4A4R3%9XEX;55S'ZEI!CCS>'>V4[C'OM<-!U!>'\>Q
MN._RRB"3CSZ@'E;8-#LE7C.BNWC 8!TD;O3Z0;]PXM+%4QV20%=1)/W8FRJR
MN^OGWXB.19TA-F,HP(BF;E=F KW+ Z4Q>_W+?92^RYP1GC3\.0I 4Y5U81-Z
M6F;^SR/K^]I"DN<*1F:LW8&O%W'THR,=QK RJD;*6.$2ZO$^,SVO=FYP]LS3
MZ!".16I6F??'S:C*0.X'SMX=FVJ.7W*8P@DG?MKCG2,>M#CG ;YYXB+0+:2G
M(!MH@@Y0WFP.XT_C(QK1KW'9MRA[7<GR2VW\]"H#?1C>L*U(,#'S@:E7M(4<
M=?LW<!,AM+[L5NA6'$_(-!KFZC@JZC.,-YPS0CZ^&E,O87CRN2EDRZHI>\<M
MKTT$^@K^N5"D[+;(Y@<P0DY_SI2G*A%I=S0\1F#C31\9=$SM/:[BPBSR,;Y&
M0NE$T;*%?WJ6=C2S/LI<[?2UP@[MFDC.">/7]6ML%M'1(6I3#H;'#FQOW"QM
MO=EP\FC)VFE7S]0')N7SS//7O\QI?3,,%V--?GFBO,.ZRE*9M5%QIM*F?:O2
M?/IBE^T+Q08_35MJAK"!EJH3V8Z2(T_ST.Q%\6$VS@3#T:1"U:K)YKJ6LH[&
M.K=89L0M60T/Q0A\%5N >@ :0.2[2S>"0XT-L ^F-&*K?%;2'B>XV'$UA_BJ
MLX5F.JN!NA3L3??P]6X*^U14EHQR#G+5Y EE-.%72I-A>PF);6^PMB TH0(0
MG%D4@*B<'3+='XJPJZ4X/:)JZ"P=L:.XWF/O[#-2\\Z!V/>MJ$+AE2R=3:V"
M)=QKHUE.@FQ![0^WNJSZGYE"Y5K7#NDR-'I-RQX,#2F-9F)_@XNTEB/IOFJ\
MT:=.(_!\:'B! AR/#3N?N4NLFR:3#Y;%$NB- Q]ZT]1@IE$Z?PV3.BZ"I(4O
MA!L&3U!=?_.&EP7X#-?V#GRS973/_[MJF >@)SP-TNO)%9BZZUB2R>MC)D<]
M86)DE*%YROVEU=SBTVNB5WA*X+::A/;9AZ&ZE2%MK2<:4^7;BTBMNJ?)+CCA
M<(CIZI$(_B9Y%V9]?8SQ05(BR^J8<4-^U?LL(WLYF>GN& 'R9*HO%<-EF[)F
ME8N^$Q#VTA B8LKM/B#3Y[.QFKE9\8SUDEF9I[@U;[H*^0"VU!<^KDLLZ$&U
MI=J6?Y=;RNST9[S+1VG;YHRG+V][&I>C^E).(_!E'41IF*FVTOR[_/)4(98+
MSC$5]I?<IH!KQJ_9',"W'L:;VV\<W/HZBUMS--T>Y'YSI"FWY(LJ9C$OX+9T
MD1W,_H,M[M4'##HZW><3%W''F^.OK-8U1Z+3#$SQ:W;'0]L=FMH;3UK8_>*N
MO^1Q:\?$<ZL.A8(H0)Y[XIH'1[?<&!FOL;4G/,+;2_:&T9R1E#E=L,@,4CF!
MW#U_I.6C<SS^SEH3W2Y]R3]TV4WE"6$M&Y.SENC?'>$P_S[BC?$CXZXX%!%E
M^_-X^&6^^LKOY'/Z9<*ZX5=>G?EW9ORIS[^.O/](&_].O%\>4?6X[#=GXJ%T
M4TOL1TNN'ZGG+&63X3]'Q]%W_M6^2^I'AOFR;]CO-F,O 9?B ,"?A/??!^5^
M/G#U\M#ZD__T/_L?V__L\M(H3>B.,X29I7IX7:'"M2XKSIC#\<\0$=?Z#I&T
M6C#1FP5*8]<:;/)3O)K1?@2T(R[&-OU>WC:-'^8\^C7 &.JC+J\.3-9^H7)J
M_=YM$_QB^ 4.7=@RGK@V3QUQZ?!M>(=GOQ*VEI<(5G_3:4_S&%&:71I+Z;J*
MNF1!W01)"?W-%2X4 *>3@JLW/D:\4W&T6I>^F5W+<V6&X\J@5 %\"^K__G/\
M)\E5+I:O::PM^U0T3?R^V?-Q/4]7DQ:QB=>J@'[YI<96!%B1U4\ZB<MGG@"N
MEASARH_)![KN URN]!D'$3PJ9\PPYR>4:A1[RXM16:BG.3;BH#V9F.Q3W_3U
M2 &_WUWF>=S">KMS=P#?_??^Z<7K\=7::A(F)_2?D <=LZ=<G^AE[<_IE BK
M[0LZ.5-H^K.[EY\L/>/#59TT//_21A=ZGIJFN5T\<4,RN?KK+3.N"GDG@]%T
M_:#(H632*_TR/?6U,W&+@@Z<R\8ISSCRV&NGD>_B]*KX54T?%-KO.%\F*M%K
MULOKWT47?UW8V*^>D'H>I3_J/8F#Y*2GAMT]G)%9E:D+V1F5E+ZSZAUTKCXX
M>V,ONB+ =N1A5X6_B&,2NUO>BNG0(%=U+;9BR/[0LWP_!HQF-3OFG"(.4ZXD
MGB4WYH6B6Q-PB*R+T\ -T1X+?N\IB,QI"6B@2% DI_.-_0?V1*QVW,,BXZ&Z
MQ^N$DSGU%RW?E@!RK^&KK>X$>\(A&U]7CK!W(/H=^28VC1,%MP,VDI[W)&>%
M*LJ\O]'8D5Y8\N'2E%^VRHO1GBOW#(5[TX<?9:]=+G]EP%^6_[^[?FIV+@$O
M2A'H_(H_X'>ABO^J7/6?WD>_JG1@/OC7;;312EUJF()^"W+2[QG_?.J'IJ?A
ME^0F_8=17Y8-_U$Y!/AC<_8?7<@]??Z2+$F)_7K\3U/-#[]1O6&WYMHB[JVF
M&!ZLG=DS[2D_BLD'P]EB SC?CI@^;VX#0UW!E@MF%&94W )QYLVQD+XKLN$G
MP*[VD*QD^&$A5D"H$;6%@:79(Y#\99I1Q?#')SJ/^NR9=LU)5GBKE]=$[-\?
M'Q(-4&U8<]+OXS]'JBZ5JG3=U(Z]&>%=(_^]'40/0P$^SK).W7)9X\*\0I41
M?%4J&6[0<=1>D<E;]2 SK2O?AYE/X,NEB.K3O4M-%5!&2VPH)NRG#*O,E<\A
M2\.LO"(^5>Y^*>[*.Q^QA\T[1_IM3@A6E@ V6\ZM'1>JW=:9^_E&VJRR4%L#
M??P8SIL4E(1^?1P@X9W]CA_A5 D'982"DAQW0%PCT$!Z..KD$O9*GOS5(TGQ
MQ8\,JB@QG0*G52>!S";EYQO$&A[SE!Y =U$N*B*</^)MHE]NDNBGS H]>Q&:
M*Q"C)-;.XJN,QTRF(1Y&GZFCJ8A>WC/^I3#[/4L_$K.OI(D.Q.J[HA</[J1M
MO>9AWL#+/LY>2_VMKDN_(K\MEV7_^:KW<ZRXR^ZOKWZ*XWY-_0_E6=,O-=YE
M'1:EOTJ\S,$*4]),M,+J1O0KDQ;X?'G3U%[.S?+I=VR?CCE8[2E(GW/6&Y76
M<FP+Z\7YD]CS]I'N@>2>2^3D")1(C42IAC,<=-I8L;7T@31UJHMW6I;B0P)8
M@GX6J&'^#Z/X#Z/X'\4HB*Z*=?!R*HH&)W%H&5\/<?UJ+QP]/JXK]MZCG2[Q
M&*MF---KP\4@SM#PC'R(BWQZJ<!'>92?8^P>5BDM-GV!DVY%@.4]@$!,N^L(
M=/%6Q!-2[Z,"E<B-]PJW%&V%=*\_GU[%&!ZAV'90*'FF!:7R@WGW.KV;I:^%
M[()D2+YS0>XO64PE?4H8'K2;CO:)G-XZ$J'H?K14+$ZZ)HLS]IBKIX+]$V-X
M'$2Y55D[.R$H/DS*+X58NM"WKCLRQ93YM61W#OUD86?AM!/==36NH/>W9\'\
M';-IWS(_+8(R(RL4LWD&/J4[43S::I]>\:;[W$VIRO=8]-Q;1"M[O\8OLCWC
M1>[]XIHG0S%G=RTLXT55>;6RGA-[F^_8-^%[73KZ</U?#9S_3U]7?^EAE:[\
M?ZM\H?BO]MJ_.U2G_NOV?;;[M/_[UHAHB$1;S"7L_(#/:U0F)MA:O^2P?USM
M7P!U[_?C?Q#USB]'_H,ED/Y=].GUI:]H^J&TN>R^_>!'][VA*[\[=C=H_?'+
MOXM^7<+:#XN6^EU7ZOIO]/A18^OG\'X-^K]P&'__YFK29(+\MN@UK #<'WKA
MAI]/_,(RVK^)P24@I?\;UEU*LG^"<>8_ZG>]Y!\4W93"OAR#_&%ITKK)'S)S
M.1%W_F8V/U@-,U!&1G'H!R3]P%?,/Y[T4A7]N\)8^N_/:"-*R[C_8/T'R '^
M5-U"_['8#]3[T3$<#>K7,/Y(TI/DLOZLHG^.@?8';&(\Q_J7>OLG_?I3^NLG
M_O^[HOM'@_<_DF7/OXJ1/?A?*J+]F<U_5 6[]N_+X=5/A$//M=+E9%Y'8WK
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M2_"C /X%^?Z,E*>1^!/8H LX3;#LHA#)^:V6$[4<ZFX'85N,\K8M(<\.!.L
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M(+GO6/<I1]?X+(K<)RI9MP6WDH+LF/;\CA3";%*8 VT[$!-TE+Z. J0N%?)
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M2:9VG:3/@ ,Q!^ /:BHGN(9#[RK H.HHP#.U0H-%B6P[.1;:AHXOU>PG@"\
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M%=8^H6;]OMOL'S44.THA7DC,A:^3TND]-<J$E1ZH]]2^450J63SW)>"EQX>
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M(\#=9:;[TB\+:)S/OB&@K-NAC1U1F5+.5RW;XOZH0V8(/3G+HAF8+G*A)'D
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MC%@L%2M+2\.UY7JL*TK)RBY4-CU/>Y\)A-M&/JQ_L9W"3NB "90KERL$43+
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M.\%FC@90,<Z/4P#3=JC,E/"A#4E?JC%42UW9(+-I.S-QKI#9]SUFA(?U*7:
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M^>C:]L!)11]#]Q3ZT;^S#;\%[$Y'$M1@XQ^<H5@_8TD(A-;.\Y0^$LO)QV0
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MOSY/)3_K++0&G-3( /H*!KO.(--PO'@NR1?GCQ7EB_28](UFI'F3]W]KJVP
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M: M/O&6GX*W @[+S6CDCMX;*>!5&:MCI(M#74PLR:I,B\C^$\F:^L5,\R,5
M!J1S$64&!\<KXCM<Y(8=0]:Q=Y<<W!?]6/HR=(!Z).G1BG/J2O1E'%0UOSN,
M5RMZ*&I$TO'_.HV5*8@:CX^7%RM?'W_CT!ZK6AE?-!^NAPSL]^8EY6)(CP3K
M-*J5ZJH><P-:K[IW.'E,HGV0DPS5X!#TE.T_^#YJ(BIQ)^$PM)GVG>/3A1-M
MX7@Z1(WM%"]MOTHBZYFH]V:Z0<<GK+^Z!;-^N'J<EI86/'\V+\#KKC??R?G@
MRPA>MN)*>K53KX);KN<;\.\$QR+#73-J]/2;#3ZE-;7(2PG-WGQ>Q(_?>44\
M(T?B59?0&S'[K))M"OW(@1SCE_4UI2>8Z=U=BJV''L!U9X*[G<$('*A?D]Q1
M/RTN.J#QNOFJLL !>KJ[13L_VGR;8;$)UE1[:7#TH@D7?8>0YI#BA':HK6EE
M;N4Y&^V2UVX/!%PC"Q+0O.-&CYQY8\Q^ZH.%EPP3#:)N-['W>-_][?-S^(H/
M^ U])0%]B#<BC'77$_U"#\'=ER= ]W0=+XFG:/.M14E.61)$+2M%@VD_M6&;
MD]2,P%[ :W_2Y.3A] ?3<^T!]+V7&0?NV&Z1OE!G<>=H1/;#C[O.=CQU.2XY
M?[&SOE_E7N"/-'EF33Z^R ]BELS&CGN:XTT#Z\=>2'V8<P5_[1&?_2+ZME$M
M)E&L/^4LW(-KFY^L9S(?[\.<5BW8FZN,_:+E9N?K;TR)-O]_[+UW4%1;ES[<
MBHHB07*F49*"!,FY!04$!"0C404D29;<T (2!5I 4&)+SK22<Y"<,RTYY]1-
M;*#I_IH[4U^]]\X[\YN:JN]WYZMZ_]A5%.?T.?N<L_=:S[/6L]<^]\EB!N==
MX3EB5EI2:U=]SR'>\]:L$$*#AT,)Q3C ;]DEO$LM?Z?/O\3K^BRPQ7OE8TU1
MA$=VNP7-GE. ?!_]I.B:A 3=41^YX<=)30]9<WB!- ?>7[_%8_M7YY +FO+]
M%%^1!>"=]:*%%*)..P:OVG,J<J^K*])]YU3V4\EKTF]JG&\_=7HUJ>4A[;A8
MD>;FM=3SF\L*?[DHNJX%.05V_UUU"'<MTD.[I@*5^%N)S3=QE^O ?.!:?CSA
M5C,PTL/LCC37@J^'YDLX6,XNT]:?BO)AUT'.NPP!D/Q-C&U'R]YM3ROYJD0U
M,</RL7).*!F[5MKOA+6;F?.4$3%J7%JR_6W<6L?3B$V/0ST=+.<@;XXGGTB?
MZ(.,-W"FK\X%#YCEKB%M9Z)R7N>U#]N<C".<TR;['+D[KQRR4QJ/6WD(>M/D
MIJ=750?TS^SRO8VZ^<)R.2X@'ZJE<?5SEW4A!*T*%L%/+])8', ?SU=1NL6%
MQ6E? C(M[GC>2U*[)7Q,$\Z3.@IV6XCD?AN^9UCQDG:/W:)3Z2<1*1GS?>5Z
M_R[>B<$AXZS&UD;"Z8;?1U7^.$!VM#(=9D+A_?B)@*E15EO9T,#MB,QH <O7
MFS?G!R]'AF9\;WSX_<P7F@;>E1%@J;2>%5O)\CJMB%41CAF__._1Z#%[J47"
M(#?E\=LFM@0\S/DEP9^<MV\@A71[>$Q;#]J/JX>'%*@Y_M,PVO_"!I32_Y,P
ML+5@ZCW_*6W9W-G1)QS@,?766Q"Q1F(G#A &>B(??A]^_^SQWQ70*+SPP"KL
MJ&+K+7& 01)KO4LR<N\X"P<P+<';RQOY0 JA(HR$MU!KP7KBZ61#&%Q)\!P$
M&D0)\I]Z[5]<=O[AV=\5B?G;VU^$(I=*AW\4DBCQH3,]O=:0"YO>C@&-RYKX
M&5<!.WM4X/=#FAK_EB.A%V67(-WHJ,L,77)DE?,1!_#(66]D30_G8?O^5^+Q
M?[,= /]3?4C7?Z8I@>M!=B$>J^ 9_E,&S-SRP%/\4W3)?OF#,PU@!2"=69?*
MBRX<('T9_O@O(:_R-,Q3$_Y(%@_D'E:I7NS?4P*><$*T!_YFLTDX@#WD4!M1
MIX<>B/2F#47CT5/QD__X-4#H%OQ%=2"7C"]@;)T:5FB=Z-YH\?!("B([+?Z9
M\]CLFQ4AM]RN[?<=]LX\VOM5&5T-1)!..VT< .Z&'_X%DW:T3Y'Q(0L3*TDJ
M)>?2,<4(6;L&15?,T_$QR1BMN"'A5PND>D[ .[*LQFCU_=GV]O%;Q1R?^M_"
MG'5-6DFOT/<SUMNA&=OFD%]M**9[''X8-W-]O7>70P,03+^1ZKF6I;$(N;[!
M\M! [:R':1 9V]1LYGBB+G?-5XGY9VQ2(F$(?CB0V*1WJ(?F6[G6)M=%;G8@
M#K.G)7A'E76.OSH^Z?3C]73P(0%O:?*(9.V*58A'/1:0._MP$^/+#20!ZS0.
M"EN,6/X,1]W5^B'Q.8/_NS1SDQ^3!_Q]37G \:2J7:Z6-3NCJ1@]L4R;$P)R
M4UK(52)&M*'BVIJ%$$D&]DP+8C@L<F^I1^C!4&)2G%CUDG=Q5BZZLI77E=NK
M\JLZA7BZ*:'E"YYU.-%ZWP(.0&Q@$[4P2R75N5$=]O9".1<,FM^A;&&M2+&^
MMBV H$C9)S^2D0VD;RK:#(^C*C.B5?P4Z!([%D2E^9*9L&?VKR$R/= ^604.
M4*R*"7)%0$CK'OAZR<RTQS5X+=M8.):IB DQQ7[XS92X$4TC/BY,IPNXLG[=
M3BL]1IGIT$:%I'(4M1<)V[\S#-KZ NNS\YGOP(2=0(ZP., 9G^262".1=0-;
M#+V($7^9,&OH0.+&!^^+81GN]D]I-@TLI3YJ?%/;2.E@/9/MTS> ?H/802)F
MA>U3.:V8_+7!7M0))C2QX\()FU[GLV"&@1Z;'?6;70 0#;8T-)-9'\?%HKTJ
M1O@F*)V-H;FLX[)Q\XZDUHD!9AN3'K$N'X(@LHKMBF3$K>^%Y=-?.!-]R>(.
M5TTSZIBE<:3V!#<[R,\:52;=4"=@NJ-S9G7J;TJ2LVG8&.3F'C.Q4EH7NATC
M:FP%J^GV#C\C;),5_($,K; [-^K26G)2JE1X=;.#\*& %]:MNS&B 8BN@?#H
ME5H;$[-71K_K]_ZPWL$L%;VCKZ*E.69"C_AHR9-GJ 3T0KFV(O3>SLAVO&M]
MU4?\%/3<XPWA/$]83=2J1%>MLIX-X//I]V#[Z>"UV.0UF0/36=X&.FM6T_8S
MXTCZ[J J,=YD=Y.^C8TV+_Y/(HUH96E-K]P.>H,5IY]\$K^_<Z]-^\/RBFS*
MYFH*7<<_J<[&3>S.D8[F?'C_H86PQ_RTEN' ,>QKK&=(1WP-<P;-G>U*79(X
MP>IK,+DQ.1S O1ZD.K5@!I@2&63]_3N,0^\5*;*:!W920KA@:H4LT(@U1OGN
M5H.E1QR(@Z:8>I?G#[89-]K,29BRWX_61MB<R,2W]S-+_IKMGG%ON6;'0/;J
MD=[]]!^2 XG2E_:C'V]WS6[49Y.13J"3%AIB<V;OTX_,/U*Y8<BUCR &M505
MT.( 9!C^O#DU'Z]LKZ^4HAO '8H(V/=W^G(V=B21R33Q&R4WV0PRC&/+=5X1
MIVI<K4AY.ESY)#&%D%ZYYRT8X6-5B*9M;59-\NEQ;7B@'1>M 8#J2D< G>QF
MP6R+6_PT-JG@:TIN=%=]7+R>;,KH'(LX&B'[H8L<H;85#YQ7*#0K!077<KL_
M.^_HED&O>T+D&LX=$MZ,GS"JT-!2W-$YND;#&D5H)O=T4]$9X92C\GXE8_!
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M_)2A  EI!4V8WK<7M;HZI_DB4";+^ MFOP7%$K?5(#FH%%IWU]?B>\*8]+J
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MB$$GT<R?-]'B]TF,R+@0AO=##DI7&XV00?5@Y1@T+CP@%]?T\]/9G?/O!2D
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MOP:0'A<W0/N&CI>;&KW$DN+]2@=650T':-5U4?TI.P[LC:H)7X8L6*&EL('
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MGL&%T';P+3&L>&EEW1A\]Z[%YV^KU1[:'\7GD_4SP!HX0(P''G=. 2\8XE:
M1)=BO))_UX#="+?Q$:5..D:9PA(.>3USVF1<]4<PKUA+QAR+TLX%Q;Z2M*2O
M<243F"),;Z$@6"7GRRV,< #1O.]PMN?:MJDAF6#^AMI1:8;8V1D-5S$8ZP'G
MYUKS*$&[W-$C*1F@1N+9F67P[-UX<\R'78TL_*]OXN^NJ'&&CCW3IT;YM J:
M;H6EMW&=B7PCNQ<5^8!^8#X'&)81FY@A?YS\12?<CQV=5V1[(.W]+C)[XE"3
M_F*+3&NF(9#N2,;NFQK0; PRK*T^"A<#@,<"E 7)U)WLAF5IT33C/M2(<B.W
M;YV0H7M^.@"_4^9^)9;I$^HM-Y<".BD%>L6/^<4VI:MJ0FTL=Y';Y_:.NZ\G
M/80I8EZLC3%&*2V93LQ#F2?1)3-I<5IS6A%OGUU9"#GY*J.4NV/HQXG,3EI,
MD2G:NZ>;3#8]G1^) II/>T>%;/6!D2TOD#EA!CQ>^N.42.=FMM, T!.-F?S:
M1[)@*<,9H"8B$*R NE%NOM2G,CNBWUCI+UWT4\%EO>#;YV2 DP0[HM+&^Z-A
M<9Q-[A,HWRK'%X!K1,32IJ0?]3R0$O_.TFT;+UF! H?"]3WA/F>-$YOB515T
M9:MU<W!CWK+W3#4PK[C@%PY +>)S&[TX;B56P=<D)1F)BDKR)TCV]H!K(N^Q
MIUX9IGBJKTUX-UAN&1&"WA_N[F@_RZI(C<XJ>5:K]=!>2U/U2M0-NNBH&1Z=
M)='%H8\9DIK:6M/'9&$U07VP@,AQF-=#TA&E"CLOE9@<F9LR))XP#(??/;S'
MP>)MIW\,)-+W^GQP7!UY!GW@C7/N*[4@#R"_V3M]>A0<*R>I_X>D2^]]9NSR
MSR)/":5)3J^0O_S<&_&+61T'T!X1X6ILJ*ZU2+B:L&)#%%E?XED("H#LWQG#
M ;:^0/H*?J\7B12^H[.UG[3'HTCCM5?_)VGT*HB\<?EU)0X U\6#\=GR!AI(
MKQ'V-PZP?12+8L0J,D+.CLPN2+:,%JPP;8T[4.R :2$.,(W=ZSVM,=L7.6WL
M2@U3H-*/\;W_AT[X+QIO4W]3""H0J\!C=H;5N*#EL'N"#JTQ8Y#>^W-M95.R
M/[.Q(A2,X9"?''4=_PC!_]U-XAJQK\R.43A V1:")QK5X8_G$8+GA)CG?AW'
M&D)8 Z^D2GL<P-J<$6)8XZ(9\ZZ[SCBO+ (8,+?/OPDZ.@0=7C%1@C8N/QT'
M;84<4<U=]U3"WKF0747LS-D=9!V(>9F:BA/03?OR:)L-0RJ%&?N$^O=EAY.D
M^Y(J#A#T])B-;N71JK0;>2[UVYZ@%K+3^XGZ%Q7_EA>;W3@V_'*/<4O*)S>N
M\EHJZR9CMI.2J<::,3!8E@;R2VR1Q\3HW&H':#5W#B_9GJFF]]X3/Y_8,/VD
M7C::Y1D;DKUP(S,"BE:0EL(#&A)^' "PA ,0@1:HD'L7 .%&# $4PV,:/I!P
M(KH"-6?#DFN0XK\D 9Z%-8GC>5.I[+T-[4TL47WPQ.T^FHDQ0KU)E\<G[7;Y
MZ8FQZO/SB7;5!U;^8%5@$/A9Y4C[GCV[&G$S@+=L?MEJ1L$#*XI.2)_S=%A2
M'S9532A>^MUK?O]GWE9*2^Q4E,267ITF,F9$I]:GCV7AH>7GE7G+WJ=G$2Z-
MZDK#U5O\ 9.E_=>/<RRI9"8!^V++\M#Q&J:\K@.A,/DRR@!#>B!161>\SM[>
MY6=\0)_A2Z,?W7%FH]!.Q*!N[ (.0&K30#^"[<ANU56>88]RV1=]% \:?.6C
M5VZN!=ZO'I&'E49^^Z=*]7^Z9./_JGK]G[6K8JETJU&T\2+QQM\&?Q"CM_SG
MZ/-XUASIT)-VL-"\_-_*-<RB<LR5SP6T#UA2Z-:0]QH^C.Q]'SW<LCM_RWN]
M596;$G'-PFJV+$6,*DDPYZ5:60V-=7IX[^C_E) I6BH\;+U.P![;1-TT!WZ#
MK(\[,.*:<AA3)QY'/8#*(%_Z@UX\VDA<!]L['3?<''\;]83QD]*5$,UHZ):I
M#]*CQ5L]Z_N<V2:#?=8TS'9?9UJ1??)JWKSHX_,9)9%"-A;]!W0ZR=6C][S?
M^L-_H[\JJZEJV! 3MSG?V[%DR[U7SAT?EVE@'?]V1*W"R,=W!5/.'I%:KV92
M. -/*W.T]\"#\,^_\'"4R+NXP#+=IM16,F)6K5!\CG/\G440TWVN/&H6:-'&
MV<6'AA$^Z?,W;03;ELMN"Q]$!L Z>(?N6'!9$IXI3G5^#Q-Z69"]%S8,CW-Q
MI7=MM.L:[O#%$SB&H/].=/7MEC<V8:&'O6ZLV&^ H/.>_O[$?BO%#2K*089A
MN"AZ"D^T+6$7'RDO#1T>DRIS*BB+-W>Q^.?8TM04PTB.OC38E_74B$WJ.YW=
M(7E9;+6 [P^#V(43-KO&5DO/GI0/]?PRTDSG;BHP6$[B;D\S?MX[>M=**:3+
M.2"$Y("Z@^ZHJ!M%=IE^<!EKW%H]P-,4V^.SFFA-=T6=MZM)OOAWE"OR1\J^
M U&GFXZVVL8!)D\:WYXK[O&<J)]7+('>,_DN(,8K>#K\I""]!-A9T'&<B7B>
M,J>5H<,=%R5XB[#''25AM1H)*LED<]:(<%^MH<9EPAS\.RN#G-TL*"<NOYQ?
MQ/]L +6,U;U.L_9.EG3/\ETVZ<U'=2S7.ER+8\J/'F68AM^Y#$-P\"CBW8HU
MZ- 543G6_8#]/$$[Z4LF[/$?!/X'6'-QA_^7J*:QK1H/?=*[%[_24E 1GV\1
M$+!QR;0YZO,O.5Z;1 ]WSSYP,!WW>?LVW%(-/1,1("A(2N@\G"_:6/^3<G4%
M7/L5([+H*]9FZ#A5AO#-GV(/?TS0[GOSVH4GNS8'*CB(,%31G^-XYGG)]\ N
MUY[[KP_LIP:CC@@#P4";^9T'.ZPINQQQ)WU"D;51 @+U(6M'<*$QR/*"^:5*
M'W2HHMO^Z$M*A5"<\J]'CNX#1BC"4&$<@'B#/W=34/!7)G<^<5F$-W?46N"I
M+I (C7B& FN+)@]W/.1:"W8CFF>)_/",#86-$_LD_<AN<8:\;"K!]*%XO,0+
MBPP\?&F\!FTOE2:?OZUQ@[?UD_N)A^N'H@=JX50N &/8 !<RSSBYP5),&Z;Q
M<6N+[ G^01:55T*4&\Z?1]_W8%'-ON&,4>%QJ7LR[X@)$3$[.S:[( IM$Z_\
MS25&W\Z3MW.HJ2"7^T\-H<PBA,%ZEB)**._YJLT-\\H@CV<M"'H F8O">Y&%
M!KX &;LEWXH4C_,M9XXZ-48*@%I:.&JK"M9>ED/-E1=G4Z6D-C&']EAT#UPT
MT>,5'9;Z[6 YLU*( C 2&>P7^A",UTIV!/Y*O%Z<X9AKN$$3C] [W5^NC%"*
MR-/^7$48+&/W)MNX\D0E(,84J2.F[SY.,^#JY4Q==RMRN'>!VL5)4(,@YKJ:
ML4>;QBGGV1\[/@QUJ7#OW.TW_NGX<W1B[N6F*-Z#_ZP)V&2*7I5C=>O<B6Y[
M+-+'O@F<6-(I$:NMN$@VYDJ J57WVWU&XYWE/2K(T0'783%HL3].-&BQ!TAI
MP/]U3;!40/I6;-K6S&,,M,@Z+T>,\H&N;6(*U"$]=WTR4W+VDU7>%(JY5Y75
M>,U&1N<\,!JMN]EC;K%;')!O9IOH%Q]Z%G11E%[]J[RUA\Y\75#1=L;3JE5J
M F..HNAI<>=(Y+&YQD1V:CW=>2$4!"#8^)%Z]'ZAMW=S=#ER?*W2R,1H=BJK
MK1"E0; ?T[H05^ND=",K_YCFA4V-;WU<R4[PK$@DX0^Z NH;GWKQT^S&'U&^
MD$QTBSQ"1*)L1_1\H#;HY3*TRVWR"I&7)4$>=;7I76025D4//]],\=Q[?;D@
M0EOM6#!/C%Z!+Z=R2('Z1MH_X*1K'I1M=HZ\K?L/G5J#EMW%B;Y;Q*+UV=+
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MXT%-WP 84[G^J4&?_+4K=D\.\3T5H8IY_;CEV@5R4>5#!]IL!5[@V-P 3ON
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MKO;WURNKI_F8RQ1S_K0A)/K <26#+NRXHG;(/3 #F73.FD1QWSLC@5M@#=6
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MNS)W5J=F[]M("$Z4TJE;6[IW>XPG1;=0F/T&D*+S<U*<CNGM./5LNTIEI25
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MJT'R]Y3*+-4,E23HR@S6!+C)0/I_)VX^\1N;=5Y5NJWKQC<H8RG],^LS3IJ
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M]+/@2(ONCA<6.3,<.L23L^IF:E&L&0;JN(;*SD>W#105K[[+>?;V(18F#3
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M4$5.NHU"D-(U[J+SP<W3DF3^+M#CG7/<\ ]GRM< XMD/O<2@)A]C!$$92[S
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M@YQ;']MHZ;59KB4K)@S\EO&S@HT<%>XX"**WR^B@Z5G 8"\;8TC);>KVH4>
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MF5"^/.<$]0M5SL\FCN.R%]O)<*5O*T>B7=< /0:T1B.\#*DY5=/\$%L.3_%
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MA'!^.2TPH*Z+)N221P)_5N-RMU_(Q7QT-S_?NTPM>$ 2:-Q5%'>(]9!1#5N
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MK!L3+ <.R^$2$Q]<HZIHV.5LO)SR#%L][;A[G82"(\<SB'-+A ?E_KD_XF^
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MM0EPHS9J%A92 A'UN=:41AO74YKP(K!I70)'&= G2CNL;1&_E)US;3OC2)3
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M?+(<EI6_.4<ZF''HSB0E7V%BY94X^,>\7 2LI4[LL*F!LS0F5IUJ]^3T@_2
M7Z"K>CE2*72?GM>(:2O6^6(B0O[PG:X/YUZV?)OZQF(>@F:;5K*_[- NV8U6
MC%-,@?%%D77P:8KM%E0C81=&5B<Y!T06F7G'>((A9W*XVTH]C?X=OMU%H&L8
M'O6'6S)JQK$\X?%GF95R\9'U*B!P]/-7/N/?7X[F):^&NG&IR'KM0>J7&L\8
M11O/\0!".E,4]>7+J8Y3^>D:479= S1+LR1['^V^5+M/]3;)XUP/S5&7:#"]
M2TG6TZ_\F"^F&?Y^V (L4JML;?I3B93GUOI53N*P/I$B7A&K')ZL3EGAS2$%
M^,36 XHXF<9X8VRYA>9P$#"FV"E05K T7/4N&08UW7M3V+@N@L;48*7$5X[M
M8GVJGL)\X!U&*5LMUYSK8#[!^K'5Z\'@*OB-<=E[X&BE:BZ:^"0DL%JT( DQ
MJG2Y%IN<][B?L2@Y)E4R;8A[,^VX8-O((]3V5#)RY@5+Q.(71\<ZSBU-D@_F
M(N  7<FU1M_\^ E^=OY\[.C&E=,FFN)LB Q*K/A]::20O?)A4.+N<SE?I!?(
M7S0C'\*#XKT;,6A@(-I74,'Z-3=4+<*]^5UTCJ[H=9G?6STYNL@-'^)0AY/Y
MX!KW[T\.C_*RNC</GY$<P]-$+FIAY.B@FXDAX2GW_,TXEA- 0C"-I89$)+9H
M3/;>T"X_M172L/U.^&>/G^E7K=Y[T;2#\8#%QI.COH+-:]0O[GN5"K;T15TA
M^66)E)T]S!5)T7SC8!2?<V>Y1DJ=SGP8(F>59.0^I%I4;7M*AH(IFJ6/WT!I
M=MSUMA6R3=07-#$U^4'M]8[^69B+BY(BVY7HYT=+=2WFQ.A$AKKO ^5_S.4[
M_F[\<E5?S@Z9U49MFR0>]X2U]HI?G\T:_RE[$GOHXQ=WTH2_1<UNZGPRG7XP
MEO^X*B\&\Y#PJ/> YXL<!R4!RWJIG-7#HH\^M6@53P8C?TCY@UX8'XA I)%*
M(64"M J^^78XA9]M6^;]D=6L432A<)W1HQ1U)S689D,TA)J?7#)_1VY';BU^
M+4&!35=2XZ6)600J.KC"[^;H;G*G27FD^_WU7B]^-CFAM-9;=RB'F33738\1
MK?M7)J=OAA=RWO?' WH-G:QT,;U+==-F:$/XID[IS^ +Q?&";@IRF3!WQ##+
M#U9D<"B[;V'Z%@%&E+_= @EQ3VE[:@MIOS?Y&3BY9206C&PU2UWX4:GXU2 O
M<N^-XBL*W6O5)*(;1HZI=MEVR F#]E7CI]>?S1@S2&RIR*C !9":+;6%:FAW
M&7"V U%PV"B]K(&GR^.FQPMOZM_^R!O=2>VOX9K:$WO]#Z&?L7;H^M#>8JBG
M"AM_@7!$;#9IG^/;$UD;9"XFZBX'%MI, (RT]:>=\P<L]L#CUO.P S@%1A)E
M&ATJ4EL;R6-UVTR!-_(D)&I4_^HWXNX%?3BXH67])3(MQ]*&+L55Q-A2O=G%
M12KVFMMHK(N>#=-U%9U86Q1%$/! 2P1^X?!G<7?7)2@FKE[_<G5_8Z3D7E/:
M5=3#R&49T(L1D?F'8P+"/F>H"N%[G N",LIP!=1<DE<16OC%\!$:LIT/J0^M
MXG=F*5WY+$FDFAV7EVR9Q< MI.Z)B7Z 5L<#6&= QRV:JV;S)1L5<P\&'45J
M*Q/NPQS70OQ;[8GINUCSF I_RS*#6=N,Z,)9&D;*\ "620MW@77%F9A.TK;Q
M'R_'DAK=S.Z2Z93%K)LCOTM+X0&@FEPL-AH/""F):YFC&,:P,O48J+O?K^(V
M1U@_GOYF22ICGY'YRS5.[]V82 :=6S0?>IQ $E-Y+HW-/W+#FRG.HO" Z4;<
M2#$>$";+.%JGD+N)LM.#V8)SWCBOL;RBQ W2F"_:!(E&D^$!]E![0RQLEUDS
MX6+$=]IS?2\NNDYR;*9WTJ"YP]R@GG"__MY\7N(=OC3/Q21G5 YY[GF%,,FM
MWCA_';S$,V9_K]U;_ 0/"-P_6GUAG<ABT=VY3\*#<'Q2E-^;J)(R&BQ]5];:
M)W^E/&QRU>/CPS>1-Q;5+#UD:Y56S?:12<IWH0'MRWE4\UW6"-^ 5:US:CS@
M#[A8!=IXJ=LQ(\KWD3RU9&&7(\N#.VD:1-1-1S1'9/5U>HF#QD\^/GXMQV@K
MR?W!'\0]53=:%&7"Q\4EH4*EI4#SV_._U+?_U9W$_NFOX_DSNG*!\^.DRRG!
M%^B85*?%WL$T=O-GX_VC1^K>$DF39[C@T!AH+R+I<M7#RV;@OUN-_Z\:,Q<J
M *<X;7Z.TL0RL)NC+Y<A8!>O+U6BP1T49_<<H-OMH".K!.C"*:8#NAN,&X$K
MFN_-C[L6F#?+7*H=I5?^?=-L'XH"$VX$QWKUX0'I=X>*YF\3R'/YI<+JV_SY
ME>^5=RIL$&97"5%O70D/@'\P5QOO8_[KX1@Z.I2Q"O0A\(Z6R;IA+^0)"HAA
M]:--LX4YK';N\2&];BGQH6_!2F3LU^W5I HO BM_520OO>FF; F<6(83)1_A
M 9&Q/4YE(2K8KC!%+=S@?>  Z2B:CR;WA#9+J,"W;&;W,QY EU1&@Q%NJ$D_
MXSIDI-$O+^Z>.-@F,S=%EJ1?I38U5&<X2_],0S+Y>;P1+=6&1,/EU%:U&#<@
MM2&="N^O/#Z1N.IG6AB&'G=R.&'B7RD(;Q1=)IOY+B1W#%C>C-O6;;A>5WN<
M=]YRE==K8QZDF8=8X=(8SNV7U,_5GYS;.-[BS*R.6FZ5%;Y4\MOA 68W_DV7
M>5.:.G>K0GA;LKAF)O>+Q4>ZBRRB-0NIXR:2[S>.VBDB\("#QT;0\8_0C6Z>
M>O0+ )*F%'"KETN6T%TE^6+Y/(R"88D/9M9E><!JJC\&64;+MCD=V%4^N?!R
MTA@J'S'>NBU)OE8%O ;VDE9?\O&Y\2VGBM@P9$O+A\+EO<ROY!.!L/F#^[/0
M<8/&HP<F),T))!WBS_R5?[@(3Z]'A:A</&S7HSS9])21O&ABOELW9-8LDF(,
MR:!$W'FE'!EUSU,GJHJ#I!Z"LAV:V+XM%/M+[GTVY6=Y'C]?!5]C<YX9PO_:
M*H[U%<<%*Q#/#C-S<[F4^> !;>I:1["K;ZE:VM]\?7:]M>(PX.C,4S\4S-%J
MCDP Q_+<8,RI>9#LH2W^CIZ>>>6SS*^TT1W8G7<Y=4CVQ1"KIDUA"ET26!<C
MCF85=LM]VI>BO<!Q1LG)DZ'2YAW@TV<YCA]=G<NJB?'3QH$^DH/:$R<&TA2+
M/O9.O[X'6^E(_([9OYS]FR_V K;!KTV#+0ZFMC6NO7/\F?G0HH.#?IDC]KHL
MEJ+<9^J']9]T)RJHSG/Y8:V].U]BM(-0-WMM6>4]#0^Q1X4P\_H8 D[A<DU>
M>G!-XX0?0H4'1*O;X&H4,,GU9G59"TD8;WO0\9# RN@\.LM0G:35<^K#^Y]*
ME+?7&;O 6@@S9_2;!%WO2!JY'!4Q+[I0ACI/E);(MIVXL>+2!.A5:!PKA9GG
M\GC8J8A") WET\P([KPFH@']SQB&P62U6JR+-1LW-NWAZV^EJUVRZ=> 2%:S
M9@6;@K -7DD'B?K)%>@]/&#M&A[@!+S0J'8B14^@=5J-XFGS&[5J$B"9K:L1
MUYHMMWQ)UC>\87]1^)CH!2]LPRG!+I>^HK^3]%S\7^US4\*2L!E1J8?;$?LW
M?41_N^JZZ,+X\0 D,=B^U0@665Z)78[G:]@[>%Y!Z' QF> C>*9(,?^PXO#K
M'Z4A"E=Y HGRCSE&TM;JZ)K,1%-:O),F][[V)TGA<-)6'1,=2!DPPS'1".DY
M\=3:O5K;/;Y5E=<)\JP97:]\PGH:17<'IJ]GV1<C6-"C!<I.;K/L!B&)PB[;
MDZ'L+W'T3K]'H4%F5W^,[:R.'MMB-JX&/7XU\X3M5>([/X/S]7*.CA0N'?-A
M> CV=T6#*NPD(124%3:'!L&-^C)5,KM9<F:HRF(R[CLIKD=KD[L>TWB^3:I1
MB"\E4]Z"8T@6(Y\.[^QG3;4 6KH=/W+H1%6;-48I0"Z6^.YJ4J _'JHEM*9X
MMC2>QON_O+"Z[6RNI2ZBAQ+YI1S3$<"[UW3I4I<,L2]2*$$WOFC\4/FDG^IA
MASBW?SKN,6)9-2#.Z0?*.4RE&.&#U,2$WA7'>N<>%&\U__5@/:FMOPK"^>]>
M&/\WC1'^;JH$_H?ITI'+?IA2<!J4G#GW._IO2DRB9O,#3@(6FM;$TH\VFB3@
M >$">MY@S5-OO_ #TO^Y9_!?Z!K^&QJ%X+]R4BF"_4OWE6,;W/JIGTW?$"$]
MP?MPSX]4";PX;O/IY37K\(!E$DR87N,Q!G;.KWI$>H@'1  /N(P(%SJ ;E3S
M& ';%(;0@^M0<CQ@Q6<8^J?1U:5G53#T0&:S\7\:6/JT.T6@QS/ _Z4SQ?<&
M/("OKKX6Z;&WF3:93@YMFZ,9A.A=*T?>]*)R5&%YQ:[ MKQ5C3"3' \'=S8E
MX2AL2VYM.ENSI;"FRNKI;1&1=P*.$*JYQ29@F#)*>CPY?EQO*O_=UX12 DQ4
MNN8<14*_5/AV[N&XM.+] *WZQ W%)U$R_J[#F1_B$&;EDQI440CYOD)MZOKE
M-S[ ED9J4_LIIO;R(X3,:%S!5Y/5K_1,U3*(GE;1-3R !K0"K<<#2IRA&W_4
MBR\&!^Y!I#+413%^NJO;A656!R$D/109JU$RG9#QKW]WADGV."GI2/"J_[@V
M<XP(!AW<MP,=$Y##D1B<$C5"X;2<^IKQMGHOB/47I/6(I;YV$8$)N:N)=85B
MR0KIEO0_L*-NV178.0>-O#:-IGUR&%<AY<B 41IX^515E*FW4+T_K%(^90AW
M>WKKW+0BPW[IR4#_AQ%L>&[>!39*:5'/?"&Y(V)_Z4E>%F^?C3])/G;5ZP16
MLHVCK4J^J5:8PD#D=T)B%B&C%22,?ID,CY!6*&D_\<%J>UF\NM/FS](HP: +
M8/:U=S1*&MQPS1^L*!TYHI<E#8R5T&^3B[_=2@MA)D33H114(^Z5^0D*#RC;
MUEQ\$[DD=<^S:F0]C4EFN8W6)<T55A_0$T%.PM#W!N*$!WRAP]9!=R7[^6I"
MQ5WM%+D#[(Q6$1\#H:7N3Z[,GP1VGTQW'A?OAXD%;3?I%U7/$BGQDT >D1RQ
MX6@0F#MXP&<- HPP'<8#Y$0W#^69VJCDN4FB%#BWO&\K7B]:V]5>*\OJ4V!M
M\J-Y6S%E'C%B*IEI^F1L:V>"M*V0XG<)Z.XY<0,8U>@/EQ8 #QMG)]TUCK7\
M<NL+'C )<2.DPK5K/% @^/M8[TZ,O?"9*?%"4>M&&RV3C+WA\$G:D6&@Y%P'
M,ED*%BF93<:<FL/S9M%@YC&PI8H;) OE3EI(*,JW+C*-N<BW"A,%[7):0)6,
M#HOI6J?F(]P5+R1[I83?^%1W<S?L=.:?;-EOI!(]*T?NA3M]-_K#,L1EO;!T
MI?0<ALS1'@A^\%(G7W]*-.-P_#\TC@7HAMD26;(V';9.._N'@"WBW[A@4*"7
M_G_\8D!2M$[?CW)X-U>.3=A B3'$6^A+$^M!KM:D0IRB]%"RM.:B6;%#-KK/
M;V21:H^X0M_2O\A0&=.SC(*G%ZX#&< L>$#+^$]0XJ%=T7Q-M5830L%)'K/%
MXP1$%PP-&+47(5;)4T9-@S$W/LC4V_7#RDXSVU4K2S6HE3Q1N=H58E,>7TKN
MKBC;N)/L\3\2/N[&1"K]QV8LGGY1,BD],4I[[Y O.3,IEHF+H5[OA6O3E#LD
M,(6#N/^0.5*%13[\^&UF.Q^T+3]TG"KU?+1(MKF@\\[G_FDMJ\?L2.>RX]F(
MH_5B+XKPACN(K"F3MT;JW55E@<]CY06H6*)42+( $KOH85F>SJ4K2P]<W=AQ
MOZ.!EF!$U[=;<5&1:>O3C*2K>]+V2U+U?&73D49>#@:O$Y"&08(?)V:41H9R
M;[ E6Q9KDU7U2*9"6S2I9]N+^0.<I;KM) 4_T,>MUGSL9/;WGW'K\S$%C[=H
MDIJF/@<';5$SE3G_G*9=Z/K]R(!BS]_ 9N3B[HE13WGUD7BKJP^!/O TU\FA
MZ-H]9-E&+UU$/\MY\6K!)Y>D=$W\A?0Y/NA<E]BQTROX7H+P2*8O8;']'LD6
MV<' )'?5)\ ,NB3P*5DQNU@LME.CNL/C5MESKRU)N*,2P$-T'?CWS;Q9.%IH
M!'1#$ ^('< #4#1EMB-1O]?26.)'LZ.?(<D_%*"%-5%$;\4*?A?\;-%^HO<J
M#$NA-9U'DI:@J8[N(]O+=;!WS@JW?1.C]5W<Y^,?SM_> ?O+_&C12?HHIH;O
MY^7S4W?I(A0A9>K59+ :DG2X%&K\@R-&-$_%U8&Z+T>U/2OF#HP'5C7W9<<'
M9Q%(PU4NTZ(=;]?Q\D0V$ YKX&FUIHAZ0QM&,W7'QS_]RAICVEQA&5;=>@I]
MV$ZK=].2N%2H*9W[8\'O]/< "R$2YG)@<)U@(;I6N^T&JR+BXJ+;15<J5M-U
M=ZP@%?3F+(6EV%J7L_VM#ZAE/ 9SQ7*-ZHG74RLH^2'6U33AY=#1AELD][AF
M)2+!B3Y29<MY'K6MMYVHL?NKAG(U[#\[;OT_L&'B-MWT]KTHG#,PFOD9P:-.
M6DTT8*4;\CILCCWL>BSG^%XFYPM9?YV-7 ^>^YEA7+?^EY,:BH(!VNTR!-U>
M0^ !\D8GYTA0J#@A>)G3\AT#!?HNN"I@O;.5'D/W&-89.HT(MQFXBP=HS^,T
MH2<U&PD2JH*5EE$TKV]TJQS+A*6PQ;12]_(4*(89ID;]\6$D;D(_HK%C5W&Q
MQP#M=[]SK_#Y$'" _/@I(5MPM-DHLY?Y2!$W-T<TDWQ7D; YA\RUY&A![>65
M0L/1HE9W5V=@U ULTY,3T4?7E4.M-B]RWM4%;\=%P5HDQ^O4[.]4:-J^Y!5@
M"'_K',A*S_Q-7VH!?G42+*5I%5EW,=DX/I/0X4NC9 V$KT9E?L^.^QG552 R
MH^,RFP9$?D?5B2\[J+6>KK03.J4&L$#$9K4,>V],OQUCMFAFC^)8Q)RW99D/
M"M5DRT&Z/N\*!6[T0!L>G_M+13F702/$O4WL7R\Y/%PLL3@SL[K'=M_YD-5R
M;7O&]YI)UJ[,QM<6O\Z9M%F&'???X-:.$V:RJ+Z2C%C/ZK@_'H?,W/9=6Q]F
MC1+>-GF3B^KH>_TZQTZXF^NBV*WYCL_G[/7-F.,"9CJDV:]E&2B.2I.6-]2^
M2E*>>^'WE<6GL%KZTRT*2)R*3L6OB7R]M5.[+83%S]HH7,?-KD2%*'!;&-O3
MHBL,*\P)J4OS9]2B\Q<D,]"-BF)W7072]&M$@"M--#%__:(H<6T(;=@$(2-D
M0,7B_Y4!MSQOL_>551S86.5IE8Y??36>^,\?'+O[B=D$XZBD08OJRV"GCJFD
MX/WN,$,\P.U*$[%R=Z?L0H7@.$M]2]WXDF;KV7&H8F.FM;ORQ[.8!U/6-P?C
M\0"(\S' DW'9%@^@=SRJ&FMMFU)O-6D_J.L24WZRO*;8V3=>=4Y:K33E,RC\
M"1M=+5,C/+']!14<N2-]CRG%5)YMW_7A56?*JOL7?8CO2HPV8U5]FLN1R2VM
MJD,VL3JG1IL?.4\?J""&6;=?2@LLU-MT>.,!&+8T7D.J\?=N0;K-7XA: D$>
M@OLCS&</8W,=;$JUB_OVAD?3VJT]F; 1=#&\X8RHT#O*@09_"'?)\+1C"$20
MO5>/\":G( @ :CKAWXLNZ8>@_^J3HJ5IYWW-*8PYMW)<&'43]XS,!E<%U3(5
M=07=;EQY,@:]-&O^)LMFK[/@%RR!5,,]ZT5<7 ?APJ/J']9-$]AN:!+LY#84
M2\?DK:YK'ADGC[9=;."'=LO4$C!B*73#(OH3]$#3 ;1=1. 864OKF+CIQO-M
M.EP0)UH)#V [&<;5_,DVX&?NAZPX<TS46EWM<C F/-D)ZPO# L;SQI,@[PDH
MTO725?S7Y3Q3LOE='DJ,F(<L@>;&T#TCG'Z&TUV[^Q?5W1$>0""V7>&9T/%,
M*/<AF3Y.@Q9T?A: !SS+,06%F0M+-EZ5T=HQ0F#\CRG.3^(NQ\>J^1_0-1 >
MX(@'7.C5ZQ/&Q6?F##S ; BZ\;"N<$$30R 0N_-XP-NA:.3J 7<N*N-0)NRR
MM%= FRPUM%N5\*"FH%C&A%&,U9!5 Q+B&<,C;-#/!H$Z!PTY'_.@WU1K_EWR
M8-I&:6K<ZR1MSR:4H4(9),]%?Q]'4Z_B,O)\)8O9FY^# ]EK%&Z 5 _C6;-G
MHQW*[U <#%SPF([N&G]MQI"WP<R"-E\B&15A3]Q7C2MY6;.+VTEWZWRS?,Q2
M<],\2E*^27TNSO?.Q"*+58S*>6QC3WQ^Q5E6 3=-O#Z?^ET9C6HFT!+MUSQT
MSW+KY^;W0XKM5(O$*V]>>-HPYI%$',G.8O  0W1&,;BH(G(Q5<CV^;*=&_L:
MSSS](DG^.E%5R?CBO+].2Z+BWJE5<G%+Y,JK$/V+,%]?30C%\_B%K'N]S@4E
M+JKWW&U<_]RFI_\)3 M%R\MRF=F.%ST(LCAISFYB\E2<E,VBQP/ ^K7C5U"L
M30)+(9DC;GWY!=.151RV7X4_"T]$O?=%^E@:N:BB?(1)!QV'HC;V-^!T@PV\
M;QN ),]1&BG.(@.1F>;5 HR0)N2L[ E4<K01O9A=7 NUV4SZJ1E09O).@:3B
M_6]U\HC]'[P*4J:_H$M1E;0Q"^%5SU,<!8(G,Y]XO?([.W= K)%X9R$]56-;
MFR-=15Z;G2SFR,]T +3.@S#;GX>EI99 H34[W@T-S-.J\@<1-->$3UF9T:O1
MVQ'ZE?*W/)!*5SFI.$=8.#?2;UW1\(CPDHS3..;899ZEN(.>:Q?%LH\L)LZ&
MR%X4CDN#BN3@&WK>WVYE:]Y^HRLQ@3Y+0DK0K)@S-JY(Y$#'?T$W="VV$&V-
MI.Y<N4.6<2^0.]E=70LQP.?[G;.O /=JF&4_SKS,H!D)%"?]Z4MA\Q</'+/7
M%)UD9,6GFM_?WA _O<TJ@#TR  Y5%UMVS+&AP_HR;24MFQT>8#<B*X4%+IR:
M=$\P0O:BBJ9NHN 08W6#&H4F%+RC.<]X3RQQ?YWK*$KTBN;2-'2_X%1U5?KF
M0B&4Q$Z=P3KE!2PE=/SQ8P[2Z@T *!3Q@\F4.U9]\R<3_>..@]FM_^354R>_
MA,#$%]_#U:?C 8,(LWE=G<50$3^)-"G4-.X5\$^>5#CJYG1V91,/.-X%XC[R
M]#3\*_$:%8[1[[4F>OB,62H'VMW230A?P@3PD01W@M\>:EQ9M"($@J\$-JDV
M7CEH[+Y![YNSU5(GOMB)29C5P<U!CU[!7>!D:&="5/0DL-)*&):>,Q?9Q0-Y
M?RS3\U?5E\5?#\+$?9BED,*XIY((K$OX6;D3YNW0W';+6,VG5[!2$PBN:YD!
M#VCX&-WQ0Y88VJ5$B!HE6E QN%5=667CK^2A+?;$.2LN%G%%[4<*3MHFY8XN
M@\$RY#HI:"^X APLV:/P#O$NW.&QC"<G$2BD&6-? "<=$0%20?C'5D?+7HT;
MZ5!7+?S\U-W20_(45-^$09G21'>2L>\VCX@43KS9X^M1SD6QJW/I.!F\#0NT
MING548S6@</\[F_'V(.H[ZMYZG_L42Y.2$)_$3,^L%!:-*Z);A.XC9Y0R0;K
MJ"33)'AT2SA]$X"F!,HA3.(0--W@Z);N18H[&\G0M#=?EX+LYM&>7PUN-S1Q
M N'EIIPN]9Y"<)TTV;U91'9AF_0_TLOV/\X4<.T*R+_% ^[(:#IEAO%0I_/\
M/4SN'B\!;S2NY-B#CG=!N"C5*5@K:UIE)]'_U(=) ]M_="\(A%6<]_UH+VX-
M3TUW+@\UU/DNHUFQ.!?7K'< 7E\*[*_T2&\F2DG4>Z$$Y%5!OX<NT&P :>I
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MFBY[3J7[V5I^^;'>QFP]!6N4?691']'37\BU2.*O5E51#PXEB-PB9U.85/
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MH1<S!H/('6?^$I;ZG4"2UTT,>>@F/"<M!>^>@XX-$DH)5QBV?2R/VGZ?A/<
M=;:=TQTO_B51T;)2U^UC,](LTX5Y"">*/ZY"LOT?MMPKA^6<)O71%U72-'[2
M&=6C_&D2JIR)2>:V]X>HJ%V>#=>3^4&XOIC_!)Z_LA/%GGE6R-#KR.Z9+8(
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M\J\.E^P/M/+@#RW<,6B;4=Z82MC^]R"K'/K[WJ\UW6 B+ZI7$O>S(,"8S[^
M;SM*$C,W#S'8S1@#(K9>MZPTTW?1'_):0T_.N-'!-J/]K6QT=)XH8:_TE*7R
M<](WX#W,)%HOEA#^3BS621O-T:*[O0R:WT9R_R1:O5M_'[L5)6>8YBP$#1UA
M[;7W/%8$#*>(J9<JKH"(YQ<K7I5=/#!J4J%A744=&6TO@6_->FC+J_72JZ5=
M:WA_*+E; ?Z.?;2['7T==A[J$:_ %SD27M_<OM/4#99'IC?:-#&3.BRKQ3M[
MO[.PT:.#KN"+_*BA=DT4I >:;D1< 3R53=%>6J#(9LS@<5QS<ZX )A?&,S1Y
MBX_[9_U3+\>35T'+[E> B98K0'S;95EEI$C+*Y>A&N%67;X1%-]R&JACQJ2J
MXJENJU6>?1O0"VHO.7M4Y"<"QU\,]A&<B7SO(/<H@>3-5_FES1'(RN]^JA;-
M:N!;OCS@_MCMO/+9P[E-2LINJT.%C\XG#R8#\RY3OFT\0/07IK'#AJW,N.L8
M9G%&.]ZZV[_NIUF]X]]CA"B] @1+/(03AMF[WG9]G) X1';MR3MM@IZW.%AO
MK^VF9S4?+0\%8H>*&>+=<PSC-(DL8XYL%*8 ^ KQ3K=PYJ4LSXN>K@Q]O6.9
MH.=)? .'H@A)^%);.TYB1^_CR&E\]=JQC, J.-1M@<R^0O]YG6@*8)8"%5NX
M_VU3S.5L>'J >@4:'I'9G07)V#2IC<:>W=\\*?,62F>"X\SY]/=?Q-S>:Y@]
MID%?;[F00O@NS].U<\XJUK:D8 VD[SQ@?.SU]CNN>,CN5&&!NEYQ)6F15KRC
MF\QM&WCBT07Q.A?'WA6@AE'SD5Q-A!KJ\R/S&W?=UM9H+,8S)V"@+E_3KE;F
M:,66VHHH\LBY:M;E2NPF(J26>]?P-:N9UXFN+0^YJX)BM3SN[=N*W:)+73+-
M!Z5C=]B?TRU? <J(P>PB)DMK,<Z3D5*W^1;VRS(J:Q)W-C0A..^;FNA("?*:
M3;N,[YT P_/#GVK4U*H]'62X%7L)<\(&Z\TC!DL4;'.^;?/PW'';8_JV7QA!
MF*<$7F)H  6GWZF%<\Y_V<^B++&5+W]/(#8M(LSD!%C=C3U05R)2W8QU+5)2
M/W6@_*DX*U[:T3(!6^@BT!-YH-%[?//)%S./6:,Z.'?HK?PWT51]-UYF^Q5\
M-HDX0TXW+GC0=PK5OOY^K"\\$8$=_( ZBB>M$SK4C/5%[XZ'39>[WLN8WMB8
MT5X9CB SB\54>@<;>:>@=,C UVKVIX+QC>(]RR&H^!8@>A:\-5TH9KY:3(_3
M$=M('7ZN[:*UX]CMV!#]LAVYNO,<A$]KBK#/D]W$S7JEG$'<XF%4522W0DAD
ML#C_0L5 ,6:(;SW/X1:V"<_X6%6$2-Z^K6A9&NNL6Q3D8*4-LL_,B3\G6!SW
M5.HZ4;3R!Q+M:OMPY'IN1Z3J@[8ZD#<.8XPO+OR@%U5L+]6(T,W1S5$S>.;]
M:'VCL3*AG\8$I@[PUF*):%LV-MX>,]@2LK$MR)QC@"QHRE5-.FBP(P-XMH_;
M7)N<T+>XT[CLP%VGAM2Z%=/5O37X$B^9>/WP(N=UW!C*I]^A[D^]KH8_VS8/
MJVN-C)H[=KGICPHD[/+2;M06EW62[S&G2A\3PCT$_>:>C5&#D<R_EHCO%* L
M4Y5A'W\K/EX2'0D^I!H'[<ZW';-/(]A^WLS41C?EHP-L&%>-4<'5P\@S^TO<
M:N/N1TD7E>C&-);VZ'.2_2O [N45X-C =:MFT_@6:$T9$\G+SZX HX[365,"
M?H(N(V@JC-O+F/CW&M/^SV]0^S>MF7J%.U2@F)[.6NLTN>6R^?:Z+028)&70
M%;2$Y=_WL,6F_1[)/();/GW#ZN''Y?X^1O+7(N)R:U-Q>:MD7!N/2G*%J-_8
MCV(B\:?_K%3X/ZE!^I_V7X<L_PG\U0%Z#[0F#48BHI'3(59'BR%QP\I6[@L%
M_MFAYKDW NNFXVYZ1W\9/B>"HEL9T35??"BK(?;$"P:-P1Z<;6[*L,3[Q""\
MZ.[&0@D]VU2RU4'=YX7T'?0D+?FIBZ^B7H +K**N  /7VTJ=>F?:W@E\>:-@
M7J#_2/AE@$1+*"/L_O1$PAH]-<>*;G7X" ^P)*:B1Y."\9!C,8UTIT$A(:J6
M[E$TOQ==^+*BKYC"<K_AB_MR-&0)V%(.#HY[<]Y$1IIPA6[UQ9TJ2RUUTLK:
MQRS?%G=S5N]?L%'T%$A,ML#4K*CE)DU$#L=<7(_[#.@O;VC'55+/V\9I/\YO
MZ!0"?VP E9(NO5^,T2QFD9=X?1;B1V>SP%Q]85[M,#N3^B-Y_6L8S[0E(/ZD
M6WQ'W*8#S0!3KZX*B!F*Q#+0K]V:U[FK I^S"  E^%+?()K5[[G!3LP:P\#Z
M(\,$MP_NFJJ-OCM9ND&I;KTO/$0IO0[R!TP4[?4;0CQT"K9.Q.Y\AAZ*;5T!
M3F# 4D3Q<JF1K=.N0=2XZ!N';BI['N&],^>F0MKB.!@+*EH4=.F#>WJ \8;W
MK1=/!D'' L6IJ=9 2K6 !$J#\S/Y,?N:%DD._BVQW:0;1?::0[>4.9YL :=.
M%+F.I!%$7-""9VOS4I';]8)\3A1.MVEQRH#+QJCH4^.3(>-+P'0QZK>]A=YK
MQ&^JTN)P6["=\PVTW@7W[H-WIY0W:A902O"(5KKQ[/$?3&P%AH42)KNDOG<(
MG4>\G'R! 8B?N+D!X^=U0<D3]&3K<<IT<\4-YE&L"== +K;86' F-+]PH>8$
MHQ 5E3M/-?<=&S^.^H\_7O(N5W%VE;Z;\]4Y$=ML*(W47[8(<RG6JB?27Y"&
MZ*+['S _.36YC>+333:.:I;)MH)_VT:^#9@1VY.T)]IQ\F270UEOHCBN !28
MO8!!L,R95X 5]L7JUL2*][X)-2V#A,%HP?I1 5F7IN_AVTG<=1M]AP8PG%,6
M0'3/[LZ"!(9%D.A@@!']A/;0/2'B^7E%9[Y;B196-.]P[Y#$?UYRWC:61&0M
MEZ')#.;:%A,[1*A3#Y\F#Y6HQ;T^?CC'?&_D'/UU9W]L3?Q]Y9?'U_VSF(0&
MV[%HCL::Z!$:"ZSHP7M^AG4?M-V_^RPN1-NE."/.BHSQ.=5V>Y"O>C/C> ]-
MD$4\Z@@:^H[6B'RMXL!*%D))C7 G"9V1DY06+.VZB3=S);&/.!H^QWH7G@KL
MT9/X@(H\H KCTM$VIW%Q_)$77UZPJ08>$1D)K,@F$I+NP/+GHD[-C3.<@-N1
M3(FC)7),\?:43%> 1C8M-VM9#X\C-LD?/J7K;6GKIIOS=90'1H.P*\#3*11U
M#@)RH%YQMRTFKJ.47=@I_('(C))H]%!SX,^HNG@%>%U>M![Y,&PE]AECH9;Z
M'%WU[M<^KI6.=L'U;^=^4XLJ<./0,7I^.5]?;E[Y'LK=.,^E:TBMLBK869<7
M[7H)YQLNQ<Z@8'UI#@R;;^J]08=Z*WK47HSF1O@6(JPO#UPFDGV%A3[25)@U
MTZS=ZF&D7T!KVG2"R 4,.5?K)H\*=".N;UXZ$;[&?.$>RU1I7XT'98&4A%XR
MW[?C.[;2XY)5=9-E4H.',F'FM,-VWDLF%JU\"]5%96D%^M8S+O=.G3P3C\K6
MWIA&PXLUN\[$!6Q^\L@'?[<IX9\""W]#8.%O$U>]UL);X3ES.]I QDZ[E'E3
M0 7=]_M^U7;XLUJ&6?6^P)7RD!K]Y3?$^Q.V%GR&[$S6@&$FD9(TY57I%%LG
MTW&7[^6FZH$<<9X/6CZW"R/?^A9=IA[84(H>C[4,*V75#^.B9,>:%9UJ7PM5
MMKY,@$C?-)X NDM\(YNPKEO\GBQ^FKE^WF9>%V>;4KL_DUN1[IBJ45_]HS]B
ME7D@_5TCL/<*\%O&&8TPQ+A;;O#:P17 IE0\XH+2]W62\S1K.>,5X!UFF:N=
MH96N *>-Q\9X-E!8G(?;M-8%Z#MZM.U,_VQOYD>+ ]^9\UB>QCJ9FP'PJ=VH
MQ0,XX0HCPL\T9_NQ4G8UI;EK;Q!1#$!<_P:=!Q:M<\_[_E5NXD&AY)G]#.I1
M+DKMPQNXQX/ZRU@[,RT;F2RA@BT#PVS&E19VJZD6 UNB?F2SG=F6,RS!R=TZ
MMO'*$-JJCQHW'; YT/DMUODXN>9NSE_3].+LE'J/P-=1*LWQ*B$*T^NZV1^"
M(#_>ED2.8&_AG.VF-^S]$#CT_1Q9PR85ZDST(10PM-=P[GLTUEH2.' AYN>.
MG \$3].,E9,F6Y9PRLGQ(W^JC/A/_#UT\+_OL"7KK<1+^.L0EI!F!<_\QF6R
MLP['3FE/]7/'DULMG9_3^6K@$O&D:@-A14^;7@?5<4>O&IQ@MV6B;D.[T_%J
MX':II+'XJ/N7Z3XN5P#S%@UTFHR##[762$TY[LXU[@>),YJ@IG3!<_UR]DX,
M<=DUE"NJJ)I;LM;QK$V,0&)_H2/Z!+=M:18Z,NC^).+ZB#= CF*3W2803M\)
MQ?&PD4U$'ZE,(&Y(W4NCL#*NC)Y'MS1.4Q)V1=_3[ZD0^(@SY.>1[7Q>&:^;
M4G- OL/ZKEP 6/)2DODT>BW[D'15R7%^BVTJ7SR[\%9(SG#9KE:C;?WC38><
M)53Q'-2$UV96@B.K9XDW-%/5(O2GDD/Z305, /CLB#":W:O[$*_Y\=$:30F[
MYXRX<B$*&T.),?&<@0_S$%W@J2QUM8(2 S9AU7COJC#$(VTT<?^(Y.(I>?OI
M$0EHK"5>QW^_6N'"HYV;LSHT R]./@;8[8<'[OVY^XP(KP#9C.7.A:7PY)>N
M.3X-RVG2M"Q=2-O+;I\/+%HQ49G.?6>?-\E.\)R8_M(K&@O(UFOB==<; J</
M70 TC)=O3KG4X]62\,3IK%(^XMGM.9/;C$H37FDP9.E.9QC9>]<*+5*@P=KO
M_EK)?HF%%=U1DRI>I!;V3C0JT#%./&DE/=_>="F\V%/'<SJBXNG'M9CV,"0
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M5:<Y7"(9+Y358F8ZJXDK"5-YT#1XZRW!7E1'3=#(VF+'VNGGR;+@-L[/TE>
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MQZX#PEHR&/!W4\SL>?E%NI:GQ(O6]V[;V][M?PR^C\UT@7NMR4X_JYFEZPI
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M O1GPWB';S,_O798)HM=IKRZ)T^B$IP2]?^P]YY137Y;OV@4%00103I(Z%5
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M*460DMV][>S76E YONHE8J)6Y_;[A;XGEFP:Z]()/N%+&*U1/;%(::E%HBM
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M?11S6T?\2^2]D*WI03^1'=@#5Y-,#Z!FE<RM$OEE^72HE!.HB15'<?C@]B<
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MMN,[XXW<R4/'&3?\T4@UKY$?8?R.K/&=P3ZV8T:^?CW*&CYP7>EQFLU=7U!
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M9LYL-HC#NJK_?->=O(9D8D]H &S98PBR=<)_20#-QSI<AY_.?[X"E_X927J
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M@ON P8'U]!$(>F$O5S'JU^UHP6'8PM5T#Q^!_WV3Q#'0 #_([_[D1@*79]$
M!3;O]S0S;AGH<S O SB^4P_25I?Y>>-I$\#AMHEV,Y9#A6!4Z="<?^D*0 2D
MP+S3U]7VFR6Z6_B9WJ<U?VTP/.KEP@DB22&M?SVP@>Z3,3V]X!/(]UM0Y'&[
M1R,J)W8Q3V6JNK@1XN4Q^"0V=\X@_&@K&C.2#4V0+Q8/N^]WY"X^0.)C'3,U
MS./KUKS[Z EQ7RV@%S2Z8#Y#>D21YXON5%;0OX HUL4;.)X$ZW; ;HYUS&$9
MT(8%WP*DE-L[W)^+&[>N30]L[&DO8%26:%)X-HI;(/5LO>]A2P4JUCVRFV]R
M/RF-8^_NX'@Q,;R>QS1&$K;S*Z(O2!\8GW@'[ITAJS#VQH%M-:R2J74/6^D3
MZ<Q>TD=6@3J\HY0.YXE]J *&WU>C;T\9"M)_UO?Y-"!M9Q+0.HVW:3V6&2G^
M3N&'K,*03#YGTRM)@!1A!SP0HQHN;55HUD^TB/CX'DWY,:%"/;BQN.?V^OM/
M48F^74TLZ&/$K9%RHD(>]0#<;TV*WOL,8AT.?JE;6_F'"&H?CI'CR;0+Y6@;
M_O0$ []-&55%1B<2D/S*7'Z<5L+C3VVOG'SV9WJ&&\1?TYG2=B0Z) !\^LR#
M=<#-WTC/DMK0]NUGQ[Z2*A#YLIC?$@DVI5T+75K'VGC^Q]U8'H8M%$<X[PK7
MHX]B/+&'[4X?@!?K@>?:]5(+\Z%VR\85=/K473U4L=XD;Z@8TSO*5K)2>U.*
MR0PJQ%,YE&K'CY5])3M8V-JV*>3?;JIE/%(\0N3Y0#+;,RPH]0Q>4%1^XGHC
M4%U3C%7D0!?L$7KP*.Y'U/*&"2<(<I+-]/0T^MQO\B:Q6:,8&A>Q.EROD'QR
M!$JJG4&3_%W+8 ]&Y!IEAZYYM2(D">F-!C9)(L)%Z'@BP(O]K %DX7R/OL:H
M>K0DY2Z0!$]U!ODHN-)M)=]E.F  _5)8*5$X?B7E-1[F>*)3'9L+L>^S)='X
M:P)I6[O91VE?+GN)?WM@>V.'^8(_N7'G?D_JM$!$/JS&FE:%*Z<_#.V4,RS=
MB.+'?E4&GJ_QXSY;G1-IC:#&RN#UX 6_S57VT*I^08'H74EDH@<0%5R.2J?0
MMTJHU//Y\J*(YFUTC\_OIQVO[N/*MRBTLU**/K4^ZR!6!+)M>8'&_0MF-A+R
M;PV"A^7E'GWS)@W$(,T7TL.@1K1EM&Z91',3N><IHJR?)QZ.^=9"BSP:FVG-
MPWFU[?R#=YD^%64"!:-D()^\_701C*,-)!X_^M]5.$[/MX\9<<DPU+<NX:,A
M>I-:00I3\M(_1[-YFK;*@9&T5M.-)V8)[JPK?L^=M,F!OEDQD,<7K@C&<=?/
ML]Y:R>JC;(=\;!*@@,BF^TU0\YQK^!%9#MSY,=4"7E5\$8&YU07Y5I1LC!$V
M5ALI++M;.*X0'N$*6OIEJ6P['9'O06TG9=Z@^(/O*T- BO48-$9\[R^#2BM?
MQ(C*O^IJ"M:AN<7049?;= 6X)X*XA\F?UJJO&5D.8'/HN1>IOZIQ1_"#^S%"
MM\!:40DJKT-[_TE9] $RW$<$$N0C"TYG9']XT>,)::39P$2&S-".[T/:E.<)
MXLOCA=QSJGF7*9LCZE^=G )_UR/;YJA&?+1S+J->A:\XO4L4]T@>!:Y*TJ+[
MC!>0GVQ6(9,(^Y\RBM,AI%4,J"IL*)9'=S1\R3)E)%/2:37'-0%(+VP:*#JE
MC8VUO2@AEQW(>2;MO5B7T-; /NJCG4^W\PS):!O)2JV '"39,F0+:2&AF.VE
M7)V;ZQ;JZ9.L9&@F@NK_]*'1VN_523)M$[0JE%0$]0UQU][\Q>W_C/%]X("!
MZSI7KA+)TQB$ME69]$ SY$#:(OWX@@KWD6>=Y)/Q :,UY+CU/.QP_CZ6&7D4
M1;HQ%=&^FC0X;<!:5-S#].Y&=\<K9Z/OBZG<OLZMM,&)-N@L)*F-W-<O&<NN
M31Q'!9O]?):9>N0KM$XJ0"[D^+D8]L/1%>#\).H*\(QBT?@?DO[(:MVG)S6N
MA;5?C#C5J1$R3_'">/H%E7J?E*W<.8M^EU%?%H9K6>QW>"E&*JR*;UA  /F>
MMT$31U[Z@/Q>C!H *C'A$PO?*%D_;U]-%B!F*^LC?2-N0__>FZ'<O%6/M8$9
M39R60+G _N7N(SDWQHL^S+VQ 7KKT$4@U?Q\6SX3_TJ;/)H[(@,GWN>EUFQ/
M?$8I!F:J>E:S]$3_O<M3/S.@#O45X$.ZWM[7F;?NU<LC.;F:<39>A76D>M/M
M]K>LZ048%8;D;OZD!OA1L)%#;VS][2.51WH[[$:/O:?8IZ,N=WWEPSFYP&_S
M==]P&WOK3EX,H)+H.$.E7[<5FF\YR!JP+^R&;XYHLYCYA%AZ.K]UIYC-&KC=
MIE+-^CP@IYY*"8,LG&)4D>N?N@)0GW7NIIRO :*Z"+>EU?=#E,?98_:4$BXD
M5_I7P_G>FN#V]G'TWM!T0RP3VK6:F<?:&N%A1PY;][:&IZ6,Y^*7%BI>Y*R<
M=O+*:+5'1MC;*;"XC- X^,K=1*982ZYF+Q(M>>;-@MHFFGB;U)& ^X"B-)*/
M#4_B/OB".9^)]R8(? 'A-*S+]O>:];TMXY>,ZZC8%)BGIIE(+GH=%$X OA:K
MV<2OQ*'PK$@>U)J_.5HGIU),H,12=.]B0]+SHW.QK[?YH'>TL1PSJV,^<Y L
M@/MG$\"-O,?:XO'.CXJ*4.8 -L+HC*974C<TD")*D3:[F8J:.M+32_;8T'C8
MR8,_-_=XL/GRHA^V(.?X]K&4E&33G8_=E06$2F]/D7:^\3P+\L1%[YOH5H[M
ML(^:#Z^5*&H-D/6P&PIU 1G7&!8KLS4$@@M6VC12-@V9(7=]WB8K_0IKU:](
M.A"O4OXVX^GO?9-D[GP9IC<V[B<V?9D8^V*$74@0S8LB?' %J,G:79J!19"0
M^5#5AZ%R]['H/CPROP$I6Y>C&S5/SA<NK9.C4/+AJ2<57XNC]D1Z=2^IAZSX
M-0R*20UR6=Q=0<<S2'=!X=+>5<5'-:4/8ZS7@4%@JO36.7IO>!N7^T^*K]\W
MH_T/\/:ZP9.=KZP2 OW(IBP22#=IVX;FYN2>RY-Q'62^3?-<B7K>17T$LA[.
MY]%6<6I#DCQK/^QQ[OE_E$YKQ,N#T:_[RZE-LT ^2!1RP>YU-*)Q2YMB?P'(
M!D-T5-"N#Q>BSY2[N.*=T92-([/;VJ@+^ H0Y*OXVHAQ?S=YT5:DP)73O3/U
M]V^'];E\;]J6.%4Y5V3F#LNJ1U0@F&L.8]9EB:Q8Q75#QOP.K=M -YJ[3G:V
MIFI?@\76F1^8C+BR)]24_(@:<,1I]U@#;[O"7].4P6N])YP/X.G<3T&'G97&
MK2,T?N0>W=D$+MG:_6+)WXJ/4:7G.CL:\;G<\<Q$\1U!>QT04K6"[-G\9_96
M*40O[75H\%?MLM#AX;Z2R'P,78?:TB-1_9 1]C(+!7F?X-#IRU@D.)/^O9.U
M_R#X[JQTGFB]-[TC7JR]C;(0B4RG/\:L/E!MI. (SKF]S9M961G^UB3" =RP
M-G-@S5V46OC0BQ3NW;=.&Q'4 ,^9F3!DQ_"Q6,RX-U,OS0\B>QB8!NVE10K5
M<HQ^'K)(0(UBN-9;)Y#C%$&+L+N61H]+#D0(/L7=."AZ&,IR#E25I$W2EF"H
MI3"**M.S\^@,]..:QU@-N5Q,.\/>I;P0VXGA?^/Y^\*O'EX1N^07P'0')*9A
MZ0WGYL2> E<,<@KW]0W+HY-?5E<TA#!R\JXH[GWQ,X+,87GH?;C0T;&6PUHD
M>W3?BJ\ W\TJK;Z65_=F?PI8*7;6PU0O/I)_%>!-5N/R0'0E6*@1=K$<]<W[
M#30/0]1IO41GJ:',Q;N[TR3X5>.=Q$;PMMKWHST#]M!])=QK'17[5V%S#'?#
MD&M?SL.C@\ZQ8UOG<E%OOUL.35B.;]VN<0[:[*SFJ#X5286JCH>6$XROKB8/
M&IKCGGJ%7'HK7I^^I#/FAKI&_]VR+;@+H_2O&BZ[#U_D15"-_^ /AF0<P]S?
MM6M^G5J1S_<!79]?/+DK0!%P%!GM8WK]:QV&S(+UP:>PO-EJWS$F:B-\1F))
M<[R10V1:*6F) %Q<"^8*@*HH7D20$<MUK+:(^WR,LCD0MPGP)8_$E>5U<T>4
MP&548\+TUIW3_Y('W#*RW5]#G12BB,TV#U]5E<1+V&*S*7>WG\V02*AW4FR(
MB"0YU?"34-&ZF?.@'[9> ?:C/<"[U$,J8U47+VY= 3P]6= T0 V>5;T+LCJH
M(48H?]:ZLI+6<"[]T=?A1&;%U+$O#$H+3-2WODBLW[:4^1%6*M"N[F2E+N/S
M</ 6\C1INVOZC3'S3'2SV44G..,-K D^M4774G//CW9_-C[^HU!;8EPGNLO3
M9- QML/[QI\.0V>E-5EJIV<L8FVTTGHX?^_LWT_U/X4%LTCIYZ<W?8 1GEEK
MCO"[J&A8TTTDT7T#WH(QDSAX!1KK(T6NH]=;EFE/RK5K[M!5!3/7A/O\!A'@
MF';.WA7%&:DP='B$,0P9VGE6!N.$#70GY2T+)T&H"+?/WV;NTHTX2#_<2Q\H
MM)W#.@R3W;01KMTP:VY*?V]%8O?,:MD5&.C'5A;=T&%KGXG'K:$2[OO)!@"C
MS21I@5'_GO 5% ^!SW3(KW=4K/PXEAA%DP[/^[LAEZ@^H<96:E/T!VR9@.M!
M;OD @8.T3'2?MW&PZSQ&X4A<1, 4E-23(B\J*'_JOYM;O%AW!6@%WN'=+B+;
M,JZ)W/D24#$8N!(#J>N\'5*!?X30CA1'A3*'4K#($O[,O/%T';#-0UM$HI!*
MSJ)M+>H()/7Q:B KU9=Z M2N5AG:I=%-R#F0.KB/7SSPDN%AR[6GW7.9=K0N
M>GJ*SI#BD&MKE!L@/KX&^5%IPX5"H?83ZT<3 H8O"()7\'L3-PEV05&H,/3.
M\X73,%M31VN*\NTWV$+Z9B(2 [# &<[5Y3(Y(I&BOB1=V(UJD;^-#D*MKS<Y
M,:%,_D3A_6%NDY-C.. NP'G3ZWZ<,8HMJQ+XP&8U@CJ[S*F;">\#(04-5E=K
M"M;\I_2V%^Y*7/_5'-XCV "YQ5X?VP*^/U+'E%M&F1B_J&I6[1@<.^A]8T-;
MHN7)2FBJI"N'9IJYK"PYE&G]7YVO^W?N[K_>^B^?NY/7O):_?.W2'79)@!P;
M.XC,O=Z ]<#Y[G4@0EJ4 MY>[+")@L-7'@GA9,9AQ[.0(R9C*/2WI#DVJ. *
ML%4#6Y<)!_\W]MX[KLFOVQ.-BM)!*=*+TA1$D"*=B$H70@>I*B E%.DM$ 7I
M3;K20N]%NM1(EX[TWCL$$FJ D-SXGCOW_-YWYIR9.S-GSKEWYH_]^>3)LY-G
M/[NL]5U[K[6^_4]\.BZ"]?^0&^, 5SX]?U-BY6VP0W&\N80#$&(C#"^T_]7;
M#R"/GI@Q@_Z<Q6U(/6_Q1>?F&QB@VVSLRMZYU[/:(3-[@M3/+ZX.3$$U/H11
MTL\7&)$U \=2?B,=\K?V?$\/#CX2=]=X@@*;1'U763[,=M\CQ=9NK!_.RDG#
MW'DR#M#4)C2TY3P5W6%)HH6YA6:O*L8P1J4S4YP;X" Y*I&A#J<"[#,*_Y9(
M)#80O#S 2/YTE(N#P<JAK+N8K11ROD).J84$AM+>U=>+_%Q;IR+([,XQY\IQ
MP>K3(_ND -FA(&4R,WL]]J'QR^!+[/EJM/&%BYOYP]R^BC1BA13(97J-O(L?
M*<J5]?$(>5M&V#X5U<IM9YKTS]!*K^[AJ.FRV'I#F^DT5&QL \D_'-S-[;;+
M_N$K6K;!+R=B'"";L]0:\IZ^?#FMNPUX?B<.V\*)32A=1;"#9<G&V'5O&<0-
MA0,7U#W/.#A0);#/T$,.GBN(\A5?8V%*]2QOJE<AYR6;&$9F EC19/.63W;*
MRK&J+_'G#(;L\M8,E.0D.FP&?NH88%&GT%$W0G0+V#@.EXM&TWI.AHM8(<_"
M'.V>\3$JF5+#EJ3+5Z/'=!<9T94@6N,IB?>'B%+-URH?I4>N?8GNOH&]82(4
M+!(?T\D8=3N>=:.\S?Y.C<!=T@WCUOS\K]#%-\^C-Z!+H@=N[9B'(\ J"!-+
M>QE7RY=!EZN%\(L_+I?%/\IL*S=BIH.#^44W:#3EWSM OEQ[!R"(^WF]&8S'
M$X0<Z6T2)WT]R^ER/V9G$3<),]]1@-3'-UK8/-^AN).X^FY^<KQO0SQ$PFR5
M7^,+,G'+6[6(!I*J"#?&+*6+HQT%@OC5L\T_G$EZOBG? + ^2B5;]9<D0_5L
M&RX22LOQVE)O:?>^HKJ7/&_$ XYN(LQ3 "V;!JZ.$B$??[?BI?[%[H ]55B<
MI%U9)+^K@ [(]5(D8" 6Q[+Q5UTXJ? /IFPP9Q7J10MHUZ,[5R3L[>VK^:P>
M..@/_F!??9C*>T5, #M3;';R(T32=H>GJX9R/YV!\%>LWWB$:)W)WE+D&7,K
M7J37C.LJ,'@CDVKIV[7!UL]X;!:H=L/S>O]SA9-8S:= >%,Z=(G+&L[%.7RN
MJX)0S1S:6;RYU](QD+U#=W]=[M[CL,KZX]Z";J@AZC*$JZ8^<<'UR0!UO*M#
MT<^E /3D1,(1*)J,I]NP]6,AJ/JV.P[@<\-C-_G!H);[NTZM""TG&??--C@R
M"2.&/(6=+E9ZN9^..AXV]:^P_.A2/(.K(,-W'2MLZ9XVGIU35?M41,XJ,W0O
MF[U":V-?7E%CF]AQ@-]@LZ>[\$-!6[.3$[R@LOGM@""EILEF<)/I_NF'1X"?
M]5X[PJM;QD\+:.P.G]H?3#H->/H.82*$H9.CT"VW$_)H3  "OAN+%T5F L;X
M^=\N=N4KA@U6B4A-L?/\6M#UD.V%YVH'_W(YJ?'BBSK$HY<:#MV+#E@T(-5'
M_[.G5;MD=(2;AS\QH,OBQX_X6#J9(6?E<G7T2 1$+/\786_=5YZY;/-SQL-2
MRK:+H9".3>4J.E:%1>&S@A275-\5&<IU]3 5NKOWZG05)F4T,'=_8_M[1:66
MG3"/G]NSZ7:!_$XVTCF1I]E+:5[WA=/Z0NW+LJ14 9[B@SH!L^?CBV@]UB=X
M$0?$OL+/U<[?. !)>Q?PF! 'Z/D*13<4-#KRQ8C7-D^)^)@%N.$ :&7($YL"
MV9M=9"Z?9N278-T!4=/E, A>6G($U>$E_Q%>\G>5VZ+-,W>P;,-E)2=@EQNB
M/;$B1[1HWFL26KY\G?]0MR G-J4B[UZ=^F.CM,4 +(U<\=;W'</.\8[GZR_:
MR>LUGK-&= 2,N7R4-$]OCT+! F?;O+>_'QE:FXHF/GS][!&%W.J4/]\60H+
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M#)QKZ8Q9:?)W9T5+%;3#5#-_3^%-&]E9;+W (>WAR5]L7*'[W8Q= 209 !E
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MU[S]B3#""R%M*6?>GW<FPS9]V%05[ZM1J5(7=RT)5:8&$682_BCGGL"H(B^
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MY$9:F,(MWR%L@&FA*1<JR<Y4\'<9M_8:$9T3R\\OL<#[0$D=W8VPCMK"1M;
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MQ5* ,Y:N9XD[9&>52B/9ZZLTL8LD6WP(?-FLBD+)\::B,Y4R$6DALSVMGB]
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M;F9=,A6ZB4,%BNV$:@>06(N#.R/@[<;KTP#<R]\.EFR\U]O R%2C&1.<50R
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MZN,Y([FVAQHYLB@N5R/MI=I)UM9$KQ/A>25K$J_:AVZNQ1%<:DT_UB>=M('
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M1KF/O-"24\RCG&Q4,; #91[3)C#RB)?7Y]C<Y>-I?26:X$=P;H##ZY4G=1G
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M=CF&<?=5_,5U+"# "+R2@_OJV$#??2Y?_WCT^3Z<@#6K(?H_58Q:=N)$86-
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MJ;IX4D/Z5507?+[M:/$;]G-E-M=%D@,)\EL2!\T_:*BSJ!&;%U]7>+?AS'#
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MI6)+INC$ !;,+'AS([^9P7L%0THG*.P@*)GG3O*)YL;+[*)X=*B,VZ8L;?1
M$LD,$[$/G61!R58:(X=@7L#-0J&[Z[4WZ]WIU#7&ZXX0+]JR5$,-C(Z7YS6!
M$K6E]!VFA-R-"G(UR[.S)1-+P4PMO@,Q0F1G?F]\??4LL0 "2-N\0NP%SQD
M/_4T58@>W!0[7I2<-E8A(#H^S<:T[CYC5?4=Q..3YG#9-![3K/TN"163C2@Z
M6<8P(PU]EEH]6@A,?O,9?ETGQ)S(:^J$"!%#N/ABUIONMJ:MYT&15C1#NGU[
M^]=^-9:."=-WX]MCC%QV<V\ZVC01?%04<>W3_P*#G:8YY*3HU9#.MCT<4&1X
M0[!1@F% RJQO[")VXO!/XDT$<.#M\\U+T'M$:STBM$L92" PDFA-//=.'7UT
M1-5TUV$1C-K):T9*+/E%BTN#R$]3KDE1/M5U52]B$P:&B$ZL!BFG[JM7%C"?
MWR\7.['T(,RA8'C\H8V\JMM?#+[?L%0BN-ZCVQ0!\OATF<PX8&^RRK-)8MS4
M0F;\U9HQL5PPTL&XZ":YAD)V+T;$SM+^N(1-_KX"C"M ,+H("\@46C/YL'C)
M?4'33FW\OGMS\29BPLU_")5HHHQX&&V^/ _Y+G9+:GJZ2W'1R1YR2=PT79T1
M%R%2X#=ER1T_^.>\4(\-#L3(#BECFGLP[SB*D%<[>V]5X- P,+^4<G&_*M<V
MC3CS46;!+P.%,^DD1ZX'O')CO3<B&-#,9+9Z>KM^-YWI*= BU@7>FAO:A^:&
M.X\9]<N"!N*H% ]Z5,[HRD'?G2B1MMIE".*D=WQ=JQ88?:@ ,@E!HS9Y[#EZ
M+!(XZ7C[:%WGB39>7%%\'R.Q/+T1O*#;J+]+-UV$VGX!*50P%+ (JTZ-#(A9
MRHK*Z)5ZPW?"B7Q;\5?IFJUF*J0GF-A;AK5TA>?W7*\CDXR(RCL*]45\NG"!
M0;0K+B>22_S;0H*&[?3HL&VQ!,2\!9Z"#D^CO/RPAP4<&TQWF2.5,2^'[F+:
M3K$ %"?H;5GR[E9L>Y3Z/6]E603_+0FE(1,5,VOUY)=;8RW7IALM&:<E2;T[
M7^Y/;%4L?;YV.">;;D$\#%3/W-BD7FSFVB+=?G0[^6#@MT1D<7Y'OJ9,S=('
M2'MEKH2/R6!WDX3(2KU8)"C,B=.LKB9.D;"7,;I'3I.79$T_\-D/:DAP%8@W
M-RH96DER<"WI4JH4M(C)@C7?4J ;$$@_()&0@7? S\N0?GH!KV#/2GY.<V=0
M[ON0M Z]$$0UIPV=&7.1^NP3E%W>;_)M9%CBP#VCT;(M96TSHZKW\*,H/("]
MU&>^]0,+O!UB$\H__E.LLO_9YK]G,IL)[FWZC@7 BDU1 .A]J,-HRZK)!'AG
MFOL2H%?R&<TC"6+ ,%X2$;!F-69O_7_&K%=QLG!.6<6-.KGBC1;(U$<=H"-G
M4BY]!W &1IWOKS!< U_;'+D/S0)MV*&8FV@'=M%8P(O.WI:UC8&3J[%7;/[G
M_S<7Y\J]#[  3-/J%6> C_:K ?$L5G,?1L>("$7@N^]Q7\IVM?5PIFMA!SXF
M;L "6H@PY. _=U[K2;R-. 3O1JMCWL/ 9TLM[;%_^AQY<^1U5B/D@D$+=Q4>
M"Y=()WCVGSM9;6[3K% 63._5IFHZ+RP@D ;-^M?>#Z/$?Y]^Y;V%S<_L CVM
M$-V'CU'4!XU_^JGS[\PLKO\/9I;_2,/CZ^2QJ[#QXL@RNBUP+S/S;:'TXU7H
MX.U5BT"!)01:'1&=M'BANMUK+NS-4B6+_W/O5<<1Q3'=FYUFHM'&EQBK[+<E
MD@"R3%:T^ZH'VLU *UTW08ZB8-B@[>?1&*+>B8'H6[=5VWG7V%V(<8-;K#WL
MYC(]J5T@UU3"^NZME.NL9A_5R*W?X6NZ!GYOLL:0PT*%]B],\J(VG-(^HP+Z
M-RNY\9#@CN'R7Z\_N&8_\A\TQ@),\!=OVA5JQ93)<279;@EEFBX=A'Z'+WQ\
M6EU_TS$O;H27[.SA.Q[D3?H84$P=W#I,8"0\6V>RF-#W33TA[0C5Y4S 6"4/
M4'"L&QAV"9K>+-:1^Q(P'"K'Q2YQ#^>BMS+_M@J#CV#& KJH!7*H,SYZFU=*
MZ:[S$(AH9="O:[K\1+GL&#U(1'AUZFHF@E?M>'BHB(,$\<:4 ")GMYJ6/O'^
M(0-*\L(HL C>T4&=\]VTO,^6X;Y^B:D-(Q90+HT'OUX=O 12I)VRG71=#XYA
MQP)6=':G=Y.IQ07'XV-Y]:-JS_#LCHPDP[.W);D0MX,D#H?$0Y3#1^#778=[
M<#>%8N<'FA8^J1GJ<T+U"8PW^(W^8DWZ$E0V[J[*)U,MB+),]QQ+N'MCM>R$
M\1!,W0*Z#76ANB!(!#?Z4G(N*8-LOL6*/96*S*C%NYYSQ9,C\S='^:^Q+SPV
MG@T9/!@9J"D-* 0C4W' >@$C842E><:T;1;BJ7(2P=&'!2Q;8P'J8.0)/8(/
M"\AK0?LV&=)1_N%3?SM"'JV"!6SA LVC?W47+" <<BF!FYM)<.<()@,+0&P_
MPQWR%]J&OY_N:YZ!4;3:Z!<?*3(6./T!P9O?([I9$>Q*_[<K>O] 6]O#,@BG
MGT@IT^B]P=?4=NS9,OP4E?FI"* ==<^7VO;7G*:>KJ0]G&C7%QQ3F;KV)M^*
MY[XOT?8K\*;.<:[_U(HIH?*2TSUE4%5T3EW"] NT@KH**B;T:)]C%$V/,!E6
M5BCVE]DC:@=D'=A:)/[X'?/"[_B@RWTZ,DTSO"LTOZ#FSJ9O$D68O_E2YK7/
M.S.>8S^-V)PN-D0N.48:S1"V!B+/_(757E. IHW,+UO!J6@)T.V)3U^+/=0J
MGY;^VDDZ7 @[L)@45RXP[G<=-ZK;&K5X!P0 H*Y(OQ4AA$DJH]>K\@6#C_=[
M"PX5,Z)(I+Q7 QEF>\7!V:K9WMV7%J\8ZN)+S1X[Z_Q,)\GL17/8<22K2@S;
M*V\$??*4#!JK+ J@5*B>V,O6CB$G\,0"R+Q8)A.'[>CO;\6!'M&VE-=*]</+
M-,$?W_77+$H)#'B++:LE%M@Z&V[7Q/_:)F65%R*ILFR]6(JE19%-?T.T= 8P
MP^3JRL:=[N^CW'E"@IT4VA83?I-0=?/INZI__CV9U^>WZ2/_@8NQ"E$:R6BO
M$[WJDD L;$4 E@%-87!VU@O!W6/3+2P@:Q4JA@1E*19[#P]+!<_^>EZ7=$'4
MF(]*[GGT#J67Y8^S]7C)"4S+Q!]:'4-0FQ@#Q8L[M-"V+[=+Q>5]?!C-,F86
M2!/1SWJH4(NDR+23A7NS/5Y+36IWM'DEBM\%\:%9\.$[)L9P=8P,=<NE:^QY
ME6\U%.>,ACC$=/:'JD^2WD6'O^CEV)%U\.>\*'>9//R]T=BA5J@%LL&'"1I$
MJ%%V?7M=V!2O< ER_@U*#<]#QU"S7(+;<$;ZH&EAF3E:L&9QMI;SG>W24W?3
M X=M_&:^B.F23RMN!'?J-16.Z(,-5*A#(U;K:U]A 6]#!Z,5>N<5 !@\8 R)
MW5G$.;3M$:LD.8+ 1)0_N;P@8HFR=&)8OO8Q_:!+VAE(G1II=7@S2:"!G/#:
M+/\ #>'ID[#U"BB5FQ'LKG"^84'E*5Q17*N/T.&9_N&JY<U$!GS\:EE%HT>9
M"%#'M._7IDI.SCDBB.@RTV/9K7=2OP]B?O-ZEXYW8R8T*Y6+.,)*'X,;&.UO
M R_!=GW=RFY9?%%?LT92K#-4K8T3?-)3N;F4^1Z)6%V*PB9U'PBB'((%=>.?
MO9)Y3ZIMCH?V@PT%<HQSB4LL%PWH]2=]&K@+I9)QS0%GW!;8Q3Q$)F:!J-U-
MG9J"NB_EF&*\;N=@ 3ZO%]^@/.CC)2@2;07*^D(2HG)RZXI6 KB(#-M0G_A8
MF5D-O/LPE%(*P D$E!CIX\94$\O_/3IL@2WZG<0+-GR!3? ]R:=;D)\I!FJQ
M[C5Z0NQF"0K=FV/$+_Q_WV&(X8.)E *7U,*9<Y<W#PQX'8K)^X=Z:7K;8TO5
MP(O\6FK\"\]U['2R^ST@?ZFELO8GGUA*/M.99)2R_,@0P2R\XKF\$-L/Y#,
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MF27Y 7@:<E2Z59](]RIA*6B"^"C1W9?HPM'G* @?L%>O  0\Q)L$[LRH7]Z
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M4P]9]C(F8^":-7O_;MO3YQR'\QO95B,+T&=P"DLZ]:G#BXTL/T%_#YM/]G>
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M+/BDSWUGD@&\_;P$(=50=QS<Q4J \[O^9-F(^$G]0ZF-^>M )2#3>:D><8:
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MW*?\W'.]KUWEN'C*<:I8\=M.3[%WMTLFD[UZ#@GM-[;M@/@(@D*X["Y2]^J
M43= $D3_.\;/8T.ZU&4&QC>=YF@3@)G ),DVP4@XK)45(M._$/I$.8I%U.H]
M7 YBT7"1YLVWF#RFJR_)$Q S2*J!OO9J)O1"YV66H\.\VDY/<A6([SBQHZ[:
ML]"9AE*KM"SG*L>WA\%QWD]\!RA/O*-'THKC94AUH,_U@FY1[L?Q]2^^,S%2
M^U+&$C-17L9#MX1@F*M:?9JA=EWHR+S ,+4\K0;M4H=XTRWK[ZIA;JCTQ$IY
M>:!1[3<C-3"W9]R>QG9AFHR<HZQ3-FA%Z [PU$VJL[O!SF_K4I/P]-% F0[/
MV2&!O<%;,"REF[\BOM8/IPM*0#+0Y!G<[7E+LJ*A/$:L$L B4MGAE!% >3O?
M>2.Y_"N L)&=T?$,IW=3TI,I\.=O-T=Y73QA[N@@]NY([=_GGSS3,3=TU%32
M9$#V$]G8GM1F74"L)7A-SP#5X])L<T8S8Q%.=,)(SKPDV%'[=7# QTDBI)4V
M7B<]B/['FOF7+18QJYJL2-?!P5&? 5'$K6QR:?&2!5E-#"D1"*TKM^'AP!MH
M+=\&*I?7+#-?9/PU:<->M1FTJ'18WK?Q[6( ^WSW9?B\>K3B=],)[X=-^3U
MW&K($WC9I5I5PZ\/S'^J36(Z\0J*' ,8"L3VI@IR*>H:,R?S*8H_=$WP>H9Q
M8$AD]QU3!51R/E5QL9D+WZ+H73%P7$%E$I2'\:LT0*7T(T7STGP9/<9(K:^.
M/4J.!IV2?"JR%[ORA5(:K1+IQS7^SJL@W.&\/_VXCB+9&#^BF_A!;T [>AF^
MXC2[2+)CLHO @^'PZ"LVVM_Z@Y]C=K/'F_E#26:C7F[(<L>FS'^)R1D35<EJ
MLL&N^-7WT<-/)/2$@,3K6=V-[CS<?<V<>FN_HF4\?:#7#[7?5K_-<Q_7[9.^
MZLFJBLKXTD+B5K9I3WT1/<OLSI1&3M".0S=>6VWH+]!B4K$C4%-*V8$.=1@J
M.;'Y]$&I!-"N''Z!L/KSLI3&/:F$C;?$T0 #=KX4Y,7?X+P?+<,9O^3T6G9Y
M;1)[K<D8-JAS3!!ZY"PG5XSNYYVBH4W-.1N:+_A.V'^Q62<T4+G0D4%&)3PK
MZT+*+-AIIRH*?^?:NY-!P1:[YX#BA0Q:S9LR\"I=@"U"U]@$+V!ZK(J(ISSM
MQT.L7G)5_322[\E>G7:*HA#C(+CS\K!T!]VLX2RQSN %A-7LSY\4*M<M(>7;
M%66O]S#Q_-6YXL=?F*LBK,>F$)<?%3_L!(K'+RF#9L5M;+(NE-?7M^WO  1>
MK[Q7Q-@/IY&Z%K063=V</$\P1H7Z:.-_*TO*I\0ULG I:_R' L&G=-^63CCG
M4 D**NO=MM59P@%NLMWK=EYX],,C4+X8K_76 X(,.B^%52(_+5V@TF(SB ;X
M$.RZZ;7 <46)6%J'OD?%A'[Q[W\)R:0<UR)\,_\?M1>=!MG-^_+E,W/PW@KX
M[&G9%T/8BVTSS64SKI76*X*YO_3/B/5O[>[3Y^C;OZ+P6[ZE&7%-!-G>-<-K
M@;;[<=?2;_ZY_34"AW;;P4&2 J9<;$/Y@[7?SDS/Q3LA.P8// OW6EA:Q;UJ
M74_+YW_]?$U6.^#O._/K2-^V1V0SH]OEX@<56VGP9E?<]:=&VX!D47Z#)PH2
M'V\D3RMY8OK4/V7ZI!+#9^2M%:D7%"D6JPWDMJ-H?DT['^$LDM34-Y;'4VWY
MGCQ@N.ES$[L.O49K7V0.0WE5UTP5D0 1]N>J:>%B(LOG=(F6FTB.[=$%N)&S
M\I,;R=107'_ U1=[_UT!PNN;&3:8L;*YEX1G?N)#UC PYZO#;2DN.(^/FNP4
M_?#DJU.5XK[%\(O9^PF(:U_AB6ON30*V^!GYW&69#H%# 68#43\9:F0P:7^(
M3ZTQ6OG0)VO7+.UROUQ@ )S$H]7O?64M@;?:OC;@U=832&2K(&'.1_?#7 7J
M'(D3+5F<NO&SBK@3'T2+5 ]Y4[WNM?*,:)3R+B[D4TR.E4:/*U9O;V3H;Q);
MH['JN&QK%XW CJZ8'9+10 O_>#MQ"+R>.C-(+.@LWM%H"&SQ*O[6%4J@G+X4
M+ OC"*GU\-Z*L/D\L?B*Y'D)A$XJVGFKU2C#\AP2I"1GNXS'*U='=DJCWOC*
MI7?9 \E;S+B:HT%1+8"S0.-,HJS7:ZYL8%B$,$(.37.@X-X^A\!^+9%$ZX&G
MJ_6G^I[.\-4H0J^/M15Q^[-\1?H#9%OITK?C-<( H2\>ZTYK8E8@$_$>#D(%
M9[%WH<?-K&L*VPWJ4U5S+K[?'AVX,CP[M.LZ/.J1GF[D($)(C_.RB2]:F>GN
M'&:?TD?RM\U*X_;^@I+OS8P'R\K,ME.>S3:/#(0>$\#U*8\R,O9O10:@"[,W
MY><+MZSC"/HU$0(R[<:V/)R"UAE=D<]E'D\\H\#(:J+<E\7E'4U,^TGCR@JQ
M[X.8$S35(AZ8F@IB8ZJ C PT(5XFD8_7_27*M3MJ'@VWT^MN^V/2KD?ERG_<
M*%<M).=P3R^5=.M).\Y7TIZY <E7QQ*Y\W?'?$7A7B*"'5U*2(^NB,@::5#2
MQ9YUT2!P%O?SN@/V=\%GQ^K[9IY:PY]0"#\]0]($[JA]!PCP[[Q(AL2L>V?*
MG-0>S@4QE&%X>&CDFDY5\2OP.:'@U!/G\DRX\(ERAO"R=S*'J9T[ L ,*S-<
MG@ZR/FMLME2_*DL9"(CV6<WX@63K16!4B+-;<A3!XQ1AM_E'C,%4,6_[$][Q
M0UJI0'2+$,W1JJHQ)U8:/BYD%'8VX5@*'1="$;2F"W1):TS=6RI9>N]UO-9Z
M1>L<=0WG.[L'\Z QX%X'P>W3ZM,[0.0=8-U]&KBW/#-*2X)"=<#W*(^!!3S3
MF9J&/S<+0C)&>+ .G]\!PJ8I-8I?I 4&7X1*=HZP\[,?KOBHQAS= ?;*HMJ1
M3"W'"G%+"ME4.(HQ'V:HAO);,,;:SL\15F2*,OII+"4OV-7.A758J;K2F2::
MV/)N*V[[7[MT8W]L"AXEL-FJW3#0]3S.UW#O+Y]XG15<,6(@A6A7OE:F=$CH
M2#.7D():934UOH=W6SN2]!?]*6W:H^)5H*)CET(+%"6J/U]7/;,-6YJ]GDI(
MNPW>\,XS"1NZ,3BH%QSAQYVX4-U_\2WOH'!G4EG2],L_UQQ(?5?O %?HW7<
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M+?:E3NQU+S429BZ@UNZVI%T$$6/ROE._'+@),*/Q^%2X?'9)"A6S+I?F[>X
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M<RICQ?G*+?N\H0\?,RI:+FT124[)),.SU1L:[N\8OYO2JFC_(BZUW+KVDBX
M0V9R342%<*H"S\Z+CT#@%W;7&J45%G)P1]/X),9@A4[TB?&"MX4.E?[1=WU!
MY1+^5"J#%QB8X]3+UUQ*&JGN<9&EQ@[UU[WE<Z8_O!SHNYL+N04*WKB+$Q"[
M:$\9A G1@@C??K+],G3$[<-]X&,ME1#[0[KMVJ/8=&AZY,"@-E.!7/O!_Q_X
MNC'?(PI7;&L6:+BNA):\+.L_ZPVH4/<\[=5^<H_1^$B3T+M.'Y8X4?YR-#$A
MXF6R0+2B2RJ)++7TO?*\8DQ=F$&8\+<O]:UCKWR^'2J'9%N?LRCWGPM7<^8T
MO*D6+QIQ39*B3UZ688(K%D.;?F].T&M^P>LF4)5C]5UV=?7>+,<<:TE82?JX
M#MN(8!G<L^([5+91W*4A;LQ?BM><()ILR/46_='(/2 =FHCEQL?%9*UHD?E:
M&<GE&9FH8UIAC,U))+#YK4EJ&.H4<PHBVA%I#$Q\W/XF>,@G^M4P]U-,<<9.
MMUX7$PLB*1T?: R1CP>V1?7<X'KR?9'BZ#O$TV4N'\;J3LN)MF4>!XEYF# W
M&$:\84ZT&C85^/14ZHU-*K%J1=ZVI[%TM*=Q0*7)7/XSS0U-[8!A85ZMM9H:
M'KG \>068D)$VHI:&F,7%4V.5I7M^1@U5G!:O"AW_C@;LQ^CI>X)<83$#2!L
MC[3G;EU#G0:3R6>>[[YW[HF=E6?:!-%^9< /CS<T=?!>>_'SQTCP5$-R*ZVW
MHL]S</9#RQG6.)RU$FQ;FE&7ZM'/WX^T-_+VO!5KRG<6.2:T[2^,?<#]Y%IE
M=]9.]!C:DLN=$0XKR6B7D.&8Y+"_BINK_>2%Y;K\P5V5<V;/TABV3F.B,+ZT
M?%MG>5%9CH'Z53I!4J65J5H[.SUM]&.D4 R.;L@YZ/R#P_(_E#VWBQDO<.9
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M;S"OFM]\S'T\:F)\G"]!9ZSD]-YHO&0!J97^#B;[2^)-_4(*/7+.]^0$ !R
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M+M<ITPSN\4R*5.+M%^_[Q:0(IH&B/<0$O:ZOG[4E"H+%'V$$-G]_%TBA2AJ
MZ_&RS@:D8/-V=B.M?":@_'F#$72(EHY"YB.#;$&S I16DV!;2:LEUN<146$M
M!79E8(YV54ODAGZ;O''D<3G"%$5_RSZE@[I6N@%TC]X \"$_VH[7BT!+!3<
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M+'U)H(IQ+'M<R@8*QK2/VTY_0F9JV';'^N(WT;?)&T"T;_"P3+.!"WIWU>D
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M("9_@NVFXD:I]LAKTDN.@)B(.>/Q9K4;P#U(I%KS7'-![N<-A< ,,J1LY9/
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MW8?,_40@D' G);0P=P=<8+%@5OG\@S'4^E/!K#<U&\6VQC;=NX,.+5GN7\X
M^D$?@_:E"RR[I=,%X F9,>2!<']U.6YN8E.E2H'R:T\<QB9,;B #SD@*&^U$
M);WXT:BV]=TF.*T)G+=REBH(^C):]3K7X#Q6@A(+%C5LWD*DI/H&>/<T30,H
M:01GF%DB,+#4\*)+B#=T&S;W3=EKI?%^O?0#15$+L:O9/[&7&K-,??(S0^;]
M?<3:M(U\X<]]#$6PQ$9A(73<7P2>%#(RCW SL8])_L4O'O$5U*BBLQL4F%P6
MULY(:F'2A.J:9B*QRXBCW9]E81+7!H:$RH3-99Y$#D?)C:U,L4RN?O_@@6M@
M/X]]@79XTE=C'N*).9&ZIC3.OIX"S4[9N[Z+482U'PJN@[8=*962AKTK/QA2
M_+SCFRBVW>UM$"4$)+&58:FLG/+0K+48H!'2N<Y2$>'PQ!-]@O4RR/NT/*^X
M2P:-O/M51]MV9XFOZ4[=F0\MI72I^/C;,KSY>K_0G"8NYD*=JF>Z']IF7OD?
MM@2(5"ZCA(E[8BRTQ]HJ@%4U^$U P>&E,Y\4Z=]'\+2<6^U0WQKOPUZGB_>@
MN5[46*Z&Z21%KS$>>1I8V4\MQJ2CWXE^[>Q<9R9O+GR-<^=*%L=YL]RBI_D&
ML*(9Z4$U>4I,M)MD0&96+-CCF,N[,_ C3T/SW:HTN-37,08=WTL#42W9MX(U
MWN==Q;1@7.^=WFX)YWML+H\PUQE>+S\1VQN8GN913<OU)BI='=!RGS_;R2^V
M>_'V4GTJVPW".LL:]W['68*X7#4P#>14M%T[?5;>BA\^]4P:INAS?DJQWD;C
M<;PVX^TZM_'%DVP([993'Z/8V*;7&6I(PH1*[+6S/M*%(KD:IOU5RNUH%K.+
M%J5SN.<<6D=06G%'SF1BL]EB])7UVSK(MY.G/%Q79%>2+YJJCJ6N;P VR=D+
M8#[J6467A(MIC^5K@+=]YYFQ;6]J1*,KD6Q<PSL_FP][7$.!DJ!?F+<$"(GV
ME+D&?9TNSAF'#3N4G7[E!)VDVKQ652\JJ^C".";26WP&O<.B_=E6>1AE[5N<
MNA@=JT@YOP;."+7Q;WE^O],RCO:DGQ@@:%\R>LL=6W_X9PR;XFJGSUM-7KAP
MHH2S8H&#6-*#+>0>Q$&!%;]5VGX&[X\KU1&U(XMR"#YI,M1,^\M53)\<WK%-
MJIUM6?-*<=?J]C\[U^9+2]3CU9"U;*.+2^47KH.5HU1:$_[HA'>;U@%9W<W-
MGS<R+=MR9'H[[W<_DD7K>'<TDEPG/U_WI3=F%UM7^OV:IK@ZT^ZOO,3%9>)(
M61W$M*8Y$PQZ!+J'E&V#M>PZQ*[\>MHP*UJF^J0/Q;(]+FYA=[:3$K?^)?2S
MS2"AEQ(%7+XK9N405V+N.=S"_$GHW9C:2J*2]EA%'&KZWSJMU"9V]BL/RCWL
M=P>*HZ:./YO^'-*6B8I.F/!?"B^7@3\;7+T!1)[-"C<06KU%R;[Z)%(^R&4#
MXY2DXROUB]9B?I*C56 X*E<4V^Z,K9O$3>Y;R5$G$6M&&;R5%=FUQ=^L"37A
MP]NJW!$-<V'D?A&*D1OX$Y@L'6K?_U!& I'F.BXO:6BK>J%3WTNRF=$K\&0S
M':*:T#O,%X7B,/)V8>%P<ARXZW*N!AA[<BK6?@-XCQ+>%]'WG/7X+.+YJ40$
MEJ&\:AZ)[90KEC^9.N61,WD]B4A'>P<LITQ-B>DN.\?&M!$!-,1I?I#>.JD]
MWMW*C7 K8?T&E>4Y_8#SRF;1R-<Q5KY__ZA.]K=U2V>%E-%*DQ/Y%A6-_TZ6
M=F[&Y]C7G]R!&KT39"IZK0F36 7LQ>.C*<8!U[6%K[!/4XMYFK?HZ35<@;T5
MYV5D4,90I$[1HO 9N#0 K!G95S(24&1X_LFT8C8C./&AV[;A$E9-H3F/DGQ:
M:KB+%*?2 M9*[V8=>K6&5MVN5GE42\YM@I<U3?QWSJ2QE\VP#!;L!A#AL;1/
MC%"J >W= -@&CF\ 8V^B KT<KMYO/G!LK=DWQQD5WB?6: BSF+@!5+/%.XRV
MS3(GV2T36+4SI:RT_D7"5,^VU8;TR<3TXUOJ[@\3WN=1PJ7Z<ZNLR99W\WTH
MOLT;WZU3F;%\:?B& @='>G>DV3)WY[(G:"J%Y0;PVXD@LM-)''JAI-4@*[R.
M^ONQN.H3K;<;.0VIXP?^ ZMIQ%TT]*<EY@\G@=6L\0*CP-L9;>:9$KAMFT?D
M>#-"L?-J+-W\H!")*=KPM12^?=PYW[O82=C.K@)/O$N<_G) J6'"/^)<,%^5
M-R?)_K[I?(>- \_@KT+R^QPV<4-W/LRGP!W4>M+9X:B22XN05RE3O0=5A;-S
M/A=I:$.Y_YO1T=YMU;KZK)'E"YCL_ED_0?RRQ[,>G/^+O;>,BJ-KMT4[@01B
M$-PE 8)T@!!<.T#P0.,NP1V".YW@3O $=Y?@P8,[C4-P=VNT@:8YS;OOO?O-
M^^WO[!]WC"MGG!\U!JNZJ*Y:O9ZYGJ=JKCEO3H7OQI&7[1=/7HR 1F9SFY 6
M\^_H4V^Q2M=,24XI,,8$!]];8YX(#IK,2QW3&]4*W @]VB'""3[T%,\\I" D
M_(HVN_D:>UOC(A[)"_\(FV>^F'6L^/5FSBBT;-[81CY-88]]IFDRLZ[&YWA&
MR_);M#J=8AE96 !&.3[3Z+5FNJM96:"X 5RFTUF79=1[UN*I(HU5XL./FNRS
M>8;3MP!_8=@3Y/MGILB?$ 5=X^5JR'W$QX3W4CK%I;3/'7N-G>8IO5JI<05W
MQ[Q?0'J^W%$WL7<8[!02:UI)ZI3B+M1XH7]884?"^#4GK(2HM[DFW5/6JQMF
MVW093(U47ZFA?\7"!F"WU?S# I7]#__E(KU.$T5K>55![JY$N<KB+4O+# LJ
M_08\X'?/S=!UP)KQ/<%NRHG-6P *U.Y>@2_> N* D<A732$A79SD*E$C? I)
M#0(T'7P8$8ULV<TY^?!./^E6 CR%GRQ[[DP^6?0^$#2M6\ CZ^H;12G.>27U
M<?H*V1'AIU/V;QM.7RLG/[]'[7$#Q.C@OJ#"\Z:>W:IY:_BAUC[S/>^#>Y?K
MIYNH4LARUO'ZB1<KN+:\*DS"UI8X@O,4X)VW4%WP*LNTX4W. \8ZYJBU6P!>
M=8EJ^PI6C+5IP8*65E,CW4J LYB!\2<IP-(1  &<MOS'[+Y_1B!$G*AHFZJO
MJP-+4AEW;-"AWK[RG\B(6L>RWC"[^,C"[L.NFZ4K 1M#"IR"K[:YCZ65O3E4
M7\PD";*^BY9JY,V5 5;VG$>Q\Y/'TSV4$AQT,^UD=E$<17CDBED7ZFK.))FE
M2JZD1&$?ZM%^_N1*E>,>&0A:4Q^%[/91W0#4PA"6BDBN<C$2DQ]A]PXWI%2D
M=(T,R)1+&\,+G$"$"-F&GY$BWZM*[M/_WF3'-W<]D*#]ZJ;PJV?(?4)KT9>T
M)@U/9YMTZV>CKLBW@:>+XG-N5RM-MN*CZ2,<EK)<T]X["V\^7Z5NPGA!X;HY
M^YJC_-C3C$"HJAOK9V\ZR9K:>DCPAG%\UZM8;4FL\\>?% *=T6%S$T:!71!\
M\KG0F*RMIY)AC*!&DE-T$NRZMC6[",MX6-=7%F_FN>VOR#U=G7<92>GF!&\A
M7)RGG"7%A%Q1FC,=Y<*/_<+Q/Z4[$CA8<,6J%@\EQLFT@<7@J6SYB%>PAU^>
M[/ 15EVHX83O116) @W3$IZZ4%F%W0*$:I<C(XQA8K&3I*&LY^&9 0L\)UG;
M#93IJX)U!%L$*Y1876FP=L7JV@<&;C99,]A':S5"WQ6D9&;$3FQ"[)3S*'6^
M[Y^MZ_+!XQP(T^LQ_,$IGGK]\:Y3WL2P<@QGJ-)LWE@UK+GRE>_2O(R\__E0
M^5YPP%N*('EQ+_:TMI]Z/DC*T#T7H9=UD4X=T<36OW\XYU\/"#ZB#;NFTOQ&
M&Y/$4IR]5M!=($[EUTP[A:\-]]7%D5ZK"P^5ZP$+'..37^$*;AL?881[4M4?
MMB?VZXI1DJ2+*"3?NP4(]#)-;X;%; %_;V7-2@J58"5="!!U@G /SJ!8TTDR
M22FL2@'.6OG[N6;M]WFH?:-Y!"@#C\J,CQI'YUQEQ!/-*:6,RK_,SP>;&))&
M2PE*E;V #R[W<-PH3FG4//:YMA\*2<=F^^3B37URP+[09-N&@@0SO7/L6E2,
M6ZHH)41QB%':6M+1] GQ0GH<I&\!92:HZ"T2587E!35:%PUFN3+JDDG^C#^B
M"&OGF6^ XY]W#]B=$:3!?A%..:;?HYW] 7"Y+!I'T"_/VCYU]9YIPYPPGB9=
M_K4AA7D9#-+%2.]4LG@3ZO$UBU$E6J[G1.$(K-BHQ)6Q0LLMYM;!S$ _9O?1
M[C DPTE_M24@^LFT+>G%!^*WUH:TZCW$* 1-OO?3ZPY"DVCM!O$ZF8!=.RI1
M :)HXSASRA[F3A.DC1QJ[5F\MP ,UWIHYY7$S)(208>Z5A VHM+6<(ZRJW;C
M+:81&X/Y_93T4WIR-?^M<JDE4)CO![\84P?JVGL1+A*O'MM+R,]"7O)/-8R/
MAX2.F:B0U(F/SE-QN5HB<15@E%,@*]*TF5@=MZ3*'S7:H&N>7J1.T38?0V;V
MY156'*M)8M-?;]K^R6K"3OF'5/.*RI].A&>55 'T@T:0CK2,##%\M5@OZG_'
M'"486)D9M0P@48]*CDP?]*S-1J&DN:M/V^^>5QL[/+.?5C<^\2)VM^?5"4?*
M/J/'V%(#(/66&V6/(3W+F9 I!-45FV5NP,!*IR5#U@[IG07"<!DIO'R5N R%
MTG[N;;(C[:]LYAQ9^*BO*)L1SB5I02TXXO%T(U7FPLV@UQ>/(>.0BI;]Z_.K
MTR6!9TMU"+T"_H%]RC0T-#M6&!NHK7ESJG8-6XS!OM2-W&FG#F2*5@'G7MY^
M*9/B[7I44> SG;H*XL?NN <G/4L,^5<#P_CRY+H<A]QD_)>9!"N+I+> -<Y<
MR%3#W;-GSC_;CD+LK]6.?@_!R5IQX<T')FZ#37'- KWX]P>Z,[^<0@6+3+LA
MSTH0G-GA8+F&5'7"=]'=0J/M@IC43T]F*79_P'F^>)+PDER6::==+V.<ED0&
M/Z9:/B\F-K(2O93,K7*BVV<>[N-XL>=6/WU$0=EWK=8<*%EA^NI ;$ _8E29
MZEODN;!A:COG#O1(M?WZ]6OW'.AYP(*.SZ58RWS7.X2LW2W@\7/N2.M@:/_3
M;,@B#[+ZE("@4/IM!2%IK"E9SZ4((PM'B0(=6G]]U;<W&' =+828%V>))6,V
MW.)0[<E/L7MQ! WE5 P@Q7=ER8V*&9XZ)4R?\?6& !08AZ1-#=T]HY[,C<J*
MD@$/?YUB^2%]4E1<</1G0U+J*2FL'^:LI'B]4+-,$3F6TX$JC<=L 4C.[S=I
M0I=*O]5,-TVPK"5'-F$JRWO[L8&^E0*7=<8)F_FK\7[H\7&'O.U&LR/W=NT>
M#[G"C3/O8^EQM9!/ULXI. D,%\!S6KK^*?J!Q9H>HR^992QJ0MUHZ02._.B4
MALHEUUX4H=(-AEM DNI4ET>^4CL75\G Z'SP<].*HOL0V!*(M//O>G]),7'
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ME:6<5>P6!X,*O4N!<T7]S<RNXAX]F;!7W\G(&L3N+\O;RY,'HM7I(A>EQX[
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MEQ8/UGM%_ YJ320.\OYVT(']2^TC\BT<LK*-*-$<S/CT)GI!K))W!RV+W/%
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M]'*_ENL]JUX 7H)@I-.K!+-:/\581SH=OS#,O2')2#@DS3W40(U)V@#W;_/
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M_[IW35+N\T6O0;S&>3[=E;?UX&OD?O&\6[^6]>AY)Y4E=$*C!1=9OC(CB3=
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MQ;N,02=@%I5!-@VZL_R$)I(G;^LMS@'59[.)>TZ(18L]:"PECJ+>#@>%[E)
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MTNE[W'(31H*%4$MCS3 * ZL3$H$7G7=VFV]\^!+PN2\_^HMKF[>@=K6EA94
M1)K)SBUUSRBX)<5.HU_J[M'$F_9H!\XG9"6& 5]0/T*G^X5K[<C-XVNRBI\X
M%BM3QH2+<?D$58/^X*PEF55*&D[8GC2.%'TZ*O/ :L(#LE9Z?-BK7+!9;O3Q
MG=M+4K @UK0R8C&&[^'-1AM]'(&[\# 6KPTQGA;G ..+#4X]KL*9^0:J+^BT
M,I>HCF$S[LQA:$M<LQ:]6=C^D/6IK\6H2$1&WZ-5C\ACVH42N*&NGD:7W'.!
M:U+DX%?HTF<5"<T5'JD_>-.J;@4#WD0',%*.^1, HXJ<(#=LE^HPGEE2K=T*
M\%MOM_,W"Z)> H"!SP;MM>2U/GV:%I=,A%'7J11@K-2&L@9Y<3_WGG6M="MV
M$():2!U&16=I#B2O\=FP[?&LR*(;)N6JU1\'=!2!(B&[U_ *][L\MQ9Z">]X
MPM*A8^E0KLQABQS3QVK.1K8#*S%@K]??@WN2IGY^W;TMZ0IZQBF<@U0/W7'/
MSXZ85[GSQJ-OZ;J.<C%VCCMM2<VMU^.0>IUZ?I91J-O<=K]>68A$"CG_R?<J
MJM8E=J<3^,Q#DXBN03?XN4!F]0+'F;I%^O<Z?E=\Q!OHE%S=G9A=&C*%T'V=
MP8F6&BUZ/9(2^6F[^*)8,Y!*AP>B53E0%E:DO#K/X-9=B?C*O#CG(T3H,IPV
M#[UMX4/U353B_:]HQ(AAVE4E]6_[!])$2V \'+T^%HFU<&>3H2\5J6CF,F#3
M\H76LZ)N2C_TYA9LKM'9:>6CGUKW*"!_0TXJ]ER6!$O.F:,&I1P>J],?GUBK
MT/CU0O:CX:-:DP@B #3U;,.U6UW%^$M>;T7>!&=T^QPTI/+^LLJ\BU^-M8W"
M2RBZ7UX7AKN=\_Y'XG(2;D*XFS$L.O*XKZ\=OC%:7Q$*LSS)U!L94^B31MFU
M&H-:!-DC,^CU(0^/E>RFE;T)I,E*L!O]!7UU)JCOS2UZW\ 66\RP=Z:7EN)\
M]-06[^%X4Q-7A&<,'Q]:Z;_<8TOHEDTU+:J>)*0SF4I=SO:J;:GQ6E^'NB]!
M*+%OYOG(,-F#[8J(W3OQ VSW%]M^.6P+QFN-$\// 30P[%EDJ0Q^Q>/C[FSH
MV"?(B8CRD<%(.6W[$Q/:ZEZESK5EM^&)OM;ZNX+"TR%5\G36<E2PJ.WJ^1K8
M):QR!=KT'/#K2'=^2/-ZM8[:<PV)K7W6?ISSC)ZOV_H,B,Q+WW]%#7*O[./4
M9L0[0LH 7^EW2@>=60S:->6?5WH4!M4V?AZ=7/ (7T"O2U4['W!L#:B*D%>Y
MX]^W3[TLN!Y>5F(>8W>0:W.)5!0>'TO^DT*W(#LVYEEOJ25I1CD*5V\VKTI/
MJM8:$JI&Q["CT)Q?6873E]YXWF"!@GUP5B>$O+!498S(MKSV8IYH*9$Z\3I3
MP'VB693POFU*KJ%EC7/]V9=T0_=^B8?[,@WOG5A+<I[#6'<Y(NS,RZ=*C6A:
MU<G79Q@&K&V%DN&EW3QM[78\$.ZR+UX_QCS!QNAFG'R/**ZA#^=KG@D7MA^S
MT;)AZ@OD*W8&75]SK71P3Z"<+.@XE9UJ<7@G1NV'5H$,8\61R58]'"N;>_7S
M+7U+!4O*XJPWKJU?L<+0X)X84^+J*8_U>-"5N"?=H--KG+BPF"_/#^,Y;/)%
M=\7K!;4PU846_;/CJBL&/Z]''$[PRK(YL3!_'2EU1$>.>'6^W-.3OF3(CXU-
MVL+10SLE+^K<+P@7VHJ+O^2_*#=]=J_RMS4"!<OP&!7GUJB'%LJTBWL'O0Q/
M?2%-F+;HS(A+V1CE[F@0LXAO&GHV0GUIZCB"\!LA;U5'YV%C^_"8ZYQDM9T7
M24:?N GGKR:*:34\<OBXH6PAEG=G\+?U&?\U;-O0G&T\/0>\2Y- E-.5>0Y0
M7L8QN66K4V%><=9\E,;>>%UUQSYV6 1 &+VVHRO#8IS,!]@0\">P<J0!;7V$
MG0J[Y33SD8L&8PTO*4_:\*$O9U41<A+_:C?!]HAI+0>\SM.+*=1[O$9\+[U$
MXE$5C,FM$RN9NUKC7> G/3)L P+,D_YXN BL[^A8?#EF)C0PV<BV)_8TX_EV
M>[JO@*I7Y7R]!Y3"+7)/[TZ+@NS'<\"0$-VX="0!R&AT^-7/ W$T'C!F;YZD
MAL)-'/B$3JW2PE4I.MO59$&CA;J<?T' #@9C+? ;Y@D\-L+HJA3':AZ]GQ/>
MU]=@UHNNV>DS+5W*$A7.97I?%-$%S;RG!I-:X5#WM&<^D5;?!^I4,MR"1&RX
M-8)6[!Z$/G5FSE*[QHS)1K+74%D^,N"P')!_!Z3"FO %[;L5EAU76(I6$PQ'
M#"A(5)9P^D)GMN^%&Z5\7!&^ML<O98965T=-#:X=DH=M*=UD-"-_XDU[P#GN
MP\;,'1.T,@\+^Y!**!Q8X-6A36+:N&@"DB3S@8)=9.B\I()F)H"W-JYQU*1X
M=9L;F2KD9%1XE&RM':RMEV=\>I6I\Y/U^O!1]F8M:]ODCUE*FY('/O<$!5)O
M60H"!SX19^&M:5\4EGZ-YL,#U9;+6Z2.0,B;.#'.R&.X?:YMD<U.D6EY32"'
MO\X$NJ-:EWD^I@ :0MI?V<@13D:,65! 6XN5?FIUR1 PZ/%C.0+.,"],BA7'
MU\V,(7E2@L/G1C;A6?Y-''ORW_EOPE.I1(\D3A<BCYFCM8093K,_36WM;+M3
M@871-X/1LJM)VU]++?I \<GI3PB GR??:;AU$'UQWN_QV'+G:^LC"[&V/EC5
M>=PT\P0#5D[5CMUTP(?F>/^&\76+;=)U+6+QC&-6;<^-]EA9?SB+XLK+G,\,
MQT,_6XH#145YZA3X^H"Y >EV'K]QQ<!_K2;4]\.,*D$>NVP6]XF@X1'E.QBU
M.=1.D)U7-L.=V"/-*@O]E0+"'Y?-<L3WX7J!S&*L2NP"-;FD=P T8HMS[P2W
MP/PHZ-,$'30>Z(3L*'XV,=..#NE,/'Y[=*P$1$D<YH_F*^46!PDQ9GZ9U>K$
M2B_P^)S.]\R$.$(1:I'+Z\+!G>&OM%P&JGC=?NR 2\#42- Q[]$YX.#4$SM3
M/QJ:QU$T_G"KJO:(>%[FOM4)+%A*T,8]<^HLU;5./Q%;[I6GR/;*CTFV>*9N
M\J]=%E6%W0OB7I2KECDS$PUO'T1=M:@\VG,?TV*E YH;?=R4 !#)<G/.QR/R
M,([-(F-)JGV_5CQ;0V#=>EV?'!1HR8>)JU%#.*69J'^0P"@(O\3^8:SS0\&#
M,Z:="!.?"O%I20U,;?X::O:%RO+DL]H,[XJP*N]K5[,\SP'A(M92&Z[)8F+Z
M-E/0A;A5(!ET478 L1%\(#RD%:<B4JW)GSZEM0QUGQ_ ZJ'!P4+V;F%R##=]
ML.IVK [NEQ>!/URP5D-UHO,]K*VZ038"#L8  3F623;WM>@SN;ME\+)3:;6!
M+;NB]"J_D\S0:VM1/_9&ZSA;)?!3T<Q'.6EY(K3](,MQB<(Q<HOR)-SI'$">
M9*&0'?(B5"V+Q[!&&A?:UW_@Z>WYI&R$!S%BU,9X8\5B5?O4_QJ6^]$WRW9E
M5SVY?\?T:34UE27E,>OKID'7$AP[65]I>R8A=W /W72[3!C57=T#_$=1$8CD
MN#ZD=OK2=PZM<!\.UPL*15IAABW!)MU2?;"1@?)81^!<7,;K!J-@.J(<PMT"
M _56"(EE)0G1Q)O2Z&\T6_:;EU,G_5A\.+[C1 00_H6)3[F<KW6PH!03V(WN
M#@^:=Q4.YU7>=I:Y4IVZUTBOVOIS4%VP.2%&]\%/!W>V7:NT8C/D#O8#O>C9
M.UQV$1C3_&CH8-S)L&"'3R,QF@+(WJORA>\G#>/*:+I2M23-=?;+DZ+WTD-C
M9=-+G&=OK_K0Q] >>.Z4"OTH,^ER[6#R68<9C$>,ZH\^$=<E\#NXFI(ZKRKZ
M:ECW=L("$Z'!L-FWH0,"GIX:P:X@3MG\S$L.7427(P\"\K#&J(H4#YMXE>2>
M0IVL\H@7!"?Q=,P+0L-LTX4J>9>+?TT/Z)2=KI;SR,P<$K $N;5\8'M4Y"\9
MH+%>,YJ8-NF=H54?-,K:E,AP)>HKDSI2N?>0:WV,;P#L#&J+(FE:>LZD\.IL
M%:D!0B]?K=PG V)<6QQ)/+FW$E0'KX^95 Y)\1]>'I%P4-ZZE=]8R^$TK,M<
MM$!*\G@8.53.O7-W^XU>)(A]\AU;[I)VY-?1)=4D'J%]Q2A+@]$"8+OV4*Q6
MG2&E_;73ARGOW?COL]K:#R_7!]4]UCD'Q 9&X1I>G@,&[H,+X&ZE3U"#A/D0
M-@&![:>^/*Q1;QA/3=$[!L-Z2Y4FJ>%%/R?7;33!]N< DH)F&7/U4DM/)4)H
MS&<\H(."LIP-B,*=^"@O"4TNN@?S$&)CR+QS<H_HJ)/?QQ?1MQ6R;2;6@I70
M84_0-_,\7[$'EH\L?XE^V6P;>*@2&\\EOGA+<))HM-[VN_,LQ1HS?1"=LR>B
ME.VG#EG\3HPX[I;%4&QXL7^A]M?AE/!S ."%%3TT8'.KO,*NG-<EH^(%*XZ:
M<YBLVV^2NLFB9K2 LUUO"*959T5N+W;*GQ+N1LY/B'_EM_6V@^L,I_?X>&!>
ME&W?VS"L#M\ZQ*0BR3S0-MPXM=OJ)\>P<\"3>B/A9;N2.(BS'.<(4TZKC:#A
MB!1OM/G&@]SOV]65P?'1_.U,AD2,9&O:N%MK!H=Q&3/9152'AWUWDPW=&V\$
MIZQ8+!+&8:.8ZV<*\G^9)UE/1&:(QEK=%.TL3Z:[HTA\?5U>,6/#PP?QDJ^L
M.TIFO$3VE,Z="0_4U 47ERH"=Q4G]B#@%O"])$/H=2O!QZSM#UP$:R3X;Q2R
MOK[&FD;=XL4P(DRJI3("U$#4U)HF7BIOZ;FC68824.,Z!X1Y09%1F\:N3W%#
MYP#U4^E6>-RB"J[2BG=JJQTL^$6/&I73>D(35+:EP ,^W>P3ZNJ0RO'RY<=R
M62X0;<X$.>0!K9B<I+M"FZ/:Z*D:@-XNDJ,V(B+C>Q_8YA;):BM=GXNW&@V4
M]TBVW ;:#&[+MS;L)A\*8)MSFP&>H>UQ&6G*?$]ZB'_WHGBYUB"(PL$+9!)>
M05? '%L#'TP!-F(@?B.?\GK5[$J*&,^+C4NO_C-?^)_YPO\3\X7479BQML.9
MF_Z3SHB);5O:+5^E4F*)$C&Q%<(<J1.]YS^I5?@)9#LYO\(3ZUX5(3[4Z;A[
M%()9[T1.$9P#'C0VX;RA]*.?Q%-K:5]SU=@/N7CLO/>Y.^U6J7O*2$\62\Q[
MG"/J^=ZDDN&JDI0)EKNRMO:W"]YVF_/G3XA1F,B7*0^>@]U41,))#2=,SN[*
MLE>]%A>X)2 3D(,$NZ-CP7$')#8W.>]>ZU=_2,?P905P,N>(&>C*D51\Z1@G
MX34TDDP/:_,6F$%F#)7]VB%WVP.KWQ.5EFT4._'USE<%+C#'>3I\6Q=Y/FXK
M1D&TI^&M1@",<TB]C+$"ACC-;JDJK)OST'6U?/1E0G]4>\IR ]V_+\T-:I\A
M/ >\5WC*RV-+[TD2="_[F5V$;^]-B47318*AM13W^Y"$O+XM[MR]?1G__ZZ+
M@!I< "-:I.2:,6,A*,E?^@YM]EW&#?@('W/YZ66/22UT;;IHP:2T_U$QGJWT
MX%W;H/+ZA[IX$U\0?8Y%L07]^QG5^ (31S[CCU.LE8NDMZD'?$*Y12#DYN]4
M%WL*U]#=0R;3+'8=23SO;'AZN.[G;MSESKBJ0*>K]5$Q-P<?ZF2DNMFD6>3$
MW0UQ-XOVSSV)U=YRWF(^T:3.+C*QOX.[5JS9A[_KZQHAO,)=I=(T0K1(FZXV
MD-0GB=Z7FC-LD6N<FJ(@RS5N1V7'30?>OY?]*^XK5@DOC^!6,X6R0<489O5]
M>-FBM1&R8FNGG6YG-!,-:X%@G@A_P =GF_#RX_AY?)QIOHN.?],F MO&E4>C
MS!1OK>G5U(7L32DMMJ@?T<1&Y8$P6XXPNG/ XKLRO'VYZ#D>H[M.[BQND]:Q
MKJWMOI.W/D..!F+9#2C6(::GO*;F6(0@5.WX!TZGUHBS"71,'HMK8,/%38\*
M*BEE.@W9:J@&4FD^U]?4X7,VEE0EMMO9LGGL/2OSYMF9@,6H1V#\U_!#O?@C
MKJK.()UW@D-IZ3_U]$K>EF!5"F;,/:1J K.3#]%D/0\>/0^GK"7[M,)T]MWJ
M=?0G@;B7Q-'^9(]5;4E%RJ2:E3'=-M[YDP;3:U<'KW]A5>-UW>Q[I-#89I_J
MQCB6J]<+N54GTL" ?E(BZV>]390" #:1Z6!O0F_HP;U$QB)KD;128]..YCY]
MO/:QOB)?O*]AY8KR'TGE:XKGCL3&OC^2^&\?7O[)(./_9TGG0M@_350?F.%6
MCGS,>@;Q!@+>@WNVKWPOO2YV[3=%;C6" =I!#SS!0,ZN%&06V[7-[EX-QC70
M_,YFX=W3/])9CG]+0!/\D9YV7()>I+,$FKWP_DTO\U^2BY%/&<E;V/#\W&8-
MHA)XNI*>2\>Y"T\4CGBTT=K E;K&ZI*T^^Y;>_A'A#--E)P?N @-;0&]&G@]
M\,J!H_YXJ=W<#Y?I$SQ:C7C/S'1J"Q>IE""\ NN\K?!861&"N7:FKZ?*WDDC
M8J_G,YB>'66 .HRX[??UUUH)P>GG'R[ EI5X4$B/>W!;$:^<9_9Z5V;+0+*9
M;9?<@PQTMX]"?6B^I<>;U)*<'A-OXAZ[>\WW<2\/64=+WA^_^=D;^NDXK2N*
M!6.Q,"TJ-V0V6!["3%O7_$#P0S?!1X',>WV:']]YI'ZF3D9SML6GWJNI*!^*
MBTC)>\WQ4J_')%)6&M#NX[ZEY5:*=$H%?JL>GAMA\;SG*VEVQ51\CL!73OQ$
MCR%M37"C9J0XV?;F\=1],1#7$>?XC:3UT "O5>27_'NG')Y$C?6\ANHWIV>[
MZ.07?RADV<?)132OJY U5?>1NY$9HQKJS^!(TZ2GH@D?#",&'W]94MZK]G1=
M"-C9=+FM85%QZX4AR].7LA\>2I#E>)08X4;R1*<V#Z\WRN]+D>[S,;O-X-A&
M[M3J1(G%[/+=%6MWH"'DS)%5]0AL;4M!S39>IWV)>T0=HM1LI.Q^IL1V\.-$
M3^OW%YS!JJ<+S[?;OP),D] D&V%]H3[B*BIOG09Y.B=FISYXKX"V1,2 <N-)
MF6?9)VQOY_-L"A-=D2O!MEZ:</7Y'M/KK"_"%.C<XB$:H)HZ3[/(MOKXJCX*
M3*4*ZFJB18[A9(@9.<&5[RFU&O;54=F*PU].QTC(VE+>V#Y6S1Z7;G!_,E,4
MI=KZH:_AGGV*ZO-^^Q0)[KAZC]1)>5,\H!"1X1B,P;7V#NW6V40,5&80CQ;2
M5X2OJ0H[42]"*'SN]##]G+@9<3^LFYVW6&-7W4EKDNGZ1JI,0Y$[Z)>U+2^@
M,U3$R_NJU=*6R-51+WFS*\WQ5I-E2@QB;+6^ZAN& Z$VE?W++</VROSKQH->
M[/- <H4C Y\4X1;3F+>NVC<<>^D^=/9E*?(T(.:V=&Z$.>88P[E^++Q;:V1\
MB&WU%K:Q(<TJ<SE$LVFTI&G>>GF/*= 12"'4(<QW&5*6>R.^8*5E)?_[ ;9-
M<4&[8$;7ZA%[H&;$T @Y%H2&8=F3C,*<6%45QOVX\GXX2S/>G F>W3""M9T#
MCOTNLFI#Q89(XY:/;K@NH=>WW98B?D@K-$WAN+CS,+/G@(=\IV[G@ FG>[DC
MNI2Y*\$VJ>Y9X(T$$1ODV;W>@>G.^CE?K\$O)A>[1PGZ;%=R2 HQZL8HK IO
M7H[2Y6>R%%?UC/;:M#^2$87NV_G'DWO#M(>?O?QI_%)/.H'A U K_.R*,QZA
M%RU4HV[G,LF-A]V-$?2G98Q:PHQ(5,"XGB@$"_.Z]-(@:4)M>].]0([<*M8#
MI9/;XOS?%G// :;A7UQ8I\9*QGIG2<;A+=(/"9NORYT#$&K0+&_*%WI*3U>;
M.FL\ O\EF];_SM87%P.E3L:"!K5U%F>;N<W7QB.5-BH$/[17/(3%>4Z[<?J]
MP;5AFNTMG(B%8J8,=R47HX_G/ Z !D<U$Q4;_<M-6)Z#*DWYEV[M. K@)CX,
M?F^">P1^O7 &F=[!E89V<M<R4;CHB:["F?  J _GTZY_LA/JP^EF*NOL.6#-
M.77W;+IT>S+\K-];<<6 BV<UZ:';^[@IR)3GR!M,K$)4"S-3PV"F3?J\%+?'
M0W&M8S]55&O/TD[@?FW!(8^K\'<E5FI"MO 50K_1\@+IQ(H8<$ZX%\-H]K>1
M'2R_!YR!WX)5<2XSK[E8^ND*#N!M]6NC"<>NKXH$ 5^XQ712OFD.\\U)B[LV
M0U9R&8@AWX>_LG'I<+,I'_XH_+E"]$[IR*,51K/4\8,BRX()E;Q HJXO0/6.
M75BXP<^:U,I72$]V"V91/;>Q N6%:P@C49PTN BY10\D6Q7Q,)5\ZO^0SK?M
M$,>!5;/J\*&SV,/DM+O.<#1<SJI-;'C+>52LUB_]R6PM$&Z?#J_Y1"/[M3HY
M]R30:PL%;S'0"SK8Z$XQV-A$==HL9;A;']MTV0<2?1/>5[TXWURC%R*\T6UC
M,+9UJ]UF^>YQ^&>;+L$XUA*A-<-X/6K/O>8$;W7]<T!@WASBY 8^7BF<Q<H#
M4>52%SX2AHU+/@=\R,!10_POBG// ;%:4+03M*D !3DC0.Q:VN%X<X[ ;W#G
M@&ZTU.1\7V@9A!)J"C4%G^5LXER33W-4:RM,=@A@-1X>>J481YQ\!">N+NT"
M!KJUM\*(5QM^)^R__UO"OOAWPOZB+^<!W RU@@VC5S]S?WP!(O/C%R,^9/1L
MO>EI"/[LY7(.^$QT5@?=XCHP9L#)>D#//!4O2+9WX7^A4BC(@':0J5\T)\>[
M<7)E2'/4SWQH&ZRC]C>!Q@J"=G^X%J54-YZM<G^@.35-?Y/%6PG2583E:!!%
MD&V1E]9,*+&PI2)$D"</@8&2\RV=-,U%\@R%111\8S^UL'[YT*L9IBC>948E
M5U:^(6+09^%*;,WQE\G70IL>I!<:S!GCY3!LJL+$J:IPS!Z]\A%: X"<72]H
M0+U-9HZ=V^(:%2:6_RZ5NMWLZ),YENSEY"]GGSYEPA\7)Q@9S.6./0<\!N<@
M)S]L8P6SII[X*/'<?96:L<@(])B -(?TD"TH+Z?\MA-&LU%EB\-8TH*FCL*!
MR;*UZ [3XR!I3/N",?MKMZ9M2>#5#1J*LP&+NU$.7=ID/T-SL4\3)^.FD#Y$
M$*D:WKR7O<J3O3'W0$V,Y.UGZ"&L%62!!OOA.73L)W3T6\.528GQ#3UY6K88
M>5K;EMS7LD?'[<O<KO_MDHH$="1>OK56XXT8YP4$J;G,S<IOP^5\=Y?8HA.E
M0A@ ):QQS[ES$^81 281B<ZZ'R,_Q \NXBR)-HS(@AN87[@E(#\VE(6]+6]X
M%)-@K50>><O?)7R_ERNXV8KOQJSEX.K,W2%6"5_'0W>V>/FIY@ Z#9>52 %I
MQ2SM-"+7O%MYNES\0\8A4I#YVIT0@Y3LB#1]-1L3[_7WI+W3HI5O-,C@CK%#
MS"/(:69IPN91"6UK6L,GU)]O7+4MM-]6 D6H9)N?V$80!*B6^(^*++U_2F-_
MP)F'M3PP$<^NUFV7E[#EZ5+;2M5$=^/D\"O1%7IV66>'V$L!E9V(E.;MVM'9
MW6:IU(Z6Z;L_\<-!@.9J+O:"T4<A%F^,\9Y(CCK*'34SIH&QR;&BEZXV5K49
M=1_S%$V]M@+X<DD"/9:3945-HWJ?5JE')S;8I+H*4SJW^HJ/.8-M$^0O:4$
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M!FSM'&!65;/G=0P=W7H['3&^T<L?.M] A7G\",V;DMM=,'Z6A4S4(4M:\U6
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M5X"/?#+B4%RQ2&RBT.4[\R=7/G%_^P-B 1VX"UV$G.,78VH.H(M0DR&J-XV
MC!#N8?%_QC"]D<02?%_M<7$>]8V^/@<RPJS4EA2]Z9,XUP;"?96'&@8^V<)4
MIENW/>@7(^X<L7UF]WKGO0DWLH"0@S/@2.VD@2_R]@P.*60^D#RA(W;_(XYZ
MD:49%6&I[&7#OFVT$[WN.BZSY/T3@%LQ7@OP/I^+&B7K6CH"9O7^AP*+S.E"
M>I?D)_%3VKO'UO/E(^6FI?V!.2RSZW5WKWFQD12H9CBPPOK)AL[^MZ)2%I24
M&?-'%.X5(-)+IZ1YG^!,N&S[E!A]:,%MVYH16=\:L1X6*:,MJ8B(?U4[/GW2
M@C9L=Y7>_+S^/BI ,OGHM=B1E*C0ULD_D"/G-97N\HMQCL3DKPOJ9H2LUKO"
M)]'<&8)1OX2_ [MMJ=93]^33,6"Z;;(D-WFMK(SB 7EX?/!Z76UHBZ?<)EOL
M5\.@\U*@&_\Y*<HK9 =-OJ3KS?F=%4K@\83(E1'#?D3?*LJ0YKGB2P%6_&!/
MNA6Z9FAH-H.W\D'M*8/SS PV+&AGRT6OR)%EK%QFU>Z 14), Y:7J0)U34^$
M:_P-G-]X_RKXF-J[C3HM,4+R)F7W+DG,>/6"-08HJ49M 2]?)),?,4__E&;T
M!F)3T'362[\L_3#%\L E"_5!TLESZL7XI?6(_3B)>S]<RU0U80T$))=D)/*K
MH+UN=B_=@>$?*S7VSIJ+R3$$,CI!_ =_J)?Q7>B)7N*7F!5#6NC)*A!Q,2>Z
M!OW57_:JTRCGYWY*X$S7WNW)^IHU+9*)=X>ES?Q^MNZ-K-=^@Q.]T]G^Z_[U
MBJQE_,I)8GYRRXUWS-^<4Y^'U$12HGA[V\>56)CN;03NV;U8^7@Y3C=QYNN1
MKZGNN:/*%)-;/D>.!B)IGHV_9XY>.Y]OV>#;?U/]A5%SIQ,0.5YC$G0%>% ^
MTT"M0B-7\Y!/[(:'MJ^L:O7-8_8(>:A8L?'A$C"DZ(?9I_%[Y73TG&//T;1^
MH",3O^FQV8WI\I^3,\>N.B0*/@'2)IW CT5D5NS]SGCB!X;)WQ&0E]'[;='6
M?9\-IN2:34JC.OCW#^)@.?0514@HYK7)"?(*4+X]4A[.U/MBY.W($>KE*_E!
M2]9()S4GFZ^HT,5^^?8KP!1TZE"__<1$!#)-%2]1:4JI>3FBD<^NF;#S;J-Z
MR,$@(>T6=,5D%+*] =FX41O) .D*+H1,$&UQI;4NW#4!JRG754#CIN43[?G_
MN-^&4T[HA)=M"TY33M-'C&&2W@]E31#OR'WYDK[BVL1^E!NCFMW[63^SY[1T
M"7(?N))A97(R<P60E?(A-]9<W _0GPBL!YGG&\WI2CZPGRU56(U8,:?LP1F-
M.-X:T\[*YO[^YCM'<Q[O]VN^US_5$-/!PR81*Z0/+]T9SN]=MY^%8I[S0R8<
M_W0]IL"_>)XG];_S)P\A]R!=W597 *QU#E(W,-7\@ET['^*_Z&N^_&_I:TK*
MP\<_NF>B(A;:]7VU65UX-Z!;%G_8FAXWH9_#C'V +=*<94B+4+K=.JZ!:H,@
M7+,V3)H,-F'\6.2U36.DU&/#/4GB917_/JIZ,?)PH0)<6;)(1 )FUA3O]"]F
MK:YZH7!'@(E/4OS(,6+Y@+S6VG'5*S-12>O'.KG+J51'"+*?;]GE2^?*MKZ8
MP ^9[O<73CY#M0S&$!S]> ::(];/2;8BZM'&O8PO&;Z9HO/IJ$YXWG)6>*4F
M]^5F?_N0;A8-OM'HB[0]]'Z)BK3/V0ST^45L2^;W18O$6%6@T]@'4."9$U+_
M!OG0-RUS\U=KCMCT]AU1YF%%PMM2U0SZ1_8XJ+LSS>,ECR.JJ)-[*_6:ED!B
MTXVS-WS4EG3B?XWMF;-M-^JBI08J[S!55(7,D^&3*1"3N;UZ<DOQ^@.4$X2X
M'NL$\(G\BN&R_?T_+_Z@-8M[Y00-ZCJ'UTNAS9VN $2D+2O1M[IML=,59P)F
MO[QNQ[Q5DL/=]AKE#5J^IQ=D<,$KC!F\B1"V?"2/)EH];F*KY>C6RW,976G3
MC+'J+ [,0$LA4(A3OYU%5W5G\;/#+]4225^(!E_[DH\.R;Z>FYL:H\S-^O(/
MZD1>16!0,Q9['1.='P#/J<?+,?B4VA@6:<O:(5GRX$'P_E\5@M1^XSD>$OT-
M@S%M"79&(9AV?A"(77;DY=! TE2&CK2NWX[YG>5HK(V<P;QF^-.4\^\!PQ?,
M2JLJL8[2"Q)#W5FW6SUP6R"2MR!:(X>&>)?Y[O":3Z151OU;M0AWU2:##>(\
M9H!0MW-:LZQF'9*O38W*S]3\1Z^5W=E]VZ5WS1J. 5&1!\R22/4=\XD7\VP,
MEAIJ(:DLV)/'Z)4C!J(PT8^^V4TZ-SH?^..)+K-8CJ8I'4,)WVVF@]U:E35R
M=I"WW-0_P,:PP8,=6:S<Q$#P%E'NIS'*HAS^*N_>3^\O-YZXI:Y$Y"#H<P;?
MY;&:4^X$*I'4)9^^P5JOW#HGDJB5#PZYJV)KAU/WL1YU6\P"@(8&L?@X&@:V
M$#WL&.]L!1WLI#*I?'<^C:]UGG7%'9&.W=9>:Y1"O7,-+=DMPHE;T")H5&A]
M3_)SH^D*<._B]$0RY0W+!$L8UPLEXV&:U%A9<'$24J;-^.&;''".4J*3GW7/
M8CMG9QXSH;@3_W:,0>"RK]\*B>"<0O_4W1\+%]MN$"4ZJJ-;03].W:3$ZR'P
M]5"2TQY$<?RC1(NO/H7RL#ZB7H8:&(L;H]>8B@Q</D32>%D541PK]=,T, Z8
MJM:.H.#O6C\F'P7C+I7[TKW)MV[G%=*A>GX:=S_"P:O*,*UW=/1MWL7P0BE)
M4L%>JUWAAC?!T@D"]GGGZ$Q;=N!^%:78Y;*3_.(3T:/"WV2$]@L^HK".FHDL
M[?B0X3C7KW[$(I8DG"W^K<EGR(&:+7"[$'I.5>P,K_)CD<>^O *%Y[2#7T[?
MB(K1L=(OARUO;QLQM #/V"O3CL>O"_+L-J+ENK:H*!_TM#+Z38XX.>9.DUGE
M#2N>B#$$-@I$MB=R/"3TTZS"L7O@6.WF($54)8,"O3&^!S?B.ET*#.<Y+F(%
MPHTD8JA/.I$M;>M5,I?/2ZR'A))4(/)5HX5I+@*\CG-J+W)F:4.X9/D\)9YD
MJD.=##('I'_[SK>+QF:"3+S!5P#C8'1!$&KU"L 8SHZI@V(^<5<A^-!!M>R7
MGNP'.7Q+3&_0'I[TYLB'+:?&I!-OD!:?;CZ@DA%]COFAN8"',AC)49\%Y:!D
MVBD:'P]F-'[.'Y V"'I^!="Y[!P\QF:5)?JGE6[3X5_'W1T*QP\?*3+;A1&
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M]CLS'2+#]#T?UIZGG5;3)W6.-]16%0C9\-8F?_-TTK S$L0"Q9J!UI9Z]BL
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MLU3^Y;]KRBH:GL7K# YD9O12O@:*IX8 NDSN@ETIG[ZCUOBY(9O\^@K -1I
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MUQSYD!_L%L4'"6[$:U24CQ9E,#RIB6#7;EJ7^-!IJD^=%EDOFQ?ZUI4[R3V
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M5OET7ZD5.T?=OE;/]:*4;7D&?Q34H*PJ>5"FW"E\:ZR+G_,B&?2"4KTJ.F@
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MV;3REVC4Z6NEZ /VLYUZ")50#+&'M%$,[QZXW"<D#O4AN+\IH^@J?@8@$3=
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M4G9U!YJ_,Y56;;SDR)K2F&-?+*W.YR\JRL&Y8H#6PO'B5[<-]_SI&:!%^0Q
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M(9D^/'5P4;:F3=YUYZP-ZM_/7C:]&B15SJ6QJ+%UH$\$'\6C>!0/*);_?Q,
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M./"PB/!$D3-$#:9\<@E0" Z$Y\ ;]PA<)C?R&S^BPHC"6L:_!JP_ZP8EE!X
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M1'\<V?O</%#X#CH1"MN0(W/\)=,D-(64WG0O);-/2!16(3LU7I0+B:)\%@0
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MG/37]CH#_)6%X3VV;^GR4D9Q((E;//EW]?*_K7IYJ^C=R)@$QT(01865.N;
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M+ 1 (9Q'7;=]WTG8..&?IRGN=2, '$)?D3DL<P3@'K]^Y@J_95GF:_9$W5E
M+0DH'DXC@$!DCQ"XE^,_>WR24/T!U6/-%L:?'DE]H7/8R!YC_IQ7-3A)^,I=
M)'F/0:DBO\?J4VGPT]8K+N0.V%NY>-F?>7CL#34^I"S5PQ@S.,&4#V1P_".!
M@2/9='[)XF)0UG>NK>$@ !/7DHW=I&'9I;2FUA]T8<G78W;':"9H_.V7<UUF
M+:X&[R^,J,+W:?IB%I>YA9CKT+7-BT/0@K=?I G:SQ*_;)1X9M^"RU"1M]'G
M"%&5SFNRXJJXCJ792G_,+!?(HEPXLO/A8IJ3QR].$MUC3I9%/&;/O&GS;9[1
M?>+0D(F^]"TZHLCMN';?N(7(\B(?!SI,.;+G0O=SC#7V3"<"U>Z2B#R)F-Z/
M2C6=WX7*)K_64^:L:WW6&3N7*[I.4^]A*O-+.!9::"7%)_9&S2T7VK"1 _AD
MB6%>?B&VK",IJYT8HQ1!E>0#+I\+&32 G K)=F=:^QV<-4=:8,%O3\J9/-!D
M?D&:4FUJ.SVB#+0/OOO?(JGE)#SN@@)G\*TY$;CRWPT- \U@X\2%L!7W#B;+
M>>B>F"#;B3Y!:#O__!L%;2IZG3'@.;AP:F<5>[QA;I:7L<W?_;=X0MW6_!L@
M]SDH*U04I*+9QX6^U/;NK%^K5_P\W@=)7*3!+G+CV#"/YO@E>1\'ZL2P6'>T
MV+FRM/*,7?_GRD_IVXI5UV%JP;4#H6%1S==2&=VE_6",F?2,_]5S#W'68!+#
MJ&UP7(0 NA4-Q"&=(OA@P/K9'+HSB  DA#P(="/A=%WU1X1]Z]9D>YN-Y9"W
M#A<IV>3:BOU$KPB^'L$P$Y(-_UGL3K#.C "T!R9['#1O/(VE83:#F..C,;SH
MX!!=[CIV;EX/]CJ2R]@K4:K.[W4?,4_"HND,M.7U[OHBE&E9:W#ISI:\N8.5
MUH2&KZ8XOE7I"JU/X]:< O_V<I#YH; B%]^A@?G H)!PM<FZO%>OH'J&-C,S
MO=.=F0Q[-09FD9LL\QG[T4W\,(MJIKY<H_LPK1'#;>5:D1!B[GLF1LMMP1YK
M!D=O7$6.75,W<@RF:([>DAAL'XAL8><D_E4ER[$XH/(KC^I>X-COUOE^6[-U
M7\N+]CE5BQ +][+ ![XRU?PE]\5D9TOM@3I^QSC!.;3C<;WT%JL6#.$?V93Q
M_M4L1:^^W0YF821O5*'WW]"X7?TZB!O&$\2M)D&FKNR%W1.G[>;43<Y*;Y4I
MK!)%_C@R(>9>D,1$:)^/\*=>EE^5'N/?K"_/J^J-U)*J>U]LGKL?@;9+.4AK
M,V<SPC/.TZU@83'+IJWPX4N1FWRW@Y"1?(Q'P"X#WVWN6U)]6S2!]G"T-:Z]
MF-GEDHIP.=\O0^/??XUA?]D6\=JFGK>RM#9Y'K7S)8GC4WT".T CVY&L3G7%
M_LN*Q>I#9]P]J\FNBIK\2R*+DZQPG4P,I9XB F9K%J6"CS\V1*]^UAM:?-D5
M;&.@W"\O]2B_/^MG#WQ8X/7UQYG!?=2?#H,LB)T\E N_A):4=W[XO+928H<G
M?R$X3>Y:X-=YBZ4L(3&,&-BF5#_W7)3.,N_& *_5YUGOD&OS8?R#/0<.K[3U
MX[ "L"K?7;[Y_#X?%8OO7A,"N-D4?>Q)>(RVD*C5II$7N];&\;MLLB@3E+O6
MOY![KO]'LN#&F/U[<N5MW0_#<DWI)U1S/16/L*D6?T[XL9C1^> ,\"4JI;WF
M(+KDA9<1Z:(7DM8U"W&C$?ZVMM@4DK+3<SUXYW9@\#19S._??CHN,>23SLGB
M?E(J682E/-OJ=A_OK'5$3A+<UJB^.R*'1RK7X&748NN6FR;R^7=!H).'/(.O
MQJ[69C91%GH>VDO@!9F]\-&@VS@A$ BE^)B"TZL6$NI7]RZ(D"XDH20"))A6
MG/L5="&]]E9RD/"G\<9"K1VX@;@8"ZZ$S<4M#<$DG,\IQ)JYOJ]C[#_/]2PN
M\FD;8UO^+&THYOM0%Q".9'N\3I@@0'*5MS^>>\&3;)#;Y XT15><PNM1A1-M
M:^TW?"^[$9YP XW+.'7D%RJG6D0NT5;[R<N)>QM5ZA9&S=>WP^?F*.<'%]7Q
M=KM#5?%Z*A4IP)#)+D0[;,S([5V4Z8\K+ZAJRLNF=]/F4K!KI-9)Z]8:0Z4R
ML!XJ920,ZP/S1SRMSM\F+=OFS2<J/M$RO6?W(?;X<9A!AO^"_W"G15CO9XG@
MW8F*8**%8&,K;J7\AR9/P_EJ:6V"]@TUW1BE-.S+MQE6$HWK/_(-LFY_DS:M
M_K@Q[!)UGZ[4=A9?]"M#B-2,_JHNC2^<7&O.:1[J9K<S\CIH+OK;\.NQ#^3W
MZ4I2^S#TLF>6B^/-;_5/K]=A&K/1!WJQ4 1Q>L[W/N ,\-ALKF9K#MVKOJ#\
M\E8,EUM<!^C]=1J=,(>!=9K7[#Q7D^F,KM(+J6-C"!]WEO$$ZG%HP!Z-I_6E
M#*.I2!"%?P^5H)2A^Z+VD)Q5$4 ;[3,JJ@0QGNYI( (PZ(+.U:GM$*F/O81?
M"83"O5SCX>@R<&+]%ND^!RK1(6VM=K:>, K:4I:7+RN$.)Q_5W_(H- (MDR2
MXBM1_#AI^E$+9S_N_9O9(5.,X;+CBB5'#W4#NSH'0BSGMW(%EA7MG ^]);7Z
M^W>"58AB-0C<I)H"U;2=;:GN:[I$YP?6OMR]A@]=7X[/=OGU\NB6S63<PY0I
MX@@^KN_8=,>1", ,'N<1]"5NJIT.+R(LGOZ1#A7_KLJ'UOS"F$G%E4;?O.T6
MV5\TEXXT6DO-&<@ZN9H)9\JK.A5Z6;<^T!?FE4C?$//*X#\,[XNWTU@DU=N2
M7*_/=/N^GZK:M2U/U;9 <FUDLY KMTV!J^$2X;@YF[V\]@Z:4$JTFPTN/>[-
M$B?5X!<L\RQOS=C'G=D-@\QB#<,D\ G'+7)"D[3-'$6,\C7D7BRU!3053\^2
M"_;N'#R[D[%8[=^QRT^=:X*AZ)#\2PQORCYLI#RM$X,^0%W.S65E5IKM<YAY
M[(1QH!R7!["HO[S. G\HAP!V$T!N>JNO/'YGGYK[I :O_<"]V_9NNHRDQ2V:
M/4D'!'" MF"PA\NPI\[T;.53Q2']0*^474BUW&?"\"XKP>EI2&__!^M/\P,'
M51T9Q0N#)9C/(_>9@6;2WM3G13&Y8Y25=YXZ.^1Z"RJZX'TC">70F/^=WPR]
M3=LOK]I ,0#[^/1SJCR^QW3M$QH-76\#*15^UM=?%\@U'Z>38[JJ[*Q^^4G"
MVQW/KJS7V0C%;?BLWY2F*97?-O_:K&4,IE!*[140(A3\#'(IHZ-.C<3H!4!.
M/_CP25).T/VFIA^^SS6=!1KY8SU-<B+O*[3?IL.>+PT83-FCJ56:Z[K].;TQ
M?X&=,ZV!!=C:M58=^;0MU&_,/.#XIE>1P,&%1D3/^5KCP(O"_/EKQ/K5JJS^
M&RKR K5SZWN+\D$23QPB7[+@7WY0@@FI&= ;]-]:K-(>5#,CMK;ZP,+\0B?
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MEW,L^Q_E6%45\H;0DZS3*]/6)^ #S-JS#O$/';*X70MF!99Y=^6CVZH*8\;
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MR@9G!2_"J/("=I_K8=^A7"9G)"5WMV-ET$'/[U7M&AU+EZ<F'Q\\--/T+CV
MY$#>#UD8_/C(]5'C<9Y08^A71='D<C@V]EI"O Z6I8#N-WAS/W2.$C1!3\HC
MYD@W*Q=K6.'JTK+MXPQ,5<_MN[T?$S<[Y\$8MZ-9G<DV,_%JI'J<3T;44SX
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M,CVG0A\*^ASL#>"4:>(N ':00RW$X%B7Z:($"6_3N70B>W$+@Q(P[_Z^?@0
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M!B!YR>/;0IZT/^<HIL/6]WD6NK*0X<MH[Q'('[(UZTE@H+"UTD&6=[W/!:!
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MG^(EN3X"%=PDHN!P>TK7^LD6V0V-'O,Y '*V(2B$<S[@7C U6[AT&F?32V'
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M-!1G24%LE$+>3%_9('_O^VNQP0ENCC'8KPQ@OT-9;I^D$(D5TT9AHK4,N!%
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M7MGT_T=KD\NW,1[2 X]<<DF+^@96:J5>_T,_E?(OUI6)G4DT?KFEA"#HN0O
M&VIJ24H#$!W">.K!<M+X,#1*FW-.^JD),,^ZDEXME2>S^^N:GVX'67V\-_W1
M^@-%,^L'KHJC;[Y' )@S1FEC:;S"I,5J/;*E.F=_(->\=9_ N(8T82(+,6O,
M5P:S@J=TJZ4_1K\#H%G1[[R\_ 2'#3&&LN7Q/33)--C5U0=-DDU1U]]=^?A1
MYW*91_#+W*["+47<PW8]G*KTJ3A Y&%=M%RU4(I 90VPK,_% IB$9(=M&M.&
M^VC0A1C?[SI^>F+_0*OI O#*^Q1G4K7\AS'-,QA^H ':;%857;D"2U$2L771
M[;#]9W.0*= Y3?FFZU** '[F*LYPO_&QI3PGLUH'1WFU'M*<D'U4Y$\2]CN!
M=T8%S42^^,2V$UBPQYSS#AW]=LLG/_6#&!&C/[9C$6@06??"JB=6(6N;H?*5
MY=V^UQZ-6J)O/SX-K^@#[:2S57C![/DQBY7Y/3[.N>>UQF>BS\S*F/7H[L[Z
MH7 R>P6O&4JS"JK-G 7KY\\6S!=5G%JO)3XI9CN; ;T$$H:LV6QT4!DG#WC
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M+/]O)N7_ZTS*W)=L!BH!LG;@/(/LY#?CI3^_X#Y^60=5]SG.)LQ7J &5,K)
M>"QKM#B.<J)2]",Y1KZV0/"I!@F^LTS7_/@U2.7^I'=9S:&,JKN*JB\+HRFN
MV88>6_R 0OU<XGTO;%8N-*@0ZP1=Y'NVRU?Q$5[9G^M&L':EJ&=8*FHFPWG/
MVMVS#]>R;*^9_:-<L_BB-.SA@^_C\"RYH*0N+Z;NQ'8L)(U+[M>S+%/G1C>?
MF,,+^(RO /C*0/PWX&$=JAM =?,P ]?3BL-.!C(9OIPV/UW/]:(C[45H3+9<
ME'(1O_D<8XE#@03]UV/"M;6DG61XB=9QL"2PQIEUSO8**N. NJ,+YS84ND>^
M'W%,5Y'QO:W*](V-DHX$Z:&^;MU,><RU[I#)U+&3B(I>D!M+GH56_B#*D')+
MYF14[_@"\?8/#>XW(SAK72>D6<3A[A%2PL=@O:HO.DE%DU3/E4@)U%#LP;[&
MV)[RSLK9JVAT^78DA4:V9.U7YEW/ T^-;8^,-(XPR\4S>S9XQVE$J#D^?3FZ
M()F.5O VGCYQ:=_A"0&%EPHIY70P?,LY)&TTF*&?KHP!UW=KRELK*T1;@6<
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MU![4]F<G&SA7#N6=J<%:J+MXY$X0F=T$->>I_(S.KBO^D[542K9M?\;W!O
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MTQT@_$7YM:E:DNYPUI"5,E>L'>;SM[Y$ -MPH+5V*D-Z:E03\CE_%,!>[9]
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M53NRIMB8H(LO5=^;D [X-;FB\5R&CX_2UZY8"6%%&D\B:G8<M4<AQWK.<M'
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M*EUV_JXAV^V>/)(]H#PHVVAU\7/X2YICINZ#;3JS*<>&>;\4A'X3W "P"Y0
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MB6%,6L/+>^L;CJT! 7US9>Y*$7IJK9],7[QYEVI]HB"U!'H!QM)MBWB2GG;
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M&WT2G:3DT&I2#L"+*^YGA9)N-_7:)9%P5]:DS@[+LGA..'L\@+'2M[YXT*I
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MZY1,;Q%TV@Q*%WY:DVGY\%9"PO-E\AD8N+>30)80Q%0EU<M((>A7831[X52
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MPV?H)"FB"V#.W_/SWA&4BH/Z@3R%% 3KA<VQ;"J.=L!)O)D#&L:2+Q3:EW)
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M>0<:!MDM#-P%LW0=*[%0=NX;WZ?O*[4V W.^6 Q.29P+Z1NM./:;_U OZ/5
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MN@V:/U K"<EH?(\%!-DM\B)O8 $KOYI0FGP.(?[$5<$*.2/D(IGJ>[MN; 2
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M([^.WL\.H]&R0''P4F ! RGTY_>@RT8R0QH%W53U3 ]KCF#_<4?NOSZGNOV
M8HS] BH&:<E 0% 7/[& @#L8@?^X$CPV(/4S?G>BZ&_1!_[<"GI@)>;6CIXM
MY'2X3A$;-AJ+7^%,=@*,@:R\'&_:'BM8W9K[-#/VNSLTF]I9 ;?6Z%%2"#2H
M[,N.?A_E,K<L?F37TWJ"/TKW!9Y=_VB9D)["RGAI)G3/!*"OEW D"\F5B/*M
MTW8M,KR4'F5L'"DVO#.(7A5_\D<)(%'1VN;75)2%\@6]W@3W4@S TI]]EOL7
M"^',6_V?K9#F$%F4UUDA\#8*/"+H.3P!-OW1L.#U<8D=F MJ/0:E>@LX,Y44
MQM76/NDR$[WA9Q.5)Y46[UA MSXPU?1S_[Z._%K;R]P7P!X3QVBYVJICEAJ]
M& +/X+&6O@QK ODN+$#.!!7DIR=C77)?[XL2/GY9R:$#BG%J'GWM!(BZ!3DH
M4@*&S'&,ZDJ+";9P CSZ;[S$1^]HCXR^1@!_)!%+Z"[/T9ZS!RN@I#P?XK-,
M3::0;!BA0&(G?B"5LN'"Y?(?E=%SL[?(&"GIC5SVK,=,;1I9AU#"#FM;'B4M
M\CUMHAY(MG6DEGI*SHEPE(@ZF/I73[CN%XZ >(7FZ_4/EQS:F">RQ"03'V'Z
MPYI\V$"(@]81="R$?R!;#0%KVWW9UG.JI3@.MEJ,%1Y@PP)LH^=:3XJ):]G5
M*DM%.9>\&B9M2:\X@E<;Q37#W8."SJ?68%_PK?0G>MMNT_:_(!,,NY@#M-RR
MX0/5<%V&KRQA4Z(D@9QY/]7%[EFSWA0TMU+,A'%F[E"OH;074EG;*W_:+Q\6
MQ_KO;3T1AI=@#DY!V4Z-=\_K;-Q(M20?OW-PS+2L[^QFO6SV&]D?V33,^U/N
MPKXXDJ\0QA!CHL_#ES.@SA>D<R;I/X8!>B:H&H\;RJ:3>QY"33 <\X/)JQ8'
M\%#N%*8IEN^%LL\OGZ6!.)"5X6/&S*,M.B(2J3$)D$6Z\:M"3[F0!7XL(,C>
M"DJ$TLZKQE/R,>TG^BPMBZ_2F88.\N.6 =Y#/N*B\2[K]V4]2% >8HX^TXBU
MI@@+UI@.C3WIHM5!>Y["93.JX>0HI2&4X,.?>$6GZ5WWI']K@':K'&#@GL/<
M_H_IBA)Q\*4!,EU/53F?7M@M\YMV"QAV>I2$LF][[A:%6'&F!'HF6"ELIJ[D
M!#1<M(UA&!57RE?(M>;;CZO6,"07W,E_1M!;W*-Q0?%U7;MP2T*(@"U;T\(Q
M_XZY",!#,"]@>_Y&.>WPW'8IC$!RX!ICS6HH&G_)YK<-18LWVP&N>3L"L_E,
MX0QFG5Y ;F1R0_X6B968\ERZ,++.,OF%A"-_3$?]5OQZXH#A)XF4^Q8AOL83
M3>6^:G1?'YC32@A5H5UMR=%",<T3*6,1V]T5A)<1O2&\ H<"T:K.*M8-'K+B
M>8R]*1<K*\QX1:3$%:;$_Y _R,)/]V68@)2):[E>/+QG?:<,,\7+B064 =NT
MFR:ZW*OX=&=;70CMDBAT[R'O.7-N[5)HA("';$_8GI8N,9SC/U-U.J>)::EY
M2E*V)D'$M$]!UYGB:S58CQ8;T OS]W$_9 'M",^" @;0)X8L-MO<#J]BP$.\
MKK]O$[H\D+V#N2^'?R B>)@ZA@L6U*=5@IC#>L32O@<&@E\G+IMPZ7/SV*\\
MQGDMX^L,5SP9_%%# MPBRWA%@A?! HY)P&<0Q#H([>*PJDOW/]TQ=#F/L081
M2,IEA',.B;_^FT_(:=3J_ZCNH+^".--R!M[+X1['QP<[+ SG #=&/K":I=?<
M$#L)"3VN/KDK:8"H(H+MR\Z.A9B W0Z;0E!R>9XV:A3)KM,/*3VG/SEMM#;X
M0((;V3:2ESIO+D=)'B^0?D%%0G[;0W&N>38%K59GMA()U28W%6^X/[4EAM&C
M-D9(^)=H$O-#?63I&?+ IO?$*$B2941)X)Z<W[UUM[HC+, WA;Y7\)B2X;U4
ME\3M[&SJTK WK2W>4"[EQ2+W.T3.&Q-;R[F7SW!&PX\A09MB ;\>8P%8P#4H
MBG,KGP/SXY+*3]E#TGX$0^-9\-J7)Y&)@)A0GX02%0/*]L8/\2<&@Q5H.VI<
M>69<3BT#=([V9G7\-;<$-'K*OV8]&8RNBPRF+%J4?Q?%&':+C.0Y@02 M+>N
MSH=0P;XX1_YMF))XM".I%C 4Y9+A:<UX^BU.<,#&\K;%0!-LV?#ATL!#:W^N
M:GK+QX32H+K*2%3F#'1)\CA=H7?0S:8CN72F8GF 6FFI[XWM+?GC2>)'83%S
MH'G&44P@HE@VG+."F<S4*SXAX8^&RH?_#1;XOR#$S?Q_8W^G_8/]C;-TTHIQ
MKT6<\RM_=^".YP>CNY[!<V@^X_[NB<NAA"Y,YHSV\.E1NYL#;=M]KMB>]*&)
MS.M\=WV_&G8?1+336U8DM)ZI/^!BZ+;5.5'9/J?S_XC4EO T<&$L(U0?B$N+
M*+32JIU+<((9\FQ8&,!H-4X99VBH+S[K#A<+*!NNJ]3J*^'M#IC3AIXRWFK,
MA0N?PQ>-=KF?V+C'K6T-.3U1.ULZ0<(/6<HR);7-[<)@?71FM>*RX6S%K?W_
M+;S8#VOVIZ!CFVCC7]'5"V#^2=_&WW+2-9![!L\@(1?0D"$(!VBJO<?_CGL1
MOVW$XNZ+C6N-2DU<*<XOOC->9?-,GE>I)2@<Y,!\B-+T2YJE'=#C((XTGY7P
MY?P9F,E0.AF!;^?3I:9P(3#M2A*U7W5C;>1NW-ENM-!QUVKHGDAGL3/GUY+S
MOKS"UEVD65;)?= H>50(7/TWFO/71M$8);-)DDYXU"S_YBZ>T0\$RY>J<6)%
M"YM,(@&[]XI0?QN\)>&@-VW4A+-25&)1\10A]L[;8PEXQ<^7Y[=L!OP?6,?K
MGM?K?/ MV/BM^YS>2^,'*/;=^43MA/CGLK00 U&.T1-Q[<6F2+?;O,?[=PN%
M<OH5C'@TZ_NE[.M*)J8:\NL?/J_0XXTDM TK>=ST5>W%[C59U%MO$[)] 2W%
MLQ>MPCTC&U[:$9+,VV(48?NNO7HV^,'7T\$Z,R4]@?TTQ)C$58\J=:/Y&4-%
M4@7Q(LZ;--?;$F+L;3+.H[  QM,"S"%DHZ(87&O5SI0LLM6OHGR5I&-IZJ>0
M!>DB;\4T+&,!@S)>L [X10 6, U!PPP__T]W]#4:^8?A*!:] ^TV9:,V?\88
ME?JJ$GFPL/%@9G 7U5Y' U\]Q:(V*N8)9((*E.@S1J:N7DHDGI+N[CE7@5#5
MKQP]H97@=ETF?:- D!1U9D>D#846<T""Z,@45B0?U1FTL+!;?W2J2X>TQDI<
M['"^1U"@(I%5:/\_)"HDWL_*;IN%/CH! )YU_%OO'S,0=1MPTD>!K7>R)QR&
M!G?#<L*G[K"FR42SC9;5I=S$RV.IKP*?MY9Z1,C\4"!1N7$FO8AN(;HG"9-L
M*6_DW>+3\W0?[Q 5BJ@I>XQ(TJ#J1!]K8*[7:^4D"HS]U@D?CE@-VT(*=[!X
M#4M8J$K+BE@5*5QX;9>OQW0>P-6KJH/WICB_>=V([0G S3MVJEN-6G#S<U!>
MMTO&W.;P?:U^&<MS2H(+$=0HM",5;,7Y/1VL_IDK$AY!1Z[D]:"-W"FVM%KI
M1TVSK2]\-^7MY7*-@"\5%A"SJX>IZ41--3QHK^SU6KQK2(YK^D8I7_',ZB=[
M2KJ:Z_7[_X(SQSBTL_9$I61K;?*VWT!R$] CJ()UHQM80-=V%F2B96+HO_ER
M)/.@ZRD]*:BX<ZCBZ*P->L%&#4678@%#"D;/)P;F[T-6OEM#3GNQ !EF96!H
MH79S@[)((X\-0CJN*.W;Q]>93[NG,?AOIGUU$-RSHUJ#.E9P@7[&*&F'HZ<B
M>/O(B51M&(KEH#MI$27E_)%)NM.:6%:/TOP,<%^R9H_3JH-$NV1 Q8V5F71
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MK/$85T7=I7P'XX<U^5$+$8(VXB9%I$JC+P**BA:#HWT%9>[^+F:W_!KT/"/
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M1R'$U^@(*UCKNN30Q]:JH;9R'W@[\R(A*S+%H NO(PG@A<NA<'G71S'-E.>
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MUT%"23!OQ=UI*9*_^IW+*7O0:S 5*!JTJX,&M5J5R>ACK)-(3ZE#GT''0:V
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M"V5\10Q=+",9T<5)TFO:P"SC]YFB]@MEG*Q.;B8P":D*,)MG,.\NP/PDC,<
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M8"TNOYP*&_<$J8%GWHL%1,+44C OHKLQ])6/JX%K9<M#5#;H6@O?@+AHXEG
MH0^'3#Y-?+_".8J"&&!?:&-@!M<6S+P;K=>3,\HY</D?_IHU/8( 'G=F/Y*(
MSQ-?8+B9=KQSO148Z*F#G9BS]PQKB06L,8#URNG>*L[@S(G++Z6"H&4B@2DD
M -;+D-.<9_&*Z'A>2#I:8,<<O0 Z/4>Z%3. %67DL..<(,0V UN8495G!&1N
M-E;)"6Q#1C0@6] D4WHY>(%I"S*U^GY"+E6BV!Q_E09Y+"N"CX E5MG0M'!+
M%C-5PHX-D([)[ =6*:<$3$?--H'_KZDI&]@YF\V_>3#=23W8BI#3Y#&SO@@6
M<J)3=)&8IB@T35&.=[[=#,5$O/4B IC"92U1#/&0L^*=U*I[Q?08V;*$6$[W
MEDP4R,&@9UI$"BG2)6/B0%T/7SL=#(+OIB,4KO>XU1;U3VGM%K&J!XEC*?TY
MAO$<3KSM8$:]39@0T)@-#^YXO"40G1V(SC$G^@HZ7?I57W.RZV''"*1C>5+
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MBCESJLC2_?3^;R&9X_4 TE%Y)J1Z3F8D$:LOA#](==-]7A-+=R![& )@K:O
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M!"F]"?9.W\K7>=W*UBY)R?" BG#*/:MBLKCW*P[M,_Z-X9>T5SP*,'ZVNK1
M9&=3D?6NFU:5NBE2[+):G_;^NBKX.LNE+TCB_O7:E K90JQP]%(6_/\37LB
MM+C##2RP3#:"X>I5JE/9()IRE]P\Y: !\F9]N/V)#RUF'[Z,[7*Q1U] *0G%
MO+LSB=X&9@4/^_\3BZ;_%T#N)MZZ@M!N4HWIK16?@E!W4:^ZT$/B%H317A[J
M+43M1[?-45*!-&B#FY<GMZ:)YLCM_\0D\CZICJK4.S!I!L*D-A?CA1D2:\#4
M?<=TK392OH=IOUI @UYAR&)6622 L:.Q=,HUBWHKN*<5V6@Z)&>S @S&O.0/
MPT>EA7%Y#[J/_RLQ6W"%E$2#=@GJ 0Y(\BY$MS3SX6$JD09QO?,C\21UH5<B
MVS5RP;1P'"QTK]?AZB(6'Q]JHMHN9R"][F"%$Z763 @4O,8']B9PUK24N$8]
M'FC:F9%=0)()&0L9:E ?NYE[X2[[R_.Q0M!O#LOKW!N_-9XUDLKOR*@=WKO:
M_Z)PD>QAF;H: 0% WTH%L#R,&5EBPCNH356>;"9W L^)5(:D;<=ZYR0,'4D6
MVZA;$R-QMCLT2Q-A+;XB5]JKU^]V7>!$796<\" LRTM2)'/+[6SO=VLQPU7'
MU_&,[)Q<9A3U)F!B8S]82DV!^;"1W6<7RX+ T8A#&N^XWEXU*[V@#Y9:OZ)2
M19Q'CZ"/W1G3":_]]6,TU5EG<!<-JL_<XAUV_)K/81VV%_BKS283J8?=^$DO
MG-$9NWWWG39;UQ5 @UR"MA#?VB%7CAS>F\G>:&*WKO:VZ2V!8Y<_&_9 $";/
MJE[D,UZP PO;@\PP&G:.$BW=G=#2=T9ZB^^6+LX8973BR!2'<_,MF8LRJ/B<
M!@\UI>]++YDL<Z_\G>I&@S3UT3P9)_=2#DB=W\QS4#WZ]8]'W^[\( _)"X23
MPX8#O$*'SCH,:'Q5_W"GXN22$H5UR#,)Q*=]6EL;%;=4)']PY>UJYJ6O(S.
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M*!YV*B5D6PAAWW,8\1)&1O"Y%^?(Z8VLQR8?O91U^BE%5'G_7B.8C%4PU[Y
M4VT+L*VN)A/O6<[:)49?$FG;3BWT)=!HMOJ^W8>KR+K8D&J-@&B;1+@LT^RT
M]8N2OGJ?=//<&7ES8YL8O>YS-7S@M:-60;9?WOO_ N_UW_+_D_QKFUBQX;^F
MSO.?C?"B=8].O4.-GDU-)XZ$;CF\;Y[JN?6VZV+^_]5Y_O]#A23]7S #0O.?
M2QM/?P&#609,81V96;>15SO!F_Z_H SVSIKD_WWS+.G_0].M1VWTN0XF.K45
MUM/E4X$9'+Q%04R7JO]?]!8>[R/6@M%O6#LAS<0$ -':DYI'H.Z'_2C'=]'"
M%^^-!IEN -2Y)Z9@R\S3\CT0SKM^)%GAMIL\5CJJB:MQ=[D6IW7JO=/3_X$I
MB@I*7R@_=7OQM^#[^W]U<?%_R_]^\M\%W_\;RG\7?/^_$.T>X),#N2Q4IK:=
M',6.\-^+B-DSK_&:6^"AAP>I&NB@8B-!DE1/>R%\^KL#$4 5R^]PIB\%^WA#
M6=C_51:C"-[5\^]=,MKA7K<&$1=9? LD&I<N13AFK3J;;Z%%K]S$W\,[VVO:
MQ%)0L+R$;12^-4I,2G0JT"R.V:RN0M++6$[I3CM)3_SIW0(OQJF6RD;!R\]E
MRET9<W*>73,<%X_DESF&=678M "%E/0G BLI[B"29O94LWLO7\3W4]E>F#R_
M (M@GT1L7OU(D]@2#LNO4X/DC&1LRY)IL8![,;)34U+(R!$YH$4#WN(C;QVO
M;J1^VN7JY,]FDJV[0S+)NHGRZ1XN\K$]D6!@,<X%X08&YBH4WOP<ZN;3TR!O
M@UB*B*%-N^7JLK3 <V5/@?02+0K!,[N[#/X"H7=VJ^3PMS@L/'\JU0T ?8J3
MWT#^/E1!^_XJ"85;JM)$4$; R@6<X0V>[N*@+EGY)J&&KYWH%6JVH9ZM,_?T
MS2"78N_T\6'(HLB$EW:AX9PEQ5GL2U)\.FG>M$W:]4@/(K?-UL,+*F?XY?H-
MX-=4^<0$6+%G,# MR^7VBYM])E-3=M4929]F9^WGHP5(* -,W(H[DA:?#J^W
MI%KUGAM_2:.B/0&.7Q'VHUWA5I+/APV/M8)?99W)B$;^^&QNSS$&0,5.X8\V
M'JO6U:'S5PM*]@T53HJ]EC,$Y22/5Z\&?@-#FCP_YN52",;,0KL8_,GN4Q.'
MX0.T*L(B/I^_"DP'UW$F(Y1O5RRW(DL>^1'1]%1M,G^4T]:K'_T@E.$HS9K=
M;CXV(.!0^47'K%XJOS9S*0:,7 SE:V4>6]!_WB[[J>$L4[HC:*C:47D8R^SF
M:%"G]VDS:7)E\+%8[H.&+2F.BQ2ON*H]2%70OB,\.[N^WK]O5BFU,(Z2D29#
M7IA08L!N"O84PV<M$B707 =8]7H5F8^]? ]3)-.OEDE8!8:FGY*'K!Q2;&%9
M(J-2'>LUJ-R8#"I83[OM#WA%2ON4!7*H_]ZLG7)0GB/V4T,MR4P8X)&R*L =
MUOQT;(TGKV,J0O0Z23QZX L^DI^U[C.;"@_ZV^R(OF$B2KY=M+3MMWG*P%+0
ME?H]W$W*'B;BIEV8+HHK=@7]//-=XR-9D8[/C.9$7;! :IO'*I./"RG*OA7+
MRMO^VY6-@EMY4@R"!'VQ,7;>18IQ/9L98E;N+-_\91\_=9%(>!AOZ(K<[3"D
M1ZF4%QH:+D;O]0A'S;\)#S9)I'H01RYUF"%O:'D#Z#2PVY8D]=1)?;)#M/;P
M2<S7_LQ^'.P];1^:;7P%I')<?6+2KI Z#G92\ :PFF7U)B[ MC# 1E-#6P:G
MFXYCLA)&9R%J'708;VY/^T('DVO=F?=1/$9AF3CX%ATY(K0QB<\>8.MNH]O6
M)MPDVX*UPRG5,;$M[,]DHTR>F\>BR*E>1PV8QO*C$H5DJQ0HBNU2LB9_]\SL
M4/G;1LU#[3\\HG?E]6UP0$&RZ656?^!6.Y_^15GM4Y([C1YL'U&.(JRZGOGT
MT\EO=."@J6_WCBR?$O-V_U,9MR(Z9R5=:^4]WX#98=MUX5U_QPC3Q_B&IRTE
MZ&0%).;14.$B 4,:0I#T5_ JJ(U(Z#Z+U7V-<.VW$]DY-;5A![,<7VB<U+_'
MTN!^5.@1EIQ@!AL;.J]P/]FESNR(= 4W-AY_MO896>M<9]B?XRTZ K  8GMO
M?1PC$HA)(GD"FYO")G!:X);\L:S.HW&5< CC$-)!X<5_EZ[821[1X_ >GGFY
M)$O%<E0RVMQ5FE?,7P"7@$7XT.@*AGN#N\\GR;IW+JXY<H<;/V:YA6*:1"^@
M7H_?VZFA=UMWT6:%;4I:H9$ZX!D^CS#6PI>L)<JNG?7<(62P3XM%BG):9#1I
M6)S\U; -_"X0T3=I&F\%[O,_;'XW@.C-DR+5^ D&9BU2E\\G[!Q"<E,G0X^@
MJ9&\^RQ2D<MV/1 S_%C5K476D48I<>2V:X97$OI8/F&WA@78@>=!EU#2MP&U
MJBN_M5:X6[$\<MYR-A'1S?@PEUU(H7V<=?]P-#!U!,>"XY=9V/$26C^#YEC1
M.U5]]CX-)K?U_.IV.:7#&' N.FI^X(<AT]SK): \I"A#?BH_3^@^YPA/X7VQ
M%_8@$HQFJ97/RXG/531+HHL$\UT9ZERC3 "'[T\Z]=#E!;NB+B&6LQHUK]Z,
M9E8JVRA6^$JJ*JS==;S0%D$68^6;'+%UX!M CJS'#WC)]">M%^?JM4><[?>6
MRE/CQX)P)^//+3]%6"PZI2_]V6RF-K*\# E,\C;.<W_XYWF<VC&8@BP@ Y.T
M.=M 6/QC1S"E.9/H.J+9NO)W@G>>8T!4(,XX]7<LQX@)"C ,/:?^1N].]^Z4
MH]9K>FYXL]3L8*Y",#*'+%7P4QFL@TY@&,./X+C*MB'H\6=>1)\RUJR&M56@
MFU;""SO4KZM'()C*#-);ADQK!LHC?&RYC5.,NS>S.**FI]_N:OVLL['P)6^!
MJ9/(0Q)[]?$D,BV?TM+M%/*?M>.'C-41<60MS-'?<>+1VD#N+FXB><'.$-5$
MV&:V= -,"__O!L^0LL=$[9T0<CR10MF$(]Z 9J;"1J.@3VE,<3+L/$[V54(Z
MH9Q=C9>TV@U59"^I@6Q=!%0@09ZQQ62./4FW0T>S,-9<5359M0GG=+$WE4+0
MQ'FMX9-[0R^] ;3Q>ZQ5K955'W<XACZBNU=JERSG=M2C#YG8HB=:RT)>HZJ#
M$/)')38H^ZF>KY\=E_R6D /O N,:Y"Q+F/:^]<VCX=#H5<(M#L_(5ST!/4?Q
M68$\%^4-A4/0DWI4_]"%,/,-H*S\!K M>ANL-,#0A=#LN8T6%S)-S[E= ]&)
M S@7HS\NE7GLSWOVKIE/O7BL^.1)&QMPT,N!UJ#SD7?JV>L5_/_PW.OD/=O
MQQB^XKZ?I:O0/VOWHK8%33-FJ(PFZW=4.&U($SX6&<L*@A]39N@:J//?^_9U
MF?496"+(;JKEJ3B/A9-QQ*(!JS!OZZ-;6AK]"+(N'9[4RM8%>B)6S\'W!H7W
M#<$!JK)(5N)]:&L8377R43SJ!F XD0\NMN$?TY:2-;7*>#$J+@*(?]>DH!NL
M_OQ8[)K,,4KTY+Q,K9G7S?HC*V?5"_U5MU">T_7C2TU6\%YHHH+LS*_A@A()
M_,Y+8"AOO?-.8Q_OL# ;/5VMA'QMSS^"#1O_Q/ M' N6\G2JUGKZU.:^ H,%
M)?&*'"S/K2P1%-7H[>GH;EQ<E<8C?$]K)2N2KT>U.,XG%UCJ 8IHU,S>%O4^
M2/;V7#?4UQ4) ['-N2SWB0#\>B24[8P>BAMDH5WEFP(TFZ_$*_1M98_2CP3]
M,A.5;94%*$;'UXM9ZPIJLK8-26LFK;TD'E*?1#)?B@6[V*V5N:TY(VHL?R07
MZ>Z*.D&#,X72K;A<)$?K6MG=Z.F^CT]IJ^KJ@1V=>65P31Q[-N_(UY48S(DR
M?B3_ .4(:D'7K'B*O+676-@@?J#7WKW1Z8C63.= P((%P&^,+.-&Y>C9%UX,
MWQKSI\?X"%GM7XGP#]XEW%;ID8[-8A/<_+9XEM2W3XQW?II<?A;<9:HI_DA>
MVBI+ZV%6@G^N*>GP%#,*A 4O%O^CU,92/:0C1&V6J*QSZ*YE<LI0 /^UC&KJ
M8'WRG\4KZ<W'O%$ G._D Y98UDEK'XZ93S&+UF-Y/(<A?3)I43X?^"XGA]I)
M+E@\M*]O(?4(7-^GY0; /*9\ _  7N-.QBIE*(UWJ?L,$E]'&V:'%1=8:D$U
M<PR6YKMM[\8\Z)FFDFBN"AWSI"@HP]M=Q0_F7&=[O*0//T<$WKG5+=[,T2I^
MVR\9-)/K.L^;7NGSM'4Z--R_!#9<;I2.Q4UV69;05)AKRI*'XX?S*Z6[GR@<
M0L[B^-C\LIQ%U.+]-7!^#^'']A2"F\*M.0>*6+-CVL(*\RV3H$WE=3_3S0/%
MY RD<!S22 ?TOC]I;I55G10H!4F57]GDV]'7+#[QZ;+]>D*I"K%,5AGG=-8C
ML"W)Y=5[*R2WKKAF_HP +SV]C*-XNDI6??S4&B17:54J=\#Q21N==N3MNP/Y
M6<8+BS"D#E,N),YZA<78%0#1QSC*TNHS3]ACHSN&7F?7>9,@2$*<MR<7%Y'M
M#OM5SVL-(KJK260RWV[4ARD+U*G%Q=4;RY*GENQ>FH?LRW;EN\0\'_SM;LY8
MX=>;FWB&-ZIMEDB^"4=%MUMP==:,I[M=_(^(F(>\ 43P0QX74GM/\_DEU<18
MQY#HN]*M,A2V@0VR3;0>N[Q=<QHBM](&4I3QB]BZ6O0R91D?Q;S'9?*:'C+R
MN/4S S18I8&E:^?46TR><B9:%/JB=#J,J/)P(4AK/,^-OZ$NV[I"_D%%FCDN
M&T/)!*<1]O6MGSX]9,'Z6PG4%4\CL!3H9&W4L^8?EU5+L]1/(^2\*I7KB#+K
M\;_#I> L:-;6SU4_/MP-^1+G04Q=KZR-B YV*@[VA0BLYA.=:3R\,\@3]UI"
M3*N*?GXVC"=/C=VB-SV/O-WB!D#1R.,MVLFXH'L@3.3XZ,%%H?!ERGY6"L>7
M)!U3,*-]HM-[*;H.+1LNL1R=05ZTSB6'F.X4_R')#.=&H=U[OS0Y8+_YQ1>F
MAZPLY<74WM=EA<9$IPEM5A;)3C9WJ( R/=F#4\\F]G2SP_*+;C5$,)/Y+$O8
M?U;<QN'^CITP%0LR5W"_F$M-PRG]0[O^3[U]44>!7SRJ5U0.\H:4.-H%57[\
MIU+ZP$@L8_M*7<NORJV<AO%!(3RF7,F!*+"D;[21R925J.^HD]+^Z_T;@)S?
M^IVH._2WAFL'HCX&!E[R3 @\."2S! R\2LA]B<$BC_9/6W%0 KD,)>M<P0(?
M.0KD7>120CH+$4]#K1DZ1(XB'A5*SD&&]"0?H=.<)63Y(UUFK+D7JN49"C7-
MML@*UW6P\K--=(W=B,.0;&M!;E)H?K*K+4/N8!J%3%O\ ?$P2=89N5J"V06T
M_''@=MFGWI9W8P4E)/=VN>%NBFU8];=[J<Q,SLYB8(Q]9E?-[HN2/2?90H[O
M)23DZ(KN-JC#_ (.TVC<S]_Y1,\IAR1\>WK/R5L,.5;O47=W*4F(J0*W+)'2
M1?/XTCBDZ%^DFBKLD'>B8W91J16=+5^P+]QBE3=B/]%7^IC,T!HKT-J-GA9R
M2C*@,]L] K6:N<9FLN*Q4 )_2;'$[KY%1).S!GN0ZET_7WPI?7B')X=2"\X.
MM],7*.[Q!P<1>5P3H&%F)#1-[Q>4JB\MNRXA?3!E<N?!G$Y9:9[N^T29G,(5
MORU+Z+(DR8*2_7)^F$QB34.<\'5"$&RCJ^%R4&W=FJ9-?T2=D+6DR;;# Q+R
M(<Q ZW!OFX-<9KUA+?I<ZM9S_&T+'<^N@&.4<BP\/E,'[6/LYE2R$&;XCOYW
M5NQKD?(VIWW<7<"'5;^_=!:PF]-9!+E<NWW&)BH^]F3XJ$ZZD.$GJS'FK,3Y
MH4ML07*=BW,I)_^(L4"R.Z43A1]U0D*L2-]8SZM_[G]OL4_BBB1+)#=[KH(F
M0;W!XQGGK=8O47CQP1R>QY:5'/_V_/K[';J8UD=@G@-/M4]*G9=@ZY.]_3RC
M</_*AQ'9#[L9+T?$17D*C9@<'BEV?/]5LRSJ(TSV;RV8UFJ&7BV4&/XQW%>6
M["W'PVT-,+FA;8/@Z#*+^M/\6:>YR@R>R%;(G\"(E1!5BUJP36BD@M*; 6H.
MFC<HPW"$R(MHQ:8K&>D[,>XJ7_'S%W%&JRWX)R-R;X.YH=4JC-S*WJU?!7D8
M<JB^J"L=JM,!/Q99%?-;9AVB:]H=R?]7\B6+7#=#@3J((!U3[/:/F$6N2FX
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M5M-DE[2.#;T!$-@&-P^MP8PMKG@B+AXT8"^[8-!EC/)R;R/%$C(.K>YNK.=
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MES> #@EM(Z?K6?>XR/D$"\H@G+'U>1"AI7A<///0K!S/84O/F:9J$?EK0CS
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MA5;N8@?1)['_(15E"GI4=RS9MKKW9UM@AT:,@*5.8PK>1+5Y+/RP%Z)T7.S
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MG7W5^5%)IBYA^!6O"/Q\$GA+SCF].R ,>KJK#R0O.N\NK++M89;//=5\AP5
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M1MU,UKN@3(.9PYG?1 %T=<G_*4MDDYE%1UWS-7=3LI>GK_M\XC_WP7L!4:;
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MMOS2@=O!2*M4YZM\5!X,_H*O;S?ZX6OS_JKQ47=:^EEJ(,49M\ALZY)A@%
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M;>J&[][G;;@A16MJ_)D@/^/7=?,]X>"!D,YZXF.6I[L>5E&];2KD^T2\C
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MI):5)7QD6MOCR\T['@1M33S*HR=-*OQ$1(5_A?B]&OD=XO? M.EY\*2&?N:
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M@?^I\W -^B$<AB%3L+V4O]3;-ZK_A&ZIL-H-=ZQ%>:A&95O3*CM?Q#T?;D&
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MTEVRJ#VSHZFF8]@:/?NVP22L!Q^<>E78C:'C:Z9')A6XN?YTYUK\%6@2&17
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MS=E7R P"-PQ7'VI>Q8== 28J(.=WX:Q_ZQ;=KA/ ?CVZ IR?0*\ $N05S8'
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M*%T3N^JDPL/3W3W-W0TW@@N@N"*<X!2N!<K0W2&($9,>;<:#AXNLJ[:R%^W
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M@P:N  8D5P!MM )0<_0H[XL>J]FSU"U1WR'B9%\9 G=?16&'MR\<.D_I=-_
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M/Q/\Y01/]%+PE(!-R?*TZB<(K,.$G.Q&S?M8+*40+,A7LO=2]G;-Z0UHG S
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M6^=K_K/&?I*VT(-45\,.#\7R0JS@,$=*1URP&_]L-G_5T#O=<VN #R:Q<JD
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M5^ V773 T)%NKO P:_O(&>E<L1O=N,\3F9[,52'$-W1DJ6X7,\7) G9;JJX
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M#927KQ(>>LZ?9CMH=G*PS5Y[1\J&D\?KQI.8A62C$;X4"W35V-K-_;>)+%>
M1O)?D3@I\-D$[V)S0#S]\W+J<&2;MF;56QTP%R?1/:I-X<-SL$*!Y^.*"S;^
MJ#Q=]NWL;W4$+0,_U1XTZU+#J&6GHG."HM=E,DVGUU/@4U[P][5:R_TTM.3B
MW^@EBJC/X*WGR'T_417J#YO!+WP/;KH^>41D-Z?$L+5O(%MPYT./A K/W4T+
MUN]GP*A&ZJ8ABSJ*VF8@I"NX\$]F(UMVL0UBX>"9!?"X[3SD!_9=71J>J,E2
M(/:[ AMN!K()@^MBTJX C/OJ?PD_Y6/KPE%"NM\.-R.K<2'NQP/7!/1 \=C@
MXGJ[9ZE4%V#5[#_@;C5!HM::[S6O>@3B:F2Q!9L$9U> )0$LU/8*,'$/%.MU
M0]E@A:\5\J<85OO6_UD\C'P LWUZ ?HE_J3N066,4IIAO_BG;US;4H[D&PLT
M7/[0UA3=FY*SE.FZ'EVU5P"$Y ?\-%P?!8-+4.4=_"<2-^D7.ONN &43@WPK
M"^4I07Z_7":^/3P5V+VQJZ[\^E(>7#+XC[K%;3I596KCLO>?>.[8_G@09JMT
M5+B*ULNX0+T7_P$:3UN&G]V^5CGT G&^8XCQ$E\+5:H^6,8T+-AQ??N ^:(+
MDJ.8.)_$+%\!W+\)^E%,% +_XH_4VLSS,GO2H]NZ($/^\DF8[]T3^*L<C<]"
M&D_._>2GW*#39_3Q4F[3!O,RIYPPY4U&/D.G/EDBJ1G<$^ ZJU<,L%+&3<K.
M;-E*ROU'VN7J%8"@))6]%N@]3W$%<(S"O6I,#D0^<_H.YD_E> -R,_UU_8//
M<+&&HNJ?)A=H-SVPZ= -^6@I!T1MK90Q+*@"L2.DBAL&HO)&P".K6VYWKP!N
MI=@M^])#SK5IUE<U 4JUKZS2]DKXGC_U_R?9'O_"O_ O_'\#4.3OW2/M_U#P
M<><+Z+Y28M<5(!@D^2:$!<YR_OK?XK4=3;Q;-A2E1OFL0%93SSCKEM%HT$N(
MW A&:)E%N]_KIANW<+V2-4UXCUVM3(WHRNRYW:8XPR"'IWQFW\\Y8W7<Y\C[
M/V8=#7'N7YJ<QAT5=%JU$3'VC+ZF,XZ/21[AK60Q>.LOUWT<7>HZ%32'R<$J
M='BW/##4.XJUU6_P>DF?Q6U%WUUO4,61(8*:-T[EKP#-91 T.5,,&JI1[O-L
MU#*C>0;Q ]CC@/"\"9+3,UAA*G##DX)I2AK5VGXVX:E+4Q<$>#\9NJL6$.3$
MJIP+9PA&WPD4"'0R&;'FM(*E\MV1M/ZM?@_WZ!WM"CX:_A$C FN$^UMSKH)5
MG>SE3#*D #=!= NQ;C;^#1RY& 38=.4+R9T%!\>SI[S8R4.?A4.^(Z?P[]1.
M813.I4&+_C>?1?Q2A7,(N8<2*AYL;'I6Y[)XF6_)W[ZSU&(TL\YW;.R9E7<%
MZ-(^_),;_,UB>ULS/!*5U'5VN)P?BSY>8@B(> ;:_PK*<9]HB_?'XN6XW2)7
M^_C+V0I9?]SG /I_V'O+N+B^+5NT$D)(@@5WBN!.L.!5"00/$-R+$" $".Y:
M,0+!"B<0)&CAA;L$=W?WX%*X%%6/_$_+.=VGS[M]N_O=<]_O?!@?%A2;VGNM
MO>:8<XTY)WD=RY/T.P:[(2K,XYMKLVDA491=>#@5JKZP<L_]SW7..1ZRF<JN
MBKLL$LGS&HZU5]WR,C_I,8!8NOI,H3AIS_J8-VNEH A$7)W6*WORK5^S.9_G
ME;3@:G5>WKH6!3ZO1_=WYA=4BV%J APZ<7T"HF>:[V^=-:&X^IE#ER/2(ZCH
M[NOH4#*$_0ARL:K:ZFH=#]E)\\5>'N,[2%AD[[HB93MDM^EI()?D6-GF$WW?
MQDP4=;T;</FFOGF^&U^Y.7QR-N>M'7<L&U;A@UL=]3[;!1O3L,_E1[;\'EG^
MK>&J=?8 5"'\ (6OPB6T#'DDVBVXX0N&N"*CFS" >S'93@V.=9J44G[;EO0+
MU];K[_R$%EK>,-4/FU8G\DJ.1K??/^'Z=&EV4"C8.L\VYJ/O4EFY>,_T@BF,
MA5&T=,#GT.U,<F70(6<H,F9*V_%A-#5,L_@OV&&^25"N;L?$YS!JT4 ,H &
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M;>PQTO+$NV[7[2<9U2-6 BA+5U:4]_TNGKYIKG!H$#U^:-'T<%0(JN*P\M#
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M#\<]WMDL'\WE\&FSM>/6[7X<<MS,4:JZVHQBXED[]()D%[Q]#3XVBNE#D6(
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M8P 4G-U&ZJY>VGE:F/OC\6JD*!FIP=J;;]&S*V:C:"YHYR=7#,#X=_*TO^=
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M0[SYA8Q5'] [$44,&,#)=6Z;1THS%YWW%<3PNQ4U'8M3)>-3I<[))2VHA^.
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MA'@S7\[<]3(5'6,J7"!V:=P.GN]$NU2;O*Z.<[HFNPV95CSC3;7/>#_Z\Z/
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MS(G#(U27*5;OFAKBK(Q^95AR[75S[*DH2.:D7$ CE9\@F!8>B^E?8JZ/FV5
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MJH8F_QZ;@;/]G?G::S8:]O!W)7A-=60D*XR]3S+F?Y6<^,\YV1?@,'W^N;:
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MEAX:2K_2B\*4S$0M'U&=>EX/O?.D&VQ,"SF'WD/X^O"M>DN(80[AM3J+]2Q
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M[7[LN58U$EBLJ6F;8ZX/8_&ZC%K5.1'7Z9D6G"9S)W1PP_JN$DQ(4_#ZRU5
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M*>9Q64BNBFA5G+-;7H-V_HB7:]Q@[IP2#Y-.$&4OQ658!%S;BO3U(S;_1_@
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M5&:#^YK1 KZJK[6&IAO3\,]^OKOV&L&6SGL_UQ;J%N(FUJ-7ROB5/TZ$^D-
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M.:7#[[LNRX3\]0<UE(>YK]_8 L\]+X<A/PBG_'G&VZE0,9XPY1@NOL\6#VX
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MLOOY43(9:]KFZ$2GOB'*5]"=*X;>0V&G.(T8JO*U&$I,JP.++=R9QL7>Z*I
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M:1%WF<G:,#5?6+&H[;.4WX.0R5EA6S%2-XXHAUM6PRC5F+4&R871RB0#*MC
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MZ[51( S"YS93P!;/;E>I*_0:3JM/<M99H@ 5W'DF:[KQ;O?U8)R9*C#87G]
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MJ,<H22@/L[T- &TJ;>EEA[(09%Z PI/SL_+VW73V;VXTPB_XO]<GY;#R1K[
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MO4Y.+KD$8@,8.'IZQI,TVL7-;@#/^N1O (A4T/4CF]G=K@;=K)UJ$(U WY9
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M3+2"-@"D=1.]=)T!XK(KQ(K!N>C!M8WD<;N?"#HL3WGLY-@N;Z#M^W@!Q0W
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M\9!.&;IQ.3R_7?VZ:D0%4P$CK;X!T)N#<MVKP)-UD06&NG.RXD1\"#I36M2
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M2?U=J&/ _0KQQZA7E[MZQL3H%(HP5$:/_)FG13]V%_%:?LF$?LDD;7C;RO6
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MR :UT+;?3,AKAL,V"K%@.I]LNQ1!*!1[=%4QS<  4_N /HF(7+RK-XJ\.[@
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MKZ=EI$%79NU.J4T;=K"ENS'/!,@0TS'^!E&#5/&:E('#P%@4J U.W/&XPTG
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MC/R^92W_/R-;'74/62M0,FN#9Y,(XF2"WT7FR^\#(_&77C-AMA"[D^S_ROL
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MNLH?P&/9Q. (*=@^/T_F2R7G(=R?KV_'P"?06S_I=C#$93A&T6I#04VR6G>
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M.X#!V%]#SL?/PV[DUM1UIH@J5K0\H=$H!C0C>Y-S!=X9;)P<:<)V%+\@$TW
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M #:(^0!#*/RE4_7F"33D+&3BE:<<U3H.@/RX SX\PP%B$S <?^UUD@X<1.(
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M/_E;_;;WB1F=+T/X%WH&I:_C.<<H]@$(&0H=!== \<NSC>7Y()I&O:?&RST
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M8N90J?Y"<A]2(7!F?:89K=AQ5=S?T)=DC+?&]*95TF3E69V ;(/"#(UC[R\
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MI3GDS#=WO0P':+^/-^&#-K"++2@Z93&[F7:I4,[PX[Q&P.8KZ%_N@1%W1G&
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MELV4 VO11:FAEW[_=UG;%$@"0OLT[#BYAF&1(EYO613;E1@FT!ZSX';I.:&
MX8"=)X,/%'" 6MT*#0.N48,';Y!'LXVFR2NMR&SHMCD.T O"3NL\E+YU&:)1
MTXA7D1!H'+]*W2^]^>K R+,T%[A!-JP6YNACD/2JG+!KD62VR^1!]5C>V.H%
MLYT2WO5ZX7KP?2OC[)A="K!?6!B99CQ<NI1?=C^V@ZGI;AO1]7"AF^'B'-<
M6IO9N9G9X1R 0CX>[*29HUVC93J#0B-=M[Q >$8X8*7IUI(Z^BFT&KS\]F2Q
MY@QZT-$_7>5^H2 V?ZYK)D>YQL[N]OQ-=FDT<!*Q,>U[ORX<KU$B%DJL%WS3
MJ-/8<I&]W;2C\N5P#B>G.18"IH"O/I:(C9/6:#M)E<NB-9\,1?,+\/2I_<%W
MT?FO9J)'RXWA')%I;K=DE/23,^Z/@.NJ;\_S#1Y(CP('12QVFS9$OP]NZ+?<
M1,(P]QL>SKC/^DZO&PEB+1/75KA*(O&8N<.;7:HU?NR^6C6:FW\:EVBL_(5
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MV_H-#1[0:0@?KH]2K0_8-MPKX8R%L-,KLSGWM&UK+RW7"?]>*XE:\C0/_EN
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M5!%!BR&R:C;]VUX)]I^C F>EPK\<3HJB102V4XA0ZLZ+Q==/3\:%*O<_OW0
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MQ-9"QP3..3""[/HWO"W+<70DQS4&(#L?^&!$)E5^7\A8KHA>O(3@7!<#?<U
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MI%H2"A12%(D:[75FHI<:]\!Q.@EO+>>(%4AD>D8</T<:O1QJ-RQZ+(0];Y
MY;;]>8?R]-?/3;!@N3M&C)-<$_C#!3CO$O';K5C%RX8I_RTM$)IUT1QO$>9
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M8G;R#]*4'>)+_@L\^L]*^]]J]9MG3U_>9#D?MAXIBI8=]3-X_5L1&KO UMU
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M=4;OA$KIB2W]M8OMJKT\7G,"TO'23,,I#QCH^IZ.0DMSX>3@&E#C3)4[WS&
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M;XT)."5PA-!PXF[OMET^&(8J,<SS"+:%,K@?[:2[AB*?\Y\&J] NZMED7JT
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M. =;E\?3=*)CFU,FGOU=DPRMVG&B%2S4D74G@O#"G[@/#_?9S9Q1%V3EW4@
MM>F[5)2;+3'Z#+. NW^%\J!+RTLJ=W$#9W>/>WTA4<XVR!<00BK.4/Z5%=AQ
MB^H[6P(A\;OJTCBK<U(H?[\?$\3CD+[^+)+OM5O6DQDM:\XYT%X;<B!^TT&R
MX:;71M/)XD2PRU*P&Z=,!LVYZPN4M(\2>.6D&+>]<E+^BH0'ID]-%:D:N0W,
M-RBU;:EGO.E58NQVIX+ F]X;;0M?6C*_5A8:X_ V:>JY0\*%<?ZR38DU_2]P
MLNFZVKO0[Y1*QY"[62K_;+Q(.!E$< PL2*BP=I'^MA 6.[OM8#QLVN=0PBK%
MB$ZD>/%2;T]WG?X$?#B@-&;6*9"Y7_YCF&^&RBCW$]%[(XMFRKS.X?>H*_(I
M<9/>7'YJ$ ?CC0P#]+MN:%49F R:I@H'6?+N&&O=\RJ%YQHM>ID>A&VGW+JB
MTY+Q<%=[6>LV?T/M1?.N;!]M[Q7_SP5,GJ:'93S[0W/F;%AHH]F]TQ$7@OI=
M/YE^*QVS=$K)7I KD]1T7M+&\33$'6@UO1\]$>WID*',W:[ _V-&[LN[^R(7
M.2^VR XV\3;E+MM(J;F\+XV32_HM[O!H(TS_?)^SY-6<=A#XV?-9A&.R\<R)
M4)')'BO:H1<X+EM]OTV0V,BSE)#615G%.L2F:8G3P3[9Z/:,U?"WC'%5DH W
M.Z?Y7>E>,JC3-*M:7?DFUTI)G__"[T*OFXE3:'SB]H'UG(&3L[L!>MHZ[+7E
MFXNA;+OPQ_DY:GT:; .6$%7YU4W8&R+G&P<^)_K.]K@;4O$ 9.M<+89CFOC6
MZ]*.W2:4U><FPNPA+JC>L7<R;HNK+ Q?2C?Y8<YM7;Y\):2S%(>8$60_CS+O
M:2P2;C=J,)%YY/)!+W2AASY=2C%QZ_:#[-4X;LU$+7OX25S7#$T)G>.P2FFD
MN0RCY75=V%2I*.(5!?8:O"S"QVF6?=>/O9?8QHJQN:UZ6X$$Q(8%F,M,@]0Z
ML%H-,C7T#4-@J[**00FIS*<546,\'WA; $"4NF+9+KONCOGNW%#6LD*6(+WE
M/[S6M8:8LSC@N5,5Q9W8"D=^A(>GB7X+4Z#D>&N0[]+A[J:,5C '8\M4/LE_
MAM^F.4<"4EM7ZA2C6J%R$P>S0S5O<I:-W0K@&<C,J9:?)II?V%W"Y6MKEI.%
MC$SCORWX!ZLW2.\@@GW ]MGC,9W9P9:Z,"&%O8\$^I\WO(=J("XXCV8HW8[]
M^_SC4L+;PW.ODAZYL4M^G3N7E,J^WZQD F;=2+T7J'7F:V7W"9M'Q_;,*@AV
MD]<FT3FB#P,8[>+%AMU.'SH(U7NOM!GP0\Y65;$]@D8\WC"->^7CX3Q[77A(
M0]PDO<A*[;OUB\8U'7J9;U*<X3)6IZ:Y@UK #(Y7U#_Y-:2?F#H9VD*S5F[S
M\\/.#LOVSQK_ADJJN$#79\7CC$Z"\D_=I6PL!R,JTGF;SQ5-9&GJ<[NE0<4,
MJA71DOB/^3;$FLRC6N7F*',Y3(O2X'/YR\O#DO'6\R55XYWGC;Y:D9W:R\?O
MT0.P^A"GR0\Y<#_J;_^DC!885Y=I8>=WOB2POGMF7;]6^3JE!B?5YAS+#W8I
M4**&<!BSA?'S,9PW64&>"",!IN#L'!@C>.[+,FJWA:P@N9]!F,:\P92V-_=N
MM%&VG>&0TLN]WC;MWYJ#..\@Y(0_ECUN--[A++-O\B3@=-$3/1[@)82RWZ)Q
M/Q@^@4<HBDUOX-]IDX%7)ZRO'/%.9 *G.Q,#?S=T?G=+W*5@BH+QF)G8R <Q
M$G"\8 .M$?8S<3JMK+8D:<BI6,6G8I9WY-8"=?RBCS*Z"]QX<#_>+YE#;XOM
M_5Z*8V?F\/Z@2]: 4S)'5W>(NJM9_\9:B3J-<-Z\D</"[<5EETBB7$2-$?QT
M8$L+C+; ZI#M&@E0$](\1QMY4WF*3]Y*3FK:RNTJG 348RL?-FJA!P^U %CQ
M!S'B>B>Q6%H0+YV<=]<@NC>IA2NRX4('?\Z]$*/$\..O!Z)'].6$'_:75"FX
M94PVN9R<?<D1U!.>BH6S5%;A7F,O?^$JNFGL[ 2;>_:D^9ZDF%7MC5LL!X99
M.)EZ)G/Z/K\N1Y^.SR^&)2D?M39D]M FT$.]/BLHV>WP,;+-I_1L;80>/-^-
M+XB98;5N[KEJ0[%>63K'LQ*];Y@%\3 KP5X+<L@>.\NDOS\[&<U*UL3@'WO9
M.PY\2)-^GOX-]/GQSO)'7A%WY&B6Z2 #M1S8N 8-39.:T[[$1![A[Z++[3(J
M_A^4]X(<9[GT^37YY+3/UURO,%Y*FM<O^6<KW5R9N7EE]M(/(IMAM2Q[]#?*
MPVM]7MX]KK!+>/6J=RLJKHF,;."H!\F<@WJ;7>%K/[J531E7XW'%B@>-YA\&
M/\G3#(*,<5U.V:H)$UW.EZEQ>HTXT*L?>'Z4L&#L;O/,8#?3LS%1YR2:EATX
M*V8A "X.#8V4J(WV9HJAC,IS*1:>7]M\2%$=RI:T/Q>_6^D67UGV^'&TMIT9
M\A3..@?QUL?:%TTP.<L:=[9(YK&!7O=4S1<>ZEHE[_P7L+/R['4SY7[CEO-U
MN?> ,Q,"'82A%N<1(KNTLX'?32SRS<Q-Z:D8[HESPNU;V>WAJ!K30#:."OGM
MN9K,&O8F%FGYU=)%Y(N<2P4E&8NQ2_*9GHQYFFC&M%L='(/S%WR>#Q3T/_V,
M'C"J,3?XY*>6BU\^#:+"%;545DM'A"29F'#-6OE;KA&7E?%2ZUK#\6HQ)4D!
MLG=B/PZ.KCU;XK);K(M\Q=?^DD:NR7!@&^=F)K2B5?Z@9^)N;^F]%S3-?JGY
M\NW=XYK? [O[& .G&$ZRV??>SEX!*?H.9;["B35^]Y$?+.GBT:7D$PC06SAA
M1>UX:Q%/N[UD J4NMG5CU]+&ZN\AKT2F!@=+B4IV<?K=I<>=V\Z#OM]UW\2M
M3\E0V3JM/P[58(!P5<@\>.12_NK6=I.W9&"Q2K4,>D5.2 #$+>\.:ER(E9-3
M+8B/,BTS*0K_R)K=OAN<J\1@*/*_E 7_#_V_(\9FBQ$[#O;!C '71;JFMPNN
M/<+<6B^I=_8*ND/&PFQ4:X22%NMKJ/0%GP\A"\DPMMXM\PS'&-:D?*0:.CN
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M^#E\K7L.,DX]&A/TP"Z&[R7.Z$R-'?12ST%MR!P1!"F'E#7,&(6\/WS"6?'
M*^$%;I65&DO=5]F^8)OYU/V>FMHB;Y:CXUK>5]OU@JMO& _[U-!ZOJHYI5Z[
M$5E=<R/+0Y(Z.Z-4[3)^MWN?RN2'G>)-^5 ?DNF;:UOY2#?+CBGV=>W&V+6'
M6]MMC(+I:^GXX]XR68Z/>8ZK6)VI. @1X,\/13+B H5/X]P7]*/ $JGU+4S.
M-6T_6+;7?5\7G*Y#,:V[(<XI9=B5NO>TO&RZ'$6'XG>GBW))^GQQ@<W0=P9V
MIFXF\;BOD">M"::-EV6D(;GYGE_, O$,3M4S%1+"KF504QHI:.)S;IR)&U;H
MT'Z#VER,**,8';GE^%AW[%"IHW!%7%OIB2L5XQ?)=Z[JWJGV\H6932]8;8/7
MM2WD1-ZXQ/<:&#YH5] 1I9$]I_0V_DFODK(L9JR^WU2=39M'8/.&/DCG&0LW
M8Z+M#!T3\3%C$ORQ\W4BC:,V<H[N6:_]2?%=LD!>![C4\F$+(M$7SZ):-YPO
M=QKTO#(+NG]P;-T7&[^8.R_,L*R[/,4[ !=BJZII> U#/WB1B@%.#<7(>V0C
MW^4LM6B,+JU@ARZ(T*'W*8W0 2."1Q7IS(/1*$9;CNO%8DMQ5T*P7,*;;:!!
M7[D#P\1)GPM%OB>M^DN,T@9\OM4E9+_1#?>GN,QQXZ4M@I;(OGS@F!<_E;7Y
M\%W951/^QW.K'KNCBS+3')^ZVL43G,Y?X5M65343&^%-B5^/;.Y>960XW]D"
M')L8EAJ2#FES8H#X<HO(5V4(O)I.K@IE.["4R&0H[+K4QO">RZ'52HH:F_GT
M;;PW/9RS$H?>M6];(P%H]LEYE;:JM?+N,V+$@IJ7M?<&H7/"WB3 ;(X$](0Y
MW#D7L^[R)$?MY,NBE7B^TU7CZC2T>W$/QN^<H8U6.>>R(\$8GI^Q_#@<EF5L
M%G"(LOELU3),.<0D[5@J1-Z/M+PYDI7=<1D)%G8&[IFO@Q?TB$]C.PS[):XJ
M!:;:NMYN.ZL)?]TO>\G]267-^V)MI2L!C.;K1*36^ZZ:JC=CX(VNRPK[\6^0
MIGUNS*.6.49F8(UOIIQ)GU=M1T-6+$.P04W"."6)O3X24%@[6"H!E5PS$8M,
ML'Q,=!N"&)J3@+=?&MSC$:.U7;MA)* 2A7 <MEYY#:M*2EQI( J3@%:RUB*\
M>+]OF(OG)P%13FDD8-R)P+93C&;4$'?1R;ZN_]&D9_592LB/Y:,D%[(("UP#
M(0ANO@0=,8>.IHGLP^S'JU"L9\#2V[[2&X>*ZL4UH_.$%(:XIRYE+_U#]U8L
MQ"$D@*@\:4^L-3DP[*UE(P&1EJHD ,X+W3YF,OC6DJ&WXTY:NM2U7?'%E.\9
M6/G73M?:2KI$)5=*UF>I=R1"-!(%TRMRE92<7)P\:&+'(#_?;4,F;H#?9=N2
M)5LVEACX^5(-8:<D1?)4?WNA_W9;+LUO$7C'G ?^PF3ZZQNKV[CJ\?%RP50B
MOH\2]/GK:0;]TW(NJ@,6UN'9UJZ$FW4OPKUL"G.WC>LUY-Z0;=EC)6MP\#;-
MW";*M)])\XOQ^@VHP-!'G19Q>RX=@<BR*Q_F0,V)\>=M5^5#>-/$PC 1$5 T
MWU )N\RAY"K"DG(_R8]  FY.?;G';]]D/(I9"'0JL?9'VKM267:+JE.Q[%+.
M'9[: K^UV)3"O2?TDX!4.F^&R!9Q+88L.&NVP3T66OH'RL[&>FIBFR+IUS43
MQP?0M6R0Y:UF$92RKRV#[EB,O!7PUOKY]*,HA7TM/^BI]>626)AUIN+\P]'Q
ML:9AJW-\]*VGBG2O?:D4?V-W,[KJ%%_Z>FZF[5?6PT.3!UXL/_60/VU+C6L_
M9Y\7D&!53SFA\L;-Y\SGZ;XB]L%5LY20Z[2\*45<6(X@NA]E<4;]44]><-JG
MT<$R7)0*KO5-]*=$&IDI7J=2:;V,41*DN(5BANP1SYG9:_8CBOP&=W_0?UY8
M'=UR6"K^6<6'1;Q'D"?I\;>*!][<MKSI#+UA4I)2/#V\60M)K ^-[8,M0[CF
MD^Z=2EW6T/L^+)ZHIL@>F&WM=GDNCYEFS@\8<I>H'$$H,3RX 9?&\C32&0LS
M1M#A+-1#=@_ .UTOSDS,W@*)3A\;#-[=@RO!V3%?/LM+V[^=C2@^(_=9>3O_
M>GJN+ZV]:B[7GDTRSE ;2T4HJ<>]5PNO7^8YYI,Q$75<++)M:4<"H<1(-QF?
M;OTHI:@ KY R<O])]>"JX#RH3J+]"CXXU[TLMJQGOS3NQH12@E-P0^B!E?93
M9I,+ANRS"':RY;Q @)& \ZA2 KR3!,02S;N^0$>ENC?ZJBYA4>&H+8 $E$40
MT@W5^'15/P]'A]WL71ZK(0&[!N]]L_;]G$8=YF =DV7N@X*A6Z&S^980SB88
MYO.S(COPDT-0W(L>3S^GSPE\I2ZO">M)@QY-B,UK]HA=^G(2T.M@ZE$GO']!
M&+QZF00<"$DS&'(^FAM4X@A*ZU72JQET71.G@$+M[>@59=L_X[N>VDV2$06_
MH,7]@6"F2V'IO11<"M*UU/<Q=FM XN[OB>2R"H0<UJZ('M6+/0/G#*# BA\3
M9/SL,"-X9M,Z9-BH/S/FW;&KE?>XDOR!H42F;]%:CU)">"]J&\7)7^U9_?FL
MH"11^J3>!QV3-!V:Y1L:YF45955OU1UD7>YZR3I>!#7J%C'V2PF"6Q!.V)UA
M,A0I<O>D:AGSP:^/B>VY8_>'K<TET1O[PO&PPW[HXM6:J((T';MF/:NYQ*.X
MM*,BOVQ;#?:G-9P%G.\F%+76D:U^'JY:-=E48ZXAW[9/O?^)V16G5K)>=1#L
M4OO+ZO\-HM)"&>U1F%"<XX;AH>28'[)HSV37<6*YYH7S7E%_"0?C, )]#3.9
M =]U*O)-A:Z7;8R7C'I-VZPO9'HUX[)) !?*@ 24@@^D>'&&1[_(RJP4=2"U
MHJF_NO'3NI, %U;WR[148C!XFFSJ]-:';$=.&I1D+:%&$=:'%WDZM_8V]DNW
MQT3,8B"H>N%]-KP2<8G\% .+0W7?/V].BT_06?;F_MO\/KN01=W]-&3%J/]K
MC"H5=Z72Y?!4RL$5[R_>Y7=+^UO$E5.;T:_Q2C(B9J+&1S.L@#-!4!H8IQ$2
M4/RH*F[-9-<WD;&PS-&E(F@OP+6$O$X1/X^1 "?0H5I!@EY:M&B^)(T4IPV1
MV2D0L=!"GA9"FP1@VTL<L!'UT97!EW8GV*S3_2]#45S#4*,R/XY>^*Q595]>
M!NT-CQ]I1$AK)L2=6=#BI\4+ K]QOT2'I7.&>8/;672H0U3F4<!\[LYLDA!&
M"?4F3?X:)J83TW1RTMFIRB-6;(!^1M.3^M9*?V8*3K&Q!U+4T+.L+1QW[;Y+
M$Z'MA*C\I\L13V1Z>;DJ4K^AM<LZN)\Z:2LINGG:6])_\7"AJS9JWC>]C,S0
M>&JGH61C#/%70GQ2LLD=,56#OF']Z+)/82S^=Q7^[Q_I,B&PNO?[2ICZ75>D
M2NP'GX1^8.-]/'Y+2LZ+HF=8>T;&07.O8<^]4O:;DK>HIRW7ZIVOLB+3%Q)L
M.'8",(<_5J8)-^]5/GLZL,#3%2NOK\?!J K,)LN3  5##CTXY_6*TE1VV4Y]
M7/F0H783'&?YH"_5+WPN.KR%-C?)OE? *=^-G]?I>:;J6H99;VO0&S#2<9 C
M-]W(WOCY$#-&8&@S5#1IZBU'H]=P#/Y237G98$D^O;=<WMWVMPOSC\:UOK6V
MS.L_:Q?,%] 23Y9@D<GPIF(PL'A7,FY!M^@AG3A*]<0B2FY$%&S-L8#7LNOB
M7PS[HFKVV>\R=B@./>FMU>=HH,I==?CS2GG]R?HHZ80$C-1LIMHR?TOMI44/
M#FXLW7"86T+%5G"IP9S8-E+NPR-ZZ)[]B%V.DM(H2]_'C(2DR>/5!R1@ECG(
ME7!ON5U=0W6N+&;&)OQ6>Z&.PN6-.6>SP?GVT8<39K?:&UA5[CG_8"'&S",H
M\Y-,?.WUXUQ493LX\(_.'WM*!E,!M[AMKO%%Q8F&>L6#,%4^$B1 7KJ,<!!!
M L(-;='(L\80V+T(O>_ASZ8C/]_I_'I3H6Y1A6!O$!([LZO4+*8UY;%/]6]^
MSK^E27L!Q7R'+E\@ =%@0IB#6H!:V9QA(=*"69G>R6X-:M&SP5M 3V32(MR!
M;MJ0,5+J+W_G^R6_(UHT03\C";EOB= Z,C*9TC8%X05@!V])P!R2!%@J__9C
M0 34@8-OT:^9\FP1Z?'AFR'39/1H10(&>$C ->CA)?"O/^3_UOHGJ!T:#,-
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MLI^V7$I46R8*JL]\>H<G6RG/_12GDS*>?L^V#OA:1AQ)P,(0]'#WV2$="G]
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MNVLD _&<WEGCO)*G*)TO]!J].Q;1+]7B8XCDN-%_I1=OD?/0).OAU81].W"
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MPH]A#<-WZ)G'%9B2+3.;>^3GXFD^W;HX__(A!G)KYW@5_>NR\,J,?,N*ZK*
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M-5O0E8[*:">W[V;,@V8)'@H6XE5E/W^>OAS\;Z55"VZ8VL?!F'>^=)W6]'^
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MU,AFHA].S1^@[$,ON)<45JZNALGQM*9[BNPC7N9J/. O ]+5RNZ^10 QVQ>
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M"1P^KOLOG2,ELAIOX:B_P[$7@($+@">1](+1)&S@\NRX)?M,-@C6(EW&=ZE
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MVUD33N)\PS* YU:B*@Z*8[EB'HJ5PVU8APM E'SL!<!X[G*\3TW;THS9'[L
M;.9(]VSF82+GSQ]WTM \M-@W^#JV5_ZEYK6:S&TDD:5TX"SQJ"?P6C93IE!Q
MWG+V_:-WKSL'?_9KN0^O0'MG%'IXBQT-(1A"N<6YDUM"<V>$T["U*D0J%N\"
MP+H3>@$P 9U;K0,=.HTA[:?Q[[E"N7\4?\YTD TT8S$'UB(>H+K:C#WDT,+I
M!48SZPB2BM89T^AO%-MQ^(=P926Y/.J%^ZK<K$481$9/B:O8<G5P3FU9E&IA
MH_+!BQ/&"T"+59<DR>*))'.)T%!P7N4G80AEU W@!XX:Z;&F% 0?&M*Z"=39
MWA7T"/B<(#^-*EOA.0%%Z*Z/K"O'*TXE&%YUUW#0OE-;/$>#9:H*? $34 H[
MN?+S^)Q??FZL0;/3^T%RQ^F^):7<4MN'NWY<JY97(!RU;)<.W"BMFYKWKAGA
MK!L]6,OJ_O;$N!N(>=#<7SOW09PF=J'$<DII!+@4P_!*1$/"K.)];/<:6*.!
M]*NS6(E%H25TI[BMHK 7?%HF!?D[QY80Y4<8U$(NP:(NN%>7!GZ16HL=C6RK
M[UTI0)=71:*&KBYWEY<E+76P9;'Q:+ 0/\27O"*OXKJ(M:J%47: ]*]7J,>Y
MRM-KD*%71YTG1;?3#K>UEW#\&)GS3 ^>S(7UY]46_,,&2O$J,[T4(^!4J99U
MK5I>BUO&6F5OQ6>>=GE3XEIK:F)U*FK]%#^IU"E]8NMFM6W=OWG0@P^T6DTG
MG5)Q6U3AGYW1S_7(;]NF8UUAQ %A1&N:"PIA:3;AN5F\T@U6'[^<\DGGN@?Y
M>-.W+UC0:C3'VSK+UAAG+_FS$O 62 ET,7JYJ%*-E-?V(34J$ODK/S3QK<5N
M0*E#3F<>"Z??CY';7?[<RKKFDI[G!>H',[A.\MZP=.SP!%9L?I9L\[\G0M>.
M-^T@LSLR0KA6I>W\H(6:E8"BE7H)S(41'J?5@&(<]+))IY+Z-2MUSSM/CZ33
M+4,<(WG9PJTTDM(K E<SX.$-/"C!=I.1JOR>:PN/G09F.#CV2IVP)JBYH],)
MD/*8=897P_WKS(,%=%.X<82U(Q0Z1R1I5A9'KU&VRM#1IW>Z]_,<E(>::[6"
MITE$DD_GO"55*:E_-?4S.8/Y&7I:<RFGTEJYQ$V"<^+H#<^=.E^.Z@2QS"A;
M)=;GO>VC%*V(F$J3$^+9"\"XF_0!JXF!H:&,N0UU9842%06G5OBU*[X31&CB
M.7\FUMKFFE1>IXPRY7Z\A&?S*1< A_@;\MS3KOG*%OI,ZU!B=#5.04+ZC!".
M"XMIW&CXMLC1WFC2,<OBAVM;Z13-KM133)T6GM_QN(]<H:8RBRO]SL?G$! -
M^^W/NH;01=)(<##22\XLTMJQ;_QAU5Q\?/\.^'TT1K?.E;@],8T&U;M>/2S#
MUF;N-<@'\H]4(UO7Q%2WT;\+/5BN:IQA_/(J(Q5\8'9XZN\;/0>L^R&?%2Y_
M2M<;FLI6EQV%&OC@#=S4H4B>X7T\LNOG*ZA+$RV?_*5'AY7 7'15B*=^D2RP
MCKM>T-TV--_(OHKAJ5[Z.^QUGJ&3<>("3R:T7$J'-;*Z.;2P0>.]E$=0)]FB
M=\4WLO=,H/J/W-\;&V/,$Y.<;:7\:(J6X<U\Z5*&AK$FCW]("HCX2LH33,HG
MYH9^_'(GN#A;R;1U'LE4L^2A*XTNET_:E?_\XT6DP\]ZMBF%.R:W3;>(D+BK
MQN_\L;1PC'C'8M7KI UKMV.>AR9  '.;F*2WV;B,H\W5Y8JJ<3ZVS\JYO[CK
M9"]!3,YT,T#P]]YTK@IK%&\ 3MR_G5;3XC26>J0T&9:$!];ZV*D(_- B>D"]
M>>P-1I6DID^:&)4[@6K8^&\P'B ME_P'[+'A;O!@[YMS[4XCKNY:-54N S]7
MO!#,GSD"\:?]#XMM)!8(0W9V9(T-6TUIY-?9/YE$8*ZK0L:9#2:54\XW4P;C
M+:UB$U:E%B\ %-(AGDJ.A?RWD9YL?&GY_CYDS8X[*A[-;<TG]TXAYU47@*$!
MHWLE*(B:B*)@Z#?I<BYENE*SMSL7@*]OJ7P$!E\WBK2ZLP\$2;*;YLQ*0B29
M7J^\CX$[A;43^+A33,;KR[5RQ@?!14=M%4_.NL8@ILCOKSDTZG<,7NPPKQ)>
M )@05BAX)%;*;:'^L7VA@8&1S)6<P0%.V=LW[>L9@NB04EX6LU(H B:^P/N+
M'PTM'][76WX1[]SO4NUI+BI5YK[2D+"ZP!O&\BE&"@P*(/!!&W7B'9]\D,Z5
M:,O1L!WC2,BEJZ9VZFZZAXD8^9K&M;_%QF\PU?:9[2.+&$&,PN($%C2.H_XI
ME=B^+=F="W78)_<B9O1^CH\9)UE ^-,.O -V?;@7PN!TIVF V.Y=ZQKD$?@3
MPO*)(E)+CB@$H*WN ]AZ8-DO64@AF*GJN9-SFOX0\]LB,W4#N4HE6)Y(E5 F
MZU.SEY('/.343-.^W]_.<F">(JR@]T:%0%:-0G=J/]9QQ8@^ET*]]Z[<I%?)
M2: 7"D_)?19EV'6+6I*R$*^KFDHK:3F\[BJ]@T8B_U ZGZN=>N6@IP+59&DR
M<*;L%K"C A7$XB2J@WP+;E8^)@;-!>J.;0K:8VP?/I(P][O]T>LQP!(1CJ.9
MQ"2LJ#Q53;4^I#U;Z-K) \,9"X[IUD<DQS\-H-([^935!;M7U+'VTYV7+]^F
MC\S#)35:8T?\Z@4*JH;9=8WHH'8)%660WH$*>(6&L*\V5%4E.JW]JHQ=^Q1J
MUXG!A+2R9M2)6$6,-8YZO^3.DVF\)4J E(+RGA3^?%.1O4.,E6.'A77)?L>M
MW>B@+\R< Z60X<8BE9$2IW!A$G"O-,\DP41H"OKP<%=?:]E +GEHU79?A]/*
M&S2(%34U-E2+F%EBB!<N_P(4J)01/2XA)I$=T"I_6L_PL91[;J?GUC7"J<UM
MJ#%:HH5^I[FTHW!=F>='EEX2_H-LA;"4\*\W&7&O+\="06GT#:CJ@(1>G-HQ
MO_)(W?W>CJAK+1X'/=LQ[H?\2&J"D=&:?MOL4 .@\:^U+YAN"F$DQ=!EN*.U
MQ9^E3/<-.99U +;(4E(2C[:RND -HN@HF?D0M 20J0N*Z5HDD5 +^EX=S][=
M?YVE]+K4AY()K 1RE_!S-6K[@+[J(ZEI=1V+H.E90[3O@5V+KMR3U,JQ+O;[
MRB+#&UN'1.APAV5/&-I$]?-(:TR7"LMW?D:_PI9Z_!33G7QP4V6V&]Q3#:V<
M++%2/E2<<_**O!O\:K>WG&^W\Y%8ZV(]Y#I&0A45F#9H\-HP6"QIN9,>(K-%
MF*M<(=24^RVI2'E,+IW&@@3AJJDQP@KX)LGQC3#3?I\7)WG5GIE0:,GK'K*]
M^IEI0WE\FF@*N<NM_9M,"^7I^0BU4N*.9E):W5'YZLQ9H("^9DUWSOLH)!V;
M WS:7*I+K.!]?(J^-BL[NVCJ]BM,J'$E:C;(L6 F2H?]A'7&G_5(?0?V]:B4
M!C00JF-UI)F[7NW[2,9AYY.DUVY3<^'1NHZU)W[AIGN<>WKX(77C'FI(3Q82
M$Q312&A-3@C.BWA2:2V5DU-"M;OBV$Q@9E'IY: K9JXX<?Y4R$/J;1H!2B=W
MP<M<KZ$Q;5AQ5Y'O@W$PLP"30_;X;'W=@XIE)ZJ[2()/?^=I'#)37 "ZOQ3!
MQN/F3O%*(2U-A*-8OD42'=R1A]+=>@+Y.RY<8,_]>.J?&V,Q)FOC8_;4E! [
M-F4]%/%]?/#T2 ';JM,#/LO4]$^MGG]C"A>KR*K/FX1UJ==.)]GFW;!0FB?L
M7/3R][%?#]EN F(,SMK S&EM.$,W]ICUO&O77M8KL^P02M\OD:9R-51%OTZP
M1D0%FB31#7JB1?*/#H$7@+L,2:M>GQZDI'(>RP__^Y-FL%?$S; (\6\M&S8K
M'W,ZN !HE']F4'CTL"_7M;7E):&ES4HL6J3#_CQ2(V9$L<P%;-FV>3FR]TE@
M<^E4:(24&_\(/2J=(ZX=?-,$MO'HTC7@27_-,?)"5F4C1CA*C,V)I1H?CA 2
MZ8!<!O_J\R^7P;_'P)L*E1OTWJG<_%7MK"R3Q;3GL# ?ADQFBF-TV'7D22V:
M^3VB(EDDF"/]V^0()95-M-Z2#^21A[KK?I$U8[G39,+.LG1@^I[J >QTY0)P
MRE=45 RY_N:8GC# 6K >'KQ:K4,Z1*FU'(QD8<+%5VMRN/&O%\G=<R/LD#YA
M;N#%[<'6AJ#-1ASADM0%KI%?3X7AYE)9C\VTNLLEKHF^G7ZAN+X#JB],5KU/
MH<JMJI(F@GZ'4Y FO0#421\\1YB5XG=!+YL8LDCR -?KH;A8 5"\YW+3VQ,=
M(#0W))SRTB_%("5Y@WH51M,@!C?&Z.SJ/U1@RK1:CA:=KTL@KC@]WP'[%6Y
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MN$E,HWW!%B?/D[T'3(7P#.E T,SF@"!OT'&=R%>EP^[)3BD^_V*U)]\;J7P
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M-# V,E\Q,BYJ<&?$NP545.O;-K[I$ 6$D0X%I U"FA%U2 $! 6D5E%*0+F%
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MM3?]A$7.4]-S84<0W%,9Z7FBG_\-WA-;N/M&'/X[PN,ZG;0P5/V/&1 #+HR
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MMN.&=CAZH.^/H4W)?<)"8J_\4:3<#P48+(;\>/ED&4QJM=J=TF/5V,6RV?2
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MGS,W&[JB(_.#7-,0'>*Y"EYKGY&G]Q*7U2HB56R["6Y#<1D.!M1SB2MNW<T
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M/0)B'W=^X+,>'*'>-ESJ<R 0YO(4F-_ ]RC.S!B^EI0RKE.CD&C2^87-^V"
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MWRJ;I/Z=AP+,4(!*1#NM6"%M8VML55-%RDCDQ5^-$:*75:;(NYXGO6MPO==
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M1VSMN#Y"CVT:A>3P=Q!J;9U2;6WX*%+N6! Y@@(6TG+4RVO\)C;!B_&[@R@
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M\!)@L!;'\ES[.\\DEX#S+Q!5A2J/.OJN#O]%T(/>E$7]52\GNET%:3S3@K9
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M+^/;TXZDTZ=FZ*$IFS /BP0;TP<SOB)A+.O$>2= ".*>=IPH3,.ZK'0T[Q.
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M<IR<&SKP:+' S;>C_2L7;Z8;1UCN:JTGL2&=._ZO44!Y]N[VT!$2<"K/)SG
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M71 _93+].A-N\6Q]CZU!7QFIJJ%2V? "D/BL779@=,9R8L6'9M#KQ8C_;H#
M/9U^B^EJ^AXF4GR@3$=-;F^TBX7P/&^ANZJS#/$(:2;<^[?LS\_[CUB*L*"N
MU)8:ZV-C<BO621;6 #&Z%+MYE1V" KOM(P%//%R%Y54HZ3W!N%-&B$#_ 'T4
M,S\W6UUD=;K@V<_V3V\>0>];M\H/P?F_M66Y?X%I T'\X$6CIWVZH8*/@[LY
M&TP# J>>9[-D$&+;A"W-EO$=Y(IA-<$[*Z_X9'UE@\IB%3:TBA5S/']^38L.
M]C4$>6-"J"!/ZUU/*\F]2#D%8!MM)#W\<01=?$'==;73Q*B?W'&F7TF5"/-&
MVV /WQ)Z,[#]F>*17\I=CV74"5SO_<RDWZ.^04( \6MMQ4-C<-DLV&4I?3L<
M)LRGHH1D;_9EF2R;TOVP@O0ND061BD7$77#:ULWFX(JHKRG/N]A1GB%3.N9V
MSHG*<8DL#;E6QU/)/^+B[0.#.Y<H<X]$EJ8ZXD7#\_K-08\I>TZ;G('D" >2
M9R1W95?N$6CAK^L0*559C76% \.O6UE4SX\>XIWIW"OXC59&8I/#C8D(L)5G
MA[\@8*!\[<O\=J5WRDF^"J]&SQ/7L&0$19*-O/A[U1EUP_;Q 5_VS["S3_HL
MU?2%^5Z?@[W>M*&PIEE6VDBS1"6.'W=9>PQ;0 A06C=";-^H,'&@@:^/5^^Z
M9@2;+.O3\XL87:J>0^6#KO8L%]X^SQC4:)'-W.XNXZ?]M3?;#.N_E9K@$^IA
M(I+LUYG?(IM][JLJ\N?XI!=I!H6P7P+XR'>ADV15#B"0*C'QM?2*RHB!$<9/
MVI_M'\JQ-)G4_&6 ''R:LI;[/&V[>^/F[+""%@N.;/F/0?2/_(&..S5=XTCT
M41%?R)Q1.V-$7J_8BI!5I0S;B @7K93^:8K\1:Y#H<_7!71P77G$P([NSY42
M"8[SH:L2IH<1LLP%F5L]TXD7U(2X@@ZOYXWKF2KR-1&:1P8KW$I=8IE#ZDWL
MB2+Y"TP?9X\^J*XDIA+L=I;H\.X03,UV?M[*W$<ERQT0(<?=X_E]O&8TEBOA
MR2)[GS1EX<2GDP?A4/N58)J7S&&3S3)?T9F;M=DI"%LT[7/W$IX??.4(<3*F
M;UL\[14\SW.V7$4_.ZYT=5'FDGT_T\[TDB! N<<ROG&:@ 3*4_4T-?W<[?H_
MM\VB3()7'/U>Z,+2:+HA/GQ#?X6EIMT$JGHYWN0V:H1% ]N=I@*QW_F1VP0(
M83>B47N9&(=(%UY(^0W_GJD"M[:"T//0G67'T$\@EZ<:?%M:IM^418R//XMZ
MB%7"R/RN00:.W[)+JY@D]D;YK>-BQ8D/9\_08%>.?=V^XZ&S4?\GX@>D:W^Z
MLXULU5<WN*/K2K0UQH]PCX@::MYS9E#HX*^5W%^B#1G]S.42&G/1$6:#HX J
MK\"].)<\>Q/X^7FGE+(D+*V6NPF<XM4E@%P["+K!2GC03(*8SU]6CJV(4KZ[
M-?B^&%6(D;(')FWR>M\P2CN_AV+(06R(3OT)E6/S3Y9]UCL+/O4(63RR(6O7
MXT^+USKF!"PI8@E.L4O9;Y0DJ:5A$%VO2V6 D'<#]I>/NUY5 IO&B4[U>#)@
MP-<(KE! ]H^YK_FP310R9%<L 62&Z;4 IKS5*_C;9(N&8M^@*YK?<2=7Y,E&
MRP 5(_RK_KZ(R/S9@PJ!<TP\84)$EC3_U/[%AD[%XSP(C".-89_;S>;GQLZ@
M=Q;W+=*'9DXR/RI"EY(-RVTH=)=LRFKNM=DG"?X]!:@Z<$R7/E/>;3O!/QIQ
MZI:NJ]L8>?%%S6%'ZH":"L1089ZKNR5(S[O+GB#;_-3#6\%Z;]S"U9+@2PY*
M$ASH5PN]F[Q8)=N0M]V']Q&Y0)"!]IOB3?G-+>M-79;2'GBV#JGZ,UEZ$FV8
M6Z:*(:=1"GG'(^B</)#Z&$NAL&C4;F2_3T]M/0Z#_6SV]?[.NB]"YVJE\SZU
MP03=VL_/J1_^5NX.&RB616%FF0.6^]#'IV*VF^VJ>""?[5I?WQ< LY)(AY=$
M;7CY=ITT3/#QH?T6.?$EP!Q>>SPBM4W_YS$'1Y=:"(:>64[5;DDJ1F,)E6ZS
M9,.PN[ZSMW6/WM6&J#0=]N::/.6B7K1B9-M(SU94&F]?)X!H!AVWS4*.<OHS
M,DU9T2310YE$:8^G27!%6+OJ?=8S;]OY&'1 WBHJ20K<QWO<')V0UVN/WQD]
MU6E\5%^*'-_EYV43;%G/6_9T_>PR>+:MZZ1F:*6K,\GSK[9Q'9X"@: 5_?_*
M-"]8!I]1(Z[2<<+T*A8'SVB/")IA =F3?SJ*E^/Y>V%Y"<BDK5_%@A-Z&I]W
M0\:P7(L31Q":Q$^7@-'?!EV=^92[L.V_I]JW%F_=\UY2,7>^PZ0;^XW I7*V
M0S"UT_= I:$%_-]TQ8PXAS^O"/;G*M13D;\P)G$>&+(W0$=@-DUC+IY,J>9K
MB%T'<P(?3$> X7)?3&(EF7H.J*UF#5,FS?-UMB0NF&<T:%;RJ]CWMK5\N<N>
MO;O%%$VFMS?!_Z0BF=-7/N*]A+:&+P\:"RRX8ZD0LO'U,2M'FM-M20+C.T5I
M9G?G3V@$\F=?I)YBXG&MV()6R P<NCQN?$)Y@+A3]&56.1.U4<^U./BGKC+.
MN]?R!N-^QR%N")JZN$V0&%:W5:@5\Q@ ^?G/ $<TOQ:GB7YOB,:M?#RVB\F9
MLP6#WRSOY4"*\N[POQY)%S($]5"L&GZO<Y S5;=UJ'KYF-]"+N_TE_*(0:>]
M?>W'I':ZF=:)<Q^15#*8D]7/P(LWQ..*!Z#]$4B$#,7^+4&+$HZ8Z#?#!%X.
M4X>VT",N 8.!>'G8)2"D2)-;:RSQZ:N:K>)!FCX>82K>J.*>TJ3O!B>ATN*)
MV9F&^O(RLW1=G2P?CF1R1DJQ7-FG@?*H:^!/<C^0VP\&7E(??R#:/L+'SHP+
MG#B<Z/XZ,0K;R\> 2*!=)?]V_,5Z[0^UT""X&N!>U^M\,IM9J ':<0%V1OOP
M$N!-T 7LAC3)F[^MU.;$)*G2O]TF(LL5,3K CX*#E%SMF;C?DAZ&X<@\DF=-
MY5W%-4EB-G@Z1<*UO(W?1:]I22FQ">^$3FA1YQV6B;_ZB9%BO6NE]Z-1LVC'
M[M&&'PWG!CE]$??>Q(J;N9*I"3R,7L>%/=OS;:J#G=,T)*/NS3!/U&94HK.5
MPV>)UGC3B'U\+$.69)(B3:^[PX+WKCCG0>>JVJF4\:AP$9N.@*U7'H/#HE>E
MK6CN(."<86X_C:P%+=/W\Q+0Z.]N"%%U'"WCOY4H:EDU/2/G:L/<=J>1BUJH
MDKP+:Q5?57GN7# SJ[3:\G-F6JGC+1EQ8MXB =^<_O&'O"M_@"#RH1LF-2AM
M,:[8AFTZ%D'T4;^V8L@MGE11N20)8[[X\,+G72P9=5M[M2?*(^74ZHKY4:6*
MJU@KME>T";R!Y/$A??9#%!45.1!1AJI?Q_38>1Y&O+R!I?@663K<<^D!UK<(
MNHW$]U@C6A%GP=!I 5Q*Q/M-1Q<*_99U1QW8TA\*,3/(CE#2O560\<5:Y7;;
M[B5@^1AZE8O[.U9$:N81#=_ <I-MJ2&$(H=[P(_U<X-+;*L7P0]^QN,(LG!R
MNR9;?]DD;Y]%, _:I7Z(KT/B_2"N+49,#(4=NYO@2;;/UR\!*>&;1\S;M]0O
M 9'9ZSA7*(X<7;2I]>KM2%$1@#X<\-G5=OVPWTDSE5<SW))'X>54?H;_NVO?
MO@(6;G:AO,#95A'#O1+N"CI+C$''1]1_[UX"K&5^?AS)X)/.@8@[JX?.T[.G
MC#5!6U@1T"OK!N.YBW/(&\SZ%JDQGW=LZNTS!RX,!LD>$G-_@;)!TD-TUH+-
M@\>6/\::2Y!H$X3=?WRO%GQ3!S*EBHYRMI8+2^ 42C^81@$<!\$=^4Z+D/8(
MM?!RLT:!O26C:9ETJP?G!J9"W#!,Z!&&=;W"?<PSF)Y.9(4!E[AYCEDM-37I
MKGE!!W@V0[9 P?-&>OI$]WVV]QUCLHT;^085LR.V%?[%U$>NV]]WQ$%!".4.
MTNN6&W&OP,,V?+[^YF$/.D]@G)@GOQ#6WQ5&S&L9WR3Q6L].$&"4M:4D*6DU
M/>G7C^"_SE)\$K)U-1%,OB],NSO3MJR+JH*%/7-NT6#U@YLH?PSBCJZ[:[:W
MH5TII0^$HVMZG[OF%F@&:HW%[T3]:=<,XDV+E:!GOL/W98X<_=@J(M[^D3//
MSUM,4=]Z<(*C&Y :N'M[^V1"M^[$H3$SM*L%M$V0R\\-QIP:"7,?Y0=%T^ M
M:O)W<_;8,UAO7BT[/MWR(LSTHTE"$)A$'CU&R"$D]QY@ PE@C[ @A/BX!MKJ
M;:PET#CHP.X>M*N=  "&JN;C.4'(%9/&2P#\=^DV''13-*+3?>\2@)?^"]W.
M((22'4C$*?02P.**Q Q#8UU$VK67+>Z?)JR,@PZ$IZ'H+0+5-FFPJ$_LQ,O_
MLCO'&>-N:Q>.H6=IM-.O]_<WA)?'WZ_MI,+V=6(/(#]1]>8?9>+=F?,2++G5
M@;U5$LM?V,47UI.<?KN=KT:/#Z L/X<-S)Q_H%PW>*S)K02W$)<5<7&9IT2N
ML5_E*QQ[_"D(/B7<MB#K5;/P,K2-KM;I)(T,>Z<SZ]F-V4O 5>.7H7"/"$*D
M8L,%XNR-5XT,<PD\Z.U??!V(X!0H)X+JW/G7.')/(5M"\TJ%R<ERR<BDQ_1G
MU3O? F9G.FG=;[Y5PI()7VQGEY2D;)[I1%8"[:?J(PYV/;=SJJL=#B2Z95):
MITISP*D.CRA,QW:<O4'J''J&'&&D+@>,+-728U/[O8Q5Q8T!6Z"&^P$=]E$S
M/NPAQP]=G[)7]]-8'0"OV:]*7W34FKG$[QNV?%-?8%Y48 S4.%T_$NGC+BO6
M5+]B"M&JKGAIXHLG,R>'G7A?2.J><^+L=M=N7=QUH0/Q0=GS)#S-\%N7'!<(
MO6>5E #EIZB-8V[Z][.*SWDN 3N9$UJ=LC%R7QJ%QE<A<2,+WB4/6:R8=5+L
MCS8-AM]FA:D[6*K8+ZFR3!XK>?TJE26_M7Q "I\RGC+F$JT25*W*E>]F59NJ
M]\BNK$T9<$Z9TPJ1V^B!6 9J#2=*JJ3O?-14XDZSE1!G5M48!ZW<(%B&T0AT
MXTDX^SM##96 '?Z1Y=N-811W&#JQWP0(=C@%QI&@);5B$^(U!KP$"42=.?YB
M_1(@*[+EO)I"1S#CB%[<X=52&T82?6^?;6M7NZ:F<K3(K#K!SUZ UQX5@^V&
M&VOO.\?.A4IK-7Y(45O=B1+T!X+)F($7*"-@C=3.'^+;'[IZSPD$+5V;7E,Y
M&I(02_X$/JB\%Y<A4/X^_*=[Y7SMQS]8SH/E/9'T0IUP!:7JRLZ^WA^7 #<'
MD-ZB%VLN(]#J@PF)-OO'[@[&4_ 1%C+"(QD:Y_I:U:%K/TY+GKNI@-B7O)DT
MNLI+-P<7J.\JQ\;S;2U"O/NB%60$O?>^W%!\*[%0=&:'T\G/10V-!3%LJ[^5
M[C@96;=;9!;6M;HE13DWLSAX@23(R66]Q.R#S=K/)S:P*)]WGE4O0)+5  #@
M&=D+GL#]QIQ&M_*-Z2"\N_V6!V5O:ILVD[8TYIG1482R$H,N@X+)P$K9_9E$
M625EGO*-?_KL0XDG=JJJ&YU7!^/\$!]1WS? !W#NIW-6ZD\[UEUN9J)28K?U
MG#,FK,:/"V"S:>HO.L".ITF)'>5%C/0H%RW>(X0$S!!ZJ@(JO[5&&]-[=(T_
M&5=SCM9?(DBJX@U'F\\J8KNC"!_D;TC?UM.6S4I5\4W'24CX?GO@7>N;H,V8
M!6]%T.!1$?*.,0[Y^EM"E0K=P3PG)_MOGTP:.\T20Y4W*6.UM=B<X4!V3.'2
MV9.7)V;N(GPD-!QW99GN?H*/9NUB[UP"'DZGGO_!77<6Z75CQ,M6@3#3YS>W
M("&(C@$K[)L#1L3IQ2]\K=AA;K[^__MG0<EGIP?E^FKNA5,OFFBLB#[(RQ)'
M@QX9%1A!%HV\E*PN 01S&&)HX*XI0+K3C<VL2-OY]%0>DT_<EIXDDXX(/5\_
MH.G0EEM^<PFPY8>NARP?B@R,HV(SPA\V#&6$\+QL^:\-*A"J>YCX"2=]MTF7
MKN4^+S@%6!PD^^U4^T:Z#K."MB]S6D>.5P(]HX+Q8,ZR4:H!9O7XC;6,/U#K
M\ *D4EW3=3OX8,5R39H23=/C)O;.'/6D/*K[ON]"3+<]^I >FP]E-(9V-H2(
MX80C'8^,M\^U>2!?CN/M#>05W2:>K<.EU,B-*/OL8;4>8^Z=P3LRK86]Y3Z[
M=G,(EIRH,W3&*R'P355&4H5W/0KI<&B'*-NRBGXVF7>=8\26&P@.TAOX4<3V
M<&?@YE7[3<>&/;,G0#8E,+;\Q_(&@'50I,%1<EJO5\I[8J@&2VH-"TR[D/G^
MJ7HU!HH[<L19I3S^U37$#W,A(EMZ >?R')68*Q5ACS(/YI"_'4',Q=P,5^@8
MA^[_\4AS#1[< AU;C^UE+]8.L\MSU)-T.&ZB?/PH6^ 0%XL+A9JOUPQ^KQ#7
M4;S ";Z566GV+)5N;&!L.8::#2V9/#OT.<(#06^TB4VMT55#^@*Z3/S>9(YG
MV@7<^6P98=QA1!L\>@<C[2AO<EMX9GDXRYO%%9TFEL(7^)J\[<C]V L%8':Y
M:D#86><$8?@,'9XY:3&3]W]8-DOXI:64)!:VR%4@Q_^L]+4$YF$2_B?\B[;Y
MLINCG96,SW:I*9H=-%(];/A^=B%\ 3=TU1.=6MMT495>ZU'NS!-#)"J/U0GJ
MB06=8WITFVP1CZKH<<O^RY6J'EF?2N1+,OSEB-Y3?+W94UY8&+8EQ4.1K^U1
MX1]*4U/[^B-6.N:,PCHPN,)=>%HX@CAXC8,4O\$,1D<9$#T.YH@&<R0.)/.;
MN[SYZ*V[.5[;F.K1;+.[[ JD3BZ$$O<;3-55?; EIN\41SPFR2.A(E^Y9[CN
M7V$E<DO,U\4B\;;7^NF/(ZP;_OW;>.[:&R^G,GWJD9H$2M?^%^>E=$7X,3</
M<-KX5P^0F'U.O)_5T*P_<&"]U>7>Y.8]R6]K;S,4/CLX=K%^%<ET=K4SOY&X
MIADAV*&#D?F.&E.]N<@OK"+_*CDJ:+!$#;8I7Y+]!/'ID=7MST4U.HX#@H,5
M%ICX>I5Y=0A0O0<;9?,E^AG]]-#RAGNF>EU%64FT2CU=T'19GM?QM6K]?E:U
MX;7[-C:Y#F4*7:R+FLYWE-<U$LQJO&+I-(D!/BR8C*Q?M1ZT:8ATW9[R,#7E
M/ Y_3G&6A-_#<DX,_M3J7W6^$G'L =(4E!9MZ&VSQ- W?D8NB; 'V!FG70*
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M]3,MTE2;X[K3AT#Z1KNT%7RLTU)1GW@VY%<M15BZ^O&"66JB,+!A\ @>\A5
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M.=+,6*2G%:KY4NHT%WI2.'$X\FY9E*;5#SY&/56F!_%BE$NV&RGJ+ZWHCJ=
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M;O]?SE&!$WB0F)3-4IG?XH(\?[PW)^TS=2,FL*8X^TC[DB,"A/8[ UZ?T=T
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M#U-1IX[X:OF__,LZXC^:<C%>6L+?/KB&#5-''MH(>I>O.1P?>^SOQ$Y?E)F
MNF8@$5QWOY[@A[M2\T0S^.,@UBN[/8;SEZ@$'54?LVL5'@(C8*&U92<;NWH
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M.8/1X1<*LU>&K5D&)J0CP>QX08^E2$],W#*HCC)REH;IWQ@;;# _)% S*4"
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M<J5+0^Q][B8-.-?&>U0]!_^@P>LF5V_PTO5Z\<,.6R(?.AAQ84T(K^\B%W.
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MJ [?^X<Q9*+ZRS091#U%94AEZ.J1Z*U(S]']H1OZEE?H+EC1%V_$K_D1_SV
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MC0#T@7)7G:#NB:7M9?HLKZK^L3*"_-N<-$52(<CO"X)YFG4V:FQ"P%V-Q:%
M_7HYT0H0;UR^BH<L\N@HAP,X_2+N6]'S=06LG1;$A74]/S("@UZC8F%H#N\(
MRB+FF) DAEU::_H.'EWLX5INJ<S3RWA UXK$/Q&A7(' ;Y?Q%I_UY=.5%>L9
M?))\__-Q_(EF.:(HT$4EF$:%^ZV'.LJ:BQG^-WM=J.>0^<;FF?T4HT?5! _S
MC"I[BJ0F&F<AIEKS1+/BAF\W:X"GM_0O >,/K@YAX_)21\)RA-.=BXNT.3@5
M  ]N2_,*'\W79)!RIG_)JC86)]24+D")[-EO!<6@!*X*^.T;C#B,EHS_2!5
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M&M7&LA+-E03PP2QUC/BVJ1WZDIXF/DY>GU=@.N'VD0E*N&.=;WZ=4L$S?PF
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M]7^))&B!8RCD#1?\.T*J'1_SN!FE6FLO V9/'1*[EN12L$H7V?KOMR\4U2>
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M8EL_HE=Q>9<;AIZ3TE^K+ VUW&_IR[7P>K'(ZDOF;G4[P?QCRE*P9N++&Y>
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MR0E.=B_8N2]\+CAX171O9AWG0S(60:>'BEHT[+L_,[ #@L?*Z8,M>\%M76A
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MV2KH$%^+J/E?5VO#</P?>($W"94UE#3RPN<N) WJV+1:M#5W>J8>^R@>;JC
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MJ4E,WUZA;<XM*HM]Z->V3UC#+CZW)L[FO6H2]2??VGYP-^'M@<@L'NV<DM2
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M#FDH?Q,81M#.[6Q-OTANN\,KL79[P6$3=H(4^RCN^4U9$D>:4*J0#%!4] Q
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M2CG^!Q^F\^7E ,76-L7--;!9+J2Y8J3,9KD6"= #DGVA4>Q3?JR$ E7*68Q
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M^]F"<,=5\ $MH!!^O"."&/H<M3UMD\147(.PH:^^PQZ;\(%M$<L+V(0(PO,
MW1$L2X\AUIY>>&[%.KI1DFJ X@<VT-?"U^&E@^/FBILG:==GX0LD**KOJ,H6
M?8#?P-0G(KQYA\?*O@3\O)<U<^^1_9VPG-7C.R[7"I\D=*#$J=KK#'&X!<W:
MF+4U67:4-U?E]P/:M31!/2?RZ??TI^\"5^MAG>LO^/5>U_"J?(#!FG$M?W ]
MZK6W]ZF9?E1<&0HXGL/L'Q9J*^<;! $Y\RVISU36:%(!5$]JK8HOS&S_*A%4
MT7C*X?GQT\>TJN4JR/_\Z\T X9Z8'5ZQ9^=V)G-:Q=A>E4Z-:KCZ<=-L@"0"
MQ3O"V_07\[_A0K9ILAV*]ZC5PD [V2@J>40AVX@U".ZPW$>UX96=UO6U,'<D
M2$&@#F><P6F)O$O8GO7U/,3S(JH9*A"WQE\3W.NT;_13GZ*C9H_QD&Q?)@$Y
M9YKN:V'LK_GI*67P]KSK5TWD)YL\+ZK0;[2D'Y(6'].F\)9GE7,*,0RF@4U6
M6K[<4%TZO1#]00/GZ7067]U/_8?&5F1>BF!55VUK?,A6);V QT&M=K;!OT28
M!8Z^ 3E0K[*(=[A&,'?[:B9*2A0M/>)W![7FN3<U:6)PY],*BR4^\SN83\;D
MM.;\H?+\>T$]/6] S$I"*J>N2@ ;S4X@7.+"8AX &N@F646%* 0+3:[$XPW@
M?X7=<.P<H92Q('LTN2:EX$$4F73F$FK][V\</*O. CZ#5O=?<0E3=]!H\(Y_
MT-;UN[G26KB*XE*(Y";7B'5U(_AW(8X!8*;,=<$I'HYD^-T3O96CY5B SZCP
MX<G4=PN1-^U]K#"A?!91A"'HJ\N:7%I*EZC?4I7;7,W+>6D9\*I'/50O$.7$
M1^\MIS]RY@WIA'Z%,@)F^)V0*N+=(ETU#OCH5X5'BGO'K76)WO?J'_:<:&'\
M:S5U/^O.DDFY:3P6@F8B+;0^Z89_9PT.HK)7W@I7,F#F-M!/'EJ#\5:A'":S
MBA];L>$/T#;#3K%:PP[;-T"<3UM)4G.J^HL[T31H@YV7)5B]GL=L$IW]W_;U
M7VJ56+O')U#1 WDPQY<(>DT$';S$?(868/L)<A(S_\:YC C(CUL--S+">;\.
M&!Z!*<^[%^0 V'69H+LPNB'-#*1P3W4@'5[%%WRAWLGDJ;V%![+[O?+S(J<G
MIKJF!0OJ)[2H!H#FIH?OY7O!W[DUW)P$,'QAG.^8= ]E.4^%?VL.0, Y3S6L
M\85CCSZ>->$+$K'!1! K'61]%7YP&^4#9^ /;8TP YDI..49&RH^%:&@N#F)
M\L*'X0L&R2[=D)=9N^[E(B&_]J?-1$WW\VSP&F_#0)WSM=QX7-[>TA\NDB6G
MXWJJU8.B BV'_7MK,M-_/NKMD'%D#RUUG#WYO(L5P6*XW,;3D"2K4$[;EP_8
M'U<^\P] YK",;CC_9!HLC!:O>?RO G2]$<$)534@^BDZJT3977)&6-HS:,>'
M#&,9(AV]ZGW, ITRD<]NOT4(__[ NZ'$2LC90X%-!K,'A6XZ;C8(,V;"M_FP
MHPX0C>JA;9JUT:/.^MK'6V1;O!G.NFSI90F";E)!A.89K9*8H265Y]@^2K*F
M3E;,Y7PLPQZ&7Q\R_I(P-]=Q(#3T9YKO^TASF\!'6 SH]]UF(!.^(H+4R@<P
M/)]7:^FX[K,\]/;V=EUJ\WP096[V4)<(>NOC#V\N@!:N-S"7CQ7]BM/?>GO"
M28),/Z1=\A3>,S0Y_Y$QAO-^RR1453Q<1=9+2?&@_W^KAROUH_F!M6:54)PE
MN&>C+KI=EP7O;W,1@F#Q9JTGB9 /NVOW,VK[8G^Y\9V @$@XW$+BR/*ESPM(
M3=?7D+@;!>-W\&\!08@[5C^[I$O%P.3U<M:GA KO!;T$#]L72VA]8\I4>F>:
MM?1]B(;T$>Y^_T''@FFUJ<VL,;Q9KD]@L4( "_VF.P^N?YE?KV;6BJ,L0*G3
M-$G5&+;S4T\%/IQ,(<$&2)<' KAUI8 (@MPV.YZ [PI-J^2O#B@/JL)A3!^/
MHY<U%&95!4YA $'[FIIP!DBPW6R&V/ 2FI28$E$$]JF[V0D6 /2&B?,.+P4M
M/H[9V89210<#W3=86Y9*:1HR/XFN(MI11)"#G=G!3>#,QG4 EOY^D"WVTR!=
M3*F W[?;JKXD[??/JSRWV#TZT72L!;3F,DPW?*'?_WZ^T!)#+-M:@@/C%5F)
M.-9%ZJKY\I8I$_Y5,ZVB6YHFG&V;+#WV#/5%>>V_V1E+X.]<X$]AOYP# TT-
MYJ[!FS6MD$? WKV"UD9)RA['/"ZH[L-^41@Y1/(P&GR-^AU@#;6^_&6'-/ ,
MEG)>8*9S7F &.=ULQ"9O+8]L/%RRS6FH")=;0_#D@0.%P$=]"4!.XX6<$AH7
MM/\RRF? *$CLTW+UOQGE2XNX7G9FR\/ZR0&E"Q*99#W*:6=/Y\L@%6Z-.'(#
M /(/ 6C^YQ$'8)*P+E6#^.4PKB#%5_1*MPJH-.2O>XVV<DZOZ9/_C.RZN1X<
M?HC>3.4C!.G!C\_@[74MQK9(XWHO9E/AI$3^"IF??3)%]TV$/V:[E*=.5HA$
MFSS]%2_<M7("+;033Q&O0#*//+\HSRP0$SD)_03]B@6_J*HHC=F#6JF\E:Q"
MO*":AYA.SQCF[QI7,C\O<BW,3TY+ITRPX)@D@MQ)*<2+-WBF7*4%AG(:AQ>J
MWI8*51AD,H\<LDU:GF $:5R4$MLX#T49UU</&7\^0C&Z1?FZD7QG&05E9=/.
M%(_XV/RG4JT"A:(9&H*%22\J&A,N%OLQ MEP$K+=N"_DVBJ#"$4'K4AK2OIX
MGO&&*^]7)O40V'KXMK^-.%G5I)9LN2*VHG[X\Y3?@MKKB:M*D>K%*HTL?!:[
M\>0J_Q'O^B$S;$P\(GQ7^0BFT3QT@PCRNK>R'K[<RI'Y)+\F!8%PD D?V@'1
M/0F+$F/=@SP ]Y7[,?_[XH1W]NBHW;,P4O2X B%H%-8TL_>PA0"HF3_RL?":
M9_ +I>Y\OS<YOR"F,B%2HO1H)O9B]ABEQ=CI>IBAZ "Z_TRBB@CJ4/7F,&6V
M[<HNY2JN$$DX.FIAZXW69JM0-SRZ)1=)>\M"QYQ*!@C)0GBS@E4MW<S,']@H
MCS.5SGNHZ]769-/,@B;F\JSO'602692MMZ5"0;L$7RA 8\G.[X%(;1!!VQ7G
M#Y=6(S5**F*[J^HJPW932Y3SG0\X,PF_AH"/R@$@$AR#MV<3:S.@R68O$T5C
M98343[:!?_M7$D$W3:A"#OS5%>Q>5J>1/]1_Q2- 4[3Y270=V5P.J1#\1U@*
M_E=8!G].+GUT@UZ1C75'SINYQ^';VE![4F]=*[<%QFX6DPM_;8<\H/[W3EV1
M9HOGKI/Q9.=GCR[6HF=DQ6?6FUS]-LP3M^7CD#T"K8@V_M&4&>U)<L8K8;1S
M5E&6W]<N-F#QRDS]F40$ACK=*WQ!/K:;K;?<,C[BD&7]#VQ <-.T6^>#5.&/
M"O[!-/J C R-.!$WE8\?:T09IV[J#CRZO<JO)]S5?T<4%S73G=P1;\ 5MQ37
MW;GRH,>;LSZVR+F!:Z=5Z>K:;;+B#?IXCEG+$1]_R,^Q5%BM8E7?:2(+0X,J
MQ#C(0/^!:N(4PMR7X(761-.AT,]V?0WO&:Y=R'IGSIX9;X;./0LHT_VVE,^L
M:*8#@YG>""'8/2IZM>?(M&7%MFAY1HY2]A(RN;P4AN^\;?6K)V?)>0/^<V6Z
M7GA\[6KG\XI]]F+DO':RVXZ<ZU4Y23MVAU'C5PQ=0H:#G[Z-1>R.K^-) :EX
MIW&+;U\H==Z,"D"L%YQOEX?TFH.\95>W@:4&=\!X/T 05C7VC.W'Q D/NGA&
M#DY@8M>(H#V&1H @A$$.V$R+34W<GNZ^6 IY6O\:@66VDO50E<[)LAO[:)%C
M-(Z"> 0JD=!+]<^[P""MN,S59"5;I9O*TX:/P9XC!-U28R>$3'O:FS>23<C3
MY8SDY>1JZC'#%#N.,/88=?9DY?NHX:QU/]I\\<F*+VS6(I<7?OYIB2&MX(=5
MH1_O='*U>OCZ;$%PY&AUE'+7T./<<LF.UGB8%6KRWC6VZ'N(%X=GKB:(=Y!%
MD_,LX-Z+Q8 GPA GL]7X7K<T8*]&>X"/9TY&1SR_A?(%,FIU?7JVU_GF0W8B
M[D*OM]3A8N5QC'%/:VW*@A2IN=1['\<2YPPS, X@1L %>3*"IJ)BUNYS*+)^
M4F -/XP4GD.5=1N%MI_<TWOM]I,)$PO-^V.V=['DKTE,>9C?ETW"TQZ<7W+A
M''#1HFC%71O\QP3P^8RU]][UXF"RU8U;FG*O;5__H_1J>9H6>%/,, 'PU5<A
M'U47*#:"Q]&;"(IH7!2'K(<300)&+,!KGQSZSSP(0<5X*R+H[N"_!C[]VH'@
M@QWAZY4'M"X$&FX\J::I1=$:59Y]K+)QXFAXJ\ /S>']==.4#@KUKVC6O*_E
MKW4^0;.Q+DM;98PVGY;>WE<?F UX"TV&9GBI$.2P '=?@9K-\7QKV[0A/$V8
M.6PB@N*\'7SB2\^+@;9QLT105UU%W/7$O/,OXFAK,@1?% #DH1DUD">>U:O5
ME0($_U,OXLSOKQ_K#\67T35/\JK;O18(TH!EIIR6[P,?V,\4#H3;X (">PYL
M[HV)63MB8+LZYB[N,U4HO@;\2T)YKTB=\*P2>3AU_K";:8$I-/^:/>;MX<WS
MC&KKV*;N4O1?!5!5]EM^@!E9@9RV7GW^JYN=T=PC./E@(ZX"Q[ G8UK./7$5
M*<=9]UE'8PV(W1Q;Y-ZE<\>I:-DG9*H-6]>PT@0OD59+4B"> \MR))RY&&;/
M#W3(^-E<P$!>C"F9>MS#1#>I/(CMVNM:6G2-MYP<OG]^Z\#1RU+;]Z'2P]_]
MOU<<LM6?=J03XO[0+NG)1)Y5F=59&?N[\(["XFO&EH5NYU M2%BP9%YO?BOY
M9^>->-SV"?6)SC0Y$83XV'\,^#*V'=N+0&]#C@P13>S^WS8\[^<<"IGM_8&;
M;Q1TE_.=4)@ _-_FK_O*D=X>WY[D3Y.,J)T__9<MZ\'C&P>KW+'!!ZT WPF0
M^C*TK5"GV?Z3R_U$D F"$,2K/$/NBE4+(RSX7_?6T1+4ROH8V=D4XB_GDY7S
M6LW_5O)>>#BS4L[(H9%1XM9F9M7[8 763B%9Z,#FH96>QY.>X*OW<#Y@S>2%
M P<??^XCZF6C)]UWUZ0ZZCUO,V1_RZ:#><N\?I4^E[#&*R:OX?F\JJHV174:
MD6<;^_'S3QTQ@\P5L.;$B9Y.2=U064FUIV6\Y4CR84#Y3RRBI;B0S__51Y:F
MI'M,UWP0ZCDGXL^*II(T4X_%& R5#2<'SN>]^?2^\HHY*72+?U)L8"5M&#TQ
M0GA6OIZT^P5</,%G>1>2[=QDJK@2M<)HF,92!?-W_!7\=G.IPA>0,I@VJ]%Z
M/L*S([/#*<C!71.740'/XM7R=J\>JLH)IFN)-02AWQC&!0CV# !!E,T)YB'?
MAW8PM4CP0WE'QTYZNDAX$B%N#"HUNP%_U;N^@CR[#/OJJ2/O:9Z?R1'VXV*<
MZJLVR(=%)TFA_!F3G\Z"1VTI!].3E"U;(^"=T#7P_CB&@',B<-8T;JI""/!-
M^/8>$10)'D^&XXF@<0 (EP @1-L]V5=<@C:+QSRVJJK0(V4--3\?C #[7G'S
MJFU;D^QC#::<9_;@OU8H^L<*AO]>(4E9:U*ULCIA?L+BT?E.O?5([$@2O*K?
M0 .$\D_@>ZF>\?H:-Q0CY:LC'VU.A4?P=)&SW_!E:-I)P(>HG[DXK1K*$WKC
M&ZYX"K5[E6K:.;:%"[-]O+P[A<!";4S=42$,2],;*_#5*!X[WLYDF+9TG$%T
M,"^MN0N9*.L00),[TO_X!(ZXM<;U66F7J.=NG[PL7+L]OZV>=I&T[]VUJ-!B
M_/K-IJ:&EC?PT!XZW (1-&IRMUULU3AFR)!.BG[)?>TQ$92+.!O$%W07C%@0
M09K@T\P3O;B:.QJ9*%.AJ%C!XAAV43FV8JGU?B6 'K$?<M9"[B"Q<<V0U>_G
M\K6J)I]WJFJNV%,IM>@09G"'?O]B"HZ%Z@]L<+W'0;]H\9IXV"U"^>HH;>7S
M$3%U.B*HL!0'.2A( Y+6IQ>-?^4/7AV\U?$& 7'&L_(.OGB3[\P3@J,8(()"
MJ&9%$C>UIH.%EFD4AY7W(-,>#P*^U3]:"A_O:<F5AV1[QXE+*;Q(ZR9 -H',
MDT\$/3%-,+4#,C08T :'H_!$M$JVD1M/Z,,%OA,7(@C01QOEB/^9ZO?:JYM@
MW#@+/WUH^0>RQU0.D$LBB T*GHL#O_M_G_1WI]ELCS:!4 4^(X>5H@3^?I2!
M;KTYN7_VG_*9TB'4V+%JB*ZY_GTH22EE>3NL<8^I!K@<_*[JL+O!P<^/<B'R
MI[N5LH0KY9^],\+M5YE1F=]D\IJ+>S_I+)GXA"]NNUW=E*K[5<K#=W=A%MT
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M)9;C2R]G(L_PQD_&@RPHGD==5E4RO;*J2[BN[UOJ45S<K_^CD 61?\!<S4!
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MG,;^8D7"GL*T44&X[_R"CIMAJU9&/1T^%('N$ES< 2$5L!NPC" _/(:+G"N
MJY9GV:>Q#4=<+0Y:;FW#UM<< =>0FPQ_'^42!U H7>]$E/:)PC]##Z_;8E\K
M/;Z/I_F^N%9ZR/VE]"!ON+@"M%L*J'XYV/7!RG*J_AMZO*,^XNSSXU]YM;BO
MZG_N=X8CR?<I-!9>8Z_/!^F^Q>&X(0(<#JY 56!E[*2Q=5 U UZ<,<N')MAG
M^!G.*2K_0W^TB-RC)D:'35EBO*\EH 3O2Z.+;<,=OC <<0ABW%6W]50_(LE&
M&I1N1"\)MP1$Y3E%(0AVFQBAW3_FD9.@4B]E$<+D%.D\&"$]SL)>R\T/E$\3
M1W>9N6FX+Z0*+C\1V5^8PO)>S%7[/EZ*'RW5&CYZIXO"JL7U_WZ0/8_P!ZD4
MU8TD/*=ZNLC\VPIF57_P)\RS?\1Z,-$TT>SV/9!F!WDZY9"MGABUJVC #-71
M"H/=9(>KG\7+B?%IYGX[,<X20^NU4T(IDX4"ECM.6]FXNIM9(++W/T[2G_WF
MX6$/.$372_P. %:]":A_T?N &(YRI?/*5?D57S(HE6T_QH2"7(N=@O\2.]%Y
MK;<9HBX0H&NQT^ VCI2T6[A),+=7S9]3NG%?7/QE^ P=ZGUTN,B_<3T97K:Q
M$QE4ONU_#T%^UN;8%;.F^^C1C0T1_Z_H"(/#!XEN?@^6AIS68NKYH W"#!FJ
MG0UM;2(GR0]R6(0AUHX5^34%9U2@4F]D%8(B<5.\LI!#A:\LF'$<^!Z7HFF/
MP\++//4&^^Q$V_CXG;.F>MMN44<VYK\[.$TJ3AMW+S+O%!L5U3VFPY6=88NG
M8;0=$[/RS<<#.908 *C4MIRW.B^T:,NKX_,WKZ(W0]JZE7^*:P," I "]P<J
M3UTJ!7D:U+DUW5I@]N4CN_P38BFBKI\E%N4,G;WCD"7[CU1SIJUM+TI(_C1\
M669>L[@"F"$9U-3+*1)B28L]RI>KM@QN-.E&X.W4W=C-,>_T8NMR!'UC/H!Q
M.Y?L:+H7L@3]<11GUVV;FDDFSZL!O&AMLRT//$M"^$2.EKYWZ>SX(S8D[KTU
M)=JG8)>GU\5&9KP#Z41&T&_+-$$@\4(]1RM=#\3ESI<:(X?W"+??[]GED$HS
M]N)"0=S:WHYSWYA7KX5V*&/1[1;XB4AD"L^G&>U%V7HH/LI;7QTKVI/=$7\_
M5I5FPA7OL!-2']4J0N3\C4(EO'RGOQ_$Y*2S:/J9AXS#*CMS@6#,,ZSX=9UF
M_4^&O[?Q^C6UT/0$VL]]_?Z4G80$XB6FYVCYA=%KAA'K"-C7T4D*1G*RW;6H
MKV&G+4YKBPZ^+-V PDM=,XA+;%F3?0KE?;K?>SG5''R4.$"*R]4L&WSJ+<O5
MEWY.R1@>J ]D/^KMH>[-38LB&Q$(VV5RXDS="10V8V6;5S/HR#.X EAM)HZG
MO/0:"IY.72JH"7)]6?LH[27=\H]NP\MU(0R[OJ::5 %!IA& !U#"A@@_E76)
M3>QB/[SYF#4X.RXKTDU<9(4D:ORD!!8,WOHYN[F'(QR%^Y'$)QAK_\<VY0HK
MUDX_+"(:)IW0K)1X1RQ8S<Z).7C^7(>'_;1YR,_\\\ =.6 EXZIB_S!O X>/
MS_?N\$B^DKN,9\!ED3]Q$A$%/79\:75/!<7I?*B1=A0Z56,EB9YTKS\0O^0X
MICJY\*9'FERJ5" 6CQPXA\WH!!_(#2(9@DQ5[%,J^,+KZ/._(**EG[3W$#V#
M,Z>R%?0\;>1$W\CF#PB<9<0N=?- >7%D@W^64'E8 2*J*2=NQE+A;U'C^65:
M&JSI*I9X!5!L&J%]LEL9'3<8$^W_R=$FS2=H69<SM=1K%?.5R^SX%7N4(Z3+
MS6NG3$ X9V2WG[P=79S>A)T\V=54+$[?<,S@'?(5;WHO()HBQ^CWG:=78:LO
M'<2DNF@094 '<>%,0X!Y>+5-C7IEO/>"RG0AB5)67[23;KX/625&>5-WD>#[
MFXJ4CZW?6V8@[LO?(C64IGKI4KWTZC+<.Q )@@/[QG_Q%1>"W_;*WF5F'!-+
M?S28&Z\XY6H<;&ZA=HX7ZMBNK2,=H<NIRCWLFI)F@K0K34HO6_].K&'080D!
M1J1J_0B7(PW2X;3=+?E^5&H428;=XF(S:OG\[J.XC+E6<4;6HPS>H&70.=D^
M=#<#&ZYS%(J$_C>1CQ8*^F$LJ95,3<:5FM"@;7'^G,+U"G"QT-S;X-T8W-9\
MQ+6)*^5:H DN)A)DYF"3C C0BE;]13[V,WMO\:COWQ4^JL0'D4FM/D'-:!\9
M[ )6L]\7ES>CB1B0)\T7A&#5_VW+K%&XZK+L6U3,^MT(YB*F1'<A3;58U<SB
MB_1@:,[=J3VZ8L9;?$<WL)L25:.>=UI;EA-/?O9X1U1>MQR!;.$WBV'IJZ9[
M:%UDAWI#-]J(2OCNG@$;MH]ZQ_@3E$3IQ7.VP?7BOV.GM(Z.D[YDQ&"SQ^<:
MG?^L&+R?GF5+>"3[\[:XK"Q$S-/P-06AX*FK[GBF\#2.2JWC'Y7Z&AEI"5A2
M[82O/^&,!"V1V;C^4I"G2;3+O 0*8Z5J[4"J=:/<I&.C@O*SE\_V%';8\P[7
MBI(HG*P/JF6:=/1<9[R)?T-!-IMH=F-CZVR9)W$<G\WOLS1.-HJ7CP!++#9'
M9$/U?HBU7G2NJ]1#( 7)PA3E&W(%2&#SH@/)[.3\]$3OOD#)G_)/IG%4K !8
M394WYVQ"*=I $T'2_ZW[05W+Z4E1HLZ=A/P9JEW;; 750]+W47D*70:(-/-G
M4_(JWVT&J#77_$4B--IUXP%F0=J-<.;S&P:)_06Y7S]DFL5ZWFR(:M=)WII"
MG/'&&B\R=W?U@KKB4(C%D;7:0DZ5MD5T2Z7/%P_S6-]E\1MJ&$D,I* NP-[.
MHL8I/H&*TH<D].BZU2&S_*AD?(R=8 ]K3;8_0W<R4L;<C2@'R,P8V$)6+%,X
MHPG,=>FP+\VMJ(^=<GW.85<5D-=RJ^9%#D_6]6X;W8#/[=.H_"W#PW-KVM(/
M@C&?N_(6!YY\CLBW#G[I'M,YT8E5,MWR*I7X45J=>ZE_;Z<T*"VH\8?PP\["
M##TBL/#RY$<K)YE.LU2GG1N@17TEON^))C<#8A46"([FR2%*Q5L?I":K/Y"%
M7P$\SQRZHGI_9E,\GPFU.:I3?=6@#S*HJ/.UU7Y9S@JX0Z. OC'@C77F8V\K
M'O)E7GK=4*,O<:2G+]=NNXXQ.:5",L#6=<&!_D=<)0Z%"<MI3/+[LOED9FV,
MA,\96ML^J"),C\[*)!J;Y(??3PF3Z%,:)WR6I/\$!KDMI%&OAK$X3\<Z^^8O
M'PEW+6JHU"L.D[%I:Z>;@U/D$.HM#A&IS1;&T0N64>HB 7N0(=N&)SGOZ[LY
M^__4MKV9;E;)R+4WQ;N96D[X'1]<OD0&5EMFCWB^?XM<ZS LWL0B6>*.#XQ.
MQ3L#V^B,;##DJROR !,\^UY@/OOT^!*D654/<A>^X7#F@_T&,]9Z\!_-N1H4
M?\'Q41'TP!$'<TW7UM\[3K50CRU1[W%Q3WU]*LV(T6Y?EQS%H[Q\ O)7*4^[
M#I:S,$XH@B49'\@S-[;?0.9;)"W 0(^%6?K-OA)5//HF)2-_.<9W&B6Q%4^!
M'"5P'.G,MN$VX5;_HU4C3DN$%=J.\CZA4<7?. VG_#WR8\/"%AN(=U(Z" #<
M^"!R0Y-#ZO*9/<RT?:.LN;.&6BVE^^/L_0/;'C:GFHGE0AR$;)Z^L $/Z?RN
M\Q""G\DY^R=4FGO.)K.ZN:BV43\>1=X?QCM]+V]-?!9ECH8F>'\LT"3(O(T'
MN/$;"'XSDC6\PUP9N)>Y&J4E/J!Q^* RF2O=C$9G336111Q>> KL$1:)_<D3
MY^Q-VE1GECR\::$Z_W-=/&"+8CL2HE30 J.P7H4$.IHY"#4=G:^[NZ1>K#6*
MMGE/C-F"O )<*/J>(4^,D5C7+?55L'0J1YD3EGVP^>>^Q,C- &M1WTPB6_OM
MDY,KP#98C'V2F_-Q<V7LE-M]VL!;WCX82 ]27,2._6WBL+UB:K'IC?%R8!5U
M:B_<1=&YOD(<KZ7YWY*<%[HN;70##=&*O[)C%'F0MXS&6/^K#=:W!+(*'DW:
M6!5 F37:MM/PD5C2^V'6H7V=>^^^_GFC[NZ&(ZEJVLB=<?)!_=<FM2%/PI%@
M*F!R$\60E@;C#^7V]=M?H_J$2K/U=35DP,HJ#&W>9/6E:&<%JDM:6VI9XS93
ME%R9SP4X?\0T@BG"- )((@M\9W1CARV]N&C:FMQB:;%NXXM(W0DP?FV+[PGK
M4^<FL4:MV*D.^2>2"9B*W]CF7#M/4:Q,+70>BKD[GF:@/P#UXD2L\\E/"FV(
M!__8- A;V#\G7[P"^%V?I]=!1''RAR57<EAM@X[P$*#M*57,K?&8\3+(WX<C
M;3M=2B80A8'2%8H;'I0Y8+QQ?($=$L6XU[&=+3&_S1E7'D(Z(14'45_4^:GM
M=GZ]@Q;$P/$PL="DU4V52AJPI+H@F/6P.H[EL*N@A<J4=#>)SAV)?[!^?%I&
MWIA?:CSG*2?_R\(8[]4 HG4:JO(*7?1\3$W+K-5=R_*;Y@1_A-12_VR;-4<T
M7D3OBXS,+4A3U8%_C&U+,FMJU/G6)$/T[])131F"(J <;FZSY>K[Q=2G15%^
M_P6BUK,VY6$A:<IL)X_Q? ::8BYD+L<!Z.I)+>>>FZBG_0KO[ST\'HQ$ZF'R
M&%^#5XE5KILSA),4BQV&%'L2=E&L=0W)N;Q+6/GXMGN -M23<2'0H.46K^[O
M&*G0&,;6HI.;17-64^Z9'66ES.Z@CC/=8]HQMJ;Z;&[(3-=!8HU3H0QGXSB<
MA9&$VQV__*PL_D.O)-4MHU"8I3$DOV-5YU4,JU_C];KW@_)"N=S-GS._ !/M
M-M"07P2=6O&-P_0PZ=Y<53;+*.&I#I?MT$:)X +=S:%Y!?LYI>,N3;H0NH!2
MXKO:D_I;$:??J9;?#LG.4IZ!@FFA0=Z".AN%X(1)ZE[?LJZH*8.9B8&UJ?Y#
M4%%ZL]I<(T@:D:(Y_+W>]>XZVV_7[KWG<2@/^=IXA2?A/A4926S$"+Q '5X9
M6A(.-:8<&YZB;("6)INLTNO7*SGFGM\?<P=SM2Q;$1$/!900W[@"='7L7X:A
M!PP/\W)I11Q_:-W1[N80)Z-=/\9#%M'C7<L9YL\HSI.=E-5-E68L'0Q4<<5O
MM\T5 -O$\I=XH<-+ G8%>(R[>G%].E"*_^UL$"=<>80;_';$;D_R5OW]B9W9
MKG5-7\E<.ETE*]/?W^YZ]B#IFDF2E]'<91%<JZ5[-.0_4^,PG<@+;RQPPVJ3
MP^;PY[^EPD6L%/?T'[$LP1G^VMY)() /)LIQOL_7:'_\YF>SGKZN'#<ED5P_
MSJY%IU-W$BP6%W^&\P@333H35[N$3D\7VQI6R1('5LH%16:[4,DREK"UI7HX
M;)Z/&P^'KOIJ+ %K0DXNY?IW>)EA!P^6M]'%=#;R<.V*Q'$'__F2F3\TSW_9
MN,14.O(BMU'C=HO$YQ3&?\5<FE>'-^@_14I5YE8LUFHZ3S 0["N/OS0V,3 V
MF.98\PH^[EX]AG/JHZ)GMJV)+0;Y6=!N@CYL+>P(Q@'3&&Q>N6W^U_%O-4,S
MH#O;]>)!7U01=$.J8:Z1N2/CB$O/3P-G4.#:R88O<_[U]F9Y5L6BX3D5)V@!
M>H$'SAE/\?R[\JC'<(FGL&X=RX=CCAO_.F5NZ\F E:P!(:<O"+H.D]#!<A@G
MPS6(Z>\KP-'].MPM\X.:?2CY_ .Z%U> 8H<LV&.8 11I=R*PPE_@!N3*,@A9
MY#ZGN ::YC2O66_63\TKAL&84ZR;9A-ID:W!&'3EWK\>$9PX7HB#FUM-U[N
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M1LO *8Y1K3)]+MS]>>9;GV?3CIY-W\UHK5M33ICE'FR\I\C;Y#Z< V)X_N4
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MA&$9QFPQ9"I'8!DV@@QE 8;/AM^:AN^\ !QZCO3U@,[6 YP]R@+TT7P@".J
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MUB"6$H!,#91;SX"*/V@/"U *?RRL+AU]RQ@4\G.'$)<?H"[3VVP!5<S25Y<
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M>9BA"(5BG(,(6S(_D<+Y[\\@-&?:HI V?=Q+XQP56;R9;O,G[W#%3_RP8<!
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MA\V($VSP3B-TH@4:P#=SMQ[%I*LR/\8AUV]]=C7S^W1-@1ODZ#/5)@=X_)N
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M6%_2,Z>(4T=?[Z;\-0F#NB^Z4QKN<YW/+ >N>F/6SSUFP!./L-J'8[XJGC@
MDP@0V=>8X%.AOU 9*^KWQ=#+/E!2IJAS3=]*EYP6$.+ @M<:5T*)#J!'BXT?
M7L9-\7AKARJ:IAIZWEDE^+5#;G2R&^W9U9EE[36>]/4)4+W>?U(YKG#WZ"&C
M&TP315);7:222++C7&+Y-H/"\>!7NTXI[>NA50N&)4Y*V3-.MIKN5XG$!IQ9
M'BLFM(R*+%LW?._DH@9::\NWKV04D?[H)(FF$^C\^9 V7])P81I(I?]H1=%^
MU&]KA4_ZQUS1>9U6)S7KKKJ><IWJB,( M=^$[-A^YJTI*]V)FW&/X[C=746W
MNV@*)W3*)HU[;)QOR4D^4Q^J]>>>E<;+QZX(&QS F!4'&(RR-X#A[5FX0%IO
MENF><\[6(^?.*V-!H[=4L%"Q5Q:6ZPR7Q=8J=[% C\*M>P^\) OSTE28Y<%L
M=R<:5*Q>5P5HI(@&(N1?J.( 3>FJQ)MZ1<O[I,+SD_*EY,EIKXL(-R&-48TE
MSAAK)Y.=9[YP2$L,R9B/5-&&!;B\F*U*=]$X6"O#8T9T@%%0/P')$#NYE2AA
M_*JV/%UP<FCTE#$4=A6Q'J00A,RL/'MTYVY]#?M]![_7IQT*TH'N?3:R%+M
M[J$4S:+>G5-A[-]F'TZ7[,]#=7& ?3G\Q]O5?/B,[O#1+'@B @?8Z-K^N?_
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MY0T0XV^1W5:"]ND4GD%U5;_RH-ZWC&CTG9ZW*/#0.G6W9SC*4>EFN@91SVV
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M>7S\#5$Q%,F5\Z-XX5(DY</YU,M@NI_5J)*E" 6MFI$'K]Z\V&+UU[ZO]D0
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M)$\9?ASK%*3T]H<I]<[MD0YIKWN7MV;OFT>37B_ 4/FY;H!(\=)-K@+O].+
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M&P4?-Y3S) :O^PD."D3Z%8(-$"E5%H76='8XP#=38X.SS_,KS[KK:#L</+?
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MID2E?0H+NR7K6ZC&^OPTBT8.]"*3I+V$8W'F?A][@=:F:%TE==[BKG$YC]^
MIO;LBE*BD267S(UH!5&V,@YH;KS.FSYC/?17L:6465Z6!*8[C[?OBFEDOV9
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M>'G#/B]?5:T?^FPL VK\WP7W@VZ<A1^K,=E8RAZDCPYU4:Z]O!<2FU:E(1W
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MD\[6[?^("C&L#+H7H#?*''9U]&F-JS;3>X)VT)^3,-4FE$9]N4ZU9*?/3G
M"I2S;$ K7?G@QI2+4Z>%($M.X>7L>W?]B:["%5H-9C*8)G9=6:\D/FK+!T61
M7Q='=K)(->6J+$DY>9C05J3+*V9K0&-<5AY*WI21#.\MV51WC(A,W[,AL67+
MR!M]I%MIT)'*.%8<YF@E[N#XL?4+(; K0%\=!6SE-\54"'D[/I)A=+LL=4M"
M04WY0(K/:$Q(WZ=/'.WMG)8@?V98Q3V(9:Y4:P/?%K 5K^G@;Z,@.-N%N@>F
MF=;P7*\/3&H9<)APG0:26\69FBI3:[VZ"4R1WRF4@*R.-SB."=-6V&JL81?6
M]%=X?>N)%D2S&T;M7<7@V]LUT-?88Z@A\-EQ8<6_S8RM2)7AI<=YN*XI\AP'
M0/.*[['5E-\A-I>,/2O+H@[# 5:_1EY%(QF\)\@/P%@Y;A@:"\;<830_MWBC
MDDZ=$/X]3/'N0L GJ)AL1EU8_W*?>E9E?)/?G<0=H\HH.U;&3]_S, =D\\.5
MC4-"/< S<QNKR][,\EG'E^%7YY?(PTO,*!2*E7^(]I9FAQR]?/[&>HYY#-G7
M.&40.$%2S16X>&D]/8M ,L,Q962K@A6S^=;T6_QL:H8TXCU".C=VRMY8?)KY
M[HQGU&S7[H;$\G;X6OGVV7&]\A1VLE08[B_7[Z H]=<V!85#QJ7^D9XZG4_"
ME;O0-D\F'L!E<SK!YFPK=HSD<U%U1>3J.,!$H2#^]8B(?#TT9IKIP_9KJXW)
M3'F=4A\A@_-\<U39O]6E3*D*F#G5=)IO2479QX0Q\9!6_=);QM8O#6 #C.Q)
M11L=T_8"XT_U]TXGQ@T>I9V*:'3:VUQ&2@*('A-M &#I<'5H]Y*4W[+ZRQYZ
MQE(6<ZZ S.6C<VMH3O&6 3P52;JYI^I$&*T(E!GTHY:O_!)RXE7?QSF\,K;G
M+=)B.20?O6DWA /8E)H[%/LY99[7@2<[Q-VWIVKK=5OHKE:(9>  S\*58GB8
M$^7M^+LUB,]MUCG84Z9<,N9TP[7$]%G,BO-&*89K%1N84=\Y6GBA;>3XT0KL
MA=J(?[:J.9*)%]=P6HN0FMO::GTRG&*5(F'(_9K@0] +4<"E,P#W.NCF5IX1
MXLI>3IG9P#VNO'SUEO5YP)OD@NU:Z/?5"OJS/;$9ZOE5(II%!8(#:HC!BR\[
M2'N-@M\W3X6/N/1,R(-&[%-#4_0FWI';Q* Z<8![)2+8^FD<X F4<L)H;.?E
M30/KJO$#?\5H[A YVNTFT7Q[8?I=N;%]&"]ONCQU7D+:APT!FQ0J!NN:F0ZA
M% B_07W HFDX=LP&\\&;XVB1MOS!3*V3,KC)*\;> @8LL-UC+T]GKTQ1?".;
M$/>(J^>8)=9@++=0(>&W5 6^^/<R,(].D4>JJ077U%JV#,W=V>Z!;7WM=!+>
MA+U3M@01THS2@^5.A_OE!K>+F-O,Z6TMS8-8?D5Z V7G\XPLAURER%7&M:]F
MF5_I'ZA];92 9OK:8%92+]*.O3M\5^]!A=)RD-^.;8CVR:4/32?Y14'PFLR=
MKG3ZNK931E S$]T(VU&)2ZADKS^=QO NRQ?Z[F:TIJ1YX5MQMX\XP+1CJP.M
M4OCD>[Y[.(#E2)KS%-S+-+2!.YFD$KK )*UHKGD6!'5:6O*NF?-.SDZQ%+-B
M->N=U_ 4YF_I^W'T,8%6Q%/@T;W/'[_(B$V)D_?7KR^"ST,K&Y'#:IAK$_X3
M];^C7^SM"6RM$@[PA0YN>8"U,).^E9_BS0FE?U;]UD3)[('M"F!?-21@U L'
M0&[3H,A;UC:AX-+,N5EY0\N%Y"EQ+]TK"#^%$)/AU;!)5D52[H)F#7I_<G.C
M4>#-<UU[RHX4>) 6X'HL"Z3M>YQ?19"DY Q5YJXSQW!\U-* ;X;W<X'NW.3E
MJLH@)Z4S[<>PRXC.\)APU]@',L,_9I4?1XT>]5#\S #=TQ>'UA=NVY44F#YW
MK-HK8N#"4#F N/JAX33@-V<9:Z.;3ENG4D2_O5A4E2ER">_%!,3W_=AP@*X@
M,/;8%,UOT_)N?U]H,W)<UWE:6=?*@Y5#<3LR>H;\1[&Q36W[;IWA[%;5Q,U*
M$06>UMHT)P'B]EN9J]JJBUS/!SX/P%Q1^.C!K('W#VV083@7;,K&JR*022ZC
MP-O^MO-JJ\-&#;)).,?:+MM37?M>?[$[F :O<85_EP;JP!O:&W\L<CMJ7\OR
MS:^M1ZZVC^2WE!^6?92Z^EP_I$U\MISS.EW'%RK%1U_O]Q3F'P.8N#D79PKR
M3<WN*U7GI]_YQV:EIC]JO/G_@2Q82E1D4_H2FY7XZ'ITR!7%E9L*LH8=MT,X
MOT9EF6_]VV*NPPIKR"W4^TA&9\V[.,#(#&197SOA?YL]Y,5_4O8M/D;PUM-Q
ML545<'&T%,Z* KS(K(/:VTZ=X:>"2D+]3L.*[<D-V8=6>%G4W5VJF;VTY[W>
M:G_&CO[7Q:0F[@AWK,(U\'8?Z)@=JCQM,OZ@9'QN0J?!GZK_YU*UJW9W=Q,1
MHU+A:=*$5V"+S73!G@5IN>3PG7=>KT_60E\XYJ\[1+'EKGB??J!_B@,$FDT*
MR6M\D$D#(C/>B/%*>:#-:9:IS=2NH)R>R_%-*[TW8K&[XE24MGY?9DIM5'?
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MZO[M>J!%0X\J[ ?0F> ='(!:H2+OO&>?S./T__KYLZ9&L!:G(9+>:3G48SC
M']?[VR/N6N$  K]:,Z3Z-<*W<( _K_CW9SPIQP&2?1<O:+V@]8+6"UHO:+V@
M]8+6"UHO:+V@]8+6"UHO:+V@]8+6"UHO:+V@]8+6"UHO:+V@]8+6"UHO:+V@
M]8+6"UHO:+V@]8+6"UHO:+V@]8+6"UHO:+V@]8+6_U]H_?/<3A/-O_W?"9#0
MJLI+(6#G =_BH9W9D4CNPL_>2(6[L8/AJ^W] OY*2'X8ZW*6. G'5_C1I__N
MW6$O<($+7. "%[C !2YP@0M<X (7N, %+G"!"US@ A>XP/]!R%7ADB7M8;D2
M157&OT/$.O$C92#ZW!(AV]ZJ- CEM=W-_1AA(^'IDWGS]5YLL&!3=W?3#@?!
MUA;W"NRFA\02>ZNW7D68,.=R@%>1FH77"HL;F:@HZ(F$^_IT YD'>KN3B2[=
M52"J8'.OM(_YO>38JP0GHB<.3<LQ25(' "FF\+.0Y9,Z9T<$&>.C_C6+VVZQ
M'4-M*T#^;KN AG%E]W,.6"CXF/H[#M T"4:E -!.X4<#@0TW)B1ILZUO3^WV
M"O9)+BGV:@J]YS!R?<G?YUG501[F-38?_OH@*837LBJ8^#:QR61XMR-_YP\:
M)P"[W54!Y[3(%T1#GW2[O=;]_9A1Y,IJ%$;6MUH^)/5YVZQ9!I8N@Y<<FUG8
MY^KK%DYCUA&=P;G&<@D5AD04,P+XVV=9]2&[)/KR\3*+I"6 8"@?!FD0/G\Q
M5B(\<0#]X'P_/TAWU[E),78V^ DGP_M+M"QQJA+.'5MS %3,HC$YEE)_G]?L
M&D'?B?>Z8!.Y6V>#H+\CB@Z [@\_G/>?I^"%6V;-_+3N!VI]FS(PNK0N[QQ\
MUYWP)4;.>9[!CVU+_/Z6A^63&AO]WB<J=9_[&65]1S7'5,58G;N:MQ\SK<OY
MI+H>G"[))R^.(XRJW/D#(W8IN>8:IUA4ZT)/&#*<I$1A&B@@@OE7N\ZI 5,5
M")(_=3>1/OC7B%P:XUR.$L,I488,*\%/#A@=:A[!BP.TX "6@T)*\(CMS_#-
M/=U].5I6#M,G#C-(@/>*9[B/%"H6%(P#+#XP3$V\RE=>Z%O1U\,F""?/$^WW
M+6L'^%K*><0TS8=Y!3<*-=!/\#*M;7' IPT+R(Q'7PKP;[59WLU0[+>9SO]O
MW^_M A>XP/\K7/HN']<QU!6^T53$?=V?_(6<Q4^4:2O:XG2Z''-+M;RVV51\
M;HS%C-PHX7)%T7I,!(@&"K6'2O(O>D;RLYR)B'2AK.B_/)5**K7+2WOI]/C!
MN3LJ)L]X$[;(R*55\^E'B;< 0[8WF<\W[\H%P<U(5TE7R.5S1M=%\+7GGODM
MK^K'&"WX'[:R*E][/'=>VFD[5P.U7\QKA1%[>,@4H6(,A_F$7X5$S\QV#!DR
MS6+=F.HO;8X([[IYY4(*B$%E^[MVD1[S*\]@56(=#AX;8"[ &5''':_<"@18
MJWK$-C?I!7:(>5QT::YO->T>:0 DX=)FI+>N3-&V*:TD1U'15I5!]LW;M)Z/
ME&ZR9UK0:@^H/H;^F#AYGP&B4<BUJ;W? +&YT3H]J\QJQ40ID'W,2',=,2(\
M[J.&& B:6)PKLDNICUHY'>^CAC\Z>E#<.W.UB1W@VGV,S"0%DDBSQ@ W!7-F
ME*X6692KEJZ_#O<27\^[ZR_6N6QR8U'[SCS3;LKR.D^)"B=['=&;_\7>>T9%
M\67OPH4(#8(@.=-(D Q*SHV!) J"2DZ*DH/D)C:(Y"0@H*B 9"1)1G*.DI-D
MFISI1D)#-]UO_V8^W)G??^:NN^[]SYUW[O+#LU9W]:FJ4[OV?O:S3Y]3!?IU
MJ6YHNN;A=QB5/7,&A3!G)?TJ#B"3EWEVS'']W.FT1&G_\9)YK-B<V27.\HGH
MH:#$U7JGH2E+:UJ"H^Z.\%'ST"8N?9.@O+Z?IU?4+Y1+*2\^EGQ6L/XZ0[Z;
MHBV6YEL4#L*&VH\&\*'0[06(6=W8?H/R^MIQCD..2-*DZ6"$!H  >$O'BET@
M%6;Q_ U3DKEWKAN,CDISA3[WN@E6IL&>TQ*TS2?ZHV_+F;#!,0\X9;&;WV=
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M("\V,K+Q];__O1^_\1N_\:_%(>6,/%9C#:\:+/&J07>J=.IMP,CBH;80G@?
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MX';DL7R6)CYN&6>$I PQNS6%@2C5%QA I7" N5QT_HOD$1.A!SD_HXN<IWZ
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M]Z%RPD'X0+AWL'>%G."8:=._TS7>CP4%(U]_B5A5B1AD7[8R^X[.09[K>Z@
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M=G:&E.$"^=[X1QV$ #P?V7; ! 3[!*:VV R[XM6QBQY\_.YTZ>41WGEJ:XC
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M*GOI->5/;.:,2_#\6!">)X?F96R=Q_2UGF/3<[^^_96S1/KVI2=$,\9*J N
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MHSI-LECKI-*IPD/'3.+$=\0+@I\_55*^HQ-OW/X,I_=E1SJ@I=@XN[G X@)
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M6\;8&I=\4R.&[_L?K].KX46+YE9.*H*Q/_>.X:&U9[D>HQL'VS($KE?"FVI
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MQZ(>LC23S9>2V(GK0@E'P:Q#)#3.U'-*PL&S HO.,NQ4Q(F:1TSR-/[E^S$
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M[060RUZQ11 GZC#!>WQX-EOLF-0//=E9XU/:2P:W!]9> %2]BX10T4OYT[P
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M= V0=PD3^4A_',F97P&?,WF%0@HV?WE2?<';C)Z1;6._&V)PD)"94OC%Q3:
M6ON!U3^Z@.:<<_Y,F*%2FQ#N,/GR 4YITO ^-2P@LPAVJ8./)B %25&I.BC'
MO$GKA,3BC-YV3(QMZZ.%G<QGCI$6](=LJP9P)'' /HQJ_)VH]/TEZ-#/.KZH
M,\:35X?))..6$=ZBV0K+$QNTWQQ_.I<'PV='>P;-'[SPE4(,Q]KU=V6/=ZB@
M?Y2]5U]!/-R9+F?$ J]Q(F$Q4)*CK'7)D4(5O,.]LDN]!9GUOZ3XPJ!3Q)U!
MPZHT&CK]$@OP ,LELBKZJ.SY<EN^N5OC=[0^!&TWL2BO,9WLGP%'ARHP-03X
M[=SC+_#GEO1A-'>+P_?!S7#. <X2PUZT;#K*J7.STOA[8Q#C1':;S^-(SJP3
MR[!'+#R(21.>/BSPP[+<G4TH)ZPM.28,(=SO)Z.+V7F(REK03RD+3BG1BJ7>
M90V5^0%^B$;PSN3DS YL/OE1*O]>@3Z<VA5XHL,/:AHW#>*K[4P?S^%RK*FL
M#AKZN.L)RW!O>?''[ ;W/R)N?YQT?9 H?NYTHF;4)>PM%G!'U,BVY4K-UG*L
MLQB')R5E?C+JP+5DUC<-\ZB_BD.S8\DT4,KU><W@1X=D^2#BK*6Z0].>O7W/
M9D1XT*%;P&8*&\7:<JWS4 5\]B(XP+9W:E3I,:XYJLE_@JT2SCGG3T/.E(W)
M@(RLY6&NYA9K&")YM]N'FN*>RKRQYTR3 7EWI@/IQ58V>;E36"5$"C%%=V=$
MC@,58M,Y$63H\K+'0:63?O.=K$\=U3;>N"G:;F#^8VY@I*.3WX)W_[L?VP"Y
MFB6RME&-VF1UY/*U];Z[[/#9VZ=Z.AG>$HB\3Q>41<KSC#V$IGR1'T_?P&<!
MZLK\IDC2%X5"I?$T.6^?J%G)I-3.@N+WB/S$1$PO6_M>*Q:7,EYTNWBKFH+A
MTF:'!TVZJ;2-%$<5 MY\>=K 2%C>\$B<IUR-^)7+P2%:I:S"W=*T#"GPVC9K
M EW[I#EJT4*<Z3+TXR'KT1\X"?\/WJV2UP\UAKM6D#$6* 6?R$GM;/SR!C!;
M9P%%'2$%3X=G.M2/.A"0,1A&%JV!.2C;C:[9_2\V\IXY[ KZ-FV(\^4/AF'F
MZ-"CND,S.!8PJ8'HUAJ+JU55FT5R<#S==JQ'(TU\$/TM>:(:7>JW#3ON^<6T
M6TARSKP^&5*YIYJ4RS8    1L$K(?U[W?\XY?X7[$9QT>29-'W]W7NWS)((8
MTW4\DHQB4PU50@0FVEXE= NP^!@Y'^7'C@6T&LM!$5>]H,VI#W2>P60HO/";
M!.=]H1TUH(;Q#P9E;T6JOGV6+'OD^T4J/ =RTPK?"9?=4WC!K]ZV,:$8S-47
M.'C;1469F >["<]P##NA,B)N(+]];[PTH?DC(B:YA\1#%XTQ[:BA:I7Z8J#R
M5E2C0I_,L(B53=*5\9'9NLJ<B1="4=.A,B^CZ<@\O=(K:D]\S[3;3];SCSHV
ML/K-801.1SV>8H&G^EA@_U')QL$O4\W)!']D^?:LG!BT_=H(="L($QE1=?*[
MEWX2@K]3U6K0+X,D_Z4V4K#-ZZ:Q]LT6Z#)NFT\VR6R9>/HX'OL:^!(.M 0%
MY([FL5=PN*)]=S!2A(Y)?%$E.\SPS-:Q.^:E1BR)HQ@"6$>-KL0P5[0(_1V\
M1YYXC_9UA2.*7KJ<#Y"<<\Y?\PSUO5-M<)][_\QDG=3*CNB*FK&>382"T1'-
M0A(]TGBD*?>%#\_!?,T NT_SA#H[?MG'MTQ.Q*RS"*EG->)P#$4%,B#V ^V(
MMN%G#X;V]U1?PESS2/^WG=._X0_N[]"Y>^F\:[?,,9!@UED<;5K/?7.B_0U5
M)M^?;&U78J-4SWY=G6%B-37&Y#$6(%%\A 62:V!GB$%HX_LAR*H@3D*\10%+
M5&:+&^3R094/3ZOJ9G&S=[:Q*AO!D9MD/5R""<,^DHWRM2=#.=\I&^ 7#9>!
M7S[^,IEA''DC4K8'Y9J/4[^ :]^AO28]&-0+R)SJ"]@^W0\L4'O53]8><X4?
MA'DC!<40<J*&5CD#UVD2IO67@H_UPM]PGU":\/_O)@UML%SM3^M%2YIE:%QO
M.^S;%$@%=JWP=<^5_K^O]-DSQO"G9K*3:02!0BN<S,3JA49!S<9WQMU?&5Z[
MMKUXT<%Q-T)K'QPNDM<\%=OM/'=0G! ?O%VB5G&+5QI\. E;JZQ1K] *&G<;
MK1;Y4= <KVDNL[*T"HF#7EU?C9OW+\*U(4KA3W"BP3GG_(_CGW[LUD1G82)^
MJ%K//L.PP)Z+CT<8_G$%MIR*R-=.LMK*74S2G6"R,@[>!-KS^1#F0C:^PO$/
M8)R=_ YC]O.<)!#3 <3W2"?.W*AUW6'DN$&3[>5FQ^NMR2=XKQ_TG9]!<\XY
M_SXTB2[SY%>;J5RR]9NV;C3Z0\GVY*^*Z'&Z(04;Q;Z(Y46+I]VJ6D'B@W/-
MIM 6B$DF!<*S]DW=&]JXV.0F)!WPO$&S< 1E\@R5!:T.&$'EZX8K9X)J;]8@
M ]+11W&'B.,KWY4+WO2&[:I)GG'A__BCQI[_V9<VX']"+J<>@DB[0TZ?5URG
M6?D"KCFY +F:CABO-UP5FK[L-J7N !TS(=ZH+*AEFZY9KK#)N#U1_8'A/C0<
M"YR,HC?ZBB=$!XH[#477R-0_'; Z0:5RHT@?TW[[&TX .N><?W:(U//ZI%KG
MF+)(%BVM-QVGJ^U;AJ%7]G^PUXV7Z0U[8S -MX4B#Z, WOIV-E;/D1]]\F#.
MSQM3NDO7:X>>\[)Y]T^I;V=O.\:<7-UG!L\BAFP?K,FH6;.3X9';4+YWE6AG
M(X9A2CP%@^585N5NS/ -8P&+&CO? ?N 9]!Q9D;DRJ3>)U,46RL+<97-%LFR
MUSOJE9\E[1(K._!N=_Q":KS!<?25OO=O7+)F[D7TO96'WO39L!N8,WUKJVHQ
MD.3*3#90<88'8'1^NKLMB+S4G6AV#>0DX*XL,\K/>"P5Z6VY9@++?.$J59,P
MM7:D;50_Q<+11LS0L"\3 ;KN)[PEPSQ7=?TJ.47]S45A^1R5WB\)(X$7<P?,
M;[%;GPW>)UY[\ <N"OQ5MFU&-G[9R5S^TJ_Y>#7TUXFPOWGHAJ;>^R7N4HIY
M6& "= 9F=COXY0W P?0'!.V%BC_;L%^ZX;7D#OXE[OW/F\<FE!+WC$:^G7T6
M3T.?17@PXO-<:*8N+WM3^VT*"L/\M83+GXLJFMQ?@2F];WLM@ZO46%:(BR*H
M\K_RFA0:<3;Q0SH&M@^(F'[.BZP4'9QIK1E//2KC()4_KZ0\YYS_&,FZR^YT
M\DB.E9H?E)-EZ.IZ5S4,,9*HNNX^RFU^AGA*% L$V2U7AE&8#'Z(9V(2\3@.
M]"*?$GYMTI3K'J2&."B#94W# 3:>MTLSOXVIZN2CG]0.,HVYVW7-S>SF] L<
M&WX[?F1.,5V,9]E4Q\ B3IO$7GSMPY;X38&+D"U.E*_.NH%)?N:&KO_&O:J0
M9:K615G05V:5!1/A-+0 DBY8D")]GK>LY,K[?A&X]TZO&;BI'LX9(9%OB%@)
M%*DCU2_)^T3US>FJ2E2G2!B1D)>O/.@%,)KR_U4D#>)%!C776#9AN*O[M_AS
M6"Z*V5J;.<&=>)GF_-:U7C1A@8#V>?#Q7C\6V!F$H8W-T?=PLAOP'3HA>$8=
MVZX7K$>I\RCZP7K/H! :AO?PDKISVF?'4-]2E:]8H'$1"4(?KT&/UK5^JRHT
M2KJ&!6"R@I@SM=_*"I.T'Y]9E.TQPT8]W- G_Y6_5QFV@=Z$/EV:V5MC"<("
MI#'-D+V5="PPD_67@D0G]R",]W[=Z0'G;_6('DK@Q[GHAK.@>&A/FB<8+:!U
M&0OT),5C =^T?ZE-_'W#/):H?7#F$!^R&&,!N:A5**)"1A'WDZ?IV4G,7^HF
MZ3C?05=Z-+! W0,HTF7E@_9!PLQ/\#^C]07>EDA28Z3EVYU7:K:O]C42/UGU
M#06.Z,W&L:%\>!-2$EIT-='-/=<ZT^G YK&G=H]1CO/,EO6WUGD):)U\"EJU
MOC 4EKG=O8DY<#/]Q9!\F93@9QOB7E$J0;LG#O</K2>R)_<AO_16WZ_=L]?!
M_5OSKF*!_R_Z[\]V][^)@AC6DWB*PTSAMM0.%3RLRL9P9DW]?4Q&N=0D=%^6
MTQYI"Y^W^4%LD):V(IZFO3>I&/^4^T&F(N@>]V"TQD#^JKTU%J ^2.1HY674
MD)5HH+A-%WQ$&>WDL)#DP]/SJWT;/5QYXB$Y,\U>R+:BU;2::%G0+]WGI8PJ
MS%N7VH:9B69\*32:A)-^"&\"?N*UFN:++@WESD&/&8M-3[# &RR@S/_HEJA1
M]+)PLWF%M[6Z>G2EUJY<8DH([Q2$^Q_MOLXYYT\%=XS:8@-[%?,AM^T[H:[7
MO13+U68M,Y>]C:]Y>1FS["F72>)-T^[I6S),*A//'?<2?[.9YNVK%J<]4S]@
M<SYZ:IJ@O-:G,ES]PPA5EF-#=QW>I&O_DMWVVX3,V.*)(*L/D5:-QW<COI$4
M'\6>"EW)F)<3YG:0:D4HFTGZ'"Q8CK+WR2Y_M;3C,_JG:>]R\M!8@.H60>32
MZ'U"6[HYL9+<G_9H-9\;A3'+SRWV+*%'P1+@8,ZP)WK?K>2H?S.B2ZP=9T2&
M?8+RQE#D<$&N+Q]*?:ZTW4.V#O_3DY>6 TM=M@;N TWB34=7ER)\V#\J0SD:
MDLG'>20$KE5$_O2W6KJ[\.HEO>4ZC_K?MK8R7QBGJS-S%3+/Z8+X;7?LS..0
M?/WKK$D:TC>-WE3=4)!U[!82-ODD3TC3@-J8+PV?9=8<;[I?7%V1Y.X]R]^8
MF%W^.O&GU'LHSQ)T+LT;=S'Y<%/,,2XW#DT&6:140"ZXGVHASP*&EF$V+G9Q
M_>\^&A$21 NW7LIF$4 .OYX-E5@9MNN0J=A]$NS6+B UZ^GU!>0)K''E7RL^
M2ZEF<WQ5J&7Y?4(9SN+<&):]?;L0\EYTO93N,"']K?@P'>6DP<^JU#BQCH*3
M7L($7M(6N5M],HR9N<LE[M?T;CP+?_2C0^6Y]LA&KYOH2BD6*+9\FUY)V?DT
MNX%28L^ JXUED9ASMPOP/*/14!O:%)T2(M>X6QFQWNWX(4ZXX8"E^17K+D]F
ML/?#5)2&AE1$B7LIPF[T#6&",F;]VR)L:=I/C"L?K#4NWGC/B<U66E\_&)[P
M+#+227R%9NV$I2;#/48]]&&_P$)E<4QJYGVO;/PVMMY>HG":3_GN;]01W;$<
MZ3DF-W*_7Q874WOF28@?[1/@$766ZLTN4%V8N;[,/[IW1QOC/O/%MQAODUI7
M*\C[7II[OKJQBG*UQF<GUU()<_OMHB2%DS,;@S]L;>[QRKP]^@/_0\P8=#4M
M3[UR)KAN]WZ)UNES7%0=7<%SO(YS\O'9$+,.+#!IA07\(=&XKV.1M/__A0&O
M2YLI>WD+)F/M)Q0OM@L%NY@4RWY">U:4(^FZV#/+.B ]2X_R;^SE+3HX";_>
MIYE"RW!^@<U&XERQ=P^T2AERC'L._;# !9P]Y5K?2(81=>CP<<$S: ,62*4M
MLC%LQ *[XE9U!UB &!-F\,U;M8D&?>D$TG;B&L*5GP:A^8=+VCGG_,G@GEJ3
MLCWFV-,J+N?TMP@PA7S,T<@/2KI296$MHN'"OGBLE J.C@I96TT&R52@1.<^
MO=Y-KRN3+;U[$7S4GP O1S'CF>[;NBJ]?!4]>I,3\33DH)(+OS%/CLP]<$;(
MP'2T0R^98A6^MKMPD'<Z5QN<;Z5+-WRR(,G/4RR=N4=TJUM2(B_ST?"K+=J1
M+:G81=T^5X%)6/*Z9T3LYSDHG3ZJT)Y]8.'3TU*7>[M^I-'"]<D4_VT=JGV%
M= NM]EK8H5Z?!B&V4A7,;-UNI/6\O#CY?<F9+W,["ZX0MK]<&YJA0N802*G\
MCB'T_7<B_2\Q!QQ^<GR(W+!*RQ9;.JTOJ?=L<AM(/T@^Z)3*:O4RUQL?0G;!
MT/&AT%,&G$"I9V^^ (X%%\@W/6=:>3\_MM3/3;;B0P_+7)^EY1P@ZSK62U9P
M0U#8-+PH&.?FM(I6W=:Y]%O5F%QFB$76*61R@^5FY> !B++ET&8C2X!=?^ZZ
MZ<>X\0IVMU8OO($2/>1*?3B5,B)@.S=E>CJWY2V'I4:\WF,=#[N0FZ/M^UL1
M^WB;20R(HZ!]9MFZ.:82?T:-E!M3! '#FA)/G)SAZ=XU\X\M40'((D/NYX[4
M)^\+P[)ZXDGD)O,S@;+!A&VH)>B*L>QTYEQ%AF6ION^877A/G"*A@RS>9"9+
M<M)R.93X9M#"4/ZG6#:]6%6V"@MZ]"K^H"^[-PNB)LA/T+[8D,K2*U-IY1)!
MWO2+_&E0M'.KIK(D?JF2!::K<G]7,<?J2IL!?:FQ?";*R;7\Q*<I,C_7,[_9
ME10QT?S\'?ZIW-.>K >\31 +5+J<^! '\9%:1M'-E1V&RY%GA-_P0?,N!SUA
MM;=Z,OC@SXPS/ME)O<,\"8H\ZKQZ8,K@38M(S_>SAZD7NKLPDNHE2<-$/RUQ
M5;U[HDFQR=+$L( ?LLL =3Y5B'M/C=\B':%B7V()B?71GB_31S/G5A7H&,LY
MJ:T2QPWBS9G^<*WA\VS-GCNRN'D/-,%FTK%^NVQ>4?!LSVBG]<QDPQ25*A 7
M9L!+R9Q;_019XV<A<< WBG-'(?&'7N$S\X9"X%B^&Y8G=@KHMIP99EQ_E6RT
MQ^H,SCU3W=IEPCS"VS2HJ^\AX?3/+/Y1_&KH6AD_,S(VM#K9DD^XC"",,B(H
MC,6F!V)IZ^D%H9]:S;TF5C;<Q:K9^*B!P-,[_?7!0G]M;.V3!)_.6WAW[JK)
M!I)[?T((<9NC?J3+6))2.U<G>IARP_>N^XE!K(P];;  LU)J,&BL>,/E;-I]
MC\F.$W/,Q=N_)4> TJFFHPD;#C_+.9PMP0()<W'/:EQ7&!4P3*^.<.'U@E,1
MVGBX_0$^J5-:1&I;&%31U"25-Z7R2S;9FRUY,*\WT7">"#087]VIDR*5L8'/
MYTVR0-IIV$TL\%IO2 >)!9HNV\F)6"L3M8E'ES_Q_*;'N9^?+:,A>E 64.*Q
M7WAMD*WHT]8=QQTSKML/2=^4;\/I)9/)U7^-<V!8H/$YL@?CX]*#IA3$ @QY
M]JV56* Y7$\Y$$2OF,615$:"_)PK8IC_N<2OB< H,;V\)S\=\ +_+3NSX>WU
M-,\<<QEDGA7A/ES-*-:EC@JZ^/4%[+ 3"RC=<-+9&\(%O8*ZOO!8+%#>AP4(
MH.S4VDKF;G__3-2C4J3'""5\+!*BN;] QQ$MG/U Y"M/]!AO750>;-53UU-L
M$L-1L&&H'W^)2;%B$IIN/F(AI7;OH:&2_O$V?3KWTY506(ON/71^YCK.(D>P
M.LTO@PWFPV4!6&#1K@^Z@0&=T9?<1T4%\J*H]J%1^UO4VJ:JOCS_Z%7,YYSS
MIT,7]$[F^5>4M>J@H%X/_O5IP82'6 !O"S5?G?\859B_4<3(?*$KEP#&M?NA
M4]HRC$)B8]0R@QSP7*Z8MP4W%7@D)&XZ%#YXP+>L<L*U>.:I%V<S0W] VFXP
MTA3G*V]'Z_'0.Q,V9R*/=C:J+9L-AVKU+B(I*EA5HI58C(H8.)Y-C1XNS,@U
MUO#.'GYZ)L,C2FE#-V'@IBAI5$LL#[++3 <<3_2:(-3N&;.F&R,/QMD.HC<_
M<3Z=(-%B^?CLUJK-B+?HG+%P8YR@349:7;5T6K3>9+<7U:BG Z'MWR948*8Q
M+-#N7H8%"C]!][_7MK)2^@N16Y+C*QM^?242BN< _GDEU'RF3G+JBZ7DBFBJ
M/)C-_4<3YCI*9^%@*)?V(8'SIY?VS!JI7]M&FX_&U=]K.K:MDUNC\A>2RN:G
M+MRCF%#W[]EZHB3=NL76!D)\JV_U=),9&8Q68NHK=DJIO-G$2_;F@$9S1+E_
M\[G0V%JIZRY+/AE)T-X%/YFJ63T_P>I;&<8V!M7D]EZ^WZ,,Z\B9%&$?7=D7
M(NHI%D/V8*&^%$/5S M9,GJ9=[# DZ0U^^L52FW^/@WO[+5@44D4CJ,C@\5A
MW]=U/@A%^5]L$\';S0S%B&W("2$:>I4_$6:.D_ WOZ\2UO"G& (W7L(/@ZD?
MF+[V):Y&E 79E? _(/+' @^?7Z>CMYHWVB*3OL6GQO*Q1Y)F36Q<(-92,FGD
M;I&_V;!JLH[]3Y(:>;"PMQU".3L55:I%9UVH?BC.%]W.I\@Q_AP_)L)O]O)T
M6N3=%53,0FW9O.#%SJ^)<N/CAA_1V=G?)J,WT J/SB;W99(NG41^OTAVD?6R
M.^L0_:M['-,K6S>M7;6-+.5>&*:4^B9;^,EDSG*^%O2&9$[;C.=6&4Z9\L#M
MJ4.#5%^WL[M..L)/Y0XZT=X(\I,-^_DIN:F5'TFBACW\3D]=Z"E4CM1?]SR3
M7.=='>?"7\I57%BN^8:2,J;<M!W>MB*O+MNX-MFA?(ET[-U.4O5K8^@F%IC5
MV!+-J];.FE"SLPQM^Q&A-/[SK7_/FUXF+I;JPP:Y[DJ6Z'C3%_<$VNV$82*&
MR=XG*PS9^WBS4' U_C=3$\7Y7(&Q;<IKEZ=5KBZ]YY8VKU\,8P+?I1B#\Q/#
M9RXKS,ZEA/(Z>Q;X)+I<67$P>B+6'8"<D>B1V#)],(3_=8W<Y3"C/^=>J_/R
MYU<SL#QA>1:J4PCJRJ&L&MKPFV&QV,:EB&;5<B':V3;(V,1[D,_TT#X_]1^U
MPADL\\M4HB%2'*-.FX4%7M;M/]"[82IKBBHZL-ST,#T-!R-4=A64J'55'/[>
M,V!TXR)IGWMH(<) K3]L[$;.Z#2$6-+HL !HS?@C/:?>I\T2.:_@[ YZL!DH
M)%7;%+(^(RQ]/[Z[VHGB-CH5\;V8*B9F.&0I2UQ24BZS)* )#KI-;5;\P!1G
M%PW'G,$T[DI154I8(!\%V7\V?,_&W12CO$6'J9O%=5.H#BB8_EG=:XC*,5BS
M3XEF/VC^ZS]\F>DYY_QYP+]AH9H8119!'2LO/^DC9--8;88$MS@9M6=^MGXE
MLK'TC5=8P%VZ1V+A^T*=P5%(ZO?5<=<R*UL7:8F\I[($H1U)GQX.:94W)(-@
MWC1S4XS-\5UGA7FY.0&M_#T@,6=88CGQGLQAOE>?MWB:NR>(]VYA!%F8\.MX
MNT3]74^]!%3H;)T@)&C[K"6W :.%@20Z2T%#O<UF>=-^U$6XOOE64D.092*W
MX )^S28;#GBJM&"!8THPIM8,4^S-BOOB4T(VEK76C(+"?*^M^?(C%,?A3*65
M?@GB-AYR3^2[U0MF#S?>;!E#&T''E%286G/,![SIOC_PN"N]WP]]U_C^59E=
M,0#[$8F.F5+$-!9!5[]EC_+^=JCS[]>0_-4](NZ!_#[;&_Y%QWOT,'PUCT]9
M]# +*FA*]'N<-$9-_KT1IAS]SQ_L9JAW--G9JFREJH\6'-<V>6IC:$]C.,W!
M.)_!D3J8OF=/C_\>QH4IF0)-S3T7*'*5,Z7"C"4]3#VTRK-</SQCT SARJ-:
M_\L(5TDU+DMF<PW% J8(Z&I+3L+O1\:_@Z_<;(%>\(W\E[GF-5#+[3_!XM=S
MSOE3D6UJ?>B9^,/0U*#)&=_)[!,^V<GLT5&VR'WB#S@Q;4EK6$&<M9?%?"M-
M#.7L%==&+9=7&>NUFI)OR_6P.RGB/?,.'O$6\%$@GBBDV==1=+:Q]\)7<+&G
M1I3I+\EW0/'EF02#Y/A7/<M57?C6XE4BI[\TP\=.H?5^+,M5BRY1-'UOV "=
M#XN4Z[Q=,BH(Y[NU(+E@R8)RF7?F-^8X!TX[>P8]27I13^?.3)M</6/CLBFU
M9KC?!4V&E4ORHGJ)O?XH1_;/$R]+4E=]I\B1I[[A0\C-E3'=-C8P:+BVK+L3
M)W.8H_ML\W&$FJ3HCZQR__:G#\-'M??!B[K\;F:F@OPW#O7FO>'D+2.'H\?V
M#PP\^>LZ%W$J[@"[_YN6GX^YG7/.WP.-R>'AQ+VBA-U=\\!IFLE=R5G0WGB.
MWANT,I)F):3Z01++@%KT^*7J--6]TS'/*S[RDO@#,=-^LM F7\X!&9W,DNG/
M;)?#'JBF 5(L8T#2Q47H.]:7(\*S=41C*!4-RN0KIG=3MX3]?9V$ZWODA5%'
M>0E^)#:5K6';#=H*?#\=@ .1]<#M?M)3R5R!E"L-0M11C*G<LR% *V(E[%4D
MM>R@I_=BIRT;+UL8K;P#L\\CC%FM1.[)\4+S"2$6:+*G'I^Q+B-[8B%DT.'\
MA:*P5@KAX*.0[](K^LY;X>OC]=)U7>FW4P5?MIXX-,DB%, !@/5YB/Q_>B#<
M-$)_5I%YLG8]R$WD)Q#3$H92<B+ BR.Z)##9YSYQF0'-[IE!G2N=U6=#>UC@
MM5-&ML!I[IL4,E]1Y42V3^R6=CG.]W)L'AW&,ITF19@&Z-_EER+=3#\Z0-\.
MX<KIKD\)X0)R[4FQ0-M4"A8808-/;MEP_!)#?P]J#KME6@]+14=F6J6$G"@B
M[Z?\"78_/.></PGX$.-!2%$QN>+]'7N[74&&=A+'D_EJM]GA#_;5&A[97?&G
M[/JZ=FK1=\-65AGW\C61F!V4_$%B1<]8C];=,$QLJS>(]^QS#E[XO-4>_"43
MU  X^-==+B7MWR7<MF$A'C3C(8M#?OX8O-DFY+BMYX"V^8!BRQ*IU,S,**0O
M^V1Q-\EAUI^X@!N&HO$4*'_D#GT@&.X_;#S&L/ T_SJ*%70X_-W!@7_0$D,H
MSS)V'B#_YR33LE)DAHS70BP&[LCORFLA<\[$!,4.M,R/P^]E=U;.F3%?=CX0
MG5(Y<O<87-]7Z;0PW?*H!5\L#:K% EH;/[M30GC?GKS_UP?D7%_/.>?OX4)2
MOKD+/^U)\V7RKNKW_E-$2VRP[FJM.8HBD4B:26L]E4[#I=U6AUL\5QY=\0D%
M.<GGN^>#4-ES&N%LN&#O;;P6H6UFE,&#M\O<E=LG3)9R==KR+'-*#DD$J%#+
M>6G]G/QE5=%7]W.8 A[WW,VL^WZ*A&MNX]0W9\O&:* :DEFSG>[TOEENE7/9
M>34U2P2OVUM[6#EF]O.WH?JD(]HVX7;B'2RP4 %^EP/R-[!13'MA$),**KY;
M>.UIPR.": @M?&[+2.!'UHLZ*IFG3+H.D/@C_KF%R_"ICYBT,^)TK\/0M(E5
M ]&\3U:@&'MZ>2U=60VPDQKGACS=ZA]T"!CO+R7>)G6_*C>@]<MB(9H%+/#[
M@/FO[A+^"NSWRZ<W?#FP0/OM(<A6/"9$?3%[)1L+T)KDG$7R8@''5,Q%C"K.
MF+;MOV?)IIC(N\8F=C@J H+W^*':\L]=J'N,H3AX-<&D8<1NIOD 4Q)D/%HW
MU4CMQ5OW:?>8^%27D_*C;+J _HG@FD^#$K7>I8-_\U[GLWSGG//WH&TTH>!A
M>Z/DIQJ?4)9>>*LB_NA@\7WB$%3F[-E4<9?;7-G>7+=2=BF[)B0@DOP$G.M<
M@,J$)]%?F'Y\0']9X(Y;@?VQL@IA ZN/Q'QM6(J?G">$JMKFVS-&PR^2"[2'
MWW\ZH\#]\9H(<"CZJ:>@J* <]=.NKF/;"8^Y1WN1"O7Y7[F2R4 D*,6[B-A0
MA6<Y>VIO1)L_3J\,1+SIA<J5U.GLY.<63W#G"]Z@-&RL2G.Z1 (AR4IU#U)'
M$CBUIYOP=]RY7:'SU-_3Y8*?R+GT_J<4FM%]]KAZ2.R(YBDG^((78W!RA_!.
M=-%[K0XAWE12C7&=D%4/AFW1IS=I.*$>V8)ZF7,5+(4"YA'7T&R.:!NAC,KX
M[LJH4RIX_]>LYD>'L<_9C&"7#NZ22PF^*CGPK&O&&=>\[_^OLQ'G<WHA72,'
MV5"*U7BIW$EG-<+:_@T2_Q4^.C]5YC-/[60;7<SU/OX20]7E"-+P%MKG>*WT
M^:Q7I#WWD\EY_NVFY9DVULKTHY\ZNQ E$LXS/B?;DN+QOU3?2I\T_0%O\/<9
MD-.>^Y[&FU:;.3/"!=,XG>EOM?HW\ _XDX+Z_:1"N/+ED*8M-A R][ UXGMQ
MJ\W4/=?;J"QFZ0D)F"<I)^\3)_?='S>">UD2#K)_S @WOZU\Z8$0)/'>O^1S
M-,'S,.I1E(I&Y/U!MO)HSH^WLR\$VC933;X.X][1*P[79+94+1G,[;\3N'SK
M.E\R$;#??0F<"QBG%'B;SG^VOV@%&Q>_+'.:KF\63"%^BV#7BXS[>^U%9!J+
MR$!F><10KH6_?/0=4W>&Q<L.PK#D-7EFI7]W*9\>_UP/V-J$:UB@>(+1JR5N
MC&%:3>?"97I!@EN<^>F B\B_C<$]3KHVO(663IY:'^':H:GTUY$J9.<"!U_'
M242>8#T6N+R%MG1TL^,SZ78''#+NSPU(=#O<=)Y@/AFQ_O<^5W1!BW["75PC
M9-O&LB+:FLSQ3FX9)\'B%R8*&$P=6+/*<VM(XB]#1KQSN6@[/JVZ=$N#5,(V
M!Y!A$;K(]H4"$YN58T-K0!$OEOI-8\GPMMPS(C7V64 ZVNK" <UB%K*_;7K3
MAV+68.7,*E%CX>PG+NEFR5O11P8$QLS1HY7-$@RM'X@%WJQZ?+3 [.G@C+I/
MK*CD)$>$G*H+?U(U83'L1MOBUFQ.05+JH%"_+[D0(6N3]R=X^,_YOPF%S3P(
M_<X ?N: 22G' O[@W4M#=1N5T%6.*M [R.XU&_!!TTG( N8BM(U3%PODK6&!
MY 3@P."/*KSZ)RCMS"PNM<DJQ?>3-%OE(1GI\QOCWGF/<X-J.M]3^2,Y95I[
M"%\GOH!>*3(5MXF?\^>B>VE%G+7]XK;034]M)9^K(2%%$.8L71>.%;$)'Y-E
M@:_/6,\V3=?;%SUU?5[IU8M^J-^?2%BQ:8#WA4LE;?\\TPKX05+^D_&P>UM@
M9#LW'=T8PI7'MG;[7XWYG^TM"ZL?/L]>EP.7%_<)LOVHB<>S='T^+MQ]L9U@
MOUMZN,O,_?N.?@%BJVLXP):Y:_\)3?#09S:9+>WVEZ_ F._ 'K]-R]6#S+<E
M8!"J\UX";[!M6UG=([+H DF\$'3%JI"4XWNI?BL,S\B.-V>&%0OY0*9'2L"S
MBD'VR,6 2'9N&<NDS#*%Z7#+QO&#E;<'LM!6SP]=(MHB<:67.*YP<@(%3)9)
M;\H>CL<H(^K>\<MP9Z""&A(^1'7QEXO3DIU&*Q/X=S N]12N=8-> /M8@/3Q
M^B$+2TG)\';T\LFMP%C]0K;2>0_.4AN+0C2_6[8IRK5_P[!4PV:-3O!*EG&J
MC#F+ ESB*/_FD(S]/)0!%>(#;LCI'5<&[<20="?O+O7P@.CQB?=: "]9FGGQ
M<97FG8OPLPS1X)*+*8QIC\J] G08VKE9UR)F'4V^SNY<;I^'DAN^B!Z7S8E^
M_EAKZID$'VPS9F-;LE65<,MS83.)>7 ;NA*>5N2K>L\#5E\E7RK5-<=47=@L
M6^JOA7D+X?F)3.]I_O92U,,%-&5U=_/ML\EY#I_O$IU'^,-%U0S$S5:OF#%T
M1M8#ZCU?)G;1W)#J%90\F@M_59V7L3$[5S"('SIWS6<\:]+B](LWW.I8SK0J
M(O;-0OZ[89,KID7RH2[?B[8OKRR%N0IX.?92^"9:X9>E5!OP:H74\FL[C#A9
MN^[X^[4?VLF%[IWN:<8KH++F6N@<7NR^4'\KK!Q/+N=E]O(-)R(99)E2';TP
M7SR"P:NM*'U>.+*5(.I"0N)G=*&#GBG,_,FN\+[H*%IJ2%36IJ%T/"+;<652
MB_VC3T@=U[/4 ,!5!&](+QCE0Y2)/,0XMY4FS"Z IQZ"#\YXLY&?O96D5EEH
M[U4Z!"A 5K& \.(B9@^FL-;BH?*F;NYF]7!^"8C,^V@S:$O(=]%AJQS)R12[
MM28/OJMW;1X<.$X<[.*8-9W;8<1<:QG#JLUE0K3Y9@(_C(G$\C5=ZZ=:>[JZ
M(\(BS,I9+OP(BF I"<A _3"J1<$=4TC1:S>K_1J65/K,UJH8:X]DK? 'K@=?
M"[X>?KLUA.:1*WYRYC!=*/H>\5LT1"!3Q$)ODBV0U;&FVT%XK8%S].INE]C(
MO%9$;G<61<$P;816;/ XX4O'W;<$4=M6^)-<^0S]W@H+D43N(9WJ2.J'ZV+Q
MT1?G;S2'-7]Y#LZ2E=.5E15.V,^G$ZN6D;V)Z+<;[&0-0\.XVB9]H?$9*@OR
M3""X1GBE7;@M%I#EB-8Z7>3" F/9_3*R5GPRXNGC>)B,?O:3]\E4IC(H.(:*
MM.L%7 L)Z?%MD^L";ZM03*C<0K:;8&)7I=311K;/VEYH%35WPZSL]S79)L5?
MK61XXF)/5&A3)31$)&Z@A,:9\LEZ7RD#O2492&8V:J!&<2[RTIKOE<+HD7N/
M00D-:7&ZD]LJ=]\#"Z-ZHDC#%H/,P%<U,FOBUZ?GYRTF,085X]EM31>DHG9:
M7#WYRJBLI%Z5V2\;U>38"L^2=S^BE6"B<.[W$]0V.@KU-LM *6I13<=%>PBQ
MEH:%[X)7:S./DWB[S(9K;[@O^+3&4%F?.$K>_ABLI=U4]G,*I"F\AOL6&M,L
MV,]"@WO%$\$A9-T4K@)?;YTQR*?>1<7,0TA?M*>CAMO'*(AA!;S)&,3$;INT
MXZH'9PAPJ,[#:_-1D#^EHC3VAK\.1?2UMB>>EVT@S7+7!ZIOI==@TKGU&QJO
MDU6'GPTQ=P$O^DRX9/20^'"GGS*R+UZ^0K@>1\TY'L16EMW=@O=G8H&WG//>
M].5:5)_8-Y:P@)6Z8]1J9ZF?;'3(;L\EM,)03DDQ8B=LUDH@;;S 2,B6/0EX
MZ:"P2N^VL0X*3!(<J=:8#U?GOXW6,B/CZVN]'O8D'D]S"4@2EF>)ASH?RDJM
MKQ+*W17D_.D@0;!WK!>%)BT%B95Y+L9?X&KHR9MW/@8-UX#@;A;P^LK!IJP2
M]X;]F5V<<Q_J\+Y23.FNOKWZIM*KE65"1P^<A5/$CM_"!=Y@5.A"/NJ.R.I<
MB5+,@TKB#@JAPF_K*R.CT" 9X[H@.:Z-N(6',49Q0Y_<V/E=>^.8HG99QX5W
M(E+\9+]GO1C7R2A+-[(NZSN.&\@;,9H]:&,]\<=#\W;+D,_744VXIV(HM:Z,
M]\A,7%)[Q_@>T%RV"PLZG2YG6JZT#Y8ZVPF2N79C.?%FX-:R:O3MUZ6+BP@%
M9CRFDU["2!(4G0KBC19'$F>TM9]NPER3V'0Y/8"'TKMG=/0Z?^= B\BZ;/P+
MQF=RM7OWI4[;].B<//.MAZC/+5?M T1Z2E\(?2F]<S]3D-<3#]VC(,_X2"\X
MD@I]&[GY\Q6CQ< ^\CV+$+6O4!G?5*V1C_30!X1;"R.AX4<9M96VBT^I3-6N
M]91'N28 AU*\73*"R.N;QETIJ+S!Q^OO6[LCFCJOS%Z@COBIK,KV9N*+.4IK
MWM:K&:X3HU][>L<5\Z!9YL-=VBE8)7'R!NZN*3F94AYL]%"@Y&RFY)Z23V@P
M.;;I&#)(RHBIR'M=G>>7X]P0OTKT.</ZVWA^L-T;D:*+@:.!>\6V]_&DY=GW
MF=5D?WMTD&4(6,L]1?&8C>5IVZKJ*,^^Q8/6T=:?F%B*R(49*A3$*%(-&>:D
M\1+%8N['<-D\?'UA)\]SA3,"1,_*,J2?Q(G(^SS?)<E7<N,]G_VR"OM=FM[9
MB$O$(YDHW0ZIMI#5AB@_G@ZGBP<TRUB 5L8TV]WR5("99=.P$_*QO^Q#?OTX
M</R:N6=)GCD^$"V:@=*[>TKTF?$M?\VT\N2N^-T8%(4?R5Y^1'S+RV(?&:I@
M]FA7AH4E/!7,VYG%D4RC1&4(Z*=M??Q#0]W=AG'QKA^13^/0O"M:-%B@T10Z
MS\L/:5;L&KKXJ"R4THFY('7Q6%,K%_!:CIQ+%!MH=#60.;RL1M)8^]))^:*U
M&/JGPK:F1]8!A-S:,S](.< 1CY8GF.E%>& 8A]@6ITP8R6RQ$JI@?.G=T&<[
MV IW.62U;GVO[=ACT1$N6H54::X,"O06M9>+=V"M2E@S Q4:DI8$S[UF#EJ1
MOSI-@["(F;O($:GYV$3MW1Y'XAMIO%X' ##?I^D=A@0(Y M6<Z=/K5\Y+M.C
M;>>++!;8:F)[#;_-4_8?R147_M>4Z@>R-O-Z$>*3UK?$8)E4'[C??3A@DO;N
MZMU?D/OR:.>OU2H99)Y2;?^?2];!Z5_KE=4% U[>?U^R/%21ILT@YLZ;B(.L
MPH&&B665 /BP[OJ4<!E8'3BLY&W% G.74# B :KF936I8^CXE2_FGD);N>#_
M7*X 64V<I/UGFF42[^/$MW_Z.35,D4JM1Q,/TN_'IVT"GJL+-0C/^_1MTL9-
M1;N*G\E5-_NJ2K2;W3,=%;#;R-JD$:8#E3W_5N-3"6CSX^=E5?2"G3S<P:]L
M=K*7N$C;A,$Q&ZV(\G!C&L_I@6;&DQ@\EEE=W*AWWN-N5>V6;<A_VBO:J45I
M57J2& /F>=H1+<Y&\=UQ\CY1++5>O'OV_(_T4ZMIZA+QHXE2C_4,I;9U2A7!
MF:0O;KCO:JJ2^T]?!E1VSK>X#4.;*S-BPU6W?.G?,?EPQZS5T<AP1;JQI'*D
MD]GL!7R<1&(VPF?>]\S)LPPH.6 (4.'6\[/#;K?2,[Z]D;O_,B=[,L-'.A*>
MA/M@/"6/D7 ,)_SK5"*;4H"]BW$#HW\[(XO8K%//%\<S]SP7$4A(+5M+5VL6
M1T*.T[<1(C+0D1D#RY<]]"K^V&K^Y6K3X&DB+*"9<'# RU41E:#HR"*5V% P
MZS@2YKG7D^;.VQKG*S1PU6J@K?KMO)?3V,1J_=%##-LZWL ?63-QSM\$GJ'V
MIZWBSHH%5AF'JBRV\@=*[F TWPPC%NCIP:AS8@$JT]M]\F!9:&,7L@Z-Q@*+
M*5"DR.]>B>[S4^/MC?S^OU3^G8M(O#"10;KF9VH]];CEY3'R,H3_T16Y9#TO
MA";W]7X74R&QN]T?)V_!XFK4_YB1^7^2T?FJC"G^ZA:C.7#=U^^/=/J_K75I
M2J?&,[[-#/O*0^,:?X!BUJ'I4?1QO!"@UQ'Q.M!Z)VNR<L'!]$C)BU0HW:9X
MV]=#CKSU^Y?"#T9>&\?Z5=\G T+;'NZ)3\.?Z@]>46/_$C.8P-O1K.>2^;.G
MLL-I]/GH\]L4.ZZG!2DAO%0#_V;%__C]J(1=SFAGF@UN=,>ZL?<U.!9+WZZ7
M:"*:?:]BK_FADC;<?FZ+=D*])-J:M8R [:[",U*J;H#YC%<Y! A9!Q>/WR/:
M37KY\G.0=E38""X"&)E%:+T[N,=H#'Z^-W:_8\,OXG-ATJFJ'6A@1'2'IM.]
MKMY3+S297^HLZ4SOI9MCGKY9\E.TXL3N=3^I@"<=#*H\R@K$_MQL$1+/5%.4
M5/MN?^>JOR\%2),@:@2-D,2-N2XBB5:BW5'7)B\P=T;(N;=O2^?OMHEN.ZK'
MW(EN;4AU(<N1?M/;2PQ#6U;18HCTG;M:)JTCGS#\P (1D=VE&*:)4/N@<9$G
ME\DX-#5]]V@Q)2W>+I4Z17VYPGLRT1W*GH0DDF"$8.](IE5<IV6R]7#VT=.2
MD%O=[B3$^\DDM;PC=$U)#+5#C(1?[RJGG:UPDD"$>+MJJ5%&-G1T<@+#CBXB
M,1(!SP'_XTY5E;N+[V4E#W/KPL.OHS@FKTD;8&ZB]D=78,TDJ[4L:=HH?"5]
M/Q+;)B8R[^;HF2P1O'Z<5\&;@U[UEK5]^GUL@_9;X5FQ4'=(.9%2P\P!ZQYF
MVZ,]_R'B1MU8]:44E3*&8K5;&,34F8T_:N55(/G5%J<!X78!XJ=^Q,MJZ.RA
M'-N ))CMBUOOGNFCUNKQ3^X3FEZ>"@61K\>;8X&LXEA,&C>KWF<T:1EIA@V=
MA&2TU0(G9.H!]/#%!N:&,7]FTY1Q^]*"OA\Q09R+Z<9C4Z*M.!!>SIN<HP>J
M'MLWZT[Y 4]"]\S&'M1'M,9("<<*M_";[=TWL$[9[%%1C:]F:=/3M"2LKY?:
MMTK4,+%+IA=RY8,,JB1N)' %E>)3H>%+\HP0AN+/."TA47![F;/V'/))B MS
MX5850@)]239;<:XG3*3&ONE0RMR)C^XP;HW44-BI@9J\<_TB6/LD:>R#4.P3
MDBC_B[,ANS &;TX07T)=P,<)XZP]\A3FT"_03B&YM<.U'KL/>.O1BM2MPNRJ
MRV+3 1^8<_V%9"DNK4S#3&P0 _"CJX.YR38*@5D72MOU;84"UG.D)<[D9>%R
ML?(LG/F5ZU#P2];3QG$K8@(7G2N^;S&Q6['SOG3<66CWP;S7;?X:_IFNSJ^7
M,/JB6Q_PYK$ ([NXYW) QC<\?VG\&8&.NM,;7M31"F86_:J-TNYL?,V+6SK@
M6=[6ZN>)6@N!45;-0HV'[6%F2^3+E"<)^Y%@F>!9?JMF5?NB HE]&?" "-Y2
M[96!=-2GA>PN>WW&35OULFCYAL5CQS.  &;D/"*Z;15ZE>=Z@!+ \ZT>OU?O
ML_<5?>(WVV-BG\(W/)+J'&_*)4)Q4:(\H1DJLNFJ:<C+!P,/_2I3@R+N2!N#
MO,&*O5C@(."EMCQ-#A__JRKZESE?]6V_,IJ%>W)MF'!+M2-5YL/B<GG)K\-=
MQ6#'YFD75#2-"[?Q=DIKLA]ZL/7GLUR_$XK_@7>0.9,^GQ-%Q73'IN@)0]#[
M"O@U34S09&3O?>(\@_&)T7&XC0V)(H%&"5NXPW?9@'NXY[O96QNQ5?MCCC3[
MQ]70*@+A%H') NU.P=[(I80E#*$\86V9@UZ<^WUP\C/HQ[Q3N%[4*(K*,$ZK
M<CCR\DGY*$27I@M-5[HK0\D^NNP%]U[XAJ=W<A4H07IN;&(!4%Y*/1903>"J
MV H$88$B'5B :]USE%M&],W^X^BR^:W(7I(5.4FCHE4#XSSE,0&#V[>F],"G
MDGFGC:6A9G/\U\<>D<<Y$L&/2OVU5A* D=_\86NM\&-C YMQN;JK#*SA!'?,
M>/(BC"S+NJJP +/H6A(C4NSS?.(M>Y&U-V87]#_O-,-_@'J2@DJL3<8,7X@Y
MC9O(QTQT5)F(,Y#A;KT68N\1PF7 /;11[^'%)\?CK,[L&C-C X,L4PH,(GA;
M<H]\'>([36\*3*%6F!UAZKLXS=(SE)'-,'CB>[C:F80%>"AQ#GQ$ X$%6D,7
MF%E4XJ[1'.0-ENN<IGV9BQ^=14[0-'J_=*L:V9>5U(=F/TME)BTP/?MPGS@+
M93#Z&*6E4M9*YNJ(?S J?+)<[3O,+<?KK9:XS?YAM?03SW?UUY<E[LN21L7,
MY"?G/Q]VMIVK46PCH,]9W*UO7PUB.5B&7HB^99:K*KQ<'$5T HQB+/QDGXV/
MDTI;Y>:FJ"8'WV:WNDF-RU;C<)W6(R>X2EL9]/;YT-TG)J,TW*Q,1;0DCV!:
MG]T&O1*R$<J]+7,:$QD$'B,!*N4Z)E A*,\$*O.;RE-<P^Y3*)\FOE>^M*YQ
M 8KLA2,RT-PE-O9!"8Y/ S^EQ=##"=O R41^-W%WT1:Q_<FVZNSY6 Q+U?W(
MLX02G P_FU%&Y%P-;9:;^<:9L$O9%K8;(DMTTS=S5(\363*]8=2[O]A@SS^F
M<.!*BGL^1HH:2"8FX"0^;8/7SX 60,WD,;*U?ZI:-F/ZO=P \\B'S+ /YL^@
M.J;=-9K5\0OI]<;"*J7M/V/46.DQZZ]QM^(^L==L11*48#4:PG_(]5JN_#XD
MW2.^1?@L%<DK/T"-'QL &EIB [\')WK6!?'7MLR%\TS0[^;,W[XUR=KE(?<U
M4>LPP)]5D8]*I2S,I^T-;/ J+FM$\BM*E6T1$R@Y%6BQ]*J@]T)]H3?O>=FZ
MQ_O3K\\PBMKT=32/"'%C 4O7AIF^  #W&RP -TR^UF=+=,DB[N&67S)4^%BO
M0"_$^V%W*E)<8>"1/\GMCZUREA_>] S8 IY;*?"TU?M\FVPA_6-WPCS&*3T@
MZ>[PM\5KOASNZWN&PT2GC ]R%]_?]) S@LKC<8XP'71YQD<FW4'0%C]C%Q_3
M9_+\7^R]>3S4;=___Q$A81!9PE2($%FR,TJH)$NA;)-4=I+LPXA0LHO*7A0E
M)MG7L>\A^[X-V9G!,)CE-^?WC]]UGEW7?5_W>5]G]WG>USU_/.MA9C['YS@^
MR_O]>A_+^^ '+9+?UD/BU+4[CDE7F["57=#25^!KR-?IH,L7;WXS8!<5H3+2
M O@#4\AO?-0,A-'._W2^CNZU TN1_(HLJX]4T7X@#1(PP.%?5S>HDQ_2UL81
M,L):K##X-K+H_L<E%T$?(U3#I9C;#X-]@@I1[%0S!9_2V/U%6NU[/O>(>UK;
MD8"$*^J"C^9&^:?X]QU&<YV<5IRLBXJ"3P0*C<0TE1KQUU5&35UU9<UK#;C/
M?V&>-UAY#_P0<MZR4?V@*Y@=INSR"7=A::7I[5HM(T:G1)S]8?N6P.[]"I_Y
M2G=OOJC'Y\KN[N?:8D Y$4%8*W5>4$TV4#*PQK#1Q4"]Q:BWR3'IM89:F: 9
MF!T/'U'Q)@%>3L2B?V"6BC#^L[7HO1D5\NUIP&CORJT3$@(4N@*)7"75Y>6#
M>3-LATU8S6BY#UR]E[1$90ZOU#,W*3'A0W_I74D#R8Z%RT[<S<65-2^&K=A2
MIV#FWE7-/W;/7E,?24"(QD7RT<X1U//TIF"=$QS(IX2^*B$X._27OJAS-<4X
MOT\MEX$Z@2F;];/0Y9O0@ZN54327Y113,9,*2X 1,20 ]'SB5)(F>LO4/;-"
MXAQ;2X,[*]6FGTPT1 F)GJPM)O)T6Y4E"OI=6Z7YTF+RJI97"^3HB55<#9M1
M.^,4-R,7RM%* BYNG!SC@I7*R*UW,VR/_+^89-X)QII^"Y>@ZW_L> FB97[6
M6/662?JI'-A%C P.6A=G/AHM*>QR<FS'^#A^,H!FSX:C?S *[VE'H\1V /:E
M-X'OBTHE7$:=!TZ//\$1$EM]LM) "#MUBJW^E,B&EG:%>]=[NEP?)Z\J1,VT
MNQU3'2[JL+C]E%]H/C<)2(V7Q(O ]UY#-K1)0+$^7;YTB.$G*L.SYWE9+4]8
M VAH$S:_<-<Q;Y9>P%!]^.0L,PEPS]_UR$&BR?'1$ED3M8*)PR9;>D'0H9&Y
MR'>$JGF_A'LOV_?YQX<4FSR3_6]0+;WX"ZRZH_"/,)]\6NG^QLO.PGEMP.S=
MHM.AL=UYQ(Z/9SIS;+[[Y%';:M[PE"M[LG'<+!_&!?S8W2P59R2?FWY'?-=X
MA]AVRJ,_)5-NJ/20!-23 *I:_O<O:R',=S%/Z&[VN9_2,8[^<"@A48OOH=GC
MT;0D=/KAD<G&56NCN!5__B]R;W"@DJ^OJX/2\<]V.$9@TM^P7V7TJM,LC_B]
M7S-Z8!,'>P)H?VT]]\W6_^BW2F4@2O=SV"GBZ4OD2MS<Q#WZ7OSSIJ+_I*U:
M4G_H#LC%)9$ H<,WR.\<=.^T6"PB%8&_Y5.PK8(@-$7A!':/DV-M@=(_M-_C
MA_B\]8<U*_9O, *,)FCA!1(@L#@B\K8Z&G_C9_7!_)G,XPU09X3K+MN[<S[<
MD2QB.S=V8=;9;44&JYICW[,Q0NQ1SKF,2ITX_R)6CO&3ZM./_"?0:RDS?F=6
MSHD\U[IFT#V-<ED_O>+0 :J#LMO)E*)WGCTYJRCXW<YIE->=GAY"L,(!IKCI
M["$^,;U>6*.3NMZ\(^^+* ?JM*NQI7L\6R!ZLRZ'J56>PP$76VU8[JF:S/'Z
M\XD]12/KZ%?.G>NK/.^5^"1[-.$@S1O5YT?GJE\U#[[SB0"\TAH_NTL^Y>&/
MVXE_&_$@*[GUM"'D.$1INVW&W24TPQ@SGO7L7C]#;D'#LOWQ3@_>J#1/A*I8
M<3JS2W,BM5=<'6?QV72':)K/Y">6)QF%X09'/)AD4'$X6)2-+OXT>;\T>,A,
M%BDBH"B5O'7;+1R[.&0SZ!"*@=?SB36:G,(*.1S;KO'.4&\_!:DLXU95[+('
MUL2$+3$2<=,YI\KZUGI.A&=:OQ94"ZO2V\">K*SRY_;:'A!PL9G)U''6JO55
M NW/GN83,[F(4W3B6Q^MU,AN_7 5[)E0QD "UN,VY7NCF@)4)M9O5&)>-B@?
MR\F^>F=M260Z//+H&1RUPGRU7IY__-;7!QMXQ0@\G//9H#YK(VMX\]UB' /;
MV0!:IAJ4JFI.:3I("=?[Z#;ZHGZ@C.K,">YYJEO(5^ 4%YA*X3ZXGL CSEH.
MDD_;;H43$M]B!@-'FQ(\$NH-]ME&6WK 8[M)S[C #5*1<*6%PG;V7MD<9?JA
M+Z8UT3FL?:*/TWH"I/R/FS^' LN&1T>8\J,4FR=/N)* *!-%M'&?QE39_%3A
M3N2D.H<Z^!4DQ=U? KWIE57?:R?FO7U>[(2=2A7^-!U7RQJ=#_00SAMV9KK=
M3\A9K?N.Q%>YKTGM4JK2KK74"'O@@QWJ*\-ZH[PEV"SEY0/Y!!Z]^+MQ"G<-
M?:*]=E:33:YT<.A(4:FW"J(//D@]A[/.PGUT@SO)#[FSJ=D=<+[LA7J 2DT[
MNSJ$,7^%,T)=/F%V"*\+WO;4X"I['<#_+9H.;@KD9(YIYN%]'%8%<TP_A7^_
MJ&"8<[3)Q:]Y<]QRYF^EN_$SH=52II;E;W*-6>HT#%XK%8>4TRF;C$*N]_(Q
MS3*Y6[LZQWH[B3L^QJ1DAMMP<^,7J)N(AS.@7EEF_1;7-H\>:CW.#?8DMEH.
MFH<^5J%//12&8U*?4!V^8-:ZL1T\_CBB>;^I? _ J IU?M@_/]8Y9$732UU#
MI ^WWCCN;[1B&A^N]/ZUNY5"AXF4K-Z65=B<BOP4;3<,FNT58J%OT>HEU &]
M/YR?4A_+C%K0OH8=Z:8+PM$U2'M1-W).@ >C8EP$DRSR-YJ%CT%5/6(F>VFK
M!KC?E@:?"KR1(,QMHD5^H\]S?/4JJ$F$/,\ /0HYU@@(]4%A5$/; LOF## A
MC&5TIRSD2.:EYI0O[2XQ2Q=L$H%MQ?=A$YR)WH8BT?=2AD2SL8*#($BC'RWD
MB$;F^>_C%V8SQFL.?ZQ^  #W0DNWFWP?IJ&S*W4_FHLYI I=9B%L;PJF5 5,
M1MFOJXBA]S70KX^,-&Q.H&B7'AYFC+SPN"ZR&C\5I\ZG(W)/M(9#@(:UEF.J
MW&@%R4 \:6D&O4 "ACT5]=L.=6A^B52]M*"]/Z[K.WX'EU2WYQ*VU96_),6;
M=_6Z,.B(3Q"^64.=)Z'$>&<@?]RT(^Z\Z-IE <<<D+6.J]O!E(HQ\Z^\+$W2
M&U=JC;0_"#^V5"<!]'B==U<GT5&X5YJLCIOB";/P2>[6U511'?@3I8D/CV*]
MDAI<7'G27FD+M,T/R6SM31%$J.EF/"-?-LS)$L1\%^5Z:+VW681>!$56 <<^
M*V_X,F E0SPF[^&\,T^=M92+Q@RZ%<!/BLF;XVYEV2L=3(AY;QXA=\R;,8^H
ME]@K-U[F\LJ-Z)77I9-O(7/I2V__3NZG0_2.UB=N2+AVO0/(H5E3F>EZ@^FI
M5YEW+]YD5I!6@!)BJ]Z*Q'+%BO2)V[XQTKZMQ(!R)P& '!*E"VE@LP^4+9"Z
MTS?J/)8]AS9[L'1YU2(78&]]'SEQ2/AUG2;/2P]5=JI8NRU].L7I-%[;:C$[
MU.?D3QA%_JM(L?*@^NRUK$T^3*/3)-1TL?BZY41GM-F%BLR8+@">.K[<"=-%
M!TZ0@VP_[?.5/.[UQ9N'Z-KI^B_-^2='7366@9W"W,^5EJB8N9%X4("F2WQ%
M[7$-]68Z/?'PQ7L8N2)/EV-":?&%U-W.L.R]*1X]SK*^:B4[N2S&,^^*KK(H
M47]G@:]G6.9.=S';$;EZK'NW<.B,UX(N56*>]]60;9^/U#"1@,/'B&R+[N=/
MC-TT)21Q\4,3D')K8[RH(L##^?E)::40+1KISRT"W8-!=IXEX$-X7W<;7]ZH
M=V/H6]J2_->:#5(O*=(1#UIN_>U%M[9/5 M&\<FTE>OX+E!+9^8KG)*CHW.0
MU(AIV:Y-/^QSO^B]P]E#A:,+$OKAQ-5:@26EJ*:<):+(-UD14UUMPY(G 9>B
MO"2&E@Y$ZGK/S==4G#YUOV!0.%#ZX5$SUQ/4O2<2<A<A-(4.EV-UKQ!G\)(W
M^V$O7/(.N;1$+:KS^V&H&U].2*0J-P3>E+V9:9NKP>L=3JO#.OY9^UK X\DT
M3W0$8JB2+\,,==!Q9@PR(GJ(<!EQ"O>.KVH^K%"28=&UD=UC@46;@?%BSV<4
M]9"8OQIV%7,QNB%&ZXVU)L-'9:KN7Q:D#"HAFE9/=<C!0HLC/GM3>[Z"\\HY
MC#H\@X:FXS5)P),ONOK(3G/35Y#%U-K-M=7:Q5&.47TJ2V%,E#Q1]IMLM=:"
M24S4KMT)*"&AZDMIBL/TSG97I&/EI9$WX::5XF>"J]WFBE><Q\?V]>GL/W)<
MR*92KP$>'/3*>CRVA.3!^GX+S$]Z356S7Q$(Z@XC^^G*8U.TZ%2$7W;KQ\/#
M$KUV!T;;1W2<(0UP46#%YK73ZNQKXJR]177 _4J'J<!S3?EY4(7V7=O#OA52
M>R2 R8>89;NS9S3WPHV+?X;NV;W#%5;W!#R448IYGC75AZ ';XW72%8/#4J+
MO=R 50)G::7=^KKI;ED*^\S?(+PY'O' ^%",R6,2(#XS!M=W&!4+ZU4!!OA5
MRS 7$]-?O_?F,B,D.=>,@9)<%Q0Z%=.9$8;YH3=Z)3X)<X=]/_6,&"YE*3 %
M9FF= K%#O>"6:IJ5L4X>S>V\R4XP[(@V_"K/3M@<_M:4+KCQ6VBY!M-, -N2
M9#6PXLN*36=.^-'\LNO*&J,K>]MB+@:)K_UBC4Y5NJJQX1"7;'C SWH$K3N'
M[Y6T8$_(? 7_8S,*+,WC$.G-,[:/GJJ,9IN_\"VE<C?I! #&SSO\0UW.BW_K
MXYZK_(\-KH41X'4JWE>R#OGT9<)@-W+;HO.&=* ;JV-&E*$2*W'GNN6R@[N+
MGP-?_Z=66;:\V5BYML_;YU[.N!Q>K!;K56O.;GA8)G4U645W";3)Q^2=@Q?
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M7483ED*9IM@&%&/DFR#0 X<NF"8Z2*NO7C>SK-=9:94:ICN(N]RVO?! JB=
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MJ':6ZF>ZDHELA\/QM^FESA[?F1IL3:.^'ROYW/2*\'B\L/:>][7)KYJ )PD
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M.<RH)K(711D_UC,*6[<E\.3!;6!&1"*"!#S6( %A")^W 2J<^\HSB!TL',\
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MW JWMOZ_]KX[JHEN?7<0!)02$)!.4!!0I'<$ B)-1(K2(:B(=.D0:B@"TIN
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MA:RA0@5#$N;&%9(A]CFL:+5E%$8ETSI(8^B X_S'Z1<&L7$UA0R%<*/O2+/
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M>5Q4\FWHV#%-RNVH5<9]Z864S)IOF0G$O K-@.*^$8FBS)CZ6ES$D?VG^;*
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M#7DFMV0 #Q88*D)'@;_;DSFI9#Y7>?KQ5_-S:Z=E1U'T(:K>S/#18_[!#P3
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M7]B\=>/=*M1=ZI4M$*ZX(ZZ96P)?\I;MSG]R4,ZJ(NER]O7X:@T0;0@\!EP
M>A"XUL0+ $UU%L_)]:=\%P @_H\_4X.S.PG"N^DYA%W#$?Z7YO]ST(FP"\!&
M]_:PN&>^<BZ$4[6FVB3FB\Z8[X.2-1+Y+FD_AWTCNW\V5[A![[9($C8^6"3Z
ME 9-UM32;F?9$$WKD/.=*/=B'L](>_E5WDVFMBHZ^^6&GE"7)-H$RF?$K_6!
MN=%OU_8)69\#X"E1 $,W8!4YPV!=5BFH)IXG(^\DVU4-^5^20#;+EAC=7$O[
M]Z(]<1]63-24.P+:Q*^>K9+9-YB&1UX7-;[II>]\N%N)%H:3GM00,:7W\?BL
M1I]IYQI.35K7J4N)RCE9.-U_$"E]]2D->(NXA.79D)4@U1"BG\-530_(JZIU
M+'9O^%B__L8-'CO^ESKAMBV=#OOCA=J9*<>B?DW_4/U->G]TJ-/;#CU#,E"D
M>ME<YE7A^%A#;H1<@IY15MB=(_TOU0D$%-&\ZC)V =A>*IK_T_4B)P1'+Z._
M&(*7Y%25/79><M@O)<O3/=KL@P+A_/4+ -^S\W&+-L^SX@9K,WK'N-#%"K42
MB+W&"BB27 YY#R<WIXY=O;00U/Q'5M?P=N@)]:&@@J>8._"Y-0<\8XL$#P?3
MS_% 92-X=,U;J@A_FJE_XQI7+Q,,7LTZBU7F$.]OJC)4T\YIS__R]8+^Y>M%
M>[P._:=Z18&#%@[!J+^*^%E&#?O+^YC(6WCD281N@(V\@:?!1\_8\<^!&2#Y
M5V.^HZU]G]M-B/N*S0OE+A> KL\7 ,5M.$;(3GO1(AVCC-<L)!< [$8SRF3B
MX\2@\>W%F)4?B:'M]:$!CA+^!6R'/? T:WK@P4+!?6C Z7Z0\>%#'6@C#R[<
M:K'I3X/(YV@;RF@(A<H=IH=V?!_?AOOM2&%DW!<Z)N96B&6=JOJ)1M:<L-8<
MH'V*-0LPNGA+\K(OBN U/K+ L5\T]T.:6-*DATPJRZ,SZQJ?9,J(//:G^X1B
M>V QNYR/^8-+-/%9EO7G;IZ'OZEP/11P!/!_1+=(^G-&%5 F@N^:4ZM4Y7WF
MYR\U-_G9Q1P;H^P!:HVZ/2M=!'T+EMQ6B$XD?*/20\1,,'F[9F74(S9-N&1F
MR39!<#W\48,FMC^&OWM^)T?#QP(4Z*JM,.(FG/^5J7;S G#+>76T@2J?T]3Y
MQDF 26V+BHID%A,2SH+&;SP6@E<7@*KF<_;M22\[Y_A4DK'LSXN"M9\<YG"J
MYXE(>+#=+_21DIV6"V;E+=;Z*P74E"=MU50)[2A1_H]6C,N<AFG[=P6G)6\M
M8FWG*$N.PO.4O-"S5/BU@[+OO_FG)2F@W>6>^(\@^ +P7+$?/70!X 7_MKL
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M-8$(D%>$0.(:-VR%"VI0)N2!#U4IMCI""%;!5>=?&K3Y;RUH"@P<LEB8]]Q
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ML=FZRS3EC \=I(Y+7U&98T]3_[?F=%)2@BD#A427]-F$ ARMKX!\)"M(YX@
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MAQGFK_.MA^B0Y?R'D?>/#4L[,S2\4YD^7B<ZN(R/F5H,>K:NI?J="X>B6Q>
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MESL*T)\YB?=7=.1EN.I)T7Y)>)>.+AW] QWI5-67E[XV2WH:60QP8T6'P#[
MC.?"3P ="$SRXM(^R=R,00)?13+(Y:SJI8-+!_\I#H8X^,@5YIK&7] HZ0([
M&OF1V^:G9PU'FB?Q:_DWVF/&^N3[&J4(G[UC3@L"FG9L$:\#SIT-%\!OH<NM
M#;O7J Y&()%0LNI<+\9O8^B7?/O\;W 4Y>^RGR8:813ZH0&(0'P4 !, ?2R
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MJI[Z9TVY0(N:!#UXY"#4W=>^4\HH"8"@(,%%ML_;WG-E!:,A,X+\!Y1HH7J
M A+--1#5!"*AW@I:98--[HO=(-9W//9KRD,'0OI*M(?]40WN)"_BUM2=IT@L
MR^$JOOV4+@3?EHNAU"+3'QUI?]E^@B%ST(@"1,#,C7(65?%!+T=VY,<*=X.M
M;ISL^88]0(J K[V/DJ./4E:U&&C;DR]NRTP,^R4L R:I'A.J6D(JY>)AZ\\Q
M%R)RM)4IO(YULW[2N= ^T^*K\3K_S-$JI.F+<Q3#L$S\@/[4T5MVSI@0MD-W
MY1TFY>[L13W]Q81#8HXKJV6P7;IA3W5I2]W;<CPWV20DRM_N:?G>&/)2K&&+
M>N#/5#%8W8G@SJJK#;Y=*2<?$6)B_&;L($V=4/^# /VZG9,FQ'BV5[3O/B5#
M9?1QDEC".9:8FMZ*CO6PZ>T"^Z3>.S=E%L\MO4NJ1 <HG:4,1DJ_\]8,W:+H
MD%ZP<J::URBE(#_3<+50X*AUFY31$/4M7=*H<KU0N!Y//$03\:_J,E_')#7!
MACS0/DU^:\V99E8FY6OW:*(IV8B-3QL_CRY\:-,_-O5JHWXWN:^TD"L"7"\X
M'4^]5__][J0Y>;WMV7*AW9W&4&DA]SBDCI]S?_WUN9KD8^G2\)-]]'@)1_+F
M[:[:*TTIW3W\H6_0;W>'.K+[ZGYGD5PIF@"906OQ*(!U01B4I3UC8"!CCW,0
M$OK&GF3AE&Q]X"[O,Q5_E5<B>99EG[-.*3WG<$]PIE! +2@"FBXU6J#[Q%>
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M;U\SJKOZ97'99RQ@^9[Q,"QMHB?.);(G93T&$_"^OFJ@KQ_NQR49&Z7]Q6N
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MNE&1WGH!>AX^%J__R8:4VI5+GIE*NSZ*^4Q7SY!-+(G.M!(H'RW,,$TZ\;>
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M58*#W5VJ%J(\/F@5K-NO32G:XO\P0R*<V!JQ:8#76'*1^=H]1:%PJ'H],K7
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MQV%R0]N3$U2ON7L7+:DW<*-@[?=PMESUDS;-;A:A)*TSN_P6YE?0 ];3Y7*
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M4N5/^)SC$%$ G9 &8D:LPG9]E:""6<E]UV-HR17[Y[O"([I]5H<^\\U6JIB
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MAH?CPQ'/@ ,-$L_4APC)<^,-2OQX2'6@IV*[". OJ2&H;@_6^5YB-'&XV5%
M2VOM2:VY^IDJ7-]B+^;^:WV$T?2,?(FL!64B29#,NV0>_^34'/+=_;_!:^)?
MU?A %WS&TQ-MV083@I-P3K^#'G;.G[L*'EH**& 9(Y8'1\EF7 \G[! \( @_
MM.R7,,E9'X#F1JH-^# ##?X ?*_($6F46Y<UK\)WFW7;H*!$W9ER!ZTLC>+
M*_T4RH$7AU@-@RR0]DL-D=Z)CRF/Q2V7=HIN'_?VXUHUJNZ1-1I6'1/0\/+B
M:WL4;W4(0&]Q#:%%,NMM!XQ?+S__@)<B_-3E@A/6J%C @F ]^/&R,.-[-TOX
M-G[ $\E3K=3[?C9X?8ZN,[+*L11G/S9ZY6G?:=R45SRBQJU56;"&\:S4PYK/
MRAH3Z)ULN2Z6;UD_=H#3"_1Z'A:V+[X1BD;B:=JE);S-:'ID&2(,\.V^4NA/
MW$N]$@(+O_?808!WZC'7&-C7K=W1[!EP%CMC(>]AGI,69R4">">>KK9#;NRB
ME+RP+G7?:/VJ<J:-<D( FGW'Y6+V=21JK,3S<!9\Z9G3(Z,>)Y=[3U@CJ28F
M7M^]UG#I8G!DH8K@E6#8MG_3E.9 F<B=I80'@Y)Y.5=2O)@C17J )T8VDUG;
MI<:3Z^4Q#0%Q<1S4[W'&6(C=[UW\''R2.40%8BLJ7N\7WH-C&] 4IF]\:,X^
M_UN77,,+9_MH9[V8YQ/F^FBIJGSNKMFB>8O#612L:U.:H7H!3"J[6 22R95/
M9V%IES#' 'GOW,#J,@PM>LM>E V=5.V%;8^V=/!PUC024I>XQFS^X=G7_!D?
MP^][QR$NN3.6[;A+'"(\[0$9&W;*-3%P_T]Z4\I#9-_I4SQP*N XGBC# (FA
M%E/V$0D-_S&QP,:G?3L+IJ1\O0 8IM.CDZ0PO)T?=^PGML\EWS8Q>_FAZ'H0
M,_DXBJ4_;02E=R*LE?]NO'7ES>-WENQ$J=GL&_@^J*C, 0GM3S4.6094EG<E
M9>A; =_E^2*&.:3I,8=5HM*WSX]7&OSM7X_P>TK-7/.C)AZ8EJ'KK_#,U%QK
MSL#EO^;;")>DO@>B?";F:K9A$>-JVM%P%QP@@N*:0E-L..9ZDG8K*_GHV3V/
M20X\KX]^![D*;*UA9^/E&J_%/N2#;Z!O+6&L2]O+T@7]=);%QPRIRJ>C.P>:
MHT<W!;N'9DU5G>)8)VH!<,?50PP0>9MWTE7_UJD1&[ :,8'UB\H9>]I<2A)*
MOOMI=CG;I5>8Q67,J6#^#ZW[4PV!@ZD98<W!++FZDJK2J*"EFRT#T9+RTD7:
M2 -X5V41? ]=\,)*P=A0&0-X*5*/&U6TJQZD2'(5(].O9=8!PS1K;$\X]N*H
MF=0:B'WFHP[9:MB;GEC KU$9A7<=CRL?M<_1.TV-309(91<!R CX5(^=3L7@
MUF=/UP[ZC,>T),>OKE]QU#T$PX9F"_7DRQ*>]'W0>C4_OTKG8L9\X^$[F4LO
M9+:E*;E=_=3/9G:X[VUVO67N/65Z^5&?(9/X:JHLXGKV0M=R]1"/(3O8"\0!
MKWBZIG!*?M@>_.1;<+/WDT=I*F:E\A: &[Y,W_ JRPE;#=&BJ] [+.'0,I(.
MX%-X?VM>\2$%2DE4:B5 <K?9>XN!I9_;3<7_4EZP^AH\")RZ_MJP#!LYX;]I
M;CR1:V,2SK?H=?9_T+=PX6(:]8_3<[7:G!PI#_ZF\E%]DTV$DE&FT5T"'ZQC
MJ+N42GM$^GU2[T/6UZV#BFOM5$3MB\,X*RE,"*G<19_CRF$>(AZHQ]6]J,@7
M ,H[Y5GRI%2VO65YZ?I8E*&04.\>?WJ?*A]58?L"6^#EHL7RRJH(RZ VWGO,
MQ*\918PO1"&:7'-+$6PAB['D<#?.CF;&EQN$.QQXJ[SXGL<8H.FD6/;>H%J6
M $@([^ Y0VY,X_&:W5J'5>0BX4I@<RM3L#P]%<D[NQ40]5IGFF>UUA#6*^K0
M)7TZEL<)0.&T+YC.[97K^*DTQ#W15IDL-;),7N*=0;U_B=0DL/ZID,T-[Z.
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MS7DA<6E;KOU45'"+X=DU%ZI0BP1=C8W[ )?,WQ]F^K<*%]Y@/R*, / PO2<
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M/%Q]R.@+S@9SHZ:R!GU8^4H!F[X.F0.M6G:&PI=X)AJ?F22.#\=49$: 2-B
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MCW&?4OA/!S_PU8GZ%8IE1YGZ"<HEF6=VL[Z>] :KHV\@LT+1&?L!3D46'+$
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MI%6IO6EF*6-$@8W/M;(U#7X3,JZ/Q",(HROH;QW*4T%LS,G=AD<$@$X)^:,
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MCQ;G-AI^ ]ER<C8.W_T-Q[G4[D9!KZ"/7TG,>MA[P47..I9E5A/)7T%\H\C
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M^DTHPUA^(_C8W%L/_Z+(:G&VO9EHEC9Y>-'(C-%'7$YV]G6J0</4%,:FC3N
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M[J8G,ODNWE>PW(>DYRME_P_[2J"",[(<1'O\F56S09VWMR%CW+RZD(<#,:T
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MC_2>3L*#PY/NOTZ],K ["=F_:%+H?B.@5/>F,L(UAA"VMX(7_3"61;SF)SJ
ME,U<3VNU>/_@(/#AR&0KB96^C0QX]_O+;EXB)-B!0D1SC>-8NSK/>ZH\/2?^
M:<Z72A"7;SQ+&YQGU(Q4=\\PSHJ)G?90,."^1 9@*8CT_?P<E *O)!D Y8N/
M2[SR-HB9A2YVH,"FZ22);B(7_G3NF$ 22RP-\IUJK+B<8\0VZB>M]!X_#M@]
MUX"W?B\B]SQ#XZ73!\%S3Y!-KA?WI'=FK#Q8JPQ2A?"L9>]](*YP\; _:T(.
M0=L"03[IH (S)4I67/NNLKDM[EGO@G!O2P:&;WJK<]$.A.([,C]$%Z"CB1?[
M?TS^7+W[GF[&N 4%D>Y>@&202E8'_R'/SR[RRA'@OPB93<-)\9'-'YT:'6+N
M=J^Q1Z^AV+7OO.=9[5OZ>QRX0#2>R1-K'OY5IMCHP=ZD?P?Q6>TK#ZIL/FSY
M>CJ((Z0!<L%'],/;)TH.(JB;A9W?U8BGH%2'6I#@FFN$3[[)AC7&WA;3MV.M
MSJG>V;?HAJW9C6:G,VG63YT:\.%G2PJ:L&5*MJIP'AB\3CI/Q)M>W?TH$QG<
M'-]J>;K)GCO X.=-5="57"U%7@G!QEIVF/:A1MHYV_NPY Q'71>QOGB2,L*$
M1/V=N@XJ@7?_RI J7+LEDBF ]1)C2G.[.$\SXTK8[J]." /RLD:,;8Q\JX-3
M[LO"F*]<W^&MR:J0[W)*K#DU=,OO>D%H/Z;3\*P%7+C*\Y/!D":7\Z 7.N.O
M*&,Z$GGZ%RRNN92SY$MSBI-Q,Z=,YQI[?,RGF=/\F4R[2Q^?49F FQ"G;:&W
M_]KNF=HO^N>@BM2[5C%9Q-Z0MI&T>3W]W!ZS1/X7.X<YMC !5:'>: "3JZ4"
MN-3(X%Q@C4^+ ZP>6K]SZA"S6H_ S3 1S;%1NBY"WTO+POJ'A>Q@34X-[Z1Z
MWSZG!OR>B_QMY!:@5PF:>WG/5FJXJDUEYFK(P/5Y+;.CUH[V[7'PX[>YB-]$
ML]+PM;XN@4(R .\NLR0#OI)=T#85 +;Q!9=C.KQ+Y8V9U&K?5_G8(>1M1?RE
M\/GPW&Z.D)#]O78N62EM+IB^K6J@/Z3'J_!O^_Y90S&.YY93A7Y?&@NR]K)N
M^\+$>\4YQ=?IKI!#&("WPH$12"&G:5S4BMGK0/?GEI_X'-VC-!,AH3DBL[6A
MI"LZCCFV=M8.^DP,V5_?>UE<[L%"ZRGYZEPM_7HNDC5[F5,WIN:[YWQ(5>6!
MRR45>R1UB9\.2@ZK,%Y#C5N?#B:*5]JO1:O?CI]^R_!H!CM(?:C_A-)]9LQ$
M44HS3M'3G[7')LA^__1Y]-WZ.>QO.6)#"5+TNV8&[%7CDPK8E!UL3U957=O%
MRXKZ4*^:!= #1>QHI)V'/=U_5 R+]216Y]VYK#K*&O609H>VQ%%+D;O'GRCK
M,0MGO)7L+7#A\56/2>H+Y5*[ "F^&DYM:H/66U+TM'BK/4G%%V7;S$)53Y3$
MZ7V?(0/KD/6SZU>/]..+UC:Z(JNV4[))N/RML.O4W<2+,R(ZC7XBM4,%MX3G
MWF%NG+_$9E%7'-;(E\W#LE_P(",,^.M9U["%,?H.&Y%\"_47\8^0#G?9>5N0
M:?J$)S]M*D/V$$%NUX(##BP\&5Q4F:C.8;-7ZU&\):O%SVBCZ$7#-\+?#,BT
M,,DUBM3X?0_IM+-L-*/G%-H=0NIX'W^'T;V@%Y,YPT,OYD(&'ENN0A,IG3\5
M2+DF#4*D-X9C0WBLW].!1XLGPE_VPMUS =.I=NGXK" 1XHOO(L5QXFS,A;"K
MW,&"V4(3X$X_\YV/SV@C&F>GPQ1X/BP?/A])[66X$?7ZLZZ7:/*[:F^]LB 2
MQ]2UDN-J3')\)1*T("!;-G\D5N;C3CV>.K3R5WPEG^TCBM>!I6D-[73I=?=.
MF'0(.R1>0/'I6S@]ROJZF+3'>9VZ%3)+1?CK98&.)-U\""&I@ R<2VY.3$=E
M$]Z?"1GH28"2(DY[RU.<&)27H)2YK/V])4O(5N<6G=J30NH-Y ;QJ7Q.'^O]
M[.? =7: "?A.\6+;$#JB[- .B%,]=]+$H+K(L]S@2P=Q4NHF[2KT\]_,G/_Z
MRYMUK/PTY^M96U_STH8WIMZI'1+F%!_8R-L3*6^]HS#SD*<4G_8&RSI",9,"
M1#&/95/EA64OD^$8@=@SY78A+]L+^!AN; 82SB77\[+Q7L2MN=_J:WN[\;(\
M1JPD!=_B60> &N57O_W=L6[#SQ,5AASDG-E"Y2"NUM3O8EL3F3H^T])2Z>(4
M.?8%AZNO_,TR_ID0ZA)'A"25IN%O:5[0<+8:MG=SOOW XZY]M!2W?8O?BU2[
M_J6_/?Q:O@ZI*WQ-DO?UUKS=_%*<Z8\QH*1^EKO@#3>O%,K1H24,:,*[?_FY
M0N*J'"C^*8))G??YX3D:_\!ZTQ+84@.'YL)#4L_":9?W(7:Q'(X;)HXP]9O,
MOD,<U(-Q=:OKIE_^'BZE$HYFCS=#);Q%]-7*RTJ1H>[M W>>N:=D,O[RY)#W
MK1;JS4ZG>]-<]\<?RM[5&^F#Y75/1'5%8",6?OR3>^J_$K[F+@T;D1+O?<E6
M65"ZOEZO,QJPIN*I[ /!9P6+_DALJ Q(H)4^)Z KTD,53])6W-PM>)7A+_?*
M[ SQ =[J)^B#&Y7C:SIAW@="Z.PHA;,;8H@\+^OW<J)9!'V-2^[7-22[Q-<4
M/(T'C[R8IC_G_?JK^FT6-'7EK_=N,/3Y!IEXICELTPI503QDRRS+'N^C)#8H
MRR04CG5\?QL6M;[[1&;&<,4^<GQ[OET-2'')RN*7E_$H4*1<@8,\!+,;I#I&
M'RJ(.%J7N\ +'XM;^"GBQP&+:Y+$FQ*J]*]=A:PDZ/!CR\UF'^,'((_VSET_
M51T?7YK\DO%+R@U&I% )OU(=>+%:&P\*6?-Y\DT]R^SKG<*)J%HO28Y&D)_F
M@IT>9<V"$_2G)''5G:A&H[1DZNV@CZK&QW..B0H'/U_UUXC8G=TS'D\K:B #
M0I+)#):T^3[Y#PLL,_RE1&E\Q$MP30VD/5WDH'.0>:T 9&/Q)\K5=/U?O(DO
M&=8SZ[)2UI/[6B?\B4I*A\";$7V_JH]1ST.)LOCIBT>RF,T$X9H!P5BI;21!
M#&$Z#:_VODJ)'&J8"0;BXSM#2"67,G3=ID& <-CDI\)YQ*R_KQ?Z.\4'>DXW
MB]+:3@F&M6 UQL7&-G0<NEF^-+F<Y7-?E,J#O">Q5>/*0EZ6#O+X]<DM6'+>
MFX^PIP9#I5$E[N+/SOB59(P0 C42-0<O7U 2G&F=_*QI >EAG2,#.'_88H.'
M XEC4([ OGCVRH_-_9CN?KC,'F5];-Y WL%#FD9*AS:(X:_8G;9;"J.EYRV.
M)@[#-GTX9C1 =(K]_,F1]W5'11H9G%/6M4;>'F(J*RE&)VY&98N>OIAL.FQ5
MEEIOT,66 *\*X&25OU,OK\;C6:#Q3RZ.CK? Z1.?U_A:WD\QLA5>,.1_U5"U
M._'-)5=S=CJ*D#8ZS>93^'+OLUP,ZLMB?8K7QM'QZB@E8I; A334_YC^D8>A
MCZ^IH?5J.FNEM]:,$(8S4*\.5]_\*V(@W8#)ZN'E]"0YH:.I:)=D=Z=O&_S1
MZM1ETLTVE'BC>C,8*2M2FKZZ%[HHQMY7)FSYFOT0WRV?4YCA+[:;=PG5Q&E2
MZ?>5+O8LY(SJ6KOW>1*L0) R.:E1"A>K/'#=7Q?K4%+JK))P9)1[W &ZF!)=
MB[K-(D))UYI+"SSFC&\WAJ1*1 3T"+%-+0[J>\_TG#* W3\3PSUA>^%'FP.[
M9<2B;51C%IIUJ(\2(&<0Z/5J""EC&T57D7OG6EXCBXXGZ'I_+D>=79%:[?(R
M_>>\_6=A2HQ@4IFWO<K)@AG0LK[;QG6/=3I_GC_> LY$]&@B=1.JYL-%B]OF
MHN0V%1BP:(_IS;\"8,^"((5+C/>.)1R93?)V<;+#?!I7REX)>UH2S,'0DF5=
M2D]XX#7JQ\I",87E_7N=>U4?QXN"!9VYWSWDJ>@6TIRM#=[T$9D=M2^A-2O6
ME/[4$EEAR:6(0D<YKYM&LE!]+EBZIR#0;S500F-)'UT?/1L3HDH[C,R%T:(4
M6"JB"=;:V^MM$ZQ7SY:3@6+$UB+/ 2E^;8<2PZFG^^BB:_M*A+;MJ-_E/\9G
MQ&_0A<>EQH_!A.KN*9P/_G'KEAL'&\A)GTO-36O$NE;'U)>R5B82BF:5JFKC
M]'#S_6.F8I[O)T.?BPQ^?+&O6?8X-5T_F](:J5(XNXC%/?SCK2R(=,(DXGB'
M#$B(9#5L,J\>)DT3BG2Y7"0SU&ONR]-RZ>-Z^JO#PH""ER_M?XPJ6UN?4W8\
MM_ZPUXGV8%/O/\'-B!.<X 0G.,$)3G""$YS@!/\D"$D:H'<*0,L8,O"\)FRX
M[Q-??-N8^AR3POL*,D P(M&0@:\)'62 EPR< ]:R\R5)EVH#($LO_Y !5&T#
MXH1QPCAAG#!.&">,$\8)XX1QPCAAG#!.&">,$\8)XX1QPCAAG#!.&">,$\8)
MXX1QPCAAG#!.&">,$\8)XY_)R'U"WWQ(&_HM29Y-]]UN.M!ZI:>=R3D%86FL
M^!X(C/9D 8K_?MZ1:ZH(#OH%*PI2R["].*GR)E8@8'U4>5Z).O:;QTX^/8FC
ML0&R<P$-V=PQ(SI4OPL#\&2 8 VB(P.]&B9DH+8/CJ^$S*;(\9,!)1%7$AE0
M(0,MJR/7TT%@,O#>"8<XIBGI.3IF(P-<F2=B)V(G8B=B)V(G8B=B)V(G8B=B
M)V(G8B=B)V(G8B=B)V(G8B=B)V(G8B=B)V(G8B=B)V(G8B=B)V(G8B=B)V(G
M8B=B)V(G8O\WQ3!$1ER/*HYFO\A&7W];8NQ7ZZTO[,"WF,A?-26C&4$J6KT,
MVGW_NC/)3W""$YS@!"<XP0E.<((3_).@+XFIY5RN 1T)[@6QN1SG^/44993>
M6^]V:3QJ\)=Y=)->Z%M-85G5A]M1L(3G#-)4[U5]#WXN_6,/4RXG SRP51)S
M[6]X4]5ZFMTV9+XVL>C5]-Y3UZJ=_!_=V'7W>_NR[IY]N<FN*5;6'.EGES+^
M3\Y5*4_C(MXG T'W#H?'CT374WU>/9E^O;4W@V4?<U7D*?F7];7>4P1&'F)<
M.2AB;QK<'-PXWL7RB3%>:@(0G!?@!ML"PW_KD?FW9F ;H\T/67TB]IL7%AB/
M4G6?A;RHKV?07%;D>?XWI2<%'W96>\Y/+=UN;3GLEHA5*IOGPTK)M[8O'L]N
M^C/:_M]^#^E_-MSX\S"Z::M])28CP=K2/]U-8(]UD1/=8LK9,/MUP/[:H#ON
M)>.\JE_0.\WYG2[ ZPGK_*%U2]==C'E2PF?YI!3,P[F+5+NSF@6*WGZ\\38>
MCG [GJ%O^!Z:P!L";S@,?%^?^EN/_VA=9;'G3[GYKNF02I$I SE-8C-[3P86
M.YY3DG0M,H!OA\RZ$1Q)/B5F1[N4U)P['?0PHZ+V' S]!!\R1@:*9JK"UZHD
MC[^RNE:YWWD/F93H?T:EPHK P,^/P8P?)&I7G?:_?"72JW512FNY-^606I&+
M14\_Q$?)&F//*_^H[:7!2+S03=:;C=D[$*V8 \ZAOYT!]2_# E$3&\G6$/YG
M[U7L4O;+TJ"7K?(]Y@I9RTD8R*RG\B+VZ)2F(,1[7=E=(1F2!WA-LG;#+%L.
M)</Z$MHM>=H92HI'#(%=:CF$,P$KT??WDV)9VPE9J$/-(,<7Q;7OM@RO(3K-
MBC*BSSQ<%)9G!-QT]9/)0,,J;IIX8%N[OP(A26LKX1,;R]C.*R88I=MP\UV[
MCH]U/CX$=AY=_Y7T(_-,W/=)6[;+G??ZQ/.97WZ@EN+=H7((VX833/VXR$":
MB#[I6(T,H*Z3@6#T;.W!UA!\<Q!.=/&7OQ+6A*L-$T8:_U"'OV!M<E:[$Q0Z
MI.Q I6D!.PBV_^><:JOBZB>(;PF?51GU%E-_JWMW_/[=.=[%WV"=G2YG, [Y
M=1M_'" 8EU:]][4*_"1MV%_>(6Q1[@[6EZOY=<?+.U'S9XS&W@C[>P6DJI43
MG9.6_IW?+B1J8F0UZ5_'KNB;_Z81T"HPY%X\)R]S,4W1AL2#/YT66@S;%;H:
M;VFAFYNMF\.4V7NLJC;WFEHO[.:/G]GUWY8]C();71F+GP@%<5@ W;35@/'_
MIK47RHEBPD4O+<>:C:@X<VMUOKCB]FS<7V<D5>&%\=M_['DS)M.A1.<,@I8[
MM+/?E)6AM#>B@K9BC7;P6,Q$C2AZW8<(-U>?6]STS79 #5COIH.,,RIZ&&#3
MJGBCNZ./+2N4$DJ3Z?EXTZUC-B#<KRIE_MV*\OMM :OAJL*5P>(<B>U+]6R=
M*9(,<]&ZH#=N/2:'5OZ.?[L$%QF/)GE^;;S)(<T-Z7AN%'=K<O]]A?VG_N;;
MO;M=@-O@WY]7_$> =0[,3086J,F (_CH:;4?,A";1JR#KV/)@$TO[0^"!TGE
MBR ).4L&>D_;Z#F&P.<,^^&KW>!C0"^>(F#"AB!=%GU_;GG,Q\;YUZ.*N7ES
MVJ_\%?(AV#5%V3&AYC<D,*&Q>7J9Q#?TK<@0/I\R:@.@P%7LS[EW6E%R7FV0
M!L?S2X7%ATQ5"ZU93I$:QD66 [%B:=H4P_"68)WWHR/$N1]^ZI5[]D.V:T&\
MW(U.&33CW,*D*K8"Y]RQ?]5NKZ:*+"ZMB!W#&'RV2)*\3K&>H#E7-,=>.OV@
M?@)1$"^Q.S2<^=6.3?_B5$.+P1CF_AH@:^KBRR2U+[&B2QGJ_<C=38*:G*"W
M3PC;:9_LV\Y'+3/@Q@2BD-@LXL-T$R_+\XKX;]5%\&O6[L+=,CD7/.><=W44
M>;ZSZ'_Q,<++=R.^&RU7NC5%3TTI8'"M>@]4^'](<\A91P5Y]=)F]!F06']7
M#2 E+,]\=75V];($R25>8+-?;S.)A7&@9HW_;;!)$OB\M"#QF8T,[^6 +9'M
M"#)0C/J#0&?]!'A46#%Z8YI1I"O9M<C:>S+>[RRT'SO'C-LR/9PC=J7*)E62
M 9I\"P7[L@_U*=SOAINE=UM=7E./7"^X(+,92>*&-O(6=V7;Y([K(E,MRL&3
MKMLW]AR??BJ ]I6$RWL_"M3^'5V-;.3G/ZUYGVY-">,O2KG@:_BK:<'%-F[T
MC>6(A.O*0'^M.>2S_'N[MG0%*<)GEP$560.;1P<ZY2CFQ734W=N+J6F/@'U.
M(939S/>=&XM&A- G:)W*,TII^X$7T6,_QP@%S7"FW;<#2%6!FD*^->&C#M$G
M?:V>\C4ZX[^[ &\W5J.&PW&=W^_V^I\G3%DQ165)@[%CY6GAE9$;R;.RAKFB
MMT1>VLW=QSUJ;79_Z!SMY02Y"6PN%; 5XA-#)8Y%G^ 60S@-)4!%"WLDO8F.
MM+TH9W^U+K0<R/L"D6,P_^.D*>RCNM^T&%MHRJ6>_0YK?#/@?9H5D\J!OU<]
M4\":%2*GPM]EQW^3FC]Q:]\7K;J!W(+$T.BU%&(TS\-ZC,K[?'@7Z.G=Z9VS
MA5BD>Z0<TJW3H4_/+BOR9JG ULC Z=W+[.4A3797ESAXK1ZG@_<;+Z)K;FJ>
M(C0:],MID &ZM%##T8X#+76QEU@?GYPJ0GPY:M!=G&IU4 LJ*!J>7XP(3XS,
MMBW+?%268#%,<F6I"RW-?HS=M.0EI(/>9""M-+%FH45RPSH\0@\8GCM??O[&
M*V9;FK+,^,7S$UEJ@N56S<[?J%SQ4&P5(^$LO(Z>T19J06]88VI9?12&,0,^
MCZV0 ^/^39M7O1PB>P2Y?;*V.+J\>>+72[]3PI:4-@ED1X6 <CUXL03P5$-!
M#OS)P#B*-%"@W4<&YLZ^( -0RI>E*\BR_^$3T#]?DX$MFM]DH(#R9>>\(MOK
M?'X425[S7%V"^\.XE8&(#$DA3C+@Z;^B^8*DR6HS V:'M4O4HDL\1;#)3#\5
M#/Q]^=GIQZ-D]OZMA2Z:05XD!"DNG1 DOD0/4!L7*OB_4Y.7KMO-J3E/",E>
M/BS$D8&(0&4G.H.-E\^^:YH39@);N+:[70!YHS"A5H7;JS(_/N?:_'SQ$VK$
M/U[XLNQ+)H.'FQ2ECW?T8R=74Z\10G^9C,!>Z60M]9:VW>I@$24#I[BWC_O&
M"XQ^NN$L==[15A2BA^VFD<\S[FS(^Y&PW;XJ@+<(ZUPJ%2' T\[#]2OLA_X%
M8X&HLHNQINZG#,%53F=I"]@7PT+SY<SP]^;'-3\M&YVJ>!Y]QTR,IUO:=;T!
MD9T.,L] 0LG +%/)]_OHRGOE#K<R.Y.?<](*N-S[;1F'SA?*(%ACD[^\U<BT
MHX&_'L_7UCLP>L[-W'C4N N^_Y V4TO%4S^"='E%;&6QL>:BSM7NS5O&']"N
M#DO/91G>"L,9+,6I5HKU(Y5Q<.,AQ?+A75S1;X%WG+,!/2X&.K?D:+%F=)FF
M,+A![(H$_YW[CXJH>C]U/R]<CO6D6&Z?BM,4I65LH9BCTZ16"5C Q!>:.K>7
MO)GE1#4>V22 XCR2F_>-))L[2@?=C#?7DCU_3#HNREZ3*QW[*H:HCO#&Y OX
MW2-\7/=D[.O;4;UJH<4O^HE*/N26KWK#X=MTT(L,Y*O%F86B'WP5?6[SL?,*
MYO=*JJS>CM4C(":^=HZS/5$%N[('2/D"ZN.O="^X(\I?"37R@S89+J91 CM3
M6&(+&3A@7(;OKDT?LGK!(\2KS?1[C= /:HY89V,,GBS*P:^OW$U/PL&YEI)(
MH;YVEVI_^=;8\(MP'6>HN^=[O:Q#B5/ME+#.>VF^D_.UR1V9F()E=I>\QTA?
M"U_?+MUAH+]U;F;.RAS]ZU]S>J.9A)E=8BHW(?[7BKLP3:&M)(?>4?X/U?;?
M.Y!COXR:^(*TXAQZ>WVLRF[PW'T-STW'F,%#UL2LKQL@2T7>@=FT"X:$+-7P
M9T6RZ@<O@WZ+7-RG/0B<L"@5JK\6_IR@C@7=XT/+V-?5B33T\'K2[##5U/9B
MJJL>#;W9S;O'>+]%2P39$<^?O4O;&Q7T[/08'A1BMJ57HGGD20;ZWE77()5G
MT<3X/!W2%'S'/!WD2(GPJ,6:.#MES@1Z_.R*4.*X^0WK#3]'$F3=3@@O,+.!
MWBC%"_Q:KUD>,SQ'_+-X;!$X( 5OY$-[XD-,O=>?=C3>>U"5(QSWJVPJI@;C
MIP;!73;VNXQC<2:*A#P)8)Y:;G50#@:JMJPX]FGV2:P[Z2"5=[ ->TQY<&/S
M35I5GL&(0&W]%"(8#]I+#+'JSW)Q$-^C$INZ=E1KPHUX45K-^7\_'_Q/!+ED
MS$:UA\106O!;8M'$NF>"6$?"&P'XIYYY4WB0'/UW K2%?P^6-?@H4&* $>7A
M]/DH4^%3]QF['A$(QAF_IRP]\7NBA@K+JVMU"\+*NEY,%8H1/6?#>ZTHENO(
M@-A_._%<NCK'FC+\Z7MDQ^S"=^]94:Y)F-HS%_,$U0?L,P_//$>EOP3_0A?K
MAQ*-S=9JN9<YBPWUMF*Z^P(K)06E=^O!\8#W2Y:P^H]WHW4CWH%HM'NI#'CO
MU9"Z<'H%+EQV]*]4'%7A'_URA?R0V]BK9&#4ASWA:XU=U<?[%2W/79J.MMBV
MTQD005"N@0*DO*?O3YO21%6-+S')'_0>W\SNOBLUE]9>34\Z#V&DA*:UW^$S
M+/!9J-TL*%2!!X<*6GL[:E&;-*M</*7[2-&BB0Q<!)DX+YO^",$+-1JMMX^K
MN%TM:3P>V8A[A5UB>K0X#GD$+.6^_2*IL0TIVCG2T!3C(O6<0U5QM#B=<8X[
M&&J_GGZF*O=U]QHKRX5.% #2@8)RH5 ?+?R<D5NXC$UO+'-,#+=YY%;,"@Q%
MI-'7P#LV+XR!"*JY!@?;V9*/:1_(,WNG9HWSEO3[R.#\<:7O>&=I]^)'+ICP
M5M'BLF93?=M6[BCRJ*:]L/]NL[=WR9EN?4;Q0V:OUV'JW+[$JW]DS>S_ [G3
MS"O+Z02_(]T897I8^,TX_ZX^5=\V:GS>S>VTB'U[4)#(^F#,7G@)XY*N$'BQ
MU%\:$5+#HG!WL$!. \/L\$*,)QMURM K!;$1$1#UI?*4T*A?O?6>LLW>0X5.
M508%@Q&UHW+4BP,]VL8JW6(<4_0'8!J4Y#Q1*')LEY4.8B&$S)H1E$NX1"_"
M8%ROF^K$;?9?Q&7SP=U^*]%&3>*A!;-=+^249E=%M"7&;O%WB&92OP=_DM!$
M7;I/!NH..VE+<MK/B,6F21WKZ@OBM+>[<%V[GP4^W2IC\A*ZCMW6.:!D-/]V
MZO0'0KQ^$YPK[PV'2A-S!\OC("L6K6KT\GX1 5VFWP,%X_627^(%G^&9?@QX
M"@\@KUR=4K<,YBD?TU1H\)<O^X]&]ZB&%;<B4_E:QNA/ROM+SN] \R8I8 [D
M'?%D*(\JU?'!96T(?EAP)Q_[9'"MQ%L .;!A65[F%Q52^W5'H<5?!'T>;W&T
M!CU5J3ANM&(PPTO<X-_2,:WV%$71'Y<F/4W)VY]<=.MY#/QRIL0MCNW^$GZ<
M!'WUY/I+B4;OXRQ=Y1N1R8MEZEP.&%J!MW7=\JMYE Q(LQ&^([IL1C@-)NB?
M_4;4PW6'9]@<VBIE=^UY6T4F225R^=<?=<MN$]"FE,2.EP!OBN/R%OJ3*)_^
MQ5W,5Q:<+IW.V"$BT_$DJ/&%M:/=Q7M;T0^ROY=SU/' P/&&_T<UU/_-4\DE
MFR@]J "N&1)XUC!UI?W;C-A;K3071:+=(^0B5GY<>9;>VTW -V-=V8OU'.I@
M/9W)<G8S&!11(M1S@1#$]>DQRO9.70(TB_\HD\\RR\$_;,_LM^%Q])AO+*CH
M?" HX=YYTL:=$;_G ;B-(1$YZF]7 ,G&A10/80VXT?(2=;/"98(^B7E=M:-I
MBO?,V)W;C)R^(U8K=.#)-\Q*V#(?_1R"JX$F,\RK0S?2/?S#5L=2W6S( J,.
MOCFZ%J=01+5NNQ40,9?5#7G.VD9D06[[B/F^4K]&G]>8&M8N11PDO:5:_OA7
MNHUVB^28?)?QSO#3#-6*S="\V24BU#Z=,EZVS8@TF<"W=6^5^V@K5GP+5Q6Y
MAPL]/?%JJ!B;8>'EK/L/[ZL^<'XGV:[V$PO&G8=BLT:,;8Q\JX-3[LO"F*]<
MW^&MR:J0[W(A TQ(/CF1])!RI>/O[C2)M/GUQ!L$ZS07KPA]2\73SN!+HC7-
M,T+?&$OROT=1;79C(%<EQM&Q1*?:<9MOR^W3OE,>)CMUY[+ N&O$;&K]V8+@
MMY^1YVW<LFWN28I-R+;5>+^-*=W@<U%[S("=JIPF/"!*DH'[I'@RX$])O(.=
MDC2;'1F6*J^E_?C&&3%M7?IP-#/4N9P!C,360B+=IL#XS1"B^IVR/U4W7,?.
MHBTE!PH/J9. B3\#N<4CC^]=<M\K%'.\0?,HS#@@A0H=</ \Z1]88RSR4<[Y
M$3A[M*ZMPB""$?[UE%I2A6-? -12G-/M)S99K,!<5J:M-G9K4/+KLUQXZABP
MH,!+>$;HT$;B13\H501UNF=RGWVYX@*IO'M&QGV)KN#ET>FT4<:L4;ZC.^RW
M#RQ?@#>P/"'S!F"F=>V!.IG[?-0^"C8HEZ:RW?Q4?SD=##@8/LLT^ ;Y9';&
M/O,BT)<U^?YI>L#Q<#T-KZQ'LU=MB$00GC8DM^0A^G4Y0K@F@HG=SWP(PFU(
M3P:H5V_S#A=<9^]^Y(/=U3))J]?HD6R4'+:*-:^<D%[*S41T:2XJ\G[^6]'S
M,X;19: Q2:3E.ZS12GG^L;^50[M\#R&)TIYKL![2^6KPFIZ#:A8L2+7=>5Z0
MXC>AZ=[;8Q6B[VA*O^?&JE^[WB98*V(XQ=-WB^B:;<<K-'S;_JLAAPY8J)5E
M71%2F0G.@MJIS7@0@R00A_^-O?<.:BK\]KTW-=*+]!8$% 3ITJ0$4 1$I"A%
MJ@A*[RW44*274 04:8((B( HG0#207H1E)Z$7A-JJ'GQGCMW3GG/F7GG_M[?
MG+G7/SY,,F0GV7NM9ZWO6GF>9R^!]QR 0W^!SUN^)M68BP3/DKFK2ZKU4TW&
M.81P#SNB)%P1FF:3"GPJ,:C:D+!+5Z\CKC9<6ZD0BLOYR=Q6 :)B?W#QJRDZ
MJ!FK$B^V+-!(4[(.(T>?L1;,!JI@TP9;2HL#-&QH>%8(WN%XP9LAI$%130%E
M_[#6U_]V^^NNGS=GVNLCCY6^,.GDP_@L@=[N)0MQ3/=EX?^JJ/,D*OI \6MU
M59C!X[F7?"7=^2$P#G^CS[AT4#VFIH+XKH36"PF!@^M7&%? 1-NH4^D*VY0;
M-!QU!V9T9WC@S9^NXJ4:_]$L ?4A_1+5H4O .:Y_ZS$CRUS1=HJZFYM2U"\C
MQX4$^P,\ %H[&A.W[P\VZ[]/<2?[PX7L$-H8#S"5CTXCSV=TCLI?Q/*MU#W#
M [U4\DC%QG;,Q4#VU^LI3QG\J19AJC V *W@RI!#CLMX@9)WPP,O&JWXBK-L
MXLF8AQ>?[<V<&GU3$]2FUV(G5=?]T5ZG2.612^]%5 &]LV2M/\F4NR9.8I;R
MA*/X) S&<9G4\0#K75![0+U+L_WM)]SE;N:/'EI/\R^M386(!_.9]Z$J.->:
MF2N?;U 0I]H-\KD88W\_)CX)G$M[W+8K<WEP[./56OJKMAYM!+R)[^MCFNNY
MN=KY1ZN5Z.P?._A_+$25[BUK#(YT;8WWS$O6UA+3=)P8M,0W7.VSMD=1/+M7
M$\_S-B.,-C?MVV8W&",('-S!:HN":95$>@-Q[[2_R*>6L]V&-"Z<5,ZHUY?-
M6G:7B+9I5*!?)ZANJ243$<< ':].G8GA1QD35<U75R&_N>A,>W4I$M1>=:!!
M?5VTP4]=<8R [Y] SHB<,JC#Q6!-UE''<;],F+QCX*1\3CS6R6&/=,XH)IJZ
M$.I(XOSNKLR/N?)7)55_L%S*3]YX^#*,'#C\J?N)49F<%" *N6F7'R*X?L<Y
MI\SZ>MIY@YEI[U&!>S<>,#X=3Z^I.32LG#9I2VIEV](8<6,((,^,!;"B7 K-
M(KCW+Y#CKPL1E%]6P%Y?J'AI'L?3X&C0%@.VMJY%O]MM[<G;7<E?)3#GAUJ(
M)-ZN@)]NA^I='S'HADGSE)S45;CF$58J&"'[7!GL)-?V/L4\2 _3ETM4&3Z7
M!^MJ.X]=3[L6LY0<EG_SI?4OZH\A"@4+Y=^$.HOM/"63J?DC-$[SLF3/#K$'
M9:()L-T;O_' +Q7(OEG:8"#GK#=:^/FQ1R6[SX]<HR2ZLP0O&!L>6-3^A@>^
MA,%6ZP4(5]JT;PC1D*CY@W9V9C\DG0HQZAT3PMAVA#)Q07B APF.!\P@)>7I
M(0JNZ(2OPH-Q7@P[7NG2+K_T/]"<^94VX#P_W/T Y7UT)69Y]I[("^_US@NK
MW/PD"#GZ0A8/=.?$X0'S&Q=:%LG(^6,FK]R3O2@\H,Q 4&C!CS5E M/NQZU*
M?//3T]"0[;L5!=KX?E8Z+=1Q(0[K6?J !R:_XH'5KCP:IXI<*2K6R^"3OO(P
M*9EALFSYV<*F7GWE3HCCZAVLHL2RD"L\]>T;@91EXU;(G( R. :-S:.QK:D)
M&YR2=[1+$7BN6\)&24+TI>32N&((2^2J@A:RKY25ATJI[7#@^TT!L C96FKK
MX8TZT;"&C@KJ@OR'_88<.N19@?6R[AN3KAL6%;=**'5NQ3/2:4ER??>60EN2
M_BP/?%QFT<WU2R$+UF"^"UHLVLVC@/SKJ'7W@7=<^Z&^7%O99R>=O"M"?1=R
M>* ?=#$'.<SV?TC;-/2*)TR,HO<9G8IB/Y2! ,7%->GEB >B?2VXL<(]B50#
MMV_R:=\PY>9!JB"-\( *XWH+I@K!?ODH]RSMW>4+*R1Q3Y&S-!TR#=D?O]FX
M7(^A0Y*J:Q?PR<Q:K;>D^=N>"<Z37D;(RR-N?,0#J%7@4@P4+LR?4%YZP.?Y
M,S4W2P:%NTC+J_8UW]8R4,X/YK3S_.BOV47+$7]-C"+VG#F9#, #Y+6M+?N7
M;]-;TH)K2+2,; :%7'OW,%%QFTYF[H&,^"JI94J0 .&EU/#VF4 P?IS5F/ZH
M<?96)ZC'9_$TB>#,<>#B4HSTN%X&WXJ7EU^F=+(JB%EG^!9)XEO715-2D:L!
M,OP5MS0KKN'F\<"U)M&+ILLS4\VC>8+)2:6.03K?Z6+LZC'(P@-^T\O6QZFF
MM_64P8IG>I4@E,*(ZGNV-2LY!<(.DJ&ULXTYKX$[5/Q:-6-;2;>DL='C!/$+
MWB<Y13.3"6=J>""ENA /3-=>Q$MM[0-&,<9B8Q>0!TEA]*9OB>(/YEGY+_6V
M7(5S!2T>>!>"!VHKS@N5N;+1"2_V14$.,I62MRXL,ZZ*&OC(JX ?KF J1'!6
MY5"C=I]:H\SJ7;62!Z>T?O1R&M\W59,D/'/SRC=0/Q&I4-*E K/HCXGJA^R5
M9SWE <B5,(0P"@R:GK-8^^C8F:*QG#3$LQC)Y_89-"OT2Q?T& ]0:%U>:];+
M:_VT!1<+0=I#92["(<="EQ>03OW?&_/2EJ:7MB2"+8[/GYD#?K9QWN=LHN I
M:%R[+X]5_8WL>RXA/=3L82#*NJ%ZI>I]8OT/(WR57VR\*3_+AP]/<EY:=O([
M'K!CNBSQDX^79(YA3AD^,VC9^2S;^$EKRINNQ&X=C=8)J@*#;L#W/)J<Z@2A
M4U<TR6"F^]> \XI!I4=E)T26JNV4/AAU2@%Z@7$>@=4\2@(+H4)8;ZLF'K"4
MO!RZ&17.>82(QY;3'P-]*],)O@RYNS;:<M1=F<]Y%/RQJ1RAU079-=W//3F^
M#$?#$R&*-0@M-.PL<K_EY-#UG+SIWSZ]_/<_ZX=O!&^[Y:Z%[66,C-BY"!<.
M:(*J1[8L(H;P@!7%_#FI"7"H0VMG&,PW4C0F^OK-AR7SX'VG.Q*G<"SG1E>5
MHNECG"FJWJM,FV+M6P]%-D)BA?#)QG3QV9U$150]'F"!ZH]U3HE_RSKV[/*=
M'B1]Z P?YT*OK0H0N4PM4_39;3L7:EJEW>6+]F#A0B&,_E4KL.#[A5 3YO[7
M"U8LN1]3L!7[98A,IX9%<ZU"#U>4ZG6B^&0ZLQ^&78'8<R?B =D\&K=/_C5%
MI D?9AUDU&FGN\R;SH$C?B)L:=HBC-7["&*#62J9V7UN_].//XL'S>DYM'19
MX>R$V'[[B?#T1(%IUZ7=6-X,DG1L<!T;9S?>Y8J5W&^;_ 9K>XIL.6&Y77%&
M!3]SC!@+IEC=M4^O*+9P$(*."#VLO"-82I<"".AP"DZ>W=2YK,B'MDOQ ,P:
M#Z"]"#HN/>XW5 B5,>W5-QV0(/BRC]W>4&TW=^=FZ_IGR3#8*ZZ#G4__JS=E
ME(BK18KD?L"YK.B.NHA^K*LEF))[:RQ!TQ3RB5IY!2/U,U 02W,X^2IEPFC6
MNRB9:''Q]7K"\0O8PHT0^<S_!LW _RXH/&YC;T%"'1J_Y5:9'^S/N)\854_&
MFLJ.-"OUW)"G1R$S^%O><1FU^%A93"J30+N[P<=7[/# P0^=Y>K- Q2$Z0-;
M1:)7$P^AA5H"KZ"\ OS["=KULK@9N+0J]ZGKR6)+C\&?@?/E["Y24;23WH13
M[V6*D'ZGE28Y+U.W<")TNNO*NJ-'+- 6WAK,4JM?DK?6 3Y><RF'81<<X[%#
M;5MWG"6"U%7#-VO=[IM-=Q]=)TH-_866[;8 -?E',!"L0,C.S*5K/PX46OX8
MM7@J<),WZRV/@N=V$1%_N7J3]X7 Y'/,?)3+@2;P,L:=#8SV;(-_U%'Z/ID<
MR.-^&58)STQ"G#.G'J\2^L54H7?/-CS1"6,?<PNF"'VT;J4D3PLRT)Q3#H-R
M[4Q$8Q2>EO45VU<VFL7$CUJ(3U4V>V9W-VMP4P=,VGLC=6).GK/72:VYFGL\
MU+-HS#U=5B8X,?J @VA%J6/2W]F3AYY&)/^B06Q*=.]!TH4\0A3ZOL/HRZ6<
M-;T4_:42SY9XWX@,;$NF>5\PH6M(H=]13=*7,8[K'5<&2ECR:57'XYE2)D'(
MTH<7EXK?3 R,83MTO'GQT]K5[3YEI1!ZC/<V@>(_:WJ;GVW7^?RO*4/)VBVJ
MW(=;Z)/)DLGLP)?5>PAV8J2FF'G!U=5"8YB$ %$9)O<LI@%\'KZ%!_9-)CH]
MP32BAJ??_;5*H\3;%VL52E2-0!@B3*?7/L$[E.@QD[?KR=YECE>66KXLH5O0
M0R9XH#SI,JN5H[M]UXJ@8*.W,S<#?"*"?"$]XL>30AC]$13FY\$8Y:U)4Z,9
MP428!$P0V/]QZ=2LMX.]Z-6:QOS3YJ(HZSE5-ATSQIK9H8^U$PC7]&;N9+T5
MT4RJ/ +!1QL:!(@RQQ$$R*!'OY%!7!,S7[ZG3$C%9,PP,BY)[UF>W<3._[9Y
MNS2Z+&CS'64,)Z@\7UHI>L])%3 +G>R^"IJ^K5NWU^&QLW ^4SX_Z0T$\'QY
M0?F!D9<[O)5Q:$.)8@2A4MI>O)ZLY3;<P:OQ\-5],<U!4HE'?BL<Y&,CK/,J
M8YF6!Y$3///F!5+^(6)HC&VD=71' VG6DR-';^OCY,R]W&A+:N>J4N;)?>!P
M>39MJ?:^K"XD@497I;5['!M[*#B )8L)E/KT%KL8)Q?_EO78A^/B-4$H!MVI
M@X)3OURKM301B_4\OY"HP.WAPLT3H#O?)S(&)FDI.Z,UY5;GE2 52Q:=_S<Z
MB(2"7GDGLH5Z=CT%&*!'W89TK42 '^8$A5;D>@DS=^3<FE@:O_UKMOQ>E[TH
MRY;QO-P@>IZ/%J2X,1PL.WO'_D0QC]_F:^]-SJ_OE2_UR8!O#LTH<N3L^L<I
MU;Q@I(T/T8X\9>79T%(LL.=801ZH,T8[VUJAY;^1\CSV8 8/S$L -*,U"B"L
M(-IP/./N9('QSJ"^7-CF'%K.R!+I(O_,-IY::,RQHUE\K7(MF&=,ZMU#-<4?
ME<\++DSN&]$<M!/@ 8(\&N?R@*<8BP04E06G^I-8T\C(:VRJ-CSB88_<Q%,\
MAV07#'^^Q@,.E;5UO*3&:=BUY,R<_P-<[+^_:]&]$4Q_3AB:HKE CMD*T$7@
MWJ.-;P=)_;*7'G07>!S2TBD$NP[ZY9YJVL)T9N>TX$IM_.#>;KDK)RSB"E+I
M@T=0]$$YI#67]M899U$OI0G-E,M'IP$/EYITSA!V:H#KW",H!%33]W':GHLN
M5^>;=CKF:4\T6>]I4>JV_^2;0&H\D!19>9DA"BZ<M?RP%5L^,DSS&/CF7H'=
M45"M;$^7^]+D]84_A7X;J[N?Z"%L6FDTMFX/T53'AP>\5LJ ('X+*JQ6AR0N
MJF/M_:]NON2G&L_INF1N?\NA!C;@#2"SE8DF7_5+9=7RZJH%TYP*U":C=[Z%
M78O2EDA1L;2OF=*^-PA%I658US[@R/9*>/QVQ-=YLYM@#*\R:3+FLCBA]/?2
M,W5 :[T*;". 8I,T>WOBZ7++I *?HN$$#G3M*.* /DVR[]GA+FLI*=2>FQYR
M:Q;SQA82H\X'%60.TAGDU-?LK9_+J>L^2,;!>Y+G0F[?3C"<-!TM.Q#B%W5U
M:WR='"9/&]1*#"XTK[B)NQ; E_FRXGG_0S<MCD_BPW7/8/L$%F7_0&<$_:LI
M.);EKIW!Y&.!5H<Z6V3;J%.1\UQ;;[/MZ:PEG2,U0#T/5]".P?D^C#7W?:A)
M/WK=QK&N59_6ABZ'RN[?RF;X9?EV$]ER?/X3MK,).W.!X_1S_LQ7G36ZN.C&
M UVK1,.W=LJD6!1.A8I%K'JY;.A!9HF_.8QB'7U\<RD0/@W5KVY-&?3*ZK6]
MYA<FDUV()U0,V1CP7XD\D[='!O'9U^CK\%W[??3H>XW.,,&)P>DTN_F#D2U7
M9W0.&2F;'#/W,*E+!&J N<.P5#HW@-6Z776324TIPA\/W#4\T'9\..+<?Y*V
M*=U#&NRS>+C@#8GPNRC"/'Y0E]2<76+V._R,GONM^E@23,*!0C2,2:^_+*A,
M1\'ZTUT@.K<C_>()P=!&9N%.IPZSR5J#F;[ZQ^D5RO;M\F![T[$O1">I%M-6
MUJ1OBZ9_3>5I<,??#R?*._']-'4C]"/4I\/$/KV4,I#9Y?/*3[BGR1/ :"!8
M#',P$85F+V/KY=MU-6>;N@[98(3_  Z=BD^,1M/2@I!;\GH3^^<F*)Y)0W9$
M:N[K15]0.0WO\# 10KZ@.P\:W*<5'R:,)N_@^NQGC:N\\=DATXNM)L.S:*;<
MJBZ^:Q[N7ZL&!/9]@+I<X(%.#,YDH8[.7"S[R=DGYITO0\46-,%":Z_4$ACI
M5/-#&)\\(U@5DJ"A,3;%I6]8)EANU8I]IN=(:+POUW4G2Q2&9"S]%Y^!=G>(
M4EGB'#M*T9R,$,_EF(^ [8\,A11(P^QY+X>-T;<QFX0;,:@T1K2W8$_[M=#U
M*]L"1*F8V@[%JQT^(Z5FW;:PT.8IV^G4BU8%L1//=:'BS.VI.1JE@.C\J(HW
MVXPPR4XWD^[6+2*][(]?4X+DWO%]@-VQG005#7,8WH(16=.\#53N;XZSK[H(
M& #L<&.HPL)7D.>8Q9'9>;G6[/NKZ)7:ETIOT,=&KLB^;,,]E>I<DVHMTQ6S
M7C:NG%=P)/]85G X>WLN]6T::HT,NK9)WY@P_OIV1J5/=ZAA8/^-8J)^I5O0
M!P$]^5BN=^SLI6J$WBJ]RAX<U$L!IT%"6JV6]%6S'EU"SH^6Y;7U&(2./P@^
MA"&*BI1RTWRKVW#A2,/0LH'K_83:2DO'PJ325W,T[YY?R:.>T(KFB=;B&_E@
MF[3YG6B^S$^]0S1ZHG:")@_G;U2?OGCLJ4/;(P@+A2%,965//'/H@DF[KI.<
M*7<I[.:/@<#F>&"T48<J$#*,$+L(JA)5G!,_C MCC3HM8+%LS_4'HI"3$301
M"%DFI')+(X\IW "]]! /?)7$I1K/_YN>J-"HT-5.+N:O6)>WG!%GM72='&W/
MGKV@JB/E;$4OWR8P0AZ=19M SMTN/C:8%!2LZ=IEJM6\<]I5D%ZK9%.EH-L)
M :T9%1/U!O_G[4_&7%0+Z=J<:.)/*;+R?*;.V*#L-,]&UL$G)X:S:9^,?TU/
MW3/N)M:B3U=(*B!2.M,E/D#!6%H6/49A&[]A^]9&-4;"*$N"M>";XUL[.^6B
MO.FSA *AXS>!U,MW& 8]MI3%I4SJ-N(*2]0+A:IWS16&7YU.)_MB=W:QENI&
M,?:6NV[ZL,E^/'!R?96H&@/O*!,UKTF<U\V1Y]0&GO*^V7K*0OT@M=L,X\=U
M\&O(S]'1R<5%Q"H2D'B1W%:N5!2[>*:-&5+%<NSX5F]6F-<J#'MYSGODD!VQ
M*-67&_Q'HX3PXJ*PU)R&OQ$0),HEHKM/ 5LB'QF,\E^IWU\PLL<<M3DC=6C\
M9.2U#_K\:DD>J68]XU;$0/0#GLRQ8+BBD(^7IU3'+*Q)USU8N[\>ZDWF#95(
MC0V#D@(]\< ;FG,$;.O.@3#X0CD=?+ %O@@3XOW/([3KM')-S9?I]]=YU-2$
MQT/$!P!H;9Q7'QZ(FI/5H5]+<AE;26H6WRV5F8\_L4U10GA5Z/Z9YNAE23>E
M+IR]J27Y3*HJD<G 5;OIHB#<Y"C=9RHBJR8CB>]PMWPRH>LN^5[9XX6:!.]K
M07=.EKOYEEC\>A3%4VB6M0'?S/3Z0CM,54/B>U>GTBE-P'H>\.;_992 "S=J
MQA6AXIQY-6)2']5ZW(MO MU/.R>]0XTXR3)<JOB^<>\U^X"'O?7%IC1*\CC=
M=<DBYCTN0 NSE/';J]$@@EJFUBCIY!N7SN/](98\BG2F.*NBZ=\%C9_I/EME
MQ_ 3L?+M64AA6R[N^EN>!\A<1%A,F]7&!I(4XAK6YU 7J%V94'*!6F]=%;D5
M03NBDC^_;74H\>"!7I-1/+ UC0?NLQV>+'E7 &LF.]%Y$]OEHO3+5._T^76C
MK'IZ!'4VS T 1A1XSPU\>( 'JDJG-]+PP"O0@\L_[1?TKE460;7]>PI-&TLK
M+G/O/,?F0NYPWF^;?S)6[B22&LA,]V;&MY6SZ9P*FA%U8+H3D2-4/UH-?5NU
M$<G^P6"]ONU'<P&G^@'C]L^,<IRO%O;ZF^J?PH8V9J^=TNQZMS]X0)*[;Q,H
M97^V;T (B>0&N7I$W U>5];@0A>?L/5-(AS?0_U_+S:T1"Q3O*Z-:==8J27Z
M&/2(Q-VHA?C6A[>9W28Y5X;N91+<!$<+G7WJRL 8:5:_M1FOIHA;*%(RX4\I
MVW33/(O.HP23/75HAF!'L&KKU4UIW\(*R8B$CJP?)P7UX@&VPQ^1HZ-S;1/R
MIAJ\85>ZZ&7'!8M/GHP3H$R,SK(8<@_V(!<Q_H=32V5G)(73T Y<MH@HU9HO
M[%;#L=\+0>AT3M1$0R8@U(&PQ@/76S3Q0,4[R#F5X[1C^CB"I' ]1[ 62WG$
M'.=+U+$>O<Y[_0HO=XEB_7+(G4RL: (>V&6_M-'&[Y9]P<M/0#Q>$!;MG#0\
M8CYB3D9<T5-K_!1&-B3W6)E3^Y_5,?AW3=(C_\7/P5SV=V!QIAW)9A;5:.U;
MG9S#W0W*W[&ULL>)<GG4?_JYU#(H4"@*^S)[I777(;TG,'*(GKJ19GQ?$8ZV
M<,:DS#GJ1$M,S]S#:G-6?5I%DV@():D%S-I<*ENY(OA5.*U@@Z7?#9#@O% %
M"Y]_O#5/B*BE1>O'7V86LTH]PFA[/B=;@#*W#)H1ZK2,;>G0*O,_)HB<TZFZ
M4]M/Q,7[* " 8'\<@FE7=:&I&JD/&^KJP\A8F*4W&=\097&$=[D?/U%BQ33G
M(K6E/GOA :GD10F%5#';Y\H<2< JR &8NAPN!.5Q/!)W(N\32WSIX1V>C++O
MO. (- S0U#2_LU9#R@^TK2RYY+;=)\,#-I/UDU*H"B)[)=$ >]$IU$WA=L&F
M1L%O1(ED@AZDLB>Y)L":7;'35D3V:Z9\33[:KLJHI*5W1*S\XZB/_^1U7_]]
MH;F.:T)N1*]48]7":G#2A>T"@_T<!1>!P0:_H'>[32QC;ST'V\52W1.X:E(Y
MY>M[,Q<AN99E\[(AAE<S'UJH!IU]\%6LYYE_F'SL7H+CPD1RL1GBQ'NQP2_X
MX7-Q'J(LC,05SLI,8 .AAFKB;9?VT(9Y@S-)]6>-6?D40RPWAHW>G$'&7!!6
MZ( 6)@=Q.F*)XYA)^U06@\>K>9>UOM=06*9Y=5MO\?KCN?R]);Y@#1?_JRGN
M<%6:)G_M[.R:7%O&PBPR$H16-:]*2'X(?X6T3KR_-33&ZW!LV512]+5+?WAX
MELMO>./PP:"\T8?)=Q6MLS<#U<\+#M<&DC(&F$Q)/;.VYG.,E'YW!^XI<T5X
M.V6D>T[UY8K834EWF]&%GVVTG5TOT<1,=QUENE1]O?ZY_8<? R="IE> <Y+U
MB!WN'GOTJ0/+_VH?SFCR^<YK8H3?[L>$FEXN_P4\H'HECTI(6W7P8MC<Q/RN
M8K/D\GWD:_><IM)07#B676>LJF1_EF=;/ON^MWA&1.TM<BC?%[2O+K#JIW0L
M$4@5W_P<2R1X(O41?;S#.(P+0-X/SS<K_-FN63QS[8??PI7QDU><.N.90!$F
MKFW/GDUAJ@S%D',F^CKJ4X<<Z(+X47"(_\^=V!R.=^:8NIR?%+/&]6EZ1M>'
MX\6XSFF0YC__-("IS@*LBE</&Y3>WS%=9^KAT1%#OE26Y<Y9H*3#':$1B/%-
MKXW'WGZ^E+3.PDTSP'W)[@JDF6]T,\.JR=)X1I)"0U#_JV]OW/1ZMY\<G= 9
M,\T3E:4;R)CL?^U.3HO]=8VWY?J[8UU2ZLH F4Y1KJDI>TS=6-F%CEAX,I/'
MKLS' )J\#8OM3XRJQ03*WP$WDA>K2ARC9U+6A^82O^Z5A?.F9B0E;@;@@6LY
M0)G)/WP>WG\Q/X]-P>0B-*"PWZV6;HOJ?(*CY.P*:55Q'@T]S@]5@;LK)3]/
MA0MY9QR(NONE)]:"H!?<ILRB*+\O5_'B-"CW-\G\U,*I..M5OW K\(XM)WS)
M.%@ <Q^.J@M%1'=ZY;VJCR/HYB Z1V["*%_6P7%Z7XZ/+^93>X=F3P5FX>5X
M8$V9%0_0!9HHF ?9(RMH(AO@@Y2[]ZFOI[(0P'ZS\N5B>@]<J5:3<+[MA_YF
M?#))N?)PM&>?#$KSQ.L3%PM&*0ZI-O^"0M/K2:E9O\<B5_L7L,K!@-=K@A_0
MZ6[I.<K(Z?[J@-*X[&E>HRN F4WJX)W$N>8TWS8EP6JL3\+A*32367UW*2+Q
M@33!PA$'QDTP(R&0PA$MP"WJ=5AK>$SW@QDZY9YDQ*NHJ&:.R8AP5N#]P$[Q
ME.NE'V7*CP7"365.>4J"3L#OLM[6H3%GC].AFQ)Z'2M.N0021\:HHW-1O(I?
MFJNG+@,+FVW,_BILU#I.CYS)U)Z%=':F^(([J,FQ..5V)G_L$Z.$\5)>RDA0
M,6]=A=2$$L4:<VI5@_/^%-0E\&N. \U'#4A)'O6*,98Z-<^T:BI[7\S*EU@X
M(WA>\  2 :TBW$,5=5R3OS>R-NPL0H:29=C?GYFYX#MD''L:2/LU\87CEH,?
MFE.?A?C>!5_M;H7ZR+XY1.6+EK#T;^Z((+E;0<8'_!O*=+@X3;:=J(JJ-B15
MAYH!7,WEDTZ-<@4/SAGEA0DN@>5MH+3NI2C?U3RR2J+D;!^)G N*LD[>9NS'
M%7UOD(ECT/1E;X>65HM8R3Z3)[PC=G)!K$MZ,F?25-R@]<;D5WQ,>-B;D_V*
MF[BW6-+!C4=!H+MUIAE9$?4YO*\ISCLA'3JLO/'N\R%GE-K'7->>Y40.Y0[!
M]LN_M4.HJD2I'M7:?;6PJ)C-1(-L3S_)@BUTF@ P%4)2-!(A4N+3Z.J2._A6
MYPF:O"6$56EQTOH?N6;T?V+H&GT;6GU.>*3U!NG".\5^^EGN,8Z6REY/F>LZ
M9J_3$A/IX-O,CB60_G+<$665S( @2H&\"A'S]UWUM.@[/(5\I6BI;CU\+G%C
MC[0-,C<H#_[QY4QO(0'<Z4[D1Q>[ID+FR424* LZ;?]UP?)G*6^!U=[>>0M_
M:F[CH5[COQ1!DA<\N"IHP\E8NP68RAN<Q;H8SZ%U0XSPL@25T(0@4]?GV$>N
M87:B-O?K-%RO*?F"NU;273M2]]>>*(@O!#&WQ37_8$I9+3&L?[/4HQCU3"E\
M(W--@.@UMC;1&<%*5?O6X<B(6;[F?CDM4-?+G^7-V10DN/,JT, 1M<6^=8B]
M+0)?ZJ/@>.U$U+HMM[!@(,J&8YKLTE6V6-MR*=OE?2V"K4)SE]_W]X]M1(J2
M3T'5-:29OBKT[[)>3_M.\BODC@\+42S0CBM!]E;/4\1LZ3;]C'MKP.AA?J6=
M8&?X@E$'V0)WDN+DFE0?Y]<*4OU-K+G,<:L'1'QUAB ,PG7F+^66PX-[_-XQ
M0]]">7?M2()^T*I5G;_^\?RJ&N CDYF=F.W@4B&"#*,JK&T,N=(%/3@3ZO".
M^]U\$WHX,:83T97MNNOWBB/Z6T9RD^2O()#)7 V.T^EK2<-D8;I"_&?#5C+.
MXUOS/YJ853#+&<A2\->U]+;K3JP<68A7OM;SQY08$D T^K;WQ)E<0"$IG1_F
M]=U$QH8*KI!0"W7,=,?:PKD^'E"9[$B/X0N)3-UNYV:1CRJ@0IQ2=_/."+W%
MZH1ZN3()I&S+1&*-',S:W+[[$'M9'9Q=)LP#1'6 GE>&6'4EZU40B?C!FL5C
MK"2**GLBZX0ZRJU65(["4T%=@/DT%A:=(Z'.@FXAP+&\VU50;56DRH7D7(9/
M<]O(8'8["[9LEQ$;1)-EHU07]=#1$S<E1*X_H,0.?6E)!377W_*9FX5D2^24
M=#'" (F@WO*N?^S* CNLXPG)=H9XVXQZE<R1L4<1AIMM-#]$00NY$MN"I!S?
M"91!$3I;[<50M_/<A(+X8&3 L_V=X>6FC*U#F TSS#%\L\-&>YGJ%:PIRP>2
M9H4K:&6#Q*)(=WD91\/HEV^!.-QHCJ(JS\3_[!IPOWUEY318AQ_BNUG@H]2(
M!PH!VS,UK!W6^Z H$J'$M@Z1E>QED4U_^(SD4C+;I,#:^7\B9/+O(N=I?J^Y
M)<VI!FY#$H9NS<?PKXT60ZV_GXA&, >]%KX^HE_F*=Z7%$#]/0@T*36J"[J)
M=N68ADJPNTK\W"X7\75*,.,F<$_1D5V7]S\QF+^"^S39.24SO86R,P?WI3/)
M"?P"A<]XMG[_9"&%$:Z(SPMI&IN:-5U4%S!'VW>IF,7O'S#ZMEDP5F$2DYR$
M;?S>+DIH"8505 )>FV(@!H(F-09=$F'K"^4,/'"PQ7\1YM@;#(+UW#7& ^5Z
M>$"ZXGE]J$O9RUH/U0?Q\4;%Q-:Q*X%""^:2;5?-^HJ&?(7,!$O/W_\,(9+M
M8O ?!CW\P?K@"XE&*[&;&O11JI]HVQ#8W,3RWDZ1&57SL\>I7![ES76KZI--
M 4TVT*AV$\N83;7R(M*#NPUR#%O0H6+(6"%@_FU\TYM=S]O6EQ+C3-7$04LJ
M.52$-@-WP+E^V4\I3L"+!C/8(GZPY%K]:'OEH<G9(TN$W1HT'_J^\3(MH;SI
MEMXB\D4-M?)6SXL+@V&H)](BXKV9\/BRMNK:%1O[[U=>^9++GVOF$>,>(W_O
M0RBJCI+?;+M^V'OH)-838J7"U:1S=L7(]_^'./Z_BU&2?8-T";B;?QRLC3#E
M=1<_U0Q]!147 _F(CZ.:@O\YJNTO?_G+7_[RE[_\Y2]_^<M?_O*7O_SE+W_Y
MRU_^\I>__.4O?_G+7_[RE[_\Y2]_^?_*?[QA#L/ZX&3+-\B7"M)O\$TT%__@
MIC,>"-D[UB5UC0TTP@-7MG.+YE3L,D8LS/C(^V35V$.OA0*+[J9EWBZUC@Z3
M=!09^AMD[DVOO;F]NYN@2A]&V5G4(T@+SB,.<?$0%[VEN/CL9CU^V4'-(:XZ
MV2'+A;3AZ4[B]8+'>.!5DR_3G43/HT>!32TBLT5$B@WNRIQ%L0IZ+Y#"$O*G
MN'*^6,U7W,J?3-TI Y*[?SBF_+M[M\#_S29GJTR079H:/%"N=18!>)@8=>I0
MK&>0$=1GCJISBTX53)'MSY 187D:31;/ I!EDD:8FH);$YC" 02-@A&!\HL7
M)/5*42P0LP/"3V>"X^52HD1M+B_LN>8,0Y\V;+%P!P-H3![U5&S1)X<:-N&X
MN749O6G3(I*9 Z40;_Y?GF;W6E@1XAS33)SW#?! 3@SYUKDQ>#1$D3JV%7,4
M[Z5S]?W%8"/IB]-A#6F-EBA8<4_9N[<3$Q..4<0?- 9;_9-(H7ED=N7"2@)0
MMU6M3S^.: M^C*@3Y4G4ZY)QW^3E2-1DU+E@P@-1>.#;Q?2AXN,?>PJ?_6YF
M_QHRQRGX<Z$G0H0&L.8KXRY6(X%2 9],IBNIW*]R*2O4,+(G+J1 R'>JID=*
M[ U]VZ3CS;ZG$KN4UJNTGKQ$0)"3<*_<*VN^Z9.'DRE:"FW*$ZNOK.U8Y*QV
M+%9>>&5,2!^YD](-T?]X'\4MUC/4<IM D;$?&HX"12%DY&H0C1*SE"YAL[Y?
MSP-HWLLMNAM/P%@0HMZRB6K-U<2AR]I7IB [Z?S[>33*^>^K&FM;JA/71Z$K
M82JO4Z0I/RM5PU$T3,90EZ.'U8C(I7F]I&ZZB"<1W,7'7^\KX=9R]@F:U-RF
M,CKAE&N3RP,FZ]B?-9)37:P$)RF2N)?5!Y:L]B=*WPK7?*6/7J+U!2H9U-J8
MGA7X&-/U;E(!7D^,Z$H##3%=:5Z'*,>X[D<LET>J#&EWA, H8X<QD_ J489^
MY\W"%*$\">XZW?+V:>+PC=8\ZIS8E4!-=-#5MO[D=6;*29HP[@A?)46-51#G
MP,O57(9 J;+9LD]]BA\&IZU-J\@Y#H$P]64UP.>UWA-O<^M'PYM3._J-B5,$
M9X_\E+Y3:QXR$/C'[M7BAI!IJ7:UXUFP(*N'P16YH[7."D'(TW.V/?UO#?;I
M@[RWADFF!?16R^(/5V2/_GR)@6&I1E<ZNYJ3LOP'23J-#OV 575L5HC&.HW_
M8 VV/,V]W"'3E"PO5?ON]8XQ$N.P, +N[:'@!5V0NIH;<PM+H*B]V_.XK4D'
MR-('VI 6W.G-<Z%\S$[<OBM#5_?#AEE!RE[BN)I[7'7;BEWJMPD:U1@3*J 5
M:I@IHD^6?(_ZZGF ;U\.]89J=+CV";ZI^?VZ/(%4@;NN)207QQ%B$.S91=K$
M:K# "$*=73HCB&.S0)2+O 'NK3!,VL1@)(ZBB>;BPLPL3^UN]GF)-U!XS_4=
M;"J]6DGN!+SVC7)_GSW'-(VCY)A.QNE!;V_SVN&!9N/<T<92T]* :>-MYY>:
M><F^?-&_*143 .W_L6'J75]?5RO'ZS]GL*W$UJ)\\8Q/@AQ?->"ZD0%^#^[5
M'FF=XZP &'JSZ-+-5/+KX30X/- ^Q_=N\]#WI5!^L+$(LW7M:1-\F -KSMB_
MX>@HU1ZFSV?[K$F#2$$7)([" YRF4$-'QWM?,T]UZ]@+:N%+Q_ZVLI<V)\ #
M[%Q7L6KST0F+O@V<$ZE2-?W=[KEOI#>M!8MP0?*3KS>X%$>]P=$G.M'6-0@F
M'[?H1?5[>V0D@\JS<!3GJ=%GZ.,N$]\X=$.0$GMQ1*4N'K S,-L>%(]4>DTP
MHJ=F TWM,,QA'GU4&,"QJ\KYV(F<PN9< UP&.([H/C6_?I#0-*/RRK/C:[%5
M#Z6$Y,Z CC()8SARZ'+$Y&CM?XU<EGS!G:@C]\0F:[\5,JN41GQQ9V1+03TH
M?Y8U+_T'^([]H@$=R519ZZ#F<4C7G6&0EAE_I-*-*5Q&QU=[NK5OW\666=_N
M&HL>98!%N59&/]N#KWHI>IK':7Z)O-!\P<?WD99VP2:W*4DIO]S.?RZB&%IJ
M5/EE["%;0B7/^L+WN&5DY5%HG^>&,J<B8W@0JH\*TNECP9G.GHY Q&NRYY?$
M4WY97(%\#_ W5"K#FK:=&+0K\^<<WG.N.-1H)X'LB ,7Q,,@9S6/'"Y<#!(/
MT)O%F3Y=#%MK7I2Y69T;CPU3.7G9T  (?+I37EEDY^/L6V+>[0Q<\"OD/@/Q
MG9*C+-&02$/M_'E]]_.#"/&39M@#8/^!T)LJ[%'4SK[CP(/!M8^FLO'?E)F=
MWJOGUTA.9Z'GJKVH7*8[3(2;2^U2/ES=GOH&L#@_+^*FOQ,^%W*[N%QD$@6/
M$KEM[ZW)A9KB>]=KO*RRK/$+M&3 SPLJ,XQ#341)YTKM&CNTV$;>2[R_^WA)
M. L&KLRC/HQ-)$/7U\:BF&D8BCE9?/4EJ#0O#36$"^AB@\54N);MK[K$/JWI
MJO.R%+R;0CK*LB([I-+IQ0#H/6VXJ'5&SC*A#1HU+:Y(;QLKW_(5TPO1X-38
M>6H4K(0YCTRP+;$PORWD1YO.0K[]NN3 8%!^+RM@&*2CYC<5:(OITZR:7M>
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M"6P(E)-V7P:'B!T1IIM42WG6"4>T"04;U9F-=2]C48R9K/3&62_,6<2L-M4
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MP:_UN5M?1@[.Y>_712Z52Q$2:[.5J/5V]VN"=DE#9(KSBS?8/K/=2/8L,?L
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M/= B\.B,3&TJ/G#XC!RH5/)8_D_%Q4K70DXLXF51=75IC>!Q?]F@@>C.1_Z
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M/S'M4] ^NV;?)R,>9^\2&;DDOCA'5^>5B8U3U;C9.[LOO;/WH/9Q.$.0[K,
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M9F*5E%#@X5IT&=&4-H'OER?G)ANN>S^,0T4X8JR2+'N<5I -/U&(IDJ.='F
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MFB1;"K08.C&9\@R;6-4=I!3ILP"O%&?0?8@6Z!'6A^ HKA'\@R$D]SOR[_M
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MV[#AM)(U3*BG-4#JU0.>:$]^_P\(_GDNK,?B+?L;L3C$_V'O/:.:ZM9]\6"
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ME[/[PG=(_:6A(Y=D[>Y0Q(77,J:\,5(JB<:VU\&'V?L".OLQJ.@-*R<=>R8
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MS7=Z9]6TS5.'CHX-JW9'P4X25P R$'MF6.SB3QHOVYB+VKF#O=5,1EM"=M,
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M(M:5I(>"H>;-5&&/HS.RF3W%.9A"O"PH<8(1N[9>FPJ]87:)Q+,_= 7:_)#
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MJ+X\W>=JZIY4HUBJ[6A\"T(,BJPZJZ^65]6CNI@X.5;\R7#.W+L@/(]=XBM
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M.^%PC#(\HKNFD@[_"6](.I#EV5H0&-?UYV'AM87/A![N$:EI10HO=8\[6-2
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MEJ"D;:,L>8#'S^"FV[[PK$A\ELHE%8N;+=+SHP(QLSU?X.5Q34J[\\VAU^T
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M\:%DNM9H%%3,>)IFH>>* PGQ/ _W4>#K'DJW)_9PFK:O"G]9)^+,.PKH!]+
M/6&@1']@>:%1N# ?D:!ULKW;F5L'<YT6MM28O_3#.40.,8D6@@H*;WEN;-@A
M\C-@P)J;K7=<'.[<P> /BC580JA'WP+@CT2H'IR%#NG5T*3=P<6QQ/'WI.;
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MH#]$N"M>%I',W"G%<.A-NO+$ =_7UK3>6>5Z?](1Q/=XP #U>T'Q[)'2,3F
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M$[/'J*+>^=5X((CA-76,3G;^##@,.4TPG;/RMRXIF)"*/3J%6&OWMC!G+Z\
MRO*Q&G.GM:$"8L_2R4BL;7 M9IW5@O3QZ==@CD8E\2=_6]1D.\QC<=Q!HRU6
M.T;LC%%F%\DKU8[T-/'O6[@#:/CN[/P_D3,;6 (O<*GA/G4Z-85J[5X3DU+R
MZUZQ'AQ=MU^DWG\!:?2?-X9Y0"*PI-P[$#ZMV'E-N8_\(P)O!H0J;&Y\\J+T
M4@G=6E2N#ST/JC=5?,@]=0<(Z*:5)O#]EQ ?MUNQ6:@[$']/(O[;U\/GNH^;
M-3W3/$S60B7GU#JC$7:5WYN91+18!IE'02^Y/\4A69FRZV( R%*H0Z_$YGG)
M35')WLBCF?J1?H'VIY\3'Z>"<S)Z$%@7B7^7\]/"0WZ^=PUGCM9<>N=X@&B*
M$(MM[/[9]C5<"C=1'N!1_T]0 ") ]D%D&(4+[89/QE&-A!=QH2JE@Y(H-4/4
M?!1/N\KW-Z7&J*&-3,&Y%P0K.I>W;S7Q.R@G,0C=EM]2]*5[5*Y1T(^ZQTNE
MCN1['80L'4[&E64@\HGU+4+<9AKBA8U;=QRV_T2F^B_6VBIB]W,?+XU[2?TF
M,3)X:LA0^_TIL]</AO/3/%)H#%<&BKW*#^KMLJ=?1ZLZ+_!56;8Y3N2)!<Y.
M@$8'P'U&7QJ1_3& J <6D>_ E^Y&5]Z_0$#\DSI_6-K-^ =W['T'KJ-$3M*5
M$H9,0'),Z+%X<4USS(HYNU=\FCA_=IPB 4HX99U14'_*_4G#W!E9DQG!1ZL3
M6E1'Q!8@=V@N6-3VOY6Q.2#P#F#6@4961YZ"S*]E^'[09VQ0E8F0PO'?N"-7
M.P!>3_1QRY:]ZWH:(_5G/+X%V*A%R%,_IM<-U:Q\O>F)3E1:F[N(.;TQ-D9A
M8F5GY%.GE9*Y!_Z(<IA8R;$T.2W\(SPH8DK\0UWHBTV!T:3R]DC,5U(-N+W]
MO\F-N?$]N0;VP5+7/A83&;+>9V (9[5<%=;OQ?="!2:QS1QK"#76C!XK;6;$
MDBREC.S+TK__=P>A]',Q3B0: W3ADU%D47QKH3SRR2L3 O=Y'C(\VL\B[XL[
M%Y>:S_O[L+IF#M:4#J$)9']7<1PCK6/LH#//&S<!R(UC<1H$H]^\_O]&+(U@
M[@#]\TQ44]S5/+IFRGSD(E%Q1ZK\%L!GDU"NO*DS25,;U:89Q\(3GFW3X=5\
M@B6&L$/.>YN4X]Z3.IW3CJ?UTU"\]HO,+*IOH_B7)ED0N5-HVK]@(]"LV0%(
MNN?%N4E'K_R)6##Q-47.RY*PSE_^C(7*'F"V_F-8834WQ/";R_*(5$YS'DGK
M/S^6A29-@-I+S,6[%=NO?JIO^!8P(_G5IR(1''+1?-\B::[">^H0+CE)8KAH
MHH9KLE=S&?'B(76\''<)S; X@Y\F@:&\!:9-=4X81+QHZQM<TWZBBYTZR-":
M<=)40EY:=C@:*7*+N,A+%1MJ"^LGW@$H<$:P:@"U_^A\E]_>.R98)34J!D9!
MR\5+#+W9!J ?_YR95UICJBWS+TE8]LOP@(":"0I3W!-%53^+PEL;9\+!%X5.
M?8M=I</C;W^W>[D;J>12_EFH$7]L9+?_DLRQ\Z].>:]/"7)#9--K-<5JA<X;
M_4A[&P_E44SG-A1;&IMFG!"[H+2!XU>7VM'Q9$P=DG0L+Y_J5? .!+2%,<7Q
MP_ZB&E=\ ,$@^IFWO\.38]*D\:+!J%7M%A94E0:APQ0F\C6UOB:W:.+/\PO"
M#!BKSL322=S'8-'22F;:O>TWJ+1\W[BWM^;II*1D7U=?(I8H<GNKO)T&3]11
MR'AHOAO/.%PQHRCM]8%)5E)S2A9%R $GKG;,ALQS[W)S8EO 'V;,UV7RQ ]O
M'!\*'(42/B4._-C*2*^=8/#;L8$&8_Q53]677)PY9#B/:$:?#TU@U/&KG4UX
M+OL9!+T)X2R$5=6GT:Z',.(PQ^N!< =+1141WIO@866ATE3CA417X$/ @2W4
MJ^?J;*7A@Q=3P1.PO0BUAIWK\XE!JUNV2<N;EUTA'K$W;AHSU<XV)_K7KPV0
MW?*:2<06Q*2^.<I (\!>:64U^1Y9(<92IRNZ<1ROKAX4[(*1]);!E"?NB3:N
MDD64>3WSVY@F^1E?\_[H^(*)@#'H(6"'LUKFEZ._7=6.GM$W[^F#K2U^CM2;
M="+D9!<MMD+QS>Q9!9!*8[W#T]9IN>IVWL'G2:#9Z7)]Q5^R+$$=)<DRAO^S
M@_KD$?ENZ&="!B[NXPG.VVL@OT3<1_0+_LUGP'>'MO\^RZY%C6H/?@0GB]:"
M;OL9*R&_0\@W!FD3ZQY)X X!C?;^TEQSUQ/OGE,^6HR?*KE"X[SJJCT!;1]C
ME*LOX(\,!CKUMT=2T7> F/3>3H9DVRRBZ[@!^U>D]&UN0Z/BVYT$OGNE__*#
M&Z<5%175T3)/HY94YQH]Y]!1JI^_M\7_(<K"#9E_@C.G9;(YEP0=0\1*JS,:
M6\<SL+'7K2AL];DUT6NP^4BA31G_"RP9PL[+6YG"_,KJK>5 CUW"6@Z 4IKX
M\93=0"S'R%^;-5!N:-(2B20I8LL=U:>%004.%I#[0\(=E7T5WI$] ^XM5E,>
M1)\5F.PX?V>%CKX[EHR+ >S8EF>:4(O U JIZVZ^[XEI6:=?'P)&=B1G6_]?
MB@1&I7N)=%(_L/.0KK\0U>RN[1XPL1IT493&V?V?B_/Q_@M[L<WVKSY9JU5I
MF8.1L)4D4[IMUF6(Q/<5@R=EON#,_C;)#3\\=/;7@I>D[?E8Q.R)/8M>^))@
M[[^H*)?L,Y0W[O%79IOYE&C JRD<C%"UZ!?3(&[GG#FQ^,\Z-G8]&VNW/OMZ
MTUIHY@B/&X$QHYFGLX["+^(>N#3":3^FT-+J7KIH,$<$1!& Y<$Y(N@4C(;>
M;VH<I).11L-3TY^/0)>1_G$I1V&F_A0#'LZ4_>3<B:,AOV<V!)(2%==ER;5,
MYKK*5HV]*_J,0-G=,9)_K 7+9+T*;>EI61)Z6_\J""B].?K7M#^H:)<*XZ#U
MLCB?%W_A9W#43!,J,= 2B9EW^_]HEL?WKA3:O. =+V^'=*]E,IP(6QM7^GYN
M2P/Z;$(F^!>K_JO7D'?5]VK2]M>9/CW-\6B,5?7+>*[_C"&=DPBG9U#R%X'Q
M/_&3<F17WTL_B-Q?CDB#O[ZVL2G^@P!C2+;7(5&6S>H_'KC_](W_\E)+%%08
MC:^)>BHB&+8?TXWR3*G:N5)MO#HLN<EWG:XKS+&4F7EJ814L[38D]Q<0Z3BA
M*G 2Y"PTI>2-C11JS*>L!]1)\'*!-5E ?)LFC[3Q/S9=11RN&1E.NK[_$2.2
M&+***SSI+YVYM]T- XTC_UHS"@*O9!ON(=Z%C?-!/(#[J99);E]%;,41X5"
MEP?/V+*)VO-ZR$_=-ZFX6SLR9E_^]0)<?75G9^?[<Q^]=6)W,)9T\.YG?ZUE
M.G@0/H'3O1_SUU)!U;?@>^8QGGK*'B^-WQ1U_$PDL("J?L-AR9>Z.(76_JM+
MI!]DDKCMF3]=EEC=TDUEG3$!O-6L@>$ >UW=%O/.\DBW_ML"+ZX45,?R^%&,
MU/OC90WNQZ:*]_DER9.0&M]L=P0TQ$YI\TAK_]/[M[!!I6I%&/KW;4UI2L4&
ML]I*BPXO;'2'I5OG-N.TWY0LR@L*CB:];.,?8<5)UG"3I?I?ODCE74=K*R:]
M>K'^Y)LQEX/WW//M,6*$I^P.V;XIZ*].H4<3#-1BM%??)>.;3'IWVB<^L-5/
MQX5(A.3\@?8P?I)WMQCNIK02O^\; _"@3( '/3+&V,BVS&SW/:'_F'#KJQ2X
M=P?(^5/6+NTA?!%17]&6OBIU[C+&LD;R<_B!& .I&L#N?_G=+Z+SHD!*)Y#4
M[D 1]$MA7_NEM4(B(V8WNX1AMH*1V21L</ZJ:+!J:U?P-3F1]$]/T;&)U58)
M)@6W3,#.SC^OQFM00J&I<K<19>M;-EVLW#>\_D>4G8S6+(@THI5R6*LY=&$C
M)"03\)\M?34P9KM_A>4?2QO=CQYE\TZJIXD5Q/V1EX&_/]Q8@^A+WUXT 'SQ
M*+OMTW.X4"Z-,\(DUB0VZG9S7)\=Y$/?DG1S-3U=NYH/^@^ 0E,=;TWV3,=*
M1H,.;3)I+-.H.4=5P_*9NB$%50 /=^V7X9H%8K@,6;D3:?_%<Z:@SP9FC)S2
MG6T\>.J;,HLZFC+H:QGXQ6G-P /_P*U_TTBVL+^-M/6/1CJICV4_#RB7!5BU
M(+,LXWX1O/D/Y0,.?-36CJ9J*\>$'$+QO[**-(K WVP*5!OR9Y%K^'L)P_ZA
MCLQHT.OS6+<RNSQXW^CR1\^$7$M*:X*RY:QKO+,)/]C?\O(9H,-VN\B% HC&
MXXQ,7K_MMI2Q3&8908Y"Q*YO_B=]?4$/Q41&<B.?AG1W=62S1+EX0M=;HEAH
MAIAUD$:!+V>*IJ1>E*TN)M?U.0V* !BA"D_64"Y*P'" HY8);WHA9EIKRO'H
MV^"*CDEW"LT=H#8?%/Z%P48*(6U_%-&0;>$=<0?H:T7T@#U Y$OR'@\=R15<
MQ,WZZ0#[ME!)Y?;6!'A@1W''S+%11Z7^8WG6\#F6;DDY(*\R!^Z5ON6_Q4KB
M--9,CAAY8DB1H8:+;\Q:)6LKQL/K)MLOPY^/.W>G*1M)&RW)>@>PX3CRNUYS
M9^*:/_07=[;Q;_SN0";%=A!,_FO0>PEP4?F7T^M>S_AS@$MV+_ZJD\S02ZKS
MN7ZES1$:-D4N2/OM$YSY/9AT1%M)1T010:[CAB#[N4FBJ[@VB0LS23MS_M).
M8R8V#0=Z.\V:=DQKOJGK2AV_(#8$-G7_/5GH+Y,L&2T(MBFB3#I6-WR^L5VM
MI8D1Z!O%^!49'>*.UY(D34CUM-T!K/.(U63FCN ,Z73Q9V>S79']\91%V75?
M?ZZK$PWWE0ZOX<YX]OQL30]Q/"6B]3 G$H(%G'VG3>,7;-=!WO_B\=$7(I@4
M$]8C<5,2*72$49"2 S/E!E@<ELX3C"D7<"M960ZY LFJ^.([G]K]VM&?,Q+N
M-5]1(6*1;EEE>*A ) B18!+_"XY5A38:&&HP\)XADL/+6?N@FTER+6&T$+4=
M#&H((MU-9V+UBRTXM^T7^:@ X=1Q'NM^FB8^PGHF-O3$^SM[$^9-\6YT>/*6
MI*1)"%;13AJX++R3]'V ;C#L81XG4[ F =EZE!7J L*'%<2;N:"S64@[ILR(
M_4KO.95W1:X\!,QQ$TFT=(YFXIIA<V&I#UUA7'H<^FWQ>$#R+?X^/"@:*L;E
MX QR+!&_'FN__5Z.T1ZV;[P5_"JSVK1'336Z<$MIFG<'0 P&\U>>,8H.%H/>
M] >RA4ZJ>WYJF-*[M'B&P^)>(,Z*$+N-?#)NZB^Y;D!AB/)LLWERWD_K?C9S
MO\P]8],SC4,J9>ADJ]);&?L,5%2<!.<B89HVK%FF[.YLBO=:CR)FC*!G83R9
M;Q*N<0:C;B^,(M_]F')O6XP6;*FJ)%=" "C27)I[!L7& 9*#G]@:H^'75BS7
M(I_29!5_@C9[FQ'-]WTOH&']1C=-D:</SI257,KO<Y*J0@/W$DRN/4>0>D?U
M^WXW[ BU)$K05GC^RP*<]W$NTA7C_B0.I=X0A+JIFOY? VO1]^A^:LZZ0;B%
MWV?-+HBT-^"@G3Y_LM!.VV2/9,L>]CEBZ^P.L"C]Q!>/@.9LTGYNMH'3/>#Y
MD5;S_0$0A5*WAR-IV-)I14,T_.8ER*W7-RT;E"!CV^7Y8-#@4;?-4IPF 4D)
M-!8>*S_C;PF/%3=#D&8Z^L8,D+0RO4XE?N!L<K)8.DZQ;-M)-EO)U\X/-1ZW
ME-IU]BH:\N7 ,T[@Q_DHQ[R-*QS4-[^"TS'UE/K<B#$;JU5N^L8/](2W%N<D
M8$UP>$*Q6DQ*+RV)+Z0AX,-!?16S1G/RDQ,Z.(^T?^'3.))KWY,<H 0@#)Z3
M5&R">7?TOJWQA+<20>3,?DY/U H)7CL[Y++I,R/]C16)E8Y/C#A4TA,O/&%L
M<N<([2=5M)_ )$8@%*<.WN!=6U> G"? (QQ-4VTO :'GAUQ$]+$C(X\6^Z=:
M&#U+1V[P7*[40SP0#L)S4FI>KHZ'G7ZF K1TG,E\ZWQQ5!_)3$ZE?;KWI>1+
ME"LP;EK3ZQ:U2\;MMAJJ20-N.>1H2 93M'.Q [7+;FOV9P=G*6K(<W%-P--&
MG.$>>+" O^$Z)Y9K?1&IT2>H9EM!I BVG:I/4J;'5LI^=.F3#)FT;X#3=-4%
M/F2KMR 0T?N--TR?D8$;).  A%/'@X2EF=0HWJ8@@^Q2GS>WQEES]CBWTN=_
ME-U-BIN[Z!>;\F,D4J71;9NM@C\EO4><@AQBT"0PMG%L]!0Y+W7],5@3%O<)
M)V%79XYD-;9^C(\2AO%T%C-;*CZU"!NCG< 1GU"7?KG5!OV#\=.@3L^QY'J7
M6 CFW?:R#'[B):TNC9-'\M(QJ?"WE/;W=J<B0YI/KZ3E& =>_K B%@P5'.[!
MED-+RHQLKQROPD^_<]E2N[5@@R]8$PGF@E_N9::EKZOA'5H]@L%DFR&<,YP<
MM9R,DTUS-5(4):N3/!?19U$_]:_R3=.V;PU>MS^_T=#!N(M#G55GA;JH]FN\
M(_LE&K,=;.R'KB75T@Y?=6_?? K.(6.4COPP662PIT>7!6(+1S; 7L#&[U<\
M)?B5:(N;A+$CR_U0X:!-/KUG]!EJ6),8HZ2%L>J22($;AWVWFQM+RT3H-$%8
M&0TV<G<-;Q_.G=X!2(SM99CFCI[5MM6V)O5DAW+7U Q_XH#Z(JJ?%T9H(;KH
M_JPNLL;GV_;7N_WH73*AF'45)PJ9=!X,EK[7/!FYZ!2T_GQF\.BTPPST^0X
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M/7.QPS5=BAN&J6-A?FC\1R'G4U/Z[]<UA[A>.C.G&SBYOC',#-ZYFC.']=^
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M'.5_8)Q^T:!L2_,C!O>KG-3H=6<Z;[_;QVU<?O$**X/PB>5G.2N[_>IQ878
M!IO#G)QE"4T<-,WE56!\":G:>87S8X:;I62-'2[1(2I1B2,(5K+(:$FXCI6:
M?$3*P@DB@F.0X-8$..<0%K!_[(T8HG-O_> C%/^DO7;IX&7M3]F'Y1H<C$%
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MU+6-F+1"1 (FO[WN83<%_L 3DQ^ 70&02P<%U"%Q+NEL28C?TW%E=)QF6^0
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M6N P':0<Z*' C-=,%]*"CP7BB;DU+QT8'IW6OHE_D2\ ,^FUABLC?@I)X1K
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M7(:>>WMD^2J)+3?$,1<=YJ,SS0C>+)J&B6S0BELU\D@?=\;U9THGR_ZB]Y^
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MDQE_DU>_\L-,.6,$]*%Q?P&+SUUHP?"][&G0L$*)S3+#<4"E^?I5B5C:?);
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M1')PU:K,KKM""GW!(/@&?L"U\>IPE.DY3!*AHF'E(+R*%?0D=9W3:YCRV0,
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M96+K(S:('YW(-J*J.!HX'38R9 *OC4<(:\^'/J>S'/WL&9GIL;+HZY+3WY*
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M:IZATPO<&_ZLUI8-B?7'XO*TI;:A/6:HM3%\76+;HI3&>A8]M^;7V2AO>H7
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M8 )*K[7*L:AYCI:C*#=U0D+!,-E +(48P&J'ANP)820ZI$DQ]@D>7I@6^);
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M;3M$#LC#AF+8,L1HLP660/.%8ZKR AWVBW.,]^[QHH/H#'2/04)!<Q)<1T?
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MI>A))U?H@>/V_:[ZJ3-YO*$&A@%A M:PQ25;9*U#47$P2,(P3&!)$LF%HK;
M:EV>=\!&"M(1X5=Q6R2QI:^"1)E9J:3'\5Q&IL3(KTO-CU(3@IO= :Z'VKTV
MBP]&I5?6^9V87[W*J8UX/132+T;5F7ECC8ZH.DB2H<DC/?LM'_R,/I:O\0XU
M3L GRA8-I;?#B["70UPV3P0N/4ZWHO'U>[^,=4E'73!2<EF+$H$"JG(4QIZ]
M=B1Z-4=QM7,I9D[5W^^Q5ZS?M,:.MFCVI0[1M3R1AMJ\G,;[\W8>KLF#M@UN
M16;Z70[O*J[6F6M:W,/^*GJ+7@C8N%L_UN6<.<B& IZ%5/>&%V&+?TB2V7IE
M>3MX"=A;G2D^3]9[_@V.:;\"\VQ4*.GW4NPP^_9[(Q2F0VGP++%T_:JG3=W9
M64/WB0R%QW7EMB-LASS--%OVB^9?AH\\OZ*DG)2I=,(N_D^N8[T\/LRJIX@!
MW:K^4[ O$ \*:?&<D+8_S\,6\L,)%_0VRT/FPHV>/"ZL>RA A4==WRQC":\N
M7C4_P*Q<,[F"Y$SJ\G&R.3-%629DQ94*.U6NG<"F"/.ME4,!]S\*?CZ]BAM+
M'3RA4((OG'MY1;S,7D'S:7_<]*MY$P1HM+6O\ON4,>"[4"'/E!$L5^9_;II2
MFEI:$YSQLH^NZ2G%VQ')H:XLLO>.W=D J?@"ATX*U?T&QPO1[T0_0R&+&S^5
M#@_WHN-W: R"@I:J)SPVSN0X5/\OS'35H;D:Z-AGS5K0AEM_^F1Y9TA3*(B<
MQ;%NG&\S?70E:U\+!4A4[D>^0@&(U*U O6LO[!#S=AL)F0]'=MAJ]1Q#BR+<
MX!'8TO:5T=15N[C?[YPJ4%34YTF.J6Z7<8@A6XG=9]4PE-L:S?U%F!G+Y;D8
MLLS3D:RNIG-G0'%Q1D1=)P5>_0$%I,X@%>%;CC."6Y5WNVPS!7^N770I,J4M
M#.9[,\PAE<&VDJLYP8W8R \MN'?L/OR;/!]Z#2"#B0T=]U5%SQ = CZ*&*(9
MM0\ZPH2G]P^'A0W-?<NI4 "!0.@V;(#A_EKBVM8OD?4JH9:Q!?W1E;3*>4$4
M$%QY$&W.N3&^V'\J42//_)V:#.6'N+]/%P/JO7)C,$)XM<I6Z\9HGD>L^7[N
M:)G3S\<!9;N]2BB , 698/R+"P7T]]AEXI==N_%11H3O^VP:VZO&XN!+RWU3
M]O[F>)1T%NJ$Q]'9?TP+4B;%S1D/NG5_CIYQ%7?Z.?)@V)_#]BU]V  *J/X(
MKF8O4A$%;#F^GZ\^U6'V[?$;_W4$EVEM%-4^\T!VW^?.K8#AYZ-YY@:K_K&*
M]>G* @[JSMV@;FB@8X*'H730O>!*7ZGW00%CS)UFY<BV/?%&?WW1Z%]5>$)#
M8E:LK)1.;"QA_=\07)4E._>VW'53D+W#4PGBXM_]?YCO;5:I$0;%5K.R<OL$
M@LYM/!1__1<)RG3G&OKS((R\F7<1[]Z"<V#--(W&/)[G4%3D7*15,(SDUXF'
M5V>!\VD]G,^7^;.@>&0=B<?$H7APWE7GV]'EB0K_ZL8>G_'A6,#O'(=AGZ')
M*IK'HNVX1A"]PMGKW=%]7A\36$+Z"']N9#\G8LUM_&C0$/P)[]MS!K8<-B&8
M2D^\(S/)5P[V9=<EX8IKQGZENL;#1D;,;B7:# TZ!%ES)!_F<V_G5]O$77U4
MW,#<6<"NY3\<Q&FE3PTZ"A:J^=KA+^.'%DI]!@;')&@3 S=D-K=W=1S!O1^\
MN9:SU53)Q^#.Y7_ <V#-T>U/%YETO5[6-8S;J(?_532YFKO(^[, ;^Z&HQ@^
M"A #]]/O"2AX!!1%!%N5>;\X4\2-]F?$)SHRO[.O.YRZ9QVI2;A!NJ-MO F*
M;N-#9$NQ=1,\UWA(WW9TLJ%]N8[OJ?]XJ)4LG B_4<F$ACT^->YWA-<0S^\)
M']@TPT!E![)U\@$*"'??MFTMKE=\JR!C^#(_K-];QGET)0,%S%\!17_T(/HQ
M[X"PU15S>C/'T-KB<T/VWAHT0>'-B@J+.O$5I"H[]K8V6@6T:>5;U%P8P)5"
M>:'='M*7^ZR7?0O'\2PS(B?L/2;%7[^IS]D7XPVS$#2K33F[:*\)+MAM=#0D
M>JYK9&/^[_SH<7[Q\.PU)@('G2"!W#',8_5 >U\:SQ7G-QYBHP#KN:O&< M7
M(]N?(8W#_CQTSJ2*(9HK@EOWWXK-; 6\G;J\%"/+M[.<<9!QQ3JHE;9O$@2&
MM@__C8&>3&4\6>309_>'L,9!LA"G[_U?L,XU;":">$=;F&S([32ZD@V?YP"7
M$P4<A-E%)05LV2:)Q;Z==I6CW9H0-4^Z:26K=T$SI"]-(NMS:]6H=4Y1";*]
M?^9&KLT:G[__A,C'PKPQTL77 C_%AZ>7&!^L%<ZPT3G3&/60#(S/O%ZTY]>.
M>1G?FCD<&7\G**XYF"PZ86ZH5P^)^>EJ$%UW0\1Y/DIFV$VXGGK:N;*K]DJR
MCS 1>?"[CY-'%*SMRLRDNQSN]@589>JQV?D<&N%_F]/0?O#@LB-MP(4.&*]R
M4N$R5D!=B!.9$0*$H&<J^B@@]LH^(G9";O^"V^C^+_BD)@J@,5A=OGQOZ&M2
M9NS.C<W*7VLHH"$-R5^Y\G(!OCX%>K8:^Q8S 8^F#9OU<)2=+<5>-PT:)#=J
MT$8P3C"+R>6DRO#$0<SKD,H="<0ID(LF8OS3.?L39J"D=-[F4AH-<=[I.+<0
M/12P\LH:MCZ#[LM2B+6,W-+6M%V?X8]?K:B?P#Y6)\74J>-M/QK]%L'O_IQW
MV5SMEH/%4$*:-ITT,9ER\M7C(*::C(.>BB]K5T;XM%( H] OBOKBH(4N]=!0
MK;YW2O8Q=!S66?2X]?NU\#4\%'#/8"3!FB1Z0A*GH5CK1[%A@EB]AB*??R$.
MRQ9G%.?PFPC7--=8L^?-:ZMETUC4+<*QICJP,:H>^$PK"KB0LM-II^1$DG !
MX9!3SENN3BS,HTW_3,/2'Q0W6D,B]8I"I5?N-JOB3H6;U%_J[9<4\HO(G?A2
M,Q7*13X.5J\K6;YH5^)9I_A!^B&CE%SECO)5D(4E\UAD$BF3JGTN(A\<_.D?
MC/50K7/>2N&)R,<O1$VL65TRE^J;-;R$Q.9=(QX;4IN *M!Y[G\QC439H;NC
MLN2D.N119![I7?A+MWY! X32BQU#T[.9!RHUL/Z>,X8>V<U]<DU3$T+7%Z*J
M;UBR:$HH\0 80^W4%[.\^;=H91Q[8DB?-^"NN8IV-M[^A+EG=\J:2[^-0:FV
MG2>X;[5X4^,G$C:9I,[=3Z L:$J/8/_(_G]#[8P[^$>7E)*?MJP5?O 8=';&
MZG+KZ=UG&@4=*Q00"-_C?'N+2U8I6/]])K>RN\V62+_-]L^U0=M%4P$2=?83
M(L<57[!2J^/4*"KLIU8GMPQ6B]P1G7BU#%^(0 %&"0-R):*S4[,I3>1?N+Y>
M"'.X?L>=YIZNU'_O6Q^'IS1.,F10"1(*&G:R@K& 7P0**,! 99U"[8_O.F(J
M+[ZYQ\#_@2Z2_AWJG%=%THA8/H%X^'^=C.%J^WS:"F:^2M?]ZMK9>6+O^08[
MF%3W3$'"V(%:OO'IV_.,[R6OFM<[BE[=?YF:3F_!?V/B^]F Y%F(QGV3U*;&
M=J8H&(]Q.3FY0;?*5?-JG)2@9?9M62ZN"_[\(_%[^Q+[55EU/KQ7+>MN79ZU
M[!]:RWYF=&5/JVB?.:)CVD*S((%GKT$X9:S+W;RC0OOSO9[XB&IZ\9*S\#)K
MKDI>#&2+,_NN#:-.^\"M%-R\Q('Y:_57AV3I/.12Q7],>E)6N+#\"F_NR/#L
MF#=(?<C-6)D7U3'-PT+.)*<Q1(:(0LSPBM_MR6\:Q7/YJ.00U&&M>R-\G73<
M8$I_WV.-:S:69.&QRW.)_*[QJO60&;7]4]?O_II9R6*;./NLR(V"IE8M0/A[
MM7R5G:EI0'O.KZ@I\?,NQ19ZLF76?#^XRPSU?5S6@<& >JY?-(M16_E=X;.S
M$95$FT*D9$.O1BFLBCCM<H>_??,H.N\91A]T[^!#NIYN>%^>8FKK03=;R YQ
M5%+7= '_H_:#PCFW+U8SR+U:^)X&S-=)KTG:(_# 6HTF.<_>Z57A19M/*=O,
M1F1P'$"+QB)%^Z7N[8(/.6/O]JSI;B>M7JA;OEA8PFCV47"5] .P.J>09ED4
MA?/%Y]X;=X5/JPWB%N9&S1GB%2^86;1E+.>0C%T;Q3?/]@H5L5TD4#/SC]V^
M3;;355PV3)#B'H^SIYTB/* [$%*1&[XU6\^VR;9ZL6@33X700F/V<:G"QU$<
MP>5G9)BG;C"^R8PMAY^R>O^9OY=F.'.L!-$AN#=JYLW$O9.*MYGE\=+D=K""
M$,MVTK>1/<+ORY"GF,]^<D#A_^0ZUK'#!!X'AR4[E,^6E/JG&*D$Q %!ZW)\
M[@,Z ''XCB*IR8XD"F"D10&[NZ#C+N/&ZCI:3?H+&$4!O;W(;USM7(VU<++W
M I[7*'1\KM0&4*9C.EZM.O]C\.O37]Q.(P0[+Q]G6BDDS>?<8 MEN&@186&"
MP7*UU> 4CY8H_WB6D%JPCL#^W1_N5T[K-3VV.2/]$:.$52V /V ,;K#1JE9O
MRU7#^O+'V[$PQ49:RGMB+WX@=OW*N<8-@_MW6L;:[AC(AIB*-7PYT(P:)% K
M:FCZ(+B2E[,C_==XB4?GS5"  PK@7/_Y#+:&48D"LK,/0G7BOB.35;95UK+<
M4,#7^X[BUYY4R(BS)\9H(<Z-*-#ZWE!7V,4P)*GT>J)F?SI8[()JRGOY.>K]
MR*=&":&F92+O@X>FRSIZ"E/&/![*OE"&IR@3WYAH'@MUF)=D=/RIR]^I;$C
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MANQJ0X5:EP\,2T][A+;G<IOHM3-AS(R?R6%O*0:5'I7RSF;JQY(LG'WY69_
M:8;Z)@SIHWQ/-<J=A'_KS'MA=<Z\XAOJS?4@%5 VHKF<'O +UPB.[H)6GI9#
M34,LJ5D'<T3)5=VTXYH4[=J"WJLQL<>!US\]<"]]^LN<'Q1#Q-RY+LV0+]P9
M/[%7\^T^U' YXB8D7XW/T.L;'A52TK>\S^CEQ,%HGJSRL"Z__IEC!]\60PL4
MH@:]1Q-H.S@/1EZF]67MO>-0$RGDQ>MZP^D+RH+ED-[\$QP09_I1P$)_Y09K
MEEYI+ :\P0F^N_7P@,"*<Y_X[?ZE#<6U;%!*&MV1.Z!'*>.6Z:J#@$V:@7[M
M$_CLA9(5%$#.FU0R1R.X[[4!BLM6 $C$*-]-7/EU=AH%>, VF/3T_NTC-8:
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M-)$2A1$!ES#-\J=,VU?2HFY]G#A@U>,>S8@G]%#5J^+V#YP/Z2"Y ]BY2UX
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M0V328\T9GJ=R]]_D6B0KI:DV;"J:Y(7,YXL]3!S,:-308':I%2:$/%03VOG
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MO[]<DKK[92[OGI$= :/69SG7YPC7L/6,/M_IJFMI.C)>T3R: D$1PRFO@9.
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M]F')C*6F :.(XFHK<KC[TO:Q1/7!J[W2"$?M"0&?PC'7@J D88[%X[ZX7([
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M4Z1"/>DTTFQ_YI.W@I>_T$"UFOJ-P6MW%SD@;2%?LBKJ#>#%@2S#JYO-U=1
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MW<78 +;]'6@D;VML,7_E#9LG;^OF6%>L)&!:TQN75WAY(=R&AY_[H\<ZM1Y
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MK6F\4L.(;K(RQ/SX8('X*[ED>D[P>BERQP%'-CXR"6_\;1)^&<A'5-^(-)O
M\)=%UW%()!1(?;23$^ZKZ@FUVCQ>^W?G-9,2_EG5SHION8_2B5?.9)SPGW1S
M$9H8P-W\V";U,S9 2TYZ^P46;W78;R73]XO$?C83CB,L1Q)L<K9]&*G*B";(
M:"TWD/8?' &&)7CT/+I]%%G9QH2LZWSTA'-A'H &7U!'G;AX$),4?0 02O,!
MKIV 7+I:#?+(K?>_;B1CE^,M5>][M7 ZQVFCH'ID9/S2EJ4K7=W4.0B2>@Y\
M!OE;"J!P;<!*P(2G]7GLTRZ^8@\=N!0G*G7^J3JDK<>3O018(9V[1RND1CW,
M!E;HD9YT13KFZ;,\R^$^X-S0-X"WSP!'LXDD&L_]$?CYNJ$1-E3:5LSQ5?1-
MPDOE[+1M)-G,3)BRCP?OKD')E5NZGE0Q?8OJFE#+IVFJ>&[0G=UFA-FISXF+
MHFGIA[.]M>S 9.=W_S:?S[]$_KNQ706"!F)]/T!.W5H(YTAIY'KQ@H[%X_Q;
M7^YRS*>5Q4)>CY*A57'NH'B+YE7]._3T5JI#PS6]A0&]"UAVITG/]&>7=[U]
M'KD,$.B U<3*;_EN3T8EGU>4X7HM;AW]TQ!\?PHSW8!,A-M8<OCY25MK QI]
M39G34E%9*&'\0K$W!^OZ#14J,MW%8]S_1E&RHR^BY_K>#548\O&J!B.6,P_C
M;+LNCSJMY%"MT(S=O(VW(OU&+O'7-/]K6$[ 7KZ12>31KX_;>T,#C8$/,VIX
M8@>O^]*E;<6%@K<NT4"ET ,E7SFZ5XR9,UFL% U=JQB4PL1XFX^/TD#YUM7X
M+R_<V^2@W9GYONG1:;;9;C:B2=X6:)9L:W(T5RX\H>2G_&]8!5F>M$$1SN[B
MZXCH?+8H-ZH=O$<'YX1O3#LJ;6//#(]J,\4_= N.Y8Q\>GN[&Y+"[F1D;?5,
M??;:12037KN.6[W:;O >M*\\+K04O]^T]FN%FXZ1<A+(RPO[.,2L.:J8K/;
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M%^,^-LZK*+4<*:-"RP['L^_8\1ELY0@4\ZC4X1P#])<6_7:3CZ4O-DQ,L)A
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MD3M93]W4=QM&2I&C5L6%8X=&S2/U!&)TRG[#$N&66GX^TIVH0(WKFMDEQDP
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M_H@1)$'3^C#^&Q"PROU4"H9LG#,;RS%T.][@4E#>#<9I"V'*U?T4"N$GD$E
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MZ^M RS:18\XE2.07ZU\,X>**,(U*"8.VBL91WORJEM#L^HC%D29PK"Y4 3E
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M.:/X)NTL184G=URHX&>^*;^,YF9^N?![^% G'5_X:;^=.#\ _;,Z:(#;29?
M%S<Q'&B>HDY,-%?%YNP%B@1Q^TBA-:Q#J][G>)+Z\;GA$[S74L".+5%B4';(
MDFG8TG#-2D-U#&O&89HV/>F/\Z!CNA#DI0X0Q81FP^3#D_FK(V-X)_L><-'
M1M4_IJZBE]S5Z?)'<\%L5J<.49?@_7CC_F--%7%5=KST@)<<2XTCW[;^LF=^
M@UVO650=9,<1P;XK2U\$P%J?_EEY*#4Q]0/#S_^2I1ZUO6?\EUXT1S<I LTL
M9(=Z>VX7Q0[5V[NA),]A0[K#> ?\+P]GJ<]7K[+VLE9- OY3>TK3-M:+WD1K
MK\#17$(E_F_/?;&[V!=O6[1&149C/DP&5IQ#F**B#-JN?'YA1_A_(/4QG15#
MF>"=6;"Z9@SZ?)0*Q60!=IVWQ\W%UX ':\Y*R"S^=<ZS^9O>P8+[Q-+&/YIK
MU<FWYYGWZI9N!S8<0V]"C'%,6@Y.<])2G884F(&>LL>"\R9IU;&-&=H/!^.S
M]W<<:D1IRJ"/]!W6C,O#VY ,Y]#'$X$4=IYGA%.O*F:G$U+TZ5A"?J^'G/2@
MN(;]Q9?IV3K5H E/P]:1D/S7= 'B(%@C_M&RAKMQG%Z?UFP\^6@@Y39<@Z3V
M_/FSE3#N);G-,5PAX$>HP8B TA,<Y;BN+O$**'?WOOSL9+R;KG7F ST3VU7Y
M'$DET5H PUK#+&]7J@$\,@_F?L+WD_S5OFO@]CTM,Y#+D*FCN.U@OF*I\0=%
MC4^CNO^+J['.1V#L!54X\M,PDN [2.W9UD6S7A6CP+VGUP!C]"C)WJ77A4?+
M$C#4@67?+?M55)FK@Y40 7K;UWT!'5 "#PE\-#E@39Q1UI,ZVI4CM"[&'/Q]
MR!)8"&NAH+>0=7_=U_$PN(=Y(D6QQDSTVY=U&N-,F45HN.]57<03Q[T)47D'
M*WV"\^"8(+I%Z20X]3H=PQ47?*/<O'/NQ:@8\%9"7L7,_/)*G=P@R:5%P,A@
M@+(UQV!U[<,^;9IU(#F/>587*_/;CT]@+T[%Z@[-C-,Z>.]U@W-B.6T!354]
MLN(F/-T'@T!> \1E:?&^XVIC Z8BE!G/G#W.'ZTAR.!2"[L85.7Q-G2MVP -
MQT3MI3#8V=''?=)L%E;-.7GR'*X[6E#1'.]/%O-T\,[>G3.\=$2+]6)K0Z$1
M\/?"I4=M("@B]KMGW\G0Z*.F(4+4RU&/B-QW:/D=Z 6%6\3,12G#IV.Q*_O*
M6WQA&G>8F>).?M*,?=UQ*U;\7'&T"@U!R7JO/AK9&XL_WV5,!C[_7HY!'DA#
M6XHOL>4O,IQ1G.TKW";G>X'-NCGCXB#M;S"'V)]7,SJ(N+V9K-<B23N<^9'%
MXI0A*;9*+WU,(R2HYC81OSP*C)Z,-W)8Q4F3R>) Q4GH3B]T<8S;8L5\+[8^
M$[WH#^L BC+0.H)E3U';$>538JC6\Q'5]+F#L&"IKSH_H['.Z[IM2#;TRP%>
M=/TU0-/DALDU8"'K_+Y V\7RE;+K&S3NEAO\MY@#5KR*7=L67 2]06\_W_R?
M+]BT^Q.R^W,;',>_!R,N2\!PH6O )^@+J#P2= U@;"R\<HL_3Q\E13TW-@W.
M+#:"1XO1VRYYDYX1^/U&*K2O<UU-T'<7%JYGIC8$<'73.NP5>Q085TX9_Q!]
MV32]DD:HY2#1(B31;-6\X<8VP!#.XM0HMN84-L<:Y1'[Q.R3JCZ9![[P-< F
MY$)7:1$:!K3.X#GICI..;7#(%4V^!K3Z7>$Q]K6PW).3ZLECX4Q] Z!+]-.I
M[!Q+K'"L3O]6LY9%?G)\N#B\X&SZR/ +^ Z: N66]6NBQE\3@=^M&*5DS"?;
MV,H4M!T6Q[SGEV6&A,<;&2E[N;#^[(QE@3VS]A1FF?CHRX,ZY$EY$6@%^G._
MC (,&F<=J?%SD*,@/)#P3(KMH&9&W(K*5E(H+7TFKIKG?GGIH-'^8%H!IX-S
M3T/4CU%:A%3?A.V@)BNRK%W1OQ0#<<=5J%@#(O;$2_O\.99%AXB45DG7?XM:
MR2NL!HR= K.O['\+Q-_;]%UYN,,S,MW\<A&^59C5G>]3PZ&27!ZG(*WF!4J>
M\Q=$4%1/OW[WH'H'H5AZ'O:HUAT86O4YF*=&S!Y_(>+U&Z6+=R[?+ZP/H.IY
M5EH:_9(XQ8_#(XO&@R>2=$A)S6/5R3G9;TAN * 2R(RE.XL5M'0L J,./LC+
M"&+)BT3@PSW.H<A YDD]N=,IF2>S(]1'4OTN"#BP,R"<X:JTUY'G<5-]XM*2
M7*(^=5437:*](CG]>9XVIR.J/P(^*GCT#%I@NRPQU.]Q06HT+>/CP-K2J<3-
MQP.7H[FEFVIO2K"_F*D@$,F<B9-8(3]M''!;%6_[IY<)"T+ Y$%BEU)$]+3*
M3B+Y96_0'2:O"_!%7'Y8OG6) 60@MEWU/F&8YNB62,B._1T5=SC?Y*<NC7>-
M8O&J2&NHL2+N5(<U@X_U!^'N(GP5\#.3XNP-ST#&T=3! 17^AMG6H[IB".?
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MT*]; K_-O"R\A0+%>\^C0037@$OK:T#.1)T$S36@>R(;O03FUPM\@2F>[=<
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M=UR4C8L'N38[<?#%?93_/+;QPGV,&#OFD>>M?V;GE!_6;Z/>MA=V^K!D';X
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M#@$UFZ]R\##@"BO;E0NP7QWTKS^-3B28.?9\K@%=).</',#;/X''%BGKXQM
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MO$N"HQ<;1&;L4%VD:)Z5X=4;V47)NHC++_S@G;9/^3I&']ZR\>C5^@[XGR-
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M4\]T^9IU%GG7E6>P_8>S)/XA7__MCJR:T10]MJ'E/8*#$WR+6?\B'0^O]I_
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MKQ1;0%@3JMU')_UJE\-\(]VF7+C:&!-=C6H.L$.Z>XL?#6_309?>$$<:<)E
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MH:8\^/,?JXOB%$ZOG:6R*)0-W+K^D776KG/ML%/:(LA&-_A0L CNBP4.Z+!
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MBFW<9.:5?DG/#J6!AS2%I-"F?= 4!+&.<X2DFHKB9PHT(_'5T]I#2/MM#RQ
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M=S/&NM]N^"[HO&9GPR%/[,>Q:G\M/RF/+L_I'F%RX>+ #W'6=:HGYF<O2+^
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M?.M_4XI(XDM&>FXD@-2D-84&DYZZO-1>Q]J/3KZX1;-TKG(*++8 ?0$=,^R
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M]EF71.I>"O)D+FG47X!\0)3HSKBJWH^)\H*CVY_CZ!Y4$OF6<&,@]C#WZBD
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MXY4ZM(["('*+2',QBL8$Z1MKH>T/4"<_'H+53K%K#_V=>5K3]1>$]W7C7T2
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M\J!J:_&#($BRTVJ'3@0JG6-]I&])3)'L7-950+>\Y>QC@$0#<',"P5LWLM"
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M,#,I::^1K(&[T<?\8*T?IS@EXC6VP75+I^!O=%-"+KKZU5'I="[.CL==I->
M1B76A-\)_7$<[U9?HH9A[DCW)]IF ?8S30(+U:*F1--D\$7@Y-ITQ0-VI5>
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M]_QZWNY)Q/V6")<NM/$0OH,*3E#[M:FT73-9OQ%5+OR@Z .GM5%57= +?XD
M&4I<#45&B7%>WDC>.8W/\A)>/%Q6II0,T?,8YY?E])T9N\32?\+CQKA_)3]Z
MD_S(\CO*,!^R-&/QT-W=WJ'W^1T>6=UPHG>),6GTKB,V<HJL%JXQ&K3Z&E6C
M3KVPTJ3'70V<KC9]8H/NQ8ZHHNYI[L;LW&Y%S3G?9^IT,S2U5\).J\G,M:Q_
MOCB3ZE6;%JM /OJ0ZF5+?ZB,N91=Q[F/(X0Y_8.)U6:W[5B\TQ@\#7[H:C#_
M<FOQ'@5N5JHTX#)O.GW(HC$*^J!6?!(6SB]F$/RE#_GPAC+#'/=[7T:L[S5
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M*4S6U4MXE)A8A\\:C@HI[<\VLY^;[6< @VW]HOA9-,!W I^NT[U&*UJZ*7S
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MYQ>7.N4:_V0 *6A(X'=_V;DU__U95 BOXQEUE(BGI1G;7E9559"!/]]L8!8
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M[V:29^CU?Y=M!4O[1ZK5F<"57<0Y>(3LZ!K0F79.MXD%+8^O 2RS 5V.!M<
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M=>M-I$!S5[O=MX/.S0T!:'1>\^NM-PLJGAL5/.R;&;6E*:.Z)W92@_5"LR'
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M"9V%+8 &D+ 1G7.A?K5R/N3HJ@C]LGE8 ,(5:/."J3OCAY^,G19T,-ED_@)
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MO0!\NM\,/B"X '3L@7?5P7II:+@/%Z:S#2QT-G-"HWS^O> RO?'L G 5B/Z
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M@XCG,=V-E9NO%$%"\[7R"Y;/STS.[C=_<:F4F3#ZPKC_O29WM=W6@RC;_-O
M!6#18!B\/LIQ#M!,1+T[FFF>!HW0(CJ\LYU"Z6V\GI[YRZ[@-?8/!=EH6B&_
MJ465J6_:FNR"0MUY>>S,*]+=-&FIN[P\KDDWB-!4GVJF?3BM@U5GMX.-#;K<
M0X3FO*G%"YP>[$SI=%[?+8R0R=(C,[HK:VE)D%RH,;K[>2Y0XA%A@UJ7<N1X
M3Y6$LMO4O<'_&][[L_UQ^'0OV8-\KNB$Q!Y\NA=P2<:W_]L+*PMBQ [O'*6R
MB)7U73K^J9N?_V+5X/Y=VK\#(5MMK!YCMPYJ&/K:[$X@=+%,%R9#^WF>UD>(
M FMU"]&B^9*[=J^0-$@*B]&Y>]9<+L)T9!/)4VI'F]JJCO"TF-?[MJN(3!'R
M!>K[#S"4NQ(>GXWH-0NBR/K%][Z!7N$.)9KO3*B,\.(5B>C!^%(?-3X8O/_M
MS&CA&A)P?UT_0I+#E/:(DY+*]+8LL4P>!2 _GY.8T(NPJ7KF@3.WTN[[$I>>
MT>,O%X"\FI#W<6-AZRDV[<542%E).4OA#-G+XY^6I'X8NM<Y/PK1ZF9'#98$
MG P-:.7P]9>@6U;L&]M6AQZOUH00 ]%^/Y\\"OSVK',QR0-'E'68N> H<L5D
MPQ#1M.,8;#>WC:]EZF1]OQ_GO/<N@^*R,5D';AIU 7<[#7']+L_I\Q_RUF0E
M29U,23U/;^I_Q1TXU7PK*1>UM/2X46#OX%%U2*\YC]PS$XD,44&2'C1HIW7;
MCX=\PSJK,E*+/>'-FW>:INK4#<L_>4<&Y;9&*8,L999%-&<GB$C$[\:,CQ]=
M^VJ5#GRZGP14GAD[V$XQ=1?<91GE*)UPSNZ3>=:VVF:PSU6,ML-*2B51KJ4K
M6J>^/67U D!@_!TN?P$@6=M;&Y8.9Z>"L-F,+><> =R6>2>G)\@/)H)?5^1%
M/@CE;B G _III4=%N85QAF@$<,QR$$P[ZS3WYLS(7H^,']=M:('A7:NBVM63
M)%:QVMK(;974HO+TFY/?Y&YW[:OFJ=@T=\V4^MRC^SYZ#Z_=6E6G_M%P]@A:
M.-?T:".8MX6-@N>3W_4P%$[92O;B1%7T/04R?<)!*W?1.7DV]LUYE]F9ZG3Z
MO,F-9G+  5VY74*<]V$WF]6"^DYVE<5BC>U^HVWKE^+M#HM#46GJ4-<;Q(_+
MMI@4V1C&9@^(KID9MCPN<LY0I_ [H#M^3"Y\9[]?O/T;P&CI>Q=SUF-!*X%&
M2:T;*B,'8^6A--N*7V/"EAA#OI&S1C2BB4!^>ND1"@;/4W8,_/O]:OD?0.CH
M)DE-39P[6?J<%VAMO'#G="A"0[1C$^T,!7HT[_(H'-"1& =95FPQ$,>Q",*O
M.[]V5I+@LUIEZXDLBY)+IBSQ;OM(3"@J"P7>-1TVPU C>,X<)1/F'X122$CX
M2+M?T[9_]9?/#V<9^\,9I;>3=92S4$>IZZ_C4%[RBE[:F/!CCS/ $)X+:PIR
M[SLF??13>8.D'2VZDW7\Z>#[=YT3RTR7['WBAIYGE,^6:5VQ$X]^7 ,[A\0:
M=3V*_#A248EN\QJQ8S^4\$)?<;MX;4@N&E*K'6,?=M_\3;0:U-/['W'2_AF0
M^.. 1.MO6'R@17X&>ZR7/._KX)6;6A< XH.3D0W>S^*LI%M)WL>$MCFKR(-#
MV*<+@'N?(]PV7#:]I!8$&W?V?1FV-OWBJ26-_;-]2J?KGLZ'4$%ZF0Q3>H<7
MS[3BPP#7\ABK$TQ_)#_.AH6SH=+Z/Y>54U5&"U![GA2I%3'5U"A1H*5+'P0N
M:>E8=I/0\GQPXA)K22),EI8[#!J%181HA;*]?TS7S>,OB6JWI2R0YS2 -8&_
M\*XYS"5L]H[$A5MO/]E?UIDLR[@F*K3H:EA4[HH,0,OGH((&9,UIM9J6=!Q!
M/":GX> +@+KZA^^/7>Y+F&V)&?>JC&II/D>0[]S1D=$1Y2H;&=\'?Z9A\YF?
M.".2_Z(KRWI%N-6?;,.76E:@3\A^RR9&H%JN8SP38>C(T?1JQFB$:&<['*C+
M?P'0SOM5L1S':<*!F68,3="0A4?:6#<G+BU7.] +X$G2YZXVS% U;'&(%V4[
M(4Q?1>5G\0;R1@HTJUYFE&S^58Y N7B%1P/H5_O<>I[@$;F&$?\'+UW)B&J=
MZO:T-2*Y"6/\K*]>J491 YK""L+<63PC@TM@4C*K(5*ZC_?O"5\ <%&:&5IY
M.I0.;Y[C(>ZXAK%VH9][ $-%+ T-<\+YQN_1<811)GT'?P_?[W7MB:17+HL4
M2J=]TM,.N(*(TD8,W0T,Y<>ZZDONJK.)H+N0,KKS!-1MET9;*L(>X7/7<U=-
M2DNH<WB#4YY)/IWNV/WRIZW17BY<E0L#&(DZ2LE=G.2BB;+1^UOC+3R6S3#A
MB!4/<]+Y%Z.F<X_3JQWN=ZQ9(E'!..1T.WV>]?-)]-N=#*EJ095EP:5";JP=
MO+>8K38A[MRT]F+MIXC#;K1(D$PMJ<D2#7GR%Y/T6! &WE83U"4W]&&4??<E
M:U?]0V8PS:J,*P^G;_CIVN%:^4_(+^EKLH@^]\$;7).)E5\GTFCNOB!"R=@W
MA[FGP'>X]0/F;QCO3.?F12X-O:I:3_:OW9\/1X=0F/QED:PC?CQ_K '((Z,]
MX*V=RGCP]H9++PW3' B'B%A[4N$\[<CPEA_KXG:?E%UR4PT0I08^I+H ="IA
M^DHWV#-1+@N4B>;1CL,P7.4I[KVJPW8ZH/:AN7F!V]@#-]/(#U^-A/C$"PI4
M3*=$;Z^JYC 8ETLG70":,BX N<L8.?"1/?COOSNL'/-S:DV(MO;D$7.%E%8W
MD"S?1Q5H[I*&S);O+&[%?DEZP+I7LFCEB%N9 WYY7Q4_YCTB;SB+)B!MM0+R
MXU0O*_8"P+VQDZFS&SJA=GNA4F[?^F:M^:[JZWM7M3*K[RZ4NL1CGB'S-#]-
M&4R9Z@LC'&Y)/CE"E@H3MKHWX8FU"Z!-E74G.QP2PEE%QX.Z!]#B;^=O\:;T
MO=(!UOJ%]Y,?T)T>0/G>Y&M]QL>1%;WQ;EBQ9PH[&V/F_4-%'N?'VU1NE%R)
MF,R[=MB*E2K^M0O F^GB_EBK;[6[R0605:UID5V)M8T4X&#_.']'NF9X!)W)
M3\G#95RQ5#>D]9P'Y1EN\]'H$_%H@KV(J7ZFO5641J_M<.G:.PBO#BS@QN[-
MYZACN>>#:9^HP$C-(O7?49$5J6:ISGU>=;?%WX,'T8*;GF=3V2T>7@"\$P[E
ML%= >YRFD$MV"I/T@#:R<*^#4!W,L^.9PVTFC(^Y-THF5;* WW:0Z)P(;5[_
M2^!>!?H$V=W.OP#4D>Z9T:$%W7W K>$]!T&_+3+TZ[^9W<4-9D45?P6C-?.0
ML>Y8Y?KELC2)+N0DB-G] Q>PV20/F7QY.9R 'U,#WR-9*5\V> !>:%; ?E@1
MVH\%1$$-GBNM^"7RU3 (1%,:SJO?$Z9T:Z74L-?=76D.P3CDI',:$*[VM-QX
M$'%/27P//UAZ]T$\+'ZT:598XJ>6TG4OSQUJQ"EB6K;Z$?1!M)%+BVM 8#U0
M3_+&RIEBDB*)DY6$X)P.2JER53\K>XWOM"+YQF'& __WD]5D=,6XDW>DYUY[
MBJ7T<>!-2SNN43R[SN):NG@W?'\H#_TT2 ;]B+SQ%D-SB4G5+)C37';\U7)%
M]L=:IDX/PBZL8T[0]$]F2OYW;$31ZRO]!.". JP^0$:#3@%%2;^]($V^DU%P
MOX3W\D1%W[,_2!R_$ME-=:=V6":BE2+6R?&*NC1]I"N^?_>K$D0:]^MIG:D7
MT++:>P&OIFR^N.Z!A#+FX2?W#^&G.Q"L?U1N"\(!+2I]Q_I'QQ> 09N1W#.8
ME)5C0N#DFBLT+/3-<8U?D\Y$CJ9%B@> *FKC,0]4OUGGF\X4WT]VMK$OU.)D
M=+FT>T3%A=ND*'W@@Q5?I=BYS1\,6ADQFHYD5P6IC-Z&V[S< 7^:W0F+84C2
MY+#=ZUR2I6.?3+KB)4P(TM8(Y_BZ+>:F\SPM/8A%_E=8,>^\( ?\ ;N />J1
MFS/[F\L<\<-.4WVN=@<%#HO@?1O@,L:#98[&/!X!8:N="M?]&_7Z+UOQ(9CD
M@RO))%]-2AIU[3! F?SUCN+3CX0XXHNS-CHD3:C2.6AED$,9(BR#H8#X)@N>
M[U:[!*$42#LWMW+[KG(GAXV9$TMC]-,O:B%8$)G'",UN]:QX:O8@SWELPFJ8
M^<MR-JE@'I0MHZ3$9_3)R4>IXNR%*#\R<G1!)U85G; G6)]A%_(*8Q)=SUB^
M0B.CZZ%:L/IP=KT;6=&FT?>7V][&JH\68)J")%:UB<W@/5U>R#$6^_XPE>*O
M4G2'LB\78EU21N_? O%_I:1WF:WB#.%OZLJ1L@U7O1[5U%265$0NK1GYX[7I
M2PL -)/7@:0;T$7GLD2F[XT-"1IC 9.WC3 ",+HV#">D93R#7G$UNVG,_\DL
M_YF1*V3 DU>I&4,T4BLE/_ZB>.*:?U7T'/>*<-0![-3Y@Y3(".'7P2#-^$%X
M&[5]9:=AMM^!D2WX@$OV G#+MP6XOYP-GLD#H6IJ(+B3N?N\Y1I;#Y!T6 $1
M;Z-49PZI_VK#"Q()SG7=$7+ G2H1\0N F*O)^2E6BL$9&%+<SZ#E?JQW!U<!
M[SJ ,<3'Y_^'O?<.:VK;]H:#HBA2I/<BO:/T'D$A%"%20T<%I(/T3@2D-^E2
M!.D=I'>0WD&ZTD/O$&J $+ZX[[[G[+W/>^Y[O^^?>][W.W_,YUDKR5J9<\PQ
MQ_R-,4<!08_0,+LRZX_7OYX7S8\#PMZY^:.\3D:N3EEO &0@) _^0^A(6M(-
MP"?[!K"\?0- LA]<1J*E>!Z:A4%_NA&BNJQS5&6#MB_!L9 76^GGVV 43Q1"
MGY;^!I NR8^Z5OCE0'$#^$.WH_YP'6DM?/IN/1.]"P:T+>-?'(\##R;2D09_
M'5'1#> PKW4;C1ACTJ\_T_WAFOJ'W39LZ'G&7^CVER%!;@ P,'3"%;WK J_$
M@'^X%OVZ.-F1'/+LSR1S^O-XRM"H)PV-= Y^1SU_OW9\W5H4)$@8]!>2;?YE
M/$;H>\D;@.HB,NX&L+OYY[OU#B@$SY(9_R]$&_W+D%K1P,03E=7ZMP*X?[\9
M"D254O^;#_[-!__F@W_SP;_YX-]\\'\['SR ^QO-">M89+O>$L5"C?QY&N40
M4O9'.^_3/5] =T]^GXB%1'@H:[2ZYO@+2S#?;,L2<(D5:35ZLJ<R *G4:WP0
M5^?;P$<;]#WRRQ7EH=U#!+[V(5+YW7:B4-B4N8/+#: )G_&4]E2I'<72=-A=
MF/B27P#35X+BPL0(?B*0%_1A9>@%LR(?Q/<D@L2P^PA7KOO!@-DBSB8-U8])
MM++SG][BM_^A_D_37RL$C0[ZL*71@I"BEP'$JH;V^_\0Q?IGA^D]Y^5T<N"J
MS2^#,#%:X8F!J! A B>D^&X ;0<7X;^CY0Q#HS]Z5*MUW@!(8O567O^J5BK]
M%SQ^B_^.VN#3EWP*FQS-"1FF!3)ORYMJ&T+T+-R8\3(:5NA/5WV<=@XNL'X9
M7%E0<G5T_G1'K//HFRNT:E"W'6='VNM0->'Y>6TXR]B,2]7 4*^-*8\@NZ(P
M4>I;FN60O10GPA4_U'G66T59T0K*C6E'KOP3$".4&M$,+G&92-;2HM9/<97^
M!^-X&?]A%#+^@!A:MWA)"<G55)0H#@8GZ;.5.O9DE_DZ.]S'?/81-*%%UQ%%
M$_5P%OK6DH]M8DFU.N0&$!6 YJ0%= /J8^/V)-V?4/0*/]C,;+H!K. C0U31
M/5^%7CY0)1G<U5@;(&/\SE:H"T+Z6@-W%H#7F)HS,0G_U(:NF3O!5;*?69UV
MM,"9U#HI<U2(UCL;[O<A.8;LQ38Z\@5;R:1+6W($I'&L#S&Q[%52]!CMI'^<
MYQ&GK0[U\3KK[^5GALJ2Q*J6QYSNCAW-EWXT_:*CT1#E/"RK4\JJ@'#%BU]1
M\'HNR)[#<R3_M>*5W](&=WI*P2YG31Y30F=;7YF[-IHTLG_E$&JZ?QJ^7[J!
MUJ=":UI/+],O;T_C'LZB%.^BU[ -]$1].D/I>AXYW !MA_)O4OXZ[XS[GXXW
M^-\UCL#:7*BU^;0N]//JQ4[MX&RC'?U)[XABJZS [CY+:?$@$!OABB+XS*/'
M6^V=Y]5M@#(<--4PI@#.7UOI[H\M7([IZ>4G:#,;E$9\#TT.I4YQ?9494R$Q
M<P[S[B2JFN$I?,,JHN"0C:\\,'V4;X+P7+:1C194=F8. 5/EQEA[+#VF&VZ6
M"AV?'1SX\;3K\"#06D+8<E0WT-WHVF0D8FAO5[+(,I13:-;U;0%3<13'V(1P
M-U7\*^RDMYBT0:N"Y<5> GY69=6;M7+=:C^/^L0ATQ;443DF%L C[7W@3O'B
M)4:91LFV<E>1B^A6.Y_*]0A/[#=:KL9@O?F=\C[;)T>"@Z582W)B$#"L]9;%
M EWL'L_Z_B%= L0@ SAO:'_:5UH8.JQI,AG!*'=_CD,\S,VV9-7/;4H^6ZTT
MG.]> 5OQ$%AT0HJL0I_BQ$#AB^BRJ.-1E!DU*CU",Q%V PBU^Q:E.JVF#1+Q
M##&])L<^Q>;4U'W+\P&'#M=-K:?CL<C[I%*3984Y!]"7$]K%:\O99/)]^IC[
M'R74V$'JH[[D#.FR;U=G&P55%71H[:&'P\L+NW.;E!DUP/88?G:CK#)@#JD1
MKIWM@>Q(L//;^C8*[?G/J1YDMB#;Q7@/29*\FL^U_&</6SH80N@#'H7(]% &
M:-( J#' F:&]$YSQ<"Q_:*V7M$7A=6OOE1C#A:'*WJQ^K4$'C?U80R'[K_3#
M2;(*.FCQ*9\5#P?Y V',$]RV+8MG=H^$]HY<]S<D77$@FK(D*LK9Z3(::C:E
MN6]KO_QP\QO9G1ZUO1T7[>8V4IA^Q!E@%WBYGLY)0Z=/4& =WMCN :U,\X3D
MCJH(,I.8O"CH5MD]QCB<U9O@(3GUMF'21PXUKUE[VG:YZM(%.1W@ZUX(/8:E
M' PB^( 3-P"5^")948VX^$]R<6_V_9J*.IYDMQ)7NZW*.KGSQ,<'2M\9EB;9
MKEY+(T$CEY)?23/UTJ_Q"A,[>&4LD:JG M5&@?*V/N,9"]4IL>G<?>UH(=,1
M/>N?7O+RM[DJ@]-FE/9P,5;.*;$ ;STQS)!EUC6GN<>??#CM5W6 YW.A4-_,
M>->=&+=U/PIV#6YVJE+5Z5=1V9UZHJH%XES&OWL#L$7XC6M>0://G&2/FC[/
MUM3;-@:*K>0X:Z@^B[5@829.L<J'<"Y'W86V*^7KSGNW[B[(V,RN'LP/>^R3
MHQG-/C:LX3Z:YA_GV\Z*1/?.;8Z-3>;#5Q@IBNGNNX%1!.;[TWNMEE?2ZNF<
M;^?,YC9*G.)>9H]]%<G=)^E'^+>USK;05TWZ+*YZ?R;P*F-UV2O5*X5%UFT9
M:!)GL9(Y$8;&5&*O>>DM+2(4>;ASKJ _FSYP1K'Z[*:?!Z![2"'2^"5.(_X3
M1'QY\0&T7=7.AFQ6:FB57\BKY*I"*K.!@RT\U>#[&@GS6ZW*2CT;O@>L#)JA
M)!]BFD0>1*:AXMLMH3CSO+@+_OE4H/GZ-PX=9J,]C$=H:,!6&+Y&YH2>:<7!
M8SUHX,SGTYFALAT64_4Q80N*H-R-VW319;(U-8'#4YQ6;IWO.C,(L%YQZ++%
MK7&W$Z_@^H6RY7/]3TO(_Q/:A4I+^.$T,K0!>.W^[%< P,7P7SXXL4_'%BL7
M9U0+92N36/V;1?58DFXY++9$J:3'AIB4B_!.K1P^)^$W7BZ'=RWS0QZF;F8=
MB_AMQ8BSR_6M9VVO&5\\O $0IPS/7>&!)["GDL.4*[''8N(T/#Z_L:0CD%!,
MMQQ_5#EJ/8?:U _OA5#T]=<:G8-."VL]#CKQ[Q$XECRS*=P:B.(S)\;]$CT'
M .5QAIY26D=GCTJH93;98E=\[7WEX2<>JK]3X^^4?BR>E$8+QPT*<<IN_1K+
M@18H"Q&-1?C'R9-EM&/$"-;EDV3E1KZM!E\ *.WQM[AM:$!%_4[XY;0F7%T_
M4?XP[)GMU=N6CWJKU"0O"#M];MLAL8/PW9DG&"%SMGI9PAJ(L'S+Y*PM6ISQ
MH=V=S^<O^/RQ\E=QH%6=^+9)JL9P+1'EGK/2%$[G*Z&)^>E<KZ] ^/8B @K;
M=,+'GLF7/BO*UMFGJW_#1R;UWGYKXKPT-R5&950FG)G97?A(Y(%1,$3UY[:+
M[G!:LDNSF177J"R+5Y%?(7A@Y$7D^]3(H'&C;X9,37!P4,K+ELA[:T15VK[R
M^@!\!_?U B_EPQ.QD0!;GD[C/9=[9A%7N]0-UX_Y3V\5>OTI%HDR+(B/6']2
MD_3DZR*U$6),I#K%4Y*A7_G>S%>K!/OU>X-0T9Y/HA367LV-TXR'J!M =T(#
MSA9LB*'_:'#^B3OK.W*%:@?1:+?NA?F=*2\T\F?PJ;T!&!*A$4Y-*6BI!QER
M#CU%/W;)(Y8_<&XG8XJ_4*(SNI,\E9/E1JJLJTUOH,CIMJ"M3439JQA(+?Q4
MX0"1G-@V,SD2[,5N6FB0K2!Q=<[U-(#*(,Z8*>V]:R&4H'7UZ63K3C)TT^HE
MDN]5*YY3S9M;OD^83NB:/<)XE"Z2YZ\,#1.8X8D1>Q*LMT!K@MT98K&8#\;'
M'6D[I%+3)UZAV?@!2/>90ZS%I9@0=@<'SLJF9B_27C\OP$LI2]]MZ@;0V<+2
M*)]S TC4'E23&G/#M,&BTC!.US\KDT/K/>E+!Y<XT-6J1:2L7EADB'Z?LL:4
M6L6IZ,\FS16[>Q(.;C'M5-<22Y)#=8 ""6=RBC-ZLTA9#[RH8AVK&7VQ@ \M
M)H212!+)B<A.B+ CG*J-S&5,;\[2@HNO  *JC@O$*K_@C$#H%8!,5R250!5U
M5W))[VA@#N1F%A<J]\B9%49H@G)8:<UKK01$)E23%2$O=EL>(1K0BJ^6D+KV
M,QM&,"/C_<E@  X\D 3R$EZ3E[] P]CN\F1AD>EUJ:U!.0[F*76:_.79IGMQ
M603TZ/Y8ZPX:)F\R--)A;B9<D@58OPHA&HIA3C!3'6C$2?-<$:%M#Y.5%K<4
M']:D5O^^5LJ R,LK:+ZR3?<J?%"=;5\@LE.[SRZ5*F25=6@4_@K^-FW7^*&1
M'LR6OF_I!N!F5DY__63(Z72-\C%J +%3J"L#3G2*U#=N9.B'ZBJ.@Y4#Q_.8
MS9Q.Q!>)YG;.&JSM8 -4G@,=C_&I=V\%'SJXFVZ(>YZ745Z9A4)AEM=%5T+3
M*$+>BY,YB=93\IW6J]3K_=9XSVMW.N0<Z *MORHZI46I?)B.+'?=CMQIKTUC
M;[PR0C+-V)0DS*>;78G?;A6O-<.;ES)2J1XT1%1V^K#"[PS'+L%P'NI\KC1Z
M\25\@Z8-8/+P[GT1EF:6)N/VRR4$='D/HC#-:+[4$/>XODVD35POCT-Z6QPE
M\G)J?R8RRWXMS,-56%T?OA'HK&1E8]O/_69FJ]."._/];/#F/6PLY'TY^VE_
MPWC5V3EIUUM@&P%'F15V)FL*;4^"M@(.IH/O4P1K.^]*R3K3^">:1%<,Q,%U
MH=^WR%* 7JH?0F*K*UR-_?W',TJWZT9"9NY/-3$*1',*#D4?KV#S:>.1^SQ/
MSR>&V5H]T5Q?:W(%F6D(EJAQ$\DV3>12Q<PP7#E&]%1LU*A@K6BC -/06B2C
MA4!D[CK!J@K&AL/A_<MPNNYZN]"&#PWQ"_$P)6J)<WZN&-\^"AB6(193ZN7M
MYZ\/',H5<PJ.&<L/[8)[0B5$\;[TATB]<,S$N6,_39WV6'ICJG:GMPG[&"'<
M<XXB;4QQ(I-HWW@_>'>5\2NS M8<QC#G&%*ZJ.?+)EE#ZGL".PI3K$9:8A\F
M7Q7[JN*& /8%LH0=QR0IO@F[%L8HO*V7NGVF@*&Y,4Y2@U8HYD,L)K:E8U"D
MA&D^P@HR9L,%JXX1;W\>:/H&-(A%_GI'0XK(_"A"ZK@34N_9+*<URTBK@W&1
M K>^ 2PR3E7^YFH[ &L]CT(%5EL^V5CC<TBLV&C9R$"$KNC6C(4GWTDE<YV=
MN)=+S[.P<<![7$8R<2#Q\@9 :,/#4S6K??K=^*@D/BAASJM>? 058/04\G'G
M!G!D(+!XGG$#^*[, 79^O<Q8V:KA@B)K@7M/3NPL*W,,#]]Y^L:<G' H3;JC
MUG*)R]E*DFCYK!4*?1QZ+T8-[.!0!W!E:4YN$A4P=UZ,@+@D/M*=MS74(6@-
M9QM>[%R1^IF9HG*^R]'7$\]M,)PI:=2SP'GKX%G@K/RX$0N%K4O"1Y.EI4")
M<)>>#$%=.V*WZ;;$)\(A2_XOQTV] ]?O /Q'9+X83^,TK42>;G/\+1/_-_A0
MLI$;(R1B4F7 [)-9N70=W5A,LNW4]WKU&(B:JU )SU)+5>#^E#07$;W;G-,K
M][NYI70PP?$Y-U+RN=@S]]40QZW/BU>"KB2I\2ER7Q,%--! *OOE?WIBK_PJ
M)FSYR]C!A*;+0DW+@QO H-UO&9BZ_EE0/R2#]]QNIQXM9/T\JG_95/K_\[R/
MY&\>SA93?SLW=,+H1OS=P=G0^>\'AT),Z(<>_<U3VL&(T!EK'$GDNI8JV::-
M<68\LGD/:552!D1\LX=Q&GFNHGO(5&)>-"$[#HF1"'L^KJ<]57QRRNQU(9-
MDUB/O&NUV:BDS67#4%T381S(C!W<#""!M>)]DQ(?=[P!*/_2R9L@<GS@),87
MSR;I,T,YPS?^IS,[_+41C)K(@5[V=]R1[V4<:_&!)X0FXX>4VC"0UUHKW3O1
MVD-01[6W^)51(2H <,W:YACHIIV!MH*@.!5LL=FX%"&;WSP2Q&.=NK$;BTSK
M7Q%!=O@X;VJN >^,4/[8NXJZ+C LT7E#4EAA6?0K#8IV4L"_:/)&@D\<"6A
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MYZ2Q;-> @LK: 2/HH_^V*.LT)J^M?$E4V)AB&A8GU6-(0X3)[0Q#%?R:I\@
MDRVR=$*!:]KAL9X.7<C/-P%:C.N\@W7;4.^)4]:)\=!S]X98-<-SEAJ#,$*$
M</<,Y%(E<7GK]+XZ5F\#U^TKK\&."RVT@$8:W0#N$_/]-&RW<0X#)JS?5>/W
MC^B ;XMK\9[U= $O24]:KQ"M2(_\30]@N-$R<TMKP6;-F7U#E2O+@G;[UYFG
M3'9O5%Q0&C,-7D/WI71X-/:.)55"V8KQL@9_U3!A]NRBVQ=&!<9OQ:_[$-P
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M(C6F#@300 )OR,;5&4?*ND3BG:+ZD.:3U(?X$D334TFPU@ON!0;TFM5"V6L
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MLA5.9G_!;"^:G!M B._!>^##$QFEA ,GL8^)D@ECDFKM_;A"[0\X3>[CW"-
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MI@)=GT"  >X]G4;D<PA_G>1N=FR+A)BXR"<]GSK\-J9;)+'J!:$=B_=.N8W
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M;U&-_L$]2XHW@$5@A&>U%61>$4L2WT.M8.["LPMZ)&(%/;T! %'AEI?J\C>
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MG4]3,Y=WAQB9F9V((>D=<&QS":6"G]L*-C0!*2\*1[/<(ZIK\M>^*ESZ:,J
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MPXX)R5HI1<W*!?MN-<G\&011TJ7&+CX@D%I7;%.+47;@D'FF^,DU5OON_]$
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M$H!*O]YQG0'I2\!*0_:+KD?]?1L)NKP6@NGWCD,_Q9I _OUV)I9$D0SKC3S
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M+M&3&W+M-3>+&T ZE7F+0.*QQQ,H3B;"]=JWYL=PE<'R? DJI="F)HK0.X$
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MM-Y2M&^BH@=')OC7TGTO3(:CH%T(XWHQF;UN=VC+><37*IE1G?!H7MY=EB!
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M3JV>>6EELIMQ-E(PXS,$QH>V5DZ/E\J!F+LPU.#2!A8KW4\O@JE[J-77"N/
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M[J,V!;T5G3(,*(4/B^^/3CJ2/T#>)N%IF=;<[MMQLI_EP3/_SMN>RX10*R]
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M7&T)K@=99-M3 P^I;=XWT^"[X%5\<+>;GXF:]U&_>-FU<BY77\8PGGIO;G%
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M45"A=I42U_K TKD-&TT[DJZ>?;,4#]M?/_N=8C[=B*'=?ZGTXEZX5W3H,74
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M]%1\FUQX?W%F5B@F+U8Y# L='&DF_3T] !$N6;1+U'_QO#;J<)C]$L?,<*9
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M/R59LV5#X'2.O49!AI%9JB?DA?)=+N=.H76R>-Z]T\%].<2LVI2'C 9A;[U
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M4+Y(WG>O[VF^>P\0!C!7_OG0E5'<VF#LV5I$U,M_).KW(91:6^!A<P;]9[>
MJHM-8BJ5P5J) [+MPHF8[_LAV<0D=&UW:7:I_P?>Z!_<T>\[F\-8H)[B;-1;
M?)>X!(!3_OJ!'"D\NQB_@N^.@C'TZF_TSC\W,#TBW=8I"P&6.]2LTL^6"J-!
MB]C\C8IL&W.B$(_!>D7U\<FVQ5O0::,.^II4M_KT >J"Y]1M17AK[CS%V![3
MAN+(V7?0I>;*;PH.PABR5$$75!UN?!\:F[PIEU%N=4Z9,8 /O;[<C4YW[B6Z
MY?1UW1+6+S^;?E#;\&1<:5Z8ZNC*>S1E<K_I \C3#8DX#;_-$WI-+\&&'^DD
MUY(/.N+K"9Y2+H'$G4N_E?K=C][Q4UUFA5;1Z8JRY\FNL$RJW1>3E#00!\.+
M08'JW6]J0PT5]N.]DON[WIO?,WCVDIRBQNDBUL@_5Z\I,MK"FEF#[AG=&^U,
ME@P*+R<5>]'"%]9=WOOJVT#5S^"$UC2>"5&^PI98BJ-[Z#%4F/?=O+S[?@\7
MH#5Y8;GX<L"-4I=W-/7]WC<$XQ+V,;$U=X#P-E)\7[L8-#5!.@YP,JIKKHC*
M[Z?0*CWO,7A_7_<[,B_(>L='2G2\:;(LZDW)%9:+TOC^?NE'L$F:E]8L-\V:
MZBEEA> P89NJY:% !]/9N?IOJ\G]6A!]H/S) R6!;8G<3PO/X$;I,'(Y'9(Y
M(Z4."$<MFQ@ 27@V?-)1FU/M&9_/+$:49JED) >71IJUG*% 8C7K%&L@PG5I
M4*Z->L9X!E^O_PS,:OG[=S*Y^X:0V@U,A9U) 7UY7KYZ;$-UF?J"J-KX\O@/
M^8<N[W\D\$\6VYS/R.SER+R._77(;/^YXAO/WJ +RKBON;Q@R@^]R+?L5N.5
M\GZ0D,3-:,HY"ETHTTW12C*U6"6.U[,%]VR3DIC$!4I2!392'9V=PYJKE[&H
M?AOOGO^,JA1"/E/M^TV;<G_;1_X,[%FFVMG\Q+^3+#+.;3?D3!?D^VA=IW[O
MNGO;&AJC,FRBY1_3Z"[C$$A%C>R Y[CT4\TVK&PHQ+5B7F->N)R:&29G]9*C
MUL$O/S')W+_3(L<5M=UYO[XSS8IZ@?!!O?6CA A75<S%6)+:;YCN+NW<&PXW
M)SG4!6BEGGO.OEQP^H30408\G]BWP28<:B[1OW7<2:]E7,ZZE^,CR&9*JR-+
M@E\RQ+]5$>LU-SL5G8RI.E75(%E(J)^8DAXMVU\JKTK:WY8D>)8)I#AY*\10
M!T)'M&UTYK^-KCI@&'NLV"YH%H21]0T4_!3??\Z1-2FAS8C_T+LGC6'\1<5/
M==)2V/,8'S^X:ATCZ8%11,Z6EB=',G:ZV;/(!9H 2H4[^;"<<=/2!@[NE%PO
M76*KK-"!\:/TD,GCS32F46]M!])/(?%"/MSYS[WL'P3!C)+S%V=MDKR))YT?
MLV^\VFP?N0703D=VQ:I#[5Q]A+TPI[_60,NF-"[\3]'1$-HIC/Z-)C#R1)P
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M6]B*/?R;/NE6^X/SZX:)*R$W[K.3J[0(&?6Q4Q\)_4K])OY]D6#50YI5KV=
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M_A+GPQB*\18=@VDQ61_$HIUGPL*@CY.,8%5LH.\UQ\0\T]VTC_J,?EQ&$10
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MO=ZQ>N<)@D6@B5J;#+Y2V2%CN]7%J;[)G<$=!J4W'&S!<?+WO,"=V4"QF.X
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MHJ0 K-67N[93@=>U0,>(["DHFN:I%X>&/J!8D9@U;-,N2^_76<O@1L!$2O\
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MPT-_<+>A0? OLH5#@<2XQDN0)[ZK!JY BSU#.0 R6G"%*0*:-Y0F\\92X)'
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M0#D'0G7=0NR\'SNJ!A4=-^I'[Y;+,Y;DU06_(R*29G][X8H=]C'QSLK^77%
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M_?+E_5779M;-GZ-L>X#XW6>OUJF*<@MU8#Q0T<P 7MNKT_?<7Y?D -2$>LE
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MT^)Q@HP6<(ZF@#:>[M@-/\OW_))WQQ)6V\C2VJ*?/&;TK=D\@MBFD?O:%<#
M27X:9Q;9G21/1?:DUQF6!*LS)^_'Z!A*7?I1U4.?-^WQCL;].K[B0\Z)R9PG
M-"[PI>L-K-<_6:31T?]1?V2!]::R/)UO!&=2K+YFZ-+M9%<1FW[ZC%6K> /<
MV4W(>#UJ[WZ74MVY7+;MS1H3C]Z&@6."[6*4DY[H6\DC;Q<W\"42SA5I,ZZT
M\#H>=DNQ06P(VI5-=O=;ALV8$ZF$L*39^7H=2&7'YHMR^?M>X<6;SUZ,:5'S
M\7261 -D29[ZOK8M-JRMW6LQN%6O&^\B"R(:-:R49R]SB4%,=%+PQFWM-F2L
M:/( X][JX]+SMC'RC<$:U:%3["[ZG$3.QW*%NP8\!>M+OY*NEFM?&YET8^$V
MEC?1Z+R>V<(OA?V.<LRIL<G+#"6P<G(]VG65_Z6^$LHF]6,0<95,\*$5VU3^
M:2@J1N&D=W]G2.;D!N-LTNPSRUL* #;61SO\^I%^X_MWKY93_FW@P/^.]ETR
M%&M@;&PR^(3\MY2TQ9(3!.#I!<%ZW%,90B\33)K\[(O@Q-^%W W!1.T;LO\M
MIZD9B-"4 AV835M,V^1$KLO^IQ0%& D0!?=GVN(!KXGQ@#$7@RP_/L)+)N7A
M ?-.%Y3'6^!_[O_[(^92!K-\<'W=GY^@+QBV0OZ# 23_&O^U!I!W>BR+$0^(
M-R#8O% >,.J2F>3?7S&-%5E5U.>VM/L=O9/Q]\B 5&AMCQ@=W"FNCRP5ZP9M
MW^*+3G8GC?;DI)0K*/$3GM:H74%S),$69K*K)4@3/OM]@)R^$UDHKAAL25?G
M^-9.LSDQ$^[6^N)*=*4$P\C21;;+T<QF]%3\:0[\-<C%SA_U!@^(\JD)'?S>
ME6PQU 3CU!Z#+O'1OP5&N>$!;E."']8:$!3=3K^8!KJ,S'I+JEQH/D'B X\7
MKN'$K#OYED3026"X),UP3'Q/V[[D5C!0?<B?7-;>"+X1>6K(TE;]]FK#1-YW
M&N9?YI+8JZ1(L9RJVH>6$TF[]]-]6*9^5]JT-3 ,Z?4K]1J*)M6)78:H'+6'
M2+F=GDIE1QY?:MO85U#*KB/['B?70#1QI0IK 5^#@Z]O2>E%I[; 9F]V"A*]
MD_:(G[ZBH0CLO.E3$)'?D[.5[/.6C;@^G.O1^3!6_9B;&UEDGT"[,TREQV?R
MMEUG&$>0-'T%,7B R5V<JBG45 M9CY,5=<)L"QX:'OMHHSF.^( ]V?V'+&"<
M:D$Z#@7"D$%-H7>F\8#U)MOV@Z>_C]6/=]P?0CX7'0CJ=+M?L,MZKD6GN>5Y
M:P]0*5&XOZ )QSZ)-YUEMKVA3*U4S @H*7E 31Y(WME2 CR3D,0#=C_A >-O
MH 8YI;/>),10[HTA*)6A(GC57WM.[P;4GDMD)H03^"T0?&U=[N9BS=+MAGIS
MS7B/#O_+23K8(Y.V/^>K?/.C)7 2^/]B[SW#FFK7==$H*""]-RD*2!,0I;>(
M" A\]!+I*B)-1'HW"M)+Z @"H7>(2.^=T#M$Z:$7*:$&"&&';\ZSEO.;9\V]
MKG/MM<[9U]D_WC\C(^\8XRW/<]_/^Q0<FH=EX-[LEAKZK1/V_@=+S5!Z<2-X
MR*'#K>F:Y[F\'%'@D"_Y0\/7P4R'VW)MTVIC"V7EX<H.U_$56?U/TY9/1%?2
M'A)G8\Q&7/ECJR8=>$Z3%E[$2YZ]ICZ"F>0! WGT*E.^SO#W?.#Y(?>I9".-
M?XSV%73@)R^<9,%2Y>QCR_FMH\(#8 2](RF>YK<><:K9T\*L\\)B\LW%>*$(
M<HK$\K<[#H(&!VT'L^QM Z]'KZ7LZ0(G:QS\YO>%-H%'A\##:Z8Y55#1:O\[
M8ZK8,P'9%_PIF#;9QKH#$\U6$('"^%A*6!18E VI[D-%C>5T6/5R];P$=+&=
M4F7A/KS[$G!(!WL,DT5WG\LPOQ-./>F6@W) -W0UEQ0-L,Q2S;? W=!,,.(S
MVYF W6<T;B;94_FQ]<U8/_ZFO7Y[\@ 1CY27,5VT0"V_&K;?[9&%4!1A"8;.
M2S#Z:LS)STX@N"&G=2NP^;U8 \B.N[;N!W\W5OP2T$^,G0,>IWJM>+)U70).
M/X&GX=BQ$FN,-9P:<\]KA4;;D#F%NW/HE!**;>+ 5F;MH>@T@Y*-I *50MKY
M2?S$JV^6-PF"N\,O 4<H-AQ "@+NL]L CP9PSQ$K :_,][>"6<YNTS5GV[*1
MRCP3W2:[>_9'WNMHZJCT-.WZ3] Z<,^1/;5A.>(PWY684:&3?1FO5]Q5[K/^
MUVE^>Z5>8^EN'3O/1+NN)3_@D!>J0PK2!J:]X69SR#\YA"<=YVT59(+E. 1W
M&&RJ7?3#CLT73-!6.)7-W&&^TW<)R KP.O+8;>M9JD7MU,L(U/%:1(^4A?OS
ML!^8=:I6=Q@P+^#T\_=_RC?P_[V2-PUC. @1X@8^IM2\H.?R,O7,NYHKJE^7
M@%]WH6>"JJ.)7>%VEP#2-,N]9JRJ((ZMVC<?JB%&X@^@;;@;>>I %U4X?2YD
MKF3P!1(,)\"(7V64>N'Z-PVM1P]*J*)@W!5\61U\F_%>U%WLFX_<F;4J<ESH
M)]Q34VVQV'ZJ;YBVR=ROBZG$SV/[ODW8Y\96O-R#K^?=+.A2<U%-,0M)/OSW
M\,Z>G&?L,3;&;QT+WD@, AA% &?\B17H,*3:5K> P)'IP=#=3J:+-.W:+PLD
M\2W+"&WUW&J:USGEN*&/^D>C;U&!K5BR$E3TXK!)OX*=WC>G+#;R(_5X:/=H
M@S-RP$%+C51:^Z#4A*I@^5EM2\]*')E?<ICM<JVBM)B+R)_#AZ- *%9(Q@WL
MV/B+JC<KVE\%E4M'!B6VPK7BCZEM; =4^5/&,-Y(7XT%>;OB)Y:<-PSU,V<T
M'XM_BC5E$4N>H8FK>JE(H\/PM^//U]6A,G*1W6<[7XKS\)EK6@D.,NYU3!DG
MC^NKL8 TQC%#O\[/C9N%F+%##WNJ);O>:SSR/]6ONYEZ_+=U59B<4&"9;5@Y
ME^&4<+SY)/%#$C= BW3::9:F^TWH(E<"(]6S&4M3!@KE,IJS?QT9DB\DQ#[V
M*Z^A+@HG#1DYG8C:/L6V+$^ZA2RF,G?82VV(!RZTT/2<YSVN'93;8PW:S[.R
M"TOBMOM* Q)R1]&W)8C'3IG8UG/[*84JGLODV?&V,A+[=Y<F,.IX<"3?F[T=
MRJ@A'*6D2";PCHNG\<O9/[G57A%_6E065IE9\YP@#QL>TSC9P+^DC(D4@QZ3
M7T%<>X4ER3)PNW@3'FY[M/X-SAHT1C8X+P Q_6S'NY> 2KL?F[CU2AD?@*7"
MUN%6H2'+G[#!'PW&*JD+89L6<?NKT[O3 QB$TV&O1W$::$?H@@34 ,KZ@M&6
MD8&@G8]N794=F/FG_!=_B6"=VNJ4>P#NGL8]S8SWZ@R]-(4;19KO@T,0_O,'
MC'\_)GC2T/Q;B&M.");_7G47;BT6D_C])\]%R:Q:S01QA+!=L[;NG/RG3))/
M8Y-#4MJU03>(T491/Y88W-V<CWNIX3]-,I:F3^.2E5Q>K^#_A"R:4[0C4X5%
MB8.3G_VQ0;TMP<>P/X<^+)&V^_)N.ZNF.IXK4)\D,NC.IQW^$'0M3I8\PG73
M 9ZLA1!M@;#7:[^/B1:ST.LHIDVMR3Q]?AU,IH2<EMP=X#$3-X[F:ZB\?RP;
M6@NE0]=C*6U<.L[)IYIF>2%R[P:^3 _-2I[/S?+G&)!DQ/EEOZ8<1B3[_%:U
MNB W-C[)]?72S9&-N#\K7&J;FLI;VG,-C/>04$8,<:3<8%VML6L.PS)6I<"9
MYDT^.C8Q*(U= GP? '-TPA*ZDS2$T4GSVB:#GY;FR=&ACO8V;A9UDM,WVGZ]
M.7,#/G9N7:QC3IJ<G+0+PL]^9NIWU,*X&*LN+5S RY^KINCHOP@."@RL*PY<
M%?$TXOP4[8/@N\8)Z+"([KE;B1%>+!*B,QQP?7ECW/$IUIAQ6-"8L:65'07I
MUWT? [*.UQ'X^<@IE*?@_G\VT&H!^Z]BRMR!.+&O?R7VQW&SQUKC$#B_KR4R
M=(Z[/3.M\9;YSN[JGPX.T,<CO[NR$WS"_(?>&X909MS"=L'QR6].5\M4<\$=
M V_>GK\RDEE@B=:4+[;.?GEMTVB;!*7_8P"!81VVV@XY2[>D6\\)IT 2@"Q:
MM(^ 2T] P^K9I0-\_.U I#,Z#.M3T7Q^Q'T)H#?[M'?0B< *E#4F8YFMIXAH
M:1X77\.W2BDKX5+5!KW1@A$UZ;FY:"N^>?MG_Z!4S%/4T5"@*S$SRZ->.\@1
MXAKB_<\1W6D9J!E!B4L:.4H8919RD?XVN[+]2[=%_"M C^Z,<V1:4[P&J?*7
M ?VP6+^9==R0QO[SP?^_M94&\*+XWGS :DW5%V5?_OMN:X"4M5A_!)XLQ-;&
M].<M'6WU\H+,FMW L\#:8H\/ZFK&]8^2<N[.,$0_"&L%\C#V#)GOG",2S7U4
M42Y2 ?W:FS^>QL<K_\Q<N.Z($;6-M<\9[M)?8B@0K3VDQ8W7UW]%0UF=<8+L
MZ9;F.2$W-BRFX0 )PL25<%_ENTV$*:!'<+O-->_B,S5N%?28>>X5854-8O^N
M6TV!2&#2VN0EP,.<8\.()[-FZ.E_1TC@_VG_Z]NI1E/X'@(36@>\\+SB2K=.
M!_]RX= 1>DNJ3)I#)Y0')K/\3SKG8"BLCF)<1BPY1=M?-FSE:_B7KWY //]3
M1,:(/J-3?:P$;V=G"ORC"V6ZA^H@@9;@&W,YIYMDJVL$ZP^ M]9+[3,:*I(G
MD7CM#T6<[DC,9+^ =(]7Z-A7OP_7 _')N"/G_;G+4),97(NI=6HT2GSO=UJV
MV5/ 1$.+LD4_\C-35I=W>O+4=0V4XWSL<>);G1E;IX9):#0+Y7%JT/DET3;J
MM.-)UHQ#Q6/JEP OM@M\!$Q;D2I1M,&/8L7^1";S+Q0OE$O0#O].'UC<*>%?
M\[;#7AZ="B,"X@&ULC[T5IO-X@!)VU>=L^MF4TKKY*YR'>3]>%.UZL2+7$-!
ME"*:#,]G%1S?B7%UFT['O1?WN@0TU YM^FJDUWVO;(+TU5<%(B69+<,EUF W
MDY.K^7\DZ?K,C+A9,>9C#/<Z<VJ]5=::XORK)#)>KU6I??IT.#1:)B.+O+#H
M,N,QIT9'SDS_[ RLK(SR72#O%8,B651D-<M@3ZN&1>PDGU;5*7ZFNDYH71*M
MR2)YO<+F(+MQ7,B*5WH@P.,P!+Q7WNF>6&;8XXS<&GVH=:VZ $\6C_?^30_V
ML\-C)B6M7OV/?$J$LJ1_6/;J(0?>I"9+M*) ;4IXW-,Y9,"5Z&I?^"%\RR1B
MO'J>%J-B1R,V9HSV&NCQ? XP'E\[AP, CR(K-^#M1M2JEE+WDE_+)(H50(=H
MLX/+,C-Y]+0#]!D 7K=R).#/2U1<UF3O'=+J\05H7?_TD4#>S!0%P\I+@2[<
MP1?XH )M72*GWI7Q(!D352-ES*>WP*TYX 6^_A1/@8 U[3(8ITM6;UP"'-C.
M-1J=0O/5$D!WLR47%ST1&$'P5;+?!)Q2^X"CG8N;=IIA4S=6ENG*?FZ^7(VV
MT!E1_JC2,C2T:WI!LTLV'R)3"?RZ)_&;&[$:<@@3S*1YX0R^("TJR$P4K^^5
MTP2G\$N;C+S%R&</Y9EU,4G2K[QU9G:S/.3 H(Q$]/)>3:D;IFGO[;97IS&@
M=O+RY@".5G62>C[?[QVUD^_]LIM8SRQT6G5_/>;G]QVW?;+_6NX:K^M/;3QQ
M!=E4KG([V/O07P*^S/_MS"CLMV"S37C;K!-""3MQKJHZYQ!;W0<XG$=P>B$R
MA$X<MFIQLMG/6Y$6QT3;['-PHR -.U\ 1PAA[M6!3MZ!=S]A1=>>+]=)2?&G
MXG#;&.Y)N9> $QPXA6E<&?95L(?S)SMA-T:&M9^S[7W98#L8-3\_M@$C'^"T
MPEHQ].37R(O:QG^/5ILP1ZL=@D]W<'UL-[<5V+%RC>Z*A!5Y6+V)>=KFSTP"
M[?UBLNP".25]#L:AMS,*V',8QUB.FJ_.Z!53ZH^$,[:0$,$4KI("*5X"H/.8
MSY< I *5F'4Q&*WJHGL)$,K"7C2C=7!?HYW%=OK!_!S9W!8-$ETOAJ)5*BQP
MO^- AD\U6K<9R3DRA&E6/F7;2Q>TU3:$[D7;$&#-%R]P[\X^JHEI;C\=OAG_
M5P:YTUQ=@=OEPH3 W;J#YO"I^/@U_VV.JKI0$/UZI_9WQY6>H2TC'?1(!!A9
M/B2'FX\>Q='F/^V^9P^;G-'F./%"_[=D\%Q;Z[UCE"B&A4M X%7:F6*RJPG&
M^X+*"[=OX,@ENA4"R\4W;OT1/?%U1$D9D5>S9U<TZ]XE54=DYGT.[XX499R2
MBBJ4N%[QX<X6:;''Z$5[+&G]1=J=>G;\A:7-G\ (;_KV71)YY"[9DW-]V+L1
MRS2-O.BH]*5TME*[ J,XAXD4H>1&9>9UR*.@A9.0'/]^S_MW'4Z7#X0=1IY=
MV$$1/BPP#^O3Q$F-;_Z='<H^X)/A\X:SQ::D7'42$*6(KE*,TA))9+J?;&N^
M_HJO.M?G@ J96&1B9*5:B:HLL1:U65??><''OC8 EF/6=XCCU.OH]7H:XZB,
M5$QITIMO2<\3W\; 8Q[W_'K44N25EF>5M7%@;O['M^F.A_W@*):>P^+5\9R=
M+"/MN#LVWV=I%SZPHXM*-V.[DUWR-,ME^+H(OBAY<-7Y'W:^,$*/=4S&AF0B
M''X&V;QY*'2Q_Y,MQ_K;?EEL9ZLLY>&LS@0.0!*#_Y[%L88-#Z/%-# N95#&
M!/?DG:9!A7,&?8_^@0V:JM_^W9>?FY[^C3UCEV.#9C(&QX<X D-PF'</O-X)
MR[=;D;V'MDD>B#@-[Q9XQ_$E76*V\E,7^-:Z*"P8RS7)?;]ZWU !&L.L)!QP
M"?A$_@7+O5]:6#$S5=;^I,*F<^;L8>CI03N8ZFB :5_8UU4LX[7F+D=JM9RL
M/D3R+ 74/#VCZ&Y/VT_&&?B:2FDIBY>18+_49NS]S':.D2C=YS@0Y5)S,(6'
MD5#9S\]0?<>HSYAO_B-?YX<_R"6ASB\!+!Y0+>A HE$]I)1N3H$*\E80:)2O
M'1??71 <SE)M-7H(&I(2ZIBGLJ%B3_XU/^V?$+JVRHTE.&DV.MXE]8B!=S*I
MSO^D,V&)Z<#I0+%#X)*J2PYI;XZ9J(@QCA=#, JHYN *(3HUB]Q-5L7O'>'4
M/1&U'&F&*J7FIN@(V&;FE(0KT;8.#Z7)='7":$^%PRL0B[$,&: P@E$DB:JC
M3: 4#L,HX40!GL$EH-0&)[5*/-G:FD_9?C5OI32?72N0,5QDHS R-+8&,667
M3ZM;D,3>SR_N[\=+*6.ND6#Q!O'GV"*F[J4GGKE@U7NOTQ[S6W 0!.*[B%:P
MCS/M..L7INH+PB=<0-(+ZCH'AGMOH/FVU)X(G=.O\]8FBTK:+0"7ZW5\R[:#
M\"SZ_E@E^G#12P!:"?/(/;\P,.GQ,[UP?X[WCWY)86D/9B,B88L7GEF?*R<N
M6A]*=[>X;*K($EP"GH/&Q!/HO,)9%8^RZ;7QZOO2'FQ!35B/H )-GY!V*D?"
MEE9YG4R?[@\;WY!6N<WBSVE%6R*54MAC^](H+'_,X:D'?0B&NMA#^U7,Q:L8
M(F/; 3PZ]1^#8U&$$D/OX*.-W$BVD!U7:?X(UF,%_I^%#61P[KZ-B@LRX2/X
M2Q-XAWDP71I719#:V%WP]VP_0^YXM\07A->47P[I#AU-H44S3.6/!]ZY6"\D
M"^,#($<I*U_7"?'FH:J3[BZ[LH->-GR3>65;(B!BE*;1A(@#V>,SBSZBA/<Q
M,\H3] 3AQSUPN1^[S\%$,LHEFXG5D^(GU'-&G111ZH_HK>?=KN_(I+9SXU\"
MR%FV;JC7'+"\^ZXO27YEPWND2]"Y6PI^H4X>M)UL?-KLQF+Y=#^QWC)X[3:)
MUUJEQ\U*)(MS>Q5JJ/#'E:?"*_%D2&SXTHJ%N08B"6-SA91P>@2&T[KI3'/A
M4SYY@O>2'9T=+( +01@X^&],KQ04C:' J;;=OYT&'O4FSS,+D6(X<4SL]3O:
M12 ]1OEX^Y4 U>S!C<0A,7)27A;@ A]8[*59V:*IDQ 9^L.N;B)^QY<(<E0M
M4GD-,7VOR7&TI*MQ\=G=YL9GBC/GI8)OH@2O27]91L4.RJK0-A)N]9_=_E*P
MGEZ7UKX7IE3S;6\F.: CYI/7:2B=1:6VD[A%F06TA=SH4 IF<:SYK:5*@+)2
MCX@^1OYQUL>;$BU=?)V6DLXJY9DI>J\R_?[DUS#H#I8+74JJX]%5Z/-ES7)*
M(/,\H\YW7E63$J.)< TKH&M;5)?JOJT4E?J=<G-0<N@;.UAJ^L>S58^:YV<W
M0T_A2NB@1?6[VYSVJM[="F^>O4OIONW.^#8>PU^$LNJL?<<>.M]>GT[.8),7
M_<'RE:3BT!]6"4>W'7M8B,Q:RK1L?QU+\:^*H!)#+%+^J-M)?^YF%VAY"6A2
M@6^8]>RM=95[% XN3EWHF4]]-!Q_H9HGLU3&L+;)JQ$66K.Q:"'>ZTYC8!XL
M>BY$NO'05GSPJ:U;IM!<]) B*X:M&Q%@!Z9J4"G^8U4:45;-O1(Z_*OEY.4!
M-7KIATZ N&QHD9G(H3?TZ8BYN(TYA8]ZCBEGEE[:!L%<Z$9_8?M8FO(XA9V:
M+KIH42U"R;#B?,S&%LU[+9#[9TOW#(@[Y0!TY&DR\ IIEX8CEJ\]C(Z7M/>J
MDCS=N9,<1>L:(!6D'9$UMPT:7TRD1L;ME'HB.B\<BV6DR1*I/W&=8[!-1@O0
M7(V1PP$;GP<C]"I[]@W]-6GG%W>&SKEWR,_7"%"B:TW<\0V.*%460>Z7#K>;
M7Y/D2>AS=K='-GOOT^YH*UWE)<[0IN'+_T6@.O7A%XV&UX<+D%R8PBH;+0YW
M(4LN 0@,#O4+%VVH<V ?5[$=[;)A_?A7F__RZWJ-*[$]=UO"R4F,I]N>D=+@
MCR%FY2V0,3(DC7%*1S0?=F-"CL\C46MB9H.:6<WJ1=1T,1$'VQ\QV0ER?HUV
M;6+8.Q#5@P85W^.PVF]ME%0\'[TL'_?(7@C#FW1R%TL'D$:/W$*E;O$'HW8A
M&7L5=P?[.:>*_>\PQX> &^:P_J@S]/9N!$;35S+9]-T1PR6 A.I+W >B3QHT
MEEQ.MJ\X".R'<JUA@!$Y7KNIM[KRGM)F7:CO7?L6_2'=R$\<J_",(C-&W-I+
M5>ADLDR=+%@U'G**[H9:!;_3\60D3G[W.2J!CPQ>-Z)(&S+Z9Q5VI#D3<-GQ
MZNC;Z\I@,VO7UB0"[E[";?07AW_F"AJ7>_25'O/(^W<CYQ9<[A]MH+G-*,;G
MYDBAK?RK0A+#5SU["(;<58!MC/9N1N>,_]$/O_;X98S=SRL4!UP7P*UF, )C
MUUZRD+"YRN\!<OE>\]3D4P(WP-EX?L_/(Q;[:?Z4%8CE:VQ09W)E<HZ'Q/2A
M1-<["[56FV'K7E ,9S+WQ8WBYMVS2T $VUZ,-?20[OLEH'D+*[H"_?W_$+2\
M# X!/][%0-@N ;0F\_KM.,0\U,D:=!PICO5IKDW+NP00W<.!!7D[H7-L\Y*&
M)L7ZX&98X<\$BX_X?3V8K=YF)#Z*^P*O>5\&C-'7M%J 4"KZ.G!LH!6C#2&I
M; "VDP(9 6(P-4K!,%"XT1K78^L_.I7]KW<F^\]$-*V";S0OFX^#M];!Z]<;
M'S8,+51CPLX@%[[D%P!0KD'\!S$+!;0U4NZW(RZQO:/$$!^"O!]F[*N]'#0U
M?4_/;S* @S[$)_T>J^DJ=Q7^:(?#Q# )\.$UQ6U\A*.A5(0<G&#AXL-)6_)W
MM'A'@)80QM.4[M1018)15N_ _P<.MO]N@BW-ZY*CK$2]B1FN>;9K@3^MH3SC
MH(#MV3U%0+:DY@J<Y2+2M]X_--\0?R(6E9*H6_[.5X/ ;,%_QR4@1]#RX&'A
MS-V%XPVL\K"+MJ)S:E""QY>A)7"PHX?A:X^*OAL'[ZIBB%.N:R)K]:PR.$]@
MBF,BOM)*56J^4H/\'N,O\,TTQX^X9Q!0T1DS6G2?L^BYIX%790UE__(- VDO
MZ$D4Q+XE31*F67+O4.6MA<J]Y;D3"0<6]-T^W='5\0ITPIA>A8*(TQ,QA^E!
M,NDSUO2E%+TY!A1^&@?:47:V_5U=*-&+U+*3)!!LW"_[/-:8]?[DM@L;V9SI
M3%V@\,.G0<612@#,^7$I"(G]*@;=:T*MZN1NOZG1 M=I\6".UU"YE8&-':/Z
MLG-37Z $&&D[3Y:Y2D^J/X9[CKU=WQ,J1/2_]\:T'QW!S&]=XP0024KLFA"T
M#A/XK;!?^]I#='*JTW@]'N19-ARJ-^%W577L/VWF)_^/:R([_^XZ%+'G6GVL
M5&11ZG#@\PW>TS6S8V#>.%3J!7*5Y$'.GLULAL?9V'I/T,+)6;E])2X!\[O8
MKJO8RV7?PQ/<!LW"\ ?"!480(R;!J!F67Z]QE_PQO&"D=-6NI=#%,<\W4Q9[
MVEYR%J.3\J_8,YHLN('I-C<&CAYY42=3_1^Z&ZW)W;<=L6/EK:P)%%<TYGS"
MQCAX(MM4.?+[/5O@5AGT):#A$F *,<7!H*C#?QB#[T?-9#9F=T-Y*HTM'&__
M84@_X )(>[0?#>VJY,D0JZ)6*7K4(<?K 5+<6VGZ<J:>^'/**NJ9#\+W!S&D
M0;.@9-X/ND\T =ZJPW&63/3T)8 U6?S")?%40.WW2CQJ]B/U$J-JE)87UE[Q
M--HF<&M]^R=GI(\T:IKJ?+\9=[UVG@>XG12)KK Q8)17IJ?17K-8&T?90?(]
M_WW>LVAHJZ]M!JO-\]#RY;#H5035/+J]\P^DNYDM/8!O_\G:QT<7$PQKPZ!1
M+[E$A\P-NCK[_ XQU&<"AOO>92?<G.?)I[!V,_:O[5)UFP;'52?4? ]Y4JCH
M99^U,DATGU&;_5S8#9YDY8E_^R9XRO8IU5V!VM<M/5.^7BFL[8TNH/"2W.[E
MME[>^D;#*9SRZ'4G2=;S([H77P5G2K (7[@6:S*;V $DMJ7_]G-J,\VR8X<C
M0FZ(9P:>WF-B,/F/]K;]AH=J--U[TMGI*XQ$).15_+9ZXV.U V;EN1.0C,KF
MD _,(X)&/W>XZE/)6 0HY,9V.@(PUY9NCS>QH0.0EP#*F9*2BOU6E].?-]KL
MW\ S\/U\RY,/!L07YG+<<P4ZY[)H<]KS+:N%Z;J\A;M;S_!,;ES$SX44J=O(
MO:JK3+3A>=:.UTJPSSY1J+>2Z96DVOB\OL?:EV.1G,X:RQ@LEN-<9< <@\^<
M[9CRFES3.3*PML\\#,M84TM1-V]<('%@^=G^$@!_#AUM.&_'4DPVW9F=L44@
M5GF2@KT+J!W=\#+S6UK./O)+=YD1->SY=EPW'%V=\CEUOAN_;'$G2$+F+)E#
ME7[%0;NWT=@Y)^/0M+)?W&UDQK@WIITO4%DAJN6$EN.!_OV.&WB<:7X-U0M5
M>9QU;CFYSSJ*R6*?$@WBO7[ ZL]'OFA+'C;'5^/WO$'6BC>"5>CA1MQ^"S1>
M+N7UV;+WI-G P?Y7;]=?%UE2IKJ+>8$B/>&\,HC2/-+CIR196/QG!'OWBM?-
M*1MD8;,EV=1]#D[+A$NUZCE#Z>S1T+<'TZ)+<]1[9 6+W7.+]*%3 \PVR288
M>(V6U!)$WG@*T3JKT3:P([*U?H3'E&#=D,4,M61DA[Z%=%6Z;)0(%83;3G[8
M-V(- W9 B*9-U/"GJGZ^<HILMHI;\/>3,-JDG'PV^532 ."_2>H3US_X:Z<S
M*5*%FS/YK V.E3^>/^H!1^47J3^9%,DPTF>NE?6 =H9M5$+H?UH;9&3;N>A3
M?IHT?.#M>NKVH?)7=:+V\^<S9AK/0@FG0!RE$XS =!@MVM)&*-C'U[5DEG1.
MZ3R(RTD&SGEM>P*GMMQ"C<Q,@X)])G/KT@9R-E V1OJY4#*9>NL$]L==[X6A
M!5MH1%\R%!,  _[I;Z+45 J+<P6>$IN!$>Z7@.$(,S8WRW #;;G24@=MU$F@
M2-'I6YBHGEIP) L=+YO-86\!XW&I]R(0,J94':L\NLJM&_5*10NW4NJ@X%W*
M4]=#F,0>T-\*Y5;89<'IY</MVK'@!#\/!3> Y8?2A6^I)28;,^F5CM?>*9+=
M4D0<SE-,RPXFOA]KB_A6&S)L-?P.#QB@66";(*7XU7237GOZ<1[SLD3/(6O>
M#[T$ X,IUS@#M_?98GNEXQ$$ '#:T0$THD'?>3'"R=!(X9C'-&92L+?V_,>1
M1 ^F[I96WI" &%^)N16+NZP&.%R.,72A*WJ3FEWBP"+@"12<].F"WZL/+L?:
M-"HH*@%KJ:X"##(R^[Q((<EGW-I(/F"A7]@I %LG,D4<&H&_?$T0NM]S]_Q!
M-]Z!:,AB\[7-)LJ(=ZQZ-=^C?AT@NULYLLA^KHT[H@W2!K^Z_0&?F@Q=C1D^
M+N&'R]V>/,+_-E;))K72RI?V-"R%),WP\3I_!BRMZ0J,7P)P^/#*X7V8U)?8
M4-_O<W'$NIXKAQO-OQWG_;UY#G5!3JE+@+_8KVQ]!T,!YOLZ%="KD@Z99HWD
M2\J8D$GH,<65;XGG6AOLE-=(\V_^(J8NEX#/6"NH\072!Y)C?55HB.*_P0WU
M_[3_ M?>%:FS1^WF^WSK.!B[0H[]R+_VUPLC73X\FQV_(E1Y,AL.HOX[3^!0
MS;]GBE-NM\??@DYYU.[[0/G1XE;2%_ <MO^YYY5&&)9"?#L?=G%Z"=@: R/Q
M$K%^1)> #Q TPE[1\T3R?B0'ED*EWAR.NS:$'@6W$3E> H CX/F;]:$\-8:W
MQ3'LB>8'I^07^S9 Y(V&;7>"9;NZS+" :!Q]:R/VGMJ<Q\&52\ MF"^2N(^9
M]UW:XLUG",=;&IH;9B'_?@XP\KYLU6!8=&)<;/VQIZFVF@M^BK,I.8;]#(HY
MP;'')ASF"2FV_P=GKRI."!"WSSCT+@%I5<TGTV"4"'3O\R9T'K<'FX;0H/01
MU:7O,@=8BA+0Y#SV'(C$,37"-R4;!!<X(KX%RM16;(.G@MN8BW#RF^W\].I7
M-QR4D%G$H4:_1J9003J9!33P.:YW81S0;#5Q[_"]=0E0VSMJ0&CS=2%L/P81
MI$9Z^Y)Z=_Z37UGLR4B$ZWF59^)?W,A @V#<#"QG;IC_+<&#+R,H&!W^#=Q^
M%2ID0/#\SZ2)I140NOI\94&?SMIH8UDGAM6FO$#]-,)5S=J[@>89C+#KZ!SD
MJ0B$ML^K($S]<5+TQP4@RG\W#;Q@;O3K Y/'\:#]PWF%"4$JXGQ Y)P*(3$?
M^-9:^LMALB46=5=]DST=9=*;!>-QG%Z^- 8:C8NF0NUN8.OQTB=6.T\;ZB_H
MSPY+];Z.L)1DEP[8[I-'2!5#K<=</K_B('SW^EK-*XV)I6G24X3QPE"P@1E_
M@K$A!UUBKV$,G4\(=1E!+5X^YD.*>5<1@2E(??RI_4K/M8_-+_3#KFV?0! $
MHU4YS'KEDEL#JK&.]]#J2&+B+4/7V2<T-99QG0XT8?$FUQ+8CV10&Q"SM*+\
M#3>IQBRC3;HRDR>S^EV.A[+*2#/G/7?S2GM!>S)#2L%1@P0N&<_@QX.RS]BQ
M; IFJ2(CQAVC W>5F4C*ZP& DWOQ!J>]Z5F_)B!),FK9/4@HS>P/90Y(>3<3
M(P&!S;6X-03^A[N-^W"=6!#Z0_+G'P=68S^SV5_0_9"_<#8C7U*W%0!W5I]]
M!@2S^"FG;1;2L,$9,7:S+HURID+(?@/=9376M.E6!KY.(HX];K8 .Q RXN1!
M.\9IY<?IO-IWJ802JQ?%M*56SQ18_9VO02>;4L9<!,15QN@U*\I#[-L"+'G(
MDR*W+Y9V[%9Q&P/<C<P$(S!L9\)VFTS/ W>B]FP,RU?-F3:BK;$/)^ZG/X[*
MGHZ^^:"PY0$>RT?;$X>;LS?V;B8Z\DJ_*F?L&;HEC GP&.JX6F?)L(LRW#I3
M,>M<"-990\XEX2?]%"A0@IM0R6>6?@M[E5YBH (V2L,3J9;C1-V)_O$U]<GZ
MM1CC&], WYN/,?PX@4;N8:>^-YF64$7!\T*8LX-TG\T .)8.^UKR&OH814(U
M0$G]PY2_XBWA:?2G5DS1QNPCW?))$;1#\1O#DA5& [;NR XO;;-C@Q\/$NRK
M:]M]M/8B(E8_.1=/3V>#CIL;W!7AR4FG_A;-DD-FPG,UT,]>Q<=I#XQO."^;
M=6VN.T?TYGPZVU,>3C[4##F[J(I'JH7=<[4K6MG/"GXP0W/TULL14@ 316N^
M%$!$IM?\<>H6K<*?XM@;AW?@,#Q"7*>!U.EM\%3 $4V(,QA!> F(]R)OBV :
M);_)M25//> SZAD)XDQ_]56SNE=#=FNHZ>JP]$3\XCWD%%3H\\@)]_$NF8ZC
M\O"*4I[\2X!+D JWF2(X1,HL#4L^(337-@$S$"%^_U*7_73\_8\AU7U(8)5;
M-5:BO+JA*G"13H4H\C59'J%CZV)CV&]5H.RZL7\!'#3S.S\,U*:5SS:]+TIR
M*B.^&T\9=SI<MWJKS:YHDI)RK64Y5E=;T9DEX_G<?1Q$FB>>MTF 4:E+Y1O$
M1661D$O@'Q_B@"!WN*L#8:KL+X%MKM U#V<I:7O+Z<AP*?\S'8P<:@E=(EAR
M=,V>%*->R_&9EIQ5ZJ,*IW_*A:+1YY@U)8WLVXU?9_:!%![,IGOCUQ>Q/]7+
M[OB@3:3\O%F74 RPQV@[U,TEK?HP^8DDIB=?[=_HW](828V(E"(CKW:RJT/Y
MSL9#/U<J-[_>-_HY9G?;X57V#=9EQ"</5DE+5%=X&?\CXIQ7]*4C?6RYUTK&
MCJ-\X/>S?MD*@FH/L_<4G/%:':G4B"-@MT,9GWM1>(V[N=%YN; J1F33E5'7
M]_D]"(.:D!V]"EV1WOXSVI*_'RMRE6\@#XP8N1H\+TM/Z&^)U$IX?:SAE!@Q
MJW\\#=@'^K$=L/S-8<RL5J.ZJS,02_6GQ[*,VA)!<,1.&5T0,=O=/G(Q*9%B
M"4P<]JU=S)@,_:+ JY;YYS9.?6\?!=TOJF>;)9%W:)=!J:.BHCS&C Y4!(Y[
M'*$[.Q(7PN8*Z#?>QA 2FYB?O_9)O]\@?'#S)B$<(8K@]9;@9_5Y4:27^$C.
M>P\1<@0DW&Q=M'EZ][&@/<."Q&T*^?59SU]@OC/5P4W^<V;O;B)A3:;>ST=3
M[1R'H@?P#IL201G/ MFO',JU>"*^Q)^O-9NLS8MN \DG$"U>CV-W/279GL#9
M<OGX.1>SS1@KN<F"-W#@<DU:\Q^XA"\7$D;RW,-9.720\.[#+RTUB=8"_.X]
M7<^&Y#?,)6=P ]HN?N$KC@TRUP.IN_V*;O\<VI!TL-NI?G=>!14B]JU8V_1Q
M^;9\ &E,'E[U[-"2J29.DY/^5+,0JW=DZG,J_Y).4DMI#]AA77/?,#1G B];
M7GG(XW1D1J4;&+?OEI4TS]"Q9[IQT._RA+#BA^1A7@(E0P&<$_B$@B6O%58_
MXM%POQOU#O^&::KL\&%UTV2JT?UX['3SA#GN$O" ?Q3+?0GHD9X ;T.P$:H'
M0I_9]J6A9T>QIR4\TJ,6A25F8B)84?-G9X-?\Y:#%ZL?+97=[P0?:T["?+CW
M(J'.N7*U8 >6?MB=2/QX<;X;7<8$X6O-;[TG@!%&+B%%-G4)SK>_,?MXT;Z:
M+[T$C)9@[J%<(ZJ@]P+ [Z.><3XT;H@(>*_,']O"'GZ^-I76U#=+53W))KQQ
M<J8!+33R33CK)0X6_AC#?L<#SAHT QIHNC]"$-2@Z9O+01_*?5-,5O4!2>T1
M.P5YC>AA6E;A\PVZ"-=\4T6'6T=6$D/#KL  '\1BH[6'?\?)5'(@Y< ]#M)Q
M]FL@N2" 3OO<[C=42I7I4+H/]27@KE+$)<"L %,(#ZG,QP"1?;,JV$-M["^P
MY] MX$,@R008'S>-T5E@1"&8#RGW:,OV;MGPHG,#M&*0X&7W8S!J"?)RVY#G
M0*-K'\K%?TJ+)5T?</3VA0UV-C1,=VE*NK4+<R,8<# IPIOTA0?_4WN\-C>Q
MAX(_VSQCP4UPS@^,<*3Q8:%:LGIDN"1[]/Y)*&Y6WT_B4!,6?,$PD;$(99SS
MB.0WYIHE2[5C*GZ_MON-86XN;]@-TS.$,L=$,LU?@(<N 5E,=>0,:"I[9LWJ
MR6+Y6(TT$1ME#Y:/6]@>;O_IO%QOV5E!S\G$1ONZU.9V2!!<F:C$%K5XD7A"
M\> 2H$7NC!UAJ??U\M+W9&L'!M^B$B P3%F3MA?DE+&H>'T)X$![@4I!7&;O
M'#P.>22<O(/ZYNXU)>JC#'+<SL/4G)#RRP$$MX   "Q=1@!)*MXN9=^@;?SD
MI+ V>3U=<%!Y('"3?MCK@^@"*\_8RJ@,J,!(4CJKYHW!NFILK>:R/.S#7F+8
M6QGU''E.YRZA)^1R,]7])?.1"TN2M)5V^T5OG9$E0X+VO4WB>X&IL'5WG8MD
MGMW%B.Q ),5-SNMN,9+L!Z=K)1Y@?^"RZPAX:Q]X00BJ\=CJK&)E&]Y!BA-.
M?1X1>=\2D4"BA$?Y@V0MK1*))<$!883BWV-<[BCR[TN'4?9M<]@/Y>$DX8IT
MVY_Q#/_@+^Y=X@'"\=/;]L!?K%=EB*:"NIQ?70("'7P(+@%)_G^F0BOQ9O%8
M:P&??@'^>72**!M'8#GXB3%<%ZY7$E'JRCA)_D\A[/\<Y:XLC,[T\&3;6[L*
M@/"$U_PU.S?M7_/F5B)"?5[@/JD*@6W0O0K2-)707&360O== @B:5Q_]/9UU
M@"?X][RZ:M08 W6'B  :[>>,_]FH.U;-3#0S',M2'4/*;SRZO1A]4K=_*M'U
MP3K"YA)@@<$].^.JUE.SW26@RV[$NH1%Z>19I[:*H?A)"B+21]9]T8&T*M62
MD[+?4GGV$44-X^'-JHHB4-GH_1(NOM=^^"&AAUQZ>)!W?+.T]&YE>7RKJ[=6
M9,P7BL"4C26_6$VDXBN"^_C?LUSK,8!OX(:KM#24VF86/S.[&#=AV=H1BYHD
M&W.\8Q_@'S[32F<F/6!]M$G>[#B_7_H$2(@^><9F-=( PD_X"("^U3%\O [@
M0^.P;+2BSE?5+J<\1NDCF5U-M+VK;[YROD?U\UB]&(ZX:AV?=(]NR>VT%I(E
MJ.K.KGWXF7UGL;%>#[%2T@)).'E;\8A"K'>DR!)M1A^:N-T]C6[OP.9D5)XS
MURWQ@3"_'V"'0 :$HQE?Z^OYA+4-Y/\]3N-_?NCSE_(B2S+4[\]*FU]F#M+:
MST@(I@![P]MCX=H;IM!.Z"FM/7CK"'A(4,J,K,;$D3["3ET"UO-*-QTUR797
M79_PCKK+OD8S:VX[NY["T#ILUW\<U]5> N#@MKID_L U@>A>Z/6?Q_70?3:D
MNMR-RFU/\8M]_N(K5MG#=MWXN#$1BZ8):HDZ;H[%7D!0I74XLJ8\"*1UB1]I
MT+9_5\ZH8,B_PQ]9NL26X]+\6W!P^;^H5%*-H1Z"G _]AY5*]B$1S:@-G,A5
M <>,-]\ +E,7XB;<!:=QU15_"RQ,7,C#^+F:G^U SXA*(:=..++<KXGKE(\'
M!D2)=TH#R>UB;!PW=MV&XZF?W2.DB8XA(.#$VQY4M&"HE>8H= ZG7?:ZX5-;
M-*^^*$1M,EN^JM8'B:I^3-0&26=@"_#ES]J<G%J-MB\P>K<O2.\4U(4<))3@
MCI*G/0"'B'A#2= )JP/[N;SB;0L63E9\[9@].ULFL;J4FD8+NBK90/+/:<SJ
MMXW5;P]YZ)*Z<;UH;7QR,>--.78 HZT+7&MONI-,DT@O)LYE\%3B-+Z&8Q^F
M[;^DGC^JG)HSZ$I1<\?0)U=B*RV+NTKB""8<RG\)H/6(*K;F;&I._?*1$%#&
M";6\#7W!KVIKBUD5315WL*H]7(D8;AK;+IUP*T;=3[>2F+F&K7R545YE+,TC
MH+7R,L*"@&&!!*R:7#.D8E^@]H\)C4_+V]Z7P,,./5*N1WC3+;2S1RPLA)YI
M_N6F]E;HOM1Z\]'IE4T@%]+.$4:-ZCAS:G)'9U'!47A:?,*-KU[)8BIAF?QK
ML%#H/G .-VD2S8?7=(/089T8MD>()E:ENWMD45FW.P9:X""+"SLH>C#4A]OR
M#MO#>1Z"'UVGV"=U0 !NV81<I>HCW[1+0^-TVUW?O MP'C8L)A?8>1H/7/ )
M9_,#[U-,X'1D''B@* F=48^E8\VKE^@P=MY8X=:$BXY=*?:H0!B."61A[4%R
M0F@C[VCZ8 &.N;OABD[!#0'X46OC) MGCM.Y"-7RVJ'>E2"#=3<@>3AWBY%R
M=$2:RB !ZIUT,^H70MU<TD,!7@?Y[-]*8^-LR>%@?7N)(#S^'1QOQMO@N!H5
MI#M^/WE>X[NZ1$V[VNII),$Y-Q[!7'D\HZ2U'<D?-+0G$C"J+\R=4N5&2]WB
M,7$M+5T'8].C3:F_54-=WCSK&E#],5UTG4$IW7_<43]XY.[[R)T_%K!"6Z0O
MD1X5Z)GBQ/WMM^X1#XR/>,]PGQU0!SPV]]M><>E %+]CYO>OV&O6KL"[!%R'
MR:%>?_> +V9[_?&VBS#76#Y@1=\S#K6NP-9>Z1WW .Z _[[C$T?$D[N1'Z]]
MY./>:56NS0%^*(+:$R!ZI?ZUR=PJ_">QK[VS5:'FS<R8L."5NY;.@=PR^[Y>
M.-1\Z.XO6.'=3#PE%T0?_R;+*D&Y/U)NST%W=UZR&,:&9A6B><[\]>G3B9=L
M]<[PY.89"PS$XI>Z)T$ 1BT?S6UFWW.WL[FOH<+1[[',GM>#-8*S-U\O?KG,
M4K,=>VZ5RP5/N(,MYGX-[I;WA+L.CID_\K!N:>(=-=IB?=P0W*2D)![9-%=Y
M.)A4\'.+R4=\\M']R?WP(O)EY5>R_&M0%@^CI78I3!^.$*;/2*O8WPT7'/VP
M.^'U0;E1G:#!T"-G;^"M+X?)4 <UX1X=;&W)*D8X&F,<.(_QIEVMH^\B5?NC
M3,WXG*9Y?YSO&=?^5P#@42O!UO,/@JCCG,66;\]"[%Y%U!AW.<?^*'?GV&,=
MSU)2-8KT^"(A_4YS#X95/A<Z6[NJ3+]N=+J+U.*&'S^][G@[^]PGL.ES%B6*
MG @#_'+E"C#^WVX(+Z\T]5897@*-'Q$**%R,<"Q4#[N*!I!W7 )N#MWKF!QF
M;9:A2L?T?M++XO[.-<C[L[PT,Z.RKKJQ2NVKRF(:P0I72#N_VT(DJ?K_T\(M
M[XW@G8T$3R=V*OJ^JJNL5CE%CL 9=7R_+V#CM<,2.GH= [];>2N^\-#MG&1]
M\#UM5S-PE0<9V_?R?6%V"EX7P]GDQ;UD-XOPN/AA7'^!_[*8R573-[Y0A:M5
M/YJ?D[>CP$IFWP(:K:ZBH0L_.'^<35$CEOU ;%]T>/.KO]_3#7>W,E5TK@-#
M9 0*NCDJ)[?5HJ.^QU("U1><AU37\VU*NK+_KT!0)$8>I:FP-U?KF#UGM"GD
MZ%#MK,!$*QWWH%607(FE"-3V063,QX)E/-F%7IOX509V.+1V-L7"CDTUCXC+
MV_I)$8&@WI&4U+_YE]>P,?CHC34(Y%>EDF;-SRG[\Q6G&2FGO3<FX&988CF;
MA/K+>.=Y]$KJ$&97-7Q^%S.G $V4("F6BDS[ OPDMM$C:&?]IK"U+^$LU91&
M6\OZ_[ZR"UMH@[X%DE100$$K=/%Y]I<G-^J*Q!:+9[N7;MDECS4]0'OK3@B(
MH-\>B29LO@X@[F30ZF]5>K\6GIQ#).H2OF) Z>:@.VR=_49/I_^QUD,5F6MF
MA@4^#F,"KO?\^M22=R:>%]0\##[Q+EQ8]GV6^2"NZO:F$ANUK$YH_[#H%AN5
M]=ZFEW>YPCUY4,OKEQ//K[\'G\$S2J34C95T;(K2,T-Y2?[?CK3YWS*ZY[^P
M_?\KTISQ _OP_0:5[)X\\SO"93.1S5[B+ S>^^!'9LR+0H%UQT$R$0YO3XXM
MXI-O]%E<Y-R&C'LCAL<-HO*191%&P@5-:WW:=D8[R4U/I=*R;-,M^E1F 7@_
MF)+[Y!$8!??S,/Z^ H:/HW5E>-SH+WO21W*5AQ>T>9/2'&R%[M$M'AS(G.:@
M-%EEW=>UXT$\]-+L9V"/\VBX@]&6Z,7-H0ZOIW6N^U"!4P/=0"7<2X6.998Y
MV\^F"N<QP.,%R)./=F_8-3$U.CR<M&%7ZG=_S\OW>-U);N,8>.$UX#WK8+R_
M;;:FU=Q*?/N><B+^(<!YXPPT/F[01W&6E82D/?1BE5T0"@2I>=\L@>'@ 4<=
MOSCCFW?][=\(4ER[UR*;2@HY5++-,GFMK&_SY?=PVRSHU_'SJO?,IE+D,"AU
MG_:UFS$ATE$&$)&I>SFWM>?:!G>MD?H*?BJ<[_G7<1@_1UE8)[N@Z)Z'>(<Y
M^19H3F:\5$ D[#R8K7?ZOL'@YH^0:ZUX!%&*7@@_@;6*/;/X&_T/%1XJ!$4J
M\O4Z>?EWEYSQ]F;%Z7G?HM%[L^([)(8.V=NNS/6U4):_R("GWGQ_#R\\_/ %
M$ @SYR0O13LA<8I-I ="1IM&Y7TPVI2=64B;HI^6K=?.*_?ZU]"7PV;2+2QW
MP\VIT56WJ)52RV[Y'1/4A2__G \SDM^!R.;>+(.:JS"IHP3#G/)CV4 -N>R3
MTLA0W<*5O"<%6A'BOC^1EP#J"A8++53VV$\;$.+!%XOKS^QG$>Q>GT(/(4$&
MB6)R>&/V.]LKU:DRLR.J 8S._-%1GK<I[/(SXPK%:2G;0L-G=FL'T&=3BP<M
M9ZF-Q51#CS(#(CGO#QS 'DN*XJ *J0OIFW8XG3M]LOI% U\,'N?D8.C#H-O1
MH2>J/!'*##6?UPO4-<YO7(6.,I@)[ TTAU8H?TO"%-"<1O7>=)/80#O[FP,W
MFU@0#4)N1IN3BS-=']2^E'\[[JU9.CL8\)56M+M5RL2@G\&4_&LHH6^KB:/F
MV<\C4HV7;3>MOD1B7&'F:->],W/R9ZZF((=C?]YG2 .2.[KC,1+WO1Q;6&N7
M1JSSI 95^Y[8(./,'[E;W4#9G8.PE,\O >4=38^_NHX]U7@"<$P!DWE=W'!N
MO@FLC.@\WI78N"XCN.A&5$U>)V7%."A;/M7X(31>9WBE[%W\IO,,3@SV_^ ?
MDA.TJ9Y*"'K)$A _,%8RN/K\KA6[O4S4#2\66NU$_MI'03(FFD)HV1Q;*:MC
MQ'% P$1>TO+;\Z<"K+\\D[H>#SX$2ET%W3NMNM-*."DJLO*B(.>@<Z>97BXF
M\Q@ZJNQ3RWTUJZK=]1ONYB3-E1#_5_;&@W.CPM6/J$S:/U5+KC'.0MZZE7:%
MYNF@M,LH<VPCW6<.A$+,R7=$BR#;J7=%O1N_U 1)//PH\7('@,>"AG'22W5%
MEAN&P(H54M3(3L(<V>;,'BHW^FHKZO%+%(DZ\;V,R^E/A:1A./:V]%$WEG5F
MIWNL<HOP.&/\(NZ>$!(N0\W\#V'I['[\=A[;"Q$6@9R$P5G7]$@ P%LQH2'C
MSE[).EE,=H\S0_E(-;\*R@C#JNKO^RN,]S+'M 9D?^G:J>WTY5:DS=Z4_-$;
MSZ5Q[)T&1#DK38@*41BJO<R=,U6JJC=,_Y2"UUC#258YB1$JJQ_#,$6930W9
MBT/O[*^&9UE$OK<KSPS2KMG_;,.E/;@FA*(;73UO\8IOS&FHIFZ.K^*)JA?C
M>O*>@/NC.@YM#I"#QC OK!I'8249YX]@2:+UF6L<X=%F"$7*_'&3)WIZN7F^
MX;-@A7(4'43LJU<VG)MO:9>#+%P6CHX\0DK-MVM2;E!_[WQSLN=D8*PO$ W7
MWR07W8!2.6"TLXSD"]9!@=)/;[RSH,B*ET1B+;E9('FLE:TV0'H?14M><:Q2
M%C5EU#K'"UF:=#SH>SM551NS>[2SXOP:&R</#G>OH:$ZJ:_463<I-(AGNEYI
M[QY8'!9O@U6P[0C!BG:)E.EONNPFU]\3+7$C:-?I+P%,L#?5K[^-(*OBPCUC
M^BWA-<R@9.2A.ILVRCWX*>5N@LWR0Q,-\$?J!#<@9-&C)'.EH4)99(F4@]3P
MD.US//N>6<3!2\5P#376I,>:!["[WTB78&'V[]-[WL2>=JQ](O$@1M_FN01\
M^B"Z]8&SLMF<8/:Y]3<1A#J@.L2G4X<&J3+304;/O64RCU-)A.9HISGLFG[5
MON":901U/ZCM6LJ*RNW82T D0N9UC-.FFX:@3K@4QS .U'=LR#FAA (K-S#Z
MQ>ID(04J-(GE#Z6,) UTEOT(;X>>3$L_6]N[J$Q=OK9D]SKR>;99,P\^A=V3
MT%'7VS&FX38C6O8G,L1=0+)* ?KGLUF&IG//U0Z>OHC(MH:XOG6&6\QO)1\Z
M!)T=UWK;NNQ2V"3NS;351FYZN\OSG0ES, =M'6U-CSPMK%4:N$5#PS5 YV@F
MNT=CQO_I78GAG7&D"?^W4TOSG>I#X++'RNXGC+J%M.*]$.][1-?2@[OS6/9K
M%^O9F-#0+BP]"O_X$C#UV;"[2PU$-T*A%1LP.)B5<6;5J)R#L1K?+NGP2DB]
ML97?$L^Y;]@XA&^U?L.>W(9AHU!RLTXGL=&EGYD\2&JE,V+E"".09S35RIF3
M9YX46B!!G(+EQML:+<>0?<(X9.%!T6<*\&K1ZD58R%EB\"_+L<7*T-Y!$R+:
MY_7?\&_3M2QQ?#LN8?MLQE1;,]G5>/]=0D+O%G$:?J2\+D3K&C#"V$G[G9*M
ML"M5KK<]C;:)<NY_L9/]/R42^6NJ$2])2"=U>_<E( BH=86K9%O^RNM@-&C<
M,SCL81<>?V8]*6W072+ 1%0U'RU>6:TWVL 44T%=YFC92X P]/PE[MWXQ_G[
ML.3@?JL_@=O1K>?0Q>]V/F]QXKBE^Z\PM;\)19:8NYF0C--UB>X>C_V  I&8
M%%<\/*BND>OJ!XE+0 P4*72"N 0H@7+U5<54HHG$IGY=54Q]^7MF%L.ZP<8<
M](>)=ZYJ%=4AT[8QQ'1R+=<U5XST_1?!1#9- E5^+(\' V\*W(Z2,&#<E,1_
ML>"VK2'6E-V7/+>S.E R3E]59FJL^KV5+TA9MQUO>+P2I#ZV?5@B-M<VHMIZ
M'?^QA@8!K-$HNQ=4E?'7K#"X=O--QB*+D.KX_6*A=PU%7Q%$[]*,Q?:?,73C
MDSW;"C6U,AO% &VKI7*FC#NV*U5NA+&]N,:]7TK_#Z6D2^L[L%1C/L;V^%*?
M4DE(C"39WQ<_&G<B;&W9GJI8"2WW_:-V^31F_>W4K+RW'>U$1=%]JGP75YD'
MLJ1J^BZS<O.J8_:_!&B**=B?XB\O>)U/% XD%TUK_6?=I/XW*>]R;<@CK_4,
M')95I79:FD6W$NI)DB5=EK*BF2/=AJ7\MA??V"%&;=)=7N/VZ'L,(</2+?X/
MH3Z#D^N:G)ZU)?D@J <4:0H-%LT;3Q]G[5F53)6!/1 ^NAW^H7)=1#<\Q718
M@S*Y(EI9>=3>1?;>M/IW [KCK4KWV[&#*G++,6"FO$6A6QMF/)44FP^HU@DC
MK0=_<@QE8(/N5N7GN'M'=(KVV9-S._@].$TO;5B4V<\=IX:4[FZ85@?ZT&:A
MC1Z^S7AH\JU]9B P"O+8L>68]>> BYZ^:G9V\4_*+,+Z;-R:EL^@[2=VM1.M
MCZ'2X^GT6@AW-#%(VLMZ,EJI9OJ$N%$QIRK:\O'^'1WY(0GY3G<]71V[5Y:$
M/;/II>(=;*0N#I1;5)ONB>(;(I_DG[]^W  @T.>N+G'3T\I>*B125#%2%.!0
M\U<<M:^8?A.-K%8/'J5X#O$! %5S%L$DAAXP]<BN,^/@Q<B7#QX\(*VY+NT/
M[[>S#17<=:S)K?6ZC0AH(,_U4+5+>LM='UU*JX\YT;GY:.R6K*VZ>=?<[1'8
MZ[$CZ4L W_OTBC=$#"\@6ME,ZW91J*%/+U NE ,T10[Y;6)P?I(B(=.2><8>
M@BK-$AU;G9/NF/<!!5FD/@)[YUW.#5.6\_&/J.ND#65RN0ODC$L=A[2$.PU9
MR?<T_>C/5<\,8IY]\.B<R?@2W3WU$0"/E( )C,O@+49(F<98GSP,?RWZ_33]
M$C O>6'+;'[#(VU?^[81[7[9[OU[=TZK;K@X70*\%2!3TABF.%I+A.A%68:A
MPSL/?>9OILUFE8=Y(96.&1XX.:J#Y;G+]1 8OE=[/*/HB+V.MK_X]%Y4W3#&
M5-[I3@29 >O/(3?X@NRYVU176-[6)/#5^,*CZ5WR\O[7RRXKSV2WI,K#LQ.?
MVC^)R[IY5MZ+)5N_!-B-.QQM11EFRNEIR*],)P*UA"\!OJ"R"5(VQ;%#9K8R
MFX1%8M^58X<WIQ#=!,[CHJ-4%6?5U?&,'C(MF!QTX21H1Y K:5?TP:BD$W[9
M$N?:>?RZB$YXBAN?5G@3)VV/!P0Y&;1HK[Q]HK1*')-A6I(*ZH<#JO3V"6@G
M1U14\ERH0F/*)9M)T%)];=?7?HDG[K<_N+&8&H_@0'_4)Y!8FM^C3<SW.&DQ
M*LDR,I^'.^)1J*K8\#*R8->,=OA[&NSV"KWK-RJ%R$^]<U^-&I817H-S$2W%
M_EB"Y9@(\'K_ZLV,X["U'JY&FR[,FBI.IH*=.5D3$#Q;Z)CL<]=M0SGAH+8F
MBKV254@V8?;X[JU.?D;QWD)FQ_O>Y(D,#&L$MT%XXOX-:OBYXL.N5.UUQN60
M 7G:C!P?291< 8_YKY\"%MVD7(B=-O]Y@ECTK?65JE*CVPT#14IT;ZI;M\2A
M_X.]]PQKJMW61J.H5$&:]** * A([XF(=!$! 6FA28WT7B,H@E3ITGN3$I#>
M>Y/>>PF]0Z@!0O+%=^U]SONNO=<ZU[6OL_?WG7.M'_-'YLPUDCGG\XPQ[N<9
MX[X[R?1" O>*OI=V2CU]CC.;#_+W;'!$DQYFYWX^2?W9W*FPVJ;W"AK:$& H
M3K#)F5)8D^WD/)0#)WSVN]'5\,_^[[^? =81+(9X?ICZQ:Q1^<M>=] TW3>]
M<Y8AHM366ITC;%9VOTP)GD@8O?[8II1Y\#QZ"?T=9;65M1K%7\1.:YW9;GM*
MV*]VIM1[%<_-_5[4DO5#%!IGMD*S"$K8G].R["VF#Q;PEC17YZO^M3(6MD1/
M)CXY>E[[.@)FV7-W/KMB+9.9=TT:D$5$R9)+O:IEJMC8GVW2GRTUKKRHOAY.
M@&S3.(Q!IG2J#8DR.I>E1JI>DU1O'"XW)HX(LDX(!.O+BICY<[.0X:WK%]:<
M,DTVZ2R5,WV: <?!!CT]>6:M5=NTFU?VS_N2OW_J%&/,+<;-UI*T[%29%W\V
MMG'KPB^(TQ]AWL%%UR9,8DHFE.X30$+QFO+-)?_QI]T;YQU_;)ME_-XV&]@.
M.G1O%-G97:P>=1HSD-.F1H=PH.,0 TNO@@LL207D CSE'@14:P[XQ#/I3$Z]
M:C'.%Z[9$] T"X!M-;*,=NS'.Y3)# ?(RG;:M946B7446 Q\'M62DJ%L0R8N
MI_C"IU,FA+Q?G(I8%"$J2)C<!QFNS'-%<K$__T#1WJ\^?DX53.Z(Z-*S_#ZS
ME>"D^GY/6[K[^5ZWZ>":^I27XYC:2_3P")?I*U3G_ Q_^(=]#  8 RN)#YC8
M<I5L#-KPXEW1I^NPBS*RKX0_Y['FZ7V(V)KS#-HL>)3@8O[R?5:Q7Y"LJ<P?
MK1M1S93K*0^1_5E;99*541]FHG_@'5?M!C*9]-AV>]+:?XIM'\@RA#WR,*5<
MRET)"*SO"P4IX6^:1(%2,( M?5E?1(%R0PS7:;!PJ8O(<415UZGDY&F!DUDM
MC1RE<IW>*0>'"/>#6E_VJ@31]&\V"BR&O]K&2%OR.5G2'L,>C_\NR#*%:%VZ
MHEC0MM/<K)_ZKLSF9]\5VY>LB&SI5!K</W$];+.:^6Q@FO1KN,.$OO%#I"&Q
M!Q&Q"GN86%2'Y6XN9*K#^$D5),5?QLWTO(O+:!^_9*30Z-// ; LJD7U4G/C
M2Z/ +'BN U(\790H2L"=_J&3Y$K17?4@ZMJREE_QC W[UB I,)F'/VN_J!%$
M?)-:"M+IWB3@_(J ML^SM)8E"L@VCE$=2-%9DV( ]5,BP&;RG3#.@54D?)EL
MM2-WRZHQ))(7=1XT(6#.YF0D(2,B+N0Y[E6#P$'+[4'0C;J76KE(QQ7EF-.1
M68B+<7L=((ZT<;,36D_"(7F!XNRM=V5U=-O0BF77"MUX6IS[P!?G%N-R93J^
M[.L-(8XL\UO+ERG9A\)HF7XE=&,7^B/GV$XO$)NA==?D0R>G_B"Q2S;273'7
M9$+*/RX&=3*1.J7B17V %Y^2I?L7RM%);>HW!9Q*BG0)KA^C["=GU*Q/YH5$
MKIX&LZ3V/4._E8U>+?9S"[)S^7 >Q-GC!4)4SJRO69_.WK JM.,V-/Z5&UZ?
M^TWL"'^ORZ-J&13R9M-CKS/9-JL+2F1$PVW2<.,]4= T]0M0,(.GZJZYYSM@
MZ>NY24E@T*H$_DHJ4CF],>I*?-? ]+V>.]IL;QH#>&^2S=^5(H$!?&:_ J'9
MFJRO#.(Q "Y40R(VO?OIF+R8S:W@Z'#*.=,6E7+)$$.YGD#2R<GPRJ WSW)Q
M^NSLF_ML1U?""$/+"XX]^J3?O;2._%ZV$Z9--P?ER^[Q&QE['[ X=O7AT6S-
MY*LFCK1+* O '.<L8 ((N0Y(*B'$-D</Z23.P1) 54U$(X6&;SJ ""8/>=H?
M>T'85A]U[:K/^MM]L>7W2/*3^R5&[V.</1JI-S&4K4.LE[_M$JWZ!JS?9F1B
M[VXW:^0G%"M[HD$#2LL39,^HMT.YT8@<3K.4"F/?R(SSU@(]-N]O()A5JRF]
M(M?C/OW<K>>_J\ A%N;A2NF0^[B@[+'FY_F,?IW?(A"<?6AFE*KR'6V!9*KW
M,T&(IQOK\B0YH*]-4@?=#"3M('(F0N1KS^^ZUJL;W97 L.:U)@#^Y<I$HYEK
MI'O\?(K"^P^Q[$_;S\\%AV4CX^H')#1<25S$H[;%DL^*W"8]_.<FA>^.KQEW
M,7X:<ARRXRCRC//S(=.>F9&!+HMX775=^*>#ZD)(AYOJ%W,GBSR<BV**0EYP
M*EE8KP  $;+W &)$!"/O KM>AAA]3HI9W?6"ZMM^;GP  5(FB$R8U8[ZWBAB
M,WY+M+H+:G:7%-GX!EFL&,2S #[PDS^]*W8_ @-8JWVL_?;R"ST:EV6,]N*\
M$TU0?^B2P^)@5O(]RM8^+/.J:+/M=.<D;RQ4Q3E*C#_SX)$W70;$A?'!2,:8
MT];G;PI(/F%GHZGPXPZ+R7Z#NR@M]B]>2F2]#VB]9_&**5)PSPVV\5%?8=F0
MV"*@G$FMOX$EW2G0"EF  ;!Q:F( E:!+-LXJ)#D&P.BQ>.T4<"%IST0)7<VV
M6CSKP@!>9CM!\5'2.4B(U*1MA;@OQ0OY%X]I+.E(CO+VH2IZ6J]B-K/JPSBL
MGTK;UDG^"D)P*:TD7[V2C<F:E;NW1)=C;C*H]T3/?I9]1R$'Y3!VWY0V)P;"
M^A+5.?;S&6/+UQZ4C-$NNW584Y%:0[&G,V44' ,@V_)A'^U8C[=C56WKG),P
M'XZKDCXMLNK)*3?;RBD.CP>R;L7IV(:=LCCD6O?E+%/M=L^%>(LR^3N!;CO-
M3GNI K.IG<O\[H3)K>*:=5(MYD!O[.FKA*$?3FV)[<ZP80!?N"KDE_#@N3'V
ML6]\MF2[#'3&D:XK$%L*NCIQ93(N;KJ7LF^#WOQRC/AXDUM,ZVTNCWEI"ZW3
M=67DMFNTJMYYD)=EEIOBO.Z;F 3W.R:5P7?DSKN,]B$QC^8C%I]@AVUZ1KW8
M^4I*WI'PE$"P2"::5%P@ -%BX&&:B_6[]'3]CSI-!^65.NU/V0H,C/A3=YQ@
M-?O16KQP%8;-!2[E6 <!X: :3^T2>N)5%Y:43,3-6H^>G.3X89HGG&D901OU
M2BOZ)*T1X7MTD>9&T97^KMWSXDX,GA$OE.N8HZ,UIH>&P2QY*,<Q1@-DK.7]
M85E<W5A+?&#3$SUOT1\3& "]\[C7'#90!F]1.X'B372N\),P -UL[T'7C&I;
M0B_U(90<ATY_,O"T5H;_9J$;W."C3P!NT#[DB4S'=&*G?4*]]OH?9)!*O\D@
M@WXG55T2+!@ 2XX_-@>C@UY35XP@5Y8-4(]TGHJYGLE-H>K\4_NN5.*3.+EY
MRZ&>L K[6ADLF-2L,,J[ &,C&4MJ[WR5R\3=D..0E2)7]>"0IX/<%?*_8'Q3
MEVUO*R+/%>K+O[8J2)#0EFYF1W^$ZEP\7%Z *,5S[3]TR_D:)&'S[&U86M E
M4_,B&0C./\[]M.FG3]=JV_K!E5Q\ZG<B$XO38IXWR(JL>8-X6PE24T<)Y0JS
M!%,S:@G#[U\I8[C=A J=C!G$OBHE=*D>FJC4_SS\/*J7*4<YWA-+^2&D>$C8
M9&@%T>$AZ8BF0CQ->7Q8NW-O*M 4^HRM)I$YAO5&G46G_5:'^TDJ ^,31E$)
M/HVA&$/;6FP _+##3C.@G&5-&[WUXDD#B5%&*8IG&<]+!;ZCKT.-2G_V8'FQ
MNK/YFY2$AP<Q7E%0?X$XO]/OG,<>+(;\:KM4L\?E'S=K8Z[.(OOH"%4^<(/=
M<MOQ@K;O,*Y#H5YKF5H@KYR)6:RL1WA6V-WJCF/H)XDEYX.W^3W%$ NS'2FE
MR,N4"!G*3K>J97 H7,O3(.'\#;CR\-M-QB9Q*,D2_EE^B%YRA$.2,>R1BY/6
M9STO^TGM8^L<RV%8EN\<VLA?=[11=*'PEZ DXX)\.-'$P)MP.SK1@TZYB8HS
M\F>7XYS[GJ:4$? #<DN?QR57X#C[=8XD!3HB[#0-L%V%@']:%M$,)5C]9M64
M_I_<G/S?<0#589D2@AC P^)P# #\!@/8O-GH^!].-=";MX85ONX>PZ*70=&;
M_Y/RI_]'BA#"!'[KB#S43[W^K/X'56F<'D]'O^1!/8X#(B116\U!TG<&RMR.
MIG2:SPDI*!@U_X;BP8*ZX&PH%M-1G)Z8>E7!K;6=>,BW+J,V>OT,WW?I!WRY
MQH?E940\^LKV=7S%F:@PE_G34-#LO8;5 2]RO5!B[)-/VOV?&A6DT7PQA@01
M?B32>CX%AVUMM%DY!C][+%G(M(L,+%BQ&9P4SN'-.MHG^8*E?)]-$2R#Z4A1
M>%XV\?$V_V,T;OQST/FO3Y>3)EF;"6;^'ZQ/>D7V,EGOX_>8;"NLH@73981%
M):<R7Y-.8]&IVKL_K[%IO1G]4*$K6]Y4&;9\ASDZPH%/_!H27(L$P8._*K5/
M3O1>=^?<@J[\ZCHMO@S*?B)G]C*_TX!,Q!L$!_GOFAZS?ED_]&VNB?,]\"=,
M[:Q[9Q2TP!9$/2(R9*1* < MH;A\(BIJ(]+*B_Q=YA/TQ\T>PD*9CD1FH%.2
MOTE/]BN. ]J];;@<.UW5=4O<N)JK0KMD9Y-2<Y87_6T#P(C>8$OUTKF_5DF[
MVS9?2RX=HC-]5@@=[4@E6XF;$DF16OEO-7VN!-HXU:1D*#1EX?_GDFT3A?]N
M-$K]33/T&0.XY"KH\2))LV+D'YYH73^#*!-W='.2W'&GWI<X62*=%.E>B0)7
M+#==D)\V71ZF8L=^A6,3O@G^DOP[D_.H[JYP+ZCB!%\YG9S$<K8&^U0=967,
MX6BKL%I6E#+1A_>,$+\C4?@;0WLDB?J.7DH\O BZ3,2N-7FJO?>4_=;LS',[
MH8U/56F,&ZPK6SI,-".RA^.^-*2$+?5GMS(-4R<B%V60297#3QG91KR^?92K
MH BM7F&JV0K*0TE,CD?QA$<.]);,AOOSY/#,U/,7@V?!LO@:\;[$WGQI)B!I
MW10\Q(>9([VMVBR@;)FAB]XC ,FGT&87T6TQ!][)D-1=:!#TA,\2>KX'1?:+
MM_F0()3#0U\W%6X+4=U]*BO:=SLFR?J&&UYF:,&%FD=NWS[I^?N:AY,.56&@
MU5RDTO4I!C <,XFL:I] 4PXSHM\?OS=9:[LGLK"1"^]4=F#\\VZ"N@_78VOI
M5K1;?^Y,TBNZ_123;6!BDPZ92@QOC4A^Q5RPRJ%-TXJ2\YB71L'\;!OO7"SI
MW6IPVM)A4R![SFNK_JXVP@8&VHW6VNO3AE\\I*]6/@2(MG!^Q"V]97YR\H/#
MNS#X[-Y.DV.G!-./!0CH?N-XGJYWPJ&N@+J<W[-M7Q7<W-<QI8AX5 -(+HIF
MUJ&+L?IFO!DS$^-^^PVY?7SO!F%WI=2NR84<9,<:H3+Y@$CPGIQ[IX\>$3HF
M%U4?GNZ?D,VV+@>!)T.[2D/5#<;92T:+\=R<-O&ODK\. E;2F3<D:]]6,1&\
M'QDN]N(M7M19>-RMK6?\0IPLS02!>PI34$[1N?!T,;2>'64H?5UXG55+=X7G
MO%C3CB3O.-=IF]N<F<%S+F )N'7[6-;N-2X-O3F] ][9+X1[/4(XO$B"[6SZ
MZ<D!R\#WW(5H>/@RKV]8LHH@?6'NRN[-*<-@8V[[N0NN$ Q@)37;*87G\*T/
M:R3AE6[5S_$BN7UNJEQ<9F&?FA8&/H^3'R-\34YR#8\%&U(7C%J6N,Q;+XNR
M%NZ/KT+DOG'U-ZS<3!>+?-YL<PU@8<'-ST<_PTZ1&*9K'VPX2*MX^Q,1$.C%
M]6-VRX>O4ILY^4PF3R:$<5ID6\S\8S/]<A$*&TDB.$"7J-]2(%:0Q&0]E;CI
MWKA]84'0Q:.JU#-<Z#49I$^"$K+,1+%%F*&]P "2K3"V,9,Z5NQKW\,MMI\5
M.=V^[>&3BP&P3ARCFP\P@ QE4R^VKRR'K$_3<%B/^.W'-IBZ"51CTA:_KS%:
M18!EO1;QN+B6^;?$!C)M\V!]41*?Z)J6F$D'1'NZ&B!>8@C*LXKL^6FKNJ;R
MD^GZ^& B,M'. Z\"G)/B@?I!^ X34J7>K$9<>99,'%H4A;)T%)69*]9X;;^V
M;>FVV%%U5G6&ICL\\;$I<QTO16?+;_-WVD=%->,()N*V"C;TH1],VMIR)T8:
M&]Y,+?C"?D0Q2/+9-K3V6!]A5Y+*RKO-R\B+ =RXY@>G2D?Y1\M0_PC])1=M
MY<. (/E8Q#8FX*VF+ZU$(-.?W2*J(?F..#6PA?&S67DC$;0[U14;D7_?_$KQ
M@?I;;PZ$*:!S2,30P\2RWR[U#FA5I0X#@)UC)Y[]Z/KZI^IH"JL"Z_S-"O6W
M8T7EH7P;;^J,2W337;O4=R5[EKRMYNV9[M_*;79E!.]E6-3W,0KM'^PE-X5Q
MBA3TL+CWQG(E7<?D?O5ADSB?U/E\*?NYZ\,]F=2%CSZ9KJ_?K9JGG0R#\+D^
MR*>^G!2DXZP0U6:(^2+WRI]0'^K_$J=5YWD5P<,K^I?66^>R4/H-X"GL[;;
M;KFL:N9]&)<VO#8VNV .N=)ZZ5)W9UZV]8S576M_(.<EQ\H1:,-WVNLOHV4
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MOG17@7-P5-!_.=5?9_++;L(E>_B;\A S37]YM^9M10S =8X\#%E$@M1'LV$
MJ0SLZ&L%#*#K"=V*[5<&Q8HOW]Z&W#.*N@5=_*4T:Z"6.I[PLZ8'J=1!E4(Q
ML=Q8Z?(LEM 13T*)T9T)7"T9OF*@JCW? C6]/5\6X/>>C 4GR8_?X,$@>[)$
M9."(Y*[N>Q."&DG "2P#309NV&B[>NF 7Q4I+S4H<C<BM:7TXNTR2RZOFVA=
M-34&<+_>5BCT0P)C_).P([BP"L>S/ONDT,QJDYTI;P<))951F"!D<[>0:[6Z
M)FJ_\Q/KY<1@."QK3,*]2.D!:_;H"_ZI!U.@$]J30=]+ ?RLQ9U7:7.]O)6R
MZ&U (91/[OJ((R9?O2:QP6-BTV1K$<?Y2<;=/*NSB4)9%VG2[Y\V';1.^M],
M-MZ%>.@7Z&V=DVY;-7F(#&55GQ)V@UYM[("QL]YH;\.Q"/Y$9P((.33PDU M
M,)#*L_QQZ64/7&V,>WR#:9Y!MWK))$_P)!*7-"\B)A7'7O6C2DE/U\;KC)QL
M.>%\)XL?BMT(GA!&_DC/SL/QD&S#@+LNOWRN5A[PD3"_)Y/TB=D ,QV>92Y;
M:PA<"S$?53W=:Y5MF XW0LN\'8.9CE4H%6Q]+Z\B%RB4[WJJ $OS(;54M43?
M]MMZ$0_+<L\RK%\B^U&S#]## )I#G16N'EO8=4C(Z+N(4B+)G:QQ@ UX-5V\
MP<;JH .;0;2X'FZ0Q(,?2,53YC$3M<CW'1+F3Y@9 R:GCON]U?5@[=[<7%K-
M'AGRO@D++(YT]C'OZ7[R[U5[XQ<:@?4FS&7TGHKJAFW$>+$CLF9D2QF_NO.*
M.<]:A_!2?U$?\O/ &0I7(RGV1C>*REG,ZU,7/.DVM),ZA<$$>J,\L[7GR:,$
M\!_Y_" YS0T,>KWY3BPTEVKHPK9C\4@,TG1&6HUUC*&J2->VVH"OIQ8GUT"N
M@;FZJOE0SS+&-@Q@7,VM#BVG[(IN%6:ZY"V8],'=0LC ZZZES0_6:X^J[,\I
MWX:/)YX4K0'E]=9R568TULQNGS?/R]*1<\7";O=WZWT'LU"S#PFIP+^!"([B
M9$.G&11_)E&RW&)2O*)M?(=H)YUUV] )8IM)A;C@C+*SGPHF$T1&628LYW4F
MO&8O0S&.9X]YD7&M&P^:B#_/P@ <;\1A "]8#@LP #*)=PN4A[."93>@+J\T
ML?X=EXD?36\R%U8Q@+J+C3..:MB$N/1WA\6&CZA>'3).N9QU-VRP#T?BYD#S
M[W6\LM77%:')<O1BWBJ\CW3C>]C6$C1[V)\.M*/?1X'C,KPHQF%[:MZOT0SB
M'OND>'T_><J(/H+XWP))+%6M@$)4Y+=-2WUS-4P'#![(K=6)GMYL#"CBU+#W
M*N5K,UH1[&?9@)*CV"9."!5LK;/#5<L#;1S)8B*HZBA$5S955OGU;GN'_"K.
M?G<SR]!/Y&&C)B(G\4[$"I=FY_0+*?J-7JGAMZAF$J,D]4R-0=G7C_QR+>5,
MQM%_V0%U3I%$R*$>^E GG''E',G>F^4D\MNH.0.0(V\LU(!\FXZXK0Q.ST G
M-[1!##9)"Q83\0_NB[*QE++F73^#BO5T)53$UR9^8=P\@@1_+=Y_7UT=@[U_
M[B/1'F./2,BP$\DGL8%\JSBQF#$/8Y%?G</Q;$P:W3C'_>^]N$;2Q[W<S<K\
M+8IBB@F>#2QGAH]]0FJ-Q&1;%?/$/A*Q(LVKR?*Z6@9]FID(A;#-^[=[))&&
M_,R@B"9ZGYST*=Q8I<)]W#O<@-=+=F3O))S1RF4BD,4WWO0M Y7'%V;B-M8E
M%^I<V8*H,B)EO%&]87$,P!>$V/B])",/C1HS8 2M&V  5>'7V6HH? P@7-(6
M72N-2LE (C  /@S@NAZZQQ%^ ;UVX<( :C$ _4'F2C_/NL BZ^&L6/.W\I,%
MO"(X.X,[X![XP2?UK=K&J+P%JV>O'GQ3MK=A88$0O^4T7[\H3?+M*K(S($JC
M8B)U<C+YR.J*TA2RW3)0'H6I=DR3^V?2%%LRZB)@4E=@?^LB.?3/'E2-K%CG
M*@!ZI^OZ!-(K<1<&;15=OJ([8^GF65.)\EVKNH6F%X8;*&]KWMM.,!W_O,*K
MUSX,&O["N=JOV.K-J5XSNA_]]&RD_#7NJT\AX;:*CX$6U24=,JU6&< &&#=R
M>)FGU,)NTZ[D&";OWI"A'G%1PG3><UIT\"7E@;YY\]G1G'R&[CWK=3.;[CO4
M4>@!T<O)3\@F RBY6\JY&EM]G'<))Q%EH%TF0Y@H<'5,+?=@9VB25-N3S2:S
MG@Y^AA .*BP?(8D<;'2,Y*4]FCMCM9/LAN4/DXE,B(QK4 !^9 )N3&E]]Z(Z
M/)@J%ZWHB7:?S,H"#C]I04TQ7:UZ3.:-3:8*%$T5<@'?Z?]>K"L5"R=!KN7)
M7R[$YZP&9E3RKY1R=T"54XL<4PD% D^A##/XT1*:>9-/LQV(%Z@P $8.*,$L
M<H60)VB7'4U5B@=,G\, =EOSO6CJPV:[S-BO)C4C7R:=WS:X>% \GLU PJ>S
M[+SO32A#H46ZY>\(NB<0Z)QZ:]ON%]#-"/(]/#.-U<<KO+/6J@T1LZL#_208
M_#6,0D?^4Y+I=VM59.3MM[9]A2]WE_>]\@VTW<P0%22$EL)ANT?*EN1UO#U<
MY>:@,,CJS"6LY9N"]5+1_2>RD_?MR?!::-[8>5\4)[WNAK=XO3JT#6HZ4JNP
MO3+!IF=J-=8@E;IQVXR?I;X;-=%P%JF>%?:36Y/J""VTHB9VW'Z GBAJF1\*
M*_EFC@N:APAL]]K2I<*IYZ8N44UQ$^7K:SGQ<65G,4E>TVIM2Z:[$[_.+\>$
M1K[AASTFJCYC=YAD7SX(\&CZ;$+%3[U?^&[OZB4S*K?$T.=@6_)*:U1077UT
M:=RIK@BX)BUM3RX[3=/,0G,95C%(>]28^[XD>LZ:83"NGGU9%T:P<V@EM!9B
MZ/^;+8[+A#WF\M+C'N<V1.D[[,-2G6^5M 3DH?"/DFY0!.Q;KO_>1B0-;Z/0
MXZE37,J3U-:K3-?# T5SZT%JM_ 2+4/<M:!14DI3%GJ*^3D2)F05!L!V'P-
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M)J-K>VP1J0$6Q((W'K2R- ;0,7KF5(=^L&?/T(2#]:EP)S='M%>%P=4I$P9
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M,DG@ BN"GL36T:5$IU%:ZD,=I>^N.VNXL=5;CD6'>3W)\J_;A(=*;<3IL1B
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MPUI"FGBNU<5-)XSOMJS:#UKY6#+"4 \G>G-,9%D.>6CASU$7ZW]VOV6^R)K
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MXM:XF&BYH97;0^5PWEOZMANF7A>7S97C638.SZ:[6N]]2E/4I(P)&:EO4=.
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M1CQ1\C.H/\1LV]O;[< U770'R:MO"%8A)9(_1N;VGU!HMXS6O;P^1\IFZ/D
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MY\=)\;X1ZT#&@ 4SN$I09N-QMU%W?J\7\078#KXD3$"U,**2_%<]-@Y#.ZF
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MS#K\R *$S>YY.X>7R5.'B!.C 0U"/66^UH4%2>79)=3OU9.7,4@A\4\ _B<
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M4*1KZ9Z0O&D6'(8X\I>=7*DUO5I;"*?I"6_AW!:)KZZ))/Q<RW!'BVYP47D
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M1&L$&L"-FFR'@C%C[CU@*2- D4*0SZ#'%FC E]S?7V^3PWXBM"]#S\N(+M$
M;)2LI[0#]+ "NDV$!B2 D=' WU^K=$*Y5EH'_S3XGP;_T^!_&OQ_FL&_23!&
MG>0]$"\#8W1S_T$79+:ZQ_FSW8"QID29M\,)988 Y<?HK$>;AT^.AF@FK@&S
M2]A4,P0MBVDT'(F+0>-)/:/2)*F?__L=^O@O$JS 7VV_Z4O+D7[YJ+=G'3X"
M:$"\_R?HK#&2^&SNWVFJ=\H*;6Q-G8; (>N^6']$+O]"0DM$=K6&!GAH-VH'
M=:'JP0LD^Y,[K[/,-JZ X-@]]9]7F=:K2&Y]JSAC&8!B7L>-']/EZSQ74VC
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M'<79O4,21&7R<^8;3X&=\Q*I9R3=<"F9A XT@,P%R6N!]X3EQ;M-BM)(PH.
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M8C+(BUP;,4-!;XR%R\P$6;&*ZG7U_V)F?^;2_Y)+U[R18TFW9NF&>:)R%S0
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M#20UA/#,Z3(3K_Z9U^301G<\;Z921.XD1)M[J975,?1\X)5C?N-:^X+Y2S3
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M(2 ?53&XE82=J^3,$-@E$)L:WY8R=.N52G&(FN,P#B-06=RZ: P!72Y5[C1
M ZQF]06^&5&EWK++'\<^\*,HB_^'&D;.9$!\,09G4:7'T>2OA>F%S:.AM[4
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MO]-:,HA)\'<<:\I_L/WOEK:G,=)JP"%']O8]O&!6P:M_TAVG<Y=EZG53^]%
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MD41EO6[QQ:@<MG+#7P>*X9QHD::I1B6VNL^M,_<>4+,%!FA\A*IL\_9@@=<
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MVK^DUNN^993 M,<JUJ.N 2GP/DT,GY^3]8C-12G8E?R5!D5BPX;G_?.E^NC
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M69R(/)_U?Y_$'(OEQ2]67!^N[A\<@GO@4O3REJVSKM:>CV)@E1&, J+5I]H
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MET&Q 4S,G_<-S"B:@1HHJ9*TR\O"O(8D$ <E:8).#WO<<_8X8D?!!6G/,;"
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MSCMQ/.!Q6HCQNLQAD=FRZSS,UZ-538&OF\E3@[GG??.**.N;_MP,X'0AN09
M)EVS?'G&I>4*R-0OWQB]_$@:6QJ;PG*$5>OI\EZ/'W"FZUVS\Q1<9X+K6XT^
ML=M*^ >_R8[@*?Q%. 2V-*C-LQAL'XF869,U09,'>J*:/CB('ME)0W@VSTPT
M7H"0QA-K@5G;+?=%;HG1P=]61S[R2?G\EO'SIRSG^.YR&>6U:MRSCI*E$@E
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M2L$@G>DGPYL?-J,WT0S4SXN\[(2R6W>AUMPMD!)OXW5E\?"\IQSOGLU*_AX
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ME5&D@%W)U!$Q1M?'X;*/Q8;TUT=#-B#HC9J\W5+T?<A+[:B^#EZ.@1(H%<L
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MIUD%(TPE#^[1>7JJEFWRM \(G"5SUG6M;D[&"/$.'9.Y(#L,I243XZF8TX6
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M2_3M0".9;A4(K\Y?63R%$[=2'($39S6L88:7V,UJ(]3/*@QZF,,'*YT,YQ3
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MN9);G@0'6UEA^*ZSV%/80NIR*I^<-]>.9ZC[VHFK'$W=,& I'^M'0:P"7_/
M%Q.(IQ:5=][NC&N0#P,\[THY?> K+<MGKN'91)SL^FL (U&F::XUB("36 GZ
M-D'H-H'-GE+(=X]ES*@@NKR5 N5U7W9O4CEZVAFEHWO?UF9 \=ERO-D=/,A$
MF<%XX^)]M^UJULI,ZZAD45O\Z'BTTDM*^RW[82&J[)!Q;=8>1S*/%BT;UQ,A
MG5U-MB9^5QMK'/$[+A4LDOZW)"=&-9[#?,7=:-0^X"37W\+.O%1OE/_C!J*P
MFX)M-*KI9Y>8L^H8.&DCFN74U.!.+9)F@7>JB9:9U8Z;/)EF7M,XSS,U^QI
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M'2/*#Q\=7 *ATNPB>:,['GO\0NRI+RHZG\)Q,P*\Q+O%B[GKP35@#1]\#3#
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M%\XQ??\P767'2I:5V[%?C L3(2P&@79S%H=9SCR.R\)9E'A8BTV-8MY+E;H
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MH7E=0I23/1[Q3.HA4OB#O$0+-;VDH-76R7H)_-+MI%Y=PBVFHK=ZMSQ"1H_
M?A^1\O@S-"#3J4S ['P!M9_@K?))\U:EV=$S'J7A0WL6^_5U\^<9K2&E3@_G
M09U"MK.96#G\K&PF\E&O[MQ;;C[RWY\7([=(BO!=#JJ<W$>&^CL<WUDH.8ZJ
M$U26,M8+(!2<Y^&59T@]9]X9TQK*7NC)CV)+PGX:8_^E;<[[!^N0SR.+YQ\:
MH&;DH4_M;.K=<03-@,JO5L>*,N&QJ"+7K-DMA'QJY[C5T_OK,0(#=!;WKS:!
M3'01"@+W&L*![_PEQ]F==NVOBMS:L78\TSO7T+PR,U0Y B>JK4;[[JU?\QJ.
M.#M+^,5_-"21>[_PSCJ0_E9P9RDZ>I%<TK'->,MZG"6U)M[0W-O9T\Z:PI7?
MA'1-:6#I@VJW^F1]5Q^=[M_[./Z#0P 4"CIFF<$$/SO@+7Q=_@Z[2R8R<U3U
M-6!,46\$XV^);,"[9Z!3[%)RC)&*P^-&8^[=@I2]2;QJO$QUN@9\09N/\MPX
M*Z;_EZU7_DL/=;&"93UBK3EHPA-2!;!'.NW:1>\N?*.&*2]9.Y,G+6P%N&SF
M-Q1M[^,_9O+.ITA]KX4"[C+4444P%R5PLM:+6/I MLM4>%YY\";W[JB)DM0=
M.<*7.?;Y[5D< *J?2FPR(IRXH0V"A$6XJ]0PRU-5,M(&2=\\"SF6[9J%5W$8
MP-)D-LP=V:184,+"E#?K44Z7\)6550:V$)LIPY9D XD:_TQQ&?$;"[5BK1["
M<?Z0,5_]6?DR'K$.F&]GE.UW7P)M>224$DPVG_5E9@I+IHC[JV) $DZ-?-=5
MI&3T2P2[L[99M&'VK#N9=_$GJ46+/KL"D?3NTC$%E;A:D^XG$;W]XU[\.5O*
M<@S)EFL\&=ABQC68(,DMB4.$/V?>ZFBG4MNV.:R(K<4XC&C[IP"*53U$=_BB
M[M+86A-CQ25(A7H"JU*=P1,E:CF4](KQ/2N@$L=%6!$/Y7K+&#@,M?CR!>AH
M#FHGH5U GV4B9!_;*&D6N8SB?/,U+]TJNA*7)VC#!5&^6:N0-CEK@+?-IUW5
MD-N<-] G1QP[Z!C3P^AG#YVIMBC8\.[I;[QKOI/$D%PB6;[SS'Z8^" VJF-+
M$L]"Z8W-1[[8L11Q)-NH5@4'YZ@'6W#DE+6</ P8=-KWI<_"/,I[NLYFR8<2
M)+MM4>C,@(@J>&W](7_33SC9_<-W5PD60N=AKOMM%*IQ&,G,* 3D;2D-4"7;
MK+'E$)/_KI"ZZIP.)U2Q:=:,D7NKUCI1?":G8N-M&]NNX%*WY2V5>4'4/P)K
M?97PIO?BAY]B'T6&[S7 FYEW1DF!.\[%*(Z6?6S <A'?"P1Y5^E.H-MP>B5N
M2WKV$T"V0_0F7PW 1 )P(JQ28A:T;7^I])M4&Q)XFFJUPGSV4%%(,W#2[B44
M2W!/PFI,@K4V8UQ..:(H^Y>U2Y%-?MOFFU*ZA\V)N+=(^Z-_)94X+X?37"C4
M3!RP:^VSMTY); H\[!;F!T5X8)Q& $/-AY6TK0WP/UTW+<K+*II1K!<;IHP.
MSH-+B8]S/COH[NE/?7T+";7%UW_X1(=+,J9[K#=D:ZF(%=</_[V$4$C"[%1<
M5L+7-;L6<KC'\9MMPO.<L\<ROI<O!/+W6TC@/@^P!!M3L%(K^E]XM[QGK<#\
MP4@]53_YK\#I\87N^0_5?@)&^L%DGUFLF/+_K9L?5QY&Y\4J&IH2DLOBBAYX
M]5#X^G;;(]1+;MC?&:-#JKC<S"!O88UGF0Q[?>+5LW-OK-M^U /S_?M93S^9
MCT3Q]I@;=C4BU9(FG/=,M4Q/*#Z4*=SJV=:N>I^L@R5S0"2E.E:U;W4W2*E*
M9DQ!P^6U029%2+/$@]D/EJ*DG3*PVM<N_2.806ZJZU-HK2(+X_//&=J4L#*+
M\X;6"9^CL!7'&X184F6:R>F5_5QO=H;ZM?\EM8+U\]%AX)F-M69YNF+525:(
M:.F"$<>CO0N:ZJSQU-_A3G-L$1UJ8U4HJ\7>UAJ9.'-+VHUW%]CYI7HMS[;8
M&99%$9$'P1K PHU&#Q9:02DSW8)NG>RGDK"$\,P7,<-0?L"3S5Y7$!Q? 5#2
MP)0S:[N7$Z,N:5:&&4]ZQ^"J$J]K *-KXE6WKCGI58X'SMA;S57-44-5 '8&
MX0Y38[5?_P7.\%05.[]>!-,9JYVH$5W&PH ?>)ZFRB*3K_K5N >7 '7$S +3
M<[WRM[Y/'%, +[!Y%._POZCB[HSI7,6-83*UR^>E)PRTAX)QD2!'5AF2AIJ^
MX5^F),"+45Z^9-CAJPF(5AC7O%!*V8SN"^PM /81T=28QCZCM>[([S<7Y<F%
M6V3ZU;@OK9YE:2X+AHM7W-U'TJDE_*BQX=G>$)GYYN5/M7KQLI9T=Z)5NU)"
M_K>+SG>$0A#$XE/?HU2[-;KP^L#SCVGIG?(62A)XM45W8L9(U5O(QS]66SK+
M><HGQB1P,G[;I(]0O+-:5HT9,GBU=70)'?3!C '+T:Y2-/&&*294>._'>?"X
MWVAIR-<<W\DA1JWRV:=XKWC+6RI)S!<_TZA3LQ%7K)[Z:%+1'#I4&TL^8:^[
MY"=XARI#+8GY(U^IZH33@"C-D V;X7&&LK1\5[VH.UU2U58%+6V^J>'-5/"V
MG 1Q2T9\E:"H^/)(T.&&I3ISB58]S>_V4F_?._CMV95PR^4KF2\1M?R:@@]%
M_.W6,LP:<5A0.?O6WZ^8],^9#"P:7'(A)0%3A;Q94>IT] #:/+YH%4U-'<L$
M):W?/>NSG???SBEP.4Z>3$XEL=CN&^V5?2HU5H%A!YT)DJE\/!\OIT^;K]F$
M"0)SG4[?YZS^D&71R0Z.7+;U"V+G/4T;8KD&2!!-;&.,:/9;XXF]U<]4.0X]
M.SVQEU,(YGZ'A+UO$V$NKY5&_I/(B>A3G*$=(/RY_N%01[NZS8]<8?AY2Y;3
M8#PO46N6QMRN/I44>4;L'4)<J(&$076Z(\@4;X^+*=N//H1D7&#24(D8@/^!
MN9;O2&]FR$;H,-#D9<-:6 $)+>U,;E;&Z,BXDZBP>*"TTR[X.9W-('^ER2F:
MQOI-"'/-0K$,?=;+:A".15+S4F-+N1;'"^QO%5Q/([[/2/I4U2X\&SOC\RVS
MT7?U=9$<$0GX/.PN7.$#X2V7$+-T):;S)#K\6')&+FC#L7I"'6<X84\*5!J2
MR-U^)L2>63VQ=&S(H5MZ;JL@V$=W3N02HN'R \/-_%*;E<;JI!GG1=Q>8^<^
M4N47DE+5<A+/_Z$B\LU.!=-52?$6NN&_FC*S7)C*^%Y9OS]KIE@J9 Y#3#N!
M'SH1"EJ6Y9Q;:B"82F="<I6MY6*V7S?^@N1M\Y%)M$9#9GKL@-[9"8C8/J35
M.J$JO_> ["PIHB8(8AW5\RC;;C/'IE[R7)<JO5U"IZ8V9'R:W(+8Y$5&.#'=
M\JN?I&)3[(0'^X9:^AO_,U: NK&RIK7&T[..P$+W0W98R#I'"ZF;SXKR$:KT
M%W I1.G&A=VVKLA*,6?:ZV*2U,F.K,)H[JZYNE-]_8QC<.X2RL57S^2QN U.
MQQT90ND7!60!:HA;RDIO<YEMVU^$N4C(2\F53Y7(5Z,J%)_LS4N-1D@MZQ9Y
M<8SBSG;6]M=? ]3I]5H1C\#:^Q99&"]IB/F+K+3DG%\6YZUF$_LQ]RMCB&-Z
M)O^=(;7>_;(SU'E]9/)/NV@.I)2+\3]Y3.1GX#/ ;3$F=X&S92)/F#+;K3TM
M=RP(F'#8WVS6-* Y7HT'7'E'5AT>,'@^+C1 ^_JA3!7_ /4VM !I/6%M-;PO
MX_PR(TF!,S,V#VXM/<Z9TUQ>=5Q*KUR*-JYY39WV@#:?J$2"*-;FP"I&YV:"
MQ^P?LG<TA,Z/,)!WEL**2-+QLP A@GE^IKVBN;V"U^#A5L-4^TB^9O%XX?XC
MRJC514M2I+5^R%-K53S&;&H_$IXKND#0_.S/;^1SJ878#HJ&N_IZ2W<3M8ZZ
M#LII]N_3Q>U3W'/\#*)9C'=9X*UO">IP[(!HC]C;.UZEB#\55 .YI6#-TAX5
M&CPZU7)*Q^=)?"_"S\]%;.+,TI\=<(<J=615N^NXK66#2W>*8,_Y5$G"R/;_
MBZ8!7A #23=KM(0>$-V4B4$<=[TV_W+!0V D@%(S-;I @E CS>%F$H["-=RY
M]:F%X^]Y2[(/31.C+QMP<K^EN5$[9#QR?83RAJW#.VS8(?&F60LMA1T/L#Z_
M!^8+1U*L6HS4:I_.L$QFVRC%90K/2R]C@(GZA7A5XV2U;KC4^P^'I")9Q^X]
M1P0R8BF>XUYO8.$'%3:\J40U5M,@5SQ_&O^H6]M1#E*EBM6NJDK#E_5!>]E]
MO>ZI95V.D+?L2)G,Q5E]ZEN#2I])$/M&+Z,/K ++5FS *W=KSZ6"3D-#/9E_
MGAR8+3V!DC?<NHR=F&ZV#?$ZTLZ1@_ 5KV?&+C?C+'8D$;4DV\70DKHR'M9?
M]9R4"J^<?P<7;"=9:6K.S5>\6__RA"= <@%.H9$]ID):S6&T+B]+$?1M]K=;
MY/(1EV6"@U42[JQIS&PL;R.PN<H9A=\BR"N,-!IO_Y8]SLO7O$5M\O[!Z;#,
M]KY^I(2&$)B \7>?);&).WN+_PK^UX9.LL2OF9Z49)Q)Y(;'"7>P?!?3]L#X
M=IH1/(%T(72JX0 U-1(<[%?8A@I9><H;+(23WEJ;:%X8_=1Y5MISV%JK^33M
M\U1Q&X(H >HT+)=-/Z&KB5IX@7UNAG\G F^_NC\U-ROR5MT.UI/%T6C][Q+*
M:0DQ]1SQJ4M[[CG7 $([7A,W$<[EW=GOOWVTS-Y]N6"I1W@OHUAU?NJ333M%
MUEAI[Y]6Z"_R;=:>8+&D'U+8-X;9_Z1PG*W.BDVJCKDKOYBDL$$<BA0$AGB)
M\J4,$GP,IHZN_!+EQ/C+[_4Y;[LE%?<TDL@J22/XU+/>T'\M<.=Y2L9^;,<'
M8XH((6BQTEMS4[/2(!97KS$7\V_S2)7ZJ4Q/NX<6B1-ZH/X*F<<?OE-^R@F+
M=(S4GH%[+UTV\9N*+F2Y[M3:?$_VV2]*\4W;%*2#6DH\\M!BQ>%9Y.=);6^J
M?3ONS-3";44\;GDA8]:M5XOW\/[PJVYRDC+EK#A3ZW@!1YZKNY_$!&"BTQ#P
ML]8,:>KI#VVTS[WV6YW68"2W(MQH :>EB!"EV- &BJ6\XI&7-? B^UR66;=L
M\:::QCM^HSV?EUQQ.GV^A,38D<"#NK;8D.PYNMHZ@[)BV0Y\7_0%E06PJ;ZD
M*[B7R6:5I0GGF.]M5B8$A6W[X#;#K@&=S?0TU8UUU5_O)5WTV;&G%-D*-SQ2
M$$)7;Z'Y:],.VSR*GXWV\8P\(A"8K'S9NX7-4+N5RQ)>M?BZ.R9,5T,E"FYN
M[FRXE&SM.6!9LD$@_<Y14BE0<]5_"&-'5!A='5:I-'/<T[M2.=]/EE9A&1LZ
M.]&XOPN\KW5NTA.V9#^*5MN.4Y+OW^9H#V-GY-A,<JMLFZD.^@I>9H45,!S2
M'[#7748(4H,?TQ:>C2@T/48:U%3[]T\[Z5SIK)%K\RA5_=B]^,IZVM;3[*%'
MI+M=)*.;;C+11%GJSI"[PDF ?*V2:^&A6J/]\2?;Q5/\)DA*0C?@G)3QM.PU
MK#:(W8LS2]S0%DN,7Y%#,/JH#^'QJ+TF/Y=Y7LLB",?%:VC^FP\;;*HVI$J0
MC8%&\/7BG5]]X3U@^\DG6S[Q;98+]$?\GXWT6 W&39M_?+$)W+FM,$D5'O88
M^]6G5TC 61)3V%[QV6N,&O7]3K.T/_)8V!8I>2C>VM1@>[LW Z"(]85-4;0.
M,='$O#2O?=')V"7&2KO_Y=!O%O3IG)$"@/WZ\IAUW (R'%.E%K"7[)I<IQ&'
M"6D;E^P(YW87J"JMA_@V4<Z%IE]'Z!X+_A1\'O1NZ2@%44WT,I%9Q2]ZXQH
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MSA39XV$*KQF[*!G5#1(FX25(#@2(?C5*%P&8K<NO3?VX'!:Q5[%7Y_6:]'2
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MMMG@X#:__PJPNJMZ!4 &70%:-;E;2<[8:64P]@%7 .ER]V2RI(P[X\$/0G-
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M5R3F82NFG#=N<=>*TB\R\20P#'EG4L;^+E@^ASM$#++PU !+6B0\7X;O]V-
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M2>/^0#>O:84-?JQI9-^+:8KQ30I5*?MD0R@D\PK0951U!2@NQ67]:X-@N2M
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M/&MVJY*92LSV.WGF2S:*J0?><2BKV_SM\. :N9UV?@9"4M4*>Q^?M8C6U8Q
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MK^"5M.6Q+1GOM\R=W\!C[N&=5&#)(%>GTU.?UX/OMX.LFBOLLWU6?<(P3K#
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MQ[]294W%4\DS4*S9%&I"FGFX33\ZELH:<+3B/WI<F S %L!.+'9>6'8.=7#
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MO4V2A*GBP1;;;XY&0KA37Y&4V7JEV<)4DF6%6$8EI^*>\&70!0FWS>7-]UN
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MM+F!UQ:OPM@4B#Y&$9V<V/,1WP*(@(@4_?@H.;<<O;?&#V/UU50!BXLQG)W
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M1U0[=<!KZ6N:L@" "(GF=&-8B_3!_#EY(?S>%H$BJB/'J]E4^N,J#9,WIN5
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M=@@7"8T[&F670)_YX10VS=.>#E7N;1R@V!&@HXR/#/=@D4=E!*YZT?BNQ&1
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M&MLWVL^+UQUV7A*B\W%\Z!3XUXK%-F+X&N$.R@)^H;21<;PA&M6%O??^HTO
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MU)O74/Z)(.Q13SP3[8,CN"IJ-?.$GK:DHE:%RSV-9/N;O6]&Z%AZ[%9MP8N
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MN.R)\&N0=8-;"[ZPFD$F;LE3-& ZWI8R+%9G>3T%JN8B\YFS^/D_.%5-FZ]
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M@W9)UNE6;][(L=W7C'!NH6?_=YUCP<EXQAFDIMQZHJQUB#)R\34;9NQBWGP
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MZ@NL*]!R+^<WEG6OK:B'/>-@BWPN[7DY'C![5]UY0,V7L7'@CI-)FO,>LL5
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MVS[O'U0>[TU,=ERY4^2BF*Y%]>R2MM8C9LB^)4Z>&G2T T6Q&8-N@!=G]?
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M!J+YIO#<FH^VGH@F>TI'-O<?&Z'(:*5!F&IR.6(W]\W:6-E2;.DZU46.5&G
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M50>I;7F%!HI)-=[B9F;%A]#;/N>DOAR!?D:@L%=)]VXR80'>>9(/<0=G/I@
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MES4;=8H40-HG@#I'+?[[(C/OF'O")#U@^HS/J8YVHK(F?[-*]N51;^SR]YC
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MLA!P/GK\S/>.A8S9I,I+7YFB3(K';(IX@)XXN#N5*]QG4MM^Q&T+D;[C 3Z
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MFZS_)NN_R?I_"%D9+"Y[1463OM7:L(%A1%ZMPTGYLMS]-=998?6OL;W^W[U
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M5LK-2IC4Q\W>%_2B(!J[@5/"JGO]$/-Y>7+-P2'/9-J,_! XR:"7VS/&*-C
ME3)-APKV)F\]-V:8MI[IIID]%GE^EY9%RI)MXZ&081P:V>I)W60=IYO8PUV^
MK:?/1GOVP^:H*"*"N]"+I;HZ>%CJK?%]Z")1/O,,2CNSB[L2Z'#8/J24X<>&
M!WSN."^]Z-Y^M\^!4R+P]>8G*(;4&?O/GMS!"=V 7F*J:MX]!1)T,"+W MJP
MUM$5IW"NAFMX2?B+U!5\LVE)-P[7"+^8YK=>,7!*<\2/.4J\@#8< "\(Y<#W
M$M,/1T'[^Z"SEE-D(5:OW-N-6RV>SM"FQ?<:$_0A6/+@ WAQ 7P2>HC(<%>7
M)#5Y6OVMAB[<:L(?I@F]? G+G5%>\Y+:51,F; 5C1/L7_LSR2E+OC6"DN?/9
M:#(C]O&5M*G( )'ML<.9AJ_F:*BF@TEY]U&TIJP1S2@TV*AT/_&#VZ;[^TF=
M3T^^7C4"6DT0/Q(C>J>@:CXR$T&BUP"O8_=Q;E4WGNEHH9P@6!59T_-LCR,7
M66+]OX$%N7NP_UG9H'?/#&)((QDYX]\91"2\XUK.?$T%I^?\'V4-6J'L]*PZ
MJWE)NZ-:"J^9PW[X:0TS;SZM&LW05L_G9J$[BXJ&7@8;S_O=7:"<GW;D\/MB
MI)0H"2,83UZ^@0,K4L@Z-0K(S1:ND&@%KFZ?VUZL]:YM:41U0RNQ&\UBU2-=
MG9,];6FM[FRSAR4%0AK2L1+<<JKFPQR(WS.3]M3YKG:"ZC<C"],'\("\,]VC
MP]20PCR[-\ZE]<E3)P=3;P,RTXN-_%P7C-+OB!9R:DW?T6O:_7KIW$[Z7RLD
M)6;_5#LWB":8ELP8Q-D0]'X1'O"G9PN.(MSGTN+?&VHJR:.:Z8S$+'->>Q=;
M,ONHT*GZQ:? ,@N[<6SHG)E3RV&>^T:6^K/2']YDARH,5)G+%(96CU5PET:D
MRNT\CWRADE2-53<>\I/(WT0^ *;6G5IA1ZI9A9E7,>[YP4#BOONZFS4EAIG.
M\Y6Q2-Q]D\JG+5:-ELR3_7*P%>B<B/-")<% 5G[U$\3Q^QIYX_$ "J&\APMT
MF-\6X-ENM#S)^A1MY:QS?M72Z["%'[%NQYMQK:&"_6N_6/Y&D_DU,.:(I,#=
M>;!*H<"TX2E_4 Z(6P?$#Z\%E\Q GR(ABZ5.?@QY_IFT$Z(V)><M3F#0IOD#
M!V__+//3\>$>QS=)VDK=2GEL&+U4DU;ZDFJ=,\7]U3OG8S_TF-&:U_PQX[$9
MTQH.28K?=4]YI%JN=H27IX82;[L$F(007C[HOMQ$YO= R"RGRO^.<B;Q5F=+
M@M.7TC6)CB:9PL9]ZB)A]6N$L_=^/^<VY5C8CW/UEV:'ZNR.H:;?'),_&7SR
M$Q\]ZFDPG8BHBFT6X1?L]5R4:!?J9$\^\NG.DF"*RA]($R,YA(4G2\?^="AL
MO7D=ZOH0=649\JW_,28<Y1.^,L'08^18PD8AS_7)3>9G!L5R?'.6Q,+0@OF-
M?3$L6VW-X0 &V$[ME.N<^<P'RNHPZ;CSO*Y*+<);V]"*H.H_*GAUA->3^Z9K
M'$ZR3:VW+EL1\=*BG/?7_&OU24/*\NVLOC"L;__<R%MZ@(D.J<W5$/%?*XL%
MOE2;CI4-+X&VSO!^VULN)>L1V22?GLQ?W9@)/#U&<%3O=X0YZ5@E%WVU!-7I
M1>+L+Q5%^#KT::,4G*FJQ 09YQ];RZYB[=E"*[^_[*'T9X7Y[.&:[!9X!9QY
MWV0Q?6^=MG2&0"W-=?XH(CW3KN_YI3&J.#FM3GM*7A7(]/L@N3BUVK1L"OIC
MKE186TL/Q/?3J&O8=#+US_*T3LD]BF[Z?4%D @> W/AT&&DP6O1"P-A>S&,_
MKLY*2/ 69H[^97^VOS>\PGP*DM;XJN@W=J!"]]N.MM-2R^U,JB)WB]M^ZF15
M>0IV+SF2;!S[]X>59)2/F<"20^C_B[VWCFHSVO9%TT*+0PL$*=866B"X%@L4
M6KRX!*?%I4!Q")("I11W*%[<H;A;\>*:XAK<79.;[GWN/F>_?<Z5<=\Y>[QW
M^\=OC&0DWQK?FFOJ6G/-"<FJC(?K%.;N+1L^Y]E:QT2^HCN?</2F.?B<O8P7
M@T/29MGFD4#JCW&;MD_W[@I2O9EH6A*9VVELEO3DRUOS0MK5JVBYHDQLA]=.
MF<Q#TS)'2H$YAA?RX5^Q#2MRXU.WAY2Z^<9NF#AA1H;WNJ=%QXZO=J;YD0U;
M"QUT>/+%4])>QK37?6_%Q2=?;_OL$8E>BDZLGCV*18:ZF)?71DW;'U7/WYP\
M/EUUXE,Q&(T'/5<8*^P?>G<1PA;N9^N) C0S*#'"O?<6#F@F$$A\2_(NH7<A
M$?,NA&!.QRNS?*OZM=SBGU%6+^P$Q?TQ 84G*A_%0"=T :(DB9-*NPT7(>^5
M@RUF/@-.'83M6\\8IX,]0#:<+54%R4K2:$O^94\4^G<Y)V<MV+">S-\IZ?7P
M(+=PI%2H+K+%#+T^ QZ&G\1657ZWF)ZS+FEI#1,1ZQK47>YL#,_9A /,!! F
MQAM:=\5.2/0"?'9Y;5[I\NMT/)5,X+K#S0VXW&RCD?1@+\V>V1;2.R.7_XK0
M,W%6FPJH%8'[;>N0I2]=K]AY/%1+[GYZ5 (61P&>IU ROXJZ\G>K'4J%2Y>B
M'8?F@Y;;N^B(T\@0"2J<<WO1%B?UQ-D:_[[F=*KI;'#MBHAI8?]NH_6RL+Q=
M16>!/&(% UH8V25@AAD^6+ZW;U=E/<2_96EK2^U_+TSV!  3E\A6O>I1K!*V
M))DI]GRX-,-26U)\LAO]>FFD<9,0>^.#+A"1"J[P$*-8L%4E,ZIX0K]_][[,
MC8,8[DGX78NKDM@LD@*]GV^^<DTWF$BT#">?()MH_D,/QQSG:'QB=M3I<G.C
MZ*<8_JD;>Z,([URKG@X/<1TB]FNU]++])<3.4."A1[8A]YJU;IXN%F9F/M(9
M[8?@# 5Z#ZVB(Y3>"HK!CCD4P,M8K%CO8$_QT$2M@ZEK5+HN84E[\GXL9C\>
MJ^GG92S5>R2=Z[J]9/9-N.LTW"SK_G7CIP2*@E'6A<'+[<:?S:+!WZ'P!C<7
ML $;+=\D0I:#VP%"S?%69C$-^C.;7=(C2:UPETI3%!;%_]DL3+(]$VB*CD98
M?IVT8+N)0<;>-E>/^4F#_'P<GTQ[Y%_6A\7Z'6*TU=S?4S!_\[&7RO><*[]7
M<Z_5%:M9M*K=,G$^.[/'4*DICJ";M<"A^%2MK20>6J;(W@VJ8N;C<_R5U$H+
MU&"=MD"'F2^(W\)6)N[E^HE0>E%&C8XRC\BJ&M='?GR\4N$!B;<2984[:^&_
M2 PI)<'G9E+7I%UZ.6!Y0?5ZXI1 4SA)T+RJ4OKV] >U"6&!,(G?A5F%TUJF
MN\R(^J=LBXX3CH>;<5#IC\Y4\A2>>60BGV9UH]I%HA3<"0,\$\T:C#V>QH51
MQLYRZ->MTUZ46AZ6W@36I]TZH !3_F[Z38TUKEPSK?YKD;X985FIOH5$1?J]
M'99\QAO7'E]LBU=2<<ADLI1[MARP"Z"3Q789FSP+>D)YDL(8,*H5?]HL^!<M
MMP#]@TL/7>NZW>JH8OP@;+54;TTLK(."^M2J?&MNUD3_U8K8P>%NW+KMCP)T
M_A+MPOOI=J3%U=D"(^L)QB]UI-]^<V6 U[N%D=@LRO_"Z0T:,O/^B+N,I'.3
ML"Q],EF:.84I[?2P%C%3X0%PISV=NVA!2M*H(9NF@\84+=E]I C$:\8/E?[N
MHK+<1;[5Z(7W)$+*,RGDQ?>W[C>M-]L#GH)H]TXJ&NW>H?V.#:.FLZN?!')=
MUL(Q"_A]5:T"RP65=>9D"MC'$C*'X0'35<W1RY^L<[66:@._<;^09/#EV?SI
M<P&O@?NX1;>_:*9JYE+,D7<1JZO%.ZH].1/-O%(K\C1=IA&:>UL]CGC(=$=3
M4IO?9YB@=5$M7W[:8\0H%S)U72Z=[_ER?''LAL4>/_1ZIFRU(Y,2W'MU9V$6
M"H]UDYJ4;R';M.^J8_E0G@K%% [?8!'U"-XU.-6Q9&RHC_BDAYAJ M"--EFW
M>A/9X-YO:58YNXR_ UL/NO)2HKPRG@P&<=8H-Q2KB'XY-OS;<3:DQ(T$^;KX
MQ2T<K=ZF&\/_-<5D.Q43!8AD44 !G%& $_[\XAM>#:+EBHR_AC[=RP.%.$Y]
MK=S9!L]%/[U%NT>@S(,&S9KRB9(B<^>0>9"[:4-]M/]52O=1J3R<U]K+0S;Q
MQ\H3/5,]9RD:J@7:V"6AP6"O;U8$UNZ44EC,CZ_+B33 *$"V\ZC5AU5S&O4E
MM6GZ#>@BDFGKPZL,R9R]@<X.G[.0#\&S5XXA7D39'^S=%CHB9KZ2:WY-I^@K
MJ( MO":YFE2W7]@6"AO7+ME_;N=B)IKS1=D^=@;WJS_34:>MDR'!KDE:E^91
M!L)F)4I:< ,W%OD>U!+^?GZHZ\5,C/_7HAZ9ZU:?*#'J\!]-PFW-9$H$ED7/
M0.<52SGVPU"F,^I;QY.\&YLEPPN9DY.H&:N%F=4NI;LOH>EB/2A 8.8,A[5W
M$M&O%E/;AAAORJT#?3<WRX:/M95FSQS[6+C>AW>L')7,-W]X>B[7;-H_6:-<
M38@CK7:S;8PD22.^3>M%3D2;<:4$-B"ONF ZC $.KL% $8D0&P:/A%1@REM+
MY3>MY5U:MH^='ZL_*JXPL#B?S.,>T^VEH-R2B[RU7C_]W]%P'.;FCCK.7MD3
MX8#0Z7D$=>D E5_E80^892.%1[5ZHO+"SH9A ;\P<BNW5O03)/'BNJWFX;Q"
MT>8(Y>.8^-K0^W(O5.<7CY2R[75<T+X74?./,VO/B$Z59DWZ"2A=5TV,AD5.
MPA".$+=EYD:!B:,D/]K[5_<*43G[+JSEC#5\#?&;NQCJ@(Q\79LPFY;"#L$^
M$EM\K#Y/%&P8KX7U*G+%$5DMA0) PJZ/V[9/3XJ0):,-9@O:"E/TXS?.#Y/:
M=*+">HHOA=(V#5XMR<=4'FHF\(8 ,;>RD[X-4=Y:S]O:&#>5Q8TB7G6#2"/N
MA*PZALL=$#B^:ASF(Z]L>/51*?XY9SE''@H@HO%NVMZ>\4%B5,()GUMI1V!F
M4A?QEU]<80Q2W<8A*Z=%&XWFRTSOFWMI"SF#*2@!WVG[I98N)TU38M=*\]B:
M*NW _0.G#.=HOXW;*E_E@^= I&9Y7ITJ6'?)1%>$2S@6T#1#O1)U-P_I7BIX
M"+L)G<Z]]>3S, PX^7+"1CS]0X0LU)&>:-FQCVXHMYJE\]_D?JE)Z4TP_"RF
MU;%_<TH4 *VJ.O_\N%+Z[O(P:10/G)*!\ZSMIJVDOMDEX%I-^EHT':>VBH3Y
MR%SBI7WR ^SML4A(:2-:R4C-?:L;1W!Q/HGCTSK'&*?Y9J(B(AQ3\O75@TPJ
M7OT+O\*V0K>4@<I@!O[#(M"6 X6O+/TA@_ETO2%@TU'/C5X;MX5O(XKILWU:
M1/B:_04$Y]L&>?/C<;+)$<XFDYCP.+Y3L26#XQS+ TL=TZ;0V@[E;RK=:K.W
MLKTW%L7/L/,>9Y(+"E:LNSU#6_$UE>..I8^BW]:: \><J?1U?K#,"&)&]' 3
MV6\1I0,1!B('3M,VL_7%(1X[9D:C(*)35NCA[:C'V>9FJJ$\O$H!&#A6:O*1
MJU?%-VN%$N1 A( (%(PH,DC8AB1&B7YL:O13*D_<6Q.GYF(V,X(-\1TWISO9
M5;$45B0/\?0-&7Z-OK4Z72LK<8M;8_$(#BQ9->NP!WW$.=, :.J5B9"(<!.4
MA&A\=O05X-T875VPURS<Y?]U;DUWR7BV<(9G>$O*\N,;"A#^!068IQMLFNQ&
MRM[6W/K^KE*+>Y#W+]L4^>EG01U>T9MRQ[!@V.%^-JR)XTCG).C??EM/OWGM
M!$%2\8B2HK5NFSL*8(#V]5_IK'N^LSKS9AL??<W2[!)C7FM<2S=9S^$O=L1I
M (.CF6%XLCZ-]D+V=%N]L5S9KG@\M.5X0FCWRB_9RSI]0*HD5\@OE@9'E&9K
M$CY/X3M"C1?\4E5F2,\DHGT&Z_A^_=;E#T$[IZ1)KEYP]OCK0IMG-$H?K-\U
M.BY#_(V$BI)>MCYY\.+VY+["FX/=AAQU+F:I4>EZ]Q%WI'1BJLL<TF"IP=8^
M&6K>)-KL4AFOWC1A'#>IFU]U_UVUI(/)T)OU4NAY,9"/Z>0K.21.T*[LNBOT
M@]"!P(K R7)YOGQT?A6H>2R]_^;-J/?<$J+YU74?^5RX^OO[MRYIK?"O&]#3
M0;]GLW&9:[4U%H[)I(R91/9!5W?_TF;XF?Y(3S:-ESC%TV:G\9VPE )];7((
MI]S(GEI;6Z=-@)6*O1G%IY5GO'H'DV'. ]Z3W9@= _6JA-CBYRWMAZ7?-/ZV
MM=YVPSDBVILM7_"S-FYG-QR<B56Z['B)NV\-.EZ+;:!ZM]1'=8[+E/']Q7]E
M40LG9Z:=$$[U1?B(*+ES] _H*^8>,GN.Y0<8Z##9/@U7J(R*_G?&A,CJ?^4Y
MAXC=\M!-J&;+Z6K:%=4DO UV&?K7DR<M&'#.L#,"%"&GG5%3-K]^^5"WY3[I
MI\DT:A( W6<4X+!4 K:W '<L1@$P3W7^/W,?]3]$3N_33I*>=>R/%70O6=)0
M@$_[[; 38K3($L,.^>QS!3U!:\XL:KF'O1P0XXR,NH4+Q9L7*( XQXT/(PI
M(GW#Z$V% GR+1[Y$NY"!!6= 6.QM%TRW'048ZCS/_)\^D/E+ PDYQYH\0 &.
M#[TVCM+^IW4]=WZ?-AK\;Y\V5O[_\[01+6J1*,!__W4X&[F'--<76Q)+."'X
M7VI,]\\&4&=?H6R<WZOZY_RZF8O[",LN6I?;#WMKF 7=A3-/6PK9?,K1!8N.
MSDLTR+?CIM.//79:U/C)E-[@JXD;M#R-5_L([ZMQ(EG7QJKRSP\.W$1-\I(
M\\YO&P=R4>U9O[J?TOS<M/V8?XI)"-)MXE!J<?;HP].-4_&W3(<\AN('U4@*
MEVE3IAV$6<!.[HVU' #%?H1?2/.*7=W=7+C 35O2<5+IOPX [3Q]VA7T)5U#
MZG>UMFPV4E7*<(\E!2QE,X\4]KF4^G+V'S!@6X'E(AT^O>TCG6CD^.C#JRJG
M& W'7N=G/SC2-?L4R\>,CHJ*W]6\ ;RV(!<X/;VQFB!5W],H,H/]$$Q'VSQR
M112@51T%P!T)$U@*?!H(I)?$S<N\\W(#L,,\KF;3U!&E^[MNL"E5*+E<0TIN
MW1AK3D)9O>QC36,?GRCI;-X-(>'7D?S11L82VLHS.:3))CYA%W01Q;C,<\&Q
M+J!IRT0O/Q[M7S.Z/"%<GY])>-<"K8*8#5;D.JE2R.4:4W+KQUC78\L2GOEH
MAX%["LDFXR:5O]C8+/L^=B!FP,T\ /*1[G6: +]Z"J='R8Y4'BG!RG,O-%-(
MGT^VCGI\^5M_@.R,H%>X@^,G;!Q:,[?IQJ0[C5CT^%@Y2X."FSJ\:@K%GT:A
M//?'V@RHR[\J$,:3'3B(=%D";B@B=>*A9FG>/^%Q_'!6/URS0+WP'$F=C(#G
MI^_EN'08-"O'WCO=H@!&Y375"Z'(-W))96,"U*=B*=*.F9:N%90EE3.""/I[
M"!_M\&5)_8S@IF[3LGO%*<4A4BSR%C8KC"X]QM@\VSZJO8_DJ:2?LF3Z%A5Q
M8X/%2;>8\?MI:8;;,"VFW>A;IM1N6!2#F*OGEV79OK#O[);N3L_O8:_[UV<%
M47A7!:  V.2?/1=XKME<S06.3;H1#<"1$8EH72Z!SKV@_!RM9^&_-'\N['QM
M"^B[1S3N! 91.+$]G3=)) !U,2LC]-E&M)7R'MOKD*JX"/^M#'MWTT&.7QX/
M>##>=G!.F_R=6-#B!.\!T>>'-01LLF@U9(E]JU,O!ZI;K8]:(A\N-,W5MBQS
MU]3\/I,#>,J+EPR]0O)9!8%<09,@_4VHUW7AO);.;'D(BP)N'<:PB0;L[_E8
MK8$<M&/>G6YQ""L<+5*[G7&B&RTM\%<N "AS C:8+=*KVQBJT78QHG] J;U>
MZOO,_L[3Q#?&_6V:W3E+?AIL(L"E/N8X"Z?:FOR>8\HLC ,C23L5C0&&8@?W
MIW,[P'5#TB3E5!8J+39&#^7.^=>JZG5+D+!;&)=!L.2#>-82YNY4D1RB3R*B
M(N!T:=NM%JN(RWA\0H?YA!.,\*')FKR,:)N&\HP8C=]5E#\#@]V7Z(@6JC=/
M"KWF^M]V*<%M6:R"+*N^)RHY)H6W&E"$UK#'9:$ 5:PA8D\GZLS?6>:V([1G
M7MG1G1N]K+NIGPABKI/=Z\@$EN-F_[L\DBU,4+CW#Z(7QT8B]\F/+,&4DH9?
M-P\9"PWR'*IU^)T(HTJAJ9F[E$*E%3_0/+8<9W"$7TC+U:M'<C%93#IF_8XW
M->1'^8%=0.7EI\DK$PE)P?M2EIQ>-22ZE2JO;/9PF=^C%=V3A%&+1[RCC>6;
M_$3T968NU1):J5G)#E8GG)UVN*\P+4EE./."@.I0 /.)6H.1[..\$C:;_2><
MLVVDA[3YH/MJ%X_B@EX)UJ#9@Z:&ADT<!3"S!-P^JG3:)[)\].:S/!7VNX@0
M.PRV\#>IUHI!N8)@JF<2+.J_BV\S9>=97+D4%-2<?9BUN<Z&1YZ K>F00!3
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M/H0X^)@N'[V<#9)J,:D[L=C%JFB)S\J(2\_<G"XH6)AJMZ_9BS>0'CXM@EU
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MQG1%H%'P076-1I)RK$.!TL.P_H5A6'3R;QMK^GN?(082T[YD1W91\,2YP(H
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MBLS[FLE$,:U23UL0EY)!C"BEMFF^X7_L5 7WG#3%MAT@#KLN[=]A!FBV:$Z
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M0MBHP43(/MG4!2[77-L*QP&,*Q%(2$CVCTN#T]*?[(1W8$G @WLMN>;C(GY
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M_BLA=B1,DH;1(1'[L[#J2)-CR@'>JG)H/K:<OL%0-GF]'U,$!;\#4$L#!!0
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M"L 7,[&3  ?AQN"T>-L/_3WA5FK3W@"YW0T,OH!SV15F26OC;N$V;A?;;7B
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MCSI4S245-M [H'86<.WHQN^QG)A;@<M;E5Q/'@K?>I?Z9,ASM(YTM^%>DX3
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M/+09'KGUULOE2BW7" 9>%E:M*A0 7:@I"Q*?7QBQS(3,W_I5.[KFI:_Q:5V
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MX !8-?287P;\TG?0+=(),9SAYJJO?VXB,T=#J]!TVAM[\B#V- #?/:W33G
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MTGX=3 50G-4UIZ;&#7GSH_1Q /GVBEK"I>6E[%[>[97=!JW^G,:9#QMN54K
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MY-@_[,JTM)E-86#]BG)5IGJA(LGE,MULKSY=!27EB]>:W-\WCSF0:4@WPPM
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MUBA^3>FJ6"W-C\"S%32]Z>)?.]MW)IH.H5D[K"W'M9:5GK?X?O_^DBJ\R$X
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MB/DVO/5\KC7?$.ET"[EH/2Q'?6'-# :M&]T#-<-W;!#0H=.M2?;N($I&[1[
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M_1_./R.7>\!$]>$LU>H,A-T#Q\^.MNY<,Z_RO4!TH/5D0_#,).B:!) ^8NN
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M-Z209T'XN3YLC-I]%YOVW1J'[%ND2O<H_NC1]3AJ\D_/Q?-W:)'4)9\;;3$
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M WN_F1C.!?,1JP]V15I_B*X\7\\G+7+13H#-5.@MSG?;V3#-TVO0.-IM2ZY
MDZ$ >"M<Q17YP =\#_AD3_U*L#>-8_1ZS?F!A&=UP&?NABG.SL3?Y^9E.*-?
M^Q%Z/RH>ER"YHT'D!JX6:=7.G,S:X.&HMF@E;@](X;9-45$@0,$B]/1WG1,F
M56 T*@G==1,8^6Q";XV=_LE__DZ5_]H]I+\'Y.6SN%LFH1*J*47]9QS"/_"W
MAO* 4/3EV*-Q^3JJ3]Z.5?^XSO2?X2^Q"^9_>1Z\)=&=&;8)1?F=7[<A$I74
MF'S3]R"QWOWO;DG^!_YBT&IJ#1H0G>"DFDH.W-75YPES.S"@/#BIK7SF+##Z
MJ.G&6= $QC(C^Y$ 8T^X.1PR2J!,AP>8%86PGRK6X^A))><I0 W]_?I76YQS
M6:IEBR,_DKAKSGRN2RY9L&!]7B(L3C!,CB2P) J>226)T0D86+&HUIPZ8?X
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M2GOFL[1/B;H\E1HYMT/(4E[QBRM<LVY[EJ]??;MI"+^IQ2]_\24Z=5H%RJ)
MD=(0L&=T#2<Q#97\] 8-H[_;%=5EZ>G1'%B[8^*$X.EV9ZPRQNDFP!]7 5%&
MT8VM=].B+2BRVMBLL:K]E3++*])A0!8IT$TLPXLCR^/%4-ZF0XJ[:CNE;.>M
MW<FMCKXP-8-47YF5-G9&\.M7QKRS?>/&$KNV4I%;QM+@6/)POL<X@I(3R6C*
M=DQ!: YCF/"/>9#0(&?!S882=V..MK+SHLCTIP\A@WUXLOZF(M22(G]8CXX.
MK=[KI3[QT:7&EN6VU0'L,PT>'HXBWH(&?>=TM/:=<DNUBT0SU^AZ^250H2]9
M.UD[NB%6I=J!<NB=CRON3-3('53Z.FM'44GRO_H2S;^&X:O@W>NT?J\%'%K0
M;K9/98ZZS>1!#P,Q"&7EO5:FU!%@GI%/V:&/ 6I($X+ZJ>6(%BT_A[[]:M>W
M6:<W.^&492I2+ZAPPKV+R-+^M6MGEC]0(OSF !)^1)NYZ-\,U)OZVC73\6KC
M(_LA:V)3@T=C4/SU6>G^X#,%QTN:PQ$E-+)LQN$7I@+9ECD@#?\G+G/6?0V5
MLN@I;V%I($-XR"O+\2L*F)B&5D]1L(Q-DH9*&K^9-Y2I+%.$YG>(]_]FE:;_
M$-OD;&;9O/_4MR86#]2=GNEASW=XOF-@V#U4R_TL.H2A:>BC&1G5.F_TMHDM
M1UDS.][8@FM!Q1NNHSW-T9"/O\[#336C.ND/\7G9>JM=8WI-W]_13>LH/-4G
M'[LH-*<;4NY<F%F,J+5V"UP,/BE]Z^K]:W#Q^]9$Y7H$1+[F.],*3).KKH'8
M20N6-,K&0%43MY27\\#+F?7AN 8<'4OP"@\"0P%!4J)#^-'3,AS+5&DK[BP.
MW0<YK/_EO[UOX=9:) A;HTV3DY$D3,W'VZR5LI[*NLU2G<EMM++^.1\97S]L
M#NL&!03*2Z>!%*QLU1^6G[:,WQ_I0YL-Y+6NN&O5#+$DSEV]U:=@Y*VAPG$R
M(UH8J8H#UXRL/J\AI/(%H1XIX#OFYU#R(QGY"FFCA_$L'U!BOD-F@^K@NE\K
M@LTV; I6>#0VPC/CL^R"-/R9X^G^%Z>]J"8OA5.5BG_SPLN4W; \Z_-@=W4)
MY.F9.NVCQ8I'MQ-7.-^.'0PDN$['S&8P=PU4U W8,8AWT0NCMJQT[%%A#79B
MV@"J6J+P/:09DS]&K"[QN"Z4>IEZ)*OD"=7L@E%![T#3&+IEJZ,7LR7EG_"E
MFK^$]2^5ZL;0/L(U@.[M(7?5Y"K:L83%E[+UX+BZF%4B\Y(-;-$]9-8!ZC?_
M+-=G7 VYD,7+B 8 \@"7TKTW-7PSF!CM(K"">,F!6GZST:'W\:PN//F9T"NI
M]M\B=?Z;G3;^]R*C_HO^?-.GV_'DY/(F>:Y0E;6+"%:64]%O@L#R'!*'*;5#
M^V<P91?'8ZZ55)9J0E#W@(IR?YH627X136E>QUF?5BX-P42]U8^Q:DESCGXQ
M>&D3"AQS9]3L*RFI0JC:PB&7P2B476.0 ("L#3O[5I;8.J*2U .)AU5K-4?)
M/EN@A"P,0=3/GO [CS(B*^35J/2P<,E@YZ& /#*-;BOZY<4Y5V#(AM2![UEM
MCV+;*4#1\3.VI5GCJ0DF\BJ)_)I.#];12_Y7^^^^&?R_ &@JM;FA>Z::GGM]
MI61R<\R8G.U$.[<0 JVQK$8TN: ?K'U#MCAE/YD/W7783/,.@68AF24+.[5\
M(UI9]#@K6NJ8*4^E/4\RF(3E=<[6F/H-N9AR,'56'EDMUGQUL%]A>X>KSA3V
M@M^RZ%,>25%_?%9X3A0M=JSA3&@>%KFJ_L]:AHR)*H']-C>T'59(CA>QL:^C
MCYN&0U?/&I&Q/3DJ'9,32R?-:4YFL]FPB$=O*F',P$%9218#H^ 'G* ZL?B3
M[NXJD&J5!HVCZ.<RH2/<3KM755<.J(PQ>3D,P0Z#3"5?1[&L9NR)("!;X?S"
MT"PK)=L:^]B[@^=Q5G(T,9OFT!=L^[: TE EA%A)O@ :W=.?3:;-+SN]'U>.
M:\K3AC >ZJ>HF>"Y4G<BRY8_(WCY<YU4D *Z;PE \IN 9B"1DI0:&TQBREF$
M>&O B*8T#(FE6=J>>EDBCS*5)MP#)' 4VVR]6(D-^7;I DC%5M1)U:%?] P(
M_ B\M3[.R]2GA)6._Y08X'KS2PX/3;ZT4WZR.X4B\EL]#_A*2?LMA?FM,EB#
MJ.,A6/Y.M7!6*E$J<7@PBF:<ZH35$/C'(@5:WMLS?E2YR\<KTV0GPH,D9:;,
MM'>\_<;;#O-<7*7K!]#+IO?&0O;V_@VB"QQ\KPPJQY-X-)+Y@4V?O*3YFGJ2
M%WXV=T"C:1*D/LF(2^KKV02OQP>,=EQI3]F>LC1*DTZ785H=OQ.B^@+3"#'P
M/O#1.R!ZG:\VIFFKWVM#(C<%8-&[\F0@,H$/P@I^7:1(E0B?/&3@AHBWOX/(
M_D[E+VO:D:I-^?,["IBDKMYM?=WD%Z1SM](/[PSRY3EZ98@5>#-_M(_+2D%9
MUX!Y?]#?,\:IB3]HNAX>SW /H*LV@:G!%>VQAF31<YPW$/9=;S9Z^F4^1>0^
M^)12,<O?/;O_:Z2G8">O-FFMH98O0BPE$QMQIM:>,;XS^=SU^I/@YDC,M7[Y
MY%12KD%$VR^#C=$N8::%SQJNI[R;B:#$9S%5L7)#O4OII8'23F+V-2YZP'.K
MOI/R(S**7YAK1R4>N&3@Q.*"5K,TH_AU6[U1^WF3\"_7F E>0L=#: D,DKM,
MCEG?"S;KJG_R.FU[=&G(<A^&=^*J@D_7W'&AI2?UX^_L$5LH5--[9!^ST'*L
M*E^W^0M2Q8>MK'I\8?,249^4G:VDY^KCW,4H+,G^(3@HD3T]QTJJ\:GEA<-X
MV 9EDKSC5WI!'4+J'+T(^C 30B1@;F.QI6$$(7;L&W"/..9W!?N$?74)4L9'
M%=6X>#M7MF(?VM*D!4O%NXU>^7"5L%&3P%- J&S'0QOK]D/NZ[ \J4>;]7D9
MFZ#>?#$=*_=WRWC66D>$)L$%.0&K+[+X7H0QG95Q%''J&"R$=6-QGG8[-1$1
M5@L2\S6Z4PWG722J3/E,*R&=F$%A*)Q]@D0K;+5\ZF'!X0F-QEBN$V^BV5^F
MV8J@\_;K/UJM+VC\YFBW,)J062GZ/%K') [OD#D4\HBB6 XWG_!B7=<,)YA%
M1C(/E.I."T"78+9\$&JO7X?%^FG9G&+P7&!7<E+%MUDML3<T1,<LAMF=7$U\
M<!9]9/AZAKJ5&[<G4_E]AU1@BC?O>HR!,ATQF"3VIURJ0\IS>Z]*!;C9C[54
M9ME^VMJQR3X4>U2W%S4Y^3O%F)7YYZ4PB2,EEW4I,7RC'Z+@7&(A27SD*%]O
MPAM5'!EIPJX_K7#U.W>T603SH(M8 W")4UZ0YA1\XH ,K&,K0%6](;054GJJ
M^P6=&<=5%2(GV0?O,=N!QZ>6E2\ON\*4JUYHU=;=%+'=O D6>=U:XE9/?RKX
M($O@DHQCV@-Q0#2W'EJ@,JYJ]=%I6$E(HL5$@Z*HRLP5)V(@3[1RV+5NXF7R
M2TZ)>?>3[*K6QDD+7((*3I$ ^8G0V>V<K[!<6$U$<,/$4XQVHF%7BZXCJ^^?
M<YY;4#9#<DN=DYTMQM1*,,<T L9*&-(@S(-=N9EW?>7W@#2GF\)3HM@<Y=W5
MB$!UR'M)HO@F<7M>(C$N:8<[NB-Z(>EZK;>35/[5>0H_$S &<J2)AOD@B\;Z
M/S+ .5J]II"4IJ.E-&2BT"VZF:8MM>F?O,RAHZQXJ6CN6IBGX!7:Q)91EEP3
MAMLN=XF+$!P9$P-OWASPFA?WAG\ED9D1D,*&U5J:S0M0A ^&V=*X!+:==AM\
MUW2>_;P&L:D_Y#24LO?+C-:AEM( A>P(G6[&"GU9-TW: +J?6N,:!.C4X(0A
MK\678E[HJL,<7>!':D6Y0S.94-:XW7\8H?\\OM(^IGMGTDZ2IR8UA8.L,[DT
M<A"Q'!TA_1Z693S;ZX4D2W'&V[U+)MH=F\+\[I3H%\D-2H'\".:1Z T5-R]M
M%F/!5VE*'*8RMI-'4);ADK!S>]1P'%SW_!YU9RAA=F9IC[Y^\] >&78,9(QG
M3[JR2J[MG!<H-Y[U7?D@X/E/O=.3'\Y8L[*I/@0B%,ZL<RTZ^P]2L$SI5\?O
M_EO^+X'CTYW<-^'8,V=''X!E),PS:L>J^/S%E_7-AE'J99ZYVA\!Y@31!EY.
M$^&9GL[6GYT@=2>2*N$B_6KB31*YDUD^')H^AU$0J2']U&'X,/XR<-)L2,$P
M2)ZVJHQG#S+H#)6+\Q=EY>]TWZC)RNM!\97+0I7?K'[IA.7!1":?K05PX>WZ
MZ7"X??W2M-YZT*S;:1 O;S>FH]5%1+LLH!HV68T:)"NFF/+V:D:[T9OWB;IN
M\.(H41K!EPU92LT 0^>F#Z.19P,1+T82^M,DZ= E.C,(=P<0&^--X^R;C/0E
M5C!R;6>QN92IE>R&0#MO(9C> &P_2HS>NU5A?S90'0C /!(G7*K>K.53><VE
M9NC*HN#$<44Q.U=*N%_[GNM%"/UZZDF<FA$<3D;&'GF64/"D]CS<0SDH$6)N
M%=6+N8*SVJ3_IH7,N>A)_W8>T4$"_]EYS1X]=]'ZNQ58_!>'16?1#XT)H_71
MJUXX,[\4DR7)BC_7HV >P30(<QP&4JOW6QAGK(L="Z+Z<F4-6#:;K$#<"B/N
ML<FPEYOK+K.#G!M;V@LGRX\@PV[HL[D?^M)<=@R;78.#;,A&]0+CHIL">0\&
M['VOH&L]$ZH%3E-[;=,.>19C>N\JBKEXPFP!>3//H(?#I5'M*MA)1#W.*;*?
MJY-X67M4N][D ;1?H,3(BRH3H49(<\!EU>V,OL$/\.=F.@2Q3;[UJ,A ALQ\
M.*1]I))/O=#5_'^I!*KUG!K@)5LJ?56=L+9A_T;V IWB+2C!L)OA:WX#Z]/Q
M6I(RO::FH GT&%FMMC6&ID2MANOW66QK%^'8<B?B6'OB<WR2](+Q KQCH 17
MO9.YW>W''?QZIYSV2+E^@81J__65B]_KV*)G:8E% </L[RYBMG]LQP[D8:,3
M3C26\S)DH#.._8HDWHLLL'J)SW6LND9U.CR9[4 ?ME5$,0FI81GH[9@I8JET
M2%0M'6QKX %55D\5DJJNH=7-[3<]*9$R>S4W-"^5LGY24.!MB!/6&+N'=_:5
M*O[,\O7!<2RUPJ][ .7V]_F#AL#7L>>^99($769+%-:G96)'2]78</:WMK/7
M72!1X5^67E06^W>EERVRS\S=V,,G@ 1/!R _JD3EG43Y!./6U]#WC.B,_!"'
MIU\&K8"8K_2UPJ='R1F[!+3/;-Z[/R%4,\B;)G2"G$Q673(ZA.&P=I^27U9C
M]29KL\FO-K9^!O4(9-9HPZ^@OY+/.'EB@H5W72^N2D9C,Q\8J3%2Y.0GZK:J
MK&EM3+J%773R[D9%;3)W./[;:Q#[2O/'QXX;U3$2I2D H-Z>>1V49+ /KHF]
MGHRPP_&>7KBB$ JNT!:)[&Y0!S=D803A-6J)HFO'*DR91>M\8L06+3P/XY4[
MI51KBHTS.AT!E:MP:,8DK6G%A+]?\5C,Z5C4ZQ7R@I$2\=HOH35#2N@@%)<6
MCQJ2$;N=,1\9&Q4\$>H/ ZQD^YNIM+_C\KE93PP'3%6V60Q*5O?!?,&2+S;E
M8/ZDT <!U;L'C,J4^D,W$W ^?5M0:[+3RBS.-I."-\JIJ.COZ=G.2WWD(D.]
MTIS2CMO6R$/(=*E4R]^HP*4)M7--_@(;?_^W0 ]S[;R3FIA!=?(6J>+<LV8B
MT28: 'T0(_1DX.,0",E;>%@165^2EPY7IVLE666\PA7%\CP<&]_7NU!]FE9@
MJF!6D=<5?01E[LM9U'1B),1WOP?X\_N\E4U9HP IZBP]JX58HRWQD;QMFAFV
M4W3VVB3FX*%),V5-NSA-O)TT(BKRZ=->N_UE=$0;'!YW3E*&>T14J0\!8<H@
MF4J[DSJ<)PLZO#C,-5>3)MJCDM!J]%(YFW9NM]\612J,4P>+]GS5)U@P,C!,
M&665\QI^2-7T"6WS'@E5"_< L/Y:Z9'13W!:A71CZ;@1'?SZ??V,];2,<QU#
M<S\:GFRUFV[H>8RH0;5'A5E1U-$UGADX(G!>/*JTI;Z,="[I),?N'L#6S[OY
M:DHV>5R:"!45:.-F9_G#7QN8D<^4B]KX3>5PVQ3\(SB#5QW*]&@F9:AV/)Y4
ML,PL\E;/"]5-/+AD>*0<'ZD',J-I(G%"N*I(#&4J?/IWU:-9:M/3>OPHID&A
M^TBY=<Z1>0K[.X66K*,)-#3^\8O9(RBSKD*YQA2%.@B,R% HUO+3\!>>4)-X
M%E2>CS++L3Z_DYQ[.,%E05^^J\P'98/&;;#/@HP1]P"7LZ(U@5[>/I ;8G?Z
MTR\#O.-H/S4-N,5[_6=L2A_<V1^2O,6/5(LCK#OQM5*69N35%QD,I%.V0K T
M6/,GE^Q(=)(2W0?B-D1GIM>01_X9,L"?7\1M=?6IH$*QGM3K<:&FNAU0&ZH.
M>=.6DI+ZP+W<0)D+I\;]X]/YY,.]:,23(LGL1LZ>7]&&3JX">>[%5]@LU21_
M!,&6T-],^?ZC=_N_ Y 3CDK#;[-RD\P,^DE&9YJBQ[/LPSAE44!C'S*FBK #
MC%Q61]'YSIK*E0(&F4IV5.9>M0U_QT_[65#BGNHE+20WQ\BTJQ6L"JX>\QS[
M(Y"USP,=+:9YY?HU-I[W\VK(C1V>@J=IPVLL$GH53A>QW@3+5.A$/=GZR=]L
MH>Y9V%N0L/+"R,K>:)=G39+"RO<M$M2+$/3\#,G(XPA9FHWXZL6(@$#9Z_R/
MUED-?IGQ4JS8#GKCA3O*\J3:V87MW6GB:H;&4!%&L:_"RA\#TT6.YNI?<\VT
M^'^3FXKD :86J&AN#-)D0EGZ,)E*\SJ-".NFMG0M7G]'3O68TBP@L]N,=MP9
MR*XWM?84'R<U6!ZHVT<J>Y-O;9U552MGJDHD@ZIL+*Y75,3/X(6*J1!'J*KE
M,6_>6!7S;+NC6$V7G$JT<%8^;ZE))1O[Z*20=W?N,)"X"&GE,;J4D4T^&*3G
MF?,B;$V$6B\(JI0E3:A.HHJF@BJ(]\V_, :8X^2.'O@B53KUP#E]G?FG2@>/
M)WE6%1=Y/2AAPV&ND>R#7;':)PD 9:!0\9\6._EI/Y,3,GU:P-Q9=7-,F=%_
MBD7XMZ"4S)O ($.*8IHF#3@5L>B:D]I)3@FP.9Q=)^LJLX(YRCF%OHY .SK7
M7VKZJC5^Z%@4%/'NN4.G68G39!IW^;%@!)HFPQ;18:40E*D$EY,I,]O_,0<]
M7E?@EY-'OO+-3R61%Y3*9;(K'_Q3Q86-(IE1/(7KY>?^4J#L1/$-OQ6O\GOI
MR.@J?@.8%\3AR6*5PWQ#DPIW<3.7P;2%%]ZIKK:Q$.?9*?$U@9KT\^>:E4\!
MZ[$ZJ>V)JT^XG$2YY<I_F=$VF:ZBUWQ;M974B(#,51UX*$_GI6()Q\7(J<#4
M=*A8$9G+=(9ZI0P44<(P9]RGZ9?FE0)V%_*BUH4B+="$U25]726'Y]J4DOE%
MLRI;T&G_AU0I">(9?,Q+OKTB34^\?H5I'A_>?;/*1,<&S'%/"Q+AI8H&)$B0
M.5.D*6QUF=(IB%EHD^.R5!SS5<U+5Y1# 6*[JR7CTJ[*BXNIQ]K:#Z]1_6^6
M/_Y."T+_;"&^S>1!+&@BP'SEI#TL&W9WC/> J&2?!F:NK#*4IQC;8'#Y/:#(
M.$?HB_]?8)OI/X4HWS9_;EPK/29D9"U$0EJ!>3)G^&X3B-T.L6G8VQ>'-,_0
M3 NM5I=;+4F$[PD/"*4:I.'P/EGS'#\X*VD6AI]F<U!MA.+-DAWDY^[V)TT.
M?/_NHM9:H#?1L33 &?6F$#V]B$=--]5?@>6/?FJT/[;PN76RDC#E,N+.:.NM
M]=MF^(?>?7;[Z(&#ZA2GU9&=_I/80D@UOX3>[=,RSDL7[]UWO<UXG@+-B]<_
M8JFF=TY 0%B1B^!=EFQY/]@;M;S2/$;5L->LKS27Q,R?,SI=B]*W@*D4/)6R
MN#[R63V0US+]@02>_--$T^LJ_3?D$GAM\@NVTW'<U]KG'-=K2*C-M+(0HI]M
M4LJI>AH*F75<N/>KL,C9/GRF/@^"*#&I^7(R6^;2_)FA]-O2\1_0>NFX![D8
M )+5>$0/ZV?Z*; H#,%_WE&WTR74F-:?\L8S=C8>+-/W1[J?S+%*:\NMI(*"
MOK:R1XI47;BV158-8/RLFEF8:7CYB6>F,86#T+.QY1>UI*&TVWE7)-;2[G>.
M##!=__K+8337WOR">'D>YXW+C_B\6:26C:DVJ\;XBQ<1-\.OB )=H<_'I2&N
MK#V5KMYPZX])V=\=^L2/AZZ@:WTL<C3^ C1GV<4?O?:_5^4HSE8?I@$EG5"'
M"Q<Z69K8&@,">E@'/=W6.@5C%2:RN[Q>) &-30RTRD*<]-D9#+FQ<O7!0A%K
M.[J4*N!ZJH\$3.$L$4Z4![4W^(=)A88[SW;<P,SRJEMEQF9&!W!C(KV+A#;N
MJ$0F+C;=;2_9:L]+HU#$<@=L8IFAG*[?YD.:(PYVVJT5[;"#@2CIQ%FL,\3B
MBBJVX,*]5^,U_6<T\2YTWGY#3V'[WOT)7^&/O-N.("T1:05WZ312#5R5W K9
M+SX=C5,.=PTBVH&)G=W88C &V6N&QBM6V?#"F4V[=C65LU=5!\2CRA+?N^JI
MNV1YLZ2)!M;7#T>^=$O_T?,H]S<UZAI31*(\2@_Y[;^^.>^O )!P*9C?!5;$
MAIGSVF_0M(&E;:8Z]"M6-Y2F40X]6CZ</!]#&CV?</>-<+3\(3/X\^^FI+]'
ML#!>;^;\D?^4\@_YH$S9JK]E,4R]'9>3TV+K @C2C[T:NO%8X6+I+P+;^:YM
M)C\?NX8>1P2CE[C;1'JZON<&ZVE^";/C&7"_QOS%,J)=?R9H6IK_TOKXY]M,
M*#.5WZ+KL[:#$KGDP./5;A4MGZV,>P#FF6MF!$8"4Q0M4YNJP*,FJ78QWJ^=
MYUA@Q^Y]BF/QK;2Z,NO:NJ##149_Z1A&4FV-F5(^,0U^K=N274]189_.F'%I
M(MFHO^@Q48KE"$_=9_Y-+\4JV="\PO*C \*'%EEJ.T=)^2,\^9RT*_CJDC+G
M&Y^71\AN78%2[R;(DH(E)JJF/EI\RW8Z4^O=2S[TQ@?[_##&KK)4@.=\'@&6
MGK&)OV9"KBEE7 5VD30AY>@M?#6N&G9X_B;260"9_B[K5^E<B\UMYL^Y\VX]
MODC2A7$) ]RS[ \^^YF^HLL=[CM'_(%5M^_FOSJX4-T#F%(.UB-W]'GCX7L"
M)VE8.S--M))6?I7S&_UWU9$YG@J(FC+V8_U=N<Q^1:7C)X4 @3[1RW2<&N@O
M2%J$-V9M$]_JH9N$P"^Z4-9+F$,6Q-WF,\]ZZ\1A5GVM=UAPQHE8'%*&M/HT
MKY?XFW*/185#5HCC[C&%S]6>;^Q:K7]6P['T\"#VVI!.B_&6!%62YBF[=J=L
M%;]>^)3VF,7'2QPT+U9QE2/OP,)M!PBQ>YBZ[NN<G"CJ^HAZHI4TLCO:'2JV
M2<?!)_@;&Q&"5/+]!CB^+T_3<;/9RJRKR>4.][?D#]9)Y9^N<Q;L]32A'LFV
MMU CM*.SE?.YAU'TWPU0D90S7L)R(:E,$Y["&:7E^0N7SC:U9D@QW4$2U(&
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M02]9VUKPIVZLR^X![W_TC7<LBTXM=Q2DYDUMI9=EB(E9I;V]L'[QW2;Y;%-
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MV&]RA:=GQ(8@#EZ3J;$V):7G^S&K-G"Z;V?XY%LV'[&JGGZZ'$VX6;BL.3)
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M\?WP*^N$ZL+HP;Z:E5NTG[?)W^\!EEB=^1?7"A-J%>42T,'MPZTKT^8B^%8
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MZ?UBLDDX*R$53JMFO[Z1*B-(G4%TFA!MVO ^W/QMFO,<RF>S<0GJ"5^.\;\
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M7U\5?!G5I6R(M*[!4K$=]XKHR]FX=6.MK1)+4/;S'T#:>?T/BOZ-*(H4[6T
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M5 "OWFE)V2'I5]BK>#7P0B\LY,S$7W\ CT(07K8ELCP3'SM79+CNPV1:^UM
M@L%?1VEN)S6>NW7OC;?PA0+^2M$-'\W YU21MIOLM!U\1 J4;%LL(A)6/\,
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MFM.7,PM^D:A?VL"D90P_>YIKYE@3W_<&%RK.9U]A-/32;NA%#'@9=!Y0[8:
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MM_;=/"B>/E[$3W+B\$(PUW%PR&!65D$P&"/!<+^!M60I$GJ+*#1OG.C_B(=
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MI"KV/R75FPAX!2#C^M\<L3*^]-' ;QDC"\+ ;(;E@1O==S/ 6H51K?<,IN7
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M-IJ) GG;:Z=06;>]9TAZ,\G#<QFL*(^2#C/\R.\,R0LT2HG9RZ_JJ;I? AN
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M(BR91]!YNM6Q/I4W]6_7E"\%M1\'9JJ[>Z53Z4PG-8IC40+8NSNA%3#(REU
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MV =1M%\8QW*AT<'/(P2C3WII%FIVJ_-V& 5'CV*PI)H9>WWP&Z*@G<*,(FT
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M@S6%>'+%>^*1L.Q8>?./!A(<^HZ6Z=!-K&<F>!]?SA8+%O9@\FI\+ZLT3VU
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M&#<=;AZ<@/4/_0,BR%CSQZF<\C\]4'A<^"*79]TY]WMG!^@-5HVE?&6G+FH
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M^\4C9IBI%Z(G,09S!+C1[4=)PG-WT:K9<2_WP2!*?"%_DN6&<Q1:',';X6%
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M7V"OU\@_AVRF<EDO14%>\=P2=ZK+=.A=$&\RQ [12^O&JJYC2)YA20HZBC[
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M<9=;.WR1P=)'&NF/(>/GXJA!J39G@HV]Z(8O<D9XV,MCW+X58G4)\NQ,DRU
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M+YX_*/6M59VZ1UG1*U6U0'LQ35QW+,'V=2N/.J6@>=1HOMPEEY9[KH)14Y6
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M5J)5^15]NV29OI/,I$*XBEGMK<^T-T-=%J'18"^F"PI"\,4!]/*,;%X;>B1
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M+&(N;;KM5:.U'>\6AJN>O*[IYH_PJF(L\TJQ?SPJJQH?5EI\B,:YQBH:'T(
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MV+M1QGT[HX)\GS\!LJ&<@_%/H?/$518Y*5QX!0XF?)8*GVK&)N4;1G/I;F?
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M\=!YY:KL3C>=JSK2_^21V=,7_*K#A3F.!X0!ZVF]-FW [(P;0,I:N0J5]PV
M-J9QHR/Y&'F:9D]<+]) .\?V58H73Z[SRWX*GU,_,\G.?J,#>O:(3B)EZ _;
MG@;F*&!8Z'C]E)DNB"(B8GCTY,-JEPA@C5]?E0W]%LF(=7SGITPI,G/9J6OV
MR$JKG$3*KC()RQ?/E:Y(2*FD/KJ&Q>0R^6T91::9&DZW484I[M@H03QWHSR'
M$J]?W@ VE"US<XE?M5T4T%-93/18W  :F8QO 'R&ERVV\B]23IOPGSENX6>[
M^U7'>X3@E0^24P4&M18GMFAH?5(W0 H\2[PRFV)F*=Q_Z,O#[FV>> -XKZSG
M7"G;F3V[H%R8F6%NFM4YX$S)@<1G&].^!RH2L0M/ E2<%6YH<#M$HGP*(I>H
M;%_N Z"M'E4OU]<I?EC&748=_52%3CCY0%OF4YYG +UY GNQ655>"DOKML97
MX)A&4UG#$U122E8I<W/T- ]%08S5X2%S,%4RF+RX?[-('+5RN[720DHQ5BZ:
MWJ&9'X86K<5!#C:,_TC:L [ISJ[ME&R0]5/V,PASR>YY#@'L0%=P<=9I#W5C
MH@HO>;C"FUME6>*46^2\?_BUD:#8&"4 V&T<T3Y304S]QRT7Q']*>TU(REY/
M,8"#/?]=>#ET<)  (/EV73H3XZ>8T>0M@*3ZCT"3(/NM1T Z\Z=.BS^N*?[)
M&4']4W653R6??L[11D(:C)7AH_FUK F!I(+$KVT8?X0\?PXTW7ZRD%"*C_@/
MO\5?+20Q":%&^I 8^U%@5J W-=M2Q6(X=:#O("L+ "UXT+1B9MB^ *(L-,_9
M3>,LC]'C/WBM]/++&W-M;37!SFA+KP1!W1CH54&:\ %]H<]U)^ENOFNS@G-5
M<18OV7TUM@CBH"N=9L1M<JLW^/H"SB$*ZORX_D9Q@_H[E?G\U3U\R!E!)$Y3
M)(N7Z]#'>NY8'1NVSI,E6PD(DP)H26DH=P*]G($V _/1BLJ5<@,\\1,GT"N-
M%Q(687E/1.QYW[7.RT=(+EIIX!S&JQ,+/:"&$J8$8Z;;NFRE3IJA5XG:6U?@
M\([.ODN3U=OA^X;6S8S+]2VOQVP>A*['J<\3*?XJ>)5WA$_]$<S.Y:6 \6"2
M0EM7A.(VK\@=E;VI-G_I<<=-_DASQ8C-*K8*SC/VD#;(]S4K.2GAXCUDKYK"
M@U3\\"=AP0L5G5MV]^>=7Y/;?B$_T^!KL749>5=8_SKUQ.J ZE3>K-MT!G\8
M+/(DYII$8+U78%R@MTI]Y9*[LCJL%A?XPX4$W_I*BY/GY;F/P0II-P#5.07I
M)%W)O/:&2$C8-)$\6!!')ME)Q;0R@N1+SE(4%T4$S)0Z"?6C(=@W[-OA Q'F
M<!F)CEM<Z:*',!=QAP@V*Y@DH=XCEJ#=O <3>NKGZ%FW.;=#-&22A!A7Q.W>
M9@@WF3YD# AB/N]L0J<+6U.-,?S)Z80RYJ]Q<D!UP94/J2S ]&S;3-SV5%\W
M >1411-8M%U$FN7.,5[<&QM!!UC;W>:SFTL'] V_#AEIN,R!OCDU(F55F!6[
MFS8B9LT7G'$]4$"?,*-CM,T:.(I[^53LVJ/M:D^95SB[SY@"/-51^*%+F?1X
M._4&(("ZGVY'$+53PW-,*!:?[VBQ50ZE\GMR ,()#<;RC)>K&&%B3&&19C'@
M72B_I,.8,C4DWV%'YMRF*N2OS9PQ0Z3PHE'JX.+,^U##Y+*-5&)2VVNK;"_M
ML3T&#L=[X*%NW;E2QC:UEST>C6K@X]>F+Z$&P]@0FJL89.O&:6RM,:[,MQ*4
M+=D0U>,VS$G(&3-WVM.2[%7<2_@,3403WN]C(18'2_-4^PRH3M1]U3AXU.EI
M%U11D)URE5XR9&#^4JN]!E-(S66E;'1SM.Q2XE)V_3"7&_T&,)7G5BFS_MBO
MSUIT?9R]M)==C<240 *ON+"#\HLZ0<_'PGI#I%OT&"R&@85NW7T2\W.G!Q%7
M-X U.KTB-_Z*K_JPI='2?[]!36>&2F#?0'K0/98XEC27O\4_+^;4XWSD=FR_
MU]1_O%_@K9TL/R5J5 5A&?F,!BEUXT%-A JWW8LJH$.7G50.Y"D>S.67M-0*
MFRVMZC ^MA&7KY;A'GUQ*B6M$&YDI7<#N#(S#F",N8^7*D;;.R/4)KF(/M*P
MP9MX,E#@2!R8C#8=D=D]L/AZ=R13-N'Q<N4:ZZRJ290K=HHO*;V9,V5E+7(B
M>._QC,0PXISD:@ .EY[$"5=^><-7/9Z/[; 7D$8_2M5N12 4;T/?Y;/3O(F,
M2K6[<*O" H\3ZW 4J'UT!V+TV!R9=3_I_F'N8R=%L4Q0MPHZG>\T-I/Z<HM\
M]L<"^;<JX"OTKR-/7KS'GLG7V.U6-RV3GE706HHC28E=F"@ /^*E+K7<&$YT
M:1Q@6(E5]NE4/B.D%]/5$@@P%!F,8F\]MH9L!E[EZS!P64QE]\@3?1[?Z/'\
MEOE]G+,B+CB-.A^R#QMM0&]IHCWNLSW,NP$\:%HRR6I^74EO'C9JE5X[_(QQ
M*:50B=@+NOSQ/.I1C.2^2=_XE3F0ST[,-'>2,3>-E'YIT46_UGF11IE6]"XG
M:.)4%GP C>D5/5M<MIU6EOUX.%>D?;:7_S0Z@8=@J3L[9S@UP%_K!E#P;0Z9
M2C3OZ_X9'AM8Q"DS#SA\JK@R:;UV QBL-(/5T%>4?*G5KB7*O5IVZR5JNYJY
M##J_C9G"^N)8>$7'RWW=5<>XM' _HFZ_%M@B6/TAC_ ]YM3JRP0_<M%RH^"W
ML*\JUU9KA?<ZD.34H*6+L&!"3,E")1Y_LNX/'F$[]UT>?),POZ1= 5*'"*.Y
MR7<\\!;_G%OP@D>!.ND^!^Z)H\DCYTD1(B]K60+H:4 7KLQCO*DVR4P1 +$T
M;:'H@S0_5#*()#7BR7%O.IQ#A'LDSBL95\2LR#XWQ9\;'K;[R4T>9[NNU9(]
M8XIU!-;D<\3QP7D;<HR,2)G7XWZ\_MCUNW*\H=-[8PG/K#P6RV&JM9ZO<ZTA
M.9PYU"EUU.=?\Z<:F=\,)<AS.>93EF_RRAWCF%I&F32X1I,+I+MP69@IFE6.
M./0OM,EG*T<_8Y/-6YN,/\ZD[[#ZQ$LSR^UA#]=Y[HY";P#\]:?G-X @4\]&
M4X[+T\RK2X%YL4O*",\^B.=<TS6P9C%:1D;&<N=\T[9A,1D(1,X\FFZL';(\
MO*HW#3#:3F06Z*R&$K 8)[<D,,<&6;ODYY]#FVUJA! ?6*#'C;Y/H(O<C)FP
MP!*2CO5)$)!4Y14E1><.E^W/DR8X6F]D,!]NJ@KML:?WC^^6=O# J;M0\M$0
MMQFP[K/6Y-,>/.)BJR[@>L@OBA81.,:.A)VEO!+59YN*ZW]<XJQ?-1ZK/73=
MD,V=U6QUP&!?1^R_>4X!UPP?,II_&BEMRJ70W5)F%VY"[9L?A!9 EJ6>O(DR
M 4@GER?NYM<PDJ._J)7(S)3&[](.<BDA1RG=R'EN3Q==-4P9]KE,=9'/UR[A
MT;!CZZ@\!UVG.UT8%46B>DPO3(HNK2)DYTDOGWD *L3._$*L>'JC67=$DK_'
M+:@>:%IO7(5K7;"]?#&^:1X/O=AY7'J5.M5EX,4AO$*"62#Y+;NU2CYO662&
MN9&V,"U5R<P;0IVOD+7-ACN3)KS)HJX4.3\?1"F0#56_T"2OO>M"OLPBT!J=
M!18!]NO]K\@A0Z+2B3;\(+M3:@NL7V!? )['?+L-_B09>/'L"1*'^.ONEWQ;
MS8T;8\GNI!HV\JAGIRLIO6>:*5:SI?0J0LFSM"34=D4L\03S5"%\^-/A\TM6
M<^[> Z!A -YJX%"-9*-&M9-*U(X*(Z^$,;:!T!?"K_??G8\21W1D;8 [:#H8
M(K9$MYYL.=CCOF)@<]@JXU7!-W5F^'1MI^%X RAAU1+[2+E_^-WKZKC%^C!V
M]'N47]!(STHI[<*C%E%F'\CZYE-NRU#D!D 6Q6IYJ6T58S9)0G<!OL62H;_9
M].B6QT0F?FJ8WT#%@UT1OJAWU5Q30%SUP8?\"I0PF+W)LZH2G-U@32_9UW2H
M3<P[]<YW+P*T<)*SA3.;*GLUKX:)I0FH [*!M="Z(+U>[/!4^O&E,89LLPBS
MY\O!X_XS0EHR7SRJTF-QY0A3&6Q<XL,*:YWV]B,B^8?3*Q84;KD2WZ<$I4W9
MM9$II+!$]?F'\\,7D.VG/"G"L!0O4C%)&M)MCOY^\H_5>B<VA==[6:8'GOF>
M)T'/W_EJ% UEUL_J3KW?B%"B4Q"NEZ(K>L89U'KO,/G>E\!TU6P8!EU&; @:
M4[^\5/*$IHRQU(CJ^)*74!8H]\+:)(H]#U\EFYAZC3]=&F5LBQM22$KOR0(U
MWY*5<(V2"G"('%KN%3@_0HD$U?J%T6>87*ZBWJ\PWL^W'Z^.XI/H83^_QY@I
M89%CTM\+1<]M70WZYGD$(WTT^8["T81?!8_R*UU&\,KL#4"0N8?-G#88B1GU
M:<0(2K>C/U%;IB8G+"VF,>IZ06JGI#B1199DI"!%4Q@CUB9<FH"E%XD9/]^Y
M;N^\?S:IC+MR,41[L+GPNXS/T6&^4EAD)_.3=PU 5XEA]<;-1YYVT\Q0\PT>
MJ>I32X;5]]NZM<*!5Z:3V_.N)LHCLA-V 5+@!MU*7UWEA&K.6+"A0F0@,O"+
ME+M8V;M;3?'$;V[E"[]?%=I*#;?G8!KIYMB/(B!)&&+J$=W#<"76&-*7R_UN
M)NN5YV3.\ .:W>1PIW['US21CA)8-P#3EX;V(@KAJM_ERA^/;X#N>;2E<2EX
M/T:LF"O7\NQK3CP9<2C6-!W#VHQQ==01)LNY%O6_ <@DGHS?  BL7+T'5)?J
MINSA@N&1YYR2OOB'OIR7F+Q+8R)LZD]?;*;TAV( =*]!8?,G[YC2HM3( Q%:
M5Q!]*_B"XCWV-:1 ^YJIQ?I/BP[=+;_/Y''(XV.=WCE"B5V0JMBF_/@T3$O1
M()(+Z)<']L%(6I*7E3,7SMQ[EN;WQ)JP;J")T2F/F)V)1\Y78++''JRCKKW^
MSJCBHUK$ _QO7'G20%T?)5N*@9RV4+RO#1F1:;@U,@&*]=>]Q0>(V_J-D)7#
M&76ED3O%E;I/FES0BA<TVC/W]?T4WW+Q:(#Z!F4U?$MXB#V:M2:<!P)KW$*L
M->T="$1S[XPB,%(&$8L.U7JUYULI>E-;:0H_Y;5HI_VVX)]Z9QL"5\.1.'A!
ME(R&(86:8[*:(?Y3!)])4JI@)J]N+RY\H"8V2;)/0KTU\5*AW#'<0S]N-#_\
M9VH,*AXARTH_O@UTA_^.6?I%A?8C*OA+6G#:_6"**+>YQ[=Q<82_VAH(X;98
MS\\/S+?!])^K4."1?)JT7I?^A;L"!N5C)'\IUO-3!NF?@ND_F>/HV 2"O]BY
M?V5@B"D'= ZG$W]LSU&J7,!CWI-!!9>,$@. R:9YLVJ"3]Z%DG$MLZH=*CP\
MRW!><3;@<N2B_"*"[0?X[K.N;E6@TX'@F\#WWF*>I<4(+.A=R@"ZF!)OUGW_
M@1MUZW14"_O;</4>\M&P$5\C&]\+>X$@XR;6J>YB2H[L]O8>,1$RIID-CO*O
MSJQ5V+UO<8$OX%Q*K_?<]=ZKJ$TD+)^P,/E96+FZ-ZTF]A,945R4[)_*2AL+
MS;?O80^>APHPW0"T+)48:#&+U_>RB;Y.>Q)4_T1;E.L.6IUU@2+"Z@3#VLKI
M3]K0#Y3=D=#""9WS20U8BLM3 H< '4C#"]6YJDF#=M +#]BV#7>$- -C\YQP
M)#=.&JZ D56W$KYN%"H-_9M 'N86NX"%E@-^<[W'?$(K):6$)B!IYO:DQ^4V
M'-;"ZEK(1\6<GU/"31%?!FZ[(..#]"\8;P#7;BNW@4X!J1II[I/><';W)"_<
MT2HI :P65[O09R5>Y39BV(,5'/J?K[MN(\E<]3L^0D-,7A23KP W@-=CIMEF
MX/6O]/F!%\$ ]=:*O5?R4QT$&NUYG8(4P33,8JSRPE:@)J ?59@_!76/V/"8
M:?($8V+FV>"\5NL*U==DLC=+&<65Y7)#0A1F3LB?(-[5LEAM*^O/_'E4"1;6
M[4E?-"MS*&2<0I?LCY0H%&X 13LW@-5>JXOOH_F)"WCT;U)]-O=9M-.P>NRX
M[7>'&6J.@L)LO0ARFJ<7/'^9.JPPJ:FAW^N[V"?=%3BF9+]@PI!O\'ZJ?1F#
M Y'9_+[JB(I"%+OX!!"%N36SWR,]!(-I)\/SC8JP&@EI@&&$1$C=2(%@8\Q&
M';N.G @W!#!O*,NH(GQ) ;$P,6=V)O )Y5<Y\S7N1]"2]7W2S/K*\\-W%091
M\35IMDW*?,?R&)'XP]DW\P'Z1.RT]9?D+E8GI-<7^4Q4P]=V!N>)O0&^05>.
M4D5#6^ DY4>LKPV+-=39].;$ G@-'4E7-1DE8-*,LMF7:[)O"QFFZ^RGBSR=
M.Z "&-KNB7+[GR_# SU 02+W!5WB92'T3<W1DEPZD761CDT#=^T^47F?Z6LJ
MW\)V' G$WYO\/M)%\'[6_7+?I3"[)&!(WR-8MGV.[HK6%YL! >9P/A,^M[X<
M@?*2,'JVPIO96BH"YLDMJ26*#987PH]Q6B16\TK"*) (Z!S2(V[OT<IH]>8<
M017!R_QML9K_3!+^S^-O5;!!*&(\G9!]*^(\G:7_I?_H#N30; '4Y5D,"__N
M5G" V5JC"8M?;W6O5QCIS#3M).Z>'.D_XF2K_D(90Q5:]/U-&VF\(5@;G;8H
M'<1I&6*4SCD<\+[,J*XZCQ+*9D%D^<$'S\W^DNXIA$8IF[;8-FI3<;TU3I&\
M"&WMT!-+?3WJ*4KYEUB*\(JV@WP;R!#FA^P7FL,G0#-F*(G:IFI=Y87A9CD>
MN:LQ:JF%R34ENUR :YHIN38P.@O8.R 33 O%KVR M2A@RJ1Q493PJ/&J93:_
M;[I?G-!@K5F6FBV=/7U63(0!24V!9(IHDQ-K/(1R9.IS<THJ:BV4<F>Y*9BC
MQ)5U6+ OAYCPZG.>C]%WJP60I*V$0R"G,9%;O<>,4238L6]A:D,[)(W'/._[
M.IV1*J!;4LU1W$$!4Z5YWQ.4*KY?VW>#91(8H=R6X1X;:)_-["DS&?KA*G2W
M)7#BU(&)25+>I9"R8EA^.P=%@A.XIAP:X"J>0MJ8I%(<H5"K)EO$6S/HD)$\
M'7-;/_B<M?&YFZ!O'A+FO-GR1LGPDX/-9T)CEB+6[IQP!DUGWA0%GM%F"P=T
MX;6CCL:HH&S*^TO45<@-3'$I](=!) ZKIPQG&*I]B<7Q$:N"%+2DV771FK7V
M(L;1'**A+=FL+P<V0Q]\W[^;,C;.9-%+F2>BZ\B-"IE4$>[/":<3;F:_9^I$
M0H8HSOIN?"27%*O!V)B(U"@T$H\"J^<N?MA5M"?<=+/UG$,)V:R^ 9P=Q%Z?
M@J;&M0,NP-RM[9E)9MT5>[P/9?;<$T3'K4/%V-0;*SO[S/D*$9VT>0^G66(@
M)?;NK\QL4W.>TP;J!E&&O+8JB!2_FKSL>:%"V.]K-S4FUV7.HM#_'J06&0;Y
M^L1?SGP0&,KQ*<U03%9(D[$4-S*GEP>G/7FMP4P^F".R433]\R' (*;XUZ\5
MQ+Y.7R#OC!7'I*O%4/Y1KZI27'Y24',1SB33*'O-_XP1HTK5(U$.PMG6F$76
M7$:\Q2IW%'XKJGIK=(M<C4RN!1G%PWM/0X^XTN0-%=MXO%H<L1C'P]P!P/;U
M,,(@2?Y3GB 'MG>^<J/Z!VQ?ANU;S:Z>FUR.4X1<=(J(J-HV@K<#,AG5LAUX
M%R!N6?J1_8% S@R5)I"Q_H9"7?+?+RGD!OXIBY<FW=& <BM[>JU=?]"B8:.<
MLD#AB2PCMB#_&F*BCJTD42AX,R0\F]&TTA%N=>5Y_:\(X1'= #ZT]=P[!OEJ
MD7Z(8-\32-6K[$0!&C4R<9]C'^DJY6BX?F0P>M0L:-T?%H/S_9@'W4&'7.*M
M0  :'20WV@4Z<ZA+96^(RHF&K)":98<VO=O,LZ,M/*#\%3:3D&[[&D^C*'^[
M4LXT4Q=DJ]'":F22@IK4D4O D.Z[DAAQQP@<VAQL'E]5';-OQ>[PX+15L 5G
MS':B8T7HB<)<_Z#VZQZ6^:XFYY*<#^7&'O.#9:6NGS?MBC$\'+1RZ!Z>QIQF
M  ))=_2*MAF-JCYUL$;K;PA/-HRN2L\[.4QVT! 5ZQ4>K=?,R LEX+X#3YGC
MEH5^2+97)(8@*2Z'K82EV4;IAYNX>"LSK97/Z==IM9U8[9?:$1Q]J"XZD#-<
M7'*%+)I+@+:$R+$^*F;A+2,D5^>B:GPID2_&U6O#I^*5E\?+/8F&T55XZ=V]
M <P FQNK5X/<555L4N^F]BL@F-YM)Q^-@MQY.X9DT>TS$"2F E*M@8HJ;<J8
MQ?_(D,2]%7.?_N(\B+G_["0MG:QMV7K6Z%+R=#!:RB8E6$Z"Z<Q^W/LA4DYB
MAST..<XI-3$'?SZB$9A<*5[[1_6U$7+GCWHS,)/RJRI#T,5BLPTV<8%#0R]N
MNX&\$OKO:@#2E/[CI]V&?GZN;!EZ6P$33\%T^*>;0Y)_%B*Z?7CG^XSAV2\=
MT__EM?J5AAE\1SZ%+:ZTJL#H0LB\A?">5N>LV%>3([<E^)S8V!^S(43^O21Q
MY9(-?7M7(J<SH2YW6J@]-T/T!+2F#2]<QL/['<%K (#XY[/%2WA2/H-M^^[$
M0^$PWZ7:]8/RPLR"92"+IN8 V_,22^;.MR8(7M^]>51L,^8TS!R>LM/J6(X)
M:_HFQ%M[J&ID6=3:6$O86EAG:MZ)6 I]X)UY/E1;HEO7>G3BV_!L<ZGM OT*
M75?&RH*P/7(YA+2I8J&T)-YC=0MK:MKC2/4[A[6Z]K-W%$-N@RB'NC["RBJ"
M"67&A!H)N/X>2?M8C4P;JO:C3LK$9>'=8G-O/!07:( U*NR&W@]=$%LK.X?&
M5@Y*39WG^=5[E!CG%0T_?@-29YB9<'M.6?EP7@V[)=JNJVM3#)=M%7\X;'#S
MI!T;S%-N;-%?=,;7WU$RW#WZ-%@2SNO[>2E^1-KN&7]:,6:ID]L)PT-0DTJ*
MR)O0B:OX>]3861T]SH<=RWU//>T_I#-]L!XW=(PQNR]-P+M7RD$PO[5X8*D7
MZ/D80:LNEZQT(+V-E PL:U)H.=#4O2(QT[?'PC8BWXW](/PM\C/3M2@_UWJ0
M?P>I0)"$F)CIW?+2X">7M+1F/V'I ZC#6&_)HZPNL<O<S_E;GYY'ZH:*HEN?
M!\6JS3S77^+-/DY"^_3WJAH5)ZGOQ.?CN65_.Q]]!>;=SS-YWOV6KJBD3$/#
MX*,KAFQVTKVU_XY"54#?!7,!]A%+1;>!78_(:NEP4!1E4*N2W]T\:VPE,YE8
MF/F+W'2PM!U<FI5FJ=4&334V>7DHP&BA;IK?YZGP+4-R C^%AT_XPK58N;_.
M,*B1/]_>8)-#R7AG?!POI.4G+_#YRKPD[XJD;9.=-D_ :;K41&7,\-135X2J
M>B21-:A@*Z>L3.CV$K CD9>H**;D(HA.W]S]J0/5TVKN]K$W-1?6W)@)_'4+
M7ER0T7[0G<+JIPH?EKXG"JN1&7AQCP:L.0Y,?9D$C:/(]DS&. R35!%+7T>:
MYR2%QO%SADG;.L8P',>\*F0Q(&W#;P#*#(&KBMXTT"!=9(:=J1BFP5#EBQG7
M@.^:,%KC"[X66/022!A$7QD$GE[O];#B+^3#^M,(XMI][E>3N2CB6#N/A;9=
MK0#IY!/\K4Q2AD1?[97QQLQ3V.Q7)Z1%:-65,TT<.@,6R:CS"6)'7P1_0Z"
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MXAK_Z4#,T=(M7B;RAV/ROJ0S,K*K6FQO[6&76%PP/5.%T[378H3=\^0O-ET
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M=XT4,.=>]9-U+M/;75[#Q.-H&9Z#N7P/QK3@D"=%C85"%33\QC'30%P0,0=
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MX51I&L\69:H(CJLCK]+SS1A7@V;NNU:8?1Q68E-H95X,)KY.?J;Y!,47]+#
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MZFU?PH,4=XZV,G,;&'J1)&I;-&[5?B#5F*->>H,P%_[-]SJ>S!J,0;;'EW&
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M!+^5*S_ Z4< .O8<:%;$]"SZ9X47OD](:2B.YEL].BTZ7D)B56?L/@I.&KO
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MSJZ3,_1%DL=S73,9_K&&FHA/:B]=2?V'4BOM]5F%UAH[JBG+.)48R=J )9V
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MALVQ&2S9]]L'K@'T;'LP;?3;4PVLPUSO]5-%A/: ,[+TQ<=9#<(,5='<:WD
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M?']\" 8>'A[! P(*0D(*OJ<T3_G^TP>J%4!\'[L)*P$3@P%PCQ@#DQ@#U0X
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MD9>D-VBE$O0_30?_-?IX@P($_Q9! 1+^8(R;QOI;J5 JPN@P%*#.M*YCD"B
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MQAT'_3>QUEP.<N0X6RV^/"^ 7?E(EF3[T?I _L!%:.>6V.V":3UAA?2RB(A
M$_A^F"\#RVAYS:4ND>R^TKOWY*8SCG[:*[[B8W\"=!!KB\=V92"?Z!?%Y9&'
M\O)XB_:'*40"\?>M"^_YKSV7J!<<];GO]DD=,;,O+NMF;-G@2E/2J+\'V@03
M3?=ZI^CJ]TUF.G4SZ@*C_P6,P"&1-N)TTSK?1@N$('C"6<)?5K4)+]1GBA-Y
M9<Z#SSC]T=6=EQ:X&X,#D*[CF!C6XP_R/?M4&*""VN6.4)LR57$>OI01VT\,
MT-G^Z/)]PED\<%[_^Y,1DE"?1C(2N%FM:GZFW&\$B*M8*0Y"0\P6&C[&]PS3
M=MXK"ZE_115@]))WK([UV#_2>:^U^H%7%JN/B#-5?C*@]M/K-KMOR(HFS^+%
M> HQ6/^4,7]\?=LY<T-=04RRY'G+[; 75C!_V*W=OFHOW@+YOBW%MAT/BCZI
MDX7ZM\61*%L2U+UD*NK";R%UIHNCG;V MZ6,',XTGOFHU"6'XF]L'.2+1'\;
ME*$OX R9 F\:'%2T<*[Q&G(N;+Y/-DHD<\F_E7()K<1]_B)S5OHCO6K3EQCU
MF\5\JC*>YN\I!MVXA#(0Z;=-;.L<RU]U[2B!HN)Y_8ADY*ND,BP5%7G5S!L
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ML/M'PZ+<H"2.$'(-2O*UMG5RCWAK-B&FT!'?(\:;$^W78@,DNPE7D?PU^I
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M)N*89<[>0:! 69?3Y=_I6.R+Q'TI[MO-4A0Z=\]>FYI<LWI6=.VRL+PD8F
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M0_4J!S$P?Q\0([6EJ&&L-"BPEW7L8 62Q\J]Z.?^/^K>,BS.+TD?;D(20K!
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M6J1#0>R$?%=H8_T\HG^K&*>N3,X0]+O-U.?)KL[)[:/#P:Z>-+IP,YWDY!>
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MV=7;.Q%$'@QR.G<=6#*L5/F^&7?:DU&2(B@3H!CRT=+SE]O59+ @7W'&T2K
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MD?'KH(RV8=DU(?D5%R&)58+#YMS,&I[8W:2"6@.A9"_PN-^8CNF26:W%%N)
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M>L39=#_9&>?WC8CHN9>4Y7E2[H.IM#Q=XA;^O_7._:6FC@,5TL]&2BFX-2O
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M-FF)&]"E->CZD0=!-7U@$[>]1?7CC7=#!&^GJVDNC++/*B]$5A>QF3RPKNX
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M8JRH4II+L(L!:OG8VDDX2 H5]HQ_VBI\K7R?2]5(_?YU":FVY:27[$?01NX
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M7OGSH_I+D]I;B-(ZM1*] GH_Q!J,0^5_0J-#7JZS1/YT9SZL)"8%U8<LVQ!
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MQY/EX4[:-]TRJPAU/M-XVN#U!*68A82Q%7B3!%C99W,4VV=F,K:^(4)*_6]
M\/]5-F7W\7DL62A"DX,X:Z;9]PIQD6!E@6V(M@7!_E,USC;!8(?0SJF.0C!)
MC0 [- MG,8=H3GQ\G(O63?(MZQD)HF, <]<1@O^/ZVEH!D>*!E:_$1;I8[J)
MG2PQW>D0(4>T;EO3WP,CF(#CXA.3^8-QB?GN 74T4=D8?<109^X"SR7!<82*
MWJ*?LX3MP=6/R5?779#L*XPWI3)].V\(G$?RSA)5H(12?V8S@BS^'3S9:5 >
M7E)>=UR&_+:@K^\)GD<A9R%]>R@9L]RHQI/E3&8EU4<L5']"V.U=V94F8'_&
M%2,Y1A2Q((I7VQ!I3M8#+7/[+3\ZK=O:?7;X[2FI%S_:'#A*"_>7#_WAQ\N&
M^;:*BA_08G>4SU9K]OH\?DO-+&+B1A'#=;;-0M.F#%/<HR=;$&(/T<]5>U@H
MX?WS.'[^RW9*D]7_XKGW_QV-F-6?OJ^5XF3=NA^[1$K(P,K3MT2$>P;F 3""
M_E$9X]1^RDT?+E(UX!XP4(>$JJ3C%%5<]-%?0"T*Z04!(!P("/RCV%:TJ)O<
M++(Q34:<:7:\%0G5>DB3?G2T)U \&[\;INMV8HN\Z&;6.6'YXE0?F!EI(EV*
M=_2SY 4)#S*6[.8XMXHWUC8A?]R?>459=@\N#%*]FE6,,FW\^CY8FG70TY1K
MMHQDAX*I+KZC;3)LG0ETRB2B0CE*A#E?V/PC\%V9 K)  (W6Z(1_M#?40[^Z
M^*D=W=-#5GLJ],)F6'[\)@7#BA0UW$NHLJ+^;FQB[6YT0FO?/)D:=":_I/FA
MD. =!#RB.BJ]\5=OR%]EM$DJZ#;"(K%KUMNDB _)7.+&,QYJ42Y4;\5"@+]-
M%I02) B<=@;39&?S_8806F&4/#:7H4M[M:6QA?JH-^>?BZ[UPW@SL"([D4,J
MHVGT7SL,;Y4G]<Z&CS)(5%R2^+89,ZN$<1[V%^G_!K_\]>6TO\*@]B_C*/9]
MT;VLZ\$>,'.Z,!/]DK&40D((.<J_];^".A2?[1>=AQP^P#O.3(&N,>8Y;",W
M7Z&=-9/3Y[U]J/J\V3]U%"]^B]N/-P2AI5NE5-&E@W%Z:)*7+CQ)'BLZ5_LX
MK/HXMY8G@W2P/S.$^<?!_[\Q_Q.3<&:!/EWO=ES<4@K^(EGL"?.5I0^5S=#-
M(=:*-(8!=^K %5/A]A(A/VKJWU(-PE+KICG.@]8#*14UJ3JJ>01(*5<Z)Q)F
MW[;SP-+Y,[<Y1,6PJ,;?E(=%V7Z0)U J_E-X)"/(K/!X0<RF,2>2\;P84ZJ3
M'M%C@;Y9I&(DK19;P[;C4>[_"IGM*Y%AU+0F4[2BDH[&^UWM<)G?,AIQX=M.
M",(_CQP,H#/F !6MQ,]AK%OWP#^HUC)UU,D:KJ>'I00]N0=VIJ#*YWSV^*KQ
M?E "5?:_&H'^,C,.HA//&PGQ)@#I3*+"<'2I4D(JQ;;>/)5YGT(;UM\#7"FC
M-#"2_3V2\M>#352Q<YEEQ>T>PQ^Q[=WXA?U<2VH]Q$2,SF721C;Z%I1<,'!6
M(!M1+HEVUY?A^?;L^N[? VH*-K9B!AZ)N[N;K)WC9IG%^__V\3EO7K2I&R<!
M "L$3#<EE65V+3O,=XZ4/<:E0H2O!\BLH2\"H"XY4WJ+Q0_48R&,!?SB?_4O
M:G^UQ9"-C4)PFXI(@?D?*$)D,&\+?BIM/0X&?VS*,&E4 FRQASAZR,?%UMZ'
M2"XKC<&(R>2(+R&ENIWIA]>4U]\14U+6KWK7.'HIEUA2#AEN?'KN?I]RK=:W
M4*YRF&6&5-;]2=R4G^"@J>D;A&6S/JH<^$B]YJG)87T/4'+< TTLS37W0(39
M71PG_R&>N3:>7WBL"E3F/\Y3T["Z6H^KJ<!*H/:M&FR,1%F**#%7::A7#<BR
M+&E_6,??)TR\5R +?4.G\0X!CF8$G?PW@+C_$AAE7= MW 0B!4RG;IC?\"M[
M0SF6-0T[30D.V($3.,J_W1G)Z[PMR*/\HG,(I9A>7K#HZIGHN6]!:<BDE"EU
M<(]MKZ;@BM+%;<3MXK9YCZ.7:/>?QA2F=G\2#;;:&Z^>NX/2L]D[X:PK393_
MN'5SZYTG])DAQL4#^)PO-L!^.\KSX=#\G G%)Z"+\:+^)MTLMT"NSY-Y$\_#
MC6U/<2N4LT2Z&Q:![6-+$:(0S\\OF7GCM<Y;": +=U+65I3TA#J<#<WI!0@\
M-#4(U4D9U^%FD//CTR)K;&C<I-=^9$9;Z<[KRK0>67_2@AGS.!_3]S)<T&.6
M*$V,+=70M=,$)5K)$);D0]=@WW*K56G\P>8ZZRB&TXQ&HK$<YDKE\-U?1\)0
M-KL#-\=.S9&2KH5O[^.Z79[;I<U16$I!K#V&E7E(,O#;/G',86&A\M%R39Y]
M&._H@M8-\7PO$4STV$#KLB9+OUP3_5HFWDLN7<9VV+R;Y-N)R;/"&/J-E=8"
M:].^!#%R(U/$,&-SJO2M\JCBN8_8;,9&)O:YQ8+OUZF@S!S%V!RZ!&9!"Y:/
M!_OU!=-NT4K8.YR/=6U^?3@EG#%H;M>1MC;"4ZC:5;7_P5?8DM*[7/0YCBF?
MMV4X)_@(S5XNTD.3J $[Z)007W][08[WYINRY&+OI-&VP-3'TUDY;_'-O7A>
MJ?>-ILR^HA[X$PR(&3ZH8+X"_XO/F>5SV:;$Y);IHTY/PGBUFYOC#]=E!@@E
MO0+[T,8:, Z35IJ8"A8,W(JT:],^N&5&M3.)NFX0O(Q8@Q+RRF9]&9>[W;2.
M%!B-%)PB/*15;QRK*M(NH3>;'O@T8R>]&E)F2AETHX93;YGUSDR="(&ENRV6
MG?K;)E#JT3SC1&RTXJ;'(V%,PDW514L1K,D2FN^-UP:I#LMR1[)XWCLCJ_9T
M%JM9 %1U0I]8$[ZEO;"UV_/@>D1_=6WS7VF$&RE=-#!0'_@2L>T OU;381^*
M";U]I00&_Z,H0>L]?@(' ($/]:+_)_'I$Y9];=I'H[@'Q/1^_R.*\\B'#NX!
MXB]0@C>I;0]HC5RS>'A,>=W>.&M[<1:QI4?X3Q&L/N"8@#\2_X?],%X2P6/:
MSX,\<^S3'DW$O+[P='39C*)UM]R>+AWOVJOM>!;J@<Q?QGWP-)6G)5)W,-O\
M;'B#?7=74!W*RP1UKMA=-GKF;^.+'K=X26[JUR1,%:WOJT+<V$"/X%5'3O]E
MV9";R6J6GX6>!:@525G']WPUJ"I2^"%FX+A"N7BC-KH<DS@I!/,PW2B3+'W2
MD^2,( F+"&+-XI2QL-O.8K 5NJO&G%&QM4PE]C08[2E2>*G63(:A$NZH=YH0
MZI2<#(TK)20E*XK$\OF:9Y[V/$)SHF7('+^Z3E4^QXY3T*=:W\KP8$+5NGN2
MO]GY30OSKV48;3^Y3VXS5M.YWCT07985<67\)XQSL)?+TC=L0R_,?0,I7%<X
M*E>>Q@^T,5^*G@^Y)M1&:NG(.-HMTXI%*]BE/;\'HNX!V7O ^1XXTYFZ"#9U
M]ER6,:K&^%%,'.<1!VSD"*I\3[X9VE9[PR".YZ+P<BANJIM7QX\M=UKZ$.Q'
MS8=YLE*O1&PAD+KW([ZVID66=5M]DW]-\^UR&;[9H9G&J*T6"6/[-PY@#<LR
M]K G2$V[>3RK.OAN"&-;OI@C6GI+H4B&OC1_JUU\^@NSB^S53826TJG$EAZV
M_SVPYCCU?:?H'O@EWKAV#ZA_EUWR>NJ[4OF/-Y/N:$],T_\\OE3TZSNG4HC>
ME@OX+@WMI'3EYQOK+'2 5 JISC=$BL0@_1YX"[X,V7^ ^=4%T7,HSHS!]TST
M>V"_RG?O]^"*#Q/HUL]JOFO,\ ZUD5PH)G<FYAX0BKE$7[UC\NUMM'TX6^8F
MS(7$]>8CF^].B"_U:Y%G.U<HMN>R/L654 (UOO^=%1?Z%!Y!'(08V0]Q/1'X
M0,0%Q.HI:57;?Z]@1[5L72DC,:GZZ*P+R3R0:,4]T'BKX.32N]UCWWLRK(CB
MF$;WP*C3]\#\76Z**V_'S8>']%3#]0]:X,WZ]@SZ_D;_;?U]=48TQT[CGR)<
MC>V'GI*X#F-F]AJ?;?!,;_D(-,1PR,DN:U9H<NHCU_3)XI.?DE^JFBQI[>?\
MDH8/&?QZ@JJ_R/VT3>);LDJL,:4-ORPM?12 (X5W D47\8_E4FB>O<&ZFC O
MYF)2\]B_E7E8@.D#^#R%,F\3*[UG0BBC2EQ8RD:+;XRQQL0$4"[K/*UQ.;._
MM'L=]'TWGU"8X!ES9715:O\W\[.Q12FW0Z8TCD"'+*HWA8SPA.?GS$-Y.L-.
M"7BO2YA-+0F)B>^!TS<)4"?F5D(A''.SK!R_ON:?,0R?3@I,.+FS=8/[VK$/
M"F:AXS,$0;/0BD<FI&BH9:-B-M529XDNA357WM75G95=>,71T?HP(&6BD)%:
M)L=8H[F\!H&KND$?]:86:"4C^8:*^I @.%AKE7@:V>:+T]0'&T/:8(;8W._4
M:0+!  9(#@H:G"E7^7L+[O]=K80_9DC_HU#H8;I.^7<[;R8B:EH[XO.\?_SL
M%M8?M0=Y5$J:X_#O'+%!T$S>2N;WWNZ_T_>3&Q>^H5U_"AQ+?PH<NK87EQ&W
MR_I[M3>>4B>EZ+-W(D;W@)NFYP.&4(S>,IO4#P3_DOO32,#O?_7?O/^/&!H3
M0XA)$M>GA:?78MN/EE2-=,V^H.G/VW^\X]IYM-?=S(.T2FM>"O<+A3%AK*T>
M"@]E?WA2)^J5M=[CX:6ZHYF<JYI?TE^*?3%F^05L$64'ZAUR&BET-S/JGE-&
MXTR:.$N@>K;5('2[3K#^'7'J_N5G8<^CI:>KHB5**V5,NRXIMB<EY 3M#?H-
MT' <T_ 3T!>V_9)<OO@WVD;D$-1DT:#2LG4M*]INGV/V+7W"R\^[NY4@?VR=
MCH,9W4\^R<<0C,0=9:I(SAJ!4,K#W'3"P=$@U<5;J@.I=_IJS&E$&)H,-N4O
M@Z;+21TA>/#)&;SU6/P?[+[=T2_QACY\@WKB'B/=!$HA3ZD"L^,A:S=B9%*J
M-588MJ!\D&']I&U;"DH8:>3#X1%[81*RR<\J/H=]#P)W.1U<BJ/@@BK)-$R#
M E[FUMP\(^H"3,)T51 ;]P 4$@5&A"NP3NFTI%)];>\CVGXXO[J*<>5N6+_1
M$6:QMY+Q+<;CXU%:%6A(9D6PZ/2(-:/CW&@FVW>OSNC8E<4HQ? >"!/MP.W:
MU%L6V_27:G8*JWTW)V)P NJ_!]K?O/PIE/'X^H/+GK!(546JA=8#00NNHMU8
M\!G5BCQ_;U]I?K-3_$8_G7$%QJ]U(^6:]\G_BC+%>TQP/*-ADIMU@$@ZIEST
MKB&A4WQ!QE#(9GA(U^6YZ+?NBH@$\GQPJOY;E;$U44O(84P?.$K"DB2\A.\I
M1T"P;]!FTM34:EC5YARJM[W\P5*P$^(1ZDW*"*IQK4!7PF]=2_@V(+JJ&--9
MN?AHI2+H,MMK]C,P!74I.#/G!9TK."Z0Z=H["AK:+!Z-  ,EV8(=3._ZB$17
MY2E8OM(<Z6"?1'4+DFQ?&4=U.41W63,$)=B,U).-@+,$YOK?.I2Z@]%NS&D.
M,2?3J3_=L:YF,>[H*S\)+>4(GQBX2.XWS^@EK76$8,F%O56)['LZO2KJ^K"^
M=XA3\A?*4Y8M9$?JCOKTY6'66;BK-J,1'C^F0M_^_/8;S+<"X[!Q_K*GZ'N1
M\#N<W>,*\4VI^&?WMW+--^N?L"\F?F/>IK(:@2G>D;/80#X]GX.7\C_<T0^'
MW$,KQ3SE[S66*V=2MDKI=,^9:/^V821(K0W%K:"TGWOZ,FUD)W L%2%-5G8N
M1XC"R+(Z%J8 $_?75<[HHC1(V^II_F;X?),"D1?*7?4$3@9[D5^H$0%H8-8M
M?*4OB66MEY@ZH?ZDU%+K.X+[R3+-3=3J.K)+:81>K71V*!^:8T1_P78PB=![
M(=PJI]S:!UXU93UWK5$D>9N*B9FO;] R^Z[*8S+L0ND;S]*K<.:6R'PJOFY'
M'?(N=ZP,8.&M';DD$ZE6M%FG7=YO 4J+GPD4VKU[6@T6G2\__! XA.!U<K/U
MMUWNC#62*N'W$0;YFRG-$%CKN9X7!]G1*_(-6<R5Y"-*M(SV;Q9U@FT<5CR>
M6O^H=O_J$)PFGB9:\CII;_\K=<@5>VL:L67!9_-@%^\Y>RT1>IS+1[JD?@7\
MZ%ON118*&^)%9-YU0G=5W0AGA1<*Y\QT7^K!4;I7<MU77I)"3KF63*3F,;;@
M_10R952RAO6-/"H% 2&I^437/.FKB9KG_74&LDL/-US[H#::U0YN.^>H#T9A
MEC!"=DP"UI5"GM>'T=3 +M>\6D\(>,]F.IH$XG<>D"%[= Q[3SL<$*PK+0.3
MHP .EBM?]S(Y],2N#V%P)ZX+79V&P7IUM,@ZT56%B>CYTSHIHF%N!+5REB%1
MCP6P833UXJ2OJ?&DW\6$X'E&H46E32TT_,5'X7M )Z9+DMHJP*_1V<K<0*;\
M2W\W.W^/#M"6H#SA5 #^441G6@I:B7Z+H[_-&51,VW[^@9P%/A$@V:[$A6%4
M*J A]2D 1<L0;0@0XTJ:*'PLHP&.?H"+KPPAFTG4&.R^V;7(+H23 @42]6)$
M6R'K3B<U%-21H4:UDS RT5H,P=H7/I]OS/$[CW6RQ)P?\P)><"?N"4.C/,+>
M'1K<%2).U 5.,U ?3ZV+?(>5Q=_"2$VO9?RM]8ENEC"Q%#?BM7)GBQ:I?6NQ
M$FY0RR OJ%&8$2EZ.RDM]\[D&W*@$O(?&$NJ27E]A!(M\H QED;2N&'<0N4"
M;[[< R]W\=SA1K9"3G LGX?E6<A3CZ^V]0P."JB'W58C!?/2&D6SN]^:"S%7
MH-0)&=<2CKT"OK,_A-"G0Z&CUU0A2#8^6\.V'AZY#2.7R9&>KG?.;V7-1)=I
MZHS\7P6N-()"/\#XN0Z%SC+@C0&7K>]<PJM^Y4W:!L>)=^?]V23%R4G$8OLJ
M\3#WF&X #D-"J#4Y(SA.X<-#0I-N??0I*+T)3=8-<2JLH3H9_ W'C<[!XG=P
M-'Y>#61>H^KIEVM.^@A@-=T#Z(T^UQB?_1&E(3V5WW8/D,AX23GZJ)(^:GD/
M^B <YI20*5HQ2(:9HX1:[L55LST6"=CUH,+P)(JEL!.)Y;"D_YP2X%;HB!;+
M=@^,21'MZ6N_V:0RG&)4G?>"'JW:F(%ZN7]F'H,9&?Z02)"0E/U[>8$ *;LE
MSO/2' @Y&GE1W"%?X'Y)*]CE=Q+LT;YSF-A@Q5X8MM@#]:;/S,3'.:#,H 6<
M&@IHRED$E3/$H[(+:/@&/WVYV\V*NN)V#L?XOI=\J^%0H[(71-G4'F]>72(4
MG&X<U%3^($-)Q@^.6N,?T;8ZB%B,-7!\<<4S,D>%\><>LG5=:+%FW*YB)Z8O
M<VW13M$$R#23MJ#= Z4)'44 XL4CL-!*PWLQ"@1H )M0MCS1 /^LZ:!N:11W
M<CVT5UO2 X/R,'\]'+P2V$M46@V@L[,S@F,C.C5U'+EX1XW]XDS(%018AMZJ
MQ R%LMJ[(%-8V.+3/??T\HMV+RFBAU:&2J)RS,#X-R><V9CUIQCI@@XCL0G*
M2MY:1+]O9Z]@NNYT+@FSI[;FOQDTQDX(K];MH% >+T]<4.("B6M7%U%OUDR)
M(?[@+5T+0]*>*BE?1)+;^_FB_$1:\?[5]9X<ASLR.=]:O3636B]X. +$I&!M
M>,R;0>6T>6-!O?(UZW-?//@L#885-PEJ+57<U?%M%P^$]=B/H\+(<:9*_9*=
MS+"IE2@GOSX+LN7:Y'C;%?4ST#E(@HIJS6-*>"7P<U^$'>DW06<X^J'!]DQQ
MKC3A^X@:QSLND8R"+=7]!N6#S>C,VJI%5BWH^BJIISK)DL;8ASE4^VXS,'UU
MT;RJ=3SN7J@OONK \TKS8!]MI"/-!]KN^41"6 $8^;B7]$$X1 XX'@300-]*
M<"FN877 +?S@YR^F:^[O##ZG\U,/?"D90?C];##O"6*E(69\$L;/?2A?_GI$
MKQW:>JEIZ^'ULF2!*9D1=H2*?8'0:=!MJ44%=H:<S:NHT%'G7.!8[[@'ACB5
M7EP)]WNPYX3? V\0LX-^3_FNC4F2N]AP_/$@?193XT(Q)D1!?Z!I!!4YX:HT
M?D4&(8.[XS<6=;HSI"A&&."I6?"!L+G0G::OLV[-7EV()WX'G'C8%'-* )(T
MG=Q3EXDSY*=%NS$388IWBR>B%C478J?UTW]=&/K9A^.W7FYB.3;>4&NW&_P)
MDK"51%.#Z7CZ87Y/<%X5)LH@Y7>5H]6+HH+>'MFUZG2&:P<T*NL?F( <1M+0
M-.=-?A[\3[A9[+C.J#>^7)T+..AGR0W*"!8J1Y_4#)I$K;A=NNSFV8"]>J:&
M..6OU<T/QQV)FDS]FYA,>J--\[NMI)F"+T$1XJ?4K)!?;&W$&(G9J+0,(;MI
MH6I Z/:/KZPVLF_),4[N9>(_E0*,\Q\RN?&FYU'9G'BH>W.:\M,SKDX]7*"^
MVI#->%P"EWM@BZV-/%"8=DJ'DJL!'-'X$+(#(*L%ZM@]D&.7<U8.X*#B%K\R
M:O"DSM<#K5_*456"I\(K]UT-N]*3AT,M%TUX1_C:!%N,] DK)-#=#:UG!)31
M>!J&SN+7WE*Y]5WW\V>3Q!<4RNM,((EC/P"QP:% M]-J)*\-H2N4P]=4DK9U
M-9(1C*6[IZL0J\!<'(65]8#NPV7SV_(TY5^VNQLP9;FL1>SZ.:I.BWV?!.'Q
MBZ_ZN(D@0!AYNK#'((W9/KT'M?P@)U5>M9=+/>9]O4=U<C6E>H'>>?);K_G;
M+"4NOS+<Y6H$'.><%UISBE;Z %_)E$&;W\*6FH,N.P)F%QIL5Y8P-%E6</$M
M:A)[O!$@.E>2YGUC4B.-7P_'1N[P7LEGV"H+F5[ MO0)6(A#.!.[!364@IOR
MRDEA\VF,2$D6'FDE/#O2G7;A:Q3FI@T3)]UX,C5OR"'#%Y,M >_N!D(E 6%2
MBFJ'P_>6IL?VM>2_P$D)G:Z\753?OFQ0V1I-CPTZU]$>@_^NEY66?^U-NA_Z
M7X>+Q(TT%(7B=@$.FUT.1$_I8;=E?"S3JO#)M8 ']/I#@A9\8XMW>,$@,'#3
M<CH%<, >$"SZ2V>M!G5FTV=6D2WRK9&YG6>7J4@]Q'_6$H&;+6H39.B\T:!K
MA%,C]I3'R&\+0O;]K#LK1U%DVF_%R+^5@FFH^.VV8Y1Q,O4P1GOUZ8G?R4^A
MMF/0T4;FP4RGTSHSZOX)*)5_BH;6D@6\Z]L=LJUK>XC%",?2=OJJSM+9,V20
M6\*V ?_8SZC]O5ESKXVT?@T1M=18RC\[&3GXV*GOQ=?LN(@D14<UJ$B&"<EL
M84*/QRB4QHLD3?RI\PJ,?:.ROL5PZG6$!75-PWAB8F*Y,(JE$K$F&D.,*M^R
MD@70G;BP$%;I7[0C;EZIPYL*VJBQ>7;.#&4RM&[M HR3AR25C4RH<,,F'HVN
MSYA@?Q78J)GP=0QUE,-FL :,O<O4E&+,:7/-@W/[[)M+B1)L&W<MS<D<'N76
M( >'\\,Q.CVO"7!A>E@H4.[JB574.CJ&<TOSNMB8WB&ZI<OZ/3\(T4&;NV%
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MTL(QE<-C7TW@^?#M/*S.AC9F.0!G0M;*;;72UH"7\I/%>JVMSGF=W^MI&4*
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MO,&EY .M$(:JGU_,0R /V3I[@)4BT^+(JYL7D@8/.,RF-ZVM6J3/\NPJ3 E
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M^Y^=^>;,[/[_L[,[LV>_XCSGT%W5577?>]_[//?6VXV<0ZX!C]_**L@": \
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M':6[ZWDBXH(.P]1TM&=65_>'M4C ]%Q(KLTCI4DB(#)PIO'MA<,WXW.J!B0
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MZIK&R><MM0&F#0&*&9PO"7)BL:$GZ<W:*?K@WB70">2BC.<\3X_+*2)#G<.
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M2(FP2M)0*^A++$'@E+O(JI8<44_H<\W([S73%JXJ;(A36[74VSK2?LY/"/W
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MQ!6BEI_/3$MW=GD<03\A+/A*&H5Q<[=X=E:RX7FTM]ZIFF7-"Y%9-#B)R5Y
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MP#PN\"V(F 9!YNGK'7$26'VD-_-BUJUF4#8O-RJ'AN M$@@6NX9((CK_>KI
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MZ/J-4N%5D#1'*>7.F5]*'K4/E>+UO>TV OCX\Q9(%[>Y0,ND :76#\8HLY&
M]MZ>H875@3BXRGQY,O2#\X(O/-$%2_W\FG1^T>#Y$"X#S1=V_Y,C?01=LT5\
M>^^VI%1U0)H@RBQI%.-BA7O&;6)6Y'Q^&]89/:];DZ(<G>1FNNEB-[K2[<-6
MP8LIZ?ZG5?/L!)[D"3I T-]3&VMPPWVBKD%Y@!?65P27S>UU%P0F>\QQN%G-
ML6X>H0\>R+W^Y'X),8,D^E$C@7XOE=L];H2_[;[-WT: />&L(.K2&'V!(SF^
M=+*/G[09["=]M'A17MPJ-YN?TIM!@>CW$N?@=F1XZ84=RO>2;HM^Q%]<'!+5
M^KSYQW"VIY-1'XU](KG+35&WJQ0)#&I2:)2?MD$M-%G^X^C"/89",H FVG:Z
M.HU>95P =NAZH%.V]A)S;@SO+#Q#_<2(\DX:)MLS,#':1>9^]O)(.$XXL7Y%
MGND)$O@\AC7VZ'<\CRA6C**1UZE5%[]G8#O9GXW73#/A=O-SVRD 3<9("\%_
M6"I1"J1K<#/SURAT>\E]D>):]2SIF17#N[6H)GHS0J8S'T9;%NEB5(0J0NE<
MP/7@A,^]ISZ(M_<G=Y/@75>T2^,0:/"8A+A74>XKK0!A#$F<<N%UAZ[!-OJ4
M[L9?7Z;+SA!%(5@@O558#"J>"?Y:9]16YL5]N(QH0O&8/Q)@ VZ)_Y80'?D^
M9OM++':W44F(KZ<T<# \,3:6=:]V+.P0SNJGF7V04:U5714H'+RF;[?TB[N)
M/HITOQ:,V\QI#3&RQ;>X2FDJ2C:UY_E-D9K6[#3L1BYFE["=HF>@U_V\"8]B
M7IH$K0]&OY$8M.G,6?;SZ*1C.S,>4)F,2T]8TNZ/UNU>!T<>6.0+S3%,2>0:
MW$^S/%26+#D@Q\AZY"B_-H9)'RIAD@U[U7GD7;/0@],AV]R4\9)]@ /T$3=-
MO8=,S[ \BGANV5 .B%7K>$GI/X+6ZST^AB!<-8;E&SKT)&V^GYO_@K?EUK>\
M+UDR)-C'4 M# @YX1*5.S!!L355_K!^LZ =B_^20T#]NM;6Q5HPV+\Q@CQ(;
MC&E7)=/#:E1N)VNK\PB\"J_Y2Z3D1=TE5HVG\Z9K1/,]F"7GI'?9V0+[LUM#
M>56UY$;>*BL?LMMV-.KMWRZ\A&?#AR]+]99.(_.3M9IH*FD8HW/O-&;^7#DD
M.>^>W\E??/(1>"R#P4[SL;B8!R U5ILL@U(+!WMV/A 1V=/*CGD>84C!PRB*
M6;)//C:GVR\P4DSBRE+V^="KH7KIEL7>T%V"[6INP4@!1[23:O$TL?%6N;#X
M"!'%@M<*#0.[7#7M64+-WN=\<C.9HID=?TMSNAUS$?HY031K[):$)CR4G;RC
M;KCPXV/E'99CA&:-L;A(?7_WI50DL5IH[#Z*/!10:< U$XC&5&B'X,*2SBJ5
M&/6B%$_W=*EF#)8&_ Z(X.BW]VR$X2!R/$PP_BX?:;P%5SG6Z6WA-1*@NCD+
ML>3HBE56D-Q%/P*APRX4SUI_L%3%V0V@[;Q<XDO%0]#,:AL_^DC', 7G+^HM
MM/;@Q!OPZI6E^[;06@'S.>-^=Y8?U:J04S?U]*6]J4LUX56PCZ-?/-I2+,"4
MBC8U^_VS$FS^/L[K/F&]CM")Q'_4R5\[<"#J8J72C_VSI9=%RJO3J;D(/X7C
M65&6>KU39T5>2Z:X?F9_J1&8[^8B(<UNF!,N1LOWA_5?H5K06QJJ0_9U,#XL
M3NVT%D*6ES]DED XU+#>FW4%@4@\W&P!]8KQ--:(<YG=6'V%RF825/Y;HJ)>
M)10)G+_(N-UM&VEJ7)=B1P)]^> #5"(64S&KXD8"WM^*6M9&;T@$5F^W[Y7L
M9\@#05OO)\$'25#!IE=SO41PZ]NV(50NM'SVG]1_QB!WOA$:F?_]N]LQ-K5!
M<-'&3,CA4K +M)+YT8Y$5=Y$7TRYZDKS/%\TJN*RU(85O4IL^[OABL.>CEAM
MN8-*$CW1C!9KIM:CNGQY==6Z7B\2OQJU4AUPG^PBHA%RD6GE*?9(3WI,;9+I
MK_Q]H]+;=FZXA@0@,/"EG>_[MK-CT!(BX;PM"KS5]!L)&)\B@=V%VRSPYA*X
MX9X5?7LU&#5:1NJ(1L6_?L+C-KE5%^: !)YO@PYRVV[1($6% !-:K)/22L:*
M\4B%A$F>C=AHL/UA=4FGM1?#^G/:DAXDL*X#?X<$LE"Y[:0"(8!V"5BPH 7
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M6[-"JVU/\/)!V*0OEDU)D<M(5+^NHITL)<9$:4R?E+8674]F4PW__ WVHB=
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MF$:%\ZR7876\MN<H4V,W#5SF&GS;ZGJZ:Z:^9- !MN,H^VZA8*U97E!?CHO
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M@UO;AINPUY&,O]2CZV][^M4L2S"0)_C:!G"_.XR02T.NW@6][Y;DG1KHCRL
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M\-]TCZ::?->%S@,\K4()P_.VB:E)GH#L&JB_,TMT],CMC3&,8"XB_3-KT'.
MCF,F=S\)V9!KBG;5'U$ZIPEK!/UPG_"C,]]<L9G@'XTYCF N)OAGTS1]XFK0
M-WK3DDQ&\(BYPTG]4M@075,<T\#U.S1GD.&Y>GT44V8/P+\!.FNS/F!Y?0*^
MB\F\BC0/<# U6T*WEV%88K%!=\QFCAM?;A A<@"F >Y,^O6JGJ?\(#B-T"V
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M=IYJ!BX[NJX,AP_Q6+TI!:JA /F3+8^W&V\?VK5(C:]5N,X%S)':#%PU7!(
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M_JRKE>"(E\*^V+^L;/)3#Z,<AU:&0(_+"#OV*H5GBH$G<U,%\WFBP:-)Y_W
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M^#=?!F* 3AQ4="F&'J^SFA"BDO&8X"!RMA]XNQT+! :O_]H3@NE^L\V%DGU
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MB/S1HX<$'V\ZC%\&9F^;LZ*21Q(+U/%U38G+)_GN5^'0!UWHG>.&O9KP(W-
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MBTO_F?H=)H(I]M2Y;ZC=N,$8)-FRXOW8QCM?S%.,]<L72' PU"Y?H=2Q:?^
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MZ%C5;<AT&B9\-WVJE,#/-6XO$LPA?8Y]7.0^^>VG@W72^@&NY?!7?PY]HQ@
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MB?U!9.Y//Y;BPK([E2T4+=> L%G@A7";%JZ%DJPU0U3P$WD>4BQDXQ %\%X
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M&V?H@R5BOB3=T@#T2X5ZTM-@O$H<LM4Y:VH:UB1@B_13PBFKQ3JD",&%^%Z
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M1').-A"Q!,7+>,%?1?'D8QOY"3D52:O]2*'DSM<,<C -I6K\TCRSG[XRO2)
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MWEOYBEYZ+1 N D^G+^Q20$*&LC+O$UCN/WJ!&A"&HVCHL/5VT,P>@*NC]PQ
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MIS=HA-7&]:=FKZ*35H,NLPMV&K;=[1OZUTT&)*-B+5QI,4D6+OT<SM70#,(
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MQ8I*Q<I=$9Q[HW<D66CR&SEO68:3$W)Y:FG#"1YWBO[U7?3\E'/-1.K@!G7
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MH*K!C9@7[&7,65^;DK%T')U*&+&&AX&^9+#5O696G,Q-M_CH6H^,#/Y7D >
M2Q@?;N^%QY)Z7WS5#V5P&"Y)7WF\ KG#<^.F(#'IO.%82:V&L"-#;_A=R624
M]_S/0$1P?N= $I'5&/-[*M8M<#%FU]:\SF7GVJ2#;\B0U^9M.@*1\2,L$-SH
MXZ+6AGP)^^B _??<NF[82 ;Z:-H3(@JF*$@EEB9E@T&E16Y_0W>!4!8)7R81
MV.A#=[(=\)V^#7$IK&E;)44%+V9#58J=P$P1IKF"UM0QHD $Q]B6X=>'O<M:
M@L,W%2C#X\/B4(RB(M\A8O.<S7C2Q(A1CF[N08J3A_/>1E6S@+D@P8?B71OE
M\=S5--6JV>*0^L5^%!;Z?_I/F?,'ZPN(^UUM1U_$OKJ_OYZ$6+8#"QTFXTR\
MD!YWJ9E*Z?+0G&U@:[P[NI31S![,3:I#[&1!^]@6.,;\G)CMS,^Q+!7<V4I/
MT2)05[!S7B;.TO/H^'&EL[-1!=<122ED6YLHDUD[V(^>G^="D?L 8$+P0$M_
ME+"&!YKZT4^?4V/'A,70J\8-55\=TU^/GG4#"@^%3M,T$)D'Z,EA(V:62&/9
M\F3AWPI1.+VR!5GJB^+'S^F&X=JN:"X+=MZP\^VOAHT6Z30IQBOE/F*5WBEP
MQN.?5&%RAHN-<_N6D=+1HTFRQ$8@P,016OV\M ]A]*BW4PTZ2M;,#$\%-5C.
M"X<YMI%CW,(A8U#7$M*H*<FWNAQG:^?_VU3RFZ=(J];&5NACBF(#EPVD#QP
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M%?#$7Q?:AD!X8?F5FN+ GZOC=6M*P^UU:A,K\FN8FD=8U\#(*E%1RF@<<H5
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M^CL$HF?TZ'O!\"2$GG"E_;K^5<^;01OW!M\_F@R.ZH<]&YU/\Q9UC(?(,,Z
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MM?I;Z[/?Q]X;.8W\!3Q4D)&7 5#N 0#*W1^ G .> P_0T3'0T1Y@8&!@8C[
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M-H9J&!^3MS3JNU3_E'F$EF9*MK2KQ\&;I=8(![4)7I$YVZWL5!%YK=<Q4O)
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MW+/81H 2_'$YM4=/UBV6V)-<OHJ:J&O>,F"QS(\)TBLS"=G)A&Q60:W@*DB
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M)L6\/57Y8'+,- ^9N@L@CXR=CIP1"H\/;M_=Y7A)J"S\,1*@M^N^]6TY)MD
MD8%7,XWO<A!+RRFE$X*!& E\"$_#@JMH'\4=3.]^Y7B(T\N1O?N1Z*9WZ%Y-
MH]YAEL;A8,Q5LGN9B4%G ']/'P^^H=FJ']^F"9I=#-?]7N'WS=YY'+Y._N X
M-S_&(,O#K@*BV\G*!/!%;PY;A$*G5+CADPMQG=$SVSW2W07K"_S[7?SAY4C
M-1C7K9D,KE@$CU)24H#MBSQ@HLH\>=BS#VX*#T<]*\4:?.3DZH#M.\/X BPE
M ?U.%_'Z@^"(5":+%NKW>X79R6[/,I14G->@9!XR2*#U*G-FD4<AY@G<(DK$
MT/W7*<-H$^B71<FSW+SLGM5.VAF8NM_^.RK0YP(_D:Z6F5F.KY>-6V3B<])O
M;G#O[#=6_<Y^[])TAKI#4LKT"JW"I$Q4-Z0ET_=NXV9L^WE]GZE.'L!&*U>M
M']>^OO[NV&BY[O *<[U)9:5E:40\!@GL5BG^,BH4;RA<>(H&J]'4V*J[*]"'
MK3MG4]J<UDO>L!]\$&ZJCK]X:N-V(<#2$%'?I2/JHCW$?$BR[J@B%C?OW#9
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M2[!DA@%_%K"64((7I1WR!X3# &DMM2!5C'3BRK_=.(?SM*.;B9=Y/#\/ 'X
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MIMD7.OPV?];-I:,5)(#*EZ'IDI\=//3VHU8-48#.__.:N>7LX3S!M($6*=*
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M[GSP"9ZC[VG011WY[DW;53T1%ZSY04P2&L,<]UAZ^F?*LYKZ*X*E39O]!-B
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M%Y&D& LEZ LVC$?';S9%\B^ V$N?4$7/O. _:O9?"J V7UGUD3MJ3!?2_XY
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MVR@'$O2Z]L80644\PZ]D',%'(Z4-1\M#^QH878_ :$4VA;3C5;_&9JN6B#\
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M1T\X#*KQ75A(TD/PT@/F]=D)1EX:#O;!4T1/%_<>MYGQUBZ%!F'YWB7 !P,
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MFE;M5!E&4RX=EQTD*7QO$J%+R_-)(\P0+OM/I)>AMMC*&\Q>9&C?)^2+T.!
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M5'/8G\E<*"AWX0:K[P>Z+1G9S.K._M$ 7QVD< 3&:!KHZGM+19YJKG=IL"3
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M!'TLD3A[W^T[5,X'^PBW$O'70H3)O%.\X_MFY"@'DE=;5G9Q8BMD$6P0FL6
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MF'XTZ$'$"V?=X L2F>Q*CFC])?EY[]4O*!G6YYHTOWZ5(;TO?2@ /[^X\_.
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M2YSJ/7<:,3S!_?DO##I]@HGI>G)\R.;G($?UC?B'"KVVOE!X7;,L0=]VLL.
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M4SVD"VL9J2<;[X;??FWRW4GISJ2-Z_9X:30@\8:A7KF+;53E)AO734Q!>OI
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MJJ5&:*@F7G4M$+>F4(V\[L3 ZT+92GRR1<Z":-+V<K8$XHNH*/IYTI\_!E9
MJV?E8OP,[A& S!5+HR@G3JJ/PJYI<_^\R5?=K(L ,!R//:(C &^(:PREF2.5
MKRB_;RAZ2GS]\UICF)/J30NY<0U#47N_)#T"0(>" %3$/.ZOO$8 XCF-$8!*
M=M#5*]5U6V;(!*%8GNVJ+W49G_U-95%%>=Z*W3%]C.,GVZB@A*8P 56<<D7V
M&RS0"W8O5;@"+B.\A1$!&%=PS7KEQ%@_]>51"HG0_("4_UNTBZ[\"X-[M_SP
M]9L2U&:/<Z\Q_5BR:8Y<X7' D5BY$[X7I=HX+\WC@-1-]B;:P3Z$[]Y';SL5
MDD=+=I6# 'R8ETG-ZY*YT&K6OPJ_TWM\CKA.I,; G?7N'\:U+[AP7KJ.@B@$
M3_'ZBKRB=&:@Z\NGG6C10=\6^#NR<8#X=YP^14\A%L^&E6:%C1DWP5(W& L/
MZFY$;*L#60+?&7'GG>QFCPK$7J_(9??A1SJZ=TB0LT(,< S6 *Z_9WA?PMZL
M&C>':T*:LC2FU\A42UV#]<=C-P+%*@F]0-TI1DP3P%:.J<GV^);,$7UTR8^Q
M<B,2YG][P6NJRMO&63P?<$+B6690:"=K\\ZH;B'C)E[AIHTSED$AS#7%[_Z*
M$Z(;+<U(RM 4E>Z+!V7DB;N%SA KTC*22?]$&GHT,EQ],Y4@AO(5?(%I$OTG
MFHJ$)K7'1(VVCT&( )8[]!EMR:"0?Z&Q154-/%-[5^9D0;@XW&2J<7=H$@Q[
MI0^!" MG\DXS5.TQ<F#_N4<[0 5H3;AYNRW*$(^PU !!7!.0!4:(6J9)D,8'
M4?+RMK";\T48]ON+<?9XG%C9@^Y,>WCZNC$N:]>4'8GO#(L>X?L^UR:^#@O?
M-$B.'7O.7G*:A<ID>>.7Y]DZCBY60!>UT5K_\J.RY:LZB=^;@FFLCTF\!*#9
M6J$6IQPE]$B>ZVH!TOI_N!55;-2.ZPKCZ%&U&/C&PZ8YAI'_!U^3_QYR^MEL
MZK.N08_UJ[S.='&XOW.(A)QU&SUKYE=?/O5EFL*GGDY%6"5:[O5&X[.5\@\:
MP?>CD\)Y'/W]BB\<4#X&N,=YK]G$Z:9KC0OY9K  0QIM-Y$V/:X7?,?1G+K!
MX ?/L+GC!_/%:=Z*400@S%E?TN%9X+%^0P .'Q& /:%7?L*JZ:6^3_*&S4W3
M%AG6 @/!PG%KV.-8>]<Q+Z3,/TR>K'A$[U_>#6;;@,B>IQ;M2P1@0.T,\N12
M#W]3"O.BAQ5M"'C&@5$T:DZ>UZ<7K4?C\V+"[P-M2 D8V,W3]%CI1N/1>HAG
M=99ZQ74*+UR=F?6Y2H7EH1.8+M:1X<L?L '.%^8AP6"-NN.+;TPQJRO'<7ZS
MI)Y.W$L@_)QI?;?H]L:JP]#^L?7(/>UV3]+9KR,;N#ZG.I%H2\E'+Q3?[;VC
M!KKJG%T99986F).G,1:],]74^?27/\X>D-5-P 2GGK:(EV<T%J5# !J!$NWO
MS=L;)?@''D3AGR&\W*';/V]Z(B,LK;@DK"Q*;8VT;'V8"W\EU)8ZT+0?\:D!
M>" E+/&Y9N;]7^DBLL[[:,M=$0 \P7FN1XX4?;JG/W#%QI_Q8\->3^Q^WI^*
M#X6A%&H932W@GL'T!C2^^)#, /!,#X4\H0(9UO<<';SV#\@16)A, #&F68ER
M6Q_>F*O?$99)/^-1EW"P%3?'XP)F)EYBT$6'3.MCRW0=-ADWI8Q+RKD7&IOR
MVSE,.W[0,&W]B:31M5"14PR3Z*;0R^%=X*E=9Z+YNCM,)OH(S(9Y,ZBN<=/E
M(==1%U%_9ZGP<NHB,:.83!M\,46.:5>0DIP4IP5$A[_$'L+<A7><4^^DVPF0
M *V19I0/(5)L+^HRW[812NKLN918?>_V$)74/0VMRC?#BI@&3*HQ\E_?E>IW
MP8EJS^ 9SDY$DV/.[HG.KNQ#_=WNI=)4XU-=C8)&;JZ"0Y0"3I^"75QEJ6+!
M/IEHYP,S^:AN(WH,K("O+)H_ @IKI6GFU8225K\[:9.FE16:Q _V/7)>E9\2
M> 5,=3=J5C7WJQVLIQ0_#U6\T=?N'V]^].98*F!E>[P(%'5"L3L[:,68+N,A
M$M1>,<E#/ED&IL"76U.Z]M?>U\^TSMZP!,!E=ST"DO97J,<3N^[]DN.'I] S
ME2%\O=A4&[\DA2Q:.9Q>AB( JK:2"?Q]#ZLFSK)4NW%E.5-^N-;6%-^JPG8P
M=I"#MI''UDU;JKX9=7/?W%&BI]04+CE'6A\GM>99"V4LO3%@T:H(KZ^0YGUA
MGTP@E)FRT?1@*IE)ST']PX>31@&@-06="> !@JP70RQPTD%MJ^?E_WIW5(@G
M9$V"%__@TGS15(-1#?WGAG9]C:>+OQK0R^F-!MZ^S,=8CU2_V41?'-I?NT1(
ME0I$'Y#^,TRH(8]Q??!6VCN*4\XH2'4CC; (VHH<?N9NP%3TQ]L**@N'*<@E
M(\60P7U&@<WA<[5B#[K>YX4' M]DM]21UI&2E/6\/1>T#G=HCX:#E[ZXF!$@
M  FZZ$_>RH\QJF>#J.'M>J@ 7)9;UNEDH<H"6_[] #(U AL;A=#<2XR.7<G-
M\Q(_J3R6H)Q%NV?'<@$"C_@TQ++QC-=MXQY8M5Z#^I6.)_U+/5>7,P5@VM(\
MY25GP>1U=QOKDK^OQ_P"B$M*86RF0-PR.XJ,WJ3B=_R<7<$)"$!S48BA9QO.
M:/6KUII*,[,5*V^7*B0+\@&L#+%L3$EK!(!^%1TTNPL?Y##_C@ <N.$_8/4\
M 9WTS[9\P">)+K?XY%,%ESH /#A_B/HY>OCF[&2/5<;Z _.D24PV=8]KWZ$L
M&0+P'+"VJ',1@#FSQ;NT J=M2"]PM<YRF(3]1FJ9_]$89 YMC &]4?-8&67-
MR"69=5X*SI.(]'BRQR?TTAOK=NZ\4.8&;S<LHT[C@C=ES#8"A0L(?OU6A0PM
M>#KMQ][=5$K""JC&"FTU]Q7T+'UREWIE <<2S@N5:FL.QIK11@>M7*WUU;0^
M1 K1]5>?J8&66F<9!=>M\4XX,0YHJ:^'".E&WT0CC0">(PO.JDHD=&.ZATF:
M3A$!T" U/\QHD9/2*_S[/% =9: Y89E]8QJZLY@ZB+L3"+4[F2*C"9EZ">#8
MEX<7+0UF+@KK:8NH$!K@63#<!1M[J@7RDMVU4;EEX\B$>E3+KR\VS"BE2AT5
M+#9TM-,62#]Z@TBO"LUPTMR"6MJ%QKV<Y.*Z&BT-E23>%^JGN/YC B[&X?<Y
M;Y1*N8UVJMI2$)"(?ER^E*4Z#42168"S/LB:'VL6#^SLGGI[WSG#QTRTX5SI
M<FL2E;5?+J.*YB]G ]9_@]H]]<S^"DII]\QJFIHL>[D:020LFY0]L(L?J*[@
M;69STNP35[.UQH*SCLWR%<OB"E_*17[14P9];E_[RC]6#O"Y27P6:KZ\]VM9
M]QBE2;B_618&,3 '8H7>/Z%QV/\_?*SO_]\H*+:C\"@GB_M0#6E4V'X[$=9Q
M,Z82KG9V$Y=7(YU1N&@L@4,:RT<65VDT]7_Z&.G_Q;\+6[6^_MJ&M6G'UX?U
MH,G/T4I4SL<?_KZ.+<T,;ER9&8.)P&5=0+/;8_ 8>P#HAJ3@.1\Q(P!/#U$(
M0$3> [86 I#S')'A3ST(0#?TF @I]"FT!#0^ $(  C80@ U;>.=TVYY5&P+0
MY@PZ%VI2 'P"?;(WOWIMC@"LUK?!TF2JP+SWY,^E_^F2^:.:XX0LF?F<4<H3
M3@H"<'O""V>).^)6A8>I(@ /MZ0(P"OCV@]HI/^[9@C.2^K; 3<4)RHM$N9_
MX;-X2V\UNZ&#G::<@2Z6S)R+.?\C$@S1O/]LEM*_,:E\@0T9^]^8-?'/G0(]
M(@&=_VS6/WMF.3>0K^V?O$/[3YZ!V&;C_'_3C'<+-/E_-!Z94A[Q[W;_,6K3
M\S(SD/%Q-)%OI[Q.CS(XM[MNBQF>YY>!W<@]#K.TZ]]:(MP:\O"9?XX/495F
M,G[<"NMK4SEB ^1&_E_\]W!L@@"$@+;069\"GJ_VH!4A8%<X+@+P@RKK^NY9
M%^09!8IC;3ZZ;_YZI*3.-O[D*M5%F^C!EU=2T=DLH0N-K3E'UFY)5&R:^>)@
MX4NFM^SR\H<<:YQ'-KYYG'[D9E=I:3MR[\V*3P5H?E2FX*LP+0E/)J?QLKQL
M BZ/]UMSH%*_]H='B1EF$"K0B'ER@+HW,\$A5C-,Y^,[%%\JN'OZF@:*QH8,
MSIP:J.S]@M9[$P.VSA-T:*#$&+'7"O4+7W_IP9EK7+VMSYRV#_C:AL)PR=DC
MI^.-V4=^H692/ +FP-,%C?>1.3=1#J\VU;H72@PL&L&ZX#1UHJ]H HLYQ"OF
ML"B%J074YFGN^,*OU<%K"1KR5[?9N)K]N;%Y#/\Q&?6=LX1;5]B]EO/0>YWG
MYDJ#XW"8-@@#E2[9BW-!9UTP/U?_;+=&IV_?<UVITAITHH)5ZM1-GUJ'C6DD
M6GG$_W8D9W1^;-,T/4G,F]M+?C/924 D>R*YE7B@YL"I2%4)ZM\-W=7.X.1N
M49W65+!P^Q\>TQ?6N':X$CSXDG6PN&>+G#Y!N*&!S+'PSK)^GCXF_/.*LW&:
MP]#R?MWE$*428S9/-)_<Z3W4\QMHR[#VO@T>9@_T/0P]QX5F?14@C_D,^=C2
MR,=Z*$M1JZD (/J_^&^"NC3KS.DQ< L!J!S*>J*8&?>H '6T72 GPMMX0%?
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M*$\"T(H#BM'T B+2VRIC<H&:D:\-/2[BE9WF>"N+#/-*S*'=5@YI+$QP.@1
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MHGS),^"-\>[.?%;3@8OTEUGM@D&W*=="U4OF7$R&C^*]KH'^O3(4H\+:C0A
MIT82:9!G/JCK.3J[/6S^'B_I4*Y-;ONN E96Y'?Q": )]9?O]-%+<:Q1_(M[
M4>; 6+=.D1@,NK^FSOKF!AP:FF.,CO*B?NOTZJ48587OYCWT)L_%'8.;JWQT
M(J IM?^A>I/UO(]HA(,@UPR77*R6/Y4[SAWYE/WZ1DBZ-XN5E0-BL<)0";[Y
M/?IT6C*\;"O^1JF$Z7NUJOU@77\?E^OJ4WE?7">DS(\TKX-+GP63O)=,B3&!
MZ(F#G8L9:NU@^[I/J(GOKXG5)PV)%A>Y>]V[:SL>MU*1VCO6%OJ7D+<RW2 <
M"I<"= >2K""^2BU):.*LOR>NB$-=BZ^-0PBP2D7'+?:-MWE?!:?%/VHYU)AH
M<?_ZL)<^)Y\E4RRG$P^U!^#EK6'I%BK]O6=QCU'"6?H(P/B( Y3UOVP5 AU_
M#"\VI3N\AB^/5.'ZTH7NF/$Y7^S>Z27IM=8$WZP.U4<W<J(#W/NW+**P]]PY
M!1L#$RFM/D:_E.M "^2:^.?OQ/\]0-H%O1(L?5+5/%N<-U(5[_!LU J10--/
MO*-0'6&!:\1X4'RO22K3FB[5@&RA6T;;G!/OU>I%YJGTJB>XM*6!G#=H6&#^
MOH6PF][3=S7)IL+ _-]EE@ROFAUINMH0@#^-&F0P3Y,I/WW\J&81VBSA]A3A
MISFW_26".XL6GLB F7V7@$IJA^F+DD?@9H:Y=7+*>EU-/1-:VH=WYF;-%D7G
M\(B2@_NVT*AYRGC*("\+D]RMBM.N<A]WHI:"C$G*W 5[]=TT&.O[&3_ZC2=5
M>:!AP80CV9"3"_I@.#D@JPA]"6N[F=5SHPUCT<Q8?MV0)]E[N"E?"V.3;'/?
M;%=!!M@RWA(&]:C>@G--7E=2 WU(TIE_WNAQ M(.3-NX'+N8\+\":+4-5QAA
MNK[Y=OLE^^(QVT_'9<4#KZ)_V_QYPL.?$CH6_/ ';%6''AY=L7)TV?;2*ZH'
M"IKWA#:R-4Q]AJ =3/>E&&+<);7P+U0UTZX?FPJVD:ZVID'Y[$D2"L _3GJ,
M <C[O_'+?7&)DE0YF404+YILHKPT],]MPFIM!0O.$H>_'_G-:N$/N^K[J:?!
MT\_?2('4)JQ;=, Z .3:A'P:I4+@+%O1L7M+Q W-*:]P7Y+M/6^$I/&FL<Q+
M6-C %^XO:)_"&SZZH$DW)QZ;E2H0$Z;PE]%E/Y<S)5S_ZR^-2U?,C?9O=GP;
M)LG"]5R#9!T-<E-Q)I;>)+XY.*\?_/L[F/WJ?VG^Z6?"4E3:&F"5ZT,P!VO?
M=PS="<5W.MOW6=WZ.9K_@;:W#(HSVK9%.R&$)%@@N#4)[L$= @1W=PF$H(V[
M!@CN'MR=QAMW=Z<)+HU[X]+ R][WU;O[G/W>>:?NK?MC5?6/KJY:J[\UYYAS
MC#D^=4*'&AH,4Y.Q2WWL,R_U^8J*\N]X^%AL;TE])%%(-%GQ?T*8D#:]PQ>7
M9+F2F%]5#^=]Q-D-N*RTS06KFX]M;#X]9&I7FK=_^@NY*P2D-Y9,/*T\Q^:J
MMG8[@ 8B-T4#FZ<DA_/7T'N;GXP4VB^2='_:-S3R'E]6*N4FUYT$'UE?QDM=
M*.*[.>SJWB;FUD$5F3.M%QE"U1W"I.(1DOOJB(\FX+U[R1 O=G=3?C$2!TCZ
MDH_F( 7@X4QR=KYD2K+.I<H3=VS,L=>+H?2VH7OQ\XS)6?PR;6R65YC(#L1+
M<B-#<T#X_2M-UN4%BZ28%R0;;DRSL#6:RTKMW"P(=-]2)N?DO,')K1YR=J%R
M5G"=!MZ[X4[-/UM&^E0U@@R<C(CN;P;B'K;35<VE"%?%JTR>& %$*2BWHL1<
MQQT8IFGS%AO@#-%_J)SQ3?KK%-&L-++>09;<R[>U3RDQD8N!GPE).R9D&C:8
M//OX3-L3\Z0W)/#@S:(W:/GO"ZITSU X#]64#E9OOA0[+$Z8]!?X?G!SW"1K
M*=E_ B9=\Q?11X@L2H@,]EG?RO;<GU3"4."VH>1X-1)I3. !&]:9R9<^395R
MN<&:\GY*TBMMW'_KVAKN_VX!C/$?B>P]?DWA];6[%T// ,-DX7O.8B0/^575
MHX<_//=0KL#MU\W:K<^ 8X#D(GH_-Q:"TB2RS3[:8S[3#6SD7A1K$OE:^_?Z
MNY&9W-3[39A*HR(=380XFC>!Q%M>6P<%[R Z<*AG'E8W;I*4;YUP54_]E0I7
M;*;,,P!O=+< =.C[XP&]2IGN=R->EEG_^A\8:77$;CT#^_&%#OG9X+OY/J]&
MX*T<S\/N\HL(UT]USL1BWZQ,7:U1GP%F++2*J]$VQ/ !3D4'O-'@K\3.A!J(
MY0S%D4$+> "9;P")<[_ONQR7/EOF_@SF;,: +$@(EDS0$].OBRP]C<QD!\ZE
M[;E<GII0(GZ?L8\\RP.3]C^%(.I7-),%WG23TIP]M5HF3SIXO!_;/BLX[BL6
M"X8GCQ16!N?T\#0H!?WIN;GQQ5CS*,M+ JG[0LCV*WN_=]*HJR^MV:RR'ZZ6
M*Q;(@G(7\E])VQMO&F&^^&-F=SVN(,A3?/FP!2=%X$-;M1;-T"0("QC\!7^B
M7!1,>BMK*K,Q%SEPE+ $B[DP36D[1BUUA)-ESGGW)_XM;!KOTH[XN1G03E?2
M=^==3J%E>@>&9U'Z$VC[.Y+N'SU5VG14?RH]_2*J6OSZ#/CSUH90?E&*6?)&
MSN\&MI_Y%XK-GF.&/ /,^3)2FBE'C=<' <DV;LLHA&5KZ(@ILV(!_LX[+RB$
M?*RV'>>2#)8*AHLIARM#0=H8"WBD-=U#09&U@S0=$,-;W>)PGBN"S?.=U@3:
M(/3?+D(%+;2G^I6W*%G$WF;W1QZF>]/S/;'OQYF^B-E,/CXNW+D\ R"IX'QW
M<"G-==X*Y[HHJ'>OM,439DO<9MF[J'9F#BU!8DS6B*(&G%4L4 77.]CO]XF;
M>@-#KE ]RZS#=3])FW2QQ?IW?,$4NNJ;O/3()54:;<Z'27MVT0%6WF!I>]C?
M_#VE1!O.:<4@DEKA/V'5B?GCCPN[@C=F5\4V$)RSX\>N)I7)-:%;;8\4N]<]
M5YT#,%7T3SOZ[[2^?Y<=RG\004K0'"3WC )D\]5$I7_WEIBUC#-DV^4RWL!5
M2[=O ?9%I91<@0]+HH_FFW0O@*=?WY5SN:RT1%SU<9&*/6'S%S/%"G14#]:L
M/ .J/V6^]SAGSY))4VZ+[EF,2 WLER^8+F4E28QUK//&L+C"2Z*<F9<'O?0>
M/4:U>5!N?'CH"'?]F[YU:AEE!>>R.^*5K+#7%U%_*:'Z8FSRWO^HRYG>:9TZ
M11["FO"2*]#,]T+/6_O)KOXZ^_ZH>E_B<_)['JLC,HI%MZ6G&UL1*:"HMR.#
M[]LJS\#9,.#5._#O9\ B2H19@7P>*M=,A6Q=))TQ"_I@S\D ?_"WJ-^;*:5Z
MU,$EOE;COE-4XD$N!R;D&47[\0$*U;5Q3]/7![ ;^6+:Q7#$F]?X0D7I4Y.^
MY@.!B:FXC?%*?'1V'R^41<E\] =.09=C5H</7Z']*T7ZLK&8,=EQ;3=(_6M@
M)>X:2U9,]+IOMN^1&RE.RL4([*]@85-SVT_#+>%:/J#<B#[[@V(I_N#),.^O
M]<39=VC)$C]2*FN0YQ<!Z#-1*,0>,-PHF8U$JEGAJH;U#7Q; SN?ZU'H> K6
M;.:AJGT-?V.O4O'A=L1&=-.86=J^2< 35AX!GY\AD^+9;]_=HNTE:%3VM414
M(Q,4.ML_#1ZTUO%.?[DP8.36S[<+$<]!S,\0[S:"Y,A1)I0:%:\!,,)#E0.\
ML2)Q4\\W;$S^ULZ"<FY=%,O.A?OQZ%9*3]#P)X%I=MP6UWB:I'M[/]GLIZED
M)Y=E?=2WMOWI)(]E@^+TQ+?U\1/SN. 2YLQF'"K9D&2SA0B2]M.-I5,U7:5X
M<9;<W[W)'VJ)/_'QF(R?RC?M0BL4"T8L\A=0;5<GC+_Z*2+JGLX>%6B-]>69
M^(^!1L''XA&W=^$_,3=1</\'Z$7/V.*^'A% 3Q1X[U%R\N;(TN(?\I%9=O'J
M?Z4PELH5WSP#!FLMKGP?T: K2.]&Z_2%Y=J]A? 9.(>L8@DIHUIA" :%6F=^
M!K-&R&S1[TYKK7;X9 D!^8/2ZT2<6><X3B>CP1[RJ,V,_R6V@DP21BJFWWB;
MP 'BU^>S9K*I(%Q[@S&MX .QZO9AF+L"OKG-15W*XCN4]3>DAV.NW0%1!,\T
M>6]P,S:],69Z#8D^S=C*AE!"D.NY,-\HZIPP(_@+;ZTZ^>8R4U"2"6LR4D)'
M>,\G*.?%[)5E*X))U):W&?8JW 4;0KW4B]Q\YGM]S^(8#V;N?@QK(D>])8E6
M8&B#1T=R\LQ(35W2^A\LYLM2*PJI-!0=3A@Q#->-4:/3+_4\478$'.OH7=2Y
M8G&+T_?Z,@([YW-NMY=$X>U^, (C]OV2]Y&C)A]%T-B? 5X=0)DFV@LF_A35
MA":RMHZ-?@,WVX%%Y/"#,[?0BFT_KP70N!2Y@\>9);0-Y@G6W/@"/:+TY._B
M$V=)\CDTBQ&,M#S,^H#@Q? 3J-<L<W9D-#7V4SM9EGCMS1#8-'7BE.4W3=RX
MR,M<J6(7.4NW;K_DE_J[\&BK.56Z>$5DWT1WX(D*Z@1&ZG;EXIZ1Y#BS32AY
M!F@M*5T<SCXYYVTJ$DN7(!CEK62:K:PZ^'AVL-(Y0 BQ^T<&FGYR#B!&XD_R
MWWXH'?>EG;>AV2MN$N<'BZ-91R#U7Z6-&Z0*+D^$PG[7I1'&1\VQO.,"$X59
ML3.WN[I0\NJS7RX>Y4FVWH /LBV N \[MH7295\.=;C]6Z5=6<+R9G>UC#^W
M8MM\)AT0EMN]+(\F6>SS!OYDHGG5QV%!_--.)HN1S"H/CA]P&?W.2PB.-0U+
M%)IYYY[Y/? "TGCX!"^9'O+53;;@E;[61T0E=R8G$P7[UXV4-:5:;(4S'SE(
M#U6P;W:$.?,3/Y!2B#<F,60Q55"?*XXUH""=HUDI;DR$U8EL>+-(\_WRM9'2
M=1+8 HT )S_H4:<Y;\H[]BU6AEY&4K%,2W@ZL_U4Q_D)(+E:!" 4P;3],Z!+
MD@.#=./,\JLU9*NUL]A;A0&E'Z/; DW/@,/<,U^ACDCWDW!8VNYMFZ.)(*P]
M@W,T:>JKXG ^"1U015@G>J.BQ'E#7TQGDC-$OC7T;5L4E^"["BF@>A<"W5%C
MD7'B; JA2"9^U5YLAAW5XJ/\]W(ZJF7'NQ[>Q]/7V(?K@I\DE>$?!KCO?:/*
M+Q_Y3J3 QV@_-I3.CJ0H@:!&Q)B3(9Z7F&ONK?%4W5*R_^;.]A<G'OZ7<;[Z
MD)WI?4VB>3_.9P#^2M']U_GB06\<+F*R!3OA=<[IV[A]+\G2VY>]&]-N>:GB
M]\?COJ?QDO3R[JB9\K+CT(<C)Q<R3M?;K_=;<3O7!&AH R4)7MF/"B+%[>_=
MPF[TICD)(,0ES#9,NQJ8'X?>C'0BYCKX+EK:V)[6>FMO7[.))]SGRA6UCY+X
MPO*!I?,F&RG'7@QPECZ-B1#&P*9&I"KU'E]JC@+DX>-YY>[\],W5$<D#$;AP
M/Q^D(21>?K+B1_31Y[MY"1;5@(DJ@F= >UE'U FLSP Y:E>FY8%S;+N1[O,S
M(,D681C[2C-ZCV&S306F.>_TB,OR:<YK4'^[ZX7T%H8O9G?S,R!@?A[/1.VL
M[YY#4\/!O8S8&7#6<]&%,$_'CLI D<E+6+F.C=X0A_N4P(C'^!2QAE5E&@WK
M7E.&J@F] >H1335#O61AIQ\,+=J!;4\3TT>ZWY-1Y\:EQCUW49 FU;."EQ$R
M\+_YL_#X&9!'5.L%+-=%",&YJG.L4AK\W5O_,!.0YJ/!:";]A8EL74V+\_+5
M5R-;GG[-6 K1W]J6+ I5^SZ6Y"TW1J9?B1UG!I,\S$6'-->#GP%O?X06[>NT
M_!'WQ&=I><>V_$'MZ>-MTDR_H='9?/!06ZIL8.SV%Y<*-KXG&DZ4W@R" S*6
ML_$(RL5IW3=(]R0P#G'+]*3F,%#QD/B*N?4MO@&4Y0ILUMV<F<N"]KY6TA?U
M>Y3HF>^ZX6_.:! <1>VL/JO2O'EV0@ALO:4]"J.ZL;_#(/"V4ET_7-3N*[7X
MH,O47FM+=S'T,/X3=HYR%P:&H\C59FU&!R(&U0-G<N7X>3!8LR9PVE9=\8)/
M/3DIKYX!PN?\OB]U#ER>\!N2M5I2=ZYW;\9VTA->V74D"ZOJ,P&,C)QRFY9:
MFI9PA\MQE,4_!OXW<@;6A(#&I, ,7[XYV^C 3X8A+_E-@JM'M1 =,:OW9#K-
MZQ]6JO7G(X^+&L\N?CM\M2&===4YKTLQ;HWLJ]'#>1@\$H6MX09:" ?G')NJ
MF8"=R^.GR)+/'BM\JRFE7=U1:4YD/5R1ECBA4.$@9RUG$!&=<>1'\R?)4+Z/
M?\%UM:[D=W?UI41M+G#9Y-_B^X?(OTZ*_+\M=0B!6>.,S3=(VE"FU())_$.Y
MY.ORJ2]DQ$4],-D.PN5;SR=LBZ_U>9Z#THN=)M'0NE99]TW4RI ;/L'H$(4,
M'(T2<@N@Y?=/\;=QEM<!SP"J 9UG0 7-'9-C.\_D=SAF[XHQ%.^3>3F>VZPO
MEIJ!,..\3FU26[1@84Z1SZ[C64=O<W (1WCC%=VK"^VQ[;<#B#JRJ[[;VH'%
MMH9HJF3%QK0'%H5$BE2.A\B)L:Q*X430K7"OATOL6>')"13'_V1,F]K@F&Y#
MZ]$-418Q=6F+K^^F<8X*0K=A@JA06P7W7T2)H @;CB<8-Z69.Z:G4^!<+5^W
M>2K3=+DN1B842-=9&,<J4D0$&%BL%\%?ER^ZY-G#:'M!W!.FE!W\@#_]@@<W
M09R%LT+8AT3._1JG"OY2^KH5RR2^P1N2/8I(YJZKP!GG_<W?:XSE&[_RF=4'
M27QPZ6C%E^M7I/LJ^DVWKSM*;P_UJP+ZQ&3]H3_^4,=;P@21K2V;"\&%;@%=
M]:AED.[1;#WI#Z9F_-59'B,S DP%MT6;MF%&<Q2)TX2R-,D?#60]U4]Q]Z'W
MDE$"N-_,"T#'9[%!O.2V5Z73^^X^OYAM-%F$GDPC77N%/L(5P\W.YH-^X-DM
M?M=;<1T\G"BR=LUEP4"(G)WD@#@SJSBER+[4BM.M(\VF7]_@2HRH*@*\9.>2
M-4-AU;-+7IH\@TB4T;L!^_JFSX ^3 R=99TN*[OY\PER4:;9C)\WPALJ)^6Y
M=4P.+4W#X[N",$P"?3?;3<Z2S(-O1525*53-9*15;@BXCA"*+Y:5Q$5O,WAK
M2F<4?"W[V2[;UQ,XW!0=HL,*Q^\]E.>D/%_U%*F.OOE)^:-9.#B3*DF?[["'
MJ/0W1)"7$%<W<N^U,"NB6D':@<&&=NA!(_^R/;.0.GA3T-@WD(QRUG26QG/$
M,Z-:3G='Y*$=9<>7;_86! N] I.=RLU6$$(8W%*E\ATOI'Z/^^3=&3?Y8OH.
MX<,-'[V? ?#2-*6SJUFRUY->NGF1#?5)PPTO)->B7YFMD6(V3)?T,^_??&)/
MK4NVG5T[,XNP 0N\*#O4@?0VV(+L1@@<AW@(# OEE6<XHDG=QB>MV*V*%(*\
MZMX7?EE:\IO4, R\3(MTW'@- 5D6G"#/IQ;SU4^^!299&<K D])*W3"8L+V-
M]CPR:B@E)%_9968I\>;/I6WK2Q+J4W$7M%^4GXDWA)>;MM7!<::6=;]^:<CB
M=?V;MKT]Y\7!EC%[J9RK!3S4_&XC,?SWF+WS\5Z"R5JS"*<=)LOS!^D:-!U-
M2LK\"D#7#2^"81IA5B +=A-3J?KYP\)X&%/E#;E/8@+,XL!61G[&AB;3PL6'
M&W[$5/X,L'X&F"Y*#1R=#:0; 466EJ_ MF_=XO6F$5JK6'#V\- ,V26]&WM_
MCQL"E/,^\746H#F4C#A &LJ,'+@=PLHVFO\:*8?L2J;_X>E#5GA2<T76AW]P
M^/8X[#$2SX VQ(B/:)W%0>KD,!.S)O[?JKG0%'(3PAE-<)AD[U9N$;.X_%E$
M($V$.*3SWK@M7$+:9(I1Q;.@.1$T*=B='JHPE82R!G;'#$;0%;B5;:*$&?^]
M$%!4_Z'M0=57+68%GE2!"7PV62 3FS?^JU1AGP<HZ2,P?-^%@<UC"TD%OX_@
M_$.M^_\7JU$L=Q'$SP!R7N'#\]UG@ 3$Z3\QQK,O3 S5U>J:4M"2ZB^",UBS
MDE^]IFA\%7"KYKK*/'5$?9ZY.^KUTBNG$;._/I\XS[23]Y71?%0:1^@*F0!;
M-;(WAE4P,,+-G#KQQ-7T5LJ8GI/[>PLI_O5X,H>KU6Z9@;0;391C#Z,[BFO]
M5.+ [=RC;E^J1([9%F7%ET3"J02_3Z^1D^&XO?69.M_8^KT2[_3A4]$KP/%\
M*ZVP&,TP6$FZM ,G^MPS8"-JV%V<9CS]VL7P3&%ZI-=#//'X>+U1O:Z9;DN2
M8'PS.\C+9?S+,^#G'.%5!O6)OG9^RH_,=9H_0QL) "'EQ^7/C(HY%3H,2"_O
M'/M51.:D^@6%Y52IJC Y'"B_EY*TO+@1@=W%,"@>_R@;)DEEN-_[<5XL(& Z
M4=90V'&VZUCB5BG7.+55&P7/]&6DL\;%C#!#64L%-81PZ KJR(ZX3_/C-T@A
M&@?6[#R.C^OL?-KG!HBUZF&XZ&W^W?D"I@ZNM!2$JI-0Y7'*_:'&PUMB1=J"
M8^.$E>:;F>H_$Y7F#:F1EPW8J+^25E06M!PP>97XL>T<GW"+3#8?J5&M/'7#
MIV<^T4M33ZO5\^ZTGG@BQ^9]CPP5:XP1.KCAY%XP[N>:$MB42=>)>@9 _?[Q
MTY3I*\VN=RD=.%NRE;CN4^2L(>H"DPZ5_9[>5KH;:-"D>;Y?R=@$VZR1A>(O
M7*(4QPX?&2HF$<)F9;<\"P:=:/(4O],(OCU-"NO-OWV,$V#U=LTU8*B+9QMZ
MU=4N\471IK\]^)!>2Y(2(G.-4$QQTT2SE-];J;PE\RN[K95MF:D @VQE1@?5
M#2T 67(/][,:[>231U<?7$&?>LQ!4"ZI@56ORX'2J+<W%=Q'U28$"$M:1H&8
M;JVP[R=?)-B*<BHS@^QI%.0'U&^\)@HSE:75PU1=//\>U(*^U3W5=1Y';6,F
M=_WYNB9)V0W A2;*N]0-H6SR.B@)^X!RC:DQLA!0A1GA?#KAL5%8=2%SQYID
MYTJ"%M,VL:T2KE4=H?R/@_J>5_90=T1KBI.A3<-MDW%UXNS"MQ-I19UACU;V
M/NAE,I4[8Z_WS('CF+QPJ!/#BC%A!94V4Q*^N+9FH.,:&8R"LU?,J'J(@L.Z
M>)=6JM-6A<[&&MN\GM(TB\+2+SYU:F=BB?;<_/BP)'7XVQ%)T^.VKSS&F@)<
M(L,DGRG])H+FQ?4ZWGD7C67\T1M@H%H5E./WI^EM[5B:AI7K)IRM]"B1JV4[
M<8=-*%,;N[*D$;:9(R%6QS+/1LCA(_W']/K"Y;]Q)FBV.460<CT!D;5;M.R*
M[T,SQ>+,3T>5SEEG&L!8]I,@BB#J*2N27Q8ND5BX0.Q>0>A(P6&.TY#PZPSS
M F$5G-E''9(KH3WQ+MN,!L++1*$&J.39*=C%OI8^/_2-E?W[!*7NN#1,/!'L
M'SM[TQG5V;.%_ZE(E=X=5QA-C_/T_PPH6PP.<](]#&>:V5FE:Y")HP-$V"D6
MHZ1N)'6)]TA7A0QV6MOI3F=Q)JA\'7P?)P$@V8+&C0,%-*FCUJ*-/R:H7CNV
M7FDV@/B?BNR+W-*D9S2V#1RJI?D%6(N9(!B\UZ^V-FO[RPJ&XZI2=!Z.,QV6
MS6*!-[5_7L2&;6_6:,'48]_8?>Z\%MP/ZO3.EJ$0TN"J]4/H^^7RMES'*? Q
M/)'V,19FU0:HSBT^0H[O2:'@33#9T]PWZ84$&? G7(:V%UO*IIN"0(7FM@2%
M,@O^LB^Q$;M(.T;\+WT3[14M/GPD]E3]6/6Y< BV1/XP$F&"" M,E_W3Y'#H
MFWR5DU\39K!"16/E]0P *Y1ZFTBW@.3JPCE'1\'6NT%*?"\>5XKB=:&KGZ?R
MW8['=@P#5X=%XZ\JN>*Z#+['FE#AGU8!G<BRP#(@X_XW"/.2]+^E&^G?X%:'
MRYB;S#&35;1;LJ]C,P1Y.$R3\T[(S4L49HP+& **]%O]^&<_*7'#+16(H=T_
M5/NVLY]G K>,YK[^GNAZMBG.+'1D>)&UE>(9\&FLZ&^\O&37=0[]UQY3]LN\
M3)RFAKBWKU7$Z7MFL524O^!PA!L>/0HQ"2R'9JZX[#8:+ !E.K0CC>!N/RU9
MFQE5Q+;EBLK>^Z@B#A7^%^1ZI3<W5?OU^/@-3/4$%&R\UR]_DH/PY4'ZSB9F
M6!WJ?YA9+UY$&(.717#GZNHOLN,(E?+RG$PI7@&[6POG>X4$X+5C[MF47$3&
MK%J+<J;P$P_H::"S(<&R@:%Y\W%,E%8NM: (#NA5=')4Y.&M1A2ZS2B%!M->
M9I&"%WLN*8D%C?S//Z]7R1G. ])W+\K""Q<*TYO=ZJ./+#.U?D54K,D17<AS
M;ZJO)A<>UK=_HG4&"8;\HC_&CN\DN!9X1)<4 L.1!0A?MS=P=<D(7#!(O)"Z
M7?);SE2$*2Z,E.'7!W]UQ6M_?=:7N+BBNP<M8<L8=MFUN'X-@9 R#VC6<J4&
MUKGB;06Q-@X.[NMA^K?*;M)=ZF9AN86Y840Q+<!HL[FVK<E0)J'.A2UPI'Z?
M'WFYE'A$YL8?L4U8HAVAP6\--:OH8[:G^2^K]_&%@-.VR#&-54$B)M&U-L"#
MZ@B3<V"B;,D^D4^M)1.$0:KB&QH!90 Y4 ?F10K3E]G52^XQH*S7XC3WHSWX
M3(64F:7@=J@EMAD(32YQ2Q*44$L^JOE=3J[6]6.Y)\L(,$8V[EKU".;7OQ*D
MA_7<RR]I<_;]8B,F\4ZS>P:H1Y@ 8Q"E*\>)]7EF3 5;=)RM>9C$402:65RU
MFVW<&^"3EI)EB883K/7H8:1AT4X'02GA0!4X=^15&WLG&>D<N"C2YO0+.VO$
M>Q^]RV/1(NH;%(VW^A7)_%:VKVXMQU69VB.M2 ()N>G3CTWI>^"OHOOK+E?H
M>R3K'I@SK$CKB,.M(XR^7W'V'QCP>G8$)I-13.=+G5)@E940MS:PT5=1["D(
MY=:TRL,$77JZ,@DZ:C(Y6V?5W$<'WU 6"P=31TF/V%TGP$KUF5UOVHFG(,2G
M]2O[D_(.)JQWY4*@?*SHPK=%/3D62A:8^7TF[[1X/H*[$?EDD%$WU:</ >5(
ME<O:@M$)RZ+#NJX$^[?0K&@!,<>-K'=ZEERQ9<NOM2:K!E4&""D6"\</Z!(*
MR#2YRBTK@@L*HYP"JW]9;.%R;?CH?<C,,K D$&#/U=77T>LI[(S7H4FV67<D
MNNA$3.SJN?H[LQ#K6^+%'3"!///UNTVYL6(?:O_8KPD8UU#!62*O# D.=0S"
MG<VKM48[W_I7X+N@T( U*2OF!J^K:KPZ_/:/<RVBRPK+H4H9(OB6R[AW/_N%
MP2+N&Y'83^=6+6"NMS;4BLS2! XC RCGN*,'0LRS7L#U1F;G*?3Q6HY($N6O
M$E#>=?@?-+-#+7,?^N7%2'FR%39N<(XZ"MGOJ^NQ=]BKL$2IXQ&?%K(<$Q.K
MPH4!,].7(K8$W1(!+]S'-.4QY:*UO/49<_5%YJWT7EQ@_?SL"Q"FWX!$$[KY
M+VUD0PMJGL9G?QUB:>H%$7898<I!7>)AOK@6.JNQMIN4]:D3ZJC;'%IH+=4!
M [/VHD5,6GR3\M31LK533BM"]SO7T^.T-C91^UO*H\&\NW".%4W1Z:O!)$&%
M?N)$U<0+_-A+SMUV2CA+./$FVN+K0'OKL$_8M"E?@*XT\8IS+$*?+-KQN,_U
MM%+ JQ;,VERQV\CRC3?CSX#I*,F\1K[J.8>]J%.IL]7H'%N^'UG(M<)H@QVL
M"$LK,+Y\VRSH"C6-IZ"E_AF@RH"9P@\W^%;DEM</7B][!F#K+^L2&];N+/BC
M+_7Z*4BNSTTJPJ!33R3[S7,'X9$2YY\I(B60.@0>7HC]JFR4*&>").WJD@44
M])4+@4DC&(IY>O1>!%$0[&2XYNXWS%_/SVO8RSI;.J*5\XJEPPTLXQ#JJ1,/
MVD+CV157M?0MU7^_L\39D7=[=OB$,G?U1DGW(-6[+I+QJYE)()4"IK$((A(#
M6V<95TJ0J$&U.;<5MI$5O0O_W#ASI:EX_.:"TCK/]G=&OZ#D55D'9JMLR>'-
MXI'.K^)]"\?M'@BK7Q)P4JT99/#X+M)\&'K@JJ8L+E+\_R6"2:L\4,S?2^:N
M)G>G,$Q4E,MD^#WIY2@X=Z21^@LKFB-0VP06?\!0"$>S&]IXV."KCO@JC3H?
M=H[.=G&D.:F_4G22\XW">@L^SD WU"\S4.+?,PT6S4O0C5NH%%LNKF"7NPT$
MN7ZB6LE;0A$0.NY$FN&$@E=:0F7DB>^T5W']&*)UIME4YDAPS6?SF'7"1A-B
MLN.^()5PHD..P>LF('N<+@7,I(TJWW?GAB%9[T'.0'2J^GB7J=$;9.KPO 32
MIZ#&8YH^#X7P@M[K1>_=ZYJ ]F\.ZF\G4)# 3O3,\Y[IV+T%#$PMF=O <$;#
M/GR=5R/;(SC?YM(CI/NE<&'<[=0-+7!<Q.A@C, O"5P[ ,F[;6>0Y8W:'-Z3
M9[![%9)4!QW/#6ZZXN_1X9$)?L<QF[,J>_ODJST32?8RF7S+F>GYAQ;V&0Z6
MD(GLM$.>\FF+@F_;I BDTRC(4D=$I1=O[D"Q6Y@65>IVMYB%S6O5>?MKW(M9
M;4V-:/ZNY3<'F&#MI/NK?&7*TX\:S-RD/91;J;AOSO.3?DT0JC@F[#+4>POG
MNM5*PE]5H@=.NBN9Q@9A"+9963F<+#7:'$9<&+*Y>?:S[6<RZCO<"73C!C"2
M,RLL8S#HBM]&ENCH6W*WX.DN=;-2EDM%>""7/Y5O'2,I5O2SMHGM68*9<\Q>
M9>K-V_VM<E?< 9R2BK-F63U<-_''W ZZ[H&:$?7LG97DC8[.#"G55+V1@S8%
MT9:;)4+RC)Y:C)_Z])NT*3UQUT+JP@F]6L)OE3N'",>%Z2?]W2J,I+-COX?V
MJR=L81G0X"5[%8!2H8[<H@68AC)7QZ\[]U-)P7EH?#1C5P*I2FGQKAH,N$$%
M$ECV6>P_$G&4=4@^_EMO[^,Z$5RJU0J6%E]FL#!B09691H==EAO0(-AFN8'"
M%'&@K@29L,ZM]F+??(,0V2CSUH\1)7T;*[TA=3A1A+N;BM)[>"RYB?)GUXE(
MOA>, RA\\[0_<7<H6D3C^U&F3KUU0B'\ZXS1G.G<I]I0E@("]\Z[WRH5D47,
M%?<UBQ(L*UP<MW=A9ZSW[[9\*"Q]Z*9 \RI3IGZ,'\,?*=R0&_ Z.X65M;F$
MR.$10B]G$2+%$[9U2Y3U<J5L;#V\0#&U[,6V(>=/!2,@"/^/,]M@'?Z0\5A0
MS4;/:(L":9 4S05G]2LL71&2]Q+5?42!7Y5_9KM4L'K)^OC@^MJXPY\!YH_)
MHRM^D0N7I==/ MY_LW%A1XF?X%9GZ:?(EC4:H$@?#2%K:8R!CMY![ADT$M6
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MK/F%D_H0NQ+</9?5OC7W=&U]^,15-UEN_(!>ML*ZH8Q3FDT&T96>A#!Y:C7
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M!CL#,GD@ 2'G7'O\MSPO)CAR>T9)?1ZJ)'M*2L^WL!<-T4:8,%V^M9X)S-L
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M+?,#C531"-*JNQQP;Y5_#2V0PV60P<$<8%B)\H#L,([$6,QF=%(32O(U9N5
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MW'W74O?-U&)7GVX=B5<:X$;0=_)9ZX]YB:&VB"HA5H2'%P9C(^C@P[)252-
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MDXY#*CT/Q5"0S28C2/&$)[3$IR<CWXK217Z%[?;[D&5T]'?MQ!;2,3B6=<V
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MXJ7K=_3AAJ8);W%TI*\^B'Y?QA-7B3\L4V )P&!@B+M)7:[\"J&#8OT5X)"
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MN[6#&_D7]5:A)T" (WS(51[+AFI?MGPC\P26T#+!W#I%OURY@H >Y%NO_DG
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MU9M15-8"RX%55BSPZ*<"Y3Q=-@B'K39)H-@3(%+3RDQP859,L-O(C1)+*>V
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MW71SR61N-T$%,[(<OW/1P%*$6*I^U/3D57/5V:6>[(2GJ#N*D)\HV9BD6V*
M-^, 5)<Z?RG(WH0618Z+@^Z*LH@\I/PS*@4);J8.X/0) .%!T(\?\K'P<KQP
M8T_J)7L(?@#W2W R5BS6K+D4UH*GO:EW9N8<WX#?NJ>%D'8PJ<P?ME' ^"[*
M::/<[%F'ZIW]!8T==,]T,H$1$'40/+AO+>(QZ&9BW2D><!JO1?:):]:S[AO#
M"_)V:7=1GDC5 Q6[VY??PYX/HMA^ZIF.UY9:42.!B00V*J*8DQ'-C#'9E,-F
M5)U-<;JB&D4O&".GJSWU"JX=Y!KD]%YO(BP0+G+Q2>1Q$4E\9!>Z#;K;"62R
MF?"&RJ%H7WNVCNG,&CQ3K'I4@A[E/9U;EEA6B)"DE>&[PX^AB?8BNW1]W+.%
MWYM(2^5=\LQO T:GK.)B]GO T;\._#EWQ$.-\@/2)1W=8E]@=>*PAQEE3H>E
MS\X1W,*%LQ.$^W<'*B]YJ['H\XQ)TK .(+'I2Y=XLA)'+NM;49S?'Q@+CS7R
MS<R*CQK3LY+X$@338C@$2K'%&9.'ZJ*R4%['#B!U Z&*QCM@Y^I0\\.O8>%C
MC3@$WLA$%KL6"@H<GV]Y.VY3]XA(X>>04BK?0_5M++!"?2:Z:Z;\]$$7-+YZ
MK@87:;WJ&%4![0J6TO"F020F+2XKQ>6/:R4;_ON18DR3IA7CDQ]EW0XV:G*O
M48#).Z#S64H9I;Q@6&%)12\WIX*RA2"&#-S801_#]R4Z3,KYTZ\WPG\"Y.U>
M89ZZFE))MIHM@.!Y0D$\MP+&RRQ);:T_S]2HH6Y/:)YC\_%EC\EB<3<6%@<_
M+*/>AL"GYR@(N$]/?I&%5?"WK%-;B+6@K\2KJ<SORH8]\.:E^QH^7!(O3F46
M79+9'T)7P/;W^_VE198:.NJENLN+DC88%V[$2'\RK^@WG9RF.NWKJ8)Y0>F\
M61E7:1EC09Q'4G!DTW4/(C20!KM*I_Q+M/6?A%&M4\)I^KIS0D\QJZ@\;>VZ
M&G%NJW-+2Q9NG3FJ\9A^TJH4[K^K8](TL)CU-?R&)')#?C2%^FMQ];PY#-31
MBN,)1,A7SB^Z\4H_ZFW=@([W?3!VP30I8^FX,3$-?_[UJ&&^:^XW"!77"&[E
MEZ"Z).!..=(?4MO]3U]=7-Q?!H"5-_I\3%<SV)O.U4/<V8^&=T;N5\1R%':C
M(PQ)Z7JV;%#VMY;./.W7&^?'[^=02EG[;2.&\[5&X7'(3>^]UHG?MR> ^4?A
M@ :? '.M>[,3TL9G3J_2YZX6 K WL8"RY88<;QF2CVHT4[<-",[EQ:9)9>FY
M;K")Y[<B@<J]]Y+NI,V=[VR9+D_S*OGZ&]@H'C]4Q^FZ\(2M 0-BQB3QJ?\K
MH/;?T,X9_;?Z!*I?"J![QLFY(OQ+7<^<,6'?]O>9>\;H]4IG4Q=K[:3US.+B
M<A:BPT?$ZA,@I-? A 3[Y-Z2Z+II@ICA(NW-E4;FL:(+JIBJ?^QB@+R9BT@F
M,/W;O.+)^SN8<,]% 5H>.Z$X>QC)VQ[ !*-_O$Z<<2&JJ>,P;E&]2?'2;P/)
MHCGF3FW <;][\>$K'1BP(S%P6?7N#PS0M 72D (_SQ@:.'SO+)/'5SVZ$'%O
MII7-]=50:"X';6MX?\L4&NE4QBKSR8+*4&GEN)&LJKU6A+M.EQ</E.[:+WU2
M($!P/^XZDT_7EJI&Z^ZT?7FL5ADQJ2?++5JTK MW<J&Y$D8U(?-5UV%8US$9
MG/.L*RHQ##TB[: \WM-EKA?,U,-7"%/3""[4AZ\2+]>Y6H_-B9Y2L->C\E&L
MF!UWN='O@$3PIS(EISX0MXX5O*=6/;HW4-8930FMWG6[@1&I%SM(N^ZZ;^ I
MZQ7V_8?WZO_%29M_L5\GFD%,]Q(%^_46N%F8VR<9TJ2,R<>%'8NXYZF"\_D)
M&XLNWZ*/T[U0#;H;]UJOSS(?Z^M.RY8QG@"]E89_,,H3H#B_/[4Y5-T,OS^U
MLF=Y7DSX_ G0H/;1@>C#JQ(('^#9>*,5BF:BE&_OX& 6;'/7UF[([I$B@]C+
M7NN@:GLH.0GK@]',WA[DT/$Z^[NB/Q^QIQC*],C253GE,X6<+HVX?"?O+7T:
MF;&"&*9I_"? ?021](-MYA/ !#K7/LGY!$#WCHUH^7C]!.@!_^93%#[Y:ZLY
M7,_P7/ =T#2\]J>^4 ^IO=<+^S/SQ+'Y7/KP%#8%W CWK0B&\/UQZ5+=3UIE
M YPD=YNU3L*JSI%OI)QK5I#VV8=L(C(X7VD$,''7FQ24EH-NM#I>*+X,SM<I
M>"]BOI>[,[[,.29"ZEIB9=\MQSC#[/(-A>3"\>H*?TX&6:6**YJRQHQ.6XS!
M2SK?M:=]TP&Q0+MX2NPR ;EL:#+A5BC]E$8M+2#32U<&&GB09<4!:8DS"X6,
MY2VLU@%^]JZL-5,1!>:7A-!.)$P+2GZM;+I+&OKN+TK0=K\7M\.S7?9RZ.OC
M$IC8!<2H72AM@7GZ.K2.%*W;(:4U9Y>Y9"?$L;=(CN,^//[;:X["GWR]6:_^
MP_)2X.[N2V)M%NO\3UGA+H+U;<]+]HBF$@),+E-GG?V=>XC"FL+<&2(V*ZP<
M04>O]:2+72. +',\V. "I'A%J=B[H8-1)613>;GNSCQFGO0L1PLV%8_*QY$K
MI=L+[LG?%I<I)FG."4I4.%)L1=^?E_D"V@C^RDC&NTLTXUSBKR\ON9-;]M'/
M>I<E2:95P=Y44RUZY))OE3(2=:+G['8I21Z-E5 UQRN=L-]NZQ@',H;+D@L^
MNDEY]CP!6C1IJEM7L3*5#:Z+N!L'CMW8/GH&^QS%KS_2U)X/O90=RYTMU +-
M8VUR 3*+=\V1<*[+55MN''U>&7S&EK'N;\O4EP'F\UMY6G@,WD:D%KY_)';]
M/ A\V_; 6)SCR\^Y\MW1Q=*;8IKE0=U:* _H_Q4*<GW7H;$03H.>>C=#&)=Y
MMYVR792%86NAXU31U1Q0)NHSPJ?N$U5J"6EU$KW%T*%[#LM]-7GK>:*U$ I.
MT)5F%_V%#</6V8"VD&H-""R"ZZY2AMKXNP9_2&%783%6Y_A2P*OAE3\D+&SP
M<".>?_03O7^A*(GW;.T)\%;%H0243-K/]IR@AQ) VGE+LG;*O3G. 'NV0%Q\
M6:Y]G?]JZ"X LJC!R-?4\].AYK4B!K9##\!!7\&$@G291T'&Z-%.2Q$AXD,$
MU0XN\].6+8WAHSK/]4?5-;HH'&"RYPC..6TCI<_(.^@%8'P/VQ<AY@1&0 F*
M"$*Z17LLNTX81!L>2]K%C>]TD_6:O(YTA/C+Y58?3!FOLT&13&RXB6WK3D/F
MVTKSUZ%Z,Z;-$033<MJ'SV*9*EKU9B]+=$I)H^"RRGD9=?Q%-#\A3G>,LC&\
M_4(%[R,KNMQ%DI&!6.?H<*O/V3,V1O0V*/;]V$)/ ,X;#>8:C4?4QJIIQ-O;
MSG<X1[4NJF0=:6][A""C]=?);W-MJ1J.:S/M*(@E^E>#R2'G)1J@E%&E7&\W
M'8/HMBP+XS8:&8+#88>T,_$?K$&V:62YW-R=><M#+%UA7/F7TKU*"K;"]5WJ
M"YR!V_*FML*'?!G))&0U*QO.28\:$E&*NK>C_1E:#+_F6U MTZU@Y6G4S4TQ
M E*$8> TBD?* ]$8#\JI%K+K&+G22%J5)K,,Y5H*0UVR)X"KPS49X_B>[[5A
M#C4LEB:;I8\FOC:;DAJP=S[D<C'V<EYUNR+ML8^_(@?"$!'UGT$<&*B;_.1N
M=>0.0_H!7/RW*W.DXG]\?V3/"3"8^9XS:\%2=16"*97<?27\@@NV_V-.=G_H
MI#R"J8G2Z.PK^ ;UT.K7 VA4<\3]*!@.Q%WFGLZU/V4',IBA?1_%FC+0G+*^
M:%;Q$K\4/QN<I1UU1OJMSG!0*"_FEF%B.9Q[^B>2P-EH/O'JR/'3HO7G+J0]
M 0(D0&] J3[H.H-2KZ8FPX3;?8$98+(88@V\UV6$,LB.E'#W2#\1!ETMF;>I
MY?T3.N3Q+*#$R(<CY2-]D"2]I(QV/'H_UO8="O]K\P2M- &^_JHT?_JI-7)T
M(<L=@6L'I43VNGMW0?(&][@G ,:E^VH:B5[RKFI1(7%6#D1 C0B__.C L9'0
MQH9&RPJA-[SOKNE[/8_0R$;P&]=4NM1,/&M3YW.3+L6=GTL_$>R.1)!JU^S)
M !$@R]\$0K)KI>0[NK4!60M[,QF?%2K$T5[K]F,GDKE;4]BE[.7+2SI\6H%J
M#YV*]N<TL+YUY54^#EA0UN>0PVM+VHP4!)%*"[]R@#=8E.8F*-LY&_YU))0Q
MY[@N[,( 0R^H)JFYFGP)Q-_/>TWN_BL0'4:2QR[#^"P&5X[$&Y\0F0377Y!(
MGC:7GO>=HY?J:N:;G4?Z\>G+KAL2N3=>V_.CTU.>U:O -WK7FB#([6)(<'IU
M5P:5PMK>CH'"SM7E;4'FBXL\_T^THML=HS/X.IZ1O>=%&I>A>@-<RI+&UO_G
M-:S/B2)R:[ )Q:PP?V%SI*'8!YV'%\*:#@&]A'Q]!RJZ;=-UL?,_?T6(HXZ>
M L49&.XOFT@%JL(:>+R8^>G%N']O'R(^CM$$$AJ:YS+Z0V,4[<%IA:A? I!P
M"HM&4%(U(9T,I_*,VJ S?"+K%(O&6.U*>?&I(&6.)X# .=&*8^_]@\XX^\@1
M$GG69N/NK6X(=Z#5U1. LG^0Z+*54E ?RQ-8A'SW!##S])9JLMD9;Q[^-*V5
MP7-7AL:-T!EJO60IY(Z[P0P_M;N*.__03"+N_/FH=Y>:OJ-TYO ]-)QZRC'\
M"R?@,Z.OHD&2!M^.I'VAJ<?%^Q%B=V^L52F[WEVZ JY44O$BYUY!#Z.E@)_R
M<TQ7+U',)J#I+6<??SS8,G2YO>@)<0H-ZFN)H29AD#PMB51@!'T\:=XHVWN;
MMXF8C<#\X;ESU*.LU]]$7'D*YTC[^'XD]Q24$2O)36HLZ?BE_Y\4ZW4ROOQ_
MV>=#^\-YUH9];C>7^ZL]&?]<UQ7TX/!84 /[#U_VY1<,H'>QA;$A-!8S=6?,
MLOP;J(M^(9GU8QO._7P"X!*R<O?IO_[P*5@<N)5-OG1Q#IN0;7S7X*AJA?9[
MKK_Y&0F)9FBBZ@]V]3@3%Y^96VEO^KZQ0J=LYWJH\\J<:V#W"F82E(4$.TMG
M.T%K<?:MI*E!4]9Z)/3+[BBT!\+UV^"PS\JV<%M\IL:6<M")E%/B!*4HY<?<
MCQ3'F"CKE4^$DQD;:#N9[@O3GN]6\\8HH\ ./<1A\SQ(9^=(5!H*U7E+YBXV
M^(/,&TBGLJC]'77<:3-NDB]"U'N5%!7 PPDF^COJ$17SI\+;)GA$S>AW<"[O
M!.L>Z97:"4_^(C&P":>!KI[(0&A0<);Z?A&VL'O*A?N9X@MS7DVB./?P3E;\
M)B"'#0'+4L=X,TLCW3143R"^SBP>TC':,3*KY")WQFG-9))H4-6LTJ+&UAL>
M.PRR!L:K5=9..FIE#,]-"Y8JK;<M67>+*CC72MLHZVBZIZ?'A9*<1K\G1"L:
M_GW1[F_W.59[8LV?,+R_ZC,G69M6Q9'O,^[B01-+;_)$/0^)8B8@E0H*^]:Z
MO9A*_7G7MYT^.](?RHM,7XV)00-WA:1='V^GTTEP!F=DJKY^=$5.H"P"8&[-
M);50C"_TU!XH7,YA3;?Q=Q.L;8CTX#W+ES23*;>(EJ.R<FS,_1ICJ/4#>(##
M!B12/ A6.3SEGZ4,7'A_QGE5ASF*$H\OQMW,OQIC4!.@U8O=K"V[OF*,&R6\
M.\AKJRO#9-L/&\.I>K%ET6TG^N9?_%5#I!&!QJ6%"#<"E]Y]KYT;9VVE]!';
M5<1_VXH@W^^!M'>3PW=GR'>9@T2!+5M5$"Y6;!^S 9K<(EE6;@^_N[T8/N6'
M2?+V/XAHK$F8O^5Q=L88E*[<.M4-G)HKOU)RO\VX&-=@@2.\!"5- J4\0F?^
M\#HSZ\8-GXZ**^[XAV0$^6O?.7C?>,WE$R"16.IA+U(ZMF[,_/EE\=HK@?:]
M?9X!EMRBC(3:T.:@NYZ<1YKB=&#G[<UPKGL#=_*?*\ TB^QDX>]7O)_7G3<3
M*XQ!?Q!YY=G2>N4F_%,3M%F4D$@QT#$<+[&Z6HS];J+O#WC5$)IN_L\WR:$*
MKY$2>3E(OZV=/I:AMVEEC#_ML6=?:D+Q8+>PHU)HJV'24+?..F43!N]L(A<#
M5J)_E6?>RZ\*VWRN3T$@)AS1;*WQPC[)[,WP<\=+3IZ>$6G6C/-GTMV !G"^
M9R-!N=Z?SK;=//M%.QT5([78:53KK@3H.Q1X!8]>MZ;[JA96L>#0\[RFIEE]
MGZJ)ZJ/\8O4\SWYX=B"G]OA DW1 FW)MKFX YNQ65E;^GYQC:6!9[E.XX\Q*
ME.=,-U9:S&\+X@>FFSV#]R%7H&;:I6AHB 8$(F%";+YBA)V(YO/++(FR$=#W
MG_7M*21P2Q&;+&'S*X]':]O*T3-( 8;9+#A/PWQ%#X6W<=8Q0>O(M9RGTW6!
M+&85TX:-M2&T3E_>TG[E-3Y?@8R\M5]%62%27$6-@N\L8SFB'^@L'7J\!*6Z
MR7WUYFWKF/1X NC836W;!!9L*5.-B(\QQ8PHWE"X"FUQ<C%'+B;L-CE#&>A@
ML=OC555_L(C??UK&L%]B>P)$+F/Y_%8![NG)_[NE**G\/]*F^LM<I;N!.,*'
MK631;QX10_8K+E%/ -\NC^J*OV3)E&,-:,$S(\7@JZL8DIKJ:F]X"QEO_+"N
M+I38A;-$B]F:)=.DN:F:-\]<ZS$>WV/$C^M/B%5<M1+ZY5+X6SOIE(R =[!#
M^,H6J+.3=J,^+*!VLQA)!S\FA]B\<]2A'D5M@KRY04#ECR>Z*D R=C0Q&GR3
MC=ZW'*)(M.%3A]+M=:JZZ"Q-<J5RY*X)DL'D=^M(VB(<QQL9F:ND"J>,0S+4
M$:_5P_=_F!6@T2*33#-46_=(=%#!W,*? $%P9E7QX^[4@CEXYQ/ *&8U#H>-
M2&*$.]1AQ09/Y[G)&,NQ8([UH_KVNRB0SJXW:<21:F-EF 6&W_[O&[^J3[U(
M5%Z<.@+"!?4N7L+YY6%P.E/E%H+RLK:EC*:+78&OI>DY>E3+]^R(B=]+.C$L
MS+0_(L;_']:^,BK.9MVR"03WX$&#NP1W0O#@[L&"!7>W(&FTT>#N[N[N[JZ-
M>^,R?&?.S)PSZ\Z=>V;.C_I1O;KZ[56KWJJ]GWKV?L35[X'E^A)EB=M_LM[I
M2HC/H+IIAQJF>*D_T8^\T&FL:*X=C#KD'\Q526$P_*P.XCF+HLM43UP QO(8
MC=CB7 U:.F#W,*B]X4268Y&!\J(6KN*\YLUE(C%X04?A"J+DAJ>C78);??^$
M4:Z@,X;%ZANWR^P)EO&K45G7-2YZ!'KYA,:#V0%/J?EEX?/ [JYE:R8?._SK
M<>7['TT/%_(1! %M^7D'&R^GW&$]'I7]E]CCTOQ3DL?E3!J<;D)ZM2?Z<*>D
M"5U:I25UWO8E[;Q^,30&MY:]EE,O*.LZRT>\8:RLKFVC>S70Q5$=QAX;28=%
MY= !J">*1,Z9V:M'Q,3MYRD3#"X7:#5+[%/6J\3>BLW-J"KIN:Y?*UO86I1H
MU;^H^AV+>3&7]"TM1#Q*MP4M60EHB? 5#E#8AZ&1V<V33U6499RG ]FKK4HT
M\Q**?C(^SF)(I7CM6D,':"H7#MFH)7R>3(/3XB4.]-EBE&)@W_<<_&/-PXTH
M('5,/YN^J1](-A6_)?O#:BAS\6FF&S7'Z$ 7!M>;9&**3PA>2\REX#R7,<%[
M]Q60%^U,=)5R,57C%-<Z3;.Y^KRG&C0E!'/@[AUJ@"E:M!+([-9=P _G!J>;
MS>]<DAY"C#CEV ZW<HCYS7@&1\RDT19Z:,0-CA#CS@YX6E)C4[VXOF[YN>>V
MW@YD1_,(HA+< M])',TU,@/'&<_\,??PM(]#V5U--RL#@J G=A#[V*PE#U*4
M IKXF5KS-\K:?M0T3^1YU@BU_2(YC;E"&R=)=:UU:D>Q6>KN3W* )?MAA.01
M1+(-W"\D-JL&AC7^2+RNQ5+4@2OY_T?!?^WI7%OA3)K9N&\$]RL>"+";,.,!
MW.H],B+=(8  P4X^B!IKU2M?7P$FL;N)P2N".SX/Q7TC;+4A"37Y%TY7 H3$
M'$HZ<3CIH%ZOQN?WK&4K83&]'S3DZE$(,;L9C%ZT-GR] UIUIC)QN#YY-'QJ
MIK,OCL[T29.?:_-F)RVR5XF.W+[7@>SJ\:=,A/H$[SD)?IBF"()M;_Q2)<U*
MD%:4UA[N6)N8;QF?%. F_"?O%9!FT^<=W&H^OVB0+<>>32!W(6A=DT_;*&];
M)KH%"[)QRZ&\__4Q5%V)T&E)#M6K>5Y?<46$:+8EZEMF-DBZ0J"S-*FI0K'@
M0%;6D9^]*B(',;SLD\@P<.Z"Q)\CG'-S;0BWI8::Q@C?B?B7TY.8@<BFE_.!
M,:B$RI]FIGJ0-U85^FC^O%Q@.LFY\N:Z4D-S^B8B2V9>OT'1V31FV-=+YZ88
M 2_,;E! ZM""3_)]:U/^!;'&0U):_L"T^+T_<.(OP[1*+M R:S ,F)P"-0<U
M1\WM0"P)RQ1?/VZMO_".61'XV%WQ:8A  TI"[VBP_T 7VQ4<7,LU66M&+?J8
M]46ZK<AGS'+:J=6._<]WC4S+XN'\RY,,4?^3>8H;@+VLRW0ZNWQD_Z8><6F3
M@*P%_9_/KE/O'[]&F>/"\UAJU!=O3_!P4Y]GJ\QR)'+(LO5_P[DI=X$>IE[:
M9E(H$]2A1].:V.1UIT\@Z*O-6NU(>M <-N7WIVRN5=-G'!<^E-I(VY@]P["X
M/#@7L32&ME"/W-4NQ(>>C:S @JH58R,]PF0(;^WR'0TSOF5_^']W'?A[@^'R
MN0 +/3O8[&JV8;\-,^Q^:7P%*&NI_X<?"Q/>AF02F%Q7CSAKCRS'BTY3%SS,
M)20[Y-RQ619(G(6P,7ME1FIE;SLCL?'GW]I]T15U'+-,G?8TY8PSHJSM2]WK
M='C)XHQ!A")AH28ZZLLJ5.I7J0N'7*U_=;?+5ZN%U]86:-^(K4&Z_^M8TUZ]
M;^>?@HEM-G(U&O-)=1>X%63Y'_?8;A1]2Z=[4DIP0!9;,E# SR<[W?Q@#L=T
MA4G,/2<T9.4^_#&V=J8U67<5DQ;9*RU>\2JUMOB7MNV<BP:X+H(@GR:A:S(]
M/I-12(8 _QLIFBA>:+$:#SB[>.Y\XT2(%\W4^O7+QML_BZ,]/&>'0U\^73\K
M3L:^ IJ'W[Y\P/" XKWQH#1#8EFOF5W_F3IIFRYQ9P:RG\YK.$RT&U3KX(:=
MK-MM#Q1R'B+@5 S[#NH\FLMDM4"W4+ H_5Z%6W]I4@\4UB)OB%))@4[9N-ZG
MS\CRY6F6_72LOZ0GBTAE396ZC8P6UP" :]Q.DC_VR,P]G"B1IFQL_4Q-'K<&
M+Q15%@\$[+#?,\<+_%@CXC#]H#M22&J+2[%Q-BX4;UYU]^."\:G6-&& \SC7
MA&;J6"GG'2^QZX/Z]Z+BU")8.3DX91EAPAQWDST;ZT^5"2-)E/5A>JOX&OYR
M,LA16*;YREIZ1-.FDZ44TSN(%^++62FVQG Q#>X!:1YSHW_'ZG A_"*4894'
M2<:?CC0:2)I"[XST[_?!59%S"3V\3TD>8OGFE8QSE8YH,:BN(JOKDQ)'FK2,
MD0'DR[0QRA<H]RN' 8[57"]# 9=84/FY!VK>>-6-,T[TG8PKZ0*KUV#\&V(@
M'^+XR]R<I]J+7M!'^:GQM9E<^35)H8-HXO0S@NCQ;O6DWBX+03H0%4C;D1,C
M?44$0M*SMM?4\<X7"P G3 --+7:^EII)7ULC=FJ\IYTH=V LF!O)4?X_^+%F
MO2#IE!7S2Z^=%[(Z'DPQH9$ FSOBA(0F.B^+B4'4D#U\AA5'P^$;)GR/+:H\
M>\(>*]YHE,"MJAAMR:=X(5M:^\N%\S0R\4N3U&55.<_&BWZXCOF06M7*F*K!
MQ]5C1RSUI,,V.O-:'J:?IM&4B#B<_:IGG;F5%Z6]XPG8HP=U880U;1J,;V_U
MLUP^,^M -0'_*5S.I(Y7<+CHF-(6^G>VXPA56RF]GLA7@*KCY"%.U:J,=70
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MBFQ:Z99]&F0[<6:-A[':($0K=9QU#N NH)^14,6I-#>%;2Y>UY/@ I%+,-#
M$GW8):&EADEY<9(FP7,EZ7&OC#[<^OP208ZQ_O4=JA0W==@K(%!E)FE3$+$Q
M:(EF9HE*H\Z%EIQ"':AA7M^4VU%?49.TIW_:$QCR5(RGK-3,2Z<:JR6E!V[I
MS[^#,0OKD_U(U\[>44@:D!874^"I<KX7R2Z;N? Q?G&W060G0V?'>0<LE.KZ
MDIU]R/LU2^!+GX>I /\,?7I^J:BI.2/D&"<*>?ASR(1'#'!22;O>@3HD?E)-
M\-?Y6J/=-A&LK/BVG-GMV""AK:^W AQ%'128?ZNZG+1^WAM/1V/<C7=%>[DF
MA[N?U33B#WG$;"ULU O!N4EM:Y>8"VPZE/F\6Y@@#_?)_8PWVN_(H._TCO4X
M?9Q7QSMAT#C'T=F^'M<\HPZKUA'-7&;#E5=>/^\D05O/Y#;ZM1)/1VP7H#-3
ML^GAL(%>Y<=L?L3]%\)%CMM(]A[H3UQL]16*Z6#@<<RM)EC$8Y!$5E$,&TS<
M\>\RA;9_H6HWC36_2"&%RN4YVF^?:P)N..&R'=9;^X +21)(IEI:UEH*-M.9
MSD3+W\O*E;5RT"N*6?B8BA'')[ Q'(\AO <LM2661^6*J]H,3^K<@#F0] MC
MQ6W=8 C]>0-TG?V*/RZ$MW9#.^"-^;2UM>MK[5!8@:I/&&M,H0L+:F3=ERQ#
M;!AW2/L6HSDW_:])@=?V):K2V$(-J^D)/QR,:.AB5^+WK]W*&3<:_!%,5./M
MU2@%-/QB'E0@>VD,\XB>PE/8'V\YY7)?RMR>6?5 [)/:/5.CGR0(PJIY.DC"
MO3Q_Y"SIHE&5(BB'4;Q,M6_US]F$*.:<GV:$(!A!?T=]4C-Y!80[%K#?I(V9
M-,5&@[+ ,!$[#Q[S2&Y;NH:0Q9Q6$-8K ,;4PN\:*U^-=66_:Q=R]#BI)M,8
MS8M(AX.&N"OE1-+E/E-DGP'F*8.-+ \KSUXY9C^B?_2B?Q0+E><)Z;?!_0,(
MA]^-D#_0\3MTF$MMK0SOO\J;CFF,HY-#E6U>'^H<<SW2"RV2>4XNO/-0;U*^
MD=QBD:7B#FD*8[T9Q[\MX^M>4CXBZ%%@?L@AV[,1(VHGCCN:$B6LQ,L)UV-C
M40T2(9$^[,[+6MP .QG1@?Q7O7,^'#ISS@4=6C8H ;C< OM83XYT("_9/]:H
M)IR@>26L&#Y81>M'??>+:.@UZ]XD>K>V(4\<9TU(&)E 2F(PH18W&IBZ+^)D
MB=PIN ^"-CI(VN<7C;\0SS<OTQ;+,G?H=W&Q8_NP4[>)2?].,V3#L6A^;DE@
M/,PFN4>IQ)#>$<=04YII?,N$AX33LJ:^NJX&K[X>2.KQZ?V+BKRYE5/]";H8
MTS2H%:H?+(R7AISD5H-I'*UIH)EJE9/ ET;JK>0P^# O*@E0>.<+V'_/^-_)
MZ=^*/4P7_HT99"#;_*.GMN$_JJ;W_[>K/W$3,89C; DE.4 &_/\*^#>NHQUQ
M<GH35P UO>U(1FM,;02.)/1G*&JFUH\'JF39JOKC.PB=RJG\IVZP6,6*AG<S
MR23#16Y/>@$N>DQMTQ ^O)=19P0ET29:;N498NYRONC9.;'D$1<_C2+2P24^
M)_SB0NS=UI(T\6SF%/FQ-"VH>@%W%=BU V/6O(PC,A[2+/2V)\0^%=HAG1,+
M1X5>E8SIT.F*"O-2UY,V-;]$!$K!<\6C="T[9^TC^'B7)9 D[M[!5+:,YA+L
M<I&T1LK.UVSRF0M)*VHVRM[1D02Z= ;)!1W3?7I5;&QC,8NK4B;S:GV-.0[M
M5H12E&XI:R"7B3 #%.1,)XEUG;@S:(4SQ92:8RK1V%65.J[OXVZD+?1R1!R,
MEE<-FPW&R9\ZX2._E4=O['%MU$,IZ5? '-@:B47#72EOV^/D5F-?O.9FGTED
ME?\GB8/+L</=CV8K+KVZE@#'<4(V9%OM(.*LEB')*06CZ"] "3C"#VG!2Z4'
MN':+*UN'/&D3QI(@\.XMT<6)+G62>U-54Y :<GXF'.G4/$:N:R"NHD:F?+5Y
M;R@SWW# 2LST^8%N ZFOA.@_!QL-[X+U7@: -(R9CVKY]LY:R]"WD;>161%[
M>?-.#>R,_"O2R#$\BS!(M[D.DQ+W6PV,3$3J^C.GQ&O?F?;NF6LE[[4=7P%I
MZ!X/]:4 W:KHO;&'K7XIUD-!BD:^\K,=_*#Y21_4(2&"0T<2%&VS3+"I1^D7
M:]/FY 2'9[B*XB8YD$F6!F5JK BYGA1_==I.VE[Y/T>YHUW'UH^]J1O=;@H:
M>T*D'KL!/JRZ-OXVAL'"X4S6BM C75#D?@UVTP+B#CIOY_SQCJRG[B ^BQ1B
M5B,^/LR.=^W@3T$#E]5=FH7DMOU3X9.UQI1&JM7(K'"2TDW:SD%ZGY@J@:G#
M0SX9*2;CP7!<N^7!7H?Z%Y:(.1?. Z*>=_SA^<C:Q)!NC;OHE[XI&3PP%:;K
ME\PF")Y ,>'8[@X3F&2U<ZLUC)B PS"?,?'"K8S.56LJ$V5KE%%9LVDV;4T]
M-7&34IB$%I]G4$A_5\6D/7XWE2HN1YU,HY+!=2];4%N80"BN8QC9Z7:\E!<!
MI61+P3<\!QDUL5R.1<HL\IV3":W>MR\;">M7-#JPIW _E20^U9C:QW_G 6R@
M'24)2XQD<O_H@"8ZZ'4>K2C3E,.7VC!:*QC7/N2 &FH*>+D1MQ>,\YY7\#!A
MTZD>W"-:3FR[&+_;*\!%^1S+\['B\\%:0O0K@(D%U8UHWT[>KK"A%4VUXB(\
MK.[%:ID"$%590!GJ?OY>X6+U/J'[9OQGYPEES&UT1  1U$/ZK@YC>&^2186.
M/#1'FT0RI@_&32F*I<('^)HCA5> 2>"2F!*;E%$']S7)6,M/:R+E +MO#RT)
MV'1W(>)6-O/#RMB,.:U><Y,U_A\2"5BCL]>)PJWN'"0:VN=+X0/GN(TQI<B4
M./W&]95<2VT !VRI6KIBV69;DF]$^:](&K]A*QZ %T _DB_%GC.>W_^#[1=8
M&L=E:FM2#'O"E4QA14M;-T/F#WF<!"EO # )".WP^T+?][@6+Z>UTC=W"ZJ.
MYAS[%8"6:ZO>]&Y?R[_[L3ZUM)+;!)G\QSCT"K+#D1Y8ASF"GX_ABJG0;*)P
MN<Z /1EW 7Q=4B0JTV]?\><;126=TURZGVCG&L9$+3/B,%;%WD$./4-VL!*J
M.O%"KQ..'D:U/\U62[S,W29 N!ZOY[LSWM'=?/R"KH[&4 *+W->BSLL2YQWG
M!_6Z)3GKGQLI9=,4%H]>;)_%>&B913U_Z"*SQP!O]=;23,P<=3G7[M:Z39!=
MX%ZTZ#9F'VA*Y52B%]Y@.^S_34."/>S:_2+DR?,*,)!\!90Z<?QS'^#$_B^*
M4K WA/#8<:=;Y#AH)I[3[EUP^J'Z%9_"/2#?[]J[;>_RNZ\6!'%LVI'2-^VF
MST^TE-(9RDRTTOD9/&OUY9X$7P$@W+?-KTQHKLURAH')<?B^I&R;=1P)VXGC
M=!W>::$6#0F%(\4K;R".3IX284!HJHF^N&]_NZM9-L^=TDY/P,[49_-$:5/[
M47#L/#E(,34Y"#NRSK*VY-G^D(\1\>%0V\XVJFO,T"#JC@C%OG<Q]4K]=\_=
M48^[>&U69^Z!NMVZ!1<71K*C[RF-J*G==?D7/UVK;4U4'1IDKPN=!/\G+DLS
MD_E?G,6<&86?Q&!$E-[WBYU!ROI2EA8_P*RW/ 2ZMO>3W+T"IMJ/8GQX;X#W
M9UM[C:C%6[WU];87BQ*[.'#^]Q1O$%SW_5GB5I+*L:VB^)4T2#PW=8'.;R4M
M#B+TZ]ID@I_5*-\O.(+%^-9A\-ER\.6#*^-9^;Q^6TBH!MH#;\4K0.,5L/:
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MQ#1<V#!FSWGREI[FXU=\AEUO0&.PF[TV[+,"Q/D<U+BJNKKZ1A)Z4^*_RSB
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M:(C@J0$6>!_[9U3SPY+\F=]]RLR!NWSK9>2'5^XWJR3HAEK*Q#;VJ8[NL3O
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M"G<.6B ?\'%2E)806'*5@Q [%1'CL2\]&XAZ^ F0T6#%)EO\MHF0Y+;@F1[
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M&\@9E7DH+'MGZ_+]NW1HCU=LR$(W$^(Z*@IO?R% \PSK*>J%XS>@*O=I,;7
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M-9GKN&31"%6>%**X\^YY%SI?84_#:6MQO\$ 0*#>FAQF-.@\D!32/7!5TR3
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M_*DU[.O&1KK+X*H@VY[S<W34C^6<50[*\2FZ;;-%<W6B_, 6N:I/KI"4LHJ
MTN*R5!F\;49& 8@097PO)W,:XOCV54L3*-U2SW>H/*ZIMX"3G2]R.FC3#4$A
M)[S9XDL.CM&P07I72'L.\)I(OD7>*F\"]_@<970,_E69&:!=,4?0R&$!KI(6
MB(_Z,%L[CH-WG5WN_/$<GPT^^\9")H4 *+'#7F_(''[5Z(F4?S 6HZ5//$[
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M:'R1EO";W^SL/I>9N8$PE+AK&6O0X\OW(_I(.6@*M^3@$R>B6MIJBC'!7V.
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M/X7JS*YF.A%Z^WJSKU^DOKG8(NE$]C\"GW*E'X&LMLP'N('$*LM8QPZGS2,
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M^.];@1@H^]49CZ521LA8G-I;W=!]$7"],_^-(68OE8Z7YXK[Z-AL'<C*Y!&
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MV_7/>B@LGJ)\]W+XHAA[X9:IXO.2/7RGM>I53:>58!KSFMH&=WG';VT6U\^
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MQ2_8;4)ONFVTV>87]R4,Z$.TFDN"W-RV-+YJ>/[UB5G) Z[)I.B!=J7!P^]
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M>6OI;ZT0$>Q<*OI^7_*76":8NH#N_\6$!P3K?V7,3=?;'M5:LE8S@Y&1;@W
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M%-.(MD:<5;=:E2FG0^:]U[**G.0<=0J*/E!LC-F]ZTNSV9<WF[>,>E;-TQY
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MLH0CR3+XI_J4)(T1W 5MW(^4OQXL4+,J)T1T%LU^THV?&_=IEAAI(DJ#*YX
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M":#O0PXZ_V@&N7T])?$$P(SJ0I&QKV!^W&DDR8'@+%G]>G5\F&3TW:[<#L[
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M#/UB_ -NQ78Y=*6[:?;J*RM]PM6\]N:B$I2NG .*Q-,U=>C5G+Z@I:=+^<O
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MO.[4T9*F<_V:SJI)'7(2ZZDL=<T]XQ]+OO1K@U-\?<X89S.BC:;J*G:UU>;
MZ'WM>"HKPV?(QY2[ET1)5<3B![!<$&!6JGK<8RQO %+;\!D[KC1;FP_Q?NKZ
MYB* R^X%E,]1?E\V*KBQ5?]>_;CE@WNI0>0IP=++(G2..5CW:P15=^"P)V,D
M*:H45BD[D32 $&ET?^5U37TS8JP]05%!5?3BW,V]X6EZ#S+N\:^50-EQ:,K(
M__DWH*A:=<+I*[(0UU#<SUKAA)AE95S1"5QD2;14KBN_]1_ )296 U]50P03
M=6)(V55GT8MOBODM*;6X7#LI2@"G^PH+/\E1EE(Q":JYU=3.MQ]W0@@>U'89
M'E2X9M*+)_BP!-+=Q3!*B3WO8P%84Y.LM/A<>8Z>-,Q=H4S<A^RWG%+T.*._
M!#*_\8R9H*2KRRZD"U3E\<#N-F&O?8RF'<$_#>PFH\21+QN$2;Y=G:K"1<<@
M&0(SNZJS'PJ3+^ _2)<7WW] M%^4?A24_Z\.R/X3 2:-S_(7_MW='BN#9R&5
MB*ELG)C_9NL];EH;DS'9*=4!"K]"8%SE6IYH"4_OK/AF2!=,8,RIW3[Q8I1H
M=#;OA4T>K/B4=]3T3KW@X':%XC<8$F9I>9.,$_\).\JK\IPRM!G:@FONS=SO
M&URRM%G:NFCR)-;COOHB>$NI\:_C[OWKJ;5:WS<>R)4T4T83,R@:;$)&T>Z\
M9KL>OAX6A?N ,Z:[8^,D$G#<C?Q9]!SKP]?,2W\KUNHKG<1!9>A <>*4=Y6J
MYTO/ *LSMEJ&)T%.1$"PWN:U(RD_^I>Z_1!,GJ@9!]D^[#$V4;UBN47C0PF[
M'F.I)X,PY;,EIK*"JFDAJ8+ <@(+RU]$9FBR%+X=(Z\\,=>S"/6D$+$;]U8!
M5\T-VJA!1$)^(JV!Q3H4TOH8#@X6NOB"'G3+/U^+F-_*")>5%O^<=RF,1;MK
ML"U>Z,]_!M@,VW)')02<26YO;5F+0'8@AZODSX#-3>EG@)?Q#F2+9U9N!6.M
M JR:>7@F?U]XMGR=QBO5.K)-^>5GL$JPP-7!!=67D'O2?@3%^#. OM*H0KZ=
M3/#LY&I\;96T,@H!A-2B;]=#4&-O?B4$BP&'[1OOZHD#Q%M8QWKPJ!1#&_V.
M"L&HOM<9!US3B%>&2W]2_W0,LXTR2SK@KI"\^W[;*\I\ AGTY6'W'.:UCKD9
MO&7OJ@I[1_LF1GQOE?'FT #W#Q)%:UNUKQMM*#(^3[/QNFEB%$)SIF=#MD5P
M;7/CY:\3-B<G-I2A<*]=?_RB,5,7OBNB457_$Y@A?6OJYV_=;T4(9AU?I7PO
M'_E=W%D7IVW/%MRT9A(VK)+8]0S +K>"9#CEI@W&67%PQ(E.X4!8L[HK,>W,
MU3^.RUG=4EL,A8K-&>91_KHJ:\C\>$:1F?%JNBYY8I  F*\BAOHUAMUGLR1W
M0D\WYLQOF1188FB/S]H0SIHZ,B\7XP\UG?O.CCN0H6 21>4W&_/J0]>")J3<
MUX7>,)N\I:8V<"-0CI^^I5GM;M2-;<>13 '$N(7R@9\NTIRD8S.;*LFS*;_!
MNL-EU4Z"9TJDKP%_^P^':\2Z3!"S 2ED(%JV>5&?/+@WS1\RQ9WV>X8G1C9?
M$\MM8+%&7/B.YKJ2K=+VKMK9.7@=:"BF9R@N7+[!7LN$"D1)OSY!Y]F8'I=Z
M_$;Y3B]/V'W-\_)EJUY'0U]?(N,5=5SP+WC9_.&?($R49P"FU#[%BYS1IRO@
M<EEJ0Z^7:=;)F*H44?S8_],TZ[_%B[,_6.K"C7GMW9RV'G/I%X;_1OK)+8B+
MHU6C03>Y=R,$\S+*YW#[D6$.U:ZQ9FUG*?<R3+FIDCQ(5-91G=GB3B)Z3;KY
M.3A:5*5I\KT.V *9#H&FXGYW73IEU29-/#"U/8RI/W:S*T^@E0J=V]?;$OCR
MNJ]-<41D7>ACH^@$I&P$Z5T8D,B27PL]+E#*ZX$W[RG/A.)\]]T\(V5;>ZS>
M0WHMQ\.$2U9W.T%OSWI@9(N753BAJE%U+]'H7=H?KTS:<(7JT'TT?$N*5MSB
MBE"0(GWY8)&:QE81NE4LM2C6=:)K[;%7FU;PC,4S@'FX9=QT[%HP4G:;B]M'
MRXTC,2H]R/,X<4G<(6WW-XVQM@FP7TB1%G=# 19J$4]KLE;2QX\,+9V,,O?)
MVV,GB:$AT$^NJTBXT/NM&:Q4W= D9]G4HF]CWK$/_94EK@$T%@]D7O&"3EF(
M6 0?J \N-;>W!&4FC5*,FK6DVS:0K0ZZQ>19/'CE\.15>45MNIQPQ#^0EL4J
M,<_DO!\,YHYTF45:]$X=K*L6]BF=RGP@>MG(YGCD__9;99KJF"-;^O8\^^Y3
MMJQH<3GL'*>H1)G9)U@1M+/"P#CKC7\4_<M%8C,Q;"5C7<$6/70]BJ*2>4#C
MP<FJ$Z&1B=;X#8$7J8"-<7*4TM?X]6SP?3J^3+O!XVP^1*9+4YZ'-@\R+]P&
M#:I/65T@55\TU).P7+_M800\S< %-,D"G7LXY[L"G\+M>5JJRW/>-3WM3'#U
M2G/IDR8=Y]\TA8<:2-\"[4[&2_I5Q,D?-!U?JM<TG&6FL/9LX3'/2^BTA)AO
M$0X-O_JH63]UU=T>#NKN.,%A5XDA_IB#2@K./D@\9%\R^O752YGIS=<H[OB8
MCUEF;C+UP)B,0F>,524P75M6Z<%CIAB&#=@PM-;?VE94&FS()U[H4ZL\66<_
MVUB=/"/IBINVP_+.Z\C$WYK6O!7@I?%_.U%M<J> $-<6O7X&>#X#\C*A_-2O
M7%EBL_CZNAM<YGG .8=C.KH&G55]A\$>QNA([ESGU^5/:C<S"-N=B:[?;5?C
M26N4VX'*UY5<7'^FN]5!^=>?#_]H1S.).*;R7#N_27N%-;R!-7O+ 03(O#R
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M=+Y=3+QW$<7:*TO.A^;/KTH+5?U381 F]J]J:O]S_6NC>L._-#MEOQKX#QX
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MWQ/-$.RDPCSY0!NI<HY,[/AMJ+Z]&Y'6B@[Q-V"'.6-)8C%+AS"71@'0[?Z
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MQ]W%5@.5X&ICBH#1 ^;B_5G1<#S'$X$?0!WEG([\T7ONHDG"@IBAUQP:5C_
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MK(C^*4_+;ZQK^(J;^MZ[FGC4]#[&CE:#V*2CF-A8C!$I.J._2[8_*F&EU45
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M]B.[O6=\[ZWJ5V,]:>#VD_!@KQFC%S-TZA'LA.A/)Z)@5XWH(O.)/,')YKV
MY8U7>HKNQJU3^;2_MUF@1ZW?MD&UZ\ZOC.[R=",&9A@XG"@#LEU)K1/L\5O#
MUJ7J&P.X@GF36//%*SA^TPQ" 2ZXXOIR%V <GPI;.\\9!#'DS ALZYZGUT/1
M,AZ8:DL[2+$=,:$,W125WZ.#O'4SDOCQ..E*T+?UM/1"*!#0(S#!_P&?IQUD
M+F0]A"9%AN*UYN=5FNQF++DQ&*D_2@T3+OH%II2^*$>77'T%+\N\%3B*YXZV
M=ZQ<,ABL?@>!X.A<:7DY9)5@,?6QG9H82N58_%1HFJ$_*)5>33O,Z-;F(V75
MEHF9&V2I;1DGR?Y*<4#CX&AU)(T$!TH<2D.;(3X%C3, FNVG.^I L0.FN0]S
M8_:,==\BCI9D9UFA6*6AUE:.W4B+Z0BB+A_8'UZ_/XJ%^S-X%&8K!-ZL72(S
M9D-R1NC#3WP5;8) !8S-5& *R.(]-1O=$C6VM'RH$N8>LWXKNWX_>[77QUM7
M*L[UK:X7 Z'S\'9F@EK"/$_S[5P,6KQ0@3##CR$\#6,MUJ8N5 Z<HHGLHR_T
M8X*^H9^!E7^LD$W6":L-',JCZJYVCQ#N1J G<,UMD:XG@=@M^9C=7GG8TKK9
MDU"9CVMPVX\V[&F]_3V:X91 <*)!"HRZ>GGUW^L(%?UA92/$'\C<-EQ],=_[
MED:TT'ZP9TAGO2VTE4L=R-90J+]T;N/=QW5K9-I@EM5139FOZ9^%OC<A1_=G
M/@/>D%PA4?V@G1';T:(,5)H1)F\GPQ;E3&U]I/2^N4ET<)/[M4G59/ TIBP*
MYM7?1":ACBLO&V#GZZRH&)2?< ZN-<>B:VK4>O0P(6(4$XJ'T^EO4W;'V"V?
M1EPY\OKSK; FN_=I;<CI5 E9JB2.R\'/T/T&=!5NSK-$0"M-P5VD,)ZB:U^I
M+NU@1?^GW3<-'$3HGNQVV!/$>NI;'X9)"<9C5ZB#C"M;O19DPCVB):9&SF7/
M?V28QG$8\[('J<D$?[[M]9_FF?" ;M='B8$#;AVQ;]9,\FF$@FL('4W\$T]U
MNQ@2=I7^;BYZ*>H?\^])(T:-!R63D^\Z29(7U!*+.*KX%I:CF0T_]1&+B).@
MSS3[CV+O/3C4BW5&^A9A"B54F[Q%#>??>PG W5[Y7>"C+=,.LOW\:JN@JQPG
M1D..N!?W+T$+=Y3X"K6"8GD;[M_4VHDLMVG;_R7&]1CV VR)#HNG#BN7WWM+
M%@CCF3"O'Q':74Q](M\@'F>VJ19E6'+(KZ0J23%90SI?1SPV(O94RLEF,Z^]
MU<Y&$@M@J#\(\CF52H2&>EH:^_@?D%WR;[#MY;;Q/:FG;AK6YP8R'1754UVF
M5Y8A)ZY9C@1<<MQI^>[0Q0J=:^XL9V8P?O]W@U@.N<?NP-7#!VU;\_4,,K7D
M,UHIL&F:!;YTCS0[9W9,CI+8U?Y"J9V 588]SW;;*+.]2YARF*V(T]K'X-:6
M;;(QG&5;&%/0@MKN^.JLT4:FO?*<!#-IF9_MW';TD,YV[>'GB,=1Q<N!T7>B
M7!S]-Z/KH%/G &"1[<W'C_5:4;.JO49T5FQ$K1*W-,4/FF2X.#9^$05"6J76
M-:^E=SS,<%/EEEYZTYI^/U)NM23/-.JO<'2^0$!XDYUE%J6*FW4?_OYKY-E3
ME#SQ-#]9U!@)D%T;G8B?_C(CV:_JP4 I3[^*^ *=?G?TY&INW@U].NKJ!#59
MAJ>\/Q7"N*T.BW>"TKKXZ^5] 6@<7 FE@1R:ZHR)7_&35W<#,0O2U-337%:=
MFQ:>8 GT>:Z6)> E_*8!',DW_4)GN#DPY;Z9I8=-NUME3]?P^- HG"[*C.89
M;=#-AQ\\@-#7N=*HTCAC7*M3UI4Y%;N="*I)'N67# O'TP67.K^)G@$^ BZR
M<%%L;:D +C"Z'%?.;#BQ1%U>4)8?OW:[C9+C-J,^\R[?@/D.^MF3J]+C9YW#
M.VW+$AL]WO0S/:57]5G,S?T<M*?QKM4*7KVZ(2=B)759F+8-?IX%V\>)=(/=
M8%I=YOS-Q];:?8/)_JU]*7?')QM3[(6$,MZ-HV.G!V\^S?8$M3>^DN^QQ;@2
M2A)G$2^:SWKX5N4PEVW9^JO$'#9#^7?WLV!$4_/[I%8%Q1VQ&,D[EHG' YQ@
M)"."IZ7 ,<$8NYN\]6.RSZ$8%E]E+%W9!DORS8(,\ FK]PI"P.TUJ=U,ES;@
MPQS0,%,+=TY_67MAT>L&E234CQ35G_6/)XA7),R5K^V4ET=7.AYF/0ONE.7;
MJAJ:,U<4CYOO0*>&,'N\$_9@TAS*Q$*CU2["J@^+>CNRE@VJ8>0OXS($ +QQ
M_B<BA341RK2%Z;?/ )'":2X_Q<YBOZ>9R5/^1[+I2%6(1Z(]9LJK=/.L;:-F
MG9D@DO&K[J2$95D/YF.@T[VRZJBX\ME1+'T"DG<"8?P$)KG;.<I%5I#@;:]]
M,\I7'SLEUE7U_XV]MXJ*L\W:!HO@[L$AP9W@6D@('MQ="G?70!$< H4%".YN
MP=W=W=W=W?^\!_/-=*^>Z>YOS=?_',S!7G5XKWJ>O>]GR[6ORY\L#$)>9*^F
M]I TK2CF2FSX;RNKP+G<7%,H5$^F8;+K%B<H3X 4!R@.A9^MPBXPGWCB9Q#,
MM^I1>-;-_"-%_43^!%_>B$GA '4A#/3PD#;CMN-^B2?9Z1[GJ-4CNZB9XQE"
M/;-F=[+3#LHVU.L$32G (1(GG3L>-PN%K80_)05]Z"8G<B!BR/.2K3G\ABR0
M'^/!BJE9[G#MB% DB)&'TFLZLG:5:X%<\EBUTL<(FZ2-^.E*&"&G7PHJP>)!
MFWCZZRY7I.MJ#@8\[PUI,UC+V8:DPR7MRWQQ% ;9KT=PNJ4J1-/8394*I+3.
M+0()\B7#ZCVAI\SB^A!U*>&'*EY4E&T,"ERI3@.C>WH,.[Q?U!T;]M:8#*&L
MCR(/@.I%KCJ'WQ!&QCV.SP+]QB>!.^<+-WLDC=,_OJ]79?G8/KJ\#C6.?G6@
M7%08GH=GQ]#WF<]'Y63T"3D0%H.%1+Z! P%"1Q-@"R-^"%'8$[CH._C,*J9J
MF )!NKHG$U4,7*: 112HTT.G@7D#W!1H:'(3N?+(21?V4;P!2H4[8G<-*%!C
M/"@+X>MS-%3X(FG+K='4H=LJBMGE&<_K?KE]&_ #P/,(O,;A_=K_'!VSYN;0
MMS%5"N I\0=13Y'__MB__42F59'_1>M0S-B,5*VCCF(7>'\$X2EXQSA8@=*<
M.)SRG+V$.W5O!!3O661PN3+"@C>?CVQT[[^F(,O(0"L7_:TK)!/T(1#?=S0W
MM*/'?.+_&3".F^QF/MS^T=2,,A8":Z$H*Y5E@DMEZF1-(@P?A0:/$_S]Y$Q;
M_;T4-8$"=DK<*%3)4K(4N8'K.O:X,VZS:>(0GRSN@P (,KU\X3\"[.UD;Q=0
MS@PM [$0QHM,S^B2XVCOB_=]%%\5?CX0EZ"(72T5L]K]^*%*ZF7B64@KCF-V
M64U,X-IZ#R<EVC(E48E6-$UC/7*#@#,_?^GG#Z?R#\\-A_3=7!.=&@6'8/JD
MRI]GF<UTCH<X 8$P?TE3,; K#_F0=7&U;+6 N^\P^<@;_%:,=3#0YR:$WP"M
MQ=.%N+A.-<(# ^U',L*P)I:D1!,W LDM@O#@L\#%KHN_]FZA!B.1+;6<;"<$
M1%RPT.+OP&V1-]L^SN6E[K$R0A>LX_&7F+,V?%^C@-+<0M%E>6& CJH+2+#[
M$;8>LN;8<T6C,G;DT]&CVF%E8Y :2GZ42#^GVM/7BNE,<SN;C_41C24AJ(:1
ML-H+[VWP%%NF$'D7<)*SQYXBHH5)@+B#H<V@W%;JNLK9#V0]B)=4SQ"10N4^
M0F.E$!?)LNH&>?RFD*+8XRV*FPRT^+"PU</5TX],U1<C!/L7]09@3*7Q?] >
M8.*:4O\=,WB+R?BGTO?R\I]_FFFDA4Z8**LA(5**%)X1&/J50E:A#TOC^3TU
MQO,3R=.<HCA=S! Q:R)5-$CL<-0>?DL846!B2?CJZP9%A P[:;N:>/&F%9.0
MB(T:O,RO.EB%TNFTU9F.^^(>OJ!8AX)%C@D]B[K#U2^9=[ P!KX2F2>OG+MS
MZI%\"--U\!^@UPYTG7^7>;8$14^Y#_4@%MWG$<TK[E1&8%LKHV9LQ9.%GBF.
M;7F0/#<A(WNSL3GZC$2-07S3Y:P2/+C)0Q.8\P'8$%9%YC,.'!TL89W;LAUI
M@4+."C6:5="58E7P.O8H/1WN9X;B4YVKZ+"D&UT2E=:=8W"JFI&/ I]:M)8N
ME!%MGL9PV"YK!PQI7CKNRTM-\P#Q:;0.:B7*RT7*U?V,^98'&JX4[]&!M'"$
M)OZ[[7-O6%3=HP*BM?.X%>[@DNM/WPV#Q&/$E\$>L5$(U\1SF??</0F-M;6=
MEX>T)9NU-$,;BO8JZ'MZ0D3B)5]_1(F0R7M^@P-QG_Y:=R8XTIC))*"N1293
MZ'! G?ZL024%HB&*VE:)VW@$A]_DQPQ].7_VT1#&H!/6DSCLWLL8!2/=H",<
M<7OV)M*UA4BXV=$%?44QCK2=V5/)IF6HM';^$ZE&'_[!IB;T<"NW=J( E07/
M*'D3X)4>W-G<MQ%>C-XM^Z&BW<SY6?I3N=U];!Y7\;JL-*7NY!<_%[+3J^<J
M?>X#[K/<PUO/ +#GJLE/K_7=1KHC.(A6HRS[T6"Y<^P02G2GHAL=45)ROO[2
M89)+RTV)GR2-\'[[+:=EPV@VO0C)-=L!GJ5A=!8_$O>J7O+/1PC#KCRV6,&"
M58*6;;8;9]?BH ('1$X"=!^NWO L>X'B0_+C2Y-XSZ ^/!(Z]0<$A^L.W+UT
M@NK[S0NJM&)X5OTEN/[3H;5+!FVEB<>4FQJ]0/G 6N['L=#-VB?5SH/9(M-$
MW'[E_?H[SC.L_KOA<2WR(N&MNY$IQS1?MVO.[5:8>D&">^TR]\!/==B\D/>"
MV3MDA9P'@E"-D*OV1Y6)UDO#=Y_EI,";8ZU.TGEW)$RXD"!V:B%W/,&L&%=$
M.PK2[XA"<5(ZY=TL&!(;9PAZLO7>61LH&,P>C%T$S_"<2>JN7+:#>R/C7^QJ
MZC?DJI8#\>\L'X\F6XWN'7)KB[=*N3XU2.J/13W"[CULMJ:=:<UZYA@&:W&Y
M"_4.OP$Z-<W2TD'X?ZZDQ>;)%J^MB!_($0P*T#OTY[&GO&2SS4&-%M\0-O\B
M:!HY'R;![I(J+D&YJ#[!O9?35 @TCD);A^Z_-O)2+];2T];7+KF-[1.0G=@R
M:)]#/E]4J:L*FD^/?^PE*N@X5?TB)X1:!";<9VXFR!YSO;.7X(P;2JF.=ZP6
MBVSE*=.*=W3C/Z#.*'&&"82) 1#'6/4XK^%H:CQ;39^6,8,G:)@LJ5;B8&PZ
M:*;H/<JE2%$KXA).YCP#'^GZ(8<[J4*8XW/ADDS6@AQ2Q.<9-:^3K-76@KKE
M??+R244Q<J\!ZC\3&*X$0V#8@I00!/SX)^>0O7/0X2Q=&T?C[)RH?Q5=Z"U1
MAJ]J$6,<YKP!$$G@0;J0] )MRUJ,-<V!7>WAINAS<8DM34X;Q683-[.&O37\
MZ[MI#GZ[C]"RUL;U=OI,PJB1PV2=S82MP1<^6:5X(64X=C_DIF2K,*=&$F B
MVZV%(KY=Z#H+$I'ZT"_?\;\!_#/^/'GW7P>W%NR/ZD7/<J&Y]]Y%@6.#17VD
MWP,]SCJ(L*F;"O0Q+[L X62NO&^ !:NYFQ?^)VWAMJFG9>%]P1R'QUG.]#.T
M<+Z7B4M93[O.D<];QN/(<9?'.]@OT2D??G*C+ BM=+Z:-D],9$5GVXMFTK??
MDJ?;.'&F#KN]O\2)YT(I 8I9SLR$&SWHCN6=&?H?5R2[Q#'3A'U.D^W8F7%D
MAS3<E&@<E[F,")UXMN;O:%M\/<!=%H7;(M%L4:_EC]93I^D^PY*TF1\"F&-.
M2'?#B:(0OWYNL9.?/JXY>V?AZNG2S;;,]R7HG4-\),KA:N*BQUV)CHY<(!67
ME<69>RV<^4;M%..TV;?HC;67+'X?@>F[>"7+WTL$G+P9(>]4-U^6!!(?Y(#P
M FY%? --+;681VQB^1KLT#N?=Z7R#$2@)$DSG''&5K79Y.T,*;\N(#J!/[J2
M?2%Y Q!&LLM_K&LD1!74L+/+]^N08RL16$K4>-D54FXO."5$)>]5]5=*4&AV
MUO:^7S4(%F+MO&C?6\-EMYC52IT6?Q[P)B=I'_'W?QU$PSNT?!D67V1AGGF/
MSQI$=_G]*+8'#TVY3Y#>/5EJ-F>*XX0JX'Q>7"3%F1< 2_95/55ESH^SM1X3
M X15V\D'HL'EBC5Z3"LW ^$/R;/U"F'KTFD2.]K*[4V3HM=ZZ</NCPLQQCOX
MOP&^A3&8TL;C@T+A<'%H2=N-PK;,/-74R/Y\-#_]>_-F[29)EM*TU0WHWA6)
M_'I@A/&29:S6@5;,R-/#]1RK1\ %S6!)SM-&D'='J?9.XK&IMOW7'A\=P:[T
M,C0A^N&IW:G-\=.X#?/)=T=N.,%>=KW:#J_D(O# 2_KX[I;!@7RN8 '"L&&3
MAL8X\E::G)YY@/!)=1JP2JU&$JZ\@#J6^]DCI/DIX V0UD5)_^>+"48:JPHL
M+2LE?9P\8'(+K+VR;>[ )L5SW/(?A:<A*%Z<?)B+$K- *2^@?Z\.L6,PPO9O
M^.U.Z=QG9^DMN<\4-V01OQA8TK,GR\O=VQ5O?AN#MQP.6@O+LLZIKB:EP"J<
M1D(TXWTP#@E_ ,VC!4][)8U/I"%[:=?$<_NY)WO/I5)?RK'7USE\?U3[XL#H
M(.;$%#$^X8^(2;CW$<ZQ!-2W0DQLO#69M$S:/SL#?YO[3,CORV0<LJP#/2L&
M _!?HDEO=\N9RK/YM'I0^M1?8J1I2%$>[V:(7K\H,863M)? .5/"=3[ G(6;
M$Y@=.\2:#Q5J38HF@<_[3+?(H-U!LJW4>;Z2B:7K,=;<*H':5-_>?MU+YTRV
MR)Y3X\4O="]-*GSW)+#@^C(;L/X@NL_J/QU]IM58[[506IWK1*PNDF1*\M4J
MO.!Q&SW/ZCT'!'^K,6;P@$-A\XMZPV#&J"C^1:>_?_C%@3;A60+-0J:D2?QU
MA1687IXI%CI^9=Y@_6;4W"O4NDLJQ"(AUOPBQB8[PK2.[&H$D<)L'+.O;K(P
M+\FE@[J0<H1DLHDIENX-$&F? TD=PKSRA-#/!L$H+W<)L/6!+YOSI+YU'O4K
M$4%#T/'Q2PXVXG>U"YV?9+*-)S_]E'#;"=4@9E7MN ;VFA^2(%]9.JWLQ[,@
M7M*TN01(\F+&()J2^:5XBW'-]@*AE6KKJB@U5]^K!:2<1-'9K#_Y.IWY*^F-
M&+($GSS7:TF:SM=.B+O6GA;[/U.">$_\5:^GX]=4?SQ)(P8.APS942Q[%/$,
MT:X;K'LZA?&A%_PP:B6/W[QT8TWVT","MA@86^.] =RC'T"S>=Y:!]4\J5^L
MO!C? ,9KSTA/@WBDRUCPXZK\O[8;6YL2I.OJ6<_H["]6/,@EB$FRX2E!,!>3
M95+,\=^80YAT%KGF0;70:&2N[YX^&<[5L@LG*/<_BP%JYLHR-*F\(?,>>"A]
M-)2>3Y"MI)-G1KC4C1\V>BL)=+1A[A/VE>(: /A"F&VRSOI(S)S",IV< WJI
M9C@LV5TN+Y,6;_0-W;I L%N.ALY:EP-5S"!7DR079>!O_#X(G.2> .%>_K.X
ME\;:'<^W-HK<M%DFL$IC3;/NK*N8\@ -T;8):O,+-(K7]FT.85QO:HY^2>EM
MZ+$Q1DZ90YOK2FYD[4;LL2R[DGK#S ZA-5MR0;3:YI?ZRP08$Y5S1WNGJ?#I
M^,J#VT?8S>6E1DJ3^%,Z^5^CW2C;;X#WQ^&>V^HB6R[D";)\Q!9%HLQ/45TG
M)6N7E_B^3OLB0BQ3)(<]RQ1:,SE3I^^2B50DXO]4D$R)575"Q^$^- >: S"S
M8S;,N18NM_@KWW[?^9B'["'IVK/[0_9PW53TJRT/:S&DYR[$!09 R8.JG^5P
M(6@>,-_#8,>=\1PM, [?QY !&0VQ/R_L#?'_+CWEBD[_JBJ3C#=I37D!+4TY
M;23*.>3_G=%](-P+(*AO#Y35FER=G)U]839P-Y-?U?,8V\6#L5]J"S$ G?<R
M<'RVL=E*._T3(^XA#L0)VLVY\!\J0:<0-#:',"M[+R*\01=9)2;>A?@9<CQL
M%E%F*:3\I0^Q]TASJDB9*@! .W0-R++#=-HFNS9(HE5LK97WV^_HV-$M_RC)
M \A,C<(MDVUG&&V.PE^#N;]EBU";^5LR"8#-?X$?F:0?9T=ILQM,R2Q_:O<6
MWR4F_W[^<R<V:<JBI1<=L8[M$MARY)LLH@]"#GGO^.4WD@!-(!.[?(T.$RM\
M" (&I24_E,)ADL>T@4;WI3C.Z4>'*T_HI!8Q@$?J3/CYH@SAXJ>8&=P\9G&/
M :;OTV;EL[\7EP5@B-FQ-,C EM<D;E]:ZAMBK$0;J/%=T*MO^P6SO^NXW$9S
M)>%S^ ;R1F-'I5ZD7\WZTL)B2>H[V)3Z0BWY>A&[O0&0HBF[;4,Q7PZ?>U*B
M>"DN@);:!5\,]2;%8NC@82,9;FZ*+@S..D@-*+' 7\=AQ&9\7&'J?K5OE1.T
MD^7"HE@T?B4._SVFULMZIB0>((OTFT=/NG#4<R=RKSV?"W;(["[8 >#KHWA-
M$09P#MS2<"!P(C]5U=LB\4D5XK-L@#FU+AM?\EWW#)^HY/8NO<+!AVH+(+4'
M5LE55<O\*,R"D@G_1+JV]S#^L1*:F'$"],&V8T]PVB."J*1"**$>:R1\QV'M
MNF#BMLKWD&*U@W6 DM@>R)<4_^[[%Z>0 *EP]C+7=)$C88S/0U&#[14BS:22
M@KZJ30[(,7<QC%)XPQ*%)V%!G.%DM%&Y _S)$0M ^1:;@T?Q])VO+C*5@0B7
MN')28V"?K?,,$UW2=AUIEB]*C*;6<3K;X=<\^P[/1Q,G',5>=,,5!(A+U7".
M]D+]95X=MS$]+@YL*4N_.M/%K;=]1(527:[_)0D");9@I1QC3'\9,0#(4FV3
M K.O'XI L.60'[G"O*0H\;/3;#4G<B"$E;3'U-:^ZX.:"JL,1R F^YA>9VZ=
M4UZ2W/N8\7V58L"0'T(_>7PBBL]7.GS>1=8D;\7A_]LV"_&XF ,!Q#SF"U!U
M&E-)49AX9\S/.11_R+3*8NHV?E24 'Z?1RBD /3[PC0>H6[ZI$8C^$NS/+/\
MTPFXX*_.PXYRK[P%35SI?MTB^(5+Y2KK\51/8D<[GG TL8CYB&B?YE8")K*K
M5/?#IPY I*A&8WJ ,U#U>>D'PJS/E-A3'5G(KB_7?IG./N%I6ML%W05,)>T!
M6D::Y0NW?6>T@&B9!HJ5(%GT3Y=T>3 G^"PVB*P4X,*AQIRZN8*N'#O@KQ!A
MRX=/_;+L^VAC3;CX7_L4""QV'Z>.\YI2*W!H=2-_ES-<[.R66KF0+3X/7&L'
M8W<#^Y\2B5]QQY^_7'"FQB<+1OM3=?<C&ZR+LR&,[4PV)RA>,.<6Y>:X*55U
MF">3RW6-IRM#;A:"LFG.4"GX#O+:Q=4U?MABQKYZ%/S\M:WD1LT[YB!]V5SI
M 9&T79V>1-!=QEAXO-"+2%*CC;%0,V&ILH(^4L3J\=_;)3F4BN&(Q:PP$:SN
MT4,8$TFSC)%"4:?Z2?) D9JCO!4\O!**%SBV=:#H)R'_5:%(!I 1XPY0-%N&
M4=O[$ 6T&/ODH7F.!N^PFC 0]2Y-LW]4,F_C6Q;OLOMM#Y$O5!H;'Z'&PJ3P
MOMSS15CB5H0-9C_1_!T0_#B#QGYE0_OK$*K7PHF:0OWSW"F'$(9$X5(?D31;
M"83G0SA9KB=L?O</*U%O1C4$YM-MS?><H+H\1*$$R\L:36J;=EO&^:VYU:0.
M?XSN(/@VRT'GCXJ!L8(94V9I6_)!,IE8R[AP7T(KB[SI5SS(_)NEH?<;U7Y1
M61@G>S_5/RUL0<^C6<TQ#!;*=JH9P^(H:OK^O=O/B3D;VQ-H&/@OJP_Y<)]O
MI^%? $>B/S,M- ^Y'O=[^N@R'%IN-WNMSS?K9_V:#FCS9[+[>/-Z<,OIO#,X
M7-25:.Z>[_]*;MF**6I#F#OR@_@!BZS16^6V;.65KV?[]4P,S$W6PTWP7-S/
M4F+KO+1@??;1W9;<IBS\DYAZ63!"BYR)DN+X_ 5+J LZKF6$=P'/*%<?X<O\
MW+BZRP7L5M.]W89,++W 1&]!^R=*$WC]P>;:GU484$;"Q[+$38@R7C= 99W+
M4D'H ZX)&0(/4XEH491+S0:R."=2E/OO!?? --IQG05)QW'>7O2BM-X&\F%Q
M9"P@>P\5$OVLP>YI$C#)#E+Q0-,_H3W21[3S !;1L]BTP[7T89@6G"D8Y"K'
M[$RA!,V#M;K+YC;.OIM=Z.74X=$>Y'Y>B/\*&J:XA[_)'<*W%+08$QU_174W
MN3XAM['<!5;I/5>\X\6$O %"_]1FGQ-Q%#N01+$"(G#H"_8!^W0W(S1N3I6L
M.VJ\X!!"^&=*/8RFVB\K3AA7ZS?++6V8T?=SPP$8]NZ<MR3NW#WR,*VQ!0.E
M\SW)R/'#1=DO*L'EZ^!49X74EEG'S<*U-0F7#1N"&I:@193XRQ!.9!6VQ;&7
MV65WP2()&'7%S"/P8B@EWJ>7!*4Z?ENF7]N%KY>/A<=_;>5>L,N,-Y-SG"B/
M7IT0-,=%..W2\4(#0RAG2:LN])6F.?%9&$ML2G)]TYGUFW?D54'CD=9*SCO4
MXS/FXG3+C[ KH(C4>7K:(58>@/H0*<.,LMJ%:VZA=@7F@/W7KT*-/,J/T,J'
MKSP7I W8HEZ%@P;@%APP>7H!B55:J872]LPO];(B38I5QF</P\TW +I(+F,O
MJO2A9&D9N2VB4I>'\O)?3\&D^#!JG_";VNUOQCI;&#57<WO=1JCC[(9CAIT0
MTYA5]]W 01DB.'%E/X1]J^9)'[H5BSNL-5V+*+U#)=2\0XD/@<<9SM '8:&*
MK\K2[NF[RS<1HN(RZ,&--35+)55#-AQS2EMG_2*4K_  +RA]#O6<^^3-G=&6
MC0..(6\>+8$MXTN/Y,J6SG"'I.+SL0XV]V!56?%+EOMXK5JYC>XR/MH;TAJ5
M,X0Z<OH:->E/0(F-R.!1_PV$KX6UA^</E]N.;(**]^B[5E4<(.AW8=NQ34W\
M6[CX.9$IK?3W%M<LN%)NA$:CSXD*D.]_O 0L"";<8#AL>W]O--?CB=/HW3?X
M!O A\,J&!+4:S7)XK2 K)\A/?V25)SB;"#8"BI2%.396#*D1E[T@<9KVOIY]
M;8(<#FZLI[$WZ*)]LJS!S0QM8/E1,Q1ANZ1>WQ:CW62*2F#K3U(QV>+?"<;$
MZ[TKS]%=[#&CB='5'WXZ1=@0<R<1I#/V4XVG,=\6C3/A^3 ]B)@DGOU#,*AE
M>GW<!:=RVB1H9ILH.DF<7.0D38AOSX?"_724A.6)1KI>JLQ4F#(:8!#B^;Q:
ML[=*?5&;N5DJV#G[BB^SB'ZS_NW4P4_JKKW,-(OCL7)'/0OIALQ?D(![L;OQ
MI).,?(P.30+U(W%Z.YAOXYE]H_@,YPAS7I.&Q.1G9#SGJ:RW4);Y;1)<M%W>
MP@<-0QVS)M+MIU@Q34T-VL[3X_&_1'Z/_DUYYHEI3H3K)S!K7$XT9#Y3OH7"
M%?K92Y7?F[@UV8/D3VZ9LU81XRK:60$EK'\GK'BO9)FC::GF6>);TTQ[/NR0
MSJ11N'8-:^\=60-:<W^2T]1;Q:=)(D>J[A=^5I^[+DS54)8:F&]4H5>+58@X
MEC<KD"W5[\N3FX V(1\0"'&O-Q9B'C,09MH7IS]ML'?VB-54W*7/C^6@..MO
MZ)_G_\V[54_=X,6"<W!@EY?-/)57B%YA/TF2JT)[3<$H+VS/6VAVT?/S+MXM
M9G$(O]9U.<!N\'>O.EDW&L_U"+=64E+$;-O<YE?[FUS9$;$%VY.Z9]8I"]>C
M@OGEE17\[=<)'38*$S4! VJO%.QT1RLFYKVFA%?,X&@W<2X9ES3*$-"._FW_
M.J0K[2;59,L*R(>G6NN19)%FBHF!]:GOH\A9+_L2;]'$?;H<ZY)VU"&3[>)V
MZUCJ'-5/]-M0:S(#;S$JO5A':1GY=L<N-<4?#CZWB[8N24M@DR&T*E+YF+2O
MOUFHC2DQ<-P,)*!;)7,G-@D#\ A_'A.4CS.WNT,^1F$?#6&?RN<ZJ0OR5C0T
M5-7'S[H'5C_U4[B;T*ND\8=O^W#4IG%5_M9,XK<PY6:OWOX(I4#\I_!KAWF*
M5;X)TTEY'NQY46JKN?T&>5I<"\U@-FGX\^<T<]20N*2<4A#)\1_@7S@H_(!L
M5OHZ*Z;1EA6-\-6CVT[?R;G8LE_*X("]_',?+39M>&VR*OD3^INLLBF8"6(=
M[ &G#P;Y\]C*^O>;DQ>EVUR.&;6IIE#G'7,PQ%N9'90NVTB%ZCE)<C+ZW2&&
MQ=)LEBRRUTNO^ ?5=')YET<L@>RT83Q55U_"I+H\N>0IZMX5R!;(9JZ 0=T4
MKHV.LS'L!F+U,:*/!K%U3RL,7&2$\UI2+F[$+ RZ_22@<%_,=[[(I,,.,?S.
M F'Y#IM6#'EM$0JTTY]-=O4,VI$6@/> ,KZ*'DZUY.3 F3D1Z4!5*94=5V]P
MV9ZA0ZX''V<UUV31B+&:1D[4^GO GEL%[/?'&5GJYWO()?]ZFFQ+XD<C4(*%
M9 ?HM1_&UVM/,.Y'@?MBGT)5PV\,>1S'7D5J:U(O$V^@)>TW"^.D@,:HFE@G
MX2A&!-9^RGB:*1KD8_;57",Z'EXG)E2J@+(B<6+(V=#C_&)CFQV:'C#%DDIF
M@5#&8*1;KF]W;3\PE/>&TE/U=D+'O&(Q=^!)QY9&VX]OI,G!"(A(0S$^1^.V
MV40TV_PR1:&OC8">U( 1)3E <6^_\.C+'S89V??X39GRW>).A@+>*,] WS=%
M1C':'JD!2UI#!FDE/_^I(=#(-Q%^G:.$2AG;^$M$3>-P+&'>#]MW2EZ0H*8Q
M! GJ_ R1O!(FDB)IRL:?%?SG(IC;-S30E*Y]3GWHF]H%=M]$G1SL/L5S1U7R
M]=4=?5\C03B;;7P#(+K7]DF>5W8PFI2]%U_"0?0=].0Z#7"Y.UFL#-\BX 5B
M'AH5#KI;VH<UN3ZWE1_9IJNVZ*/JR114$C#9(6")!]AA!;8;H"L( QX-R+0J
MWL?<)<E.K@S"]AQYE%P0A\R#3*?6;&?V6AF2TGOCG727UEZBAZ,E*&6AP[>Y
M$$PHQLL%N].F7X1ZX_E4(_)2/J9M? RG&,T R#L6>7FJE6-*B<@G6GHX=*K'
M2<A'KSA7%+[/YFKAG5AFM+-N7^,Y^*#<'CF-'?[HR#?3H@8^9NB=&6"RHB]1
M9Z4=,O:>55R^\@.R'NBTY(<>,^56FTHA5&B^JZ1&[;!-26MW7(U0R[LHC3N.
MCZW)V=2VJ/. <DN$@O71<3%,V3I2.5)65FALVO_<->N\(J=N,O=X[,S%):%4
MW=C4;)WZ^5,FAA_Y#WA+/[XT*9KI)S4K/?G")G>CC9_#.+DSG5'O)>O[]6]_
M$6,NI5N.55ZTQ">;P%8NR0BI1V]]H(\WFM>Y@>8YF2SJVK01A/=CJF03<6$:
M_TE-*+SP$;PZM'XUCJXHS7G S2!ESFMH1?5^\^6,:;1+ :)-5#W#M,66);&C
M\Z7-O1=-E*5Q^V(9^T1+01YW&E$ BS&:9[ RQ8_A5\7%::KC<0*&K.W\@R,W
MW.U60VDJVJ*V%9S%N 3E9?/NQTE@WT<P5/C3;HA*H.25V#*]4BK=Y8AFDHJB
MF.+'?PMT >,TAEO-Q'&9H\BRZL;SKG#_4<=3-KN[DJ-2AGV,L837%922W@6]
M#RM1?#!Q!+<X<8H+"G*N3R+-$U..@Q^WA;XLE?X_F(=^UUHAIF@Q#%$ )+]&
MQ["!&6='<*!V"%=^+#7T%/L)VW2# +%^\'I9!24Q/&JQ4(K2IQ2P#X?>##.4
M$QO)RD_6PY.8$06>S'S@" ?/NN#=N@8(E'6=H"$YYU&]L=.Q.70:^FZ)+XX*
M:LSQ/%,?P*?Z"KJEZKWYEK#[ *_AW >WTA;1KM\'X\T.<I/+J/5("PBL\31
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MGJEJK)[2K'N8O\9^X HQVPDHJ=*$'B2=B[QDG:->X,&YUA*0K1L<'-QT.^N
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M\6GX/FYA%:01UUSXYFQ32V/_W=\7_U^!F>=GPLL8&5_7G$MNUMU1X#?!+88
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M1XF]6*SG;J[G:VBZ41]Q4.'25%E5K NY'1W,U'?^L_)^U7@2.T=?U*L\=;+
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MKDOPZ-K.=9F%9L,4A0/+^ZCHK-@2WJ\-0P5@+)*F)UNI%V1/YS] #LY0&/0
M\2;/$Q6B1Z;P7YQH7!$44,#EOB$!''H+=T/UXXK2@>LJON9U%>>ZBF^&-B%T
MZ0B?<W3*^;J8]U>_I2)[,EE.I_*'3H2X_",O#,G4WH:X9T[SMRPQ@HP\E&0P
M=,VCKY1/X-N]\#LH/DQ2$2@U'5)S:2(EABO9!)HY$2/$Q\+4S"-'5&?](Z6:
M(IQ4&S9VI6I8@'XF/-!>=$1G??YG[?'(X/!.H=SU:I2T@C+Z6>AD_+/:_)4K
M$IB4=\LM44%[6.;$I@M4S%86')Q*4,04NEIOC7J@\]D5*D;X96T@W+!L>DY7
MTK2;B@@Q;,F/: U*;;^N"9J'_-5[P&'8(+^);FM@7U<JT14VRNOR)?H,T,4_
M'\*3*U6$/.HI1Y K8.*S?LF6Z2$/*H:;2$2A 6Y97JU(Q@_)X&".HIOR*)C)
M1M<)M='E+MQ_M432?LFB!O_JE*#7Y$0WG=#51M\0F71?&<+K1LAUK92C1!%:
M!0^)2X6"KFX5#."X@SXTK1B7(P%41+UA\VST]U1$NQUJ#PY):E"G7 +OE['R
M0 +G^#,H9O01;]*$W_;L85XW6ZX;.^GAQYJ8P\/:0QCHY_RK9GJ62=YPW=G)
MQ!Q"=X?0]]$'##1LH/#QNGKHFO+OO12M?VNRO#@37RZ35D>A\HBDS+\'"R69
M" I4*"\R#-FM0H2[GY<U1L/TD0#K/ JS*N<OQ+932:#)!J"P"T:L)<@YG7#J
M!2(5%?+3]I;HCTL3P0(UQ_?W7]6/4$J$?&63.>S&O]D>"D]VRS>%9M:CU!4T
MI7%U%8T$PL;ROU>N.7S3WI?K?UNB@@0^L"V9GB.&(?L[J?#W"?,XDDI!/VV=
M"C%23\H@![7>XPP=.UPNDG,H9FP78Z 3'UY9FA%XN*1;QTE!)DW3\([NU6.U
MN3!-I=P;X5'J'72FE98!\2W6E9@(F<I[/AI-5(7>*Q(7>T;+SX:_'7\'#"<H
M+*C<I1B=)HQ2S]@ ![:#J/J64F]WW_V,!-Y,E89/8BR6C@W6( PHNK7D;<G3
M"\.?*??,HG)?7>8"2JHSP]?'(I4Z]53W*S=6Y+I!HQZN^<?:6%L:-[==O!]
MDUPU2,5_?J3+I</&ZZ11.A;K/KW;:'\@'3S'<,"+B#$%5T7C=^4]PN*4OE0:
M;'!7;-Y]^F$@+U,HJC#$F7;Y&YXU_>4JB*OHH+/E[GAYW4FW1Q#CO>-S?.8K
M;\B0OA3((>/3M/Y9C.Y%1F]N>O"F:'C.8A,J_&9"U%8A?,:V3.D@*T]0%O/=
M#[)1P]WG38<ZS$>_D,!V 63CEDG6014J< ==XK,C0J)J<N &R4Y-OBPMJ-AH
M4XQ8 \:2\PFN#/%N)K%Y=]O^5W*UV 4W<6<.;+9 ,J'A8U2Q9^[+HUG[SE-6
M(F__DR);W[BM6O421]]:Y6%!QTG=U*LO$\0'AHXB[6KRX'95TIN0"6%)!.N$
MX/B/0_'YND 3"RIY<GWE;E5K1^'D&1&]/;,4JF<L]F,&]/[GP1>VSRM#.N:)
M][!5Z$TF"1:P(X]VB5!!Z.&5ES!T:;7$F_'MH9+XXU\OCEHEF*\H:PYH#15-
M2&9[^?..>"E>(:9WW,/&2D UL<LK*U E1*Q)E1AF8^80:"7%$G)*&(($Y G/
MW_]C8+W]77@]X\[Y^V".XNC/W"/25# \]0/ABH&< KRX*4[/ %^#XC5 @-4_
MZ47$0/U W7Q@ZNV)5@+[UQXVK*=DH,3+)%O%9AH:YMLR3+$6.HGQL\+I"]DU
MIR((5OC#X7(;@HHB"MI)FUX>Z(/0K:>);U_S1M?QU%M07SBN.&^F2,.^X7TJ
MC]A)%AP&VV2^&%&V]^GWPP<X66AHMG_K?QW.ZN_;)ZKS3ZWYKB5/D1?TSY*5
M9Y6I-I@.\?@Y&:*!!?&T/PBF->$/^WK$AXKF[E@/7NRA(@>2_(I?5M+D!W1;
MKN\3</-[1\2PGW7+TD54/$7Y/=7VIF-^JWD8#BKZ(#/*XW[O*-I[27VRFXK%
M4DUK4LHB<L&M1MLI1<\Y>T$.+P@<;J0$%VA7Z\:U[6BF-O#V^>#!L<U1P%"S
MZ>[]=0%"Z";MTB<A.J6<;=_'6-C%,/CRF.*#90ZCKM-BGK)J\D;D,H1FEJZ+
M@XK&2+3-RU4 \5@7": R3$=TANF!#L6VPP[4Z]@_22I[Y(MR_9"^*P<G"2?W
MLL/U.GH>W\)_3K\/VD%!V86@> VW=NGMJ%B/XM7YL$AE4-!Q4'I89N1N;SIS
MSRM3 &-F&&:QT#[ALNFX="./5ZY8;VJ>\<5FV$]9X&09;WNJP?#LR8C96&"0
M;24!S^Y74F7I'>Z>-Z>BR])?3X274@1A>?G6^OPV&1J\'Y-R,#(D7L>G9 5R
M207F#7B\)E!15KAW\A)?><!]_MMF#S2G);A:7%7LQ/JKXX7PJVT(SK%UKJHE
M%>GO <%'W4^"O,+=F(S/2HBLZ^)J1'CM.:O9[VFOV^].%+DBL&#Q>9;N10WA
MI1YL U^%@B;7;?IQP3>I4VM%NZ6 I;R1/ ;=XL=6OZ)78][9&PZ$Y((AVM$:
MHT53= ' PB&-AH+.4,31J)Z7%\&!8]N!50IIM):2;]WWNS(+MSHE%S]ZX;IZ
M4QS-6JM['M1\L#(9T"/<\F1;X#7M*%DSRJTJU99[KB)M'-[L;';A,=I$[,GH
M^;PX)M5A\_2;R6I\7L\B7K:=VS%N0TF'-^\PG"!#GE:.YDOQM!'']PRL)B9G
M>365,&F#O>>TG,5N.V:;J;AP84O"&\N.$ XF"<F/PNR_^?"9/EV,^\,YH69\
MN%'=7GIKQH@B$[9B\%&[^U5+U+IV',?Y-,X/ZF6M31^WBRBU%QW.]CB#4Z]2
M#-9[I*W$;D5/I#3T:Y3EGD6^;V!+]]U&W(%QDGQ:AUXM?Q+4F"P.8C[Z94 D
M,&A\NMY@AR"%@L<DWWF"BMCZ,Q1*UGC,N?.T(GNPS>:K-PT9*6!Y11NN)!VY
M_?<R7GYF>".1);_.9I 4/:C0O4SO7/*NO.I7Q781J'U<0>RUP>2KZ@B_[F:_
ML&.I".;U;+4G6:+<2KDC64]S;DED=#:R@F^H0KW"0B^\.E:*[%E80@+U ("8
M6LO$@]Z6YQ/]VT&6S_GY@@8I/L2&ITWAD$."8=!V'4JQ[U8/!B2\HXT(7[0.
M(.*]XQ&@C4'7 C FAYA[^!H^LIT\$N(JGZA<^30!-EKHKZX*WVZ/ZCZZ?^M4
MU,@JQX0FD/7XLKJ%0<WIT),#:MVNY5055GHVOF8<T1]TQ9T(:UO:E5--F) ;
MR8F:'@@<3#$8&'_-\RCWA0.N[CITG89BA=*P,B-[EBZ1>SO1[?=J9O"CK(BF
MDN5GG<+W:DK,GJG'BO3T.58>Y+3VS1,9]>1:EDF=IOB4?]5D_>"EQ 3V\.VR
M#[<>M!X%+3INV2RZ\3+.$GV'N%2]E%&K7NU% I#IO:,D>__5DPII#X\N*5,+
MCV;N83@_U$-[[&7XD4'2YNF>",\=1R%B.[!I%_MOO9Q64\P.<?Y/PDHB-I!C
MCB3[KF?X^X-8&QK?"N:D807WXMT>1J:YO5ECJ;2NQ/ 3<=8:BIQ)"L]@:%=W
M<%CU+1+7#'7;HCMM(I"\8TO]C.=-#?.+^BH^@K-S):8L*A"!))/DD\C?:N_:
M7TCJ\RF=T7UBR@+?.JW(MWJW=JE56S/G\/B'$'%WD@M3+*U+1;XE*=Y(Q8U$
M;>J'=S_GLL\X@<+X7X/6F*JRJNYL2'/ Q"#9;6QS@1*FS?[V5<[MS9 ?X4PU
M.QZ ]<]GSQ@B1PLX6[!?^)N,+? '#UM1V5M*WS$G4WHDYY+Q]LU.,1Z0JM55
MY:X1XHT?;*1XP)=,FOG+T8TV[VHI"O<@?+DI=[V*U4I%</5+C@IIA!2H^@ 5
MF=82::++BG,GD* Y\HB6LP3OV'PDD!ERSV^6I2KVOHN-,4/:39=-$P)YBMM^
M'SMCN6KCJE%^X8U%&9PP0<'?V*=4@$5FJS$@$!N5.&0<%ILNW]3J6MY\)E"K
M"DYX8K;_(AP"<(]YTX%=-&["9$FAV#4UCH[WV??, ;P%8+!&>%%:8-SL "^D
M@E<=>"RD&G24%*-)H2$E2$[OTN\H-Y<_)<%U6<Y"51.(=N"=Y%K/ ]L&<45"
MG)N./[P>L;$[N]4]/TCBO^6V_AUO*EM-_GFX@(/+8Q-2&*0 5M'^/6>R'*ID
M7:/8%SFIJ =2EU)S;TR&.K91!C594^D/PA6453@O<%J8DM^!?W1,F?HZ@2-?
MA>5PEHWW2O)CA<\[*R(!PWHFXX/!H(KSD-DM[4RW)7SJ+EH$<'0B)NSGS&55
MKFBFF[LQ-KF[C\+DT&I:U3LG1BA,KG"80@(M'(PBB3)-X)6>NW/[L9+'1+@*
MN.[^*6(,UETV[_?>99,9&JO:<E 3D\78_M1/!RLNK65E:S 4U^YZO0(+D7S-
MV, 8/" V/AHT:;?+8]"IX2JBV>3XO2 LQ7>IT!35IUGIX?$%<0@ZPOO&N)2O
M/\)X'UH1&.XI7H+5_A[;VR9V.(5(08;],B<4X56P5K,0-[YDY#:462JF*(>*
M>DC.QV.V'$N$N$:?BZPX-0+0L=1@N)+3]J9%. E63RTN1AG^";99JLH(+&(A
M#-0JM!EI&36G/O%*K=5%3TR[&LLJ8E]W'A>RXFY[<1Q]7N3Q82\R9V8KKK9B
MB47Y)=VY&OMLA N![1.?!@_'9Z.YRR 6*UW=3;<4V46(O[XKM&B\26)2898W
MO27^@/V.QT&_JYWG/:@39\7Q)CMH+FI-!G(PCED=00LWKDW84B6^U7VG\M'3
M$H%X5(1<FEHK=9%J=<3=@ K<-<4:&FIJQ ;WLRS6)Z+W(.)6PNP%+F3)M.X*
M(E*(LT7B@.)TSEL5'8DNX/?4D4C :X]B+84?]BP?[$!3LC._.^7TXD=9J#+I
M.BR^&HN&96:!<.W!(+EUK61DP\<B5_S0ESH_>;X<_W;(]" QF5W@_Z2'X+3=
MN9)EJ1@#>KE2H^SP)!R'PKU-U17<6JVRI&R='FR,G=F\\3R1=X_HB,#*CA4Y
M12229B4-4"Z1ZP0E(0&J-)V12B(IZ[X"L++R<_H*YD4^/8HYF.+BFX(EI;N-
MM9\-+/=[Z_($E:2>>A'G22_05D!_-/\"^YV</-?&O'#^@4%O<V81/721NR<1
MA2<9O"?-[*FB<5/)J8A/=&VT$G-O)JM:2A!/KTMTMV4]Z[5X./S[S%PL1^ZE
M2B+E.^_;8/5QMF>[>_STSFXYKP<7$JW<O,G!#Q]SU1JU*UWV./(IKK7K^UF9
ML(V?N)E'(0'=VJ2>LYCN1UZ8X< *%$?WQZAM^>;-.)%XRF+W<M(R,IB_ZJ3&
M>?#I<:6FE&J[*<X]/\K4MK,B^W+SZ>>W&6JO)@!,=SN9BXD88Z-!2SNH<1NK
MD(+=07?6,XUO>)$F>0N#(57VLUVOEYY16KN*&C6G/;"X2A-EF<\]*\Y9<O7[
M=D 4?M$08'V59</T-8;F\O$+\Q(&#3L($9PD*>W\#6D68>1:UAD32-\#.M%"
M:QO:5 $JMZ@+V6G4&_Q16^QJ.^#*B=@H)OQ;HV<\UDC3AGHH./;QUPYP5<NR
MZL%W*"(X7L3F;DY<V>V!CH\:S!@1WFU%KM*,,';\3^P'.-OEF1\?CF?B,/Y<
M,3_=P!5KD;(>*EG\52\EG;$4,I0G\$E/>3H./PT(.9&JBY+" 5L$>]_;;F2N
M=:ZHB=?XCK?BAS?55<*S')UTO#D2+F30J9-0KOZI-9G=S7J2L5:: GR?#U1&
M(-UD%0^ZH'"4O@/C?<U;UY]FW(.]E1GB-K#J.(A1&]Z6-!':X>J(O09^SQ;^
MRL%<\4Z$V);8MDD>=&))(>VBG9:OQNGL_DPD0_UA4JWRI*KS"W?'Z"@)';L\
M"J<]CM$,K</JWX?3ES>*!"^LN7\SWOAB]"ZR>H5I2^IRS/VT*<R$*5A-?,+$
MC_E>L.RM-@XL!Y+#Z&T_ 22 64)>E#>8(B*V-7+JL$K(D5[XDWM+#8)07LM#
M B_R(,=:)7';?Q\HMKILWV[=95FMY2C1@&DL.(WM-5554)\],U*NQ/_J<.^S
MJQB"8GG+.X!AE8W"Q5''/ZE&*W&1Z4-MSB?F\(LMC>^6>R(LM:NKC/GU=@IN
MH,B2)V4PN45N S\U&WOP[)SU1Y2+F:>35UP>_/000?$RQ_*@PSDO,DX/Q(I%
M_[Y+9V3U>&4Y%!:>LY3L^BQ*L6FL.)OTIJ#;!QWJSH<W.9AD#=BTLZO*Q!,S
M5%6?IQR(M$+P5!)UGD2Q7*W4?$X="[-+88<)N9K=F-D@:]BQ$K19;8YG@()O
M'2]<6??SG-R8E99CBUWM^)'T^EO,-]'-;N'-1D)8E2O.C!XC2XR:%1+@J.,^
MZO1XW_44+BBU63WZ,6]&)8LV0>6A@#<]F$7CP.DBR3"IZK-P6L1;WUAU@TK9
MF9S+BM2#&VV4)F0'Y.Y> 56DC\;[."TG5<U_$#7;-Y=\*RP/DY[6J1TKC*0T
M.M80RP#Q)#H\;6P26&^B6(+0-JVX^"/JS9# T%RL>+C.(8,A%WG] +<,*E6+
M1O?/JYN.!4R0P($I0GD\ W$,NA"P;GY ?$[SH.GB$I6#RE&<\)5D/MM.\#"8
M[S2OM% T'Q"Q>=',]"Z86T*%!_SVZ)$RDS18<;&X="F3ZG$( TC2^$E _)G\
MLNL$L\=!\(D$L?\<17F(S4]]D9*DN 2'IH]D]) PS8/!=IBG&&L"WR="J6-F
MENZ^RUS1RS179F^L^4@3L7Q8M.'X;*+VZ-Y[K-LJ#P+8&8.EM6"$I'DZ1I.D
ML[2&ACMG-8UD,''=J03S2*9]MI\!B$+KP .F%NM$@X1EF3KK"DWERNK6GHA3
M SN-4LSZX3:]4:<:[#BJB8>%1(XW/[C!Q2<*871+H_$B]S>][TXW*A@LULLW
M]RR?I9I(OX1=#"UKT^;8Y_W*RPB+8(CC9/ZZ%/<P_/&KXO#[NN'X+*79^DV>
M6E#![5IKJU,2W]RI.Q:/34\VQ%A&O^_"(IZ ;UFK6UFM2QFJ)Q6VUB(!?$^)
M,;AA^II@90+X'=U768D&%_X#LRV\!M#BA#]DD6>"H%:1]O7W>;M>^_I3&:_+
M2ZRAI0;;SD;1,BA?*DY86+FV23G8[[=G'BD1UGV&!J#3SHU"F.O!N5E-%I<R
M*L%Y.M)(!#899N8;7[MXLE(>%<,D0T;O?:\$U)J**[A@R1,X]O[UX-;8HF%5
MJ*1LD?&#B=JBGD&E98>@C$E]K(MQM:+9_IA6:]5/-JM8&$L.8>?!J:]%ZD-.
MC^."\;Y;SV-_$WA02Y2VS<%Z3A5 (=T28^ZZ101>T8_<$K?9B_9@2_EFP];0
M;G&+WA]O2TKQ&SWM?CW;@>W3X;U75>,KUI=8'P3O7^V8^:*]6J.;=,6FMP J
M_(B0%(VGM"5['M0>IR^7@34P#*F%R V6JCCXEY_2Y:@7NN5M7#(]U/][N_W@
MG 6<"5Y14+X=^_JE7Z8SMOO$][]-&*YJ_OG]/]6/?[/^H9XW%_Q#CU)/A8+\
M?8(K$X_JEI=&VOYQ#^-(%IP1VI"<G[6CLT4&-5%F>]LBNDX8\,(B15EZ+1'J
MJN8WTL+M'B1Y.9F<Z7GS<V9^Z'):B^B)V;8):&F0>LN$<XP]SOJK7G<E<\7-
MIR08R]Q)E'L:DI<8QOV]#I82K,Y9A)K:4746)2A$P/,4\7C7ET-0OMDUZQR9
M:7SYD75Y0Q[<]:F>-P^LHWUY[QLE1=G+KV[*NHQI2$!@U-P]N&*QB<&ZD:8Z
M=&I.<KR@S5"](X/E-X3@C'ISQM[01!KFSQ]J>.,M;W]E*@$IMB>5I8"?\C$-
M,\:)M%]:OH*>>SJ72LRR4V$_?R"(^+B$:E/$U?U#QXZV'"@N?79,EDYVG<MM
MK<&TU1M_Q)/N='!G<V_U4J\?";QU?F<S&VJC=;5L*F*P[5[\E4XQ9\NU,K)T
MIL_6[I>?EQ*VHTD+U%1_M,)TMVF7X='>4=_A0Z_T-]'O/7\NVXL.X*WJ& K^
M<!T:N27Z7&'J3-R4S//A+[A^P2V%B[4+L0!KQM^L,M4T)]J.@T5N.>VV@1?Z
M 0\251NDETZ?W4OM>VFWU7PK\^ #_8%>(\_V5&?BL@!.>)&7-?&DF2W?C7CY
M :,DK-")Y'EK]^(<VJY<*]<J^[R9 GN[8<!+AO5(/<;"?#^M8"!Y:G5T'\$
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MB\&-P%R7PNW;H5O[*RYOL[_2OV(2^@O281TE3!W--*FJE77-KM$CDH.;F@F
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MC#B_6Z@#N<=$&_.)V?U0T>YBJJ.A2,V\LD]QW*A8B8?QPLD:"PNW<W(+W\]
ME'#E>F^ &^RNB:]DP5\A:R(4=U'3%JD:IH\^ILL0PF3H@T\8FM@L;"=$PN73
MCBUZ4O?8N[3NMB[YS80<P^C1YJS5G@8C@ R>Y'$H#0[@O@U.'&V<J0R+BQ\T
M)2;^Y+:0NF3%JS#^J,G7O3J&*9YL6V*%#B%;8K[C1E_=9$Y?-1[[F.G<N_.5
M4!M]VPE<"%E=7C#GDM+]](2VSLCT4?3&)^(U,0G^233V<'U IB9F<MF,;@Z
MCRZYF3EC#:X7Z_(;;TP89$9_Y12X$,M7C,*Y<FH;N>\ 'P<ZMCV"4)][%OTL
MW-G1*2ZOM+-PCH@@J:C<E2#.9^*7KPZQ=+)74H&2E/VIM*'4T^YUOVS*H<ZZ
M]'N=+&3P_>M^(H*"?6")L\Z3 ,O,V;X;Q;'"O9=]<;[V84X$C6ZSJBT_PGHL
MW>T)[M<6JU;X>GX!5KF!O;FYX'P->?5U*4[:932:SU[-B%G2!,^<"9OU"\C/
M)%0IW]B:J<[A/#[2?U:Q\B5\G!M MNW)$8YR#OI\#"R_2H L#B\V#+VWK;'F
M\193A"SOZ:I4HZ17GUM0J;QN>/G-_D7^^8-CHKK9U)V!>9A%?89G\NQZKZZU
MVPI80OT&)WU? =MVS/B^C2AIKNYF#56!V.\8$:<X@IVP@.$S-PWGH$;@D^_6
MB<Z'E2\/V<Q&16W>NQ^U4FQ&R\1J,=NQ.;CX5I3U,D9(E#)U&SRM#=RK;!*7
MNAOVT?PM(KAGGB$)!Q 3^MJO_-I<4%+\Z.4:TB8HI]K)W8@F.V8T.<F*L&!U
MN;%Y]167,677X+6ODCB 2T3GF'1GQ^!C<U[NB^$D# Y@J//K%Y\K?Y.JB,E<
M.3!%$]3>LNQ&,L*EK_L\+FY&1:K2$&AH&5-6_;;\4<<@ANWT3'QB3MN%4,$'
M/&J<LG89X\2]1 PN,9C@%P'>VN*1?<!T6=::=Z,) AZ\G$JW8&"9<!124'3:
M3,_Y&J>")FN)L+!YNI?-5_ET\\0T&T1D=AW:$R&&V?@C1CG>HCTM'_.:GP$?
MI$LJ'+&.B<E.I1RM);Q.'-*F-_[I',BXL:-/%KW"J: <3;FLT5"S7T%7QC T
M=923H/")[G@A_.%%1*KS=WW^ICEI.@>Q)#>_.77YD]D&72#%IG<.D:SJQT2Z
M[L6-?#A;0U5"_Z&N]A3YZRY=Y/%IH7_I:\1 =:>ZV/?TKJOVV9G.T?YY"@O!
MCS&N.8$LG,QA%&K.S$LD)^$@^1_(R;@AILPO#7GIM<,UOYQ *Z^_]S] # XJ
M"B P\EDGM E.3%=ZH@#/OIT+C5JDM2^ J#-V^Q,45?I.%U6RMAI)EM$],YOI
MN"QS-FS3<53Z27L]W2=%FYDIRXGU?/RP;W_ /H^>O&YS*N/Z:%[85=* ]1+=
MW=E SS:LOR95,=KK['64ZS8-)3-SP:\K3V"5M%'IMIM]D>Z"0M47T>J/?3ZS
M1$V$LI.?&]_E0<R=R6^=+FLI2X(;6S88L421;B+;?G,9H3*?H.WW<W$ $\^B
MX8;%5=>DA=J?<SB 4ZWPJ662O[#HR%-FE@8VUM^V!KS2+^?WV4=4JB)E<0!_
M0GD< !:Z>+D'1:=L;E0IA%)STI5%R(6]CJAE J6[@DXGBW  "9'%2^SBBD%>
MOMP68J= Y;>QKNS[I26_LB.83G!NB9.EDHIS!0\4<6VT96/Y"'MIB'U2*R8Y
MS\G/460V\"#$-%S!D9%<J !:765X<6L!NGB* ]#D[A_*C<H-[G<F?!)BSEB=
M+%>T'F1E:XJ>M<"2C55>/5G??UJ:(I=H%V3"!(<F5!QSWYJS& D-ANV>YF5U
M:V/]QA:/^3=K-$8,="OODXXT"P!5TI;K#.^[?"\&78(5'SUY<XN9Y#ELUV<,
M/'!N2@W9#,^[F>=<GD7LQV>60X*$\)(5'SYGQ9ZWYL-%[^<JWZ.<W?NV*T4)
M^LIZ,94Q9&_KT%;*FJ!!?R=""UOU(PN=<:18+YUAFO(KBIYNGUU,<XPA?>NP
MS]).;>G8;'B"KR']":IDGVI>S\%VF]V35J)A\INX$OD#1E'X+W?@NSU,T:^J
M>7K^(;$/Y.S"M0ZQU#WP+>WZA1_ P.*LL6-TE&+-&G&4W_@%7JU.7818%7&V
MC:HXNY//H+DA 8!DEEKKM;G($5LE_,R+?&9B%")'^X/9'P?8U(:+U34W--E-
M"9#W0X9_=GI[!DEH5 [972K$\?'R1#(YO+'[1K:P&$!7L4^'G.E,F?2SSQYL
M_D#^:F,U7N;:J7A@1;A;R>!;M%_'A@7F1U>SZ(G&-IC)0*.UZ*[$]2\2>^JW
M#.TLI.*WRD@F1S!@UV+ZD6MT ,1WKXPE-]A1BC+0G%AKW%\QFH!TM.SX>+@
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M<G6S<-FE4F#=*G//B3*RU*K(?'P7739S_!Q[!P?H/5X\V6(]TMGW>K%38;Y
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MNX="SP9[6(*W(2>Y(W_B\X\,P?/'VXT27"U+Z*X!WKG?=37.1C%+ +6-J>O
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M(#C:K1U(Y,+ 4L\B74EJZ^"6CIYK=5O)O" YWU$?SYODURV17%W7#;X-LY%
MWR$Y.0AC8'SIIM@<>CTI!7D>"YC[VK8$*OCC*^A2(DW1"'NG]R9^G+*7[4":
M?L<HR=&MI2W\*8V^@H;C *.N2X2;Z;HU^,;&CH&*P2+2+!+]^H!(B&H0@@-X
MLYAHSQ"A3=R^KHMS[1RXELKFR'1*?"+L%>$+X[UX>J7HVN6  ]P=AT<ZOH=N
M9,,PMI9)A;DE#Q0UYN;_\A M'MSTN%]2[;-<)%*"8(SV%Z!F!')^[6.^H!-
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M*=]%!6YZF9!G,&W)6:38_2<>4X4X:G.Z I#BPS[,)3K&!9(7#%T!Q@M>MLL
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MY1PQ.2UE!L E7F;/Z6W>7XK=TV&S+FWE3^\BO%4R. [[MQ@X69$9.WJUA/E
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M"V6'J5079K%F$=IC.;&K?B,OO +4$WV(_YZXY:=5CKD.>54)^]?GE*;N<!=
M*L,#>/?,1A\"C4MGJF^Z2P1.M7^QI0VN.R=#YZBI9CHJ.XN.K\H3JNL:ZD\:
MM#F8BS?94%HIL'VF%II#1R_Q5*4;1 VG6"IV^4VKWY"A7^0_/0^6BHQ(=1=%
M214YAC'Q+/>S3KH4()[^8*Z42&K4C$=9G#ZUSTC(S][SI!X-"72_8VV3U5I5
MX[=4J3I4J$B)1HCLQI[EE58;YN@2VPCEG04_%^.O( 2J&BET3CNU)-UXKV?_
M3/7NMWZ2X7 5<80=L-'M]EE03,+4?RPW" 61SNC=7T[XI3Y[#E.K\.E@!H2]
MNQ/T8E"![/!K^#O^E4 $"8'KD21T3?1_DJV>R,!PH)K-U6'O+-1R='I7\]<<
M1?P&D.>W)-W>K8_7&#%AA,I0>K!/DSU,!1FT:[95"NTBI,$^F7T#C.]0/VEW
MTI9/.&U.D.K!&V=K_IO'0)]$T @[Z%& '?\>)_.8^^+\%8#G%?#-XT*TTW+?
M<WADBGX[\<4$0#;8-;2586,]^%14,GX?RMB=*Y[#&O51!$ 2#JVM12O!I]&N
M3*HD:HH?^&=U*8N6F6,DF$4EGW:NU>$WP6YS"][Q/2;5U=Z'ISY(>4O8[>=C
MDU3K08S/'+-6+,7I+NW[4MA'T,^KQI37S/!%L/>#+8]7FR,%-@$YJZ#G&QI4
M+*MOK@7;_B74#BBX BP-M&S6*CDQ9WIZ2[+2]A.MK7Z[2+U,4D>3V<H R=UO
M"?O#Q_<.GBFSTEPB3+R> ALSSQ);YNO6U: )O"]-A@2;[ 0_L564!X4+&?))
MH0"/CZ@'-//K)O<<WB3W[?<8)Z$&@KDP]!G<9<7MY[_"EN?G/'>@@^)X0_+O
M%^B.V=:5<K/W"]*KJR/7$C6Y#D2[/KA-F,&0VQW3"4<3%=70 3L!JW#Y:A_V
M*\"".[G5F-&_@9?- VDKSOY\>60-HP/U]5KOWS(&BAP62*#,#.%TQV[@$L'&
MWQVQ(95D#?9)NF.*O#*]3*+ICH'^CU.R0N$I6"HHFQ92XMG!L\T\[1F1=Z*&
MV2/EPX28FQ/]D<-HMK82YY<&>H5P[K34GJJ?*L+P#^)63/++_/Q0SL*UH+"R
MVXG]3FXD*+AW!K+!S^ISKZFE06!4_JB@"6H@:\,SLG]BQ+7?YP]&%GE$22P3
M5KA@Z42^$'C*>,FG<>[(0H&([6@.H3*/?ATUGINE=Z )=60,3+P=3B2RPR^Z
M96$^IJRK%ZE%_KBF0^/+D>9QQ7=W50?>:.9O6;G&HE%SJ< X &C0_2'2UL:.
M=-^/62B(;+](SHGFQ)$1;T<@2;=*(U SKY_*3-@DB-=+B@'*S>_ANO24>_'@
MSX#J78FD-I\-D#^Z*O]1+D*'>\GA4QX;S9G^NP9-C-_,L>XQD!F]-M(LIEI2
M_$E/PV&*Y,XP=<?\.S& &!D.Z$/7GWUT,G.\3H 491^WC_@5/U7G\EA:+:3W
M"/@_0ECJ[BQ/>*=-2/!'EQ>51NO:"7ZC,BDUN]]A],XM*9II>\#S;WEK)QYZ
M;0R>?OGFTPX7+B\PX&@!8*2.(M)#H"9?5G-,*57Q-D^ FI1F2EU'.Y@H><S*
M9-2>.*4\%A*SFW8%T%P/U@BIF3UBN=#Z;8@F;].\=S-.NOZ#6Q,P'BS8F8]0
MX]>++TD5D53M']N]KU@Y(12GS#]F)]3Z#:_=,3@]I)">8]. .0S9TB:6EP6$
M0!^K""O9.UH27B;50I8,>Q9QO&+3D[@DW.YQ+&KD]-1VZ07\2\.<(?9R )]2
MK,A_Q#;[_:IP3C'O5K3F/"E2!D[Q5NF.-"->L#"?_N/S"/\S"QSO]9L7@5!N
M44R:[ZE$?VKU;I?8%+U?__6+5.9$\ U_/ALMMZ)EBR?=/28>HDO0#??WR/.9
M79FNDX"/Y=4#-PMOT:%&)&$4P_5?QDIK\FDUJT:LJ;C;:GYY9+*<4^S($9U/
M&" 'VE.;STMT#>L%>]IOR+$OTS(QD@]>& _7F;4;$HS46II1;?)+N_I+Q'6.
MBIABM]]A>C8'F&J\8CV[+25C<@WG8Z'V[A.R#K'P%B/J3969TFR>5#5 ^,AI
M<KV_E'7O6R@8@"Y +S,1'+MT[(_@:/ @RH 1-;_.49*P:QQ?<-"Q)%67Y?Q1
M4I>28?:5TL-?J5!!Y\455+@K?C"?W70-.1&&R;__T[Z[++L63Z5I:<A#O'Y/
M.XS1:^,MD-*R5BN1_1U100^>-]-YN3XFFY\SJZX GX*]*HQ>(SCSZ[69[OY)
MI>7,_*YTOT6@C:4EE?I]X@\'N!&:\@KP%,>AG:X TV6(LAVC&[ U\!7 "E>D
M65#1V-D"HV;L:+L"G 'WP-L_C,Y)OT3.88QP7 J+P%;*7@'^3!"_A2S*:&+9
MCO]2)3^/;DLZ8-D&GI#C,-ISH8,Q#Z7E@;.[#B$7A#W7N0EG%E6%%P)P>A3+
M?X;3XBH+=\F!37(:75)!5ZO_K2"V'B6&K'EU9E6?.LRSZVZ^^"G-KEI\6YT*
M<0$/*@#CQP.3X=&@!K0QXB>R/>6$]L!8J?ISB;'4ZP1A#Z+%2\)T@T^BH/PA
M.@O_>R53\=X5J7.?Q-KZXYP#BYM7;>7PX1^96^UTCH\Z FHITM#C?8]XB@PY
M/]SIK+>.%FT"8'HPQ3:&3W,Q?"B52-"/D>D3BH3BZ82+KS@&MX^/5KU=%#YA
M\[:EFUS6WF942]9L$4QMU*G&1'#V:E_"\Q5FX48=;[,1X?OB&&L)W#=3>W*+
M^P-[.Q&X%3)_;G_<IY$C)ZGPD[YO(\CZ1R)]]$OD;'2%#=U>&<$]2ZM<.B +
MVP([EDT2]!V-(^ULI<!C!(Z)'^^<6_N6[FII-XQPF5!*?L^,WSS%?^;YQBVL
M(DDEP2Z$[A\7_WPTIU124*V:^BE>\QNN_%'T]9PY;.-#?1**.;CZ"N!C?53.
M2=KZ4/7W%_B8PCD?(1+^^Y_2N*>^QYWNHJGUF5\"!V79H2RJX=2_G[!MQH_
M/4T_?(E:B3R1TJPMK2RLC1W>>N2_3/N$5?@M:S(\Q5UO,0C4,<YG$>LQJFK
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M-.-+>[D' S6+6IG.H"6&S6@;"UU,F+XRL(\IA;0S?[((R^5J#-3-QE&DE>;
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M[*WVCK$NT.VH5GKXY$M.C#&%*&F2K"B&+O&I(1-C")4?NU47Z]WN[B\:P3^
MNN<"C8;"I2C/B!.E]D"+L(P97SH;SJ/9/\<W'9A"BN@=U -_#0FR9Q(JRO<+
M:A6A:Q81"A+1]0SV>%7/^!G?'9[2G:.:-K>G:_>VFY@?E_YN>_0M2P OO@W_
M5</I\(IG&<[MZ D0#\4SQ?*!C%H8;G7XN4M#,_1R/\CU%A">5W;,&Z,]T\B.
M!S>N ,08U1S%>H\<<Z15BX)MB\C^3WH.5.,I7&_X"$*&$1@TJPG79VJHKXHF
M4("8JF*^8CPLS-YRL^4*IOO\2EA-$2/59/=JB2Z22S964J#6<,0CNE'_&I['
M6W!KX:>5U5M%O[S8YYGE;V+/I%+)2P3;K2G_WZ3/'NU_KQXL19&.1[(MBT]6
MR!%? :+\^@G'E#Q?U+9GE-14%M9Z[XUK^B_3DM^'OV4MBW=)&1I0<0]7D]1#
M&/FL*-4H>U+UJJ3,NSN^#T^[E)-?!'5N;\))G".44*<^3(^":<(B>FJ+C1,R
M)X!SDM+8E-J)U@5"(7'1E23I]VZ?%5@)WQ6S''6)6 ]>: KFZ,V&#1D&1)R$
MC@GT;.2W(\W\QF'L:)C:7"@_=SP<O(L7,EZM3+E$Z"=$?P58?E>T&86@=]%^
MU0&?>RMQLB6O.]4/<K3+48\HEI=<(B>>=Z[1IM%L2_FI47HJ+LSUDI!^Q22<
MCW#T1- YMYDAZ8>UL=<;BF+ERA8NR]!%9N<M<C9XO@>>F?&U@(3G?4<2[EUU
M IVT-86DA6ML,8#E1<D.! A-\:[-AGXKGK]GMYJ9626I<'I"'<_QI$<Y*&<X
M2(0=RW;C'YFR?VT6=!T?-0*;2$OJL]AR)^D.05$,NCM> 7X37M;"=CE1TR>\
MP0N'.'Y1$7*9;BBN&-(8T'H%H/[IN'!'XN6E#X+H?>3)],(5(+4KL=<3]W#U
MA5*!4+]T31,'^P]YF2Q>WTGUH_E+^'_$FZ2%N*!;EJJ$#.[-J)54F!?L/J0H
M_O,P5EBD$3][5NM0:$2GS6R1%R^G&]$ULMLC;G_(+A%O<OQ1!%^R,5N"MN *
MT*RT),XDVWCHO_,;-B(KPH%JAU'H ]O[8#WEQ8,//I(_H!78_4 P%)KC(2TJ
M-2-?9M-^8!&WX<IO\]U!2\/Y>'>VXO24-B+T8V5D>NBWP))[D"V+VX\+1GJO
MMPBZY4K8U*-M)>'('BDL5)<7WC$@UZF/?0T=V,Y">RP38801=Y1JO&>@+'PJ
M"W.:^T<WGT@UCFHHMZ49//HU8I:,L1FU>E\X7+HQF5_7TL5>R6[UI )_\Y#R
MN"/=.=U#&L%[6\^YY\4%2)$MACS.4F0%9-R0DW@%^+9K2)J-D42I1(O+G$OV
M-=[$>YA#_[8^3@[V5.=-O,MG^P_9/4EQR;U:2HL+]$;.+]4/DWO+;4-YN/V6
M.K*.WD^.]8&6G/R/Y5YO7@&,@[S=>\HG"<=<WL%N'P\08?B')?AZ')Y>>/X1
M\%M]3BV*O;5.N,!^O!G_5B/[9MXQ:Q!#L)8N$RDV.AU=(NLMJ=B57OZ+O8>Q
M>ZB:.74P>P=&H>&NM)P ;)Q^+65KV;U35OKMBS8/ :$I/ML5 #Y<**&.@BH.
M[FL.0 (M!-B_JG2B90P7A5'"5B*$\-=:TC;6R>XOD84W P)$VU<<EI9L9F$.
M/F>=0CW=8_'EXE6C!7\FGAYV^&$@6<[PM\(3.ZGX)JHLS>U5_83HV+:"@+9$
MTE', _<'M3>47(@/K-ZX%^-AXICD#PL<:U*AYD6K W$QAU94JK*J''\PS.,-
M)>[&)_2,O@Y$@<X(Y@^8;@5<1_09R\U 3RUM/O0>,/K.)P,Z<8N("$U;)1,S
M?NCMT;&$L%%BIV0O>C74&4C/1'8[K)/E1.@HY#M&SQ3A@9=<HTVZ".'9&ZLB
M(;__55+CW"XX<N"M2)<RDSU#-J$")B1V _X6I=54L^WFQ^,NMFUGU5I8&O:]
MBP[QM77)QS"-D6RMTD6">MEWCX3TCX5LTTQDQ4>CBPT2XP6A/!Q7D'O/J1Y0
M(D=MZ:S7(ES/.9XRLHOWED- 10MTS\GXDM#.@"8 &=%:'=^R&YH19QT8P_&N
MU],W4_0<L6W8DO8IEK"E[X9Y;9OWPS<36K8'PQ2-I]M#\G8=CU(<PC6#UWX5
M'D34ELI[H4N:&#)_<$#*S]1F%%M?2EBV&!<1AMIX;0ZHZX_9SPNCW+%\XWU=
MFO[]C.EYW($YIQQ,_?P>8HX%'TN#=O>MC-6C8PYVW)(:<7:;YICW_.(*,$53
MN[[LA/EE8'2Y<1V:K)7J3HX#:]9JN [1<!D&[??D@'7)CET!YG'833;=F'RY
M)"/SHE9%L0;X$W:@)OA7N%Z*8>76CB?U%:#KU3!LMP+KYSH.NR.ZZ6YS+._R
MOP_+6'Y+)773W!\+D@3]UP*\.@O_C*^11V1B?@A:GZ_R'NKZ8(QEL3N]D!\,
MRYN&O!=4PSM>;T*ZU@$N7K^ZP,B'S.D_'6'T[@(\R1EZVU%%>^%=BOJ<&=JM
M*B_-AE1@!!R!6CYM7*&OP]O8Y%GY3.Q%..59O"8GA@SQ47W1 :5EQ77.T1HR
M( D2D1A8[5\NOFK7GS.3_LF?Y(<B8FI2MG^TBG$N?BK*W-I=B/T3T>QG4W:2
MQ77C)/5@,D*.4!&X1"T.?^>Q$S_S<F\]_0X6\30/TVU/,RWA2Z!OV@IV_?D_
M]&T+2B!HZ'*?["!/!#O1;'05*U_#&Y=+T+@[);*YHX67Z?*">RT+P+EPT$^)
M;92$5!TMWL8QR93LP?CY<0F.MT,.W&3[.W]M*FS,(K+D4\0(;$[Z8^$CB[KE
MG2;\8=HA[/LQ)WDOF"(,/9'LKH/*C\JO>#$R+CI,[-1G]W6!KW/:YRSL:#/^
M[%TFS2K0A5(P65PV2<6Y13:DG9DD=G[XU8H+A17WP_9%;5L^V/3-P"M F9%
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MA]#]>NTX@&<$FP%?TI1YZ<T+76^D<X&=PJ&]LCR&+,QC/\SK$P\(5E9OX/P
M=@F8")PHL8 =<,[#)B)PUQ#4?BQ)+WD&KZ:I R[M):^;ETR*NP]*'1$"'>K
M=V%BA_X-:181G\Y_:84>J'N_7A1+_',%2*S,C:TNBA2U[5Y+"BPM'RD[,[U]
MDU:FAYZP 44^<.:__M.-*FRS_LG05W8%$B_.EGVYA4'_Q6,@_M:X+;"$I2:@
MY %> S7'V<<,2LT2P6SE>=3D6C94CI=\^U[]V A/$XY'L*8>"@V:2]VHB1E7
M5H@B^K;V4#S!9_0+6#>3/7"4?=ZW>Q#SU*G@I<10H;\@G=R7+_N;N->4-_<2
M4CF\SSR^>:.[WH<EN+U.2774'H<U-HE\_6OD)EG4>Y(.NSC.)B(-#?I@+@_'
M6O:B7D8))G-PN]**M#_AR;@"?#N^53SQ@__9:!6$R]6J7^L\I+V:G-F<W,&<
M)O7V:GZ3#D _W*=AT.XL]K#LHSQ9X-M?*W>_2,,UD!.^[R>X:OVZ[[3J*]$S
MBAPSIXYGF&?V^F>,IG8._#?VWCNJR69K'XZBHJB@ M*$*"!5Q (B-;90!0S2
MI*H(""B]MXB(8BB1+@@$Z4B3WHG2B_3>F_0::H"0?'<0GT?/.<]YVW?>=YW?
MRA][K9"Y9L_>U\SLV1/NN>="3(F=QI";G'07HQP7>8#I)#T!!-AU>[.+3^C-
MFB=[]];S%HDD!HM-;T0.^[?Q(U+6ABKS;/(AJNT?LSW![\>[X10;D,E27H7J
MKV$E8\@KM+E(L>P$U!=*DYRLME7T$:/6NTWNR$BU[:8Y\M6DP-;N1"4SM8P$
M>R^6$'//2\E'0>*'>C&(=<VW=[8$,MU>K(]G3 <UV'?(7XS[#T]6BWSX".N)
MA$)I5%]SIMJ'X*'UBUN3.U '<<?JM_#O6J7 8(2WJP5T6N<*I6/.06DH>&^3
M=:["-^F>H6=[X,1#TFNI8#RTCW]K77?G4'%P9D*14'(FC1+BIBSO;>I6W%\>
MBEXL_H_.2^<MJ6ST"E@]:PC)L[P<:1LI->N'5>,<%1?.GC?0KV(-#&63J%C%
M';\9/9,YS?A2Z^P%E.V=ID'=E09'OH[4-YZK.>7D/E5Z08X?"2!Q*-5 4%4)
MMN^36%IP7GHQVR<-:>?WE=\<1F)FL;XYDGQ4*J'K%U&65-L60>#0+\E*D@I7
MM(]M];:*"=DD:\B9>[.JC(J/O:5R=2DQ491=4EX6D4NZA+AD^>A^L$2%+_D(
MJJR064TY>PD?F5'UB;W/\Y'N)-!/6W=:!;9J5KR*'J2DQ>9&V-8SE!^;R!'[
M]0!T+?&=0P[QELNBIPW$&TSL[^,E-8G'D%^T#U9(C4H20+[HL=8F?*'0<MI9
M-;.Q=.QJ%M C/KAD3YJ/2T%JHS2P&]$IWU:1%/":(K,U^,[A+O(D>(WJ"O%E
M?*],BI<2<%ZY!) :\4U9YHXA. \SR"S0]5.26<B*AH2EZ,_I4DMY.*]@U!)D
MYWARXT%'B ?ZN];>\>WG4/F7R IS8)@LGRP 6DW'-=PP=B* -@_W Y-1#6\0
M)?BT=F$_XN"/8\\@NVC?U7O[6UN5FO<1=R^[YZ._*&W$TI1,@>)BXV+W-W-%
M_2C?WP*E 95, 3M^4#8,"K*+_/7\,^R7@]$/-T3&,B44HA&\;6(WB&>0?DJZ
M[%)Z)0HKZ2QD% M_[)(PMTT .:VG?L@3%9)_ W9B=E(+:[G/E<1[Y:/PS4'.
MC+]\_:*.*%0JXXV>;DK'@A/=KR]Y;=,=B\?VP$?.5 U+N@X0W[U</1737?[9
MQ2#='##G_KZ6&HRTO^2<_[EC*0D'I:=NKJ5MW\*6C/*=9WNY4M<>I7!5XDY^
M-9G][-K9L)4M'GU:OCKO<7+[K/[YTNM/FQ@_I%[$<U9_8^4^2][M7X#[9(@=
M&&E&GW^=V##54D6.?VWR-3%EY]7QTIQ[:\]UQVQP7^+]XLN?02;CRAU\L/M>
M0,YT"KW"<QAOF;UU;4O1;;+3L[S5G[SRV?8)V<)8,Z6D?>/EKS"5N:B@E-OI
ML*)<EZMCX*,]]F/EGQ[Z<^0KKSQ+4\F,]6MC@_!:;+%TK.B/QU5Z?.\,@0FH
MG2B0.5F81&O95:$QX)&I^6!6Q*/X2$3&;>NIY(" %Y3D[&%)#BYVB5I,7GU)
M"P9GR=A;Z1Z3*R@*)'TMEYL2Z6"[KYQ2PQ6-:*_H6!H$1NKA#<]G:[I9.S%S
MC9IU0UFV-YG-+;I:"Y%,.%D"Z%4]](T"OG8;'&*>M8DR6KGJH5]U#;EHLYY&
M@0@Y,-!C'!NH=;_%@P:F?$/5URMM1@>,EANX,CT<Y.A6E[_ZJ!F9:@B327[Y
M7#2F9S7=]]K$>6U=F: G(++S,:^/.46D>KM<<>S8+!6:H@AU5VB/*&'6@VV^
M%AP14-4I([]5J2QGE8TQK&@PK#Q9$NV1T=:76BQUOAKL4K0Z!UH7K&R!&M$G
M)K,=45"R"Z#@BDZ\J1.7@-/;IGJ3:HV:8\9#HS4=T,^JYA/I;*]9M%UO<'A.
M>^5E\'A9[,>ES]$('D^*10D6W!T6J@<IZ7PZ+A)&8JV/V;[Y+!VZ(7;"_- 5
M<9=D]^AXF)*J_BU3RJG5)K#S/?>*7JEUA5 CL6NMEXQB\[\8?#T HO'S]EZ;
MX_TV%>U9"7UP8)*[B$AM]*T2N5O8ZAVOCP^,4-T2=CV/U(N;<I\/N'4Q44)$
MEGMY] _RU7O(W!R\$#QCECW0(#%0^L1[VRK\R20M+<W]LX"&A[3$8VJHI=>S
M]XTAC[<-0TV;'5S-0KPS<ZW<=P8CUQI@,K$=[\<XZ:QM=(0Q*!R'W7H>Y.$V
MV.\DTBQBPK2VT2K[<8$&UT?VH'>R"@IS@,;'XG(R@$DA40^FX=T29CVIG517
MYS_8/;((?W9]RZ X%\&C=Y#9*TA&H4[Q82J2"IN@ME39A8H;R'[DN<+ZJ%#X
MD-1!Q38&>HE7JN(TO8J2MW:[% UT*5]AKA]/#6AS_LPEO:'Q9WHKD+$8SJI%
MJH,[@ZA/5QT%+-PV%P6'5U457E%Z(!(+(T/2<?J=@H<'CW,,BE_CJ%FQFI"5
MRF [NFG8W,4]HDA3.X(^Y6.LSKAU*XU9YWE<O<WYSPYIKHB<PW%/O",>Y'WK
MZ;.?'*7#<00'OX/K[R#GEJ\N;$N%%K'1;\?0?GO:VX%W2Y*"Q_<+7$U@8*:W
M4V6NSKD7'8:0K5$*C[MHL"8>(HT=H0NF?M"J=9WL2N^E<^CA"Y*0Q1@-.@C3
MJJ"'3]J'Q-J+E!V!K-S7Q]@OXU5&E%5=RPXET\)XM:9P#\;DU2J[9+O2,OHD
M*\J?@_L5K68L^O'T:98(7F5_5<DK 0%%%//%_)C;6DO]EWN%Y;8/5[6_UGM]
MLYO7]\;TUYHO7RHM!)0"E8/>CPE#!R]LB)KY,O+>B9^5:V=]APQ]W',6?$MV
M<IGF'\T'P(@AC:3^19P4QD2[<]3$25#[2H_;L7./6R^)>V&07RB&N:*SO96M
M):^$QR]R$/_=>.Z^1O')@3L;]XJ;>?=C8C\<1<IW7\=]8N3>-VL+9YR?NS":
MG;WTZ;;9*0_IUHU]4CO;2030+_=J%-LBFKK+,_(ZC3=PR,>_78<!^1TF[BU*
M-2OH%%GYVPNR*^UGJPB@I3"M!W([J'5(%MM%L<6KMJ.0'OIIK2":,=G+=M*A
M:DF"1I> 0'W[++!<D%F51U[L=.:[[')E]IF"G<P!=VM3E^KT_*_I\FT2UWNS
MS]EHLSP)Y-J<U[I29">JR225P%&L@6A4'N-KB>558.1PJG<V71J^GUFNPM=-
M/T8&9'9I>CK8CL3!6\U/U^4>'_X:)KD"3GCD3=45Y_"<)HC^HD<]-2Q9RW]T
MU*GH3>2$$4?8[1!_R0O?7&3$PGP!F\B:2W\YRCB G<6C;Q- MO")((\E0[P4
MD*>FRT#".A>K==>VP-M '!5( 6/\NL ;!I:#I[&H-'MC]FS+O/7#ESXK2#\!
MF9_<<FMS]ZL&J<'-,.6WGP;V3X=Y6SXT52^[3MY\JAP29*]":QEWQ+@E\#(M
M:TKH MW0&>M8C]*O<3IR_(_,ZQGQ'LF-8C ,F19&_=+ W<\/#"'Z+VAON[_3
M+&*)L!][P1L<'6XD*1++W17>\0&(A=E7*&9PO!ARS:4H=;YQ32]0S[6L8XFU
MDT8S">FY"N8F@=%Q>^'#R0-5S<P]<FA;IOBUUO)9_7>N3]*7DT\!7"[I#DQO
MQ0C%2-&#(U=TJ*"&<V?-UCY%-,EBR*NT]6 ^PZVI;?*>J+6BXEKI]>M?<%F+
M.F;LR M(=M\F-O]OWRS5(V-1&L]I8Q_'9'C/R)HN/])&NHG9 >N-XOH;G)QK
MWSJ:'Z^YZ73-E !Z,BF*EAU+C ;"[6/O<.V6DE$"Z!2\3&WTB*!NIDN(LW&D
M6BB:GK[1'!+TL 4JX*]ZHP^8:5S1[Y%*':67@:W*4[HPW76JH/4/MN[?M@WF
M"[0,F0ZYAJ;S12/>?Y5Z/*ET'_L>!J6]<] Q^",&.3_(4M@*_VSKL(Y\/K&3
M)6IW3KN[ITEK3' \6[F.0C.$PM]C4V<$2J-RPH:%#K->,'(7:G2E0;^(H].B
M0'C6=\;U#4M45TPWSJ)U\/RV:X ##:KR^Y4:R+&@]!/164%<]:H^CW3,5>]N
M:")]&1DKJOKNMC\)(#>N.;E/XM7KZ[AD=PQ_I3Q<UV<^2K\MI?]13!ZGD^]U
MP]GNU6IR<L%RF*S 1^9GPH]Y9!YDI2]Q^L)'*/PWT5FE/>M1[BSPD#S3Q74%
MUXUI99S):#KVKF#^&G^&2\"3HU0A$YNA7_7"A^%.;3E6@2K+%TU-8YUD+)=U
M;U6A;-:993M7#(!4_DF(@461$3G#?&L)626*%ICQ7$OCC0$[7NMFUS^NN':@
MF=2%Y-W;.HL'$6>HC3(D8Z/#M!6097BA3F=N_BT:O'[6R=)>K4P6)[CU-F*U
M'NPKHEF!-FLU8PW %K]^0#[BGS-*HUP7J)\,+2L>!H;Q,LZL>3\U9412T=B+
M:4;D-^$TM@K4Z;4&4\[<3&@;7_BC5PH:MT1]<!:KH.TN5(NLP,.<S^.>2>=-
M=M\>X6&&-:ER[/(XKQ??3W6NSSIX.6VJ?XRA^IZCY6$QBB_1 3+)EY.N%\7T
M77 55A<SW+XM5?"V6C&K)I-L<[YZ5DUSS.[-_HA@QB33+]7TX"UF>T':D,]N
MA97*"X[Q19@T_(SPN99G2@V:;F+5W]XY>6Q'[5CIZ-DY6,'M^#KZ%\4K4@N^
M^V6JMPNH5)WTK;J?Q(V[RYL!] A VA%\,P'TUJS/M6N< *J'\QLT#,V%3]I-
M:]G0C-.>-[C[9'3!]TV5*Q>0/Q5I,Z*Z\;6>JOS\#2LBU(WFXBZ\D=$((_:4
METJ6=H^@-/=/=MG+C7)DC%S'-QR12SX6L&[TMBR@RPC/ J<R7C71]65D*SL^
M&)H(O2BLGBL=@[F KBN^",2]&#X-00_'=ZIWU_FLQBQ+,I"WVF)E--D:BZIK
MV]Y]4E#426A+=3@_/]\8XR0X_KU)L**A4.;,]XQ$K@1Z25%JD4Q415D1>+_]
M(OX$:IX*&[R3-^^JB\M;7G\V@*]MM',-JH8I -/Q297"Q:DI9\-1)%8NIR4)
M6&_?>SQ>Q@U=_2@V2=;56C##%>\O6W.>D].6MM-><?1TQLCE[[?JK1XKR&=7
MC#CNM.'$PKLXH1P!JH\8@([JGW<%$FL6,X%D+(KY'/=97*WNN$(^=NCC!87G
MV0.2,OMQR6?O'-@Z13_L-+S#6[:;7N-S[A?T81-&7Q>,2K-G(?4]7KU(+C]2
M+TUYW5#,K\O-S=T];'1W[5/Q\T[@%JTEYJ(R'?9JHX?R1N0_]\GFG1:NS4&=
MEQ(65501=[1HE!:<6H>?L7[C(;\0Y$*#KCC+S8H_$+0^K\,,->2!!:<REI5(
M\W(XQ355'S_)JF<4-W.J%AFDWT//V?_ZF:O*5_L/H[XEH[0F]N%&G7=0 YH9
M_>4MJ"3<)2H++2A-C.S)SO)(UMB@#Z+_C-K0?Q;>U.K2&]H;V@.0G,!F*K*N
M57-[V^DZZ*J6;(;DD:H'ON0S1OY.=%\5J>A337$WK[QK,Q@<8L/N.XC4^;ZO
M#:N8:@6AP]T*0R/4%-R"HMIN2ZK;^66@T<_VK1TJL5W0Y-]G?SQ,<*<197I:
MD "*]&<Y9"Z2%1[@^[WKF]7?G7U,<]3!]3?6$4!%\4GIH<PT,&U.>ABP*01D
MWR"6;50-=Z[P0J_=NF*?6/UKU+=MQ1#O3VF7@8VI77J))9Z]$SYR#G-\(GD=
MGK4#;(DT-^:_D*4=<G145:'E.2(:/2!S/3$OFIBWN\<O=2$%%X]R!NF99VI\
M1V5I7<1^%:\^B_R"6/T A!B]*GD\TNY8Z)<3(G6'UVK[FO)F=<[M=M94)^WD
M<6KQ05T?//AD "4JJ6B=TB\1XFF%2WZ' 5<QZZIXS&?G2X8>W1\/=6GUF^MF
M@E,ZS.J80<]+'HT:?PO$&<2WQKF%RE!?&4[V,%FNU+NW$%Q1^P$Y_IRLHC#]
MM9E\8XCU(\,O?H>/^8,<+T&0XI(*A]/OM4D(W]([FOQTF=>#P;_UQE<D/"C#
M#1N&">,5ON^=)_DN];KSA8UTK/;@F3X"B$4D;<YZF?A*PMFC#[!# G[9CM>"
M61^C9],^6)#W2(%#(;++/#PJAUD'>6)FM#H$-7>,-Q=MF)(NFM(_+(IT;Z9\
MX421 *5-<K?K(!X#.W[\J!KJ1M>%-3G3)[GO)/K'+%?U<3?9,$DX^?1^>Y1N
M08>IVJ/ $=9CZI+N'O=<(QR?^%LT/(')UFV K^;Q V.*VY-;)919FSZ9N^;L
ML+L,%.3(^:;TDDG8'5ZS1"A+TOYCW'ZYLI= 9/;D;.[MU &=1=)X(7MGY*#1
M5A@**@TX9$A+S.:]P;>?CO) -29S9B!GG@6S"C2PCLH<&>[/OR&^5-#4QC:K
MHS^J2#^KP_/^6IS->Y4\*3/Z/D;PH_YE!V&)-7?H]39OVSN-V9,QA@E8.V ^
MK%.]F5M-G^.'S+7,K;AVY=FQ3S)1BFQUA0W(KW\H2.C+^^:',K7R#A^-C@Y_
M&+W@P>/O+U/BN_$5? H]<KS%H V=Z=HSH26 -^QU+M97L?!)V"YQF0W!< ")
MV1$J3S-!8(.+FK_(5#>$-@4QFU]M:\U,C(\**"174N#AFWI9:$9A/ZN^%!CW
MG)WZ0<;!>0/V!!U@]VN]C:PX0S'Q-+[5^-O[VLH!EA%]3+6LO5MIJ]FC@'RW
MX)N;_CEB:*95T*OR!&-3[+"(9,P*I4D95TK)C[@U9!\RVEB0]F4]US/L>?++
MM(QKTV=8*IO,HFB_[&U>&13N_]B\!B0NH9$Y312/>66"3?B =,VGMDG+[O[J
M=6#BLE2/^09C^/M6/]3$XOG/!=_$/DFU]Z -3Y+4R#:A6'F9:5C8[VS>W,EQ
MK=<@AOV]J.H-SR.K[)>KQ[7 ;UUY3+9P9L_)+D88C!UG+A#MMRB'Z%3'7[\N
MG,:(@,4=GGU4?U))MB$"[B9F!>1FRB$-.Q'K33D'Z%=P)45V\$RK#;1LPI@N
M+;SL46IUDHO7W(>SZLYHH6^-1\],DFT/1B2'1Z?[65G9L/7*A?AO';0I/8A!
MX\[9T64"XV0G:YXK&2E:WY>-6E=P[#H//<[->T4/2#JM2X4PAC@.C7819'=I
M]7A?"HONAPG#8PW$]"4AQTH9)K^W;^4%-@5\G6)\YJU&(:*PFBNWQJPM]=KA
M,'=UZWNMCI?D$ZR=%%"8NI88,J6622EFC=X;P_CCWJX&V<2U__)R]TSL=B4]
M =0S^_4IL4\Z>1*L.@71/GD!U>PB'.'!/?1T=,=+JIEO^>XCCY>C%+'2>01/
MU#$.\=<>TJJUL#A7+^830 !UL@SPY-!:O-++")QIA%,37ROQ@KAA25L*J9#7
M*[/8"3L5HLK .==&[<&9!JQX>):.J4[T&0&I5TPE5^\AM"PSGOE)C3Z !]EK
M_^RSM;,IH7,:DU7C3GHL'@G2_KE2$7;(@(1SRN&1)8H)&LMR?7T1DNLF];61
M)F\_6/L+U^K=@RE<\K;EL-&'O/60.;"BT1C05\^N]+&NEHE67Z+".G'JT]FU
MX^1C"LD&;RFSC%BB7KPPN,4:P#!Y]GAJM0*Y@J+CS'V $EG<.F-T7G0U WB+
M/OU0=);UPRVF:FI@<[LN?W_,VU5G@$U:[US3XL4AD*-S<M<*[03CHN>:[BF=
MHQ&J\Y,V-=!A]H?K*F<HW6=]37@0B<0IK) ]B;G: 1FQ@E=X;5_=)L-KES9-
MN&3M1!14-;4)CEO#[CR,^9P )."AR2,EAOB3BR=Z9M"&VU(]X7E!:(.YER+#
M8^EQUH-"Q'.L1X(##B+7%;MQ215]^)8)PW$V^EYQDU?1'UZ:SLG&!FJI?B/^
MMB+G:)#D$J-;[9307U+R#6[3MGFR&:FG$Q.#,XOD"A;7DWOPGM(@UR5V1QFS
MA5@6X3E_N-Y:BZ<1?%1\VE7(W@HLZ/N)*AN&VHG,$E3TO3;*5ZC@QRM]<W.A
MG^M^W[C6Y IX9(Q&F>>$H/TG9%+&*!6-,9ZC:&5--/?=?ML[Z L62*AN-8.P
M1&RG.(UJTOEHX;[G Q[6$L<P4CA6D>EV?/5Z<5D+\:>:=E\K]^EIK34:@;"L
M,\2$L+K:511("/NV(?CSZ,?;G*$$$!^N87N= ,J\[(-.M6B'R5Z&J=[D%A;]
M'(V8<66Q=W&6&F.2,WHGGL*0'Z$H"65SGSE*2]X=]KQ'^]7C[ZU2N5@JJ%>9
M#KG7_+-S?N\&M8LPGX,.3$9>2R1;XBB%8ZYE#Y[#G%__5)^M)1.H]? 5B,>]
M=O(I0_HS;,DH> Y%X2/"P3JIQ"$A>N>2%E[X*'(=&>>\K7Y/?M LJ>VMOVI\
MX8_3K3]7_'[L_5'?C)%D_<Q@P?8+ :]\U<Z-G3%/;23//6[7XFRVM.G-D+TC
M#\Z_X_,")X<<USD)U>>Y%U#B\]$SB?9)DUDQ=BPN]NZS;*_:)W.<-MZN>C;F
M+!S8@'1L\+4\A^#&;_['3E>DK0G3VS9JNM<,@V7'IA(8[_G6W$\'@I.'-?XH
M)F?1W>R[/WUE0VPYM>;5^6-2DN3D!URHP*^%$3R]\@]"B8GJVG&GT8X0SU6'
M['H"Z%C&:U@Y'YZ!WOJA<VET<2F"6Y)"Y%QC;/SBV6@$SUN*##T7F_C!2@=]
MT:]61TUE3@R[XYWL/JTJD76L*OKDY6*D*',2SO><8?)DJG]\N3WMDF+;T_6T
MM\ 0,D>&E:N0]UYOPC?I'(<^F?JZ*J0>YB47V96(L\A4]VP3\'K+SNEN.0+:
M*)N$W$6F.B ]<;HIV$_F6T&-CU4'F(OUGEGLD*\!RZ '5-FH2I254\.JY3/Q
M=Y"K!4N0"EWL;8&^#Y"Y]%R'-H<B?,OX_/ Q/:/5-+N*K2$<NRM;<4=ITSH\
MFU9"=6?;_*/CL&%"W!.84E3 Q,S])$Y:NL^JU1XVBUA)9QFCY)T/\Q##H>W4
M;2%329W\Z]L]T[T94_$=':'<V0N^?=60$^@1@>QL]VW^.;BA'\JN5ZRAA[YZ
M@#Z- ^"*AZ<F2;YA4$IN&'D:7L:4*I^XXS4?J5]T<WRS5.=*74\CU8:C4P>2
MV7X(3RWGQ0W/ H;^$_WJB G3?JEM-F9>_VA?:$-#NVNK5G%(,S?F[QYA%ZCC
M?N>H^A:#TF@;6<X15<\Y2UY_SHQ'H:3F %@AJ$L*4U3^W75%L;U]BT<2OFZA
M0W4C98!>XC6FHMTW1+QQ=NRUKZ=\?) +[_JI0&_7ASGF+)S8#^GV_MQ\MU-]
MO'Q2#Z+56+P'%)L? D.)F\N'2TK9@V?M?(Q>T3VN^1NIQZ"T_?8FH\%%(UC_
MWL>%'F%+&8WF,\+;Z5UHYZ5+E[6NQPE>0?AG\5P-U!YMLLS#]D4+R)I:-]P2
M/LP4?,EWW^J!STWC,!V<:6LGQ_:A((<+J/+)S"K(F=/IIZ*4G0XSN1@G6"5A
MA) V330+KV=L7M>$>ZD?:A^+7YCO2ZIRW*>I0X6- !;;^%<"37/(G,>2 =^V
M%1I+,CX30"(K+7+*(Z=3]015C;6ZVENZ<A3G2VPW[B\[H[+KGBQOF/9%]GQI
M&G_0#E,S864J3<F+GU$KA"[KJ&N5E)0](;_=2 5;U F-P1D7>ZB*Z\K[CD4:
MY#WW06XHW(1XIG,Q&W6<>J5?8)Y$S$^AV+:1T1<EOHE,^2>KI/!OE!=+KW6G
MZ,TQ0BO2''>BH=Y4];9P68QK>PZ%]W%7()MIQB*K"H<03,]W:C3-+7.;??S<
MJTT3$BPM KS5(#)R&K'^F9<"PR.ZLV%JUCY7GANJY;2E JMGO_0)ZKYV/!GG
M4I2,=O<ZOWLOV8.G>8P5=7="4DZ?E9+N$L-S0C9JUM+H1FU+!=&GZX_=9>RL
M8+*O6?B"F\1OC4U%E[A7:'B@W9U/7NU-^_H<E)>C@[[,I":1/^/ZNO29@:'E
MSP2^+*2$\YJMFO,[Y6:E5J7.R;.P081H,UD2]#Q7U-%KC!Z#H0[, T$5[Q09
MZ@K/@*O;G5AX6U;-O$/,J_Q,3A^U<G,7(]=C$0D2.Z7XD2PR:'Q5N>YD\,2[
M)"[G"^L83,"-O@;?A**V>B1XBUG/>(A!W_\:4KKMSAWD6A=?OOM<#+)K*9TG
MCI;"^V1,A;*)E>2L9FF[C75[#M/;BPEJJO7AYI3FHOOF#@FG#>E@DW?R/@Y,
MH[M+%7NI#4/74_L<FN3=(1$.7Z*3RBYV7?61X>U9H&VQ%ZT$+[V=61[:0<[K
M/#G$'&GZ33]P\CID8,<D(NZ3D:"!;(!7H8@9@WT>_M1LGPGJ\TY K7=U7L.*
MD%7XY-,T8S?H$?84M]K: 0\[/!TV"!AQG1ZG0W<"UE%\H<5-V7.-"H[/(8WY
M%!I*P%@_P\DE6I&7-$@ &1EWY>%U0]9#!Y]_R,JSHO;>F%6![G=3_,@WX&$3
M>0;KEF)O*Y"KJIE\?OBFT!(!5#@@-2.>'! 7"V3)B<0LN?8YQDO6^M"L?/';
M(D]$/JY6(PC//_70=:$:IH=O/0OD8S[V^5&JIM['2[/N+:P-(32JDHYJ]DB&
M65^X5'5MX-RL7Q$96<(-*F:3-P:&C[]5O@__<0U5?J64'C?QOSW[=)!ZF/MS
MCK2EH3L^Z-I<3?C5>?5&FHL667WQ)HT'N:)A2OULPK='3B.XXJ6S*;AHCFDL
M.D,PE/7E8<8]/5AX9*:L*=Z(J1V'2C >3C*2Y=&X7&8*+!_\6"W=M7T$4&T3
MOLP-XP59V?M<G!MHD[A^;\YD?L9.7 Y/1[5S [UL]N,2H#\^IU^,1NI3EFU5
M*DS:C.IZHI?\GOI/#_7H&@[6#1KV"HV1BU]#3FH)TJA4\8BPGA?B= #%Q=)D
MG^)S%$#3.C<(SA% &1:%U*<)H!SKFBJ+S.()A */9A!#G>@NKO;''3"[GZO,
MGKIR%;0(I,I6T1K0)>6H2ZO5/3NA?LSF[+8U2Y 'E";EC>TJ\<W6#\V>LG 5
M-?.9S0\KS=J=5-FL649%66#!XTVT;V3D[NOG]SU7YS;B-O+D_=R,/V=<>%?F
M8%GJ?.$+VB>BVC?FF' WTR0"K9,L%"T#PVVD4BHQ]V5YMV>9VLWN4)2OL?J;
M(<*48N@OF#%COIA_.K+UTJ2.*VD=)K!5T9BLC5E/38FY>?*T:O6G6PH3TQV%
M>/791I-@9FYN*=G\V-RK@>$YCUN@-*>L&<F]!>5!%^X5-CREE"^..6N81@7#
M%4R99.5B$QZVN-LD]%?M5-Q-@UQ%+/?R,%\O:6!3M6BYVJD[ZNM+]SVKE+/%
MCQS?H+60CN&$E4AZ*7H\>X="1RSKS3:[ZOI8L")HKW\L7''4<BJ2!K;Y$;X/
MWG\/F#'*AJD:6.O08B X-J7^VG5(]N9,,E+(H-^P>ZM=XGP7>H2UO7-C;LBP
M[P32,!3]D5/XRUK*S=9P;LOD_C2[^OIFA=7QQRD,,L<H;Y*_,RJ9-O*W"[.K
MJ$\VH1\IRJ!3BOKZH;%;W<DG >7XI:2K)>=5AX#7[7BM8XLGZYC5M\:>DO5;
M0YJ.*2&"#J=ZV;!W?!"GD\>&'[AI(WKZHDBMJ3UDB;IM!?=I%4UMG>/C?4W-
M%SM\7>7 SDU(77%F<$+/G1P=@TG/8IC3*'=(8X5JC>6[<\/@^S,N!-#6FB<W
M-U1#AI?M6E^'%Y3FWKFGT8@#UB+\WFO:#*=.S%H\R]_/[= K3K,&3EQ/RZ5Z
MZ^@D>;S2I]VL7U+E"TX&7%=<%7%OY+0)8Y;OVT@4?T7J)?Z%E$7FDC,\R F3
M]YW%5DG&&=F7"*"/?7DJ/F_UYC1])=ZGZ1 9KDL9#*%1:J70R&)=1R;"]8T[
M-P;5/GS/$!5ZWG3 YNM::OHI>S3^%!-]:FGY.OPBC&-1U-5^-[</B5*RD.^/
MXPCR(#YT%<JZ>P]%H=EQ;!;^Y+9,U#9=KUBMT,**K9ZWWL>T)TK-K8Y78H#]
MXU,3#=1Z%?%NV8#OFT6N\GT9'F1IY'&PV+B/O$>*BB+BFI"E;7'R>CNA>=_<
M/@Y-3C)H&3*9> -3)U"IVS(@>+2U5:F-O2C>>*,0^C6L[K''9P;INL^K;+BP
MN10\:Y7RT;Y#Q\CYCCZA7A6'7-4B=SPH]](I3-+2MSJ. "HK;\T@@%BZ"@@@
M"SCV4R,:^X;MG.;12Z^0:P%G_+!4F#3&X) LSP&C3*?ZO@_;K_,+0^,"EQZ@
M0W)N0FD-'K>-^8WX/7G;PZQPF_LKV.=*\ N1':'JKG<\<3A>2T"G.IIM;!/<
MFJLV2ADLU?#<GBHS"8B7R8U<B_>F*\-XLJ3L'#!';!_752S@5QN^X,AU&PN8
MI91+.@Q/#2JT7MJ.B=*-FE=.,DJ,^QPG+&<%6/IJ$7]^Z F^@0 *UE%=A/0Q
M5/4"2ZH'32Y-['B^VB.K,52V4< #8+?^?.7<T[S-S2HU(F+ZJ86BN7>X+3&"
MLJ6V%YOLQ"0H&NZ@QC>3\^ 1X:Y,)H&Q<;'1P96R"IH(KBC8W8"T+$Q>C\#4
M<TC6QB;,<\.AN_'059^<6AB4W;\[@6-C]VDCKI.M4X-\^-HVI;8Y"=-6!0)(
MR-32JNW09S-3B2X7"ZL\PP@VF3SA*@6+L)?NMV1$?6IS#+B2MPPRG&)K-#JU
M>,&A]/J:,SPOXF@N<S[W'1RJ?A>T?Z*VH^C]^Q-P,D2FLU7\F)=3,; BH7$J
M#CM\4NSRXBF^A=O55Z53@J^575AB?[? YEL>#Q<93\@/FS$(<]"0H5_^9@53
M0L31Y)ZOK3=/[E4A@-8-XHY/!DUL.I7*]UF]D](":\3(W0C(C9\H&@7/)WY$
MSI4J!E=,?AL(Q^_/.$A#<2JS^7GN0B7-/8"IV%9GM9V0!"FC=7ZA1YQV'_*$
MV5>_KJ7PAI:VV0ELVV[Z-NUZ=Z\5(7,^24$^^3+4.DP700!E67>G2E1..#AL
MXOH-V2/?;Z0]@]V66:"0?R8G5NI2D3EFNL'G/<D@',\H>__&"]B-Z!>G@_V#
M7U"N AD.2 .(]" NH/U]1D;<3^DI=%9?AI2 @+&>_8)XD]N/<@VNZ!=T)31V
M0$V@ORA7RH>6]^<20&[P*4F$F#CQ8A@S+!W^U=,4EDDM6ZG:=AC4T="3!@8%
M_;N++>386H-H^2"O4&%<=<\\_MLT6@_R3?I+V4LGU;Q*),W308X0V>>L*_.L
M!P-EMA/D"_J0Q8<<&5<0/,)T0I>C/[4+BP ;856#_VL__E9H>YT%T,W6\).Y
MR6FZ+J@YC)]IZ?W2R8<W(5S7OS3I+CJIT4'O!G6\8;"LE5X=0D0*MQ7+'/2-
MB&E:]U+O:PJ^S<39]/+3H3F6?>R8?JO.XCH$E[>RRKM)(6&K2[O;XU\OM?AW
MDS64!YY]*<$C6_.M(//]NO:+W[^]77?0?'SQEK?'V35.I)9M.D=TM(62JG[;
MAU<%?NW.-S#LKER8)QNYD]?\N%X.Y 9=0,C4DK?[.YE+,0!K'(]_9B;'WK_K
M3NS](/+?EGN[3]@IM=XCV]V+QNY'W)?FEO]Q-4ET\#NEYGW VGV)V:B]I3/B
MAGL.'Z>QQNW=9([/3O=8CCSYK0Y3&W$#W$W6ZO&;8/_%\)V)NJ2J2^2C)A[1
M\; )59Y3XR%7Q,E'X=XI.!D;?:.XIDGU+_&2+MY%L6)ZQ_8-4^'LNU"M2BWT
MB<GG&DTM)Q[OKH7$"TVG]K5'^P?>(S9_V8BX9SH(Q)38?<1'!"F((7X_$'+>
M 592'-P-+J!HMQM1][X0H\NA_8%*%##BG2E*^YX"E>B)SQH>YI;2D(5UNOU,
M10[M!YQKW0=\>OCCTT!B3 X-B$+CIMQ=8B[X@IB)>A/5W=A5K^0;&!@3MWLE
MRT&N:1E9D7O$1Q)?$ ,9S6X$!.+88]_ $7EF[K(7U"5\G(X:H-U;@*)V#3W(
M%1M'4P74ECX8C> Z<3\I>P;$!5C!1<R@?W0"\?*K7:/I*78_$3W=3;#WGI6,
M@@WN'O"*B[JYRPD07?<])1)%?%0RBJAV]\.N\42['W)%NT'/[MJ%@$ES0\]2
M'*=A?,@51_,R4&D7"="DA !Q$Z-T]FYW[SZ7221]/X*+V(+\>>Y8T/_-Q34D
M(<F_6G:S$5D-69"=\4'F1)H7,%FC@]Q1^]V@^U_L[A]V)RA9JDB82%OB"=NX
MV'DYZ4? 1+@+3#5ND!(0IX@9CM$Q4K B!2N2D.1?*Z1@10I6I&!%DG\+(04K
M4K B!2N2_%L(*5B1@A4I6)'DWT)(P8H4K$C!BB3_%D(*5J1@]5\.5N1X6MV7
M!-#N'<SW=]_7F+RDNWOGLAG^8A$C]TI] 4L=N*YTS)< \E ;1F^1P;^W#^&T
MP4N?<'0$T TS7-@' L@KK0HA/-XO'@@)<JEF)H HTK_"5P\10+5):&PA9$0%
MRX]_,;0I*$0 T6G[T%C5YSMQP7FV?47_>>-<DR'FZ_?P*AMG[' \Z(,$4#,3
M <013P"-3OUNC*T K.GBR-Q'7/+"]46LBBO@7Y007EZ> *IL^1MCYI[&1&J7
M]]S>5.NW&/K=AYC?K;'I;I$2*WJ3^68Y/7\,_9L/4G]CSFQ&M*^#'94^U;BN
M1?5O3B!_MZ9+#WIF>8%$*(E0$J$D0DF$D@@E$4HBE$0HB5 2H21"2822""41
M2B*41"B)4!*A)$))A)(()1%*(O3_!T*S_I+09#&&WP@U_#M"D0 45DT E:4L
M&?["4N2Q7UAZ]),E7PB>ULP=\HL_J7_6*J+8\T?9@@!:2G;^O>6?U:X2&X;M
M]60,$O!3>WB(Z.<WP$]^',\BX$@S&*#!@-B1Z3\[4NH<X&?15_0J.>!GZ"[I
M:O9"1-*O[I+N\H-TVW^$PP(X NAW()Q'F JK0KRL+PJ"O]NP1R3ZZ] ?%6>G
M]HB$U<#+TI?L=O810,L&@)\A>-HW[N@IJCUGNOYPQ@]PYM'PXA89 ;3K#7@I
M10P8*S?@N-#=(53X8PB)LOT#H#/XKX!ZPP30'TA^'"\8,+"9[2=!J3\(HJSY
MCAY1QT+P;N ??DKA>/E_ O7_!!KN A_8W]X%\N\!#\/_ H?]#0?YQS@"Z)\!
MDU-^!6K\V3(M %0\_(N)?XN4^L\BL0 2\@,I!W1B5QED]0BQ$^'83S,_.K$\
M4U@1JUIZ$NAM1?S=^KT[\OX2.'CJ=V!?F>XN\.T_ RH!<RAW*61G/WSYL2Z>
MI_#3[FPPG_-5P].B7Z&GJ('Q L QRO"RO/\L#/4/8=6O@$G\"RZ?B$/_#4YS
M#T?[CW%AO^":/""_P@J6$OXGL*Y?8>BEM&)N8&2GX]Z'$$"(M.C=D1TNR@;\
MY6$SHKMU$/Z] HU3 0,XWK_"V?V&P_U7<.B_Q;T'< Y$'#"A?@#3Q7X%1OXS
M(-]? 9U&S'X%.O^G@,!<'CH*;P:&+<=YXJ"._SFH)^ CNO:Z>#?XYN6]T;\(
M!/R_!U9?!<;F=AD!M'IT;W!"?JNH+;@;ZZ[;"J.P:GA@,8LRQ$L1;8H#+(&/
MP+<.P;\[ +6F?RP9Y1D-\#+T4O4.&619[(<CN,N (TTXY*XVOI_:TK$WQ/8*
M.'?M.\M"_T-Y -'AX#V'SW3]7A"#/T%U#-X,&,U6"\P7-;G=5:61V=<,?P+\
M2P$PXPY3O89/ >N'WW>BO[$__17ZFY)$ N@5>3EDE?@V_V4X1J45)B50]";K
MC=Z'WPN T7IP!+7K+@1PERLF[(>[P(S=_1[H$&(!9&3_4M,.&7Q9#(53L0Z$
M-0!+[DCW)/'KKI]?@Y?<L"9X-_0FBR(P[D6X)G;'O17JUZ^1V)MB@@ _0S_X
MT6:FL9+;):[I]P* N$A&@!^S/>)\$<)Q_<Y^<U;HI9?V9K]J$_I%&RU1FZ54
M1B-@_=$1]"_6'UP:VB%#_[!>F6A]+4NU*$ 9_VL@#C#]PAE3.7R5<H^SEEW.
MV)W.;.#.#IX!K+'[H[?,*.'-HC][ZS;T3.O"&<"XH25W>RN\V]!/XXJ% >,6
M]XP[OF=<$[R,:J1IBQS^W6C7-/*E2:)I D33!/9,$P=,@[R!3#'_8AFX'/6'
M9<TM>Y810+AS+,R[IDGNF88$0+NVR1!MN_G3-B#O>&5O1S2.<=>X6V*BN\;Y
M[!IW\*=Q '/4(T-;P/JX9]Z1I8T=8(G]81_-#_NJR''G)%B 5N%_M(JB@C=#
M]AI5W=G3YD:\]^ ->@I8P/UB]]S@+1]:!?*#FE; #?2><0_A9;0CB[\T>G2)
M /JC5;,]9^G!2QY8.!Y0NNM""/X$&E#T9ZMK- 4H\^](/?*_*2!.&L,W!-!D
M^9_(S9_(IO\(^<,3=Z#$ &A9 KQ'WVUKJLVE/3=*H!<-^X79NH%P\TKH!@&$
MHOK!JA3N7"$Y#ONCHP>B??\*U/L/0:(W=T'>0!<#4^O-4\C*R!Z-R;8(X5W[
MC^)/S)/CG2'+5W\L*#]!**!/4NNX)ES*_<6](=C;J^!=6YOV7'1UWW4$"!78
M3_U[+0(>OX+\WN*4[LK8WRN[(\"_B0&4I>\I>^T!*(-LTOZJK )0=OL6H R,
M0_Q0YKFG3)>HK'!/F2+VCO7ORGS?_*FL[Q=E4K=_5P;_H0QG8KK'!!W^)!\5
MWAF^#"Q8/N"EMT__0!C_-6+\[Q#B  +]$S&%^D<(ZI\(?AQK&"=N$_Y=C0!B
M[-DSM@HP]OX=P%A^HK%C4O])#/_O&+U=C!KT5TSA?X0!\KO#:5X ?[I$_JIR
MN6)"-RC5UX'5:.1T"WP2Z'Q6-!;(Y _G^@ @^#\ H?\YZ IDA.XW3.F?F)RI
M_Q*&'BCZ!52%_ WTYH(3 WC)^RD!M#*YVP' IU=Z4H"GD%U/-59AW[:)(,B2
M]]0>"+P+,B2"%'&>1% [[%MYL+@W"BMIC=Q<!089$B\ +[L:"V]*P-^!8U*-
MN28>U;-4*>+81*1P6_#O0%5&R AC*V2R#3 ,@NW,H;&Z-([4X\2?3&7#NT"6
MV7:'A8\1>&5ZMT$3#83P>\OJC-U73 +;$0G4)I!%5R&QDJNHO08%DZ%TQ$;4
M<&R.BG\VPM0*_]E(*HTVT1/=)5\CR)Y>HB-6,G\ZD@VSE5#IKB=^*PM\JXOS
M' (&!%NA&FX+")B2@,;V:*_/X]K>:*R4=?KF&M"R#]%5T3AX4SK^CADF59:K
MB/*'!KM_JL$S=7XTV^VAVS7)@B^UUVN;''DTN(]Q12- )"$)24A"$I*0A"0D
M(0E)2$(2DI"$)"0A"4E(0A*2_+\B/$P%#3GA;1[]>K>^L&!I!9F?D@400*]*
MS397D?@M 7B9KA!N2XH <F&<R>7<4%N.>0RW@?/8W>G9$-;%RDT00"AI F@Q
M1@IW?@7>% O?:$E+WD5<(X*CIRYLAZ?_412#/[6)GFR%;$]UJ61 "M%!3-3;
MR9LPZ],NC6I_%+400$><AU:FP3NK)I^Z40.Z=3YO=SIPB85')29Y_RQ[^J>1
M@AW/%!?2QR4K\#-X9>V#**N@_]B!BR^;"NH(H#\+(2/\'_ N; 10J8^-YJY9
MNQ;2W33L'X?_609>"FD@@"3\"* AR<+47<-V;?2*REJP1/]2B/R%'&W57=-V
MK80V/R Q1V*.Q!R).1)S).9(S)&8(S%'8H[$W#]C+BB[+PN>4&E9<Z+4]9Z5
M]RE('.TST*&#-(@?+\=+-%WD2^&+G%BP'W8[I"%#SX.L:#[0KA9D_V9,/B@V
M]9"'X7K9=2'J4WZ3/8Y^FVID<,SMRKS68$94S[M5WT'!>Y SU%N=+1^O6371
M*HB8NG!"G5,YO9WEV4S-3AB_(("R;&<@9XU02\'8$/QK9DT"B.P) 33Z"9^R
M';IC*8Y,YDH/)(!&^##\.\=$\O"']IY@/F+V%C[UJ .]=(WX)&6RQ,A:S;I$
M2G3I?:!+\BK0JY=FAK!,/QZ-/%]ZG@#Z^$:5 /K2 \%^DDC9?M/%UKV5B=A4
MQ)\:.D4 -9<GPX>?[3Y\_+L1B5M9"V MI-Y,'>\X!"OG+$< W:9,)8#<,G>?
M>=8<U=VBMS'#'=]]?'6F*=^%9"_)7I*]?VGO_=_L'5/CPY^US^QCT2FRM2"
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M"/;6HAU&RK@I^D)NM]G*].,9L^%<+1Y@L5Y*DN.=Q*O6&3_NXVGA?+P(I6L
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M)O"Q1ON,:32"."9@XR6E>F'WS@GSOQGB8"4X$IU;8F]=YS3T+$+@I%X%)YK
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M-,2:1K+_C*=]2Q3SF*D5N2;XQC]AQI-,Y.<4>^V. .3>'Q4'TG@ K%$.A^/
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MU.= U\H>SLUH<>MH@TIU5?<[9O^7"TKNFFB(?/:;D*QY_<=$ .]I*)8+>(?
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M7G>N&818%B +[;B,;.WT&:2Z<FYNP;S@40>^LV%O0<](7>2KTLOLLC?H@3,
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M'-+&T+"1+#@K#)4/6&#,.\NWA6SRC&8$,PH"_4*B$T*V(PYNK@=L3N01H%[
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M^:0S[C\?48)#_)M14YN4:C*F'_\_MZMTT]_L*LW[KUVE_W\@5UHQ,SCIIW@
MHHZ0'Y4UW/AQ1M!=&&[@S3\X;\@-/L4#4K%1@EC'HJPPT(SHWQ41_#/D!Y:
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M ^Q@LC,@5)(3?(VTO0C%3%G6.0P59'+,D<8MRZ"L#:G$4%G. *P]@-2#%<\
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M-F6GEKP((9U^F7< 7>4KLC.MT^*_3KJ&A^6%, EC,:C)J9QM:,2QN4+CEYS
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MV9&;"YAS3IM;8V-U]A*@4G@RFOW-[*H^#"#K'O7@N]!8)%QD"Z/8[$7>!.<
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MT==013OU' C<8+EW^=[?##!ZW1I.@L1QV&\')H*LJ83!&Z/N ")F6_5\/^M
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M;G0]6,ENO,1>1LF,G]8.=$P]T_=(?8BE0"71BH\71L+DQ.^5:9PWPS0>TJ*
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M9^8D74UQ^NC97@4] ;Z6$%>5\8AY&BWO'ET1HC7[<I1NC/GR:WJ'*$ S@!>
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M>#E&I6KQA'FH.^;M4%=\*D'BE5X*3LH]VU$H7M5+IS E,J<PR?F,E)?3#'
M*)NQ#N>7B/>X9;^SNZ8//=O7.M*8$V?ZM$N93S1/<HV\NV>K;BFH:NB^PG?&
MNU+]B/5@;B__^VH1KOWB2.;Q(W]+0;'L>HXGA2VYK/+H_>1.FZ-"DN<_BOF.
M\&N%P8EZ95PCG8P]VD5++_@N5^*#:1/#$[-)&1JS4UV"VM6$26]X9@VJH_;)
M*UT9L\EM$]?"#C%/A9#;U?C5@ROD#%R*R!8.^Z=R\G2LPEF[:'%])QK2Z@=_
M-)THPT1^U@]?\YEDK/:<$:LRF^PXP8''J-D!SZE.!O@B.;^TO>RYUP6XH _[
MJA(_4).]Q9UBTI3X).JC2"_?!>7U^!6ME('K.\N<0,V /72M4TJT23CA(-&\
MV4PDQ_;%XO/75?(W*JNCN>?"X_B!SM;O=#)630JG\YKPF8LQ/%E:'UV&(X>Q
M(NQ7:3[>1,%V$WYY;WZ$>8YV?]: -O+ .GJ6=K 7#=7Y5-ISDYQ 8I4W#"0
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M4K2-^+LQT]'7H:\1.?'JH4XGU/%>RVZT[6%.N@O8ITN+' U%EL/[)&IF9?P
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M-]1R6UY*O1AT?Z/ Y_7$<RUO:RPYT/SXD$E :NWW.<['>"F\#S+ZRF2%G*W
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M+0KC)U28).:J(]/.1CXO CU*?6(5O*NK]\_.__4VU5HF76[912ZG8^>BVZ4
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M7J;L>N#O>_[(@<L>6\5WV'M&OK/GVE!CN9?ZQ ,TU^32,@,E!&^+Y$*7RNX
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M;,*H.CRW/N-6'[%X+_LX8(/U<,YP6-;X: B?!IH7"E] 'R(*M8UIJU:QA^K
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M<V>HJ$:M_V%$=G]=B9S QQ5(]*,2BT$FIOPQ6\'B*FN#9<DSVU%9_W<?"1-
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M[:Z^!^T)2N)"#5!XBA1_;O[':A.VB5= MM77^&6OD9-?*,F-;=\V@$QZUP_
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M)YX/;U\"FKP2SE!I/KU-J%GJ9''?Z_W1Q972H:86-:>&7A*,)SB*5] 6\*+
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M0*QK#/^;-J3,MO!?Z/<R,0I1\'3DUR]%$?.T_D8[HLJIHL[4VS_9%S_ZG.0
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M2/^WY%/]?[WHT-\4^/@*K$W@]L:XX,2D0YH9\B'-XW,9)3O6GV#1\+^J\LD
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MU]L2,:$[NPHU+'1TW_0["<%S;,RR4T]";O\<';PJ)J&B 7V;=B$A<_8J$TN
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MQ84D>42_I1]%O=W"$XT?WN42&_2TWF1TMM!IN@9#$O/XLOH</JA9+UY+<WG
M8!T/2:%6<>G2WK;B>G-(533 FUBLEGR,X*\OF77P> BN#IQ20K\5))X'T.U=
M JC>?'T,O6XH+YR8K"_2E9O'[WY#FL6*'27:A*5?".U#:3M [KY+KWHA8X!H
M[?)W ;80IR]? D"O\HL?HW@>M^K&.[O_"9SS^%\FR"B(G?#*UU$XXDO 4[K\
MOT]CV;$BA] X$:Q1^[_4D8#H9T.[+'OQ#?^(B/(K=OV3Y/'"=>J/UWOT/]^K
MLOH2P.8#@=YJMN&,O^9!GL+\_6+*DR->)-J6;;6.]'\VD^MZM'/OQ\^PX1FO
M5E(B^>T;W,X[F<BRM''34P_%H0:I^6C@FJZV;E"V27J7#W-+/-93P+I.__QY
M_*>GQ=_:I(!M!Z>!O(B,R'P"A$U@R"MDIVW#,U=B^%..?4UZTV3*A6'S+E M
M?Q2WK?\2B/1[:?7PG$$Y["I7U*.G9U>O2%P"?-P.$8H9WVQM; L>Z.V>)I3)
M[&^UR3T>EZ\<*6<LG[\$<'_6>B; @NL# ).V3-*HT9$^7I+._)ST3-%+-#W"
M3QB[ 6F:,O%^&#/9VS/JCQ+?Z8[OS'SXGZ03(8U$IY4MI.H?:9)6Q]]8V?Z]
MO)3/ /+Q\ZA+DW4<(C"<:24);F=7I8ZT!_OC0@MDZ7*NID4I(#YDD*?Q2"O3
M2:3GPSV<!EX]RZF&CYAQV<8-_HG%767P@/#0B$F3!0.N"?-%;VIJ*X7G6@69
M5YXT71NN]B=L*H>$ +7*L:6*_LC7,P)?D!;*,K:R@84U&1G";K]KY%51[-55
M89NSREPQUI$*/.NM=R,/)I"<Q5@K4Y,Y,H%)OBR&^%FCVU83/Q65TEE@:^NC
MNM'3"H3G=$]C9^.N&=EV/GQS_GB(YF B26?YS%;:T',I&C/W[M.L(,:BTHXX
ME(L^_)U@#.Y'H!L,@0%_UU97-^XG:9[=^)84C!-PRR1+?:;K>I8Z\>!9G;2\
M)+LL"5>"F=-MO1X"*<UK5S"Z_M*GL&5\]D&IX0PR):\F[*4(3"M0OOB,^\'B
M;OB?UG8#.Z*:3#ZO^1)7/TX6(P,X?JQ\0<@? 'R6:M<.LVM1 ?8EUQQS[>+M
M([AZAOMNVBQ]$[D"RV,\7*VGC!R9Y#O5[[M(F?KZ>Q7'N? P0-2%'1GL/]%T
M8-,)@'KZ+\F>8\PX;QO\H0"/H_7TXYJQQ*VU)5%YF\*;=QI47WR_=T!7UBT;
M4;(?R3U >%ZMX."?I \SLC)#1G'2!=,!RA5C&14SEC&,]@'M#$UKT6N'A/_D
MR>;B-4\7"H[9&5U 4BSLZ"J-':GL[01\6;L$&,Q:_E_LO6=84^NV-AQ%1:F"
MTDN4(DVZ2"<@T@6D]P "TJ3W&HI4Z0A(#46$4$6:= 2D%^E([[TDU  A?&&=
M<YUON?;:^WO?]^RS]_G>LW^,'S.YKLR9^<PYQGV/9XQQ5^U]R&A;K$MASE9U
M=#.^C7F(H0C#(!N4XJO\OA6#[_%X$QN;MW<)-\YH;0<T$-#@$1U#BR&KSQUM
MCBT*W.# 50#BB*+T>39,_4NYUO/N]#D>5_-T VLPWWC2=A7ED]I7PD9]#\R,
M0+-O3. 4AR71+;XD(:V:=C5M)^5&/4]!B,&=M M(DI040>YHW)?;P^6KMMO2
M+[LU_%BE;XOB>ZR<O'6!$FPZ6OG>?T^.<3PZ%FWV0O-8WX#Y.RF'\JPF_#0A
M5\^O]1+HWGUNX&T#C]-FGY*[D*6FL0^SI.,BD@Q):/I8R>?%QWJW/]C@!T;$
M=NB[">XZ&%R0@(?F<,K$^B\!]VHZ4*(_CF@(%>M"5*KW:>4"F6>+8R,@=_B&
M-XE$SFQ&N$LV&()&I1WB)*X7#:JQ""HD)Y'G=R10F[?VX:K^*-K+&2FN#TZ4
M8N8O- 5 :A6=:T?KJST)<FRN[Z58Z]!+=5*\^G@M?D\K/UO-,8GWOE$.K;HC
M^OH09X4A84-)%G8\]U=SW :] +*T !D3 ZG[JN]KTB>62$A,'<0>_N 3W@-:
M4J975IT+NX0J,'W(L65XY<[$%""$LY.?G1IOR?&-_./4KADR:@CSUA$83NHQ
M)8M\3L"<$J3VW0R)*]LXZ"UV7/N6]D7[0AK'D>UML.,=FDB7^RJ]IQZ2L4Y.
MU)> <!2;W:(UB;0=Z^[C#Z\[E%_*V$.4?QRX>I9&H)YF=Y]+QVL$B]$G$NN$
M'P*YL*/S^SP92>1S$U)J_]U=;6[I(DKJF\P^#^8.$TW=LL1BNX8^, 'Z#>0Z
M^]Z#%XE1EOOT,S6DWM(INP1$1;]9VT+5LC*[<!0EQ$BG0WG=7@,CG,^+M5JJ
MJS15/*J)WTRD!JP1?-R7I;F6YZ[4LO8"WA"9ONQKT";_;=A>H.?>B,./L5$2
MD8&D]R4:?;TDK>X]K9.?"A<567>[Q_L"\!M-/,+K[$_799G"=RTPOL9-0@#&
MQE5"V(ZF&76)]%*L^5QYD!4D'EO_7=_[Y[KLCL'*_6=*'.M,-_FN"M[D)/XW
MQK7]M[!?]I,G"CM\A2&]6%?]N@G6,DO2Y- %7MSY#E04&>0($TG.>(1.A. #
M@<!] 8-+P'@@AAUV;DUO%J),C2%72A:O_J[B(;2\").6>U+YP+L3S0-V7$#K
MVZ#1KTL>Q_04)]1')502"*7RA1J:BI[V,.!>6S,/?^-PN_NF8&E>LB2+)@!&
M_N"0KW,3BE?/6:#T^JF--3UU6:4/!GHV>V#!:;:R21)J3!W56QMM+7C[2L2X
MW1,MPF5(H5C I2A2!LC<"YD-?8.9&71E?L4)CZ*;!S<6T^IK40  \A \!+U5
M_S2*HJ22'PNIJ_X-%4.Y4<&)O0ZF%C[<NJ\SH+,LO(PB/SS#T_#2=4"JT+84
MH9^^1'HMA, [@L>$HY$7-79"#A<MXBV^6*4U?&,8V/-TJDZ8'O.R8NX?7<"_
M-@7^A]O_G]M/_K.6^\>.,4.=Z>9JS7*]FH>,SR*T2FYWD&#P!OR3B#"&/M3F
M75Q$7P)"B]='7C;TZTNQJ%N_WRN"+ -M+@'Z2:<X&<GW7Y&K,C(4,*MDU*MM
M8<'^XN^;(:/1XF2&<.#%;<W<WQ\(1,\/#**?#RR8D_Q**#PT$RX!#]]QGB&C
MKYC(9N6W*[D$[M8W+>',I2\W_NFE0O\3[+^N'.KWQE*R1<E;=U.*XK6)'S8L
M3X/]=YS<0KR["9Z =$,'GAFB;\F@GRPCQ/P?MEBGF-!^U?LZ<%2:Q"9O2+!E
MKY<:YFSS3 #0%;NCSTQ;T\Y6N(G8M7^L#Y7<%%B)LAB333>@BNEV)%Q2+DUZ
M B2R E,WZ16++2RMK46#& ('0R0OV#;8L;5"P#]V^&3O%[G=J;,4G)1HQ3OY
M=L.7)$%>"5N*<O-3NB(E<_87_O^X/=:U[1&[WU2D=3[,7]NT'(U?]!'ST6JE
M3(@LN^ZQ\],$F[I*@/IPX,5Q'ZX#OUE6/^$[,)E0;,4!QUOCJHO"KHO!DZTZ
M()QRER20V>P!C.*&,]]^YE E5C[$_!U;H$>=70R]\,%AZ:=#*N%(4.N92\)P
MR-> 28%EX^&'XBC?RDI=A\@BIX7-?IL#RB=_A /4N["E)OSUR8A:WRR8![^*
MB:<'\5,>+()GL3_"AP:/&H0-O_"GF'5 ;:G;#4TX>[EC@P$G)/--5^-3LZU^
M&Y\JQ>BI]6WOE/@C9F6[0(<DQ;F*S"S4(UOR&OJT'9DJ4B1A0W\M(^\(^G4,
MJ]W;IF6G'TW;#^TN 3FD#3U_*]QJ /W3R*&+I5NP([/[*OHAF7\K]?_R#WHJ
M?QA#<:6T!N7+N 00TX94#4J1+ %E_]F*7O\WVW_91LS'QYE^LC>C;BFK*?R#
MXVI1]%5[,_1*(><M!I&S%ZYLCJ5SN'BE'16>/TTH\7&0\DZ@_O+L?#$VMD%]
M?EQO(3HT9<S?,V!QTWKJ^EQ#P.M9\=V7&1+'_82>U2'6K\VI3?5&M<_HP@.Z
M]VF>=>/VF!/BK3-(TWRC@&VE;?_>\Q)]8$U\==T_3EE"_Z(IJI[;#08Q;RW2
MJVS?R1$.X#XDD![>"1RP4J9I]7"8C]1D ^S8_X##TK[L4OEU,+%]-6GP_HDC
M]QC1@5,NWTMR_>BQ,GDQ3%5-L<I)JV2CBR&ZV*)@TOVKP=-1VTO TO*S +#3
MP;SMA9.F]:_^F8T'0K3N6EY/1MF?CM=IC^AR#N_VN<T4/ER:(N)V":#OQW!$
MPUL5>01N)I1'!D]2Q&(JZBN;JLE(W;BFG\E=ES4ER*/QH%8_^N[-@@D(M\;1
MM1C<FT6Y8\50-/GD;4WV7Y<\[4$ 47X<3?.@L[O%\K\[*'( ?H/FH,*@+?UL
M?]!5W/^U3RJ0#<FX:1+\\VJP=]9?]53_LK_CZ_]?)Q+]_]HOV,!J1W44$VAP
MKXH(]S$>)V5:V61%_JS]/T8:E,87JJ#D2KKN!!T52V734^$/)W1\XC6HM#R8
M.&#65-]SMD")DV)U4$*/70?HW0<2?0W.I5&0YG+D:H/6 L!X/KY.@-_19JV*
M[&RUWJD533F"4O!-G/2IXV(BY,63(=^50WFZE.8<XE,2$JXGUIK53,<\PEVZ
M.04S.1(LVGJ2G6T3_.[]]$Z66![LY_J9]_CX\..G"+QRX#*VHP];QU%31,K[
M Q%/]B+-S^8K<2YS#X$O=H#%JLCRQ3LNG,3I+, +TM;(G!Q9\<?*)4)>3EO*
M<,)6_T5ANQU%53FZX2XZDC _2UD!)I$%Q]M'8B-9M]M%AFGDR]-.69++4"H(
M3['545*)B[&J=\#L\-UZ-H3MG&IM5(]>@+#<1QN8 P7=XV/\^(2U1MDSS=Y+
M $X](U]9V./7_HCHI\(A[$>G8<!<]Y.(>GJG!1H-FV6(T)B1[NP;$WL:"9K0
MSH$1-7#_IS#MI)W\\[X9H/SX>V3'HFWEPA[)[(9K8A7A#:JG%64U)C4D4?;S
M+DR5;[R9$#=JFX(SNE=Z!O(^1W!OFM"S0!V"@>)LO>@K(;;GOPFQA<N'V^OO
M\CPIUCAG9#X2,C!?W,VY2#8CS4CL\F*@4TA.<'O\1GE&@^$82W! =QT-1,:#
M1U&\A5:>'P?[V??9I]L+%%@3C9XMT2?L;/4Y7 +PZO%-%@5*7-@U:/6T3?=5
M21RSIB@88IR:V89IK$>3I+_\$&%TRYN05IUYD.S'Q!!W1U#T;&G]IE#:NQF%
ME]D%"G/Q/_:CD?IHNDL E)T3?8&)8M_'J_5D7U<&:P)X,TVBTL)/>1H+]/*+
MGA!Y"-(QL]>/TY>,ZD-_J(#OZ'9JZ\8EG"8G+Y926/K>J\)W;5> W?]@DW,^
ML NIY9T^7Q+X[O$H!V'7-NY$6A$WVR[F3Q\JB%)88X(#Y5?XBL%[;91][5G.
M"@K"*R\=[[JJ;&.3;*))D')YN6_Y=2\!J:*]^=13M[B+=(#.L5W&<[$#U$=\
M73A6^],AJKF6NI3TL9^1E8M>.AHEGP*.17^:)9*HRF0RWP(9MC<8MO@*#J%T
M"";DJAM5DME-WWRF-H6A'PZ &UMJYHB\Z89LWWR,ER36-2A8H;/$;5_[L=M%
M<32P !8U]O'*W.(VF(K'7_G80/A*@-4G^D'T,XN5(*G=7>HCB^[A4:"&)G9X
MO4&>NU*;LON+^*Y8_%JB6LD+;!C:ATU!=B1[[(F7HO1=3>$/B>(?ETMDZ.$B
MOB0'(>^.?HI(+5KWK,:FT*P*VT."'R@-[FP=/?J2JYRB:2[E.1U;NVFW"21%
M*;MQV)A6?WEA]/AE,$C54&0T$KAX7&<IA'$P15IP9[L8Z0O/@!P:T4*U;T!<
MFTI\'GPM TOY?O[O%C7*22*DHA[4\R:!X\/9HV@BI.O^:'!:W(3^M7V>SB$6
MT,XMAJ5U*:L5.3$]:D20:TV)!RB*3\_ [OM);4)\8G7Z*[/'7-)TXA*TF0$@
MG"-(X-P^(^9Q,(R#K+.!Z?,W3H0T<QR,75,Y'CA&U0R(S8[NS/V^J#?=-$&8
MSGZGMKC\2JUZ6?1N]I]/,L6*_=N:\;N&?PM7U^:C\.8QC(P$8J!<^-MY_M;4
MU.O!5VT+Z%R,Z_QR)=52K]E0J(^)TA!5#-[7@1QB@=G 8UIPA9'3HA-DS*%H
M%89TDY^)_XU?_$<;%F<;Y452\&$R']7^*J-1E@F@O$P$<(=VK=1$Z8=+OHAD
M3BML2D*$ZX6>41KSJVOT C<0,=;]8EP&/1[YZ[5X5.^Z9RVEUIRX)](\+RX!
M_0W2[?TT0BVSW3.NK3>L*0F-N#47WZMM]N;PLT8Z/R]7)*E7?#S$X)#9(_P9
M0.AHG?P5&;G IJ,KR/<A^7W,"Y7ZP .-!^-DA0,N"*J.@05DGGN%@>B'OL]^
M>I:3?=/WOB[XU'3H[MEX$RVD"JO8IC#&EPA:9A,++IWWQ2LG<B/?Y@E6=Y5E
MY5JG@*OO)"DV!*_(8!LO^T@LNQ3C[ ,ID&8H? _L<!'>AU61IG?X&N4T!L8+
M,MZZ,IA,C3A'RK.;R%2,&-\TJ0DSQ5&27W8$874LR*O(&;Q1?S3ED+A>)T42
MN+AW3P^I]RSQ^%FQ_1QC/1-:%V37["(VBX3)59OJIX37\;UJJLQ K[:S!.I/
ML3[IO':*M6:KK.0*W;?J\U#^5@<K+161<[-?64U>B)TX8>A6]*P4[$C4?)1V
MNM2+B?YRQG\C[WU+<2_,.5)8IVJ(HP15=Q[SB;R^6KB:.">&2Q ;5FRU'TT)
MZ3*#CU\X!5X"9$0]&_2SXU[TWW.T$?.7NJ].^1O"/PGW-C9>(-_YV%1=E\"!
MRYKJK#DI+;02HH\.KC;*$$YU7PL*_,Z*+4TS$A&HG]<VPV4%OM7P4.=C)9MC
MJK1#Q4+TL*65<K!0O)78S7)BXH$WNM-Q7BRG$$96$$ZC1E=OQ/NYBA5SXZO3
M_7T5N?\3IC(&6;Z9#QFO@)[=*1S]E5N50-L;7FQ!", 1^S@G*7"KDY3# \.R
M@PM"PH>7@"0HYPCF_=\GS/HS;"T(#'7L(@BR?JPTV%D=KO%^/K#L]%8FO"DR
MNU[]RZ@IT8RS7#0N4]DA* MV50G0V8!Q+H;6& 8GZN$#\+DFY5$=A+)CA$5U
MJ-L<HUB5?/>]^/-/-D6W!@?'GFM)XT7P%.4]B%81)_CCVQJ(J$8%&V.<BPO&
M):9\@INC&B\!4Z"+E*R_]D6]+F3O$L!_2FV-7-.0NJ]5Y?+7UH:"]FI(%4@/
M\R-W+@&'>EJ]KDV($\(+9\,U0Z5?%$<,.0OON[@(F G>JOU\SAM(@:#?8DO5
M\^JDQ,VGRWBT19U/H3QOO6I(JCVYD?%X9'O[:W6XJ[K^FMTY*$2YI<(<&;^X
M%:K+-*;/YL+=2LD_KR$!#'JU02F*;H)UF)G@*HI$=HG>=WLM&J3!:DMF$PLN
MLOHI1;L'KY4SA=\,2=$.LB3!A3@+7@B-:WAYV>3I*'AX\$C:X>QZ4,.Q3W<T
MGN#3L6-+E _3">JY'R>B#VBUT0SQ8'Z$7MN!E>\#'SJ*VU_*'NI(+,HY=(%>
M[* (BXUR=AYMNW3[=J<TKAZ7(S($5BPJ; 3D,Q&B/7?)O1ZL':'8Z("1E)O=
M>&>^:8@3=2VUTT10=WD]!7SVX#OIZMFJZY?/&U3;T\.TY](R6./CB YS#[B>
MK 6YCI5665]@15_9N-@\ZUCI3QEII](B12=ZIY8FH@KHO>ZJMWP)YSX3#(*$
M'<)ZY" EPDI7OOW5ZNQ-,;*QE.YM\EVZATL)=ZX%^VJI(7UO>(:?- '<(U$*
M"^ZV3 ]FFKW#!ER-L/N0 83C?.FZEAP6VS;/RN.7,]8$2U!ZZ+9QNR=SV\K"
MVT/DJ('*G9F]R!!@NLPB\%U R^R8J%"[(.>CJG /D?$9:L:1I[-<VGXRN1Y-
M49C Z#$&VIH?._$3HY5:+-0YPG^V:/%X$)4_1HT=6Q;G* ' B^H0.>P0.A>R
M8GW1.CGZ/HUNX!F\.I(/W_!;[:<ZB#%.*F-L[*M7A1QMTS*"'2+FT*$:7,/P
MVE=6; Z$@39TM:Z _GAF7_=-^@%)@Y6Q,.P07XI-3X,Z,EGG<VA:!"DC>1Q$
MZ'1R'"VV< DH>8?:4(LP<WM5J&2_HC5RUE^&DER,9&M]FN&;:T^2>J'/TAL'
MJ6T:F?<:"[K8IK2%.O@X?C>NCLQU%)K'0^P9<FU-SLR%5B8?L;5?+.>M2 S>
M=U;9!IU=;+&JG\[648T7;X^EIA]= MJ+Y59 /\\,/JJL15?PRLJB<!8_#HOQ
M&12M\QEP8(>F\>J6::ID9'(++HF8^DC)+<P%-EE^44AWW;>@%2?7T_.CN 9L
MZR44FT#Y/$3(M#P:WG[4.&B[\E7[99W>BVLQ?H*3XH",/')4G_5YZL3:)<"B
MFGO3$QCZ9(YH K?OZ;Q\.HTR(<6A\00ZI,I:J=$87AU:(L)=TIK_3"<'^PT"
M*YJ;4.5"YFOIIU=?@[W4:Z+$C9R)V0YORG:"$LPTH?1"S)K'[PQZ!XC<DY3@
M[6FV1W?L]>B8DY(2_-:QC]9YP8801*&JA_*Q;Y+E?8^E';PA8M#UKR6<WQL?
MI+8U/JQIC.T*<5!P$27F<@>.G*=L>3^$?U*T5@Y1'2W)F)PT([S_TG^5![K(
M ,^,2J->J[2"M1#5]WMHPE3U*_H,[BT)Q+E$ZWV677I#*#3.9 >6CU,2<@:E
M>YQ$[#ZL0T3!'.SH>O#*R:XD=?T#V'ZX- 42L1?*9<WU#K,N2[I4[(GY^Y'O
MC/CR+3M*(V0'.R.BWA:RX=V5>2EEP'=K[YY0?[8\'V&F[WV,!PW$>$^#JQV^
M2-?*/Z9"K!/SVOK/#%O!_Q'J_K5S\G^%_6-V3E@32R\!#ZY&>)_\IGGG"K.Z
M!.S?;/KWJ0V*MDQE^[D^@GE(:PD]/4NMY\//,W33%P=YTUSZV5:%?I<I*4F3
MM.H@P'\TTT4?+F"BO2CU''P]OQD8)!;.]GY/S AA;[S$;N?K=+Q1FS'5#Y(/
MGFNM79F^(UH5F:^(&_$Q=K*.C?#5+7P7**F(Z*/D1;4"Z0@;/L)4-[/W>#QH
M$?Y%AZ%B=\)%?<];&;5*Q7AQ.NURP=I^[.0,<;=W>7QSYB+<G,2>+\%6'&4F
M!?HFEB +]Q%D%P ^9116/(KY$O!6K<WP$# *@A,HPTMMH(NE;[.J>'(/AQMY
M5V1L%QJA7%A')5; 2)6J@N>3"AQI]EALJRH#L_192]5;JGDJ%_$R\N'GSR&W
M#XOU7HSMH6<^S>JV,GYN5<;*?$QN=%V<XAM?UV][_&'_ML=_/V'O#)QK4[B1
M>!:4PZO77Q?S)0$46PJXXF:,]_Z-F[&P6LIUY[RIA;_,CO-15D2*IWH3I:WY
MC(1LM$1O& 3_NBCMWK285655/D-='>IN'_UNV%61.:+\4Q(\*0NS3#2+.W/P
M8KOC-= K&E$NWC.M?KXCY9]T(T\(RY3C\;^7OC]7(AC3I_:]55VR/2S(5; I
M>YK3.JN,8IC4FN1>]OD"Y!5]ND=QP;9I=6JH-[A;0?-J3;%.E2&H$S\"&]PK
M&KK:8-)R-5GRY'/XG.'!@]K(9ZE!S[8X;=H()([FHU?D*_2+%D7XI&XML1.^
M+$T6L5Z!M-@4G6I/'=?P1N^9KUXX@7,60>]2-!HB8BVD%0JK58E-*)Y'1S<<
MX,41OC&9&^\H>FS'UZ?+)JS.:S#=Y2<JMQR_+<APIB)-P/^&6X->6%HH8V/>
M^"%2T?;6'M?4M,T:]EY7](8A2&NT%@PE3<C5M80O]52%O;J!9XY%<9;1%.D]
MM[A'J+!02J0_4<L5(KPS'47+.PQ4@@;=-TW[\,IHA'[9A\WBU5-[\EL3+ZQ7
MHJ4Z@+F*8/YYP_"[EBE6EKI[R2OB63:[1&[&,E+&XU%^X1LNT>\R:,LK7@_K
M&CR;CXZ]84,9B!XT(ES&?[4A)ZR]$>EIRU^S9DCB78I4+A6IM]U?/."^V DL
M70@_5/Z%\C_,-YRV2@GZ?C1\*\.-1Q +ZU%#T_P)*DP5,KX,/<,9.]* ?73\
MD<3W>D#\;]:$_!TK3^914DLV"K+C)6]LYBLLLJ<J.B/T$K#3N(Y*)'\(=[-A
MHLV"R1;P8,?D$N -N@20R* >^YB@?8H@>R&7@,5\K!'F4LY+0%!T$62@,OH"
M?@E :0#A94?1I\=EEX!&C#L*SR1\F5US";B]5:V+AHI^'['/Z>!HIKN!9T2[
M?#8N(7Z39$T(&GVD)ZJY/R;LQ1/3CX"9OHDA]X>F3F+^04O'&&AML@.-A*!9
M_42?A>]? I#:9QVH<^U+P!SA)>"[RB4 %X@Y@%H#SS'X"5D .,+YRZLV& ^N
ME#M*)Z::>AMIZFKTW,C_&WW-DVO%4B0KEX _7J[$K[N#<DY+%YK[0]8Z[-LM
M+R*I2*0[;Q@MK9Z4V#8470U1.]#90SQ<][*YKP+F/O3_9U>*_;X_*&8Z<\Q7
M5(9V_U6%F2!-E4P=\&2<9&MTV1?O^MH2?ZB9]^Z['6&/ 3D-4"S?5D*QP= ^
M5U:!7=UKZ?B%2*!DW=?:X:*V>_J7@&((]Y2;()K.82#7>E"#3U1I0&9XM;$Q
MV;@ZU.P#QF,)QV_H;/ZL?*]E$H,LSV^UG \KI@YDWX91<NSZ:A(H"4<G 4.+
MHZ]-=IG/V]"QJ!=^X)\_XWX,>L8V\*1.&'/'Q=C18R/&W.NN(5;2CM< RP^.
M3$8Q $2W(?8_&B1TE6?"PR)!OK9YBC$_/T7-WGF4T")#F>0J"L!B&(^:8K@$
MW*]W-D^R_^&\E"!]XWK-@L/%6H>8GQ?.$(9YW3GR>49X:WTBT6-&J@L[Q_PA
M[\YH$Z'G+HIWX=P.;]U^8VPZX70EYBA.<C1ZG[;Y94/G7.'])B\Q\#NG?O1M
M2*\;>N82<)SKN>(!_$9XBF$,4TWHD5+][.KVCF T,<Y!$SDR7A?>%%'1I8N(
M"G165Z (XGI++8!?+<HUX^.EE:W%CL"50,_!(WM5.FHWYT[@GKO@'(1^=,_0
M)WPG*P/U:9^9_BQMGF!5G-@8&4D=\*.Q'/A)2"D?$TLC\\#[XL%E$>:MK7&:
M<NTF?+ZE8N2S&<9XGU'H+N-1\WD>^K1C$=\)0KR[BL ./81B3Y0]WK_#P25$
M+, 4%5[WX<('UDY[D<Q3>-YH-K(E<FU13D1Q(7375I]OF<,X;1Z_E\O-"'!+
M@D9T*[_T 7P(>,U;^>N/C[%!P9D _VF?[>4.Y)JC^5@#V?>4"?A)L)T+=33/
MDZF[2TFV9*5@)5^_08'S21<<M1/1G;$U=NRPRG2[Q8@4Z52WY0U-P 7,^R/C
M,34_P[V>N_5$S0/%KD*[U98+.W0^TD=EU"8K+Z77;+MK-A4=@7<J),T6QD?S
M6@VL./2Y5]X:S9N>Q<<CPU?1[)ME/8OI_ JUB<K;2'J=/%EQ]D23-'/J'2SJ
MDX(552CKNHQ(EG+Z;A\;!<IEZ8O=@WI*VIB!#\>$:=$F?GU'G3?0B:_AAI$5
MH[P;OCQ?ZY/MG[L)?_:X!%A^4%M"=BQ\>"6;/7S$$ G0T CFND_@AX_"<4-Q
M0 @N 0.)L$N ;P[&PVU,^I"^S9.?[#%4'0A$>8GEPAK]2Z=P1<&/\[>_Q(Z8
ME)MD"(@L4>/LL36+."WA<QJ..N_H28?O3Z)'4$.*E'CSP<^X.F*<QL<G&YS:
M/*<3P==KQQXX4!=;E%)%+Y@#KH-(R7,%W@Q5]N1J2:<V1#FU@05&[5R6%N:P
MFYGJ)<^WZK'5MQTR #<BRO;:6<B:,SB_*HMM=? [Z!]Q?VOJ&9B_J@@<9YH'
M4EF(W1NVO;E2B1H_(;:-D\UY]C3*C[CY#-I>NX?41]-<;4:HH2]D,"YS5*!;
M2(JBW3ZE?F6?=VV\WF0>-Q12';XY*5GU3>AB86[/1/#8]JN Z-;PD_-S&S7E
M@+-^"<;Z=1IR3^"R%]'$>"H&*Y*(L!=9DNFZ?(^"K>A+OX0^X@W$Q**B;7L(
MCG) [=NXC<F,C'VS![$,D4H",U^!%S=\?8]X AU6K7H+7(BAK&XOHMNA^SK>
M?)< _7D,B!T 9_U)8@.L@*!$TW N)H9 [*E;[>SPHNZ:SBL\%/@D:5?BK37J
M.^BR:GEV@V*"+*;CA_E>-75&X"%[RP;_YP0E'3EVO==OQ3@0,I'US\;0)/'G
MPB_\"'D6+52:2#M%SIA1RGGFBP8N]8P+,HT)&?N+?-J#:==69=UO!LQ?FUZL
M=&Y@[9$>7BS[[&\<P.U7.'UVU>+?B@S,G'9_U^(T.8D_SEW;1PGQ+O$%-]@K
M2BTN)U3PK:09S>SV:RG!.R)0DGD=10;(JM46O;?$K39WC+*4V6** )O"M$)G
M6C+S/[T-:/IFH8L"V7%4;VZ72JRJM0.:J8*%8PC<!07;"?W1]+JXVD]$O2YN
M[4_?5I4CLQ(@!_"?Z&UUT'AI?6*[];);0I7G]KIE7V7.\Z$(@UQ2]=&=QI_9
M<Y/^=?W5<2(F@MVQ%];]8G>F>2T]*ZOV$@7CQ&O6=629@'"B4RW8> R*XI&H
M&CC(/9H(<6B.=9I"#Y=U&BHRA&V-J$B9VOZS=X/_SXI"8'^ ('\HN?0,(ED]
M!MUUL4Y_-CFSLQV@P)I#(M-_!RLZI8&N/G#]6?@WA&VU4^:&BH'N1Z4]@8@P
M"?J;VL?T0U_G?@4;+['S5<"&?T0<H%^QACAMEI0'Y!>85*@@@6C/*[!VK5+[
M9E'6W<;]W$CF!B)1[/VU.14I1S07@G$M!/W]6'8> O+=XY-KG_G:?OOHR;61
M_X63T6"W04[)BB\!6SN00^Q2SN(=N^_59T=QNC.2;T+C[EP+TZ;VDW'TL;[E
MA[..XEWL.F0120[L>]7QX=N*Z#BHI\'I_4OLNHFY*2O-,!=+YCBF=9E]L>"B
M\;#UVHOC(*=5W:X/$^A]TA5#%&&#YUADB8YU8H"USBTX=C(1B ?H<&&!)?][
M7$K8/K=/$8)N&+\$/+-*_0;=/[\$O,$$3ZN0O_8%PO(2T(2:6W8H74K7P&"H
MGV-_[8GX50+:D%L\:Y=.FD+3_C;*>F/N#^4VJ\*&R/,0="WG04F16.]\N[?L
M&1TH..-NV E'U,=+0*5($8AN](?EF4%P G9\WL]O-K0 .N:6-=JOFSY]>MDU
M::DSZ05$49UL*XIFR_'Z([2J+R*='CK.R$T[I9R5--HC@[(5LI$MASSHU4WI
MFB"_)3PY^CR3V%--I%NA# >WF'IO*H3(.C&&@72R/PN/F2NVPWFS0-1/@(0)
MQ>A[I?2 QCRP_G&02$\W/S$&R[(-TC/I<J[*E)\W'%[\9%X7N@YYZ]\AXH#4
MLG1:LL/3G;JS//Y&1Y3NO>S<2?<R.L$Q56GZD_W'7*H##+'P. C:S87 A!HN
M=OJ&,ULJ]LL3: ,?-4C.)[1ZI/25=3VCBW'Z@6I&>_MJU)DC(.(U([.3VB4V
MQ?LWW'@ DLZ;V*Q"9W!AYY+]R56J.HM=]A4YXP1)^JQ.(Z_P\ 0@)UODNQQY
MD>EN+3$;Q!PJ6JCCPIOR6#G(P<,7\,47Y,%0W'&^['2J%8G<0\NDFZ ;\;W(
M6CXQ-3\UBA./>\D[M<:G 0D.:[T$4*#Z]O[J(I7FB?PZ3+KTPPYD:1=XMM[4
M'R'6RPTA%@M!?M@!MLYHQ(8R2-?0!JMC'_(MTN(%LZ L<SJX;N(/4=.^#8P]
M\S=\C@R1HUP+V:MH6<!OD]*(EK(M4*X2+_V </MH9>)83Y88CQ782@]#OU61
MU*X@+WZ4^^.L-GS)6QC!)C'V)F9F5C)O%G"C3)]+JE^0M2- Z&2@4@NAW#8#
ME!M>4>399=N1\">ZW>C^XQ+@$2K0\7GK</7SL6-#D<NYMN.!/H+SKB1)4QB?
M[(..>)IE&"V![\MEPJ&&#OF4UTC^56P3U@V>M_3Y+5SZ/EQLW[;?[%;Z*%$)
MNUC:EICBU CVW!N!CJ2<^>(_FL6_\R3HAAY[TT_D5K7M7']UT7:<(!>L^I%W
MC45LE\=U!2C[QY?(PP&^H_!\#9S,FU@ @H!&C='#GD@RS=IAV^!'U3$YU'>I
M!H.]B )$([U  8V/+*O/3#531B=U#5NR\,J?$AMA@C*<,!^DLJWU+DX1%Y>/
M=(E^D&WU$A#ZXSMV])%I"-6+\#5L9#))ZM&CAF@]9.1"'^W@<M09V\89P],2
MH,.)<3/M)2!KPU!LDVQXTS.R[Z@'BZ\MDCYVF&$-:S+A=L5N]_=^=N:<V<;_
MST0F)?2>$ R"[WGSOLI+BS^-!$F+H%.  :09<OA0-^%W!]J+H$"0S.D]4%#:
M'Q.7*[]JF=^ZVI#NP"_'8<YND/S3A-B_[.]K;+_K4?(B<=_KL#OU@TQUH(>*
M+5 6K?=0CXS_F+($4_PJM:H!B8C@A+>$,Q<I_:G8?,$)G&\LW<GV+7;B(RGV
M80:B/NUL/Q%>]/V.T*:U$P5,5/D"09#LC U^L#$."WT<>G\I[WIN=HD+]0EO
MGOP3]-WL<%9\G)2,9/,BRP/MN6?E>MU<W9 /HJ%'I;3C8@16K@=)@[8F==5,
MH:O"#.!Z\]UJ6_>MH88OX5_5W[ORPN3YQ.C7@I &B\?O'PZ-:@G,VK[J& \>
MV#"P"T83>JCE#H1R$$NI0;\T*U%=K"Y%&Y^.%ZMH;O4E=^ J<9Q'1CT)9@AG
M4+\B'N0XV.+8QF"M)6"P[GBHMY97@:Z!-L.][<DOG0O!(QJ"+40CM$>;(YH.
MJ>]J^=(%^G32FOSJ^3T6[ B?0GT8B.7-+9VPB+\^()AW^NY,]I=W)-ZF+HI;
M13\?/H!4H[VJ2)KA1*.[+@%M6M5ZTL:5P8\>?'F@%I6&DQ@.&W&:3G'.45X0
MG"-!\BHBS/+U<KD-I+E)N@F3;SD%"$>;;+6S=?$1OFU\5)&<.,3,:=)/LI3P
M,G93DBC\9)*EI2@G^U'N;<69C)MY* :$Z/37VJC9+NZXH5[R"\"+ W#A N?U
MC8Q[H?4Z-8T.81QI1K'K.4P6%S[*\IO,V1IF[.1J6;>%,XN ]Y *B@B#N%;/
M(+-H,74$?%WY@':T0>J9C7".YON$Y'G/Z!9EXDFE'G-J_D%3&^>$EQG"P?3
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MR0%,1[OEOKM)OPR,6#[C^?Z?&1#L<?+]0N,-BB'%G;ZW\0,':.(9.;27<\V
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M-&L:^_[>9^Z7R8>G3LAS+2_&HGLZ#3EM3>;NO=)<7$^)(AQ^O/KDHNH->V/
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M<ZM[6*W;D-AY6,N<74,HWHJ(*K_P7V!74,$CU5Y@([MPMDN J!(N&'+H3@W
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M#<?&4C,F#.ER&=24RBJEL%X_:VC[->EYW,UI& KPBO34\"\?Z&0F9.&N6?+
M/)#RFRMW;G]2%*3KV7@HP$;NSLK%3/LY)M@4WOPG07F,;.I% 7(C86.A*,"I
MZKG#S=[*#;J:(ORM9]QZ_^9U5C+L%Z8#_FXJ^E'A;ZD+,X9[']4 #F[ZK&4D
MJK/I9ER[((:CWVRN0X!PN=&N]P1WPSRSNU/U#$(T"PQZ#C/H8]_!CHTY#?66
MK6XR4LXJ4J[<)]_':B:$O09]Y5?[F;/ZXK7K7ED8I#9A+7W'=05GK]XE@TYO
M$)[(C;4F!XSQHDV"-:O7U,32R"I&WKPQ;',>-K&X K%2W)@T9C_UE9P5>T^V
M;*[H0R+:^U/X64+VMSB-&P+["\)<3CNEXJ@PSO2,5C#"7Q(%,'QZ#9G)8@JI
M$F.M>-7NK4@1[Z= :,SZ+_/=VN'NUM]6DZ<38!<%*Q8M0;Z60PG&0*FTF]/Y
M-:HA'7N[#2))WA<)#3N_9"01Y5O@<".BI*XV^F33Z!B1S>BZ*K0.C--O%T:9
MWN^ORHT(X)EE<'7( 0>.L0[ZETA9MHF;$'M'@B("4*Q-A7B!1D0F3E:?,I]$
M//BK!-U*=ZGOJUG.9\+1"G1CI=+O0&5INP(K,91MA1:7\W89WA9(2LVDX7B"
M2V4 S76?'\]LRWA0,<83[S.%&.:G[F)*GM,*/!+1_SSA[%/<Q77-G))]<8\E
M'T-"X,U(624/9)<@\(:GI! A_S!@M>/F*;1M#*[=))@Z-0C*VAK;3]NS38);
MWC]U7Q8%J/I3<T'9]&LS^\^DUP?G8I;K_I^T]&G\G[W\3E;SWF/S2[81+PC-
M("!8S(DKA+_59L8CM?DSE4D^G7 851.L<PR!H3U.RS2^#@.&<;F6XI1F\=([
M2ZS'OD.^]R<]_9S0HB[FS*K]6C/P0-I-S<9QTP__L8+KGDM_:>D]1# FA$<.
M*48Y$LMAQ.:+/G&^#Z A,RFS)[_GN^T<R&,?J9G&8$FK<F-M&FF>:'3[2\>,
MA=L_L6\8)OM-\P3X+6PF%+3*/-MJ\P,L^FLI-II10L=%(E>:1 M++6R=AE+E
MB:>L^M0]O#+DUPVWI'![_L6R3B$0#AF:?9JTJU=8>R"L>UBDJRW^3=D+4;X_
M#S..-,;?4BQMD<I_-2G-M.OPP:ADZ6VD2+P7@_O^5+$T=N%13=Q3^69E<0+M
M$V2CY9HXV8K&#S>K3;5&M,$8V"^@TWV$LV.KW*9Z<A4I$("[E![#>9BWA/S!
M=)V?=+>);)6M]'X!HJG26OEX@Z$B>#6Y488"K##*WUEET<K?YA='!1LAHR_+
MKOO7XJ*>PP3#$]E9R11Q27EZZ;;Q^ZF^^I@!)+Z,D?BJ0GP5[1A3CRHJS*!K
MP:(9WGRT<C<F-6+ U26IWINO04MOM<)=G%R'3OO$Q><N@5-IDYF<*MXR N6W
MQLY8N;[X$X72T[6-3QXMXEKIQ.ICN2"!'OMCA7KP713@F1\]\L]P0DG2W32M
M5.N\7?<;MVA_P]HF.^D[>8F-1)7&>^/\=]_[8CZBM355?'!RQ,QQ8G1#94RI
MB%%5?EDN$RN68=[-;GJ*9_P*TE]W1:QGT._DP-[+_Y:&02JHP/49I&2WG=J-
MRL<L3FWR0TNRS.-2P2_ZBS$%_IJ%-NI)+6\=Y\*[Q'Z(R_8_/;%>QIYERHBI
MM(&Q@'I&<4H0 PCV+9J7%)QNBG)TZI/RO'0E% PI )P=,?WU)=/>3?IF5KP_
M_.*Y P8W&1>@(:8FT&=_@FSUV7Q(59YY=8W)>*)0BE$P[1!$(H= KT3VMV2=
MDKR/=\2;"S -"C 0\6=R3#X*P'9=_@H%2(A31 ' #>WG/,8*\&/D&R4'9"OP
M6GM$#PL1[6U\Y_<W&YL!ZABZ?T'$/ $BSK5&4N\_:GTM<P]R!BH"DGVAA=:G
M-O.559F/$V0YALN)^ M"'O>C"V%<7((KJRH_M-:D36YBQ*M0R=(1Q_SJQG Z
ML-UL)_4TN>T26?B]&,ISQ&'GB(E1FO7H7)Q7%-@Q$9822]\GN:22"PGHBH=Q
M(5  :]#5I0I24!;!2D"$ HS]*;H),$,!UEV;@'TQILJUL2OJ-5%JA#%Y4L]C
M7_/T*3]B7J'@;X+T5=K<,$6]K0E6UB+G)3LS [Y^A7Y:=G=Q8(D<L=T3_ L,
M.A_@9Q^AATK/1CDQJ!O*%AN\T7O)*,\&[WQ&[2RJC7<"Z6]CGK[XRN^UCIRJ
M%QL4RQ!C'=6I]\\'&P$$#@5B=)5$Y79R<>R$I<;A-Z-.=CX.P@\_J[/'BZYN
MM;769[&76U4]=X0I!$Z$N=$_0VJ>!?0$8 Y![;PV@_CN4MU[#Y=DAR@8DBBN
M:%IEQ$_:B.'?*N!:T[IL_5XFV.R/>S;Y(+;XP0L)(W;JM)-L:L([[RZ)G+Z=
M9Y*N::, -%R%]>P?\B0=6)'"Q;R!\(?&VP8I(>M@D@7/!#"'?6%K<VL\MMV2
MQXOM'"I9J7&\AG[E#"UV E$;UQ9#_H-:B33P(_B]I:67R;R/Y*3N':[-%:XP
M)U--J&*Y6WV#*QX#.Q.,RC1Y*3##&Q*&N+<!"?G*]RIS;W9R:]F Y##C+@$)
M=!1@N!,%L$<!;K4J$7]_GU-Z D1:$-QZH #SM0[KQ8C >V\/#[C#T(J#WRNB
M*2-R_\Y#&!0,/!7/OCE/NJ[TPS86_[N4ZHY"M&R?=3"2XO0XSO<>"#V"1!V_
M2,!9$";6WZ;N6_YZ+IIZ4G*Q0F9HFX8?53C<8/B2Z?7&QH!\!R@H!&APJUWI
M:W%RM8 0):O&01</-I$:??O6,8"I\\:BA6EV7G^HP>[]Z[.W^Y0L>SH9:-=I
M.\6,0D4WU)IYNR.]'\?>P^FA)T17/<1]V*"=V9[+H^U[JT!Q ZG8>R(PFNYF
MG^VM8X@U'<16%U@@G;-#)F+PW'WAS9-DH%=3C?\+>82M0L.VA+7!>:G&1E $
MK-?[C?%#7VDQUA?>H?$33:%:1(,#8L'(JE*$\HEY?UCMH!N5I_SD,0-G;".=
MH-@7B<R!"Z"4T@FX5]RR^R7[>YBTGT4P(<.PE.P!N?OELUN39H-"EF+TD>@/
MV TS_ %_C^/S_Z+?S24(EVFF8(O,_(7Y 4E,^2(^TT7 T^PJ6_IN$+&845/7
MJXKYYB7YWI_!B<K^NT!7EW. .RFPK?9W_DWK095W=G<<]I[$DXFC@UKLPTUK
M>['I6]$:%JI71UABVI9RS9$Q'9C]SZBC)R'4!1M'8S*$:G%L]\%>@N3_ =TT
M_U3^@QG!*>8O?D\AQ$N-V.VL.,P25!K49?<-GG;:$I.%E*Q0^R-79;!\Z>Y5
MRE)@$B&;.@@/*!<4R^.B/65!UFI##1YPA5UR$O")504<UQG?I=3J:?@7$>@-
MNLM:&HFNW^[+M['NG!C]2M#]'9YF8?_J.BKC3N:A#ZE+/2WFR=T1V*7,Z+=?
MU9XS+L7BCV@  '<JAY1_(^_H5SF6@)DD5H\#MH'!(V+=<&&AX80FKKOS7UC[
MAOQ\TDY$0X\C&.QYJZ(?T<]%=DZ+X4(S969RDF1^ACT+9/SYFEEC#R?P9D,;
M'=J<?HSFB8";[%DS3G%1X_HMQF4@8L7QG8MISB /LE^8M4X(C^*Y'(P9YT6R
M\YF&T/)-5R 94( NP5)IJSJ7@/Z6B7QVZN@B>1.136]G/_8FL#"\/G^(,]6R
M:M[AJ9YKOI-:QG/A)3@W\%O56'=3C_=EH'DIT_#8$UZVC,\!:\8=6S\3#<KD
M?A'9V#\N7R=X$O?8TWY;_5$<=]>KN R^K&_]'P8/._:U^3GT.%RD:J:A4$YZ
MO#BI\;B.(/817\])S_[^-(>02H8'[+X_3TN6:L.'B$<E--&G$F4+=>":)0;6
M:;&E4-'+![;6E'*!IM'!M5W;]3) =>L&3L6+YYK^LTLOK[.*#4!A8N8E\*0^
M[Y#D K+VN3JOX5O]8=,)KU'AYW'*GV:SX]S6H<?8AH9O-CG-[WH>BX2]][KY
MA(U@"^O&0[]]VJ6FPF;7U-YSZL-U0G"[G0TG94B,^M@HWQ3)/I-)UEHU!W=1
M2%)K=W^2BT.*J3MWKBIN&U0#PXIK,9*8R)N?M_;VXM@<$QJ%CCGC>[OA1L\*
MQM;:BBNN&=9E5AA4B$AD#&WY5G3^R)W[X.SL:6QS1+QF&4PO_68F*"^:K;(B
M!VU'0J'P*4F:]L>1$64E85UZ_+7M-8^P\26#NRB=0&5#DV@S3EXYG+( *4/9
MS[Z6Q?"FB>4E/=R2ZFU]X4&#*RQXZDJ<(QL8\0(%P H8-T4!&(M0@#7V42ZW
M):;^-;>4&FCYE\1YZ+1!7W7+>S)1@_>!TQ^:S\9L;#@5-2V8!3#3DB&E1[7;
M:=L]HH-N=>,MS.^YCN-_R+/')<BMKB=T;!#)45Q49H>G#<\S!]MOUSVW_!I.
MV-[<7$H+'V6/@_NM.3SR-.TNIQDM*"TQH+EBT/\EMU_K_!0+?:I1@#LV8[;1
MC<UG,;6ZZ*,$&XD@NO84VOZE8U3"8387$'[!E XC0P$49S3D82E9+\SMB?9X
M/HNMNSS.PB<8QA>OGK)%D@4$M^_PH ")4P$PTF'X<:\1'DPPM+@^2EVV+=PK
MI6!! 1\ZXZP1'2LNXJW)L/ S'T[(E >FV-_S+OS[RP!#8->2GI]VIQ-NZ.)E
M8NUW$WG&5QB6$L-84 /WXO+?.\;47&Y4VZP8:@_<J^1!%@9H1RHDN609J?%[
M2D)=1E87^PL+=B*_](<&$ZD\M5T&MC^!QFS.]@EHX&&]M'0ID&X1O^)+L[?H
M2X;YF?FW_8]%+HW:J[@G!%:B*-.;F^<\O;'(#3:(Q$$M<.:LX.N;MJ0"G9TT
M7W<1OZ;N!RZ!,W'.*B['\H4/JRH*6=]YZ,F>\?I^6"MI8<S#;515<7M^"@UW
MI*@>E/CD=L>>' N*K"<+5M-O)J\'[+\?B(2?;WHB="BK83Y*S4WC![6X9KR,
MT;V;:DDASWSGSLFWIP3:H2"JW2S66DGJ4CRX\?*\J&_'%?L=]$C$HQ=7SI ]
MHLTFEF/A>]MC&'[^&IZ$Q_1Y<75#?=(O9TEL^L?;5F+1IEC"-Q==OJ_K;U4^
MU7K>T=W#"=_O#KN& N;P!(PLLIGQ;3QS;B$4P'&:^=B0LJ%-)KUQ!,'4Y!/W
MH)LJT7],+('3CZ\9!;"H6FN!K+9\AEL@7^"5>^IXGT8A27??[7'Y)4DOI]V[
MJ9SI_[XW^??(F3$M/$F]!6*'H,D195R\]9]B(Z*0I*H+GK.[CJ!IN"B_<>AR
MP)M?>-@>:_=Z]?1TD%T&^_A3@2F,>5^?+ MWRDY,%Q1!9EO<FNJNN:3 *2-$
MY3(56SLQ&^LN_Z97H]DYJSC!,[T38H1I#@.&5%G(/7NVJ#^P\)TO^MYIMZP&
M#XRZ[.[24L^NP9Z&'0K(I3ID9(M8'@D)?;@.AIN4P>>WJ(PQ;'F5>4-GUJDM
MMYQJ V!K[+A0$G7953=+C!>IO+R6#:M.\&"E-BO#2-;7X!?N5L<L8,%:^-?+
M&Q0@G./B<WULMY(U&?T#X,O7C'/E0^\3);):T%0$@80(28K6*61OWOSWI<=\
MG\S=MBE^U8."+DLO'4J-YKGL5*3S6L;D8*.-^9ZQXEA]W#(QK+BD\RQH$4*/
MY:X5LE4Q16]M;(UXIH]JO[D"L749-P^$GPKRH@!EGTYYYNS'2O=X@D<)+(YP
M?NJU(X07U8R,2T9@H.YQ^9(QMP^E^CV"\B1J#TA],A[*//.A10'41;D>P?,6
M>M.X6T-\&^,/LHB<U6#9/;3]"#Q\//98 6+?NAK!DA(N![N?^ZP.7$QR=E##
M,?HL  H@7CZ" D!%8(*1QUDK72(FW59AMD:&G(Y.60$A_MD\NPK<SM1[+#M7
MXA*19\E1:REI#X>6K)OR E/JYLN\?=A<SIF25.%INU#;J&9;G<J+=-U9]G2J
M'.7A1&SR9PF(.*/?_B/GT]EVI$W5.^=:EF%N%+4!^+LW(5UY(TXX _ODSR7I
MZ^0K14(K<_,\M(7OL:MM%!0%P%Y>QJ2S4&'"*\8:MD=#"(-"WB,8)F0RH5+^
MW5?SP<<2 P4AP!M"A"W!VLAB4]7]&EN,'R4LROVBBCER+Y+]B->_,[/G[EZM
MH[/PN^-1Y*-9!JRJ&7)@3J5Q,ZX'C]&%UBVM,0$B@QH%N!@.V.6%E$.^W <_
MS%B@.Q?@S=O:O:?U=?-N7^I3DQA>GE1M)XP! K*FRUS/)64/O7]XLX\<B'FL
M 4D\(_6-'^]>9O].X"9P<X]UCSNFYM[_[8UL.-=*^!!8D/5&4WKQR%\3@*\B
M_O!MWGIC 5-Q&5#:*W.[1TG?<(9*Z<0B_?)3&($7;V*.)07ZI_REIIMW0]8P
M]86GS&I3G-]=+M7+^ [CH^Y#+4T?P9FY[(_97>GBE)%G$S"R-7&J=Y$WO2_$
M)$V??N6P')27I08_R\)WRLK8.(L-ZQ2Y@$2(\>$7>E'S#!_M:3UY?3)'(P^J
M5 Q6.' JI1"ES\V+9%-Z\&_P8OR7R=]UTNSE5Z   [BJ]\&F->B<6%MEW:C(
MK3V,2\;KH<^(IX#/R%^F4]\C<"^L\?^=2]3_WWMFV%*JW>?](P*\&Y8<'!CR
M)<H*4 "%9H/^'OEH6K2916H+ 97;W9F 2J'RGQ'I/_6%58)F&5T/-=3='A9]
M,]$6]U=+&BL>!G'97+"MM9$LA/NB6S,#VU-T[WV<+Q@Y9%BIJ>WU@X5=0\IP
MEM_2'2>2=[@?0*!A1+$FNM\>GC::+UX%/_>CG=25<@.R56/<-JI*!,]!U&""
M/4EC_$:$D[CBAQ-JCD\L<9:(Y[*P+_LK/_9#2\0X3KHUO\?9*G]D]HF0A0V8
M"B.P) _$7;0)G R/AO?\80V5*5L>G7'7Q$<HP/X="G!NX+93N_V'.TGE#W?2
MU;T/=(+D36O"?Q<20'.J9.5A-<:>H\?=VFF.-0V?>.0Q-GL:.LFI9'B+/<:U
M#8UT81*CAL0&DV+&%E%M%%JL[Q[;TS,ZRS+3.V>_%R\)4OH=HBM493Y^(=(+
MTX[@0+#GO<P7DS'.-)5+#DHU70"]4H'JN7NH&<\M++^2C_2<?<=<-4L!S 4S
MPB,8MZ-\;6VA?H))-M%C*=>*R8LN"R$  I=8EL\.[-SE$CI+#N,70[9?'3B>
M-]4[G@Q',=AC"K)28)T*<'BM="G9'9TKQE!NK*TK^[((C7:I  .QSD@;8>A&
M*,#G@"YM%YD.@U&Q<#3DF:/**J]_CNKJ=*,L941W1E2WO^#]5])[1$*S+8OO
MCZKN]AV_2@-H)*3K$/F"2'B'/4![]H4KA_AQ+55(*,8Z<V+/.<"-J1$<*H(]
MX4O_.+&<8V3W;.,Q]SM:$O]7P%*!?CA8-?@>8A"93-12#1SRVV+V%%GW*&P\
MKAX\DI\774^K>K,U^9OB5EXFS<']H]0Z"D#B^:GF'@RC'79V9.VV:8E?_XJ^
M-9L0C//5S>%.ZLDBUZP3H[#3#Q'WW@Q<KY.=;7XD)@OUL2+"];.5C22A4A<Z
MRM-4VP&(:13<8UR+B+54@TDCP8>Z>D>\Y+0YT:<L34BUW\=CX(%L*<CY,:'U
MOD_1*&-</BNYF</1]X. @1%K[2BKJ[HL$GA179K AB"E3,% ^K-,0\SU$(P@
M+ZU1OE&"5H]V0K?K%G$H:W$=HSTGM;[,GJ/J=X;O5VC*XKL*V2V)>T*:+?JI
MKV-;86SS_>HB6E'F3. 2YXIJXEJJJ4\>IFU"5^<%OE(PC@>CRV0_N*EI(G_[
MFDX-#R!*X)Z^?-"[!^Q1,<:*ANJ['HNB2_VMDL+8$'IT"MK&JFXD43L^"C >
MH(@"= R@ 'VE\YR#!E^7%4Z3HPD>(V2K9X^UE=KKDMY.#\X_3S]J/,<(##YX
MM<>3=EC^"\ET'ZV*EN\"Y]/\*XLE*JW>E0;MX@Y\VWA/*S<JZT]0Z6Z$.;L)
MP_K\$6RYM<H:J9%Q9"ZT!#\)H/S6J_^-5-DA/5%YFQ#:?LU).7;[X]Z U.[5
MC.'])!#O*25A$11+Y-94VY/?-1(OWDOQ%NR]\[Y!NH4N,WQ)$4<> SR8)[/=
MO"H16C-&HQT"J6$Y\0X)8<M7#L>"COF!?7XVF_@6Z?-][_98BE*J#G8K_.F'
M*N$1YR-84CX[A)\$XX1C2#Q,7E+CXXMFOX7I(]EAFJF?SW.]7(MT:>JD'L13
M2JWL8+F<7Y#:2H[SHP#XUD.FQ5(_Q(XL3%-<]OH;J[#63E4<W*!WJCWF/VLS
M6WH![U^J?1IKT+CVF2ZD4&*L+LB *@VVR@= .>&?4\I+02%V\QTQMT\]TNMW
M6[ZC &VVX)/B2(X6[8*[IF7L7+9;!GDLM-;T_("L9!=IR/T//K$>]"DV>%']
M_3H5Q&]Y6R$*/)L$2S]6E=WLII3YE%1+@I;H[$E;D*3!5%?[335*[\R0NK_'
M1\UCE49-(6@B[U<Q=5 %OBPT>[3,EZU%T BC3J;/;C/Q1=S;HS]U(#DPL=<.
M.+:$==RS&O@R3J>TMM%P'AX'7*,NEU,C,BR)DA;_[$KUV?0+QEU=K_Q)EG_4
M-?V?V*B87KDC8AE>X=]?IE?8([S8.,#B)TD=;&3G<<(VLC&2U2S&FM0SNR85
MNQAJO&E4+VU@HR#*)SSY&<G@%1MWHB']XZMBJ=&B#94<'7>;.M#@DSSH*\)V
MBCY6R$0N3UINXG492X>J"$ 4QXVD4%C174@C6H*$M,\S&YH2N*:;M9OOPPX1
MMCX\$<R^_'+B?;%Z"[&49AGL7<)7C4XNB*-U""3\)J]"*!0GQEHSV \).*\*
MZT8!'K6 \I7K!2T,%5R?@;,#*;,-@\%K<I?@5WF5,^F36[8$\J(%=&5Y?^,<
M JSBZ+%4C$0#B3Q%I6'OK 1$#2=S>ESZ%LPD=[/6YS9<#!Z.=:1K)<14M?++
MZ6\2+6 ]\R:B</8[88=8E<?(R[X9+I;)6-J(8Y]JP[)6E8LKL4D5_*"L($L>
MSGTNEG1->>[')?]]XH7ZD%)M[/R2\*/@T@OF4C$WL9EYEB^;''-0A2=P52VM
M5F@K>\_L:XCF3]T$9]./R9Z#1Q7"P('UC-E*4M;:,HZ"F6\;VL8/[(S4[01V
M\^*8<3F^QZ_7/T^]UDJ).]%^_2/!;-J^2@ 3V(DLX[M 9[X *^95SF9!>'6\
MY9=[M&;'=1>D[>R(I#$4".DE/^6X/RC,BQR>.U.!J]-2H@#9A_I(9/^][=F?
M>%%)__U[?4UX=>PR8X0BK9PJ8*R=5)Q4/:.PF8Y_G2"$0H+^Y*XXXMR:O_DW
M4RPVA<[/%^AFU+$Y<9.-E<10B9"<_9?SA97+>6<+U6:Z9J\+5F,=/UU=5!U%
MDFPD)V$I\_J.V)".PK,[]00CH0^0*W9=041;7"G2ZY"&2X$)-?F7F1/JD8DU
M8H%M&*\M&,4DGT7]2'^E7UR% NP::L6<-'??",0LLC"GK>TM'6XT)82>:QM6
M?C?%G;YD7H382NN7"S;SQN X><B=62&QX?;"9)(^99MR]+S]"\C?D(()Z;<%
MFXV.Q>2^+*6EUNXBO5&_;5Y6+RZTOW-:F?8&.AF9E_CB36UE9JO,,M=&9]&G
M$')BBGMP>5]$LO8YQPYK%&(CY,[L"%;[PHJ5D_8$B6V4,\)_OW$B/LIGN..+
M,YAIU8<^#;N(T=I6S=I7B]5=\6%0ER'T^\3B6743*5YQ[!,UIU%;809WZ;[,
M(I_(GSPH2).CMW@_Q<V1Z.P- "EL"@"#EVFG+Q1;7]N.*)DW?=MR3.PCX>,Q
MC<Y=9VK%C%1P5M[]LMM9D#8W.O[3-H!@IVY>,__7B7X08>&SZD'F1 #-';M,
M))M^6R%#X@\>7]VJXE $GT]IW1*,B4[=J7$,!\1WC6[,O3NKK8=L?IAA7M#8
MDL%J.CA$JX,L@)0CC)%+L[6XALQ*DP+L4>QJ6X,,+W_PBE4(=:)CV5QAE1/.
MIZZB ,$.+QR.+BJU^M9FY2 #=;%KO#%)0R\?C;T%>#LO)\\HE;DN-F4())5K
M2N6):[^=6IW\V6PH\?MUMP-17P/YP!_2OEK[/X21"O/_$^$:A_L_]70P3CX2
M"ZMN\DWB*,6A:-5U"AXS>)^MMU$ )Z1P-H$1E]T(9*U?'Y,>\&M%5LP.][UC
M'5S*'S[/#DHC3<>:KCIRPP1V@)S#3K \D.)&$:8?K(ONM3#FY\O9W2O3B <E
MB(<Z>44:7^K-NS*>G^14^?1FX4\A3.WL,',%IA7M-Z<7?I0R1+LD"XQ/_ \-
M%/(CAJJ$N8HV6LHT-^N:6!E1U<G&?(GWQJ ^82=^!P<6&@RUOYT^>A$H5A#.
MI':^J;*EY)U):E,QU3J\A&.GU_]U!P5XR*_/^KDI^; O]V<0/>[F\XL!C*3K
MN+Y6-EQ/N_=R'-!8<M-[:#/-5G(.<&138#._MW[O6/N .,+&P#VR!%^)&7/;
M\&B7#I.(X"":]$]88.B.[;8* 3LHPK5059%JX!7 61FF">:_79*0I#G,[*W)
M@%I$Q&>X[;&WP#^L5BJJPABS*MVL7XBXY4?T))8:"X2Z?Q[8W@(D3<4V]KK+
ML&70%J<+_ZJ5SCTGM=RGI/T&_DTEKCXJ^I4O'OBL]$*+.O@(STK-@'7!=-I:
MP,)+_+BC54*>?&Y?F_OY3LWK'^NPAWZ[+]H>SLDR.=0V1T">'8:B/:7]QE@^
M:U7I]_/VZYU>\K$IWYL39"IT@>N'M7N$ \5F^&;&3;58DIZKFJZ@WTBBO.X3
MH]_Z-B^=YXU>)2W\:C82I'C,/BJ@$J3'.+ULD>GG9H+-T/<J^=4!IJ/LFI*W
M&ZE:1GX-DRL4%$$KB=41KJ5J+R;)D'"E<_@ .-R(U%STM.S0(PB12_LU-^15
MC[GGTG@'^^V=]<EGJ\F;]5?%9KY97XB0: 'IH&<Y]"AI[1;N(( ;-5<0RL4J
MW9P7Q*LBK#$F,#NA7C#5Q*FFKF4I .5"W\W"N[6\=+URO@-;H  _1>I>'O6]
M+$'"2L5T5P]!?2]GQVV(#=_4'1DJ-;,ERO4+:QCBD5QG7C=%_>Y/39FG=@B5
MH-Q9)IEI_UEA[["1/F1U.49'VMF?%[PPV\S&4K"Q<=1/7E+^)NAT$O>6]9!3
M58SX><QT] 9AY+HK,$0$*ZRVW$]]WF>W^%-BE./.8.*CT0?X,I[;E1[\&NK6
MNABY%/SS<_=0(#&<\^ 0?,A0VQ(D?+A![KFA^JM[D?+,3WLU)<I-=+#8V&"N
MW#4\3H#DUBRT?SJ[TMOO;PM)]S\6\BO9JS\+&;%+4R+UA_W[/F;"@W-)G53H
M3-D%^,O0;FFTR2!\_  /FG!8?Q44YIMUQ0B)]C[\]PQH^T_EEUIOIVG?0D,!
M'("W"JV1+1[K]8@.T.%]4&*M]=.?_T,$DIB[[2]] N#'?QE-6-;>)_,4_D&:
M1(OYKS );0#Q+UDXO_AR_WE7&+#@<$=YX= _NV)SPE1-3M%#:ZER%+\R6=U&
M:(#=@D]/\[XQD:]_HOW2!H(T1 P#84CCTOFE%3WK$Z^K>E5]J7BQP8)'C>>#
MQ?H&"\OZA;T5,!7<TQ]OH,EMGQUM4L/Y/2_N,,\4DR,KN]YS(\DP2$%?23>1
M%# [2/=6 +YG2I];D" 7QD3T*I%+],DO%6$:;-#G/NHAI5^9RO*<=G$F8" \
MJ&][K2[X80F'F E P0UKA/F<&BDP8;-"AA"VM.E7\0)OL[FS]0SD7"[JX$M\
MFG7XA. IVZ-]GMZ+I(_(;TC:JHOIPV:P6]0N0?,$W/D\L,?N.DW(E&=+^>PF
M_OK/F)O$UHLOE#$AO<F_'((\YX6?%DF2"VP@'\&P3W1@F&'E@@A/^X80GT9J
M4JQX0=_/?DH^#[V>]CK@#'FLX7$B1Y\WW<V.OA8=1##<:<?ES?ZLN)O]8"A@
MW>]JY<LXN9UA(\'2M@AY.CK1=XA0;.;T#_D$/"'6E*#KY IM,2^ -\U@:SE1
MPX$]F'_JH]_&P?&\+9*+I0IV7Z;Y AX=KNETXD:O.COMJ3 OS@#)K&S7N/",
MK.<TV'.M%*G1GFT&&&^_+CU>R1$Q;MK41Q9GP;/VN&@0KR?.%85[FEP?U2BL
M(BH>X?=X(])?C;U6:?6>I.N+#,]5DR%]]QYMAWU$@L#3K^+G0JO1FJ!\E?%@
MC*$<6Z07*,H)!4 #*Q6JE9]6!>>E&QR[>R[,S>LC'%-6-.N"?&PG]00RT7-?
M?#-ZA#RAWS=*OX>QQ6$!.VB%*, J=0#4X+C'&$MIC4K'C8;[\\S'4 TL/+KM
MYY('DH- C7W=&^9>1<\G<YY%RSYX,H\9XC:)J&^2T=E\UC&\O35%!YF)Z(>4
ME52J^LW_\M1W^BHG9B)=UG;%5M5[CX/>?)[O(X_.,(U5P8IMW<?5@C?FZ?=H
MR,G74A6M<=.;O<WZ-H %?L_&A>ZIK=XP6P2SC% +0?2D>S*,FHPY$[S%?W )
M#.'42M[,-8 YJP4U.JP=9J0:/>+M*XC2_[KE2QL5JK*U5N$I*'.R5;YZQ[FS
MTV3V@\I-WK#2U((SWY;(:3I>9=W0_(_:1%]ZJ$4\^X8CDK4*2=19W ?A" A7
M@NT*V\:9XTG3>#J8&PZHT).%1H7$=^)::34;BKXPC\Y&GX_!I<5$48!7>%PH
M .#^B.. _7+A*F]_I)R>R4S^H3'=L!4ZP5(YFE6#ET.? Y(.)U-!IP/Z;= ;
MTXLJ1=7IVNQ(CPGK&[N".F]J=<P4+U"XF?/B:L(@#M_%T:,N0U=)MB^'1[]K
MIET]^;\>:-E14@D=6EQWZ]&5@3XB6HC[V/M;5'*RB1#&TS]_?I5BJ"ZG3XBG
M>*_.=^ 4>>G'IUPWZ;K@@\O_V^$!QBMEE>G;K-HM511@L',,!3#H1R9QB-B/
MU,ZQR\ B_<8]M?L\C$B:C7'A55PU%6CJRZLL76#)1"%V).2CR^'>K\XOO/'O
MHH-$*+MAH!#^%5(=<BYZ7)'2)XLLUVL2R_FQ?\H*6Z[D8+25)ROO*)]&8*12
MZA.<>XW;S[659Y7OM<HZN$YF52^29'(PU@><B7M]X4U^CY,01"!EY+,6$#+K
M,2F1FS-XEUE"D$%'1.]^V<_BG^&CB0*0>L):Q.;M9MJR($V: TN,BW:GJW?C
MQ44^9]/^\0:^>B<]WK8&G2_.#$PW:T]U]24.9,9!Q/#S0O(16\+1=X5'@Q$G
M4[VIWH<QHYFE=?NWCUE=K@J4OSDXRF ?][HBF;](095,9/K(?ID.]OE+]3H#
M<5VI;G4N\#S4H[LE"A82Z1J>.^O4B7R27_5^?$5:#R,[_(C *N,9-8M^D^/Q
MHB. SGJ0R]KLB9UZ2VS :HO.2>MYXRVDT"GVZQL4@/(\;0U).D_E@*8GRCDE
MEJ@8Q.W44')'HFVMH;;\L8QM>EQ-FA0S][]'POX[16Z85)$'[=4@<TXAF!F6
M'5GEJUT2A^UI>=4EL^#D6!GRT0T0MTHSYA^\G/^425J^A/T+0JE\R5<6QD]+
M,^'LNN EJ"BTJ4]-07!+']]6<!OM/9I:M&!-:5Z7;57XOOY51%;QXFW2X,VL
M]F=?5FNH.//!=YY$+VX(,7#=X<,<?E<33NF@.-E FJ/M<LH!C !OE]!FA<(-
M),'#H%6?*OBB<CPY/@3Q[0N2]/!BDQ8-'4G6'AF+*;7X^-Y[.QF!E<MGB,.T
MHOPMOR)LZO%R=NM%)7D6OUXY]6TR ^';NX:"W4MLXER=WEZ:&@+3)ENZ6-I<
M9X^SW[]"L..N@Q 1E]D7R.P;3H4#A/C][LTFW^^>X_WN/0A% =SC\U+K' 8F
MP8SP=VN07B3#]SA<,GD<K"N&]Z!SMHNR4V!HP*E:BS3RH/U&2(T@5*H<UM$(
M,[KQ.=20.:G]&2(!H6O)VDPWL9RCZ0>J*)PKT2O43O"7^TE,/)#&>;AJZG34
MOYBEY 7N"9K7[N'"MW4A.)<^G0D__/%ZY$8(K*WU./=+4($9X?@$*(CUH;B-
M?&LO^ 6\/T?_9:9#54]D*NNS4!-,L5[Z(+].\AO@!Z-B(R]8Y"6Y&"->.?=9
M%:>VB64&"T-VS@ PO%"^S>T#1'[*0\08 P482,@/@)0%L"UZZ$QDSK&Q#/%1
M \25/L"9D6]BJ)"M&M>:P C*QDDQ8N^!7O.FW@JS@-K,%?B.C9*1.ZMB2N:*
M:>P)6FJO,6&M,;$R02J CC:;\S@9:S6P'5CI?>C4_MA59J*%"GTXT)Y+9=XX
M,+X +QAT],EI@:F9S8UF,Z>DM\2V>1I6J:)=,]XF9+0G.*K^* _CT"#1?[@!
M?3&+5>W?*#.8A$D$^2K" M0G)S\\3NRKB)5Y91XH-U;=QV[;U<;7=%(X#S?N
M=?++?(^3<H4F0^K].*'3^++9--LN:[#?A[I<5X K]."\DEFN>H(??N!ZZQ:*
ML8U>3KN1M;W<$!=ULY@6$/9L*L<Y+N YOJPGY&&HWZ!Q-UTKWO]D?C8RA.7-
M.E1;S4>R\"R,T G>#I/$W0%F^2_2&J>,%93[[: @ DEH-L'"G$SYMJGK*5K0
MD7?2^8YXB+VF#]6 &Q6NSX+[TF-81;A?^(A.B5U]:86ZPL JDFV';#XUI' Z
MB&U9!SK[UGDP@S=I=]0_?W'ZWA$&;$C6WON$/\9$I@(AWQHZUN$=E];!#_T0
M(]]I\4((^(EY!T\+KG&OMWC@.[=4%."U0.'*C^NONCY^HC25)&JZ-/_EIN6O
M\G=\%1=_U_M7# -KB*QTI^:+!;5NM5"V;K6*00Y\40"I[H& S>VA"QR6O+_Q
MP?Z_O_K[#Z$\)?W[X"$9HLT'PUDYE'@PLWX>#KH[[6PO?"?!(*T2>$.*) \8
M%)UL/ZQ'QGBWKA,0=T,-<11G<1F[,U-@Q%<K*W-NH#OO/KBB(]/)"[70L02Q
MA(2LC*-^I+CAB/"NH+/UTJ36@>_=*IC4:IZVU*UBW[K$<"^QYJ/GA.X[P643
M18*OIR*.$BUN\RN]E5CJXVY4Y'8"C"E;LSJJ+58D?*SH0OX9D-)9V4@48$-E
M%@78[PJX(YOQA7VIFD@K%)(NY.HXC0OS%Y]$\.0-%2TO+,OS0RPTK=04/FF2
M6+[ =RZN]7'S@OSUCD[ ;OA BT9"VIWTVQH-C< QP?)NXLL))UK25G+J4D1'
MI0@[_V%IC;:693(<JS>JP%-4JV:ZW4TBJB%\0\@$6^BMVT! *A(#BQ34I<1I
MG3_MJ^25Y!3 3L<#]/(PG_/3OT?]+NV$+5S.64*!KAOOTR8T5^.+E+H=)7[/
MKR#++I7X5(+EIS@J.$*?UT?3(6GVO7[FNTUO%5((ZQE;WB#B."&@M7!XC5UY
MM'3Q7O9^W'.9-8S/-]#O*$ ,J+>PQ1+&I7)R\-&HJW^K$;">L7F]7C=#^SEM
M#\E@!5IH>])P.EX[4WSS1JC/\[8[:\&EOX0T\,3G#?=NJMYA!Y[ /OFZ^V8=
MJVCCE7W[4:2-8FIVV;AZ\/:E'VUQ$5N(:AE E1NPP][+WXJK/(WDLO6V;_XX
MQ0 62Z 791[6$<DHQ:+"!G\$\\.CH*TR>.H+O?-$9,VUG9DD1#U<,N@-_1C>
M_@(D694>_&"J@D,?JO:3"C&:>U@<@/AV'U9$Y2-)PX+;=^Z#W22^ )@;,*R-
MT8IR)(\JO>'G[7>0%^G09X/ULNK5.,A\9I6OXLE1PL>1AVLV3VF(J"R6LLM=
MT1'1$[=#"ZIW(^"<6V. IPA$3:;NNW1+O?FWUTN_=!\):_6A &HZ($J.S0 "
M'>7<:*=%*&S<7!D;T:XGAI9KXYW5"(JN7>'A9!JHBPCE+71J!B[-.X*(=[/6
M>T1>2#P?MS\?A!,S_UI9=/J5W1$H?6U1=<1IY&W':)M1%W-RU3D?&_'!YRZU
M?:Q>'M>O2"WQ'?$$O'SE[_]BE527T8N&$X%NN&4OH3P)3R.W 4!7E3: 1%R2
M.LCK\G@#!@XUJ3];,/S.NE.#Z7"[X7*CD2KB_?+)I;)(H0NG0R@2NRY\2.)K
M@@PW;NMB&:8R%N.=DJNW1%3QSDN0R=0S;OUCKIIARXV+S0CQ\B&W0_>K-8MB
M_, <:3;K<.B1/8,!^DZ/.WK&XXWL0N^V] ^8R44+.OKVIW;KA$7K29]$L_6^
MG3$>\Y8V- J2%KMTUA[B'/> " 5N%9]0KKWT2B:@NEQG$[^NNH(>1U<@?IXL
MW17H&>7:^Q9$,_4FAV'%CF7E7##5B FB (S=NO?8PO@NI<F!"HX)Z8$)'%9Q
M7'A"-KXX,O2_NL>2%[3KD9/JRA,)(4+R1H[+!P=[N$.B=J\G]14;U&V]9" Q
M?9*DVQ*DL,/ES)+V,-_W2JT;;V1IAH-#=P NQ],@J97I<_]GL*-OT$IWB%)[
MK)MN_AGMZG-V\E$L&OW<41$G2)TRD7+_ZW(LJIKXV3::/2/*!CO;SJNIY^%D
MMN[O=0"\CBKXH-_T9U7]'5DO:%^,#Y_F]7NA>[GD96'W21&\\D)(%D[[/_.T
M[U;PF9[AJ%*6D'L>SQ^[N&I''9LIU^NR@G4>E2Y.>ZO>$/ZF_BB4L1.C[&B;
M-LRI?[)RJ>N4+U*MY,M+G\SB"&I9J)WAJ&.=!G'<%9X3Z.$Z?;?@Z8:=;5<^
MY+,QK"II#6]2SY-8R^.90]00Q9%."+(V_20-<H#$"#+,\<OS8ABKPA^[2TE$
M4K'NZWK3]-Z[.ZI_5:=A#H]#OGIJ? *\>Z15^"_?",6MCDT@WXQ!+4D+ P9,
MAOX?)B3O2J^_MAUW_JF7X^G^V!7) E;=_=]I-?]O^?\H_Y)YQ*CW[\KI]4"4
MW#TH /;7/[4BCG]J1;!0@(D$2",D]*_CG#6-U^EQ$=QYD>S$_ZH]/.ARAJN"
MDX.A;W#-*IU>C+MS'7:/K05=+R%IHS$O)^@(60S.DAGUXVZW6FT:;HT?X )I
MAM;TE62'Y+^EZ4MA2MD#!4>:;U<$E6L+S!KU+#2BMJ-3I;Z7V-MQ@$U.JRK7
MLL2VS4K(+2&817DU GR'KC2T?6H<14FF#L^00I4)!%L/K=2DGS8PI'3^%1]I
M.O"/@-0 QCH+AFCC*D1M(!ZMDAP.YYBBJ$+KX[:AMS5U_LVY@:HW[J3>D2P8
MB7.L55%TO"*A,N3F'^)E<XO57E$$G$3O2%BEWA(KG:%A"/ZF'Z O%JHD7XLE
MGQ5*4'OZJ8P;"ZJ2%U7'D/@G$8WY!]$(3)C)R*H.=#^NX'UT+I"513.^EJ%"
M&U-<T)U -Y_S ;[VLR3O0(FY03L583'M5+3;]$8_33\BNE=;^+G,N/BI/@I
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M.+!SP)EDY1&3T=OTU(+^U)"EAB6+3<CQ5A8&L%"* 2QO8@#^N2D8P,"/- S
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M?=:[Z=>V%B9I7$EE[L=$O'?XZA0I)%P[T*Y_I(("_:G=$)(O5W_)!142"9G
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MA:;:90=/<E;K&3" S@30E1/T8D);)[85=O' % ,H*,( ^$,@%&R%C3WS^!A
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M=-:9ZGM&59.TW2'%EB#TYY36FDQ<] 1(O]X-B3\,+_0+#W9@2X,XG-7)&+B
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MNG;"6P#X>UFIJ<KV[K%DS+GTT$,FG_8,CZO<]-FK0!4\.P,IL' 55?8YM9?
M&%F!-[U6RL=)39W%FP]J?G@W>/Y&RI/"GXPT38?G>\:B@?6/M%\:E@;!6!6H
MW>_-^DR,9\(#_6UJ0=G;/#SV,]4Z5TT/V.G7F1)]=G3]2?@C+1JSQ07"(E_%
M<(>+@25O:FH8$;G[ GVKX<*9:=N$D"5M#("!KV>Z>]:0KU'HUADHR>5$%6LJ
M29F?6=M"K!&AANP08XUL;"0X$P5"TH!DK!I\RH0,E<(Q@#;^H,H97];4+?2^
M*SZ_*0Y,[W1!26U/:TH#:I2\5U34'B%1U!X2])$E)Q2 ]_HF\*7:\]:;. S)
MOC%5M$'5'6>F <ES9+</I#_=NV0_INW!0=]4(3L6>/2,N7V#:5'W*36XG<<]
MG9WD9UE$>K #ZJU\$X( UN@^D0\66$PB,ZLG+P\;O1/<D<1.DS_HC8.S$[^9
MD],3+Z8$?8Z%IGE]$G($+D32-SIIGI&D96\VAM[7N3%_9QP%\CS7(QUE)_AD
M71X7N)-,Y@&7@%"<L+"D\5 '?26IX'W&AJ:?;7VB*]P]UK!17/P 64,X7.#J
MT+@B5X\>&RL(._LAO]@:F>5E[V:X;P>5/YT<4MT6T 3>5@9C;>^*I\H2\,JF
MU=T[S8JK6/1#%K415KW7*AN%PIQ55=NQ_C'[EX+_*GGY%WE2-2M#\:*)#V'Y
M*.'W3NIX!(&C-.VES%DU\ILU3_,&A#XWS[/ I^A?C]%7E<U*521 !P\1OBPF
M=0CHJS>/?V@T+AR/<CQ 5M%F_)NT2\==,I1;T5B"6O8L-4(L^RS5B?7=(%5A
M$HN$NNEPP  9#M48%("(E#(2IA@#=U5]_.IGV\3;KW@9/M\0XX4?8IUK,?PZ
MF[FF#<L"38K$F, ECSV>]OCDDE?E>S:.Q3=43=AX^']VTE/CY3N5*JEA/7NQ
M(=8[B'B8XJ88<V7TOI<R5LY+AR1;^D!;O%G@93._-A^PC8VYU^9?NXL+FL?#
M$2I.-Z7.'3++)*_<?"8BJ]*_?P(B0^0/WS7>.[DD:HIGEN+K^,G$M&VGVQ_W
M0VN+PE.=V[R8+ #7O6A?(9O+.H21A]':AXRYYA2_Y= YS*'0C%A#JU8:R/^3
M(_*17W+C^!KILZDYDF&+WE[X61)WU'?-2?G.X>8$C79IE2Y!(_R1U!#*FDI&
M8VST]HQ@91<%]+)9V0ES6ZO@+K9NQK5"%? ;TN;K'!8&[J.DTT1-31F>/=%Y
MGM[;2G#SW22-]SM=1E+/_:TS^JE<KMG<'S-"R;'FEH^5X<T117J?_ $K1[FJ
M2HI:@RL'@D ONY4=+S?&BH=%>]T/K5!LO^[K3()E&8]E%%G6_!Q6!;*9_ZAY
M^3];\U*C%M27KM?*7TO,C%(-.:0XLV\(D.S;R%WP.S(M'U+2?EO!_;,_$/@$
M#V^;4WDB?*Q4./C5V" 69Q/\*\*)_XJ#Y;?5X'IY T2]/UV]+R87R33QQBII
M^PLB:X>/.0J&,YY><G99SELV?P_JLR,1S:U40B2"JR<RXKV@L$W7*OSAM),K
MK(X5,B#_(7GT.ZQ !;S#QK%.V.GC?\!-4?48P SH*C[E]T[4:D$., ">"RI+
MQ(::. FXW.D?B6O_P^/_PD9#>96>XADZEH3I;4[5%[?O/HII(=OI9T>.2-=]
MFM:.__KOM;BD>F=G"_(E,?O["FRW G3/HGQ.J$;=37*-\Z:N"IIM^.^VN5@9
MKSHM?C2?FEZNKOO\58T:K/%SB%5]0PG6Y9\H06G(K>%KYX_WD\MD>AE8HV%M
M8 7O]17[<#^:GF[Q4LG4TG]L5U:<1)GLM[&QR=P.TC@\U^:'SNQN;27^>VB/
M80V#3R<9E=_H_T>AZI\H5-.50"_(CJS75[__^:;FFT_4"6T8I=]@F?@[A$>;
MEDNP& ;P_@%]2]@6QT=;!]^7\N[J:]SQSN_EN'Y;;?RG)]56'&5US"5_86-\
ME+_2?CZM34YW#\"436*.]"_(-:3>^UIO51LW>2FS<<.O"7"*FY14 ,R=+/EK
MVK%#S8GZS8P,EJP:KR]OJM[C*N@ A+KHU"&!M4J9KC%\6IW=T/N4RW&O#0A%
MF^AIPX3!EI_C].;D<EC*4[*TMM0Y].9[UK0[P@Y*RSE>4P$4E)E'3N_HJK<+
MS#SSG''C+#J+[K^-YWMM^^Y#YTI=O;9XEN3,G"FS<8AE0T*7GZWNC&:5$"\@
M/J9__\XE;\$>K-=7;3;,ET,X,/[YGFUU7?#F_ZQ*^Z\%I(^^E4*O9@-B,N>&
MEE_@//]0V6]W_O'DU>XYZ=BN^9 X2<#_-&-&74?XR7 !5^#P^^HYST\!GWO>
MA3IMD%U9*B?(63.,_&HK]#\F?Q;9_>7-L=2,89@L>[LMWM.L+?[]A(*.Y_%6
M \E%1%2[QDV@@VOR_1/8"<U^=\+_9.WE_QGC+UK6_]7B[?F+O]4D25?5&]?V
M/22DH2!S#*OX]C0?_^:B51@"*F-%KY4\&RK6X2E)12($8H/Y>S :N?J]]M,K
M/IK]E,07HN,ULND5YFQPB!]Z.I7L;.SG&J]WT%J.Y5$D/##X20#CR L=.KQS
M#O85V))P\MBL4R'-J&--'\MJD]L=B3DH_.<I7IVT>8%%##/Q_)FJR)#T+-X@
M3?2<_O6<!G/I?3<-G7$-UTN60W>OC8(A/6S,==N[!@, +5S<!B'B04LO)B ;
MEUCSR80!/-#! *:B/0H[4.$+>[4@4P0D;EL5'(-%NOH%&,# .?J- OHI%"%[
MNG"!Q@ ZI3& UJ&K.' U"M()*H=?P9;0IME*?WL&R3-CO9U#K"-$S[2<00(O
MDC/$W6Q0C,@#% 8 667  );-,(!/#;H8 .P ]0F&DJ/]-X+\+FT(I]"TZ^[1
MI&L-\-B=AN,K#.!+% 80G(8FOG)!0QJ.B"&'KR F:OL-M$>$?U#_!_5_4/\'
M]7]0_P?U?U#_!_5_4/\']7]0_P?U?U#_!_5_4/\GZMG^%O6IO5D9<;Y9Y R)
MU_1<EA?N/TU?[AXJL:(T3H3T2)R=D0:[Y6Y3?)QQ<GG^^6K8MN'+<L;0"7#.
M8E'2BOR^WW%ORYI"Q\1TM9G!BNAY-$W'/2!'\C,/"G;WJ]T1N/S7">2VSOW+
MA+=2'=3:",F-@26];-5784\7)'[*:MLUKLV&Z]9$@7?ZVB;.QOABY@@MK_DC
MRVC -6/^)$HZ'6;_R$I/$V(&+?H2 YBHQ@ VY51<.='ZD#T8ND_Q=X[KL8+.
M,8 $5#@7RB$G-00XP]_\K\@X*T9)8GE_IQ!!B/X$5/[-+RI)N.DF!O#$%%X2
M,MRPRFZ, >C?_Y5T5:=>F_L7C946N]&WW;\ME;\3)P%G_77EVO_O4,<+J56Q
M6DH@C9CHKXX->H='?LHTB&_.)_"G?I4+J;7;(S*'F<'.\_,6!QDB=-WB]]8,
MZB2[;UUI<PG&2X:B0 D)U#K;AW0](G:1NP*+Q!")/O/=\0DPYQG4&VQ8GUK;
MH7)X.K:>D0XQFDUP_<%2P;U'40(\:+H1D9S4<5PHG_V5RLH^A0LXR5S TT;#
M&=-^Y6CU\)I3CM2;J- \H[,.YX--@3$@Y+9K\>G;:6A( :LQ)*'')^[C@**M
M*H&'D8KJ26W2IVU+L]RD*S?OS[\2LL^O+AJB=6,.VNKO/EE1C':R M()A.L)
M)E<)0COHM^)[X&VK/!@ R49-A=5@WWHU,7N3UC!1<=26X;,^Z3:GJNT3\+-#
M'(V&H5=D;(Y;J+CX+4/6(FT6M?"7C>?7*TZR5ZN&=DWC*F19:ZWW0HVB;R0#
M'SU,Z[5.3ZR2_:JDPUVX3*T\L<P:'GUW?.:99]VAFX5#XD8D)W*(K.H#<63X
M^D089%5N% /XE1X,Y%R*1870H^MID>JPWSG^&:$PVH<!D+H3>:IA !%Z,^@&
M, ;PVGVKE@\K(?58HZ&G^&N_K=J)]G)O8,50BI>+2FEU&0\^Z6/%6U[Y?N>/
M0DT;W!?@:X&AZ)[TOJM"XZO8XH='SG?1\M=FT(4%\_QH+N7 _>&J^[ #RA*!
M;>;4JOXOJ94#Y*Y^2A6C'TJI*5?K:W7;5:#1TG0&9X+$"A_L5*T%7RSO\1.6
M:[K&+!\MX:Y7?"D?6;A3^05"!!17$)LIZYV3TY(Y$\(-Z1_,'+5VM'0KTW;T
MW8ME"X$\D33<FSDIL&SA1V=FN<YHC>P7>/9HFWP5IXU)LV:8YL-A@FK)W%WH
MM#;7[MW+2L5JA8M08."+_3U83S*S++T!%6W*<@:PAF0NND_F&/(0TJ4R")H+
MQ  DZAR];X[9.,'NW:FYJ-U"K>O.J+F2=0"NZ12&[:<6(<+2YOIGW@>0I=OC
MNA+S<97QEG&'6G3Q/G.G@8F[[;J@60X3XAS'T9W#&("O>O^%@*TD$[R1Y@?L
MQ:=:;9-@+FB(266<MR'5?J.1,_ESPF5 ]IFYV7R&A\2IS.;!=D':.YL<\V.-
MN6=F3W7SKC4AH>U5+_ 1PY:Y&T-EJP^1D=RC[VO$ B_3'>]NA1,>[Y3=UKO+
MO6TV\R&B>3>3O D0H;R\O*O\U9@R+ID&7I"TE *:#.T_-O3H;4PD6"2X%EY6
MI0-IF7-0FG@U4U5&"15:^<:2%%))-@#WT4(S'))6!)PLE,G7&X4ZM]TRN .#
M4_?Q2<@[NQ=)*"E6#U&^ B=-:;H.M-VJ<-%*,^>&QH0]42[T&_'Q"T]2J!->
M::GG&!J=-9^GBU5DL7^?&*EA./29<!Q6HNT _#PM-*H+%4FMLKGMVB8HNJZE
M^X:UC-D;I?-QT8F.1H)0T1VLHMG-QM9;V26M>Y-T QD8>BIDJL:OX$\'-F;R
MFC$(=:&C =!D\NT*&2O@NL8L>?8TD.F*LV__M&$1AG%@ "P-IC;!DU!SB+_.
M_F8A3TW5(<SOB\[L[(_L3%_!Y@7N8=?5JZ5!A\Z-^1HO0@T_O>%WHZQC0T:=
MS%=J/DTT)QFXT>?B$JE1Y;W=ORFC4X)?HL6\!-#36+7H*+!I'_<&RKU02=Y1
M*?6B[;NAG1-V2>!GT-_4>>%Q=J#HJM72[N!J/RS'!"ZN*!) 5:Z^UO1V[H<X
M>ZR>YKN!7"Q/V3>N]G;/A"1"UFIME@62\/O'[]SH.UWY&AQT@YFL:Z->X]HI
M5P0&< OZ67W,.JJ-,V'6FGOW8,UO*W$1 UC@S1ME*Y@+TY458'089,Y3N*.S
M ]:2O[*?>E<%9LE,XZ7N/J&=N-@;Y3)]/U)=J:1:YE3K]633_)BL\(9QBFU*
M_;M.,KIPN_"DG63XHZ!]IS[^9=8WNN=G1^^.4J151C[B>898L'9\DY>6%MO)
M2JW,EVT/&.F(B9?AIQ1^DGB(+JIV&,"!RF<*,8?JE-^6EG0H2PUI.@RO1.(%
MFE1_6E[J#'GPT79#<!$)4%B2?CKW9754;2HS>ZM\NCY!R'\ZQM>XQ8J7/M%7
MJ DP#@FL!6:ZFIM</DH\X,:I[;U#Q.G3"'#*J58;+ZC'C5(<9:OMV2B/7*+L
M4?IIQ8@+:%K!BU@@)6RY>H\!: ^:5HV:'O_0_A'*W:;#K,;;[#,;7R,MOI.2
MM+Q:.AK[YPV[)%L.+NZ?'%Q:8@!I-%4-E)J(_%=U\A[Y\D,GD%?WK7-X=CGN
M^@G@T:\=S-2)+%D2DO<M]4B_2M+KGF\].%J)N&9\,<-W-740-5ZZ>C57.#H
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M>$^2 VUY52R]/(!GLKZ]:LFO:#,?!>/F0I\+0GO#Z_C'/+B*W:/V:/;,7$[
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M/ J*HH)([T@O M($1 C%4*4WZ2H( M)[C8!20@<!Z;U#Z+U*"[TWZ:%W"#5
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M>=*P3#STH]"0O:(=1XEK7)=@.2P-G&:>YUS5X1<=[DEC*X.5ZS# ^K-%,EN
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M?ZOI9% L"T"PDN$<$6T9Q1I^G:CA]U)<A+0<<<R"I[9O )OX!EH!OP\E)]X
M#,O F[?KPB&J<8=%;X"^>V08JW\&+';TIHXQ/9R,HW\L416</H@W$HFD80/"
MTTN66Z24&H<POA%5EP.>Y=XQC#<T+V P0'TH#WW^1N(^[!U1V1 <1+V8IO7+
M/;,(48(*JD_]!^/:-U-/WAM Y&OP5/L-0'[LW[UBB50>IT5HI^/\E5XML3WU
MB&,+>+J&C_["$8\LQ$R^J>;:NP3]Y73,U0$-\F)!-Z;? (;OL*#X"= <)_R;
M&9#NZ>,6FK>+6_6G<9!G'YYDX9*H^DI&*'/N2L"J17>R#\^#3UH(Z+.>N&E[
MV$^.>L%W_$8"QHZ(&WO)Y4OOR/[$28?B=*+OEE]1=Y5D8YD[6/N;AHD1GQW)
MTK;9XBOW5@>'C(:$?"27J)/9%[D\!M\%]\@B2*]^-]*"&[#XG-95+3Z"B?;,
MVSWX8>)I;$=&AW[M+0RU;'LM@0 :!G4_8DGJBPY!'U+AMZ*_@_BS?F0SL9"$
MRQ49D=X NC,+P%,-6A/OD*,2I'Y5+Q@?=M:DVN.<%L$1##JH9WW(CYC;#[P!
ME 2@8WQ6^@CR49*CGX/:AK!E.YSOR@QM&;"TN])PXXCW/V>*F?>.AYU 76"D
M^;F>TB,'C$-Q#WGX5J"+/,>76@@T1TW\$#><XX(F_A\$FH_39#-5 C,SOCR_
M(Q;Y5TK+V+JPS"$Q5O/ V-B$<6!#'425D#?L+56,\!G#*;3("&R.%"TIO972
MT2U.=5L]\F**#Z&L(GL2;"!L.Z;,'1\&UW#WB (R&#RJ2GSK2FYE@BU'[*.-
M4_%YXW3@,_K>W$_P$RWAH:\W@".<%LQ=^=P TB _$89E%C<  LTJ0L89+S]6
M@BZ?<O&'TO<!J#FJ,^*FPU2T^/D-X/00>$*@P<B1[FGT1/]QZ7Q2(8W8Y1)X
MI9VX!-48F=+<R]$_^=_U#,Y$DT QUB^6$'Z-B?9<#0D<>)^<48H79JA%G^7Z
MN,!=J*>=6?$6VRL<>[<V$]7H)$%)5XZ?*,MA%#B_.1XNXD=(' O_BMNZ%'($
M%K>4-GIB7HKTX9=C>N^Z32X]JA&-$J;&$]Z ="&C3<Z]":)>PR[Y>WAH,F-6
MT)?%PM^SB29"+O2-.41B/7&R0-E(W4GQ+\K.&6ZT=4/L8CYVL*G)>HO60ZUT
MFDPXQUU)00DRGU9J7  P%G]%[S3DH'_?4FFNH-TDE"DT,Y)XY*>6%CDV31I$
MXQ^][@M"[F !\.5UV16$4P.!1PS;P+.^&X T$RU^RZK,6,M>"3K$78P.8U_A
M>3> 6>YKLN^>8AB_HU6Z 52W7/+L&%TX'5\_!*^=]YWRB3%\.H]3T;&8)(AG
M*OM@H&&RU_VT;!';X?2L$$V.F$R&9FD=/Z\>Q[_+? 4%3P.'CT]W##3M:9@/
M29*+.IDZLRPM/6\]S233P1-Z^-(;.!C8RVG?S40NK3]R%=8,66ZFW*EY"8VV
M,W?=8YQ\4T!=_YUNB5;M1>IH@VX0J/-7@J2\:CWNL3 & D0@?U3@SV]=QBWL
MBUFWO!'#'UYNXOU-$P,\2_5/@1.1[P;]H+GB.<;OPT%C:<KMF%70%S1:U\C(
M%%CPF+\T&$#= +:7)#O<4]H10L0KP?#9>>.VR_"@=:ZINPYT '#1FU2>LEUE
M],L)L"Z"?X%YV-& XK;AF8MF+>.*@U\5F->%MJU)OEVAIG0$/D8@)4%EJ$K6
MM2\,#&=!%!-O<;\PW=.YX.Y/AU.;73FT.T^]N<I575-$7UY>2^.OZ <$32,S
M86<O<8&7G/G]TZ]H!($K7TAWD!.BA!HTV(B[%3F&UB^N*&1O ;V^]#K,VB-2
M];6FVA5?2%EY0.>M+8-[< N?OX+:#Z1<&-\ PL;65*PMUXY)^1)4P,#(24O9
M,J2#RFN5@NHH0-J[6Z4(_9:VD@OB??#.:<L)-O3O;57U2_YRK6CJ\%=6"R04
M^+]A(YLW@#@CX##PMXVPH11_1^T;P%0;6+?J\ :@#.EK>P$-ONI+&F @\)43
MHDTCUEZV04%8T,V$EY.PK\!5U=$;P,Z\><U5R0^FJXU-*^T$Y!=*8+#NFY$D
M_F7ZZ95\$V!:B7R)(,(,%2.*=3T-/K$<S6PXP5W$/16EA[ 6A8;@4_QF]<S'
M_"CW]0\MVK8^LHQA+FYG/_ZQ&,XPR3PRVGB!NA6C"T(GX.7:#: "-_-P%OUZ
M&KA3E#I8K7RN/-Y9LL@M55S"B&!.BELDSJR.,!4)>LH%&-1@'=KDF-SI/U6^
M>.8,/L2_!HR ?K6(0Z%Q^5LQ@ZZG4JXL:CA7>6#$*32L;I$:,XF8?'!]ZB7%
MI"TRTDGL+NCP#"SR4XLNZHWI:T8,*K:[)-!O5$TE]-1.MI:-FFFM9GCUY?$2
M_M7N*EI@Q/,%1G$O\"]W6(ZA8'FG833G8KO=%VZ7KY\1\?<BO#-I=><]U<N"
MD>^]*D5?0%BAQEE'UVXX_FCFZ46]6@CEI-:/6UWDU<W>+1[;EE!$5]:ET=<#
MIB!('^OC3+S9L/MG*\!0>T,N-JBG].A)GT-=^G1YY*#PPF+4E"KB=I?"P3V#
M>WY\;5I6!7P1^,!TED-H@&7;!F]3[@?\ %T-=_"WY3K<5U?MZ[+3N_=Q@5Q@
M0@,G^T7\JGL'C0Q6%*D+>H0/_42?VP,E@;K;ENQQ&RXO<JU!QD"]T>5)1\O"
M^YK*B>3W])!&2+U#(2@AG#W&ZJ,R-IG$;X5M:I^7F<]X=:YVW%L*:3!9$:(&
MTL1LM-Q_6V'YS(VQ31G]NO#;=5*SM$--57A_(8);5<X39)P[Q'$-(=)A?MOZ
M[ %ADAFYB#A,=,<""'F)K5ID]\LH@PZWH$P:@)6&Y67JVO^(=IDDNA!CT#1'
M1,_LQLS;O<7]#!.*R*78[LAV,Z071$.^6G\C9A'6F8;? /[>6WXG# $..MFS
M5"L?K\S;+S[@1!_W0OA\<2-]W7" V1Z:)MO>C&..H=*C74=:<M#F=:)2JB4S
MJI 4G-'O+$0'9&B&),:);.[6;D31#< "Z>!@!SLP]D&>._(O^E<'V<#OY0"L
MZV)6C>>6]C"(QV*H@_:"X)3V"K.29SY)77J.XULY]]"SY :07L6!WED7\3Y?
MM1GBG9WM$]DP^610-@4P;5R$=U987$YF+S^8$VW]_!0F_7F?80P+X$%QXI%W
M9R!K<JTZR-B$T;F[TVVH[:JDW' [0;25S99,2!W&+E]Z>7+]*> G!S8F5Z-,
MB9/=+&=@R/OXWC?+A&!+ ?3ALYN87PYS..)CD3&P(:1;/04R$HMUB(U["CD:
M8$9S*JQ@QZF4NOZH+[SU\P')'#IFVZG*<MZH[-L#G=FZM4MN5.R#Q?-UM.;6
MJ&Q$QU'WK"I1!>$T7M7ZRW^[XO(\.%$GS=B'GI?PE"RC>F?8T=D; PX?(G-@
MRE,'3LD?1(+V<[!EUJ2+:UBB>\B6 #S3";O@?WI"(O"OR[TW *V1_>=Q[#]]
M+V.8WGI3:6=K:MJI31" Y+JVT#BXBT0G)&K%9GG$#-ADT3@W %HH&+Z?3F3(
MWU!=SE4M:+'&$ $05Z]S\!M_&-[59%'N&/[$O'[U_+F._ !3 [&M1DC(TG/1
M>\!D^80U<_HD6E[[R.+?&<*:J!X&<"R>'K"@?2W]D9C 1T,1=^VDO&I9-]&R
MBN^%P=%'X$WF6INOBPAX/GA* RU='7ZX:LR]#%MW;'XQ;O3F,&9WN*?<[,$3
MFAL #V#E<$ %:9<-,X:[[I>^VNGB%3%.NBT9O@XFU/($?SA?P&\D.!K^\-F#
M;>-D0!!^BA),>5P5QG?59S4B6[=I+XOZ203N*Q8)0#5-E8UKF07RYYT6X^UW
MCI,X,O."O\'F@<GF$XKJ*L'R8UPV.3< ;>R/W8.\'O@=2]X"44TG C'%^5VH
M9^,?ZT:LB[*\VB;%C7$*"DU6MB*4ERV;2D21JB8(<Y?SXM"*WK*2DFY\(/)\
MTW*X8$<O>7HP]#JA5CMVNWS1E0%&N+T\-_#>4^X#CHHLHUD%UL4-@%LM;\.7
M\H<N^;+<!SM_.2+>FG$*E52.J0^Y>!]SUJAI#<><9FU>ML%-6B\R7[WT(+AV
M]Q@W9!MG'$7QY!E*7C')EH9>3WX@HH4JVC8_.VP]3)0JV53OL5GKQ9))VAMT
MPS[;E1C2W3IUH^QHP6-)8<(]GKU?G2)F\C20%A+!?D&?$#4=YL:_?"Z4>@=9
M(7TX'X+QQ9K&V".7OD:[]%LR$E&MEPE;_^SYVV#_.,2\JZ:5!,W'K)"BIL..
M4F ^JK \5TUUP\4HB'^%"V2&I'$I\,3$^,(<_>D!\SPWARZ55#8\?./S*RK:
MMFBXZ$[/QSP=D35ZQTC2,$$3VFML;;"+TZ/0I"GUZNETR7VO;YHC586B'LJD
MU<_6.3OO.<UH!AA?A'U/BF.0(TJ[&+-1CT7&9"0V,8MJ 4"=D1>0TVGEDU=H
MIQ%78QT##_'JINYC^=T?>*-X+2LG OG\/',2C(1TKEEJ8;F9MY^#W+0""FAO
M[=0WQWGJI-T;E9KM?\>;=#;7Z$%!7P?OF\!5CO*<)W?HJN%UC>YTIJ&HC+A0
MK>7C/<*BR2T1T19+5G1__5C&RH8(@_XSQ#'H/X_L=BVM?[U)1=5&8 GOF'X#
MX^?Y+ON!"P22XH1=TZ#XSK!CS('@.,**H^/L.;+W6']BTL/_V8+X-V+?8Y_S
MP"7NVPWX2-UZ6M2E!?!\#XBL[T6ZKL@@E$HRWFC(PG#=+D(^UGL_5(8;)FMK
M=LH/_,-SDP11G ;X:"\!VJNS5)2!@R'^^%[<,@?8S ;2=5)+T)OV^$4L5GX7
MV3L'U,Y4(8LB@CFQ8-O%W:NH:(HD*^".*QW5$WQ)OD[YA(I*>5LKJ#D5?B<9
MZN"Q>:09Y?+L19-[R'.8#;;MZP;C4$GZ2\#S.VXE'<_Q@T^>2TO,1H!WLMVM
MB,7NA26<K]H:$9V26U7JZ;$N?JJ/B =L]]8*79KX(7%S,SS%#\^",V??@LSS
MO+< I@32@H(.Y]<68,B9,E?<>_?:6>QB2G?4D@,&JJ$S&JS8T:+J\E7-(;X5
MTI1AL%H4'D@D6]& T/PE=!#&],^=!O4W0AK?9R#CY&3?U30JY)G@$_90^/BU
MWY:B69C_YKYF:NF^%QZP]V3]8IJAFT'%CS%Z;Y--6E5-OVQJ/+]-B3M!UYT(
M1>Q^CGX\MAYSWOVX"Q8._Y )_$+<HOKSE<L+A/(#:X@&7FB("4&$6SX'FTCU
MP(>B*%S6C(C_\ &:OW+':)?]K1?<9'A7" ^PS93TGSG!X:EW@:NV#1@(BHG#
M(Y%3=1/:R.ZV&\!O$K.._P+>I_^U"-/^S\AB#-?^9]WA"L);!Q\J([1/QR_+
M,1!,:OC_2L?V/_)?+D) 2G"W*>WEN='U_0*;N^"^@^L*# 0KH/T?OEW8F8N^
M 1R#([M:PIPT5$$>9O_EG13_1Z)E%'@#6+WE= .X]9LUS>*?7AL'HA]>TZZ^
M09/8_;UX&F-N=$16CG$QS,=/GAH6ZI/_IJ.G>M&/\;%3O/_TWC2H7I<A 0V]
MKTBB]N/MYP^E-[ZL0$<]'+I%ZTZA.1"[Z.!Z9E4U+;-D7>2!QO!W7==$^=HG
MS$3*%"O@_(TUXWT\]HX4X?&JJD^O^#+U1<IFSX+&K<)%D4(X8RPU4@9[Q+FO
M7-88HO0<:"3RD$#U,:<F3E1#LJ0;$Z&!O@SE2_\%D96QI%3=TTO6_&09$7W;
MG'0/*M) %%N>SH[18:3KY^4=.[=B&()VF6%*%+:FZ+?\V;F ?M(QL<\RXIX=
MQ4.SS0X"@VNBZPR+46W2"O,%+EBJOD4S/2++Z,/8,PQVWY(YL-[H?M:XBC5'
M\X,V"$L@%6Z#;X#):!\;@)(7IS.>T.O+$=ZQB8/N&B><4K!=Z3%'#1OV[KTX
M9;.X-'G9%>V0.X2&.LY&HECR@#X -/%&O6DA%/G(2'F"?\OZY-1F7I%$5O]2
M\ V-$MXC=R]BGN28A'HNE89Z9[-;P([I_>^=F>:"<8*, -_79$,C<LQ%2+YV
MP<GSJ9=GU?AGH3^9B&I8*?/I'$7+IK6M0(("EJ"W\HE-J_L?7)OO0SU9\MJQ
ME9^5T! SJ/7/A7W1 K?W*21R/PBTWENOB1MR*-=@G5Y)HMC>S![:/PJ/7E@7
M6@S2TG9!4]5 !B<M@^[,E,D:<XE/HY:<5[6ETF08Q:A&EV/(&15D8R+]<2/\
MZ,*Z*C]EK;D>^7[+6B52!<F9$98@$XV&!<[=^%LJ/ZV)2Y$)#SES^OGM>@F=
M%@UHPTJ6'XE6-N$H-G@49O%T&\AT9SF$$*;P]72]G,H:T67KU)L?[VE30I_Y
MTWZM9#X\\R%."JUW-F;,HOH"*SUK)?99O@'@;:M:JB"C)>Y 5[ &@^QU$*UT
M+BN^HCB3#?5L[*$*/W(5A8Z2'H()]XI7>+;=%?>:1D.(5'AJG:XZ"(8F*ZHH
MFUR6L<M^S;R5,\OF"'#[B&U]F8+L:0N'S8YM%FC25RFH&0B+,G'B3I(\-Z]^
MK*/']O:]..1^#\K2!Y$3X%#DNO/&J&Q>SN001C4&(F?WZ_=$3;?241T;AH/>
MF"[O:RQE%=D26+R\ ?@:7U%?1V^[OY%Z;"!U'NG::EV+E8._)$M40TO$:2)%
M$Y]M..3@]RU&\@MXB3'Z4ML+).;:I,L2I2#;)S6$$H4;R&A,*@>^4N)[3M?^
M69P,)BGS3@1O(_I@QF+Q"*<9X[ANOQL7< CJ-M0$O!Z/7P]Q4Q&R?>N950*X
M2@KQ,A<6EGL$DGRVZDV(2: QF0.Z&0?MRV'394AL]&1K9^UYV-G#'V]//I^J
M[\'@;Q=QC9V&#TPXOEHF8>U\(T<[+6J.1X=*C_ O9\LQNPVDAE;9X*65(5[$
MV^Z1$%NKV*_,I5!NXT\E)7A-=7@DOZ8$XYN3\@[> -@;@Y-S:>?UT3E->!!]
MQ.)WS^C9'RN>U'".4-YE*^.W[YGS[:)#_(^.>X2W:J^<5YJ<CO[>YBEW1/4W
M1>\*,;&)6]$,7L-2L9K" 7[75+WGG&C-L_;AQ\)"NS)BS>=QRRD)D00..8L@
MX#E #<@K<<W1F%$RPX+@B,BO17'!$BTHSH->&6&]W9S1F(RU1Y7KR]J^=;=>
MNK5]5WD#LL_/R:O((%-3'KNM$!=J:^)PB2\NHA5*S)L\$57._KRBP<5,="71
M?!]%#;Y3R:O(Y^;QFYRO Z($.,MLG1R;<7W9]N"'B?_'8T$9^ICW\60A?GL&
MCXCJFA945L_KPF0Z=3<"^17E9Y:'E$AU=7,/JF_K_$A9M:]=P2';:)&(LT,(
M6.^)#66;QUGE]QS1\_H6*).3]1B/A>">L+-_7[%226+R8K1/P3K<O<2+9E@P
M,9A_[D8H/(TC<;JZ7E_/FO\]*?F7*@12CBNMTJOYA5WZGN@C3F(F&B<X+8YB
M-K(7O>PZ_ZZ"44\8^[Z@GR^^)]O/C?P24 8D?V!@/O(>*P>#+S( ;AEJJ$<Y
M($;(]-,..UT[.3>3<%-XT OD7$VBLC6),?H0T&UL_5,ZO-RY4X$/$*I92/@[
M%7DE@U[=?ANN@#P9"KZ&6=F" EXY=EL U!)>'#,?$,!%WUB5L"#EW/_D4^^3
M%RQ"HK4"OU0E8S*6!2E[9#<:':Q$%_U*EJK]Y7)LN#_;Y9L*1<JUTHR[4LQX
M*..\E7!X&-'?;+JYJE;$QT 0X568GA%FX_)=/^6<I]=3JK*NZ;#.?W3!,LCS
M1(1><B_,K;58^8$49\NWDVFST.48.I7N;<WOEX\M#2'"__(0?&OQ";>FIFB?
M\"OD?=YGK E]O\C[NI/T"8\PW3M;RY:,0(68.8=PWE)5$#$360JWKV7J_>WG
M/PG[.&#?9,<K!!G2B!7@U]D#<=^>^F\OO&5Z(LS&3OQ^*!V: 8%BIA6F[/&#
M8TB ^L4%FF/&D"FF71?:/TC_P6\5V!FBG3[R^F.?;9)P$;'?BH(;M)$A3\+F
M8;3\=L-O&[J82B-N C'N[FO$C,EP'Z)'U_O:(MJ=;)X]":+Z'H-;NC$\ZCK4
MAEFS]&!V%LN<THO7>H1?VC$KJ;L?6F!\1'/PHB[R57!<3(J+^<J @M2#C\M6
MS*MRM'>7G_.VIPD!V5:=<(AJC!X?"(A;-0IGZ<OQH0KY"W^[)#EM/*S*G9KX
MMU.FR.WUV],\.OQ>SZ&<;V'_;"9YZ)E#0Q].]) S2_[9RB+448<@<IRW]*<:
M[[V3[-]L\RX?N]C9NX\MDW'T#TU+7F3"-YNGC$6HS](5B*E]L*)#D@B&2IHF
MD-GO"#_7&QSI1_L\QI5 V>-O&:P1>X\ @_3#35<.&VC<SQ+.PS8"C?2:XS(8
M]GE2&!/'_)#VTB+',FW7+ZZ4T1-75C&=U3< %K-D0N9=FT%>X6W@RQ-V5B<C
MCM#*.W)L;$;JE!T+M $=[@HZW0OZ$)=.9KZJEO;)V@%@A^ZY'[V!B/[8Q]K*
M(+N'B.,JCT?S]V@"L+TEFW@AJLEQ'-I2,2+-)KM#P%ID,G7K4:45\_8RO)1(
MOND^<%Y-#M4I!P?C;A/N<"YS$RPM\,P3L>"8=V$]%B*CQK')@QY!1#/D1[1(
M*ZP6E#;^O="0B^1:L#2ZMW6H+\7(FU']VY;%G+<?V:BJ#^P?Q?4=.-RQ76 _
MC-F:4.^@H7U/C +S=322X[\)043AW1/USDU9_Y=6#+Y1%4+WQ)BN@\\ISB*=
MK!PSUPF8;P'WR[ ?>B1\OKP!!+XRHIT^4133HQ36?K*@V(7CE;NU%7U2(I%1
MDL*A^428\<1^^/@13KO@2]H.UTS(S-;N^W!:BT^!TLPT2ONIKBE\>X:I(&*^
MQ,0&]L<J6C))6Q0?44;$W-R,Y74*6N9V?*]_XLG0ON Q# 41Y7*]^RJL1-KI
M330.K!KK$*.UK]ET8'SGTX!%3KZT:BNQHS*+4E30(+!T5YS'K++/0X58KB?I
MPB>;;D-*/B54QO0XSK@$EZV[-+-.-1I1FL^0Q#TC.8+^,@/O)VUPCDC0JGEH
M&\/!>!+P)E:]IT^4-CR/?,X3ASWP%L.+K49>YSKUQD2L* W%-Y1F0#CX)*$Y
MH<PQKH'9\6FV1 ^CG%,X0I'&N0O3.A8/W,SL/@_1$Q-*JZ3@OX$<L!:J5^I[
M1,#=V)P)OO/&O,.-],67,K1R2-_QOC^Q,7Y"UCR1T^_ 5-K#WF0K8\AKV\[H
M<GY2P/IU3M)638@1F9M;!++F[YO>+T/G63$(+9E$@.4'ZXT(/"53A 8*S>M?
M"C'VI/XX&1):<%\!W)J;RE75* !9$N=S)65GI7RS$FM;?%/JVSOAW(Z[IZ*D
M/'YU7LBOJD.Q2[PQZCJK/^PDO#QU$O!BX"E/SSVX=AC1B;7P-OZKE;03"O9,
MQAIM>E4;,^-^@5#G8QA:*SSC[0!UONVQLMA=GIV0+W<=QJ-A*YOU5B'NIHE6
MQ@1,="'2][=M7TX4L/6Z:,EW,SP0J7%V:\Z&#YBUU<\E#/FO")*,FO19W%WF
M=3/(C"7?"I.!1YM[LYMOX5]*QWL0PUR[1EOBZ2[/H)>8YY7: 56NL(0[OVH[
M A-XBG_7E3)UO&9]H;-&+7LJA)WZ'GDYE6&>\!$:F=MI;)KX-/"=62'-ZF6T
MUF;^]_VB2I T%?1 B[C-4^*PZ+*C6M#Y\4'M EW<)S3A2'BIJ'?5_(C\$SL7
MJ22BB7C=MJY'@LJ^O;^<VV]C&\8+[=O-G8J=FD+8Y:>7&XWAE,629YR6H.B^
M<?CL]SE2[Y>/E0%A28<R.TI3RPK3N;]0$EGS/QW]'AJ_L18-FV2@\D@XH>
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ML=DK38Z?3AWZQ ]2*YUELC<^G %9\Y192:3&LRG3ZYJJ]Q$Z,M[,.IGS\@H
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M..4>H7%"X*A921F5'Y[/D,R,$WL$T2@&1V\KDV&EYD/;VC4.!^,_$F?GY.>
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MOM:TH+)/YB/]TE.!F1.%P+YS/((MC_37K'6UGWL8>R4@A[FGM2<8>(##4]"
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MO!VGBQDLB#+&M+4@IW<TJ]SGIEG>+$BR'.6AQ#UA5S>V-[=8:@J?+6L@@R_
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M$6F8R!1UE4%'U-D+2&OPJ3#E7W4QXX-9ON\PZ9E=.9^M$;NJV_VR!U#S.@^
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MI(F:,?"DVB[C:XU4Z97HX>IQWDY8Z%3Y4TMAK,-DJA2:,K!D/EPKI<\K]+9
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MK.M&[)HCS.J:,;A<V9%2BSS(6O!^5_4_U2_EP434XL3HB"(GF[ #/M4Y JV
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M,T,*Z._Y\K^'3(_X*J>76U4[FT7)]YPHTYA!5F_.JZI=D/W)H<=22E)6+>]
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M]W.7EFI:.:B"_*I+SGQ%<VCA]A!4Y\8\?NU.4]F@%5<R_[+^B1^F62TSSCU
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MU55!3_VY_?X;>^\9%66W9HL6@B**HF01*"0'"9)SB4H6D)R#(%ERCJ4@.8.
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MH97WF+-C_A]O17AC-W9C-W9C-_;?S907]%Y;V]&?]O[HHDAP,_ET6]; =.U
M;DOS^'9%P/Z2<:*2@.BM@W&FD5L$:$"A>COE4*=:!FV]\59W\G2P77)_>T)X
M84%*$K$Y=:O KYR]6+#<#S)_;V7APZ9CEP'.'6P1 B0>.-[E2CS..MLR>F:.
M1BW<>S!2O_''!9]GT41M]!M6MZF/IY?.AI06607?I\#5,9Y=+_JYKOC!4L-3
M%>[6/0Z[B>#9Y++6&1>:^5NI :ZPM@VE'XAK35.MBT6R,3YV@P>*NQ-B P9P
M@LB (&\3A%,7Y:[<V.OUK_JKW>XM'F5-3(6#.!7$1=3J:\:E39%?U#F#+MP$
M6H@#K4M"S+_V+C>5:T>)YY?"IU%O?BO]Z2+0_ET46#9C88#EMXFR"36+9HW4
M'CKL:.:M4%)<M9WDVW>;T+R-!MPG/9>)Z&H-J#"M1@/2KX/)$8^BIB (H=5!
MD<["]GEOM[O<T%XA[$@)RL=Q43OO=OK8JG6*2/>3FB5)Y-4F]YVM>5S ]M'=
MPN8E0$DJV4*Y*]J4VM)&27OY8UKK/CU+ \KFY@BEYZ5.\ "-GBT="J6H?<X*
MWPZP'7^*NZY5[IJ?#\]G_S/L/1UA5?V[ZD97:38DP:+*QHLL=@1WR\6G<AC.
M*Q(O!,Z&/(%R*9W4--70WWX&!M(\W2?!GP(DA&C2UQU.DM,UO4@&2I=,-$(W
MSI2>ZFBS5[NZ)I)=0!X_[[=Y=!FC=4O 1)")[G/&1AHG@349Q:3_@IYEG!9W
MK\G)AA 3E1(-=3V5R+L5^O(V1?99B@D-J?I5&\Z.T3LM&1?AW-'= B(^N.\/
M[=F2PE89D -F7H;W%H=MA7]%=A+TW=TY4E"-TY11*2)OY'>KUA1900.>[+30
M?)VG\?(:P>,_Q2>*K!-#I?D4ZQ-T:8C3-#745H>N4,\?):F_%(WIQH/EKC#\
MK<'2X!QSN:;V,2HJ=\@FA]/+\2&_[O(GG_N>2!ZY%XZC.+G9Y4/%H2M/>ZYR
M+;?D5Y["(,M)LA^-8" G8)FUA:_@Z%F]QF_]@_+YS_AKMZ,RQ0BV?8K3A!B\
M"(O;&O5VK(=\:7;=S@WHQK)KFNO]!)2;:>._"@PO8 ^Z>>;G/(S+5P(+-TK>
M.WQ/?CM*<(U>,PK>V$6J@ZIZ[V%-TBYMFRD8KT9T:AY.I/,NS+&YFK8I-J*B
MZ,!9DS/;_51^NH;W>XW?,8/I<_S"+/<G^]T-VOFABV3)'H3,T:9I,ZR%9_13
MBAP< U/<*IJOM\L9UU8E2Q,-S49AC8-R+Y6N:N8>BH3?4EIG98!'VYC=+]DF
MFV)5%*!,]<4G+9E5^B$^1S5T&%I2L*OA69;]6VN!'@IYFO@#1E<HWEWL[M])
MFO[TNWQ_[Z;[HO*C1X5,]$0+D>*J[^)LN^KIRZVF-$,^'MDA1+RL"V0W?LM\
M>]UHZX$3?M[;B[#F43NNR8N=ES:W= ![.1 .U(X2))%\HG/E\7,4?(+2KL^%
M^^D>$.ZI-(T=/I=L071N/6^34N3&]8[T8?WZH7F/<..)%^1%"]!">"CHP=PN
MN"'P5;Z@Z$^XK>,"(2[Y%8ID;HHC:M6:W4ZZ?N(@NTZ&?38^01(K<A+?P4_Z
M]9X6$%KC#+J$38"/YL#'+BKA6XS[;TWO2K*E#9)T@-LG_]PT'/]ST] 2#>B:
MV@IJTC1?U<C8UX!81']ND8U_M0[#QE=T!VV1<*3&-DJR1MOVI52K*\BK5H]]
M3#\\-PTE.51Z[@,X]"F)!CV>.]30!W9<3&\7)#P!9I>HA#.P^ZF&NYF[2#J0
MMA)^[!J>/?/AWU.($^SW^^FY]4EZW;HZT*+\F6QF#$-(M_JH/QO!.TG"+SE_
M6@2:B8<R%S&S#?O^NST3-2Z"1:WSX;;(YT<TC1[4SYBYLF/\9 X[,KY.I\&?
M8K;_DVOPO'%=W &UP3"#VIKM_A8]V%T#ZF_OZ2JTI<*:ZW+H>?X/G=>L8^"F
M8 ]PGD'SQL+%\ZI/9;P!O4^EL?F:DDLIEKX43-C$O@FT]G M_72'?*% D*FN
M7&1E*,\R%VZNVM2<9!S ](2I2,03:^%:)=RGCR-/S@!A^'ILN_P10K*NCELV
MW]WVZF06#PFEQ_>$%@#3K.!NW7/@8";^=+U:2 ZH/C%U3:CM*-PI54W84>Z
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M#$@['S'TXY<^QJ\54S("#?.Q\.^'.BIKFIV1M*$![>T3]WC[5^37/C:;+LP
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M34P$9Z*:V1*"5MD/=CC?KUC/%V+U? M7.GD%TBD<_QH_QJA.1V8V=!ZZR4M
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M'N]H6+!"NI0=DXN%-_/<3&Q(VN6MTS;5WQ7@4AHE.WS]JB,AV-7'_Z<6E=:
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M#!./U<DL9)+8AIBRIJ/<$^:\CD(%2-^]':GIE[PO?'9WE-ENG&^?;[,XJT5
M"-1>#X0_Q#TKRMZ?/Z%R<4[$.+IKBF7N3(^YZ;VN>P\!NTI%8L/-CD BV)Y'
MDWCB)M_U6T+6$%R5 B%#AW1P7_EF?48PZ(1N%W2.">E2# K\E^,<V7H1Y"CL
M<4/-!ZL*>C6#*^])&N4$U5_>63E*#;_R7T@^HO^'E=IJPLGR)LK_C)P&P:\U
MI26E/;ARRW \,KZT;R\1NBBP+G#/]5(^?U^G]SYQ[Y,,PKK\.+!A$0B%01S
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MZE$K!GL$,XI.%@WH4O['699XAHK_T+U<6NS8_0:^/&]9-T(#_CH'T,I]*!J
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M_G8OQ\R7[DX*&F"H#-XV;BZ&#*S&OT%$?HQ4&/UJ*$6L+.D15(OY!/Q'C&3
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M>*_U-;KEV6::YCU>- N0#-VEBY;8O6U"9LDXF%M!&O,?BR4\\  T@"X0\P'
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M4IO\0)N@>.M24U]+N,??6<%6E6^PO-]_RD*Q&V30LRO)0+_63V-OI3?*;]H
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ME9=+MK6%+7GS3KBK- RD#4IP_D>_V'*SI!IU/:I?4+/U<]%+H^"4]'TIE\*
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M1)0*,AF^UCF&<NIR_=G;WH^8NAL_<NMAH!WJCBC:Q*TRN[:7L6G4A9 '[/Q
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M[U<U?SG8.-$Y><"A3^?YO7P+E5LH =GV-,L62%[1T9+;O(/5,EY)PH0R8=N
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MCL<,^S8SM^ M#V-K;$J1%[#6OO%8<P+M(]_'EJE::+163,.+;_7&GSFG<ME
M^HK$H>WA&.;](L,7&]JW5775R>F)HO<I>S_F92YD'J(G-+7#$I"<I2T3-LYN
M]BC5#KCT>D&4F2;50"<]]"@W#@WC6(7@1[!23F%$F>N2*&?<0JBNYAW!R%X)
MLLSL^JLDQ$.L_ZS;U2408Q5S&A6LP<2TEV*-4\+GQ;<\(24YPBJ87A:S\OZA
MI3NH0 F9'):^&[;&5_/;A)<_7?!&D9@>JSX$+(2G9K)^3""K1[V5CIS D4.$
MUJ>OEZ".M!;T<Y%RPIO_;*,U<?9UPS2XSY698B%M0ZYRYYUVQ-DU(#Q.L!UO
M/9$PSUZHX 86JDMN/#P[@Q??^,"KE:0<;P49F,?E4,;8!G6D'PS7(4<;HUK[
MACXMN,MUG#M0+2G4J!"2$'_DXS]L*"_A$M907MPLP?FDR+O*\*]5*T?DW6CE
M)8S"^OMQYLJYIIAY-,T>TH"A0Z]6ST:65(S"@=%@O^$]X?#;R,[)7?;X.3?"
M]N?:VQX$&":T$>:IZK[1CVM )Q3K?A%Q#9 0]MG?.G*::N67AV.3LCV69NK:
MY-+K!Z_6A!S2?%9]E.V73O1!(YA+<(%V@LDI>#M\N\N@V<7\FSM?]WCG(N,D
MDOZ#S&2G;?.3U%L A=U6.(!JQT H?YF>!GVVN$LX%-:]DJ:+\9MP_;FBVG".
M>59[1+";8EC)VKR2U!%K<# ."+\ZR,TE/?-$F]5@^->F7:SSQVO9I7J*@/$N
MA ?;_+U2/2<'6FQL1]+;;\C!C8*5FZZX[<V)GBT=(_LCI?U2!<&2=;5^KPC%
M$/ C[F#"]V5S\]WI6GJIQ>,'Q$[=]/9.X9&908IA.N/&4P)>Y5*:@<G/2+-W
M23?Q'8$D@AR4LR?231<\W'DLQI(ON%^1_H*><L)6"[>-X1/'9H6=),:77!T/
MNL-OG4,:I&.B\[Q[@"H@,AVCN\BH&LNX'7Y^CZGR5CS@A9F7+\%%:&Y1W.HU
M(.2YY3K_.\O.$  !D'=Q1'(:?R1?N//N-8 PJ5-<^:-@5_K.8(<=GH0"ZIAV
MUUJ&HJ]O<M=L_>("_914V>W=[_1ISJ*^C_8 9*4@/ ?2KKK6?.6IQ6MC*__Y
M.QY!CHD7CRJ,HAEQ5\] N(.$F/=R[VA!%N?A"+1!;QRN 3?+20DL>E[#)VNK
M"V:6^(9@1\(5GO>?@8B&I?9I#RUY/:TD:T6!(9!CX&\0\(H0[%.R?4:S4#)G
M]<QCM#3DYI%I!T#6,<^5M>&O>PHT4VN>C$JSB;+^?U8@S5*V'.AKSN=@VP6=
MU?,DL7 @F2![30[^QN#(S>=8^DZ32X>E6L][4<L&0%4_W<-9\;WN39V*V_!!
M3TQA% Y.AU!!PL[W'>(MOYEX&:-AA>.E0F5)']2_N-DU;F&%X(&!=0FLE?DO
MZI*T\^3;@0DZ3B/T-^C=>SQW6MC*I!I7!O1FY/FC-?2)O?L=,GO\41.++&J+
ME)/^ +GI#8EK0(-U!DI? 9Z7+,F3"3SOGZ@?4C4,9,[5&"@1UV7/J1+Z;X6#
ME[',UX!!_C_E\?L)B_\(OK<07';Z0N(D,+"K,0CO$/4UX-_JKD] 09#C9SA(
M9%A^#<C.]S0U-,9 8A)5L;NM[]1E*-H]L_]+);K_^UX$O;.5F, CR%Y+)IJL
MLL ;9VQ/>$)P<@O!E';Q8JG<NWUD=]^=^O2>B'-<OF%BC)5#P!I1&MU;;^ 9
M2:9NP"0'_*:\D ;Z,@(F)G\#P?4TK>2.P(!<8>=/.#$/NC$ $84=QW-[E.A]
MJR$[QR_4\D!'F9VXPU;0@M1D$GRD)]I=VV/?Y2D.ZL%X@(,O]/I\4ZOFR<+7
M,@ATS],UW]1,"<R<7FX'U(U7P%Y=^.]+ _P/#&E7(0%BW<GB0[EX13.4%V_O
MLTIC1Y>!19A Y_$T4P8%.D'+X8=GT9(N+0XK)G6/"(S&S\C2[OC97:Y[+^6[
M1W5": O#:D6,J^\UN12\UNN>BHGDZS0OI'/K@5$$MY$@^/N9&( 3YP_#4\%X
M)TP4,RCSY<UB#P>ZV9.[7"KE1"*6>G/A@5C?2?4(,5]D;_SNE'XQ3>:MFD<D
M/I7*E/<K9\JG(ULV>C'QYKN2UN9K=IB01,C9?=6K1RR>% GI=>FF).EY7"0M
M[ ]$8#E^AEY_!X%_A#>6%#@K9K(0/.QJ 97KNWL9U$X^_6S)Z!W/_'G7G=,W
M*P7-)H\*6_$QG#2EJ:TM2Y5VKYA_W>O#-TT 9VTA:&< JCY$?97D*+1X4]6K
M_8+_JQ:SB:>)$Q@)^8KE&.-AX,\?<J,"<4^%FA)+VDM]0/GI380S[R\6/J6>
M"+"C</8D[>0-F74[DT"K!-KSF#>]HJN_<\[TJ@.@JB%'YSSLE'*\1+BM@0KK
M/-/U?&PQ^^*$SF?ZUP!PX&)R@7=E*;16+S!$("S,%.2I5_N<,WR-S8UM^X;4
MY*'A';A,DO\^H0;;!"L0VLB$,U=3GT<72,G/2>QC$;F-#@%[(RE*KXI-P1IE
M-S2>2=.1&3W9I=2T;$H8BOC9.75<HR(YL7P-X$0?MLRM"G> $?0]9VW1ZBYT
M^"ELG[A_$M\D-0/<&+EE7" Z'#!AD-S&&9>F:7 7>P\5E+4KAI\&;DIOS3]]
M5O(FB8_PN!\P3_W]GN>:Z-9L V^8(=\X<JMZ7* Q<976U=(T6:Y_4!:@N80G
MBHY27.?Q)EL-TTGA$""125:XU84G#Q+L%2S,Q3Q'J)1SVHXO]C^0W;'%OB$]
M5QV$<$Z^)/.&B>9KEZWU&6>AF HEVIZT32@*)^#7Q]/2V9H15%:0(XX,P/_(
ME-C#\*ZD\A)M_]XY>U]U.3;80<)USH:^U_Z]C<.")C,8PV]CGC?GD^/<HJ,C
MT?6&7>[61C"]?%GC1,G\]IF* )UGAB8\":O($G7EA*,T,K5NUP : 0Z[&BYE
M;?SY3]0!6?=<I41WIOTN4CI0'LN@!]N&_#70B9JE)U,"T?P7B+H[+PF(.I&"
M^R?_ZNK"1Q JP[[K^8SIEF:Q0 G'$XLQV[CP&JGW<*/03?C7EOK^KWH>C_H;
M@H$M ?XQAX2]F&;8*&6&!+QVHZA!V;7OD>UJM2*3PT'M=R=#@]4E__,S?DE8
MT(F;E:/O<,]YS,DHQ-VWQ:WBJ?>C5==OG1*@8EL":J'!1R?=7 JR%(*-\6S:
M4<W&]:AT!.6 W@]LY^_T_#H>FM4U?"U$KQ:2>CU6S"]*=]7[(0Y)=^.\DQ&.
M4+QL*H7XSVYAF,[KP<]YSQ+OZ\[T<)JDKSF8L=G=30- ?F90HAQ6A\2[= T.
M%A,VYGXYQLI? RR"#]0<5?!,QE7(PA3BV"?C)_*BO/^]EA*9[XTHQ? A?*9J
M(0[W8IHX;)F=[6HZ^?)#")+*OA\K-*=3-?0KZ.B? ?_?T@):EWXU^4PEK)#P
M=9_Q<FY2N?:F^MN(2OYZTE+?@P4@I.K7;.34QVM&Q*;L>$TRO)729$O<S0B*
M!#1BM6@_::VQ*7+P+,5,>C_"<50&5?15W#5 6O&D,A0+3))'!,"RW\WN MOD
M>FY< R)\&[>VVUOU5B(#B]V]VBM-2_1\,I;G6_R$2S%Y[ 2<\OO6D$X&X#A&
M.:\MO:A[Z.[]_E[[W]^W^[T85+<4WFX4+;U,9Q/CE%1E0AGC9/\:)_LI@YRZ
M>[J+:_@)_'W:I]3K]\7B,G5/]Z ,[KK#$_-2S29[]?;O3!^(GLTVBE92(0C:
MH\@L']V:D;[*MU*888$NX5WE[9*.,RU^Q^E.R"$+66$0DK&G)7'8_^0]OL7.
M>.IF8[C59$$C#;?[6I?=ZM%]P6W9R"G!X_(U6\(W<8GK$9T9#OOBX!(,S:B1
M"GP=G8?XE*1F;]R[U6]XXZR/VZ>;-/\]2G5YX5>C4N6#'\Q<7RECI'2BZ/CO
M ?9&L4]:D\F8(M3).=EO:,D"\+X7E6I(M,0(9"OJ+XZ91_V5A3"(>HS3)2D<
M*364P[URW3TI;A18%R%\)G<FDS3K.[+E 6U]/==L)H6@OBPLS%=#@9<7(!V>
MR(WA\@]G[B9UQ[];MI>>-JH\*_/"4U;PHM5/NN/S\6P<>V./XH2M$W+!KMMS
MY0)$WX2-NZSX"J*\5M.-NL42KB*3-N>4<1IS0,8C.RI&25"K?#N^5J"KJY^H
M]Q"+H[%]DC77@(H??S)4FE,VI.@MSM&D_N7[@NP28?&QLB:+Y9_?Q?3'<I66
M;1ZQVB@(WOH&3OUGHE"E0@73:J)?,2JJ0VC*4[E^EDVI*R%N\&U[@+W*.[^)
M4(YF97VM..=9N?C_N>(Y%",!!X8X\U+/&NWJVL58T\A38U!SM[+Q C]ZIIR5
M-!V(6I@'AH5S_UX&44HP.!L87QH."UV2[,6Q$I#U.\J?$11AK(>M]Y3MY&IA
MI];I? @G\FVPR :I&</RB>$-!WAN-YG^ )W8^PQFQV+.^=?9/R6>X?_@AV58
M6VEI:L>)(LAI$E9KS"N]N7 +L\N[!LS97=$A\\M1O!U8IE:E(3W5R]<[5"%&
MPS'/LF)O4WS>57ZU3,)Y_AJNDEYH]>Q"6.TB=6V^/+QW4%1#[B57?H6EN$*-
M:SO'N*)2=@^DO11N='4#>FQEA^6)0FGYXG!.EC!66?D:T 4SEN'Q<",U)=TP
M<OCGC4V23'+?1YU/OX^_/WX:G?AV<>B+BBJW0NF$V@9;,\?+YY-,ZT->;WQH
MC:#C^N_GAGLE82 .C"R)E]'G-J9MF!1#S?=)N[6:MMJ(#ZPK=66?[:F>KQ7P
M9WA>65T#HK ,TJN],ANIS#1E2H&NE]6\IG:OMB&DA>%&*+PN7>=N46>E1H^?
MUNZ#_3['R5?6)?!26N'B7P,: 7.A39*:JVR=R@R\I 8[G@;[X/HDAV]*+WZ-
M"7PX>;!P3YH)[[3+@R#@M,\%0K&3J/9%:?[Q1X*%%XX]<,#D@?#*5FBM:(##
M-NS9O?S#I#XU?NS4'31QRMG23=3M\5]3(USR/"X<29^J_3Z7_IK.'6>J]+Z7
M?M-6(->T8<(*G!*?$).$B)+UD6N_XT5$&=O^@>F]R87-<?U>S=6-2@:X>3!D
MY1%"IB"O?^AF;%P.\GD] <.:/Y("23[:XW K^HW?:HRB6$8XX2^*%9R]R91,
M&_8Y9'6=S=T6?><?)<3["=@B2=B'I-^U&'(\EF^1X7#BC):4Q[R$9XU++;J4
MVO%2'W>8&:8+^1R-M7D@I!K9@C%R7B5-\0^AO0%7$WA$($9.Z>6CA]1"I*2[
MR3M#N7X7:Q3S*/X5>LPYPA 525%?'77OJ=N7XXPL(:E=]/F!WU0%)SFR,7Y#
MNS77N 6EDZ>0YTX)&\8W;79M,F6B(OD,1>T68ZQK\K3>JI4 U)X!Z&XHZ<>Z
MN4D2RB5R/I8AUV!GSPD%_)]^<?U=!MKZ[_WHKP'=026886^CRU95N0L&\^P_
M#;,*K@&P"2,T5:55)<7H'^8V#MG;Y;TB!M>"72T1/:/'/WA71B9P7WX\XOQ?
M7DXPJB"PY>D->LH#G$=LTX?H'NPE(ZXJ9UMHO:):*6?DECM !58[S<K4DV!_
M7I2VNG"@0"$>56V$V-9A.$2Q\N_DA$+X[M&!(4G=FXWRA54VT:,&WW N)[UQ
M4)V =3EH^-@;.;=ILU ?[6EBGB]\. %KX/7,2(]T^BL%X=TBU2ADA6Y,ZM=9
M9HTO(A.25%TATJV:_VFL:#S.PGE<72'0S/WO\)SEI(WB^.4KI>8?2QM7.8_"
M?/GK'6/2W/8TZCEU<W&.ZT\ 9>3*MQ[[.6$>ECGK+3I1]N2Y#NK'X2+?7.BK
MAXQLL)LJ+43>4%*D#IP-X7-:(B[V? VJPZ53I*A\0O5K^+E2_&YMY7W+6?SB
M#+1](;5\O#_3-:"I<>L"?&=%G M*@:I0?6CU[* ^I)KH&G#'H=TO8P F!8VP
MGL8\'\M*4_9R<O!<_J+5JV5\-(]UF7U%K W/>R8;\]J?*#A;2R[K9J3%+UWQ
MJ$1-RX'70;!O&,VG3B469TKAT:BUM&IV;,+.Y";-E$M4F*NV_Y:2=CA9][/<
M0= (,)_<E^L,]_](FC,R9<BU67_](^._\DV%64<[Z /"9:KU[ #K>PV8]W@W
MUPSL:L[(2,ACCG7;-]=X6FN[I6QHLS9G66/T8&>1M3Z<G+B4UU#'";;;XDNQ
M(TBRD-^*S*NK5^?^KMAL0)M-GLT#=I@($O@D5[ KU%0; *YSO/,XVH1A;0+X
MDG/@F19W)SX><\:7AH?+DF"Y9H\6_O+:)M$!&2F'GC?+]Q?0D9([]0P/$+X5
MQ&+UP1\NQ<E:&8>I($T4TF@M1UFTTDN/+6N175TCRB6K#)$PY=\)+-^#PI+>
M$S("D_U)?Y)JZOVCH+A4C"#HDX2HV?OJEP:(S?ZMS>CP-=";#$X?NS?8Z=\5
M.$0@WG<"LTNN=UV4WHG)B$_+'2S_@4_MV'PX_#]T3?MV'3,\J%,>F2@K].B3
M3F@XDLH!2;"):=UK@'?_&=&Q&7-&6G.5>QY^B6E-=^CF\^$\*RS0V3WC-?<A
M&KCKY#^I6B09 :Y1M#G]>&;SBZ<H8W&5MM1]ZXM,+ <YGUC:%XXQ^1C9,?G=
MX,_5_'0  @UE^[O+/EXR"=> %7K8:_MF\X&&-:#^3=)U3N/E(3>=]Q(*E<GO
MB4EC/CTKC_IYXX)&/V8I5?IDP-9 1:Z39G</*U33\!F2(R-@W[Y,UD+0)W&9
M.4!Q(-AKY7NSMJ5U//]'.G?6C^['[]QL+^I=YD'E+J=OXW45G^13R]3S%";_
M>XJ!D]A( *06HUZX9V1[W-:W@=WJ7X :)U[.?>5/<ZY(B5]/4: @K.40\FCY
M*UX[@PK+E2I=61(C/!\QPUK@B7*$/P-F8SCGW%7=(L8[(3:7N4#S8^A.LFIK
MIO=I16Q:H3EETQ-CE5T%I+GP\@A95Z5%U>TXX>_L"A,9"O2T\T C?9B"OG8Y
M',W!"ZEQYNH9YSE6()17\5RCJ]3L8:K#!_O@]52_?KJ!H/C1?EM8+AK54_0"
MHDMGS.:\3Z096@TF#48O4X:L7#XQ;6UV><#LG:#_Y=%N#YVGCXP+ ^T8M,H;
M9/[^Y45,@0G7PLA3Y/H4.$B"Q#A[Z&PNA.9<C4W*.9T\HUFNLG%KQT"+HT\O
MD2G X&+=(\/_3[1%\T^ARE@K7V,J*>%54!=,]WRN_N+R&N"P86R[#Z$\]/0$
M*\LHL$XVWXO7UX0Z_9W\9)V.,L"YG;Q,Y.DU $T$TRG6A5A8NKGJ8: U+Q%V
MW:Z'&OR15];"[8O :T" M:(UL-:GT+E &6LXG$5LS#86R-([*@*U2/[^HWNL
M1>D)]?V;O;0)! 5RGY9AHFMS2GI1A(M]CB%-^*0/OV_H,=K[H'T%T\M0-,<&
M9@9&,I/K-4W)]?(5/=22]AUISLO^R .M#;A=B&#?JBK9GH.2.:WM\SF'9OAL
MKM26I/+;MYH:FZP:<2H2!94=Q6QQO^K:'/I+FWIZX%^O 70P<?@X]A5Z:>4:
MD$USZF5M\>G@8UU]N!RQ(ME]UYN-1\0H.2S9PLNSO8,EBTLP_$)/Z%C5H$?2
M8DM9:5"4QN%8S.K?6S=KFP<+1!TLW-M2/L%$B=L="=EV4PF_B5+5';XWIIRB
M+$P9\^IGYC&+)?00BOTZ.=B'>Q-UO.>0,[^*)6G<^Q10LA$?/FGY+)=<;[M?
M)<GG8_V\A:VY>V<55'?U.ZKZPNATL'!QI,U3.U0I1;5U<![(#;8F]V7%+2$'
MLK<"*I>&KW7>7]BYD_>F/\FU8UVSYUM06I2&Z$@=)R0$>LR>B4:I[FEQM] ;
M5Z+ "DTZ#,-7-C";P5=QD:E!D$&@9_[ ?CG/>IN=M?N9^.R&M\NJO+,RI9Z)
ML_5<'@>=SZ0J_LAX?3&:9I"&(,HX>*YGE<LL&&G.!MGZGCE5AH.JR]6M-)&5
MKN@(N,URFZ+_KE-LSSQ6B^AY6+,;1[^CMF)79A":.0441%&H7/_(9NN9Y,MH
M(?^='E"$B[.Z.H>H>+5\EXP._C]3!4[[-VV\F<[LJ)572>MM3X1]U_J[^9Z?
MUT,42QP5Q,]8\_2L%@9'_I,H8[%[:0<4'F?IH.-3NC_'^N#H^'R+J(.J%WN^
MHYLHM/1Q_*#<[>CXR;MS8]JZS_Q1[4$LO='L;:X#%)N>A9A$<1"* *?PXUS)
M3?"H66]3TF"IA?J!N<LH+M&?/8L+5^R%S*G0]Z6/F,OG=XIR0@='?R$2(]%+
M7VUMLJD;WBC=1YH>H,*CNJO:Z/80!CMW\U0N>6WX;@KCQTD8[XQB*>9@+*O
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M3SIYK&W@V#>O=^JN?7Z,@7GHF&<;U!V41WGJ"18<Y;O[N3(<BUCZG#Z#C+/
M]OFZ*EXN\Q^"W'DPF7?$;W32YND?(]^DZ-RH351_^IBE 12JL]W.=W(0Q6V
MZ^]I54Y\COU1U7O0&:VP0GB+VQ3%I1*A,,%1BAZ1#M8'C!Y>KXRN#90 WD*(
MD+;!Y=;Z&(TCPLB4YL.AJ\&.726J.I%!?!B #6FQL&Y<:EIM$3R5F6:.EV>*
MK(G.PGNL_+"7N1RLEKX2:)QJV-9%_=!>[)DK8^!ETORGJ,K1#<RK ,L@658F
M#FD1:QX[*NS.FZ;49=PW E-=5?UF#L8Z+Z$9&KJM?+"MW%J1_'SO-VZVOG>
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M=CS^S^8O)=SBDB-#,9DH%R_FJ9 :HR?B#W!6&X+, S237MQ J!]@UZD9VT/
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MKTFBDX98[@%E7 SZDL**7S;F=CY1$.F,2WL$(WC%>$9W^S1D%=?ZH06<.52
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MQE)NM#V6:$_XPMV6K-LS.5-D\#ZK,M9%HBH^TWMW/^?G+AX0ZN?3S:58QWG
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MGT<WG<=>J-BT3W.SH,9&?)[?5L<0QY;QU"'<H_PEJ7$-:]HKO./\G22U>NT
MZPN8HJ<BL[47?MQC&XLDZ7U[Q@A.7ZL(JG&1?/6HJ.\<]Z6+-?HD2%3YZX)Z
MY*N/?JRMJ6LC$7/I,^=<87MB^$=MO;H#/ZZPDF:I>A_2\X]J.KSM!I&\"%/Y
M)I\J/1:&FU.,&T!\!H"8 ZAW_:UFV,O/<YQ*(57C,Q-51FI58>\GH!5<:144
MJ%<*1,98(1#_FGLOT]K#@P@P(S.VKS]:#4A+6*-^ER*GH)M&^(FTFW^2UCI8
M/B.QIU4D9F)_PI=^4QEQ7+%'&_KJ]&&)UO+M#[1>R9AN04J-G'O1_*_T!-S5
M.T 8['1^?H1X[Q"HW];'+GJ<GJ#JUJW8@_V=ZM"Q! 6,O"=HTAT^^ZO/?EJ#
M[CQ+T<U\$+,MPTE-#Z<%MV)R>JV^CTX204@TC;BX[(RGE]7&P^N!U%E;]].=
M_K@L^!W@F825SW4Y$,OT+2\N@<<F&6Z]>^S-W@1[V7GT[MB35$,YU9XO=DO8
M,W40$MDU(+5):<HK =VDML4>1G<X#OVG[ M)C_M#0^NEJ+,QP_=:B8G.-J(S
M<4DON.+*?'A#FZ6AD:9,>>J,L^]6J2ZB55[)VA2$RJF^S3WYG9FZ4/+$YK.(
MS.S>G]<]HS/%&CH'W%!6=\GTG+5]OR3D2$R@EP_9TBN;B=JHWA1)L4<TV:B+
MJ&&1$:WDV2>IJ[!P03#AGO_"7'A4?4,C@W0T<0C6EU--MW8ZQW&['Y/>#=)E
MO)J:NWX772X$#AC6B=KMVEBU6C@_O\@)\>O'/2AB$^W1/I>5'<9T[S[Z7(T(
MCU#F=JA_8<4]_Q&IWP%@]J!34N6OM4F7),XF(X1(RC!K%&5DI1>!V%F%US?.
MME._=D:U?BG='H: 1*WVRC\\U+XG\B_F=9&!<W'1/1#;9J*CXW*B 6 X_[_;
M&-,KF4YG.Q*8&K2;N""-K9&(N"** C[[5-U4;4*DX)(ES<!A-OH:Q!_T&A?F
M< HA1/OW=#R7\'<*)7Z>,WQP4> 15W4A DR"&G**JM0Y1XP6Y5WF_M-W->SM
M2"NGKZ,>BCNG6+; ,*AP]>O7GB_1G^1 43&'!\1YU:'"5#;QVHDR."JR6JGV
M3&0DJ9FN,+'$CN=_;NR_=3X:P;!^_$)Z63K3BW?AT7R$[PF3S8OJZS['DU::
MV2F)*]O]MS9)S*&<_6<\#_8P9-.LTQ)$?+6:=P#H3W<Q6Q$ LE_<G<I[R!]*
M)J?**.80D/NA[5F@^=LW@=@!Y]D'));25*"+;MX9=&ED>S 32GO<(9<['5LF
MX6-MHX$2YS.WQ@0Q1-.(1P+GQ';9>09:)^I<#YTS_'35+%+0A6"[8?JJ#O9W
M(P/AS_,%EC[W*%C3 =8)?NHH=M[R8V$G(SA0J.+]T&;>P67:J27_;TG.L>W"
M Z#PZ]LT/U$QVLC.'%+UF1NF<S&;-HB[K3Q>BUY(]G'GDQED8?SPUU5)[OY#
M$/?:4R]%4E=Q?4(Y^4?U[(6#EWY*Z\8+[?^W1!A0^S45R%@Z^U=V<V&(<';"
MU:2'N8E!U[;#B51]5((I0RRG+=F=S>=EBU%8G'M!S-YVV68@O,"=V]DC&342
M KVQL"<M^#.C48_;"W&6IO.N%^T..%^_"AN<\TU= T:D&>PNT68:)+QB6C!:
M;T[HK(X8F2R1@F>=*;TLW?E0&9W.V6K7S-_OX@6)"N;6_3E12S%Z\&%-\? I
M9QD"=].<4!1#/E+LOW=#OM(,PK6'XKML+;WWD&PW=CY5%V>_!X;3G>T?P[L#
M[X@+4C>=]]<#O5S69D*'M_Y,?!<Z-'4,QE;>F0GES88!H[M%NU%'"03EAHG8
M"Y7?@S5<F5/[<6><EV&HF9(QF2REH8>E]8<%8QTWDDB;F<B,$^VI=9(]RGU#
M31IQ+%%F23RV%$<VS39T[.H(L9F)O/6OZ4SQC 21- A7  [VIE:<;2A1TV:+
M6(SHXN%H $M>FDF%'P7, P&**J=/^(4_1Y\U"/5@'?U83^A?7?EFY0"[9,\4
MDK_C??4BV;%H+I2Q(8YIJ_2,;=<=_+Q%EB1G*J,C7$IO</$O8B[-!7$'B.VS
M3KP#D S1VJS'A>444&Q--CT]-3X7W!>,O0?0I_;!U-<NYQ_=7S9G#B7U7L\7
M/VT\?K-^K#A [^@0W7^N;$VV@O"^N%>XVL_IO=:6(R_&'<'(5%_=;4.'U3 )
M@R?5M.;)\VQQ8>U;DB>Z('K?N3]"]9,21#X>[F$N.<ZPG\G+&[JXR'N%H!OC
M;ZBTJ9K1$%NU26)GRHTZ^)-(')*_[=".Z2+%9BGPSP6;9IO[E 8^7;E5ZU@2
MF^'>^$DQ9[SD8/@ZG8K\1%KCDR*0_9!SO.3?\(N#]U?JPBK<H56X;@HJR$-0
MZR/D6O3WU4^^0376$&;7G3C:Q,%IUIEX":^ROSEB/>TSWL+5-Q&'LJY11 \K
M-[#45)6?GRFQ:RDZ1.S4SVLZ;+U< 3XF>FPGAV=BW=IHP=I1Z9;MFC_K,1*8
MM;N=]Z-^\:];3$SUD\U ^Y5F'JJ=<C+HNDE'*LYO:@XU=7DOT/@O!W:58D]1
M646#7"V;BL!WR#@SRTD!X1DNQ)\NP68*R_Q%::M[H6D\52HX$B7U,AY:N_CT
M^A'NI>GF0937PV=N241KE,P)CA/W'!H;X&"SG[LPW!.S!WSB10!2'VNK<EJZ
MM&0\XLY])S,"ISWXL)/0 8J&.>3%:'[+V)!),U_FT1H,5$;> 72J9KYUYN+G
MF,/_X9;?N"PG#2!N(DUH3[&%S(T,*NV9GX_4 WC*NE<*>:KM1E7+'2#FONZ"
MQ_>6]-C^&BQQ]R0KKRX_#Y1IU5ICODTMD/M+T3>9G/VL253BS"60<&IW6M=[
MSBM-R#NI0@CY70%A&H.C)OM294#FAXJ\R=_V0&WD)G1-A:)[6;'N^EV5L8O7
M"?GK9H6105FO*RYX?19ACI/8?A:-'<*K5\3\.W'RD5Y)P?K<QO-03?=#OYDN
M,+XC/6O]^(1"S;7RFV-JW*SHVF>-UYVV/RI'.G5KS-"VNC7U*B<CM@(:16\6
M!C]CI?Y>OX!RL&]Z*_\,$/2^SK;MH'NJB;P(-QW0KK^6;&_R>^"B=ZF@3JB=
M/#MC*TM6<)DSBR"G*LG_[^<#X1?C,NI*JB;#1#T@HF53>*SA6*5L;@TAX7$G
MGM#MDKP<K3G&*]T1X4*WP\M5#UN9+[\<-1_Z^'CQT)N39R/$-%]6,S?#8?V7
MX8GL[#'G&.II3\<^B3X!D;*K!(*!W2"(,/C#%0 7ZB\< 1>W60VBX!+J)2GS
M460.VJ$]L[HD^HUE>*J9=@BMIGU9TOKAL'\N >)4MC-#09F,Y[0EDU \>N5/
M/$G?#:\'$OE.K&XL%'?,3IU^$!^J0;B*='N?C?PZZV&>F-[.XW>;^*Z:E=',
M/T24 '<,)( FACB;-W'(?W/5EZ,I<N_/1PY]V%TFJ&O1>C=Y9J)K4>J;LFI%
M@91;M?KD%Z/P,$GJ4-Y<=%?5<<:NJ,QH59=U;!.]..SX^[G.8?1*CKCJI,6Q
M\X\3X9XF(^KD+^X%"9_UE&7)"187ICG364+AS9VYCR8%EZ.1RVK%EW/,W55#
M;%EAV!9T_,T,B.\PC;QL:T39"U<M7=LO'4Z(Q =$U;-O6AG&TH@?D$9;4*_0
M;R%[KSR+%M#+/6)E3YW8VC/% @>]OU:F?^%6>^BL@XT:\@\G-][SCCI7L2L8
M%^'!O@&EOH,'>1@U7G]HX%8][OIL0'OL7]7W\,J5LR4OYJMBWV*6S),GO5VH
M0%TMW[>Z*O) FVO.3 GK9WP%MN@00&*@7E8@*1)E[R(AS4=01E#7NG'4_@&W
M@8KZ@GFZKO7U'BD-%ZC#FW'I2#V-GXF6Y/NJ'MT%[QV@)VBO&;F9"(R\D;0J
M[):F0.%8$BU9#0"[H@4+%^ROOM06&][&*['G58D]*-E[+IO;7*A6;-;3NF33
MWJ,C&249)1'3(DN#5[X]PEP_'NB&/+2-58QR]'^QZ?;X>@]R'HP$':X#2Z'$
M"!=:A^AS$_%V_CGCZJ0/S:^(5<7B[]>O[]X'UYYG3D'?I[^HC<N23W0TPZ\K
M;WFTI=Z4MKO$VIPL?+-;2F*;5/A3#"!N]9UJ;T>*K*II0H*M\*])S\:"M',I
MDS.N(U9O[\IT%UFA,.L'[9=RA-L<+;?QK846DNF3E@IL]_76*&AY+Z=ZG01
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M;1<2I!IAQA4<'1FZPH52O@LG\8I'<'L$30Z>\]R$:C7!YN,1/O-/P06I<?0
M^I8/C4B"\Y@=G]4@S=47NEAY.=VTMJE) .;BA]XW')"HBCH7/'21"[%]5>VT
M1\I$G#5^<I,1'99$&$;-:/6(RCZ844?!^M@9-00O)IC(:5L"PNAP'!925,6I
MNV3[2H]N/]J;F$IE_E#V\]0T<((.ICA=8E=7JDKR^0<YCM3R$ PAHEBF!1?E
M5O*;]"T_AS3@+CS#98L+%MR>"T_S3_CF8?/RCQJIG (U,S,U_1J\1V'Z#!1Y
MD5BP>P[C"A.U]KT&UT8V2D4"(T6S?#8"F]-U%P:^6>6/PODKT6 3!>@9""3+
MH?QJ(7G[AT?[3B_BDAZB.\55Z\3GN%<T3ZN<[6,U2^1N-R'H2&<YYOR1F\1N
MQ)A>^^KU+H&K&3F,MO5K\0]WJMK*V!N3!QA0P$FIXF26)HU#-DW4/*<:,?HB
M:&/Q9&=.ZZ:4[-WJ[U/JK=R"BYV)>+Q62OWO?/H./J,+Y@<^-A+GVUA%<^@.
M_9K:B#G@PUTF=@TKZ<P5K) [P*M=LW^):[:[+;Q=I.P="A /F&O[JJR&>E&U
M:F(O ";IVYH#$9L*LQ#V^+CMY<KZXRS^KJW)W8C099^3X8_[Q&]JLM:BK(^2
M_?Q:^+,7C9]EJK]RU3(V%3,-KBF(T60SC.PBEZBN89+$.OT _E57AP,1"@\5
M0TP7%>BD??5</URK%X'2R#:B0V>>U]> ^8SPWKL9_7XS'Y++]QA@[=VW6>_9
M]F0OF'[&W(1?V][31S1+])(=B]:J2 '#F.BV-V)_%5&.W-),Z<<L;HUOI'(,
MC)Y>IETAJ+6NO& *XUY0D''=M6SXG_Y\FIE\1LDOWF4EZ_5HQ:*\"W0<A,ZQ
MQDZ*GF\NJ8&_ES&^IM^:Q(@.3765K"\$(<AO_:D\]%:G62SMMX*U+HYV;D <
MI%+6TU0 >9/+-*K2TJ3A\33:$O=3YX,G6_72-[\K'3M:I9PD7B2OB=B$VKE1
M9<.<PWS/S^C 6J_;V)H:MP9&C@Y&MV_8BAWGK'V$KEK6C-\DUL^F-O6>C5CL
MNX-ABN\C["H9%;\GLT9WZXR%<1*IRTI5I38W"\545S_9A%NL=2*G"AS)' 5/
M+X_S)0' SMDMX/ OPQ,N23TS=(//JQ4^?6?VSVY?>J7O (ET4YYKWYSVHTO_
MG]3YX(8U]NFCSJRZ3D6V02YF$0ZBDNWB>=SZ( Z_8*KY^41^I2F84R69-?]/
M48N)=$!"<-W2F-J\\O>6.+%L8*07F,0>PX3Y/6V><<";_DN'S>$D@BM!^W0K
M"<PQC;XW?4Q2^?_D7I]:ZJD8CW0"+XG/@-<V=X!\DG!N^V)SMXVBJ4-W*=I)
MKQQ'A:I1 5U'D>_O%Y>MT@:J_IPL6(WF^@-4'"'A]5PD55,N*K-;0^)NN;-T
M8,,QM(<M74/80:%.9R;WL4*0ZEK^*?999769U_-4C=$O6IHQ[I,GRP1[SW/#
MUSX@NVO$C3DAIWY_HYGC$M18Z'-[8DXY3M3H>1M02V&ND$"_H*""D3/!Y=T9
M+IM\,Q/&CG87EM@S';8K[4F]&A-YE3E4$*%X9R['9.59U>HR(=9Y=EI6H'MQ
M(_4V8!?,G38/CGBF6F1BI@MO:@)_S>(#X/L?MT=?H=ZC#<PC_ESKI&[FVL<9
M2,I\HL)88]*W=;0RF3>B?A#9-17YG?[2;5X)OPX*/\W*R 0.N3GRX)<N)+1(
MRO%NRSG PKVNX\W6"/J4YXM_)M,A(A1I'!)X[Y4J^<[['VGE .VX9_[/C]L>
M_Y4O#E1MK8V\U9:Q4;-(#E'EVXR#M41G^]G0.'F4H2-]/&Q6/00+.Z>/+[>%
M.S=H:%')QIC4,L<ECNJZ"8'Y4JAYZ#,>+\H!<2DQ[!F0#%&KV/Z-RCVEOKOG
MS#]@P[85984#"3J+*M?QTO214C;81@A:4X7#I[Z!1E7'*>B5%>C/'L6;O;+E
MIZTGO)J@5[9G^7_\EXJMUO#@/)5*$PL,+_ &G-GB9]E*^[-#_:AZ)N P(93(
MLT#=,7K>B&2+5T'N^VV]3YC9Q+O?9NN(*[$5S&0[2+%,!^I4]!7XVMS$ZJ-3
M]FE)<(,Z#A/?NX.5=@/M_5@3P\Y>KHF 7\D1^KN8%V!4#)8)3K>A$B_)QV%'
ME7]SY<[QM8EZ@^M>UUIN]@AML#[42%SURH[>--W-K%XDITY6  BOX3&C"L '
M(P\&:$\6A\JVK3^G^O"]$0'$G1_,T#6N->\F^#(W-63@)4EH_I#7&DN+(Y:O
M<UF;(OHK&RC&/X*A<VC(2H"5W>9=K:VQ KI9T[^PO_+'GHC9KUO\,"\]7MC6
MM,[S.*R\S:;RZ:JG)9V57A3M9QWCJ]5XX;7PSM2]+-/L<I8RTL%CYMW]H5JL
MH^,5M^6EVC2RLOD?V1\02K>*M;=LG5+"6B4.67'U8I[PKH<LJSVJE!)$'JGH
MYRT\'4_U*0?'ZXSF'=,OTQ=#J.E$U1]?3>2C*NOP%<F"'T^2$\N4X*"QBV]J
MBO\EK'L[>/S*KE7&M']N%V,31-DY5QE>61FR]@&_THT X3,BH^8ER3])W[K8
M6NC_RSG3RW^OT:ASW&E8V-R6^F+'U&BM><BJ$V4$[F(KF1O!)JG^[-.?FW](
MN$+?6K<]?3Y2[JO*:33&H>CQ@?G;H%:+?A$>P\6CH@+=%##?3M\>^;&(T],.
M#]\U/,%X'XU&]D-=JA\,3NT7#['Z$,!XIVU3ZIE 4&6![A4$DI?.FN&L<*K>
MM'*Z[G:3*%K@Z _IN.X9]PK0RVC/KI8(:IM[NP!\F]B1?:7[M5Q_CR+6P\(U
M5<Y_Y;AX+%+=?M+=]/.X.GB->^R?+.EL4.?\]0 !1]_^X5;]A^P(.VMVA3E?
MD<K4H50,L9KX(%AX7[SA4+SAX[#'GC&D*_$2>Q8\TWX'&%7Q IVP@1= =P#[
MZ:& 9%ZUY>0M>AJ4:I-@7)9)6@-E%G1PF:6F*>G-)_R&(0BR,NE&,.;,T,3,
ML/77+V>?4 #N]E^1G07/,B >E/G8B_-/&WRAZM$IG0+&+ FF6%8N92!(][B0
MT(Z-2XW_Y%X[_%J$MDSM9V9Q]?TYDB@26Z$]:/^XX@K.+-+#0QD*2-'6IL&&
M&RRD3W%H0+W!.C-VP]:CIQ<N\.FQU+,Y#K8C6>52S]N_(J?_?.GD*H3'GOP;
M='B%:8&4YWQ! LN^<7+<M9X\99@7A/@ CN(N%PAH,E)P^XS;\%VDQ^K(X$KR
ML\\RQ=FCI ?U(RPK0/4WP&1S\).SYSNE4D9& ;23JT/!3I5^BS,=WZ "@B.1
M7@%?BJ23R>)#M^B$N7$W>0VE"%&??Q4,%3CT6DY9]FX(77[92_X;Z6:2XY>9
MR(SI1F4D0XTJ6=)"[P ':0S &\\0+>H -6^C=/9KD+\X'4_GT^9O/$]4!*&=
M/Y58WM"S<71 -/0"&25FI$@GBG+U,O027QWS?G!6TW04OK?%T37WP*1_!\@Q
M0L8-N*P8X2V+,X?D5,T 4K5<%F]ZP$LW<6WDZ,H#KX=(S*<B$U6MNG7@\4#<
MBFT<(L4?ZTHW;+6TA=Z[I<)D8>'G);RX%[=A\'=JS\\R\-,#S-^@,H<+?.LF
M%H8/ZQO5^IBP,YAR67;+MWO !MHU%?C5782?'>&]<SDET+0_6#49-^H;?K-W
M?,H,E!'7,UH%DQBA,U6NWSENC%#/"Q@,=\SC-@HVF5I][[F-1%F>J(37MTO=
M,.R$MIH#(Y44KQ6:#T-@MJQ.7YM0'.>''1T9QW\755P8FW5X\,/Q:(!Q"0M/
M!G]"#%%U%=[3,RD&]KJH BWCN,L&DH\T$1X3HC>7(](>:[";F//ELZNV*^P9
MZ55.G1ID1B;)18,!H9PH^ NFPKXH7T4JS[X_WX10]PZP6OR7*0#Z5*LYX>R1
MMB(#SDC1!C9N\>6ZWD0PHZGB]UA^+(CIR3OB%\MMR1T05[G'5P&(\;U^.&5Q
MSQW@*:?6XLCLG/MG5_XV6[4? @ANW]:@CR][4I13E;^]7=V?JS6S0Q%6^4CN
MQ:T)T3!+(+%P$_SQ">N2F1T@A%[--BF'RBT4*P<=)-XA]TL1 3A?N0/P:,*D
MT#]QS^5RW49R_>X G\:+A5^ZMWS9E9:1&%ND#S,6CKG1"_Q5[1O0L<W2EAK-
M@OV"S^_W"'4/2R[@7M'.+OJ94M<WVW!5#]DP2V0S2#I&HLT<SYNA6@9-4C8#
M4D/K/A]K@*5K1<1*QT%/LK_5ZFE.M74P>ET?>.C]:FIR-NIWQKH#^(6P'9.E
M;C_?"DN&G9K(&<VS]_E5%*_OG]%%]V@")'QV3,-DZ:=-Y/>M)CP&:]5(1J W
M2O$'AX<1$ $_BA'FCYJ,ZT[#4DC0<#V&U71QUM=]R4B\%+HN[%"XFO2#V0J5
M/!]B?)Y:W%5X8YXR3LBD>?@=WXF 8C^8NLLI4.>>9DWG,6UZ=X W_F.%!\Q.
M<:G!PWI+&US<$QJHC3A-TR4U^T*CO#\D0@,+(@#^*DDP[1V S\>HXQQ#BU2M
MLW<1&"^?'[XN_)A\_ R7UA-[SY">M,'(!<]>H^BU4XKJ(U&+1DQ1$0IX$W/5
M<.MWS^K?GT<*;?37"\21)/(O]8@CFS&RBJ"]G3O *7D)W #AW?#M&B@#M)]D
MO7R??+-D()E&"+UIRR3*V_M5.D[9X2_S,7?7FXO!G#H$X/3P=BGR18OPGU;"
M&N0"DU8T;)&7I>?[V=-M4"[H25.7G*KF==Q.OV9,7#!*XN7W7<./(/NI,Z/F
MYB;*6^7A(5K3A6S>BYL6^U9>E 'R%JY['O5BLA(T)2?-**\R2^>W0H2LS(/[
M;VDVN43[-(SMS#S/GU/J3Y+-+E%+HL=: 3H7Y3W-5:G>!=F2);?9KW#)Z\<[
M2ZB4+PI [P#<J$9Q$&DR&BO1WP@2.?-+W3&18(]2XWU^5&&@"YU;<LA,%54Y
M$)F]!SEE=0!]NP.@?H%616= VTJ38.$[ ,++I_Q6_YLFIM(0Z1-K,TWOQ*\M
M&Z;=L%)*$_A;1,+;8B$ =:"\YOTCP,*FN"YGHZM&(H&J@U'&E\[5$2 $"T ,
M<-E(@$IF.96I(!>J'=0=M/NT3KM2=5"4+49"8/EJ]P[0JYZ7+KO))K0C?@JT
M*ESV/?[KXB4^'VOR*C#)2&;6_O5KD^C>X:#$X!S5KDXW-%&[\(MI^9RU37Y^
M+V]&>?HPT9XJ*/3)PX91@6TK];+ZL81'H,_6D\',XX^:OR_:7_^1B'DB2OOH
M(3':VOR:U*!I23?@.;NAL%&V7.**"UK1LW/J#*IZJ/RM<.D;E87\QW7:\Q7+
MAAN>/,>K%X5N+EXEL3DO]2Y>O,]@N?(X1K1I[!P,V=%S-R._@2W0$>,Z,:11
MZQH9TCN8\2OBJ_/3<O%Y)YF_W$YL";YF^=U_@9@VA[($AYU]%5;<#PUL!5Z$
M<9$,K]O;&3!6R<JRYI[T0:LF\NH3$O8EOF!M>&/3<JKSA((Q\BF^=;8-H=IX
MRR/XR?_%WEM&M1FN[8)I@>*EM+BV>)%2W$FAQ0L4=VB+%5+<-2U%6BQ(@>+N
M7MS=*1H\N'N"!DC"T'W6=\[>^YQO9LW,C[/6S/?CR4I(PIOW?6^YKN>V-:GP
M>$I#CQ_<\%@9SIQ -Q;G_'PI/+%S<IB1K>Z,H;9WC%*8==@(;+FS?F!$(O(6
MH#R=U:AI\M:F201W;%WZJ6?9ND++Y.%G-BY^T?I$F79+W$VMR#Y<YMU]DY:X
M#?&@GR+NAXW/H\13+H#3S54*XZ,0(3L'[0;N2KOGGZD;]( N,U]P@:9<'JMY
M^>QS+\XD,O9=+)]QED*?BUJB:(&74\8K/[GKC&+5[$:.K2MG0-Y).]<\2QDK
M(M'4EIJ.U(T<**7[#6TAS!H-$];0<\+]Y&\NS_3C#:CC=%QB[HEN;(#;01)K
M/!N-\;EY2-NQ+:4< Y:%$?Q5ES-J=KC0DKY!7_[NQ843R6('36^S6WNO+6.3
M^I_X="%U%B<&*JA#F30+R+W*U%C)@>;/;\JXT!<L[U[BMZ],AX3ZBA6:*7F
M<;_;']I-WU<M>C#OV'SF*':M*Q)X"]@HW+\%'-VQ^6S-IC]&F%>7R^?'[)@
MV[PKJY*WE(+TJ%%VN/37 I!PG8-U&6RWF+; ,L2=\>F)8V<+#68"1')_>7[4
M_=*Y[\-+FXV1[2O:V!APJ@LC?MMZE^8MH*P0%>%N^B\3C-5*D@L_:(9J'WE!
M L_]=%7I/,&O(78;IY(QL(HUJGZ->L9VS*^-&>5E(AY[THW6J6/[%W-AU)Z
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M.-A!F*"%V"L;]TE$!P;8R]^:YT6I43:-#=JI31NF!1DDS82<+?HO#+35$2G
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MB7]NA $R%KM6O#>Z_ TAGCZS;_-SW:7FFPV,]FA0P>\]\:E!Q\17V?0_S-%
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MSRY5!OG<U<)R$W\-;@+Y P_6UR3]!(6\-L<\ V$7_@>U$I=N$=2+ 47A\>P
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MU5_0^@?FB=371>:(U%E.#M;$2 !60SE] U2H+32-J6%2<*B!VU?"H?LWQRU
M7X*B;XEGSN7+ ^_0HU86DR%+^(U>$H6E"TU?' N=1%%:VK MI!.$QR-YSUKP
MO5>".LOOBJ/7<5AP B#=.(F[9(?6<E+^I#MK72<03^;SQY@1GX0[2#,!$W5
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MXZ7!7_<$3:O7;^C1ARC'?*#!XVFKY$NW ^6"N]P&VW-QD7HBA!($(N;,)RY
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MLJ3?'"K! HM(#'XB_6')6&1'Z D<_M*+:&J&3\-;>@8[@[)J(LM.DUDJU2N
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M'XY0J/AJ2&FI7<^W?'U#.4/O25[ A[5-H,ALB=7J&78+&@#QD(0_-1#LL$=
MIUH/B\",JB1WBV-)O5=A[QLFMEH2WP6H*)$&P1*ORGL<BYP6XY"'2?\Y-12[
M=7FF6*#HFEO?><3(GYG?=OE):G D_(?4\%:C,C6":7F*@5C/6SZ=E]>*7&M(
M<CNLB 3\Y+N72S&56QB_N*!:F K,,'FAJDG6O?5@[H9$".GE$"TR:ZW;<!+U
MJ#%[2><=]DA]1!14:*\3">_+3A-G^A93^GD(^)^2R9QV I)-+NK#-*-#D,X4
M\9X,U04[!U/^%](OV_A_[>(8U;+^2Z/Q__[Z=[.Z[:]@$O .)1I@"[Y4.FP#
M-\GO7O..#H.76<Z0XQG04Y0<+AIP.-T*YX.\@_ BW.X5,18:<'&P>D.EG:>Y
M(]E[3?D%#3@IG@XD53=@*?K_LLW[7WFY?^<Q\'X!0Q;S.0I\*X"6SK(^EJ)
M,;%@>0(=C":M7>Q]K&FG2_KY2,JV8@4&_ESR@PS&G$^)+2$FA?HEY:^O]8%\
MYK<#7L#SB:83+@Q$;X=&'^KIK(:7-#ZU<CJ/XE$.V0C@NB*_VFHA_61H5^E#
M6FP3F'&ZB"/EU\OCW/KZ>(8 YI=GPFWW6MK(CE\R3)H;=ZRJ0Y[.P;E_MTQL
MR3=>%01P[^Q.Q$-QS))P:'J'N;]V@ ,>TM8+2TY[\4]GI6FA*"HAT/PHYU7R
MU96%>:FO07,)VL[7ACP FTNFW6VQ-?-9&OL>A>113>C)'[)P!X6!;7GIDA*1
M&^1JO*=JX/H=;V>R>\7$\7=N<R>:V)&5$M![E"P=_5BIF'S6DJ7;[VL-_R#C
MIG!A O%V- "/D;7'31\KD^W]ME?B\6[HP0K'#R;=Y_&8/0>.E I]C-!\T1R'
MRL:'LEB5W&T -_YM5T_L+M"C8CT+IP6KAJ\VG:1#&.JI\,^-3DN/&!)N%1")
M&WMZO>^M:1EZ0!?%3[_5.?<.#('*<!]$F4$:_GAIVP<N0:!-A.\WL$/Y^]SX
M&QN+>%VZ8A. 61I(&S0@:I0 #9A51 -2-?=:**''&8%5"E6#G$-%ROV,& WR
MXCJ;4. ;CE1$R%JS?'?EWIF.BC5%A25!NM>?D8U?/?=9V?E&LS!?XXY@6U4I
MBLL8P>)BI X;1$E1@>[<P'=8VL6S3V' ]IO@\)<O/T[N5(>4;IN;?!WZ'<#=
M0SJE8:DB8&WTZL."O.&G>])_>$_Z,_JT!6&,;^,,H2I;3QC%N[ ,WA;YPHRR
M5[<Y$1L-7A8+U#J?/^,SL*<Z]Y%Q2KNZR0Z(C6^;$T(A76K6$L2U%3Q$-98'
MSV-P=S_>1L![@8%N_#L-5YWZ@[:?JE<?K9:E>:4-V_GJ+-8O?)7#Q=QFM!]S
M>"<2W%T1AGTI\>OQ5SO!/-\<CXQ^+ZW8T+@FW7!SUE>Z+/DF^;#6L$QH4)#=
MGU@C)5=]Z?G.6DH66K_=LXM2%4SUNNDJ:G'I@Z'Y80<*5[\:U]W\3W\+PSHL
MP(35^'>F+J.4JV&'N1_W;?)9<>@CEDQH?,:XD<635J8#\3%?G>(</5_UQG2B
M 2R4#FB 02\JCM-S^VLY@DO=.(P$43!L??G, .>J-@65PZ)2=R#NJ>VBFJTZ
M<T2:-<M_6Y%0>?_8Q&50S3E_B\$\5MO0@.MG_%PWM\ ; $2QU?^DZK#8F5[L
M3P.;G5^T//^ MS T'@WXSI?2:"AM;?DE&<RMTL@+$/ ?^>"IEKQEH1'FPG"G
MFJ)[#R5TF6B T01X[T73[)H],H#?_N8DXP87 OHO8_8AA:"^F6NW^'O\N*6F
MUB&:4XN5KP$$3O&DLF5R >IV)<:%BW^-[LO[D0KC3+/>3SVP<$8=,)X1LV<T
M:1=<72O["A49XR%E'U6N4WLQTM^:I6=1/DEW):I;?>> T'8RLH9X\S?5S% ;
M0FUO]F?KEV9VMR,:T_*Q/D9+: C<89/EZ#ELF_&&9TNX%U^)L]=G4",:@#@6
M9H>XS%OYIE6<J:(.L0YSC\%<>CN/,V$V6>UW47F8J=01^QF%=.9G1E/_[4LJ
M+& N^96KH:$5X'8NVOP?W_2F[_.9R<Y6VKRI':Q.TIB7=:,X8^SEFV48(^+%
MR\7=IU6#*B:;TZ@,GR<)"^[2#<";2PT<.+V?U&6^8G'CY8L&[W)EK^SY3\FB
M/QC3GQ&1AM)2.'^4D\J?38S"=U]L/U-*)YMB:)W425!6KA"4WWMT1-07?D5&
MN]W:;4S,-<^BS$FU(E4C%R1+2>L9Y$JYW\/ND[PW[CM=NG%BAMC9%W.#82I!
M9U*]^SAI [OZ'#&$>.CJGFN"Q:*4X/:TX+ZPTOOEGXT&L']K;\&>;**U.,2D
M#NMW3]Z??1A\]6;7ZM;\P-,$U)5LL] ;=$$KLIRM6_;18CR'B97)K8T%GK=5
M%CN/]SKQ96JM.0?4#?66]1["=D#[AA>.*"SH\FZ0V"N^P?E,2^2LS^61 @!^
MV^:$T&8D]X<!.VHKT^@N:3]/Z!($OC(P#1%F"F*T/$PK'36JXLME*9!3?1)J
M$;9)YV]B_LEZ U]H9E'M5B\G5LXUB2<G:!/A;]3L.:L+L;R2>(7X5)X]?#'\
M4YO]AT.2=/""J*,[TCJ9[@G,/,(ES M"\>MEU:T908W6T>-3@X^U!@2QBKOA
MVH4,3 Y%#(&R /:"-H KZ38'$\0U$,=)6%27=]27V#V44[Z343X^8&6_JU"F
MW:*?B<;+W/*&X +R%B(&D^STL.-WA6$'<2VJ3H=1TKH]B>4^<!1Y.N+Y+3W-
M29.KA7.QRS8R+F^IAOLRSQD[9O;!&R$TP/5G5L[)+SF-@.W8Q?)9]\&N:(1Q
MIYO@*$-80"YG](4ESF:47?Z<-B_4Z6V<"C2G=C+[9?+WQJFG:,#+J4^JXOWV
MG62JO>L]E1N$ZOP@&BNPQ=EHOSGNM<.> H!5:(NU_^)1LS@Q8X0Z*3LKAJ8<
M /-/9C7%66:WDM-N;(4^G2Q,8V)3!F86L;%H<4YC$_("XW:O*QP-:,JG]=(N
MMEP(K"G.UU^='V"N3</,)I(YW).7%J6R*\S3LZ:RN?&!2^M;SEIG(MLO_T8M
MA!_TT+VW_4JC]7NUT$D)DZ-LVJ")G=<:LGZ-L"W A[4A5</^ Z%2:FIL@WG1
M;(2W%8RLNJURC'-+ERG(N,K 5GAN44'S9OU7#/RB-,N7_5"J-#=89=Q$Z-&7
MC_J4NQ3FPLBBEG+H#\D@\L%W]:&V6LK5Z3LW\.@O&#I/7E/X)V#3WL;YJ^*]
MCM_J+]K5()2E'0U4-X7*A5&'%UO^8:/[W5.]L_K8KG6="-93NF[XYE=WEY]^
M8SIEHBCX-)?^[@VMBF=>L,FKI/4[@0XSN829&5:#3&9E=H!#^I(6=H08ILG&
M5J0#RSP_11!CO>R(O.FG)7,8:3:S:_I088=6>':#R$'0V<E*QXAU8Z$6A[M:
M4^0RV9M^_IV$_(V>$)(%SM*@LA^O*Y59F:(<=2GN0!+51O;8B-V>]SWIK%.?
MRR>G@JS=<3Z#*B!8M[$.Z?#FY(/IH(-&RV=.A5#!\).FCPOA$7G7Y*[G9$%K
MW%U^< TB&$; 5Z_(AZYD\@H3-E7BKVA%.IZ3-3'BB<1ZQ7K%:1=]F?2DDN('
M>AR0;660'I?Q29+MI;^J#4D72C))F61W _@(LGU"N$+TBY+SDBQ++"OWK\9Q
M;?,-RX+/L><",+ 74ID'3E04G'HZJXZE%S4G2T^/MDD61_S'@S,OX(R9M!&Z
M$-;[MSW:7LL#Q+6R=,MO?';+W*_FM"=U[80:XT@E@&F]8D)4%O=>VI?OWRC5
M#DS*,NQB1S:FAGOZ$4J:-8CC:NH9P0T'@&35 K!'E7GN,N\8K*/$%%\;>)=)
MX1&-*S^](#LD=RV?F]=?D,U@QYEA6G+\FHTI&>_H2X#PL5RW9&JIJ[,^UOOH
M/1A,\TI50<UCMUXLPR;&,/YI;$7HGHB#FU/"$:SYWVO(OI+[8D\=H]B&-X+3
MQ^;J/S,^7C'G/MZOI?4Y;,WZ"YWLW):B5W]]\LQZ_V<7O%F.0&AMP 4M4:_(
M3JT3?_&B<54>4\A<W?(K6!T99GXF_[)6/)6]##NW0T32T+^:1F'>@V49<$K+
MO$/RFJ4FXV+&^(Y@5F8CC=W'J9,J*,D&EC-+;"/W,_KWELM]NBSR?0B]6PT2
MXWR4Z,7$ Z)N) \,,2!G<@&@?AIZB7J$=-_JP\MW6]BXUB!A,RWTSASY1NLY
MIAIR>$?1/O*$40YPR)=(A9T0YI#I31>"LOSG_GM2)QR"QE!4QH8A9]6=$@,T
MX7&N*B6%LZEX%,LY_VY-"S4B<&UTR>)9PD)-1N-6;9K?G$2XW-(N0B\]3ME0
MG4W$T=.0=[JX78+=/715%Q:8%E$<PC"Y:*)0&F_^&1\#W@94\^$H\R(*27\A
M8UN@8IJI5^D+*UWD(>NU+5E-6%<[7,5UF[>8:<!<?%L3Q93(LRR*G91B1H0'
MKG-?(QHIRGC)[-I?LJLA$"JNVA2UEH'T=4]!-4@AMR$&9<_65P,N@+B@$D4P
M?TG 13;W]>->:N5=8?6[]4-U\I]?(LS)#V0AO&G_;K UL&X"-<IJ)6>&J2?/
M'KVJ(SZU%[Q34$UQF/*$EQV$1HCJ_]$(,Y@]Z?AK-P&B1?BC <PI':N7^VA
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MTM[H:F'GU;L+G'T@?KR#!A3B3MJ)1!G%+ZNKYUN[TK)6#_L>Y9:@ 7U$:F@
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M=ZLL@AEE@'O/=*@*9167>9ZS23GVV\X=(DTV., $"+N#&VTZ2XUH^49KT70
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MG?M,U1@:/!Q8T%0=#Z[6Z^G8K;:S9UH3%Y2T3GLC-NR;[1O=!EBNQA[L[*M
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M=MBC;=.F!GEAIGL?@JP-+.#M0@]P:PI5^P]9GNBS5I2 (2?8D%$I_OBKVK7
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MF/(TNA10IIW:^MBT,5@2FM[S-U!+ P04    " "R@7=6R))%+\SG!0"\=0<
M$@   &EM9S(V.#(R-# V,E\Y+FIP9^R[=UQ4S98NO $) @HH(!D4$) D23*-
M(B @DK. "$@2D21-;()(SD%%H)&,""V2E2@Y208!D9QC$QMHNN]N?-\SYSUS
M9NXWW]RY?]S?P5_I[J)WU5I5M9[UK+5*[ _L-$"IJJ2B!.#A P >^ ? 3@ *
M  D1$3$1(0DQ,?'Y\R2DY-07R,G(R.DO7::@9F9@96%F8&)BXQ#@8KO&Q\[$
MQ"W.PW=32%14E)5+4E9"6$9 1%08-PC>^?/GR<G(Z2Y<H!.^RG15^+_\@VT
MJ$@(%2@$"/"N ?A4> 14>-AF@!64DQ#O[ ?XXP</G^ <(1$QR7E2,O +Y90
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MS,^Z\:^%2A%<&K$@!@XU__,P^W?C_4=RZ3(\A :I7WQP%D@8];% 'T,NC$P
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MG?BAA\2&F0>UMH:P(K4C1W2C%J55B0Q [*K"$<,7PQ'=RQ[?W>UBF)X--SZ
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MS>;-S%R,CF*/R%<,),U=7J2[FIE@V_R$G<L,:[.L/2]\R:=""0S*4=5[<!K
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M[4/'7"NVRMP]<2FW:Y-VUKI>E]97E3O&!RF&1T_X1ZUHC<08M3<Q+;@6;];
M]F&CX\<BZRF*.[7KM2Z;C6N5X1APIG8="11@L>'@77G,LR%U2-@2\?'>Z3'S
MD@20W 5#;!@G@>ZIS'E!3S?9TXCX4Y9MRFJB;K02IWI?I141"2GQZ;<XB=L7
MJN7H/A;NMN!A&S?^5IFZLO2H[E*23FJ5*",XX:^@R7%6+NNVO&5:9[GQ"RJ#
M#F_GRZ)H5PS.?*@=5F/2 (GPMKC;(^XQ@*.@:CIYR$MX][+C#\)7JQ@+9?W9
M#H]!9*Q7J\#,UB76!OF?S?@'^ 5I(S\1#S#/GPW+K%TUUN&Z6L:]M:BR5:YG
M+T![BZK/0T]O%GE&/?>K"?3V_3?N.N1+'^#WMX PR&V@[V/1'^I../M9%9YT
M']7K*;(G,>&6UY*3.I9_*]"Z0^_ >I1*O04NDE4NU3$=?S7KC*WE6X-+-0S!
M,[IO-H247GO9PEJVK43G3OY2EBW:H.BX>YC^ IG(6L1779.R/YM5G;@0%ZDJ
MVI&=XRF\[C-9$+TN*<T?6&28^.B),C)C?YX2I9%>*+<S  QZBPES==]X[P.+
M4E/?:YQ%J3!<?KWDL[H!VT?[CN(VB$3'[:K=EQ-ZN<M'F5GORQQ,)-Y&Q#8U
MOX,W5T%&8NOD:(W*G493(,::[^#SII"]'\A/^5]<E;U9=./[8CH.OIH.?]@E
M@1B:RNO(@9D#T+/P'.&GT9<Y\S.6&3V:[R$[="10!?*8[Z7;;:)B%_C8D@3Z
M.E;IPTL"==\^K<1?CPN<01URW(1O9!'#K+2(; Y$D0EG,"-DGAGX46,2:/^I
MB;-)&.X"\;XN8F\:8!H22_O[V\9&;3#:^!A%VO2)?LU99EAX=?H;M,'DLM_$
M2[U$7H@S%1*96J18C&T(2[^_I,[I(.8P./'A'@'/+%%WQ^<B%B<4\;UPA96.
M#0R\L!LXT/U;48')FB2_82)]H\]CW\,GG@Q0G[+"Q=U?M8I):%V/I_BL^Q5-
MWC67Y7@47P*\.S1&YLM9XR>^!<+O.?SNG@EN8+A:%Y2<D4.7X4=_GRM[7[6J
MOG8U$F.,%<NWL<^P;5\H&"V-)G:L(4P/T?3W=6\T^M%3R^758H-#S:KBQ+L.
MA)="S&VS3F*)$E21NSI!"L,OU&@XWLXXG1M%<@=/<Y<IJLOKT]IK1XEK"&<$
ML0GS/WZIZ,XYJZ.H+,'E(>#GI%!1QI[<?%NM*AP\JPEM(^SE?:S6:0^0^A+T
M9HK2[Z)^^</%+G3'TP!HSBH\8:22MZ%?7(>1S<8F-*KJG2WXW6(UG-FMT-3N
MR =Q)>)\7+R.;/$FV3H$A0YG3@J++Y%P#!</E=.754B%;D84"?UB].-_D!J%
M/_]7MA7Q7$E#Q+?!_?&>\'?(U7'L!EXO6;<U>.YLP27[\O#X%@(V]L<!=]!G
M?^A9EG+M@<<K7C0PB<S6/ I<F4-:N%@E#/E\2@( @$C-HT5$9SW3B*IG]LC^
MM#5-M(_=+7U%>\0W=??I""#P8HG56=LY_G6;.@I=&FVRI[9\;QW#_D]T=_Y'
MB?QI?740";3]I Q^M#I]1/XODP-TSCJ"N6A+?.N,^+ZDXUC/?DA;(D4@!Y6L
MF:,),PE$ WL/7WXYC,3>T23>J*_$L!!"8/_VTE@M3HWU;;BA_JS_,Q@;CT\@
M!G$9DD#D9B307/;I_9$6Y.ZMU6D\!_!MF)_OZD[D%??T""^L;5@\&V:\\&2H
M2'B8_HF1QL 9^5$!Y@THA=G368YE$N@];#2JKQ4Q8_UC;8A(8RTZMJ8WIE;D
M[\[>02W@UY'LN_DL%J#'^6M*$RYWFCN'=;I%PF[)0AA%)HGK'1>R!KMTB%;6
M[XM>X]&SZ'A!S?--&2$?#2=,2^;C8-W1^%!<4JX&]A$Z+$*16>Y+Q%2:G=!Z
M@47U)[]'=JW&(5QNG$/,KUJ/EM0;@O9[7P<M7F+@#!L"[XS7&XKI-F3F(1FL
M72[U.+JGKU[J$Y94E2C]&IY,%R,Z4FJ]@CSK%JN!VPI:V'D57@WEW^^/=)F'
M+PLD@XOL3;@P1903;DKZ9F0(S>3XBL]4K,19$NB-3[WUM6>U"_'A4P7<SW-^
M3G(6>"O-/%;CINA_XG?[313J^*'K7M%G N2K$3[,J&Q@X_ZTS+M>2J\R(K]L
M)*CC8 6JY%;TS+\IA:8VA9DQY/)YPZN^S8SE($Z[NY![5H)K;]*-KE:*3[7U
M&)2WN'KT['7S?OI6%?.(U]2O)31+@;G/OOY!_=9, N%] F+_//R$A<N-SW/Z
MA\CA!1'(^N7?.R*MR$:GEY 0=UA+U.$U@[839^@)F75\8=:<$N&CD"FQIHCX
MKKQ+]P->*TXSXBC0&X([PT8@SP]D@U@(8"DN0&_I#4E'2FP%2YZCF8")E^#V
M5OOG7?;:K#H;<!:*+,\[P"+_.D-U(H'HYVY[W>O_R!V[N9(2JKE;^*JV*$"7
M?Z=M?V"SL2Q(N;W5L175G$"%S?Y<IN\4MYB0N SF^ 1OXC*K[TT-)H&N=)B<
M-1G$]1[81$:] ,F;E:A-[(Z!.#VW('%NY0IG-MGG$%NL6@H>>LU1P0R%'=Q%
M>:T=WZYW:W&?^P$^%MDIX.-C=C&EEJJ]NM1$ @7#W,6Y+X]<^?F5L%^QB5R+
MLG@!#W#FKO=P7B9>=]MS\I3L%Z_UDY *XH^YW5,#]NE6FB-#<>HF1!'@-K."
MD&)]=P>K$H%-#)%5K_06\>&1'NH"2FBXI?)"M;NYP^92GJB4P$[^%1:MG2[3
MW R,HGPOQQX/("\R,/_QNEC_XP08D_>G\=RJ +9DQ<M^3ZF8H( S/@AP4K6>
ME!>TY(V??]0TJQ]TIQA#X=A8!$!AX/@<]! W -\:0A <:J;_Z;#TIDE8\LU*
MBTZRE?[M?BA&\_UXAK25(^%6Y9[58GD4IUNLL:[JAJ[CV;_H1!G9SWN>KYJ0
MKR[T"1U](&CFJ)*_D/Y2X:+.!V_E&=@AHY/FT6[4H5[/%,\0APY..-.K%]Q;
MY:++=6=IH:U"%*J$YZMP.ZOXUL(FAM.'>7O#\8G);N+H>Y_Y4Y>O ?LO)-"/
M#C4?61WR$_/\4/<C\(HQ2YLYV>ZE385&$J@?CC%"-3$<@@'\6PM 'IUS 7,.
M:R2F5VM5J5^FXGSWS.*0H;,ZDV#FW'8"Z'SC2(;9B'=#\I<M<_MIK@;4H3Y0
M&^<^EB6!RBOJ>3 F^?LI[&6#/ [?CEX9F<K$R#+)-;P*QAZAJ;!!"R]P)S6B
MY"B_YZV>R;: 6K,NPJ^\V<I:1OO+&VEW,6+"J[2E2*!W[ (%.O:#@PS\4<S_
MF3;YSWCG7.4\MPMJ*4:'T:TO7FDX?H^CPH'T4/("IXXT^B10T0H)M/NRR 6O
M1!6'W>\_/-DM01+E@8DU+Z+!00@12:@3N"8)E'[.47O 04;T7,V3M[N( !/)
MBK( -VNMV*[)*]92AF0.DZ;R <G1*1G1R_33$<2+]PN-U'.6!Y2LO:],\@J+
M7BR8K#K.AU_U%E-WD_!@")2_:75T7M58R273C)[J$Z!'[Z=T>^!2&"HOZV@D
MQR[ZBJ\IM,5\:^/*6_9(\7?=M]'N-+3TA($%G8[S[]JFITD@H!JC5MQL^+"O
M8F]#-V^2\]6E,]UK843HR-DU'LV@ _!+/P;=9 PN$5\F]=J9C#T=*G37!9#-
M/MFY7=:";#"O^] D/+1,BD7<N'_*BVZP5<);.9KF4 CSUJLY[]8^V'%[O_!S
M*Y#^B[B4K#-=:Z]'6*^.<H)?3Y$)\)76.6.V\Z&^I3QO//)!1)RP3COJ517X
MB"8_*D3^+LXBF&#A;FJ1PWJSJ14K,CH'^YB*XE,^'J\945<>]JK]PF@7<::[
M, R*_0I?!1:D#C!Q5(EP#7&4"-E6 O)(C^O4K+85\=NL]CG\7V:U@[_-:AE(
M($:]+D/DW@';Z1WO.&"UNUT,9-,%$NBI /$Q0",[T=BV)G>OVW,<Q@8BY]V_
M,;DJ[*O7#OE1]^ZLK9C _MLG/PS4S9_>.SCWK#G+F>7$"_4$W_$B09Z&10'N
M;FD7R3':H W1.M1##0]83<GA[E1G*6>M2B<@K*^<P6SS&,WX2>E093/W# _X
MA[_MSAN*4'9\]!];MGY .)K]1SCV09DA\Y]7I_?;2" E/J_C5'A[1R8)A)Z
M'K$6I3;<@'=(_BXIC519S,.UK#630+06I_:'__ :@RK_=MZ _<MY@W-OQ_P?
MM='R/+/2W^$<N_(N_ZAS+K"";U\"-$,A(&+2V/,,"R+UJO_7KF==SJB'[EQN
M!5^]7\ZI9@&DN\"9[:_';Q><VMLGSD<?H4\++2+A\PHCP/<<T%R "O4'CT:Q
MGLPS;\"I"=9O]QG=K(A:7"UO?=K7W:*5>[M)(#<F^PW?L3KM./WHX?[0DF2
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M@U#,-_PH?):S=4;19Q)@L:M2>2[$AAT--<@.9&W>'OP'5RW2/C65NVJ.. D
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M\&T*SKR,W@P/PR,P/-OY'L/8-F#]DSR!G[KXG9%ZJ^;#ZYGU<[F9 *DR3<[
MW2*!&HI/K)>LCB!SC52S(^G1_7-M)P2#PZ:29@*5A@@>P;.JR4D"M8<5  "7
M@>AL,"S*KK.:TP2MT4M+Q$;[;T"%AV:)EV0M6DZ-$&,_[/V7Q;MO"&>I-H[Z
MV[B?&1&%]!$<'*X1-HKR&WX,!)^')]:)<-8U^&8[A@ ,'T]*(# H9^$GK.4
MP%V F17CO7/K'E%&7^+VYO*K7%9WH_JCD+<>B3E;@J=\0D]N](BAJ@/2IZ6'
MC^:BLGHJ[_8O%G&$?H8\IO1USRZ)W??42\X]&,NL(N3-YQXE_$1L7UX#[S,D
M ($OT0/5NU!*O9[A5:YP44^YE7F/Q0_=@Z6/#'=@[V!)<1L//71IR,!*$D)J
M!$X\E AYGQE+I+'P"_+ D(A31#7#Z=?GXZ^<+QMLV;EL]-(/YO-%PQ$J@AXJ
MN3Y"!$O?<^68O)G+S*7ZT]<7OYO.V'?K<\>>_(O:FJ2C;<_:A!V!%,5XI4:.
MQ$AES,20N)8QU:GA1N.>B)]!QH>U@Z.7':&+#.*._1\P>W3P*WH^T@#KZ2.!
M)A&'F2\([/X]N'X?N*,E#S$7>2P!\W(&P"N-!*J%[*@LPEN57L%6NW>XR(F*
MZB+$ACE ^/[T%L*HWR]#4EJAW\SRJKH\@RG"/OI(76VP_'.A S-_AC5'/#'=
M8E4B*CP\N99?=#>U6>;I9WG;?PWL 8/O0&SJ:K1I8(WNVFHJ7 5[M#_MB]BF
M&08>40-?YB\NPMY./TMX9@>]^%&DQ?LYP_.H)29VS%H-OB87>=Y6)?M,6D@Q
M><YX)!PD&)B7A4V_@6Q)R :HJ]EOE?V/!;$G;A?1A#SD/](\J0!2!F6$CPI8
M_4& ]6$1[,9R2Q'E.<E^/J-7Z>B\<G\J+9]YJ1N)!**)/P<8#0< VU^7YKU9
MC[24Z4C)PD(TE<LG54X2A&QLBPOO76:Q;6BC5IJS]+FSNMU5\'R%UI[BUOM?
M'K5,D'N0I[H-9U2^8HR">1QY;U(YD-F30*6T[?A!&*_/;;_7BML+I>H%D31T
MC>%'D1#1YS##IP4K07T[H=>^UFC<RK$IY"NK"5JD&A47YHUXUSM"=9GHS'SQ
MW5&A]?P0@8T_C;TD<R3EM8YMJKCG=[CTH79#6DF%IT@0=ESY8&[@@>20 FH-
M*J(G#\X9#3N6E/M#4[I/__Q\4(_W=>>P&;7FM%.*4J^-A,]H#"\C_C2$Z_PG
M9H2(3'W/)8'L+R3^GL4[L@*"#S%<S$,?%';EZ,4DPZ,ZZ]OF=E\2P1.BO=IN
MG^#3SXGELSZLIV1;$0B[9<CNBR(/_'<RO'/VO),;P-_@EZJ!YS$)&#/,JAT>
M/"XQ5C+X7OSJAZTM3T#<6M"+NX2U91(HA/WSL@_YT+>*SO97YQ6?15>ZG_V@
M](",UUMP*8I.Y;M;J6)B.PW7+EW+/MF/(C=\N14:PE#$1L9/P_/1=Z6*G+"<
MES_W"7OT]+,A0NJWM@D\]> ]QIH^BS]H<ASM7FAHL],64[ZK"/(]W"P2P0/2
MAX\%T  >D)-+<<MP\C3G/F?E]D/NE2=@NU3$";5>BM<?16N+P3A]M$[E TEI
MA._(=>'BW&GF,ZF^5[4]8;RG^Y\LK9,Z2[@S\?$9A[K?W?-O#T\<>9X!)P*_
M_9<1C<0\\>IE'NP.I/6[O-B]5[BI;0?^\H@V+BES@&"\,1AYL=LLR.U]BBKM
MS*Y*0XO]Y9_E5/Z:,B_KNDP[[@IR-SIB_. =H9VI8^'\2+N[#406H\Y/,SH)
M5O-2*%;7F]W_QAR\.<MR;=SQ@-I6/I41C^X>WJ,*?UR*]\P33-XH?K.SJK)!
M?-T S0?P_*PT#L$D7QJSMB[/X5F7O2U$5VWJN_W-'0"\D=>N%BXWNQV4I7C1
M0]R\KY#TY6*099;+ +Z_;C#)##80Q7 7W_\-?M[W9VCH4O[J?XZY^DN$NR5J
M!2J+;\ 5$4SSC>[^L*X&<;\3)=_]JR$ #ZQ?5RD!_6L$V3>%2JS^G9@NIN/:
MUUN0DRUYOQ_IN?3CSFNL<=]K7J'C0(I=;B.+J):D[:B06_G<\B-:]T 3+#.F
M\611J];#?Y:CHN,)CT^=CO/A:!T NRY5 _E\2<D8.O-HTX>"!.J&$P'*LU_@
M2 *Q(><]H*=RN=P)_!=\$4(" 5KS6+>:! J?WI83.07ML4#":R82R$4I92"W
MM.;K]=>F[T =_#'U#V<9 B!ESF#\8Q$>W?(R[XK5YBVU6Z[>+(>8@<KDCSJC
M* UZAP6E- ($6V;"B&V,6=&56>E3=YL_F3 +A&SZHQJL6[P<YZJ]].>N"_\0
MM+CTJCQ\_YX/CCLKAT!EM0L+E[]U+%&%G0Q/[_U$66=NJR6=:S^Q)_]KK^AB
M_IN?2!]C==P%E2%,">U1+TK=$TQ__]O8XXKMAU97(M5K_6X94;:Z+Z74 1P]
M;D\O5,2VP.M*#G1EX%"/T:"L7[GLSBU))RDNLLR0D?9\OIA8V=F&,Z6U,OB/
MI:(=_%V\B.-#98#U"!"_:1*B 283UP9O&L)EG5#"MW7!Q*M1>(,4<1(H%454
M 91*R].%@NFCX_=+P)\%B0T6IG__S8_PIO<D4 X Q[SP8W/[:6RY+$!T[R,(
M<0#1#4DG7LJ*@/PVX/]. N$N.HQLG7C_0 43]0 MYHB%!2UBOP6>)/"G[P_I
MZ\_!!+I^95$4BCGV:GBO_?#A?<Z/P)'KAE[K5-RF"39B6F4+01T_(H%N(/Y\
M*G/O&GMO6I'5.7C.A/O!S335=9T9I]E[%U<&/YJ-,UOU)5]\52$W/;/G9^#&
M)!/7>]PQ'_=^7P;$/2VR:MU*<,WMR'=#/ZO^\"5'YB%[S&/JX#=MW^P1.1(;
M2%H^?7DNR\Z,"QPJ!>M>K9#V4*S(^;'RA/?.JA84K(69)M[DG.Q)T)9HY]UT
MBO"QW^A>B)I]G2/\!5-[K;\]=,N)J5"#_C[/]@O!\$+$[(0(I.4<VWFS]P=$
MVLRHY7./B)>,^8>&HY[\K^RYL].P['/(D%,_:\=3B#OCE$+V75VUS4.N+'%T
MZ3"#_IC,RUO>8'&M &]ZHQG'\MCB\E\#(O(%'+Y'28F$F[EP=J3C,/&658DE
MD?9.7PS[D7/@)R;J>V?!J#?@!]9+-0>:$?L% D%EQW$4(845%3*43SL $@@W
MP-9T!C?"PF!CI\;@R3^@*@2Q8;YA+YJ7O)LFSUWO=2OS;MSE@H_^]!J&/B)<
M"9S#PVW7[\:[&_M\!M9B"0E4"%XCG\-K*1#_=T_P>NL9YU#^L%PK#L5#VTN<
M!TW78"<I=0E_^(2O(RB,P-0F6;BS^P*X2 @V2P__"H@^CBW9X[E>@*-%%K[L
MV,Z/MNFSB/S\B?A6:48PN#!]3IQR>H[^>[B#VH\CN/M#N,'"VF.O:ZUYMK:S
MIWMG3@V@8;-^@GVF1O@#5;'Q3G*;,YP;4GOD5XI7O]8[8OA3*GUH6/3)\C>9
M-&N3@PZI4;;/P4UU3YNP<J@P<;<G3"A/ZAD+\-T.@N!D@U!G,4&N[NF(\BNM
MO2F&78F>I_AHZ>4U1<L4J?]..,4M0!B^/9?U3I<Y3U9%T]%VDS9J")WG97-J
MLH\B-M&00%_GLY[BBVFAC=$SI[L#G+Y_^A+5,=7OS"25X(672SZPGW3&2$<)
MB[;-G7L)G9&^A6B1+?W[5K'IW]IEY"+.S^]XP?,K1-_O$^\QK.@2_[[EF46
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M&V"%5+5KA_=H8%N9.[:O+]=NG$T&48'(^FB/P(V.;>XS0M?2#A60'^U_Y=R
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MFG%Z)V<@VR8B1'Z$D,G<8MKHZ1%=-@ ;P*1I31,^ K1K&4QM3P*)HGY_6$L
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M PGD&CTO+9PC_+Y@=-7N',KF1D?EW0FR!<=-,0C[D:;!8+Z7\PPZE$8GK2Y
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MP#/$<:M);81;365@@D^M O/BZPCT%PWUB <Q-R+Z:5F=N7?ON]^WM,2RM$2
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MXU-3LV*-8LYYL#W29Q<R)TE:>0.V/2F[Z3MW/LE3Z.8_^/.N+^/6U9'U\TL
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M%&JMX31:*9C#R=WW8O"_-4C(B.(0R)K5)>#5(2YPQ&K@Z+VBY- 9?BLV(JH
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M 0@S0/M?FX'_9I1NMMX"'K4L\XS9V8M7?>A>&T V=TEJ\'-.[9BH.R2T$(>
MH3&'B(N;^3!4<=' ;S<7-L_M>%$^6:60;)]88)<2YYD\W)T9QASRW]]D:4UK
M\P.$@(^NG'/LXY;?)!%6K%U^K7D"'^Y62!C7F%HE9C!Q4M=27 4]1(@O>8E4
MGF_-?III_="&IX$!]Z]:A!YX74_R_4L/RM0ALNT6? /XHFK:];5![/=W/4K"
M/F'=;+#B&K2Z'0YB<*T>H@/O[WSNIFQ+&UQ7?#%TT<7U>>HJTG>'4*[.*7.>
M-/^D*J-719HP VG1 /_]\++W^T LL:(/O-95KT\CMY1_BS_G-U#Y69X6#QS
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MQ5N Y'G)+<!/%73$-R"5J)LZ56HR&JJF^=ONK.FUO@Q<@FY\UJ<;D]@1DUB
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M"ZAH'[4==$S]MBH@'B_K;>29.[1FJ*-LS8_JZ=RE4KX;P!.F)6%N';]5&JP
MX0BM*G)T-,X:A'R?^R&G26>TD]/3<Z6A9-U!-AFL+5.4IV0##'+^).FYQ+UF
M'IDTP&[JK5<JKW,^W)L95FYN[)D_M*:MH^S,S[/>1NK678HQD43GQ5(2OAP%
MSGVQFUF+9KZ91B<>_<X*ZS"XF75LQ=)\A!V3@[9=4^_# R5VCPN.Z:$*P60F
M[7^KAKSZB[N02*%P<"<D)RD2@$J;O,WZ >A1H0(6;0YU(OPD\=5&&PCA9N)/
M6%5QFJ;X33@I#^GH4L&N#NL$58@HP9+KOO:3#PB!GIV/>ELB3*M''[^HPX>X
MN-CIB':5><*MS+!,R>:"R=*H8!]R;]&8;M(?E<_N5:*K%@6MCN41GJA3D4X>
M?)/?/Q55L# ACY';IS4UVGE \JPY\FB^\B+MP>^2_8P8SS0*6L>G9L;1PX^4
MG#4M:[,JL)/!22<P,9$C]><E;LEG1]%?RK5BO9R<VRGRJ::*?17?U/ZN8@F_
MKL9Q=%B?"P*87&,V(>+LQ%#0EL'O%@BF,IS^ATG$2O1J-"FMI$;\)\SH<;Q=
MW1RJ8-:4$DN<?[]Q43+/TY9&,T&#_W;K0O5E'ZF)Z1085Y+T.^ZR?&4-F=(6
MF)GENWU0,X\TJXN:_[8SGOAGK\TS)2R-$=/C,S:QE?%-0,]'%E]<*:BJ:CAB
M/11=S.]V:7R%(><S+.( 2TP_1@N1";&<T/?*FX8"4UM>S7E82D8YAOJ=)=\;
MB0Z??6H5Z*'T!*;ZLBT+>^XWXN3,#F%'OTZP*B$OT%2+_$@E46HC-4)3<3^=
MQ]S/$/;B2/2\\*)#NS&0H^[II_?EWP8E]TG0'J5$>F_\.&L"J1P1KKE[9:]X
M?PQY23M%$(\6_1E .:#T']:EPJZ$W8;=8.9X0==SC#PS"9-[S<2$2A:-;)KQ
M5#![\[Q4"J$&G_]@ LWBRME]!9G(]KZ-[7'3A =)/5=^3/?7=5A*_Z.YUFJ&
M>J\,B-$G^.(O91Z_HC/M7OHX?M)=]V'0-^G7B$)?SUYDCO;K!S1H9 H_4.YL
M=$W>MOM5,5PFW5QTO-'4"%PM5KO%DA6..&\N6&BK]-[>26?>,2N.8HSNCS@Z
MMNB>$7TZ!%CPT<C]N:&WE2C,$V"$HN?K]J2;TOIK;K+WPY_=+LB*+W3"'.OE
M>3OX-+O-J:WD"L;@M%&5NV9;6QLJQF=I<^X?PC2(A0UXT'8_OGW@H;2-)17!
M9-4PN=)HJ3DXX&6#6T9;V^57K)3S 6M%A!*\Z=*OU*)VDU\QOKQ/'QNGN9?S
M6DD?X9&*#:;FMR>5;;WMV1JW''J?Q3\K&J.]0U+JGR7XQK?1&U4565)8'0O,
MC/<P=+99X90>]5>$"93X2RPN)TGOQ6,_>ZO7T=6.F[)%]X_HVRQB-QJCV/D2
M28I/)3\7_VRL]_-WZF_P!E:_9<D&I7$2)B<,!Q-AGQ':]A@A79*8C'FRY/W/
M9,EX>M:8"\$)#-]0)_S(I5V)0(\:]7TQ^Q^%.A#6>_XJ!_;VB!;*PTFA7?//
MFT.? D\'W\[!%3K'G9%/Q7LZ)960[S_-(X4T%P;E"$O_FC]6>8S#;E6M*GEA
M/AMPA7]O(SQ :4\E,[>^LJZ\SMNZP=-V4[F%(%\E$7R,2Q-6D;N5G/MCW65>
M;&,K,I>Q'_TJ+2 \*'7O368#.E1W]?F;#FD!L1HNU$OBX@%EA,Z-K'(;6ERH
M=!9J9VLLA&&H:CMAK,J_YC!3R^,KDB$D4%&7TS*&E,$59/XPSBA.LID:>18H
MK[V=47;EQ_)TD-$OW_7C"3N DWNXZWX_@B<Y>V99$4$8OM9KE^@3.C_Y ^@'
ML_2*1V-\MB]3@[MQ+XE.%Z^N;P'39(W<31>K1$F@@BTR'R_?B(&Y<->ZA 7Z
MS_Z5QR\PPHXL83QE,ZTG<Q9><9Q=ST5B=.0*L\9C.-&E[]?A.*K899DA4))N
M2MM=G1]A>394RV"20.QKCMX0*5JHI*U48%2C T_:]-EI]HQN ,*&>+%\OP4$
MZ:Z*-K241W*E0R^#;P'AQ:)J'5X38<^M=/1__P -R8+W=J,:!6XLF:3W^AQB
M?F>QW^T)EK 8/MIU/^]U-L^R(GXLYM:/4U1?_>C1 Q*1 .:/Y?)H0P3EE4XT
MA"Z. =D.$I01+-\JI/X@>IW^9=#CRF>FPU4\>/IM/[._T)0Z1\9]E4.X4?H[
M7ZWS?:S,53'#ULB2;WS-O#\(B\+K:-A[4IZX Y=4B02!F%&G-T,1RTV6^&\@
MAH#L &B14OBONA%V-W.T=K3:JSV&2*')Y_\ 8(PEBB"<W9J$;4?;S!VU]E4F
M6LW2OHXI_T!M<'%DSXY&W%( IT3FEA*O=V(K AD3G7'</0ZBQHN5/%A<A"Y\
M"A'_Q)5)0H&W@&<+.;< 0]#UL\DT&)(V*?J.-@D_?@AWI:+TG\0V"!3*QZ;U
M"SXX=G HTFA_+<)&/[=).O.()_!2W;V:.-D&+GV6?5[Q[GFBB"DY52V- ")D
MC!F<9!F1)FAES*RBA0RV$#;,R6?LR*,\=8LNH<4LO"_/0-(E.,""$'73/_]5
MKPM$P,]Q8US[3+T@H\]FLT2R,.PPI9S:<03*XI-V'?7A/(J38LLL!^X-/0'1
MEYH==YV\3N]IJDR;L3'O3^..B-(#YM#1GAL[Q+E+>S'_CDS*MXH104K=[+=^
MMD:VIRH[+^Z'[_.\&5V3.\,B_RKK&*\;HL/=,8Z"+EP26E'55[4+0KD%K#U%
M-@9D;/FJ]>6M)5E"T0;(W/+"/<W@^4T:4:R=,W@?@[0-5C0IAF-QE9OH6\2?
MD;N@PQK=]7CNQ<BG-IM5:K,?Q9,T,E"3FTPSW*[%2XJ]6\ >5?H5M\*)SEDZ
MF(RJK !:/6&-PWQU0%?^D@.]H2>CL?<1-X:![*:!M6_&SI7),^L;YJM1>EO_
MS1J/\>J'77*[;;""4>MHS$;#2IM395285LTPK\!IB<'$ADE-3X %YT!EC-MW
M,THA;*HO)*MIQMW-O/:D5I_[$C:P%$U9,+GZ*59IS_>$O#1Q(D,+=QPKDS\D
M>;N3I19/G.]38PQ_QN4SV!G=:%_?+V-;KTGEJF?ZG,4N(R.QYB"1FT'(4O*3
MN<)AW1MI#S,^J^A<:055S=NP6,YHC!]5.S*^DG%PO!@D/BM)AVHT\\PV7).L
MDMX"HKZ H/6)C"73"BD+!12^A$6%4'/=X<OQROZO+K> -'"2\O668WK7CX+<
MM,[*"3!C9CHV]YP2!6?7L2(-VDMINJ305L"C[&%4QA+R 53ML1+8]3X]?(+"
M?T/99JM.](<,\\?_N-M@4<L[L6I1FCNT/!1>MJ2=,<+P8%YD4RYJ;8TL6 6"
M&^:2KV/=1.9(!JZ0T7R! 4-+UCN:6?<6G#D7[/L'A1B@[!4$]^<#$9YLD,F.
M6^R +3G1)T4?(KT8N:<A)+U#!AN-@Z7_O3@4,A#2F>D+]N$WODY?P8UL6>9N
MK-;U=J\IK\)9+TI/G2Z/F1+8]Q-K//'OT@B?Q1K@!SV[&O76_D[^1VSQ4E3^
M2YOKJ,#<H^H45WK!,J+%<9JJJ,@5(:7<4,EM;C[SU.+"N)3[OE?8IXG!G2M'
M]-3*R2=4T>U!4W"4U-Z*IA"+TGJ.3U3<R9P(,(M1<1>1\R46014-AXWQ=W3T
M(-*W %%.4@P[A#=0D5?@>-GGLA$_@^0ISY2\ PW,-Y'!13L.E1-D&F=S"K-W
M^TDVJ'?;2:--_O3GC"JJ>KI#E@X0O0Y:'AF'HYX<;>4,C&@MER94K8FO9'9?
MG5V>VW)0F.2+.NA^@RD1OXBUZQG\XZ'X2<FX8'9&P&M1DYT/>$>/(DAC;@%R
M]9_H!DVFZS!^)SZ+23'XE??:6A.L\\^'DUGRUG*R/F>X^GME\HX3SWI[4*2H
MQY;H;O;_%HK1S&GY=#;;[U);/>+*M.P8%\.B96JT]Z*MN.O?T<^("WTR_M^8
MC#8?^'"L8(48)U-BJ<4P$0@)Z<AIQ($#'E $&LI#^1^6^)!G2S@2?!Z@+&3I
M?A9O*K EL4:VV<EGXO9N3-5=3*O(RR#+,=LJH3ZBR#9M1CJ:)P4?5RJR.X/J
M4RDR-;EB>$5<90]#03CCT.+9(L6O6(G5C34)"RY=6[F2X#I24HSHMOOU[&G!
M=,GCYZ%B I8MTSF9HZ7P!;6/[YO?V("\!6G$VAO?'^PHSDX?;%#WBT301-]L
M"(H/ELDOIWY@<:N-E1J/09/<I]&1(U3'CGG-!79.[L__2 /\6!_/(.S\P%)6
M04I5^N^H!Z62AUR!);<"ZKXRNZ7YUD6^O499,('F4A"C2DF\0YE$-_=BQ(0&
MGM1/GM[[-CGR+CKRYHGC59]T<]?D^<*^GUOSQ372A+$#PH>C2HO.F$WXH5OZ
MMZO C"(.]_$!G[#V-W\D[D''QK=_'T_(-E#R,[YC=KZ-]4G> G*/L<L3(_JG
M[ABOJ)I.8O^8#3M[I,,K"X6R\5-@!+%F[:@WZ6E6CFL>0A D#^!= K> LI"*
M2[MB'$69\4KM3K+XN(D?%$MRM3BGHK@JHSGRHE_F:&NDG\IZH8N19->F/OWT
M/$:;A/D9$^NOUP" *V\OAX7X,9=E^MD%LB1Y\0/#+:!7Z#=H/PH>H7#D2]P.
MIPXW&,N.E1P?P=_@-[.6!P X>QD(]UOP2MCM&S$*='5T^QV%+W7?AV)5O%=G
M #AYH$V*:M:MN+U1GOYUV1PV>0OXJ-8).@7\!D$>*4.*P[:4>&(&[ BJ"K*@
MUMJ3X90\KY.7U9ZF8%.+.-8NF4=W.>LDBC]JU#;'4F*/8)(F%=,+?0J+#\U>
M2TADDD1 Y"\Y&?'1?4((,:,&/[;(E5-%EN]C*>KPPZDF#I;D]RM])2WT3$TB
MIZ??>C_FM!;]]S];ZKE9*"!4G\E/=3QA8I(X\:&]-5K%KUN F\#GBN>D2X^4
M9.70[S;=_UF_GOV/^G6QF9F5XV6V_7<)GND'W?A$9H>M%,D5"%"8[*+(=O[5
MTYJ<?_BDM>?A:2^E1:WV@5=J8I<P<&_MVBW5^7RIUNC1(EM4/NT:;BN<;WUF
ML(B_IEAO1PNSB/:PMO 4E03U&"4=-]BUX8NJ!:^OY-L4.UE%+60<2S%A^]*(
MI"%+>SPE1I6H.7I2?.WE>,L>*0<\C&\I'1(.#83[Z:3#4>3AA(<SG?C]2_U0
MFM %L[$UZ0CU!%9C:H#0IF@1\X ^N=&8@I:8S?Z+$GNH-$PBZO*>%0CZD &J
M:1*- 'G8(Y5.73_U*=X54#R6V++.W$XIX:L[%8]$H *YWRV[46>$)W5EF2+N
M"-0D4W(+T /EEZ4.&$DM"SF"\(GB-&^B D04\W]NZ&X_V1OD87\V-.9)2G5Z
M778/FM9'0SOSLN$%[9=YDU;@0:S.B6Q=,&U-^>#H<%_/NK;"][OG5TB+L'B?
ML5YD^K_XF9-=Y"9D>Y[W-+)KT#N!I">,>]9Y3& ;.OQ0KTA!2.M5.JZ(QK,#
M,L5[\/&1P$NBPHL/6$>4'S^87"EUS:URO7\%6J0]ZM9)L[A@B=$',R,,J3\R
MY<.&4CQM>9$,7M"(+Y[$![G1LD65"FGN^(@=*98NYW "]Y5(Q(L0(5,#DXRR
MB;.ZYOIF8*/TNZ]YHW;\5YUH7Z[V&0B#D1A4R>Y/"NX-S98XT2V@)ZL0@9DJ
M;@',$%NQ<]OG;VJ::@22,1[5#3ZZ,V[G99Y']K PH;(;;_'CLG1I8UDSU_<?
M:+TZ8&_+K^\;CQV(3=<<<!FR\HLWI42G6QWO?@VNKT]84<6.J7.C&4])KKQZ
M5$Z!([S]O!^_  $?YQCUS&E7<YF#+$FZA$E?.R5V$F R]2$;*[*^!J#&6(7<
MD[;7@7)TND<'ARM\8=K>B ?#7TD4F$" H9GZ SEUP+T^,(AZO"YKKE3>37!&
M)V9EQEO^E1:G/'9@H5R0' Q'T3S/8/&0R,V=F(ZKH3<TW<[+'#7,9*I$06A\
M4M-=DSND%&'3/D>TT4D&4]7R/=A%:DK"PHQWG4^1!6WR*W,3B[>K6TS^A(S;
MNA HL#,VL][2"2 C<_%2/)HZC!ZB'++_N3)9+_M>^OR/.EA<K-H U?JQ8GF@
MM)A<]B>92'43UZ4B;#RH&M-G9![M3AZP9+V8Y8P25DS#'J1IDQ]D,KW_X/>&
MJ[*J"3>@45J()3>)&LU\TT7J$A^'>[>=[";%YG@[EI#2YP?M+6!8/N=70WPO
M>Q>=-[#C\)* [1:PFYU^A5=&R:P1]OVI?QM&?ME[J"]"IH-:;EP0CD>2+]7^
MXR3N49HV0L9[0"H(DUH .J71%P\2<20*S;L)N%K0?BI#SQ^._DF>]K'<(6SW
MRP1"0\3S$3(PWG*%EU_B<CV[?PLPKJBMG8Y8>&5ZOIGK(+!EE:QD)1D++HUH
M(8)FP?&%O[Q4X=7\COJ=Z_)+BDF*XVQ4]T1=7_+&Z,:@(?/.PEO:+C>%H->B
M#E9D^=GQT=RV#>72;%;;<-()5X&7$\D^94]\)]\_?CY<3IIGZ&&H._:.9][R
MF%7Q(DG.H7G34H#JM"Z^(T%WJB<G.R>7.H?2DOEG:OSOTV;]G,:*EFP+7:">
MR[<'%B6G$*V05"?>U2C/-R#^P@L#HDG629<9&^@9^"'7+<!G(Y'[0(NV@129
M*4UZ>M?;:2PS3#[G[8J,NW&0!BG#%HL9\('UR3>7,1, &+:7#WHF@8A%(Z2;
MP#HL=O8/K(>?FH^94&/#P*4@.OKR[(B5S]W/N(7.-$EH(!F\Y^3ANB&,1?PS
MMF=KIOLVI0PO''08D_S$4C##+.BJDS+3&,(TKGMVU*/R>=$_J8YJED0%\_G*
M/&4K 4>1;NU)HIZRRMQMPI[SH!,6>2Z7&"O[#3@;/>MJ\8P+1IW;9T!=^%&@
M+^J?6T,4-ZJ:_!Y3)WEB<.-<F7UB03Y]E(^!L+CYT>2\$^\)M"_P,IE<T2E.
M=YHD(.QW'62BPJ(A9RRWNQ!P"[AZ9,T<8QF:6X,L.KSKD 6@W,IJ^D<9XYV_
M029CG]ZEA0'(Q"ZRMO%/C:$J";+9$;*$\05CIK_T76TC %GH/\R)K(9 ^9-X
M_I/@)5$=51U%UI[F_BDT]5.3OO^/JL9OR'VLNSSQNW^75NH@*TSO:E71<_;E
M%6?\[DI. :7][:!CK$1X [(38,1?/UF9E^>(AYR412Z>(&ZK)NHFQT#8X.?1
M+/P=\/SH%E!9U&V=&]4:R:I\]%9%FK# [Y]%+EJY,!J("]G WLQ$!EF_I<7U
ML]!/4HIMO6< O.X"JI3+>._#-NVLV#9W/&;F1O=2<DI=YH]/8"V8?1569.3+
MF3DJ>G4K+6%DRD&'K],)<'W=22Y'&3"CT_ITTWS]!&Z8:X*;.2V\&K=M\U]>
MZ0VEB)2246SZMX =!^50%R>[&ZUS];<-.,>7&V5PZ3I^13J'XGWYW)K6!.*4
MM6K-5Z=>T2O7()C>%2=N%%R^$9$NF.ZEK,YQNO2VN'SRZ#!J^>I47&\"V&%(
MOMV, Q^'CP0<&%9YZHH-ADW-M@C.=5RWUUKF)2]E)&O3,OH3-#RI>M&**@J@
M+!0:4;OPU*V++;H>]"@"OO90Z_8R!-/7A2L''-/7:)A?2S('IJR2&&^_@>:M
MT$<O4[X6QKJVWJ:+P>/D?$8XHQWL1@'+K57V!QT_G@#MQAD.% FOVL,BW4#G
MN,HWI'3.UP+7KPV"C4LXC(?&09W*(<FRX8WBZ$%!5:=.W2X53X2H]3,HW(R'
M?K&40NF0M+F;-Q^!MP#I;H.'!A=_Y1&L+"(D<Y/AI=_4V3M># 4>OZF*NMII
MN4*99--7_BMM64*)$20K+:_K1K+2!?>2E+?EZOKNK;)4G;^Q:.:5<\T#_P-U
MM*DOPY$:7+X980AM0*=.6@/QGX (;Y].=LKKHH1_W2E4+&272IPD$ERPK.)=
M0=4*2K/>$L?Q +Z :$3-TAV;U(>Z]X,< --^3EHBU&NGF^/) U#YY;A1$<[Z
M[!ZQV?PH'L>=<A#*6;>X=\T"X+1, !J]F@13+.PWLF3G#;?$["(XXGGT/,65
MTG%_2$U!:3R1>2J?<20@):'XE,UXE=W_W2'AQ^=DX# !$RH]DRL[$?A3N>)^
MY<@$>WH.7J;E*)J-3TMRH&=%L-V?%D7JU&9'&AQUI]GN8GC0I-Q> ).3<9NI
M*=< ;@;ET9!*],R/#T /L9,V./V$[8:8;?$(C>YK\0@IBL M&1G9)@^EH)N)
M)%^<_;A#]%]L]8*/CW'/J.9WMX?N0]. A% O2@F4[*4OFR'\;@+PX "QJ@@Y
M 1:VI!&9;*M>_J8U3]R_9>]*TY=R6S:W:[RP2[L4S7C:'VZ3/R;!S:*X!;06
M??E;6J_70TT/] B:UJVF=BQ-C1_I"89T'#-004L\/0MHWV_VZE?D0>N6UT=@
M6N=;ZFS-V=A3E-DDBY<QY' TZZ'=;<,0+WQH5ILSEHV\"+6^+B&<%;5[)1L>
M?Z(AQ+T1E4'RQ6EPUXRP;AGG(4QVY2N. /U6VHN33>H'B0EK+CTD5&N:E-[!
M;4JH>S/2$PV\'C'[C5_D46]TTN1$/>W$EU *L^N,G2PZTBS)%Y]4+2\?HO<3
M %DOTK>^+ZU:19]0U2U+ %59-LD.FED\PJ^=?X[JM$]7C578?:$T%&\4%959
M5$ZD*7&HS.].H'O/,"3*+X'D,[E[J=F@;JDE3(<A6(3..'M!9P=7A,ILXQ,O
ML[O<+T[%P.'(WVLNZJ\Q%7[5N](I+3!,7,QD$Y&Q7A47T4A@WW=3!Y2_X?'C
M </YVA !Y3YD$@;=6;S8$8<+ZC\/!:VE[(#.L4$W1-;K.QLYK[E?;]H]JRRH
MZC.<Y,@<ATD4&+:7ENOK*W)C #@UG60<%Y.W8.A+3#!C5]H?/<.6GRE_]-7.
M#8#W]2[6*,Y+C17'2OE\52=?5^F/S?64YSK[R>\X3KDR#&N-7O!8I@$@!NNJ
M;#;O'X1A#+"DW7><_[*6[F1M5>&HP#6WF:&D5*=H0AOK8;Q\#KYWS'O]WD,#
M/4US^^"7[VYH$W3S?<P]XTR]UZF_3HIEC^^UI'JRUY4:0L,U$E7&S4X88OTP
M,,.GU=U0$1(U'JO]F^M;34)QP4I.):]LTS:0])1E6Y5-<F)5V:QU02Z&T[>G
M[4:<>>X(&'@*I+!,MY3"G:%]U9:ONQS:_2KZ(G'V^*?/B'Y91PNY\K+O>V'O
M)/W3H@#\M]/-;T/%=S%R!8?RKS!5LVS?";SW;)I)SDJ=/&59?&3-LUTS$A_#
M<UPM$,W345:. %6N]RM8MM+##,B4'WNH'-H.BZZ'\'2JF]2#\#>WA\9Q=2YG
MJO+$/.:ZJCC,65S$_KJGL%Y_%=NZ>/QL*_UL&WA<EK#+#"2(*#?$%B_M'@4A
M&9F^;M\Q,LF*^ER7(3!9;R%H<J[EBK3L6_/?.' O#&\!T;$("U96!SKED>:(
ME B!$V!6:[J3!>WQNT7SUCRIE1OQ*A=EV0+>]^$;$^%"<Z]9$6Y2T7)6N 7L
M+)\]P,V[B!)_'1\,,>[ Z\CK71'^>-^R7]I&&?)-P/B,UE@L<&[B^4][2B5/
MD'BPR[:"=JN;OA#$]+.KX86LLA/N.\:4E/5>O#&PI=2,\H=@XU(? \A!/%?
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M0*AMCL4L#6G;[JFH[$3!9)&/->06,'TFK.^%L([N+B*A4RXG!#YY.^IXMP!
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MK$CL#4:-5=E+"]E]*\'W=S;*TI#,A:7F8?[,W!0^QE 4'T89S<8MH-O:OM,
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MO<"<<R$6%[G9+OZ$=YH:G?V5!VMQKF#&*4VSX ZWL*9RQR'&@H=XY\Q 8_=
M53*MM67W4;[Q9]\'/3T790^_M]2/<60T_4A=J@NJD7U&)0'/FFWR%5Q:?-*Q
MTH(KE4^MGO*$XNC^8#=P&"([45Z @6Y:(<0X'J%-/]D8]?3OM4A\6XMD+6MN
M@?!&8T3\O="X4<_D\V"M#"9#H")M86+CH0B7%<6"MQ,APBLNZ\4/-%LU"]20
M3B^[=*++]?JH&(=\P7ZN/8S+C4:L=L-CP2W#\\<U2(YK0Q4KG:#FV-RY'6+[
MZH4%'IKH2=2QA3KKZNQD88<"(:=7Z[SVV%#KY8GH\]E>HY-A,]WM<7L&BH^4
M+TY58L^*1957W:+M:>A3<^<6C+-ZVNG$7S^$_?1\'@I3SO<HTHPY/Y<YO@ ^
MPYE^JWX._-Q[&/:S4-V^^,Q$$7^R04F;:CG/QV%T\S-[5H[>#$JK?9@$)^HX
M)._X?@-6N#BVC\1(@M2Y-Y3K8S)/Z%,&#-*=X%R)\YZRQ%W[=CAC"R2W-+':
M;H!*-MWN[<<D7]P6!HSR3'4BR,A'+F6KY,S-"!]BSZ5]I??1X'-G[#8'8D2$
M]L.7!.1_9;(E5%E/U61<T/Z6K[)OC4/3 -P2T@.SWJ;451YK]%P:+:I:;OBH
M9$OSR-C'IV1/0H!&++/Y?5U-PNB.M>68R7!=I#2#\%L*O,O?JNE"%7/)IS<I
M<5GEIRWAE1XBYDNAQC4=E>5LO[_> JK 91L/@3)E7W87/N!X!.[#*1/EDMJ2
MVTY(#MX;1Y]UV %?::7"WD".AAN-1,I+V>Q[:T.N\#\X0H'#86'*":^Q&R4W
M PHCF<-8%#NN7M9?A+"ZU ::;;PIUB)5WQF ,C) 2C_M%_3$ST?O@S!X47.A
M9DJJ'N=#^6)O4C;[#(BI3WOG/'8>E'%"HU=05W!)]86 I]:2MAF; 00I-7I.
MT^*OM*H\5G7#V^ /XF;0PU3#+<W"!#1I4"G>V;Y1%G' \+I,^YY9E[TQV"CU
M)BP[((RQ-/ SR[9X$.A8Z33]VO86D)76;%.6#?\K7-CL]&'0Q%W]$,RW=/B)
M?]]5K&:%1-.07]/;6W9=,D;._(S6A3+8P(/<:_&G(8[%\_M]N/SG<KU:1&'\
M3REK\._!>*!:3$?VW<0H!\K8VZ.7CLRXU3UUV)TGZ[> !O"3R+INX_2G.61V
M'T[[4DT5Y_(NTD:(NQ6-!9]8<&<++H^N\5"!ZM4?I9U-0KV[%RB.'*XIG!X<
M4+R;T<]'AZ=*^6*(_3Z19JZ@*<HB-!5$HWALE?J@*222.=-KQQNC$S?(4<)6
MK'QYZIS5RL#[Z1A%3&_L+2 2KA_D<>:+!6GI^N&1^"JF^TV2KEHEZ="1(A @
M>($1"/6:3(9I0#H_ (\XZZI>)"3[6:K(2CM\<!"]+R=PD?/:5DS^495 [;6<
MC0L"J8 VQ&\!=K> :\T&[\7[4X8>?<IX.YE,1@'S^"39UV%:M WFD3Q='CN^
M+"'0)[< A$N\=K\%S%05'&49QG1(58\LT>G<A"MTP#US!6#R0#^QJI0Q5QV9
M\3D-=";$^;GXTB-T-"+&)'(MCW?ND=]7HPXEG_>@A5-KI7H@7 '.*@M4Y(L!
M%KGIS9S=A_?=AUS=5!T(8*?GJSMZNAMAJ%XU5J+E<L'-:IFRA.^5XD8I?TK8
M:"E#EI7@NJ-^H3T&Q6I5@W;MR)M&?QNC%C:-=ZS[2CI3=]@CN&^P2+M  O7-
M OA$B$VE$4J8Q]=[5P"]=),JAP >'$X%1-5<:-*H&_%#J ('OYR4Z_A.W/XG
MT)MV5YPFHW9YU;0X2N>_@.T6EO\-&H<HL"@;H1*&%7C/71EV?L =]G',]<W!
M%K>(YKF?8?^)@9);=L'0OI_P9*$EPP#JK)VNU PNCDZ/+^\,3:/TC;H%Z.;S
MC?@('U7"B2=H:NKB%Q5JG])%?%T/B85_]S).N8KZ5J8.S5G./L((HCJ?1UUX
M&R@B+:.8=\3^(>7FQ5E^N,MZWSE?3(2'X$^KJ-0B*>F1,A^)(HG<[:/@VB]'
MM<OJCXJ5WV%<#IA/#K<\A'%112S'C>=(G ](:THNSH<7WMO^[.3K)(INK>H3
M73<DDU@9'X&+#:61A$B'&\B--(W2F[?4MLX(KXI0W_C*%^L;KXH%&?%TY,WJ
M66'7W:RL"/2>,Z1W U,]+SH18'K%]K4BN:#<*-LBGG]W2@=T*/_T_**4Z$<$
ME;V7V4FGTW7EN6CIT&IJ>(_T>:@CBAOGZQ_I/4%PUUD)]^6H$#*ISA+[?-VH
M)G*P/)X@8 G6X[5TM&_(H7$#?-L\["K@BB-F%N8Q9-SQ:*>C5O2G>CY'118]
M28&MJ,JXSPLH2/QCJ?3O L_3@B\?G00_W@)<6S(.]:1])7(-M],?^Y#HR(U\
M:P#_='SD3I)-*3M.\?C#IV:[B<J"2E&KDU>U0TFV3*^B(SHJC.?>P7FWE5K<
M=#.M1U4JLRI$C3M Q+PXP XOMU1'RP+>B6%6NY%N4M47^XD8P""O#Q6%;1E;
M%T*I?7*0V=R+MWZL,HY=<I0WUFO)5]XK0%@(V="- P(3!YEJIJC'UZ<2,/>]
MB;^BV(2Q+^* AB)+;@$?LFX!J_'+5SE]!CN3-8Z?\(:$>S+J_7[)#;7PJ88M
M$*SB1 K%YZBM8-Z]'!GS@*Z^-FP!C8.U%.^QJQD#X(,KI=<MH,T>FS7*<44X
M_^3[%[;GCVX!7:LT6]\";Y95!)VZUL=R-]G57<0PH?IY6YP_?8NRW;T24)<O
M(U$$+V6=QV*WNY@'6XZ,.^KI^F?:S<;9'W]>F<()DWW?N00G+=5:68RD)\9=
M+N$WBT!9N1Q_5RWS\MW5NY/=%*_ -4*P9=WUF%"AIGI3G\6YAYA0Z^C[U1<Q
M K> )LIAYTM"X&"#+?'/!?*CDJ(9*5HG4F)\;?UOCV35CE,^ 5]-_M*@?3)@
M+:1LSQJM$,Q":Z,1=XTW6JC^['QX4* @[]#*"]1I_TDQ6XJ]*B/K*Z>S:#XI
M9Z03(MQQSY6UV<Q39BW+_D );?1H>,'D7KDXXT_8GO(!8AS<W2)(]6TR'"8!
MF8314+'45H<^J$B_..^F0!?5@@@"7XA:Y#S_(&]'N-W5E\UO+@\Y1.[\ 7&'
MC$"VOK0_]'E;6T.T+%]23CD?)Y^7\*@':HSLGPD020>L/&4N\B-!X1E\2 JS
M7@N["FY+/U:NC+HZ,KRY7U&&5L7?/AY[8="S 5IV@UK#?5SMK\^ MP"*,IJC
MW!K;%7&B1:L)2V8)\<0J,P#G+%E!#UKDMXMB3!8/5;#^2+]JXPZ+'&-F&/(E
MC'H0 &HIHK:2SYHKOE7.E+9D$M"3C8WM%8-AEQMKR7+W+O$V'.C#(;3&5&0=
M3NN&S8,&B+?LO@C=(1ZKVVWM\GVN?L01U/C0HCIR>/9Q3LS@!*?>F;B+2^\0
M ^I"/DSFR /RR9^"B/S)FSHJ_1]!*W0D_<9Y #^,@JT7?">5)P.NPD..K#%]
MFVRT8.TOU[$3=5G$6@L)W29Y9%1[1'D5^C#G"EF4(:DTTTUZRTZ3#P ^O;%F
M?HL:_&>&4_K3!]>#V0I%9UV/A$Z!01Y*A'G?_1,G"A>=M^>5)2&3497IPIQZ
M16!93SO9+\&1P9-Y]QLQ?C83-$$B2VU**VA?/9=P(,9B7!4XI8;(GCZ+>@BM
M> -)*Z$<J"R>^.E76\/ \NQB]7HA^,I$<RBJ^>ESL$^1'*OJ0A?&"8WE?3.S
M-@Q:A_NX$MN3(Y)//I8,%\8SC0<MQ AX'2"62S3Q9RSY[(0%(JRRYK[9_GI=
MM"6JO"2\F@@YB.(($9$PS>ETF,2W9;OYC<H* CPLR^+;U^EH%</!EWJ,-YLY
M.R-Q<]'=]Q#VD*'TWN'KXID+XP;Z(#J60=VG=F<<V%!4N3 ,"YMWJ!=O9+!$
MOAQ&%OO*PY0<GX,H64=?:6^I#5 I#_"U@N$2NI>3T58S50<U!4KY5D\J)_%3
M$D0!>X ]C!S5'#*\:YUX$?7J3R$7^^2K]/[Y_13/AX?RY*#DB[B/!;N>/P+A
M ZXT\\)\'F9 !_OW/WMR&?3YKS0'HLFWMMDXK *<MX<G!ZJV@-@P5X[@*H'3
M_NV*[+GO>CU0HCU0B!L@=FAS-BF>RM +70IOZ&!\:M4UXMF%Y&^&L;(5KCG)
M*3&P,*=HVYY5A/?%ST.LW*+EP_T0FEO J[&NMX7'D,W/RIF;[IN[!J@Z8^DB
M=D8ZZ17Q47]'81LP2DC?O-V!ZQ!>:XQG3$.;)0-S48Q[CQ"^+"0-L#N$F@W5
MN@70+LK? JH7KP1W0Z!MJTPS1XT\)NM/(S3**.71I\ ?KP 28MG7SK_J4N;>
MN_7'\*X*NLC*EO@80<[C:68MA_OS&XWO9;1+?Y9K-1ZR^X87P*ED_M;'<2SG
M,QL\RMDF>]6%.]1!U!/+@$;:?N^I<?Q*H<'F.'$"%24T>'G=M]?5ZO(X+VK=
MXVL>Z1K>%@C/4- C4*H>LE'CG+/PKO_A\J2 *\W3X'+".1C)1&[E$>^,E#P\
MPOL)IZ277* @$$(YW:V'J]!RU/U*[K"R1(5X(^%Y@!1\&QUT2@\K?.JA')N1
MHZN1LR^4U<M2!)'U+Q,Q^N"@@R/TY/HZQ1V^<E5S3)'6>I+ [[0C%%051^ZS
M&ZI),#_F_/@^Z(FA(N,HG-*#(@64-=T=&]7$FW=5 ?Q&U5Y:/*>1L-<71,<_
M5RTI9;YL&)RL_#6$]?UUKOEE3MRQ8WIC=VQKJ=H;Z&*VI+X-;W]#9DF0)>E[
M3=)=F.P),-X#7E=F)?9L/+MYO)1,GB*U$+>7!+X3V0%+21XHB$!OK#+M)SC_
M%'+>KQSI]@@TYJ+X10:T#NYG (88>NVS5AEB04]>6T27E&5U&2R8=G0/J>9%
M#SE>3O:?62N/V_,631VRLIO4U(+7]1_A#E]%&;?E,>-="Z$YJLYX955" R$;
MRIC1^9;[K%=Z$0%O34N&2+"] YP#HXP'>5HG\SR"5_;JNS_=3R+Z^CAMXPGE
MV@_P-]IWE]9I@FUH::+"DU]^CVW4-)KJQGZ=FYJ"+'XZPR6PZC4RHE+6IK-O
MP+\%>*2?)%^A*@S[\$!.9*WS.-M5'/E.5[D%6WLPR@26B8_I"V'\D#4#$DB
MWCQSM[M;BV6=&PEC;1_"\AIY4I_2%77"S%<:THEV1Q<0B"43O_H[UPKO%<AC
ME>%X"]WD4%-3E\8C?S@@UN!$5%8%.I_]8I0]/5=?/]Z&1:Z=SC$MJZ [5^9#
M/&%P-Z60-LKBU@5_W^OG4HR)J).?JU9X-:X?D-Y8(8+X-)QE4(@7CRVGH51
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MOFM(ZX_6;TY:'BB)RBA*[+NU+7/1<?T7-=EB1(U9G?./4B?6(P&=W$\;G@1
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M[[36_O6!S,/Q]Y_?W8T0=".2'Z-D+=%6&).!A5W[#TN'$]=X@?@4TPZ+-"E
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M;ME.NXO\_P_%_@/%F"D7R8(.^BG7RV_I;ECS%>2_JE1,X]%]11I6_Y)WV*E
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M_<G9)@)9EF=+:5'!4#"AC)*M<&@A,:[\$'9!9D/!XR1>EKC$H2^(2_RK_D#
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MJSJA3?S 'B\54C(WR1@NVMQI[O3U?H@NZ4/<-=8S@5YW[2#GS4C*#:@CE5G
MKR16-V<"@.HW ? )85_Q*V1C1C+80$J=R_3M@+^NBEB>DV@&5^^^LQ2;/@'P
M&4_,F1#U<]Y7#0N [].>[TV>2MLSS.*"#H%8;/RY''@2]X  2/BSTSZ^J82[
M?+L^V 0G3\2DWV'(*IB0!C%];.G%]B0107&CS:3Q$S%+,7%0@\MQ-H@-UC$
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MW4+*7B>W!EM)[*LT^S[ &BA6F=95WB;OR_LVI,H\C+PSOX/?QI\C)"7-G_N
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MNM%SHWJ48).JI/:(<E$PCTQ6"8MN_</X_?P\+XK)Z[C7QEY6Q(6:H,2B(PF
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M_89UA_MRM^.EDG_GU9O3J !?;<25IXBC'GRZVN,ZMJ"H?UHH#NGT)?Z<!+/
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MAT5"]%;SGLHCA8&4$.^*Y[].I=N:OA[QXK*RFR](:@W5EHH;FR!%VG/^NF-
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M'W%5<DZ(2 =]KC64N,UHVQ2-*VX>3H7B$L;ZVR77K[=%O;E*=<D]P2/9%_P
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MDW@$;Y'ZVAX?"5NLM3*_P^N$.MP&=H#E:/J0S]&7&TMW6:!4C]XKV9FK3[?
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MWO E/B(.-IP]+TGY<_+0HW*6S*_Y;TW!B<T_Y[5DMWAQZ8 _P?G^^"M0'4H
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MMI4KXP[##GHV'T]L#%BM]AU?H='MO-WYMM1OPLWZ^'Q D19M6ITE[AO?UQ.
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MS;"/",;*.LSZ7IA^5#W6?G'U!470[9!BX.(&@*V811^E\K:!U.96I8 #Z[>
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MU^X/.#@A"\&GGG;JSODY5?SZ\\9["NNC1^GY%5]KAX3F*RL"U;9N2:C.FU4
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M'1UZ<L/39FK"5',5WT4I\??X?EL%?YFF+6O@F=^TZ]ED7U>WKY(SR4BG\_Z
M8))%YGG-IZ('C#&@.:J/*0ZE.+)I9;[;OE+SE-)O[#@E]0P3.RKRR7MKZD67
M3'QTU&2ZZ74JXZ1)'RK$M>T V'HAXSZ,.]^UERX?W#(+6GP?[SCX ;%N3ITQ
M.TV.$2*K#Z/0H.TO>\UU5-O),H'J8J4^T*9E?WN;"S?X]8[?-0RS-I5Q=Z$=
M7[5NG7R6Z!G@MN5Z$*Y? M$'09*B'-LU2NU7<\>:UF5E$I[3T/"==)9=8@)
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MMK[*,!W*M5"ICPU9LQ<*XU7C<&C\7RD(R4BUQWV]RZ5"MZH_4)*][Q%?$M#
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M0)',P,XDT2-)1V7/@K+_\WO(?9)0QHEN-5YNI+OO5NR2AA1:;PK;MQ.Z7>F
M%U8C[@W=E?/M$U029'# ;2A$NP6M\B!F!/(79K ,#B69'_BE/[L)<JJ)W,'B
MO<=^,@<2SHC3 .+4+<C%HG07RT"N]TUB;0?+>%:98U:9$7V[5O7C5O5SCGI^
M4F8[;QA#/G "/M\^\D/23<1/"OGG 2<B<N\8XWTN@S^E[,ZDXT/0\7E]HPE%
M0977EC!O\E(!W:-DJ 1Y>+&<ZF8 ]8WS5!;( 0Y2X[^_.C>$RB0+(TZL0B;H
M1,<D?WC9D7,T^TVV[:%J?JD-F4NIH2%*93MDWW2QJ.M&>?WYF\^UMM;6VEI;
M:VMMK:VUM;;6UMJ_I[%>G-'Y,GE\*:WZ&B]!MW*F-MT$.5"RFW,RV ([\?P,
M.'HY_>K91.K>O*N:S&>C0X*-CR?%OW6A\KX[ON0AH[P<?!);S9Y( Y@P2%(1
MAR,-</&A 8Q=5X2Q;QQJ)<J4IXP'<4KQQ9_)9YK=]'5AK_)I *L*#=C&C*(!
M,6ZB*WTT@/ *,SD^"-Z\ZH9]NU C7 ?-ZJ]90O.?&5,:X(Z Z)7)A]6,J1Z3
MV!EO: :60OV$&12=\A-U6N:.5'*)^?TB-&OQ28-F1241%/KZO#:\K9G\8,5D
M6Q>EZJ6ZD=F?FA%_JEIR!/=3OY8M@_9CH:A(:'Y9T0S-JKIKJ020*A1(N!R%
M):^T@3TP&O!!G?+"N!J1=[2DI]/5E'48Q&=)@,3E-] <"4X#T G4/7S0C%AA
MR7BY')KJ:8%FJ#G8&NHUU&NHUU"OH?[/HW[0SY?6W5Z+/PO!>*5%\'='M.CJ
M2ZXD>2^*RY5B;2NLI.A21YM0VQ@JG'%L[%:BQ0XC"_MU0KGE&TRKGMKPT !/
M.1IPP$KPRD25\[/R8V4X"TQT3&23NNZ2ZW $&)AM?'+25= ZG<AM=:I@B(W-
M0IC+_OD-#!O]C"*6?_8<DK_=M&QS_675:$!@;76\[71(.-E;?("-_[I/Z, F
M%]D#BZS5W>ZGOERMSKWO]FB1]UI,Q3Q)AQ57(:)QROVQ2)]1YQY$M#T)I754
M8JBQ.WG'A2_;D%/&GQ<*A:OY9VV*[%^T/T3+\ZY#/'E-E) E^HAU=Y:")<+P
M"4.FFI&6<P/A+BKNQVQ)Q.@>)6?%H(X967CJ2R@.4)1 **KW32DE-. B#8 3
M&(H;C'8H(28Q,U0X_O2*&_4%%8&'N<07LZ,1;[!8 O@>-C5#<B+0@'?RPVB\
MI0"UA@K5 S1@(R(?.]8S0 . Y2CA]RD)*\(K-,";O(O:30.2P4#RAFYSS.;X
MP#7!:X+_]PMFX!)2BM:25C%$9C.=7Q%=I6!Z301QV"KJNND<E,^'UY9VG!]2
M#$4SP[+($ZJP?1.95SRRZ[B#SR8O5EH>"M<RWG8V$R> 18MPYRJY-"=7Z%?L
M-VP[+42J5(6W2F#-!DK81];KA+=AQ^*O>YI(U,NQ.GL\(W&%9A\644NR-=P9
MA;[?,M>^)"K6TB\=TKR74VNQ[LO%NFDUB=M0KN'Q^F^?@^A-J+_),N@R/ W+
M?KN1ROK ::">O3.(6<T.'(NZXFF-;F2Q1/;YWI"P%[=P=S@W-IJQ$WP\$&3[
MDBIVG@)0<U^(5G 9XJ;[<_W<>/@7);YPEA:-F:!=2O?(RI(#U>*+XXIM,<?Z
MQ]C&=M, ]0L*XK,,9!I  P;W0D-*U)<5L7Q'BKM?M)/W)'6(:I:N;@1-4+8F
M/T:,0BG^B<GW39\O%?"%732@^MCJOLT-G6DL?(YM:1A.-.Z#>!K^;A[85!UB
M#EM.QNG'%X=0F9&[P,^G:<#^JF][4+^+H-:E=WDB!N$=3\$AT)L8G:_DPD_F
MB]Y/ V*]J8J!JWM;OTN@1.H7DL%J1/Y1&E!# V#S\C;H.21!34Z1!BC"R _@
MJWMTOXN@VP]UU">@S54:$$:%#[MVL0[&X*.<'U#OPXF;$?2-H]\%+)G:3,Q"
M*JF=T  O3$;4+18*?T3T07ZE;$3,;0?I^U^_LD_6=+4.4!4I!=Y4% &,G+B-
M"@;++/IAI"W@MQC\SML65H2I@JJ 6S R!AH^CK>,8@[^%V_^SI\M[&0<2&18
MB\=:/-;BL1:/M7C\&^(!S;=6W1,M9XT)R$=[9B83U+_3@QW.GKA5TP4P1P*K
MVAN9BB8;P1(X@4EOE[OR4Y,I]MO6XR9/,*.**>'&AC<S+#@'MHET&(O.R6]&
M#Z:7[A]S>,+_J'_#1,Y1>!!N3#^//G^Z9^VQ(6LT*2]_T"7#I6^\O-]75K!_
M5)O %QFGQ*+#?_*7T^[7VE_MQGC[U"/?/1,%I0YB6?Q'>KP7)=3]$J=8[UP8
MV:L<95/=^)JB;/#E=APU\O9C0K6?0Q6>LW5=FO.$>DD7U],]=M'C#B.S4P1/
M1UQ[F]%XQ"&1N/!^#8>*6X20CEG,V7"#J7KM-FX1]R'C$!BW&>5VYV0N_+%W
MZ)=TA>"+X)(Z5:+6B."+PO+CL,\LJ!ME47.L#18]L"/7R\?9A!FA6;Y4Z0TR
M"=926 1C'"4Y<QM&G1L@#!-Q$^_(PL;6#^,267L6F\K'VQX)Z[T9,FY5(D6K
M6R5W]YP0L;[QE!2_&R'3D8\_42"U*0Z]"QQ)?$"Z4:*N)>1U"> "DEXG1S:!
MC.=&DX,:C3F?D6'R#_H^U$+][J'*Q%"E/K$_([G\V5$%-^)7&O F%O2_DX.2
MK4*!YA,!J(>!;63=:IBW*\KM6?F"*?W)L1Y\QD+@ST?P,O+0,>FM5!/D)%ET
MCC>8!G@Y)8(_GYO[DU8AWYCX%#3K X,X([X_/0BN/CUH_CNG8X[Z8B$-J"M?
M06PC/Q[$KCYX..OVQX.'WUBMTN,#(0@WX&T$XT'E0S2 <>8<#8CQ[?G^:.1O
MK(;6+!XVV/FC5%P9#3@@+4I N2K_\J3@'\P3Y@D3CC0@TGO)DXW(]!$L*VI$
M_/*0X:^LK?I*<'T,N0Z1C<=6!YRGLG;_]@CD+XR%[0*D+G#X*B7&BWK&P?AW
M'R7\QBC1TJ#<,@'E#MB:>]?<N^;>-??^_\B]S/@9U:E;K@H96++:&1JP\R:R
ML_0M?&83Q/6"Y;"IX]+#N4GAE2WS1"JGJICU(HNMQ0%ATGTK,7#=A-W(-45)
MRJT0.&F/<--HNLE3E'[14R1_6>UU^C/>LM&'G!+']^Q;T7[>L(Y\P=MVI#'&
M+'W\SMX5B87JA/CI&JHR>BDC-\*CKY[_$@,NR]>>*E592?YP6UG,+^Q5Q4#T
M>2D%2];#U)D/G $O9G<ZXZ/\7]4@1A(1PI[*#T@H_9>$$-7F<_I62;MCB*;\
M-3U!$P242 I9]FK$EXQR5V6I*JH<HJR Z[0*MM%TF\O-64YR>C/R<X!0*<:K
M MS11@,,MY"Z9;>2S>=%)UY1D#?CBY-59J-37TX%H%8,-A .(8YRU[?.USL5
M2OKD3)EO>H04&B@6L^OQ3K=K?=^<E(8RQ&EN>_JYPOQ%S(V;#4JL-4[_^J(3
M2C;#N:S\7-?V,P9=.^5RY 1I -0K+N;>'JM)&+I?$*;7-%H5E?!&9H^ITN$Z
MUI,?#_8R#BW:<HZUR"9 W>#"4]"NCX&\#=MGL"<-,RY3'N(H/3<?M-ON 7Z&
MT/R"ORSJ97IN(_S !AH@8MK+-"D3M=!W-UGM%BJH7[O>LB4BNZQJA&(]#T\A
M5%UN$L.:K\B9$?8302-LNJG>U^YQ3=:\_' G_N!7R&$W3XDQ=MM[.6G[T^W2
MG01F^+?%+"LOUM\.4N)D>MSOSZO8H'YR S[YL(>05;B?TO97)4[U/C'0/0+,
MRR( RR^]G>(G:CN/V]A6VY-:*)CR>H6C.^J;YB57I!2)#J#>I$"&RL!$;7H)
M[%2XME?RDNWX-<6^'8P]>S-1"F^.2\Y+I6_)*5'8M5'GQ,? Z8H$DG:A<+2V
MF2A:[<63.%7X=@WBCLL)QH5HA?LOE%@C4_[S!>_OC2DZE^/]-C^Y<^5=BJD"
M\?T6\C7'S0L-WU44.J:Y$<_'?,HVP^MXG3B78^XSP^F'.&5ON(DUT4HKL)S/
M5$YB'_D2<M">+6;GE9O/A,>@B=<=TQTD/U#H73'^;*Y5\).DL@!\*7CZ@5&Z
MTNWRH^E<792+0@5GV=V$7;DYV6<N%E0?U[^(U;I*L8K_4NSR2L]:/S;"/G#&
M'4,,'!=NF)X4$1V8FYZ*CW2S-1@8&S-XF8HG-5XQ5HM,[\EQV%T-<B<L9N3Z
MQ>FK-N0O+C_?76OO;%;O_0*:@Y6;F*G,7HQ(FSHW/)>,F*LT#AWIR"(+6Q:C
M-!H<=_"IY8?7^3YGX$SSV&$QVGVLZ7;>Y:%;CC>ECE6[;&@K H70!:[!P_'3
MV(R7H<>]]SE<,S'K(3>,+^C<",)<ME*WR8U8OFL:[\D%[J0!ZGJ.PZIBOCEA
MD5-E]JG<YK*Q\6BA\__:J?,OU<1U\#E?SF55/CA<9P<DV-FT9RVRUC?ML8O,
MN'$N@4NW8_W;$K.J"0YQF0M7JP=P3^P)$)+ (0/MKL7I5#ON80N;0_R,,,1=
M+BSC@L#0(O_K!6.?P6NWT%J4=J-Y\LYE=<(#T\V#F?>F+X,<[CY4_H4,I/JL
M35;*D-Y@^3X:$&[G_F!^')0I2")P:):N/_\BSQY.'!6C <LX0G_AE.Q[&:4
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MM;D[1V)+N_J,1TAT-??,T7WF6(P3R8:I;$>9.#]+6FR^BV3I/BD\X+38O^4
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M,B(#FMXZD'96WT&%4N6R2YZWUQ[UYS++W!Y(YRPPO ;)7U*FT-Y\CTQXZI(
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M!@P%8F@21A OWUH\;);'P26^GI1R\BH?2(C]0Z?@/]+(@K P9HOM1YVSD?%
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M;/?TQ$"YO?8=]3E5C@($&JS[F7.'2@_7ZE239_:[T(#W7M+X4]P3I ?F<8$
MD'*3$:Y5Z9U GG^H>AJI/] "HX(:N8AQ)ZC&;:E(>B0%/G!CQ5<3 =Z,E1@9
MH?C%CJ*<%Z\[YK_$7CN__$%-_XAG<#.+7.FKI[.D[15+D,85=[\[LP,' R]W
M#'IG2H4_1$=!9L1?+A(! 3B>F+?VN>NZ_JOS<P/VCO<")+NTOP IQ@,FM&<V
MG=':4S+L52DM,OX^N\:#'R.X\X@ ?TV4(>XBJ9=&@'@#AQ'Y]=EP+IY"#2LW
M8!!> HW2*XFT=%2D4JKKW,VNJ F^RW(<(705S[\'YKC<WA]84'!<^KVZ%/[D
MZ3NF&T\VJ63486DT0Z0&R\,@SR] ]\U9",]@6$WP;Q6=EZ#XA@AH'VGNX)H9
MYTI/GAUYZDF394Z]6:.8FG:KS?EY9C=_LA4 A>[GFK4G7!W><X!?V:A@# 5K
MSE#'.LP45JZ*K,@S\1E<MGTKF[;17GEW0E7Z;LC?G:DQUJ_6D:S>8WS;@PAX
MLU;"<NJZ?_[Z/^)#*W6VJ,_B=!\L^:<]\]P3KG>2)Y1R7=$I]1WFXB.,"B0Y
M_=&MP+6]^1G)1&KJ'2) ;9Z@##VNV1._@Z*O,\E2=*G('M,VV9^[\QAO<U6T
M:0NNU)&GL4+C%.3_67'JZ0:)$ONJ_)=93UWK4N-7QP%*\$;D!MW\)YT,IPA7
MN5/64,\5R?(U*+I<G!2!2<'QL23P"RK,D%$#R8ICGOM5ZTI&IX=@&H,;J1VY
M)< &-V12"K4H;@0/[Y7>NCD(]:,(E^78&!>1ZIMDU,C)[=@^5N!>A5/A93&T
M7W-EQ7'^?><5MD_IU 6\XQNNB:JO0^$*.,GN7>ZS&^Y=UY[/_%&2)N'TXY)7
M0%Z6,.7/+%U!(8[T$&[^]__YCT& L+_.8PL-S>8GF*TGK=A]>\\^S4YK%]G^
M0(EL:! !?_'%B/)C_NWW&(&X>(F0$,PA=MN/<-!:D#%JS4\$E%P?*L'.IG6_
MJAO>*_S9^:1"F@4L=?Y$C-_@2O%=N/IP3H$B53N.*BA\EE\U1.?5SV!O62*@
M0?NB&W-LI<JP7F)VXN\$I8B6OS''CXIF'+@,S(6.CS3B&)!Z@Z0)>"&;Y*<+
M#'$ )#OIVON1QJU-PW.*\<)UZ#[O1N/1%AWA"_=X+]"7:BOM8%+VK-UP*]?K
M/Z7I9+V$A]"N9O)S-R0AX*@1O4>0/B6![D;CX:4"JB#X_G,I(@!,0MFT>FO\
M2U*LX 7%X:S/+W"/%Q)66"(/)J"G# .KCF7_06$JD 3*TP'KW"(\Y??1=?$/
M&U(+=9+M]T.OFQE,7E>4-DBAI-F'XQ\U//K]628M(J!I$HC-V\!?0(6I37<(
MF>5#Z"II09>:EI86,S5Y3I3H%SPFUG[T6:%WN&=6PI_Q9!FOZ_[>NO+COS@#
M+G(GY;MS.U?5I'*R*H%U]+F05O(+6J;_V_>B>K'Q)"JR1PJ%BD@S(H.VX5/A
MAIHZ2!2RQ"2JP[;5\W)+0F9^AU98Q>!-E'@7^\UJIA*17(ZJ@#'RU"7MQ0"^
MZN5(GSR8FO+%*L._J+RRYB5B'J\:QO\V;)(G2ROQE<A-*0#95GC5"<WUE+7N
MSYM3\2]?NGBQ8666,);&8XL'.A4^79LD9^!2-#]6DXC=;?## O,-S,$4?/JE
MC1-K0IA:J U71/5QOT0 MT*9AN:O6(HWN<]TV 8YTT/6Q/[S 8G9"W4;R\_:
M8C0WPZ6LI$O4TNJY3CWO=%;WX0>3?O8UZV#H^H?11K20,H&K,HS\D7MR:3NG
M?$?G: RH&XJ.P\83 IA(#IGL(Q&PE+?3V$9%J_?\\]%TB3U\[GF$USM*$J.J
MYF9@[AP^!/F:L3 *3NL8&RC-31TSDY4@XCFJ+WE4XX%<1P,4+K7R&).$)*5O
MISGD*62AXA]QX:@96YW^F(SJ>C%T:M#L;SSX6\'OOW?<_ZO=CV]3/J5;((4[
M643 (/,/21+.=S4#S]TJ"0&QC9@[!&DL<&L#>DA>0!4(W7^N3'IJ(>FI66Z'
MT)FL TGWWWQ>Q /V[G\FW^D?8<L-I(YH)#_WY"5\.?(F=83,;U%HM/%0@-00
MI)[@;29-D[>D $'BO<?OGO"!XHZLSRFYQS,(*[P)!Q.P4X;693>3?\TS C-A
M!@AO$D'G[L($?S!*'QC>0&KT%C-/,_OS_&-@:9OQ]#&4WTG)/J65)NL)9_=V
M)S6YF.4?*,F_2$5!0HHXFN!4C8O7J^KCS]1WX&;2^I[PGFD?Y9-PMW%+:9TG
M2NO/T3;9,3Y_4M5 !2 .%/(RM 5B:F9]GD9Z6-= [<\#X8_&+"Y&L4(9[!-;
M[=U)<OM07Y9]"3CN,/JTT/,:V'UAP)\(0 =!$.J$B3/#75U>WNTY0WW[E+7A
MH?KK>64Q60XRC+?]>-C6#/]"$',B33'H_U^F ^G2ND@"K%163]"9Z79MAL9^
M0T\C/7V_,VQ%+_4*VAK_P,VR#S%-F%SK6]W;]ZBONQ!J)1F;F2<]O+)I<EU=
M<V9JD#3O__7NI)C^$G#Y;1TI,O]*!*Q7;5K3>SPE OQ*VZA(0:'%>;R#>2IH
MTAE%QM"/P>=_1P/]&A<I?WT:;I@]'GBQB#@01_(R:.H;<YS5>VXH9!H(TE1M
M#"46K(X%OOU+3<W3%RS!VX04,HTFW!:W,IHXHWI'!$PK:'#0SZ':U5+>VF4,
MB;.1&"N8U#[OMZ#GM.4)&'Z"_%@Q$:#_N^07CP.C=."QUM</"-<&ZTD>E&_O
M=*73Z(UD^U!4EB9&*)B$5BR!U@+P,D_X#A==WV2C%3US L/&EDYV]:XU9Z5R
M?"$LZ<^264/\^*&+X_F5D[=POZK0(FC-K ;A$AD6E+H.OP(M+N]A>GL&[3][
MVL,;?RQ1^\,^=$\$GS_*K3"L%F7+UZH68S0RMM:5Z!\V]S5OP,0NF[M61ZAB
M>##<CV6$\<CZ)MXBG%*2V].K>\D,=4^QO6+H(W.6/+V$&$MW[3RM"Y4LQN'#
M;D2SR_=+-5_WOKQD;O.$]#[&,A45-$GE;@S0.=EMSD>HX[>4S9323T(E8LU?
MG,_EB)M@W"PARO&*OPH_EE4D*/2(%XAWJ$]<:%EV7#[: 1N"]Q:M?9UT-6>$
MI_J&YOL89BK6OP4)6ZS%':U+'.C T6E$P"8)J'^R$"8U&6,RTA]G,1Z<9+K1
M(/#15<#MVXTXK@8=9.'2$!YY,SMZS=3R>\6!TU&+Y6PH0:3/U13/"<4E /=)
MCJQ"R\%<1KA6J$TU^=15J[-P MHE-DVHYMBG,<KPX7TXQUE::W2YGR^90B.V
MUXFMG_#<Q?T,U.*KYD^W(V;OZG?"QTSO=5]XP1.RUHT#+7G5);+X%(W<LN+U
M+@^6(]\CJXIPOSRP)%OH(NOK(3GW&*,9ERBUKW/2;R?#!M9+;0LGKZ:9EIJB
M<V>VXGHRJO"R=,J+&FM;9G@]:7*PL#^]1>VF%'7H-CU>_G=9HN_JJK=%QD1&
M->\"\C( %R;4\Z/45IU-TZYR2DN3(%M-AW*T@&XL:FKVCY+F%W>CA.X_EY#V
MZ$,97IYS>:/Y^9L\CU^@T,DCEP_G0VY6]!O8\>$CD,IPP9'>DZ=[.QE5%1$?
M,B+M)!LZ!\.E(4H9OL^1TII@TP'"36Q6GLLG^FVK##J<G4UDJ674 T*/FSN+
M$I_!)!;U_?12F+ :O]/K'#H";A8^E+L%)-OY%-.386YIE4D$Y%8I+GC2VY_Z
M'A5!"7>A02>H'9S6S-$!>[]D$K?IMDF^:/S8^VK5)!1O, X>\EU(I>VIP+[=
M+[8X5\^4JJYCLJU4KD!OCSO.2^>:,F,P1?_F:CB"9<;P. A? X?^,4BXJO,*
MTU>X2>4@RV-M)?1@+<TJTWC8#*G\8WA'H)9S>]L2Y3/W_&*'+P :?"(^%/NY
MW:[)IK7?;C5/WM*:,J5 : P3M.!/*S+HH$D&\-)<9/FS"O>_N'O/N":_;5TT
MB HJB#3I!"F"=.DM1%2J0J2&CH)(B?1>) )2I$5 0'H3 2F1WGOOG=![[Z$&
M".'"6O>LO?[K[G7V_7#V^; _S-\/4N:;]YUSCOF,.<9XGEDN;W1;$P3SNB3+
M";@-+SAUWB2(.;81%/OP<=46=P*Q[ SY;NKL:,RT"HEF#W0U:C[!48R2X5J\
M"9;C'H*YL]?@J=N&)51M//03UC%*=7H)\)SG(;&7  ^F2\!BB73\GMFKLD$D
M=PG=:+6;CB%=X,)^T@V\7ND/-QD%2#+[PW1WYZR+(TG-?EL<R%ZLE[7"F>A.
M1_>CGM2H:#>1*GIDLB]":(U<NU05,V6(?XH_/-YP^,/X,VEISDMSUO/A7G76
M$"9L0T33E'_"7TT4[M961HV]X&P+J+TS.:F?UUKC6::4R3PQ12EW"7!#L#K-
MX1TA=<+$YK\R?Z5DD;V;E8[W; VPQ<FIB>!C)>;HCT\NSG)S:>,[I1*:/3L'
MG^'E2\ZU81%FN!I6'.S*+HH_,*?5-_4_KOR /WQ+'&=RD/_B/][7))DKDK@^
MH/,@"?,4O;)M$+]\QT/\;:ZO5AUB-V1[Q;>_*6!A*]N2;X:Q7/EY/;7GL$TH
M9_LFPC@7)$EJI M]M' )"-"5#_XQU6XX].9>L7XSWK1WZQ&."8Q?3]-BIO0;
M4<43BJ:@GQ5R$0\%+T9'[_$=AT6Y48R=UO9JR;)/VAD=;.K0GK1N5C0$/_^C
M]Z[JXE/'_26SPC"".G;DHJ:U- 'L-Z9T^'"=:O3Y&ISI5_XZ')_W]<9$+9*L
M47I?]\D'F[?=MZ7+P4J#PUJ_1)MK[N?,KS:_0E#UL(6.)@Q,-5#]."&%_V;Q
M[G4G4UQ,2AH9@\7)UM:D&5JX&&WDFW"H"!8?:3'.?8;?_1"08E%+/]02'?OQ
M3\L(0LNY5:"M(D]B-5(?%1;PGH7WE?+4*8OZT!5TR^TR=<R[M5QTL<QJ+TZ4
M.91ZNP;<-$M'7!/B?'844M1%?>\XWEY@<3B[OJ__8(UK *L^U\/24MH9@Z9,
MO,U2$7SCY6:K7?MJ*I*_#D.3S9IWD9@S\0JX=Y&J*P *ZQ\9V'XR;'C:MF4Y
M&+6^9;YI1&^%Z^Y(LXBDB76-WO,CA$^KN=CM@-NXZNLHG$I&6(:$.<Q&(C;T
M'T&.VMN&"@RKZ4U0^!2ZGL2CAL_XA/4(U:5^O&BW.WP$3W0W^X*]E>[Z4BC:
M_,!08MLC-I G;/[9O!P<J&;Y?EU.1#>*<(&==6G+B?* JAEQRN'>=^%D=($'
M6Y\X("'SO%H87P*:1>/*CG?'<8/SU<A"F\EZ!I>0P\.L5&$:@[B%[$X[)8Y^
MC/C5WDKT]]+A>XMP;%@T_/C^-<V'^ZJOYY4/3!C]N=)H4AKU51<BV+5_=MP*
M.<@%TGL*7?7>I1N@BD.= V.L_[C!/QP(^G_H=2'9=3S.I&G1L/<@5_N>2'FS
M1/RZ=A"]>H7C4 KP2!02^F@.@@]O)"<^A$^ K<[56<S:]X^W^\[E03!D5@[;
MD]+0+-G6N."IT\F%V8"Z@FI]5/BCAQ/?!'U;I;JQBP=7=U6?D[CG]<53<2&>
M6,CGG1L^Q#=$KKI,NIR:<:4V (WTG4-'?XM6@QQ;&']3I#@7W=Z2$Q ,W]6I
MO85Q(?#9L>%5WJLI3WPH'-F^CRTA8/VTF)!8=]*>EV[ Z;QAWW5W6N]0\N7+
M,.$P84U9 &=6/<"9TDA]:/O(BG<34JGVMN)KFJ<)$VE(R F#?(UN6H7*N=&+
MI6F]5\/53Q8(BI,]J9P+"8(TVGOO:_:?V7V#Y[G[!Z!KA4K">%Q48E=4_9-0
M%K-M:C\_D_0OU% USSP8E-(S_[-A6XJY!(Q R*TBP/J,<B2I-Z%1,UBB$3*Y
M\]M(,VYXHYG6U59+O&O@-9@HN[OCMA.EJU8#"B6&+89\>(QX,;@T(T]N^$#D
MZLE0)."<P-[2G!NTO=E6Z9;.MQ?<XBVG)HE(AR,VA_"'3;S[1T$Q]=,Z5]!+
M920W[37B"&^)U67C88U\X\R]02DVZZ[,YAXI7S+]+E^6<[,_QY2"CM\_EO#&
M-2M!(PLE:*^5VOO_.^+M#3DSL.N&ZO%JZSN4]GAT"8A)YAO^-Z51IUT+^97"
MR;00"K?]CP3CT.GOB6T'K%XW:F:;)]KW+@'^R".UU+@99E6]5(=&W^WRH%,5
M148=6GGCWJ4B\JFX]:8V*$LPC20;:<DL]M%H_&MTQ+AD^.U4FJ\QI>B#1S@3
MW"U]Q3\5M.;#4NG'ZD]]N[>K 6/8T!=$@WI]].BGBB9OUYH*")A0KV,$S!>^
M)+#^_.0K:[;FGBNQ$F":75^?T2VS1S)MLV"4)0[T,X?&C2!,)7-2TH*"5E;N
M25I86YLJI'Q])15F2W%_J5] EZN[Q";473BQ^=OZL2A5@QA9-"D+\*./W8ZL
M:BEFW7SGUJB?D&+2:^B-YP3]O\]/\D#?SZFK95FW'4;7<B$DKF6RZ)=LAUTE
M;I0N4O=%VGVG/X%:9:V&A49#1H1&^E5E!2S2ROQ6DC2"6&G,G._^!G7\?'H(
MQ<O!OMT;35#2%3H+J3ML$4E9K1(!/X,EVH1U4F_MK7.-Q4\!+VX4:_PZN[J4
M<-5U[O"%Y*(UPH[Y5VJF@>X-<<=WG-DG:W88*#Q]L]*PSM+:L6HLW_CF[2??
M-(X:",(QPYUD86M9FE]P#\T'9"D?>\M2ML#J*+#":4IOR3L^B;$*Z'*\_>E>
MP.1TR'JNKFH_%JOR%!HIJ<O5SHK9I/:4G5\Q/8+U9.Z/6>XDH^L48QMGUUV<
M4RX!%"J%WD?GF8<YQX);'ZX/X(:S<K>!AH,EYT;%Z] ! SGIXR9_E?*IS*@U
M=V]=X7BMJ9%K>7'*52B0!BMNY<!-8OH[.K23C!E!0P"<_1VB7_I8/43ZL3L/
M98>KT0)C^$+7^/;'M]5^*8'=V_:!.65,3D2?+,-JT&9-E4+;-O@=6;V91#P%
M!? Y,U_,AV16).S>1.,4JG]G#?D($E9 PX\#.B'.NYSO8$M)5@WJ_*L_I;C^
M,F)NG5^L; ";E1N$/=L19\+=/$S36&70I8"I1Q::0?Y>U ,E06(U]U:^<DVV
ML<:<<-BJC=WX_6D,??HAP7BY0"#!&/G8A0+Z3;1-N_DG>\"/MB3JF;>+ZT5G
M*-D4K-[>3@&W\\EC XEYS U/ZHZ^9XNGWSBGG^1]_) S9-V1$-,&/B5<FSWJ
M-%HI62K9!-/'&EX"9$V9LOV?$TJ11B$?YU>";TAAY=$ZQVR>!VB3IAAWLV!>
MX4?DPJ%H,M84,LH]_">@,#GY L:C0V&[6G[TCM]\U<B@DP==#E(:[ZGV@OSS
MC$" _[M>C>/#?%TU2UV6.E+"3L:#@H,2/[_13 _*Q 0^H?T_FK(TFQ=<&S7W
ME'%M_4(78G\^E)8IQ,:(?;B+QR*=^;CZ7!&3/E?UZDO9D"-7CDABH]?*('4#
MJW<OZ@R:-:+U/3%2BX58Y6F5RKRL'>TEH(6'O"ENNC72#98EM6<UU=_JI[),
MQ/_*MS]LN(=\H=8/"1.9,,C[E18Y]53#PN19RER2[=+Q8>Y%0IX'G8>V(6IX
M)RM?O3F9U!,TG^G*RZO<LW!46DHW#CF73[NXTU=BAT"//GI,WK0S<(7G\NO!
MT4W8-8V5(P4UI IO3U*-K"T.B,F>GW9VW4Y<+JC\MJU1C@]CK.=?/&AQH10(
M#@LI[Q6 !O^],M4>QXSQG=\EZGQ;52EH<+_TN%X2B?I&M:8@A2)E;]-N6N C
M$>3+,;2ZN@:4UB$ZFT:I1*Q*Q/V"<B4.TIIW=]O'4BM&P@.X"*R1P7A?R[GD
ME^F@G6/2,&["K2Y5!<Z:\L43YT7AK0H,->:V$<[FEKFL^;$ULFYE6-Y98GA?
MV-6VZY5^A9"CIM<F<FE7$%;9DZQ?B1MM9+\#ZCWFPL\&O[,Q]"^JD3D'\_TO
MKAW@$TP93A[D@FND IX]S6$LE=*[<HZ3KB[^[A[B@GJD;B\&I\2&N'"(N288
M=1<MMG:=JAX1]R@*3*MMB.98"4V/%HX0F<L)\<5 P;FN)$VZ4VR\0EG,7G;"
ME80)'DM.6 ?M7*6-L!C?3S0'1&H=-W.X!83LGW16TC_X%(BTPL#0CY6U- :$
M.]+/M?I+4=RV'\#3UI,U)'"D$0B-\N:MIG,-83N72Q9GID'[D)QHNY\?@G_0
M)_PK<[2BG##S.QJ5D+X_6?D.]3@61HZ]O+QS?E&N\_AODDKE'6L$3/[UZU4,
M.>GY#^.<S?)HGG!=&>D5K/QB'G[C<GI=U;0C &SZV>;;ZF3*8I)"ZN-#F2<<
M.44_TZK#5A<S"KL;43+1VH6V@U-?6)WGN. 226V+8?'<@65GLCV%D3X#"FSW
M=MNOH#)TRVRL:Y.BM&*C6,LP>(&'O5EDQBO&@V*.J! _ '+R?9]++37'VC+.
M<HTC[?>&1%1TN G;3JK]-1O$.CWZF@UBV'\Z6 ,:M0&D%VHW=?PS:&T=I4*Y
M].TEW6PZ\& BUA3=!8F0I:H4[B9T+Q:\8X=Y4#N269!L LQ5J\EWKZ&,37/U
M54)3IE8,[K*4R[;NB;UG+WJRI)7X8:1,6%G8D4)59Z*U*F/M8=JJ1DW0!+."
MVBD;0A\@#O:[8_36BD<G7=;-]!+01OSX,7.34E5%J]RZ@3'!>F@;,$H=L9AK
MBN8+B(6.V(@"N][F@4+.::1D>5>1 _I: 6A($^UP\#W]FB_; WR 9Y"B&] #
M%N&)8;'R'0N:5B7T.UD*-8Y_/09$&SC@Y(A?X6JOSTE[W&<"KJ I+OX28%@
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MZ=SFM/X@IB;_)L4>'E/SP55/CI$)#?*/[FV/[ @PI7GTC'LV1?@(5%+\T'E
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M+42<!-6AU"[^2T^:(!;[;_U_;2 I>.FM+ZX&>@EXX3Y[G0K/C+T$'!W.GMV
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M,^)%-6MBYN8/AX\\6@=W1R)OZ(;=N>E!>&!A.9/NU[I*E5#!MK23I&CITRM
M+/C0LQ>R@,%#^Q87&'$,LCZF]>4:PD^';_=\&"16.? N80O<?)>[)3'_D/D
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MZ1R]+E^P)W>R<($]&J/6+80-9E.V?2UNRXIY^N(HM_UD[HE9]F""[ER]5-L
M1>BAAI=V<6[I\ M% O&,%\MAZ2>FN[[I[,-WJEGM\(9]'LM$C8J388B*@AS!
M9K;5;K0[:GE7%HII7&D80OQ:<^2LG^=J8?)JL*68G/SE*^%B86%57DIOMCS
MN\0,IN8GY1UV;^HB5K/84[EH<06^5*Z]R%,-(LPKFK_KH8)"5S&;3[-7!2I/
M0=-_]]!1N&W2!I:[!1C4[@%OG]Y56H54I 9+?95*D)7U1P*.Y=^M3U!%MM[0
M%5I>8S6HHS8$HAF] NWDAI4CBVMD/5K>H=175:L82<T4T(\$CW'?]/[/U;PX
M6P":(F-]=ZDJ2 [>V]G"_$7P^2-_GW=O3')I>0X50D-1&V#C_3VZZOJ4Q(EG
MI"L7!75QQ3"]=[Q*A&QA?-M'T2#2\B"@OS@NPU>EBV3.ZM3-9ZV<SV=%P>6O
M 4]?"9<4Z0.*:%D2"$N+)MU\E:;L>6-_H8ZK!+P/WG0KS#G,3,-N V)71_%V
MV\^HCN:6.UI)]H2K!ETYXG[)(W,(\]$I+.!!JD$-."]GLA J8DR.:?0QIA.\
M::;6Q+1-W#'U8?18?5'S&O#*[7QF1N*%M.AQ9?;DE+52XM1]=1$&7&AFJYV5
M6(2FJL!<D(,Q.JCPEX3]:'(3JGD4J&V)&3Y8VA#\\5+E9G"N_B,N^7"XY/H[
M;N^5U/<)U/G9S3G#07SPEOION\<CQ0OJ)#K@1?M]#[9ATI.=WHF3;4CNF**'
MFJ;F_NG#6X3'>4-8KB!@<I=V>5E^%T0G1J&?6N%B1SK0A>E*F3'"3[1"]689
MY5B5!T\G6]R]X';H#\<L!%F8%S,%!AW_\?()+<U]QB2R(L8 WV$^8^]ZO2]#
M)G>'+_+J3Z93UBW([1+9]>F:N]Q9.IYOJ,3*W?C!HH-\Q(C*TX_K]2TS_3RB
M%Q<=B@['%]LUL,#GSYR=<TR[SP6/>4U^'\E2;I]Z#;AQ,'7B"1UD12L[W,/:
MQ#L?\+AX7M)=>B%ES9M+5A^]]]:0:ZU]!*FKCE1DY1/J#AI5DFA !Y V7XE,
MVP'O!HFM7CR'SU5/=1S_7$Q\:/&M31O9XUA>6JR_I1_3S"#!M_71( SCC,LB
MPR/8]MUK0!X[-*!<N1M(>@JF<7!?7EY85N9WBWX2.BHX^BNP:'M++///7-6Y
M)H95ZZ"3OVJNX1L1D+^+\ADX(_Y^)/:,G9P_ELX0KB+UX$*N9!16HJ%1<C^R
M@-?^Y-9?=W\;C'MW.5X#B+VT[N_YTE5O3G]+'JGUZ&2]1:_+W<:M]41F/$_L
M@5E*-(0WL4J+'N5^#> @5KX&E$-PE,8![5)G1K&J%/%M3WRNH&PI]V2^PMK(
M6B%_)<'MW3FR'!8[H>.KT#F1(EG-EHBX!H2M(R(_EE#P&\?7&"\I[7A.T<\B
M1M[(UU_TG/7L:30EC9\1A*UQ\B+JV@DPYU H'TT7$^58DQ9189'=3VD2]F*?
MAF#"@X/QXA07,Z8.:-19UO'"A<L<;&W80GS:_W4R[3)%BN1I7XE!^F'%=R7R
M<[V6^J<?J1VCW$?,(;,&I8L8XBK_F,J9MY&/#H=<V(&?;;!Z5IHHYH).%N=G
M>O4-^*@W<<_)9E+%6FL@]7T_IGQDC9=Z8##BF)70C=C?^+]6@K[?:>L_%S-O
M@=3!$Q(?17+!3^_1R]QI@=>V.6TP;+Q/;MO8J@>B7OUY3R+[P 2+[;T&],#T
M6>744LD=WRRW+U_<R\,5HB_  MT_"A6L-ME7X137 ,5^L[3()BG;56<6^QIA
M+?:'O\\UVVJT1O'0NN8\\&KPAZJ^_4>;=0G<6Q3X^-S.[8:^!.#/TPQ[<YZ,
M+E_/9#.=@J!_TX,N=0T@4N^T.+DJ 2W_F:Z]Z!L@GG([*F_>/G6$K=/EZ_T"
ME@HF%" DQ;M8R:%OD$S):V,!+/ZG<X<EG@O;V(H-X^LJ@0&I4$ M1$1U$UWX
MC+9 8YJ.RT!^TN-AW9E'?WM[/=Z*.*=^:%3&UD;"?&?V,;\]$+E)AGW'I_GM
M9U5"1\?2,&N/)*OAIXJ-" #))4)G1F3AP)BM2UX*U.>IAGLB./HP6O)+ +1^
M3(;>:1UN^82P>.<%I34S67"@H4F4)=16;"P.NS,BI6.HC:&"+WCPAYWK#7Q4
ML@'77E66IWOGT>8/T]7Y#[BHG 8,SXB: ._94^S6CD5%ZJV<*^UW+M"-E=N^
M0KU?#6;63N_ 93LA,X4G22+./#U*R@_=_%AF1'5<G]5H\@3VOO,K:4=#PJ%-
M7W?.GVQ<2!#*JQ*<RD^%6BB/(-C:TL,YQ[=?1?K9=%1YSJEHUQ_5/YZ9SFG!
MU06!ITVSK[,FA4;0HLL\YWBU9(,)?&7ZM3T)=RP_91\NCF068\%Y%HX-X3[Z
M]](2&RI67_J^E7N'A+K7HAZM^EEX)<%$P(?]PJ'7@(3O966O[5INPO4N?\\_
MLR>,2175:N;/MWS*Q0&N'P;(19 V!#S7[NAWE+ .&C3OAG-AK:X!9SBJ6^W8
MZ[C00C#[N0E89$'5.R?X_/5ZTGW/"YN1/3V+%6M+@R/M/ZWR;EG?_PE",3.T
M;D@5@&8J03MZFWJG,[$8_ *_#MC2^LNZII@5A5B!1=U[FOX#Z6W7@ B.5>@%
M=JKU:!^$<6G8G8Y[DRS)N[K-4\_6S@T-_)OKA>"5D8CD(_D<+MH+"',V$6]S
M$PFVZ.4%NG'Y)D9X4E:9UPQV1R UE5#FM]M)(+?<;> '2*'C;-4(P,]$Q9VC
M'(R'6\7R-D#MI@SF0KZ"TNWHED1Q2'AETV^J?ZT>46276Y\PD?3/B24D@5H@
M$29^X>AO(BD%BYI=\9P_@68@Y00OE5J3>E_6! 9^'G[ ?/%^%.S>'>QI9+P=
M)0J^/W=!5_#)\_LE=&QBIS/11*=T-6]V"QJE)V:2S3>W9&8XS%59G[YD.:YB
MFD?6I3O3,%Q4!'B$Y!O\)GUGV[9WRW$6VD)@_[/OP+)D89Y'BIC_S<N6!:IK
M@'RU.5GH2[[W[M!^UH!_+AM>@0Z!&=GZ)=7@!X *P W5%;PE7/4 =WYQX@";
M3Z_RN$G55"?Z@Z]J"/("2!<#3O>;I%;(R% V734^A2:)XVLK4>X3$ !I9H07
M,EX-,S FS;WJ;R$:UN*+@E(WM BD:NCX5[)_H&:&85I("2Y-XRXOW[1$%S<D
M?+4I^2.CYT@UU(A4I6&#R9'5;>A[;?<=NAIG5\67!X$9P)2AZS[*YL]XVJD\
MCHRGO FIB1<UC[<H+RN&9*2AHQ3F0T48\G'!M_ZB!TI;_8;)FPTQ>L%1+.LP
MU?-BH2"B")O;ZUWDJLS>":,/,8/9FV;F<U\G5]#5>KG*"?/S0[[NC,U-6OSC
M/Y['WU:G&,6ST$31=T9U+%'73&S,GZ5RFH0UR_; 1)8!>"CMU1%\.WEJ5Q&M
M:@'/^,*MM\N<\LT$*[>\O".,F] ""4UR9+8E"V7?=\_FRC/=+?WOI2YY<<."
MR2 YC$_W';>@M'Y\VO#4;X.BS@(?*HX%/UD+G<K'CSQ#O6W)^EXN\*VI%A<"
M5EDTM'Z;+P<Z1]^W?X=HMZ<9QWYO&DGBAQZ)SJ?45S2DSWFOJ!)_<@JP-E"1
MY_3K>O*0;N&KLB>)3>M16?V5XV2UZWMYQN:W23TFF7(CBDHG;,SO/='3;$%W
M7O7:1D>;M_VVQK$.[XD#^T%/\*Q^0B)FA&M23/U*'P1\V90%,P^QSQ< %P:$
M4'EV9C%--JF7*-L4=JEOT'S:X%>_VI)KA3J<$9.%!5"2,IVAS_:8.PJL=)!M
M7,>LS?@OQD6OZ$:-=VO<312 D6(]P?TPK?JB%+\"NQ02]J]-76-56^->@28$
MC5D'WS0*_><%MR=Q"'+V#11'H5Q\"VQ>Y\9RT_XEB]H"_?T7"O0)NK0N:%EP
MF5D/EYF7:K%_I/5;@5?!$MAW*7O3UP /<-_%/A 3MWTB/?=OMNG\![2[_$^S
M_XA!!_DV) 6&-PC;"9H%/!M:XZH6!14CZ ]T;$DJF.X%9GTYP^IY[0[G55']
M*IZ&J,E.,2:.^'UM=W;=LK!W,.=/]2/092J!R95\K&K,ZH#)?+4G\53R* 6.
MJ)WM^:\UU";X,<B^XK:Q7* [L6#<34VERQ">MZ1;-<J/(\6[Z2'?A-7;>UWQ
MZNN9F!BV(>NVS;MX#F2LX"!ZBK$WJKH..?38!7!'./-G#]FB*URNQ+CI9/57
M$O'>;*B\48QA' [>;#F6(L3SO<INKWDYJ74.@J%+P#_"?ZO09ZFME5$6DTBW
MSRU!K&4ZN;X73/9KP2\<&I!=.ZHQ6FE,6O $87D(%Z(<VG:\V^"2PCY#%Y_O
MN="B)CM 5+Q!$A: !$:7W^#.3]=+8+=GMXK0>\!^251_%56">[2"Y]< O&4,
MWVR9$GE^D:<1LT14UV2\;[3V5@"6RV2]=L)U?Z6QNJ4Z=8US5E\J)>;9/ID5
M9H^X'?UQ(N@9Z1DK#\X5V-\[(-F0ZNR_NB/OUUZ!IFYVY01=2=ZV2)TK;H@2
M47+>D!=5A1C3PS<,_N91C09_T1U4.%K-?&!&/0=/;)XAM[KL?(^.W0IANP;T
M%D1='F$B_&E5ZM9T+=2S%3]K:-WB47Z;MA6GA0?J&VA%=E\#"@)2_%W?M6[8
M6*#7K@'CS6I08:Q$WR#'-<#GHJ)\CTZDHN,[>[8#/%7JS9,V+DA! "A.5O%6
M0J98?%/QN2?^ R+/S2*85DXO_@E4>H+?>K*:FW_M9E4Y'MN/0Q!>LIF_%Z.D
M6GZ5UJFD2'IQF>&KR+(0UYQ].MZ44:]-RS"!O)N@-D7SPEZZ;KJ>]PXL1'FC
M1-Y^Q[[.V<J$Q]W*/_0)8F65TJF*\Y_(;7R[< C@QN**M^STE=]1K.#225?:
M\/:AVIN7,K<N0 7>K[_S5LL=)&YO^159[EQ^;2:I+_#?3K)_W*+$/TO[@$N.
M0&T!'H&,3ZB)#[PG Z\8Z(W^? Y<GVMH)43Y=-DI;/FEVKNR/3P'$5'$D6EM
MF_I&G]ZIXCL.IZ[^F$R2E3=Z&8O4"_#.^.X\"C>GKJ$3ZG:=P3(@M[WC'RR&
MY<95/F[#GQQ-^,G:(&1MF6(C=3,@%E%4?: 6S"LGKIXJWH^1Z]N_ WMRBG.O
M&;CS LE9G<3#M@@IXI1B."Y;-)@$\9XXON90^_K5MCIJR,K\)X2VV6 =:V[K
MK$AI@+='DJX7=H<SZ"!>G2$ +QU>S]#/)@7K2C][1+Y ;W%WN:]NY)-.]EF+
MQ9ZYLJ6+"Y+>T7+:2$\XT#K4O,>P[(Y&ME1F_T ^#Q1V#8#WVJ\-,0_"4[\(
M]Y"KBS[_B!=W&\!P#6BKN$CO@XM= V8Q"A\KNGQYK8#F>1=6"*C:9.G,RPD7
M9WK:5.%O6;T5F+UN*W^GPZD9'E'A&W*?F1&4\*2S4QM-BZEKP$KRYTY8'0Y?
MUV1'8? =>R2V+KO2 .2OEL]YR9R;08C]Z:WD?*O5K1P>XBW3$HWE0P@+:#T?
M*]9MTBEPL.'&-<0_?HMI(_VLJC)&=+."OBGE0S_#22TM5A?AJ?N0R/T8@R^8
MC]!SF$[3_3/WB2#>WH#99FK_D$QE2TGVK&\HT-GO>?28RMB/3AY>Y3JHR\2V
MA+%S62?#%TME+EH87NF)"D98K ^":+\03HL1>UQ@9R 2]CRNQ=104@8,P#)D
M=S1%SMUW]Z;D?!ZMLOHBP:TD>3);;0_[T$')9%9TPS6)ZH2=X6I]XI@93>7A
M,TV3%AI?EG\2L1JGG=H[<Z-!2/0JD\D6EW'S/=Y69SIIL7MK3V!&S&JFO$Q,
M#)W7I_AKGH?22-S)P M=:FKL$C*>WTMC';8KK/59BJ>/Q)=-3-SQU 99XEQT
M2MR,\P<NHQ-9-V@6N%*HBV?[,C@.RG2TD16Q9C&%<_=7RRS$O14L9TV/*YI;
M@GSS(WA%(RTS6\DL/%4WXN6BO)<]WC!W#"2$*6L@;M[\R)IQ(6P[>@K, AHC
M!T[<3^OYQ&L"LI;T+.96QP-[M8YE';NRCX4=F)&+):.R=W#%M0N$Q!6)3/]K
MP/]S/]-!SS6@H7?S@LG%"'L%S-[RJN[#/$LT4 @3.4]?N8_BL[W 5D^KLKOU
MC*O!HIM2K=X!Z8Z7'SCVESK<H:ITJ:Z]R0<*!NN<KN!= V;*&>[R:/YTM [P
M+_.;Z!P0@)T^ER=Z%63T]LG*'=S_TD+7[(!+]EOI(_[NWQN"$J%I#^1FD;VC
M(.E3Z:8>-;W2!E9A!Q=:QY:RUHE3(N[<.C+=_^H6IO\W;4S_64;HLB*A[SD?
M8\[&[Y1E[:27QO;@I@<ADNI$J;($U?ALZM!K?BC0P.B;1].2B@3I+WF7\-<S
M$]6]?MMMU"&/:BG8RFH@Y&LR\?6DP ;LTI5RJ]KTITGS1@94K$=ZDZ^LA0(J
M9DV.1D>]=M+%=;UGIK8Q<T-)9S>Y?3T,J/TQV$H#U;T:6-?>Z/CU@315$NLZ
MG"=[@Z^[>OG.7@C#E^17/U(E>U4G76(BW80ZP6TG(VK=Y44ZX4C)/.,".:#(
MCO.S=8((9U;.:<</V[W$)/QY\N$MC]$S8+^1'M^6QY.I_I//'$F?4\,\[C'E
M9^W[]9^5.]1X:1$Y9CW\Q/D5,LB[@<]#;V6.J5@ON \A=* H>P5M,!CU"HP/
M-*F:$ @]X?K((PGD/;?:OZT1;$GR>+Z=X;'@[/K+6)$,@!!?$OS1.V=91J?C
MJK#M5U]\!B5IB9H88^6$I<_;=D=]J(:,(3(35O^D=-WX(S>6C^+;OV<0_0\2
M=/[/,*I-($W3 \$<<K\HS?"F4<[!NC$E(X*'5ZJ,9.:/?SM.?2\.SS ;HV*!
M,.D'^9J)OU\_NH_RN553T<HY%;)/P>+%L!UW+)T5;E#FE[?*E%BF<FYL=0UX
M:U;+H2U"G 6*BL]']*W/II_,C[Q?XJOQN=?MZ).7$^M6C\M1"+/8?,YJV6VE
M,@D_[*V8%C&_+)6S@I8O][''"AO8<D7W@)%H,==[IG>J379=S/Q>SA*U*M+B
MPZE&R2)"1-CQ\]Z1>7J3,:.N7':!M\2^QNA5J\\[JGB>$/8GO0@D)=A#O<SD
MAI5RT9V,+9P,\:DW35=SBU[2OJBE$)_2GI_,?B*=;*&-<GP6A6.(E>,Y#YO"
M+Q9 ]%E&K>1:$P6Z\-;W7N [)L*&SXU]:9.V3!\P0Q[L2^[P?2L/J/8_-6'\
M', T8E"'(THQX_^>SO#/_@>$,/0?') %(%L7\H[E \EPP2B%&:[Y-^>P_7>8
M9_;?V1C2_@$9;/W[BG8!IZ"%@A/YP/LX1T@&@5_\RW&DTLL!O7<L<?<"9Y)1
MV9V>=K7._ [F/4I7\^#5:X#U-2#+<=J^_ .KL'2D$JV-Y4?EG/(,<4Y=#N^*
MWOCV9U2D!GDF(CVB![XZXRE) P=K2AN%^(+!;D\?K)68FBXZT,@['??+CH2F
M2G&-DL&A!FD=TB3#9E4;-S,P"0- EB<E/G1,7PKE+V6X\T!'5UO,,?WEYY^U
MS4^MH(,GLA'):S9VFI#&$TQ<*X'=HSS[(X&!4&^WIY97W8PT>S/ *X?MEC]H
M#B6Z 5KL:+$*O3J9 #[%?5NZ4^,"P<1"#3Y5P4Q[]CB/7Z,\[)<9!E3\:GK-
MU8H^ =YPC=54IN2?DJY1#99?7W[5]KI@,4NL&%F6<_\S%[0E(D!,T=71U9XY
MS?GFRQRI>;I;#Y!M18ZR&J[.VK_F"2(-'7BSS7/,;=8/1.?V^ *^^1NH#\M(
MKS!/$)Q -;Z[.!VX4NG#YAY,:3Y)P0> Z/P<L#T0H8HZO9B"_LH=MV52).//
MA=UQ((GL;*A<+PG!#@A?7_Y?^)WWQUUC[ZI!46KJ"K5F)DD]E8-)HJ2M@6DX
M=T--I%O3]U2A6?3;:K_/P9;Z*MN&O-DZ?O;JYM< F2P.5T^Y_!;GIN-GG(];
M)'C=D52B#>5YDC=,+HL 6,PO4%G ->",*?$:\*3Q$89 "UY@1J/V+&6"?Q(=
M30E2V_-/$3_J\]_C*$U)T9"WC9_[O;#\@K4Z3#5?+M'3/'/5E;@PYGY='1_'
M_ON;"8G@IU=:%W(D[LI$3K&B\<%43RC1FUWK!48>!=:^KX^+_?P]^T^ ?;CX
M6I5[">5%I":*9Y>I>U95-P\^H.J TV8]Q3%C.J2Q]8]N=PI%47MVYTZV[RQ7
M3\OCQ!^.9HOOK/>L4O-FL_DX6O6<7H%TQ]<?&RW)NF?YW*,E^\:R5KRPN BC
MB*I+-XEQ?V?V@2& "&D #PD[:MJ%D54E$&R0\B)3P1#[A3FC3@I0D*#)B>S,
MMQ,BOJ4XL0LFA7Z$L!I%T2%F><7OZC M&,*OX>_(SOI2S95V&)AX5K[<;LX9
ML_)!I?$AAU8JP0X#R.L2'7 5<&9 77/N?N$KI"B,G_F3Q3+;E*Y85(.=(5YP
M$(@\S%XUU.OIJ)8W3ISI@^6DZG;J;Q?(R0C_D?QPW\^ @K>/FZ0K(MO3;5[A
MP0!<%Z%H@P<KE^Z>:Q^$.C<5K($O[S"7\TV5.Y6YWOA08F=+/!!C=1=<:)^*
MMHG ^;,YODK8BGX]1G<==LOW57=/)H'F7&.6/MNC%"==1XG<FJR(XF/7![/!
M45V>/V@35NZDP0*PW[#>>V+FVUH_FVP<2U2X>(4*#3NM=A.-+-V9.H(62>-"
M*/9TZRDJ7YRXXNU> QQG6D8'/Q^\;.5+K(,#BS!\DP[$CGSJ+!W3T[3XP4>\
M0O7H-4A!+/0 YDF&'X&N%E1?S!)9XP/]1,5B^5_[_VJSHKU[0K9M'K\JTS<2
M[KR5V&9(U1657,4#G+A=_7:\:N]+NOV^@$U*0]/'$HKY(DKDCTIU_1IU%>K%
M>KOPUP_1<6]JH!_BC;7?FQAN=6R>=,ZDZ$YEGE[L^+7D! KF?=?R?SPXL-GR
M_@<:+Q1E4((R>2%M'HH+Q_Y\)J=OVS+@\H![0D"BJK]TA\%.]YLI0VY%(Y:V
MS?'.R12C@8-KP M>XD'=YI]9TUKUO)2R7GU[.F.FJE6'8.W\J2^K:>+'LTOJ
MKER#_(*Z*Z<L9]#7<.PW,3G2Z6TW6VYJ3<\34E)0]KK.8+Y]Y<#X$&1.E8VA
MLHE7%9W$ZQBH'BCYRV<:\23\D(_\UDWT2C!?+=6'>#\.9^W-%3>*CLGDK2:+
M4S +@@L3EQYUY>M0=AORW;B+M;:E/E+(\Z?4%^6-NX$D#4I?1,O8&[SSDQX/
MBCS)3SYTU\!VC@-W:&RN >]VL51C##WIL1_B]]U'N(IA4CT^K47KGF8+"[A*
M4)=J[GG9*S "%2O*]7.X-/[BDZ?H/ 7QENRM+8+J@M4G<&!2S](A^[ C#ZW7
MH//K:EXG_D-!DJ"+0V4K<J$,,FNRFZH]9\(YFT?[ *;E$0P;HC1(G7?9/[>B
MHK+YH:U(&?E?O3_ZQ_S$ H?^6, %=/8"&S5B#3P^V41'_)?JT][XBPZ->3"I
MG:]KR[;21*'KD:I#'$C;V$NG.7P\\(L;RO9IK?/H3KJ3!BPUL>CJEH.VXMT%
M<O77N;$\)/_>7/7_T(S_5O9_D/-_%_OW1\[_?[#_;EM?_]%&1C4#W'@]V;H'
ML[@BF2G;P2W)W5;D'@WV'5^_V,@%K=@C-#KM&O!,;"^ &?,![7H5T(U;K43(
M$[*53O1.T)DV%F& AEG\VT%R HS./A;"L17S$ER4-;MB_FBPAX#0N%OB\>'_
M([D&Y!ZH7GDCZ(P9J^1YD>G\/U>@_3].#N]O3.K1/]##!_V#TVODSC6@7GTK
MZ(P-J^1VP?3EWQ3'^-_5_A-%/7[L8[1L ]<<A^[?YJA]\NQPM>]R@.![WU4P
M[TBTF-?HJ4S)^9RQ:)?#<M=V!'.VA=,,V*2]V*ZH$%7].WND_HUZ\!:R_QI@
MYXHI<?"Z2';J*=/43[K(VE5\YNA)=9!O("3I5_ $]A1V5\/PZRVJD;T6D7%9
MH&1M0Y*JH!!M]XU(&X)"CR?,F71<\:+. 1:<<[:QZU4BY=,NF5(LR-T,A%X_
MGWG72<]9"^2IHG[KI(!HHT1C<Z9EJ/Q)+8I4]8QJH!L![#PV)?SBRJ8 FFYZ
M9H>) 1;<#R_X>4?S\5AE96YN;7WDX:*@P*:JY4<;,]*G5-0Y14:[^I$P]"I+
M^#T)"8] O,ET_4!2V(R MNGS;,HJ2B=^FD,Y?8Y>6$=ME2OE#GK/WT?B:6$[
M)\VK<H)1)(8W4XK#)T:/93%9W"ZWOMFU5UHPPLO9-LFHG.:H]T8D#Y(]%/6V
M0+'_-Q4/=TEE?NZ/JD<TNTPLKKSC;]7?B6R\:+1@6@2O:-C! @JRP&_.TR8(
M<\R%_=G/ +ZBDE4'ECR<Y5\\8M>=L9RHD,!$BJOR6UQ,3HEW6U&[7*='9D&O
M>F75^879$W\,-(@_9>K2^63#.*KDGOHKF%+_4720ALWJ]]>IQWPQU&]Y6]3"
ME.0\%-F_^CQSYO"Q]0OLFFFHC14+%O8KFR;F\H[/>T6[>A:WD3@Q:V!@+K%Z
M1+.+UL)=UO1S,2:>\8FWTN,7OHST:/,Z%X/-R9?<KBUX]GV>/89DOJ;TW6W:
M-Q!)KKHRA_;NI;D'VM_SRX)?/,)'I9]WU=1Z+"FZTBO 2C:* !M,]9P-#2<6
MD30OC>SFJH<FBR@?]T4L#@-HQ<HDNJYN\*2+J??K/F:R=A><.!K$!W?$3+@X
M*]Z2CGDJ)5*56^GE[*LU4W:W.WR^(T/Z?N2S0SZUG_9E#XKM2[[E5GA#J7;I
M\ F/7(!!;D'?>[;:CQ(Z8[NBUA)"^8O!5*>\6H(('OR]ZI@KWA0I,:\8;Y;,
MKS+&O.7914:PFC!8SRI7>)+$HS<R]R?IJK4=J3,[8GDCH:6S=CYO85AW!O^.
M.)L,--Y2NL9.^)SQSRNJWM\8=?C55%_$T- /KANJ>?0@Q+@[:L;\G\ZK;2P_
MMFW<W]/4=E\D$HFK>3.FBQ30[U6ID: YUVZG>6)XW#N*UP]4V[182PU+^F3H
MFOGT<H]\!>M$MOO<DL<I@J='IK(F]X?7-8#6;BXS[EQ\(FE4:5P5_^Y/ !X7
M .['F, [_1YJC/J@Y3BOLJ72%2G[ B %8.I"CZYS--!EF/\J6+L&4)"1[-I+
M/^>H^W+V/#ZS)3_;\LJA,*+$[^?ZRS Y*Z6PI7$;KJ$/8=D\;&X+*B/X&0:,
M")JNU("F(LA\K_20E3NKRC@WD<J%7[M<;Y"!8Z[?B?I,M>B/ZC $APT_R?<<
MOP?[/=5N#C05L>DIZJ8P[L)^5D5Z5;9BUAN_?KD!&%7%^LR#< ^HM$=40D)2
M<I'$B@"+9OT99R.06 6A/1SNB=T2;66VH\LO(5^0JQI^HENG42_5JYV(GM%2
M[>YU[U$S+K1"0?2RG\,WE_*<$IM&]^=^WM#=G-)T4[9ZA0K4_JH_RG^TK6OT
M5N,7VTWNC01A#?<0:41"MGLAS/C&,R_!]\6NO(W"Y:7^BUGOQS-7R1AV4]$A
M:;FR-&\W?K;7L>XO#(4.[Z]GJ\W\;K4-=+ Z,*BJ/I6CCNW*[CK3;V'_\"R+
M/OJ0$]#[4.]XGF6=0 I&N#NIOV@]8?*5,ZM=T:"U.4KS1];9RAKWO4:K(H 7
MT_:WX@:FZMNMA1\N[019(S**+V!X3MYL-Q$9X+8Q6\>(J7W[?^+P^K<KUP4H
MGB7FU->?"-*4"MW=EV\./6/7?P&D%+UCK>=W9/GJR2-VM2?G%X;9XV4ZR08J
M4:_N_*ZLSJV_TNDQUDQSMG4S5O_LTG^_N6::P:I<I5?;[);Z!Y-/^5G1W.6>
M+Q UX"+[<XGNS>K:VM?E,RPDR1, BJR4KX^Z[]Z0BK-GW"\FO1E#'B&/^0$L
M,*C,FN:8##.HGQLS:A!OA.Q-1ZYU.*]J,A)V/CRG*G@U82R<K&%VBRJYS"]9
M;90J9-F#7(D^E8,^,^K%"LAX>QV5]ZWIJS'?!O.R71IS'@5:C]?#89<<IB@C
M[HCJ-*V'8\-=R\AITH9TN[ZEM(_D4$'R%_M!>89+:I2J<DT>/[3;^+]E!'J:
M@L#>?'(&;1U_%F!$^3T7\]XL0AA91?G_Q=Y[1S7U;NVB45247J47*:(@(+T3
MT5^H M*1+B!5>J]1$)#>09$BO1/I':07@="#5$F T D]0$ANW-^]^^R]S[?'
M/?>,>\XXX]S[Q_IC9:RU1MYWO?.9S_/.N>8L[LDYXMOZCQSFQTWS]TZ;>0V^
MFCZQGP"]]0WMO9_-]%WMY^"&[[(6!44)#Q?U8IR\SJMDY\&)NM1?R?EXW'EU
MV%"8]Y.V9<$HOT;X,9GKL)34P"'KS PL=A,K.'6" S Y&$U_7ZROGY3.RRMU
M2],97(I?E=N9]N1W7^AE]%FHI+*.]GNI"G@7GRM6:>0L/3><"N(7+"T&:<V(
M9<F /MA,.T_>L@I;2C+>)'S8;'6HID#E="0X."9QH18/689NO>ZG2AMLUHWQ
M?+>W6='.U&MDTT[I2)RPG\]/[;HM$@=RT,8#ETI159Q.U_+#]D/2V7+:1?W-
MAKAHMI0"ZJ1K=\USD)<7TIP$C, !>H&GLT DMS_G4[V_?:V4'5)5INK$\5C\
M]]?[46N"'5SHX#&;6%;X9FCL.#O?11*OJ02<+>*4X9:-'[]) HU)T;C'_CV"
M0X[TVBS(FRM#,YATV:,*]1=]]Z6=VQWSH<S8H.$(@U>M-%1*7)GQ+0&Z!<M]
MXFD;2[0#/P]YGL>=[TY4+G6M?)<5NEF 9/9(1A/M_ HIM6%_Q,!U0K-HXO,\
M)I__<YT!3PE&$77]L9\[P[&!\-8"^UNV2':V'E'[%4I/TN>K%L+J#J/=7S\2
M%5Q:4Q$B^H"V,F;=9]_;J[Q2/R!(W9$]EY0==<IFYF(Z5"$&A/(?=:/AT?</
MGX[K2XT.F<*?T?WD=-YOAFHZ#*+Q_)L#+[(A'[%UJVQ^#Q__7'1B$4_VX<;&
M6OD]TN(Z.QSN4@+4A+CMC9I4.?PTFQ(%WK.G<J"SO[_SR+O8P"7!4PN*F*R-
MZ.._-:C;$W@G^##2%7RX.[&[MOQ)KD#;P-;I=?:#&3;0N,#IW=5C,YK;.@TJ
M .I=D>1=7B<1@^^S_&W7\MM2B(.ZWY!I5B6$CMDH;7O8R'$1VBHR:PJP_^H>
M)R&$]M[K;6,?(Y$LE%*40*"ZK2?,^Q#TA"S?\S71#V0U3V*\V<D2&][W1L36
M\]\WK)R=GV%)3%3V"-<:&@-^.JLD)W:0-BLM%.M/?'NF]N:Q#EM*-6:.05);
MR<T$$@Y>*W=<.1W6Q+-BXX?KN;'S6K/K$#KT]GG/_)JW^*R;K*409]V/D N>
M_01_-UBVQY;IL#AZYJQF'[ :?O<2)@/GMP)-U<O)K^A,=4S)[LI&'&F=L?SP
MLDH<VC/ *,")-4GGN-?7/&1='GVZJTN==&]?B>UQJ<,65[3&:,-(UK__UU55
M;2Y*A\$YQ>@%[=G"\/7*JL096EJUF)ILQ5WPO0.S][*.%LO,TMOSR_5Y/]>?
MWOT*:U!>BK'^ &O74W42LP9)EQ9[>Z;H.<E?DFIJAIS-)9,,LOB04.X&;8]:
M.M<3\=T7I/ZE";<7??2F*6F#>XFKK,Q*X;V?%-15VDNRLLQ)K"E9\^][>?_C
M!#-4^BRN$0=X(UW_J6VE=G=C779T^:M'YI5^V'TJ^UT:7;KTAHR@YJ;VEO#Y
MV^P,#Q,X0OS=?0MJII_4/R(YD_ ^?Q6^L*' [@4M4M@!A>Q8]M'H!UZ>Q3L%
MG#T^=;Q;=40WF+1^_V6FA1./[)K5#NA#7:,H?CQW_ILWN_28]AQ5)]?^FA:3
MD5%R2S6.G!7NF;:.F1E<B[-+,LPRDW@UO.U.S_J1%1Y-M.E%H_6L^V^C&H3)
M:N:AG3B=C*[YVQ9WM2M&YG;"7FG(;6]\*7OM>)_2W/[\GIO3H^$6O.F1LU\Q
M>GLW-:?N!:EY:H$>_.?;5#'_I2MB;%QCP;9[G5%PZ5L?CJH-M8"/"1^VG_%$
M/>'+N_[[/_C_\.: !ZQ#$K6?59G%>J!U=-"3YV?V5\2&!5%,V,"#"/]-^[I9
MN+:F#<V?F::%FJ$1/2W>#9X![4H_.\DBU_VHV+Z\YQ6F8PYGV<DMFC*.5)'[
M_&]C!0;DB)Q/8%2XN=$"^.UU+31FJ'6/U6R1V8I)PQ$R584#U(FVJBUEF\\_
M4/&VE?%Y) D-KM?@YZO1A2]$+=VW*T&F#S:FF3C/A55GVA*(]:+9X$#,0__"
MOO0S@SG,Y\ EO. [%CF^$>/$6O>HH>K#V.."RZP9&@,61"<+#M!-?9V# U"M
M-%Q#1G" -*S9Z%?P+ZFQ@\D4R[7=$&TM ULKD.VF4?'9;-C;T@MYS?G<UX'M
M"PW(!E>1"_VPAQ6B^U4A^+?_YK^:/MI>!QR %B-8L"A[T^_ 6H-I]Q,]09)0
M4P*Y1G]&=%KOL%M<C:T+R'7>M@]"Y"!\=WDCX*&<_,S]B8M2]N"'K6%OO4@*
M:#G90[MH))OV*3/?HJKM\J) ?U_)M/'PR@ L90[ITC8.8'.E^>LL>"=X="'+
MH(I,_LS?N^*  #V I9:3WCC89;,Z>GC4<+%LLW]CS#O>J,K V?GC\<#7]-+I
M"1 M]W\\;=1WIT]]E1R_7.R4;D)%DRJ$.*GHW&ZM(1IH8#*H8[@Z+.I4ZF1)
M=?9NU2T;P^S%I]HW "'W>&214CC SOS'3+\6AI9J[;6 ['@0C2[C?[[-:D#@
M<2BXBY7#<P=KY]%AA;.<.L2!55:KW*5-F9#[W!<-H<6#DKRHI)#_IY;W/RW0
M\#\B%?^_[[CPT3XT_X28$9@0N];3LW&E,5,&,,6S.*IZ+HXXZNM6>@:!0('%
M., ]ETCPYIN93I2X)I:W,+J_X]%'3 8V+P!S3H(#C&1,;1\TQ\,XYRZSHRX.
M%-&=<'5I$-TH6>&=X+>IS^7E" 1/[[27][ ^G@HT* IJU'0GRJKI1I-3^U,>
MS)UC=J0F4R3$B\UH18V_ZOXI>O9_ZP;^"_H^=ASJ$/6-VQ\F5J>:U8^2*; 7
M(,HV]7C?J=%\6O;1+^M3J=C=9I'O;>CX52:&$1%'U_1;H>N*1_&CNE&UQ;[(
M'L:*$!EUAYD"EY8DH=BO<W?ZU0,;=8QP@($UMM,)<);GM9GXXJKAT(K5SO:C
MO&;RO_XS(.6C,SST_O!-E6/Z5)D])>;"I/7#MIX"Y^6TF=CL.NK@HQBIZHK+
M/.>S:N<!DA$:9M:F,;<]<T$3$W4?-^Z^7LB3R6J?Q#$UZNED8^U":+E4.>S,
MGQ]:Z-3![2N_-:Q4V5W@<36W+'11\\%4K'V$+FW+S4G4HQOQF.LE@Z%_B*38
MT>T@.E0\5F6O^-KK;XY!S_X17YZ=);>V227+*(V6"=+P?^F-.7)A="2\_3E4
MQY2WVX\_D4*V1M&[E7J.<I"^S\97L%^ZS'&V02+=?<G8I.E3Y.?:QW)WK:#F
MDZWD#+Y<OG'*^WLVRBY:WFPB,BQ^G)*;[OZSX+!@YH[DTH$2!Q^*GUP\GEHO
MDEI;A;C(LC_OF*KJ7F=]&7JD>Y9NS/H!1&/P>)9&2[<^2(.?3;EYFF>=77W!
MWUGN)I;K WH\]83:V\#V-D)E_5 P:C=0R $=)T$J0C:BJ+(36N^!3N*KGSF1
M"5+K2;:_&\T<_$HYB)-77O,'!9#H.(<8K:D+@Z>;,H[,4HUR6BI/1*M 1]SI
MW;*!!*9T&/9YY#592_P:#H!Q;[$=KJ3EC_/UD!GJ/V= P703YDWM? +2MH>&
M=#T&37['@&M6+BFJCMKB7TVY!!+"G8!Z:9=JFQL>R)?#"LXCE4-00L[% (-*
M)0YU*C4F9Z57PTJN_OI>29W"O])!K>[M$QO+-&G#Y*R.6MM79 7'B4Y<[?*'
MJQ[CB8VL2T*FA;!PSZ_M^@O:21.WI\DW^(I_-M<F&+.X^I4M<Z""O\#%CGGT
MP[<,B-W8S"V4G@/-W4PJL\LK?3E?-TR)E8XN?Y%:H%E+TG45OH<DB(&LZQWN
MT$$L@TFYZO9-T/D;Q"Q"B\JSSW]?;!<S_+8Z[-\UT'&QS]UA?**E<+MP+%/G
MG4,94<G9?O$1^]7,5:M:P(Z*DW/>:XM4[Q:)YWQ0+R"A@QF]O9@YR8HJ9PQ=
MVJ\%M!+/KXAJAG/1O.F\_ !1W>28S$K/L1WE27Y1=;EW%8EIM-P=-D-<IURP
MG*W9%=3W0 .OH$##+7TE:R&"V!X>P+6K"E!AR]0LK"J>%FWIEZ_)NV/5PT$P
M<7;*.L")B?H=2+M**M+KG6YSYMA4Q;].I,^C%<89$U* ?%#VK7)D[93#&5/&
M]V+V6VU]_?LN%R>2I]G5 _1ZP/?PIDY&7XUE/@F8Z*>^PKVBARY<3B3E21J$
MBBP>>QHX0)A>+@X 7<[' <!XF_E4I([JZ9E%M4VMK/QI=-@V459RRE7XJ*EO
M20W%ZZ"M[X;12.Z^A)Z=1^Q!/M]XS,1-4!M'CH0=5HFL8AK<?$/UXK5YQ9*%
M[AZS?6F6"4%V^)]S;CK6H\["[%>OI2K?%6486B<,,^J3N#]CI@ ,T"KU!A-/
MM>&MU\[R#/;-PD11&E&TNL+VX;R@D*E^(K9?'70*^B4K5*!2H5!&+!JWS:H0
MOTX2<)^@E+7SVF$-RY6JKO0\Z41FR](*V=^,3(5B93*#Y1ZW*-97^!J8A2K
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M/"I((--3WB9U[M]YXLC!7 [X<1FJ7E1/E>0\E,W]CXT6FU>A%_=%<RZ/(G"
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M8D\U;[K5H.9E\47BT;=T8#$!\YIM=IL7\I0\DN!530"IB%J+Q'$YJ/[PB'H
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MQ+OPUR2_YP*(F+3M#5V,]3G/8F;ROIWFKRZQ5FJS^7Q-:W=QX%U9'D=ZX^B
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MOZZMVN. _2*964MQQ%)UX"J\P=+J6[7^S,.:FM="WP5XR8H-\%CBCT7RTC!
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M>\.5@)BF962H.4XJUU@J.\)TU,8J<#(AB^7!'RL TV_3$ZT<=5\>\FV2!:0
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M'A8GA;-.'HE=@A_+1EA<D>U8^0%1;-,0]@,D&VUS!6 _4,0%APY7@ R&ABO
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MP5OR6[^OED3 G;L,86LY/O5I/^K4"-%"DCHS$%]F*SY>VZ"C"'G&1R?LB(B
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M3B]),>@NTV4X*C#)?1QB&OO0)^YGD7XUT;%4RI-Y1-4;]*AVTYA+DAV!E8:
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M>E\\B/#ME(XV]_D^0P_4TW'DA Q'3N2:3JKR[V<^".-4K.N1\OM_<U7_OZP
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M7%+^-+AT,X1Q!K0@"5&-UIFQRBW ;<F%C9M"4X-07'UQV"FS:!#71PNJK8.
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M?Y;T6LX71E"*=B7JUF?HX]!!W=+:F"O #6&.M8-;S5I-+8UC)0:KYYN0A.D
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MC>H;^@%J@^7S=3CPG0CZW3@SL10/MIE6!:F,;=G=V"*%$+8A):5-WVI\X/I
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MZA;X%><7$#7JC2M285<D^>;ATFZ?Z?K7=.CBO:=QKM+/OAFGF)$$&.K<O#.
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M%Z])C,?;7%_I>L@ZWGB#V.T.P#T67SR/%YBR52(#^;XX)W'>!52P5#I<H6C
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ML;6KVQ I4!Q: ZF0_QI!:X;6:$X\9B)?!N%A*ZUIO^C:?65T6P[!A6*>?OB
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M^;-_V9!A:J%O;0M:%D(WQ>XM%<+NSLM0"]0@=U^NO7J SY#)G7YENHZ_4?C
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M1N?!%UJY!)]<@QOI[VW^_X&T]6:4$'=.!>Y40\7$[7!7.I3E&4UDEJ(*FLP
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MY6?E=5:%D%FR[W$,^5#SQKEX@"26_P=49J=\1EMAE+UA*%M/S)'\U0 _OVC
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MC^(G+VHL^#^O7H[PR0M74KA:MZ:!1J2.]R#-CJNH?'/I71[Q(_H3HT[5B9?
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M/:)/M"!\SR4)D[5O^ZDRS-,]ZQRMVNIM^/UFP5 3)19.,VJEJ.C[<>KTB[#
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M9!&.B6X\-R'RN*X]@GYO_Q:]]DO>^,X!]L<ZV^]Y[NAX>,AJ"Y00.5%GN\B
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M+'ZO*L>_\O$2X)#.</3EB_31&HT#:<#^6HO9(ISDYBYTJ6/D]5#X7L@^+/P
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M4+'=E%E@@H8-GQ,NGZ'V]&SW:UOLMB8+DEE&[85E6;E?R;\9,HD5;3V]8 U
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MS%T3Q^H]<%_A-NZ3MFW-9>9>9F/?F6^S8K;/,O3*]^=_&OOJ&<B-6K+XR*?
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M8*?0K U]G1P,L/+B55U@MN0'=A##!,<[5\NW=F>$WY303%EBS1?*ZB7^7%<
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MU.Q<R FBV"/%9,_1:KITM.JCR2ZRP#7(K3\ZQDU<6XFHL-W]6MSS'&*;@%>
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ME8=W+&[]YN)<U#PU2L=MUI5W*[V@$'GZ8!7A>1JTZGSK%-&DK*2N])O(H2N
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MLK_5DY4V(D"M'1@<LA,O\<7;XR[#I;G58CF\I !?T^!EILZ<_/B#G*QRJ?<
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M!CM4KHDY7X6=\UJOP>ZJL-6&'X=EBS@UA49[8)=B\KQ(#OAQ\I,55P"#L2N
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M<J\Z@P^'V<>O "W1U.C<\@.];\*1Z=61SJ#-\YK=UI*APGEPFK.XZ0X-?CG
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M2#V]$%?T)!;YN/->!XZ2IK=HIGK>1A6ET\$]8JYT9SR^:63!F/8Z&/<$HC>
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M8-;3C?,/2<%BL([6!SXH]@.V_+C+L!.[:KO+O:G:G:G(6:&[ES/.>T9J2U>
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M2,,8/PG7*\"=VI,0K*)W]XD*#T[_+.WTVO*8FCSTT3NK;(Y84,'V7@%VYJ\
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M?V8VE+;.QJAY;U0AF#P]VOJ&%K8?A\,Q/\-HP>WW(#&\*>B<E2E?$-'FA4F
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MSKC'YV^LBTJ',N&=W*\]B&B6@KQ\A\0F\?>F//^0KW.DD/N6ZYB#S&43_.B
MR)=9Q'W+;UEY/:RG(7F8/90>>\ETNBNV ;4;?C9L,O(XPU#LHXZ!]7,8+D .
M?Q:>3BMS;FS]>H'$!<CBP4;S+,\OY#_LR+NYN@5KNEGQFD<&I#K>=".__480
MRH^\C0[%5!JG/@$+LQ]#02CKULL#8@6WIMN'MHM5TO9OEVV>;WBR!Q)H*SS>
MBOHR:MLKG\6OEU42;W-FQQN,MEUQ1*L\R['U/A]SH#W+ISO2$24]V?4[/XC8
M+Z:7[YC*($M+]XI#R*W$WINUSW\1J357$&Y$21K'>CXAQEB]4GY@((2@V,0R
MU5#:U0S)Q"7*?CS ;L=H'!^82RW84]@ *4^DM+F2#?E.&)-U+3\I6^-)ST[H
M+4$ VV9BZ>C8]HD$0OY[Z%%@IA8$XRRZ,HGJ^+ E;S<?^LB9,FDY.5_S/P$,
MI8.^AMF>27>&#^)MJ3TD7U#'$=1G^E6(GI4\Q75()Q[=R%L2\%I!78+3-0!>
M?F&0[ EOI860"GV34E1K2"I-/3/N\_2<!!-;!L'7GW8\8' 9EDCB'L\_4.D'
MOA@WJUN6XFQS'S*QFS"WCC"8C%[[M5:>[OM]V-/>4(,,_1&NIW?G-*QB6YPW
M* 1O4E#H-P;W7^)<_I2;_<*!<88!\L8ZPRKEPY&-\,WI=_FV);:#"Y-J&T9]
M=Z)/D[KP8S[CC3(4EJ%3E)"C@KW%<U>I#]\4^-;XQB&008;F=T&K&9O7@)/^
M:\"QI0$GJA<KPZ!QY0&^PM>)HH1P/RD8X_?/SWNU?<J0')^65]I3%9GE_/1F
MD$T7QWXGX/>.27(ARK&UWJ'M><*L6853ORV=U8#SI[[G(*VX S.]/!-T4&>R
MN/5GUQ:VRBJ%)QGMO%;A_!N#'UI8FIN:0*IHJ:5(":>:H?X"M=C4>?TH_QN$
M\'6[63;2L'Z]0BV?R/57P_Z/T :ZZ;)GE),-3 (S[$3Y6/P[>*C[#6Y6;B2Y
MU.RL0;^IUS*YT&(_NBWXX*%]U6=:A58U'OSQ'BV<'$!U#<=2+?339=N^,Q;&
M!O>WND^-/TC^(.V#J'\D>"]2RBW++SG(9*?^1+-P])2'"\J/SD'=]J._!OP\
MMNWSZ'!Q$61JSWW+D]DG,^!S\S'BY0HMYUN'?RV/FD(]=]J:F5RHL=]A-L##
M5K*WSB=X^2L1&P2=4!+Z0$:_E]S7@.00JA:<.1Q=&' OD7Y^NCV^58 .]'*P
M2/R@ZHE."MAOCTVIH>/,')O[-Z@KT=7[*[=!9B&'PZ8T_R!&*?_R"5;L+;.%
M8[+,0>51K'>L,2H_%"/FG>Q=G77J-?^8)S^!?4V9E:DH;I3A"$+NRU$_#%JV
M7U*="4G#6R=V?Z^"PX"2DY:<DT?[&@2(1H-E>RBUV=3<?#O%-K%>=2+TQI1A
MS*[[91O[*#!/=#@J8V0P=9GSEBT?&&];:<XJ^JU<TFLZH*;MF%D;5F9\X:0;
M]*7X'[4N_V]*!_]W:W']+;,TT?>?=6=[,";8*GDN[G$]_JC&>R9Y:*+)U][
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M)@@E'5)KQ#N8^,>,OT75Q>;^.17$4P ;!#KG%<$-K2*&3^,6SCU:XUC[NVO
M,N]Z#R^PN'WS8O62?<C_X38+^809LXY<L\&HZFYMM,.J#,]*Z(-$DJ@;!Q"[
M13[^'Q4-(=OS<DR#M:Y6HJQ!<9I#Q@J217#)]35^RYW2)^="4CP#5U1%IL\3
M>!(&GP3%CI<:\"&7%5*63F/ZO,B2,'B"P.]E/QJW>(5CW]Q#O?Q3Z?3_/Q>2
MB'?.GVJ303AG,;>V>?@]_X_+%T%]F5/,/Q]W*O5[WZT.SYVJ;RI+M<+C%_Y:
M.J0$5P\,-]!R_RE'N$;-"Y% ZRS-5RV'6R8^'T]S9JT:[?UD<!4P%FN6[AUG
M+F=3+Q03D">7;XOR<GHAD?Z+91=>)Y0E[S):L.ZNG</@\\'*\YNNN$"(&Y^\
M.@NQN\T *);.'.,9<2X_E^ON\:8/_B"\FW.\.0&=VR'-9->A?N\^,"#IEN^$
M\=)$_51WE/^A8I[O Z1;=8./=&E!V_JT8>VK'(O#;@$SO^=THF?TRTW;M0)!
MVY&+=!%^Z[6)L E1[',#GU?C"2[6^BQ$S\;JH^-%U\.7DZA7W'BZVM@"M@GW
M>3?,P[&4D6W2;(:/!A]$(VWORV!('M<IUK#&6IHK&"1AG(FO@O(2HI>WRA$.
M^:#A#'HA"6)*_*V:2>3%Q0)NEG]A@>#BX= U8/-^LQ*T]-CQ_,86#F_N ;&!
MO"_5N]IN-3QN9@-W!93@ BKI-N\ZPX7/,BTFC %QY83-;K8H:L,\2K?N;"+]
M+HT+KEVQG%?^W;A0GN>6R8<+Y4]-<6#-#XZ-M%O%_I?-K>!V\<)KP"UO(/=$
M->;NGY". P>F(SA/*_0GI..!5\F+P1.N?W9?72?0]&W!6!YA:0%[3C6DL9'"
M9#)6BY2^2^9(!/0)B.0YWVZ*7?E%ED9DO?9P,6Y?$H826DG4U/^$4C]AV/51
M_.2KNNA(9/,X-RW[&F SD+6?>_DL=Q^[*"%.NI$P7P]#&V7BGO4[ JN" ]WM
M!OV)VJ[WYV:8G'4B*I0N%#3"L81IG!&FAF8BVB71MH])2#45!N0]01$Y0Y:H
M6[^15PA(/@@![-I9VRCR;>-DJ8J6U^7FDB(L-M.C3I.(_7S1MI4I6A/DXB72
M\]J-(&J%Q_F$[H(2-U3=6(;4/8Q.[DN(EX %._:2^B38(LSLT-KL[CP?D-T.
M=DB+BP1EA^!-A:I&RB74LCF-X=9PT.G'EPE?G"^KZ-E1B_Y""46X3C8[PS9T
M_Y%:.P8&<D-H%I0A#6]Z8TO"L=1#(C;"N-=(>I&ZGWR*G)Z!.SHRP*GLJ,D5
M -0(])E2J"%2/Q^_]BX5GS,C^9GI#8OSQ=C.>I4\W-AWD?[9TK8%'5.:D+M[
M2-ER+ \=ROMHM%0_;#-ZB<E^%<:R*H(F0MF=Q@: 41NXL9M0 B=,.#@&9+ZC
M11><]/RC"-A<WZ#'_X\)(/Z80# <&V77>[=!W!E") [Y:]VON;0O ^Y;. 8T
MD0OIM]\4CU+L-*-$6_>!R)Y-52*8[89Z<N^4,2S=P3[X:!S;%]L:BX]N=B2P
M)W6OWG'&[U[KIQ<5[1(C&+7<ZO>IB?:EM%IAEM)6.!3 (7FMC[2B)_K,HUA(
MIK\OBB"X*I;$),Q-52':>/\E[)GC\0=(J+G=?/J*Z.&OY%(Q;<B3R0L">51L
M",;ZW7CX(ZLUM8HIDT]T@;<52$G$X-3Y2P<D6_ZT%3ZF_ N]ADP-#<P#\)^<
M@_<(T/$:/39[C,4YU%9B)/<(I:NVY_'0I2Z.;BS?EB42A(J7V!O!33A.\_Z,
M92-N849LR-;GQVCYXP23';.-ZG]EBO^S1O=_O_HO;Q_&J[C7I9A9C"[2Y_U;
MO#8Q^NX+:V"&MY67=8SK1B4*;]9!6JWK7ND,Z^M8*#W&'L:OY5:UE[6ZP6]_
M=W_/SP^TU),&"G9C_C [:WS^N/6.YF$Y8]AQR\-?)W>%CY0;+J56%;B?SXIU
ML8^2C]>3$J+SG@6^AQ)<<$37*MU^^=[/3]Z;8]S=8,_1^9$68@V#+#__U+4M
MP;!;&EDL6ZQC=B#7W[9V_%B7,H]7S?'*7\$CV%C'CYI1M_M+>J<)9DWBPUEI
M/1>4Y>-&0E*IRQ:WW-1OV;.?43UAII,\!=T<BS?,^$KM"'3'^:%/W+NN 0^7
M JF<8-^IMZ2?C@YD+)V3$QY]T(AO/+Q!X(RIQ<A[E<7F5Q<7&T]QP[\N/#[6
MPM$HH6VK0<W/15U(E[2R/"6+I2N1<E#("7G>SG@-_\R;N0I9'^Y%2!MTR:S;
M#%A@6!62XVQS9?'EA]]S28831Z)M\VE_8$T<;/R%9*IT\0**#A3]J"?-3LC@
M9+(D^5=4GJP9+$>X. P=>PU@208>P ZI9R;(44"LU"/0 GB5-_;6GR-'3$D5
MGUT#7"&]1XJD%OFF=AZ@=[\B^U-N5>\3MYQQZ$UA^,J,_:Z$+3O!'J$XHU N
M);T![NJ!G71< _*\D[Q%2]YOCJXIOT+]I'>05&/Q$LY $,<8[G%2O#@@*?"T
M>J $54="(D#5V?;V%<4^=(@>00YS<V@!IBEUA>\FXY6P,3J'V./FP:.<@X)M
MTD'7BS>-&^K-*6JCK(V?EY9?.V]+!.W*ZZQV#M?KVR1NKWT-ICF@14./%&N&
MU&+DDX7B[JTZT6L4/-M&QA81#4P(V1R;\JO"3?ND7XU<]GF3'FT9"?7X/J_Q
M<B5<,YT,<;-F_BE#C^G"[+R79!<OCZJVEN;/+1Q,7*I7A-@Q5)T6<OLTI'+@
MQY.53]<=,]\2ANLTC;RCF)I5IL2+IT+ZYV05SU-ECL^TN\>;!A^>D1'?"'XC
M*GF\T:2\?#FC>D"F^B"MX(5FU+9G7("8XQ;:8-#4Y9+?E.]06BY9'3(N=K4S
M@QC?R+5A:-WQUC8-GES<C5-\WD*R,I,V6J:Z=%+R93-^8#% ,O<[>P$>/>;H
MW,#8'!3VV4)?*P8^\7I;/8]PP*>2ZE]I,5XU[:K1%QU5M;XEFOL\I'./-([Q
MCJ'*4#:47TL=2GZ'WSV'\/P:\!8 UK0?[+7TGMB-91>'\#.FX)!PH-:P0,RW
M8J-YDF7N&^\]S#[[OYBH*KZMV2.#_Y9\OI$U$,!!GJG8Y+WQV?$:4"DI]K[/
MA8.]&UQT?/78E#Y#(D_+F\F+V5Y%%V*JEFJEQ.;UUJ$\.]ERD^!AH\+%U@%T
MGS\=,*(T\'PO8;A)HO,B=+)1@L-N,G[ML]S=H)C2$SHZC'V/\X6>5>(>K<AH
M^F'5!H/J#YC7O*]H[3IV\AI0?A_[_1J@<F#?VWC+R0+%&BNI1OQ0^JOCEEF.
MB>%G!]/FC;Q$C6]$*>\F=BZ"7;!/1D,@2UN)P@_KKGINQ(0> '\\1<>9WO**
MC15ZZE%*+,0*MWG\>^#5(F031!1%+6!KR!^I\[('5M[673H?N7$- *SQ#C:S
MV+'M?7#=<,P4/M+T+ES$*@(S/B:G,=68L32-R; YS.D97"[,8P*H$*1VYE/B
M:U4X0*//^!:RGTFZ-H&$6I-3FR7F,$^L^\[?^]@Z$:QL UD]EDJ.X(*F2_>A
MH!3@KNX"\(1[WD_D?&GA=.0W"8TG%$IWUUE7?2B5ES7.Z85(+_;'-EGP<:'H
M#>AB\T_.:V"5EU9;I]8A)C:NS<(BO&. \L/TWK97QWQ<P>2/RV+NY9<K+FPS
M$*@*1'[BP%4B]LG<V0M_#+_Z^#4 [\"LJZ<LF%F.EX1,089ZS?_)8,[0"57\
ME/N,R<V>IKA03:DZ M1I"1)=NPS\55 CW+%V]#O/**KZ<FC+VS_+L7!*T</N
M,MMY(9#4R6][S&NA;4YY^-1/;.;L(^?73QLA= /2.><&V09)X3F[=J*N4K,T
MG#M4>NI-?K(17"7W?OXO5-'_G[KP?A?/V_^Y)OK]X8AC:1^V:T *1&#T/R_Q
M_?^NHNF8+(<\VPG:L_BPTD79??B@MW?"X+WU3Y,;&*_ES4;V[Y7;>M"-'J/.
M-K$/NXK?$=L$WD<+P6;D*0:CQAW>M;9:5M8U3RA>_K)^*+<3E EN.BZSLT>A
M*.%O' PT@S1&.ITF*(H(LW1: Y5ZF;"YQ]3[^LWLR(SH7/WJ^O58*K("I2%'
M]M: 0;_M3=N16)ZY=&>[DO/,7LL!K 2X#^]?PJ,>$%+PZO,AV$[HB=#Z-8!!
MR$]$#]N.'1CE$Y"$@<!3ZX;"&[V=[@E1BUB]:31ENS<S-+ RTC[:7CUBB6UZ
M2-DUHF45*2.6K7S)(:KLXR5Q#3!B[J?2,MEX91#F:S*\-MAH8+&L2GLXOQCR
M0'$N3?(UEAT8!W4L<X$;$:)H/PN4)%**YV?<OJWQM?$3 8SW&G"SE+LW64$O
M"W$[>?U'9-'O,IMJ[XS:^[Q?@X*E=,]TCL6 P?HH]1I@J*^07Q%H/@0T%WN@
MY*EU'H=^UWBY6-9\:&3FZ?UQ;:^[]K,(,HOUR:5%F"A<7PB"@ICZ-*GTMB5_
M[EY;MM66C'_[@=Q)8G&##LNF6X@]2@PU/I.\ NL@;D<7VC%07P/"Z1RK(]8L
MT^3&,LXY8V4-0 <19PLAF:PX;!?DH-K%L#URQ>*\L':9CS)QV8&H5.5ZJDSW
MMD0N=0<FQ<_E9+1&I3AYB(Q2P@<-DGR?C>8CH;%ESXCW>E+XQP?N+%EINXLT
M>P&1K'9K K:T'T($(W-$%Z#K/E7M**.97F?)2*;';%[,,3<+Z#FPU$LLI#4)
M< C5N_&R[/[*)WYY$R..Y +F5B>7/QH<HUC8L+W(>MN?W9$9,A%D$B^D41AE
M+31$I0:9T[:B@/3UT+X?F?$B,N2UV%3L%W]#$))="^A^S[3?^K*GB)DFW]K'
M@SHXN&-U-<QAV=8DID&7 BQC+HTV4*]%1Z-N&O=KIGQZ7%>GJ2Z,%QSE 9?9
M^60_Y>L_+/"I*H?^]<*[U^Z93MY8NGY/4/ S,.TVV9SJ4DC#"Y)BL9I&LK>'
M"A_;I#0V].1]2N?;WP!A=-.;%W:B*R$<$1RZT50\V5&W\+[C_<PW"+P&M#Y%
M66+]A1PQC-!K %,.EAP2"3Q"%8,7Y\#H-8T*\[[(TT.L@C<\"L/GL PC[;>^
M+S =ISK=.P?<V70.PK(:I&-H)AZ&:C4A3WH%%72><9V?,ZO3^U7<<\9VERR@
M%?P?@1&=.$09Y/9'^,OR=^8M5$C<B@-(KWG$T%+Y53^O2?L&2>YCT3<:\\5:
M*O?X<CBY57+?9@_M>H_GLT1GFVUK?ZP>K/R*1>$%H-.)D%# YD?/@\X4HTSH
M)?J^8Z5)T-!<^#1D'^EY;&)0A-'DA]T3<J%_[4PFX2<YBMA*0SD2;68*P4;6
MZY"]\P^@W]:Z' Y>L-8"#HFCD&T0;VX!YX;)$KFK5;VR&ND4/5W-(H"F((#I
MAJH9CM01(CIBS]%C,.0'&.9C[#]?A:4;_$1@IO><?@M&YLM)$"$I(3P9,,KW
MI?O]HF][C(I/T A+;9G<8C*,8]!L\ZE2'QO0IH8 K9LN>O&V\"+A%0@9A7EU
M#8!$&U\#;N]< ^"\BDL' 1B=[^@_DA]:(R_U&]X:6HF0"S\)9;K-<10[4-8M
MT_%+VE:\2(7/0\K%\ \7S\*!]6'PYL-&Q<6YM:J0AB)34P03#6HR_E#IMY["
MR;;]3!7D_,8V\&2/$QMHOUIU)%DS [-F1(W,/-.*?6;$\M D(2I6"64>764.
MM(M<VKM)2_-$N4I/@64%V+Y1<:\6HU&3@Z9LH<DDJ[;->ULW]H NWDE4'KMM
M_?U$:H=SB1;##IEDOY1P/&U>.$:(L#AJC6!3CSM!+/;#/#PJ\\M#M I,"XT)
M#41(6'C4M&*'%$BO/B!SU(OR$\%%A\)YHG44:F36>Z)>7R <P_<##7UY2?/]
M,[5$=JH@R\,3@H7:@W/=D?BHLGY>F0%AXY3C?FW$JY'EYI\9[VH2K0PUUDFS
MJ"VRPM>5TSAL+?'9DVXE,ED35#N!>)#$,%)/Q%+>S,+686.RY<'L<Y%.Q:MG
M<B/;"F*+ZTV,+0L4I9*Z6Q9>#-/;N13D+A6:MY5-#DEU*C<"1D>2)/AMML.#
MWRX\&DN=UY*GCJO%.5.K"%5'^BWQJ"^_C/U2:467(I3Z>K>&0C?,%@S-V)#[
M&<M^?"5"7)$*ZEJ#2RN.!]R[=EN]R0;O]+YO$-\WI34JGSBNK;HK;?&(@M0\
ME=3-8C)6I1[9P1'7A6*7?/%U*I'B<Q03RRP%;\L)D- 3MC1WG)8<*YE@=*^&
M9@7$[ZU,?^$3Z[V/(4;)+K1_A/^P"TNN_^84!=O>D%Z8<[2<*-_3X_%V4=1]
MP6MZV&^8&6XNM8UP1G$N!U1$O'DTKA BS$Q!-; ..!/E1%$?&'WK9DGP1%%P
MO&+*,ON^)]KA"6U!T6(XIL,YO&"6YXJ7$A.@2SYQ(TXV@[,\.E?K7UM&:C'A
M^?(6^3,E-*BH6UJC%PFS$*,&>>KPX:1*V2?%A?J 0CK6&,(R 76T1=96)K?X
M6H/ZMU?*MRJ$)Y<_N(S$2Q&HY\2U[-G\R!UO[R%/*JOF_FL"_, U@.28Z^2
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M3/ ;?$Z."US0*= Q5=FO#MCA0WO8*>F?U%0'$\A_T?A* QVJ!UJ$RN'<P4(
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M/&KZ"-49A98AOI:#QVP'X*N! Q U6-6(;P7XY9S'D"J=:*&LS?WYDP=:OV\
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M3862;#]@/VWMY*<K^UN7BTAYK8(BI[1EK%6P39*J*<>\"1.,D=5\<^=[XA)
M-,82)P@55RP7+WA)D_&AOL6DGM3LVS# 5Y\N^C0'B>?/$-[V2$__$US/Z_LY
M\,)RZE=ZNL.Y)IC-IL1H1Y(ON8O'LE;TFZ/(T4KH_?O=)(QL:P_\FN"&-X#[
M0UCG\EH[^Z+U!D!5ED\AS402K<!G-U!8N&1GNVM$%9KSSIYS.)9+/.4!< 44
M71;?%-R1E#*#!YWA2+Y?M2LA_X-S$]?3D\4$]_/7!V#)@$LP3%O+=(!+PYIW
M([(9R!<YNKF"%RK U- <OZA4[DC93K%V]%)X.[8J1L4;F%>6NBQAT=DP43_J
M*I.@B+5@N:"EZXG5C"V=S]!/('98"<I9;\1U^O0&0/3CVR_%.;U:I@JG.<A#
MR4\'?2M5:*'59$/K)9WYCDF]D-5^YZ-ZVH#S,U"I04JIQYX%&:V-JA,HA')P
M(]7$RL+D69#WMI+?1[M<0(_4K CU6<DA2EN&RB5M3+<A2E.K+UE8?6'JXM-Y
M'R9N! 7K=$0E*%R)Q/;7A1P&2?T6%*4SQ?AR)-0@W1J7/4W+D1+A P_<<F><
MY$Y[E^LNZ?2>+G)FUFTD"&R63V_=+^K)[D@:Z#[/?O9=+')Z3W6TWM"[B[*L
M&E8;[".,T8T*3\[\^M:_=_B=,&T.0N**I."G9.1E8&P),E%/KO_$%J=G&PK^
MYL'N0/**:'TR-&_&\*+B3KQ\REU<YZB6?.H;0(IZ'LR39SRNE-1E!/W\AT=H
MTP271=T^_;[:?CLNIEIFW^?5TOV5^BO;I+1('8:2G'5>+U,6O$B@4EK*9,)9
M?I?J)6![\1P!0<X4%PRL[FNHU)77_;85+_R=31;]BN( Y#WN6J2B?#7(+Z6F
M.*\,^KZ@:_2J0%?*W?9J^3M.YAEHLFE696P3%5RT:+@C--:9/]M7(6:98NXK
M"GW@ST(-UUHR%%,?;1([XU2A8Y;;<.!T+_8)QBMG*+3N&!<'E:'TP7433?R2
M(S8B\Q*95%'JCI$YSMTB%#UE'QZ'6TEX/1'K8YY,5;P4"CQM?6#SEBDR_RR"
MIOTX*UU$->/TG/R<MG!U4/V":<Q%0M*8WE!&.4)POXX"0'BZEN:X'7GJW4G+
M7XDD2-9E$*S=$?D\O-!CF'_I6BANO!R%DG_^_N'@VH(^CR5U>@(+!1YUI'_T
MML*^LG-@;-[U=W^N3MWGRT]$52I=:7,^U9R)2=664Y=Y'GC!K7)>9#0HUTT8
M";7,7HV17SBG@90L%NK"090["W1URJ"?;B^$.^:?XD;O.';ZOB(_86Z^O;!"
M5>RQ^44ZAHV45S3E"YOFYI54;A_$_8"Q!$AY ^A-+L1Z<:[K1.WK=QYPS)MY
M54P]9*\CBXZ8/[UC"*]3W:;EV:B="Z?@AQ_EU41GR;DLSW6G/ZWB96X!Q=?@
MV.B/7ZG*^FLF%5DOP=B_BB0?WM5K!=JM^K>[*87A*!C)/O5=K8.FM]U"@57U
MAHK5K44I-')2-.+SDYCSRU $&D%CFJFP$T\==I6V&/]\O)A[=)V])Z<P^<@W
M\0(Q0F#96W'?UAYZ/;1)1>Y7N=,2M?"R,C^M>":1^&AX30YMM7#G^X$X65X3
M5/<+[VT5#[ Y7089WWGV\/C')HN^W\=7G-I7*LB\YKL)#IO63Q)X._&RZ+AC
M>K;PQNJW#;E1MK6]8S:B@^N#JY\4,V]IKN;_NO_4CRY0'6%[#QO0T%)\K)S4
ML7=ZM[][11TO-#.7Y<P9-TBS6RL<B4_.&,JV23)6CQV4S1S*-0O+.IX_>-F[
M^867+_*>9+,$>]/A2ONL>6[=U0#'$N9VPR&IRAGF\?@Z=/EGY2=?7IYKZP_U
MWXRU#>@X8K8B98[U)\5-2R13E_L6QE3]KUV7F!2]UYSP,JC3\F?:4+IYB?Z*
MA<82PQJL[+=$3MJQ+@5E8X<K^2C2$F&>!+92F:/V_\2W^ FX:AA(G!R^'AE/
MRE989K7KW%<]U?1JF5-R5;6NSDY*OBDB2YX.U&@Z!K<ZC Q.[RQ!V6$#DBW=
MZ:3JIIXD3W7088=HDM++^S@*.6?F%\$[/*A)]TZ'"Y)W6 )5 1%U2A 0NPCC
M62^VCQ?6>9 /BA0HY5.,[8N_W+%<2VZ0H0FGL\<[.33<"%Q2E !JA+_5GRT\
M(",72GRI_9XG!6B+D-_=US$B#*5:$0K)-4F09\;WY>,"]3?3I^I6[7V!DA@,
MUZ\@C7:^HH8-*D;@U[R7.SIO_$ML-HCE3E9;K7=,4<9VG#]LYO6.%,>&$W/L
M\"*[B/WJR<#M/QC0LDC"7QE53DI/&/+,=T##7B=)[)J.;B&%&NK@Z/5+]Y!#
M-$G!_-9,8_,:&^W5^P?R+!EX:<!6)>T2OP?CX@I?SKMF(CKX_9UT9U.+[PFW
M;3)(-EG,34+"2T<A8934MF']N_<_OKPH9W ]70+GCHCHLG%.+1/4/JD0;]C!
M8JKEEEPK9P>O<SVM3MN8)ZLTPQ2[T*^R=9*8C!**O[2S8,@LXUCYBM=1;N;2
MJ 19Y-2/GI-_\D5[_<'T$Q5B-IJ0* &^\ZR<<W;:O13M'JYB#W]MY NL%P]:
MLWP6$E?7I!$9C$<H"E1R\HOC]>$<FR>8MW8?,Z15RBC O5SZ M&#= Q8FB+F
MSO'Q4CG;'TQMXM_%VU%=L:G/<O[H4_[[[9>DC;1:<1BX%HXFL>(G<)D)BG"F
MDC[>/)?^3'OE=;:$G4''X049(Q:)Y&.1B'8#UR-]:<_E09G[P;UV<YN_/W^%
MW+Y5YK[LC@Z+@<#'L+B&0WD@*=G!D=5I7-[6$!D<QOA[-:B_@T2RT+V+]:X;
M=%7XP+F-;GE(G/96ZR1HM$FQQ$">[\@D,.BA*P[CNW>Q;>0G!54_DH)_[LLH
M9N#HRRPHI&OA9\/*F9L?Q_H-,M%T9^]3.4T=;V.HYZRR]VEI)PY,ZC3JGL,^
MS;GT?[Z$:L/]JP=5-;ZLP,&5\1R-,E/'Y&?9Z:K*BRHB=QN\V UEF:P>%Q8T
M=K4AC4.S$),I%;;']AM,=BM[7:XL4V9^IKL&$^E?3AT>R22DL4R\^ ;Z55/P
M44.R9UUC[!-(3]F2.1/IH%C5 'A%^*Y @CS0@@8RTX;F&+%./G/4GH])J(IM
MZ3T>@ 77-L@)&5%-E*F;K9O$?9J?0G?B')-5+RV2";;BUM2&T(^7UL6];'-,
ML<>I%7^$$1B'IZB&<T&_^J9"5I=!7H6+K$ZJ:Y0!UUG6^J$]TU6KE5P^6ECD
M9S2+:07_@<_3=<@[4<%-/.;.'NBJ>PRA?B?!EDN0"--_^:M-<08'NY6HASSP
MS6.6VE#UA;YV+7.<_-^N/1HI::=J82YCWO3FS$7\M1_BX[)VC(1;E2T,/T0I
M$25RWGK*?79"FU]8"@HMSS%Z&"0\HD:\3J8E [BE#\#?CWM=H 5@)0>XD/U$
MJV$?J ZZO%2]OE,H8Z]A&)9":M6RJ9SYY[@1RR+@)<:7 -C3W]4T[VD4U<;X
MI7].H)<H>/K9$_J&'9KA,\V0?T$.#5@ZQ5SM' SJA1<I'D6*=/*1_*EK\-&*
M39 ]M!8WO!C131# NR/Z<__G-MWN*W*\]$.S]%]:AO2[Z@CWL-(3@MWXAK$#
M!.?<J;K*79'5C:6H[F;:IMT5B[XB#R]I "@)O9I&*:X>,+?X_,O'MP8C6UX,
M#=W0@W8M&4623WBEGE4),_"H4[;]DX&@\I%,NU)N7+YS7.@751KA-G&XUFKH
M6BWB0Q[2PA'ZK">;6^.2Q, AL$S<U#SC99),A*E <KQKW)R]DRHC!N%EFF_-
MUCWBM"-:T?3-B[)G^4,:_?.D5$3C[B9QW9#7*L6U=75+>0F*3S]<%5Z6=*Q4
M9[J^(*G(9;N6<FE&O5IP7G]=B"3!?!)UOT;3H=TJ3G>-:3S"5?4Y!A\,FNKB
M?LZ*D[I]BV9-,J_0<%LPZ=FT#>[8B=BUJ8*__FC>6)G1FR"[QB1>'$)N$ZC_
M'/C;P#*1A.0SJ66DP/ T#<&3YXTW@(GXW5H:V5RO-'^:.5$BJ!#RPEVMHY#^
M .\KS[CCK,#/N;_=%U-F$_@5N]5?3/9"&Z[IZD>+&$P(RDSC$+%GU$WD\_QU
MG_RDC:SW+T>#V5UTA^G71,6C'(-_.7$>60&>#V."QK-FH<GL\FS2##E(");D
M+--61'"N'L,.Y'48=OUW9#7@^<XZCQ?N352O7QF'NMI\.@)(-[WQR2X#FIS<
M3N;6/X06TO3.U8S@/&2!AIP#>\M!@5Z<1%?\,?.A7):S\;U++"AKV^#4C-TG
M;G!V26,!Q/W#8U9<QST;< ?E LR3<^%[Z71_;7SP1MW4;5!Y#\4F _6CRU--
MS89(A='Q:F7I!5'J)^'VAZ<0TBF4WM!V*7VT>%\NWITZ%FJGCT_RG3RWDR(=
M@N%)W/JM1#NU]UT2?SG]N*WBN?;.]',[7JZU1V<'7+1I\K(L 11;.$/(K(+S
M21Y'(E+^;#-I>$S<V]'<H\$B['G2Z!)-JR4.OJI2]!C-.4[4.XXWB^QK%]EL
MK,>2D%BQ<#71F=<OOE,NT8?JXO7K4T?O)\5'Z_ &J>-'?Y654C38E .G>A I
MGT/%I8IHDZ>?B&P=J(  7YH?-QTNB\R;%XE<#;*;8>Y6![<SFX,B.<9/%(Z!
M0:)IZ2;F!9SKI]65XB&:RNR9XK3?!;9/UQ:!XD(YNS7NH];::=[2] &2IF6W
M\*YR-/+MY8U[M;B&J3S3 D%A500>OZ)*=,EHLA-%T G,=;Y$>4B'+ADX?>CJ
MC^JMX;TZM5/&@QZ3-"^+DJ@V/XJH@VTYR$+<[$6U0[L#40G!G2:>3F+?J=6W
M19*?U-6A&NM4 3EPP=XU/V:L861!=I=!I4Z7G"WYJU45Y:F8P6RK\AZJD&%>
M;@._YR\O;YUN%J"2L>@#:RVP $QU7UYJD8<H7 5)&S\H$/>S2M7YT18!*Z-0
M.8O_;#Y<#_)_L??647$_R[[H)$!P"^X$"2[!?4(('B"X0P@6(+CK$)+@$B!
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M,B$$-!  NL'50*6W7+1:UB(LYU !RQPWE >+S7< NU/WRZK>@\#SG@!P.%H
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M"C"&M5#9[#8 89%E/(]ZX4KDF$AO=<BNFYC]4]$:5V)P6U^%2['0[0[PR'O
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MPZ0#Q?D9HS$^954>0/+*BZA8Q)<_!$IR^O@#E=<I;1&ER:DUJ3"_<]".I*B
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MO-T*,Q(3?];Y2W]/>&_DMXLISG>WP,A5-5X#]+/^YC+U.%\_NJST^6;\(O<
MTJFSSNUS-MA4JZH! 'VJ[]T"<3Y'V4/8%NJA>U5.<S;SZ]*#U4*_[C@8VL$?
MW^4;?&!%F?KMX4)]@K<;FWK!0R2TR/,Q%MK0>1VBSK$(79(OFS13CR>=N=!P
M:V5?@L%:"T[Q <WLYD!ND[T<GX*S'0TTE))0^IQXUG7%VUI=0MC,6[(*EU3U
M9ON=QG03TZSWNTC!@=5 *P\X[BMK+^L)=5/HZCZQ=O2[$\.)Y8_M3A]OB+?8
M0M-XMPVDG"2>'AE"83/=<"D:[/069,<=:E 2(@&[DQ>40"+$;$$WI[.//&2V
M4!'D<1YB02ZQ!$>&*'*#DYA89>43I(/#^0=DVF;TM28>SM1Y)#,1%Q /OGPN
MDW[%;J?8&*DZ:@-[W]FSJ@/ %>K>1CKG2["5DV%(QXH&W2FZ*-9]C5%^.B""
MXIG-UH?24]< F?@5\M/+N6O HGIAJFC$OGJU].\2,.:6)"KZOXI6YW%EX].]
M@FN_*5)P)/J"J/U0HRJ.PWBJ*N.I_*1=.FCYHZNQ5D%!@6FA>3X3',S%T[JM
M[ CW!&U360;C>.</_N*?<UAZ1=.E'1+ZF>+I C>BJ[HH$TS"E@@5/*Z@80T:
M10WGE )?[#C"E*IYJ 6+>1MN.DSAA(4LPH._/#MEOW%[S*G>L(--^KWR"[H;
MO]Y@CA#%5#\-^4>]!3,5+#QNSW:?$[ \SXCVSQ<MV5SG+Q*2T&+7[\R:Y G?
M\VQ,*1LPNU4NLRX'+Q"S0&J'12/5QVD:^IQL2+;NZB@+X1;?'9#5YDW_#\7X
M:A"HZ8XZ:V?$JC:$3)O9?VFXVA#_> T0*D"L-Y,UT'#F6*?1E88U=A1Z<3(8
MRDL3O@*(AJ5<^K!]CXW_1LJX^GBEV#.>=,WP!C+//.F#KM9G\V-3O]?V\Z1,
M!H 6HHA/)C!?-.* 'PA$ZBE46YE.%#&WX)I5^&N*G=U/<LQAW']OHOLH_,"#
MJY/C*8%@!]Q0UX^B\9,\G2'(_=[MX,D 1,^AX>BRUS0_$,]*,*:<KVQ&>H37
MA:/"%.,!PQD[@&&8W>%261SDB0]?%YUX/(?!!22RH$XA*,[>$?;[][V$;CR8
M;2^E$W?-!?CZ5Q9DF9#51@!U>N5-VGW_0PY3/W)^/LJ#/+;P1V,5[)C$:\"'
M9=CW@LW%D.9CU6O ?@K_*:E(,_[+X"Z0<K[N(/HC@@AU]ILD^5WSP*!CG#'0
M[HS2U:T)=J?T/??#EL4+0NMFQ%XSBM03V%[$HZ#5XAFFG"E6>OL;J;3L3 MT
ME'\3B@-9$\['CK+L&K"EL=__=Y\T=NOB<4XGX]4!Z86<..\'$PRQ;\?XS-\]
M#3&J^"ZN0WY;"/4 =)AN6&IX;Q5X;R<-!WYS%T4L,DTAWPF/1)XS(\DA;B6#
MM^Q]4(W$JYJQ3G@_RL'\V2U WO;Z5>;9U+9CD"Z;9-_BYSP-9<-?GGR>@3)B
M<-W9/@?>3R&,G'M>+!1/:V8C0R4(@Q[!=W@4VY ,55%8+<H' -)=<KD&D.\:
M/;(CDSQ"Q U-U?;[U=4,$CRAIH\0ZMFL75*7CDM#,>A,^NN*EC.TUGT<;WH^
MNX.'5S1P6I8K'G"'SE?C<.:/*[<D<7M4XB?<=5(A1F%C9&>%?H>[IC-R<$6S
M\?)/_DP51;9F)L_X+_X=AR9/Y@X:"857+90?O\B+45FT4"QKVZ(3F8]@HO\0
M>GG.^EXVW3U+>;@NWDS\YU*(AD&^OKO[B4IUWMKBW0\5-"9MU0+G,YJI3EYV
MPDP_JF6<J&X$Q/"&'9!N08^^N(,Q@?O,UP! YC5@!=Q1*:J@MRP3+C']_H>"
MQ'OOLI:]&'JG]5+,4<OFEM=*XRLI9.JRS_MYG<.13E_!-E=7&]"ASP@(6,R2
M1R$X0/,UMY?544DZ'(I\W<!_#7CY>RT^JEP#X'R31[ @AO#44X(G*I+/!BP>
M  @W0_P/NPQ)2T/[$PU+S$Z#5%C1L4\;"KI Q.MP1J*,+7NYA-AXF:C(A8'!
M>8#SK=6YT\.0KZV.YO%L:OY;7H^3,RT%]A)G#)-_M/<W,YZ52&<%;/6*:&8[
M0 B\V5V6(PE74#H2D\ZO&FX?E_BEL-#P]C!&;-*4&V2_KE[8B)I@K7R7$<(F
MSROVS_V3$)"'6&(K+8!,QBVB;L!8D!2_39$6F%HI]$Q5\-&:DSJ&3\*B4LL?
MF8R17P.>/< JAT/O89ZPVW!!=&(W:.^)R37@>X<4P>+W][ZD.U[CO^O],@\:
MWBXM&<4\'<P$"VB62W?J:<CGMN7:.V;9KC+;WCBL7VBLQCSD(H ,-6)E[A()
M!*W@,=D!O:OO4R2FE1UTHO:N5OOG,[RC,J+O .!;G%VM!B8X1*&Q,F*VG>A,
MM%V?*CRKBQ6Q>@ =A2G&#XL.L+Y>S>E35$S!R-A= ^XF!C5O88_=$1X(\S3R
MW^Q1)SPQ2)/K.3+@[>Q'>\XH:)]P,6\[EBPJZMG= B2!MO7"*NRLVE&H$__%
M8%I$4MALF4#<MI3!U)[)T>2G]21+DV$^K81'MW*K2A^_E'YA',%#Z%'T;5D^
MU.,)I)8^SBZ='$:)U%@N4E.=F.WP##N_1[AARM2;G"-\"ZI!(=$.GYJL&,FM
M-8 YC"3RV8&!$M[/&R5HD"$HEVWM&0A/S\G0&RH_9-D^&KPE H>&&MY/8V];
M"><4F+&W>RR!_X'[RQU13]3#M$TR-!7<\Q=8N[#AS?[M7H*,(TY5)846QYQ%
M\L,.L*K8;MI3DJP\044(P_A6(<.J$?Y=_"ZC4=>(UG5YR*+PX+8^<RB&:Z:H
M?@IIX7W.0]#\@45##31WRRS2\#M1D1FE8VR9S.O\5K;]%$C'O*JX?!>/%'&0
M/(OF7/2H/5,R_'8I4FN8]-BV.M.:DF/.?L=2=<?]TSKY>APWR.NJF#<2HHOJ
MK2R,"5-]WB:P+M#[3SV')JNPS+Q;9!-3"SKF7S'Z8\8 -:6E: U(*,X\N,M7
M%-*/@UD G<5[D;H?=ME=?(3,=F%&LF56I=Y#/@V^/.)"?ZYCOO)D/B[VQ_9R
M$_O)T S(9 :$;8N-"<ZK[<VRX?L$TNU7B.741#OL$4@J+!X+U\/4YV#\P:7(
M0"QIW/D=] _*+19=LD/[\]NA#J"H>T4,Z*?&7*M=0PC/W]=&2K>/!M&)/=>
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MP]X;7<QCQ)'IIS#U$<@:D0F6PN#8,T-?<PT(J>9^ZF?U8:Z/XQ>"MC>'^1I
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MCCVMX!@7O[CM8&N2<Q"O/8Z^T*G8TB7@/M"0/6]83/#'ED >:7:=QW?OT;(
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MW+N)O"ZJ,;5KT/K (>+>+1][2> "M1>*P^-7T\KY2F?T+0H>O6>^QC@_[DN
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MBM-5]%L2-<OU:I\P24NSC]WD[I"7HH_0:DV[,=( ='%PR)DSE#OY+DU&6 C
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M-TY$&XO&QHS,,CSR\:#=P/9X1BQ[H%H^?#H@%&"6HZOW,,7C.9O);Q @14+
M_N%_)4OM7Q;V'D2_%(;COQJ9EL&(C0^AQ<F/3KLFUB,Q(I7_D#"X]W\O8?"6
MQ!-\I"?QMF/.-8#&>K.)-L4]2&7W0]LU@%;W'ZY DO_Z"N2_<+O1X_U/;\KT
MFA\2H=\4=15U@Y"[FLQMI5C*F@W8_H#=E\I=[(HZ_/=LP>$,Q^)L?YTMN'
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M#%HC,KX&&.'^3L.E;*- !R-9FA5-!E[@SD(FF3 O4UT<:%*S)GFII?#X(GP
M%'RS?_^K]AKPF?>"]GX3CG!4!KY7S> 6@7G\NHFLA/;<^FD1Y^X*;;I$0?X
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ML7I4TTMN5<DWBN-X<-UTRE==9=Q7@T\L>_<1KA>\Y8"1>\6 9ZGI[OM*RT4
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M;?_P"Z,TT"9HS:?W558HW^?C?[K*M4ZA+0=\1+RR]:?DP[3_PP(]=$6_F@"
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M8Y >Q,5W@&(G<1'>:F_ML4;;3"(GM6QOG[[0L&$%M:'+TKB<WN@J[S@OHP@
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MM*FQ6+Q$+S)JI:4_W?26IIG0D?^_(J06@8E2E5"HD:Z]$YR.AM9Z^YF"*(]
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MO=L;&&,]VVL?:Z;,M#SO KTY8-\X1J(W(Z 8TV8F @#&:HR_4"0 $'R]503
MS2F-Y:$EZ9M\P?K]D8N(1[HRKSOWZS4H6"[43*S^3)FZ&Y)+PFD4:_?7M"7Y
M4T,KP^NK!N04HTQGRTOT/5,0TX8&=_[O:@YW20NI6&RP.J\PL&]E?(MF^4U;
MTTU?@O*[?0MF<ZYSHX56(R5(9M/<Z)'>>35PG"[ZDJW'C:02^M,<Q< (;Z^8
M&T2L%$EA9D@ T'-W+%R'7K[M00"8WY_3P']>!T9*DB!JP*YMWIZ!1Y7E(TL
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M"L'A^WIDSMLIR1+1'@[Q5X93ZI566I"Z&$'\QX4ST:<$ (,BCK>%B,=_,Q,
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M'+_\&.N\Q9X?#AQ+"C4AAXP]%#]L\PW42!IV;:V%RFZ:YB=*)+7\^-B&C,5
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M_,O$4_'G09]KXB<\<_-RL>5/M6-YJYJU]VX/0HA'/BI"\3-C$M5(I:[IV.6
MKE,.B3O:P^$/CFWR$E$WL&.'<$4$[:8HD[K/U:]VXR_5'DWZ-/V*$8+*<W*^
MY>5?' MU-) JDJ#\@_]&!9O@F8>5"=4<V>>B@S4<2QDK-%-WD]$!JNI\1BK'
MPND,]5[=6!4.(:1/[ 9HI+3Z6G$%WFSEM[XC*6)[.GXD_$$0'Y?45Y(<(9'A
MG2T8/G6$E^_E3'G5F5<O!R$5!S\H5/'0:>;[7*@ZR>4O%*'QT%^9W:*'TGGG
M94=1=? <=*WIC.LNH@5#<OE \!J<J:H/G3_ZNBRTZ<M\P:=%E-Y3X[3A(MF[
MT4:/9A2E'71:)I>8I<]TN+K.37?KJ$%S0 /E% Y3=7O<CM:)8&[+RW= ]^Y.
M;W!"(WP5:OS0+3 >EW<>5]MWRM;+N@Z^^C =)S^1E-GE0>0>.YSG-%4>+!7)
M^>J\72J=_C$ RC2467V()5-!+"@UN]?*YL6%T*DH)16LP>L=QF#A1GEA/@+C
M5&Z59M-748%70V'.TL(\S?/E=]V'12VV+)3PZ.L7Y,2.#^<P(LE@M]HPMXC=
M&=L1_1Z_];KT^R>+$D8YZQ2J4)_K3ZQL'KTPSEZ"LKEMRS1J8[W9T,E[LM8_
M(C;-D(-C^_&!L^4O[E_W6[D#D _Y@AI@H)(=Z:3S58<0,?3'2-&M\8_(+-"3
M%NU:.:4I50R\5Q-5JQ5A^-K78XR$>(Y"6\@J_QN+/]*><,[OO%@^(E!.%_HH
MP!*O+QN1$9]NW^M;J!6\:O[F3$BS-5_]V/E 830A9W(RCW#3['FOM*FOY.>;
M,[$4*:(UZN.?>4H"3]5.^+W*]U\&B ZYLVWG&1AW'%%HF4T]TY9,=NFNQC0;
MKBK7(=4R'[D;X-.XTKB$F[M?WLW= T;YW-PC*Q91UX6]$,*QU=7%E>=C_TRI
M?$^U&I>;+L2XK\NW[3Z#[HEZ6]!%V># B*]NAXK04S+0K(_0D_)RT.>DLR*&
M46\OK:2=8CW#4T=W+!4G$#G#-!G$$7"CI&<%5N#YMEG<I:.T^=G*W20=)"Y\
M':2EY>COKMN;W.[)M-*>O>*A+SXZ?'>8G'+T>3H<_2:2"R;1XIHD38C(]'%K
M-/,__2:_U-:\L)6+I1"R=FTEL@+KL])APUDIQY>B%VXP.)]TW*64Y!8W=>;V
MP_7UV\2+)^Y14FK7:VPGZN'S<=MKS?%G$4YV9VWEJZ./EM=G!':F^TO9F^P-
M+%N':4>O96^,1XKI:1*Z^3=#+CIYVDN"[F1S0;_6!?^^F.:A+[S6S4EZ?:(I
M0)MD _<!U^C[X4Q+\D?Q@G8+\@I3J*L,98KZWBR9%R.OJLF&>S!N+"94O7(+
M=BR,$$*PGT_O3VI1-BJI+^X[M_$H?Z(2N8?[PA-TOU!>:3J"L2FN@[]_4[<S
M/+WD&%A5H8*7L?)3OL<[+U7KZ%LK[^,_C^J<P:W$O3F\X9RY04L;K1BA.6(S
MCBZ3FJ_C+("BRQ%Y<O*?; D:KKM/0-,6.HY@--[H\^3\*&]%ZQN]UV7/O!C[
M-I"Z[KTR1/#0V&DY8Z>\:=8FIL/3-[KUC]'M&O8K_!#TO+88M$Y;1?=-!5,*
M9/^F"V)JDD_>/=_Y*.L7#',/%PZ)]*JZ'.V0_*@2\K-S"UH4;_1BW!2UO#T;
M_5ER/3),B3Q-/N0Q6="#%A:M>F\\\DB\H+J_-LJLN8J4L$*9'2DK=#T!(1_>
M2UBL 4V.7SQE5'VC%DZ436K:&T<ZM..0H9&9Y\;',D2Z2,]AL]E4 #1O$0?<
M 0"Z3P>J)=X\[X47I&]0ZB4[V@MB\O26#(@K%-B,*)N.A<[:WY2@_P[Q0"/E
MY>92'0:>2V=1 36=$9@_;NUN9UCI[A5A<D=EGLV4/H1X?(=]*8V!_OAA^>..
M'?+FD]89:IAM]7?24%G0[@-8TZY13DBS2II"J&7\UBZ8P?I9(C?*-+D7MD$%
M)'O.) EGG? Y;W+.M=+$CU77*-;'J'DMI7/;/[C3^NPN7(^+@J.9Z2VNU(K0
M"Z']TZZQ-M?HC< "S$(GBH>3%^\5%K3<7/*L@BBS&4D,_:,WFO[GZ*[82Y(I
MN^7M7IMV2)S]ZTTJ\ !BJ6?:G2K4,_NB\T5S$T@["8:;M>3V>6_.T;/\X)L0
M+/!<$@\5\/ W='D6(._Y;NWG;HR;3TB[%,E!6"L50.N7,#,%>A&4P+IL<R:N
MC4@\VJRPJ+PW=[JT+/R\FC@CNG('K55K;&6_Q^V?=.%$Z&U/EUQ#@M&6R\W'
M!YX   O FVV74N.^\+_O4O3_)]';&.GF)L>&'>8[\S-X</B8;V8/K78?-:YL
M.X@2)$)<E"Q2-3U,6*/Z+HLW&'+1&ZE 6(5.5/V8^7QO$@$7*5_H%,)U(AYV
M\Q_7K-+@D,_T4,RAL&,-,30_GK:]+A(E\[4HB=D7@Z@Y,^3KOZ)P= AL(='V
MDF2T:Z@2.B7<P130'-#N=<W'&!?8FHQ6*0-S9NV9RM&2J!?35H6QCR6W.9'P
M3!*([X==[@J?:=% WK.!HH"FM<_COJ *2FFJQ1\I4RO\V9MWWMNR"_[+YN-?
M_\%E?$VRZY$2-=H[N2>G75VS3B)3 =O0M&&4&-<0BV3(KI'CA)G],BU3'AYI
M.G_RO(S/K&YNID PZ%P5M]#(&OM)*<V+E3]/?_C0]?-MRA1%P,=!F]5'2\GQ
M2!RQHV;!0,4$CA?<X7OO?8:I&R<&;PTC\=L^Z'Y6:35_U^_MZ?R@$%K919<?
MB<CW;O^J6GR71+Y91%)-;9T"@2SMW8X?:E;6C]DQ=LO$W6-VT%&7<] S,K1-
M#.#'I7\.21NU=+C:<6BK+_2 S-DX*9D9B&';#J?"4K==RONTF=6V9VSG4H(K
MT& 2M!P?<,35Y9R9P^-L_5AX^QG*T@0ME2O39J@VO:BB=6GAYR9]Q8"R?L4S
M!,:KFLQMI7>?J:=(*K7NG"Z8EJ'W7-13QR-;XE_,#)L9JYY=Z#*KEI[YIKIH
ML:?LN')_RU5\^X2IBG-K9YDB"(]"EM)7#YRO"&.!]K@<SV+2@GF]M\4</)@I
MM5+'B]M"AEWQV1RF/R<EESB\IC;/9;WZ&'K6M$3_>VI<XM%,%7&,%WM#P'6"
M.P2!SS+^\LK!-6/\C=4%WA#6[]<7@D(6Q[KUN&2J4]4;-$U5.P?&SA*>3MP3
MR0R>S$NU+KR4?/FS:\/0]'N/B:O7=C+;\"$MF(DF>Q<;MC2>T_Y>#\&$AU:M
M/;5$1.]0"W;*:OE"B9Z7(JR'=&1JG,?AW)Y9W-30"8;%-;8UONZ3R 4Y3(5=
ME53DTW2E3'N\[^,_Y-X7@Y=;*Z62E6]CK_EQZZ5R.O9EYO"UI8Z?NVCKZ'O@
M8WCTK:1#OF(-HR<->^55 R\EIX\-J0R\,U@5'1/7VIHXP2BUW*<;OL)1':G?
MEY;^0_AKT!F2V*FP0)>F!=TU\H.RY^+G%0853@_78] Y.K<D7;V5LK4D?T(-
MQ4.?SPVG$^)5^[H_'3@]*#)#5_CYO,P$%2B!08)L/U,X\4%14SFH$XO2IXPT
M)#E.#(/&;M9&O?*\ W U\+@CMJN$8C5N+1Y?V%"-+?ZDW;+&R>9X]M"'2@&Z
MT&+?)WO'IC?73)/H<)=*/_I$BIT@/-?D;CV3>*B5V#;#D]TP0]<PWT77JNV0
MDMW?TVW(?\=;RZV6%O%SM9[DK@1=NX";RV13Z^0;NO41<=GXM0S@+96J?%C3
MW'A=+,3T:G;Z.+8CR[X\#H%7.3YRO3OLS/OI,P]KO1!"F9=LW>R;HN6ST('6
MCMDFFC;^![2=+J]$2_.P4ORWT2 ,Y;3/R\8$U#8J+*VB\JGQFZ$?*,6S"]?W
MFLJY.A\+CPEF,D6>/JG[VL&E<D*<9(X/>Y]D,',U!KJ3[_3V]+INZN;''>XU
M),DK^/OA?.XA@X;((3&A"[P[U[ *+UH"F97M5^Z7ZDANG_"[5@V&X:C 9$D0
M.VQ%>-=P6M]&*%FRZ+C?4ZPV>D)!^X..LLW%:W+%/C=NF H@ NYU;05JMY05
M&]L;85Q%$6=]1,>4F>?47%_)KD-EMS7X'Q24&]*+O[A![\9R2%OYFM;BI>;&
MA/#WU4FGI\B,QI6$&DR!O?3Z4.#'_AK"2F+J)[5U;[I(<?=-M%L*@E_Q0?R]
M4"F&<7=0BR)'+\DDK306N^+9?D,6F7!A"YS:YTUZCC<I$>,)D*V/-I<?D:JV
MEC3-CN-BO%&K-K$1J1H$\B-R(QYG36<L)+S6']VV?0IKG,6;JH@.#6MO^)S^
M!JI!92P'Q=ZUMY GO/1".9TZ,&@IMWJJ+>R2;.BGMH;E(W-UH2DY0^FX9F1.
MV^+%JY'^C6#6(ES0:R?1Q(R$F]S^89R7I9WEZ'X8*2FSQSA5%Z=(Z!C>L###
M"WPRXMYYX?%NZ;!Q7OM+_]8;E%P6)913)=>VSECM+81KS,NJ"VEL_6_92VNN
M>A4,FWWF"V-C_1R2DL5Y<)T65M.*@PGHR;>E5(!9U=66/F;L1UN=S/2AM]T%
MG(!L$AL5^.28C L+KCN-:XE[%WKR',/[["^7P69;T[B\KT*5XV(7F1+TW+'_
MVE&"@?$E2=1Q:I1%X\B72*N-X<[P-RC,@A_KXAH"K^,XC0K#%.45:95]U[*X
MLG$O?KQ"+W0MK+4T\*2R/5.DT' J]VO]\<M>MD]1X4$B;X[ZK#SB<*E^7>XV
M0S[*2M27U0ZN,9BN?> @.UD1-OKNQ,C(I8$A:.A)Y.Q3RQLZ!BO1!(/GQ&H8
M3[YA[[+H9JWBV.<>"=[:FOLRF"XZ(LH/:4*KUL')5,"B![9P(;]?U)9RW0].
M]E>G A\2VIP]%%@G+(_5*%A/!2H9]+ITO1GJ=),E+XS(3L(KVD@=YJB;>$S3
MR[@8C3C[9>-5L4=)#YPHQ.->[[U;N_J1P9!U22QD:P:V*87VS$?$\CS$*"$B
MV&7MESL/PL(M1)D&,GH:;!>KE]=JP+72UIL?R\9X\>7-YLK.GB=ES>89IA8#
M*KI@!>]MDR&"2WV1I9M2[.!!L5!C#';5DB<_7/NHCT53H]_-'X,'O@799UAM
MW*)D=OFQC+^5\] QN3I<+7M"W826):O]UM-#TUNM._&'D&"[) \@5)><-63O
ME>?J??ES2(9?X>;!2K0$'H18+2T3_WR,XQZ>4[Z^&K)H+A,@LE1[Q?P[ST/%
M)&[9I4LMX^P^E:4GMJ\>,^Q-_2)SF0H$4P'9[[AQN #F4L.]MH?PG6@_*E"D
M0 5B-2=11S7S;@F\OV(HY.L<2HXG.?8YK227E*N)3AM/W0@UX&%:0S\/XU;\
M&DD%,%.^QG?Y[SIIY]Y7!+^L)]$YK4R5EJN=B;!&2)0:^-'IZBC[K(P;!IY0
M%SZ3@A#\NTZG,A#5TRCK7[;HF77+^UJ A1>R>_VY"D;>*FM=NFQT&Y_G<K.Z
M:[4F^_/",/GNAX!\:/)V?GSCV.7U8&.'HH"0YZN<Y/&'VSOY8Y3&8=T2?[.L
MYBBH\P01J61A,@4Z.KK@QB5N4RQP5)Q7X5T7IO!6J?Q=A43SSD1T6-Z3[)4L
M1W ]+J"FTXS^<I@N+6&+W"R=!8/Q3@/A[<>&\T7JY]_*9^YE$HTR%HFQ&=F/
M!(K?/E#"\.H367]@4,\;O[_$.,^C0UI[FM'>JC]*?RLG]/H]<D0=-1,:*8<2
MQG3"](:[0GX@3=?-+2<"*/YU$1^59\&&<@4W+/R<[[CO&A7K&'%'1WYV3S]"
M4L,MB3TE%G]+H0(&16&7YH!UZ9F;F&P?ZX8AU6<K ;6*Q[XWG1AI^Q8=I #7
M8F $UPR0V69U=;L1;%:,'C^#3<?/OJX,5>>CBF3#5.@O%WPYLRT5,BEVQ(2@
M\G5NJ$?EE?;CGCBK+Y:3%C43KDFDA(6?9W(=:9%^_+.'_/R53D;CQ22Q/I+R
M:8Z$K>NLL5-\I <\&Q5/_%P[\SP\=#3+=DX@(AO4ON:G&Q](NQ<L<RX.H20_
MWCS.N)EGX7MIL_+[.[G9!/%W4P\50_A<)EM+7=<#6/% @'*6?7A=[OI%4AGW
M#D+8P-11XXT&LY;6MKR_.@',X1ECU!_R^? %X0=\WEDC?D$&V 2+&*N4'^EQ
M[QQY2ZO<6!GUL-JZ/EC?G!+]KVYQLXVOS^(^9/PFXQ6L$#-( G^J(5'Z3N*J
MAR-J>=[Y]K'T*8&Z:U\IJ5U&0N/T =?YSTHQB[<F<=8\F5XL)F)J=$P_]IK?
MY@_+&%WVY7B)4Q',4/?,T_Y^W3=X\%;8='62'Q'TN59/NS=W,T=P>5DTM;P\
MW,HZXK%BW?S(ND,'^^7WZ96/TP\'" IWEM:'08;!4HI\E!_K[E<NDU'+PW53
M69]7IO/'M;86KNB&O_<2>AS>G\;.W)]7NY4;5WXGK>M6M<6U4T)-(_I]^J]]
M R"'(;<Q*IDI/I%F!WG>32HYS;%!1@5\1N3<9#T[/"WX<8:)4^V'I_O%Q:SO
M\H]6/;+9;A 07E;?YLOSZ#.HBG;>D=3_$*-NUWFLF@#).]]L@HT[J4Q>+/\,
M.W-Z%Z,ZZ1)2EF ^XUW5\=52X[2SAL==Y:26XO9 &7 E^DY*]L [PTK6)CVM
M;5IN7B3]Y^%\IU%A*#L\EH#:LW2^I LK#GP']>9Q'E_!L(_K*.O%^,=PJDB7
MW\G59B5HJ^$UL^!ZY2,+AR,?R#U *L*)/$B'X91H)X>P'H=O>.&UIT,(-2HP
M2*S-S4:]OLNGXKH6,3[?DUQ*@.36/+%P*&.]X"L.?S6]<)/FL'9DA2U=)$$?
M>Y?=QMAQ#"\FH>.FS;UC41U]A$LR#4<'52W>;[1)]74K/QAV7AZBQ545QO
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M94NDL1YO:[-$% 4)%W1O,6L6VMJ?3\V8$$_%:K/W+XZSS#BALT:?\4[#8ZA
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M+3(P,C(Q,C,Q+FAT;5!+ 0(4 Q0    ( +*!=U:M2<$FCQ8  #(  0 /
M          "  <I^! !E<2TR,#(R,3(S,2YX<V102P$"% ,4    " "R@7=6
M(%SROAP3  #@%@$ $P              @ &&E00 97$M,C R,C$R,S%?8V%L
M+GAM;%!+ 0(4 Q0    ( +*!=U9[H^G)ES,  *VC P 3              "
M =.H! !E<2TR,#(R,3(S,5]D968N>&UL4$L! A0#%     @ LH%W5ND_PK+@
MO@  /(P( !,              ( !F]P$ &5Q+3(P,C(Q,C,Q7VQA8BYX;6Q0
M2P$"% ,4    " "R@7=6D \.WHQ1   A&P8 $P              @ &LFP4
M97$M,C R,C$R,S%?<')E+GAM;%!+ 0(4 Q0    ( +*!=U;>%[N:90H  '9B
M   .              "  6GM!0!E<2UE>#$P7S(Y+FAT;5!+ 0(4 Q0    (
M +*!=U9.YN"7:EH! .SH#P .              "  ?KW!0!E<2UE>#$P7S,Q
M+FAT;5!+ 0(4 Q0    ( +*!=U;M@Q;[,@,  .8G   -              "
M 9!2!P!E<2UE>#(Q7S$N:'1M4$L! A0#%     @ LH%W5NKOC&>N @  \0X
M  T              ( ![54' &5Q+65X,C-?,2YH=&U02P$"% ,4    " "R
M@7=6P5C,XD0(   X00  #0              @ '&6 < 97$M97@S,5\Q+FAT
M;5!+ 0(4 Q0    ( +*!=U;WQS=K1P@  #]!   -              "  35A
M!P!E<2UE>#,Q7S(N:'1M4$L! A0#%     @ LH%W5M'5@RK&!0  4BX   T
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M9S(V.#(R-# V,E\Q,2YJ<&=02P$"% ,4    " "R@7=6J34;"'9F P"^U@4
M$P              @ &:(AT :6UG,C8X,C(T,#8R7S$R+FIP9U!+ 0(4 Q0
M   ( +*!=U:>3A',:BH# ,TK!0 3              "  4&)( !I;6<R-C@R
M,C0P-C)?,3,N:G!G4$L! A0#%     @ LH%W5OJ_%LX6" 8 ;T(( !,
M         ( !W+,C &EM9S(V.#(R-# V,E\Q-"YJ<&=02P$"% ,4    " "R
M@7=69OXHVW>+ @!KK0, $@              @ $CO"D :6UG,C8X,C(T,#8R
M7S(N:G!G4$L! A0#%     @ LH%W5M]\&]7?' $ !&H! !(
M ( !RD<L &EM9S(V.#(R-# V,E\S+FIP9U!+ 0(4 Q0    ( +*!=U:'3KIM
MVRD!  -S 0 2              "  =ED+0!I;6<R-C@R,C0P-C)?-"YJ<&=0
M2P$"% ,4    " "R@7=6HA9>-E?5  !I*@$ $@              @ 'DCBX
M:6UG,C8X,C(T,#8R7S4N:G!G4$L! A0#%     @ LH%W5M4C L<\50$ !'X!
M !(              ( !:V0O &EM9S(V.#(R-# V,E\V+FIP9U!+ 0(4 Q0
M   ( +*!=U9X6\<JX5(! ,=Y 0 2              "  =>Y, !I;6<R-C@R
M,C0P-C)?-RYJ<&=02P$"% ,4    " "R@7=6&_J Y?Q!!0#IMP< $@
M        @ 'H##( :6UG,C8X,C(T,#8R7S@N:G!G4$L! A0#%     @ LH%W
M5LB212_,YP4 O'4' !(              ( !%$\W &EM9S(V.#(R-# V,E\Y
:+FIP9U!+!08     '  < .(&   0-ST    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
